PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Gratten, J; Wray, NR; Peyrot, WJ; McGrath, JJ; Visscher, PM; Goddard, ME				Gratten, Jacob; Wray, Naomi R.; Peyrot, Wouter J.; McGrath, John J.; Visscher, Peter M.; Goddard, Michael E.			Risk of psychiatric illness from advanced paternal age is not predominantly from de novo mutations	NATURE GENETICS			English	Article							BIPOLAR DISORDER; FAMILIAL RISK; AUTISM; SCHIZOPHRENIA; RATES; DETERMINANTS; ARCHITECTURE; VARIANTS; PATTERNS; REVEAL	The offspring of older fathers have higher risk of psychiatric disorders such as schizophrenia and autism. Paternal-agerelated de novo mutations are widely assumed to be the underlying causal mechanism, and, although such mutations must logically make some contribution, there are alternative explanations (for example, elevated liability to psychiatric illness may delay fatherhood). We used population genetic models based on empirical observations of key parameters (for example, mutation rate, prevalence, and heritability) to assess the genetic relationship between paternal age and risk of psychiatric illness. These models suggest that age-related mutations are unlikely to explain much of the increased risk of psychiatric disorders in children of older fathers. Conversely, a model incorporating a weak correlation between age at first child and liability to psychiatric illness matched epidemiological observations. Our results suggest that genetic risk factors shared by older fathers and their offspring are a credible alternative explanation to de novo mutations for risk to children of older fathers.	[Gratten, Jacob; Wray, Naomi R.; McGrath, John J.; Visscher, Peter M.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia; [Peyrot, Wouter J.] Vrije Univ Amsterdam Med Ctr, Dept Psychiat, Amsterdam, Netherlands; [McGrath, John J.] Queensland Ctr Mental Hlth Res, Pk Ctr Mental Hlth, Wacol, Qld, Australia; [Visscher, Peter M.] Univ Queensland, Diamantina Inst, Princess Alexandra Hosp, Brisbane, Qld, Australia; [Goddard, Michael E.] Dept Primary Ind, Biosci Res Div, Melbourne, Vic, Australia; [Goddard, Michael E.] Univ Melbourne, Dept Agr & Food Syst, Melbourne, Vic, Australia	University of Queensland; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Queensland Centre for Mental Health Research; University of Queensland; University of Melbourne	Gratten, J (corresponding author), Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia.	j.gratten1@uq.edu.au	McGrath, John Joseph/G-5493-2010; Wray, Naomi/C-8639-2015; Gratten, Jacob/G-1485-2011; Visscher, Peter/ABB-6151-2020	McGrath, John Joseph/0000-0002-4792-6068; Wray, Naomi/0000-0001-7421-3357; Gratten, Jacob/0000-0003-1293-409X; Visscher, Peter/0000-0002-2143-8760; Peyrot, Wouter/0000-0001-7954-8383; Goddard, Michael/0000-0001-9917-7946	Australian National Health and Medical Research Council (NHMRC) [1087889, 1067795, 1103418]; Australian Research Council [DP130100563]; NHMRC [1078901, 1078037]; John Cade Fellowship from NHMRC [1056929]	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); John Cade Fellowship from NHMRC	This work was supported by Australian National Health and Medical Research Council (NHMRC) grants to N.R.W. and J.G. (1087889) and to J.G. and P.M.V. (1067795 and 1103418) and by Australian Research Council grant DP130100563 to M.E.G. N.R.W. is supported by an NHMRC Principal Research Fellowship (1078901), P.M.V. is supported by an NHMRC Senior Principal Research Fellowship (1078037), and J.J.M. is supported by grant 1056929 from the John Cade Fellowship from the NHMRC.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Collins FS, 2015, NEW ENGL J MED, V372, P793, DOI 10.1056/NEJMp1500523; Crow JF, 1997, P NATL ACAD SCI USA, V94, P8380, DOI 10.1073/pnas.94.16.8380; Crow JF, 2000, NAT REV GENET, V1, P40, DOI 10.1038/35049558; Day FR, 2016, NAT GENET, V48, P617, DOI 10.1038/ng.3551; FALCONER DS, 1965, ANN HUM GENET, V29, P51, DOI 10.1111/j.1469-1809.1965.tb00500.x; Frans EM, 2013, JAMA PSYCHIAT, V70, P516, DOI 10.1001/jamapsychiatry.2013.1180; Fromer M, 2014, NATURE, V506, P179, DOI 10.1038/nature12929; Gaugler T, 2014, NAT GENET, V46, P881, DOI 10.1038/ng.3039; Goriely A, 2013, AM J PSYCHIAT, V170, P599, DOI 10.1176/appi.ajp.2013.12101352; Goriely A, 2009, NAT GENET, V41, P1247, DOI 10.1038/ng.470; Gratten J, 2013, NAT GENET, V45, P234, DOI 10.1038/ng.2555; Grether JK, 2009, AM J EPIDEMIOL, V170, P1118, DOI 10.1093/aje/kwp247; HALDANE JBS, 1947, ANN EUGENIC, V13, P262; Hultman CM, 2011, MOL PSYCHIATR, V16, P1203, DOI 10.1038/mp.2010.121; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; Keightley PD, 2012, GENETICS, V190, P295, DOI 10.1534/genetics.111.134668; Klei L, 2012, MOL AUTISM, V3, DOI 10.1186/2040-2392-3-9; Kong A, 2012, NATURE, V488, P471, DOI 10.1038/nature11396; Lauritsen MB, 2005, J CHILD PSYCHOL PSYC, V46, P963, DOI 10.1111/j.1469-7610.2004.00391.x; Lee SH, 2012, NAT GENET, V44, P247, DOI 10.1038/ng.1108; Leitsalu L, 2015, INT J EPIDEMIOL, V44, P1137, DOI 10.1093/ije/dyt268; Levinson DF, 2011, AM J PSYCHIAT, V168, P302, DOI 10.1176/appi.ajp.2010.10060876; Lichtenstein P, 2009, LANCET, V373, P234, DOI 10.1016/S0140-6736(09)60072-6; Lichtenstein P, 2010, AM J PSYCHIAT, V167, P1357, DOI 10.1176/appi.ajp.2010.10020223; MacArthur JAL, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004195; Malaspina D, 2001, ARCH GEN PSYCHIAT, V58, P361, DOI 10.1001/archpsyc.58.4.361; Malaspina Dolores, 2002, CNS Spectr, V7, P26; McGrath JJ, 2014, JAMA PSYCHIAT, V71, P301, DOI 10.1001/jamapsychiatry.2013.4081; Mehta D, 2016, JAMA PSYCHIAT, V73, P497, DOI 10.1001/jamapsychiatry.2016.0129; Michaelson JJ, 2012, CELL, V151, P1431, DOI 10.1016/j.cell.2012.11.019; Miller B, 2011, SCHIZOPHRENIA BULL, V37, P1039, DOI 10.1093/schbul/sbq011; Moloney DM, 1996, NAT GENET, V13, P48, DOI 10.1038/ng0596-48; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Pedersen CB, 2014, MOL PSYCHIATR, V19, P530, DOI 10.1038/mp.2013.69; Petersen L, 2011, AM J PSYCHIAT, V168, P82, DOI 10.1176/appi.ajp.2010.10020252; Power RA, 2015, NAT NEUROSCI, V18, P953, DOI 10.1038/nn.4040; Power RA, 2013, JAMA PSYCHIAT, V70, P22, DOI 10.1001/jamapsychiatry.2013.268; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Rahbari R, 2016, NAT GENET, V48, P126, DOI 10.1038/ng.3469; REICH T, 1972, ANN HUM GENET, V36, P163, DOI 10.1111/j.1469-1809.1972.tb00767.x; Ronald A, 2011, AM J MED GENET B, V156B, P255, DOI 10.1002/ajmg.b.31159; Sanders SJ, 2015, NEURON, V87, P1215, DOI 10.1016/j.neuron.2015.09.016; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Sandin S, 2014, JAMA-J AM MED ASSOC, V311, P1770, DOI 10.1001/jama.2014.4144; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Sullivan PF, 2003, ARCH GEN PSYCHIAT, V60, P1187, DOI 10.1001/archpsyc.60.12.1187; Uher R, 2009, MOL PSYCHIATR, V14, P1072, DOI 10.1038/mp.2009.85; VOGEL F, 1975, ADV HUM GENET, V5, P223; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Weinberg W, 1912, ARCH RASSEN U GESELL, V9, P710; Wood AR, 2014, NAT GENET, V46, P1173, DOI 10.1038/ng.3097	53	69	71	1	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2016	48	7					718	+		10.1038/ng.3577	http://dx.doi.org/10.1038/ng.3577			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DP9TK	27213288				2022-12-25	WOS:000378840100008
J	Iorizzo, M; Ellison, S; Senalik, D; Zeng, P; Satapoomin, P; Huang, JY; Bowman, M; Iovene, M; Sanseverino, W; Cavagnaro, P; Yildiz, M; Macko-Podgorni, A; Moranska, E; Grzebelus, E; Grzebelus, D; Ashrafi, H; Zheng, ZJ; Cheng, SF; Spooner, D; Van Deynze, A; Simon, P				Iorizzo, Massimo; Ellison, Shelby; Senalik, Douglas; Zeng, Peng; Satapoomin, Pimchanok; Huang, Jiaying; Bowman, Megan; Iovene, Marina; Sanseverino, Walter; Cavagnaro, Pablo; Yildiz, Mehtap; Macko-Podgorni, Alicja; Moranska, Emilia; Grzebelus, Ewa; Grzebelus, Dariusz; Ashrafi, Hamid; Zheng, Zhijun; Cheng, Shifeng; Spooner, David; Van Deynze, Allen; Simon, Philipp			A high-quality carrot genome assembly provides new insights into carotenoid accumulation and asterid genome evolution	NATURE GENETICS			English	Article							DAUCUS-CAROTA; 1-DEOXY-D-XYLULOSE-5-PHOSPHATE SYNTHASE; FLOWERING TIME; GENE; SEQUENCE; BIOSYNTHESIS; ALIGNMENT; EXPRESSION; ROOT; PREDICTION	We report a high-quality chromosome-scale assembly and analysis of the carrot (Daucus carota) genome, the first sequenced genome to include a comparative evolutionary analysis among members of the euasterid II clade. We characterized two new polyploidization events, both occurring after the divergence of carrot from members of the Asterales order, clarifying the evolutionary scenario before and after radiation of the two main asterid clades. Large-and small-scale lineage-specific duplications have contributed to the expansion of gene families, including those with roles in flowering time, defense response, flavor, and pigment accumulation. We identified a candidate gene, DCAR_032551, that conditions carotenoid accumulation (Y) in carrot taproot and is coexpressed with several isoprenoid biosynthetic genes. The primary mechanism regulating carotenoid accumulation in carrot taproot is not at the biosynthetic level. We hypothesize that DCAR_032551 regulates upstream photosystem development and functional processes, including photomorphogenesis and root de-etiolation.	[Iorizzo, Massimo; Ellison, Shelby; Senalik, Douglas; Satapoomin, Pimchanok; Spooner, David; Simon, Philipp] Univ Wisconsin, Dept Hort, 1575 Linden Dr, Madison, WI 53706 USA; [Senalik, Douglas; Spooner, David; Simon, Philipp] USDA ARS, Vegetable Crops Res Unit, Madison, WI USA; [Zeng, Peng; Huang, Jiaying; Zheng, Zhijun; Cheng, Shifeng] Beijing Genom Inst Shenzhen, Shenzhen, Peoples R China; [Bowman, Megan] Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA; [Iovene, Marina] CNR, Inst Biosci & Bioresources, Bari, Italy; [Sanseverino, Walter] Sequentia Biotech, Barcelona, Spain; [Cavagnaro, Pablo] Univ Nacl Cuyo, Fac Ciencias Agr, Natl Sci & Tech Res Council CONICET, Cuyo, Argentina; [Cavagnaro, Pablo] Inst Nacl Tecnol Agr, Estn Expt Agr Consulta, La Consulta, Argentina; [Yildiz, Mehtap] Yuzuncu Yil Univ, Fac Agr, Dept Agr Biotechnol, Van, Turkey; [Macko-Podgorni, Alicja; Moranska, Emilia; Grzebelus, Ewa; Grzebelus, Dariusz] Agr Univ Krakow, Inst Plant Biol & Biotechnol, Krakow, Poland; [Ashrafi, Hamid; Van Deynze, Allen] Univ Calif Davis, Seed Biotechnol Ctr, Davis, CA 95616 USA; [Iorizzo, Massimo; Ashrafi, Hamid] N Carolina State Univ, Dept Hort Sci, Plants Human Hlth Inst, Kannapolis, NC USA; [Ashrafi, Hamid] N Carolina State Univ, Dept Hort Sci, Raleigh, NC 27695 USA	University of Wisconsin System; University of Wisconsin Madison; United States Department of Agriculture (USDA); Beijing Genomics Institute (BGI); Michigan State University; Consiglio Nazionale delle Ricerche (CNR); Istituto di Bioscienze e Biorisorse (IBBR-CNR); Centro Nacional Patagonico (CENPAT); University Nacional Cuyo Mendoza; Instituto Nacional de Tecnologia Agropecuaria (INTA); Yuzuncu Yil University; Agricultural University Krakow; University of California System; University of California Davis; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University	Simon, P (corresponding author), Univ Wisconsin, Dept Hort, 1575 Linden Dr, Madison, WI 53706 USA.; Simon, P (corresponding author), USDA ARS, Vegetable Crops Res Unit, Madison, WI USA.	philipp.simon@ars.usda.gov	Cavagnaro, Pablo/E-6091-2019; Grzebelus, Ewa/AAX-5337-2021; Iorizzo, Massimo/AAJ-3952-2020; Yildiz, Mehtap/ABU-1488-2022; Grzebelus, E./AAE-8271-2019; Sanseverino, Walter/AAX-5254-2021; Grzebelus, Dariusz/I-8832-2014; Iovene, Marina/J-5593-2015	Cavagnaro, Pablo/0000-0001-5838-0876; Grzebelus, E./0000-0003-2067-585X; Sanseverino, Walter/0000-0003-3324-5912; Grzebelus, Dariusz/0000-0001-6999-913X; Iorizzo, Massimo/0000-0002-0032-8247; Zeng, Peng/0000-0002-5460-2256; Senalik, Douglas/0000-0001-8526-0554; Simon, Philipp/0000-0001-6978-6062; Ashrafi, Hamid/0000-0002-2094-2367; Macko-Podgorni, Alicja/0000-0003-2416-2808; Iovene, Marina/0000-0002-5992-8677; Bowman, Megan/0000-0001-5742-1779	carrot industry; Bejo; Carosem; Monsanto; Nunhems; |Sumika; Takii; Vilmorin; National Science Foundation [1202666]; projects RGV-FAO [D.M.3824]; Polish National Science Center [2012/05/B/NZ9/03401]; Polish Ministry of Science and Higher Education to Faculty of Biotechnology and Horticulture, University of Agriculture in Krakow;  [PONa3_00025-BIOforIU]; ARS [ARS-0425034] Funding Source: Federal RePORTER	carrot industry; Bejo; Carosem; Monsanto; Nunhems; |Sumika; Takii; Vilmorin; National Science Foundation(National Science Foundation (NSF)); projects RGV-FAO; Polish National Science Center; Polish Ministry of Science and Higher Education to Faculty of Biotechnology and Horticulture, University of Agriculture in Krakow; ; ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	The authors appreciate the financial support of the carrot industry and the following vegetable seed companies-Bejo, Carosem, Monsanto, Nunhems, Rijk Zwaan (RZ), Sumika, Takii, and Vilmorin-with additional thanks to RZ for providing DH1, BAC libraries, and BES. S.E. was supported by the National Science Foundation under grant 1202666. M. Iovene thanks the projects RGV-FAO (D.M.3824) for partial financial support and PONa3_00025-BIOforIU for funding the acquisition of a fluorescence microscope. A.M.-P., E.M., E.G., and D.G. were supported by the Polish National Science Center, project 2012/05/B/NZ9/03401, and the statutory funds for science granted by the Polish Ministry of Science and Higher Education to the Faculty of Biotechnology and Horticulture, University of Agriculture in Krakow. The authors thank H. Ruess for assembly and annotation of the plastid genome and R. Kane for support in the development of plant materials.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arbizu C, 2014, AM J BOT, V101, P2005, DOI 10.3732/ajb.1400252; Argout X, 2011, NAT GENET, V43, P101, DOI 10.1038/ng.736; Arscott SA, 2010, COMPR REV FOOD SCI F, V9, P223, DOI 10.1111/j.1541-4337.2009.00103.x; Arumuganathan K., 1991, PLANT MOL BIOL REP, V9, P208, DOI [10.1007/BF02672069, DOI 10.1007/BF02672069]; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; BLAND JM, 1995, BRIT MED J, V310, P170, DOI 10.1136/bmj.310.6973.170; Bowman M. J., 2012, THESIS U WISCONSIN M; Bowman MJ, 2014, J AM SOC HORTIC SCI, V139, P63, DOI 10.21273/JASHS.139.1.63; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Bremer B., 2009, TIMETREE LIFE, P177; Broman KW, 2009, STAT BIOL HEALTH, P1, DOI 10.1007/978-0-387-92125-9_1; BUISHAND JG, 1979, EUPHYTICA, V28, P611, DOI 10.1007/BF00038928; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Campbell MA, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-327; Cavagnaro PF, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1118; Chain PSG, 2009, SCIENCE, V326, P236, DOI 10.1126/science.1180614; Clotault J, 2008, J EXP BOT, V59, P3563, DOI 10.1093/jxb/ern210; Cordoba E, 2011, J EXP BOT, V62, P2023, DOI 10.1093/jxb/erq393; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; Dai XB, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-321; Darzentas N, 2010, BIOINFORMATICS, V26, P2620, DOI 10.1093/bioinformatics/btq484; Dong F, 2000, THEOR APPL GENET, V101, P1001, DOI 10.1007/s001220051573; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Elsik CG, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r13; Estevez JM, 2001, J BIOL CHEM, V276, P22901, DOI 10.1074/jbc.M100854200; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fuentes P, 2012, PLANT MOL BIOL, V79, P47, DOI 10.1007/s11103-012-9893-2; Gambin T, 2013, EVOL BIOINFORM, V9, P17, DOI 10.4137/EBO.S10619; Glaubitz JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090346; Grzebelus D, 2006, MOL GENET GENOMICS, V275, P450, DOI 10.1007/s00438-006-0102-3; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Huang SX, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3640; Huang X, 2014, CURR OPIN PLANT BIOL, V21, P96, DOI 10.1016/j.pbi.2014.07.003; Ichikawa T, 2006, PLANT J, V48, P974, DOI 10.1111/j.1365-313X.2006.02924.x; Iorizzo M, 2013, AM J BOT, V100, P930, DOI 10.3732/ajb.1300055; Iorizzo M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-389; Iovene M, 2008, AM J BOT, V95, P793, DOI 10.3732/ajb.0700007; Iovene M, 2011, CHROMOSOME RES, V19, P493, DOI 10.1007/s10577-011-9202-y; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Jiao YN, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-1-r3; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Just BJ, 2007, THEOR APPL GENET, V114, P693, DOI 10.1007/s00122-006-0469-x; Just BJ, 2009, THEOR APPL GENET, V119, P1155, DOI 10.1007/s00122-009-1117-z; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Kim BR, 2005, BIOTECHNOL LETT, V27, P997, DOI 10.1007/s10529-005-7849-1; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim Seungill, 2014, Nat Genet, V46, P270, DOI 10.1038/ng.2877; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lamesch P, 2012, NUCLEIC ACIDS RES, V40, pD1202, DOI 10.1093/nar/gkr1090; Lang D, 2010, GENOME BIOL EVOL, V2, P488, DOI 10.1093/gbe/evq032; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lau OS, 2012, TRENDS PLANT SCI, V17, P584, DOI 10.1016/j.tplants.2012.05.004; Leigh JW, 2015, METHODS ECOL EVOL, V6, P1110, DOI 10.1111/2041-210X.12410; Levy YY, 2002, SCIENCE, V297, P243, DOI 10.1126/science.1072147; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Lois LM, 2000, PLANT J, V22, P503, DOI 10.1046/j.1365-313x.2000.00764.x; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; Macko-Podgorni A, 2013, GENETICA, V141, P255, DOI 10.1007/s10709-013-9725-6; Majoros WH, 2004, BIOINFORMATICS, V20, P2878, DOI 10.1093/bioinformatics/bth315; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mi HY, 2013, NUCLEIC ACIDS RES, V41, pD377, DOI 10.1093/nar/gks1118; Miga KH, 2014, GENOME RES, V24, P697, DOI 10.1101/gr.159624.113; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Nakamichi N, 2007, PLANT CELL PHYSIOL, V48, P822, DOI 10.1093/pcp/pcm056; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; Noh B, 2004, PLANT CELL, V16, P2601, DOI 10.1105/tpc.104.025353; Novak P, 2013, BIOINFORMATICS, V29, P792, DOI 10.1093/bioinformatics/btt054; Novak P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-378; Palaisa K, 2004, P NATL ACAD SCI USA, V101, P9885, DOI 10.1073/pnas.0307839101; Parra G, 2007, BIOINFORMATICS, V23, P1061, DOI 10.1093/bioinformatics/btm071; Paterson AH, 2004, P NATL ACAD SCI USA, V101, P9903, DOI 10.1073/pnas.0307901101; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Peng YH, 2014, PLANT PHYSIOL, V166, P1241, DOI 10.1104/pp.114.247668; Pritchard JK, 2000, GENETICS, V155, P945; Prufer K, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-41; Rodriguez-Concepcion M, 2013, ARCH BIOCHEM BIOPHYS, V539, P110, DOI 10.1016/j.abb.2013.07.009; Rong J, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-895; Rubatzky V.E., 1999, CARROTS RELATED VEGE; Ruiz-Sola M Aguila, 2012, Arabidopsis Book, V10, pe0158, DOI 10.1199/tab.0158; Saladie M, 2014, J EXP BOT, V65, P5077, DOI 10.1093/jxb/eru275; Salse J, 2009, P NATL ACAD SCI USA, V106, P14908, DOI 10.1073/pnas.0902350106; Sanseverino W, 2013, NUCLEIC ACIDS RES, V41, pD1167, DOI 10.1093/nar/gks1183; Santiago N, 2002, MOL BIOL EVOL, V19, P2285, DOI 10.1093/oxfordjournals.molbev.a004052; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Scaglione D, 2016, SCI REP-UK, V6, DOI 10.1038/srep19427; Schmieder R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017288; Sherwin JC, 2012, T ROY SOC TROP MED H, V106, P205, DOI 10.1016/j.trstmh.2012.01.004; Simon P. W., 2000, Plant Breeding Reviews, V19, P157; Simon Philipp W., 2008, P327, DOI 10.1007/978-0-387-74110-9_8; SIMON PW, 1987, J AGR FOOD CHEM, V35, P1017, DOI 10.1021/jf00078a038; Simon PW, 2000, THEOR APPL GENET, V100, P735, DOI 10.1007/s001220051346; SIMON PW, 1989, HORTSCIENCE, V24, P174; Simon PW., 2009, PLANT BREED REV, V31, P325, DOI DOI 10.1002/9780470593783.CH7; Spalik K, 2010, J BIOGEOGR, V37, P1977, DOI 10.1111/j.1365-2699.2010.02334.x; Stanke M, 2006, NUCLEIC ACIDS RES, V34, pW435, DOI 10.1093/nar/gkl200; STEWARD FC, 1958, AM J BOT, V45, P709, DOI 10.2307/2439729; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Truco MJ, 2013, G3-GENES GENOM GENET, V3, P617, DOI 10.1534/g3.112.004929; Van Ooijen J. W., 2006, JOINMAP 4 SOFTWARE C; Vanneste K, 2014, GENOME RES, V24, P1334, DOI 10.1101/gr.168997.113; Vogel G, 2005, SCIENCE, V309, P86, DOI 10.1126/science.309.5731.86; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Walter MH, 2002, PLANT J, V31, P243, DOI 10.1046/j.1365-313X.2002.01352.x; Wang H, 2014, MOL BREEDING, V34, P2065, DOI [10.1007/s11032-014-0025-3, 10.1007/s11032-014-0163-7]; Wang RL, 1999, NATURE, V398, P236, DOI 10.1038/18435; Wang YP, 2012, NUCLEIC ACIDS RES, V40, DOI [10.1093/nar/gkr1293, 10.1093/nar/gkr1132]; Wei N, 1996, PLANT PHYSIOL, V112, P871, DOI 10.1104/pp.112.3.871; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; WELCH JE, 1947, SCIENCE, V106, P594, DOI 10.1126/science.106.2763.594; Wicker T, 2007, NAT REV GENET, V8, P973, DOI 10.1038/nrg2165; Xu X, 2011, NATURE, V475, P189, DOI 10.1038/nature10158; Xu Z, 2007, NUCLEIC ACIDS RES, V35, pW265, DOI 10.1093/nar/gkm286; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zagorodskikh P., 1939, CR DOKLADY ACAD SCI, V25, P522; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zhang GY, 2012, NAT BIOTECHNOL, V30, P549, DOI 10.1038/nbt.2195	128	282	293	8	114	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2016	48	6					657	+		10.1038/ng.3565	http://dx.doi.org/10.1038/ng.3565			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DN0HE	27158781	Green Published, hybrid			2022-12-25	WOS:000376744200014
J	Welte, T; Kim, IS; Tian, L; Gao, X; Wang, H; Li, JN; Holdman, XB; Herschkowitz, JI; Pond, A; Xie, GR; Kurley, S; Nguyen, T; Liao, L; Dobrolecki, LE; Pang, L; Mo, QX; Edwards, DP; Huang, SX; Xin, L; Xu, JM; Li, Y; Lewis, MT; Wang, T; Westbrook, TF; Rosen, JM; Zhang, XHF				Welte, Thomas; Kim, Ik Sun; Tian, Lin; Gao, Xia; Wang, Hai; Li, June; Holdman, Xue B.; Herschkowitz, Jason I.; Pond, Adam; Xie, Guorui; Kurley, Sarah; Tuan Nguyen; Liao, Lan; Dobrolecki, Lacey E.; Pang, Lan; Mo, Qianxing; Edwards, Dean P.; Huang, Shixia; Xin, Li; Xu, Jianming; Li, Yi; Lewis, Michael T.; Wang, Tian; Westbrook, Thomas F.; Rosen, Jeffrey M.; Zhang, Xiang H. -F.			Oncogenic mTOR signalling recruits myeloid-derived suppressor cells to promote tumour initiation	NATURE CELL BIOLOGY			English	Article							GENE-EXPRESSION; STEM-CELL; T-CELLS; BONE METASTASIS; CANCER-CELLS; MOUSE MODEL; B-CELL; BREAST; INFLAMMATION; GROWTH	Myeloid-derived suppressor cells (MDSCs) play critical roles in primary and metastatic cancer progression. MDSC regulation is widely variable even among patients harbouring the same type of malignancy, and the mechanisms governing such heterogeneity are largely unknown. Here, integrating human tumour genomics and syngeneic mammary tumour models, we demonstrate that mTOR signalling in cancer cells dictates a mammary tumour's ability to stimulate MDSC accumulation through regulating G-CSF. Inhibiting this pathway or its activators (for example, FGFR) impairs tumour progression, which is partially rescued by restoring MDSCs or G-CSF. Tumour-initiating cells (TICs) exhibit elevated G-CSF. MDSCs reciprocally increase TIC frequency through activating Notch in tumour cells, forming a feedforward loop. Analyses of primary breast cancers and patient-derived xenografts corroborate these mechanisms in patients. These findings establish a non-canonical oncogenic role of mTOR signalling in recruiting pro-tumorigenic MDSCs and show how defined cancer subsets may evolve to promote and depend on a distinct immune microenvironment.	[Welte, Thomas; Kim, Ik Sun; Tian, Lin; Gao, Xia; Wang, Hai; Li, June; Herschkowitz, Jason I.; Pond, Adam; Dobrolecki, Lacey E.; Li, Yi; Lewis, Michael T.; Zhang, Xiang H. -F.] Baylor Coll Med, Lester & Sue Smith Breast Ctr, One Baylor Plaza, Houston, TX 77030 USA; [Welte, Thomas; Kim, Ik Sun; Tian, Lin; Gao, Xia; Wang, Hai; Li, June; Holdman, Xue B.; Herschkowitz, Jason I.; Pond, Adam; Dobrolecki, Lacey E.; Mo, Qianxing; Edwards, Dean P.; Huang, Shixia; Xin, Li; Xu, Jianming; Li, Yi; Lewis, Michael T.; Rosen, Jeffrey M.; Zhang, Xiang H. -F.] Baylor Coll Med, Dan L Duncan Canc Ctr, One Baylor Plaza, Houston, TX 77030 USA; [Welte, Thomas; Kim, Ik Sun; Tian, Lin; Gao, Xia; Wang, Hai; Li, June; Holdman, Xue B.; Herschkowitz, Jason I.; Pond, Adam; Kurley, Sarah; Tuan Nguyen; Liao, Lan; Dobrolecki, Lacey E.; Edwards, Dean P.; Huang, Shixia; Xin, Li; Xu, Jianming; Li, Yi; Lewis, Michael T.; Rosen, Jeffrey M.; Zhang, Xiang H. -F.] Baylor Coll Med, Dept Mol & Cellular Biol, One Baylor Plaza, Houston, TX 77030 USA; [Welte, Thomas] Diana Helis Henry Med Res Fdn, New Orleans, LA 70130 USA; [Kim, Ik Sun] Baylor Coll Med, Grad Program Integrat Mol & Biomed Sci, One Baylor Plaza, Houston, TX 77030 USA; [Tian, Lin; Westbrook, Thomas F.] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, One Baylor Plaza, Houston, TX 77030 USA; [Xie, Guorui; Liao, Lan; Wang, Tian] Univ Texas Med Branch, Dept Microbiol & Immunol, 301 Univ Blvd, Galveston, TX 77555 USA; [Mo, Qianxing; Edwards, Dean P.] Baylor Coll Med, Dept Pathol & Immunol, One Baylor Plaza, Houston, TX 77030 USA; [Westbrook, Thomas F.] Baylor Coll Med, Dept Mol & Human Genet, One Baylor Plaza, Houston, TX 77030 USA; [Zhang, Xiang H. -F.] Baylor Coll Med, McNair Med Inst, One Baylor Plaza, Houston, TX 77030 USA; [Herschkowitz, Jason I.] SUNY Albany, Canc Res Ctr, 1400 Washington Ave, Albany, NY 12222 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of Texas System; University of Texas Medical Branch Galveston; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Zhang, XHF (corresponding author), Baylor Coll Med, Lester & Sue Smith Breast Ctr, One Baylor Plaza, Houston, TX 77030 USA.; Rosen, JM; Zhang, XHF (corresponding author), Baylor Coll Med, Dan L Duncan Canc Ctr, One Baylor Plaza, Houston, TX 77030 USA.; Rosen, JM; Zhang, XHF (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, One Baylor Plaza, Houston, TX 77030 USA.; Zhang, XHF (corresponding author), Baylor Coll Med, McNair Med Inst, One Baylor Plaza, Houston, TX 77030 USA.	jrosen@bcm.edu; xiangz@bcm.edu	Nguyen, Tony Minh/AAH-1121-2019; Lewis, Michael T/A-9572-2009; Li, Yi/A-7635-2009	Nguyen, Tony Minh/0000-0003-4879-3962; Kurley, Sarah/0000-0002-4127-1443; Li, Yi/0000-0002-9976-518X; Xie, Guorui/0000-0002-2414-1241; Tian, Lin/0000-0003-3661-4453; Zhang, Xiang/0000-0002-5674-8670	Cancer Center Support grant [NCI P30CA125123]; NCI [CA183878]; Breast Cancer Research Foundation; US Department of Defense DAMD [W81XWH-13-1-0195, W81XWH-13-1-0296]; Susan G. Komen [CCR14298445]; McNair Medical Institute; Helis Foundation; NIH [CA148761, CA16303]; Cancer Prevention and Research Institute of Texas (CPRIT) [RP120092]; NATIONAL CANCER INSTITUTE [R01CA016303, R01CA183878, R01CA148761, T32CA174647, R01CA193455, R37CA016303, R00CA151293, P30CA125123] Funding Source: NIH RePORTER	Cancer Center Support grant; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Breast Cancer Research Foundation; US Department of Defense DAMD(United States Department of Defense); Susan G. Komen(Susan G. Komen Breast Cancer Foundation); McNair Medical Institute; Helis Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention and Research Institute of Texas (CPRIT); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We would like to thank Novartis for providing BGE398, and H. C. Lo and D. Weiss for helpful input. We also thank the Antibody-Based Proteomics Shared Resource of the Dan L. Duncan Cancer Center supported by Cancer Center Support grant NCI P30CA125123, and A. Welm, Huntsman Cancer Institute, USA for generously providing some of the PDX models. X.H.-F.Z. is supported by NCI CA183878, the Breast Cancer Research Foundation, US Department of Defense DAMD W81XWH-13-1-0195, Susan G. Komen CCR14298445, and McNair Medical Institute. T.Welte is supported by the Helis Foundation. H.W. is supported by US Department of Defense DAMD W81XWH-13-1-0296. Studies with the p53-null tumours were supported by NIH grant CA148761 to J.M.R. and with the WNT1 iFGER tumours by NIH grant CA16303 to J.M.R. RRPA experiments were supported by Cancer Prevention and Research Institute of Texas (CPRIT) Core Facilities Support Award RP120092 to D.P.E. The authors acknowledge the joint participation by Diana Helis Henry Medical Research Foundation through its direct engagement in the continuous active conduct of medical research in conjunction with Baylor College of Medicine.	Acharyya S, 2012, CELL, V150, P165, DOI 10.1016/j.cell.2012.04.042; Almand B, 2001, J IMMUNOL, V166, P678, DOI 10.4049/jimmunol.166.1.678; Baselga J, 2012, NEW ENGL J MED, V366, P520, DOI 10.1056/NEJMoa1109653; Blokzijl A, 2003, J CELL BIOL, V163, P723, DOI 10.1083/jcb.200305112; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Bronte V, 2003, J IMMUNOL, V170, P270, DOI 10.4049/jimmunol.170.1.270; Bunt SK, 2006, J IMMUNOL, V176, P284, DOI 10.4049/jimmunol.176.1.284; Bunt SK, 2007, CANCER RES, V67, P10019, DOI 10.1158/0008-5472.CAN-07-2354; Bunt SK, 2009, J LEUKOCYTE BIOL, V85, P996, DOI 10.1189/jlb.0708446; Buzzeo MP, 2007, EXP HEMATOL, V35, P1456, DOI 10.1016/j.exphem.2007.06.001; Cao Y, 2014, CANCER RES, V74, P5091, DOI 10.1158/0008-5472.CAN-13-3171; Chang CH, 2015, STEM CELL REP, V5, P378, DOI 10.1016/j.stemcr.2015.07.009; Chi H, 2012, NAT REV IMMUNOL, V12, P325, DOI 10.1038/nri3198; Coffelt SB, 2015, NATURE, V522, P345, DOI 10.1038/nature14282; Cui TX, 2013, IMMUNITY, V39, P611, DOI 10.1016/j.immuni.2013.08.025; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; DeRose YS, 2011, NAT MED, V17, P1514, DOI 10.1038/nm.2454; Dey JH, 2010, CANCER RES, V70, P4151, DOI 10.1158/0008-5472.CAN-09-4479; Diaz-Montero CM, 2009, CANCER IMMUNOL IMMUN, V58, P49, DOI 10.1007/s00262-008-0523-4; Donkor MK, 2009, INT IMMUNOPHARMACOL, V9, P937, DOI 10.1016/j.intimp.2009.03.021; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Du R, 2008, CANCER CELL, V13, P206, DOI 10.1016/j.ccr.2008.01.034; Dumitru CA, 2012, CANCER IMMUNOL IMMUN, V61, P1155, DOI 10.1007/s00262-012-1294-5; Gabrilovich D, 1998, BLOOD, V92, P4150, DOI 10.1182/blood.V92.11.4150.423k45_4150_4166; Gabrilovich DI, 2012, NAT REV IMMUNOL, V12, P253, DOI 10.1038/nri3175; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Gallina G, 2006, J CLIN INVEST, V116, P2777, DOI 10.1172/JCI28828; Gentles AJ, 2015, NAT MED, V21, P938, DOI 10.1038/nm.3909; Granot Z, 2011, CANCER CELL, V20, P300, DOI 10.1016/j.ccr.2011.08.012; Herschkowitz JI, 2012, P NATL ACAD SCI USA, V109, P2778, DOI 10.1073/pnas.1018862108; Hoeflich KP, 2009, CLIN CANCER RES, V15, P4649, DOI 10.1158/1078-0432.CCR-09-0317; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Iglesia MD, 2014, CLIN CANCER RES, V20, P3818, DOI 10.1158/1078-0432.CCR-13-3368; Kim K, 2014, P NATL ACAD SCI USA, V111, P11774, DOI 10.1073/pnas.1410626111; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kowanetz M, 2010, P NATL ACAD SCI USA, V107, P21248, DOI 10.1073/pnas.1015855107; Li HJ, 2010, BLOOD, V116, P1060, DOI 10.1182/blood-2009-11-255075; Lu HH, 2014, NAT CELL BIOL, V16, P1105, DOI 10.1038/ncb3041; Marvel D, 2015, J CLIN INVEST, V125, P3356, DOI 10.1172/JCI80005; Movahedi K, 2008, BLOOD, V111, P4233, DOI 10.1182/blood-2007-07-099226; Nagalla S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r34; Oskarsson T, 2011, NAT MED, V17, P867, DOI 10.1038/nm.2379; Pond AC, 2010, CANCER RES, V70, P4868, DOI 10.1158/0008-5472.CAN-09-4404; Psaila B, 2009, NAT REV CANCER, V9, P285, DOI 10.1038/nrc2621; Sato T, 2010, ONCOGENE, V29, P2746, DOI 10.1038/onc.2010.28; Serafini P, 2004, CANCER RES, V64, P6337, DOI 10.1158/0008-5472.CAN-04-0757; Shipitsin M, 2007, CANCER CELL, V11, P259, DOI 10.1016/j.ccr.2007.01.013; Shojaei F, 2009, P NATL ACAD SCI USA, V106, P6742, DOI 10.1073/pnas.0902280106; Sinha P, 2007, CANCER RES, V67, P4507, DOI 10.1158/0008-5472.CAN-06-4174; Solito S, 2014, ANN NY ACAD SCI, V1319, P47, DOI 10.1111/nyas.12469; Song XP, 2005, J IMMUNOL, V175, P8200, DOI 10.4049/jimmunol.175.12.8200; STROBER S, 1984, ANNU REV IMMUNOL, V2, P219, DOI 10.1146/annurev.iy.02.040184.001251; Valdez JM, 2012, CELL STEM CELL, V11, P676, DOI 10.1016/j.stem.2012.07.003; Waight JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027690; Wang BT, 2011, P NATL ACAD SCI USA, V108, P15201, DOI 10.1073/pnas.1103746108; Wei G, 2006, CANCER CELL, V10, P331, DOI 10.1016/j.ccr.2006.09.006; Welm BE, 2002, J CELL BIOL, V157, P703, DOI 10.1083/jcb.200107119; Yang L, 2004, CANCER CELL, V6, P409, DOI 10.1016/j.ccr.2004.08.031; Yang L, 2008, CANCER CELL, V13, P23, DOI 10.1016/j.ccr.2007.12.004; Yu XB, 2008, CELL STEM CELL, V2, P461, DOI 10.1016/j.stem.2008.03.001; Zhang XHF, 2013, CELL, V154, P1060, DOI 10.1016/j.cell.2013.07.036; Zhang XHF, 2009, CANCER CELL, V16, P67, DOI 10.1016/j.ccr.2009.05.017; Zhang XM, 2013, CANCER RES, V73, P4885, DOI 10.1158/0008-5472.CAN-12-4081	63	133	136	2	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUN	2016	18	6					632	+		10.1038/ncb3355	http://dx.doi.org/10.1038/ncb3355			26	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	DN0JL	27183469	Green Accepted			2022-12-25	WOS:000376750100009
J	Becker, R				Becker, Rachel			Beyond building proteins: tRNA synthetases outside of translation	NATURE MEDICINE			English	News Item																		Fang PF, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7402; Fox PL, 2015, RNA, V21, P615, DOI 10.1261/rna.050187.115; Froelich CA, 2011, BIOCHEMISTRY-US, V50, P7132, DOI 10.1021/bi200989h; He WW, 2015, NATURE, V526, P710, DOI 10.1038/nature15510; Jordanova A, 2006, NAT GENET, V38, P197, DOI 10.1038/ng1727; Kim D, 2014, TOP CURR CHEM, V344, P207, DOI 10.1007/128_2013_455; Kleeman TA, 1997, J BIOL CHEM, V272, P14420, DOI 10.1074/jbc.272.22.14420; Mirando AC, 2015, SCI REP-UK, V5, DOI 10.1038/srep13160; Park MC, 2012, P NATL ACAD SCI USA, V109, pE640, DOI 10.1073/pnas.1200194109; Wakasugi K, 1999, SCIENCE, V284, P147, DOI 10.1126/science.284.5411.147; Wellman TL, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-620; Williams TF, 2013, SCI REP-UK, V3, DOI 10.1038/srep01317; Yao P, 2013, EMBO MOL MED, V5, P332, DOI 10.1002/emmm.201100626; Zhou JJ, 2014, J BIOL CHEM, V289, P19269, DOI 10.1074/jbc.C114.571026	14	1	1	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2016	22	5					452	453		10.1038/nm0516-452	http://dx.doi.org/10.1038/nm0516-452			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DL3DI	27149213				2022-12-25	WOS:000375514000003
J	Li, XY; Xiong, XS; Wang, K; Wang, LX; Shu, XT; Ma, SQ; Yi, CQ				Li, Xiaoyu; Xiong, Xushen; Wang, Kun; Wang, Lixia; Shu, Xiaoting; Ma, Shiqing; Yi, Chengqi			Transcriptome-wide mapping reveals reversible and dynamic N-1-methyladenosine methylome	NATURE CHEMICAL BIOLOGY			English	Article							MESSENGER-RNA METHYLATION; RIBOSOMAL-RNA; NUCLEAR-RNA; OXIDATIVE DEMETHYLATION; MODIFIED NUCLEOTIDES; ALKYLATION DAMAGE; BASE MODIFICATION; METHYLTRANSFERASE; N-6-METHYLADENOSINE; N6-METHYLADENOSINE	N-1-Methyladenosine (m(1)A) is a prevalent post-transcriptional RNA modification, yet little is known about its abundance, topology and dynamics in mRNA. Here, we show that m(1)A is prevalent in Homo sapiens mRNA, which shows an m(1)A/A ratio of -0.02%. We develop the m(1)A-ID-seq technique, based on m(1)A immunoprecipitation and the inherent ability of m(1)A to stall reverse transcription, as a means for transcriptome-wide m(1)A profiling. m(1)A-ID-seq identifies 901 m(1)A peaks (from 600 genes) in mRNA and noncoding RNA and reveals a prominent feature, enrichment in the 5' untranslated region of mRNA transcripts, that is distinct from the pattern for N-6-methyladenosine, the most abundant internal mammalian mRNA modification. Moreover, m(1)A in mRNA is reversible by ALKBH3, a known DNA/RNA demethylase. Lastly, we show that m(1)A methylation responds dynamically to stimuli, and we identify hundreds of stress-induced m(1)A sites. Collectively, our approaches allow comprehensive analysis of m(1)A modification and provide tools for functional studies of potential epigenetic regulation via the reversible and dynamic m(1)A methylation.	[Li, Xiaoyu; Xiong, Xushen; Wang, Kun; Wang, Lixia; Shu, Xiaoting; Ma, Shiqing; Yi, Chengqi] Peking Univ, Sch Life Sci, State Key Lab Prot & Plant Gene Res, Beijing 100871, Peoples R China; [Li, Xiaoyu; Xiong, Xushen; Wang, Kun; Wang, Lixia; Shu, Xiaoting; Ma, Shiqing; Yi, Chengqi] Peking Univ, Peking Tsinghua Ctr Life Sci, Beijing 100871, Peoples R China; [Xiong, Xushen; Shu, Xiaoting; Ma, Shiqing] Peking Univ, Acad Adv Interdisciplinary Studies, Beijing 100871, Peoples R China; [Yi, Chengqi] Peking Univ, Coll Chem & Mol Engn, Dept Biol Chem, Synthet & Funct Biomol Ctr, Beijing 100871, Peoples R China	Peking University; Peking University; Peking University; Peking University	Yi, CQ (corresponding author), Peking Univ, Sch Life Sci, State Key Lab Prot & Plant Gene Res, Beijing 100871, Peoples R China.; Yi, CQ (corresponding author), Peking Univ, Peking Tsinghua Ctr Life Sci, Beijing 100871, Peoples R China.; Yi, CQ (corresponding author), Peking Univ, Coll Chem & Mol Engn, Dept Biol Chem, Synthet & Funct Biomol Ctr, Beijing 100871, Peoples R China.	chengqi.yi@pku.edu.cn		Yi, Chengqi/0000-0003-2540-9729	National Basic Research Foundation of China [2014CB964900]; National Natural Science Foundation of China [21472009, 21522201]	National Basic Research Foundation of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors would like to thank G. Jia and C. Zhang for assistance with recombinant ALKBH3 protein. This work was supported by the National Basic Research Foundation of China (no. 2014CB964900) and the National Natural Science Foundation of China (nos. 21472009 and 21522201).	Aas PA, 2003, NATURE, V421, P859, DOI 10.1038/nature01363; Alarcon CR, 2015, CELL, V162, P1299, DOI 10.1016/j.cell.2015.08.011; Araujo PR, 2012, COMP FUNCT GENOM, DOI 10.1155/2012/475731; BALLESTA JPG, 1991, J BACTERIOL, V173, P7213, DOI 10.1128/jb.173.22.7213-7218.1991; Behm-Ansmant I, 2011, J NUCLEIC ACIDS, V2011, DOI 10.4061/2011/408053; Chan CTY, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001247; Chujo T, 2012, RNA, V18, P2269, DOI 10.1261/rna.035600.112; Cozen AE, 2015, NAT METHODS, V12, P879, DOI [10.1038/NMETH.3508, 10.1038/nmeth.3508]; Dango S, 2011, MOL CELL, V44, P373, DOI 10.1016/j.molcel.2011.08.039; Dominissini D, 2016, NATURE, V530, P441, DOI 10.1038/nature16998; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; Duncan T, 2002, P NATL ACAD SCI USA, V99, P16660, DOI 10.1073/pnas.262589799; Falnes PO, 2002, NATURE, V419, P178, DOI 10.1038/nature01048; Hauenschild R, 2015, NUCLEIC ACIDS RES, V43, P9950, DOI 10.1093/nar/gkv895; Helm M, 1998, NUCLEIC ACIDS RES, V26, P1636, DOI 10.1093/nar/26.7.1636; Helm M, 2014, CHEM BIOL, V21, P174, DOI 10.1016/j.chembiol.2013.10.015; Hodgkinson A, 2014, SCIENCE, V344, P413, DOI 10.1126/science.1251110; Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]; Juhling F, 2009, NUCLEIC ACIDS RES, V37, pD159, DOI 10.1093/nar/gkn772; Ke SD, 2015, GENE DEV, V29, P2037, DOI 10.1101/gad.269415.115; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Li XY, 2015, NAT CHEM BIOL, V11, P592, DOI [10.1038/NCHEMBIO.1836, 10.1038/nchembio.1836]; Linder B, 2015, NAT METHODS, V12, P767, DOI [10.1038/nmeth.3453, 10.1038/NMETH.3453]; Liu JZ, 2014, NAT CHEM BIOL, V10, P93, DOI 10.1038/nchembio.1432; Liu N, 2015, NATURE, V518, P560, DOI 10.1038/nature14234; Machnicka MA, 2013, NUCLEIC ACIDS RES, V41, pD262, DOI 10.1093/nar/gks1007; MACON JB, 1968, BIOCHEMISTRY-US, V7, P3453, DOI 10.1021/bi00850a021; Maden B E, 1990, Prog Nucleic Acid Res Mol Biol, V39, P241, DOI 10.1016/S0079-6603(08)60629-7; Meyer KD, 2015, CELL, V163, P999, DOI 10.1016/j.cell.2015.10.012; Meyer KD, 2012, CELL, V149, P1635, DOI 10.1016/j.cell.2012.05.003; Motorin Y, 2007, METHOD ENZYMOL, V425, P21; Ougland R, 2004, MOL CELL, V16, P107, DOI 10.1016/j.molcel.2004.09.002; Ozanick S, 2005, RNA, V11, P1281, DOI 10.1261/rna.5040605; Peifer C, 2013, NUCLEIC ACIDS RES, V41, P1151, DOI 10.1093/nar/gks1102; Ping XL, 2014, CELL RES, V24, P177, DOI 10.1038/cr.2014.3; Roost C, 2015, J AM CHEM SOC, V137, P2107, DOI 10.1021/ja513080v; Saikia M, 2010, RNA, V16, P1317, DOI 10.1261/rna.2057810; SCHEVITZ RW, 1979, NATURE, V278, P188, DOI 10.1038/278188a0; Schwartz S, 2014, CELL REP, V8, P284, DOI 10.1016/j.celrep.2014.05.048; Sharma S, 2013, NUCLEIC ACIDS RES, V41, P5428, DOI 10.1093/nar/gkt195; SRIVASTAVA R, 1987, BIOCHEM INT, V15, P1179; Suzuki T, 2011, ANNU REV GENET, V45, P299, DOI 10.1146/annurev-genet-110410-132531; Trewick SC, 2002, NATURE, V419, P174, DOI 10.1038/nature00908; Wang X, 2015, CELL, V161, P1388, DOI 10.1016/j.cell.2015.05.014; Wang X, 2014, NATURE, V505, P117, DOI 10.1038/nature12730; Zheng GQ, 2015, NAT METHODS, V12, P835, DOI [10.1038/NMETH.3478, 10.1038/nmeth.3478]; Zheng GQ, 2013, MOL CELL, V49, P18, DOI 10.1016/j.molcel.2012.10.015; Zhou J, 2015, NATURE, V526, P591, DOI 10.1038/nature15377; Zhu CX, 2014, ANGEW CHEM INT EDIT, V53, P3659, DOI 10.1002/anie.201310050	49	334	351	6	133	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAY	2016	12	5					311	+		10.1038/NCHEMBIO.2040	http://dx.doi.org/10.1038/NCHEMBIO.2040			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DJ6KY	26863410				2022-12-25	WOS:000374322800004
J	Braasch, I; Gehrke, AR; Smith, JJ; Kawasaki, K; Manousaki, T; Pasquier, J; Amores, A; Desvignes, T; Batzel, P; Catchen, J; Berlin, AM; Campbell, MS; Barrell, D; Martin, KJ; Mulley, JF; Ravi, V; Lee, AP; Nakamura, T; Chalopin, D; Fan, S; Wcisel, D; Canestro, C; Sydes, J; Beaudry, FEG; Sun, Y; Hertel, J; Beam, MJ; Fasold, M; Ishiyama, M; Johnson, J; Kehr, S; Lara, M; Letaw, JH; Litman, GW; Litman, RT; Mikami, M; Ota, T; Saha, NR; Williams, L; Stadler, PF; Wang, H; Taylor, JS; Fontenot, Q; Ferrara, A; Searle, SMJ; Aken, B; Yandell, M; Schneider, I; Yoder, JA; Volff, JN; Meyer, A; Amemiya, CT; Venkatesh, B; Holland, PWH; Guiguen, Y; Bobe, J; Shubin, NH; Di Palma, F; Alfoldi, J; Lindblad-Toh, K; Postlethwait, JH				Braasch, Ingo; Gehrke, Andrew R.; Smith, Jeramiah J.; Kawasaki, Kazuhiko; Manousaki, Tereza; Pasquier, Jeremy; Amores, Angel; Desvignes, Thomas; Batzel, Peter; Catchen, Julian; Berlin, Aaron M.; Campbell, Michael S.; Barrell, Daniel; Martin, Kyle J.; Mulley, John F.; Ravi, Vydianathan; Lee, Alison P.; Nakamura, Tetsuya; Chalopin, Domitille; Fan, Shaohua; Wcisel, Dustin; Canestro, Cristian; Sydes, Jason; Beaudry, Felix E. G.; Sun, Yi; Hertel, Jana; Beam, Michael J.; Fasold, Mario; Ishiyama, Mikio; Johnson, Jeremy; Kehr, Steffi; Lara, Marcia; Letaw, John H.; Litman, Gary W.; Litman, Ronda T.; Mikami, Masato; Ota, Tatsuya; Saha, Nil Ratan; Williams, Louise; Stadler, Peter F.; Wang, Han; Taylor, John S.; Fontenot, Quenton; Ferrara, Allyse; Searle, Stephen M. J.; Aken, Bronwen; Yandell, Mark; Schneider, Igor; Yoder, Jeffrey A.; Volff, Jean-Nicolas; Meyer, Axel; Amemiya, Chris T.; Venkatesh, Byrappa; Holland, Peter W. H.; Guiguen, Yann; Bobe, Julien; Shubin, Neil H.; Di Palma, Federica; Alfoeldi, Jessica; Lindblad-Toh, Kerstin; Postlethwait, John H.			The spotted gar genome illuminates vertebrate evolution and facilitates human-teleost comparisons	NATURE GENETICS			English	Article							RAY-FINNED FISH; MHC CLASS-I; COMPLEX-CLASS-I; COMPREHENSIVE ANALYSIS; PROVIDES INSIGHTS; GENE DUPLICATION; HOX GENES; 2 ROUNDS; ZEBRAFISH; COELACANTH	To connect human biology to fish biomedical models, we sequenced the genome of spotted gar (Lepisosteus oculatus), whose lineage diverged from teleosts before teleost genome duplication (TGD). The slowly evolving gar genome has conserved in content and size many entire chromosomes from bony vertebrate ancestors. Gar bridges teleosts to tetrapods by illuminating the evolution of immunity, mineralization and development (mediated, for example, by Hox, ParaHox and microRNA genes). Numerous conserved noncoding elements (CNEs; often cis regulatory) undetectable in direct human-teleost comparisons become apparent using gar: functional studies uncovered conserved roles for such cryptic CNEs, facilitating annotation of sequences identified in human genome-wide association studies. Transcriptomic analyses showed that the sums of expression domains and expression levels for duplicated teleost genes often approximate the patterns and levels of expression for gar genes, consistent with subfunctionalization. The gar genome provides a resource for understanding evolution after genome duplication, the origin of vertebrate genomes and the function of human regulatory sequences.	[Braasch, Ingo; Amores, Angel; Desvignes, Thomas; Batzel, Peter; Sydes, Jason; Beam, Michael J.; Letaw, John H.; Postlethwait, John H.] Univ Oregon, Inst Neurosci, Eugene, OR 97403 USA; [Gehrke, Andrew R.; Nakamura, Tetsuya; Shubin, Neil H.] Univ Chicago, Dept Organismal Biol & Anat, 1025 E 57Th St, Chicago, IL 60637 USA; [Smith, Jeramiah J.] Univ Kentucky, Dept Biol, Lexington, KY USA; [Kawasaki, Kazuhiko] Penn State Univ, Dept Anthropol, University Pk, PA 16802 USA; [Manousaki, Tereza] Hellen Ctr Marine Res, Inst Marine Biol Biotechnol & Aquaculture, Iraklion, Greece; [Pasquier, Jeremy; Guiguen, Yann; Bobe, Julien] INRA, LPGP, UR1037, Campus Beaulieu, F-35042 Rennes, France; [Catchen, Julian] Univ Illinois, Dept Anim Biol, Urbana, IL 61801 USA; [Berlin, Aaron M.; Johnson, Jeremy; Lara, Marcia; Williams, Louise; Di Palma, Federica; Alfoeldi, Jessica; Lindblad-Toh, Kerstin] Broad Inst MIT & Harvard, Cambridge, MA USA; [Campbell, Michael S.; Yandell, Mark] Univ Utah, Eccles Inst Human Genet, Salt Lake City, UT USA; [Barrell, Daniel; Searle, Stephen M. J.; Aken, Bronwen] Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Hinxton, England; [Barrell, Daniel; Aken, Bronwen] European Bioinformat Inst, European Mol Biol Lab, Wellcome Trust Genome Campus, Hinxton, England; [Martin, Kyle J.; Holland, Peter W. H.] Univ Oxford, Dept Zool, Oxford, England; [Mulley, John F.] Bangor Univ, Sch Biol Sci, Bangor, Gwynedd, Wales; [Ravi, Vydianathan; Lee, Alison P.; Venkatesh, Byrappa] ASTAR, Inst Mol & Cell Biol, Comparat Genom Lab, Singapore, Singapore; [Chalopin, Domitille; Volff, Jean-Nicolas] Ecole Normale Super Lyon, Inst Genom Fonct Lyon, F-69364 Lyon, France; [Fan, Shaohua; Meyer, Axel] Univ Konstanz, Dept Biol, Constance, Germany; [Wcisel, Dustin; Yoder, Jeffrey A.] N Carolina State Univ, Dept Mol Biomed Sci, Raleigh, NC 27695 USA; [Wcisel, Dustin; Yoder, Jeffrey A.] N Carolina State Univ, Ctr Comparat Med & Translat Res, Raleigh, NC 27695 USA; [Canestro, Cristian] Univ Barcelona, Dept Genet, Barcelona, Spain; [Canestro, Cristian] Univ Barcelona, Inst Recerca Biodiversitat, Barcelona, Spain; [Beaudry, Felix E. G.; Taylor, John S.] Univ Victoria, Dept Biol, POB 1700, Victoria, BC V8W 2Y2, Canada; [Sun, Yi; Wang, Han] Soochow Univ, Ctr Circadian Clocks, Suzhou, Peoples R China; [Sun, Yi; Wang, Han] Soochow Univ, Coll Med, Sch Biol & Basic Med Sci, Suzhou, Peoples R China; [Hertel, Jana; Fasold, Mario; Kehr, Steffi; Stadler, Peter F.] Univ Leipzig, Dept Comp Sci, Bioinformat Grp, D-04109 Leipzig, Germany; [Ishiyama, Mikio] Nippon Dent Univ Coll Niigata, Dept Dent Hyg, Niigata, Japan; [Litman, Gary W.; Litman, Ronda T.] Univ S Florida, Morsani Coll Med, Dept Pediat, St Petersburg, FL 33701 USA; [Mikami, Masato] Nippon Dent Univ, Sch Life Dent Niigata, Dept Microbiol, Niigata, Japan; [Ota, Tatsuya] SOKENDAI Grad Univ Adv Studies, Dept Evolutionary Studies Biosyst, Hayama, Japan; [Saha, Nil Ratan; Amemiya, Chris T.] Benaroya Res Inst, Mol Genet Program, Seattle, WA USA; [Fontenot, Quenton; Ferrara, Allyse] Nicholls State Univ, Dept Biol Sci, Thibodaux, LA 70310 USA; [Schneider, Igor] Fed Univ Para, Inst Ciencias Biol, BR-66059 Belem, Para, Brazil; [Meyer, Axel] Univ Konstanz, Int Max Planck Res Sch Organismal Biol, Constance, Germany; [Lindblad-Toh, Kerstin] Uppsala Univ, Dept Med Biochem & Microbiol, Sci Life Lab, Uppsala, Sweden; [Braasch, Ingo] Michigan State Univ, Dept Integrat Biol, E Lansing, MI 48824 USA; [Campbell, Michael S.] Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA; [Martin, Kyle J.] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England; [Chalopin, Domitille] Univ Georgia, Dept Genet, Athens, GA 30602 USA; [Fan, Shaohua] Univ Penn, Dept Genet, Philadelphia, PA 19104 USA; [Hertel, Jana] UFZ Helmholtz Ctr Environm Res, Young Investigators Grp Bioinformat & Transcript, Leipzig, Germany; [Fasold, Mario] ecSeq Bioinformat, Leipzig, Germany; [Di Palma, Federica] Genome Anal Ctr, Vertebrate & Hlth Genom, Norwich, Norfolk, England	University of Oregon; University of Chicago; University of Kentucky; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Hellenic Centre for Marine Research; INRAE; University of Illinois System; University of Illinois Urbana-Champaign; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Utah System of Higher Education; University of Utah; Wellcome Trust Sanger Institute; European Molecular Biology Laboratory (EMBL); Wellcome Trust Sanger Institute; University of Oxford; Bangor University; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); University of Konstanz; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; University of Barcelona; University of Barcelona; University of Victoria; Soochow University - China; Soochow University - China; Leipzig University; State University System of Florida; University of South Florida; Nippon Dental University; Graduate University for Advanced Studies - Japan; Benaroya Research Institute; University of Louisiana System; Nicholls State University; Universidade Federal do Para; Max Planck Society; University of Konstanz; Uppsala University; Michigan State University; Cold Spring Harbor Laboratory; University of Sheffield; University System of Georgia; University of Georgia; University of Pennsylvania; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); The Genome Analysis Centre (TGAC)	Braasch, I; Postlethwait, JH (corresponding author), Univ Oregon, Inst Neurosci, Eugene, OR 97403 USA.	braasch@msu.edu; jpostle@uoneuro.uoregon.edu	Schor, Jana/F-8503-2017; Schneider, Igor/K-6164-2012; Wang, Han/A-9774-2008; Lee, Alison/HCH-1286-2022; Berlin, Aaron M/AFY-6549-2022; Yoder, Jeffrey A./I-5329-2019; Cañestro, Cristian/L-9661-2014; Beaudry, Felix/AAL-9802-2020; Meyer, Axel/C-9826-2009; Thomas, Desvignes/AAX-3526-2020; Bobe, Julien/I-6851-2017; Ravi, Vydianathan/B-2759-2009; Braasch, Ingo/A-6948-2010; Stadler, Peter F./L-7857-2015	Schor, Jana/0000-0003-1200-6234; Schneider, Igor/0000-0002-9046-7338; Wang, Han/0000-0003-2420-3147; Lee, Alison/0000-0002-3773-1021; Berlin, Aaron M/0000-0002-0714-2808; Yoder, Jeffrey A./0000-0002-6083-1311; Cañestro, Cristian/0000-0003-4623-8105; Meyer, Axel/0000-0002-0888-8193; Thomas, Desvignes/0000-0001-5126-8785; Bobe, Julien/0000-0002-9355-8227; Ravi, Vydianathan/0000-0003-0807-7697; Braasch, Ingo/0000-0003-4766-611X; Barrell, Daniel/0000-0002-0977-0963; Martin, Kyle/0000-0002-4081-6835; Venkatesh, Byrappa/0000-0003-3620-0277; Guiguen, Yann/0000-0001-5464-6219; Nakamura, Tetsuya/0000-0003-0183-1685; Stadler, Peter F./0000-0002-5016-5191; Mulley, John/0000-0002-1537-7316; Kehr, Stephanie/0000-0001-8461-5763; Smith, Jeramiah/0000-0001-5333-5531; Di-Palma, Federica/0000-0002-4394-0102; Ota, Tatsuya/0000-0002-1115-5169; Amores, Angel/0000-0002-9307-3609	US National Institutes of Health (NIH)/National Human Genome Research Institute [U54 HG03067]; US NIH [R01 OD011116, R24 OD01119004, T32 HD055164, R01 AI057559, R24 OD010922, R01 GM079492]; Feodor Lynen Fellowship from the Alexander von Humboldt Foundation; Volkswagen Foundation Initiative Evolutionary Biology [I/84 815]; National Science Foundation (NSF) [1311436]; Uehara Memorial Foundation Research Fellowship; Japan Society for the Promotion of Science Postdoctoral Research Fellowship; Marine Biological Laboratory Research Award; Brazilian National Council for Scientific and Technological Development (CNPq) [402754/2012-3, 477658/2012-1]; Brinson Foundation; University of Chicago Biological Sciences Division; NSF [BCS0725227]; National Strategic Reference Framework [SPARCOMP, 36]; Ministry of Education and Religious Affairs of Greece; Agence Nationale de la Recherche (ANR) [ANR-10-GENM-017]; Wellcome Trust [WT095908, WT098051]; European Molecular Biology Laboratory; Biomedical Research Council of the Agency for Science, Technology and Research (A*STAR), Singapore; European Research Council [268513]; Ministerio de Ciencia e Innovacion [BFU2010-14875, BFU2015-71340]; Generalitat de Catalunya, AGAUR [SGR2014-290]; National Basic Research Program of China (973 Program) [2012CB947600]; National Natural Science Foundation of China (NSFC) [31030062]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD055164] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR020833] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057559] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R21GM079492] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R24OD011199, R01OD011116, R24OD010922] Funding Source: NIH RePORTER; BBSRC [BBS/E/T/000PR5885] Funding Source: UKRI	US National Institutes of Health (NIH)/National Human Genome Research Institute; US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Feodor Lynen Fellowship from the Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Volkswagen Foundation Initiative Evolutionary Biology; National Science Foundation (NSF)(National Science Foundation (NSF)National Research Foundation of Korea); Uehara Memorial Foundation Research Fellowship(Uehara Memorial Foundation); Japan Society for the Promotion of Science Postdoctoral Research Fellowship(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Marine Biological Laboratory Research Award; Brazilian National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brinson Foundation; University of Chicago Biological Sciences Division(University of Chicago); NSF(National Science Foundation (NSF)); National Strategic Reference Framework; Ministry of Education and Religious Affairs of Greece; Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Wellcome Trust(Wellcome Trust); European Molecular Biology Laboratory; Biomedical Research Council of the Agency for Science, Technology and Research (A*STAR), Singapore(Agency for Science Technology & Research (A*STAR)); European Research Council(European Research Council (ERC)European Commission); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Generalitat de Catalunya, AGAUR(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)Generalitat de Catalunya); National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank the Broad Institute Genomics Platform for constructing and sequencing gar DNA and RNA libraries and J. Turner-Maier for the gar transcriptome assembly. We thank the teams of the Bayousphere Research Laboratory (Nicholls State University) and the University of Oregon Fish Facility for gar work and husbandry. We thank J. Westlund for the design of the species illustrations. The generation of gar sequences and assemblies by the Broad Institute of MIT and Harvard University was supported by US National Institutes of Health (NIH)/National Human Genome Research Institute grant U54 HG03067. This work was further supported by US NIH grants R01 OD011116 (alias R01 RR020833) and R24 OD01119004 (J.H.P.); a Feodor Lynen Fellowship from the Alexander von Humboldt Foundation and the Volkswagen Foundation Initiative Evolutionary Biology, grant I/84 815 (I.B.); US NIH grant T32 HD055164 and National Science Foundation (NSF) Doctoral Dissertation Improvement Grant 1311436 (A.R.G.); Uehara Memorial Foundation Research Fellowship 2013, Japan Society for the Promotion of Science Postdoctoral Research Fellowship 2012-127 and Marine Biological Laboratory Research Award 2014 (T.N.); Brazilian National Council for Scientific and Technological Development (CNPq) grants 402754/2012-3 and 477658/2012-1 (I.S.); the Brinson Foundation and the University of Chicago Biological Sciences Division (N.H.S.); NSF grant BCS0725227 (K.K.); call 'ARISTEIA I' of the National Strategic Reference Framework 2007-2013 (SPARCOMP, 36), Ministry of Education and Religious Affairs of Greece (T.M.); Agence Nationale de la Recherche (ANR) grant ANR-10-GENM-017 (PhyloFish; J.B.); the Wellcome Trust (grants WT095908 and WT098051) and the European Molecular Biology Laboratory (D.B., S.M.J.S. and B.A.); the Biomedical Research Council of the Agency for Science, Technology and Research (A*STAR), Singapore (B.V.); European Research Council grant 268513 (P.W.H.H. and K.J.M.); the Ministerio de Ciencia e Innovacion (BFU2010-14875 and BFU2015-71340) and the Generalitat de Catalunya, AGAUR (SGR2014-290) (C. C.); US NIH grant R01 AI057559 (G.W.L. and J.A.Y.); US NIH grants R24 OD010922 and R01 GM079492 (C. T. A.); and the National Basic Research Program of China (973 Program) (2012CB947600) and the National Natural Science Foundation of China (NSFC) (31030062) (H.W.).	Albertson RC, 2009, TRENDS GENET, V25, P74, DOI 10.1016/j.tig.2008.11.006; Amemiya CT, 2013, NATURE, V496, P311, DOI 10.1038/nature12027; Amores A, 1999, METHOD CELL BIOL, V60, P323; Amores A, 1998, SCIENCE, V282, P1711, DOI 10.1126/science.282.5394.1711; Amores A, 2011, GENETICS, V188, P799, DOI 10.1534/genetics.111.127324; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Andrey G, 2013, SCIENCE, V340, P1195, DOI 10.1126/science.1234167; Auguie B., 2017, GRIDEXTRA MISCELLANE; Batzel P., 2015, ZENODO, DOI [10.5281/zenodo.35461, DOI 10.5281/ZENODO.35461]; Berezikov E, 2011, GENOME RES, V21, P203, DOI 10.1101/gr.116657.110; Berlivet S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1004018; Betancur-R R, 2013, PLOS CURR-TREE LIFE, DOI 10.1371/currents.tol.53ba26640df0ccaee75bb165c8c26288; BingulacPopovic J, 1997, IMMUNOGENETICS, V46, P129, DOI 10.1007/s002510050251; Blanchette M, 2004, GENOME RES, V14, P708, DOI 10.1101/gr.1933104; BOGART JP, 1994, J HERED, V85, P322, DOI 10.1093/oxfordjournals.jhered.a111470; Braasch I., 2012, POLYPLOIDY GENOME EV, P341, DOI DOI 10.1007/978-3-642-31442-1_17; Braasch I, 2015, J EXP ZOOL PART B, V324, P316, DOI 10.1002/jez.b.22589; Braasch I, 2014, COMP BIOCHEM PHYS C, V163, P24, DOI 10.1016/j.cbpc.2014.01.005; Broughton RE, 2013, PLOS CURR-TREE LIFE, DOI 10.1371/currents.tol.2ca8041495ffafd0c92756e75247483e; Brudno M, 2003, BIOINFORMATICS, V19, pi54, DOI 10.1093/bioinformatics/btg1005; Canestro C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000496; Cannon JP, 2008, IMMUNITY, V29, P228, DOI 10.1016/j.immuni.2008.05.018; Catchen JM, 2009, GENOME RES, V19, P1497, DOI 10.1101/gr.090480.108; Chalopin D, 2015, GENOME BIOL EVOL, V7, P567, DOI 10.1093/gbe/evv005; Chang NN, 2013, CELL RES, V23, P465, DOI 10.1038/cr.2013.45; Crow KD, 2012, GENOME BIOL EVOL, V4, P937, DOI 10.1093/gbe/evs067; Danilova N, 2005, NAT IMMUNOL, V6, P295, DOI 10.1038/ni1166; Darwin C, 1859, ORIGINS SPECIES MEAN; Dehal P, 2005, PLOS BIOL, V3, P1700, DOI 10.1371/journal.pbio.0030314; Desvignes T, 2015, TRENDS GENET, V31, P613, DOI 10.1016/j.tig.2015.09.002; Desvignes T, 2014, GENE, V546, P386, DOI 10.1016/j.gene.2014.05.036; Dijkstra JM, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-260; Dirscherl H, 2014, DEV COMP IMMUNOL, V46, P11, DOI 10.1016/j.dci.2014.02.018; Dirscherl H, 2014, IMMUNOGENETICS, V66, P185, DOI 10.1007/s00251-013-0748-z; Duboule D, 1998, CURR OPIN GENET DEV, V8, P514, DOI 10.1016/S0959-437X(98)80004-X; Duester G, 2013, SEMIN CELL DEV BIOL, V24, P694, DOI 10.1016/j.semcdb.2013.08.001; Faircloth BC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065923; Fisher S, 2006, NAT PROTOC, V1, P1297, DOI 10.1038/nprot.2006.230; Flajnik MF, 2010, NAT REV GENET, V11, P47, DOI 10.1038/nrg2703; Flicek P, 2013, NUCLEIC ACIDS RES, V41, pD48, DOI 10.1093/nar/gks1236; Force A, 1999, GENETICS, V151, P1531; Frankenberg SR, 2014, DEVELOPMENT, V141, P2921, DOI 10.1242/dev.108407; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; Gehrke AR, 2015, P NATL ACAD SCI USA, V112, P803, DOI 10.1073/pnas.1420208112; Gnerre S, 2011, P NATL ACAD SCI USA, V108, P1513, DOI 10.1073/pnas.1017351108; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Grande L, 2010, COPEIA, P1; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Grimholt U, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0309-1; Grimson A, 2008, NATURE, V455, P1193, DOI 10.1038/nature07415; Hagedorn EJ, 2014, EXP CELL RES, V329, P220, DOI 10.1016/j.yexcr.2014.07.030; Hansen JD, 2005, P NATL ACAD SCI USA, V102, P6919, DOI 10.1073/pnas.0500027102; Harel I, 2015, CELL, V160, P1013, DOI 10.1016/j.cell.2015.01.038; Harris RS, 2007, THESIS, DOI [10.5555/1414852, DOI 10.5555/1414852]; He XL, 2005, GENETICS, V169, P1157, DOI 10.1534/genetics.104.037051; Hertel Jana, 2015, Life-Basel, V5, P905, DOI 10.3390/life5010905; Hinrichs AS, 2006, NUCLEIC ACIDS RES, V34, pD590, DOI 10.1093/nar/gkj144; Hoegg S, 2004, J MOL EVOL, V59, P190, DOI 10.1007/s00239-004-2613-z; Holt C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-491; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Kawasaki K, 2005, P NATL ACAD SCI USA, V102, P18063, DOI 10.1073/pnas.0509263102; Kawasaki K, 2014, J EXP ZOOL PART B, V322, P390, DOI 10.1002/jez.b.22546; Kawasaki K, 2009, DEV GENES EVOL, V219, P147, DOI 10.1007/s00427-009-0276-x; Kettleborough RNW, 2013, NATURE, V496, P494, DOI 10.1038/nature11992; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kurosawa G, 2006, GENE, V370, P75, DOI 10.1016/j.gene.2005.11.015; Lagman D, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-238; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lartillot N, 2013, SYST BIOL, V62, P611, DOI 10.1093/sysbio/syt022; Lee O, 2015, CRIT REV TOXICOL, V45, P124, DOI 10.3109/10408444.2014.965805; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Loh YHE, 2011, GENOME BIOL EVOL, V3, P55, DOI 10.1093/gbe/evq085; Long W L, 2001, BMC Dev Biol, V1, P6, DOI 10.1186/1471-213X-1-6; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Louis A, 2013, NUCLEIC ACIDS RES, V41, pD700, DOI 10.1093/nar/gks1156; Mano H, 1999, MOL BRAIN RES, V73, P110, DOI 10.1016/S0169-328X(99)00242-9; Montavon T, 2011, CELL, V147, P1132, DOI 10.1016/j.cell.2011.10.023; Muffato M, 2010, BIOINFORMATICS, V26, P1119, DOI 10.1093/bioinformatics/btq079; Mulley JF, 2010, MOL BIOL EVOL, V27, P2386, DOI 10.1093/molbev/msq121; Nakatani Y, 2007, GENOME RES, V17, P1254, DOI 10.1101/gr.6316407; Naruse K, 2004, GENOME RES, V14, P820, DOI 10.1101/gr.2004004; Near TJ, 2012, P NATL ACAD SCI USA, V109, P13698, DOI 10.1073/pnas.1206625109; Nelson JS, 1984, FISHES WORLD; Nikaido M, 2013, GENOME RES, V23, P1740, DOI 10.1101/gr.158105.113; OHNO S, 1969, CHROMOSOMA, V26, P35, DOI 10.1007/BF00319498; Ohno S., 1970, P1; Pagan AJ, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a018499; Parra ZE, 2010, EUR J IMMUNOL, V40, P2319, DOI 10.1002/eji.201040515; Patton EE, 2011, METHOD CELL BIOL, V105, P339, DOI 10.1016/B978-0-12-381320-6.00014-X; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; Postlethwait J, 2004, TRENDS GENET, V20, P481, DOI 10.1016/j.tig.2004.08.001; Postlethwait JH, 2007, J EXP ZOOL PART B, V308B, P563, DOI 10.1002/jez.b.21137; Quinlan Aaron R, 2014, Curr Protoc Bioinformatics, V47, DOI 10.1002/0471250953.bi1112s47; Rabosky DL, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2958; Ravi V, 2008, CURR OPIN GENET DEV, V18, P544, DOI 10.1016/j.gde.2008.11.001; Reitzel AM, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-6; Rennison DJ, 2012, MOL PHYLOGENET EVOL, V62, P986, DOI 10.1016/j.ympev.2011.11.030; Roach JC, 2005, P NATL ACAD SCI USA, V102, P9577, DOI 10.1073/pnas.0502272102; Ryll B, 2014, EVOL DEV, V16, P123, DOI 10.1111/ede.12071; Sallan LC, 2014, BIOL REV, V89, P950, DOI 10.1111/brv.12086; Sasagawa I., 2008, FRONT MAT SCI CHINA, V2, P134; Sato A, 2000, IMMUNOGENETICS, V51, P108, DOI 10.1007/s002510050019; Scannell DR, 2008, GENOME RES, V18, P137, DOI 10.1101/gr.6341207; Schneider I, 2013, TRENDS GENET, V29, P419, DOI 10.1016/j.tig.2013.01.012; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Shaffer HB, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-3-r28; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; SIRE JY, 1994, ANAT REC, V240, P189, DOI 10.1002/ar.1092400206; Smith JJ, 2015, GENOME RES, V25, P1081, DOI 10.1101/gr.184135.114; Smith JJ, 2013, NAT GENET, V45, P415, DOI 10.1038/ng.2568; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stoltzfus A, 1999, J MOL EVOL, V49, P169, DOI 10.1007/PL00006540; TAJIMA F, 1993, GENETICS, V135, P599; TAKEZAKI N, 1995, MOL BIOL EVOL, V12, P823; Taylor JS, 2003, GENOME RES, V13, P382, DOI 10.1101/gr.640303; Toloza-Villalobos J, 2015, J MOL EVOL, V80, P57, DOI 10.1007/s00239-014-9660-x; Venkatesh B, 2014, NATURE, V505, P174, DOI 10.1038/nature12826; Vilella AJ, 2009, GENOME RES, V19, P327, DOI 10.1101/gr.073585.107; Visel A, 2007, NUCLEIC ACIDS RES, V35, pD88, DOI 10.1093/nar/gkl822; Wang H, 2008, J MOL EVOL, V67, P29, DOI 10.1007/s00239-008-9121-5; Wheeler BM, 2009, EVOL DEV, V11, P50, DOI 10.1111/j.1525-142X.2008.00302.x; Wicker T, 2007, NAT REV GENET, V8, P973, DOI 10.1038/nrg2165; Wolfe K, 2000, NAT GENET, V25, P3, DOI 10.1038/75560; Woolfe A, 2005, PLOS BIOL, V3, P116, DOI 10.1371/journal.pbio.0030007; Yoder JA, 2009, DEV COMP IMMUNOL, V33, P135, DOI 10.1016/j.dci.2008.09.004; Zakany J, 2007, CURR OPIN GENET DEV, V17, P359, DOI 10.1016/j.gde.2007.05.011; Zhang YA, 2010, NAT IMMUNOL, V11, P827, DOI 10.1038/ni.1913; Zhu M, 2009, NATURE, V458, P469, DOI 10.1038/nature07855	132	349	364	13	134	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2016	48	4					427	+		10.1038/ng.3526	http://dx.doi.org/10.1038/ng.3526			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DH6NZ	26950095	hybrid, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000372908800014
J	Francis, KR; Ton, AN; Xin, Y; O'Halloran, PE; Wassif, CA; Malik, N; Williams, IM; Cluzeau, CV; Trivedi, NS; Pavan, WJ; Cho, W; Westphal, H; Porter, FD				Francis, Kevin R.; Ton, Amy N.; Xin, Yao; O'Halloran, Peter E.; Wassif, Christopher A.; Malik, Nasir; Williams, Ian M.; Cluzeau, Celine V.; Trivedi, Niraj S.; Pavan, William J.; Cho, Wonhwa; Westphal, Heiner; Porter, Forbes D.			Modeling Smith-Lemli-Opitz syndrome with induced pluripotent stem cells reveals a causal role for Wnt/beta-catenin defects in neuronal cholesterol synthesis phenotypes	NATURE MEDICINE			English	Article							MEMBRANE-BINDING; NERVOUS-SYSTEM; DIFFERENTIATION; ACTIVATION; BRAIN; 7-DEHYDROCHOLESTEROL; MAINTENANCE; PROGENITORS; FIBROBLASTS; GENERATION	Smith-Lemli-Opitz syndrome (SLOS) is a malformation disorder caused by mutations in DHCR7, which impair the reduction of 7-dehydrocholesterol (7DHC) to cholesterol. SLOS results in cognitive impairment, behavioral abnormalities and nervous system defects, though neither affected cell types nor impaired signaling pathways are fully understood. Whether 7DHC accumulation or cholesterol loss is primarily responsible for disease pathogenesis is also unclear. Using induced pluripotent stem cells (iPSCs) from subjects with SLOS, we identified cellular defects that lead to precocious neuronal specification within SLOS derived neural progenitors. We also demonstrated that 7DHC accumulation, not cholesterol deficiency, is critical for SLOS-associated defects. We further identified downregulation of Wnt/beta-catenin signaling as a key initiator of aberrant SLOS iPSC differentiation through the direct inhibitory effects of 7DHC on the formation of an active Wnt receptor complex. Activation of canonical Wnt signaling prevented the neural phenotypes observed in SLOS iPSCs, suggesting that Wnt signaling may be a promising therapeutic target for SLOS.	[Francis, Kevin R.; Ton, Amy N.; O'Halloran, Peter E.; Malik, Nasir; Westphal, Heiner] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Program Genom Differentiat, NIH, Bethesda, MD USA; [Francis, Kevin R.; Wassif, Christopher A.; Williams, Ian M.; Cluzeau, Celine V.; Porter, Forbes D.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Program Dev Endocrinol & Genet, NIH, Bethesda, MD USA; [Xin, Yao; Cho, Wonhwa] Univ Illinois, Dept Chem, Chicago, IL USA; [Trivedi, Niraj S.] NHGRI, Computat & Stat Genom Branch, NIH, Bethesda, MD 20892 USA; [Pavan, William J.] NHGRI, Genet Dis Res Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Francis, KR (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Program Genom Differentiat, NIH, Bethesda, MD USA.; Francis, KR; Porter, FD (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Program Dev Endocrinol & Genet, NIH, Bethesda, MD USA.	kevin.francis@sanfordhealth.org; fdporter@mail.nih.gov	Xin, Yao/L-6259-2019	Pavan, William/0000-0001-8281-5120	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); National Human Genome Research Institute (NHGRI); NIH Center for Regenerative Medicine; NIH [GM110128]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000139, ZIAHD008825] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000068] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM110128] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIH Center for Regenerative Medicine; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the intramural research programs of the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and the National Human Genome Research Institute (NHGRI), a pilot award for iPSC research from the NIH Center for Regenerative Medicine, and NIH grant GM110128 (W.C.). We thank K. Perez, N. Khezri and G.F. Rodriguez for assistance with hESC and iPSC culture. We also thank C. Toth and A. Ely for assistance with mice and sequencing. We thank A. Dutra, E. Pak and the NHGRI Cytogenetics Core for assistance with hESC and iPSC karyotyping. We thank L. (Chip) Dye and the NICHD Microscopy and Imaging Core for electron microscopy assistance. We thank B.S. Mallon (National Institute of Neurological Disorders and Stroke, NIH Stem Cell Unit), S. Kuznetsov (National Institute of Dental and Craniofacial Research, NIDCR), and P.G. Robey (NIDCR, NIH Stem Cell Unit) for experimental advice and the i19 and i21 human iPSC lines. We thank G. Mostoslavksy (Boston University) for the kind gift of the STEMCCA plasmid. We thank D. Kotton (Boston University) for the kind gift of the Cre-IRES-PuroR plasmid. We thank F. Zhang (Massachusetts Institute of Technology) for the gift of the pX330-U6-Chimeric_BB-CBh-hSpCas9 plasmid. We thank J. Mills (Children's Hospital of Philadelphia) for experimental advice, the National Heart, Lung and Blood Institute iPSC Core Facility for assistance with lathosterolosis iPSC generation, and M. Rao and K. Pfeifer for critical discussions. Finally, we would like to thank the patients and guardians who participated in the NIH clinical program and contributed to this study.	Ahn S, 2005, NATURE, V437, P894, DOI 10.1038/nature03994; Amar MJA, 2010, J PHARMACOL EXP THER, V334, P634, DOI 10.1124/jpet.110.167890; Ananthanarayanan B, 2003, J BIOL CHEM, V278, P46886, DOI 10.1074/jbc.M307853200; Blauwkamp TA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2064; CENEDELLA RJ, 1979, EXP EYE RES, V28, P673, DOI 10.1016/0014-4835(79)90068-X; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; Cho WW, 2001, ANAL BIOCHEM, V296, P153, DOI 10.1006/abio.2001.5225; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; DAVISSON MT, 1987, CYTOGENET CELL GENET, V45, P70, DOI 10.1159/000132432; Elkabetz Y, 2008, GENE DEV, V22, P152, DOI 10.1101/gad.1616208; Fernandez A, 2014, P NATL ACAD SCI USA, V111, P1409, DOI 10.1073/pnas.1323697111; Frolov A, 2001, J BIOL CHEM, V276, P46414, DOI 10.1074/jbc.M108099200; Gaoua W, 1999, J LIPID RES, V40, P456; Gofflot F, 1999, AM J MED GENET, V87, P207, DOI 10.1002/(SICI)1096-8628(19991126)87:3<207::AID-AJMG3>3.0.CO;2-5; Hirabayashi Y, 2004, DEVELOPMENT, V131, P2791, DOI 10.1242/dev.01165; Hsieh JC, 2003, CELL, V112, P355, DOI 10.1016/S0092-8674(03)00045-X; Hu BY, 2010, P NATL ACAD SCI USA, V107, P4335, DOI 10.1073/pnas.0910012107; Inestrosa NC, 2010, NAT REV NEUROSCI, V11, P77, DOI 10.1038/nrn2755; Jiang XS, 2010, HUM MOL GENET, V19, P1347, DOI 10.1093/hmg/ddq011; JUREVICS H, 1995, J NEUROCHEM, V64, P895; Koyama-Honda I, 2005, BIOPHYS J, V88, P2126, DOI 10.1529/biophysj.104.048967; Krakowiak PA, 2000, AM J MED GENET, V94, P214, DOI 10.1002/1096-8628(20000918)94:3<214::AID-AJMG7>3.3.CO;2-I; Krakowiak PA, 2003, HUM MOL GENET, V12, P1631, DOI 10.1093/hmg/ddg172; Lee RWY, 2013, AM J MED GENET A, V161, P2407, DOI 10.1002/ajmg.a.36096; Lie DC, 2005, NATURE, V437, P1370, DOI 10.1038/nature04108; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Ludwig TE, 2006, NAT BIOTECHNOL, V24, P185, DOI 10.1038/nbt1177; Mellon SH, 2007, PHARMACOL THERAPEUT, V116, P107, DOI 10.1016/j.pharmthera.2007.04.011; Mermelstein CS, 2007, DIFFERENTIATION, V75, P184, DOI 10.1111/j.1432-0436.2006.00129.x; Mohn JL, 2014, MOL PSYCHIATR, V19, P1133, DOI 10.1038/mp.2014.61; Munji RN, 2011, J NEUROSCI, V31, P1676, DOI 10.1523/JNEUROSCI.5404-10.2011; Mutch CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012376; Porter FD, 2011, J LIPID RES, V52, P6, DOI 10.1194/jlr.R009548; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Sheng R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5393; Sheng R, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2221; Somers A, 2010, STEM CELLS, V28, P1728, DOI 10.1002/stem.495; Sowers LP, 2013, MOL PSYCHIATR, V18, P1077, DOI 10.1038/mp.2013.71; SPECTOR AA, 1985, J LIPID RES, V26, P1015; Stahelin RV, 2001, BIOCHEMISTRY-US, V40, P4672, DOI 10.1021/bi0020325; Stahelin RV, 2001, BIOCHEM J, V359, P679, DOI 10.1042/0264-6021:3590679; Tierney E, 2001, AM J MED GENET, V98, P191, DOI 10.1002/1096-8628(20010115)98:2<191::AID-AJMG1030>3.0.CO;2-M; Wassif CA, 2002, MOL GENET METAB, V75, P325, DOI 10.1016/S1096-7192(02)00010-0; Wassif CA, 1998, AM J HUM GENET, V63, P55, DOI 10.1086/301936; Wassif CA, 2001, HUM MOL GENET, V10, P555, DOI 10.1093/hmg/10.6.555; Xu LB, 2013, J LIPID RES, V54, P1135, DOI 10.1194/jlr.M035733; Xue W, 2014, NATURE, V514, P380, DOI 10.1038/nature13589; Yamaguchi TP, 1999, DEVELOPMENT, V126, P1211; Zidovetzki R, 2007, BBA-BIOMEMBRANES, V1768, P1311, DOI 10.1016/j.bbamem.2007.03.026	51	31	31	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2016	22	4					388	+		10.1038/nm.4067	http://dx.doi.org/10.1038/nm.4067			13	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DI4GF	26998835	Green Accepted			2022-12-25	WOS:000373457700014
J	Hilbert, M; Noga, A; Frey, D; Hamel, V; Guichard, P; Kraatz, SHW; Pfreundschuh, M; Hosner, S; Fluckiger, I; Jaussi, R; Wieser, MM; Thieltges, KM; Deupi, X; Muller, DJ; Kammerer, RA; Gonczy, P; Hirono, M; Steinmetz, MO				Hilbert, Manuel; Noga, Akira; Frey, Daniel; Hamel, Virginie; Guichard, Paul; Kraatz, Sebastian H. W.; Pfreundschuh, Moritz; Hosner, Sarah; Flueckiger, Isabelle; Jaussi, Rolf; Wieser, Mara M.; Thieltges, Katherine M.; Deupi, Xavier; Mueller, Daniel J.; Kammerer, Richard A.; Goenczy, Pierre; Hirono, Masafumi; Steinmetz, Michel O.			SAS-6 engineering reveals interdependence between cartwheel and microtubules in determining centriole architecture	NATURE CELL BIOLOGY			English	Article							BASAL BODY; CHLAMYDOMONAS-REINHARDTII; 9-FOLD SYMMETRY; HUMAN-CELLS; ELECTRON-MICROSCOPY; MOLECULAR-DYNAMICS; NATIVE PROTEINS; PROCENTRIOLE; CENTROSOMES; RESOLUTION	Centrioles are critical for the formation of centrosomes, cilia and flagella in eukaryotes. They are thought to assemble around a nine-fold symmetric cartwheel structure established by SAS-6 proteins. Here, we have engineered Chlamydomonas reinhardtii SAS-6-based oligomers with symmetries ranging from five- to ten-fold. Expression of a SAS-6 mutant that forms six-fold symmetric cartwheel structures in vitro resulted in cartwheels and centrioles with eight- or nine-fold symmetries in vivo. In combination with Bld10 mutants that weaken cartwheel-microtubule interactions, this SAS-6 mutant produced six- to eight-fold symmetric cartwheels. Concurrently, the microtubule wall maintained eight- and nine-fold symmetries. Expressing SAS-6 with analogous mutations in human cells resulted in nine-fold symmetric centrioles that exhibited impaired length and organization. Together, our data suggest that the self-assembly properties of SAS-6 instruct cartwheel symmetry, and lead us to propose a model in which the cartwheel and the microtubule wall assemble in an interdependent manner to establish the native architecture of centrioles.	[Hilbert, Manuel; Frey, Daniel; Kraatz, Sebastian H. W.; Hosner, Sarah; Jaussi, Rolf; Wieser, Mara M.; Thieltges, Katherine M.; Deupi, Xavier; Kammerer, Richard A.; Steinmetz, Michel O.] Paul Scherrer Inst, Dept Biol & Chem, Lab Biomol Res, CH-5232 Villigen, Switzerland; [Noga, Akira; Hirono, Masafumi] Univ Tokyo, Dept Biol Sci, Tokyo 1130033, Japan; [Hamel, Virginie; Guichard, Paul; Flueckiger, Isabelle; Goenczy, Pierre] Ecole Polytech Fed Lausanne, Swiss Fed Inst Technol, Sch Life Sci, Swiss Inst Expt Canc Res ISREC, CH-1015 Lausanne, Switzerland; [Pfreundschuh, Moritz; Mueller, Daniel J.] Eidgenoss Tech Hsch ETH Zurich, Dept Biosyst Sci & Engn, CH-4058 Basel, Switzerland; [Deupi, Xavier] Paul Scherrer Inst, Condensed Matter Theory Grp, CH-5232 Villigen, Switzerland; [Hilbert, Manuel] F Hoffmann La Roche Ltd, Roche Pharma Res & Early Dev Mol Design & Chem Bi, Roche Innovat Ctr Basel, CH-4070 Basel, Switzerland; [Noga, Akira; Hirono, Masafumi] Hosei Univ, Dept Frontier Biosci, Koganei, Tokyo 1848584, Japan; [Hamel, Virginie; Guichard, Paul] Univ Geneva, Dept Cell Biol, Sci 3, CH-1211 Geneva, Switzerland	Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; University of Tokyo; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Roche Holding; Hosei University; University of Geneva	Steinmetz, MO (corresponding author), Paul Scherrer Inst, Dept Biol & Chem, Lab Biomol Res, CH-5232 Villigen, Switzerland.; Hirono, M (corresponding author), Univ Tokyo, Dept Biol Sci, Tokyo 1130033, Japan.; Gonczy, P (corresponding author), Ecole Polytech Fed Lausanne, Swiss Fed Inst Technol, Sch Life Sci, Swiss Inst Expt Canc Res ISREC, CH-1015 Lausanne, Switzerland.; Hirono, M (corresponding author), Hosei Univ, Dept Frontier Biosci, Koganei, Tokyo 1848584, Japan.	pierre.gonczy@epfl.ch; hirono@hosei.ac.jp; michel.steinmetz@psi.ch	Steinmetz, Michel O/AAA-3349-2022; Müller, Daniel J./A-5967-2010; Deupi, Xavier/B-2424-2009; HIRONO, MASAFUMI/G-4948-2014	Steinmetz, Michel O/0000-0001-6157-3687; Müller, Daniel J./0000-0003-3075-0665; Deupi, Xavier/0000-0003-4572-9316; HIRONO, MASAFUMI/0000-0002-2497-4227; Noga, Akira/0000-0002-6209-1011; Guichard, Paul/0000-0002-0363-1049; Gonczy, Pierre/0000-0002-6305-6883; Kammerer, Richard/0000-0003-4570-5197; Kraatz, Sebastian/0000-0003-2265-9052; HAMEL, VIRGINIE/0000-0001-5092-2343	ERC [233335, 340227]; JSPS KAKENHI [24370079, 25113503]; Swiss National Centre of Competence in Research 'Molecular Systems Engineering'; Swiss National Science Foundation [200021_134521, 31003A_146520, 310030B_138659]	ERC(European Research Council (ERC)European Commission); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Swiss National Centre of Competence in Research 'Molecular Systems Engineering'; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	We are grateful to V. Oliveri and U. Sauder (University of Basel) for excellent support and access to the electron microscope, and to V. Olieric and M. Wang (Swiss Light Source) for beamline support; we thank R. Kamiya (Gakushuin University) for insightful discussions. The molecular dynamics simulations were performed at the Swiss National Supercomputing Centre and at the high-performance computing facility at the Paul Scherrer Institute, and the EM of human centrioles at the EPFL EM facility (CIME). This work was supported by grants from the ERC (AdG 233335 and AdG 340227; to P.G.), the JSPS KAKENHI (24370079 and 25113503; to M.H.), the Swiss National Centre of Competence in Research 'Molecular Systems Engineering' (to D.J.M. and R.A.K.) and the Swiss National Science Foundation (200021_134521, 31003A_146520 and 310030B_138659; to D.J.M., X.D. and M.O.S., respectively).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Arquint C, 2012, J CELL SCI, V125, P1342, DOI 10.1242/jcs.099887; Azimzadeh J, 2010, CURR BIOL, V20, pR816, DOI 10.1016/j.cub.2010.08.010; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; BORNENS M, 1987, CELL MOTIL CYTOSKEL, V8, P238, DOI 10.1002/cm.970080305; Bornens M, 2012, SCIENCE, V335, P422, DOI 10.1126/science.1209037; Brown NJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069986; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Culver BP, 2009, MOL BIOL CELL, V20, P1865, DOI 10.1091/mbc.E08-08-0838; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Gonczy P, 2012, NAT REV MOL CELL BIO, V13, P425, DOI 10.1038/nrm3373; GORMAN DS, 1965, P NATL ACAD SCI USA, V54, P1665, DOI 10.1073/pnas.54.6.1665; Guichard P, 2013, CURR BIOL, V23, P1620, DOI 10.1016/j.cub.2013.06.061; Guichard P, 2012, SCIENCE, V337, P553, DOI 10.1126/science.1222789; Guichard P, 2010, EMBO J, V29, P1565, DOI 10.1038/emboj.2010.45; Harris E. H., 1989, CHLAMYDOMONAS SOURCE; Hatzopoulos GN, 2013, STRUCTURE, V21, P2069, DOI 10.1016/j.str.2013.08.019; Heymann JB, 2007, J STRUCT BIOL, V157, P3, DOI 10.1016/j.jsb.2006.06.006; Hilbert M, 2013, P NATL ACAD SCI USA, V110, P11373, DOI 10.1073/pnas.1302721110; Hiraki M, 2007, CURR BIOL, V17, P1778, DOI 10.1016/j.cub.2007.09.021; Hirono M, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0458; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jana SC, 2014, CURR OPIN CELL BIOL, V26, P96, DOI 10.1016/j.ceb.2013.12.001; Jerka-Dziadosz M, 2010, CYTOSKELETON, V67, P161, DOI 10.1002/cm.20433; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Keller D, 2014, J CELL BIOL, V204, P697, DOI 10.1083/jcb.201307049; Kitagawa D, 2011, CELL, V144, P364, DOI 10.1016/j.cell.2011.01.008; Kleylein-Sohn J, 2007, DEV CELL, V13, P190, DOI 10.1016/j.devcel.2007.07.002; Lau L, 2011, PROC SPIE, V7910, DOI 10.1117/12.881221; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Lin YC, 2013, EMBO J, V32, P1141, DOI 10.1038/emboj.2013.56; Lukinaviclus G, 2013, CURR BIOL, V23, P265, DOI 10.1016/j.cub.2012.12.030; MacKerell AD, 2001, BIOPOLYMERS, V56, P257; Matsuura K, 2004, J CELL BIOL, V165, P663, DOI 10.1083/jcb.200402022; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mottier-Pavie V, 2009, MOL BIOL CELL, V20, P2605, DOI 10.1091/mbc.E08-11-1115; Nakazawa Y, 2007, CURR BIOL, V17, P2169, DOI 10.1016/j.cub.2007.11.046; Nigg EA, 2009, CELL, V139, P663, DOI 10.1016/j.cell.2009.10.036; Olieric N, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-56; Pfreundschuh M, 2014, NANO LETT, V14, P2957, DOI 10.1021/nl5012905; Pfreundschuh M, 2014, NAT PROTOC, V9, P1113, DOI 10.1038/nprot.2014.070; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Qiao RP, 2012, EMBO J, V31, P4334, DOI 10.1038/emboj.2012.280; Rodrigues-Martins A, 2007, CURR BIOL, V17, P1465, DOI 10.1016/j.cub.2007.07.034; Shimogawara K, 1998, GENETICS, V148, P1821; Sir JH, 2011, NAT GENET, V43, P1147, DOI 10.1038/ng.971; Sizova I, 2001, GENE, V277, P221, DOI 10.1016/S0378-1119(01)00616-3; Sonnen KF, 2012, BIOL OPEN, V1, P965, DOI 10.1242/bio.20122337; Strnad P, 2008, TRENDS CELL BIOL, V18, P389, DOI 10.1016/j.tcb.2008.06.004; Strnad P, 2007, DEV CELL, V13, P203, DOI 10.1016/j.devcel.2007.07.004; van Breugel M, 2014, ELIFE, V3, DOI 10.7554/eLife.01812; van Breugel M, 2011, SCIENCE, V331, P1196, DOI 10.1126/science.1199325; WRIGHT RL, 1985, J CELL BIOL, V101, P1903, DOI 10.1083/jcb.101.5.1903	54	51	52	2	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2016	18	4					393	+		10.1038/ncb3329	http://dx.doi.org/10.1038/ncb3329			24	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	DH7LX	26999736	Green Published, Green Submitted			2022-12-25	WOS:000372976600007
J	Beltran, H; Prandi, D; Mosquera, JM; Benelli, M; Puca, L; Cyrta, J; Marotz, C; Giannopoulou, E; Chakravarthi, BVSK; Varambally, S; Tomlins, SA; Nanus, DM; Tagawa, ST; Van Allen, EM; Elemento, O; Sboner, A; Garraway, LA; Rubin, MA; Demichelis, F				Beltran, Himisha; Prandi, Davide; Mosquera, Juan Miguel; Benelli, Matteo; Puca, Loredana; Cyrta, Joanna; Marotz, Clarisse; Giannopoulou, Eugenia; Chakravarthi, Balabhadrapatruni V. S. K.; Varambally, Sooryanarayana; Tomlins, Scott A.; Nanus, David M.; Tagawa, Scott T.; Van Allen, Eliezer M.; Elemento, Olivier; Sboner, Andrea; Garraway, Levi A.; Rubin, Mark A.; Demichelis, Francesca			Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer	NATURE MEDICINE			English	Article							SMALL-CELL CARCINOMA; INCREASED SURVIVAL; EZH2; ADENOCARCINOMA; ENZALUTAMIDE; PROGRESSION; ABIRATERONE; REPRESSION; SIGNATURE; ESTROGEN	An increasingly recognized resistance mechanism to androgen receptor (AR)-directed therapy in prostate cancer involves epithelial plasticity, in which tumor cells demonstrate low to absent AR expression and often have neuroendocrine features. The etiology and molecular basis for this 'alternative' treatment-resistant cell state remain incompletely understood. Here, by analyzing whole-exome sequencing data of metastatic biopsies from patients, we observed substantial genomic overlap between castration-resistant tumors that were histologically characterized as prostate adenocarcinomas (CRPC-Adeno) and neuroendocrine prostate cancer (CRPC-NE); analysis of biopsy samples from the same individuals over time points to a model most consistent with divergent clonal evolution. Genome-wide DNA methylation analysis revealed marked epigenetic differences between CRPC-NE tumors and CRPC-Adeno, and also designated samples of CRPC-Adeno with clinical features of AR independence as CRPC-NE, suggesting that epigenetic modifiers may play a role in the induction and/or maintenance of this treatment-resistant state. This study supports the emergence of an alternative, 'AR-indifferent' cell state through divergent clonal evolution as a mechanism of treatment resistance in advanced prostate cancer.	[Beltran, Himisha; Mosquera, Juan Miguel; Puca, Loredana; Cyrta, Joanna; Marotz, Clarisse; Elemento, Olivier; Sboner, Andrea; Rubin, Mark A.; Demichelis, Francesca] Weill Cornell Med, New York Presbyterian Hosp, Caryl & Israel Englander Inst Precis Med, New York, NY USA; [Beltran, Himisha; Nanus, David M.; Tagawa, Scott T.] Weill Cornell Med, Div Hematol & Med Oncol, Dept Med, New York, NY USA; [Beltran, Himisha; Nanus, David M.; Tagawa, Scott T.; Rubin, Mark A.] Weill Cornell Med, Sandra & Edward Meyer Canc Ctr, New York, NY USA; [Prandi, Davide; Benelli, Matteo; Demichelis, Francesca] Univ Trento, Ctr Integrat Biol, Trento, Italy; [Mosquera, Juan Miguel; Sboner, Andrea; Rubin, Mark A.] Weill Cornell Med, Dept Pathol & Lab Med, New York, NY USA; [Giannopoulou, Eugenia; Elemento, Olivier] Weill Cornell Med, Dept Physiol & Biophys, New York, NY USA; [Chakravarthi, Balabhadrapatruni V. S. K.; Varambally, Sooryanarayana] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Tomlins, Scott A.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Van Allen, Eliezer M.; Garraway, Levi A.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Van Allen, Eliezer M.; Garraway, Levi A.] Broad Inst MIT & Harvard Univ, Cambridge, MA USA; [Sboner, Andrea; Demichelis, Francesca] Weill Cornell Med, Inst Computat Biomed, New York, NY USA; [Garraway, Levi A.] Dana Farber Canc Inst, Ctr Canc Precis Med, Boston, MA 02115 USA; [Garraway, Levi A.] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA	Cornell University; NewYork-Presbyterian Hospital; Cornell University; Cornell University; University of Trento; Cornell University; Cornell University; University of Alabama System; University of Alabama Birmingham; University of Michigan System; University of Michigan; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Cornell University; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital	Beltran, H (corresponding author), Weill Cornell Med, New York Presbyterian Hosp, Caryl & Israel Englander Inst Precis Med, New York, NY USA.; Beltran, H (corresponding author), Weill Cornell Med, Div Hematol & Med Oncol, Dept Med, New York, NY USA.; Beltran, H (corresponding author), Weill Cornell Med, Sandra & Edward Meyer Canc Ctr, New York, NY USA.	hip9004@med.cornell.edu; rubinma@med.cornell.edu; f.demichelis@unitn.it	Puca, Loredana/O-4182-2019; Benelli, Matteo/I-2497-2018; Giannopoulou, Evgenia/K-9576-2019; Demichelis, Francesca/J-9829-2016	Puca, Loredana/0000-0002-0895-1519; Benelli, Matteo/0000-0003-1227-356X; Demichelis, Francesca/0000-0002-8266-8631; Rubin, Mark/0000-0002-8321-9950; Varambally, Sooryanarayana/0000-0002-2277-1127; Tagawa, Scott/0000-0003-2777-8587; Prandi, Davide/0000-0001-9885-6074	Damon Runyon Cancer Research Foundation [CI-67-13]; Ann and William Bresnan Foundation; Department of Defense [PC121341]; US National Institutes of Health (NIH) [R01 CA116337, R01CA157845, R01 CA183857, 1K08CA188615, U54 HG003067, U01CA162148, 5U01 CA111275-09]; Starr Cancer Consortium; American-Italian Cancer Foundation; Nuovo Soldati Foundation; A. Alfred Taubman Medical Institute; Prostate Cancer Foundation Young Investigator Award; Associazione Italians per la Ricerca sul Cancro (AIRC) [IG 13562]; European Research Council; Prostate Cancer Foundation; Stand Up To Cancer-Prostate Cancer Foundation Prostate Dream Team translational cancer research grant; Entertainment Industry Foundation [SU2C-AACR-DT0712]; NATIONAL CANCER INSTITUTE [P50CA090381, R01CA116337, K08CA188615, U01CA111275, R01CA157845, U01CA162148, R01CA183857] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000457] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067] Funding Source: NIH RePORTER	Damon Runyon Cancer Research Foundation; Ann and William Bresnan Foundation; Department of Defense(United States Department of Defense); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Starr Cancer Consortium; American-Italian Cancer Foundation; Nuovo Soldati Foundation; A. Alfred Taubman Medical Institute; Prostate Cancer Foundation Young Investigator Award; Associazione Italians per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); European Research Council(European Research Council (ERC)European Commission); Prostate Cancer Foundation; Stand Up To Cancer-Prostate Cancer Foundation Prostate Dream Team translational cancer research grant; Entertainment Industry Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank our patients and their families for participation in this study. We would also like to acknowledge R. Montgomery, A. Armstrong and R. Szmulewitz for contributing samples and S.S. Chae for his technical assistance. H.B. is the Damon Runyon-Gordon Family Clinical Investigator and is supported (in part) by the Damon Runyon Cancer Research Foundation (award no. CI-67-13). This work was also supported by the Ann and William Bresnan Foundation (H.B. and D.M.N.), the Department of Defense (grant no. PC121341; H.B.), the US National Institutes of Health (NIH) (grant no. R01 CA116337 (H.B., F.D. and M.A.R.), R01CA157845 (S.V.), R01 CA183857 (S.A.T.), 1K08CA188615 (E.M.V.A.), U54 HG003067 (L.A.G.), U01CA162148 (L.A.G.), 5U01 CA111275-09 (J.M.M., M.A.R. and F.D.), the Starr Cancer Consortium (H.B., L.A.G. and M.A.R), the American-Italian Cancer Foundation (L.P.), the Nuovo Soldati Foundation (J.C.), the A. Alfred Taubman Medical Institute (S.A.T.), a Prostate Cancer Foundation Young Investigator Award (E.M.V.A.), the Associazione Italians per la Ricerca sul Cancro (AIRC; grant no. IG 13562; F.D.), the European Research Council (consolidator grant (CoG) SPICE (Synthetic lethal phenotype identification through cancer evolution analysis); F.D.) and the Prostate Cancer Foundation (H.B., S.A.T., M.A.R. and F.D.). H.B., J.M.M., SAT., D.M.N., S.T.T., E.M.V.A., O.E., AS., L.A.G., M.A.R and F.D. are supported by a Stand Up To Cancer-Prostate Cancer Foundation Prostate Dream Team translational cancer research grant. Stand Up To Cancer is a program of the Entertainment Industry Foundation that is administered by the American Association for Cancer Research (grant no. SU2C-AACR-DT0712).	Abeshouse A, 2015, CELL, V163, P1011, DOI 10.1016/j.cell.2015.10.025; Akamatsu S, 2015, CELL REP, V12, P922, DOI 10.1016/j.celrep.2015.07.012; Antonarakis ES, 2014, NEW ENGL J MED, V371, P1028, DOI 10.1056/NEJMoa1315815; Aparicio A, 2014, ONCOLOGY-NY, V28, P831; Baca SC, 2013, CELL, V153, P666, DOI 10.1016/j.cell.2013.03.021; Barbieri CE, 2012, NAT GENET, V44, P685, DOI 10.1038/ng.2279; Beltran H, 2012, J CLIN ONCOL, V30, pE386, DOI 10.1200/JCO.2011.41.5166; Beltran H, 2011, CANCER DISCOV, V1, P487, DOI 10.1158/2159-8290.CD-11-0130; Borno ST, 2012, CANCER DISCOV, V2, P1024, DOI 10.1158/2159-8290.CD-12-0041; Carreira S, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009448; Chakravarty D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6383; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; Chen HB, 2012, ENDOCR-RELAT CANCER, V19, P321, DOI 10.1530/ERC-11-0368; Cheng ASL, 2011, CANCER RES, V71, P4028, DOI 10.1158/0008-5472.CAN-10-3342; Clermont PL, 2015, CLIN EPIGENETICS, V7, DOI 10.1186/s13148-015-0074-4; De Bono JS, 2011, NEW ENGL J MED, V364, P1995, DOI 10.1056/NEJMoa1014618; Epstein JI, 2014, AM J SURG PATHOL, V38, P756, DOI 10.1097/PAS.0000000000000208; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; Gundem G, 2015, NATURE, V520, P353, DOI 10.1038/nature14347; Hansel DE, 2009, PROSTATE, V69, P603, DOI 10.1002/pros.20910; Hieronymus H, 2006, CANCER CELL, V10, P321, DOI 10.1016/j.ccr.2006.09.005; Hu R, 2009, CANCER RES, V69, P16, DOI 10.1158/0008-5472.CAN-08-2764; Huggins C, 2002, J UROLOGY, V168, P9, DOI 10.1016/S0022-5347(05)64820-3; Kanduri M, 2013, EPIGENETICS-US, V8, P1280, DOI 10.4161/epi.26546; Karanikolas BDW, 2010, PROSTATE, V70, P675, DOI 10.1002/pros.21112; Knudsen KE, 2009, CLIN CANCER RES, V15, P4792, DOI 10.1158/1078-0432.CCR-08-2660; Lim JH, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1776; Lin D, 2014, CANCER RES, V74, P1272, DOI 10.1158/0008-5472.CAN-13-2921-T; Lin LJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111260; Maley CC, 2006, NAT GENET, V38, P468, DOI 10.1038/ng1768; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Prandi D, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0439-6; Pritchard CC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5988; Rajan N, 2014, ONCOTARGET, V5, P12126, DOI 10.18632/oncotarget.2573; Robinson D, 2015, CELL, V161, P1215, DOI 10.1016/j.cell.2015.05.001; Scher HI, 2012, NEW ENGL J MED, V367, P1187, DOI 10.1056/NEJMoa1207506; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Smith BA, 2015, P NATL ACAD SCI USA, V112, pE6544, DOI 10.1073/pnas.1518007112; Steffan JJ, 2012, J BIOL CHEM, V287, P29968, DOI 10.1074/jbc.M112.379396; Tan HL, 2014, CLIN CANCER RES, V20, P890, DOI 10.1158/1078-0432.CCR-13-1982; Theurillat JPP, 2014, SCIENCE, V346, P85, DOI 10.1126/science.1250255; Varambally S, 2008, SCIENCE, V322, P1695, DOI 10.1126/science.1165395; Wang HT, 2014, J CLIN ONCOL, V32, P3383, DOI 10.1200/JCO.2013.54.3553; Watson PA, 2015, NAT REV CANCER, V15, P701, DOI 10.1038/nrc4016; Yao JL, 2006, AM J SURG PATHOL, V30, P705, DOI 10.1097/00000478-200606000-00005; Yu J, 2007, CANCER RES, V67, P10657, DOI 10.1158/0008-5472.CAN-07-2498; Zhou ZX, 2006, CANCER RES, V66, P7889, DOI 10.1158/0008-5472.CAN-06-0486	48	842	860	4	92	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2016	22	3					298	305		10.1038/nm.4045	http://dx.doi.org/10.1038/nm.4045			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DF6DC	26855148	Green Accepted, Green Submitted			2022-12-25	WOS:000371445100017
J	Duman, RS; Aghajanian, GK; Sanacora, G; Krysta, JH				Duman, Ronald S.; Aghajanian, George K.; Sanacora, Gerard; Krysta, John H.			Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants	NATURE MEDICINE			English	Article							D-ASPARTATE ANTAGONIST; BDNF VAL66MET POLYMORPHISM; HIPPOCAMPAL CA3C NEURONS; MEDIAL PREFRONTAL CORTEX; NMDA RECEPTOR BLOCKADE; MTOR SIGNALING PATHWAY; C-REACTIVE PROTEIN; STAR-ASTERISK-D; MEMORY CONSOLIDATION; INSULIN-RESISTANCE	Depression is a common, devastating illness. Current pharmacotherapies help many patients, but high rates of a partial response or no response, and the delayed onset of the effects of antidepressant therapies, leave many patients inadequately treated. However, new insights into the neurobiology of stress and human mood disorders have shed light on mechanisms underlying the vulnerability of individuals to depression and have pointed to novel antidepressants. Environmental events and other risk factors contribute to depression through converging molecular and cellular mechanisms that disrupt neuronal function and morphology, resulting in dysfunction of the circuitry that is essential for mood regulation and cognitive function. Although current antidepressants, such as serotonin-reuptake inhibitors, produce subtle changes that take effect in weeks or months, it has recently been shown that treatment with new agents results in an improvement in mood ratings within hours of dosing patients who are resistant to typical antidepressants. Within a similar time scale, these new agents have also been shown to reverse the synaptic deficits caused by stress.	[Duman, Ronald S.; Aghajanian, George K.; Sanacora, Gerard; Krysta, John H.] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT USA; [Duman, Ronald S.; Aghajanian, George K.; Sanacora, Gerard; Krysta, John H.] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT USA	Yale University; Yale University	Duman, RS (corresponding author), Yale Univ, Sch Med, Dept Psychiat, New Haven, CT USA.; Duman, RS (corresponding author), Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT USA.	ronald.duman@yale.edu	Sanacora, Gerard/AAF-1135-2019		US National Institute of Mental Health [MH045481, MH093897]; National Center for Advancing Translational Science [1UH2TR000960-01]; National Institute on Alcohol Abuse and Alcoholism [P50AA12870, M01RR00125]; Yale Center for Clinical Investigation [UL1 RR024139]; state of Connecticut's Department of Mental Health and Addiction Services (DMHAS); Yale University School of Medicine; Brain and Behavior Research Foundation; Pfeiffer Research Foundation; National Center for Posttraumatic Stress Disorder; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UH2TR000960] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000125, UL1RR024139] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R29MH045481, R01MH105910, R01MH045481, R01MH093897, R37MH045481] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P50AA012870] Funding Source: NIH RePORTER	US National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Center for Advancing Translational Science; National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Yale Center for Clinical Investigation; state of Connecticut's Department of Mental Health and Addiction Services (DMHAS); Yale University School of Medicine; Brain and Behavior Research Foundation; Pfeiffer Research Foundation; National Center for Posttraumatic Stress Disorder; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by the US National Institute of Mental Health grants MH045481 (R.S.D.) and MH093897 (R.S.D.), the National Center for Advancing Translational Science grant 1UH2TR000960-01 (J.H.K.), the National Institute on Alcohol Abuse and Alcoholism grants P50AA12870 (J.H.K.) and M01RR00125 (J.H.K.), the Yale Center for Clinical Investigation grant UL1 RR024139 (J.H.K.), the state of Connecticut's Department of Mental Health and Addiction Services (DMHAS; to R.S.D., G.K.A., G.S. and J.H.K.), the Yale University School of Medicine (R.S.D. and J.H.K.), the Brain and Behavior Research Foundation (G.S.), the Pfeiffer Research Foundation (G.S. and J.H.K.) and the National Center for Posttraumatic Stress Disorder (R.S.D., G.S. and J.H.K.).	Abbott CC, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.124; Abdallah CG, 2014, AM J PSYCHIAT, V171, P1320, DOI 10.1176/appi.ajp.2014.14010067; Agudelo LZ, 2014, CELL, V159, P33, DOI 10.1016/j.cell.2014.07.051; Ampuero E, 2010, NEUROSCIENCE, V169, P98, DOI 10.1016/j.neuroscience.2010.04.035; Arai AC, 2007, CURR DRUG TARGETS, V8, P583, DOI 10.2174/138945007780618490; Arnold SE, 2014, NEUROBIOL DIS, V67, P79, DOI 10.1016/j.nbd.2014.03.011; Autry AE, 2011, NATURE, V475, P91, DOI 10.1038/nature10130; Autry AE, 2009, BIOL PSYCHIAT, V66, P84, DOI 10.1016/j.biopsych.2009.02.007; Barouk S, 2011, ENDOCRINOLOGY, V152, P1745, DOI 10.1210/en.2010-1290; Bath KG, 2012, NEUROPSYCHOPHARMACOL, V37, P1297, DOI 10.1038/npp.2011.318; Berman RM, 2000, BIOL PSYCHIAT, V47, P351, DOI 10.1016/S0006-3223(99)00230-9; Bessa JM, 2009, MOL PSYCHIATR, V14, P764, DOI 10.1038/mp.2008.119; Bloch M, 2003, COMPR PSYCHIAT, V44, P234, DOI 10.1016/S0010-440X(03)00034-8; Bocchio-Chiavetto L, 2010, WORLD J BIOL PSYCHIA, V11, P763, DOI 10.3109/15622971003611319; Borrow AP, 2014, PROG NEURO-PSYCHOPH, V54, P13, DOI 10.1016/j.pnpbp.2014.05.009; Boulanger LM, 2009, NEURON, V64, P93, DOI 10.1016/j.neuron.2009.09.001; Carmichael ST, 1995, J COMP NEUROL, V363, P642, DOI 10.1002/cne.903630409; Castren E, 2005, NAT REV NEUROSCI, V6, P241, DOI 10.1038/nrn1629; Castren E, 2013, TRENDS NEUROSCI, V36, P259, DOI 10.1016/j.tins.2012.12.010; Cavus I, 2003, BIOL PSYCHIAT, V54, P59, DOI 10.1016/S0006-3223(03)00236-1; Chandran A, 2013, PROG NEURO-PSYCHOPH, V40, P240, DOI 10.1016/j.pnpbp.2012.08.001; Chen H, 2006, NEUROREPORT, V17, P863, DOI 10.1097/01.wnr.0000221827.03222.70; Chen ZY, 2006, SCIENCE, V314, P140, DOI 10.1126/science.1129663; Choi J, 2013, OBES REV, V14, P232, DOI 10.1111/obr.12003; DeWilde KE, 2015, ANN NY ACAD SCI, V1345, P47, DOI 10.1111/nyas.12646; Dias BG, 2015, TRENDS NEUROSCI, V38, P96, DOI 10.1016/j.tins.2014.12.003; DiazGranados N, 2010, J CLIN PSYCHIAT, V71, P1605, DOI 10.4088/JCP.09m05327blu; Diazgranados N, 2010, ARCH GEN PSYCHIAT, V67, P793, DOI 10.1001/archgenpsychiatry.2010.90; Dinan TG, 2009, CURR OPIN PSYCHIATR, V22, P32, DOI 10.1097/YCO.0b013e328315a561; Dowlati Y, 2010, BIOL PSYCHIAT, V67, P446, DOI 10.1016/j.biopsych.2009.09.033; Drevets WC, 2010, BIOL PSYCHIAT, V67, P432, DOI 10.1016/j.biopsych.2009.11.021; Dukart J, 2014, P NATL ACAD SCI USA, V111, P1156, DOI 10.1073/pnas.1321399111; Duman CH, 2007, BIOL PSYCHIAT, V61, P661, DOI 10.1016/j.biopsych.2006.05.047; Duman RS, 2006, BIOL PSYCHIAT, V59, P1116, DOI 10.1016/j.biopsych.2006.02.013; Duman RS, 2012, SCIENCE, V338, P68, DOI 10.1126/science.1222939; Duman RS, 2012, TRENDS NEUROSCI, V35, P47, DOI 10.1016/j.tins.2011.11.004; Dunn EC, 2015, HARVARD REV PSYCHIAT, V23, P1, DOI 10.1097/HRP.0000000000000054; Duric V, 2010, NAT MED, V16, P1328, DOI 10.1038/nm.2219; Dwivedi Y, 2009, NEUROPSYCH DIS TREAT, V5, P433; Fan L, 2010, J NEUROSCI, V30, P4390, DOI 10.1523/JNEUROSCI.4333-09.2010; Feyissa AM, 2009, PROG NEURO-PSYCHOPH, V33, P70, DOI 10.1016/j.pnpbp.2008.10.005; Fortress AM, 2014, LEARN MEMORY, V21, P457, DOI 10.1101/lm.034033.113; Fortress AM, 2013, LEARN MEMORY, V20, P147, DOI 10.1101/lm.026732.112; Gardner A, 2011, PROG NEURO-PSYCHOPH, V35, P730, DOI 10.1016/j.pnpbp.2010.07.030; Gass N, 2014, NEUROPSYCHOPHARMACOL, V39, P895, DOI 10.1038/npp.2013.290; Gatt JM, 2009, MOL PSYCHIATR, V14, P681, DOI 10.1038/mp.2008.143; Gaynes BN, 2009, PSYCHIAT SERV, V60, P1439, DOI 10.1176/ps.2009.60.11.1439; Goshen I, 2007, PSYCHONEUROENDOCRINO, V32, P1106, DOI 10.1016/j.psyneuen.2007.09.004; HABER SN, 1995, J NEUROSCI, V15, P4851; Hao JD, 2006, J NEUROSCI, V26, P2571, DOI 10.1523/JNEUROSCI.3440-05.2006; Hardingham GE, 2010, NAT REV NEUROSCI, V11, P682, DOI 10.1038/nrn2911; Hendrickx H., 2005, NEUROBIOL AGING S1, P1; Hoeffer CA, 2010, TRENDS NEUROSCI, V33, P67, DOI 10.1016/j.tins.2009.11.003; Holtmaat A, 2009, NAT REV NEUROSCI, V10, P647, DOI 10.1038/nrn2699; Homayoun H, 2007, J NEUROSCI, V27, P11496, DOI 10.1523/JNEUROSCI.2213-07.2007; Howren MB, 2009, PSYCHOSOM MED, V71, P171, DOI 10.1097/PSY.0b013e3181907c1b; Hughes Zoe A, 2009, Curr Mol Pharmacol, V2, P215; Iwata M, 2016, BIOL PSYCHIAT, V80, P12, DOI 10.1016/j.biopsych.2015.11.026; Iwata M, 2013, BRAIN BEHAV IMMUN, V31, P105, DOI 10.1016/j.bbi.2012.12.008; Jernigan CS, 2011, PROG NEURO-PSYCHOPH, V35, P1774, DOI 10.1016/j.pnpbp.2011.05.010; Jiang B, 2015, INT J NEUROPSYCHOPH, V18, DOI 10.1093/ijnp/pyu096; Jourdi H, 2009, J NEUROSCI, V29, P8688, DOI 10.1523/JNEUROSCI.6078-08.2009; Kang HJ, 2012, NAT MED, V18, P1413, DOI 10.1038/nm.2886; Kangaspeska S, 2008, NATURE, V452, P112, DOI 10.1038/nature06640; Karki P, 2014, MOL CELL ENDOCRINOL, V389, P58, DOI 10.1016/j.mce.2014.01.010; Karpova NN, 2011, SCIENCE, V334, P1731, DOI 10.1126/science.1214592; Kassi E, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-48; Kaufman J, 2004, P NATL ACAD SCI USA, V101, P17316, DOI 10.1073/pnas.0404376101; Kaufman J, 2006, BIOL PSYCHIAT, V59, P673, DOI 10.1016/j.biopsych.2005.10.026; Kessels HW, 2009, NEURON, V61, P340, DOI 10.1016/j.neuron.2009.01.015; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; Khairova RA, 2009, INT J NEUROPSYCHOPH, V12, P561, DOI 10.1017/S1461145709009924; Kim JM, 2007, BIOL PSYCHIAT, V62, P423, DOI 10.1016/j.biopsych.2006.11.020; Kiss A, 2012, BEHAV BRAIN RES, V227, P100, DOI 10.1016/j.bbr.2011.10.047; Kleinridders A, 2015, P NATL ACAD SCI USA, V112, P3463, DOI 10.1073/pnas.1500877112; Krishnan V, 2008, NATURE, V455, P894, DOI 10.1038/nature07455; Krishnan V, 2007, CELL, V131, P391, DOI 10.1016/j.cell.2007.09.018; Krishnan V, 2010, AM J PSYCHIAT, V167, P1305, DOI 10.1176/appi.ajp.2009.10030434; Leone T, 2012, GLOBALIZATION HEALTH, V8, DOI 10.1186/1744-8603-8-39; Levinson DF, 2014, BIOL PSYCHIAT, V76, P510, DOI 10.1016/j.biopsych.2014.07.029; Li NX, 2011, BIOL PSYCHIAT, V69, P754, DOI 10.1016/j.biopsych.2010.12.015; Li NX, 2010, SCIENCE, V329, P959, DOI 10.1126/science.1190287; Licznerski P, 2013, NEUROSCIENCE, V251, P33, DOI 10.1016/j.neuroscience.2012.09.057; Liu RJ, 2008, P NATL ACAD SCI USA, V105, P359, DOI 10.1073/pnas.0706679105; Liu RJ, 2015, NEUROPSYCHOPHARMACOL, V40, P2066, DOI 10.1038/npp.2015.70; Liu RJ, 2013, NEUROPSYCHOPHARMACOL, V38, P2268, DOI 10.1038/npp.2013.128; Liu RJ, 2012, BIOL PSYCHIAT, V71, P996, DOI 10.1016/j.biopsych.2011.09.030; Lopez-Leon S, 2008, MOL PSYCHIATR, V13, P772, DOI 10.1038/sj.mp.4002088; LOWY MT, 1995, J NEUROCHEM, V65, P268; Lu XY, 2006, P NATL ACAD SCI USA, V103, P1593, DOI 10.1073/pnas.0508901103; Lu Y, 2008, NEUROBIOL LEARN MEM, V89, P312, DOI 10.1016/j.nlm.2007.08.018; Luoni A, 2015, INT J NEUROPSYCHOPH, V18, DOI 10.1093/ijnp/pyu061; Luppino FS, 2010, ARCH GEN PSYCHIAT, V67, P220, DOI 10.1001/archgenpsychiatry.2010.2; Lutter M, 2008, NAT NEUROSCI, V11, P752, DOI 10.1038/nn.2139; MacQueen GM, 2008, BIOL PSYCHIAT, V64, P880, DOI 10.1016/j.biopsych.2008.06.027; Maeng S, 2008, BIOL PSYCHIAT, V63, P349, DOI 10.1016/j.biopsych.2007.05.028; Magarinos AM, 2011, HIPPOCAMPUS, V21, P253, DOI 10.1002/hipo.20744; MAGARINOS AM, 1995, NEUROSCIENCE, V69, P89, DOI 10.1016/0306-4522(95)00259-L; MAGARINOS AM, 1995, NEUROSCIENCE, V69, P83, DOI 10.1016/0306-4522(95)00256-I; Magarinos AM, 2000, P NATL ACAD SCI USA, V97, P11056, DOI 10.1073/pnas.97.20.11056; Manji HK, 2001, NAT MED, V7, P541, DOI 10.1038/87865; Manji H, 2012, NAT REV NEUROSCI, V13, P293, DOI 10.1038/nrn3229; Mansur RB, 2015, NEUROSCI BIOBEHAV R, V52, P89, DOI 10.1016/j.neubiorev.2014.12.017; Markham A, 2012, EUR J NEUROSCI, V35, P366, DOI 10.1111/j.1460-9568.2011.07965.x; Marosi K, 2014, TRENDS ENDOCRIN MET, V25, P89, DOI 10.1016/j.tem.2013.10.006; Maya-Vetencourt JF, 2008, SCIENCE, V320, P385, DOI 10.1126/science.1150516; Mayer EA, 2014, J NEUROSCI, V34, P15490, DOI 10.1523/JNEUROSCI.3299-14.2014; McEwen BS, 2012, NEUROPHARMACOLOGY, V62, P3, DOI 10.1016/j.neuropharm.2011.07.014; Menke A, 2014, DIALOGUES CLIN NEURO, V16, P395; Miller AH, 2009, BIOL PSYCHIAT, V65, P732, DOI 10.1016/j.biopsych.2008.11.029; Miller BR, 2015, CURR OPIN NEUROBIOL, V30, P51, DOI 10.1016/j.conb.2014.08.012; Miller OH, 2014, ELIFE, V3, DOI 10.7554/eLife.03581; Minichiello L, 2009, NAT REV NEUROSCI, V10, P850, DOI 10.1038/nrn2738; Moghaddam B, 1997, J NEUROSCI, V17, P2921; Morrison JH, 2012, NAT REV NEUROSCI, V13, P240, DOI 10.1038/nrn3200; Moulton CD, 2015, LANCET DIABETES ENDO, V3, P461, DOI 10.1016/S2213-8587(15)00134-5; Murray CA, 1998, J NEUROSCI, V18, P2974; Murrough JW, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.10; Navarria A, 2015, NEUROBIOL DIS, V82, P254, DOI 10.1016/j.nbd.2015.06.012; Nemeroff CB, 2002, NAT NEUROSCI, V5, P1068, DOI 10.1038/nn943; Nestler EJ, 2014, JAMA PSYCHIAT, V71, P454, DOI 10.1001/jamapsychiatry.2013.4291; Nilsson S, 2011, CLIN PHARMACOL THER, V89, P44, DOI 10.1038/clpt.2010.226; O'Dushlaine C, 2015, NAT NEUROSCI, V18, P199, DOI 10.1038/nn.3922; Ongur D, 2003, J COMP NEUROL, V460, P425, DOI 10.1002/cne.10609; Osborn M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072813; Ota KT, 2014, NAT MED, V20, P535, DOI 10.1038/nm.3513; Packard MG, 1997, NEUROREPORT, V8, P3009, DOI 10.1097/00001756-199709290-00004; Palucha-Poniewiera A, 2014, NEUROPHARMACOLOGY, V82, P59, DOI 10.1016/j.neuropharm.2014.03.001; Paolicelli RC, 2011, SCIENCE, V333, P1456, DOI 10.1126/science.1202529; Pasquali R, 2012, ANN NY ACAD SCI, V1264, P20, DOI 10.1111/j.1749-6632.2012.06569.x; Patton MH, 2013, J NEUROSCI, V 33, P16865, DOI 10.1523/JNEUROSCI.2449-13.2013; Paul RK, 2014, ANESTHESIOLOGY, V121, P149, DOI 10.1097/ALN.0000000000000285; Petra AI, 2015, CLIN THER, V37, P984, DOI 10.1016/j.clinthera.2015.04.002; Phillips M, 2008, MOL PSYCHIATR, V13, P833, DOI 10.1038/mp.2008.65; Phillips ML, 2015, AM J PSYCHIAT, V172, P124, DOI 10.1176/appi.ajp.2014.14010076; Pilc A, 2008, BIOCHEM PHARMACOL, V75, P997, DOI 10.1016/j.bcp.2007.09.021; Pizzagalli DA, 2014, ANNU REV CLIN PSYCHO, V10, P393, DOI 10.1146/annurev-clinpsy-050212-185606; Popoli M, 2012, NAT REV NEUROSCI, V13, P22, DOI 10.1038/nrn3138; Preskorn S., 2007, 115 ANN M AM PSYCH A; Price JL, 2010, NEUROPSYCHOPHARMACOL, V35, P192, DOI 10.1038/npp.2009.104; Price RB, 2009, BIOL PSYCHIAT, V66, P522, DOI 10.1016/j.biopsych.2009.04.029; Raison CL, 2013, JAMA PSYCHIAT, V70, P31, DOI 10.1001/2013.jamapsychiatry.4; Raison CL, 2013, BRAIN BEHAV IMMUN, V31, P1, DOI 10.1016/j.bbi.2013.04.009; Raison CL, 2006, TRENDS IMMUNOL, V27, P24, DOI 10.1016/j.it.2005.11.006; Reaven GM, 2011, J INTERN MED, V269, P127, DOI 10.1111/j.1365-2796.2010.02325.x; Rethorst CD, 2014, J CLIN PSYCHIAT, V75, pE1428, DOI 10.4088/JCP.14m09009; Rubinow DR, 2011, DEPRESS ANXIETY, V28, pE1, DOI 10.1002/da.20833; Russo SJ, 2013, NAT REV NEUROSCI, V14, P609, DOI 10.1038/nrn3381; Russo SJ, 2012, NAT NEUROSCI, V15, P1475, DOI 10.1038/nn.3234; Sanacora G, 2014, MOL PSYCHIATR, V19, P978, DOI 10.1038/mp.2013.130; Sanacora G, 2008, NAT REV DRUG DISCOV, V7, P426, DOI 10.1038/nrd2462; Sanacora G, 2015, NEUROPSYCHOPHARMACOL, V40, P1307, DOI 10.1038/npp.2014.338; Savitz J, 2009, NEUROSCI BIOBEHAV R, V33, P699, DOI 10.1016/j.neubiorev.2009.01.004; Schafer DP, 2012, NEURON, V74, P691, DOI 10.1016/j.neuron.2012.03.026; Scharfman HE, 2006, EPILEPSIA, V47, P1423, DOI 10.1111/j.1528-1167.2006.00672.x; Schwartz E, 2012, NAT MED, V18, P496, DOI 10.1038/nm.2716; Shansky RM, 2009, BRAIN RES, V1293, P108, DOI 10.1016/j.brainres.2009.03.062; Spencer JL, 2008, FRONT NEUROENDOCRIN, V29, P219, DOI 10.1016/j.yfrne.2007.08.006; Spencer JL, 2010, P NATL ACAD SCI USA, V107, P4395, DOI 10.1073/pnas.0915105107; Spencer SJ, 2015, BIOL PSYCHIAT, V78, P19, DOI 10.1016/j.biopsych.2014.10.021; Stellwagen D, 2006, NATURE, V440, P1054, DOI 10.1038/nature04671; Stephan AH, 2012, ANNU REV NEUROSCI, V35, P369, DOI 10.1146/annurev-neuro-061010-113810; Stone JM, 2012, MOL PSYCHIATR, V17, P664, DOI 10.1038/mp.2011.171; Stranahan AM, 2008, HIPPOCAMPUS, V18, P1085, DOI 10.1002/hipo.20470; Sullivan PF, 2000, AM J PSYCHIAT, V157, P1552, DOI 10.1176/appi.ajp.157.10.1552; Sun HS, 2013, NEUROPSYCHOPHARMACOL, V38, P124, DOI 10.1038/npp.2012.73; Tabak AG, 2014, LANCET DIABETES ENDO, V2, P236, DOI 10.1016/S2213-8587(13)70139-6; Takei N, 2004, J NEUROSCI, V24, P9760, DOI 10.1523/JNEUROSCI.1427-04.2004; Trivedi MH, 2006, AM J PSYCHIAT, V163, P28, DOI 10.1176/appi.ajp.163.1.28; Turner CA, 2006, BIOL PSYCHIAT, V59, P1128, DOI 10.1016/j.biopsych.2006.02.026; Unger TJ, 2007, J NEUROSCI, V27, P14265, DOI 10.1523/JNEUROSCI.3308-07.2007; van Dooren FEP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057058; Vertes RP, 2004, SYNAPSE, V51, P32, DOI 10.1002/syn.10279; Vogelzangs N, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.8; Voleti B, 2013, BIOL PSYCHIAT, V74, P742, DOI 10.1016/j.biopsych.2013.04.025; Volkow ND, 2008, PHILOS T R SOC B, V363, P3191, DOI 10.1098/rstb.2008.0107; Volkow ND, 2011, TRENDS COGN SCI, V15, P37, DOI 10.1016/j.tics.2010.11.001; Voss MW, 2013, TRENDS COGN SCI, V17, P525, DOI 10.1016/j.tics.2013.08.001; Walker ER, 2015, JAMA PSYCHIAT, V72, P334, DOI 10.1001/jamapsychiatry.2014.2502; Wallis JD, 2012, NAT NEUROSCI, V15, P13, DOI 10.1038/nn.2956; Watson K, 2014, SEMIN CELL DEV BIOL, V36, P130, DOI 10.1016/j.semcdb.2014.08.013; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Wedrychowicz A, 2014, WORLD J PSYCHIATR, V4, P103, DOI 10.5498/wjp.v4.i4.103; Wei J, 2014, MOL PSYCHIATR, V19, P588, DOI 10.1038/mp.2013.83; Whiteford HA, 2013, LANCET, V382, P1575, DOI 10.1016/S0140-6736(13)61611-6; Witkin JM, 2014, J PHARMACOL EXP THER, V351, P448, DOI 10.1124/jpet.114.216804; WOOLLEY CS, 1992, J NEUROSCI, V12, P2549; Yoshihara Y, 2009, CURR OPIN NEUROBIOL, V19, P146, DOI 10.1016/j.conb.2009.05.013; Yu H, 2012, J NEUROSCI, V32, P4092, DOI 10.1523/JNEUROSCI.5048-11.2012; Zarate CA, 2006, ARCH GEN PSYCHIAT, V63, P856, DOI 10.1001/archpsyc.63.8.856; Zhang Y, 2013, NEUROPSYCHOPHARMACOL, V38, P111, DOI 10.1038/npp.2012.149; Zhong P, 2014, NEUROPSYCHOPHARMACOL, V39, P1763, DOI 10.1038/npp.2014.24; Zhou LH, 2015, NEUROPSYCH DIS TREAT, V11, P715, DOI 10.2147/NDT.S61997; Zhou W, 2014, EUR PSYCHIAT, V29, P419, DOI 10.1016/j.eurpsy.2013.10.005	194	748	790	13	331	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2016	22	3					238	249		10.1038/nm.4050	http://dx.doi.org/10.1038/nm.4050			12	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DF6DC	26937618	Green Accepted			2022-12-25	WOS:000371445100010
J	Solomon, B; Kingsford, C				Solomon, Brad; Kingsford, Carl			Fast search of thousands of short-read sequencing experiments	NATURE BIOTECHNOLOGY			English	Article							CASCADING BLOOM FILTERS; RNA-SEQ READS; TEXT; COMPRESSION; EFFICIENT; INDEXES; GRAPHS	The amount of sequence information in public repositories is growing at a rapid rate. Although these data are likely to contain clinically important information that has not yet been uncovered, our ability to effectively mine these repositories is limited. Here we introduce Sequence Bloom Trees (SBTs), a method for querying thousands of short-read sequencing experiments by sequence, 162 times faster than existing approaches. The approach searches large data archives for all experiments that involve a given sequence. We use SBTs to search 2,652 human blood, breast and brain RNA-seq experiments for all 214,293 known transcripts in under 4 days using less than 239 MB of RAM and a single CPU. Searching sequence archives at this scale and in this time frame is currently not possible using existing tools.	[Solomon, Brad] Carnegie Mellon Univ, Sch Comp Sci, Joint Carnegie Mellon Univ Univ Pittsburgh, PhD Program Computat Biol,Computat Biol Dept, Pittsburgh, PA 15213 USA; [Kingsford, Carl] Carnegie Mellon Univ, Sch Comp Sci, Computat Biol Dept, Pittsburgh, PA 15213 USA	Carnegie Mellon University; Carnegie Mellon University	Kingsford, C (corresponding author), Carnegie Mellon Univ, Sch Comp Sci, Computat Biol Dept, Pittsburgh, PA 15213 USA.	carlk@cs.cmu.edu			Gordon and Betty Moore Foundation's Data-Driven Discovery Initiative [GBMF4554]; US National Science Foundation [CCF-1256087, CCF-1319998]; US National Institutes of Health [R21HG006913, R01HG007104]; US National Institutes of Health as part of the Howard Hughes Medical Institute (HHMI)-National Institute of Biomedical Imaging and Bioengineering (NIBIB) Interfaces Initiative [T32 EB009403]; Direct For Computer & Info Scie & Enginr [1445606] Funding Source: National Science Foundation; Division of Computing and Communication Foundations [1256087] Funding Source: National Science Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R21HG006913, R01HG007104] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB009403] Funding Source: NIH RePORTER	Gordon and Betty Moore Foundation's Data-Driven Discovery Initiative; US National Science Foundation(National Science Foundation (NSF)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Institutes of Health as part of the Howard Hughes Medical Institute (HHMI)-National Institute of Biomedical Imaging and Bioengineering (NIBIB) Interfaces Initiative; Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE)); Division of Computing and Communication Foundations(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This research is funded in part by the Gordon and Betty Moore Foundation's Data-Driven Discovery Initiative through grant GBMF4554 to C.K., by the US National Science Foundation (CCF-1256087, CCF-1319998) and by the US National Institutes of Health (R21HG006913, R01HG007104). C.K. received support as an Alfred P. Sloan Research Fellow. B.S. is a predoctoral trainee supported by US National Institutes of Health training grant T32 EB009403 as part of the Howard Hughes Medical Institute (HHMI)-National Institute of Biomedical Imaging and Bioengineering (NIBIB) Interfaces Initiative." We would like to thank D. Filippova, J. Fong, H. Wang, E. Sefer, G. Johnson, and especially G. Marcais, G. Duggal and R. Patro for sharing their source code, and for valuable discussions and comments on the manuscript.	Baeza-Yates R. A., 1999, MODERN INFORM RETRIE; BLOOM BH, 1970, COMMUN ACM, V13, P422, DOI 10.1145/362686.362692; Broder A., 2004, INTERNET MATH, V1, P485, DOI [DOI 10.1080/15427951.2004.10129096, 10.1080/15427951.2004.10129096]; Brown C.T., ARXIV12034802QBIOGN; Burrows M, 1994, BLOCK SORTING LOSSLE; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Chikhi R, 2013, ALGORITHM MOL BIOL, V8, DOI 10.1186/1748-7188-8-22; Crainiceanu A., 2013, P 2 INT WORKSH CLOUD, DOI [10.1145/2501928.2501931, DOI 10.1145/2501928.2501931]; Crainiceanu A, 2015, INFORM SYST, V54, P311, DOI 10.1016/j.is.2015.01.002; Daniels NM, 2013, BIOINFORMATICS, V29, P283, DOI 10.1093/bioinformatics/btt214; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Ferragina P, 2005, J ACM, V52, P552, DOI 10.1145/1082036.1082039; Gog S, 2014, LECT NOTES COMPUT SC, V8504, P326, DOI 10.1007/978-3-319-07959-2_28; Grossi R, 2005, SIAM J COMPUT, V35, P378, DOI 10.1137/S0097539702402354; Grossi R., 2011, 2011 First International Conference on Data Compression, Communications and Processing, P210, DOI 10.1109/CCP.2011.16; Leinonen R, 2011, NUCLEIC ACIDS RES, V39, pD19, DOI 10.1093/nar/gkq1019; Loh PR, 2012, NAT BIOTECHNOL, V30, P627, DOI 10.1038/nbt.2241; Marcais G, 2011, BIOINFORMATICS, V27, P764, DOI 10.1093/bioinformatics/btr011; Melsted P, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-333; Navarro G, 2000, INFORM RETRIEVAL, V3, P49, DOI 10.1023/A:1009934302807; Navarro G, 2007, ACM COMPUT SURV, V39, DOI 10.1145/1216370.1216372; Patro R, 2014, NAT BIOTECHNOL, V32, P462, DOI 10.1038/nbt.2862; Pell J, 2012, P NATL ACAD SCI USA, V109, P13272, DOI 10.1073/pnas.1121464109; Philippe N, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-3-r30; Raman R, 2002, SIAM PROC S, P233; Rasmussen KR, 2006, J COMPUT BIOL, V13, P296, DOI 10.1089/cmb.2006.13.296; Rozov R, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-S9-S7; Salikhov K, 2014, ALGORITHM MOL BIOL, V9, DOI 10.1186/1748-7188-9-2; Stranneheim H, 2010, BIOINFORMATICS, V26, P1595, DOI 10.1093/bioinformatics/btq230; Witten Ian H., 1999, MANAGING GIGABYTES; Yu YW, 2015, CELL SYST, V1, P130, DOI 10.1016/j.cels.2015.08.004; Zhang QP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101271; Ziviani N, 2000, COMPUTER, V33, P37, DOI 10.1109/2.881693	33	71	71	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2016	34	3					300	+		10.1038/nbt.3442	http://dx.doi.org/10.1038/nbt.3442			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DG1CJ	26854477	Bronze, Green Accepted			2022-12-25	WOS:000371802600026
J	Huang, SW; Weigel, D; Beachy, RN; Li, JY				Huang, Sanwen; Weigel, Detlef; Beachy, Roger N.; Li, Jiayang			A proposed regulatory framework for genome-edited crops	NATURE GENETICS			English	Editorial Material							ZINC-FINGER NUCLEASES; DRAFT SEQUENCE; RICE; DOMESTICATION; CRISPR-CAS9; CUCUMBER; INSIGHTS; SYSTEM; MAP	Crop breeding is being revolutionized by rapid progress in DNA sequencing and targeted alteration of DNA sequences by genome editing. Here we propose a regulatory framework for precision breeding with 'genome-edited crops' (GECs) so that society can fully benefit from the latest advances in plant genetics and genomics.	[Huang, Sanwen] Chinese Acad Agr Sci, Agr Genom Inst Shenzhen, Shenzhen, Peoples R China; [Huang, Sanwen] Chinese Acad Agr Sci, Inst Vegetables & Flowers, Key Lab Biol & Genet Improvement Hort Crops, Minist Agr,Sino Dutch Joint Lab Hort Genom, Beijing 100193, Peoples R China; [Weigel, Detlef] Max Planck Inst Dev Biol, Dept Mol Biol, Tubingen, Germany; [Beachy, Roger N.] Univ Calif Davis, World Food Ctr, Davis, CA 95616 USA; [Li, Jiayang] State Key Lab Plant Genom, Beijing, Peoples R China; [Li, Jiayang] Natl Ctr Plant Gene Res Beijing, Beijing, Peoples R China; [Li, Jiayang] Chinese Acad Sci, Inst Genet & Dev Biol, Beijing, Peoples R China	Chinese Academy of Agricultural Sciences; Agriculture Genomes Institute at Shenzhen, CAAS; Chinese Academy of Agricultural Sciences; Institute of Vegetables & Flowers, CAAS; Ministry of Agriculture & Rural Affairs; Max Planck Society; University of California System; University of California Davis; Chinese Academy of Sciences; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS	Huang, SW (corresponding author), Chinese Acad Agr Sci, Agr Genom Inst Shenzhen, Shenzhen, Peoples R China.; Huang, SW (corresponding author), Chinese Acad Agr Sci, Inst Vegetables & Flowers, Key Lab Biol & Genet Improvement Hort Crops, Minist Agr,Sino Dutch Joint Lab Hort Genom, Beijing 100193, Peoples R China.; Weigel, D (corresponding author), Max Planck Inst Dev Biol, Dept Mol Biol, Tubingen, Germany.; Beachy, RN (corresponding author), Univ Calif Davis, World Food Ctr, Davis, CA 95616 USA.; Li, JY (corresponding author), State Key Lab Plant Genom, Beijing, Peoples R China.; Li, JY (corresponding author), Natl Ctr Plant Gene Res Beijing, Beijing, Peoples R China.; Li, JY (corresponding author), Chinese Acad Sci, Inst Genet & Dev Biol, Beijing, Peoples R China.	huangsanwen@caas.cn; weigel@tue.mpg.de; rbeachy@ucdavis.edu; jyli@genetics.ac.cn	Li, Jiayang/AAG-4377-2020; Weigel, Detlef/C-1418-2008; Weigel, Detlef/AAR-3312-2021; Weigel, Detlef/GSJ-0799-2022; Huang, Sanwen/ABE-9053-2020	Weigel, Detlef/0000-0002-2114-7963; Weigel, Detlef/0000-0002-2114-7963; Huang, Sanwen/0000-0002-8547-5309; Li, Jiayang/0000-0002-0487-6574				Arabidopsis Genome Initiative, 2000, Nature (London), V408, P796, DOI 10.1038/35048692; Baltes NJ, 2015, TRENDS BIOTECHNOL, V33, P120, DOI 10.1016/j.tibtech.2014.11.008; Berlin K, 2015, NAT BIOTECHNOL, V33, P623, DOI 10.1038/nbt.3238; Goff SA, 2002, SCIENCE, V296, P92, DOI 10.1126/science.1068275; Huang SW, 2009, NAT GENET, V41, P1275, DOI 10.1038/ng.475; Huang XH, 2012, NATURE, V490, P497, DOI 10.1038/nature11532; Ledford H, 2013, NATURE, V500, P389, DOI 10.1038/500389a; Li T, 2012, NAT BIOTECHNOL, V30, P390, DOI 10.1038/nbt.2199; Lin T, 2014, NAT GENET, V46, P1220, DOI 10.1038/ng.3117; Araus JL, 2014, TRENDS PLANT SCI, V19, P52, DOI 10.1016/j.tplants.2013.09.008; Obama B., 2011, FED REGISTER, V76, P3821; Park SJ, 2014, NAT GENET, V46, P1337, DOI 10.1038/ng.3131; Qi JJ, 2013, NAT GENET, V45, P1510, DOI 10.1038/ng.2801; Schonbrunn E, 2001, P NATL ACAD SCI USA, V98, P1376, DOI 10.1073/pnas.98.4.1376; Shukla VK, 2009, NATURE, V459, P437, DOI 10.1038/nature07992; Sternberg SH, 2015, MOL CELL, V58, P568, DOI 10.1016/j.molcel.2015.02.032; Townsend JA, 2009, NATURE, V459, P442, DOI 10.1038/nature07845; Wang MG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122755; Wang YP, 2014, NAT BIOTECHNOL, V32, P947, DOI 10.1038/nbt.2969; Woo JW, 2015, NAT BIOTECHNOL, V33, P1162, DOI 10.1038/nbt.3389; Xie KB, 2015, P NATL ACAD SCI USA, V112, P3570, DOI 10.1073/pnas.1420294112; Yu J, 2002, SCIENCE, V296, P79, DOI 10.1126/science.1068037; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; Zhou ZK, 2015, NAT BIOTECHNOL, V33, P408, DOI 10.1038/nbt.3096; 2012, EFSA J, V10, P2561	25	133	161	7	158	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2016	48	2					109	111		10.1038/ng.3484	http://dx.doi.org/10.1038/ng.3484			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DC2JV	26813761				2022-12-25	WOS:000369043900004
J	Saksens, NTM; Krebs, MP; Schoenmaker-Koller, FE; Hicks, W; Yu, MZ; Shi, LY; Rowe, L; Collin, GB; Charette, JR; Letteboer, SJ; Neveling, K; van Moorsel, TW; Abu-Ltaif, S; De Baere, E; Walraedt, S; Banfi, S; Simonelli, F; Cremers, FPM; Boon, CJF; Roepman, R; Leroy, BP; Peachey, NS; Hoyng, CB; Nishina, PM; den Hollander, AI				Saksens, Nicole T. M.; Krebs, Mark P.; Schoenmaker-Koller, Frederieke E.; Hicks, Wanda; Yu, Minzhong; Shi, Lanying; Rowe, Lucy; Collin, Gayle B.; Charette, Jeremy R.; Letteboer, Stef J.; Neveling, Kornelia; van Moorsel, Tamara W.; Abu-Ltaif, Sleiman; De Baere, Elfride; Walraedt, Sophie; Banfi, Sandro; Simonelli, Francesca; Cremers, Frans P. M.; Boon, Camiel J. F.; Roepman, Ronald; Leroy, Bart P.; Peachey, Neal S.; Hoyng, Carel B.; Nishina, Patsy M.; den Hollander, Anneke I.			Mutations in CTNNA1 cause butterfly-shaped pigment dystrophy and perturbed retinal pigment epithelium integrity	NATURE GENETICS			English	Article							AGE-RELATED MACULOPATHY; MACULAR DEGENERATION; PATTERN DYSTROPHY; ALPHA-CATENIN; RETINITIS-PIGMENTOSA; PERIPHERIN/RDS GENE; MOUSE MODEL; RDS GENE; CELLS; CADHERIN	Butterfly-shaped pigment dystrophy is an eye disease characterized by lesions in the macula that can resemble the wings of a butterfly. Here we report the identification of heterozygous missense mutations in the CTNNA1 gene (encoding alpha-catenin 1) in three families with butterfly-shaped pigment dystrophy. In addition, we identified a Ctnna1 missense mutation in a chemically induced mouse mutant, tvrm5. Parallel clinical phenotypes were observed in the retinal pigment epithelium (RPE) of individuals with butterfly-shaped pigment dystrophy and in tvrm5 mice, including pigmentary abnormalities, focal thickening and elevated lesions, and decreased light-activated responses. Morphological studies in tvrm5 mice demonstrated increased cell shedding and the presence of large multinucleated RPE cells, suggesting defects in intercellular adhesion and cytokinesis. This study identifies CTNNA1 gene variants as a cause of macular dystrophy, indicates that CTNNA1 is involved in maintaining RPE integrity and suggests that other components that participate in intercellular adhesion may be implicated in macular disease.	[Saksens, Nicole T. M.; Schoenmaker-Koller, Frederieke E.; van Moorsel, Tamara W.; Boon, Camiel J. F.; Hoyng, Carel B.; den Hollander, Anneke I.] Radboud Univ Nijmegen, Med Ctr, Dept Ophthalmol, NL-6525 ED Nijmegen, Netherlands; [Krebs, Mark P.; Hicks, Wanda; Shi, Lanying; Rowe, Lucy; Collin, Gayle B.; Charette, Jeremy R.; Nishina, Patsy M.] Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA; [Yu, Minzhong; Peachey, Neal S.] Cleveland Clin Fdn, Cole Eye Inst, Dept Ophthalm Res, 9500 Euclid Ave, Cleveland, OH 44195 USA; [Yu, Minzhong; Peachey, Neal S.] Case Western Reserve Univ, Dept Ophthalmol, Cleveland Clin, Lerner Coll Med, Cleveland, OH 44106 USA; [Letteboer, Stef J.; Neveling, Kornelia; Cremers, Frans P. M.; Roepman, Ronald; den Hollander, Anneke I.] Radboud Univ Nijmegen, Dept Human Genet, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Abu-Ltaif, Sleiman; Walraedt, Sophie; Leroy, Bart P.] Ghent Univ Hosp, Dept Ophthalmol, Ghent, Belgium; [De Baere, Elfride; Leroy, Bart P.] Ghent Univ Hosp, Ctr Med Genet, Ghent, Belgium; [Banfi, Sandro] Telethon Inst Genet & Med, Pozzuoli, Italy; [Banfi, Sandro] Univ Naples 2, Dept Biochem Biophys & Gen Pathol, Naples, Italy; [Simonelli, Francesca] Univ Naples 2, Eye Clin, Multidisciplinary Dept Med Surg & Dent Sci, Naples, Italy; [Boon, Camiel J. F.] Leiden Univ, Med Ctr, Dept Ophthalmol, Leiden, Netherlands; [Leroy, Bart P.] Childrens Hosp Ophthalmol, Div Ophthalmol, Philadelphia, PA USA; [Leroy, Bart P.] Childrens Hosp Ophthalmol, Ctr Cellular & Mol Therapeut, Philadelphia, PA USA; [Peachey, Neal S.] Louis Stokes Cleveland Vet Affairs Med Ctr, Res Serv, Cleveland, OH USA	Radboud University Nijmegen; Jackson Laboratory; Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation; Radboud University Nijmegen; Ghent University; Ghent University Hospital; Ghent University; Ghent University Hospital; Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); Universita della Campania Vanvitelli; Universita della Campania Vanvitelli; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center	den Hollander, AI (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Ophthalmol, NL-6525 ED Nijmegen, Netherlands.; den Hollander, AI (corresponding author), Radboud Univ Nijmegen, Dept Human Genet, Med Ctr, NL-6525 ED Nijmegen, Netherlands.	anneke.denhollander@radboudumc.nl	van Moorsel, Tamara/G-4693-2016; Peachey, Neal/G-5533-2010; Simonelli, Francesca/AHE-7571-2022; De Baere, Elfride/E-7405-2017; BANFI, Sandro/K-3963-2018; Boon, CJF/P-7534-2014	Peachey, Neal/0000-0002-4419-7226; Simonelli, Francesca/0000-0001-8520-6769; De Baere, Elfride/0000-0002-5609-6895; BANFI, Sandro/0000-0002-6541-8833; Krebs, Mark/0000-0001-9017-6066; Boon, CJF/0000-0002-6737-7932	Foundation Fighting Blindness Center [C-GE-0811-0548-RAD04]; Netherlands Organization for Scientific Research Vidi Innovational Research Award [016.096.309]; Nederlandse Oogonderzoek Stichting; Diana Hermens Stichting; Research Foundation-Flanders; FWO Flanders grant [3G079711]; Belgian Science Policy Office Interuniversity Attraction Poles programme [P7/43]; Netherlands Organization for Scientific Research Vici Innovational Research Award [865.12.005]; Foundation Fighting Blindness [C-CMM-0811-0546-RAD02]; US Veterans Administration Medical Research Service grant; Foundation Fighting Blindness Center Grant; Research to Prevent Blindness; US National Institutes of Health (NIH); National Eye Institute [EY016501]; US NIH National Cancer Institute [P30CA034196]; NATIONAL CANCER INSTITUTE [P30CA034196] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY016501] Funding Source: NIH RePORTER	Foundation Fighting Blindness Center; Netherlands Organization for Scientific Research Vidi Innovational Research Award; Nederlandse Oogonderzoek Stichting; Diana Hermens Stichting; Research Foundation-Flanders(FWO); FWO Flanders grant; Belgian Science Policy Office Interuniversity Attraction Poles programme; Netherlands Organization for Scientific Research Vici Innovational Research Award(Netherlands Organization for Scientific Research (NWO)); Foundation Fighting Blindness(European Commission); US Veterans Administration Medical Research Service grant; Foundation Fighting Blindness Center Grant; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); US NIH National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank S. Kohl and C. Hamel for providing DNA samples of individuals with pattern dystrophies, J. Hansen for help with animal care, and JAX Scientific Services, including Genome Technologies, Histopathology Sciences and Imaging Sciences. This research was supported by Foundation Fighting Blindness Center Grant C-GE-0811-0548-RAD04 to the Radboud University Nijmegen Medical Center, Netherlands Organization for Scientific Research Vidi Innovational Research Award 016.096.309 to A.I.d.H., Nederlandse Oogonderzoek Stichting and Diana Hermens Stichting awards to C.B.H., a Research Foundation-Flanders grant to E.D.B. and B.P.L., FWO Flanders grant 3G079711 to E.D.B., the Belgian Science Policy Office Interuniversity Attraction Poles programme P7/43 award to E.D.B. and B.P.L., Netherlands Organization for Scientific Research Vici Innovational Research Award 865.12.005 to R.R., the Foundation Fighting Blindness (C-CMM-0811-0546-RAD02) to R.R., a US Veterans Administration Medical Research Service grant to N.S.P., a Foundation Fighting Blindness Center Grant to the Cole Eye Institute, Cleveland Clinic, an unrestricted award from Research to Prevent Blindness to the Department of Ophthalmology, Cleveland Clinic Lerner College of Medicine, US National Institutes of Health (NIH) and National Eye Institute grant EY016501 to P.M.N. and US NIH National Cancer Institute award P30CA034196 to The Jackson Laboratory.	Ach T, 2015, INVEST OPHTH VIS SCI, V56, P3242, DOI 10.1167/iovs.14-16274; Agarwal A., 2012, GASS ATLAS MACULAR D, P254; Boon CJF, 2008, PROG RETIN EYE RES, V27, P213, DOI 10.1016/j.preteyeres.2008.01.002; Campbell M, 2006, EXP EYE RES, V83, P484, DOI 10.1016/j.exer.2006.01.032; Chen SY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051705; den Hollander AI, 2004, J MED GENET, V41, P699, DOI 10.1136/jmg.2004.019562; DEUTMAN AF, 1970, ARCH OPHTHALMOL-CHIC, V83, P558; Fogerty J., 2011, 174DELG MUTATION MOU; Fossarello M, 1996, ARCH OPHTHALMOL-CHIC, V114, P448, DOI 10.1001/archopht.1996.01100130444016; Grover S, 2002, OPHTHALMOLOGY, V109, P1110, DOI 10.1016/S0161-6420(02)01029-1; Hammond CJ, 2002, OPHTHALMOLOGY, V109, P730, DOI 10.1016/S0161-6420(01)01049-1; Hawes NL, 2000, INVEST OPHTH VIS SCI, V41, P3149; Huveneers S, 2012, J CELL BIOL, V196, P641, DOI 10.1083/jcb.201108120; Klein R, 2002, OPHTHALMOLOGY, V109, P1767, DOI 10.1016/S0161-6420(02)01146-6; Klein R, 2007, OPHTHALMOLOGY, V114, P253, DOI 10.1016/j.ophtha.2006.10.040; Kobielak A, 2004, NAT REV MOL CELL BIO, V5, P614, DOI 10.1038/nrm1433; Leckband DE, 2014, ANNU REV CELL DEV BI, V30, P291, DOI 10.1146/annurev-cellbio-100913-013212; Li JF, 2015, CIRC RES, V116, P70, DOI 10.1161/CIRCRESAHA.116.304472; Longbottom R, 2009, P NATL ACAD SCI USA, V106, P18728, DOI 10.1073/pnas.0902593106; Marano F, 1996, GRAEF ARCH CLIN EXP, V234, P270, DOI 10.1007/BF00430421; Mason John O 3rd, 2015, Retin Cases Brief Rep, V9, P164, DOI 10.1097/ICB.0000000000000127; Nagai H, 1996, EXP EYE RES, V62, P55, DOI 10.1006/exer.1996.0007; NICHOLS BE, 1993, HUM MOL GENET, V2, P1347, DOI 10.1093/hmg/2.8.1347-a; NICHOLS BE, 1993, NAT GENET, V3, P202, DOI 10.1038/ng0393-202; Paffenholz R, 1999, EXP CELL RES, V250, P452, DOI 10.1006/excr.1999.4534; Patil H, 2014, J BIOL CHEM, V289, P29767, DOI 10.1074/jbc.M114.586834; Peng X, 2012, J BIOL CHEM, V287, P7728, DOI 10.1074/jbc.M111.297481; PINCKERS A, 1988, OPHTHALMIC PAED GEN, V9, P77, DOI 10.3109/13816818809031483; PRENSKY JG, 1983, ARCH OPHTHALMOL-CHIC, V101, P1198; Provost E, 1999, CURR OPIN CELL BIOL, V11, P567, DOI 10.1016/S0955-0674(99)00015-0; Rakoczy PE, 2002, AM J PATHOL, V161, P1515, DOI 10.1016/S0002-9440(10)64427-6; Rangarajan ES, 2013, NAT STRUCT MOL BIOL, V20, P188, DOI 10.1038/nsmb.2479; RICHARDS SC, 1995, RETINA-J RET VIT DIS, V15, P68, DOI 10.1097/00006982-199515010-00013; Rudolf M, 2008, INVEST OPHTH VIS SCI, V49, P1200, DOI 10.1167/iovs.07-1466; SANDIG M, 1988, EXP CELL RES, V175, P1, DOI 10.1016/0014-4827(88)90250-9; SARKS JP, 1988, EYE, V2, P552, DOI 10.1038/eye.1988.106; Schlegelmilch K, 2011, CELL, V144, P782, DOI 10.1016/j.cell.2011.02.031; Sohn EH, 2015, RETINA-J RET VIT DIS, V35, P48, DOI 10.1097/IAE.0000000000000263; Sprecher E, 2001, NAT GENET, V29, P134, DOI 10.1038/ng716; Stepniak E, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002949; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Torres M, 1997, P NATL ACAD SCI USA, V94, P901, DOI 10.1073/pnas.94.3.901; Vaclavik V, 2012, RETINA-J RET VIT DIS, V32, P1942, DOI 10.1097/IAE.0b013e31824b32e4; van Lith-Verhoeven J, 2003, MOL VIS, V9, P138; VAUGHAN DK, 1987, EXP EYE RES, V44, P393, DOI 10.1016/S0014-4835(87)80173-2; Williams MA, 2009, AGE AGEING, V38, P648, DOI 10.1093/ageing/afp136; Wu J, 2004, J NEUROPHYSIOL, V91, P1134, DOI 10.1152/jn.00958.2003; Xia HM, 2011, EXP EYE RES, V93, P862, DOI 10.1016/j.exer.2011.09.020; Yang Zhenglin, 2004, Ophthalmic Genet, V25, P133, DOI 10.1080/13816810490514388; Zanzottera EC, 2015, INVEST OPHTH VIS SCI, V56, P3269, DOI 10.1167/iovs.15-16432; Zhang K, 2002, ARCH OPHTHALMOL-CHIC, V120, P485	51	27	30	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2016	48	2					144	151		10.1038/ng.3474	http://dx.doi.org/10.1038/ng.3474			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DC2JV	26691986	Green Accepted			2022-12-25	WOS:000369043900011
J	D'Amato, G; Luxan, G; del Monte-Nieto, G; Martinez-Poveda, B; Torroja, C; Walter, W; Bochter, MS; Benedito, R; Cole, S; Martinez, F; Hadjantonakis, AK; Uemura, A; Jimenez-Borreguero, LJ; de la Pompa, JL				D'Amato, Gaetano; Luxan, Guillermo; del Monte-Nieto, Gonzalo; Martinez-Poveda, Beatriz; Torroja, Carlos; Walter, Wencke; Bochter, Matthew S.; Benedito, Rui; Cole, Susan; Martinez, Fernando; Hadjantonakis, Anna-Katerina; Uemura, Akiyoshi; Jimenez-Borreguero, Luis J.; de la Pompa, Jose Luis			Sequential Notch activation regulates ventricular chamber development	NATURE CELL BIOLOGY			English	Article							EXPRESSION DATA; CARDIAC DEVELOPMENT; SIGNALING PATHWAY; GENE-EXPRESSION; HEART-FAILURE; NONCOMPACTION; CARDIOMYOPATHY; ANGIOGENESIS; MICE; DIFFERENTIATION	Ventricular chambers are essential for the rhythmic contraction and relaxation occurring in every heartbeat throughout life. Congenital abnormalities in ventricular chamber formation cause severe human heart defects. How the early trabecular meshwork of myocardial fibres forms and subsequently develops into mature chambers is poorly understood. We show that Notch signalling first connects chamber endocardium and myocardium to sustain trabeculation, and later coordinates ventricular patterning and compaction with coronary vessel development to generate the mature chamber, through a temporal sequence of ligand signalling determined by the glycosyltransferase manic fringe (MFng). Early endocardial expression of MFng promotes Dll4-Notch1 signalling, which induces trabeculation in the developing ventricle. Ventricular maturation and compaction require MFng and Dll4 downregulation in the endocardium, which allows myocardial Jag1 and Jag2 signalling to Notch1 in this tissue. Perturbation of this signalling equilibrium severely disrupts heart chamber formation. Our results open a new research avenue into the pathogenesis of cardiomyopathies.	[D'Amato, Gaetano; Luxan, Guillermo; del Monte-Nieto, Gonzalo; Martinez-Poveda, Beatriz; de la Pompa, Jose Luis] CNIC, Intercellular Signalling Cardiovasc Dev & Dis Lab, Madrid 28029, Spain; [Torroja, Carlos; Walter, Wencke; Martinez, Fernando] CNIC, Bioinformat Unit, Madrid 28029, Spain; [Bochter, Matthew S.; Cole, Susan] Ohio State Univ, Dept Mol Genet, Columbus, OH 43210 USA; [Benedito, Rui] CNIC, Mol Genet Angiogenesis Lab, Madrid 28029, Spain; [Hadjantonakis, Anna-Katerina] Sloan Kettering Inst, Dev Biol Program, New York, NY 10065 USA; [Uemura, Akiyoshi] Nagoya City Univ, Grad Sch Med Sci, Dept Retinal Vasc Biol, Mizuho Ku, Nagoya, Aichi 4678601, Japan; [Jimenez-Borreguero, Luis J.] CNIC, Cardiovasc Imaging Lab, Madrid 28029, Spain; [Jimenez-Borreguero, Luis J.] Inst Invest Sanitaria Hosp La Princesa, Madrid 28006, Spain	Centro Nacional de Investigaciones Cardiovasculares (CNIC); Centro Nacional de Investigaciones Cardiovasculares (CNIC); University System of Ohio; Ohio State University; Centro Nacional de Investigaciones Cardiovasculares (CNIC); Memorial Sloan Kettering Cancer Center; Nagoya City University; Centro Nacional de Investigaciones Cardiovasculares (CNIC)	de la Pompa, JL (corresponding author), CNIC, Intercellular Signalling Cardiovasc Dev & Dis Lab, Melchor Fernandez Almagro 3, Madrid 28029, Spain.	jlpompa@cnic.es	Walter, Wencke/ABA-6205-2021; Benedito, Rui/G-8295-2012; Martinez, Fernando/E-8026-2016; Torroja, Carlos/N-6022-2014; Martinez-Poveda, Beatriz/T-6973-2017; D'Amato, Gaetano/S-1847-2019; Benedito, Rui/AAQ-8096-2020; De La Pompa, José Luis/F-9719-2014; D'Amato, Gaetano/Q-3141-2019; Uemura, Akiyoshi/I-7510-2017; del Monte-Nieto, Gonzalo/R-2831-2019; Jimenez-Borreguero, Luis Jesus/L-8107-2014	Walter, Wencke/0000-0002-5083-9838; Benedito, Rui/0000-0003-2458-3055; Martinez, Fernando/0000-0003-1904-5164; Torroja, Carlos/0000-0001-8914-3400; Martinez-Poveda, Beatriz/0000-0003-3927-3877; Benedito, Rui/0000-0003-2458-3055; De La Pompa, José Luis/0000-0001-6761-7265; D'Amato, Gaetano/0000-0003-2640-5826; Uemura, Akiyoshi/0000-0001-5574-5470; del Monte-Nieto, Gonzalo/0000-0003-3830-2226; Hadjantonakis, Anna-Katerina/0000-0002-7580-5124; Jimenez-Borreguero, Luis Jesus/0000-0001-5870-237X; Luxan, Guillermo/0000-0001-8350-8659; Martinez Estrada, Fernando O/0000-0003-0908-9366	Spanish Ministry of Economy and Competitiveness (MINECO) [SAF2013-45543-R, RD12/0042/0005, RD12/0019/0003]; EU [FP7-ITN 215761, 28600]; BBVA Foundation for Research in Biomedicine; NotchIT [FP7-ITN 215761]; MINECO; Pro-CNIC Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD052115] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK084391] Funding Source: NIH RePORTER	Spanish Ministry of Economy and Competitiveness (MINECO)(Spanish Government); EU(European Commission); BBVA Foundation for Research in Biomedicine(BBVA Foundation); NotchIT; MINECO(Spanish Government); Pro-CNIC Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Y. Fukushima (Osaka U., Japan) for help with the generation of the R26-MFng targeting vector, RIKEN CDB (Japan) for producing the chimaeric mice, the CNIC Genomics Unit for RNA-seq, the CNIC Advance Imaging Unit for CMRI analysis, B. Zhou (Albert Einstein College, NYC, USA) for the NFATc1-Cre driver line, A. Martin-Pendas (CSIC, Salamanca, Spain), P. Munoz-Canoves (UPF, Barcelona, Spain) and J. M. Perez-Pomares (Malaga U., Spain) for critical reading of the manuscript and S. Bartlett (CNIC) and K. McCreath for English editing. Funds were from grants SAF2013-45543-R, RD12/0042/0005 (RIC) and RD12/0019/0003 (TERCEL) from the Spanish Ministry of Economy and Competitiveness (MINECO), FP7-ITN 215761 (NotchIT) and 28600 (CardioNeT) from the EU and a grant from the BBVA Foundation for Research in Biomedicine (2014), all to J.L.d.l.P. G.D'A. holds a PhD fellowship linked to grant FP7-ITN 215761 (NotchIT). The MINECO and the Pro-CNIC Foundation support the CNIC.	Arbustini E, 2014, J AM COLL CARDIOL, V64, P1840, DOI 10.1016/j.jacc.2014.08.030; Benedito R, 2009, CELL, V137, P1124, DOI 10.1016/j.cell.2009.03.025; Bjarnadottir TK, 2007, CELL MOL LIFE SCI, V64, P2104, DOI 10.1007/s00018-007-7067-1; Captur G, 2014, CIRC-CARDIOVASC GENE, V7, P241, DOI 10.1161/CIRCGENETICS.113.000362; Captur G, 2010, INT J CARDIOL, V140, P145, DOI 10.1016/j.ijcard.2009.07.003; Cavallero S, 2015, DEV CELL, V33, P469, DOI 10.1016/j.devcel.2015.03.018; Chen HY, 2009, PEDIATR CARDIOL, V30, P626, DOI 10.1007/s00246-009-9406-5; CONLON RA, 1995, DEVELOPMENT, V121, P1533; Cruz-Adalia A, 2010, CIRCULATION, V122, P1396, DOI 10.1161/CIRCULATIONAHA.110.952820; de Boer BA, 2011, DEVELOPMENT, V138, P159, DOI 10.1242/dev.051086; Del Monte G, 2007, DEV DYNAM, V236, P2594, DOI 10.1002/dvdy.21246; del Monte G, 2011, CIRC RES, V108, P824, DOI 10.1161/CIRCRESAHA.110.229062; delaPompa J, 1997, DEVELOPMENT, V124, P1139; Dirkx E, 2013, NAT CELL BIOL, V15, P1282, DOI 10.1038/ncb2866; Epstein JA, 2015, CELL METAB, V21, P163, DOI 10.1016/j.cmet.2014.12.015; Esteban V, 2011, J EXP MED, V208, P2125, DOI 10.1084/jem.20110503; Fischer A, 2004, GENE DEV, V18, P901, DOI 10.1101/gad.291004; Grego-Bessa J, 2007, DEV CELL, V12, P415, DOI 10.1016/j.devcel.2006.12.011; Hertig CM, 1999, J BIOL CHEM, V274, P37362, DOI 10.1074/jbc.274.52.37362; Hinz B, 2015, MATRIX BIOL, V47, P54, DOI 10.1016/j.matbio.2015.05.006; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Itoh M, 2003, DEV CELL, V4, P67, DOI 10.1016/S1534-5807(02)00409-4; Ivins S, 2015, DEV CELL, V33, P455, DOI 10.1016/j.devcel.2015.03.026; Jiao K, 2003, GENE DEV, V17, P2362, DOI 10.1101/gad.1124803; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kanzler B, 1998, DEVELOPMENT, V125, P2587; Kelly RG, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a015750; Kisanuki YY, 2001, DEV BIOL, V230, P230, DOI 10.1006/dbio.2000.0106; Koch U, 2008, J EXP MED, V205, P2515, DOI 10.1084/jem.20080829; Koo BK, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001221; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Leask A, 2015, CIRC RES, V116, P1269, DOI 10.1161/CIRCRESAHA.116.305381; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Luna-Zurita L, 2010, J CLIN INVEST, V120, P3493, DOI 10.1172/JCI42666; Luxan G, 2013, NAT MED, V19, P193, DOI 10.1038/nm.3046; Mancini SJC, 2005, BLOOD, V105, P2340, DOI 10.1182/blood-2004-08-3207; Maron BJ, 2006, CIRCULATION, V113, P1807, DOI 10.1161/CIRCULATIONAHA.106.174287; Martin M., 2011, EMBNET J, V17, P10, DOI [DOI 10.14806/EJ.17.1.200, 10.14806/ej.17.1.200]; Mckenzie GJ, 2005, J NEUROCHEM, V93, P171, DOI 10.1111/j.1471-4159.2005.03010.x; Moorman AFM, 2003, PHYSIOL REV, V83, P1223, DOI 10.1152/physrev.00006.2003; Moran JL, 2009, DEV DYNAM, V238, P1803, DOI 10.1002/dvdy.21982; Munch J, 2013, DEVELOPMENT, V140, P1402, DOI 10.1242/dev.087346; Nowotschin S., 2013, BMC DEV BIOL, V13; OKA C, 1995, DEVELOPMENT, V121, P3291; Panin VM, 1997, NATURE, V387, P908, DOI 10.1038/43191; Patra C, 2013, P NATL ACAD SCI USA, V110, P16898, DOI 10.1073/pnas.1304837110; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Ritter M, 1997, MAYO CLIN PROC, V72, P26, DOI 10.4065/72.1.26; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sarma RJ, 2010, PROG CARDIOVASC DIS, V52, P264, DOI 10.1016/j.pcad.2009.11.001; Sedmera D, 2000, ANAT RECORD, V258, P319, DOI 10.1002/(SICI)1097-0185(20000401)258:4<319::AID-AR1>3.0.CO;2-O; Soufan AT, 2006, CIRC RES, V99, P545, DOI 10.1161/01.RES.0000239407.45137.97; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Tevosian SG, 2000, CELL, V101, P729, DOI 10.1016/S0092-8674(00)80885-5; Tian XY, 2015, CIRC RES, V116, P515, DOI 10.1161/CIRCRESAHA.116.305097; Timmerman LA, 2004, GENE DEV, V18, P99, DOI 10.1101/gad.276304; Towbin Jeffrey A, 2010, Heart Fail Clin, V6, P453, DOI 10.1016/j.hfc.2010.06.005; Toyofuku T, 2004, NAT CELL BIOL, V6, P1204, DOI 10.1038/ncb1193; van de Weijer T, 2012, AM J PHYSIOL-HEART C, V302, pH709, DOI 10.1152/ajpheart.00710.2011; Waller-Evans H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014047; Walter W, 2015, BIOINFORMATICS, V31, P2912, DOI 10.1093/bioinformatics/btv300; Wang YD, 2010, NATURE, V465, P483, DOI 10.1038/nature09002; Watanabe T, 2010, MECH DEVELOP, V127, P418, DOI 10.1016/j.mod.2010.07.001; Wessels A, 2003, PHYSIOL GENOMICS, V15, P165, DOI 10.1152/physiolgenomics.00033.2003; Wu BR, 2012, CELL, V151, P1083, DOI 10.1016/j.cell.2012.10.023; Xu JX, 2010, GENESIS, V48, P390, DOI 10.1002/dvg.20626; Yang JW, 2012, CARDIOVASC RES, V96, P276, DOI 10.1093/cvr/cvs250; Yang LT, 2005, MOL BIOL CELL, V16, P927, DOI 10.1091/mbc.e04-07-0614; Zhang CJ, 2007, DEV BIOL, V305, P14, DOI 10.1016/j.ydbio.2007.01.034	70	112	112	2	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2016	18	1					7	+		10.1038/ncb3280	http://dx.doi.org/10.1038/ncb3280			17	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CZ3VA	26641715	Green Submitted, Green Accepted			2022-12-25	WOS:000367030900013
J	Ye, K; Wang, JY; Jayasinghe, R; Lameijer, EW; McMichael, JF; Ning, J; McLellan, MD; Xie, MC; Cao, S; Yellapantula, V; Huang, KL; Scott, A; Foltz, S; Niu, BF; Johnson, KJ; Moed, M; Slagboom, PE; Chen, F; Wendl, MC; Ding, L				Ye, Kai; Wang, Jiayin; Jayasinghe, Reyka; Lameijer, Eric-Wubbo; McMichael, Joshua F.; Ning, Jie; McLellan, Michael D.; Xie, Mingchao; Cao, Song; Yellapantula, Venkata; Huang, Kuan-lin; Scott, Adam; Foltz, Steven; Niu, Beifang; Johnson, Kimberly J.; Moed, Matthijs; Slagboom, P. Eline; Chen, Feng; Wendl, Michael C.; Ding, Li			Systematic discovery of complex insertions and deletions in human cancers	NATURE MEDICINE			English	Article							PATTERN GROWTH APPROACH; GENOMIC CHARACTERIZATION; MUTATIONS; VALIDATION	Complex insertions and deletions (indels) are formed by simultaneously deleting and inserting DNA fragments of different sizes at a common genomic location. Here we present a systematic analysis of somatic complex indels in the coding sequences of samples from over 8,000 cancer cases using Pindel-C. We discovered 285 complex indels in cancer-associated genes (such as PIK3R1, TP53, ARID1A, GATA3 and KMT2D) in approximately 3.5% of cases analyzed; nearly all instances of complex indels were overlooked (81.1%) or misannotated (17.6%) in previous reports of 2,199 samples. In-frame complex indels are enriched in PIK3R1 and EGFR, whereas frameshifts are prevalent in VHL, GATA3, TP53, ARID1A, PTEN and ATRX. Furthermore, complex indels display strong tissue specificity (such as VHL in kidney cancer samples and GATA3 in breast cancer samples). Finally, structural analyses support findings of previously missed, but potentially druggable, mutations in the EGFR, MET and KIT oncogenes. This study indicates the critical importance of improving complex indel discovery and interpretation in medical research.	[Ye, Kai; Wang, Jiayin; Jayasinghe, Reyka; McMichael, Joshua F.; Ning, Jie; McLellan, Michael D.; Xie, Mingchao; Cao, Song; Yellapantula, Venkata; Huang, Kuan-lin; Scott, Adam; Foltz, Steven; Niu, Beifang; Wendl, Michael C.; Ding, Li] Washington Univ, McDonnell Genome Inst, St Louis, MO 63130 USA; [Ye, Kai; Wendl, Michael C.; Ding, Li] Washington Univ, Dept Genet, St Louis, MO 63110 USA; [Jayasinghe, Reyka; Xie, Mingchao; Yellapantula, Venkata; Huang, Kuan-lin; Scott, Adam; Foltz, Steven; Chen, Feng; Ding, Li] Washington Univ, Dept Med, St Louis, MO USA; [Lameijer, Eric-Wubbo; Moed, Matthijs; Slagboom, P. Eline] Leiden Univ, Med Ctr, Leiden, Netherlands; [Johnson, Kimberly J.] Washington Univ, Brown Sch Master Publ Hlth Program, St Louis, MO USA; [Chen, Feng; Ding, Li] Washington Univ, Siteman Canc Ctr, St Louis, MO USA; [Wendl, Michael C.] Washington Univ, Dept Math, St Louis, MO 63130 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Washington University (WUSTL); Siteman Cancer Center; Washington University (WUSTL); Washington University (WUSTL)	Ding, L (corresponding author), Washington Univ, McDonnell Genome Inst, St Louis, MO 63130 USA.	lding@genome.wustl.edu	Ye, Kai/B-3640-2012; Slagboom, P. Eline/R-4790-2016; Ye, Kai/GSD-9856-2022; Yellapantula, Venkata/AAM-3996-2021; Wang, Jiayin/C-5047-2015	Slagboom, P. Eline/0000-0002-2875-4723; Ye, Kai/0000-0002-2851-6741; Wang, Jiayin/0000-0002-3862-6557; Jayasinghe, Reyka/0000-0003-2368-4890; MCLELLAN, MICHAEL/0000-0002-2703-8784; Scott, Adam/0000-0003-4066-6053; Yellapantula, Venkata/0000-0001-9848-3263; Foltz, Steven/0000-0002-9526-8194	National Cancer Institute [R01CA180006]; National Human Genome Research Institute [U01HG006517]; Department of Defense [W81XWH-14-1-0458]; National Institute of Diabetes and Digestive and Kidney Diseases [R01DK087960]; National Institute of General Medical Sciences Cell and Molecular Biology training grant [GM 007067]; National Human Genome Research Institute Genome Analysis Training Program [T32 HG000045]; NATIONAL CANCER INSTITUTE [R01CA180006] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000045, U01HG006517] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK087960] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007067] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Department of Defense(United States Department of Defense); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of General Medical Sciences Cell and Molecular Biology training grant; National Human Genome Research Institute Genome Analysis Training Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Cancer Institute grant R01CA180006 (L.D.), the National Human Genome Research Institute grant U01HG006517 (L.D.), the Department of Defense grant W81XWH-14-1-0458 (F.C.) and the National Institute of Diabetes and Digestive and Kidney Diseases grant R01DK087960 (F.C.). Additional support came from the National Institute of General Medical Sciences Cell and Molecular Biology training grant GM 007067 (R.J.) and the National Human Genome Research Institute Genome Analysis Training Program grant T32 HG000045 (M.X.). We acknowledge The Cancer Genome Atlas (http://cancergenome.nih.gov) as the source of primary data, and we thank M. Wyczalkowski for technical assistance and members of TCGA Research Network for helpful discussions.	Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; Creighton CJ, 2013, NATURE, V499, P43, DOI 10.1038/nature12222; Dees ND, 2012, GENOME RES, V22, P1589, DOI 10.1101/gr.134635.111; Frampton GM, 2013, NAT BIOTECHNOL, V31, P1023, DOI 10.1038/nbt.2696; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Han SW, 2005, J CLIN ONCOL, V23, P2493, DOI 10.1200/JCO.2005.01.388; Kanchi KL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4156; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Kloosterman WP, 2015, GENOME RES, V25, P792, DOI 10.1101/gr.185041.114; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Lara-Guerra H, 2009, J CLIN ONCOL, V27, P6229, DOI 10.1200/JCO.2009.22.3370; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nangalia J, 2013, NEW ENGL J MED, V369, P2391, DOI 10.1056/NEJMoa1312542; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Pritchard CC, 2014, J MOL DIAGN, V16, P56, DOI 10.1016/j.jmoldx.2013.08.004; Rahman N, 2014, NATURE, V505, P302, DOI 10.1038/nature12981; Rehm HL, 2013, GENET MED, V15, P733, DOI 10.1038/gim.2013.92; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Roerink SF, 2014, GENOME RES, V24, P954, DOI 10.1101/gr.170431.113; Ruppert AM, 2009, EUR RESPIR J, V33, P436, DOI 10.1183/09031936.00162307; Sordella R, 2004, SCIENCE, V305, P1163, DOI 10.1126/science.1101637; Sudmant PH, 2015, NATURE, V526, P75, DOI 10.1038/nature15394; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Weinstein JN, 2014, NATURE, V507, P315, DOI 10.1038/nature12965; Ye K, 2007, BIOINFORMATICS, V23, P687, DOI 10.1093/bioinformatics/btl665; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394; Zhang YJ, 2012, BIOINFORMATICS, V28, P479, DOI 10.1093/bioinformatics/btr712	33	66	66	0	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2016	22	1					97	+		10.1038/nm.4002	http://dx.doi.org/10.1038/nm.4002			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DA1YA	26657142	Green Accepted			2022-12-25	WOS:000367590700021
J	Alexandrov, LB; Jones, PH; Wedge, DC; Sale, JE; Campbell, PJ; Nik-Zainal, S; Stratton, MR				Alexandrov, Ludmil B.; Jones, Philip H.; Wedge, David C.; Sale, Julian E.; Campbell, Peter J.; Nik-Zainal, Serena; Stratton, Michael R.			Clock-like mutational processes in human somatic cells	NATURE GENETICS			English	Article							BREAST-CANCER; LEAST-SQUARES; SIGNATURES; GENOME; MECHANISMS; EVOLUTION; REVEALS; ORIGIN; AGE	During the course of a lifetime, somatic cells acquire mutations. Different mutational processes may contribute to the mutations accumulated in a cell, with each imprinting a mutational signature on the cell's genome. Some processes generate mutations throughout life at a constant rate in all individuals, and the number of mutations in a cell attributable to these processes will be proportional to the chronological age of the person. Using mutations from 10,250 cancer genomes across 36 cancer types, we investigated clock-like mutational processes that have been operating in normal human cells. Two mutational signatures show clock-like properties. Both exhibit different mutation rates in different tissues. However, their mutation rates are not correlated, indicating that the underlying processes are subject to different biological influences. For one signature, the rate of cell division may influence its mutation rate. This study provides the first survey of clock-like mutational processes operating in human somatic cells.	[Alexandrov, Ludmil B.; Jones, Philip H.; Wedge, David C.; Campbell, Peter J.; Nik-Zainal, Serena; Stratton, Michael R.] Wellcome Trust Sanger Inst, Canc Genome Project, Hinxton, England; [Alexandrov, Ludmil B.] Los Alamos Natl Lab, Theoret Biol & Biophys T6, Los Alamos, NM USA; [Alexandrov, Ludmil B.] Los Alamos Natl Lab, Ctr Nonlinear Studies, Los Alamos, NM 87545 USA; [Jones, Philip H.] Univ Cambridge, Hutchison MRC Res Ctr, Canc Unit, MRC, Cambridge, England; [Sale, Julian E.] MRC, Mol Biol Lab, Cambridge CB2 2QH, England; [Campbell, Peter J.] Univ Cambridge, Dept Haematol, Cambridge, England; [Nik-Zainal, Serena] Addenbrookes Hosp Natl Hlth Serv NHS Trust, Dept Med Genet, Cambridge, England	Wellcome Trust Sanger Institute; United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); Los Alamos National Laboratory; University of Cambridge; MRC Laboratory Molecular Biology; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital	Alexandrov, LB (corresponding author), Wellcome Trust Sanger Inst, Canc Genome Project, Hinxton, England.	lba@lanl.gov; mrs@sanger.ac.uk	Nik-Zainal, Serena/ABD-4437-2020; Wedge, David/AAC-4977-2021; Alexandrov, Ludmil/AAS-1454-2021	Alexandrov, Ludmil/0000-0003-3596-4515; Sale, Julian/0000-0002-5031-3780; Wedge, David/0000-0002-7572-3196; Jones, Philip H/0000-0002-5904-795X	Wellcome Trust [098051, C609/A17257]; Wellcome Trust Intermediate Fellowship [WT100183MA]; Wellcome Trust Senior Clinical Research Fellowship [WT088340MA]; MRC grant [MC_U105178808]; J. Robert Oppenheimer Fellowship at Los Alamos National Laboratory; US Department of Energy National Nuclear Security Administration [DE-AC52-06NA25396]; National Nuclear Security Administration of the US Department of Energy; MRC [MC_UU_12022/3, MC_U105178808] Funding Source: UKRI; Cancer Research UK [17257] Funding Source: researchfish; Medical Research Council [MC_U105178808, MC_UU_12022/3] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Wellcome Trust Intermediate Fellowship(Wellcome Trust); Wellcome Trust Senior Clinical Research Fellowship(Wellcome Trust); MRC grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); J. Robert Oppenheimer Fellowship at Los Alamos National Laboratory; US Department of Energy National Nuclear Security Administration(National Nuclear Security AdministrationUnited States Department of Energy (DOE)); National Nuclear Security Administration of the US Department of Energy(National Nuclear Security Administration); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We would like to thank M.E. Hurles and R. Durbin for early discussions about the analyses performed. We would like to thank The Cancer Genome Atlas (TCGA), the International Cancer Genome Consortium (ICGC) and the authors of all previous studies cited in Supplementary Data Set 1 for providing free access to their somatic mutational data. This work was supported by the Wellcome Trust (grant 098051). S.N.-Z. is a Wellcome-Beit Prize Fellow and is supported through a Wellcome Trust Intermediate Fellowship (grant WT100183MA). P.J.C. is personally funded through a Wellcome Trust Senior Clinical Research Fellowship (grant WT088340MA). J.E.S. is supported by an MRC grant to the Laboratory of Molecular Biology (MC_U105178808). L.B.A. is supported through a J. Robert Oppenheimer Fellowship at Los Alamos National Laboratory. P.H.J. is supported by the Wellcome Trust, an MRC Grant-in-Aid and Cancer Research UK (programme grant C609/A17257). This research used resources provided by the Los Alamos National Laboratory Institutional Computing Program, which is supported by the US Department of Energy National Nuclear Security Administration under contract DE-AC52-06NA25396. Research performed at Los Alamos National Laboratory was carried out under the auspices of the National Nuclear Security Administration of the US Department of Energy.	ABDULLAH MB, 1990, J ROY STAT SOC D-STA, V39, P455; Alexandrov LB, 2014, CURR OPIN GENET DEV, V24, P52, DOI 10.1016/j.gde.2013.11.014; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Alexandrov LB, 2013, CELL REP, V3, P246, DOI 10.1016/j.celrep.2012.12.008; Barnett V., 1994, OUTLIERS STAT DATA; Behjati S, 2014, NATURE, V513, P422, DOI 10.1038/nature13448; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Bolli N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms3997; Conrad DF, 2011, NAT GENET, V43, P712, DOI 10.1038/ng.862; Davis CF, 2014, CANCER CELL, V26, P319, DOI 10.1016/j.ccr.2014.07.014; Fousteri M, 2008, CELL RES, V18, P73, DOI 10.1038/cr.2008.6; Gerlinger M, 2014, NAT GENET, V46, P225, DOI 10.1038/ng.2891; Helleday T, 2014, NAT REV GENET, V15, P585, DOI 10.1038/nrg3729; HOLLAND PW, 1977, COMMUN STAT A-THEOR, V6, P813, DOI 10.1080/03610927708827533; Horvath S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r115; Huber PJ, 2009, WILEY SERIES PROBABI; Ju YS, 2014, ELIFE, V3, DOI 10.7554/eLife.02935; Kong A, 2012, NATURE, V488, P471, DOI 10.1038/nature11396; Michaelson JJ, 2012, CELL, V151, P1431, DOI 10.1016/j.cell.2012.11.019; Murchison EP, 2014, SCIENCE, V343, P437, DOI 10.1126/science.1247167; Nik-Zainal S, 2014, NAT GENET, V46, P487, DOI 10.1038/ng.2955; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; STREET JO, 1988, AM STAT, V42, P152, DOI 10.2307/2684491; Wagener R, 2015, LEUKEMIA, V29, P1612, DOI 10.1038/leu.2015.22; Welch JS, 2012, CELL, V150, P264, DOI 10.1016/j.cell.2012.06.023; Yates LR, 2015, NAT MED, V21, P751, DOI 10.1038/nm.3886	27	523	529	0	47	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2015	47	12					1402	+		10.1038/ng.3441	http://dx.doi.org/10.1038/ng.3441			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CX6LT	26551669	Green Accepted, Green Submitted			2022-12-25	WOS:000365813200010
J	Loh, PR; Bhatia, G; Gusev, A; Finucane, HK; Bulik-Sullivan, BK; Pollack, SJ; de Candia, TR; Lee, SH; Wray, NR; Kendler, KS; O'Donovan, MC; Neale, BM; Patterson, N; Price, AL				Loh, Po-Ru; Bhatia, Gaurav; Gusev, Alexander; Finucane, Hilary K.; Bulik-Sullivan, Brendan K.; Pollack, Samuela J.; de Candia, Teresa R.; Lee, Sang Hong; Wray, Naomi R.; Kendler, Kenneth S.; O'Donovan, Michael C.; Neale, Benjamin M.; Patterson, Nick; Price, Alkes L.		Psychiat Genomics Consortium	Contrasting genetic architectures of schizophrenia and other complex diseases using fast variance-components analysis	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; PARTITIONING HERITABILITY; RISK LOCI; METAANALYSIS; INFERENCE; SUSCEPTIBILITY; INFORMATION; PROPORTION; TRAIT	Heritability analyses of genome-wide association study (GWAS) cohorts have yielded important insights into complex disease architecture, and increasing sample sizes hold the promise of further discoveries. Here we analyze the genetic architectures of schizophrenia in 49,806 samples from the PGC and nine complex diseases in 54,734 samples from the GERA cohort. For schizophrenia, we infer an overwhelmingly polygenic disease architecture in which >= 71% of 1-Mb genomic regions harbor >= 1 variant influencing schizophrenia risk. We also observe significant enrichment of heritability in GC-rich regions and in higher-frequency SNPs for both schizophrenia and GERA diseases. In bivariate analyses, we observe significant genetic correlations (ranging from 0.18 to 0.85) for several pairs of GERA diseases; genetic correlations were on average 1.3 tunes stronger than the correlations of overall disease liabilities. To accomplish these analyses, we developed a fast algorithm for multicomponent, multi-trait variance-components analysis that overcomes prior computational barriers that made such analyses intractable at this scale.	[Loh, Po-Ru; Bhatia, Gaurav; Gusev, Alexander; Pollack, Samuela J.; Price, Alkes L.] Harvard Univ, TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02163 USA; [Loh, Po-Ru; Bhatia, Gaurav; Gusev, Alexander; Bulik-Sullivan, Brendan K.; Pollack, Samuela J.; Neale, Benjamin M.; Patterson, Nick; Price, Alkes L.] Broad Inst Harvard & MIT, Program Med & Populat Genet, Cambridge, MA USA; [Finucane, Hilary K.] MIT, Dept Math, Cambridge, MA 02139 USA; [Bulik-Sullivan, Brendan K.; Neale, Benjamin M.] Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [Pollack, Samuela J.; Price, Alkes L.] Harvard Univ, TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [de Candia, Teresa R.] Univ Colorado, Dept Psychol & Neurosci, Boulder, CO 80309 USA; [Lee, Sang Hong; Wray, Naomi R.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia; [Lee, Sang Hong] Univ New England, Sch Environm & Rural Sci, Armidale, NSW, Australia; [Kendler, Kenneth S.] Virginia Commonwealth Univ, Virginia Inst Psychiat & Behav Genet, Dept Psychiat & Human Genet, Richmond, VA USA; [O'Donovan, Michael C.] Cardiff Univ, Inst Psychol Med & Clin Neurosci, Ctr Neuropsychiat Genet & Genom, MRC, Cardiff CF10 3AX, S Glam, Wales	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital; Harvard University; Harvard T.H. Chan School of Public Health; University of Colorado System; University of Colorado Boulder; University of Queensland; University of New England; Virginia Commonwealth University; Cardiff University	Loh, PR (corresponding author), Harvard Univ, TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02163 USA.	loh@hsph.harvard.edu; aprice@hsph.harvard.edu	Visscher, Peter/ABB-6151-2020; Zimprich, Fritz/O-1406-2019; Konte, Bettina/AAT-1142-2021; Wu, Jingqin/V-9319-2019; Myin-Germeys, Inez/L-5106-2014; Agerbo, Esben/A-2645-2012; Hansen, Thomas Folkmann/O-5965-2014; Pantelis, Christos/H-7722-2014; McQuillin, Andrew/C-1623-2008; Meier, Sandra/AAB-1242-2021; O'Neill, Francis A/C-5582-2008; Degenhardt, Franziska/H-4169-2017; Fanous, Ayman H/O-1263-2017; Wray, Naomi/C-8639-2015; Webb, Bradley T/B-1459-2009; Hammer, Christian/C-5827-2014; Bergen, Sarah/I-8313-2012; Hartmann, Annette/AAS-6331-2021; van Os, Jim/C-2113-2014; KUČINSKAS, Vaidutis/A-4798-2013; Kendler, Kenneth/AAF-2876-2019; Mattheisen, Manuel/S-3725-2019; Melle, Ingrid S/B-4858-2011; Roffman, Joshua/G-8228-2012; Slominsky, Petr A/B-4640-2016; Slominsky, Petr/AAO-1852-2020; Mattheisen, Manuel/B-4949-2012; Reichenberg, Abraham/GQB-1227-2022; Mattingsdal, Morten/Q-9367-2016; O'Donovan, Michael C/P-7005-2018; Ruderfer, Douglas M/M-5795-2016; Lee, Sang Hong/A-2569-2011; Golimbet, V/E-2328-2016; Lee, Jimmy/ABB-2919-2020; Collier, David/D-1649-2011; Magnusson, Patrik/C-4458-2017; Mowry, Bryan/G-5046-2010; Franke, Lude/P-7036-2016; Domenici, Enrico/K-8194-2016	Visscher, Peter/0000-0002-2143-8760; Zimprich, Fritz/0000-0002-6998-5480; Konte, Bettina/0000-0001-5287-308X; Wu, Jingqin/0000-0002-2052-3875; Agerbo, Esben/0000-0002-2849-524X; Hansen, Thomas Folkmann/0000-0001-6703-7762; Pantelis, Christos/0000-0002-9565-0238; McQuillin, Andrew/0000-0003-1567-2240; O'Neill, Francis A/0000-0002-7531-7657; Wray, Naomi/0000-0001-7421-3357; Webb, Bradley T/0000-0002-0576-5366; Hammer, Christian/0000-0003-4548-7548; Bergen, Sarah/0000-0002-5888-0034; Mattheisen, Manuel/0000-0002-8442-493X; Melle, Ingrid S/0000-0002-9783-548X; Roffman, Joshua/0000-0003-4073-532X; Slominsky, Petr A/0000-0003-3530-0655; Slominsky, Petr/0000-0003-3530-0655; Mattheisen, Manuel/0000-0002-8442-493X; Mattingsdal, Morten/0000-0003-4440-0324; O'Donovan, Michael C/0000-0001-7073-2379; Ruderfer, Douglas M/0000-0002-2365-386X; Lee, Sang Hong/0000-0001-9701-2718; Golimbet, V/0000-0002-9960-7114; Lee, Jimmy/0000-0002-7724-7445; Bacanu, Silviu-Alin/0000-0002-4364-1583; Bruggeman, Richard/0000-0002-3238-8471; Nothen, Markus/0000-0002-8770-2464; Walters, James/0000-0002-6980-4053; Gusev, Alexander/0000-0002-7980-4620; So, Hon-Cheong/0000-0002-7102-833X; Stogmann, Elisabeth/0000-0003-4688-8482; Ehrenreich, Hannelore/0000-0001-8371-5711; Mors, Ole/0000-0002-5660-0393; Julia Cano, Antonio/0000-0001-6064-3620; Collier, David/0000-0003-4087-1559; Magnusson, Patrik/0000-0002-7315-7899; Borglum, Anders/0000-0001-8627-7219; Mowry, Bryan/0000-0002-4115-5645; Adolfsson, Rolf/0000-0001-9785-8473; Myin-Germeys, Inez/0000-0002-3731-4930; Sim, Kang/0000-0003-3209-9626; Pocklington, Andrew/0000-0002-2137-0452; Franke, Lude/0000-0002-5159-8802; Legge, Sophie/0000-0001-6617-0289; Djurovic, Srdjan/0000-0002-8140-8061; Demontis, Ditte/0000-0001-9124-2766; Papiol, Sergi/0000-0001-9366-8728; Knight, Joanne/0000-0002-7148-1660; marsal, sara/0000-0001-5515-3854; Buxbaum, Joseph/0000-0001-8898-8313; Domenici, Enrico/0000-0001-7436-6919	US National Institutes of Health [R01 HG006399, R01 MH101244]; US National Institutes of Health fellowship [F32 HG007805]; Fannie and John Hertz Foundation; Netherlands Scientific Organization [NWO 480-05-003]; US National Center for Research Resources [1S10RR028832-01]; MRC [G0800509] Funding Source: UKRI; Lundbeck Foundation [R155-2014-1724] Funding Source: researchfish; Medical Research Council [MR/L010305/1, G0800509] Funding Source: researchfish; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR028832] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [F32HG007805, R01HG006399] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH101244] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Institutes of Health fellowship; Fannie and John Hertz Foundation; Netherlands Scientific Organization; US National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Lundbeck Foundation(Lundbeckfonden); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We are grateful to K. Galinsky, T. Hayeck, P. Palamara, J. Listgarten, V. Anttila, S. Sunyaev, D. Howrigan, R. Walters, P. Sullivan, M. Keller, M. Goddard, P. Visscher, J. Yang, S. Ripke, D. Golan and S. Rosset for helpful discussions. This research was supported by US National Institutes of Health grants R01 HG006399 and R01 MH101244 and US National Institutes of Health fellowship F32 HG007805. H.K.F. was supported by the Fannie and John Hertz Foundation. Members of the Schizophrenia Working Group of the Psychiatric Genomics Consortium are listed in the Supplementary Note. Statistical analyses of PGC2 data were carried out on the Genetic Cluster Computer (http://www.geneticcluster.org/) hosted by SURFsara and financially supported by the Netherlands Scientific Organization (NWO 480-05-003, principal investigator D. Posthuma) along with a supplement from the Dutch Brain Foundation and VU University Amsterdam. Analyses of GERA data were conducted on the Orchestra High-Performance Compute Cluster at Harvard Medical School, which is partially supported by US National Center for Research Resources grant 1S10RR028832-01.	[Anonymous], 2013, AM J HUM GENET, V93, P1151, DOI 10.1016/j.ajhg.2013.10.015; Aschard H, 2015, AM J HUM GENET, V96, P329, DOI 10.1016/j.ajhg.2014.12.021; Banovich NE, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004663; Bengio Y, 2004, J MACH LEARN RES, V5, P1089; Bonnelykke K, 2013, NAT GENET, V45, P902, DOI 10.1038/ng.2694; Bulik-Sullivan B, 2015, NAT GENET, V47, P1236, DOI 10.1038/ng.3406; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Chen CY, 2013, BIOINFORMATICS, V29, P1399, DOI 10.1093/bioinformatics/btt144; CHEVERUD JM, 1988, EVOLUTION, V42, P958, DOI 10.1111/j.1558-5646.1988.tb02514.x; FALCONER DS, 1965, ANN HUM GENET, V29, P51, DOI 10.1111/j.1469-1809.1965.tb00500.x; Ferreira MAR, 2011, LANCET, V378, P1006, DOI 10.1016/S0140-6736(11)60874-X; Finucane HK, 2015, NAT GENET, V47, P1228, DOI 10.1038/ng.3404; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Galinsky KJ, 2015, BIORXIV, DOI [10.1101/018143., DOI 10.1101/018143]; GARCIACORTES LA, 1992, J ANIM BREED GENET, V109, P358, DOI 10.1111/j.1439-0388.1992.tb00415.x; Gelfman S, 2013, GENOME RES, V23, P789, DOI 10.1101/gr.143503.112; Gibson G, 2012, NAT REV GENET, V13, P135, DOI 10.1038/nrg3118; Gilmour AR, 1995, BIOMETRICS, V51, P1440, DOI 10.2307/2533274; Golan D, 2014, P NATL ACAD SCI USA, V111, pE5272, DOI 10.1073/pnas.1419064111; Goldstein DB, 2009, NEW ENGL J MED, V360, P1696, DOI 10.1056/NEJMp0806284; GOTTESMAN II, 1967, P NATL ACAD SCI USA, V58, P199, DOI 10.1073/pnas.58.1.199; Gusev A, 2014, AM J HUM GENET, V95, P535, DOI 10.1016/j.ajhg.2014.10.004; Gusev A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003993; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; Henderson C. R, 1984, APPL LINEAR MODELS A; HENDERSON CR, 1976, J ANIM SCI, V43, P1188, DOI 10.2527/jas1976.4361188x; Hinds DA, 2013, NAT GENET, V45, P907, DOI 10.1038/ng.2686; Hoffmann TJ, 2011, GENOMICS, V98, P79, DOI 10.1016/j.ygeno.2011.04.005; Koren A, 2012, AM J HUM GENET, V91, P1033, DOI 10.1016/j.ajhg.2012.10.018; Kostem E, 2013, AM J HUM GENET, V92, P558, DOI 10.1016/j.ajhg.2013.03.010; Lee SH, 2012, BIOINFORMATICS, V28, P2540, DOI 10.1093/bioinformatics/bts474; Lee SH, 2013, NAT GENET, V45, P984, DOI 10.1038/ng.2711; Lee SH, 2012, NAT GENET, V44, P247, DOI 10.1038/ng.1108; Lee SH, 2011, AM J HUM GENET, V88, P294, DOI 10.1016/j.ajhg.2011.02.002; Legarra A, 2008, J DAIRY SCI, V91, P360, DOI 10.3168/jds.2007-0403; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Loh PR, 2015, NAT GENET, V47, P284, DOI 10.1038/ng.3190; Lohmueller KE, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004379; Mahajan A, 2014, NAT GENET, V46, P234, DOI 10.1038/ng.2897; Manichaikul A, 2012, PLOS GENET, V8, P285, DOI 10.1371/journal.pgen.1002640; Manichaikul A, 2010, BIOINFORMATICS, V26, P2867, DOI 10.1093/bioinformatics/btq559; Matilainen K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080821; McVicker G, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000471; PATTERSON HD, 1971, BIOMETRIKA, V58, P545, DOI 10.1093/biomet/58.3.545; Pers TH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6890; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Ripke S, 2013, NAT GENET, V45, P1150, DOI 10.1038/ng.2742; Ripke S, 2011, NAT GENET, V43, P969, DOI 10.1038/ng.940; Speed D, 2012, AM J HUM GENET, V91, P1011, DOI 10.1016/j.ajhg.2012.10.010; Stahl EA, 2012, NAT GENET, V44, P483, DOI 10.1038/ng.2232; Sullivan PF, 2012, NAT MED, V18, P210, DOI 10.1038/nm.2670; Tange O., 2018, USENIX MAGAZINE, V36, P42; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; Vattikuti S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002637; Visscher PM, 2015, GENETICS, V199, P223, DOI 10.1534/genetics.114.171017; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; Wood AR, 2014, NAT GENET, V46, P1173, DOI 10.1038/ng.3097; Yang J, 2014, NAT GENET, V46, P100, DOI 10.1038/ng.2876; Yang J, 2011, NAT GENET, V43, P519, DOI 10.1038/ng.823; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Zhou X, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003264; Zuk O, 2014, P NATL ACAD SCI USA, V111, pE455, DOI 10.1073/pnas.1322563111	64	237	239	0	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2015	47	12					1385	+		10.1038/ng.3431	http://dx.doi.org/10.1038/ng.3431			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CX6LT	26523775	Green Accepted, Green Submitted			2022-12-25	WOS:000365813200007
J	Menachery, VD; Yount, BL; Debbink, K; Agnihothram, S; Gralinski, LE; Plante, JA; Graham, RL; Scobey, T; Ge, XY; Donaldson, EF; Randell, SH; Lanzavecchia, A; Marasco, WA; Shi, ZLL; Baric, RS				Menachery, Vineet D.; Yount, Boyd L., Jr.; Debbink, Kari; Agnihothram, Sudhakar; Gralinski, Lisa E.; Plante, Jessica A.; Graham, Rachel L.; Scobey, Trevor; Ge, Xing-Yi; Donaldson, Eric F.; Randell, Scott H.; Lanzavecchia, Antonio; Marasco, Wayne A.; Shi, Zhengli-Li; Baric, Ralph S.			A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence	NATURE MEDICINE			English	Article							ACUTE RESPIRATORY SYNDROME; RECEPTOR; DISEASE; CELLS; INFECTIONS; MECHANISMS; FITNESS; VACCINE; ESCAPE; MICE	The emergence of severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome (MERS)-CoV underscores the threat of cross-species transmission events leading to outbreaks in humans. Here we examine the disease potential of a SARS-like virus, SHC014-CoV, which is currently circulating in Chinese horseshoe bat populations(1). Using the SARS-CoV reverse genetics system(2), we generated and characterized a chimeric virus expressing the spike of bat coronavirus SHC014 in a mouse-adapted SARS-CoV backbone. The results indicate that group 2b viruses encoding the SHC014 spike in a wild-type backbone can efficiently use multiple orthologs of the SARS receptor human angiotensin converting enzyme II (ACE2), replicate efficiently in primary human airway cells and achieve in vitro titers equivalent to epidemic strains of SARS-CoV. Additionally, in vivo experiments demonstrate replication of the chimeric virus in mouse lung with notable pathogenesis. Evaluation of available SARS-based immune-therapeutic and prophylactic modalities revealed poor efficacy; both monoclonal antibody and vaccine approaches failed to neutralize and protect from infection with CoVs using the novel spike protein. On the basis of these findings, we synthetically re-derived an infectious full-length SHC014 recombinant virus and demonstrate robust viral replication both in vitro and in vivo. Our work suggests a potential risk of SARS-CoV re-emergence from viruses currently circulating in bat populations.	[Menachery, Vineet D.; Yount, Boyd L., Jr.; Debbink, Kari; Gralinski, Lisa E.; Plante, Jessica A.; Graham, Rachel L.; Scobey, Trevor; Donaldson, Eric F.; Baric, Ralph S.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27514 USA; [Baric, Ralph S.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC USA; [Agnihothram, Sudhakar] US FDA, Natl Ctr Toxicol Res, Jefferson, AR 72079 USA; [Ge, Xing-Yi; Shi, Zhengli-Li] Chinese Acad Sci, Wuhan Inst Virol, Key Lab Special Pathogens & Biosafety, Wuhan, Peoples R China; [Randell, Scott H.] Univ N Carolina, Dept Cell Biol & Physiol, Chapel Hill, NC USA; [Randell, Scott H.] Univ N Carolina, Cyst Fibrosis Ctr, Marsico Lung Inst, Chapel Hill, NC USA; [Lanzavecchia, Antonio] Bellinzona Inst Microbiol, Inst Res Biomed, Zurich, Switzerland; [Marasco, Wayne A.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA; [Marasco, Wayne A.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; US Food & Drug Administration (FDA); Chinese Academy of Sciences; Wuhan Institute of Virology, CAS; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Universita della Svizzera Italiana; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School	Baric, RS (corresponding author), Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27514 USA.	vineet@email.unc.edu	Plante, Jessica/GRS-0172-2022; Graham, Rachel/AAM-9048-2020; , Pathology Services Core/CEZ-2246-2022; Shi, Zheng-Li/A-1013-2013	Plante, Jessica/0000-0002-4768-7458; Graham, Rachel/0000-0002-3143-6515; Shi, Zheng-Li/0000-0001-8089-163X; Menachery, Vineet/0000-0001-8803-7606	National Institute of Allergy & Infectious Disease; National Institute of Aging of the US National Institutes of Health (NIH) [U19AI109761, U19AI107810, AI085524, F32AI102561, K99AG049092]; National Natural Science Foundation of China [81290341, 31470260]; USAID-EPT-PREDICT from EcoHealth Alliance; National Institute of Diabetes and Digestive and Kidney Disease of the NIH [NIH DK065988]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI109761, R01AI085524, F32AI102561, U19AI107810, T32AI007528] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK065988] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K99AG049092] Funding Source: NIH RePORTER	National Institute of Allergy & Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Aging of the US National Institutes of Health (NIH); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); USAID-EPT-PREDICT from EcoHealth Alliance(United States Agency for International Development (USAID)); National Institute of Diabetes and Digestive and Kidney Disease of the NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Research in this manuscript was supported by grants from the National Institute of Allergy & Infectious Disease and the National Institute of Aging of the US National Institutes of Health (NIH) under awards U19AI109761 (R.S.B.), U19AI107810 (R.S.B.), AI085524 (W.A.M.), F32AI102561 (V.D.M.) and K99AG049092 (V.D.M.), and by the National Natural Science Foundation of China awards 81290341 (Z.-L.S.) and 31470260 (X.-Y.G.), and by USAID-EPT-PREDICT funding from EcoHealth Alliance (Z.-L.S.). Human airway epithelial cultures were supported by the National Institute of Diabetes and Digestive and Kidney Disease of the NIH under award NIH DK065988 (S.H.R.). We also thank M.T. Ferris (Dept. of Genetics, University of North Carolina) for the reviewing of statistical approaches and C.T. Tseng (Dept. of Microbiology and Immunology, University of Texas Medical Branch) for providing Calu-3 cells. Experiments with the full-length and chimeric SHC014 recombinant viruses were initiated and performed before the GOF research funding pause and have since been reviewed and approved for continued study by the NIH. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Agnihothram S, 2014, MBIO, V5, DOI 10.1128/mBio.00047-14; Al-Tawfiq JA, 2014, LANCET INFECT DIS, V14, P992, DOI 10.1016/S1473-3099(14)70840-0; Becker MM, 2008, P NATL ACAD SCI USA, V105, P19944, DOI 10.1073/pnas.0808116105; Bolles M, 2011, J VIROL, V85, P12201, DOI 10.1128/JVI.06048-11; Deming D, 2006, PLOS MED, V3, P2359, DOI 10.1371/journal.pmed.0030525; Frieman M, 2012, J VIROL, V86, P884, DOI 10.1128/JVI.05957-11; Fulcher M Leslie, 2005, Methods Mol Med, V107, P183; Ge XY, 2013, NATURE, V503, P535, DOI 10.1038/nature12711; Graham RL, 2013, NAT REV MICROBIOL, V11, P836, DOI 10.1038/nrmicro3143; Graham RL, 2010, J VIROL, V84, P3134, DOI 10.1128/JVI.01394-09; He BA, 2014, J VIROL, V88, P7070, DOI 10.1128/JVI.00631-14; Kaiser J., 2014, SCIENCEINSIDER; Li F, 2013, ANTIVIR RES, V100, P246, DOI 10.1016/j.antiviral.2013.08.014; Peiris JSM, 2004, NAT MED, V10, pS88, DOI 10.1038/nm1143; Qiu XG, 2014, NATURE, V514, P47, DOI 10.1038/nature13777; Relman DA, 2013, JAMA-J AM MED ASSOC, V309, P1531, DOI 10.1001/jama.2013.3678; Ren W, 2008, J VIROL, V82, P1899, DOI 10.1128/JVI.01085-07; Roberts A., PLOS PATHOG, V3, pe5; Rockx B, 2010, J INFECT DIS, V201, P946, DOI 10.1086/651022; Sheahan T, 2008, J VIROL, V82, P2274, DOI 10.1128/JVI.02041-07; Siegrist C-A, 2013, VACCINES, P14, DOI DOI 10.1016/B978-1-4557-0090-5.00004-5; Sims AC, 2013, J VIROL, V87, P3885, DOI 10.1128/JVI.02520-12; Spruth M, 2006, VACCINE, V24, P652, DOI 10.1016/j.vaccine.2005.08.055; Sui JH, 2014, J VIROL, V88, P13769, DOI 10.1128/JVI.02232-14; Sui JH, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000197; Yoshikawa T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008729; Yount B, 2003, P NATL ACAD SCI USA, V100, P12995, DOI 10.1073/pnas.1735582100	27	462	499	5	316	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2015	21	12					1508	+		10.1038/nm.3985	http://dx.doi.org/10.1038/nm.3985			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CX9EV	26552008	Bronze, Green Published, Green Accepted			2022-12-25	WOS:000366008700023
J	Christophorou, N; Rubin, T; Bonnet, I; Piolot, T; Arnaud, M; Huynh, JR				Christophorou, Nicolas; Rubin, Thomas; Bonnet, Isabelle; Piolot, Tristan; Arnaud, Marion; Huynh, Jean-Rene			Microtubule-driven nuclear rotations promote meiotic chromosome dynamics	NATURE CELL BIOLOGY			English	Article							REGULATES SPINDLE ORIENTATION; SYNAPTONEMAL COMPLEX; DROSOPHILA OOCYTES; 3T3 CELLS; PROTEIN; MEIOSIS; MIGRATION; ENVELOPE; SYNAPSIS; CYTOSKELETON	At the onset of meiosis, each chromosome needs to find its homologue and pair to ensure proper segregation. In Drosophila, pairing occurs during the mitotic cycles preceding meiosis. Here we show that germ cell nuclei undergo marked movements during this developmental window. We demonstrate that microtubules and Dynein are driving nuclear rotations and are required for centromere pairing and clustering. We further found that Klaroid (SUN) and Klarsicht (KASH) co-localize with centromeres at the nuclear envelope and are required for proper chromosome motions and pairing. We identified Mud (NuMA in vertebrates) as co-localizing with centromeres, Klarsicht and Klaroid. Mud is also required to maintain the integrity of the nuclear envelope and for the correct assembly of the synaptonemal complex. Our findings reveal a mechanism for chromosome pairing in Drosophila, and indicate that microtubules, centrosomes and associated proteins play a crucial role in the dynamic organization of chromosomes inside the nucleus.	[Christophorou, Nicolas; Rubin, Thomas; Piolot, Tristan; Arnaud, Marion; Huynh, Jean-Rene] Inst Curie, Dept Genet & Dev Biol, F-75248 Paris, France; [Christophorou, Nicolas; Rubin, Thomas; Piolot, Tristan; Arnaud, Marion; Huynh, Jean-Rene] CNRS, UMR3215, INSERM, U934, F-75248 Paris, France; [Bonnet, Isabelle] Inst Curie, Lab Phys Chem, F-75248 Paris, France; [Bonnet, Isabelle] UPMC, CNRS, UMR 168, F-75248 Paris, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; UNICANCER; Institut Curie	Huynh, JR (corresponding author), Inst Curie, Dept Genet & Dev Biol, F-75248 Paris, France.	jean-rene.huynh@curie.fr	Rubin, Thomas/L-4788-2017	Bonnet, Isabelle/0000-0003-2343-3784; HUYNH, Jean-Rene/0000-0002-4078-399X; Arnaud, Marion/0000-0003-0534-2379; rubin, thomas/0000-0002-6774-1917	European Research Council (ERC EPIGENETIX) [250367]; Institut Curie; FRM post-doctoral fellowship [SPF20111223331]; DEEP LabEx; FRM Ingenieur Fellowship [ING20140129247]; CNRS; Ville de Paris; ANR; FSER (Schlumberger)	European Research Council (ERC EPIGENETIX)(European Research Council (ERC)); Institut Curie; FRM post-doctoral fellowship; DEEP LabEx; FRM Ingenieur Fellowship; CNRS(Centre National de la Recherche Scientifique (CNRS)); Ville de Paris; ANR(French National Research Agency (ANR)); FSER (Schlumberger)(Schlumberger)	We wish to thank F. Llense for observing that Mud co-localized with centromeres and E. Heard for suggesting 'rolling' nuclei. We are grateful to S. Roth (University of Cologne, Germany), M. Welte, J. Fischer and the Bloomington Stock centre for flies and reagents. We acknowledge great technical support from the PICT@BDD imaging platform. This work was supported by the European Research Council (ERC EPIGENETIX No 250367). N.C. is supported by Institut Curie, FRM post-doctoral fellowship (SPF20111223331) and DEEP LabEx; T.R. is supported by an FRM Ingenieur Fellowship (no ING20140129247); the J.-R.H. laboratory is funded by CNRS, Ville de Paris, ANR and FSER (Schlumberger).	Basto R, 2006, CELL, V125, P1375, DOI 10.1016/j.cell.2006.05.025; Baudrimont A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001219; Bhalla N, 2008, ANNU REV CELL DEV BI, V24, P397, DOI 10.1146/annurev.cellbio.23.090506.123245; Blachon S, 2008, GENETICS, V180, P2081, DOI 10.1534/genetics.108.095141; Boateng KA, 2013, DEV CELL, V24, P196, DOI 10.1016/j.devcel.2012.12.002; Bolivar J, 2001, DEVELOPMENT, V128, P1889; Bowman SK, 2006, DEV CELL, V10, P731, DOI 10.1016/j.devcel.2006.05.005; Brown PW, 2005, AM J HUM GENET, V77, P556, DOI 10.1086/468188; Cahoon CK, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1004051; Cain NE, 2014, J CELL BIOL, V206, P163, DOI 10.1083/jcb.201405081; Christophorou N, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1004012; Ding DQ, 1998, J CELL SCI, V111, P701; Fichelson P, 2009, NAT CELL BIOL, V11, P685, DOI 10.1038/ncb1874; FISCHERVIZE JA, 1994, DEVELOPMENT, V120, P2609; Gerton JL, 2005, NAT REV GENET, V6, P477, DOI 10.1038/nrg1614; Grieder NC, 2000, DEVELOPMENT, V127, P4253; Hiraoka Y, 2009, DEV CELL, V17, P598, DOI 10.1016/j.devcel.2009.10.014; Huynh JR, 2004, CURR BIOL, V14, pR438, DOI 10.1016/j.cub.2004.05.040; Huynh JR, 2001, DEVELOPMENT, V128, P1201; Izumi Y, 2006, NAT CELL BIOL, V8, P586, DOI 10.1038/ncb1409; Jeffress JK, 2007, GENETICS, V177, P2445, DOI 10.1534/genetics.107.078717; Joyce EF, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1004013; Koszul R, 2009, TRENDS CELL BIOL, V19, P716, DOI 10.1016/j.tcb.2009.09.007; Kracklauer MP, 2007, FLY, V1, P75, DOI 10.4161/fly.4254; Kracklauer MP, 2010, J CELL SCI, V123, P2763, DOI 10.1242/jcs.066589; Lake CM, 2012, ANNU REV PHYSIOL, V74, P425, DOI 10.1146/annurev-physiol-020911-153342; Lee CY, 2015, CELL REP, V11, P551, DOI 10.1016/j.celrep.2015.03.045; Macqueen AJ, 2005, CELL, V123, P1037, DOI 10.1016/j.cell.2005.09.034; MAHOWALD AP, 1970, J CELL BIOL, V45, P306, DOI 10.1083/jcb.45.2.306; Mathieu J, 2013, DEV CELL, V26, P250, DOI 10.1016/j.devcel.2013.07.005; Merdes A, 1996, CELL, V87, P447, DOI 10.1016/S0092-8674(00)81365-3; Mosley-Bishop KL, 1999, CURR BIOL, V9, P1211, DOI 10.1016/S0960-9822(99)80501-6; Nguyen-Ngoc T, 2007, NAT CELL BIOL, V9, P1294, DOI 10.1038/ncb1649; Ni JQ, 2011, NAT METHODS, V8, P405, DOI [10.1038/NMETH.1592, 10.1038/nmeth.1592]; Obeso D, 2014, CHROMOSOMA, V123, P43, DOI 10.1007/s00412-013-0439-4; PADDOCK SW, 1986, EXP CELL RES, V166, P113, DOI 10.1016/0014-4827(86)90512-4; PADDOCK SW, 1986, EXP CELL RES, V163, P525, DOI 10.1016/0014-4827(86)90083-2; Page SL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000194; Page SL, 2004, ANNU REV CELL DEV BI, V20, P525, DOI 10.1146/annurev.cellbio.19.111301.155141; Page SL, 2001, GENE DEV, V15, P3130, DOI 10.1101/gad.935001; POMERAT CM, 1953, EXP CELL RES, V5, P191, DOI 10.1016/0014-4827(53)90104-9; Rothballer A, 2013, CHROMOSOMA, V122, P415, DOI 10.1007/s00412-013-0417-x; Sanchez T, 2012, NATURE, V491, P431, DOI 10.1038/nature11591; Scherthan H, 2001, NAT REV MOL CELL BIO, V2, P621, DOI 10.1038/35085086; Schuh M, 2007, CURR BIOL, V17, P237, DOI 10.1016/j.cub.2006.11.051; Sheehan MJ, 2009, P NATL ACAD SCI USA, V106, P20989, DOI 10.1073/pnas.0906498106; Shibuya H, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004821; Shibuya H, 2014, NAT CELL BIOL, V16, P145, DOI 10.1038/ncb2896; Siller KH, 2006, NAT CELL BIOL, V8, P594, DOI 10.1038/ncb1412; Starr DA, 2010, ANNU REV CELL DEV BI, V26, P421, DOI 10.1146/annurev-cellbio-100109-104037; Stevens NR, 2007, CURR BIOL, V17, P1498, DOI 10.1016/j.cub.2007.07.060; Szikora S, 2013, J CELL SCI, V126, P254, DOI 10.1242/jcs.114355; Takeo S, 2011, CURR BIOL, V21, P1845, DOI 10.1016/j.cub.2011.09.044; Tanneti NS, 2011, CURR BIOL, V21, P1852, DOI 10.1016/j.cub.2011.10.005; Tapley EC, 2013, CURR OPIN CELL BIOL, V25, P57, DOI 10.1016/j.ceb.2012.10.014; Technau M, 2008, FLY, V2, P82, DOI 10.4161/fly.6288; Theurkauf WE, 1998, DEVELOPMENT, V125, P3655; Trelles-Sticken E, 2005, J CELL BIOL, V170, P213, DOI 10.1083/jcb.200501042; Tsai JH, 2011, J CELL SCI, V124, P1955, DOI 10.1242/jcs.006387; VOLK T, 1992, DEVELOPMENT, V116, P721; Woglar A, 2014, CHROMOSOMA, V123, P15, DOI 10.1007/s00412-013-0436-7; Wynne DJ, 2012, J CELL BIOL, V196, P47, DOI 10.1083/jcb.201106022; Yoshida M, 2013, J CELL BIOL, V200, P385, DOI 10.1083/jcb.201207168; Yu JX, 2006, GENETICS, V173, P243, DOI 10.1534/genetics.105.051557; Yu JH, 2006, DEV BIOL, V289, P336, DOI 10.1016/j.ydbio.2005.10.027; Zhao TT, 2012, SCIENCE, V336, P999, DOI 10.1126/science.1219147; Zickler D, 2006, CHROMOSOMA, V115, P158, DOI 10.1007/s00412-006-0048-6; Zickler D, 1998, ANNU REV GENET, V32, P619, DOI 10.1146/annurev.genet.32.1.619	68	38	38	1	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2015	17	11					1388	1400		10.1038/ncb3249	http://dx.doi.org/10.1038/ncb3249			13	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CV4XT	26458247	Green Submitted			2022-12-25	WOS:000364270500005
J	Guinney, J; Dienstmann, R; Wang, X; de Reynies, A; Schlicker, A; Soneson, C; Marisa, L; Roepman, P; Nyamundanda, G; Angelino, P; Bot, BM; Morris, JS; Simon, IM; Gerster, S; Fessler, E; Melo, FDE; Missiaglia, E; Ramay, H; Barras, D; Homicsko, K; Maru, D; Manyam, GC; Broom, B; Boige, V; Perez-Villamil, B; Laderas, T; Salazar, R; Gray, JW; Hanahan, D; Tabernero, J; Bernards, R; Friend, SH; Laurent-Puig, P; Medema, JP; Sadanandam, A; Wessels, L; Delorenzi, M; Kopetz, S; Vermeulen, L; Tejpar, S				Guinney, Justin; Dienstmann, Rodrigo; Wang, Xin; de Reynies, Aurelien; Schlicker, Andreas; Soneson, Charlotte; Marisa, Laetitia; Roepman, Paul; Nyamundanda, Gift; Angelino, Paolo; Bot, Brian M.; Morris, Jeffrey S.; Simon, Iris M.; Gerster, Sarah; Fessler, Evelyn; Melo, Felipe De Sousa E.; Missiaglia, Edoardo; Ramay, Hena; Barras, David; Homicsko, Krisztian; Maru, Dipen; Manyam, Ganiraju C.; Broom, Bradley; Boige, Valerie; Perez-Villamil, Beatriz; Laderas, Ted; Salazar, Ramon; Gray, Joe W.; Hanahan, Douglas; Tabernero, Josep; Bernards, Rene; Friend, Stephen H.; Laurent-Puig, Pierre; Medema, Jan Paul; Sadanandam, Anguraj; Wessels, Lodewyk; Delorenzi, Mauro; Kopetz, Scott; Vermeulen, Louis; Tejpar, Sabine			The consensus molecular subtypes of colorectal cancer	NATURE MEDICINE			English	Article							III COLON-CANCER; MICROSATELLITE INSTABILITY; RECTAL-CANCER; TUMORS; CELLS; CLASSIFICATION; PHENOTYPE; RESPONSES; MUTATION; GROWTH	Colorectal cancer (CRC) is a frequently lethal disease with heterogeneous outcomes and drug responses. To resolve inconsistencies among the reported gene expression-based CRC classifications and facilitate clinical translation, we formed an international consortium dedicated to large-scale data sharing and analytics across expert groups. We show marked interconnectivity between six independent classification systems coalescing into four consensus molecular subtypes (CMSs) with distinguishing features: CMS1 (microsatellite instability immune, 14%), hypermutated, microsatellite unstable and strong immune activation; CMS2 (canonical, 37%), epithelial, marked WNT and MYC signaling activation; CMS3 (metabolic, 13%), epithelial and evident metabolic dysregulation; and CMS4 (mesenchymal, 23%), prominent transforming growth factor-beta activation, stromal invasion and angiogenesis. Samples with mixed features (13%) possibly represent a transition phenotype or intratumoral heterogeneity. We consider the CMS groups the most robust classification system currently available for CRC-with clear biological interpretability-and the basis for future clinical stratification and subtype-based targeted interventions.	[Guinney, Justin; Dienstmann, Rodrigo; Bot, Brian M.; Laderas, Ted; Friend, Stephen H.] Sage Bionetworks, Seattle, WA 98109 USA; [Dienstmann, Rodrigo; Tabernero, Josep] Univ Autonoma Barcelona, Vall dHebron Inst Oncol, E-08193 Barcelona, Spain; [Wang, Xin; Fessler, Evelyn; Melo, Felipe De Sousa E.; Medema, Jan Paul; Vermeulen, Louis] Univ Amsterdam, Acad Med Ctr, Lab Expt Oncol & Radiobiol LEXOR, Ctr Expt Mol Med, NL-1105 AZ Amsterdam, Netherlands; [Wang, Xin] City Univ Hong Kong, Dept Biomed Sci, Hong Kong, Hong Kong, Peoples R China; [de Reynies, Aurelien; Marisa, Laetitia] Ligue Natl Canc, Paris, France; [Schlicker, Andreas; Bernards, Rene; Wessels, Lodewyk] Netherlands Canc Inst NKI, Amsterdam, Netherlands; [Soneson, Charlotte; Angelino, Paolo; Gerster, Sarah; Missiaglia, Edoardo; Ramay, Hena; Barras, David; Delorenzi, Mauro] Swiss Inst Bioinformat, Lausanne, Switzerland; [Roepman, Paul; Simon, Iris M.] Agendia NV, Amsterdam, Netherlands; [Nyamundanda, Gift; Sadanandam, Anguraj] Inst Canc Res, London SW3 6JB, England; [Morris, Jeffrey S.; Maru, Dipen; Manyam, Ganiraju C.; Broom, Bradley; Kopetz, Scott] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Homicsko, Krisztian; Hanahan, Douglas] Ecole Polytech Fed Lausanne, Lausanne, Switzerland; [Boige, Valerie] Gustave Roussy, Villejuif, France; [Perez-Villamil, Beatriz] Hosp Clin San Carlos, Inst Invest Sanitaria San Carlos, Lab Genom & Microarrays, Madrid, Spain; [Salazar, Ramon] Inst Invest Biomed Bellvitge, Inst Catala Oncol, Barcelona, Spain; [Gray, Joe W.] Oregon Hlth & Sci Univ, Biomed Engn, Portland, OR USA; [Laurent-Puig, Pierre] Univ Paris 05, Paris, France; [Laurent-Puig, Pierre] Hop Europeen Georges Pompidou, AP HP, Dept Biol, Paris, France; [Delorenzi, Mauro] Univ Lausanne, Ludwig Ctr Canc Res, Lausanne, Switzerland; [Delorenzi, Mauro] Univ Lausanne, Dept Oncol, Lausanne, Switzerland; [Tejpar, Sabine] Univ Ziekenhuis Leuven, Leuven, Belgium	Autonomous University of Barcelona; Vall d'Hebron Institut d'Oncologia (VHIO); University of Amsterdam; Academic Medical Center Amsterdam; City University of Hong Kong; Netherlands Cancer Institute; Swiss Institute of Bioinformatics; Agendia; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of Texas System; UTMD Anderson Cancer Center; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; UNICANCER; Gustave Roussy; Hospital Clinico San Carlos; Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Oregon Health & Science University; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Lausanne; University of Lausanne; KU Leuven; University Hospital Leuven	Guinney, J (corresponding author), Sage Bionetworks, Seattle, WA 98109 USA.	justin.guinney@sagebase.org; l.vermeulen@amc.uva.nl	Vermeulen, Louis/B-7488-2008; Wang, Xin/A-1130-2012; Miquel, Josep Maria/AAG-3508-2019; Laurent-Puig, Pierre/K-3641-2019; Perez-Villamil, Beatriz/AAB-3572-2019; Kopetz, Scott/AAC-1387-2019; Gray, Joe/AAX-9549-2020; Tabernero, Josep/AAG-5026-2019; Manyam, Ganiraju/E-9150-2012; Manyam, Ganiraju C/B-5890-2014; Soneson, Charlotte/J-6740-2019; de Reyniès, Aurélien/Q-8640-2017; laurent-puig, pierre/B-2226-2013	Vermeulen, Louis/0000-0002-6066-789X; Wang, Xin/0000-0002-5122-2418; Laurent-Puig, Pierre/0000-0001-8475-5459; Perez-Villamil, Beatriz/0000-0002-6881-7442; Kopetz, Scott/0000-0001-9647-3416; Tabernero, Josep/0000-0002-2495-8139; Manyam, Ganiraju/0000-0001-6006-8961; Soneson, Charlotte/0000-0003-3833-2169; de Reyniès, Aurélien/0000-0002-1328-5290; laurent-puig, pierre/0000-0001-8475-5459; Homicsko, Krisztian/0000-0003-0912-6198; Laderas, Ted/0000-0002-6207-7068; missiaglia, edoardo/0000-0001-9221-0117; Bot, Brian/0000-0002-2412-6826; Boige, Valerie/0000-0002-7817-4663; Medema, Jan Paul/0000-0003-3045-2924; Schlicker, Andreas/0000-0002-6588-7883; Sadanandam, Anguraj/0000-0001-8485-5150; Bernards, Rene/0000-0001-8677-3423	National Cancer Institute [U54CA149237]; La Caixa International Program for Cancer Research Education; Dutch Cancer Society [UVA2011-4969, UVA2014-7245, UVA2012-573, UVA2013-6331, UVA2015-7587]; Worldwide Cancer Research [14-1164]; Maag Lever Darm Stichting (MLDS) [MLDS-CDG 14-03]; European Research Council [ERG-StG 638193]; MLDS [FP012]; US National Institutes of Health [R01CA172670, R01CA184843, R01 CA187238, P30CA016672]; National Health Service; Katholieke Universiteit Leuven [GOA/12/2106]; EU; Research Foundation Flanders; Belgian National Cancer Plan; NATIONAL CANCER INSTITUTE [R01CA178744, R01CA184843, R01CA172670, P30CA016672, U54CA149237, R01CA187238] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000371] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); La Caixa International Program for Cancer Research Education; Dutch Cancer Society(KWF Kankerbestrijding); Worldwide Cancer Research; Maag Lever Darm Stichting (MLDS); European Research Council(European Research Council (ERC)European Commission); MLDS; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health Service; Katholieke Universiteit Leuven(KU Leuven); EU(European Commission); Research Foundation Flanders(FWO); Belgian National Cancer Plan; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	The authors would like to acknowledge the goodwill and generosity of the colorectal research community who made this study possible. J.G. and S.H.F. are supported by the Integrative Cancer Biology Program of the National Cancer Institute (grant U54CA149237). R.D. is supported by La Caixa International Program for Cancer Research & Education. L.V. is supported by grants from the Dutch Cancer Society (UVA2011-4969 and UVA2014-7245), Worldwide Cancer Research (14-1164), the Maag Lever Darm Stichting (MLDS) (MLDS-CDG 14-03) and the European Research Council (ERG-StG 638193). J.P.M. is supported by grants from the Dutch Cancer Society (UVA2012-573, UVA2013-6331 and UVA2015-7587) and the MLDS (FP012). S.K. is supported by the US National Institutes of Health (grants R01CA172670, R01CA184843, R01 CA187238 and P30CA016672 (Biostatistic and Bioinformatic Core)). A. Sadanandam and G.N. acknowledge support from the National Health Service. S.T. is supported by the Katholieke Universiteit Leuven GOA/12/2106 grant, the EU FP7 Coltheres grant, the Research Foundation Flanders and the Belgian National Cancer Plan.	[Anonymous], 2014, NATURE, V513, P202, DOI [10.1038/nature13480, DOI 10.1038/NATURE13480]; Brunelli L, 2014, ONCOTARGET, V5, P4722, DOI 10.18632/oncotarget.1958; Budinska E, 2013, J PATHOL, V231, P63, DOI 10.1002/path.4212; Carmona FJ, 2014, CANCER RES, V74, P5608, DOI 10.1158/0008-5472.CAN-13-3659; Carter SL, 2012, NAT BIOTECHNOL, V30, P413, DOI 10.1038/nbt.2203; De Sousa E Melo F, 2013, NAT MED, V19, P614, DOI 10.1038/nm.3174; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Gavin PG, 2012, CLIN CANCER RES, V18, P6531, DOI 10.1158/1078-0432.CCR-12-0605; Hoadley KA, 2014, CELL, V158, P929, DOI 10.1016/j.cell.2014.06.049; Kamphorst JJ, 2013, P NATL ACAD SCI USA, V110, P8882, DOI 10.1073/pnas.1307237110; Le DT, 2015, NEW ENGL J MED, V372, P2509, DOI 10.1056/NEJMoa1500596; Lei ZD, 2013, GASTROENTEROLOGY, V145, P554, DOI 10.1053/j.gastro.2013.05.010; Li YL, 2014, CANCER CELL, V26, P262, DOI 10.1016/j.ccr.2014.06.014; Llosa NJ, 2015, CANCER DISCOV, V5, P43, DOI 10.1158/2159-8290.CD-14-0863; Marisa L, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001453; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Perez-Villamil B, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-260; Popovici V, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-439; Roepman P, 2014, INT J CANCER, V134, P552, DOI 10.1002/ijc.28387; Sadanandam A, 2013, NAT MED, V19, P619, DOI 10.1038/nm.3175; Schlicker A, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-66; Sinicrope FA, 2015, GASTROENTEROLOGY, V148, P88, DOI 10.1053/j.gastro.2014.09.041; Son J, 2013, NATURE, V496, P101, DOI 10.1038/nature12040; Tran B, 2011, CANCER-AM CANCER SOC, V117, P4623, DOI 10.1002/cncr.26086; Van Cutsem E, 2009, J CLIN ONCOL, V27, P3117, DOI 10.1200/JCO.2008.21.6663; Van Dongen S, 2008, SIAM J MATRIX ANAL A, V30, P121, DOI 10.1137/040608635; Ying HQ, 2012, CELL, V149, P656, DOI 10.1016/j.cell.2012.01.058; Yoshihara K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3612; Zhang B, 2014, NATURE, V513, P382, DOI 10.1038/nature13438	30	2510	2590	14	345	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2015	21	11					1350	1356		10.1038/nm.3967	http://dx.doi.org/10.1038/nm.3967			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CV9QH	26457759	Green Accepted, Green Submitted, Green Published			2022-12-25	WOS:000364621200021
J	Iversen, L; Mathiasen, S; Larsen, JB; Stamou, D				Iversen, Lars; Mathiasen, Signe; Larsen, Jannik Bruun; Stamou, Dimitrios			Membrane curvature bends the laws of physics and chemistry	NATURE CHEMICAL BIOLOGY			English	Article							LIPID PACKING; AMPHIPATHIC HELICES; PROTEIN FUNCTION; BAR DOMAINS; N-RAS; MECHANISM; AGGREGATION; MOTIF		[Iversen, Lars; Mathiasen, Signe; Larsen, Jannik Bruun; Stamou, Dimitrios] Univ Copenhagen, Bionanotechnol & Nanomed Lab, Copenhagen, Denmark; [Iversen, Lars; Mathiasen, Signe; Larsen, Jannik Bruun; Stamou, Dimitrios] Univ Copenhagen, Dept Chem, DK-2100 Copenhagen, Denmark; [Iversen, Lars; Mathiasen, Signe; Larsen, Jannik Bruun; Stamou, Dimitrios] Univ Copenhagen, Nanosci Ctr, Copenhagen, Denmark; [Iversen, Lars; Mathiasen, Signe; Larsen, Jannik Bruun; Stamou, Dimitrios] Univ Copenhagen, Lundbeck Fdn Ctr Biomembranes Nanomed, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen; Lundbeckfonden; University of Copenhagen	Iversen, L (corresponding author), Univ Copenhagen, Bionanotechnol & Nanomed Lab, Copenhagen, Denmark.	stamou@nano.ku.dk	Stamou, Dimitrios/D-5042-2016; Larsen, Jannik/AAE-4195-2020	Stamou, Dimitrios/0000-0001-8456-8995; Larsen, Jannik/0000-0003-4754-2803; Mathiasen, Signe/0000-0001-6854-0044				Ahyayauch H, 2005, BIOCHEMISTRY-US, V44, P11592, DOI 10.1021/bi050715k; Andersen OS, 2007, ANNU REV BIOPH BIOM, V36, P107, DOI 10.1146/annurev.biophys.36.040306.132643; Baumgart T, 2011, ANNU REV PHYS CHEM, V62, P483, DOI 10.1146/annurev.physchem.012809.103450; Bigay J, 2003, NATURE, V426, P563, DOI 10.1038/nature02108; Bigay J, 2012, DEV CELL, V23, P886, DOI 10.1016/j.devcel.2012.10.009; Brown MF, 2012, BIOCHEMISTRY-US, V51, P9782, DOI 10.1021/bi301332v; Cajal Y, 2000, BIOCHEMISTRY-US, V39, P413, DOI 10.1021/bi991927i; Callan-Jones A, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004648; Campelo F, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003556; Cui HS, 2011, BIOPHYS J, V100, P1271, DOI 10.1016/j.bpj.2011.01.036; Dacosta CJB, 2013, NAT CHEM BIOL, V9, P701, DOI [10.1038/NCHEMBIO.1338, 10.1038/nchembio.1338]; Demchenko AP, 2009, BIOPHYS J, V96, P3461, DOI 10.1016/j.bpj.2009.02.012; Domanov YA, 2011, P NATL ACAD SCI USA, V108, P12605, DOI 10.1073/pnas.1102646108; Drin G, 2007, NAT STRUCT MOL BIOL, V14, P138, DOI 10.1038/nsmb1194; Groves JT, 2010, NAT STRUCT MOL BIOL, V17, P659, DOI 10.1038/nsmb.1844; Hatzakis NS, 2009, NAT CHEM BIOL, V5, P835, DOI 10.1038/nchembio.213; Irannejad R, 2013, NATURE, V495, P534, DOI 10.1038/nature12000; Larsen JB, 2015, NAT CHEM BIOL, V11, P192, DOI 10.1038/nchembio.1733; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Madsen KL, 2010, FEBS LETT, V584, P1848, DOI 10.1016/j.febslet.2010.01.053; McMahon HT, 2015, J CELL SCI, V128, P1065, DOI 10.1242/jcs.114454; Mukherjee S, 2000, TRAFFIC, V1, P203, DOI 10.1034/j.1600-0854.2000.010302.x; Parton DL, 2011, BIOPHYS J, V101, P691, DOI 10.1016/j.bpj.2011.06.048; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Phillips R, 2009, NATURE, V459, P379, DOI 10.1038/nature08147; Reis P, 2009, ADV COLLOID INTERFAC, V147-48, P237, DOI 10.1016/j.cis.2008.06.001; Reynwar BJ, 2007, NATURE, V447, P461, DOI 10.1038/nature05840; Simons K, 2010, NAT REV MOL CELL BIO, V11, P688, DOI 10.1038/nrm2977; Sprong H, 2001, NAT REV MOL CELL BIO, V2, P504, DOI 10.1038/35080071; Tonnesen A, 2014, BIOPHYS J, V106, P201, DOI 10.1016/j.bpj.2013.11.023; Vanni S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5916; Weise K, 2009, J AM CHEM SOC, V131, P1557, DOI 10.1021/ja808691r; Zimmerberg J, 2006, NAT REV MOL CELL BIO, V7, P9, DOI 10.1038/nrm1784	33	54	54	2	83	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	NOV	2015	11	11					822	825		10.1038/nchembio.1941	http://dx.doi.org/10.1038/nchembio.1941			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CU1HS	26485070				2022-12-25	WOS:000363272100002
J	LaFave, LM; Beguelin, W; Koche, R; Teater, M; Spitzer, B; Chrarniec, A; Papalexi, E; Keller, MD; Hricik, T; Konstantinoff, K; Micol, JB; Durham, B; Knutson, SK; Campbell, JE; Blum, G; Shi, XX; Doud, EH; Krivtsov, AV; Chung, YR; Khodos, I; de Stanchina, E; Ouerfelli, O; Adusumilli, PS; Thomas, PM; Kelleher, NL; Luo, MK; Keilhacke, H; Abdel-Wahab, O; Melnick, A; Armstrong, SA; Levine, RL				LaFave, Lindsay M.; Beguelin, Wendy; Koche, Richard; Teater, Matt; Spitzer, Barbara; Chrarniec, Alan; Papalexi, Efthymia; Keller, Matthew D.; Hricik, Todd; Konstantinoff, Katerina; Micol, Jean-Baptiste; Durham, Benjamin; Knutson, Sarah K.; Campbell, John E.; Blum, Gil; Shi, Xinxu; Doud, Emma H.; Krivtsov, Andrei V.; Chung, Young Rock; Khodos, Inna; de Stanchina, Elisa; Ouerfelli, Ouathek; Adusumilli, Prasad S.; Thomas, Paul M.; Kelleher, Neil L.; Luo, Minkui; Keilhacke, Heike; Abdel-Wahab, Omar; Melnick, Ari; Armstrong, Scott A.; Levine, Ross L.			Loss of BAP1 function leads to EZH2-dependent transformation	NATURE MEDICINE			English	Article							CHRONIC MYELOMONOCYTIC LEUKEMIA; MYELODYSPLASTIC SYNDROMES; MYELOID TRANSFORMATION; SOMATIC MUTATIONS; FREQUENT MUTATION; ASXL1 MUTATIONS; PROTEIN L3MBTL2; IN-VIVO; EZH2; CHROMATIN	The tumor suppressors BAP1 and ASXL1 interact to form a polycomb deubiquitinase complex that removes monoubiquitin from histone H2A lysine 119 (H2AK119Ub). However, BAP1 and ASXL1 are mutated in distinct cancer types, consistent with independent roles in regulating epigenetic state and malignant transformation. Here we demonstrate that Bap1 loss in mice results in increased trimethylated histone H3 lysine 27 (H3K27me3), elevated enhancer of zeste 2 polycomb repressive complex 2 subunit (Ezh2) expression, and enhanced repression of polycomb repressive complex 2 (PRC2) targets. These findings contrast with the reduction in H3K27me3 levels seen with Asxl1 loss. Conditional deletion of Bap1 and Ezh2 in vivo abrogates the myeloid progenitor expansion induced by Bap1 loss alone. Loss of BAP1 results in a marked decrease in H4K20 monomethylation (H4K20me1). Consistent with a role for H4K20me1 in the transcriptional regulation of EZH2, expression of SETD8-the H4K20me1 methyltransferase-reduces EZH2 expression and abrogates the proliferation of BAP1-mutant cells. Furthermore, mesothelioma cells that lack BAP1 are sensitive to EZH2 pharmacologic inhibition, suggesting a novel therapeutic approach for BAP1-mutant malignancies.	[LaFave, Lindsay M.; Papalexi, Efthymia; Keller, Matthew D.; Hricik, Todd; Konstantinoff, Katerina; Micol, Jean-Baptiste; Durham, Benjamin; Chung, Young Rock; Abdel-Wahab, Omar; Levine, Ross L.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10021 USA; [LaFave, Lindsay M.] Gerstner Sloan Kettering Sch Biomed Sci, New York, NY USA; [Beguelin, Wendy; Teater, Matt; Melnick, Ari] Weill Cornell Med Coll, Dept Hematol Oncol, New York, NY USA; [Koche, Richard; Chrarniec, Alan; Krivtsov, Andrei V.; Armstrong, Scott A.; Levine, Ross L.] Mem Sloan Kettering Canc Ctr, Ctr Epigenet Res, New York, NY 10021 USA; [Koche, Richard; Armstrong, Scott A.] Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10021 USA; [Spitzer, Barbara; Armstrong, Scott A.] Mem Sloan Kettering Canc Ctr, Dept Pediat, New York, NY 10021 USA; [Knutson, Sarah K.; Campbell, John E.; Keilhacke, Heike] Epizyme Inc, Cambridge, MA USA; [Blum, Gil; Luo, Minkui] Mem Sloan Kettering Canc Ctr, Chem Biol Program, New York, NY 10021 USA; [Blum, Gil] Mem Sloan Kettering Canc Ctr, Triinst Program Chem Biol, New York, NY 10021 USA; [Shi, Xinxu; Ouerfelli, Ouathek] Mem Sloan Kettering Canc Ctr, Chem Synth Core, New York, NY 10021 USA; [Doud, Emma H.; Thomas, Paul M.; Kelleher, Neil L.] Northwestern Univ, Prote Ctr Excellence, Evanston, IL USA; [Khodos, Inna; de Stanchina, Elisa] Mem Sloan Kettering Canc Ctr, Antitumor Assessment Core, New York, NY 10021 USA; [Adusumilli, Prasad S.] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA; [Abdel-Wahab, Omar; Levine, Ross L.] Mem Sloan Kettering Canc Ctr, Dept Med, Leukemia Serv, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Northwestern University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Levine, RL (corresponding author), Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USA.	leviner@mskcc.org	levine, ross/AAE-7658-2019; Thomas, Paul M/A-6233-2011; Krivtsov, Andrei/AAJ-9966-2021; Melnick, Ari/AAA-5763-2020	Thomas, Paul M/0000-0003-2887-4765; Doud, Emma/0000-0003-0049-0073; Ouerfelli, Ouathek/0000-0002-7038-0219; Koche, Richard/0000-0002-6820-5083; Chung, Young Rock/0000-0001-5752-8322; Spitzer, Barbara/0000-0003-1603-1381; Durham, Benjamin/0000-0001-8090-5448; Krivtsov, Andrei/0000-0002-5511-1686	Pershing Square Sohn Prize;  [2R01GM096056];  [CA172636];  [F31 CA180642-02];  [P30 CA008748]; NATIONAL CANCER INSTITUTE [R01CA169784, P30CA060553, P30CA008748, F31CA180642, R01CA187109, R01CA176745, R01CA173636] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000457] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM120570, R01GM096056] Funding Source: NIH RePORTER	Pershing Square Sohn Prize(Pershing Square Sohn Cancer Research Alliance); ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Pershing Square Sohn Prize (R.L.L.), by grant 2R01GM096056 (M.L.), by grant CA172636 (R.L.L. and A.M.) and by grant F31 CA180642-02 (L.M.L.). Work in the Memorial Sloan Kettering Cancer Center (MSKCC) Core facilities that supported these studies is supported by P30 CA008748. R.L.L. is a Leukemia and Lymphoma Society Scholar. We would like to thank V. Rotter (Weizmann Institute of Science, Israel), X. Jiang (MSKCC), and M. Ladanyi (MSKCC) for generously providing plasmids for this work. We would like to thank D. Scheinberg (MSKCC) for generously sharing the mesothelioma cell lines used in this work.	Abdel-Wahab O, 2011, LEUKEMIA, V25, P1200, DOI 10.1038/leu.2011.58; Abdel-Wahab O, 2013, J EXP MED, V210, P2641, DOI 10.1084/jem.20131141; Abdel-Wahab O, 2012, CANCER CELL, V22, P180, DOI 10.1016/j.ccr.2012.06.032; Alimova I, 2013, NEURO-ONCOLOGY, V15, P149, DOI 10.1093/neuonc/nos285; Beguelin W, 2013, CANCER CELL, V23, P677, DOI 10.1016/j.ccr.2013.04.011; Bejar R, 2011, NEW ENGL J MED, V364, P2496, DOI 10.1056/NEJMoa1013343; Blum G, 2014, ACS CHEM BIOL, V9, P2471, DOI 10.1021/cb500515r; Bott M, 2011, NAT GENET, V43, P668, DOI 10.1038/ng.855; Campbell JE, 2015, ACS MED CHEM LETT, V6, P491, DOI 10.1021/acsmedchemlett.5b00037; Dey A, 2012, SCIENCE, V337, P1541, DOI 10.1126/science.1221711; Gelsi-Boyer V, 2009, BRIT J HAEMATOL, V145, P788, DOI 10.1111/j.1365-2141.2009.07697.x; Guo YH, 2009, NUCLEIC ACIDS RES, V37, P2204, DOI 10.1093/nar/gkp086; Harbour JW, 2010, SCIENCE, V330, P1410, DOI 10.1126/science.1194472; Knutson SK, 2013, P NATL ACAD SCI USA, V110, P7922, DOI 10.1073/pnas.1303800110; McCabe MT, 2012, NATURE, V492, P108, DOI 10.1038/nature11606; Morin RD, 2011, NATURE, V476, P298, DOI 10.1038/nature10351; Morin RD, 2010, NAT GENET, V42, P181, DOI 10.1038/ng.518; Nishioka K, 2002, MOL CELL, V9, P1201, DOI 10.1016/S1097-2765(02)00548-8; Pasqualucci L, 2011, NAT GENET, V43, P830, DOI 10.1038/ng.892; Pena-LlopiS S, 2012, NAT GENET, V44, P751, DOI 10.1038/ng.2323; Qin JZ, 2012, CELL STEM CELL, V11, P319, DOI 10.1016/j.stem.2012.06.002; Qin JZ, 2010, J BIOL CHEM, V285, P27767, DOI 10.1074/jbc.M110.115410; Scheuermann JC, 2010, NATURE, V465, P243, DOI 10.1038/nature08966; Su IH, 2003, NAT IMMUNOL, V4, P124, DOI 10.1038/ni876; Trojer P, 2007, CELL, V129, P915, DOI 10.1016/j.cell.2007.03.048; Trojer P, 2011, MOL CELL, V42, P438, DOI 10.1016/j.molcel.2011.04.004; Wilson BG, 2010, CANCER CELL, V18, P316, DOI 10.1016/j.ccr.2010.09.006	27	216	220	0	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2015	21	11					1344	1349		10.1038/nm.3947	http://dx.doi.org/10.1038/nm.3947			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CV9QH	26437366	Green Accepted			2022-12-25	WOS:000364621200020
J	Park, JO; Rubin, SA; Xu, YF; Amador-Noguez, D; Fan, J; Shlomi, T; Rabinowitz, JD				Park, Junyoung O.; Rubin, Sara A.; Xu, Yi-Fan; Amador-Noguez, Daniel; Fan, Jing; Shlomi, Tomer; Rabinowitz, Joshua D.			Metabolite concentrations, fluxes and free energies imply efficient enzyme usage	NATURE CHEMICAL BIOLOGY			English	Article							ESCHERICHIA-COLI; CELLULAR METABOLITES; SCALE; ISOTOPOMER; QUANTIFICATION; QUANTITATION; OPTIMALITY; STRATEGY; NITROGEN; EXCHANGE	In metabolism, available free energy is limited and must be divided across pathway steps to maintain a negative Delta G throughout. For each reaction, Delta G is log proportional both to a concentration ratio (reaction quotient to equilibrium constant) and to a flux ratio (backward to forward flux). Here we use isotope labeling to measure absolute metabolite concentrations and fluxes in Escherichia coli, yeast and a mammalian cell line. We then integrate this information to obtain a unified set of concentrations and Delta G for each organism. In glycolysis, we find that free energy is partitioned so as to mitigate unproductive backward fluxes associated with Delta G near zero. Across metabolism, we observe that absolute metabolite concentrations and Delta G are substantially conserved and that most substrate (but not inhibitor) concentrations exceed the associated enzyme binding site dissociation constant (K-m or K-i). The observed conservation of metabolite concentrations is consistent with an evolutionary drive to utilize enzymes efficiently given thermodynamic and osmotic constraints.	[Park, Junyoung O.; Xu, Yi-Fan; Amador-Noguez, Daniel; Fan, Jing; Rabinowitz, Joshua D.] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; [Park, Junyoung O.] Princeton Univ, Dept Chem & Biol Engn, Princeton, NJ 08544 USA; [Rubin, Sara A.; Xu, Yi-Fan; Fan, Jing; Rabinowitz, Joshua D.] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA; [Shlomi, Tomer] Technion Israel Inst Technol, Dept Comp Sci, IL-32000 Haifa, Israel; [Xu, Yi-Fan] DuPont Ind Biosci, Expt Stn, Wilmington, DE USA; [Amador-Noguez, Daniel] Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA; [Amador-Noguez, Daniel] Univ Wisconsin, Great Lake Bioenergy Res Ctr, Madison, WI USA	Princeton University; Princeton University; Princeton University; Technion Israel Institute of Technology; DuPont; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Rabinowitz, JD (corresponding author), Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA.; Rabinowitz, JD (corresponding author), Princeton Univ, Dept Chem, Princeton, NJ 08544 USA.	joshr@princeton.edu	Park, Junyoung/AAL-8090-2020; Rabinowitz, Joshua/GPP-4019-2022	Rabinowitz, Joshua/0000-0002-1247-4727; Fan, Jing/0000-0002-5326-5358; Park, Jun/0000-0001-9869-8993	Howard Hughes Medical Institute international student research fellowship; US Department of Energy [DE-SC0012461]; US National Institutes of Health R01grant [1R01CA163591]; DRC [2P30DK019525-37]; NATIONAL CANCER INSTITUTE [R01CA163591] Funding Source: NIH RePORTER	Howard Hughes Medical Institute international student research fellowship(Howard Hughes Medical Institute); US Department of Energy(United States Department of Energy (DOE)); US National Institutes of Health R01grant; DRC; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors would like to thank the Gitai, Silhavy, Brynildsen and White labs for strains and cell lines and H. Haraldsdottir, E. Noor and R. Fleming for their help with Component Contribution method. J. Fan was supported by a Howard Hughes Medical Institute international student research fellowship. Funding was provided by US Department of Energy grant DE-SC0012461, and US National Institutes of Health R01grant 1R01CA163591 and DRC grant 2P30DK019525-37.	Antoniewicz MR, 2006, METAB ENG, V8, P324, DOI 10.1016/j.ymben.2006.01.004; Bajad SU, 2006, J CHROMATOGR A, V1125, P76, DOI 10.1016/j.chroma.2006.05.019; Beard DA, 2004, J THEOR BIOL, V228, P327, DOI 10.1016/j.jtbi.2004.01.008; Beard DA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000144; Beg QK, 2007, P NATL ACAD SCI USA, V104, P12663, DOI 10.1073/pnas.0609845104; Bennett BD, 2008, NAT PROTOC, V3, P1299, DOI 10.1038/nprot.2008.107; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; Berg JM, 2012, BIOCHEMISTRY; Buscher J. M., 2004, ANAL CHEM, V81, P3212; Chassagnole C, 2002, BIOTECHNOL BIOENG, V79, P53, DOI 10.1002/bit.10288; Clasquin M. F., 2012, CURR PROTOC BIOINFOR, V37; Cohen P, 2002, NAT REV DRUG DISCOV, V1, P309, DOI 10.1038/nrd773; Cornish-Bowden A., 1995, FUNDAMENTALS ENZYME; de Godoy LMF, 2008, NATURE, V455, P1251, DOI 10.1038/nature07341; Degenhardt K, 2006, CLIN CANCER RES, V12, P5298, DOI 10.1158/1078-0432.CCR-06-0439; Dekel E, 2005, NATURE, V436, P588, DOI 10.1038/nature03842; Fan J, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.65; Feist AM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100155; Fell D., 1997, UNDERSTANDING CONTRO; Flamholz A, 2013, P NATL ACAD SCI USA, V110, P10039, DOI 10.1073/pnas.1215283110; Fleming RMT, 2009, BIOPHYS CHEM, V145, P47, DOI 10.1016/j.bpc.2009.08.007; Geiger T, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014050; GUTNICK D, 1969, J BACTERIOL, V100, P215, DOI 10.1128/JB.100.1.215-219.1969; Haraldsdottir HS, 2012, BIOPHYS J, V102, P1703, DOI 10.1016/j.bpj.2012.02.032; Heinrich R., 1996, REGULATION CELLULAR; Henry CS, 2007, BIOPHYS J, V92, P1792, DOI 10.1529/biophysj.106.093138; Henry CS, 2006, BIOPHYS J, V90, P1453, DOI 10.1529/biophysj.105.071720; Hoppe A, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-23; JOSHI A, 1990, J THEOR BIOL, V142, P41, DOI 10.1016/S0022-5193(05)80012-8; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; KATZ J, 1993, J BIOL CHEM, V268, P25509; Kummel A, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100074; Leonardi R, 2005, PROG LIPID RES, V44, P125, DOI 10.1016/j.plipres.2005.04.001; Liebermeister W, 2014, P NATL ACAD SCI USA, V111, P8488, DOI 10.1073/pnas.1314810111; Lu WY, 2010, ANAL CHEM, V82, P3212, DOI 10.1021/ac902837x; Mashego MR, 2004, BIOTECHNOL BIOENG, V85, P620, DOI 10.1002/bit.10907; MINAKAMI S, 1965, BIOCHEM BIOPH RES CO, V18, P345, DOI 10.1016/0006-291X(65)90711-4; Nielsen J, 2001, APPL MICROBIOL BIOT, V55, P263, DOI 10.1007/s002530000511; Noh K, 2007, J BIOTECHNOL, V129, P249, DOI 10.1016/j.jbiotec.2006.11.015; Noor E, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003098; Raamsdonk LM, 2001, NAT BIOTECHNOL, V19, P45, DOI 10.1038/83496; Rabinowitz JD, 2007, ANAL CHEM, V79, P6167, DOI 10.1021/ac070470c; Ralser M., 2007, J BIOL, V6, P10, DOI [DOI 10.1186/jbiol61, 10.1186/jbiol61]; ROSENBERG H, 1982, J BACTERIOL, V149, P123, DOI 10.1128/JB.149.1.123-130.1982; Schellenberger J, 2011, BIOPHYS J, V100, P544, DOI 10.1016/j.bpj.2010.12.3707; Schellenberger J, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-213; Schomburg I, 2013, NUCLEIC ACIDS RES, V41, pD764, DOI 10.1093/nar/gks1049; SCHUSTER S, 1987, J THEOR BIOL, V129, P189, DOI 10.1016/S0022-5193(87)80012-7; Sundararaj S, 2004, NUCLEIC ACIDS RES, V32, pD293, DOI 10.1093/nar/gkh108; Tran LM, 2008, BIOPHYS J, V95, P5606, DOI 10.1529/biophysj.108.135442; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; Valgepea K, 2013, MOL BIOSYST, V9, P2344, DOI 10.1039/c3mb70119k; van Eunen K, 2010, FEBS J, V277, P749, DOI 10.1111/j.1742-4658.2009.07524.x; Vojinovic V, 2009, BIOTECHNOL BIOENG, V103, P780, DOI 10.1002/bit.22309; Weitzel M, 2013, BIOINFORMATICS, V29, P143, DOI 10.1093/bioinformatics/bts646; Wiechert W, 1999, BIOTECHNOL BIOENG, V66, P69; Wiechert W, 2007, BIOPHYS J, V93, P2255, DOI 10.1529/biophysj.106.099895; Xu YF, 2015, ANAL CHEM, V87, P2273, DOI 10.1021/ac504118y; Xu YF, 2012, NAT CHEM BIOL, V8, P562, DOI [10.1038/NCHEMBIO.941, 10.1038/nchembio.941]; Yuan J, 2006, NAT CHEM BIOL, V2, P529, DOI 10.1038/nchembio816	60	196	199	5	106	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUL	2016	12	7					482	+		10.1038/NCHEMBIO.2077	http://dx.doi.org/10.1038/NCHEMBIO.2077			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9EP	27159581	Green Submitted, Green Accepted			2022-12-25	WOS:000378087500006
J	Aze, A; Sannino, V; Soffientini, P; Bachi, A; Costanzo, V				Aze, Antoine; Sannino, Vincenzo; Soffientini, Paolo; Bachi, Angela; Costanzo, Vincenzo			Centromeric DNA replication reconstitution reveals DNA loops and ATR checkpoint suppression	NATURE CELL BIOLOGY			English	Article							ALPHA-SATELLITE; EGG EXTRACTS; GENOME; ACTIVATION; INHIBITOR; STABILITY; REPEATS; DISEASE; BINDING; MITOSIS	Half of the human genome is made up of repetitive DNA(1). However, mechanisms underlying replication of chromosome regions containing repetitive DNA are poorly understood. We reconstituted replication of defined human chromosome segments using bacterial artificial chromosomes in Xenopus laevis egg extract. Using this approach we characterized the chromatin assembly and replication dynamics of centromeric alpha-satellite DNA. Proteomic analysis of centromeric chromatin revealed replication-dependent enrichment of a network of DNA repair factors including the MSH2-6 complex, which was required for efficient centromeric DNA replication. However, contrary to expectations, the ATR-dependent checkpoint monitoring DNA replication fork arrest could not be activated on highly repetitive DNA due to the inability of the single-stranded DNA binding protein RPA to accumulate on chromatin. Electron microscopy of centromeric DNA and supercoil mapping revealed the presence of topoisomerase I-dependent DNA loops embedded in a protein matrix enriched for SMC2-4 proteins. This arrangement suppressed ATR signalling by preventing RPA hyper-loading, facilitating replication of centromeric DNA. These findings have important implications for our understanding of repetitive DNA metabolism and centromere organization under normal and stressful conditions.	[Aze, Antoine; Sannino, Vincenzo; Soffientini, Paolo; Bachi, Angela; Costanzo, Vincenzo] FIRC Inst Mol Oncol, IFOM, DNA Metab Lab, Via Adamello 16, I-20139 Milan, Italy; [Aze, Antoine] CNRS, Inst Human Genet, Replicat & Genome Dynam Lab, Rue Cardonille 141, F-34396 Montpellier, France	IFOM - FIRC Institute of Molecular Oncology; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier	Costanzo, V (corresponding author), FIRC Inst Mol Oncol, IFOM, DNA Metab Lab, Via Adamello 16, I-20139 Milan, Italy.	Vinecrvo.cosianro@iforn.eu	bachi, angela/B-3527-2015	bachi, angela/0000-0003-4842-6556; Costanzo, Vincenzo/0000-0002-2920-9508; Soffientini, Paolo/0000-0002-1730-5615; Sannino, Vincenzo/0000-0002-3570-7810	Associazione Italiana per la Ricerca sul Cancro (AIRC); European Research Council (ERC) [614541]; Giovanni Armenise-Harvard foundation award; EPIGEN Progetto Bandiera [4.7]; AICR-Worldwide Cancer Research [13-0026]; Fondazione Telethon [GGP13-071]; AIRC [IG 14578]; Action for A-T [16IFO01] Funding Source: researchfish	Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); European Research Council (ERC)(European Research Council (ERC)European Commission); Giovanni Armenise-Harvard foundation award; EPIGEN Progetto Bandiera; AICR-Worldwide Cancer Research; Fondazione Telethon(Fondazione TelethonEuropean Commission); AIRC(Fondazione AIRC per la ricerca sul cancro); Action for A-T	We thank H. Mahbubani and F. Pezzimenti for technical support with Xenopus laevis, J. Gannon for antibody production, M. Lopes for helpful discussions, J. Jiricny for MMR antibodies and A. Losada for CENP-A antibodies. This work was funded by the Associazione Italiana per la Ricerca sul Cancro (AIRC), a European Research Council (ERC) consolidator grant (614541), a Giovanni Armenise-Harvard foundation award, the EPIGEN Progetto Bandiera (4.7), AICR-Worldwide Cancer Research (13-0026) and a Fondazione Telethon (GGP13-071) grant awarded to V.C. A.B. is funded by AIRC grant IG 14578.	Amiard S, 2007, NAT STRUCT MOL BIOL, V14, P147, DOI 10.1038/nsmb1192; Balestrini A, 2010, NAT CELL BIOL, V12, P484, DOI 10.1038/ncb2050; Bermejo R, 2011, CELL, V146, P233, DOI 10.1016/j.cell.2011.06.033; Bermudez I, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq687; Bernad R, 2011, J CELL BIOL, V192, P569, DOI 10.1083/jcb.201005136; Bloom KS, 2014, ANNU REV GENET, V48, P457, DOI 10.1146/annurev-genet-120213-092033; Burdova K, 2015, MOL CELL, V59, P603, DOI 10.1016/j.molcel.2015.06.026; Chaudhuri AR, 2012, NAT STRUCT MOL BIOL, V19, P417, DOI 10.1038/nsmb.2258; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Costanzo V, 2004, PLOS BIOL, V2, P600, DOI 10.1371/journal.pbio.0020110; Costanzo V, 2001, MOL CELL, V8, P137, DOI 10.1016/S1097-2765(01)00294-5; Dunleavy EM, 2009, CELL, V137, P485, DOI 10.1016/j.cell.2009.02.040; Errico A, 2012, CRIT REV BIOCHEM MOL, V47, P222, DOI 10.3109/10409238.2012.655374; Errico A, 2009, EMBO J, V28, P3681, DOI 10.1038/emboj.2009.304; Furuyama T, 2009, CELL, V138, P104, DOI 10.1016/j.cell.2009.04.049; Harris MO, 2015, DNA REPAIR, V28, P1, DOI 10.1016/j.dnarep.2015.01.014; Hashimoto Y, 2006, GENES CELLS, V11, P993, DOI 10.1111/j.1365-2443.2006.00998.x; Hashimoto Y, 2012, NAT STRUCT MOL BIOL, V19, P17, DOI 10.1038/nsmb.2177; Hashimoto Y, 2010, NAT STRUCT MOL BIOL, V17, P1305, DOI 10.1038/nsmb.1927; Hirano T, 2012, GENE DEV, V26, P1659, DOI 10.1101/gad.194746.112; Jonstrup AT, 2008, NUCLEIC ACIDS RES, V36, P6165, DOI 10.1093/nar/gkn640; Koch J, 2000, HUM MOL GENET, V9, P149, DOI 10.1093/hmg/9.2.149; Lupardus PJ, 2002, GENE DEV, V16, P2327, DOI 10.1101/gad.1013502; Marheineke K, 2004, J BIOL CHEM, V279, P28071, DOI 10.1074/jbc.M401574200; McGarry TJ, 1998, CELL, V93, P1043, DOI 10.1016/S0092-8674(00)81209-X; Meijer L, 1997, EUR J BIOCHEM, V243, P527, DOI 10.1111/j.1432-1033.1997.t01-2-00527.x; Mirkin SM, 2007, NATURE, V447, P932, DOI 10.1038/nature05977; Murphy TD, 1998, CELL, V93, P317, DOI 10.1016/S0092-8674(00)81158-7; Nasmyth K, 2001, ANNU REV GENET, V35, P673, DOI 10.1146/annurev.genet.35.102401.091334; Naughton C, 2013, NAT STRUCT MOL BIOL, V20, P387, DOI 10.1038/nsmb.2509; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Rudd MK, 2006, GENOME RES, V16, P88, DOI 10.1101/gr.3810906; Sanborn AL, 2015, P NATL ACAD SCI USA, V112, pE6456, DOI 10.1073/pnas.1518552112; Slean MM, 2008, DNA REPAIR, V7, P1135, DOI 10.1016/j.dnarep.2008.03.014; Voineagu I, 2009, MOL CARCINOGEN, V48, P309, DOI 10.1002/mc.20512; Vos SM, 2011, NAT REV MOL CELL BIO, V12, P827, DOI 10.1038/nrm3228; Zeman MK, 2014, NAT CELL BIOL, V16, P2, DOI 10.1038/ncb2897; Zhao JH, 2010, CELL MOL LIFE SCI, V67, P43, DOI 10.1007/s00018-009-0131-2	38	75	76	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUN	2016	18	6					684	+		10.1038/ncb3344	http://dx.doi.org/10.1038/ncb3344			21	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	DN0JL	27111843	Green Accepted, Green Submitted			2022-12-25	WOS:000376750100015
J	Courtemanche, N; Pollard, TD; Chen, Q				Courtemanche, Naomi; Pollard, Thomas D.; Chen, Qian			Avoiding artefacts when counting polymerized actin in live cells with LifeAct fused to fluorescent proteins	NATURE CELL BIOLOGY			English	Article							CYTOKINETIC CONTRACTILE RING; FISSION YEAST CYTOKINESIS; F-ACTIN; BARBED END; MYOSIN-II; COFILIN; FILAMENTS; MECHANISM; DYNAMICS; FORMINS	When tagged with a fluorescent protein, actin is not fully functional(1), so the LifeAct peptide fused to a fluorescent protein is widely used to localize actin filaments in live cells(2). However, we find that these fusion proteins have many concentration-dependent effects on actin assembly in vitro and in fission yeast cells. mEGFP-LifeAct inhibits actin assembly during endocytosis as well as assembly and constriction of the cytokinetic contractile ring. Purified mEGFP-LifeAct and LifeAct-mCherry bind actin filaments with K-d values of similar to 10 mu M. LifeAct-mCherry can promote actin filament nucleation and either promote or inhibit filament elongation. Both separately and together, profilin and formins suppress these effects. LifeAct-mCherry can also promote or inhibit actin filament severing by cofilin. These concentration-dependent effects mean that caution is necessary when overexpressing LifeAct fusion proteins to label actin filaments in cells. Therefore, we used low micromolar concentrations of tagged LifeAct to follow assembly and disassembly of actin filaments in cells. Careful titrations also gave an estimate of a peak of similar to 190,000 actin molecules (similar to 500 mu m) in the fission yeast contractile ring. These filaments shorten from similar to 500 to similar to 100 subunits as the ring constricts.	[Courtemanche, Naomi; Pollard, Thomas D.; Chen, Qian] Yale Univ, Dept Mol Cellular & Dev Biol, POB 208103, New Haven, CT 06520 USA; [Pollard, Thomas D.] Yale Univ, Dept Mol Biophys & Biochem, POB 208103, New Haven, CT 06520 USA; [Pollard, Thomas D.] Yale Univ, Dept Cell Biol, POB 208103, New Haven, CT 06520 USA; [Courtemanche, Naomi; Chen, Qian] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA; [Courtemanche, Naomi; Chen, Qian] Univ Toledo, Dept Biol Sci, 2801 W Bancroft St, Toledo, OH 43606 USA	Yale University; Yale University; Yale University; University of Minnesota System; University of Minnesota Twin Cities; University System of Ohio; University of Toledo	Pollard, TD (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, POB 208103, New Haven, CT 06520 USA.; Pollard, TD (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, POB 208103, New Haven, CT 06520 USA.; Pollard, TD (corresponding author), Yale Univ, Dept Cell Biol, POB 208103, New Haven, CT 06520 USA.	thomas.pollard@yale.edu	Chen, Qian/AAV-1871-2020	Chen, Qian/0000-0002-2768-6570	National Institute of General Medical Sciences of the National Institutes of Health [R01GM026338]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026338, R01GM026132] Funding Source: NIH RePORTER	National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The research reported in this publication was supported by the National Institute of General Medical Sciences of the National Institutes of Health under award number R01GM026338. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The authors thank C. Lamoureux, J. Johnson and C. McGuinness for carrying out preliminary experiments for this project.	Aizawa H, 1997, CELL STRUCT FUNCT, V22, P335, DOI 10.1247/csf.22.335; Amann KJ, 2001, P NATL ACAD SCI USA, V98, P15009, DOI 10.1073/pnas.211556398; Andrianantoandro E, 2001, J MOL BIOL, V312, P721, DOI 10.1006/jmbi.2001.5005; Andrianantoandro E, 2006, MOL CELL, V24, P13, DOI 10.1016/j.molcel.2006.08.006; Arasada R, 2014, CELL REP, V8, P1533, DOI 10.1016/j.celrep.2014.07.048; Berro J, 2014, MOL BIOL CELL, V25, P3501, DOI 10.1091/mbc.E13-01-0004; Burkel BM, 2007, CELL MOTIL CYTOSKEL, V64, P822, DOI 10.1002/cm.20226; Cao WX, 2006, J MOL BIOL, V361, P257, DOI 10.1016/j.jmb.2006.06.019; Carvalho A, 2009, CELL, V137, P926, DOI 10.1016/j.cell.2009.03.021; Chang F, 1997, J CELL BIOL, V137, P169, DOI 10.1083/jcb.137.1.169; Chen Q, 2015, J BIOL CHEM, V290, P2289, DOI 10.1074/jbc.M114.612978; Chen Q, 2013, CURR BIOL, V23, P1154, DOI 10.1016/j.cub.2013.05.005; Chen Q, 2012, J STRUCT BIOL, V177, P32, DOI 10.1016/j.jsb.2011.10.005; Chen Q, 2011, J CELL BIOL, V195, P485, DOI 10.1083/jcb.201103067; Coffman VC, 2013, J CELL BIOL, V203, P101, DOI 10.1083/jcb.201305022; Coffman VC, 2009, MOL BIOL CELL, V20, P5195, DOI 10.1091/mbc.E09-05-0428; COOPER JA, 1983, J MUSCLE RES CELL M, V4, P253, DOI 10.1007/BF00712034; Courtemanche N, 2015, J BIOL CHEM, V290, P4038, DOI 10.1074/jbc.M114.608117; Courtemanche N, 2013, BIOCHEMISTRY-US, V52, P6456, DOI 10.1021/bi400682n; Doyle T, 1996, P NATL ACAD SCI USA, V93, P3886, DOI 10.1073/pnas.93.9.3886; DRENCKHAHN D, 1986, J BIOL CHEM, V261, P2754; Elam WA, 2013, BIOCHEM BIOPH RES CO, V438, P728, DOI 10.1016/j.bbrc.2013.07.109; Gandhi M, 2009, MOL CELL, V34, P364, DOI 10.1016/j.molcel.2009.02.029; Gerisch G, 2000, CURR OPIN CELL BIOL, V12, P126, DOI 10.1016/S0955-0674(99)00066-6; Goode BL, 2007, ANNU REV BIOCHEM, V76, P593, DOI 10.1146/annurev.biochem.75.103004.142647; Huang JQ, 2012, J CELL BIOL, V199, P831, DOI 10.1083/jcb.201209044; HUXLEY HE, 1967, J MOL BIOL, V30, P383, DOI 10.1016/S0022-2836(67)80046-9; Kaksonen M, 2003, CELL, V115, P475, DOI 10.1016/S0092-8674(03)00883-3; Kamasaki T, 2007, J CELL BIOL, V178, P765, DOI 10.1083/jcb.200612018; KANBE T, 1989, J CELL SCI, V94, P647; Kovar DR, 2003, J CELL BIOL, V161, P875, DOI 10.1083/jcb.200211078; Kovar DR, 2006, CELL, V124, P423, DOI 10.1016/j.cell.2005.11.038; McCormick CD, 2013, BIOPHYS J, V105, P1324, DOI 10.1016/j.bpj.2013.08.017; McGough A, 1997, J CELL BIOL, V138, P771, DOI 10.1083/jcb.138.4.771; Murthy K, 2005, CURR BIOL, V15, P724, DOI 10.1016/j.cub.2005.02.055; Paul AS, 2009, CELL MOTIL CYTOSKEL, V66, P606, DOI 10.1002/cm.20379; Picco A, 2015, ELIFE, V4, DOI 10.7554/eLife.04535; Prochniewicz E, 2005, J MOL BIOL, V353, P990, DOI 10.1016/j.jmb.2005.09.021; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; SCHROEDER TE, 1972, J CELL BIOL, V53, P419, DOI 10.1083/jcb.53.2.419; Sirotkin V, 2010, MOL BIOL CELL, V21, P2894, DOI 10.1091/mbc.E10-02-0157; Wu JQ, 2003, DEV CELL, V5, P723, DOI 10.1016/S1534-5807(03)00324-1; Wu JQ, 2005, SCIENCE, V310, P310, DOI 10.1126/science.1113230; Zhou M, 2008, MOL BIOL CELL, V19, P318, DOI 10.1091/mbc.E07-08-0783	44	71	71	1	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUN	2016	18	6					676	+		10.1038/ncb3351	http://dx.doi.org/10.1038/ncb3351			15	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	DN0JL	27159499	Green Accepted			2022-12-25	WOS:000376750100014
J	Li, M; Jaffe, AE; Straub, RE; Tao, R; Shin, JH; Wang, YH; Chen, Q; Li, C; Jia, YK; Ohi, K; Maher, BJ; Brandon, NJ; Cross, A; Chenoweth, JG; Hoeppner, DJ; Wei, HJ; Hyde, TM; McKay, R; Kleinman, JE; Weinberger, DR				Li, Ming; Jaffe, Andrew E.; Straub, Richard E.; Tao, Ran; Shin, Joo Heon; Wang, Yanhong; Chen, Qiang; Li, Chao; Jia, Yankai; Ohi, Kazutaka; Maher, Brady J.; Brandon, Nicholas J.; Cross, Alan; Chenoweth, Joshua G.; Hoeppner, Daniel J.; Wei, Huijun; Hyde, Thomas M.; McKay, Ronald; Kleinman, Joel E.; Weinberger, Daniel R.			A human-specific AS3MT isoform and BORCS7 are molecular risk factors in the 10q24.32 schizophrenia-associated locus	NATURE MEDICINE			English	Article							MAJOR DEPRESSIVE DISORDER; GENOME-WIDE ASSOCIATION; POSTMORTEM HUMAN BRAIN; COMMON VARIANTS; GENETIC POLYMORPHISMS; BIPOLAR DISORDER; EXPRESSION; GENOTYPE; METHYLTRANSFERASE; SUSCEPTIBILITY	Genome-wide association studies (GWASs) have reported many single nucleotide polymorphisms (SNPs) associated with psychiatric disorders, but knowledge is lacking regarding molecular mechanisms. Here we show that risk alleles spanning multiple genes across the 10q24.32 schizophrenia-related locus are associated in the human brain selectively with an increase in the expression of both BLOC-1 related complex subunit 7 (BORCS7) and a previously uncharacterized, human-specific arsenite methyltransferase (AS3MT) isoform (AS3MT(d2d3)), which lacks arsenite methyltransferase activity and is more abundant in individuals with schizophrenia than in controls. Conditional-expression analysis suggests that BORCS7 and AS3MT(d2d3) signals are largely independent. GWAS risk SNPs across this region are linked with a variable number tandem repeat (VNTR) polymorphism in the first exon of AS3MT that is associated with the expression of AS3MT(d2d3) in samples from both Caucasians and African Americans. The VNTR genotype predicts promoter activity in luciferase assays, as well as DNA methylation within the AS3MT gene. Both AS3MT(d2d3) and BORCS7 are expressed in adult human neurons and astrocytes, and they are upregulated during human stem cell differentiation toward neuronal fates. Our results provide a molecular explanation for the prominent 10q24.32 locus association, including a novel and evolutionarily recent protein that is involved in early brain development and confers risk for psychiatric illness.	[Li, Ming; Jaffe, Andrew E.; Straub, Richard E.; Tao, Ran; Shin, Joo Heon; Wang, Yanhong; Chen, Qiang; Li, Chao; Jia, Yankai; Ohi, Kazutaka; Maher, Brady J.; Chenoweth, Joshua G.; Hoeppner, Daniel J.; Wei, Huijun; Hyde, Thomas M.; McKay, Ronald; Kleinman, Joel E.; Weinberger, Daniel R.] Lieber Inst Brain Dev, Johns Hopkins Med Campus, Baltimore, MD USA; [Jaffe, Andrew E.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mental Hlth, Baltimore, MD USA; [Maher, Brady J.; Hyde, Thomas M.; Kleinman, Joel E.; Weinberger, Daniel R.] Johns Hopkins Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD USA; [Maher, Brady J.; Weinberger, Daniel R.] Johns Hopkins Sch Med, Dept Neurosci, Baltimore, MD USA; [Brandon, Nicholas J.; Cross, Alan] AstraZeneca, Neurosci Innovat Med & Early Dev Biotech Unit, Cambridge, MA USA; [Hyde, Thomas M.; Weinberger, Daniel R.] Johns Hopkins Sch Med, Dept Neurol, Baltimore, MD USA; [Weinberger, Daniel R.] Johns Hopkins Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; AstraZeneca; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine	Weinberger, DR (corresponding author), Lieber Inst Brain Dev, Johns Hopkins Med Campus, Baltimore, MD USA.; Weinberger, DR (corresponding author), Johns Hopkins Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD USA.; Weinberger, DR (corresponding author), Johns Hopkins Sch Med, Dept Neurosci, Baltimore, MD USA.; Weinberger, DR (corresponding author), Johns Hopkins Sch Med, Dept Neurol, Baltimore, MD USA.; Weinberger, DR (corresponding author), Johns Hopkins Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD USA.	drweinberger@libd.org	Ohi, Kazutaka/J-7851-2019; chen, qiang/GWZ-7308-2022; Cross, Alan J/L-5456-2016; Maher, Brady/GPC-8697-2022; Jaffe, Andrew/GPF-5693-2022; Jaffe, Andrew/L-3089-2016; chen, qiang/HGU-5418-2022; Maher, Brady/L-8314-2016	Ohi, Kazutaka/0000-0001-9577-9640; Cross, Alan J/0000-0002-2992-2258; Jaffe, Andrew/0000-0001-6886-1454; Jaffe, Andrew/0000-0001-6886-1454; Maher, Brady/0000-0001-5930-885X; Brandon, Nicholas/0000-0002-3917-0096	Lieber Institute for Brain Development; Maltz Research Laboratories; Brain Behavior Research Foundation; Common Fund of the Office of the Director of the US National Institutes of Health; NCI; NHGRI; NHLBI; NIDA; NIMH; NINDS; NCI\SAIC-Frederick, Inc. (SAIC-F) [10XS170]; Roswell Park Cancer Institute [10XS171]; Science Care, Inc. [X10S172]; SAIC-F [10ST1035, HHSN261200800001E]; Takeda Pharmaceuticals Company Limited; F. Hoffman-La Roche, Ltd.; NIH [R01MH085542, R01MH093725, P50MH066392, P50MH080405, R01MH097276, RO1-MH-075916, P50M096891, P50MH084053S1, R37MH057881, R37MH057881S1, HHSN271201300031C, AG02219, AG05138, MH06692];  [HHSN268201000029C];  [DA006227];  [DA033684];  [N01MH000028];  [MH090941];  [MH101814];  [MH090951];  [MH090937];  [MH101820];  [MH101825];  [MH090936];  [MH101819];  [MH090948];  [MH101782];  [MH101810];  [MH101822]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH101810, R01MH090936, R01MH101814, R01MH093725, P50MH084053, P50MH066392, R37MH057881, R01MH085542, R01MH097276, R01MH101820, R01MH090948, R01MH090941, R01MH101819, R01MH101825, R01MH090951, R01MH090937, P50MH096891, R01MH101822, R01MH101782, R01MH075916] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA006227, R01DA033684] Funding Source: NIH RePORTER	Lieber Institute for Brain Development; Maltz Research Laboratories; Brain Behavior Research Foundation(NARSAD); Common Fund of the Office of the Director of the US National Institutes of Health; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCI\SAIC-Frederick, Inc. (SAIC-F); Roswell Park Cancer Institute; Science Care, Inc.; SAIC-F; Takeda Pharmaceuticals Company Limited; F. Hoffman-La Roche, Ltd.; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank A. Deep-Soboslay (Lieber Institute for Brain Development) for her tireless efforts in clinical diagnosis and demographic characterization; R. Zielke, R.D. Vigorito and R.M. Johnson (National Institute of Child Health and Human Development Brain and Tissue Bank for Developmental Disorders at the University of Maryland) for their provision of fetal, pediatric and adolescent brain tissue specimens; X. Xiao (Johns Hopkins Bloomberg School of Public Health) for her technical assistance. This work was supported by funding from the Lieber Institute for Brain Development and the Maltz Research Laboratories, and from a Senior Investigator grant from the Brain Behavior Research Foundation (J.E.K.). The Genotype-Tissue Expression (GTEx) Project was supported by the Common Fund of the Office of the Director of the US National Institutes of Health. Additional funds were provided by the NCI, NHGRI, NHLBI, NIDA, NIMH and the NINDS. Donors were enrolled at Biospecimen Source Sites funded by NCI\SAIC-Frederick, Inc. (SAIC-F) subcontracts to the National Disease Research Interchange (10XS170), Roswell Park Cancer Institute (10XS171) and Science Care, Inc. (X10S172). The Laboratory, Data Analysis and Coordinating Center (LDACC) were funded through a contract (HHSN268201000029C) to the Broad Institute, Inc. Biorepository operations were funded through an SAIC-F subcontract to Van Andel Institute (10ST1035). Additional data repository and project management were provided by SAIC-F (HHSN261200800001E). The Brain Bank was supported by supplements to University of Miami grants DA006227 & DA033684, and to contract N01MH000028. Statistical Methods development grants were made to the University of Geneva (MH090941 & MH101814), the University of Chicago (MH090951, MH090937, MH101820, MH101825), the University of North Carolina at Chapel Hill (MH090936 & MH101819), Harvard University (MH090948), Stanford University (MH101782), Washington University St. Louis (MH101810) and the University of Pennsylvania (MH101822). The data used for the analyses described in this manuscript were obtained from dbGaP accession number phs000424.v6.p1 on October 6, 2015. Data were generated as part of the CommonMind Consortium supported by funding from Takeda Pharmaceuticals Company Limited, F. Hoffman-La Roche, Ltd. and NIH grants R01MH085542, R01MH093725, P50MH066392, P50MH080405, R01MH097276, RO1-MH-075916, P50M096891, P50MH084053S1, R37MH057881 and R37MH057881S1, HHSN271201300031C, AG02219, AG05138 and MH06692. Brain tissue for the study was obtained from the following brain-bank collections: the Mount Sinai NIH Brain and Tissue Repository, the University of Pennsylvania Alzheimer's Disease Core Center, the University of Pittsburgh NeuroBioBank and Brain and Tissue Repositories and the NIMH Human Brain Collection Core. CMC Leadership: P. Sklar, J. Buxbaum (Icahn School of Medicine at Mount Sinai), B. Devlin, D. Lewis (University of Pittsburgh), R. Gur, C.-G. Hahn (University of Pennsylvania), K. Hirai, H. Toyoshiba (Takeda Pharmaceuticals Company, Ltd.), E. Domenici, L. Essioux (F. Hoffman-La Roche, Ltd.), L. Mangravite, M. Peters (Sage Bionetworks), T. Lehner, B. Lipska (NIMH).	Agusa T, 2011, INT J MOL SCI, V12, P2351, DOI 10.3390/ijms12042351; Antonelli R, 2014, ENVIRON RES, V132, P156, DOI 10.1016/j.envres.2014.03.012; Geng ZR, 2009, J BIOL INORG CHEM, V14, P485, DOI 10.1007/s00775-008-0464-6; Ghiani CA, 2010, MOL PSYCHIATR, V15, P204, DOI 10.1038/mp.2009.58; Harrison PJ, 2004, PSYCHOPHARMACOLOGY, V174, P151, DOI 10.1007/s00213-003-1761-y; Huffaker SJ, 2009, NAT MED, V15, P509, DOI 10.1038/nm.1962; Ioannidis JPA, 2001, NAT GENET, V29, P306, DOI 10.1038/ng749; Jaffe AE, 2016, NAT NEUROSCI, V19, P40, DOI 10.1038/nn.4181; Jaffe AE, 2015, NAT NEUROSCI, V18, P154, DOI 10.1038/nn.3898; Kunii Y, 2014, MOL PSYCHIATR, V19, P192, DOI 10.1038/mp.2012.174; Law AJ, 2006, P NATL ACAD SCI USA, V103, P6747, DOI 10.1073/pnas.0602002103; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Lin S, 2002, J BIOL CHEM, V277, P10795, DOI 10.1074/jbc.M110246200; Lipska BK, 2006, BIOL PSYCHIAT, V60, P650, DOI 10.1016/j.biopsych.2006.06.019; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Morris DW, 2008, BIOL PSYCHIAT, V63, P24, DOI 10.1016/j.biopsych.2006.12.025; O'Donovan MC, 2008, NAT GENET, V40, P1053, DOI 10.1038/ng.201; Oberdoerffer S, 2012, TRANSCR-AUSTIN, V3, P106, DOI 10.4161/trns.19816; Prata DP, 2009, ARCH GEN PSYCHIAT, V66, P1162, DOI 10.1001/archgenpsychiatry.2009.147; Prince M, 2007, LANCET, V370, P859, DOI 10.1016/S0140-6736(07)61238-0; Pu J, 2015, DEV CELL, V33, P176, DOI 10.1016/j.devcel.2015.02.011; Rietschel M, 2012, MOL PSYCHIATR, V17, P906, DOI 10.1038/mp.2011.80; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Ripke S, 2013, NAT GENET, V45, P1150, DOI 10.1038/ng.2742; Ripke S, 2011, NAT GENET, V43, P969, DOI 10.1038/ng.940; Rodrigues EG, 2012, BIOMARKERS, V17, P240, DOI 10.3109/1354750X.2012.658863; Scharpf RB, 2011, J STAT SOFTW, V40, P1; Shi JX, 2009, NATURE, V460, P753, DOI 10.1038/nature08192; Shi YY, 2011, NAT GENET, V43, P1224, DOI 10.1038/ng.980; Sklar P, 2011, NAT GENET, V43, P977, DOI 10.1038/ng.943; Smoller JW, 2013, LANCET, V381, P1371, DOI 10.1016/S0140-6736(12)62129-1; Stefansson H, 2009, NATURE, V460, P744, DOI 10.1038/nature08186; Tao R, 2014, JAMA PSYCHIAT, V71, P1112, DOI 10.1001/jamapsychiatry.2014.1079; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tyler Christina R, 2014, Curr Environ Health Rep, V1, P132; Valluy J, 2015, NAT NEUROSCI, V18, P666, DOI 10.1038/nn.3996; Wedenoja J, 2010, BIOL PSYCHIAT, V67, P983, DOI 10.1016/j.biopsych.2009.09.026; Wood TC, 2006, J BIOL CHEM, V281, P7364, DOI 10.1074/jbc.M512227200; Zhang JX, 2010, BIOL PSYCHIAT, V68, P795, DOI 10.1016/j.biopsych.2010.06.004	39	99	101	2	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2016	22	6					649	+		10.1038/nm.4096	http://dx.doi.org/10.1038/nm.4096			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DO0NQ	27158905				2022-12-25	WOS:000377476000022
J	Choi, VM; Herrou, J; Hecht, AL; Teoh, WP; Turner, JR; Crosson, S; Wardenburg, JB				Choi, Vivian M.; Herrou, Julien; Hecht, Aaron L.; Teoh, Wei Ping; Turner, Jerrold R.; Crosson, Sean; Wardenburg, Juliane Bubeck			Activation of Bacteroides fragilis toxin by a novel bacterial protease contributes to anaerobic sepsis in mice	NATURE MEDICINE			English	Article							PATHOGENICITY ISLAND; ENTEROTOXIN; ADAM10; FAMILY; SUSCEPTIBILITY; CLOSTRIPAIN; BACTEREMIA; MORTALITY; INFECTION; COMMENSAL	Bacteroides fragilis is the leading cause of anaerobic bacteremia and sepsis(1). Enterotoxigenic strains that produce B. fragilis toxin (BFT, fragilysin) contribute to colitis(2) and intestinal malignancy(3), yet are also isolated in bloodstream infection(4,5). It is not known whether these strains harbor unique genetic determinants that confer virulence in extra-intestinal disease. We demonstrate that BFT contributes to sepsis in mice, and we identify a B. fragilis protease called fragipain (Fpn) that is required for the endogenous activation of BFT through the removal of its auto-inhibitory prodomain. Structural analysis of Fpn reveals a His-Cys catalytic dyad that is characteristic of C11-family cysteine proteases that are conserved in multiple pathogenic Bacteroides spp. and Clostridium spp. Fpn-deficient, enterotoxigenic B. fragilis has an attenuated ability to induce sepsis in mice; however, Fpn is dispensable in B. fragilis colitis, wherein host proteases mediate BFT activation. Our findings define a role for B. fragilis enterotoxin and its activating protease in the pathogenesis of bloodstream infection, which indicates a greater complexity of cellular targeting and activity of BFT than previously recognized. The expression of fpn by both toxigenic and nontoxigenic strains suggests that this protease may contribute to anaerobic sepsis in ways that extend beyond its role in toxin activation. It could thus potentially serve as a target for disease modification.	[Choi, Vivian M.; Hecht, Aaron L.; Teoh, Wei Ping; Wardenburg, Juliane Bubeck] Univ Chicago, Dept Microbiol, Chicago, IL 60637 USA; [Choi, Vivian M.; Hecht, Aaron L.] Univ Chicago, Interdisciplinary Scientist Training Program, Chicago, IL 60637 USA; [Herrou, Julien; Crosson, Sean] Univ Chicago, Dept Biochem & Mol Biol, 920 E 58Th St, Chicago, IL 60637 USA; [Turner, Jerrold R.] Univ Chicago, Dept Pathol, 5841 S Maryland Ave, Chicago, IL 60637 USA; [Turner, Jerrold R.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Turner, Jerrold R.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med, Boston, MA 02115 USA; [Wardenburg, Juliane Bubeck] Univ Chicago, Dept Pediat, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago; University of Chicago; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Chicago	Wardenburg, JB (corresponding author), Univ Chicago, Dept Microbiol, Chicago, IL 60637 USA.	jbubeckw@peds.bsd.uchicago.edu	Crosson, Sean/AAE-2453-2022; Turner, Jerrold/H-1502-2019	Crosson, Sean/0000-0002-1727-322X; Teoh, Wei Ping/0000-0003-4588-3022; Herrou, Julien/0000-0002-8585-8043	Department of Pediatrics at the University of Chicago; Pilot and Feasibility Award from the Digestive Diseases Research Core Center at the University of Chicago [NIDDK P30DK42086]; Burroughs Wellcome Foundation Investigators in the Pathogenesis of Infectious Disease Fellowship; US National Institutes of Health Medical Scientist Training Program at the University of Chicago [GM007281]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK067887, R56DK094954, R01DK068271, P30DK042086, R01DK061931] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007281] Funding Source: NIH RePORTER	Department of Pediatrics at the University of Chicago; Pilot and Feasibility Award from the Digestive Diseases Research Core Center at the University of Chicago; Burroughs Wellcome Foundation Investigators in the Pathogenesis of Infectious Disease Fellowship; US National Institutes of Health Medical Scientist Training Program at the University of Chicago(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Department of Pediatrics at the University of Chicago and with a Pilot and Feasibility Award from the Digestive Diseases Research Core Center at the University of Chicago to J.B.W. (NIDDK P30DK42086); by a Burroughs Wellcome Foundation Investigators in the Pathogenesis of Infectious Disease Fellowship (J.B.W.); and by the US National Institutes of Health Medical Scientist Training Program at the University of Chicago (GM007281 to V.M.C. and A.L.H.). We thank D. Hecht (Loyola University) for his generous guidance on the establishment of a B. fragilis program and for B. fragilis strain 638R/TM4000; D. Missiakas (University of Chicago) for alpha-RpoA antisera; J. Gordon (Washington University) for the pSAM-Bt and pKNOCK vectors and Escherichia coli S17 strain; and Y. Fu (University of Texas Southwestern Medical Center) for germ-free mice.	Ani C, 2015, CRIT CARE MED, V43, P65, DOI 10.1097/CCM.0000000000000555; Brook I, 2000, J MED MICROBIOL, V49, P827, DOI 10.1099/0022-1317-49-9-827; Calis J, 2013, NEW ENGL J MED, V369, P2062, DOI [10.1056/NEJMc1312359, 10.1056/NEJMra1208623]; Claros MC, 2006, ANAEROBE, V12, P17, DOI 10.1016/j.anaerobe.2005.06.005; Cui LL, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0796-x; DARGATZ H, 1993, MOL GEN GENET, V240, P140, DOI 10.1007/BF00276893; Franco AA, 1999, J BACTERIOL, V181, P6623, DOI 10.1128/JB.181.21.6623-6633.1999; Franco AA, 2005, INFECT IMMUN, V73, P5273, DOI 10.1128/IAI.73.8.5273-5277.2005; Franco AA, 1997, INFECT IMMUN, V65, P1007, DOI 10.1128/IAI.65.3.1007-1013.1997; Goulas T, 2011, P NATL ACAD SCI USA, V108, P1856, DOI 10.1073/pnas.1012173108; Hartmeyer GN, 2012, J MED MICROBIOL, V61, P1784, DOI 10.1099/jmm.0.049825-0; Inoshima I, 2011, NAT MED, V17, P1310, DOI 10.1038/nm.2451; Inoshima N, 2012, J INVEST DERMATOL, V132, P1513, DOI 10.1038/jid.2011.462; KASPER DL, 1979, J INFECT DIS, V140, P724, DOI 10.1093/infdis/140.5.724; Kato N, 1996, CLIN INFECT DIS, V23, pS83, DOI 10.1093/clinids/23.Supplement_1.S83; Kim JM, 2002, CLIN EXP IMMUNOL, V130, P59, DOI 10.1046/j.1365-2249.2002.01921.x; Labrou NE, 2004, EUR J BIOCHEM, V271, P983, DOI 10.1111/j.1432-1033.2004.04000.x; Mayer CL, 2012, TOXINS, V4, P1261, DOI 10.3390/toxins4111261; McLuskey K, 2015, BIOCHEM J, V466, P219, DOI 10.1042/BJ20141324; Moghadamyeghaneh Z, 2015, AM J SURG, V210, P838, DOI 10.1016/j.amjsurg.2015.04.010; MONCRIEF JS, 1995, INFECT IMMUN, V63, P175, DOI 10.1128/IAI.63.1.175-181.1995; Ngo JT, 2013, INFECTION, V41, P41, DOI 10.1007/s15010-012-0389-4; Ortega E, 2010, TOXINS, V2, P2117, DOI 10.3390/toxins2082117; Powers ME, 2015, CELL HOST MICROBE, V17, P775, DOI 10.1016/j.chom.2015.05.011; Powers ME, 2012, J INFECT DIS, V206, P352, DOI 10.1093/infdis/jis192; Rawlings ND, 2014, NUCLEIC ACIDS RES, V42, pD503, DOI [10.1093/nar/gkt953, 10.1093/nar/gkr987]; REDONDO MC, 1995, CLIN INFECT DIS, V20, P1492, DOI 10.1093/clinids/20.6.1492; Rhee KJ, 2009, INFECT IMMUN, V77, P1708, DOI 10.1128/IAI.00814-08; Robert R, 2008, EUR J CLIN MICROBIOL, V27, P671, DOI 10.1007/s10096-008-0487-5; Rocha ER, 2013, BIOMETALS, V26, P577, DOI 10.1007/s10534-013-9650-2; Shokhen M, 2009, PROTEINS, V77, P916, DOI 10.1002/prot.22516; Snydman DR, 2010, CLIN INFECT DIS, V50, pS26, DOI 10.1086/647940; VANTASSELL RL, 1992, INFECT IMMUN, V60, P1343, DOI 10.1128/IAI.60.4.1343-1350.1992; Vena A, 2015, EUR J CLIN MICROBIOL, V34, P1621, DOI 10.1007/s10096-015-2397-7; Vivares D, 2005, P NATL ACAD SCI USA, V102, P18848, DOI 10.1073/pnas.0505833102; Wang FD, 2014, EUR J CLIN MICROBIOL, V33, P2041, DOI 10.1007/s10096-014-2175-y; Wei DH, 2013, BIOCHEMISTRY-US, V52, P5145, DOI 10.1021/bi400629r; Wu SG, 1998, P NATL ACAD SCI USA, V95, P14979, DOI 10.1073/pnas.95.25.14979; Wu SG, 2009, NAT MED, V15, P1016, DOI 10.1038/nm.2015	39	59	60	1	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2016	22	5					563	567		10.1038/nm.4077	http://dx.doi.org/10.1038/nm.4077			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DL3DI	27089515	Green Accepted			2022-12-25	WOS:000375514000020
J	Kadoya, K; Lu, P; Nguyen, K; Lee-Kubli, C; Kumamaru, H; Yao, L; Knackert, J; Poplawski, G; Dulin, JN; Strob, H; Takashima, Y; Biane, J; Conner, J; Zhang, SC; Tuszynski, MH				Kadoya, Ken; Lu, Paul; Kenny Nguyen; Lee-Kubli, Corinne; Kumamaru, Hiromi; Yao, Lin; Knackert, Joshua; Poplawski, Gunnar; Dulin, Jennifer N.; Strob, Hans; Takashima, Yoshio; Biane, Jeremy; Conner, James; Zhang, Su-Chun; Tuszynski, Mark H.			Spinal cord reconstitution with homologous neural grafts enables robust corticospinal regeneration	NATURE MEDICINE			English	Article							AXONAL REGENERATION; FUNCTIONAL RECOVERY; STEM-CELLS; NERVOUS-SYSTEM; PLASTICITY; INJURY; RAT; GROWTH; PROGENITORS; TRACT	The corticospinal tract (CST) is the most important motor system in humans, yet robust regeneration of this projection after spinal cord injury (SCI) has not been accomplished. In murine models of SCI, we report robust corticospinal axon regeneration, functional synapse formation and improved skilled forelimb function after grafting multipotent neural progenitor cells into sites of SCI. Corticospinal regeneration requires grafts to be driven toward caudalized (spinal cord), rather than rostralized, fates. Fully mature caudalized neural grafts also support corticospinal regeneration. Moreover, corticospinal axons can emerge from neural grafts and regenerate beyond the lesion, a process that is potentially related to the attenuation of the glial scar. Rat corticospinal axons also regenerate into human donor grafts of caudal spinal cord identity. Collectively, these findings indicate that spinal cord 'replacement' with homologous neural stem cells enables robust regeneration of the corticospinal projection within and beyond spinal cord lesion sites, achieving a major unmet goal of SCI research and offering new possibilities for clinical translation.	[Kadoya, Ken; Lu, Paul; Kenny Nguyen; Lee-Kubli, Corinne; Kumamaru, Hiromi; Poplawski, Gunnar; Dulin, Jennifer N.; Strob, Hans; Takashima, Yoshio; Biane, Jeremy; Conner, James; Tuszynski, Mark H.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Kadoya, Ken] Hokkaido Univ, Dept Orthopaed Surg, Sapporo, Hokkaido, Japan; [Lu, Paul; Tuszynski, Mark H.] Vet Adm San Diego Healthcare Syst, San Diego, CA USA; [Yao, Lin; Knackert, Joshua; Zhang, Su-Chun] Univ Wisconsin, Waisman Ctr, Madison, WI 53706 USA; [Yao, Lin; Knackert, Joshua] Univ Wisconsin, Dept Neurosci, Madison, WI 53706 USA; [Yao, Lin; Knackert, Joshua] Univ Wisconsin, Dept Neurol, Madison, WI 53706 USA	University of California System; University of California San Diego; Hokkaido University; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Tuszynski, MH (corresponding author), Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA.; Tuszynski, MH (corresponding author), Vet Adm San Diego Healthcare Syst, San Diego, CA USA.	mtuszynski@ucsd.edu		Poplawski, Gunnar/0000-0002-1917-3441; Dulin, Jennifer/0000-0001-5767-4290	US Veterans Administration (Gordon Mansfield Spinal Cord Injury Consortium); US National Institutes of Health [NS042291, GM008349]; Craig H. Neilsen Foundation; Bernard and Anne Spitzer Charitable Trust; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; Kobayashi Hospital Furate Research Fund; Japan Society for the Promotion of Science; Busta Family fund; Bleser Family fund; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB014986] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008349] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042291] Funding Source: NIH RePORTER; Veterans Affairs [IS1BX003125, I50RX001706] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [15H05989] Funding Source: KAKEN	US Veterans Administration (Gordon Mansfield Spinal Cord Injury Consortium); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Craig H. Neilsen Foundation; Bernard and Anne Spitzer Charitable Trust; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; Kobayashi Hospital Furate Research Fund; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Busta Family fund; Bleser Family fund; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Veterans Affairs(US Department of Veterans Affairs); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank L. Graham, Y. Yang, E. Boehle, J.K. Lee, M. Kim, E. Liu, R. Pope and T. Moynihan for their technical assistance; Planned Parenthood; the Rat Resource and Research Center, University of Missouri, Columbia, Missouri, for providing GFP rats; James Thompson at the University of Wisconsin-Madison, for providing hiPSC line IMR90; K. Wewetzer, University of Freiburg, Germany, for providing 27C7 antibody; R. Darnell, the Rockefeller University, New York, for providing Hu antibody; Y. Jones for use of the electron-microscopy core facility at Cellular and Molecular Medicine, University of California, San Diego; and the Nikon Imaging Center at Hokkaido University for use of the confocal laser microscope. This work was supported by the US Veterans Administration (Gordon Mansfield Spinal Cord Injury Consortium; to M.H.T. and P.L.) the US National Institutes of Health (NS042291 to M.H.T. and GM008349 to J.K.); the Craig H. Neilsen Foundation (to K.K., H.K. and J.N.D.); the Bernard and Anne Spitzer Charitable Trust (to M.H.T.); the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation (to M.H.T. and J.C.); Kobayashi Hospital Furate Research Fund (to K.K.); the Japan Society for the Promotion of Science (to H.K.); and the Busta Family and Bleser Family funds (to S.C.Z.).	Alaverdashvili M, 2008, EUR J NEUROSCI, V28, P311, DOI 10.1111/j.1460-9568.2008.06315.x; Bareyre FM, 2004, NAT NEUROSCI, V7, P269, DOI 10.1038/nn1195; Blackmore MG, 2012, P NATL ACAD SCI USA, V109, P7517, DOI 10.1073/pnas.1120684109; Bonner JF, 2011, J NEUROSCI, V31, P4675, DOI 10.1523/JNEUROSCI.4130-10.2011; Cao QL, 2002, EXP NEUROL, V177, P349, DOI 10.1006/exnr.2002.7981; Chen H, 2015, J CLIN INVEST, V125, P1033, DOI 10.1172/JCI69097; Cho Y, 2013, CELL, V155, P894, DOI 10.1016/j.cell.2013.10.004; Conner JM, 2005, NEURON, V46, P173, DOI 10.1016/j.neuron.2005.03.003; Conti L, 2010, NAT REV NEUROSCI, V11, P176, DOI 10.1038/nrn2761; Coumans JV, 2001, J NEUROSCI, V21, P9334, DOI 10.1523/JNEUROSCI.21-23-09334.2001; Cummings BJ, 2005, P NATL ACAD SCI USA, V102, P14069, DOI 10.1073/pnas.0507063102; Du Beau A, 2012, NEUROSCIENCE, V227, P67, DOI 10.1016/j.neuroscience.2012.09.037; Fawcett James W, 2012, Handb Clin Neurol, V109, P503, DOI 10.1016/B978-0-444-52137-8.00031-0; Garcia-Alias G, 2009, NAT NEUROSCI, V12, P1145, DOI 10.1038/nn.2377; Garcia-Ovejero D, 2015, BRAIN, V138, P1583, DOI 10.1093/brain/awv089; Girgis J, 2007, BRAIN, V130, P2993, DOI 10.1093/brain/awm245; GrandPre T, 2002, NATURE, V417, P547, DOI 10.1038/417547a; Hollis ER, 2009, P NATL ACAD SCI USA, V106, P7215, DOI 10.1073/pnas.0810624106; Krajacic A, 2010, BEHAV BRAIN RES, V214, P323, DOI 10.1016/j.bbr.2010.05.053; Lee YS, 2013, J NEUROSCI, V33, P10591, DOI 10.1523/JNEUROSCI.1116-12.2013; Liu K, 2011, ANNU REV NEUROSCI, V34, P131, DOI 10.1146/annurev-neuro-061010-113723; Liu K, 2010, NAT NEUROSCI, V13, P1075, DOI 10.1038/nn.2603; Liu Y, 2004, BIOL CELL, V96, P279, DOI 10.1016/j.biolcel.2004.02.001; Lu P, 2014, NEURON, V83, P789, DOI 10.1016/j.neuron.2014.07.014; Lu P, 2012, CELL, V150, P1264, DOI 10.1016/j.cell.2012.08.020; Lu P, 2012, J NEUROSCI, V32, P8208, DOI 10.1523/JNEUROSCI.0308-12.2012; Ma LX, 2012, CELL STEM CELL, V10, P455, DOI 10.1016/j.stem.2012.01.021; MayerProschel M, 1997, NEURON, V19, P773, DOI 10.1016/S0896-6273(00)80960-5; Molofsky AV, 2014, NATURE, V509, P189, DOI 10.1038/nature13161; MONTOYA CP, 1991, J NEUROSCI METH, V36, P219, DOI 10.1016/0165-0270(91)90048-5; Norenberg MD, 2004, J NEUROTRAUM, V21, P429, DOI 10.1089/089771504323004575; Ohtake Y, 2014, BIOMATERIALS, V35, P4610, DOI 10.1016/j.biomaterials.2014.02.037; Peljto M, 2010, CELL STEM CELL, V7, P355, DOI 10.1016/j.stem.2010.07.013; Perry RB, 2012, NEURON, V75, P294, DOI 10.1016/j.neuron.2012.05.033; Rosenzweig ES, 2010, NAT NEUROSCI, V13, P1505, DOI 10.1038/nn.2691; SCHNELL L, 1990, NATURE, V343, P269, DOI 10.1038/343269a0; Starkey ML, 2012, EXP NEUROL, V235, P53, DOI 10.1016/j.expneurol.2011.04.008; Steward O, 2014, J NEUROSCI, V34, P14013, DOI 10.1523/JNEUROSCI.3066-14.2014; Steward O, 2014, CELL, V156, P385, DOI 10.1016/j.cell.2014.01.017; Tuszynski MH, 2014, EXP NEUROL, V261, P494, DOI 10.1016/j.expneurol.2014.07.011; Tuszynski MH, 2014, CELL, V156, P388, DOI 10.1016/j.cell.2014.01.016; Tuszynski MH, 2012, NEURON, V74, P777, DOI 10.1016/j.neuron.2012.05.006; Vavrek R, 2007, J NEUROTRAUM, V24, P1667, DOI 10.1089/neu.2007.0290; Wahl AS, 2014, SCIENCE, V344, P1250, DOI 10.1126/science.1253050; Weidner N, 2001, P NATL ACAD SCI USA, V98, P3513, DOI 10.1073/pnas.051626798; Whishaw IQ, 1998, BEHAV BRAIN RES, V93, P167, DOI 10.1016/S0166-4328(97)00152-6; XU XM, 1995, EXP NEUROL, V134, P261, DOI 10.1006/exnr.1995.1056; Zukor K, 2013, J NEUROSCI, V33, P15350, DOI 10.1523/JNEUROSCI.2510-13.2013	48	206	217	6	86	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2016	22	5					479	487		10.1038/nm.4066	http://dx.doi.org/10.1038/nm.4066			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DL3DI	27019328	Green Accepted			2022-12-25	WOS:000375514000010
J	Li, XJ; Qian, X; Peng, LX; Jiang, YH; Hawke, DH; Zheng, YH; Xia, Y; Lee, JH; Cote, G; Wang, HX; Wang, LW; Qian, CN; Lu, ZM				Li, Xinjian; Qian, Xu; Peng, Li-Xia; Jiang, Yuhui; Hawke, David H.; Zheng, Yanhua; Xia, Yan; Lee, Jong-Ho; Cote, Gilbert; Wang, Hongxia; Wang, Liwei; Qian, Chao-Nan; Lu, Zhimin			A splicing switch from ketohexokinase-C to ketohexokinase-A drives hepatocellular carcinoma formation	NATURE CELL BIOLOGY			English	Article							METABOLIC SYNDROME; PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE; ESSENTIAL FRUCTOSURIA; ENZYMATIC SYNTHESIS; ESCHERICHIA-COLI; BETA-CATENIN; ACTIVATION; PROMOTES; MYC; PATHOGENESIS	Dietary fructose is primarily metabolized in the liver. Here we demonstrate that, compared with normal hepatocytes, hepatocellular carcinoma (HCC) cells markedly reduce the rate of fructose metabolism and the level of reactive oxygen species, as a result of a c-Myc-dependent and heterogeneous nuclear ribonucleoprotein (hnRNP) H1- and H2-mediated switch from expression of the high-activity fructokinase (KHK)-C to the low-activity KHK-A isoform. Importantly, KHK-A acts as a protein kinase, phosphorylating and activating phosphoribosyl pyrophosphate synthetase 1 (PRPS1) to promote pentose phosphate pathway-dependent de novo nucleic acid synthesis and HCC formation. Furthermore, c-Myc, hnRNPH1/2 and KHK-A expression levels and PRPS1 Thr225 phosphorylation levels correlate with each other in HCC specimens and are associated with poor prognosis for HCC. These findings reveal a pivotal mechanism underlying the distinct fructose metabolism between HCC cells and normal hepatocytes and highlight the instrumental role of KHK-A protein kinase activity in promoting de novo nucleic acid synthesis and HCC development.	[Li, Xinjian; Qian, Xu; Jiang, Yuhui; Zheng, Yanhua; Xia, Yan; Lee, Jong-Ho; Lu, Zhimin] Univ Texas MD Anderson Canc Ctr, Dept Neurooncol, Houston, TX 77030 USA; [Peng, Li-Xia; Qian, Chao-Nan] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Guangzhou 510060, Guangdong, Peoples R China; [Peng, Li-Xia; Qian, Chao-Nan] Sun Yat Sen Univ, Ctr Canc, Collaborat Innovat Ctr Canc Med, Guangzhou 510060, Guangdong, Peoples R China; [Jiang, Yuhui; Wang, Hongxia; Wang, Liwei] Shanghai Jiao Tong Univ, Sch Med, Shanghai Gen Hosp, Shanghai Key Lab Pancreat Canc,Inst Cell Metab &, Shanghai 200080, Peoples R China; [Hawke, David H.] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA; [Cote, Gilbert] Univ Texas MD Anderson Canc Ctr, Dept Endocrine Neoplasia & Hormonal Disorders, Houston, TX 77030 USA; [Lu, Zhimin] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Lu, Zhimin] Univ Texas Grad Sch Biomed Sci Houston, Canc Biol Program, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; State Key Lab Oncology South China; Sun Yat Sen University; Sun Yat Sen University; Shanghai Jiao Tong University; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Lu, ZM (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Neurooncol, Houston, TX 77030 USA.; Lu, ZM (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA.; Lu, ZM (corresponding author), Univ Texas Grad Sch Biomed Sci Houston, Canc Biol Program, Houston, TX 77030 USA.	zhiminlu@mdanderson.org	yang, zheng/HGC-7753-2022	Hawke, David/0000-0002-6102-7843	National Cancer Institute [2R01 CA109035, 1R0 CA169603]; National Institute of Neurological Disorders and Stroke [1R01 N5089754]; MD Anderson Support Grant [CA016672]; James S. McDonnell Foundation 21st Century Science Initiative in Brain Cancer Research Award [220020318, 2P50 CA127001]; Sister Institution Network Fund from MD Anderson; NIH High-End Instrumentation program [1S10OD012304-01]; CPRIT Core Facility Grant [RP130397]; Odyssey Fellowship from MD Anderson; National Natural Science Foundation of China [81272340, 81472386]; NATIONAL CANCER INSTITUTE [R01CA109035, P50CA127001, R01CA204996, P30CA016672, R01CA169603] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS089754] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD012304] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); MD Anderson Support Grant; James S. McDonnell Foundation 21st Century Science Initiative in Brain Cancer Research Award; Sister Institution Network Fund from MD Anderson; NIH High-End Instrumentation program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CPRIT Core Facility Grant; Odyssey Fellowship from MD Anderson; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank B.-F. Pan for technical support and D. Norwood for critical reading of this manuscript. This work was supported by National Cancer Institute grants 2R01 CA109035 (Z.L.) and 1R0 CA169603 (Z.L.), National Institute of Neurological Disorders and Stroke grant 1R01 N5089754 (Z.L.), MD Anderson Support Grant CA016672, the James S. McDonnell Foundation 21st Century Science Initiative in Brain Cancer Research Award 220020318 (Z.L.), 2P50 CA127001 (Brain Cancer SPORE), a Sister Institution Network Fund from MD Anderson (Z.L.; C.-N.Q.), NIH High-End Instrumentation program grant 1S10OD012304-01 (D.H.H.), CPRIT Core Facility Grant RP130397 (D.H.H.), the Odyssey Fellowship from MD Anderson (X.L.), and research grants 81272340 (C.-N.Q.) and 81472386 (C.-N.Q.) from the National Natural Science Foundation of China. Z.L. is a Ruby E. Rutherford Distinguished Professor.	Asipu A, 2003, DIABETES, V52, P2426, DOI 10.2337/diabetes.52.9.2426; BONTHRON DT, 1994, HUM MOL GENET, V3, P1627, DOI 10.1093/hmg/3.9.1627; Bose T, 2008, BBA-GEN SUBJECTS, V1780, P800, DOI 10.1016/j.bbagen.2008.02.001; BUNN HF, 1981, SCIENCE, V213, P222, DOI 10.1126/science.12192669; Chan SL, 2014, CHIN J CANCER, V33, P481, DOI 10.5732/cjc.014.10133; Chen ZY, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-245; Cunningham JT, 2014, CELL, V157, P1088, DOI 10.1016/j.cell.2014.03.052; Diggle CP, 2009, J HISTOCHEM CYTOCHEM, V57, P763, DOI 10.1369/jhc.2009.953190; Dyballa Nadine, 2009, J Vis Exp, DOI 10.3791/1431; Eriksen TA, 2000, NAT STRUCT BIOL, V7, P303; Fong ZV, 2014, CANCER-AM CANCER SOC, V120, P2824, DOI 10.1002/cncr.28730; Havel PJ, 2005, NUTR REV, V63, P133, DOI [10.1301/nr.2005.may.133-157, 10.1111/j.1753-4887.2005.tb00132.x]; Hayward BE, 1998, EUR J BIOCHEM, V257, P85, DOI 10.1046/j.1432-1327.1998.2570085.x; HOVEJENSEN B, 1988, J BACTERIOL, V170, P1148, DOI 10.1128/jb.170.3.1148-1152.1988; Ishimoto T, 2013, HEPATOLOGY, V58, P1632, DOI 10.1002/hep.26594; Ishimoto T, 2012, P NATL ACAD SCI USA, V109, P4320, DOI 10.1073/pnas.1119908109; Ji HT, 2009, MOL CELL, V36, P547, DOI 10.1016/j.molcel.2009.09.034; Kashima T, 2007, HUM MOL GENET, V16, P3149, DOI 10.1093/hmg/ddm276; KELLER W, 1984, CELL, V39, P423, DOI 10.1016/0092-8674(84)90449-5; KHORANA HG, 1958, J BIOL CHEM, V230, P941; KORNBERG A, 1955, J BIOL CHEM, V215, P389; Lanaspa MA, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3434; Li BS, 2015, NAT MED, V21, P563, DOI 10.1038/nm.3840; Li S, 2007, BIOCHEM J, V401, P39, DOI 10.1042/BJ20061066; Lim JS, 2010, NAT REV GASTRO HEPAT, V7, P251, DOI 10.1038/nrgastro.2010.41; Lu ZM, 1998, MOL CELL BIOL, V18, P839, DOI 10.1128/MCB.18.2.839; Lyssiotis CA, 2013, NATURE, V502, P181, DOI 10.1038/502181a; Mannava S, 2008, CELL CYCLE, V7, P2392, DOI 10.4161/cc.6390; Martinez-Contreras R, 2007, ADV EXP MED BIOL, V623, P123, DOI 10.1007/978-0-387-77374-2_8; McMahon Steven B, 2008, Cell Cycle, V7, P2275; Mirtschink P, 2015, NATURE, V522, P444, DOI 10.1038/nature14508; NOSAL JM, 1993, J BIOL CHEM, V268, P10168; Rauch J, 2011, CANCER RES, V71, P4664, DOI 10.1158/0008-5472.CAN-10-4447; Tappy L, 2010, PHYSIOL REV, V90, P23, DOI 10.1152/physrev.00019.2009; Taus T, 2011, J PROTEOME RES, V10, P5354, DOI 10.1021/pr200611n; Trinh CH, 2009, ACTA CRYSTALLOGR D, V65, P201, DOI 10.1107/S0907444908041115; Wang Y, 2002, CANCER-AM CANCER SOC, V95, P2346, DOI 10.1002/cncr.10963; Willemoes M, 2000, J BIOL CHEM, V275, P35408, DOI 10.1074/jbc.M006346200; Xia Y, 2007, MOL CELL, V25, P219, DOI 10.1016/j.molcel.2007.01.005; Xu YL, 2014, GENE DEV, V28, P1191, DOI 10.1101/gad.241968.114; Yang WW, 2013, CELL CYCLE, V12, P3154, DOI 10.4161/cc.26182; Yang WW, 2012, NAT CELL BIOL, V14, P1295, DOI 10.1038/ncb2629; Yang WW, 2011, NATURE, V480, P118, DOI 10.1038/nature10598; Zimonjic DB, 2012, INT J ONCOL, V41, P393, DOI 10.3892/ijo.2012.1474; Zuo T. T., 2015, CHIN J CANCER, V34, P56	45	105	106	1	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAY	2016	18	5					561	+		10.1038/ncb3338	http://dx.doi.org/10.1038/ncb3338			25	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	DK3RH	27088854	Green Accepted			2022-12-25	WOS:000374834600013
J	Pao, KC; Stanley, M; Han, C; Lai, YC; Murphy, P; Balk, K; Wood, NT; Corti, O; Corvol, JC; Muqit, MMK; Virdee, S				Pao, Kuan-Chuan; Stanley, Mathew; Han, Cong; Lai, Yu-Chiang; Murphy, Paul; Balk, Kristin; Wood, Nicola T.; Corti, Olga; Corvol, Jean-Christophe; Muqit, Miratul M. K.; Virdee, Satpal			Probes of ubiquitin E3 ligases enable systematic dissection of parkin activation	NATURE CHEMICAL BIOLOGY			English	Article							PINK1-DEPENDENT PHOSPHORYLATION; PINK1; REVEALS; DIUBIQUITIN; SPECIFICITY; MECHANISM; COMPLEX; PROTEIN; PRIMES; CHAIN	E3 ligases represent an important class of enzymes, yet there are currently no chemical probes for profiling their activity. We develop a new class of activity-based probe by re-engineering a ubiquitin-charged E2 conjugating enzyme and demonstrate the utility of these probes by profiling the transthiolation activity of the RING-in-between-RING (RBR) E3 ligase parkin in vitro and in cellular extracts. Our study provides valuable insight into the roles, and cellular hierarchy, of distinct phosphorylation events in parkin activation. We also profile parkin mutations associated with patients with Parkinson's disease and demonstrate that they mediate their effect largely by altering transthiolation activity. Furthermore, our probes enable direct and quantitative measurement of endogenous parkin activity, revealing that endogenous parkin is activated in neuronal cell lines (>= 75%) in response to mitochondrial depolarization. This new technology also holds promise as a novel biomarker of PINK1-parkin signaling, as demonstrated by its compatibility with samples derived from individuals with Parkinson's disease.	[Pao, Kuan-Chuan; Stanley, Mathew; Han, Cong; Lai, Yu-Chiang; Murphy, Paul; Balk, Kristin; Wood, Nicola T.; Muqit, Miratul M. K.; Virdee, Satpal] Univ Dundee, Med Res Council Prot Phosphorylat & Ubiquitylat U, Dundee, Scotland; [Corti, Olga; Corvol, Jean-Christophe] Univ Paris 06, Sorbonne Univ, Paris, France; [Corti, Olga; Corvol, Jean-Christophe] Ctr Invest Clin 1422, INSERM, U1127, Paris, France; [Corti, Olga; Corvol, Jean-Christophe] CNRS, Unite 7225, Paris, France; [Corti, Olga; Corvol, Jean-Christophe] AP HP, Paris, France; [Corti, Olga; Corvol, Jean-Christophe] Inst Cerveau & Moelle, Paris, France; [Muqit, Miratul M. K.] Univ Dundee, Sch Med, Dundee, Scotland	University of Dundee; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Sorbonne Universite; University of Dundee	Virdee, S (corresponding author), Univ Dundee, Med Res Council Prot Phosphorylat & Ubiquitylat U, Dundee, Scotland.	s.s.virdee@dundee.ac.uk	Lai, Yu-Chiang/AAR-8005-2021; Corti, Olga/AAC-3160-2019; Corvol, Jean-Christophe/F-2124-2017; corvol, jean-christophe/I-6387-2012; Corti, Olga/I-4981-2016	Corvol, Jean-Christophe/0000-0001-7325-0199; corvol, jean-christophe/0000-0001-7325-0199; Corti, Olga/0000-0003-2093-7389; Lai, Yu-Chiang/0000-0002-8254-3732; Virdee, Satpal/0000-0002-7052-9802; Wood, Nicola/0000-0002-3347-6625	Scottish Funding Council; UK Medical Research Council [MC_UU_12016/8]; A.J. Macdonald Menzies Charitable Trust Prize Studentship; Wellcome Trust Senior Research Fellowship in Clinical Science [101022/Z/13/Z]; Medical Research Council [MC_UU_12016/8] Funding Source: researchfish; Parkinson&quot;s UK [G-1506, H-1403] Funding Source: researchfish; MRC [MC_UU_12016/8] Funding Source: UKRI	Scottish Funding Council; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); A.J. Macdonald Menzies Charitable Trust Prize Studentship; Wellcome Trust Senior Research Fellowship in Clinical Science(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Parkinson&quot;s UK(Parkinson&apos;s UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We are grateful to the Medical Research Council Protein Phosphorylation and Ubiquitylation Unit Proteomics and DNA Sequencing Facilities. We are also grateful to I. Gilbert for support with chemistry instrumentation and access to modeling software. We also thank J.W. Chin (Medical Research Council Laboratory of Molecular Biology) for critical reading of the manuscript. This work was funded by the Scottish Funding Council, the UK Medical Research Council (MC_UU_12016/8) and pharmaceutical companies supporting the Division of Signal Transduction Therapy (AstraZeneca, Boehringer-Ingelheim, GlaxoSmithKline, Merck KGaA, Janssen Pharmaceutica and Pfizer). K.B. is funded by an A.J. Macdonald Menzies Charitable Trust Prize Studentship. M.M.K.M. is funded by a Wellcome Trust Senior Research Fellowship in Clinical Science (101022/Z/13/Z).	Berndsen CE, 2014, NAT STRUCT MOL BIOL, V21, P301, DOI 10.1038/nsmb.2780; Borodovsky A, 2002, CHEM BIOL, V9, P1149, DOI 10.1016/S1074-5521(02)00248-X; Borodovsky A, 2001, EMBO J, V20, P5187, DOI 10.1093/emboj/20.18.5187; Chaugule VK, 2011, EMBO J, V30, P2853, DOI 10.1038/emboj.2011.204; Cravatt BF, 2008, ANNU REV BIOCHEM, V77, P383, DOI 10.1146/annurev.biochem.75.101304.124125; Cui CX, 2006, PROTEIN EXPRES PURIF, V50, P74, DOI 10.1016/j.pep.2006.05.019; Dadova J, 2013, ANGEW CHEM INT EDIT, V52, P10515, DOI 10.1002/anie.201303577; Ekkebus R, 2013, J AM CHEM SOC, V135, P2867, DOI 10.1021/ja309802n; El Oualid F, 2010, ANGEW CHEM INT EDIT, V49, P10149, DOI 10.1002/anie.201005995; Haj-Yahya N, 2014, ORG LETT, V16, P540, DOI 10.1021/ol403416w; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hong V, 2009, ANGEW CHEM INT EDIT, V48, P9879, DOI 10.1002/anie.200905087; Kamadurai HB, 2009, MOL CELL, V36, P1095, DOI 10.1016/j.molcel.2009.11.010; Kane LA, 2014, J CELL BIOL, V205, P143, DOI 10.1083/jcb.201402104; Katrun P, 2010, EUR J ORG CHEM, V2010, P5633, DOI 10.1002/ejoc.201000641; Kazlauskaite A, 2015, EMBO REP, V16, P939, DOI 10.15252/embr.201540352; Kazlauskaite A, 2015, FEBS J, V282, P215, DOI 10.1111/febs.13127; Kazlauskaite A, 2014, BIOCHEM J, V460, P127, DOI 10.1042/BJ20140334; Kazlauskaite A, 2014, OPEN BIOL, V4, DOI 10.1098/rsob.130213; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Kondapalli C, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120080; Koyano F, 2014, NATURE, V510, P162, DOI 10.1038/nature13392; Kumar A, 2015, EMBO J, V34, P2506, DOI 10.15252/embj.201592337; Lai YC, 2015, EMBO J, V34, P2840, DOI 10.15252/embj.201591593; Lazarou M, 2015, NATURE, V524, P309, DOI 10.1038/nature14893; Lazarou M, 2013, J CELL BIOL, V200, P163, DOI 10.1083/jcb.201210111; Lechtenberg BC, 2016, NATURE, V529, P546, DOI 10.1038/nature16511; Li GR, 2014, CHEM COMMUN, V50, P216, DOI 10.1039/c3cc47382a; Lin DYW, 2011, J BIOL CHEM, V286, P441, DOI 10.1074/jbc.M110.167643; Love KR, 2009, ACS CHEM BIOL, V4, P275, DOI 10.1021/cb9000348; Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140; McGouran JF, 2013, CHEM BIOL, V20, P1447, DOI 10.1016/j.chembiol.2013.10.012; Mulder MPC, 2014, CHEMBIOCHEM, V15, P946, DOI 10.1002/cbic.201402012; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Nguyen DP, 2009, J AM CHEM SOC, V131, P8720, DOI 10.1021/ja900553w; Niphakis MJ, 2014, ANNU REV BIOCHEM, V83, P341, DOI 10.1146/annurev-biochem-060713-035708; Okatsu K, 2015, J CELL BIOL, V209, P111, DOI 10.1083/jcb.201410050; Okatsu K, 2013, J BIOL CHEM, V288, P36372, DOI 10.1074/jbc.M113.509653; Olsen SK, 2010, NATURE, V463, P906, DOI 10.1038/nature08765; Ordureau A, 2015, P NATL ACAD SCI USA, V112, P6637, DOI 10.1073/pnas.1506593112; Ordureau A, 2014, MOL CELL, V56, P360, DOI 10.1016/j.molcel.2014.09.007; Pickrell AM, 2015, NEURON, V85, P257, DOI 10.1016/j.neuron.2014.12.007; Plechanovova A, 2012, NATURE, V489, P115, DOI 10.1038/nature11376; Popovic D, 2014, NAT MED, V20, P1242, DOI 10.1038/nm.3739; Riley BE, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2982; Sarraf SA, 2013, NATURE, V496, P372, DOI 10.1038/nature12043; Sauve V, 2015, EMBO J, V34, P2492, DOI 10.15252/embj.201592237; Shiba-Fukushima K, 2012, SCI REP-UK, V2, DOI 10.1038/srep01002; Smit JJ, 2014, EMBO REP, V15, P142, DOI 10.1002/embr.201338166; Sommer S, 2013, BIOORGAN MED CHEM, V21, P2511, DOI 10.1016/j.bmc.2013.02.039; Stanley M, 2015, ACS CHEM BIOL, V10, P1542, DOI 10.1021/acschembio.5b00118; Stieglitz B, 2012, EMBO REP, V13, P840, DOI 10.1038/embor.2012.105; Trempe JF, 2013, SCIENCE, V340, P1451, DOI 10.1126/science.1237908; Virdee S, 2010, NAT CHEM BIOL, V6, P750, DOI [10.1038/nchembio.426, 10.1038/NCHEMBIO.426]; Wauer T, 2015, NATURE, V524, P370, DOI 10.1038/nature14879; Wauer T, 2013, EMBO J, V32, P2099, DOI 10.1038/emboj.2013.125; Weissman AM, 2001, NAT REV MOL CELL BIO, V2, P169, DOI 10.1038/35056563; Wenzel DM, 2011, NATURE, V474, P105, DOI 10.1038/nature09966; Yang B, 2012, NAT METHODS, V9, P904, DOI 10.1038/nmeth.2099	60	71	71	1	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAY	2016	12	5					324	+		10.1038/NCHEMBIO.2045	http://dx.doi.org/10.1038/NCHEMBIO.2045			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DJ6KY	26928937	Green Accepted			2022-12-25	WOS:000374322800006
J	De Ravin, SS; Reik, A; Liu, PQ; Li, LH; Wu, XL; Su, L; Raley, C; Theobald, N; Choi, U; Song, AH; Chan, A; Pearl, JR; Paschon, DE; Lee, J; Newcombe, H; Koontz, S; Sweeney, C; Shivak, DA; Zarember, KA; Peshwa, MV; Gregory, PD; Urnov, FD; Malech, HL				De Ravin, Suk See; Reik, Andreas; Liu, Pei-Qi; Li, Linhong; Wu, Xiaolin; Su, Ling; Raley, Castle; Theobald, Narda; Choi, Uimook; Song, Alexander H.; Chan, Andy; Pearl, Jocelynn R.; Paschon, David E.; Lee, Janet; Newcombe, Hannah; Koontz, Sherry; Sweeney, Colin; Shivak, David A.; Zarember, Kol A.; Peshwa, Madhusudan V.; Gregory, Philip D.; Urnov, Fyodor D.; Malech, Harry L.			Targeted gene addition in human CD34(+) hematopoietic cells for correction of X-linked chronic granulomatous disease	NATURE BIOTECHNOLOGY			English	Article							THERAPY; STEM; EXPRESSION; VECTORS; OXIDASE	Gene therapy with genetically modified human CD34(+) hematopoietic stem and progenitor cells (HSPCs) may be safer using targeted integration (TI) of transgenes into a genomic 'safe harbor' site rather than random viral integration. We demonstrate that temporally optimized delivery of zinc finger nuclease mRNA via electroporation and adeno-associated virus (AAV) 6 delivery of donor constructs in human HSPCs approaches clinically relevant levels of TI into the AAVS1 safe harbor locus. Up to 58% Venus(+) HSPCs with 6-16% human cell marking were observed following engraftment into mice. In HSPCs from patients with X-linked chronic granulomatous disease (X-CGD), caused by mutations in the gp91phox subunit of the NADPH oxidase, TI of a gp91phox transgene into AAVS1 resulted in similar to 15% gp91phox expression and increased NADPH oxidase activity in ex vivo-derived neutrophils. In mice transplanted with corrected HSPCs, 4-11% of human cells in the bone marrow expressed gp91phox. This method for TI into AAVS1 may be broadly applicable to correction of other monogenic diseases.	[De Ravin, Suk See; Theobald, Narda; Choi, Uimook; Lee, Janet; Newcombe, Hannah; Koontz, Sherry; Sweeney, Colin; Zarember, Kol A.; Malech, Harry L.] NIAID, Host Def Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Reik, Andreas; Liu, Pei-Qi; Song, Alexander H.; Chan, Andy; Pearl, Jocelynn R.; Paschon, David E.; Shivak, David A.; Gregory, Philip D.; Urnov, Fyodor D.] Sangamo BioSci Inc, Richmond, CA USA; [Li, Linhong] MaxCyte Inc, Gaithersburg, MD USA; [Wu, Xiaolin; Su, Ling; Raley, Castle; Peshwa, Madhusudan V.] Leidos Biomed Res Inc, Canc Res Technol Program, Frederick, MD USA; [Gregory, Philip D.] Blubird Bio, Cambridge, MA USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Sangamo Therapeutics, Inc.; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Malech, HL (corresponding author), NIAID, Host Def Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	hmalech@nih.gov		De Ravin, Suk See/0000-0002-9800-774X; Zarember, Kol/0000-0002-9624-7096; Malech, Harry/0000-0001-5874-5775; Gregory, Philip/0000-0001-9249-2468	intramural program of National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health [1 ZIA AI000644]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000644, ZIAAI001151, ZIAAI000645, ZIAAI000644, ZIAAI000155, Z01AI000988, ZIAAI000988, ZIAAI000991] Funding Source: NIH RePORTER	intramural program of National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	These studies were supported in part by project 1 ZIA AI000644 of the intramural program of National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health. Human CD34<SUP>+</SUP> HSPCs were obtained under NIAID IRB approved Protocol 94-I-0073 after written informed consent. Murine animal studies were performed under National Institutes of Allergy and Infectious Diseases (NIAID) Animal Care and Use Committee approved protocol Laboratory of Host Defenses (LHD) 3E.	Astrakhan A, 2012, BLOOD, V119, P4395, DOI 10.1182/blood-2011-03-340711; Biffi A, 2013, SCIENCE, V341, P864, DOI 10.1126/science.1233158; Brenner S, 2003, BLOOD, V102, P2789, DOI 10.1182/blood-2002-05-1482; Carroll D, 2014, METHODS, V69, P137, DOI 10.1016/j.ymeth.2014.03.026; Carroll D, 2014, ANNU REV BIOCHEM, V83, P409, DOI 10.1146/annurev-biochem-060713-035418; Cavazzana-Calvo M, 2000, SCIENCE, V288, P669, DOI 10.1126/science.288.5466.669; CHALLITA PM, 1995, J VIROL, V69, P748, DOI 10.1128/JVI.69.2.748-755.1995; DeKelver RC, 2010, GENOME RES, V20, P1133, DOI 10.1101/gr.106773.110; Gabriel R, 2011, NAT BIOTECHNOL, V29, P816, DOI 10.1038/nbt.1948; Genovese P, 2014, NATURE, V510, P235, DOI 10.1038/nature13420; Hacein-Bey-Abina S, 2003, NEW ENGL J MED, V348, P255, DOI 10.1056/NEJM200301163480314; Hacein-Bey-Abina S, 2010, NEW ENGL J MED, V363, P355, DOI 10.1056/NEJMoa1000164; Kuhns DB, 2010, NEW ENGL J MED, V363, P2600, DOI 10.1056/NEJMoa1007097; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Marciano BE, 2015, CLIN INFECT DIS, V60, P1176, DOI 10.1093/cid/ciu1154; Moehle EA, 2007, P NATL ACAD SCI USA, V104, P3055, DOI 10.1073/pnas.0611478104; Orlando SJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq512; Song LJ, 2013, CYTOTHERAPY, V15, P986, DOI 10.1016/j.jcyt.2013.04.003; Song LJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058757; Stein S, 2010, NAT MED, V16, P198, DOI 10.1038/nm.2088; Tebas P, 2014, NEW ENGL J MED, V370, P901, DOI 10.1056/NEJMoa1300662; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; Vierstra J, 2015, NAT METHODS, V12, P927, DOI [10.1038/NMETH.3554, 10.1038/nmeth.3554]; Wang JB, 2015, NAT BIOTECHNOL, V33, P1256, DOI 10.1038/nbt.3408	24	134	138	0	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	APR	2016	34	4					424	+		10.1038/nbt.3513	http://dx.doi.org/10.1038/nbt.3513			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DI6NL	26950749	Green Accepted			2022-12-25	WOS:000373616100024
J	Saunders, JC; Young, LM; Mahood, RA; Jackson, MP; Revill, CH; Foster, RJ; Smith, DA; Ashcroft, AE; Brockwell, DJ; Radford, SE				Saunders, Janet C.; Young, Lydia M.; Mahood, Rachel A.; Jackson, Matthew P.; Revill, Charlotte H.; Foster, Richard J.; Smith, D. Alastair; Ashcroft, Alison E.; Brockwell, David J.; Radford, Sheena E.			An in vivo platform for identifying inhibitors of protein aggregation	NATURE CHEMICAL BIOLOGY			English	Article							ISLET-AMYLOID-POLYPEPTIDE; CRYSTAL-STRUCTURE; FIBRIL FORMATION; ALPHA-SYNUCLEIN; BETA(2)-MICROGLOBULIN; CONFORMATIONS; CONVERSION; DOPAMINE; DYNAMICS; CURCUMIN	Protein aggregation underlies an array of human diseases, yet only one small-molecule therapeutic targeting this process has been successfully developed to date. Here, we introduce an in vivo system, based on a beta-lactamase tripartite fusion construct, that is capable of identifying aggregation-prone sequences in the periplasm of Escherichia coli and inhibitors that prevent their aberrant self-assembly. We demonstrate the power of the system using a range of proteins, from small unstructured peptides (islet amyloid polypeptide and amyloid beta) to larger, folded immunoglobulin domains. Configured in a 48-well format, the split beta-lactamase sensor readily differentiates between aggregation-prone and soluble sequences. Performing the assay in the presence of 109 compounds enabled a rank ordering of inhibition and revealed a new inhibitor of islet amyloid polypeptide aggregation. This platform can be applied to both amyloidogenic and other aggregation-prone systems, independent of sequence or size, and can identify small molecules or other factors able to ameliorate or inhibit protein aggregation.	[Saunders, Janet C.; Young, Lydia M.; Mahood, Rachel A.; Jackson, Matthew P.; Revill, Charlotte H.; Foster, Richard J.; Ashcroft, Alison E.; Brockwell, David J.; Radford, Sheena E.] Univ Leeds, Astbury Ctr Struct Mol Biol, Leeds, W Yorkshire, England; [Saunders, Janet C.; Young, Lydia M.; Mahood, Rachel A.; Jackson, Matthew P.; Ashcroft, Alison E.; Brockwell, David J.; Radford, Sheena E.] Univ Leeds, Sch Mol & Cellular Biol, Leeds, W Yorkshire, England; [Revill, Charlotte H.; Foster, Richard J.] Univ Leeds, Sch Chem, Leeds LS2 9JT, W Yorkshire, England; [Smith, D. Alastair] Avacta Analyt Plc, Wetherby, W Yorkshire, England	University of Leeds; University of Leeds; University of Leeds	Brockwell, DJ; Radford, SE (corresponding author), Univ Leeds, Astbury Ctr Struct Mol Biol, Leeds, W Yorkshire, England.; Brockwell, DJ; Radford, SE (corresponding author), Univ Leeds, Sch Mol & Cellular Biol, Leeds, W Yorkshire, England.	D.J.Brockwell@leeds.ac.uk; S.E.Radford@leeds.ac.uk		Mahood, Rachel/0000-0001-7709-2300; Radford, Sheena/0000-0002-3079-8039; Foster, Richard/0000-0002-2361-3884; Young, Lydia/0000-0001-9668-6366; Brockwell, David/0000-0002-0802-5937	Innovate UK [131841]; Biotechnology and Biological Sciences Research Council (BBSRC) [BB/M01259X/1]; European Research Council (ERC) under the European Union's Seventh Framework Programme (FP7)/ERC [322408]; Biomedical Health Research Centre (University of Leeds); BBSRC CASE studentship - Avacta Analytical plc, Wetherby, UK [BB/H014713/1]; BBSRC CASE studentship - Micromass UK Ltd./Waters Corporation, Manchester, UK [BB/I015361/1]; BBSRC [BB/F01614X/1, BB/E012558/1]; Biotechnology and Biological Sciences Research Council [1065203, 1088554, BBS/B/04803, SF16972, B18705, BB/M01259X/1, BB/C507029/1, BB/E012558/1] Funding Source: researchfish; Wellcome Trust [092896/Z/10/Z] Funding Source: researchfish; BBSRC [BB/M01259X/1] Funding Source: UKRI	Innovate UK(UK Research & Innovation (UKRI)Innovate UK); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Research Council (ERC) under the European Union's Seventh Framework Programme (FP7)/ERC(European Research Council (ERC)); Biomedical Health Research Centre (University of Leeds); BBSRC CASE studentship - Avacta Analytical plc, Wetherby, UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC CASE studentship - Micromass UK Ltd./Waters Corporation, Manchester, UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	J.C.S. is co-funded by Innovate UK (131841) and the Biotechnology and Biological Sciences Research Council (BBSRC) (BB/M01259X/1) and was previously funded by a BBSRC CASE studentship (grant number BB/H014713/1) sponsored by Avacta Analytical plc, Wetherby, UK. L.M.Y. is funded by a BBSRC CASE studentship (grant number BB/I015361/1) sponsored by Micromass UK Ltd./Waters Corporation, Manchester, UK. R.A.M. is funded by a BBSRC studentship (grant number BB/F01614X/1). The Synapt HDMS mass spectrometer was purchased with funds from the BBSRC (BB/E012558/1). M.P.J., D.J.B. and S.E.R. also acknowledge funding from the European Research Council (ERC) under the European Union's Seventh Framework Programme (FP7/2007-2013)/ERC grant agreement number 322408. R.J.F. and C.H.R. acknowledge the Biomedical Health Research Centre (University of Leeds) for funding. We thank J. Bardwell (University of Michigan) for his longstanding collaboration and advice at the beginning of the study. We thank S. Webster (formerly at Avacta Analytical plc) for his advice and helpful discussions. We are very grateful to D. Raleigh and L.-H. Tu (Stony Brook University) for kindly providing the synthetic hIAPP and rIAPP peptides. We thank R. Wetzel (University of Pittsburgh) for providing the WO1 antibody. We also acknowledge our collaborators and all members of our groups for helpful discussions.	Aarabi MH, 2012, AFR J PHARM PHARMACO, V6, P2374, DOI 10.5897/AJPP12.616; Aitken JF, 2003, BIOCHEM J, V374, P779, DOI 10.1042/BJ20030422; [Anonymous], 2014, SCHROD REL 9 3; Baell J, 2014, NATURE, V513, P481, DOI 10.1038/513481a; Baell JB, 2010, J MED CHEM, V53, P2719, DOI 10.1021/jm901137j; Bitan G, 2001, J BIOL CHEM, V276, P35176, DOI 10.1074/jbc.M102223200; Bulawa CE, 2012, P NATL ACAD SCI USA, V109, P9629, DOI 10.1073/pnas.1121005109; Butterfield S, 2012, J MOL BIOL, V421, P204, DOI 10.1016/j.jmb.2012.01.051; Chen YR, 2006, J BIOL CHEM, V281, P24414, DOI 10.1074/jbc.M602363200; Cheng BA, 2012, BIOCHEM BIOPH RES CO, V419, P495, DOI 10.1016/j.bbrc.2012.02.042; Cheng BA, 2011, J AGR FOOD CHEM, V59, P13147, DOI 10.1021/jf201702h; Daval M, 2010, AMYLOID, V17, P118, DOI 10.3109/13506129.2010.530008; Eichner T, 2011, MOL CELL, V41, P161, DOI 10.1016/j.molcel.2010.11.028; Espargaro A, 2012, MOL BIOSYST, V8, P2839, DOI 10.1039/c2mb25214g; Foit L, 2009, MOL CELL, V36, P861, DOI 10.1016/j.molcel.2009.11.022; Giles K, 2004, RAPID COMMUN MASS SP, V18, P2401, DOI 10.1002/rcm.1641; Hailu TT, 2013, ANAL BIOCHEM, V434, P181, DOI 10.1016/j.ab.2012.11.022; JELSCH C, 1993, PROTEINS, V16, P364, DOI 10.1002/prot.340160406; Jespers L, 2004, NAT BIOTECHNOL, V22, P1161, DOI 10.1038/nbt1000; Jespers L, 2004, J MOL BIOL, V337, P893, DOI 10.1016/j.jmb.2004.02.013; Kad NM, 2001, J MOL BIOL, V313, P559, DOI 10.1006/jmbi.2001.5071; Kim W, 2006, ACS CHEM BIOL, V1, P461, DOI 10.1021/cb600135w; Knowles TPJ, 2014, NAT REV MOL CELL BIO, V15, P384, DOI 10.1038/nrm3810; Koo BW, 2005, PROTEIN SCI, V14, P231, DOI 10.1110/ps.041051205; Lee HJ, 2011, EXP MOL MED, V43, P216, DOI 10.3858/emm.2011.43.4.026; Lee LL, 2009, PROTEIN SCI, V18, P277, DOI 10.1002/pro.33; Li J, 2004, FASEB J, V18, P962, DOI 10.1096/fj.03-0770fje; Mangione PP, 2013, J BIOL CHEM, V288, P30917, DOI 10.1074/jbc.M113.498857; Marek P, 2010, ORG LETT, V12, P4848, DOI 10.1021/ol101981b; McKoy AF, 2012, J BIOL CHEM, V287, P38992, DOI 10.1074/jbc.M112.348037; Meng FL, 2008, BIOCHEMISTRY-US, V47, P6016, DOI 10.1021/bi702518m; Meng FL, 2011, J MOL BIOL, V406, P491, DOI 10.1016/j.jmb.2010.12.028; Meng FL, 2010, J MOL BIOL, V400, P555, DOI 10.1016/j.jmb.2010.05.001; Morell M, 2011, MOL BIOSYST, V7, P1121, DOI 10.1039/c0mb00297f; Nesterov EE, 2005, ANGEW CHEM INT EDIT, V44, P5452, DOI 10.1002/anie.200500845; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; Noor H, 2012, PROTEIN SCI, V21, P373, DOI 10.1002/pro.2023; O'Nuallain B, 2002, P NATL ACAD SCI USA, V99, P1485, DOI 10.1073/pnas.022662599; Palhano FL, 2013, J AM CHEM SOC, V135, P7503, DOI 10.1021/ja3115696; Pieri L, 2012, BIOPHYS J, V102, P2894, DOI 10.1016/j.bpj.2012.04.050; Porat Y, 2004, BIOCHEMISTRY-US, V43, P14454, DOI 10.1021/bi048582a; Qiao Q, 2013, J AM CHEM SOC, V135, P16092, DOI 10.1021/ja403147m; Quan S, 2011, NAT STRUCT MOL BIOL, V18, P262, DOI 10.1038/nsmb.2016; Romero D, 2013, CHEM BIOL, V20, P102, DOI 10.1016/j.chembiol.2012.10.021; Sgourakis NG, 2007, J MOL BIOL, V368, P1448, DOI 10.1016/j.jmb.2007.02.093; Sipe JD, 2014, AMYLOID, V21, P221, DOI 10.3109/13506129.2014.964858; Sparks S, 2012, BIOCHEM BIOPH RES CO, V422, P551, DOI 10.1016/j.bbrc.2012.05.013; Tipping KW, 2015, TRENDS BIOCHEM SCI, V40, P719, DOI 10.1016/j.tibs.2015.10.002; Tu LH, 2015, BIOCHEMISTRY-US, V54, P666, DOI 10.1021/bi501016r; Valleix S, 2012, NEW ENGL J MED, V366, P2276, DOI 10.1056/NEJMoa1201356; Walsh DM, 2009, FEBS J, V276, P1266, DOI 10.1111/j.1742-4658.2008.06862.x; Williamson JA, 2007, PROTEIN SCI, V16, P110, DOI 10.1110/ps.062486907; Wu C, 2006, BIOPHYS J, V91, P3664, DOI 10.1529/biophysj.106.081877; Young LM, 2015, NAT CHEM, V7, P73, DOI [10.1038/nchem.2129, 10.1038/NCHEM.2129]; Young LM, 2014, J AM CHEM SOC, V136, P660, DOI 10.1021/ja406831n; Zelus Casey, 2012, Open Biochem J, V6, P66, DOI 10.2174/1874091X01206010066	56	57	59	1	89	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	FEB	2016	12	2					94	+		10.1038/NCHEMBIO.1988	http://dx.doi.org/10.1038/NCHEMBIO.1988			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DC6GG	26656088	Green Accepted, Green Published			2022-12-25	WOS:000369317300011
J	Elkins, JM; Fedele, V; Szklarz, M; Azeez, KRA; Salah, E; Mikolajczyk, J; Romanov, S; Sepetov, N; Huang, XP; Roth, BL; Zen, AA; Fourches, D; Muratov, E; Tropsha, A; Morris, J; Teicher, BA; Kunkel, M; Polley, E; Lackey, KE; Atkinson, FL; Overington, JP; Bamborough, P; Muller, S; Price, DJ; Willson, TM; Drewry, DH; Knapp, S; Zuercher, WJ				Elkins, Jonathan M.; Fedele, Vita; Szklarz, Marta; Azeez, Kamal R. Abdul; Salah, Eidarus; Mikolajczyk, Jowita; Romanov, Sergei; Sepetov, Nikolai; Huang, Xi-Ping; Roth, Bryan L.; Zen, Ayman Al Haj; Fourches, Denis; Muratov, Eugene; Tropsha, Alex; Morris, Joel; Teicher, Beverly A.; Kunkel, Mark; Polley, Eric; Lackey, Karen E.; Atkinson, Francis L.; Overington, John P.; Bamborough, Paul; Mueller, Susanne; Price, Daniel J.; Willson, Timothy M.; Drewry, David H.; Knapp, Stefan; Zuercher, William J.			Comprehensive characterization of the Published Kinase Inhibitor Set	NATURE BIOTECHNOLOGY			English	Article							DRUG DISCOVERY; PROTEIN-KINASE; POTENT INHIBITORS; INTERACTION MAP; IN-VITRO; SELECTIVITY; KINOME; CANCER; ANGIOGENESIS; SCREEN	Despite the success of protein kinase inhibitors as approved therapeutics, drug discovery has focused on a small subset of kinase targets. Here we provide a thorough characterization of the Published Kinase Inhibitor Set (PKIS), a set of 367 small molecule ATP-competitive kinase inhibitors that was recently made freely available with the aim of expanding research in this field and as an experiment in open-source target validation. We screen the set in activity assays with 224 recombinant kinases and 24 G protein-coupled receptors and in cellular assays of cancer cell proliferation and angiogenesis. We identify chemical starting points for designing new chemical probes of orphan kinases and illustrate the utility of these leads by developing a selective inhibitor for the previously untargeted kinases LOK and SLK. Our cellular screens reveal compounds that modulate cancer cell growth and angiogenesis in vitro. These reagents and associated data illustrate an efficient way forward to increasing understanding of the historically untargeted kinome.	[Elkins, Jonathan M.; Fedele, Vita; Szklarz, Marta; Azeez, Kamal R. Abdul; Salah, Eidarus; Mueller, Susanne; Knapp, Stefan] Univ Oxford, Nuffield Dept Clin Med, Struct Genom Consortium & Target Discovery Inst, Old Rd Campus, Oxford, England; [Mikolajczyk, Jowita; Romanov, Sergei; Sepetov, Nikolai] Nanosyn Inc, Santa Clara, CA USA; [Huang, Xi-Ping; Roth, Bryan L.] Univ N Carolina, Sch Med, Natl Inst Mental Hlth Psychoact Act Drug Screenin, NIMH PDSP,Dept Pharmacol, Chapel Hill, NC USA; [Huang, Xi-Ping; Roth, Bryan L.] Univ N Carolina, Sch Med, Div Chem Biol & Med Chem, Chapel Hill, NC USA; [Zen, Ayman Al Haj] Univ Oxford, Radcliffe Dept Med, Div Cardiovasc Med, British Heart Fdn Ctr Res Excellence, Oxford, England; [Fourches, Denis; Muratov, Eugene; Tropsha, Alex] Univ N Carolina, Div Chem Biol & Med Chem, UNC Eshelman Sch Pharm, Lab Mol Modeling, Chapel Hill, NC USA; [Morris, Joel; Teicher, Beverly A.; Kunkel, Mark; Polley, Eric] NCI, Div Canc Treatment & Diag, Rockville, MD USA; [Lackey, Karen E.] Med Univ S Carolina, Charleston, SC 29425 USA; [Atkinson, Francis L.; Overington, John P.] EMBL EBI, Wellcome Trust Genome Campus, Cambridge, England; [Bamborough, Paul] GlaxoSmithKline, Chem Sci, Stevenage, Herts, England; [Price, Daniel J.; Willson, Timothy M.; Drewry, David H.; Zuercher, William J.] GlaxoSmithKline, Chem Sci, Res Triangle Pk, NC USA; [Knapp, Stefan] Goethe Univ Frankfurt, Inst Pharmazeut Chem, Georg Voigt Str 14, Frankfurt, Germany; [Knapp, Stefan] Buchmann Inst Mol Life Sci BMLS, Frankfurt, Germany; [Overington, John P.; Willson, Timothy M.; Drewry, David H.; Zuercher, William J.] Novartis Vaccines & Diagnost, Holly Springs, NC USA; [Fourches, Denis] N Carolina State Univ, Dept Chem, Bioinformat Res Ctr, Box 8204, Raleigh, NC 27695 USA; [Overington, John P.] Stratified Med, London, England; [Drewry, David H.] Meryx Pharmaceut, Chapel Hill, NC USA; [Willson, Timothy M.; Zuercher, William J.] Univ N Carolina, UNC Eshelman Sch Pharm, SGC UNC, Div Chem Biol & Med Chem, Chapel Hill, NC USA	University of Oxford; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Oxford; University of North Carolina; University of North Carolina Chapel Hill; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Medical University of South Carolina; European Molecular Biology Laboratory (EMBL); Wellcome Trust Sanger Institute; GlaxoSmithKline; GlaxoSmithKline; Goethe University Frankfurt; Novartis; University of North Carolina; North Carolina State University; University of North Carolina; University of North Carolina Chapel Hill	Drewry, DH; Zuercher, WJ (corresponding author), GlaxoSmithKline, Chem Sci, Res Triangle Pk, NC USA.; Knapp, S (corresponding author), Goethe Univ Frankfurt, Inst Pharmazeut Chem, Georg Voigt Str 14, Frankfurt, Germany.; Knapp, S (corresponding author), Buchmann Inst Mol Life Sci BMLS, Frankfurt, Germany.; Drewry, DH; Zuercher, WJ (corresponding author), Novartis Vaccines & Diagnost, Holly Springs, NC USA.	david.drewry@meryxpharma.com; knapp@pharmchem.uni-frankfurt.de; william.zuercher@unc.edu	Zen, Ayman Al Haj/D-9035-2012; Muratov, Eugene/C-4454-2014; Knapp, Stefan/AAG-2347-2019; feinstein, doug/M-9414-2019; Fourches, Denis/H-4336-2019; Roth, Bryan L/F-3928-2010; Tropsha, Alexander/AAB-8324-2020; Overington, John P/G-8607-2015; Roth, Bryan/ABE-7032-2020	Muratov, Eugene/0000-0003-4616-7036; Knapp, Stefan/0000-0001-5995-6494; Overington, John P/0000-0002-5859-1064; Roth, Bryan/0000-0002-0561-6520; Atkinson, Francis/0000-0003-4688-959X; Muller-Knapp, Susanne/0000-0003-2402-4157; Drewry, David Harold/0000-0001-5973-5798; Fourches, Denis/0000-0001-5642-8303; Al Haj Zen, Ayman/0000-0002-2145-2925; Elkins, Jon/0000-0003-2858-8929	AbbVie; Bayer Pharma AG; Boehringer Ingelheim; Canada Foundation for Innovation; Eshelman Institute for Innovation; Genome Canada; Innovative Medicines Initiative (EU/EFPIA); Janssen; Merck Co.; Novartis Pharma AG; Ontario Ministry of Economic Development and Innovation; Pfizer; Sao Paulo Research Foundation-FAPESP; Takeda; Wellcome Trust; BHF Centre of Research Excellence, Oxford [RE/13/1/30181]	AbbVie(AbbVie); Bayer Pharma AG; Boehringer Ingelheim(Boehringer Ingelheim); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Eshelman Institute for Innovation; Genome Canada(Genome Canada); Innovative Medicines Initiative (EU/EFPIA); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Merck Co.(Merck & Company); Novartis Pharma AG; Ontario Ministry of Economic Development and Innovation; Pfizer(Pfizer); Sao Paulo Research Foundation-FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Takeda(Takeda Pharmaceutical Company Ltd); Wellcome Trust(Wellcome TrustEuropean Commission); BHF Centre of Research Excellence, Oxford	The Structural Genomics Consortium is a registered charity (number 1097737) that receives funds from AbbVie, Bayer Pharma AG, Boehringer Ingelheim, Canada Foundation for Innovation, Eshelman Institute for Innovation, Genome Canada, Innovative Medicines Initiative (EU/EFPIA), Janssen, Merck & Co., Novartis Pharma AG, Ontario Ministry of Economic Development and Innovation, Pfizer, Sao Paulo Research Foundation-FAPESP, Takeda, and Wellcome Trust. A.A.H.Z. acknowledges support from the BHF Centre of Research Excellence, Oxford (RE/13/1/30181).	Anastassiadis T, 2011, NAT BIOTECHNOL, V29, P1039, DOI 10.1038/nbt.2017; Ardini E, 2014, MOL ONCOL, V8, P1495, DOI 10.1016/j.molonc.2014.06.001; Arnaoutova I, 2010, NAT PROTOC, V5, P628, DOI 10.1038/nprot.2010.6; Atkinson JM, 2011, CANCER CELL, V20, P384, DOI 10.1016/j.ccr.2011.08.013; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Bamborough P, 2012, EXPERT OPIN DRUG DIS, V7, P1053, DOI 10.1517/17460441.2012.724056; Bamborough P, 2008, J MED CHEM, V51, P7898, DOI 10.1021/jm8011036; Belkina NV, 2009, P NATL ACAD SCI USA, V106, P4707, DOI 10.1073/pnas.0805963106; Ciceri P, 2014, NAT CHEM BIOL, V10, P305, DOI 10.1038/nchembio.1471; Cohen P, 2013, ACS CHEM BIOL, V8, P96, DOI 10.1021/cb300610s; Conway JG, 2005, P NATL ACAD SCI USA, V102, P16078, DOI 10.1073/pnas.0502000102; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Davis MI, 2011, NAT BIOTECHNOL, V29, P1046, DOI 10.1038/nbt.1990; Dranchak P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057888; Drewry DH, 2014, CURR TOP MED CHEM, V14, P340, DOI 10.2174/1568026613666131127160819; Edwards AM, 2009, NAT CHEM BIOL, V5, P436, DOI 10.1038/nchembio0709-436; Ember SWJ, 2014, ACS CHEM BIOL, V9, P1160, DOI 10.1021/cb500072z; Fabian MA, 2005, NAT BIOTECHNOL, V23, P329, DOI 10.1038/nbt1068; Faivre S, 2007, NAT REV DRUG DISCOV, V6, P734, DOI 10.1038/nrd2380; Fedorov O, 2007, P NATL ACAD SCI USA, V104, P20523, DOI 10.1073/pnas.0708800104; Fedorov O, 2012, METHODS MOL BIOL, V795, P109, DOI 10.1007/978-1-61779-337-0_7; Fedorov O, 2010, NAT CHEM BIOL, V6, P166, DOI 10.1038/nchembio.297; Folkman J, 2007, NAT REV DRUG DISCOV, V6, P273, DOI 10.1038/nrd2115; Fourches D, 2013, MOL INFORM, V32, P827, DOI 10.1002/minf.201300076; Gao YH, 2013, BIOCHEM J, V451, P313, DOI 10.1042/BJ20121418; Guo KX, 2014, J BIOMOL SCREEN, V19, P538, DOI 10.1177/1087057113520325; Hasegawa M, 2007, J MED CHEM, V50, P4453, DOI 10.1021/jm0611051; Haystead TAJ, 2006, CURR TOP MED CHEM, V6, P1117; Huber KVM, 2014, NATURE, V508, P222, DOI 10.1038/nature13194; Jester BW, 2010, J AM CHEM SOC, V132, P11727, DOI 10.1021/ja104491h; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Knight ZA, 2005, CHEM BIOL, V12, P621, DOI 10.1016/j.chembiol.2005.04.011; Kuramochi S, 1997, J BIOL CHEM, V272, P22679, DOI 10.1074/jbc.272.36.22679; Metz JT, 2011, NAT CHEM BIOL, V7, P200, DOI 10.1038/NCHEMBIO.530; Miyazaki Y, 2007, BIOORG MED CHEM LETT, V17, P1773, DOI 10.1016/j.bmcl.2006.12.077; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Paolini GV, 2006, NAT BIOTECHNOL, V24, P805, DOI 10.1038/nbt1228; Posy SL, 2011, J MED CHEM, V54, P54, DOI 10.1021/jm101195a; Reinhold WC, 2012, CANCER RES, V72, P3499, DOI 10.1158/0008-5472.CAN-12-1370; Shoemaker RH, 2006, NAT REV CANCER, V6, P813, DOI 10.1038/nrc1951; Takle AK, 2006, BIOORG MED CHEM LETT, V16, P378, DOI 10.1016/j.bmcl.2005.09.072; Verheul HMW, 2007, NAT REV CANCER, V7, P475, DOI 10.1038/nrc2152; Viswanatha R, 2012, J CELL BIOL, V199, P969, DOI 10.1083/jcb.201207047; Weinstein JN, 1997, SCIENCE, V275, P343, DOI 10.1126/science.275.5298.343; Wilhelm S, 2006, NAT REV DRUG DISCOV, V5, P835, DOI 10.1038/nrd2130; Witherington J, 2003, BIOORG MED CHEM LETT, V13, P1581, DOI 10.1016/S0960-894X(03)00135-5; Workman P, 2010, CHEM BIOL, V17, P561, DOI 10.1016/j.chembiol.2010.05.013; Wu P, 2015, TRENDS PHARMACOL SCI, V36, P422, DOI 10.1016/j.tips.2015.04.005; Zhang JM, 2009, NAT REV CANCER, V9, P28, DOI 10.1038/nrc2559	49	196	200	1	68	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2016	34	1					95	103		10.1038/nbt.3374	http://dx.doi.org/10.1038/nbt.3374			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DB8HQ	26501955	Green Submitted, hybrid			2022-12-25	WOS:000368758200033
J	Green, CR; Wallace, M; Divakaruni, AS; Phillips, SA; Murphy, AN; Ciaraldi, TP; Metallo, CM				Green, Courtney R.; Wallace, Martina; Divakaruni, Ajit S.; Phillips, Susan A.; Murphy, Anne N.; Ciaraldi, Theodore P.; Metallo, Christian M.			Branched-chain amino acid catabolism fuels adipocyte differentiation and lipogenesis	NATURE CHEMICAL BIOLOGY			English	Article							ADIPOSE-TISSUE; FATTY-ACIDS; METABOLISM; PROTEIN; OBESITY; VITAMIN-B-12; ADIPONECTIN; FLUX; ADIPOGENESIS; DEFICIENCY	Adipose tissue plays important roles in regulating carbohydrate and lipid homeostasis, but less is known about the regulation of amino acid metabolism in adipocytes. Here we applied isotope tracing to pre-adipocytes and differentiated adipocytes to quantify the contributions of different substrates to tricarboxylic acid (TCA) metabolism and lipogenesis. In contrast to proliferating cells, which use glucose and glutamine for acetyl-coenzyme A (AcCoA) generation, differentiated adipocytes showed increased branched-chain amino acid (BCAA) catabolic flux such that leucine and isoleucine from medium and/or from protein catabolism accounted for as much as 30% of lipogenic AcCoA pools. Medium cobalamin deficiency caused methylmalonic acid accumulation and odd-chain fatty acid synthesis. Vitamin B12 supplementation reduced these metabolites and altered the balance of substrates entering mitochondria. Finally, inhibition of BCAA catabolism compromised adipogenesis. These results quantitatively highlight the contribution of BCAAs to adipocyte metabolism and suggest that BCAA catabolism has a functional role in adipocyte differentiation.	[Green, Courtney R.; Wallace, Martina; Metallo, Christian M.] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Divakaruni, Ajit S.; Murphy, Anne N.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Phillips, Susan A.; Ciaraldi, Theodore P.] Vet Affairs San Diego Healthcare Syst, San Diego, CA USA; [Phillips, Susan A.; Ciaraldi, Theodore P.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Metallo, Christian M.] Univ Calif San Diego, Inst Engn Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of California System; University of California San Diego; University of California System; University of California San Diego	Metallo, CM (corresponding author), Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA.	cmetallo@eng.ucsd.edu	Metallo, Christian/HCH-3476-2022; Murphy, Anne N/H-3217-2016	Metallo, Christian/0000-0003-2404-3040; Green, Courtney R/0000-0002-9279-0649; Murphy, Anne N/0000-0002-5222-9902; Wallace, Martina/0000-0001-8272-5678	US National Institutes of Health (NIH) grant [R01CA188652]; California Institute of Regenerative Medicine (CIRM) Award [RB5-07356]; US Department of Defense (DOD) grant [W81XWH-13-1-0105]; Searle Scholar Award; American Diabetes Association [7-05-DCS-04]; Medical Research Service [1 I010X00635-01A1]; US Department of Veterans Affairs; VA San Diego Healthcare System; NIH grant [1R01NS087611]; Seahorse Bioscience; NATIONAL CANCER INSTITUTE [R01CA188652] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS087611] Funding Source: NIH RePORTER	US National Institutes of Health (NIH) grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute of Regenerative Medicine (CIRM) Award; US Department of Defense (DOD) grant(United States Department of Defense); Searle Scholar Award; American Diabetes Association(American Diabetes Association); Medical Research Service; US Department of Veterans Affairs(US Department of Veterans Affairs); VA San Diego Healthcare System(US Department of Veterans Affairs); NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Seahorse Bioscience; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank R.R. Henry (R.R.H.; Veterans Affairs San Diego Healthcare System, San Diego, California, USA) for human adipocyte material. This work was supported, in part, by US National Institutes of Health (NIH) grant R01CA188652 (C.M.M.), California Institute of Regenerative Medicine (CIRM) Award RB5-07356 (C.M.M.), US Department of Defense (DOD) grant W81XWH-13-1-0105 (C.M.M.) and a Searle Scholar Award (C.M.M.), as well as grants from the American Diabetes Association (7-05-DCS-04), the Medical Research Service (1 I010X00635-01A1), the US Department of Veterans Affairs and the VA San Diego Healthcare System (R.R.H.), NIH grant 1R01NS087611 (A.N.M.) and a grant from Seahorse Bioscience.	Adams SH, 2011, ADV NUTR, V2, P445, DOI 10.3945/an.111.000737; BARLEY FW, 1972, J BIOL CHEM, V247, P4270; Birn H, 2006, AM J PHYSIOL-RENAL, V291, pF22, DOI 10.1152/ajprenal.00385.2005; BUSE MG, 1972, J BIOL CHEM, V247, P8085; CHUANG DT, 1983, BIOCHEM J, V214, P177, DOI 10.1042/bj2140177; Commisso C, 2013, NATURE, V497, P633, DOI 10.1038/nature12138; Cynober LA, 2002, NUTRITION, V18, P761, DOI 10.1016/S0899-9007(02)00780-3; Degnan PH, 2014, CELL HOST MICROBE, V15, P47, DOI 10.1016/j.chom.2013.12.007; Divakaruni Ajit S, 2014, Curr Protoc Toxicol, V60, DOI 10.1002/0471140856.tx2502s60; Divakaruni AS, 2013, P NATL ACAD SCI USA, V110, P5422, DOI 10.1073/pnas.1303360110; Fiehn O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015234; Glass CK, 2012, CELL METAB, V15, P635, DOI 10.1016/j.cmet.2012.04.001; Haarmann A, 2013, MOL GENET METAB, V110, P472, DOI 10.1016/j.ymgme.2013.08.021; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Herman MA, 2012, NATURE, V484, P333, DOI 10.1038/nature10986; Herman MA, 2010, J BIOL CHEM, V285, P11348, DOI 10.1074/jbc.M109.075184; Hsiao G, 2011, AM J PHYSIOL-ENDOC M, V300, pE164, DOI 10.1152/ajpendo.00219.2010; Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842; Kang D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109878; Kapadia C R, 1995, Gastroenterologist, V3, P329; KEDISHVILI NY, 1994, ARCH BIOCHEM BIOPHYS, V315, P317, DOI 10.1006/abbi.1994.1506; KISHIMOTO Y, 1973, J LIPID RES, V14, P69; KOWALSKI TJ, 1994, AM J PHYSIOL, V266, pE151, DOI 10.1152/ajpendo.1994.266.1.E151; Lackey DE, 2013, AM J PHYSIOL-ENDOC M, V304, pE1175, DOI 10.1152/ajpendo.00630.2012; Lee MJ, 2013, MOL ASPECTS MED, V34, P1, DOI 10.1016/j.mam.2012.10.001; Lee MJ, 2012, OBESITY, V20, P2334, DOI 10.1038/oby.2012.116; Lynch CJ, 2003, AM J PHYSIOL-ENDOC M, V285, pE854, DOI 10.1152/ajpendo.00153.2003; Mardinoglu A, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.5; Metallo CM, 2012, NATURE, V481, P380, DOI 10.1038/nature10602; Newgard CB, 2012, CELL METAB, V15, P606, DOI 10.1016/j.cmet.2012.01.024; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; Nicklin P, 2009, CELL, V136, P521, DOI 10.1016/j.cell.2008.11.044; Phillips SA, 2008, AM J PHYSIOL-ENDOC M, V295, pE842, DOI 10.1152/ajpendo.90359.2008; Phillips SA, 2009, AM J PHYSIOL-ENDOC M, V297, pE767, DOI 10.1152/ajpendo.00378.2009; Reinstatler L, 2012, DIABETES CARE, V35, P327, DOI 10.2337/dc11-1582; Roberts LD, 2009, PHYSIOL GENOMICS, V39, P109, DOI 10.1152/physiolgenomics.90365.2008; Rosen ED, 2014, CELL, V156, P20, DOI 10.1016/j.cell.2013.12.012; ROSENTHA.J, 1974, AM J PHYSIOL, V226, P411, DOI 10.1152/ajplegacy.1974.226.2.411; Sears DD, 2009, P NATL ACAD SCI USA, V106, P18745, DOI 10.1073/pnas.0903032106; She P, 2007, CELL METAB, V6, P181, DOI 10.1016/j.cmet.2007.08.003; Si YG, 2007, AM J PHYSIOL-ENDOC M, V292, pE1637, DOI 10.1152/ajpendo.00670.2006; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; Su X, 2004, BIOCHEMISTRY-US, V43, P5033, DOI 10.1021/bi035867z; Tchkonia T, 2005, AM J PHYSIOL-ENDOC M, V288, pE267, DOI 10.1152/ajpendo.00265.2004; Turer AT, 2012, DIABETOLOGIA, V55, P2319, DOI 10.1007/s00125-012-2598-x; Wang TJ, 2011, NAT MED, V17, P448, DOI 10.1038/nm.2307; Young JD, 2014, BIOINFORMATICS, V30, P1333, DOI 10.1093/bioinformatics/btu015; Zhang YN, 2014, NATURE, V513, P440, DOI 10.1038/nature13492; Zimmerman HA, 2013, MOL GENET METAB, V109, P345, DOI 10.1016/j.ymgme.2013.05.010	49	226	237	10	132	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2016	12	1					15	+		10.1038/NCHEMBIO.1961	http://dx.doi.org/10.1038/NCHEMBIO.1961			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY8QW	26571352	Green Accepted, Green Published, Green Submitted			2022-12-25	WOS:000366674400006
J	Mancuso, N; Rohland, N; Rand, KA; Tandon, A; Allen, A; Quinque, D; Mallick, S; Li, H; Stram, A; Sheng, X; Kote-Jarai, Z; Easton, DF; Eeles, RA; Le Marchand, L; Lubwama, A; Stram, D; Watya, S; Conti, DV; Henderson, B; Haiman, CA; Pasaniuc, B; Reich, D				Mancuso, Nicholas; Rohland, Nadin; Rand, Kristin A.; Tandon, Arti; Allen, Alexander; Quinque, Dominique; Mallick, Swapan; Li, Heng; Stram, Alex; Sheng, Xin; Kote-Jarai, Zsofia; Easton, Douglas F.; Eeles, Rosalind A.; Le Marchand, Loic; Lubwama, Alex; Stram, Daniel; Watya, Stephen; Conti, David V.; Henderson, Brian; Haiman, Christopher A.; Pasaniuc, Bogdan; Reich, David		PRACTICAL Consortium	The contribution of rare variation to prostate cancer heritability	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; LOW-FREQUENCY; SEQUENCE VARIANTS; COMPLEX TRAIT; MULTIPLE LOCI; RISK; 8Q24; COMMON; IDENTIFICATION	We report targeted sequencing of 63 known prostate cancer risk regions in a multi-ancestry study of 9,237 men and use the data to explore the contribution of low-frequency variation to disease risk. We show that SNPs with minor allele frequencies (MAFs) of 0.1-1% explain a substantial fraction of prostate cancer risk in men of African ancestry. We estimate that these SNPs account for 0.12 (standard error (s.e.) = 0.05) of variance in risk (similar to 42% of the variance contributed by SNPs with MAF of 0.1-50%). This contribution is much larger than the fraction of neutral variation due to SNPs in this class, implying that natural selection has driven down the frequency of many prostate cancer risk alleles; we estimate the coupling between selection and allelic effects at 0.48 (95% confidence interval [0.19, 0.78]) under the Eyre-Walker model. Our results indicate that rare variants make a disproportionate contribution to genetic risk for prostate cancer and suggest the possibility that rare variants may also have an outsize effect on other common traits.	[Mancuso, Nicholas; Pasaniuc, Bogdan] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Rohland, Nadin; Tandon, Arti; Allen, Alexander; Quinque, Dominique; Mallick, Swapan; Li, Heng; Reich, David] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Rohland, Nadin; Tandon, Arti; Allen, Alexander; Quinque, Dominique; Mallick, Swapan; Li, Heng; Reich, David] Broad Inst, Cambridge, MA USA; [Rand, Kristin A.; Stram, Alex; Sheng, Xin; Stram, Daniel; Conti, David V.; Henderson, Brian; Haiman, Christopher A.] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA; [Rand, Kristin A.; Stram, Daniel; Conti, David V.; Henderson, Brian; Haiman, Christopher A.] Univ So Calif, Norris Comprehens Canc Ctr, Los Angeles, CA USA; [Kote-Jarai, Zsofia; Eeles, Rosalind A.] Inst Canc Res, London SW3 6JB, England; [Easton, Douglas F.] Univ Cambridge, Dept Publ Hlth & Primary Care, Ctr Canc Genet Epidemiol, Cambridge, England; [Eeles, Rosalind A.] Royal Marsden Natl Hlth Serv NHS Fdn Trust, London, England; [Eeles, Rosalind A.] Royal Marsden Natl Hlth Serv NHS Fdn Trust, Sutton, Surrey, England; [Le Marchand, Loic] Univ Hawaii, Ctr Canc, Epidemiol Program, Honolulu, HI 96822 USA; [Lubwama, Alex; Watya, Stephen] Makerere Univ, Coll Hlth Sci, Sch Publ Hlth, Kampala, Uganda; [Pasaniuc, Bogdan] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Southern California; University of Southern California; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of Cambridge; Royal Marsden NHS Foundation Trust; Royal Marsden NHS Foundation Trust; Cancer Research Center of Hawaii; University of Hawaii System; Makerere University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Pasaniuc, B (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA.	christopher.haiman@med.usc.edu; pasaniuc@ucla.edu; reich@genetics.med.harvard.edu	Mancuso, Nicholas/GLQ-8627-2022; Li, Heng/D-9344-2011	Li, Heng/0000-0003-4874-2874; Eeles, Rosalind/0000-0002-3698-6241; Pasaniuc, Bogdan/0000-0002-0227-2056; Mancuso, Nicholas/0000-0002-9352-5927; batra, Jyotsna/0000-0003-4646-6247	US National Institutes of Health [R01 CA165862, U19 CA148537, UM1 CA164973, RC2 CA148085, U01 CA1326792, R21 CA182821, U01 CA188392, CA128978]; European Community [223175]; Cancer Research UK [C1287/A10118, C1287/A 10710, C12292/A11174, C1281/A12014, C5047/A8384, C5047/A15007, C5047/A10692, C8197/A16565]; Post-Cancer GWAS initiative [1U19 CA148537, 1U19 CA148065, 1U19 CA148112]; US Department of Defense [W81XWH-10-1-0341]; Canadian Institutes of Health Research (CIHR); Komen Foundation; Breast Cancer Research Foundation; Ovarian Cancer Research Fund; NATIONAL CANCER INSTITUTE [U19CA148112, U19CA148537, U19CA148065, R01CA128978] Funding Source: NIH RePORTER; Cancer Research UK [15007, 16563, 17528] Funding Source: researchfish	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Community(European Commission); Cancer Research UK(Cancer Research UK); Post-Cancer GWAS initiative; US Department of Defense(United States Department of Defense); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Komen Foundation(Susan G. Komen Breast Cancer Foundation); Breast Cancer Research Foundation; Ovarian Cancer Research Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Research UK(Cancer Research UK)	This work is supported in part by the US National Institutes of Health (R01 CA165862, U19 CA148537, UM1 CA164973, RC2 CA148085, U01 CA1326792, R21 CA182821 and U01 CA188392). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. Many of the risk regions examined were discovered through contributions from: P. Hall (COGS), D.F.E., P. Pharoah, K. Michailidou, M.K. Bolla and Q. Wang (BCAC), A. Berchuck (OCAC), R.A.E., D.F.E., A.A. Al Olama, Z.K.-J. and S. Benlloch (PRACTICAL), G. Chenevix-Trench, A. Antoniou, L. McGuffog, F. Couch and K. Offit (CIMBA), J. Dennis, A.M. Dunning, A. Lee, E. Dicks, C. Luccarini and the staff of the Centre for Genetic Epidemiology Laboratory, J. Benitez, A. Gonzalez-Neira and the staff of the CNIO genotyping unit, J. Simard, D.V.C. Tessier, F. Bacot, D. Vincent, S. LaBoissiere, F. Robidoux and the staff of the McGill University and Genome Quebec Innovation Centre, S.E. Bojesen, S.F. Nielsen, B.G. Nordestgaard and the staff of the Copenhagen DNA laboratory, and J.M. Cunningham, S.A. Windebank, C.A. Hilker, J. Meyer and the staff of the Mayo Clinic Genotyping Core Facility. Funding for the iCOGS infrastructure came from the European Community's Seventh Framework Programme under grant agreement 223175 (HEALTH-F2-2009-223175) (COGS), Cancer Research UK (C1287/A10118,C1287/A 10710, C12292/A11174, C1281/A12014, C5047/A8384, C5047/A15007, C5047/A10692 and C8197/A16565), the US National Institutes of Health (CA128978) and Post-Cancer GWAS initiative (1U19 CA148537, 1U19 CA148065 and 1U19 CA148112-GAME-ON initiative), the US Department of Defense (W81XWH-10-1-0341), the Canadian Institutes of Health Research (CIHR) for the CIHR Team in Familial Risks of Breast Cancer, the Komen Foundation for the Cure, the Breast Cancer Research Foundation and the Ovarian Cancer Research Fund. D.R. is an Investigator of the Howard Hughes Medical Institute.	Al Olama AA, 2014, NAT GENET, V46, P1103, DOI 10.1038/ng.3094; Al Olama AA, 2009, NAT GENET, V41, P1058, DOI 10.1038/ng.452; Amundadottir LT, 2006, NAT GENET, V38, P652, DOI 10.1038/ng1808; [Anonymous], 2013, AM J HUM GENET, V93, P1151, DOI 10.1016/j.ajhg.2013.10.015; Baran Y, 2013, AM J HUM GENET, V92, P882, DOI 10.1016/j.ajhg.2013.04.023; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bhatia G, 2015, BIORXIV, DOI [10.1101/022418, DOI 10.1101/022418]; Browning BL, 2011, AM J HUM GENET, V88, P173, DOI 10.1016/j.ajhg.2011.01.010; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Cropp CD, 2014, PROSTATE, V74, P1579, DOI 10.1002/pros.22871; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Duggan D, 2007, JNCI-J NATL CANCER I, V99, P1836, DOI 10.1093/jnci/djm250; Eeles RA, 2008, NAT GENET, V40, P316, DOI 10.1038/ng.90; Eeles RA, 2013, NAT GENET, V45, P385, DOI 10.1038/ng.2560; Eeles RA, 2009, NAT GENET, V41, P1116, DOI 10.1038/ng.450; Eyre-Walker A, 2010, P NATL ACAD SCI USA, V107, P1752, DOI 10.1073/pnas.0906182107; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; Gomella LG, 2011, CAN J UROL, V18, P5875; Gudmundsson J, 2008, NAT GENET, V40, P281, DOI 10.1038/ng.89; Gudmundsson J, 2007, NAT GENET, V39, P977, DOI 10.1038/ng2062; Gudmundsson J, 2007, NAT GENET, V39, P631, DOI 10.1038/ng1999; Gudmundsson J, 2012, NAT GENET, V44, P1326, DOI 10.1038/ng.2437; Gudmundsson J, 2009, NAT GENET, V41, P1122, DOI 10.1038/ng.448; Gusev A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003993; Haiman CA, 2007, NAT GENET, V39, P638, DOI 10.1038/ng2015; Haiman CA, 2011, NAT GENET, V43, P570, DOI 10.1038/ng.839; Hazelett DJ, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004102; Hazelett DJ, 2013, CELL CYCLE, V12, P379, DOI 10.4161/cc.23201; Hjelmborg JB, 2014, CANCER EPIDEM BIOMAR, V23, P2303, DOI 10.1158/1055-9965.EPI-13-0568; Huffman JE, 2015, BLOOD, V126, pE19, DOI 10.1182/blood-2015-02-624551; Kichaev G, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004722; Kolonel LN, 2000, AM J EPIDEMIOL, V151, P346, DOI 10.1093/oxfordjournals.aje.a010213; Kote-Jarai Z, 2011, NAT GENET, V43, P785, DOI 10.1038/ng.882; Lange LA, 2014, AM J HUM GENET, V94, P233, DOI 10.1016/j.ajhg.2014.01.010; Lee SH, 2012, BIOINFORMATICS, V28, P2540, DOI 10.1093/bioinformatics/bts474; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li Y, 2011, GENOME RES, V21, P940, DOI 10.1101/gr.117259.110; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Lin K, 2011, PROSTATE SPECIFIC AN; Lindblad-Toh K, 2011, NATURE, V478, P476, DOI 10.1038/nature10530; Lohmueller KE, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004379; Melnikow J, 2013, MED CARE, V51, P301, DOI 10.1097/MLR.0b013e31828a67d3; OEHLERT GW, 1992, AM STAT, V46, P27, DOI 10.2307/2684406; Peloso GM, 2014, AM J HUM GENET, V94, P223, DOI 10.1016/j.ajhg.2014.01.009; Rohland N, 2012, GENOME RES, V22, P939, DOI 10.1101/gr.128124.111; Schumacher FR, 2011, HUM MOL GENET, V20, P3867, DOI 10.1093/hmg/ddr295; Service SK, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004147; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Speed D, 2012, AM J HUM GENET, V91, P1011, DOI 10.1016/j.ajhg.2012.10.010; Sun J, 2008, NAT GENET, V40, P1153, DOI 10.1038/ng.214; TAKAHATA N, 1993, MOL BIOL EVOL, V10, P2; Takata R, 2010, NAT GENET, V42, P751, DOI 10.1038/ng.635; Thomas G, 2008, NAT GENET, V40, P310, DOI 10.1038/ng.91; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Witte JS, 2014, NAT REV GENET, V15, P765, DOI 10.1038/nrg3786; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yang L, 2013, AM J MED GENET B, V162B, P419, DOI 10.1002/ajmg.b.32169; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022	59	85	86	0	20	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2016	48	1					30	+		10.1038/ng.3446	http://dx.doi.org/10.1038/ng.3446			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CZ7BQ	26569126	Green Accepted, Green Submitted			2022-12-25	WOS:000367255300010
J	Ingles-Prietol, A; Reichhart, E; Muellner, MK; Nowak, M; Nijman, SMB; Grusch, M; Janovjak, H				Ingles-Prietol, Alvaro; Reichhart, Eva; Muellner, Markus K.; Nowak, Matthias; Nijman, Sebastian M. B.; Grusch, Michael; Janovjak, Harald			Light-assisted small-molecule screening against protein kinases	NATURE CHEMICAL BIOLOGY			English	Article							ACTIVATION	High-throughput live-cell screens are intricate elements of systems biology studies and drug discovery pipelines. Here, we demonstrate an optogenetics-assisted method that avoids the need for chemical activators and reporters, reduces the number of operational steps and increases information content in a cell-based small-molecule screen against human protein kinases, including an orphan receptor tyrosine kinase. This blueprint for all-optical screening can be adapted to many drug targets and cellular processes.	[Ingles-Prietol, Alvaro; Reichhart, Eva; Nowak, Matthias; Janovjak, Harald] Inst Sci & Technol Austria IST Austria, Klosterneuburg, Austria; [Muellner, Markus K.; Nijman, Sebastian M. B.] Austrian Acad Sci, CeMM Res Ctr Mol Med, A-1010 Vienna, Austria; [Grusch, Michael] Med Univ Vienna, Comprehens Canc Ctr Vienna, Dept Med 1, Inst Canc Res, Vienna, Austria	Institute of Science & Technology - Austria; Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences; Medical University of Vienna	Ingles-Prietol, A (corresponding author), Inst Sci & Technol Austria IST Austria, Klosterneuburg, Austria.	harald@ist.ac.at	Ingles-Prieto, Alvaro/A-4365-2017; Janovjak, Harald/O-9070-2016; Grusch, Michael/C-1183-2008	Ingles-Prieto, Alvaro/0000-0002-5409-8571; Janovjak, Harald/0000-0002-8023-9315; Grusch, Michael/0000-0001-5486-9340; Nijman, Sebastian/0000-0003-0464-6661	European Union Seventh Framework Programme [CIG-303564, ERC-StG-311166]; Human Frontier Science Program [RGY0084_2012]; Herzfelder Foundation; Ramon Areces fellowship; graduate program MolecularDrugTargets (Austrian Science Fund (FWF)) [W 1232]; FemTech fellowship (Austrian Research Promotion Agency) [3580812]	European Union Seventh Framework Programme(European Commission); Human Frontier Science Program(Human Frontier Science Program); Herzfelder Foundation; Ramon Areces fellowship; graduate program MolecularDrugTargets (Austrian Science Fund (FWF))(Austrian Science Fund (FWF)); FemTech fellowship (Austrian Research Promotion Agency)	We thank M. Ernst (Medical University of Vienna) for fruitful discussions, M. Spanova (IST Austria) for technical assistance, R. Chait (IST Austria) for photography, X. Amouretti and B. Harris (BioTek) for hardware specifications, R. Stahel (University of Zurich) for mesothelioma cells, and D.M. Chudakov (Shemiakin-Ovchinnikov Institute of Bioorganic Chemistry)/Evrogen (Moscow) for mKate2. This work was supported by grants from the European Union Seventh Framework Programme (CIG-303564 to H.J. and ERC-StG-311166 to S.M.B.N.), the Human Frontier Science Program (RGY0084_2012 to H.J.) and the Herzfelder Foundation (to M.G.). A.I-P. was supported by a Ramon Areces fellowship, and E.R. by the graduate program MolecularDrugTargets (Austrian Science Fund (FWF): W 1232) and a FemTech fellowship (3580812 Austrian Research Promotion Agency).	Bradley M, 2002, J COLLOID INTERF SCI, V251, P78, DOI 10.1006/jcis.2002.8383; Burke P, 2001, MOL BIOL CELL, V12, P1897, DOI 10.1091/mbc.12.6.1897; Chen Xianjun, 2013, Curr Protoc Chem Biol, V5, P111, DOI 10.1002/9780470559277.ch120267; Cravotto G, 2006, CHEM SOC REV, V35, P180, DOI 10.1039/b503848k; CROUCH SPM, 1993, J IMMUNOL METHODS, V160, P81, DOI 10.1016/0022-1759(93)90011-U; DiNitto JP, 2010, J BIOCHEM, V147, P601, DOI 10.1093/jb/mvq015; Fenno L, 2011, ANNU REV NEUROSCI, V34, P389, DOI 10.1146/annurev-neuro-061010-113817; Grusch M, 2014, EMBO J, V33, P1713, DOI 10.15252/embj.201387695; Jamil MO, 2015, CURR ONCOL REP, V17, DOI 10.1007/s11912-015-0451-3; MOHUN T, 1987, EMBO J, V6, P667, DOI 10.1002/j.1460-2075.1987.tb04806.x; Olson EJ, 2014, NAT METHODS, V11, P449, DOI 10.1038/nmeth.2884; Richter F, 2015, PHOTOCH PHOTOBIO SCI, V14, P270, DOI 10.1039/c4pp00361f; Shaw AT, 2013, NAT REV CANCER, V13, P772, DOI 10.1038/nrc3612; Shcherbo D, 2009, BIOCHEM J, V418, P567, DOI 10.1042/BJ20081949; Simard JR, 2009, J AM CHEM SOC, V131, P18478, DOI 10.1021/ja907795q; Szobota S, 2010, ANNU REV BIOPHYS, V39, P329, DOI 10.1146/annurev.biophys.093008.131400; Takeuchi K, 2012, NAT MED, V18, P378, DOI 10.1038/nm.2658; Tischer D, 2014, NAT REV MOL CELL BIO, V15, P551, DOI 10.1038/nrm3837; Toettcher JE, 2013, CELL, V155, P1422, DOI 10.1016/j.cell.2013.11.004; Xuan J, 2012, ANGEW CHEM INT EDIT, V51, P6828, DOI 10.1002/anie.201200223	20	36	38	0	26	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2015	11	12					952	954		10.1038/NCHEM.BIO.1933	http://dx.doi.org/10.1038/NCHEM.BIO.1933			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX6TG	26457372				2022-12-25	WOS:000365834000013
J	Guttridge, DC				Guttridge, Denis C.			A TGF-beta pathway associated with cancer cachexia	NATURE MEDICINE			English	Editorial Material							RELEASE CHANNELS; WEIGHT-LOSS; MUSCLE	Cancer cachexia leads to involuntary weight loss resulting from the atrophy of skeletal muscle and adipose tissues. Now, in metastatic mouse models of cancer, investigators reveal a cross talk pathway between bone and muscle that provides a new understanding of wasting in advanced cancers.	Ohio State Univ, Coll Med, Arthur G James Comprehens Canc Ctr, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA	James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Guttridge, DC (corresponding author), Ohio State Univ, Coll Med, Arthur G James Comprehens Canc Ctr, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA.	denis.guttridge@osumc.edu		Guttridge, Denis/0000-0002-7276-6609	NCI NIH HHS [R01 CA180057] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA180057] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Andersson DC, 2011, CELL METAB, V14, P196, DOI 10.1016/j.cmet.2011.05.014; Bellinger AM, 2009, NAT MED, V15, P325, DOI 10.1038/nm.1916; Body J. J., 1999, Current Opinion in Oncology, V11, P255, DOI 10.1097/00001622-199907000-00004; DEWYS WD, 1980, AM J MED, V69, P491, DOI 10.1016/S0149-2918(05)80001-3; Fearon K, 2011, LANCET ONCOL, V12, P489, DOI 10.1016/S1470-2045(10)70218-7; Hopkinson JB, 2006, J PAIN SYMPTOM MANAG, V32, P322, DOI 10.1016/j.jpainsymman.2006.05.012; Marx SO, 1998, SCIENCE, V281, P818, DOI 10.1126/science.281.5378.818; Waning DL, 2015, NAT MED, V21, P1262, DOI 10.1038/nm.3961; Yachida S, 2009, ARCH PATHOL LAB MED, V133, P413, DOI 10.1043/1543-2165-133.3.413	9	21	23	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2015	21	11					1248	1249		10.1038/nm.3988	http://dx.doi.org/10.1038/nm.3988			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CV9QH	26540384	Green Accepted			2022-12-25	WOS:000364621200006
J	Huang, L; Holtzinger, A; Jagan, I; BeGora, M; Lohse, I; Ngai, N; Nostro, C; Wang, RN; Muthuswamy, LB; Crawford, HC; Arrowsmith, C; Kalloger, SE; Renouf, DJ; Connor, AA; Cleary, S; Schaeffer, DF; Roehrl, M; Tsao, MS; Gallinger, S; Keller, G; Muthuswamy, SK				Huang, Ling; Holtzinger, Audrey; Jagan, Ishaan; BeGora, Michael; Lohse, Ines; Ngai, Nicholas; Nostro, Cristina; Wang, Rennian; Muthuswamy, Lakshmi B.; Crawford, Howard C.; Arrowsmith, Cheryl; Kalloger, Steve E.; Renouf, Daniel J.; Connor, Ashton A.; Cleary, Sean; Schaeffer, David F.; Roehrl, Michael; Tsao, Ming-Sound; Gallinger, Steven; Keller, Gordon; Muthuswamy, Senthil K.			Ductal pancreatic cancer modeling and drug screening using human pluripotent stem cell- and patient-derived tumor organoids	NATURE MEDICINE			English	Article							IN-VITRO; BREAST-CANCER; BETA-CELLS; TRANSCRIPTION; GENERATION; MANAGEMENT; CULTURE; SOX9	There are few in vitro models of exocrine pancreas development and primary human pancreatic adenocarcinoma (PDAC). We establish three-dimensional culture conditions to induce the differentiation of human pluripotent stem cells into exocrine progenitor organoids that form ductal and acinar structures in culture and in vivo. Expression of mutant KRAS or TP53 in progenitor organoids induces mutation-specific phenotypes in culture and in vivo. Expression of TP53(R175H) induces cytosolic SOX9 localization. In patient tumors bearing TP53 mutations, SOX9 was cytoplasmic and associated with mortality. We also define culture conditions for clonal generation of tumor organoids from freshly resected PDAC. Tumor organoids maintain the differentiation status, histoarchitecture and phenotypic heterogeneity of the primary tumor and retain patient-specific physiological changes, including hypoxia, oxygen consumption, epigenetic marks and differences in sensitivity to inhibition of the histone methyltransferase EZH2. Thus, pancreatic progenitor organoids and tumor organoids can be used to model PDAC and fat drug screening to identify precision therapy strategies.	[Huang, Ling; Holtzinger, Audrey; Jagan, Ishaan; BeGora, Michael; Lohse, Ines; Ngai, Nicholas; Nostro, Cristina; Muthuswamy, Lakshmi B.; Arrowsmith, Cheryl; Roehrl, Michael; Tsao, Ming-Sound; Keller, Gordon; Muthuswamy, Senthil K.] Univ Toronto, UHN, Princess Margaret Canc Ctr, Toronto, ON, Canada; [Holtzinger, Audrey; Nostro, Cristina; Keller, Gordon] UHN, McEwen Ctr Regenerat Med, Toronto, ON, Canada; [Wang, Rennian] Univ Western Ontario, Dept Physiol, London, ON, Canada; [Wang, Rennian] Univ Western Ontario, Dept Pharmacol, London, ON, Canada; [Crawford, Howard C.] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Crawford, Howard C.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Arrowsmith, Cheryl] Struct Genom Consortium, Toronto, ON, Canada; [Kalloger, Steve E.; Schaeffer, David F.] Vancouver Gen Hosp, Div Anat Pathol, Vancouver, BC, Canada; [Kalloger, Steve E.; Renouf, Daniel J.; Schaeffer, David F.] Univ British Columbia, Dept Med, Vancouver, BC, Canada; [Kalloger, Steve E.; Renouf, Daniel J.; Schaeffer, David F.] Pancreas Ctr British Columbia, Vancouver, BC, Canada; [Renouf, Daniel J.] British Columbia Canc Agcy, Div Med Oncol, Vancouver, BC V5Z 4E6, Canada; [Connor, Ashton A.; Cleary, Sean; Gallinger, Steven] Univ Toronto, Div Gen Surg, Toronto, ON, Canada; [Tsao, Ming-Sound] UHN, Dept Pathol, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Western University (University of Western Ontario); Western University (University of Western Ontario); University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Toronto; Structural Genomics Consortium; University of British Columbia; University of British Columbia; British Columbia Cancer Agency; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Muthuswamy, SK (corresponding author), Univ Toronto, UHN, Princess Margaret Canc Ctr, Toronto, ON, Canada.	smuthusw@bidmc.harvard.edu	Roehrl, Michael/AAU-8506-2020; Tsao, Ming-Sound/M-3503-2017; Tsao, Ming Sound/AFQ-7332-2022; Gallinger, Steven/E-4575-2013; Muthuswamy, Senthil K/AGY-2834-2022; huang, ling/ABB-1647-2020	Roehrl, Michael/0000-0003-4892-1098; Tsao, Ming Sound/0000-0002-9160-5405; Muthuswamy, Senthil K/0000-0001-6564-9634; Keller, Gordon/0000-0001-9309-9297; Arrowsmith, Cheryl/0000-0002-4971-3250; Connor, Ashton/0000-0002-7596-3771; Nostro, Maria Cristina/0000-0003-1166-8252	Ontario Institute for Cancer Research (OICR) PanCuRx program; Canadian Cancer Society; Lee K Margaret Lau Chair for Breast Cancer Research; AbbVie; Bayer Pharma AG; Boehringer Ingelheim; Canada Foundation for Innovation; Eshelman Institute for Innovation; Genome Canada; Innovative Medicines Initiative (EU/EFPIA) (ULTRA-DD grant) [115766]; Janssen; Merck and Co.; Novartis Pharma AG; Ontario Ministry of Economic Development and Innovation; Pfizer; Sao Paulo Research Foundation (FAPESP); Takeda; Wellcome Trust; Ontario Ministry of Health and Long Term Care (OMOHLTC); Campbell Family Institute for Breast cancer research; NATIONAL CANCER INSTITUTE [R01CA159222, R01CA098830] Funding Source: NIH RePORTER	Ontario Institute for Cancer Research (OICR) PanCuRx program; Canadian Cancer Society(Canadian Cancer Society (CCS)); Lee K Margaret Lau Chair for Breast Cancer Research; AbbVie(AbbVie); Bayer Pharma AG; Boehringer Ingelheim(Boehringer Ingelheim); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Eshelman Institute for Innovation; Genome Canada(Genome Canada); Innovative Medicines Initiative (EU/EFPIA) (ULTRA-DD grant); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Merck and Co.(Merck & Company); Novartis Pharma AG; Ontario Ministry of Economic Development and Innovation; Pfizer(Pfizer); Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Takeda(Takeda Pharmaceutical Company Ltd); Wellcome Trust(Wellcome TrustEuropean Commission); Ontario Ministry of Health and Long Term Care (OMOHLTC)(Ministry of Health and Long-Term Care, Ontario); Campbell Family Institute for Breast cancer research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank members of S.K.M.'s laboratory for helpful suggestions and discussions, D. Barsyte-Lovejoy for helping with epigenetic drug screening experiments and members of the PanCuRx team, including D. Hedley, for support and assistance. This work was supported by the Ontario Institute for Cancer Research (OICR) PanCuRx program; Canadian Cancer Society; Lee K Margaret Lau Chair for Breast Cancer Research and Campbell Family Institute for Breast cancer research to S.K.M. The Structural Genomics Consortium is a registered charity (number 1097737) that receives funds from AbbVie, Bayer Pharma AG, Boehringer Ingelheim, Canada Foundation for Innovation, Eshelman Institute for Innovation, Genome Canada, Innovative Medicines Initiative (EU/EFPIA) (ULTRA-DD grant 115766), Janssen, Merck and Co., Novartis Pharma AG, Ontario Ministry of Economic Development and Innovation, Pfizer, Sao Paulo Research Foundation (FAPESP), Takeda, and the Wellcome Trust. This was also funded in part by the Ontario Ministry of Health and Long Term Care (OMOHLTC). The views expressed do not necessarily reflect those of the OMOHLTC.	Agbunag C, 2006, METHOD ENZYMOL, V407, P703, DOI 10.1016/S0076-6879(05)07055-2; Boj SF, 2015, CELL, V160, P324, DOI 10.1016/j.cell.2014.12.021; Chakravarty G, 2011, EXP BIOL MED, V236, P145, DOI 10.1258/ebm.2010.010086; Chakravarty G, 2011, CANCER BIOL THER, V11, P71, DOI 10.4161/cbt.11.1.13952; Chang DK, 2014, CURR OPIN GENET DEV, V24, P74, DOI 10.1016/j.gde.2013.12.001; Ghaneh P, 2008, POSTGRAD MED J, V84, P478, DOI 10.1136/gut.2006.103333; Hick AC, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-66; Huch M, 2013, EMBO J, V32, P2708, DOI 10.1038/emboj.2013.204; Jennings RE, 2013, DIABETES, V62, P3514, DOI 10.2337/db12-1479; Johnson AB, 2008, MUTAT RES-FUND MOL M, V640, P174, DOI 10.1016/j.mrfmmm.2008.01.001; Kanji ZS, 2013, CAN MED ASSOC J, V185, P1219, DOI 10.1503/cmaj.121368; Kolodecik T, 2014, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00415; LAITIO M, 1974, J ANAT, V117, P619; Li XN, 2014, NAT MED, V20, P769, DOI 10.1038/nm.3585; Lyttle BM, 2008, DIABETOLOGIA, V51, P1169, DOI 10.1007/s00125-008-1006-z; Marusyk A, 2012, NAT REV CANCER, V12, P323, DOI 10.1038/nrc3261; McCracken KW, 2012, SEMIN CELL DEV BIOL, V23, P656, DOI 10.1016/j.semcdb.2012.06.009; Nielsen SK, 2008, DEV DYNAM, V237, P2039, DOI 10.1002/dvdy.21610; OUTZEN HC, 1981, TRANSPLANTATION, V32, P101, DOI 10.1097/00007890-198108000-00004; Pagliuca FW, 2014, CELL, V159, P428, DOI 10.1016/j.cell.2014.09.040; Pan FC, 2011, DEV DYNAM, V240, P530, DOI 10.1002/dvdy.22584; Rezania A, 2014, NAT BIOTECHNOL, V32, P1121, DOI 10.1038/nbt.3033; Riedel MJ, 2012, DIABETOLOGIA, V55, P372, DOI 10.1007/s00125-011-2344-9; Schiesser JV, 2014, ANN NY ACAD SCI, V1311, P124, DOI 10.1111/nyas.12369; van den Beucken T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6203; Viale A, 2014, NATURE, V514, P628, DOI 10.1038/nature13611; Vincent A, 2011, LANCET, V378, P607, DOI 10.1016/S0140-6736(10)62307-0; Waddell N, 2015, NATURE, V518, P495, DOI 10.1038/nature14169	28	410	428	10	118	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2015	21	11					1364	1371		10.1038/nm.3973	http://dx.doi.org/10.1038/nm.3973			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CV9QH	26501191	Green Accepted, Green Published			2022-12-25	WOS:000364621200023
J	Kim, D; Kim, YG; Seo, SU; Kim, DJ; Kamada, N; Prescott, D; Philpott, DJ; Rosenstiel, P; Inohara, N; Nunez, G				Kim, Donghyun; Kim, Yun-Gi; Seo, Sang-Uk; Kim, Dong-Jae; Kamada, Nobuhiko; Prescott, Dave; Philpott, Dana J.; Rosenstiel, Philip; Inohara, Naohiro; Nunez, Gabriel			Nod2-mediated recognition of the microbiota is critical for mucosal adjuvant activity of cholera toxin	NATURE MEDICINE			English	Article							DENDRITIC CELLS; VIBRIO-CHOLERAE; T-CELLS; DEVELOPING-COUNTRIES; ANTIBODY-RESPONSES; IMMUNE-RESPONSES; VACCINE; NOD2; DIFFERENTIATION; PEPTIDOGLYCAN	Cholera toxin (CT) is a potent adjuvant for inducing mucosal immune responses. However, the mechanism by which CT induces adjuvant activity remains unclear. Here we show that the microbiota is critical for inducing antigen-specific IgG production after intranasal immunization. After mucosal vaccination with CT, both antibiotic-treated and germ-free (GF) mice had reduced amounts of antigen-specific IgG, smaller recall-stimulated cytokine responses, impaired follicular helper T (T-FH) cell responses and reduced numbers of plasma cells. Recognition of symbiotic bacteria via the nucleotide-binding oligomerization domain containing 2 (Nod2) sensor in cells that express the integrin CD11c (encoded by ltgax) was required for the adjuvanticity of CT. Reconstitution of GF mice with a Nod2 agonist or monocolonization with Staphylococcus sciuri, which has high Nod2-stimulatory activity, was sufficient to promote robust CT adjuvant activity, whereas bacteria with low Nod2-stimulatory activity did not. Mechanistically, CT enhanced Nod2-mediated cytokine production in dendritic cells via intracellular cyclic AMP. These results show a role for the microbiota and the intracellular receptor Nod2 in promoting the mucosal adjuvant activity of CT.	[Kim, Donghyun; Kim, Yun-Gi; Seo, Sang-Uk; Kim, Dong-Jae; Inohara, Naohiro; Nunez, Gabriel] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI USA; [Kim, Donghyun; Kim, Yun-Gi; Seo, Sang-Uk; Kim, Dong-Jae; Inohara, Naohiro; Nunez, Gabriel] Univ Michigan, Sch Med, Ctr Comprehens Canc, Ann Arbor, MI USA; [Kamada, Nobuhiko] Univ Michigan, Sch Med, Dept Internal Med, Div Gastroenterol, Ann Arbor, MI USA; [Prescott, Dave; Philpott, Dana J.] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Rosenstiel, Philip] Univ Kiel, Inst Clin Mol Biol, Kiel, Germany	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Toronto; University of Kiel	Kim, YG; Nunez, G (corresponding author), Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI USA.; Kim, YG; Nunez, G (corresponding author), Univ Michigan, Sch Med, Ctr Comprehens Canc, Ann Arbor, MI USA.	yungikim77@gmail.com; gabriel.nunez@umich.edu	Nuñez, Gabriel/A-7160-2014; Kim, Donghyun/J-3609-2019; Kamada, Nobuhiko/AAW-3299-2020; Rosenstiel, Philip/A-5137-2009	Kim, Donghyun/0000-0002-5137-2213; Kamada, Nobuhiko/0000-0002-1980-4178; Rosenstiel, Philip/0000-0002-9692-8828; Prescott, David/0000-0002-9798-9526	US National Institutes of Health (NIH) [R01 DK61707]; University of Michigan's Cancer Center [5 P30 CA46592]; DFG Cluster of Excellence 'Inflammation at Interfaces'; BMBF [TP5]; University of Michigan Germ-Free Animal Core Facility; Host Microbiome Initiative; NATIONAL CANCER INSTITUTE [P30CA046592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034933, R01DK061707] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan's Cancer Center(University of Michigan System); DFG Cluster of Excellence 'Inflammation at Interfaces'(German Research Foundation (DFG)); BMBF(Federal Ministry of Education & Research (BMBF)); University of Michigan Germ-Free Animal Core Facility; Host Microbiome Initiative; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by US National Institutes of Health (NIH) grant R01 DK61707 (G.N.), the University of Michigan's Cancer Center Support grant 5 P30 CA46592 (G.N.), the DFG Cluster of Excellence 'Inflammation at Interfaces' (P.R.) and the BMBF grant TP5 (P.R.). We thank M. Zeng for critical review of the manuscript, L. Haynes for animal husbandry and the University of Michigan Germ-Free Animal Core Facility and Host Microbiome Initiative (G.N.) for support.	Abt MC, 2012, IMMUNITY, V37, P158, DOI 10.1016/j.immuni.2012.04.011; Allen EK, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-22; Braun MC, 1999, J EXP MED, V189, P541, DOI 10.1084/jem.189.3.541; Chattha KS, 2013, J IMMUNOL, V191, P2446, DOI 10.4049/jimmunol.1300678; Datta SK, 2010, P NATL ACAD SCI USA, V107, P10638, DOI 10.1073/pnas.1002348107; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; Duan W, 2010, J ALLERGY CLIN IMMUN, V126, P1284, DOI 10.1016/j.jaci.2010.09.021; ELLOUZ F, 1974, BIOCHEM BIOPH RES CO, V59, P1317, DOI 10.1016/0006-291X(74)90458-6; ELSON CO, 1984, J IMMUNOL, V132, P2736; Eto D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017739; Freytag LC, 2005, VACCINE, V23, P1804, DOI 10.1016/j.vaccine.2004.11.010; Fritz JH, 2007, IMMUNITY, V26, P445, DOI 10.1016/j.immuni.2007.03.009; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Grassly NC, 2009, J INFECT DIS, V200, P794, DOI 10.1086/605330; Hasegawa M, 2008, EMBO J, V27, P373, DOI 10.1038/sj.emboj.7601962; Inohara N, 2003, J BIOL CHEM, V278, P5509, DOI 10.1074/jbc.C200673200; Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009; Jiang V, 2010, HUM VACCINES, V6, P532, DOI 10.4161/hv.6.7.11278; Johnson RA, 2012, CLIN VACCINE IMMUNOL, V19, P1712, DOI 10.1128/CVI.00321-12; Karnowski A, 2012, J EXP MED, V209, P2049, DOI 10.1084/jem.20111504; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Korpe PS, 2012, TRENDS MOL MED, V18, P328, DOI 10.1016/j.molmed.2012.04.007; la Sala A., 2009, J EXP MED, V206, P1227; Leung DT, 2011, CLIN VACCINE IMMUNOL, V18, P1317, DOI 10.1128/CVI.05124-11; Levine MM, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-129; Li XL, 2012, J CLIN INVEST, V122, P963, DOI 10.1172/JCI59097; Lopman BA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041720; LYCKE N, 1992, EUR J IMMUNOL, V22, P2277, DOI 10.1002/eji.1830220915; Ma CS, 2009, IMMUNOL CELL BIOL, V87, P590, DOI 10.1038/icb.2009.64; Magalhaes JG, 2011, P NATL ACAD SCI USA, V108, P14896, DOI 10.1073/pnas.1015063108; Magalhaes JG, 2008, J IMMUNOL, V181, P7925, DOI 10.4049/jimmunol.181.11.7925; Mattsson J, 2015, MUCOSAL IMMUNOL, V8, P815, DOI 10.1038/mi.2014.111; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; Oh JZ, 2014, IMMUNITY, V41, P478, DOI 10.1016/j.immuni.2014.08.009; Park JH, 2007, J IMMUNOL, V178, P2380, DOI 10.4049/jimmunol.178.4.2380; Pavot V, 2014, J IMMUNOL, V193, P5781, DOI 10.4049/jimmunol.1402184; Porgador A, 1998, INFECT IMMUN, V66, P5876, DOI 10.1128/IAI.66.12.5876-5881.1998; Reinhardt RL, 2009, NAT IMMUNOL, V10, P385, DOI 10.1038/ni.1715; Schmitt N, 2009, IMMUNITY, V31, P158, DOI 10.1016/j.immuni.2009.04.016; Shaw MH, 2008, CURR OPIN IMMUNOL, V20, P377, DOI 10.1016/j.coi.2008.06.001; Shulzhenko N, 2011, NAT MED, V17, P1585, DOI 10.1038/nm.2505; Sunahara RK, 1997, J BIOL CHEM, V272, P22265, DOI 10.1074/jbc.272.35.22265; Warner N, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003305; Warner N, 2013, J IMMUNOL, V190, P3, DOI 10.4049/jimmunol.1203103; Williamson E, 1999, J IMMUNOL, V163, P3668; XUAMANO JC, 1993, J EXP MED, V178, P1309, DOI 10.1084/jem.178.4.1309; Yamamoto S, 1997, P NATL ACAD SCI USA, V94, P5267, DOI 10.1073/pnas.94.10.5267; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053	48	63	65	2	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2016	22	5					524	530		10.1038/nm.4075	http://dx.doi.org/10.1038/nm.4075			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DL3DI	27064448	Green Accepted			2022-12-25	WOS:000375514000015
J	Newman, AM; Lovejoy, AF; Klass, DM; Kurtz, DM; Chabon, JJ; Scherer, F; Stehr, H; Liu, CL; Bratman, SV; Say, C; Zhou, L; Carter, JN; West, RB; Sledge, GW; Shrager, JB; Loo, BW; Neal, JW; Wakelee, HA; Diehn, M; Alizadeh, AA				Newman, Aaron M.; Lovejoy, Alexander F.; Klass, Daniel M.; Kurtz, David M.; Chabon, Jacob J.; Scherer, Florian; Stehr, Henning; Liu, Chih Long; Bratman, Scott V.; Say, Carmen; Zhou, Li; Carter, Justin N.; West, Robert B.; Sledge, George W., Jr.; Shrager, Joseph B.; Loo, Billy W., Jr.; Neal, Joel W.; Wakelee, Heather A.; Diehn, Maximilian; Alizadeh, Ash A.			Integrated digital error suppression for improved detection of circulating tumor DNA	NATURE BIOTECHNOLOGY			English	Article							TYROSINE KINASE INHIBITORS; GROWTH-FACTOR RECEPTOR; CELL LUNG-CANCER; ACQUIRED-RESISTANCE; EGFR MUTATIONS; RARE MUTATIONS; PLASMA; GEFITINIB; LYMPHOMA; QUANTIFICATION	High-throughput sequencing of circulating tumor DNA (ctDNA) promises to facilitate personalized cancer therapy. However, low quantities of cell-free DNA (cfDNA) in the blood and sequencing artifacts currently limit analytical sensitivity. To overcome these limitations, we introduce an approach for integrated digital error suppression (iDES). Our method combines in silico elimination of highly stereotypical background artifacts with a molecular barcoding strategy for the efficient recovery of cfDNA molecules. Individually, these two methods each improve the sensitivity of cancer personalized profiling by deep sequencing (CAPP-Seq) by about threefold, and synergize when combined to yield similar to 15-fold improvements. As a result, iDES-enhanced CAPP-Seq facilitates noninvasive variant detection across hundreds of kilobases. Applied to non-small cell lung cancer (NSCLC) patients, our method enabled biopsy-free profiling of EGFR kinase domain mutations with 92% sensitivity and >99.99% specificity at the variant level, and with 90% sensitivity and 96% specificity at the patient level. In addition, our approach allowed monitoring of NSCLC ctDNA down to 4 in 10(5) cfDNA molecules. We anticipate that IDES will aid the noninvasive genotyping and detection of ctDNA in research and clinical settings.	[Newman, Aaron M.; Lovejoy, Alexander F.; Klass, Daniel M.; Kurtz, David M.; Chabon, Jacob J.; Liu, Chih Long; Bratman, Scott V.; Diehn, Maximilian; Alizadeh, Ash A.] Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Newman, Aaron M.; Klass, Daniel M.; Kurtz, David M.; Scherer, Florian; Liu, Chih Long; Sledge, George W., Jr.; Neal, Joel W.; Wakelee, Heather A.; Diehn, Maximilian; Alizadeh, Ash A.] Stanford Univ, Dept Med, Stanford Canc Inst, Div Oncol, Stanford, CA 94305 USA; [Lovejoy, Alexander F.; Bratman, Scott V.; Say, Carmen; Carter, Justin N.; Loo, Billy W., Jr.; Diehn, Maximilian] Stanford Univ, Dept Radiat Oncol, Stanford, CA 94305 USA; [Lovejoy, Alexander F.; Klass, Daniel M.; Stehr, Henning; Zhou, Li; Sledge, George W., Jr.; Alizadeh, Ash A.] Stanford Univ, Stanford Canc Inst, Stanford, CA 94305 USA; [Kurtz, David M.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [West, Robert B.] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; [Shrager, Joseph B.] Stanford Univ, Stanford Sch Med, Dept Cardiothorac Surg, Div Thorac Surg, Stanford, CA 94305 USA; [Alizadeh, Ash A.] Stanford Univ, Dept Med, Stanford Canc Inst, Div Hematol, Stanford, CA 94305 USA; [Lovejoy, Alexander F.; Klass, Daniel M.] Roche Mol Syst Inc, Pleasanton, CA USA	Stanford University; Stanford Cancer Institute; Stanford University; Stanford University; Stanford Cancer Institute; Stanford University; Stanford University; Stanford University; Stanford University; Stanford Cancer Institute; Stanford University; Roche Holding	Diehn, M; Alizadeh, AA (corresponding author), Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA.; Diehn, M; Alizadeh, AA (corresponding author), Stanford Univ, Dept Med, Stanford Canc Inst, Div Oncol, Stanford, CA 94305 USA.; Diehn, M (corresponding author), Stanford Univ, Dept Radiat Oncol, Stanford, CA 94305 USA.; Alizadeh, AA (corresponding author), Stanford Univ, Stanford Canc Inst, Stanford, CA 94305 USA.; Alizadeh, AA (corresponding author), Stanford Univ, Dept Med, Stanford Canc Inst, Div Hematol, Stanford, CA 94305 USA.	diehn@stanford.edu; arasha@stanford.edu	Newman, Aaron M/ABE-1620-2021; Alizadeh, Ash A/C-5594-2009; Wakelee, Heather/P-2623-2019	Newman, Aaron M/0000-0002-1857-8172; Alizadeh, Ash A/0000-0002-5153-5625; West, Robert/0000-0002-8330-8283; Bratman, Scott/0000-0001-8610-4908; Kurtz, David/0000-0002-6382-4651	Department of Defense; National Cancer Institute [1K99CA187192-01A1, R01CA188298]; US National Institutes of Health Director's New Innovator Award Program [1-DP2-CA186569]; US Public Health Service/National Institutes of Health [U01 CA194389]; Ludwig Institute for Cancer Research; Stanford Cancer Institute-Developmental Cancer Research Award; CRK Faculty Scholar Fund; V-Foundation; Damon Runyon Cancer Research Foundation; Siebel Stem Cell Institute; Thomas and Stacey Siebel Foundation; NATIONAL CANCER INSTITUTE [U01CA194389, R01CA188298, T32CA009302, K99CA187192, T32CA121940, U01CA152662, DP2CA186569, U01CA196405] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); US National Institutes of Health Director's New Innovator Award Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Public Health Service/National Institutes of Health(United States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA); Ludwig Institute for Cancer Research; Stanford Cancer Institute-Developmental Cancer Research Award; CRK Faculty Scholar Fund; V-Foundation; Damon Runyon Cancer Research Foundation; Siebel Stem Cell Institute; Thomas and Stacey Siebel Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the Department of Defense (A.M.N., M.D., A.A.A.), the National Cancer Institute (A.M.N., 1K99CA187192-01A1; M.D., A.A.A., R01CA188298), the US National Institutes of Health Director's New Innovator Award Program (M.D., 1-DP2-CA186569), a US Public Health Service/National Institutes of Health U01 CA194389 (A.A.A.), the Ludwig Institute for Cancer Research (M.D., A.A.A.), a Stanford Cancer Institute-Developmental Cancer Research Award (M.D., A.A.A.), the CRK Faculty Scholar Fund (M.D.), V-Foundation (A.A.A.), Damon Runyon Cancer Research Foundation (A.A.A.) and a grant from both the Siebel Stem Cell Institute and the Thomas and Stacey Siebel Foundation (A.M.N.).	Bettegowda C, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007094; Bratman SV, 2015, EXPERT REV MOL DIAGN, V15, P715, DOI 10.1586/14737159.2015.1019476; Butler TM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136407; Chen GL, 2014, MOL DIAGN THER, V18, P587, DOI 10.1007/s40291-014-0115-2; Costello M, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1443; Dawson SJ, 2013, NEW ENGL J MED, V368, P1199, DOI 10.1056/NEJMoa1213261; De Mattos-Arruda L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9839; Diaz LA, 2014, J CLIN ONCOL, V32, P579, DOI 10.1200/JCO.2012.45.2011; Diehl F, 2008, NAT MED, V14, P985, DOI 10.1038/nm.1789; Douillard JY, 2014, J THORAC ONCOL, V9, P1345, DOI 10.1097/JTO.0000000000000263; Drilon A, 2015, CLIN CANCER RES, V21, P3631, DOI 10.1158/1078-0432.CCR-14-2683; Ellis PM, 2013, J THORAC ONCOL, V8, P1136, DOI 10.1097/JTO.0b013e31829f6a43; Garcia-Murillas I, 2015, SCI TRANSL MED, V7, DOI [10.1126/scitranslmed.aab0021, 10.1126/scitranslmed.aac7551]; Gregory MT, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv915; Hafner C, 2007, P NATL ACAD SCI USA, V104, P13450, DOI 10.1073/pnas.0705218104; Heitzer E, 2015, CLIN CHEM, V61, P112, DOI 10.1373/clinchem.2014.222679; Higgins MJ, 2012, CLIN CANCER RES, V18, P3462, DOI 10.1158/1078-0432.CCR-11-2696; Jabara CB, 2011, P NATL ACAD SCI USA, V108, P20166, DOI 10.1073/pnas.1110064108; Kennedy SR, 2014, NAT PROTOC, V9, P2586, DOI 10.1038/nprot.2014.170; Kinde I, 2011, P NATL ACAD SCI USA, V108, P9530, DOI 10.1073/pnas.1105422108; Kukita Y, 2015, DNA RES, V22, P269, DOI 10.1093/dnares/dsv010; Kurtz DM, 2015, BLOOD, V125, P3679, DOI 10.1182/blood-2015-03-635169; Leighl NB, 2014, J CLIN ONCOL, V32, P3673, DOI 10.1200/JCO.2014.57.3055; LEON SA, 1977, CANCER RES, V37, P646; Lim C, 2015, ANN ONCOL, V26, P1415, DOI 10.1093/annonc/mdv208; Lou DI, 2013, P NATL ACAD SCI USA, V110, P19872, DOI 10.1073/pnas.1319590110; Marchetti A, 2015, J THORAC ONCOL, V10, P1437, DOI 10.1097/JTO.0000000000000643; Misale S, 2012, NATURE, V486, P532, DOI 10.1038/nature11156; Mok T, 2015, CLIN CANCER RES, V21, P3196, DOI 10.1158/1078-0432.CCR-14-2594; Murtaza M, 2013, NATURE, V497, P108, DOI 10.1038/nature12065; Newman AM, 2014, NAT MED, V20, P552, DOI 10.1038/nm.3519; Oxnard GR, 2014, CLIN CANCER RES, V20, P1698, DOI 10.1158/1078-0432.CCR-13-2482; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Rehm HL, 2013, GENET MED, V15, P733, DOI 10.1038/gim.2013.92; Roschewski M, 2015, LANCET ONCOL, V16, P541, DOI 10.1016/S1470-2045(15)70106-3; Samorodnitsky E, 2015, HUM MUTAT, V36, P903, DOI 10.1002/humu.22825; Schmitt MW, 2015, NAT METHODS, V12, P423, DOI [10.1038/nmeth.3351, 10.1038/NMETH.3351]; Schmitt MW, 2012, P NATL ACAD SCI USA, V109, P14508, DOI 10.1073/pnas.1208715109; Sequist LV, 2015, NEW ENGL J MED, V372, P1700, DOI 10.1056/NEJMoa1413654; Sequist LV, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002003; Shiau CJ, 2014, J THORAC ONCOL, V9, P947, DOI 10.1097/JTO.0000000000000196; Taniguchi K, 2011, CLIN CANCER RES, V17, P7808, DOI 10.1158/1078-0432.CCR-11-1712; Thress KS, 2015, NAT MED, V21, P560, DOI 10.1038/nm.3854; Yatabe Y, 2015, J THORAC ONCOL, V10, P438, DOI 10.1097/JTO.0000000000000422	45	595	663	2	168	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2016	34	5					547	555		10.1038/nbt.3520	http://dx.doi.org/10.1038/nbt.3520			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DL6FL	27018799	Green Accepted			2022-12-25	WOS:000375735000036
J	Willyard, C				Willyard, Cassandra			Foretelling toxicity: FDA researchers work to predict risk of liver injury from drugs	NATURE MEDICINE			English	News Item																			0	4	4	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2016	22	5					450	451		10.1038/nm0516-450	http://dx.doi.org/10.1038/nm0516-450			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DL3DI	27149212				2022-12-25	WOS:000375514000002
J	Kakkis, ED; Kowalcyk, S; Bronstein, MG				Kakkis, Emil D.; Kowalcyk, Sara; Bronstein, Max G.			Accessing the accelerated approval pathway for rare disease therapeutics	NATURE BIOTECHNOLOGY			English	Article									[Kakkis, Emil D.; Kowalcyk, Sara; Bronstein, Max G.] EveryLife Fdn Rare Dis, Novato, CA USA		Kakkis, ED (corresponding author), EveryLife Fdn Rare Dis, Novato, CA USA.	ekakkis@everylifefoundation.org						FDA, NEW DRUGS FDA CDERS; FDA. Us department of health and human services food and drug administration, RAR DIS COMM ISS DRU; Food and Drug Administration, ACC APPR; Kakkis ED, 2015, ORPHANET J RARE DIS, V10, DOI 10.1186/s13023-014-0195-4; Miyamoto BE, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-49; Sasinowski FJ, 2012, DRUG INF J, V46, P238, DOI 10.1177/0092861511435906; US Food and Drug Administration, 2014, GUID IND EXP PROGR S; Waisbren SE, 2007, MOL GENET METAB, V92, P63, DOI 10.1016/j.ymgme.2007.05.006	8	4	4	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	APR	2016	34	4					380	383		10.1038/nbt.3530	http://dx.doi.org/10.1038/nbt.3530			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DI6NL	27054988				2022-12-25	WOS:000373616100014
J	Sveinbjornsson, G; Albrechtsen, A; Zink, F; Gudjonsson, SA; Oddson, A; Masson, G; Holm, H; Kong, A; Thorsteinsdottir, U; Sulem, P; Gudbjartsson, DF; Stefansson, K				Sveinbjornsson, Gardar; Albrechtsen, Anders; Zink, Florian; Gudjonsson, Sigurjon A.; Oddson, Asmundur; Masson, Gisli; Holm, Hilma; Kong, Augustine; Thorsteinsdottir, Unnur; Sulem, Patrick; Gudbjartsson, Daniel F.; Stefansson, Kari			Weighting sequence variants based on their annotation increases power of whole-genome association studies	NATURE GENETICS			English	Article							WIDE ASSOCIATION; PARTITIONING HERITABILITY; GENETIC-VARIATION; DISEASE; CONSTRAINT; DISCOVERY; ONTOLOGY; LOCI	The consensus approach to genome-wide association studies (GWAS) has been to assign equal prior probability of association to all sequence variants tested. However, some sequence variants, such as loss-of-function and missense variants, are more likely than others to affect protein function and are therefore more likely to be causative. Using data from whole-genome sequencing of 2,636 Icelanders and the association results for 96 quantitative and 123 binary phenotypes, we estimated the enrichment of association signals by sequence annotation. We propose a weighted Bonferroni adjustment that controls for the family-wise error rate (FWER), using as weights the enrichment of sequence annotations among association signals. We show that this weighted adjustment increases the power to detect association over the standard Bonferroni correction. We use the enrichment of associations by sequence annotation we have estimated in Iceland to derive significance thresholds for other populations with different numbers and combinations of sequence variants.	[Sveinbjornsson, Gardar; Zink, Florian; Gudjonsson, Sigurjon A.; Oddson, Asmundur; Masson, Gisli; Holm, Hilma; Kong, Augustine; Thorsteinsdottir, Unnur; Sulem, Patrick; Gudbjartsson, Daniel F.; Stefansson, Kari] Amgen Inc, deCODE Genet, Reykjavik, Iceland; [Sveinbjornsson, Gardar; Kong, Augustine; Gudbjartsson, Daniel F.] Univ Iceland, Sch Engn & Nat Sci, Reykjavik, Iceland; [Albrechtsen, Anders] Univ Copenhagen, Dept Biol, Bioinformat Ctr, Copenhagen, Denmark; [Holm, Hilma] Natl Univ Hosp Iceland, Div Cardiol, Dept Internal Med, Landspitali, Reykjavik, Iceland; [Thorsteinsdottir, Unnur; Stefansson, Kari] Univ Iceland, Fac Med, Reykjavik, Iceland	University of Iceland; University of Copenhagen; University of Iceland	Gudbjartsson, DF; Stefansson, K (corresponding author), Amgen Inc, deCODE Genet, Reykjavik, Iceland.; Gudbjartsson, DF (corresponding author), Univ Iceland, Sch Engn & Nat Sci, Reykjavik, Iceland.; Stefansson, K (corresponding author), Univ Iceland, Fac Med, Reykjavik, Iceland.	daniel.gudbjartsson@decode.is; kari.stefansson@decode.is	Albrechtsen, Anders/K-4281-2013; Stefansson, Kari/AAE-7187-2019	Albrechtsen, Anders/0000-0001-7306-031X; Sveinbjornsson, Gardar/0000-0003-2429-9468; Kong, Augustine/0000-0001-8193-5438; Masson, Gisli/0000-0003-0493-8242; Gudjonsson, Sigurjon A./0000-0001-9314-7412; Oddsson, Asmundur/0000-0002-4606-5163	Lundbeck Foundation [R215-2015-4174] Funding Source: researchfish; Villum Fonden [00007171] Funding Source: researchfish	Lundbeck Foundation(Lundbeckfonden); Villum Fonden(Villum Fonden)		Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Cooper GM, 2005, GENOME RES, V15, P901, DOI 10.1101/gr.3577405; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Eilbeck K, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-5-r44; Ernst J, 2012, NAT METHODS, V9, P215, DOI 10.1038/nmeth.1906; Finucane HK, 2015, NAT GENET, V47, P1228, DOI 10.1038/ng.3404; Francioli LC, 2014, NAT GENET, V46, P818, DOI 10.1038/ng.3021; Genovese CR, 2006, BIOMETRIKA, V93, P509, DOI 10.1093/biomet/93.3.509; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Goode DL, 2010, GENOME RES, V20, P301, DOI 10.1101/gr.102210.109; Gudbjartsson DF, 2015, NAT GENET, V47, P435, DOI 10.1038/ng.3247; Gusev A, 2014, AM J HUM GENET, V95, P535, DOI 10.1016/j.ajhg.2014.10.004; Hazra A, 2008, NAT GENET, V40, P1160, DOI 10.1038/ng.210; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Iversen ES, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-398; Kichaev G, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004722; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Kohler S, 2014, NUCLEIC ACIDS RES, V42, pD966, DOI 10.1093/nar/gkt1026; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; Minelli C, 2013, GENET EPIDEMIOL, V37, P205, DOI 10.1002/gepi.21705; Pe'er I, 2008, GENET EPIDEMIOL, V32, P381, DOI 10.1002/gepi.20303; Pickrell JK, 2014, AM J HUM GENET, V94, P559, DOI 10.1016/j.ajhg.2014.03.004; Roeder K, 2006, AM J HUM GENET, V78, P243, DOI 10.1086/500026; Roeder K, 2009, STAT SCI, V24, P398, DOI 10.1214/09-STS289; Schork AJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003449; Sham PC, 2014, NAT REV GENET, V15, P335, DOI 10.1038/nrg3706; Sveinbjornsson G, 2014, HUM MOL GENET, V23, P6935, DOI 10.1093/hmg/ddu399; Thomas PD, 2004, P NATL ACAD SCI USA, V101, P15398, DOI 10.1073/pnas.0404380101; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Yang J, 2011, NAT GENET, V43, P519, DOI 10.1038/ng.823	33	105	105	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2016	48	3					314	317		10.1038/ng.3507	http://dx.doi.org/10.1038/ng.3507			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DE8QW	26854916				2022-12-25	WOS:000370902600016
J	Boyer, TG				Boyer, Thomas G.			TRANSCRIPTIONAL KINASES Less is more (or less)	NATURE CHEMICAL BIOLOGY			English	News Item							CDK8; DISEASE		[Boyer, Thomas G.] Univ Texas Hlth Sci Ctr San Antonio, Dept Mol Med, San Antonio, TX 78229 USA; [Boyer, Thomas G.] Univ Texas Hlth Sci Ctr San Antonio, Inst Biotechnol, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	Boyer, TG (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Mol Med, San Antonio, TX 78229 USA.	boyer@uthscsa.edu						Cee VJ, 2009, ANGEW CHEM INT EDIT, V48, P8952, DOI 10.1002/anie.200904778; Clark AD, 2015, CRIT REV BIOCHEM MOL, V50, P393, DOI 10.3109/10409238.2015.1064854; Dale T, 2015, NAT CHEM BIOL, V11, P973, DOI 10.1038/nchembio.1952; Firestein R, 2008, NATURE, V455, P547, DOI 10.1038/nature07179; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Mallinger A, 2015, J MED CHEM, V58, P1717, DOI 10.1021/jm501436m; McCleland ML, 2015, J PATHOL, V237, P508, DOI 10.1002/path.4596; Pelish HE, 2015, NATURE, V526, P273, DOI 10.1038/nature14904	8	2	2	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2016	12	1					4	5		10.1038/nchembio.1985	http://dx.doi.org/10.1038/nchembio.1985			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY8QW	26678610				2022-12-25	WOS:000366674400003
J	Parisi, C; Tillie, P; Rodriguez-Cerezo, E				Parisi, Claudia; Tillie, Pascal; Rodriguez-Cerezo, Emilio			The global pipeline of GM crops out to 2020	NATURE BIOTECHNOLOGY			English	Article								Although a few arable crops and agronomic traits will likely dominate commercial varieties for the foreseeable future, with many being stacked together, more quality traits and specialty crops are being introduced into the pipeline.	[Parisi, Claudia; Tillie, Pascal; Rodriguez-Cerezo, Emilio] European Commiss, Joint Res Ctr Inst Prospect Technol Studies, Seville, Spain		Parisi, C (corresponding author), European Commiss, Joint Res Ctr Inst Prospect Technol Studies, Seville, Spain.	Claudia.parisi@ec.europa.eu						[Anonymous], 2004, EPTD DISCUSSION PAPE; Cockburn A., 2004, Journal of Commercial Biotechnology, V10, P209, DOI 10.1057/palgrave.jcb.3040076; Conko G., 2012, IS THERE FUTURE GENE; De Schrijver A, 2007, TRENDS FOOD SCI TECH, V18, P101, DOI 10.1016/j.tifs.2006.09.002; De Steur H, 2015, NAT BIOTECHNOL, V33, P25, DOI 10.1038/nbt.3110; Dodo HW, 2008, PLANT BIOTECHNOL J, V6, P135, DOI 10.1111/j.1467-7652.2007.00292.x; EuropaBio, 2011, APPR GMOS EUR UN; European Commission, 2008, COEXTRA GM NONGM SUP; FAO, 2014, TECHN CONS LOW LEV G; Gil-Humanes J, 2010, P NATL ACAD SCI USA, V107, P17023, DOI 10.1073/pnas.1007773107; Graff GD, 2009, NAT BIOTECHNOL, V27, P702, DOI 10.1038/nbt0809-702; Grushkin D, 2013, NAT BIOTECHNOL, V31, P10, DOI 10.1038/nbt0113-10c; Harwood JL, 2013, EUR J LIPID SCI TECH, V115, P1239, DOI 10.1002/ejlt.201300257; Huang JK, 2002, SCIENCE, V295, P674, DOI 10.1126/science.1067226; ISAAA, 2013, POCK K 42 STACK TRAI; Kalaitzandonakes N, 2007, NAT BIOTECHNOL, V25, P509, DOI 10.1038/nbt0507-509; Kalaitzandonakes N, 2014, FOOD POLICY, V45, P146, DOI 10.1016/j.foodpol.2013.06.013; Koch A, 2013, P NATL ACAD SCI USA, V110, P19324, DOI 10.1073/pnas.1306373110; Lusser M., 2011, NEW PLANT BREEDING T, DOI DOI 10.2791/54761; Lusser M, 2012, NAT BIOTECHNOL, V30, P231, DOI 10.1038/nbt.2142; Mao YB, 2011, TRANSGENIC RES, V20, P665, DOI 10.1007/s11248-010-9450-1; Miller JK, 2010, NAT BIOTECHNOL, V28, P1012, DOI 10.1038/nbt1010-1012; Sithole-Niang, 2013, GENETICALLY MODIFIED; Stein A.J., 2009, GLOBAL PIPELINE NEW; Stein AJ, 2010, NAT BIOTECHNOL, V28, P23, DOI 10.1038/nbt0110-23b; Waltz E, 2015, NAT BIOTECHNOL, V33, P328, DOI 10.1038/nbt0415-328; Wolt JD, 2007, BIOMASS BIOENERG, V31, P831, DOI 10.1016/j.biombioe.2007.04.003	27	81	83	1	45	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2016	34	1					31	36		10.1038/nbt.3449	http://dx.doi.org/10.1038/nbt.3449			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DB8HQ	26744975				2022-12-25	WOS:000368758200020
J	Marguet, SL; Le-Schulte, VTQ; Merseburg, A; Neu, A; Eichler, R; Jakovcevski, I; Ivanov, A; Hanganu-Opatz, IL; Bernard, C; Morellini, F; Isbrandt, D				Marguet, Stephan Lawrence; Le-Schulte, Vu Thao Quyen; Merseburg, Andrea; Neu, Axel; Eichler, Ronny; Jakovcevski, Igor; Ivanov, Anton; Hanganu-Opatz, Ileana Livia; Bernard, Christophe; Morellini, Fabio; Isbrandt, Dirk			Treatment during a vulnerable developmental period rescues a genetic epilepsy	NATURE MEDICINE			English	Article							CATION-CHLORIDE COTRANSPORTERS; POTASSIUM CHANNEL GENE; NEONATAL SEIZURE MODEL; VISUAL-CORTEX; MOUSE-BRAIN; SYNAPTIC PLASTICITY; INHERITED EPILEPSY; SPINDLE BURSTS; IN-VIVO; BUMETANIDE	The nervous system is vulnerable to perturbations during specific developmental periods. Insults during such susceptible time windows can have long-term consequences, including the development of neurological diseases such as epilepsy. Here we report that a pharmacological intervention timed during a vulnerable neonatal period of cortical development prevents pathology in a genetic epilepsy model. By using mice with dysfunctional Kv7 voltage-gated K+ channels, which are mutated in human neonatal epilepsy syndromes, we demonstrate the safety and efficacy of the sodium-potassium-chloride cotransporter NKCC1 antagonist bumetanide, which was administered during the first two postnatal weeks. In Kv7 current-deficient mice, which normally display epilepsy, hyperactivity and stereotypies as adults, transient bumetanide treatment normalized neonatal in vivo cortical network and hippocampal neuronal activity, prevented structural damage in the hippocampus and restored wild-type adult behavioral phenotypes. Furthermore, bumetanide treatment did not adversely affect control mice. These results suggest that in individuals with disease susceptibility, timing prophylactically safe interventions to specific windows during development may prevent or arrest disease progression.	[Marguet, Stephan Lawrence; Merseburg, Andrea; Jakovcevski, Igor; Isbrandt, Dirk] German Ctr Neurodegenerat Dis DZNE, Expt Neurophysiol, Bonn, Germany; [Marguet, Stephan Lawrence; Merseburg, Andrea; Jakovcevski, Igor; Isbrandt, Dirk] Univ Cologne, Inst Mol & Behav Neurosci, D-50931 Cologne, Germany; [Marguet, Stephan Lawrence; Le-Schulte, Vu Thao Quyen; Merseburg, Andrea; Neu, Axel; Eichler, Ronny; Isbrandt, Dirk] Univ Med Ctr Hamburg Eppendorf, Expt Neuropediat, Hamburg, Germany; [Ivanov, Anton; Bernard, Christophe] Aix Marseille Univ, INSERM, INS, UMR S1106, Marseille, France; [Hanganu-Opatz, Ileana Livia] Univ Med Ctr Hamburg Eppendorf, Ctr Med Expt, Dev Neurophysiol, Hamburg, Germany; [Morellini, Fabio] Univ Med Ctr Hamburg Eppendorf, Behav Biol Unit, Ctr Mol Neurobiol, Hamburg, Germany	Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Cologne; University of Hamburg; University Medical Center Hamburg-Eppendorf; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Isbrandt, D (corresponding author), German Ctr Neurodegenerat Dis DZNE, Expt Neurophysiol, Bonn, Germany.	dirk.isbrandt@dzne.de	bernard, christophe/S-5937-2016; bernard, christophe/A-4929-2012	bernard, christophe/0000-0003-3014-1966; bernard, christophe/0000-0003-3014-1966; Neu, Axel/0000-0001-7045-7194; Eichler, Ronny/0000-0003-2947-9513; Ivanov, Anton/0000-0002-8650-6322; Isbrandt, Dirk/0000-0002-4720-1016; Jakovcevski, Igor/0000-0001-7673-9600	German Federal Ministry of Education and Research (NGFNplus/EMINet project) [01GS0831, 01GQ0809]; Deutsche Forschungsgemeinschaft (DFG) [IS63/3-1/2, IS63/4-1, SFB936, B3, SPP1665 IS63/5-1, Ha4466/3-1]; Human Frontier Science Program; Werner-Otto-Stiftung (Hamburg, Germany); Hamburg macht Kinder gesund e.V. (Hamburg, Germany); L'Agence Nationale de la Recherche (ANR) [ANR-13-NEUC-005-01]; INSERM	German Federal Ministry of Education and Research (NGFNplus/EMINet project); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Human Frontier Science Program(Human Frontier Science Program); Werner-Otto-Stiftung (Hamburg, Germany); Hamburg macht Kinder gesund e.V. (Hamburg, Germany); L'Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	We thank K. Sauter and S. Schillemeit for excellent technical support, H. Voss for expert animal caretaking, I. Hermans-Borgmeyer and C.H. Peters for in situ hybridization, M. Bindszus, R. Schubert and J. Szeremeta for help with genotyping and A. Isbrandt for comments on the manuscript. The study was supported by the German Federal Ministry of Education and Research (NGFNplus/EMINet project 01GS0831; I.L.H.-O.: 01GQ0809; D.I. and A.N.), the Deutsche Forschungsgemeinschaft (DFG; IS63/3-1/2 and IS63/4-1 (D.I.); SFB936, B3 (F.M. and D.I.); SPP1665 IS63/5-1 (D.I.); and Ha4466/3-1 (I.L.H.-O.)), the Human Frontier Science Program (D.I.), Werner-Otto-Stiftung (Hamburg, Germany) (D.I.), Hamburg macht Kinder gesund e.V. (Hamburg, Germany) (D.I.), L'Agence Nationale de la Recherche (ANR, ANR-13-NEUC-005-01 MOTION; C.B.), and INSERM (C.B.).	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Adelsberger H, 2005, NAT NEUROSCI, V8, P988, DOI 10.1038/nn1502; Allin M, 2006, PEDIATRICS, V117, P309, DOI 10.1542/peds.2005-0539; Ben-Ari Y, 2001, TRENDS NEUROSCI, V24, P353, DOI 10.1016/S0166-2236(00)01813-0; Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; Ben-Ari Y, 2006, LANCET NEUROL, V5, P1055, DOI 10.1016/S1474-4422(06)70626-3; BENARI Y, 1989, J PHYSIOL-LONDON, V416, P303, DOI 10.1113/jphysiol.1989.sp017762; Biervert C, 1998, SCIENCE, V279, P403, DOI 10.1126/science.279.5349.403; Booth D, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD004218.PUB2; Brown DA, 2009, BRIT J PHARMACOL, V156, P1185, DOI 10.1111/j.1476-5381.2009.00111.x; BULLITT E, 1990, J COMP NEUROL, V296, P517, DOI 10.1002/cne.902960402; Chabwine JN, 2011, J CHILD NEUROL, V26, P657, DOI 10.1177/0883073811401395; Charlier C, 1998, NAT GENET, V18, P53, DOI 10.1038/ng0198-53; Cooper EC, 2001, J NEUROSCI, V21, P9529, DOI 10.1523/JNEUROSCI.21-24-09529.2001; Deidda G, 2015, NAT MED, V21, P318, DOI 10.1038/nm.3827; Devaux JJ, 2004, J NEUROSCI, V24, P1236, DOI 10.1523/JNEUROSCI.4512-03.2004; Dzhala VI, 2005, NAT MED, V11, P1205, DOI 10.1038/nm1301; Dzhala VI, 2008, ANN NEUROL, V63, P222, DOI 10.1002/ana.21229; Evans DJ, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001240.pub2; Fellini L, 2006, LEARN MEMORY, V13, P473, DOI 10.1101/lm.259206; Fellini L, 2011, BEHAV BRAIN RES, V222, P380, DOI 10.1016/j.bbr.2011.03.040; Freitag S, 2003, BEHAV BRAIN RES, V145, P189, DOI 10.1016/S0166-4328(03)00109-8; Hanganu IL, 2006, J NEUROSCI, V26, P6728, DOI 10.1523/JNEUROSCI.0752-06.2006; Hazan L, 2006, J NEUROSCI METH, V155, P207, DOI 10.1016/j.jneumeth.2006.01.017; Hensch TK, 2004, ANNU REV NEUROSCI, V27, P549, DOI 10.1146/annurev.neuro.27.070203.144327; Heyser C. J., 2003, CURR PROTOC NEUROSCI, V25, P818; Huberfeld G, 2007, J NEUROSCI, V27, P9866, DOI 10.1523/JNEUROSCI.2761-07.2007; Kadir SN, 2014, NEURAL COMPUT, V26, P2379, DOI 10.1162/NECO_a_00661; Kahle KT, 2009, J CHILD NEUROL, V24, P572, DOI 10.1177/0883073809333526; Katagiri H, 2007, NEURON, V53, P805, DOI 10.1016/j.neuron.2007.02.026; Khalilov I, 1997, NEURON, V19, P743, DOI 10.1016/S0896-6273(00)80956-3; Khazipov R, 2004, NATURE, V432, P758, DOI 10.1038/nature03132; Kilb W, 2007, NEUROPHARMACOLOGY, V53, P524, DOI 10.1016/j.neuropharm.2007.06.015; Koyama R, 2012, NAT MED, V18, P1271, DOI 10.1038/nm.2850; Kwan P, 2011, NEW ENGL J MED, V365, P919, DOI 10.1056/NEJMra1004418; Leinekugel X, 2002, SCIENCE, V296, P2049, DOI 10.1126/science.1071111; Levelt CN, 2012, ANNU REV NEUROSCI, V35, P309, DOI 10.1146/annurev-neuro-061010-113813; Lewis DA, 2002, ANNU REV NEUROSCI, V25, P409, DOI 10.1146/annurev.neuro.25.112701.142754; Liu YQ, 2012, PEDIATR RES, V71, P559, DOI 10.1038/pr.2012.7; Loscher W, 2013, NEUROPHARMACOLOGY, V69, P62, DOI 10.1016/j.neuropharm.2012.05.045; Margineanu DG, 2006, EPILEPSY RES, V69, P93, DOI 10.1016/j.eplepsyres.2006.01.005; Miles R, 2012, JASPERS BASIC MECH E, P1; Minlebaev M, 2007, J NEUROPHYSIOL, V97, P692, DOI 10.1152/jn.00759.2006; Morellini F, 2006, EUR J NEUROSCI, V23, P1255, DOI 10.1111/j.1460-9568.2006.04657.x; Neubauer BA, 2008, NEUROLOGY, V71, P177, DOI 10.1212/01.wnl.0000317090.92185.ec; NOEBELS JL, 1979, SCIENCE, V204, P1334, DOI 10.1126/science.572084; Orhan G, 2014, ANN NEUROL, V75, P382, DOI 10.1002/ana.24080; Paxinos G., 2007, ATLAS DEV MOUSE BRAI; Peters HC, 2005, NAT NEUROSCI, V8, P51, DOI 10.1038/nn1375; Pressler RM, 2015, LANCET NEUROL, V14, P469, DOI 10.1016/S1474-4422(14)70303-5; Puskarjov M, 2014, EPILEPSIA, V55, P806, DOI 10.1111/epi.12620; Rheims S, 2008, J NEUROPHYSIOL, V100, P620, DOI 10.1152/jn.90403.2008; Rossant C., 2015, BIORXIV; RYAN LJ, 1979, EXP NEUROL, V66, P493, DOI 10.1016/0014-4886(79)90197-3; Safiulina VF, 2008, J PHYSIOL-LONDON, V586, P5437, DOI 10.1113/jphysiol.2008.156257; Sawallisch C, 2009, J BIOL CHEM, V284, P9225, DOI 10.1074/jbc.M808425200; Seelke AMH, 2010, BRAIN RES, V1324, P34, DOI 10.1016/j.brainres.2010.01.088; Singh NA, 1998, NAT GENET, V18, P25, DOI 10.1038/ng0198-25; STREIT WJ, 1987, J NEUROCYTOL, V16, P249, DOI 10.1007/BF01795308; Talos DM, 2013, PEDIATR RES, V73, P24, DOI 10.1038/pr.2012.151; Topfer M, 2014, EUR J NEUROSCI, V39, P673, DOI 10.1111/ejn.12424; Tremblay P, 1998, P NATL ACAD SCI USA, V95, P12580, DOI 10.1073/pnas.95.21.12580; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Tyzio R, 2014, SCIENCE, V343, P675, DOI 10.1126/science.1247190; Vanhatalo S, 2006, SEMIN FETAL NEONAT M, V11, P471, DOI 10.1016/j.siny.2006.07.008; Vanhatalo S, 2009, EPILEPSIA, V50, P1292, DOI 10.1111/j.1528-1167.2008.01894.x; Wang DD, 2008, J NEUROSCI, V28, P5547, DOI 10.1523/JNEUROSCI.5599-07.2008; Wang DD, 2011, CEREB CORTEX, V21, P574, DOI 10.1093/cercor/bhq124; Wang HS, 1998, SCIENCE, V282, P1890, DOI 10.1126/science.282.5395.1890; Weber YG, 2006, BRAIN RES, V1077, P1, DOI 10.1016/j.brainres.2006.01.023; Weckhuysen S, 2012, ANN NEUROL, V71, P15, DOI 10.1002/ana.22644	71	71	71	1	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2015	21	12					1436	+		10.1038/nm.3987	http://dx.doi.org/10.1038/nm.3987			12	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CX9EV	26594844				2022-12-25	WOS:000366008700014
J	McCreery, MQ; Halliwill, KD; Chin, D; Delrosario, R; Hirst, G; Vuong, P; Jen, KY; Hewinson, J; Adams, DJ; Balmain, A				McCreery, Melissa Q.; Halliwill, Kyle D.; Chin, Douglas; Delrosario, Reyno; Hirst, Gillian; Vuong, Peter; Jen, Kuang-Yu; Hewinson, James; Adams, David J.; Balmain, Allan			Evolution of metastasis revealed by mutational landscapes of chemically induced skin cancers	NATURE MEDICINE			English	Article							SQUAMOUS-CELL CARCINOMA; EPITHELIAL-MESENCHYMAL TRANSITION; MOUSE SKIN; TUMOR SUSCEPTIBILITY; RANDOMIZED-TRIAL; SEQUENCING DATA; RAS GENE; HA-RAS; PROGRESSION; CARCINOGENESIS	Human tumors show a high level of genetic heterogeneity, but the processes that influence the timing and route of metastatic dissemination of the subclones are unknown. Here we have used whole-exome sequencing of 103 matched benign, malignant and metastatic skin tumors from genetically heterogeneous mice to demonstrate that most metastases disseminate synchronously from the primary tumor, supporting parallel rather than linear evolution as the predominant model of metastasis. Shared mutations between primary carcinomas and their matched metastases have the distinct A-to-T signature of the initiating carcinogen dimethylbenzanthracene, but non-shared mutations are primarily G-to-T, a signature associated with oxidative stress. The existence of carcinomas that either did or did not metastasize in the same host animal suggests that there are tumor-intrinsic factors that influence metastatic seeding. We also demonstrate the importance of germline polymorphisms in determining allele-specific mutations, and we identify somatic genetic alterations that are specifically related to initiation of carcinogenesis by Hras or Kras mutations. Mouse tumors that mimic the genetic heterogeneity of human cancers can aid our understanding of the clonal evolution of metastasis and provide a realistic model for the testing of novel therapies.	[McCreery, Melissa Q.; Halliwill, Kyle D.; Chin, Douglas; Delrosario, Reyno; Hirst, Gillian; Vuong, Peter; Jen, Kuang-Yu; Balmain, Allan] Univ Calif San Francisco, Canc Res Inst, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Hewinson, James; Adams, David J.] Wellcome Trust Sanger Inst, Expt Canc Genet, Hinxton, England	University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; Wellcome Trust Sanger Institute	Balmain, A (corresponding author), Univ Calif San Francisco, Canc Res Inst, Helen Diller Family Comprehens Canc Ctr, Box 0128, San Francisco, CA 94143 USA.	abalmain@cc.ucsf.edu	Jen, Kuang-Yu/AAM-5429-2020; Jen, Kuang-Yu/AAM-5722-2020	Jen, Kuang-Yu/0000-0003-2815-5912; Hirst, Gillian/0000-0002-4502-0035; Adams, David/0000-0001-9490-0306	US National Cancer Institute (NCI) [UO1 CA84244, UO1 CA141455, UO1 CA176287, RO1CA184510]; Barbara Bass Bakar Distinguished Professorship in Cancer Genetics; US National Institutes of Health training grant [T32 GM007175]; NCI F31 National Research Service Award; Cancer Research UK; Wellcome Trust; Cancer Research UK [13031] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [R01CA184510, U01CA176287, U01CA084244, U01CA141455] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008568, T32GM007175] Funding Source: NIH RePORTER	US National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Barbara Bass Bakar Distinguished Professorship in Cancer Genetics; US National Institutes of Health training grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI F31 National Research Service Award; Cancer Research UK(Cancer Research UK); Wellcome Trust(Wellcome TrustEuropean Commission); Cancer Research UK(Cancer Research UK); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by US National Cancer Institute (NCI) grants UO1 CA84244 (A.B.), UO1 CA141455 (A.B.), UO1 CA176287 (A.B.) and RO1CA184510 (A.B.), and the Barbara Bass Bakar Distinguished Professorship in Cancer Genetics. K.D.H. was supported by the US National Institutes of Health training grant T32 GM007175 and is currently supported by an NCI F31 National Research Service Award (NRSA). D.J.A. is supported by Cancer Research UK and the Wellcome Trust. We thank our colleagues for their help and comments in refining this study and manuscript. We would also like to thank R. Kettleborough and R. White (both at the Wellcome Trust Sanger Institute) for assistance with MiSeq analysis and E. Wu, K. Copren and the UCSF Helen Diller Family Comprehensive Cancer Cancer Center Genome Analysis Core for assistance with Affymetrix microarrays and with sequencing.	ALDAZ CM, 1989, MOL CARCINOGEN, V2, P22, DOI 10.1002/mc.2940020104; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; BALMAIN A, 1983, NATURE, V303, P72, DOI 10.1038/303072a0; BOS JL, 1989, CANCER RES, V49, P4682; Brabletz T, 2013, NAT MED, V19, P1104, DOI 10.1038/nm.3327; Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; Carvalho BS, 2010, BIOINFORMATICS, V26, P2363, DOI 10.1093/bioinformatics/btq431; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; CHEN B, 1994, CARCINOGENESIS, V15, P2031, DOI 10.1093/carcin/15.9.2031; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Ciriello G, 2013, NAT GENET, V45, P1127, DOI 10.1038/ng.2762; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; Cox TR, 2015, NATURE, V522, P106, DOI 10.1038/nature14492; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991; Engel J, 2012, CANCER METAST REV, V31, P235, DOI 10.1007/s10555-011-9343-7; Finch JS, 1996, CARCINOGENESIS, V17, P2551, DOI 10.1093/carcin/17.12.2551; Fisher B, 2002, NEW ENGL J MED, V347, P1233, DOI 10.1056/NEJMoa022152; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; Gad H, 2014, NATURE, V508, P215, DOI 10.1038/nature13181; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Giancotti FG, 2013, CELL, V155, P750, DOI 10.1016/j.cell.2013.10.029; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Huber KVM, 2014, NATURE, V508, P222, DOI 10.1038/nature13194; Ise K, 2000, ONCOGENE, V19, P2951, DOI 10.1038/sj.onc.1203600; Klein CA, 2013, NATURE, V501, P365, DOI 10.1038/nature12628; Klein CA, 2009, NAT REV CANCER, V9, P302, DOI 10.1038/nrc2627; Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lin Z, 2010, BONE, V47, P55, DOI 10.1016/j.bone.2010.03.013; LINARDOPOULOS S, 1995, CANCER RES, V55, P5168; LOEHRKE H, 1983, CARCINOGENESIS, V4, P771, DOI 10.1093/carcin/4.6.771; Martin M., 2011, EMBNET J, V17, P10, DOI [DOI 10.14806/EJ.17.1.200, 10.14806/ej.17.1.200]; McFadden DG, 2014, CELL, V156, P1298, DOI 10.1016/j.cell.2014.02.031; Mittal D, 2014, CURR OPIN IMMUNOL, V27, P16, DOI 10.1016/j.coi.2014.01.004; Nagase H, 2003, CANCER RES, V63, P4849; Namiki T, 2011, P NATL ACAD SCI USA, V108, P6597, DOI 10.1073/pnas.1007694108; Nassar D, 2015, NAT MED, V21, P946, DOI 10.1038/nm.3878; Peinado H, 2011, SEMIN CANCER BIOL, V21, P139, DOI 10.1016/j.semcancer.2011.01.002; Pickering CR, 2014, CLIN CANCER RES, V20, P6582, DOI 10.1158/1078-0432.CCR-14-1768; Quigley D, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0669-y; Quigley DA, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r5; QUINTANILLA M, 1986, NATURE, V322, P78, DOI 10.1038/322078a0; Roth A, 2014, NAT METHODS, V11, P396, DOI [10.1038/NMETH.2883, 10.1038/nmeth.2883]; Sadej R, 2014, LAB INVEST, V94, P41, DOI 10.1038/labinvest.2013.136; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Takeda Y, 2011, BLOOD, V118, P464, DOI 10.1182/blood-2010-08-302240; Talevich E, 2014, BIORXIV, DOI [10.1101/010876, DOI 10.1101/010876]; Tsai JH, 2012, CANCER CELL, V22, P725, DOI 10.1016/j.ccr.2012.09.022; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Veronesi U, 1999, EUR J CANCER, V35, P1320, DOI 10.1016/S0959-8049(99)00133-1; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Weinstein JN, 2013, NAT GENET, V45, P1113, DOI 10.1038/ng.2764; Westcott PMK, 2015, NATURE, V517, P489, DOI 10.1038/nature13898; Wong CE, 2013, GENE DEV, V27, P670, DOI 10.1101/gad.210427.112	60	74	76	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2015	21	12					1514	+		10.1038/nm.3979	http://dx.doi.org/10.1038/nm.3979			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CX9EV	26523969	Green Accepted			2022-12-25	WOS:000366008700024
J	Moon, DH; Segal, M; Boyraz, B; Guinan, E; Hofmann, I; Cahan, P; Tai, AK; Agarwal, S				Moon, Diane H.; Segal, Matthew; Boyraz, Baris; Guinan, Eva; Hofmann, Inga; Cahan, Patrick; Tai, Albert K.; Agarwal, Suneet			Poly(A)-specific ribonuclease (PARN) mediates 3 '-end maturation of the telomerase RNA component	NATURE GENETICS			English	Article							DYSKERATOSIS-CONGENITA; PULMONARY-FIBROSIS; MUTATIONS; TERC; LENGTH; GENE; DEADENYLATION; PATHWAYS; EXOSOME; CANCER	Mutations in the PARN gene (encoding poly(A)-specific ribonuclease) cause telomere diseases including familial idiopathic pulmonary fibrosis (IPF) and dyskeratosis congenita(1,2), but how PARN deficiency impairs telomere maintenance is unclear. Here, using somatic cells and induced pluripotent stem cells (iPSCs) from patients with dyskeratosis congenita with PARN mutations, we show that PARN is required for the 3'-end maturation of the telomerase RNA component (TERC). Patient-derived cells as well as immortalized cells in which PARN is disrupted show decreased levels of TERC. Deep sequencing of TERC RNA 3' termini shows that PARN is required for removal of post-transcriptionally acquired oligo(A) tails that target nuclear RNAs for degradation. Diminished TERC levels and the increased proportion of oligo(A) forms of TERC are normalized by restoring PARN, which is limiting for TERC maturation in cells. Our results demonstrate a new role for PARN in the biogenesis of TERC and provide a mechanism linking PARN mutations to telomere diseases.	[Moon, Diane H.; Segal, Matthew; Boyraz, Baris; Hofmann, Inga; Cahan, Patrick; Agarwal, Suneet] Boston Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA; [Moon, Diane H.; Segal, Matthew; Boyraz, Baris; Agarwal, Suneet] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Moon, Diane H.; Segal, Matthew; Boyraz, Baris; Hofmann, Inga; Agarwal, Suneet] Harvard Stem Cell Inst, Boston, MA USA; [Moon, Diane H.; Segal, Matthew; Boyraz, Baris; Hofmann, Inga; Agarwal, Suneet] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Boyraz, Baris] Hacettepe Univ, Inst Canc, Dept Basic Oncol, Ankara, Turkey; [Guinan, Eva] Dana Farber Canc Inst, Dept Radiat Oncol, Boston, MA 02115 USA; [Tai, Albert K.] Tufts Univ, Sch Med, Dept Integrat Physiol & Pathobiol, Boston, MA 02111 USA	Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard University; Harvard Medical School; Hacettepe University; Harvard University; Dana-Farber Cancer Institute; Tufts University	Agarwal, S (corresponding author), Boston Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA.	suneet.agarwal@childrens.harvard.edu	Boyraz, Baris/AAK-1836-2020	Cahan, Patrick/0000-0003-3652-2540	Translational Research Program; Stem Cell Program, Boston Children's Hospital; Manton Center for Orphan Disease Research; Scientific and Technological Research Council of Turkey; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007574] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK096013] Funding Source: NIH RePORTER	Translational Research Program; Stem Cell Program, Boston Children's Hospital; Manton Center for Orphan Disease Research; Scientific and Technological Research Council of Turkey(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank the patients and their families for participation in the research; B.A. Croker, G.Q. Daley and L.I. Zon for comments on the manuscript; and K.E. Gagne for technical assistance. The work was funded in part by the Translational Research Program and the Stem Cell Program, Boston Children's Hospital (S.A.); the Manton Center for Orphan Disease Research (D.H.M.); and the Scientific and Technological Research Council of Turkey (B.B.).	Alter BP, 2009, BLOOD, V113, P6549, DOI 10.1182/blood-2008-12-192880; Armanios MY, 2007, NEW ENGL J MED, V356, P1317, DOI 10.1056/NEJMoa066157; Aubert G, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002696; Berndt H, 2012, RNA, V18, P958, DOI 10.1261/rna.032292.112; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Calado RT, 2011, HEPATOLOGY, V53, P1600, DOI 10.1002/hep.24173; Cao Y, 2008, CANCER SCI, V99, P1092, DOI 10.1111/j.1349-7006.2008.00815.x; Codd V, 2010, NAT GENET, V42, P197, DOI 10.1038/ng.532; Cristofari G, 2006, EMBO J, V25, P565, DOI 10.1038/sj.emboj.7600952; Dehlin E, 2000, EMBO J, V19, P1079, DOI 10.1093/emboj/19.5.1079; Egan ED, 2012, MOL CELL BIOL, V32, P2428, DOI 10.1128/MCB.00286-12; FENG JL, 1995, SCIENCE, V269, P1236, DOI 10.1126/science.7544491; Fu D, 2003, MOL CELL, V11, P1361, DOI 10.1016/S1097-2765(03)00196-5; Goldfarb KC, 2013, BMC MOL BIOL, V14, DOI 10.1186/1471-2199-14-23; Greider CW, 2006, COLD SPRING HARB SYM, V71, P225, DOI 10.1101/sqb.2006.71.063; Hao LY, 2005, CELL, V123, P1121, DOI 10.1016/j.cell.2005.11.020; Heiss NS, 1998, NAT GENET, V19, P32, DOI 10.1038/ng0598-32; Houseley J, 2009, CELL, V136, P763, DOI 10.1016/j.cell.2009.01.019; Jongmans MCJ, 2012, AM J HUM GENET, V90, P426, DOI 10.1016/j.ajhg.2012.01.004; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Kirwan M, 2009, HUM MUTAT, V30, P1567, DOI 10.1002/humu.21115; Kirwan M, 2009, BRIT J HAEMATOL, V144, P771, DOI 10.1111/j.1365-2141.2008.07516.x; Kiss T, 2010, MOL CELL, V37, P597, DOI 10.1016/j.molcel.2010.01.032; Korner CG, 1997, J BIOL CHEM, V272, P10448; Korner CG, 1998, EMBO J, V17, P5427, DOI 10.1093/emboj/17.18.5427; LaCava J, 2005, CELL, V121, P713, DOI 10.1016/j.cell.2005.04.029; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Lee JE, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002901; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Mason PJ, 2015, J CLIN INVEST, V125, P1796, DOI 10.1172/JCI81506; Mitchell JR, 1999, MOL CELL BIOL, V19, P567; Mitchell JR, 1999, NATURE, V402, P551, DOI 10.1038/990141; Park IH, 2008, NAT PROTOC, V3, P1180, DOI 10.1038/nprot.2008.92; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Patro R., 2015, 021592 BIORXIV; Rammelt C, 2011, RNA, V17, P1737, DOI 10.1261/rna.2787011; Schmidt K, 2013, WIRES RNA, V4, P217, DOI 10.1002/wrna.1155; Soder AI, 1997, ONCOGENE, V14, P1013, DOI 10.1038/sj.onc.1201066; Soerensen M, 2012, AGING CELL, V11, P223, DOI 10.1111/j.1474-9726.2011.00775.x; Stuart BD, 2015, NAT GENET, V47, P512, DOI 10.1038/ng.3278; Trapp S, 2006, J EXP MED, V203, P1307, DOI 10.1084/jem.20052240; Tsakiri KD, 2007, P NATL ACAD SCI USA, V104, P7552, DOI 10.1073/pnas.0701009104; Tummala H, 2015, J CLIN INVEST, V125, P2151, DOI 10.1172/JCI78963; Venteicher AS, 2009, SCIENCE, V323, P644, DOI 10.1126/science.1165357; Virtanen A, 2013, CRIT REV BIOCHEM MOL, V48, P192, DOI 10.3109/10409238.2013.771132; Vulliamy T, 2001, NATURE, V413, P432, DOI 10.1038/35096585; Vulliamy T, 2008, P NATL ACAD SCI USA, V105, P8073, DOI 10.1073/pnas.0800042105; Walne AJ, 2007, HUM MOL GENET, V16, P1619, DOI 10.1093/hmg/ddm111; Warlich E, 2011, MOL THER, V19, P782, DOI 10.1038/mt.2010.314; Westin ER, 2007, AGING CELL, V6, P383, DOI 10.1111/j.1474-9726.2007.00288.x; Wong JMY, 2006, GENE DEV, V20, P2848, DOI 10.1101/gad.1476206; Yamaguchi H, 2003, BLOOD, V102, P916, DOI 10.1182/blood-2003-01-0335; Yoda M, 2013, CELL REP, V5, P715, DOI 10.1016/j.celrep.2013.09.029; Zaug AJ, 1996, NUCLEIC ACIDS RES, V24, P532, DOI 10.1093/nar/24.3.532	54	105	108	0	10	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2015	47	12					1482	+		10.1038/ng.3423	http://dx.doi.org/10.1038/ng.3423			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CX6LT	26482878	Green Accepted			2022-12-25	WOS:000365813200022
J	Nuccio, ML; Wu, J; Mowers, R; Zhou, HP; Meghji, M; Primavesi, LF; Paul, MJ; Chen, X; Gao, Y; Haque, E; Basu, SS; Lagrimini, LM				Nuccio, Michael L.; Wu, Jeff; Mowers, Ron; Zhou, Hua-Ping; Meghji, Moez; Primavesi, Lucia F.; Paul, Matthew J.; Chen, Xi; Gao, Yan; Haque, Emdadul; Basu, Shib Sankar; Lagrimini, L. Mark			Expression of trehalose-6-phosphate phosphatase in maize ears improves yield in well-watered and drought conditions	NATURE BIOTECHNOLOGY			English	Article							ABIOTIC STRESS TOLERANCE; TREHALOSE 6-PHOSPHATE; KERNEL SET; CARBOHYDRATE-METABOLISM; TRANSGENIC RICE; GRAIN-YIELD; PLANTS; GENE; IDENTIFICATION; ACCUMULATION	Maize, the highest-yielding cereal crop worldwide, is particularly susceptible to drought during its 2- to 3-week flowering period. Many genetic engineering strategies for drought tolerance impinge on plant development, reduce maximum yield potential or do not translate from laboratory conditions to the field. We overexpressed a gene encoding a rice trehalose-6-phosphate phosphatase (TPP) in developing maize ears using a floral promoter. This reduced the concentration of trehalose-6-phosphate (T6P), a sugar signal that regulates growth and development, and increased the concentration of sucrose in ear spikelets. Overexpression of TPP increased both kernel set and harvest index. Field data at several sites and over multiple seasons showed that the engineered trait improved yields from 9% to 49% under non-drought or mild drought conditions, and from 31% to 123% under more severe drought conditions, relative to yields from nontransgenic controls.	[Nuccio, Michael L.; Zhou, Hua-Ping; Chen, Xi; Gao, Yan; Haque, Emdadul; Basu, Shib Sankar] Syngenta Crop Protect LLC, Res Triangle Pk, NC 27709 USA; [Wu, Jeff; Mowers, Ron; Meghji, Moez] Syngenta Seeds Inc, Slater, IA USA; [Primavesi, Lucia F.; Paul, Matthew J.] Rothamsted Res, Plant Biol & Crop Sci, Harpenden, Herts, England; [Lagrimini, L. Mark] Univ Nebraska, Dept Agron & Hort, Lincoln, NE USA	Syngenta; Syngenta; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; University of Nebraska System; University of Nebraska Lincoln	Nuccio, ML (corresponding author), Syngenta Crop Protect LLC, Res Triangle Pk, NC 27709 USA.	michael.nuccio@syngenta.com	Paul, Matthew J/R-6384-2016	Paul, Matthew J/0000-0002-2001-961X; Primavesi, Lucia/0000-0003-3719-4569	Biotechnological and Biological Sciences Research Council of the U.K.; BBSRC [BBS/E/C/00005997, BBS/E/C/00005202] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005997, BBS/E/C/00005202] Funding Source: researchfish	Biotechnological and Biological Sciences Research Council of the U.K.; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank E. Cates and M. Yarnall for technical assistance. L. Payan, C. Chaulk-Grace and L. Mansur managed the field trial locations. We also thank our Syngenta colleagues for their enthusiasm and support of this work. We thank M.-D. Chilton and the anonymous reviewers for helpful comments. Trehalose metabolite measurements were done by Metabolon. Rothamsted Research receives strategic funding from the Biotechnological and Biological Sciences Research Council of the U.K.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Araus JL, 2002, ANN BOT-LONDON, V89, P925, DOI 10.1093/aob/mcf049; Araus JL, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00305; Arora R, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-242; Barker T, 2005, PL BRED RE, V25, P173; Bartels D, 2001, PLANT PHYSIOL, V127, P1346, DOI 10.1104/pp.010765; BIANCHI G, 1993, PHYSIOL PLANTARUM, V87, P223, DOI 10.1111/j.1399-3054.1993.tb00146.x; Boyer JS, 2007, J EXP BOT, V58, P267, DOI 10.1093/jxb/erl177; Boyer JS, 2004, J EXP BOT, V55, P2385, DOI 10.1093/jxb/erh219; BOYER JS, 1982, SCIENCE, V218, P443, DOI 10.1126/science.218.4571.443; Campos H, 2004, FIELD CROP RES, V90, P19, DOI 10.1016/j.fcr.2004.07.003; Castiglioni P, 2008, PLANT PHYSIOL, V147, P446, DOI 10.1104/pp.108.118828; Cattivelli L, 2008, FIELD CROP RES, V105, P1, DOI 10.1016/j.fcr.2007.07.004; Cortina C, 2005, PLANT SCI, V169, P75, DOI 10.1016/j.plantsci.2005.02.026; Dreni L, 2007, PLANT J, V52, P690, DOI 10.1111/j.1365-313X.2007.03272.x; Elliott J., 2013, 1301 RDCEP GRANTH RE; Garg AK, 2002, P NATL ACAD SCI USA, V99, P15898, DOI 10.1073/pnas.252637799; Goff SA, 2002, SCIENCE, V296, P92, DOI 10.1126/science.1068275; Grassini P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3918; Habben JE, 2014, PLANT BIOTECHNOL J, V12, P685, DOI 10.1111/pbi.12172; Holmstrom KO, 1996, NATURE, V379, P683, DOI 10.1038/379683a0; Ingham DJ, 2001, BIOTECHNIQUES, V31, P132, DOI 10.2144/01311rr04; Jang IC, 2003, PLANT PHYSIOL, V131, P516, DOI 10.1104/pp.007237; Jones B, 2011, WIRES COMPUT STAT, V3, P188, DOI 10.1002/wics.162; Karim S, 2007, PLANT MOL BIOL, V64, P371, DOI 10.1007/s11103-007-9159-6; Kim JY, 2000, PLANT PHYSIOL, V124, P71, DOI 10.1104/pp.124.1.71; Lee SB, 2003, MOL BREEDING, V11, P1, DOI 10.1023/A:1022100404542; Li HF, 2010, CELL RES, V20, P299, DOI 10.1038/cr.2009.143; Li HW, 2011, PLANTA, V234, P1007, DOI 10.1007/s00425-011-1458-0; Lopez-Dee ZP, 1999, DEV GENET, V25, P237, DOI 10.1002/(SICI)1520-6408(1999)25:3&lt;237::AID-DVG6&gt;3.0.CO;2-L; Martinez-Barajas E, 2011, PLANT PHYSIOL, V156, P373, DOI 10.1104/pp.111.174524; Masuka B, 2012, J INTEGR PLANT BIOL, V54, P238, DOI 10.1111/j.1744-7909.2012.01118.x; Miranda JA, 2007, PLANTA, V226, P1411, DOI 10.1007/s00425-007-0579-y; Moon YH, 1999, PLANT MOL BIOL, V40, P167, DOI 10.1023/A:1026429922616; Morsy M, 2015, J INVESTIG GENOMICS, V2, P2, DOI DOI 10.15406/JIG.2015.02.00015; Negrotto D, 2000, PLANT CELL REP, V19, P798, DOI 10.1007/s002999900187; Nelson DE, 2007, P NATL ACAD SCI USA, V104, P16450, DOI 10.1073/pnas.0707193104; Nuccio M, 2015, RECENT ADV GENE EXPR, P41, DOI DOI 10.1007/978-1-4939-2202-4_2; Nunes C, 2013, PLANT PHYSIOL, V162, P1720, DOI 10.1104/pp.113.220657; Nunes C, 2013, PLANT PHYSIOL BIOCH, V63, P89, DOI 10.1016/j.plaphy.2012.11.011; Paul MJ, 2008, ANNU REV PLANT BIOL, V59, P417, DOI 10.1146/annurev.arplant.59.032607.092945; Paul MJ, 2010, PLANT SIGNAL BEHAV, V5, P386, DOI 10.4161/psb.5.4.10792; Pelleschi S, 1997, PLANT CELL ENVIRON, V20, P493, DOI 10.1046/j.1365-3040.1997.d01-89.x; PILONSMITS EAH, 1995, PLANT PHYSIOL, V107, P125, DOI 10.1104/pp.107.1.125; Pramanik MHR, 2005, PLANT MOL BIOL, V58, P751, DOI 10.1007/s11103-005-7404-4; Ray DK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066428; Richards RA, 2000, J EXP BOT, V51, P447, DOI 10.1093/jexbot/51.suppl_1.447; Romero C, 1997, PLANTA, V201, P293, DOI 10.1007/s004250050069; Ruan YL, 2010, MOL PLANT, V3, P942, DOI 10.1093/mp/ssq044; Saini H. S., 1999, ADV AGRON, V68, P59, DOI [10.1016/S0065-2113(08)60843-3, DOI 10.1016/S0065-2113(08)60843-3]; SAS Institute, 2009, JMP 8 STAT GRAPH GUI; Satoh-Nagasawa N, 2006, NATURE, V441, P227, DOI 10.1038/nature04725; Schluepmann H, 2003, P NATL ACAD SCI USA, V100, P6849, DOI 10.1073/pnas.1132018100; Schluepmann H., 2009, ARABIDOPSIS BOOK, V7, pe0122; Schluepmann H, 2012, J EXP BOT, V63, P3379, DOI 10.1093/jxb/err311; SCHUSSLER JR, 1995, CROP SCI, V35, P1074, DOI 10.2135/cropsci1995.0011183X003500040026x; SCHUSSLER JR, 1991, CROP SCI, V31, P1189, DOI 10.2135/cropsci1991.0011183X003100050023x; SCHUSSLER JR, 1991, CROP SCI, V31, P1196, DOI 10.2135/cropsci1991.0011183X003100050024x; Schwachtje J, 2006, P NATL ACAD SCI USA, V103, P12935, DOI 10.1073/pnas.0602316103; Shima S, 2007, FEBS J, V274, P1192, DOI 10.1111/j.1742-4658.2007.05658.x; Snedecor G.W., 1989, AMES IOWA STATE U PR; Van Houtte H, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.23209; Virlouvet L, 2011, PLANT PHYSIOL, V157, P917, DOI 10.1104/pp.111.176818; Vogel G, 1998, PLANT J, V13, P673, DOI 10.1046/j.1365-313X.1998.00064.x; Xiao BZ, 2009, MOL PLANT, V2, P73, DOI 10.1093/mp/ssn068; Yadav UP, 2014, J EXP BOT, V65, P1051, DOI 10.1093/jxb/ert457; Yeo ET, 2000, MOL CELLS, V10, P263; Yu H, 2000, PLANT PHYSIOL, V123, P1325, DOI 10.1104/pp.123.4.1325; Zhang J, 2010, PLANT J, V64, P604, DOI 10.1111/j.1365-313X.2010.04354.x; Zhang YH, 2009, PLANT PHYSIOL, V149, P1860, DOI 10.1104/pp.108.133934; ZINSELMEIER C, 1995, CROP SCI, V35, P1390, DOI 10.2135/cropsci1995.0011183X003500050022x; ZINSELMEIER C, 1995, PLANT PHYSIOL, V107, P385, DOI 10.1104/pp.107.2.385	72	247	260	21	271	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2015	33	8					862	+		10.1038/nbt.3277	http://dx.doi.org/10.1038/nbt.3277			13	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CO6OB	26473199				2022-12-25	WOS:000359274900026
J	Martell, JD; Yamagata, M; Deerinck, TJ; Phan, S; Kwa, CG; Ellisman, MH; Sanes, JR; Ting, AY				Martell, Jeffrey D.; Yamagata, Masahito; Deerinck, Thomas J.; Phan, Sebastien; Kwa, Carolyn G.; Ellisman, Mark H.; Sanes, Joshua R.; Ting, Alice Y.			A split horseradish peroxidase for the detection of intercellular protein-protein interactions and sensitive visualization of synapses	NATURE BIOTECHNOLOGY			English	Letter							LIVING CELLS; IN-VIVO; EXPRESSION; FLUORESCENCE; CONNECTIONS; STRATEGY; ENZYMES; MARKER	Intercellular protein-protein interactions (PPIs) enable communication between cells in diverse biological processes, including cell proliferation, immune responses, infection, and synaptic transmission, but they are challenging to visualize because existing techniques(1-3) have insufficient sensitivity and/or specificity. Here we report a split horseradish peroxidase (sHRP) as a sensitive and specific tool for the detection of intercellular PPIs. The two sHRP fragments, engineered through screening of 17 cut sites in HRP followed by directed evolution, reconstitute into an active form when driven together by an intercellular PPI, producing bright fluorescence or contrast for electron microscopy. Fusing the sHRP fragments to the proteins neurexin (NRX) and neuroligin (NLG), which bind each other across the synaptic cleft(4), enabled sensitive visualization of synapses between specific sets of neurons, including two classes of synapses in the mouse visual system. sHRP should be widely applicable to studying mechanisms of communication between a variety of cell types.	[Martell, Jeffrey D.; Kwa, Carolyn G.; Ting, Alice Y.] MIT, Dept Chem, Cambridge, MA 02139 USA; [Yamagata, Masahito; Sanes, Joshua R.] Harvard Univ, Ctr Brain Sci, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Deerinck, Thomas J.; Phan, Sebastien; Ellisman, Mark H.] Univ Calif San Diego, Ctr Res Biol Syst, Natl Ctr Microscopy & Imaging Res, San Diego, CA 92103 USA; [Ellisman, Mark H.] Univ Calif San Diego, Dept Neurosci, San Diego, CA 92103 USA; [Ellisman, Mark H.] Salk Inst Biol Studies, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA	Massachusetts Institute of Technology (MIT); Harvard University; University of California System; University of California San Diego; University of California System; University of California San Diego; Salk Institute	Ting, AY (corresponding author), MIT, Dept Chem, Cambridge, MA 02139 USA.; Sanes, JR (corresponding author), Harvard Univ, Ctr Brain Sci, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.	sanesj@mcb.harvard.edu; ating@mit.edu	Yamagata, Masahito/H-6695-2016	Yamagata, Masahito/0000-0001-8193-2931; Ting, Alice/0000-0002-8277-5226	US National Institutes of Health [R01-CA186568, R37NS029169, P41 GM103412, R01GM086197]; Howard Hughes Medical Institute Collaborative Initiative Award; NSFGR fellowship; NDSEG fellowship; NATIONAL CANCER INSTITUTE [R01CA186568] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086197, P41GM103412] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS029169] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute Collaborative Initiative Award; NSFGR fellowship; NDSEG fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank J. Einstein (MIT) for preparing neuron cultures. W. Wang (MIT) provided yeast expressing the LAP peptide and gave helpful advice for yeast display and AAV preparation. P. Stawski, K. Cox, and K. Loh (MIT) provided synaptic fluorescent protein fusion plasmids. F. Touti and H.-W. Rhee (MIT) synthesized biotin-phenol. FACS experiments were performed at the Koch Institute Flow Cytometry Core (MIT). Funding was provided by the US National Institutes of Health (R01-CA186568 to A.Y.T.; R37NS029169 to J.R.S.; P41 GM103412 and R01GM086197 to M.H.E.) and the Howard Hughes Medical Institute Collaborative Initiative Award (A.Y.T. and J.R.S.). J.D.M. was supported by NSFGR and NDSEG fellowships.	Arac D, 2007, NEURON, V56, P992, DOI 10.1016/j.neuron.2007.12.002; Atasoy D, 2008, J NEUROSCI, V28, P7025, DOI 10.1523/JNEUROSCI.1954-08.2008; Azevedo AM, 2003, BIOTECHNOL ANN REV, V9, P199, DOI 10.1016/S1387-2656(03)09003-3; Chalupa LM, 2008, EYE RETINA VISUAL SY; Chao G, 2006, NAT PROTOC, V1, P755, DOI 10.1038/nprot.2006.94; Chen I, 2011, P NATL ACAD SCI USA, V108, P11399, DOI 10.1073/pnas.1101046108; Chen Y, 2014, NEURON, V81, P280, DOI 10.1016/j.neuron.2013.12.021; Choi JW, 1996, SCIENCE, V273, P239, DOI 10.1126/science.273.5272.239; Colby DW, 2004, METHOD ENZYMOL, V388, P348; Craig AM, 2007, CURR OPIN NEUROBIOL, V17, P43, DOI 10.1016/j.conb.2007.01.011; Feinberg EH, 2008, NEURON, V57, P353, DOI 10.1016/j.neuron.2007.11.030; Galarneau A, 2002, NAT BIOTECHNOL, V20, P619, DOI 10.1038/nbt0602-619; Guo P, 2012, J VIROL METHODS, V183, P139, DOI 10.1016/j.jviromet.2012.04.004; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hong YK, 2011, J COMP NEUROL, V519, P1691, DOI 10.1002/cne.22595; Jagadish S, 2014, NEURON, V83, P630, DOI 10.1016/j.neuron.2014.06.025; Kato S, 2011, J NEUROSCI, V31, P17169, DOI 10.1523/JNEUROSCI.4005-11.2011; Kim J, 2012, NAT METHODS, V9, P96, DOI [10.1038/NMETH.1784, 10.1038/nmeth.1784]; Kim SA, 2011, P NATL ACAD SCI USA, V108, P9857, DOI 10.1073/pnas.1019003108; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Kugler S, 2001, MOL CELL NEUROSCI, V17, P78, DOI 10.1006/mcne.2000.0929; Lam SS, 2015, NAT METHODS, V12, P51, DOI 10.1038/nmeth.3179; Lawrence A, 2006, J STRUCT BIOL, V154, P144, DOI 10.1016/j.jsb.2005.12.012; Li JL, 2010, FRONT NEURAL CIRCUIT, V4, DOI 10.3389/neuro.04.006.2010; Li XW, 2014, J BIOL CHEM, V289, P14434, DOI 10.1074/jbc.M113.529578; Lin ZL, 1999, BIOTECHNOL PROGR, V15, P467, DOI 10.1021/bp990037r; Liu DS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052823; Looke M, 2011, BIOTECHNIQUES, V50, P325, DOI 10.2144/000113672; Luker KE, 2004, P NATL ACAD SCI USA, V101, P12288, DOI 10.1073/pnas.0404041101; Martell JD, 2012, NAT BIOTECHNOL, V30, P1143, DOI 10.1038/nbt.2375; McClure C, 2011, JOVE-J VIS EXP, DOI 10.3791/3348; Michnick SW, 2007, NAT REV DRUG DISCOV, V6, P569, DOI 10.1038/nrd2311; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Pinaud F, 2011, P NATL ACAD SCI USA, V108, pE201, DOI 10.1073/pnas.1101929108; PORSTMANN B, 1985, J IMMUNOL METHODS, V79, P27, DOI 10.1016/0022-1759(85)90388-6; Remy I, 2006, NAT METHODS, V3, P977, DOI 10.1038/nmeth979; Rhee HW, 2013, SCIENCE, V339, P1328, DOI 10.1126/science.1230593; Rossi F, 1997, P NATL ACAD SCI USA, V94, P8405, DOI 10.1073/pnas.94.16.8405; Shekhawat SS, 2011, CURR OPIN CHEM BIOL, V15, P789, DOI 10.1016/j.cbpa.2011.10.014; Tsetsenis T, 2014, J NEUROSCI, V34, P15083, DOI 10.1523/JNEUROSCI.0348-14.2014; Wickersham IR, 2012, CURR OPIN NEUROBIOL, V22, P121, DOI 10.1016/j.conb.2011.12.001; Wilkinson B, 2004, BBA-PROTEINS PROTEOM, V1699, P35, DOI 10.1016/j.bbapap.2004.02.017; Yamagata M, 2012, J NEUROSCI, V32, P14402, DOI 10.1523/JNEUROSCI.3193-12.2012; Yamagata M, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00018	44	97	101	1	100	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2016	34	7					774	+		10.1038/nbt.3563	http://dx.doi.org/10.1038/nbt.3563			12	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DT2TT	27240195	Green Submitted, Green Accepted			2022-12-25	WOS:000381335400033
J	Cui, X; Lu, FL; Qiu, Q; Zhou, B; Gu, LF; Zhang, SB; Kang, YY; Cui, XK; Ma, X; Yao, QQ; Ma, JB; Zhang, XY; Cao, XF				Cui, Xia; Lu, Falong; Qiu, Qi; Zhou, Bing; Gu, Lianfeng; Zhang, Shuaibin; Kang, Yanyuan; Cui, Xiekui; Ma, Xuan; Yao, Qingqing; Ma, Jinbiao; Zhang, Xiaoyu; Cao, Xiaofeng			REF6 recognizes a specific DNA sequence to demethylate H3K27me3 and regulate organ boundary formation in Arabidopsis	NATURE GENETICS			English	Article							TRANSCRIPTION FACTORS; SHOOT MERISTEM; GENE; PROTEINS; POLYCOMB; ALIGNMENT; DYNAMICS; IDENTITY; NETWORK; JMJ14	RELATIVE OF EARLY FLOWERING 6 (REF6, also known as JMJ12) counteracts Polycomb-mediated gene silencing by removing methyl groups from trimethylated histone H3 lysine 27 (H3K27me3) in hundreds of genes in Arabidopsis thaliana(1). Here we show that REF6 function and genome-wide targeting require its four Cys(2)His(2) zinc fingers, which directly recognize a CTCTGYTY motif. Motifs bound by REF6 tend to cluster and reside in loci with active chromatin states. Furthermore, REF6 targets CUP-SHAPED COTYLEDON 1 (CUC1), which harbors CTCTGYTY motifs, to modulate H3K27me3 levels and activate CUC1 expression. Loss of REF6 causes CUC1 repression and defects in cotyledon separation. In contrast, REF6 does not bind CUC2, encoding a close homolog of CUC1, which lacks the CTCTGYTY motif. Collectively, these results identify a new targeting mechanism of an H3K27 demethylase to counteract Polycomb-mediated gene silencing that regulates plant development, including organ boundary formation.	[Cui, Xia; Lu, Falong; Qiu, Qi; Zhou, Bing; Gu, Lianfeng; Zhang, Shuaibin; Kang, Yanyuan; Cui, Xiekui; Ma, Xuan; Cao, Xiaofeng] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Plant Genom, Beijing, Peoples R China; [Cui, Xia; Lu, Falong; Qiu, Qi; Zhou, Bing; Gu, Lianfeng; Zhang, Shuaibin; Kang, Yanyuan; Cui, Xiekui; Ma, Xuan; Cao, Xiaofeng] Chinese Acad Sci, Inst Genet & Dev Biol, Natl Ctr Plant Gene Res, Beijing, Peoples R China; [Lu, Falong; Zhang, Shuaibin; Kang, Yanyuan; Cui, Xiekui] Univ Chinese Acad Sci, Beijing, Peoples R China; [Ma, Xuan] Shenzhen Univ, Coll Life Sci, Shenzhen Key Lab Microbial Genet Engn, Shenzhen, Peoples R China; [Yao, Qingqing; Ma, Jinbiao; Cao, Xiaofeng] Fudan Univ, Sch Life Sci, Shanghai 200433, Peoples R China; [Yao, Qingqing; Ma, Jinbiao; Cao, Xiaofeng] Collaborat Innovat Ctr Genet & Dev, Shanghai, Peoples R China; [Zhang, Xiaoyu; Cao, Xiaofeng] Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA; [Cao, Xiaofeng] Chinese Acad Sci, Inst Genet & Dev Biol, CAS Ctr Excellence Mol Plant Sci, Beijing, Peoples R China; [Cui, Xia] Chinese Acad Agr Sci, Inst Vegetables & Flowers, Beijing 100193, Peoples R China; [Lu, Falong] Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA USA; [Zhou, Bing] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Gu, Lianfeng] Fujian Agr & Forestry Univ, Haixia Inst Sci & Technol, Fuzhou, Peoples R China	Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Shenzhen University; Fudan University; University System of Georgia; University of Georgia; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Chinese Academy of Agricultural Sciences; Institute of Vegetables & Flowers, CAAS; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); University of California System; University of California San Diego; Fujian Agriculture & Forestry University	Cao, XF (corresponding author), Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Plant Genom, Beijing, Peoples R China.; Cao, XF (corresponding author), Chinese Acad Sci, Inst Genet & Dev Biol, Natl Ctr Plant Gene Res, Beijing, Peoples R China.; Cao, XF (corresponding author), Collaborat Innovat Ctr Genet & Dev, Shanghai, Peoples R China.; Cao, XF (corresponding author), Chinese Acad Sci, Inst Genet & Dev Biol, CAS Ctr Excellence Mol Plant Sci, Beijing, Peoples R China.	xfcao@genetics.ac.cn	Lu, Falong/Q-3013-2016; Zhang, xiaoyu/GXA-3206-2022	Lu, Falong/0000-0002-8321-4818; Zhou, Bing/0000-0003-2846-1813	National Basic Research Program of China [2013CB967300, 2013CB835200]; National Natural Science Foundation of China [31210103901, 31271363, 31428011]; State Key Laboratory of Plant Genomics [2014B0227-01, 2015B0129-01]; National Science Foundation [0960425]; China Postdoctoral Science Foundation [2012M520020, 2014M550874, 2014M550101]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Plant Genomics; National Science Foundation(National Science Foundation (NSF)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	We thank Q. Zhu for technical assistance and W. Qian for discussion. We thank the Arabidopsis Biological Resource Center for providing T-DNA insertion lines. This work was supported by the National Basic Research Program of China (grants 2013CB967300 to Xia Cui and 2013CB835200 to X. Cao), the National Natural Science Foundation of China (grants 31210103901 to X. Cao, 31271363 to Xia Cui, and 31428011 to X.Z.), and the State Key Laboratory of Plant Genomics (2014B0227-01 and 2015B0129-01). Research in the laboratory of X.Z. was supported by National Science Foundation grant 0960425. B.Z., Xiekui Cui, and X.M. were supported by the China Postdoctoral Science Foundation (2012M520020, 2014M550874, and 2014M550101, respectively).	Aida M, 1997, PLANT CELL, V9, P841, DOI 10.1105/tpc.9.6.841; Albert VA, 2013, SCIENCE, V342, P1467, DOI 10.1126/science.1241089; Bailey TL, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks433; Bowler C, 2004, PLANT J, V39, P776, DOI 10.1111/j.1365-313X.2004.02169.x; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Coleman-Derr D, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002988; Crevillen P, 2014, NATURE, V515, P587, DOI 10.1038/nature13722; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Finnegan EJ, 2007, CURR BIOL, V17, P1978, DOI 10.1016/j.cub.2007.10.026; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Hibara K, 2006, PLANT CELL, V18, P2946, DOI 10.1105/tpc.106.045716; Holec S, 2012, PLANT PHYSIOL, V158, P35, DOI 10.1104/pp.111.186445; Hou XL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5601; Inagaki S, 2010, EMBO J, V29, P3496, DOI 10.1038/emboj.2010.227; Johnson M, 2008, NUCLEIC ACIDS RES, V36, pW5, DOI 10.1093/nar/gkn201; Klug A, 2010, ANNU REV BIOCHEM, V79, P213, DOI 10.1146/annurev-biochem-010909-095056; Lafos M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002040; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Larsson AS, 1998, GENETICS, V149, P597; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Lin RC, 2007, SCIENCE, V318, P1302, DOI 10.1126/science.1146281; Lu FL, 2008, J INTEGR PLANT BIOL, V50, P886, DOI 10.1111/j.1744-7909.2008.00692.x; Lu FL, 2011, NAT GENET, V43, P715, DOI 10.1038/ng.854; Lu FL, 2010, CELL RES, V20, P387, DOI 10.1038/cr.2010.27; Machanick P, 2011, BIOINFORMATICS, V27, P1696, DOI 10.1093/bioinformatics/btr189; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Najafabadi HS, 2015, NAT BIOTECHNOL, V33, P555, DOI 10.1038/nbt.3128; Noh B, 2004, PLANT CELL, V16, P2601, DOI 10.1105/tpc.104.025353; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Steffen PA, 2014, NAT REV MOL CELL BIO, V15, P340, DOI 10.1038/nrm3789; Sullivan AM, 2014, CELL REP, V8, P2015, DOI 10.1016/j.celrep.2014.08.019; Sun B, 2014, SCIENCE, V343, P505, DOI 10.1126/science.1248559; Sun Y, 2010, DEV CELL, V19, P765, DOI 10.1016/j.devcel.2010.10.010; Takada S, 2001, DEVELOPMENT, V128, P1127; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; van Dijk K, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-238; Vroemen CW, 2003, PLANT CELL, V15, P1563, DOI 10.1105/tpc.012203; Wu MF, 2012, P NATL ACAD SCI USA, V109, P3576, DOI 10.1073/pnas.1113409109; Yu XF, 2008, P NATL ACAD SCI USA, V105, P7618, DOI 10.1073/pnas.0802254105; Yu XF, 2011, PLANT J, V65, P634, DOI 10.1111/j.1365-313X.2010.04449.x; Zhang SB, 2015, CELL DISCOV, V1, DOI 10.1038/celldisc.2015.3; Zhang XY, 2007, PLOS BIOL, V5, P1026, DOI 10.1371/journal.pbio.0050129; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	44	96	99	3	119	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2016	48	6					694	+		10.1038/ng.3556	http://dx.doi.org/10.1038/ng.3556			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DN0HE	27111035				2022-12-25	WOS:000376744200019
J	Nguyen, MK; Kim, CY; Kim, JM; Park, BO; Lee, S; Park, H; Heo, WD				Mai Khanh Nguyen; Kim, Cha Yeon; Kim, Jin Man; Park, Byung Ouk; Lee, Sangkyu; Park, Hyerim; Heo, Won Do			Optogenetic oligomerization of Rab GTPases regulates intracellular membrane trafficking	NATURE CHEMICAL BIOLOGY			English	Article							GROWTH-FACTOR; ENDOCYTIC TRAFFICKING; TRANSFERRIN RECEPTOR; LIVING CELLS; AXON GROWTH; PC12 CELLS; BLUE-LIGHT; ACTIVATION; TRANSPORT; ENDOSOME	Intracellular membrane trafficking, which is involved in diverse cellular processes, is dynamic and difficult to study in a spatiotemporal manner. Here we report an optogenetic strategy, termed light-activated reversible inhibition by assembled trap of intracellular membranes (IM-LARIAT), that uses various Rab GTPases combined with blue-light-induced hetero-interaction between cryptochrome 2 and CIB1. In this system, illumination induces a rapid and reversible intracellular membrane aggregation that disrupts the dynamics and functions of the targeted membrane. We applied IM-LARIAT to specifically perturb several Rab-mediated trafficking processes, including receptor transport, protein sorting and secretion, and signaling initiated from endosomes. We finally used this tool to reveal different functions of local Rab5-mediated and Rab11-mediated membrane trafficking in growth cones and soma of young hippocampal neurons. Our results show that IM-LARIAT is a versatile tool that can be used to dissect spatiotemporal functions of intracellular membranes in diverse systems.	[Mai Khanh Nguyen; Park, Hyerim; Heo, Won Do] Korea Adv Inst Sci & Technol, Dept Biol Sci, Daejeon, South Korea; [Kim, Cha Yeon] Korea Adv Inst Sci & Technol, Grad Sch Nanosci & Technol, Daejeon, South Korea; [Kim, Jin Man] Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, Daejeon, South Korea; [Park, Byung Ouk; Lee, Sangkyu; Heo, Won Do] Inst for Basic Sci Korea, Ctr Cognit & Social, Daejeon, South Korea; [Heo, Won Do] Korea Adv Inst Sci & Technol, Inst BioCentury, Daejeon, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); Institute for Basic Science - Korea (IBS); Korea Advanced Institute of Science & Technology (KAIST)	Heo, WD (corresponding author), Korea Adv Inst Sci & Technol, Dept Biol Sci, Daejeon, South Korea.; Heo, WD (corresponding author), Inst for Basic Sci Korea, Ctr Cognit & Social, Daejeon, South Korea.; Heo, WD (corresponding author), Korea Adv Inst Sci & Technol, Inst BioCentury, Daejeon, South Korea.	wondo@kaist.ac.kr	Heo, Won-Do/C-1696-2011; PARK, BYUNG OUK/AAB-3590-2020	Kim, Jin Man/0000-0002-4751-7125; Lee, Sangkyu/0000-0002-6916-3372	Institute for Basic Science [IBS-R001-G1]; KAIST Institute for the BioCentury, Republic of Korea; Intelligent Synthetic Biology Center of the Global Frontier Project - Ministry of Science, ICT and Future Planning, Republic of Korea [20110031955]	Institute for Basic Science; KAIST Institute for the BioCentury, Republic of Korea; Intelligent Synthetic Biology Center of the Global Frontier Project - Ministry of Science, ICT and Future Planning, Republic of Korea	We thank N. Kim, H. Lee and M. Lee for helpful discussions, and D. Woo, H. Jung and S. Kim for technical assistance in neuron culture. This work was supported by the Institute for Basic Science (no. IBS-R001-G1); KAIST Institute for the BioCentury, Republic of Korea; and the Intelligent Synthetic Biology Center of the Global Frontier Project (20110031955) funded by the Ministry of Science, ICT and Future Planning, Republic of Korea.	Barbieri MA, 2004, EUR J CELL BIOL, V83, P305, DOI 10.1078/0171-9335-00381; Bugaj LJ, 2013, NAT METHODS, V10, P249, DOI 10.1038/nmeth.2360; Ceresa BP, 2006, J BIOL CHEM, V281, P1099, DOI 10.1074/jbc.M504175200; Chang KY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5057; Chen D, 2013, J CELL BIOL, V201, P631, DOI 10.1083/jcb.201210119; Dou ZX, 2013, MOL CELL, V50, P29, DOI 10.1016/j.molcel.2013.01.022; Duan LT, 2015, CHEM BIOL, V22, P671, DOI 10.1016/j.chembiol.2015.04.014; Eva R, 2010, J NEUROSCI, V30, P11654, DOI 10.1523/JNEUROSCI.2425-10.2010; Falk J, 2014, J NEUROSCI, V34, P373, DOI 10.1523/JNEUROSCI.0876-13.2014; Fili N, 2006, P NATL ACAD SCI USA, V103, P15473, DOI 10.1073/pnas.0607040103; Gil JE, 2012, J BIOL CHEM, V287, P41268, DOI 10.1074/jbc.M112.419127; Gillespie EJ, 2013, P NATL ACAD SCI USA, V110, pE4904, DOI 10.1073/pnas.1302334110; Goldenring JR, 2013, NAT REV CANCER, V13, P813, DOI 10.1038/nrc3601; Heo WD, 2003, CELL, V113, P315; Hutagalung AH, 2011, PHYSIOL REV, V91, P119, DOI 10.1152/physrev.00059.2009; Kalil K, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00062; Kennedy MJ, 2010, NAT METHODS, V7, P973, DOI 10.1038/NMETH.1524; KILLISCH I, 1992, J CELL SCI, V103, P211; Kim N, 2014, CHEM BIOL, V21, P903, DOI 10.1016/j.chembiol.2014.05.013; Konermann S, 2013, NATURE, V500, P472, DOI 10.1038/nature12466; Kyung T, 2015, NAT BIOTECHNOL, V33, P1092, DOI 10.1038/nbt.3350; Lee S, 2014, NAT METHODS, V11, P633, DOI [10.1038/nmeth.2940, 10.1038/NMETH.2940]; Lowery LA, 2009, NAT REV MOL CELL BIO, V10, P332, DOI 10.1038/nrm2679; Matsui T, 2011, TRAFFIC, V12, P1432, DOI 10.1111/j.1600-0854.2011.01240.x; Millecamps S, 2013, NAT REV NEUROSCI, V14, P161, DOI 10.1038/nrn3380; Palamidessi A, 2008, CELL, V134, P135, DOI 10.1016/j.cell.2008.05.034; Palfy M, 2012, TRENDS CELL BIOL, V22, P447, DOI 10.1016/j.tcb.2012.06.004; Park BO, 2012, CELL REP, V2, P976, DOI 10.1016/j.celrep.2012.08.038; Pfeffer SR, 2013, CURR OPIN CELL BIOL, V25, P414, DOI 10.1016/j.ceb.2013.04.002; Presley JF, 1997, NATURE, V389, P81, DOI 10.1038/38001; Ramirez OA, 2011, TRENDS CELL BIOL, V21, P219, DOI 10.1016/j.tcb.2010.12.003; Robinson MS, 2010, DEV CELL, V18, P324, DOI 10.1016/j.devcel.2009.12.015; Rosenfeldt G, 2008, MOL PLANT, V1, P4, DOI 10.1093/mp/ssm002; Sadowski L, 2009, EXP CELL RES, V315, P1601, DOI 10.1016/j.yexcr.2008.09.021; Sann S, 2009, TRENDS CELL BIOL, V19, P317, DOI 10.1016/j.tcb.2009.05.001; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Tsuboi T, 2006, J CELL SCI, V119, P2196, DOI 10.1242/jcs.02962; van Bergeijk P, 2015, NATURE, V518, P111, DOI 10.1038/nature14128; Villarroel-Campos D, 2014, J NEUROCHEM, V129, P240, DOI 10.1111/jnc.12676; Yang HW, 2012, MOL CELL, V47, P281, DOI 10.1016/j.molcel.2012.05.007; Zhang J, 2007, GENETICS, V176, P1307, DOI 10.1534/genetics.106.066761	42	44	44	2	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUN	2016	12	6					431	U86		10.1038/NCHEMBIO.2064	http://dx.doi.org/10.1038/NCHEMBIO.2064			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DM2EW	27065232				2022-12-25	WOS:000376160600013
J	Nagasaka, K; Hossain, MJ; Roberti, MJ; Ellenberg, J; Hirota, T				Nagasaka, Kota; Hossain, M. Julius; Roberti, M. Julia; Ellenberg, Jan; Hirota, Toru			Sister chromatid resolution is an intrinsic part of chromosome organization in prophase	NATURE CELL BIOLOGY			English	Article							CONDENSIN-II; TOPOISOMERASE-II; COHESIN; DECATENATION; ANAPHASE; DEPENDS; WAPL; SEGREGATION; CLEAVAGE; REMOVAL	The formation of mitotic chromosomes requires both compaction of chromatin and the resolution of replicated sister chromatids. Compaction occurs during mitotic prophase and prometaphase, and in prophase relies on the activity of condensin II complexes(1,2). Exactly when and how sister chromatid resolution occurs has been largely unknown, as has its molecular requirements. Here, we established a method to visualize sister resolution by sequential replication labelling with two distinct nucleotide derivatives. Quantitative three-dimensional imaging then allowed us to measure the resolution of sister chromatids throughout mitosis by calculating their non-overlapping volume within the whole chromosome. Unexpectedly, we found that sister chromatid resolution starts already at the beginning of prophase, proceeds concomitantly with chromatin compaction and is largely completed by the end of prophase. Sister chromatid resolution was abolished by inhibition of topoisomerase II alpha and by depleting or preventing mitotic activation of condensin II, whereas blocking cohesin dissociation from chromosomes had little effect. Mitotic sister chromatid resolution is thus an intrinsic part of mitotic chromosome formation in prophase that relies largely on DNA decatenation and shares the molecular requirement for condensin II with prophase compaction.	[Nagasaka, Kota; Hirota, Toru] Japanese Fdn Canc Res, Div Expt Pathol, Inst Canc, Koto Ku, 3-8-31 Ariake, Tokyo 1358550, Japan; [Nagasaka, Kota] Tokyo Inst Technol, Dept Biol Sci, Midori Ku, 4259 Nagatsuta Cho, Yokohama, Kanagawa 2268501, Japan; [Hossain, M. Julius; Roberti, M. Julia; Ellenberg, Jan] European Mol Biol Lab, Cell Biol & Biophys Unit, Meyerhofstr 1, D-69117 Heidelberg, Germany	Japanese Foundation for Cancer Research; Tokyo Institute of Technology; European Molecular Biology Laboratory (EMBL)	Hirota, T (corresponding author), Japanese Fdn Canc Res, Div Expt Pathol, Inst Canc, Koto Ku, 3-8-31 Ariake, Tokyo 1358550, Japan.; Ellenberg, J (corresponding author), European Mol Biol Lab, Cell Biol & Biophys Unit, Meyerhofstr 1, D-69117 Heidelberg, Germany.	jan.ellenberg@embl.de; thirota@jfcr.or.jp	Hossain, M. Julius/L-4532-2016; Hossain, M. Julius/P-2932-2019; Ellenberg, Jan/I-4688-2014	Hossain, M. Julius/0000-0003-3303-5755; Hossain, M. Julius/0000-0003-3303-5755; Ellenberg, Jan/0000-0001-5909-701X; Nagasaka, Kota/0000-0003-0765-638X	Japanese Society for the Promotion of the Science (JSPS); Humboldt Foundation postdoctoral fellowship; JSPS; Ministry of Education, Culture, Sports and Technology of Japan (MEXT); EU-FP7-Systems Microscopy NoE [258068]; EU-FP7-MitoSys [241548]; European Molecular Biology Laboratory; Grants-in-Aid for Scientific Research [26640086] Funding Source: KAKEN	Japanese Society for the Promotion of the Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Humboldt Foundation postdoctoral fellowship; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); EU-FP7-Systems Microscopy NoE; EU-FP7-MitoSys; European Molecular Biology Laboratory; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank N. Daigle and S. Alexander for their technical support; F. Uhlmann and S. Gruber for comments on the manuscript; S. Spencer (Stanford University, USA) for the DHB mVenus construct; S. Mori and O. Gotoh for statistical analyses; and all members of the T.H. and J.E. laboratories for discussions. K.N. acknowledges a fellowship from the Japanese Society for the Promotion of the Science (JSPS). M.J.R. was supported by a Humboldt Foundation postdoctoral fellowship. The EMBL Advanced Light Microscopy Facility is acknowledged for support in image acquisition and analysis. This work was supported by research grants from JSPS and the Ministry of Education, Culture, Sports and Technology of Japan (MEXT) to T.H., from EU-FP7-Systems Microscopy NoE (Grant Agreement 258068) and EU-FP7-MitoSys (Grant Agreement 241548) to J.E., and by the European Molecular Biology Laboratory (M.J.H., M.J.R., J.E.).	Abe S, 2011, GENE DEV, V25, P863, DOI 10.1101/gad.2016411; Bakhrebah M, 2015, J BIOL CHEM, V290, P6156, DOI 10.1074/jbc.M114.627109; Baxter J, 2011, SCIENCE, V331, P1328, DOI 10.1126/science.1201538; Charbin A, 2014, NUCLEIC ACIDS RES, V42, P340, DOI 10.1093/nar/gkt882; Farcas AM, 2011, MOL CELL, V44, P97, DOI 10.1016/j.molcel.2011.07.034; Gandhi R, 2006, CURR BIOL, V16, P2406, DOI 10.1016/j.cub.2006.10.061; GRATZNER HG, 1982, SCIENCE, V218, P474, DOI 10.1126/science.7123245; Green LC, 2012, J CELL SCI, V125, P1591, DOI 10.1242/jcs.097790; Haering CH, 2008, NATURE, V454, P297, DOI 10.1038/nature07098; Heriche JK, 2014, MOL BIOL CELL, V25, P2522, DOI 10.1091/mbc.E13-04-0221; Hirano T, 2012, GENE DEV, V26, P1659, DOI 10.1101/gad.194746.112; Hirota T, 2004, J CELL SCI, V117, P6435, DOI 10.1242/jcs.01604; Houlard M, 2015, NAT CELL BIOL, V17, P771, DOI 10.1038/ncb3167; Kueng S, 2006, CELL, V127, P955, DOI 10.1016/j.cell.2006.09.040; Liang ZY, 2015, CELL, V161, P1124, DOI 10.1016/j.cell.2015.04.030; Mora-Bermudez F, 2007, NAT CELL BIOL, V9, P822, DOI 10.1038/ncb1606; MURRAY AW, 1985, ANNU REV CELL BIOL, V1, P289, DOI 10.1146/annurev.cellbio.1.1.289; Nakajima M, 2007, J CELL SCI, V120, P4188, DOI 10.1242/jcs.011528; Nasmyth K, 2011, NAT CELL BIOL, V13, P1170, DOI 10.1038/ncb2349; Neef AB, 2011, P NATL ACAD SCI USA, V108, P20404, DOI 10.1073/pnas.1101126108; Ono T, 2004, MOL BIOL CELL, V15, P3296, DOI 10.1091/mbc.E04-03-0242; ROCA J, 1994, P NATL ACAD SCI USA, V91, P1781, DOI 10.1073/pnas.91.5.1781; Salic A, 2008, P NATL ACAD SCI USA, V105, P2415, DOI 10.1073/pnas.0712168105; Spencer SL, 2013, CELL, V155, P369, DOI 10.1016/j.cell.2013.08.062; SUMNER AT, 1991, CHROMOSOMA, V100, P410, DOI 10.1007/BF00337519; SUNDIN O, 1981, CELL, V25, P659, DOI 10.1016/0092-8674(81)90173-2; Tedeschi A, 2013, NATURE, V501, P564, DOI 10.1038/nature12471; Uhlmann F, 1999, NATURE, V400, P37, DOI 10.1038/21831; Uhlmann F, 2000, CELL, V103, P375, DOI 10.1016/S0092-8674(00)00130-6; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; Wang LHC, 2010, J CELL SCI, V123, P806, DOI 10.1242/jcs.058255	33	51	52	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUN	2016	18	6					692	+		10.1038/ncb3353	http://dx.doi.org/10.1038/ncb3353			17	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	DN0JL	27136266				2022-12-25	WOS:000376750100016
J	Rothhammer, V; Mascanfroni, ID; Bunse, L; Takenaka, MC; Kenison, JE; Mayo, L; Chao, CC; Patel, B; Yan, R; Blain, M; Alvarez, JI; Kebir, H; Anandasabapathy, N; Izquierdo, G; Jung, S; Obholzer, N; Pochet, N; Clish, CB; Prinz, M; Prat, A; Antel, J; Quintana, FJ				Rothhammer, Veit; Mascanfroni, Ivan D.; Bunse, Lukas; Takenaka, Maisa C.; Kenison, Jessica E.; Mayo, Lior; Chao, Chun-Cheih; Patel, Bonny; Yan, Raymond; Blain, Manon; Alvarez, Jorge I.; Kebir, Hania; Anandasabapathy, Niroshana; Izquierdo, Guillermo; Jung, Steffen; Obholzer, Nikolaus; Pochet, Nathalie; Clish, Clary B.; Prinz, Marco; Prat, Alexandre; Antel, Jack; Quintana, Francisco J.			Type I interferons and microbial metabolites of tryptophan modulate astrocyte activity and central nervous system inflammation via the aryl hydrocarbon receptor	NATURE MEDICINE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; BLOOD-BRAIN-BARRIER; REGULATORY T-CELLS; NF-KAPPA-B; MULTIPLE-SCLEROSIS; MYELOID CELLS; BETA; DIFFERENTIATION; EXPRESSION; RESPONSES	Astrocytes have important roles in the central nervous system (CNS) during health and disease. Through genome-wide analyses we detected a transcriptional response to type I interferons (IFN-Is) in astrocytes during experimental CNS autoimmunity and also in CNS lesions from patients with multiple sclerosis (MS). IFN-I signaling in astrocytes reduces inflammation and experimental autoimmune encephalomyelitis (EAE) disease scores via the ligand-activated transcription factor aryl hydrocarbon receptor (AHR) and the suppressor of cytokine signaling 2 (SOCS2). The anti-inflammatory effects of nasally administered interferon (IFN)-beta are partly mediated by AHR. Dietary tryptophan is metabolized by the gut microbiota into AHR agonists that have an effect on astrocytes to limit CNS inflammation. EAE scores were increased following ampicillin treatment during the recovery phase, and CNS inflammation was reduced in antibiotic-treated mice by supplementation with the tryptophan metabolites indole, indoxyl-3-sulfate, indole-3-propionic acid and indole-3-aldehyde, or the bacterial enzyme tryptophanase. In individuals with MS, the circulating levels of AHR agonists were decreased. These findings suggest that IFN-Is produced in the CNS function in combination with metabolites derived from dietary tryptophan by the gut flora to activate AHR signaling in astrocytes and suppress CNS inflammation.	[Rothhammer, Veit; Mascanfroni, Ivan D.; Bunse, Lukas; Takenaka, Maisa C.; Kenison, Jessica E.; Mayo, Lior; Chao, Chun-Cheih; Patel, Bonny; Yan, Raymond; Obholzer, Nikolaus; Pochet, Nathalie; Quintana, Francisco J.] Harvard Univ, Brigham & Womens Hosp, Ann Romney Ctr Neurol Dis, Sch Med, Boston, MA 02115 USA; [Blain, Manon; Antel, Jack] McGill Univ, Montreal Neurol Inst, Neuroimmunol Unit, Montreal, PQ, Canada; [Alvarez, Jorge I.] Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA; [Kebir, Hania; Prat, Alexandre] Univ Montreal, Neuroimmunol Res Lab, Ctr Excellence Neur CRCHUM, Montreal, PQ, Canada; [Anandasabapathy, Niroshana] Brigham & Womens Hosp, Dept Dermatol, 75 Francis St, Boston, MA 02115 USA; [Izquierdo, Guillermo] Univ Seville, Mol Biol Serv, Seville, Spain; [Jung, Steffen] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel; [Obholzer, Nikolaus; Pochet, Nathalie] Broad Inst Massachusetts Inst Technol MIT & Harva, Cambridge, MA USA; [Clish, Clary B.] Broad Inst MIT & Harvard Univ, Metabolite Profiling Platform, Cambridge, MA USA; [Prinz, Marco] Univ Freiburg, Inst Neuropathol, Hugstetter Str 55, D-79106 Freiburg, Germany	Harvard University; Brigham & Women's Hospital; Harvard Medical School; McGill University; University of Pennsylvania; Universite de Montreal; Harvard University; Brigham & Women's Hospital; University of Sevilla; Weizmann Institute of Science; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Freiburg	Quintana, FJ (corresponding author), Harvard Univ, Brigham & Womens Hosp, Ann Romney Ctr Neurol Dis, Sch Med, Boston, MA 02115 USA.	fquintana@rics.bwh.harvard.edu	Pochet, Nathalie/Q-1322-2017; m, Lior/AGK-3671-2022; Clish, Clary B/ABB-9374-2021; Clish, Clary/AAB-7124-2019; Bunse, Lukas/L-2975-2016; Jung, Steffen/K-1409-2012; Quintana, Francisco Javier/AAB-6915-2020	Pochet, Nathalie/0000-0003-1820-5656; m, Lior/0000-0002-1296-6692; Clish, Clary B/0000-0001-8259-9245; Bunse, Lukas/0000-0002-4490-7574; Jung, Steffen/0000-0003-4290-5716; antel, jack/0000-0002-5148-0636; Prat, Alexandre/0000-0001-6188-0580; Anandasabapathy, Niroshana/0000-0002-0473-8358; Kenison, Jessica/0000-0002-5599-3228; Kebir, Hania/0000-0001-6174-8846; Chao, Chun-Cheih/0000-0003-4108-2658	National Institutes of Health (NIH) [AI075285, AI093903]; National Multiple Sclerosis Society [RG4111A1, FG 2036-A1/1, FG1941A1/2]; International Progressive MS Alliance grants [PA0069, PA-1501-02847]; Mallinckrodt Pharmaceuticals [A219074]; German Research Foundation (DFG) [RO4866 1/1]; International Academy of Life Sciences; Ministry of Science and Technology, Taiwan [104-2917-I-564 -024]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Brazil [BEX 0571/15-6]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI126880, K99AI075285, R00AI075285, R01AI093903] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society(National Multiple Sclerosis Society); International Progressive MS Alliance grants; Mallinckrodt Pharmaceuticals; German Research Foundation (DFG)(German Research Foundation (DFG)); International Academy of Life Sciences; Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health (NIH) grants AI075285 (F.J.Q.) and AI093903 (F.J.Q.), the National Multiple Sclerosis Society grant RG4111A1 (F.J.Q.), the International Progressive MS Alliance grants PA0069 (F.J.Q.) and PA-1501-02847 (F.J.Q.), an educational grant from Mallinckrodt Pharmaceuticals (A219074; V.R.), a fellowship from the German Research Foundation (DFG RO4866 1/1; V.R.), postdoctoral fellowships from the National Multiple Sclerosis Society (FG 2036-A1/1 (I.D.M) and FG1941A1/2 (L.M.)), a fellowship from the International Academy of Life Sciences (L.B.), a postdoctoral Research Abroad Program award from the Ministry of Science and Technology, Taiwan (104-2917-I-564 -024; C.-C.C.) and a fellowship from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Brazil (BEX 0571/15-6; M.C.T.). Cx3cr1-CreERT2 mice were a kind gift from S. Jung (Weizmann Institute of science). The pLenti-Gfap-eGFP-mir30-shAct1 vector was a gift from G.-X. Zhang.	Allen NJ, 2012, NATURE, V486, P410, DOI 10.1038/nature11059; Alvarez JI, 2015, NEUROBIOL DIS, V74, P14, DOI 10.1016/j.nbd.2014.09.016; Alvarez JI, 2011, SCIENCE, V334, P1727, DOI 10.1126/science.1206936; Apetoh L, 2010, NAT IMMUNOL, V11, P854, DOI 10.1038/ni.1912; Atarashi K, 2015, CELL, V163, P367, DOI 10.1016/j.cell.2015.08.058; Axtell RC, 2010, NAT MED, V16, P406, DOI 10.1038/nm.2110; Baruch K, 2014, SCIENCE, V346, P89, DOI 10.1126/science.1252945; Berer K, 2011, NATURE, V479, P538, DOI 10.1038/nature10554; Bessede A, 2014, NATURE, V511, P184, DOI 10.1038/nature13323; Borden EC, 2007, NAT REV DRUG DISCOV, V6, P975, DOI 10.1038/nrd2422; Boverhof DR, 2004, MOL PHARMACOL, V66, P1662, DOI 10.1124/mol.104.002915; Chung WS, 2013, NATURE, V504, P394, DOI 10.1038/nature12776; Dann A, 2012, NAT NEUROSCI, V15, P98, DOI 10.1038/nn.2964; Ejlerskov P, 2015, CELL, V163, P324, DOI 10.1016/j.cell.2015.08.069; Farez MF, 2015, CELL, V162, P1338, DOI 10.1016/j.cell.2015.08.025; Fitzgerald DC, 2007, J IMMUNOL, V179, P3268, DOI 10.4049/jimmunol.179.5.3268; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Gandhi R, 2010, NAT IMMUNOL, V11, P846, DOI 10.1038/ni.1915; Goldmann T, 2015, EMBO J, V34, P1612, DOI 10.15252/embj.201490791; Innocentin YLS, 2011, CELL, V147, P629, DOI 10.1016/j.cell.2011.09.025; Ivashkiv LB, 2014, NAT REV IMMUNOL, V14, P36, DOI 10.1038/nri3581; Jack CS, 2005, J IMMUNOL, V175, P4320, DOI 10.4049/jimmunol.175.7.4320; JESSEN KR, 1980, NATURE, V286, P736, DOI 10.1038/286736a0; Khakh BS, 2015, NAT NEUROSCI, V18, P942, DOI 10.1038/nn.4043; Khorooshi R, 2015, ACTA NEUROPATHOL, V130, P107, DOI 10.1007/s00401-015-1418-z; Kim RY, 2014, J NEUROIMMUNOL, V274, P53, DOI 10.1016/j.jneuroim.2014.06.009; Lassmann H, 2014, GLIA, V62, P1816, DOI 10.1002/glia.22597; Lee YK, 2011, P NATL ACAD SCI USA, V108, P4615, DOI 10.1073/pnas.1000082107; Mascanfroni ID, 2015, NAT MED, V21, P638, DOI 10.1038/nm.3868; Mascanfroni ID, 2013, NAT IMMUNOL, V14, P1054, DOI 10.1038/ni.2695; Mayo L, 2014, NAT MED, V20, P1147, DOI 10.1038/nm.3681; Mc Guire C, 2013, TRENDS MOL MED, V19, P604, DOI 10.1016/j.molmed.2013.08.001; Mitsdoerffer M, 2009, ANN NEUROL, V65, P487, DOI 10.1002/ana.21722; Molofsky AV, 2014, NATURE, V509, P189, DOI 10.1038/nature13161; Monteleone I, 2011, GASTROENTEROLOGY, V141, P237, DOI 10.1053/j.gastro.2011.04.007; Obermeier B, 2013, NAT MED, V19, P1584, DOI 10.1038/nm.3407; Ochoa-Reparaz J, 2010, J IMMUNOL, V185, P4101, DOI 10.4049/jimmunol.1001443; Opitz CA, 2011, NATURE, V478, P197, DOI 10.1038/nature10491; Palace J, 2010, ARCH NEUROL-CHICAGO, V67, P1016, DOI 10.1001/archneurol.2010.188; Prinz M, 2008, IMMUNITY, V28, P675, DOI 10.1016/j.immuni.2008.03.011; Prinz M, 2011, NAT NEUROSCI, V14, P1227, DOI 10.1038/nn.2923; Quintana FJ, 2008, NATURE, V453, P65, DOI 10.1038/nature06880; Quintana FJ, 2013, PHARMACOL REV, V65, P1148, DOI 10.1124/pr.113.007823; Quintana FJ, 2010, P NATL ACAD SCI USA, V107, P20768, DOI 10.1073/pnas.1009201107; Rieckmann P, 2003, NAT MED, V9, P828, DOI 10.1038/nm0703-828; Ross TM, 2004, J NEUROIMMUNOL, V151, P66, DOI 10.1016/j.jneuroim.2004.02.011; Sandler NG, 2014, NATURE, V511, P601, DOI 10.1038/nature13554; Schroeder JC, 2010, BIOCHEMISTRY-US, V49, P393, DOI 10.1021/bi901786x; Shao W, 2013, NATURE, V494, P90, DOI 10.1038/nature11748; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Sofroniew MV, 2015, NAT REV NEUROSCI, V16, P249, DOI 10.1038/nrn3898; Stockinger B, 2014, ANNU REV IMMUNOL, V32, P403, DOI 10.1146/annurev-immunol-032713-120245; Townsend MK, 2013, CLIN CHEM, V59, P1657, DOI 10.1373/clinchem.2012.199133; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Tsai HH, 2012, SCIENCE, V337, P358, DOI 10.1126/science.1222381; van Loo G, 2006, NAT IMMUNOL, V7, P954, DOI 10.1038/ni1372; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Viaud S, 2013, SCIENCE, V342, P971, DOI 10.1126/science.1240537; Weidemann A, 2009, J CLIN INVEST, V119, P3373, DOI 10.1172/JCI39378; Wikoff WR, 2009, P NATL ACAD SCI USA, V106, P3698, DOI 10.1073/pnas.0812874106; Yan YP, 2012, MOL THER, V20, P1338, DOI 10.1038/mt.2012.12; Yeste A, 2012, P NATL ACAD SCI USA, V109, P11270, DOI 10.1073/pnas.1120611109; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Zadjali F, 2012, FASEB J, V26, P3282, DOI 10.1096/fj.12-205583; Zelante T, 2013, IMMUNITY, V39, P372, DOI 10.1016/j.immuni.2013.08.003	65	669	691	17	242	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2016	22	6					586	+		10.1038/nm.4106	http://dx.doi.org/10.1038/nm.4106			15	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DO0NQ	27158906	Green Accepted, Green Submitted			2022-12-25	WOS:000377476000011
J	Cohen, NR; Ross, CA; Jain, S; Shapiro, RS; Gutierrez, A; Belenky, P; Li, H; Collins, JJ				Cohen, Nadia R.; Ross, Christian A.; Jain, Saloni; Shapiro, Rebecca S.; Gutierrez, Arnaud; Belenky, Peter; Li, Hu; Collins, James J.			A role for the bacterial GATC methylome in antibiotic stress survival	NATURE GENETICS			English	Article							DNA ADENINE METHYLATION; ESCHERICHIA-COLI DNA; GENE-EXPRESSION; MISMATCH REPAIR; SALMONELLA-ENTERICA; SINGLE-MOLECULE; SUBINHIBITORY CONCENTRATIONS; ANTIMICROBIAL RESISTANCE; REPLICATION FIDELITY; PROTEIN INTERACTIONS	Antibiotic resistance is an increasingly serious public health threat(1). Understanding pathways allowing bacteria to survive antibiotic stress may unveil new therapeutic targets(2-8). We explore the role of the bacterial epigenome in antibiotic stress survival using classical genetic tools and single-molecule real-time sequencing to characterize genomic methylation kinetics. We find that Escherichia coli survival under antibiotic pressure is severely compromised without adenine methylation at GATC sites. Although the adenine methylome remains stable during drug stress, without GATC methylation, methyl-dependent mismatch repair (MMR) is deleterious and, fueled by the drug-induced error-prone polymerase Pol IV, overwhelms cells with toxic DNA breaks. In multiple E. coli strains, including pathogenic and drug-resistant clinical isolates, DNA adenine methyltransferase deficiency potentiates antibiotics from the beta-lactam and quinolone classes. This work indicates that the GATC methylome provides structural support for bacterial survival during antibiotic stress and suggests targeting bacterial DNA methylation as a viable approach to enhancing antibiotic activity.	[Cohen, Nadia R.; Collins, James J.] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA; [Cohen, Nadia R.; Jain, Saloni; Shapiro, Rebecca S.; Gutierrez, Arnaud; Collins, James J.] MIT, Dept Biol Engn, Inst Med Engn & Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Cohen, Nadia R.; Collins, James J.] Howard Hughes Med Inst, Chevy Chase, MD USA; [Ross, Christian A.; Li, Hu] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Ctr Individualized Med, Informat Technol,Coll Med, Rochester, MN USA; [Jain, Saloni; Collins, James J.] Boston Univ, Boston, MA 02215 USA; [Shapiro, Rebecca S.; Gutierrez, Arnaud; Collins, James J.] Broad Inst MIT & Harvard, Cambridge, MA USA; [Belenky, Peter] Brown Univ, Dept Mol Microbiol & Immunol, Providence, RI 02912 USA; [Collins, James J.] Harvard Program Hlth Sci & Technol, Boston, MA USA; [Collins, James J.] MIT, Synthet Biol Ctr, 77 Massachusetts Ave, Cambridge, MA 02139 USA	Harvard University; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Mayo Clinic; Boston University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Brown University; Massachusetts Institute of Technology (MIT)	Collins, JJ (corresponding author), Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA.; Collins, JJ (corresponding author), MIT, Dept Biol Engn, Inst Med Engn & Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Collins, JJ (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD USA.; Collins, JJ (corresponding author), Boston Univ, Boston, MA 02215 USA.; Collins, JJ (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA USA.; Collins, JJ (corresponding author), Harvard Program Hlth Sci & Technol, Boston, MA USA.; Collins, JJ (corresponding author), MIT, Synthet Biol Ctr, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	jimjc@mit.edu	Shapiro, Rebecca/I-9247-2019	Shapiro, Rebecca/0000-0002-7119-8865; Belenky, Peter/0000-0002-1682-945X; Gutierrez, Arnaud/0000-0002-9512-0659; Ross, Paige/0000-0002-4157-3951	Defense Threat Reduction Agency [HDTRA1-15-1-0051]; US National Institutes of Health [1U54GM114838-01]; Mayo Clinic Center for Individualized Medicine; Donors Cure Foundation; Howard Hughes Medical Institute; Banting Postdoctoral Fellowship from the Canadian Institutes of Health and Research; Wyss Institute for Biologically Inspired Engineering, Harvard University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM114838] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003644] Funding Source: NIH RePORTER	Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Clinic Center for Individualized Medicine; Donors Cure Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Banting Postdoctoral Fellowship from the Canadian Institutes of Health and Research; Wyss Institute for Biologically Inspired Engineering, Harvard University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank T. Ferrante, E. Cameron, K. Allison, J. Winkler, J. Way, C. Gruber, P. Bhargava, M. Painter, N. Sherpa, T. Lieberman, L. Certain and Y. Furuta for critical feedback and technical support over the course of this study. We also thank M. Conover and S. Hultgren (Washington University School of Medicine in St. Louis) for generously providing the UTI89 strain, as well as related reagents and protocols. Additionally, we are grateful for SMRT sequencing support from M. Zapp and E. Kittler at the University of Massachusetts Medical School Sequencing Core and from S. Mark, K. Luong, M. Weiand and O. Banerjee at Pacific Biosciences. This work was supported by funding from Defense Threat Reduction Agency grant HDTRA1-15-1-0051, US National Institutes of Health grant 1U54GM114838-01, the Mayo Clinic Center for Individualized Medicine and Donors Cure Foundation, the Howard Hughes Medical Institute, the Banting Postdoctoral Fellowship from the Canadian Institutes of Health and Research, and the Wyss Institute for Biologically Inspired Engineering, Harvard University.	Baharoglu Z, 2011, ANTIMICROB AGENTS CH, V55, P2438, DOI 10.1128/AAC.01549-10; BALE A, 1979, MUTAT RES, V59, P157, DOI 10.1016/0027-5107(79)90153-2; Barrick JE, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1039; Baym M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128036; Blow MJ, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005854; Brunet YR, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002205; Brynildsen MP, 2013, NAT BIOTECHNOL, V31, P160, DOI 10.1038/nbt.2458; Camacho EM, 2005, MOL MICROBIOL, V57, P1700, DOI 10.1111/j.1365-2958.2005.04788.x; Camacho EM, 2005, J BACTERIOL, V187, P5691, DOI 10.1128/JB.187.16.5691-5699.2005; Casadesus J, 2006, MICROBIOL MOL BIOL R, V70, P830, DOI 10.1128/MMBR.00016-06; Casadesus J, 2013, J BIOL CHEM, V288, P13929, DOI 10.1074/jbc.R113.472274; Chen SL, 2006, P NATL ACAD SCI USA, V103, P5977, DOI 10.1073/pnas.0600938103; Chinnusamy V, 2009, CURR OPIN PLANT BIOL, V12, P133, DOI 10.1016/j.pbi.2008.12.006; Courcelle J, 2001, GENETICS, V158, P41; Davis BM, 2013, CURR OPIN MICROBIOL, V16, P192, DOI 10.1016/j.mib.2013.01.011; DOUTRIAUX MP, 1986, P NATL ACAD SCI USA, V83, P2576, DOI 10.1073/pnas.83.8.2576; Dwyer DJ, 2014, P NATL ACAD SCI USA, V111, pE2100, DOI 10.1073/pnas.1401876111; Fang G, 2012, NAT BIOTECHNOL, V30, P1232, DOI 10.1038/nbt.2432; Fijalkowska IJ, 2012, FEMS MICROBIOL REV, V36, P1105, DOI 10.1111/j.1574-6976.2012.00338.x; Flusberg BA, 2010, NAT METHODS, V7, P461, DOI [10.1038/NMETH.1459, 10.1038/nmeth.1459]; FRAM RJ, 1985, MOL PHARMACOL, V28, P51; Galhardo RS, 2007, CRIT REV BIOCHEM MOL, V42, P399, DOI 10.1080/10409230701648502; Galhardo RS, 2009, GENETICS, V182, P55, DOI 10.1534/genetics.109.100735; Garcia-Del Portillo F, 1999, P NATL ACAD SCI USA, V96, P11578, DOI 10.1073/pnas.96.20.11578; Goh EB, 2002, P NATL ACAD SCI USA, V99, P17025, DOI 10.1073/pnas.252607699; Grant SS, 2012, P NATL ACAD SCI USA, V109, P12147, DOI 10.1073/pnas.1203735109; Gutierrez A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2607; GUYOT JB, 1993, NUCLEIC ACIDS RES, V21, P3183, DOI 10.1093/nar/21.14.3183; HALE WB, 1994, J BACTERIOL, V176, P3438, DOI 10.1128/jb.176.11.3438-3441.1994; Heithoff DM, 1999, SCIENCE, V284, P967, DOI 10.1126/science.284.5416.967; Hernday AD, 2003, MOL CELL, V12, P947, DOI 10.1016/S1097-2765(03)00383-6; Hobley G, 2012, BIOORG MED CHEM LETT, V22, P3079, DOI 10.1016/j.bmcl.2012.03.072; HOLST B, 1992, EMBO J, V11, P3635, DOI 10.1002/j.1460-2075.1992.tb05448.x; Horton JR, 2015, NUCLEIC ACIDS RES, V43, P4296, DOI 10.1093/nar/gkv251; Kaldalu M, 2004, ANTIMICROB AGENTS CH, V48, P890, DOI 10.1128/AAC.48.3.890-896.2004; KARRAN P, 1982, NATURE, V296, P868, DOI 10.1038/296868a0; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Kohanski MA, 2010, MOL CELL, V37, P311, DOI 10.1016/j.molcel.2010.01.003; Kultz D, 2003, J EXP BIOL, V206, P3119, DOI 10.1242/jeb.00549; Kunkel TA, 2005, ANNU REV BIOCHEM, V74, P681, DOI 10.1146/annurev.biochem.74.082803.133243; Laureti L, 2013, ANTIBIOTICS-BASEL, V2, P100, DOI 10.3390/antibiotics2010100; Lee S, 2009, P NATL ACAD SCI USA, V106, P14570, DOI 10.1073/pnas.0903619106; Lobner-Olesen A, 2005, CURR OPIN MICROBIOL, V8, P154, DOI 10.1016/j.mib.2005.02.009; Lu TK, 2009, P NATL ACAD SCI USA, V106, P4629, DOI 10.1073/pnas.0800442106; Marinus MG, 2010, MUTAT RES-REV MUTAT, V705, P71, DOI 10.1016/j.mrrev.2010.05.001; Marinus MG, 2009, FEMS MICROBIOL REV, V33, P488, DOI 10.1111/j.1574-6976.2008.00159.x; Marinus MG, 2000, J BACTERIOL, V182, P463, DOI 10.1128/JB.182.2.463-468.2000; Mashhoon N, 2006, J BIOMOL SCREEN, V11, P497, DOI 10.1177/1087057106287933; McKelvie JC, 2013, BRIT J PHARMACOL, V168, P172, DOI 10.1111/j.1476-5381.2012.02134.x; Mesak LR, 2008, ANTIMICROB AGENTS CH, V52, P3394, DOI 10.1128/AAC.01599-07; Miller C, 2004, SCIENCE, V305, P1629, DOI 10.1126/science.1101630; Murphy KC, 2008, J BACTERIOL, V190, P438, DOI 10.1128/JB.01373-07; Perez-Capilla T, 2005, J BACTERIOL, V187, P1515, DOI 10.1128/JB.187.4.1515-1518.2005; PETERSON KR, 1985, MOL GEN GENET, V201, P14, DOI 10.1007/BF00397979; Poole K, 2012, J ANTIMICROB CHEMOTH, V67, P2069, DOI 10.1093/jac/dks196; Poole K, 2012, TRENDS MICROBIOL, V20, P227, DOI 10.1016/j.tim.2012.02.004; Prieto AI, 2004, GENETICS, V168, P1787, DOI 10.1534/genetics.104.031062; Provencal N, 2015, J EXP BIOL, V218, P123, DOI 10.1242/jeb.111401; Pucciarelli MG, 2002, MICROBIOL-SGM, V148, P1171, DOI 10.1099/00221287-148-4-1171; Rohwer F, 2000, APPL ENVIRON MICROB, V66, P1001, DOI 10.1128/AEM.66.3.1001-1006.2000; Sabo EM, 2014, ANN PHARMACOTHER, V48, P380, DOI 10.1177/1060028013517661; Schadt EE, 2013, GENOME RES, V23, P129, DOI 10.1101/gr.136739.111; Schroeder EA, 2013, CELL METAB, V17, P954, DOI 10.1016/j.cmet.2013.04.003; Sexton Jonathan Z, 2010, Curr Chem Genomics, V4, P34, DOI 10.2174/1875397301004010034; Shaw KJ, 2003, J MOL MICROB BIOTECH, V5, P105, DOI 10.1159/000069981; Srikhanta YN, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000400; Tavazoie S, 1998, NAT BIOTECHNOL, V16, P566, DOI 10.1038/nbt0698-566; Tippin B, 2004, TRENDS MICROBIOL, V12, P288, DOI 10.1016/j.tim.2004.04.004; Urig S, 2002, J MOL BIOL, V319, P1085, DOI 10.1016/S0022-2836(02)00371-6; Vasu K, 2013, MICROBIOL MOL BIOL R, V77, P53, DOI 10.1128/MMBR.00044-12; WANG MX, 1992, NATURE, V360, P606, DOI 10.1038/360606a0; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Wexselblatt E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002925; Wigle TJ, 2009, J BIOMOL SCREEN, V14, P1092, DOI 10.1177/1087057109342126; World Health Organization (WHO), 2014, ANT RES GLOB SURV RE; Wyrzykowski J, 2003, J BACTERIOL, V185, P1701, DOI 10.1128/JB.185.5.1701-1704.2003; YSERN P, 1990, MUTAGENESIS, V5, P63, DOI 10.1093/mutage/5.1.63	77	51	53	5	47	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2016	48	5					581	+		10.1038/ng.3530	http://dx.doi.org/10.1038/ng.3530			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DK3RC	26998690	Green Accepted, Green Submitted			2022-12-25	WOS:000374834100020
J	Fladung, M				Fladung, Matthias			Cibus' herbicide-resistant canola in European limbo	NATURE BIOTECHNOLOGY			English	Letter									[Fladung, Matthias] Thunen Inst Forest Genet, Grosshansdorf, Germany	Johann Heinrich von Thunen Institute	Fladung, M (corresponding author), Thunen Inst Forest Genet, Grosshansdorf, Germany.	matthias.fladung@thuenen.de		Fladung, Matthias/0000-0001-9301-8581				[Anonymous], 2015, CIB RAPS DARF VOR NI; Bahnsen U., 2015, FINDEN UNTERSCHIED F; Buhk HJ, 2014, NEW BIOTECHNOL, V31, P528, DOI 10.1016/j.nbt.2014.02.007; *EUR COMM, 2011, NEW TECHN WORK GROUP; European Commission, 2016, NEW PLANT BREED TECH; Federal Office of Consumer Protection and Food Safety (BVL), 2015, WID GEG CIBUS RAPS B; Federal Office of Consumer Protection and Food Safety (BVL), 2015, LETT RESP REG CIB IN; Kommission fur die Biologische Sicherheit (ZKBS), 2012, POS STAT ZKBS NEW PL; Wagner D., 2015, GENETIC LIT PROJECT	9	9	10	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2016	34	5					473	474		10.1038/nbt.3558	http://dx.doi.org/10.1038/nbt.3558			2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DL6FL	27153271				2022-12-25	WOS:000375735000018
J	Nielsen, SR; Quaranta, V; Linford, A; Emeagi, P; Rainer, C; Santos, A; Ireland, L; Sakai, T; Sakai, K; Kim, YS; Engle, D; Campbell, F; Palmer, D; Ko, JH; Tuveson, DA; Hirsch, E; Mielgo, A; Schmid, MC				Nielsen, Sebastian R.; Quaranta, Valeria; Linford, Andrea; Emeagi, Perpetua; Rainer, Carolyn; Santos, Almudena; Ireland, Lucy; Sakai, Takao; Sakai, Keiko; Kim, Yong-Sam; Engle, Dannielle; Campbell, Fiona; Palmer, Daniel; Ko, Jeong Heon; Tuveson, David A.; Hirsch, Emilio; Mielgo, Ainhoa; Schmid, Michael C.			Macrophage-secreted granulin supports pancreatic cancer metastasis by inducing liver fibrosis	NATURE CELL BIOLOGY			English	Article							DUCTAL ADENOCARCINOMA; TUMOR PROGRESSION; BREAST-CANCER; CHEMOTHERAPEUTIC RESPONSE; RESIDENT MACROPHAGES; TNF RECEPTORS; MYELOID CELLS; INFLAMMATION; PROGRANULIN; MONOCYTES	Pancreatic ductal adenocarcinoma (PDAC) is a devastating metastatic disease for which better therapies are urgently needed. Macrophages enhance metastasis in many cancer types; however, the role of macrophages in PDAC liver metastasis remains poorly understood. Here we found that PDAC liver metastasis critically depends on the early recruitment of granulin-secreting inflammatory monocytes to the liver. Mechanistically, we demonstrate that granulin secretion by metastasis-associated macrophages (MAMs) activates resident hepatic stellate cells (hStCs) into myofibroblasts that secrete periostin, resulting in a fibrotic microenvironment that sustains metastatic tumour growth. Disruption of MAM recruitment or genetic depletion of granulin reduced hStC activation and liver metastasis. Interestingly, we found that circulating monocytes and hepatic MAMs in PDAC patients express high levels of granulin. These findings suggest that recruitment of granulin-expressing inflammatory monocytes plays a key role in PDAC metastasis and may serve as a potential therapeutic target for PDAC liver metastasis.	[Nielsen, Sebastian R.; Quaranta, Valeria; Linford, Andrea; Emeagi, Perpetua; Rainer, Carolyn; Santos, Almudena; Ireland, Lucy; Campbell, Fiona; Palmer, Daniel; Mielgo, Ainhoa; Schmid, Michael C.] Univ Liverpool, Dept Mol & Clin Canc Med, Ashton St, Liverpool L69 3GE, Merseyside, England; [Sakai, Takao; Sakai, Keiko] Univ Liverpool, Dept Mol & Clin Pharmacol, Ashton St, Liverpool L69 3GE, Merseyside, England; [Kim, Yong-Sam; Ko, Jeong Heon] KRIBB, Aging Intervent Res Ctr, 125 Gwahak Ro, Deajeon 305806, South Korea; [Kim, Yong-Sam; Ko, Jeong Heon] Korea Univ Sci & Technol, 217 Gajeong Ro, Daejeon 305350, South Korea; [Engle, Dannielle; Tuveson, David A.] Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA; [Engle, Dannielle; Tuveson, David A.] Lustgarten Pancreat Canc Res Lab, Cold Spring Harbor, NY 11724 USA; [Tuveson, David A.] Mem Sloan Kettering Canc Ctr, Rubenstein Ctr Pancreat Canc Res, New York, NY 10065 USA; [Hirsch, Emilio] Univ Torino, Dept Mol Biotechnol & Hlth Sci, Ctr Mol Biotechnol, Via Nizza 52, I-10126 Turin, Italy	University of Liverpool; University of Liverpool; Korea Research Institute of Bioscience & Biotechnology (KRIBB); University of Science & Technology (UST); Cold Spring Harbor Laboratory; Memorial Sloan Kettering Cancer Center; University of Turin	Schmid, MC (corresponding author), Univ Liverpool, Dept Mol & Clin Canc Med, Ashton St, Liverpool L69 3GE, Merseyside, England.	mschmid@liv.ac.uk	Hirsch, Emilio/F-4848-2013	Hirsch, Emilio/0000-0002-9073-6024; Schmid, Michael/0000-0002-3445-0013; Engle, Dannielle/0000-0003-1876-7675; Nielsen, Sebastian Rune/0000-0002-8449-476X	Medical Research Council [MR/L000512/1]; Pancreatic Cancer Research Fund; Pancreas Biomedical Research Unit/Cancer Research UK PhD fellowship; North West Cancer Research; Sir Henry Dale Fellowship - Wellcome Trust; Sir Henry Dale Fellowship - Royal Society [102521/Z/13/Z]; NATIONAL CANCER INSTITUTE [P30CA045508, P30CA008748, T32CA148056] Funding Source: NIH RePORTER; MRC [MR/L000512/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Pancreatic Cancer Research Fund; Pancreas Biomedical Research Unit/Cancer Research UK PhD fellowship; North West Cancer Research; Sir Henry Dale Fellowship - Wellcome Trust(Wellcome Trust); Sir Henry Dale Fellowship - Royal Society; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank the flow cytometry and cell sorting facility and the animal facility at the University of Liverpool for provision of equipment and technical assistance. We are grateful to J. Y. Kim and J. S. Yoo at the Korea Basic Science Institute, Mass Spectrometry Research Centre, for their assistance. We acknowledge the Liverpool Tissue Bank for provision of tissue samples. We thank A. Taylor and P. Murray, University of Liverpool, for technical help with lentiviral particle infection. We thank L. Young, CRUK Cambridge Research Institute, for assistance with animal models. We also thank the patients and their families, as well as the healthy blood donors who contributed tissue samples and blood donations to these studies. These studies were supported by grants from the Medical Research Council (grant number MR/L000512/1) and the Pancreatic Cancer Research Fund (M.C.S.), a Pancreas Biomedical Research Unit/Cancer Research UK PhD fellowship (S.R.N.), North West Cancer Research (M.C.S. and V.Q.), and a Sir Henry Dale Fellowship jointly funded by the Wellcome Trust and the Royal Society (A.M., grant number 102521/Z/13/Z).	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bao SD, 2004, CANCER CELL, V5, P329, DOI 10.1016/S1535-6108(04)00081-9; Bleriot C, 2015, IMMUNITY, V42, P145, DOI 10.1016/j.immuni.2014.12.020; Camps M, 2005, NAT MED, V11, P936, DOI 10.1038/nm1284; Carvalho PC, 2009, BIOINFORMATICS, V25, P2734, DOI 10.1093/bioinformatics/btp489; Chen X, 2013, J NEUROSCI, V33, P9202, DOI 10.1523/JNEUROSCI.5336-12.2013; CORBETT TH, 1984, CANCER RES, V44, P717; Costa-Silva B, 2015, NAT CELL BIOL, V17, P816, DOI 10.1038/ncb3169; Coussens LM, 2000, CELL, V103, P481, DOI 10.1016/S0092-8674(00)00139-2; DeNardo DG, 2011, CANCER DISCOV, V1, P54, DOI 10.1158/2159-8274.CD-10-0028; Elkabets M, 2011, J CLIN INVEST, V121, P784, DOI 10.1172/JCI43757; Erez N, 2010, CANCER CELL, V17, P135, DOI 10.1016/j.ccr.2009.12.041; Erler JT, 2009, CANCER CELL, V15, P35, DOI 10.1016/j.ccr.2008.11.012; Etemadi N, 2013, IMMUNOL CELL BIOL, V91, P661, DOI 10.1038/icb.2013.53; Friedlander SYG, 2009, CANCER CELL, V16, P379, DOI 10.1016/j.ccr.2009.09.027; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Hashimoto D, 2013, IMMUNITY, V38, P792, DOI 10.1016/j.immuni.2013.04.004; He ZH, 2003, NAT MED, V9, P225, DOI 10.1038/nm816; Hellerbrand C, 1999, J HEPATOL, V30, P77, DOI 10.1016/S0168-8278(99)80010-5; Hildenbrand R, 1999, J LEUKOCYTE BIOL, V66, P40, DOI 10.1002/jlb.66.1.40; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; Hirsch E, 2000, SCIENCE, V287, P1049, DOI 10.1126/science.287.5455.1049; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Kim S, 2009, NATURE, V457, P102, DOI 10.1038/nature07623; Kitamura T, 2015, J EXP MED, V212, P1043, DOI 10.1084/jem.20141836; Kitamura T, 2015, NAT REV IMMUNOL, V15, P73, DOI 10.1038/nri3789; Klein I, 2007, BLOOD, V110, P4077, DOI 10.1182/blood-2007-02-073841; Li Z, 2012, J PROTEOME RES, V11, P1582, DOI 10.1021/pr200748h; Lim C, 2013, NAT REV GASTRO HEPAT, V10, P452, DOI 10.1038/nrgastro.2013.55; Little EC, 2012, J SURG RES, V176, P359, DOI 10.1016/j.jss.2011.10.025; Malanchi I, 2012, NATURE, V481, P85, DOI 10.1038/nature10694; McAllister F, 2014, CANCER CELL, V25, P621, DOI 10.1016/j.ccr.2014.03.014; McAllister SS, 2014, NAT CELL BIOL, V16, P717, DOI 10.1038/ncb3015; Moriya K, 2011, GASTROENTEROLOGY, V140, P1653, DOI 10.1053/j.gastro.2011.02.005; Neoptolemos JP, 2004, NEW ENGL J MED, V350, P1200, DOI 10.1056/NEJMoa032295; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Ohlund D, 2014, J EXP MED, V211, P1503, DOI 10.1084/jem.20140692; Ozdemir BC, 2014, CANCER CELL, V25, P719, DOI 10.1016/j.ccr.2014.04.005; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; Pellicoro A, 2014, NAT REV IMMUNOL, V14, P181, DOI 10.1038/nri3623; Pyonteck SM, 2013, NAT MED, V19, P1264, DOI 10.1038/nm.3337; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394; Raso C, 2012, J PROTEOME RES, V11, P3199, DOI 10.1021/pr2012347; Rhim AD, 2014, CANCER CELL, V25, P735, DOI 10.1016/j.ccr.2014.04.021; Ryan DP, 2014, NEW ENGL J MED, V371, P2140, DOI 10.1056/NEJMc1412266; Schmid MC, 2011, CANCER RES, V71, P6965, DOI 10.1158/0008-5472.CAN-11-0588; Schmid MC, 2011, CANCER CELL, V19, P715, DOI 10.1016/j.ccr.2011.04.016; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Sevenich L, 2014, NAT CELL BIOL, V16, P876, DOI 10.1038/ncb3011; Sherman MH, 2014, CELL, V159, P80, DOI 10.1016/j.cell.2014.08.007; Shree T, 2011, GENE DEV, V25, P2465, DOI 10.1101/gad.180331.111; Sperti C, 1997, WORLD J SURG, V21, P195, DOI 10.1007/s002689900215; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Tang W, 2011, SCIENCE, V332, P478, DOI 10.1126/science.1199214; Vanharanta S, 2013, CANCER CELL, V24, P410, DOI 10.1016/j.ccr.2013.09.007; VANROOIJEN N, 1984, CELL TISSUE RES, V238, P355, DOI 10.1007/BF00217308; VANROOIJEN N, 1994, J IMMUNOL METHODS, V174, P83; Von Hoff DD, 2013, NEW ENGL J MED, V369, P1691, DOI 10.1056/NEJMoa1304369; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001	64	235	244	1	71	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAY	2016	18	5					549	+		10.1038/ncb3340	http://dx.doi.org/10.1038/ncb3340			24	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	DK3RH	27088855	Green Accepted, Green Submitted			2022-12-25	WOS:000374834600012
J	Strauss, SH; Sax, JK				Strauss, Steven H.; Sax, Joanna K.			Ending event-based regulation of GMO crops	NATURE BIOTECHNOLOGY			English	Letter							GENETICALLY-ENGINEERED CROPS; PATTERNS		[Strauss, Steven H.] Oregon State Univ, Forest Ecosyst & Soc, Corvallis, OR 97331 USA; [Sax, Joanna K.] Calif Western Sch Law, San Diego, CA USA	Oregon State University	Strauss, SH (corresponding author), Oregon State Univ, Forest Ecosyst & Soc, Corvallis, OR 97331 USA.	steve.strauss@oregonstate.edu						Adamczyk JJ, 2004, J INSECT SCI, V4, DOI 10.1093/jis/4.1.32; [Anonymous], 2015, ESASC STAT NEW BREED; [Anonymous], 2015, NAT BIOTECHNOL, V33, P1213; [Anonymous], 2015, NBC NEWS        0319; Beker M. P., 2014, ILSI ARGENTINA BIOTE; Bradford KJ, 2005, NAT BIOTECHNOL, V23, P439, DOI 10.1038/nbt1084; Camachol A, 2014, NAT BIOTECHNOL, V32, P1087, DOI 10.1038/nbt.3057; Cocciolone SM, 2000, GENETICS, V156, P839; GIDDINGS LV, 2009, SCI PROGR; Herman RA, 2013, J AGR FOOD CHEM, V61, P11695, DOI 10.1021/jf400135r; Herman RA, 2009, TRENDS BIOTECHNOL, V27, P555, DOI 10.1016/j.tibtech.2009.07.003; Holdren J., 2015, MEMORADUM HEADS FOOD; Kershon D.L., 2014, NABC REPORT, V26, P159; Miller JK, 2010, NAT BIOTECHNOL, V28, P1012, DOI 10.1038/nbt1010-1012; Pompeo M., 2015, PROTECTING OUR FARME; Povero G, 2011, J PLANT PHYSIOL, V168, P270, DOI 10.1016/j.jplph.2010.07.022; Prado JR, 2014, ANNU REV PLANT BIOL, V65, P769, DOI 10.1146/annurev-arplant-050213-040039; Ricroch A. E., 2015, CRIT REV BIOTECHNOL, V26, P1; Ricroch AE, 2013, NEW BIOTECHNOL, V30, P349, DOI 10.1016/j.nbt.2012.12.001; Schmitz RJ, 2013, NATURE, V495, P193, DOI 10.1038/nature11968; Schnell J, 2015, TRANSGENIC RES, V24, P1, DOI 10.1007/s11248-014-9843-7; Shi JP, 2015, CURR OPIN PLANT BIOL, V24, P47, DOI 10.1016/j.pbi.2015.01.008; Sparks B., 2010, GROWING PRODUCE; Steiner HY, 2013, PLANT PHYSIOL, V161, P1587, DOI 10.1104/pp.112.209817; Strauss SH, 2015, SCIENCE, V349, P794, DOI 10.1126/science.aab0493; Strauss SH, 2010, BIOSCIENCE, V60, P729, DOI 10.1525/bio.2010.60.9.10; Thukral N., 2013, REUTERS; UK Parliament, 2015, NEWS PARL; US Environmental Protection Agency Office of Pesticide Programs, 2014, EPAS REG BIOT US PES; US Environmental Protection Agency Office Pesticide Programs, 2011, CURR PREV REG SECT 3; US FDA, 2006, FED REGISTER, V71, P35688; US Food and Drug Administration, 1992, ADA FED REG, V57; USDA APHIS, 2015, FED REGISTER, V81, P6225; USDA-APHIS Biotechnology, 2016, REQ EXT NONR STAT PR; USDA-APHIS-Biotechnology, PET DET NONR STAT; Weber N, 2012, PLANT PHYSIOL, V160, P1842, DOI 10.1104/pp.112.204271; Wiedemann PM, 2005, ENVIRON HEALTH PERSP, V113, P402, DOI 10.1289/ehp.7538; Williams JW, 2007, FRONT ECOL ENVIRON, V5, P475, DOI 10.1890/070037; World Health Organization and Food and Agricultural Organization of the United Nations, 2009, COD AL FOODS DER MOD	39	22	23	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2016	34	5					474	477						4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DL6FL	27153272				2022-12-25	WOS:000375735000019
J	Helman, A; Klochendler, A; Azazmeh, N; Gabai, Y; Horwitz, E; Anzi, S; Swisa, A; Condiotti, R; Granit, RZ; Nevo, Y; Fixler, Y; Shreibman, D; Zamir, A; Tornovsky-Babeay, S; Dai, CH; Glaser, B; Powers-, AC; Shapiro, AMJ; Magnuson, MA; Dor, Y; Ben-Porath, I				Helman, Aharon; Klochendler, Agnes; Azazmeh, Narmen; Gabai, Yael; Horwitz, Elad; Anzi, Shira; Swisa, Avital; Condiotti, Reba; Granit, Roy Z.; Nevo, Yuval; Fixler, Yaakov; Shreibman, Dorin; Zamir, Amit; Tornovsky-Babeay, Sharona; Dai, Chunhua; Glaser, Benjamin; Powers-, Alvin C.; Shapiro, A. M. James; Magnuson, Mark A.; Dor, Yuval; Ben-Porath, Ittai			p16(Ink4a)-induced senescence of pancreatic beta cells enhances insulin secretion	NATURE MEDICINE			English	Article							CELLULAR SENESCENCE; INK4A/ARF EXPRESSION; CANCER; MICE; SIZE; PHOSPHORYLATION; METABOLISM; CLEARANCE; RETENTION; BIOMARKER	Cellular senescence is thought to contribute to age-associated deterioration of tissue physiology. The senescence effector p16(Ink4a) is expressed in pancreatic beta cells during aging and limits their proliferative potential; however, its effects on beta cell function are poorly characterized. We found that beta cell-specific activation of p16(Ink4a) in transgenic mice enhances glucose-stimulated insulin secretion (GSIS). In mice with diabetes, this leads to improved glucose homeostasis, providing an unexpected functional benefit. Expression of p16(Ink4a) in beta cells induces hallmarks of senescence-including cell enlargement, and greater glucose uptake and mitochondrial activity-which promote increased insulin secretion. GSIS increases during the normal aging of mice and is driven by elevated p16(Ink4a) activity. We found that islets from human adults contain p16(Ink4a)-expressing senescent beta cells and that senescence induced by p16(Ink4a) in a human beta cell line increases insulin secretion in a manner dependent, in part, on the activity of the mechanistic target of rapamycin (mTOR) and the peroxisome proliferator-activated receptor (PPAR)-gamma proteins. Our findings reveal a novel role for p16(Ink4a) and cellular senescence in promoting insulin secretion by beta cells and in regulating normal functional tissue maturation with age.	[Helman, Aharon; Klochendler, Agnes; Azazmeh, Narmen; Gabai, Yael; Horwitz, Elad; Anzi, Shira; Swisa, Avital; Condiotti, Reba; Granit, Roy Z.; Fixler, Yaakov; Shreibman, Dorin; Zamir, Amit; Dor, Yuval; Ben-Porath, Ittai] Hebrew Univ Jerusalem, Hadassah Med Sch, Inst Med Res Israel Canada, Dept Dev Biol & Canc Res, IL-91010 Jerusalem, Israel; [Nevo, Yuval] Hebrew Univ Jerusalem, Hadassah Med Sch, Computat Ctr, IL-91010 Jerusalem, Israel; [Tornovsky-Babeay, Sharona; Glaser, Benjamin] Hadassah Hebrew Univ, Med Ctr, Dept Internal Med, Endocrinol & Metab Serv, Jerusalem, Israel; [Dai, Chunhua; Powers-, Alvin C.] Vanderbilt Univ, Med Ctr, Dept Med, Div Diabet Endocrinol & Metab, Nashville, TN USA; [Powers-, Alvin C.; Magnuson, Mark A.] Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37212 USA; [Powers-, Alvin C.] Vet Affairs Tennessee Valley Healthcare Syst, Nashville, TN USA; [Shapiro, A. M. James] Univ Alberta, Dept Surg, Edmonton, AB, Canada; [Shapiro, A. M. James] Univ Alberta, Clin Islet Transplant Program, Edmonton, AB, Canada; [Magnuson, Mark A.] Vanderbilt Univ, Sch Med, Ctr Stem Cell Biol, Nashville, TN 37212 USA	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hadassah University Medical Center; Vanderbilt University; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; University of Alberta; University of Alberta; Vanderbilt University	Dor, Y; Ben-Porath, I (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Inst Med Res Israel Canada, Dept Dev Biol & Canc Res, IL-91010 Jerusalem, Israel.	yuvald@ekmd.huji.ac.il; ittaibp@mail.huji.ac.il	Magnuson, Mark/AAY-7172-2021; Glaser, Benjamin/F-8411-2017	Magnuson, Mark/0000-0002-8824-6499; Glaser, Benjamin/0000-0003-4711-5000; Granit, Roy Zvi/0000-0002-6487-2559; Helman, Aharon/0000-0002-3415-154X	Juvenile Diabetes Research Foundation; Israel Science Foundation [1009/13, 41.11]; Jacob and Lena Joels Memorial Foundation Senior Lectureship for Excellence in the Life and Medical Sciences; Diabetes Onderzoek Nederland; Alex U. Soyka program; US National Institutes of Health (NIH) Beta Cell Biology Consortium; Leona M. and Harry B. Helmsley Charitable Trust; Israeli Centers Of Research Excellence Program of the Planning and Budgeting Committee; United States Agency for International Development's American Schools and Hospitals Abroad Program; Network for Pancreatic Organ Donors with Diabetes (nPOD); US Department of Veterans Affairs; National Institute of Diabetes and Digestive and Kidney Diseases-NIH [DK089572, DK72473, DK104211]; Vanderbilt Diabetes Research and Training Center [DK20593]; Alberta Innovates [201201154] Funding Source: researchfish; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK106755, P30DK020593, UC4DK104211, U01DK089572, U01DK072473, P60DK020593] Funding Source: NIH RePORTER	Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Israel Science Foundation(Israel Science Foundation); Jacob and Lena Joels Memorial Foundation Senior Lectureship for Excellence in the Life and Medical Sciences; Diabetes Onderzoek Nederland; Alex U. Soyka program; US National Institutes of Health (NIH) Beta Cell Biology Consortium(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leona M. and Harry B. Helmsley Charitable Trust; Israeli Centers Of Research Excellence Program of the Planning and Budgeting Committee; United States Agency for International Development's American Schools and Hospitals Abroad Program(United States Agency for International Development (USAID)); Network for Pancreatic Organ Donors with Diabetes (nPOD); US Department of Veterans Affairs(US Department of Veterans Affairs); National Institute of Diabetes and Digestive and Kidney Diseases-NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Vanderbilt Diabetes Research and Training Center; Alberta Innovates; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank M. Barbacid for CDK4<SUP>lsl-R24C</SUP> mice, L. Philipson for MIP-CreER mice, R. Scharfmann for the EndoC-beta H2 cells; S. Efrat for the pTRIP Delta U3-CMV-nlsCre vector and C. Wright for the Pdx1-specific antibody. We thank N.E. Kidess-Bassir for histological preparation and T. Szoke for experimental assistance. This research was supported by a postdoctoral fellowship from the Juvenile Diabetes Research Foundation (A.H.) and by grants from Israel Science Foundation (grant no. 1009/13; I.B.-P.), the Jacob and Lena Joels Memorial Foundation Senior Lectureship for Excellence in the Life and Medical Sciences (I.B.-P.), Diabetes Onderzoek Nederland (Y.D. and I.B.-P.), the Alex U. Soyka program (Y.D. and I.B.-P.), the Juvenile Diabetes Research Foundation (Y.D. and A.C.P.), the US National Institutes of Health (NIH) Beta Cell Biology Consortium (Y.D.), the Leona M. and Harry B. Helmsley Charitable Trust (Y.D.), the Israeli Centers Of Research Excellence Program of the Planning and Budgeting Committee and the Israel Science Foundation (grant no. 41.11; Y.D.), the United States Agency for International Development's American Schools and Hospitals Abroad Program (Y.D. and I.B.-P.), the Network for Pancreatic Organ Donors with Diabetes (nPOD) (Y.D.), the US Department of Veterans Affairs (A.C.P.), the National Institute of Diabetes and Digestive and Kidney Diseases-NIH (grant no. DK089572 (A.C.P.), DK72473 (A.C.P.) and DK104211 (A.C.P.)), and the Vanderbilt Diabetes Research and Training Center (grant no. DK20593; A.C.P.). Organ procurement organizations partnering with nPOD are listed at http://www.jdrfnpod.org/our-partners.php.	Abella A, 2005, CELL METAB, V2, P239, DOI 10.1016/j.cmet.2005.09.003; Acosta JC, 2013, NAT CELL BIOL, V15, P978, DOI 10.1038/ncb2784; Ahmadian M, 2013, NAT MED, V19, P557, DOI 10.1038/nm.3159; Annicotte JS, 2009, NAT CELL BIOL, V11, P1017, DOI 10.1038/ncb1915; Avrahami D, 2015, CELL METAB, V22, P619, DOI 10.1016/j.cmet.2015.07.025; Baker DJ, 2016, NATURE, V530, P184, DOI 10.1038/nature16932; Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600; Bandyopadhyay D, 2007, AGING CELL, V6, P577, DOI 10.1111/j.1474-9726.2007.00308.x; Bao XY, 2012, MOL BIOL REP, V39, P1609, DOI 10.1007/s11033-011-0900-5; Basu R, 2003, DIABETES, V52, P1738, DOI 10.2337/diabetes.52.7.1738; Brady CA, 2011, CELL, V145, P571, DOI 10.1016/j.cell.2011.03.035; Burd CE, 2013, CELL, V152, P340, DOI 10.1016/j.cell.2012.12.010; Chandra T, 2015, CELL REP, V10, P471, DOI 10.1016/j.celrep.2014.12.055; Chang JH, 2016, NAT MED, V22, P78, DOI 10.1038/nm.4010; Chen HA, 2009, GENE DEV, V23, P975, DOI 10.1101/gad.1742509; Chicas A, 2010, CANCER CELL, V17, P376, DOI 10.1016/j.ccr.2010.01.023; Correia-Melo C, 2015, BBA-BIOENERGETICS, V1847, P1373, DOI 10.1016/j.bbabio.2015.05.017; Dai C, 2012, DIABETOLOGIA, V55, P707, DOI 10.1007/s00125-011-2369-0; Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191; Dorr JR, 2013, NATURE, V501, P421, DOI 10.1038/nature12437; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Fingar DC, 2002, GENE DEV, V16, P1472, DOI 10.1101/gad.995802; Gauthier BR, 2009, CELL METAB, V10, P110, DOI 10.1016/j.cmet.2009.07.002; GIORDANO E, 1993, AM J PHYSIOL, V265, pC358, DOI 10.1152/ajpcell.1993.265.2.C358; Gonzalez-Navarro H, 2013, AGING CELL, V12, P102, DOI 10.1111/acel.12023; GUMBINER B, 1989, DIABETES, V38, P1549, DOI 10.2337/diabetes.38.12.1549; Holland AM, 2002, P NATL ACAD SCI USA, V99, P12236, DOI 10.1073/pnas.192255099; Iozzo P, 1999, J CLIN ENDOCR METAB, V84, P863, DOI 10.1210/jc.84.3.863; Janzen V, 2006, NATURE, V443, P421, DOI 10.1038/nature05159; Kaplon J, 2013, NATURE, V498, P109, DOI 10.1038/nature12154; Kim WY, 2006, CELL, V127, P265, DOI 10.1016/j.cell.2006.10.003; Koyanagi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023238; Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475; Krishnamurthy J, 2006, NATURE, V443, P453, DOI 10.1038/nature05092; Kushner JA, 2013, J CLIN INVEST, V123, P990, DOI 10.1172/JCI64095; Lee YJ, 2014, NATURE, V510, P547, DOI 10.1038/nature13267; Lujambio A, 2013, CELL, V153, P449, DOI 10.1016/j.cell.2013.03.020; Milo-Landesman D, 2001, CELL TRANSPLANT, V10, P645; Molofsky AV, 2006, NATURE, V443, P448, DOI 10.1038/nature05091; Moreno-Asso A, 2013, DIABETOLOGIA, V56, P1761, DOI 10.1007/s00125-013-2930-0; Morita M, 2013, CELL METAB, V18, P698, DOI 10.1016/j.cmet.2013.10.001; Munoz-Espin D, 2014, NAT REV MOL CELL BIO, V15, P482, DOI 10.1038/nrm3823; Munoz-Espin D, 2013, CELL, V155, P1104, DOI 10.1016/j.cell.2013.10.019; Nardella C, 2011, NAT REV CANCER, V11, P503, DOI 10.1038/nrc3057; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Nicolay BN, 2015, GENE DEV, V29, P1875, DOI 10.1101/gad.264127.115; Nielsen GP, 1999, LAB INVEST, V79, P1137; Nir T, 2007, J CLIN INVEST, V117, P2553, DOI 10.1172/JCI32959; O'Gorman D, 2010, TRANSPLANTATION, V90, P255, DOI 10.1097/TP.0b013e3181e117ce; Ohn JH, 2016, LANCET DIABETES ENDO, V4, P27, DOI 10.1016/S2213-8587(15)00336-8; Rane SG, 1999, NAT GENET, V22, P44, DOI 10.1038/8751; Ruvinsky I, 2005, GENE DEV, V19, P2199, DOI 10.1101/gad.351605; Salama R, 2014, GENE DEV, V28, P99, DOI 10.1101/gad.235184.113; Scharfmann R, 2014, J CLIN INVEST, V124, P2087, DOI 10.1172/JCI72674; Sharpless NE, 2001, NATURE, V413, P86, DOI 10.1038/35092592; Stolovich-Rain M, 2015, DEV CELL, V32, P535, DOI 10.1016/j.devcel.2015.01.002; Storer M, 2013, CELL, V155, P1119, DOI 10.1016/j.cell.2013.10.041; Takebayashi S, 2015, AGING CELL, V14, P689, DOI 10.1111/acel.12351; Tokarsky-Amiel R, 2013, CANCER RES, V73, P2829, DOI 10.1158/0008-5472.CAN-12-3730; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Turner NC, 2015, NEW ENGL J MED, V373, P209, DOI 10.1056/NEJMoa1505270; van Arensbergen J, 2010, GENOME RES, V20, P722, DOI 10.1101/gr.101709.109; van Deursen JM, 2014, NATURE, V509, P439, DOI 10.1038/nature13193; Walsh RM, 2012, J GASTROINTEST SURG, V16, P1469, DOI 10.1007/s11605-012-1914-6; Wicksteed B, 2010, DIABETES, V59, P3090, DOI 10.2337/db10-0624; Wiederkehr A, 2012, MOL CELL ENDOCRINOL, V353, P128, DOI 10.1016/j.mce.2011.07.016	66	168	176	3	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2016	22	4					412	+		10.1038/nm.4054	http://dx.doi.org/10.1038/nm.4054			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DI4GF	26950362	Green Accepted			2022-12-25	WOS:000373457700017
J	Ji, Z; Song, RS; Huang, HL; Regev, A; Struhl, K				Ji, Zhe; Song, Ruisheng; Huang, Hailiang; Regev, Aviv; Struhl, Kevin			Transcriptome-scale RNase-footprinting of RNA-protein complexes	NATURE BIOTECHNOLOGY			English	Article							LONG NONCODING RNAS; IN-VIVO; NUCLEOTIDE RESOLUTION; BINDING PROTEIN; ELEMENTS; SITES; TRANSLATION; SPLICEOSOME; ANNOTATION; CLIP	Ribosome profiling is widely used to study translation in vivo, but not all sequence reads correspond to ribosome-protected RNA. Here we describe Rfoot, a computational pipeline that analyzes ribosomal profiling data and identifies native, nonribosomal RNA-protein complexes. We use Rfoot to precisely map RNase-protected regions within small nucleolar RNAs, spliceosomal RNAs, microRNAs, tRNAs, long noncoding (lnc) RNAs and 3' untranslated regions of mRNAs in human cells. We show that RNAs of the same class can show differential complex association. Although only a subset of lncRNAs show RNase footprints, many of these have multiple footprints, and the protected regions are evolutionarily conserved, suggestive of biological functions.	[Ji, Zhe; Song, Ruisheng; Struhl, Kevin] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Ji, Zhe; Huang, Hailiang; Regev, Aviv] Broad Inst MIT & Harvard, Cambridge, MA USA; [Huang, Hailiang] Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [Regev, Aviv] MIT, Dept Biol, Cambridge, MA USA; [Regev, Aviv] Howard Hughes Med Inst, Chevy Chase, MD USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute	Struhl, K (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.; Regev, A (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA USA.; Regev, A (corresponding author), MIT, Dept Biol, Cambridge, MA USA.; Regev, A (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD USA.	aregev@broadinstitute.org; kevin@hms.harvard.edu	SONG, RUISHENG/W-4784-2019; Ji, Zhe/P-7094-2018; Ji, Zhe/U-8320-2018	SONG, RUISHENG/0000-0002-6856-4721; Ji, Zhe/0000-0002-1809-8099; Huang, Hailiang/0000-0003-1461-5762	National Institutes of Health [CA 107486]; NATIONAL CANCER INSTITUTE [R01CA107486, U24CA180922] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG006193] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by grants to K.S. from the National Institutes of Health (CA 107486). A.R. is a Howard Hughes Investigator.	Baltz AG, 2012, MOL CELL, V46, P674, DOI 10.1016/j.molcel.2012.05.021; Batista PJ, 2013, CELL, V152, P1298, DOI 10.1016/j.cell.2013.02.012; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Diaz-Munoz MD, 2015, NAT IMMUNOL, V16, P415, DOI 10.1038/ni.3115; Eichhorn SW, 2014, MOL CELL, V56, P104, DOI 10.1016/j.molcel.2014.08.028; Freeberg MA, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-2-r13; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hendrickson TL, 2001, P NATL ACAD SCI USA, V98, P13473, DOI 10.1073/pnas.251549298; Hirsch HA, 2010, CANCER CELL, V17, P348, DOI 10.1016/j.ccr.2010.01.022; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; Ingolia NT, 2012, NAT PROTOC, V7, P1534, DOI 10.1038/nprot.2012.086; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Ji Z, 2015, ELIFE, V4, DOI 10.7554/eLife.08890; Kiss-Laszlo Z, 1998, EMBO J, V17, P797, DOI 10.1093/emboj/17.3.797; Matera AG, 2007, NAT REV MOL CELL BIO, V8, P209, DOI 10.1038/nrm2124; PEATTIE DA, 1981, P NATL ACAD SCI-BIOL, V78, P2273, DOI 10.1073/pnas.78.4.2273; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Russell AG, 2006, NATURE, V443, P863, DOI 10.1038/nature05228; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Silverman IM, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-1-r3; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Will CL, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003707; Zhang CL, 2011, NAT BIOTECHNOL, V29, P607, DOI 10.1038/nbt.1873	25	33	33	1	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	APR	2016	34	4					410	+		10.1038/nbt.3441	http://dx.doi.org/10.1038/nbt.3441			5	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DI6NL	26900662	Green Submitted, Green Accepted			2022-12-25	WOS:000373616100021
J	Tai, YS; Xiong, MY; Jambunathan, P; Wang, JY; Wang, JL; Stapleton, C; Zhang, KC				Tai, Yi-Shu; Xiong, Mingyong; Jambunathan, Pooja; Wang, Jingyu; Wang, Jilong; Stapleton, Cole; Zhang, Kechun			Engineering nonphosphorylative metabolism to generate lignocellulose-derived products	NATURE CHEMICAL BIOLOGY			English	Article							L-ARABINOSE METABOLISM; D-XYLOSE METABOLISM; ESCHERICHIA-COLI; L-2-KETO-3-DEOXYARABONATE DEHYDRATASE; ALCOHOL-DEHYDROGENASE; LACTOCOCCUS-LACTIS; PSEUDOMONAS-PUTIDA; PENTOSE OXIDATION; AMINO-ACIDS; ONE-STEP	Conversion of lignocellulosic biomass into value-added products provides important environmental and economic benefits. Here we report the engineering of an unconventional metabolism for the production of tricarboxylic acid (TCA)-cycle derivatives from D-xylose, L-arabinose and D-galacturonate. We designed a growth-based selection platform to identify several gene clusters functional in Escherichia coli that can perform this nonphosphorylative assimilation of sugars into the TCA cycle in less than six steps. To demonstrate the application of this new metabolic platform, we built artificial biosynthetic pathways to 1,4-butanediol (BDO) with a theoretical molar yield of 100%. By screening and engineering downstream pathway enzymes, 2-ketoacid decarboxylases and alcohol dehydrogenases, we constructed E. coli strains capable of producing BDO from D-xylose, L-arabinose and D-galacturonate. The titers, rates and yields were higher than those previously reported using conventional pathways. This work demonstrates the potential of nonphosphorylative metabolism for biomanufacturing with improved biosynthetic efficiencies.	[Tai, Yi-Shu; Xiong, Mingyong; Jambunathan, Pooja; Wang, Jingyu; Wang, Jilong; Stapleton, Cole; Zhang, Kechun] Univ Minnesota, Dept Chem Engn & Mat Sci, 421 Washington Ave SE, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Zhang, KC (corresponding author), Univ Minnesota, Dept Chem Engn & Mat Sci, 421 Washington Ave SE, Minneapolis, MN 55455 USA.	kzhang@umn.edu		Wang, Jingyu/0000-0002-8209-7576	Office for Technology Commercialization of the University of Minnesota; McKnight Land Grant Professorship Program; National Science Foundation through the Center for Sustainable Polymers [CHE-1413862]	Office for Technology Commercialization of the University of Minnesota; McKnight Land Grant Professorship Program; National Science Foundation through the Center for Sustainable Polymers	This work was supported by research grants from the Office for Technology Commercialization of the University of Minnesota, the McKnight Land Grant Professorship Program and the National Science Foundation through the Center for Sustainable Polymers (CHE-1413862). We thank M. McClintock and K. Fox for assisting with revisions that greatly improved the article.	Andberg M, 2012, J BIOL CHEM, V287, P17662, DOI 10.1074/jbc.M111.335240; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bastian S, 2011, METAB ENG, V13, P345, DOI 10.1016/j.ymben.2011.02.004; Berthold CL, 2007, ACTA CRYSTALLOGR D, V63, P1217, DOI 10.1107/S0907444907050433; Boer H, 2010, APPL MICROBIOL BIOT, V86, P901, DOI 10.1007/s00253-009-2333-9; Brouns SJJ, 2006, J BIOL CHEM, V281, P27378, DOI 10.1074/jbc.M605549200; Cirino PC, 2006, BIOTECHNOL BIOENG, V95, P1167, DOI 10.1002/bit.21082; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; de la Plaza M, 2004, FEMS MICROBIOL LETT, V238, P367, DOI 10.1016/j.femsle.2004.07.057; Djurdjevic I, 2011, APPL ENVIRON MICROB, V77, P320, DOI 10.1128/AEM.02049-10; DUNCAN MJ, 1979, J GEN MICROBIOL, V113, P177, DOI 10.1099/00221287-113-1-177; Edwards MC, 2011, APPL ENVIRON MICROB, V77, P5184, DOI 10.1128/AEM.05700-11; Engler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003647; Gao DH, 2013, P NATL ACAD SCI USA, V110, P10922, DOI 10.1073/pnas.1213426110; Gorke B, 2008, NAT REV MICROBIOL, V6, P613, DOI 10.1038/nrmicro1932; Graham-Rowe D, 2011, NATURE, V474, pS6, DOI 10.1038/474S06a; Himmel ME, 1994, ENZYMATIC CONVERSION; Hosoya S, 2002, FEMS MICROBIOL LETT, V210, P193, DOI 10.1111/j.1574-6968.2002.tb11180.x; Iding H, 2000, CHEM-EUR J, V6, P1483; Larroy C, 2002, BIOCHEM J, V361, P163, DOI 10.1042/0264-6021:3610163; Li CL, 2011, BIORESOURCE TECHNOL, V102, P6928, DOI 10.1016/j.biortech.2011.04.005; Lin YH, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3603; Liu HW, 2015, METAB ENG, V29, P135, DOI 10.1016/j.ymben.2015.03.009; Liu HW, 2013, APPL MICROBIOL BIOT, V97, P3409, DOI 10.1007/s00253-012-4618-7; Meijnen JP, 2009, APPL ENVIRON MICROB, V75, P2784, DOI 10.1128/AEM.02713-08; Moore RA, 2004, INFECT IMMUN, V72, P4172, DOI 10.1128/IAI.72.7.4172-4187.2004; Niu W, 2003, J AM CHEM SOC, V125, P12998, DOI 10.1021/ja036391+; NOVICK NJ, 1982, J BACTERIOL, V149, P364, DOI 10.1128/JB.149.1.364-367.1982; Oshima T, 2006, MICROBIOL-SGM, V152, P2129, DOI 10.1099/mic.0.28753-0; Perlack R.D., 2005, BIOMASS FEEDSTOCK BI; Pharkya P, 2003, BIOTECHNOL BIOENG, V84, P887, DOI 10.1002/bit.10857; Radek A, 2014, J BIOTECHNOL, V192, P156, DOI 10.1016/j.jbiotec.2014.09.026; Shaw AJ, 2008, P NATL ACAD SCI USA, V105, P13769, DOI 10.1073/pnas.0801266105; Steen EJ, 2010, NATURE, V463, P559, DOI 10.1038/nature08721; Stephens C, 2007, J BACTERIOL, V189, P2181, DOI 10.1128/JB.01438-06; STOOLMILLER AC, 1966, J BIOL CHEM, V241, P5764; Watanabe S, 2006, J BIOL CHEM, V281, P33521, DOI 10.1074/jbc.M606727200; Wei N, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3580; WEIMBERG R, 1961, J BIOL CHEM, V236, P629; Xiong MY, 2014, P NATL ACAD SCI USA, V111, P8357, DOI 10.1073/pnas.1404596111; Xiong MY, 2012, SCI REP-UK, V2, DOI 10.1038/srep00311; Yim H, 2011, NAT CHEM BIOL, V7, P445, DOI [10.1038/NCHEMBIO.580, 10.1038/nchembio.580]; Yoon SH, 2009, J BACTERIOL, V191, P1565, DOI 10.1128/JB.00586-08; Zhang KF, 2014, IEICE ELECTRON EXPR, V11, DOI 10.1587/elex.11.20131003; Zhang KC, 2011, CHEMSUSCHEM, V4, P1068, DOI 10.1002/cssc.201100045; Zhang KC, 2008, P NATL ACAD SCI USA, V105, P20653, DOI 10.1073/pnas.0807157106	46	84	89	7	96	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	APR	2016	12	4					247	+		10.1038/NCHEMBIO.2020	http://dx.doi.org/10.1038/NCHEMBIO.2020			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH2DA	26854668				2022-12-25	WOS:000372593200011
J	Kvedar, JC; Fogel, AL; Elenko, E; Zohar, D				Kvedar, Joseph C.; Fogel, Alexander L.; Elenko, Eric; Zohar, Daphne			Digital medicine's march on chronic disease	NATURE BIOTECHNOLOGY			English	Editorial Material							UNITED-STATES; ADHERENCE; THERAPY; MEDICATION; TRIAL		[Kvedar, Joseph C.] Massachusetts Gen Hosp, Dept Dermatol, Boston, MA 02114 USA; [Kvedar, Joseph C.] Harvard Univ, Sch Med, Boston, MA USA; [Kvedar, Joseph C.] Partners Healthcare, Partners Connected Hlth, Boston, MA USA; [Fogel, Alexander L.] Stanford Univ, Grad Sch Business, Stanford, CA 94305 USA; [Fogel, Alexander L.] Stanford Univ, Sch Med, Stanford, CA 94305 USA; [Elenko, Eric; Zohar, Daphne] PureTech Hlth, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Partners Healthcare System; Stanford University; Stanford University	Zohar, D (corresponding author), PureTech Hlth, Boston, MA USA.	DaphneNB@puretechhealth.com						Alzheimer's Association, 2015, 2015 ALZH DIS FACTS; Andersson G, 2014, WORLD PSYCHIATRY, V13, P288, DOI 10.1002/wps.20151; Anguera JA, 2013, NATURE, V501, P97, DOI 10.1038/nature12486; [Anonymous], 2015, 2015 EMPL BEN SURV; [Anonymous], CHRON OBSTR PULM DIS; [Anonymous], DIAB PREV REC PROGR; Au-Yeung KY, 2012, INT J TUBERC LUNG D, V16, P1498, DOI 10.5588/ijtld.11.0868; Belknap R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053373; Boland MV, 2014, JAMA OPHTHALMOL, V132, P845, DOI 10.1001/jamaophthalmol.2014.857; Brewer JA, 2011, DRUG ALCOHOL DEPEN, V119, P72, DOI 10.1016/j.drugalcdep.2011.05.027; Bricker JB, 2014, DRUG ALCOHOL DEPEN, V143, P87, DOI 10.1016/j.drugalcdep.2014.07.006; Centers for Disease Control and Prevention, 2014 NAT DIAB STAT R; Centers for Disease Control and Prevention, 2015, STROK FACTS; Centers for Disease Control and Prevention, 2015, CHRON DIS OV; Centers for Disease Control and Prevention, DEATHS AND MORT; Centers for Disease Control and Prevention, LEAD CAUS DEATH 1900; Centers for Disease Control and Prevention, ATT DEF HYP DIS ADHD; Centers for Disease Control and Prevention (CDC), 2016, AUT SPECTR DIS ASD; Centers for Disease Control and Prevention (US), SMOK TOB US; Crimmins EM, 2015, GERONTOLOGIST, V55, P901, DOI 10.1093/geront/gnv130; Cutler A., 2015, AM AC CHILD AD PSYCH; Delbanco S, PAYMENT REFORM LANDS; Elenko E, 2015, NAT BIOTECHNOL, V33, P697, DOI 10.1038/nbt.3284; Elenko E, 2015, NAT BIOTECHNOL, V33, P456, DOI 10.1038/nbt.3222; Gaskin DJ, 2012, J PAIN, V13, P715, DOI 10.1016/j.jpain.2012.03.009; Gerteis J, MULTIPLE CHRONIC CON; Iuga AO, 2014, RISK MANAG HEALTHC P, V7, P35, DOI 10.2147/RMHP.S19801; Kish LJ, 2015, NAT BIOTECHNOL, V33, P921, DOI 10.1038/nbt.3340; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Nathan DM, 2007, DIABETES CARE, V30, P753, DOI 10.2337/dc07-9920; National Institute of Mental Health, AN TOT DIR IND COSTS; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Pew Research Center, 2013, BROADB TECHN FACT SH; Pew Research Center, 2014, MOB TECHN FACT SHEET; Quinn CC, 2011, DIABETES CARE, V34, P1934, DOI 10.2337/dc11-0366; Renders C.M., 2001, COCHRANE DB SYST REV, V2001; Rice JB, 2014, DIABETES CARE, V37, P651, DOI 10.2337/dc13-2176; Sepah SC, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.4052; US Department of Health & Human Services, BETT SMART HLTH; Viswanathan M, 2012, ANN INTERN MED, V157, P785, DOI 10.7326/0003-4819-157-11-201212040-00538; Ward BW, 2014, PREV CHRONIC DIS, V11, DOI 10.5888/pcd11.130389	41	70	74	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2016	34	3					239	246		10.1038/nbt.3495	http://dx.doi.org/10.1038/nbt.3495			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DG1CJ	26963544	Bronze			2022-12-25	WOS:000371802600014
J	Lecca, S; Pelosi, A; Tchenio, A; Moutkine, I; Lujan, R; Herve, D; Mameli, M				Lecca, Salvatore; Pelosi, Assunta; Tchenio, Anna; Moutkine, Imane; Lujan, Rafael; Herve, Denis; Mameli, Manuel			Rescue of GABA(B) and GIRK function in the lateral habenula by protein phosphatase 2A inhibition ameliorates depression-like phenotypes in mice	NATURE MEDICINE			English	Article							LEARNED HELPLESSNESS; COUPLED RECEPTORS; SIGNALING COMPLEX; DOPAMINE NEURONS; STRESS; CHANNEL; ACTIVATION; REWARD; ADDICTION; SYMPTOMS	The lateral habenula (LHb) encodes aversive signals, and its aberrant activity contributes to depression-like symptoms. However, a limited understanding of the cellular mechanisms underlying LHb hyperactivity has precluded the development of pharmacological strategies to ameliorate depression-like phenotypes. Here we report that an aversive experience in mice, such as foot-shock exposure (FsE), induces LHb neuronal hyperactivity and depression-like symptoms. This occurs along with increased protein phosphatase 2A (PP2A) activity, a known regulator of GABA(B) receptor (GABA(B)R) and G protein gated inwardly rectifying potassium (GIRK) channel surface expression. Accordingly, FsE triggers GABA(B1) and GIRK2 internalization, leading to rapid and persistent weakening of GABA(B)-activated GIRK-mediated (GABA(B)-GIRK) currents. Pharmacological inhibition of PP2A restores both GABA(B)-GIRK function and neuronal excitability. As a consequence, PP2A inhibition ameliorates depression-like symptoms after FsE and in a learned-helplessness model of depression. Thus, GABA(B)-GIRK-GIRK plasticity in the LHb represents a cellular substrate for aversive experience. Furthermore, its reversal by PP2A inhibition may provide a novel therapeutic approach to alleviate symptoms of depression in disorders that are characterized by LHb hyperactivity.	[Lecca, Salvatore; Pelosi, Assunta; Tchenio, Anna; Moutkine, Imane; Herve, Denis; Mameli, Manuel] Inst Fer Moulin, Paris, France; [Lecca, Salvatore; Pelosi, Assunta; Tchenio, Anna; Moutkine, Imane; Herve, Denis; Mameli, Manuel] INSERM, UMR S839, Paris, France; [Lecca, Salvatore; Pelosi, Assunta; Tchenio, Anna; Moutkine, Imane; Herve, Denis; Mameli, Manuel] Univ Paris 06, Paris, France; [Lujan, Rafael] Inst Invest Discapacidades Neurol, Albacete, Spain; [Lujan, Rafael] Univ Castilla La Mancha, Fac Med, Dept Ciencias Med, Campus Biosanitario, Albacete, Spain	UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universidad de Castilla-La Mancha	Mameli, M (corresponding author), Inst Fer Moulin, Paris, France.; Mameli, M (corresponding author), INSERM, UMR S839, Paris, France.; Mameli, M (corresponding author), Univ Paris 06, Paris, France.	manuel.mameli@inserm.fr	Lujan, Rafael/G-2555-2015; HERVE, Denis/E-2929-2017	HERVE, Denis/0000-0003-1376-1522; Lujan Miras, Rafael/0000-0003-2001-9545; Mameli, Manuel/0000-0002-0570-6964; Lecca, Salvatore/0000-0001-5411-5485; Pelosi, Assunta/0000-0002-6927-4494	INSERM Atip-Avenir program; European Research Council [335333]; Paris School of Neuroscience Network (ENP) Chair of Excellence; Junta de Comunidades de Castilla-La Mancha [PPII-2014-005-P]	INSERM Atip-Avenir program; European Research Council(European Research Council (ERC)European Commission); Paris School of Neuroscience Network (ENP) Chair of Excellence; Junta de Comunidades de Castilla-La Mancha(Junta de Comunidades de Castilla-La Mancha)	We thank C. Bellone, M. Carta, E. Schwartz, C. Luscher, F.J. Meye and members of the Mameli laboratory for discussions and comments on the manuscript. This work was supported by funds from the INSERM Atip-Avenir program (M.M.), a European Research Council starting grant (grant no. SalienSy 335333; M.M.), the Paris School of Neuroscience Network (ENP) Chair of Excellence (M.M.) and the Junta de Comunidades de Castilla-La Mancha (grant no. PPII-2014-005-P; R.L.). The Mameli laboratory is part of the Initiative of Excellence Labex BioPsy network. We thank J. Kovach and Lixte Biotechnology Holdings, Inc. for the gift of LB-100. The monoclonal antibody specific to GABA<INF>B1</INF> (clone N93A/49) was developed by the University of California, Davis-US National Institutes of Health NeuroMab facility (Department of Neurobiology, Physiology and Behavior, College of Biological Sciences, University of California, Davis).	Bagdy Gyorgy, 2012, Neuropsychopharmacol Hung, V14, P213; Beaulieu JM, 2005, CELL, V122, P261, DOI 10.1016/j.cell.2005.05.012; BREIER A, 1987, AM J PSYCHIAT, V144, P1419; Brown PL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060678; Buynitsky T, 2009, NEUROSCI BIOBEHAV R, V33, P1089, DOI 10.1016/j.neubiorev.2009.05.004; Chan SF, 2001, J NEUROSCI, V21, P7985, DOI 10.1523/JNEUROSCI.21-20-07985.2001; Chourbaji S, 2005, BRAIN RES PROTOC, V16, P70, DOI 10.1016/j.brainresprot.2005.09.002; Clancy SM, 2007, J NEUROSCI, V27, P6388, DOI 10.1523/JNEUROSCI.1190-07.2007; Cryan JF, 2010, ADV PHARMACOL, V58, P427, DOI 10.1016/S1054-3589(10)58016-5; Fatemi SH, 2011, SCHIZOPHR RES, V128, P37, DOI 10.1016/j.schres.2010.12.025; Gonzalez-Maeso J, 2003, EUR J PHARMACOL, V481, P15, DOI 10.1016/j.ejphar.2003.09.002; Guetg N, 2010, P NATL ACAD SCI USA, V107, P13924, DOI 10.1073/pnas.1000909107; Hearing M, 2013, NEURON, V80, P159, DOI 10.1016/j.neuron.2013.07.019; Henn FA, 2008, BIOL PSYCHIAT, V63, P1101, DOI 10.1016/j.biopsych.2008.04.008; Jhou TC, 2013, J NEUROSCI, V33, P7501, DOI 10.1523/JNEUROSCI.3634-12.2013; Jhou TC, 2009, NEURON, V61, P786, DOI 10.1016/j.neuron.2009.02.001; Jourdain P, 2003, J NEUROSCI, V23, P10645; Kawaura K, 2010, YAKUGAKU ZASSHI, V130, P699, DOI 10.1248/yakushi.130.699; Knoll AT, 2010, BRAIN RES, V1314, P56, DOI 10.1016/j.brainres.2009.09.074; Lalive AL, 2014, J NEUROSCI, V34, P5107, DOI 10.1523/JNEUROSCI.5203-13.2014; Lammel S, 2012, NATURE, V491, P212, DOI 10.1038/nature11527; Lavine N, 2002, J BIOL CHEM, V277, P46010, DOI 10.1074/jbc.M205035200; Lecca S, 2014, EUR J NEUROSCI, V39, P1170, DOI 10.1111/ejn.12480; Li B, 2011, NATURE, V470, P535, DOI 10.1038/nature09742; Li K, 2013, SCIENCE, V341, P1016, DOI 10.1126/science.1240729; Llamosas N., 2015, INT J NEUROPSYCHOPH, V18; LOGOTHETIS DE, 1987, NATURE, V325, P321, DOI 10.1038/325321a0; Lu J, 2009, P NATL ACAD SCI USA, V106, P11697, DOI 10.1073/pnas.0905930106; Luscher C, 2010, NAT REV NEUROSCI, V11, P301, DOI 10.1038/nrn2834; Luthi A, 2014, NAT NEUROSCI, V17, P1635, DOI 10.1038/nn.3849; Lujan R, 2014, TRENDS NEUROSCI, V37, P20, DOI 10.1016/j.tins.2013.10.006; MAIER SF, 1984, PROG NEURO-PSYCHOPH, V8, P435, DOI 10.1016/S0278-5846(84)80032-9; Matsumoto M, 2007, NATURE, V447, P1111, DOI 10.1038/nature05860; Menard C., 2015, NEUROSCIENCE; Meye FJ, 2015, NAT NEUROSCI, V18, P376, DOI 10.1038/nn.3923; Morinobu S, 2003, BIOL PSYCHIAT, V54, P1060, DOI 10.1016/S0006-3223(03)00417-7; Morris JS, 1999, NEUROIMAGE, V10, P163, DOI 10.1006/nimg.1999.0455; Mucic G, 2015, BEHAV BRAIN RES, V280, P45, DOI 10.1016/j.bbr.2014.11.024; Nemeroff CB, 1998, SCI AM, V278, P42, DOI 10.1038/scientificamerican0698-42; Nobles M, 2005, P NATL ACAD SCI USA, V102, P18706, DOI 10.1073/pnas.0504778102; OVERMIER JB, 1967, J COMP PHYSIOL PSYCH, V63, P28, DOI 10.1037/h0024166; Padgett CL, 2012, NEURON, V73, P978, DOI 10.1016/j.neuron.2011.12.031; PORSOLT RD, 1977, ARCH INT PHARMACOD T, V229, P327; Proulx CD, 2014, NAT NEUROSCI, V17, P1146, DOI 10.1038/nn.3779; Riven I, 2006, NEURON, V51, P561, DOI 10.1016/j.neuron.2006.08.017; Shabel SJ, 2014, SCIENCE, V345, P1494, DOI 10.1126/science.1250469; Shumake J, 2003, BRAIN RES, V963, P274, DOI 10.1016/S0006-8993(02)04048-9; Stamatakis AM, 2012, NAT NEUROSCI, V15, P1105, DOI 10.1038/nn.3145; Strekalova T, 2004, NEUROPSYCHOPHARMACOL, V29, P2007, DOI 10.1038/sj.npp.1300532; Takahashi LK, 2005, NEUROSCI BIOBEHAV R, V29, P1157, DOI 10.1016/j.neubiorev.2005.04.008; Terunuma M, 2010, ADV PHARMACOL, V58, P113, DOI 10.1016/S1054-3589(10)58005-0; Tye KM, 2013, NATURE, V493, P537, DOI 10.1038/nature11740; Vollmayr B, 2001, BRAIN RES PROTOC, V8, P1, DOI 10.1016/S1385-299X(01)00067-8; Wang MH, 2014, J NEUROSCI, V34, P7485, DOI 10.1523/JNEUROSCI.5294-13.2014; Wei DP, 2013, CLIN CANCER RES, V19, P4422, DOI 10.1158/1078-0432.CCR-13-0788; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	56	95	96	0	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2016	22	3					254	261		10.1038/nm.4037	http://dx.doi.org/10.1038/nm.4037			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DF6DC	26808347				2022-12-25	WOS:000371445100012
J	Peng, JC; Valouev, A; Liu, N; Lin, HF				Peng, Jamy C.; Valouev, Anton; Liu, Na; Lin, Haifan			Piwi maintains germline stem cells and oogenesis in Drosophila through negative regulation of Polycomb group proteins	NATURE GENETICS			English	Article							HISTONE METHYLTRANSFERASE ACTIVITY; CAENORHABDITIS-ELEGANS; PIRNA PATHWAY; TUDOR-DOMAIN; PC-G; MECHANISM; INTERACTS; GENOME; DIVISION; BINDING	The Drosophila melanogaster Piwi protein regulates both niche and intrinsic mechanisms to maintain germline stem cells, but its underlying mechanism remains unclear. Here we report that Piwi interacts with Polycomb group complexes PRC1 and PRC2 in niche and germline cells to regulate ovarian germline stem cells and oogenesis. Piwi physically interacts with the PRC2 subunits Su(z)12 and Esc in the ovary and in vitro. Chromatin coimmunoprecipitation of Piwi, the PRC2 enzymatic subunit E(z), histone H3 trimethylated at lysine 27 (H3K27me3) and RNA polymerase II in wild-type and piwi mutant ovaries demonstrates that Piwi binds a conserved DNA motif at similar to 72 genomic sites and inhibits PRC2 binding to many non-Piwi-binding genomic targets and H3K27 trimethylation. Moreover, Piwi influences RNA polymerase II activities in Drosophila ovaries, likely via inhibiting PRC2. We hypothesize that Piwi negatively regulates PRC2 binding by sequestering PRC2 in the nucleoplasm, thus reducing PRC2 binding to many targets and influencing transcription during oogenesis.	[Peng, Jamy C.; Liu, Na; Lin, Haifan] Yale Univ, Yale Stem Cell Ctr, New Haven, CT USA; [Peng, Jamy C.; Liu, Na; Lin, Haifan] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA; [Valouev, Anton] Univ So Calif, Keck Sch Med, Dept Prevent Med, Div Bioinformat, Los Angeles, CA 90033 USA; [Lin, Haifan] Shanghai Inst Adv Immunochem Studies, Shanghai, Peoples R China; [Lin, Haifan] ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai, Peoples R China; [Peng, Jamy C.] St Jude Childrens Res Hosp, Dept Dev Neurobiol, Div Dev Biol, 332 N Lauderdale St, Memphis, TN 38105 USA	Yale University; Yale University; University of Southern California; ShanghaiTech University; St Jude Children's Research Hospital	Peng, JC; Lin, HF (corresponding author), Yale Univ, Yale Stem Cell Ctr, New Haven, CT USA.; Peng, JC; Lin, HF (corresponding author), Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA.; Lin, HF (corresponding author), Shanghai Inst Adv Immunochem Studies, Shanghai, Peoples R China.; Lin, HF (corresponding author), ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai, Peoples R China.; Peng, JC (corresponding author), St Jude Childrens Res Hosp, Dept Dev Neurobiol, Div Dev Biol, 332 N Lauderdale St, Memphis, TN 38105 USA.	jamy.peng@stjude.org; haifan.lin@yale.edu	Peng, Jamy/N-1134-2018	Peng, Jamy/0000-0002-4043-8475	US National Institutes of Health Pioneer Award [DP1CA174418]; Mathers Award; US National Institutes of Health [1200-HD071011]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K99HD071011, R00HD071011] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [DP1CA174418] Funding Source: NIH RePORTER	US National Institutes of Health Pioneer Award; Mathers Award; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank R. Jones (Southern Methodist University) for the E(463 fly stock, F. Peronnet (Institut de Biologie, Paris) for the corto<SUP>420</SUP> fly stock, V. Pirotta (Rutgers University) for the antibody to Pc, H. Siomi (Keio University) for the antibody to Piwi, D. Godt (University of Toronto) for the antibody to Tj, and A. Fire and members of the Lin laboratory for assistance and discussions. We also thank H. Qi and J. Klein for experimental help, M. Reddivari for the isolation of recombinant PRC2 complex, Z. Albertyn and C. Hercus for help with Novoalign, and N. Neuenkirchen and X. Cui for critical reading. This work was supported by a US National Institutes of Health Pioneer Award (DP1CA174418) and the Mathers Award to H.L. and by a US National Institutes of Health grant (1200-HD071011) to J.C.P.	Aravin AA, 2007, SCIENCE, V318, P761, DOI 10.1126/science.1146484; Billi AC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003392; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Brower-Toland B, 2007, GENE DEV, V21, P2300, DOI 10.1101/gad.1564307; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Chen C, 2009, P NATL ACAD SCI USA, V106, P20336, DOI 10.1073/pnas.0911640106; Cox DN, 1998, GENE DEV, V12, P3715, DOI 10.1101/gad.12.23.3715; Cox DN, 2000, DEVELOPMENT, V127, P503; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; Deng W, 2001, INT REV CYTOL, V203, P93; Eun SH, 2014, SCIENCE, V343, P1513, DOI 10.1126/science.1246514; Grimaud C, 2006, CELL, V124, P957, DOI 10.1016/j.cell.2006.01.036; Ho L, 2011, NAT CELL BIOL, V13, P903, DOI 10.1038/ncb2285; Holdeman R, 1998, DEVELOPMENT, V125, P2457; Huang XA, 2013, DEV CELL, V24, P502, DOI 10.1016/j.devcel.2013.01.023; Iovino N, 2013, DEV CELL, V26, P431, DOI 10.1016/j.devcel.2013.06.021; Kodjabachian L, 1998, EMBO J, V17, P1063, DOI 10.1093/emboj/17.4.1063; Korf I, 1998, DEVELOPMENT, V125, P2469; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Lin H, 2008, COLD SH Q B, V73, P273, DOI 10.1101/sqb.2008.73.056; Lin HF, 2015, DEV CELL, V32, P772, DOI 10.1016/j.devcel.2015.03.004; Lin HF, 1997, DEVELOPMENT, V124, P2463; Liu L, 2011, DEVELOPMENT, V138, P1863, DOI 10.1242/dev.059287; Lopez A, 2001, MOL GENET GENOMICS, V266, P572, DOI 10.1007/s004380100572; Margueron R, 2009, NATURE, V461, P762, DOI 10.1038/nature08398; Marinov GK, 2015, DEV CELL, V32, P765, DOI 10.1016/j.devcel.2015.01.013; Mi HY, 2013, NUCLEIC ACIDS RES, V41, pD377, DOI 10.1093/nar/gks1118; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Pal-Bhadra M, 2002, MOL CELL, V9, P315, DOI 10.1016/S1097-2765(02)00440-9; PalBhadra M, 1997, CELL, V90, P479, DOI 10.1016/S0092-8674(00)80508-5; Peng JC, 2009, CELL, V139, P1290, DOI 10.1016/j.cell.2009.12.002; Salvaing J, 2003, NUCLEIC ACIDS RES, V31, P2873, DOI 10.1093/nar/gkg381; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Shen XH, 2009, CELL, V139, P1303, DOI 10.1016/j.cell.2009.12.003; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Smulders-Srinivasan TK, 2003, GENETICS, V165, P1971; Smulders-Srinivasan TK, 2010, GENETICS, V186, P573, DOI 10.1534/genetics.110.119081; Sytnikova YA, 2014, GENOME RES, V24, P1977, DOI 10.1101/gr.178129.114; Thomson T, 2009, ANNU REV CELL DEV BI, V25, P355, DOI 10.1146/annurev.cellbio.24.110707.175327; Vagin VV, 2009, GENE DEV, V23, P1749, DOI 10.1101/gad.1814809; Valouev A, 2008, NAT METHODS, V5, P829, DOI 10.1038/NMETH.1246; Wang JQ, 2009, CURR BIOL, V19, P640, DOI 10.1016/j.cub.2009.02.061; Watanabe T, 2015, GENOME RES, V25, P368, DOI 10.1101/gr.180802.114; Yan D, 2014, DEV CELL, V28, P459, DOI 10.1016/j.devcel.2014.01.020; Yin H, 2007, NATURE, V450, P304, DOI 10.1038/nature06263	45	31	33	1	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2016	48	3					283	291		10.1038/ng.3486	http://dx.doi.org/10.1038/ng.3486			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DE8QW	26780607	Green Accepted			2022-12-25	WOS:000370902600012
J	Schneider, RK; Schenone, M; Ferreira, MV; Kramann, R; Joyce, CE; Hartigan, C; Beier, F; Brummendorf, TH; Germing, U; Platzbecker, U; Busche, G; Knuchel, R; Chen, MC; Waters, CS; Chen, E; Chu, LP; Novina, CD; Lindsley, RC; Carr, SA; Ebert, BL				Schneider, Rebekka K.; Schenone, Monica; Ferreira, Monica Ventura; Kramann, Rafael; Joyce, Cailin E.; Hartigan, Christina; Beier, Fabian; Bruemmendorf, Tim H.; Germing, Ulrich; Platzbecker, Uwe; Buesche, Guntram; Knuechel, Ruth; Chen, Michelle C.; Waters, Christopher S.; Chen, Edwin; Chu, Lisa P.; Novina, Carl D.; Lindsley, R. Coleman; Carr, Steven A.; Ebert, Benjamin L.			Rps14 haploinsufficiency causes a block in erythroid differentiation mediated by S100A8 and S100A9	NATURE MEDICINE			English	Article							HEMATOPOIETIC STEM-CELLS; RISK MYELODYSPLASTIC SYNDROME; DIAMOND-BLACKFAN ANEMIA; BONE-MARROW; MYELOID-LEUKEMIA; HUMAN 5Q-SYNDROME; SUPPRESSOR-CELLS; UP-REGULATION; DELETION 5Q; MOUSE MODEL	Impaired erythropoiesis in the deletion 5q (del(5q)) subtype of myelodysplastic syndrome (MDS) has been linked to heterozygous deletion of RPS14; which encodes the ribosomal protein small subunit 14. We generated mice with conditional inactivation of Rps14 and demonstrated an erythroid differentiation defect that is dependent on the tumor suppressor protein p53 (encoded by Trp53 in mice) and is characterized by apoptosis at the transition from polychromatic to orthochromatic erythroblasts. This defect resulted in age-dependent progressive anemia, megakaryocyte dysplasia and loss of hematopoietic stem cell (HSC) quiescence. As assessed by quantitative proteomics, mutant erythroblasts expressed higher levels of proteins involved in innate immune signaling, notably the heterodimeric S100 calcium-binding proteins S100a8 and S100a9. S100a8 whose expression was increased in mutant erythroblasts, monocytes and macrophages is functionally involved in the erythroid defect caused by the Rps14 deletion, as addition of recombinant S100a8 was sufficient to induce a differentiation defect in wild-type erythroid cells, and genetic inactivation of S100a8 expression rescued the erythroid differentiation defect of Rps14-haploinsufficient HSCs. Our data link Rps14 haploinsufficiency in del(5q) MDS to activation of the innate immune system and induction of S100A8-S100A9 expression, leading to a p53-dependent erythroid differentiation defect.	[Schneider, Rebekka K.; Chen, Michelle C.; Waters, Christopher S.; Chen, Edwin; Chu, Lisa P.; Lindsley, R. Coleman; Ebert, Benjamin L.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Hematol,Dept Med, Boston, MA 02115 USA; [Schneider, Rebekka K.; Ferreira, Monica Ventura; Beier, Fabian; Bruemmendorf, Tim H.; Carr, Steven A.] Univ Hosp Rheinisch Westfal Tech Hsch RWTH Aachen, Dept Hematol Hemostaseol Oncol & Stem Cell Transp, Aachen, Germany; [Schenone, Monica; Hartigan, Christina; Ebert, Benjamin L.] Broad Inst Harvard Univ & Massachusetts Inst Tech, Cambridge, MA USA; [Kramann, Rafael] Brigham & Womens Hosp, Div Renal, Boston, MA 02115 USA; [Joyce, Cailin E.; Novina, Carl D.; Lindsley, R. Coleman] Dana Farber Canc Inst, Boston, MA 02115 USA; [Germing, Ulrich] Univ Dusseldorf, Dept Hematol Oncol & Clin Immunol, Dusseldorf, Germany; [Platzbecker, Uwe] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dept Med 1, Dresden, Germany; [Buesche, Guntram] Hannover Med Sch, Inst Pathol, Hannover, Germany; [Knuechel, Ruth] Univ Hosp Rheinisch Westfal Tech Hsch RWTH Aachen, Inst Pathol, Aachen, Germany	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Dana-Farber Cancer Institute; Heinrich Heine University Dusseldorf; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Hannover Medical School	Ebert, BL (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Hematol,Dept Med, Boston, MA 02115 USA.; Ebert, BL (corresponding author), Broad Inst Harvard Univ & Massachusetts Inst Tech, Cambridge, MA USA.	bebert@partners.org	Lindsley, Coleman/AAA-3040-2021; Germing, Ulrich/AAX-1036-2021; Ventura Ferreira, Monica/P-5910-2017; Carr, Steven A./AAH-8366-2019; Kramann, Rafael/K-7995-2013	Ventura Ferreira, Monica/0000-0002-1437-1342; Kramann, Rafael/0000-0003-4048-6351; Chen, Edwin/0000-0003-0742-9734	US National Institutes of Health (NIH) [R01HL082945]; Gabrielle's Angel Award; Leukemia and Lymphoma Society Scholar and Specialized Center of Research (SCOR) award; German Research Foundation [DFG1188/3-1]; German Cancer Aid (Deutsche Krebshilfe) [111750]; Edward P. Evans Foundation; German Cluster of Excellence program Regenerative Biology to Reconstructive Therapy (REBIRTH); confocal microscope facility, a core facility of the Interdisciplinary Center for Clinical Research (Interdisziplinares Zentrum fur klinische Forschung; IZKF) Aachen within the Faculty of Medicine at RWTH Aachen University; NATIONAL CANCER INSTITUTE [P01CA066996] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082945] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gabrielle's Angel Award; Leukemia and Lymphoma Society Scholar and Specialized Center of Research (SCOR) award; German Research Foundation(German Research Foundation (DFG)); German Cancer Aid (Deutsche Krebshilfe)(Deutsche Krebshilfe); Edward P. Evans Foundation; German Cluster of Excellence program Regenerative Biology to Reconstructive Therapy (REBIRTH); confocal microscope facility, a core facility of the Interdisciplinary Center for Clinical Research (Interdisziplinares Zentrum fur klinische Forschung; IZKF) Aachen within the Faculty of Medicine at RWTH Aachen University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the US National Institutes of Health (NIH) (grant no. R01HL082945; B.L.E.), a Gabrielle's Angel Award (B.L.E.), a Leukemia and Lymphoma Society Scholar and Specialized Center of Research (SCOR) award (B.L.E.), the German Research Foundation (DFG1188/3-1; R.K.S.), a Max Eder fellowship provided by the German Cancer Aid (Deutsche Krebshilfe, grant no. 111750; R.K.S.), the Edward P. Evans Foundation (R.K.S.) and the German Cluster of Excellence program Regenerative Biology to Reconstructive Therapy (REBIRTH; to G.B.). We thank D. Haase (Georg-August-Universitat Gottingen) for the cytogenetic (karyotype) analysis in individuals with del(5q) MDS. This work was supported by the confocal microscope facility, a core facility of the Interdisciplinary Center for Clinical Research (Interdisziplinares Zentrum fur klinische Forschung; IZKF) Aachen, within the Faculty of Medicine at RWTH Aachen University.	Barlow JL, 2010, NAT MED, V16, P59, DOI 10.1038/nm.2063; Bibikova E, 2014, BLOOD, V124, P3791, DOI 10.1182/blood-2014-06-584656; Bresnick AR, 2015, NAT REV CANCER, V15, P96, DOI 10.1038/nrc3893; Chang KH, 2014, CELL REP, V9, P2084, DOI 10.1016/j.celrep.2014.11.031; Chen XH, 2013, J CLIN INVEST, V123, P4595, DOI 10.1172/JCI67580; Choesmel V, 2007, BLOOD, V109, P1275, DOI 10.1182/blood-2006-07-038372; Du W, 2013, J IMMUNOL, V191, P2806, DOI 10.4049/jimmunol.1203474; Dutt S, 2011, BLOOD, V117, P2567, DOI 10.1182/blood-2010-07-295238; Ebert BL, 2009, LEUKEMIA, V23, P1252, DOI 10.1038/leu.2009.53; Ebert BL, 2008, NATURE, V451, P335, DOI 10.1038/nature06494; Ebert BL, 2011, SEMIN ONCOL, V38, P621, DOI 10.1053/j.seminoncol.2011.04.010; Ehrchen JM, 2009, J LEUKOCYTE BIOL, V86, P557, DOI 10.1189/jlb.1008647; Fang J, 2012, BLOOD, V120, P858, DOI 10.1182/blood-2012-02-407999; Frisch BJ, 2012, BLOOD, V119, P540, DOI 10.1182/blood-2011-04-348151; Hiratsuka S, 2006, NAT CELL BIOL, V8, P1369, DOI 10.1038/ncb1507; Jacobs-Helber SM, 2003, BLOOD, V101, P524, DOI 10.1182/blood-2001-11-0084; Karbstein K, 2011, CURR OPIN CHEM BIOL, V15, P657, DOI 10.1016/j.cbpa.2011.07.023; Komrokji RS, 2013, BEST PRACT RES CL HA, V26, P365, DOI 10.1016/j.beha.2013.10.013; Kordasti SY, 2009, BRIT J HAEMATOL, V145, P64, DOI 10.1111/j.1365-2141.2009.07593.x; Kristinsson SY, 2011, J CLIN ONCOL, V29, P2897, DOI 10.1200/JCO.2011.34.8540; LAJTHA LG, 1961, P ROY SOC MED, V54, P369; Li CS, 2009, BIOCHEM J, V422, P363, DOI 10.1042/BJ20090465; Matsson H, 2006, BLOOD CELL MOL DIS, V36, P259, DOI 10.1016/j.bcmd.2005.12.002; McGowan KA, 2008, NAT GENET, V40, P963, DOI 10.1038/ng.188; McGowan KA, 2011, BLOOD, V118, P3622, DOI 10.1182/blood-2010-11-318584; MEANS RT, 1995, STEM CELLS, V13, P32, DOI 10.1002/stem.5530130105; Morrison SJ, 1996, NAT MED, V2, P1011, DOI 10.1038/nm0996-1011; Mueller A, 2005, J BIOL CHEM, V280, P29186, DOI 10.1074/jbc.M505000200; Pang WW, 2011, P NATL ACAD SCI USA, V108, P20012, DOI 10.1073/pnas.1116110108; Pellagatti A, 2010, BLOOD, V115, P2721, DOI 10.1182/blood-2009-12-259705; Raaijmakers M.H., 2010, NATURE, V464, P852; Raiser DM, 2014, LEUKEMIA LYMPHOMA, V55, P491, DOI 10.3109/10428194.2013.812786; Reynaud D, 2011, CANCER CELL, V20, P661, DOI 10.1016/j.ccr.2011.10.012; Rhyasen GW, 2013, CANCER CELL, V24, P90, DOI 10.1016/j.ccr.2013.05.006; Rossi DJ, 2007, NATURE, V447, P725, DOI 10.1038/nature05862; Ruggero D, 2014, BLOOD, V124, P2784, DOI 10.1182/blood-2014-04-526301; Sawanobori M, 2003, LEUKEMIA RES, V27, P583, DOI 10.1016/S0145-2126(02)00095-4; Schepers K, 2013, CELL STEM CELL, V13, P285, DOI 10.1016/j.stem.2013.06.009; Signer RAJ, 2014, NATURE, V509, P49, DOI 10.1038/nature13035; Starczynowski DT, 2011, J CLIN INVEST, V121, P4095, DOI 10.1172/JCI58818; Starczynowski DT, 2010, CELL CYCLE, V9, P855, DOI 10.4161/cc.9.5.11156; Starczynowski DT, 2010, NAT MED, V16, P49, DOI 10.1038/nm.2054; Strunk BS, 2011, SCIENCE, V333, P1449, DOI 10.1126/science.1208245; Strunk BS, 2009, RNA, V15, P2083, DOI 10.1261/rna.1792109; Su SB, 1997, BLOOD, V90, P605, DOI 10.1182/blood.V90.2.605.605_605_611; Takizawa H, 2012, BLOOD, V119, P2991, DOI 10.1182/blood-2011-12-380113; Tan MJ, 1999, FEBS LETT, V445, P265, DOI 10.1016/S0014-5793(99)00135-0; Verschoor CP, 2013, J LEUKOCYTE BIOL, V93, P633, DOI 10.1189/jlb.0912461; Vogl T, 2007, NAT MED, V13, P1042, DOI 10.1038/nm1638; Volarevic S, 2000, SCIENCE, V288, P2045, DOI 10.1126/science.288.5473.2045; Wei Y, 2013, LEUKEMIA, V27, P2177, DOI 10.1038/leu.2013.91; Zhou X, 2013, ONCOGENE, V32, P388, DOI 10.1038/onc.2012.63	52	143	146	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2016	22	3					288	297		10.1038/nm.4047	http://dx.doi.org/10.1038/nm.4047			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DF6DC	26878232	Green Accepted			2022-12-25	WOS:000371445100016
J	Buono, M; Facchini, R; Matsuoka, S; Thongjuea, S; Waithe, D; Luis, TC; Giustacchini, A; Besmer, P; Mead, AJ; Jacobsen, SEW; Nerlov, C				Buono, Mario; Facchini, Raffaella; Matsuoka, Sahoko; Thongjuea, Supat; Waithe, Dominique; Luis, Tiago C.; Giustacchini, Alice; Besmer, Peter; Mead, Adam J.; Jacobsen, Sten Eirik W.; Nerlov, Claus			A dynamic niche provides Kit ligand in a stage-specific manner to the earliest thymocyte progenitors	NATURE CELL BIOLOGY			English	Article							STEM-CELL FACTOR; THYMIC EPITHELIAL-CELLS; CRE-RECOMBINASE; TRANSGENIC MICE; EXPRESSION; TRANSMEMBRANE; GENERATION; MORPHOLOGY; EXPANSION; MIGRATION	Thymic T cell development is initiated from bone-marrow-derived multi potent thymus-seeding progenitors. During the early stages of thymocyte differentiation, progenitors become T cell restricted. However, the cellular environments supporting these critical initial stages of T cell development within the thymic cortex are not known. Here we use the dependence of early, c-Kit-expressing thymic progenitors on Kit ligand (KitL) to show that CD4(-)CD8(-)c-Kit(+)CD25(-) DN1-stage progenitors associate with, and depend on, the membrane-bound form of KitL (mKitL) provided by a cortex-specific KitL-expressing vascular endothelial cell (VEC) population. In contrast, the subsequent CD4(-)CD8(-)c-Kit(+)CD25(+) DN2-stage progenitors associate selectively with cortical thymic epithelial cells (cTECs) and depend on cTEC-presented mKitL. These results show that the dynamic process of early thymic progenitor differentiation is paralleled by migration-dependent change to the supporting niche, and identify VECs as a thymic niche cell, with mKitL as a critical ligand.	[Buono, Mario; Facchini, Raffaella; Matsuoka, Sahoko; Thongjuea, Supat; Luis, Tiago C.; Giustacchini, Alice; Mead, Adam J.; Jacobsen, Sten Eirik W.; Nerlov, Claus] Univ Oxford, MRC, Mol Hematol Unit, Oxford OX3 9DS, England; [Facchini, Raffaella; Matsuoka, Sahoko; Luis, Tiago C.; Giustacchini, Alice; Mead, Adam J.; Jacobsen, Sten Eirik W.] Univ Oxford, Haematopoiet Stem Cell Biol Lab, Oxford OX3 9DS, England; [Waithe, Dominique] Univ Oxford, Weatherall Inst Mol Med, Wolfson Imaging Ctr, Oxford OX3 9DU, England; [Besmer, Peter] Sloan Kettering Inst, New York, NY 10065 USA	University of Oxford; University of Oxford; University of Oxford; Memorial Sloan Kettering Cancer Center	Jacobsen, SEW; Nerlov, C (corresponding author), Univ Oxford, MRC, Mol Hematol Unit, Oxford OX3 9DS, England.; Jacobsen, SEW (corresponding author), Univ Oxford, Haematopoiet Stem Cell Biol Lab, Oxford OX3 9DS, England.	sten.jacobsen@imm.ox.ac.uk; claus.nerlov@imm.ox.ac.uk	Giustacchini, Alice/D-4074-2018; Mead, Adam/A-8796-2012; Jacobsen, Sten Eirik W/D-3974-2018	Giustacchini, Alice/0000-0002-8733-8594; Mead, Adam/0000-0001-8522-1002; Jacobsen, Sten Eirik W/0000-0002-1362-3659; Facchini, Raffaella/0000-0002-6026-6893; Waithe, Dominic/0000-0003-2685-4226; Thongjuea, Supat/0000-0002-9129-4694; Cunha Luis, Tiago/0000-0002-6305-1257	MRC [G0701761, G0900892]; Cancer Research UK; Leukemia and Lymphoma Research; MRC; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD038908] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA008748, R01CA102774] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL055748] Funding Source: NIH RePORTER; Medical Research Council [MR/K01577X/1, G0801073, MR/L006340/1, G0501838, G84/6443, MR/M00919X/1, G0900892, MC_UU_12009/16, G0701761, MC_UU_12009/7, MC_UU_12009/5] Funding Source: researchfish; MRC [MC_UU_12009/5, G0501838, MC_UU_12009/7, MR/M00919X/1, MR/L006340/1, G84/6443, MR/K01577X/1, G0801073, MC_UU_12009/16] Funding Source: UKRI	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Leukemia and Lymphoma Research; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank C. Blackburn (Institute for Stem Cell Research, UK), J. Nathans (Johns Hopkins Medical School, Maryland, USA) and M. Fruttiger (National Institute of Medical Research, UK) for providing Foxn1-Cre, Rosa26-CreER<SUP>T2</SUP> and Pdgfb-CreER<SUP>T2</SUP> mice, respectively, A. Samraj for screening of targeted embryonic stem cells, and the Wolfson Imaging Centre for image analysis. This work was supported by an MRC Strategic Award (G0701761) and MRC Program Grant (G0900892) to C.N., by an MRC Program Grant to S.E.W.J., by Cancer Research UK and by Leukemia and Lymphoma Research. A.J.M. is the recipient of an MRC Senior Clinical fellowship.	Badea TC, 2003, J NEUROSCI, V23, P2314; BRANNAN CI, 1991, P NATL ACAD SCI USA, V88, P4671, DOI 10.1073/pnas.88.11.4671; Bunting MD, 2011, IMMUNOL CELL BIOL, V89, P185, DOI 10.1038/icb.2010.142; Calderon L, 2012, CELL, V149, P159, DOI 10.1016/j.cell.2012.01.049; Chasis JA, 2008, BLOOD, V112, P470, DOI 10.1182/blood-2008-03-077883; Claxton S, 2008, GENESIS, V46, P74, DOI 10.1002/dvg.20367; Ding L, 2013, NATURE, V495, P231, DOI 10.1038/nature11885; Ding L, 2012, NATURE, V481, P457, DOI 10.1038/nature10783; Farley FW, 2000, GENESIS, V28, P106, DOI 10.1002/1526-968X(200011/12)28:3/4<106::AID-GENE30>3.0.CO;2-T; FLANAGAN JG, 1991, CELL, V64, P1025, DOI 10.1016/0092-8674(91)90326-T; Gordon J, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-69; Gray DHD, 2002, J IMMUNOL METHODS, V260, P15, DOI 10.1016/S0022-1759(01)00493-8; Grover A, 2014, J EXP MED, V211, P181, DOI 10.1084/jem.20131189; Gu Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025984; Hager-Theodorides AL, 2002, J IMMUNOL, V169, P5496, DOI 10.4049/jimmunol.169.10.5496; Heinonen KM, 2011, BLOOD, V118, P5163, DOI 10.1182/blood-2011-04-350553; Kapur R, 1998, BLOOD, V91, P879, DOI 10.1182/blood.V91.3.879.879_879_889; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kisanuki YY, 2001, DEV BIOL, V230, P230, DOI 10.1006/dbio.2000.0106; Koch U, 2008, J EXP MED, V205, P2515, DOI 10.1084/jem.20080829; Krause DS, 2012, CELL, V149, P16, DOI 10.1016/j.cell.2012.03.005; Kwan J, 2004, J IMMUNOL, V172, P3999, DOI 10.4049/jimmunol.172.7.3999; Lennartsson J, 2012, PHYSIOL REV, V92, P1619, DOI 10.1152/physrev.00046.2011; Love PE, 2011, NAT REV IMMUNOL, V11, P469, DOI 10.1038/nri2989; Mikkelsen HB, 1998, NEUROGASTROENT MOTIL, V10, P11; Moreira Pedro N., 2006, V349, P151; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Ramasamy SK, 2015, TRENDS CELL BIOL, V25, P148, DOI 10.1016/j.tcb.2014.11.007; Ramskold D, 2012, NAT BIOTECHNOL, V30, P777, DOI 10.1038/nbt.2282; Red-Horse K, 2010, NATURE, V464, P549, DOI 10.1038/nature08873; RODEWALD HR, 1995, IMMUNITY, V3, P313, DOI 10.1016/1074-7613(95)90116-7; Russell E S, 1979, Adv Genet, V20, P357, DOI 10.1016/S0065-2660(08)60549-0; Sasaki T, 2010, DEVELOPMENT, V137, P3941, DOI 10.1242/dev.051359; Scadden DT, 2014, CELL, V157, P41, DOI 10.1016/j.cell.2014.02.013; Scadden DT, 2006, NATURE, V441, P1075, DOI 10.1038/nature04957; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Shah DK, 2014, J IMMUNOL, V192, P4017, DOI 10.4049/jimmunol.1302259; Sitnicka E, 2007, BLOOD, V110, P2955, DOI 10.1182/blood-2006-10-054726; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Takahama Y, 2006, NAT REV IMMUNOL, V6, P127, DOI 10.1038/nri1781; Trampont PC, 2010, NAT IMMUNOL, V11, P162, DOI 10.1038/ni.1830; Tsai PT, 2003, BLOOD, V102, P3947, DOI 10.1182/blood-2003-05-1657; vonFreedenJeffry U, 1997, IMMUNITY, V7, P147, DOI 10.1016/S1074-7613(00)80517-8; Zhu J, 2007, BLOOD, V109, P3706, DOI 10.1182/blood-2006-08-041384	44	32	32	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2016	18	2					157	+		10.1038/ncb3299	http://dx.doi.org/10.1038/ncb3299			26	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	DC3NZ	26780297	Green Accepted			2022-12-25	WOS:000369127300005
J	Burstein, D; Amaro, F; Zusman, T; Lifshitz, Z; Cohen, O; Gilbert, JA; Pupko, T; Shuman, HA; Segal, G				Burstein, David; Amaro, Francisco; Zusman, Tal; Lifshitz, Ziv; Cohen, Ofir; Gilbert, Jack A.; Pupko, Tal; Shuman, Howard A.; Segal, Gil			Genomic analysis of 38 Legionella species identifies large and diverse effector repertoires	NATURE GENETICS			English	Article							PNEUMOPHILA GENOME; LEGIONNAIRES-DISEASE; COXIELLA-BURNETII; PROTEINS; VIRULENCE; RAB1; PATHOGEN; SYSTEM; EXPLOITATION; ACQUISITION	Infection by the human pathogen Legionella pneumophila relies on the translocation of 300 virulence proteins, termed effectors, which manipulate host cell processes. However, almost no information exists regarding effectors in other Legionella pathogens. Here we sequenced, assembled and characterized the genomes of 38 Legionella species and predicted their effector repertoires using a previously validated machine learning approach. This analysis identified 5,885 predicted effectors. The effector repertoires of different Legionella species were found to be largely non-overlapping, and only seven core effectors were shared by all species studied. Species-specific effectors had atypically low GC content, suggesting exogenous acquisition, possibly from the natural protozoan hosts of these species. Furthermore, we detected numerous new conserved effector domains and discovered new domain combinations, which allowed the inference of as yet undescribed effector functions. The effector collection and network of domain architectures described here can serve as a roadmap for future studies of effector function and evolution.	[Burstein, David; Cohen, Ofir; Pupko, Tal] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Cell Res & Immunol, IL-69978 Tel Aviv, Israel; [Amaro, Francisco; Shuman, Howard A.] Univ Chicago, Dept Microbiol, Chicago, IL 60637 USA; [Zusman, Tal; Lifshitz, Ziv; Segal, Gil] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Mol Microbiol & Biotechnol, IL-69978 Tel Aviv, Israel; [Gilbert, Jack A.] Univ Chicago, Argonne Natl Lab, Biol Div, Chicago, IL 60637 USA; [Gilbert, Jack A.] Univ Chicago, Dept Ecol & Evolut, 940 E 57Th St, Chicago, IL 60637 USA; [Burstein, David] Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA; [Amaro, Francisco] St Louis Univ Madrid Campus, Dept Nat Sci, Madrid, Spain; [Lifshitz, Ziv] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Div Epidemiol, IL-69978 Tel Aviv, Israel; [Lifshitz, Ziv] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Natl Ctr Antibiot Resistance, IL-69978 Tel Aviv, Israel; [Cohen, Ofir] Broad Inst Harvard & MIT, Cambridge, MA USA	Tel Aviv University; University of Chicago; Tel Aviv University; United States Department of Energy (DOE); Argonne National Laboratory; University of Chicago; University of Chicago; University of California System; University of California Berkeley; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Shuman, HA (corresponding author), Univ Chicago, Dept Microbiol, Chicago, IL 60637 USA.; Segal, G (corresponding author), Tel Aviv Univ, George S Wise Fac Life Sci, Dept Mol Microbiol & Biotechnol, IL-69978 Tel Aviv, Israel.	hashuman@uchicago.edu; gils@tauex.tau.ac.il	Pupko, Tal/HGF-1353-2022; Gilbert, Jack/AAF-3270-2019; Burstein, David/Y-7993-2019; Segal, Gil/H-7987-2019; Amaro, Francisco/Y-5610-2019	Burstein, David/0000-0002-6219-1880; Segal, Gil/0000-0003-0392-253X; Amaro, Francisco/0000-0002-0061-477X; Pupko, Tal/0000-0001-9463-2575	National Institute of Allergy and Infectious Diseases [5RO1 AI23549]; Division of Biological Sciences of the University of Chicago; United States-Israel Binational Science Foundation [2013240]; Israel Science Foundation (ISF) [1092/13]; Edmond J. Safra Center for Bioinformatics at Tel Aviv University; Fulbright Commission; Ministry of Education of Spain; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI023549] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Division of Biological Sciences of the University of Chicago(University of Chicago); United States-Israel Binational Science Foundation(US-Israel Binational Science Foundation); Israel Science Foundation (ISF)(Israel Science Foundation); Edmond J. Safra Center for Bioinformatics at Tel Aviv University; Fulbright Commission; Ministry of Education of Spain(Spanish Government); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We wish to thank E. Levy Karin for her kind help with some of the phylogenetic analyses. This work was supported by National Institute of Allergy and Infectious Diseases grant 5RO1 AI23549 (H.A.S.), and the costs of DNA sequencing were supported by startup funds from the Division of Biological Sciences of the University of Chicago (H.A.S.). This work was also supported in part by grant 2013240 from the United States-Israel Binational Science Foundation (G.S. and H.A.S.). T.P. was supported by Israel Science Foundation (ISF) grant 1092/13. D.B. was a fellow of the Converging Technologies Program of the Israeli Council for Higher Education. D.B. and T.P. were also supported by the Edmond J. Safra Center for Bioinformatics at Tel Aviv University. F.A. was supported by a postdoctoral fellowship from the Fulbright Commission and the Ministry of Education of Spain.	Ardley HC, 2005, ESSAYS BIOCHEM, V41, P15, DOI 10.1042/EB0410015; Beare PA, 2011, MBIO, V2, DOI 10.1128/mBio.00175-11; BORK P, 1993, PROTEINS, V17, P363, DOI 10.1002/prot.340170405; Brombacher E, 2009, J BIOL CHEM, V284, P4846, DOI 10.1074/jbc.M807505200; Burstein D, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000508; Carey KL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002056; Cazalet C, 2004, NAT GENET, V36, P1165, DOI 10.1038/ng1447; Collingro A, 2005, INT J SYST EVOL MICR, V55, P1863, DOI 10.1099/ijs.0.63572-0; de Felipe KS, 2005, J BACTERIOL, V187, P7716, DOI 10.1128/JB.187.22.7716-7726.2005; Diederen BMW, 2008, J INFECTION, V56, P1, DOI 10.1016/j.jinf.2007.09.010; Feldman M, 2005, P NATL ACAD SCI USA, V102, P12206, DOI 10.1073/pnas.0501850102; Feldman M, 2004, INFECT IMMUN, V72, P4503, DOI 10.1128/IAI.72.8.4503-4511.2004; Fields BS, 2002, CLIN MICROBIOL REV, V15, P506, DOI 10.1128/CMR.15.3.506-526.2002; Fields BS, 1996, TRENDS MICROBIOL, V4, P286, DOI 10.1016/0966-842X(96)10041-X; Fontana MF, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001289; Gomez-Valero L, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00208; Havey JC, 2015, INFECT IMMUN, V83, P3506, DOI 10.1128/IAI.00497-15; Hayes CS, 2010, ANNU REV GENET, V44, P71, DOI 10.1146/annurev.genet.42.110807.091449; HENNECKE H, 1990, FEBS LETT, V268, P422, DOI 10.1016/0014-5793(90)81297-2; Hubber A, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004222; Ingmundson A, 2007, NATURE, V450, P365, DOI 10.1038/nature06336; Isaac DT, 2015, P NATL ACAD SCI USA, V112, pE5208, DOI 10.1073/pnas.1511389112; Isberg RR, 2009, NAT REV MICROBIOL, V7, P12, DOI 10.1038/nrmicro1967; Jank T, 2012, CELL MICROBIOL, V14, P852, DOI 10.1111/j.1462-5822.2012.01761.x; Jeong KC, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004695; Kaneko T, 2002, DNA RES, V9, P189, DOI 10.1093/dnares/9.6.189; Ko KS, 2002, J CLIN MICROBIOL, V40, P2653, DOI 10.1128/JCM.40.7.2653-2658.2002; Kubori T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001216; Leclerque A, 2008, FEMS MICROBIOL LETT, V279, P167, DOI 10.1111/j.1574-6968.2007.01025.x; Li XQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088339; Lifshitz Z, 2014, INFECT IMMUN, V82, P3740, DOI 10.1128/IAI.01729-14; Lifshitz Z, 2013, P NATL ACAD SCI USA, V110, pE707, DOI 10.1073/pnas.1215278110; Mishra AK, 2013, J BIOL CHEM, V288, P24000, DOI 10.1074/jbc.M113.470625; Mizuno-Yamasaki E, 2012, ANNU REV BIOCHEM, V81, P637, DOI 10.1146/annurev-biochem-052810-093700; Mosavi LK, 2004, PROTEIN SCI, V13, P1435, DOI 10.1110/ps.03554604; Muder RR, 2002, CLIN INFECT DIS, V35, P990, DOI 10.1086/342884; Neunuebel MR, 2011, SCIENCE, V333, P453, DOI 10.1126/science.1207193; O'Connor TJ, 2012, SCIENCE, V338, P1440, DOI 10.1126/science.1229556; O'Connor TJ, 2011, P NATL ACAD SCI USA, V108, P14733, DOI 10.1073/pnas.1111678108; Portier E, 2015, ENVIRON MICROBIOL, V17, P1338, DOI 10.1111/1462-2920.12604; Price CTD, 2011, SCIENCE, V334, P1553, DOI 10.1126/science.1212868; Price CTD, 2010, J EXP MED, V207, P1712, DOI 10.1084/jem.20100771; Puigbo Pere, 2009, Journal of Biology (London), V8, P59, DOI 10.1186/jbiol159; Segal G, 1998, P NATL ACAD SCI USA, V95, P1669, DOI 10.1073/pnas.95.4.1669; Segal G, 2005, FEMS MICROBIOL REV, V29, P65, DOI 10.1016/j.femsre.2004.07.001; Shen XH, 2009, CELL MICROBIOL, V11, P911, DOI 10.1111/j.1462-5822.2009.01301.x; Tan YH, 2011, NATURE, V475, P506, DOI 10.1038/nature10307; Vogel JP, 1998, SCIENCE, V279, P873, DOI 10.1126/science.279.5352.873; Weber Stefan S., 2006, PLoS Pathogens, V2, DOI 10.1371/journal.ppat.0020046	49	150	152	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2016	48	2					167	175		10.1038/ng.3481	http://dx.doi.org/10.1038/ng.3481			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DC2JV	26752266	hybrid, Green Accepted			2022-12-25	WOS:000369043900014
J	Chan, CTY; Lee, JW; Cameron, DE; Bashor, CJ; Collins, JJ				Chan, Clement T. Y.; Lee, Jeong Wook; Cameron, D. Ewen; Bashor, Caleb J.; Collins, James J.			'Deadman' and 'Passcode' microbial kill switches for bacterial containment	NATURE CHEMICAL BIOLOGY			English	Article							ESCHERICHIA-COLI; LAC REPRESSOR; BIOLOGICAL CONTAINMENT; CRYSTAL-STRUCTURE; TETR FAMILY; DNA; BINDING; BIOCONTAINMENT; CONFORMATION; SPECIFICITY	Biocontainment systems that couple environmental sensing with circuit-based control of cell viability could be used to prevent escape of genetically modified microbes into the environment. Here we present two engineered safeguard systems known as the `Deadman' and `Passcode' kill switches. The Deadman kill switch uses unbalanced reciprocal transcriptional repression to couple a specific input signal with cell survival. The Passcode kill switch uses a similar two-layered transcription design and incorporates hybrid LacI-GalR family transcription factors to provide diverse and complex environmental inputs to control circuit function. These synthetic gene circuits efficiently kill Escherichia coli and can be readily reprogrammed to change their environmental inputs, regulatory architecture and killing mechanism.	[Chan, Clement T. Y.; Lee, Jeong Wook; Cameron, D. Ewen; Bashor, Caleb J.; Collins, James J.] MIT, Inst Med Engn & Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Chan, Clement T. Y.; Lee, Jeong Wook; Cameron, D. Ewen; Bashor, Caleb J.; Collins, James J.] MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Chan, Clement T. Y.; Lee, Jeong Wook; Cameron, D. Ewen; Bashor, Caleb J.; Collins, James J.] MIT, Synthet Biol Ctr, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Collins, James J.] Harvard MIT Program Hlth Sci & Technol, Cambridge, MA USA; [Collins, James J.] Broad Inst MIT & Harvard, Cambridge, MA USA; [Collins, James J.] Harvard Univ, Wyss Inst Biologically Inspired Engn, Cambridge, MA 02138 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University	Collins, JJ (corresponding author), MIT, Inst Med Engn & Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Collins, JJ (corresponding author), MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Collins, JJ (corresponding author), MIT, Synthet Biol Ctr, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Collins, JJ (corresponding author), Harvard MIT Program Hlth Sci & Technol, Cambridge, MA USA.; Collins, JJ (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA USA.; Collins, JJ (corresponding author), Harvard Univ, Wyss Inst Biologically Inspired Engn, Cambridge, MA 02138 USA.	jimjc@mit.edu		Chan, Clement/0000-0001-7940-3459; Lee, Jeong Wook/0000-0003-0705-0177	Defense Threat Reduction Agency [HDTRA1-14-1-0006]; Office of Naval Research MURI grant [N000141110725]; Air Force Office of Scientific Research grant [FA9550-14-1-0060]; Howard Hughes Medical Institute	Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); Office of Naval Research MURI grant; Air Force Office of Scientific Research grant(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Howard Hughes Medical Institute(Howard Hughes Medical Institute)	We thank J. Han for assistance with molecular cloning. This work was supported by funding from the Defense Threat Reduction Agency grant HDTRA1-14-1-0006, Office of Naval Research MURI grant N000141110725, Air Force Office of Scientific Research grant FA9550-14-1-0060 and the Howard Hughes Medical Institute.	Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bacchus W, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.48; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Bell CE, 2000, NAT STRUCT BIOL, V7, P209; Cai YZ, 2015, P NATL ACAD SCI USA, V112, P1803, DOI 10.1073/pnas.1424704112; Callura JM, 2010, P NATL ACAD SCI USA, V107, P15898, DOI 10.1073/pnas.1009747107; Cameron DE, 2014, NAT BIOTECHNOL, V32, P1276, DOI 10.1038/nbt.3053; Cameron DE, 2014, NAT REV MICROBIOL, V12, P381, DOI 10.1038/nrmicro3239; CEBOLLA A, 1995, APPL ENVIRON MICROB, V61, P660, DOI 10.1128/AEM.61.2.660-668.1995; Chappell J, 2013, BIOTECHNOL J, V8, P1379, DOI 10.1002/biot.201300018; CHENG SC, 1984, J BIOL CHEM, V259, P1571; CONTRERAS A, 1991, APPL ENVIRON MICROB, V57, P1504, DOI 10.1128/AEM.57.5.1504-1508.1991; Csorgo B, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-11; Cuthbertson L, 2013, MICROBIOL MOL BIOL R, V77, P440, DOI 10.1128/MMBR.00018-13; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; FRIEDMAN AM, 1995, SCIENCE, V268, P1721, DOI 10.1126/science.7792597; Gallagher RR, 2015, NUCLEIC ACIDS RES, V43, P1945, DOI 10.1093/nar/gku1378; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Glasfeld A, 1999, J MOL BIOL, V291, P347, DOI 10.1006/jmbi.1999.2946; JENSEN LB, 1993, APPL ENVIRON MICROB, V59, P3713, DOI 10.1128/AEM.59.11.3713-3717.1993; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lewis M, 1996, SCIENCE, V271, P1247, DOI 10.1126/science.271.5253.1247; Litcofsky KD, 2012, NAT METHODS, V9, P1077, DOI [10.1038/NMETH.2205, 10.1038/nmeth.2205]; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; Mandell DJ, 2015, NATURE, V518, P55, DOI 10.1038/nature14121; Maniatis T., 1982, MOL CLONING LAB MANU; Meinhardt S, 2012, NUCLEIC ACIDS RES, V40, P11139, DOI 10.1093/nar/gks806; Meinhardt S, 2008, PROTEINS, V73, P941, DOI 10.1002/prot.22121; Mignon C, 2015, PATHOGENS, V4, P157, DOI 10.3390/pathogens4020157; Moe-Behrens GG, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00005; Olson EJ, 2012, CURR OPIN CHEM BIOL, V16, P300, DOI 10.1016/j.cbpa.2012.06.003; Ramos JL, 2005, MICROBIOL MOL BIOL R, V69, P326, DOI 10.1128/MMBR.69.2.326-356.2005; Rovner AJ, 2015, NATURE, V518, P89, DOI 10.1038/nature14095; SADLER JR, 1983, P NATL ACAD SCI-BIOL, V80, P6785, DOI 10.1073/pnas.80.22.6785; Salis HM, 2011, METHOD ENZYMOL, V498, P19, DOI 10.1016/B978-0-12-385120-8.00002-4; SCHUMACHER MA, 1995, CELL, V83, P147, DOI 10.1016/0092-8674(95)90243-0; Shis DL, 2014, ACS SYNTH BIOL, V3, P645, DOI 10.1021/sb500262f; Smith AB, 2006, NUCLEIC ACIDS RES, V34, P4667, DOI 10.1093/nar/gkl636; Sousa A, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0838; Steidler L, 2003, NAT BIOTECHNOL, V21, P785, DOI 10.1038/nbt840; Voigt CA, 2006, CURR OPIN BIOTECH, V17, P548, DOI 10.1016/j.copbio.2006.09.001; Wild J, 2002, GENOME RES, V12, P1434, DOI 10.1101/gr.130502; Wright O, 2015, ACS SYNTH BIOL, V4, P307, DOI 10.1021/sb500234s; Wright O, 2013, MICROBIOL-SGM, V159, P1221, DOI 10.1099/mic.0.066308-0; Zhang YL, 2003, MOL CELL, V12, P913, DOI 10.1016/S1097-2765(03)00402-7	46	159	169	7	140	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	FEB	2016	12	2					82	+		10.1038/NCHEMBIO.1979	http://dx.doi.org/10.1038/NCHEMBIO.1979			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DC6GG	26641934	Green Accepted, Green Submitted			2022-12-25	WOS:000369317300009
J	Kumasaka, N; Knights, AJ; Gaffney, DJ				Kumasaka, Natsuhiko; Knights, Andrew J.; Gaffney, Daniel J.			Fine-mapping cellular QTLs with RASQUAL and ATAC-seq	NATURE GENETICS			English	Article							ALLELE-SPECIFIC EXPRESSION; MAXIMUM-LIKELIHOOD; MOUSE-BRAIN; DNA-BINDING; CHIP-SEQ; TRANSCRIPTOME; CHROMATIN; HUMANS; IDENTIFICATION; EQTL	When cellular traits are measured using high-throughput DNA sequencing, quantitative trait loci (QTLs) manifest as fragment count differences between individuals and allelic differences within individuals. We present RASQUAL (Robust Allele Specific Quantitation and Quality Control), a new statistical approach for association mapping that models genetic effects and accounts for biases in sequencing data using a single, probabilistic framework. RASQUAL substantially improves fine-mapping accuracy and sensitivity relative to existing methods in RNA-seq, DNase-seq and ChIP-seq data. We illustrate how RASQUAL can be used to maximize association detection by generating the first map of chromatin accessibility QTLs (caQTLs) in a European population using ATAC-seq. Despite a modest sample size, we identified 2,707 independent caQTLs (at a false discovery rate of 10%) and demonstrated how RASQUAL and ATAC-seq can provide powerful information for fine-mapping gene-regulatory variants and for linking distal regulatory elements with gene promoters. Our results highlight how combining between-individual and allele-specific genetic signals improves the functional interpretation of noncoding variation.	[Kumasaka, Natsuhiko; Knights, Andrew J.; Gaffney, Daniel J.] Wellcome Trust Sanger Inst, Wellcome Genome Campus, Cambridge, England	Wellcome Trust Sanger Institute	Kumasaka, N; Gaffney, DJ (corresponding author), Wellcome Trust Sanger Inst, Wellcome Genome Campus, Cambridge, England.	nk5@sanger.ac.uk; dg13@sanger.ac.uk		Gaffney, Daniel/0000-0002-1529-1862	Wellcome Trust [098051]	Wellcome Trust(Wellcome TrustEuropean Commission)	We thank O. Stegle, M. Hemberg, G. Trynka and the three anonymous reviewers for their helpful comments. N.K., A.J.K. and D.J.G. were funded by Wellcome Trust grant 098051.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Babak T, 2015, NAT GENET, V47, P544, DOI 10.1038/ng.3274; Banet G, 2000, MOL BIOL REP, V27, P157, DOI 10.1023/A:1007139713781; Banovich NE, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004663; Baran Y, 2015, GENOME RES, V25, P927, DOI 10.1101/gr.192278.115; Battle A, 2014, GENOME RES, V24, P14, DOI 10.1101/gr.155192.113; Berndt SI, 2013, NAT GENET, V45, P868, DOI 10.1038/ng.2652; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Degner JF, 2012, NATURE, V482, P390, DOI 10.1038/nature10808; Degner JF, 2009, BIOINFORMATICS, V25, P3207, DOI 10.1093/bioinformatics/btp579; del Rosario RCH, 2015, NAT METHODS, V12, P458, DOI [10.1038/NMETH.3326, 10.1038/nmeth.3326]; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; DeVeale B, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002600; Ding ZH, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004798; Gregg C, 2010, SCIENCE, V329, P682, DOI 10.1126/science.1190831; Gregg C, 2010, SCIENCE, V329, P643, DOI 10.1126/science.1190830; Heap GA, 2010, HUM MOL GENET, V19, P122, DOI 10.1093/hmg/ddp473; Kasowski M, 2013, SCIENCE, V342, P750, DOI 10.1126/science.1242510; Kasowski M, 2010, SCIENCE, V328, P232, DOI 10.1126/science.1183621; Kilpinen H, 2013, SCIENCE, V342, P744, DOI 10.1126/science.1242463; Koren A, 2014, CELL, V159, P1015, DOI 10.1016/j.cell.2014.10.025; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Lefebvre JF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038667; LEIGHTON PA, 1995, GENE DEV, V9, P2079, DOI 10.1101/gad.9.17.2079; Li G, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks280; McDaniell R, 2010, SCIENCE, V328, P235, DOI 10.1126/science.1184655; McVicker G, 2013, SCIENCE, V342, P747, DOI 10.1126/science.1242429; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; Okada Y, 2014, NATURE, V506, P376, DOI 10.1038/nature12873; Ongen H, 2014, NATURE, V512, P87, DOI 10.1038/nature13602; Panousis NI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0467-2; Pastinen T, 2010, NAT REV GENET, V11, P533, DOI 10.1038/nrg2815; Pickrell JK, 2011, BIOINFORMATICS, V27, P2144, DOI 10.1093/bioinformatics/btr354; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; Seoighe C, 2006, BIOINFORMATICS, V22, P3032, DOI 10.1093/bioinformatics/btl521; Shabalin AA, 2012, BIOINFORMATICS, V28, P1353, DOI 10.1093/bioinformatics/bts163; Sun W, 2012, BIOMETRICS, V68, P1, DOI 10.1111/j.1541-0420.2011.01654.x; Waszak SM, 2014, BIOINFORMATICS, V30, P165, DOI 10.1093/bioinformatics/btt667; Weirauch MT, 2014, CELL, V158, P1431, DOI 10.1016/j.cell.2014.08.009	39	96	96	0	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2016	48	2					206	213		10.1038/ng.3467	http://dx.doi.org/10.1038/ng.3467			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DC2JV	26656845	Green Accepted, Green Submitted			2022-12-25	WOS:000369043900020
J	Hammond, A; Galizi, R; Kyrou, K; Simoni, A; Siniscalchi, C; Katsanos, D; Gribble, M; Baker, D; Marois, E; Russell, S; Burt, A; Windbichler, N; Crisanti, A; Nolan, T				Hammond, Andrew; Galizi, Roberto; Kyrou, Kyros; Simoni, Alekos; Siniscalchi, Carla; Katsanos, Dimitris; Gribble, Matthew; Baker, Dean; Marois, Eric; Russell, Steven; Burt, Austin; Windbichler, Nikolai; Crisanti, Andrea; Nolan, Tony			A CRISPR-Cas9 gene drive system-targeting female reproduction in the malaria mosquito vector Anopheles gambiae	NATURE BIOTECHNOLOGY			English	Article							HOMING ENDONUCLEASE GENES; DROSOPHILA; SPECIFICITY; EXPRESSION; NUCLEASES; GERMLINE; TOOLS	Gene drive systems that enable super-Mendelian inheritance of a transgene have the potential to modify insect populations over a timeframe of a few years. We describe CRISPR-Cas9 endonuclease constructs that function as gene drive systems in Anopheles gambiae, the main vector for malaria. We identified three genes (AGAP005958, AGAP011377 and AGAP007280) that confer a recessive female-sterility phenotype upon disruption, and inserted into each locus CRISPR-Cas9 gene drive constructs designed to target and edit each gene. For each targeted locus we observed a strong gene drive at the molecular level, with transmission rates to progeny of 91.4 to 99.6%. Population modeling and cage experiments indicate that a CRISPR-Cas9 construct targeting one of these loci, AGAP007280, meets the minimum requirement for a gene drive targeting female reproduction in an insect population. These findings could expedite the development of gene drives to suppress mosquito populations to levels that do not support malaria transmission.	[Hammond, Andrew; Galizi, Roberto; Kyrou, Kyros; Simoni, Alekos; Katsanos, Dimitris; Gribble, Matthew; Burt, Austin; Windbichler, Nikolai; Crisanti, Andrea; Nolan, Tony] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, London, England; [Siniscalchi, Carla] Univ Perugia, Ctr Genom Funz, Dipartimento Med Sperimentale, Via Gambuli, I-06100 Perugia, Italy; [Baker, Dean; Russell, Steven] Univ Cambridge, Dept Genet, Downing St, Cambridge CB2 3EH, England; [Marois, Eric] Univ Strasbourg, Inst Biol Mol & Cellulaire, INSERM U963, CNRS UPR9022, Strasbourg, France	Imperial College London; University of Perugia; University of Cambridge; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Windbichler, N; Crisanti, A; Nolan, T (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, London, England.	nikolai.windbichler@imperial.ac.uk; a.crisanti@imperial.ac.uk; t.nolan@imperial.ac.uk	Marois, Eric/H-9246-2016; Galizi, Roberto/H-5999-2019; Nolan, Tony/I-4925-2012; Marois, Eric/AAZ-5549-2021	Marois, Eric/0000-0003-4147-3747; Nolan, Tony/0000-0002-2982-8333; Marois, Eric/0000-0003-4147-3747; Kyrou, Kyros/0000-0002-4919-2459; Hammond, Andrew/0000-0002-1757-5009; Simoni, Alekos/0000-0001-8629-721X; Crisanti, Andrea/0000-0002-2406-4426; Burt, Austin/0000-0001-5146-9640; Galizi, Roberto/0000-0003-3134-7480	Foundation for the National Institutes of Health through the Vector-Based Control of Transmission: Discovery Research (VCTR) program of the Grand Challenges in Global Health initiative of the Bill & Melinda Gates Foundation; European Research Council under the European Union's Seventh Framework Programme ERC [335724]	Foundation for the National Institutes of Health through the Vector-Based Control of Transmission: Discovery Research (VCTR) program of the Grand Challenges in Global Health initiative of the Bill & Melinda Gates Foundation; European Research Council under the European Union's Seventh Framework Programme ERC(European Research Council (ERC))	We are grateful to C. Bamikole, A. Hall and D. Fabrigar for experimental assistance and to P. Papathanos and S. Fuchs for useful discussion. This work was supported by a grant from the Foundation for the National Institutes of Health through the Vector-Based Control of Transmission: Discovery Research (VCTR) program of the Grand Challenges in Global Health initiative of the Bill & Melinda Gates Foundation and by the European Research Council under the European Union's Seventh Framework Programme ERC grant no. 335724 to N.W.	Akbari OS, 2015, SCIENCE, V349, P927, DOI 10.1126/science.aac7932; Bae S, 2014, NAT METHODS, V11, P705, DOI 10.1038/nmeth.3015; Baker DA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-296; Bateman JR, 2006, GENETICS, V173, P769, DOI 10.1534/genetics.106.056945; Burt A, 2003, P ROY SOC B-BIOL SCI, V270, P921, DOI 10.1098/rspb.2002.2319; Claycomb JM, 2004, DEV CELL, V6, P145, DOI 10.1016/S1534-5807(03)00398-8; Deredec A, 2008, GENETICS, V179, P2013, DOI 10.1534/genetics.108.089037; Deredec A, 2011, P NATL ACAD SCI USA, V108, pE874, DOI 10.1073/pnas.1110717108; DiCarlo JE, 2015, NAT BIOTECHNOL, V33, P1250, DOI 10.1038/nbt.3412; Esvelt KM, 2014, ELIFE, V3, DOI 10.7554/eLife.03401; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Gantz VM, 2015, SCIENCE, V348, P442, DOI 10.1126/science.aaa5945; Giraldo-Calderon GI, 2015, NUCLEIC ACIDS RES, V43, pD707, DOI 10.1093/nar/gku1117; Hong CC, 1996, GENETICS, V143, P1653; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Konet DS, 2007, INSECT MOL BIOL, V16, P199, DOI 10.1111/j.1365-2583.2006.00714.x; Papathanos PA, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-65; Port F, 2014, P NATL ACAD SCI USA, V111, pE2967, DOI 10.1073/pnas.1405500111; Simoni A, 2014, NUCLEIC ACIDS RES, V42, P7461, DOI 10.1093/nar/gku387; Thomas DD, 2000, SCIENCE, V287, P2474, DOI 10.1126/science.287.5462.2474; Windbichler N, 2011, NATURE, V473, P212, DOI 10.1038/nature09937	22	645	679	11	468	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2016	34	1					78	83		10.1038/nbt.3439	http://dx.doi.org/10.1038/nbt.3439			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DB8HQ	26641531	Green Accepted, Bronze, Green Submitted			2022-12-25	WOS:000368758200030
J	Kidd, BA; Wroblewska, A; Boland, MR; Agudo, J; Merad, M; Tatonetti, NP; Brown, BD; Dudley, JT				Kidd, Brian A.; Wroblewska, Aleksandra; Boland, Mary R.; Agudo, Judith; Merad, Miriam; Tatonetti, Nicholas P.; Brown, Brian D.; Dudley, Joel T.			Mapping the effects of drugs on the immune system	NATURE BIOTECHNOLOGY			English	Article							IMMUNOLOGICAL GENOME PROJECT; HIGH-THROUGHPUT SCREENS; GENE-EXPRESSION; ALZHEIMERS-DISEASE; SET ANALYSIS; CELLS; MOUSE; INHIBITORS; KINASE; CANCER	Understanding how drugs affect the immune system has consequences for treating disease and minimizing unwanted side effects. Here we present an integrative computational approach for predicting interactions between drugs and immune cells in a system-wide manner. The approach matches gene sets between transcriptional signatures to determine their similarity. We apply the method to model the interactions between 1,309 drugs and 221 immune cell types and predict 69,995 interactions. The resulting immune-cell pharmacology map is used to predict how five drugs influence four immune cell types in humans and mice. To validate the predictions, we analyzed patient records and examined cell population changes from in vivo experiments. Our method offers a tool for screening thousands of interactions to identify relationships between drugs and the immune system.	[Kidd, Brian A.; Wroblewska, Aleksandra; Agudo, Judith; Brown, Brian D.; Dudley, Joel T.] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Kidd, Brian A.; Dudley, Joel T.] Icahn Sch Med Mt Sinai, lcahn Inst Genom & Multiscale Biol, New York, NY 10029 USA; [Boland, Mary R.; Tatonetti, Nicholas P.] Columbia Univ, Med Ctr, Dept Biomed Informat Syst Biol & Med, New York, NY USA; [Merad, Miriam] Icahn Sch Med Mt Sinai, Dept Oncol Sci, New York, NY 10029 USA; [Merad, Miriam; Brown, Brian D.] Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USA; [Merad, Miriam; Brown, Brian D.] Icahn Sch Med Mt Sinai, Inst Immunol, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Columbia University; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Brown, BD; Dudley, JT (corresponding author), Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA.; Dudley, JT (corresponding author), Icahn Sch Med Mt Sinai, lcahn Inst Genom & Multiscale Biol, New York, NY 10029 USA.; Brown, BD (corresponding author), Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USA.; Brown, BD (corresponding author), Icahn Sch Med Mt Sinai, Inst Immunol, New York, NY 10029 USA.	brian.brown@mssm.edu; joel.dudley@mssm.edu		Tatonetti, Nicholas/0000-0002-2700-2597; Wroblewska, Aleksandra/0000-0003-2059-6158; Kidd, Brian/0000-0003-2110-1145	US National Institutes of Health [R01AI104848, R33CA182377, R01AI113221, U54CA189201, R01DK098242]; Jonathan E. Gray TCI Young Scientist Cancer Research Award; NATIONAL CANCER INSTITUTE [P30CA196521, R01CA190400, R33CA182377, R01CA173861, U54CA189201] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI113221, R01AI104848] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020541, R01DK098242] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM107145] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jonathan E. Gray TCI Young Scientist Cancer Research Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank G. Hoffman and B. Readhead for useful conversations about the computational methods and suggestions on the manuscript, L. Li for assistance with the electronic medical records from Mount Sinai, K. Oguntuyo for assistance with the qPCR reactions, and A. Rahman for sample preparation and acquisition on the CyTOF. This work was supported by the US National Institutes of Health grants R01AI104848, R33CA182377 and R01AI113221 (to B.D.B.), U54CA189201 and R01DK098242, and Jonathan E. Gray TCI Young Scientist Cancer Research Award (to J.T.D.).	ALVIR JMJ, 1993, NEW ENGL J MED, V329, P162, DOI 10.1056/NEJM199307153290303; Beghi E, 2011, EPILEPSIA, V52, P40, DOI 10.1111/j.1528-1167.2011.03035.x; Bellucci R, 2012, J CLIN INVEST, V122, P2369, DOI 10.1172/JCI58457; Benoist C, 2012, NAT REV IMMUNOL, V12, P734, DOI 10.1038/nri3300; Beyrau M, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120134; Cheng Y, 2014, NATURE, V515, P371, DOI 10.1038/nature13985; Cherny RA, 2001, NEURON, V30, P665, DOI 10.1016/S0896-6273(01)00317-8; Cipolletta D, 2012, NATURE, V486, P549, DOI 10.1038/nature11132; Devi S, 2013, J EXP MED, V210, P2321, DOI 10.1084/jem.20130056; Dudley JT, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002648; Emert-Sedlak LA, 2013, CHEM BIOL, V20, P82, DOI 10.1016/j.chembiol.2012.11.005; Evans DC, 2005, CURR OPIN DRUG DISC, V8, P44; FAGIUS J, 1985, J NEUROL NEUROSUR PS, V48, P65, DOI 10.1136/jnnp.48.1.65; Fisahn A, 2002, NEURON, V33, P615, DOI 10.1016/S0896-6273(02)00587-1; Fortunati E, 2009, CLIN EXP IMMUNOL, V155, P559, DOI 10.1111/j.1365-2249.2008.03791.x; Fox RI, 1999, CLIN IMMUNOL, V93, P198, DOI 10.1006/clim.1999.4777; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Grossi C, 2009, J ALZHEIMERS DIS, V17, P423, DOI 10.3233/JAD-2009-1063; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Iorio F, 2010, P NATL ACAD SCI USA, V107, P14621, DOI 10.1073/pnas.1000138107; Iorio F, 2009, J COMPUT BIOL, V16, P241, DOI 10.1089/cmb.2008.10TT; Jagtap P, 2005, NAT REV DRUG DISCOV, V4, P421, DOI 10.1038/nrd1718; Jahchan NS, 2013, CANCER DISCOV, V3, P1364, DOI 10.1158/2159-8290.CD-13-0183; Johannessen TCA, 2008, CANCER TREAT REV, V34, P558, DOI 10.1016/j.ctrv.2008.03.125; Jojic V, 2013, NAT IMMUNOL, V14, P633, DOI 10.1038/ni.2587; Kim YJ, 2014, ALLERGY ASTHMA IMMUN, V6, P156, DOI 10.4168/aair.2014.6.2.156; Kolar D., 2008, NEUROPSYCHIATRIC DIS, V4, P389, DOI 10.2147/NDT.S6985; Kronke J, 2014, SCIENCE, V343, P301, DOI 10.1126/science.1244851; Kuhn M, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2009.98; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Lewis JD, 2008, GASTROENTEROLOGY, V134, P688, DOI 10.1053/j.gastro.2007.12.012; Lin S, 2014, P NATL ACAD SCI USA, V111, P17224, DOI 10.1073/pnas.1413624111; Maloney DG, 1997, BLOOD, V90, P2188; Maugeri-Sacca M, 2012, MOL CANCER THER, V11, P1627, DOI 10.1158/1535-7163.MCT-11-1040; Miller JC, 2012, NAT IMMUNOL, V13, P888, DOI 10.1038/ni.2370; Nam D, 2010, BIOINFORMATICS, V26, pi511, DOI 10.1093/bioinformatics/btq380; Novershtern N, 2011, CELL, V144, P296, DOI 10.1016/j.cell.2011.01.004; Qiu P, 2011, NAT BIOTECHNOL, V29, P886, DOI 10.1038/nbt.1991; Rahmatallah Y, 2014, BIOINFORMATICS, V30, P360, DOI 10.1093/bioinformatics/btt687; Robertson AL, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007672; Roge R, 2012, SCHIZOPHR RES, V140, P204, DOI 10.1016/j.schres.2012.06.020; Romano A, 2014, J ALLER CL IMM-PRACT, V2, P3, DOI 10.1016/j.jaip.2013.11.006; Rouleau M, 2010, NAT REV CANCER, V10, P293, DOI 10.1038/nrc2812; Salama A, 2009, EXPERT OPIN DRUG SAF, V8, P73, DOI [10.1517/14740330802577351 , 10.1517/14740330802577351, 10.1182/asheducation-2009.1.73]; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; Shay T, 2013, P NATL ACAD SCI USA, V110, P2946, DOI 10.1073/pnas.1222738110; Sicherer SH, 2014, J ALLERGY CLIN IMMUN, V133, P324, DOI 10.1016/j.jaci.2013.11.013; Sirota M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001318; Stepan AF, 2011, CHEM RES TOXICOL, V24, P1345, DOI 10.1021/tx200168d; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Summers C, 2010, TRENDS IMMUNOL, V31, P318, DOI 10.1016/j.it.2010.05.006; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Tatonetti NP, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003377; VEZINA C, 1975, J ANTIBIOT, V28, P721, DOI 10.7164/antibiotics.28.721; VOGELSANG GB, 1992, NEW ENGL J MED, V326, P1055, DOI 10.1056/NEJM199204163261604; Walker RG, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001033; Ward KE, 2010, AM J HEALTH-SYST PH, V67, P206, DOI 10.2146/ajhp080603; Wu D, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks461; Yaari G, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt660; Zhang X, 2002, INT IMMUNOPHARMACOL, V2, P1029, DOI 10.1016/S1567-5769(02)00057-7	60	54	55	1	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2016	34	1					47	54		10.1038/nbt.3367	http://dx.doi.org/10.1038/nbt.3367			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DB8HQ	26619012	Green Accepted, Bronze			2022-12-25	WOS:000368758200026
J	Klebanoff, CA; Rosenberg, SA; Restifo, NP				Klebanoff, Christopher A.; Rosenberg, Steven A.; Restifo, Nicholas P.			Prospects for gene-engineered T cell immunotherapy for solid cancers	NATURE MEDICINE			English	Article							CHIMERIC ANTIGEN RECEPTORS; ANTI-PD-1 ANTIBODY; SLEEPING-BEAUTY; PD-1 BLOCKADE; STEM-CELLS; ADOPTIVE IMMUNOTHERAPY; SUSTAINED REMISSIONS; METASTATIC MELANOMA; INDUCED PLURIPOTENT; ESTABLISHED TUMORS	Adoptive transfer of receptor-engineered T cells has produced impressive results in treating patients with B cell leukemias and lymphomas. This success has captured public imagination and driven academic and industrial researchers to develop similar 'off-the-shelf' receptors targeting shared antigens on epithelial cancers, the leading cause of cancer-related deaths. However, the successful treatment of large numbers of people with solid cancers using this strategy is unlikely to be straightforward. Receptor-engineered T cells have the potential to cause lethal toxicity from on-target recognition of normal tissues, and there is a paucity of truly tumor-specific antigens shared across tumor types. Here we offer our perspective on how expanding the use of genetically redirected T cells to treat the majority of patients with solid cancers will require major technical, manufacturing and regulatory innovations centered around the development of autologous gene therapies targeting private somatic mutations.	[Klebanoff, Christopher A.; Rosenberg, Steven A.; Restifo, Nicholas P.] NCI, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Klebanoff, CA (corresponding author), NCI, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	klebanoc@mail.nih.gov; restifo@nih.gov	Restifo, Nicholas Phillip/M-6549-2019; Restifo, Nicholas Phillip/Z-1614-2019	Restifo, Nicholas P./0000-0003-4229-4580; Klebanoff, Christopher/0000-0001-9645-3896	Intramural Research Program of the National Cancer Institute, Center for Cancer Research of the US National Institutes of Health (NIH) [ZIA BC011586, ZIA BC010763]; NIH Center for Regenerative Medicine; NATIONAL CANCER INSTITUTE [ZIABC010763, ZIABC011586, ZIABC010984, ZIABC010985] Funding Source: NIH RePORTER	Intramural Research Program of the National Cancer Institute, Center for Cancer Research of the US National Institutes of Health (NIH); NIH Center for Regenerative Medicine; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Intramural Research Program of the National Cancer Institute, Center for Cancer Research of the US National Institutes of Health (NIH) (ZIA BC011586 and ZIA BC010763) and the NIH Center for Regenerative Medicine. Additional support was provided by generous gifts from L. Jinyuan of the Tiens Charitable Foundation and the Milstein Family Foundation.	Abate-Daga D, 2013, BLOOD, V122, P1399, DOI 10.1182/blood-2013-04-495531; Adusumilli PS, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3010162; Ahmadi M, 2011, BLOOD, V118, P3528, DOI 10.1182/blood-2011-04-346338; Ahmed N, 2015, J CLIN ONCOL, V33, P1688, DOI 10.1200/JCO.2014.58.0225; Andersen RS, 2012, CANCER RES, V72, P1642, DOI 10.1158/0008-5472.CAN-11-2614; ANDREWS RG, 1983, BLOOD, V62, P124; Ansell SM, 2015, NEW ENGL J MED, V372, P311, DOI 10.1056/NEJMoa1411087; Araki R, 2013, NATURE, V494, P100, DOI 10.1038/nature11807; Bear AS, 2012, MOL THER, V20, P246, DOI 10.1038/mt.2011.288; Bollard CM, 2014, J CLIN ONCOL, V32, P798, DOI 10.1200/JCO.2013.51.5304; Bonini C, 1997, SCIENCE, V276, P1719, DOI 10.1126/science.276.5319.1719; Breart B, 2008, J CLIN INVEST, V118, P1390, DOI 10.1172/JCI34388; Brentjens RJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005930; Brentjens RJ, 2011, BLOOD, V118, P4817, DOI 10.1182/blood-2011-04-348540; Brzezianska E, 2006, MUTAT RES-FUND MOL M, V599, P26, DOI 10.1016/j.mrfmmm.2005.12.013; Caballero OL, 2009, CANCER SCI, V100, P2014, DOI 10.1111/j.1349-7006.2009.01303.x; Cameron BJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006034; Carpenito C, 2009, P NATL ACAD SCI USA, V106, P3360, DOI 10.1073/pnas.0813101106; Casati A, 2013, CANCER IMMUNOL IMMUN, V62, P1563, DOI 10.1007/s00262-013-1459-x; Chen YT, 1996, P NATL ACAD SCI USA, V93, P5915, DOI 10.1073/pnas.93.12.5915; Chinnasamy N, 2011, J IMMUNOL, V186, P685, DOI 10.4049/jimmunol.1001775; Cohen CJ, 2015, J CLIN INVEST, V125, P3981, DOI 10.1172/JCI82416; Corbiere V, 2011, CANCER RES, V71, P1253, DOI 10.1158/0008-5472.CAN-10-2693; Cox DBT, 2015, NAT MED, V21, P121, DOI 10.1038/nm.3793; Crompton JG, 2014, TRENDS IMMUNOL, V35, P178, DOI 10.1016/j.it.2014.02.003; Crone SA, 2002, NAT MED, V8, P459, DOI 10.1038/nm0502-459; Davila ML, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008226; Desnoyers LR, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006682; Di Stasi A, 2011, NEW ENGL J MED, V365, P1673, DOI 10.1056/NEJMoa1106152; Djenidi F, 2015, J IMMUNOL, V194, P3475, DOI 10.4049/jimmunol.1402711; Draper LM, 2015, CLIN CANCER RES, V21, P4431, DOI 10.1158/1078-0432.CCR-14-3341; ELLIS TM, 1993, J IMMUNOL, V151, P2380; ESHHAR Z, 1993, P NATL ACAD SCI USA, V90, P720, DOI 10.1073/pnas.90.2.720; Fedorov VD, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006597; Feldman SA, 2011, HUM GENE THER, V22, P107, DOI 10.1089/hum.2010.064; Field AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068201; Frigault MJ, 2015, CANCER IMMUNOL RES, V3, P356, DOI 10.1158/2326-6066.CIR-14-0186; Garfall AL, 2015, NEW ENGL J MED, V373, P1040, DOI 10.1056/NEJMoa1504542; Gattinoni L, 2012, NAT REV CANCER, V12, P671, DOI 10.1038/nrc3322; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Gonzalez-Galarza FF, 2011, NUCLEIC ACIDS RES, V39, pD913, DOI 10.1093/nar/gkq1128; Gros A, 2014, J CLIN INVEST, V124, P2246, DOI [10.1172/JC173639, 10.1172/JCI73639]; Grupp SA, 2013, NEW ENGL J MED, V368, P1509, DOI 10.1056/NEJMoa1215134; Guha P, 2013, CELL STEM CELL, V12, P407, DOI 10.1016/j.stem.2013.01.006; Hacein-Bey-Abina S, 2008, J CLIN INVEST, V118, P3132, DOI 10.1172/JCI35700; Hamanishi J, 2015, J CLIN ONCOL, V33, P4015, DOI 10.1200/JCO.2015.62.3397; Hanna JH, 2010, CELL, V143, P508, DOI 10.1016/j.cell.2010.10.008; Haridas D, 2014, FASEB J, V28, P4183, DOI 10.1096/fj.14-257352; Hinrichs CS, 2013, NAT BIOTECHNOL, V31, P999, DOI 10.1038/nbt.2725; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Howie B, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac5624; Hunder NN, 2008, NEW ENGL J MED, V358, P2698, DOI 10.1056/NEJMoa0800251; John LB, 2013, CLIN CANCER RES, V19, P5636, DOI 10.1158/1078-0432.CCR-13-0458; Johnson LA, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4963; Johnson LA, 2009, BLOOD, V114, P535, DOI 10.1182/blood-2009-03-211714; Jungbluth AA, 2001, INT J CANCER, V92, P856, DOI 10.1002/ijc.1282; Kacherovsky N, 2015, BIOTECHNOL BIOENG, V112, P1429, DOI 10.1002/bit.25538; Kantoff PW, 2010, NEW ENGL J MED, V363, P411, DOI 10.1056/NEJMoa1001294; Kerkar SP, 2011, J CLIN INVEST, V121, P4746, DOI 10.1172/JCI58814; Kershaw MH, 2006, CLIN CANCER RES, V12, P6106, DOI 10.1158/1078-0432.CCR-06-1183; Khong HT, 2002, NAT IMMUNOL, V3, P999, DOI 10.1038/ni1102-999; Klebanoff CA, 2012, J IMMUNOTHER, V35, P651, DOI 10.1097/CJI.0b013e31827806e6; Klebanoff CA, 2011, CLIN CANCER RES, V17, P5343, DOI 10.1158/1078-0432.CCR-11-0503; Klebanoff CA, 2011, IMMUNOL REV, V239, P27, DOI 10.1111/j.1600-065X.2010.00979.x; Kloss CC, 2013, NAT BIOTECHNOL, V31, P71, DOI 10.1038/nbt.2459; Kochenderfer JN, 2015, J CLIN ONCOL, V33, P540, DOI 10.1200/JCO.2014.56.2025; Kochenderfer JN, 2012, BLOOD, V119, P2709, DOI 10.1182/blood-2011-10-384388; Kochenderfer JN, 2010, BLOOD, V116, P4099, DOI 10.1182/blood-2010-04-281931; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Koneru M, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0460-x; Lamers C. H. J., 2006, J CLIN ONCOL, V24, pE20, DOI [10.1200/JCO.2006.05.9964, DOI 10.1200/JCO.2006.05.9964]; Le DT, 2015, NEW ENGL J MED, V372, P2509, DOI 10.1056/NEJMoa1500596; Lee AS, 2013, NAT MED, V19, P998, DOI 10.1038/nm.3267; Lee DW, 2015, LANCET, V385, P517, DOI 10.1016/S0140-6736(14)61403-3; Lee DW, 2014, BLOOD, V124, P188, DOI 10.1182/blood-2014-05-552729; Linette GP, 2013, BLOOD, V122, P863, DOI 10.1182/blood-2013-03-490565; Linnemann C, 2015, NAT MED, V21, P81, DOI 10.1038/nm.3773; Linnemann C, 2013, NAT MED, V19, P1534, DOI 10.1038/nm.3359; Lohr JG, 2014, NAT BIOTECHNOL, V32, P479, DOI 10.1038/nbt.2892; Long AH, 2015, NAT MED, V21, P581, DOI 10.1038/nm.3838; Louis CU, 2011, BLOOD, V118, P6050, DOI 10.1182/blood-2011-05-354449; Lu YC, 2014, CLIN CANCER RES, V20, P3401, DOI 10.1158/1078-0432.CCR-14-0433; MALAVASI F, 1994, IMMUNOL TODAY, V15, P95, DOI 10.1016/0167-5699(94)90148-1; Martincorena I, 2015, SCIENCE, V349, P1483, DOI 10.1126/science.aab4082; Maude SL, 2014, NEW ENGL J MED, V371, P1507, DOI 10.1056/NEJMoa1407222; MIETTINEN PJ, 1995, NATURE, V376, P337, DOI 10.1038/376337a0; Morgan RA, 2013, J IMMUNOTHER, V36, P133, DOI 10.1097/CJI.0b013e3182829903; Morgan RA, 2012, HUM GENE THER, V23, P1043, DOI 10.1089/hum.2012.041; Morgan RA, 2010, MOL THER, V18, P843, DOI 10.1038/mt.2010.24; Motzer RJ, 2015, NEW ENGL J MED, V373, P1803, DOI 10.1056/NEJMoa1510665; Nishimura T, 2013, CELL STEM CELL, V12, P114, DOI 10.1016/j.stem.2012.11.002; Palmer DC, 2015, J EXP MED, V212, P2095, DOI 10.1084/jem.20150304; Parkhurst MR, 2011, MOL THER, V19, P620, DOI 10.1038/mt.2010.272; Pastan I, 2014, CANCER RES, V74, P2907, DOI 10.1158/0008-5472.CAN-14-0337; Porter DL, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac5415; Porter DL, 2011, NEW ENGL J MED, V365, P725, DOI 10.1056/NEJMoa1103849; Powles T, 2014, NATURE, V515, P558, DOI 10.1038/nature13904; PRESS MF, 1990, ONCOGENE, V5, P953; Rao SP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039416; Rapoport AP, 2015, NAT MED, V21, P914, DOI 10.1038/nm.3910; Redman JM, 2015, MOL IMMUNOL, V67, P28, DOI 10.1016/j.molimm.2015.04.002; RETTIG WJ, 1989, ANNU REV IMMUNOL, V7, P481, DOI 10.1146/annurev.iy.07.040189.002405; Riddell SR, 1996, NAT MED, V2, P216, DOI 10.1038/nm0296-216; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Robbins PF, 2015, CLIN CANCER RES, V21, P1019, DOI 10.1158/1078-0432.CCR-14-2708; Robbins PF, 2013, NAT MED, V19, P747, DOI 10.1038/nm.3161; Rodenko B, 2006, NAT PROTOC, V1, P1120, DOI 10.1038/nprot.2006.121; Rosenberg SA, 2015, SCIENCE, V348, P62, DOI 10.1126/science.aaa4967; Rosenberg SA, 2011, CLIN CANCER RES, V17, P4550, DOI 10.1158/1078-0432.CCR-11-0116; Rushworth D, 2014, J IMMUNOTHER, V37, P204, DOI 10.1097/CJI.0000000000000032; Scholler J, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003761; Schumacher TN, 2015, SCIENCE, V348, P69, DOI 10.1126/science.aaa4971; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Singh H, 2008, CANCER RES, V68, P2961, DOI 10.1158/0008-5472.CAN-07-5600; Singh H, 2014, IMMUNOL REV, V257, P181, DOI 10.1111/imr.12137; Snyder A, 2014, NEW ENGL J MED, V371, P2189, DOI 10.1056/NEJMoa1406498; Sotillo E., 2015, CANC DISCOV; Spiotto MT, 2004, NAT MED, V10, P294, DOI 10.1038/nm999; STASHENKO P, 1980, J IMMUNOL, V125, P1678; Stemberger C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035798; Stevanovic S, 2015, J CLIN ONCOL, V33, P1543, DOI 10.1200/JCO.2014.58.9093; Straathof KC, 2005, BLOOD, V105, P4247, DOI 10.1182/blood-2004-11-4564; Tanyi J.L., 2015, CANC RES; Themeli M, 2013, NAT BIOTECHNOL, V31, P928, DOI 10.1038/nbt.2678; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Tran E., 2015, SCIENCE; Tran E, 2014, SCIENCE, V344, P641, DOI 10.1126/science.1251102; Van Allen EM, 2015, SCIENCE, V350, P207, DOI 10.1126/science.aad0095; van Rooij N, 2013, J CLIN ONCOL, V31, pE439, DOI 10.1200/JCO.2012.47.7521; Vizcardo R, 2013, CELL STEM CELL, V12, P31, DOI 10.1016/j.stem.2012.12.006; Wang GC, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003647; Wang XL, 2011, BLOOD, V118, P1255, DOI 10.1182/blood-2011-02-337360; WONG AJ, 1992, P NATL ACAD SCI USA, V89, P2965, DOI 10.1073/pnas.89.7.2965; Wu CY, 2015, SCIENCE, V350, DOI 10.1126/science.aab4077; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515; Ye QR, 2014, CLIN CANCER RES, V20, P44, DOI 10.1158/1078-0432.CCR-13-0945; Yu AL, 2010, NEW ENGL J MED, V363, P1324, DOI 10.1056/NEJMoa0911123; Zhao TB, 2011, NATURE, V474, P212, DOI 10.1038/nature10135; Zhao YB, 2010, CANCER RES, V70, P9053, DOI 10.1158/0008-5472.CAN-10-2880; Zhou XO, 2014, BLOOD, V123, P3895, DOI 10.1182/blood-2014-01-551671	140	236	255	2	193	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2016	22	1					26	36		10.1038/nm.4015	http://dx.doi.org/10.1038/nm.4015			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DA1YA	26735408	Green Accepted, Green Published			2022-12-25	WOS:000367590700012
J	Thome, JJC; Bickham, KL; Ohmura, Y; Kubota, M; Matsuoka, N; Gordon, C; Granot, T; Griesemer, A; Lerner, H; Kato, T; Farber, DL				Thome, Joseph J. C.; Bickham, Kara L.; Ohmura, Yoshiaki; Kubota, Masaru; Matsuoka, Nobuhide; Gordon, Claire; Granot, Tomer; Griesemer, Adam; Lerner, Harvey; Kato, Tomoaki; Farber, Donna L.			Early-life compartmentalization of human T cell differentiation and regulatory function in mucosal and lymphoid tissues	NATURE MEDICINE			English	Article							MAINTENANCE; EXPRESSION; SUBSETS	It is unclear how the immune response in early life becomes appropriately stimulated to provide protection while also avoiding excessive activation as a result of diverse new antigens. T cells are integral to adaptive immunity; mouse studies indicate that tissue localization of T cell subsets is important for both protective immunity(1-4) and immunoregulation(5,6). In humans, however, the early development and function of T cells in tissues remain unexplored. We present here an analysis of lymphoid and mucosal tissue T cells derived from pediatric organ donors in the first two years of life, as compared to adult organ donors, revealing early compartmentalization of T cell differentiation and regulation. Whereas adult tissues contain a predominance of memory T cells(7,8), in pediatric blood and tissues the main subset consists of naive recent thymic emigrants, with effector memory T cells (T-EM) found only in the lungs and small intestine. Additionally, regulatory T (T-reg) cells comprise a high proportion (30-40%) of CD4(+) T cells in pediatric tissues but are present at much lower frequencies (1-10%) in adult tissues. Pediatric tissue T-reg cells suppress endogenous T cell activation, and early T cell functionality is confined to the mucosal sites that have the lowest T-reg: TEM cell ratios, which suggests control in situ of immune responses in early life.	[Thome, Joseph J. C.; Bickham, Kara L.; Gordon, Claire; Granot, Tomer; Griesemer, Adam; Farber, Donna L.] Columbia Univ, Med Ctr, Columbia Ctr Translat Immunol, New York, NY 10027 USA; [Thome, Joseph J. C.; Farber, Donna L.] Columbia Univ, Med Ctr, Dept Microbiol & Immunol, New York, NY USA; [Ohmura, Yoshiaki; Kubota, Masaru; Matsuoka, Nobuhide; Kato, Tomoaki; Farber, Donna L.] Columbia Univ, Med Ctr, Dept Surg, New York, NY USA; [Gordon, Claire] Columbia Univ, Dept Med, Med Ctr, New York, NY USA; [Lerner, Harvey] LiveOnNY, New York, NY USA	Columbia University; Columbia University; Columbia University; Columbia University	Farber, DL (corresponding author), Columbia Univ, Med Ctr, Columbia Ctr Translat Immunol, New York, NY 10027 USA.	df2396@cumc.columbia.edu		Gordon, Claire/0000-0001-5172-4728; Farber, Donna/0000-0001-8236-9183	US National Institutes of Health (NIH) [AI100119, AI106697, F31AG047003, AI083022]; BD Bioscience Research Grant; S10 Shared Instrumentation Grant from the NIH [S10RR027050]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027050] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI083022, P01AI106697, R01AI100119] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F31AG047003] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BD Bioscience Research Grant; S10 Shared Instrumentation Grant from the NIH; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the US National Institutes of Health (NIH) (grant no. AI100119; D.L.F., AI106697: D.L.F., F31AG047003; J.J.C.T., AI083022; K.L.B.) and a BD Bioscience Research Grant (J.J.C.T.). These studies were performed in the Columbia Center for Translational Immunology (CCTI) Flow Cytometry Core, funded in part through an S10 Shared Instrumentation Grant from the NIH (grant no. S10RR027050), with the excellent technical assistance of S.-H. Ho.	Allan SE, 2008, EUR J IMMUNOL, V38, P3282, DOI 10.1002/eji.200838373; Booth NJ, 2010, J IMMUNOL, V184, P4317, DOI 10.4049/jimmunol.0903781; Burzyn D, 2013, CELL, V155, P1282, DOI 10.1016/j.cell.2013.10.054; Burzyn D, 2013, NAT IMMUNOL, V14, P1007, DOI 10.1038/ni.2683; Chalmers IMH, 1998, BLOOD, V92, P11, DOI 10.1182/blood.V92.1.11.413a39_11_18; Chaudhry A, 2013, J CLIN INVEST, V123, P939, DOI 10.1172/JCI57175; Farber DL, 2014, NAT REV IMMUNOL, V14, P24, DOI 10.1038/nri3567; Ferraro A, 2011, DIABETES, V60, P2903, DOI 10.2337/db11-0090; Gebhardt T, 2009, NAT IMMUNOL, V10, P524, DOI 10.1038/ni.1718; Gibbons D, 2014, NAT MED, V20, P1206, DOI 10.1038/nm.3670; Kimmig S, 2002, J EXP MED, V195, P789, DOI 10.1084/jem.20011756; Laidlaw BJ, 2014, IMMUNITY, V41, P633, DOI 10.1016/j.immuni.2014.09.007; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Mold JE, 2008, SCIENCE, V322, P1562, DOI 10.1126/science.1164511; Mueller SN, 2013, ANNU REV IMMUNOL, V31, P137, DOI 10.1146/annurev-immunol-032712-095954; Ohkura N, 2013, IMMUNITY, V38, P414, DOI 10.1016/j.immuni.2013.03.002; Peoples JD, 2009, AM J PERINAT, V26, P647, DOI 10.1055/s-0029-1220788; Pesenacker AM, 2015, EUR J IMMUNOL, V45, P333, DOI 10.1002/eji.201344205; Sathaliyawala T, 2013, IMMUNITY, V38, P187, DOI 10.1016/j.immuni.2012.09.020; Schenkel JM, 2014, SCIENCE, V346, P98, DOI 10.1126/science.1254536; Seddiki N, 2006, BLOOD, V107, P2830, DOI 10.1182/blood-2005-06-2403; Seddiki N, 2006, J EXP MED, V203, P1693, DOI 10.1084/jem.20060468; Shiow LR, 2006, NATURE, V440, P540, DOI 10.1038/nature04606; Teijaro JR, 2011, J IMMUNOL, V187, P5510, DOI 10.4049/jimmunol.1102243; Thome JJC, 2015, TRENDS IMMUNOL, V36, P428, DOI 10.1016/j.it.2015.05.003; Thome JJC, 2014, CELL, V159, P814, DOI 10.1016/j.cell.2014.10.026; Valmori D, 2005, J CLIN INVEST, V115, P1953, DOI 10.1172/JCI23963; Verbsky JW, 2013, CURR OPIN PEDIATR, V25, P708, DOI 10.1097/MOP.0000000000000029; Yang SY, 2015, SCIENCE, V348, P589, DOI 10.1126/science.aaa7017; Zhang X, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008748	30	191	196	1	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2016	22	1					72	+		10.1038/nm.4008	http://dx.doi.org/10.1038/nm.4008			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DA1YA	26657141	Green Submitted, Green Accepted			2022-12-25	WOS:000367590700017
J	Arafeh, R; Qutob, N; Emmanuel, R; Keren-Paz, A; Madore, J; Elkahloun, A; Wilmott, JS; Gartner, JJ; Di Pizio, A; Winograd-Katz, S; Sindiri, S; Rotkopf, R; Dutton-Regester, K; Johansson, P; Pritchard, AL; Waddell, N; Hill, VK; Lin, JC; Hevroni, Y; Rosenberg, SA; Khan, J; Ben-Dor, S; Niv, MY; Ulitsky, I; Mann, GJ; Scolyer, RA; Hayward, NK; Samuels, Y				Arafeh, Rand; Qutob, Nouar; Emmanuel, Rafi; Keren-Paz, Alona; Madore, Jason; Elkahloun, Abdel; Wilmott, James S.; Gartner, Jared J.; Di Pizio, Antonella; Winograd-Katz, Sabina; Sindiri, Sivasish; Rotkopf, Ron; Dutton-Regester, Ken; Johansson, Peter; Pritchard, Antonia L.; Waddell, Nicola; Hill, Victoria K.; Lin, Jimmy C.; Hevroni, Yael; Rosenberg, Steven A.; Khan, Javed; Ben-Dor, Shifra; Niv, Masha Y.; Ulitsky, Igor; Mann, Graham J.; Scolyer, Richard A.; Hayward, Nicholas K.; Samuels, Yardena			Recurrent inactivating RASA2 mutations in melanoma	NATURE GENETICS			English	Article							METASTATIC MELANOMA; CANCER; BRAF; INTEGRATION; MUTANTS; REVEALS	Analysis of 501 melanoma exomes identified RASA2, encoding a RasGAP, as a tumor-suppressor gene mutated in 5% of melanomas. Recurrent loss-of-function mutations in RASA2 were found to increase RAS activation, melanoma cell growth and migration. RASA2 expression was lost in >= 30% of human melanomas and was associated with reduced patient survival. These findings identify RASA2 inactivation as a melanoma driver and highlight the importance of RasGAPs in cancer.	[Arafeh, Rand; Qutob, Nouar; Emmanuel, Rafi; Keren-Paz, Alona; Winograd-Katz, Sabina; Hevroni, Yael; Samuels, Yardena] Weizmann Inst Sci, Mol Cell Biol Dept, IL-76100 Rehovot, Israel; [Madore, Jason; Wilmott, James S.; Mann, Graham J.; Scolyer, Richard A.] Melanoma Inst Australia, Sydney, NSW, Australia; [Madore, Jason; Wilmott, James S.; Mann, Graham J.; Scolyer, Richard A.] Univ Sydney, Sydney Med Sch, Discipline Pathol, Sydney, NSW 2006, Australia; [Elkahloun, Abdel; Hill, Victoria K.] NHGRI, US NIH, Bethesda, MD 20892 USA; [Gartner, Jared J.; Sindiri, Sivasish; Lin, Jimmy C.; Rosenberg, Steven A.; Khan, Javed] NCI, US NIH, Bethesda, MD 20892 USA; [Di Pizio, Antonella; Niv, Masha Y.] Hebrew Univ Jerusalem, Inst Biochem Food Sci & Nutr, IL-76100 Rehovot, Israel; [Rotkopf, Ron; Ben-Dor, Shifra] Weizmann Inst Sci, Dept Biol Serv, IL-76100 Rehovot, Israel; [Dutton-Regester, Ken; Johansson, Peter; Pritchard, Antonia L.; Waddell, Nicola; Hayward, Nicholas K.] QIMR Berghofer Med Res Inst, Brisbane, Qld, Australia; [Ulitsky, Igor] Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel; [Mann, Graham J.] Univ Sydney, Westmead Millennium Inst Med Res, Ctr Canc Res, Sydney, NSW 2006, Australia; [Scolyer, Richard A.] Royal Prince Alfred Hosp, Tissue Pathol & Diagnost Oncol, Sydney, NSW, Australia	Weizmann Institute of Science; Melanoma Institute Australia; University of Sydney; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Hebrew University of Jerusalem; Weizmann Institute of Science; QIMR Berghofer Medical Research Institute; Weizmann Institute of Science; University of Sydney; University of Sydney	Samuels, Y (corresponding author), Weizmann Inst Sci, Mol Cell Biol Dept, IL-76100 Rehovot, Israel.	yardena.samuels@weizmann.ac.il	Niv, Masha/AAL-1123-2020; Scolyer, Richard/AAE-8511-2019; Johansson, Peter A/K-1053-2014; Wilmott, James/AGA-8227-2022; Di Pizio, Antonella/M-9141-2019; Di Pizio, Antonella/ABC-6792-2020; Pritchard, Antonia/F-4288-2010; BEN-DOR, SHIFRA/M-6718-2019; Ulitsky, Igor/HCH-7453-2022; hayward, nicholas k/C-1367-2015; hayward, nick/AAV-8802-2020; Waddell, Nicola/H-4929-2015; Mann, Graham/G-4758-2014	Scolyer, Richard/0000-0002-8991-0013; Johansson, Peter A/0000-0001-7015-5452; Wilmott, James/0000-0002-6750-5244; Di Pizio, Antonella/0000-0002-8520-5165; Pritchard, Antonia/0000-0001-5336-0454; BEN-DOR, SHIFRA/0000-0001-9604-1939; Ulitsky, Igor/0000-0003-0555-6561; hayward, nicholas k/0000-0003-4760-1033; Waddell, Nicola/0000-0002-3950-2476; Samuels, Yardena/0000-0002-3349-7266; Madore, Jason/0000-0002-3499-474X; Niv, Masha/0000-0001-8275-8795; Dutton-Regester, Ken/0000-0002-8884-6355; sindiri, sivasish/0000-0003-2516-969X; Qutob, Nouar/0000-0003-2746-7367; Rotkopf, Ron/0000-0001-9503-7348; Arafeh, Rand/0000-0001-7107-2982; Mann, Graham/0000-0003-1301-405X	Intramural Research Programs of the National Human Genome Research Institute; National Cancer Institute; Australian National Health and Medical Research Council (NHMRC); Cancer Institute NSW; Israel Science Foundation [1604/13, 877/13]; European Research Council (ERC) [StG-335377]; ERC under the European Union's Horizon research and innovation program [677645]; Henry Chanoch Krenter Institute for Biomedical Imaging and Genomics; estate of Alice Schwarz-Gardos; estate of John Hunter; Knell Family; Peter and Patricia Gruber Award; Hamburger Family; Rising Tide Foundation; NHMRC; Cure Cancer Australia; Melanoma Institute Australia; NATIONAL CANCER INSTITUTE [ZIABC010984] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZICHG200365] Funding Source: NIH RePORTER	Intramural Research Programs of the National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Cancer Institute NSW; Israel Science Foundation(Israel Science Foundation); European Research Council (ERC)(European Research Council (ERC)European Commission); ERC under the European Union's Horizon research and innovation program; Henry Chanoch Krenter Institute for Biomedical Imaging and Genomics; estate of Alice Schwarz-Gardos; estate of John Hunter; Knell Family; Peter and Patricia Gruber Award; Hamburger Family; Rising Tide Foundation; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Cure Cancer Australia; Melanoma Institute Australia; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank T. Wiesel for graphical assistance. This work was supported by the Intramural Research Programs of the National Human Genome Research Institute and the National Cancer Institute, as well as by program grants of the Australian National Health and Medical Research Council (NHMRC) and Cancer Institute NSW. Y.S. is supported by the Israel Science Foundation through grants 1604/13 and 877/13, the European Research Council (ERC; StG-335377), the ERC under the European Union's Horizon 2020 research and innovation program (grant agreement 677645), the Henry Chanoch Krenter Institute for Biomedical Imaging and Genomics, the estate of Alice Schwarz-Gardos, the estate of John Hunter, the Knell Family, the Peter and Patricia Gruber Award and the Hamburger Family. I.U. is supported by a grant from the Rising Tide Foundation. N.K.H., K.D.-R. and R.A.S. are supported by fellowships from the NHMRC. A.L.P. is supported by Cure Cancer Australia. Support from the Melanoma Institute Australia is also gratefully acknowledged. We thank the TCGA Research Network for generating some of the data sets.	Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Dutton-Regester K, 2014, ONCOTARGET, V5, P2912, DOI 10.18632/oncotarget.2048; Fang JY, 2005, LANCET ONCOL, V6, P322, DOI 10.1016/S1470-2045(05)70168-6; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Jayawardana K, 2015, INT J CANCER, V136, P863, DOI 10.1002/ijc.29047; Kiel C, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004560; Ko LJ, 1996, GENE DEV, V10, P1054, DOI 10.1101/gad.10.9.1054; Krauthammer M, 2015, NAT GENET, V47, P996, DOI 10.1038/ng.3361; Krauthammer M, 2012, NAT GENET, V44, P1006, DOI 10.1038/ng.2359; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Maertens Ophelia, 2014, Advances in Biological Regulation, V55, P1, DOI 10.1016/j.jbior.2014.04.002; Mann GJ, 2013, J INVEST DERMATOL, V133, P509, DOI 10.1038/jid.2012.283; Miao WY, 1996, J BIOL CHEM, V271, P15322, DOI 10.1074/jbc.271.26.15322; Palavalli LH, 2009, NAT GENET, V41, P518, DOI 10.1038/ng.340; Papa A, 2014, CELL, V157, P595, DOI 10.1016/j.cell.2014.03.027; Rodriguez-Viciana P, 2006, MOL CELL, V22, P217, DOI 10.1016/j.molcel.2006.03.027; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; Siegel R, 2012, CA-CANCER J CLIN, V62, DOI 10.3322/caac.21153; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Solomon DA, 2008, CANCER RES, V68, P10300, DOI 10.1158/0008-5472.CAN-08-3272; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wei XM, 2011, NAT GENET, V43, P442, DOI 10.1038/ng.810	24	64	66	1	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2015	47	12					1408	+		10.1038/ng.3427	http://dx.doi.org/10.1038/ng.3427			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CX6LT	26502337	Green Accepted			2022-12-25	WOS:000365813200011
J	Shimada, K; Skouta, R; Kaplan, A; Yang, WS; Hayano, M; Dixon, SJ; Brown, LM; Valenzuela, CA; Wolpaw, AJ; Stockwell, BR				Shimada, Kenichi; Skouta, Rachid; Kaplan, Anna; Yang, Wan Seok; Hayano, Miki; Dixon, Scott J.; Brown, Lewis M.; Valenzuela, Carlos A.; Wolpaw, Adam J.; Stockwell, Brent R.			Global survey of cell death mechanisms reveals metabolic regulation of ferroptosis	NATURE CHEMICAL BIOLOGY			English	Article							LIPID-METABOLISM; SQUALENE SYNTHASE; DISEASE-MODELS; CANCER; IDENTIFICATION; EXPRESSION; NETWORK; PATHWAY; TARGET; DAMAGE	Apoptosis is one type of programmed cell death. Increasingly, non-apoptotic cell death is recognized as being genetically controlled, or 'regulated'. However, the full extent and diversity of alternative cell death mechanisms remain uncharted. Here we surveyed the landscape of pharmacologically accessible cell death mechanisms. In an examination of 56 caspase-independent lethal compounds, modulatory profiling showed that 10 compounds induced three different types of regulated non-apoptotic cell death. Optimization of one of those ten resulted in the discovery of FIN56, a specific inducer of ferroptosis. Ferroptosis has been found to occur when the lipid-repair enzyme GPX4 is inhibited. FIN56 promoted degradation of GPX4. FIN56 also bound to and activated squalene synthase, an enzyme involved in isoprenoid biosynthesis, independent of GPX4 degradation. These discoveries show that dysregulation of lipid metabolism is associated with ferroptosis. This systematic approach is a means to discover and characterize novel cell death phenotypes.	[Shimada, Kenichi; Skouta, Rachid; Kaplan, Anna; Yang, Wan Seok; Dixon, Scott J.; Wolpaw, Adam J.; Stockwell, Brent R.] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Hayano, Miki] Columbia Univ, Dept Pharmacol, New York, NY USA; [Brown, Lewis M.] Columbia Univ, Quantitat Prote Ctr, New York, NY USA; [Stockwell, Brent R.] Columbia Univ, Dept Chem, New York, NY 10027 USA; [Skouta, Rachid; Valenzuela, Carlos A.] Univ Texas El Paso, Dept Chem, Border Biomed Res Ctr, El Paso, TX 79968 USA; [Yang, Wan Seok] St Johns Univ, Dept Biol Sci, Queens, NY USA; [Dixon, Scott J.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Wolpaw, Adam J.] Childrens Hosp Philadelphia, Div Hematol, Philadelphia, PA 19104 USA; [Wolpaw, Adam J.] Childrens Hosp Philadelphia, Div Oncol, Philadelphia, PA 19104 USA	Columbia University; Columbia University; Columbia University; Columbia University; University of Texas System; University of Texas El Paso; Saint John's University; Stanford University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Stockwell, BR (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.; Stockwell, BR (corresponding author), Columbia Univ, Dept Chem, New York, NY 10027 USA.	bstockwell@columbia.edu	Skouta, Rachid/M-2690-2019; Shimada, Kenichi/AAD-7996-2021; Skouta, Rachid/Q-7132-2016; Stockwell, Brent R/AAE-7200-2019	Shimada, Kenichi/0000-0001-8540-9785; Stockwell, Brent R/0000-0002-3532-3868; Skouta, Rachid/0000-0003-3324-4362; Dixon, Scott/0000-0001-6230-8199; Wolpaw, Adam/0000-0002-1373-7648	Howard Hughes Medical Institute; US National Institutes of Health [5R01CA097061, 5R01GM085081, R01CA161061]; New York Stem Cell Science [C026715]; US National Cancer Institute (K99 Pathway to Independence Award) [1K99CA166517-01]; NATIONAL CANCER INSTITUTE [R00CA166517, R35CA209896, R01CA097061, R01CA161061, K99CA166517] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085081] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York Stem Cell Science; US National Cancer Institute (K99 Pathway to Independence Award); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank H. Li (Columbia University, New York, New York, USA) and C. Henderson (Biogen Idec, Cambridge, Massachusetts, USA) for providing mevalonic acid and farnesyl pyrophosphate, C.-I. Liu and A.H.J. Wang (Academia Sinica, Taipei, Taiwan) for the truncated human squalene synthase construct, R. Weinberg (Whitehead Institute, Cambridge, Massachusetts, USA) for engineered BJ cell lines (BJeLR, DRD, BJeHLT, and BJeH), E. Schon (Columbia University, New York, New York, USA) for 143B cells, E. Lee for assistance with ACC experiments, and V. Viswanathan for helpful discussions. This research was funded by the Howard Hughes Medical Institute, the US National Institutes of Health (grants 5R01CA097061, 5R01GM085081, and R01CA161061 to B.R.S.), New York Stem Cell Science (grant C026715 to B.R.S.) and the US National Cancer Institute (K99 Pathway to Independence Award 1K99CA166517-01 to S.J.D.).	Alegre-Aguaron E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088053; Aravind L, 1999, TRENDS BIOCHEM SCI, V24, P47, DOI 10.1016/S0968-0004(98)01341-3; Backman TWH, 2011, NUCLEIC ACIDS RES, V39, pW486, DOI 10.1093/nar/gkr320; Cholody W. M., 2008, US patent application, Patent No. [PCT/US2008/006015, 2008006015]; Chugh A, 2003, PROG LIPID RES, V42, P37, DOI 10.1016/S0163-7827(02)00029-2; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; Dixon SJ, 2015, ACS CHEM BIOL, V10, P1604, DOI 10.1021/acschembio.5b00245; Dixon SJ, 2014, ELIFE, V3, DOI 10.7554/eLife.02523; Dixon SJ, 2012, CELL, V149, P1060, DOI 10.1016/j.cell.2012.03.042; Fradejas N, 2013, BIOCHEM J, V450, P427, DOI 10.1042/BJ20121713; Fuchs Y, 2011, CELL, V147, P742, DOI 10.1016/j.cell.2011.10.033; Gueyen N, 2015, REDOX BIOL, V4, P289, DOI 10.1016/j.redox.2015.01.009; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Hayano M, 2016, CELL DEATH DIFFER, V23, P270, DOI 10.1038/cdd.2015.93; Hirsch HA, 2010, CANCER CELL, V17, P348, DOI 10.1016/j.ccr.2010.01.022; Hitomi JI, 2008, CELL, V135, P1311, DOI 10.1016/j.cell.2008.10.044; Imai H, 2003, FREE RADICAL BIO MED, V34, P145, DOI 10.1016/S0891-5849(02)01197-8; Kaczmarek A, 2013, IMMUNITY, V38, P209, DOI 10.1016/j.immuni.2013.02.003; Kamphorst JJ, 2011, ANAL CHEM, V83, P9114, DOI 10.1021/ac202220b; Kono H, 2008, NAT REV IMMUNOL, V8, P279, DOI 10.1038/nri2215; Linkermann A, 2014, P NATL ACAD SCI USA, V111, P16836, DOI 10.1073/pnas.1415518111; Linkermann A, 2014, NAT REV IMMUNOL, V14, P759, DOI 10.1038/nri3743; Liu CI, 2014, ACTA CRYSTALLOGR D, V70, P231, DOI 10.1107/S1399004713026230; Romanowska M, 2007, LUNG CANCER, V55, P35, DOI 10.1016/j.lungcan.2006.09.007; Santos CR, 2012, FEBS J, V279, P2610, DOI 10.1111/j.1742-4658.2012.08644.x; Shimada K, 2016, CELL CHEM BIOL, V23, P225, DOI 10.1016/j.chembiol.2015.11.016; Shoemaker RH, 2006, NAT REV CANCER, V6, P813, DOI 10.1038/nrc1951; Skouta R, 2014, J AM CHEM SOC, V136, P4551, DOI 10.1021/ja411006a; Song JH, 2015, ONCOGENE, V34, P3728, DOI 10.1038/onc.2014.306; Takahashi N, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.176; Tansey TR, 2000, BBA-MOL CELL BIOL L, V1529, P49, DOI 10.1016/S1388-1981(00)00137-2; Vanden Berghe T, 2014, NAT REV MOL CELL BIO, V15, P134, DOI 10.1038/nrm3737; Wolpaw AJ, 2011, P NATL ACAD SCI USA, V108, pE771, DOI 10.1073/pnas.1106149108; Yagoda N, 2007, NATURE, V447, P864, DOI 10.1038/nature05859; Yang WS, 2008, CHEM BIOL, V15, P234, DOI 10.1016/j.chembiol.2008.02.010; Yang WS, 2014, CELL, V156, P317, DOI 10.1016/j.cell.2013.12.010	37	404	424	25	228	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUL	2016	12	7					497	+		10.1038/NCHEMBIO.2079	http://dx.doi.org/10.1038/NCHEMBIO.2079			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9EP	27159577	Green Accepted			2022-12-25	WOS:000378087500008
J	Wisnovsky, S; Jean, SR; Kelley, SO				Wisnovsky, Simon; Jean, Sae Rin; Kelley, Shana O.			Mitochondrial DNA repair and replication proteins revealed by targeted chemical probes	NATURE CHEMICAL BIOLOGY			English	Article							POLYMERASE THETA; OXIDATIVE STRESS; MTDNA INTEGRITY; CELLS; DAMAGE; RECOMBINATION; MUTATIONS	Efficient and accurate replication and repair of mitochondrial DNA is essential for cellular viability, yet only a minimal complement of mitochondrial proteins with relevant activities have been identified. Here, we describe an approach to screen for new pathways involved in the maintenance of mitochondrial DNA (mtDNA) that leverages the activities of DNA-damaging probes exhibiting specific subcellular localization. By conducting a siRNA screen of known nuclear DNA maintenance factors, and monitoring synergistic effects of gene depletion on the activity of mitochondria-specific DNA-damaging agents, we identify a series of proteins not previously recognized to act within mitochondria. These include proteins that function in pathways of oxidative DNA damage repair and dsDNA break repair, along with a novel mitochondrial DNA polymerase, POL theta, that facilitates efficient DNA replication in an environment prone to oxidative stress. POL theta expression levels affect the mutational rate of mitochondria! DNA, but this protein also appears critical for efficient mtDNA replication.	[Wisnovsky, Simon; Kelley, Shana O.] Univ Toronto, Dept Biochem, Fac Med, Toronto, ON, Canada; [Jean, Sae Rin; Kelley, Shana O.] Univ Toronto, Dept Chem, Fac Arts & Sci, 80 St George St, Toronto, ON M5S 1A1, Canada; [Kelley, Shana O.] Univ Toronto, Dept Pharmaceut Sci, Leslie Dan Fac Pharm, Toronto, ON M5S 1A1, Canada	University of Toronto; University of Toronto; University of Toronto	Kelley, SO (corresponding author), Univ Toronto, Dept Biochem, Fac Med, Toronto, ON, Canada.; Kelley, SO (corresponding author), Univ Toronto, Dept Chem, Fac Arts & Sci, 80 St George St, Toronto, ON M5S 1A1, Canada.; Kelley, SO (corresponding author), Univ Toronto, Dept Pharmaceut Sci, Leslie Dan Fac Pharm, Toronto, ON M5S 1A1, Canada.	shana.kelley@utoronto.ca	Kelley, Shana/H-5856-2015; Kelley, Shana/ABA-7403-2021	Kelley, Shana/0000-0003-3360-5359; 	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	We acknowledge the Canadian Institutes of Health Research for their support of this work. We also thank S. Liyanage (Princess Margaret Hospital) for assistance with Seahorse analysis, and J.H.J. Hoeijmakers (Erasmus University Medical Center) for providing Rad23a<SUP>+/+</SUP> and Rad23a<SUP>-/-</SUP> MEFs.	Ashley N, 2005, EXP CELL RES, V303, P432, DOI 10.1016/j.yexcr.2004.10.013; Bacman SR, 2009, NUCLEIC ACIDS RES, V37, P4218, DOI 10.1093/nar/gkp348; Bellance N, 2009, INT J BIOCHEM CELL B, V41, P2566, DOI 10.1016/j.biocel.2009.08.012; Carreon JR, 2004, ORG LETT, V6, P517, DOI 10.1021/ol0362818; Ceccaldi R, 2015, NATURE, V518, P258, DOI 10.1038/nature14184; Chamberlain GR, 2013, ACS CHEM BIOL, V8, P1389, DOI 10.1021/cb400095v; Chatterjee A, 2006, ONCOGENE, V25, P4663, DOI 10.1038/sj.onc.1209604; Falkenberg M, 2007, ANNU REV BIOCHEM, V76, P679, DOI 10.1146/annurev.biochem.76.060305.152028; Fernandez-Vidal A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5285; Fonseca SB, 2011, CHEM BIOL, V18, P445, DOI 10.1016/j.chembiol.2011.02.010; Friedman JR, 2014, NATURE, V505, P335, DOI 10.1038/nature12985; Gao YK, 2011, NATURE, V471, P240, DOI 10.1038/nature09773; Grawunder U, 1997, NATURE, V388, P492, DOI 10.1038/41358; Holt IJ, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a012971; Horton KL, 2008, CHEM BIOL, V15, P375, DOI 10.1016/j.chembiol.2008.03.015; Ishikawa K, 2008, SCIENCE, V320, P661, DOI 10.1126/science.1156906; Kazak L, 2012, NAT REV MOL CELL BIO, V13, P659, DOI 10.1038/nrm3439; Lakshmipathy U, 1999, NUCLEIC ACIDS RES, V27, P1198, DOI 10.1093/nar/27.4.1198; Lange SS, 2011, NAT REV CANCER, V11, P96, DOI 10.1038/nrc2998; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; LeDoux SP, 2007, NEUROSCIENCE, V145, P1249, DOI 10.1016/j.neuroscience.2006.10.002; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Mahon KP, 2007, CHEM BIOL, V14, P923, DOI 10.1016/j.chembiol.2007.07.011; Marroquin LD, 2007, TOXICOL SCI, V97, P539, DOI 10.1093/toxsci/kfm052; Mateos-Gomez PA, 2015, NATURE, V518, P254, DOI 10.1038/nature14157; Mourtada R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060253; Pinto M, 2015, FREE RADICAL BIO MED, V85, P250, DOI 10.1016/j.freeradbiomed.2015.05.005; Pohjoismaki JLO, 2012, NUCLEIC ACIDS RES, V40, P6595, DOI 10.1093/nar/gks301; Rhee HW, 2013, SCIENCE, V339, P1328, DOI 10.1126/science.1230593; Rin Jean Sae, 2014, ACS Chem Biol, V9, P323, DOI 10.1021/cb400821p; Santos Janine H, 2006, Methods Mol Biol, V314, P183; Santos JH, 2003, J BIOL CHEM, V278, P1728, DOI 10.1074/jbc.M208752200; Sheng ZJ, 2012, J CLIN INVEST, V122, P4344, DOI 10.1172/JCI65053; Tann AW, 2011, J BIOL CHEM, V286, P31975, DOI 10.1074/jbc.M110.215715; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; Weterings E, 2008, CELL RES, V18, P114, DOI 10.1038/cr.2008.3; Williams CC, 2014, SCIENCE, V346, P748, DOI 10.1126/science.1257522; Wisnovsky SP, 2013, CHEM BIOL, V20, P1323, DOI 10.1016/j.chembiol.2013.08.010; Yoon JH, 2014, J BIOL CHEM, V289, P13177, DOI 10.1074/jbc.M114.556977; Yousefzadeh MJ, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004654	40	65	66	1	74	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUL	2016	12	7					567	+		10.1038/NCHEMBIO.2102	http://dx.doi.org/10.1038/NCHEMBIO.2102			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9EP	27239789				2022-12-25	WOS:000378087500018
J	Cherepanova, OA; Gomez, D; Shankman, LS; Swiatlowska, P; Williams, J; Sarmento, OF; Alencar, GF; Hess, DL; Bevard, MH; Greene, ES; Murgai, M; Turner, SD; Geng, YJ; Bekiranov, S; Connelly, JJ; Tomilin, A; Owens, GK				Cherepanova, Olga A.; Gomez, Delphine; Shankman, Laura S.; Swiatlowska, Pamela; Williams, Jason; Sarmento, Olga F.; Alencar, Gabriel F.; Hess, Daniel L.; Bevard, Melissa H.; Greene, Elizabeth S.; Murgai, Meera; Turner, Stephen D.; Geng, Yong-Jian; Bekiranov, Stefan; Connelly, Jessica J.; Tomilin, Alexey; Owens, Gary K.			Activation of the pluripotency factor OCT4 in smooth muscle cells is atheroprotective	NATURE MEDICINE			English	Article							DNA METHYLATION; EXPRESSION; DIFFERENTIATION; MOUSE; ATHEROSCLEROSIS; INACTIVATION; GENERATION; INDUCTION; MARKERS; HYPOXIA	Although somatic cell activation of the embryonic stem cell (ESC) pluripotency factor OCT4 has been reported, this previous work has been controversial and has not demonstrated a functional role for OCT4 in somatic cells. Here we demonstrate that smooth muscle cell (SMC)-specific conditional knockout of Oct4 in Apoe(-/-) mice resulted in increased lesion size and changes in lesion composition that are consistent with decreased plaque stability, including a thinner fibrous cap, increased necrotic core area, and increased intraplaque hemorrhage. Results of SMC-lineage-tracing studies showed that these effects were probably the result of marked reductions in SMC numbers within lesions and SMC investment within the fibrous cap, which may result from impaired SMC migration. The reactivation of Oct4 within SMCs was associated with hydroxymethylation of the Oct4 promoter and was hypoxia inducible factor-1 alpha (HIF-1 alpha, encoded by HIF1A) and Kruppel-like factor-4 (KLF4)-dependent. These results provide the first direct evidence that OCT4 has a functional role in somatic cells, and they highlight the potential role of OCT4 in normal and diseased somatic cells.	[Cherepanova, Olga A.; Gomez, Delphine; Shankman, Laura S.; Swiatlowska, Pamela; Alencar, Gabriel F.; Hess, Daniel L.; Bevard, Melissa H.; Greene, Elizabeth S.; Murgai, Meera; Connelly, Jessica J.; Owens, Gary K.] Univ Virginia, Robert M Berne Cardiovasc Res Ctr, Charlottesville, VA USA; [Gomez, Delphine; Shankman, Laura S.; Owens, Gary K.] Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA USA; [Swiatlowska, Pamela] Univ Gdansk, Intercoll Fac Biotechnol, PL-80952 Gdansk, Poland; [Williams, Jason; Geng, Yong-Jian] Univ Texas Houston Med Sch, Ctr Cardiovasc Biol & Atherosclerosis Res, Houston, TX USA; [Sarmento, Olga F.] Mayo Clin, Dept Gastroenterol & Hepatol, Rochester, MN USA; [Alencar, Gabriel F.; Hess, Daniel L.; Bekiranov, Stefan] Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA USA; [Murgai, Meera] Univ Virginia, Dept Pathol, Charlottesville, VA 22903 USA; [Turner, Stephen D.] Univ Virginia, Sch Med, Bioinformat Core, Charlottesville, VA 22908 USA; [Connelly, Jessica J.] Univ Virginia, Dept Med, Charlottesville, VA USA; [Tomilin, Alexey] Russian Acad Sci, Inst Cytol, St Petersburg 194064, Russia	University of Virginia; University of Virginia; Fahrenheit Universities; University of Gdansk; University of Texas System; University of Texas Health Science Center Houston; Mayo Clinic; University of Virginia; University of Virginia; University of Virginia; University of Virginia; Russian Academy of Sciences; St. Petersburg Scientific Centre of the Russian Academy of Sciences; Institute of Cytology RAS	Owens, GK (corresponding author), Univ Virginia, Robert M Berne Cardiovasc Res Ctr, Charlottesville, VA USA.; Owens, GK (corresponding author), Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA USA.	gko@virginia.edu	Gomez, Delphine/J-6349-2019; Turner, Stephen/GXM-4654-2022; Murgai, Meera/AAW-1114-2021; Tomilin, Alexey/AAA-8774-2022; Tomilin, Alexey N/C-3361-2014; Cherepanova, Olga E./K-1277-2015; Tomilin, Alexey/AAK-3068-2021	Gomez, Delphine/0000-0002-3880-6961; Tomilin, Alexey/0000-0002-1137-7167; Tomilin, Alexey N/0000-0002-1137-7167; Cherepanova, Olga E./0000-0001-7775-6488; Murgai, Meera/0000-0001-5015-839X; Turner, Stephen/0000-0001-9140-9028	US National Institutes of Health (NIH) [R01 HL057353, R01 HL087867, R01 HL098538]; AHA [11PRE17008, 13POST17080043, 15SDG25860021, 11PRE7750030, 15PRE25670040, 15PRE25730011]; Russian Science Foundation [14-14-00718]; Federal Agency of Scientific Organization; US Department of Defense [W81XWH-10-2-0125];  [R01 HL100257];  [R00 HL089412]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098538, R01HL057353, R00HL089412, R01HL100257, T32HL007284, R01HL038854, R01HL121008, R01HL087867] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007267] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHA(American Heart Association); Russian Science Foundation(Russian Science Foundation (RSF)); Federal Agency of Scientific Organization; US Department of Defense(United States Department of Defense); ; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors would like to thank R. Tripathi, M. McCanna, T. Karaoli, T. Lillard and J. Sanders for their technical assistance; A. Newman, M. Quetsch, E. Schutzenhofer, J. Roithmayr and R. Haskins for their help with image analysis and cell culture experiments; S. Guillot at the Advanced Microscopy Facility at the University of Virginia for help with confocal microscopy; BioConnector Service, University of Virginia, for help with statistical analysis; D. Trono from Swiss Institutes of Technology, Lausanne, Switzerland, for the pLVTHM vector; H.R. Scholer from Max Plank Institute for the Oct4<SUP>flox/flox</SUP> mice; S. Offermanns from Max Plank Institute for the Myh11-CreER<SUP>T2</SUP> mice; and G. Randolph for the LysM<SUP>Cre/Cre</SUP> mice. This work was supported by US National Institutes of Health (NIH) grants R01 HL057353, R01 HL087867 and R01 HL098538 (to G.K.O.); AHA 11PRE17008 (to L.S.S.); Russian Science Foundation grant 14-14-00718 and Federal Agency of Scientific Organization (to A.T.); R01 HL100257 and R00 HL089412 (to J.J.C.); US Department of Defense Grant (W81XWH-10-2-0125, to Y.-J.G); AHA 13POST17080043 and 15SDG25860021 (to D.G.); AHA 11PRE7750030 (to M.M.); AHA 15PRE25670040 (to D.L.H.); and AHA 15PRE25730011 (to G.F.A.).	Alexander MR, 2012, ANNU REV PHYSIOL, V74, P13, DOI 10.1146/annurev-physiol-012110-142315; Alexander MR, 2012, J CLIN INVEST, V122, P70, DOI 10.1172/JCI43713; Athanasiadou R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009937; Atlasi Y, 2008, STEM CELLS, V26, P3068, DOI 10.1634/stemcells.2008-0530; Botquin V, 1998, GENE DEV, V12, P2073, DOI 10.1101/gad.12.13.2073; Buganim Y, 2012, CELL, V150, P1209, DOI 10.1016/j.cell.2012.08.023; Cantz T, 2008, STEM CELLS, V26, P692, DOI 10.1634/stemcells.2007-0657; Cherepanova OA, 2009, CIRC RES, V104, P609, DOI 10.1161/CIRCRESAHA.108.186064; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Cole JE, 2011, P NATL ACAD SCI USA, V108, P2372, DOI 10.1073/pnas.1018515108; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Edfeldt K, 2002, CIRCULATION, V105, P1158, DOI 10.1161/circ.105.10.1158; Feldman N, 2006, NAT CELL BIOL, V8, P188, DOI 10.1038/ncb1353; Firth AL, 2010, AM J PHYSIOL-LUNG C, V298, pL548, DOI 10.1152/ajplung.00314.2009; Gao YW, 2013, CELL STEM CELL, V12, P453, DOI 10.1016/j.stem.2013.02.005; Gomez D, 2013, NAT METHODS, V10, P171, DOI [10.1038/NMETH.2332, 10.1038/nmeth.2332]; He W, 2012, WORLD J GASTROENTERO, V18, P712, DOI 10.3748/wjg.v18.i7.712; Holmberg J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018454; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jez M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089546; Kehler J, 2004, EMBO REP, V5, P1078, DOI 10.1038/sj.embor.7400279; Lambert CM, 2010, CARDIOVASC RES, V88, P196, DOI 10.1093/cvr/cvq152; Lee J, 2012, CELL, V151, P547, DOI 10.1016/j.cell.2012.09.034; Lengner CJ, 2008, CELL CYCLE, V7, P725, DOI 10.4161/cc.7.6.5573; Lengner CJ, 2007, CELL STEM CELL, V1, P403, DOI 10.1016/j.stem.2007.07.020; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Liedtke S, 2008, BIOL CHEM, V389, P845, DOI 10.1515/BC.2008.098; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Manabe I, 2001, CIRC RES, V88, P1127, DOI 10.1161/hh1101.091339; Marsch E, 2013, CURR OPIN LIPIDOL, V24, P393, DOI 10.1097/MOL.0b013e32836484a4; Mathieu J, 2011, CANCER RES, V71, P4640, DOI 10.1158/0008-5472.CAN-10-3320; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Nishimura RA, 2014, J THORAC CARDIOV SUR, V148, pE1, DOI 10.1016/j.jtcvs.2014.05.014; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Pidkovka NA, 2007, CIRC RES, V101, P792, DOI 10.1161/CIRCRESAHA.107.152736; PIEDRAHITA JA, 1992, P NATL ACAD SCI USA, V89, P4471, DOI 10.1073/pnas.89.10.4471; SCHOLER HR, 1990, NATURE, V344, P435, DOI 10.1038/344435a0; Shankman LS, 2015, NAT MED, V21, P628, DOI 10.1038/nm.3866; Shatrov VA, 2003, BLOOD, V101, P4847, DOI 10.1182/blood-2002-09-2711; Shu J, 2013, CELL, V153, P963, DOI 10.1016/j.cell.2013.05.001; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; TAKEDA J, 1992, NUCLEIC ACIDS RES, V20, P4613, DOI 10.1093/nar/20.17.4613; Wirth A, 2008, NAT MED, V14, P64, DOI 10.1038/nm1666; Wiznerowicz M, 2003, J VIROL, V77, P8957, DOI 10.1128/JVI.77.16.8957-8951.2003; Yang SW, 2015, TISSUE CELL, V47, P115, DOI 10.1016/j.tice.2014.12.004; Yoshida T, 2008, CIRC RES, V102, P1548, DOI 10.1161/CIRCRESAHA.108.176974	47	116	117	3	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2016	22	6					657	+		10.1038/nm.4109	http://dx.doi.org/10.1038/nm.4109			12	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DO0NQ	27183216	Green Accepted			2022-12-25	WOS:000377476000023
J	Fukawa, T; Yan-Jiang, BC; Min-Wen, JC; Jun-Hao, ET; Huang, D; Qian, CN; Ong, P; Li, ZM; Chen, SW; Mak, SY; Lim, WJ; Kanayama, HO; Mohan, RE; Wang, RR; Lai, JH; Chua, C; Ong, HS; Tan, KK; Ho, YS; Tan, IB; Teh, B; Shyh-Chang, N				Fukawa, Tomoya; Yan-Jiang, Benjamin Chua; Min-Wen, Jason Chua; Jun-Hao, Elwin Tan; Huang, Dan; Qian, Chao-Nan; Ong, Pauline; Li, Zhimei; Chen, Shuwen; Mak, Shi Ya; Lim, Wan Jun; Kanayama, Hiro-omi; Mohan, Rosmin Elsa; Wang, Ruiqi Rachel; Lai, Jiunn Herng; Chua, Clarinda; Ong, Hock Soo; Tan, Ker-Kan; Ho, Ying Swan; Tan, Iain Beehuat; Teh, Bin Tean; Shyh-Chang, Ng			Excessive fatty acid oxidation induces muscle atrophy in cancer cachexia	NATURE MEDICINE			English	Article							TUMOR-NECROSIS-FACTOR; STIMULATES LIPOLYSIS; CELLS; LIPASE; MICE; METABOLISM	Cachexia is a devastating muscle-wasting syndrome that occurs in patients who have chronic diseases. It is most commonly observed in individuals with advanced cancer(1,2), presenting in 80% of these patients, and it is one of the primary causes of morbidity and mortality associated with cancer(3-5). Additionally, although many people with cachexia show hypermetabolism(3,6), the causative role of metabolism in muscle atrophy has been unclear. To understand the molecular basis of cachexia-associated muscle atrophy, it is necessary to develop accurate models of the condition. By using transcriptomics and cytokine profiling of human muscle stem cell-based models and human cancer-induced cachexia models in mice, we found that cachectic cancer cells secreted many inflammatory factors that rapidly led to high levels of fatty acid metabolism and to the activation of a p38 stress-response signature in skeletal muscles, before manifestation of cachectic muscle atrophy occurred. Metabolomics profiling revealed that factors secreted by cachectic cancer cells rapidly induce excessive fatty acid oxidation in human myotubes, which leads to oxidative stress, p38 activation and impaired muscle growth. Pharmacological blockade of fatty acid oxidation not only rescued human myotubes, but also improved muscle mass and body weight in cancer cachexia models in vivo. Therefore, fatty acid-induced oxidative stress could be targeted to prevent cancer-induced cachexia.	[Fukawa, Tomoya; Ong, Pauline; Li, Zhimei; Teh, Bin Tean] Duke Natl Univ, Program Canc & Stem Cell Biol, Lab Canc Therapeut, Singapore Med Sch, Singapore, Singapore; [Fukawa, Tomoya; Huang, Dan; Ong, Pauline; Li, Zhimei; Teh, Bin Tean] Natl Canc Ctr Singapore, Div Med Sci, Lab Canc Epigenome, Singapore, Singapore; [Fukawa, Tomoya; Kanayama, Hiro-omi] Univ Tokushima, Grad Sch, Inst Biomed Sci, Dept Urol, Tokushima 770, Japan; [Yan-Jiang, Benjamin Chua; Min-Wen, Jason Chua; Jun-Hao, Elwin Tan; Chua, Clarinda; Tan, Iain Beehuat; Shyh-Chang, Ng] Agcy Sci Technol & Res, Genome Inst Singapore, Singapore, Singapore; [Qian, Chao-Nan] Sun Yat Sen Univ, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China; [Chen, Shuwen; Mak, Shi Ya; Ho, Ying Swan] Agcy Sci Technol & Res, Bioproc Technol Inst, Singapore, Singapore; [Lim, Wan Jun; Chua, Clarinda; Tan, Iain Beehuat; Teh, Bin Tean] Natl Canc Ctr Singapore, Div Med Oncol, Singapore, Singapore; [Mohan, Rosmin Elsa; Wang, Ruiqi Rachel] Nanyang Technol Univ, Sch Mech & Aerosp Engn, Singapore 639798, Singapore; [Lai, Jiunn Herng] Singapore Gen Hosp, Dept Colorectal Surg, Singapore, Singapore; [Ong, Hock Soo] Singapore Gen Hosp, Dept Upper Gastrointestinal & Bariatr Surg, Singapore, Singapore; [Tan, Ker-Kan] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Surg, Singapore 117595, Singapore; [Tan, Iain Beehuat] Duke Natl Univ, Program Canc & Stem Cell Biol, Singapore Med Sch, Singapore, Singapore; [Teh, Bin Tean] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117548, Singapore; [Teh, Bin Tean] Agcy Sci Technol & Res, Inst Mol & Cell Biol, Singapore, Singapore; [Teh, Bin Tean] Duke Natl Univ, Singapore Precis Med Inst, SingHlth, Natl Heart Ctr, Singapore, Singapore	National Cancer Centre Singapore (NCCS); Tokushima University; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); State Key Lab Oncology South China; Sun Yat Sen University; Agency for Science Technology & Research (A*STAR); A*STAR - Bioprocessing Technology Institute (BTI); National Cancer Centre Singapore (NCCS); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Singapore General Hospital; Singapore General Hospital; National University of Singapore; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National Heart Centre Singapore	Teh, B (corresponding author), Duke Natl Univ, Program Canc & Stem Cell Biol, Lab Canc Therapeut, Singapore Med Sch, Singapore, Singapore.; Teh, B (corresponding author), Natl Canc Ctr Singapore, Div Med Sci, Lab Canc Epigenome, Singapore, Singapore.; Tan, IB; Shyh-Chang, N (corresponding author), Agcy Sci Technol & Res, Genome Inst Singapore, Singapore, Singapore.; Tan, IB; Teh, B (corresponding author), Natl Canc Ctr Singapore, Div Med Oncol, Singapore, Singapore.; Tan, IB (corresponding author), Duke Natl Univ, Program Canc & Stem Cell Biol, Singapore Med Sch, Singapore, Singapore.; Teh, B (corresponding author), Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117548, Singapore.; Teh, B (corresponding author), Agcy Sci Technol & Res, Inst Mol & Cell Biol, Singapore, Singapore.; Teh, B (corresponding author), Duke Natl Univ, Singapore Precis Med Inst, SingHlth, Natl Heart Ctr, Singapore, Singapore.	iain.tan.b.h@singhealth.com.sg; teh.bin.tean@singhealth.com.sg; ngsc1@gis.a-star.edu.sg	Huang, Dejian/A-7439-2010; Tan, Ker Kan/K-2506-2017; Fukawa, Tomoya/AFV-7106-2022	Tan, Ker Kan/0000-0002-0410-0450; Wang, Ruiqi Rachel/0000-0002-5099-8177; Ho, Ying Swan/0000-0002-9292-3106; Chen, Shuwen/0000-0003-1245-1469; Mohan, Rosmin Elsa/0000-0001-6809-7679; Teh, Bin Tean/0000-0003-1514-1124; Chua, Benjamin Yan-Jiang/0000-0002-9529-291X; Shyh-Chang, Ng/0000-0003-3138-9525	Agency for Science Technology and Research (ASTAR) Joint Council Office grant [1431AFG128]; Singapore National Medical Research Council [NMRC/STaR/0024/2014, NMRC/GMS/CIRG/1332/2012]; Duke-NUS Medical School; National Cancer Centre Singapore; Polaris program under ASTAR Strategic Positioning Fund [SPF2012/001]; Genome Institute of Singapore	Agency for Science Technology and Research (ASTAR) Joint Council Office grant(Agency for Science Technology & Research (A*STAR)); Singapore National Medical Research Council(National Medical Research Council, Singapore); Duke-NUS Medical School; National Cancer Centre Singapore; Polaris program under ASTAR Strategic Positioning Fund; Genome Institute of Singapore	We thank all our respective lab mates for their helpful discussion, and E. Peh for technical assistance with mass spectrometry. This work was supported by the Agency for Science Technology and Research (ASTAR) Joint Council Office grant 1431AFG128 (N.S.-C.), the Singapore National Medical Research Council grants NMRC/STaR/0024/2014 and NMRC/GMS/CIRG/1332/2012, Duke-NUS Medical School, and National Cancer Centre Singapore (all to B.T.T.), Polaris program grant SPF2012/001 under the ASTAR Strategic Positioning Fund (Y.S.H.) and the Genome Institute of Singapore (I.B.T. and N.S.-C.).	Argiles Josep M, 2009, Curr Opin Support Palliat Care, V3, P263, DOI 10.1097/SPC.0b013e3283311d09; Bernet JD, 2014, NAT MED, V20, P265, DOI 10.1038/nm.3465; Bouhadir KH, 2001, BIOTECHNOL PROGR, V17, P945, DOI 10.1021/bp010070p; Cohen S, 2015, NAT REV DRUG DISCOV, V14, P58, DOI 10.1038/nrd4467; Cosgrove BD, 2014, NAT MED, V20, P255, DOI 10.1038/nm.3464; Das SK, 2011, SCIENCE, V333, P233, DOI 10.1126/science.1198973; Ebadi M., 2016, CLIN NUTR; Fearon K, 2013, NAT REV CLIN ONCOL, V10, P90, DOI 10.1038/nrclinonc.2012.209; Fearon KCH, 2012, CELL METAB, V16, P153, DOI 10.1016/j.cmet.2012.06.011; FEINGOLD KR, 1992, ENDOCRINOLOGY, V130, P10, DOI 10.1210/en.130.1.10; Gao S, 2016, AM J PHYSIOL-CELL PH, V310, pC66, DOI 10.1152/ajpcell.00052.2015; GREEN A, 1994, ENDOCRINOLOGY, V134, P2581, DOI 10.1210/en.134.6.2581; Guttridge DC, 2000, SCIENCE, V289, P2363, DOI 10.1126/science.289.5488.2363; Horowitz JD, 2010, CURR OPIN CARDIOL, V25, P329, DOI 10.1097/HCO.0b013e328339f191; KAWAKAMI M, 1987, J BIOCHEM-TOKYO, V101, P331, DOI 10.1093/oxfordjournals.jbchem.a121917; Khaw SL, 2015, CELL REP, V12, P1080, DOI 10.1016/j.celrep.2015.07.032; Lopatin YM, 2016, INT J CARDIOL, V203, P909, DOI 10.1016/j.ijcard.2015.11.060; Mastrocola R, 2008, FREE RADICAL BIO MED, V44, P584, DOI 10.1016/j.freeradbiomed.2007.10.047; McFarlane C, 2006, J CELL PHYSIOL, V209, P501, DOI 10.1002/jcp.20757; Min-Wen JC, 2016, SEMIN CELL DEV BIOL, V52, P110, DOI 10.1016/j.semcdb.2016.02.005; MORI M, 1991, CANCER RES, V51, P6656; Selvarasu S, 2012, BIOTECHNOL BIOENG, V109, P1415, DOI 10.1002/bit.24445; Silva EA, 2008, P NATL ACAD SCI USA, V105, P14347, DOI 10.1073/pnas.0803873105; Skuk D, 2010, MOL THER, V18, P1689, DOI 10.1038/mt.2010.128; Son Y, 2013, METHOD ENZYMOL, V528, P27, DOI 10.1016/B978-0-12-405881-1.00002-1; Tan AHM, 2014, CELL REP, V9, P24, DOI 10.1016/j.celrep.2014.08.043; Tisdale MJ, 2002, NAT REV CANCER, V2, P862, DOI 10.1038/nrc927; Trendelenburg AU, 2012, SKELET MUSCLE, V2, DOI 10.1186/2044-5040-2-3; van Hall G, 2003, J CLIN ENDOCR METAB, V88, P3005, DOI 10.1210/jc.2002-021687; von Haehling S, 2010, J CACHEXIA SARCOPENI, V1, P1, DOI 10.1007/s13539-010-0002-6; Waning DL, 2015, NAT MED, V21, P1262, DOI 10.1038/nm.3961; Woods MN, 2009, AM J CLIN NUTR, V90, P1566, DOI 10.3945/ajcn.2009.28137; Zuijdgeest-van Leeuwen SD, 2000, METABOLISM, V49, P931, DOI 10.1053/meta.2000.6740	33	125	130	2	67	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2016	22	6					666	+		10.1038/nm.4093	http://dx.doi.org/10.1038/nm.4093			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DO0NQ	27135739				2022-12-25	WOS:000377476000024
J	Lera, RF; Potts, GK; Suzuki, A; Johnson, JM; Salmon, ED; Coon, JJ; Burkard, ME				Lera, Robert F.; Potts, Gregory K.; Suzuki, Aussie; Johnson, James M.; Salmon, Edward D.; Coon, Joshua J.; Burkard, Mark E.			Decoding Polo-like kinase 1 signaling along the kinetochore-centromere axis	NATURE CHEMICAL BIOLOGY			English	Article							AURORA B KINASE; MICROTUBULE ATTACHMENTS; PLK1; PHOSPHORYLATION; LOCALIZATION; ARCHITECTURE; INTEGRITY; SURVIVIN; DYNAMICS; REVEALS	Protein kinase signaling along the kinetochore-centromere axis is crucial to assure mitotic fidelity, yet the details of its spatial coordination are obscure. Here, we examined how pools of human Polo-like kinase 1 (Plk1) within this axis control signaling events to elicit mitotic functions. To do this, we restricted active Plk1 to discrete subcompartments within the kinetochorecentromere axis using chemical genetics and decoded functional and phosphoproteomic signatures of each. We observe distinct phosphoproteomic and functional roles, suggesting that Plk1 exists and functions in discrete pools along this axis. Deep within the centromere, Plk1 operates to assure proper chromosome alignment and segregation. Thus, Plk1 at the kinetochore is a conglomerate of an observable bulk pool coupled with additional functional pools below the threshold of microscopic detection or resolution. Although complex, this multiplicity of locales provides an opportunity to decouple functional and phosphoproteomic signatures for a comprehensive understanding of Plk1's kinetochore functions.	[Lera, Robert F.; Johnson, James M.; Burkard, Mark E.] Univ Wisconsin, Dept Med, Div Hematol Oncol, Madison, WI USA; [Lera, Robert F.; Johnson, James M.; Burkard, Mark E.] Univ Wisconsin, Carbone Canc Ctr, Madison, WI USA; [Potts, Gregory K.; Coon, Joshua J.] Univ Wisconsin, Dept Chem, 1101 Univ Ave, Madison, WI 53706 USA; [Potts, Gregory K.; Coon, Joshua J.] Univ Wisconsin, Dept Biomol Chem, Madison, WI USA; [Suzuki, Aussie; Salmon, Edward D.] Univ N Carolina, Dept Biol, Chapel Hill, NC USA; [Coon, Joshua J.] Univ Wisconsin, Genome Ctr, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of North Carolina; University of North Carolina Chapel Hill; University of Wisconsin System; University of Wisconsin Madison	Burkard, ME (corresponding author), Univ Wisconsin, Dept Med, Div Hematol Oncol, Madison, WI USA.; Burkard, ME (corresponding author), Univ Wisconsin, Carbone Canc Ctr, Madison, WI USA.	mburkard@wisc.edu	Suzuki, Aussie/ABF-4170-2021	Burkard, Mark/0000-0002-4215-7722; Suzuki, Aussie/0000-0001-7390-5116; Lera, Robert/0000-0001-8713-4279	NIH [R01 GM097245, R01 GM080148, R01 GM024364]; Cancer Center Support [P30 CA014520]; NATIONAL CANCER INSTITUTE [P30CA016086, P30CA014520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM024364, R01GM080148, R01GM097245] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center Support; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH R01 GM097245 (to M.E.B.), NIH R01 GM080148 (to J.J.C.), NIH R01 GM024364 (to E.D.S.), Cancer Center Support P30 CA014520, and http://www.Effcansah.com. The authors thank I.M. Cheeseman, S.S. Taylor, and T.J. Yen for contributing reagents, and B.A. Weaver and members of the Burkard laboratory for helpful discussions.	Arnaud L, 1998, CHROMOSOMA, V107, P424, DOI 10.1007/s004120050326; Barr FA, 2004, NAT REV MOL CELL BIO, V5, P429, DOI 10.1038/nrm1401; Baumann C, 2007, CELL, V128, P101, DOI 10.1016/j.cell.2006.11.041; Beck J, 2013, NAT CELL BIOL, V15, P430, DOI 10.1038/ncb2695; Burkard ME, 2007, P NATL ACAD SCI USA, V104, P4383, DOI 10.1073/pnas.0701140104; Burkard ME, 2012, ACS CHEM BIOL, V7, P978, DOI 10.1021/cb200551p; Burkard ME, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000111; Carmena M, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001250; Cheerambathur DK, 2014, CURR OPIN CELL BIOL, V26, P113, DOI 10.1016/j.ceb.2013.12.005; Chu YJ, 2011, J MOL CELL BIOL, V3, P260, DOI 10.1093/jmcb/mjq037; Colnaghi R, 2010, J BIOL CHEM, V285, P22592, DOI 10.1074/jbc.M109.065003; Domnitz SB, 2012, J CELL BIOL, V197, P231, DOI 10.1083/jcb.201108147; Elia AEH, 2003, CELL, V115, P83, DOI 10.1016/S0092-8674(03)00725-6; Elia AEH, 2003, SCIENCE, V299, P1228, DOI 10.1126/science.1079079; Elowe S, 2007, GENE DEV, V21, P2205, DOI 10.1101/gad.436007; Foley EA, 2013, NAT REV MOL CELL BIO, V14, P25, DOI 10.1038/nrm3494; Foley EA, 2011, NAT CELL BIOL, V13, P1265, DOI 10.1038/ncb2327; Godek KM, 2015, NAT REV MOL CELL BIO, V16, P57, DOI 10.1038/nrm3916; Goto H, 2006, NAT CELL BIOL, V8, P180, DOI 10.1038/ncb1350; Grosstessner-Hain K, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.008540; Hanisch A, 2006, MOL BIOL CELL, V17, P448, DOI 10.1091/mbc.E05-08-0801; Honnappa S, 2009, CELL, V138, P366, DOI 10.1016/j.cell.2009.04.065; Hood EA, 2012, MOL BIOL CELL, V23, P2264, DOI 10.1091/mbc.E11-12-1013; Hornbeck PV, 2015, NUCLEIC ACIDS RES, V43, pD512, DOI 10.1093/nar/gku1267; Kang YH, 2006, MOL CELL, V24, P409, DOI 10.1016/j.molcel.2006.10.016; Kang YH, 2011, J BIOL CHEM, V286, P19744, DOI 10.1074/jbc.M111.224105; Kettenbach AN, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001497; Kothe M, 2007, CHEM BIOL DRUG DES, V70, P540, DOI 10.1111/j.1747-0285.2007.00594.x; Lera RF, 2012, J BIOL CHEM, V287, P42812, DOI 10.1074/jbc.M112.412544; Liu D, 2012, J CELL BIOL, V198, P491, DOI 10.1083/jcb.201205090; Liu D, 2010, J CELL BIOL, V188, P809, DOI 10.1083/jcb.201001006; Liu D, 2009, SCIENCE, V323, P1350, DOI 10.1126/science.1167000; London N, 2014, NAT REV MOL CELL BIO, V15, P735, DOI 10.1038/nrm3888; Lowery DM, 2007, EMBO J, V26, P2262, DOI 10.1038/sj.emboj.7601683; Maia ARR, 2012, J CELL BIOL, V199, P285, DOI 10.1083/jcb.201203091; Maney T, 1998, J CELL BIOL, V142, P787, DOI 10.1083/jcb.142.3.787; Meppelink A, 2015, CELL REP, V11, P508, DOI 10.1016/j.celrep.2015.03.052; Nishino M, 2006, CURR BIOL, V16, P1414, DOI 10.1016/j.cub.2006.05.052; Oppermann FS, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.O111.012351; Park CH, 2015, J BIOL CHEM, V290, P8569, DOI 10.1074/jbc.M114.623546; Park JE, 2011, P NATL ACAD SCI USA, V108, P8200, DOI 10.1073/pnas.1102020108; Phanstiel D, 2009, ANAL CHEM, V81, P1693, DOI 10.1021/ac8019202; Qi W, 2006, MOL BIOL CELL, V17, P3705, DOI 10.1091/mbc.E06-03-0240; Santamaria A, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.004457; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Suijkerbuijk SJE, 2012, DEV CELL, V23, P745, DOI 10.1016/j.devcel.2012.09.005; Suzuki A, 2014, DEV CELL, V30, P717, DOI 10.1016/j.devcel.2014.08.003; Taus T, 2011, J PROTEOME RES, V10, P5354, DOI 10.1021/pr200611n; Wan XH, 2009, CELL, V137, P672, DOI 10.1016/j.cell.2009.03.035; Welburn JPI, 2010, MOL CELL, V38, P383, DOI 10.1016/j.molcel.2010.02.034; Wenger CD, 2011, PROTEOMICS, V11, P1064, DOI 10.1002/pmic.201000616	51	30	30	1	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUN	2016	12	6					411	U61		10.1038/nchembio.2060	http://dx.doi.org/10.1038/nchembio.2060			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DM2EW	27043190	Green Accepted, Green Submitted			2022-12-25	WOS:000376160600010
J	Taslimi, A; Zoltowski, B; Miranda, JG; Pathak, GP; Hughes, RM; Tucker, CL				Taslimi, Amir; Zoltowski, Brian; Miranda, Jose G.; Pathak, Gopal P.; Hughes, Robert M.; Tucker, Chandra L.			Optimized second-generation CRY2-CIB dimerizers and photoactivatable Cre recombinase	NATURE CHEMICAL BIOLOGY			English	Article							PROTEIN-PROTEIN INTERACTIONS; IN-VIVO; ARABIDOPSIS CRYPTOCHROME; OPTOGENETIC CONTROL; DROSOPHILA CRYPTOCHROME; MEDIATED INDUCTION; PLANT CRYPTOCHROME; ELECTRON-TRANSFER; MAMMALIAN-CELLS; GENE-EXPRESSION	Arabidopsis thaliana cryptochrome 2 (AtCRY2), a light-sensitive photosensory protein, was previously adapted for use in controlling protein-protein interactions through light-dependent binding to a partner protein, CIB1. While the existing CRY2-CIB dimerization system has been used extensively for optogenetic applications, some limitations exist. Here, we set out to optimize function of the CRY2-CIB system by identifying versions of CRY2-CIB that are smaller, show reduced dark interaction, and maintain longer or shorter signaling states in response to a pulse of light. We describe minimal functional CRY2 and CIB1 domains maintaining light-dependent interaction and new signaling mutations affecting AtCRY2 photocycle kinetics. The latter work implicates an alpha 13-alpha 14 turn motif within plant CRYs whose perturbation alters signaling-state lifetime. Using a long-lived L348F photocycle mutant, we engineered a second-generation photoactivatable Cre recombinase, PA-Cre2.0, that shows fivefold improved dynamic range, allowing robust recombination following exposure to a single, brief pulse of light.	[Taslimi, Amir; Miranda, Jose G.; Pathak, Gopal P.; Tucker, Chandra L.] Univ Colorado, Sch Med, Dept Pharmacol, Aurora, CO USA; [Zoltowski, Brian] So Methodist Univ, Dept Chem, Dallas, TX 75275 USA; [Hughes, Robert M.] Duke Univ, Dept Biol, Durham, NC USA	University of Colorado System; University of Colorado Anschutz Medical Campus; Southern Methodist University; Duke University	Tucker, CL (corresponding author), Univ Colorado, Sch Med, Dept Pharmacol, Aurora, CO USA.	chandra.tucker@ucdenver.edu	Miranda, Jose/HCI-6099-2022; Tucker, Chandra/F-6842-2011	Tucker, Chandra/0000-0003-3033-1786; Hughes, Robert/0000-0002-4465-4212	National Institutes of Health [GM100225]; McKnight Endowment Fund for Neuroscience (Technological Innovations in Neuroscience Award); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100225, R15GM109282] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); McKnight Endowment Fund for Neuroscience (Technological Innovations in Neuroscience Award); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. Constance Cepko for the pCALVL-dsRed Cre reporter (13769), obtained through Addgene, Dr. Matthew Kennedy for critical reading of the manuscript, and Jessica Spiltoir and Qi Liu for experimental assistance. This work was supported by grants from the National Institutes of Health (GM100225) and the McKnight Endowment Fund for Neuroscience (Technological Innovations in Neuroscience Award) to C.L.T.	Aoki K, 2013, MOL CELL, V52, P529, DOI 10.1016/j.molcel.2013.09.015; Banerjee R, 2007, J BIOL CHEM, V282, P14916, DOI 10.1074/jbc.M700616200; Boulina M, 2013, DEVELOPMENT, V140, P1605, DOI 10.1242/dev.088930; Bouly JP, 2007, J BIOL CHEM, V282, P9383, DOI 10.1074/jbc.M609842200; Brautigam CA, 2004, P NATL ACAD SCI USA, V101, P12142, DOI 10.1073/pnas.0404851101; Bugaj LJ, 2013, NAT METHODS, V10, P249, DOI 10.1038/nmeth.2360; Cadwell R C, 1992, PCR Methods Appl, V2, P28, DOI 10.1101/gr.2.1.28; Chen D, 2013, J CELL BIOL, V201, P631, DOI 10.1083/jcb.201210119; Crefcoeur RP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2800; Duan LT, 2015, CHEM BIOL, V22, P671, DOI 10.1016/j.chembiol.2015.04.014; El-Esawi M, 2015, PLANT SIGNAL BEHAV, V10, DOI 10.1080/15592324.2015.1063758; Engelhard C, 2014, PLANT CELL, V26, P4519, DOI 10.1105/tpc.114.129809; Gao J, 2015, P NATL ACAD SCI USA, V112, P9135, DOI 10.1073/pnas.1504404112; Giordano F, 2013, CELL, V153, P1494, DOI 10.1016/j.cell.2013.05.026; Guntas G, 2015, P NATL ACAD SCI USA, V112, P112, DOI 10.1073/pnas.1417910112; Herbel V, 2013, PLANT J, V74, P583, DOI 10.1111/tpj.12144; Hughes RM, 2012, METHODS, V58, P385, DOI 10.1016/j.ymeth.2012.08.004; Idevall-Hagren O, 2012, P NATL ACAD SCI USA, V109, pE2316, DOI 10.1073/pnas.1211305109; Jullien N, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng131; Kakumoto T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070861; Kawano F, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7256; Kennedy MJ, 2010, NAT METHODS, V7, P973, DOI 10.1038/NMETH.1524; Konermann S, 2013, NATURE, V500, P472, DOI 10.1038/nature12466; Lee S, 2014, NAT METHODS, V11, P633, DOI [10.1038/nmeth.2940, 10.1038/NMETH.2940]; Levskaya A, 2009, NATURE, V461, P997, DOI 10.1038/nature08446; Li X, 2011, P NATL ACAD SCI USA, V108, P20844, DOI 10.1073/pnas.1114579108; Liu HT, 2008, SCIENCE, V322, P1535, DOI 10.1126/science.1163927; Liu YW, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003861; Maiuri P, 2015, CELL, V161, P374, DOI 10.1016/j.cell.2015.01.056; Matsuda T, 2007, P NATL ACAD SCI USA, V104, P1027, DOI 10.1073/pnas.0610155104; Muller K, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt340; Muller P, 2015, FEBS LETT, V589, P189, DOI 10.1016/j.febslet.2014.12.008; Muller P, 2014, SCI REP-UK, V4, DOI 10.1038/srep05175; Nihongaki Y, 2015, CHEM BIOL, V22, P169, DOI 10.1016/j.chembiol.2014.12.011; O'Neill PR, 2014, MOL BIOL CELL, V25, P2305, DOI 10.1091/mbc.E14-04-0870; Ozturk N, 2008, J BIOL CHEM, V283, P3256, DOI 10.1074/jbc.M708612200; Partch CL, 2005, PHOTOCHEM PHOTOBIOL, V81, P1291, DOI 10.1562/2005-07-08-IR-607; Pathak GP, 2014, ACS SYNTH BIOL, V3, P832, DOI 10.1021/sb500291r; Polstein LR, 2015, NAT CHEM BIOL, V11, P198, DOI 10.1038/nchembio.1753; Schindler SE, 2015, SCI REP-UK, V5, DOI 10.1038/srep13627; Shimizu-Sato S, 2002, NAT BIOTECHNOL, V20, P1041, DOI 10.1038/nbt734; Solov'yov IA, 2012, J AM CHEM SOC, V134, P18046, DOI 10.1021/ja3074819; Stanewsky R, 1998, CELL, V95, P681, DOI 10.1016/S0092-8674(00)81638-4; Strickland D, 2012, NAT METHODS, V9, P379, DOI [10.1038/NMETH.1904, 10.1038/nmeth.1904]; Taslimi A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5925; Thoing C, 2015, J AM CHEM SOC, V137, P5990, DOI 10.1021/jacs.5b01404; Vaidya AT, 2013, P NATL ACAD SCI USA, V110, P20455, DOI 10.1073/pnas.1313336110; Yang HQ, 2000, CELL, V103, P815, DOI 10.1016/S0092-8674(00)00184-7; Yazawa M, 2009, NAT BIOTECHNOL, V27, P941, DOI 10.1038/nbt.1569; Zeugner A, 2005, J BIOL CHEM, V280, P19437, DOI 10.1074/jbc.C500077200; Zoltowski BD, 2015, P NATL ACAD SCI USA, V112, P8811, DOI 10.1073/pnas.1511092112; Zoltowski BD, 2011, NATURE, V480, P396, DOI 10.1038/nature10618	52	155	163	1	79	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUN	2016	12	6					425	U78		10.1038/NCHEMBIO.2063	http://dx.doi.org/10.1038/NCHEMBIO.2063			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DM2EW	27065233	Green Accepted			2022-12-25	WOS:000376160600012
J	Eckalbar, WL; Schlebusch, SA; Mason, MK; Gill, Z; Parker, AV; Booker, BM; Nishizaki, S; Muswamba-Nday, C; Terhune, E; Nevonen, KA; Makki, N; Friedrich, T; VanderMeer, JE; Pollard, KS; Carbone, L; Wall, JD; Illing, N; Ahituv, N				Eckalbar, Walter L.; Schlebusch, Stephen A.; Mason, Mandy K.; Gill, Zoe; Parker, Ash V.; Booker, Betty M.; Nishizaki, Sierra; Muswamba-Nday, Christiane; Terhune, Elizabeth; Nevonen, Kimberly A.; Makki, Nadja; Friedrich, Tara; VanderMeer, Julia E.; Pollard, Katherine S.; Carbone, Lucia; Wall, Jeff D.; Illing, Nicola; Ahituv, Nadav			Transcriptomic and epigenomic characterization of the developing bat wing	NATURE GENETICS			English	Article							GENOME ANNOTATION; READ ALIGNMENT; EXPRESSION; IDENTIFICATION; EVOLUTION; LENGTH; DATABASE; PIPELINE; FEATURES; PATHWAY	Bats are the only mammals capable of powered flight, but little is known about the genetic determinants that shape their wings. Here we generated a genome for Miniopterus natalensis and performed RNA-seq and ChIP-seq (H3K27ac and H3K27me3) analyses on its developing forelimb and hindlimb autopods at sequential embryonic stages to decipher the molecular events that underlie bat wing development. Over 7,000 genes and several long noncoding RNAs, including Tbx5-as1 and Hottip, were differentially expressed between forelimb and hindlimb, and across different stages. ChIP-seq analysis identified thousands of regions that are differentially modified in forelimb and hindlimb. Comparative genomics found 2,796 bat-accelerated regions within H3K27ac peaks, several of which cluster near limb-associated genes. Pathway analyses highlighted multiple ribosomal proteins and known limb patterning signaling pathways as differentially regulated and implicated increased forelimb mesenchymal condensation in differential growth. In combination, our work outlines multiple genetic components that likely contribute to bat wing formation, providing insights into this morphological innovation.	[Eckalbar, Walter L.; Booker, Betty M.; Nishizaki, Sierra; Makki, Nadja; VanderMeer, Julia E.; Ahituv, Nadav] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA; [Eckalbar, Walter L.; Booker, Betty M.; Nishizaki, Sierra; Makki, Nadja; Friedrich, Tara; VanderMeer, Julia E.; Pollard, Katherine S.; Wall, Jeff D.; Ahituv, Nadav] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA; [Schlebusch, Stephen A.; Mason, Mandy K.; Gill, Zoe; Parker, Ash V.; Muswamba-Nday, Christiane; Illing, Nicola] Univ Cape Town, Dept Mol & Cell Biol, ZA-7925 Cape Town, South Africa; [Terhune, Elizabeth; Nevonen, Kimberly A.; Carbone, Lucia] Oregon Natl Primate Res Ctr, Div Neurosci, Primate Genet Sect, Beaverton, OR USA; [Terhune, Elizabeth] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA; [Friedrich, Tara; Pollard, Katherine S.] Gladstone Inst, San Francisco, CA USA; [Pollard, Katherine S.; Wall, Jeff D.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Carbone, Lucia] Oregon Hlth & Sci Univ, Dept Behav Neurosci, Portland, OR 97201 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Cape Town; Oregon Health & Science University; Oregon National Primate Research Center; University of Colorado System; University of Colorado Boulder; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; Oregon Health & Science University	Ahituv, N (corresponding author), Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA.; Wall, JD; Ahituv, N (corresponding author), Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA.; Illing, N (corresponding author), Univ Cape Town, Dept Mol & Cell Biol, ZA-7925 Cape Town, South Africa.; Wall, JD (corresponding author), Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA.	wallj@humgen.ucsf.edu; nicola.illing@uct.ac.za; nadav.ahituv@ucsf.edu		Terhune, Elizabeth/0000-0003-0202-6936; Gill, Zoe/0000-0002-5960-2941; Ahituv, Nadav/0000-0002-7434-8144	National Institute of Child Health and Human Development [1R01HD059862]; National Institute of Diabetes and Digestive and Kidney Diseases [1R01DK090382]; National Institute of Neurological Disorders and Stroke [1R01NS079231]; National Cancer Institute [1R01CA197139]; National Research Foundation (NRF; South Africa) [NBIG 86932]; NRF [85207]; Office of the Director, US National Institutes of Health [P51OD011092]; J. David Gladstone Institutes; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD059862] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA197139] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090382] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008284, T32GM067547] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS079231] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011092, S10OD021596] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Research Foundation (NRF; South Africa)(National Research Foundation - South Africa); NRF; Office of the Director, US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); J. David Gladstone Institutes(University of California System); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank the Broad Institute Genomics Platform, Vertebrate Genome Biology group and K. Lindblad-Toh for making the data for Eptesicus fuscus available. We would also like to thank M. Kelley and E. Driver (National Institute on Deafness and Other Communication Disorders) for providing us with newborn Mllt3 mice and M. Petersen for assistance with sectioning bat autopods. This work was supported in part by National Institute of Child Health and Human Development grant 1R01HD059862. N.A. is also supported in part by National Institute of Diabetes and Digestive and Kidney Diseases award 1R01DK090382, National Institute of Neurological Disorders and Stroke award 1R01NS079231 and National Cancer Institute award 1R01CA197139. N.I. is supported by National Research Foundation (NRF; South Africa) grants (NBIG 86932), and C.M.-N. was supported by NRF grant 85207. L.C. and K.A.N. are supported by the Office of the Director, US National Institutes of Health, under award P51OD011092. T.F. and K.S.P. are supported by a gift from the San Simeon Fund and institutional funds from the J. David Gladstone Institutes.	Agarwal P, 2003, DEVELOPMENT, V130, P623, DOI 10.1242/dev.00191; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Ball S, 2011, HEMATOL-AM SOC HEMAT, P487, DOI 10.1182/asheducation-2011.1.487; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bisson JA, 2015, DEV BIOL, V398, P80, DOI 10.1016/j.ydbio.2014.11.015; Blanchette M, 2004, GENOME RES, V14, P708, DOI 10.1101/gr.1933104; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Booker BM, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005738; Borodina T, 2011, METHOD ENZYMOL, V500, P79, DOI 10.1016/B978-0-12-385118-5.00005-0; Carroll SB, 2005, PLOS BIOL, V3, P1159, DOI 10.1371/journal.pbio.0030245; Chen JQ, 2015, J BONE MINER RES, V30, P369, DOI 10.1002/jbmr.2348; Collins EC, 2002, MOL CELL BIOL, V22, P7313, DOI 10.1128/MCB.22.20.7313-7324.2002; Cooper LN, 2012, WIRES DEV BIOL, V1, P773, DOI 10.1002/wdev.50; Cretekos CJ, 2008, GENE DEV, V22, P141, DOI 10.1101/gad.1620408; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Eloy-Trinquet S, 2009, DEV DYNAM, V238, P1195, DOI 10.1002/dvdy.21946; Francis-West PH, 1999, DEVELOPMENT, V126, P1305; Gao B, 2013, CURR OPIN GENET DEV, V23, P438, DOI 10.1016/j.gde.2013.05.003; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gunnell GF, 2012, CAM STUD MORPHOL MOL, P1, DOI 10.1017/CBO9781139045599; Haas BJ, 2003, NUCLEIC ACIDS RES, V31, P5654, DOI 10.1093/nar/gkg770; Hall BK, 1995, INT J DEV BIOL, V39, P881; Harris R.S., 2007, THESIS PENN STATE U; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hockman D, 2008, P NATL ACAD SCI USA, V105, P16982, DOI 10.1073/pnas.0805308105; Hockman D, 2009, DEV DYNAM, V238, P965, DOI 10.1002/dvdy.21896; Holt C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-491; Homma S, 2009, GENE EXPR PATTERNS, V9, P1, DOI 10.1016/j.gep.2008.09.004; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hubisz MJ, 2011, BRIEF BIOINFORM, V12, P41, DOI 10.1093/bib/bbq072; Ito T, 2010, SCIENCE, V327, P1345, DOI 10.1126/science.1177319; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; KINGSLEY DM, 1992, CELL, V71, P399, DOI 10.1016/0092-8674(92)90510-J; Kondrashov N, 2011, CELL, V145, P383, DOI 10.1016/j.cell.2011.03.028; Kong L, 2007, NUCLEIC ACIDS RES, V35, pW345, DOI 10.1093/nar/gkm391; Kozhemyakina E, 2015, DEVELOPMENT, V142, P817, DOI 10.1242/dev.105536; Lallemand Y, 2009, DEV BIOL, V331, P189, DOI 10.1016/j.ydbio.2009.04.038; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lindblad-Toh K, 2011, NATURE, V478, P476, DOI 10.1038/nature10530; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Martin GR, 1998, GENE DEV, V12, P1571, DOI 10.1101/gad.12.11.1571; Mason MK, 2015, EVODEVO, V6, DOI 10.1186/s13227-015-0001-y; Mason MK, 2010, ACTA CHIROPTEROL, V12, P161, DOI 10.3161/150811010X504662; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Merino R, 1999, DEVELOPMENT, V126, P5515; Nagy A., 2002, MANIPULATING MOUSE E; Neph S, 2012, BIOINFORMATICS, V28, P1919, DOI 10.1093/bioinformatics/bts277; Parra G, 2007, BIOINFORMATICS, V23, P1061, DOI 10.1093/bioinformatics/btm071; Pignatti E, 2014, SEMIN CELL DEV BIOL, V32, P119, DOI 10.1016/j.semcdb.2014.04.004; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; Quek XC, 2015, NUCLEIC ACIDS RES, V43, pD168, DOI 10.1093/nar/gku988; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Rallis C, 2003, DEVELOPMENT, V130, P2741, DOI 10.1242/dev.00473; Sears KE, 2006, P NATL ACAD SCI USA, V103, P6581, DOI 10.1073/pnas.0509716103; Seim I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3212; Slater GS, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-31; Stanke M, 2004, NUCLEIC ACIDS RES, V32, pW309, DOI 10.1093/nar/gkh379; Swartz SM, 2008, CELLS TISSUES ORGANS, V187, P59, DOI 10.1159/000109964; TAYLOR GP, 1994, DEV BIOL, V163, P282, DOI 10.1006/dbio.1994.1144; Tossell K, 2011, DEV BIOL, V352, P341, DOI 10.1016/j.ydbio.2011.02.002; Wang KC, 2011, NATURE, V472, P120, DOI 10.1038/nature09819; Wang Z, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3133; Wang Z, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-619; Weatherbee SD, 2006, P NATL ACAD SCI USA, V103, P15103, DOI 10.1073/pnas.0604934103; Xu HB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052249; Xue SF, 2015, NATURE, V517, P33, DOI 10.1038/nature14010; Zang CZ, 2009, BIOINFORMATICS, V25, P1952, DOI 10.1093/bioinformatics/btp340; Zhang GJ, 2013, SCIENCE, V339, P456, DOI 10.1126/science.1230835; Zhao YG, 2003, P NATL ACAD SCI USA, V100, P9005, DOI 10.1073/pnas.1537759100	77	42	45	2	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2016	48	5					528	+		10.1038/ng.3537	http://dx.doi.org/10.1038/ng.3537			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DK3RC	27019111	Green Accepted, Green Submitted, hybrid			2022-12-25	WOS:000374834100012
J	Marakalala, MJ; Raju, RM; Sharma, K; Zhang, YJJ; Eugenin, EA; Prideaux, B; Daudelin, IB; Chen, PY; Booty, MG; Kim, JH; Eum, SY; Via, LE; Behar, SM; Barry, CE; Mann, M; Dartois, V; Rubin, EJ				Marakalala, Mohlopheni J.; Raju, Ravikiran M.; Sharma, Kirti; Zhang, Yanjia J.; Eugenin, Eliseo A.; Prideaux, Brendan; Daudelin, Isaac B.; Chen, Pei-Yu; Booty, Matthew G.; Kim, Jin Hee; Eum, Seok Yong; Via, Laura E.; Behar, Samuel M.; Barry, Clifton E., III; Mann, Matthias; Dartois, Veronique; Rubin, Eric J.			Inflammatory signaling in human tuberculosis granulomas is spatially organized	NATURE MEDICINE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; MEDIATES RESISTANCE; LIPID MEDIATORS; HOST IMMUNITY; SUSCEPTIBILITY; INDUCTION; CASEATION; INFECTION; GROWTH	Granulomas are the pathological hallmark of tuberculosis (TB). However, their function and mechanisms of formation remain poorly understood. To understand the role of granulomas in TB, we analyzed the proteomes of granulomas from subjects with tuberculosis in an unbiased manner. Using laser-capture microdissection, mass spectrometry and confocal microscopy, we generated detailed molecular maps of human granulomas. We found that the centers of granulomas have a pro-inflammatory environment that is characterized by the presence of antimicrobial peptides, reactive oxygen species and pro-inflammatory eicosanoids. Conversely, the tissue surrounding the caseum has a comparatively anti-inflammatory signature. These findings are consistent across a set of six human subjects and in rabbits. Although the balance between systemic pro and anti-inflammatory signals is crucial to TB disease outcome, here we find that these signals are physically segregated within each granuloma. From the protein and lipid snapshots of-human and rabbit lesions analyzed here, we hypothesize that the pathologic response to TB is shaped by the precise anatomical localization of these inflammatory pathways during the development of the granuloma.	[Marakalala, Mohlopheni J.; Raju, Ravikiran M.; Zhang, Yanjia J.; Rubin, Eric J.] Harvard Univ, TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Sharma, Kirti; Mann, Matthias] Max Planck Inst Biochem, Dept Prote & Signal Transduct, Klopferspitz 18A, D-82152 Martinsried, Germany; [Eugenin, Eliseo A.; Prideaux, Brendan; Daudelin, Isaac B.; Chen, Pei-Yu; Dartois, Veronique] Univ Med & Dent New Jersey, New Jersey Med Sch, Publ Hlth Res Inst, 185 S Orange Ave, Newark, NJ 07103 USA; [Eugenin, Eliseo A.; Dartois, Veronique] Rutgers State Univ, New Jersey Med Sch, Dept Microbiol & Mol Genet, Newark, NJ 07102 USA; [Booty, Matthew G.; Behar, Samuel M.] Univ Massachusetts, Sch Med, Dept Microbiol & Physiol Syst, Worcester, MA USA; [Booty, Matthew G.] Harvard Univ, Sch Med, Program Immunol, Div Med Sci, Boston, MA USA; [Kim, Jin Hee] Natl Masan TB Hosp, Chang Won, South Korea; [Eum, Seok Yong] Int TB Res Ctr, Chang Won, South Korea; [Via, Laura E.; Barry, Clifton E., III] NIAID, TB Res Sect, Lab Clin Infect Dis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Via, Laura E.; Barry, Clifton E., III] Univ Cape Town, Fac Hlth Sci, Inst Infect Dis & Mol Med, ZA-7700 Rondebosch, South Africa; [Via, Laura E.; Barry, Clifton E., III] Univ Cape Town, Fac Hlth Sci, Dept Clin Lab Sci, ZA-7700 Rondebosch, South Africa	Harvard University; Harvard T.H. Chan School of Public Health; Max Planck Society; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Massachusetts System; University of Massachusetts Worcester; Harvard University; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Cape Town; University of Cape Town	Rubin, EJ (corresponding author), Harvard Univ, TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA.; Dartois, V (corresponding author), Univ Med & Dent New Jersey, New Jersey Med Sch, Publ Hlth Res Inst, 185 S Orange Ave, Newark, NJ 07103 USA.; Dartois, V (corresponding author), Rutgers State Univ, New Jersey Med Sch, Dept Microbiol & Mol Genet, Newark, NJ 07102 USA.	dartoiva@nims.rutgers.edu; erubin@hsph.harvard.edu	Barry, Clifton E/ABE-7992-2020; Via, Laura/AAD-3917-2021; Booty, Matthew G/G-9536-2012; Sharma, Kirti/C-5944-2011; Barry, III, Clifton/H-3839-2012; Sharma, Kirti/GQQ-4921-2022	Barry, Clifton E/0000-0002-2927-270X; Via, Laura/0000-0001-6074-9521; Sharma, Kirti/0000-0003-3704-1466; Barry, III, Clifton/0000-0002-2927-270X; Behar, Samuel/0000-0002-3374-6699; Raju, Ravikiran/0000-0002-0276-208X; Booty, Matthew/0000-0002-0835-3439; MARAKALALA, MOHLOPHENI/0000-0001-7476-1652	HHMI-K-RITH; US National Institutes of Health (NIH) [1S10OD018072-01A1, R01AI098637]; National Institute of Mental Health [MH096625]; US Bill and Melinda Gates Foundation TB Drug Accelerator grant [OPP 1066499]; US Public Health Research Institute (New Jersey Medical School) central grant; Division of Intramural Research, National Institute of Allergy and Infectious Disease, NIH; Korean Centers of Disease Control, Ministry of Health, Welfare and Family Affairs; NATIONAL CANCER INSTITUTE [DP1CA174427] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001067, R01AI098637, ZIAAI000734] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH096625] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS105584] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD018072] Funding Source: NIH RePORTER	HHMI-K-RITH; US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); US Bill and Melinda Gates Foundation TB Drug Accelerator grant; US Public Health Research Institute (New Jersey Medical School) central grant; Division of Intramural Research, National Institute of Allergy and Infectious Disease, NIH; Korean Centers of Disease Control, Ministry of Health, Welfare and Family Affairs; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank the patients and staff of National Masan TB Hospital, as well as the technical staff from the International Tuberculosis Research Center, for their participation in our studies. We acknowledge A. Martinot for generating some of the H&E-stained images and for useful advice on the pathology studies, and thank members of the Rubin and Fortune laboratories for useful discussions. This work was supported by a Visiting Science Award from HHMI-K-RITH (E.J.R.), the US National Institutes of Health (NIH) grants 1S10OD018072-01A1 (shared instrumentation grant for the MALDI orbitrap; V.D.) and R01AI098637 (S.M.B.), the National Institute of Mental Health grant MH096625 (E.A.E.), the US Bill and Melinda Gates Foundation TB Drug Accelerator grant OPP 1066499 (V.D.), a US Public Health Research Institute (New Jersey Medical School) central grant (E.A.E.), the Division of Intramural Research, National Institute of Allergy and Infectious Disease, NIH (C.E.B.) and the Korean Centers of Disease Control, Ministry of Health, Welfare and Family Affairs (C.E.B.). We would like to acknowledge the PRIDE Team for upload of proteomics raw data.	Bold TD, 2009, CELL, V136, P17, DOI 10.1016/j.cell.2008.12.032; Cardona PJ, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/868246; Chen MJ, 2008, J EXP MED, V205, P2791, DOI 10.1084/jem.20080767; Cilfone NA, 2015, J IMMUNOL, V194, P664, DOI 10.4049/jimmunol.1400734; Cilfone NA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068680; Clay H, 2008, IMMUNITY, V29, P283, DOI 10.1016/j.immuni.2008.06.011; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; Dambuza I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025121; Davis JM, 2009, CELL, V136, P37, DOI 10.1016/j.cell.2008.11.014; Divangahi M, 2010, NAT IMMUNOL, V11, P751, DOI 10.1038/ni.1904; Divangahi M, 2009, NAT IMMUNOL, V10, P899, DOI 10.1038/ni.1758; Ehlers S, 2013, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00411; Fallahi-Sichani M, 2011, J IMMUNOL, V186, P3472, DOI 10.4049/jimmunol.1003299; FLYNN JL, 1995, IMMUNITY, V2, P561, DOI 10.1016/1074-7613(95)90001-2; Gideon HP, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004603; Guirado E, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00098; Kaplan G, 2003, INFECT IMMUN, V71, P7099, DOI 10.1128/IAI.71.12.7099-7108.2003; Kim MJ, 2010, EMBO MOL MED, V2, P258, DOI 10.1002/emmm.201000079; Lin PL, 2014, NAT MED, V20, P75, DOI 10.1038/nm.3412; Mattila JT, 2013, J IMMUNOL, V191, P773, DOI 10.4049/jimmunol.1300113; Mayer-Barber KD, 2014, NATURE, V511, P99, DOI 10.1038/nature13489; McNab F, 2015, NAT REV IMMUNOL, V15, P87, DOI 10.1038/nri3787; Peyron P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000204; Prideaux B, 2015, NAT MED, V21, P1223, DOI 10.1038/nm.3937; Prideaux B, 2011, ANAL CHEM, V83, P2112, DOI 10.1021/ac1029049; Ramakrishnan L, 2012, NAT REV IMMUNOL, V12, P352, DOI 10.1038/nri3211; Roca FJ, 2013, CELL, V153, P521, DOI 10.1016/j.cell.2013.03.022; Saunders BM, 2000, IMMUNOL CELL BIOL, V78, P334, DOI 10.1046/j.1440-1711.2000.00933.x; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Serhan CN, 2014, NATURE, V510, P92, DOI 10.1038/nature13479; Subbian S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132249; Taylor JL, 2006, INFECT IMMUN, V74, P6135, DOI 10.1128/IAI.02048-05; Tobin DM, 2013, CURR OPIN PHARMACOL, V13, P641, DOI 10.1016/j.coph.2013.06.007; Tobin DM, 2012, CELL, V148, P434, DOI 10.1016/j.cell.2011.12.023; Tobin DM, 2010, CELL, V140, P717, DOI 10.1016/j.cell.2010.02.013; Ulrichs T, 2004, J PATHOL, V204, P217, DOI 10.1002/path.1628; Via LE, 2015, ANTIMICROB AGENTS CH, V59, P4181, DOI 10.1128/AAC.00115-15; Via LE, 2012, ANTIMICROB AGENTS CH, V56, P4391, DOI 10.1128/AAC.00531-12; Volkman HE, 2010, SCIENCE, V327, P466, DOI 10.1126/science.1179663; World Health Organization, 2015, WHO TUB FACT SHEET N	40	157	159	1	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2016	22	5					531	538		10.1038/nm.4073	http://dx.doi.org/10.1038/nm.4073			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DL3DI	27043495	Green Submitted, Green Accepted			2022-12-25	WOS:000375514000016
J	Reis, SA; Ghosh, B; Hendricks, JA; Szantai-Kis, DM; Tork, L; Ross, KN; Lamb, J; Read-Button, W; Zheng, BX; Wang, HT; Salthouse, C; Haggarty, SJ; Mazitschek, R				Reis, Surya A.; Ghosh, Balaram; Hendricks, J. Adam; Szantai-Kis, D. Miklos; Tork, Lisa; Ross, Kenneth N.; Lamb, Justin; Read-Button, Willis; Zheng, Baixue; Wang, Hongtao; Salthouse, Christopher; Haggarty, Stephen J.; Mazitschek, Ralph			Light-controlled modulation of gene expression by chemical optoepigenetic probes	NATURE CHEMICAL BIOLOGY			English	Article							HISTONE DEACETYLASE INHIBITORS; HDAC INHIBITORS; OPTICAL CONTROL; TRANSCRIPTION; PHARMACOLOGY; ACETYLATION	Epigenetic gene regulation is a dynamic process orchestrated by chromatin-modifying enzymes. Many of these master regulators exert their function through covalent modification of DNA and histone proteins. Aberrant epigenetic processes have been implicated in the pathophysiology of multiple human diseases. Small-molecule inhibitors have been essential to advancing our understanding of the underlying molecular mechanisms of epigenetic processes. However, the resolution offered by small molecules is often insufficient to manipulate epigenetic processes with high spatiotemporal control. Here we present a generalizable approach, referred to as 'chemo-optical modulation of epigenetically regulated transcription' (COMET), enabling high-resolution, optical control of epigenetic mechanisms based on photochromic inhibitors of human histone deacetylases using visible light. COMET probes may be translated into new therapeutic strategies for diseases where conditional and selective epigenome modulation is required.	[Reis, Surya A.; Ghosh, Balaram; Haggarty, Stephen J.] Massachusetts Gen Hosp, Chem Neurobiol Lab, Boston, MA 02114 USA; [Reis, Surya A.; Ghosh, Balaram; Haggarty, Stephen J.] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Reis, Surya A.; Ghosh, Balaram; Haggarty, Stephen J.] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; [Ghosh, Balaram; Hendricks, J. Adam; Szantai-Kis, D. Miklos; Tork, Lisa; Mazitschek, Ralph] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Syst Biol, Boston, MA USA; [Ross, Kenneth N.] Massachusetts Gen Hosp, Ctr Canc Res, Boston, MA 02114 USA; [Lamb, Justin; Read-Button, Willis; Zheng, Baixue] Genometry Inc, Cambridge, MA USA; [Wang, Hongtao; Salthouse, Christopher] Univ Massachusetts, Dept Elect & Comp Engn, Amherst, MA 01003 USA; [Wang, Hongtao; Salthouse, Christopher] Univ Massachusetts, Ctr Personalized Hlth Monitoring, Amherst, MA 01003 USA; [Haggarty, Stephen J.; Mazitschek, Ralph] Broad Inst Harvard & Massachusetts Inst Technol, Cambridge, MA USA; [Ghosh, Balaram] BITS Pilani, Dept Pharm, Hyderabad Campus, Hyderabad, Andhra Pradesh, India	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Birla Institute of Technology & Science Pilani (BITS Pilani)	Haggarty, SJ (corresponding author), Massachusetts Gen Hosp, Chem Neurobiol Lab, Boston, MA 02114 USA.; Haggarty, SJ (corresponding author), Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA.; Haggarty, SJ (corresponding author), Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA.; Mazitschek, R (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Syst Biol, Boston, MA USA.	shaggarty@mgh.harvard.edu; rmazitschek@mgh.harvard.edu	Haggarty, Stephen J/M-9495-2016; Ghosh, Balaram/GLS-7644-2022	Haggarty, Stephen J/0000-0002-7872-168X; Ghosh, Balaram/0000-0002-3425-2439; Robkis, D. Miklos/0000-0001-5958-5478	US National Institutes of Health [R01NS088209, P50CA086355, R01DA028301, T32-CA079443]; Tau Consortium; Bluefield Consortium for Frontotemporal Dementia; Pitt-Hopkins Research Foundation; NATIONAL CANCER INSTITUTE [T32CA079443, P50CA086355] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS088209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA028301] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tau Consortium; Bluefield Consortium for Frontotemporal Dementia; Pitt-Hopkins Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank members of the Haggarty and Mazitschek laboratories and T. Pezeril for their constructive feedback throughout the project. We acknowledge financial support from the US National Institutes of Health (R01NS088209 R.M. and S.J.H., P50CA086355 R.M., R01DA028301 S.J.H., T32-CA079443 J.A.H.). S.J.H. is supported through funding from the Tau Consortium, Bluefield Consortium for Frontotemporal Dementia and Pitt-Hopkins Research Foundation. The computations in this paper were run on the Odyssey cluster supported by the Faculty of Arts and Sciences, Division of Science, Research Computing Group at Harvard University. We thank S. Johnston for acquiring the high-resolution mass spectra, and members of the Arduino development team and the open-source Maker Movement.	Andrews DM, 2008, BIOORG MED CHEM LETT, V18, P2580, DOI 10.1016/j.bmcl.2008.03.041; Arrowsmith CH, 2012, NAT REV DRUG DISCOV, V11, P384, DOI 10.1038/nrd3674; Banks JL, 2005, J COMPUT CHEM, V26, P1752, DOI 10.1002/jcc.20292; Bantscheff M, 2011, NAT BIOTECHNOL, V29, P255, DOI 10.1038/nbt.1759; Beckers T, 2007, INT J CANCER, V121, P1138, DOI 10.1002/ijc.22751; Beharry AA, 2011, CHEM SOC REV, V40, P4422, DOI 10.1039/c1cs15023e; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Bradner JE, 2010, NAT CHEM BIOL, V6, P238, DOI 10.1038/NCHEMBIO.313; Bressi JC, 2010, BIOORG MED CHEM LETT, V20, P3142, DOI 10.1016/j.bmcl.2010.03.091; Brieke C, 2012, ANGEW CHEM INT EDIT, V51, P8446, DOI 10.1002/anie.201202134; CHIRLIAN LE, 1987, J COMPUT CHEM, V8, P894, DOI 10.1002/jcc.540080616; Copeland RA, 2006, NAT REV DRUG DISCOV, V5, P730, DOI 10.1038/nrd2082; Fehrentz T, 2011, ANGEW CHEM INT EDIT, V50, P12156, DOI 10.1002/anie.201103236; Fenno L, 2011, ANNU REV NEUROSCI, V34, P389, DOI 10.1146/annurev-neuro-061010-113817; Frank JA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8118; Garcia-Amoros J, 2010, J PHYS CHEM B, V114, P1287, DOI 10.1021/jp909557h; Goldberg AD, 2007, CELL, V128, P635, DOI 10.1016/j.cell.2007.02.006; Graff J, 2014, CELL, V156, P261, DOI 10.1016/j.cell.2013.12.020; Graff J, 2013, ANNU REV PHARMACOL, V53, P311, DOI 10.1146/annurev-pharmtox-011112-140216; Graff J, 2012, NATURE, V483, P222, DOI 10.1038/nature10849; Haggarty SJ, 2011, NEUROBIOL LEARN MEM, V96, P41, DOI 10.1016/j.nlm.2011.04.009; Knight ZA, 2007, CELL, V128, P425, DOI 10.1016/j.cell.2007.01.021; Konermann S, 2013, NATURE, V500, P472, DOI 10.1038/nature12466; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kramer RH, 2013, NAT NEUROSCI, V16, P816, DOI 10.1038/nn.3424; Lauffer BEL, 2013, J BIOL CHEM, V288, P26926, DOI 10.1074/jbc.M113.490706; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; Marenich AV, 2009, J PHYS CHEM B, V113, P6378, DOI 10.1021/jp810292n; Montojo J, 2010, BIOINFORMATICS, V26, P2927, DOI 10.1093/bioinformatics/btq562; NIINO H, 1988, CHEM LETT, P1227, DOI 10.1246/cl.1988.1227; Orozco-Solis R, 2014, NEUROSCIENCE, V264, P76, DOI 10.1016/j.neuroscience.2014.01.043; Schonberger M, 2014, NAT CHEM, V6, P712, DOI [10.1038/NCHEM.2004, 10.1038/nchem.2004]; Schroeder FA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071323; SHINKAI S, 1983, J AM CHEM SOC, V105, P1851, DOI 10.1021/ja00345a029; Stockwell BR, 2004, NATURE, V432, P846, DOI 10.1038/nature03196; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Zheng YP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3203	38	53	55	1	63	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAY	2016	12	5					317	+		10.1038/NCHEMBIO.2042	http://dx.doi.org/10.1038/NCHEMBIO.2042			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DJ6KY	26974814	Green Accepted, Green Submitted			2022-12-25	WOS:000374322800005
J	Robinson, EB; St Pourcain, B; Anttila, V; Kosmicki, JA; Bulik-Sullivan, B; Grove, J; Maller, J; Samocha, KE; Sanders, SJ; Ripke, S; Martin, J; Hollegaard, MV; Werge, T; Hougaard, DM; Neale, BM; Evans, DM; Skuse, D; Mortensen, PB; Borglum, AD; Ronald, A; Smith, GD; Daly, MJ				Robinson, Elise B.; St Pourcain, Beate; Anttila, Verneri; Kosmicki, Jack A.; Bulik-Sullivan, Brendan; Grove, Jakob; Maller, Julian; Samocha, Kaitlin E.; Sanders, Stephan J.; Ripke, Stephan; Martin, Joanna; Hollegaard, Mads V.; Werge, Thomas; Hougaard, David M.; Neale, Benjamin M.; Evans, David M.; Skuse, David; Mortensen, Preben Bo; Borglum, Anders D.; Ronald, Angelica; Smith, George Davey; Daly, Mark J.		iPSYCH-SSI Broad Autism Grp	Genetic risk for autism spectrum disorders and neuropsychiatric variation in the general population	NATURE GENETICS			English	Article							DE-NOVO; TRAITS; VARIABILITY; PHENOTYPES; COMPONENTS; MUTATIONS; ETIOLOGY; DISEASES	Almost all genetic risk factors for autism spectrum disorders (ASDs) can be found in the general population, but the effects of this risk are unclear in people not ascertained for neuropsychiatric symptoms. Using several large ASD consortium and population-based resources (total n > 38,000), we find genome-wide genetic links between ASDs and typical variation in social behavior and adaptive functioning. This finding is evidenced through both LD score correlation and de novo variant analysis, indicating that multiple types of genetic risk for ASDs influence a continuum of behavioral and developmental traits, the severe tail of which can result in diagnosis with an ASD or other neuropsychiatric disorder. A continuum model should inform the design and interpretation of studies of neuropsychiatric disease biology.	[Robinson, Elise B.; Anttila, Verneri; Kosmicki, Jack A.; Bulik-Sullivan, Brendan; Maller, Julian; Samocha, Kaitlin E.; Ripke, Stephan; Martin, Joanna; Neale, Benjamin M.; Daly, Mark J.] Massachusetts Gen Hosp, Dept Med, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [Robinson, Elise B.; Anttila, Verneri; Kosmicki, Jack A.; Bulik-Sullivan, Brendan; Maller, Julian; Samocha, Kaitlin E.; Ripke, Stephan; Martin, Joanna; Neale, Benjamin M.; Daly, Mark J.] Harvard Univ, Sch Med, Boston, MA USA; [Robinson, Elise B.; Anttila, Verneri; Kosmicki, Jack A.; Bulik-Sullivan, Brendan; Maller, Julian; Samocha, Kaitlin E.; Ripke, Stephan; Martin, Joanna; Neale, Benjamin M.; Daly, Mark J.] Broad Inst MIT & Harvard, Stanley Ctr Psychiat Res, Cambridge, MA USA; [Robinson, Elise B.; Anttila, Verneri; Kosmicki, Jack A.; Bulik-Sullivan, Brendan; Maller, Julian; Samocha, Kaitlin E.; Ripke, Stephan; Martin, Joanna; Neale, Benjamin M.; Daly, Mark J.] Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA USA; [Evans, David M.; Smith, George Davey] Univ Bristol, Med Res Council Integrat Epidemiol Unit, Bristol, Avon, England; [St Pourcain, Beate] Max Planck Inst Psycholinguist, Nijmegen, Netherlands; [Kosmicki, Jack A.] Harvard Univ, Sch Med, Ctr Biomed Informat, Boston, MA USA; [Grove, Jakob; Mortensen, Preben Bo; Borglum, Anders D.] Aarhus Univ, Dept Biomed Human Genet, Aarhus, Denmark; [Grove, Jakob; Werge, Thomas; Mortensen, Preben Bo; Borglum, Anders D.] IPSYCH, Lundbeck Fdn Initiat Integrat Psychiat Res, Copenhagen, Denmark; [Grove, Jakob; Borglum, Anders D.] Aarhus Univ, iSEQ, Ctr Integrat Sequencing, Aarhus, Denmark; [Grove, Jakob] Aarhus Univ, Bioinformat Res Ctr, Aarhus, Denmark; [Samocha, Kaitlin E.] Harvard Univ, Sch Med, Program Genet & Genom, Biol & Biomed Sci, Boston, MA USA; [Sanders, Stephan J.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA USA; [Ripke, Stephan] Charite, Dept Psychiat & Psychotherapy, Campus Mitte, Berlin, Germany; [Hollegaard, Mads V.; Hougaard, David M.] Statens Serum Inst, Dept Congenital Disorders, Ctr Neonatal Screening, DK-2300 Copenhagen, Denmark; [Werge, Thomas] Mental Hlth Serv Copenhagen, Mental Hlth Ctr Sct Hans, Inst Biol Psychiat, Copenhagen, Denmark; [Werge, Thomas] Univ Copenhagen, Dept Clin Med, Copenhagen, Denmark; [Neale, Benjamin M.] Harvard Univ, Sch Med, Dept Psychiat, Boston, MA 02115 USA; [Evans, David M.] Univ Queensland, Translat Res Inst, Diamantina Inst, Brisbane, Qld, Australia; [Skuse, David] UCL, Inst Child Hlth, Behav Sci Unit, London, England; [Mortensen, Preben Bo] Univ Aarhus, Natl Ctr Register Based Res, Aarhus, Denmark; [Ronald, Angelica] Birkbeck Univ London, Ctr Brain & Cognit Dev, Dept Psychol Sci, London, England	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Bristol; Max Planck Society; Harvard University; Harvard Medical School; Aarhus University; Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH); Aarhus University; Aarhus University; Harvard University; Harvard Medical School; University of California System; University of California San Francisco; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Statens Serum Institut; University of Copenhagen; Harvard University; Harvard Medical School; University of Queensland; University of London; University College London; Aarhus University; University of London; Birkbeck University London	Robinson, EB; Daly, MJ (corresponding author), Massachusetts Gen Hosp, Dept Med, Analyt & Translat Genet Unit, Boston, MA 02114 USA.	erobinson@atgu.mgh.harvard.edu; mjdaly@atgu.mgh.harvard.edu	Davey Smith, George/A-7407-2013; Ripke, Stephan/AAK-5486-2021; Evans, David M/H-6325-2013; Daly, Mark J/B-2453-2017; Bybjerg-Grauholm, Jonas/AAO-5447-2020; Mortensen, Preben B/D-2358-2015; St Pourcain, Beate/K-8004-2017; Sanders, Stephan/S-8645-2019; Mattheisen, Manuel/S-3725-2019; Hansen, Thomas Folkmann/O-5965-2014; Hougaard, David/AAD-6368-2019; Mattheisen, Manuel/B-4949-2012; Grove, Jakob/K-8112-2015; Ronald, Angelica/C-7812-2009	Davey Smith, George/0000-0002-1407-8314; Evans, David M/0000-0003-0663-4621; Daly, Mark J/0000-0002-0949-8752; Bybjerg-Grauholm, Jonas/0000-0003-1705-4008; Mortensen, Preben B/0000-0002-5230-9865; St Pourcain, Beate/0000-0002-4680-3517; Mattheisen, Manuel/0000-0002-8442-493X; Hansen, Thomas Folkmann/0000-0001-6703-7762; Mattheisen, Manuel/0000-0002-8442-493X; s, hema/0000-0002-3440-9475; Samocha, Kaitlin/0000-0002-1704-3352; ripke, stephan/0000-0003-3622-835X; Mors, Ole/0000-0002-5660-0393; Anttila, Verneri/0000-0002-0073-4675; Grove, Jakob/0000-0003-2284-5744; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Moran, Jennifer/0000-0002-5664-4716; Demontis, Ditte/0000-0001-9124-2766; Ronald, Angelica/0000-0002-9576-2176; Martin, Joanna/0000-0002-8911-3479; Borglum, Anders/0000-0001-8627-7219; Baekvad-Hansen, Marie/0000-0002-5881-1776; Sanders, Stephan/0000-0001-9112-5148	Wellcome Trust [102215/2/13/2]; Medical Research Council Integrative Epidemiology Unit [MC_UU_12013/1-9]; National Institute of Mental Health [1K01MH099286-01A1, 5U01MH094432-02]; Brain Behavior Research Foundation (NARSAD) [22379]; Lundbeck Foundation; universities and university hospital of Aarhus; universities and university hospital of Copenhagen; Stanley Foundation; Simons Foundation [SFARI 311789]; MRC [MC_UU_12013/4, MC_UU_12013/1] Funding Source: UKRI; Lundbeck Foundation [R155-2014-1724] Funding Source: researchfish; Medical Research Council [MC_PC_15018, MC_UU_12013/4, MC_UU_12013/1] Funding Source: researchfish; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH099286, U01MH094432] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council Integrative Epidemiology Unit(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Brain Behavior Research Foundation (NARSAD); Lundbeck Foundation(Lundbeckfonden); universities and university hospital of Aarhus; universities and university hospital of Copenhagen; Stanley Foundation; Simons Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Lundbeck Foundation(Lundbeckfonden); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank S. Hyman, T. Lehner and N. Kanwisher for comments on the manuscript. We are extremely grateful to all the families who took part in this study, the midwives for their help in recruiting them and the whole ALSPAC team, which includes interviewers, computer and laboratory technicians, clerical workers, research scientists, volunteers, managers, receptionists and nurses. The UK Medical Research Council, the Wellcome Trust (grant 102215/2/13/2) and the University of Bristol provide core support for ALSPAC. Autism Speaks (7132) provided support for the analysis of autistic trait-related data in ALSPAC (to B.S.P.). This work was also supported by the Medical Research Council Integrative Epidemiology Unit (MC_UU_12013/1-9). This publication is the work of the authors, and E.B.R. and M.J.D. will serve as guarantors for the contents of this paper. The ALSPAC GWAS data were generated by the Sample Logistics and Genotyping Facilities at the Wellcome Trust Sanger Institute and LabCorp (Laboratory Corporation of America) using support from 23andMe. E.B.R. was funded by National Institute of Mental Health grant 1K01MH099286-01A1 and Brain Behavior Research Foundation (NARSAD) Young Investigator grant 22379. We thank the families who took part in the Simons Simplex Collection study and the clinicians who collected data at each of the study sites. The iPSYCH project is funded by the Lundbeck Foundation and the universities and university hospitals of Aarhus and Copenhagen. Genotyping of iPSYCH and PGC samples was supported by grants from the Stanley Foundation, the Simons Foundation (SFARI 311789 to M.J.D.) and the National Institute of Mental Health (5U01MH094432-02 to M.J.D.). The authors would like to thank the Exome Aggregation Consortium and the groups that provided exome variant data for comparison. A full list of contributing groups can be found on the ExAC website (see URLs). This work was also supported by a grant from the Simons Foundation (SFARI 307705; to S.J.S.).	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Benyamin B, 2014, MOL PSYCHIATR, V19, P253, DOI 10.1038/mp.2012.184; Borglum AD, 2014, MOL PSYCHIATR, V19, P325, DOI 10.1038/mp.2013.2; Boyd A, 2013, INT J EPIDEMIOL, V42, P111, DOI 10.1093/ije/dys064; Bulik-Sullivan B., 2015, RELATIONSHIP LD SCOR, DOI [10.1101/018283, DOI 10.1101/018283]; Bulik-Sullivan B, 2015, NAT GENET, V47, P1236, DOI 10.1038/ng.3406; Bulik-Sullivan BK, 2015, NAT GENET, V47, P291, DOI 10.1038/ng.3211; Constantino JN, 2010, AM J PSYCHIAT, V167, P1349, DOI 10.1176/appi.ajp.2010.09101470; De Rubeis S, 2014, NATURE, V515, P209, DOI 10.1038/nature13772; Fischbach GD, 2010, NEURON, V68, P192, DOI 10.1016/j.neuron.2010.10.006; Fraser A, 2013, INT J EPIDEMIOL, V42, P97, DOI 10.1093/ije/dys066; Gaugler T, 2014, NAT GENET, V46, P881, DOI 10.1038/ng.3039; Hanson E, 2015, BIOL PSYCHIAT, V77, P785, DOI 10.1016/j.biopsych.2014.04.021; Hollegaard MV, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-58; Iossifov I, 2014, NATURE, V515, P216, DOI 10.1038/nature13908; Kanner L, 1943, NERV CHILD, V2, P217; Krumm N, 2015, NAT GENET, V47, P582, DOI 10.1038/ng.3303; Lee SH, 2013, NAT GENET, V45, P984, DOI 10.1038/ng.2711; Loh PR, 2015, NAT GENET, V47, P1385, DOI 10.1038/ng.3431; Lundstrom S, 2012, ARCH GEN PSYCHIAT, V69, P46, DOI 10.1001/archgenpsychiatry.2011.144; Mannik K, 2015, JAMA-J AM MED ASSOC, V313, P2044, DOI 10.1001/jama.2015.4845; Moreno-De-Luca A, 2015, JAMA PSYCHIAT, V72, P119, DOI 10.1001/jamapsychiatry.2014.2147; Plomin R, 2009, NAT REV GENET, V10, P872, DOI 10.1038/nrg2670; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Robinson EB, 2014, P NATL ACAD SCI USA, V111, P15161, DOI 10.1073/pnas.1409204111; Robinson EB, 2011, ARCH GEN PSYCHIAT, V68, P1113, DOI 10.1001/archgenpsychiatry.2011.119; Robinson EB, 2011, J AM ACAD CHILD PSY, V50, P376, DOI 10.1016/j.jaac.2011.01.005; Ronald A, 2006, J AM ACAD CHILD PSY, V45, P691, DOI 10.1097/01.chi.0000215325.13058.9d; Samocha KE, 2014, NAT GENET, V46, P944, DOI 10.1038/ng.3050; Skuse DH, 2005, BRIT J PSYCHIAT, V187, P568, DOI 10.1192/bjp.187.6.568; Sparrow S. S., 2005, VINELAND ADAPTIVE BE, V2nd, DOI [10.1037/t15164-000, DOI 10.1037/T15164-000]; St Pourcain B, 2014, MOL AUTISM, V5, DOI 10.1186/2040-2392-5-18; Stefansson H, 2014, NATURE, V505, P361, DOI 10.1038/nature12818; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011	34	237	239	3	88	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2016	48	5					552	+		10.1038/ng.3529	http://dx.doi.org/10.1038/ng.3529			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	DK3RC	26998691	Green Accepted, Green Submitted, Green Published			2022-12-25	WOS:000374834100015
J	Valdmanis, PN; Gu, S; Chu, K; Jin, L; Zhang, FJ; Munding, EM; Zhang, Y; Huang, Y; Kutay, H; Ghoshal, K; Lisowski, L; Kay, MA				Valdmanis, Paul N.; Gu, Shuo; Chu, Kirk; Jin, Lan; Zhang, Feijie; Munding, Elizabeth M.; Zhang, Yue; Huang, Yong; Kutay, Huban; Ghoshal, Kalpana; Lisowski, Leszek; Kay, Mark A.			RNA interference-induced hepatotoxicity results from loss of the first synthesized isoform of microRNA-122 in mice	NATURE MEDICINE			English	Article							GENE-EXPRESSION; MESSENGER-RNAS; RAT-LIVER; IN-VIVO; MIR-122; HEPATOCARCINOGENESIS; BINDING; MOUSE	Small RNAs can be engineered to target and eliminate expression of disease-causing genes or infectious viruses, resulting in the preclinical and clinical development of RNA interference (RNAi) therapeutics using these small RNAs1. To ensure the success of RNAi therapeutics, small hairpin RNAs (shRNAs) must co-opt sufficient quantities of the endogenous microRNA machinery to elicit efficient gene knockdown without impeding normal cellular function. We previously observed liver toxicity-including hepatocyte turnover, loss of gene repression and lethality(2)-in mice receiving high doses of a recombinant adeno-associated virus (rAAV) vector expressing shRNAs (rAAV-shRNAs); however the mechanism by which toxicity ensues has not been elucidated. Using rAAV-shRNAs we have now determined that hepatotoxicity arises when exogenous shRNAs exceed 12% of the total amount of liver microRNAs. After this threshold was surpassed, shRNAs specifically reduced the initially synthesized 22-nucleotide isoform of microRNA (miR)-122-5p without substantially affecting other microRNAs, resulting in functional de-repression of miR-122 target mRNAs. Delivery of a rAAV-shRNA vector expressing mature miR-122-5p could circumvent toxicity, despite the exogenous shRNA accounting for 70% of microRNAs. Toxicity was also not observed in Mir122-knockout mice regardless of the level or sequence of the shRNA. Our study establishes limits to the microRNA machinery that is available for therapeutic siRNAs and suggests new paradigms for the role of miR-122 in liver homeostasis in mice.	[Valdmanis, Paul N.; Gu, Shuo; Chu, Kirk; Jin, Lan; Zhang, Feijie; Munding, Elizabeth M.; Zhang, Yue; Huang, Yong; Lisowski, Leszek; Kay, Mark A.] Stanford Univ, Dept Pediat, Stanford, CA 94305 USA; [Valdmanis, Paul N.; Gu, Shuo; Chu, Kirk; Jin, Lan; Zhang, Feijie; Munding, Elizabeth M.; Zhang, Yue; Huang, Yong; Lisowski, Leszek; Kay, Mark A.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Kutay, Huban; Ghoshal, Kalpana] Ohio State Univ, Dept Pathol, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Gu, Shuo] NCI, Gene Regulat & Chromosome Biol Lab, Ctr Canc Res, Frederick, MD 21701 USA; [Lisowski, Leszek] Childrens Med Res Inst, Sydney, NSW, Australia	Stanford University; Stanford University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Children's Medical Research Institute - Australia; University of Sydney	Kay, MA (corresponding author), Stanford Univ, Dept Pediat, Stanford, CA 94305 USA.; Kay, MA (corresponding author), Stanford Univ, Dept Genet, Stanford, CA 94305 USA.	markay@stanford.edu	Gu, Shuo/K-5404-2016; Lisowski, Leszek/AAU-2228-2020	Lisowski, Leszek/0000-0002-4772-8651; Gu, Shuo/0000-0002-7924-5363; Kay, Mark/0000-0002-2799-2615; Valdmanis, Paul/0000-0001-8840-6969	NIH [R01DK078424, R01AI071068, R01CA193244]; Canadian Institutes of Health Research; NATIONAL CANCER INSTITUTE [R01CA086978, ZIABC011566, P30CA124435, P30CA016058, R01CA193244] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI071068] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078424] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH grants R01DK078424 (M.A.K.), R01AI071068 (M.A.K.) and R01CA193244 (K.G.) and a Banting Postdoctoral Fellowship from the Canadian Institutes of Health Research (P.N.V.). We would like to thank all members of the Kay laboratory for input and suggestions, and H. Vogel for EM image analysis. Dicer1-knockout cells were kindly provided by B. Cullen (Duke University). We would like to thank the Stanford Functional Genomics Facility and the Stanford Center for Genomics and Personalized Medicine for high-throughput sequencing services.	Betel D, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r90; Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; Castoldi M, 2011, J CLIN INVEST, V121, P1386, DOI 10.1172/JCI44883; Chang Jinhong, 2004, RNA Biol, V1, P106, DOI 10.4161/rna.1.2.1066; CROSS NCP, 1988, CELL, V53, P881, DOI 10.1016/S0092-8674(88)90349-2; Elmen J, 2008, NUCLEIC ACIDS RES, V36, P1153, DOI 10.1093/nar/gkm1113; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; Gatfield D, 2009, GENE DEV, V23, P1313, DOI 10.1101/gad.1781009; Grimm D, 2006, NATURE, V441, P537, DOI 10.1038/nature04791; Grimm D, 2010, J CLIN INVEST, V120, P3106, DOI 10.1172/JCI43565; Gu S, 2012, CELL, V151, P900, DOI 10.1016/j.cell.2012.09.042; Hand NJ, 2009, HEPATOLOGY, V49, P618, DOI 10.1002/hep.22656; Helwak A, 2013, CELL, V153, P654, DOI 10.1016/j.cell.2013.03.043; HOMMES FA, 1970, BIOCHIM BIOPHYS ACTA, V222, P251, DOI 10.1016/0304-4165(70)90380-6; Hsu SH, 2012, J CLIN INVEST, V122, P2871, DOI 10.1172/JCI63539; Kandathil AJ, 2013, GASTROENTEROLOGY, V145, P1404, DOI 10.1053/j.gastro.2013.08.034; Katoh T, 2009, GENE DEV, V23, P433, DOI 10.1101/gad.1761509; Kay MA, 2011, NAT REV GENET, V12, P316, DOI 10.1038/nrg2971; Krutzfeldt J., 2005, NATURE, V438, P685; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lares MR, 2010, TRENDS BIOTECHNOL, V28, P570, DOI 10.1016/j.tibtech.2010.07.009; Loeb GB, 2012, MOL CELL, V48, P760, DOI 10.1016/j.molcel.2012.10.002; Luna JM, 2015, CELL, V160, P1099, DOI 10.1016/j.cell.2015.02.025; Maguire AM, 2009, LANCET, V374, P1597, DOI 10.1016/S0140-6736(09)61836-5; Nakal H., 2005, J VIROL, V79, P3606; NUMAZAKI M, 1984, EUR J BIOCHEM, V142, P165, DOI 10.1111/j.1432-1033.1984.tb08265.x; Rodino-Klapac LR, 2007, ARCH NEUROL-CHICAGO, V64, P1236, DOI 10.1001/archneur.64.9.1236; Sekine S, 2009, GASTROENTEROLOGY, V136, P2304, DOI 10.1053/j.gastro.2009.02.067; Tsai WC, 2012, J CLIN INVEST, V122, P2884, DOI 10.1172/JCI63455; Xie J, 2012, NAT METHODS, V9, P403, DOI [10.1038/NMETH.1903, 10.1038/nmeth.1903]	31	26	29	2	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2016	22	5					557	562		10.1038/nm.4079	http://dx.doi.org/10.1038/nm.4079			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DL3DI	27064447	Green Accepted			2022-12-25	WOS:000375514000019
J	Chan, P; Han, X; Zheng, BH; Deran, M; Yu, JZ; Jarugumilli, GK; Deng, H; Pan, DJ; Luo, XL; Wu, X				Chan, PuiYee; Han, Xiao; Zheng, Baohui; DeRan, Michael; Yu, Jianzhong; Jarugumilli, Gopala K.; Deng, Hua; Pan, Duojia; Luo, Xuelian; Wu, Xu			Autopalmitoylation of TEAD proteins regulates transcriptional output of the Hippo pathway	NATURE CHEMICAL BIOLOGY			English	Article							STRUCTURAL BASIS; C-ABL; PALMITOYLATION; YAP; CANCER; COMPLEX; GROWTH; TAZ; ACYLTRANSFERASES; DIFFERENTIATION	TEA domain (TEAD) transcription factors bind to the coactivators YAP and TAZ and regulate the transcriptional output of the Hippo pathway, playing critical roles in organ size control and tumorigenesis. Protein S-palmitoylation attaches a fatty acid, palmitate, to cysteine residues and regulates protein trafficking, membrane localization and signaling activities. Using activity-based chemical probes, we discovered that human TEADs possess intrinsic palmitoylating enzyme-like activities and undergo autopalmitoylation at evolutionarily conserved cysteine residues under physiological conditions. We determined the crystal structures of lipid-bound TEADs and found that the lipid chain of palmitate inserts into a conserved deep hydrophobic pocket. Strikingly, palmitoylation did not alter TEAD's localization, but it was required for TEAD's binding to YAP and TAZ and was dispensable for its binding to the Vgll4 tumor suppressor. Moreover, palmitoylation-deficient TEAD mutants impaired TAZ-mediated muscle differentiation in vitro and tissue overgrowth mediated by the Drosophila YAP homolog Yorkie in vivo. Our study directly links autopalmitoylation to the transcriptional regulation of the Hippo pathway.	[Chan, PuiYee; Zheng, Baohui; DeRan, Michael; Jarugumilli, Gopala K.; Wu, Xu] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Charlestown, MA USA; [Han, Xiao] Jilin Univ, Sch Life Sci, Minist Educ, Key Lab Mol Enzymol & Engn, Changchun 130023, Peoples R China; [Han, Xiao; Luo, Xuelian] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Han, Xiao; Luo, Xuelian] Univ Texas SW Med Ctr Dallas, Dept Biophys, Dallas, TX 75390 USA; [Yu, Jianzhong; Deng, Hua; Pan, Duojia] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; [Yu, Jianzhong; Deng, Hua; Pan, Duojia] Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA	Harvard University; Massachusetts General Hospital; Jilin University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins University	Wu, X (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Charlestown, MA USA.; Luo, XL (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA.; Luo, XL (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Biophys, Dallas, TX 75390 USA.	xuelian.luo@utsouthwestern.edu; xwu@cbrc2.mgh.harvard.edu	Deng, Hua/D-6393-2016	Chan, PuiYee/0000-0002-9133-9506	Stewart Rahr-MRA (Melanoma Research Alliance) Young Investigator Award; Department of Defense (DoD) Career Development Award [W81XWH-13-1-0203]; American Cancer Society [124929-RSG-13-291-01-TBE]; US National Institutes of Health/National Cancer Institute [R01CA181537]; National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases [R01DK107651-01]; National Institutes of Health/National Institute of General Medical Sciences [R01GM107415]; National Institute of Health/National Eye Institute [R01EY015708]; Howard Hughes Medical Institute; US Department of Energy (DOE) [DE-AC02-06CH11357]; NATIONAL CANCER INSTITUTE [R01CA181537] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY015708] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK107651] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM107415] Funding Source: NIH RePORTER	Stewart Rahr-MRA (Melanoma Research Alliance) Young Investigator Award; Department of Defense (DoD) Career Development Award; American Cancer Society(American Cancer Society); US National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institutes of Health/National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of Health/National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); US Department of Energy (DOE)(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a Stewart Rahr-MRA (Melanoma Research Alliance) Young Investigator Award, a Department of Defense (DoD) Career Development Award (W81XWH-13-1-0203), and grants from the American Cancer Society (124929-RSG-13-291-01-TBE), US National Institutes of Health/National Cancer Institute (R01CA181537) (to X.W.), National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases (R01DK107651-01) (to X.W. and X.L.), National Institutes of Health/National Institute of General Medical Sciences (R01GM107415) (to X.L.) and National Institute of Health/National Eye Institute (R01EY015708) (to D.P.); D.P. is supported by the Howard Hughes Medical Institute. We thank N. Bardeesy, M. Fukata, K.-L. Guan and K. White for constructs and cell lines; J.-R.J. Yeh, H. Yu and N. Gray for discussion and critical comments on the manuscript; and the Taplin Mass Spec Core facility at Harvard Medical School and the Proteomics Core at UTSW for proteomic studies. Use of the Argonne National Laboratory Structural Biology Center beamlines at the Advanced Photon Source was supported by the US Department of Energy (DOE) under contract DE-AC02-06CH11357.	Benhaddou A, 2012, CELL DEATH DIFFER, V19, P220, DOI 10.1038/cdd.2011.87; Chandra A, 2012, NAT CELL BIOL, V14, P148, DOI 10.1038/ncb2394; Chen LM, 2010, GENE DEV, V24, P290, DOI 10.1101/gad.1865310; Duncan JA, 1996, J BIOL CHEM, V271, P23594, DOI 10.1074/jbc.271.38.23594; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Faergeman NJ, 1997, BIOCHEM J, V323, P1; Fukata Y, 2010, NAT REV NEUROSCI, V11, P161, DOI 10.1038/nrn2788; Greaves J, 2011, TRENDS BIOCHEM SCI, V36, P245, DOI 10.1016/j.tibs.2011.01.003; Hang HC, 2011, CHEM REV, V111, P6341, DOI 10.1021/cr2001977; Hannoush RN, 2012, METHODS MOL BIOL, V800, P85, DOI 10.1007/978-1-61779-349-3_7; Hantschel O, 2003, CELL, V112, P845, DOI 10.1016/S0092-8674(03)00191-0; Harvey KF, 2013, NAT REV CANCER, V13, P246, DOI 10.1038/nrc3458; Ismail SA, 2011, NAT CHEM BIOL, V7, P942, DOI [10.1038/nchembio.686, 10.1038/NCHEMBIO.686]; Jennings BC, 2012, J BIOL CHEM, V287, P7236, DOI 10.1074/jbc.M111.337246; Jiao S, 2014, CANCER CELL, V25, P166, DOI 10.1016/j.ccr.2014.01.010; Johnson R, 2014, NAT REV DRUG DISCOV, V13, P63, DOI 10.1038/nrd4161; Koontz LM, 2013, DEV CELL, V25, P388, DOI 10.1016/j.devcel.2013.04.021; Kummel D, 2006, P NATL ACAD SCI USA, V103, P12701, DOI 10.1073/pnas.0603513103; Li Z, 2010, GENE DEV, V24, P235, DOI 10.1101/gad.1865810; Liu-Chittenden Y, 2012, GENE DEV, V26, P1300, DOI 10.1101/gad.192856.112; Martin BR, 2009, NAT METHODS, V6, P135, DOI [10.1038/NMETH.1293, 10.1038/nmeth.1293]; Menendez JA, 2007, NAT REV CANCER, V7, P763, DOI 10.1038/nrc2222; Nagar B, 2003, CELL, V112, P859, DOI 10.1016/S0092-8674(03)00194-6; Noland CL, 2016, STRUCTURE, V24, P179, DOI 10.1016/j.str.2015.11.005; Ota M, 2008, DEVELOPMENT, V135, P4059, DOI 10.1242/dev.027151; Pan DJ, 2007, GENE DEV, V21, P886, DOI 10.1101/gad.1536007; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Park GH, 2014, BRIT J PHARMACOL, V171, P4051, DOI 10.1111/bph.12755; Pobbati AV, 2015, STRUCTURE, V23, P2076, DOI 10.1016/j.str.2015.09.009; Resh MD, 2006, METHODS, V40, P191, DOI 10.1016/j.ymeth.2006.04.013; Resh MD, 2006, NAT CHEM BIOL, V2, P584, DOI 10.1038/nchembio834; Roth AF, 2006, CELL, V125, P1003, DOI 10.1016/j.cell.2006.03.042; Smotrys JE, 2004, ANNU REV BIOCHEM, V73, P559, DOI 10.1146/annurev.biochem.73.011303.073954; Sorrentino G, 2014, NAT CELL BIOL, V16, P357, DOI 10.1038/ncb2936; Tian W, 2010, P NATL ACAD SCI USA, V107, P7293, DOI 10.1073/pnas.1000293107; Turnbull AP, 2005, EMBO J, V24, P875, DOI 10.1038/sj.emboj.7600565; Wan J, 2007, NAT PROTOC, V2, P1573, DOI 10.1038/nprot.2007.225; Wu S, 2008, DEV CELL, V14, P388, DOI 10.1016/j.devcel.2008.01.007; Yang JY, 2005, BIOCHEMISTRY-US, V44, P11903, DOI 10.1021/bi0508082; Yang ZY, 2014, MOL CELL BIOL, V34, P1607, DOI 10.1128/MCB.01346-13; Yount JS, 2010, NAT CHEM BIOL, V6, P610, DOI [10.1038/NCHEMBIO.405, 10.1038/nchembio.405]; Zhang HB, 2004, J BIOL CHEM, V279, P407, DOI 10.1074/jbc.M306559200; Zhang WJ, 2014, CELL RES, V24, P331, DOI 10.1038/cr.2014.10; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zheng BH, 2015, ACS CHEM BIOL, V10, P115, DOI 10.1021/cb500758s; Zheng BH, 2013, J AM CHEM SOC, V135, P7082, DOI 10.1021/ja311416v; Zhou Z, 2015, FASEB J, V29, P724, DOI 10.1096/fj.14-262980; Zimmermann G, 2013, NATURE, V497, P638, DOI 10.1038/nature12205	48	126	131	7	47	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	APR	2016	12	4					282	+		10.1038/NCHEMBIO.2036	http://dx.doi.org/10.1038/NCHEMBIO.2036			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH2DA	26900866	Green Submitted, Green Accepted			2022-12-25	WOS:000372593200017
J	Crocker, J; Ilsley, GR; Stern, DL				Crocker, Justin; Ilsley, Garth R.; Stern, David L.			Quantitatively predictable control of Drosophila transcriptional enhancers in vivo with engineered transcription factors	NATURE GENETICS			English	Article							CELL RNA-SEQ; PAIR-RULE STRIPES; GENE-EXPRESSION; POSITIONAL INFORMATION; REPRESSOR; REVEALS; BINDING; EVOLUTION; MODEL; SPECIFICITY	Genes are regulated by transcription factors that bind to regions of genomic DNA called enhancers. Considerable effort is focused on identifying transcription factor binding sites, with the goal of predicting gene expression from DNA sequence. Despite this effort, general, predictive models of enhancer function are currently lacking. Here we combine quantitative models of enhancer function with manipulations using engineered transcription factors to examine the extent to which enhancer function can be controlled in a quantitatively predictable manner. Our models, which incorporate few free parameters, can accurately predict the contributions of ectopic transcription factor inputs. These models allow the predictable 'tuning' of enhancers, providing a framework for the quantitative control of enhancers with engineered transcription factors.	[Crocker, Justin; Stern, David L.] Howard Hughes Med Inst, Janelia Res Campus, Ashburn, VA USA; [Ilsley, Garth R.] Grad Univ, Okinawa Inst Sci & Technol, Onna, Japan	Howard Hughes Medical Institute; Okinawa Institute of Science & Technology Graduate University	Crocker, J (corresponding author), Howard Hughes Med Inst, Janelia Res Campus, Ashburn, VA USA.; Ilsley, GR (corresponding author), Grad Univ, Okinawa Inst Sci & Technol, Onna, Japan.	crockerj@janelia.hhm.org; garth.ilsley@oist.jp	Ilsley, Garth/V-6413-2019; Ilsley, Garth/B-6320-2015	Stern, David/0000-0002-1847-6483; Ilsley, Garth/0000-0001-9863-5802	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Achim K, 2015, NAT BIOTECHNOL, V33, P503, DOI 10.1038/nbt.3209; Arnosti DN, 1996, EMBO J, V15, P3659, DOI 10.1002/j.1460-2075.1996.tb00735.x; Arnosti DN, 2005, J CELL BIOCHEM, V94, P890, DOI 10.1002/jcb.20352; Arnosti DN, 1996, DEVELOPMENT, V122, P205; Ay A, 2011, CRIT REV BIOCHEM MOL, V46, P137, DOI 10.3109/10409238.2011.556597; Badis G, 2009, SCIENCE, V324, P1720, DOI 10.1126/science.1162327; Barolo S, 1997, EMBO J, V16, P2883, DOI 10.1093/emboj/16.10.2883; Brown CD, 2007, SCIENCE, V317, P1557, DOI 10.1126/science.1145893; Clyde DE, 2003, NATURE, V426, P849, DOI 10.1038/nature02189; Crocker J, 2015, CELL, V160, P191, DOI 10.1016/j.cell.2014.11.041; Crocker J, 2013, NAT METHODS, V10, P762, DOI [10.1038/NMETH.2543, 10.1038/nmeth.2543]; Crocker J, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1102; Crocker J, 2008, PLOS BIOL, V6, P2576, DOI 10.1371/journal.pbio.0060263; Davidson EH, 2006, REG GEN GEN REG; Deng QL, 2014, SCIENCE, V343, P193, DOI 10.1126/science.1245316; Erives A, 2004, P NATL ACAD SCI USA, V101, P3851, DOI 10.1073/pnas.0400611101; Fowlkes CC, 2008, CELL, V133, P364, DOI 10.1016/j.cell.2008.01.053; Fujioka M, 1999, DEVELOPMENT, V126, P2527; GLASS L, 1973, J THEOR BIOL, V39, P103, DOI 10.1016/0022-5193(73)90208-7; Hare EE, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000106; Ilsley GR, 2013, ELIFE, V2, DOI 10.7554/eLife.00522; IP YT, 1992, GENE DEV, V6, P1728, DOI 10.1101/gad.6.9.1728; Jaeger J, 2004, NATURE, V430, P368, DOI 10.1038/nature02678; Jaitin DA, 2014, SCIENCE, V343, P776, DOI 10.1126/science.1247651; Janssens H, 2006, NAT GENET, V38, P1159, DOI 10.1038/ng1886; Janssens H, 2013, DEV BIOL, V377, P305, DOI 10.1016/j.ydbio.2013.01.010; JIANG J, 1993, CELL, V72, P741, DOI 10.1016/0092-8674(93)90402-C; Jin H, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003195; Junion G, 2012, CELL, V148, P473, DOI 10.1016/j.cell.2012.01.030; Kim AR, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003243; Kulkarni MM, 2003, DEVELOPMENT, V130, P6569, DOI 10.1242/dev.00890; LANGELAND JA, 1994, DEVELOPMENT, V120, P2945; Levo M, 2014, NAT REV GENET, V15, P453, DOI 10.1038/nrg3684; Ludwig MZ, 2005, PLOS BIOL, V3, P588, DOI 10.1371/journal.pbio.0030093; Ludwig MZ, 2000, NATURE, V403, P564, DOI 10.1038/35000615; Lusk RW, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000829; Menoret D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-8-r86; Moran E, 2006, MOL CELL BIOL, V26, P3446, DOI 10.1128/MCB.26.9.3446-3454.2006; Panne D, 2008, CURR OPIN STRUC BIOL, V18, P236, DOI 10.1016/j.sbi.2007.12.002; Panne D, 2007, CELL, V129, P1111, DOI 10.1016/j.cell.2007.05.019; Patel AP, 2014, SCIENCE, V344, P1396, DOI 10.1126/science.1254257; Rastegar S, 2008, DEV BIOL, V318, P366, DOI 10.1016/j.ydbio.2008.03.034; REINITZ J, 1995, MECH DEVELOP, V49, P133, DOI 10.1016/0925-4773(94)00310-J; REINITZ J, 1995, J EXP ZOOL, V271, P47, DOI 10.1002/jez.1402710106; Samee MA, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003467; Satija R, 2015, NAT BIOTECHNOL, V33, P495, DOI 10.1038/nbt.3192; Segal E, 2008, NATURE, V451, P535, DOI 10.1038/nature06496; Shalek AK, 2014, NATURE, V510, P363, DOI 10.1038/nature13437; Shlyueva D, 2014, NAT REV GENET, V15, P272, DOI 10.1038/nrg3682; Small S, 1996, DEV BIOL, V175, P314, DOI 10.1006/dbio.1996.0117; Spitz F, 2012, NAT REV GENET, V13, P613, DOI 10.1038/nrg3207; Staller MV, 2015, P NATL ACAD SCI USA, V112, P785, DOI 10.1073/pnas.1413877112; Struffi P, 2004, DEVELOPMENT, V131, P2419, DOI 10.1242/dev.01075; Surkova S, 2008, DEV BIOL, V313, P844, DOI 10.1016/j.ydbio.2007.10.037; Surkova Svetlana, 2013, Cold Spring Harb Protoc, V2013, P488, DOI 10.1101/pdb.top075101; Swanson CI, 2010, DEV CELL, V18, P359, DOI 10.1016/j.devcel.2009.12.026; Tracey WD, 2000, GENETICS, V154, P273; Treutlein B, 2014, NATURE, V509, P371, DOI 10.1038/nature13173; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; Wong D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-7-r70; Zinzen RP, 2006, CURR BIOL, V16, P1358, DOI 10.1016/j.cub.2006.05.044; Zuo Z, 2014, GENETICS, V198, P1329, DOI 10.1534/genetics.114.170100	62	18	18	1	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2016	48	3					292	298		10.1038/ng.3509	http://dx.doi.org/10.1038/ng.3509			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DE8QW	26854918				2022-12-25	WOS:000370902600013
J	Koorman, T; Klompstra, D; van der Voet, M; Lemmens, I; Ramalho, JJ; Nieuwenhuize, S; van den Heuvel, S; Tavernier, J; Nance, J; Boxem, M				Koorman, Thijs; Klompstra, Diana; van der Voet, Monique; Lemmens, Irma; Ramalho, Joao J.; Nieuwenhuize, Susan; van den Heuvel, Sander; Tavernier, Jan; Nance, Jeremy; Boxem, Mike			A combined binary interaction and phenotypic map of C. elegans cell polarity proteins	NATURE CELL BIOLOGY			English	Article							YEAST; 2-HYBRID; DROSOPHILA; NETWORK; GENE; REQUIRES; HOMOLOG; IDENTIFICATION; MORPHOGENESIS; LOCALIZATION	The establishment of cell polarity is an essential process for the development of multicellular organisms and the functioning of cells and tissues. Here, we combine large-scale protein interaction mapping with systematic phenotypic profiling to study the network of physical interactions that underlies polarity establishment and maintenance in the nematode Caenorhabditis elegans. Using a fragment-based yeast two-hybrid strategy, we identified 439 interactions between 296 proteins, as well as the protein regions that mediate these interactions. Phenotypic profiling of the network resulted in the identification of 100 physically interacting protein pairs for which RNAi-mediated depletion caused a defect in the same polarity-related process. We demonstrate the predictive capabilities of the network by showing that the physical interaction between the RhoGAP PAC-1 and PAR-6 is required for radial polarization of the C. elegans embryo. Our network represents a valuable resource of candidate interactions that can be used to further our insight into cell polarization.	[Koorman, Thijs; van der Voet, Monique; Ramalho, Joao J.; Nieuwenhuize, Susan; van den Heuvel, Sander; Boxem, Mike] Univ Utrecht, Div Dev Biol, Dept Biol, Fac Sci, NL-3584 CH Utrecht, Netherlands; [Klompstra, Diana; Nance, Jeremy] NYU, Helen L & Martin S Kimmel Ctr Biol & Med, Skirball Inst Biomol Med, Sch Med, New York, NY 10016 USA; [Klompstra, Diana; Nance, Jeremy] NYU, Dept Cell Biol, Sch Med, New York, NY 10016 USA; [Lemmens, Irma; Tavernier, Jan] VIB, Dept Med Prot Res, B-9000 Ghent, Belgium; [Lemmens, Irma; Tavernier, Jan] Univ Ghent, Dept Biochem, Fac Med & Hlth Sci, B-9000 Ghent, Belgium; [van der Voet, Monique] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, Donders Inst Brain Cognit & Behav, NL-6500 HB Nijmegen, Netherlands	Utrecht University; New York University; New York University; Flanders Institute for Biotechnology (VIB); Ghent University; Radboud University Nijmegen	Boxem, M (corresponding author), Univ Utrecht, Div Dev Biol, Dept Biol, Fac Sci, NL-3584 CH Utrecht, Netherlands.	m.boxem@uu.nl	Tavernier, Jan/AAG-3636-2019; van der Voet, Monique/F-5772-2012; van den Heuvel, Sander J.L./B-8892-2011; Boxem, Mike/B-8857-2011	van der Voet, Monique/0000-0002-8829-1767; van den Heuvel, Sander J.L./0000-0001-9015-7463; Koorman, Thijs/0000-0002-6064-3353; Nance, Jeremy/0000-0003-4212-7731; Boxem, Mike/0000-0003-3966-4173	Netherlands Organization for Scientific Research (NWO) ALW Innovational Research Incentives Scheme Vidi grant [864.09.008]; NWO-CW ECHO grant [711.014.005]; National Science Foundation Graduate Research Fellowship [12-A0-00-000165-01]; NIH [R01GM078341, R01GM098492]; ERC [340941]; NIH National Center for Research Resources (NCRR); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078341, R01GM098492] Funding Source: NIH RePORTER	Netherlands Organization for Scientific Research (NWO) ALW Innovational Research Incentives Scheme Vidi grant(Netherlands Organization for Scientific Research (NWO)); NWO-CW ECHO grant; National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ERC(European Research Council (ERC)European Commission); NIH National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Zerial for providing the MZE1 strain, C. Bargmann for providing strain CX9797 and a strain carrying the Pdes-2::myristoyl::GFP extrachromosomal array, and M. Harterink for strain STR62. We thank S. de Rouck for technical assistance, and M. Vidal for permission to reanalyse MAPPIT data. We thank F. Zwartkruis, M. Gloerich and A. Thomas for critically reading the manuscript. Some nematode strains used in this work were provided by the Caenorhabditis Genetics Center, which is funded by the NIH National Center for Research Resources (NCRR). This work was supported by the Netherlands Organization for Scientific Research (NWO) ALW Innovational Research Incentives Scheme Vidi grant 864.09.008 to M.B., NWO-CW ECHO grant 711.014.005 to M.B., National Science Foundation Graduate Research Fellowship 12-A0-00-000165-01 to D.K., and NIH grants R01GM078341 and R01GM098492 to J.N. J.T. is the recipient of ERC Advanced Grant 340941.	Anderson DC, 2008, SCIENCE, V320, P1771, DOI 10.1126/science.1156063; [Anonymous], 2014, LANG ENV STAT COMP; Armenti ST, 2014, DEV BIOL, V394, P110, DOI 10.1016/j.ydbio.2014.07.019; Balklava Z, 2007, NAT CELL BIOL, V9, P1066, DOI 10.1038/ncb1627; Beatty A, 2010, DEVELOPMENT, V137, P3995, DOI 10.1242/dev.056028; Bei YX, 2002, DEV CELL, V3, P113, DOI 10.1016/S1534-5807(02)00185-5; Berkowitz LA, 2000, DEVELOPMENT, V127, P4419; Bilder D, 2000, NATURE, V403, P676, DOI 10.1038/35001108; Boulton SJ, 2002, SCIENCE, V295, P127, DOI 10.1126/science.1065986; Boxem M, 2008, CELL, V134, P534, DOI 10.1016/j.cell.2008.07.009; Braun P, 2009, NAT METHODS, V6, P91, DOI [10.1038/NMETH.1281, 10.1038/nmeth.1281]; BRENNER S, 1974, GENETICS, V77, P71; Chan E, 2013, J CELL SCI, V126, P1692, DOI 10.1242/jcs.124594; CHEVRAY PM, 1992, P NATL ACAD SCI USA, V89, P5789, DOI 10.1073/pnas.89.13.5789; Cho A, 2014, NUCLEIC ACIDS RES, V42, pW76, DOI 10.1093/nar/gku367; Cuppen E, 2003, COMP FUNCT GENOM, V4, P479, DOI 10.1002/cfg.318; D'Agostino I, 2006, DEV BIOL, V292, P244, DOI 10.1016/j.ydbio.2005.11.046; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Eyckerman S, 2001, NAT CELL BIOL, V3, P1114, DOI 10.1038/ncb1201-1114; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Gobel V, 2004, DEV CELL, V6, P865, DOI 10.1016/j.devcel.2004.05.018; Goehring NW, 2013, TRENDS CELL BIOL, V23, P72, DOI 10.1016/j.tcb.2012.10.009; Gottfried I, 2010, BIOCHEM SOC T, V38, P187, DOI 10.1042/BST0380187; Grant B, 1999, MOL BIOL CELL, V10, P4311, DOI 10.1091/mbc.10.12.4311; Gunsalus KC, 2005, NATURE, V436, P861, DOI 10.1038/nature03876; Hibbs MA, 2007, BIOINFORMATICS, V23, P2692, DOI 10.1093/bioinformatics/btm403; Hoege C, 2010, CURR BIOL, V20, P1296, DOI 10.1016/j.cub.2010.05.061; Hoffmann M, 2010, DEV BIOL, V339, P268, DOI 10.1016/j.ydbio.2009.12.002; Honnen SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032183; Humbert PO, 2008, ONCOGENE, V27, P6888, DOI 10.1038/onc.2008.341; JACOB L, 1987, CELL, V50, P215, DOI 10.1016/0092-8674(87)90217-0; Khan LA, 2013, NAT CELL BIOL, V15, P143, DOI 10.1038/ncb2656; Lamesch P, 2004, GENOME RES, V14, P2064, DOI 10.1101/gr.2496804; Lemmens I, 2015, METHODS MOL BIOL, V1278, P447, DOI 10.1007/978-1-4939-2425-7_29; Li HZ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0057809, 10.1371/journal.pone.0066745]; Lin YC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5767; Liu J, 2008, DEV CELL, V14, P751, DOI 10.1016/j.devcel.2008.02.015; Maniar TA, 2012, NAT NEUROSCI, V15, P48, DOI 10.1038/nn.2970; Orchard S, 2014, NUCLEIC ACIDS RES, V42, pD358, DOI 10.1093/nar/gkt1115; Parker JA, 2007, J NEUROSCI, V27, P11056, DOI 10.1523/JNEUROSCI.1941-07.2007; Phillips BT, 2007, P NATL ACAD SCI USA, V104, P3231, DOI 10.1073/pnas.0611507104; Praitis Vida, 2006, V351, P93; Rodriguez-Boulan E, 2014, NAT REV MOL CELL BIO, V15, P225, DOI 10.1038/nrm3775; Rolland T, 2014, CELL, V159, P1212, DOI 10.1016/j.cell.2014.10.050; Sanchez-Alvarez L, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002257; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; Schonegg S, 2006, DEVELOPMENT, V133, P3507, DOI 10.1242/dev.02527; Simonis N, 2009, NAT METHODS, V6, P47, DOI 10.1038/NMETH.1279; St Johnston D, 2010, CELL, V141, P757, DOI 10.1016/j.cell.2010.05.011; Stetak A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006019; Tepass U, 2012, ANNU REV CELL DEV BI, V28, P655, DOI 10.1146/annurev-cellbio-092910-154033; Tu ZD, 2009, GENOME RES, V19, P1057, DOI 10.1101/gr.087890.108; Vidal M, 1996, P NATL ACAD SCI USA, V93, P10315, DOI 10.1073/pnas.93.19.10315; Vidalain PO, 2004, METHODS, V32, P363, DOI 10.1016/j.ymeth.2003.10.001; Waaijers S, 2013, J PROTEOME RES, V12, P3181, DOI 10.1021/pr400047p; Walhout AJM, 1999, GENOME RES, V9, P1128, DOI 10.1101/gr.9.11.1128; Wang L, 2009, BMC GENOMICS, V10, DOI [10.1186/1471-2164-10-220, 10.1186/1471-2164-10-S1-S1]; Wildwater M, 2011, DEVELOPMENT, V138, P4375, DOI 10.1242/dev.066431; Winter JF, 2012, NAT CELL BIOL, V14, P666, DOI 10.1038/ncb2508; WOODS DF, 1991, CELL, V66, P451, DOI 10.1016/0092-8674(81)90009-X; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684	61	13	13	0	21	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2016	18	3					337	+		10.1038/ncb3300	http://dx.doi.org/10.1038/ncb3300			26	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	DF0LT	26780296	Green Accepted			2022-12-25	WOS:000371031300015
J	Tang, QZ; Desai, TA				Tang, Qizhi; Desai, Tejal A.			Approaching a cure for type 1 diabetes	NATURE MEDICINE			English	Editorial Material							BETA-CELLS	A study has demonstrated that transplanting human embryonic stem cell derived, insulin-producing cells shielded in capsules made with an optimized biomaterial can achieve long-term cure of diabetes in mice without the need for any immunosuppression.	[Tang, Qizhi] Univ Calif San Francisco, Dept Surg, San Francisco, CA USA; [Desai, Tejal A.] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Tang, QZ (corresponding author), Univ Calif San Francisco, Dept Surg, San Francisco, CA USA.	Qizhi.Tang@ucsf.edu	Desai, Tejal/AAN-7626-2021	Tang, Qizhi/0000-0001-7313-3574	NIBIB NIH HHS [R21 EB000570] Funding Source: Medline	NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))		Bratlie KM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010032; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; Jacobs-Tulleneers-Thevissen D, 2013, DIABETOLOGIA, V56, P1605, DOI 10.1007/s00125-013-2906-0; Khosravi-Maharlooei M, 2015, EUR J ENDOCRINOL, V173, pR165, DOI 10.1530/EJE-15-0094; Naujok O, 2011, MOL THER, V19, P1759, DOI 10.1038/mt.2011.165; Pagliuca FW, 2014, CELL, V159, P428, DOI 10.1016/j.cell.2014.09.040; Rezania A, 2014, NAT BIOTECHNOL, V32, P1121, DOI 10.1038/nbt.3033; Russ HA, 2015, EMBO J, V34, P1759, DOI 10.15252/embj.201591058; Scharp DW, 2014, ADV DRUG DELIVER REV, V67-68, P35, DOI 10.1016/j.addr.2013.07.018; Trojer MA, 2013, J CHEM-NY, V2013, DOI 10.1155/2013/946739; Vegas A.J., 2016, NAT BIOTECHNOL, V34, P306; Vegas AJ, 2016, NAT MED, V22, P306, DOI 10.1038/nm.4030	12	4	5	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2016	22	3					236	237		10.1038/nm.4060	http://dx.doi.org/10.1038/nm.4060			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DF6DC	26937617				2022-12-25	WOS:000371445100009
J	Zheng, GXY; Lau, BT; Schnall-Levin, M; Jarosz, M; Bell, JM; Hindson, CM; Kyriazopoulou-Panagiotopoulou, S; Masquelier, DA; Merrill, L; Terry, JM; Mudivarti, PA; Wyatt, PW; Bharadwaj, R; Makarewicz, AJ; Li, Y; Belgrader, P; Price, AD; Lowe, AJ; Marks, P; Vurens, GM; Hardenbol, P; Montesclaros, L; Luo, M; Greenfield, L; Wong, A; Birch, DE; Short, SW; Bjornson, KP; Patel, P; Hopmans, ES; Wood, C; Kaur, S; Lockwood, GK; Stafford, D; Delaney, JP; Wu, I; Ordonez, HS; Grimes, SM; Greer, S; Lee, JY; Belhocine, K; Giorda, KM; Heaton, WH; McDermott, GP; Bent, ZW; Meschi, F; Kondov, NO; Wilson, R; Bernate, JA; Gauby, S; Kindwall, A; Bermejo, C; Fehr, AN; Chan, A; Saxonov, S; Ness, KD; Hindson, BJ; Ji, HP				Zheng, Grace X. Y.; Lau, Billy T.; Schnall-Levin, Michael; Jarosz, Mirna; Bell, John M.; Hindson, Christopher M.; Kyriazopoulou-Panagiotopoulou, Sofia; Masquelier, Donald A.; Merrill, Landon; Terry, Jessica M.; Mudivarti, Patrice A.; Wyatt, Paul W.; Bharadwaj, Rajiv; Makarewicz, Anthony J.; Li, Yuan; Belgrader, Phillip; Price, Andrew D.; Lowe, Adam J.; Marks, Patrick; Vurens, Gerard M.; Hardenbol, Paul; Montesclaros, Luz; Luo, Melissa; Greenfield, Lawrence; Wong, Alexander; Birch, David E.; Short, Steven W.; Bjornson, Keith P.; Patel, Pranav; Hopmans, Erik S.; Wood, Christina; Kaur, Sukhvinder; Lockwood, Glenn K.; Stafford, David; Delaney, Joshua P.; Wu, Indira; Ordonez, Heather S.; Grimes, Susan M.; Greer, Stephanie; Lee, Josephine Y.; Belhocine, Kamila; Giorda, Kristina M.; Heaton, William H.; McDermott, Geoffrey P.; Bent, Zachary W.; Meschi, Francesca; Kondov, Nikola O.; Wilson, Ryan; Bernate, Jorge A.; Gauby, Shawn; Kindwall, Alex; Bermejo, Clara; Fehr, Adrian N.; Chan, Adrian; Saxonov, Serge; Ness, Kevin D.; Hindson, Benjamin J.; Ji, Hanlee P.			Haplotyping germline and cancer genomes with high-throughput linked-read sequencing	NATURE BIOTECHNOLOGY			English	Article							EML4-ALK FUSION GENE; CELL LUNG-CANCER; STRUCTURAL VARIATION; PROXIMITY-LIGATION; IDENTIFICATION; FRAMEWORK; VARIANT; DISCOVERY; ALIGNMENT; MODEL	Haplotyping of human chromosomes is a prerequisite for cataloguing the full repertoire of genetic variation. We present a microfluidics-based, linked-read sequencing technology that can phase and haplotype germline and cancer genomes using nanograms of input DNA. This high-throughput platform prepares barcoded libraries for short-read sequencing and computationally reconstructs long-range haplotype and structural variant information. We generate haplotype blocks in a nuclear trio that are concordant with expected inheritance patterns and phase a set of structural variants. We also resolve the structure of the EML4-ALK gene fusion in the NCI-H2228 cancer cell line using phased exome sequencing. Finally, we assign genetic aberrations to specific megabase-scale haplotypes generated from whole-genome sequencing of a primary colorectal adenocarcinoma. This approach resolves haplotype information using up to 100 times less genomic DNA than some methods and enables the accurate detection of structural variants.	[Zheng, Grace X. Y.; Schnall-Levin, Michael; Jarosz, Mirna; Hindson, Christopher M.; Kyriazopoulou-Panagiotopoulou, Sofia; Masquelier, Donald A.; Merrill, Landon; Terry, Jessica M.; Mudivarti, Patrice A.; Wyatt, Paul W.; Bharadwaj, Rajiv; Makarewicz, Anthony J.; Li, Yuan; Belgrader, Phillip; Price, Andrew D.; Lowe, Adam J.; Marks, Patrick; Vurens, Gerard M.; Hardenbol, Paul; Montesclaros, Luz; Luo, Melissa; Greenfield, Lawrence; Wong, Alexander; Birch, David E.; Short, Steven W.; Bjornson, Keith P.; Patel, Pranav; Kaur, Sukhvinder; Lockwood, Glenn K.; Stafford, David; Delaney, Joshua P.; Wu, Indira; Ordonez, Heather S.; Lee, Josephine Y.; Belhocine, Kamila; Giorda, Kristina M.; Heaton, William H.; McDermott, Geoffrey P.; Bent, Zachary W.; Meschi, Francesca; Kondov, Nikola O.; Wilson, Ryan; Bernate, Jorge A.; Gauby, Shawn; Kindwall, Alex; Bermejo, Clara; Fehr, Adrian N.; Chan, Adrian; Saxonov, Serge; Ness, Kevin D.; Hindson, Benjamin J.] 10X Genom, Pleasanton, CA USA; [Lau, Billy T.; Bell, John M.; Hopmans, Erik S.; Grimes, Susan M.; Ji, Hanlee P.] Stanford Univ, Stanford Genome Technol Ctr, Palo Alto, CA 94304 USA; [Wood, Christina; Greer, Stephanie; Ji, Hanlee P.] Stanford Univ, Dept Med, Sch Med, Div Oncol, Stanford, CA 94305 USA	Stanford University; Stanford University	Hindson, BJ (corresponding author), 10X Genom, Pleasanton, CA USA.; Ji, HP (corresponding author), Stanford Univ, Stanford Genome Technol Ctr, Palo Alto, CA 94304 USA.; Ji, HP (corresponding author), Stanford Univ, Dept Med, Sch Med, Div Oncol, Stanford, CA 94305 USA.	ben@10xgenomics.com; genomics_ji@stanford.edu	Greenfield, Lawrence/K-2292-2019; Wong, Alexander/GZM-2929-2022; Lockwood, Glenn/N-7078-2013	Wong, Alexander/0000-0002-5295-2797; Marks, Patrick/0000-0002-3231-7163; Heaton, Haynes/0000-0002-9649-525X; Lockwood, Glenn/0000-0002-9241-9372	US National Institutes of Health [NHGRI P01HG000205, NCI R33CA174575, NHGRI R01HG006137]; American Cancer Society [RSG-13-297-01-TBG]; Doris Duke Clinical Foundation; Clayville Foundation; Seiler Foundation; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [U01CA151920, R33CA174575] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P01HG000205, R01HG006137] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Doris Duke Clinical Foundation(Doris Duke Charitable Foundation (DDCF)); Clayville Foundation; Seiler Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by US National Institutes of Health grants NHGRI P01HG000205 (to B.T.L., E.S.H., S.M.G., J.M.B. and H.P.J.), NCI R33CA174575 (to J.M.B., S. Greer and H.P.J.) and NHGRI R01HG006137 (to H.P.J.). The American Cancer Society provided additional support to S. Greer and H.P.J. (Research Scholar grant, RSG-13-297-01-TBG). H.P.J. also received support from the Doris Duke Clinical Foundation, the Clayville Foundation, the Seiler Foundation and the Howard Hughes Medical Institute.	Abate AR, 2009, LAB CHIP, V9, P2628, DOI 10.1039/b909386a; Adey A, 2013, NATURE, V500, P207, DOI 10.1038/nature12064; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Amini S, 2014, NAT GENET, V46, P1343, DOI 10.1038/ng.3119; Borgstrom E, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8173; Chen K, 2009, NAT METHODS, V6, P677, DOI [10.1038/NMETH.1363, 10.1038/nmeth.1363]; Choi YL, 2008, CANCER RES, V68, P4971, DOI 10.1158/0008-5472.CAN-07-6158; Cleary JG, 2014, J COMPUT BIOL, V21, P405, DOI 10.1089/cmb.2014.0029; de Vree PJP, 2014, NAT BIOTECHNOL, V32, P1019, DOI 10.1038/nbt.2959; Duitama J, 2012, NUCLEIC ACIDS RES, V40, P2041, DOI 10.1093/nar/gkr1042; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Frampton GM, 2013, NAT BIOTECHNOL, V31, P1023, DOI 10.1038/nbt.2696; Hopmans ES, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku282; Jung Y, 2012, GENE CHROMOSOME CANC, V51, P590, DOI 10.1002/gcc.21945; Kaper F, 2013, P NATL ACAD SCI USA, V110, P5552, DOI 10.1073/pnas.1218696110; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Kitzman JO, 2011, NAT BIOTECHNOL, V29, P59, DOI 10.1038/nbt.1740; Klein AM, 2015, CELL, V161, P1187, DOI 10.1016/j.cell.2015.04.044; Koivunen JP, 2008, CLIN CANCER RES, V14, P4275, DOI 10.1158/1078-0432.CCR-08-0168; Kuleshov V, 2014, NAT BIOTECHNOL, V32, P261, DOI 10.1038/nbt.2833; Layer RM, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-6-r84; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Lipson D, 2012, NAT MED, V18, P382, DOI 10.1038/nm.2673; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mills RE, 2011, NATURE, V470, P59, DOI 10.1038/nature09708; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Myllykangas S, 2011, NAT BIOTECHNOL, V29, P1024, DOI 10.1038/nbt.1996; Pendleton M, 2015, NAT METHODS, V12, P780, DOI [10.1038/NMETH.3454, 10.1038/nmeth.3454]; Peters BA, 2012, NATURE, V487, P190, DOI 10.1038/nature11236; Regan JF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118270; Roach JC, 2011, AM J HUM GENET, V89, P382, DOI 10.1016/j.ajhg.2011.07.023; Schrider DR, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003242; Selvaraj S, 2013, NAT BIOTECHNOL, V31, P1111, DOI 10.1038/nbt.2728; Shen JJ, 2012, ANN APPL STAT, V6, P476, DOI 10.1214/11-AOAS517; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Suk EK, 2011, GENOME RES, V21, P1672, DOI 10.1101/gr.125047.111; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901	40	366	459	2	98	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2016	34	3					303	+		10.1038/nbt.3432	http://dx.doi.org/10.1038/nbt.3432			11	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DG1CJ	26829319	Green Accepted			2022-12-25	WOS:000371802600027
J	Cadwell, CR; Palasantza, A; Jiang, XL; Berens, P; Deng, QL; Yilmaz, M; Reimer, J; Shen, S; Bethge, M; Tolias, KF; Sandberg, R; Tolias, AS				Cadwell, Cathryn R.; Palasantza, Athanasia; Jiang, Xiaolong; Berens, Philipp; Deng, Qiaolin; Yilmaz, Marlene; Reimer, Jacob; Shen, Shan; Bethge, Matthias; Tolias, Kimberley F.; Sandberg, Rickard; Tolias, Andreas S.			Electrophysiological, transcriptomic and morphologic profiling of single neurons using Patch-seq	NATURE BIOTECHNOLOGY			English	Article							CELL RNA-SEQ; CLAMP ANALYSIS; CORTICAL INTERNEURONS; EXCITATORY SYNAPSE; CEREBRAL-CORTEX; RT-PCR; EXPRESSION; MOUSE; SMART-SEQ2; DIVERSITY	Despite the importance of the mammalian neocortex for complex cognitive processes, we still lack a comprehensive description of its cellular components. To improve the classification of neuronal cell types and the functional characterization of single neurons, we present Patch-seq, a method that combines whole-cell electrophysiological patch-clamp recordings, single-cell RNA-sequencing and morphological characterization. Following electrophysiological characterization, cell contents are aspirated through the patch-clamp pipette and prepared for RNA-sequencing. Using this approach, we generate electrophysiological and molecular profiles of 58 neocortical cells and show that gene expression patterns can be used to infer the morphological and physiological properties such as axonal arborization and action potential amplitude of individual neurons. Our results shed light on the molecular underpinnings of neuronal diversity and suggest that Patch-seq can facilitate the classification of cell types in the nervous system.	[Cadwell, Cathryn R.; Jiang, Xiaolong; Berens, Philipp; Reimer, Jacob; Shen, Shan; Tolias, Kimberley F.; Tolias, Andreas S.] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Palasantza, Athanasia; Deng, Qiaolin; Yilmaz, Marlene; Sandberg, Rickard] Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden; [Palasantza, Athanasia; Deng, Qiaolin; Yilmaz, Marlene; Sandberg, Rickard] Ludwig Inst Canc Res, S-10401 Stockholm, Sweden; [Berens, Philipp; Bethge, Matthias; Tolias, Andreas S.] Bernstein Ctr Computat Neurosci, Tubingen, Germany; [Berens, Philipp] Univ Tubingen, Inst Ophthalm Res, Tubingen, Germany; [Berens, Philipp; Bethge, Matthias] Univ Tubingen, Werner Reichardt Ctr Integrat Neurosci, Tubingen, Germany; [Berens, Philipp; Bethge, Matthias] Univ Tubingen, Inst Theoret Phys, Tubingen, Germany; [Bethge, Matthias] Max Planck Inst Biol Cybernet, Spemannstr 38, D-72076 Tubingen, Germany; [Tolias, Kimberley F.] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA	Baylor College of Medicine; Karolinska Institutet; Ludwig Institute for Cancer Research; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Max Planck Society; Baylor College of Medicine	Tolias, AS (corresponding author), Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA.; Sandberg, R (corresponding author), Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden.; Sandberg, R (corresponding author), Ludwig Inst Canc Res, S-10401 Stockholm, Sweden.; Tolias, AS (corresponding author), Bernstein Ctr Computat Neurosci, Tubingen, Germany.	rickard.sandberg@ki.se; astolias@bcm.edu	Deng, Qiaolin/AAD-6905-2020; Berens, Philipp/A-5653-2009; Cadwell, Cathryn/AAD-7800-2022	Berens, Philipp/0000-0002-0199-4727; Deng, Qiaolin/0000-0001-5934-7816; Cadwell, Cathryn/0000-0003-1963-8285; Shen, Shan/0000-0002-9621-0314; Sandberg, Rickard/0000-0001-6473-1740; Tolias, Kimberley/0000-0002-2092-920X	Swedish Research Council; Swedish Foundation for Strategic Research [FFL4]; McKnight Scholar Award; Arnold and Mabel Beckman Foundation Young Investigator Award; Deutsche Forschungsgemeinschaft (DFG) [EXC 307]; German Federal Ministry of Education and Research (BMBF; BCCN Tubingen) [FKZ 01GQ1002];  [DP1EY023176];  [P30EY002520];  [T32EY07001];  [DP1OD008301];  [R01MH103108];  [F30MH095440];  [T32GM007330];  [T32EB006350];  [R01NS062829]; NATIONAL EYE INSTITUTE [T32EY007001, P30EY002520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB006350] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F30MH095440, R01MH103108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS062829] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD008301] Funding Source: NIH RePORTER	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); McKnight Scholar Award; Arnold and Mabel Beckman Foundation Young Investigator Award; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); German Federal Ministry of Education and Research (BMBF; BCCN Tubingen)(Federal Ministry of Education & Research (BMBF)); ; ; ; ; ; ; ; ; ; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank A. Morgan for technical assistance. This study was supported by grants DP1EY023176, P30EY002520, T32EY07001, and DP1OD008301 to A.S.T.; grants from the Swedish Research Council and the Swedish Foundation for Strategic Research (FFL4) to R.S.; grant R01MH103108 to A.S.T. and K.F.T.; grant R01NS062829 to K.F.T.; the McKnight Scholar Award to A.S.T.; and the Arnold and Mabel Beckman Foundation Young Investigator Award to A.S.T. C.R.C. was supported by grants F30MH095440, T32GM007330 and T32EB006350. M.B. and P.B. were supported by the Deutsche Forschungsgemeinschaft (DFG, EXC 307) and the German Federal Ministry of Education and Research (BMBF; BCCN Tubingen, FKZ 01GQ1002).	Alcantara S, 1998, J NEUROSCI, V18, P7779; Ascoli GA, 2008, NAT REV NEUROSCI, V9, P557, DOI 10.1038/nrn2402; BIGNAMI A, 1972, BRAIN RES, V43, P429, DOI 10.1016/0006-8993(72)90398-8; Brennecke P, 2013, NAT METHODS, V10, P1093, DOI [10.1038/NMETH.2645, 10.1038/nmeth.2645]; Brose N, 2008, TRAFFIC, V9, P1403, DOI 10.1111/j.1600-0854.2008.00758.x; Burkhalter A, 2008, FRONT NEUROSCI-SWITZ, V2, P155, DOI 10.3389/neuro.01.026.2008; Chan CH, 2001, CEREB CORTEX, V11, P1191, DOI 10.1093/cercor/11.12.1191; Chao HT, 2010, NATURE, V468, P263, DOI 10.1038/nature09582; Clopper CJ, 1934, BIOMETRIKA, V26, P404, DOI 10.2307/2331986; CONNORS BW, 1990, TRENDS NEUROSCI, V13, P99, DOI 10.1016/0166-2236(90)90185-D; Darmanis S, 2015, P NATL ACAD SCI USA, V112, P7285, DOI 10.1073/pnas.1507125112; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Fishell G, 2013, NEURON, V80, P602, DOI 10.1016/j.neuron.2013.10.035; Fremeau RT, 2001, NEURON, V31, P247, DOI 10.1016/S0896-6273(01)00344-0; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Jaitin DA, 2014, SCIENCE, V343, P776, DOI 10.1126/science.1247651; Jiang XL, 2015, SCIENCE, V350, DOI 10.1126/science.aac9462; Jiang XL, 2013, NAT NEUROSCI, V16, P210, DOI 10.1038/nn.3305; Kalashnikova E, 2010, NEURON, V65, P80, DOI 10.1016/j.neuron.2009.12.021; Kharchenko PV, 2014, NAT METHODS, V11, P740, DOI [10.1038/NMETH.2967, 10.1038/nmeth.2967]; Lin L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3270; Ma J, 2014, CEREB CORTEX, V24, P2604, DOI 10.1093/cercor/bht114; Macintyre G, 2010, SCHIZOPHR RES, V120, P143, DOI 10.1016/j.schres.2010.04.002; MARSHAK DR, 1990, PROG BRAIN RES, V86, P169; McGinley MJ, 2015, NEURON, V87, P1143, DOI 10.1016/j.neuron.2015.09.012; Miyoshi G, 2010, J NEUROSCI, V30, P1582, DOI 10.1523/JNEUROSCI.4515-09.2010; NEHER E, 1976, NATURE, V260, P799, DOI 10.1038/260799a0; Olah S, 2009, NATURE, V461, P1278, DOI 10.1038/nature08503; Picelli S, 2014, GENOME RES, V24, P2033, DOI 10.1101/gr.177881.114; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Picelli S, 2013, NAT METHODS, V10, P1096, DOI [10.1038/NMETH.2639, 10.1038/nmeth.2639]; Qiu Shenfeng, 2012, Frontiers in Genetics, V3, P124, DOI 10.3389/fgene.2012.00124; Ramon y Cajal S., 2002, TEXTURE NERVOUS SYST; Ramskold D, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000598; Sandberg R, 2014, NAT METHODS, V11, P22, DOI 10.1038/nmeth.2764; Stanco A, 2014, NEURON, V84, P940, DOI 10.1016/j.neuron.2014.10.040; Stuhmer T, 2002, DEVELOPMENT, V129, P245; Subkhankulova T, 2010, FRONT MOL NEUROSCI, V3, DOI 10.3389/fnmol.2010.00010; SUCHER NJ, 1995, NEURON, V14, P1095, DOI 10.1016/0896-6273(95)90257-0; Sucher NJ, 2000, CELL TISSUE RES, V302, P295, DOI 10.1007/s004410000289; Tang FC, 2009, NAT METHODS, V6, P377, DOI [10.1038/NMETH.1315, 10.1038/nmeth.1315]; Ting JT, 2014, METHODS MOL BIOL, V1183, P221, DOI 10.1007/978-1-4939-1096-0_14; Toledo-Rodriguez M, 2014, METHODS MOL BIOL, V1183, P143, DOI 10.1007/978-1-4939-1096-0_8; Zeisel A, 2015, SCIENCE, V347, P1138, DOI 10.1126/science.aaa1934	44	268	269	2	83	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2016	34	2					199	+		10.1038/nbt.3445	http://dx.doi.org/10.1038/nbt.3445			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DD0OK	26689543	Green Accepted			2022-12-25	WOS:000369619100023
J	Kessel, M; Masella, R				Kessel, Mark; Masella, Robert			Preparing for crises	NATURE BIOTECHNOLOGY			English	Editorial Material									[Kessel, Mark; Masella, Robert] Shearman & Sterling LLP, New York, NY USA		Kessel, M (corresponding author), Shearman & Sterling LLP, New York, NY USA.	mark.kessel@shearman.com							0	0	0	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2016	34	2					133	136		10.1038/nbt.3475	http://dx.doi.org/10.1038/nbt.3475			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DD0OK	26849512	Bronze			2022-12-25	WOS:000369619100009
J	Nomakuchi, TT; Rigo, F; Aznarez, I; Krainer, AR				Nomakuchi, Tomoki T.; Rigo, Frank; Aznarez, Isabel; Krainer, Adrian R.			Antisense oligonucleotide-directed inhibition of nonsense-mediated mRNA decay	NATURE BIOTECHNOLOGY			English	Article							STOP CODON READTHROUGH; EXON JUNCTION COMPLEX; MUTATIONS; THERAPEUTICS; NUCLEAR; GENE	Nonsense-mediated mRNA decay (NMD) is a cellular quality-control mechanism that is thought to exacerbate the phenotype of certain pathogenic nonsense mutations by preventing the expression of semi-functional proteins. NMD also limits the efficacy of read-through compound (RTC)-based therapies. Here, we report a gene-specific method of NMD inhibition using antisense oligonucleotides (ASOs) and combine this approach with an RTC to effectively restore the expression of full-length protein from a nonsense-mutant allele.	[Nomakuchi, Tomoki T.; Aznarez, Isabel; Krainer, Adrian R.] Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA; [Nomakuchi, Tomoki T.] SUNY Stony Brook, Sch Med, Stony Brook, NY 11794 USA; [Rigo, Frank] ISIS Pharmaceut, Carslbad, CA USA	Cold Spring Harbor Laboratory; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Isis Pharmaceuticals Inc	Aznarez, I; Krainer, AR (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	aznarez@cshl.edu; krainer@cshl.edu		Nomakuchi, Tomoki/0000-0001-7300-9311; Krainer, Adrian/0000-0001-9024-9501	US National Institutes of Health (NIH) [R21-NS081448, R37-GM042699]; University of Pennsylvania's Center for Orphan Disease Research and Therapy; NIH [T32GM008444, F31NS087747]; Cancer Center Support Grant [5P30CA045508]; NATIONAL CANCER INSTITUTE [P30CA045508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008444, R37GM042699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS081448, F31NS087747] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Pennsylvania's Center for Orphan Disease Research and Therapy; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank F. Bennett for helpful discussions. This work was supported by US National Institutes of Health (NIH) grants R21-NS081448 and R37-GM042699 and by a research grant from the University of Pennsylvania's Center for Orphan Disease Research and Therapy to A.R.K. T.T.N. was supported by NIH grants T32GM008444 and F31NS087747. We acknowledge assistance from Cold Spring Harbor Laboratory Shared Resources, funded in part by Cancer Center Support Grant 5P30CA045508.	Baker BF, 1997, J BIOL CHEM, V272, P11994, DOI 10.1074/jbc.272.18.11994; Bhuvanagiri M, 2014, EMBO MOL MED, V6, P1593, DOI 10.15252/emmm.201404461; Gardner LB, 2010, MOL CANCER RES, V8, P295, DOI 10.1158/1541-7786.MCR-09-0502; Giorgi C, 2007, SEMIN CELL DEV BIOL, V18, P186, DOI 10.1016/j.semcdb.2007.01.002; Goldmann T, 2012, EMBO MOL MED, V4, P1186, DOI 10.1002/emmm.201201438; Hossain M, 2012, GENE DEV, V26, P1797, DOI 10.1101/gad.197178.112; Jeong JY, 2012, APPL ENVIRON MICROB, V78, P5440, DOI 10.1128/AEM.00844-12; Jolly LA, 2013, HUM MOL GENET, V22, P4673, DOI 10.1093/hmg/ddt315; Karam R, 2012, RNA BIOL, V9, P22, DOI 10.4161/rna.9.1.18010; Keeling KM, 2014, ANNU REV GENOM HUM G, V15, P371, DOI 10.1146/annurev-genom-091212-153527; Keeling KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060478; Keeling KM, 2011, WIRES RNA, V2, P837, DOI 10.1002/wrna.95; Kole R, 2012, NAT REV DRUG DISCOV, V11, P125, DOI 10.1038/nrd3625; Loughran G, 2014, NUCLEIC ACIDS RES, V42, P8928, DOI 10.1093/nar/gku608; Martin L, 2014, CANCER RES, V74, P3104, DOI 10.1158/0008-5472.CAN-13-2235; Mayeda A, 1999, METH MOL B, V118, P315; Mayeda A, 1999, METH MOL B, V118, P309; Ni JZ, 2007, GENE DEV, V21, P708, DOI 10.1101/gad.1525507; Pan Q, 2006, GENE DEV, V20, P153, DOI 10.1101/gad.1382806; Popp MWL, 2013, ANNU REV GENET, V47, P139, DOI 10.1146/annurev-genet-111212-133424; Rigo F, 2012, J CELL BIOL, V199, P21, DOI 10.1083/jcb.201207087; Shibuya T, 2004, NAT STRUCT MOL BIOL, V11, P346, DOI 10.1038/nsmb750; Trcek T, 2013, GENE DEV, V27, P541, DOI 10.1101/gad.209635.112; TRECARTIN RF, 1981, J CLIN INVEST, V68, P1012, DOI 10.1172/JCI110323; Winkler J, 2010, CHEMMEDCHEM, V5, P1344, DOI 10.1002/cmdc.201000156; Zhang Z, 2007, P NATL ACAD SCI USA, V104, P11574, DOI 10.1073/pnas.0704946104; Zheng W, 2008, GENETICS, V180, P1391, DOI 10.1534/genetics.108.095737	27	49	56	1	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2016	34	2					164	+		10.1038/nbt.3427	http://dx.doi.org/10.1038/nbt.3427			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DD0OK	26655495	Green Accepted			2022-12-25	WOS:000369619100018
J	Rajagopal, N; Srinivasan, S; Kooshesh, K; Guo, YC; Edwards, MD; Banerjee, B; Syed, T; Emons, BJM; Gifford, DK; Sherwood, RI				Rajagopal, Nisha; Srinivasan, Sharanya; Kooshesh, Kameron; Guo, Yuchun; Edwards, Matthew D.; Banerjee, Budhaditya; Syed, Tahin; Emons, Bart J. M.; Gifford, David K.; Sherwood, Richard I.			High-throughput mapping of regulatory DNA	NATURE BIOTECHNOLOGY			English	Article							ENHANCERS; DISSECTION; DOMAINS; GENES	Quantifying the effects of cis-regulatory DNA on gene expression is a major challenge. Here, we present the multiplexed editing regulatory assay (MERA), a high-throughput CRISPR-Cas9-based approach that analyzes the functional impact of the regulatory genome in its native context. MERA tiles thousands of mutations across similar to 40 kb of cis-regulatory genomic space and uses knock- in green fluorescent protein (GFP) reporters to read out gene activity. Using this approach, we obtain quantitative information on the contribution of cis-regulatory regions to gene expression. We identify proximal and distal regulatory elements necessary for expression of four embryonic stem cell-specific genes. We show a consistent contribution of neighboring gene promoters to gene expression and identify unmarked regulatory elements (UREs) that control gene expression but do not have typical enhancer epigenetic or chromatin features. We compare thousands of functional and nonfunctional genotypes at a genomic location and identify the base pair-resolution functional motifs of regulatory elements.	[Rajagopal, Nisha; Srinivasan, Sharanya; Guo, Yuchun; Edwards, Matthew D.; Syed, Tahin; Gifford, David K.] MIT, Comp Sci & Artificial Intelligence Lab, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Srinivasan, Sharanya; Kooshesh, Kameron; Banerjee, Budhaditya; Emons, Bart J. M.; Sherwood, Richard I.] Brigham & Womens Hosp, Dept Med, Div Genet, 75 Francis St, Boston, MA 02115 USA; [Srinivasan, Sharanya; Kooshesh, Kameron; Banerjee, Budhaditya; Emons, Bart J. M.; Sherwood, Richard I.] Harvard Univ, Sch Med, Boston, MA USA; [Kooshesh, Kameron] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Emons, Bart J. M.] Univ Utrecht, Program Canc Stem Cells & Dev Biol, Utrecht, Netherlands	Massachusetts Institute of Technology (MIT); Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Utrecht University	Gifford, DK (corresponding author), MIT, Comp Sci & Artificial Intelligence Lab, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Sherwood, RI (corresponding author), Brigham & Womens Hosp, Dept Med, Div Genet, 75 Francis St, Boston, MA 02115 USA.; Sherwood, RI (corresponding author), Harvard Univ, Sch Med, Boston, MA USA.	gifford@mit.edu; rsherwood@partners.org	Guo, Yuchun/A-4805-2011; Young, Richard A/F-6495-2012; Guo, Yuchun/Q-8587-2019	Guo, Yuchun/0000-0003-2357-1546; Young, Richard A/0000-0001-8855-8647; Guo, Yuchun/0000-0003-2357-1546	US National Institutes of Health [1U01HG007037, 1K01DK101684-01]; Harvard Stem Cell Institute's Sternlicht Director's Fund award; Brigham and Women's Hospital BRI Innovation Fund; Human Frontier Science Program; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG008754, U01HG007037, R01HG008363] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK101684] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Stem Cell Institute's Sternlicht Director's Fund award; Brigham and Women's Hospital BRI Innovation Fund; Human Frontier Science Program(Human Frontier Science Program); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank F. Zhang (Broad Institute of MIT and Harvard) for reagents, the MIT BiomicroCenter for high-throughput sequencing assistance, and Y. Qiu for flow cytometric assistance. The authors acknowledge funding from the US National Institutes of Health to D.K.G. (1U01HG007037) and to R.I.S. (1K01DK101684-01) and Harvard Stem Cell Institute's Sternlicht Director's Fund award, Brigham and Women's Hospital BRI Innovation Fund, and Human Frontier Science Program grants to R.I.S.	Arbab M, 2015, STEM CELL REP, V5, P908, DOI 10.1016/j.stemcr.2015.09.022; Arnold CD, 2013, SCIENCE, V339, P1074, DOI 10.1126/science.1232542; Ay F, 2014, GENOME RES, V24, P999, DOI 10.1101/gr.160374.113; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Chen SD, 2015, CELL, V160, P1246, DOI 10.1016/j.cell.2015.02.038; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cradick TJ, 2013, NUCLEIC ACIDS RES, V41, P9584, DOI 10.1093/nar/gkt714; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dostie J, 2006, GENOME RES, V16, P1299, DOI 10.1101/gr.5571506; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; Guo YC, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002638; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; John S, 2011, NAT GENET, V43, P264, DOI 10.1038/ng.759; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Koike-Yusa H, 2014, NAT BIOTECHNOL, V32, P267, DOI 10.1038/nbt.2800; Kwasnieski JC, 2014, GENOME RES, V24, P1595, DOI 10.1101/gr.173518.114; Li GL, 2012, CELL, V148, P84, DOI 10.1016/j.cell.2011.12.014; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Melnikov A, 2012, NAT BIOTECHNOL, V30, P271, DOI 10.1038/nbt.2137; NELDER JA, 1972, J R STAT SOC SER A-G, V135, P370, DOI 10.2307/2344614; Patwardhan RP, 2012, NAT BIOTECHNOL, V30, P265, DOI 10.1038/nbt.2136; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Rajagopal N, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002968; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Sherwood RI, 2014, NAT BIOTECHNOL, V32, P171, DOI 10.1038/nbt.2798; Simonis M, 2006, NAT GENET, V38, P1348, DOI 10.1038/ng1896; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; Vierstra J, 2015, NAT METHODS, V12, P927, DOI [10.1038/NMETH.3554, 10.1038/nmeth.3554]; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Woo YH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012158; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032; Yue F, 2014, NATURE, V515, P355, DOI 10.1038/nature13992; Zhou YX, 2014, NATURE, V509, P487, DOI 10.1038/nature13166	40	153	159	0	81	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2016	34	2					167	+		10.1038/nbt.3468	http://dx.doi.org/10.1038/nbt.3468			10	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DD0OK	26807528	Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000369619100019
J	Sheehan, H; Moser, M; Klahre, U; Esfeld, K; Dell'Olivo, A; Mandel, T; Metzger, S; Vandenbussche, M; Freitas, L; Kuhlemeier, C				Sheehan, Hester; Moser, Michel; Klahre, Ulrich; Esfeld, Korinna; Dell'Olivo, Alexandre; Mandel, Therese; Metzger, Sabine; Vandenbussche, Michiel; Freitas, Loreta; Kuhlemeier, Cris			MYB-FL controls gain and loss of floral UV absorbance, a key trait affecting pollinator preference and reproductive isolation	NATURE GENETICS			English	Article							FLOWER COLOR; ANTHOCYANIN PIGMENTATION; EVOLUTIONARY HISTORY; ULTRAVIOLET VISION; PETUNIA SOLANACEAE; FLAVONOL SYNTHASE; GENUS PETUNIA; MANDUCA-SEXTA; SPECIATION; GENETICS	Adaptations to new pollinators involve multiple floral traits, each requiring coordinated changes in multiple genes. Despite this genetic complexity, shifts in pollination syndromes have happened frequently during angiosperm evolution. Here we study the genetic basis of floral UV absorbance, a key trait for attracting nocturnal pollinators. In Petunia, mutations in a single gene, MYB-FL, explain two transitions in UV absorbance. A gain of UV absorbance in the transition from bee to moth pollination was determined by a cis-regulatory mutation, whereas a frameshift mutation caused subsequent loss of UV absorbance during the transition from moth to hummingbird pollination. The functional differences in MYB-FL provide insight into the process of speciation and clarify phylogenetic relationships between nascent species.	[Sheehan, Hester; Moser, Michel; Klahre, Ulrich; Esfeld, Korinna; Dell'Olivo, Alexandre; Mandel, Therese; Kuhlemeier, Cris] Univ Bern, Inst Plant Sci, Bern, Switzerland; [Metzger, Sabine] Univ Cologne, Cologne Bioctr, Cluster Excellence Plant Sci, Mass Spectrometry Platform, D-50931 Cologne, Germany; [Vandenbussche, Michiel] Ecole Normale Super Lyon, UMR 5667, ENS Lyon, CNRS,INRA,UCBL, F-69364 Lyon, France; [Freitas, Loreta] Univ Fed Rio Grande do Sul, Dept Genet, Lab Mol Evolut, Porto Alegre, RS, Brazil	University of Bern; University of Cologne; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Ecole Normale Superieure de Lyon (ENS de LYON); Universidade Federal do Rio Grande do Sul	Kuhlemeier, C (corresponding author), Univ Bern, Inst Plant Sci, Bern, Switzerland.	cris.kuhlemeier@ips.unibe.ch	Freitas, Loreta B/D-9948-2013; Vazquez-Dominguez, Guillermo GVD/L-7818-2014; Moser, Michel/AAD-5093-2019; Sheehan, Hester/AAB-2321-2021; Freitas, Loreta B/E-7366-2010	Freitas, Loreta B/0000-0002-0728-4945; Sheehan, Hester/0000-0002-2169-5206; Freitas, Loreta B/0000-0002-0728-4945; VANDENBUSSCHE, Michiel/0000-0002-4192-7369	ATIP-AVENIR (CNRS); ANR-BLANC grant; Science without Borders, CNPq; National Centre of Competence in Research; Swiss National Science Foundation; University of Bern	ATIP-AVENIR (CNRS); ANR-BLANC grant(French National Research Agency (ANR)); Science without Borders, CNPq; National Centre of Competence in Research; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); University of Bern	We thank C. Ball, J. Sekulovski, N. Signer and R. Zimmermann for expert care of our plants; M. Saxenhofer and A. Feller for help with genotyping and screening transposon populations; P. Morel and J. Zethof for help with the amplification and sequencing of dTph1 transposon-flanking sequences; A.L. Caze for help with phenotyping hybrid progeny plants; and A.L. Segatto and C. Turchetto for field collections and DNA extraction. K. Snowden, A. Amrad, K. Hermann, H. Summers and S. Robinson provided constructive comments on manuscript drafts; A. Amrad, R. Koes, J. Stuurman and T. Gerats provided advice and suggestions throughout the project; and R. Kopfli assisted with figures. M.V. was financially supported by an ATIP-AVENIR (CNRS) and ANR-BLANC grant. L.F. was financed by Science without Borders, CNPq. The remaining authors were financed by the National Centre of Competence in Research "Plant Survival" and grants from the Swiss National Science Foundation and the University of Bern.	Albert NW, 2014, PLANT CELL, V26, P962, DOI 10.1105/tpc.113.122069; Ando T, 2001, ANN BOT-LONDON, V88, P403, DOI 10.1006/anbo.2001.1485; Segatto ALA, 2014, MOL PHYLOGENET EVOL, V70, P504, DOI 10.1016/j.ympev.2013.10.011; Bouck A, 2007, EVOLUTION, V61, P2308, DOI 10.1111/j.1558-5646.2007.00214.x; Bradshaw HD, 2003, NATURE, V426, P176, DOI 10.1038/nature02106; Bradshaw HD, 1998, GENETICS, V149, P367; Brothers AN, 2013, J HERED, V104, P853, DOI 10.1093/jhered/est059; Castel SE, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0762-6; CHARLESWORTH D, 1979, GENETICS, V91, P581; CHITTKA L, 1994, VISION RES, V34, P1489, DOI 10.1016/0042-6989(94)90151-1; Colosimo PF, 2005, SCIENCE, V307, P1928, DOI 10.1126/science.1107239; Cooley AM, 2011, CURR BIOL, V21, P700, DOI 10.1016/j.cub.2011.03.028; Cronk Q, 2008, J EXP BOT, V59, P715, DOI 10.1093/jxb/ern009; Davies KM, 2003, EUPHYTICA, V131, P259, DOI 10.1023/A:1024018729349; Dell'Olivo A, 2013, EVOLUTION, V67, P3023, DOI 10.1111/evo.12178; Dell'Olivo A, 2011, EVOLUTION, V65, P1979, DOI 10.1111/j.1558-5646.2011.01279.x; Dziedzioch C, 2003, PLANT BIOLOGY, V5, P331, DOI 10.1055/s-2003-40802; Edwards SV, 2009, EVOLUTION, V63, P1, DOI 10.1111/j.1558-5646.2008.00549.x; Faegri K., 1979, PRINCIPLES POLLINATI; Fenster CB, 2004, ANNU REV ECOL EVOL S, V35, P375, DOI 10.1146/annurev.ecolsys.34.011802.132347; Galliot C, 2006, PLANTA, V225, P203, DOI 10.1007/s00425-006-0342-9; Gegear RJ, 2007, AM NAT, V170, P551, DOI 10.1086/521230; GOLDSMITH TH, 1980, SCIENCE, V207, P786, DOI 10.1126/science.7352290; Gould K. S., 2006, Flavonoids: chemistry, biochemistry and applications, P397; GRANT V, 1949, EVOLUTION, V3, P82, DOI 10.2307/2405454; Guebitz Thomas, 2009, P29, DOI 10.1007/978-0-387-84796-2_2; GULDBERG LD, 1975, AM MIDL NAT, V93, P35, DOI 10.2307/2424103; Hermann K, 2015, PLANTA, V241, P1241, DOI 10.1007/s00425-015-2251-2; Hermann K, 2013, CURR BIOL, V23, P873, DOI 10.1016/j.cub.2013.03.069; Herrera G, 2008, J COMP PHYSIOL A, V194, P785, DOI 10.1007/s00359-008-0349-8; Hoballah ME, 2007, PLANT CELL, V19, P779, DOI 10.1105/tpc.106.048694; HOLTON TA, 1993, PLANT J, V4, P1003, DOI 10.1046/j.1365-313X.1993.04061003.x; Hopkins R, 2012, SCIENCE, V335, P1090, DOI 10.1126/science.1215198; Hopkins R, 2011, NATURE, V469, P411, DOI 10.1038/nature09641; Kay KM, 2003, BIOTROPICA, V35, P198, DOI 10.1111/j.1744-7429.2003.tb00279.x; Kelber A, 1999, J COMP PHYSIOL A, V184, P535, DOI 10.1007/s003590050353; Kevan P, 1996, TRENDS PLANT SCI, V1, P280; Klahre U, 2011, CURR BIOL, V21, P730, DOI 10.1016/j.cub.2011.03.059; Knapp S, 2010, PHILOS T R SOC B, V365, P449, DOI 10.1098/rstb.2009.0236; Kronforst MR, 2006, P NATL ACAD SCI USA, V103, P6575, DOI 10.1073/pnas.0509685103; Lorenz-Lemke AP, 2006, MOL ECOL, V15, P4487, DOI 10.1111/j.1365-294X.2006.03100.x; Lorenz-Lemke AP, 2010, MOL ECOL, V19, P5240, DOI 10.1111/j.1365-294X.2010.04871.x; Marchinko KB, 2009, EVOLUTION, V63, P127, DOI 10.1111/j.1558-5646.2008.00529.x; Mehrtens F, 2005, PLANT PHYSIOL, V138, P1083, DOI 10.1104/pp.104.058032; Orr HA, 2005, NAT REV GENET, V6, P119, DOI 10.1038/nrg1523; Orr HA, 1998, EVOLUTION, V52, P935, DOI [10.2307/2411226, 10.1111/j.1558-5646.1998.tb01823.x]; PEITSCH D, 1992, J COMP PHYSIOL A, V170, P23, DOI 10.1007/BF00190398; Pollastri S, 2011, ANN BOT-LONDON, V108, P1225, DOI 10.1093/aob/mcr234; Quattrocchio F, 1999, PLANT CELL, V11, P1433, DOI 10.1105/tpc.11.8.1433; QUATTROCCHIO F, 1993, PLANT CELL, V5, P1497, DOI 10.1105/tpc.5.11.1497; Raguso RA, 2005, ANIM BEHAV, V69, P407, DOI 10.1016/j.anbehav.2004.04.015; Rausher MD, 2008, INT J PLANT SCI, V169, P7, DOI 10.1086/523358; Rausher MD., 2006, SCI FLAVONOIDS, P175, DOI [10.1007/978-0-387-28822-2_7, DOI 10.1007/978-0-387-28822-2_7]; Reck-Kortmann M, 2014, MOL PHYLOGENET EVOL, V81, P19, DOI 10.1016/j.ympev.2014.08.022; Schwinn K, 2006, PLANT CELL, V18, P831, DOI 10.1105/tpc.105.039255; Seehausen O, 2008, NATURE, V455, P620, DOI 10.1038/nature07285; Shang YJ, 2011, NEW PHYTOL, V189, P602, DOI 10.1111/j.1469-8137.2010.03498.x; Stehmann Joao Renato, 2009, P1, DOI 10.1007/978-0-387-84796-2_1; Stracke R, 2007, PLANT J, V50, P660, DOI 10.1111/j.1365-313X.2007.03078.x; Streisfeld MA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003385; Stuurman J, 2004, GENETICS, V168, P1585, DOI 10.1534/genetics.104.031138; Thomson JD, 2008, INT J PLANT SCI, V169, P23, DOI 10.1086/523361; Venail J, 2010, PHILOS T R SOC B, V365, P461, DOI 10.1098/rstb.2009.0242; Watanabe H, 2001, J JPN SOC HORTIC SCI, V70, P33, DOI 10.2503/jjshs.70.33; Wessinger CA, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0349; WHITE RH, 1994, BIOTROPICA, V26, P427, DOI 10.2307/2389237; WHITE RH, 1983, J COMP PHYSIOL, V150, P153, DOI 10.1007/BF00606365; Whittall JB, 2007, NATURE, V447, P706, DOI 10.1038/nature05857; WIJSMAN HJW, 1983, ACTA BOT NEERL, V32, P97, DOI 10.1111/j.1438-8677.1983.tb01681.x; Winkel-Shirley B, 2001, PLANT PHYSIOL, V126, P485, DOI 10.1104/pp.126.2.485; Winter Y, 2003, NATURE, V425, P612, DOI 10.1038/nature01971; Yang ZH, 2012, NAT REV GENET, V13, P303, DOI 10.1038/nrg3186; Yuan YW, 2013, CURR OPIN PLANT BIOL, V16, P422, DOI 10.1016/j.pbi.2013.05.004; Yuan YW, 2013, GENETICS, V194, P255, DOI 10.1534/genetics.112.146852	74	76	77	5	111	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2016	48	2					159	166		10.1038/ng.3462	http://dx.doi.org/10.1038/ng.3462			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DC2JV	26656847				2022-12-25	WOS:000369043900013
J	Durruthy-Durruthy, J; Sebastiano, V; Wossidlo, M; Cepeda, D; Cui, J; Grow, EJ; Davila, J; Mall, M; Wong, WH; Wysocka, J; Au, KF; Pera, RAR				Durruthy-Durruthy, Jens; Sebastiano, Vittorio; Wossidlo, Mark; Cepeda, Diana; Cui, Jun; Grow, Edward J.; Davila, Jonathan; Mall, Moritz; Wong, Wing H.; Wysocka, Joanna; Au, Kin Fai; Pera, Renee A. Reijo			The primate-specific noncoding RNA HPAT5 regulates pluripotency during human preimplantation development and nuclear reprogramming	NATURE GENETICS			English	Article							EMBRYONIC STEM-CELLS; GENE-EXPRESSION; SELF-RENEWAL; LINE-1 RETROTRANSPOSONS; TRANSPOSABLE ELEMENTS; MICRORNA; TRANSCRIPTION; EVOLUTION; PROTEINS; NANOG	Long intergenic noncoding RNAs (lincRNAs) are derived from thousands of loci in mammalian genomes and are frequently enriched in transposable elements (TEs). Although families of TE-derived lincRNAs have recently been implicated in the regulation of pluripotency, little is known of the specific functions of individual family members. Here we characterize three new individual TE-derived human lincRNAs, human pluripotency-associated transcripts 2, 3 and 5 (HPAT2, HPAT3 and HPAT5). Loss-of-function experiments indicate that HPAT2, HPAT3 and HPAT5 function in preimplantation embryo development to modulate the acquisition of pluripotency and the formation of the inner cell mass. CRISPR-mediated disruption of the genes for these lincRNAs in pluripotent stem cells, followed by whole-transcriptome analysis, identifies HPAT5 as a key component of the pluripotency network. Protein binding and reporter-based assays further demonstrate that HPAT5 interacts with the let-7 microRNA family. Our results indicate that unique individual members of large primate-specific lincRNA families modulate gene expression during development and differentiation to reinforce cell fate.	[Durruthy-Durruthy, Jens; Sebastiano, Vittorio; Wossidlo, Mark; Cepeda, Diana; Cui, Jun; Pera, Renee A. Reijo] Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Durruthy-Durruthy, Jens; Sebastiano, Vittorio; Wossidlo, Mark; Cepeda, Diana; Cui, Jun; Grow, Edward J.; Pera, Renee A. Reijo] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Durruthy-Durruthy, Jens; Sebastiano, Vittorio; Wossidlo, Mark; Cepeda, Diana; Cui, Jun; Pera, Renee A. Reijo] Stanford Univ, Dept Obstet & Gynecol, Stanford, CA 94305 USA; [Davila, Jonathan; Mall, Moritz] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; [Wong, Wing H.; Au, Kin Fai] Stanford Univ, Dept Stat, Stanford, CA 94305 USA; [Wysocka, Joanna] Stanford Univ, Dept Chem & Syst Biol, Stanford, CA 94305 USA; [Wysocka, Joanna] Stanford Univ, Dept Dev Biol, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University	Pera, RAR (corresponding author), Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA.	vsebast@stanford.edu; renee.reijopera@montana.edu	Cui, Jun/G-6230-2015; Mall, Moritz/AAA-3558-2019; Wossidlo, Mark/M-9690-2019	Cui, Jun/0000-0002-1926-1759; Mall, Moritz/0000-0002-1278-2594; Wossidlo, Mark/0000-0002-3184-0753; Reijo Pera, Renee/0000-0002-6487-1329	Stanford University Center for Reproductive and Stem Cell Biology [U54-1U54HD068158-01]; Basic and Translational Research of iPSC-based Hematologic and Vascular Therapies [U01-1U01HL100397-01]; US National Institutes of Health [R01HG006018]; California Institute of Regenerative Medicine [RB3-2209]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P50HD068158, U54HD068158] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL100397] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000044, R01HG006018] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007790, R01GM112720] Funding Source: NIH RePORTER	Stanford University Center for Reproductive and Stem Cell Biology; Basic and Translational Research of iPSC-based Hematologic and Vascular Therapies; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Reijo Pera laboratory for thoughtful feedback and comments regarding manuscript preparation. We thank Z. Siprashvili for assistance in the protein microarray experiments. We thank S. Marro for the neural transdifferentiation experiments and L.B. Torrez for the siRNA experiments. We thank G. Glinsky for thoughtful feedback regarding data assessment. This work was funded by grants U54-1U54HD068158-01 (Stanford University Center for Reproductive and Stem Cell Biology), U01-1U01HL100397-01 (Basic and Translational Research of iPSC-based Hematologic and Vascular Therapies), R01HG006018 (US National Institutes of Health) and RB3-2209 (California Institute of Regenerative Medicine). No federal funding was used for human embryo studies.	Alcid EA, 2014, GENE DEV, V28, P2348, DOI 10.1101/gad.250902.114; Au KF, 2013, P NATL ACAD SCI USA, V110, pE4821, DOI 10.1073/pnas.1320101110; Bengtsson M, 2005, GENOME RES, V15, P1388, DOI 10.1101/gr.3820805; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Buganim Y, 2012, CELL, V150, P1209, DOI 10.1016/j.cell.2012.08.023; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Fort A, 2014, NAT GENET, V46, P558, DOI 10.1038/ng.2965; Gagliardi A, 2013, EMBO J, V32, P2231, DOI 10.1038/emboj.2013.161; Giordano J, 2007, PLOS COMPUT BIOL, V3, P1321, DOI 10.1371/journal.pcbi.0030137; Goke J, 2015, CELL STEM CELL, V16, P135, DOI 10.1016/j.stem.2015.01.005; Goff LA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007192; Gong CG, 2011, NATURE, V470, P284, DOI 10.1038/nature09701; Grow EJ, 2015, NATURE, V522, P221, DOI 10.1038/nature14308; Hagan JP, 2009, NAT STRUCT MOL BIOL, V16, P1021, DOI 10.1038/nsmb.1676; HARADA F, 1987, NUCLEIC ACIDS RES, V15, P9153, DOI 10.1093/nar/15.22.9153; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; Hockemeyer D, 2008, CELL STEM CELL, V3, P346, DOI 10.1016/j.stem.2008.08.014; Holdt LM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003588; Jia H, 2010, RNA, V16, P1478, DOI 10.1261/rna.1951310; Kapusta A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003470; Karginov FV, 2007, P NATL ACAD SCI USA, V104, P19291, DOI 10.1073/pnas.0709971104; Kelley D, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-11-r107; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Koziol MJ, 2010, CURR OPIN GENET DEV, V20, P142, DOI 10.1016/j.gde.2010.03.003; Kunarso G, 2010, NAT GENET, V42, P631, DOI 10.1038/ng.600; Lazzeroni L, 2002, STAT SINICA, V12, P61; Li JJ, 2014, GENOME RES, V24, P775, DOI 10.1101/gr.162230.113; Loewer S, 2010, NAT GENET, V42, P1113, DOI 10.1038/ng.710; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Lu XY, 2014, NAT STRUCT MOL BIOL, V21, P423, DOI 10.1038/nsmb.2799; Martin L, 2012, J CLIN INVEST, V122, P1589, DOI 10.1172/JCI60020; Melton C, 2010, NATURE, V463, P621, DOI 10.1038/nature08725; Mercer TR, 2008, P NATL ACAD SCI USA, V105, P716, DOI 10.1073/pnas.0706729105; Moignard V, 2013, NAT CELL BIOL, V15, P363, DOI 10.1038/ncb2709; Ohms S, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00338; Ohms S, 2014, ONCOTARGET, V5, P4103, DOI 10.18632/oncotarget.1822; Orom UA, 2010, CELL, V143, P46, DOI 10.1016/j.cell.2010.09.001; Pang ZPP, 2011, NATURE, V476, P220, DOI 10.1038/nature10202; Raj A, 2008, NAT METHODS, V5, P877, DOI 10.1038/NMETH.1253; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Rogers J, 2014, NAT REV GENET, V15, P347, DOI 10.1038/nrg3707; Santoni FA, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-111; Siprashvili Z, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-633; Spengler RM, 2014, HUM MOL GENET, V23, P1783, DOI 10.1093/hmg/ddt569; Tanaka Y, 2012, MOL CELLS, V34, P509, DOI 10.1007/s10059-012-0242-8; Ulitsky I, 2013, CELL, V154, P26, DOI 10.1016/j.cell.2013.06.020; Ulitsky I, 2011, CELL, V147, P1537, DOI 10.1016/j.cell.2011.11.055; Wang JC, 2014, NATURE, V516, P405, DOI 10.1038/nature13804; Wang YM, 2007, NAT GENET, V39, P380, DOI 10.1038/ng1969; Worringer KA, 2014, CELL STEM CELL, V14, P40, DOI 10.1016/j.stem.2013.11.001; Wu Q, 2006, J BIOL CHEM, V281, P24090, DOI 10.1074/jbc.C600122200; Zhang JQ, 2006, NAT CELL BIOL, V8, P1114, DOI 10.1038/ncb1481; Zhao J, 2008, SCIENCE, V322, P750, DOI 10.1126/science.1163045; Zhu YY, 2013, MOL CELL, V49, P298, DOI 10.1016/j.molcel.2012.11.011	56	124	137	1	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2016	48	1					44	+		10.1038/ng.3449	http://dx.doi.org/10.1038/ng.3449			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CZ7BQ	26595768	Green Accepted			2022-12-25	WOS:000367255300012
J	Schmidt, A; Kochanowski, K; Vedelaar, S; Ahrne, E; Volkmer, B; Callipo, L; Knoops, K; Bauer, M; Aebersold, R; Heinemann, M				Schmidt, Alexander; Kochanowski, Karl; Vedelaar, Silke; Ahrne, Erik; Volkmer, Benjamin; Callipo, Luciano; Knoops, Kevin; Bauer, Manuel; Aebersold, Ruedi; Heinemann, Matthias			The quantitative and condition-dependent Escherichia coli proteome	NATURE BIOTECHNOLOGY			English	Article							EVOLUTIONARY CONSERVATION; GROWTH; ACETYLATION; PROTEINS; REVEALS; PHOSPHOPROTEOME; QUANTIFICATION; IDENTIFICATION; COVERAGE; DATABASE	Measuring precise concentrations of proteins can provide insights into biological processes. Here we use efficient protein extraction and sample fractionation, as well as state-of-the-art quantitative mass spectrometry techniques to generate a comprehensive, condition-dependent protein-abundance map for Escherichia coli. We measure cellular protein concentrations for 55% of predicted E. coli genes (>2,300 proteins) under 22 different experimental conditions and identify methylation and N-terminal protein acetylations previously not known to be prevalent in bacteria. We uncover system-wide proteome allocation, expression regulation and post-translational adaptations. These data provide a valuable resource for the systems biology and broader E. coli research communities.	[Schmidt, Alexander; Ahrne, Erik; Bauer, Manuel] Univ Basel, Biozentrum, Basel, Switzerland; [Kochanowski, Karl; Volkmer, Benjamin; Callipo, Luciano; Aebersold, Ruedi; Heinemann, Matthias] Swiss Fed Inst Technol, Inst Mol Syst Biol, Zurich, Switzerland; [Vedelaar, Silke; Heinemann, Matthias] Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Mol Syst Biol, Groningen, Netherlands; [Knoops, Kevin] Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Mol Cell Biol, Groningen, Netherlands; [Aebersold, Ruedi] Univ Zurich, Fac Sci, Zurich, Switzerland	University of Basel; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Groningen; University of Groningen; University of Zurich	Schmidt, A (corresponding author), Univ Basel, Biozentrum, Basel, Switzerland.	alex.schmidt@unibas.ch; m.heinemann@rug.nl	Knoops, Kèvin/F-6247-2012; Kochanowski, Karl/ABE-7236-2021; Heinemann, Matthias/B-9421-2008	Heinemann, Matthias/0000-0002-5512-9077; Volkmer, Benjamin/0000-0002-9945-9772; Knoops, Kevin/0000-0002-7539-1160	Netherlands Organisation for Scientific Research (NWO) (VIDI grant) [864.11.001]; Dupont (Dupont Young Professorship Award); Swiss National Science Foundation [31003A_132428/1]; Commission of the European Communities through the PROSPECTS consortium (EU FP7 project) [201648]; PROMYS consortium (EU H2020 project) [613745]; Marie Curie Intra-European Fellowship (IEF) [330150]; European Research Council [ERC-2008-AdG 233226]	Netherlands Organisation for Scientific Research (NWO) (VIDI grant)(Netherlands Organization for Scientific Research (NWO)); Dupont (Dupont Young Professorship Award); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Commission of the European Communities through the PROSPECTS consortium (EU FP7 project); PROMYS consortium (EU H2020 project); Marie Curie Intra-European Fellowship (IEF)(European Commission); European Research Council(European Research Council (ERC)European Commission)	Funding is acknowledged from the Netherlands Organisation for Scientific Research (NWO) (VIDI grant 864.11.001 to M.H.), Dupont (Dupont Young Professorship Award to M.H.), the Swiss National Science Foundation (31003A_132428/1 to M.B.) and the Commission of the European Communities through the PROSPECTS consortium (EU FP7 project 201648) (R.A.), the PROMYS consortium (EU H2020 project 613745) (M.H.) and for a Marie Curie Intra-European Fellowship (IEF) grant (330150) (K. Knoops) and the European Research Council (ERC-2008-AdG 233226) (R.A.) Further, the authors would like to thank J. Radzikowski for performing a number of experiments. We also like to thank D. Bumann and S. Marguerat for critical reading of the manuscript.	Ahrne E, 2013, PROTEOMICS, V13, P2567, DOI 10.1002/pmic.201300135; Ahrne E, 2011, J PROTEOME RES, V10, P2913, DOI 10.1021/pr200152g; Ahrne E, 2010, PROTEOMICS, V10, P671, DOI 10.1002/pmic.200900502; Aidelberg G, 2014, BMC SYST BIOL, V8, DOI 10.1186/s12918-014-0133-z; Akhtar MK, 2009, METAB ENG, V11, P139, DOI 10.1016/j.ymben.2009.01.002; Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Beck M, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.82; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Bonissone S, 2013, MOL CELL PROTEOMICS, V12, P14, DOI 10.1074/mcp.M112.019075; BRUNSCHEDE H, 1977, J BACTERIOL, V129, P1020, DOI 10.1128/JB.129.2.1020-1033.1977; Colak G, 2013, MOL CELL PROTEOMICS, V12, P3509, DOI 10.1074/mcp.M113.031567; DENNIS PP, 1974, J BACTERIOL, V119, P270, DOI 10.1128/JB.119.1.270-281.1974; Dorman CJ, 2009, ADV APPL MICROBIOL, V67, P47, DOI 10.1016/S0065-2164(08)01002-2; Ehrenberg M, 2013, BIOCHIMIE, V95, P643, DOI 10.1016/j.biochi.2012.11.012; Galperin MY, 2015, NUCLEIC ACIDS RES, V43, pD261, DOI 10.1093/nar/gku1223; GAUSING K, 1977, J MOL BIOL, V115, P335, DOI 10.1016/0022-2836(77)90158-9; Gillette MA, 2013, NAT METHODS, V10, P28, DOI 10.1038/nmeth.2309; Hammar P, 2012, SCIENCE, V336, P1595, DOI 10.1126/science.1221648; Hu LI, 2010, MOL MICROBIOL, V77, P15, DOI 10.1111/j.1365-2958.2010.07204.x; Ishihama Y, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-102; Ishii N, 2007, SCIENCE, V316, P593, DOI 10.1126/science.1132067; Jones JD, 2011, PROTEOMICS, V11, P3012, DOI 10.1002/pmic.201000812; KOCH AL, 1988, CAN J MICROBIOL, V34, P421, DOI 10.1139/m88-074; Krug K, 2013, MOL CELL PROTEOMICS, V12, P3420, DOI 10.1074/mcp.M113.029165; Lee MV, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.48; Li GW, 2014, CELL, V157, P624, DOI 10.1016/j.cell.2014.02.033; Macek B, 2008, MOL CELL PROTEOMICS, V7, P299, DOI 10.1074/mcp.M700311-MCP200; Maddalo G, 2011, J PROTEOME RES, V10, P1848, DOI 10.1021/pr101105c; Malmstrom J, 2009, NATURE, V460, P762, DOI 10.1038/nature08184; Marguerat S, 2012, CELL, V151, P671, DOI 10.1016/j.cell.2012.09.019; Masuda T, 2009, MOL CELL PROTEOMICS, V8, P2770, DOI 10.1074/mcp.M900240-MCP200; Picotti P, 2009, CELL, V138, P795, DOI 10.1016/j.cell.2009.05.051; Salgado H, 2013, NUCLEIC ACIDS RES, V41, pD203, DOI 10.1093/nar/gks1201; Savas JN, 2011, TRENDS BIOCHEM SCI, V36, P388, DOI 10.1016/j.tibs.2011.04.005; SCHAECHTER M, 1958, J GEN MICROBIOL, V19, P592, DOI 10.1099/00221287-19-3-592; Schmidt A, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.37; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Scott M, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145379; Shahab N, 1996, MICROBIOL-SGM, V142, P1927, DOI 10.1099/13500872-142-8-1927; Smith VF, 1996, PROTEIN SCI, V5, P488; Soares NC, 2013, J PROTEOME RES, V12, P2611, DOI 10.1021/pr3011843; Soppa J, 2010, ARCHAEA, V2010, DOI 10.1155/2010/820681; Soupene E, 2003, J BACTERIOL, V185, P5611, DOI 10.1128/JB.185.18.5611-5626.2003; STOUTHAMER AH, 1973, A VAN LEEUW J MICROB, V39, P545, DOI 10.1007/BF02578899; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; Volkmer B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023126; Weinert BT, 2013, MOL CELL, V51, P265, DOI 10.1016/j.molcel.2013.06.003; Wood TK, 2006, APPL MICROBIOL BIOT, V72, P361, DOI 10.1007/s00253-005-0263-8; Zhang JM, 2009, MOL CELL PROTEOMICS, V8, P215, DOI 10.1074/mcp.M800187-MCP200	51	389	391	5	149	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2016	34	1					104	110		10.1038/nbt.3418	http://dx.doi.org/10.1038/nbt.3418			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DB8HQ	26641532	Green Accepted, Green Published			2022-12-25	WOS:000368758200034
J	Toth, M; Antunes, NT; Stewart, NK; Frase, H; Bhattacharya, M; Smith, CA; Vakulenko, SB				Toth, Marta; Antunes, Nuno Tiago; Stewart, Nichole K.; Frase, Hilary; Bhattacharya, Monolekha; Smith, Clyde A.; Vakulenko, Sergei B.			Class D beta-lactamases do exist in Gram-positive bacteria	NATURE CHEMICAL BIOLOGY			English	Article							PENICILLIN-BINDING PROTEINS; CRYSTAL-STRUCTURE; ACTIVE-SITE; ACINETOBACTER-BAUMANNII; CARBAPENEMASE ACTIVITY; STRUCTURAL BASIS; CLASS-A; RESISTANCE; MECHANISM; INHIBITION	Production of beta-lactamases of one of four molecular classes (A, B, C and D) is the major mechanism of bacterial resistance to beta-lactams, the largest class of antibiotics, which have saved countless lives since their inception 70 years ago. Although several hundred efficient class D enzymes have been identified in Gram-negative pathogens over the last four decades, none have been reported in Gram-positive bacteria. Here we demonstrate that efficient class D. beta-lactamases capable of hydrolyzing a wide array of beta-lactam substrates are widely disseminated in various species of environmental Gram-positive organisms. Class D enzymes of Gram-positive bacteria have a distinct structural architecture and employ a unique substrate-binding mode that is quite different from that of all currently known class A, C and D. beta-lactamases. These enzymes thus constitute a previously unknown reservoir of novel antibiotic-resistance enzymes.	[Toth, Marta; Antunes, Nuno Tiago; Stewart, Nichole K.; Frase, Hilary; Bhattacharya, Monolekha; Vakulenko, Sergei B.] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA; [Smith, Clyde A.] Stanford Univ, Stanford Synchrotron Radiat Lightsource, Menlo Pk, CA USA	University of Notre Dame; Stanford University	Toth, M (corresponding author), Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA.	csmith@slac.stanford.edu; svakulen@nd.edu			US Department of Energy (DOE), Office of Science, Office of Basic Energy Sciences [DE-AC02-76SF00515]; DOE Office of Biological and Environmental Research; US National Institutes of Health (NIH), National Institute of General Medical Sciences (NIGMS) [P41GM103393]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103393] Funding Source: NIH RePORTER	US Department of Energy (DOE), Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); US National Institutes of Health (NIH), National Institute of General Medical Sciences (NIGMS); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The Stanford Synchrotron Radiation Lightsource (SSRL) is a national user facility operated by Stanford University and supported by the US Department of Energy (DOE), Office of Science, Office of Basic Energy Sciences under contract no. DE-AC02-76SF00515. The SSRL Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research and by the US National Institutes of Health (NIH), National Institute of General Medical Sciences (NIGMS) (including P41GM103393). The contents of this publication are solely the responsibility of the authors and do not necessarily represent the official views of NIGMS or NIH.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; AMBLER RP, 1980, PHILOS T R SOC B, V289, P321, DOI 10.1098/rstb.1980.0049; AMBLER RP, 1991, BIOCHEM J, V276, P269, DOI 10.1042/bj2760269; Antunes NT, 2014, ANTIMICROB AGENTS CH, V58, P2119, DOI 10.1128/AAC.02522-13; Beadle BM, 2002, ANTIMICROB AGENTS CH, V46, P3978, DOI 10.1128/AAC.46.12.3978-3980.2002; Bush K, 2013, ANN NY ACAD SCI, V1277, P84, DOI 10.1111/nyas.12023; Cho H, 2014, CELL, V159, P1300, DOI 10.1016/j.cell.2014.11.017; Clinical and Laboratory Standards Institute, 2009, METH DIL ANT SUSC TE; Colombo ML, 2004, ANTIMICROB AGENTS CH, V48, P484, DOI 10.1128/AAC.48.2.484-490.2004; Curley K, 2000, BIOORG CHEM, V28, P338, DOI 10.1006/bioo.2000.1184; Docquier JD, 2010, ANTIMICROB AGENTS CH, V54, P2167, DOI 10.1128/AAC.01517-09; Docquier JD, 2009, CHEM BIOL, V16, P540, DOI 10.1016/j.chembiol.2009.04.010; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Giannouli M, 2010, J CLIN MICROBIOL, V48, P1223, DOI 10.1128/JCM.02263-09; Golemi D, 2001, P NATL ACAD SCI USA, V98, P14280, DOI 10.1073/pnas.241442898; Golemi D, 2000, J AM CHEM SOC, V122, P6132, DOI 10.1021/ja0013881; HEDGES RW, 1974, J BACTERIOL, V117, P56, DOI 10.1128/JB.117.1.56-62.1974; JAURIN B, 1981, P NATL ACAD SCI-BIOL, V78, P4897, DOI 10.1073/pnas.78.8.4897; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kaitany KCJ, 2013, ANTIMICROB AGENTS CH, V57, P4848, DOI 10.1128/AAC.00762-13; Kernodle DS, 2000, GRAM-POSITIVE PATHOGENS, P609; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leonard DA, 2013, ACCOUNTS CHEM RES, V46, P2407, DOI 10.1021/ar300327a; Macheboeuf P, 2006, FEMS MICROBIOL REV, V30, P673, DOI 10.1111/j.1574-6976.2006.00024.x; Marciano DC, 2009, PROTEIN SCI, V18, P2080, DOI 10.1002/pro.220; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Maveyraud L, 1996, J AM CHEM SOC, V118, P7435, DOI 10.1021/ja9609718; Mourey L, 1998, J AM CHEM SOC, V120, P9382, DOI 10.1021/ja9817996; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; OUELLETTE M, 1987, P NATL ACAD SCI USA, V84, P7378, DOI 10.1073/pnas.84.21.7378; Paetzel M, 2000, NAT STRUCT BIOL, V7, P918; Patera A, 2000, J AM CHEM SOC, V122, P10504, DOI 10.1021/ja001676x; Pernot L, 2001, J MOL BIOL, V310, P859, DOI 10.1006/jmbi.2001.4805; Poirel L, 2010, ANTIMICROB AGENTS CH, V54, P24, DOI 10.1128/AAC.01512-08; Poole K, 2004, CELL MOL LIFE SCI, V61, P2200, DOI 10.1007/s00018-004-4060-9; Powers RA, 2001, BIOCHEMISTRY-US, V40, P9207, DOI 10.1021/bi0109358; Santillana E, 2007, P NATL ACAD SCI USA, V104, P5354, DOI 10.1073/pnas.0607557104; Schneider KD, 2011, J MOL BIOL, V406, P583, DOI 10.1016/j.jmb.2010.12.042; Schneider KD, 2009, BIOCHEMISTRY-US, V48, P11840, DOI 10.1021/bi901690r; Smith CA, 2014, ANTIMICROB AGENTS CH, V58, P2135, DOI 10.1128/AAC.01983-13; Smith CA, 2013, CHEM BIOL, V20, P1107, DOI 10.1016/j.chembiol.2013.07.015; Stewart NK, 2015, BIOCHEMISTRY-US, V54, P588, DOI 10.1021/bi501052t; Sun T, 2003, PROTEIN SCI, V12, P82, DOI 10.1110/ps.0224303; SYKES R B, 1976, Journal of Antimicrobial Chemotherapy, V2, P115, DOI 10.1093/jac/2.2.115; Thomson JM, 2006, J BIOL CHEM, V281, P26734, DOI 10.1074/jbc.M603222200; Toth M, 2010, J AM CHEM SOC, V132, P816, DOI 10.1021/ja908850p; Verma V, 2011, J BIOL CHEM, V286, P37292, DOI 10.1074/jbc.M111.280115; Walther-Rasmussen J, 2006, J ANTIMICROB CHEMOTH, V57, P373, DOI 10.1093/jac/dki482; Wattam AR, 2014, NUCLEIC ACIDS RES, V42, pD581, DOI 10.1093/nar/gkt1099; WAXMAN DJ, 1983, ANNU REV BIOCHEM, V52, P825, DOI 10.1146/annurev.bi.52.070183.004141	52	47	48	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2016	12	1					9	+		10.1038/nchembio.1950	http://dx.doi.org/10.1038/nchembio.1950			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY8QW	26551395	Green Submitted, Green Accepted			2022-12-25	WOS:000366674400005
J	Dale, T; Clarke, PA; Esdar, C; Waalboer, D; Adeniji-Popoola, O; Ortiz-Ruiz, MJ; Mallinger, A; Samant, RS; Czodrowski, P; Musil, D; Schwarz, D; Schneider, K; Stubbs, M; Ewan, K; Fraser, E; TePoele, R; Court, W; Box, G; Valenti, M; Brandon, AD; Gowan, S; Rohdich, F; Raynaud, F; Schneider, R; Poeschke, O; Blaukat, A; Workman, P; Schiemann, K; Eccles, SA; Wienke, D; Blagg, J				Dale, Trevor; Clarke, Paul A.; Esdar, Christina; Waalboer, Dennis; Adeniji-Popoola, Olajumoke; Ortiz-Ruiz, Maria-Jesus; Mallinger, Aurelie; Samant, Rahul S.; Czodrowski, Paul; Musil, Djordje; Schwarz, Daniel; Schneider, Klaus; Stubbs, Mark; Ewan, Ken; Fraser, Elizabeth; TePoele, Robert; Court, Will; Box, Gary; Valenti, Melanie; Brandon, Alexis de Haven; Gowan, Sharon; Rohdich, Felix; Raynaud, Florence; Schneider, Richard; Poeschke, Oliver; Blaukat, Andree; Workman, Paul; Schiemann, Kai; Eccles, Suzanne A.; Wienke, Dirk; Blagg, Julian			A selective chemical probe for exploring the role of CDK8 and CDK19 in human disease	NATURE CHEMICAL BIOLOGY			English	Article							TYROSINE KINASE INHIBITOR; BETA-CATENIN; MEDIATOR COMPLEX; POSITIVE REGULATOR; TARGET; TRANSCRIPTION; CANCER; PROGRESSION; ELONGATION; ACTIVATION	There is unmet need for chemical tools to explore the role of the Mediator complex in human pathologies ranging from cancer to cardiovascular disease. Here we determine that CCT251545, a small-molecule inhibitor of the WNT pathway discovered through cell-based screening, is a potent and selective chemical probe for the human Mediator complex-associated protein kinases CDK8 and CDK19 with >100-fold selectivity over 291 other kinases. X-ray crystallography demonstrates a type 1 binding mode involving insertion of the CDK8 C terminus into the ligand binding site. In contrast to type II inhibitors of CDK8 and CDK19, CCT251545 displays potent cell-based activity. We show that CCT251545 and close analogs alter WNT pathway-regulated gene expression and other on-target effects of modulating CDK8 and CDK19, including expression of genes regulated by STAT1. Consistent with this, we find that phosphorylation of STAT1sER727 is a biomarker of CDK8 kinase activity in vitro and in vivo. Finally, we demonstrate in vivo activity of CCT251545 in WNT-dependent tumors.	[Dale, Trevor; Ewan, Ken; Fraser, Elizabeth] Cardiff Univ, Sch Biosci, Cardiff CF10 3AX, S Glam, Wales; [Clarke, Paul A.; Waalboer, Dennis; Adeniji-Popoola, Olajumoke; Ortiz-Ruiz, Maria-Jesus; Mallinger, Aurelie; Samant, Rahul S.; Stubbs, Mark; TePoele, Robert; Court, Will; Box, Gary; Valenti, Melanie; Brandon, Alexis de Haven; Gowan, Sharon; Raynaud, Florence; Workman, Paul; Eccles, Suzanne A.; Blagg, Julian] Inst Canc Res, Canc Res UK Canc Therapeut Unit, London SW3 6JB, England; [Esdar, Christina; Czodrowski, Paul; Musil, Djordje; Schwarz, Daniel; Schneider, Klaus; Rohdich, Felix; Schneider, Richard; Poeschke, Oliver; Blaukat, Andree; Schiemann, Kai; Wienke, Dirk] Merck Serono, Merck KGaA, Darmstadt, Germany	Cardiff University; Cancer Research UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Merck KGaA; EMD Serono Inc.	Dale, T (corresponding author), Cardiff Univ, Sch Biosci, Cardiff CF10 3AX, S Glam, Wales.	daletc@cardiff.ac.uk; paul.clarke@icr.ac.uk; dirk.wienke@merckgroup.com; julian.blagg@icr.ac.uk	Schneider, Klaus/N-6604-2014; Samant, Rahul S/ABB-8354-2021; Dale, Trevor/D-3749-2009; Ewan, Kenneth/N-3554-2015	Schneider, Klaus/0000-0002-3068-8681; Samant, Rahul S/0000-0003-1952-259X; Raynaud, Florence/0000-0003-0957-6279; Dale, Trevor/0000-0002-4880-9963; Popoola, Olajumoke/0000-0003-0452-0401; Czodrowski, Paul/0000-0002-7390-8795; Clarke, Paul/0000-0001-9342-1290; Ewan, Kenneth/0000-0001-6622-9009	Cancer Research UK [C309/A11566, C368/A6743, A368/A7990]; Cancer Research UK; Royal Marsden National Health Service (NHS); BBSRC [BB/G016887/1]; BBSRC [BB/D00117X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D00117X/1] Funding Source: researchfish; Cancer Research UK [11566, 15937] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Cancer Research UK(Cancer Research UK); Royal Marsden National Health Service (NHS); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK)	This work was supported by Cancer Research UK (grant numbers C309/A11566, C368/A6743 and A368/A7990). We acknowledge Cancer Research UK funding to the Cancer Research UK Centre at The Institute of Cancer Research and The Royal Marsden National Health Service (NHS) funding to the National Institute for Health Research (NIHR) Biomedical Research Centre at the same institutions. We thank A. Mirza, M. Richards and M. Liu for their assistance with NMR, mass spectrometry and HPLC. We thank S. Gaus (Merck Serono) for excellent technical assistance. We thank the team of Proteros Biostructures GmbH, Martinsried, Germany for the Reporter Displacement Assay and in particular E.V. Schneider and A. Lammens for the X-ray co-crystal structure of CCT251545 with CDK8-cyclin C. We thank G.J. Feng and B. Lloyd Lewis for assistance with organoid growth experiments and F. Runge for development of the esiRNA protocol (BBSRC grant number BB/G016887/1). We thank N. Evans for editorial assistance.	Adler AS, 2012, CANCER RES, V72, P2129, DOI 10.1158/0008-5472.CAN-11-3886; Alarcon C, 2009, CELL, V139, P757, DOI 10.1016/j.cell.2009.09.035; Allen BL, 2015, NAT REV MOL CELL BIO, V16, P155, DOI 10.1038/nrm3951; Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Bancerek J, 2013, IMMUNITY, V38, P250, DOI 10.1016/j.immuni.2012.10.017; Bantscheff M, 2012, BIOORGAN MED CHEM, V20, P1973, DOI 10.1016/j.bmc.2011.11.003; Blagg J, 2014, CURR OPIN PHARMACOL, V17, P87, DOI 10.1016/j.coph.2014.07.007; Cainap C, 2015, J CLIN ONCOL, V33, P172, DOI 10.1200/JCO.2013.54.3298; Carlsten JOP, 2013, TRENDS BIOCHEM SCI, V38, P531, DOI 10.1016/j.tibs.2013.08.007; Cee VJ, 2009, ANGEW CHEM INT EDIT, V48, P8952, DOI 10.1002/anie.200904778; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Conaway RC, 2011, CURR OPIN GENET DEV, V21, P225, DOI 10.1016/j.gde.2011.01.013; Donner AJ, 2010, NAT STRUCT MOL BIOL, V17, P194, DOI 10.1038/nsmb.1752; Eggert US, 2013, NAT CHEM BIOL, V9, P206, DOI 10.1038/nchembio.1206; Firestein R, 2008, NATURE, V455, P547, DOI 10.1038/nature07179; Firestein R, 2010, INT J CANCER, V126, P2863, DOI 10.1002/ijc.24908; Fisher M, 2011, RSC DRUG DISCOV, V5, P1; Frye SV, 2010, NAT CHEM BIOL, V6, P159, DOI 10.1038/nchembio.296; Galbraith MD, 2013, CELL, V153, P1327, DOI 10.1016/j.cell.2013.04.048; Galbraith MD, 2010, TRANSCR-AUSTIN, V1, P4, DOI 10.4161/trns.1.1.12373; Garuti L, 2010, CURR MED CHEM, V17, P2804, DOI 10.2174/092986710791859333; Gozgit JM, 2012, MOL CANCER THER, V11, P690, DOI 10.1158/1535-7163.MCT-11-0450; Huang DZ, 2010, BIOINFORMATICS, V26, P198, DOI 10.1093/bioinformatics/btp650; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Jarde T, 2013, ONCOGENE, V32, P883, DOI 10.1038/onc.2012.103; Kahn M, 2014, NAT REV DRUG DISCOV, V13, P513, DOI 10.1038/nrd4233; Kapoor A, 2010, NATURE, V468, P1105, DOI 10.1038/nature09590; Kim MY, 2011, INT J ONCOL, V38, P1375, DOI 10.3892/ijo.2011.948; Kim S, 2006, J BIOL CHEM, V281, P14066, DOI 10.1074/jbc.M602696200; Krasley E, 2006, GENETICS, V172, P1477, DOI 10.1534/genetics.105.052266; Lipton JH, 2015, LEUKEMIA RES, V39, P58, DOI 10.1016/j.leukres.2014.10.005; Liu BY, 2012, CANCER RES, V72, P1568, DOI 10.1158/0008-5472.CAN-11-3668; Liu J, 2013, P NATL ACAD SCI USA, V110, P20224, DOI 10.1073/pnas.1314239110; Mallinger A, 2015, J MED CHEM, V58, P1717, DOI 10.1021/jm501436m; Mokry M, 2012, NUCLEIC ACIDS RES, V40, P148, DOI 10.1093/nar/gkr720; Molina DM, 2013, SCIENCE, V341, P84, DOI 10.1126/science.1233606; Morris EJ, 2008, NATURE, V455, P552, DOI 10.1038/nature07310; Nemet J, 2014, BIOCHIMIE, V97, P22, DOI 10.1016/j.biochi.2013.10.004; Ong SE, 2009, P NATL ACAD SCI USA, V106, P4617, DOI 10.1073/pnas.0900191106; Porter DC, 2012, P NATL ACAD SCI USA, V109, P13799, DOI 10.1073/pnas.1206906109; Rickert P, 1996, ONCOGENE, V12, P2631; Rieger ME, 2010, MOL CELL BIOL, V30, P4267, DOI 10.1128/MCB.01418-09; Schiano C, 2014, BBA-GENE REGUL MECH, V1839, P444, DOI 10.1016/j.bbagrm.2014.04.012; Schiano C, 2014, BBA-REV CANCER, V1845, P66, DOI 10.1016/j.bbcan.2013.12.001; Schneider EV, 2011, J MOL BIOL, V412, P251, DOI 10.1016/j.jmb.2011.07.020; Schneider EV, 2013, P NATL ACAD SCI USA, V110, P8081, DOI 10.1073/pnas.1305378110; Shankar DB, 2007, BLOOD, V109, P3400, DOI 10.1182/blood-2006-06-029579; Sharma K, 2009, NAT METHODS, V6, P741, DOI [10.1038/NMETH.1373, 10.1038/nmeth.1373]; Swinney DC, 2011, NAT REV DRUG DISCOV, V10, P507, DOI 10.1038/nrd3480; Workman P, 2010, CHEM BIOL, V17, P561, DOI 10.1016/j.chembiol.2010.05.013	50	97	101	1	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2015	11	12					973	980		10.1038/nchembio.1952	http://dx.doi.org/10.1038/nchembio.1952			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX6TG	26502155	Green Accepted			2022-12-25	WOS:000365834000017
J	Langston, JW; Schule, B; Rees, L; Nichols, RJ; Barlow, C				Langston, J. William; Schuele, Birgitt; Rees, Linda; Nichols, R. Jeremy; Barlow, Carrolee			Multisystem Lewy body disease and the other parkinsonian disorders	NATURE GENETICS			English	Article							ALPHA-SYNUCLEIN GENE; G51D SNCA MUTATION; GLUCOCEREBROSIDASE MUTATIONS; MISSENSE MUTATION; BRAIN PATHOLOGY; LRRK2 MUTATION; PATIENT; DUPLICATION; NEUROPATHOLOGY; PHENOTYPE	Here we prioritize as multisystem Lewy body disease (MLBD) those genetic forms of Parkinson's disease that point the way toward a mechanistic understanding of the majority of sporadic disease. Pathological diagnosis of genetic subtypes offers the prospect of distinguishing different mechanistic trajectories with a common mutational etiology, differing outcomes from varying allelic bases, and those disease-associated variants that can be used in gene-environment analysis. Clearly delineating parkinsonian disorders into subclasses on the basis of molecular mechanisms with well-characterized outcome expectations is the basis for refining these forms of neurodegeneration as research substrate through the use of cell models derived from affected individuals while ensuring that clinically collected data can be used for therapeutic decisions and research without increasing the noise and confusion engendered by the collection of data against a range of historically defined criteria.	[Langston, J. William; Schuele, Birgitt; Rees, Linda; Nichols, R. Jeremy; Barlow, Carrolee] Parkinsons Inst & Clin Ctr, Sunnyvale, CA 94085 USA		Langston, JW (corresponding author), Parkinsons Inst & Clin Ctr, Sunnyvale, CA 94085 USA.	jwlangston@thepi.org; bschuele@thepi.org; cbarlow@thepi.org		Nichols, R Jeremy/0000-0002-5228-7571; Schuele, Birgitt/0000-0002-9952-5776	Parkinson Alliance/Parkinson's Unity Walk	Parkinson Alliance/Parkinson's Unity Walk	We thank J.M. Cruz-Toledo and R. Stanley for their work on the data integration project and network-based searching, IO Informatics and The Parkinson Alliance/Parkinson's Unity Walk for generous support, and our donors and patients whose support makes this work possible.	Aboud AA, 2012, NEUROTOXICOLOGY, V33, P1443, DOI 10.1016/j.neuro.2012.10.009; Ahn Tae-Beom, 2012, Am J Neurodegener Dis, V1, P49; Braak H, 2004, CELL TISSUE RES, V318, P121, DOI 10.1007/s00441-004-0956-9; Braak H, 2002, J NEUROL, V249, DOI [1007/s00415-002-1301-4, 10.1007/s00415-002-1301-4, DOI 10.1007/S00415-002-1301-4]; Byers B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026159; Chahine LM, 2013, JAMA NEUROL, V70, P852, DOI 10.1001/jamaneurol.2013.1274; Chan P, 1998, NEUROLOGY, V50, P1136, DOI 10.1212/WNL.50.4.1136; Chan P, 1998, NEUROLOGY, V50, P513, DOI 10.1212/WNL.50.2.513; Chen YW, 2015, INT J NURS PRACT, V21, P21, DOI 10.1111/ijn.12395; Chouraki V, 2014, ADV GENET, V87, P245, DOI 10.1016/B978-0-12-800149-3.00005-6; Chung CY, 2013, SCIENCE, V342, P983, DOI 10.1126/science.1245296; COTZIAS GC, 1968, NEW ENGL J MED, V278, P630; Del Tredici K, 2002, J NEUROPATH EXP NEUR, V61, P413, DOI 10.1093/jnen/61.5.413; Doostzadeh J, 2007, PARKINSONISM RELAT D, V13, P359, DOI 10.1016/j.parkreldis.2006.08.009; Duda JE, 2002, ACTA NEUROPATHOL, V104, P7, DOI 10.1007/s00401-002-0563-3; Farrer M, 2004, ANN NEUROL, V55, P174, DOI 10.1002/ana.10846; Farrer M, 2001, ANN NEUROL, V50, P293, DOI 10.1002/ana.1132; Flierl A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112413; Fuchs J, 2007, NEUROLOGY, V68, P916, DOI 10.1212/01.wnl.0000254458.17630.c5; Garraux G, 2012, ARCH NEUROL-CHICAGO, V69, P398, DOI 10.1001/archneurol.2011.802; Gelpi E, 2014, MOVEMENT DISORD, V29, P1010, DOI 10.1002/mds.25776; Gilks WP, 2005, LANCET, V365, P415, DOI 10.1016/S0140-6736(05)17830-1; Giordana MT, 2007, MOVEMENT DISORD, V22, P275, DOI 10.1002/mds.21281; GOLBE LI, 1990, ANN NEUROL, V27, P276, DOI 10.1002/ana.410270309; Goldman SM, 2012, MOVEMENT DISORD, V27, P1652, DOI 10.1002/mds.25216; Goldstein David S, 2007, Cleve Clin J Med, V74 Suppl 1, pS91; Gomez A, 2010, ACTA NEUROPATHOL, V120, P155, DOI 10.1007/s00401-010-0669-y; GREENFIELD JG, 1953, J NEUROL NEUROSUR PS, V16, P213, DOI 10.1136/jnnp.16.4.213; Gwinn-Hardy K, 2000, ACTA NEUROPATHOL, V99, P663, DOI 10.1007/s004010051177; Ha NN, 2011, CELL STEM CELL, V8, P267, DOI 10.1016/j.stem.2011.01.013; Hamza TH, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002237; Hasegawa K, 1997, EUR NEUROL, V38, P39, DOI 10.1159/000113460; Hasegawa K, 2009, PARKINSONISM RELAT D, V15, P300, DOI 10.1016/j.parkreldis.2008.07.010; HERZOG E., 1928, DEUTSCHE ZEITSCHR NERVENHEILK, V107, P75, DOI 10.1007/BF01660129; Hishikawa N, 2003, ACTA NEUROPATHOL, V105, P341, DOI 10.1007/s00401-002-0651-4; Ikeuchi T, 2008, ARCH NEUROL-CHICAGO, V65, P514, DOI 10.1001/archneur.65.4.514; Iritani S, 2008, NEUROPATHOLOGY, V28, P652, DOI 10.1111/j.1440-1789.2008.00905.x; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Kalia LV, 2015, JAMA NEUROL, V72, P100, DOI 10.1001/jamaneurol.2014.2704; Kara E, 2014, JAMA NEUROL, V71, P1162, DOI 10.1001/jamaneurol.2014.994; Kasten M, 2013, MOVEMENT DISORD, V28, P697, DOI 10.1002/mds.25499; Khan NL, 2005, BRAIN, V128, P2786, DOI 10.1093/brain/awh667; Kiely AP, 2015, MOL NEURODEGENER, V10, DOI 10.1186/s13024-015-0038-3; Kiely AP, 2013, ACTA NEUROPATHOL, V125, P753, DOI 10.1007/s00401-013-1096-7; Klein C, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a008888; Koga S, 2015, NEUROLOGY, V85, P404, DOI 10.1212/WNL.0000000000001807; Konno T, 2016, PARKINSONISM RELAT D, V22, pS1, DOI 10.1016/j.parkreldis.2015.09.007; KOSAKA K, 1984, CLIN NEUROPATHOL, V3, P185; Langston JW, 2006, ANN NEUROL, V59, P591, DOI 10.1002/ana.20834; LANGSTON JW, 1984, ACTA NEUROL SCAND, V70, P49; LANGSTON JW, 1983, SCIENCE, V219, P979, DOI 10.1126/science.6823561; Langston JW, 1999, ANN NEUROL, V46, P598, DOI 10.1002/1531-8249(199910)46:4<598::AID-ANA7>3.0.CO;2-F; Langston JW, 1998, EXP NEUROL, V154, P684, DOI 10.1006/exnr.1998.6975; Langston JW, 2000, ANN NEUROL, V47, pS79; Lesage S, 2013, ANN NEUROL, V73, P459, DOI 10.1002/ana.23894; Lewy FH, 1912, PARALYSIS AGITANS; Liu GH, 2012, NATURE, V491, P603, DOI 10.1038/nature11557; Lwin A, 2004, MOL GENET METAB, V81, P70, DOI 10.1016/j.ymgme.2003.11.004; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Mak SK, 2011, J PARKINSON DIS, V1, P175, DOI 10.3233/JPD-2011-11025; Markopoulou K, 2008, ACTA NEUROPATHOL, V116, P25, DOI 10.1007/s00401-008-0372-4; Marras C, 2011, NEUROLOGY, V77, P325, DOI 10.1212/WNL.0b013e318227042d; Marti-Masso JF, 2009, MOVEMENT DISORD, V24, P1998, DOI 10.1002/mds.22677; Meissner WG, 2012, REV NEUROL-FRANCE, V168, P809, DOI 10.1016/j.neurol.2012.07.004; Mrowka R, 2001, GENOME RES, V11, P1971, DOI 10.1101/gr.206701; Muenter MD, 1998, ANN NEUROL, V43, P768, DOI 10.1002/ana.410430612; Nalls MA, 2014, NAT GENET, V46, P989, DOI 10.1038/ng.3043; Neumann J, 2009, BRAIN, V132, P1783, DOI 10.1093/brain/awp044; Nilsson E, 2016, J INTERN MED, V279, P141, DOI 10.1111/joim.12409; Nishioka K, 2009, MOVEMENT DISORD, V24, P1811, DOI 10.1002/mds.22682; Obi T, 2008, NEUROLOGY, V70, P238, DOI 10.1212/01.wnl.0000299387.59159.db; Plasterer T.N., 2011, CORRELATION NETWORK; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Poulopoulos M, 2012, MOVEMENT DISORD, V27, P831, DOI 10.1002/mds.24962; Proukakis C, 2013, NEUROLOGY, V80, P1062, DOI 10.1212/WNL.0b013e31828727ba; Puschmann A, 2012, PARKINSONISM RELAT D, V18, P332, DOI 10.1016/j.parkreldis.2011.11.019; Quattrone A, 2008, MOVEMENT DISORD, V23, P21, DOI 10.1002/mds.21701; Reinhardt P, 2013, CELL STEM CELL, V12, P354, DOI 10.1016/j.stem.2013.01.008; Reyes JF, 2015, NEUROBIOL DIS, V77, P266, DOI 10.1016/j.nbd.2014.07.003; Richards CS, 2008, GENET MED, V10, P294, DOI 10.1097/GIM.0b013e31816b5cae; Ross OA, 2006, ANN NEUROL, V59, P388, DOI 10.1002/ana.20731; Sanchez-Danes A, 2012, EMBO MOL MED, V4, P380, DOI 10.1002/emmm.201200215; Sanders LH, 2014, NEUROBIOL DIS, V62, P381, DOI 10.1016/j.nbd.2013.10.013; Savica R, 2010, ARCH NEUROL-CHICAGO, V67, P798, DOI 10.1001/archneurol.2010.135; Schule B, 2009, BBA-MOL BASIS DIS, V1792, P1043, DOI 10.1016/j.bbadis.2009.08.014; Schule B, 2015, NEUROL-GENET, V1, DOI 10.1212/NXG.0000000000000031; Seibler P, 2011, J NEUROSCI, V31, P5970, DOI 10.1523/JNEUROSCI.4441-10.2011; Seidel K, 2010, ANN NEUROL, V67, P684, DOI 10.1002/ana.21966; Sidransky E, 2012, LANCET NEUROL, V11, P986, DOI 10.1016/S1474-4422(12)70190-4; Silveira-Moriyama L, 2008, NEUROLOGY, V71, P1021, DOI 10.1212/01.wnl.0000326575.20829.45; Singleton AB, 2013, MOVEMENT DISORD, V28, P14, DOI 10.1002/mds.25249; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Spira PJ, 2001, ANN NEUROL, V49, P313, DOI 10.1002/ana.67; TETRUD JW, 1989, SCIENCE, V245, P519, DOI 10.1126/science.2502843; WATERS CH, 1994, ANN NEUROL, V35, P59, DOI 10.1002/ana.410350110; Wszolek ZK, 2004, NEUROLOGY, V62, P1619, DOI 10.1212/01.WNL.0000125015.06989.DB; WSZOLEK ZK, 1995, NEUROLOGY, V45, P502, DOI 10.1212/WNL.45.3.502; Yamaguchi K, 2005, ACTA NEUROPATHOL, V110, P298, DOI 10.1007/s00401-005-1042-4; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795	99	37	49	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2015	47	12					1378	1384		10.1038/ng.3454	http://dx.doi.org/10.1038/ng.3454			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CX6LT	26620112				2022-12-25	WOS:000365813200006
J	Ma, TH; Li, J; Xu, Y; Yu, C; Xu, T; Wang, HX; Liu, K; Cao, N; Nie, BM; Zhu, SY; Xu, SH; Li, K; Wei, WG; Wu, YZ; Guan, KL; Ding, S				Ma, Tianhua; Li, Jun; Xu, Yue; Yu, Chen; Xu, Tao; Wang, Haixia; Liu, Kai; Cao, Nan; Nie, Bao-ming; Zhu, Sai-yong; Xu, Shaohua; Li, Ke; Wei, Wan-guo; Wu, Yuzhang; Guan, Kun-liang; Ding, Sheng			Atg5-independent autophagy regulates mitochondrial clearance and is essential for iPSC reprogramming	NATURE CELL BIOLOGY			English	Article							PLURIPOTENT STEM-CELLS; PHOSPHORYLATION; INDUCTION; MEMBRANES; SYSTEM; MTOR	Successful generation of induced pluripotent stem cells entails a major metabolic switch from mitochondrial oxidative phosphorylation to glycolysis during the reprogramming process. The mechanism of this metabolic reprogramming, however, remains elusive. Here, our results suggest that an Atg5-independent autophagic process mediates mitochondrial clearance, a characteristic event involved in the metabolic switch. We found that blocking such autophagy, but not canonical autophagy, inhibits mitochondrial clearance, in turn, preventing iPSC induction. Furthermore, AMPK seems to be upstream of this autophagic pathway and can be targeted by small molecules to modulate mitochondrial clearance during metabolic reprogramming. Our work not only reveals that the Atg5-independent autophagy is crucial for establishing pluripotency, but it also suggests that iPSC generation and tumorigenesis share a similar metabolic switch.	[Ma, Tianhua; Li, Jun; Xu, Yue; Yu, Chen; Xu, Tao; Wang, Haixia; Liu, Kai; Cao, Nan; Nie, Bao-ming; Zhu, Sai-yong; Xu, Shaohua; Li, Ke; Ding, Sheng] Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA; [Ma, Tianhua; Li, Jun; Xu, Yue; Yu, Chen; Xu, Tao; Wang, Haixia; Liu, Kai; Cao, Nan; Nie, Bao-ming; Zhu, Sai-yong; Xu, Shaohua; Li, Ke; Ding, Sheng] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA; [Li, Jun; Wu, Yuzhang] Third Mil Med Univ, PLA, Inst Immunol, Chongqing 400038, Peoples R China; [Wei, Wan-guo] Chinese Acad Sci, Shanghai Adv Res Inst, Ctr Stem Cell & Regenerat Med, Shanghai 201210, Peoples R China; [Guan, Kun-liang] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Guan, Kun-liang] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; Army Medical University; Chinese Academy of Sciences; Shanghai Advanced Research Institute, CAS; University of California System; University of California San Diego; University of California System; University of California San Diego	Ding, S (corresponding author), Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA.	sheng.ding@gladstone.ucsf.edu	Xu, Tao/I-1561-2014; Guan, Kun-Liang/ADK-7088-2022; YU, CHEN/AAF-8780-2021; Li, Ke/K-9417-2015; Cao, Nan/D-2352-2016; Yu, Chen/T-1317-2019; Wei, Wanguo/H-3172-2012; Nie, Baoming/H-4316-2012	Xu, Tao/0000-0002-3436-3024; Xu, Tao/0000-0002-4085-6191; Wu, Yuzhang/0000-0002-4049-0214; Wei, Wanguo/0000-0002-2429-8281; Yu, Chen/0000-0003-3232-3931; Nie, Baoming/0000-0002-8343-0262	NICHD; NHLBI; NEI/NIH; California Institute for Regenerative Medicine; Gladstone Institutes; NSFC [81372372]; 'Strategic Priority Research Program' of the Chinese Academy of Sciences [XDA01040302]	NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NEI/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); Gladstone Institutes(University of California System); NSFC(National Natural Science Foundation of China (NSFC)); 'Strategic Priority Research Program' of the Chinese Academy of Sciences(Chinese Academy of Sciences)	We thank Ding Laboratory members for suggestions and discussions. We thank J. Wong in the electron microscopy core at Gladstone Institutes for obtaining and analysing electron micrographs. We thank N. Mizushima (Tokyo Medical and Dental University, Tokyo, Japan) for permitting use of Atg5<SUP>flox/flox</SUP> mice and J. Debnath (The University of California, San Francisco, USA) for providing these mice with permission from N. Mizushima. We thank S. Shimizu (Tokyo Medical and Dental University, Tokyo, Japan) for providing plasmids encoding GFP-Rab9 and GFP-syntaxin7. We thank T. P. Bender (The University of Virginia, USA) for providing MIG-R1 and MIG-Cre. S.D. is supported by funding from NICHD, NHLBI, NEI/NIH, California Institute for Regenerative Medicine, and the Gladstone Institutes. J.L. was supported by a grant (No. 81372372) from the NSFC. This research was also supported by the 'Strategic Priority Research Program' of the Chinese Academy of Sciences (No. XDA01040302).	Boya P, 2013, NAT CELL BIOL, V15, P713, DOI 10.1038/ncb2788; Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371; Eisenberg T, 2009, NAT CELL BIOL, V11, P1305, DOI 10.1038/ncb1975; Fan YJ, 2010, J BIOL CHEM, V285, P7324, DOI 10.1074/jbc.M109.035584; Folmes CDL, 2011, CELL METAB, V14, P264, DOI 10.1016/j.cmet.2011.06.011; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Honda S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5004; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Kundu M, 2008, BLOOD, V112, P1493, DOI 10.1182/blood-2008-02-137398; Li F, 2005, MOL CELL BIOL, V25, P6225, DOI 10.1128/MCB.25.14.6225-6234.2005; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Mizushima N, 2010, CURR OPIN CELL BIOL, V22, P132, DOI 10.1016/j.ceb.2009.12.004; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Nishida Y, 2009, NATURE, V461, P654, DOI 10.1038/nature08455; Sarkar S, 2007, NAT CHEM BIOL, V3, P331, DOI 10.1038/nchembio883; Sou Y, 2008, MOL BIOL CELL, V19, P4762, DOI 10.1091/mbc.E08-03-0309; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wang S, 2013, CELL STEM CELL, V13, P617, DOI 10.1016/j.stem.2013.10.005; Wernig M, 2008, NAT BIOTECHNOL, V26, P916, DOI 10.1038/nbt1483; Xu XL, 2013, CELL METAB, V18, P325, DOI 10.1016/j.cmet.2013.06.005; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhou HY, 2009, CELL STEM CELL, V4, P381, DOI 10.1016/j.stem.2009.04.005	26	120	129	1	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2015	17	11					1379	1387		10.1038/ncb3256	http://dx.doi.org/10.1038/ncb3256			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CV4XT	26502054				2022-12-25	WOS:000364270500004
J	Kim, S; Nie, HG; Nesin, V; Tran, U; Outeda, P; Bai, CX; Keeling, J; Maskey, D; Watnick, T; Wessely, O; Tsiokas, L				Kim, Seokho; Nie, Hongguang; Nesin, Vasyl; Tran, Uyen; Outeda, Patricia; Bai, Chang-Xi; Keeling, Jacob; Maskey, Dipak; Watnick, Terry; Wessely, Oliver; Tsiokas, Leonidas			The polycystin complex mediates Wnt/Ca2+ signalling	NATURE CELL BIOLOGY			English	Article							PLANAR CELL POLARITY; KIDNEY-DISEASE; CONVERGENT EXTENSION; CAUSES CYSTOGENESIS; BICAUDAL-C; PKD1; CHANNEL; WNT; PROTEIN; MORPHOGENESIS	WNT ligands induce Ca2+ signalling on target cells. PKD1 (polycystin 1) is considered an orphan, atypical G-protein-coupled receptor complexed with TRPP2 (polycystin 2 or PKD2), a Ca2+-permeable ion channel. Inactivating mutations in their genes cause autosomal dominant polycystic kidney disease (ADPKD), one of the most common genetic diseases. Here, we show that WNTs bind to the extracellular domain of PKD1 and induce whole-cell currents and Ca2+ influx dependent on TRPP2. Pathogenic PKD1 or PKD2 mutations that abrogate complex formation, compromise cell surface expression of PKD1, or reduce TRPP2 channel activity suppress activation by WNTs. Pkd2(-/-) fibroblasts lack WNT-induced Ca2+ currents and are unable to polarize during directed cell migration. In Xenopus embryos, pkd1, Dishevelled 2 (dvl2) and wnt9a act within the same pathway to preserve normal tubulogenesis. These data define PKD1 as a WNT (co) receptor and implicate defective WNT/Ca2+ signalling as one of the causes of ADPKD.	[Kim, Seokho; Nie, Hongguang; Nesin, Vasyl; Bai, Chang-Xi; Keeling, Jacob; Maskey, Dipak; Tsiokas, Leonidas] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, 975 NE 10th St, Oklahoma City, OK 73104 USA; [Nie, Hongguang] China Med Univ, Inst Metab Dis Res & Drug Dev, Shenyang 110001, Liaoning, Peoples R China; [Tran, Uyen; Wessely, Oliver] Cleveland Clin, Dept Cellular & Mol Med, 9500 Euclid Ave NC10, Cleveland, OH 44195 USA; [Outeda, Patricia; Watnick, Terry] Univ Maryland, Sch Med, Baltimore PKD Res & Clin Core Ctr, Div Nephrol, 655 West Baltimore St, Baltimore, MD 21201 USA; [Bai, Chang-Xi] Inner Mongolia Med Univ, Res Inst Mongolian Med, Dept Adv Res Mongolian Med, Hohhot 010110, Inner Mongolia, Peoples R China	University of Oklahoma System; University of Oklahoma Health Sciences Center; China Medical University; Cleveland Clinic Foundation; University System of Maryland; University of Maryland Baltimore; Inner Mongolia Medical University	Tsiokas, L (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, 975 NE 10th St, Oklahoma City, OK 73104 USA.	ltsiokas@ouhsc.edu	聂, 宏光/GYJ-8253-2022	聂, 宏光/0000-0002-9973-6354; Tsiokas, Leonidas/0000-0002-3659-1813; Kim, Seokho/0000-0001-9245-3776	NSFC [81270098]; NIH [DK080745, DK59599]; Oklahoma Center for the Advancement of Science and Technology; Oklahoma Center for Adult Stem Cell Research; John S. Gammill Endowed Chair in Polycystic Kidney Disease; NIDDK [P30DK090868]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK090868, R56DK059599, R01DK095036, R01DK080745, R01DK059599] Funding Source: NIH RePORTER	NSFC(National Natural Science Foundation of China (NSFC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oklahoma Center for the Advancement of Science and Technology; Oklahoma Center for Adult Stem Cell Research; John S. Gammill Endowed Chair in Polycystic Kidney Disease; NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We would like to thank A. Pioszak, R. Janknecht, M. Ahmad, D. Sherry and L. Rothblum for comments on the manuscript, J. Yang for mouse Flag-tagged PKD1, F. Qian for human HA-tagged PKD1 and E4 mouse monoclonal antibody against PKD1, F. Cong for ZNRF3 plasmid, and E. Petsouki and V Gerakopoulos in the Tsiokas laboratory for help with confocal imaging and immunoblotting in S2 cells. This work was supported by grant number 81270098 from NSFC (H.N.), DK080745 from NIH (O.W.), DK59599 from NIH (L.T.), Oklahoma Center for the Advancement of Science and Technology (L.T.), Oklahoma Center for Adult Stem Cell Research (L.T.), and the John S. Gammill Endowed Chair in Polycystic Kidney Disease (L.T.). These studies used reagents provided by the NIDDK-sponsored Baltimore Polycystic Kidney Disease Research and Clinical Core Center, P30DK090868.	Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Axelrod JD, 1998, GENE DEV, V12, P2610, DOI 10.1101/gad.12.16.2610; Bai CX, 2008, EMBO J, V27, P1345, DOI 10.1038/emboj.2008.70; Bai CX, 2008, EMBO REP, V9, P472, DOI 10.1038/embor.2008.29; Bhanot P, 1996, NATURE, V382, P225, DOI 10.1038/382225a0; Bisaillon JM, 2010, AM J PHYSIOL-CELL PH, V298, pC993, DOI 10.1152/ajpcell.00325.2009; Bourhis E, 2010, J BIOL CHEM, V285, P9172, DOI 10.1074/jbc.M109.092130; Boutros M, 1998, CELL, V94, P109, DOI 10.1016/S0092-8674(00)81226-X; Cantero Mdel. R., 2013, BIOPHYS J, V105, P365; Castelli M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3658; Consortium I. P. K. D., 1995, CELL, V81, P289; Coxam B, 2014, CELL REP, V7, P623, DOI 10.1016/j.celrep.2014.03.063; DeCaen PG, 2013, NATURE, V504, P315, DOI 10.1038/nature12832; Delmas P, 2004, FASEB J, V18, P740, DOI 10.1096/fj.03-0319fje; Faber J., 1994, NORMAL TABLE XENOPUS, P2; Field S, 2011, DEVELOPMENT, V138, P1131, DOI 10.1242/dev.058149; Giamarchi A, 2010, EMBO J, V29, P1176, DOI 10.1038/emboj.2010.18; Hanaoka K, 2000, NATURE, V408, P990, DOI 10.1038/35050128; Hao HX, 2012, NATURE, V485, P195, DOI 10.1038/nature11019; Huang LW, 2014, JOVE-J VIS EXP, DOI 10.3791/52156; HUGHES J, 1995, NAT GENET, V10, P151, DOI 10.1038/ng0695-151; Hutchins BI, 2011, DEV NEUROBIOL, V71, P269, DOI 10.1002/dneu.20846; Kamura K, 2011, DEVELOPMENT, V138, P1121, DOI 10.1242/dev.058271; Karner CM, 2009, NAT GENET, V41, P793, DOI 10.1038/ng.400; Karumanchi SA, 2001, MOL CELL, V7, P811, DOI 10.1016/S1097-2765(01)00225-8; Kim IY, 2008, J AM SOC NEPHROL, V19, P455, DOI 10.1681/ASN.2007070770; Kim I, 2009, J AM SOC NEPHROL, V20, P2556, DOI 10.1681/ASN.2009030271; Kotttgen M, 2008, J CELL BIOL, V182, P437, DOI 10.1083/jcb.200805124; Kolpakova-Hart E, 2008, DEV BIOL, V321, P407, DOI 10.1016/j.ydbio.2008.07.005; Kuhl M, 2000, TRENDS GENET, V16, P279, DOI 10.1016/s0168-9525(00)02028-x; Lienkamp SS, 2012, NAT GENET, V44, P1382, DOI 10.1038/ng.2452; Lin SD, 2010, J CELL BIOL, V190, P263, DOI 10.1083/jcb.200912128; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Lu WN, 2001, HUM MOL GENET, V10, P2385, DOI 10.1093/hmg/10.21.2385; Luo Y, 2003, MOL CELL BIOL, V23, P2600, DOI 10.1128/MCB.23.7.2600-2607.2003; Ma R, 2005, MOL CELL BIOL, V25, P8285, DOI 10.1128/MCB.25.18.8285-8298.2005; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Mochizuki T, 1996, SCIENCE, V272, P1339, DOI 10.1126/science.272.5266.1339; Narimatsu M, 2009, CELL, V137, P295, DOI 10.1016/j.cell.2009.02.025; Ohata S, 2015, J NEUROSCI, V35, P11153, DOI 10.1523/JNEUROSCI.0686-15.2015; Ohata S, 2014, NEURON, V83, P558, DOI 10.1016/j.neuron.2014.06.022; Outeda P, 2014, CELL REP, V7, P634, DOI 10.1016/j.celrep.2014.03.064; Parnell SC, 1998, BIOCHEM BIOPH RES CO, V251, P625, DOI 10.1006/bbrc.1998.9514; Pennekamp P, 2002, CURR BIOL, V12, P938, DOI 10.1016/S0960-9822(02)00869-2; Piontek K, 2007, NAT MED, V13, P1490, DOI 10.1038/nm1675; Qian F, 1997, NAT GENET, V16, P179, DOI 10.1038/ng0697-179; Schneider I, 2010, DEV BIOL, V348, P22, DOI 10.1016/j.ydbio.2010.08.040; Sheldahl LC, 2003, J CELL BIOL, V161, P769, DOI 10.1083/jcb.200211094; Sive H. L., 2000, EARLY DEV XENOPUS LA, V395; Slusarski DC, 1997, NATURE, V390, P410, DOI 10.1038/37138; Steigelman KA, 2011, J NEUROSCI, V31, P12241, DOI 10.1523/JNEUROSCI.6531-10.2011; Tan YC, 2009, HUM MUTAT, V30, P264, DOI 10.1002/humu.20842; Tran U, 2007, DEV BIOL, V307, P152, DOI 10.1016/j.ydbio.2007.04.030; Tran U, 2010, DEVELOPMENT, V137, P1107, DOI 10.1242/dev.046045; Tsiokas L, 1997, P NATL ACAD SCI USA, V94, P6965, DOI 10.1073/pnas.94.13.6965; VIZE PD, 1995, DEV BIOL, V171, P531, DOI 10.1006/dbio.1995.1302; Wei CL, 2009, NATURE, V457, P901, DOI 10.1038/nature07577; Witze ES, 2013, DEV CELL, V26, P645, DOI 10.1016/j.devcel.2013.08.019; Wu GQ, 2000, MOL GENET METAB, V69, P1, DOI 10.1006/mgme.1999.2943; Xiao ZS, 2008, J BIOL CHEM, V283, P12624, DOI 10.1074/jbc.M710407200; Xu YX, 2016, J AM SOC NEPHROL, V27, P1159, DOI 10.1681/ASN.2014111074; Yates LL, 2010, HUM MOL GENET, V19, P4663, DOI 10.1093/hmg/ddq397; Zhang B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026533; Zhang ZR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073424	64	99	102	0	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUL	2016	18	7					752	+		10.1038/ncb3363	http://dx.doi.org/10.1038/ncb3363			16	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	DP9TS	27214281	Green Accepted			2022-12-25	WOS:000378840900008
J	Ni, J; Ramkissoon, SH; Xie, SZ; Goel, S; Stover, DG; Guo, HB; Luu, V; Marco, E; Ramkissoon, LA; Kang, YJ; Hayashi, M; Nguyen, QD; Ligon, AH; Du, R; Claus, EB; Alexander, BM; Yuan, GC; Wang, ZGC; Iglehart, JD; Krop, IE; Roberts, TM; Winer, EP; Lin, NU; Ligon, KL; Zhao, JJ				Ni, Jing; Ramkissoon, Shakti H.; Xie, Shaozhen; Goel, Shom; Stover, Daniel G.; Guo, Hanbing; Luu, Victor; Marco, Eugenio; Ramkissoon, Lori A.; Kang, Yun Jee; Hayashi, Marika; Quang-De Nguyen; Ligon, Azra H.; Du, Rose; Claus, Elizabeth B.; Alexander, Brian M.; Yuan, Guo-Cheng; Wang, Zhigang C.; Iglehart, J. Dirk; Krop, Ian E.; Roberts, Thomas M.; Winer, Eric P.; Lin, Nancy U.; Ligon, Keith L.; Zhao, Jean J.			Combination inhibition of PI3K and mTORC1 yields durable remissions in mice bearing orthotopic patient-derived xenografts of HER2-positive breast cancer brain metastases	NATURE MEDICINE			English	Article							PTEN LOSS; EVEROLIMUS	Brain metastases represent the greatest clinical challenge in treating HER2-positive breast cancer. We report the development of orthotopic patient-derived xenografts (PDXs) of HER2-expressing breast cancer brain metastases (BCBM), and their use for the identification of targeted combination therapies. Combined inhibition of PI3K and mTOR resulted in durable tumor regressions in three of five PDXs, and therapeutic response was correlated with a reduction in the phosphorylation of 4EBP1, an mTORC1 effector. The two nonresponding PDXs showed hypermutated genomes with enrichment of mutations in DNA-repair genes, which suggests an association of genomic instability with therapeutic resistance. These findings suggest that a biomarker-driven clinical trial of PI3K inhibitor in combination with an mTOR inhibitor should be conducted for patients with HER2-positive BCBM.	[Ni, Jing; Xie, Shaozhen; Goel, Shom; Guo, Hanbing; Luu, Victor; Wang, Zhigang C.; Iglehart, J. Dirk; Roberts, Thomas M.; Zhao, Jean J.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Ni, Jing; Xie, Shaozhen; Guo, Hanbing; Luu, Victor; Roberts, Thomas M.; Zhao, Jean J.] Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Ramkissoon, Shakti H.; Goel, Shom; Stover, Daniel G.; Ramkissoon, Lori A.; Kang, Yun Jee; Hayashi, Marika; Wang, Zhigang C.; Iglehart, J. Dirk; Krop, Ian E.; Winer, Eric P.; Lin, Nancy U.; Ligon, Keith L.] Harvard Med Sch, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Ramkissoon, Shakti H.; Ligon, Azra H.; Ligon, Keith L.] Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA; [Marco, Eugenio; Yuan, Guo-Cheng] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Quang-De Nguyen] Dana Farber Canc Inst, Lurie Family Imaging Ctr, Boston, MA 02115 USA; [Du, Rose; Claus, Elizabeth B.] Brigham & Womens Hosp, Dept Neurosurg, 75 Francis St, Boston, MA 02115 USA; [Claus, Elizabeth B.] Yale Univ, Sch Publ Hlth, New Haven, CT USA; [Alexander, Brian M.] Dana Farber Canc Inst, Dept Radiat Oncol, Boston, MA 02115 USA; [Alexander, Brian M.] Brigham & Womens Hosp, Dept Radiat Oncol, 75 Francis St, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Yale University; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital	Zhao, JJ (corresponding author), Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA.; Zhao, JJ (corresponding author), Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.; Lin, NU; Ligon, KL (corresponding author), Harvard Med Sch, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.; Ligon, KL (corresponding author), Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA.	nancy_lin@dfci.harvard.edu; keith_ligon@dfci.harvard.edu; jean_zhao@dfci.harvard.edu	Goel, Shom/E-2399-2011; Du, Rose/AAJ-2873-2020; Marco, Eugenio/F-4583-2011; Du, Rose/I-5402-2012	Goel, Shom/0000-0001-8329-9084; Du, Rose/0000-0003-2641-6496; Marco, Eugenio/0000-0002-3675-263X; Stover, Daniel/0000-0001-9003-8165	Breast Cancer Research Foundation; Aid for Cancer Research; Breast Cancer Alliance; Komen scholar grant; US National Institutes of Health (NIH) [R01 CA187918, CA172461, 1K08NS087118, P50 CA165962, P01 CA142536, 1P50CA168504]; NATIONAL CANCER INSTITUTE [R01CA187918, R01CA172461, P50CA168504, P50CA165962, P01CA142536] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007627] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS087118] Funding Source: NIH RePORTER	Breast Cancer Research Foundation; Aid for Cancer Research; Breast Cancer Alliance; Komen scholar grant; US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank D. Livingston for reading the manuscript. We thank R. Modiste and G. Dai at the Dana-Farber Lurie Family Image Center for MRI imaging. We thank R. Bronson and the Dana-Farber/Harvard Cancer Center Rodent Histoplathology Core for histopathological analyses. We thank F. Pan, D. Light and R. Qi (Life Technologies, Thermo Fisher) for assistance with WES and transcriptome analyses with the Ion Torrent sequencing system. We thank J. Ruan and M. Ruan (VigeneTech) for quantification of pS6RP and p4EBP IHC data by the Cellvigene data-analysis program. This work was supported by the Breast Cancer Research Foundation (N.U.L., E.P.W., Z.W. and J.J.Z.); Aid for Cancer Research (E.P.W. and J.J.Z.); Breast Cancer Alliance (J.J.Z.); Komen scholar grant (E.P.W.); and US National Institutes of Health (NIH) grants R01 CA187918 (T.M.R. and J.J.Z.), CA172461 (J.J.Z.), 1K08NS087118 (S.H.R.), P50 CA165962 (T.M.R., K.L.L. and J.J.Z.), P01 CA142536 (J.J.Z.) and 1P50CA168504 (T.M.R., I.E.K., E.P.W., N.U.L., and J.J.Z.).	Brastianos PK, 2015, CANCER DISCOV, V5, P1164, DOI 10.1158/2159-8290.CD-15-0369; Choo AY, 2008, P NATL ACAD SCI USA, V105, P17414, DOI 10.1073/pnas.0809136105; Creighton CJ, 2007, ONCOGENE, V26, P4648, DOI 10.1038/sj.onc.1210245; Elkabets M, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005747; Filbin MG, 2013, NAT MED, V19, P1518, DOI 10.1038/nm.3328; Hortobagyi GN, 2016, J CLIN ONCOL, V34, P419, DOI 10.1200/JCO.2014.60.1971; Krueger DA, 2010, NEW ENGL J MED, V363, P1801, DOI 10.1056/NEJMoa1001671; Maire CL, 2014, STEM CELLS, V32, P313, DOI 10.1002/stem.1590; O'Reilly T, 2010, CANCER CHEMOTH PHARM, V65, P625, DOI 10.1007/s00280-009-1068-8; Shlien A, 2015, NAT GENET, V47, P257, DOI 10.1038/ng.3202; Thorpe LM, 2015, NAT REV CANCER, V15, P7, DOI 10.1038/nrc3860; Wikman H, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3150; Zhang L, 2015, NATURE, V527, P100, DOI 10.1038/nature15376	13	73	77	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2016	22	7					723	726		10.1038/nm.4120	http://dx.doi.org/10.1038/nm.4120			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DQ7DK	27270588	Green Submitted, Green Accepted			2022-12-25	WOS:000379366900010
J	Luo, J; Yang, ZF; Ma, Y; Yue, ZY; Lin, HY; Qui, GJ; Huang, JP; Dai, WT; Li, CH; Zheng, CB; Xu, LQ; Chen, HQ; Wang, JQ; Li, DL; Siwko, S; Penninger, JM; Ning, G; Xiao, JR; Liu, MY				Luo, Jian; Yang, Zhengfeng; Ma, Yu; Yue, Zhiying; Lin, Hongyu; Qui, Guojun; Huang, Jinping; Dai, Wentao; Li, Chenghai; Zheng, Chunbing; Xu, Leqin; Chen, Huaqing; Wang, Jiqiu; Li, Dali; Siwko, Stefan; Penninger, Josef M.; Ning, Guang; Xiao, Jianru; Liu, Mingyao			LGR4 is a receptor for RANKL and negatively regulates osteoclast differentiation and bone resorption	NATURE MEDICINE			English	Article							PROTEIN-COUPLED RECEPTOR; OSTEOPROTEGERIN-LIGAND; CANCER METASTASIS; DOWN-REGULATION; RECOGNITION; GPR48	Tumor necrosis factor (TNF) superfamily member 11 (TNFSF11, also known as RANKL) regulates multiple physiological or pathological functions, including osteoclast differentiation and osteoporosis. TNFRSF11A (also called RANK) is considered to be the sole receptor for RANKL. Herein we report that leucine-rich repeat-containing G-protein-coupled receptor 4 (LGR4, also called GPR48) is another receptor for RANKL. LGR4 competes with RANK to bind RANKL and suppresses canonical RANK signaling during osteoclast differentiation. RANKL binding to LGR4 activates the G alpha(q) and GSK3-beta signaling pathway, an action that suppresses the expression and activity of nuclear factor of activated T cells, cytoplasmic, calcineurin-dependent 1 (NFATC1) during osteoclastogenesis. Both whole-body (Lgr4(-/-)) and monocyte conditional knockout mice of Lgr4 (Lgr4 CKO) exhibit osteoclast hyperactivation (including elevation of osteoclast number, surface area, and size) and increased bone erosion. The soluble LGR4 extracellular domain (ECD) binds RANKL and inhibits osteoclast differentiation in vivo. Moreover, LGR4-ECD therapeutically abrogated RANKL-induced bone loss in three mouse models of osteoporosis. Therefore, LGR4 acts as a second RANKL receptor that negatively regulates osteoclast differentiation and bone resorption.	[Luo, Jian; Yang, Zhengfeng; Ma, Yu; Yue, Zhiying; Lin, Hongyu; Qui, Guojun; Huang, Jinping; Li, Chenghai; Zheng, Chunbing; Xu, Leqin; Chen, Huaqing; Li, Dali; Xiao, Jianru; Liu, Mingyao] E China Normal Univ, Shanghai 200062, Peoples R China; [Luo, Jian; Yang, Zhengfeng; Ma, Yu; Yue, Zhiying; Lin, Hongyu; Qui, Guojun; Huang, Jinping; Li, Chenghai; Zheng, Chunbing; Xu, Leqin; Chen, Huaqing; Li, Dali; Xiao, Jianru; Liu, Mingyao] E China Normal Univ, Shanghai Changzheng Hosp, Joint Res Ctr Orthoped Oncol, Shanghai Key Lab Regulatory Biol,Inst Biomed Sci, Shanghai 200062, Peoples R China; [Luo, Jian; Yang, Zhengfeng; Ma, Yu; Yue, Zhiying; Lin, Hongyu; Qui, Guojun; Huang, Jinping; Li, Chenghai; Zheng, Chunbing; Xu, Leqin; Chen, Huaqing; Li, Dali; Xiao, Jianru; Liu, Mingyao] E China Normal Univ, Sch Life Sci, Shanghai 200062, Peoples R China; [Dai, Wentao] Shanghai Acad Sci & Technol, Shanghai Ctr Bioinformat Technol, Shanghai, Peoples R China; [Wang, Jiqiu; Ning, Guang] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Endocrinol & Metab, Shanghai 200030, Peoples R China; [Siwko, Stefan] Texas A&M Univ, Hlth Sci Ctr, Inst Biosci & Technol, Dept Mol & Cellular Med, Houston, TX USA; [Penninger, Josef M.] Austrian Acad Sci, Inst Mol Biotechnol, IMBA, A-1010 Vienna, Austria; [Xiao, Jianru] Second Mil Med Univ, Shanghai Changzheng Hosp, Dept Orthoped Oncol, Shanghai, Peoples R China	East China Normal University; East China Normal University; Naval Medical University; East China Normal University; Chinese Academy of Sciences; Shanghai Jiao Tong University; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; University of Texas Health Science Center Houston; Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); Naval Medical University	Luo, J; Xiao, JR; Liu, MY (corresponding author), E China Normal Univ, Shanghai 200062, Peoples R China.; Luo, J; Xiao, JR; Liu, MY (corresponding author), E China Normal Univ, Shanghai Changzheng Hosp, Joint Res Ctr Orthoped Oncol, Shanghai Key Lab Regulatory Biol,Inst Biomed Sci, Shanghai 200062, Peoples R China.; Luo, J; Xiao, JR; Liu, MY (corresponding author), E China Normal Univ, Sch Life Sci, Shanghai 200062, Peoples R China.	jluo@bio.ecnu.edu.cn; jianruxiao83@163.com; myliu@bio.ecnu.edu.cn	Penninger, Josef M/I-6860-2013; Xiao, Jian/GYU-4351-2022; Yang, Zhengfeng/AAA-7014-2020; Wang, Jiqiu/AGM-1346-2022; Luo, Jian/H-3362-2016	Penninger, Josef M/0000-0002-8194-3777; Li, Dali/0000-0002-0046-8493; Wang, Jiqiu/0000-0002-9383-7656; Liu, Mingyao/0000-0001-7339-5048; xiao, jianru/0000-0003-1547-851X; Huang, Jinping/0000-0002-3549-1490; Luo, Jian/0000-0003-3583-0154; Siwko, Stefan/0000-0003-4260-2985	National Basic Research Program of China [2012CB910402, 2012CB910400]; National Natural Science Foundation of China [81472048, 81272911, 81330049, 81522011]; Science and Technology Commission of Shanghai Municipality [15140903600]; Shanghai Municipal Education Commission [14ZZ051]; advanced ERC grant; Era of Hope/DoD innovator award	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Shanghai Municipal Education Commission(Shanghai Municipal Education Commission (SHMEC)); advanced ERC grant; Era of Hope/DoD innovator award	This work is supported by grants from the National Basic Research Program of China (2012CB910402 to J.L.; 2012CB910400 to M.L.), the National Natural Science Foundation of China (81472048, 81272911 to J.L.; 81330049 to M.L.; 81522011 to J.W.), the Science and Technology Commission of Shanghai Municipality (15140903600 to J.L.), and the Innovation Program of Shanghai Municipal Education Commission (14ZZ051 to J.L.). The advanced ERC grant and an Era of Hope/DoD innovator award were given to JMP. We thank G. Ning (Ruijin Hospital, Shanghai JiaoTong University School of Medicine) for the Lgr4<SUP>floxed</SUP> mice, J. Penninger (Institute of Molecular Biotechnology of the Austrian Academy of Sciences) for the Ranl<SUP>floxed</SUP> mice, and Y. Zhang (Shanghai East Hospital, Tongji University School of Medicine) for the LysM-Cre mice.	Abe E, 2003, CELL, V115, P151, DOI 10.1016/S0092-8674(03)00771-2; Boyce BF, 2013, J DENT RES, V92, P860, DOI 10.1177/0022034513500306; Carmon KS, 2011, P NATL ACAD SCI USA, V108, P11452, DOI 10.1073/pnas.1106083108; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; Deng C, 2013, J CELL SCI, V126, P2060, DOI 10.1242/jcs.123471; Du B, 2013, J BIOL CHEM, V288, P15131, DOI 10.1074/jbc.M113.455535; Fata JE, 2000, CELL, V103, P41, DOI 10.1016/S0092-8674(00)00103-3; Gao Y, 2006, CANCER RES, V66, P11623, DOI 10.1158/0008-5472.CAN-06-2629; Gonzalez-Suarez E, 2010, NATURE, V468, P103, DOI 10.1038/nature09495; Hanada R, 2011, J MOL MED, V89, P647, DOI 10.1007/s00109-011-0749-z; Hanada R, 2009, NATURE, V462, P505, DOI 10.1038/nature08596; Jimi E, 1999, J IMMUNOL, V163, P434; Jones DH, 2006, NATURE, V440, P692, DOI 10.1038/nature04524; Joshi PA, 2015, STEM CELL REP, V5, P31, DOI 10.1016/j.stemcr.2015.05.012; Kiechl S, 2013, NAT MED, V19, P358, DOI 10.1038/nm.3084; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Kronke G, 2010, ARTHRITIS RHEUM-US, V62, P2303, DOI 10.1002/art.27496; Lacey DL, 2012, NAT REV DRUG DISCOV, V11, P401, DOI 10.1038/nrd3705; Lacey DL, 2000, AM J PATHOL, V157, P435, DOI 10.1016/S0002-9440(10)64556-7; Luo J, 2009, DEVELOPMENT, V136, P2747, DOI 10.1242/dev.033571; Manolagas SC, 2010, TRENDS ENDOCRIN MET, V21, P369, DOI 10.1016/j.tem.2010.01.010; Mizuno A, 1998, BIOCHEM BIOPH RES CO, V247, P610, DOI 10.1006/bbrc.1998.8697; Moon JB, 2012, J IMMUNOL, V188, P163, DOI 10.4049/jimmunol.1101254; Schramek D, 2010, NATURE, V468, P98, DOI 10.1038/nature09387; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; Styrkarsdottir U, 2013, NATURE, V497, P517, DOI 10.1038/nature12124; Sun L, 2006, CELL, V125, P247, DOI 10.1016/j.cell.2006.01.051; Takeshita S, 2013, J CLIN INVEST, V123, P3914, DOI 10.1172/JCI69493; Tan W, 2011, NATURE, V470, P548, DOI 10.1038/nature09707; Tang XL, 2013, CANCER RES, V73, P6206, DOI 10.1158/0008-5472.CAN-13-1049; Wang DL, 2013, GENE DEV, V27, P1339, DOI 10.1101/gad.219360.113; Wang JQ, 2013, NAT CELL BIOL, V15, P1455, DOI 10.1038/ncb2867; Wang Y, 2013, STEM CELLS, V31, P1921, DOI 10.1002/stem.1438; Weng JS, 2008, P NATL ACAD SCI USA, V105, P6081, DOI 10.1073/pnas.0708257105; Wu JH, 2013, CARCINOGENESIS, V34, P2861, DOI 10.1093/carcin/bgt229; Wu XJ, 2005, J BONE MINER RES, V20, P107, DOI 10.1359/JBMR.041022	37	202	216	8	102	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2016	22	5					539	546		10.1038/nm.4076	http://dx.doi.org/10.1038/nm.4076			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DL3DI	27064449				2022-12-25	WOS:000375514000017
J	Zhang, H; Pu, WJ; Tian, XY; Huang, XZ; He, LJ; Liu, QZ; Li, Y; Zhang, LB; He, L; Liu, K; Gillich, A; Zhou, B				Zhang, Hui; Pu, Wenjuan; Tian, Xueying; Huang, Xiuzhen; He, Lingjuan; Liu, Qiaozhen; Li, Yan; Zhang, Libo; He, Liang; Liu, Kuo; Gillich, Astrid; Zhou, Bin			Genetic lineage tracing identifies endocardial origin of liver vasculature	NATURE GENETICS			English	Article							ENDOTHELIAL-CELLS; CORONARY-ARTERIES; MOLECULAR-MECHANISMS; TRANSCRIPTION FACTOR; BLOOD-VESSELS; NF-ATC; VEGF-A; ANGIOGENESIS; HEART; SIGNALS	The hepatic vasculature is essential for liver development, homeostasis and regeneration, yet the developmental program of hepatic vessel formation and the embryonic origin of the liver vasculature remain unknown. Here we show in mouse that endocardial cells form a primitive vascular plexus surrounding the liver bud and subsequently contribute to a substantial portion of the liver vasculature. Using intersectional genetics, we demonstrate that the endocardium of the sinus venosus is a source for the hepatic plexus. Inhibition of endocardial angiogenesis results in reduced endocardial contribution to the liver vasculature and defects in liver organogenesis. We conclude that a substantial portion of liver vessels derives from the endocardium and shares a common developmental origin with coronary arteries.	[Zhang, Hui; Pu, Wenjuan; Tian, Xueying; Huang, Xiuzhen; He, Lingjuan; Liu, Qiaozhen; Li, Yan; Zhang, Libo; He, Liang; Liu, Kuo; Zhou, Bin] Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Nutr & Metab, Inst Nutr Sci,Grad Sch, Shanghai, Peoples R China; [Liu, Kuo; Zhou, Bin] ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai, Peoples R China; [Gillich, Astrid] Stanford Univ, Dept Biochem, Sch Med, Stanford, CA 94305 USA; [Zhou, Bin] Chinese Acad Sci, State Key Lab Neurosci, Ctr Excellence Brain Sci & Intelligence Technol, Inst Neurosci,Shanghai Inst Biol Sci, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; ShanghaiTech University; Stanford University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Zhou, B (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Nutr & Metab, Inst Nutr Sci,Grad Sch, Shanghai, Peoples R China.; Zhou, B (corresponding author), ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai, Peoples R China.; Zhou, B (corresponding author), Chinese Acad Sci, State Key Lab Neurosci, Ctr Excellence Brain Sci & Intelligence Technol, Inst Neurosci,Shanghai Inst Biol Sci, Shanghai, Peoples R China.	zhoubin@sibs.ac.cn		Zhou, Bin/0000-0001-5278-5522	Ministry of Science and Technology of China [2012CB945102, 2013CB945302]; National Science Foundation of China [91339104, 31271552, 31222038, 31301188, 31571503, 31501172]; Shanghai Basic Research Key Project [14JC1407400]; Major Program of Development Fund for the Shanghai Zhangjiang National Innovation Demonstration Zone [ZJ2014-ZD-002]; Shanghai Institutes for Biological Sciences (SIBS) President Fund; Sanofi-SIBS Fellowship; SIBS Postdoctoral Fund; AstraZeneca; China Postdoctoral Science Foundation [2015M570389, 2015M581669]; Youth Innovation Promotion Association of the Chinese Academy of Sciences [2015218]; Shanghai Yangfan Project [15YF1414000]; Shanghai Rising Star Program [15QA1404300]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Basic Research Key Project; Major Program of Development Fund for the Shanghai Zhangjiang National Innovation Demonstration Zone; Shanghai Institutes for Biological Sciences (SIBS) President Fund; Sanofi-SIBS Fellowship; SIBS Postdoctoral Fund; AstraZeneca(AstraZeneca); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Youth Innovation Promotion Association of the Chinese Academy of Sciences; Shanghai Yangfan Project; Shanghai Rising Star Program	We thank A. Nagy (Mount Sinai Hospital and Samuel Lunenfeld Research Institute) and J. Rossant (Hospital for Sick Children, University of Toronto) for sharing the Kdrfl mouse line and H. Zeng (Allen Institute) for sharing the Ai66 mouse line. We also thank Shanghai Biomodel Organism Co., Ltd., for mouse generation. This work was supported the Ministry of Science and Technology of China (2012CB945102 and 2013CB945302), the National Science Foundation of China (91339104, 31271552, 31222038, 31301188, 31571503 and 31501172), the Shanghai Basic Research Key Project (14JC1407400), the Major Program of Development Fund for the Shanghai Zhangjiang National Innovation Demonstration Zone (ZJ2014-ZD-002 and 2014-2016), the Shanghai Institutes for Biological Sciences (SIBS) President Fund, the Sanofi-SIBS Fellowship, the SIBS Postdoctoral Fund, AstraZeneca, the China Postdoctoral Science Foundation (2015M570389 and 2015M581669), the Youth Innovation Promotion Association of the Chinese Academy of Sciences (2015218), the Shanghai Yangfan Project (15YF1414000) and the Shanghai Rising Star Program (15QA1404300).	Anastassiadis K, 2009, DIS MODEL MECH, V2, P508, DOI 10.1242/dmm.003087; BREIER G, 1992, DEVELOPMENT, V114, P521; Buckingham M, 2005, NAT REV GENET, V6, P826, DOI 10.1038/nrg1710; Carmeliet P, 2003, NAT REV GENET, V4, P710, DOI 10.1038/nrg1158; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Chang CP, 2004, CELL, V118, P649, DOI 10.1016/j.cell.2004.08.010; de la Pompa JL, 1998, NATURE, V392, P182, DOI 10.1038/32419; Ding BS, 2014, NATURE, V505, P97, DOI 10.1038/nature12681; Ding BS, 2010, NATURE, V468, P310, DOI 10.1038/nature09493; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Goldman O, 2014, STEM CELL REP, V3, P556, DOI 10.1016/j.stemcr.2014.08.009; Haigh JJ, 2003, DEV BIOL, V262, P225, DOI 10.1016/S0012-1606(03)00356-7; He LJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109493; Katz TC, 2012, DEV CELL, V22, P639, DOI 10.1016/j.devcel.2012.01.012; Khan JA, 2016, SCIENCE, V351, P176, DOI 10.1126/science.aad0084; Lammert E, 2001, SCIENCE, V294, P564, DOI 10.1126/science.1064344; Lammert E, 2003, MECH DEVELOP, V120, P59, DOI 10.1016/S0925-4773(02)00332-5; Lewandoski M, 1997, COLD SPRING HARB SYM, V62, P159; Madisen L, 2015, NEURON, V85, P942, DOI 10.1016/j.neuron.2015.02.022; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Malhi H, 2008, GASTROENTEROLOGY, V134, P1641, DOI 10.1053/j.gastro.2008.03.002; Matsumoto K, 2001, SCIENCE, V294, P559, DOI 10.1126/science.1063889; Nagy JA, 2007, ANNU REV PATHOL-MECH, V2, P251, DOI 10.1146/annurev.pathol.2.010506.134925; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Ranger AM, 1998, NATURE, V392, P186, DOI 10.1038/32426; Red-Horse K, 2010, NATURE, V464, P549, DOI 10.1038/nature08873; Riley P, 2010, NATURE, V464, P498, DOI 10.1038/464498a; Sauer B, 2004, NUCLEIC ACIDS RES, V32, P6086, DOI 10.1093/nar/gkh941; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Tian XY, 2015, CIRC RES, V116, P515, DOI 10.1161/CIRCRESAHA.116.305097; Tian XY, 2014, SCIENCE, V345, P90, DOI 10.1126/science.1251487; Tian XY, 2013, CELL RES, V23, P1075, DOI 10.1038/cr.2013.83; Wang L, 2012, J CLIN INVEST, V122, P1567, DOI 10.1172/JCI58789; Wu BR, 2012, CELL, V151, P1083, DOI 10.1016/j.cell.2012.10.023; Zhang H, 2016, CIRC RES, V118, P254, DOI 10.1161/CIRCRESAHA.115.307202; Zhang H, 2014, J BIOL CHEM, V289, P18681, DOI 10.1074/jbc.M114.554584; Zhou B, 2011, J CLIN INVEST, V121, P1894, DOI 10.1172/JCI45529	37	60	61	1	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2016	48	5					537	+		10.1038/ng.3536	http://dx.doi.org/10.1038/ng.3536			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DK3RC	27019112				2022-12-25	WOS:000374834100013
J	Liu, XW; Xiao, ZD; Han, L; Zhang, JX; Lee, SW; Wang, WQ; Lee, H; Zhuang, L; Chen, JJ; Lin, HK; Wang, J; Liang, H; Gan, BY				Liu, Xiaowen; Xiao, Zhen-Dong; Han, Leng; Zhang, Jiexin; Lee, Szu-Wei; Wang, Wenqi; Lee, Hyemin; Zhuang, Li; Chen, Junjie; Lin, Hui-Kuan; Wang, Jing; Liang, Han; Gan, Boyi			LncRNA NBR2 engages a metabolic checkpoint by regulating AMPK under energy stress	NATURE CELL BIOLOGY			English	Article							ACTIVATED PROTEIN-KINASE; LONG NONCODING RNAS; GROWTH-CONTROL; CELL-SURVIVAL; TUMOR-GROWTH; LKB1; PHOSPHORYLATION; CHROMATIN; GENE; TRANSCRIPTION	Long non-coding RNAs (lncRNAs) have emerged as critical regulators in various cellular processes. However, the potential involvement of lncRNAs in kinase signalling remains largely unknown. AMP-activated protein kinase (AMPK) acts as a critical sensor of cellular energy status. Here we show that the lncRNA NBR2 (neighbour of BRCA1 gene 2) is induced by the LKB1-AMPK pathway under energy stress. On energy stress, NBR2 in turn interacts with AMPK and promotes AMPK kinase activity, thus forming a feed-forward loop to potentiate AMPK activation during energy stress. Depletion of NBR2 attenuates energy-stress-induced AMPK activation, resulting in unchecked cell cycling, altered apoptosis/autophagy response, and increased tumour development in vivo. NBR2 is downregulated and its low expression correlates with poor clinical outcomes in some human cancers. Together, the results of our study uncover a mechanism coupling lncRNAs with metabolic stress response, and provides a broad framework to understand further the regulation of kinase signalling by lncRNAs.	[Liu, Xiaowen; Xiao, Zhen-Dong; Wang, Wenqi; Lee, Hyemin; Zhuang, Li; Chen, Junjie; Gan, Boyi] Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, 1515 Holcombe Blvd, Houston, TX 77030 USA; [Han, Leng] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Zhang, Jiexin; Wang, Jing; Liang, Han] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, 1515 Holcombe Blvd, Houston, TX 77030 USA; [Lee, Szu-Wei; Lin, Hui-Kuan; Gan, Boyi] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, 1515 Holcombe Blvd, Houston, TX 77030 USA; [Lee, Szu-Wei; Chen, Junjie; Lin, Hui-Kuan; Gan, Boyi] Univ Texas Grad Sch Biomed Sci, Program Genes & Dev, 1515 Holcombe Blvd, Houston, TX 77030 USA; [Lee, Szu-Wei; Chen, Junjie; Lin, Hui-Kuan; Gan, Boyi] Univ Texas Grad Sch Biomed Sci, Program Canc Biol, 1515 Holcombe Blvd, Houston, TX 77030 USA; [Lin, Hui-Kuan] Wake Forest Sch Med, Dept Canc Biol, Winston Salem, NC 27157 USA; [Lin, Hui-Kuan] China Med Univ, Grad Inst Basic Med Sci, Taichung 404, Taiwan	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Wake Forest University; China Medical University Taiwan	Gan, BY (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, 1515 Holcombe Blvd, Houston, TX 77030 USA.; Gan, BY (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, 1515 Holcombe Blvd, Houston, TX 77030 USA.; Gan, BY (corresponding author), Univ Texas Grad Sch Biomed Sci, Program Genes & Dev, 1515 Holcombe Blvd, Houston, TX 77030 USA.; Gan, BY (corresponding author), Univ Texas Grad Sch Biomed Sci, Program Canc Biol, 1515 Holcombe Blvd, Houston, TX 77030 USA.	bgan@mdanderson.org	肖, 振东/HCI-5410-2022; Han, Leng/HCH-3491-2022; Gan, Boyi/HDM-4206-2022	肖, 振东/0000-0003-1630-612X; Han, Leng/0000-0002-7380-2640; Wang, Wenqi/0000-0003-4053-5088	MD Anderson Cancer Center; US Department of Defense [TS093049]; Cancer Prevention & Research Institute of Texas [RP130020]; National Institutes of Health [CA181196, CA190370, CA143883, CA175486, CA182424, CA193813]; Ellison Medical Foundation [AG-NS-0973-13]; Gabrielle's Angel Foundation for Cancer Research; Jeanne F. Shelby Scholarship Fund; Cancer Prevention and Research Institute of Texas [RP140462, RR150085]; Mary K. Chapman Foundation; Lorraine Dell Program in Bioinformatics for Personalization of Cancer Medicine; National Institutes of Health Core Grant [CA016672]; NATIONAL CANCER INSTITUTE [U24CA143883, R01CA181196, R01CA193813, P30CA016672, R01CA190370, R01CA175486, R01CA182424] Funding Source: NIH RePORTER	MD Anderson Cancer Center; US Department of Defense(United States Department of Defense); Cancer Prevention & Research Institute of Texas; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); Gabrielle's Angel Foundation for Cancer Research; Jeanne F. Shelby Scholarship Fund; Cancer Prevention and Research Institute of Texas; Mary K. Chapman Foundation; Lorraine Dell Program in Bioinformatics for Personalization of Cancer Medicine; National Institutes of Health Core Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank all members of the Gan laboratory for their advice and technical assistance. This research has been supported by grants from MD Anderson Cancer Center, US Department of Defense (TS093049), Cancer Prevention & Research Institute of Texas (RP130020), National Institutes of Health (CA181196 and CA190370), Ellison Medical Foundation (AG-NS-0973-13), and Gabrielle's Angel Foundation for Cancer Research (to B.G.). B.G. is a Kimmel Scholar and an Ellison Medical Foundation New Scholar. H.Liang is supported by the National Institutes of Health (CA143883, CA175486); the R. Lee Clark Fellow Award from The Jeanne F. Shelby Scholarship Fund; a grant from the Cancer Prevention and Research Institute of Texas (RP140462); and the Mary K. Chapman Foundation and the Lorraine Dell Program in Bioinformatics for Personalization of Cancer Medicine. L.H. is supported by Cancer Prevention & Research Institute of Texas (RR150085). H.-K.L. is supported by the National Institutes of Health (CA182424 and CA193813). B.G., J.C., J.W. and H.Liang are members of the MD Anderson Cancer Center, and are supported by the National Institutes of Health Core Grant CA016672.	Alessi DR, 2006, ANNU REV BIOCHEM, V75, P137, DOI 10.1146/annurev.biochem.75.103004.142702; Batista PJ, 2013, CELL, V152, P1298, DOI 10.1016/j.cell.2013.02.012; Bungard D, 2010, SCIENCE, V329, P1201, DOI 10.1126/science.1191241; Corradetti MN, 2004, GENE DEV, V18, P1533, DOI 10.1101/gad.1199104; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371; Engreitz JM, 2013, SCIENCE, V341, P767, DOI 10.1126/science.1237973; Faubert B, 2013, CELL METAB, V17, P113, DOI 10.1016/j.cmet.2012.12.001; Feng JC, 2006, GENE DEV, V20, P1470, DOI 10.1101/gad.1416106; Gad Sophie, 2003, Hum Mutat, V21, P654, DOI 10.1002/humu.9148; Gan BY, 2010, NATURE, V468, P701, DOI 10.1038/nature09595; Gan BY, 2010, CANCER CELL, V18, P472, DOI 10.1016/j.ccr.2010.10.019; Gan B, 2008, P NATL ACAD SCI USA, V105, P19384, DOI 10.1073/pnas.0810584105; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Guttman M, 2012, NATURE, V482, P339, DOI 10.1038/nature10887; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Gyorffy B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082241; Hardie DG, 2016, TRENDS CELL BIOL, V26, P190, DOI 10.1016/j.tcb.2015.10.013; Hardie DG, 2014, CELL METAB, V20, P939, DOI 10.1016/j.cmet.2014.09.013; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Hezel AF, 2008, ONCOGENE, V27, P6908, DOI 10.1038/onc.2008.342; Huang J, 2008, BIOCHEM J, V412, P179, DOI 10.1042/BJ20080281; Huarte M, 2010, CELL, V142, P409, DOI 10.1016/j.cell.2010.06.040; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Jin H, 2004, GENOMICS, V84, P1071, DOI 10.1016/j.ygeno.2004.08.019; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lee SW, 2015, MOL CELL, V57, P1022, DOI 10.1016/j.molcel.2015.01.015; Lin A, 2014, ONCOGENE, V33, P3183, DOI 10.1038/onc.2013.273; Lin AF, 2014, CANCER RES, V74, P1682, DOI 10.1158/0008-5472.CAN-13-1729; Pandey RR, 2008, MOL CELL, V32, P232, DOI 10.1016/j.molcel.2008.08.022; Prensner JR, 2011, NAT BIOTECHNOL, V29, P742, DOI 10.1038/nbt.1914; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Shackelford DB, 2009, NAT REV CANCER, V9, P563, DOI 10.1038/nrc2676; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; SIM ATR, 1988, FEBS LETT, V233, P294, DOI 10.1016/0014-5793(88)80445-9; Ulitsky I, 2013, CELL, V154, P26, DOI 10.1016/j.cell.2013.06.020; van Heesch S, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-1-r6; Wang KC, 2011, NATURE, V472, P120, DOI 10.1038/nature09819; Woods A, 2003, CURR BIOL, V13, P2004, DOI 10.1016/j.cub.2003.10.031; Xu CF, 1997, HUM MOL GENET, V6, P1057, DOI 10.1093/hmg/6.7.1057	43	212	226	0	88	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2016	18	4					431	+		10.1038/ncb3328	http://dx.doi.org/10.1038/ncb3328			32	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	DH7LX	26999735	Green Submitted, Green Accepted			2022-12-25	WOS:000372976600010
J	Acemel, RD; Tena, JJ; Irastorza-Azcarate, I; Marletaz, F; Gomez-Marin, C; de la Calle-Mustienes, E; Bertrand, S; Diaz, SG; Aldea, D; Aury, JM; Mangenot, S; Holland, PWH; Devos, DP; Maeso, I; Escriva, H; Gomez-Skarmeta, JL				Acemel, Rafael D.; Tena, Juan J.; Irastorza-Azcarate, Ibai; Marletaz, Ferdinand; Gomez-Marin, Carlos; de la Calle-Mustienes, Elisa; Bertrand, Stephanie; Diaz, Sergio G.; Aldea, Daniel; Aury, Jean-Marc; Mangenot, Sophie; Holland, Peter W. H.; Devos, Damien P.; Maeso, Ignacio; Escriva, Hector; Luis Gomez-Skarmeta, Jose			A single three-dimensional chromatin compartment in amphioxus indicates a stepwise evolution of vertebrate Hox bimodal regulation	NATURE GENETICS			English	Article							TOPOLOGICALLY ASSOCIATING DOMAINS; GENES; TRANSCRIPTION; DUPLICATION; LANDSCAPES; EXPRESSION; ENHANCERS; CLUSTERS; PROTEINS; LOCI	The HoxA and HoxD gene clusters of jawed vertebrates are organized into bipartite three-dimensional chromatin: structures that separate long-range regulatory inputs coming from the anterior and posterior Hox-neighboring regionsl. This architecture is instrumental in allowing vertebrate Hox genes to pattern disparate parts of the body, including limbs2. Almost nothing is known about how these three-dimensional topologies originated. Here we perform extensive 4C-seq profiling of the Hox cluster in embryos of amphioxus, an invertebrate chordate. We find that, in contrast to the architecture in vertebrates, the amphioxus Hox cluster is organized into a single chromatin interaction domain that includes long-range contacts mostly from the anterior side, bringing distant cis-regulatory elements into contact with Hox genes. We infer that the vertebrate Hox bipartite regulatory system is an evolutionary novelty generated by combining ancient long-range regulatory contacts from DNA in the anterior Hox neighborhood with new regulatory inputs from the posterior side.	[Acemel, Rafael D.; Tena, Juan J.; Irastorza-Azcarate, Ibai; Gomez-Marin, Carlos; de la Calle-Mustienes, Elisa; Diaz, Sergio G.; Devos, Damien P.; Maeso, Ignacio; Luis Gomez-Skarmeta, Jose] Univ Pablo de Olavide, CSIC, CABD, Seville, Spain; [Marletaz, Ferdinand; Holland, Peter W. H.] Univ Oxford, Dept Zool, S Parks Rd, Oxford, England; [Bertrand, Stephanie; Aldea, Daniel; Escriva, Hector] Univ Paris 06, CNRS, UMR 7232, BIOM,Observ Oceanol Banyuls Sur Mer, Banyuls Sur Mer, France; [Aury, Jean-Marc; Mangenot, Sophie] CEA, Inst Genom, Evry, France	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; CSIC - Andalusian Center for Developmental Biology (CABD); University of Oxford; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; CEA; UDICE-French Research Universities; Universite Paris Saclay	Devos, DP; Maeso, I; Gomez-Skarmeta, JL (corresponding author), Univ Pablo de Olavide, CSIC, CABD, Seville, Spain.; Escriva, H (corresponding author), Univ Paris 06, CNRS, UMR 7232, BIOM,Observ Oceanol Banyuls Sur Mer, Banyuls Sur Mer, France.	damienpdevos@gmail.com; nacho.maeso@gmail.com; hescriva@obs-banyuls.fr; jlgomska@upo.es	Aury, Jean-Marc/N-1621-2019; devos, damien/ABH-5348-2020; Tena, Juan J/M-2265-2014; Aldea, Daniel/L-4040-2015; Marlétaz, Ferdinand/H-3018-2019; Bertrand, Stephanie/D-8482-2014; Tena, Juan J./Q-5995-2019; Acemel, Rafael Dominguez/AAM-1957-2020; Gomez-Skarmeta, Jose Luis/B-5268-2014; Escriva, Hector/K-8325-2013; Irastorza, Ibai/ABI-7349-2020; Gómez-Marín, Carlos/AAX-2173-2021; Maeso, Ignacio/F-7659-2012	Aury, Jean-Marc/0000-0003-1718-3010; Tena, Juan J/0000-0001-8165-7984; Aldea, Daniel/0000-0001-5101-0194; Marlétaz, Ferdinand/0000-0001-8124-4266; Bertrand, Stephanie/0000-0002-0689-0126; Tena, Juan J./0000-0001-8165-7984; Acemel, Rafael Dominguez/0000-0003-4120-0140; Gomez-Skarmeta, Jose Luis/0000-0001-5125-4332; Escriva, Hector/0000-0001-7577-5028; Irastorza, Ibai/0000-0001-5245-2322; Maeso, Ignacio/0000-0002-6440-8457; Devos, Damien/0000-0002-9453-4753; de la Calle-Mustienes, Elisa/0000-0002-8975-6503; Holland, Peter/0000-0003-1533-9376; Gomez-Marin, Carlos/0000-0001-9724-2919	Ministerio de Economia y Competitividad [BFU2013-41322-P]; Juan de la Cierva postdoctoral [BFU2014-58449-JIN]; Andalusian government [BIO-396]; C2A [EE: 2013/2506]; European Research Council (ERC) [268513]; European Molecular Biology Organization (EMBO); Universidad Pablo de Olavide; Conicyt 'Becas Chile'	Ministerio de Economia y Competitividad(Spanish Government); Juan de la Cierva postdoctoral; Andalusian government; C2A; European Research Council (ERC)(European Research Council (ERC)European Commission); European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO)); Universidad Pablo de Olavide; Conicyt 'Becas Chile'(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT))	We specially thank J. Pascual-Anaya for helping with some figures and helpful discussions. We would also like to thank F. Casares, I. Almudi and J.R. Martinez Morales for fruitful discussions. Work was funded by grants from the Ministerio de Economia y Competitividad (BFU2013-41322-P to J.L.G.-S.; Juan de la Cierva postdoctoral contract to I.M.; BFU2014-58449-JIN to J.J.T.); the Andalusian government (BIO-396 to J.L.G.-S.; C2A (EE: 2013/2506) to D.P.D. and I.I.-A.); the European Research Council (ERC; grant 268513) to P.W.H.H. and F.M.; a European Molecular Biology Organization (EMBO) short fellowship to I.M.; the Universidad Pablo de Olavide to J.J.T.; and Conicyt 'Becas Chile' to D.A.	Andrey G, 2013, SCIENCE, V340, P1195, DOI 10.1126/science.1234167; Berlivet S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1004018; Bertrand S, 2011, DEVELOPMENT, V138, P4819, DOI 10.1242/dev.066720; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Ciabrelli F, 2015, J MOL BIOL, V427, P608, DOI 10.1016/j.jmb.2014.09.013; de Laat W, 2013, NATURE, V502, P499, DOI 10.1038/nature12753; Dehal P, 2005, PLOS BIOL, V3, P1700, DOI 10.1371/journal.pbio.0030314; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Ferrier DEK, 2001, DEV BIOL, V237, P270, DOI 10.1006/dbio.2001.0375; Gehrke AR, 2015, P NATL ACAD SCI USA, V112, P803, DOI 10.1073/pnas.1420208112; Ghavi-Helm Y, 2014, NATURE, V512, P96, DOI 10.1038/nature13417; Gomez-Diaz E, 2014, TRENDS CELL BIOL, V24, P703, DOI 10.1016/j.tcb.2014.08.003; Gonzalez F, 2007, DEV BIOL, V306, P847, DOI 10.1016/j.ydbio.2007.03.020; Holland LZ, 2012, WIRES DEV BIOL, V1, P167, DOI 10.1002/wdev.11; Lehoczky JA, 2004, EVOL DEV, V6, P423, DOI 10.1111/j.1525-142X.2004.04050.x; Lonfat N, 2015, FEBS LETT, V589, P2869, DOI 10.1016/j.febslet.2015.04.024; Lonfat N, 2014, SCIENCE, V346, P1004, DOI 10.1126/science.1257493; Maeso I, 2012, GENOME RES, V22, P642, DOI 10.1101/gr.132233.111; Mallo M, 2013, DEVELOPMENT, V140, P3951, DOI 10.1242/dev.068346; Montavon T, 2011, CELL, V147, P1132, DOI 10.1016/j.cell.2011.10.023; Noordermeer D, 2014, ELIFE, V3, DOI 10.7554/eLife.02557; Noordermeer D, 2011, SCIENCE, V334, P222, DOI 10.1126/science.1207194; Paps J, 2012, BRIEF FUNCT GENOMICS, V11, P177, DOI 10.1093/bfgp/els012; Pascual-Anaya J, 2012, EVODEVO, V3, DOI 10.1186/2041-9139-3-28; Woltering JM, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001773	25	73	73	1	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2016	48	3					336	341		10.1038/ng.3497	http://dx.doi.org/10.1038/ng.3497			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DE8QW	26829752	Green Submitted			2022-12-25	WOS:000370902600020
J	Oxley, TJ; Opie, NL; John, SE; Rind, GS; Ronayne, SM; Wheeler, TL; Judy, JW; McDonald, AJ; Dornom, A; Lovell, TJH; Steward, C; Garrett, DJ; Moffat, BA; Lui, EH; Yassi, N; Campbell, BCV; Wong, YT; Fox, KE; Nurse, ES; Bennett, IE; Bauquier, SH; Liyanage, KA; van der Nagel, NR; Perucca, P; Ahnood, A; Gill, KP; Yan, B; Churilov, L; French, CR; Desmond, PM; Horne, MK; Kiers, L; Prawer, S; Davis, SM; Burkitt, AN; Mitchell, PJ; Grayden, DB; May, CN; O'Brien, TJ				Oxley, Thomas J.; Opie, Nicholas L.; John, Sam E.; Rind, Gil S.; Ronayne, Stephen M.; Wheeler, Tracey L.; Judy, Jack W.; McDonald, Alan J.; Dornom, Anthony; Lovell, Timothy J. H.; Steward, Christopher; Garrett, David J.; Moffat, Bradford A.; Lui, Elaine H.; Yassi, Nawaf; Campbell, Bruce C. V.; Wong, Yan T.; Fox, Kate E.; Nurse, Ewan S.; Bennett, Iwan E.; Bauquier, Sebastien H.; Liyanage, Kishan A.; van der Nagel, Nicole R.; Perucca, Piero; Ahnood, Arman; Gill, Katherine P.; Yan, Bernard; Churilov, Leonid; French, Christopher R.; Desmond, Patricia M.; Horne, Malcolm K.; Kiers, Lynette; Prawer, Steven; Davis, Stephen M.; Burkitt, Anthony N.; Mitchell, Peter J.; Grayden, David B.; May, Clive N.; O'Brien, Terence J.			Minimally invasive endovascular stent-electrode array for high-fidelity, chronic recordings of cortical neural activity	NATURE BIOTECHNOLOGY			English	Article							IDIOPATHIC INTRACRANIAL HYPERTENSION; SURFACE-BASED ANALYSIS; RANDOMIZED-TRIAL; LONG-TERM; STIMULATION; SINUS; EEG; CATHETER; TISSUE; PACEMAKER	High-fidelity intracranial electrode arrays for recording and stimulating brain activity have facilitated major advances in the treatment of neurological conditions over the past decade. Traditional arrays require direct implantation into the brain via open craniotomy, which can lead to inflammatory tissue responses, necessitating development of minimally invasive approaches that avoid brain trauma. Here we demonstrate the feasibility of chronically recording brain activity from within a vein using a passive stent-electrode recording array (stentrode). We achieved implantation into a superficial cortical vein overlying the motor cortex via catheter angiography and demonstrate neural recordings in freely moving sheep for up to 190 d. Spectral content and bandwidth of vascular electrocorticography were comparable to those of recordings from epidural surface arrays. Venous internal lumen patency was maintained for the duration of implantation. Stentrodes may have wide ranging applications as a neural interface for treatment of a range of neurological conditions.	[Oxley, Thomas J.; Opie, Nicholas L.; John, Sam E.; Rind, Gil S.; Ronayne, Stephen M.; Lovell, Timothy J. H.; Wong, Yan T.; Nurse, Ewan S.; Liyanage, Kishan A.; van der Nagel, Nicole R.; Gill, Katherine P.; Grayden, David B.; May, Clive N.] Univ Melbourne, Dept Med, Melbourne Brain Ctr, Vasc Bion Lab, Melbourne, Vic, Australia; [Oxley, Thomas J.; Opie, Nicholas L.; John, Sam E.; Rind, Gil S.; Ronayne, Stephen M.; Lovell, Timothy J. H.; Steward, Christopher; Yassi, Nawaf; Campbell, Bruce C. V.; Perucca, Piero; Yan, Bernard; French, Christopher R.; Kiers, Lynette; Davis, Stephen M.; O'Brien, Terence J.] Univ Melbourne, Royal Melbourne Hosp, Melbourne Brain Ctr, Dept Med, Melbourne, Vic 3050, Australia; [Oxley, Thomas J.; Opie, Nicholas L.; John, Sam E.; Rind, Gil S.; Ronayne, Stephen M.; Lovell, Timothy J. H.; Steward, Christopher; Yassi, Nawaf; Campbell, Bruce C. V.; Perucca, Piero; Yan, Bernard; French, Christopher R.; Kiers, Lynette; Davis, Stephen M.; O'Brien, Terence J.] Univ Melbourne, Royal Melbourne Hosp, Melbourne Brain Ctr, Dept Neurol, Melbourne, Vic 3050, Australia; [Oxley, Thomas J.; Opie, Nicholas L.; John, Sam E.; Rind, Gil S.; Ronayne, Stephen M.; McDonald, Alan J.; Dornom, Anthony; Lovell, Timothy J. H.; Churilov, Leonid; Horne, Malcolm K.; May, Clive N.] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Melbourne, Vic, Australia; [Oxley, Thomas J.; Opie, Nicholas L.; John, Sam E.; Wong, Yan T.; Nurse, Ewan S.; Burkitt, Anthony N.; Grayden, David B.] Univ Melbourne, Dept Elect & Elect Engn, NeuroEngn Lab, Melbourne, Vic, Australia; [Wheeler, Tracey L.] Craig H Neilsen Fdn, Encino, CA USA; [Judy, Jack W.] Univ Florida, Nanosci Inst Med & Engn Technol, Gainesville, FL USA; [Steward, Christopher; Moffat, Bradford A.; Lui, Elaine H.; Desmond, Patricia M.; Mitchell, Peter J.] Melbourne Hlth, Royal Melbourne Hosp, Dept Radiol, Melbourne, Vic, Australia; [Steward, Christopher; Moffat, Bradford A.; Lui, Elaine H.; Desmond, Patricia M.; Mitchell, Peter J.] Univ Melbourne, Dept Radiol, Melbourne, Vic, Australia; [Garrett, David J.; Fox, Kate E.; Ahnood, Arman; Prawer, Steven] Univ Melbourne, Sch Phys, Melbourne, Vic, Australia; [Garrett, David J.; Burkitt, Anthony N.; Grayden, David B.] Bion Inst, East Melbourne, Vic, Australia; [Moffat, Bradford A.] Univ Melbourne, Dept Anat & Neurosci, Melbourne, Vic, Australia; [Fox, Kate E.] RMIT Univ, Sch Aerosp Mech & Mfg Engn, Ctr Addit Mfg, Melbourne, Vic, Australia; [Bennett, Iwan E.] Univ Melbourne, Royal Melbourne Hosp, Dept Surg, Melbourne, Vic 3050, Australia; [Bauquier, Sebastien H.] Univ Melbourne, Fac Vet & Agr Sci, Vet Hosp, Translat Res & Clin Trials TRACTs, Melbourne, Vic, Australia; [Churilov, Leonid] RMIT Univ, Sch Math & Geospatial Sci, Melbourne, Vic, Australia; [Grayden, David B.] Univ Melbourne, Ctr Neural Engn, Melbourne, Vic, Australia	University of Melbourne; Royal Melbourne Hospital; University of Melbourne; Royal Melbourne Hospital; University of Melbourne; Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Melbourne; State University System of Florida; University of Florida; Royal Melbourne Hospital; University of Melbourne; University of Melbourne; Bionics Institute; University of Melbourne; Royal Melbourne Institute of Technology (RMIT); Royal Melbourne Hospital; University of Melbourne; University of Melbourne; Royal Melbourne Institute of Technology (RMIT); University of Melbourne	Oxley, TJ (corresponding author), Univ Melbourne, Dept Med, Melbourne Brain Ctr, Vasc Bion Lab, Melbourne, Vic, Australia.; Oxley, TJ (corresponding author), Univ Melbourne, Royal Melbourne Hosp, Melbourne Brain Ctr, Dept Med, Melbourne, Vic 3050, Australia.; Oxley, TJ (corresponding author), Univ Melbourne, Royal Melbourne Hosp, Melbourne Brain Ctr, Dept Neurol, Melbourne, Vic 3050, Australia.; Oxley, TJ (corresponding author), Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Melbourne, Vic, Australia.; Oxley, TJ (corresponding author), Univ Melbourne, Dept Elect & Elect Engn, NeuroEngn Lab, Melbourne, Vic, Australia.	thomas.oxley@unimelb.edu.au	Moffat, Bradford/L-3777-2019; French, Chris/AHA-1801-2022; Campbell, Bruce/J-1220-2019; Gill, Katherine/AAT-9676-2020; Horne, Malcolm/AAL-5214-2020; Campbell, Bruce/AGY-4147-2022; Wong, Yan Tat/G-5408-2016; O'Brien, Terence/AAU-5525-2021; O'Brien, Terence/L-8102-2013; Gill, Katherine P./AAO-1339-2020; Nurse, Ewan/J-7600-2016; Ahnood, Arman/O-8450-2015; Davis, Stephen/L-5260-2013; Opie, Nicholas/M-3831-2017; John, Sam/E-6904-2012; Desmond, Patricia/D-1966-2014	Moffat, Bradford/0000-0002-0278-4801; Campbell, Bruce/0000-0003-3632-9433; Horne, Malcolm/0000-0001-9427-2100; Wong, Yan Tat/0000-0002-5281-8221; O'Brien, Terence/0000-0002-7198-8621; Gill, Katherine P./0000-0001-6084-0296; Nurse, Ewan/0000-0001-8981-0074; Oxley, Thomas/0000-0002-5569-3612; Ahnood, Arman/0000-0002-0253-7579; French, Christopher/0000-0002-1445-8704; Davis, Stephen/0000-0003-0962-2300; Yassi, Nawaf/0000-0002-0685-0060; Perucca, Piero/0000-0002-7855-7066; Garrett, David/0000-0002-4676-8387; Bauquier, Sebastien/0000-0001-7355-5590; PRAWER, STEVEN/0000-0002-4959-0828; Opie, Nicholas/0000-0002-0342-9457; John, Sam/0000-0003-3780-2210; Desmond, Patricia/0000-0002-4803-6323	US Defense Advanced Research Projects Agency (DARPA) Microsystems Technology Office [N66001-12-1-4045]; Office of Naval Research (ONR) Global [N62909-14-1-N020]; National Health and Medical Research Council of Australia (NHMRC) [APP1062532, APP1075117]; Defence Health Foundation, Australia; Defence Science Institute, Australia; Brain Foundation, Australia; Victorian Government; Royal Melbourne Hospital Neuroscience Foundation; Faculty of Medicine, University of Melbourne; Covidien (Medtronic)	US Defense Advanced Research Projects Agency (DARPA) Microsystems Technology Office(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Office of Naval Research (ONR) Global(Office of Naval Research); National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Defence Health Foundation, Australia; Defence Science Institute, Australia; Brain Foundation, Australia; Victorian Government; Royal Melbourne Hospital Neuroscience Foundation; Faculty of Medicine, University of Melbourne(University of Melbourne); Covidien (Medtronic)	The research was supported by US Defense Advanced Research Projects Agency (DARPA) Microsystems Technology Office contract N66001-12-1-4045; Office of Naval Research (ONR) Global N62909-14-1-N020; National Health and Medical Research Council of Australia (NHMRC) Project Grant APP1062532 and Development Grant APP1075117; Defence Health Foundation, Australia (Booster Grant); Defence Science Institute, Australia, grant; Brain Foundation, Australia, research gift; and the Victorian Government's Operational Infrastructure Support Program. T.J.O. acknowledges the support of the Royal Melbourne Hospital Neuroscience Foundation for the Warren Haynes Fellowship, as well as the Faculty of Medicine, University of Melbourne for the Leslie Eric Paddle Scholarship in Neurology. We thank Covidien (Medtronic) for provision of 30 Solitaire stentriever devices as a product research grant, K. Wilson and S. Cudennec for MRI data acquisition; C. Hall, A. Stevenson and A. Maksimenko for synchrotron acquisition; G. Sharma and S. Salinas for imaging analysis; H. Lau and T. Vale for surgical assistance; and L. Warne for anesthetic assistance. We acknowledge the facilities, and the scientific and technical assistance of the Australian National Imaging Facility at the Melbourne Brain Centre Imaging Unit, as well as the Imaging and Medical beamline at the Australian Synchrotron, Victoria, Australia.	Ahmed RM, 2011, AM J NEURORADIOL, V32, P1408, DOI 10.3174/ajnr.A2575; ALLISON T, 1989, J NEUROPHYSIOL, V62, P694, DOI 10.1152/jn.1989.62.3.694; [Anonymous], 1997, EVOKED POTENTIALS CL; Antiga L, 2008, MED BIOL ENG COMPUT, V46, P1097, DOI 10.1007/s11517-008-0420-1; Bagley C, 1922, ARCH NEURO PSYCHIATR, V7, P417, DOI 10.1001/archneurpsyc.1922.02190100002001; Berkhemer OA, 2015, NEW ENGL J MED, V372, P11, DOI 10.1056/NEJMoa1411587; Boniface SJ, 1997, J NEUROL NEUROSUR PS, V62, P193, DOI 10.1136/jnnp.62.2.193; Bower MR, 2013, J NEUROSCI METH, V214, P21, DOI 10.1016/j.jneumeth.2012.12.027; Bundy DT, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/1/016006; Campbell BCV, 2015, NEW ENGL J MED, V372, P1009, DOI 10.1056/NEJMoa1414792; Cedzich C, 1996, NEUROSURGERY, V38, P962, DOI 10.1097/00006123-199605000-00023; Chimowitz MI, 2011, NEW ENGL J MED, V365, P993, DOI 10.1056/NEJMoa1105335; Cook MJ, 2013, LANCET NEUROL, V12, P563, DOI 10.1016/S1474-4422(13)70075-9; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Deuschl G, 2006, NEW ENGL J MED, V355, P896, DOI 10.1056/NEJMoa060281; Dill T, 2003, CIRCULATION, V107, P845, DOI 10.1161/01.CIR.0000048146.81336.1D; DRILLER J, 1969, MED RES ENG, V8, P11; Fedorov A, 2012, MAGN RESON IMAGING, V30, P1323, DOI 10.1016/j.mri.2012.05.001; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fortescue EB, 2004, HEART RHYTHM, V1, P150, DOI 10.1016/j.hrthm.2004.02.020; Franks W, 2005, IEEE T BIO-MED ENG, V52, P1295, DOI 10.1109/TBME.2005.847523; FURMAN S, 1959, NEW ENGL J MED, V261, P943, DOI 10.1056/NEJM195911052611904; Ghoshal N. G., 1967, Iowa St Univ Vet, V29, P19; Grovum WL, 1999, BRAIN RES, V851, P252, DOI 10.1016/S0006-8993(99)02083-1; Henle C, 2011, BIOMED MICRODEVICES, V13, P59, DOI 10.1007/s10544-010-9471-9; Ho JS, 2014, P NATL ACAD SCI USA, V111, P7974, DOI 10.1073/pnas.1403002111; Hochberg LR, 2006, NATURE, V442, P164, DOI 10.1038/nature04970; Hochberg LR, 2012, NATURE, V485, P372, DOI 10.1038/nature11076; Hoffmann A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092990; JOHNSON JI, 1974, J COMP NEUROL, V158, P81, DOI 10.1002/cne.901580106; Karumbaiah L, 2013, BIOMATERIALS, V34, P8061, DOI 10.1016/j.biomaterials.2013.07.016; Lukatch HS, 2005, CEREB CORTEX, V15, P1322, DOI 10.1093/cercor/bhi015; Mallet L, 2008, NEW ENGL J MED, V359, P2121, DOI 10.1056/NEJMoa0708514; Metscher Brian D., 2009, BMC Physiology, V9, P11, DOI 10.1186/1472-6793-9-11; Mikuni N, 1997, EPILEPSIA, V38, P472, DOI 10.1111/j.1528-1157.1997.tb01738.x; MIROWSKI M, 1980, NEW ENGL J MED, V303, P322, DOI 10.1056/NEJM198008073030607; Morlacchi S, 2011, ANN BIOMED ENG, V39, P2615, DOI 10.1007/s10439-011-0355-9; Morrell MJ, 2011, NEUROLOGY, V77, P1295, DOI 10.1212/WNL.0b013e3182302056; Muller R, 2014, ISSCC DIG TECH PAP I, V57, P412, DOI 10.1109/ISSCC.2014.6757492; Nieman K, 2003, HERZ, V28, P136, DOI 10.1007/s00059-003-2446-3; OGAWA T, 1992, CAN J ANAESTH, V39, P862, DOI 10.1007/BF03008298; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; PALAHNIUK RJ, 1974, ANESTHESIOLOGY, V41, P82, DOI 10.1097/00000542-197407000-00021; PENN RD, 1973, J NEUROSURG, V38, P239, DOI 10.3171/jns.1973.38.2.0239; Polikov VS, 2005, J NEUROSCI METH, V148, P1, DOI 10.1016/j.jneumeth.2005.08.015; Puffer RC, 2013, J NEUROINTERV SURG, V5, P483, DOI 10.1136/neurintsurg-2012-010468; Rampil IJ, 1998, ANESTHESIOLOGY, V89, P980, DOI 10.1097/00000542-199810000-00023; Saxena T, 2013, BIOMATERIALS, V34, P4703, DOI 10.1016/j.biomaterials.2013.03.007; Shao Y, 2009, J CLIN NEUROSCI, V16, P421, DOI 10.1016/j.jocn.2008.02.024; Shimoda K, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/3/036015; Simpson S, 1911, Q J EXP PHYSIOL, V4, P53, DOI 10.1113/expphysiol.1911.sp000083; Stevenson AW, 2010, J SYNCHROTRON RADIAT, V17, P75, DOI 10.1107/S0909049509041788; STONEY WS, 1976, ANN THORAC SURG, V22, P166, DOI 10.1016/S0003-4975(10)63980-X; Sun J, 2011, AJNR Am J Neuroradiol, V32, pE191, DOI 10.3174/ajnr.A2308; Teplitzky BA, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/2/026011; THOMSON DJ, 1982, P IEEE, V70, P1055, DOI 10.1109/PROC.1982.12433; Valderrama AT, 2010, J NEUROSCI METH, V187, P270, DOI 10.1016/j.jneumeth.2010.01.019; VanBelle E, 1997, CIRCULATION, V95, P438; VANDERGIESSEN WJ, 1991, CIRCULATION, V83, P1788, DOI 10.1161/01.CIR.83.5.1788; Villeneuve MY, 2003, J NEUROSCI METH, V129, P19, DOI 10.1016/S0165-0270(03)00198-5; Wang W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055344; Watanabe H, 2009, ELECTR COMMUN JPN, V92, P29, DOI 10.1002/ecj.10058; Weiland JD, 2011, OPHTHALMOLOGY, V118, P2227, DOI 10.1016/j.ophtha.2011.08.042; Williams JC, 2007, J NEURAL ENG, V4, P410, DOI 10.1088/1741-2560/4/4/007; WILSON BS, 1991, NATURE, V352, P236, DOI 10.1038/352236a0; Yanagisawa T, 2012, ANN NEUROL, V71, P353, DOI 10.1002/ana.22613; Yanagisawa T, 2009, NEUROIMAGE, V45, P1099, DOI 10.1016/j.neuroimage.2008.12.069	67	115	126	17	90	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2016	34	3					320	+		10.1038/nbt.3428	http://dx.doi.org/10.1038/nbt.3428			11	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DG1CJ	26854476				2022-12-25	WOS:000371802600029
J	Lamichhaney, S; Fan, GY; Widemo, F; Gunnarsson, U; Thalmann, DS; Hoeppner, MP; Kerje, S; Gustafson, U; Shi, CC; Zhang, H; Chen, WB; Liang, XM; Huang, LH; Wang, JH; Liang, EJ; Wu, Q; Lee, SMY; Xu, X; Hoglund, J; Liu, X; Andersson, L				Lamichhaney, Sangeet; Fan, Guangyi; Widemo, Fredrik; Gunnarsson, Ulrika; Thalmann, Doreen Schwochow; Hoeppner, Marc P.; Kerje, Susanne; Gustafson, Ulla; Shi, Chengcheng; Zhang, He; Chen, Wenbin; Liang, Xinming; Huang, Leihuan; Wang, Jiahao; Liang, Enjing; Wu, Qiong; Lee, Simon Ming-Yuen; Xu, Xun; Hoglund, Jacob; Liu, Xin; Andersson, Leif			Structural genomic changes underlie alternative reproductive strategies in the ruff (Philomachus pugnax)	NATURE GENETICS			English	Article							POLYMORPHISM; IDENTIFICATION; ASSOCIATION; EVOLUTION; FRAMEWORK; INSIGHTS; BEHAVIOR; MIMICRY	The ruff is a Palearctic wader with a spectacular lekking behavior where highly ornamented males compete for females(1-4). This bird has one of the most remarkable mating systems in the animal kingdom, comprising three different male morphs (independents, satellites and faeders) that differ in behavior, plumage color and body size. Remarkably, the satellite and faeder morphs are controlled by dominant alleles(5,6). Here we have used whole-genome sequencing and resolved the enigma of how such complex phenotypic differences can have a simple genetic basis. The Satellite and Faeder alleles are both associated with a 4.5-Mb inversion that occurred about 3.8 million years ago. We propose an evolutionary scenario where the Satellite chromosome arose by a rare recombination event about 500,000 years ago. The ruff mating system is the result of an evolutionary process in which multiple genetic changes contributing to phenotypic differences between morphs have accumulated within the inverted region.	[Lamichhaney, Sangeet; Gunnarsson, Ulrika; Hoeppner, Marc P.; Kerje, Susanne; Andersson, Leif] Uppsala Univ, Dept Med Biochem & Microbiol, Sci Life Lab, Uppsala, Sweden; [Fan, Guangyi; Shi, Chengcheng; Zhang, He; Chen, Wenbin; Liang, Xinming; Huang, Leihuan; Wang, Jiahao; Liang, Enjing; Wu, Qiong; Xu, Xun; Liu, Xin] BGI Shenzhen, Shenzhen, Peoples R China; [Fan, Guangyi; Lee, Simon Ming-Yuen] Univ Macau, Inst Chinese Med Sci, State Key Lab Qual Res Chinese Med, Taipa, Peoples R China; [Widemo, Fredrik] Swedish Univ Agr Sci, Dept Wildlife Fish & Environm Studies, S-90183 Umea, Sweden; [Thalmann, Doreen Schwochow; Gustafson, Ulla; Andersson, Leif] Swedish Univ Agr Sci, Dept Anim Breeding & Genet, Uppsala, Sweden; [Thalmann, Doreen Schwochow] AgroParisTech, Inst Natl Rech Agron, Genet Anim & Biol Integrat, Jouy En Josas, France; [Hoeppner, Marc P.] Uppsala Univ, Bioinformat Infrastruct Life Sci, Uppsala, Sweden; [Hoglund, Jacob] Uppsala Univ, Dept Ecol & Genet, Uppsala, Sweden; [Andersson, Leif] Texas A&M Univ, Dept Vet Integrat Biosci, College Stn, TX USA	Uppsala University; Beijing Genomics Institute (BGI); University of Macau; Swedish University of Agricultural Sciences; Swedish University of Agricultural Sciences; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Uppsala University; Uppsala University; Texas A&M University System; Texas A&M University College Station	Andersson, L (corresponding author), Uppsala Univ, Dept Med Biochem & Microbiol, Sci Life Lab, Uppsala, Sweden.	liuxin@genomics.cn; leif.andersson@imbim.uu.se	Xu, Xun/AAI-6763-2020	Xu, Xun/0000-0002-5338-5173; Zhang, He/0000-0001-9294-1403; Liu, Xin/0000-0003-3256-2940; Hoglund, Jacob/0000-0002-5840-779X; SHI, Chengcheng/0000-0003-2154-5491	Knut and Alice Wallenberg foundation; National Basic Research Program of China (973 Program) [2013CB835204]; Shenzhen municipal government of China (DRC-SZ) [843]; Key Laboratory of Genomics; Chinese Ministry of Agriculture; Platform of Whole Genome-Based Molecular Breeding; ShenZhen Engineering Laboratory for Genomics-Assisted Animal Breeding; Swedish Research Council [1989-2546, 1992-2685, 2013-5418, 2001-6005, 80576801, 70374401]; Uppsala University and Hospital; Science for Life Laboratory	Knut and Alice Wallenberg foundation(Knut & Alice Wallenberg Foundation); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Shenzhen municipal government of China (DRC-SZ); Key Laboratory of Genomics; Chinese Ministry of Agriculture(Ministry of Agriculture & Rural Affairs); Platform of Whole Genome-Based Molecular Breeding; ShenZhen Engineering Laboratory for Genomics-Assisted Animal Breeding; Swedish Research Council(Swedish Research CouncilEuropean Commission); Uppsala University and Hospital; Science for Life Laboratory	We thank K. Pynnonen-Oudman and S. Sainmaa at the Helsinki zoo for kindly providing a fresh blood sample for the genome assembly. Genome sequencing was funded by the Knut and Alice Wallenberg foundation (to L.A.) and by grants of the National Basic Research Program of China (973 Program; 2013CB835204), the Shenzhen municipal government of China (DRC-SZ (2014) 843), the Key Laboratory of Genomics, the Chinese Ministry of Agriculture, the Platform of Whole Genome-Based Molecular Breeding and the ShenZhen Engineering Laboratory for Genomics-Assisted Animal Breeding. The Swedish Research Council funded the field work (grants 1989-2546, 1992-2685 and 2013-5418 to J.H. and grant 2001-6005 to F.W.). D.S.T. benefited from an Erasmus-Mundus fellowship associated with the European Graduate School of Animal Breeding and Genetics. The SNP&SEQ Technology Platform, supported by Uppsala University and Hospital, the Science for Life Laboratory and the Swedish Research Council (80576801 and 70374401), contributed to genome sequencing. Computer resources were provided by UPPMAX, Uppsala University.	Amsterdam A, 2004, P NATL ACAD SCI USA, V101, P12792, DOI 10.1073/pnas.0403929101; Baiao PC, 2007, J HERED, V98, P287, DOI 10.1093/jhered/esm030; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Cantarel BL, 2008, GENOME RES, V18, P188, DOI 10.1101/gr.6743907; Chen K, 2009, NAT METHODS, V6, P677, DOI [10.1038/NMETH.1363, 10.1038/nmeth.1363]; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Foltz DR, 2006, NAT CELL BIOL, V8, P458, DOI 10.1038/ncb1397; Fridolfsson AK, 1999, J AVIAN BIOL, V30, P116, DOI 10.2307/3677252; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; HOGANWAR.AJ, 1966, ARDEA, V54, P109; HOGLUND J, 1993, BEHAV ECOL SOCIOBIOL, V32, P31; Hoglund J., 1995, LEKS, DOI DOI 10.1515/9781400864157; Hoglund J., 1989, AUK, V13, P306; Horton BM, 2014, ANIM BEHAV, V93, P207, DOI 10.1016/j.anbehav.2014.04.015; Horton BM, 2014, P NATL ACAD SCI USA, V111, P1443, DOI 10.1073/pnas.1317165111; Imsland F, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002775; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Joron M, 2011, NATURE, V477, P203, DOI 10.1038/nature10341; Jukema J, 2006, BIOL LETTERS, V2, P161, DOI 10.1098/rsbl.2005.0416; Kupper C, 2016, NAT GENET, V48, P79, DOI 10.1038/ng.3443; Kunte K, 2014, NATURE, V507, P229, DOI 10.1038/nature13112; Lank DB, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0653; LANK DB, 1995, NATURE, V378, P59, DOI 10.1038/378059a0; Lank DB, 2001, AUK, V118, P759, DOI 10.1642/0004-8038(2001)118[0759:VSFIIT]2.0.CO;2; Lee E, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-8-r93; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mundy NI, 2005, P ROY SOC B-BIOL SCI, V272, P1633, DOI 10.1098/rspb.2005.3107; Nei M., 1987, MOL EVOLUTIONARY GEN; Nishikawa H, 2015, NAT GENET, V47, P405, DOI 10.1038/ng.3241; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Saloniemi T, 2012, J ENDOCRINOL, V212, P27, DOI 10.1530/JOE-11-0315; Schwander T, 2014, CURR BIOL, V24, pR288, DOI 10.1016/j.cub.2014.01.056; Soucy P, 2002, J STEROID BIOCHEM, V80, P71, DOI 10.1016/S0960-0760(01)00171-6; Stanke M, 2004, NUCLEIC ACIDS RES, V32, pW309, DOI 10.1093/nar/gkh379; Thomas JW, 2008, GENETICS, V179, P1455, DOI 10.1534/genetics.108.088229; Thuman K, 2003, THESIS; Van der Auwera G.A., 2002, CURR PROTOC BIOINFOR, V11; van Rhijn J.G., 1973, Behaviour, V47, P153, DOI 10.1163/156853973X00076; Van Rhijn J.G., 1991, THE RUFF; Wang J, 2013, NATURE, V493, P664, DOI 10.1038/nature11832; Widemo F, 1998, ANIM BEHAV, V56, P329, DOI 10.1006/anbe.1998.0792; Widemo F, 1997, BEHAV ECOL, V8, P211, DOI 10.1093/beheco/8.2.211; Zhang GJ, 2014, SCIENCE, V346, P1311, DOI 10.1126/science.1251385	50	197	201	5	108	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2016	48	1					84	+		10.1038/ng.3430	http://dx.doi.org/10.1038/ng.3430			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CZ7BQ	26569123	hybrid			2022-12-25	WOS:000367255300018
J	Thambyrajah, R; Mazan, M; Patel, R; Moignard, V; Stefanska, M; Marinopoulou, E; Li, YY; Lancrin, C; Clapes, T; Moroy, T; Robin, C; Miller, C; Cowley, S; Gottgens, B; Kouskoff, V; Lacaud, G				Thambyrajah, Roshana; Mazan, Milena; Patel, Rahima; Moignard, Victoria; Stefanska, Monika; Marinopoulou, Elli; Li, Yaoyong; Lancrin, Christophe; Clapes, Thomas; Moeroey, Tarik; Robin, Catherine; Miller, Crispin; Cowley, Shaun; Goettgens, Berthold; Kouskoff, Valerie; Lacaud, Georges			GFI1 proteins orchestrate the emergence of haematopoietic stem cells through recruitment of LSD1	NATURE CELL BIOLOGY			English	Article							ENDOTHELIAL-CELLS; DEFINITIVE HEMATOPOIESIS; HAEMOGENIC ENDOTHELIUM; MOUSE EMBRYO; AGM REGION; HEMOGENIC ENDOTHELIUM; AORTIC ENDOTHELIUM; PROGENITOR CELLS; IN-VITRO; YOLK-SAC	In vertebrates, the first haematopoietic stem cells (HSCs) with multi-lineage and long-term repopulating potential arise in the AGM (aorta gonad mesonephros) region. These HSCs are generated from a rare and transient subset of endothelial cells, called haemogenic endothelium (HE), through an endothelial-to-haematopoietic transition (EHT). Here, we establish the absolute requirement of the transcriptional repressors GFII and GFI IB (growth factor independence 1 and 1B) in this unique trans-differentiation process. We first demonstrate that Gill expression specifically defines the rare population of HE that generates emerging HSCs. We further establish that in the absence of GFII proteins, HSCs and haematopoietic progenitor cells are not produced in the AGM, revealing the critical requirement for GFII proteins in intra-embryonic EHT. Finally, we demonstrate that GFII proteins recruit the chromatin-modifying protein LSDI, a member of the CoREST repressive complex, to epigenetically silence the endothelial program in HE and allow the emergence of blood cells.	[Thambyrajah, Roshana; Mazan, Milena; Patel, Rahima; Stefanska, Monika; Marinopoulou, Elli; Lancrin, Christophe; Lacaud, Georges] Univ Manchester, Canc Res UK Manchester Inst, CRUK Stem Cell Biol Grp, Manchester M20 4BX, Lancs, England; [Mazan, Milena] Wellcome Trust Sanger Inst, Haematol Canc Genet, Cambridge CB10 1SA, England; [Moignard, Victoria; Goettgens, Berthold] Cambridge Inst Med Res, Dept Haematol, Cambridge CB2 0XY, England; [Moignard, Victoria; Goettgens, Berthold] Wellcome Trust Res Labs, Cambridge CB2 0XY, England; [Moignard, Victoria; Goettgens, Berthold] MRC Stem Cell Inst, Cambridge CB2 0XY, England; [Li, Yaoyong; Miller, Crispin] Univ Manchester, Canc Res UK Manchester Inst, CRUK Computat Biol Grp, Manchester M20 4BX, Lancs, England; [Lancrin, Christophe] European Mol Biol Lab, Mouse Biol Unit, I-00015 Monterotondo, Italy; [Clapes, Thomas; Robin, Catherine] Hubrecht Inst, NL-3584 CT Utrecht, Netherlands; [Moeroey, Tarik] Univ Montreal, IRCM, Montreal, PQ H2W 1R7, Canada; [Moeroey, Tarik] Univ Montreal, Dept Microbiol & Immunol, Montreal, PQ H2W 1R7, Canada; [Cowley, Shaun] Univ Leicester, Dept Biochem, Leicester LE1 9HN, Leics, England; [Kouskoff, Valerie] Univ Manchester, Canc Res UK Manchester Inst, CRUK Stem Cell Haematopoiesis Grp, Manchester M20 4BX, Lancs, England	Cancer Research UK; University of Manchester; Wellcome Trust Sanger Institute; University of Cambridge; Wellcome Trust Sanger Institute; Cancer Research UK; University of Manchester; European Molecular Biology Laboratory (EMBL); Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Universite de Montreal; University of Leicester; Cancer Research UK; University of Manchester	Kouskoff, V (corresponding author), Univ Manchester, Canc Res UK Manchester Inst, CRUK Stem Cell Haematopoiesis Grp, Wilmslow Rd, Manchester M20 4BX, Lancs, England.	valerie.kouskoff@cruk.manchester.ac.uk; georges.lacaud@cruk.manchester.ac.uk	Stefańska, Monika/AAJ-2572-2021; Lancrin, Christophe/AAG-8169-2019; Clapes, Thomas/AAK-8140-2020; lacaud, Georges/ABH-5215-2020	Lancrin, Christophe/0000-0003-0028-7374; Marinopoulou, Elli/0000-0002-6379-5168; Stefanska, Monika/0000-0001-9885-7288; Thambyrajah, Roshana/0000-0002-3941-760X; Cowley, Shaun/0000-0002-2510-1305; Miller, Crispin/0000-0003-4341-1283; Gottgens, Berthold/0000-0001-6302-5705; Lacaud, Georges/0000-0002-5630-2417	Leukaemia and Lymphoma Research Foundation (LLR); Cancer Research UK (CRUK); Biotechnology and Biological Sciences Research Council (BBSRC); MRC [MR/J009202/1]; BBSRC [BB/I00050X/1, BB/J009598/1, BB/N002954/1, BB/I001794/1] Funding Source: UKRI; MRC [G0600135] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/J009598/1, BB/N002954/1, BB/I00050X/1, BB/I001794/1] Funding Source: researchfish; Cancer Research UK [15675, 19565, 12765, 12486] Funding Source: researchfish; Medical Research Council [MR/J009202/1, G0600135, MC_PC_12009] Funding Source: researchfish	Leukaemia and Lymphoma Research Foundation (LLR); Cancer Research UK (CRUK)(Cancer Research UK); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank the staff at the Advanced Imaging, animal facility, Molecular Biology Core facilities and Flow Cytometry of CRUK Manchester Institute for technical support and M. Lie-A-Ling for help with initiating the DamID-PIP bioinformatics project. We thank members of the Stem Cell Biology group, the Stem Cell Haematopoiesis groups and M. Gering for valuable advice and critical reading of the manuscript. Work in our laboratory is supported by the Leukaemia and Lymphoma Research Foundation (LLR), Cancer Research UK (CRUK) and the Biotechnology and Biological Sciences Research Council (BBSRC). S.C. is the recipient of an MRC senior fellowship (MR/J009202/1).	Batta K, 2014, CELL REP, V9, P1871, DOI 10.1016/j.celrep.2014.11.002; Bertrand JY, 2010, NATURE, V464, P108, DOI 10.1038/nature08738; Bigas A, 2010, INT J DEV BIOL, V54, P1175, DOI 10.1387/ijdb.093049ab; Boisset JC, 2015, BLOOD, V125, P465, DOI 10.1182/blood-2014-07-588954; Boisset JC, 2010, NATURE, V464, P116, DOI 10.1038/nature08764; Chen MJ, 2011, CELL STEM CELL, V9, P541, DOI 10.1016/j.stem.2011.10.003; Chen MJ, 2009, NATURE, V457, P887, DOI 10.1038/nature07619; CLARKE RC, 2013, NAT CELL BIOL, P1; Costa G, 2012, TRENDS IMMUNOL, V33, P215, DOI 10.1016/j.it.2012.01.012; Costa G, 2012, DEVELOPMENT, V139, P1587, DOI 10.1242/dev.071282; de Bruijn MFTR, 2000, EMBO J, V19, P2465, DOI 10.1093/emboj/19.11.2465; de Bruijn MFTR, 2002, IMMUNITY, V16, P673, DOI 10.1016/S1074-7613(02)00313-8; Eilken HM, 2009, NATURE, V457, P896, DOI 10.1038/nature07760; Fehling HJ, 2003, DEVELOPMENT, V130, P4217, DOI 10.1242/dev.00589; Fiolka K, 2006, EMBO REP, V7, P326, DOI 10.1038/sj.embor.7400618; Foster CT, 2010, MOL CELL BIOL, V30, P4851, DOI 10.1128/MCB.00521-10; Frame J. M., 2015, STEM CELLS; Frame JM, 2013, BLOOD CELL MOL DIS, V51, P220, DOI 10.1016/j.bcmd.2013.09.006; Guiu J, 2013, J EXP MED, V210, P71, DOI 10.1084/jem.20120993; Hadland BK, 2004, BLOOD, V104, P3097, DOI 10.1182/blood-2004-03-1224; Harris WJ, 2012, CANCER CELL, V21, P473, DOI 10.1016/j.ccr.2012.03.014; Jaffredo T, 1998, DEVELOPMENT, V125, P4575; Kim W, 2014, BLOOD, V124, P1586, DOI 10.1182/blood-2014-02-556522; Kissa K, 2010, NATURE, V464, P112, DOI 10.1038/nature08761; Kumano K, 2003, IMMUNITY, V18, P699, DOI 10.1016/S1074-7613(03)00117-1; Kumaravelu P, 2002, DEVELOPMENT, V129, P4891; Kyba M, 2002, CELL, V109, P29, DOI 10.1016/S0092-8674(02)00680-3; Lacaud G, 2002, BLOOD, V100, P458, DOI 10.1182/blood-2001-12-0321; Lam EYN, 2010, BLOOD, V116, P909, DOI 10.1182/blood-2010-01-264382; Lancrin C, 2012, BLOOD, V120, P314, DOI 10.1182/blood-2011-10-386094; Lancrin C, 2010, J MOL MED, V88, P167, DOI 10.1007/s00109-009-0554-0; Lancrin C, 2009, NATURE, V457, P892, DOI 10.1038/nature07679; Ledran MH, 2008, CELL STEM CELL, V3, P85, DOI 10.1016/j.stem.2008.06.001; Lichtinger M, 2012, EMBO J, V31, P4318, DOI 10.1038/emboj.2012.275; Lie-A-Ling M, 2014, BLOOD, V124, pE11, DOI 10.1182/blood-2014-04-572958; McGrath KE, 2015, CELL REP, V11, P1892, DOI 10.1016/j.celrep.2015.05.036; Medvinsky A, 1996, CELL, V86, P897, DOI 10.1016/S0092-8674(00)80165-8; Moignard V, 2013, NAT CELL BIOL, V15, P363, DOI 10.1038/ncb2709; Moroy T, 2011, SEMIN IMMUNOL, V23, P368, DOI 10.1016/j.smim.2011.08.006; MULLER AM, 1994, IMMUNITY, V1, P291, DOI 10.1016/1074-7613(94)90081-7; Nichols J, 2009, NAT MED, V15, P814, DOI 10.1038/nm.1996; Nishikawa S, 1998, IMMUNITY, V8, P761, DOI 10.1016/S1074-7613(00)80581-6; North T, 1999, DEVELOPMENT, V126, P2563; North TE, 2004, STEM CELLS, V22, P158, DOI 10.1634/stemcells.22-2-158; North TE, 2002, IMMUNITY, V16, P661, DOI 10.1016/S1074-7613(02)00296-0; Okuda T, 1996, CELL, V84, P321, DOI 10.1016/S0092-8674(00)80986-1; Palis J, 1999, DEVELOPMENT, V126, P5073; Pearson S, 2015, STEM CELL REP, V4, P431, DOI 10.1016/j.stemcr.2015.01.003; Pereira CF, 2013, CELL STEM CELL, V13, P205, DOI 10.1016/j.stem.2013.05.024; Rybtsov S, 2011, J EXP MED, V208, P1305, DOI 10.1084/jem.20102419; Saleque S, 2007, MOL CELL, V27, P562, DOI 10.1016/j.molcel.2007.06.039; Sandler VM, 2014, NATURE, V511, P312, DOI 10.1038/nature13547; Sroczynska P, 2009, BLOOD, V114, P5279, DOI 10.1182/blood-2009-05-222307; Sroczynska Patrycja, 2009, V538, P317, DOI 10.1007/978-1-59745-418-6_16; Stefanska M, 2014, STEM CELL RES, V12, P222, DOI 10.1016/j.scr.2013.10.009; Swiers G, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3924; Taoudi S, 2008, CELL STEM CELL, V3, P99, DOI 10.1016/j.stem.2008.06.004; Taoudi S, 2007, P NATL ACAD SCI USA, V104, P9399, DOI 10.1073/pnas.0700984104; Vassen L, 2007, BLOOD, V109, P2356, DOI 10.1182/blood-2006-06-030031; Vogel MJ, 2007, NAT PROTOC, V2, P1467, DOI 10.1038/nprot.2007.148; Wang J, 2009, NAT GENET, V41, P125, DOI 10.1038/ng.268; Wang LC, 2009, MICROVASC RES, V77, P39, DOI 10.1016/j.mvr.2008.09.005; Wang LS, 2005, J EXP MED, V201, P1603, DOI 10.1084/jem.20041888; Wang Q, 1996, P NATL ACAD SCI USA, V93, P3444, DOI 10.1073/pnas.93.8.3444; Whyte WA, 2012, NATURE, V482, P221, DOI 10.1038/nature10805; Wilson NK, 2010, MOL CELL BIOL, V30, P3853, DOI 10.1128/MCB.00032-10; Yokomizo T, 2010, DEVELOPMENT, V137, P3651, DOI 10.1242/dev.051094; Yucel R, 2004, J BIOL CHEM, V279, P40906, DOI 10.1074/jbc.M400808200; Zovein AC, 2008, CELL STEM CELL, V3, P625, DOI 10.1016/j.stem.2008.09.018	69	130	133	2	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2016	18	1					21	+		10.1038/ncb3276	http://dx.doi.org/10.1038/ncb3276			14	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CZ3VA	26619147	Green Accepted, Green Submitted			2022-12-25	WOS:000367030900007
J	Woo, JW; Kim, J; Kwon, SI; Corvalan, C; Cho, SW; Kim, H; Kim, SG; Kim, ST; Choe, S; Kim, JS				Woo, Je Wook; Kim, Jungeun; Kwon, Soon Il; Corvalan, Claudia; Cho, Seung Woo; Kim, Hyeran; Kim, Sang-Gyu; Kim, Sang-Tae; Choe, Sunghwa; Kim, Jin-Soo			DNA-free genome editing in plants with preassembled CRISPR-Cas9 ribonucleoproteins	NATURE BIOTECHNOLOGY			English	Article							TRANSIENT GENE-EXPRESSION; HUMAN-CELLS; RNA; ARABIDOPSIS; KNOCKOUT; SYSTEM; GUIDE	Editing plant genomes without introducing foreign DNA into cells may alleviate regulatory concerns related to genetically modified plants. We transfected preassembled complexes of purified Cas9 protein and guide RNA into plant protoplasts of Arabidopsis thaliana, tobacco, lettuce and rice and achieved targeted mutagenesis in regenerated plants at frequencies of up to 46%. The targeted sites contained germline-transmissible small insertions or deletions that are indistinguishable from naturally occurring genetic variation.	[Woo, Je Wook; Kwon, Soon Il; Choe, Sunghwa] Adv Inst Convergence Technol, Convergence Res Ctr Funct Plant Prod, Suwon, Gyeonggi Do, South Korea; [Kim, Jungeun; Kim, Hyeran; Kim, Sang-Gyu; Kim, Sang-Tae; Kim, Jin-Soo] Inst for Basic Sci Korea, Ctr Genome Engn, Seoul, South Korea; [Kim, Jungeun; Cho, Seung Woo; Kim, Jin-Soo] Seoul Natl Univ, Dept Chem, Seoul, South Korea; [Corvalan, Claudia; Choe, Sunghwa] Seoul Natl Univ, Coll Nat Sci, Sch Biol Sci, Seoul 151742, South Korea; [Choe, Sunghwa] Seoul Natl Univ, Plant Genom & Breeding Inst, Seoul, South Korea	Institute for Basic Science - Korea (IBS); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Choe, S (corresponding author), Adv Inst Convergence Technol, Convergence Res Ctr Funct Plant Prod, Suwon, Gyeonggi Do, South Korea.	shchoe@snu.ac.kr; jskim01@snu.ac.kr	KIM, Jin-Soo/M-6918-2013; Kim, Sang-Tae/U-9457-2018; Kim, Sang-Tae/X-8917-2019; Kim, Hyeran/AAB-5165-2021; Kim, Sang-Gyu/T-5925-2017; Cho, Seung Woo/B-2441-2019; Choe, Sunghwa/K-5650-2013	KIM, Jin-Soo/0000-0003-4847-1306; Kim, Sang-Tae/0000-0003-1645-6021; Kim, Sang-Tae/0000-0003-1645-6021; Cho, Seung Woo/0000-0001-9091-0937; Choe, Sunghwa/0000-0001-5541-484X	Institute for Basic Science [IBS-R021-D1]; Next-Generation BioGreen21 Program [PJ01104501, PJ01104502]	Institute for Basic Science; Next-Generation BioGreen21 Program(Rural Development Administration (RDA), Republic of Korea)	This work was supported in part by grants from the Institute for Basic Science (IBS-R021-D1) and the Next-Generation BioGreen21 Program (PJ01104501 to S.C. and PJ01104502 to S.I.K.).	Bae S, 2014, BIOINFORMATICS, V30, P1473, DOI 10.1093/bioinformatics/btu048; Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Cho SW, 2013, GENETICS, V195, P1177, DOI 10.1534/genetics.113.155853; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Choe S, 2002, PLANT PHYSIOL, V130, P1506, DOI 10.1104/pp.010496; FREARSON EM, 1973, DEV BIOL, V33, P130, DOI 10.1016/0012-1606(73)90169-3; GAMBORG OL, 1968, EXP CELL RES, V50, P151, DOI 10.1016/0014-4827(68)90403-5; Jones HD, 2015, NAT PLANTS, V1, DOI [10.1038/nplants.2014.11, 10.1038/NPLANTS.2014.11]; Kanchiswamy CN, 2015, TRENDS BIOTECHNOL, V33, P489, DOI 10.1016/j.tibtech.2015.04.002; Kim D, 2015, NAT METHODS, V12, P237, DOI [10.1038/nmeth.3284, 10.1038/NMETH.3284]; Kim HJ, 2009, GENOME RES, V19, P1279, DOI 10.1101/gr.089417.108; Kim H, 2014, NAT REV GENET, V15, P321, DOI 10.1038/nrg3686; Kim JM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4157; Kim S, 2014, GENOME RES, V24, P1012, DOI 10.1101/gr.171322.113; Lee HJ, 2010, GENOME RES, V20, P81, DOI 10.1101/gr.099747.109; Lelivelt CLC, 2005, PLANT MOL BIOL, V58, P763, DOI 10.1007/s11103-005-7704-8; Li JF, 2013, NAT BIOTECHNOL, V31, P688, DOI 10.1038/nbt.2654; MENCZEL L, 1981, THEOR APPL GENET, V59, P191, DOI 10.1007/BF00264975; Nekrasov V, 2013, NAT BIOTECHNOL, V31, P691, DOI 10.1038/nbt.2655; Shan QW, 2013, NAT BIOTECHNOL, V31, P686, DOI 10.1038/nbt.2650; Sung YH, 2014, GENOME RES, V24, P125, DOI 10.1101/gr.163394.113; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Zhang Y, 2011, PLANT METHODS, V7, DOI 10.1186/1746-4811-7-30	23	614	678	13	394	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2015	33	11					1162	+		10.1038/nbt.3389	http://dx.doi.org/10.1038/nbt.3389			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CW3TY	26479191				2022-12-25	WOS:000364916000023
J	Ma, HS; O'Farrell, PH				Ma, Hansong; O'Farrell, Patrick H.			Selfish drive can trump function when animal mitochondrial genomes compete	NATURE GENETICS			English	Article							DNA CONTROL REGION; MTDNA CONTROL REGION; DROSOPHILA-MELANOGASTER; STABLE HETEROPLASMY; REPEATED SEQUENCES; RAPID EVOLUTION; TRANSMISSION; NUCLEAR; POPULATIONS; SELECTION	Mitochondrial genomes compete for transmission from mother to progeny. We explored this competition by introducing a second genome into Drosophila melanogaster to follow transmission. Competitions between closely related genomes favored those functional in electron transport, resulting in a host-beneficial purifying selection(1). In contrast, matchups between distantly related genomes often favored those with negligible, negative or lethal consequences, indicating selfish selection. Exhibiting powerful selfish selection, a genome carrying a detrimental mutation displaced a complementing genome, leading to population death after several generations. In a different pairing, opposing selfish and purifying selection counterbalanced to give stable transmission of two genomes. Sequencing of recombinant mitochondrial genomes showed that the noncoding region, containing origins of replication, governs selfish transmission. Uniparental inheritance prevents encounters between distantly related genomes. Nonetheless, in each maternal lineage, constant competition among sibling genomes selects for super-replicators. We suggest that this relentless competition drives positive selection, promoting change in the sequences influencing transmission.	[Ma, Hansong; O'Farrell, Patrick H.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	O'Farrell, PH (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA.	ofarrell@cgl.ucsf.edu	Ma, Hansong/A-7794-2012; Ma, Hansong/O-7736-2019	Ma, Hansong/0000-0002-2705-1970; Ma, Hansong/0000-0002-2705-1970; O'Farrell, Patrick/0000-0003-0011-2734	US NIH [ES020725, GM120005]; Human Frontiers Science Program [LT000138/2010-l]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES020725] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM120005] Funding Source: NIH RePORTER	US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontiers Science Program(Human Frontier Science Program); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M.J. Palladino (University of Pittsburgh) for kindly providing us flies with the ATP6[1] mitochondrial genome. This research was supported by US NIH funding (ES020725 and GM120005) to P.H.O'F. H.M. was supported by a long-term postdoctoral fellowship from the Human Frontiers Science Program (LT000138/2010-l).	Burman JL, 2014, DIS MODEL MECH, V7, P1165, DOI 10.1242/dmm.015321; Casane D, 2002, CURR GENET, V42, P66, DOI 10.1007/s00294-002-0328-5; Celotto AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025823; Celotto AM, 2006, J NEUROSCI, V26, P810, DOI 10.1523/JNEUROSCI.4162-05.2006; Chen SJ, 2012, GENETICS, V192, P483, DOI 10.1534/genetics.112.143719; Chen Z, 2015, MOL BIOL CELL, V26, P674, DOI 10.1091/mbc.E14-11-1513; Clark KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041433; CROW JF, 1979, SCI AM, V240, P134, DOI 10.1038/scientificamerican0279-134; De Stordeur E, 1997, HEREDITY, V79, P615, DOI 10.1038/sj.hdy.6882760; Doi A, 1999, HEREDITY, V82, P555, DOI 10.1038/sj.hdy.6885080; DUNBAR DR, 1995, P NATL ACAD SCI USA, V92, P6562, DOI 10.1073/pnas.92.14.6562; Faber JE, 1998, MOL PHYLOGENET EVOL, V10, P310, DOI 10.1006/mpev.1998.0530; Fumagalli L, 1996, MOL BIOL EVOL, V13, P31, DOI 10.1093/oxfordjournals.molbev.a025568; HICKEY DA, 1982, GENETICS, V101, P519; Hill JH, 2014, NAT GENET, V46, P389, DOI 10.1038/ng.2920; HOELZEL AR, 1994, J MOL EVOL, V39, P191; Hurst GDD, 2001, NAT REV GENET, V2, P597, DOI 10.1038/35084545; Jamandre Brian Wade, 2014, International Journal of Zoology, P564105; Jasmin JN, 2014, EVOLUTION, V68, P269, DOI 10.1111/evo.12228; Lee HY, 2008, CELL, V135, P1065, DOI 10.1016/j.cell.2008.10.047; LEE WJ, 1995, J MOL EVOL, V41, P54; LEWIS DL, 1994, MOL BIOL EVOL, V11, P523; Lunt DH, 1998, MOL ECOL, V7, P1441, DOI 10.1046/j.1365-294x.1998.00495.x; Ma H, 2015, ELIFE, V4, DOI 10.7554/eLife.07247; Ma HS, 2014, NAT GENET, V46, P393, DOI 10.1038/ng.2919; MacAlpine DM, 2001, EMBO J, V20, P1807, DOI 10.1093/emboj/20.7.1807; Matsuura ET, 1997, GENES GENET SYST, V72, P119, DOI 10.1266/ggs.72.119; McMillan WO, 1997, J MOL EVOL, V45, P473, DOI 10.1007/PL00006252; Meiklejohn CD, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003238; Moraes CT, 1999, MOL BIOL CELL, V10, P3345, DOI 10.1091/mbc.10.10.3345; NIKI Y, 1989, NATURE, V341, P551, DOI 10.1038/341551a0; Petit N, 1998, CURR GENET, V33, P330, DOI 10.1007/s002940050344; Phillips WS, 2015, GENOME BIOL EVOL, V7, P2023, DOI 10.1093/gbe/evv116; Rand DM, 2011, GENETICA, V139, P685, DOI 10.1007/s10709-011-9576-y; Saito S, 2005, GENETICS, V171, P1695, DOI 10.1534/genetics.105.046243; Samuels DC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003929; Schmitz-Linneweber C, 2005, PLANT CELL, V17, P1815, DOI 10.1105/tpc.105.032474; SOLIGNAC M, 1986, J MOL EVOL, V24, P53, DOI 10.1007/BF02099951; Spirek M, 2015, FRONT GENET, V5, DOI 10.3389/fgene.2014.00454; Stoneking M, 2000, AM J HUM GENET, V67, P1029, DOI 10.1086/303092; STONEKING M, 1991, AM J HUM GENET, V48, P370; Taylor DR, 2002, P NATL ACAD SCI USA, V99, P3690, DOI 10.1073/pnas.072660299; Townsend JP, 2004, HEREDITY, V93, P98, DOI 10.1038/sj.hdy.6800484; Tsang WY, 2002, BIOCHEM CELL BIOL, V80, P645, DOI [10.1139/o02-135, 10.1139/O02-135]; Tsujino F, 2002, J MOL EVOL, V55, P573, DOI 10.1007/s00239-002-2353-x; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Van Valen L., 1973, EVOL THEORY, V1, P1, DOI DOI 10.1038/344864A0; VOLZLINGENHOHL A, 1992, P NATL ACAD SCI USA, V89, P11528, DOI 10.1073/pnas.89.23.11528; Wilkinson GS, 1997, GENETICS, V146, P1035; Wolff J.N., 2015, MITOCHONDRIAL DNA	50	40	41	1	47	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2016	48	7					798	+		10.1038/ng.3587	http://dx.doi.org/10.1038/ng.3587			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DP9TK	27270106	Green Submitted, Green Accepted			2022-12-25	WOS:000378840100018
J	Lee, SCW; Dvinge, H; Kim, E; Cho, H; Micol, JB; Chung, YR; Durham, BH; Yoshimi, A; Kim, YJ; Thomas, M; Lobry, C; Chen, CW; Pastore, A; Taylor, J; Wang, XJ; Krivtsov, A; Armstrong, SA; Palacino, J; Buonamici, S; Smith, PG; Bradley, RK; Abdel-Wahab, O				Lee, Stanley Chun-Wei; Dvinge, Heidi; Kim, Eunhee; Cho, Hana; Micol, Jean-Baptiste; Chung, Young Rock; Durham, Benjamin H.; Yoshimi, Akihide; Kim, Young Joon; Thomas, Michael; Lobry, Camille; Chen, Chun-Wei; Pastore, Alessandro; Taylor, Justin; Wang, Xujun; Krivtsov, Andrei; Armstrong, Scott A.; Palacino, James; Buonamici, Silvia; Smith, Peter G.; Bradley, Robert K.; Abdel-Wahab, Omar			Modulation of splicing catalysis for therapeutic targeting of leukemia with mutations in genes encoding spliceosomal proteins	NATURE MEDICINE			English	Article							CLONAL HEMATOPOIESIS; SRSF2 MUTATIONS; PHASE-I; RNA; EXPRESSION; E7107; SF3B; MYELODYSPLASIA; VISUALIZATION; VALIDATION	Mutations in genes encoding splicing factors (which we refer to as spliceosomal genes) are commonly found in patients with myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML)(1-3). These mutations recurrently affect specific amino acid residues, leading to perturbed normal splice site and exon recognition(4-6). Spliceosomal gene mutations are always heterozygous and rarely occur together with one another, suggesting that cells may tolerate only a partial deviation from normal splicing activity. To test this hypothesis, we engineered mice to express a mutated allele of serine/arginine-rich splicing factor 2 (Srsf2(P95H))-which commonly occurs in individuals with MDS and AML-in an inducible, hemizygous manner in hematopoietic cells. These mice rapidly succumbed to fatal bone marrow failure, demonstrating that Srsf2-mutated cells depend on the wild-type Srsf2 allele for survival. In the context of leukemia, treatment with the spliceosome inhibitor E7107 (refs. 7,8) resulted in substantial reductions in leukemic burden, specifically in isogenic mouse leukemias and patient-derived xenograft AMLs carrying spliceosomal mutations. Whereas E7107 treatment of mice resulted in widespread intron retention and cassette exon skipping in leukemic cells regardless of Srsf2 genotype, the magnitude of splicing inhibition following E7107 treatment was greater in Srsf2-mutated than in Srsf2-wild-type leukemia, consistent with the differential effect of E7107 on survival. Collectively, these data provide genetic and pharmacologic evidence that leukemias with spliceosomal gene mutations are preferentially susceptible to additional splicing perturbations in vivo as compared to leukemias without such mutations. Modulation of spliceosome function may thus provide a new therapeutic avenue in genetically defined subsets of individuals with MDS or AML.	[Lee, Stanley Chun-Wei; Kim, Eunhee; Cho, Hana; Micol, Jean-Baptiste; Chung, Young Rock; Durham, Benjamin H.; Yoshimi, Akihide; Kim, Young Joon; Pastore, Alessandro; Taylor, Justin; Abdel-Wahab, Omar] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USA; [Dvinge, Heidi; Bradley, Robert K.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Computat Biol Program, 1124 Columbia St, Seattle, WA 98104 USA; [Dvinge, Heidi; Bradley, Robert K.] Fred Hutchinson Canc Res Ctr, Div Basic Sci, 1124 Columbia St, Seattle, WA 98104 USA; [Thomas, Michael; Palacino, James; Buonamici, Silvia; Smith, Peter G.] H3 Biomed Inc, Cambridge, MA USA; [Lobry, Camille] Inst Gustave Roussy, INSERM, U1170, F-94805 Villejuif, France; [Chen, Chun-Wei; Wang, Xujun; Krivtsov, Andrei; Armstrong, Scott A.] Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, 1275 York Ave, New York, NY 10021 USA; [Armstrong, Scott A.] Mem Sloan Kettering Canc Ctr, Dept Pediat, 1275 York Ave, New York, NY 10021 USA; [Abdel-Wahab, Omar] Mem Sloan Kettering Canc Ctr, Dept Med, Leukemia Serv, 1275 York Ave, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Abdel-Wahab, O (corresponding author), Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USA.; Bradley, RK (corresponding author), Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Computat Biol Program, 1124 Columbia St, Seattle, WA 98104 USA.; Bradley, RK (corresponding author), Fred Hutchinson Canc Res Ctr, Div Basic Sci, 1124 Columbia St, Seattle, WA 98104 USA.; Abdel-Wahab, O (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Med, Leukemia Serv, 1275 York Ave, New York, NY 10021 USA.	rbradley@fredhutch.org; abdelwao@mskcc.org	/AGZ-3814-2022; Kim, Young Joon/GPF-6451-2022; Krivtsov, Andrei/AAJ-9966-2021; lobry, camille/A-6188-2015; /AAR-7818-2021; Kim, Eunhee/AAK-3650-2020; Kim, Eunhee/Q-9162-2016; Yoshimi, Akihide/I-3792-2019	/0000-0002-3621-4807; lobry, camille/0000-0003-0550-4921; /0000-0002-3621-4807; Kim, Eunhee/0000-0001-7143-7769; Yoshimi, Akihide/0000-0002-0664-7281; Krivtsov, Andrei/0000-0002-5511-1686; Kim, Young Joon/0000-0002-9106-6077; Bradley, Robert/0000-0002-8046-1063; Chung, Young Rock/0000-0001-5752-8322; Chen, Chun-Wei/0000-0002-8737-6830; Durham, Benjamin/0000-0001-8090-5448; Lee, Stanley/0000-0001-7110-2416; Dvinge, Heidi/0000-0003-1741-0738	Leukemia and Lymphoma Society; US Department of Defense Breast Cancer Research Program [W81XWH-14-1-0044]; US Department of Defense Bone Marrow Failure Research Program [BM150092, W81XWH-12-1-0041]; Worldwide Cancer Research Fund; Fondation de France; American Society of Hematology; Edward P. Evans Foundation; US National Institutes of Health (NIH)-NHLBI [R01 HL128239]; NIH-NCI [1K08CA160647-01]; Ellison Medical Foundation [AG-NS-1030-13]; Damon Runyon Foundation; NIH-NIDDK [R01 DK103854]; Starr Foundation [I8-A8-075]; Josie Robertson Investigator Program; Mr. William H. Goodwin and Mrs. Alice Goodwin Commonwealth Foundation for Cancer Research; Experimental Therapeutics Center of MSKCC; NATIONAL CANCER INSTITUTE [K08CA160647, R00CA197498, P30CA006516, P30CA008748, K99CA197498] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL128239] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK103854] Funding Source: NIH RePORTER	Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); US Department of Defense Breast Cancer Research Program(United States Department of Defense); US Department of Defense Bone Marrow Failure Research Program; Worldwide Cancer Research Fund; Fondation de France(Fondation de France); American Society of Hematology; Edward P. Evans Foundation; US National Institutes of Health (NIH)-NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH-NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Ellison Medical Foundation(Lawrence Ellison Foundation); Damon Runyon Foundation; NIH-NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Starr Foundation; Josie Robertson Investigator Program; Mr. William H. Goodwin and Mrs. Alice Goodwin Commonwealth Foundation for Cancer Research; Experimental Therapeutics Center of MSKCC; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Leukemia and Lymphoma Society (S.C.-W.L. and O.A.-W.), the US Department of Defense Breast Cancer Research Program grant W81XWH-14-1-0044 (H.D.), the US Department of Defense Bone Marrow Failure Research Program grants BM150092 (O.A.-W.) and W81XWH-12-1-0041 (R.K.B. and O.A.-W.), the Worldwide Cancer Research Fund (E.K.), the Fondation de France (J.-B.M.), the American Society of Hematology (B.H.D. and O.A.-W.), the Edward P. Evans Foundation (R.K.B. and O.A.-W.), the US National Institutes of Health (NIH)-NHLBI grant R01 HL128239 (R.K.B. and O.A.-W.), the NIH-NCI grant 1K08CA160647-01 (O.A.-W.), the Ellison Medical Foundation grant AG-NS-1030-13 (R.K.B.), the Damon Runyon Foundation (R.K.B. and O.A.-W.), the NIH-NIDDK grant R01 DK103854 (R.K.B.), the Starr Foundation grant I8-A8-075 (O.A.-W.), the Josie Robertson Investigator Program (O.A.-W.), the Mr. William H. Goodwin and Mrs. Alice Goodwin Commonwealth Foundation for Cancer Research (O.A.-W.), and the Experimental Therapeutics Center of MSKCC (O.A.-W.).	Bejar R, 2012, J CLIN ONCOL, V30, P3376, DOI 10.1200/JCO.2011.40.7379; Bernt KM, 2011, CANCER CELL, V20, P66, DOI 10.1016/j.ccr.2011.06.010; Bonnal S, 2012, NAT REV DRUG DISCOV, V11, P847, DOI 10.1038/nrd3823; Cheng DT, 2015, J MOL DIAGN, V17, P251, DOI 10.1016/j.jmoldx.2014.12.006; Daigle SR, 2011, CANCER CELL, V20, P53, DOI 10.1016/j.ccr.2011.06.009; Effenberger KA, 2016, RNA, V22, P350, DOI 10.1261/rna.053108.115; Eskens FALM, 2013, CLIN CANCER RES, V19, P6296, DOI 10.1158/1078-0432.CCR-13-0485; Flicek P, 2013, NUCLEIC ACIDS RES, V41, pD48, DOI 10.1093/nar/gks1236; Folco EG, 2011, GENE DEV, V25, P440, DOI 10.1101/gad.2009411; Genovese G, 2014, NEW ENGL J MED, V371, P2477, DOI 10.1056/NEJMoa1409405; Georgiades P, 2002, GENESIS, V34, P251, DOI 10.1002/gene.10161; Graubert TA, 2012, NAT GENET, V44, P53, DOI 10.1038/ng.1031; Guberman Jonathan M, 2011, Database (Oxford), V2011, pbar041, DOI 10.1093/database/bar041; Hong DS, 2014, INVEST NEW DRUG, V32, P436, DOI 10.1007/s10637-013-0046-5; Hubert CG, 2013, GENE DEV, V27, P1032, DOI 10.1101/gad.212548.112; Ilagan JO, 2015, GENOME RES, V25, P14, DOI 10.1101/gr.181016.114; Katz Y, 2015, BIOINFORMATICS, V31, P2400, DOI 10.1093/bioinformatics/btv034; Katz Y, 2010, NAT METHODS, V7, P1009, DOI 10.1038/NMETH.1528; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim E, 2015, CANCER CELL, V27, P617, DOI 10.1016/j.ccell.2015.04.006; Kotake Y, 2007, NAT CHEM BIOL, V3, P570, DOI 10.1038/nchembio.2007.16; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lavallee VP, 2015, NAT GENET, V47, P1030, DOI 10.1038/ng.3371; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Lindsley RC, 2015, BLOOD, V125, P1367, DOI 10.1182/blood-2014-11-610543; Meyer LR, 2013, NUCLEIC ACIDS RES, V41, pD64, DOI 10.1093/nar/gks1048; National Research Council, 2011, GUIDE CARE USE LAB A; Papaemmanuil E, 2011, NEW ENGL J MED, V365, P1384, DOI 10.1056/NEJMoa1103283; Papaemmanuil E, 2013, BLOOD, V122, P3616, DOI 10.1182/blood-2013-08-518886; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Shirai CL, 2015, CANCER CELL, V27, P631, DOI 10.1016/j.ccell.2015.04.008; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vannucchi AM, 2013, LEUKEMIA, V27, P1861, DOI 10.1038/leu.2013.119; Wagenmakers EJ, 2010, COGNITIVE PSYCHOL, V60, P158, DOI 10.1016/j.cogpsych.2009.12.001; Wang HY, 2001, MOL CELL, V7, P331, DOI 10.1016/S1097-2765(01)00181-2; Xie MC, 2014, NAT MED, V20, P1472, DOI 10.1038/nm.3733; Yan B, 2015, NEW ENGL J MED, V372, P1071, DOI 10.1056/NEJMc1500684; Yokoi A, 2011, FEBS J, V278, P4870, DOI 10.1111/j.1742-4658.2011.08387.x; Yoshida K, 2011, NATURE, V478, P64, DOI 10.1038/nature10496; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zhang J, 2015, P NATL ACAD SCI USA, V112, pE4726, DOI 10.1073/pnas.1514105112; Zhang SJ, 2012, BLOOD, V119, P4480, DOI 10.1182/blood-2011-11-390252	43	214	223	0	43	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2016	22	6					672	+		10.1038/nm.4097	http://dx.doi.org/10.1038/nm.4097			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DO0NQ	27135740	Green Accepted			2022-12-25	WOS:000377476000025
J	Sada, A; Jacob, F; Leung, E; Wang, S; White, BS; Shalloway, D; Tumbar, T				Sada, Aiko; Jacob, Fadi; Leung, Eva; Wang, Sherry; White, Brian S.; Shalloway, David; Tumbar, Tudorita			Defining the cellular lineage hierarchy in the interfollicular epidermis of adult skin	NATURE CELL BIOLOGY			English	Article							LABEL-RETAINING CELLS; STEM-CELLS; IN-VIVO; PROGENITOR CELLS; SMALL-INTESTINE; HAIR-FOLLICLES; SELF-RENEWAL; MOUSE; PROLIFERATION; DIFFERENTIATION	The interfollicular epidermis regenerates from heterogeneous basal skin cell populations that divide at different rates. It has previously been presumed that infrequently dividing basal cells known as label-retaining cells (LRCs) are stem cells, whereas non-LRCs are short-lived progenitors. Here we employ the H2B-GFP pulse-chase system in adult mouse skin and find that epidermal LRCs and non-LRCs are molecularly distinct and can be differentiated by Dlx1(CreER) and Slc1a3(CreER) genetic marking, respectively. Long-term lineage tracing and mathematical modelling of H2B-GFP dilution data show that LRCs and non-LRCs constitute two distinct stem cell populations with different patterns of proliferation, differentiation and upward cellular transport. During homeostasis, these populations are enriched in spatially distinct skin territories and can preferentially produce unique differentiated lineages. On wounding or selective killing, they can temporarily replenish each other's territory. These two discrete interfollicular stem cell populations are functionally interchangeable and intrinsically well adapted to thrive in distinct skin environments.	[Sada, Aiko; Jacob, Fadi; Leung, Eva; Wang, Sherry; Shalloway, David; Tumbar, Tudorita] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA; [White, Brian S.] Washington Univ, Dept Med, Div Oncol, St Louis, MO 63110 USA; [White, Brian S.] Washington Univ, McDonnell Genome Inst, St Louis, MO 63110 USA	Cornell University; Washington University (WUSTL); Washington University (WUSTL)	Tumbar, T (corresponding author), Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA.	tt252@cornell.edu	Sada, Aiko/B-1176-2019	Sada, Aiko/0000-0002-0984-4280; White, Brian/0000-0002-2954-4410; Jacob, Fadi/0000-0002-0094-8454	Empire State Stem Cell Foundation; New York State-Department of Health (NYS-DOH) [C026718]; NIH [1S10RR025502-01, R21AR063278]; NYSTEM Grant [C024354]; Long-Term Fellowship from the Human Frontier Science Program; Japan Society for the Promotion of Science; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025502] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR063278] Funding Source: NIH RePORTER	Empire State Stem Cell Foundation; New York State-Department of Health (NYS-DOH); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NYSTEM Grant; Long-Term Fellowship from the Human Frontier Science Program(Human Frontier Science Program); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank L. G. Sayam for FAGS; C. J. Bayles, R. M. Williams and J. M. DelaCruz for imaging; B. Hover and J. Mosher for microarray; the Cornell Center for Animal Resources and Education facility for mouse care; D. J. McDermitt for help with mouse crossings; and K. L. Goodyear for help with mathematical modelling. Support was from: Empire State Stem Cell Foundation, New York State-Department of Health (NYS-DOH), Contract no. C026718 (in part) for Cornell Cytometry core; NIH Grant 1S10RR025502-01 for Cornell Biotechnology Research Center and Imaging Facility. The research was financially supported by NYSTEM Grant C024354, NIH Grant R21AR063278 to T.T., a Long-Term Fellowship from the Human Frontier Science Program to A.S. and a postdoctoral fellowship for research abroad from the Japan Society for the Promotion of Science to A.S.	[Anonymous], 2008, MODEL SELECTION MODE; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; BICKENBACH JR, 1981, J DENT RES, V60, P1611, DOI 10.1177/002203458106000311011; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Braun KM, 2003, DEVELOPMENT, V130, P5241, DOI 10.1242/dev.00703; Buczacki SJA, 2013, NATURE, V495, P65, DOI 10.1038/nature11965; Chang H, 2013, P NATL ACAD SCI USA, V110, pE908, DOI 10.1073/pnas.1301430110; Clayton E, 2007, NATURE, V446, P185, DOI 10.1038/nature05574; Coulombe PA, 2003, J INVEST DERMATOL, V121, P219, DOI 10.1046/j.1523-1747.2003.12387.x; Dai X, 2004, CURR OPIN GENET DEV, V14, P485, DOI 10.1016/j.gde.2004.07.002; Diamond I, 2000, J INVEST DERMATOL, V115, P788, DOI 10.1046/j.1523-1747.2000.00144.x; Doupe DP, 2010, DEV CELL, V18, P317, DOI 10.1016/j.devcel.2009.12.016; Edmondson SR, 2005, BRIT J DERMATOL, V152, P225, DOI 10.1111/j.1365-2133.2004.06350.x; Firth SM, 2002, ENDOCR REV, V23, P824, DOI 10.1210/er.2001-0033; Foudi A, 2009, NAT BIOTECHNOL, V27, P84, DOI 10.1038/nbt.1517; Fuchs E, 2009, CELL, V137, P811, DOI 10.1016/j.cell.2009.05.002; Gomez C, 2013, STEM CELL REP, V1, P19, DOI 10.1016/j.stemcr.2013.04.001; Ishitsuka Y, 2012, J INVEST DERMATOL, V132, P1775, DOI 10.1038/jid.2012.74; Ivanova A, 2005, GENESIS, V43, P129, DOI 10.1002/gene.20162; Jaks V, 2010, EXP CELL RES, V316, P1422, DOI 10.1016/j.yexcr.2010.03.014; Klein AM, 2011, DEVELOPMENT, V138, P3103, DOI 10.1242/dev.060103; Lechler T, 2005, NATURE, V437, P275, DOI 10.1038/nature03922; Lee J, 2013, P NATL ACAD SCI USA, V110, P4634, DOI 10.1073/pnas.1213015110; Li LH, 2010, SCIENCE, V327, P542, DOI 10.1126/science.1180794; Lien WH, 2011, CELL STEM CELL, V9, P219, DOI 10.1016/j.stem.2011.07.015; Lim XH, 2013, SCIENCE, V342, P1226, DOI 10.1126/science.1239730; Lopez-Rovira T, 2005, J INVEST DERMATOL, V125, P1215, DOI 10.1111/j.0022-202X.2005.23956.x; MACKIE EJ, 1988, J CELL BIOL, V107, P2757, DOI 10.1083/jcb.107.6.2757; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Mascre G, 2012, NATURE, V489, P257, DOI 10.1038/nature11393; Metcalfe C, 2014, CELL STEM CELL, V14, P149, DOI 10.1016/j.stem.2013.11.008; Montgomery RK, 2011, P NATL ACAD SCI USA, V108, P179, DOI 10.1073/pnas.1013004108; Muller-Rover S, 2001, J INVEST DERMATOL, V117, P3, DOI 10.1046/j.0022-202x.2001.01377.x; Nathans J., 2010, GENERATION INDUCIBLE; Paquet-Fifield S, 2009, J CLIN INVEST, V119, P2795, DOI 10.1172/JCI38535; Plikus MV, 2012, SEMIN CELL DEV BIOL, V23, P946, DOI 10.1016/j.semcdb.2012.10.001; POTTEN CS, 1987, CELL TISSUE KINET, V20, P461, DOI 10.1111/j.1365-2184.1987.tb01355.x; Ritsma L, 2014, NATURE, V507, P362, DOI 10.1038/nature12972; Roshan A, 2016, NAT CELL BIOL, V18, P145, DOI 10.1038/ncb3282; Sada A, 2013, INT REV CEL MOL BIO, V300, P1, DOI 10.1016/B978-0-12-405210-9.00001-1; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Schluter H, 2011, STEM CELLS, V29, P1256, DOI 10.1002/stem.675; Sugiyama-Nakagiri Y, 2010, ARCH DERMATOL RES, V302, P661, DOI 10.1007/s00403-010-1062-3; Takeda N, 2011, SCIENCE, V334, P1420, DOI 10.1126/science.1213214; Taniguchi H, 2011, NEURON, V71, P995, DOI 10.1016/j.neuron.2011.07.026; Tian H, 2011, NATURE, V478, P255, DOI 10.1038/nature10408; Trempus CS, 2003, J INVEST DERMATOL, V120, P501, DOI 10.1046/j.1523-1747.2003.12088.x; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Vasioukhin V, 1999, P NATL ACAD SCI USA, V96, P8551, DOI 10.1073/pnas.96.15.8551; Waghmare SK, 2008, EMBO J, V27, P1309, DOI 10.1038/emboj.2008.72; Weger N, 2005, J INVEST DERMATOL, V125, P873, DOI 10.1111/j.0022-202X.2005.23946.x; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Zhang YV, 2010, CELL CYCLE, V9, P1504, DOI 10.4161/cc.9.8.11252; Zhang YV, 2009, CELL STEM CELL, V5, P267, DOI 10.1016/j.stem.2009.06.004	54	111	112	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUN	2016	18	6					619	+		10.1038/ncb3359	http://dx.doi.org/10.1038/ncb3359			44	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	DN0JL	27183471	Green Accepted			2022-12-25	WOS:000376750100008
J	Torrano, V; Valcarcel-Jimenez, L; Cortazar, AR; Liu, XJ; Urosevic, J; Castillo-Martin, M; Fernandez-Ruiz, S; Morciano, G; Caro-Maldonado, A; Guiu, M; Zuniga-Garcia, P; Graupera, M; Bellmunt, A; Pandya, P; Lorente, M; Martin-Martin, N; Sutherland, JD; Sanchez-Mosquera, P; Bozal-Basterra, L; Zabala-Letona, A; Arruabarrena-Aristorena, A; Berenguer, A; Embade, N; Ugalde-Olano, A; Lacasa-Viscasillas, I; Loizaga-Iriarte, A; Unda-Urzaiz, M; Schultz, N; Aransay, AM; Sanz-Moreno, V; Barrio, R; Velasco, G; Pinton, P; Cordon-Cardo, C; Locasale, JW; Gomis, RR; Carracedo, A				Torrano, Veronica; Valcarcel-Jimenez, Lorea; Rosa Cortazar, Ana; Liu, Xiaojing; Urosevic, Jelena; Castillo-Martin, Mireia; Fernandez-Ruiz, Sonia; Morciano, Giampaolo; Caro-Maldonado, Alfredo; Guiu, Marc; Zuniga-Garcia, Patricia; Graupera, Mariona; Bellmunt, Anna; Pandya, Pahini; Lorente, Mar; Martin-Martin, Natalia; David Sutherland, James; Sanchez-Mosquera, Pilar; Bozal-Basterra, Laura; Zabala-Letona, Amaia; Arruabarrena-Aristorena, Amaia; Berenguer, Antonio; Embade, Nieves; Ugalde-Olano, Aitziber; Lacasa-Viscasillas, Isabel; Loizaga-Iriarte, Ana; Unda-Urzaiz, Miguel; Schultz, Nikolaus; Maria Aransay, Ana; Sanz-Moreno, Victoria; Barrio, Rosa; Velasco, Guillermo; Pinton, Paolo; Cordon-Cardo, Carlos; Locasale, Jason W.; Gomis, Roger R.; Carracedo, Arkaitz			The metabolic co-regulator PGC1 alpha suppresses prostate cancer metastasis	NATURE CELL BIOLOGY			English	Article							HIGH-RESOLUTION METABOLOMICS; TRANSCRIPTIONAL COREGULATORS; OXIDATIVE-METABOLISM; PTEN; TUMOR; PGC-1-ALPHA; ACTIVATION; REGULATOR; RECEPTOR; ALPHA	Cellular transformation and cancer progression is accompanied by changes in the metabolic landscape. Master co-regulators of metabolism orchestrate the modulation of multiple metabolic pathways through transcriptional programs, and hence constitute a probabilistically parsimonious mechanism for general metabolic rewiring. Here we show that the transcriptional co-activator peroxisome proliferator-activated receptor gamma co-activator 1 alpha (PGC1 alpha) suppresses prostate cancer progression and metastasis. A metabolic co-regulator data mining analysis unveiled that PGC1 alpha is downregulated in prostate cancer and associated with disease progression. Using genetically engineered mouse models and xenografts, we demonstrated that PGC1 alpha opposes prostate cancer progression and metastasis. Mechanistically, the use of integrative metabolomics and transcriptomics revealed that PGC1 alpha activates an oestrogen-related receptor alpha (ERR alpha)-dependent transcriptional program to elicit a catabolic state and metastasis suppression. Importantly, a signature based on the PGC1 alpha-ERR alpha pathway exhibited prognostic potential in prostate cancer, thus uncovering the relevance of monitoring and manipulating this pathway for prostate cancer stratification and treatment.	[Torrano, Veronica; Valcarcel-Jimenez, Lorea; Rosa Cortazar, Ana; Fernandez-Ruiz, Sonia; Caro-Maldonado, Alfredo; Zuniga-Garcia, Patricia; Martin-Martin, Natalia; David Sutherland, James; Sanchez-Mosquera, Pilar; Bozal-Basterra, Laura; Zabala-Letona, Amaia; Arruabarrena-Aristorena, Amaia; Embade, Nieves; Maria Aransay, Ana; Barrio, Rosa; Carracedo, Arkaitz] CIC bioGUNE, Bizkaia Technol Pk,Bldg 801A, Derio 48160, Bizkaia, Spain; [Liu, Xiaojing; Locasale, Jason W.] Duke Univ, Sch Med, Duke Mol Physiol Inst, Dept Pharmacol & Canc Biol,Duke Canc Inst, Durham, NC 27710 USA; [Urosevic, Jelena; Guiu, Marc; Bellmunt, Anna; Gomis, Roger R.] Barcelona Inst Sci & Technol, Inst Res Biomed IRB Barcelona, Oncol Programme, Barcelona 08028, Catalonia, Spain; [Castillo-Martin, Mireia; Cordon-Cardo, Carlos] Icahn Sch Med Mt Sinai, Dept Pathol, New York, NY 10029 USA; [Castillo-Martin, Mireia] Fundacao Champalimaud, Dept Pathol, P-1400038 Lisbon, Portugal; [Morciano, Giampaolo; Pinton, Paolo] Univ Ferrara, Sect Pathol Oncol & Expt Biol, Dept Morphol Surg & Expt Med, I-44100 Ferrara, Italy; [Graupera, Mariona] Inst Invest Biomed Bellvitge IDIBELL, Vasc Signalling Lab, Gran Via Hosp 199-203, Barcelona 08907, Spain; [Pandya, Pahini; Sanz-Moreno, Victoria] Kings Coll London, Randall Div Cell & Mol Biophys, Tumour Plast Team, New Hunts House,Guys Campus, London SE1 1UL, England; [Lorente, Mar; Velasco, Guillermo] Univ Complutense, Sch Biol, Dept Biochem & Mol Biol 1, E-28040 Madrid, Spain; [Lorente, Mar; Velasco, Guillermo] Inst Invest Sanitarias San Carlos IdISSC, Madrid 28040, Spain; [Berenguer, Antonio] IRB Barcelona, Biostat Bioinformat Uni, Parc Cient Barcelona, Barcelona 08028, Spain; [Ugalde-Olano, Aitziber] Basurto Univ Hosp, Dept Pathol, Bilbao 48013, Spain; [Lacasa-Viscasillas, Isabel; Loizaga-Iriarte, Ana; Unda-Urzaiz, Miguel] Basurto Univ Hosp, Dept Urol, Bilbao 48013, Spain; [Schultz, Nikolaus] Mem Sloan Kettering Canc Ctr, Computat Biol, New York, NY 10065 USA; [Maria Aransay, Ana] Ctr Invest Biomed Red Enfermedades Hepat & Digest, Barcelona 08010, Spain; [Gomis, Roger R.] ICREA, Barcelona 08010, Spain; [Carracedo, Arkaitz] Ikerbasque, Basque Fdn Sci, E-48011 Bilbao, Spain; [Carracedo, Arkaitz] Univ Basque Country UPV EHU, Dept Mol Biol & Biochem, POB 644, E-48080 Bilbao, Spain	CIC bioGUNE; Duke University; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; Icahn School of Medicine at Mount Sinai; Fundacao Champalimaud; University of Ferrara; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of London; King's College London; Complutense University of Madrid; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; Basurto Hospital; Basurto Hospital; Memorial Sloan Kettering Cancer Center; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; ICREA; Basque Foundation for Science; University of Basque Country	Carracedo, A (corresponding author), CIC bioGUNE, Bizkaia Technol Pk,Bldg 801A, Derio 48160, Bizkaia, Spain.; Carracedo, A (corresponding author), Ikerbasque, Basque Fdn Sci, E-48011 Bilbao, Spain.; Carracedo, A (corresponding author), Univ Basque Country UPV EHU, Dept Mol Biol & Biochem, POB 644, E-48080 Bilbao, Spain.	acarracedo@cicbiogune.es	Gomis, Roger R/E-9788-2016; Velasco, Guillermo/AAU-9189-2020; Arruabarrena-Aristorena, Amaia/K-6790-2019; Bozal-Basterra, Laura/AAA-4291-2019; García, Patricia Zúñiga/G-4756-2016; Arruabarrena-Aristorena, Amaia/N-1858-2015; Velasco, Guillermo/H-5260-2012; Carracedo, Arkaitz/F-7029-2011; Morciano, Giampaolo/AAB-8262-2019; Torrano Moya, Veronica/D-3285-2014; unda, miguel/AAP-8322-2021; unda, miguel/D-7532-2012; Lorente, Mar/O-5106-2017; Cortazar, Ana Rosa/AAA-4463-2019; Graupera, Mariona/J-1122-2017; Locasale, Jason W/ABE-6505-2020; Zabala, Amaia/AAA-4172-2019; Valcarcel, Lorea/F-6747-2017; Pinton, Paolo/J-8025-2012; Barrio, Rosa/F-8712-2011; Sutherland, James D/K-2686-2014; Schultz, Nikolaus/ABE-6347-2020; Aransay, Ana M./F-8086-2011; Embade, Nieves/K-5190-2014	Gomis, Roger R/0000-0001-6473-2858; Velasco, Guillermo/0000-0002-1994-2386; Arruabarrena-Aristorena, Amaia/0000-0002-1636-3944; Bozal-Basterra, Laura/0000-0002-4858-2199; García, Patricia Zúñiga/0000-0002-6167-4063; Arruabarrena-Aristorena, Amaia/0000-0002-1636-3944; Velasco, Guillermo/0000-0002-1994-2386; Carracedo, Arkaitz/0000-0001-5957-1260; Morciano, Giampaolo/0000-0002-5355-0845; unda, miguel/0000-0003-2849-9459; unda, miguel/0000-0003-2849-9459; Lorente, Mar/0000-0003-0982-0956; Cortazar, Ana Rosa/0000-0002-7082-5695; Graupera, Mariona/0000-0003-4608-4185; Locasale, Jason W/0000-0002-7766-3502; Zabala, Amaia/0000-0003-2088-5195; Valcarcel, Lorea/0000-0002-7309-9924; Pinton, Paolo/0000-0001-7108-6508; Barrio, Rosa/0000-0002-9663-0669; Sutherland, James D/0000-0003-3229-793X; Aransay, Ana M./0000-0002-8271-612X; Liu, Xiaojing/0000-0002-4231-6017; Embade, Nieves/0000-0001-9878-3290; Pandya, Pahini/0000-0002-5914-1954; Berenguer-LLergo, Antoni/0000-0002-3742-8161; Castillo-Martin, Mireia/0000-0001-8926-6013; Torrano, Veronica/0000-0002-4252-1977; Sanz-Moreno, Victoria/0000-0002-5096-9456	Ramon y Cajal award; Basque Department of Industry, Tourism and Trade (Etortek) [2012111086, PI2012-03, 277043]; Movember; ISCIII [PI10/01484, PI13/00031]; FERO VIII Fellowship; European Research Council [336343]; Spanish Association Against Cancer (AECC); MINECO postdoctoral program; CIG program from the European commission [660191]; Basque Government of Education; Italian Association for Cancer Research [AIRC: IG-14442]; Italian Ministry of Education, University and Research (COFIN) [20129JLHSY_002]; Italian Ministry of Education, University and Research (FIRB) [RBAP11FXBC_002]; Italian Ministry of Education, University and Research (Futuro in Ricerca) [RBFR10EGVP_001]; Italian Ministry of Health; MINECO [BFU2014-52282-P, BFU2011-25986]; Basque Government [PI2012/42]; Cancer Research UK [C33043/A12065]; Royal Society [RG110591]; King's Overseas Scholarship; Spanish Ministry of Economy and Competitiveness/Instituto de Salud Carlos III (MINECO/ISCIII); European Regional Development Fund (ERDF/FEDER) [PS09/01401, PI12/02248, PI15/00339]; Fundacion Mutua Madrilena; Fundacio la Marato de TV3; NIH [P01CA087497]; National Institutes of Health [R00CA168997, R01CA193256, R21CA201963]; MINECO (Spain) [SAF2014-59950-P]; Catalan Government [2014-SGR-725]; European Union [317250]; Institute of Health Carlos III (ISC III); European Regional Development Fund (ERDF) [PIE13/00022]; Spanish Government (MINECO); FEDER [SAF2013-46196]; Generalitat de Catalunya AGAUR SGR [535]; Cancer Research UK [12065] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [R00CA168997, R21CA201963, P30CA008748, P01CA087497, R01CA193256] Funding Source: NIH RePORTER; ICREA Funding Source: Custom	Ramon y Cajal award(Spanish Government); Basque Department of Industry, Tourism and Trade (Etortek); Movember; ISCIII(Instituto de Salud Carlos III); FERO VIII Fellowship; European Research Council(European Research Council (ERC)European Commission); Spanish Association Against Cancer (AECC); MINECO postdoctoral program; CIG program from the European commission; Basque Government of Education; Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro); Italian Ministry of Education, University and Research (COFIN)(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Italian Ministry of Education, University and Research (FIRB)(Ministry of Education, Universities and Research (MIUR)); Italian Ministry of Education, University and Research (Futuro in Ricerca)(Ministry of Education, Universities and Research (MIUR)); Italian Ministry of Health(Ministry of Health, Italy); MINECO(Spanish Government); Basque Government(Basque Government); Cancer Research UK(Cancer Research UK); Royal Society(Royal Society of London); King's Overseas Scholarship; Spanish Ministry of Economy and Competitiveness/Instituto de Salud Carlos III (MINECO/ISCIII); European Regional Development Fund (ERDF/FEDER)(European Commission); Fundacion Mutua Madrilena(Instituto de Salud Carlos III); Fundacio la Marato de TV3; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MINECO (Spain)(Spanish Government); Catalan Government; European Union(European Commission); Institute of Health Carlos III (ISC III); European Regional Development Fund (ERDF)(European Commission); Spanish Government (MINECO)(Spanish Government); FEDER(European Commission); Generalitat de Catalunya AGAUR SGR; Cancer Research UK(Cancer Research UK); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ICREA(ICREA)	Apologies to those whose related publications were not cited owing to space limitations. We would like to thank the following researchers: B. Spiegelman (Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA; Department of Cell Biology, Harvard Medical School, Boston, Massachusetts, USA) for providing the Pgc1a<SUP>LoxP</SUP> mice; D. Santamaria and M. Barbacid (Experimental Oncology, Molecular Oncology Programme, Centro Nacional de Investigaciones Oncologicas (CNIO), Madrid, Spain) for technical help and advice with doxycycline-enriched diets in xenograft experiments; P. Puigserver (Department of Cell Biology, Harvard Medical School, and in the Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA) for providing Pgc1 alpha-expressing constructs; B. Carver (Department of Surgery, Division of Urology, Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, USA) for help and advice with data set analysis, D. McDonnell (Department of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, North Carolina, USA) for providing mutant Pgc1 alpha<SUP>L2L3M</SUP>-expressing constructs and M. D. Boyano (Department of Cell Biology and Histology, School of Medicine and Dentistry, University of the Basque Country (UPV/EHU), Leioa, Bizkaia, Spain) and A. Buque (Medical Oncology Research Laboratory, Cruces Universtity Hospital, Bizkaia, Spain) for providing melanoma cell lines. The work of A.C. is supported by the Ramon y Cajal award, the Basque Department of Industry, Tourism and Trade (Etortek), health (2012111086) and education (PI2012-03), Marie Curie (277043), Movember, ISCIII (PI10/01484, PI13/00031), FERO VIII Fellowship and the European Research Council Starting Grant (336343). N. M.-M. is supported by the Spanish Association Against Cancer (AECC). A. C.-M. is supported by the MINECO postdoctoral program and the CIG program from the European commission (660191). A. A.-A. and L.V.-J. are supported by the Basque Government of Education. P. Pinton is grateful to C. degli Scrovegni for continuous support and the work in his laboratory was supported by the Italian Association for Cancer Research (AIRC: IG-14442), the Italian Ministry of Education, University and Research (COFIN no. 20129JLHSY_002, FIRB no. RBAP11FXBC_002, and Futuro in Ricerca no. RBFR10EGVP_001) and the Italian Ministry of Health. R.B. is supported by MINECO (BFU2014-52282-P, BFU2011-25986) and the Basque Government (PI2012/42). The work of V.S.-M. was supported by Cancer Research UK C33043/A12065; Royal Society RG110591. P. Pandya was supported by King's Overseas Scholarship. Work by the group of G.V. was supported by grants from the Spanish Ministry of Economy and Competitiveness/Instituto de Salud Carlos III (MINECO/ISCIII) together with the European Regional Development Fund (ERDF/FEDER): PS09/01401; PI12/02248 and PI15/00339, Fundacion Mutua Madrilena and Fundacio la Marato de TV3. C. C.-C. and M. C.-M. were financially supported by NIH P01CA087497. J.W.L. is supported by R00CA168997, R01CA193256 and R21CA201963 from the National Institutes of Health. Work in the M.; Graupera laboratory was supported by SAF2014-59950-P from MINECO (Spain), 2014-SGR-725 from the Catalan Government, from the People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme FP7/2007-2013/(REA grant agreement 317250), and the Institute of Health Carlos III (ISC III) and the European Regional Development Fund (ERDF) under the integrated Project of Excellence no. PIE13/00022 (ONCOPROFILE). J.U. is a Juan de la Cierva Researcher (MINECO). A. Bellmunt is a FPI-Severo Ochoa fellowship grantee (MINECO). R.R.G. research support was provided by the Spanish Government (MINECO) and FEDER grant SAF2013-46196, as well as the Generalitat de Catalunya AGAUR 2014-SGR grant 535.	Arroyo-Berdugo Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095522; Audet-Walsh E, 2016, CELL REP, V14, P920, DOI 10.1016/j.celrep.2015.12.086; Bergmann R, 2000, AM STAT, V54, P72, DOI 10.2307/2685616; Buijs JT, 2009, CANCER LETT, V273, P177, DOI 10.1016/j.canlet.2008.05.044; Caro-Maldonado A, 2014, J IMMUNOL, V192, P3626, DOI 10.4049/jimmunol.1302062; Carracedo A, 2008, J CLIN INVEST, V118, P3065, DOI [10.1172/jCI34739, 10.1172/JCI34739]; Carracedo A, 2013, NAT REV CANCER, V13, P227, DOI 10.1038/nrc3483; Carracedo A, 2012, J CLIN INVEST, V122, P3088, DOI 10.1172/JCI62129; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chang CY, 2011, CANCER CELL, V20, P500, DOI 10.1016/j.ccr.2011.08.023; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Chen ZB, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000053; Cho HJ, 2014, CANCER DISCOV, V4, P318, DOI 10.1158/2159-8290.CD-13-0346; D'Errico I, 2011, P NATL ACAD SCI USA, V108, P6603, DOI 10.1073/pnas.1016354108; Di Cristofano A, 1998, NAT GENET, V19, P348, DOI 10.1038/1235; Ding ZH, 2011, NATURE, V470, P269, DOI 10.1038/nature09677; Eisele PS, 2014, SEMIN IMMUNOPATHOL, V36, P27, DOI 10.1007/s00281-013-0406-4; Feige JN, 2007, TRENDS CELL BIOL, V17, P292, DOI 10.1016/j.tcb.2007.04.001; Finley LWS, 2013, CELL METAB, V17, P466, DOI 10.1016/j.cmet.2013.02.016; Finley LWS, 2011, CANCER CELL, V19, P416, DOI 10.1016/j.ccr.2011.02.014; Gaillard S, 2006, MOL CELL, V24, P797, DOI 10.1016/j.molcel.2006.10.012; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Garcia M, 2014, BJU INT, V113, pE164, DOI 10.1111/bju.12503; Garcia-Cao I, 2012, CELL, V149, P49, DOI 10.1016/j.cell.2012.02.030; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; Guiu M, 2015, METHODS MOL BIOL, V1293, P221, DOI 10.1007/978-1-4939-2519-3_13; Haq R, 2013, CANCER CELL, V23, P302, DOI 10.1016/j.ccr.2013.02.003; Heiden MGV, 2010, SCIENCE, V329, P1492, DOI 10.1126/science.1188015; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Ittmann M, 2013, CANCER RES, V73, P2718, DOI 10.1158/0008-5472.CAN-12-4213; LaGory EL, 2015, CELL REP, V12, P116, DOI 10.1016/j.celrep.2015.06.006; Lapointe J, 2004, P NATL ACAD SCI USA, V101, P811, DOI 10.1073/pnas.0304146101; LeBleu VS, 2014, NAT CELL BIOL, V16, P992, DOI 10.1038/ncb3039; Li S, 2008, CELL METAB, V8, P105, DOI 10.1016/j.cmet.2008.06.013; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Liu XJ, 2015, MOL CELL PROTEOMICS, V14, P1489, DOI 10.1074/mcp.M114.044859; Liu XJ, 2014, ANAL CHEM, V86, P2175, DOI 10.1021/ac403845u; Loo JM, 2015, CELL, V160, P393, DOI 10.1016/j.cell.2014.12.018; Lunt SY, 2011, ANNU REV CELL DEV BI, V27, P441, DOI 10.1146/annurev-cellbio-092910-154237; Magnon C, 2013, SCIENCE, V341, P143, DOI 10.1126/science.1236361; Majumder PK, 2003, P NATL ACAD SCI USA, V100, P7841, DOI 10.1073/pnas.1232229100; Mouchiroud L, 2014, CELL METAB, V20, P26, DOI 10.1016/j.cmet.2014.03.027; Nandana S, 2014, AM J CLIN EXP UROL, V2, P92; Nardella C, 2008, GENE DEV, V22, P2172, DOI 10.1101/gad.1699608; Nardella C, 2011, CURR TOP MICROBIOL, V347, P135, DOI 10.1007/82_2010_62; Nardella C, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000189; Ortega-Molina A, 2012, CELL METAB, V15, P382, DOI 10.1016/j.cmet.2012.02.001; Piskounova E, 2015, NATURE, V527, P186, DOI 10.1038/nature15726; Quinn GP, 2003, EXPT DESIGN DATA ANA; Robinson D, 2015, CELL, V161, P1215, DOI 10.1016/j.cell.2015.05.001; Rodriguez RM, 2015, NUCLEIC ACIDS RES, V43, P760, DOI 10.1093/nar/gku1340; Saint-Geniez M, 2013, AM J PATHOL, V182, P255, DOI 10.1016/j.ajpath.2012.09.003; Salmena L, 2008, CELL, V133, P403, DOI 10.1016/j.cell.2008.04.013; Sancho P, 2015, CELL METAB, V22, P590, DOI 10.1016/j.cmet.2015.08.015; Schafer ZT, 2009, NATURE, V461, P109, DOI 10.1038/nature08268; Shestov AA, 2014, ELIFE, V3, DOI 10.7554/eLife.03342; Shiota M, 2010, MOL ENDOCRINOL, V24, P114, DOI 10.1210/me.2009-0302; Song MS, 2012, NAT REV MOL CELL BIO, V13, P283, DOI 10.1038/nrm3330; Song MS, 2011, CELL, V144, P187, DOI 10.1016/j.cell.2010.12.020; Stein RA, 2008, CANCER RES, V68, P8805, DOI 10.1158/0008-5472.CAN-08-1594; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Tennakoon JB, 2014, ONCOGENE, V33, P5251, DOI 10.1038/onc.2013.463; Tomlins SA, 2007, NAT GENET, V39, P41, DOI 10.1038/ng1935; Ugalde-Olano A, 2015, METHODS, V77-78, P25, DOI 10.1016/j.ymeth.2015.02.005; Varambally S, 2005, CANCER CELL, V8, P393, DOI 10.1016/j.ccr.2005.10.001; Vazquez F, 2013, CANCER CELL, V23, P287, DOI 10.1016/j.ccr.2012.11.020; Wojtala A, 2014, METHOD ENZYMOL, V542, P243, DOI 10.1016/B978-0-12-416618-9.00013-3; Yang M, 2013, J CLIN INVEST, V123, P3652, DOI 10.1172/JCI67228	69	145	147	0	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUN	2016	18	6					645	+		10.1038/ncb3357	http://dx.doi.org/10.1038/ncb3357			23	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	DN0JL	27214280	Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000376750100011
J	Garber, K				Garber, Ken			No longer going to waste	NATURE BIOTECHNOLOGY			English	Editorial Material							DOUBLE-BLIND; AGE; GROWTH; MASS											Amato AA, 2014, NEUROLOGY, V83, P2239, DOI 10.1212/WNL.0000000000001070; Dalton JT, 2011, J CACHEXIA SARCOPENI, V2, P153, DOI 10.1007/s13539-011-0034-6; Egerman MA, 2015, CELL METAB, V22, P164, DOI 10.1016/j.cmet.2015.05.010; Garcia JM, 2015, LANCET ONCOL, V16, P108, DOI 10.1016/S1470-2045(14)71154-4; Glasser C. E., 2015, 8 INT C CACH SARC MU; Katsimpardi L, 2014, SCIENCE, V344, P630, DOI 10.1126/science.1251141; Lee SJ, 2005, P NATL ACAD SCI USA, V102, P18117, DOI 10.1073/pnas.0505996102; Loffredo FS, 2013, CELL, V153, P828, DOI 10.1016/j.cell.2013.04.015; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; Meriggioli MN, 2015, CALCIFIED TISSUE INT, V96, P234, DOI 10.1007/s00223-014-9926-8; Poggioli T, 2016, CIRC RES, V118, P29, DOI 10.1161/CIRCRESAHA.115.307521; Sinha M, 2014, SCIENCE, V344, P649, DOI 10.1126/science.1251152	12	45	46	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2016	34	5					458	461		10.1038/nbt.3557	http://dx.doi.org/10.1038/nbt.3557			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DL6FL	27153267				2022-12-25	WOS:000375735000014
J	Bogdanovic, O; Smits, AH; Mustienes, ED; Tena, JJ; Ford, E; Williams, R; Senanayake, U; Schultz, MD; Hontelez, S; van Kruijsbergen, I; Rayon, T; Gnerlich, F; Carell, T; Veenstra, GJC; Manzanares, M; Sauka-Spengler, T; Ecker, JR; Vermeulen, M; Gomez-Skarmeta, JL; Lister, R				Bogdanovic, Ozren; Smits, Arne H.; de la Calle Mustienes, Elisa; Tena, Juan J.; Ford, Ethan; Williams, Ruth; Senanayake, Upeka; Schultz, Matthew D.; Hontelez, Saartje; van Kruijsbergen, Ila; Rayon, Teresa; Gnerlich, Felix; Carell, Thomas; Veenstra, Gert Jan C.; Manzanares, Miguel; Sauka-Spengler, Tatjana; Ecker, Joseph R.; Vermeulen, Michiel; Luis Gomez-Skarmeta, Jose; Lister, Ryan			Active DNA demethylation at enhancers during the vertebrate phylotypic period	NATURE GENETICS			English	Article							ZYGOTIC GENOME ACTIVATION; ZEBRAFISH EARLY EMBRYOS; GENE-EXPRESSION; POSTNATAL-DEVELOPMENT; CHROMATIN SIGNATURES; REGULATORY REGIONS; EPIGENETIC MEMORY; STEM-CELLS; METHYLATION; MOUSE	The vertebrate body plan and organs are shaped during a conserved embryonic phase called the phylotypic stage. However, the mechanisms that guide the epigenome through this transition and their evolutionary conservation remain elusive. Here we report widespread DNA demethylation of enhancers during the phylotypic period in zebrafish, Xenopus tropicalis and mouse. These enhancers are linked to developmental genes that display coordinated transcriptional and epigenomic changes in the diverse vertebrates during embryogenesis. Binding of Tet proteins to (hydroxy) methylated DNA and enrichment of 5-hydroxymethylcytosine in these regions implicated active DNA demethylation in this process. Furthermore, loss of function of Tet1, Tet2 and Tet3 in zebrafish reduced chromatin accessibility and increased methylation levels specifically at these enhancers, indicative of DNA methylation being an upstream regulator of phylotypic enhancer function. Overall, our study highlights a regulatory module associated with the most conserved phase of vertebrate embryogenesis and suggests an ancient developmental role for Tet dioxygenases.	[Bogdanovic, Ozren; Ford, Ethan; Lister, Ryan] Univ Western Australia, Australian Res Council, Ctr Excellence Plant Energy Biol, Perth, WA 6009, Australia; [Bogdanovic, Ozren; de la Calle Mustienes, Elisa; Tena, Juan J.; Luis Gomez-Skarmeta, Jose] Univ Pablo Olavide, CSIC, Ctr Andaluz Biol Desarrollo, Seville, Spain; [Bogdanovic, Ozren; Ford, Ethan; Lister, Ryan] Harry Perkins Inst Med Res, Perth, WA, Australia; [Smits, Arne H.; Vermeulen, Michiel] Radboud Univ Nijmegen, Radboud Inst Mol Life Sci, Fac Sci, Dept Mol Biol, NL-6525 ED Nijmegen, Netherlands; [Williams, Ruth; Senanayake, Upeka; Sauka-Spengler, Tatjana] Univ Oxford, Weatherall Inst Mol Med, Oxford, England; [Schultz, Matthew D.; Ecker, Joseph R.] Salk Inst Biol Studies, Genom Anal Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA; [Hontelez, Saartje; van Kruijsbergen, Ila; Veenstra, Gert Jan C.] Radboud Univ Nijmegen, Radboud Inst Mol Life Sci, Fac Sci, Dept Mol Dev Biol, NL-6525 ED Nijmegen, Netherlands; [Rayon, Teresa; Manzanares, Miguel] Ctr Nacl Invest Cardiovasc, Madrid, Spain; [Gnerlich, Felix; Carell, Thomas] Univ Munich, Ctr Integrated Prot Sci, Munich, Germany; [Ecker, Joseph R.] Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA	University of Western Australia; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; CSIC - Andalusian Center for Developmental Biology (CABD); Harry Perkins Institute of Medical Research; Radboud University Nijmegen; University of Oxford; Salk Institute; Radboud University Nijmegen; Centro Nacional de Investigaciones Cardiovasculares (CNIC); University of Munich; Howard Hughes Medical Institute; Salk Institute	Bogdanovic, O (corresponding author), Univ Western Australia, Australian Res Council, Ctr Excellence Plant Energy Biol, Perth, WA 6009, Australia.; Bogdanovic, O; Gomez-Skarmeta, JL (corresponding author), Univ Pablo Olavide, CSIC, Ctr Andaluz Biol Desarrollo, Seville, Spain.; Bogdanovic, O (corresponding author), Harry Perkins Inst Med Res, Perth, WA, Australia.; Vermeulen, M (corresponding author), Radboud Univ Nijmegen, Radboud Inst Mol Life Sci, Fac Sci, Dept Mol Biol, NL-6525 ED Nijmegen, Netherlands.	ozren.bogdanovich@uwa.edu.au; michiel.vermeulen@science.ru.nl; jlgomska@upo.es; ryan.lister@uwa.edu.au	Lister, Ryan/B-5168-2012; Vermeulen, Michiel/C-8883-2013; Ecker, Joseph R/B-9144-2008; Gomez-Skarmeta, Jose Luis/B-5268-2014; Veenstra, Gert Jan C./D-4963-2012; Tena, Juan J/M-2265-2014; Manzanares, Miguel/E-1702-2015; Carell, Thomas/G-4799-2012; Manzanares, Miguel/AAZ-8305-2021; Tena, Juan J./Q-5995-2019; Bogdanovic, Ozren/ABG-9527-2020; Rayon, Teresa/AAA-6592-2020	Lister, Ryan/0000-0001-6637-7239; Vermeulen, Michiel/0000-0003-0836-6894; Ecker, Joseph R/0000-0001-5799-5895; Gomez-Skarmeta, Jose Luis/0000-0001-5125-4332; Veenstra, Gert Jan C./0000-0002-7787-4940; Tena, Juan J/0000-0001-8165-7984; Manzanares, Miguel/0000-0003-4849-2836; Carell, Thomas/0000-0001-7898-2831; Manzanares, Miguel/0000-0003-4849-2836; Tena, Juan J./0000-0001-8165-7984; Bogdanovic, Ozren/0000-0001-5680-0056; Rayon, Teresa/0000-0001-5173-1442; Sauka-Spengler, Tatjana/0000-0001-9289-0263; Hontelez, Saartje/0000-0002-5286-7859; Smits, Arne H/0000-0001-5011-0898; de la Calle-Mustienes, Elisa/0000-0002-8975-6503	Spanish government [BFU2013-41322-P, BIO-396]; Andalusian government [BFU2013-41322-P, BIO-396]; Australian Research Council [FT120100862]; Sylvia and Charles Viertel Senior Medical Research Fellowship; National Health and Medical Research Council; Raine Medical Research Foundation; Australian Research Council Discovery Early Career Researcher Award (DECRA) [DE140101962]; Netherlands Organisation for Scientific Research (NWO-VIDI) [864.09.003]; Cancer Genomics Netherlands; European Research Council [309384]; European Union; Gordon and Betty Moore Foundation [GBMF3034]; Ministerio de Economia y Competitividad [BFU2011-23083]; Comunidad Autonoma de Madrid (CELLDD-CM); Pro-CNIC Foundation; US National Institutes of Health (National Institute of Child Health and Human Development) [R01HD069344]; MRC [G1000801, G0902418] Funding Source: UKRI; Medical Research Council [G1000801, G0902418] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD069344] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH105985] Funding Source: NIH RePORTER	Spanish government(Spanish GovernmentEuropean Commission); Andalusian government; Australian Research Council(Australian Research Council); Sylvia and Charles Viertel Senior Medical Research Fellowship; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Raine Medical Research Foundation; Australian Research Council Discovery Early Career Researcher Award (DECRA)(Australian Research Council); Netherlands Organisation for Scientific Research (NWO-VIDI)(Netherlands Organization for Scientific Research (NWO)); Cancer Genomics Netherlands; European Research Council(European Research Council (ERC)European Commission); European Union(European Commission); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Ministerio de Economia y Competitividad(Spanish Government); Comunidad Autonoma de Madrid (CELLDD-CM)(Comunidad de Madrid); Pro-CNIC Foundation; US National Institutes of Health (National Institute of Child Health and Human Development)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The authors thank D. Secco and A. De Mendoza for critical reading of the manuscript. Spanish and Andalusian government grants BFU2013-41322-P and BIO-396 to J.L.G.-S. supported this work. R.L. was supported by an Australian Research Council Future Fellowship (FT120100862) and a Sylvia and Charles Viertel Senior Medical Research Fellowship, and work in the laboratory of R.L. was funded by the Australian Research Council, National Health and Medical Research Council, and the Raine Medical Research Foundation. O.B. is supported by an Australian Research Council Discovery Early Career Researcher Award (DECRA; DE140101962). The laboratory of M.V. is supported by grants from the Netherlands Organisation for Scientific Research (NWO-VIDI; 864.09.003) and Cancer Genomics Netherlands, a European Research Council starting grant (309384) and the European Union Framework Programme 7 Network of Excellence EpiGeneSys. J.R.E. was supported by the Gordon and Betty Moore Foundation (GBMF3034) and is an Investigator of the Howard Hughes Medical Institute. Work in the laboratory of M.M. is funded by grants from the Ministerio de Economia y Competitividad (BFU2011-23083), Comunidad Autonoma de Madrid (CELLDD-CM), and by the Pro-CNIC Foundation. This work has been supported by a grant from the US National Institutes of Health (National Institute of Child Health and Human Development, grant R01HD069344) to G.J.C.V.	Almeida RD, 2012, EPIGENETICS-US, V7, P383, DOI 10.4161/epi.19375; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Andersen IS, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-7-r65; Auclair G, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0545-5; Barreto G, 2007, NATURE, V445, P671, DOI 10.1038/nature05515; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bogdanovic O, 2012, GENOME RES, V22, P2043, DOI 10.1101/gr.134833.111; Borgel J, 2010, NAT GENET, V42, P1093, DOI 10.1038/ng.708; Bray NPH, 2015, NEAR OPTIMAL RNA SEQ; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Cohen NM, 2011, CELL, V145, P773, DOI 10.1016/j.cell.2011.04.024; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Dawlaty MM, 2013, DEV CELL, V24, P310, DOI 10.1016/j.devcel.2012.12.015; Dawlaty MM, 2011, CELL STEM CELL, V9, P166, DOI 10.1016/j.stem.2011.07.010; Ding JJ, 2015, CELL STEM CELL, V16, P653, DOI 10.1016/j.stem.2015.04.001; Domazet-Loso T, 2010, NATURE, V468, P815, DOI 10.1038/nature09632; Dutton KA, 2001, DEVELOPMENT, V128, P4113; Ge L, 2014, MOL CELL BIOL, V34, P989, DOI 10.1128/MCB.01061-13; Gu TP, 2011, NATURE, V477, P606, DOI 10.1038/nature10443; Guo HS, 2014, NATURE, V511, P606, DOI 10.1038/nature13544; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Hon GC, 2013, NAT GENET, V45, P1198, DOI 10.1038/ng.2746; Hontelez S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10148; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Illingworth RS, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001134; Irie N, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1248; Jiang L, 2013, CELL, V153, P773, DOI 10.1016/j.cell.2013.04.041; Kalinka AT, 2010, NATURE, V468, P811, DOI 10.1038/nature09634; Kamstra JH, 2015, ZEBRAFISH, V12, P230, DOI 10.1089/zeb.2014.1033; Ko M, 2011, P NATL ACAD SCI USA, V108, P14566, DOI 10.1073/pnas.1112317108; Krebs AR, 2014, ELIFE, V3, DOI 10.7554/eLife.04094; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee HJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7315; Lee MT, 2014, ANNU REV CELL DEV BI, V30, P581, DOI 10.1146/annurev-cellbio-100913-013027; Li C, 2015, CELL REP, V12, P1133, DOI 10.1016/j.celrep.2015.07.025; Lindeman LC, 2011, DEV CELL, V21, P993, DOI 10.1016/j.devcel.2011.10.008; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Lister R, 2013, SCIENCE, V341, P629, DOI 10.1126/science.1237905; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Long HK, 2013, ELIFE, V2, DOI 10.7554/eLife.00348; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Moran-Crusio K, 2011, CANCER CELL, V20, P11, DOI 10.1016/j.ccr.2011.06.001; Nord AS, 2013, CELL, V155, P1521, DOI 10.1016/j.cell.2013.11.033; Oswald J, 2000, CURR BIOL, V10, P475, DOI 10.1016/S0960-9822(00)00448-6; Paranjpe SS, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-762; Pauli A, 2012, GENOME RES, V22, P577, DOI 10.1101/gr.133009.111; Perera A, 2015, CELL REP, V11, P283, DOI 10.1016/j.celrep.2015.03.020; Piasecka B, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003476; Potok ME, 2013, CELL, V153, P759, DOI 10.1016/j.cell.2013.04.030; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Rai K, 2008, CELL, V135, P1201, DOI 10.1016/j.cell.2008.11.042; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Santos F, 2002, DEV BIOL, V241, P172, DOI 10.1006/dbio.2001.0501; Schultz MD, 2015, NATURE, V523, P212, DOI 10.1038/nature14465; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Seisenberger S, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2011.0330; Shen L, 2014, CELL STEM CELL, V15, P459, DOI 10.1016/j.stem.2014.09.002; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Smith ZD, 2014, NATURE, V511, P611, DOI 10.1038/nature13581; Smith ZD, 2012, NATURE, V484, P339, DOI 10.1038/nature10960; Spruijt CG, 2013, CELL, V152, P1146, DOI 10.1016/j.cell.2013.02.004; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; Stergachis AB, 2013, CELL, V154, P888, DOI 10.1016/j.cell.2013.07.020; Vastenhouw NL, 2010, NATURE, V464, P922, DOI 10.1038/nature08866; Vilella AJ, 2009, GENOME RES, V19, P327, DOI 10.1101/gr.073585.107; Visel A, 2007, NUCLEIC ACIDS RES, V35, pD88, DOI 10.1093/nar/gkl822; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Wachter E, 2014, ELIFE, V3, DOI 10.7554/eLife.03397; Wang L, 2014, CELL, V157, P979, DOI 10.1016/j.cell.2014.04.017; Williams K, 2011, NATURE, V473, P343, DOI 10.1038/nature10066; Wisniewski JR, 2009, J PROTEOME RES, V8, P5674, DOI 10.1021/pr900748n; Wu H, 2011, NATURE, V473, P389, DOI 10.1038/nature09934; Xu YF, 2012, CELL, V151, P1200, DOI 10.1016/j.cell.2012.11.014; Yu M, 2012, CELL, V149, P1368, DOI 10.1016/j.cell.2012.04.027	79	143	146	3	51	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2016	48	4					417	+		10.1038/ng.3522	http://dx.doi.org/10.1038/ng.3522			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DH6NZ	26928226	Green Submitted, Green Accepted			2022-12-25	WOS:000372908800013
J	Copeland, MF; Politz, MC; Johnson, CB; Markley, AL; Pfleger, BF				Copeland, Matthew F.; Politz, Mark C.; Johnson, Charles B.; Markley, Andrew L.; Pfleger, Brian F.			A transcription activator-like effector (TALE) induction system mediated by proteolysis	NATURE CHEMICAL BIOLOGY			English	Article							CRYSTAL-STRUCTURE; EXPRESSION; CRISPR; SPECIFICITY; INTERFACE; NUCLEASES; DYNAMICS; PLATFORM; VECTORS; REVEALS	Simple and predictable trans-acting regulatory tools are needed in the fields of synthetic biology and metabolic engineering to build complex genetic circuits and optimize the levels of native and heterologous gene products. Transcription activator-like effectors (TALEs) are bacterial virulence factors that have recently gained traction in biotechnology applications owing to their customizable DNA-binding specificity. In this work we expanded the versatility of these transcription factors to create an inducible TALE system by inserting tobacco-etch virus (TEV) protease recognition sites into the TALE backbone. The resulting engineered TALEs maintain transcriptional repression of their target genes in Escherichia coli, but are degraded after induction of the TEV protease, thereby promoting expression of the previously repressed target gene of interest. This TALE-TEV technology enables both repression and induction of plasmid or chromosomal target genes in a manner analogous to traditional repressor proteins but with the added flexibility of being operator-agnostic.	[Copeland, Matthew F.; Politz, Mark C.; Johnson, Charles B.; Markley, Andrew L.; Pfleger, Brian F.] Univ Wisconsin, Dept Chem & Biol Engn, Madison, WI USA; [Copeland, Matthew F.] Procter & Gamble Co, Mason, OH USA; [Johnson, Charles B.] Washington Univ, Dept Energy Environm & Chem Engn, St Louis, MO USA	University of Wisconsin System; University of Wisconsin Madison; Procter & Gamble; Washington University (WUSTL)	Pfleger, BF (corresponding author), Univ Wisconsin, Dept Chem & Biol Engn, Madison, WI USA.	brian.pfleger@wisc.edu	Pfleger, Brian Frederick/AAA-2559-2022	Pfleger, Brian Frederick/0000-0002-9232-9959	US National Science Foundation (NSF) [CBET-114678]; The William F. Vilas Trust; NHGRI Genomic Sciences Training Program [T32 HG002760]; NSF SEES fellowship [GEO-1215871]; US National Institutes of Health (NIH) Biotechnology Training Program [T32 GM008349]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG002760] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008349] Funding Source: NIH RePORTER	US National Science Foundation (NSF)(National Science Foundation (NSF)); The William F. Vilas Trust; NHGRI Genomic Sciences Training Program; NSF SEES fellowship(National Science Foundation (NSF)NSF - Office of the Director (OD)); US National Institutes of Health (NIH) Biotechnology Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by the US National Science Foundation (NSF) (CBET-114678) and The William F. Vilas Trust. M.F.C. and M.C.P. were supported by NHGRI Genomic Sciences Training Program (T32 HG002760). A.L.M. was supported by NSF SEES fellowship (GEO-1215871). M.C.P. was supported by a US National Institutes of Health (NIH) Biotechnology Training Program (T32 GM008349). We thank D. Waugh for providing guidance on TEV protease variants, and J. Cameron for assistance with taking the photographs that appear in this paper.	BERTRAND KP, 1983, GENE, V23, P149, DOI 10.1016/0378-1119(83)90046-X; Bikard D, 2014, NAT BIOTECHNOL, V32, P1146, DOI 10.1038/nbt.3043; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Boissel S, 2014, NUCLEIC ACIDS RES, V42, P2591, DOI 10.1093/nar/gkt1224; Brophy JAN, 2014, NAT METHODS, V11, P508, DOI [10.1038/NMETH.2926, 10.1038/nmeth.2926]; Cameron DE, 2014, NAT BIOTECHNOL, V32, P1276, DOI 10.1038/nbt.3053; Chen BH, 2013, CELL, V155, P1479, DOI 10.1016/j.cell.2013.12.001; Citorik RJ, 2014, NAT BIOTECHNOL, V32, P1141, DOI 10.1038/nbt.3011; Copeland MF, 2014, CURR OPIN BIOTECH, V29, P46, DOI 10.1016/j.copbio.2014.02.010; Cuculis L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8277; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; de Lange O, 2014, PLANT J, V78, P753, DOI 10.1111/tpj.12431; DEWEY DL, 1952, NATURE, V169, P533, DOI 10.1038/169533a0; Ellis HM, 2001, P NATL ACAD SCI USA, V98, P6742, DOI 10.1073/pnas.121164898; Esvelt KM, 2013, NAT METHODS, V10, P1116, DOI [10.1038/NMETH.2681, 10.1038/nmeth.2681]; Gao HS, 2012, CELL RES, V22, P1716, DOI 10.1038/cr.2012.156; Garg A, 2012, NUCLEIC ACIDS RES, V40, P7584, DOI 10.1093/nar/gks404; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Guglielmi L, 2009, METHODS MOL BIOL, V562, P215, DOI 10.1007/978-1-60327-302-2_17; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Huang D, 2012, J BIOL ENG, V6, DOI 10.1186/1754-1611-6-9; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kaern M, 2003, ANNU REV BIOMED ENG, V5, P179, DOI 10.1146/annurev.bioeng.5.040202.121553; Kapust RB, 2001, PROTEIN ENG, V14, P993, DOI 10.1093/protein/14.12.993; Kay S, 2007, SCIENCE, V318, P648, DOI 10.1126/science.1144956; Konermann S, 2013, NATURE, V500, P472, DOI 10.1038/nature12466; Lee TS, 2011, J BIOL ENG, V5, DOI 10.1186/1754-1611-5-12; Leveau JHJ, 2001, J BACTERIOL, V183, P6752, DOI 10.1128/JB.183.23.6752-6762.2001; Li Y, 2012, SCI REP-UK, V2, DOI 10.1038/srep00897; Lienert F, 2013, NUCLEIC ACIDS RES, V41, P9967, DOI 10.1093/nar/gkt758; Lucast LJ, 2001, BIOTECHNIQUES, V30, P544, DOI 10.2144/01303st06; Lynch MD, 2006, BIOTECHNOL BIOENG, V94, P151, DOI 10.1002/bit.20836; Mak ANS, 2012, SCIENCE, V335, P716, DOI 10.1126/science.1216211; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Meckler JF, 2013, NUCLEIC ACIDS RES, V41, P4118, DOI 10.1093/nar/gkt085; Mercer AC, 2014, ACS SYNTH BIOL, V3, P723, DOI 10.1021/sb400114p; Miyanari Y, 2013, NAT STRUCT MOL BIOL, V20, P1321, DOI 10.1038/nsmb.2680; Na D, 2013, NAT BIOTECHNOL, V31, P170, DOI 10.1038/nbt.2461; Nielsen AA, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145735; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Perez-Pinera P, 2013, NAT METHODS, V10, P239, DOI [10.1038/nmeth.2361, 10.1038/NMETH.2361]; Perez-Quintero AL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068464; Phan J, 2002, J BIOL CHEM, V277, P50564, DOI 10.1074/jbc.M207224200; Politz MC, 2013, CHEM COMMUN, V49, P4325, DOI 10.1039/c2cc37107c; Puigbo P, 2007, NUCLEIC ACIDS RES, V35, pW126, DOI 10.1093/nar/gkm219; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Streubel J, 2012, NAT BIOTECHNOL, V30, P593, DOI 10.1038/nbt.2304; Stringer AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044841; Sun N, 2013, BIOTECHNOL BIOENG, V110, P1811, DOI 10.1002/bit.24890; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; Zalatan JG, 2015, CELL, V160, P339, DOI 10.1016/j.cell.2014.11.052	52	22	22	1	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	APR	2016	12	4					254	+		10.1038/NCHEMBIO.2021	http://dx.doi.org/10.1038/NCHEMBIO.2021			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH2DA	26854666	Green Accepted			2022-12-25	WOS:000372593200012
J	Si, LZ; Chen, JY; Huang, XH; Gong, H; Luo, JH; Hou, QQ; Zhou, TY; Lu, TT; Zhu, JJ; Shangguan, YY; Chen, EW; Gong, CX; Zhao, Q; Jing, YF; Zhao, Y; Li, Y; Cui, LL; Fan, DL; Lu, YQ; Weng, QJ; Wang, YC; Zhan, QL; Liu, KY; Wei, XH; An, K; An, G; Han, B				Si, Lizhen; Chen, Jiaying; Huang, Xuehui; Gong, Hao; Luo, Jianghong; Hou, Qingqing; Zhou, Taoying; Lu, Tingting; Zhu, Jingjie; Shangguan, Yingying; Chen, Erwang; Gong, Chengxiang; Zhao, Qiang; Jing, Yufeng; Zhao, Yan; Li, Yan; Cui, Lingling; Fan, Danlin; Lu, Yiqi; Weng, Qijun; Wang, Yongchun; Zhan, Qilin; Liu, Kunyan; Wei, Xinghua; An, Kyungsook; An, Gynheung; Han, Bin			OsSPL13 controls grain size in cultivated rice	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; TRANSCRIPTION FACTORS; NATURAL VARIATION; DNA-BINDING; PLANT ARCHITECTURE; VARIATION REVEALS; CELL ELONGATION; GENETIC-CONTROL; TRANSITION; EXPRESSION	Although genetic diversity has a cardinal role in domestication, abundant natural allelic variations across the rice genome that cause agronomically important differences between diverse varieties have not been fully explored. Here we implement an approach integrating genome-wide association testing with functional analysis on grain size in a diverse rice population. We report that a major quantitative trait locus, GLW7, encoding the plant-specific transcription factor OsSPL13, positively regulates cell size in the grain hull, resulting in enhanced rice grain length and yield. We determine that a tandem-repeat sequence in the 5'UTR of OsSPL13 alters its expression by affecting transcription and translation and that high expression of OsSPL13 is associated with large grains in tropical japonica rice. Further analysis indicates that the large-grain allele of GLW7 in tropical japonica rice was introgressed from indica varieties under artificial selection. Our study demonstrates that new genes can be effectively identified on the basis of genome-wide association data.	[Si, Lizhen; Chen, Jiaying; Huang, Xuehui; Gong, Hao; Luo, Jianghong; Hou, Qingqing; Zhou, Taoying; Lu, Tingting; Zhu, Jingjie; Shangguan, Yingying; Chen, Erwang; Gong, Chengxiang; Zhao, Qiang; Jing, Yufeng; Zhao, Yan; Li, Yan; Cui, Lingling; Fan, Danlin; Lu, Yiqi; Weng, Qijun; Wang, Yongchun; Zhan, Qilin; Liu, Kunyan; Han, Bin] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Natl Ctr Gene Res,Ctr Excellence Mol Plant Sci, Shanghai, Peoples R China; [Wei, Xinghua] Chinese Acad Agr Sci, China Natl Rice Res Inst, State Key Lab Rice Biol, Hangzhou, Zhejiang, Peoples R China; [An, Kyungsook; An, Gynheung] Kyung Hee Univ, Crop Biotech Inst, Yongin, South Korea	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Agricultural Sciences; China National Rice Research Institute, CAAS; Kyung Hee University	Han, B (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Natl Ctr Gene Res,Ctr Excellence Mol Plant Sci, Shanghai, Peoples R China.	bhan@ncgr.ac.cn		Han, Bin/0000-0001-8695-0274; gong, hao/0000-0002-0327-6673	Chinese Academy of Sciences [XDA08020101]; National Natural Science Foundation of China [91535202, 31421093]; Ministry of Science and Technology of China [2013CBA01404]	Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	We thank J. Wang and W. Cai for help in the construction of the MIM156 vector, K. Chong (Institute of Botany, Chinese Academy of Sciences) for providing the pTCK303 vector, P. Hu and G. Jiao for the measurements of grain quality, and J. Li, Xiaoyan Gao and Xiaoshu Gao for microscopy experiments. This work was supported by the Chinese Academy of Sciences (XDA08020101), the National Natural Science Foundation of China (91535202 and 31421093) and the Ministry of Science and Technology of China (2013CBA01404).	Ali ML, 2011, CROP SCI, V51, P2021, DOI 10.2135/cropsci2010.11.0641; BENHAJSALAH H, 1995, PLANT PHYSIOL, V109, P861, DOI 10.1104/pp.109.3.861; Birkenbihl RP, 2005, J MOL BIOL, V352, P585, DOI 10.1016/j.jmb.2005.07.013; Calingacion M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085106; Catterou M, 2001, PLANTA, V212, P673, DOI 10.1007/s004250000467; Cho HT, 1997, PLANT CELL, V9, P1661, DOI 10.1105/tpc.9.9.1661; Franco-Zorrilla JM, 2007, NAT GENET, V39, P1033, DOI 10.1038/ng2079; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Huang XZ, 2009, NAT GENET, V41, P494, DOI 10.1038/ng.352; Huang XH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7258; Huang XH, 2014, ANNU REV PLANT BIOL, V65, P531, DOI 10.1146/annurev-arplant-050213-035715; Huang XH, 2012, NATURE, V490, P497, DOI 10.1038/nature11532; Huang XH, 2012, NAT GENET, V44, P32, DOI 10.1038/ng.1018; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; Itoh J, 2005, PLANT CELL PHYSIOL, V46, P23, DOI 10.1093/pcp/pci501; Jeon JS, 2000, PLANT J, V22, P561, DOI 10.1046/j.1365-313x.2000.00767.x; Jeong DH, 2006, PLANT J, V45, P123, DOI 10.1111/j.1365-313X.2005.02610.x; Ji SJ, 2002, BIOCHEM BIOPH RES CO, V296, P1245, DOI 10.1016/S0006-291X(02)02069-7; Jiao YQ, 2010, NAT GENET, V42, P541, DOI 10.1038/ng.591; Jin J, 2008, NAT GENET, V40, P1365, DOI 10.1038/ng.247; Khush GS, 1997, PLANT MOL BIOL, V35, P25, DOI 10.1023/A:1005810616885; Klein J, 1996, MOL GEN GENET, V250, P7, DOI 10.1007/s004380050046; Lee Y, 2001, PLANT PHYSIOL, V127, P645, DOI 10.1104/pp.010345; Li CB, 2006, SCIENCE, V311, P1936, DOI 10.1126/science.1123604; Li YB, 2011, NAT GENET, V43, P1266, DOI 10.1038/ng.977; Lu G, 2009, PLANTA, V229, P605, DOI 10.1007/s00425-008-0857-3; Lu TT, 2010, GENOME RES, V20, P1238, DOI 10.1101/gr.106120.110; Luo D, 1996, NATURE, V383, P794, DOI 10.1038/383794a0; Mao HL, 2010, P NATL ACAD SCI USA, V107, P19579, DOI 10.1073/pnas.1014419107; McNally KL, 2009, P NATL ACAD SCI USA, V106, P12273, DOI 10.1073/pnas.0900992106; Miura K, 2010, NAT GENET, V42, P545, DOI 10.1038/ng.592; Park CH, 2010, PHYTOCHEMISTRY, V71, P380, DOI 10.1016/j.phytochem.2009.11.003; Saleh A, 2008, NAT PROTOC, V3, P1018, DOI 10.1038/nprot.2008.66; Segami S, 2012, RICE, V5, DOI 10.1186/1939-8433-5-4; Shomura A, 2008, NAT GENET, V40, P1023, DOI 10.1038/ng.169; Song XJ, 2007, NAT GENET, V39, P623, DOI 10.1038/ng2014; Tan LB, 2008, NAT GENET, V40, P1360, DOI 10.1038/ng.197; Wang JW, 2009, CELL, V138, P738, DOI 10.1016/j.cell.2009.06.014; Wang M, 2004, PLANT MOL BIOL REP, V22, P409, DOI 10.1007/BF02772683; Wang SK, 2015, NAT GENET, V47, P949, DOI 10.1038/ng.3352; Wang SK, 2012, NAT GENET, V44, P950, DOI 10.1038/ng.2327; Wang YX, 2015, NAT GENET, V47, P944, DOI 10.1038/ng.3346; Xie KB, 2006, PLANT PHYSIOL, V142, P280, DOI 10.1104/pp.106.084475; Xing SP, 2010, PLANT CELL, V22, P3935, DOI 10.1105/tpc.110.079343; Yamasaki K, 2004, J MOL BIOL, V337, P49, DOI 10.1016/j.jmb.2004.01.015; Yu S, 2012, PLANT CELL, V24, P3320, DOI 10.1105/tpc.112.101014; Zenoni S, 2011, NEW PHYTOL, V191, P662, DOI 10.1111/j.1469-8137.2011.03726.x; Zhang ZW, 2010, NAT GENET, V42, P355, DOI 10.1038/ng.546; Zhu BF, 2011, PLANT PHYSIOL, V155, P1301, DOI 10.1104/pp.110.168500	49	407	466	29	349	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2016	48	4					447	+		10.1038/ng.3518	http://dx.doi.org/10.1038/ng.3518			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DH6NZ	26950093				2022-12-25	WOS:000372908800016
J	Chen, FF; Di, HX; Wang, YX; Cao, Q; Xu, B; Zhang, X; Yang, N; Liu, GJ; Yang, CG; Xu, Y; Jiang, HL; Lian, FL; Zhang, NX; Li, J; Lan, LF				Chen, Feifei; Di, Hongxia; Wang, Youxin; Cao, Qiao; Xu, Bin; Zhang, Xue; Yang, Nana; Liu, Guijie; Yang, Cai-Guang; Xu, Yong; Jiang, Hualiang; Lian, Fulin; Zhang, Naixia; Li, Jian; Lan, Lefu			Small-molecule targeting of a diapophytoene desaturase inhibits S. aureus virulence	NATURE CHEMICAL BIOLOGY			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; STAPHYLOXANTHIN; BIOSYNTHESIS; NAFTIFINE; PATHWAY; C-30	The surge of antibiotic resistance in Staphylococcus aureus has created a dire need for innovative anti-infective agents that attack new targets, to overcome resistance. In S. aureus, carotenoid pigment is an important virulence factor because it shields the bacterium from host oxidant killing. Here we show that naftifine, a US Food and Drug Administration (FDA)-approved anti fungal drug, blocks biosynthesis of carotenoid pigment at nanomolar concentrations. This effect is mediated by competitive inhibition of S. aureus diapophytoene desaturase (CrtN), an essential enzyme for carotenoid pigment synthesis. We found that naftifine attenuated the virulence of a variety of clinical S. aureus isolates, including methicillin-resistant S. aureus (MRSA) strains, in mouse infection models. Specifically, we determined that naftifine is a lead compound for potent CrtN inhibitors. In sum, these findings reveal that naftifine could serve as a chemical probe to manipulate CrtN activity, providing proof of concept that CrtN is a druggable target against S. aureus infections.	[Chen, Feifei; Di, Hongxia; Cao, Qiao; Xu, Bin; Zhang, Xue; Yang, Nana; Liu, Guijie; Yang, Cai-Guang; Jiang, Hualiang; Lan, Lefu] Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 200031, Peoples R China; [Wang, Youxin; Li, Jian] E China Univ Sci & Technol, Sch Pharm, Shanghai Key Lab New Drug Design, Shanghai 200237, Peoples R China; [Xu, Yong] Humanwell Healthcare Grp Co Ltd, Wuhan, Peoples R China; [Lian, Fulin; Zhang, Naixia] Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; East China University of Science & Technology; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS	Lan, LF (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 200031, Peoples R China.; Li, J (corresponding author), E China Univ Sci & Technol, Sch Pharm, Shanghai Key Lab New Drug Design, Shanghai 200237, Peoples R China.	jianli@ecust.edu.cn; llan@simm.ac.cn	Chen, Feifei/GLR-8131-2022	Chen, Feifei/0000-0002-7251-1956; Lan, Lefu/0000-0002-5551-5496	National Natural Science Foundation of China [21472207, 31270126, 21222211, 91313303]; Hundred Talents Program of the Chinese Academy of Sciences; Shanghai Institute of Materia Medica Foundation [CASIMM0120152018]; Shanghai Municipal Education Commission and Shanghai Education Development Foundation [14SG28]; Foundation of the State Key Laboratory of Drug Research [SIMM1302KF-01]; National Science and Technology Major Project "Key New Drug Creation and Manufacturing Program" [2013ZX09507-004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hundred Talents Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); Shanghai Institute of Materia Medica Foundation; Shanghai Municipal Education Commission and Shanghai Education Development Foundation(Shanghai Municipal Education Commission (SHMEC)); Foundation of the State Key Laboratory of Drug Research; National Science and Technology Major Project "Key New Drug Creation and Manufacturing Program"	We thank M. Wu for helpful discussion, S.F. Reichard for editing the manuscript, and F. Gotz (University of Tubingen) for providing the S. carnosus strains TM300::pTX15 and TM300::pTXcrtMN. This work was supported by the National Natural Science Foundation of China (21472207 and 31270126 to L.L.; 21222211 and 91313303 to J.L.), Hundred Talents Program of the Chinese Academy of Sciences (L.L.), Shanghai Institute of Materia Medica Foundation (CASIMM0120152018 to L.L.), Shanghai Municipal Education Commission and Shanghai Education Development Foundation (14SG28 to J.L.) and Foundation of the State Key Laboratory of Drug Research (SIMM1302KF-01 to J.L.). We acknowledge the National Science and Technology Major Project "Key New Drug Creation and Manufacturing Program" (2013ZX09507-004 to C.-G.Y.) and Shanghai Committee of Science and Technology (12ZR1453200 to F.C.).	Alsterholm M, 2010, ACTA DERM-VENEREOL, V90, P239, DOI 10.2340/00015555-0840; Arias CA, 2009, NEW ENGL J MED, V360, P439, DOI 10.1056/NEJMp0804651; Belter A, 2011, BIOL CHEM, V392, P1053, DOI [10.1515/BC-2011-195, 10.1515/BC.2011.195]; Bischoff M, 2001, ANTIMICROB AGENTS CH, V45, P1714, DOI 10.1128/AAC.45.6.1714-1720.2001; Ciftci Ergin, 2002, Indian Journal of Pediatrics, V69, P679, DOI 10.1007/BF02722704; Clauditz A, 2006, INFECT IMMUN, V74, P4950, DOI 10.1128/IAI.00204-06; David MZ, 2010, CLIN MICROBIOL REV, V23, P616, DOI 10.1128/CMR.00081-09; Deleo FR, 2009, J CLIN INVEST, V119, P2464, DOI 10.1172/JCI38226; Ding Y, 2014, P NATL ACAD SCI USA, V111, pE4981, DOI 10.1073/pnas.1411077111; DUTHIE ES, 1952, J GEN MICROBIOL, V6, P95, DOI 10.1099/00221287-6-1-2-95; El-Gohary M, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009992.pub2; Fey PD, 2013, MBIO, V4, DOI 10.1128/mBio.00537-12; Furubayashi M, 2014, FEBS LETT, V588, P436, DOI 10.1016/j.febslet.2013.12.003; Gupta AK, 2008, J CUTAN MED SURG, V12, P51, DOI 10.2310/7750.2008.06009; HAMMOND RK, 1970, J BACTERIOL, V103, P611, DOI 10.1128/JB.103.3.611-615.1970; Kim SH, 2012, J BIOL CHEM, V287, P21575, DOI 10.1074/jbc.M112.343020; Klein E, 2007, EMERG INFECT DIS, V13, P1840, DOI 10.3201/eid1312.070629; Kloos W, 1985, MANUAL CLIN MICROBIO, P143; Koning S, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003261.pub3; Kuroda M, 2001, LANCET, V357, P1225, DOI 10.1016/S0140-6736(00)04403-2; Lan LF, 2010, J BACTERIOL, V192, P3068, DOI 10.1128/JB.00928-09; Leejae S, 2013, J MED MICROBIOL, V62, P421, DOI 10.1099/jmm.0.047316-0; Liu CI, 2008, SCIENCE, V319, P1391, DOI 10.1126/science.1153018; Liu GY, 2005, J EXP MED, V202, P209, DOI 10.1084/jem.20050846; Liu Y, 2010, FEBS LETT, V584, P4325, DOI 10.1016/j.febslet.2010.09.024; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Molina DM, 2013, SCIENCE, V341, P84, DOI 10.1126/science.1233606; NOLTING S, 1992, BRIT J DERMATOL, V126, P56, DOI 10.1111/j.1365-2133.1992.tb00012.x; Palma M, 2001, INFECT IMMUN, V69, P7858, DOI 10.1128/IAI.69.12.7858-7865.2001; Pantoliano MW, 2001, J BIOMOL SCREEN, V6, P429, DOI 10.1089/108705701753364922; Pelz A, 2005, J BIOL CHEM, V280, P32493, DOI 10.1074/jbc.M505070200; Porretta GC, 1995, ARCH PHARM, V328, P667, DOI 10.1002/ardp.19953280907; Raisig A, 1999, J BACTERIOL, V181, P6184, DOI 10.1128/JB.181.19.6184-6187.1999; Raisig A, 2001, BBA-MOL CELL BIOL L, V1533, P164, DOI 10.1016/S1388-1981(01)00154-8; Russell RGG, 2006, BONE, V38, pS7, DOI 10.1016/j.bone.2006.01.151; Volkman JK, 2003, APPL MICROBIOL BIOT, V60, P495, DOI 10.1007/s00253-002-1172-8; WIELAND B, 1994, J BACTERIOL, V176, P7719, DOI 10.1128/JB.176.24.7719-7726.1994	37	88	99	4	131	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAR	2016	12	3					174	179		10.1038/NCHEMBIO.2003	http://dx.doi.org/10.1038/NCHEMBIO.2003			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF5FK	26780405				2022-12-25	WOS:000371377000010
J	Min, SY; Kady, J; Nam, M; Rojas-Rodriguez, R; Berkenwald, A; Kim, JH; Noh, HL; Kim, JK; Cooper, MP; Fitzgibbons, T; Brehm, MA; Corvera, S				Min, So Yun; Kady, Jamie; Nam, Minwoo; Rojas-Rodriguez, Raziel; Berkenwald, Aaron; Kim, Jong Hun; Noh, Hye-Lim; Kim, Jason K.; Cooper, Marcus P.; Fitzgibbons, Timothy; Brehm, Michael A.; Corvera, Silvia			Human 'brite/beige' adipocytes develop from capillary networks, and their implantation improves metabolic homeostasis in mice	NATURE MEDICINE			English	Article							BROWN ADIPOSE-TISSUE; ADULT HUMANS; CELLS; WHITE; OBESITY; GENE; INFLAMMATION; ACTIVATION; EXPRESSION; IDENTIFICATION	Uncoupling protein 1 (UCP1) is highly expressed in brown adipose tissue, where it generates heat by uncoupling electron transport from ATP production. UCP1 is also found outside classical brown adipose tissue depots(1-4), in adipocytes that are termed 'brite' (brown-in-white) or 'beige'. In humans, the presence of brite or beige (brite/beige) adipocytes is correlated with a lean, metabolically healthy phenotypes(5-8), but whether a causal relationship exists is not clear. Here we report that human brite/beige adipocyte progenitors proliferate in response to pro-angiogenic factors, in association with expanding capillary networks. Adipocytes formed from these progenitors transform in response to adenylate cyclase activation from being UCP1 negative to being UCP1 positive, which is a defining feature of the beige/brite phenotype, while displaying uncoupled respiration. When implanted into normal chow-fed, or into high-fat diet (HFD)-fed, glucose intolerant NOD-scid IL2(null) (NSG) mice, brite/beige adipocytes activated in vitro enhance systemic glucose tolerance. These adipocytes express neuroendocrine and secreted factors, including the pro-protein convertase PCSK1, which is strongly associated with human obesity. Pro-angiogenic conditions therefore drive the proliferation of human beige/brite adipocyte progenitors, and activated beige/brite adipocytes can affect systemic glucose homeostasis, potentially through a neuroendocrine mechanism.	[Min, So Yun; Kady, Jamie; Rojas-Rodriguez, Raziel; Kim, Jong Hun; Noh, Hye-Lim; Kim, Jason K.; Brehm, Michael A.; Corvera, Silvia] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA USA; [Min, So Yun; Nam, Minwoo; Rojas-Rodriguez, Raziel] Univ Massachusetts, Sch Med, Grad Sch Biomed Sci, Worcester, MA USA; [Kady, Jamie; Brehm, Michael A.] Univ Massachusetts, Sch Med, Diabet Ctr Excellence, Worcester, MA USA; [Nam, Minwoo; Cooper, Marcus P.; Fitzgibbons, Timothy] Univ Massachusetts, Sch Med, Cardiovasc Ctr Excellence, Worcester, MA USA; [Berkenwald, Aaron] Univ Massachusetts, Sch Med, Clin Translat Res Pathway, Worcester, MA USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Corvera, S (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA USA.	silvia.corvera@umassmed.edu	Fitzgibbons, Timothy/AAG-3700-2020	Kim, Jason/0000-0002-7185-042X; Brehm, Michael/0000-0001-6813-3262	US National Institutes of Health [R01DK089101, R24OD018259, R01DK089185, R01-DK080756, R01-DK079999, R24-DK090963, U24-DK093000]; American Heart Association [12FTF11260010]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK093000, R01DK089185, R01DK089101, R01DK079999, R01DK080756, R24DK090963, U2CDK093000] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R24OD018259] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was funded by US National Institutes of Health grants R01DK089101 (to S.C.), R24OD018259 (to M.A.B.), R01DK089185 (to M.P.C.), R01-DK080756, R01-DK079999, R24-DK090963 and U24-DK093000 (all to J.K.K.), and American Heart Association grant 12FTF11260010 (to T.F.). The authors acknowledge the use of the University of Massachusetts (UMASS) Flow Cytometry Core, the UMASS Genomics Core, the UMASS Mouse Phenotyping Center and the UMASS Morphology Core for conducting these studies.	Behan JW, 2013, OBESITY, V21, P1380, DOI 10.1002/oby.20159; Benzinou M, 2008, NAT GENET, V40, P943, DOI 10.1038/ng.177; Bouloumie A, 2002, ANN ENDOCRINOL-PARIS, V63, P91; Brestoff JR, 2015, NATURE, V519, P242, DOI 10.1038/nature14115; Chang L, 2012, CIRCULATION, V126, P1067, DOI 10.1161/CIRCULATIONAHA.112.104489; Collins S, 2014, NAT REV ENDOCRINOL, V10, P157, DOI 10.1038/nrendo.2013.234; COUSIN B, 1992, J CELL SCI, V103, P931; Crandall DL, 1997, MICROCIRCULATION-LON, V4, P211, DOI 10.3109/10739689709146786; Cypess AM, 2015, CELL METAB, V21, P33, DOI 10.1016/j.cmet.2014.12.009; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Denning GM, 2008, PEPTIDES, V29, P83, DOI 10.1016/j.peptides.2007.11.004; dicky D. J., 2013, PLOS ONE, V8; Elias I, 2012, DIABETES, V61, P1801, DOI 10.2337/db11-0832; Fitzgibbons TP, 2011, AM J PHYSIOL-HEART C, V301, pH1425, DOI 10.1152/ajpheart.00376.2011; Gealekman O, 2011, CIRCULATION, V123, P186, DOI 10.1161/CIRCULATIONAHA.110.970145; Gupta RK, 2012, CELL METAB, V15, P230, DOI 10.1016/j.cmet.2012.01.010; Han J, 2011, DEVELOPMENT, V138, P5027, DOI 10.1242/dev.067686; Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361; Hocking SL, 2015, DIABETOLOGIA, V58, P1587, DOI 10.1007/s00125-015-3583-y; Jackson RS, 1997, NAT GENET, V16, P303, DOI 10.1038/ng0797-303; Tran KV, 2012, CELL METAB, V15, P222, DOI 10.1016/j.cmet.2012.01.008; Lee YH, 2012, CELL METAB, V15, P480, DOI 10.1016/j.cmet.2012.03.009; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Lidell ME, 2014, ADIPOCYTE, V3, P63, DOI 10.4161/adip.26896; Marcinkiewicz A, 2006, J BIOL CHEM, V281, P11901, DOI 10.1074/jbc.M600171200; Miller AM, 2010, CIRC RES, V107, P650, DOI 10.1161/CIRCRESAHA.110.218867; Nedergaard J, 2007, AM J PHYSIOL-ENDOC M, V293, pE444, DOI 10.1152/ajpendo.00691.2006; Nishio M, 2012, CELL METAB, V16, P394, DOI 10.1016/j.cmet.2012.08.001; Shabalina IG, 2013, CELL REP, V5, P1196, DOI 10.1016/j.celrep.2013.10.044; Shinoda K, 2015, NAT MED, V21, P389, DOI 10.1038/nm.3819; Sun K, 2012, P NATL ACAD SCI USA, V109, P5874, DOI 10.1073/pnas.1200447109; Tang W, 2008, SCIENCE, V322, P583, DOI 10.1126/science.1156232; van de Vyver M, 2014, J ENDOCRINOL, V223, P119, DOI 10.1530/JOE-14-0425; Wang GX, 2014, NAT MED, V20, P1436, DOI 10.1038/nm.3713; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Xiao CY, 2015, OBESITY, V23, P1450, DOI 10.1002/oby.21124; Xue RD, 2015, NAT MED, V21, P760, DOI 10.1038/nm.3881; Zhang Y, 2002, BBA-MOL CELL BIOL L, V1584, P115, DOI 10.1016/S1388-1981(02)00298-6	38	196	201	3	66	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2016	22	3					312	318		10.1038/nm.4031	http://dx.doi.org/10.1038/nm.4031			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DF6DC	26808348	Green Accepted			2022-12-25	WOS:000371445100019
J	Strecker, J; Gupta, GD; Zhang, W; Bashkurov, M; Landry, MC; Pelletier, L; Durocher, D				Strecker, Jonathan; Gupta, Gagan D.; Zhang, Wei; Bashkurov, Mikhail; Landry, Marie-Claude; Pelletier, Laurence; Durocher, Daniel			DNA damage signalling targets the kinetochore to promote chromatin mobility	NATURE CELL BIOLOGY			English	Article							SPINDLE-ASSEMBLY CHECKPOINT; DOUBLE-STRAND BREAKS; HOMOLOGY SEARCH; NUCLEAR ARCHITECTURE; COMPLEX; REPAIR; YEAST; DYNAMICS; PROTEIN; MOVEMENT	In budding yeast, chromatin mobility increases after a DNA double-strand break (DSB). This increase is dependent on Mec1, the yeast ATR kinase, but the targets responsible for this phenomenon are unknown. Here we report that the Mec1-dependent phosphorylation of Cep3, a kinetochore component, is required to stimulate chromatin mobility after DNA breaks. Cep3 phosphorylation counteracts a constraint on chromosome movement imposed by the attachment of centromeres to the spindle pole body. A second constraint, imposed by the tethering of telomeres to the nuclear periphery, is also relieved after chromosome breakage. A non-phosphorylatable Cep3 mutant that impairs DSB-induced chromatin mobility is proficient in DSB repair, suggesting that break-induced chromatin mobility may be dispensable for homology search. Rather, we propose that the relief of centromeric constraint promotes cell cycle arrest and faithful chromosome segregation through the engagement of the spindle assembly checkpoint.	[Strecker, Jonathan; Gupta, Gagan D.; Bashkurov, Mikhail; Landry, Marie-Claude; Pelletier, Laurence; Durocher, Daniel] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, 600 Univ Ave, Toronto, ON M5G 1X5, Canada; [Strecker, Jonathan; Zhang, Wei; Pelletier, Laurence; Durocher, Daniel] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 3E1, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto	Durocher, D (corresponding author), Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.; Durocher, D (corresponding author), Univ Toronto, Dept Mol Genet, Toronto, ON M5S 3E1, Canada.	durocher@lunenfeld.ca	Pelletier, Laurence/F-8858-2013; Durocher, Daniel/A-7733-2010	Durocher, Daniel/0000-0003-3863-8635; Zhang, Wei/0000-0001-5813-240X; Gupta, Gagan/0000-0002-1089-965X	CIHR Doctoral award; CIHR grant [FDN143343, MOP123468]; Krembil Foundation	CIHR Doctoral award(Canadian Institutes of Health Research (CIHR)); CIHR grant(Canadian Institutes of Health Research (CIHR)); Krembil Foundation	We are grateful to R. Szilard and members of the Durocher laboratory for critical reading of the manuscript. We also thank S. Jaspersen (Stowers Institute for Medical Research, USA), P. Hieter (University of British Columbia, Canada), G. Brown (University of Toronto, Canada), M. Meneghini (University of Toronto, Canada), R. Rothstein (Columbia University, USA), S. Gasser (Friedrich Miescher Institute, Switzerland), S. Biggins (Fred Hutchinson Cancer Research Center, USA) and M. Kupiec (Tel Aviv University, Israel) for sharing strains and plasmids. J.S. is supported by a CIHR Doctoral award. D.D. is the Thomas Kierans Chair in Mechanisms of Cancer Development and a Canada Research Chair (Tier 1) in the Molecular Mechanisms of Genome Integrity. This work was supported by CIHR grant FDN143343 (to D.D.) and MOP123468 (to L.P.) and a Grant-in-Aid from the Krembil Foundation to L.P. and D.D.	Agmon N, 2013, NAT CELL BIOL, V15, P694, DOI 10.1038/ncb2745; Aylon Y, 2004, DNA REPAIR, V3, P797, DOI 10.1016/j.dnarep.2004.04.013; Chambers AL, 2012, GENE DEV, V26, P2590, DOI 10.1101/gad.199976.112; Chen SH, 2010, J BIOL CHEM, V285, P12803, DOI 10.1074/jbc.M110.106989; Cho NW, 2014, CELL, V159, P108, DOI 10.1016/j.cell.2014.08.030; Chubb JR, 2002, CURR BIOL, V12, P439, DOI 10.1016/S0960-9822(02)00695-4; Chung DKC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8742; Collin P, 2013, NAT CELL BIOL, V15, P1378, DOI 10.1038/ncb2855; Dick AE, 2013, NAT CELL BIOL, V15, P1370, DOI 10.1038/ncb2842; Dimitrova N, 2008, NATURE, V456, P524, DOI 10.1038/nature07433; Dion V, 2013, CELL, V152, P1355, DOI 10.1016/j.cell.2013.02.010; Dion V, 2012, NAT CELL BIOL, V14, P502, DOI 10.1038/ncb2465; Dorn JF, 2005, BIOPHYS J, V89, P2835, DOI 10.1529/biophysj.104.058461; Dotiwala F, 2010, CURR BIOL, V20, P328, DOI 10.1016/j.cub.2009.12.033; Gartenberg MR, 2004, CELL, V119, P955, DOI 10.1016/j.cell.2004.11.008; Gasser SM, 2002, SCIENCE, V296, P1412, DOI 10.1126/science.1067703; Hediger F, 2002, CURR BIOL, V12, P2076, DOI 10.1016/S0960-9822(02)01338-6; Heun P, 2001, SCIENCE, V294, P2181, DOI 10.1126/science.1065366; HILL A, 1987, MOL CELL BIOL, V7, P2397, DOI 10.1128/MCB.7.7.2397; Horigome C, 2014, MOL CELL, V55, P626, DOI 10.1016/j.molcel.2014.06.027; Jeggo PA, 2014, EXP CELL RES, V329, P69, DOI 10.1016/j.yexcr.2014.09.023; Krawczyk PM, 2012, J CELL SCI, V125, P2127, DOI 10.1242/jcs.089847; Kruhlak MJ, 2006, J CELL BIOL, V172, P823, DOI 10.1083/jcb.200510015; LECHNER J, 1991, CELL, V64, P717, DOI 10.1016/0092-8674(91)90501-O; LECHNER J, 1994, EMBO J, V13, P5203, DOI 10.1002/j.1460-2075.1994.tb06851.x; Lee CS, 2016, P NATL ACAD SCI USA, V113, pE146, DOI 10.1073/pnas.1523660113; Lisby M, 2003, NAT CELL BIOL, V5, P572, DOI 10.1038/ncb997; Lisby M, 2001, P NATL ACAD SCI USA, V98, P8276, DOI 10.1073/pnas.121006298; Lottersberger F, 2015, CELL, V163, P880, DOI 10.1016/j.cell.2015.09.057; Marshall WF, 1997, CURR BIOL, V7, P930, DOI 10.1016/S0960-9822(06)00412-X; Mine-Hattab J, 2012, NAT CELL BIOL, V14, P510, DOI 10.1038/ncb2472; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Neumann FR, 2012, GENE DEV, V26, P369, DOI 10.1101/gad.176156.111; Pinsky BA, 2006, NAT CELL BIOL, V8, P78, DOI 10.1038/ncb1341; Purvis A, 2008, EMBO REP, V9, P56, DOI 10.1038/sj.embor.7401139; Renkawitz J, 2013, MOL CELL, V50, P261, DOI 10.1016/j.molcel.2013.02.020; Renkawitz J, 2014, NAT REV MOL CELL BIO, V15, P369, DOI 10.1038/nrm3805; RIEDER CL, 1995, J CELL BIOL, V130, P941, DOI 10.1083/jcb.130.4.941; Rohner S, 2008, YEAST, V25, P235, DOI 10.1002/yea.1580; Roukos V, 2013, SCIENCE, V341, P660, DOI 10.1126/science.1237150; Sage D, 2005, IEEE T IMAGE PROCESS, V14, P1372, DOI 10.1109/TIP.2005.852787; Sanchez Y, 1999, SCIENCE, V286, P1166, DOI 10.1126/science.286.5442.1166; Seeber A, 2013, GENE DEV, V27, P1999, DOI 10.1101/gad.222992.113; Smolka MB, 2007, P NATL ACAD SCI USA, V104, P10364, DOI 10.1073/pnas.0701622104; Soutoglou E, 2007, NAT CELL BIOL, V9, P675, DOI 10.1038/ncb1591; Vazquez J, 2001, CURR BIOL, V11, P1227, DOI 10.1016/S0960-9822(01)00390-6; Verdaasdonk JS, 2013, MOL CELL, V52, P819, DOI 10.1016/j.molcel.2013.10.021; Wang H, 2001, GENE DEV, V15, P1361, DOI 10.1101/gad.893201; Warren CD, 2004, MOL BIOL CELL, V15, P1724, DOI 10.1091/mbc.E03-09-0637; Wybenga-Groot LE, 2014, CELL SIGNAL, V26, P1825, DOI 10.1016/j.cellsig.2014.05.004; Yuen KWY, 2007, P NATL ACAD SCI USA, V104, P3925, DOI 10.1073/pnas.0610642104	51	54	55	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2016	18	3					281	+		10.1038/ncb3308	http://dx.doi.org/10.1038/ncb3308			23	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	DF0LT	26829389				2022-12-25	WOS:000371031300009
J	Xiong, D; Xiao, SP; Guo, S; Lin, QS; Nakatsu, F; Wu, M				Xiong, Ding; Xiao, Shengping; Guo, Su; Lin, Qinsong; Nakatsu, Fubito; Wu, Min			Frequency and amplitude control of cortical oscillations by phosphoinositide waves	NATURE CHEMICAL BIOLOGY			English	Article							PHYSARUM-POLYCEPHALUM; SHAPE OSCILLATIONS; HUMAN-NEUTROPHILS; TRAVELING-WAVES; CELL POLARITY; DICTYOSTELIUM CELLS; LATERAL INHIBITION; PATTERN-FORMATION; SYNAPTOJANIN 2; PIP3 WAVES	Rhythmicity is prevalent in the cortical dynamics of diverse single and multicellular systems. Current models of cortical oscillations focus primarily on cytoskeleton-based feedbacks, but information on signals upstream of the actin cytoskeleton is limited. In addition, inhibitory mechanisms-especially local inhibitory mechanisms, which ensure proper spatial and kinetic controls of activation-are not well understood. Here, we identified two phosphoinositide phosphatases, synaptojanin 2 and SHIP1, that function in periodic traveling waves of rat basophilic leukemia (RBL) mast cells. The local, phase-shifted activation of lipid phosphatases generates sequential waves of phosphoinositides. By acutely perturbing phosphoinositide composition using optogenetic methods, we showed that pulses of PtdIns(4,5)P-2 regulate the amplitude of cyclic membrane waves while PtdIns(3,4)P-2 sets the frequency. Collectively, these data suggest that the spatiotemporal dynamics of lipid metabolism have a key role in governing cortical oscillations and reveal how phosphatidylinositol 3-kinases (PI3K) activity could be frequency encoded by a phosphatase-dependent inhibitory reaction.	[Xiong, Ding; Wu, Min] Natl Univ Singapore, Mechanobiol Inst, Singapore 117548, Singapore; [Xiong, Ding; Xiao, Shengping; Guo, Su; Lin, Qinsong; Wu, Min] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Xiong, Ding; Xiao, Shengping; Guo, Su; Wu, Min] Natl Univ Singapore, Ctr Bioimaging Sci, Singapore 117548, Singapore; [Nakatsu, Fubito] Niigata Univ, Grad Sch Med & Dent Sci, Dept Neurochem & Mol Cell Biol, Niigata, Japan	National University of Singapore; National University of Singapore; National University of Singapore; Niigata University	Wu, M (corresponding author), Natl Univ Singapore, Mechanobiol Inst, Singapore 117548, Singapore.; Wu, M (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore.; Wu, M (corresponding author), Natl Univ Singapore, Ctr Bioimaging Sci, Singapore 117548, Singapore.	dbswum@nus.edu.sg	Wu, Min/AAK-8627-2020; Wu, Min/H-8048-2012	Wu, Min/0000-0002-9161-7940; Wu, Min/0000-0002-9161-7940; XIONG, Ding/0000-0002-2232-9013	National Research Foundation (NRF) Singapore under its NRF Fellowship Program [NRF-NRFF2011-09]; Mechanobiology Institute at National University of Singapore	National Research Foundation (NRF) Singapore under its NRF Fellowship Program; Mechanobiology Institute at National University of Singapore(National University of Singapore)	We thank P. De Camilli for inspiring this project and for valuable discussions and E. Feng and L. Cheung for technical assistance. This work was supported by the National Research Foundation (NRF) Singapore under its NRF Fellowship Program (M.W., NRF Award No. NRF-NRFF2011-09) and Mechanobiology Institute at National University of Singapore.	Ali K, 2004, NATURE, V431, P1007, DOI 10.1038/nature02991; Allard J, 2013, CURR OPIN CELL BIOL, V25, P107, DOI 10.1016/j.ceb.2012.08.012; Arai Y, 2010, P NATL ACAD SCI USA, V107, P12399, DOI 10.1073/pnas.0908278107; Ben-Chetrit N, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.2005537; Damen JE, 1996, P NATL ACAD SCI USA, V93, P1689, DOI 10.1073/pnas.93.4.1689; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Ehrengruber MU, 1996, J EXP BIOL, V199, P741; EHRENGRUBER MU, 1995, FEBS LETT, V359, P229, DOI 10.1016/0014-5793(95)00048-E; Gerhardt M, 2014, J CELL SCI, V127, P4507, DOI 10.1242/jcs.156000; GERISCH G, 1974, P NATL ACAD SCI USA, V71, P2118, DOI 10.1073/pnas.71.5.2118; Gerisch G, 2012, BIOPHYS J, V103, P1170, DOI [10.1016/j.bpj.2012.08.004, 10.1016/j.bpj.2012.05.00.4]; Gerisch G, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-42; He L, 2010, NAT CELL BIOL, V12, P1133, DOI 10.1038/ncb2124; Helgason CD, 1998, GENE DEV, V12, P1610, DOI 10.1101/gad.12.11.1610; Houk AR, 2012, CELL, V148, P175, DOI 10.1016/j.cell.2011.10.050; Huang CH, 2013, NAT CELL BIOL, V15, P1307, DOI 10.1038/ncb2859; Idevall-Hagren O, 2012, P NATL ACAD SCI USA, V109, pE2316, DOI 10.1073/pnas.1211305109; Kennedy MJ, 2010, NAT METHODS, V7, P973, DOI 10.1038/NMETH.1524; KILLICH T, 1993, J CELL SCI, V106, P1005; Kruse K, 2005, CURR OPIN CELL BIOL, V17, P20, DOI 10.1016/j.ceb.2004.12.007; Kuramoto Y., 1984, CHEM OSCILLATIONS WA; Levayer R, 2013, DEV CELL, V26, P162, DOI 10.1016/j.devcel.2013.06.020; Liu QR, 1999, GENE DEV, V13, P786, DOI 10.1101/gad.13.7.786; Martin AC, 2009, NATURE, V457, P495, DOI 10.1038/nature07522; Meinhardt H, 2000, BIOESSAYS, V22, P753, DOI 10.1002/1521-1878(200008)22:8<753::AID-BIES9>3.0.CO;2-Z; Meinhardt H, 2004, PHYSICA D, V199, P264, DOI 10.1016/j.physd.2004.08.018; Meinhardt H, 1999, J CELL SCI, V112, P2867; MEINHARDT H, 1974, J CELL SCI, V15, P321; Nemoto Y, 1997, J BIOL CHEM, V272, P30817, DOI 10.1074/jbc.272.49.30817; Nishio M, 2007, NAT CELL BIOL, V9, P36, DOI 10.1038/ncb1515; Novak B, 2008, NAT REV MOL CELL BIO, V9, P981, DOI 10.1038/nrm2530; Ong CJ, 2007, BLOOD, V110, P1942, DOI 10.1182/blood-2007-03-079699; Paluch E, 2005, BIOPHYS J, V89, P724, DOI 10.1529/biophysj.105.060590; Purvis JE, 2013, CELL, V152, P945, DOI 10.1016/j.cell.2013.02.005; SATOH H, 1985, EXP CELL RES, V156, P79, DOI 10.1016/0014-4827(85)90263-0; SATOH H, 1984, CELL STRUCT FUNCT, V9, P37, DOI 10.1247/csf.9.37; Scheid MP, 2002, J BIOL CHEM, V277, P9027, DOI 10.1074/jbc.M106755200; Sharma VP, 2013, CURR BIOL, V23, P2079, DOI 10.1016/j.cub.2013.08.044; Solon J, 2009, CELL, V137, P1331, DOI 10.1016/j.cell.2009.03.050; Takagi S, 2008, PHYSICA D, V237, P420, DOI 10.1016/j.physd.2007.09.012; Tang M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6175; Taniguchi D, 2013, P NATL ACAD SCI USA, V110, P5016, DOI 10.1073/pnas.1218025110; UEDA T, 1983, EXP CELL RES, V147, P466, DOI 10.1016/0014-4827(83)90230-6; VISSER G, 1990, BIOPHYS CHEM, V37, P383, DOI 10.1016/0301-4622(90)88037-S; Westendorf C, 2013, P NATL ACAD SCI USA, V110, P3853, DOI 10.1073/pnas.1216629110; Wu M, 2013, P NATL ACAD SCI USA, V110, P1339, DOI 10.1073/pnas.1221538110; WYMANN MP, 1989, J BIOL CHEM, V264, P15829; WYMANN MP, 1987, BIOCHEM BIOPH RES CO, V147, P361, DOI 10.1016/S0006-291X(87)80130-4; Xu X, 2007, J CELL BIOL, V178, P141, DOI 10.1083/jcb.200611096	49	34	34	0	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAR	2016	12	3					159	166		10.1038/NCHEMBIO.2000	http://dx.doi.org/10.1038/NCHEMBIO.2000			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF5FK	26751515				2022-12-25	WOS:000371377000008
J	Yang, Y; Wang, LL; Bell, P; McMenamin, D; He, ZN; White, J; Yu, HW; Xu, CY; Morizono, H; Musunuru, K; Batshaw, ML; Wilson, JM				Yang, Yang; Wang, Lili; Bell, Peter; McMenamin, Deirdre; He, Zhenning; White, John; Yu, Hongwei; Xu, Chenyu; Morizono, Hiroki; Musunuru, Kiran; Batshaw, Mark L.; Wilson, James M.			A dual AAV system enables the Cas9-mediated correction of a metabolic liver disease in newborn mice	NATURE BIOTECHNOLOGY			English	Article							HEPATIC GENE-TRANSFER; HUMAN ORNITHINE TRANSCARBAMYLASE; ADENOASSOCIATED VIRUS; TOLERANCE INDUCTION; RHESUS-MONKEYS; MOUSE-LIVER; WILD-TYPE; GENOME; DELIVERY; CRISPR-CAS9	Many genetic liver diseases in newborns cause repeated, often lethal, metabolic crises. Gene therapy using nonintegrating viruses such as adeno-associated virus (AAV) is not optimal in this setting because the nonintegrating genome is lost as developing hepatocytes proliferate(1,2). We reasoned that newborn liver may be an ideal setting for AAV-mediated gene correction using CRISPR-Cas9. Here we intravenously infuse two AAVs, one expressing Cas9 and the other expressing a guide RNA and the donor DNA, into newborn mice with a partial deficiency in the urea cycle disorder enzyme, ornithine transcarbamylase (OTC). This resulted in reversion of the mutation in 10% (6.7-20.1%) of hepatocytes and increased survival in mice challenged with a high-protein diet, which exacerbates disease. Gene correction in adult OTC-deficient mice was lower and accompanied by larger deletions that ablated residual expression from the endogenous OTC gene, leading to diminished protein tolerance and lethal hyperammonemia on a chow diet.	[Yang, Yang; Bell, Peter; McMenamin, Deirdre; He, Zhenning; White, John; Yu, Hongwei; Wilson, James M.] Univ Penn, Dept Med, Perelman Sch Med, Gene Therapy Program, Philadelphia, PA 19104 USA; [Yang, Yang] Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Chengdu 610064, Sichuan, Peoples R China; [Yang, Yang] Sichuan Univ, West China Hosp, Ctr Canc, Chengdu 610064, Sichuan, Peoples R China; [Yang, Yang] Collaborat Innovat Ctr Biotherapy, Chengdu, Sichuan, Peoples R China; [Wang, Lili] Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, Gene Therapy Program, Philadelphia, PA USA; [Xu, Chenyu; Morizono, Hiroki; Batshaw, Mark L.] Childrens Natl Hlth Syst, Childrens Res Inst, Ctr Genet Med Res, Washington, DC USA; [Musunuru, Kiran] Harvard Univ, Harvard Stem Cell Inst, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Musunuru, Kiran] Brigham & Womens Hosp, Div Cardiovasc Med, 75 Francis St, Boston, MA 02115 USA	University of Pennsylvania; Pennsylvania Medicine; Sichuan University; Sichuan University; University of Pennsylvania; Pennsylvania Medicine; Children's National Health System; Harvard University; Harvard University; Brigham & Women's Hospital	Wilson, JM (corresponding author), Univ Penn, Dept Med, Perelman Sch Med, Gene Therapy Program, Philadelphia, PA 19104 USA.	wilsonjm@mail.med.upenn.edu	Wilson, Matthew H/K-3193-2013; Wang, Lili/D-1093-2009; Wilson, James M/F-9220-2011; Morizono, Hiroki/E-9737-2013	Wang, Lili/0000-0001-9347-3939; Wilson, James M/0000-0002-9630-3131; Morizono, Hiroki/0000-0002-9678-5564; YANG, YANG/0000-0002-8190-1825	National Institute of Child Health and Human Development [P01-HD057247]; Kettering Family Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD057247] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Kettering Family Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank Penn Vector Core for supplying vectors, Penn Bioinformatics Core for assistance on deep sequencing data analysis, Y. Zhu and M. Nayalat for help on immunohistochemistry analysis, and L. Mays for assistance on manuscript preparation. This work was supported by National Institute of Child Health and Human Development P01-HD057247 (J.M.W.) and the Kettering Family Foundation (M.L.B.).	Anguela XM, 2013, BLOOD, V122, P3283, DOI 10.1182/blood-2013-04-497354; Augustin L, 2000, PEDIATR RES, V48, P842, DOI 10.1203/00006450-200012000-00023; Barzel A, 2015, NATURE, V517, P360, DOI 10.1038/nature13864; Batshaw ML, 2014, MOL GENET METAB, V113, P127, DOI 10.1016/j.ymgme.2014.08.001; Cheng RR, 2014, FEBS LETT, V588, P3954, DOI 10.1016/j.febslet.2014.09.008; Cunningham SC, 2008, MOL THER, V16, P1081, DOI 10.1038/mt.2008.72; Daly Thomas M, 2004, Methods Mol Biol, V246, P195; Dingemanse MA, 1996, HEPATOLOGY, V24, P407; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Friedland AE, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0817-8; Gao GP, 2002, P NATL ACAD SCI USA, V99, P11854, DOI 10.1073/pnas.182412299; Hinderer C, 2015, MOL THER, V23, P1298, DOI 10.1038/mt.2015.99; HODGES PE, 1989, P NATL ACAD SCI USA, V86, P4142, DOI 10.1073/pnas.86.11.4142; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Kleinstiver BP, 2015, NATURE, V523, P481, DOI 10.1038/nature14592; Lichter-Konecki U, GENEREVIEWS; Lock M, 2010, HUM GENE THER, V21, P1259, DOI 10.1089/hum.2010.055; LoDuca PA, 2009, CURR GENE THER, V9, P104, DOI 10.2174/156652309787909490; Mahiny AJ, 2015, NAT BIOTECHNOL, V33, P584, DOI 10.1038/nbt.3241; Mew NA, 2013, J PEDIATR-US, V162, P324, DOI 10.1016/j.jpeds.2012.06.065; Morizono H, 1997, BIOCHEM J, V322, P625, DOI 10.1042/bj3220625; Moscioni D, 2006, MOL THER, V14, P25, DOI 10.1016/j.ymthe.2006.03.009; Nivsarkar MS, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/397879; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Schmidt F, 2015, BIOTECHNOL J, V10, P258, DOI 10.1002/biot.201400529; Sharma R, 2015, BLOOD, V126, P1777, DOI 10.1182/blood-2014-12-615492; Shi Y, 2013, GENE THER, V20, P987, DOI 10.1038/gt.2013.22; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; Vasileva A, 2005, NAT REV MICROBIOL, V3, P837, DOI 10.1038/nrmicro1266; Wang D, 2015, HUM GENE THER, V26, P432, DOI 10.1089/hum.2015.087; Wang L, 2012, GENE THER, V19, P404, DOI 10.1038/gt.2011.111; Wang LL, 2012, HUM GENE THER, V23, P533, DOI 10.1089/hum.2011.183; Wang LL, 2011, MOL THER, V19, P2012, DOI 10.1038/mt.2011.151; Yang LH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6507; Yin H, 2014, NAT BIOTECHNOL, V32, P551, DOI 10.1038/nbt.2884	36	338	375	11	119	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2016	34	3					334	+		10.1038/nbt.3469	http://dx.doi.org/10.1038/nbt.3469			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DG1CJ	26829317	Green Accepted, Green Submitted			2022-12-25	WOS:000371802600031
J	Yin, H; Song, CQ; Dorkin, JR; Zhu, LHJ; Li, YX; Wu, QQ; Park, A; Yang, J; Suresh, S; Bizhanova, A; Gupta, A; Bolukbasi, MF; Walsh, S; Bogorad, RL; Gao, GP; Weng, ZP; Dong, YZ; Koteliansky, V; Wolfe, SA; Langer, R; Xue, W; Anderson, DG				Yin, Hao; Song, Chun-Qing; Dorkin, Joseph R.; Zhu, Lihua J.; Li, Yingxiang; Wu, Qiongqiong; Park, Angela; Yang, Junghoon; Suresh, Sneha; Bizhanova, Aizhan; Gupta, Ankit; Bolukbasi, Mehmet F.; Walsh, Stephen; Bogorad, Roman L.; Gao, Guangping; Weng, Zhiping; Dong, Yizhou; Koteliansky, Victor; Wolfe, Scot A.; Langer, Robert; Xue, Wen; Anderson, Daniel G.			Therapeutic genome editing by combined viral and non-viral delivery of CRISPR system components in vivo	NATURE BIOTECHNOLOGY			English	Article							HOMOLOGY-DIRECTED REPAIR; MAMMALIAN-CELLS; MESSENGER-RNA; MOUSE MODEL; GENE; CAS9; MICE; DNA; NUCLEASES; CORRECTS	The combination of Cas9, guide RNA and repair template DNA can induce precise gene editing and the correction of genetic diseases in adult mammals. However, clinical implementation of this technology requires safe and effective delivery of all of these components into the nuclei of the target tissue. Here, we combine lipid nanoparticle-mediated delivery of Cas9 mRNA with adeno-associated viruses encoding a sgRNA and a repair template to induce repair of a disease gene in adult animals. We applied our delivery strategy to a mouse model of human hereditary tyrosinemia and show that the treatment generated fumarylacetoacetate hydrolase (Fah)-positive hepatocytes by correcting the causative Fah-splicing mutation. Treatment rescued disease symptoms such as weight loss and liver damage. The efficiency of correction was >6% of hepatocytes after a single application, suggesting potential utility of Cas9-based therapeutic genome editing for a range of diseases.	[Yin, Hao; Dorkin, Joseph R.; Wu, Qiongqiong; Yang, Junghoon; Suresh, Sneha; Walsh, Stephen; Bogorad, Roman L.; Langer, Robert; Anderson, Daniel G.] MIT, David H Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Song, Chun-Qing; Park, Angela; Bizhanova, Aizhan; Xue, Wen] Univ Massachusetts, Sch Med, RNA Therapeut Inst, Worcester, MA USA; [Song, Chun-Qing; Zhu, Lihua J.; Xue, Wen] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA USA; [Dorkin, Joseph R.] MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA USA; [Zhu, Lihua J.; Gupta, Ankit; Bolukbasi, Mehmet F.; Wolfe, Scot A.; Xue, Wen] Univ Massachusetts, Sch Med, Dept Mol Cell & Canc Biol, Worcester, MA USA; [Zhu, Lihua J.; Weng, Zhiping] Univ Massachusetts, Sch Med, Program Bioinformat & Integrat Biol, Worcester, MA USA; [Li, Yingxiang] Tongji Univ, Sch Life Sci & Technol, Dept Bioinformat, Shanghai 200092, Peoples R China; [Bolukbasi, Mehmet F.; Wolfe, Scot A.] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA USA; [Gao, Guangping] Univ Massachusetts, Sch Med, Gene Therapy Ctr, Worcester, MA USA; [Dong, Yizhou] Ohio State Univ, Coll Pharm, 500 W 12Th Ave, Columbus, OH 43210 USA; [Koteliansky, Victor] Skolkovo Inst Sci & Technol, Skolkovo, Russia; [Koteliansky, Victor] Moscow MV Lomonosov State Univ, Dept Chem, Leninskie Gory, Russia; [Langer, Robert; Anderson, Daniel G.] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Langer, Robert; Anderson, Daniel G.] Harvard MIT Div Hlth Sci & Technol, Cambridge, MA USA; [Langer, Robert; Anderson, Daniel G.] MIT, Inst Med Engn & Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Massachusetts Institute of Technology (MIT); University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Tongji University; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University System of Ohio; Ohio State University; Skolkovo Institute of Science & Technology; Lomonosov Moscow State University; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT)	Anderson, DG (corresponding author), MIT, David H Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Xue, W (corresponding author), Univ Massachusetts, Sch Med, RNA Therapeut Inst, Worcester, MA USA.; Xue, W (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA USA.; Xue, W (corresponding author), Univ Massachusetts, Sch Med, Dept Mol Cell & Canc Biol, Worcester, MA USA.; Anderson, DG (corresponding author), MIT, Dept Chem Engn, Cambridge, MA 02139 USA.; Anderson, DG (corresponding author), Harvard MIT Div Hlth Sci & Technol, Cambridge, MA USA.; Anderson, DG (corresponding author), MIT, Inst Med Engn & Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	wen.xue@umassmed.edu; dgander@mit.edu	Bizhanova, Aizhan/ABA-6459-2020; Bizhanova, Aizhan/ABF-1166-2021; Dong, Yizhou/O-9057-2015; Wilson, Matthew H/K-3193-2013	Bizhanova, Aizhan/0000-0003-0644-5361; Dong, Yizhou/0000-0001-5786-0659; Zhu, Lihua/0000-0001-7416-0590; Suresh, Sneha/0000-0001-9545-6366; Walsh, Stephen/0000-0002-6999-8601	National Institutes of Health (NIH) [5R00CA169512]; Worcester Foundation; Skoltech Center; NIH Centers for Cancer Nanotechnology Excellence [5-U54-CA151884-04]; Harvard-MIT Center of Cancer Nanotechnology Excellence [5-U54-CA151884-04]; National Institute of Biomedical Imaging and Bioengineering [1F32EB017625]; Russian scientific fund [14-34-00017]; NIH [P30-CA14051];  [5P30EY012196-17]; NATIONAL CANCER INSTITUTE [U54CA151884, P30CA014051, R00CA169512] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY012196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [F32EB017625] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Worcester Foundation; Skoltech Center; NIH Centers for Cancer Nanotechnology Excellence; Harvard-MIT Center of Cancer Nanotechnology Excellence; National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Russian scientific fund(Russian Science Foundation (RSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	We thank M. Grompe, S. Levine, T. Jacks, P. Sharp, E. Sontheimer, C. Mello, P. Zamore, M. Moore, T. Flotte, T. Tammela, F. Sanchez-Rivera, T. Papagiannakopoulos, D. Wang, J. Moore and A. Vegas for discussions and for sharing reagents, S. Hough for technical assistance and K. Cormier for histology. This work is supported by grants from the National Institutes of Health (NIH), 5R00CA169512 and Worcester Foundation (to W.X.). H.Y. is supported by Skoltech Center and 5-U54-CA151884-04 (NIH Centers for Cancer Nanotechnology Excellence and the Harvard-MIT Center of Cancer Nanotechnology Excellence). Y.D. acknowledges support from the National Institute of Biomedical Imaging and Bioengineering for his postdoctoral fellowship 1F32EB017625. V.K. acknowledges support from the Russian scientific fund, grant number 14-34-00017. This work is supported in part by Cancer Center Support (core) grant P30-CA14051 from the NIH. We thank the Swanson Biotechnology Center for technical support. We thank C. Wang at Boston Children's Hospital Viral Core for AAV prep (supported by core grant 5P30EY012196-17). The authors acknowledge the service to the MIT community of the late S. Collier.	Aponte JL, 2001, P NATL ACAD SCI USA, V98, P641, DOI 10.1073/pnas.98.2.641; Atabai K, 2005, MOL BIOL CELL, V16, P5528, DOI 10.1091/mbc.E05-02-0128; Azuma H, 2007, NAT BIOTECHNOL, V25, P903, DOI 10.1038/nbt1326; Barzel A, 2015, NATURE, V517, P360, DOI 10.1038/nature13864; Bolukbasi MF, 2015, NAT METHODS, V12, P1150, DOI 10.1038/nmeth.3624; Chen DL, 2012, J AM CHEM SOC, V134, P6948, DOI 10.1021/ja301621z; Chen HZ, 2012, NAT CELL BIOL, V14, P1192, DOI 10.1038/ncb2595; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cox DBT, 2015, NAT MED, V21, P121, DOI 10.1038/nm.3793; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Elliott B, 1998, MOL CELL BIOL, V18, P93, DOI 10.1128/MCB.18.1.93; Findlay GM, 2014, NATURE, V513, P120, DOI 10.1038/nature13695; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Goldberg AD, 2010, CELL, V140, P678, DOI 10.1016/j.cell.2010.01.003; Hendel A, 2015, NAT BIOTECHNOL, V33, P985, DOI 10.1038/nbt.3290; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Kauffman KJ, 2015, NANO LETT, V15, P7300, DOI 10.1021/acs.nanolett.5b02497; Kay MA, 2011, NAT REV GENET, V12, P316, DOI 10.1038/nrg2971; Khorsandi SE, 2008, CANCER GENE THER, V15, P225, DOI 10.1038/sj.cgt.7701119; Kim H, 2014, GENETICS, V197, P1069, DOI 10.1534/genetics.114.166389; Kormann MSD, 2011, NAT BIOTECHNOL, V29, P154, DOI 10.1038/nbt.1733; Li HJ, 2011, NATURE, V475, P217, DOI 10.1038/nature10177; Long CZ, 2014, SCIENCE, V345, P1184, DOI 10.1126/science.1254445; Love KT, 2010, P NATL ACAD SCI USA, V107, P1864, DOI 10.1073/pnas.0910603106; Mahiny AJ, 2015, NAT BIOTECHNOL, V33, P584, DOI 10.1038/nbt.3241; Mali P, 2013, NAT METHODS, V10, P957, DOI [10.1038/NMETH.2649, 10.1038/nmeth.2649]; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Paulk NK, 2010, HEPATOLOGY, V51, P1200, DOI 10.1002/hep.23481; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Schwank G, 2013, CELL STEM CELL, V13, P653, DOI 10.1016/j.stem.2013.11.002; Semple SC, 2010, NAT BIOTECHNOL, V28, P172, DOI 10.1038/nbt.1602; Sundararajan S, 2012, DEVELOPMENT, V139, P4484, DOI 10.1242/dev.078790; Swiech L, 2015, NAT BIOTECHNOL, V33, P102, DOI 10.1038/nbt.3055; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; Chu VT, 2015, NAT BIOTECHNOL, V33, P543, DOI 10.1038/nbt.3198; Wu XB, 2014, NAT BIOTECHNOL, V32, P670, DOI 10.1038/nbt.2889; Wu YX, 2013, CELL STEM CELL, V13, P659, DOI 10.1016/j.stem.2013.10.016; Xue W, 2014, NATURE, V514, P380, DOI 10.1038/nature13589; Yin H, 2014, NAT REV GENET, V15, P541, DOI 10.1038/nrg3763; Yin H, 2014, NAT BIOTECHNOL, V32, P551, DOI 10.1038/nbt.2884; Zhu LHJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108424; Zhu LJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-237; Zhu Lihua Julie, 2015, [Frontiers in Biology, 生物学前沿], V10, P289; Zuris JA, 2015, NAT BIOTECHNOL, V33, P73, DOI 10.1038/nbt.3081	46	591	633	12	583	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2016	34	3					328	+		10.1038/nbt.3471	http://dx.doi.org/10.1038/nbt.3471			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DG1CJ	26829318	Green Submitted, Green Accepted			2022-12-25	WOS:000371802600030
J	Chen, B; Lim, SW; Kannan, A; Alford, SC; Sunden, F; Herschlag, D; Dimov, IK; Baer, TM; Cochran, JR				Chen, Bob; Lim, Sungwon; Kannan, Arvind; Alford, Spencer C.; Sunden, Fanny; Herschlag, Daniel; Dimov, Ivan K.; Baer, Thomas M.; Cochran, Jennifer R.			High-throughput analysis and protein engineering using microcapillary arrays	NATURE CHEMICAL BIOLOGY			English	Article							YEAST SURFACE DISPLAY; ALKALINE-PHOSPHATASE; FLUORESCENT PROTEINS; HUMAN-ANTIBODIES; EVOLUTION; CELLS; SUPERFAMILY; LIBRARIES; SELECTION; RED	We describe a multipurpose technology platform, termed mu SCALE (microcapillary single-cell analysis and laser extraction), that enables massively parallel, quantitative biochemical and biophysical measurements on millions of protein variants expressed from yeast or bacteria. mu SCALE spatially segregates single cells within a microcapillary array, enabling repeated imaging, cell growth and protein expression. We performed high-throughput analysis of cells and their protein products using a range of fluorescent assays, including binding-affinity measurements and dynamic enzymatic assays. A precise laser-based extraction method allows rapid recovery of live clones and their genetic material from microcapillaries for further study. With mu SCALE, we discovered a new antibody against a clinical cancer target, evolved a fluorescent protein biosensor and engineered an enzyme to reduce its sensitivity to its inhibitor. These protein analysis and engineering applications each have unique assay requirements and different host organisms, highlighting the flexibility and technical capabilities of the mSCALE platform.	[Chen, Bob; Lim, Sungwon; Alford, Spencer C.; Cochran, Jennifer R.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Kannan, Arvind; Cochran, Jennifer R.] Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA; [Sunden, Fanny; Herschlag, Daniel] Stanford Univ, Dept Biochem, Stanford, CA 94305 USA; [Herschlag, Daniel] Stanford Univ, Dept Chem, Stanford, CA 94305 USA; [Dimov, Ivan K.] Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Baer, Thomas M.] Stanford Univ, Stanford Photon Res Ctr, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University	Cochran, JR (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.; Cochran, JR (corresponding author), Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA.; Baer, TM (corresponding author), Stanford Univ, Stanford Photon Res Ctr, Stanford, CA 94305 USA.	tmbaer@stanford.edu; jennifer.cochran@stanford.edu		Lim, Sungwon/0000-0003-4045-6478	Stanford-Wallace H. Coulter Translational Partnership Award Program; Siebel Stem Cell Institute; Thomas and Stacey Siebel Foundation; Stanford Photonics Research Center; Hitachi America Faculty Scholar Award; US National Institutes of Health [GM49243]; National Science Foundation Graduate Fellowship Program; Howard Hughes Medical Institute International Student Research Program; Fannie and John Hertz Foundation Graduate Fellowship; Stanford Bio-X Fellowship Program; Stanford Graduate Fellowship Program; Stanford Dean's Fellowship Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM049243, R01GM049243] Funding Source: NIH RePORTER	Stanford-Wallace H. Coulter Translational Partnership Award Program; Siebel Stem Cell Institute; Thomas and Stacey Siebel Foundation; Stanford Photonics Research Center; Hitachi America Faculty Scholar Award; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Graduate Fellowship Program(National Science Foundation (NSF)); Howard Hughes Medical Institute International Student Research Program; Fannie and John Hertz Foundation Graduate Fellowship; Stanford Bio-X Fellowship Program; Stanford Graduate Fellowship Program; Stanford Dean's Fellowship Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank K.D. Wittrup and J. Van Deventer (MIT) and S. Sidhu (University of Toronto) for providing the yeast-displayed scFv library. This project was funded in part by the Stanford-Wallace H. Coulter Translational Partnership Award Program, the Siebel Stem Cell Institute and the Thomas and Stacey Siebel Foundation (to I.K.D.), the Stanford Photonics Research Center, a Hitachi America Faculty Scholar Award (to J.R.C.) and the US National Institutes of Health (GM49243 to D.H.). We acknowledge support from the National Science Foundation Graduate Fellowship Program (B.C. and A.K.), the Howard Hughes Medical Institute International Student Research Program (S.L.), a Fannie and John Hertz Foundation Graduate Fellowship (A.K.), the Stanford Bio-X Fellowship Program (S.L.), the Stanford Graduate Fellowship Program (B.C.) and the Stanford Dean's Fellowship Program (S.C.A.).	Agresti JJ, 2010, P NATL ACAD SCI USA, V107, P4004, DOI 10.1073/pnas.0910781107; Ai HW, 2014, NAT PROTOC, V9, P910, DOI 10.1038/nprot.2014.054; Alberstein M, 2012, PLANT J, V69, P57, DOI 10.1111/j.1365-313X.2011.04770.x; Alford SC, 2012, ACS SYNTH BIOL, V1, P569, DOI 10.1021/sb300050j; Alford SC, 2012, CHEM BIOL, V19, P353, DOI 10.1016/j.chembiol.2012.01.006; Andrews LD, 2014, BIOCHEMISTRY-US, V53, P6811, DOI 10.1021/bi500765p; [Anonymous], 2011, J APPL PHARM SCI; Benton D., 2002, ADV APPL STAT, V2, P269; BRUNE M, 1994, BIOCHEMISTRY-US, V33, P8262, DOI 10.1021/bi00193a013; Chao G, 2006, NAT PROTOC, V1, P755, DOI 10.1038/nprot.2006.94; Chen I, 2011, P NATL ACAD SCI USA, V108, P11399, DOI 10.1073/pnas.1101046108; Coelho PS, 2013, SCIENCE, V339, P307, DOI 10.1126/science.1231434; COLEMAN JE, 1992, ANNU REV BIOPH BIOM, V21, P441, DOI 10.1146/annurev.biophys.21.1.441; Ding YD, 2015, NAT METHODS, V12, P195, DOI 10.1038/nmeth.3261; Fischlechner M, 2014, NAT CHEM, V6, P791, DOI [10.1038/NCHEM.1996, 10.1038/nchem.1996]; Fitzgerald V, 2015, ANAL CHEM, V87, P997, DOI 10.1021/ac503547j; FUKUDA T, 2005, NANOBIOTECHNOL, V1, P105; Gach PC, 2014, BIOSENS BIOELECTRON, V54, P476, DOI 10.1016/j.bios.2013.11.019; Gai SA, 2007, CURR OPIN STRUC BIOL, V17, P467, DOI 10.1016/j.sbi.2007.08.012; Gorris HH, 2009, J AM CHEM SOC, V131, P6277, DOI 10.1021/ja9008858; Graham DK, 2014, NAT REV CANCER, V14, P769, DOI 10.1038/nrc3847; Hu XJ, 2010, APPL MICROBIOL BIOT, V87, P1773, DOI 10.1007/s00253-010-2662-8; Kariolis MS, 2014, NAT CHEM BIOL, V10, P977, DOI [10.1038/NCHEMBIO.1636, 10.1038/nchembio.1636]; Kovac JR, 2007, ANAL CHEM, V79, P9321, DOI 10.1021/ac071366y; Lafferty M., 2004, JALA-J LAB AUTOM, V9, P200, DOI DOI 10.1016/J.JALA.2004.03.005; Lander ES, 2011, NATURE, V470, P187, DOI 10.1038/nature09792; Lee CV, 2004, J MOL BIOL, V340, P1073, DOI 10.1016/j.jmb.2004.05.051; Lemke G, 2008, NAT REV IMMUNOL, V8, P327, DOI 10.1038/nri2303; Liebherr RB, 2014, J AM CHEM SOC, V136, P5949, DOI 10.1021/ja412379p; Love JC, 2006, NAT BIOTECHNOL, V24, P703, DOI 10.1038/nbt1210; O'Brien PJ, 2001, BIOCHEMISTRY-US, V40, P5691, DOI 10.1021/bi0028892; Ostafe R, 2014, CHEM BIOL, V21, P414, DOI 10.1016/j.chembiol.2014.01.010; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Pitsillides CM, 2003, BIOPHYS J, V84, P4023, DOI 10.1016/S0006-3495(03)75128-5; Povolotskaya IS, 2010, NATURE, V465, P922, DOI 10.1038/nature09105; Rahman N, 2014, NATURE, V505, P302, DOI 10.1038/nature12981; Rhodes DR, 2005, NAT GENET, V37, pS31, DOI 10.1038/ng1570; Rissin DM, 2010, NAT BIOTECHNOL, V28, P595, DOI 10.1038/nbt.1641; Romero PA, 2015, P NATL ACAD SCI USA, V112, P7159, DOI 10.1073/pnas.1422285112; Romero PA, 2009, NAT REV MOL CELL BIO, V10, P866, DOI 10.1038/nrm2805; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Sidhu SS, 2004, J MOL BIOL, V338, P299, DOI 10.1016/j.jmb.2004.02.050; Van Deventer JA, 2014, METHODS MOL BIOL, V1131, P151, DOI 10.1007/978-1-62703-992-5_10; Waters JC, 2009, J CELL BIOL, V185, P1135, DOI 10.1083/jcb.200903097; Wu I, 2013, BIOTECHNOL BIOENG, V110, P1874, DOI 10.1002/bit.24864; Wu YC, 2015, NAT METHODS, V12, P439, DOI [10.1038/NMETH.3357, 10.1038/nmeth.3357]; Yang JS, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002612; Zalatan JG, 2008, J MOL BIOL, V384, P1174, DOI 10.1016/j.jmb.2008.09.059; Zhang Y, 2005, MOL CELL PROTEOMICS, V4, P1240, DOI 10.1074/mcp.M500089-MCP200; Zinchenko A, 2014, ANAL CHEM, V86, P2526, DOI 10.1021/ac403585p	50	66	73	5	94	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	FEB	2016	12	2					76	+		10.1038/NCHEMBIO.1978	http://dx.doi.org/10.1038/NCHEMBIO.1978			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DC6GG	26641932	Green Accepted			2022-12-25	WOS:000369317300008
J	Cloonan, SM; Glass, K; Laucho-Contreras, ME; Bhashyam, AR; Cervo, M; Pabon, MA; Konrad, C; Polverino, F; Siempos, II; Perez, E; Mizumura, K; Ghosh, MC; Parameswaran, H; Williams, NC; Rooney, KT; Chen, ZH; Goldklang, MP; Yuan, GC; Moore, SC; Demeo, DL; Rouault, TA; D'Armiento, JM; Schon, EA; Manfredi, G; Quackenbush, J; Mahmood, A; Silverman, EK; Owen, CA; Choi, AMK				Cloonan, Suzanne M.; Glass, Kimberly; Laucho-Contreras, Maria E.; Bhashyam, Abhiram R.; Cervo, Morgan; Pabon, Maria A.; Konrad, Csaba; Polverino, Francesca; Siempos, Ilias I.; Perez, Elizabeth; Mizumura, Kenji; Ghosh, Manik C.; Parameswaran, Harikrishnan; Williams, Niamh C.; Rooney, Kristen T.; Chen, Zhi-Hua; Goldklang, Monica P.; Yuan, Guo-Cheng; Moore, Stephen C.; Demeo, Dawn L.; Rouault, Tracey A.; D'Armiento, Jeanine M.; Schon, Eric A.; Manfredi, Giovanni; Quackenbush, John; Mahmood, Ashfaq; Silverman, Edwin K.; Owen, Caroline A.; Choi, Augustine M. K.			Mitochondrial iron chelation ameliorates cigarette smoke-induced bronchitis and emphysema in mice	NATURE MEDICINE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; CYTOCHROME-C-OXIDASE; GENOME-WIDE ASSOCIATION; GENE-EXPRESSION; REGULATORY PROTEIN-1; TARGETED DELETION; LUNG-CANCER; INFLAMMATION; DEFICIENCY; MUTATIONS	Chronic obstructive pulmonary disease (COPD) is linked to both cigarette smoking and genetic determinants. We have previously identified iron-responsive element binding protein 2 (IRP2) as an important COPD susceptibility gene and have shown that IRP2 protein is increased in the lungs of individuals with COPD. Here we demonstrate that mice deficient in Irp2 were protected from cigarette smoke (CS)-induced experimental COPD. By integrating RNA immunoprecipitation followed by sequencing (RIP-seq), RNA sequencing (RNA-seq), and gene expression and functional enrichment clustering analysis, we identified Irp2 as a regulator of mitochondrial function in the lungs of mice. Irp2 increased mitochondrial iron loading and levels of cytochrome c oxidase (COX), which led to mitochondrial dysfunction and subsequent experimental COPD. Frataxin-deficient mice, which had higher mitochondria! iron loading, showed impaired airway mucociliary clearance (MCC) and higher pulmonary inflammation at baseline, whereas mice deficient in the synthesis of cytochrome c oxidase, which have reduced COX, were protected from CS-induced pulmonary inflammation and impairment of MCC. Mice treated with a mitochondria! iron chelator or mice fed a low-iron diet were protected from CS-induced COPD. Mitochondrial iron chelation also alleviated CS-induced impairment of MCC, CS-induced pulmonary inflammation and CS-associated lung injury in mice with established COPD, suggesting a critical functional role and potential therapeutic intervention for the mitochondrial-iron axis in COPD.	[Cloonan, Suzanne M.; Pabon, Maria A.; Siempos, Ilias I.; Perez, Elizabeth; Mizumura, Kenji; Williams, Niamh C.; Rooney, Kristen T.; Choi, Augustine M. K.] New York Presbyterian Hosp, Weill Cornell Med Coll, Joan & Sanford I Weill Dept Med, New York, NY USA; [Cloonan, Suzanne M.; Laucho-Contreras, Maria E.; Bhashyam, Abhiram R.; Polverino, Francesca; Mizumura, Kenji; Chen, Zhi-Hua; Demeo, Dawn L.; Silverman, Edwin K.; Owen, Caroline A.; Choi, Augustine M. K.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Pulm & Crit Care Med, Boston, MA 02115 USA; [Glass, Kimberly; Yuan, Guo-Cheng; Quackenbush, John] Harvard Univ, TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Glass, Kimberly; Yuan, Guo-Cheng; Quackenbush, John] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Glass, Kimberly; Demeo, Dawn L.; Quackenbush, John; Silverman, Edwin K.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Channing Div Network Med, Boston, MA 02115 USA; [Cervo, Morgan; Moore, Stephen C.; Mahmood, Ashfaq] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Radiol, Boston, MA 02115 USA; [Konrad, Csaba; Manfredi, Giovanni] Weill Cornell Med Coll, Brain & Mind Res Inst, New York, NY USA; [Polverino, Francesca; Owen, Caroline A.] Lovelace Resp Res Inst, Albuquerque, NM USA; [Polverino, Francesca] Univ Parma, Dept Pulm, I-43100 Parma, Italy; [Siempos, Ilias I.] Univ Athens, Sch Med, Evangelismos Hosp, Dept Crit Care Med & Pulm Serv 1, Athens, Greece; [Ghosh, Manik C.; Rouault, Tracey A.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Bethesda, MD USA; [Parameswaran, Harikrishnan] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; [Chen, Zhi-Hua] Zhejiang Univ, Sch Med, Dept Resp & Crit Care Med, Hosp 2, Hangzhou, Zhejiang, Peoples R China; [Goldklang, Monica P.; D'Armiento, Jeanine M.] Columbia Univ, Dept Anesthesiol, New York, NY USA; [Goldklang, Monica P.; D'Armiento, Jeanine M.] Columbia Univ, Dept Med, New York, NY USA; [D'Armiento, Jeanine M.] Columbia Univ, Dept Physiol & Cellular Biophys, New York, NY USA; [Schon, Eric A.] Columbia Univ, Med Ctr, Dept Neurol, New York, NY USA; [Schon, Eric A.] Columbia Univ, Med Ctr, Dept Genet & Dev, New York, NY USA	Cornell University; NewYork-Presbyterian Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Cornell University; Lovelace Respiratory Research Institute; University of Parma; Athens Medical School; Evangelismos Hospital; National & Kapodistrian University of Athens; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Boston University; Zhejiang University; Columbia University; Columbia University; Columbia University; Columbia University; Columbia University	Choi, AMK (corresponding author), New York Presbyterian Hosp, Weill Cornell Med Coll, Joan & Sanford I Weill Dept Med, New York, NY USA.; Choi, AMK (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Pulm & Crit Care Med, Boston, MA 02115 USA.	amc2056@med.cornell.edu	Pabon Porras, Maria/CAG-5118-2022; Polverino, Francesca/F-3816-2017; Siempos, Ilias/GQZ-7330-2022; Polverino, Francesca/AAL-7997-2020	Polverino, Francesca/0000-0001-9686-5698; Rooney, Kristen T/0000-0002-7495-1437; Glass, Kimberly/0000-0003-4394-5779; Mizumura, Kenji/0000-0001-8532-9670; Parameswaran, Harikrishnan/0000-0002-5324-5517; Goldklang, Monica/0000-0002-7019-3130; Quackenbush, John/0000-0002-2702-5879; Cloonan, Suzanne/0000-0001-5301-9926	US National Institutes of Health (NIH) [P01-HL114501, R01-HL055330, R01-HL079904, R01-A1111475-01, R01-HL86814, R21-HL111835, HL122513, R01-HL086936, P01-HD080642]; NIH-National Heart, Lung and Blood Institute [K99-HL125899]; American Lung Association Biomedical Research [RG-348928]; Flight Attendants Medical Research Institute (FAMRI) clinical innovator award; clinical innovator FAMRI [CIA 123046]; FAMRI Young Clinical Scientist a [YFEL141004, YFEL103236]; US Department of Defense [W911F-15-1-0169]; NIH [P01-HL114501, P01-HL105339, R01-HL111759, R21-ES025379-01, R01-GM088999]; Brigham and Women's Hospital-Lovelace Respiratory Research institute Research Consortium; intramural research program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH; Muscular Dystrophy Association; J. Willard and Alice S. Marriott Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008814, P01HD032062, ZIAHD001602, P01HD080642] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL122513, R01HL111759, P01HL105339, R01HL132198, R01HL055330, R01HL079904, P01HL114501, R21HL111835, R00HL122513, R01HL086936, R00HL125899, R01HL086814, K99HL125899] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI111475] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES009089, R21ES025379] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088999] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH-National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Lung Association Biomedical Research; Flight Attendants Medical Research Institute (FAMRI) clinical innovator award; clinical innovator FAMRI; FAMRI Young Clinical Scientist a; US Department of Defense(United States Department of Defense); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brigham and Women's Hospital-Lovelace Respiratory Research institute Research Consortium; intramural research program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH; Muscular Dystrophy Association(Muscular Dystrophy Association); J. Willard and Alice S. Marriott Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank J.S. Moon, H.C. Lam, K. Taylor and B. Ding for technical assistance. The authors also acknowledge S. Chan (Harvard Medical School) for the cyto-GRX2 and mito-GRX2 plasmids, Y. Hua (Columbia University) for the breeding of the Sco2<SUP>ki/ki</SUP> and Sco2<SUP>ki/ko</SUP> mice and J. Connelly (ApoPharma Inc.) for providing Ferriprox. The authors also thank R. Rubio for assistance with RNA-seq, Y. Shao for assistance with the microarray study and M. Ericsson for assistance with transmission electron microscopy. The authors also acknowledge discussion and input from S.W. Ryter, C.A. MacRae and P.Y. Sips. This work was supported by US National Institutes of Health (NIH) grants P01-HL114501 (A.M.K.C.), R01-HL055330 (A.M.K.C.), R01-HL079904 (A.M.K.C.), R01-A1111475-01 (C.A.O.), R01-HL86814 (C.A.O.), R21-HL111835 (C.A.O.), HL122513 (H.P.), R01-HL086936 (to J.M.D'A.) and P01-HD080642 (Project 2 to E.A.S.), NIH-National Heart, Lung and Blood Institute grant K99-HL125899 (S.M.C.), American Lung Association Biomedical Research grant RG-348928 (S.M.C.), a Flight Attendants Medical Research Institute (FAMRI) clinical innovator award (A.M.K.C.), clinical innovator FAMRI grant CIA#123046 (C.A.O.), FAMRI Young Clinical Scientist awards YFEL141004 (F.P.) and YFEL103236 (M.P.G.), and US Department of Defense grant W911F-15-1-0169 (E.A.S.). S.M.C., A.M.K.C., J.Q. and E.K.S. were also supported by NIH grant P01-HL105339 (to E.K.S.). K.G. was supported by NIH grant R01-HL111759 (to J.Q., G.C.Y. and E.K.S.). C.A.O. was also supported by NIH grants R21-ES025379-01 (to A. Fedulov), P01-HL105339 (to E.K.S.) and P01-HL114501 (to A.M.K.C.) and by Brigham and Women's Hospital-Lovelace Respiratory Research institute Research Consortium grants. G.M. and C.K. were supported by NIH grant R01-GM088999 (to G.M.). M.C.G. and T.A.R. acknowledge support from the intramural research program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH. Additional support was provided by the Muscular Dystrophy Association (E.A.S.) and the J. Willard and Alice S. Marriott Foundation (E.A.S.).	Agarwal AR, 2014, AM J RESP CELL MOL, V51, P284, DOI 10.1165/rcmb.2013-0523OC; An CH, 2012, AM J PHYSIOL-LUNG C, V303, pL748, DOI 10.1152/ajplung.00102.2012; Antonicka H, 2003, HUM MOL GENET, V12, P2693, DOI 10.1093/hmg/ddg284; Barnes PJ, 2003, EUR RESPIR J, V22, P672, DOI 10.1183/09031936.03.00040703; Braber S, 2011, AM J PHYSIOL-LUNG C, V300, pL255, DOI 10.1152/ajplung.00304.2010; Caron MA, 2009, J APPL PHYSIOL, V107, P952, DOI 10.1152/japplphysiol.00194.2009; Castaldi PJ, 2015, HUM MOL GENET, V24, P1200, DOI 10.1093/hmg/ddu525; Cho MH, 2014, LANCET RESP MED, V2, P214, DOI 10.1016/S2213-2600(14)70002-5; Cho MH, 2012, HUM MOL GENET, V21, P947, DOI 10.1093/hmg/ddr524; Cho MH, 2010, NAT GENET, V42, P200, DOI 10.1038/ng.535; Clemente P, 2013, J BIOL CHEM, V288, P8321, DOI 10.1074/jbc.M112.422220; Cooperman SS, 2005, BLOOD, V106, P1084, DOI 10.1182/blood-2004-12-4703; Crul T, 2010, CELL PHYSIOL BIOCHEM, V25, P491, DOI 10.1159/000303054; Demeo DL, 2009, AM J HUM GENET, V85, P493, DOI 10.1016/j.ajhg.2009.09.004; Filosa A, 2013, BLOOD CELL MOL DIS, V51, P85, DOI 10.1016/j.bcmd.2013.04.002; Fujimura M, 1998, J CEREBR BLOOD F MET, V18, P1239, DOI 10.1097/00004647-199811000-00010; Galy B, 2010, CELL METAB, V12, P194, DOI 10.1016/j.cmet.2010.06.007; Gattermann N, 1997, BLOOD, V90, P4961, DOI 10.1182/blood.V90.12.4961.4961_4961_4972; Ghio AJ, 2008, AM J RESP CRIT CARE, V178, P1130, DOI 10.1164/rccm.200802-334OC; Ghosh MC, 2013, CELL METAB, V17, P271, DOI 10.1016/j.cmet.2012.12.016; Hancock DB, 2010, NAT GENET, V42, P45, DOI 10.1038/ng.500; Hardin M, 2012, AM J RESP CELL MOL, V47, P203, DOI 10.1165/rcmb.2012-0011OC; Hentze MW, 2010, CELL, V142, P24, DOI 10.1016/j.cell.2010.06.028; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Huang MLH, 2009, P NATL ACAD SCI USA, V106, P16381, DOI 10.1073/pnas.0906784106; Hubeau C, 2013, CLIN SCI, V125, P483, DOI 10.1042/CS20130110; Huttemann M, 2012, FASEB J, V26, P3916, DOI 10.1096/fj.11-203273; Jeong SY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025404; Kantrow SP, 2009, AM J PHYSIOL-LUNG C, V297, pL738, DOI 10.1152/ajplung.00045.2009; Lam HC, 2013, J CLIN INVEST, V123, P5212, DOI 10.1172/JCI69636; Lambrechts D, 2010, AM J RESP CRIT CARE, V181, P486, DOI 10.1164/rccm.200909-1364OC; LaVaute T, 2001, NAT GENET, V27, P209, DOI 10.1038/84859; Lee JH, 2015, AM J RESP CELL MOL, V52, P365, DOI 10.1165/rcmb.2014-0210OC; Leopold PL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008157; Meyron-Holtz EG, 2004, EMBO J, V23, P386, DOI 10.1038/sj.emboj.7600041; Mizumura K, 2014, J CLIN INVEST, V124, P3987, DOI 10.1172/JCI74985; Moroishi T, 2011, CELL METAB, V14, P339, DOI 10.1016/j.cmet.2011.07.011; Nickol AH, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-007911; Ning W, 2004, P NATL ACAD SCI USA, V101, P14895, DOI 10.1073/pnas.0401168101; Philippot Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096285; Pillai SG, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000421; Qiu CA, 2013, IMMUNOLOGY, V138, P76, DOI 10.1111/imm.12020; Qiu WL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024395; Rensvold JW, 2013, CELL REP, V3, P237, DOI 10.1016/j.celrep.2012.11.029; Repapi E, 2010, NAT GENET, V42, P36, DOI 10.1038/ng.501; Saccone NL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001053; Sauleda J, 1998, AM J RESP CRIT CARE, V157, P1413, DOI 10.1164/ajrccm.157.5.9710039; Schneckenpointner R, 2014, INT J CLIN PRACT, V68, P130, DOI 10.1111/ijcp.12216; Shaw GC, 2006, NATURE, V440, P96, DOI 10.1038/nature04512; Siedlinski M, 2013, HUM GENET, V132, P431, DOI 10.1007/s00439-012-1262-3; Silverberg DS, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-24; Slebos DJ, 2007, AM J RESP CELL MOL, V36, P409, DOI 10.1165/rcmb.2006-0214OC; Sohn YS, 2008, BLOOD, V111, P1690, DOI 10.1182/blood-2007-07-102335; Tandara L, 2015, CLIN BIOCHEM, V48, P1252, DOI 10.1016/j.clinbiochem.2015.07.010; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; Thorley Andrew J, 2007, Int J Chron Obstruct Pulmon Dis, V2, P409; Whitnall M, 2012, P NATL ACAD SCI USA, V109, P20590, DOI 10.1073/pnas.1215349109; Wilk JB, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000429; Yang H, 2010, HUM MOL GENET, V19, P170, DOI 10.1093/hmg/ddp477; Yoshida T, 2010, NAT MED, V16, P767, DOI 10.1038/nm.2157	60	139	145	2	45	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2016	22	2					163	174		10.1038/nm.4021	http://dx.doi.org/10.1038/nm.4021			12	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DC8JX	26752519	Green Accepted, Green Submitted			2022-12-25	WOS:000369466800010
J	Guo, X; Wang, XR; Wang, ZP; Banerjee, S; Yang, J; Huang, L; Dixon, JE				Guo, Xing; Wang, Xiaorong; Wang, Zhiping; Banerjee, Sourav; Yang, Jing; Huang, Lan; Dixon, Jack E.			Site-specific proteasome phosphorylation controls cell proliferation and tumorigenesis	NATURE CELL BIOLOGY			English	Article							26S PROTEASOME; PROTEIN-KINASE; PHOSPHOPROTEOMIC ANALYSIS; 20S PROTEASOME; DYRK FAMILY; ATP BINDING; UBIQUITIN; ATPASES; SYSTEM; AMPLIFICATION	Despite the fundamental importance of proteasomal degradation in cells, little is known about whether and how the 26S proteasome itself is regulated in coordination with various physiological processes. Here we show that the proteasome is dynamically phosphorylated during the cell cycle at Thr 25 of the 19S subunit Rpt3. CRISPR/Cas9-mediated genome editing, RNA interference and biochemical studies demonstrate that blocking Rpt3-Thr25 phosphorylation markedly impairs proteasome activity and impedes cell proliferation. Through a kinome-wide screen, we have identified dual-specificity tyrosine-regulated kinase 2 (DYRK2) as the primary kinase that phosphorylates Rpt3-Thr25, leading to enhanced substrate translocation and degradation. Importantly, loss of the single phosphorylation of Rpt3-Thr25 or knockout of DYRK2 significantly inhibits tumour formation by proteasome-addicted human breast cancer cells in mice. These findings define an important mechanism for proteasome regulation and demonstrate the biological significance of proteasome phosphorylation in regulating cell proliferation and tumorigenesis.	[Guo, Xing; Banerjee, Sourav; Yang, Jing; Dixon, Jack E.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Wang, Xiaorong; Huang, Lan] Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92697 USA; [Wang, Xiaorong; Huang, Lan] Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92697 USA; [Wang, Zhiping] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [Dixon, Jack E.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Dixon, Jack E.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Guo, Xing] Zhejiang Univ, Inst Life Sci, Hangzhou 310058, Zhejiang, Peoples R China; [Wang, Zhiping] Zhejiang Univ, Sch Med, Dept Neurobiol, Hangzhou 310058, Zhejiang, Peoples R China	University of California System; University of California San Diego; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Zhejiang University; Zhejiang University	Guo, X; Dixon, JE (corresponding author), Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA.; Dixon, JE (corresponding author), Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA.; Dixon, JE (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA.; Guo, X (corresponding author), Zhejiang Univ, Inst Life Sci, Hangzhou 310058, Zhejiang, Peoples R China.	xguo@zju.edu.cn; jedixon@ucsd.edu	wang, xiao/HGB-7081-2022; Banerjee, Sourav/J-3853-2019	wang, xiao/0000-0002-4088-3341; Banerjee, Sourav/0000-0003-2043-2989	NIH [RO1DK018849, RO1GM074830, 1R01CA168689, 1R01CA174869]; Susan G. Komen postdoctoral fellowship [KG111280]; NATIONAL CANCER INSTITUTE [R01CA168689, R01CA174869, P30CA023100] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK018849, R01DK018024] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074830] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Susan G. Komen postdoctoral fellowship(Susan G. Komen Breast Cancer Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors would like to thank members of the Dixon laboratory and K.-L. Guan, E. Bennett, B. Yang, M. Kaulich and G. Lander for insightful suggestions and discussions of the manuscript. We acknowledge E. Durrant and A. Ly for excellent technical assistance. We thank S. Murata, A. Matouschek, S. Lindquist and W. Becker for providing crucial cDNAs. We owe a debt of gratitude to C. Bashore and A. Martin for the polyubiquitylated GFP substrate. This work was supported by the NIH grants RO1DK018849 to J.E.D., RO1GM074830 to L.H., and 1R01CA168689 and 1R01CA174869 to J.Y. X.G. was partly supported by the Susan G. Komen postdoctoral fellowship for breast cancer research (KG111280).	Aranda S, 2011, FASEB J, V25, P449, DOI 10.1096/fj.10-165837; Becker W, 2012, CELL CYCLE, V11, P3389, DOI 10.4161/cc.21404; Beckwith R, 2013, NAT STRUCT MOL BIOL, V20, P1164, DOI 10.1038/nsmb.2659; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Besche HC, 2014, EMBO J, V33, P1159, DOI 10.1002/embj.201386906; Bhattacharyya S, 2014, NAT REV MOL CELL BIO, V15, P122, DOI 10.1038/nrm3741; Bian YY, 2014, J PROTEOMICS, V96, P253, DOI 10.1016/j.jprot.2013.11.014; Bingol B, 2010, CELL, V140, P567, DOI 10.1016/j.cell.2010.01.024; Bonifaci N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014078; Bose S, 2004, BIOCHEM J, V378, P177, DOI 10.1042/BJ20031122; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; da Fonseca PCA, 2012, MOL CELL, V46, P54, DOI 10.1016/j.molcel.2012.03.026; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Djakovic SN, 2012, J NEUROSCI, V32, P5126, DOI 10.1523/JNEUROSCI.4427-11.2012; Djakovic SN, 2009, J BIOL CHEM, V284, P26655, DOI 10.1074/jbc.M109.021956; Djuranovic S, 2009, MOL CELL, V34, P580, DOI 10.1016/j.molcel.2009.04.030; Ehlinger A, 2013, BIOCHEMISTRY-US, V52, P3618, DOI 10.1021/bi400417a; Feng Y, 2001, CELL GROWTH DIFFER, V12, P29; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Fishbain S, 2015, NAT STRUCT MOL BIOL, V22, P214, DOI 10.1038/nsmb.2958; Gorringe KL, 2005, GENE CHROMOSOME CANC, V42, P247, DOI 10.1002/gcc.20136; Guo X, 2008, GENE DEV, V22, P106, DOI 10.1101/gad.1590908; Guo X, 2011, P NATL ACAD SCI USA, V108, P18649, DOI 10.1073/pnas.1113170108; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Hamilton AM, 2012, NEURON, V74, P1023, DOI 10.1016/j.neuron.2012.04.031; Hershko A, 1997, CURR OPIN CELL BIOL, V9, P788, DOI 10.1016/S0955-0674(97)80079-8; Hoeller D, 2009, NATURE, V458, P438, DOI 10.1038/nature07960; Inobe T, 2011, NAT CHEM BIOL, V7, P161, DOI 10.1038/NCHEMBIO.521; Jacobson AD, 2014, MOL BIOL CELL, V25, P1824, DOI 10.1091/mbc.E13-10-0585; Kaake RM, 2010, J PROTEOME RES, V9, P2016, DOI 10.1021/pr1000175; Kettenbach AN, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001497; Kisselev AF, 2005, METHOD ENZYMOL, V398, P364, DOI 10.1016/S0076-6879(05)98030-0; Lander GC, 2012, NATURE, V482, P186, DOI 10.1038/nature10774; Liu CW, 2006, MOL CELL, V24, P39, DOI 10.1016/j.molcel.2006.08.025; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Mason GGF, 1998, FEBS LETT, V430, P269, DOI 10.1016/S0014-5793(98)00676-0; Matyskiela ME, 2013, NAT STRUCT MOL BIOL, V20, P781, DOI 10.1038/nsmb.2616; Mayya V, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000007; Miller CT, 2003, CANCER RES, V63, P4136; Min MW, 2012, SEMIN CELL DEV BIOL, V23, P482, DOI 10.1016/j.semcdb.2012.01.015; Murata S, 2009, NAT REV MOL CELL BIO, V10, P104, DOI 10.1038/nrm2630; Nagano K, 2009, PROTEOMICS, V9, P2861, DOI 10.1002/pmic.200800667; Olsen JV, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000475; Ong SE, 2006, NAT PROTOC, V1, P2650, DOI 10.1038/nprot.2006.427; Orlowski RZ, 2008, CLIN CANCER RES, V14, P1649, DOI 10.1158/1078-0432.CCR-07-2218; Peth A, 2013, J BIOL CHEM, V288, P7781, DOI 10.1074/jbc.M112.441907; Petrocca F, 2013, CANCER CELL, V24, P182, DOI 10.1016/j.ccr.2013.07.008; Radhakrishnan SK, 2010, MOL CELL, V38, P17, DOI 10.1016/j.molcel.2010.02.029; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ranek MJ, 2013, CIRCULATION, V128, P365, DOI 10.1161/CIRCULATIONAHA.113.001971; Rape M, 2004, NATURE, V432, P588, DOI 10.1038/nature03023; Santarius T, 2010, NAT REV CANCER, V10, P59, DOI 10.1038/nrc2771; Satoh K, 2001, BIOCHEMISTRY-US, V40, P314, DOI 10.1021/bi001815n; Schmidt M, 2014, BBA-MOL CELL RES, V1843, P13, DOI 10.1016/j.bbamcr.2013.08.012; Shabaneh TB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056132; Sledz P, 2013, P NATL ACAD SCI USA, V110, P7264, DOI 10.1073/pnas.1305782110; Smith DM, 2011, CELL, V144, P526, DOI 10.1016/j.cell.2011.02.005; Smith DM, 2005, MOL CELL, V20, P687, DOI 10.1016/j.molcel.2005.10.019; Soundararajan M, 2013, STRUCTURE, V21, P986, DOI 10.1016/j.str.2013.03.012; Tai HC, 2008, NAT REV NEUROSCI, V9, P826, DOI 10.1038/nrn2499; Taipale M, 2012, CELL, V150, P987, DOI 10.1016/j.cell.2012.06.047; Taira N, 2012, J CLIN INVEST, V122, P859, DOI 10.1172/JCI60818; Teixeira LK, 2013, ANNU REV BIOCHEM, V82, P387, DOI 10.1146/annurev-biochem-060410-105307; Tomko RJ, 2013, ANNU REV BIOCHEM, V82, P415, DOI 10.1146/annurev-biochem-060410-150257; Vilchez D, 2012, NATURE, V489, P304, DOI 10.1038/nature11468; Wang XR, 2008, MOL CELL PROTEOMICS, V7, P46, DOI 10.1074/mcp.M700261-MCP200; Wang XR, 2007, BIOCHEMISTRY-US, V46, P3553, DOI 10.1021/bi061994u; Zhang FX, 2007, J BIOL CHEM, V282, P22460, DOI 10.1074/jbc.M702439200	69	103	106	0	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2016	18	2					202	+		10.1038/ncb3289	http://dx.doi.org/10.1038/ncb3289			60	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	DC3NZ	26655835	Green Accepted, Green Submitted			2022-12-25	WOS:000369127300009
J	Nile, AH; Hannoush, RN				Nile, Aaron H.; Hannoush, Rami N.			Fatty acylation of Wnt proteins	NATURE CHEMICAL BIOLOGY			English	Article							FOCAL DERMAL HYPOPLASIA; STEAROYL-COA DESATURASE; PORCN MUTATIONS; SECRETION; PORCUPINE; GENE; IDENTIFICATION; WINGLESS; RESIDUES; ACYLTRANSFERASE	Wnt proteins are critical regulators of signaling networks during embryonic development and in adult tissue homeostasis. The generation of active Wnt proteins requires their regulated secretion into the extracellular space. Once secreted, Wnts signal through the cell surface via receptor binding on Wnt-receiving cells, a mechanism that is prevalent in stem cell and cancer biology. Important to both Wnt secretion and receptor recognition is their post-translational fatty acylation. In this Perspective, we highlight progress in elucidating the biochemistry of Wnt fatty acylation and provide a molecular view on the enzymology of substrate recognition and catalysis, with a focus on the Wnt O-acyltransferase porcupine. Special emphasis is given to Wnt fatty acid biosynthesis, Wnt-porcupine interactions, clinical mutations of porcupine and emerging therapeutics for perturbing Wnt fatty acylation in cancer. Finally, we discuss models for the functional role of the unsaturated fatty acyl chain in mediating lipid-protein interactions and in Wnt trafficking.	[Nile, Aaron H.; Hannoush, Rami N.] Genentech Inc, Dept Early Discovery Biochem, San Francisco, CA USA	Roche Holding; Genentech	Hannoush, RN (corresponding author), Genentech Inc, Dept Early Discovery Biochem, San Francisco, CA USA.	hannoush.rami@gene.com		Nile, Aaron/0000-0002-7370-8769				Aicart-Ramos C, 2011, BBA-BIOMEMBRANES, V1808, P2981, DOI 10.1016/j.bbamem.2011.07.009; Bai YH, 2015, NATURE, V524, P252, DOI 10.1038/nature14549; Banziger C, 2006, CELL, V125, P509, DOI 10.1016/j.cell.2006.02.049; Barrott JJ, 2011, P NATL ACAD SCI USA, V108, P12752, DOI 10.1073/pnas.1006437108; Bartscherer K, 2006, CELL, V125, P523, DOI 10.1016/j.cell.2006.04.009; Beckett K, 2013, TRAFFIC, V14, P82, DOI 10.1111/tra.12016; Bhanot P, 1996, NATURE, V382, P225, DOI 10.1038/382225a0; Biechele S, 2011, DEV BIOL, V355, P275, DOI 10.1016/j.ydbio.2011.04.029; Bornholdt D, 2009, HUM MUTAT, V30, pE618, DOI 10.1002/humu.20992; Buglino JA, 2008, J BIOL CHEM, V283, P22076, DOI 10.1074/jbc.M803901200; Buglino JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011195; Caricasole A, 2002, GENE, V288, P147, DOI 10.1016/S0378-1119(02)00467-5; Chang C.C.Y., 2011, FRONT BIOL, V6, P177, DOI DOI 10.1007/S11515-011-1149-Z; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; Cheng D., 2010, US patent publication, Patent No. [US 101849, 101849]; Ching W, 2008, J BIOL CHEM, V283, P17092, DOI 10.1074/jbc.M802059200; Chu MLH, 2013, STRUCTURE, V21, P1235, DOI 10.1016/j.str.2013.05.006; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Coombs GS, 2010, J CELL SCI, V123, P3357, DOI 10.1242/jcs.072132; Covey TM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034532; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Cui M, 2014, P NATL ACAD SCI USA, V111, pE5029, DOI 10.1073/pnas.1419141111; Das A, 2008, J LIPID RES, V49, P1770, DOI 10.1194/jlr.M800131-JLR200; Dijksterhuis JP, 2015, J BIOL CHEM, V290, P6789, DOI 10.1074/jbc.M114.612648; Dodge ME, 2012, J BIOL CHEM, V287, P23246, DOI 10.1074/jbc.M112.372029; ENOCH HG, 1976, J BIOL CHEM, V251, P5095; Fernandes PH, 2010, GENET TEST MOL BIOMA, V14, P709, DOI 10.1089/gtmb.2010.0089; Fox BG, 2004, ACCOUNTS CHEM RES, V37, P421, DOI 10.1021/ar030186h; Froyen G, 2009, CLIN GENET, V76, P535, DOI 10.1111/j.1399-0004.2009.01248.x; Gao XX, 2014, NAT CHEM BIOL, V10, P61, DOI [10.1038/NCHEMBIO.1392, 10.1038/nchembio.1392]; Gao XX, 2011, FEBS LETT, V585, P2501, DOI 10.1016/j.febslet.2011.06.033; Goodman RM, 2006, DEVELOPMENT, V133, P4901, DOI 10.1242/dev.02674; Gross JC, 2012, NAT CELL BIOL, V14, P1036, DOI 10.1038/ncb2574; Hannoush RN, 2015, CURR OPIN CHEM BIOL, V28, P39, DOI 10.1016/j.cbpa.2015.05.025; Hannoush RN, 2009, ACS CHEM BIOL, V4, P581, DOI 10.1021/cb900085z; Hardy RY, 2012, J BIOL CHEM, V287, P42881, DOI 10.1074/jbc.M112.426833; Herr P, 2012, DEV BIOL, V361, P392, DOI 10.1016/j.ydbio.2011.11.003; Ho R, 2013, CELL REP, V3, P2113, DOI 10.1016/j.celrep.2013.05.015; Hodson L, 2013, PROG LIPID RES, V52, P15, DOI 10.1016/j.plipres.2012.08.002; Hofmann K, 2000, TRENDS BIOCHEM SCI, V25, P111, DOI 10.1016/S0968-0004(99)01539-X; Holstein TW, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007922; Janda CY, 2012, SCIENCE, V337, P59, DOI 10.1126/science.1222879; Jiang XM, 2013, P NATL ACAD SCI USA, V110, P12649, DOI 10.1073/pnas.1307218110; Kadowaki T, 1996, GENE DEV, V10, P3116, DOI 10.1101/gad.10.24.3116; Kakugawa S, 2015, NATURE, V519, P187, DOI 10.1038/nature14259; Kihara A, 2012, J BIOCHEM, V152, P387, DOI 10.1093/jb/mvs105; Kikuchi A, 2011, INT REV CEL MOL BIO, V291, P21, DOI 10.1016/B978-0-12-386035-4.00002-1; Konitsiotis AD, 2015, J BIOL CHEM, V290, P3293, DOI 10.1074/jbc.M114.614578; Koo BK, 2015, P NATL ACAD SCI USA, V112, P7548, DOI 10.1073/pnas.1508113112; Korkut C, 2009, CELL, V139, P393, DOI 10.1016/j.cell.2009.07.051; Kusserow A, 2005, NATURE, V433, P156, DOI 10.1038/nature03158; Leoyklang P, 2008, CLIN GENET, V73, P373, DOI 10.1111/j.1399-0004.2008.00975.x; Liu J, 2013, P NATL ACAD SCI USA, V110, P20224, DOI 10.1073/pnas.1314239110; Liu W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032331; Lombardi MP, 2011, HUM MUTAT, V32, P723, DOI 10.1002/humu.21505; Maas SM, 2009, J MED GENET, V46, P716, DOI 10.1136/jmg.2009.068403; MacDonald BT, 2014, J BIOL CHEM, V289, P18122, DOI 10.1074/jbc.M114.575027; Madan B, 2016, ONCOGENE, V35, P2197, DOI 10.1038/onc.2015.280; Malinauskas T, 2014, CURR OPIN STRUC BIOL, V29, P77, DOI 10.1016/j.sbi.2014.10.003; Mashek DG, 2007, FUTURE LIPIDOL, V2, P465, DOI 10.2217/17460875.2.4.465; Miranda M, 2014, FEBS LETT, V588, P4815, DOI 10.1016/j.febslet.2014.11.016; Mulligan KA, 2012, P NATL ACAD SCI USA, V109, P370, DOI 10.1073/pnas.1119197109; Murakami C, 2011, ORAL SURG ORAL MED O, V112, pE11, DOI 10.1016/j.tripleo.2011.03.012; Naguib A, 2015, CELL REP, V10, P8, DOI 10.1016/j.celrep.2014.12.010; Najdi R, 2012, DIFFERENTIATION, V84, P203, DOI 10.1016/j.diff.2012.06.004; Nakanishi G, 2013, EUR J DERMATOL, V23, P64, DOI 10.1684/ejd.2012.1911; Niehrs C, 2012, NAT REV MOL CELL BIO, V13, P767, DOI 10.1038/nrm3470; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Nugent T, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-169; NUSSE R, 1982, CELL, V31, P99, DOI 10.1016/0092-8674(82)90409-3; Okonechnikov K, 2012, BIOINFORMATICS, V28, P1166, DOI 10.1093/bioinformatics/bts091; OMARY MB, 1981, J BIOL CHEM, V256, P2888; Omasits U, 2014, BIOINFORMATICS, V30, P884, DOI 10.1093/bioinformatics/btt607; Panakova D, 2005, NATURE, V435, P58, DOI 10.1038/nature03504; Pepinsky RB, 1998, J BIOL CHEM, V273, P14037, DOI 10.1074/jbc.273.22.14037; Polakis P, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008052; Port F, 2010, TRAFFIC, V11, P1265, DOI 10.1111/j.1600-0854.2010.01076.x; Proffitt KD, 2012, J BIOL CHEM, V287, P34167, DOI 10.1074/jbc.M112.381970; Proffitt KD, 2013, CANCER RES, V73, P502, DOI 10.1158/0008-5472.CAN-12-2258; RIJSEWIJK F, 1987, CELL, V50, P649, DOI 10.1016/0092-8674(87)90038-9; Rios-Esteves J, 2014, J BIOL CHEM, V289, P17009, DOI 10.1074/jbc.M114.561209; Rios-Esteves J, 2013, CELL REP, V4, P1072, DOI 10.1016/j.celrep.2013.08.027; Ross J, 2014, CELL REP, V9, P1770, DOI 10.1016/j.celrep.2014.10.049; SHANKLIN J, 1994, BIOCHEMISTRY-US, V33, P12787, DOI 10.1021/bi00209a009; SHARMA RP, 1976, DEV BIOL, V48, P461, DOI 10.1016/0012-1606(76)90108-1; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Srivastava M, 2008, NATURE, V454, P955, DOI 10.1038/nature07191; Takada R, 2006, DEV CELL, V11, P791, DOI 10.1016/j.devcel.2006.10.003; Van Camp J, 2014, STEM CELL REV REP, V10, P207, DOI 10.1007/s12015-013-9486-8; VANDENHEUVEL M, 1993, EMBO J, V12, P5293, DOI 10.1002/j.1460-2075.1993.tb06225.x; Wang H, 2015, NAT STRUCT MOL BIOL, V22, P581, DOI 10.1038/nsmb.3049; Wang JB, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007963; Wang XL, 2013, J MED CHEM, V56, P2700, DOI 10.1021/jm400159c; Wang XL, 2007, NAT GENET, V39, P836, DOI 10.1038/ng2057; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Willert K, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007864; Yang J, 2008, CELL, V132, P387, DOI 10.1016/j.cell.2008.01.017; Yu J, 2014, DEV CELL, V29, P277, DOI 10.1016/j.devcel.2014.03.016; Zhang XJ, 2015, DEV CELL, V32, P719, DOI 10.1016/j.devcel.2015.02.014	99	65	67	2	31	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	FEB	2016	12	2					60	69		10.1038/NCHEMBIO.2005	http://dx.doi.org/10.1038/NCHEMBIO.2005			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DC6GG	26784846				2022-12-25	WOS:000369317300005
J	Farina, F; Gaillard, J; Guerin, C; Coute, Y; Sillibourne, J; Blanchoin, L; Thery, M				Farina, Francesca; Gaillard, Jeremie; Guerin, Christophe; Coute, Yohann; Sillibourne, James; Blanchoin, Laurent; Thery, Manuel			The centrosome is an actin-organizing centre	NATURE CELL BIOLOGY			English	Article							PROTEOMIC CHARACTERIZATION; MICROTUBULE ORGANIZATION; CENTRIOLAR SATELLITES; ARP2/3 COMPLEX; CILIOGENESIS; MYOSIN; MOVEMENT; CELLS; LOCALIZATION; FILAMENTS	Microtubules and actin filaments are the two main cytoskeleton networks supporting intracellular architecture and cell polarity. The centrosome nucleates and anchors microtubules and is therefore considered to be the main microtubule-organizing centre. However, recurring, yet unexplained, observations have pointed towards a connection between the centrosome and actin filaments. Here we have used isolated centrosomes to demonstrate that the centrosome can directly promote actin-filament assembly. A cloud of centrosome-associated actin filaments could be identified in living cells as well. Actin-filament nucleation at the centrosome was mediated by the nucleation-promoting factor WASH in combination with the Arp2/3 complex. Pericentriolar material 1 (PCM1) seemed to modulate the centrosomal actin network by regulating Arp2/3 complex and WASH recruitment to the centrosome. Hence, our results reveal an additional facet of the centrosome as an intracellular organizer and provide mechanistic insights into how the centrosome can function as an actin-filament-organizing centre.	[Farina, Francesca; Gaillard, Jeremie; Guerin, Christophe; Sillibourne, James; Blanchoin, Laurent; Thery, Manuel] Univ Grenoble Alpes, Lab Physiol Cellulaire & Vegetale, Inst Rech Technol & Sci Vivant, UMR5168,CEA,INRA,CNRS, F-38054 Grenoble, France; [Coute, Yohann] Univ Grenoble Alpes, Lab Biol Grande Echelle, Inst Rech Technol & Sci Vivant, UMRS1038,INSERM,CEA, F-38054 Grenoble, France; [Sillibourne, James; Thery, Manuel] Univ Paris Diderot, Hop St Louis, INSERM,AP HP, Unite Therapie Cellulaire,Inst Univ Hematol,UMRS1, F-75010 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); INRAE; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Sillibourne, J (corresponding author), Univ Grenoble Alpes, Lab Physiol Cellulaire & Vegetale, Inst Rech Technol & Sci Vivant, UMR5168,CEA,INRA,CNRS, F-38054 Grenoble, France.	james.sillibourne@cea.fr; laurent.blanchoin@cea.fr; manuel.thery@cea.fr	Couté, Yohann/G-2695-2015	Couté, Yohann/0000-0003-3896-6196; Farina, Francesca/0000-0002-4350-3105; Sillibourne, James/0000-0001-6755-3644	European Research Council [310472]; Agence Nationale pour la Recherche [ANR-12-BSV5-0004-01, ANR-10-INBS-08-01]; 'Laboratory of Excellence' (Grenoble Alliance for Integrated Structural Cell Biology)	European Research Council(European Research Council (ERC)European Commission); Agence Nationale pour la Recherche(French National Research Agency (ANR)); 'Laboratory of Excellence' (Grenoble Alliance for Integrated Structural Cell Biology)	This work was supported by the European Research Council (Starting grant 310472), the Agence Nationale pour la Recherche (ANR-12-BSV5-0004-01, ANR-10-INBS-08-01) and the 'Laboratory of Excellence' (Grenoble Alliance for Integrated Structural Cell Biology). We are grateful to M. Bornens (Institut Curie, France) for providing pEGFP-centrin1 plasmid, A. Khodjakov (Wadsworth Center, USA) for RPE1 EGFP-centrin-1 cells, R. Tsien (UCSD, USA) for pRSET-B-dTomato plasmid, A. Gautreau (LEBS, France) for WASH antibodies and T. Stradal (Helmholtz Center for Infection Research, Germany) for p34-Arc antibodies. We thank M. Vantard and M. Bornens for constructive discussions.	Achard V, 2010, CURR BIOL, V20, P423, DOI 10.1016/j.cub.2009.12.056; Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166; Antoniades I, 2014, DEV CELL, V28, P70, DOI 10.1016/j.devcel.2013.12.003; Barenz F, 2011, EUR J CELL BIOL, V90, P983, DOI 10.1016/j.ejcb.2011.07.007; Bershteyn M, 2010, DEV CELL, V19, P270, DOI 10.1016/j.devcel.2010.07.009; BORNENS M, 1987, CELL MOTIL CYTOSKEL, V8, P238, DOI 10.1002/cm.970080305; BORNENS M, 1977, NATURE, V270, P80, DOI 10.1038/270080a0; Bornens M, 1999, METHOD CELL BIOL, V61, P13; Bornens M, 2008, NAT REV MOL CELL BIO, V9, P874, DOI 10.1038/nrm2524; Burakov AV, 2013, CELL BIOL INT, V37, P95, DOI 10.1002/cbin.10016; Burke TA, 2014, CURR BIOL, V24, P579, DOI 10.1016/j.cub.2014.01.072; Cao J, 2010, CURR BIOL, V20, P770, DOI 10.1016/j.cub.2010.02.060; Casabona MG, 2013, PROTEOMICS, V13, P2419, DOI 10.1002/pmic.201200565; Chesarone MA, 2010, NAT REV MOL CELL BIO, V11, P62, DOI 10.1038/nrm2816; Chesarone MA, 2009, CURR OPIN CELL BIOL, V21, P28, DOI 10.1016/j.ceb.2008.12.001; Chevrier V, 2002, J CELL BIOL, V157, P807, DOI 10.1083/jcb.200203034; Chodagam S, 2005, CURR BIOL, V15, P1308, DOI 10.1016/j.cub.2005.06.024; Clark IB, 1999, J CELL SCI, V112, P3507; Coles CH, 2015, CURR BIOL, V25, pR677, DOI 10.1016/j.cub.2015.06.020; Cowan CR, 2004, NATURE, V431, P92, DOI 10.1038/nature02825; Dammermann A, 2002, J CELL BIOL, V159, P255, DOI 10.1083/jcb.200204023; Dawe HR, 2009, J CELL SCI, V122, P2716, DOI 10.1242/jcs.043794; Derivery E, 2009, DEV CELL, V17, P712, DOI 10.1016/j.devcel.2009.09.010; Dubois T, 2005, NAT CELL BIOL, V7, P353, DOI 10.1038/ncb1244; Epting D, 2015, DEVELOPMENT, V142, P174, DOI 10.1242/dev.112250; Espreafico EM, 1998, P NATL ACAD SCI USA, V95, P8636, DOI 10.1073/pnas.95.15.8636; Etienne-Manneville S, 2004, TRAFFIC, V5, P470, DOI 10.1111/j.1600-0854.2004.00196.x; EUTENEUER U, 1985, J CELL BIOL, V101, P96, DOI 10.1083/jcb.101.1.96; Fielding AB, 2008, J CELL BIOL, V180, P681, DOI 10.1083/jcb.200710074; Fink J, 2011, NAT CELL BIOL, V13, P771, DOI 10.1038/ncb2269; Firat-Karalar EN, 2014, J CELL SCI, V127, P4128, DOI 10.1242/jcs.157008; Gomez TS, 2007, IMMUNITY, V26, P177, DOI 10.1016/j.immuni.2007.01.008; Hong H, 2015, BIOCHEM BIOPH RES CO, V461, P180, DOI 10.1016/j.bbrc.2015.04.028; Hubert T, 2011, BIOCHEM BIOPH RES CO, V404, P153, DOI 10.1016/j.bbrc.2010.11.084; Hubert T, 2009, BIOCHEM BIOPH RES CO, V380, P166, DOI 10.1016/j.bbrc.2009.01.064; HYMAN A, 1991, METHOD ENZYMOL, V196, P478; Jakobsen L, 2011, EMBO J, V30, P1520, DOI 10.1038/emboj.2011.63; Kaplan DD, 2004, J BIOL CHEM, V279, P10829, DOI 10.1074/jbc.C400035200; KLEVE MG, 1980, J CELL BIOL, V86, P87, DOI 10.1083/jcb.86.1.87; Kubo A, 1999, J CELL BIOL, V147, P969, DOI 10.1083/jcb.147.5.969; Kunda P, 2008, CURR BIOL, V18, P91, DOI 10.1016/j.cub.2007.12.051; Lawo S, 2012, NAT CELL BIOL, V14, P1148, DOI 10.1038/ncb2591; LEMULLOIS M, 1987, EUR J CELL BIOL, V43, P429; Mennella V, 2012, NAT CELL BIOL, V14, P1159, DOI 10.1038/ncb2597; Michelot A, 2007, CURR BIOL, V17, P825, DOI 10.1016/j.cub.2007.04.037; MIRANDA AF, 1974, J CELL BIOL, V62, P406, DOI 10.1083/jcb.62.2.406; Mitsushima M, 2010, J CELL BIOL, V191, P453, DOI 10.1083/jcb.201007136; Monfregola J, 2010, J BIOL CHEM, V285, P16951, DOI 10.1074/jbc.M109.078501; Moudjou M, 1998, CELL BIOLOGY - A LABORATORY HANDBOOK, 2ND EDITION, VOL 2, P111; Munro E, 2004, DEV CELL, V7, P413, DOI 10.1016/j.devcel.2004.08.001; Nolen BJ, 2009, NATURE, V460, P1031, DOI 10.1038/nature08231; Pan JH, 2007, J CELL SCI, V120, P1868, DOI 10.1242/jcs.005306; Patel H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3056; Piel M, 2000, J CELL BIOL, V149, P317, DOI 10.1083/jcb.149.2.317; Pitaval A, 2010, J CELL BIOL, V191, P303, DOI 10.1083/jcb.201004003; Pugacheva EN, 2005, NAT CELL BIOL, V7, P937, DOI 10.1038/ncb1309; Ritchey L, 2012, CELL CYCLE, V11, P296, DOI 10.4161/cc.11.2.18734; Rodriguez OC, 2003, NAT CELL BIOL, V5, P599, DOI 10.1038/ncb0703-599; Rosenblatt J, 2004, CELL, V117, P361, DOI 10.1016/S0092-8674(04)00341-1; Sabino D, 2015, CURR BIOL, V25, P879, DOI 10.1016/j.cub.2015.01.066; SHELANSKI ML, 1973, J HISTOCHEM CYTOCHEM, V21, P529, DOI 10.1177/21.6.529; Sillibourne JE, 2013, BIOL OPEN, V2, P535, DOI 10.1242/bio.20134457; Sillibourne JE, 2010, MOL BIOL CELL, V21, P547, DOI 10.1091/mbc.E09-06-0505; Stevenson VA, 2001, NAT CELL BIOL, V3, P68, DOI 10.1038/35050579; Stinchcombe JC, 2006, NATURE, V443, P462, DOI 10.1038/nature05071; Tang N, 2012, J CELL SCI, V125, P4951, DOI 10.1242/jcs.038083; Vaughan S, 2011, TRENDS CELL BIOL, V21, P57, DOI 10.1016/j.tcb.2010.09.004; Wang WQ, 2008, J CELL SCI, V121, P1334, DOI 10.1242/jcs.018176; Welch MD, 1997, J CELL BIOL, V138, P375, DOI 10.1083/jcb.138.2.375; Woolner S, 2008, J CELL BIOL, V182, P77, DOI 10.1083/jcb.200804062	70	145	149	0	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2016	18	1					65	+		10.1038/ncb3285	http://dx.doi.org/10.1038/ncb3285			13	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CZ3VA	26655833	Green Accepted			2022-12-25	WOS:000367030900012
J	Pasquina, L; Maria, JPS; Wood, BM; Moussa, SH; Matano, LM; Santiago, M; Martin, SES; Lee, W; Meredith, TC; Walker, S				Pasquina, Lincoln; Maria, John P. Santa, Jr.; Wood, B. McKay; Moussa, Samir H.; Matano, Leigh M.; Santiago, Marina; Martin, Sara E. S.; Lee, Wonsik; Meredith, Timothy C.; Walker, Suzanne			A synthetic lethal approach for compound and target identification in Staphylococcus aureus	NATURE CHEMICAL BIOLOGY			English	Article							GRAM-POSITIVE BACTERIA; WALL SYNTHESIS MACHINERY; BETA-LACTAM ANTIBIOTICS; CELL-WALL; TEICHOIC-ACIDS; LIPOTEICHOIC ACID; E. COLI; SUSCEPTIBILITY; PLATFORM; DNA	The majority of bacterial proteins are dispensable for growth in the laboratory but nevertheless have important physiological roles. There are no systematic approaches to identify cell-permeable small-molecule inhibitors of these proteins. We demonstrate a strategy to identify such inhibitors that exploits synthetic lethal relationships both for small-molecule discovery and for target identification. Applying this strategy in Staphylococcus aureus, we have identified a compound that inhibits DltB, a component of the teichoic acid D-alanylation machinery that has been implicated in virulence. This D-alanylation inhibitor sensitizes S. aureus to aminoglycosides and cationic peptides and is lethal in combination with a wall teichoic acid inhibitor. We conclude that DltB is a druggable target in the D-alanylation pathway. More broadly, the work described demonstrates a systematic method to identify biologically active inhibitors of major bacterial processes that can be adapted to numerous organisms.	[Pasquina, Lincoln; Maria, John P. Santa, Jr.; Wood, B. McKay; Moussa, Samir H.; Matano, Leigh M.; Santiago, Marina; Martin, Sara E. S.; Lee, Wonsik; Meredith, Timothy C.; Walker, Suzanne] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA USA; [Meredith, Timothy C.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA	Harvard University; Harvard Medical School; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Maria, JPS (corresponding author), Hlth Adv LLC, Weston, MA 02493 USA.	suzanne_walker@hms.harvard.edu	Meredith, Timothy/X-2713-2019	Meredith, Timothy/0000-0002-1901-6841; Moussa, Samir/0000-0001-5348-596X; Martin, Sara/0000-0003-3129-7735	U.S. National Institutes of Health grants [U19AI109764, U54AI057159, P01AI083214, R01AI099144, F32AI118160]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI118160, F31AI114131, T32AI007061, U54AI057159, U19AI109764, P01AI083214, R01AI099144] Funding Source: NIH RePORTER	U.S. National Institutes of Health grants; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors thank T. Pang (Department of Microbiology and Immunobiology, Harvard Medical School) for providing plasmids and other reagents; C. Shamu, J. Smith and the staff at the ICCB-Longwood Screening Facility for compound screening; and the Harvard Medical School Biopolymers Facility and the Tufts University Core Facility for sequencing. This work was funded by U.S. National Institutes of Health grants U19AI109764 to S.W. and T.C.M., U54AI057159 to the ICCB-L Screening Facility, P01AI083214 and R01AI099144 to S.W. and F32AI118160 to S.H.M.	Atilano ML, 2010, P NATL ACAD SCI USA, V107, P18991, DOI 10.1073/pnas.1004304107; Blankenberg Daniel, 2010, Curr Protoc Mol Biol, VChapter 19, DOI 10.1002/0471142727.mb1910s89; Brown S, 2013, ANNU REV MICROBIOL, V67, P313, DOI 10.1146/annurev-micro-092412-155620; Butland G, 2008, NAT METHODS, V5, P789, DOI 10.1038/NMETH.1239; CAIN BF, 1974, J MED CHEM, V17, P922, DOI 10.1021/jm00255a003; Campbell J, 2011, ACS CHEM BIOL, V6, P106, DOI 10.1021/cb100269f; Cho H, 2014, CELL, V159, P1300, DOI 10.1016/j.cell.2014.11.017; Chung HS, 2009, P NATL ACAD SCI USA, V106, P21872, DOI 10.1073/pnas.0911674106; Collins LV, 2002, J INFECT DIS, V186, P214, DOI 10.1086/341454; Corrigan RM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002217; Dominguez-Escobar J, 2011, SCIENCE, V333, P225, DOI 10.1126/science.1203466; Falord M, 2012, ANTIMICROB AGENTS CH, V56, P1047, DOI 10.1128/AAC.05054-11; Fey PD, 2013, MBIO, V4, DOI 10.1128/mBio.00537-12; Fridman M, 2013, BIOCHEMISTRY-US, V52, P7975, DOI 10.1021/bi401177n; Garner EC, 2011, SCIENCE, V333, P222, DOI 10.1126/science.1203285; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Hung DT, 2006, CURR OPIN CHEM BIOL, V10, P321, DOI 10.1016/j.cbpa.2006.06.016; Hunt CL, 2006, J IMMUNOL, V176, P4987, DOI 10.4049/jimmunol.176.8.4987; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Ketron AC, 2012, BIOCHEMISTRY-US, V51, P1730, DOI 10.1021/bi201159b; KITANO K, 1979, ANTIMICROB AGENTS CH, V16, P838, DOI 10.1128/AAC.16.6.838; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Le Meur N, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r135; Maria JPS, 2014, P NATL ACAD SCI USA, V111, P12510, DOI 10.1073/pnas.1404099111; May JJ, 2005, FEBS J, V272, P2993, DOI 10.1111/j.1742-4658.2005.04700.x; McLornan DP, 2014, NEW ENGL J MED, V371, P1725, DOI 10.1056/NEJMra1407390; Mitchison TJ, 1994, CHEM BIOL, V1, P3, DOI 10.1016/1074-5521(94)90034-5; NELSON EM, 1984, P NATL ACAD SCI-BIOL, V81, P1361, DOI 10.1073/pnas.81.5.1361; Neuhaus FC, 2003, MICROBIOL MOL BIOL R, V67, P686, DOI 10.1128/MMBR.67.4.686-723.2003; Pan XS, 1999, ANTIMICROB AGENTS CH, V43, P1129, DOI 10.1128/AAC.43.5.1129; Percy MG, 2014, ANNU REV MICROBIOL, V68, P81, DOI 10.1146/annurev-micro-091213-112949; Peschel A, 2000, ANTIMICROB AGENTS CH, V44, P2845, DOI 10.1128/AAC.44.10.2845-2847.2000; Peschel A, 1999, J BIOL CHEM, V274, P8405, DOI 10.1074/jbc.274.13.8405; Poyart C, 2003, MOL MICROBIOL, V49, P1615, DOI 10.1046/j.1365-2958.2003.03655.x; Reichmann NT, 2013, MICROBIOL-SGM, V159, P1868, DOI 10.1099/mic.0.069898-0; Ruiz N, 2005, CELL, V121, P307, DOI 10.1016/j.cell.2005.02.014; Santiago M, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1361-3; Schirner K, 2015, NAT CHEM BIOL, V11, P38, DOI 10.1038/nchembio.1689; Schlag M, 2010, MOL MICROBIOL, V75, P864, DOI 10.1111/j.1365-2958.2009.07007.x; TAKATSUKI A, 1971, J ANTIBIOT, V24, P215, DOI 10.7164/antibiotics.24.215; Taylor MS, 2013, J BIOL CHEM, V288, P32211, DOI 10.1074/jbc.M113.510313; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Typas A, 2008, NAT METHODS, V5, P781, DOI 10.1038/NMETH.1240; van Opijnen T, 2013, NAT REV MICROBIOL, V11, DOI 10.1038/nrmicro3033; van Teeffelen S, 2011, P NATL ACAD SCI USA, V108, P15822, DOI 10.1073/pnas.1108999108; Weidenmaier C, 2004, NAT MED, V10, P243, DOI 10.1038/nm991; Wright GD, 2007, NAT REV MICROBIOL, V5, P175, DOI 10.1038/nrmicro1614	48	45	46	3	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2016	12	1					40	+		10.1038/NCHEMBIO.1967	http://dx.doi.org/10.1038/NCHEMBIO.1967			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY8QW	26619249	Green Submitted, Green Accepted			2022-12-25	WOS:000366674400010
J	Wolfenson, H; Meacci, G; Liu, SM; Stachowiak, MR; Iskratsch, T; Ghassemi, S; Roca-Cusachs, P; O'Shaughnessy, B; Hone, J; Sheetz, MP				Wolfenson, Haguy; Meacci, Giovanni; Liu, Shuaimin; Stachowiak, Matthew R.; Iskratsch, Thomas; Ghassemi, Saba; Roca-Cusachs, Pere; O'Shaughnessy, Ben; Hone, James; Sheetz, Michael P.			Tropomyosin controls sarcomere-like contractions for rigidity sensing and suppressing growth on soft matrices	NATURE CELL BIOLOGY			English	Article							CROSS-BRIDGE PHOSPHORYLATION; SINGLE-MYOSIN MOLECULES; NONLINEAR ELASTICITY; EXTRACELLULAR-MATRIX; WORKING STROKE; FORCE; ACTIN; EXPRESSION; CELLS; DYNAMICS	Cells test the rigidity of the extracellular matrix by applying forces to it through integrin adhesions. Recent measurements show that these forces are applied by local micrometre-scale contractions, but how contraction force is regulated by rigidity is unknown. Here we performed high temporal- and spatial-resolution tracking of contractile forces by plating cells on sub-micrometre elastomeric pillars. We found that actomyosin-based sarcomere-like contractile units (CUs) simultaneously moved opposing pillars in net steps of similar to 2.5 nm, independent of rigidity. What correlated with rigidity was the number of steps taken to reach a force level that activated recruitment of alpha-actinin to the CUs. When we removed actomyosin restriction by depleting tropomyosin 2.1, we observed larger steps and higher forces that resulted in aberrant rigidity sensing and growth of non-transformed cells on soft matrices. Thus, we conclude that tropomyosin 2.1 acts as a suppressor of growth on soft matrices by supporting proper rigidity sensing.	[Wolfenson, Haguy; Meacci, Giovanni; Iskratsch, Thomas; Sheetz, Michael P.] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Wolfenson, Haguy; Meacci, Giovanni; Liu, Shuaimin; Iskratsch, Thomas; Ghassemi, Saba; Hone, James; Sheetz, Michael P.] Columbia Univ, Nanomed Ctr Mechanobiol Directing Immune Response, New York, NY 10027 USA; [Meacci, Giovanni; Stachowiak, Matthew R.; O'Shaughnessy, Ben] Columbia Univ, Dept Chem Engn, New York, NY 10027 USA; [Liu, Shuaimin; Ghassemi, Saba; Hone, James] Columbia Univ, Dept Mech Engn, New York, NY 10027 USA; [Roca-Cusachs, Pere] Inst Bioengn Catalonia, Barcelona 08028, Spain; [Roca-Cusachs, Pere] Univ Barcelona, E-08028 Barcelona, Spain; [Sheetz, Michael P.] Natl Univ Singapore, Mechanobiol Inst, Singapore 117411, Singapore	Columbia University; Columbia University; Columbia University; Columbia University; Barcelona Institute of Science & Technology; Institut de Bioenginyeria de Catalunya; University of Barcelona; University of Barcelona; National University of Singapore	Wolfenson, H (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.	hw2385@columbia.edu; ms2001@columbia.edu	Iskratsch, Thomas/H-5980-2019; Roca-Cusachs, Pere/D-4309-2009; Wolfenson, Haguy/AAC-7601-2020; Hone, James C/E-1879-2011	Iskratsch, Thomas/0000-0002-3738-7830; Roca-Cusachs, Pere/0000-0001-6947-961X; Hone, James C/0000-0002-8084-3301	National Institutes of Health (NIH) [1 R01 GM100282-01]; NIH Common Fund Nanomedicine programme [PN2 EY016586]; Marie Curie International Outgoing Fellowship within the Seventh European Commission Framework Programme [P10E-GA-2012-332045]; American Heart Association; Mechanobiology Institute, National University of Singapore; NATIONAL EYE INSTITUTE [PN1EY016586, PN2EY016586] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM113022, R01GM100282] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Common Fund Nanomedicine programme(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Marie Curie International Outgoing Fellowship within the Seventh European Commission Framework Programme; American Heart Association(American Heart Association); Mechanobiology Institute, National University of Singapore(National University of Singapore); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank all of the members of the Sheetz laboratory for their help, in particular to S. Moore and N. Biais for experimental support and helpful comments on the manuscript. We thank E. Rosten (University of Cambridge, Cambridge, UK) for the technical support during the 3B imaging analysis. We thank J. Fernandez (Columbia University) for helpful discussions about step detection. This work was financially supported by a National Institutes of Health (NIH) grant 'Analysis of 120 nm local contractions linked to rigidity sensing' (1 R01 GM100282-01), and by the NIH Common Fund Nanomedicine programme (PN2 EY016586). H.W. was supported by a Marie Curie International Outgoing Fellowship within the Seventh European Commission Framework Programme (P10E-GA-2012-332045). T.I. was supported by a Postdoctoral Fellowship from the American Heart Association. M.P.S. was partially supported by the Mechanobiology Institute, National University of Singapore.	BHATTACHARYA B, 1990, CANCER RES, V50, P2105; Burkholder TJ, 2001, J EXP BIOL, V204, P1529; Cai YF, 2006, BIOPHYS J, V91, P3907, DOI 10.1529/biophysj.106.084806; Chan CE, 2008, SCIENCE, V322, P1687, DOI 10.1126/science.1163595; Choquet D, 1997, CELL, V88, P39, DOI 10.1016/S0092-8674(00)81856-5; Cox S, 2012, NAT METHODS, V9, P195, DOI [10.1038/NMETH.1812, 10.1038/nmeth.1812]; Debold EP, 2005, BIOPHYS J, V89, pL34, DOI 10.1529/biophysj.105.072967; Dubin-Thaler BJ, 2004, BIOPHYS J, V86, P1794, DOI 10.1016/S0006-3495(04)74246-0; Edelstein Arthur, 2010, Curr Protoc Mol Biol, VChapter 14, DOI 10.1002/0471142727.mb1420s92; Elosegui-Artola A, 2014, NAT MATER, V13, P631, DOI [10.1038/NMAT3960, 10.1038/nmat3960]; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Erdmann T, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.188101; Fischer RS, 2003, J CELL BIOL, V161, P371, DOI 10.1083/jcb.200209057; FREEDMAN VH, 1974, CELL, V3, P355, DOI 10.1016/0092-8674(74)90050-6; Fusi L, 2014, J PHYSIOL-LONDON, V592, P1109, DOI 10.1113/jphysiol.2013.265983; Galbraith CG, 2002, J CELL BIOL, V159, P695, DOI 10.1083/jcb.200204153; Geeves MA, 2015, J MUSCLE RES CELL M, V36, P147, DOI 10.1007/s10974-014-9389-6; GELLES J, 1988, NATURE, V331, P450, DOI 10.1038/331450a0; Ghassemi S, 2012, P NATL ACAD SCI USA, V109, P5328, DOI 10.1073/pnas.1119886109; Giannone G, 2004, CELL, V116, P431, DOI 10.1016/S0092-8674(04)00058-3; HAI CM, 1988, AM J PHYSIOL, V254, pC99, DOI 10.1152/ajpcell.1988.254.1.C99; HAI CM, 1988, AM J PHYSIOL, V255, pC86, DOI 10.1152/ajpcell.1988.255.1.C86; Ingber DE, 2003, ANN MED, V35, P564, DOI 10.1080/07853890310016333; Jaalouk DE, 2009, NAT REV MOL CELL BIO, V10, P63, DOI 10.1038/nrm2597; Jiang GY, 2006, BIOPHYS J, V90, P1804, DOI 10.1529/biophysj.105.072462; Jiang GY, 2003, NATURE, V424, P334, DOI 10.1038/nature01805; Kad NM, 2005, P NATL ACAD SCI USA, V102, P16990, DOI 10.1073/pnas.0506326102; Kaya M, 2013, CELL MOL LIFE SCI, V70, P4275, DOI 10.1007/s00018-013-1353-x; Kaya M, 2010, SCIENCE, V329, P686, DOI 10.1126/science.1191484; Kovacs M, 2007, P NATL ACAD SCI USA, V104, P9994, DOI 10.1073/pnas.0701181104; KUO SC, 1991, J CELL SCI, P135; Lavelin I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073549; Little MA, 2011, BIOPHYS J, V101, P477, DOI 10.1016/j.bpj.2011.05.070; Liu XM, 2004, BIOPHYS J, V86, P353, DOI 10.1016/S0006-3495(04)74111-9; Luo WW, 2013, J CELL BIOL, V202, P1057, DOI 10.1083/jcb.201210123; Mahadev K, 2002, EXP CELL RES, V279, P40, DOI 10.1006/excr.2002.5583; Moore SW, 2010, DEV CELL, V19, P194, DOI 10.1016/j.devcel.2010.07.018; NIEDERMAN R, 1975, J CELL BIOL, V67, P72, DOI 10.1083/jcb.67.1.72; Perz-Edwards RJ, 2011, P NATL ACAD SCI USA, V108, P120, DOI 10.1073/pnas.1014599107; Piazzesi G, 2007, CELL, V131, P784, DOI 10.1016/j.cell.2007.09.045; Plotnikov SV, 2012, CELL, V151, P1513, DOI 10.1016/j.cell.2012.11.034; Prager-Khoutorsky M, 2011, NAT CELL BIOL, V13, P1457, DOI 10.1038/ncb2370; PRASAD GL, 1993, P NATL ACAD SCI USA, V90, P7039, DOI 10.1073/pnas.90.15.7039; Raval GN, 2003, ONCOGENE, V22, P6194, DOI 10.1038/sj.onc.1206719; Roca-Cusachs P, 2013, P NATL ACAD SCI USA, V110, pE1361, DOI 10.1073/pnas.1220723110; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; Schevzov Galina, 2011, Bioarchitecture, V1, P135; SCHNAPP BJ, 1988, CELL MOTIL CYTOSKEL, V10, P47, DOI 10.1002/cm.970100109; SPUDICH JA, 1972, J MOL BIOL, V72, P619, DOI 10.1016/0022-2836(72)90180-5; STOKER M, 1968, INT J CANCER, V3, P683, DOI 10.1002/ijc.2910030517; Su J, 1999, CURR BIOL, V9, P505, DOI 10.1016/S0960-9822(99)80234-6; SVOBODA K, 1993, NATURE, V365, P721, DOI 10.1038/365721a0; Sweeney HL, 2010, ANNU REV BIOPHYS, V39, P539, DOI 10.1146/annurev.biophys.050708.133751; VERKHOVSKY AB, 1995, J CELL BIOL, V131, P989, DOI 10.1083/jcb.131.4.989; Vogel V, 2009, CURR OPIN CELL BIOL, V21, P38, DOI 10.1016/j.ceb.2009.01.002; Walcott S, 2009, J BIOL CHEM, V284, P18244, DOI 10.1074/jbc.M109.003293; Wang HB, 2000, AM J PHYSIOL-CELL PH, V279, pC1345, DOI 10.1152/ajpcell.2000.279.5.C1345; Wolfenson H, 2011, J CELL SCI, V124, P1425, DOI 10.1242/jcs.077388; Wu SP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012643	59	114	116	1	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2016	18	1					33	+		10.1038/ncb3277	http://dx.doi.org/10.1038/ncb3277			13	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CZ3VA	26619148	Green Submitted, Green Accepted			2022-12-25	WOS:000367030900008
J	Bohlmann, L; Tredwell, GD; Yu, X; Chang, CW; Haselhorst, T; Winger, M; Dyason, JC; Thomson, RJ; Tiralongo, J; Beacham, IR; Blanchard, H; von Itzstein, M				Bohlmann, Lisa; Tredwell, Gregory D.; Yu, Xing; Chang, Chih-Wei; Haselhorst, Thomas; Winger, Moritz; Dyason, Jeffrey C.; Thomson, Robin J.; Tiralongo, Joe; Beacham, Ifor R.; Blanchard, Helen; von Itzstein, Mark			Functional and structural characterization of a heparanase	NATURE CHEMICAL BIOLOGY			English	Article							MAMMALIAN HEPARANASE; CANCER METASTASIS; SULFATE; GLUCURONIDASE; HEPARIN; BINDING; ENDOGLYCOSIDASE; ENZYME	We report the structural and functional characterization of a novel heparanase (BpHep) from the invasive pathogenic bacterium Burkholderia pseudomallei (Bp), showing similar to 24% sequence identity with human heparanase (hHep). Site-directed mutagenesis studies confirmed the active site residues essential for activity, and we found that BpHep has specificity for heparan sulfate. Finally, we describe the first heparanase X-ray crystal structure, which provides new insight into both substrate recognition and inhibitor design.	[Bohlmann, Lisa; Tredwell, Gregory D.; Yu, Xing; Chang, Chih-Wei; Haselhorst, Thomas; Winger, Moritz; Dyason, Jeffrey C.; Thomson, Robin J.; Tiralongo, Joe; Beacham, Ifor R.; Blanchard, Helen; von Itzstein, Mark] Griffith Univ, Inst Glyc, Southport, Qld 4215, Australia	Griffith University	Bohlmann, L (corresponding author), Griffith Univ, Inst Glyc, Gold Coast Campus, Southport, Qld 4215, Australia.	i.beacham@griffith.edu.au; h.blanchard@griffith.edu.au; m.vonitzstein@griffith.edu.au	von Itzstein, Mark/E-4823-2010; Chang, Chih-Wei/AAD-9583-2020; Tredwell, Greg/L-2294-2015; Chang, Chih Wei/B-5064-2011; Blanchard, Helen/A-4681-2009	Chang, Chih-Wei/0000-0002-5009-0302; Tredwell, Greg/0000-0002-0020-5626; Chang, Chih Wei/0000-0002-5009-0302; Blanchard, Helen/0000-0003-3372-5027; Tiralongo, Joe/0000-0002-3529-6310; Beacham, Ifor/0000-0002-3473-1579; Thomson, Robin/0000-0002-1014-2614	Rosebud Foundation	Rosebud Foundation	We gratefully acknowledge financial support from the Rosebud Foundation and Australian Synchrotron scientists for their support during X-ray diffraction data collection at this facility's beamlines, MX1 and MX2. We thank B. Matthews, Smart Water Research Centre (Griffith University), for excellent mass spectrometry technical support.	Arvatz G, 2011, CANCER METAST REV, V30, P253, DOI 10.1007/s10555-011-9288-x; Bohlmann L, 2015, CHEMBIOCHEM, V16, P1205, DOI 10.1002/cbic.201500081; Fairbanks MB, 1999, J BIOL CHEM, V274, P29587, DOI 10.1074/jbc.274.42.29587; Gandhi NS, 2012, GLYCOBIOLOGY, V22, P35, DOI 10.1093/glycob/cwr095; Gong F, 2003, J BIOL CHEM, V278, P35152, DOI 10.1074/jbc.M300925200; HOOK M, 1975, BIOCHEM BIOPH RES CO, V67, P1422, DOI 10.1016/0006-291X(75)90185-0; Hu YP, 2012, J AM CHEM SOC, V134, P20722, DOI 10.1021/ja3090065; Huang KS, 2004, ANAL BIOCHEM, V333, P389, DOI 10.1016/j.ab.2004.06.023; Hulett MD, 2000, BIOCHEMISTRY-US, V39, P15659, DOI 10.1021/bi002080p; Ilan N, 2006, INT J BIOCHEM CELL B, V38, P2018, DOI 10.1016/j.biocel.2006.06.004; LINHARDT RJ, 1986, APPL BIOCHEM BIOTECH, V12, P135; LOHSE DL, 1992, J BIOL CHEM, V267, P24347; Meirovitz A, 2013, FEBS J, V280, P2307, DOI 10.1111/febs.12184; Michikawa M, 2012, J BIOL CHEM, V287, P14069, DOI 10.1074/jbc.M112.346288; Parish CR, 2001, BBA-REV CANCER, V1471, pM99, DOI 10.1016/S0304-419X(01)00017-8; Pearson AG, 2011, ORG BIOMOL CHEM, V9, P4614, DOI 10.1039/c1ob05165b; Sanderson RD, 2012, MATRIX BIOL, V31, P283, DOI 10.1016/j.matbio.2012.05.001; Sapay N, 2012, BIOPOLYMERS, V97, P21, DOI 10.1002/bip.21696; Shimoi K, 2005, METHOD ENZYMOL, V400, P263, DOI 10.1016/S0076-6879(05)00015-7; St John JA, 2014, MBIO, V5, DOI 10.1128/mBio.00025-14; Vinader V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082111; Vlodavsky I, 2002, SEMIN CANCER BIOL, V12, P121, DOI 10.1006/scbi.2001.0420; Vreys V, 2007, J CELL MOL MED, V11, P427, DOI 10.1111/j.1582-4934.2007.00039.x; Zhou Z, 2006, PROTEINS, V65, P580, DOI 10.1002/prot.21065; Ziolkowski AF, 2012, J CLIN INVEST, V122, P132, DOI 10.1172/JCI46177	25	27	26	1	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2015	11	12					955	957		10.1038/nchembio.1956	http://dx.doi.org/10.1038/nchembio.1956			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX6TG	26565989				2022-12-25	WOS:000365834000014
J	Adachi, T; Kobayashi, T; Sugihara, E; Yamada, T; Ikuta, K; Pittaluga, S; Saya, H; Amagai, M; Nagao, K				Adachi, Takeya; Kobayashi, Tetsuro; Sugihara, Eiji; Yamada, Taketo; Ikuta, Koichi; Pittaluga, Stefania; Saya, Hideyuki; Amagai, Masayuki; Nagao, Keisuke			Hair follicle-derived IL-7 and IL-15 mediate skin-resident memory T cell homeostasis and lymphoma	NATURE MEDICINE			English	Article							MYCOSIS-FUNGOIDES; SEZARY-SYNDROME; STEM-CELLS; INFECTION; TISSUE; TUMOR; EXPRESSION; IMMUNITY; SUBSETS; CD4(+)	The skin harbors a variety of resident leukocyte subsets that must be tightly regulated to maintain immune homeostasis. Hair follicles are unique structures in the skin that contribute to skin dendritic cell homeostasis through chemokine production. We demonstrate that CD4(+) and CD8(+) skin-resident memory T cells (T-RM cells), which are responsible for long-term skin immunity, reside predominantly within the hair follicle epithelium of the unperturbed epidermis. T-RM cell tropism for the epidermis and follicles is herein termed epidermotropism. Hair follicle expression of IL-15 was required for CD8(+) T-RM cells, and IL-7 for CD8(+) and CD4(+) T-RM cells, to exert epidermotropism. A lack of either cytokine in the skin led to impaired hapten-induced contact hypersensitivity responses. In a model of cutaneous T cell lymphoma, epidermotropic CD4(+) T-RM lymphoma cell localization depended on the presence of hair follicle-derived IL-7. These findings implicate hair follicle-derived cytokines as regulators of malignant and non-malignant T-RM cell tissue residence, and they suggest that the cytokines may be targeted therapeutically in inflammatory skin diseases and lymphoma.	[Adachi, Takeya; Kobayashi, Tetsuro; Amagai, Masayuki; Nagao, Keisuke] Keio Univ, Sch Med, Dept Dermatol, Tokyo, Japan; [Kobayashi, Tetsuro; Nagao, Keisuke] NCI, Dermatol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Sugihara, Eiji; Saya, Hideyuki] Keio Univ, Sch Med, Inst Adv Med Res, Div Gene Regulat, Tokyo, Japan; [Yamada, Taketo] Keio Univ, Sch Med, Dept Pathol, Tokyo 160, Japan; [Ikuta, Koichi] Kyoto Univ, Inst Virus Res, Dept Biol Responses, Lab Biol Protect, Kyoto 606, Japan; [Pittaluga, Stefania] NCI, Pathol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	Keio University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Keio University; Keio University; Kyoto University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Nagao, K (corresponding author), Keio Univ, Sch Med, Dept Dermatol, Tokyo, Japan.	keisuke.nagao@nih.gov	Nagao, Keisuke/P-3837-2018; ADACHI, Takeya/C-4996-2018; Saya, Hideyuki/J-4325-2013; Amagai, Masayuki/K-5325-2013; Nagao, Keisuke/J-5116-2013	Nagao, Keisuke/0000-0002-7005-3138; ADACHI, Takeya/0000-0002-5289-5980; Amagai, Masayuki/0000-0003-3314-7052; Nagao, Keisuke/0000-0002-7005-3138; Sugihara, Eiji/0000-0002-3233-1045; Kobayashi, Tetsuro/0000-0003-2316-4748; Saya, Hideyuki/0000-0001-6610-1902; Ikuta, Koichi/0000-0003-1319-1021	Japan Society for the Promotion of Science; Kanae Foundation for the Promotion of Medical Science; Japanese Society for Investigative Dermatology's (JSID's) Fellowship Shiseido Award; NIH NCI Intramural Research Programs; NATIONAL CANCER INSTITUTE [ZIABC011561] Funding Source: NIH RePORTER	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Kanae Foundation for the Promotion of Medical Science; Japanese Society for Investigative Dermatology's (JSID's) Fellowship Shiseido Award; NIH NCI Intramural Research Programs; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank M. Ohyama for helpful discussion on human hair follicles; N. Sakai, K. Eguchi and S. Sato (Keio University School of Medicine) for their technical assistance; H. Kong (National Institutes of Health) for their discussions on human CTCL; Y. Madokoro (Keio University School of Medicine) for human CTCL immunohistochemical staining; T. Kitamura (University of Tokyo) for providing the retroviral vector pMXs-IG and Plat-E cells; J. Takeda (Osaka University) for providing K5-Cre mice; D.H. Kaplan (University of Minnesota) for providing Langerin-DTA mice; and B.E. Clausen (Johannes Gutenberg University of Mainz) for providing Langerin-DTR mice. This work was supported by the Japan Society for the Promotion of Science, The Kanae Foundation for the Promotion of Medical Science, the Japanese Society for Investigative Dermatology's (JSID's) Fellowship Shiseido Award and the NIH NCI Intramural Research Programs.	Ariotti S, 2014, SCIENCE, V346, P101, DOI 10.1126/science.1254803; Bromley SK, 2013, J IMMUNOL, V190, P970, DOI 10.4049/jimmunol.1202805; Campbell JJ, 2010, BLOOD, V116, P767, DOI 10.1182/blood-2009-11-251926; Christoph T, 2000, BRIT J DERMATOL, V142, P862, DOI 10.1046/j.1365-2133.2000.03464.x; Clark RA, 2006, J IMMUNOL, V176, P4431, DOI 10.4049/jimmunol.176.7.4431; Clark RA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003008; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; Dorfman DM, 2002, HUM PATHOL, V33, P330, DOI 10.1053/hupa.2002.32215; EDELSON RL, 1980, J AM ACAD DERMATOL, V2, P89, DOI 10.1016/S0190-9622(80)80385-9; Espinet Blanca, 2013, Methods Mol Biol, V973, P175, DOI 10.1007/978-1-62703-281-0_11; Gebhardt T, 2011, NATURE, V477, P216, DOI 10.1038/nature10339; Gebhardt T, 2009, NAT IMMUNOL, V10, P524, DOI 10.1038/ni.1718; Hwang ST, 2008, LANCET, V371, P945, DOI 10.1016/S0140-6736(08)60420-1; Jiang XD, 2012, NATURE, V483, P227, DOI 10.1038/nature10851; Kamijo T, 1999, CANCER RES, V59, P2217; KANAVAROS P, 1994, PATHOL RES PRACT, V190, P767, DOI 10.1016/S0344-0338(11)80423-1; Lanzavecchia A, 2005, CURR OPIN IMMUNOL, V17, P326, DOI 10.1016/j.coi.2005.04.010; Liang BF, 2012, J IMMUNOL, V189, P4444, DOI 10.4049/jimmunol.1201181; Mackay LK, 2013, NAT IMMUNOL, V14, P1294, DOI 10.1038/ni.2744; Mizukawa Y, 2002, AM J PATHOL, V161, P1337, DOI 10.1016/S0002-9440(10)64410-0; Nagao K, 2012, NAT IMMUNOL, V13, P744, DOI 10.1038/ni.2353; Nishimura EK, 2002, NATURE, V416, P854, DOI 10.1038/416854a; Rodriguez RS, 2014, J CLIN INVEST, V124, P1027, DOI 10.1172/JCI72932; Seneschal J, 2012, IMMUNITY, V36, P873, DOI 10.1016/j.immuni.2012.03.018; Serrano M, 1996, CELL, V85, P27, DOI 10.1016/S0092-8674(00)81079-X; Shiohara T, 1997, J INVEST DERMATOL, V109, P271, DOI 10.1111/1523-1747.ep12335465; Shiow LR, 2006, NATURE, V440, P540, DOI 10.1038/nature04606; Suffia I, 2005, J IMMUNOL, V174, P5444, DOI 10.4049/jimmunol.174.9.5444; Sugihara E, 2012, ONCOGENE, V31, P2849, DOI 10.1038/onc.2011.462; van Leeuwen EMM, 2009, CURR OPIN IMMUNOL, V21, P167, DOI 10.1016/j.coi.2009.02.005; Vasioukhin V, 1999, P NATL ACAD SCI USA, V96, P8551, DOI 10.1073/pnas.96.15.8551; Wakim LM, 2008, SCIENCE, V319, P198, DOI 10.1126/science.1151869; Yamanaka K, 2006, BLOOD, V107, P2440, DOI 10.1182/blood-2005-03-1139	33	183	187	1	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2015	21	11					1272	1279		10.1038/nm.3962	http://dx.doi.org/10.1038/nm.3962			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CV9QH	26479922	Green Accepted			2022-12-25	WOS:000364621200011
J	Ryu, T; Spatola, B; Delabaere, L; Bowlin, K; Hopp, H; Kunitake, R; Karpen, GH; Chiolo, I				Ryu, Taehyun; Spatola, Brett; Delabaere, Laetitia; Bowlin, Katherine; Hopp, Hannah; Kunitake, Ryan; Karpen, Gary H.; Chiolo, Irene			Heterochromatic breaks move to the nuclear periphery to continue recombinational repair	NATURE CELL BIOLOGY			English	Article							DOUBLE-STRAND BREAK; UBIQUITIN E3 LIGASE; DNA-DAMAGE; SUMO LIGASE; CHECKPOINT KINASE; INDUCED FOCI; PROTEIN; RNF4; REPLICATION; COMPLEX	Heterochromatin mostly comprises repeated sequences prone to harmful ectopic recombination during double-strand break (DSB) repair. In Drosophila cells, 'safe' homologous recombination (HR) repair of heterochromatic breaks relies on a specialized pathway that relocalizes damaged sequences away from the heterochromatin domain before strand invasion. Here we show that heterochromatic DSBs move to the nuclear periphery to continue HR repair. Re localization depends on nuclear pores and inner nuclear membrane proteins (INMPs) that anchor repair sites to the nuclear periphery through the Smc5/6-interacting proteins STUbL/RENi. Both the initial block to HR progression inside the heterochromatin domain, and the targeting of repair sites to the nuclear periphery, rely on SUMO and SUMO E3 ligases. This study reveals a critical role for SUMOylation in the spatial and temporal regulation of HR repair in heterochromatin, and identifies the nuclear periphery as a specialized site for heterochromatin repair in a multicellular eukaryote.	[Ryu, Taehyun; Spatola, Brett; Delabaere, Laetitia; Bowlin, Katherine; Hopp, Hannah; Chiolo, Irene] Univ So Calif, Mol & Computat Biol Dept, Los Angeles, CA 90089 USA; [Kunitake, Ryan; Karpen, Gary H.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Genome Dynam Dept, Berkeley, CA 94720 USA; [Karpen, Gary H.] Univ Calif Berkeley, Mol & Cell Biol Dept, Berkeley, CA 94720 USA	University of Southern California; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Chiolo, I (corresponding author), Univ So Calif, Mol & Computat Biol Dept, Los Angeles, CA 90089 USA.	chiolo@usc.edu		Delabaere, Laetitia/0000-0002-6670-9501; Chiolo, Irene/0000-0002-3080-550X	USC Gold Family Fellowship; USC Research Enhancement Fellowship; USC Provost Fellowship; Rose Hills Foundation [R21ES021541];  [R01GM117376];  [R0IGM086613]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES021541] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067761, R01GM086613, R01GM117376] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD018537] Funding Source: NIH RePORTER	USC Gold Family Fellowship; USC Research Enhancement Fellowship; USC Provost Fellowship; Rose Hills Foundation; ; ; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the USC Gold Family Fellowship and the USC Research Enhancement Fellowship to T.R.; the USC Provost Fellowship to B.S.; R21ES021541, The Rose Hills Foundation, and R01GM117376 to I.C.; R0IGM086613 to G.H.K. We would like to thank S. Keagy, M. Michael, J. Haber and O. Aparicio for insightful comments on the manuscript, and S. Gasser for sharing results before publication. We are grateful to V. Doye (Institut Jacques Monod, France), J. Kadonaga (University of California San Diego, USA), J. Fischer (University of Texas, USA), M. Welts (University of Rochester, USA), A. Orian (Technion, Israel), S. Parkhurst (Fred Hutchinson Cancer Research Center, USA), A. Ashworth (Institute of Cancer Research, UK) and the O. Aparicio laboratory (University of Southern California, USA) for sharing reagents and the Chiolo and Karpen laboratories for helpful discussions. We thank C. Ferraro and N. Brisson for their help with Lamin and SUMO RNAi studies, and J. Swenson for his initial dPIAS RNAi studies. We also thank M. Bonner for generating the mCh-LaminC construct, D. Das, E. Lin and C. Ren for cloning and RNAi reagents, A. Kim, S. Wijelcularatne and N. Saxena for cloning and Smc5 mutant characterization. Fly stocks from BDSC (NIH P40OD018537) and RNAi libraries from DRSC (NIH R01GM067761) were used for this study.	Albuquerque CP, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003670; Andrews EA, 2005, MOL CELL BIOL, V25, P185, DOI 10.1128/MCB.25.1.185-196.2005; Barry KC, 2011, DEVELOPMENT, V138, P1759, DOI 10.1242/dev.058420; Barton LJ, 2015, CURR OPIN CELL BIOL, V34, P1, DOI 10.1016/j.ceb.2015.03.005; Boddy MN, 2003, MOL CELL BIOL, V23, P5939, DOI 10.1128/MCB.23.16.5939-5946.2003; Branzei D, 2006, CELL, V127, P509, DOI 10.1016/j.cell.2006.08.050; Brough R, 2008, DNA REPAIR, V7, P10, DOI 10.1016/j.dnarep.2007.07.013; Burgess RC, 2007, MOL CELL BIOL, V27, P6153, DOI 10.1128/MCB.00787-07; Capelson M, 2010, CELL, V140, P372, DOI 10.1016/j.cell.2009.12.054; Chiolo I, 2013, MUTAT RES-FUND MOL M, V750, P56, DOI 10.1016/j.mrfmmm.2013.08.001; Chiolo I, 2011, CELL, V144, P732, DOI 10.1016/j.cell.2011.02.012; Cortez D, 2001, SCIENCE, V294, P1713, DOI 10.1126/science.1065521; Cremona CA, 2012, MOL CELL, V45, P422, DOI 10.1016/j.molcel.2011.11.028; Dion V, 2012, NAT CELL BIOL, V14, P502, DOI 10.1038/ncb2465; Dronamraju R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025439; Dronamraju R, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000473; Eladad S, 2005, HUM MOL GENET, V14, P1351, DOI 10.1093/hmg/ddi145; Fenech M, 2011, MUTAGENESIS, V26, P125, DOI 10.1093/mutage/geq052; Galanty Y, 2012, GENE DEV, V26, P1179, DOI 10.1101/gad.188284.112; Goodarzi AA, 2011, NAT STRUCT MOL BIOL, V18, P831, DOI 10.1038/nsmb.2077; Groocock LM, 2014, EMBO REP, V15, P601, DOI 10.1002/embr.201338369; Guzzo CM, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003485; Hari KL, 2001, GENE DEV, V15, P1334, DOI 10.1101/gad.877901; Hatch EM, 2013, CELL, V154, P47, DOI 10.1016/j.cell.2013.06.007; Heideker J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001320; Ho JWK, 2014, NATURE, V512, P449, DOI 10.1038/nature13415; Horigome C, 2014, MOL CELL, V55, P626, DOI 10.1016/j.molcel.2014.06.027; Hoskins RA, 2007, SCIENCE, V316, P1625, DOI 10.1126/science.1139816; Hoskins RA, 2015, GENOME RES, V25, P445, DOI 10.1101/gr.185579.114; Jackson SP, 2013, MOL CELL, V49, P795, DOI 10.1016/j.molcel.2013.01.017; Jakob B, 2011, NUCLEIC ACIDS RES, V39, P6489, DOI 10.1093/nar/gkr230; Joyce EF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002667; Kalocsay M, 2009, MOL CELL, V33, P335, DOI 10.1016/j.molcel.2009.01.016; Kalverda B, 2010, CELL, V140, P360, DOI 10.1016/j.cell.2010.01.011; Khadaroo B, 2009, NAT CELL BIOL, V11, P980, DOI 10.1038/ncb1910; Kosoy A, 2007, J BIOL CHEM, V282, P20388, DOI 10.1074/jbc.M702652200; Kuo CY, 2014, J BIOL CHEM, V289, P20757, DOI 10.1074/jbc.M114.555672; LenzBohme B, 1997, J CELL BIOL, V137, P1001, DOI 10.1083/jcb.137.5.1001; Liu J, 2010, NAT STRUCT MOL BIOL, V17, P1260, DOI 10.1038/nsmb.1904; Mine-Hattab J, 2012, NAT CELL BIOL, V14, P510, DOI 10.1038/ncb2472; Miyabe I, 2006, MOL CELL BIOL, V26, P343, DOI 10.1128/MCB.26.1.343-353.2006; Nagai S, 2008, SCIENCE, V322, P597, DOI 10.1126/science.1162790; Nagai S, 2011, CELL RES, V21, P474, DOI 10.1038/cr.2011.31; Novatchkova M, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-22; Oza P, 2009, GENE DEV, V23, P912, DOI 10.1101/gad.1782209; Pellicioli A, 2001, MOL CELL, V7, P293, DOI 10.1016/S1097-2765(01)00177-0; Peng JC, 2008, CURR OPIN GENET DEV, V18, P204, DOI 10.1016/j.gde.2008.01.021; Potts PR, 2005, MOL CELL BIOL, V25, P7021, DOI 10.1128/MCB.25.16.7021-7032.2005; Prudden J, 2007, EMBO J, V26, P4089, DOI 10.1038/sj.emboj.7601838; Prudden J, 2009, NAT STRUCT MOL BIOL, V16, P509, DOI 10.1038/nsmb.1582; Psakhye I, 2012, CELL, V151, P807, DOI 10.1016/j.cell.2012.10.021; Razafsky D, 2009, J CELL BIOL, V186, P461, DOI 10.1083/jcb.200906068; Reindle A, 2006, J CELL SCI, V119, P4749, DOI 10.1242/jcs.03243; Riddle NC, 2011, GENOME RES, V21, P147, DOI 10.1101/gr.110098.110; Sabri N, 2007, J CELL BIOL, V178, P557, DOI 10.1083/jcb.200612135; Sekiyama N, 2010, PROTEINS, V78, P1491, DOI 10.1002/prot.22667; Smith CD, 2007, SCIENCE, V316, P1586, DOI 10.1126/science.1139815; Sollier J, 2009, MOL BIOL CELL, V20, P1671, DOI 10.1091/mbc.E08-08-0875; Staeva-Vieira E, 2003, EMBO J, V22, P5863, DOI 10.1093/emboj/cdg564; Su XFA, 2015, GENE DEV, V29, P1006, DOI 10.1101/gad.256404.114; Sun H, 2007, EMBO J, V26, P4102, DOI 10.1038/sj.emboj.7601839; Torres-Rosell J, 2007, NAT CELL BIOL, V9, P923, DOI 10.1038/ncb1619; Uzunova K, 2007, J BIOL CHEM, V282, P34167, DOI 10.1074/jbc.M706505200; Vaquerizas JM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000846; Xie Y, 2007, J BIOL CHEM, V282, P34176, DOI 10.1074/jbc.M706025200; Yin YL, 2012, GENE DEV, V26, P1196, DOI 10.1101/gad.189274.112; Zhang CY, 2006, DNA REPAIR, V5, P336, DOI 10.1016/j.dnarep.2005.10.010; Zhao XL, 2005, P NATL ACAD SCI USA, V102, P4777, DOI 10.1073/pnas.0500537102; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	70	145	149	1	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2015	17	11					1401	1411		10.1038/ncb3258	http://dx.doi.org/10.1038/ncb3258			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CV4XT	26502056	Green Accepted, Green Submitted			2022-12-25	WOS:000364270500006
J	Quarta, M; Brett, JO; DiMarco, R; De Morree, A; Boutet, SC; Chacon, R; Gibbons, MC; Garcia, VA; Su, J; Shrager, JB; Heilshorn, S; Rando, TA				Quarta, Marco; Brett, Jamie O.; DiMarco, Rebecca; De Morree, Antoine; Boutet, Stephane C.; Chacon, Robert; Gibbons, Michael C.; Garcia, Victor A.; Su, James; Shrager, Joseph B.; Heilshorn, Sarah; Rando, Thomas A.			An artificial niche preserves the quiescence of muscle stem cells and enhances their therapeutic efficacy	NATURE BIOTECHNOLOGY			English	Article							SKELETAL-MUSCLE; SELF-RENEWAL; SATELLITE CELLS; EXTRACELLULAR-MATRIX; EXPANSION; COLLAGEN; THERAPIES; ALPHA(V); SUBUNIT; TISSUE	A promising therapeutic strategy for diverse genetic disorders involves transplantation of autologous stem cells that have been genetically corrected ex vivo. A major challenge in such approaches is a loss of stem cell potency during culture. Here we describe an artificial niche for maintaining muscle stem cells (MuSCs) in vitro in a potent, quiescent state. Using a machine learning method, we identified a molecular signature of quiescence and used it to screen for factors that could maintain mouse MuSC quiescence, thus defining a quiescence medium (QM). We also engineered muscle fibers that mimic the native myofiber of the MuSC niche. Mouse MuSCs maintained in QM on engineered fibers showed enhanced potential for engraftment, tissue regeneration and self-renewal after transplantation in mice. An artificial niche adapted to human cells similarly extended the quiescence of human MuSCs in vitro and enhanced their potency in vivo. Our approach for maintaining quiescence may be applicable to stem cells isolated from other tissues.	[Quarta, Marco; Brett, Jamie O.; De Morree, Antoine; Boutet, Stephane C.; Chacon, Robert; Gibbons, Michael C.; Garcia, Victor A.; Rando, Thomas A.] Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; [Quarta, Marco; Brett, Jamie O.; De Morree, Antoine; Boutet, Stephane C.; Chacon, Robert; Gibbons, Michael C.; Garcia, Victor A.; Rando, Thomas A.] Stanford Univ, Sch Med, Paul F Glenn Ctr Biol Aging, Stanford, CA 94305 USA; [Quarta, Marco; Chacon, Robert; Gibbons, Michael C.; Garcia, Victor A.; Rando, Thomas A.] Vet Affairs Palo Alto Hlth Care Syst, Ctr Tissue Regenerat Repair & Restorat, Palo Alto, CA 94304 USA; [Brett, Jamie O.] Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [DiMarco, Rebecca] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Su, James; Heilshorn, Sarah] Stanford Univ, Dept Mat Sci & Engn, Stanford, CA 94305 USA; [Shrager, Joseph B.] Stanford Univ, Sch Med, Dept Cardiothorac Surg, Div Thorac Surg, Stanford, CA USA	Stanford University; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; Stanford University; Stanford University; Stanford University	Rando, TA (corresponding author), Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA.; Rando, TA (corresponding author), Stanford Univ, Sch Med, Paul F Glenn Ctr Biol Aging, Stanford, CA 94305 USA.; Rando, TA (corresponding author), Vet Affairs Palo Alto Hlth Care Syst, Ctr Tissue Regenerat Repair & Restorat, Palo Alto, CA 94304 USA.	rando@stanford.edu		de Morree, Antoine/0000-0002-8316-4531; Heilshorn, Sarah/0000-0002-9801-6304; Rando, Thomas/0000-0001-5843-8564	Glenn Foundation for Medical Research; National Institutes of Health (NIH) [P01 AG036695, R01 AG23806, R01 AR062185, R01 AG047820]; California Institute of Regenerative Medicine; Department of Veterans Affairs (BLR&D and RR&D Merit Reviews); NIH P41 program: RESBIO The Technology Resource for Polymeric Biomaterials [EB001046]; CalPoly [TB1-01175]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR062185] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB001046] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG036695, R37AG023806, R01AG047820] Funding Source: NIH RePORTER; Veterans Affairs [I21RX002234, I01RX001222, I01BX002324] Funding Source: NIH RePORTER	Glenn Foundation for Medical Research; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); Department of Veterans Affairs (BLR&D and RR&D Merit Reviews)(US Department of Veterans Affairs); NIH P41 program: RESBIO The Technology Resource for Polymeric Biomaterials(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CalPoly; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Veterans Affairs(US Department of Veterans Affairs)	We thank members of the Rando laboratory for comments and discussions, in particular M. Hamer and I. Akimenko for helping with some of the experiments performed with human MuSCs; L.-M. Joubert for technical support with scanning electron microscopy; E. Araci for technical support at the Stanford Microfluidic Foundry; C. Horst of Cellscale Biomaterials Testing for support in the tensile measurements of the EMF; M. Adorno from Stanford Stem Cell Institute for providing the lentivirus construct expressing luciferase and GFP; E. Cadag for the technical support with topological data analysis; M. Lynch for technical support with the micropost array fabrication; and A. Wang for technical support with the AFM measurements. This work was supported by the Glenn Foundation for Medical Research and by grants from the National Institutes of Health (NIH) (P01 AG036695, R01 AG23806 (R37 MERIT award), R01 AR062185, and R01 AG047820) the California Institute of Regenerative Medicine, and the Department of Veterans Affairs (BLR&D and RR&D Merit Reviews) to T.A.R.; by NIH P41 program: RESBIO The Technology Resource for Polymeric Biomaterials (EB001046); and by the CalPoly funding award TB1-01175.	Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013; Bareja A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090398; Bernet JD, 2014, NAT MED, V20, P265, DOI 10.1038/nm.3465; Bjornson CRR, 2012, STEM CELLS, V30, P232, DOI 10.1002/stem.773; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brightman AO, 2000, BIOPOLYMERS, V54, P222; Busch K, 2015, NATURE, V518, P542, DOI 10.1038/nature14242; Cerletti M, 2008, CELL, V134, P37, DOI 10.1016/j.cell.2008.05.049; Chakkalakal JV, 2012, NATURE, V490, P355, DOI 10.1038/nature11438; Charville GW, 2015, STEM CELL REP, V5, P621, DOI 10.1016/j.stemcr.2015.08.004; Cheung TH, 2013, NAT REV MOL CELL BIO, V14, P329, DOI 10.1038/nrm3591; Cheung TH, 2012, NATURE, V482, P524, DOI 10.1038/nature10834; Choi JS, 2015, BIOTECHNOL J, V10, P1529, DOI 10.1002/biot.201400758; Collins CA, 2005, CELL, V122, P289, DOI 10.1016/j.cell.2005.05.010; Cosgrove BD, 2014, NAT MED, V20, P255, DOI 10.1038/nm.3464; Csaszar E, 2012, CELL STEM CELL, V10, P218, DOI 10.1016/j.stem.2012.01.003; DEAN DC, 1993, AM REV RESPIR DIS, V148, pS43, DOI 10.1164/ajrccm/148.6_Pt_2.S43; Defranchi E, 2005, MICROSC RES TECHNIQ, V67, P27, DOI 10.1002/jemt.20177; Dellatore SM, 2008, CURR OPIN BIOTECH, V19, P534, DOI 10.1016/j.copbio.2008.07.010; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; du Roure O, 2005, P NATL ACAD SCI USA, V102, P2390, DOI 10.1073/pnas.0408482102; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Fu JP, 2010, NAT METHODS, V7, P733, DOI 10.1038/nmeth.1487; Fu X, 2015, CELL RES, V25, P655, DOI 10.1038/cr.2015.58; Fuchs E, 2009, CELL, V137, P811, DOI 10.1016/j.cell.2009.05.002; Fukada SI, 2007, STEM CELLS, V25, P2448, DOI 10.1634/stemcells.2007-0019; Gilbert PM, 2010, SCIENCE, V329, P1078, DOI 10.1126/science.1191035; Gullberg G, 1999, CELL MOL LIFE SCI, V56, P442, DOI 10.1007/PL00000616; Gupta N, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004373; Hall JK, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001081; Hansen CL, 2004, P NATL ACAD SCI USA, V101, P14431, DOI 10.1073/pnas.0405847101; HIRSCH E, 1994, DEV DYNAM, V201, P108, DOI 10.1002/aja.1002010203; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Julich D, 2005, DEV CELL, V8, P575, DOI 10.1016/j.devcel.2005.01.016; Kirkwood JE, 2009, LANGMUIR, V25, P3200, DOI 10.1021/la803736x; Konieczny P, 2013, MUSCLE NERVE, V47, P649, DOI 10.1002/mus.23738; Li LH, 2010, SCIENCE, V327, P542, DOI 10.1126/science.1180794; Lugert S, 2010, CELL STEM CELL, V6, P445, DOI 10.1016/j.stem.2010.03.017; Lutolf MP, 2009, NATURE, V462, P433, DOI 10.1038/nature08602; Lutolf MP, 2009, INTEGR BIOL, V1, P59, DOI 10.1039/b815718a; MAURO A., 1961, SATELLITE CELL SKELE, V9, P493; MCDONALD KA, 1995, J CELL SCI, V108, P975; Montarras D, 2005, SCIENCE, V309, P2064, DOI 10.1126/science.1114758; Nishikawa SI, 2008, COLD SH Q B, V73, P67, DOI 10.1101/sqb.2008.73.024; Ottone C, 2014, NAT CELL BIOL, V16, P1045, DOI 10.1038/ncb3045; Partridge TA, 2011, CURR OPIN NEUROL, V24, P415, DOI 10.1097/WCO.0b013e32834aa3f1; Pietras EM, 2011, J CELL BIOL, V195, P709, DOI 10.1083/jcb.201102131; Rando TA, 2005, NAT MED, V11, P829, DOI 10.1038/nm0805-829; Rathbone CR, 2011, J MUSCLE RES CELL M, V32, P99, DOI 10.1007/s10974-011-9255-8; ROSENBLATT JD, 1995, IN VITRO CELL DEV-AN, V31, P773; Sacco A, 2008, NATURE, V456, P502, DOI 10.1038/nature07384; Sanes JR, 2003, J BIOL CHEM, V278, P12601, DOI 10.1074/jbc.R200027200; Sastry SK, 1996, J CELL BIOL, V133, P169, DOI 10.1083/jcb.133.1.169; Schepers K, 2015, CELL STEM CELL, V16, P254, DOI 10.1016/j.stem.2015.02.014; SCHULTZ E, 1978, J EXP ZOOL, V206, P451, DOI 10.1002/jez.1402060314; Shandalov Y, 2014, P NATL ACAD SCI USA, V111, P6010, DOI 10.1073/pnas.1402679111; Singh G., 2007, S BAS GRAPH 07 EUR A, V07; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Trensz F, 2015, SKELET MUSCLE, V5, DOI 10.1186/s13395-015-0030-1; Urciuolo A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2964; Xu C, 2013, CELL, V155, P909, DOI 10.1016/j.cell.2013.10.023; Yang JT, 1996, J CELL BIOL, V135, P829, DOI 10.1083/jcb.135.3.829; Yin H, 2013, PHYSIOL REV, V93, P23, DOI 10.1152/physrev.00043.2011	64	106	107	3	55	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2016	34	7					752	+		10.1038/nbt.3576	http://dx.doi.org/10.1038/nbt.3576			12	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DT2TT	27240197	Green Accepted			2022-12-25	WOS:000381335400030
J	Sdelci, S; Lardeau, CH; Tallant, C; Klepsch, F; Klaiber, B; Bennett, J; Rathert, P; Schuster, M; Penz, T; Fedorov, O; Superti-Furga, G; Bock, C; Zuber, J; Huber, KVM; Knapp, S; Muller, S; Kubicek, S				Sdelci, Sara; Lardeau, Charles-Hugues; Tallant, Cynthia; Klepsch, Freya; Klaiber, Bjoern; Bennett, James; Rathert, Philipp; Schuster, Michael; Penz, Thomas; Fedorov, Oleg; Superti-Furga, Giulio; Bock, Christoph; Zuber, Johannes; Huber, Kilian V. M.; Knapp, Stefan; Muller, Susanne; Kubicek, Stefan			Mapping the chemical chromatin reactivation landscape identifies BRD4-TAF1 cross-talk	NATURE CHEMICAL BIOLOGY			English	Article							BROMODOMAIN PROTEIN BRD4; ACUTE MYELOID-LEUKEMIA; GENE-EXPRESSION; BET FAMILY; TARGETING BROMODOMAINS; TRANSCRIPTION FACTORS; CBP/P300 BROMODOMAIN; ACETYLATED CHROMATIN; NUCLEAR PERIPHERY; HUMAN GENOME	Bromodomain-containing proteins of the BET family recognize histone lysine acetylation and mediate transcriptional activation of target genes such as the MYC oncogene. Pharmacological inhibitors of BET domains promise therapeutic benefits in a variety of cancers. We performed a high-diversity chemical compound screen for agents capable of modulating BRD4-dependent heterochromatization of a generic reporter in human cells. In addition to known and new compounds targeting BRD4, we identified small molecules that mimic BRD4 inhibition without direct engagement. One such compound was a potent inhibitor of the second bromodomain of TAF1. Using this inhibitor, we discovered that TAF1 synergizes with BRD4 to control proliferation of cancer cells, making TAF1 an attractive epigenetic target in cancers driven by MYC.	[Sdelci, Sara; Lardeau, Charles-Hugues; Klepsch, Freya; Klaiber, Bjoern; Schuster, Michael; Penz, Thomas; Superti-Furga, Giulio; Bock, Christoph; Huber, Kilian V. M.; Kubicek, Stefan] Austrian Acad Sci, CeMM Res Ctr Mol Med, A-1010 Vienna, Austria; [Lardeau, Charles-Hugues; Kubicek, Stefan] Austrian Acad Sci, CeMM Res Ctr Mol Med, Christian Doppler Lab Chem Epigenet & Antiinfect, A-1010 Vienna, Austria; [Tallant, Cynthia; Bennett, James; Fedorov, Oleg; Huber, Kilian V. M.; Knapp, Stefan; Muller, Susanne] Univ Oxford, Nuffield Dept Clin Med, Struct Genom Consortium, Oxford, England; [Tallant, Cynthia; Bennett, James; Fedorov, Oleg; Huber, Kilian V. M.; Knapp, Stefan; Muller, Susanne] Univ Oxford, Nuffield Dept Clin Med, Target Discovery Inst, Oxford, England; [Rathert, Philipp; Zuber, Johannes] Vienna Bioctr VBC, Res Inst Mol Pathol IMP, Vienna, Austria; [Superti-Furga, Giulio] Med Univ Vienna, Ctr Physiol & Pharmacol, Vienna, Austria; [Bock, Christoph] Med Univ Vienna, Dept Lab Med, Vienna, Austria; [Bock, Christoph] Max Planck Inst Informat, Saarbrucken, Germany; [Knapp, Stefan] Goethe Univ Frankfurt, Inst Pharmaceut Chem, D-60054 Frankfurt, Germany; [Knapp, Stefan] Buchmann Inst Life Sci, Frankfurt, Germany; [Rathert, Philipp] Univ Stuttgart, Inst Biochem, D-70174 Stuttgart, Germany	Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences; Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences; University of Oxford; University of Oxford; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Medical University of Vienna; Medical University of Vienna; Max Planck Society; Goethe University Frankfurt; University of Stuttgart	Kubicek, S (corresponding author), Austrian Acad Sci, CeMM Res Ctr Mol Med, A-1010 Vienna, Austria.; Kubicek, S (corresponding author), Austrian Acad Sci, CeMM Res Ctr Mol Med, Christian Doppler Lab Chem Epigenet & Antiinfect, A-1010 Vienna, Austria.	skubicek@cemm.oeaw.ac.at	Kubicek, Stefan/C-2089-2017; Bock, Christoph/AAE-7618-2019; Knapp, Stefan/AAG-2347-2019; sdelci, sara/S-2243-2018; Huber, Kilian V. M./L-6921-2015; Zuber, Johannes/E-7517-2011; Superti-Furga, Giulio/AAE-5681-2019	Kubicek, Stefan/0000-0003-0855-8343; Bock, Christoph/0000-0001-6091-3088; Knapp, Stefan/0000-0001-5995-6494; sdelci, sara/0000-0003-1330-4364; Huber, Kilian V. M./0000-0002-1103-5300; Zuber, Johannes/0000-0001-8810-6835; Trasischker, Freya/0000-0003-1410-695X; Bennett, James/0000-0003-1396-8400; Muller-Knapp, Susanne/0000-0003-2402-4157; Rathert, Philipp/0000-0003-1477-136X; Tallant, Cynthia/0000-0001-5645-435X	Austrian Federal Ministry of Science, Research and Economy; National Foundation for Research, Technology, and Development; Marie Curie Career Integration Grant EPICAL; JDRF; Austrian Science Fund (FWF) [F4710]; JDRF postdoctoral fellowship [3-PDF-2014-206-A-N]; Structural Genomics Consortium, a registered charity; AbbVie [1097737]; Bayer; Boehringer Ingelheim; Canada Foundation for Innovation; Canadian Institutes for Health Research; Genome Canada; GlaxoSmithKline; Janssen; Lilly Canada; Novartis Research Foundation; Ontario Ministry of Economic Development and Innovation; Pfizer; Wellcome Trust [092809/Z/10/Z]	Austrian Federal Ministry of Science, Research and Economy; National Foundation for Research, Technology, and Development; Marie Curie Career Integration Grant EPICAL; JDRF(Juvenile Diabetes Research Foundation); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); JDRF postdoctoral fellowship(Juvenile Diabetes Research Foundation); Structural Genomics Consortium, a registered charity(University of Toronto); AbbVie(AbbVie); Bayer(Bayer AG); Boehringer Ingelheim(Boehringer Ingelheim); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Genome Canada(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Lilly Canada(Eli Lilly); Novartis Research Foundation; Ontario Ministry of Economic Development and Innovation; Pfizer(Pfizer); Wellcome Trust(Wellcome TrustEuropean Commission)	Research in the Kubicek laboratory is supported by the Austrian Federal Ministry of Science, Research and Economy; the National Foundation for Research, Technology, and Development; the Marie Curie Career Integration Grant EPICAL; and the JDRF. This project was supported by SFB grant F4710 of the Austrian Science Fund (FWF). S.S. acknowledges support by JDRF postdoctoral fellowship 3-PDF-2014-206-A-N "Reprogramming by Loss of Function". J.B., C.T., O.F. and S.M. are funded by the Structural Genomics Consortium, a registered charity (number 1097737) that receives funds from AbbVie, Bayer, Boehringer Ingelheim, the Canada Foundation for Innovation, the Canadian Institutes for Health Research, Genome Canada, GlaxoSmithKline, Janssen, Lilly Canada, the Novartis Research Foundation, the Ontario Ministry of Economic Development and Innovation, Pfizer, Takeda and the Wellcome Trust (092809/Z/10/Z). We thank all the members of the BioOptic Facility of the Research Institute of Molecular Pathology (IMP) and the Institute of Molecular Biotechnology GmbH (IMBA) for their help with cell sorting; S. Gresko and V. Ivanov (Enamine Ltd) for compound synthesis; J.E. Bradner (Dana-Farber Cancer Institute) for an initial batch of JQ1 and for library compounds; and K.M. Pugh (Target Discovery Institute; Oxford) for help with analytical chemistry. Dedicated to S.L. Schreiber on the occasion of his 60th birthday.	Albrecht B.K., 2012, WPO patent, Patent No. [WO/2012/17448, 201217448]; Andersson BS, 1995, LEUKEMIA, V9, P2100; Arrowsmith CH, 2015, NAT CHEM BIOL, V11, P536, DOI 10.1038/nchembio.1867; Banerjee C, 2012, J LEUKOCYTE BIOL, V92, P1147, DOI 10.1189/jlb.0312165; Best AM, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/868095; Bielefeld-Sevigny M, 2009, ASSAY DRUG DEV TECHN, V7, P90, DOI 10.1089/adt.2009.9996; Blank J., 2014, WPO patent, Patent No. [WO/2014/191896, 2014191896]; Blank J., 2014, WPO patent, Patent No. [2014191894 A1, 2014191894, WO/2014/191894]; Bliss CI, 1939, ANN APPL BIOL, V26, P585, DOI 10.1111/j.1744-7348.1939.tb06990.x; Blomen VA, 2015, SCIENCE, V350, P1092, DOI 10.1126/science.aac7557; Chaikuad A, 2014, MEDCHEMCOMM, V5, P1843, DOI 10.1039/c4md00237g; Ciceri P, 2014, NAT CHEM BIOL, V10, P305, DOI 10.1038/nchembio.1471; Dey A, 2003, P NATL ACAD SCI USA, V100, P8758, DOI 10.1073/pnas.1433065100; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Engelhardt H., 2014, US Patent Office patent, Patent No. [US20140135336A1, 20140135336, US 2014/0135336]; Fedorov O, 2014, J MED CHEM, V57, P462, DOI 10.1021/jm401568s; Filippakopoulos P, 2014, NAT REV DRUG DISCOV, V13, P339, DOI 10.1038/nrd4286; Filippakopoulos P, 2012, CELL, V149, P214, DOI 10.1016/j.cell.2012.02.013; Filippakopoulos P, 2012, BIOORGAN MED CHEM, V20, P1878, DOI 10.1016/j.bmc.2011.10.080; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Fish PV, 2012, J MED CHEM, V55, P9831, DOI 10.1021/jm3010515; Floyd SR, 2013, NATURE, V498, P246, DOI 10.1038/nature12147; Frye SV, 2010, NAT CHEM BIOL, V6, P159, DOI 10.1038/nchembio.296; Hammitzsch A, 2015, P NATL ACAD SCI USA, V112, P10768, DOI 10.1073/pnas.1501956112; Hay DA, 2014, J AM CHEM SOC, V136, P9308, DOI 10.1021/ja412434f; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Johnson RL, 2008, ANAL BIOCHEM, V375, P237, DOI 10.1016/j.ab.2007.12.028; Kandiah E, 2014, CURR OPIN STRUC BIOL, V24, P91, DOI 10.1016/j.sbi.2013.12.005; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kloet SL, 2012, MOL CELL BIOL, V32, P3358, DOI 10.1128/MCB.00416-12; Lee DH, 2005, MOL CELL BIOL, V25, P9674, DOI 10.1128/MCB.25.21.9674-9686.2005; McKeown MR, 2014, J MED CHEM, V57, P9019, DOI 10.1021/jm501120z; McLure KG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083190; Mirguet O, 2013, J MED CHEM, V56, P7501, DOI 10.1021/jm401088k; Mootha VK, 2003, CELL, V115, P629, DOI 10.1016/S0092-8674(03)00926-7; Nagarajan S, 2014, CELL REP, V8, P459, DOI 10.1016/j.celrep.2014.06.016; Picaud S, 2015, CANCER RES, V75, P5106, DOI 10.1158/0008-5472.CAN-15-0236; Roe JS, 2015, MOL CELL, V58, P1028, DOI 10.1016/j.molcel.2015.04.011; Schermelleh L, 2008, SCIENCE, V320, P1332, DOI 10.1126/science.1156947; Seal J, 2012, BIOORG MED CHEM LETT, V22, P2968, DOI 10.1016/j.bmcl.2012.02.041; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tchasovnikarova IA, 2015, SCIENCE, V348, P1481, DOI 10.1126/science.aaa7227; Towbin BD, 2012, CELL, V150, P934, DOI 10.1016/j.cell.2012.06.051; Wang L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3035; Wang LG, 2012, BIOINFORMATICS, V28, P2184, DOI 10.1093/bioinformatics/bts356; Wang RR, 2012, J BIOL CHEM, V287, P10738, DOI 10.1074/jbc.M111.323493; Wang T, 2015, SCIENCE, V350, P1096, DOI 10.1126/science.aac7041; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Workman P, 2010, CHEM BIOL, V17, P561, DOI 10.1016/j.chembiol.2010.05.013; Wu SY, 2007, J BIOL CHEM, V282, P13141, DOI 10.1074/jbc.R700001200; Wu T, 2015, STEM CELL REP, V4, P390, DOI 10.1016/j.stemcr.2015.01.012; Wyce A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072967; Yang ZY, 2008, MOL CELL BIOL, V28, P967, DOI 10.1128/MCB.01020-07; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhu J, 2012, CELL REP, V2, P807, DOI 10.1016/j.celrep.2012.09.008; Zuber J, 2011, NATURE, V478, P524, DOI 10.1038/nature10334	58	28	30	1	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUL	2016	12	7					504	+		10.1038/nchembio.2080	http://dx.doi.org/10.1038/nchembio.2080			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9EP	27159579				2022-12-25	WOS:000378087500009
J	Cejas, P; Li, L; O'Neill, NK; Duarte, M; Rao, P; Bowden, M; Zhou, CSW; Mendiola, M; Burgos, E; Feliu, J; Moreno-Rubio, J; Guadalajara, H; Moreno, V; Garcia-Olmo, D; Bellmunt, J; Mullane, S; Hirsch, M; Sweeney, CJ; Richardson, A; Liu, XS; Brown, M; Shivdasani, RA; Long, HW				Cejas, Paloma; Li, Lewyn; O'Neill, Nicholas K.; Duarte, Melissa; Rao, Prakash; Bowden, Michaela; Zhou, Chensheng W.; Mendiola, Marta; Burgos, Emilio; Feliu, Jaime; Moreno-Rubio, Juan; Guadalajara, Hector; Moreno, Victor; Garcia-Olmo, Damin; Bellmunt, Joaquim; Mullane, Stephanie; Hirsch, Michelle; Sweeney, Christopher J.; Richardson, Andrea; Liu, X. Shirley; Brown, Myles; Shivdasani, Ramesh A.; Long, Henry W.			Chromatin immunoprecipitation from fixed clinical tissues reveals tumor-specific enhancer profiles	NATURE MEDICINE			English	Article							EMBRYONIC STEM-CELLS; CIS-REGULATORY REGIONS; TRANSCRIPTION FACTORS; EXPRESSION ANALYSIS; ANTIGEN RETRIEVAL; GENE-EXPRESSION; SELF-RENEWAL; GENOME; CANCER; IMMUNOHISTOCHEMISTRY	Extensive cross-linking introduced during routine tissue fixation of clinical pathology specimens severely hampers chromatin immunoprecipitation followed by next-generation sequencing (ChIP-seq) analysis from archived tissue samples. This limits the ability to study the epigenomes of valuable, clinically annotated tissue resources. Here we describe fixed-tissue chromatin immunoprecipitation sequencing (FiT-seq), a method that enables reliable extraction of soluble chromatin from formalin-fixed paraffin-embedded (FFPE) tissue samples for accurate detection of histone marks. We demonstrate that FiT-seq data from FFPE specimens are concordant with ChIP-seq data from fresh-frozen samples of the same tumors. By using multiple histone marks, we generate chromatinstate maps and identify cis-regulatory elements in clinical samples from various tumor types that can readily allow us to distinguish between cancers by the tissue of origin. Tumor-specific enhancers and superenhancers that are elucidated by FiT-seq analysis correlate with known oncogenic drivers in different tissues and can assist in the understanding of how chromatin states affect gene regulation.	[Cejas, Paloma; Li, Lewyn; Duarte, Melissa; Rao, Prakash; Liu, X. Shirley; Brown, Myles; Shivdasani, Ramesh A.; Long, Henry W.] Dana Farber Canc Inst, Ctr Funct Canc Epigenet, Boston, MA 02115 USA; [Cejas, Paloma; Li, Lewyn; O'Neill, Nicholas K.; Duarte, Melissa; Rao, Prakash; Bellmunt, Joaquim; Mullane, Stephanie; Sweeney, Christopher J.; Brown, Myles; Shivdasani, Ramesh A.; Long, Henry W.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Cejas, Paloma; Mendiola, Marta; Feliu, Jaime] Hosp La Paz, Inst Hlth Res IdiPAZ, Dept Med Oncol, Madrid, Spain; [Bowden, Michaela; Zhou, Chensheng W.] Dana Farber Canc Inst, Ctr Mol Oncol Pathol, Boston, MA 02115 USA; [Mendiola, Marta; Burgos, Emilio] Hosp La Paz, Dept Pathol, Inst Hlth Res IdiPAZ, Madrid, Spain; [Moreno-Rubio, Juan] Infanta Sofia Univ Hosp, Precis Oncol Lab, Madrid, Spain; [Guadalajara, Hector; Garcia-Olmo, Damin] Fdn Jimenez Diaz, Dept Surg, E-28040 Madrid, Spain; [Moreno, Victor] Fdn Jimenez Diaz, Clin Res Unit, E-28040 Madrid, Spain; [Hirsch, Michelle; Richardson, Andrea] Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA; [Hirsch, Michelle; Richardson, Andrea] Harvard Univ, Sch Med, Boston, MA USA; [Liu, X. Shirley] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Liu, X. Shirley] Harvard Univ, Sch Publ Hlth, 665 Huntington Ave, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Hospital Universitario La Paz; Harvard University; Dana-Farber Cancer Institute; Hospital Universitario La Paz; Hospital Universitario Infanta Sofia; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard T.H. Chan School of Public Health	Shivdasani, RA; Long, HW (corresponding author), Dana Farber Canc Inst, Ctr Funct Canc Epigenet, Boston, MA 02115 USA.; Shivdasani, RA; Long, HW (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.	ramesh_shivdasani@dfci.harvard.edu; henry_long@dfci.harvard.edu	Moreno, Victor/GNN-0449-2022; Brown, Myles/AAX-5332-2021; Moreno-Rubio, Juan/M-4597-2015; Bellmunt, Joaquim/B-8151-2019; Guadalajara, Hector/AAG-6209-2021; Brown, Myles/B-6906-2008	Moreno, Victor/0000-0001-6099-4236; Brown, Myles/0000-0002-8213-1658; Moreno-Rubio, Juan/0000-0003-3335-8749; Bellmunt, Joaquim/0000-0003-2328-3421; Guadalajara, Hector/0000-0001-6297-9347; Zhou, Chensheng/0000-0001-6593-7994; Bowden, Michaela/0000-0003-4375-7823; Wankowicz, Stephanie/0000-0002-4225-7459; Garcia Olmo, Damian/0000-0002-9369-2338	DFCI-Novartis Drug Discovery Program; US NIH [P50CA127003]; Susan F. Smith Center for Women's Cancers; Susan G. Komen foundation; Breast Cancer Research foundation; Medical Oncology Translational Grant Program from Dana-Farber Cancer Institute; Instituto de Salud Carlos III the Spanish Economy and Competitiveness Ministry [PI13-01818]; ConSEPOC-Comunidad de Madrid [S2010/BMD-2542]; Asociacion Espanola Contra el Cancer (Programa de Formacion Avanzada en Oncologia); Fundacion Caja Madrid	DFCI-Novartis Drug Discovery Program; US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Susan F. Smith Center for Women's Cancers; Susan G. Komen foundation(Susan G. Komen Breast Cancer Foundation); Breast Cancer Research foundation; Medical Oncology Translational Grant Program from Dana-Farber Cancer Institute; Instituto de Salud Carlos III the Spanish Economy and Competitiveness Ministry; ConSEPOC-Comunidad de Madrid; Asociacion Espanola Contra el Cancer (Programa de Formacion Avanzada en Oncologia); Fundacion Caja Madrid	This work was supported by the DFCI-Novartis Drug Discovery Program (R.A.S.), the US NIH grant P50CA127003 (R.A.S.), the Susan F. Smith Center for Women's Cancers (M. Brown), grants from the Susan G. Komen and the Breast Cancer Research foundations (M. Brown), the Medical Oncology Translational Grant Program from the Dana-Farber Cancer Institute (C.J.S.), a grant from Instituto de Salud Carlos III the Spanish Economy and Competitiveness Ministry (grant PI13-01818; P.C.), the ConSEPOC-Comunidad de Madrid (grant S2010/BMD-2542; P.C.), and fellowships from the Asociacion Espanola Contra el Cancer (Programa de Formacion Avanzada en Oncologia 2010; P.C.) and the Fundacion Caja Madrid (P.C.). We thank E. Diaz and M. de Miguel for technical assistance.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Balasubramanian D, 2012, GENOME MED, V4, DOI 10.1186/gm346; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Ernst J, 2012, NAT METHODS, V9, P215, DOI 10.1038/nmeth.1906; Fanelli M, 2010, P NATL ACAD SCI USA, V107, P21535, DOI 10.1073/pnas.1007647107; Garraway LA, 2013, CELL, V153, P17, DOI 10.1016/j.cell.2013.03.002; Hansen KD, 2011, NAT GENET, V43, P768, DOI 10.1038/ng.865; Hatzis P, 2008, MOL CELL BIOL, V28, P2732, DOI 10.1128/MCB.02175-07; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Heng JCD, 2010, CELL STEM CELL, V6, P167, DOI 10.1016/j.stem.2009.12.009; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Kouros-Mehr H, 2006, CELL, V127, P1041, DOI 10.1016/j.cell.2006.09.048; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Liu T, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r83; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Ong CT, 2011, NAT REV GENET, V12, P283, DOI 10.1038/nrg2957; Ramirez F, 2014, NUCLEIC ACIDS RES, V42, pW187, DOI 10.1093/nar/gku365; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Santagata S, 2007, AM J SURG PATHOL, V31, P836, DOI 10.1097/PAS.0b013e31802e708a; Shi SR, 2005, J HISTOCHEM CYTOCHEM, V53, P1167, DOI 10.1369/jhc.5B6691.2005; SHI SR, 1995, J HISTOCHEM CYTOCHEM, V43, P193, DOI 10.1177/43.2.7822775; Shin Hyunjin, 2013, Quant Biol, V1, P54; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; van Bragt MPA, 2014, ELIFE, V3, DOI 10.7554/eLife.03881; Verzi MP, 2010, DEV CELL, V19, P713, DOI 10.1016/j.devcel.2010.10.006; Verzi MP, 2010, P NATL ACAD SCI USA, V107, P15157, DOI 10.1073/pnas.1003822107; Weinstein JN, 2014, NATURE, V507, P315, DOI 10.1038/nature12965; Yamashita S, 2007, PROG HISTOCHEM CYTO, V41, P141, DOI 10.1016/j.proghi.2006.09.001; Zentner GE, 2012, J BIOL CHEM, V287, P30888, DOI 10.1074/jbc.R111.296491; Zhang XF, 2008, J BIOL CHEM, V283, P35825, DOI 10.1074/jbc.M803481200	37	45	63	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2016	22	6					685	+		10.1038/nm.4085	http://dx.doi.org/10.1038/nm.4085			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DO0NQ	27111282				2022-12-25	WOS:000377476000027
J	Moore, AR; Ceraudo, E; Sher, JJ; Guan, YX; Shoushtari, AN; Chang, MT; Zhang, JQ; Walczak, EG; Kazmi, MA; Taylor, BS; Huber, T; Chi, P; Sakmar, TP; Chen, Y				Moore, Amanda R.; Ceraudo, Emilie; Sher, Jessica J.; Guan, Youxin; Shoushtari, Alexander N.; Chang, Matthew T.; Zhang, Jenny Q.; Walczak, Edward G.; Kazmi, Manija A.; Taylor, Barry S.; Huber, Thomas; Chi, Ping; Sakmar, Thomas P.; Chen, Yu			Recurrent activating mutations of G-protein-coupled receptor CYSLTR2 in uveal melanoma	NATURE GENETICS			English	Article							SOMATIC MUTATIONS; MOUSE MELANOCYTES; CANCER; SF3B1; ANTAGONIST; GROWTH; TUMORS	Uveal melanomas are molecularly distinct from cutaneous melanomas and lack mutations in BRAF, NRAS, KIT, and NF1. Instead, they are characterized by activating mutations in GNAQ and GNA11, two highly homologous alpha subunits of G(alpha q/11) heterotrimeric G proteins, and in PLCB4 (phospholipase C beta 4), the downstream effector of G(alpha q) signaling(1-3). We analyzed genomics data from 136 uveal melanoma samples and found a recurrent mutation in CYSLTR2 (cysteinyl leukotriene receptor 2) encoding a p.Leu129Gln substitution in 4 of 9 samples that lacked mutations in GNAQ, GNA11, and PLCB4 but in 0 of 127 samples that harbored mutations in these genes. The Leu129Gln CysLT(2)R mutant protein constitutively activates endogenous G(alpha q) and is unresponsive to stimulation by leukotriene. Expression of Leu129Gln CysLT(2)R in melanocytes enforces expression of a melanocyte-lineage signature, drives phorbol ester-independent growth in vitro, and promotes tumorigenesis in vivo. Our findings implicate CYSLTR2 as a uveal melanoma oncogene and highlight the critical role of G(alpha q) signaling in uveal melanoma pathogenesis.	[Moore, Amanda R.; Sher, Jessica J.; Guan, Youxin; Chang, Matthew T.; Zhang, Jenny Q.; Walczak, Edward G.; Taylor, Barry S.; Chi, Ping; Chen, Yu] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USA; [Moore, Amanda R.; Chi, Ping; Chen, Yu] Cornell Univ, Weill Cornell Grad Sch Med Sci, New York, NY 10021 USA; [Ceraudo, Emilie; Kazmi, Manija A.; Huber, Thomas; Sakmar, Thomas P.] Rockefeller Univ, Lab Chem Biol & Signal Transduct, 1230 York Ave, New York, NY 10021 USA; [Shoushtari, Alexander N.; Chi, Ping; Chen, Yu] Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA; [Shoushtari, Alexander N.; Chi, Ping; Chen, Yu] Weill Cornell Med Coll, Dept Med, New York, NY USA; [Chang, Matthew T.; Taylor, Barry S.] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA; [Chang, Matthew T.] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA; [Taylor, Barry S.] Mem Sloan Kettering Canc Ctr, Marie Josee & Henry R Kravis Ctr Mol Oncol, 1275 York Ave, New York, NY 10021 USA; [Sakmar, Thomas P.] Karolinska Inst, Ctr Alzheimer Res, Div Neurogeriatr, Dept Neurobiol Care Sci & Soc, Huddinge, Sweden	Memorial Sloan Kettering Cancer Center; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Rockefeller University; Memorial Sloan Kettering Cancer Center; Cornell University; Memorial Sloan Kettering Cancer Center; University of California System; University of California San Francisco; Memorial Sloan Kettering Cancer Center; Karolinska Institutet	Chen, Y (corresponding author), Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USA.; Chen, Y (corresponding author), Cornell Univ, Weill Cornell Grad Sch Med Sci, New York, NY 10021 USA.; Chen, Y (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA.; Chen, Y (corresponding author), Weill Cornell Med Coll, Dept Med, New York, NY USA.	cheny1@mskcc.org	Huber, Thomas/A-8016-2008; Sakmar, Thomas P/D-1833-2015	Huber, Thomas/0000-0002-1844-262X; Sakmar, Thomas P/0000-0002-2836-8953	NIH [P50CA140146, K08CA140946, DP2CA174499, K08CA151660]; Sidney Kimmel Foundation (Kimmel Scholar Award); Cycle for Survival Fund; Geoffrey Beene Award; Prostate Cancer Foundation; STARR Cancer Consortium; Francois Wallace c Monahan Fellowship; NATIONAL CANCER INSTITUTE [K08CA140946, R01CA193837, K08CA151660, DP2CA174499, P30CA008748, P50CA140146] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sidney Kimmel Foundation (Kimmel Scholar Award); Cycle for Survival Fund; Geoffrey Beene Award; Prostate Cancer Foundation; STARR Cancer Consortium; Francois Wallace c Monahan Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We gratefully acknowledge the members of the Molecular Diagnostics Service in the Department of Pathology and the Marie-Josee and Henry R. Kravis Center for Molecular Oncology. We thank T. Wiesner (MSKCC and Medical University of Graz) for the melan-a and MEL290 cell lines and intellectual input, D. Abramson for intellectual input, C. Kandoth and the TCGA for data sharing, M. Berger and N. Bouvier for obtaining patient DNA, Y.A. Berchiche for the flow cytometry analysis and scientific input, and M. Bouvier (Universite de Montreal) for the kind gift of the EPAC construct. This work was supported in part by grants from the NIH to P.C. (P50CA140146, CDA; DP2CA174499; K08CA151660), the NIH to Y.C. (K08CA140946), the Sidney Kimmel Foundation to P.C. (Kimmel Scholar Award), the Cycle for Survival Fund to P.C. and Y.C., the Geoffrey Beene Award to P.C. and Y.C., the Prostate Cancer Foundation to Y.C., the STARR Cancer Consortium to P.C. and Y.C., and the Francois Wallace c Monahan Fellowship to E.C.	Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; BENNETT DC, 1987, INT J CANCER, V39, P414, DOI 10.1002/ijc.2910390324; Bond RA, 2006, TRENDS PHARMACOL SCI, V27, P92, DOI 10.1016/j.tips.2005.12.007; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chang MT, 2016, NAT BIOTECHNOL, V34, P155, DOI 10.1038/nbt.3391; Cheng DT, 2015, J MOL DIAGN, V17, P251, DOI 10.1016/j.jmoldx.2014.12.006; Evans JF, 2002, PROSTAG OTH LIPID M, V68-9, P587, DOI 10.1016/S0090-6980(02)00057-6; Furney SJ, 2013, CANCER DISCOV, V3, P1122, DOI 10.1158/2159-8290.CD-13-0330; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; Griewank KG, 2012, PIGM CELL MELANOMA R, V25, DOI 10.1111/j.1755-148X.2012.00971.x; Harbour JW, 2013, NAT GENET, V45, P133, DOI 10.1038/ng.2523; Harbour JW, 2010, SCIENCE, V330, P1410, DOI 10.1126/science.1194472; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Johansson P, 2016, ONCOTARGET, V7, P4624, DOI 10.18632/oncotarget.6614; Kan ZY, 2010, NATURE, V466, P869, DOI 10.1038/nature09208; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lawrence MG, 2013, NAT PROTOC, V8, P836, DOI 10.1038/nprot.2013.043; Leduc M, 2009, J PHARMACOL EXP THER, V331, P297, DOI 10.1124/jpet.109.156398; Leff JA, 1998, NEW ENGL J MED, V339, P147, DOI 10.1056/NEJM199807163390302; Leiserson MDM, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0700-7; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu G, 1999, NEW ENGL J MED, V341, P1731, DOI 10.1056/NEJM199912023412304; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Martin M, 2013, NAT GENET, V45, P933, DOI 10.1038/ng.2674; PARMA J, 1993, NATURE, V365, P649, DOI 10.1038/365649a0; Prickett TD, 2011, NAT GENET, V43, P1119, DOI 10.1038/ng.950; Prince S, 2003, PIGM CELL RES, V16, P26, DOI 10.1034/j.1600-0749.2003.00008.x; Refaeli Y, 2002, J EXP MED, V196, P999, DOI 10.1084/JEM.20020666; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Sakmar TP, 2002, CURR OPIN CELL BIOL, V14, P189, DOI 10.1016/S0955-0674(02)00306-X; Tao YX, 2008, PHARMACOL THERAPEUT, V120, P129, DOI 10.1016/j.pharmthera.2008.07.005; Van Raamsdonk CD, 2010, NEW ENGL J MED, V363, P2191, DOI 10.1056/NEJMoa1000584; Van Raamsdonk CD, 2009, NATURE, V457, P599, DOI 10.1038/nature07586; Wunder F, 2010, BRIT J PHARMACOL, V160, P399, DOI 10.1111/j.1476-5381.2010.00730.x; YAAR M, 1991, J INVEST DERMATOL, V97, P611, DOI 10.1111/1523-1747.ep12482985; Zhang C, 2012, NATURE, V492, P387, DOI 10.1038/nature11701	38	170	172	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2016	48	6					675	+		10.1038/ng.3549	http://dx.doi.org/10.1038/ng.3549			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DN0HE	27089179	Green Accepted			2022-12-25	WOS:000376744200016
J	Chakradhar, S				Chakradhar, Shraddha			Prime pick: Researchers get selective about T cells for cancer therapy	NATURE MEDICINE			English	News Item							IN-VIVO; CD8(+); EFFECTOR; SUBSETS											Gattinoni L, 2005, J CLIN INVEST, V115, P1616, DOI 10.1172/JCI24480; Gattinoni L, 2011, NAT MED, V17, P1290, DOI 10.1038/nm.2446; Gattinoni L, 2009, NAT MED, V15, P808, DOI 10.1038/nm.1982; Sommermeyer D, 2016, LEUKEMIA, V30, P492, DOI 10.1038/leu.2015.247; Stemberger C, 2007, IMMUNITY, V27, P985, DOI 10.1016/j.immuni.2007.10.012; Sukumar M, 2016, CELL METAB, V23, P63, DOI 10.1016/j.cmet.2015.11.002	6	0	0	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2016	22	5					456	458		10.1038/nm0516-456	http://dx.doi.org/10.1038/nm0516-456			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DL3DI	27149215				2022-12-25	WOS:000375514000004
J	Parsons, WH; Kolar, MJ; Kamat, SS; Cognetta, AB; Hulce, JJ; Saez, E; Kahn, BB; Saghatelian, A; Cravatt, BF				Parsons, William H.; Kolar, Matthew J.; Kamat, Siddhesh S.; Cognetta, Armand B., III; Hulce, Jonathan J.; Saez, Enrique; Kahn, Barbara B.; Saghatelian, Alan; Cravatt, Benjamin F.			AIG1 and ADTRP are atypical integral membrane hydrolases that degrade bioactive FAHFAs	NATURE CHEMICAL BIOLOGY			English	Article							ACTIVITY-BASED PROBES; ENZYME SUPERFAMILIES; SERINE HYDROLASES; INHIBITORS; DISCOVERY; PROTEOMICS; VIVO	Enzyme classes may contain outlier members that share mechanistic, but not sequence or structural, relatedness with more common representatives. The functional annotation of such exceptional proteins can be challenging. Here, we use activity-based profiling to discover that the poorly characterized multipass transmembrane proteins AIG1 and ADTRP are atypical hydrolytic enzymes that depend on conserved threonine and histidine residues for catalysis. Both AIG1 and ADTRP hydrolyze bioactive fatty acid esters of hydroxy fatty acids (FAHFAs) but not other major classes of lipids. We identify multiple cell-active, covalent inhibitors of AIG1 and show that these agents block FAHFA hydrolysis in mammalian cells. These results indicate that AIG1 and ADTRP are founding members of an evolutionarily conserved class of transmembrane threonine hydrolases involved in bioactive lipid metabolism. More generally, our findings demonstrate how chemical proteomics can excavate potential cases of convergent or parallel protein evolution that defy conventional sequence-and structure-based predictions.	[Parsons, William H.; Kamat, Siddhesh S.; Cognetta, Armand B., III; Hulce, Jonathan J.; Saez, Enrique; Cravatt, Benjamin F.] Scripps Res Inst, Dept Physiol Chem, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Kolar, Matthew J.; Saghatelian, Alan] Helmsley Ctr Genom Med, Clayton Fdn Labs Peptide Biol, Salk Inst Biol Studies, La Jolla, CA USA; [Kahn, Barbara B.] Beth Israel Deaconess Med Ctr, Dept Med, Div Endocrinol Diabet & Metab, Boston, MA 02215 USA; [Kahn, Barbara B.] Harvard Univ, Sch Med, Boston, MA USA	Scripps Research Institute; Salk Institute; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Cravatt, BF (corresponding author), Scripps Res Inst, Dept Physiol Chem, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA.; Saghatelian, A (corresponding author), Helmsley Ctr Genom Med, Clayton Fdn Labs Peptide Biol, Salk Inst Biol Studies, La Jolla, CA USA.	asaghatelian@salk.edu; cravatt@scripps.edu		Parsons, William/0000-0001-6065-2340; Kolar, Matthew/0000-0001-8054-9121; Kamat, Siddhesh/0000-0001-6132-7574	US National Institutes of Health [DA033760, DK909810]; Leona M. and Harry B. Helmsley Charitable Trust [2012-PG-MED002]; National Cancer Institute Cancer Center (MASS core) [P30, CA014195]; Dr. Frederick Paulsen Chair/Ferring Pharmaceuticals; Hewitt Foundation for Medical Research Fellowship; Chapman Charitable Trust Fellowship; UCSD Medical Scientist Training Program funding [T32 GM007198]; Irving S. Sigal postdoctoral fellowship from American Chemical Society; NATIONAL CANCER INSTITUTE [P30CA014195] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK099810, R01DK106210] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007198] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA033760] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leona M. and Harry B. Helmsley Charitable Trust; National Cancer Institute Cancer Center (MASS core); Dr. Frederick Paulsen Chair/Ferring Pharmaceuticals; Hewitt Foundation for Medical Research Fellowship; Chapman Charitable Trust Fellowship; UCSD Medical Scientist Training Program funding; Irving S. Sigal postdoctoral fellowship from American Chemical Society; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We are grateful to K. Masuda and L. Bar-Peled for discussions on and assistance with cloning; M. Dix, J. Wu and K. Lum for discussions and technical expertise in designing and analyzing proteomics experiments; J. Teijaro for providing T cells; G. Simon for assistance with the HHpred analysis; and C. Walsh and M. Niphakis for numerous helpful discussions. This work was supported by the US National Institutes of Health (DA033760, DK909810), The Leona M. and Harry B. Helmsley Charitable Trust (grant no. 2012-PG-MED002 to A.S.), National Cancer Institute Cancer Center Support grant P30 (CA014195 MASS core, A.S.), Dr. Frederick Paulsen Chair/Ferring Pharmaceuticals (A.S.), a Hewitt Foundation for Medical Research Fellowship (to W.H.P.), a Chapman Charitable Trust Fellowship (to M.J.K.), UCSD Medical Scientist Training Program funding (T32 GM007198 to M.J.K.) and an Irving S. Sigal postdoctoral fellowship from the American Chemical Society (to S.S.K.).	Adibekian A, 2012, J AM CHEM SOC, V134, P10345, DOI 10.1021/ja303400u; Adibekian A, 2011, NAT CHEM BIOL, V7, P469, DOI [10.1038/NCHEMBIO.579, 10.1038/nchembio.579]; Bachovchin DA, 2010, P NATL ACAD SCI USA, V107, P20941, DOI 10.1073/pnas.1011663107; Berger Alicia B, 2004, Am J Pharmacogenomics, V4, P371, DOI 10.2165/00129785-200404060-00004; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Cognetta AB, 2015, CHEM BIOL, V22, P928, DOI 10.1016/j.chembiol.2015.05.018; Dodson G, 1998, TRENDS BIOCHEM SCI, V23, P347, DOI 10.1016/S0968-0004(98)01254-7; Ekici OD, 2008, PROTEIN SCI, V17, P2023, DOI 10.1110/ps.035436.108; Elias M, 2012, J BIOL CHEM, V287, P11, DOI 10.1074/jbc.R111.257329; Gerlt JA, 2011, BIOCHEMISTRY-US, V50, P9950, DOI 10.1021/bi201312u; HIGA HH, 1987, BIOCHEM BIOPH RES CO, V144, P1099, DOI 10.1016/0006-291X(87)91425-2; Hoover HS, 2008, BIOORG MED CHEM LETT, V18, P5838, DOI 10.1016/j.bmcl.2008.06.091; Hsu KL, 2012, NAT CHEM BIOL, V8, P999, DOI [10.1038/NCHEMBIO.1105, 10.1038/nchembio.1105]; Jessani N, 2005, NAT METHODS, V2, P691, DOI 10.1038/NMETH778; Jessani N, 2005, ANGEW CHEM INT EDIT, V44, P2400, DOI 10.1002/anie.200463098; Kamat SS, 2015, NAT CHEM BIOL, V11, P164, DOI [10.1038/NCHEMBIO.1721, 10.1038/nchembio.1721]; Kidd D, 2001, BIOCHEMISTRY-US, V40, P4005, DOI 10.1021/bi002579j; Liu YS, 1999, P NATL ACAD SCI USA, V96, P14694, DOI 10.1073/pnas.96.26.14694; Lone AM, 2011, J AM CHEM SOC, V133, P11665, DOI 10.1021/ja2036095; Long JZ, 2011, CHEM REV, V111, P6022, DOI 10.1021/cr200075y; Lupu C, 2011, BLOOD, V118, P4463, DOI 10.1182/blood-2011-05-355370; Nguyen MTN, 2015, ACS CHEM BIOL, V10, P2423, DOI 10.1021/acschembio.5b00693; Niphakis MJ, 2014, ANNU REV BIOCHEM, V83, P341, DOI 10.1146/annurev-biochem-060713-035708; Nomura DK, 2011, CHEM BIOL, V18, P846, DOI 10.1016/j.chembiol.2011.05.009; Patricelli MP, 2001, PROTEOMICS, V1, P1067, DOI 10.1002/1615-9861(200109)1:9<1067::AID-PROT1067>3.0.CO;2-4; Rath A, 2009, P NATL ACAD SCI USA, V106, P1760, DOI 10.1073/pnas.0813167106; Seo J, 2001, MOL CELLS, V11, P35; Sherratt AR, 2012, BIOCHEMISTRY-US, V51, P7794, DOI 10.1021/bi301087c; Simon GM, 2010, J BIOL CHEM, V285, P11051, DOI 10.1074/jbc.R109.097600; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Strisovsky K, 2016, FEBS J, V283, P1837, DOI 10.1111/febs.13638; Tully SE, 2010, J AM CHEM SOC, V132, P3264, DOI 10.1021/ja1000505; Urban S, 2001, CELL, V107, P173, DOI 10.1016/S0092-8674(01)00525-6; Vosyka O, 2013, P NATL ACAD SCI USA, V110, P2472, DOI 10.1073/pnas.1215076110; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Weerapana E, 2010, NATURE, V468, P790, DOI 10.1038/nature09472; Willems LI, 2014, BIOCONJUGATE CHEM, V25, P1181, DOI 10.1021/bc500208y; Wolfe MS, 2009, J BIOL CHEM, V284, P13969, DOI 10.1074/jbc.R800039200; Wu Gang, 2011, Front Biosci (Elite Ed), V3, P834; Yore MM, 2014, CELL, V159, P318, DOI 10.1016/j.cell.2014.09.035	40	46	46	2	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAY	2016	12	5					367	+		10.1038/NCHEMBIO.2051	http://dx.doi.org/10.1038/NCHEMBIO.2051			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DJ6KY	27018888	Green Accepted, Green Submitted			2022-12-25	WOS:000374322800012
J	Oakes, CC; Seifert, M; Assenovl, Y; Gu, L; Przekopowitz, M; Ruppert, AS; Wang, Q; Imbusch, CD; Serva, A; Koser, SD; Brocks, D; Lipka, DB; Bogatyrova, O; Weichenhan, D; Brors, B; Rassenti, L; Kipp, TJ; Mertens, D; Zapatka, M; Lichter, P; Dohner, H; Kuppers, R; Zenz, T; Stilgenbauer, S; Byrd, JC; Plass, C				Oakes, Christopher C.; Seifert, Marc; Assenovl, Yassen; Gu, Lei; Przekopowitz, Martina; Ruppert, Amy S.; Wang, Qi; Imbusch, Charles D.; Serva, Andrius; Koser, Sandra D.; Brocks, David; Lipka, Daniel B.; Bogatyrova, Olga; Weichenhan, Dieter; Brors, Benedikt; Rassenti, Laura; Kipp, Thomas J.; Mertens, Daniel; Zapatka, Marc; Lichter, Peter; Doehner, Hartmut; Kueppers, Ralf; Zenz, Thorsten; Stilgenbauer, Stephan; Byrd, John C.; Plass, Christoph			DNA methylation dynamics during B cell maturation underlie a continuum of disease phenotypes in chronic lymphocytic leukemia	NATURE GENETICS			English	Article							CHROMATIN STATE DYNAMICS; TRANSCRIPTION FACTORS; MUTATIONS; METHYLOME; REVEALS; GENES; CLL; ACTIVATION; EVOLUTION; PROLIFERATION	Charting differences between tumors and normal tissue is a mainstay of cancer research. However, clonal tumor expansion from complex normal tissue architectures potentially obscures cancer-specific events, including divergent epigenetic patterns. Using whole-genome bisulfite sequencing of normal B cell subsets, we observed broad epigenetic programming of selective transcription factor binding sites coincident with the degree of B cell maturation. By comparing normal B cells to malignant B cells from 268 patients with chronic lymphocytic leukemia (CLL), we showed that tumors derive largely from a continuum of maturation states reflected in normal developmental stages. Epigenetic maturation in CLL was associated with an indolent gene expression pattern and increasingly favorable clinical outcomes. We further uncovered that most previously reported tumor specific methylation events are normally present in non-malignant B cells. Instead, we identified a potential pathogenic role for transcription factor dysregulation in CLL, where excess programming by EGR and NFAT with reduced EBF and AP-1 programming imbalances the normal B cell epigenetic program.	[Oakes, Christopher C.; Assenovl, Yassen; Brocks, David; Lipka, Daniel B.; Bogatyrova, Olga; Weichenhan, Dieter; Plass, Christoph] German Canc Res Ctr, Div Epigen & Canc Risk Factors, Heidelberg, Germany; [Seifert, Marc; Przekopowitz, Martina] Univ Duisburg Essen, Inst Cell Biol Canc Res, Essen, Germany; [Gu, Lei] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA USA; [Gu, Lei] Boston Childrens Hosp, Div Newborn Med, Boston, MA USA; [Ruppert, Amy S.; Byrd, John C.] Ohio State Univ, Dept Internal Med, Div Hematol, Columbus, OH 43210 USA; [Wang, Qi; Imbusch, Charles D.; Koser, Sandra D.; Brors, Benedikt] German Canc Res Ctr, Div Theoret Bioinformat, Heidelberg, Germany; [Wang, Qi; Imbusch, Charles D.; Koser, Sandra D.; Brors, Benedikt] German Canc Res Ctr, Div Appl Bioinformat, Heidelberg, Germany; [Serva, Andrius; Zapatka, Marc; Lichter, Peter] German Canc Res Ctr, Div Mol Genet, Heidelberg, Germany; [Rassenti, Laura; Kipp, Thomas J.] Univ Calif San Diego, Moores Canc Ctr, Dept Med, La Jolla, CA 92093 USA; [Mertens, Daniel; Stilgenbauer, Stephan] German Canc Res Ctr, Cooperat Unit Mech Leukemogenesis, Heidelberg, Germany; [Mertens, Daniel; Doehner, Hartmut] Univ Ulm, Dept Internal Med 3, D-89069 Ulm, Germany; [Zenz, Thorsten] Natl Ctr Tumor Dis NCT, Dept Translat Oncol, Heidelberg, Germany; [Zenz, Thorsten] German Canc Res Ctr, Heidelberg, Germany; [Zenz, Thorsten] Heidelberg Univ, Dept Med 5, Heidelberg, Germany; [Oakes, Christopher C.; Lichter, Peter] Ohio State Univ, Dept Internal Med, Div Hematol, Columbus, OH 43210 USA	Helmholtz Association; German Cancer Research Center (DKFZ); University of Duisburg Essen; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; University System of Ohio; Ohio State University; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); University of California System; University of California San Diego; Helmholtz Association; German Cancer Research Center (DKFZ); Ulm University; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; University System of Ohio; Ohio State University	Oakes, CC; Plass, C (corresponding author), German Canc Res Ctr, Div Epigen & Canc Risk Factors, Heidelberg, Germany.; Oakes, CC (corresponding author), Ohio State Univ, Dept Internal Med, Div Hematol, Columbus, OH 43210 USA.	christopher.oakes@osumc.edu; c.plass@dkfz.de	Mertens, Daniel/F-4681-2011; Stilgenbauer, Stephan/ABE-6609-2020; Brors, Benedikt/E-5620-2013; Döhner, Hartmut/C-8933-2016; Oakes, Christopher C/H-7288-2014; Zapatka, Marc/G-9896-2013; Gu, Lei/GWQ-6785-2022	Mertens, Daniel/0000-0003-0227-7188; Brors, Benedikt/0000-0001-5940-3101; Döhner, Hartmut/0000-0003-2116-5536; Oakes, Christopher C/0000-0001-8000-9694; Zapatka, Marc/0000-0001-8287-5967; Brauser, Martina/0000-0003-4704-8215; Wang, Qi/0000-0002-6420-1720; Kuppers, Ralf/0000-0002-6691-7191	Imaging Center Essen (IMCES); Else Kroner Fresenius Stiftung [2012_A146]; Virtual Helmholtz Institute [VH-VI-404]; Deutsche Forschungsgemeinschaft [SFB 1074, GKR1431, SE1885/2-1, B1, B2]; DKFZ-Heidelberg Center for Personalized Oncology (DKFZ-HIPO); German Cancer Consortium (DKTK); CLL Research Consortium (CRC); German Federal Ministry of Education and Research CancerEpiSys network [BMBF 031 6049C]; Leukemia and Lymphoma Society [P01 CA081534]; Four Winds Foundation; European Union's Seventh Framework Programme through the Blueprint Consortium; German Ministry of Education and Research (BMBF) through the ICGC MMML-Seq Project [01KU1002A-J]; US National Institutes of Health [PO1-CA81534]; NATIONAL CANCER INSTITUTE [P01CA081534] Funding Source: NIH RePORTER	Imaging Center Essen (IMCES); Else Kroner Fresenius Stiftung; Virtual Helmholtz Institute; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); DKFZ-Heidelberg Center for Personalized Oncology (DKFZ-HIPO); German Cancer Consortium (DKTK); CLL Research Consortium (CRC); German Federal Ministry of Education and Research CancerEpiSys network; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Four Winds Foundation; European Union's Seventh Framework Programme through the Blueprint Consortium; German Ministry of Education and Research (BMBF) through the ICGC MMML-Seq Project; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We would like to thank the Genomics and Proteomics Core Facility at the German Cancer Research Center, in particular R. Fisher and M. Schick for their excellent technical support and expertise. We thank Imaging Center Essen (IMCES) for support in B cell sorting. We are grateful to M. Bahr, O. Mucke, M. Helf and S. Ohl for technical support. We also thank J. Edelmann, M. Seiffert, L. Sellner, B. Wu, V. Hovestadt, A. Kundaje and J.I. Martin-Subero for providing sample, data and/or analytical tools. S.S. is supported by the Else Kroner Fresenius Stiftung (2012_A146), the Virtual Helmholtz Institute (VH-VI-404) and the Deutsche Forschungsgemeinschaft (SFB 1074 projects B1 and B2). This work was supported in part by the Helmholtz Association, from the DKFZ-Heidelberg Center for Personalized Oncology (DKFZ-HIPO), the German Cancer Consortium (DKTK), the CLL Research Consortium (CRC), the German Federal Ministry of Education and Research CancerEpiSys network (BMBF 031 6049C), the Virtual Helmholtz Institute (VH-VI-404), the Deutsche Forschungsgemeinschaft (GKR1431 and SE1885/2-1), the Leukemia and Lymphoma Society (P01 CA081534), the Four Winds Foundation, the European Union's Seventh Framework Programme through the Blueprint Consortium, the German Ministry of Education and Research (BMBF) through the ICGC MMML-Seq Project (01KU1002A-J) and the US National Institutes of Health (PO1-CA81534).	Andersson R, 2014, NATURE, V507, P455, DOI 10.1038/nature12787; Cabezas-Wallscheid N, 2014, CELL STEM CELL, V15, P507, DOI 10.1016/j.stem.2014.07.005; Cahill N, 2013, LEUKEMIA, V27, P150, DOI 10.1038/leu.2012.245; Chen LG, 2008, BLOOD, V111, P2685, DOI 10.1182/blood-2006-12-062265; Claus R, 2014, BLOOD, V124, P42, DOI 10.1182/blood-2014-02-555722; Damm F, 2014, CANCER DISCOV, V4, P1088, DOI 10.1158/2159-8290.CD-14-0104; Dvinge H, 2014, P NATL ACAD SCI USA, V111, P16802, DOI 10.1073/pnas.1413374111; Edelmann J, 2012, BLOOD, V120, P4783, DOI 10.1182/blood-2012-04-423517; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Ferreira PG, 2014, GENOME RES, V24, P212, DOI 10.1101/gr.152132.112; Florean C, 2011, EPIGENOMICS-UK, V3, P581, DOI [10.2217/EPI.11.73, 10.2217/epi.11.73]; Garrett-Sinha LA, 1999, IMMUNITY, V10, P399, DOI 10.1016/S1074-7613(00)80040-0; Gururajan M, 2008, J IMMUNOL, V181, P4590, DOI 10.4049/jimmunol.181.7.4590; Gustems M, 2014, NUCLEIC ACIDS RES, V42, P3059, DOI 10.1093/nar/gkt1323; Heltemes-Harris LM, 2011, J EXP MED, V208, P1135, DOI 10.1084/jem.20101947; Herishanu Y, 2011, BLOOD, V117, P563, DOI 10.1182/blood-2010-05-284984; Kasowski M, 2013, SCIENCE, V342, P750, DOI 10.1126/science.1242510; Klein U, 1998, J EXP MED, V188, P1679, DOI 10.1084/jem.188.9.1679; Klein U, 2001, J EXP MED, V194, P1625, DOI 10.1084/jem.194.11.1625; Kretzmer H, 2015, NAT GENET, V47, P1316, DOI 10.1038/ng.3413; Kulis M, 2015, NAT GENET, V47, P746, DOI 10.1038/ng.3291; Kulis M, 2012, NAT GENET, V44, P1236, DOI 10.1038/ng.2443; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Lai AY, 2013, GENOME RES, V23, P2030, DOI 10.1101/gr.155473.113; Landau DA, 2014, CANCER CELL, V26, P813, DOI 10.1016/j.ccell.2014.10.012; Landau DA, 2013, CELL, V152, P714, DOI 10.1016/j.cell.2013.01.019; Lara-Astiaso D, 2014, SCIENCE, V345, P943, DOI 10.1126/science.1256271; Lebecque S, 1997, J EXP MED, V185, P563, DOI 10.1084/jem.185.3.563; Mockridge CI, 2007, BLOOD, V109, P4424, DOI 10.1182/blood-2006-11-056648; Oakes CC, 2014, CANCER DISCOV, V4, P348, DOI 10.1158/2159-8290.CD-13-0349; Pekarsky Y, 2008, P NATL ACAD SCI USA, V105, P19643, DOI 10.1073/pnas.0810965105; Peng SL, 2001, IMMUNITY, V14, P13, DOI 10.1016/S1074-7613(01)00085-1; Prange KHM, 2014, EXP HEMATOL, V42, P637, DOI 10.1016/j.exphem.2014.04.012; Puente XS, 2011, NATURE, V475, P101, DOI 10.1038/nature10113; Queiros AC, 2015, LEUKEMIA, V29, P598, DOI 10.1038/leu.2014.252; Reindl L, 2010, BRIT J HAEMATOL, V151, P25, DOI 10.1111/j.1365-2141.2010.08299.x; Rosen A, 2010, SEMIN CANCER BIOL, V20, P400, DOI 10.1016/j.semcancer.2010.09.004; Schubeler D, 2015, NATURE, V517, P321, DOI 10.1038/nature14192; Seifert M, 2012, J EXP MED, V209, P2183, DOI 10.1084/jem.20120833; Shaknovich R, 2011, BLOOD, V118, P3559, DOI 10.1182/blood-2011-06-357996; Smith EN, 2015, BLOOD CANCER J, V5, DOI 10.1038/bcj.2015.14; Smith ZD, 2013, NAT REV GENET, V14, P204, DOI 10.1038/nrg3354; Sturm D, 2012, CANCER CELL, V22, P425, DOI 10.1016/j.ccr.2012.08.024; Teschendorff AE, 2010, GENOME RES, V20, P440, DOI 10.1101/gr.103606.109; Pham TH, 2012, BLOOD, V119, pE161, DOI 10.1182/blood-2012-01-402453; Timp W, 2013, NAT REV CANCER, V13, P497, DOI 10.1038/nrc3486; Wang Q, 2013, NAT PROTOC, V8, P2022, DOI 10.1038/nprot.2013.118; Zandi S, 2008, J IMMUNOL, V181, P3364, DOI 10.4049/jimmunol.181.5.3364; ZHUANG Y, 1994, CELL, V79, P875, DOI 10.1016/0092-8674(94)90076-0; Ziller MJ, 2013, NATURE, V500, P477, DOI 10.1038/nature12433	50	193	194	0	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2016	48	3					253	264		10.1038/ng.3488	http://dx.doi.org/10.1038/ng.3488			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DE8QW	26780610	Green Accepted			2022-12-25	WOS:000370902600009
J	Dotiwala, F; Mulik, S; Polidoro, RB; Ansara, JA; Burleigh, BA; Walchs, M; Gazzinelli, RT; Lieberman, J				Dotiwala, Farokh; Mulik, Sachin; Polidoro, Rafael B.; Ansara, James A.; Burleigh, Barbara A.; Walchs, Michael; Gazzinelli, Ricardo T.; Lieberman, Judy			Killer lymphocytes use granulysin, perforin and granzymes to kill intracellular parasites	NATURE MEDICINE			English	Article							CD8(+) T-CELLS; TRYPANOSOMA-CRUZI; GLUTATHIONE; PEROXIDASE; IMMUNITY; LESSONS; DEATH; MICE	Protozoan infections are a serious global health problem(1,2). Natural killer (NK) cells and cytolytic T lymphocytes (CTLs) eliminate pathogen-infected cells by releasing cytolytic granule contents granzyme (Gzm) proteases and the pore-forming perforin (PFN)-into the infected cell(3). However, these cytotoxic molecules do not kill intracellular parasites. CD8(+) CTLs protect against parasite infections in mice primarily by secreting interferon (IFN)-gamma(4-10). However, human, but not rodent, cytotoxic granules contain the antimicrobial peptide granulysin (GNLY), which selectively destroys cholesterol poor microbial membranes(11-14), and GNLY, PFN and Gzms rapidly kill intracellular bacteria(15). Here we show that GNLY delivers Gzms into three protozoan parasites (Trypanosoma cruzi, Toxoplasma gondii and Leishmania major), in which the Gzms generate superoxide and inactivate oxidative defense enzymes to kill the parasite. PFN delivers GNLY and Gzms into infected cells, and GNLY then delivers Gzms to the intracellular parasites. Killer cell-mediated parasite death, which we term 'microbe-programmed cell death' or 'microptosis', is caspase independent but resembles mammalian apoptosis, causing mitochondria! swelling, transmembrane potential dissipation, membrane blebbing, phosphatidylserine exposure, DNA damage and chromatin condensation. GNLY-transgenic mice are protected against infection by T. cruzi and T. gondii, and survive infections that are lethal to wild-type mice. Thus, GNLY-, PFN- and Gzm-mediated elimination of intracellular protozoan parasites is an unappreciated immune defense mechanism.	[Dotiwala, Farokh; Mulik, Sachin; Polidoro, Rafael B.; Ansara, James A.; Lieberman, Judy] Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA USA; [Dotiwala, Farokh; Mulik, Sachin; Polidoro, Rafael B.; Lieberman, Judy] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Polidoro, Rafael B.; Gazzinelli, Ricardo T.] Fundacao Oswaldo Cruz, Ctr Pesquisas Rene Rachou, Belo Horizonte, MG, Brazil; [Burleigh, Barbara A.; Gazzinelli, Ricardo T.] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, 665 Huntington Ave, Boston, MA 02115 USA; [Walchs, Michael] Univ Fribourg, Dept Med, CH-1700 Fribourg, Switzerland; [Gazzinelli, Ricardo T.] Univ Massachusetts, Sch Med, Dept Med, Worcester, MA USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Harvard Medical School; Fundacao Oswaldo Cruz; Harvard University; Harvard T.H. Chan School of Public Health; University of Fribourg; University of Massachusetts System; University of Massachusetts Worcester	Dotiwala, F; Lieberman, J (corresponding author), Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA USA.; Dotiwala, F; Lieberman, J (corresponding author), Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA.; Gazzinelli, RT (corresponding author), Fundacao Oswaldo Cruz, Ctr Pesquisas Rene Rachou, Belo Horizonte, MG, Brazil.; Gazzinelli, RT (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, 665 Huntington Ave, Boston, MA 02115 USA.; Gazzinelli, RT (corresponding author), Univ Massachusetts, Sch Med, Dept Med, Worcester, MA USA.	farokh.dotiwala@childrens.harvard.edu; ricardo.gazzinelli@umassmed.edu; jbdy.lieberman@childrens.harvard.edu	Polidoro, Rafael Barbosa/A-6385-2016; Dotiwala, Farokh/S-5367-2019; Lieberman, Judy/A-2717-2015	Polidoro, Rafael Barbosa/0000-0003-2982-0072; Dotiwala, Farokh/0000-0002-7387-2219; Walch, Michael/0000-0001-7284-3291; Gazzinelli, Ricardo/0000-0003-2427-7699; MULIK, SACHIN/0000-0003-2568-3402	US National Institutes of Health [T32HL066987]; Coordenacao de Aperfeicoamento de Pessoal de Ensino Superior (CAPES); David Rockefeller Center for Latin American Studies at Harvard University; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Brazilian National Institute of Science and Technology for Vaccines [CNPq/Fapemig/MS 573547/2008-4]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL066987] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Coordenacao de Aperfeicoamento de Pessoal de Ensino Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); David Rockefeller Center for Latin American Studies at Harvard University; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brazilian National Institute of Science and Technology for Vaccines; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the US National Institutes of Health grant T32HL066987 (F.D.), a Scholar Fellowship from Coordenacao de Aperfeicoamento de Pessoal de Ensino Superior (CAPES) and the David Rockefeller Center for Latin American Studies at Harvard University (R.T.G.), a Science Without Borders Scholar Fellowship from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) (R.B.P.) and the Brazilian National Institute of Science and Technology for Vaccines grant CNPq/Fapemig/MS 573547/2008-4 (R.T.G.). We thank S. Wilkinson (Queen Mary University, London) and J. Kelly (London School of Hygiene and Tropical Medicine) for T. cruzi overexpression plasmids, K. Okuda (University of Massachusetts Medical School) for L. major, K. Engelberg and M.J. Gubbels (Boston College) for T gondii, and M. Ericsson and R. Bronson (Harvard Medical School) for technical support.	Belkaid Y, 2002, J IMMUNOL, V168, P3992, DOI 10.4049/jimmunol.168.8.3992; Beresford PJ, 1999, IMMUNITY, V10, P585, DOI 10.1016/S1074-7613(00)80058-8; Chowdhury D, 2008, ANNU REV IMMUNOL, V26, P389, DOI 10.1146/annurev.immunol.26.021607.090404; de Alencar BCG, 2009, INFECT IMMUN, V77, P4383, DOI 10.1128/IAI.01459-08; Ernst WA, 2000, J IMMUNOL, V165, P7102, DOI 10.4049/jimmunol.165.12.7102; Gigley Jason P, 2011, J Parasitol Res, V2011, P243796, DOI 10.1155/2011/243796; Hotez PJ, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002865; Huang LP, 2007, J IMMUNOL, V178, P77, DOI 10.4049/jimmunol.178.1.77; Junqueira C, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001560; Overstreet MG, 2008, IMMUNOL REV, V225, P272, DOI 10.1111/j.1600-065X.2008.00671.x; Piacenza L, 2008, BIOCHEM J, V410, P359, DOI 10.1042/BJ20071138; Piacenza L, 2007, BIOCHEM J, V403, P323, DOI 10.1042/BJ20061281; Rodrigues MM, 2003, AN ACAD BRAS CIENC, V75, P443, DOI 10.1590/S0001-37652003000400005; Stenger S, 1998, SCIENCE, V282, P121, DOI 10.1126/science.282.5386.121; TARLETON RL, 1992, NATURE, V356, P338, DOI 10.1038/356338a0; Van Braeckel-Budimir N, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00272; Walch M, 2014, CELL, V157, P1309, DOI 10.1016/j.cell.2014.03.062; Wilkinson SM, 2002, J BIOL CHEM, V277, P17062, DOI 10.1074/jbc.M111126200; Wilkinson SR, 2002, BIOCHEM J, V364, P787, DOI 10.1042/BJ20020038	20	118	122	0	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2016	22	2					210	216		10.1038/nm.4023	http://dx.doi.org/10.1038/nm.4023			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DC8JX	26752517	Green Submitted, Green Accepted			2022-12-25	WOS:000369466800015
J	Peng, YJ				Peng, Yaojin			The patentability of human embryonic stem cell technology in China	NATURE BIOTECHNOLOGY			English	Editorial Material								Although China has in the past decade been reluctant to grant patents on human embryonic stem cell technology, it has recently changed its patent policy to loosen some restrictions.	[Peng, Yaojin] Maastricht Univ, IGIR, NL-6200 MD Maastricht, Netherlands	Maastricht University	Peng, YJ (corresponding author), Maastricht Univ, IGIR, NL-6200 MD Maastricht, Netherlands.	yaojin.peng@hotmail.com						[Anonymous], 1990, EPO Technical Board of Appeal 3.3.02. T19/90, Patent No. 25050; Bonetta L, 2008, CELL, V132, P514, DOI 10.1016/j.cell.2008.02.012; *DEP EX BUS MAN SI, 2006, AN INTRODUCTION TO T, V2, P220; Department of Examination and Business Management of the SIPO, 2006, INTELLECTUAL PROPERT, P220; EDWARDS RG, 1980, BRIT J OBSTET GYNAEC, V87, P737, DOI 10.1111/j.1471-0528.1980.tb04610.x; *EPO TECHN BOARD, 1990, T1990 EPO TECHN BOAR, P3; Hansson MG, 2007, STEM CELLS, V25, P1507, DOI 10.1634/stemcells.2006-0684; SIPO, 2010, TITLE ERROR; SIPO, 2012, Patent Reexamination Board, Patent No. [FS46359, 17820]; SIPO, 2009, FS4237, Patent No. FS17820; SIPO, 2010, CHINESE INTELLECTUAL, Patent No. FS25050; SIPO, 2010, AGREEMENT ON TRADE R; SIPO, 2010, GUIDELINES FOR PATEN; The Law Department of the SIPO, 2001, GUIDELINES FOR PATEN, P27; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; WTO, 1994, TITLE ERROR; 2012, Patent No. 46359	17	5	9	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2016	34	1					37	39		10.1038/nbt.3417	http://dx.doi.org/10.1038/nbt.3417			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DB8HQ	26744976				2022-12-25	WOS:000368758200021
J	Stokes, JM; Brown, ED				Stokes, Jonathan M.; Brown, Eric D.			Chemical modulators of ribosome biogenesis as biological probes	NATURE CHEMICAL BIOLOGY			English	Article							ESCHERICHIA-COLI RIBOSOMES; VANADYL RIBONUCLEOSIDE COMPLEX; QUANTITATIVE MASS-SPECTROMETRY; STAPHYLOCOCCUS-AUREUS CELLS; GTP-BINDING PROTEIN; AAA-ATPASE DRG1; SUBUNIT FORMATION; QUALITY-CONTROL; 30S SUBUNIT; ERYTHROMYCIN INHIBITION	Small-molecule inhibitors of protein biosynthesis have been instrumental in the dissection of the complexities of ribosome structure and function. Ribosome biogenesis, on the other hand, is a complex and largely enigmatic process for which there is a paucity of chemical probes. Indeed, ribosome biogenesis has been studied almost exclusively using genetic and biochemical approaches without the benefit of small-molecule inhibitors of this process. Here, we provide a perspective on the promise of chemical inhibitors of ribosome assembly for future research. We explore key obstacles that complicate the interpretation of studies aimed at perturbing ribosome biogenesis in vivo using genetic methods, and we argue that chemical inhibitors are especially powerful because they can be used to induce perturbations in a manner that obviates these difficulties. Thus, in combination with leading-edge biochemical and structural methods, chemical probes offer unique advantages toward elucidating the molecular events that define the assembly of ribosomes.	[Stokes, Jonathan M.; Brown, Eric D.] McMaster Univ, Dept Biochem & Biomed Sci, Michael G DeGroote Inst Infect Dis Res, Hamilton, ON L8N 3Z5, Canada	McMaster University	Stokes, JM (corresponding author), McMaster Univ, Dept Biochem & Biomed Sci, Michael G DeGroote Inst Infect Dis Res, Hamilton, ON L8N 3Z5, Canada.	ebrown@mcmaster.ca			Natural Sciences and Engineering Research Council of Canada; Canada Research Chairs program; Canadian Institutes of Health Research; Ontario Graduate Scholarships program	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Research Chairs program(Canada Research Chairs); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Graduate Scholarships program	This work was supported by the Natural Sciences and Engineering Research Council of Canada (Discovery Grant to E.D.B.), by a salary award to E.D.B. from the Canada Research Chairs program, and by scholarships awarded to J.M.S. from the Canadian Institutes of Health Research and the Ontario Graduate Scholarships program.	Adilakshmi T, 2008, NATURE, V455, P1268, DOI 10.1038/nature07298; Armistead J, 2014, FEBS LETT, V588, P1491, DOI 10.1016/j.febslet.2014.03.024; Arrowsmith CH, 2015, NAT CHEM BIOL, V11, P536, DOI 10.1038/nchembio.1867; BAKIN A, 1993, BIOCHEMISTRY-US, V32, P9754, DOI 10.1021/bi00088a030; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Bassler J, 2001, MOL CELL, V8, P517, DOI 10.1016/S1097-2765(01)00342-2; Bharat A, 2014, FEMS MICROBIOL LETT, V353, P26, DOI 10.1111/1574-6968.12403; Bharat A, 2013, J BIOMOL SCREEN, V18, P830, DOI 10.1177/1087057113486001; Bremer H, 1996, ESCHERICHIA COLI SAL; Britton RA, 1998, MOL MICROBIOL, V27, P739, DOI 10.1046/j.1365-2958.1998.00719.x; Britton RA, 2009, ANNU REV MICROBIOL, V63, P155, DOI 10.1146/annurev.micro.091208.073225; Bunner AE, 2010, P NATL ACAD SCI USA, V107, P5417, DOI 10.1073/pnas.0912007107; Bunner AE, 2008, ANAL CHEM, V80, P9379, DOI 10.1021/ac8020505; Bywater MJ, 2012, CANCER CELL, V22, P51, DOI 10.1016/j.ccr.2012.05.019; Campbell TL, 2008, J BACTERIOL, V190, P2537, DOI 10.1128/JB.01744-07; Champney W. Scott, 2006, Infectious Disorders - Drug Targets, V6, P377; Champney WS, 1996, ANTIMICROB AGENTS CH, V40, P1301, DOI 10.1128/AAC.40.5.1301; Champney WS, 1998, CURR MICROBIOL, V36, P119, DOI 10.1007/s002849900290; Champney WS, 2000, ANTIMICROB AGENTS CH, V44, P1413, DOI 10.1128/AAC.44.6.1413-1417.2000; Charollais J, 2004, NUCLEIC ACIDS RES, V32, P2751, DOI 10.1093/nar/gkh603; Chen SS, 2013, J MOL BIOL, V425, P767, DOI 10.1016/j.jmb.2012.11.040; Chen SS, 2012, MOL BIOSYST, V8, P3325, DOI 10.1039/c2mb25310k; Cheng ZF, 2003, P NATL ACAD SCI USA, V100, P6388, DOI 10.1073/pnas.1231041100; Cole SE, 2009, MOL CELL, V34, P440, DOI 10.1016/j.molcel.2009.04.017; CUMBERLIDGE AG, 1979, J MOL BIOL, V131, P169, DOI 10.1016/0022-2836(79)90072-X; DAMMEL CS, 1995, GENE DEV, V9, P626, DOI 10.1101/gad.9.5.626; Davies BW, 2010, MOL MICROBIOL, V78, P506, DOI 10.1111/j.1365-2958.2010.07351.x; Decatur WA, 2002, TRENDS BIOCHEM SCI, V27, P344, DOI 10.1016/S0968-0004(02)02109-6; Deisenroth C, 2010, ONCOGENE, V29, P4253, DOI 10.1038/onc.2010.189; Drygin D, 2011, CANCER RES, V71, P1418, DOI 10.1158/0008-5472.CAN-10-1728; Drygin D, 2009, CANCER RES, V69, P7653, DOI 10.1158/0008-5472.CAN-09-1304; Falconer SB, 2011, NAT CHEM BIOL, V7, P416, DOI [10.1038/nchembio.590, 10.1038/NCHEMBIO.590]; Frazier AD, 2013, CURR MICROBIOL, V67, P226, DOI 10.1007/s00284-013-0350-5; Frazier AD, 2012, J ANTIMICROB CHEMOTH, V67, P2152, DOI 10.1093/jac/dks182; Gadal O, 2002, J CELL BIOL, V157, P941, DOI 10.1083/jcb.200111039; Ghalei H, 2015, J CELL BIOL, V208, P745, DOI 10.1083/jcb.201409056; GHORA BK, 1979, J BIOL CHEM, V254, P1951; GINSBURG D, 1975, J BIOL CHEM, V250, P5647; GOLLOP N, 1991, J BACTERIOL, V173, P2265, DOI 10.1128/JB.173.7.2265-2270.1991; Golovina AY, 2010, BIOCHIMIE, V92, P914, DOI 10.1016/j.biochi.2010.03.012; Grandi P, 2002, MOL CELL, V10, P105, DOI 10.1016/S1097-2765(02)00579-8; Green R, 1996, RNA, V2, P1011; Himeno H, 2004, NUCLEIC ACIDS RES, V32, P5303, DOI 10.1093/nar/gkh861; Holmes KL, 2005, J MOL BIOL, V354, P340, DOI 10.1016/j.jmb.2005.09.056; HOSOKAWA K, 1966, P NATL ACAD SCI USA, V55, P198, DOI 10.1073/pnas.55.1.198; Huang XW, 2007, J PEPT SCI, V13, P220, DOI 10.1002/psc.835; Inoue K, 2003, MOL MICROBIOL, V48, P1005, DOI 10.1046/j.1365-2958.2003.03475.x; Jacob AI, 2013, MOL CELL, V49, P427, DOI 10.1016/j.molcel.2012.11.025; Johnson AW, 2002, TRENDS BIOCHEM SCI, V27, P580, DOI 10.1016/S0968-0004(02)02208-9; Jomaa A, 2011, RNA, V17, P2026, DOI 10.1261/rna.2922311; Kaczanowska M, 2007, MICROBIOL MOL BIOL R, V71, P477, DOI 10.1128/MMBR.00013-07; Kappel L, 2012, J CELL BIOL, V199, P771, DOI 10.1083/jcb.201205021; Karbstein K, 2007, BIOPOLYMERS, V87, P1, DOI 10.1002/bip.20762; Karbstein K, 2013, TRENDS CELL BIOL, V23, P242, DOI 10.1016/j.tcb.2013.01.004; Kim H, 2014, NATURE, V506, P334, DOI 10.1038/nature13039; Klostermeier D, 2004, NUCLEIC ACIDS RES, V32, P2707, DOI 10.1093/nar/gkh588; KUSHNER SR, 1977, P NATL ACAD SCI USA, V74, P467, DOI 10.1073/pnas.74.2.467; Leonov AA, 2003, J BIOL CHEM, V278, P25664, DOI 10.1074/jbc.M302873200; LERNER CG, 1991, MOL MICROBIOL, V5, P951, DOI 10.1111/j.1365-2958.1991.tb00770.x; Lewis K, 2013, NAT REV DRUG DISCOV, V12, P371, DOI 10.1038/nrd3975; Li ZW, 1999, EMBO J, V18, P2878, DOI 10.1093/emboj/18.10.2878; LINDAHL L, 1975, J MOL BIOL, V92, P15, DOI 10.1016/0022-2836(75)90089-3; LINDAHL L, 1973, NATURE-NEW BIOL, V243, P170, DOI 10.1038/newbio243170a0; Loibl M, 2014, J BIOL CHEM, V289, P3913, DOI 10.1074/jbc.M113.536110; MACDONAL.RE, 1967, P NATL ACAD SCI USA, V57, P141, DOI 10.1073/pnas.57.1.141; Maguire BA, 2009, MICROBIOL MOL BIOL R, V73, P22, DOI 10.1128/MMBR.00030-08; McGaha SM, 2007, ANTIMICROB AGENTS CH, V51, P591, DOI 10.1128/AAC.01116-06; MIZUSHIMA S, 1970, NATURE, V226, P1214, DOI 10.1038/2261214a0; Moreno JMP, 1999, FEBS LETT, V455, P130, DOI 10.1016/S0014-5793(99)00858-3; Mulder AM, 2010, SCIENCE, V330, P673, DOI 10.1126/science.1193220; NIERHAUS KH, 1991, BIOCHIMIE, V73, P739, DOI 10.1016/0300-9084(91)90054-5; NIERHAUS KH, 1974, P NATL ACAD SCI USA, V71, P4713, DOI 10.1073/pnas.71.12.4713; NIKOLAEV N, 1973, J BIOL CHEM, V248, P7967; NISHI K, 1988, NATURE, V336, P496, DOI 10.1038/336496a0; Pertschy B, 2004, MOL CELL BIOL, V24, P6476, DOI 10.1128/MCB.24.14.6476-6487.2004; Pertschy B, 2007, MOL CELL BIOL, V27, P6581, DOI 10.1128/MCB.00668-07; Rasmussen LCV, 2007, MICROB CELL FACT, V6, DOI 10.1186/1475-2859-6-24; ROHL R, 1982, P NATL ACAD SCI-BIOL, V79, P729, DOI 10.1073/pnas.79.3.729; Saveanu C, 2003, MOL CELL BIOL, V23, P4449, DOI 10.1128/MCB.23.13.4449-4460.2003; Sayed A, 1999, BIOCHEM BIOPH RES CO, V264, P51, DOI 10.1006/bbrc.1999.1471; Shajani Z, 2011, ANNU REV BIOCHEM, V80, P501, DOI 10.1146/annurev-biochem-062608-160432; Sharma MR, 2005, MOL CELL, V18, P319, DOI 10.1016/j.molcel.2005.03.028; Siibak T, 2011, MOL MICROBIOL, V80, P54, DOI 10.1111/j.1365-2958.2011.07555.x; Siibak T, 2009, ANTIMICROB AGENTS CH, V53, P563, DOI 10.1128/AAC.00870-08; Silvers JA, 2005, ARCH MICROBIOL, V184, P66, DOI 10.1007/s00203-005-0017-0; SIRDESHMUKH R, 1985, NUCLEIC ACIDS RES, V13, P5041, DOI 10.1093/nar/13.14.5041; Stokes JM, 2015, ANTIMICROB AGENTS CH, V59, P2918, DOI 10.1128/AAC.04690-14; Stokes JM, 2014, ELIFE, V3, DOI 10.7554/eLife.03574; Strunk BS, 2012, CELL, V150, P111, DOI 10.1016/j.cell.2012.04.044; Strunk BS, 2011, SCIENCE, V333, P1449, DOI 10.1126/science.1208245; Sykes MT, 2010, J MOL BIOL, V403, P331, DOI 10.1016/j.jmb.2010.08.005; TAI PC, 1969, J BACTERIOL, V97, P1298, DOI 10.1128/JB.97.3.1298-1304.1969; TISSIERES A, 1958, NATURE, V182, P778, DOI 10.1038/182778b0; TRAUB P, 1969, J MOL BIOL, V40, P391, DOI 10.1016/0022-2836(69)90161-2; Usary J, 2001, MOL MICROBIOL, V40, P951, DOI 10.1046/j.1365-2958.2001.02438.x; Williamson JR, 2005, Q REV BIOPHYS, V38, P397, DOI 10.1017/S0033583506004264; Wilson DN, 2014, NAT REV MICROBIOL, V12, P35, DOI 10.1038/nrmicro3155; Wilson DN, 2009, CRIT REV BIOCHEM MOL, V44, P393, DOI 10.3109/10409230903307311; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; Woolford JL, 2013, GENETICS, V195, P643, DOI 10.1534/genetics.113.153197; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089	101	13	13	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2015	11	12					924	932		10.1038/nchembio.1957	http://dx.doi.org/10.1038/nchembio.1957			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX6TG	26575239				2022-12-25	WOS:000365834000009
J	Choi, J; Lee, S; Mallard, W; Clement, K; Tagliazucchi, GM; Lim, H; Choi, IY; Ferrari, F; Tsankov, AM; Pop, R; Lee, G; Rinn, JL; Meissner, A; Park, PJ; Hochedlinger, K				Choi, Jiho; Lee, Soohyun; Mallard, William; Clement, Kendell; Tagliazucchi, Guidantonio Malagoli; Lim, Hotae; Choi, In Young; Ferrari, Francesco; Tsankov, Alexander M.; Pop, Ramona; Lee, Gabsang; Rinn, John L.; Meissner, Alexander; Park, Peter J.; Hochedlinger, Konrad			A comparison of genetically matched cell lines reveals the equivalence of human iPSCs and ESCs	NATURE BIOTECHNOLOGY			English	Article							PLURIPOTENT STEM-CELLS; HISTONE DEACETYLASE SIRT6; EXPRESSION; GENERATION; SIGNATURES; INDUCTION; GENES	The equivalence of human induced pluripotent stem cells (hiPSCs) and human embryonic stem cells (hESCs) remains controversial. Here we use genetically matched hESC and hiPSC lines to assess the contribution of cellular origin (hESC vs. hiPSC), the Sendai virus (SeV) reprogramming method and genetic background to transcriptional and DNA methylation patterns while controlling for cell line clonality and sex. We find that transcriptional and epigenetic variation originating from genetic background dominates over variation due to cellular origin or SeV infection. Moreover, the 49 differentially expressed genes we detect between genetically matched hESCs and hiPSCs neither predict functional outcome nor distinguish an independently derived, larger set of unmatched hESC and hiPSC lines. We conclude that hESCs and hiPSCs are molecularly and functionally equivalent and cannot be distinguished by a consistent gene expression signature. Our data further imply that genetic background variation is a major confounding factor for transcriptional and epigenetic comparisons of pluripotent cell lines, explaining some of the previously observed differences between genetically unmatched hESCs and hiPSCs.	[Choi, Jiho; Hochedlinger, Konrad] Massachusetts Gen Hosp, Dept Mol Biol, Ctr Canc, Boston, MA 02114 USA; [Choi, Jiho; Hochedlinger, Konrad] Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA; [Choi, Jiho; Clement, Kendell; Tsankov, Alexander M.; Pop, Ramona; Meissner, Alexander; Hochedlinger, Konrad] Harvard Stem Cell Inst, Cambridge, MA USA; [Choi, Jiho; Hochedlinger, Konrad] Howard Hughes Med Inst, Chevy Chase, MD USA; [Lee, Soohyun; Tagliazucchi, Guidantonio Malagoli; Ferrari, Francesco; Park, Peter J.] Harvard Univ, Sch Med, Dept Biomed Informat, Boston, MA 02114 USA; [Mallard, William; Clement, Kendell; Tsankov, Alexander M.; Pop, Ramona; Rinn, John L.; Meissner, Alexander] Broad Inst MIT & Harvard, Cambridge, MA USA; [Mallard, William; Clement, Kendell; Tsankov, Alexander M.; Pop, Ramona; Rinn, John L.; Meissner, Alexander] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Tagliazucchi, Guidantonio Malagoli] Univ Modena & Reggio Emilia, Dept Life Sci, Ctr Genome Res, Modena, Italy; [Lim, Hotae; Choi, In Young; Lee, Gabsang] Johns Hopkins Univ, Sch Med, Dept Neurol, Inst Cell Engn,Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA; [Rinn, John L.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Universita di Modena e Reggio Emilia; Johns Hopkins University; Harvard University; Beth Israel Deaconess Medical Center	Park, PJ (corresponding author), Harvard Univ, Sch Med, Dept Biomed Informat, Boston, MA 02114 USA.	peter_park@harvard.edu; khochedlinger@helix.mgh.harvard.edu	Tagliazucch, Guidantonio Malagoli/E-5026-2018; Ferrari, Francesco/H-5007-2012; Clement, Kendell/AAZ-6854-2021	Tagliazucch, Guidantonio Malagoli/0000-0001-5581-4851; Ferrari, Francesco/0000-0002-9811-3753; Rinn, John/0000-0002-7231-7539; Park, Peter/0000-0001-9378-960X; Choi, Jiho/0000-0001-8839-4056; Lee, Soohyun/0000-0002-3594-6213	New York Stem Cell Foundation; Maryland Stem Cell Research Fund (TEDCO); US National Institutes of Health (NIH) grant [P01GM099117]; Howard Hughes Medical Institute (HHMI); MGH startup funds; Gerald and Darlene Jordan Endowed Chair for Regenerative Medicine; NIH [P01GM099117]; Vranos Family Graduate Research Fellowship in Developmental & Regenerative Biology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM099117] Funding Source: NIH RePORTER	New York Stem Cell Foundation; Maryland Stem Cell Research Fund (TEDCO); US National Institutes of Health (NIH) grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute); MGH startup funds; Gerald and Darlene Jordan Endowed Chair for Regenerative Medicine; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vranos Family Graduate Research Fellowship in Developmental & Regenerative Biology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Hochedlinger and Park laboratories for productive discussions and a critical reading of the manuscript. We also thank M. Stadtfeld for his helpful discussions and D. Melton for his generous donation of HUES2 and HUES3 lines. We are grateful to K. Folz-Donahue, M. Weglarz and L. Prickett at the Massachusetts General Hospital (MGH)/Harvard Stem Cell Institute (HSCI) flow cytometry core for their constant assistance and support. We are also thankful to the members of the Tufts Genomics Core for performing RNA-seq. Work in the Lee laboratory was supported by grants from the Robertson Investigator Award of the New York Stem Cell Foundation and from the Maryland Stem Cell Research Fund (TEDCO). A. M. and J.L.R. are supported by US National Institutes of Health (NIH) grant P01GM099117. A. M. is a New York Stem Cell Foundation Robertson Investigator. Parts of this work were supported by the Howard Hughes Medical Institute (HHMI), MGH startup funds, the Gerald and Darlene Jordan Endowed Chair for Regenerative Medicine (to K.H.) and a pilot grant from the NIH (P01GM099117 to K.H.). J.C. was supported by the Vranos Family Graduate Research Fellowship in Developmental & Regenerative Biology.	Abyzov A, 2012, NATURE, V492, P438, DOI 10.1038/nature11629; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Anguera MC, 2012, CELL STEM CELL, V11, P75, DOI 10.1016/j.stem.2012.03.008; Bock C, 2011, CELL, V144, P439, DOI 10.1016/j.cell.2010.12.032; Boyle P, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-10-R92, 10.1186/gb-2012-13-10-r92]; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Chin MH, 2010, CELL STEM CELL, V7, P263, DOI 10.1016/j.stem.2010.06.019; Chin MH, 2009, CELL STEM CELL, V5, P111, DOI 10.1016/j.stem.2009.06.008; Cohen DR, 2000, MECH DEVELOP, V91, P317, DOI 10.1016/S0925-4773(99)00263-4; Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330; Dunn JC, 1974, J CYBERNETICS, V4, P95, DOI [DOI 10.1080/01969727408546059, 10.1080/01969727408546059]; EVERSE J, 1973, ADV ENZYMOL RAMB, V37, P61; Fantin VR, 2006, CANCER CELL, V9, P425, DOI 10.1016/j.ccr.2006.04.023; Flicek P, 2014, NUCLEIC ACIDS RES, V42, pD749, DOI 10.1093/nar/gkt1196; Fusaki N, 2009, P JPN ACAD B-PHYS, V85, P348, DOI 10.2183/pjab.85.348; Girirajan S, 2013, AM J HUM GENET, V92, P221, DOI 10.1016/j.ajhg.2012.12.016; Guenther MG, 2010, CELL STEM CELL, V7, P249, DOI 10.1016/j.stem.2010.06.015; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Humpherys D, 2001, SCIENCE, V293, P95, DOI 10.1126/science.1061402; Koyanagi-Aoi M, 2013, P NATL ACAD SCI USA, V110, P20569, DOI 10.1073/pnas.1319061110; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee S, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0704-z; Loewer S, 2010, NAT GENET, V42, P1113, DOI 10.1038/ng.710; Maherali N, 2008, CELL STEM CELL, V3, P340, DOI 10.1016/j.stem.2008.08.003; Mai V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020647; Mallon BS, 2014, STEM CELL RES, V12, P376, DOI 10.1016/j.scr.2013.11.010; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; Matsumoto K, 2004, NAT NEUROSCI, V7, P605, DOI 10.1038/nn1249; MUECKLER M, 1985, SCIENCE, V229, P941, DOI 10.1126/science.3839598; Newman AM, 2010, CELL STEM CELL, V7, P258, DOI 10.1016/j.stem.2010.06.016; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Phanstiel DH, 2011, NAT METHODS, V8, P821, DOI [10.1038/NMETH.1699, 10.1038/nmeth.1699]; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rouhani F, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004432; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Ruiz S, 2012, P NATL ACAD SCI USA, V109, P16196, DOI 10.1073/pnas.1202352109; Sebastian C, 2012, CELL, V151, P1185, DOI 10.1016/j.cell.2012.10.047; Soldner F, 2011, CELL, V146, P318, DOI 10.1016/j.cell.2011.06.019; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Stadtfeld M, 2012, NAT GENET, V44, P398, DOI 10.1038/ng.1110; Stadtfeld M, 2010, NATURE, V465, P175, DOI 10.1038/nature09017; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tchieu J, 2010, CELL STEM CELL, V7, P329, DOI 10.1016/j.stem.2010.06.024; Teichroeb JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023436; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Tsankov AM, 2015, NAT BIOTECHNOL, V33, P1182, DOI 10.1038/nbt.3387; Wang C, 2014, NAT BIOTECHNOL, V32, P926, DOI 10.1038/nbt.3001; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang XQ, 2010, CELL STEM CELL, V7, P90, DOI 10.1016/j.stem.2010.04.017; Zhang Y, 2013, P NATL ACAD SCI USA, V110, P12361, DOI 10.1073/pnas.1309725110; Zhao SR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0078644; Zhong L, 2010, CELL, V140, P280, DOI 10.1016/j.cell.2009.12.041; Zhou WY, 2012, EMBO J, V31, P2103, DOI 10.1038/emboj.2012.71	55	162	171	0	47	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2015	33	11					1173	U102		10.1038/nbt.3388	http://dx.doi.org/10.1038/nbt.3388			11	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CW3TY	26501951	Green Accepted, Green Submitted			2022-12-25	WOS:000364916000025
J	Morgan, B; Van Laer, K; Owusu, TNE; Ezerina, D; Pastor-Flores, D; Amponsah, PS; Tursch, A; Dick, TP				Morgan, Bruce; Van Laer, Koen; Owusu, Theresa N. E.; Ezerina, Daria; Pastor-Flores, Daniel; Amponsah, Prince Saforo; Tursch, Anja; Dick, Tobias P.			Real-time monitoring of basal H2O2 levels with peroxiredoxin-based probes	NATURE CHEMICAL BIOLOGY			English	Article							HYDROGEN-PEROXIDE; OXIDATIVE STRESS; REDOX; MAINTENANCE; EXPRESSION; GROWTH; GENES	Genetically encoded probes based on the H2O2-sensing proteins OxyR and Orp1 have greatly increased the ability to detect elevated H2O2 levels in stimulated or stressed cells. However, these proteins are not sensitive enough to monitor metabolic H2O2 baseline levels. Using yeast as a platform for probe development, we developed two peroxiredoxinbased H2O2 probes, roGFP2-Tsa2 Delta C-R and roGFP2-Tsa2 Delta C-P Delta C-R, that afford such sensitivity. These probes are similar to 50% oxidized under 'normal' unstressed conditions and are equally responsive to increases and decreases in H2O2. Hence, they permit fully dynamic, real-time measurement of basal H2O2 levels, with subcellular resolution, in living cells. We demonstrate that expression of these probes does not alter endogenous H2O2 homeostasis. The roGFP2-Tsa2 Delta C-R probe revealed real-time interplay between basal H2O2 levels and partial oxygen pressure. Furthermore, it exposed asymmetry in H2O2 trafficking between the cytosol and mitochondrial matrix and a strong correlation between matrix H2O2 levels and cellular growth rate.	[Morgan, Bruce; Van Laer, Koen; Owusu, Theresa N. E.; Ezerina, Daria; Pastor-Flores, Daniel; Amponsah, Prince Saforo; Tursch, Anja; Dick, Tobias P.] German Canc Res Ctr, Div Redox Regulat, DKFZ ZMBH Alliance, Heidelberg, Germany; [Morgan, Bruce] Univ Kaiserslautern, Cellular Biochem, D-67663 Kaiserslautern, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); University of Kaiserslautern	Morgan, B; Dick, TP (corresponding author), German Canc Res Ctr, Div Redox Regulat, DKFZ ZMBH Alliance, Heidelberg, Germany.; Morgan, B (corresponding author), Univ Kaiserslautern, Cellular Biochem, D-67663 Kaiserslautern, Germany.	morgan@bio.uni-kl.de; t.dick@dkfz.de	Ezerina, Daria/ABH-9010-2020; Ezeriņa, Daria/GXM-5832-2022	Ezerina, Daria/0000-0002-3104-7093; Ezeriņa, Daria/0000-0002-3104-7093; Morgan, Bruce/0000-0001-9393-1071; Amponsah, Prince Saforo/0000-0002-5891-5823; Tursch, Anja/0000-0002-4456-4882	German Research Foundation (DFG) Priority Program (SPP) [1710]; DFG Collaborative Research Center (SFB) [1036]; DKFZ	German Research Foundation (DFG) Priority Program (SPP); DFG Collaborative Research Center (SFB)(German Research Foundation (DFG)); DKFZ(Helmholtz Association)	We acknowledge funding from the German Research Foundation (DFG) Priority Program (SPP) 1710 and the DFG Collaborative Research Center (SFB) 1036 to T.P.D., and a DKFZ visiting scientist fellowship to B.M.	Belousov VV, 2006, NAT METHODS, V3, P281, DOI 10.1038/NMETH866; Bilan DS, 2016, ANTIOXID REDOX SIGN, V24, P731, DOI 10.1089/ars.2015.6586; Bode M, 2013, ANTIOXID REDOX SIGN, V18, P1597, DOI 10.1089/ars.2012.4685; Davidson JF, 2001, MOL CELL BIOL, V21, P8483, DOI 10.1128/MCB.21.24.8483-8489.2001; Delaunay A, 2002, CELL, V111, P471, DOI 10.1016/S0092-8674(02)01048-6; Ezerina D, 2014, J MOL CELL CARDIOL, V73, P43, DOI 10.1016/j.yjmcc.2013.12.023; Ferrer-Sueta G, 2011, CHEM RES TOXICOL, V24, P434, DOI 10.1021/tx100413v; Finkel T, 2011, J CELL BIOL, V194, P7, DOI 10.1083/jcb.201102095; Fomenko DE, 2011, P NATL ACAD SCI USA, V108, P2729, DOI 10.1073/pnas.1010721108; Fujikawa Y, 2013, OXIDATIVE STRESRED, P119; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Gomes F, 2013, BIOCHEM J, V449, P595, DOI 10.1042/BJ20121432; Gutsche M, 2009, J BIOL CHEM, V284, P31532, DOI 10.1074/jbc.M109.059246; Gutscher M, 2008, NAT METHODS, V5, P553, DOI [10.1038/nmeth.1212, 10.1038/NMETH.1212]; Hall A, 2009, FEBS J, V276, P2469, DOI 10.1111/j.1742-4658.2009.06985.x; Han HY, 1998, BIOCHEM BIOPH RES CO, V243, P816, DOI 10.1006/bbrc.1997.8132; Huang BK, 2014, REDOX BIOL, V2, P955, DOI 10.1016/j.redox.2014.08.001; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; LUDESCHER C, 1992, BRIT J HAEMATOL, V82, P161, DOI 10.1111/j.1365-2141.1992.tb04608.x; Merz S, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r95; Meyer AJ, 2010, ANTIOXID REDOX SIGN, V13, P621, DOI 10.1089/ars.2009.2948; Morgan B, 2013, NAT CHEM BIOL, V9, P119, DOI [10.1038/nchembio.1142, 10.1038/NCHEMBIO.1142]; Morgan B, 2011, FREE RADICAL BIO MED, V51, P1943, DOI 10.1016/j.freeradbiomed.2011.08.035; Peskin AV, 2007, J BIOL CHEM, V282, P11885, DOI 10.1074/jbc.M700339200; Rhee SG, 2006, SCIENCE, V312, P1882, DOI 10.1126/science.1130481; Schroder E, 2000, STRUCTURE, V8, P605, DOI 10.1016/S0969-2126(00)00147-7; Schwarzlander M, 2016, ANTIOXID REDOX SIGN, V24, P680, DOI 10.1089/ars.2015.6266; Sies H, 2014, J BIOL CHEM, V289, P8735, DOI 10.1074/jbc.R113.544635; Sobotta MC, 2015, NAT CHEM BIOL, V11, P64, DOI 10.1038/nchembio.1695; Sobotta MC, 2013, FREE RADICAL BIO MED, V60, P325, DOI 10.1016/j.freeradbiomed.2013.02.017; Stone JR, 2006, ANTIOXID REDOX SIGN, V8, P243, DOI 10.1089/ars.2006.8.243	31	130	132	2	70	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUN	2016	12	6					437	U95		10.1038/NCHEMBIO.2067	http://dx.doi.org/10.1038/NCHEMBIO.2067			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DM2EW	27089028				2022-12-25	WOS:000376160600014
J	Benakis, C; Brea, D; Caballero, S; Faraco, G; Moore, J; Murphy, M; Sita, G; Racchumi, G; Lingo, L; Pamer, EG; Iadecola, C; Anrather, J				Benakis, Corinne; Brea, David; Caballero, Silvia; Faraco, Giuseppe; Moore, Jamie; Murphy, Michelle; Sita, Giulia; Racchumi, Gianfranco; Lingo, Lilan; Pamer, Eric G.; Iadecola, Costantino; Anrather, Josef			Commensal microbiota affects ischemic stroke outcome by regulating intestinal gamma delta T cells	NATURE MEDICINE			English	Article							BRAIN; PROTECTS; TRAFFICKING; POPULATION; EXPRESSION; RESPONSES; RECEPTOR; SYSTEM; INJURY; MOUSE	Commensal gut bacteria impact the host immune system and can influence disease processes in several organs, including the brain. However, it remains unclear whether the microbiota has an impact on the outcome of acute brain injury. Here we show that antibiotic-induced alterations in the intestinal flora reduce ischemic brain injury in mice, an effect transmissible by fecal transplants. Intestinal dysbiosis alters immune homeostasis in the small intestine, leading to an increase in regulatory T cells and a reduction in interleukin (IL)-17 positive gamma delta T cells through altered dendritic cell activity. Dysbiosis suppresses trafficking of effector T cells from the gut to the leptomeninges after stroke. Additionally, IL-10 and IL-17 are required for the neuroprotection afforded by intestinal dysbiosis. The findings reveal a previously unrecognized gut-brain axis and an impact of the intestinal flora and meningeal IL-17(+) gamma delta T cells on ischemic injury.	[Benakis, Corinne; Brea, David; Faraco, Giuseppe; Moore, Jamie; Murphy, Michelle; Sita, Giulia; Racchumi, Gianfranco; Iadecola, Costantino; Anrather, Josef] Weill Cornell Med Coll, Fell Family Brain & Mind Res Inst, New York, NY USA; [Caballero, Silvia; Pamer, Eric G.] Mem Sloan Kettering Canc Ctr, Immunol Program, 1275 York Ave, New York, NY 10021 USA; [Caballero, Silvia; Pamer, Eric G.] Mem Sloan Kettering Canc Ctr, Infect Dis Serv, 1275 York Ave, New York, NY 10021 USA; [Caballero, Silvia; Pamer, Eric G.] Weill Cornell Grad Sch Med Sci, Immunol & Microbial Pathogenesis Program, New York, NY USA; [Lingo, Lilan; Pamer, Eric G.] Mem Sloan Kettering Canc Ctr, Lucille Castor Ctr Microbes Inflammat & Canc, 1275 York Ave, New York, NY 10021 USA	Cornell University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Memorial Sloan Kettering Cancer Center	Anrather, J (corresponding author), Weill Cornell Med Coll, Fell Family Brain & Mind Res Inst, New York, NY USA.	joa2006@med.cornell.edu	Brea López, David/M-1128-2015; Sita, Giulia/K-2533-2019; Iadecola, c/ABB-8377-2020; Faraco, Giuseppe/AAP-6784-2020	Brea López, David/0000-0003-2365-7374; Sita, Giulia/0000-0001-6627-7078; Faraco, Giuseppe/0000-0001-8675-4580; Iadecola, Costantino/0000-0001-9797-073X	Finbar and Marianne Kenny Research Scholarship; US National Institutes of Health (NIH) [NS081179, NS34179]; Feil Family Foundation; Swiss National Science Foundation for Grants in Biology and Medicine [P3SMP3 148367]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS081179, R01NS034179] Funding Source: NIH RePORTER	Finbar and Marianne Kenny Research Scholarship; US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Feil Family Foundation; Swiss National Science Foundation for Grants in Biology and Medicine; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	J.A. is the recipient of the Finbar and Marianne Kenny Research Scholarship. Parts of the study were supported by the US National Institutes of Health (NIH) grants NS081179 (J.A.) and NS34179 (C.I. and J.A.), the Feil Family Foundation (C.I.) and the Swiss National Science Foundation for Grants in Biology and Medicine (P3SMP3 148367; C.B.). We thank A.-K. Hadjantonakis (Memorial Sloan Kettering Cancer Center) for helpful discussions on the use of the KikGR33 mice.	Abraham C, 2009, INFLAMM BOWEL DIS, V15, P1090, DOI 10.1002/ibd.20894; Braniste V, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009759; Chaudhry A, 2009, SCIENCE, V326, P986, DOI 10.1126/science.1172702; Cho S, 2005, J NEUROSCI, V25, P2504, DOI 10.1523/JNEUROSCI.0035-05.2005; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Engelhardt B, 2005, TRENDS IMMUNOL, V26, P485, DOI 10.1016/j.it.2005.07.004; Erbel C, 2011, BASIC RES CARDIOL, V106, P125, DOI 10.1007/s00395-010-0135-y; Gelderblom M, 2012, BLOOD, V120, P3793, DOI 10.1182/blood-2012-02-412726; Henninger N, 2010, EXPERT REV CARDIOVAS, V8, P1389, DOI 10.1586/ERC.10.128; Hu XM, 2013, STROKE, V44, pE85, DOI 10.1161/STROKEAHA.113.001267; Huber S, 2011, IMMUNITY, V34, P554, DOI 10.1016/j.immuni.2011.01.020; Iadecola C, 2011, NAT MED, V17, P796, DOI 10.1038/nm.2399; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Justicia C, 2003, J CEREBR BLOOD F MET, V23, P1430, DOI 10.1097/01.WCB.0000090680.07515.C8; Keller JJ, 2015, INT J COLORECTAL DIS, V30, P645, DOI 10.1007/s00384-015-2132-y; Kleinschnitz C, 2013, STROKE, V44, pE87, DOI 10.1161/STROKEAHA.113.001268; Kleinschnitz C, 2013, BLOOD, V121, P679, DOI 10.1182/blood-2012-04-426734; Kleinschnitz C, 2010, BLOOD, V115, P3835, DOI 10.1182/blood-2009-10-249078; Kostulas N, 1999, STROKE, V30, P2174, DOI 10.1161/01.STR.30.10.2174; Kunz A, 2007, J NEUROSCI, V27, P7083, DOI 10.1523/JNEUROSCI.1645-07.2007; Li GZ, 2005, SCAND J IMMUNOL, V62, P481, DOI 10.1111/j.1365-3083.2005.01683.x; Li PY, 2013, ANN NEUROL, V74, P458, DOI 10.1002/ana.23815; Liesz A, 2015, STROKE, V46, P1422, DOI 10.1161/STROKEAHA.114.008608; Liesz A, 2009, NAT MED, V15, P192, DOI 10.1038/nm.1927; Louveau A, 2015, NATURE, V523, P337, DOI 10.1038/nature14432; Macrez R, 2011, LANCET NEUROL, V10, P471, DOI 10.1016/S1474-4422(11)70066-7; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; Morton AM, 2014, P NATL ACAD SCI USA, V111, P6696, DOI 10.1073/pnas.1405634111; Niess JH, 2005, SCIENCE, V307, P254, DOI 10.1126/science.1102901; Nishio J, 2012, CELL MOL LIFE SCI, V69, P3635, DOI 10.1007/s00018-012-0993-6; Nowotschin S, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-49; Ochoa-Reparaz J, 2010, MUCOSAL IMMUNOL, V3, P487, DOI 10.1038/mi.2010.29; Park SG, 2010, IMMUNITY, V33, P791, DOI 10.1016/j.immuni.2010.10.014; Perez-de-Puig I, 2015, ACTA NEUROPATHOL, V129, P239, DOI 10.1007/s00401-014-1381-0; Prinz I, 2013, EUR J IMMUNOL, V43, P1988, DOI 10.1002/eji.201343759; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; Roth TL, 2014, NATURE, V505, P223, DOI 10.1038/nature12808; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Scott CL, 2011, TRENDS IMMUNOL, V32, P412, DOI 10.1016/j.it.2011.06.003; Shichita T, 2009, NAT MED, V15, P946, DOI 10.1038/nm.1999; Singh S, 2015, NAT REV GASTRO HEPAT, V12, P26, DOI 10.1038/nrgastro.2014.202; Stowe AM, 2009, NEUROBIOL DIS, V35, P82, DOI 10.1016/j.nbd.2009.04.006; Stubbe T, 2013, J CEREBR BLOOD F MET, V33, P37, DOI 10.1038/jcbfm.2012.128	43	515	554	17	215	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2016	22	5					516	523		10.1038/nm.4068	http://dx.doi.org/10.1038/nm.4068			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DL3DI	27019327	Green Accepted			2022-12-25	WOS:000375514000014
J	Lien, EC; Lyssiotis, CA; Juvekar, A; Hu, H; Asara, JM; Cantley, LC; Toker, A				Lien, Evan C.; Lyssiotis, Costas A.; Juvekar, Ashish; Hu, Hai; Asara, John M.; Cantley, Lewis C.; Toker, Alex			Glutathione biosynthesis is a metabolic vulnerability in PI(3)K/Akt-driven breast cancer	NATURE CELL BIOLOGY			English	Article							QUANTITATIVE-DETERMINATION; GROWTH; CELLS; ANTIOXIDANT; NRF2; EXPRESSION; MUTATION; DEATH; MTOR; AKT1	Cancer cells often select for mutations that enhance signalling through pathways that promote anabolic metabolism(1). Although the PI(3)K/Akt signalling pathway, which is frequently dysregulated in breast cancer(2), is a well-established regulator of central glucose metabolism and aerobic glycolysis(3,4), its regulation of other metabolic processes required for tumour growth is not well defined. Here we report that in mammary epithelial cells, oncogenic PI(3)K/Akt stimulates glutathione (GSH) biosynthesis by stabilizing and activating NRF2 to upregulate the GSH biosynthetic genes. Increased NRF2 stability is dependent on the Akt-mediated accumulation of p21(Cip1/WAF1) and GSK-3 beta inhibition. Consistently, in human breast tumours, upregulation of NRF2 targets is associated with PI(3)K pathway mutation status and oncogenic Akt activation. Elevated GSH biosynthesis is required for PI(3)K/Akt-driven resistance to oxidative stress, initiation of tumour spheroids, and anchorage-independent growth. Furthermore, inhibition of GSH biosynthesis with buthionine sulfoximine synergizes with cisplatin to selectively induce tumour regression in PI(3)K pathway mutant breast cancer cells, both in vitro and in vivo. Our findings provide insight into GSH biosynthesis as a metabolic vulnerability associated with PI(3)K pathway mutant breast cancers.	[Lien, Evan C.; Toker, Alex] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Pathol, Boston, MA 02215 USA; [Lyssiotis, Costas A.] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Lyssiotis, Costas A.] Univ Michigan, Div Gastroenterol, Dept Internal Med, Ann Arbor, MI 48109 USA; [Juvekar, Ashish; Hu, Hai] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Hematol & Oncol, Boston, MA 02215 USA; [Asara, John M.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Med, Boston, MA 02215 USA; [Asara, John M.; Toker, Alex] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Ctr Canc, Boston, MA 02215 USA; [Cantley, Lewis C.] Weill Cornell Med Coll, Dept Med, New York, NY 10065 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Cornell University	Toker, A (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Pathol, Boston, MA 02215 USA.; Toker, A (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Ctr Canc, Boston, MA 02215 USA.	atoker@bidmc.harvard.edu	Lyssiotis, Costas A/AAI-1923-2019	Lyssiotis, Costas A/0000-0001-9309-6141; Lien, Evan/0000-0001-7866-4761	NATIONAL CANCER INSTITUTE [P01CA120964, P30CA006516, P30CA046592, R01CA177910] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041890] Funding Source: NIH RePORTER; NCI NIH HHS [P01 CA120964, P30 CA046592, R01 CA177910, P30 CA006516] Funding Source: Medline; NIGMS NIH HHS [R01 GM041890] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ben-Sahra I, 2013, SCIENCE, V339, P1323, DOI 10.1126/science.1228792; Carpten JD, 2007, NATURE, V448, P439, DOI 10.1038/nature05933; Chen Helen H. W., 2010, Metal-Based Drugs, P430939, DOI 10.1155/2010/430939; Chen WM, 2009, MOL CELL, V34, P663, DOI 10.1016/j.molcel.2009.04.029; Chin YR, 2014, CANCER DISCOV, V4, P942, DOI 10.1158/2159-8290.CD-13-0873; Dasari S, 2014, EUR J PHARMACOL, V740, P364, DOI 10.1016/j.ejphar.2014.07.025; De Nicola GM, 2011, NATURE, V475, P106, DOI 10.1038/nature10189; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Dixon SJ, 2012, CELL, V149, P1060, DOI 10.1016/j.cell.2012.03.042; Duvel K, 2010, MOL CELL, V39, P171, DOI 10.1016/j.molcel.2010.06.022; Elstrom RL, 2004, CANCER RES, V64, P3892, DOI 10.1158/0008-5472.CAN-03-2904; Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664; Gorrini C, 2013, NAT REV DRUG DISCOV, V12, P931, DOI 10.1038/nrd4002; Harris IS, 2015, CANCER CELL, V27, P211, DOI 10.1016/j.ccell.2014.11.019; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hutti JE, 2012, CANCER RES, V72, P3260, DOI 10.1158/0008-5472.CAN-11-4141; Jaramillo MC, 2013, GENE DEV, V27, P2179, DOI 10.1101/gad.225680.113; KANG YJ, 1991, CELL BIOL TOXICOL, V7, P249; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Lauring J, 2010, ONCOGENE, V29, P2337, DOI 10.1038/onc.2009.516; Li Y, 2002, J BIOL CHEM, V277, P11352, DOI 10.1074/jbc.M109062200; lngberg E., 2012, GEN COMP ENDOCR, V175, P188; Papa L, 2014, J BIOL CHEM, V289, P5412, DOI 10.1074/jbc.C113.526475; Rada P, 2011, MOL CELL BIOL, V31, P1121, DOI 10.1128/MCB.01204-10; Rhee SG, 2006, SCIENCE, V312, P1882, DOI 10.1126/science.1130481; Robey RB, 2009, SEMIN CANCER BIOL, V19, P25, DOI 10.1016/j.semcancer.2008.11.010; Salhia B, 2012, HUM MUTAT, V33, P1216, DOI 10.1002/humu.22100; Schafer ZT, 2009, NATURE, V461, P109, DOI 10.1038/nature08268; Somwar R, 2011, P NATL ACAD SCI USA, V108, P16375, DOI 10.1073/pnas.1113554108; Son J, 2013, NATURE, V496, P101, DOI 10.1038/nature12040; Sporn MB, 2012, NAT REV CANCER, V12, P564, DOI 10.1038/nrc3278; Stephens PJ, 2012, NATURE, V486, P400, DOI 10.1038/nature11017; TIETZE F, 1969, ANAL BIOCHEM, V27, P502, DOI 10.1016/0003-2697(69)90064-5; Tung NM, 2015, J CLIN ONCOL, V33, P969, DOI 10.1200/JCO.2014.59.6031; Vichai V, 2006, NAT PROTOC, V1, P1112, DOI 10.1038/nprot.2006.179; Watanabe Toshiyuki, 2003, J Toxicol Sci, V28, P455, DOI 10.2131/jts.28.455; Yang WS, 2014, CELL, V156, P317, DOI 10.1016/j.cell.2013.12.010; Yiu GK, 2006, J BIOL CHEM, V281, P12210, DOI 10.1074/jbc.M600184200; Yuan M, 2012, NAT PROTOC, V7, P872, DOI 10.1038/nprot.2012.024; Zhang L, 1999, CANCER LETT, V142, P129, DOI 10.1016/S0304-3835(99)00107-X	40	153	161	5	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAY	2016	18	5					572	+		10.1038/ncb3341	http://dx.doi.org/10.1038/ncb3341			52	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	DK3RH	27088857	Green Submitted, Green Accepted			2022-12-25	WOS:000374834600015
J	Yao, Y; Minor, PJ; Zhao, YT; Jeong, Y; Pani, AM; King, AN; Symmons, O; Gan, L; Cardoso, WV; Spitz, F; Lowe, CJ; Epstein, DJ				Yao, Yao; Minor, Paul J.; Zhao, Ying-Tao; Jeong, Yongsu; Pani, Ariel M.; King, Anna N.; Symmons, Orsolya; Gan, Lin; Cardoso, Wellington V.; Spitz, Francois; Lowe, Christopher J.; Epstein, Douglas J.			Cis-regulatory architecture of a brain signaling center predates the origin of chordates	NATURE GENETICS			English	Article							SONIC-HEDGEHOG; MOUSE GENOME; TRANSCRIPTION; EXPRESSION; REGIONALIZATION; FOREBRAIN; ENHANCERS; EVOLUTION; TELENCEPHALON; DROSOPHILA	Genomic approaches have predicted hundreds of thousands of tissue-specific cis-regulatory sequences, but the determinants critical to their function and evolutionary history are mostly unknown(1-4). Here we systematically decode a set of brain enhancers active in the zona limitans intrathalamica (zli), a signaling center essential for vertebrate forebrain development via the secreted morphogen Sonic hedgehog (Shh)(5,6). We apply a de novo motif analysis tool to identify six position-independent sequence motifs together with their cognate transcription factors that are essential for zli enhancer activity and Shh expression in the mouse embryo. Using knowledge of this regulatory lexicon, we discover new Shh zli enhancers in mice and a functionally equivalent element in hemichordates, indicating an ancient origin of the Shh zli regulatory network that predates the chordate phylum. These findings support a strategy for delineating functionally conserved enhancers in the absence of overt sequence homologies and over extensive evolutionary distances.	[Yao, Yao; Zhao, Ying-Tao; King, Anna N.; Epstein, Douglas J.] Univ Penn, Dept Genet, Perelman Sch Med, Philadelphia, PA 19104 USA; [Minor, Paul J.; Pani, Ariel M.; Lowe, Christopher J.] Stanford Univ, Dept Biol, Hopkins Marine Stn, Pacific Grove, CA USA; [Jeong, Yongsu] Kyung Hee Univ, Dept Genet Engn, Coll Life Sci, Yongin, South Korea; [Jeong, Yongsu] Kyung Hee Univ, Grad Sch Biotechnol, Yongin, South Korea; [Symmons, Orsolya; Spitz, Francois] European Mol Biol Lab, Dev Biol Unit, Heidelberg, Germany; [Gan, Lin] Univ Rochester, Med Ctr, Dept Ophthalmol, Rochester, NY 14642 USA; [Cardoso, Wellington V.] Columbia Univ, Dept Med, Columbia Ctr Human Dev, Pulm Allergy Crit Care,Med Ctr, New York, NY USA	University of Pennsylvania; Pennsylvania Medicine; Stanford University; Kyung Hee University; Kyung Hee University; European Molecular Biology Laboratory (EMBL); University of Rochester; Columbia University	Epstein, DJ (corresponding author), Univ Penn, Dept Genet, Perelman Sch Med, Philadelphia, PA 19104 USA.	epsteind@mail.med.upenn.edu	Symmons, Orsolya/AAZ-8219-2021; Zhao, Ying-Tao/L-2288-2016; Jeong, Yongsu/AAK-7397-2020	Symmons, Orsolya/0000-0003-2435-4236; Spitz, Francois/0000-0002-1960-829X; Zhao, Yingtao/0000-0003-3748-8428; King, Anna/0000-0002-3616-8943; Jeong, Yongsu/0000-0002-0008-9928; Lowe, Christopher/0000-0002-7789-8643; YAO, YAO/0000-0002-8851-7885	National Institutes of Health [R01 NS039421, R21 EY023104]; National Science Foundation [1258169]; Louis-Jeantet Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD055164] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R21EY023104] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL119836] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039421] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Louis-Jeantet Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank J. Richa and his staff at the Transgenic and Chimeric Mouse Facility (Perelman School of Medicine, University of Pennsylvania) for assistance with transgenic mouse generation. We also thank S. Liebhaber, K. Kaestner, C. Brown, K. Zaret and members of the Epstein laboratory for helpful discussions and comments on the manuscript. This work was funded by grants from the National Institutes of Health, R01 NS039421 (D.J.E.) and R21 EY023104 (L.G.), and the National Science Foundation, 1258169 (C.J.L.), and by a predoctoral fellowship from the Louis-Jeantet Foundation (O.S.).	Acampora D, 1997, DEVELOPMENT, V124, P3639; Arnold CD, 2014, NAT GENET, V46, P685, DOI 10.1038/ng.3009; Brown CD, 2007, SCIENCE, V317, P1557, DOI 10.1126/science.1145893; Busser BW, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002531; De Val S, 2008, CELL, V135, P1053, DOI 10.1016/j.cell.2008.10.049; Ding Q, 2009, J NEUROSCI, V29, P3992, DOI 10.1523/JNEUROSCI.5237-08.2009; Epstein DJ, 1999, DEVELOPMENT, V126, P281; Erives A, 2004, P NATL ACAD SCI USA, V101, P3851, DOI 10.1073/pnas.0400611101; Fernandez A, 2009, GENE DEV, V23, P2729, DOI 10.1101/gad.1824509; Fisher S, 2006, SCIENCE, V312, P276, DOI 10.1126/science.1124070; Frazer KA, 2003, GENOME RES, V13, P1, DOI 10.1101/gr.222003; Grant GR, 2011, BIOINFORMATICS, V27, P2518, DOI 10.1093/bioinformatics/btr427; Hare EE, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000106; Hebert JM, 2008, NAT REV NEUROSCI, V9, P678, DOI 10.1038/nrn2463; Holland PWH, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-47; Irimia M, 2012, SCI REP-UK, V2, DOI 10.1038/srep00433; Irimia M, 2010, EVODEVO, V1, DOI 10.1186/2041-9139-1-7; Jeong Y, 2011, DEVELOPMENT, V138, P531, DOI 10.1242/dev.058917; Jeong YS, 2006, DEVELOPMENT, V133, P761, DOI 10.1242/dev.02239; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Junion G, 2012, CELL, V148, P473, DOI 10.1016/j.cell.2012.01.030; Juraver-Geslin HA, 2014, DEV BIOL, V396, P107, DOI 10.1016/j.ydbio.2014.09.027; Kiecker C, 2004, NAT NEUROSCI, V7, P1242, DOI 10.1038/nn1338; Kratsios P, 2012, NAT NEUROSCI, V15, P205, DOI 10.1038/nn.2989; Liu-Chittenden Y, 2012, GENE DEV, V26, P1300, DOI 10.1101/gad.192856.112; Lowe CJ, 2006, PLOS BIOL, V4, P1603, DOI 10.1371/journal.pbio.0040291; Ludwig MZ, 2000, NATURE, V403, P564, DOI 10.1038/35000615; Mahoney JE, 2014, DEV CELL, V30, P137, DOI 10.1016/j.devcel.2014.06.003; Neph S, 2012, NATURE, V489, P83, DOI 10.1038/nature11212; Newburger DE, 2009, NUCLEIC ACIDS RES, V37, pD77, DOI 10.1093/nar/gkn660; Pani AM, 2012, NATURE, V483, P289, DOI 10.1038/nature10838; Pavesi G, 2004, NUCLEIC ACIDS RES, V32, pW199, DOI 10.1093/nar/gkh465; Pavesi Giulio, 2006, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0211s15; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Riccomagno MM, 2002, GENE DEV, V16, P2365, DOI 10.1101/gad.1013302; Rosenbluh J, 2012, CELL, V151, P1457, DOI 10.1016/j.cell.2012.11.026; Ruf S, 2011, NAT GENET, V43, P379, DOI 10.1038/ng.790; Sakurai Y, 2010, DEV BIOL, V347, P392, DOI 10.1016/j.ydbio.2010.08.028; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Scholpp S, 2007, DEVELOPMENT, V134, P3167, DOI 10.1242/dev.001461; Scholpp S, 2010, TRENDS NEUROSCI, V33, P373, DOI 10.1016/j.tins.2010.05.003; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; Shubin N, 2009, NATURE, V457, P818, DOI 10.1038/nature07891; Smith RP, 2013, NAT GENET, V45, P1021, DOI 10.1038/ng.2713; Suda Y, 2010, DEVELOPMENT, V137, P2939, DOI 10.1242/dev.048843; Sugahara F, 2011, DEVELOPMENT, V138, P1217, DOI 10.1242/dev.059360; Symmons O, 2014, GENOME RES, V24, P390, DOI 10.1101/gr.163519.113; Takatori N, 2002, MECH DEVELOP, V116, P235, DOI 10.1016/S0925-4773(02)00150-8; Vieira C, 2006, NEUROSCIENCE, V143, P129, DOI 10.1016/j.neuroscience.2006.08.032; Vierstra J, 2014, SCIENCE, V346, P1007, DOI 10.1126/science.1246426; Visel A, 2007, NUCLEIC ACIDS RES, V35, pD88, DOI 10.1093/nar/gkl822; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Yue F, 2014, NATURE, V515, P355, DOI 10.1038/nature13992; Zhao L, 2012, DEV CELL, V22, P585, DOI 10.1016/j.devcel.2011.12.023	55	40	40	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2016	48	5					575	+		10.1038/ng.3542	http://dx.doi.org/10.1038/ng.3542			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DK3RC	27064252	Green Accepted			2022-12-25	WOS:000374834100019
J	Kumar, A; Coleman, I; Morrissey, C; Zhang, XT; True, LD; Gulati, R; Etzioni, R; Bolouri, H; Montgomery, B; White, T; Lucas, JM; Brown, LG; Dumpit, RF; DeSarkar, N; Higano, C; Yu, EY; Coleman, R; Schultz, N; Fang, M; Lange, PH; Shendure, J; Vessella, RL; Nelson, PS				Kumar, Akash; Coleman, Ilsa; Morrissey, Colm; Zhang, Xiaotun; True, Lawrence D.; Gulati, Roman; Etzioni, Ruth; Bolouri, Hamid; Montgomery, Bruce; White, Thomas; Lucas, Jared M.; Brown, Lisha G.; Dumpit, Ruth F.; DeSarkar, Navonil; Higano, Celestia; Yu, Evan Y.; Coleman, Roger; Schultz, Nikolaus; Fang, Min; Lange, Paul H.; Shendure, Jay; Vessella, Robert L.; Nelson, Peter S.			Substantial interindividual and limited intraindividual genomic diversity among tumors from men with metastatic prostate cancer	NATURE MEDICINE			English	Article							COPY NUMBER; INTRATUMOR HETEROGENEITY; INCREASED SURVIVAL; ANDROGEN; RECEPTOR; CASTRATION; EXPRESSION; MUTATIONS; LANDSCAPE; CARCINOMA	Tumor heterogeneity may reduce the efficacy of molecularly guided systemic therapy for cancers that have metastasized. To determine whether the genomic alterations in a single metastasis provide a reasonable assessment of the major oncogenic drivers of other dispersed metastases in an individual, we analyzed multiple tumors from men with disseminated prostate cancer through whole-exome sequencing, array comparative genomic hybridization (CGH) and RNA transcript profiling, and we compared the genomic diversity within and between individuals. In contrast to the substantial heterogeneity between men, there was limited diversity among metastases within an individual. The number of somatic mutations, the burden of genomic copy number alterations and aberrations in known oncogenic drivers were all highly concordant, as were metrics of androgen receptor (AR) activity and cell cycle activity. AR activity was inversely associated with cell proliferation, whereas the expression of Fanconi anemia (FA)-complex genes was correlated with elevated cell cycle progression, expression of the E2F transcription factor 1 (E2F1) and loss of retinoblastoma 1 (RB1). Men with somatic aberrations in FA-complex genes or in ATM serine/threonine kinase (ATM) exhibited significantly longer treatment-response durations to carboplatin than did men without defects in genes encoding DNA-repair proteins. Collectively, these data indicate that although exceptions exist, evaluating a single metastasis provides a reasonable assessment of the major oncogenic driver alterations that are present in disseminated tumors within an individual, and thus may be useful for selecting treatments on the basis of predicted molecular vulnerabilities.	[Kumar, Akash; Shendure, Jay; Nelson, Peter S.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Coleman, Ilsa; Bolouri, Hamid; White, Thomas; Lucas, Jared M.; Dumpit, Ruth F.; DeSarkar, Navonil; Coleman, Roger; Nelson, Peter S.] Fred Hutchinson Canc Res Ctr, Div Human Biol, 1124 Columbia St, Seattle, WA 98104 USA; [Morrissey, Colm; Zhang, Xiaotun; Brown, Lisha G.; Lange, Paul H.; Vessella, Robert L.; Nelson, Peter S.] Univ Washington, Dept Urol, Seattle, WA 98195 USA; [True, Lawrence D.; Fang, Min; Nelson, Peter S.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Gulati, Roman; Etzioni, Ruth; Nelson, Peter S.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, 1124 Columbia St, Seattle, WA 98104 USA; [Montgomery, Bruce; Higano, Celestia; Yu, Evan Y.; Nelson, Peter S.] Univ Washington, Dept Med, Seattle, WA USA; [Schultz, Nikolaus] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA; [Fang, Min; Nelson, Peter S.] Fred Hutchinson Canc Res Ctr, Div Clin Res, 1124 Columbia St, Seattle, WA 98104 USA	University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Memorial Sloan Kettering Cancer Center; Fred Hutchinson Cancer Center	Nelson, PS (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.; Nelson, PS (corresponding author), Fred Hutchinson Canc Res Ctr, Div Human Biol, 1124 Columbia St, Seattle, WA 98104 USA.; Nelson, PS (corresponding author), Univ Washington, Dept Urol, Seattle, WA 98195 USA.; Nelson, PS (corresponding author), Univ Washington, Dept Pathol, Seattle, WA 98195 USA.; Nelson, PS (corresponding author), Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, 1124 Columbia St, Seattle, WA 98104 USA.; Nelson, PS (corresponding author), Univ Washington, Dept Med, Seattle, WA USA.; Nelson, PS (corresponding author), Fred Hutchinson Canc Res Ctr, Div Clin Res, 1124 Columbia St, Seattle, WA 98104 USA.	pnelson@fhcrc.org	Schultz, Nikolaus/ABE-6347-2020; Gulati, Roman/AAE-4298-2019; Shendure, Jay/AAU-3684-2021	Gulati, Roman/0000-0002-7592-6567; De Sarkar, Navonil/0000-0003-2139-7951; White, Thomas/0000-0002-5013-9129; Kumar, Akash/0000-0001-9442-3597	Stand Up To Cancer-Prostate Cancer Foundation Prostate Dream Team Translational Cancer Research Grant; US National Institutes of Health: Pacific Northwest Prostate Cancer SPORE grant [P50 CA097186, P01 CA163227, P01 CA85859]; US Department of Defense [W81XWH-15-1-0562, W81XWH-15-1-0430]; Fred Hutchinson Cancer Research Center Solid Tumor Translational Research award; Prostate Cancer Foundation; Prostate Cancer Foundation Young Investigator awards; NATIONAL CANCER INSTITUTE [P50CA097186, P01CA163227, P30CA008748, P01CA085859] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007266] Funding Source: NIH RePORTER	Stand Up To Cancer-Prostate Cancer Foundation Prostate Dream Team Translational Cancer Research Grant; US National Institutes of Health: Pacific Northwest Prostate Cancer SPORE grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Defense(United States Department of Defense); Fred Hutchinson Cancer Research Center Solid Tumor Translational Research award; Prostate Cancer Foundation; Prostate Cancer Foundation Young Investigator awards; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank all of the men and their families who participated in this study. We thank A. McKenna and other members of the Nelson, Shendure and Vessella laboratories for helpful advice and assistance. We thank T. Taniguchi for helpful discussions. LNCaP<SUP>AR</SUP> cells were a kind gift from C. Sawyers (Memorial Sloan Kettering Cancer Center). We thank M. Roudier, J. Noteboom, J. Kho and all other members of the tissue-acquisition necropsy team for their hard work and dedication. This work was supported by a Stand Up To Cancer-Prostate Cancer Foundation Prostate Dream Team Translational Cancer Research Grant. Stand Up To Cancer is a program of the Entertainment Industry Foundation administered by the American Association for Cancer Research (SU2C-AACR-DT0712) (B.M., N.S. and P.S.N.), and also by awards from the US National Institutes of Health: Pacific Northwest Prostate Cancer SPORE grant P50 CA097186 (P.S.N., B.M., L.D.T., R.L.V. and C.M.), P01 CA163227 (P.S.N., R.L.V. and C.M.), P01 CA85859 (R.L.V., C.M., M.F. and P.S.N.), US Department of Defense awards W81XWH-15-1-0562 and W81XWH-15-1-0430 (P.S.N., R.F.D., I.C., R.C. and N.S.) a Fred Hutchinson Cancer Research Center Solid Tumor Translational Research award (P.S.N., H.B. and B.M.) and the Prostate Cancer Foundation. J.S. and N.S. are supported by Prostate Cancer Foundation Young Investigator awards.	Abeshouse A, 2015, CELL, V163, P1011, DOI 10.1016/j.cell.2015.10.025; Arora VK, 2013, CELL, V155, P1309, DOI 10.1016/j.cell.2013.11.012; Aryee MJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005211; Barbieri CE, 2012, NAT GENET, V44, P685, DOI 10.1038/ng.2279; Cooper CS, 2015, NAT GENET, V47, P367, DOI 10.1038/ng.3221; Cuzick J, 2011, LANCET ONCOL, V12, P245, DOI 10.1016/S1470-2045(10)70295-3; De Bono JS, 2011, NEW ENGL J MED, V364, P1995, DOI 10.1056/NEJMoa1014618; de Bruin EC, 2014, SCIENCE, V346, P251, DOI 10.1126/science.1253462; Druker BJ, 1996, NAT MED, V2, P561, DOI 10.1038/nm0596-561; Frattini V, 2013, NAT GENET, V45, P1141, DOI 10.1038/ng.2734; Garraway LA, 2006, NAT REV CANCER, V6, P593, DOI 10.1038/nrc1947; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; Gundem G, 2015, NATURE, V520, P353, DOI 10.1038/nature14347; Gupta A, 2013, PROSTATE, V73, P582, DOI 10.1002/pros.22598; Haffner MC, 2013, J CLIN INVEST, V123, P4918, DOI 10.1172/JCI70354; Hieronymus H, 2014, P NATL ACAD SCI USA, V111, P11139, DOI 10.1073/pnas.1411446111; Huggins C, 1941, CANCER RES, V1, P293; Jones MJK, 2012, CELL MOL LIFE SCI, V69, P3963, DOI 10.1007/s00018-012-1051-0; Kokontis JM, 1998, MOL ENDOCRINOL, V12, P941, DOI 10.1210/me.12.7.941; Kumar A, 2011, P NATL ACAD SCI USA, V108, P17087, DOI 10.1073/pnas.1108745108; Lai J, 2009, MOL CANCER RES, V7, P129, DOI 10.1158/1541-7786.MCR-08-0218; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Lindberg J, 2013, EUR UROL, V63, P702, DOI 10.1016/j.eururo.2012.11.053; Liu WN, 2009, NAT MED, V15, P559, DOI 10.1038/nm.1944; Mateo J, 2015, NEW ENGL J MED, V373, P1697, DOI 10.1056/NEJMoa1506859; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Meier D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022911; Morrissey C, 2008, CLIN EXP METASTAS, V25, P377, DOI 10.1007/s10585-007-9116-4; Mosquera JM, 2013, NEOPLASIA, V15, P1, DOI 10.1593/neo.121550; National Research Council (US) Committee on a framework for developing a new taxonomy of disease, 2011, PREC MED BUILD KNOWL; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Pritchard CC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5988; Qi JF, 2010, CANCER CELL, V18, P23, DOI 10.1016/j.ccr.2010.05.024; Robbins CM, 2011, GENOME RES, V21, P47, DOI 10.1101/gr.107961.110; Robinson D, 2015, CELL, V161, P1215, DOI 10.1016/j.cell.2015.05.001; Roudier MP, 2003, HUM PATHOL, V34, P646, DOI 10.1016/S0046-8177(03)00190-4; Sahu B, 2013, CANCER RES, V73, P1570, DOI 10.1158/0008-5472.CAN-12-2350; SAKR WA, 1994, IN VIVO, V8, P439; Sato Y, 2013, NAT GENET, V45, P860, DOI 10.1038/ng.2699; Scher HI, 2012, NEW ENGL J MED, V367, P1187, DOI 10.1056/NEJMoa1207506; Schweizer MT, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010563; Sedelaar JPM, 2009, PROSTATE, V69, P1724, DOI 10.1002/pros.21028; Setlur SR, 2008, JNCI-J NATL CANCER I, V100, P815, DOI 10.1093/jnci/djn150; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Tan HL, 2014, CLIN CANCER RES, V20, P890, DOI 10.1158/1078-0432.CCR-13-1982; Tannock IF, 2004, NEW ENGL J MED, V351, P1502, DOI 10.1056/NEJMoa040720; Tategu M, 2007, GENE REGUL SYST BIO, V1, P1; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Verhaak RGW, 2013, J CLIN INVEST, V123, P517, DOI 10.1172/JCI65833; Wu X, 2012, NATURE, V482, P529, DOI 10.1038/nature10825; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515; Zhang JJ, 2014, SCIENCE, V346, P256, DOI 10.1126/science.1256930	54	443	450	2	31	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2016	22	4					369	+		10.1038/nm.4053	http://dx.doi.org/10.1038/nm.4053			13	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DI4GF	26928463	Green Accepted			2022-12-25	WOS:000373457700012
J	Rackham, OJL; Firas, J; Fang, H; Oates, ME; Holmes, ML; Knaupp, AS; Suzuki, H; Nefzger, CM; Daub, CO; Shin, JW; Petretto, E; Forrest, ARR; Hayashizaki, Y; Polo, JM; Gough, J				Rackham, Owen J. L.; Firas, Jaber; Fang, Hai; Oates, Matt E.; Holmes, Melissa L.; Knaupp, Anja S.; Suzuki, Harukazu; Nefzger, Christian M.; Daub, Carsten O.; Shin, Jay W.; Petretto, Enrico; Forrest, Alistair R. R.; Hayashizaki, Yoshihide; Polo, Jose M.; Gough, Julian		FANTOM Consortium	A predictive computational framework for direct reprogramming between human cell types	NATURE GENETICS			English	Article							PLURIPOTENT STEM-CELLS; HUMAN FIBROBLASTS; DIRECT CONVERSION; TRANSCRIPTION FACTORS; EXPRESSION; TRANSDIFFERENTIATION; INDUCTION; STRATEGY; MOUSE; LINES	Transdifferentiation, the process of converting from one cell type to another without going through a pluripotent state, has great promise for regenerative medicine. The identification of key transcription factors for reprogramming is currently limited by the cost of exhaustive experimental testing of plausible sets of factors, an approach that is inefficient and unscalable. Here we present a predictive system (Mogrify) that combines gene expression data with regulatory network information to predict the reprogramming factors necessary to induce cell conversion. We have applied Mogrify to 173 human cell types and 134 tissues, defining an atlas of cellular reprogramming. Mogrify correctly predicts the transcription factors used in known transdifferentiations. Furthermore, we validated two new transdifferentiations predicted by Mogrify. We provide a practical and efficient mechanism for systematically implementing novel cell conversions, facilitating the generalization of reprogramming of human cells. Predictions are made available to help rapidly further the field of cell conversion.	[Rackham, Owen J. L.; Fang, Hai; Oates, Matt E.; Gough, Julian] Univ Bristol, Dept Comp Sci, Bristol, Avon, England; [Rackham, Owen J. L.; Petretto, Enrico] Duke Natl Univ Singapore, Sch Med, Program Cardiovasc & Metab Disorders, Singapore, Singapore; [Firas, Jaber; Holmes, Melissa L.; Knaupp, Anja S.; Nefzger, Christian M.; Polo, Jose M.] Monash Univ, Dept Anat & Dev Biol, Clayton, Vic, Australia; [Firas, Jaber; Holmes, Melissa L.; Nefzger, Christian M.; Polo, Jose M.] Monash Univ, Australian Regenerat Med Inst, Clayton, Vic, Australia; [Firas, Jaber; Holmes, Melissa L.; Knaupp, Anja S.; Nefzger, Christian M.; Polo, Jose M.] Monash Univ, Monash Biomed Discovery Inst, Dev & Stem Cells Program, Clayton, Vic, Australia; [Suzuki, Harukazu; Daub, Carsten O.; Shin, Jay W.; Forrest, Alistair R. R.] RIKEN Omics Sci Ctr, Yokohama, Kanagawa, Japan; [Suzuki, Harukazu; Daub, Carsten O.; Shin, Jay W.; Forrest, Alistair R. R.; Hayashizaki, Yoshihide] RIKEN Ctr Life Sci Technol, Div Genom Technol, Yokohama, Kanagawa, Japan; [Daub, Carsten O.] Karolinska Inst, Dept Biosci & Nutr, Stockholm, Sweden; [Forrest, Alistair R. R.] Univ Western Australia, Queen Elizabeth Med Ctr 2, Harry Perkins Inst Med Res, Nedlands, WA 6009, Australia; [Forrest, Alistair R. R.] Univ Western Australia, Med Res Ctr, Nedlands, WA 6009, Australia; [Hayashizaki, Yoshihide] RIKEN, Prevent Med & Diag Innovat Program, Wako, Saitama, Japan	University of Bristol; National University of Singapore; Monash University; Australian Regenerative Medicine Institute; Monash University; Monash University; RIKEN; RIKEN; Karolinska Institutet; Harry Perkins Institute of Medical Research; University of Western Australia; University of Western Australia; RIKEN	Rackham, OJL; Gough, J (corresponding author), Univ Bristol, Dept Comp Sci, Bristol, Avon, England.; Rackham, OJL (corresponding author), Duke Natl Univ Singapore, Sch Med, Program Cardiovasc & Metab Disorders, Singapore, Singapore.; Polo, JM (corresponding author), Monash Univ, Dept Anat & Dev Biol, Clayton, Vic, Australia.; Polo, JM (corresponding author), Monash Univ, Australian Regenerat Med Inst, Clayton, Vic, Australia.; Polo, JM (corresponding author), Monash Univ, Monash Biomed Discovery Inst, Dev & Stem Cells Program, Clayton, Vic, Australia.	owen.rackham@duke-nus.edu.sg; jose.polo@monash.edu; julian.gough@bristol.ac.uk	Rackham, Owen/AAM-3108-2021; Daub, Carsten O/A-7436-2010; Hayashizaki, Yoshihide/N-6590-2015	Rackham, Owen/0000-0002-4390-0872; Daub, Carsten O/0000-0002-3295-8729; Polo, Jose M/0000-0002-2531-778X; Holmes, Melissa/0000-0001-5894-6649; Knaupp, Anja/0000-0003-0493-7872; Nefzger, Christian/0000-0003-4631-5633; Oates, Matt/0000-0002-0001-3675; Firas, Jaber/0000-0002-4217-2690; Petretto, Enrico/0000-0003-2163-5921; Forrest, Alistair/0000-0003-4543-1675	Biotechnology and Biological Sciences research council; Japanese Society for the Promotion of Science; Silvia and Charles Senior Medical Viertel Fellowship; Metcalf award from the National Stem Cell Foundation of Australia; National Health and Medical Research Council of Australia (NHMRC) project [APP1085302]; Australia Research Council's special initiative Stem Cells Australia; RIKEN Omics Science Center from MEXT; Innovative Technology (Cell Innovation Program) from MEXT, Japan; Biotechnology and Biological Sciences research council; Japanese Society for the Promotion of Science; Silvia and Charles Senior Medical Viertel Fellowship; Metcalf award from the National Stem Cell Foundation of Australia; National Health and Medical Research Council of Australia (NHMRC) project [APP1085302]; Australia Research Council's special initiative Stem Cells Australia; RIKEN Omics Science Center from MEXT; Innovative Technology (Cell Innovation Program) from MEXT, Japan; BBSRC [BB/I025018/1] Funding Source: UKRI; MRC [MC_U120097112] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I025018/1] Funding Source: researchfish; Medical Research Council [MC_U120097112] Funding Source: researchfish	Biotechnology and Biological Sciences research council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Silvia and Charles Senior Medical Viertel Fellowship; Metcalf award from the National Stem Cell Foundation of Australia; National Health and Medical Research Council of Australia (NHMRC) project(National Health and Medical Research Council (NHMRC) of Australia); Australia Research Council's special initiative Stem Cells Australia(Australian Research Council); RIKEN Omics Science Center from MEXT; Innovative Technology (Cell Innovation Program) from MEXT, Japan; Biotechnology and Biological Sciences research council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Silvia and Charles Senior Medical Viertel Fellowship; Metcalf award from the National Stem Cell Foundation of Australia; National Health and Medical Research Council of Australia (NHMRC) project(National Health and Medical Research Council (NHMRC) of Australia); Australia Research Council's special initiative Stem Cells Australia(Australian Research Council); RIKEN Omics Science Center from MEXT; Innovative Technology (Cell Innovation Program) from MEXT, Japan; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We would like to thank all members of the FANTOM5 Consortium for contributing to the generation of samples and analysis of the data set and thank GeNAS for data production. J.G. and O.J.L.R. were supported by grants from the Biotechnology and Biological Sciences research council and the Japanese Society for the Promotion of Science. J.M.P. was supported by a Silvia and Charles Senior Medical Viertel Fellowship, the Metcalf award from the National Stem Cell Foundation of Australia, National Health and Medical Research Council of Australia (NHMRC) project grant APP1085302 and the Australia Research Council's special initiative Stem Cells Australia. FANTOM5 was made possible by a Research Grant for the RIKEN Omics Science Center from MEXT to Y.H. and a grant of Innovative Cell Biology by Innovative Technology (Cell Innovation Program) from MEXT, Japan, to Y.H.	Addis RC, 2013, J MOL CELL CARDIOL, V60, P97, DOI 10.1016/j.yjmcc.2013.04.004; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Bar-Nur O, 2015, NAT BIOTECHNOL, V33, P761, DOI 10.1038/nbt.3247; Bhattacharya S, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-85; Cahan P, 2014, CELL, V158, P903, DOI 10.1016/j.cell.2014.07.020; Crespo I, 2013, STEM CELLS, V31, P2127, DOI 10.1002/stem.1473; D'Alessio AC, 2015, STEM CELL REP, V5, P763, DOI 10.1016/j.stemcr.2015.09.016; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P1269, DOI 10.1038/nbt.1502; Davis FP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063407; Du YY, 2014, CELL STEM CELL, V14, P394, DOI 10.1016/j.stem.2014.01.008; Firas J, 2015, IMMUNOL CELL BIOL, V93, P284, DOI 10.1038/icb.2015.5; Flottmann M, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00216; Forrest ARR, 2014, NATURE, V507, P462, DOI 10.1038/nature13182; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Fu JD, 2013, STEM CELL REP, V1, P235, DOI 10.1016/j.stemcr.2013.07.005; Fulton DL, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r29; Heinaniemi M, 2013, NAT METHODS, V10, P577, DOI [10.1038/nmeth.2445, 10.1038/NMETH.2445]; Huang PY, 2011, NATURE, V475, P386, DOI 10.1038/nature10116; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Kogiso T, 2013, HEPATOL INT, V7, P937, DOI 10.1007/s12072-013-9432-5; Lang AH, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003734; Lattanzi L, 1998, J CLIN INVEST, V101, P2119, DOI 10.1172/JCI1505; Maza I, 2015, NAT BIOTECHNOL, V33, P769, DOI 10.1038/nbt.3270; Morris SA, 2014, CELL, V158, P889, DOI 10.1016/j.cell.2014.07.021; Pfisterer U, 2011, P NATL ACAD SCI USA, V108, P10343, DOI 10.1073/pnas.1105135108; Polo JM, 2012, CELL, V151, P1617, DOI 10.1016/j.cell.2012.11.039; Qiu XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049271; Rapino F, 2013, CELL REP, V3, P1153, DOI 10.1016/j.celrep.2013.03.003; Sekiya S, 2011, NATURE, V475, P390, DOI 10.1038/nature10263; Suzuki H, 2009, NAT GENET, V41, P553, DOI 10.1038/ng.375; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Vaquerizas JM, 2009, NAT REV GENET, V10, P252, DOI 10.1038/nrg2538; Vickaryous MK, 2006, BIOL REV, V81, P425, DOI 10.1017/S1464793106007068; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Wilson D, 2008, NUCLEIC ACIDS RES, V36, pD88, DOI 10.1093/nar/gkm964; Xie HF, 2004, CELL, V117, P663, DOI 10.1016/S0092-8674(04)00419-2; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zou QJ, 2014, J BIOL CHEM, V289, P5250, DOI 10.1074/jbc.M113.516112	39	160	162	3	43	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2016	48	3					331	335		10.1038/ng.3487	http://dx.doi.org/10.1038/ng.3487			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DE8QW	26780608	Green Submitted			2022-12-25	WOS:000370902600019
J	Korkmaz, G; Lopes, R; Ugalde, AP; Nevedomskaya, E; Han, RQ; Myacheva, K; Zwart, W; Elkon, R; Agami, R				Korkmaz, Gozde; Lopes, Rui; Ugalde, Alejandro P.; Nevedomskaya, Ekaterina; Han, Ruiqi; Myacheva, Ksenia; Zwart, Wilbert; Elkon, Ran; Agami, Reuven			Functional genetic screens for enhancer elements in the human genome using CRISPR-Cas9	NATURE BIOTECHNOLOGY			English	Article							HUMAN-CELLS; BREAST-CANCER; P53; TRANSCRIPTION; MECHANISMS; ALIGNMENT; THERAPY; BINDING; CAS9; RNAS	Systematic identification of noncoding regulatory elements has, to date, mainly relied on large-scale reporter assays that do not reproduce endogenous conditions. We present two distinct CRISPR-Cas9 genetic screens to identify and characterize functional enhancers in their native context. Our strategy is to target Cas9 to transcription factor binding sites in enhancer regions. We identified several functional enhancer elements and characterized the role of two of them in mediating p53 (TP53) and ERa (ESR1) gene regulation. Moreover, we show that a genomic CRISPR-Cas9 tiling screen can precisely map functional domains within enhancer elements. Our approach expands the utility of CRISPR-Cas9 to elucidate the functions of the noncoding genome	[Korkmaz, Gozde; Lopes, Rui; Ugalde, Alejandro P.; Han, Ruiqi; Myacheva, Ksenia; Elkon, Ran; Agami, Reuven] Netherlands Canc Inst, Div Biol Stress Response, Amsterdam, Netherlands; [Nevedomskaya, Ekaterina; Zwart, Wilbert] Netherlands Canc Inst, Div Mol Pathol, Amsterdam, Netherlands; [Agami, Reuven] Rotterdam Univ, Erasmus MC, Rotterdam, Netherlands	Netherlands Cancer Institute; Netherlands Cancer Institute; Erasmus University Rotterdam; Erasmus MC	Elkon, R; Agami, R (corresponding author), Netherlands Canc Inst, Div Biol Stress Response, Amsterdam, Netherlands.; Agami, R (corresponding author), Rotterdam Univ, Erasmus MC, Rotterdam, Netherlands.	r.elkon@nki.nl; r.agami@nki.nl	Korkmaz, Gozde/A-1456-2015; agami, reuven/GOG-8289-2022; Pineiro-Ugalde, Alejandro/AAB-5229-2020	Korkmaz, Gozde/0000-0002-3574-1015; Pineiro-Ugalde, Alejandro/0000-0003-2522-0627; Agami, Reuven/0000-0002-2848-2473; Zwart, Wilbert/0000-0002-9823-7289	Human Frontier Science Program [LT000640/2013]; NWO [NGI 93512001/2012]; enhReg ERC-AdV	Human Frontier Science Program(Human Frontier Science Program); NWO(Netherlands Organization for Scientific Research (NWO)); enhReg ERC-AdV	We would like to acknowledge K. Rooijers for help in bioinformatic analyses, insightful ideas and critical discussions. We thank W. de Laat, P. Krijger, B. Evers, M. Amendola and R. Maia for reagents and technical assistance. We also thank all members of the Agami group for helpful discussions. And we thank F. Zhang (MIT) for the gift of plasmid vector lentiCRISPRv2 and D. Root (MIT) for pLX304-GFP. R.L. is a fellow of the Fundacao para a Ciencia e Tecnologia de Portugal (SFRH/BD/74476/2010; POPH/FSE). This work was supported by funds of The Human Frontier Science Program (LT000640/2013) to A.P.U., and enhReg ERC-AdV and NWO (NGI 93512001/2012) to R.A.	Agami R, 2000, CELL, V102, P55, DOI 10.1016/S0092-8674(00)00010-6; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Arnold A, 2005, J CLIN ONCOL, V23, P4215, DOI 10.1200/JCO.2005.05.064; Beelen K, 2012, NAT REV CLIN ONCOL, V9, P529, DOI 10.1038/nrclinonc.2012.121; Botcheva K, 2011, CELL CYCLE, V10, P4237, DOI 10.4161/cc.10.24.18383; Canver MC, 2015, NATURE, V527, P192, DOI 10.1038/nature15521; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Cunningham F, 2015, NUCLEIC ACIDS RES, V43, pD662, DOI 10.1093/nar/gku1010; Drost J, 2010, NAT CELL BIOL, V12, P380, DOI 10.1038/ncb2038; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; Kearns NA, 2015, NAT METHODS, V12, P401, DOI 10.1038/nmeth.3325; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Kleinstiver BP, 2015, NATURE, V523, P481, DOI 10.1038/nature14592; Kumar V, 2013, NAT BIOTECHNOL, V31, P615, DOI 10.1038/nbt.2596; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Leveille N, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7520; Li WB, 2013, NATURE, V498, P516, DOI 10.1038/nature12210; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mansour MR, 2014, SCIENCE, V346, P1373, DOI 10.1126/science.1259037; Melo CA, 2013, MOL CELL, V49, P524, DOI 10.1016/j.molcel.2012.11.021; Messeguer X, 2002, BIOINFORMATICS, V18, P333, DOI 10.1093/bioinformatics/18.2.333; Muller PAJ, 2013, NAT CELL BIOL, V15, P2, DOI 10.1038/ncb2641; Rashi-Elkeles S, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005032; Ross-Innes CS, 2012, NATURE, V481, P389, DOI 10.1038/nature10730; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Schmitt CA, 2002, CELL, V109, P335, DOI 10.1016/S0092-8674(02)00734-1; Sexton T, 2015, CELL, V160, P1049, DOI 10.1016/j.cell.2015.02.040; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shi JW, 2014, MOL CELL, V54, P728, DOI 10.1016/j.molcel.2014.05.016; Sigoillot FD, 2011, ACS CHEM BIOL, V6, P47, DOI 10.1021/cb100358f; Smeenk L, 2008, NUCLEIC ACIDS RES, V36, P3639, DOI 10.1093/nar/gkn232; Vahedi G, 2015, NATURE, V520, P558, DOI 10.1038/nature14154; Voorhoeve PM, 2006, CELL, V124, P1169, DOI 10.1016/j.cell.2006.02.037; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Yang XP, 2011, NAT METHODS, V8, P659, DOI [10.1038/NMETH.1638, 10.1038/nmeth.1638]; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	38	259	276	6	140	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2016	34	2					192	+		10.1038/nbt.3450	http://dx.doi.org/10.1038/nbt.3450			10	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DD0OK	26751173				2022-12-25	WOS:000369619100022
J	Lood, C; Blanco, LP; Purmalek, MM; Carmona-Rivera, C; De Ravin, SS; Smith, CK; Malech, HL; Ledbetter, JA; Elkon, KB; Kaplan, MJ				Lood, Christian; Blanco, Luz P.; Purmalek, Monica M.; Carmona-Rivera, Carmelo; De Ravin, Suk S.; Smith, Carolyne K.; Malech, Harry L.; Ledbetter, Jeffrey A.; Elkon, Keith B.; Kaplan, Mariana J.			Neutrophil extracellular traps enriched in oxidized mitochondrial DNA are interferogenic and contribute to lupus-like disease	NATURE MEDICINE			English	Article							PEPTIDYLARGININE DEIMINASE INHIBITION; NLRP3 INFLAMMASOME; OXIDATIVE DAMAGE; MACROPHAGES; DEFICIENCY; ACTIVATION; IMMUNITY; CELLS	Neutrophil extracellular traps (NETs) are implicated in autoimmunity, but how they are generated and their roles in sterile inflammation remain unclear. Ribonucleoprotein immune complexes (RNP ICs), inducers of NETosis, require mitochondria! reactive oxygen species (ROS) for maximal NET stimulation. After RNP IC stimulation of neutrophils, mitochondria become hypopolarized and translocate to the cell surface. Extracellular release of oxidized mitochondrial DNA is proinflammatory in vitro, and when this DNA is injected into mice, it stimulates type I interferon (IFN) signaling through a pathway dependent on the DNA sensor STING. Mitochondria! ROS are also necessary for spontaneous NETosis of low-density granulocytes from individuals with systemic lupus erythematosus. This was also observed in individuals with chronic granulornatous disease, who lack NADPH oxidase activity but still develop autoimmunity and type I IFN signatures. Mitochondrial ROS inhibition in vivo reduces disease severity and type I IFN responses in a mouse model of lupus. Together, these findings highlight a role for mitochondria in the generation not only of NETs but also of pro-inflammatory oxidized mitochondria! DNA in autoimmune diseases.	[Lood, Christian; Elkon, Keith B.] Univ Washington, Div Rheumatol, Seattle, WA 98195 USA; [Blanco, Luz P.; Purmalek, Monica M.; Carmona-Rivera, Carmelo; Smith, Carolyne K.; Kaplan, Mariana J.] NIAMSD, System Autoimmun Branch, NIH, Bldg 10, Bethesda, MD 20892 USA; [De Ravin, Suk S.; Malech, Harry L.] NIAID, Host Def Lab, NIH, Bethesda, MD 20892 USA; [Ledbetter, Jeffrey A.; Elkon, Keith B.] Univ Washington, Dept Immunol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Washington; University of Washington Seattle	Elkon, KB (corresponding author), Univ Washington, Div Rheumatol, Seattle, WA 98195 USA.; Kaplan, MJ (corresponding author), NIAMSD, System Autoimmun Branch, NIH, Bldg 10, Bethesda, MD 20892 USA.; Elkon, KB (corresponding author), Univ Washington, Dept Immunol, Seattle, WA 98195 USA.	elkon@uw.edu; mariana.kaplan@nih.gov	Lood, Christian/H-5670-2019	Lood, Christian/0000-0002-6171-1952; De Ravin, Suk See/0000-0002-9800-774X; Purmalek, Monica/0000-0003-2756-161X; Malech, Harry/0000-0001-5874-5775; /0000-0002-8468-6518; Elkon, Keith/0000-0002-7340-6146	Washington Research Foundation, Leap for Lupus; Wenner-Gren Foundation; foundation BLANCEFLOR Boncompagni-Ludovisi nee Bildt; Intramural Research Program at NIAMS/NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000644, ZIAAI000645] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIDAR041180, ZIAAR041199, ZICAR041186, ZIAAR041204] Funding Source: NIH RePORTER	Washington Research Foundation, Leap for Lupus; Wenner-Gren Foundation; foundation BLANCEFLOR Boncompagni-Ludovisi nee Bildt; Intramural Research Program at NIAMS/NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank X. Sun, L. Tanaka (both at University of Washington), and E. Moore (National Institute of Arthritis and Musculoskeletal and Skin Diseases; NIAMS) for technical assistance; W. Wang (University of Washington) for providing mouse mitochondria isolated from hearts; D. Kuhns (NIAID) for scientific input, and R. Siegel (NIAMS) for critical review of the manuscript. We also thank H.-W. Sun, M. Ward (both at NIAMS) and C. Spiekerman (University of Washington) for expert statistical advice. We also thank M. Gale for providing Tmem173-knockout mice. The study was supported by grants from the Washington Research Foundation, Leap for Lupus (K.B.E.), the Wenner-Gren Foundation, the foundation BLANCEFLOR Boncompagni-Ludovisi nee Bildt (C.L.), and the Intramural Research Program at NIAMS/NIH (L.P.B., M.P., C.K.S., C.C.-R. and M.J.K.). The funding bodies had no part in the study design; the collection, analysis and interpretation of the data; the writing of the manuscript or the submission.	Altenhofer S, 2015, ANTIOXID REDOX SIGN, V23, P406, DOI 10.1089/ars.2013.5814; Barrientos L, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00166; Bianchi M, 2009, BLOOD, V114, P2619, DOI 10.1182/blood-2009-05-221606; Bratic A, 2013, J CLIN INVEST, V123, P951, DOI 10.1172/JCI64125; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Brinkmann V, 2012, J CELL BIOL, V198, P773, DOI 10.1083/jcb.201203170; Buyse GM, 2011, NEUROMUSCULAR DISORD, V21, P396, DOI 10.1016/j.nmd.2011.02.016; Campbell AM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004801; Denny MR, 2010, J IMMUNOL, V184, P3284, DOI 10.4049/jimmunol.0902199; Dikalov S, 2011, FREE RADICAL BIO MED, V51, P1289, DOI 10.1016/j.freeradbiomed.2011.06.033; Doughan AK, 2008, CIRC RES, V102, P488, DOI 10.1161/CIRCRESAHA.107.162800; Fazzi F, 2014, J IMMUNOL, V192, P3837, DOI 10.4049/jimmunol.1103516; Fernandez-Boyanapalli R, 2010, J IMMUNOL, V185, P4030, DOI 10.4049/jimmunol.1001778; Fuchs TA, 2007, J CELL BIOL, V176, P231, DOI 10.1083/jcb.200606027; Gane EJ, 2010, LIVER INT, V30, P1019, DOI 10.1111/j.1478-3231.2010.02250.x; Garcia-Romo GS, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001201; Gehrke N, 2013, IMMUNITY, V39, P482, DOI 10.1016/j.immuni.2013.08.004; Gergely P, 2002, ARTHRITIS RHEUM-US, V46, P175, DOI 10.1002/1529-0131(200201)46:1<175::AID-ART10015>3.0.CO;2-H; Go YM, 2010, FREE RADICAL BIO MED, V48, P275, DOI 10.1016/j.freeradbiomed.2009.10.050; HOLLAND PC, 1972, BIOCHEM J, V129, P39, DOI 10.1042/bj1290039; Hultqvist M, 2009, TRENDS IMMUNOL, V30, P201, DOI 10.1016/j.it.2009.03.004; Jacob CO, 2012, P NATL ACAD SCI USA, V109, pE59, DOI 10.1073/pnas.1113251108; Kahlenberg JM, 2013, J IMMUNOL, V190, P1217, DOI 10.4049/jimmunol.1202388; Kaplan MJ, 2011, NAT REV RHEUMATOL, V7, P691, DOI 10.1038/nrrheum.2011.132; Kelkka T, 2014, ANTIOXID REDOX SIGN, V21, P2231, DOI 10.1089/ars.2013.5828; Khandpur R, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005580; Knight JS, 2014, CIRC RES, V114, P947, DOI 10.1161/CIRCRESAHA.114.303312; Knight JS, 2013, J CLIN INVEST, V123, P2981, DOI 10.1172/JCI67390; Knight JS, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00380; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; Kraaij MD, 2010, P NATL ACAD SCI USA, V107, P17686, DOI 10.1073/pnas.1012016107; Lande R, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001180; Lee K, 2011, P NATL ACAD SCI USA, V108, P9548, DOI 10.1073/pnas.1012645108; Lekstrom-Himes JA, 2005, J IMMUNOL, V174, P411, DOI 10.4049/jimmunol.174.1.411; Li X, 2013, IMMUNITY, V39, P1019, DOI 10.1016/j.immuni.2013.10.019; Mehta PK, 2007, AM J PHYSIOL-CELL PH, V292, pC82, DOI 10.1152/ajpcell.00287.2006; Meissner F, 2010, BLOOD, V116, P1570, DOI 10.1182/blood-2010-01-264218; Nakajima A, 2008, J BIOL CHEM, V283, P24128, DOI 10.1074/jbc.M802996200; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Oka T, 2012, NATURE, V485, P251, DOI 10.1038/nature10992; Pazmandi K, 2014, FREE RADICAL BIO MED, V77, P281, DOI 10.1016/j.freeradbiomed.2014.09.028; Remijsen Q, 2011, CELL RES, V21, P290, DOI 10.1038/cr.2010.150; Ries M, 2013, J LEUKOCYTE BIOL, V94, P123, DOI 10.1189/jlb.0612278; Schauer C, 2014, NAT MED, V20, P511, DOI 10.1038/nm.3547; Shimada K, 2012, IMMUNITY, V36, P401, DOI 10.1016/j.immuni.2012.01.009; Sibley CT, 2014, CIRCULATION, V130, P2031, DOI 10.1161/CIRCULATIONAHA.113.006824; Smith CK, 2014, ARTHRITIS RHEUMATOL, V66, P2532, DOI 10.1002/art.38703; Villanueva E, 2011, J IMMUNOL, V187, P538, DOI 10.4049/jimmunol.1100450; Vyshkina T, 2008, CLIN IMMUNOL, V129, P31, DOI 10.1016/j.clim.2008.07.011; Wang YM, 2009, J CELL BIOL, V184, P205, DOI 10.1083/jcb.200806072; West AP, 2011, NATURE, V472, P476, DOI 10.1038/nature09973; White MJ, 2014, CELL, V159, P1549, DOI 10.1016/j.cell.2014.11.036; Yu EPK, 2014, TRENDS ENDOCRIN MET, V25, P481, DOI 10.1016/j.tem.2014.06.008	53	746	776	5	164	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2016	22	2					146	153		10.1038/nm.4027	http://dx.doi.org/10.1038/nm.4027			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DC8JX	26779811	Green Accepted			2022-12-25	WOS:000369466800008
J	Dickey, AS; Pineda, VV; Tsunemi, T; Liu, PP; Miranda, HC; Gilmore-Hall, SK; Lomas, N; Sampat, KR; Buttgereit, A; Torres, MJM; Flores, AL; Arreola, M; Arbez, N; Akimov, SS; Gaasterland, T; Lazarowski, ER; Ross, CA; Yeo, GW; Sopher, BL; Magnuson, GK; Pinkerton, AB; Masliah, E; La Spada, AR				Dickey, Audrey S.; Pineda, Victor V.; Tsunemi, Taiji; Liu, Patrick P.; Miranda, Helen C.; Gilmore-Hall, Stephen K.; Lomas, Nicole; Sampat, Kunal R.; Buttgereit, Anne; Torres, Mark-Joseph Manalang; Flores, April L.; Arreola, Martin; Arbez, Nicolas; Akimov, Sergey S.; Gaasterland, Terry; Lazarowski, Eduardo R.; Ross, Christopher A.; Yeo, Gene W.; Sopher, Bryce L.; Magnuson, Gavin K.; Pinkerton, Anthony B.; Masliah, Eliezer; La Spada, Albert R.			PPAR-delta is repressed in Huntington's disease, is required for normal neuronal function and can be targeted therapeutically	NATURE MEDICINE			English	Article							ACTIVATED RECEPTOR-DELTA; MITOCHONDRIAL DYSFUNCTION; MUTANT HUNTINGTIN; SYNAPTIC PLASTICITY; MOUSE MODEL; EXPRESSION; PGC-1-ALPHA; ADIPOSE; GAMMA; GENE	Huntington's disease (HD) is a progressive neurodegenerative disorder caused by a CAG trinucleotide repeat expansion in the huntingtin (HTT) gene, which encodes a polyglutamine tract in the HTT protein. We found that peroxisome proliferator-activated receptor delta (PPAR-delta) interacts with HTT and that mutant HTT represses PPAR-delta-mediated transactivation. Increased PPAR-delta transactivation ameliorated mitochondrial dysfunction and improved cell survival of neurons from mouse models of HD. Expression of dominant-negative PPAR-delta in the central nervous system of mice was sufficient to induce motor dysfunction, neurodegeneration, mitochondrial abnormalities and transcriptional alterations that recapitulated HD-like phenotypes. Expression of dominant-negative PPAR-delta specifically in the striatum of medium spiny neurons in mice yielded HD-like motor phenotypes, accompanied by striatal neuron loss. In mouse models of HD, pharmacologic activation of PPAR-delta using the agonist KD3010 improved motor function, reduced neurodegeneration and increased survival. PPAR-delta activation also reduced HTT-induced neurotoxicity in vitro and in medium spiny-like neurons generated from stem cells derived from individuals with HD, indicating that PPAR-delta activation may be beneficial in HD and related disorders.	[Dickey, Audrey S.; Tsunemi, Taiji; Miranda, Helen C.; Gilmore-Hall, Stephen K.; Lomas, Nicole; Sampat, Kunal R.; Buttgereit, Anne; Flores, April L.; Arreola, Martin; La Spada, Albert R.] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Pineda, Victor V.; Torres, Mark-Joseph Manalang; Sopher, Bryce L.] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; [Liu, Patrick P.; Yeo, Gene W.; La Spada, Albert R.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Liu, Patrick P.; Yeo, Gene W.; La Spada, Albert R.] Univ Calif San Diego, Inst Genom Med, La Jolla, CA 92093 USA; [Liu, Patrick P.; Gaasterland, Terry; Yeo, Gene W.; La Spada, Albert R.] Univ Calif San Diego, Sanford Consortium Regenerat Med, La Jolla, CA 92093 USA; [Arbez, Nicolas; Akimov, Sergey S.; Ross, Christopher A.] Johns Hopkins Univ, Sch Med, Dept Psychiat, Div Neurobiol, Baltimore, MD 21205 USA; [Gaasterland, Terry] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Lazarowski, Eduardo R.] Univ N Carolina, Dept Med, Chapel Hill, NC USA; [Ross, Christopher A.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Ross, Christopher A.] Johns Hopkins Univ, Sch Med, Dept Pharmacol, Baltimore, MD 21205 USA; [Ross, Christopher A.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Magnuson, Gavin K.; Pinkerton, Anthony B.] Sanford Burnham Prebys Med Discovery Inst, La Jolla, CA USA; [Masliah, Eliezer] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; [Masliah, Eliezer; La Spada, Albert R.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [La Spada, Albert R.] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [La Spada, Albert R.] Rady Childrens Hosp, San Diego, CA USA	University of California System; University of California San Diego; University of Washington; University of Washington Seattle; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Johns Hopkins University; University of California System; University of California San Diego; Scripps Institution of Oceanography; University of North Carolina; University of North Carolina Chapel Hill; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Sanford Burnham Prebys Medical Discovery Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Rady Childrens Hospital San Diego	La Spada, AR (corresponding author), Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA.	alaspada@ucsd.edu	Yeo, Gene/AAE-7676-2019; La Spada, Albert/AAG-8809-2020	Yeo, Gene/0000-0002-0799-6037; A. Villanueva, Martin/0000-0002-7630-1403; Pinkerton, Anthony/0000-0003-4571-152X; Miranda, Helen/0000-0002-4064-9790; Dickey, Audrey/0000-0001-7490-2769	Hereditary Disease Foundation; Cure Huntington's Disease Initiative; US National Institutes of Health [R01 NS065874, R01 AG033082]; US National Institutes of Health (National Research Service Award) [F32 NS081964, P01 HL110873]; NATIONAL EYE INSTITUTE [R01EY022306] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL110873] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004659] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065874, F32NS081964] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG033082] Funding Source: NIH RePORTER	Hereditary Disease Foundation; Cure Huntington's Disease Initiative; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Institutes of Health (National Research Service Award)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We are grateful to S. Luquet (Universite Paris Diderot) for the gift of the CAGGS-floxed-STOP-Ppard expression construct. ST-Hdh cells were a kind gift from M. MacDonald<SUP>20,49</SUP> (Massachusetts General Hospital). BAC-HD97 mice21 were originally obtained from X.W. Yang (David Geffen School of Medicine at UCLA). This work was supported by funding from the Hereditary Disease Foundation, the Cure Huntington's Disease Initiative and grants from the US National Institutes of Health (R01 NS065874 (A.R.L.S.), R01 AG033082 (A.R.L.S.), National Research Service Award F32 NS081964 (A.S.D.) and P01 HL110873 (E.R.L.)).	Auboeuf D, 1997, DIABETES, V46, P1319, DOI 10.2337/diabetes.46.8.1319; Aubry L, 2008, P NATL ACAD SCI USA, V105, P16707, DOI 10.1073/pnas.0808488105; Bastie C, 2000, J BIOL CHEM, V275, P38768, DOI 10.1074/jbc.M006450200; BEAL MF, 1993, J NEUROSCI, V13, P4181; Berger J, 2002, ANNU REV MED, V53, P409, DOI 10.1146/annurev.med.53.082901.104018; Chiang MC, 2012, NEUROBIOL DIS, V45, P322, DOI 10.1016/j.nbd.2011.08.016; Chiang MC, 2010, HUM MOL GENET, V19, P4043, DOI 10.1093/hmg/ddq322; Cramer PE, 2012, SCIENCE, V335, P1503, DOI 10.1126/science.1217697; Cui LB, 2006, CELL, V127, P59, DOI 10.1016/j.cell.2006.09.015; Dang MT, 2006, P NATL ACAD SCI USA, V103, P15254, DOI 10.1073/pnas.0601758103; Evans RM, 2014, CELL, V157, P255, DOI 10.1016/j.cell.2014.03.012; FERRANTE RJ, 1987, BRAIN RES, V411, P162, DOI 10.1016/0006-8993(87)90694-9; Fitz NF, 2013, SCIENCE, V340, DOI 10.1126/science.1235809; Garden GA, 2002, J NEUROSCI, V22, P4897, DOI 10.1523/JNEUROSCI.22-12-04897.2002; Gines S, 2003, HUM MOL GENET, V12, P497, DOI 10.1093/hmg/ddg046; Girroir EE, 2008, BIOCHEM BIOPH RES CO, V371, P456, DOI 10.1016/j.bbrc.2008.04.086; Gray M, 2008, J NEUROSCI, V28, P6182, DOI 10.1523/JNEUROSCI.0857-08.2008; Guyenet Stephan J, 2010, J Vis Exp, DOI 10.3791/1787; HD iPSC Consortium, 2012, CELL STEM CELL, V11, P264, DOI 10.1016/j.stem.2012.04.027; Hodges A, 2006, HUM MOL GENET, V15, P965, DOI 10.1093/hmg/ddl013; Holst D, 2003, EXP CELL RES, V288, P168, DOI 10.1016/S0014-4827(03)00179-4; Iwaisako K, 2012, P NATL ACAD SCI USA, V109, pE1369, DOI 10.1073/pnas.1202464109; Janssen AJM, 2007, CLIN CHEM, V53, P729, DOI 10.1373/clinchem.2006.078873; Jin J, 2013, J NEUROCHEM, V125, P410, DOI 10.1111/jnc.12190; Jin YN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030406; KLIEWER SA, 1994, P NATL ACAD SCI USA, V91, P7355, DOI 10.1073/pnas.91.15.7355; La Spada AR, 2010, NAT REV GENET, V11, P247, DOI 10.1038/nrg2748; La Spada AR, 2001, NEURON, V31, P913, DOI 10.1016/S0896-6273(01)00422-6; Landis SC, 2012, NATURE, V490, P187, DOI 10.1038/nature11556; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Luquet S, 2003, FASEB J, V17, P2299, DOI 10.1096/fj.03-0269fje; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Nance MA, 1997, NEUROLOGY, V49, P1048, DOI 10.1212/WNL.49.4.1048; Narkar VA, 2008, CELL, V134, P405, DOI 10.1016/j.cell.2008.06.051; Nithianantharajah J, 2008, NEUROBIOL DIS, V29, P490, DOI 10.1016/j.nbd.2007.11.006; Perrin S, 2014, NATURE, V507, P423, DOI 10.1038/507423a; Peters JM, 2000, MOL CELL BIOL, V20, P5119, DOI 10.1128/MCB.20.14.5119-5128.2000; Quintanilla RA, 2008, J BIOL CHEM, V283, P25628, DOI 10.1074/jbc.M804291200; Reiner A, 2013, MOVEMENT DISORD, V28, P1691, DOI 10.1002/mds.25624; Riley BE, 2006, GENE DEV, V20, P2183, DOI 10.1101/gad.1436506; Ross CA, 1997, BRAIN PATHOL, V7, P1003, DOI 10.1111/j.1750-3639.1997.tb00898.x; Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1; Schilling G, 1999, HUM MOL GENET, V8, P397, DOI 10.1093/hmg/8.3.397; Schuler M, 2006, CELL METAB, V4, P407, DOI 10.1016/j.cmet.2006.10.003; Shin JH, 2011, CELL, V144, P689, DOI 10.1016/j.cell.2011.02.010; Shirendeb UP, 2012, HUM MOL GENET, V21, P406, DOI 10.1093/hmg/ddr475; Song WJ, 2011, NAT MED, V17, P377, DOI 10.1038/nm.2313; Sopher BL, 2004, NEURON, V41, P687, DOI 10.1016/S0896-6273(04)00082-0; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Tsunemi T, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003799; Wang YX, 2004, PLOS BIOL, V2, P1532, DOI 10.1371/journal.pbio.0020294; Weydt P, 2006, CELL METAB, V4, P349, DOI 10.1016/j.cmet.2006.10.004; Willson TM, 2000, J MED CHEM, V43, P527, DOI 10.1021/jm990554g; Young JE, 2009, J NEUROSCI, V29, P1987, DOI 10.1523/JNEUROSCI.4072-08.2009; Young JE, 2009, J BIOL CHEM, V284, P2363, DOI 10.1074/jbc.M806088200; Zheng B, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001059	57	60	61	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2016	22	1					37	+		10.1038/nm.4003	http://dx.doi.org/10.1038/nm.4003			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DA1YA	26642438	Green Accepted, Green Submitted			2022-12-25	WOS:000367590700013
J	Harley, ME; Murina, O; Leitch, A; Higgs, MR; Bicknell, LS; Yigit, G; Blackford, AN; Zlatanou, A; Mackenzie, KJ; Reddy, K; Halachev, M; McGlasson, S; Reijns, MAM; Fluteau, A; Martin, CA; Sabbioneda, S; Elcioglu, NH; Altmuller, J; Thiele, H; Greenhalgh, L; Chessa, L; Maghnie, M; Salim, M; Bober, MB; Nurnberg, P; Jackson, SP; Hurles, ME; Wollnik, B; Stewart, GS; Jackson, AP				Harley, Margaret E.; Murina, Olga; Leitch, Andrea; Higgs, Martin R.; Bicknell, Louise S.; Yigit, Goekhan; Blackford, Andrew N.; Zlatanou, Anastasia; Mackenzie, Karen J.; Reddy, Kaalak; Halachev, Mihail; McGlasson, Sarah; Reijns, Martin A. M.; Fluteau, Adeline; Martin, Carol-Anne; Sabbioneda, Simone; Elcioglu, Nursel H.; Altmueller, Janine; Thiele, Holger; Greenhalgh, Lynn; Chessa, Luciana; Maghnie, Mohamad; Salim, Mahmoud; Bober, Michael B.; Nuernberg, Peter; Jackson, Stephen P.; Hurles, Matthew E.; Wollnik, Bernd; Stewart, Grant S.; Jackson, Andrew P.			TRAIP promotes DNA damage response during genome replication and is mutated in primordial dwarfism	NATURE GENETICS			English	Article							INTERACTING PROTEIN TRIP; ORIGIN RECOGNITION COMPLEX; GROWTH FAILURE; EMBRYONIC LETHALITY; POLYMERASE ETA; MUTATIONS; UBIQUITIN; REPAIR; HOMOZYGOSITY; DEGRADATION	DNA lesions encountered by replicative polymerases threaten genome stability and cell cycle progression. Here we report the identification of mutations in TRAIP, encoding an E3 RING ubiquitin ligase, in patients with microcephalic primordial dwarfism. We establish that TRAIP relocalizes to sites of DNA damage, where it is required for optimal phosphorylation of H2AX and RPA2 during S-phase in response to ultraviolet (UV) irradiation, as well as fork progression through UV-induced DNA lesions. TRAIP is necessary for efficient cell cycle progression and mutations in TRAIP therefore limit cellular proliferation, providing a potential mechanism for microcephaly and dwarfism phenotypes. Human genetics thus identifies TRAIP as a component of the DNA damage response to replication-blocking DNA lesions.	[Harley, Margaret E.; Murina, Olga; Leitch, Andrea; Bicknell, Louise S.; Mackenzie, Karen J.; Reddy, Kaalak; Halachev, Mihail; McGlasson, Sarah; Reijns, Martin A. M.; Fluteau, Adeline; Martin, Carol-Anne; Jackson, Andrew P.] Univ Edinburgh, MRC, Human Genet Unit, IGMM, Edinburgh, Midlothian, Scotland; [Higgs, Martin R.; Zlatanou, Anastasia; Stewart, Grant S.] Univ Birmingham, Coll Med & Dent Sci, Inst Canc & Genom Sci, Birmingham, W Midlands, England; [Yigit, Goekhan; Altmueller, Janine; Wollnik, Bernd] Univ Cologne, Univ Hosp Cologne, Inst Human Genet, D-50931 Cologne, Germany; [Yigit, Goekhan; Nuernberg, Peter; Wollnik, Bernd] Univ Cologne, CMMC, D-50931 Cologne, Germany; [Yigit, Goekhan; Nuernberg, Peter; Wollnik, Bernd] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50931 Cologne, Germany; [Blackford, Andrew N.; Jackson, Stephen P.] Univ Cambridge, Gurdon Inst, Cambridge, England; [Sabbioneda, Simone] CNR, Ist Genet Mol, I-27100 Pavia, Italy; [Elcioglu, Nursel H.; Salim, Mahmoud] Marmara Univ, Pendik Hosp, Dept Pediat Genet, Istanbul, Turkey; [Altmueller, Janine; Thiele, Holger; Nuernberg, Peter] Univ Cologne, Cologne Ctr Genom, D-50931 Cologne, Germany; [Greenhalgh, Lynn] Liverpool Womens Hosp, Cheshire & Merseyside Clin Genet Serv, Liverpool, Merseyside, England; [Chessa, Luciana] Univ Roma La Sapienza, Dept Clin & Mol Med, I-00185 Rome, Italy; [Maghnie, Mohamad] Univ Genoa, IRCCS, Dept Pediat, Giannina Gaslini, Genoa, Italy; [Bober, Michael B.] Nemours Alfred I duPont Hosp Children, Wilmington, DC USA; [Jackson, Stephen P.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England; [Jackson, Stephen P.; Hurles, Matthew E.] Wellcome Trust Sanger Inst, Cambridge, England; [Wollnik, Bernd] Univ Med Ctr Gottingen, Inst Human Genet, Gottingen, Germany	University of Edinburgh; University of Birmingham; University of Cologne; University of Cologne; University of Cologne; University of Cambridge; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica Molecolare (IGM-CNR); Marmara University; Pendik State Hospital; University of Cologne; University of Liverpool; Sapienza University Rome; University of Genoa; IRCCS Istituto Giannina Gaslini; Nemours Alfred I. duPont Hospital for Children; University of Cambridge; Wellcome Trust Sanger Institute; University of Gottingen	Jackson, AP (corresponding author), Univ Edinburgh, MRC, Human Genet Unit, IGMM, Edinburgh, Midlothian, Scotland.	bwollnik@uni-koeln.de; g.s.stewart@bham.ac.uk; andrew.jackson@igmm.ed.ac.uk	Blackford, Andrew N/H-6575-2019; Thiele, Holger/ABE-6792-2020; Bicknell, Louise/AAL-8003-2020; Jackson, Andrew P/D-3442-2009; Reijns, Martin/L-4355-2013; Bober, Michael/AAH-4553-2021; Higgs, Martin/AAK-2108-2021; Jackson, Stephen Philip/R-4548-2019; Sabbioneda, Simone/N-7017-2015; Wollnik, Bernd/GRY-6062-2022; Bicknell, Louise/GLR-4215-2022	Blackford, Andrew N/0000-0003-1979-021X; Thiele, Holger/0000-0002-0169-998X; Jackson, Andrew P/0000-0002-8739-2646; Reijns, Martin/0000-0002-5048-2752; Higgs, Martin/0000-0002-8218-0089; Jackson, Stephen Philip/0000-0001-9317-7937; Sabbioneda, Simone/0000-0001-8551-5465; Wollnik, Bernd/0000-0003-2589-0364; Bicknell, Louise/0000-0001-6899-9322; Murina, Olga/0000-0003-1650-2892; Martin, Carol-Anne/0000-0001-5914-2757; Mackenzie, Karen/0000-0002-5441-1476; Altmuller, Janine/0000-0003-4372-1521; McGlasson, Sarah/0000-0002-0077-0991; Bober, Michael/0000-0002-6178-1264; Stewart, Grant/0000-0002-0960-3241	Medical Research Council; European Research Council (ERC) [281847]; Lister Institute for Preventative Medicine; Medical Research Scotland; German Federal Ministry of Education and Research (BMBF) [01GM1404]; E-RARE network EuroMicro; Wellcome Trust; CMMC; Cancer Research UK [C17183/A13030, C6/A11224]; Swiss National Science Foundation [P2ZHP3_158709]; AIRC [12710]; EU FP7-PEOPLE [CIG_303806]; ERC/EU FP7 [HEALTH-F2-2010-259893]; MRC [MC_PC_U127580972] Funding Source: UKRI; Cancer Research UK [11224, 13030] Funding Source: researchfish; Medical Research Council [MC_PC_U127580972] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Research Council (ERC)(European Research Council (ERC)European Commission); Lister Institute for Preventative Medicine; Medical Research Scotland; German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); E-RARE network EuroMicro; Wellcome Trust(Wellcome Trust); CMMC; Cancer Research UK(Cancer Research UK); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); AIRC(Fondazione AIRC per la ricerca sul cancro); EU FP7-PEOPLE; ERC/EU FP7; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank the families and clinicians for their involvement and participation; N. Hastie, W. Bickmore, D. Fitzpatrick, J.-C. Acosta, M. Nowotny, V. Vitart and A. Lehmann for helpful discussions; R. Geahlen (Purdue University), S. Taylor (University of Manchester), D.-J. Kleinjan (University of Edinburgh), A. Lichawska and J. Mansfeld (Gurdon Institute) for their kind gifts of reagents; J. Ding, P. Hari and E. Milz for technical assistance; E. Freyer for assistance with FACS analysis; the IGMM core sequencing service; A. Wheeler and the IGMM imaging facility for assistance with microscopy, E. Maher and A. Pearce for performing SNP genotyping arrays. This work was supported by funding from the Medical Research Council and the European Research Council (ERC, 281847) (A.P.J.), the Lister Institute for Preventative Medicine (A.P.J. and G.S.S.), Medical Research Scotland (L.S.B.), German Federal Ministry of Education and Research (BMBF, 01GM1404) and E-RARE network EuroMicro (B.W.), Wellcome Trust (M. E. Hurles), CMMC (P.N.), Cancer Research UK (C17183/A13030) (G.S.S. and M.R.H.), Swiss National Science Foundation (P2ZHP3_158709) (O.M.), AIRC (12710) and EU FP7-PEOPLE (CIG_303806) (S.S.), Cancer Research UK (C6/A11224) and ERC/EU FP7 (HEALTH-F2-2010-259893) (A.N.B. and S.P.J.).	Almeida S, 2011, J INVEST DERMATOL, V131, P349, DOI 10.1038/jid.2010.329; Besse A, 2007, BIOCHEM BIOPH RES CO, V359, P660, DOI 10.1016/j.bbrc.2007.05.149; Bicknell LS, 2011, NAT GENET, V43, P356, DOI 10.1038/ng.775; Bicknell LS, 2011, NAT GENET, V43, P350, DOI 10.1038/ng.776; Bienko M, 2010, MOL CELL, V37, P396, DOI 10.1016/j.molcel.2009.12.039; Bongers EMHF, 2001, AM J MED GENET, V102, P115, DOI 10.1002/ajmg.1452; Borden KLB, 1996, CURR OPIN STRUC BIOL, V6, P395, DOI 10.1016/S0959-440X(96)80060-1; Branzei D, 2010, NAT REV MOL CELL BIO, V11, P208, DOI 10.1038/nrm2852; Chowdhury D, 2005, MOL CELL, V20, P801, DOI 10.1016/j.molcel.2005.10.003; Chowdhury D, 2008, MOL CELL, V31, P33, DOI 10.1016/j.molcel.2008.05.016; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Conlon I, 1999, CELL, V96, P235, DOI 10.1016/S0092-8674(00)80563-2; Cooke MS, 2003, FASEB J, V17, P1195, DOI 10.1096/fj.02-0752rev; Despras E, 2012, ENVIRON MOL MUTAGEN, V53, P752, DOI 10.1002/em.21741; Despras E, 2010, HUM MOL GENET, V19, P1690, DOI 10.1093/hmg/ddq046; Feng JJ, 2009, MOL CELL BIOL, V29, P5696, DOI 10.1128/MCB.00191-09; Frank KM, 2000, MOL CELL, V5, P993, DOI 10.1016/S1097-2765(00)80264-6; GERMAN J, 1969, AM J HUM GENET, V21, P196; Gorlin R J, 1975, Birth Defects Orig Artic Ser, V11, P39; Griffith E, 2008, NAT GENET, V40, P232, DOI 10.1038/ng.2007.80; Guernsey DL, 2011, NAT GENET, V43, P360, DOI 10.1038/ng.777; Han CH, 2015, CELL CYCLE, V14, P1103, DOI 10.4161/15384101.2014.973740; Jackson SP, 2013, MOL CELL, V49, P795, DOI 10.1016/j.molcel.2013.01.017; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Johnson RE, 1999, SCIENCE, V285, P263, DOI 10.1126/science.285.5425.263; Joshi PK, 2015, NATURE, V523, P459, DOI 10.1038/nature14618; Keupp K, 2013, AM J HUM GENET, V92, P565, DOI 10.1016/j.ajhg.2013.02.010; Klingseisen A, 2011, GENE DEV, V25, P2011, DOI 10.1101/gad.169037; Lancaster MA, 2012, CURR OPIN NEUROBIOL, V22, P737, DOI 10.1016/j.conb.2012.04.003; Langevin F, 2011, NATURE, V475, P53, DOI 10.1038/nature10192; Lee SY, 1997, J EXP MED, V185, P1275, DOI 10.1084/jem.185.7.1275; Lehmann AR, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-70; Lessel D, 2014, NAT GENET, V46, P1239, DOI 10.1038/ng.3103; Leutenegger AL, 2006, AM J HUM GENET, V79, P62, DOI 10.1086/504640; MAJEWSKI F, 1982, AM J MED GENET, V12, P37, DOI 10.1002/ajmg.1320120105; MAJEWSKI F, 1982, AM J MED GENET, V12, P7, DOI 10.1002/ajmg.1320120103; MAJEWSKI F, 1982, AM J MED GENET, V12, P23, DOI 10.1002/ajmg.1320120104; Martin CA, 2014, NAT GENET, V46, P1283, DOI 10.1038/ng.3122; Masutani C, 1999, NATURE, V399, P700, DOI 10.1038/21447; McQuillan R, 2008, AM J HUM GENET, V83, P359, DOI 10.1016/j.ajhg.2008.08.007; Murga M, 2009, NAT GENET, V41, P891, DOI 10.1038/ng.420; Murray JE, 2014, HUM MUTAT, V35, P76, DOI 10.1002/humu.22461; Nakada S, 2008, EMBO REP, V9, P1019, DOI 10.1038/embor.2008.162; O'Driscoll M, 2003, NAT GENET, V33, P497, DOI 10.1038/ng1129; Ogi T, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002945; Park ES, 2007, BIOCHEM BIOPH RES CO, V363, P971, DOI 10.1016/j.bbrc.2007.09.103; Polo SE, 2012, MOL CELL, V45, P505, DOI 10.1016/j.molcel.2011.12.035; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qvist P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002310; Raschle M, 2015, SCIENCE, V348, DOI 10.1126/science.1253671; Rauch A, 2008, SCIENCE, V319, P816, DOI 10.1126/science.1151174; SECKEL HPG, 1960, BIRD HEADED DWARFS; Shi W, 2010, CARCINOGENESIS, V31, P994, DOI 10.1093/carcin/bgq035; Silengo M, 2001, AM J MED GENET, V101, P275, DOI 10.1002/ajmg.1384; Slatter MA, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001419; Soria G, 2012, MOL CELL, V46, P722, DOI 10.1016/j.molcel.2012.06.002; Stewart GS, 2003, NATURE, V421, P961, DOI 10.1038/nature01446; Taylor SS, 1997, CELL, V89, P727, DOI 10.1016/S0092-8674(00)80255-X; Wallace HA, 2014, DEVELOPMENT, V141, P1332, DOI 10.1242/dev.101196; Woods CG, 1998, ARCH DIS CHILD, V78, P178, DOI 10.1136/adc.78.2.178; Zhang M, 2012, J EXP MED, V209, P1703, DOI 10.1084/jem.20120024	61	54	55	0	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2016	48	1					36	+		10.1038/ng.3451	http://dx.doi.org/10.1038/ng.3451			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CZ7BQ	26595769	Green Accepted, Green Published			2022-12-25	WOS:000367255300011
J	Kupper, C; Stocks, M; Risse, JE; dos Remedios, N; Farrell, LL; Mcrae, SB; Morgan, TC; Karlionova, N; Pinchuk, P; Verkuil, YI; Kitaysky, AS; Wingfield, JC; Piersma, T; Zeng, K; Slate, J; Blaxter, M; Lank, DB; Burke, T				Kuepper, Clemens; Stocks, Michael; Risse, Judith E.; dos Remedios, Natalie; Farrell, Lindsay L.; Mcrae, Susan B.; Morgan, Tawna C.; Karlionova, Natalia; Pinchuk, Pavel; Verkuil, Yvonne I.; Kitaysky, Alexander S.; Wingfield, John C.; Piersma, Theunis; Zeng, Kai; Slate, Jon; Blaxter, Mark; Lank, David B.; Burke, Terry			A supergene determines highly divergent male reproductive morphs in the ruff	NATURE GENETICS			English	Article							PHILOMACHUS-PUGNAX; LINKAGE MAP; MATING STRATEGIES; EVOLUTION; LEKKING; DISCOVERY; PLUMAGE; MODEL; RECONSTRUCTION; REARRANGEMENTS	Three strikingly different alternative male mating morphs (aggressive 'independents', semicooperative 'satellites' and female-mimic 'faeders') coexist as a balanced polymorphism in the ruff, Philomachus pugnax, a lek-breeding wading bird(1-3). Major differences in body size, ornamentation, and aggressive and mating behaviors are inherited as an autosomal polymorphism(4,5). We show that development into satellites and faeders is determined by a supergene(6-8) consisting of divergent alternative, dominant and non-recombining haplotypes of an inversion on chromosome 11, which contains 125 predicted genes. Independents are homozygous for the ancestral sequence. One breakpoint of the inversion disrupts the essential CENP-N gene (encoding centromere protein N), and pedigree analysis confirms the lethality of homozygosity for the inversion. We describe new differences in behavior, testis size and steroid metabolism among morphs and identify polymorphic genes within the inversion that are likely to contribute to the differences among morphs in reproductive traits.	[Kuepper, Clemens; Stocks, Michael; dos Remedios, Natalie; Farrell, Lindsay L.; Zeng, Kai; Slate, Jon; Burke, Terry] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England; [Kuepper, Clemens] Graz Univ, Inst Zool, A-8010 Graz, Austria; [Risse, Judith E.; Blaxter, Mark] Univ Edinburgh, Inst Evolutionary Biol, Edinburgh Genom, Edinburgh, Midlothian, Scotland; [Farrell, Lindsay L.; Morgan, Tawna C.; Lank, David B.] Simon Fraser Univ, Dept Biol Sci, Burnaby, BC V5A 1S6, Canada; [Mcrae, Susan B.] E Carolina Univ, Dept Biol, Greenville, NC USA; [Morgan, Tawna C.; Kitaysky, Alexander S.] Univ Alaska, Inst Arctic Biol, Dept Biol & Wildlife, Fairbanks, AK 99775 USA; [Karlionova, Natalia; Pinchuk, Pavel] Sci & Pract Ctr Bioresources, Minsk, BELARUS; [Verkuil, Yvonne I.; Piersma, Theunis] Groningen Inst Evolutionary Life Sci, Conservat Ecol Grp, Groningen, Netherlands; [Wingfield, John C.] Univ Calif Davis, Dept Neurobiol Physiol & Behav, Davis, CA 95616 USA; [Piersma, Theunis] Royal Netherlands Inst Sea Res NIOZ, Dept Marine Ecol, Den Burg, Netherlands	University of Sheffield; University of Graz; University of Edinburgh; Simon Fraser University; University of North Carolina; East Carolina University; University of Alaska System; University of Alaska Fairbanks; National Academy of Sciences of Belarus (NASB); Scientific & Practical Center for Bioresources of the National Academy of Sciences of Belarus; University of California System; University of California Davis; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ)	Burke, T (corresponding author), Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England.	mark.blaxter@ed.ac.uk; dlank@sfu.ca; t.a.burke@sheffield.ac.uk	Blaxter, Mark L/B-4113-2010; Küpper, Clemens/D-8116-2011; McRae, Susan/L-7273-2019; Blaxter, Mark/O-2535-2019; Verkuil, Yvonne I./ABH-4507-2020; Burke, Terry/B-3196-2011; Slate, Jon/D-2925-2012; Stocks, Michael/P-5417-2014	Blaxter, Mark L/0000-0003-2861-949X; Küpper, Clemens/0000-0002-1507-8033; McRae, Susan/0000-0003-3209-4710; Verkuil, Yvonne I./0000-0001-7080-3026; Burke, Terry/0000-0003-3848-1244; Slate, Jon/0000-0003-3356-5123; Piersma, Theunis/0000-0001-9668-466X; Stocks, Michael/0000-0003-3344-6036; Lank, David/0000-0002-2670-5143; dos Remedios, Natalie/0000-0002-5412-4039	UK Biotechnology and Biological Sciences Research Council (BBSRC) [BB/J0189371]; Natural Sciences and Engineering Research Council of Canada (NSERC); H.F. Guggenheim Foundation; National Geographic Society; US National Science Foundation (NSF); European Union (EU) Marie Curie fellowship; NSF Experimental Program to Stimulate Competitive Research (EPSCoR) program at the University of Alaska, Fairbanks; BBSRC [BB/K020161/1, BB/G00661X/1, BB/J018791/1, BB/J018937/1] Funding Source: UKRI; MRC [MR/K001744/1, G0900740] Funding Source: UKRI; NERC [NBAF010001, NE/L005328/1, NBAF010003] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G00661X/1, BB/J018791/1, BB/K020161/1, BB/J018937/1] Funding Source: researchfish; Medical Research Council [G0900740, MR/K001744/1] Funding Source: researchfish; Natural Environment Research Council [NBAF010003, NBAF010001, NE/L005328/1] Funding Source: researchfish	UK Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); H.F. Guggenheim Foundation; National Geographic Society(National Geographic Society); US National Science Foundation (NSF)(National Science Foundation (NSF)); European Union (EU) Marie Curie fellowship; NSF Experimental Program to Stimulate Competitive Research (EPSCoR) program at the University of Alaska, Fairbanks; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank the laboratory and bioinformatics staff at Edinburgh Genomics at the University of Edinburgh for Illumina sequencing and the Lausanne Genomic Technology Facility for PacBio sequencing. This work was supported by a grant to T.B., J.S. and M.B. from the UK Biotechnology and Biological Sciences Research Council (BBSRC; BB/J0189371), by grants to D.B.L. from the Natural Sciences and Engineering Research Council of Canada (NSERC), by the H.F. Guggenheim Foundation, the National Geographic Society and the US National Science Foundation (NSF), and by a European Union (EU) Marie Curie fellowship to C.K. The Simon Fraser University Work-Study program facilitated the maintenance of the captive population since 1993. Hormone work was supported by the NSF Experimental Program to Stimulate Competitive Research (EPSCoR) program at the University of Alaska, Fairbanks.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Aslam ML, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-647; Atit R, 2003, DEV CELL, V4, P231, DOI 10.1016/S1534-5807(03)00021-2; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Boetzer M, 2011, BIOINFORMATICS, V27, P578, DOI 10.1093/bioinformatics/btq683; Bunney TD, 2011, TRENDS BIOCHEM SCI, V36, P88, DOI 10.1016/j.tibs.2010.08.003; Campbell M.S., 2002, CURR PROTOC BIOINFOR, V48; Carroll CW, 2009, NAT CELL BIOL, V11, P896, DOI 10.1038/ncb1899; Chikhi R, 2014, BIOINFORMATICS, V30, P31, DOI 10.1093/bioinformatics/btt310; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; Corbett-Detig RB, 2012, GENETICS, V192, P131, DOI 10.1534/genetics.112.141622; Dale J, 2001, AM NAT, V158, P75, DOI 10.1086/320861; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Ekblom R, 2012, ECOL EVOL, V2, P2485, DOI 10.1002/ece3.370; English AK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041444; Farrell LL, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-109; Farrell LL, 2012, CONSERV GENET RESOUR, V4, P763, DOI 10.1007/s12686-012-9639-0; Goymann W, 2004, ANIM BEHAV, V68, P733, DOI 10.1016/j.anbehav.2003.12.012; Groenen MAM, 2000, GENOME RES, V10, P137; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hoelzel A.R., 1998, ANAL POPULATIONS PRA, P287; Hoffmann AA, 2008, ANNU REV ECOL EVOL S, V39, P21, DOI 10.1146/annurev.ecolsys.39.110707.173532; HOGANWAR.AJ, 1966, ARDEA, V54, P109; HOGLUND J, 1989, AUK, V106, P336; Horton BM, 2014, P NATL ACAD SCI USA, V111, P1443, DOI 10.1073/pnas.1317165111; Hugie DM, 1997, BEHAV ECOL, V8, P218, DOI 10.1093/beheco/8.2.218; Jarvis ED, 2014, SCIENCE, V346, P1320, DOI 10.1126/science.1253451; Jones RB, 2006, NATURE, V439, P168, DOI 10.1038/nature04177; Joron M, 2011, NATURE, V477, P203, DOI 10.1038/nature10341; Jukema J, 2006, BIOL LETTERS, V2, P161, DOI 10.1098/rsbl.2005.0416; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Kawakami T, 2014, MOL ECOL, V23, P4035, DOI 10.1111/mec.12810; Kirkpatrick M, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000501; Knapp R, 2007, BIOL LETTERS, V3, P628, DOI 10.1098/rsbl.2007.0379; Korf I, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-59; Lamichhaney S, 2016, NAT GENET, V48, P84, DOI 10.1038/ng.3430; Lank DB, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0653; Lank DB, 1999, P ROY SOC B-BIOL SCI, V266, P2323, DOI 10.1098/rspb.1999.0926; LANK DB, 1995, NATURE, V378, P59, DOI 10.1038/378059a0; Lank DB, 2002, BEHAV ECOL, V13, P209, DOI 10.1093/beheco/13.2.209; LANK DB, 1987, BEHAV ECOL SOCIOBIOL, V20, P137, DOI 10.1007/BF00572636; Lank DB, 2001, AUK, V118, P759, DOI 10.1642/0004-8038(2001)118[0759:VSFIIT]2.0.CO;2; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li H., 2013, ARXIV, DOI DOI 10.48550/ARXIV.1303.3997; Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Maney DL, 2008, GEN COMP ENDOCR, V157, P275, DOI 10.1016/j.ygcen.2008.03.023; Martin M., 2011, EMBNET J, V17, P10, DOI [DOI 10.14806/EJ.17.1.200, 10.14806/ej.17.1.200]; Mindnich R, 2004, MOL CELL ENDOCRINOL, V218, P7, DOI 10.1016/j.mce.2003.12.006; Morgan T, 2006, THESIS; Mundy NI, 2005, P ROY SOC B-BIOL SCI, V272, P1633, DOI 10.1098/rspb.2005.3107; Oliveira RF, 2008, ALTERNATIVE REPRODUCTIVE TACTICS: AN INTEGRATIVE APPROACH, P1, DOI 10.1017/CBO9780511542602; Parra G, 2007, BIOINFORMATICS, V23, P1061, DOI 10.1093/bioinformatics/btm071; Pedram A, 2012, MOL BIOL CELL, V23, P188, DOI 10.1091/mbc.E11-07-0638; Piersma T, 2005, ARDEA, V93, P49; Roberts RB, 2009, SCIENCE, V326, P998, DOI 10.1126/science.1174705; SHUSTER SM, 1991, NATURE, V350, P608, DOI 10.1038/350608a0; SHUSTER SM, 2003, MG BEH ECOL, pR7; Simpson J.T., 2013, EXPLORING GENOME CHA; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Sinervo B, 1996, NATURE, V380, P240, DOI 10.1038/380240a0; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stanke M, 2003, BIOINFORMATICS, V19, pII215, DOI 10.1093/bioinformatics/btg1080; Stonor CR, 1937, P ZOOL SOC LOND A-GE, V107, P85; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Ter-Hovhannisyan V, 2008, GENOME RES, V18, P1979, DOI 10.1101/gr.081612.108; van Oers K, 2014, HEREDITY, V112, P307, DOI 10.1038/hdy.2013.107; Van Rhijn J.G., 1991, THE RUFF; van Rhijn J, 2014, ARDEA, V102, P5, DOI 10.5253/078.102.0103; Wang J, 2013, HEREDITY, V111, P165, DOI 10.1038/hdy.2013.34; Wang J, 2013, NATURE, V493, P664, DOI 10.1038/nature11832; Widemo F, 1998, ANIM BEHAV, V56, P329, DOI 10.1006/anbe.1998.0792; WINGFIELD JC, 1975, STEROIDS, V26, P311, DOI 10.1016/0039-128X(75)90077-X	74	254	258	3	144	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2016	48	1					79	+		10.1038/ng.3443	http://dx.doi.org/10.1038/ng.3443			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CZ7BQ	26569125	Green Accepted, Green Submitted, hybrid, Green Published			2022-12-25	WOS:000367255300017
J	DeFrancesco, L				DeFrancesco, Laura			Drug pipeline: 3Q15	NATURE BIOTECHNOLOGY			English	Editorial Material																			0	0	0	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2015	33	11					1126	1126		10.1038/nbt.3405	http://dx.doi.org/10.1038/nbt.3405			1	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	VC0TM	26544135				2022-12-25	WOS:000427300600001
J	Wagschal, A; Najafi-Shoushtari, SH; Wang, L; Goedeke, L; Sinha, S; deLemos, AS; Black, JC; Ramirez, CM; Li, YX; Tewhey, R; Hatoum, I; Shah, N; Lu, Y; Kristo, F; Psychogios, N; Vrbanac, V; Lu, YC; Hla, T; de Cabo, R; Tsang, JS; Schadt, E; Sabeti, PC; Kathiresan, S; Cohen, DE; Whetstine, J; Chung, RT; Fernandez-Hernando, C; Kaplan, LM; Bernards, A; Gerszten, RE; Naar, AM				Wagschal, Alexandre; Najafi-Shoushtari, S. Hani; Wang, Lifeng; Goedeke, Leigh; Sinha, Sumita; deLemos, Andrew S.; Black, Josh C.; Ramirez, Cristina M.; Li, Yingxia; Tewhey, Ryan; Hatoum, Ida; Shah, Naisha; Lu, Yong; Kristo, Fjoralba; Psychogios, Nikolaos; Vrbanac, Vladimir; Lu, Yi-Chien; Hla, Timothy; de Cabo, Rafael; Tsang, John S.; Schadt, Eric; Sabeti, Pardis C.; Kathiresan, Sekar; Cohen, David E.; Whetstine, Johnathan; Chung, Raymond T.; Fernandez-Hernando, Carlos; Kaplan, Lee M.; Bernards, Andre; Gerszten, Robert E.; Naeaer, Anders M.			Genome-wide identification of microRNAs regulating cholesterol and triglyceride homeostasis	NATURE MEDICINE			English	Article							CARDIOVASCULAR-DISEASE; HDL; MICE; HYPERCHOLESTEROLEMIA; BINDING; LESIONS; UPDATE; MIR-33; GENES	Genome-wide association studies (GWASs) have linked genes to various pathological traits. However, the potential contribution of regulatory noncoding RNAs, such as microRNAs (miRNAs), to a genetic predisposition to pathological conditions has remained unclear. We leveraged GWAS meta-analysis data from >188,000 individuals to identify 69 miRNAs in physical proximity to single-nucleotide polymorphisms (SNPs) associated with abnormal levels of circulating lipids. Several of these miRNAs (miR-128-1, miR-148a, miR-130b, and miR-301b) control the expression of key proteins involved in cholesterol-lipoprotein trafficking, such as the low-density lipoprotein (LDL) receptor (LDLR) and the ATP-binding cassette A1 (ABCA1) cholesterol transporter. Consistent with human liver expression data and genetic links to abnormal blood lipid levels, overexpression and antisense targeting of miR-128-1 or miR-148a in high-fat diet-fed C57BL/6J and Apoe-null mice resulted in altered hepatic expression of proteins involved in lipid trafficking and metabolism, and in modulated levels of circulating lipoprotein-cholesterol and triglycerides. Taken together, these findings support the notion that altered expression of miRNAs may contribute to abnormal blood lipid levels, predisposing individuals to human cardiometabolic disorders.	[Wagschal, Alexandre; Najafi-Shoushtari, S. Hani; Wang, Lifeng; Black, Josh C.; Kristo, Fjoralba; Whetstine, Johnathan; Bernards, Andre; Naeaer, Anders M.] Massachusetts Gen Hosp, Ctr Canc Res, Charlestown, MA 02129 USA; [Wagschal, Alexandre; Najafi-Shoushtari, S. Hani; Wang, Lifeng; Naeaer, Anders M.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA USA; [Goedeke, Leigh; Ramirez, Cristina M.; Fernandez-Hernando, Carlos] Yale Univ, Sch Med, Dept Pathol, Comparat Med Sect, New Haven, CT 06510 USA; [Sinha, Sumita; Psychogios, Nikolaos; Kathiresan, Sekar; Gerszten, Robert E.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Cardiovasc Res Ctr, Boston, MA USA; [deLemos, Andrew S.; Chung, Raymond T.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Liver, Boston, MA USA; [deLemos, Andrew S.; Chung, Raymond T.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Gastrointestinal Div, Boston, MA USA; [Black, Josh C.; Kathiresan, Sekar; Whetstine, Johnathan; Chung, Raymond T.; Kaplan, Lee M.; Bernards, Andre; Gerszten, Robert E.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Med, Charlestown, MA USA; [Li, Yingxia; Cohen, David E.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Div Gastroenterol, Boston, MA 02115 USA; [Tewhey, Ryan; Sabeti, Pardis C.; Kathiresan, Sekar] MIT, Broad Inst, Cambridge, MA 02139 USA; [Tewhey, Ryan; Sabeti, Pardis C.; Kathiresan, Sekar] Harvard, Cambridge, MA USA; [Tewhey, Ryan; Sabeti, Pardis C.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Hatoum, Ida; Kaplan, Lee M.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Obes Metab & Nutr Inst, Boston, MA USA; [Hatoum, Ida; Kaplan, Lee M.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Gastrointestinal Unit, Boston, MA USA; [Shah, Naisha; Lu, Yong; Tsang, John S.] NIAID, Syst Genom & Bioinformat Unit, Lab Syst Biol, NIH, Bethesda, MD 20892 USA; [Vrbanac, Vladimir] Harvard Univ, Ctr AIDS Res, Cambridge, MA 02138 USA; [Lu, Yi-Chien; Hla, Timothy] Cornell Univ, Weill Cornell Med Coll, Dept Pathol & Lab Med, Ctr Vasc Biol, New York, NY 10021 USA; [de Cabo, Rafael] NIA, Expt Gerontol Sect, Translat Gerontol Branch, NIH, Baltimore, MD 21224 USA; [Schadt, Eric] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Kathiresan, Sekar; Bernards, Andre] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Yale University; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Harvard University; Cornell University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Icahn School of Medicine at Mount Sinai; Harvard University; Massachusetts General Hospital	Naar, AM (corresponding author), Massachusetts Gen Hosp, Ctr Canc Res, Charlestown, MA 02129 USA.	naar@helix.mgh.harvard.edu	Ramírez, Cristina/A-6975-2016; Black, Joshua/Q-2484-2015; de Cabo, Rafael Carlos/J-5230-2016; Ramírez, Cristina/ABI-1568-2020; de Cabo, Rafael/E-7996-2010; Sabeti, Pardis/GQH-8610-2022; Hla, Timothy/G-5873-2012; de Cabo, Rafael/J-5230-2016	Ramírez, Cristina/0000-0003-2589-0786; de Cabo, Rafael Carlos/0000-0003-2830-5693; Ramírez, Cristina/0000-0003-2589-0786; de Cabo, Rafael/0000-0003-2830-5693; Kristo, Fjoralba/0000-0002-8045-9756; Hla, Timothy/0000-0001-8355-4065; de Cabo, Rafael/0000-0002-3354-2442; Goedeke, Leigh/0000-0002-7690-1572	US National Institutes of Health (NIH) [R21DK084459, R01DK094184, R37DK048873, R01DK056626, K24DK078772, R01HL107953, R01HL106063]; Massachusetts General Hospital (MGH); American Heart Association; Fondation Leducq Transatlantic Network of Excellence in Cardiovascular Research Award; NIH [R01HL49094]; US National Institute of Allergy and Infectious Diseases; American Heart Association SDG Grant [15SDG23000025]; MGH Executive Committee on Research; Neural Imaging Center as part of a National Institutes on Neurological Disorders and Stroke P30 Core Center grant [NS072030]; Harvard Digestive Diseases Center [P30 DK034854]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL106063, R01HL107953, R01HL049094] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [K99HG008179] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001152] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK084459, R01DK094184, P30DK034854, K24DK078772, R01DK056626, P30DK040561, R37DK048873] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS072030] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Massachusetts General Hospital (MGH); American Heart Association(American Heart Association); Fondation Leducq Transatlantic Network of Excellence in Cardiovascular Research Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); American Heart Association SDG Grant(American Heart Association); MGH Executive Committee on Research; Neural Imaging Center as part of a National Institutes on Neurological Disorders and Stroke P30 Core Center grant; Harvard Digestive Diseases Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the following grants: US National Institutes of Health (NIH) grants R21DK084459 and R01DK094184 (A.M.N); R37DK048873 and R01DK056626 to D.E.C.; K24DK078772 to R.T.C.; and R01HL107953 and R01HL106063 to C.F.-H. A.M.N. was supported by a scholar award from the Massachusetts General Hospital (MGH). R.E.G. was supported by an Established Investigator Award from the American Heart Association. C.F.-H. was supported by a Fondation Leducq Transatlantic Network of Excellence in Cardiovascular Research Award. T.H. acknowledges the support of NIH grant R01HL49094 and a Fondation Leducq Transatlantic Network of Excellence in Cardiovascular Research Award. N.S. and J.S.T. were supported by the Intramural Research Program of the US National Institute of Allergy and Infectious Diseases. C.M.R. was supported by the American Heart Association SDG Grant 15SD G23000025. A.W. was supported bye fellowship from the MGH Executive Committee on Research. We thank C. Molony of Merck Research Laboratories for help with genotyping data quality assessment. We thank the Harvard Medical School Neurobiology Department and the Neurobiology Imaging Facility for consultation and instrument availability that supported this work. This facility is supported in part by the Neural Imaging Center as part of a National Institutes on Neurological Disorders and Stroke P30 Core Center grant no. NS072030, and by the Harvard Digestive Diseases Center (P30 DK034854).	Bonnefont Jean-Paul, 2004, Molecular Aspects of Medicine, V25, P495, DOI 10.1016/j.mam.2004.06.004; BROWN MS, 1984, SCI AM, V251, P58, DOI 10.1038/scientificamerican1184-58; Charles MA, 2012, J LIPID RES, V53, P1451, DOI 10.1194/jlr.R027011; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Duffy D, 2009, NAT REV CARDIOL, V6, P455, DOI 10.1038/nrcardio.2009.94; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Goedeke L, 2014, CURR OPIN LIPIDOL, V25, P282, DOI 10.1097/MOL.0000000000000094; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Goldstein JL, 2009, ARTERIOSCL THROM VAS, V29, P431, DOI 10.1161/ATVBAHA.108.179564; Hardie DG, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a006031; Horie T, 2010, P NATL ACAD SCI USA, V107, P17321, DOI 10.1073/pnas.1008499107; ISHIBASHI S, 1993, J CLIN INVEST, V92, P883, DOI 10.1172/JCI116663; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lu YC, 2014, CELL REP, V9, P2330, DOI 10.1016/j.celrep.2014.11.030; Marquart TJ, 2010, P NATL ACAD SCI USA, V107, P12228, DOI 10.1073/pnas.1005191107; Merino DM, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-63; Najafi-Shoushtari SH, 2010, SCIENCE, V328, P1566, DOI 10.1126/science.1189123; NAKASHIMA Y, 1994, ARTERIOSCLER THROMB, V14, P133, DOI 10.1161/01.ATV.14.1.133; Navab M, 2011, NAT REV CARDIOL, V8, P222, DOI 10.1038/nrcardio.2010.222; Quiat D, 2013, J CLIN INVEST, V123, P11, DOI 10.1172/JCI62876; Rayner KJ, 2011, NATURE, V478, P404, DOI 10.1038/nature10486; Rayner KJ, 2011, J CLIN INVEST, V121, P2921, DOI 10.1172/JCI57275; Rottiers V, 2012, NAT REV MOL CELL BIO, V13, P239, DOI 10.1038/nrm3313; Soutar AK, 2007, NAT CLIN PRACT CARD, V4, P214, DOI 10.1038/ncpcardio0836; Sparks JD, 2012, ARTERIOSCL THROM VAS, V32, P2104, DOI 10.1161/ATVBAHA.111.241463; Stein S, 2011, CELL CYCLE, V10, P640, DOI 10.4161/cc.10.4.14863; Tall AR, 2008, CELL METAB, V7, P365, DOI 10.1016/j.cmet.2008.03.001; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; Yoon YS, 2009, J BIOL CHEM, V284, P10446, DOI 10.1074/jbc.M900096200; ZHANG SH, 1992, SCIENCE, V258, P468, DOI 10.1126/science.1411543	31	174	183	2	48	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2015	21	11					1290	1297		10.1038/nm.3980	http://dx.doi.org/10.1038/nm.3980			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CV9QH	26501192	Green Accepted, Green Submitted			2022-12-25	WOS:000364621200013
J	Zhang, HC; Kuo, CJ				Zhang, H. Chuck; Kuo, Calvin J.			Personalizing pancreatic cancer organoids with hPSCs	NATURE MEDICINE			English	Editorial Material							STEM-CELLS; IN-VITRO; MUTATIONS; CULTURE; MODELS; NICHE	A new study using human pluripotent stem cell (hPSC)-derived human pancreatic organoids to model neoplastic transformation and cancer-derived human pancreatic tumor organoids for drug testing provides new personalized approaches to modeling and treating this malignancy.	[Zhang, H. Chuck; Kuo, Calvin J.] Stanford Univ, Dept Med, Sch Med, Div Hematol, Stanford, CA 94305 USA	Stanford University	Zhang, HC (corresponding author), Stanford Univ, Dept Med, Sch Med, Div Hematol, Stanford, CA 94305 USA.	cjkuo@stanford.edu		Kuo, Calvin/0000-0002-7427-5985				Boj SF, 2015, CELL, V160, P324, DOI 10.1016/j.cell.2014.12.021; Crystal AS, 2014, SCIENCE, V346, P1480, DOI 10.1126/science.1254721; Drost J, 2015, NATURE, V521, P43, DOI 10.1038/nature14415; Gao D, 2014, CELL, V159, P176, DOI 10.1016/j.cell.2014.08.016; Huang L, 2015, NAT MED, V21, P1364, DOI 10.1038/nm.3973; Kurian AW, 2010, CURR OPIN OBSTET GYN, V22, P72, DOI 10.1097/GCO.0b013e328332dca3; Li XN, 2014, NAT MED, V20, P769, DOI 10.1038/nm.3585; Matano M, 2015, NAT MED, V21, P256, DOI 10.1038/nm.3802; Nostro MC, 2015, STEM CELL REP, V4, P591, DOI 10.1016/j.stemcr.2015.02.017; Ootani A, 2009, NAT MED, V15, P1, DOI 10.1038/nm.1951; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Spence JR, 2011, NATURE, V470, P105, DOI 10.1038/nature09691; van de Wetering M, 2015, CELL, V161, P933, DOI 10.1016/j.cell.2015.03.053	13	11	12	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2015	21	11					1249	1251		10.1038/nm.3992	http://dx.doi.org/10.1038/nm.3992			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CV9QH	26540385				2022-12-25	WOS:000364621200007
J	Shahbazi, MN; Jedrusik, A; Vuoristo, S; Recher, G; Hupalowska, A; Bolton, V; Fogarty, NME; Campbell, A; Devito, LG; Ilic, D; Khalaf, Y; Niakan, KK; Fishel, S; Zernicka-Goetz, M				Shahbazi, Marta N.; Jedrusik, Agnieszka; Vuoristo, Sanna; Recher, Gaelle; Hupalowska, Anna; Bolton, Virginia; Fogarty, Norah M. E.; Campbell, Alison; Devito, Liani G.; Ilic, Dusko; Khalaf, Yakoub; Niakan, Kathy K.; Fishel, Simon; Zernicka-Goetz, Magdalena			Self-organization of the human embryo in the absence of maternal tissues	NATURE CELL BIOLOGY			English	Article							IN-VITRO; STEM-CELLS; MOUSE; CULTURE; FERTILIZATION; EXPRESSION	Remodelling of the human embryo at implantation is indispensable for successful pregnancy. Yet it has remained mysterious because of the experimental hurdles that beset the study of this developmental phase. Here, we establish an in vitro system to culture human embryos through implantation stages in the absence of maternal tissues and reveal the key events of early human morphogenesis. These include segregation of the pluripotent embryonic and extra-embryonic lineages, and morphogenetic rearrangements leading to generation of a bilaminar disc, formation of a pro-amniotic cavity within the embryonic lineage, appearance of the prospective yolk sac, and trophoblast differentiation. Using human embryos and human pluripotent stem cells, we show that the reorganization of the embryonic lineage is mediated by cellular polarization leading to cavity formation. Together, our results indicate that the critical remodelling events at this stage of human development are embryo-autonomous, highlighting the remarkable and unanticipated self-organizing properties of human embryos.	[Shahbazi, Marta N.; Jedrusik, Agnieszka; Vuoristo, Sanna; Recher, Gaelle; Hupalowska, Anna; Zernicka-Goetz, Magdalena] Univ Cambridge, Dept Physiol Dev & Neurosci, Mammalian Embryo & Stem Cell Grp, Downing St, Cambridge CB2 3DY, England; [Bolton, Virginia; Devito, Liani G.; Ilic, Dusko; Khalaf, Yakoub] Kings Coll London, Womens Hlth Acad Ctr, Assisted Concept Unit, Fac Life Sci & Med,Guys Hosp, Great Maze Pond, London SE1 9RT, England; [Fogarty, Norah M. E.; Niakan, Kathy K.] Francis Crick Inst, Human Embryo & Stem Cell Lab, Mill Hill Lab, London NW7 1AA, England; [Campbell, Alison; Fishel, Simon] CARE Fertil Grp, John Webster House,6 Lawrence Dr, Nottingham NG8 6PZ, England; [Recher, Gaelle] CNRS, IOGS, Bioimaging & Optofluid Grp, F-33400 Talence, France; [Recher, Gaelle] Univ Bordeaux Rue Francois Mitterand, F-33400 Talence, France	University of Cambridge; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Francis Crick Institute; Centre National de la Recherche Scientifique (CNRS)	Zernicka-Goetz, M (corresponding author), Univ Cambridge, Dept Physiol Dev & Neurosci, Mammalian Embryo & Stem Cell Grp, Downing St, Cambridge CB2 3DY, England.	mz205@cam.ac.uk	Recher, Gaelle/AAB-8218-2019; Shahbazi, Marta/AAM-7365-2020	Recher, Gaelle/0000-0001-9004-0118; ILIC, DUSKO/0000-0003-1647-0026; Niakan, Kathy/0000-0003-1646-4734; Shahbazi, Marta Nasila/0000-0002-1599-5747; Fogarty, Norah/0000-0003-1085-8185; Zernicka-Goetz, Magdalena/0000-0002-7004-2471	Wellcome Trust; Francis Crick Institute; Cancer Research UK; Medical Research Council; Ramon Areces Spanish Foundation Fellowship; Finnish Cultural Foundation; Newton Fellowship; MRC [MC_UP_1202/9] Funding Source: UKRI; Medical Research Council [MC_UP_1202/9] Funding Source: researchfish; The Francis Crick Institute [10120] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Francis Crick Institute; Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Ramon Areces Spanish Foundation Fellowship; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Newton Fellowship; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); The Francis Crick Institute	We are grateful to the patients donating their embryos, colleagues in the M.Z.-G. laboratory, C. Lee (Gurdon Institute), and embryologists at the CARE, Bourn Hall (K. Elder and P. Snell) and Kings College Guy's Hospital IVF clinics for help and discussions. We thank P. Braude, D. Glover and C. Ogilvie for insightful discussion and I. Bedzhov for help in a pilot experiment. This work was supported by the Wellcome Trust grant to M.Z.-G. Work in the K.K.N. laboratory was supported by The Francis Crick Institute, which receives its core funding from Cancer Research UK, the Medical Research Council and the Wellcome Trust. M.N.S. was initially supported by a Ramon Areces Spanish Foundation Fellowship, and subsequently by an EMBO Postdoctoral Fellowship. S.V. was supported by a Post Doc Pool Grant from the Finnish Cultural Foundation. G.R. was supported by a Newton Fellowship.	Bedzhov I, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0538; Bedzhov I, 2014, NAT PROTOC, V9, P2732, DOI 10.1038/nprot.2014.186; Bedzhov I, 2014, CELL, V156, P1032, DOI 10.1016/j.cell.2014.01.023; Bryant DM, 2008, NAT REV MOL CELL BIO, V9, P887, DOI 10.1038/nrm2523; Bryant DM, 2014, DEV CELL, V31, P171, DOI 10.1016/j.devcel.2014.08.027; Covello KL, 2006, GENE DEV, V20, P557, DOI 10.1101/gad.1399906; Dobreva MP, 2010, INT J DEV BIOL, V54, P761, DOI 10.1387/ijdb.092935md; EDWARDS RG, 1970, NATURE, V227, P1307, DOI 10.1038/2271307a0; EDWARDS RG, 1969, NATURE, V221, P632, DOI 10.1038/221632a0; ENDERS AC, 1986, AM J ANAT, V177, P161, DOI 10.1002/aja.1001770205; Ezashi T, 2005, P NATL ACAD SCI USA, V102, P4783, DOI 10.1073/pnas.0501283102; Faure E, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms9674; Gardner DK, 2016, REPROD BIOMED ONLINE, V32, P137, DOI 10.1016/j.rbmo.2015.11.008; Haigh T, 1999, PLACENTA, V20, P615, DOI 10.1053/plac.1999.0441; HERTIG AT, 1956, AM J ANAT, V98, P435, DOI 10.1002/aja.1000980306; Hill JP, 1932, PHILOS T R SOC LON B, V221, P45, DOI 10.1098/rstb.1932.0002; Hur Yong Soo, 2011, Clin Exp Reprod Med, V38, P87, DOI 10.5653/cerm.2011.38.2.87; Koot YEM, 2012, BBA-MOL BASIS DIS, V1822, P1943, DOI 10.1016/j.bbadis.2012.05.017; Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517; Lee GY, 2007, NAT METHODS, V4, P359, DOI 10.1038/NMETH1015; LUCKETT WP, 1975, AM J ANAT, V144, P149, DOI 10.1002/aja.1001440204; Morris SA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1671; Niakan KK, 2013, DEV BIOL, V375, P54, DOI 10.1016/j.ydbio.2012.12.008; Niakan KK, 2012, DEVELOPMENT, V139, P829, DOI 10.1242/dev.060426; O'Leary T, 2012, NAT BIOTECHNOL, V30, P278, DOI 10.1038/nbt.2135; Palis J, 2001, EXP HEMATOL, V29, P927, DOI 10.1016/S0301-472X(01)00669-5; Pera MF, 2015, NAT METHODS, V12, P917, DOI 10.1038/nmeth.3586; Pera MF, 2004, DEVELOPMENT, V131, P5515, DOI 10.1242/dev.01451; Rivera-Perez JA, 2010, METHOD ENZYMOL, V476, P185, DOI 10.1016/S0076-6879(10)76011-0; Roode M, 2012, DEV BIOL, V361, P358, DOI 10.1016/j.ydbio.2011.10.030; Taniguchi K, 2015, STEM CELL REP, V5, P954, DOI 10.1016/j.stemcr.2015.10.015; Teklenburg G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032701; Vuoristo S., 2016, PROTOC EXCH; Weimar CHE, 2013, REPROD BIOMED ONLINE, V27, P461, DOI 10.1016/j.rbmo.2013.08.002	34	361	377	4	99	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUN	2016	18	6					700	+		10.1038/ncb3347	http://dx.doi.org/10.1038/ncb3347			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	DN0JL	27144686	Green Accepted, Green Submitted			2022-12-25	WOS:000376750100017
J	Chen, R; Shi, LS; Hakenberg, J; Naughton, B; Sklar, P; Zhang, JG; Zhou, HL; Tian, LF; Prakash, O; Lemire, M; Sleiman, P; Cheng, WY; Chen, WT; Shah, H; Shen, YL; Fromer, M; Omberg, L; Deardorff, MA; Zackai, E; Bobe, JR; Levin, E; Hudson, TJ; Groop, L; Wang, J; Hakonarson, H; Wojcicki, A; Diaz, GA; Edelmann, L; Schadt, EE; Friend, SH				Chen, Rong; Shi, Lisong; Hakenberg, Joerg; Naughton, Brian; Sklar, Pamela; Zhang, Jianguo; Zhou, Hanlin; Tian, Lifeng; Prakash, Om; Lemire, Mathieu; Sleiman, Patrick; Cheng, Wei-yi; Chen, Wanting; Shah, Hardik; Shen, Yulan; Fromer, Menachem; Omberg, Larsson; Deardorff, Matthew A.; Zackai, Elaine; Bobe, Jason R.; Levin, Elissa; Hudson, Thomas J.; Groop, Leif; Wang, Jun; Hakonarson, Hakon; Wojcicki, Anne; Diaz, George A.; Edelmann, Lisa; Schadt, Eric E.; Friend, Stephen H.			Analysis of 589,306 genomes identifies individuals resilient to severe Mendelian childhood diseases	NATURE BIOTECHNOLOGY			English	Article							AUTOSOMAL SEX REVERSAL; CAMPOMELIC DYSPLASIA; GENETIC-VARIATION; EPIDERMOLYSIS-BULLOSA; COMMON MUTATION; PHENOTYPE; VARIANTS; DISORDERS; EVOLUTION; MEDICINE	Genetic studies of human disease have traditionally focused on the detection of disease-causing mutations in afflicted individuals. Here we describe a complementary approach that seeks to identify healthy individuals resilient to highly penetrant forms of genetic childhood disorders. A comprehensive screen of 874 genes in 589,306 genomes led to the identification of 13 adults harboring mutations for 8 severe Mendelian conditions, with no reported clinical manifestation of the indicated disease. Our findings demonstrate the promise of broadening genetic studies to systematically search for well individuals who are buffering the effects of rare, highly penetrant, deleterious mutations. They also indicate that incomplete penetrance for Mendelian diseases is likely more common than previously believed. The identification of resilient individuals may provide a first step toward uncovering protective genetic variants that could help elucidate the mechanisms of Mendelian diseases and new therapeutic strategies.	[Chen, Rong; Shi, Lisong; Hakenberg, Joerg; Sklar, Pamela; Cheng, Wei-yi; Shah, Hardik; Fromer, Menachem; Bobe, Jason R.; Levin, Elissa; Diaz, George A.; Edelmann, Lisa; Schadt, Eric E.; Friend, Stephen H.] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Chen, Rong; Shi, Lisong; Hakenberg, Joerg; Sklar, Pamela; Cheng, Wei-yi; Shah, Hardik; Fromer, Menachem; Bobe, Jason R.; Levin, Elissa; Diaz, George A.; Edelmann, Lisa; Schadt, Eric E.; Friend, Stephen H.] Icahn Sch Med Mt Sinai, Icahn Inst Genom & Multiscale Biol, New York, NY 10029 USA; [Naughton, Brian; Wojcicki, Anne] 23andMe, Mountain View, CA USA; [Sklar, Pamela; Fromer, Menachem] Icahn Sch Med Mt Sinai, Friedman Brain Inst, New York, NY 10029 USA; [Sklar, Pamela; Fromer, Menachem] Icahn Sch Med Mt Sinai, Dept Psychiat, New York, NY 10029 USA; [Zhang, Jianguo; Zhou, Hanlin; Chen, Wanting; Shen, Yulan] BGI Shenzhen, Shenzhen, Peoples R China; [Tian, Lifeng; Sleiman, Patrick; Deardorff, Matthew A.; Zackai, Elaine; Hakonarson, Hakon] Childrens Hosp Philadelphia, Ctr Appl Genom, Philadelphia, PA 19104 USA; [Prakash, Om; Groop, Leif] Lund Univ, Skane Univ Hosp, Lund Univ Diabet Ctr, Dept Clin Sci Diabet & Endocrinol, Malmo, Sweden; [Lemire, Mathieu; Hudson, Thomas J.] Ontario Inst Canc Res, Toronto, ON, Canada; [Omberg, Larsson; Friend, Stephen H.] Sage Bionetworks, Seattle, WA USA; [Wang, Jun] ICarbonX, Shenzhen, Peoples R China; [Naughton, Brian] Boolean Biotech Inc, Mountain View, CA USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Beijing Genomics Institute (BGI); University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Lund University; Skane University Hospital; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates	Chen, R; Schadt, EE; Friend, SH (corresponding author), Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA.; Chen, R; Schadt, EE; Friend, SH (corresponding author), Icahn Sch Med Mt Sinai, Icahn Inst Genom & Multiscale Biol, New York, NY 10029 USA.; Friend, SH (corresponding author), Sage Bionetworks, Seattle, WA USA.	rong.chen@mssm.edu; eric.schadt@mssm.edu; friend@sagebase.org	chen, want/GRX-0662-2022; Diaz, George/AAF-6199-2021	Bobe, Jason/0000-0003-1864-8609; Omberg, Larsson/0000-0002-4719-9120; Tian, Lifeng/0000-0003-1880-5811; Chen, Rong/0000-0001-6322-0340; Zhang, Jianguo/0000-0003-0723-1701	NICHD NIH HHS [U54 HD086984] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD086984] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Ballhausen D, 2003, J MED GENET, V40, P65, DOI 10.1136/jmg.40.1.65; Bell CJ, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001756; Beltran H, 2015, JAMA ONCOL, V1, P466, DOI 10.1001/jamaoncol.2015.1313; Bienvenu T, 2005, HUM BIOL, V77, P705, DOI 10.1353/hub.2006.0002; Cheng WY, 2016, BIOINFORMATICS, V32, P151, DOI 10.1093/bioinformatics/btv511; Christodoulou J, 2003, HUM MUTAT, V21, P466, DOI 10.1002/humu.10194; Dietz HC, 2010, NEW ENGL J MED, V363, P852, DOI 10.1056/NEJMra0907180; EBENSPERGER C, 1991, ANN GENET-PARIS, V34, P233; Ensenauer R, 2004, AM J HUM GENET, V75, P1136, DOI 10.1086/426318; Flannick J, 2014, NAT GENET, V46, P357, DOI 10.1038/ng.2915; Fluharty AL, 1993, GENEREVIEWS; Friend SH, 2014, SCIENCE, V344, P970, DOI 10.1126/science.1255648; Galarneau G, 2010, NAT GENET, V42, P1049, DOI 10.1038/ng.707; Hartman JL, 2001, SCIENCE, V291, P1001, DOI 10.1126/science.291.5506.1001; Hartman JL, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-7-r49; Hartman JL, 2007, P NATL ACAD SCI USA, V104, P11700, DOI 10.1073/pnas.0705212104; Ikeda H, 2003, CANCER RES, V63, P2688; Jira PE, 2001, ANN HUM GENET, V65, P229, DOI 10.1017/S0003480001008600; Jonathan C, 2005, NAT GENET, V37, P161, DOI 10.1038/ng1509; Kaye J, 2014, EUR J HUM GENET, V22, P1100, DOI 10.1038/ejhg.2013.290; Lazarin GA, 2013, GENET MED, V15, P178, DOI 10.1038/gim.2012.114; Lee H, 2014, JAMA-J AM MED ASSOC, V312, P1880, DOI 10.1001/jama.2014.14604; Lek M., 2015, ANAL PROTEIN CODING; LETAI A, 1993, P NATL ACAD SCI USA, V90, P3197, DOI 10.1073/pnas.90.8.3197; Louie RJ, 2012, GENOME MED, V4, DOI 10.1186/gm404; MacArthur DG, 2012, SCIENCE, V335, P823, DOI 10.1126/science.1215040; McKusick VA, 2007, AM J HUM GENET, V80, P588, DOI 10.1086/514346; Meyer J, 1997, HUM MOL GENET, V6, P91, DOI 10.1093/hmg/6.1.91; MUENKE M, 1994, NAT GENET, V8, P269, DOI 10.1038/ng1194-269; Nagamine K, 1997, NAT GENET, V17, P393, DOI 10.1038/ng1297-393; Nowaczyk MJM, 2001, AM J MED GENET, V103, P75, DOI 10.1002/1096-8628(20010915)103:1<75::AID-AJMG1502>3.0.CO;2-R; OKANO Y, 1991, NEW ENGL J MED, V324, P1232, DOI 10.1056/NEJM199105023241802; Pace JM, 2001, J MED GENET, V38, P443, DOI 10.1136/jmg.38.7.443; Palmer LJ, 2007, LANCET, V369, P1980, DOI 10.1016/S0140-6736(07)60924-6; Pasmooij AMG, 2010, J INVEST DERMATOL, V130, P2407, DOI 10.1038/jid.2010.163; Philpott S, 1999, J ACQ IMMUN DEF SYND, V21, P189, DOI 10.1097/00126334-199907010-00002; Purcell SM, 2014, NATURE, V506, P185, DOI 10.1038/nature12975; Rajakumar C, 2009, J LIPID RES, V50, P1223, DOI 10.1194/jlr.P900001-JLR200; Riazuddin SA, 2009, MOL VIS, V15, P1050; Roberts JP, 2013, NAT BIOTECHNOL, V31, P470; SAMSTAD SO, 1992, CIRCULATION, V86, P748, DOI 10.1161/01.CIR.86.3.748; Schwaederle M, 2015, MOL CANCER THER, V14, P1488, DOI 10.1158/1535-7163.MCT-14-1061; Shohat M, 1993, GENEREVIEWS; Sosnay PR, 2013, NAT GENET, V45, P1160, DOI 10.1038/ng.2745; Stenson PD, 2014, HUM GENET, V133, P1, DOI 10.1007/s00439-013-1358-4; Tanner AK, 2014, J MOL DIAGN, V16, P350, DOI 10.1016/j.jmoldx.2013.12.003; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Thiadens AAHJ, 2010, OPHTHALMOLOGY, V117, P825, DOI 10.1016/j.ophtha.2009.09.008; Topol EJ, 2014, CELL, V157, P241, DOI 10.1016/j.cell.2014.02.012; Vieira NM, 2015, CELL, V163, P1204, DOI 10.1016/j.cell.2015.10.049; WAGNER T, 1994, CELL, V79, P1111, DOI 10.1016/0092-8674(94)90041-8	52	197	201	1	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2016	34	5					531	538		10.1038/nbt.3514	http://dx.doi.org/10.1038/nbt.3514			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DL6FL	27065010	Bronze			2022-12-25	WOS:000375735000034
J	Zhou, WY; Machiela, MJ; Freedman, ND; Rothman, N; Malats, N; Dagnall, C; Caporaso, N; Teras, LT; Gaudet, MM; Gapstur, SM; Stevens, VL; Jacobs, KB; Sampson, J; Albanes, D; Weinstein, S; Virtamo, J; Berndt, S; Hoover, RN; Black, A; Silverman, D; Figueroa, J; Garcia-Closas, M; Real, FX; Earl, J; Marenne, G; Rodriguez-Santiago, B; Karagas, M; Johnson, A; Schwenn, M; Wu, XF; Gu, J; Ye, YQ; Hutchinson, A; Tucker, M; Perez-Jurado, LA; Dean, M; Yeager, M; Chanock, SJ				Zhou, Weiyin; Machiela, Mitchell J.; Freedman, Neal D.; Rothman, Nathaniel; Malats, Nuria; Dagnall, Casey; Caporaso, Neil; Teras, Lauren T.; Gaudet, Mia M.; Gapstur, Susan M.; Stevens, Victoria L.; Jacobs, Kevin B.; Sampson, Joshua; Albanes, Demetrius; Weinstein, Stephanie; Virtamo, Jarmo; Berndt, Sonja; Hoover, Robert N.; Black, Amanda; Silverman, Debra; Figueroa, Jonine; Garcia-Closas, Montserrat; Real, Francisco X.; Earl, Julie; Marenne, Gaelle; Rodriguez-Santiago, Benjamin; Karagas, Margaret; Johnson, Alison; Schwenn, Molly; Wu, Xifeng; Gu, Jian; Ye, Yuanqing; Hutchinson, Amy; Tucker, Margaret; Perez-Jurado, Luis A.; Dean, Michael; Yeager, Meredith; Chanock, Stephen J.			Mosaic loss of chromosome Y is associated with common variation near TCL1A	NATURE GENETICS			English	Article							DETECTABLE CLONAL MOSAICISM; BONE-MARROW-CELLS; CONFERS SUSCEPTIBILITY; JAK2 HAPLOTYPE; AGE; RISK; HEMATOPOIESIS; LEUKEMIA; BLOOD; SNP	Mosaic loss of chromosome Y (mLOY) leading to gonosomal XY/XO commonly occurs during aging, particularly in smokers. We investigated whether mLOY was associated with non-hematological cancer in three prospective cohorts (8,679 cancer cases and 5,110 cancer-free controls) and genetic susceptibility to mLOY. Overall, mLOY was observed in 7% of men, and its prevalence increased with age (per-year odds ratio (OR) = 1.13, 95% confidence interval (CI) = 1.12-1.15; P < 2 x 10(-16)), reaching 18.7% among men over 80 years old. mLOY was associated with current smoking (OR = 2.35, 95% CI = 1.82-3.03; P = 5.55 x 10(-11)), but the association weakened with years after cessation. mLOY was not consistently associated with overall or specific cancer risk (for example, bladder, lung or prostate cancer) nor with cancer survival after diagnosis (multivariate-adjusted hazard ratio = 0.87, 95% CI = 0.73-1.04; P = 0.12). In a genome-wide association study, we observed the first example of a common susceptibility locus for genetic mosaicism, specifically mLOY, which maps to TCL1A at 14q32.13, marked by rs2887399 (OR = 1.55, 95% CI = 1.36-1.78; P = 1.37 x 10(-10)).	[Zhou, Weiyin; Machiela, Mitchell J.; Freedman, Neal D.; Rothman, Nathaniel; Dagnall, Casey; Caporaso, Neil; Sampson, Joshua; Albanes, Demetrius; Weinstein, Stephanie; Berndt, Sonja; Hoover, Robert N.; Black, Amanda; Silverman, Debra; Figueroa, Jonine; Garcia-Closas, Montserrat; Hutchinson, Amy; Tucker, Margaret; Dean, Michael; Yeager, Meredith; Chanock, Stephen J.] NCI, Div Canc Epidemiol & Genet, US NIH, Bethesda, MD 20892 USA; [Zhou, Weiyin; Dagnall, Casey; Jacobs, Kevin B.; Hutchinson, Amy; Yeager, Meredith] Leidos Biomed Res Inc, Canc Genom Res Lab, Frederick Natl Lab Canc Res, Frederick, MD USA; [Malats, Nuria; Real, Francisco X.; Earl, Julie; Marenne, Gaelle] Spanish Natl Canc Res Ctr CNIO, Madrid, Spain; [Teras, Lauren T.; Gaudet, Mia M.; Gapstur, Susan M.; Stevens, Victoria L.] Amer Canc Soc, Epidemiol Res Program, Atlanta, GA 30329 USA; [Jacobs, Kevin B.] Bioinformed LLC, Gaithersburg, MD USA; [Virtamo, Jarmo] Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Helsinki, Finland; [Garcia-Closas, Montserrat] Inst Canc Res, Div Genet & Epidemiol, London SW3 6JB, England; [Real, Francisco X.; Rodriguez-Santiago, Benjamin; Perez-Jurado, Luis A.] Univ Pompeu Fabra, Dept Ciencies Expt & Salut, Barcelona, Spain; [Rodriguez-Santiago, Benjamin; Perez-Jurado, Luis A.] Ctr Invest Biomed Red Enfermedades Raras CIBERER, Barcelona, Spain; [Rodriguez-Santiago, Benjamin] QGenomics, Quantitat Genom Med Lab, Barcelona, Spain; [Karagas, Margaret] Dartmouth Med Sch, Biostat & Epidemiol Sect, Lebanon, NH USA; [Johnson, Alison] Vermont Canc Registry, Burlington, VT USA; [Schwenn, Molly] Maine Canc Registry, Augusta, ME USA; [Wu, Xifeng; Gu, Jian; Ye, Yuanqing] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Perez-Jurado, Luis A.] Hosp del Mar Res Inst IMIM, Barcelona, Spain; [Dean, Michael] NCI, Lab Expt Immunol, Ctr Canc Res, Frederick, MD 21701 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Centro Nacional de Investigaciones Oncologicas (CNIO); American Cancer Society; Finland National Institute for Health & Welfare; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Pompeu Fabra University; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Dartmouth College; University of Texas System; UTMD Anderson Cancer Center; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Yeager, M; Chanock, SJ (corresponding author), NCI, Div Canc Epidemiol & Genet, US NIH, Bethesda, MD 20892 USA.; Yeager, M (corresponding author), Leidos Biomed Res Inc, Canc Genom Res Lab, Frederick Natl Lab Canc Res, Frederick, MD USA.	yeagerm@mail.nih.gov; chanocks@mail.nih.gov	Machiela, Mitchell J/H-7335-2019; Berndt, Sonja I/J-8423-2016; Figueroa, Jonine/AFK-2752-2022; Figueroa, Jonine/GWD-1322-2022; Marenne, Gaelle/AAU-8338-2020; Weinstein, Stephanie J/P-1627-2017; Figueroa, Jonine/AAG-1065-2022; Arribas, Francisco X Real/H-5275-2015; Freedman, Neal David/B-9741-2015; Gu, Jian/Q-4780-2018; Garcia-Closas, Montserrat/AAZ-6930-2021; Dean, Michael C/G-8172-2012; Dean, Michael/R-7501-2019; Yeager, Meredith/AAA-5322-2020; Malats, Nuria/H-7041-2015	Machiela, Mitchell J/0000-0001-6538-9705; Figueroa, Jonine/0000-0002-5100-623X; Figueroa, Jonine/0000-0002-5100-623X; Marenne, Gaelle/0000-0002-4363-7170; Weinstein, Stephanie J/0000-0002-3834-1535; Figueroa, Jonine/0000-0002-5100-623X; Arribas, Francisco X Real/0000-0001-9501-498X; Freedman, Neal David/0000-0003-0074-1098; Gu, Jian/0000-0003-3499-0973; Garcia-Closas, Montserrat/0000-0003-1033-2650; Dean, Michael C/0000-0003-2234-0631; Rodriguez-Santiago, Benjamin/0000-0003-1167-3852; Malats, Nuria/0000-0003-2538-3784; Earl, Julie/0000-0001-9360-4716; Dagnall, Casey/0000-0001-7334-4718	National Cancer Institute, US National Institutes of Health [HHSN261200800001E]; NATIONAL CANCER INSTITUTE [ZICCP010178, R01CA057494] Funding Source: NIH RePORTER	National Cancer Institute, US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project has been funded in whole or in part with federal funds from the National Cancer Institute, US National Institutes of Health, under contract HHSN261200800001E. The content of this publication does not necessarily reflect the views or policies of the US Department of Health and Human Services nor does mention of trade names, commercial products or organizations imply endorsement by the US government.	ABELIOVICH D, 1994, CANCER GENET CYTOGEN, V76, P70, DOI 10.1016/0165-4608(94)90075-2; Chanock S, 2014, WORLD CANC REPORT 20, P193; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Dumanski JP, 2015, SCIENCE, V347, P81, DOI 10.1126/science.1262092; Fernandez LC, 2016, NAT REV CANCER, V16, P43, DOI 10.1038/nrc.2015.1; Forsberg LA, 2014, NAT GENET, V46, P624, DOI 10.1038/ng.2966; Genovese G, 2014, NEW ENGL J MED, V371, P2477, DOI 10.1056/NEJMoa1409405; Gonzalez JR, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-166; GRIFFITHS MJ, 1992, GENE CHROMOSOME CANC, V5, P83; GUTTENBACH M, 1995, AM J HUM GENET, V57, P1143; Herens C, 1999, CLIN LAB HAEMATOL, V21, P17, DOI 10.1046/j.1365-2257.1999.00173.x; Itsara A, 2009, AM J HUM GENET, V84, P148, DOI 10.1016/j.ajhg.2008.12.014; Jacobs KB, 2012, NAT GENET, V44, P651, DOI 10.1038/ng.2270; JACOBS PA, 1963, NATURE, V197, P1080, DOI 10.1038/1971080a0; Jaiswal S, 2014, NEW ENGL J MED, V371, P2488, DOI 10.1056/NEJMoa1408617; Jones AV, 2009, NAT GENET, V41, P446, DOI 10.1038/ng.334; Kilpivaara O, 2009, NAT GENET, V41, P455, DOI 10.1038/ng.342; Laine J, 2000, MOL CELL, V6, P395, DOI 10.1016/S1097-2765(00)00039-3; Laurie CC, 2012, NAT GENET, V44, P642, DOI 10.1038/ng.2271; Machiela MJ, 2015, BIOINFORMATICS, V31, P3555, DOI 10.1093/bioinformatics/btv402; Machiela MJ, 2015, AM J HUM GENET, V96, P487, DOI 10.1016/j.ajhg.2015.01.011; Machiela MJ, 2013, SEMIN HEMATOL, V50, P348, DOI 10.1053/j.seminhematol.2013.09.001; McCarroll SA, 2007, NAT GENET, V39, pS37, DOI 10.1038/ng2080; Olcaydu D, 2009, LEUKEMIA, V23, P1924, DOI 10.1038/leu.2009.110; Olcaydu D, 2009, NAT GENET, V41, P450, DOI 10.1038/ng.341; Peiffer DA, 2006, GENOME RES, V16, P1136, DOI 10.1101/gr.5402306; PIERRE RV, 1972, CANCER, V30, P889, DOI 10.1002/1097-0142(197210)30:4<889::AID-CNCR2820300405>3.0.CO;2-1; Rothman N, 2010, NAT GENET, V42, P978, DOI 10.1038/ng.687; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722; Virgilio L, 1998, P NATL ACAD SCI USA, V95, P3885, DOI 10.1073/pnas.95.7.3885; Wiktor A, 2000, GENE CHROMOSOME CANC, V27, P11, DOI 10.1002/(SICI)1098-2264(200001)27:1<11::AID-GCC2>3.0.CO;2-I; Wong AK, 2008, ARCH PATHOL LAB MED, V132, P1329, DOI 10.1043/1543-2165(2008)132[1329:LOTYCA]2.0.CO;2; Wu XF, 2009, NAT GENET, V41, P991, DOI 10.1038/ng.421; Xie MC, 2014, NAT MED, V20, P1472, DOI 10.1038/nm.3733; Zhang LJ, 2007, CHINESE MED J-PEKING, V120, P2002, DOI 10.1097/00029330-200711020-00012	35	79	80	1	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2016	48	5					563	+		10.1038/ng.3545	http://dx.doi.org/10.1038/ng.3545			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DK3RC	27064253	Green Accepted			2022-12-25	WOS:000374834100017
J	Aggarwala, V; Voight, BF				Aggarwala, Varun; Voight, Benjamin F.			An expanded sequence context model broadly explains variability in polymorphism levels across the human genome	NATURE GENETICS			English	Article							DE-NOVO MUTATIONS; NATURAL-SELECTION; DNA; 5-METHYLCYTOSINE; RATES; PATTERNS; REVEALS; GENES	The rate of single-nucleotide polymorphism varies substantially across the human genome and fundamentally influences evolution and incidence of genetic disease. Previous studies have only considered the immediately flanking nucleotides around a polymorphic site-the site's trinucleotide sequence context-to study polymorphism levels across the genome. Moreover, the impact of larger sequence contexts has not been fully clarified, even though context substantially influences rates of polymorphism. Using a new statistical framework and data from the 1000 Genomes Project, we demonstrate that a heptanucleotide context explains >81% of variability in substitution probabilities, highlighting new mutation-promoting motifs at ApT dinucleotide, CAAT and TACG sequences. Our approach also identifies previously undocumented variability in C-to-T substitutions at CpG sites, which is not immediately explained by differential methylation intensity. Using our model, we present informative substitution intolerance scores for genes and a new intolerance score for amino acids, and we demonstrate clinical use of the model in neuropsychiatric diseases.	[Aggarwala, Varun] Univ Penn, Perelman Sch Med, Genom & Computat Biol Program, Philadelphia, PA 19104 USA; [Voight, Benjamin F.] Univ Penn, Perelman Sch Med, Dept Syst Pharmacol & Translat Therapeut, Philadelphia, PA 19104 USA; [Voight, Benjamin F.] Univ Penn, Perelman Sch Med, Dept Genet, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Voight, BF (corresponding author), Univ Penn, Perelman Sch Med, Dept Syst Pharmacol & Translat Therapeut, Philadelphia, PA 19104 USA.; Voight, BF (corresponding author), Univ Penn, Perelman Sch Med, Dept Genet, Philadelphia, PA 19104 USA.	bvoight@upenn.edu		Voight, Benjamin/0000-0002-6205-9994; Aggarwala, Varun/0000-0002-5499-7745	Alfred P. Sloan Foundation [BR2012-087]; American Heart Association [13SDG14330006]; W.W. Smith Charitable Trust [H1201]; US National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Disorders [R01DK101478]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK101478] Funding Source: NIH RePORTER	Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); American Heart Association(American Heart Association); W.W. Smith Charitable Trust; US National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Disorders; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank C. Brown, M. Bucan, P. Babb, K. Siewert, K. Johnson, S. Bumgarner and two anonymous reviewers for helpful comments on the manuscript. B.F.V. is grateful for support of the work from the Alfred P. Sloan Foundation (BR2012-087), the American Heart Association (13SDG14330006), the W.W. Smith Charitable Trust (H1201) and the US National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Disorders (R01DK101478).	Allen AS, 2013, NATURE, V501, P217, DOI 10.1038/nature12439; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Arbiza L, 2013, NAT GENET, V45, P723, DOI 10.1038/ng.2658; BLAKE RD, 1992, J MOL EVOL, V34, P189, DOI 10.1007/BF00162968; Bustamante CD, 2005, NATURE, V437, P1153, DOI 10.1038/nature04240; Campbell MC, 2008, ANNU REV GENOM HUM G, V9, P403, DOI 10.1146/annurev.genom.9.081307.164258; Cooper GM, 2011, NAT REV GENET, V12, P628, DOI 10.1038/nrg3046; de Ligt J, 2012, NEW ENGL J MED, V367, P1921, DOI 10.1056/NEJMoa1206524; De Rubeis S, 2014, NATURE, V515, P209, DOI 10.1038/nature13772; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; EHRLICH M, 1981, SCIENCE, V212, P1350, DOI 10.1126/science.6262918; Eyre-Walker A, 2014, G3-GENES GENOM GENET, V4, P1667, DOI 10.1534/g3.114.012849; Fitzgerald TW, 2015, NATURE, V519, P223, DOI 10.1038/nature14135; Fromer M, 2014, NATURE, V506, P179, DOI 10.1038/nature12929; Fu WQ, 2013, NATURE, V493, P216, DOI 10.1038/nature11690; Georgi B, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003484; GINSBURG D, 1992, BLOOD, V79, P2507; Hamdan FF, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004772; Hodgkinson A, 2011, NAT REV GENET, V12, P756, DOI 10.1038/nrg3098; Hovestadt V, 2014, NATURE, V510, P537, DOI 10.1038/nature13268; Hussin JG, 2015, NAT GENET, V47, P400, DOI 10.1038/ng.3216; Hwang DG, 2004, P NATL ACAD SCI USA, V101, P13994, DOI 10.1073/pnas.0404142101; Iossifov I, 2014, NATURE, V515, P216, DOI 10.1038/nature13908; Kamiya H, 2002, J BIOCHEM, V132, P551, DOI 10.1093/oxfordjournals.jbchem.a003256; KIMURA M, 1974, P NATL ACAD SCI USA, V71, P2848, DOI 10.1073/pnas.71.7.2848; Kong A, 2012, NATURE, V488, P471, DOI 10.1038/nature11396; Koren A, 2014, CELL, V159, P1015, DOI 10.1016/j.cell.2014.10.025; Lanfear R, 2010, TRENDS ECOL EVOL, V25, P495, DOI 10.1016/j.tree.2010.06.007; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; LEVINSON G, 1987, MOL BIOL EVOL, V4, P203; Michaelson JJ, 2012, CELL, V151, P1431, DOI 10.1016/j.cell.2012.11.019; Mugal CF, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r58; Nachman MW, 2000, GENETICS, V156, P297; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; Okae H, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004868; Orosco LA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5692; Panchin AY, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-268; Petrovski S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003709; Rauch A, 2012, LANCET, V380, P1674, DOI 10.1016/S0140-6736(12)61480-9; RIDEOUT WM, 1990, SCIENCE, V249, P1288, DOI 10.1126/science.1697983; Samocha KE, 2014, NAT GENET, V46, P944, DOI 10.1038/ng.3050; Schaffner SF, 2004, NAT REV GENET, V5, P43, DOI 10.1038/nrg1247; Segurel L, 2014, ANNU REV GENOM HUM G, V15, P47, DOI 10.1146/annurev-genom-031714-125740; Siepel A, 2004, MOL BIOL EVOL, V21, P468, DOI 10.1093/molbev/msh039; Stenson PD, 2014, HUM GENET, V133, P1, DOI 10.1007/s00439-013-1358-4; Uddin M, 2014, NAT GENET, V46, P742, DOI 10.1038/ng.2980; Walser JC, 2010, GENOME RES, V20, P875, DOI 10.1101/gr.103283.109; Yang YP, 2013, NEW ENGL J MED, V369, P1502, DOI 10.1056/NEJMoa1306555	49	91	91	0	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2016	48	4					349	+		10.1038/ng.3511	http://dx.doi.org/10.1038/ng.3511			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DH6NZ	26878723	Green Accepted			2022-12-25	WOS:000372908800005
J	Braun, DA; Sadowski, CE; Kohl, S; Lovric, S; Astrinidis, SA; Pabst, WL; Gee, HY; Ashraf, S; Lawson, JA; Shril, S; Airik, M; Tan, WZ; Schapiro, D; Rao, J; Choi, WI; Hermle, T; Kemper, MJ; Pohl, M; Ozaltin, F; Konrad, M; Bogdanovic, R; Buscher, R; Helmchen, U; Serdaroglu, E; Lifton, RP; Antonin, W; Hildebrandt, F				Braun, Daniela A.; Sadowski, Carolin E.; Kohl, Stefan; Lovric, Svjetlana; Astrinidis, Susanne A.; Pabst, Werner L.; Gee, Heon Yung; Ashraf, Shazia; Lawson, Jennifer A.; Shril, Shirlee; Airik, Merlin; Tan, Weizhen; Schapiro, David; Rao, Jia; Choi, Won-Il; Hermle, Tobias; Kemper, Markus J.; Pohl, Martin; Ozaltin, Fatih; Konrad, Martin; Bogdanovic, Radovan; Buescher, Rainer; Helmchen, Udo; Serdaroglu, Erkin; Lifton, Richard P.; Antonin, Wolfram; Hildebrandt, Friedhelm			Mutations in nuclear pore genes NUP93, NUP205 and XPO5 cause steroid-resistant nephrotic syndrome	NATURE GENETICS			English	Article							MULTIPOINT LINKAGE ANALYSIS; MEMBRANE-PROTEINS; IN-VITRO; COMPLEX; NUCLEOPORINS; CILIOPATHY; PODOCIN; EXPORT; REQUIREMENT; DISRUPTION	Nucleoporins are essential components of the nuclear pore complex (NPC)(1). Only a few diseases have been attributed to NPC dysfunction(2-4). Steroid-resistant nephrotic syndrome (SRNS), a frequent cause of chronic kidney disease, is caused by dysfunction of glomerular podocytes(5). Here we identify in eight families with SRNS mutations in NUP93, its interaction partner NUP205 or XPO5 (encoding exportin 5) as hitherto unrecognized monogenic causes of SRNS. NUP93 mutations caused disrupted NPC assembly. NUP93 knockdown reduced the presence of NUP205 in the NPC, and, reciprocally, a NUP205 alteration abrogated NUP93 interaction. We demonstrate that NUP93 and exportin 5 interact with the signaling protein SMAD4 and that NUP93 mutations abrogated interaction with SMAD4. Notably, NUP93 mutations interfered with BMP7-induced SMAD transcriptional reporter activity. We hereby demonstrate that mutations of NUP genes cause a distinct renal disease and identify aberrant SMAD signaling as a new disease mechanism of SRNS, opening a potential new avenue for treatment.	[Braun, Daniela A.; Sadowski, Carolin E.; Kohl, Stefan; Lovric, Svjetlana; Pabst, Werner L.; Gee, Heon Yung; Ashraf, Shazia; Lawson, Jennifer A.; Shril, Shirlee; Airik, Merlin; Tan, Weizhen; Schapiro, David; Rao, Jia; Choi, Won-Il; Hermle, Tobias; Hildebrandt, Friedhelm] Harvard Univ, Sch Med, Dept Med, Boston Childrens Hosp, Boston, MA USA; [Astrinidis, Susanne A.; Antonin, Wolfram] Max Planck Gesell, Friedrich Miescher Lab, Tubingen, Germany; [Gee, Heon Yung] Yonsei Univ, Coll Med, Brain Korea PLUS Project Med Sci 21, Dept Pharmacol, Seoul, South Korea; [Kemper, Markus J.] Univ Med Ctr Hamburg Eppendorf, Dept Pediat, Hamburg, Germany; [Pohl, Martin] Univ Freiburg, Med Ctr, Dept Pediat & Adolescent Med, Freiburg, Germany; [Ozaltin, Fatih] Hacettepe Univ, Fac Med, Dept Pediat Nephrol, TR-06100 Ankara, Turkey; [Ozaltin, Fatih] Hacettepe Univ, Nephrogenet Lab, Ankara, Turkey; [Ozaltin, Fatih] Hacettepe Univ, Ctr Biobanking & Genom, Ankara, Turkey; [Konrad, Martin] Univ Hosp Munster, Dept Gen Pediat, Munster, Germany; [Bogdanovic, Radovan] Univ Belgrade, Fac Med, Belgrade, Serbia; [Buescher, Rainer] Univ Duisburg Essen, Dept Pediat 2, Pediat Nephrol, Essen, Germany; [Helmchen, Udo] Univ Hosp Hamburg Eppendorf, Inst Pathol, Kidney Registry, Hamburg, Germany; [Serdaroglu, Erkin] Dr Behcet Uz Children Hosp, Dept Pediat Nephrol, Izmir, Turkey; [Lifton, Richard P.] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; [Lifton, Richard P.; Hildebrandt, Friedhelm] Howard Hughes Med Inst, Chevy Chase, MD USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Eberhard Karls University of Tubingen; Max Planck Society; Yonsei University; Yonsei University Health System; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Freiburg; Hacettepe University; Hacettepe University; Hacettepe University; University of Munster; University of Belgrade; University of Duisburg Essen; University of Hamburg; University Medical Center Hamburg-Eppendorf; Izmir Dr Behcet Uz Children's Disease & Surgery Training & Research Hospital; Yale University; Howard Hughes Medical Institute	Hildebrandt, F (corresponding author), Harvard Univ, Sch Med, Dept Med, Boston Childrens Hosp, Boston, MA USA.; Hildebrandt, F (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD USA.	friedhelm.hildebrandt@childrens.harvard.edu	Serdaroglu, Erkin/E-9547-2016; Bogdanovic, Radovan/R-8847-2019; Braun, Daniela A/R-2259-2017; Gee, Heon Yung/K-7781-2019; Serdaroglu, Erkin/N-3838-2019; Shril, Shirlee/Q-5825-2016; Antonin, Wolfram/P-3648-2019; Antonin, Wolfram/A-8656-2014; Wang, Guilin/G-8794-2018	Serdaroglu, Erkin/0000-0002-6863-8866; Braun, Daniela A/0000-0003-3146-1566; Gee, Heon Yung/0000-0002-8741-6177; Serdaroglu, Erkin/0000-0002-6863-8866; Antonin, Wolfram/0000-0003-4669-379X; Antonin, Wolfram/0000-0003-4669-379X; CHOI, WONIL/0000-0002-4837-0436; Rao, jia/0000-0003-2839-3419; Hermle, Tobias/0000-0002-0441-7749	US National Institutes of Health [DK076683]; Max Planck Society; National Research Foundation of Korea, Ministry of Science, ICT and Future planning [2015R1D1A1A01056685]; Yonsei University College of Medicine [2015-32-0047]; ASN Foundation for Kidney Research; European Community [2012-305608]; Hacettepe University Infrastructure Project [06A101008]; Howard Hughes Medical Institute; Doris Duke Charitable Foundation; Warren E. Grupe Professorship; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [UM1HG006504] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076683, T32DK007726, R01DK068306, P30DK079310] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Max Planck Society(Max Planck SocietyFoundation CELLEX); National Research Foundation of Korea, Ministry of Science, ICT and Future planning; Yonsei University College of Medicine(General Electric); ASN Foundation for Kidney Research; European Community(European Commission); Hacettepe University Infrastructure Project(Hacettepe University); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); Warren E. Grupe Professorship; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We are grateful to the families and study individuals for their contributions. We thank the Yale Center for Mendelian Genomics for whole-exome sequencing analysis and M. Mihatsch and H. Hopfer (Basel, Switzerland) for providing histology data. This research was supported by a grant from the US National Institutes of Health to F.H. (DK076683) and by core funding of the Max Planck Society to W.A. H.Y.G. is supported by the National Research Foundation of Korea, Ministry of Science, ICT and Future planning (2015R1D1A1A01056685) and faculty seat money from the Yonsei University College of Medicine (2015-32-0047). W.T. is supported by the ASN Foundation for Kidney Research. F.O. is supported by the European Community's Seventh Framework Programme (FP7/2007-2013) (EURenOmics; grant 2012-305608). The Nephrogenetics Laboratory at Hacettepe University was established by the Hacettepe University Infrastructure Project (grant 06A101008). F.H. was also supported by the Howard Hughes Medical Institute, the Doris Duke Charitable Foundation and a Warren E. Grupe Professorship.	Allende ML, 1996, GENE DEV, V10, P3141, DOI 10.1101/gad.10.24.3141; Amlacher S, 2011, CELL, V146, P277, DOI 10.1016/j.cell.2011.06.039; Ashraf S, 2013, J CLIN INVEST, V123, P5179, DOI 10.1172/JCI69000; Basel-Vanagaite L, 2006, ANN NEUROL, V60, P214, DOI 10.1002/ana.20902; Bohnsack MT, 2002, EMBO J, V21, P6205, DOI 10.1093/emboj/cdf613; Boyden LM, 2012, NATURE, V482, P98, DOI 10.1038/nature10814; Brownawell AM, 2002, J CELL BIOL, V156, P53, DOI 10.1083/jcb.200110082; Chen XC, 2010, MOL CELL BIOL, V30, P4022, DOI 10.1128/MCB.00124-10; DUDLEY AT, 1995, GENE DEV, V9, P2795, DOI 10.1101/gad.9.22.2795; Ebarasi L, 2015, AM J HUM GENET, V96, P153, DOI 10.1016/j.ajhg.2014.11.014; Eisenhardt N, 2014, METHOD CELL BIOL, V122, P193, DOI [10.1016/13978-0-12-417160-2.00009-6, 10.1016/B978-0-12-417160-2.00009-6]; Franz C, 2007, EMBO REP, V8, P165, DOI 10.1038/sj.embor.7400889; Gant TM, 1997, ANNU REV CELL DEV BI, V13, P669, DOI 10.1146/annurev.cellbio.13.1.669; Gee HY, 2015, J CLIN INVEST, V125, P2375, DOI 10.1172/JCI79504; Gee HY, 2014, AM J HUM GENET, V94, P884, DOI 10.1016/j.ajhg.2014.04.010; Gee HY, 2013, J CLIN INVEST, V123, P3243, DOI 10.1172/JCI69134; GRANDI P, 1993, EMBO J, V12, P3061, DOI 10.1002/j.1460-2075.1993.tb05975.x; Grandi P, 1997, MOL BIOL CELL, V8, P2017, DOI 10.1091/mbc.8.10.2017; Grossman E, 2012, ANNU REV BIOPHYS, V41, P557, DOI [10.1146/annurev-biophys-050511-102328, 10.1146/annurev-biophys-850511-102328]; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; Halbritter J, 2013, HUM GENET, V132, P865, DOI 10.1007/s00439-013-1297-0; Halbritter J, 2012, J MED GENET, V49, P756, DOI 10.1136/jmedgenet-2012-100973; Hildebrandt F, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000353; Hildebrandt F, 2009, KIDNEY INT, V75, P669, DOI 10.1038/ki.2008.693; Klaassen I, 2015, PEDIATR NEPHROL, V30, P1477, DOI 10.1007/s00467-015-3109-3; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Leeuwis JW, 2011, J PATHOL, V224, P121, DOI 10.1002/path.2844; Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599; Machuca E, 2009, HUM MOL GENET, V18, pR185, DOI 10.1093/hmg/ddp328; Meng XM, 2012, KIDNEY INT, V81, P266, DOI 10.1038/ki.2011.327; Mitu GM, 2007, AM J PHYSIOL-RENAL, V293, pF1641, DOI 10.1152/ajprenal.00179.2007; Nakamura J, 2012, DISCOV MED, V13, P57; Otto EA, 2010, NAT GENET, V42, P840, DOI 10.1038/ng.662; Ruf RG, 2004, J AM SOC NEPHROL, V15, P722, DOI 10.1097/01.ASN.0000113552.59155.72; Sachdev R, 2012, MOL BIOL CELL, V23, P740, DOI 10.1091/mbc.E11-09-0761; Sadowski CE, 2015, J AM SOC NEPHROL, V26, P1279, DOI 10.1681/ASN.2014050489; Saleem MA, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133630; Sayer JA, 2006, NAT GENET, V38, P674, DOI 10.1038/ng1786; Smith JM, 2007, PEDIATR TRANSPLANT, V11, P366, DOI 10.1111/j.1399-3046.2007.00704.x; Strauch K, 2000, AM J HUM GENET, V66, P1945, DOI 10.1086/302911; Theerthagiri G, 2010, J CELL BIOL, V189, P1129, DOI 10.1083/jcb.200912045; Tullio-Pelet A, 2000, NAT GENET, V26, P332, DOI 10.1038/81642; Vollmer B, 2014, BIOL CHEM, V395, P515, DOI 10.1515/hsz-2013-0285; Watanabe M, 2000, EMBO REP, V1, P176, DOI 10.1093/embo-reports/kvd029; Wente SR, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000562; Wiggins RC, 2007, KIDNEY INT, V71, P1205, DOI 10.1038/sj.ki.5002222; Yao XH, 2008, J BIOL CHEM, V283, P22867, DOI 10.1074/jbc.M801320200; Zariwala MA, 2013, AM J HUM GENET, V93, P336, DOI 10.1016/j.ajhg.2013.06.007; Zhang XQ, 2008, CELL, V135, P1017, DOI 10.1016/j.cell.2008.10.022	49	106	111	1	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2016	48	4					457	+		10.1038/ng.3512	http://dx.doi.org/10.1038/ng.3512			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DH6NZ	26878725	Green Accepted, Green Submitted			2022-12-25	WOS:000372908800017
J	Jang, C; Oh, SF; Wada, S; Rowe, GC; Liu, L; Chan, MC; Rhee, J; Hoshino, A; Kim, B; Ibrahim, A; Baca, LG; Kim, E; Ghosh, CC; Parikh, SM; Jiang, AH; Chu, QW; Forman, DE; Lecker, SH; Krishnaiah, S; Rabinowitz, JD; Weljie, AM; Baur, JA; Kasper, DL; Arany, Z				Jang, Cholsoon; Oh, Sungwhan F.; Wada, Shogo; Rowe, Glenn C.; Liu, Laura; Chan, Mun Chun; Rhee, James; Hoshino, Atsushi; Kim, Boa; Ibrahim, Ayon; Baca, Luisa G.; Kim, Esl; Ghosh, Chandra C.; Parikh, Samir M.; Jiang, Aihua; Chu, Qingwei; Forman, Daniel E.; Lecker, Stewart H.; Krishnaiah, Saikumari; Rabinowitz, Joshua D.; Weljie, Aalim M.; Baur, Joseph A.; Kasper, Dennis L.; Arany, Zoltan			A branched-chain amino acid metabolite drives vascular fatty acid transport and causes insulin resistance	NATURE MEDICINE			English	Article							PGC-1-ALPHA; MUSCLE; EXPRESSION; CAPACITY; PLASMA; RISK	Epidemiological and experimental data implicate branched-chain amino acids (BCAAs) in the development of insulin resistance, but the mechanisms that underlie this link remain unclear(1-3). Insulin resistance in skeletal muscle stems from the excess accumulation of lipid species(4), a process that requires blood-borne lipids to initially traverse the blood vessel wall. How this trans-endothelial transport occurs and how it is regulated are not well understood. Here we leveraged PPARGC1a (also known as PGC-1 alpha; encoded by Ppargc1a), a transcriptional coactivator that regulates broad programs of fatty acid consumption, to identify 3-hydroxyisobutyrate (3-HIB), a catabolic intermediate of the BCAA valine, as a new paracrine regulator of trans-endothelial fatty acid transport. We found that 3-HIB is secreted from muscle cells, activates endothelial fatty acid transport, stimulates muscle fatty acid uptake in vivo and promotes lipid accumulation in muscle, leading to insulin resistance in mice. Conversely, inhibiting the synthesis of 3-HIB in muscle cells blocks the ability of PGC-1 alpha to promote endothelial fatty acid uptake. 3-HIB levels are elevated in muscle from db/db mice with diabetes and from human subjects with diabetes, as compared to those without diabetes. These data unveil a mechanism in which the metabolite 3-HIB, by regulating the trans-endothelial flux of fatty acids, links the regulation of fatty acid flux to BCAA catabolism, providing a mechanistic explanation for how increased BCAA catabolic flux can cause diabetes.	[Jang, Cholsoon; Wada, Shogo; Hoshino, Atsushi; Kim, Boa; Ibrahim, Ayon; Chu, Qingwei; Krishnaiah, Saikumari; Weljie, Aalim M.; Baur, Joseph A.; Arany, Zoltan] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Jang, Cholsoon; Rowe, Glenn C.; Liu, Laura; Chan, Mun Chun; Rhee, James; Baca, Luisa G.; Kim, Esl; Ghosh, Chandra C.; Parikh, Samir M.; Jiang, Aihua; Lecker, Stewart H.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Boston, MA 02215 USA; [Oh, Sungwhan F.; Kasper, Dennis L.] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA USA; [Rhee, James] Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02114 USA; [Forman, Daniel E.] Univ Pittsburgh, Dept Med, Pittsburgh, PA USA; [Rabinowitz, Joshua D.] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; [Rowe, Glenn C.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA	University of Pennsylvania; Pennsylvania Medicine; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Princeton University; University of Alabama System; University of Alabama Birmingham	Arany, Z (corresponding author), Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA.	zarany@mail.med.upenn.edu	Weljie, Aalim/V-6952-2019; Rhee, James/V-9973-2019; Krishnaiah, Saikumari/I-7140-2016; Rowe, Glenn/N-5314-2019; Rabinowitz, Joshua/GPP-4019-2022	Weljie, Aalim/0000-0002-7145-4494; Rabinowitz, Joshua/0000-0002-1247-4727; Ibrahim, Ayon/0000-0002-2359-6252; Rowe, Glenn/0000-0002-8195-9605; Jang, Cholsoon/0000-0001-6651-4213	Lotte Scholarship; American Heart Association (AHA); Crohn's and Colitis Foundation of America (Research Fellowship Award); Toyobo Biotechnology Foundation; US National Institute of Arthritis and Musculoskeletal and Skin Diseases [AR062128]; US National Institutes of Health [5 T32 GM7592-35]; US National Heart, Lung, and Blood Institute (NHLBI) [HL093234, HL125275]; US National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [DK095072]; NIDDK [DK098656, DK049210]; NHLBI [HL094499]; AHA; Geis Realty Group Emerging Initiatives Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093234, R01HL094499, R01HL125275, T32HL007374] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007061] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K01AR062128] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK019525, R01DK095072, R01DK098656, P01DK049210, P30DK057521, K01DK102771] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG043483] Funding Source: NIH RePORTER	Lotte Scholarship; American Heart Association (AHA)(American Heart Association); Crohn's and Colitis Foundation of America (Research Fellowship Award); Toyobo Biotechnology Foundation; US National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); US National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); AHA(American Heart Association); Geis Realty Group Emerging Initiatives Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Human endothelial colony forming cells (ECFCs) were kindly provided by J. Bischoff (Boston Children's Hospital). Fatp4<SUP>-/-</SUP> and Cd36<SUP>-/-</SUP> mice were kindly provided by J. Miner (Washington University School of Medicine) and J. Lawler (Harvard Medical School), respectively. Flt1<SUP>flox/flox</SUP> and Kdr<SUP>flox/flox</SUP> mice were kindly provided by Genentech. C.J. is supported by the Lotte Scholarship and American Heart Association (AHA). S.F.O. is supported by the Crohn's and Colitis Foundation of America (Research Fellowship Award). S.W. is supported by the Toyobo Biotechnology Foundation. G.C.R. is supported by the US National Institute of Arthritis and Musculoskeletal and Skin Diseases (AR062128). J.R. is supported by the US National Institutes of Health (5 T32 GM7592-35). S.M.P. is supported by the US National Heart, Lung, and Blood Institute (NHLBI) (HL093234; HL125275) and the US National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (DK095072). Q.C. and J.A.B. are supported by the NIDDK (DK098656; DK049210). Z.A. is supported by the NHLBI (HL094499), the AHA and the Geis Realty Group Emerging Initiatives Fund and Dean and Ann Geis.	ABBOTT NJ, 1992, J CELL SCI, V103, P23; Arany Z, 2008, NATURE, V451, P1008, DOI 10.1038/nature06613; Arany Z, 2007, CELL METAB, V5, P35, DOI 10.1016/j.cmet.2006.12.003; AVOGARO A, 1989, J LIPID RES, V30, P1811; Chan MC, 2014, METABOLISM, V63, P441, DOI 10.1016/j.metabol.2014.01.006; Choi CS, 2008, P NATL ACAD SCI USA, V105, P19926, DOI 10.1073/pnas.0810339105; Darland D. C., 2001, Angiogenesis, V4, P11, DOI 10.1023/A:1016611824696; Forman DE, 2014, J CARD FAIL, V20, P422, DOI 10.1016/j.cardfail.2014.03.007; Giesbertz P, 2015, DIABETOLOGIA, V58, P2133, DOI 10.1007/s00125-015-3656-y; Hagberg CE, 2010, NATURE, V464, P917, DOI 10.1038/nature08945; Handschin C, 2006, ENDOCR REV, V27, P728, DOI 10.1210/er.2006-0037; Hatazawa Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129084; Henkin AH, 2012, ACS CHEM BIOL, V7, P1884, DOI 10.1021/cb300194b; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Mullen E, 2010, INT J MOL MED, V25, P445, DOI 10.3892/ijmm_00000364; Newgard CB, 2012, CELL METAB, V15, P606, DOI 10.1016/j.cmet.2012.01.024; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; Roberts LD, 2014, CELL METAB, V19, P96, DOI 10.1016/j.cmet.2013.12.003; Rowe GC, 2013, CELL REP, V3, P1449, DOI 10.1016/j.celrep.2013.04.023; Sasaki M, 2001, BRAIN DEV-JPN, V23, P243, DOI 10.1016/S0387-7604(01)00196-6; Sawada N, 2014, CELL METAB, V19, P246, DOI 10.1016/j.cmet.2013.12.014; Shulman GI, 2014, NEW ENGL J MED, V371, P1131, DOI 10.1056/NEJMra1011035; Titchenell PM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8078; Wang TJ, 2011, NAT MED, V17, P448, DOI 10.1038/nm.2307; Xie ZH, 2012, BLOOD, V119, P4321, DOI 10.1182/blood-2011-08-375816	25	300	321	1	133	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2016	22	4					421	+		10.1038/nm.4057	http://dx.doi.org/10.1038/nm.4057			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DI4GF	26950361	Green Submitted, Green Accepted			2022-12-25	WOS:000373457700018
J	Li, XR; Rydzewski, N; Hider, A; Zhang, XL; Yang, JS; Wang, WY; Gao, Q; Cheng, XP; Xu, HX				Li, Xinran; Rydzewski, Nicholas; Hider, Ahmad; Zhang, Xiaoli; Yang, Junsheng; Wang, Wuyang; Gao, Qiong; Cheng, Xiping; Xu, Haoxing			A molecular mechanism to regulate lysosome motility for lysosome positioning and tubulation	NATURE CELL BIOLOGY			English	Article							CA2+ CHANNEL; PROTEIN RILP; TRP CHANNEL; MUCOLIPIDOSIS; TRANSPORT; CHOLESTEROL; MEMBRANE; RAB7; KINESIN; TRAFFICKING	To mediate the degradation of biomacromolecules, lysosomes must traffic towards cargo-carrying vesicles for subsequent membrane fusion or fission. Mutations of the lysosomal Ca2+ channel TRPML1 cause lysosomal storage disease (LSD) characterized by disordered lysosomal membrane trafficking in cells. Here we show that TRPML1 activity is required to promote Ca2+-dependent centripetal movement of lysosomes towards the perinuclear region (where autophagosomes accumulate) following autophagy induction. ALG-2, an EF-hand-containing protein, serves as a lysosomal Ca2+ sensor that associates physically with the minus-end-directed dynactin-dynein motor, while PtdIns(3,5) P-2, a lysosome-localized phosphoinositide, acts upstream of TRPML1. Furthermore, the PtdIns(3,5) P-2-TRPML1-ALG-2-dynein signalling is necessary for lysosome tubulation and reformation. In contrast, the TRPML1 pathway is not required for the perinuclear accumulation of lysosomes observed in many LSDs, which is instead likely to be caused by secondary cholesterol accumulation that constitutively activates Rab7-RILP-dependent retrograde transport. Ca2+ release from lysosomes thus provides an on-demand mechanism regulating lysosome motility, positioning and tubulation.	[Li, Xinran; Rydzewski, Nicholas; Hider, Ahmad; Zhang, Xiaoli; Wang, Wuyang; Gao, Qiong; Cheng, Xiping; Xu, Haoxing] Univ Michigan, Dept Mol Cellular & Dev Biol, 3089 Nat Sci Bldg Kraus,830 North Univ, Ann Arbor, MI 48109 USA; [Yang, Junsheng] Zhejiang Univ Technol, Coll Pharmaceut Sci, Collaborat Innovat Ctr Yangtze River Delta Reg Gr, Hangzhou 310014, Zhejiang, Peoples R China	University of Michigan System; University of Michigan; Zhejiang University of Technology	Xu, HX (corresponding author), Univ Michigan, Dept Mol Cellular & Dev Biol, 3089 Nat Sci Bldg Kraus,830 North Univ, Ann Arbor, MI 48109 USA.	haoxingx@umich.edu	xu, hao/GWQ-7394-2022	Gao, Qiong/0000-0002-5281-7392; Yang, Junsheng/0000-0002-6425-8495; Wang, Wuyang/0000-0003-1875-5463	NIH [NS062792, MH096595, AR060837]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060837] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R03MH096595] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS091928, R01NS062792] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH grants (NS062792, MH096595 and AR060837 to H.X.). The authors are grateful to R. Puertollano (NHLBI, NIH, USA) for providing the mCherry-ALG-2 construct, K. Verhey (University of Michigan, USA) for providing GFP-DYNIC2-DN, GFP-dynamitin and KIF5B cDNA constructs, R. Botelho (Ryerson University, Toronto, Canada) for providing the RILP-GFP construct, J. Neefjes (Netherlands Cancer Institute, Netherlands) for providing the ORP1L-GFP construct, and D. Rubinsztein (Cambridge Institute for Medical Research, UK) for providing the LC3 stable cell line. The authors thank R. Hume, R. Fuller, K. Verhey and Y. Wang for their suggestions. We appreciate the encouragement and helpful comments from the Xu laboratory colleagues.	Akhmanova A, 2010, CURR OPIN CELL BIOL, V22, P479, DOI 10.1016/j.ceb.2010.04.008; [Anonymous], 2012, TRAFFIC, V13, P108; Bassi MT, 2000, AM J HUM GENET, V67, P1110, DOI 10.1016/S0002-9297(07)62941-3; Bucci C, 2000, MOL BIOL CELL, V11, P467, DOI 10.1091/mbc.11.2.467; Burkhardt JK, 1997, J CELL BIOL, V139, P469, DOI 10.1083/jcb.139.2.469; Cai XM, 2013, CHEM BIOL, V20, P912, DOI 10.1016/j.chembiol.2013.05.010; Cantalupo G, 2001, EMBO J, V20, P683, DOI 10.1093/emboj/20.4.683; Chang J, 2014, J CLIN INVEST, V124, P5249, DOI 10.1172/JCI77598; Chen CS, 1998, P NATL ACAD SCI USA, V95, P6373, DOI 10.1073/pnas.95.11.6373; Chen HT, 2008, BIOPHYS J, V94, P1508, DOI 10.1529/biophysj.106.099366; Chen Y, 2013, EXP CELL RES, V319, P142, DOI 10.1016/j.yexcr.2012.09.004; Cheng XP, 2014, NAT MED, V20, P1187, DOI 10.1038/nm.3611; Cheng XP, 2010, FEBS LETT, V584, P2013, DOI 10.1016/j.febslet.2009.12.056; Chu BB, 2015, CELL, V161, P291, DOI 10.1016/j.cell.2015.02.019; Cong L, 2015, METHODS MOL BIOL, V1239, P197, DOI 10.1007/978-1-4939-1862-1_10; Curcio-Morelli C, 2010, NEUROBIOL DIS, V40, P370, DOI 10.1016/j.nbd.2010.06.010; Dayam RM, 2015, TRAFFIC, V16, P1010, DOI 10.1111/tra.12303; Dong XP, 2008, NATURE, V455, P992, DOI 10.1038/nature07311; Dong XP, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1037; Firestone AJ, 2012, NATURE, V484, P125, DOI 10.1038/nature10936; Helm JR, 2014, J BIOL CHEM, V289, P23609, DOI 10.1074/jbc.M114.561829; Hirokawa N, 1998, SCIENCE, V279, P519, DOI 10.1126/science.279.5350.519; Ho CY, 2015, J BIOL CHEM, V290, P9919, DOI 10.1074/jbc.M114.613984; Jefferies HBJ, 2008, EMBO REP, V9, P164, DOI 10.1038/sj.embor.7401155; Jin N, 2008, EMBO J, V27, P3221, DOI 10.1038/emboj.2008.248; Johansson M, 2007, J CELL BIOL, V176, P459, DOI 10.1083/jcb.200606077; Jordens I, 2001, CURR BIOL, V11, P1680, DOI 10.1016/S0960-9822(01)00531-0; Kimura S, 2008, CELL STRUCT FUNCT, V33, P109, DOI 10.1247/csf.08005; King SJ, 2003, MOL BIOL CELL, V14, P5089, DOI 10.1091/mbc.E03-01-0025; King SM, 2000, BBA-MOL CELL RES, V1496, P60, DOI 10.1016/S0167-4889(00)00009-4; Korolchuk VI, 2011, NAT CELL BIOL, V13, P453, DOI 10.1038/ncb2204; Kwiatkowska K, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/1750-1172-9-64; Li XR, 2013, P NATL ACAD SCI USA, V110, P21165, DOI 10.1073/pnas.1311864110; Luzio JP, 2007, NAT REV MOL CELL BIO, V8, P622, DOI 10.1038/nrm2217; Maki M, 2011, SCI CHINA LIFE SCI, V54, P770, DOI 10.1007/s11427-011-4204-8; Martin S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060152; Medina DL, 2015, NAT CELL BIOL, V17, P288, DOI 10.1038/ncb3114; Miller A, 2015, TRAFFIC, V16, P284, DOI 10.1111/tra.12249; Mrakovic A, 2012, TRAFFIC, V13, P1667, DOI 10.1111/tra.12003; Onyenwoke RU, 2015, BIOCHEM J, V470, P331, DOI 10.1042/BJ20150219; Reid PC, 2003, J LIPID RES, V44, P1010, DOI 10.1194/jlr.M300009-JLR200; Rocha N, 2009, J CELL BIOL, V185, P1209, DOI 10.1083/jcb.200811005; Rong YG, 2012, NAT CELL BIOL, V14, P924, DOI 10.1038/ncb2557; Rong YG, 2011, P NATL ACAD SCI USA, V108, P7826, DOI 10.1073/pnas.1013800108; Rosa-Ferreira C, 2011, DEV CELL, V21, P1171, DOI 10.1016/j.devcel.2011.10.007; Sainath R, 2015, DEV NEUROBIOL, V75, P757, DOI 10.1002/dneu.22246; Samie M, 2013, DEV CELL, V26, P511, DOI 10.1016/j.devcel.2013.08.003; Samie MA, 2014, J LIPID RES, V55, P995, DOI 10.1194/jlr.R046896; Schroer TA, 2004, ANNU REV CELL DEV BI, V20, P759, DOI 10.1146/annurev.cellbio.20.012103.094623; Schwarz TL, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a011304; Shen DB, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1735; Silver KE, 2011, J IMMUNOL, V186, P816, DOI 10.4049/jimmunol.1002161; Spinosa MR, 2008, J NEUROSCI, V28, P1640, DOI 10.1523/JNEUROSCI.3677-07.2008; SWANSON J, 1987, P NATL ACAD SCI USA, V84, P1921, DOI 10.1073/pnas.84.7.1921; Tanaka Y, 1998, CELL, V93, P1147, DOI 10.1016/S0092-8674(00)81459-2; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; TSIEN RY, 1980, BIOCHEMISTRY-US, V19, P2396, DOI 10.1021/bi00552a018; Venugopal B, 2007, AM J HUM GENET, V81, P1070, DOI 10.1086/521954; Vergarajauregui S, 2008, HUM MOL GENET, V17, P2723, DOI 10.1093/hmg/ddn174; Vergarajauregui S, 2009, J BIOL CHEM, V284, P36357, DOI 10.1074/jbc.M109.047241; Verhey KJ, 2009, NAT REV MOL CELL BIO, V10, P765, DOI 10.1038/nrm2782; Vicinanza M, 2015, MOL CELL, V57, P219, DOI 10.1016/j.molcel.2014.12.007; Wang WY, 2015, P NATL ACAD SCI USA, V112, pE1373, DOI 10.1073/pnas.1419669112; Wang X, 2012, CELL, V151, P372, DOI 10.1016/j.cell.2012.08.036; Wong CO, 2012, CURR BIOL, V22, P1616, DOI 10.1016/j.cub.2012.06.055; Xu HX, 2015, ANNU REV PHYSIOL, V77, P57, DOI 10.1146/annurev-physiol-021014-071649; Xu M, 2013, BBA-MOL CELL RES, V1833, P3228, DOI 10.1016/j.bbamcr.2013.09.015; Yu L, 2010, NATURE, V465, P942, DOI 10.1038/nature09076; Zhang XL, 2012, P NATL ACAD SCI USA, V109, P11384, DOI 10.1073/pnas.1202194109; Zolov SN, 2012, P NATL ACAD SCI USA, V109, P17472, DOI 10.1073/pnas.1203106109	70	218	222	6	73	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2016	18	4					404	+		10.1038/ncb3324	http://dx.doi.org/10.1038/ncb3324			26	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	DH7LX	26950892	Green Published, Green Accepted			2022-12-25	WOS:000372976600008
J	Theodoropoulos, PC; Gonzales, SS; Winterton, SE; Rodriguez-Navas, C; McKnight, JS; Morlock, LK; Hanson, JM; Cross, B; Owen, AE; Duan, YL; Moreno, JR; Lemoff, A; Mirzaei, H; Posner, BA; Williams, NS; Ready, JM; Nijhawan, D				Theodoropoulos, Panayotis C.; Gonzales, Stephen S.; Winterton, Sarah E.; Rodriguez-Navas, Carlos; McKnight, John S.; Morlock, Lorraine K.; Hanson, Jordan M.; Cross, Bethany; Owen, Amy E.; Duan, Yingli; Moreno, Jose R.; Lemoff, Andrew; Mirzaei, Hamid; Posner, Bruce A.; Williams, Noelle S.; Ready, Joseph M.; Nijhawan, Deepak			Discovery of tumor-specific irreversible inhibitors of stearoyl CoA desaturase	NATURE CHEMICAL BIOLOGY			English	Article							CHROMATOGRAPHY-MASS SPECTROMETRY; FATTY-ACIDS; GENE-THERAPY; LUNG-CANCER; ENZYME; EXPRESSION; PROTECTS; POTENT; SENSITIVITY; 4-IPOMEANOL	A hallmark of targeted cancer therapies is selective toxicity among cancer cell lines. We evaluated results from a viability screen of over 200,000 small molecules to identify two chemical series, oxalamides and benzothiazoles, that were selectively toxic at low nanomolar concentrations to the same 4 of 12 human lung cancer cell lines. Sensitive cell lines expressed cytochrome P450 (CYP) 4F11, which metabolized the compounds into irreversible inhibitors of stearoyl CoA desaturase (SCD). SCD is recognized as a promising biological target in cancer and metabolic disease. However, SCD is essential to sebocytes, and accordingly SCD inhibitors cause skin toxicity. Mouse sebocytes did not activate the benzothiazoles or oxalamides into SCD inhibitors, providing a therapeutic window for inhibiting SCD in vivo. We thus offer a strategy to target SCD in cancer by taking advantage of high CYP expression in a subset of tumors.	[Theodoropoulos, Panayotis C.; Gonzales, Stephen S.; Winterton, Sarah E.; Morlock, Lorraine K.; Hanson, Jordan M.; Cross, Bethany; Moreno, Jose R.; Lemoff, Andrew; Mirzaei, Hamid; Posner, Bruce A.; Williams, Noelle S.; Ready, Joseph M.; Nijhawan, Deepak] UT Southwestern Med Ctr, Dept Biochem, Dallas, TX USA; [Rodriguez-Navas, Carlos] UT Southwestern Med Ctr, Dept Mol Genet, Dallas, TX USA; [McKnight, John S.; Owen, Amy E.; Duan, Yingli; Nijhawan, Deepak] UT Southwestern Med Ctr, Dept Internal Med, Dallas, TX USA; [Mirzaei, Hamid; Posner, Bruce A.; Williams, Noelle S.; Ready, Joseph M.; Nijhawan, Deepak] UT Southwestern Med Ctr, Harold C Simmons Comprehens Canc Ctr, Dallas, TX USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Ready, JM; Nijhawan, D (corresponding author), UT Southwestern Med Ctr, Dept Biochem, Dallas, TX USA.; Nijhawan, D (corresponding author), UT Southwestern Med Ctr, Dept Internal Med, Dallas, TX USA.; Ready, JM; Nijhawan, D (corresponding author), UT Southwestern Med Ctr, Harold C Simmons Comprehens Canc Ctr, Dallas, TX USA.	joseph.ready@utsouthwestern.edu; deepak.nijhawan@utsouthwestern.edu		Lemoff, Andrew/0000-0002-4943-0170	Clayton Foundation for Research; US National Institutes of Health [HL20948]; Cancer Prevention Research Institute of Texas (CPRIT) [RP120613]; Simmons Cancer Center (National Cancer Institute) [1P30CA142543-01]; CPRIT [RP110708-C2, RP110708-C3, RP110708-P3]; CTD2 [1 U01 CA176284-01]; Welch Foundation [I-1612]; Disease Oriented Clinical Scholar (DOCS) award; Presidential Research Council (PRC) award; Damon Runyon Clinical Investigator Award [CI-68-13]; NATIONAL CANCER INSTITUTE [P30CA142543, U01CA176284] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL020948] Funding Source: NIH RePORTER	Clayton Foundation for Research; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention Research Institute of Texas (CPRIT); Simmons Cancer Center (National Cancer Institute); CPRIT; CTD2; Welch Foundation(The Welch Foundation); Disease Oriented Clinical Scholar (DOCS) award; Presidential Research Council (PRC) award; Damon Runyon Clinical Investigator Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank S. Yadavalli and D.C. Trudgian for advice on proteomics, D.W.Russell for guidance on biochemical assays of sebaceous glands and preputial gland dissection, J.G. McDonald and M. Mitsche for advice on fatty acid flux analyses, and S.L. McKnight for helpful discussions and suggestions on the manuscript. C.R. N. acknowledges the Clayton Foundation for Research and US National Institutes of Health grant HL20948 for support. H.M. acknowledges the Cancer Prevention Research Institute of Texas (CPRIT; RP120613) for funding. B.A.P. acknowledges the Simmons Cancer Center (National Cancer Institute 1P30CA142543-01), CPRIT (RP110708-C2) and CTD2 (1 U01 CA176284-01) for funding. N.S.W. acknowledges CPRIT (RP110708-C3) for funding. J.M.R. acknowledges CPRIT (RP110708-P3) and the Welch Foundation (I-1612) for funding. D.N. acknowledges the Disease Oriented Clinical Scholar (DOCS) award, the Presidential Research Council (PRC) award, the Welch Foundation (I-1879) and the Damon Runyon Clinical Investigator Award (CI-68-13).	Ackerman D, 2014, TRENDS CELL BIOL, V24, P472, DOI 10.1016/j.tcb.2014.06.001; Bai YH, 2015, NATURE, V524, P252, DOI 10.1038/nature14549; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Cheng JB, 2004, J BIOL CHEM, V279, P37798, DOI 10.1074/jbc.M406226200; Craig R, 2004, BIOINFORMATICS, V20, P1466, DOI 10.1093/bioinformatics/bth092; Dhar M, 2008, J LIPID RES, V49, P612, DOI 10.1194/jlr.M700450-JLR200; Doloff JC, 2014, ANTI-CANCER AGENT ME, V14, P115, DOI 10.2174/18715206113139990309; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Estabrook RW, 1996, FASEB J, V10, P202, DOI 10.1096/fasebj.10.2.8641552; Flowers MT, 2012, J LIPID RES, V53, P1646, DOI 10.1194/jlr.M027508; Fox BG, 2004, ACCOUNTS CHEM RES, V37, P421, DOI 10.1021/ar030186h; Geer LY, 2004, J PROTEOME RES, V3, P958, DOI 10.1021/pr0499491; Hardwick JP, 2008, BIOCHEM PHARMACOL, V75, P2263, DOI 10.1016/j.bcp.2008.03.004; Hess D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011394; Hukkanen J, 2002, CRIT REV TOXICOL, V32, P391, DOI 10.1080/20024091064273; Kim HS, 2013, CELL, V155, P552, DOI 10.1016/j.cell.2013.09.041; Kolb HC, 2001, ANGEW CHEM INT EDIT, V40, P2004, DOI 10.1002/1521-3773(20010601)40:11<2004::AID-ANIE2004>3.0.CO;2-5; Leclerc J, 2010, BIOCHIMIE, V92, P292, DOI 10.1016/j.biochi.2009.12.007; Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100; Liu G, 2007, J MED CHEM, V50, P3086, DOI 10.1021/jm070219p; Mason P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033823; McNaney CA, 2008, ASSAY DRUG DEV TECHN, V6, P121, DOI 10.1089/adt.2007.103; Meingassner JG, 2013, J INVEST DERMATOL, V133, P2091, DOI 10.1038/jid.2013.89; Merck Sharpe & Dohm Corp, 2009, PHARM PHARM MK 8245; Miyata N, 2001, BRIT J PHARMACOL, V133, P325, DOI 10.1038/sj.bjp.0704101; Miyazaki M, 2007, CELL METAB, V6, P484, DOI 10.1016/j.cmet.2007.10.014; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Morselli E, 2014, CELL REP, V9, P633, DOI 10.1016/j.celrep.2014.09.025; Paton CM, 2009, AM J PHYSIOL-ENDOC M, V297, pE28, DOI 10.1152/ajpendo.90897.2008; Quehenberger O, 2011, BBA-MOL CELL BIOL L, V1811, P648, DOI 10.1016/j.bbalip.2011.07.006; Rainov NG, 1998, HUM GENE THER, V9, P1261, DOI 10.1089/hum.1998.9.9-1261; Ramirez RD, 2004, CANCER RES, V64, P9027, DOI 10.1158/0008-5472.CAN-04-3703; Rodriguez-Antona C, 2006, ONCOGENE, V25, P1679, DOI 10.1038/sj.onc.1209377; Roongta UV, 2011, MOL CANCER RES, V9, P1551, DOI 10.1158/1541-7786.MCR-11-0126; ROWINSKY EK, 1993, CANCER RES, V53, P1794; Scaglia N, 2008, INT J ONCOL, V33, P839, DOI 10.3892/ijo_00000072; Shanklin J, 2009, J BIOL CHEM, V284, P18559, DOI 10.1074/jbc.R900009200; Sheehan D.C., 1980, THEORY PRACTICE HIST; SLAUGHTER SR, 1983, J PHARMACOL EXP THER, V224, P252; TALAMO BR, 1969, ANAL BIOCHEM, V29, P300, DOI 10.1016/0003-2697(69)90313-3; Trudgian DC, 2010, BIOINFORMATICS, V26, P1131, DOI 10.1093/bioinformatics/btq081; Wang H, 2015, NAT STRUCT MOL BIOL, V22, P581, DOI 10.1038/nsmb.3049; Woods A.E., 1996, LAB HISTOPATHOLOGY C; Zhang L, 1999, BIOCHEM J, V340, P255, DOI 10.1042/0264-6021:3400255; Zhang ZH, 2014, J MED CHEM, V57, P5039, DOI 10.1021/jm401516c; Zhang ZH, 2013, J MED CHEM, V56, P568, DOI 10.1021/jm301661h	47	46	46	1	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	APR	2016	12	4					218	+		10.1038/NCHEMBIO.2016	http://dx.doi.org/10.1038/NCHEMBIO.2016			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH2DA	26829472	Green Accepted			2022-12-25	WOS:000372593200007
J	Eichel, K; Jullie, D; von Zastrow, M				Eichel, K.; Jullie, D.; von Zastrow, M.			beta-Arrestin drives MAP kinase signalling from clathrin-coated structures after GPCR dissociation	NATURE CELL BIOLOGY			English	Article							PROTEIN-COUPLED RECEPTOR; BETA(2)-ADRENERGIC RECEPTORS; ERK ACTIVATION; IMAGE-ANALYSIS; PIT DYNAMICS; ENDOCYTOSIS; RECRUITMENT; DETERMINES; RHODOPSIN; DYNASORE	beta-Arrestins critically regulate G-protein-coupled receptor (GPCR) signalling, not only 'arresting' the G protein signal but also modulating endocytosis and initiating a discrete G-protein-independent signal through MAP kinase(1-3). Despite enormous recent progress towards understanding biophysical aspects of arrestin function(4,5), arrestin cell biology remains relatively poorly understood. Two key tenets underlie the prevailing current view: beta-arrestin accumulates in clathrin-coated structures (CCSs) exclusively in physical complex with its activating GPCR, and MAP kinase activation requires endocytosis of formed GPCR-beta-arrestin complexes(6-9). We show here, using beta 1-adrenergic receptors, that beta-arrestin-2 (arrestin 3) accumulates robustly in CCSs after dissociating from its activating GPCR and transduces the MAP kinase signal from CCSs. Moreover, inhibiting subsequent endocytosis of CCSs enhances the clathrin-and beta-arrestin-dependent MAP kinase signal. These results demonstrate beta-arrestin 'activation at a distance', after dissociating from its activating GPCR, and signalling from CCSs. We propose a beta-arrestin signalling cycle that is catalytically activated by the GPCR and energetically coupled to the endocytic machinery.	[Eichel, K.] Univ Calif San Francisco, Program Biochem & Mol Biol, San Francisco, CA 94158 USA; [Jullie, D.; von Zastrow, M.] Univ Calif San Francisco, Dept Psychiat, Sch Med, San Francisco, CA 94158 USA; [von Zastrow, M.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, Sch Med, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	von Zastrow, M (corresponding author), Univ Calif San Francisco, Dept Psychiat, Sch Med, San Francisco, CA 94158 USA.; von Zastrow, M (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, Sch Med, San Francisco, CA 94158 USA.	Mark.Vonzastrow@ucsf.edu	Jullie, Damien/AFO-1109-2022	Eichel, Kelsie/0000-0003-4507-5949	US National Institutes of Health [DA 010711, 012864]; National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007810] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R37DA010711, R01DA010711, P01DA010154, R29DA010711, R01DA012864] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank M. Mettlen, G. Danuser and S. Schmid for valuable discussion and help with the cmeAnalysis package used for measuring CCP lifetime, and J. Benovic, V Gurevich and B. Shoichet for valuable discussion. We also thank R. Irannejad, G. Peng, N. Michael, K. Ashrafi, O. Weiner, H. Bourne, and other members of the von Zastrow laboratory for useful advice and critical discussion. All live cell imaging experiments were performed in the Nikon Imaging Center at UCSF; we thank K. Thorn and D. Larsen for essential advice and assistance. This work was supported by grants from the US National Institutes of Health (DA 010711 and 012864 to M.v.Z.). K.E. is a recipient of a National Science Foundation Graduate Research Fellowship.	Aguet F, 2013, DEV CELL, V26, P279, DOI 10.1016/j.devcel.2013.06.019; Ahn SK, 2004, J BIOL CHEM, V279, P35518, DOI 10.1074/jbc.M405878200; Barak LS, 1997, J BIOL CHEM, V272, P27497, DOI 10.1074/jbc.272.44.27497; BENOVIC JL, 1987, P NATL ACAD SCI USA, V84, P8879, DOI 10.1073/pnas.84.24.8879; Boucrot E, 2015, NATURE, V517, P460, DOI 10.1038/nature14067; Cao TT, 1999, NATURE, V401, P286, DOI 10.1038/45816; Daaka Y, 1998, J BIOL CHEM, V273, P685, DOI 10.1074/jbc.273.2.685; DEIGHTON NM, 1992, J PHARMACOL EXP THER, V262, P532; Flores-Otero J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5589; Gaidarov I, 1999, NAT CELL BIOL, V1, P1, DOI 10.1038/8971; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; Grove J, 2014, MOL BIOL CELL, V25, P3581, DOI 10.1091/mbc.E14-06-1154; Gurevich VV, 2014, CURR OPIN CELL BIOL, V27, P1, DOI 10.1016/j.ceb.2013.10.007; Henry AG, 2012, DEV CELL, V23, P519, DOI 10.1016/j.devcel.2012.08.003; Kang YY, 2015, NATURE, V523, P561, DOI 10.1038/nature14656; Kirchhausen T, 2008, METHOD ENZYMOL, V438, P77, DOI 10.1016/S0076-6879(07)38006-3; Liang W, 2004, J CELL SCI, V117, P723, DOI 10.1242/jcs.00878; Marchese A, 2003, TRENDS BIOCHEM SCI, V28, P369, DOI 10.1016/S0968-0004(03)00134-8; McCluskey A, 2013, TRAFFIC, V14, P1272, DOI 10.1111/tra.12119; Merrifield CJ, 2002, NAT CELL BIOL, V4, P691, DOI 10.1038/ncb837; Mondin M, 2011, J NEUROSCI, V31, P13500, DOI 10.1523/JNEUROSCI.6439-10.2011; PALCZEWSKI K, 1991, J BIOL CHEM, V266, P18649; Patel PA, 2009, J MOL CELL CARDIOL, V46, P300, DOI 10.1016/j.yjmcc.2008.11.015; Puthenveedu MA, 2006, CELL, V127, P113, DOI 10.1016/j.cell.2006.08.035; Santini F, 2002, J CELL BIOL, V156, P665, DOI 10.1083/jcb.200110132; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shiina T, 2000, J BIOL CHEM, V275, P29082, DOI 10.1074/jbc.M909757199; Shukla AK, 2014, NATURE, V512, P218, DOI 10.1038/nature13430; Shukla AK, 2011, TRENDS BIOCHEM SCI, V36, P457, DOI 10.1016/j.tibs.2011.06.003; SUZUKI T, 1992, MOL PHARMACOL, V41, P542; Temkin P, 2011, NAT CELL BIOL, V13, P715, DOI 10.1038/ncb2252; Tohgo A, 2003, J BIOL CHEM, V278, P6258, DOI 10.1074/jbc.M212231200; Wei HJ, 2004, J BIOL CHEM, V279, P48255, DOI 10.1074/jbc.M406205200; Yudowski GA, 2009, MOL BIOL CELL, V20, P2774, DOI 10.1091/mbc.E08-08-0892; Zoncu R, 2007, P NATL ACAD SCI USA, V104, P3793, DOI 10.1073/pnas.0611733104	36	145	148	0	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2016	18	3					303	+		10.1038/ncb3307	http://dx.doi.org/10.1038/ncb3307			17	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	DF0LT	26829388	Green Accepted			2022-12-25	WOS:000371031300011
J	Campbell, JE; Ussher, JR; Mulvihill, EE; Kolic, J; Baggio, LL; Cao, XM; Liu, Y; Lamont, BJ; Morii, T; Streutker, CJ; Tamarina, N; Philipson, LH; Wrana, JL; MacDonald, PE; Drucker, DJ				Campbell, Jonathan E.; Ussher, John R.; Mulvihill, Erin E.; Kolic, Jelena; Baggio, Laurie L.; Cao, Xiemen; Liu, Yu; Lamont, Benjamin J.; Morii, Tsukasa; Streutker, Catherine J.; Tamarina, Natalia; Philipson, Louis H.; Wrana, Jeffrey L.; MacDonald, Patrick E.; Drucker, Daniel J.			TCF1 links GIPR signaling to the control of beta cell function and survival	NATURE MEDICINE			English	Article							GLUCAGON-LIKE PEPTIDE-1; DEPENDENT INSULINOTROPIC POLYPEPTIDE; GASTRIC-INHIBITORY POLYPEPTIDE; GLP-1 RECEPTOR ACTIVATION; TUMOR-TRANSFORMING GENE; GLUCOSE-INTOLERANCE; DOWN-REGULATION; ISLET FUNCTION; NULL MICE; EXPRESSION	The glucagon-like peptide-1 (GLP-1) receptor and the glucose-dependent insulinotropic polypeptide (GIP) receptor transduce nutrient-stimulated signals to control beta cell function(1). Although the GLP-1 receptor (GLP-1R) is a validated drug target for diabetes(1), the importance of the GIP receptor (GIPR) for the function of beta cells remains uncertain(2-4). We demonstrate that mice with selective ablation of GIPR in beta cells (MIP-Cre: Gipr(Flox/Flox); Gipr(-/-beta Cell)) exhibit lower levels of meal-stimulated insulin secretion, decreased expansion of adipose tissue mass and preservation of insulin sensitivity when compared to MIP-Cre controls. Beta cells from Gipr(-/-beta Cell) mice display greater sensitivity to apoptosis and markedly lower islet expression of T cell-specific transcription factor-1 (TCF1, encoded by Tcf7), a protein not previously characterized in beta cells. GIP, but not GLP-1, promotes beta cell Tcf7 expression via a cyclic adenosine monophosphate (cAMP)-independent and extracellular signal-regulated kinase (ERK)-dependent pathway. Tcf7 (in mice) or TCF7 (in humans) levels are lower in islets taken from diabetic mice and in humans with type 2 diabetes; knockdown of TCF7 in human and mouse islets impairs the cytoprotective responsiveness to GIP and enhances the magnitude of apoptotic injury, whereas restoring TCF1 levels in beta cells from Gipr(-/-beta Cell) mice lowers the number of apoptotic cells compared to that seen in MIP-Cre controls. Tcf7(-/-) mice show impaired insulin secretion, deterioration of glucose tolerance with either aging and/or high-fat feeding and increased sensitivity to beta cell injury relative to wild-type (WT) controls. Hence the GIPR-TCF1 axis represents a potential therapeutic target for preserving both the function and survival of vulnerable, diabetic beta cells.	[Campbell, Jonathan E.; Ussher, John R.; Mulvihill, Erin E.; Baggio, Laurie L.; Cao, Xiemen; Liu, Yu; Lamont, Benjamin J.; Morii, Tsukasa; Wrana, Jeffrey L.; Drucker, Daniel J.] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON M5G 1X5, Canada; [Kolic, Jelena; MacDonald, Patrick E.] Univ Alberta, Dept Pharmacol, Edmonton, AB, Canada; [Kolic, Jelena; MacDonald, Patrick E.] Univ Alberta, Alberta Diabet Inst, Edmonton, AB, Canada; [Streutker, Catherine J.] Univ Toronto, St Michaels Hosp, Toronto, ON, Canada; [Tamarina, Natalia; Philipson, Louis H.] Univ Chicago, Dept Med, Kovler Diabet Ctr, Chicago, IL 60637 USA; [Drucker, Daniel J.] Univ Toronto, Dept Med, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Alberta; University of Alberta; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Chicago; University of Toronto	Drucker, DJ (corresponding author), Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON M5G 1X5, Canada.	drucker@lunenfeld.ca	Drucker, Daniel J/A-4092-2010; Wrana, Jeffrey/F-8857-2013	LIU, YU/0000-0001-8359-6732; Kolic, Jelena/0000-0003-4151-1280; MacDonald, Patrick/0000-0002-5439-6288; Campbell, Jonathan/0000-0001-8223-1600	Canada Research Chairs Program; Banting and Best Diabetes Centre Novo Nordisk Chair in Incretin Biology; Canadian Institute for Health Research (CIHR) [82700, 123391]; Alberta Diabetes Foundation; Canadian Diabetes Association; Banting and Best Diabetes Centre; Alberta Innovates Health Solutions	Canada Research Chairs Program(Canada Research Chairs); Banting and Best Diabetes Centre Novo Nordisk Chair in Incretin Biology; Canadian Institute for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Alberta Diabetes Foundation; Canadian Diabetes Association; Banting and Best Diabetes Centre; Alberta Innovates Health Solutions	The authors thank H. Bates for excellent technical assistance and B. Yusta for thoughtful discussions and critical reading of the manuscript; H. Clevers for Tcf7<SUP>-/-</SUP> mice; and R. DiMarchi for critical reagents. This work in Toronto was supported by the Canada Research Chairs Program, the Banting and Best Diabetes Centre Novo Nordisk Chair in Incretin Biology, and Canadian Institute for Health Research (CIHR) grants 82700 and 123391 (DJD). We thank the Human Organ Procurement and Exchange (HOPE) program and the Trillium Gift of Life Network (TGLN) for their assistance in obtaining pancreases and islets from human organ donors for research, and we thank J. Lyon (Alberta Diabetes Institute; http://www.bcell.org/isletcore.html) and T. Kin and A.M.J. Shapiro (University of Alberta, Clinical Islet Isolation Facility) for human islet isolation. The Alberta Diabetes Foundation funded the human islet isolations. Work at the University of Alberta was funded by a grant from the Canadian Diabetes Association (to P.E.M.). P.E.M. holds a Canada Research Chair in Islet Biology. Postdoctoral fellowship funding was provided by the Canadian Institute for Health Research (J.E.C., J.R.U., and E.E.M.), Banting and Best Diabetes Centre (J.E.C.), the Canadian Diabetes Association (E.E.M.) and Alberta Innovates Health Solutions (J.R.U.). D.J.D. is the main guarantor of this work and takes responsibility for all content.	Ali S, 2011, J CLIN INVEST, V121, P1917, DOI 10.1172/JCI43615; Boj SF, 2012, CELL, V151, P1595, DOI 10.1016/j.cell.2012.10.053; Brouwers B, 2014, CELL METAB, V20, P979, DOI 10.1016/j.cmet.2014.11.004; Campbell JE, 2013, CELL METAB, V17, P819, DOI 10.1016/j.cmet.2013.04.008; Chen S, 2015, AM J PHYSIOL-ENDOC M, V308, pE414, DOI 10.1152/ajpendo.00418.2014; Chesnokova V, 2009, ENDOCRINOLOGY, V150, P2603, DOI 10.1210/en.2008-0972; Columbus J, 2010, J ENDOCRINOL, V207, P77, DOI 10.1677/JOE-10-0044; Erlich HA, 2009, GENES IMMUN, V10, pS54, DOI 10.1038/gene.2009.92; Finan B, 2015, NAT MED, V21, P27, DOI 10.1038/nm.3761; Finan B, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007218; Florez JC, 2006, NEW ENGL J MED, V355, P241, DOI 10.1056/NEJMoa062418; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Hojberg PV, 2009, DIABETOLOGIA, V52, P199, DOI 10.1007/s00125-008-1195-5; Ioannidis V, 2001, NAT IMMUNOL, V2, P691, DOI 10.1038/90623; Kaur K, 2015, DIABETES, V64, P3659, DOI 10.2337/db14-1924; Kim SJ, 2005, J BIOL CHEM, V280, P22297, DOI 10.1074/jbc.M500540200; Lamont BJ, 2008, DIABETES, V57, P190, DOI 10.2337/db07-1202; Lamont BJ, 2012, J CLIN INVEST, V122, P388, DOI 10.1172/JCI42497; Li YZ, 2003, J BIOL CHEM, V278, P471, DOI 10.1074/jbc.M209423200; Lyssenko V, 2011, DIABETES, V60, P2424, DOI 10.2337/db10-1532; Maida A, 2009, GASTROENTEROLOGY, V137, P2146, DOI 10.1053/j.gastro.2009.09.004; Mayo KE, 2003, PHARMACOL REV, V55, P167, DOI 10.1124/pr.55.1.6; Mehran AE, 2012, CELL METAB, V16, P723, DOI 10.1016/j.cmet.2012.10.019; Meier JJ, 2012, NAT REV ENDOCRINOL, V8, P728, DOI 10.1038/nrendo.2012.140; Miyawaki K, 2002, NAT MED, V8, P738, DOI 10.1038/nm727; Miyawaki K, 1999, P NATL ACAD SCI USA, V96, P14843, DOI 10.1073/pnas.96.26.14843; Mulvihill EE, 2014, ENDOCR REV, V35, P992, DOI 10.1210/er.2014-1035; NAUCK MA, 1993, J CLIN INVEST, V91, P301, DOI 10.1172/JCI116186; Noble JA, 2003, DIABETES, V52, P1579, DOI 10.2337/diabetes.52.6.1579; Oropeza D, 2015, DIABETES, V64, P3798, DOI 10.2337/db15-0272; Pamir N, 2003, AM J PHYSIOL-ENDOC M, V284, pE931, DOI 10.1152/ajpendo.00270.2002; Patterson JT, 2011, ACS CHEM BIOL, V6, P135, DOI 10.1021/cb1002015; Pederson RA, 1998, DIABETES, V47, P1046, DOI 10.2337/diabetes.47.7.1046; Saxena R, 2010, NAT GENET, V42, P142, DOI 10.1038/ng.521; Scrocchi LA, 1996, NAT MED, V2, P1254, DOI 10.1038/nm1196-1254; Shu L, 2008, DIABETES, V57, P645, DOI 10.2337/db07-0847; Shu LA, 2009, HUM MOL GENET, V18, P2388, DOI 10.1093/hmg/ddp178; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; vandeWetering M, 1996, MOL CELL BIOL, V16, P745; VERBEEK S, 1995, NATURE, V374, P70, DOI 10.1038/374070a0; Vlotides G, 2007, ENDOCR REV, V28, P165, DOI 10.1210/er.2006-0042; Wang ZY, 2003, P NATL ACAD SCI USA, V100, P3428, DOI 10.1073/pnas.0638052100; Wessel J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6897; Wicksteed B, 2010, DIABETES, V59, P3090, DOI 10.2337/db10-0624; Yusta B, 2006, CELL METAB, V4, P391, DOI 10.1016/j.cmet.2006.10.001	45	71	74	1	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2016	22	1					84	+		10.1038/nm.3997	http://dx.doi.org/10.1038/nm.3997			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DA1YA	26642437				2022-12-25	WOS:000367590700019
J	Gymrek, M; Willems, T; Guilmatre, A; Zeng, HY; Markus, B; Georgiev, S; Daly, MJ; Price, AL; Pritchard, JK; Sharp, AJ; Erlich, Y				Gymrek, Melissa; Willems, Thomas; Guilmatre, Audrey; Zeng, Haoyang; Markus, Barak; Georgiev, Stoyan; Daly, Mark J.; Price, Alkes L.; Pritchard, Jonathan K.; Sharp, Andrew J.; Erlich, Yaniv			Abundant contribution of short tandem repeats to gene expression variation in humans	NATURE GENETICS			English	Article							POLYMORPHIC DINUCLEOTIDE REPEAT; GENOME-WIDE ASSOCIATION; REGULATORY SEQUENCES; TRINUCLEOTIDE REPEAT; PROMOTER ACTIVITY; PHASE VARIATION; HUMAN-DISEASE; SERUM URATE; RNA-SEQ; MICROSATELLITE	The contribution of repetitive elements to quantitative human traits is largely unknown. Here we report a genome-wide survey of the contribution of short tandem repeats (STRs), which constitute one of the most polymorphic and abundant repeat classes, to gene expression in humans. Our survey identified 2,060 significant expression STRs (eSTRs). These eSTRs were replicable in orthogonal populations and expression assays. We used variance partitioning to disentangle the contribution of eSTRs from that of linked SNPs and indels and found that eSTRs contribute 10-15% of the cis heritability mediated by all common variants. Further functional genomic analyses showed that eSTRs are enriched in conserved regions, colocalize with regulatory elements and may modulate certain histone modifications. By analyzing known genome-wide association study (GWAS) signals and searching for new associations in 1,685 whole genomes from deeply phenotyped individuals, we found that eSTRs are enriched in various clinically relevant conditions. These results highlight the contribution of STRs to the genetic architecture of quantitative human traits.	[Gymrek, Melissa; Willems, Thomas; Markus, Barak; Erlich, Yaniv] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Gymrek, Melissa] MIT, Harvard MIT Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Gymrek, Melissa; Daly, Mark J.; Price, Alkes L.] Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA USA; [Gymrek, Melissa; Willems, Thomas; Erlich, Yaniv] New York Genome Ctr, New York, NY USA; [Willems, Thomas] MIT, Computat & Syst Biol Program, Cambridge, MA 02139 USA; [Guilmatre, Audrey; Sharp, Andrew J.] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Guilmatre, Audrey] Hop Robert Debre, Dept Pediat Hematol, F-75019 Paris, France; [Zeng, Haoyang] MIT, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA; [Georgiev, Stoyan; Pritchard, Jonathan K.] Stanford Univ, Dept Genet & Biol, Stanford, CA 94305 USA; [Daly, Mark J.] Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [Price, Alkes L.] Harvard Univ, TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Price, Alkes L.] Harvard Univ, TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Pritchard, Jonathan K.] Howard Hughes Med Inst, Chevy Chase, MD USA; [Erlich, Yaniv] Columbia Univ, Dept Comp Sci, Fu Fdn Sch Engn, New York, NY 10027 USA; [Erlich, Yaniv] Columbia Univ, Ctr Computat Biol & Bioinformat, New York, NY USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Harvard University; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Icahn School of Medicine at Mount Sinai; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Massachusetts Institute of Technology (MIT); Stanford University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Howard Hughes Medical Institute; Columbia University; Columbia University	Erlich, Y (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	yaniv@cs.columbia.edu	Daly, Mark J/B-2453-2017	Daly, Mark J/0000-0002-0949-8752	National Defense Science and Engineering Graduate Fellowship; National Institute of Justice (NIJ) [2014-DN-BX-K089]; US National Institutes of Health (NIH) [1U01HG007037, R01MH084703, R01HG006399, HG006696, DA033660, MH097018]; March of Dimes Foundation [6-FY13-92]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006399, R01HG006696, U01HG007037] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH097018, R01MH084703] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA033660] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD018522] Funding Source: NIH RePORTER	National Defense Science and Engineering Graduate Fellowship; National Institute of Justice (NIJ); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes Foundation(March of Dimes); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank T. Lappalainen, A. Goren, T. Hashimoto and D. Zielinksi for useful comments and discussions. M.G. was supported by the National Defense Science and Engineering Graduate Fellowship. Y.E. holds a Career Award at the Scientific Interface from the Burroughs Wellcome Fund. This study was supported by a gift from Andria and Paul Heafy (Y.E.), National Institute of Justice (NIJ) grant 2014-DN-BX-K089 (Y.E. and T.W.), and US National Institutes of Health (NIH) grants 1U01HG007037 (H.Z.), R01MH084703 (J.K.P.), R01HG006399 (A.L.P.), HG006696 (A.J.S.), DA033660 (A.J.S.) and MH097018 (A.J.S.) and by research grant 6-FY13-92 from the March of Dimes Foundation (A.J.S.).	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Barbosa-Morais NL, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp942; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Bhatia G, 2015, BIORXIV, DOI [10.1101/022418, DOI 10.1101/022418]; Borel C, 2012, HUM MUTAT, V33, P1302, DOI 10.1002/humu.22115; Chaisson MJP, 2015, NATURE, V517, P608, DOI 10.1038/nature13907; Contente A, 2002, NAT GENET, V30, P315, DOI 10.1038/ng836; Doring A, 2008, NAT GENET, V40, P430, DOI 10.1038/ng.107; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; DUYAO M, 1993, NAT GENET, V4, P387, DOI 10.1038/ng0893-387; Ellegren H, 2004, NAT REV GENET, V5, P435, DOI 10.1038/nrg1348; Ernst J, 2012, NAT METHODS, V9, P215, DOI 10.1038/nmeth.1906; Flicek P, 2013, NUCLEIC ACIDS RES, V41, pD48, DOI 10.1093/nar/gks1236; Gaffney DJ, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-1-r7; Gebhardt F, 1999, J BIOL CHEM, V274, P13176, DOI 10.1074/jbc.274.19.13176; Gemayel R, 2010, ANNU REV GENET, V44, P445, DOI 10.1146/annurev-genet-072610-155046; Grunewald TGP, 2015, NAT GENET, V47, P1073, DOI 10.1038/ng.3363; Grundberg E, 2012, NAT GENET, V44, P1084, DOI 10.1038/ng.2394; Guilmatre A, 2013, HUM MUTAT, V34, P1304, DOI 10.1002/humu.22359; Gymrek M, 2012, GENOME RES, V22, P1154, DOI 10.1101/gr.135780.111; Hammock EAD, 2005, SCIENCE, V308, P1630, DOI 10.1126/science.1111427; Hefferon TW, 2004, P NATL ACAD SCI USA, V101, P3504, DOI 10.1073/pnas.0400182101; Hui JY, 2005, EMBO J, V24, P1988, DOI 10.1038/sj.emboj.7600677; Hui JY, 2003, NAT STRUCT BIOL, V10, P33, DOI 10.1038/nsb875; Ioannidis JPA, 2008, EPIDEMIOLOGY, V19, P640, DOI 10.1097/EDE.0b013e31818131e7; Karolchik D, 2014, NUCLEIC ACIDS RES, V42, pD764, DOI 10.1093/nar/gkt1168; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Lamina C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102113; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; LASPADA AR, 1992, NAT GENET, V2, P301, DOI 10.1038/ng1292-301; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Martin P, 2005, P NATL ACAD SCI USA, V102, P3800, DOI 10.1073/pnas.0406805102; Mirkin SM, 2007, NATURE, V447, P932, DOI 10.1038/nature05977; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Montgomery SB, 2013, GENOME RES, V23, P749, DOI 10.1101/gr.148718.112; Nica AC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000895; Nicolae DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000888; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Payseur BA, 2008, AM J HUM GENET, V82, P1039, DOI 10.1016/j.ajhg.2008.02.018; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; Press MO, 2014, TRENDS GENET, V30, P504, DOI 10.1016/j.tig.2014.07.008; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rockman MV, 2002, MOL BIOL EVOL, V19, P1991, DOI 10.1093/oxfordjournals.molbev.a004023; Rothenburg S, 2001, P NATL ACAD SCI USA, V98, P8985, DOI 10.1073/pnas.121176998; Sathasivam K, 2013, P NATL ACAD SCI USA, V110, P2366, DOI 10.1073/pnas.1221891110; Sawaya S, 2015, BIORXIV, DOI [10.1101/020909, DOI 10.1101/020909]; Sawaya S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054710; Shimajiri S, 1999, FEBS LETT, V455, P70, DOI 10.1016/S0014-5793(99)00863-7; Shin SY, 2014, NAT GENET, V46, P543, DOI 10.1038/ng.2982; Sonay TB, 2015, GENOME RES, V25, P1591, DOI 10.1101/gr.190868.115; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Stranger BE, 2012, PLOS GENET, V8, P272, DOI 10.1371/journal.pgen.1002639; Sureshkumar S, 2009, SCIENCE, V323, P1060, DOI 10.1126/science.1164014; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Trynka G, 2015, AM J HUM GENET, V97, P139, DOI 10.1016/j.ajhg.2015.05.016; Vinces MD, 2009, SCIENCE, V324, P1213, DOI 10.1126/science.1170097; Vitart V, 2008, NAT GENET, V40, P437, DOI 10.1038/ng.106; Wallace C, 2008, AM J HUM GENET, V82, P139, DOI 10.1016/j.ajhg.2007.11.001; Walter K, 2015, NATURE, V526, P82, DOI 10.1038/nature14962; Ward LD, 2012, NAT BIOTECHNOL, V30, P1095, DOI 10.1038/nbt.2422; Warpeha KM, 1999, FASEB J, V13, P1825, DOI 10.1096/fasebj.13.13.1825; Weber JL, 2001, ADV GENET, V42, P77, DOI 10.1016/S0065-2660(01)42016-5; WEBER JL, 1993, HUM MOL GENET, V2, P1123, DOI 10.1093/hmg/2.8.1123; WEISER JN, 1989, CELL, V59, P657, DOI 10.1016/0092-8674(89)90011-1; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; WILLEMS R, 1990, EMBO J, V9, P2803, DOI 10.1002/j.1460-2075.1990.tb07468.x; Willems T, 2014, GENOME RES, V24, P1894, DOI 10.1101/gr.177774.114; Wright FA, 2014, NAT GENET, V46, P430, DOI 10.1038/ng.2951; Yanez-Cuna JO, 2014, GENOME RES, V24, P1147, DOI 10.1101/gr.169243.113; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; YOGEV D, 1991, EMBO J, V10, P4069, DOI 10.1002/j.1460-2075.1991.tb04983.x; Zeng HY, 2016, BIOINFORMATICS, V32, P490, DOI 10.1093/bioinformatics/btv565	77	168	170	0	50	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2016	48	1					22	+		10.1038/ng.3461	http://dx.doi.org/10.1038/ng.3461			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CZ7BQ	26642241	Green Submitted, Green Accepted			2022-12-25	WOS:000367255300009
J	Dumont, NA; Wang, YX; von Maltzahn, J; Pasut, A; Bentzinger, CF; Brun, CE; Rudnicki, MA				Dumont, Nicolas A.; Wang, Yu Xin; von Maltzahn, Julia; Pasut, Alessandra; Bentzinger, C. Florian; Brun, Caroline E.; Rudnicki, Michael A.			Dystrophin expression in muscle stem cells regulates their polarity and asymmetric division	NATURE MEDICINE			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; ADULT SKELETAL-MUSCLE; SATELLITE CELLS; SELF-RENEWAL; MDX MICE; SPINDLE ORIENTATION; MITOTIC SPINDLE; PAR-COMPLEX; AURORA-A; MOUSE	Dystrophin is expressed in differentiated myofibers, in which it is required for sarcolemmal integrity, and loss-of-function mutations in the gene that encodes it result in Duchenne muscular dystrophy (DMD), a disease characterized by progressive and severe skeletal muscle degeneration. Here we found that dystrophin is also highly expressed in activated muscle stem cells (also known as satellite cells), in which it associates with the serine-threonine kinase Mark2 (also known as Par1b), an important regulator of cell polarity. In the absence of dystrophin, expression of Mark2 protein is downregulated, resulting in the inability to localize the cell polarity regulator Pard3 to the opposite side of the cell. Consequently, the number of asymmetric divisions is strikingly reduced in dystrophin-deficient satellite cells, which also display a loss of polarity, abnormal division patterns (including centrosome amplification), impaired mitotic spindle orientation and prolonged cell divisions. Altogether, these intrinsic defects strongly reduce the generation of myogenic progenitors that are needed for proper muscle regeneration. Therefore, we conclude that dystrophin has an essential role in the regulation of satellite cell polarity and asymmetric division. Our findings indicate that muscle wasting in DMD not only is caused by myofiber fragility, but also is exacerbated by impaired regeneration owing to intrinsic satellite cell dysfunction.	[Dumont, Nicolas A.; Wang, Yu Xin; von Maltzahn, Julia; Pasut, Alessandra; Bentzinger, C. Florian; Brun, Caroline E.; Rudnicki, Michael A.] Ottawa Hosp Res Inst, Regenerat Med Program, Sprott Ctr Stem Cell Res, Ottawa, ON, Canada; [Dumont, Nicolas A.; Wang, Yu Xin; von Maltzahn, Julia; Pasut, Alessandra; Bentzinger, C. Florian; Brun, Caroline E.; Rudnicki, Michael A.] Univ Ottawa, Fac Med, Dept Cellular & Mol Med, Ottawa, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa	Rudnicki, MA (corresponding author), Ottawa Hosp Res Inst, Regenerat Med Program, Sprott Ctr Stem Cell Res, Ottawa, ON, Canada.	mrudnicki@ohri.ca	von Maltzahn, Julia/AFP-2284-2022; von Maltzahn, Julia/A-6689-2017; Bentzinger, C. Florian/A-1151-2015	von Maltzahn, Julia/0000-0001-7674-1487; von Maltzahn, Julia/0000-0001-7674-1487; Bentzinger, C. Florian/0000-0003-0422-9622; Rudnicki, Michael/0000-0002-3866-5249; Wang, Yu Xin/0000-0001-8440-9388; Brun, Caroline/0000-0003-2824-5221	Canadian Institutes of Health Research (CIHR); Queen Elizabeth II Graduate Scholarships in Science and Technology; CIHR [MOP-12080, MOP-81288]; Deutsche Forschungsgemeinschaft; Swiss National Science Foundation; Ontario Institute for Regenerative Medicine; US National Institutes for Health [RO1AR044031]; E-Rare-2 program from the CIHR; Muscular Dystrophy Canada [ERA-132935]; Muscular Dystrophy Association; Stem Cell Network; Ministry of Research and Innovation (MRI), Government of Ontario [ORF-RE05-084]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044031] Funding Source: NIH RePORTER	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Queen Elizabeth II Graduate Scholarships in Science and Technology; CIHR(Canadian Institutes of Health Research (CIHR)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Ontario Institute for Regenerative Medicine; US National Institutes for Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); E-Rare-2 program from the CIHR(Canadian Institutes of Health Research (CIHR)); Muscular Dystrophy Canada(Muscular Dystrophy Association); Muscular Dystrophy Association(Muscular Dystrophy Association); Stem Cell Network; Ministry of Research and Innovation (MRI), Government of Ontario; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank J. Dilworth and L. Megeney for careful reading of the manuscript. We also thank J. Ritchie for animal husbandry, and J. Fernandes and P. Oleynik of the flow cytometry facility of the StemCore laboratories for technical assistance. N.A.D. is supported by a Postdoctoral Fellowship from the Canadian Institutes of Health Research (CIHR); Y.X.W. is supported by fellowships from the Queen Elizabeth II Graduate Scholarships in Science and Technology and the CIHR; J.v.M. was supported by a grant from the Deutsche Forschungsgemeinschaft; C.F.B. was supported by a grant from the Swiss National Science Foundation; C.E.B. is supported by a Postdoctoral Fellowship from the Ontario Institute for Regenerative Medicine; and M.A.R. holds the Canada Research Chair in Molecular Genetics. These studies were carried out with support from grants to M.A.R. from the US National Institutes for Health (grant no. RO1AR044031), the CIHR (grant no. MOP-12080 and MOP-81288), the E-Rare-2 program from the CIHR and Muscular Dystrophy Canada (grant no. ERA-132935), the Muscular Dystrophy Association, the Stem Cell Network and the Ministry of Research and Innovation (MRI), Government of Ontario (grant no. ORF-RE05-084).	ANDERSON MS, 1992, TRENDS BIOCHEM SCI, V17, P289, DOI 10.1016/0968-0004(92)90437-E; Bentzinger CF, 2013, CELL STEM CELL, V12, P75, DOI 10.1016/j.stem.2012.09.015; Briguet A, 2004, NEUROMUSCULAR DISORD, V14, P675, DOI 10.1016/j.nmd.2004.06.008; Carmena M, 2003, NAT REV MOL CELL BIO, V4, P842, DOI 10.1038/nrm1245; Chakkalakal JV, 2014, DEVELOPMENT, V141, P1649, DOI 10.1242/dev.100842; Cohn RD, 2002, CELL, V110, P639, DOI 10.1016/S0092-8674(02)00907-8; Cohn RD, 2000, MUSCLE NERVE, V23, P1456, DOI 10.1002/1097-4598(200010)23:10<1456::AID-MUS2>3.0.CO;2-T; De Stefano ME, 2005, NEUROBIOL DIS, V20, P929, DOI 10.1016/j.nbd.2005.06.006; Florencia G, 2004, NEUROL RES, V26, P83, DOI 10.1179/016164104773026589; Fredriksson S, 2002, NAT BIOTECHNOL, V20, P473, DOI 10.1038/nbt0502-473; Fukada SI, 2007, STEM CELLS, V25, P2448, DOI 10.1634/stemcells.2007-0019; Galluzzi L, 2012, CELL DEATH DIFFER, V19, P107, DOI 10.1038/cdd.2011.96; Goulas S, 2012, CELL STEM CELL, V11, P529, DOI 10.1016/j.stem.2012.06.017; Hayashiji N, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7745; HUARD J, 1991, MUSCLE NERVE, V14, P178, DOI 10.1002/mus.880140213; Hurov JB, 2001, MOL CELL BIOL, V21, P3206, DOI 10.1128/MCB.21.9.3206-3219.2001; Irintchev A, 1997, NEUROMUSCULAR DISORD, V7, P117, DOI 10.1016/S0960-8966(96)00422-1; Knoblich JA, 2008, CELL, V132, P583, DOI 10.1016/j.cell.2008.02.007; Knoblich JA, 2010, NAT REV MOL CELL BIO, V11, P849, DOI 10.1038/nrm3010; KOENIG M, 1987, CELL, V50, P509, DOI 10.1016/0092-8674(87)90504-6; Kollu S, 2015, STEM CELL REP, V4, P1061, DOI 10.1016/j.stemcr.2015.04.006; Kottlors M, 2010, CELL TISSUE RES, V340, P541, DOI 10.1007/s00441-010-0976-6; Kuang SH, 2007, CELL, V129, P999, DOI 10.1016/j.cell.2007.03.044; Kwon M, 2008, GENE DEV, V22, P2189, DOI 10.1101/gad.1700908; Lee CY, 2006, GENE DEV, V20, P3464, DOI 10.1101/gad.1489406; Lewandowski KT, 2014, J CELL SCI, V127, P315, DOI 10.1242/jcs.129148; Liu L, 2013, CELL REP, V4, P189, DOI 10.1016/j.celrep.2013.05.043; Long CZ, 2014, SCIENCE, V345, P1184, DOI 10.1126/science.1254445; Lu MS, 2013, DEVELOPMENT, V140, P1843, DOI 10.1242/dev.087627; Marumoto T, 2005, NAT REV CANCER, V5, P42, DOI 10.1038/nrc1526; Masuda-Hirata M, 2009, GENES CELLS, V14, P835, DOI 10.1111/j.1365-2443.2009.01315.x; MIRANDA AF, 1988, AM J PATHOL, V132, P410; Morrison SJ, 2006, NATURE, V441, P1068, DOI 10.1038/nature04956; Neumuller RA, 2009, GENE DEV, V23, P2675, DOI 10.1101/gad.1850809; Nishijo K, 2009, FASEB J, V23, P2681, DOI 10.1096/fj.08-128116; Ono Y, 2012, J CELL SCI, V125, P1309, DOI 10.1242/jcs.096198; Pasut A, 2013, JOVE-J VIS EXP, DOI 10.3791/50074; Pasut A, 2012, METHODS MOL BIOL, V798, P53, DOI 10.1007/978-1-61779-343-1_3; Reimann J, 2000, NEUROMUSCULAR DISORD, V10, P276, DOI 10.1016/S0960-8966(99)00118-2; Rocheteau P, 2012, CELL, V148, P112, DOI 10.1016/j.cell.2011.11.049; Ross J, 2012, STEM CELLS, V30, P2330, DOI 10.1002/stem.1197; Sacco A, 2010, CELL, V143, P1059, DOI 10.1016/j.cell.2010.11.039; Serrano AL, 2011, CURR TOP DEV BIOL, V96, P167, DOI 10.1016/B978-0-12-385940-2.00007-3; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Steigemann P, 2009, CELL, V136, P473, DOI 10.1016/j.cell.2008.12.020; Tajbakhsh S, 1996, DEV DYNAM, V206, P291, DOI 10.1002/(SICI)1097-0177(199607)206:3<291::AID-AJA6>3.0.CO;2-D; Tallquist MD, 2000, DEVELOPMENT, V127, P5059; TENNYSON CN, 1995, NAT GENET, V9, P184, DOI 10.1038/ng0295-184; Troy A, 2012, CELL STEM CELL, V11, P541, DOI 10.1016/j.stem.2012.05.025; von Maltzahn J, 2013, P NATL ACAD SCI USA, V110, P16474, DOI 10.1073/pnas.1307680110; Wang B, 2000, P NATL ACAD SCI USA, V97, P13714, DOI 10.1073/pnas.240335297; Wang G, 2014, J CELL SCI, V127, P4111, DOI 10.1242/jcs.151753; Wang JM, 1999, NAT GENET, V21, P133, DOI 10.1038/5089; Wang YX, 2014, NAT GENET, V46, P601, DOI 10.1038/ng.2974; WEBSTER C, 1990, SOMAT CELL MOLEC GEN, V16, P557, DOI 10.1007/BF01233096; Yamashita K, 2010, BIOCHEM BIOPH RES CO, V391, P812, DOI 10.1016/j.bbrc.2009.11.144; Yennek S, 2014, CELL REP, V7, P961, DOI 10.1016/j.celrep.2014.04.016	57	296	299	0	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2015	21	12					1455	+		10.1038/nm.3990	http://dx.doi.org/10.1038/nm.3990			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CX9EV	26569381	Green Accepted			2022-12-25	WOS:000366008700016
J	Singaravelu, R; O'Hara, S; Jones, DM; Chen, R; Taylor, NG; Srinivasan, P; Quan, C; Roy, DG; Steenbergen, RH; Kumar, A; Lyn, RK; Ozcelik, D; Rouleau, Y; Nguyen, MA; Rayner, KJ; Hobman, TC; Tyrrell, DL; Russell, RS; Pezacki, JP				Singaravelu, Ragunath; O'Hara, Shifawn; Jones, Daniel M.; Chen, Ran; Taylor, Nathan G.; Srinivasan, Prashanth; Quan, Curtis; Roy, Dominic G.; Steenbergen, Rineke H.; Kumar, Anil; Lyn, Rodney K.; Ozcelik, Dennis; Rouleau, Yanouchka; Nguyen, My-Anh; Rayner, Katey J.; Hobman, Tom C.; Tyrrell, David Lorne; Russell, Rodney S.; Pezacki, John Paul			MicroRNAs regulate the immunometabolic response to viral infection in the liver	NATURE CHEMICAL BIOLOGY			English	Article							HEPATITIS-C VIRUS; DENSITY-LIPOPROTEIN RECEPTOR; B TYPE-I; LIPID-METABOLISM; CHOLESTEROL; 25-HYDROXYCHOLESTEROL; REPLICATION; REQUIREMENTS; LIPOGENESIS; MECHANISMS	Immune regulation of cellular metabolism can be responsible for successful responses to invading pathogens. Viruses alter their hosts' cellular metabolism to facilitate infection. Conversely, the innate antiviral responses of mammalian cells target these metabolic pathways to restrict viral propagation. We identified miR-130b and miR-185 as hepatic microRNAs (miRNAs) whose expression is stimulated by 25-hydroxycholesterol (25-HC), an antiviral oxysterol secreted by interferon-stimulated macrophages and dendritic cells, during hepatitis C virus (HCV) infection. However, 25-HC only directly stimulated miR-185 expression, whereas HCV regulated miR-130b expression. Independently, miR-130b and miR-185 inhibited HCV infection. In particular, miR-185 significantly restricted host metabolic pathways crucial to the HCV life cycle. Interestingly, HCV infection decreased miR-185 and miR-130b levels to promote lipid accumulation and counteract 25-HC's antiviral effect. Furthermore, miR-185 can inhibit other viruses through the regulation of immunometabolic pathways. These data establish these microRNAs as a key link between innate defenses and metabolism in the liver.	[Singaravelu, Ragunath; Srinivasan, Prashanth; Quan, Curtis; Nguyen, My-Anh; Rayner, Katey J.; Pezacki, John Paul] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada; [Singaravelu, Ragunath; O'Hara, Shifawn; Srinivasan, Prashanth; Quan, Curtis; Lyn, Rodney K.; Ozcelik, Dennis; Rouleau, Yanouchka; Pezacki, John Paul] Natl Res Council Canada, Div Life Sci, Ottawa, ON, Canada; [Jones, Daniel M.; Taylor, Nathan G.; Russell, Rodney S.] Mem Univ Newfoundland, Fac Med, Immunol & Infect Dis, St John, NF, Canada; [Chen, Ran; Steenbergen, Rineke H.; Tyrrell, David Lorne] Univ Alberta, Dept Med Microbiol & Immunol, Edmonton, AB, Canada; [Chen, Ran; Steenbergen, Rineke H.; Tyrrell, David Lorne] Katz Ctr Pharm & Hlth Res, Li Ka Shing Inst Virol, Edmonton, AB, Canada; [Roy, Dominic G.] Ottawa Hosp Res Inst, Ctr Innovat Canc Therapeut, Ottawa, ON, Canada; [Kumar, Anil; Hobman, Tom C.] Univ Alberta, Dept Cell Biol, Edmonton, AB, Canada; [Lyn, Rodney K.; Ozcelik, Dennis; Pezacki, John Paul] Univ Ottawa, Dept Chem & Biomol Sci, Ottawa, ON, Canada; [Nguyen, My-Anh; Rayner, Katey J.] Univ Ottawa Heart Inst, Ottawa, ON, Canada	University of Ottawa; National Research Council Canada; Memorial University Newfoundland; University of Alberta; University of Ottawa; Ottawa Hospital Research Institute; University of Alberta; University of Ottawa; University of Ottawa; University of Ottawa Heart Institute	Singaravelu, R (corresponding author), Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada.	John.Pezacki@uottawa.ca	Özcelik, Dennis/M-9961-2019; Russell, Rod/AAU-3109-2021	Özcelik, Dennis/0000-0002-7185-4690; Victoria Ansalem, Anil Kumar/0000-0002-6179-4516; Rayner, Katey/0000-0001-6230-426X; Srinivasan, Prashanth/0000-0002-4898-2205; Roy, Dominic/0000-0002-6044-0118; Singaravelu, Ragunath/0000-0002-2692-3650	Natural Sciences and Engineering Research Council (NSERC) of Canada [298496]; Canadian Institutes of Health Research (CIHR) [136807, 232063, 130365, 28637]; National CIHR Research Training Program in Hepatitis C (NCRTP-HepC); Vanier Canadian Graduate scholarship; CIHR graduate scholarship; CIHR; NSERC-Collaborative Research and Training Experience (CREATE); Alberta Innovates-Health Solutions postdoctoral fellowships; Tier 1 Canada Research Chair; Alberta Innovates [201400447] Funding Source: researchfish	Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); National CIHR Research Training Program in Hepatitis C (NCRTP-HepC)(Canadian Institutes of Health Research (CIHR)); Vanier Canadian Graduate scholarship; CIHR graduate scholarship(Canadian Institutes of Health Research (CIHR)); CIHR(Canadian Institutes of Health Research (CIHR)); NSERC-Collaborative Research and Training Experience (CREATE); Alberta Innovates-Health Solutions postdoctoral fellowships; Tier 1 Canada Research Chair(Canada Research Chairs); Alberta Innovates	We thank A. Ridsdale and the National Research Council of Canada (NRC) coherent anti-Stokes Raman spectroscopy (CARS) facility along with Z. Jakubek and the NRC measurement science and standards (MSS) imaging facility for technical assistance. mRNA microarray profiling was performed by the Centre for Applied Genomics, The Hospital for Sick Children, Toronto, Ontario, Canada Lipid profiling was performed by A. Moses and the Lipid Analysis Core Service, University of Alberta, Edmonton, Alberta, Canada. We also would like to thank E. Rildow for assistance with Dengue virus experiments. This study was supported by funding from Natural Sciences and Engineering Research Council (NSERC) of Canada grant (298496 to J.P.P.) and Canadian Institutes of Health Research (CIHR) grants (136807, 232063 to J.P.P., R.S.R. and D.L.T.; 130365 to K.J.R.; 28637 to T.C.H.). R.S., D.M.J., R.C. and N.G.T. would like to thank the National CIHR Research Training Program in Hepatitis C (NCRTP-HepC) for training and funding. R.S. was supported by a Vanier Canadian Graduate scholarship. D.G.R. was supported by a CIHR graduate scholarship. D.O. was supported by a post-doctoral fellowship from the CIHR. A.K. was supported by NSERC-Collaborative Research and Training Experience (CREATE) and Alberta Innovates-Health Solutions postdoctoral fellowships. T.C.H. was supported by a Tier 1 Canada Research Chair.	Adams CM, 2004, J BIOL CHEM, V279, P52772, DOI 10.1074/jbc.M410302200; Alvisi G, 2011, RNA BIOL, V8, P258, DOI 10.4161/rna.8.2.15011; Bassendine MF, 2013, SEMIN IMMUNOPATHOL, V35, P87, DOI 10.1007/s00281-012-0356-2; Blanc M, 2013, IMMUNITY, V38, P106, DOI 10.1016/j.immuni.2012.11.004; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Catanese MT, 2013, J VIROL, V87, P8282, DOI 10.1128/JVI.01102-13; Chukkapalli V, 2012, CURR OPIN MICROBIOL, V15, P512, DOI 10.1016/j.mib.2012.05.013; Civra A, 2014, SCI REP-UK, V4, DOI 10.1038/srep07487; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Hsu PWC, 2007, NUCLEIC ACIDS RES, V35, pD381, DOI 10.1093/nar/gkl1009; Janowski BA, 1996, NATURE, V383, P728, DOI 10.1038/383728a0; Lee WM, 2003, J VIROL, V77, P12819, DOI 10.1128/JVI.77.23.12819-12828.2003; Li QS, 2013, NAT MED, V19, P722, DOI 10.1038/nm.3190; Li S, 2014, J VIRAL HEPATITIS, V21, P121, DOI 10.1111/jvh.12131; Liu SY, 2013, IMMUNITY, V38, P92, DOI 10.1016/j.immuni.2012.11.005; Luna JM, 2015, CELL, V160, P1099, DOI 10.1016/j.cell.2015.02.025; Lyn RK, 2014, SCI REP-UK, V4, DOI 10.1038/srep04549; Mercer DF, 2001, NAT MED, V7, P927, DOI 10.1038/90968; Miller S, 2008, NAT REV MICROBIOL, V6, P363, DOI 10.1038/nrmicro1890; Monazahian M, 1999, J MED VIROL, V57, P223, DOI 10.1002/(SICI)1096-9071(199903)57:3<223::AID-JMV2>3.0.CO;2-4; Pan SF, 2014, J CELL PHYSIOL, V229, P631, DOI 10.1002/jcp.24486; Park K, 2010, J LEUKOCYTE BIOL, V88, P1081, DOI 10.1189/jlb.0610318; Paul D, 2013, J VIROL, V87, P10612, DOI 10.1128/JVI.01370-13; Pedersen IM, 2007, NATURE, V449, P919, DOI 10.1038/nature06205; Pezacki JP, 2011, NAT CHEM BIOL, V7, P137, DOI 10.1038/NCHEMBIO.525; Pezacki JP, 2010, MOL BIOSYST, V6, P1131, DOI 10.1039/b924668c; Pezacki John Paul, 2009, BMC Chemical Biology, V9, P2, DOI 10.1186/1472-6769-9-2; Qadir XV, 2014, AM J PATHOL, V184, P2355, DOI 10.1016/j.ajpath.2014.05.004; Radhakrishnan A, 2007, P NATL ACAD SCI USA, V104, P6511, DOI 10.1073/pnas.0700899104; Regeard M, 2008, J VIRAL HEPATITIS, V15, P865, DOI 10.1111/j.1365-2893.2008.01048.x; Rottiers V, 2012, NAT REV MOL CELL BIO, V13, P239, DOI 10.1038/nrm3313; Russell RS, 2008, P NATL ACAD SCI USA, V105, P4370, DOI 10.1073/pnas.0800422105; Sagan SM, 2006, BIOCHEM CELL BIOL, V84, P67, DOI 10.1139/O05-149; Saka HA, 2012, ANNU REV CELL DEV BI, V28, P411, DOI 10.1146/annurev-cellbio-092910-153958; Schoggins JW, 2013, CELL HOST MICROBE, V14, P379, DOI 10.1016/j.chom.2013.09.010; Singaravelu R, 2014, HEPATOLOGY, V59, P98, DOI 10.1002/hep.26634; Steenbergen RH, 2013, HEPATOLOGY, V58, P1907, DOI 10.1002/hep.26566; Su AI, 2002, P NATL ACAD SCI USA, V99, P15669, DOI 10.1073/pnas.202608199; Syed GH, 2014, J VIROL, V88, P2519, DOI 10.1128/JVI.02727-13; Takeuchi K, 2009, AM J PHYSIOL-ENDOC M, V296, pE1195, DOI 10.1152/ajpendo.90958.2008; Teissier E, 2007, EUR BIOPHYS J BIOPHY, V36, P887, DOI 10.1007/s00249-007-0201-z; Garcia-Mediavilla MV, 2012, LAB INVEST, V92, P1191, DOI 10.1038/labinvest.2012.88; Vlachos IS, 2012, NUCLEIC ACIDS RES, V40, pW498, DOI 10.1093/nar/gks494; Wang L, 2013, MOL CELL BIOL, V33, P1956, DOI 10.1128/MCB.01580-12; Waris G, 2007, J VIROL, V81, P8122, DOI 10.1128/JVI.00125-07; Wu JM, 2010, HPB, V12, P625, DOI 10.1111/j.1477-2574.2010.00207.x; Xiao F, 2014, DIABETES, V63, P2631, DOI 10.2337/db13-1689; Yang MH, 2014, J LIPID RES, V55, P226, DOI 10.1194/jlr.M041335; Zeng J, 2012, ANTIVIR RES, V95, P245, DOI 10.1016/j.antiviral.2012.06.004	50	47	53	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2015	11	12					988	993		10.1038/nchembio.1940	http://dx.doi.org/10.1038/nchembio.1940			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX6TG	26479438				2022-12-25	WOS:000365834000019
J	Gonzalez, LJ; Bahr, G; Nakashige, TG; Nolan, EM; Bonomo, RA; Vila, AJ				Gonzalez, Lisandro J.; Bahr, Guillermo; Nakashige, Toshiki G.; Nolan, Elizabeth M.; Bonomo, Robert A.; Vila, Alejandro J.			Membrane anchoring stabilizes and favors secretion of New Delhi metallo-beta-lactamase	NATURE CHEMICAL BIOLOGY			English	Article							OUTER-MEMBRANE; ESCHERICHIA-COLI; BIOCHEMICAL-CHARACTERIZATION; ANTIBIOTIC-RESISTANCE; PERIPLASMIC PROTEINS; ZINC-BINDING; VESICLES; DISSEMINATION; ACINETOBACTER; LIPOPROTEIN	Carbapenems, 'last-resort' 13-lactam antibiotics, are inactivated by zinc-dependent metallo-beta-lactamases (MBLs). The host innate immune response withholds nutrient metal ions from microbial pathogens by releasing metal-chelating proteins such as calprotectin. We show that metal sequestration is detrimental for the accumulation of MBLs in the bacterial periplasm, because those enzymes are readily degraded in their nonmetallated form. However, the New Delhi metallo-beta-lactamase (NDM-1) can persist under conditions of metal depletion. NDM-1 is a lipidated protein that anchors to the outer membrane of Gram-negative bacteria. Membrane anchoring contributes to the unusual stability of NDM-1 and favors secretion of this enzyme in outer membrane vesicles (OMVs). OMVs containing NDM-1 can protect nearby populations of bacteria from otherwise lethal antibiotic levels, and OMVs from clinical pathogens expressing NDM-1 can carry this MBL and the bIaNDM gene. We show that protein export into OMVs can be targeted, providing possibilities of new antibacterial therapeutic strategies.	[Gonzalez, Lisandro J.; Bahr, Guillermo; Vila, Alejandro J.] CONICET UNR, Inst Biol Mol & Celular Rosario IBR, Rosario, Santa Fe, Argentina; [Gonzalez, Lisandro J.; Bahr, Guillermo; Vila, Alejandro J.] Univ Nacl Rosario, Area Biofis, Fac Ciencias Bioquim & Farmaceut, RA-2000 Rosario, Santa Fe, Argentina; [Nakashige, Toshiki G.; Nolan, Elizabeth M.] MIT, Dept Chem, Cambridge, MA 02139 USA; [Bonomo, Robert A.] Vet Affairs Med Ctr, Louis Stokes Cleveland Dept, Res Serv, Cleveland, OH USA; [Bonomo, Robert A.] Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA; [Bonomo, Robert A.] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA; [Bonomo, Robert A.] Case Western Reserve Univ, Dept Mol Biol & Microbiol, Cleveland, OH 44106 USA; [Bonomo, Robert A.] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Rosario; National University of Rosario; Massachusetts Institute of Technology (MIT); US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	Vila, AJ (corresponding author), CONICET UNR, Inst Biol Mol & Celular Rosario IBR, Rosario, Santa Fe, Argentina.; Vila, AJ (corresponding author), Univ Nacl Rosario, Area Biofis, Fac Ciencias Bioquim & Farmaceut, RA-2000 Rosario, Santa Fe, Argentina.	vila@ibr-conicet.gov.ar		Bahr, Guillermo/0000-0003-2187-4463; Vila, Alejandro/0000-0002-7978-3233	US National Institutes of Health (NIH) [R01AI100560]; Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT); NIH [R01AI100560, R01AI072219, R01AI063517]; Louis Stokes Cleveland Department of Veterans Affairs Medical Center; VISN 10 Geriatric Research, Education and Clinical Care Center (VISN 10) of the Department of Veterans Affairs; Kinship Foundation; MIT Department of Chemistry; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072219, R01AI100560, R01AI063517] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT)(ANPCyT); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Louis Stokes Cleveland Department of Veterans Affairs Medical Center; VISN 10 Geriatric Research, Education and Clinical Care Center (VISN 10) of the Department of Veterans Affairs; Kinship Foundation; MIT Department of Chemistry; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank J. Spencer (University of Bristol), H. Menzella (University of Rosario) and R. Rasia (IBR, CONICET-UNR) for providing plasmids pET26-bla<INF>NDM-1</INF>, pTGR11 and pET28-TEV, respectively, A. Corso (Administracion National de Lab oratorios e Instituos de Salud) for providing clinical strains, and A. Viale (IBR) for GroEL antibodies. This research was supported by grants from the US National Institutes of Health (NIH R01AI100560) to A.J.V and R.A.B., and Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) to A.J.V. R.A.B. acknowledges support from NIH under award numbers R01AI072219, R01AI063517 and R01AI100560, and funds and/or facilities provided by the Louis Stokes Cleveland Department of Veterans Affairs Medical Center and the VISN 10 Geriatric Research, Education and Clinical Care Center (VISN 10) of the Department of Veterans Affairs. E.M.N. thanks support from the Kinship Foundation (Searle Scholars Program) and MIT Department of Chemistry.	Aschtgen MS, 2008, J BACTERIOL, V190, P7523, DOI 10.1128/JB.00945-08; Bomberger JM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000382; Bootsma HJ, 1996, ANTIMICROB AGENTS CH, V40, P966, DOI 10.1128/AAC.40.4.966; Borra PS, 2013, ANTIMICROB AGENTS CH, V57, P848, DOI 10.1128/AAC.02227-12; Brophy MB, 2012, J AM CHEM SOC, V134, P18089, DOI 10.1021/ja307974e; CDC, 2013, ANTIBIOTIC RESISTANC; Cerasi M, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00108; Chen XC, 1998, J BACTERIOL, V180, P527, DOI 10.1128/JB.180.3.527-537.1998; Choi KH, 2006, J MICROBIOL METH, V64, P391, DOI 10.1016/j.mimet.2005.06.001; Clinical and Laboratory Standards Institute, 2012, METHODS DILUTION ANT, V32; Corbin BD, 2008, SCIENCE, V319, P962, DOI 10.1126/science.1152449; Crowder MW, 2006, ACCOUNTS CHEM RES, V39, P721, DOI 10.1021/ar0400241; Devos S, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00298; Dortet L, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/249856; Fiorilli G, 2010, REV ESP QUIM, V23, P100; Glaser R, 2005, NAT IMMUNOL, V6, P57, DOI 10.1038/ni1142; Gonzalez JM, 2012, NAT CHEM BIOL, V8, P698, DOI [10.1038/NCHEMBIO.1005, 10.1038/nchembio.1005]; Gonzalez JM, 2010, BIOCHEMISTRY-US, V49, P7930, DOI 10.1021/bi100894r; Gonzalez LJ, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003817; Haley KP, 2015, INFECT IMMUN, V83, P2944, DOI 10.1128/IAI.00544-15; Haurat MF, 2011, J BIOL CHEM, V286, P1269, DOI 10.1074/jbc.M110.185744; Hede K, 2014, NATURE, V509, pS2, DOI 10.1038/509S2a; Hood MI, 2012, NAT REV MICROBIOL, V10, P525, DOI 10.1038/nrmicro2836; Hu ZX, 2008, BIOCHEMISTRY-US, V47, P7947, DOI 10.1021/bi8004768; HUSSAIN M, 1980, J BIOL CHEM, V255, P3707; Irazoqui JE, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000982; Johne B, 1997, J CLIN PATHOL-MOL PA, V50, P113; Kesty NC, 2004, J BIOL CHEM, V279, P2069, DOI 10.1074/jbc.M307628200; Kim Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024621; King D, 2011, PROTEIN SCI, V20, P1484, DOI 10.1002/pro.697; Kitagawa R, 2010, J BACTERIOL, V192, P5645, DOI 10.1128/JB.00590-10; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Kovacs-Simon A, 2011, INFECT IMMUN, V79, P548, DOI 10.1128/IAI.00682-10; Luo Y, 2014, ENVIRON SCI TECH LET, V1, P26, DOI 10.1021/ez400152e; Marchiaro P, 2008, ANTIMICROB AGENTS CH, V52, P2250, DOI 10.1128/AAC.01025-07; Meini MR, 2015, MOL BIOL EVOL, V32, P1774, DOI 10.1093/molbev/msv059; Moran-Barrio J, 2009, ANTIMICROB AGENTS CH, V53, P2908, DOI 10.1128/AAC.01637-08; Murphy TA, 2003, ANTIMICROB AGENTS CH, V47, P582, DOI 10.1128/AAC.47.2.582-587.2003; Park M, 2015, BBA-BIOMEMBRANES, V1848, P842, DOI 10.1016/j.bbamem.2014.12.011; Patel G, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00048; Pederick VG, 2015, SCI REP-UK, V5, DOI 10.1038/srep13139; Periyannan G, 2004, PROTEIN SCI, V13, P2236, DOI 10.1110/ps.04742704; Poirel L, 2011, ANTIMICROB AGENTS CH, V55, P5403, DOI 10.1128/AAC.00585-11; Randall LB, 2016, ANTIMICROB AGENTS CH, V60, P1509, DOI 10.1128/AAC.02444-15; Ravasi P, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-147; Rokney A, 2009, J MOL BIOL, V392, P589, DOI 10.1016/j.jmb.2009.07.009; Rumbo C, 2011, ANTIMICROB AGENTS CH, V55, P3084, DOI 10.1128/AAC.00929-10; Santos S, 2012, VACCINE, V30, P6064, DOI 10.1016/j.vaccine.2012.07.052; Schaar V, 2014, J ANTIMICROB CHEMOTH, V69, P117, DOI 10.1093/jac/dkt307; Schaar V, 2011, ANTIMICROB AGENTS CH, V55, P3845, DOI 10.1128/AAC.01772-10; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schwechheimer C, 2015, NAT REV MICROBIOL, V13, P605, DOI 10.1038/nrmicro3525; Selevsek N, 2009, J BIOL CHEM, V284, P16419, DOI 10.1074/jbc.M109.001305; Tottey S, 2008, NATURE, V455, P1138, DOI 10.1038/nature07340; Valladares MH, 1997, BIOCHEMISTRY-US, V36, P11534, DOI 10.1021/bi971056h; Veith PD, 2014, J PROTEOME RES, V13, P2420, DOI 10.1021/pr401227e; Walsh TR, 2011, LANCET INFECT DIS, V11, P355, DOI 10.1016/S1473-3099(11)70059-7; Walsh TR, 2005, CLIN MICROBIOL REV, V18, P306, DOI 10.1128/CMR.18.2.306-325.2005; Wommer S, 2002, J BIOL CHEM, V277, P24142, DOI 10.1074/jbc.M202467200; Zhang CF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064857	60	90	93	0	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUL	2016	12	7					516	+		10.1038/NCHEMBIO.2083	http://dx.doi.org/10.1038/NCHEMBIO.2083			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9EP	27182662	Green Accepted, Green Submitted, Green Published			2022-12-25	WOS:000378087500011
J	Il Je, B; Gruel, J; Lee, YK; Bommert, P; Arevalo, ED; Eveland, AL; Wu, QY; Goldshmidt, A; Meeley, R; Bartlett, M; Komatsu, M; Sakai, H; Jonsson, H; Jackson, D				Il Je, Byoung; Gruel, Jeremy; Lee, Young Koung; Bommert, Peter; Arevalo, Edgar Demesa; Eveland, Andrea L.; Wu, Qingyu; Goldshmidt, Alexander; Meeley, Robert; Bartlett, Madelaine; Komatsu, Mai; Sakai, Hajime; Jonsson, Henrik; Jackson, David			Signaling from maize organ primordia via FASCIATED EAR3 regulates stem cell proliferation and yield traits	NATURE GENETICS			English	Article							RECEPTOR-LIKE KINASE; ARABIDOPSIS SHOOT MERISTEM; GENE ENCODES; PROTEIN; MAINTENANCE; PLANT; EXPRESSION; CLAVATA1; RICE; DIVERSIFICATION	Shoot apical meristems are stem cell niches that balance proliferation with the incorporation of daughter cells into organ primordia. This balance is maintained by CLAVATA-WUSCHEL feedback signaling between the stem cells at the tip of the meristem and the underlying organizing center. Signals that provide feedback from organ primordia to control the stem cell niche in plants have also been hypothesized, but their identities are unknown. Here we report FASCIATED EAR3 (FEA3), a leucinerich- repeat receptor that functions in stem cell control and responds to a CLAVATA3/ESR-related (CLE) peptide expressed in organ primordia. We modeled our results to propose a regulatory system that transmits signals from differentiating cells in organ primordia back to the stem cell niche and that appears to function broadly in the plant kingdom. Furthermore, we demonstrate an application of this new signaling feedback, by showing that weak alleles of fea3 enhance hybrid maize yield traits.	[Il Je, Byoung; Lee, Young Koung; Bommert, Peter; Arevalo, Edgar Demesa; Eveland, Andrea L.; Wu, Qingyu; Goldshmidt, Alexander; Jackson, David] Cold Spring Harbor Lab, New York, NY USA; [Gruel, Jeremy; Jonsson, Henrik] Univ Cambridge, Sainsbury Lab, Cambridge, England; [Meeley, Robert] DuPont Pioneer, Agr Biotechnol, Johnston, IA USA; [Bartlett, Madelaine] Univ Massachusetts, Dept Biol, Amherst, MA 01003 USA; [Komatsu, Mai; Sakai, Hajime] DuPont Pioneer, Agr Biotechnol, Wilmington, DC USA; [Jonsson, Henrik] Lund Univ, Computat Biol & Biol Phys Grp, Lund, Sweden; [Eveland, Andrea L.] Donald Danforth Plant Sci Ctr, St Louis, MO USA	Cold Spring Harbor Laboratory; University of Cambridge; DuPont; Pioneer Hi-Bred International, Inc.; University of Massachusetts System; University of Massachusetts Amherst; Lund University; Donald Danforth Plant Science Center	Jackson, D (corresponding author), Cold Spring Harbor Lab, New York, NY USA.	jacksond@cshl.edu	Demesa-Arevalo, Edgar/AAX-8477-2020; Wu, Qingyu/AAF-3675-2020; Wu, Qingyu/E-4636-2017; Eveland, Andrea/M-9886-2014	Demesa-Arevalo, Edgar/0000-0002-2793-5928; Wu, Qingyu/0000-0003-3064-2445; Wu, Qingyu/0000-0003-3064-2445; Eveland, Andrea/0000-0003-4825-1282; Goldshmidt, Alexander/0000-0001-7468-6779	DuPont Pioneer; NSF Plant Genome Research program [IOS-1238202, MCB-1027445]; Agriculture and Food Research Initiative of the USDA National Institute of Food and Agriculture [2016-67013-24572]; Gatsby Charitable Foundation [GAT3395/PR4]; Swedish Research Council [VR2013-4632]; Next-Generation BioGreen 21 Program (SSAC) from Rural Development Administration, Republic of Korea [PJ01184302]; Direct For Biological Sciences [1238202] Funding Source: National Science Foundation	DuPont Pioneer; NSF Plant Genome Research program(National Science Foundation (NSF)NSF - Office of the Director (OD)); Agriculture and Food Research Initiative of the USDA National Institute of Food and Agriculture; Gatsby Charitable Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Next-Generation BioGreen 21 Program (SSAC) from Rural Development Administration, Republic of Korea; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The fea3-0 allele was kindly provided by V. Shcherbak (Krasnodar Research Institute of Agriculture). We also thank U. Hernandez for assistance with cloning, A. Masson for assistance with peptide assays, and members of the Jackson laboratory for comments on the manuscript. We acknowledge funding from a collaborative agreement with DuPont Pioneer and from NSF Plant Genome Research program grant IOS-1238202 and grant MCB-1027445 and from Agriculture and Food Research Initiative competitive grant 2016-67013-24572 of the USDA National Institute of Food and Agriculture. The study also received support from the Gatsby Charitable Foundation (GAT3395/PR4) and the Swedish Research Council (VR2013-4632) to H.J. and through the Next-Generation BioGreen 21 Program (SSAC; project PJ01184302) from the Rural Development Administration, Republic of Korea.	Bommert P, 2005, DEVELOPMENT, V132, P1235, DOI 10.1242/dev.01671; Bommert P, 2013, NATURE, V502, P555, DOI 10.1038/nature12583; Bommert P, 2013, NAT GENET, V45, P334, DOI 10.1038/ng.2534; Brand U, 2000, SCIENCE, V289, P617, DOI 10.1126/science.289.5479.617; Chickarmane VS, 2012, P NATL ACAD SCI USA, V109, P4002, DOI 10.1073/pnas.1200636109; CLARK SE, 1993, DEVELOPMENT, V119, P397; CLARK SE, 1995, DEVELOPMENT, V121, P2057; Clark SE, 1997, CELL, V89, P575, DOI 10.1016/S0092-8674(00)80239-1; Crawford KM, 2000, CURR BIOL, V10, P1032, DOI 10.1016/S0960-9822(00)00657-6; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emery JF, 2003, CURR BIOL, V13, P1768, DOI 10.1016/j.cub.2003.09.035; Eveland AL, 2014, GENOME RES, V24, P431, DOI 10.1101/gr.166397.113; Fletcher LC, 1999, SCIENCE, V283, P1911, DOI 10.1126/science.283.5409.1911; Goldshmidt A, 2008, PLANT CELL, V20, P1217, DOI 10.1105/tpc.107.057877; Gordon SP, 2009, P NATL ACAD SCI USA, V106, P16529, DOI 10.1073/pnas.0908122106; Gruel J, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1500989; Hansen N, 2006, STUD FUZZ SOFT COMP, V192, P75; Heidstra R, 2014, NAT REV MOL CELL BIO, V15, P301, DOI 10.1038/nrm3790; Hong RL, 2003, PLANT CELL, V15, P1296, DOI 10.1105/tpc.009548; Hsu YC, 2014, CELL, V157, P935, DOI 10.1016/j.cell.2014.02.057; Iliev I, 2011, PLANT GROWTH REGUL, V63, P115, DOI 10.1007/s10725-010-9540-3; Ito Y, 2006, SCIENCE, V313, P842, DOI 10.1126/science.1128436; JACKSON D, 1994, DEVELOPMENT, V120, P405; Jeong S, 1999, PLANT CELL, V11, P1925, DOI 10.1105/tpc.11.10.1925; JONSSON H, 2003, GROWTH FORM COMPUTER, P156; Juarez MT, 2004, DEVELOPMENT, V131, P4533, DOI 10.1242/dev.01328; Kayes JM, 1998, DEVELOPMENT, V125, P3843; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kinoshita A, 2010, DEVELOPMENT, V137, P3911, DOI 10.1242/dev.048199; Kondo T, 2006, SCIENCE, V313, P845, DOI 10.1126/science.1128439; Krishnakumar V, 2015, PLANT CELL PHYSIOL, V56, DOI 10.1093/pcp/pcu178; Kurakawa T, 2007, NATURE, V445, P652, DOI 10.1038/nature05504; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; McCarty Donald R., 2009, P561, DOI 10.1007/978-0-387-77863-1_28; Mohanty A, 2009, PLANT PHYSIOL, V149, P601, DOI 10.1104/pp.108.130146; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Nardmann J, 2006, MOL BIOL EVOL, V23, P2492, DOI 10.1093/molbev/msl125; Nimchuk ZL, 2011, CURR BIOL, V21, P345, DOI 10.1016/j.cub.2011.01.039; Ogawa M, 2008, SCIENCE, V319, P294, DOI 10.1126/science.1150083; OpsahlFerstad HG, 1997, PLANT J, V12, P235, DOI 10.1046/j.1365-313X.1997.12010235.x; Osterrieder A, 2009, TRAFFIC, V10, P1034, DOI 10.1111/j.1600-0854.2009.00930.x; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Scanlon MJ, 2003, PLANT PHYSIOL, V133, P597, DOI 10.1104/pp.103.026880; Schoof H, 2000, CELL, V100, P635, DOI 10.1016/S0092-8674(00)80700-X; Stahl Y, 2010, CURR OPIN PLANT BIOL, V13, P53, DOI 10.1016/j.pbi.2009.09.008; Suzaki T, 2008, PLANT CELL, V20, P2049, DOI 10.1105/tpc.107.057257; Suzaki T, 2006, PLANT CELL PHYSIOL, V47, P1591, DOI 10.1093/pcp/pcl025; Taguchi-Shiobara F, 2001, GENE DEV, V15, P2755, DOI 10.1101/gad.208501; Tanaka W, 2012, PLANT CELL, V24, P80, DOI 10.1105/tpc.111.094797; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Whipple CJ, 2011, P NATL ACAD SCI USA, V108, pE506, DOI 10.1073/pnas.1102819108; Wu QY, 2013, INT J DEV BIOL, V57, P535, DOI 10.1387/ijdb.130240qw; Yadav RK, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.8; Yadav RK, 2011, GENE DEV, V25, P2025, DOI 10.1101/gad.17258511; Yonekura-Sakakibara K, 2004, PLANT PHYSIOL, V134, P1654, DOI 10.1104/pp.103.037176	56	126	137	2	84	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2016	48	7					785	+		10.1038/ng.3567	http://dx.doi.org/10.1038/ng.3567			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DP9TK	27182966	Green Accepted			2022-12-25	WOS:000378840100016
J	Carlson, JM; Du, VY; Pfeifer, N; Bansal, A; Tan, VYF; Power, K; Brumme, CJ; Kreimer, A; DeZiel, CE; Fusi, N; Schaefer, M; Brockman, MA; Gilmour, J; Price, MA; Kilembe, W; Haubrich, R; John, M; Mallal, S; Shapiro, R; Frater, J; Harrigan, PR; Ndung'u, T; Allen, S; Heckerman, D; Sidney, J; Allen, TM; Goulder, PJR; Brumme, ZL; Hunter, E; Goepfert, PA				Carlson, Jonathan M.; Du, Victor Y.; Pfeifer, Nico; Bansal, Anju; Tan, Vincent Y. F.; Power, Karen; Brumme, Chanson J.; Kreimer, Anat; DeZiel, Charles E.; Fusi, Nicolo; Schaefer, Malinda; Brockman, Mark A.; Gilmour, Jill; Price, Matt A.; Kilembe, William; Haubrich, Richard; John, Mina; Mallal, Simon; Shapiro, Roger; Frater, John; Harrigan, P. Richard; Ndung'u, Thumbi; Allen, Susan; Heckerman, David; Sidney, John; Allen, Todd M.; Goulder, Philip J. R.; Brumme, Zabrina L.; Hunter, Eric; Goepfert, Paul A.			Impact of pre-adapted HIV transmission	NATURE MEDICINE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; T-CELL RESPONSES; IMMUNE ESCAPE PATHWAYS; REPLICATION CAPACITY; MAXIMUM-LIKELIHOOD; VIRAL-LOAD; LYMPHOCYTE RESPONSE; DISCORDANT COUPLES; TYPE-1 VIREMIA; HLA ALLELES	Human leukocyte antigen class I (HLA)-restricted CD8(+) T lymphocyte (CTL) responses are crucial to HIV-1 control. Although HIV can evade these responses, the longer-term impact of viral escape mutants remains unclear, as these variants can also reduce intrinsic viral fitness. To address this, we here developed a metric to determine the degree of HIV adaptation to an HLA profile. We demonstrate that transmission of viruses that are pre-adapted to the HLA molecules expressed in the recipient is associated with impaired immunogenicity, elevated viral load and accelerated CD4(+) T cell decline. Furthermore, the extent of pre-adaptation among circulating viruses explains much of the variation in outcomes attributed to the expression of certain HLA alleles. Thus, viral pre-adaptation exploits 'holes' in the immune response. Accounting for these holes may be key for vaccine strategies seeking to elicit functional responses from viral variants, and to HIV cure strategies that require broad CTL responses to achieve successful eradication of HIV reservoirs.	[Carlson, Jonathan M.; Pfeifer, Nico; Tan, Vincent Y. F.; Kreimer, Anat; DeZiel, Charles E.; Fusi, Nicolo; Heckerman, David] Microsoft Res, Redmond, WA USA; [Du, Victor Y.; Bansal, Anju; Goepfert, Paul A.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Power, Karen; Ndung'u, Thumbi; Allen, Todd M.] Ragon Inst Massachusetts Gen Hosp Massachusetts I, Cambridge, MA USA; [Brumme, Chanson J.; Brockman, Mark A.; Harrigan, P. Richard; Brumme, Zabrina L.] British Columbia Ctr Excellence HIV AIDS, Vancouver, BC, Canada; [Schaefer, Malinda; Hunter, Eric] Emory Univ, Yerkes Natl Primate Res Ctr, Emory Vaccine Ctr, Atlanta, GA 30322 USA; [Brockman, Mark A.; Brumme, Zabrina L.] Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC V5A 1S6, Canada; [Gilmour, Jill; Price, Matt A.] Int AIDS Vaccine Initiat, New York, NY USA; [Gilmour, Jill] Univ London Imperial Coll Sci Technol & Med, London, England; [Price, Matt A.] Univ San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94117 USA; [Kilembe, William; Allen, Todd M.; Hunter, Eric] Rwanda Zambia HIV Res Grp, Zambia Emory HIV Res Project, Lusaka, Zambia; [Haubrich, Richard] Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA; [John, Mina; Mallal, Simon] Murdoch Univ, Inst Immunol & Infect Dis, Murdoch, WA 6150, Australia; [John, Mina] Royal Perth Hosp, Dept Clin Immunol, GPO Box X2213, Perth, WA 6001, Australia; [Mallal, Simon] Vanderbilt Univ, Sch Med, Ctr Translat Immunol & Infect Dis, Nashville, TN 37212 USA; [Shapiro, Roger] Harvard Univ, Harvard TH Chan Sch Publ Hlth, Boston, MA 02115 USA; [Frater, John] Univ Oxford, Nuffield Dept Clin Med, Oxford, England; [Frater, John] Oxford Biomed Res Ctr, Natl Inst Hlth Res, Oxford, England; [Frater, John] Univ Oxford, Oxford Martin Sch, Inst Emerging Infect, Oxford, England; [Harrigan, P. Richard] Univ British Columbia, Dept Med, Vancouver, BC, Canada; [Ndung'u, Thumbi; Goulder, Philip J. R.] Univ KwaZulu Natal, Doris Duke Med Res Inst, HIV Pathogenesis Programme, Durban, South Africa; [Ndung'u, Thumbi] Univ KwaZulu Natal, KwaZulu Natal Res Inst TB & HIV K RITH, Nelson R Mandela Sch Med, Durban, South Africa; [Ndung'u, Thumbi] Max Planck Inst Infect Biol, Berlin, Germany; [Allen, Susan; Hunter, Eric] Emory Univ, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; [Allen, Susan] Emory Univ, Rollins Sch Publ Hlth, Dept Global Hlth, Atlanta, GA 30322 USA; [Sidney, John] La Jolla Inst Allergy & Immunol, Div Vaccine Discovery, La Jolla, CA USA; [Goulder, Philip J. R.] Univ Oxford, Dept Paediat, Oxford, England; [Pfeifer, Nico] Max Planck Inst Informat, Dept Computat Biol & Appl Algorithm, Saarbrucken, Germany; [Tan, Vincent Y. F.] Natl Univ Singapore, Dept Elect & Comp Engn, Singapore 117548, Singapore; [Tan, Vincent Y. F.] Natl Univ Singapore, Dept Math, 10 Kent Ridge Crescent, Singapore 117548, Singapore; [Kreimer, Anat] Univ Calif Berkeley, Dept Elect Engn & Comp Sci, Berkeley, CA 94720 USA	Microsoft; University of Alabama System; University of Alabama Birmingham; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; B.C. Centre for Excellence in HIV/AIDS; Emory University; Simon Fraser University; International AIDS Vaccine Initiative; Imperial College London; University of San Francisco; Gilead Sciences; Murdoch University; Royal Perth Hospital; University of Western Australia; Vanderbilt University; Harvard University; Harvard T.H. Chan School of Public Health; University of Oxford; University of Oxford; University of Oxford; University of British Columbia; University of Kwazulu Natal; University of Kwazulu Natal; Max Planck Society; Emory University; Emory University; Rollins School Public Health; La Jolla Institute for Immunology; University of Oxford; Max Planck Society; National University of Singapore; National University of Singapore; University of California System; University of California Berkeley	Carlson, JM (corresponding author), Microsoft Res, Redmond, WA USA.; Goepfert, PA (corresponding author), Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA.; Hunter, E (corresponding author), Emory Univ, Yerkes Natl Primate Res Ctr, Emory Vaccine Ctr, Atlanta, GA 30322 USA.; Hunter, E (corresponding author), Rwanda Zambia HIV Res Grp, Zambia Emory HIV Res Project, Lusaka, Zambia.; Hunter, E (corresponding author), Emory Univ, Dept Pathol & Lab Med, Atlanta, GA 30322 USA.	carlson@microsoft.com; ehunte4@emory.edu; paulg@uab.edu	Allen, Todd/F-5473-2011; Price, Matt/AAK-6881-2021; Pfeifer, Nico/G-1559-2016; Mallal, Simon Alexander/HDM-9561-2022; Brockman, Mark/D-1669-2016	Allen, Todd/0000-0002-6609-1318; Price, Matt/0000-0002-2918-1373; Mallal, Simon Alexander/0000-0002-7036-1309; Brumme, Zabrina/0000-0002-8157-1037; Frater, John/0000-0001-7163-7277; Brumme, Chanson/0000-0003-2722-5288; Brockman, Mark/0000-0001-6432-1426; Carlson, Jonathan/0000-0001-6618-3653; Ndung'u, Thumbi/0000-0003-2962-3992; Pfeifer, Nico/0000-0002-4647-8566	Merck; NIH National Institute of Allergy and Infectious Diseases (NIAID); NIAID [R01 AI112566, R56 AI098551, R01 AI64060, R37 AI51231, P01 AI074415, U01 AI 66454, RO1 AI46995, R01 AI071906]; Canadian Institutes of Health Research [MOP-93536, HOP-115700]; Wellcome Trust [WT104748MA]; NIH [U01 AI 068636]; National Institute of Mental Health (NIMH); National Institute of Dental and Craniofacial Research (NIDCR); International AIDS Vaccine Initiative; Virology Core at the Emory Center for AIDS Research [P30 AI050409]; Flow Cytometry Core at the University of Alabama at Birmingham Center for AIDS Research [P30 AI027767]; Tennessee Center for AIDS Research [P30 AI110527]; Yerkes National Primate Research Center through NIH Office of the Director [P51OD11132]; Action Cycling Fellowship; South African Department of Science and Technology; National Research Foundation through South Africa Research Chairs Initiative; Howard Hughes Medical Institute; Victor Daitz Foundation; CIHR/GSK; Michael Smith Foundation for Health Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI068635, U01AI066454, R01AI046995, R56AI098551, R01AI064060, P30AI110527, UM1AI068636, P30AI050409, UM1AI068634, R01AI112566, UM1AI068614, U01AI068636, P01AI074415, R37AI051231, P30AI027767, R01AI071906] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011132] Funding Source: NIH RePORTER; Medical Research Council [MR/L006588/1] Funding Source: researchfish; MRC [MR/L006588/1] Funding Source: UKRI	Merck(Merck & Company); NIH National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Wellcome Trust(Wellcome TrustEuropean Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Dental and Craniofacial Research (NIDCR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); International AIDS Vaccine Initiative; Virology Core at the Emory Center for AIDS Research; Flow Cytometry Core at the University of Alabama at Birmingham Center for AIDS Research; Tennessee Center for AIDS Research; Yerkes National Primate Research Center through NIH Office of the Director; Action Cycling Fellowship; South African Department of Science and Technology; National Research Foundation through South Africa Research Chairs Initiative; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Victor Daitz Foundation; CIHR/GSK(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank M. Carrington for comments on the manuscript, S. Riddler (University of Pittsburgh, Pittsburgh, Pennsylvania, USA) for access to HLA and sequence data from the ACTG trials, D. Claiborne (Emory University, Atlanta, Georgia, USA) for providing MJ4 proviruses with nonadapted and adapted epitopes, R.A. Kaslow and J. Tang (University of Alabama, Birmingham, Alabama, USA) for access to Zambian HLA data, and D. Goedhals and C. van Vuuren (University of Free State, Bloemfontein, South Africa) for curating additional clinical data from the Bloemfontein cohort. We thank Merck, the NIH National Institute of Allergy and Infectious Diseases (NIAID) and the NIAID-funded HIV Vaccine Trials Network for providing the clinical data set, viral sequences, HLA types and CTL response data from the Step Study (HVTN 502). We also thank the Step and ACTG 5142 and 5128 staff and trial participants, as well as the staff and volunteers of the HOMER, WAHCS, ZEHRP, Durban, Gaborone, Kimberley and Bloemfontain cohorts, for their contributions. This study was funded by NIAID (grants R01 AI112566 (P.A.G.), R56 AI098551 (P.A.G.), R01 AI64060 (E.H.), R37 AI51231 (E.H.), P01 AI074415 (T.M.A.), U01 AI 66454 (R.S.), RO1 AI46995 (P.J.R.G.) and R01 AI071906 (R. A. Kaslow and J. Tang)), the Canadian Institutes of Health Research (grants MOP-93536 and HOP-115700 (both to M.A.B. and Z.L.B.)) and the Wellcome Trust (grant WT104748MA (P.J.R.G.)). HLA typing and viral sequencing of the ACTG cohorts were supported by the NIH (grant U01 AI 068636 to R.H.), the National Institute of Mental Health (NIMH) and the National Institute of Dental and Craniofacial Research (NIDCR). Support for the ZEHRP cohort was also provided by the International AIDS Vaccine Initiative (S. A.) and made possible in part by the support of the American people through the US Agency for International Development (USAID). A full list of IAVI donors is available at http://www.iavi.org. This work was also supported in part by the Virology Core at the Emory Center for AIDS Research (grant P30 AI050409 (E.H.)), the Flow Cytometry Core at the University of Alabama at Birmingham Center for AIDS Research (grant P30 AI027767 (P.A.G.)), the Tennessee Center for AIDS Research (P30 AI110527 (S. M.)) and the Yerkes National Primate Research Center base (grant P51OD11132 (E.H.)) through the NIH Office of the Director. M. S. was supported in part by an Action Cycling Fellowship. T.N. was supported by the International AIDS Vaccine Initiative, the South African Department of Science and Technology and the National Research Foundation through the South Africa Research Chairs Initiative, by an International Early Career Scientist award from the Howard Hughes Medical Institute, and by the Victor Daitz Foundation. P.R.H. is supported by a CIHR/GSK Professorship in Clinical Virology. Z.L.B. is supported by a Scholar Award from the Michael Smith Foundation for Health Research.	Akinsiku OT, 2011, JAIDS-J ACQ IMM DEF, V58, P132, DOI 10.1097/QAI.0b013e318224d2e9; Allen S, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-349; Allen TM, 2005, J VIROL, V79, P12952, DOI 10.1128/JVI.79.20.12952-12960.2005; Almeida CAM, 2011, J IMMUNOL, V187, P2502, DOI 10.4049/jimmunol.1100691; Andrew G., 2007, P 24 INT C MACH LEAR, DOI [10.1145/1273496.1273501, DOI 10.1145/1273496.1273501]; Asquith B, 2006, PLOS BIOL, V4, P583, DOI 10.1371/journal.pbio.0040090; Bansal A, 2008, J VIROL, V82, P6458, DOI 10.1128/JVI.00068-08; Bansal A, 2007, AIDS, V21, P2387, DOI 10.1097/QAD.0b013e3282f13823; Bansal A, 2010, J EXP MED, V207, P51, DOI 10.1084/jem.20092060; Bhattacharya T, 2007, SCIENCE, V315, P1583, DOI 10.1126/science.1131528; Borthwick N, 2014, MOL THER, V22, P464, DOI 10.1038/mt.2013.248; Boutwell CL, 2009, J VIROL, V83, P2460, DOI 10.1128/JVI.01970-08; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Brockman MA, 2010, J VIROL, V84, P11937, DOI 10.1128/JVI.01086-10; Brumme ZL, 2008, J VIROL, V82, P9216, DOI 10.1128/JVI.01041-08; Brumme ZL, 2008, AIDS, V22, P1277, DOI 10.1097/QAD.0b013e3283021a8c; Brumme ZL, 2007, PLOS PATHOG, V3, P913, DOI 10.1371/journal.ppat.0030094; Brumme ZL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006687; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Carlson J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000591; Carlson JM, 2015, TRENDS MICROBIOL, V23, P212, DOI 10.1016/j.tim.2014.12.008; Carlson JM, 2014, SCIENCE, V345, DOI 10.1126/science.1254031; Carlson JM, 2012, J VIROL, V86, P13202, DOI 10.1128/JVI.01998-12; Carlson JM, 2012, J VIROL, V86, P5230, DOI 10.1128/JVI.06728-11; Carlson JM, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000225; Carrington M, 2003, ANNU REV MED, V54, P535, DOI 10.1146/annurev.med.54.101601.152346; Chopera DR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000033; Cotton LA, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004295; Crawford H, 2009, J EXP MED, V206, P909, DOI 10.1084/jem.20081984; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Deng K, 2015, NATURE, V517, P381, DOI 10.1038/nature14053; Feeney ME, 2004, J VIROL, V78, P8927, DOI 10.1128/JVI.78.16.8927-8930.2004; Fischer W, 2007, NAT MED, V13, P100, DOI 10.1038/nm1461; Frahm N, 2007, J IMMUNOL, V179, P6638, DOI 10.4049/jimmunol.179.10.6638; Fraser C, 2014, SCIENCE, V343, P1328, DOI 10.1126/science.1243727; Goepfert PA, 2008, J EXP MED, V205, P1009, DOI 10.1084/jem.20072457; Goonetilleke N, 2009, J EXP MED, V206, P1253, DOI 10.1084/jem.20090365; Goulder PJR, 1997, NAT MED, V3, P212, DOI 10.1038/nm0297-212; Goulder PJR, 2001, NATURE, V412, P334, DOI 10.1038/35085576; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Haas DW, 2003, HIV CLIN TRIALS, V4, P287, DOI 10.1310/MUQC-QXBC-8118-BPM5; Henn MR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002529; Holmes I, 2002, J MOL BIOL, V317, P753, DOI 10.1006/jmbi.2002.5405; Huang KHG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019018; Huang KHG, 2009, ANTIVIR THER, V14, P975, DOI 10.3851/IMP1416; Iglesias MC, 2011, BLOOD, V118, P2138, DOI 10.1182/blood-2011-01-328781; Iversen AKN, 2006, NAT IMMUNOL, V7, P179, DOI 10.1038/ni1298; Janes H, 2015, NAT MED, V21, P1139, DOI 10.1038/nm.3932; John M, 2010, J IMMUNOL, V184, P4368, DOI 10.4049/jimmunol.0903745; Kawashima Y, 2009, NATURE, V458, P641, DOI 10.1038/nature07746; Keane NM, 2012, IMMUNOL CELL BIOL, V90, P224, DOI 10.1038/icb.2011.34; Kempf MC, 2008, JAIDS-J ACQ IMM DEF, V47, P116, DOI 10.1097/QAI.0b013e31815d2f3f; Kiepiela P, 2004, NATURE, V432, P769, DOI 10.1038/nature03113; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; Kloverpris HN, 2015, J IMMUNOL, V194, P5329, DOI 10.4049/jimmunol.1400854; Korber BT, 2009, J VIROL, V83, P8300, DOI 10.1128/JVI.00114-09; Leslie A, 2006, J IMMUNOL, V177, P4699, DOI 10.4049/jimmunol.177.7.4699; Letourneau S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000984; Listgarten J, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000016; Liu MKP, 2013, J CLIN INVEST, V123, P380, DOI 10.1172/JCI65330; Llano A., 2009, HIV MOL IMMUNOLOGY, P3; Lundegaard C, 2008, BIOINFORMATICS, V24, P1397, DOI 10.1093/bioinformatics/btn128; Lundegaard C, 2008, NUCLEIC ACIDS RES, V36, pW509, DOI 10.1093/nar/gkn202; Mailliard RB, 2013, J IMMUNOL, V191, P2570, DOI 10.4049/jimmunol.1300373; Mallal SA, 1998, J ACQ IMMUN DEF SYND, V17, pS23, DOI 10.1097/00042560-199801001-00008; Marsh SGE, 2010, TISSUE ANTIGENS, V75, P291, DOI 10.1111/j.1399-0039.2010.01466.x; Martinez-Picado J, 2006, J VIROL, V80, P3617, DOI 10.1128/JVI.80.7.3617-3623.2006; Matthews PC, 2012, J VIROL, V86, P12643, DOI 10.1128/JVI.01381-12; Matthews PC, 2011, J IMMUNOL, V186, P5675, DOI 10.4049/jimmunol.1003711; McElrath MJ, 2008, LANCET, V372, P1894, DOI 10.1016/S0140-6736(08)61592-5; McKenna SL, 1997, AIDS, V11, pS103; McMichael AJ, 2010, NAT REV IMMUNOL, V10, P11, DOI 10.1038/nri2674; Miles JJ, 2011, IMMUNOL CELL BIOL, V89, P375, DOI 10.1038/icb.2010.139; Miura T, 2008, J VIROL, V82, P8422, DOI 10.1128/JVI.00535-08; Miura T, 2009, J VIROL, V83, P3407, DOI 10.1128/JVI.02459-08; Moore CB, 2002, SCIENCE, V296, P1439, DOI 10.1126/science.1069660; Mothe B, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-208; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; Ndung'u T, 2001, J VIROL, V75, P4964, DOI 10.1128/JVI.75.11.4964-4972.2001; Ntale RS, 2012, J VIROL, V86, P12013, DOI 10.1128/JVI.00539-12; Oxenius A, 2004, J INFECT DIS, V190, P713, DOI 10.1086/422760; Payne RP, 2014, J VIROL, V88, P4668, DOI 10.1128/JVI.03303-13; Payne R, 2014, P NATL ACAD SCI USA, V111, pE5393, DOI 10.1073/pnas.1413339111; Pereyra F, 2014, J VIROL, V88, P12937, DOI 10.1128/JVI.01004-14; Pereyra FP, 2010, SCIENCE, V330, P1551, DOI 10.1126/science.1195271; Poon AFY, 2015, J INFECT DIS, V211, P926, DOI 10.1093/infdis/jiu560; Prince JL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003041; Roederer M, 2011, CYTOM PART A, V79A, P167, DOI 10.1002/cyto.a.21015; Rolland M, 2007, PLOS PATHOG, V3, P1551, DOI 10.1371/journal.ppat.0030157; Rolland M, 2011, NAT MED, V17, P366, DOI 10.1038/nm.2316; Salazar-Gonzalez JF, 2009, J EXP MED, V206, P1273, DOI 10.1084/jem.20090378; SELF SG, 1987, J AM STAT ASSOC, V82, P605, DOI 10.2307/2289471; Shapiro RL, 2010, NEW ENGL J MED, V362, P2282, DOI 10.1056/NEJMoa0907736; Sidney J., 2013, CURR PROTOC IMMUNOL, V100, p18.3.1, DOI [DOI 10.1002/0471142735.IM1803S100, 10.1002/0471142735.im1803s100]; Sidney J, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-1; Song W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023469; Storey JD, 2003, ANN STAT, V31, P2013, DOI 10.1214/aos/1074290335; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Tang JM, 2004, AIDS RES HUM RETROV, V20, P19, DOI 10.1089/088922204322749468; Trachtenberg E, 2003, NAT MED, V9, P928, DOI 10.1038/nm893; Trask SA, 2002, J VIROL, V76, P397, DOI 10.1128/JVI.76.1.397-405.2002; van Dorp CH, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003899; Vance DE, 2011, J ASSOC NURSE AIDS C, V22, P17, DOI 10.1016/j.jana.2010.04.002; Wang YYE, 2009, J VIROL, V83, P1845, DOI 10.1128/JVI.01061-08; Wright JK, 2012, J VIROL, V86, P3193, DOI 10.1128/JVI.06682-11; Wright JK, 2011, J VIROL, V85, P3996, DOI 10.1128/JVI.02520-10; Wright JK, 2010, J VIROL, V84, P10820, DOI 10.1128/JVI.01084-10; Yewdell JW, 2006, IMMUNITY, V25, P533, DOI 10.1016/j.immuni.2006.09.005; Yue L, 2013, J VIROL, V87, P708, DOI 10.1128/JVI.02118-12	109	66	67	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2016	22	6					606	+		10.1038/nm.4100	http://dx.doi.org/10.1038/nm.4100			14	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DO0NQ	27183217	Green Accepted, Green Submitted			2022-12-25	WOS:000377476000013
J	Okbay, A; Baselmans, BML; De Neve, JE; Turley, P; Nivard, MG; Fontana, MA; Meddens, SFW; Linner, RK; Rietveld, CA; Derringer, J; Gratten, J; Lee, JJ; Liu, JZ; de Vlaming, R; Ahluwalia, TS; Buchwald, J; Cavadino, A; Frazier-Wood, AC; Furlotte, NA; Garfield, V; Geisel, MH; Gonzalez, JR; Haitjema, S; Karlsson, R; van der Laan, SW; Ladwig, KH; Lahti, J; van der Lee, SJ; Lind, PA; Liu, T; Matteson, L; Mihailov, E; Miller, MB; Minica, CC; Nolte, IM; Mook-Kanamori, D; van der Most, PJ; Oldmeadow, C; Qian, Y; Raitakari, O; Rawal, R; Realo, A; Rueedi, R; Schmidt, B; Smith, AV; Stergiakouli, E; Tanaka, T; Taylor, K; Wedenoja, J; Wellmann, J; Westra, HJ; Willems, SM; Zhao, W; Amin, N; Bakshi, A; Boyle, PA; Cherney, S; Cox, SR; Davies, G; Davis, OSP; Ding, J; Direk, N; Eibich, P; Emeny, RT; Fatemifar, G; Faul, JD; Ferrucci, L; Forstner, A; Gieger, C; Gupta, R; Harris, TB; Harris, JM; Holliday, EG; Hottenga, JJ; De Jager, PL; Kaakinen, MA; Kajantie, E; Karhunen, V; Kolcic, I; Kumari, M; Launer, LJ; Franke, L; Li-Gao, R; Koini, M; Loukola, A; Marques-Vidal, P; Montgomery, GW; Mosing, MA; Paternoster, L; Pattie, A; Petrovic, KE; Pulkki-Raback, L; Quaye, L; Raikkonen, K; Rudan, I; Scott, RJ; Smith, JA; Sutin, AR; Trzaskowski, M; Vinkhuyzen, AE; Yu, L; Zabaneh, D; Attia, JR; Bennett, DA; Berger, K; Bertram, L; Boomsma, DI; Snieder, H; Chang, SC; Cucca, F; Deary, IJ; van Duijn, CM; Eriksson, JG; Bultmann, U; de Geus, EJC; Groenen, PJF; Gudnason, V; Hansen, T; Hartman, CA; Haworth, CMA; Hayward, C; Heath, AC; Hinds, DA; Hypponen, E; Iacono, WG; Jarvelin, MR; Jockel, KH; Kaprio, J; Kardia, SLR; Keltikangas-Jarvinen, L; Kraft, P; Kubzansky, LD; Lehtimaki, T; Magnusson, PKE; Martin, NG; Mcgue, M; Metspalu, A; Mills, M; de Mutsert, R; Oldehinkel, AJ; Pasterkamp, G; Pedersen, NL; Plomin, R; Polasek, O; Power, C; Rich, SS; Rosendaal, FR; den Ruijter, HM; Schlessinger, D; Schmidt, H; Svento, R; Schmidt, R; Alizadeh, BZ; Sorensen, TIA; Spector, TD; Steptoe, A; Terracciano, A; Thurik, AR; Timpson, NJ; Tiemeier, H; Uitterlinden, AG; Vollenweider, P; Wagner, GG; Weir, DR; Yang, J; Conley, DC; Smith, GD; Hofman, A; Johannesson, M; Laibson, DI; Medland, SE; Meyer, MN; Pickrell, JK; Esko, T; Krueger, RF; Beauchamp, JP; Koellinger, PD; Benjamin, DJ; Bartels, M; Cesarini, D				Okbay, Aysu; Baselmans, Bart M. L.; De Neve, Jan-Emmanuel; Turley, Patrick; Nivard, Michel G.; Fontana, Mark Alan; Meddens, S. Fleur W.; Linner, Richard Karlsson; Rietveld, Cornelius A.; Derringer, Jaime; Gratten, Jacob; Lee, James J.; Liu, Jimmy Z.; de Vlaming, Ronald; Ahluwalia, Tarunveer S.; Buchwald, Jadwiga; Cavadino, Alana; Frazier-Wood, Alexis C.; Furlotte, Nicholas A.; Garfield, Victoria; Geisel, Marie Henrike; Gonzalez, Juan R.; Haitjema, Saskia; Karlsson, Robert; van der Laan, Sander W.; Ladwig, Karl-Heinz; Lahti, Jari; van der Lee, Sven J.; Lind, Penelope A.; Liu, Tian; Matteson, Lindsay; Mihailov, Evelin; Miller, Michael B.; Minica, Camelia C.; Nolte, Ilja M.; Mook-Kanamori, Dennis; van der Most, Peter J.; Oldmeadow, Christopher; Qian, Yong; Raitakari, Olli; Rawal, Rajesh; Realo, Anu; Rueedi, Rico; Schmidt, Borge; Smith, Albert V.; Stergiakouli, Evie; Tanaka, Toshiko; Taylor, Kent; Wedenoja, Juho; Wellmann, Juergen; Westra, Harm-Jan; Willems, Sara M.; Zhao, Wei; Amin, Najaf; Bakshi, Andrew; Boyle, Patricia A.; Cherney, Samantha; Cox, Simon R.; Davies, Gail; Davis, Oliver S. P.; Ding, Jun; Direk, Nese; Eibich, Peter; Emeny, Rebecca T.; Fatemifar, Ghazaleh; Faul, Jessica D.; Ferrucci, Luigi; Forstner, Andreas; Gieger, Christian; Gupta, Richa; Harris, Tamara B.; Harris, Juliette M.; Holliday, Elizabeth G.; Hottenga, Jouke-Jan; De Jager, Philip L.; Kaakinen, Marika A.; Kajantie, Eero; Karhunen, Ville; Kolcic, Ivana; Kumari, Meena; Launer, Lenore J.; Franke, Lude; Li-Gao, Ruifang; Koini, Marisa; Loukola, Anu; Marques-Vidal, Pedro; Montgomery, Grant W.; Mosing, Miriam A.; Paternoster, Lavinia; Pattie, Alison; Petrovic, Katja E.; Pulkki-Raback, Laura; Quaye, Lydia; Raikkonen, Katri; Rudan, Igor; Scott, Rodney J.; Smith, Jennifer A.; Sutin, Angelina R.; Trzaskowski, Maciej; Vinkhuyzen, Anna E.; Yu, Lei; Zabaneh, Delilah; Attia, John R.; Bennett, David A.; Berger, Klaus; Bertram, Lars; Boomsma, Dorret I.; Snieder, Harold; Chang, Shun-Chiao; Cucca, Francesco; Deary, Ian J.; van Duijn, Cornelia M.; Eriksson, Johan G.; Bultmann, Ute; de Geus, Eco J. C.; Groenen, Patrick J. F.; Gudnason, Vilmundur; Hansen, Torben; Hartman, Catharine A.; Haworth, Claire M. A.; Hayward, Caroline; Heath, Andrew C.; Hinds, David A.; Hypponen, Elina; Iacono, William G.; Jarvelin, Marjo-Riitta; Jockel, Karl-Heinz; Kaprio, Jaakko; Kardia, Sharon L. R.; Keltikangas-Jarvinen, Liisa; Kraft, Peter; Kubzansky, Laura D.; Lehtimaki, Terho; Magnusson, Patrik K. E.; Martin, Nicholas G.; Mcgue, Matt; Metspalu, Andres; Mills, Melinda; de Mutsert, Renee; Oldehinkel, Albertine J.; Pasterkamp, Gerard; Pedersen, Nancy L.; Plomin, Robert; Polasek, Ozren; Power, Christine; Rich, Stephen S.; Rosendaal, Frits R.; den Ruijter, Hester M.; Schlessinger, David; Schmidt, Helena; Svento, Rauli; Schmidt, Reinhold; Alizadeh, Behrooz Z.; Sorensen, Thorkild I. A.; Spector, Tim D.; Steptoe, Andrew; Terracciano, Antonio; Thurik, A. Roy; Timpson, Nicholas J.; Tiemeier, Henning; Uitterlinden, Andre G.; Vollenweider, Peter; Wagner, Gert G.; Weir, David R.; Yang, Jian; Conley, Dalton C.; Smith, George Davey; Hofman, Albert; Johannesson, Magnus; Laibson, David I.; Medland, Sarah E.; Meyer, Michelle N.; Pickrell, Joseph K.; Esko, Tonu; Krueger, Robert F.; Beauchamp, Jonathan P.; Koellinger, Philipp D.; Benjamin, Daniel J.; Bartels, Meike; Cesarini, David		LifeLines Cohort Study	Genetic variants associated with subjective well-being, depressive symptoms, and neuroticism identified through genome-wide analyses	NATURE GENETICS			English	Article							COMMON VARIANTS; RISK; HERITABILITY; HAPPINESS; RESOURCE; TWIN	Very few genetic variants have been associated with depression and neuroticism, likely because of limitations on sample size in previous studies. Subjective well-being, a phenotype that is genetically correlated with both of these traits, has not yet been studied with genome-wide data. We conducted genome-wide association studies of three phenotypes: subjective well-being (n = 298,420), depressive symptoms (n = 161,460), and neuroticism (n = 170,911). We identify 3 variants associated with subjective well-being, 2 variants associated with depressive symptoms, and 11 variants associated with neuroticism, including 2 inversion polymorphisms. The two loci associated with depressive symptoms replicate in an independent depression sample. Joint analyses that exploit the high genetic correlations between the phenotypes (vertical bar(p) over cap vertical bar approximate to 0.8) strengthen the overall credibility of the findings and allow us to identify additional variants. Across our phenotypes, loci regulating expression in central nervous system and adrenal or pancreas tissues are strongly enriched for association.	[Okbay, Aysu; Rietveld, Cornelius A.; de Vlaming, Ronald; Thurik, A. Roy] Erasmus Univ, Erasmus Sch Econ, Dept Appl Econ, Rotterdam, Netherlands; [Okbay, Aysu; Rietveld, Cornelius A.; de Vlaming, Ronald; van der Lee, Sven J.; Willems, Sara M.; Amin, Najaf; van Duijn, Cornelia M.; Tiemeier, Henning; Uitterlinden, Andre G.; Hofman, Albert] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Okbay, Aysu; Meddens, S. Fleur W.; Linner, Richard Karlsson; Rietveld, Cornelius A.; de Vlaming, Ronald; Groenen, Patrick J. F.; Thurik, A. Roy; Uitterlinden, Andre G.; Koellinger, Philipp D.] Erasmus Univ, Inst Behav & Biol, Rotterdam, Netherlands; [Baselmans, Bart M. L.; Nivard, Michel G.; Minica, Camelia C.; Hottenga, Jouke-Jan; Boomsma, Dorret I.; de Geus, Eco J. C.; Bartels, Meike] Vrije Univ Amsterdam, Dept Biol Psychol, Amsterdam, Netherlands; [Baselmans, Bart M. L.; Hottenga, Jouke-Jan; Boomsma, Dorret I.; de Geus, Eco J. C.; Bartels, Meike] EMGO Inst Hlth & Care Res, Amsterdam, Netherlands; [De Neve, Jan-Emmanuel] Univ Oxford, Said Business Sch, Oxford, England; [Turley, Patrick; Laibson, David I.; Beauchamp, Jonathan P.] Harvard Univ, Dept Econ, Cambridge, MA 02138 USA; [Fontana, Mark Alan; Benjamin, Daniel J.] Univ So Calif, Ctr Econ & Social Res, Los Angeles, CA USA; [Meddens, S. Fleur W.; Linner, Richard Karlsson; Koellinger, Philipp D.] Vrije Univ, Ctr Neurogenom & Cognit Res, Dept Complex Trait Genet, Amsterdam, Netherlands; [Meddens, S. Fleur W.; Linner, Richard Karlsson; Koellinger, Philipp D.] Univ Amsterdam, Amsterdam Business Sch, Amsterdam, Netherlands; [Derringer, Jaime] Univ Illinois, Dept Psychol, Champaign, IL USA; [Gratten, Jacob; Bakshi, Andrew; Trzaskowski, Maciej; Vinkhuyzen, Anna E.; Yang, Jian] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia; [Lee, James J.; Matteson, Lindsay; Miller, Michael B.; Iacono, William G.; Mcgue, Matt; Krueger, Robert F.] Univ Minnesota Twin Cities, Dept Psychol, Minneapolis, MN USA; [Liu, Jimmy Z.; Pickrell, Joseph K.] New York Genome Ctr, New York, NY USA; [Ahluwalia, Tarunveer S.] Univ Copenhagen, Herlev & Gentofte Hosp, COPSAC Copenhagen Prospect Studies Asthma Childho, Copenhagen, Denmark; [Ahluwalia, Tarunveer S.; Hansen, Torben; Sorensen, Thorkild I. A.] Univ Copenhagen, Fac Med & Hlth Sci, Sect Metab Genet, Novo Nordisk Fdn Ctr Basic Metab Res, Copenhagen, Denmark; [Ahluwalia, Tarunveer S.] Steno Diabet Ctr, Gentofte, Denmark; [Buchwald, Jadwiga; Wedenoja, Juho; Gupta, Richa; Loukola, Anu; Kaprio, Jaakko] Univ Helsinki, Dept Publ Hlth, Helsinki, Finland; [Cavadino, Alana] Queen Mary Univ London, Wolfson Inst Prevent Med, Ctr Environm & Prevent Med, London, England; [Cavadino, Alana; Hypponen, Elina; Power, Christine] South Australian Hlth & Med Res Inst, Adelaide, SA, Australia; [Frazier-Wood, Alexis C.] Baylor Coll Med, USDA ARS Childrens Nutr Res Ctr, Houston, TX 77030 USA; [Furlotte, Nicholas A.; Hinds, David A.] 23andMe Inc, Mountain View, CA USA; [Garfield, Victoria; Steptoe, Andrew] UCL, Dept Epidemiol & Publ Hlth, London, England; [Geisel, Marie Henrike; Schmidt, Borge; Jockel, Karl-Heinz] Univ Hosp Essen, Inst Med Informat Biometry & Epidemiol, Essen, Germany; [Gonzalez, Juan R.] Inst Global Hlth, Ctr Res Environm Epidemiol, Barcelona, Spain; [Gonzalez, Juan R.] Univ Pompeu Fabra, Barcelona, Spain; [Gonzalez, Juan R.] CIBER Epidemiol & Salud Publ, Barcelona, Spain; [Haitjema, Saskia; van der Laan, Sander W.; Pasterkamp, Gerard] Univ Med Ctr Utrecht, Lab Expt Cardiol, Utrecht, Netherlands; [Karlsson, Robert; Magnusson, Patrik K. E.; Pedersen, Nancy L.] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Ladwig, Karl-Heinz; Emeny, Rebecca T.] Helmholtz Zentrum Munchen German Res Ctr Environ, Mental Hlth Res Unit, Inst Epidemiol 2, Neuherberg, Germany; [Ladwig, Karl-Heinz] Tech Univ Munich, Klinikum Rechts Isar, Dept Psychosomat Med & Psychotherapy, D-80290 Munich, Germany; [Lahti, Jari; Pulkki-Raback, Laura; Raikkonen, Katri; Keltikangas-Jarvinen, Liisa] Univ Helsinki, Inst Behav Sci, Helsinki, Finland; [Lahti, Jari] Folkhalsan Res Ctr, Helsinki, Finland; [Lahti, Jari; Pulkki-Raback, Laura] Univ Helsinki, Helsinki Collegium Adv Studies, Helsinki, Finland; [Lind, Penelope A.; Medland, Sarah E.] QIMR Berghofer Med Res Inst, Psychiat Genet, Brisbane, Qld, Australia; [Liu, Tian; Wagner, Gert G.] Max Planck Inst Human Dev, Berlin, Germany; [Liu, Tian] Max Planck Inst Mol Genet, Dept Vertebrate Gen, Ihnestr 73, D-14195 Berlin, Germany; [Mihailov, Evelin; Metspalu, Andres; Esko, Tonu] Univ Tartu, Estonian Genome Ctr, Ulikooli 18, EE-50090 Tartu, Estonia; [Nolte, Ilja M.; van der Most, Peter J.; Snieder, Harold; Alizadeh, Behrooz Z.] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands; [Mook-Kanamori, Dennis; Li-Gao, Ruifang; de Mutsert, Renee; Rosendaal, Frits R.] Leiden Univ, Med Ctr, Clin Epidemiol, Leiden, Netherlands; [Mook-Kanamori, Dennis] Leiden Univ, Med Ctr, Publ Hlth & Primary Care, Leiden, Netherlands; [Mook-Kanamori, Dennis] King Faisal Specialist Hosp & Res Ctr, BESC, Riyadh 11211, Saudi Arabia; [Oldmeadow, Christopher; Holliday, Elizabeth G.; Attia, John R.] Hunter Med Res Inst, Publ Hlth Stream, New Lambton, NSW, Australia; [Oldmeadow, Christopher; Holliday, Elizabeth G.; Scott, Rodney J.; Attia, John R.] Univ Newcastle, Fac Hlth & Med, Newcastle, NSW 2300, Australia; [Qian, Yong; Ding, Jun; Schlessinger, David] NIA, Genet Lab, Baltimore, MD 21224 USA; [Raitakari, Olli] Univ Turku, Res Ctr Appl & Prevent Cardiovasc Med, Turku, Finland; [Raitakari, Olli] Turku Univ Hosp, Dept Clin Physiol, FIN-20520 Turku, Finland; [Rawal, Rajesh; Gieger, Christian] Helmholtz Zentrum Munchen German Res Ctr Environ, Res Unit Mol Epidemiol, Neuherberg, Germany; [Realo, Anu] Univ Tartu, Dept Psychol, Ulikooli 18, EE-50090 Tartu, Estonia; [Realo, Anu] Univ Warwick, Dept Psychol, Coventry CV4 7AL, W Midlands, England; [Rueedi, Rico] Univ Lausanne, Dept Computat Biol, Lausanne, Switzerland; [Rueedi, Rico] Swiss Inst Bioinformat, Lausanne, Switzerland; [Smith, Albert V.; Gudnason, Vilmundur] Iceland Heart Assoc, Kopavogur, Iceland; [Smith, Albert V.; Gudnason, Vilmundur] Univ Iceland, Fac Med, Reykjavik, Iceland; [Stergiakouli, Evie; Davis, Oliver S. P.; Paternoster, Lavinia; Haworth, Claire M. A.; Sorensen, Thorkild I. A.; Timpson, Nicholas J.; Smith, George Davey] Univ Bristol, MRC Integrat Epidemiol Unit, Bristol, Avon, England; [Tanaka, Toshiko; Ferrucci, Luigi; Sutin, Angelina R.; Terracciano, Antonio] NIA, NIH, Baltimore, MD 21224 USA; [Taylor, Kent] Harbor UCLA, Los Angeles Biomed Res Inst, Torrance, CA USA; [Taylor, Kent] Harbor UCLA, Dept Pediat, Torrance, CA USA; [Wellmann, Juergen; Berger, Klaus] Univ Munster, Inst Epidemiol & Social Med, Munster, Germany; [Westra, Harm-Jan] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Genet,Dept Med, Boston, MA 02115 USA; [Westra, Harm-Jan] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Rheumatol,Dept Med, Boston, MA 02115 USA; [Zhao, Wei; Smith, Jennifer A.; Kardia, Sharon L. R.] Univ Michigan, Dept Epidemiol, Ann Arbor, MI 48109 USA; [LifeLines Cohort Study] Univ Groningen, Univ Med Ctr Groningen, Groningen, Netherlands; [Boyle, Patricia A.] Rush Univ, Med Ctr, Dept Behav Sci, Chicago, IL 60612 USA; [Cherney, Samantha] RAND Corp, Santa Monica, CA USA; [Cox, Simon R.; Davies, Gail; Deary, Ian J.] Univ Edinburgh, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh, Midlothian, Scotland; [Cox, Simon R.; Davies, Gail; Pattie, Alison; Deary, Ian J.] Univ Edinburgh, Dept Psychol, Edinburgh, Midlothian, Scotland; [Eibich, Peter; Wagner, Gert G.] DIW Berlin, German Socioecon Panel Study, Berlin, Germany; [Eibich, Peter] Univ Oxford, Nuffield Dept Populat Hlth, Hlth Econ Res Ctr, Oxford, England; [Emeny, Rebecca T.] Geisel Sch Med Dartmouth, Dept Epidemiol, Lebanon, NH USA; [Fatemifar, Ghazaleh] UCL, Farr Inst Hlth Informat, London, England; [Faul, Jessica D.; Weir, David R.] Univ Michigan, Inst Social Res, Survey Res Ctr, Ann Arbor, MI USA; [Forstner, Andreas] Univ Bonn, Inst Human Genet, Bonn, Germany; [Forstner, Andreas] Univ Bonn, Life & Brain Ctr, Dept Genom, Bonn, Germany; [Harris, Tamara B.] NIA, NIH, Lab Epidemiol, Demog, Bethesda, MD USA; [Harris, Juliette M.; Quaye, Lydia; Spector, Tim D.] Kings Coll London, Dept Twin Res & Genet Epidemiol, London WC2R 2LS, England; [De Jager, Philip L.] Brigham & Womens Hosp, Dept Neurol, Program Translat NeuroPsychiat Genom, 75 Francis St, Boston, MA 02115 USA; [De Jager, Philip L.] Brigham & Womens Hosp, Dept Psychiat, 75 Francis St, Boston, MA 02115 USA; [De Jager, Philip L.] Harvard Univ, Sch Med, Boston, MA USA; [De Jager, Philip L.] Broad Inst Harvard & MIT, Program Med & Populat Genet, Cambridge, MA USA; [Kaakinen, Marika A.; Jarvelin, Marjo-Riitta] Univ London Imperial Coll Sci Technol & Med, Dept Genom Common Dis, London, England; [Kaakinen, Marika A.; Karhunen, Ville] Univ Oulu, Ctr Life Course Hlth Res, Oulu, Finland; [Kaakinen, Marika A.; Karhunen, Ville] Oulu Univ Hosp, Oulu, Finland; [Kajantie, Eero] Univ Helsinki, Dept Pediat, Helsinki, Finland; [Kajantie, Eero] Natl Inst Hlth & Welf, Helsinki, Finland; [Kolcic, Ivana; Trzaskowski, Maciej; Zabaneh, Delilah; Polasek, Ozren] Univ Split, Fac Med, Dept Publ Hlth, Split, Croatia; [Kumari, Meena] Univ Essex, Inst Social & Econ Res, Wivenhoe Pk, Colchester CO4 3SQ, Essex, England; [Launer, Lenore J.] NIA, NIH, Neuroepidemiol Sect, Bethesda, MD 20892 USA; [Franke, Lude; Terracciano, Antonio] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands; [Koini, Marisa; Petrovic, Katja E.; Schmidt, Helena; Schmidt, Reinhold] Gen Hosp, Dept Neurol, Graz, Austria; [Koini, Marisa; Petrovic, Katja E.; Schmidt, Helena; Schmidt, Reinhold] Med Univ Graz, Graz, Austria; [Marques-Vidal, Pedro; Vollenweider, Peter] Lausanne Univ Hosp CHUV, Internal Med, Dept Internal Med, Lausanne, Switzerland; [Montgomery, Grant W.] QIMR Berghofer Med Res Inst, Mol Epidemiol, Brisbane, Qld, Australia; [Mosing, Miriam A.] Karolinska Inst, Dept Neurosci, Stockholm, Sweden; [Rudan, Igor] Univ Edinburgh, Usher Inst Populat Hlth Sci & Informat, Ctr Global Hlth Res, Edinburgh, Midlothian, Scotland; [Scott, Rodney J.] Hunter Med Res Inst, Informat Based Med Stream, New Lambton, NSW, Australia; [Sutin, Angelina R.; Terracciano, Antonio] Florida State Univ, Coll Med, Dept Behav Sci & Social Med, Tallahassee, FL 32306 USA; [Yu, Lei; Bennett, David A.] Rush Univ, Med Ctr, Dept Neurol Sci, Chicago, IL 60612 USA; [Bertram, Lars] Univ Lubeck, Inst Neurogenet, Lubeck Interdisciplinary Platform Genome Analyt, Lubeck, Germany; [Bertram, Lars] Univ Lubeck, Inst Integrat & Expt Genom, Lubeck, Germany; [Bertram, Lars] Univ London Imperial Coll Sci Technol & Med, Fac Med, Sch Publ Hlth, Neuroepidemiol & Ageing Res Unit, London, England; [Boomsma, Dorret I.; de Geus, Eco J. C.; Bartels, Meike] Neurosci Campus Amsterdam, Amsterdam, Netherlands; [Chang, Shun-Chiao] Brigham & Womens Hosp, Dept Med, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA; [Chang, Shun-Chiao] Harvard Univ, Sch Med, Boston, MA USA; [Cucca, Francesco] Cittadella Univ Monserrato, Consiglio Nazl Ric, Ist Ric Genet & Biomed IRGB, Monserrato, Italy; [Eriksson, Johan G.] Univ Helsinki, Dept Gen Practice & Primary Hlth Care, Helsinki, Finland; [Eriksson, Johan G.] Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Helsinki, Finland; [Eriksson, Johan G.] Univ Cent Hosp, Unit Gen Practice, Helsinki, Finland; [Bultmann, Ute] Univ Groningen, Univ Med Ctr Groningen, Dept Hlth Sci Community & Occupat Med, Groningen, Netherlands; [Groenen, Patrick J. F.; Oldehinkel, Albertine J.] Erasmus Univ, Inst Econometr, Erasmus Sch Econ, POB 1738, NL-3000 DR Rotterdam, Netherlands; [Hartman, Catharine A.] Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, Groningen, Netherlands; [Hayward, Caroline] Univ Edinburgh, Inst Genet & Mol Med, MRC Human Genet Unit, Edinburgh, Midlothian, Scotland; [Heath, Andrew C.] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; [Hypponen, Elina] Univ S Australia, Sch Hlth Sci, Ctr Populat Hlth Res, Adelaide, SA 5001, Australia; [Hypponen, Elina] Univ S Australia, Sansom Inst, Adelaide, SA 5001, Australia; [Hypponen, Elina; Power, Christine] UCL Inst Child Hlth, Populat Policy & Practice, London, England; [Jarvelin, Marjo-Riitta] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, MRC PHE Ctr Environm & Hlth, Dept Epidemiol & Biostat, London, England; [Jarvelin, Marjo-Riitta] Univ Oulu, Bioctr Oulu, Oulu, Finland; [Jarvelin, Marjo-Riitta] Oulu Univ Hosp, Unit Primary Care, Oulu, Finland; [Kaprio, Jaakko] Univ Helsinki, Inst Mol Med Finland FIMM, Helsinki, Finland; [Kaprio, Jaakko] THL Natl Inst Hlth & Welf, Dept Hlth, Helsinki, Finland; [Kraft, Peter] Harvard Univ, TH Chan Sch Publ Hlth, Dept Epidemiol & Biostat, Boston, MA 02115 USA; [Kubzansky, Laura D.] Harvard Univ, TH Chan Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA 02115 USA; [Lehtimaki, Terho] Fimlab Labs, Tampere, Finland; [Lehtimaki, Terho] Univ Tampere, Sch Med, Dept Clin Chem, FIN-33101 Tampere, Finland; [Martin, Nicholas G.] QIMR Berghofer Med Res Inst, Genet Epidemiol, Brisbane, Qld, Australia; [Metspalu, Andres] Univ Tartu, Inst Mol & Cell Biol, Ulikooli 18, EE-50090 Tartu, Estonia; [Mills, Melinda] Univ Oxford, Dept Sociol, Oxford, England; [Pasterkamp, Gerard] Univ Med Ctr Utrecht, Div Labs & Pharm, Lab Clin Chem & Hematol, Utrecht, Netherlands; [Plomin, Robert] Kings Coll London, Social Genet & Dev Psychiat Ctr, De Crespigny Pk, London, England; [Rich, Stephen S.] Univ Virginia, Dept Publ Hlth Sci, Charlottesville, VA USA; [Schmidt, Helena] Gen Hosp, Ctr Mol Med, Res Unit Genet Epidemiol, Inst Mol Biol & Biochem, Graz, Austria; [Schmidt, Helena] Med Univ Graz, Graz, Austria; [Svento, Rauli] Oulu Business Sch, Dept Econ, Oulu, Finland; [Alizadeh, Behrooz Z.] Univ Groningen, Univ Med Ctr Groningen, Dept Gastroenterol & Hepatol, Groningen, Netherlands; [Sorensen, Thorkild I. A.] Bispebjerg & Frederiksberg Hosp, Inst Prevent Med, Frederiksberg, Denmark; [Thurik, A. Roy] Montpellier Business Sch, Montpellier, France; [Thurik, A. Roy] Panteia, Zoetermeer, Netherlands; [Tiemeier, Henning] Erasmus MC, Dept Psychiat, Rotterdam, Netherlands; [Tiemeier, Henning] Erasmus MC, Dept Child & Adolescent Psychiat, Rotterdam, Netherlands; [Uitterlinden, Andre G.] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands; [Wagner, Gert G.] Berlin Univ Technol, Sch Econ & Management, Berlin, Germany; [Yang, Jian] Univ Queensland Diamantina Inst, Translat Res Inst, Brisbane, Qld, Australia; [Conley, Dalton C.] Princeton Univ, Dept Sociol, Princeton, NJ 08544 USA; [Hofman, Albert] Harvard Univ, TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Johannesson, Magnus] Stockholm Sch Econ, Dept Econ, S-11383 Stockholm, Sweden; [Meyer, Michelle N.] Clarkson Univ, Dept Bioeth, Schenectady, NY USA; [Meyer, Michelle N.] Icahn Sch Med Mt Sinai, New York, NY 10029 USA; [Pickrell, Joseph K.] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Cesarini, David] NYU, Dept Econ, New York, NY 10003 USA; [Cesarini, David] Res Inst Ind Econ, Stockholm, Sweden	Erasmus University Rotterdam; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; University of Oxford; Harvard University; University of Southern California; Vrije Universiteit Amsterdam; University of Amsterdam; University of Illinois System; University of Illinois Urbana-Champaign; University of Queensland; University of Minnesota System; University of Minnesota Twin Cities; University of Copenhagen; Novo Nordisk Foundation; University of Copenhagen; Steno Diabetes Center; University of Helsinki; University of London; Queen Mary University London; South Australian Health & Medical Research Institute (SAHMRI); Baylor College of Medicine; United States Department of Agriculture (USDA); University of London; University College London; University of Duisburg Essen; ISGlobal; Pompeu Fabra University; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Utrecht University; Utrecht University Medical Center; Karolinska Institutet; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; University of Helsinki; Folkhalsan Research Center; University of Helsinki; QIMR Berghofer Medical Research Institute; Max Planck Society; Max Planck Society; University of Tartu; University of Groningen; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; King Faisal Specialist Hospital & Research Center; Hunter Medical Research Institute; University of Newcastle; University of Newcastle; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Turku; University of Turku; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Tartu; University of Warwick; University of Lausanne; Swiss Institute of Bioinformatics; Icelandic Heart Association; University of Iceland; University of Bristol; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of Munster; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Michigan System; University of Michigan; University of Groningen; Rush University; RAND Corporation; University of Edinburgh; University of Edinburgh; DIW Berlin - Deutsches Institut fur Wirtschaftsforschung; University of Oxford; Dartmouth College; University of London; University College London; University of Michigan System; University of Michigan; University of Bonn; University of Bonn; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of London; King's College London; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Imperial College London; University of Oulu; University of Oulu; University of Helsinki; Finland National Institute for Health & Welfare; University of Split; University of Essex; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Groningen; Medical University of Graz; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); QIMR Berghofer Medical Research Institute; Karolinska Institutet; University of Edinburgh; Hunter Medical Research Institute; University of Newcastle; State University System of Florida; Florida State University; Rush University; University of Lubeck; University of Lubeck; Imperial College London; Vrije Universiteit Amsterdam; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Consiglio Nazionale delle Ricerche (CNR); Istituto di Ricerca Genetica e Biomedica (IRGB-CNR); University of Helsinki; Finland National Institute for Health & Welfare; University of Helsinki; Helsinki University Central Hospital; University of Groningen; Erasmus University Rotterdam; University of Groningen; University of Edinburgh; Washington University (WUSTL); University of South Australia; University of South Australia; University of London; University College London; Imperial College London; University of Oulu; University of Oulu; University of Helsinki; Finland National Institute for Health & Welfare; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Tampere University; QIMR Berghofer Medical Research Institute; University of Tartu; University of Oxford; Utrecht University; Utrecht University Medical Center; University of London; King's College London; University of Virginia; Medical University of Graz; University of Groningen; University of Copenhagen; Bispebjerg Hospital; Montpellier Business School; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Technical University of Berlin; University of Queensland; Princeton University; Harvard University; Harvard T.H. Chan School of Public Health; Stockholm School of Economics; Icahn School of Medicine at Mount Sinai; Columbia University; New York University; Research Institute of Industrial Economics (IFN)	Koellinger, PD (corresponding author), Erasmus Univ, Inst Behav & Biol, Rotterdam, Netherlands.; Bartels, M (corresponding author), Vrije Univ Amsterdam, Dept Biol Psychol, Amsterdam, Netherlands.; Bartels, M (corresponding author), EMGO Inst Hlth & Care Res, Amsterdam, Netherlands.; Benjamin, DJ (corresponding author), Univ So Calif, Ctr Econ & Social Res, Los Angeles, CA USA.; Koellinger, PD (corresponding author), Vrije Univ, Ctr Neurogenom & Cognit Res, Dept Complex Trait Genet, Amsterdam, Netherlands.; Koellinger, PD (corresponding author), Univ Amsterdam, Amsterdam Business Sch, Amsterdam, Netherlands.; Bartels, M (corresponding author), Neurosci Campus Amsterdam, Amsterdam, Netherlands.	p.d.koellinger@vu.nl; djbenjam@usc.edu; m.bartels@vu.nl	Tiemeier, Henning/H-6534-2019; Wagner, Gert G./AIC-8679-2022; Lahti, Jari/P-7987-2018; Medland, Sarah E/C-7630-2013; Mosing, Miriam/ABD-9751-2020; Terracciano, Antonio/H-7403-2019; Laibson, David/AAA-7362-2022; Raitakari, Olli/AAQ-7389-2021; Kolcic, Ivana/E-2713-2017; Steptoe, Andrew/Y-2440-2019; Bertram, Lars/K-3889-2015; Ahluwalia, Tarunveer Singh/C-5549-2009; Wedenoja, Juho/AAX-7008-2020; Medland, Sarah/AAT-7595-2020; Rosendaal, Frits/Q-3842-2017; Davey Smith, George/A-7407-2013; Deary, Ian J/C-6297-2009; Bartels, Meike/D-4492-2014; Haworth, Claire M.A./C-7073-2009; Magnusson, Patrik KE/C-4458-2017; Polasek, Ozren/B-6002-2011; Lind, Penelope A/ABC-5341-2021; Baselmans, Bart ML/R-3562-2016; Colaus, PsyColaus/K-6607-2013; Gupta, Richa/J-4774-2019; Lahti, Jari/P-2283-2019; Realo, Anu/M-9524-2016; Cavadino, Alana/CAG-8915-2022; Kaprio, Jaakko/A-1820-2008; Lehtimäki, Terho/AAD-1094-2022; Rudan, Igor/I-1467-2012; Gonzalez, Juan R/B-7860-2018; Linnér, Richard Karlsson/AAA-9755-2021; de Geus, Eco J.C./M-9318-2015; Montgomery, Grant W/B-7148-2008; Gudnason, Vilmundur/AAE-7126-2019; Yu, Lei/AAT-3685-2020; Hypponen, Elina/B-2596-2014; Cox, Simon R./HDN-8568-2022; Yang, Jian/A-5852-2010; Kraft, Peter/GQH-8448-2022; Franke, Lude/P-7036-2016; Lind, Penelope A/B-2553-2009; Li-Gao, Ruifang/B-7172-2018; Wood, Lekki/B-8053-2010; Ladwig, Karl-Heinz/B-5351-2014; Johannesson, Magnus/E-9680-2011; Tecirli, Nese Direk -/G-1746-2019; Boomsma, Dorret I/AAX-4470-2020; van der Laan, Sander W./N-1330-2019; Gratten, Jacob/G-1485-2011; Thurik, Roy/A-9386-2012; Timpson, Nicholas John/O-7548-2015; Linnér, Richard Karlsson/ADB-8728-2022; Buchwald, Jadwiga/F-5463-2019; Marques-Vidal, Pedro M/C-9449-2009; Attia, John R/F-5376-2013; Smith, Albert Vernon/K-5150-2015; Scott, Rodney/B-2827-2013; Paternoster, Lavinia/C-1292-2015	Tiemeier, Henning/0000-0002-4395-1397; Lahti, Jari/0000-0002-4310-5297; Medland, Sarah E/0000-0003-1382-380X; Terracciano, Antonio/0000-0001-5799-8885; Kolcic, Ivana/0000-0001-7918-6052; Bertram, Lars/0000-0002-0108-124X; Ahluwalia, Tarunveer Singh/0000-0002-7464-3354; Wedenoja, Juho/0000-0002-6155-0378; Medland, Sarah/0000-0003-1382-380X; Rosendaal, Frits/0000-0003-2558-7496; Davey Smith, George/0000-0002-1407-8314; Deary, Ian J/0000-0002-1733-263X; Bartels, Meike/0000-0002-9667-7555; Haworth, Claire M.A./0000-0002-8608-289X; Magnusson, Patrik KE/0000-0002-7315-7899; Polasek, Ozren/0000-0002-5765-1862; Lind, Penelope A/0000-0002-3887-2598; Baselmans, Bart ML/0000-0001-9042-1041; Gupta, Richa/0000-0001-7700-5828; Lahti, Jari/0000-0002-4310-5297; Cavadino, Alana/0000-0002-5709-367X; Kaprio, Jaakko/0000-0002-3716-2455; Lehtimäki, Terho/0000-0002-2555-4427; Rudan, Igor/0000-0001-6993-6884; Gonzalez, Juan R/0000-0003-3267-2146; Linnér, Richard Karlsson/0000-0001-7839-2858; de Geus, Eco J.C./0000-0001-6022-2666; Montgomery, Grant W/0000-0002-4140-8139; Gudnason, Vilmundur/0000-0001-5696-0084; Hypponen, Elina/0000-0003-3670-9399; Cox, Simon R./0000-0003-4036-3642; Yang, Jian/0000-0003-2001-2474; Franke, Lude/0000-0002-5159-8802; Lind, Penelope A/0000-0002-3887-2598; Li-Gao, Ruifang/0000-0003-0650-1351; Wood, Lekki/0000-0001-7616-2119; Ladwig, Karl-Heinz/0000-0003-0710-1720; Johannesson, Magnus/0000-0001-8759-6393; Tecirli, Nese Direk -/0000-0002-3631-5990; van der Laan, Sander W./0000-0001-6888-1404; Gratten, Jacob/0000-0003-1293-409X; Thurik, Roy/0000-0002-0242-6908; Timpson, Nicholas John/0000-0002-7141-9189; Buchwald, Jadwiga/0000-0001-6688-8346; Marques-Vidal, Pedro M/0000-0002-4548-8500; Attia, John R/0000-0001-9800-1308; Rawal, Rajesh/0000-0002-0151-9344; Smith, Albert Vernon/0000-0003-1942-5845; Hinds, David/0000-0002-4911-803X; Davis, Oliver/0000-0002-6448-3684; Eriksson, Johan/0000-0002-2516-2060; Karhunen, Ville/0000-0001-6064-1588; Scott, Rodney/0000-0001-7724-3404; Trzaskowski, Maciej/0000-0001-8559-6525; Derringer, Jaime/0000-0002-7352-9859; Okbay, Aysu/0000-0002-5170-7781; Stergiakouli, Evangelia/0000-0003-3586-0927; Venkatasubramanian, Siddharth/0000-0002-5860-0768; CUCCA, Francesco/0000-0002-7414-1995; Van Duijn, Cornelia/0000-0002-2374-9204; Mosing, Miriam Anna/0000-0003-2049-125X; Nivard, Michel/0000-0003-2015-1888; de Vlaming, Ronald/0000-0001-6416-6067; Cesarini, David/0000-0002-0043-009X; Loukola, Anu-Maria/0000-0003-0542-5967; Plomin, Robert/0000-0002-0756-3629; Pedersen, Nancy/0000-0001-8057-3543; van der Lee, Sven/0000-0003-1606-8643; Paternoster, Lavinia/0000-0003-2514-0889; Zabaneh, Delilah/0000-0003-4740-3862; Minica, Camelia/0000-0001-7140-8167; Oldmeadow, Christopher/0000-0001-6104-1322; Groenen, Patrick/0000-0001-6683-8971; Faul, Jessica/0000-0002-6969-6478; Hansen, Torben/0000-0001-8748-3831; s, hema/0000-0002-3440-9475; Karlsson, Robert/0000-0002-8949-2587; Kumari, Meena/0000-0001-9716-1035; Amin, Najaf/0000-0002-8944-1771; Koellinger, Philipp/0000-0001-7413-0412; Bjornsdottir, Gyda/0000-0002-8100-0306; Smith, Jennifer Ann/0000-0002-3575-5468; Bultmann, Ute/0000-0001-9589-9220; Garfield, Ana Victoria/0000-0002-5127-0890; Bakshi, Andrew/0000-0001-5650-7036; den Ruijter, Hester/0000-0001-9762-014X; Rich, Stephen/0000-0003-3872-7793; Gieger, Christian/0000-0001-6986-9554; Kraft, Peter/0000-0002-4472-8103	Social Science Genetic Association Consortium (SSGAC); US National Science Foundation (EAGER: 'Workshop for the Formation of a Social Science Genetic Association Consortium'); National Institute of Health Office of Behavioral and Social Science Research; Ragnar Soderberg Foundation [E9/11]; Swedish Research Council [421-2013-1061]; Jan Wallander and Tom Hedelius Foundation; ERC Consolidator Grant [647648 EdGe]; Pershing Square Fund of the Foundations of Human Behavior; NIA/NIH [P01-AG005842, P01-AG005842-20S2, P30-AG012810, T32-AG000186-23, R01-AG042568-02]; Economic and Social Research Council [ES/N011856/1, ES/M010341/1, 1336609, ES/K005774/1] Funding Source: researchfish; Medical Research Council [G1001799, MR/N01104X/1, MR/J012165/1, MC_UU_12013/1, MC_qA137853, MC_PC_U127561128, MC_UU_12013/3, MR/K026992/1, MC_PC_15018] Funding Source: researchfish; National Institute for Health Research [NF-SI-0507-10228, NF-SI-0514-10027] Funding Source: researchfish; Novo Nordisk Fonden [NNF15OC0016362, NNF12OC1016374] Funding Source: researchfish; ESRC [ES/K005774/1, ES/M010341/1, ES/N011856/1] Funding Source: UKRI; MRC [MR/N01104X/1, G1001799, MC_UU_12013/3, MR/J012165/1, MC_PC_U127561128, MC_UU_12013/1] Funding Source: UKRI; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P2CHD047879] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000186, R01AG042568, P01AG005842, P30AG012810, R03AG051960, ZIAAG000693, RF1AG015819, ZIAAG000675, R01AG017917, P30AG010161, U01AG009740] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA036216, R37DA005147] Funding Source: NIH RePORTER	Social Science Genetic Association Consortium (SSGAC); US National Science Foundation (EAGER: 'Workshop for the Formation of a Social Science Genetic Association Consortium')(National Science Foundation (NSF)); National Institute of Health Office of Behavioral and Social Science Research; Ragnar Soderberg Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Jan Wallander and Tom Hedelius Foundation; ERC Consolidator Grant(European Research Council (ERC)); Pershing Square Fund of the Foundations of Human Behavior(Pershing Square Foundation); NIA/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Novo Nordisk Fonden(Novo Nordisk Foundation); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We are grateful to P.M. Visscher for advice, support, and feedback. We thank S. Cunningham and N. Galla for research assistance. This research was carried out under the auspices of the Social Science Genetic Association Consortium (SSGAC). The SSGAC seeks to facilitate studies that investigate the influence of genes on human behavior, well-being, and social-scientific outcomes using large GWAS meta-analyses. The SSGAC also provides opportunities for replication and promotes the collection of accurately measured, harmonized phenotypes across cohorts. The SSGAC operates as a working group within the CHARGE Consortium. This research has also been conducted using the UK Biobank Resource. The study was supported by funding from the US National Science Foundation (EAGER: 'Workshop for the Formation of a Social Science Genetic Association Consortium'), a supplementary grant from the National Institute of Health Office of Behavioral and Social Science Research, the Ragnar Soderberg Foundation (E9/11), the Swedish Research Council (421-2013-1061), the Jan Wallander and Tom Hedelius Foundation, an ERC Consolidator Grant (647648 EdGe), the Pershing Square Fund of the Foundations of Human Behavior, and the NIA/NIH through grants P01-AG005842, P01-AG005842-20S2, P30-AG012810, and T32-AG000186-23 to NBER and R01-AG042568-02 to the University of Southern California. A full list of acknowledgments is provided in the Supplementary Note.	Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Bartels M, 2013, BEHAV GENET, V43, P177, DOI 10.1007/s10519-013-9589-7; Bartels M, 2009, BEHAV GENET, V39, P605, DOI 10.1007/s10519-009-9294-8; Bulik-Sullivan BK, 2015, NAT GENET, V47, P291, DOI 10.1038/ng.3211; Caceres A, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv073; de Moor MHM, 2015, JAMA PSYCHIAT, V72, P642, DOI 10.1001/jamapsychiatry.2015.0554; Eysenck H.J., 1975, MANUAL EYSENCK PERSO; Fehrmann RSN, 2015, NAT GENET, V47, P115, DOI 10.1038/ng.3173; Finucane HK, 2015, NAT GENET, V47, P1228, DOI 10.1038/ng.3404; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; GLASSMAN AH, 1990, JAMA-J AM MED ASSOC, V264, P1546, DOI 10.1001/jama.264.12.1546; Hoglinger GU, 2011, NAT GENET, V43, P699, DOI 10.1038/ng.859; Hyman S, 2014, NATURE, V515, P189, DOI 10.1038/515189a; Kahneman D., 2005, SCI WELL BEING, V1, P285, DOI DOI 10.1093/ACPROF:OSO/9780198567523.003.0011; Kahneman D, 2010, P NATL ACAD SCI USA, V107, P16489, DOI 10.1073/pnas.1011492107; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; Kendler KS, 2010, PSYCHOL MED, V40, P801, DOI 10.1017/S0033291709991140; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Meuwissen THE, 2001, GENETICS, V157, P1819; Penninx BWJH, 2008, INT J METH PSYCH RES, V17, P121, DOI 10.1002/mpr.256; Rietveld CA, 2014, P NATL ACAD SCI USA, V111, P13790, DOI 10.1073/pnas.1404623111; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Roberts RE, 2000, AM J EPIDEMIOL, V152, P163, DOI 10.1093/aje/152.2.163; Rugulies R, 2002, AM J PREV MED, V23, P51, DOI 10.1016/S0749-3797(02)00439-7; Seeman Philip, 2010, Clin Schizophr Relat Psychoses, V4, P56, DOI 10.3371/CSRP.4.1.5; Shahab L, 2012, DRUG ALCOHOL DEPEN, V121, P38, DOI 10.1016/j.drugalcdep.2011.08.011; Shungin D, 2015, NATURE, V518, P187, DOI 10.1038/nature14132; Smith D.J., 2016, GENOME WIDE ANAL OVE, DOI [10.1101/032417, DOI 10.1101/032417]; Sonnega A, 2014, INT J EPIDEMIOL, V43, P576, DOI 10.1093/ije/dyu067; Spencer CCA, 2011, HUM MOL GENET, V20, P345, DOI 10.1093/hmg/ddq469; Steinberg KM, 2012, NAT GENET, V44, P872, DOI 10.1038/ng.2335; Stetler C, 2011, PSYCHOSOM MED, V73, P114, DOI 10.1097/PSY.0b013e31820ad12b; Sudlow C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001779; Sullivan P, 2012, MOL PSYCHIATR, V17, P2, DOI 10.1038/mp.2011.94; Sullivan PF, 2013, MOL PSYCHIATR, V18, P497, DOI 10.1038/mp.2012.21; Tian C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040004; Vallone D, 2000, NEUROSCI BIOBEHAV R, V24, P125, DOI 10.1016/S0149-7634(99)00063-9; van Beijsterveldt CEM, 2013, TWIN RES HUM GENET, V16, P252, DOI 10.1017/thg.2012.118; Vilhjalmsson BJ, 2015, AM J HUM GENET, V97, P576, DOI 10.1016/j.ajhg.2015.09.001; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Weiss A, 2008, PSYCHOL SCI, V19, P205, DOI 10.1111/j.1467-9280.2008.02068.x; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Willemsen G, 2013, TWIN RES HUM GENET, V16, P271, DOI 10.1017/thg.2012.140; Winkler TW, 2014, NAT PROTOC, V9, P1192, DOI 10.1038/nprot.2014.071; Wood AR, 2014, NAT GENET, V46, P1173, DOI 10.1038/ng.3097; Yang J, 2011, EUR J HUM GENET, V19, P807, DOI 10.1038/ejhg.2011.39; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608	47	497	505	10	181	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2016	48	6					624	+		10.1038/ng.3552	http://dx.doi.org/10.1038/ng.3552			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DN0HE	27089181	Green Accepted, Green Submitted			2022-12-25	WOS:000376744200009
J	Amaral, N; Vendrell, A; Funaya, C; Idrissi, FZ; Maier, M; Kumar, A; Neurohr, G; Colomina, N; Torres-Rosell, J; Geli, MI; Mendoza, M				Amaral, Nuno; Vendrell, Alexandre; Funaya, Charlotta; Idrissi, Fatima-Zahra; Maier, Michael; Kumar, Arun; Neurohr, Gabriel; Colomina, Neus; Torres-Rosell, Jordi; Geli, Maria-Isabel; Mendoza, Manuel			The Aurora-B-dependent NoCut checkpoint prevents damage of anaphase bridges after DNA replication stress	NATURE CELL BIOLOGY			English	Article							MEDIATED ABSCISSION CHECKPOINT; CHROMOSOME SEGREGATION; PROMOTING COMPLEX; TOPOISOMERASE-II; ACTOMYOSIN-RING; CYTOKINESIS; MITOSIS; GENES; YEAST; COORDINATION	Anaphase chromatin bridges can lead to chromosome breakage if not properly resolved before completion of cytokinesis. The NoCut checkpoint, which depends on Aurora B at the spindle midzone, delays abscission in response to chromosome segregation defects in yeast and animal cells. How chromatin bridges are detected, and whether abscission inhibition prevents their damage, remain key unresolved questions. We find that bridges induced by DNA replication stress and by condensation or decatenation defects, but not dicentric chromosomes, delay abscission in a NoCut-dependent manner. Decatenation and condensation defects lead to spindle stabilization during cytokinesis, allowing bridge detection by Aurora B. NoCut does not prevent DNA damage following condensin or topoisomerase II inactivation; however, it protects anaphase bridges and promotes cellular viability after replication stress. Therefore, the molecular origin of chromatin bridges is critical for activation of NoCut, which plays a key role in the maintenance of genome stability after replicative stress.	[Amaral, Nuno; Vendrell, Alexandre; Maier, Michael; Kumar, Arun; Neurohr, Gabriel; Mendoza, Manuel] Barcelona Inst Sci & Technol, Ctr Genom Regulat CRG, Dr Aiguader 88, Barcelona 08003, Spain; [Amaral, Nuno; Vendrell, Alexandre; Maier, Michael; Kumar, Arun; Mendoza, Manuel] UPF, Barcelona 08003, Spain; [Funaya, Charlotta; Geli, Maria-Isabel] EMBL Heidelberg, Meyerhofstr 1, D-69117 Heidelberg, Germany; [Idrissi, Fatima-Zahra] CSIC, Inst Biol Mol Barcelona, E-08028 Barcelona, Spain; [Colomina, Neus; Torres-Rosell, Jordi] Inst Recerca Biomed Lleida, Av Alcalde Rovira Roure 80, Lleida 25198, Spain; [Idrissi, Fatima-Zahra] Ctr Genom Regulat CRG, Dr Aiguader 88, Barcelona 08003, Spain; [Neurohr, Gabriel] Massachusetts Inst Technol MIT 76 561, 500 Main St, Cambridge, MA 02139 USA	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; European Molecular Biology Laboratory (EMBL); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB); Institut de Recerca Biomedica - IRB Lleida; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG)	Mendoza, M (corresponding author), Barcelona Inst Sci & Technol, Ctr Genom Regulat CRG, Dr Aiguader 88, Barcelona 08003, Spain.; Mendoza, M (corresponding author), UPF, Barcelona 08003, Spain.	manuel.mendoza@crg.es	Mendoza, Manuel/AAE-8987-2021; Colomina, Neus/ABF-7179-2021; Geli, Maria Isabel/L-3246-2014; Colomina Gabarrella, Neus/C-4449-2011; Torres-Rosell, Jordi/A-4213-2010; Maier, Michael Josef/O-8088-2015; Amaral, Nuno/K-2764-2015; Idrissi Azami, Fatima Zohra/P-5627-2015	Mendoza, Manuel/0000-0001-5522-4878; Colomina, Neus/0000-0002-1986-1199; Geli, Maria Isabel/0000-0002-3452-6700; Colomina Gabarrella, Neus/0000-0002-1986-1199; Torres-Rosell, Jordi/0000-0003-1308-6926; Maier, Michael Josef/0000-0001-8841-5283; Fredriksson Funaya, Charlotta/0000-0003-1375-1287; KUMAR, ARUN/0000-0001-8706-8558; Neurohr, Gabriel/0000-0003-1728-5498; Amaral, Nuno/0000-0003-2501-1403; Idrissi Azami, Fatima Zohra/0000-0003-3672-7618	'La Caixa' fellowships; Spanish Ministry of Economy and Competitivity [BFU2011-30185, CDS2009-00016, BFU2015-71308, BFU2013-50245-EXP, BFU2009-08213, BFU2012-37162]; European Research Council (ERC Starting Grant) [260965]; Spanish Ministry of Economy and Competitiveness, 'Centro de Excelencia Severo Ochoa' [SEV-2012-0208]	'La Caixa' fellowships; Spanish Ministry of Economy and Competitivity(Spanish Government); European Research Council (ERC Starting Grant)(European Research Council (ERC)); Spanish Ministry of Economy and Competitiveness, 'Centro de Excelencia Severo Ochoa'(Spanish Government)	We thank S. Oliferenko and N. Brownlow for suggestions and critical reading of the manuscript; Y. Barral and D. Pellman for helpful discussions; G. Filion for help with statistical analysis; T. Sanmartin for technical support; the CRG Advanced Light Microscopy Unit; and Y. Schwab (EMBL, Heidelberg), C. Lopez-Iglesias and Y. Muela-Castro (CCIT-University of Barcelona) for assistance with electron microscopy. This research was supported by 'La Caixa' fellowships to N.A., G.N. and M.Maier, and grants from the Spanish Ministry of Economy and Competitivity (BFU2011-30185 and CDS2009-00016 to M.-I.G.; BFU2015-71308 and BFU2013-50245-EXP to J.T.-R.; and BFU2009-08213 and BFU2012-37162 to M.Mendoza), and from the European Research Council (ERC Starting Grant 260965 to M.Mendoza). We acknowledge support from the Spanish Ministry of Economy and Competitiveness, 'Centro de Excelencia Severo Ochoa 2013-2017', SEV-2012-0208.	Baxter J, 2008, MOL CELL, V30, P790, DOI 10.1016/j.molcel.2008.04.019; Burrell RA, 2013, NATURE, V494, P492, DOI 10.1038/nature11935; Carlton JG, 2012, SCIENCE, V336, P220, DOI 10.1126/science.1217180; Chan KL, 2009, NAT CELL BIOL, V11, P753, DOI 10.1038/ncb1882; Chan KL, 2007, EMBO J, V26, P3397, DOI 10.1038/sj.emboj.7601777; Cimini D, 2001, J CELL BIOL, V153, P517, DOI 10.1083/jcb.153.3.517; Cuyien S, 2013, DEV CELL, V27, P469, DOI 10.1016/j.devcel.2013.10.018; Dobbelaere J, 2004, SCIENCE, V305, P393, DOI 10.1126/science.1099892; Fasulo B, 2012, MOL BIOL CELL, V23, P1047, DOI 10.1091/mbc.E11-10-0832; Floyd S, 2013, J CELL SCI, V126, P2845, DOI 10.1242/jcs.123232; Ganem NJ, 2012, J CELL BIOL, V199, P871, DOI 10.1083/jcb.201210040; Germann SM, 2014, J CELL BIOL, V204, P45, DOI 10.1083/jcb.201305157; Hoffelder DR, 2004, CHROMOSOMA, V112, P389, DOI 10.1007/s00412-004-0284-6; Holland AJ, 2009, NAT REV MOL CELL BIO, V10, P478, DOI 10.1038/nrm2718; HOLM C, 1985, CELL, V41, P553, DOI 10.1016/S0092-8674(85)80028-3; Idrissi FZ, 2008, J CELL BIOL, V180, P1219, DOI 10.1083/jcb.200708060; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Janssen A, 2011, SCIENCE, V333, P1895, DOI 10.1126/science.1210214; Juang YL, 1997, SCIENCE, V275, P1311, DOI 10.1126/science.275.5304.1311; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Lavoie BD, 2002, J CELL BIOL, V156, P805, DOI 10.1083/jcb.200109056; Lippincott J, 2000, EXP CELL RES, V260, P277, DOI 10.1006/excr.2000.5021; Lopez V, 2015, GENE DEV, V29, P322, DOI 10.1101/gad.254664.114; LOUVION JF, 1993, GENE, V131, P129, DOI 10.1016/0378-1119(93)90681-R; Mankouri HW, 2013, EMBO J, V32, P2661, DOI 10.1038/emboj.2013.211; Mendoza M, 2008, BIOCHEM SOC T, V36, P387, DOI 10.1042/BST0360387; Mendoza M, 2009, NAT CELL BIOL, V11, P477, DOI 10.1038/ncb1855; MULLINS JM, 1977, J CELL BIOL, V73, P672, DOI 10.1083/jcb.73.3.672; Naim V, 2013, NAT CELL BIOL, V15, P1008, DOI 10.1038/ncb2793; Neurohr G, 2011, SCIENCE, V332, P465, DOI 10.1126/science.1201578; Norden C, 2006, CELL, V125, P85, DOI 10.1016/j.cell.2006.01.045; Onishi M, 2013, J CELL BIOL, V202, P311, DOI 10.1083/jcb.201302001; Pereira G, 2003, SCIENCE, V302, P2120, DOI 10.1126/science.1091936; Ramaswamy V, 2003, MOL CELL BIOL, V23, P9136, DOI 10.1128/MCB.23.24.9136-9149.2003; Schmidt M, 2002, J CELL SCI, V115, P293; Steigemann P, 2009, CELL, V136, P473, DOI 10.1016/j.cell.2008.12.020; Stewenius Y, 2005, P NATL ACAD SCI USA, V102, P5541, DOI 10.1073/pnas.0408454102; Thompson SL, 2011, P NATL ACAD SCI USA, V108, P17974, DOI 10.1073/pnas.1109720108; Tully GH, 2009, MOL BIOL CELL, V20, P1201, DOI 10.1091/mbc.E08-08-0822; Wang LHC, 2008, CHROMOSOMA, V117, P123, DOI 10.1007/s00412-007-0131-7; Wang LHC, 2010, J CELL SCI, V123, P806, DOI 10.1242/jcs.058255; Woodruff JB, 2010, J CELL BIOL, V191, P795, DOI 10.1083/jcb.201006028; Yang SS, 1997, J CELL BIOL, V136, P345, DOI 10.1083/jcb.136.2.345; Ying SM, 2013, NAT CELL BIOL, V15, P1001, DOI 10.1038/ncb2773; Zhao XL, 1998, MOL CELL, V2, P329, DOI 10.1016/S1097-2765(00)80277-4	45	36	36	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAY	2016	18	5					516	+		10.1038/ncb3343	http://dx.doi.org/10.1038/ncb3343			21	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	DK3RH	27111841	Green Published, Green Accepted			2022-12-25	WOS:000374834600009
J	Keener, AB				Keener, Amanda B.			Saving face: The search for alternatives to life-long immunosuppression for face transplants	NATURE MEDICINE			English	News Item																		Dolgin E, 2012, NAT MED, V18, P12, DOI 10.1038/nm0112-12; Fryer M, 2015, EXPERT REV CLIN IMMU, V11, P1189, DOI 10.1586/1744666X.2015.1078729; HIVELIN M, 2015, ARCH IMMUNOL; Leonard DA, 2014, AM J TRANSPLANT, V14, P343, DOI 10.1111/ajt.12560; Plock JA, 2015, TRANSPLANTATION, V99, P1765, DOI 10.1097/TP.0000000000000731; Schneeberger S, 2013, ANN SURG, V257, P345, DOI 10.1097/SLA.0b013e31826d90bb	6	7	10	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2016	22	5					448	449		10.1038/nm0516-448	http://dx.doi.org/10.1038/nm0516-448			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DL3DI	27149211				2022-12-25	WOS:000375514000021
J	Zhu, ZH; Zhang, FT; Hu, H; Bakshi, A; Robinson, MR; Powell, JE; Montgomery, GW; Goddard, ME; Wray, NR; Visscher, PM; Yang, J				Zhu, Zhihong; Zhang, Futao; Hu, Han; Bakshi, Andrew; Robinson, Matthew R.; Powell, Joseph E.; Montgomery, Grant W.; Goddard, Michael E.; Wray, Naomi R.; Visscher, Peter M.; Yang, Jian			Integration of summary data from GWAS and eQTL studies predicts complex trait gene targets	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; MENDELIAN RANDOMIZATION; RHEUMATOID-ARTHRITIS; HUMAN BRAIN; RISK; SCHIZOPHRENIA; EPIDEMIOLOGY; DISEASE; 16P11.2; LOCI	Genome-wide association studies (GWAS) have identified thousands of genetic variants associated with human complex traits. However, the genes or functional DNA elements through which these variants exert their effects on the traits are often unknown. We propose a method (called SMR) that integrates summary-level data from GWAS with data from expression quantitative trait locus (eQTL) studies to identify genes whose expression levels are associated with a complex trait because of pleiotropy. We apply the method to five human complex traits using GWAS data on up to 339,224 individuals and eQTL data on 5,311 individuals, and we prioritize 126 genes (for example, TRAF1 and ANKRD55 for rheumatoid arthritis and SNX19 and NMRAL1 for schizophrenia), of which 25 genes are new candidates; 77 genes are not the nearest annotated gene to the top associated GWAS SNP. These genes provide important leads to design future functional studies to understand the mechanism whereby DNA variation leads to complex trait variation.	[Zhu, Zhihong; Zhang, Futao; Bakshi, Andrew; Robinson, Matthew R.; Powell, Joseph E.; Wray, Naomi R.; Visscher, Peter M.; Yang, Jian] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia; [Hu, Han] Zhejiang Univ, Coll Life Sci, State Key Lab Plant Physiol & Biochem, Hangzhou 310003, Zhejiang, Peoples R China; [Powell, Joseph E.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia; [Montgomery, Grant W.] QIMR Berghofer Med Res Inst, Mol Epidemiol, Brisbane, Qld, Australia; [Goddard, Michael E.] Univ Melbourne, Fac Vet & Agr Sci, Parkville, Vic 3052, Australia; [Goddard, Michael E.] Dept Econ Dev Jobs Transport & Resources, Biosci Res Div, Bundoora, Vic, Australia; [Visscher, Peter M.; Yang, Jian] Univ Queensland, Diamantina Inst, Translat Res Inst, Brisbane, Qld, Australia	University of Queensland; Zhejiang University; University of Queensland; QIMR Berghofer Medical Research Institute; University of Melbourne; University of Queensland	Yang, J (corresponding author), Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia.; Yang, J (corresponding author), Univ Queensland, Diamantina Inst, Translat Res Inst, Brisbane, Qld, Australia.	jian.yang@uq.edu.au	Hu, Han/I-7652-2016; Zhu, Zhihong/F-8720-2015; Montgomery, Grant W/B-7148-2008; Wray, Naomi/C-8639-2015; Visscher, Peter/ABB-6151-2020; Yang, Jian/A-5852-2010; Zhang, Futao/D-2733-2017	Hu, Han/0000-0001-9317-6133; Zhu, Zhihong/0000-0002-6783-3037; Montgomery, Grant W/0000-0002-4140-8139; Wray, Naomi/0000-0001-7421-3357; Visscher, Peter/0000-0002-2143-8760; Yang, Jian/0000-0003-2001-2474; Zhang, Futao/0000-0002-6043-1756; Goddard, Michael/0000-0001-9917-7946; Bakshi, Andrew/0000-0001-5650-7036; Powell, Joseph/0000-0002-5070-4124; Robinson, Matthew/0000-0001-8982-8813	Australian Research Council [DP130102666]; Australian National Health and Medical Research Council [1078037, 1048853, 1046880]; Sylvia and Charles Viertel Charitable Foundation	Australian Research Council(Australian Research Council); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Sylvia and Charles Viertel Charitable Foundation	We thank J. McGrath for helpful comments. This research was supported by the Australian Research Council (DP130102666), the Australian National Health and Medical Research Council (grants 1078037, 1048853 and 1046880) and the Sylvia and Charles Viertel Charitable Foundation. This study makes use of data from the database of Genotypes and Phenotypes (dbGaP) available under accession phs000090.v3.p1 (see the Supplementary Note for the full set of acknowledgments for these data).	Albers HM, 2008, ANN RHEUM DIS, V67, P1578, DOI 10.1136/ard.2008.089060; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Brion MJA, 2013, INT J EPIDEMIOL, V42, P1497, DOI 10.1093/ije/dyt179; Chung JY, 2002, J CELL SCI, V115, P679; Claussnitzer M, 2015, NEW ENGL J MED, V373, P895, DOI 10.1056/NEJMoa1502214; Davey Smith G, 2014, HUM MOL GENET, V23, pR89, DOI 10.1093/hmg/ddu328; DAVIES RB, 1973, BIOMETRIKA, V60, P415, DOI 10.2307/2334555; Eaton WW, 2006, AM J PSYCHIAT, V163, P521, DOI 10.1176/appi.ajp.163.3.521; Ference BA, 2012, J AM COLL CARDIOL, V60, P2631, DOI 10.1016/j.jacc.2012.09.017; Finucane HK, 2015, NAT GENET, V47, P1228, DOI 10.1038/ng.3404; Freeman G, 2013, INT J EPIDEMIOL, V42, P1157, DOI 10.1093/ije/dyt110; Gamazon ER, 2015, NAT GENET, V47, P1091, DOI 10.1038/ng.3367; Giambartolomei C, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004383; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Golzio C, 2012, NATURE, V485, P363, DOI 10.1038/nature11091; Gusev A, 2016, NAT GENET, V48, P245, DOI 10.1038/ng.3506; Inoue A, 2010, REV ECON STAT, V92, P557, DOI 10.1162/REST_a_00011; Jansen RC, 2001, TRENDS GENET, V17, P388, DOI 10.1016/S0168-9525(01)02310-1; KATAN MB, 1986, LANCET, V1, P507; Kuonen D, 1999, BIOMETRIKA, V86, P929, DOI 10.1093/biomet/86.4.929; Lawlor DA, 2008, STAT MED, V27, P1133, DOI 10.1002/sim.3034; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Lynch M., 1998, GENETICS ANAL QUANTI; McCarthy SE, 2009, NAT GENET, V41, P1223, DOI 10.1038/ng.474; McKenzie M, 2014, BMC MED GENOMICS, V7, DOI 10.1186/1755-8794-7-31; Nemani K, 2015, PROG NEURO-PSYCHOPH, V56, P155, DOI 10.1016/j.pnpbp.2014.08.018; Nica AC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002003; Okada Y, 2014, NATURE, V506, P376, DOI 10.1038/nature12873; Patsopoulos NA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003926; Pierce BL, 2013, AM J EPIDEMIOL, V178, P1177, DOI 10.1093/aje/kwt084; Plenge RM, 2007, NEW ENGL J MED, V357, P1199, DOI 10.1056/NEJMoa073491; Powell JE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035430; Psaty BM, 2009, CIRC-CARDIOVASC GENE, V2, P73, DOI 10.1161/CIRCGENETICS.108.829747; Ramasamy A, 2014, NAT NEUROSCI, V17, P1418, DOI 10.1038/nn.3801; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Shungin D, 2015, NATURE, V518, P187, DOI 10.1038/nature14132; Smemo S, 2014, NATURE, V507, P371, DOI 10.1038/nature13138; Smith GD, 2003, INT J EPIDEMIOL, V32, P1, DOI 10.1093/ije/dyg070; Stahl EA, 2010, NAT GENET, V42, P508, DOI 10.1038/ng.582; Tsitsikov EN, 2001, IMMUNITY, V15, P647, DOI 10.1016/S1074-7613(01)00207-2; Veyrieras JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030629; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; Wood AR, 2014, NAT GENET, V46, P1173, DOI 10.1038/ng.3097; Xavier RJ, 2008, NAT REV IMMUNOL, V8, P631, DOI 10.1038/nri2361; Yang J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003355; Yang J, 2012, NAT GENET, V44, P369, DOI 10.1038/ng.2213; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011	50	874	887	25	232	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2016	48	5					481	+		10.1038/ng.3538	http://dx.doi.org/10.1038/ng.3538			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DK3RC	27019110				2022-12-25	WOS:000374834100005
J	Boettger, LM; Salem, RM; Handsaker, RE; Peloso, GM; Kathiresan, S; Hirschhorn, JN; McCarroll, SA				Boettger, Linda M.; Salem, Rany M.; Handsaker, Robert E.; Peloso, Gina M.; Kathiresan, Sekar; Hirschhorn, Joel N.; McCarroll, Steven A.			Recurring exon deletions in the HP (haptoglobin) gene contribute to lower blood cholesterol levels	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; APOLIPOPROTEIN-E; NATURAL-SELECTION; HEMOGLOBIN; IMPUTATION; BINDING; POLYMORPHISM; PROTEINS; SEQUENCE; RECEPTOR	One of the first protein polymorphisms identified in humans involves the abundant blood protein haptoglobin. Two exons of the HP gene (encoding haptoglobin) exhibit copy number variation that affects HP protein structure and multimerization. The evolutionary origins and medical relevance of this polymorphism have been uncertain. Here we show that this variation has likely arisen from many recurring deletions, more specifically, reversions of an ancient hominin-specific duplication of these exons. Although this polymorphism has been largely invisible to genome-wide genetic studies thus far, we describe a way to analyze it by imputation from SNP haplotypes and find among 22,288 individuals that these HP exonic deletions associate with reduced LDL and total cholesterol levels. We further show that these deletions, and a SNP that affects HP expression, appear to drive the strong association of cholesterol levels with SNPs near HP. Recurring exonic deletions in HP likely enhance human health by lowering cholesterol levels in the blood.	[Boettger, Linda M.; Salem, Rany M.; Handsaker, Robert E.; Hirschhorn, Joel N.; McCarroll, Steven A.] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Boettger, Linda M.; Salem, Rany M.; Handsaker, Robert E.; Peloso, Gina M.; Kathiresan, Sekar; Hirschhorn, Joel N.; McCarroll, Steven A.] Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA USA; [Salem, Rany M.; Hirschhorn, Joel N.] Boston Childrens Hosp, Div Endocrinol, Boston, MA USA; [Salem, Rany M.; Hirschhorn, Joel N.] Boston Childrens Hosp, Ctr Basic & Translat Obes Res, Boston, MA USA; [Peloso, Gina M.; Kathiresan, Sekar] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Massachusetts General Hospital	McCarroll, SA (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA USA.; McCarroll, SA (corresponding author), Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA USA.	mccarroll@genetics.med.harvard.edu	Handsaker, Bob/AAX-9095-2021	Handsaker, Bob/0000-0002-3128-3547; Salem, Rany/0000-0001-8816-6862	National Human Genome Research Institute [R01HG006855]; Yerkes Center [P51OD011132]; US National Institutes of Health/National Heart, Lung, and Blood Institute K99 award [1K99HL122515-01A1]; Juvenile Diabetes Research Foundation [JDRF 3-APF-2014-111-A-N]; National Heart, Lung, and Blood Institute of the US National Institutes of Health [K01HL125751]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL122515, K01HL125751] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006855] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011132] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Yerkes Center; US National Institutes of Health/National Heart, Lung, and Blood Institute K99 award; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); National Heart, Lung, and Blood Institute of the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank C. Usher for comments on the manuscript and work on the figures. This work was supported by a grant from the National Human Genome Research Institute (R01HG006855 to S.A.M.). The Yerkes Center (grant P51OD011132) provided primate DNA samples. R.M.S. was supported by a US National Institutes of Health/National Heart, Lung, and Blood Institute K99 award (1K99HL122515-01A1) and an advanced postdoctoral fellowship award from the Juvenile Diabetes Research Foundation (JDRF 3-APF-2014-111-A-N). G.M.P. was supported by the National Heart, Lung, and Blood Institute of the US National Institutes of Health under award K01HL125751.	ALLISON AC, 1957, BRIT MED J, V2, P1137, DOI 10.1136/bmj.2.5054.1137; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Asakawa J, 1999, P NATL ACAD SCI USA, V96, P10314, DOI 10.1073/pnas.96.18.10314; Browning SR, 2008, HUM GENET, V124, P439, DOI 10.1007/s00439-008-0568-7; Cahill LE, 2013, J AM COLL CARDIOL, V62, P860, DOI 10.1016/j.jacc.2013.04.079; Cigliano L, 2009, FEBS J, V276, P6158, DOI 10.1111/j.1742-4658.2009.07319.x; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Delaneau O, 2013, NAT METHODS, V10, P5, DOI 10.1038/nmeth.2307; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Ernst J, 2010, NAT BIOTECHNOL, V28, P817, DOI 10.1038/nbt.1662; Froguel P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032327; Guthrie PAI, 2012, GENE, V499, P8, DOI 10.1016/j.gene.2012.03.034; Hardwick RJ, 2014, HUM GENET, V133, P69, DOI 10.1007/s00439-013-1352-x; Hindson BJ, 2011, ANAL CHEM, V83, P8604, DOI 10.1021/ac202028g; Howie B, 2012, NAT GENET, V44, P955, DOI 10.1038/ng.2354; ISHIBASHI S, 1994, P NATL ACAD SCI USA, V91, P4431, DOI 10.1073/pnas.91.10.4431; Koch W, 2002, CLIN CHEM, V48, P1377; Langlois MR, 1996, CLIN CHEM, V42, P1589; Levy AP, 2004, ATHEROSCLEROSIS, V172, P361, DOI 10.1016/j.atherosclerosis.2003.10.014; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; Llorente MG, 2015, SCIENCE, V350, P820, DOI 10.1126/science.aad2879; MAEDA N, 1984, NATURE, V309, P131, DOI 10.1038/309131a0; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Martosella James, 2008, V425, P27, DOI 10.1007/978-1-60327-210-0_3; MCEVOY SM, 1988, J BIOL CHEM, V263, P15740; Melamed-Frank M, 2001, BLOOD, V98, P3693, DOI 10.1182/blood.V98.13.3693; Meyer M, 2012, SCIENCE, V338, P222, DOI 10.1126/science.1224344; Nielsen MJ, 2009, BLOOD, V114, P764, DOI 10.1182/blood-2009-01-198309; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Prufer K, 2014, NATURE, V505, P43, DOI 10.1038/nature12886; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Regan JF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118270; Rodriguez S, 2012, ANN HUM GENET, V76, P352, DOI 10.1111/j.1469-1809.2012.00716.x; Salvatore A, 2009, J NEUROCHEM, V110, P255, DOI 10.1111/j.1471-4159.2009.06121.x; Salvatore A, 2007, BIOCHEMISTRY-US, V46, P11158, DOI 10.1021/bi7006349; Scally A, 2012, NAT REV GENET, V13, P745, DOI 10.1038/nrg3295; SHINDO S, 1990, ELECTROPHORESIS, V11, P483, DOI 10.1002/elps.1150110609; SMITHIES O, 1955, NATURE, V176, P1265, DOI 10.1038/1761265a0; SMITHIES O, 1962, AM J HUM GENET, V14, P14; Soejima M, 2008, CLIN CHEM, V54, P1908, DOI 10.1373/clinchem.2008.113126; Soejima M, 2014, CLIN CHIM ACTA, V433, P54, DOI 10.1016/j.cca.2014.02.029; Spagnuolo MS, 2013, J PEPT SCI, V19, P220, DOI 10.1002/psc.2487; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Tripathi A, 2009, P NATL ACAD SCI USA, V106, P16799, DOI 10.1073/pnas.0906773106; WEJMAN JC, 1984, J MOL BIOL, V174, P343, DOI 10.1016/0022-2836(84)90342-5; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Yang YL, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054736, 10.1371/journal.pone.0055384, 10.1371/journal.pone.0067755]; Zethelius B, 2008, NEW ENGL J MED, V358, P2107, DOI 10.1056/NEJMoa0707064	50	56	59	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2016	48	4					359	+		10.1038/ng.3510	http://dx.doi.org/10.1038/ng.3510			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DH6NZ	26901066	Green Accepted, Green Submitted			2022-12-25	WOS:000372908800007
J	Johnston, CW; Skinnider, MA; Dejong, CA; Rees, PN; Chen, GM; Walker, CG; French, S; Brown, ED; Berdy, J; Liu, DY; Magarvey, NA				Johnston, Chad W.; Skinnider, Michael A.; Dejong, Chris A.; Rees, Philip N.; Chen, Gregory M.; Walker, Chelsea G.; French, Shawn; Brown, Eric D.; Berdy, Janos; Liu, Dennis Y.; Magarvey, Nathan A.			Assembly and clustering of natural antibiotics guides target identification	NATURE CHEMICAL BIOLOGY			English	Article							SELECTIVE MEDIA; BAD BUGS; CARDIOLIPIN; DISCOVERY; SEQUENCE; BINDING; INHIBITOR; ALIGNMENT; DRUGS; TOOL	Antibiotics are essential for numerous medical procedures, including the treatment of bacterial infections, but their widespread use has led to the accumulation of resistance, prompting calls for the discovery of antibacterial agents with new targets. A majority of clinically approved antibacterial scaffolds are derived from microbial natural products, but these valuable molecules are not well annotated or organized, limiting the efficacy of modern informatic analyses. Here, we provide a comprehensive resource defining the targets, chemical origins and families of the natural antibacterial collective through a retrobiosynthetic algorithm. From this we also detail the directed mining of biosynthetic scaffolds and resistance determinants to reveal structures with a high likelihood of having previously unknown modes of action. Implementing this pipeline led to investigations of the telomycin family of natural products from Streptomyces canus, revealing that these bactericidal molecules possess a new antibacterial mode of action dependent on the bacterial phospholipid cardiolipin.	[Johnston, Chad W.; Skinnider, Michael A.; Dejong, Chris A.; Rees, Philip N.; Chen, Gregory M.; Walker, Chelsea G.; French, Shawn; Brown, Eric D.; Liu, Dennis Y.; Magarvey, Nathan A.] McMaster Univ, Dept Biochem & Biomed Sci, MG DeGroote Inst Infect Dis Res, Hamilton, ON L8N 3Z5, Canada; [Johnston, Chad W.; Skinnider, Michael A.; Dejong, Chris A.; Rees, Philip N.; Chen, Gregory M.; Walker, Chelsea G.; Liu, Dennis Y.; Magarvey, Nathan A.] McMaster Univ, Dept Chem & Chem Biol, Hamilton, ON, Canada; [Berdy, Janos] Eotvos Lorand Univ, IVAX Drug Res Inst Ltd, Budapest, Hungary	McMaster University; McMaster University; Eotvos Lorand University	Magarvey, NA (corresponding author), McMaster Univ, Dept Biochem & Biomed Sci, MG DeGroote Inst Infect Dis Res, Hamilton, ON L8N 3Z5, Canada.; Magarvey, NA (corresponding author), McMaster Univ, Dept Chem & Chem Biol, Hamilton, ON, Canada.	magarv@mcmaster.ca		Skinnider, Michael/0000-0002-2168-1621; Johnston, Chad/0000-0002-1988-709X	Natural Sciences and Engineering Research Council (NSERC) of Canada [RGPIN 371576-2014]; Joint Programme Initiative on Antimicrobial Resistance - Canadian Institutes of Health Research (CIHR); CIHR Doctoral Research Award; Canada Research Chairs Program	Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Joint Programme Initiative on Antimicrobial Resistance - Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR Doctoral Research Award(Canadian Institutes of Health Research (CIHR)); Canada Research Chairs Program(Canada Research Chairs)	This work was funded through a Natural Sciences and Engineering Research Council (NSERC) of Canada Discovery grant (RGPIN 371576-2014) (N.A.M.) and a Joint Programme Initiative on Antimicrobial Resistance funded through the Canadian Institutes of Health Research (CIHR; N.A.M.). C.W.J. is funded through a CIHR Doctoral Research Award. E.D.B and N.A.M. are supported by the Canada Research Chairs Program. The authors acknowledge and thank R. Epand for valuable communications.	Arias-Cartin R, 2012, BBA-BIOENERGETICS, V1817, P1937, DOI 10.1016/j.bbabio.2012.04.005; Baumann S, 2014, ANGEW CHEM INT EDIT, V53, P14605, DOI 10.1002/anie.201409964; Berdy J., 1980, HDB ANTIBIOTIC COMPO, VI-X; Berdy J, 2012, J ANTIBIOT, V65, P385, DOI [10.1038/ja.2012.27, 10.1038/ja.2012.54]; BIBIKOVA MV, 1981, ANTIBIOT MED BIOTEK, V26, P488; Boucher HW, 2009, CLIN INFECT DIS, V48, P1, DOI 10.1086/595011; Bush K, 2011, NAT REV MICROBIOL, V9, P894, DOI 10.1038/nrmicro2693; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Cociancich S, 2015, NAT CHEM BIOL, V11, P195, DOI 10.1038/nchembio.1734; Cundliffe E, 2010, J IND MICROBIOL BIOT, V37, P643, DOI 10.1007/s10295-010-0721-x; D'Costa VM, 2006, SCIENCE, V311, P374, DOI 10.1126/science.1120800; Donadio S, 2010, J ANTIBIOT, V63, P423, DOI 10.1038/ja.2010.62; Doroghazi JR, 2014, NAT CHEM BIOL, V10, P963, DOI [10.1038/NCHEMBIO.1659, 10.1038/nchembio.1659]; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Fischbach MA, 2007, NAT CHEM BIOL, V3, P353, DOI 10.1038/nchembio0707-353; Fischbach MA, 2009, SCIENCE, V325, P1089, DOI 10.1126/science.1176667; Forsberg KJ, 2012, SCIENCE, V337, P1107, DOI 10.1126/science.1220761; Fu CZ, 2015, J AM CHEM SOC, V137, P7692, DOI 10.1021/jacs.5b01794; Gibson MK, 2015, ISME J, V9, P207, DOI 10.1038/ismej.2014.106; Goss RJM, 2012, NAT PROD REP, V29, P870, DOI 10.1039/c2np00001f; GOUREVITCH A, 1957, Antibiot Annu, V5, P856; Hadjithomas M, 2015, MBIO, V6, DOI 10.1128/mBio.00932-15; Hamamoto H, 2015, NAT CHEM BIOL, V11, P127, DOI [10.1038/NCHEMBIO.1710, 10.1038/nchembio.1710]; Huson DH, 2012, SYST BIOL, V61, P1061, DOI 10.1093/sysbio/sys062; IVANITSKAYA LP, 1981, ANTIBIOT MED BIOTEK, V26, P83; Kawai F, 2004, J BACTERIOL, V186, P1475, DOI 10.1128/JB.186.5.1475-1483.2004; Keller S, 2007, ANGEW CHEM INT EDIT, V46, P8284, DOI 10.1002/anie.200701836; Koch MA, 2005, P NATL ACAD SCI USA, V102, P17272, DOI 10.1073/pnas.0503647102; Li JWH, 2009, SCIENCE, V325, P161, DOI 10.1126/science.1168243; Lin AH, 1997, ANTIMICROB AGENTS CH, V41, P2127, DOI 10.1128/AAC.41.10.2127; Ling LL, 2015, NATURE, V517, P455, DOI 10.1038/nature14098; Machaidze G, 2002, BIOCHEMISTRY-US, V41, P1965, DOI 10.1021/bi015841c; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; Medema MH, 2015, NAT CHEM BIOL, V11, P625, DOI 10.1038/nchembio.1890; Mileykovskaya E, 2009, BBA-BIOMEMBRANES, V1788, P2084, DOI 10.1016/j.bbamem.2009.04.003; MISIEK M, 1957, Antibiot Annu, V5, P852; NAKAJIMA M, 1983, J ANTIBIOT, V36, P961, DOI 10.7164/antibiotics.36.961; Nakao M, 2001, J ANTIBIOT, V54, P926, DOI 10.7164/antibiotics.54.926; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Newman DJ, 2012, J NAT PROD, V75, P311, DOI 10.1021/np200906s; OLIVA B, 1993, J ANTIMICROB CHEMOTH, V32, P817, DOI 10.1093/jac/32.6.817; Oliver PM, 2014, J BACTERIOL, V196, P3386, DOI 10.1128/JB.01877-14; Over B, 2013, NAT CHEM, V5, P21, DOI [10.1038/NCHEM.1506, 10.1038/nchem.1506]; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Payne DJ, 2007, NAT REV DRUG DISCOV, V6, P29, DOI 10.1038/nrd2201; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SHEEHAN JC, 1968, J AM CHEM SOC, V90, P462, DOI 10.1021/ja01004a043; Skinnider MA, 2015, NUCLEIC ACIDS RES, V43, P9645, DOI 10.1093/nar/gkv1012; Srivastava A, 2011, CURR OPIN MICROBIOL, V14, P532, DOI 10.1016/j.mib.2011.07.030; Steinbeck C, 2003, J CHEM INF COMP SCI, V43, P493, DOI 10.1021/ci025584y; STOLPNIK V. G., 1966, ANTIBIOTIKI, V11, P567; Thaker MN, 2013, NAT BIOTECHNOL, V31, P922, DOI 10.1038/nbt.2685; TISCH D E, 1957, Antibiot Annu, V5, P863; Tsai M, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-13; Vining C.L., 1992, CIBA F SYMP, P184; Walsh CT, 2014, J ANTIBIOT, V67, P7, DOI 10.1038/ja.2013.49; Weber T, 2015, NUCLEIC ACIDS RES, V43, pW237, DOI 10.1093/nar/gkv437; Wilson DN, 2014, NAT REV MICROBIOL, V12, P35, DOI 10.1038/nrmicro3155	60	64	64	3	101	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	APR	2016	12	4					233	+		10.1038/NCHEMBIO.2018	http://dx.doi.org/10.1038/NCHEMBIO.2018			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH2DA	26829473				2022-12-25	WOS:000372593200009
J	Visvader, JE; Clevers, H				Visvader, Jane E.; Clevers, Hans			Tissue-specific designs of stem cell hierarchies	NATURE CELL BIOLOGY			English	Article							SKELETAL-MUSCLE REGENERATION; MOUSE SMALL-INTESTINE; SATELLITE CELLS; MAMMARY-GLAND; SELF-RENEWAL; PROGENITOR CELLS; IN-VIVO; TUMOR-SUPPRESSOR; ADULT-MOUSE; LGR5	Recent work in the field of stem cell biology suggests that there is no single design for an adult tissue stem cell hierarchy, and that different tissues employ distinct strategies to meet their self-renewal and repair requirements. Stem cells may be multipotent or unipotent, and can exist in quiescent or actively dividing states. 'Professional' stem cells may also co-exist with facultative stem cells, which are more specialized daughter cells that revert to a stem cell state under specific tissue damage conditions. Here, we discuss stem cell strategies as seen in three solid mammalian tissues: the intestine, mammary gland and skeletal muscle.	[Visvader, Jane E.] Walter & Eliza Hall Inst Med Res, Stem Cells & Canc Div, Parkville, Vic 3052, Australia; [Visvader, Jane E.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3010, Australia; [Clevers, Hans] Royal Netherlands Acad Arts & Sci, Hubrecht Inst KNAW, NL-3584 CT Utrecht, Netherlands; [Clevers, Hans] Univ Med Ctr Utrecht, Canc Genom Netherlands, NL-3584 CG Utrecht, Netherlands	Walter & Eliza Hall Institute; University of Melbourne; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center	Visvader, JE (corresponding author), Walter & Eliza Hall Inst Med Res, Stem Cells & Canc Div, Parkville, Vic 3052, Australia.; Visvader, JE (corresponding author), Univ Melbourne, Dept Med Biol, Parkville, Vic 3010, Australia.; Clevers, H (corresponding author), Royal Netherlands Acad Arts & Sci, Hubrecht Inst KNAW, NL-3584 CT Utrecht, Netherlands.; Clevers, H (corresponding author), Univ Med Ctr Utrecht, Canc Genom Netherlands, NL-3584 CG Utrecht, Netherlands.	visvader@wehi.edu.au; h.clevers@hubrecht.eu			NHMRC Australia Fellowship	NHMRC Australia Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	We thank P. Maltezos (WEHI, Melbourne, Australia) for assistance with figure preparation. J.E.V. is supported by a NHMRC Australia Fellowship, and thanks the NHMRC IRIISS, Australian Cancer Research Foundation and National Breast Cancer Foundation.	Asselin-Labat ML, 2010, NATURE, V465, P798, DOI 10.1038/nature09027; Barbera M, 2015, GUT, V64, P11, DOI 10.1136/gutjnl-2013-306171; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Basak O, 2014, EMBO J, V33, P2057, DOI 10.15252/embj.201488017; BISCHOFF R, 1986, DEV BIOL, V115, P129, DOI 10.1016/0012-1606(86)90234-4; BJERKNES M, 1981, AM J ANAT, V160, P51, DOI 10.1002/aja.1001600105; Boras-Granic K, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0487-6; Brack AS, 2012, CELL STEM CELL, V10, P504, DOI 10.1016/j.stem.2012.04.001; Brohl D, 2012, DEV CELL, V23, P469, DOI 10.1016/j.devcel.2012.07.014; Buczacki SJA, 2013, NATURE, V495, P65, DOI 10.1038/nature11965; Chao MP, 2008, COLD SH Q B, V73, P439, DOI 10.1101/sqb.2008.73.031; CHENG H, 1974, AM J ANAT, V141, P537, DOI 10.1002/aja.1001410407; Cheung TH, 2013, NAT REV MOL CELL BIO, V14, P329, DOI 10.1038/nrm3591; Choi N, 2012, CANCER CELL, V21, P253, DOI 10.1016/j.ccr.2012.01.005; Cicalese A, 2009, CELL, V138, P1083, DOI 10.1016/j.cell.2009.06.048; Collins CA, 2005, CELL, V122, P289, DOI 10.1016/j.cell.2005.05.010; DANIEL CW, 1968, P NATL ACAD SCI USA, V61, P53, DOI 10.1073/pnas.61.1.53; de Visser KE, 2012, J PATHOL, V228, P300, DOI 10.1002/path.4096; DeWard AD, 2014, CELL REP, V9, P701, DOI 10.1016/j.celrep.2014.09.027; dos Santos CO, 2013, P NATL ACAD SCI USA, V110, P7123, DOI 10.1073/pnas.1303919110; Dumont NA, 2015, COMPR PHYSIOL, V5, P1027, DOI 10.1002/cphy.c140068; Eaves CJ, 2015, BLOOD, V125, P2605, DOI 10.1182/blood-2014-12-570200; GRIFFITHS DFR, 1988, NATURE, V333, P461, DOI 10.1038/333461a0; Grun D, 2015, NATURE, V525, P251, DOI 10.1038/nature14966; HOSHINO K, 1962, J NATL CANCER I, V29, P835; Hsu YC, 2014, NAT MED, V20, P847, DOI 10.1038/nm.3643; Kuang SH, 2007, CELL, V129, P999, DOI 10.1016/j.cell.2007.03.044; Lafkas D, 2013, J CELL BIOL, V203, P47, DOI 10.1083/jcb.201307046; Lepper C, 2011, DEVELOPMENT, V138, P3639, DOI 10.1242/dev.067595; Lepper C, 2009, NATURE, V460, P627, DOI 10.1038/nature08209; Lopez-Garcia C, 2010, SCIENCE, V330, P822, DOI 10.1126/science.1196236; Marshman E, 2002, BIOESSAYS, V24, P91, DOI 10.1002/bies.10028; McCarthy JJ, 2011, DEVELOPMENT, V138, P3657, DOI 10.1242/dev.068858; Metcalfe C, 2014, CELL STEM CELL, V14, P149, DOI 10.1016/j.stem.2013.11.008; Montgomery RK, 2011, P NATL ACAD SCI USA, V108, P179, DOI 10.1073/pnas.1013004108; Munoz J, 2012, EMBO J, V31, P3079, DOI 10.1038/emboj.2012.166; Murphy MM, 2011, DEVELOPMENT, V138, P3625, DOI 10.1242/dev.064162; Nguyen LV, 2014, CELL STEM CELL, V14, P253, DOI 10.1016/j.stem.2013.12.011; Orford KW, 2008, NAT REV GENET, V9, P115, DOI 10.1038/nrg2269; Pellegrinet L, 2011, GASTROENTEROLOGY, V140, P1230, DOI 10.1053/j.gastro.2011.01.005; Powell AE, 2012, CELL, V149, P146, DOI 10.1016/j.cell.2012.02.042; Prater MD, 2014, NAT CELL BIOL, V16, P942, DOI 10.1038/ncb3025; Rios AC, 2014, NATURE, V506, P322, DOI 10.1038/nature12948; Ritsma L, 2014, NATURE, V507, P362, DOI 10.1038/nature12972; Roche KC, 2015, GASTROENTEROLOGY, V149, P1553, DOI 10.1053/j.gastro.2015.07.004; Rocheteau P, 2012, CELL, V148, P112, DOI 10.1016/j.cell.2011.11.049; Rodgers JT, 2014, NATURE, V510, P393, DOI 10.1038/nature13255; Rodilla V, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002069; Roth S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038965; Sacco A, 2008, NATURE, V456, P502, DOI 10.1038/nature07384; Sambasivan R, 2011, DEVELOPMENT, V138, P3647, DOI 10.1242/dev.067587; Sanchez-Gurmaches J, 2012, CELL METAB, V16, P348, DOI 10.1016/j.cmet.2012.08.003; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Schulz TJ, 2013, NATURE, V495, P379, DOI 10.1038/nature11943; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; SMITH GH, 1988, J CELL SCI, V90, P173; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Stamataki D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024484; Stingl J, 2001, BREAST CANCER RES TR, V67, P93, DOI 10.1023/A:1010615124301; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Takeda N, 2011, SCIENCE, V334, P1420, DOI 10.1126/science.1213214; Tao LW, 2014, STEM CELL REP, V2, P770, DOI 10.1016/j.stemcr.2014.04.004; Tetteh PW, 2015, TRENDS CELL BIOL, V25, P100, DOI 10.1016/j.tcb.2014.09.003; Tian H, 2011, NATURE, V478, P255, DOI 10.1038/nature10408; van Amerongen R, 2012, CELL STEM CELL, V11, P387, DOI 10.1016/j.stem.2012.05.023; van Es JH, 2012, NAT CELL BIOL, V14, P1099, DOI 10.1038/ncb2581; Van Keymeulen A, 2011, NATURE, V479, P189, DOI 10.1038/nature10573; Visvader JE, 2014, GENE DEV, V28, P1143, DOI 10.1101/gad.242511.114; Walter D, 2015, NATURE, V520, P549, DOI 10.1038/nature14131; Wang DS, 2015, NATURE, V517, P81, DOI 10.1038/nature13851; Wang FC, 2013, GASTROENTEROLOGY, V145, P383, DOI 10.1053/j.gastro.2013.04.050; Wang ZA, 2013, NAT CELL BIOL, V15, P274, DOI 10.1038/ncb2697; White RB, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-21; WINTON DJ, 1990, P ROY SOC B-BIOL SCI, V241, P13, DOI 10.1098/rspb.1990.0059; Wong VWY, 2012, NAT CELL BIOL, V14, P401, DOI 10.1038/ncb2464; Yan KS, 2012, P NATL ACAD SCI USA, V109, P466, DOI 10.1073/pnas.1118857109; Zammit PS, 2004, J CELL BIOL, V166, P347, DOI 10.1083/jcb.200312007	79	96	99	1	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2016	18	4					349	355		10.1038/ncb3332	http://dx.doi.org/10.1038/ncb3332			7	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	DH7LX	26999737				2022-12-25	WOS:000372976600001
J	Yu, CN; Mannan, AM; Yvone, GM; Ross, KN; Zhang, YL; Marton, MA; Taylor, BR; Crenshaw, A; Gould, JZ; Tamayo, P; Weir, BA; Tsherniak, A; Wong, B; Garraway, LA; Shamji, AF; Palmer, MA; Foley, MA; Winckler, W; Schreiber, SL; Kung, AL; Golub, TR				Yu, Channing; Mannan, Aristotle M.; Yvone, Griselda Metta; Ross, Kenneth N.; Zhang, Yan-Ling; Marton, Melissa A.; Taylor, Bradley R.; Crenshaw, Andrew; Gould, Joshua Z.; Tamayo, Pablo; Weir, Barbara A.; Tsherniak, Aviad; Wong, Bang; Garraway, Levi A.; Shamji, Alykhan F.; Palmer, Michelle A.; Foley, Michael A.; Winckler, Wendy; Schreiber, Stuart L.; Kung, Andrew L.; Golub, Todd R.			High-throughput identification of genotype-specific cancer vulnerabilities in mixtures of barcoded tumor cell lines	NATURE BIOTECHNOLOGY			English	Article							KINASE INHIBITOR SELECTIVITY; DRUG-SENSITIVITY; RESISTANCE; RESOURCE; EFFICACY; GENE	Hundreds of genetically characterized cell lines are available for the discovery of genotype-specific cancer vulnerabilities. However, screening large numbers of compounds against large numbers of cell lines is currently impractical, and such experiments are often difficult to control(1-4). Here we report a method called PRISM that allows pooled screening of mixtures of cancer cell lines by labeling each cell line with 24-nucleotide barcodes. PRISM revealed the expected patterns of cell killing seen in conventional (unpooled) assays. In a screen of 102 cell lines across 8,400 compounds, PRISM led to the identification of BRD-7880 as a potent and highly specific inhibitor of aurora kinases B and C. Cell line pools also efficiently formed tumors as xenografts, and PRISM recapitulated the expected pattern of erlotinib sensitivity in vivo.	[Yu, Channing; Mannan, Aristotle M.; Yvone, Griselda Metta; Ross, Kenneth N.; Zhang, Yan-Ling; Marton, Melissa A.; Taylor, Bradley R.; Crenshaw, Andrew; Gould, Joshua Z.; Tamayo, Pablo; Weir, Barbara A.; Tsherniak, Aviad; Wong, Bang; Garraway, Levi A.; Shamji, Alykhan F.; Palmer, Michelle A.; Foley, Michael A.; Winckler, Wendy; Schreiber, Stuart L.; Golub, Todd R.] Broad Inst Harvard & MIT, Cambridge, MA USA; [Yu, Channing; Garraway, Levi A.; Kung, Andrew L.; Golub, Todd R.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Yu, Channing; Garraway, Levi A.; Kung, Andrew L.; Golub, Todd R.] Harvard Univ, Sch Med, Boston, MA USA; [Schreiber, Stuart L.] Harvard Univ, Cambridge, MA 02138 USA; [Schreiber, Stuart L.; Golub, Todd R.] Howard Hughes Med Inst, Chevy Chase, MD USA; [Yvone, Griselda Metta] Univ Calif Los Angeles, Los Angeles, CA USA; [Ross, Kenneth N.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Palmer, Michelle A.] ImmunoGen, Waltham, MA USA; [Foley, Michael A.] Triinst Therapeut Discovery Inst, New York, NY USA; [Kung, Andrew L.] Columbia Univ, Med Ctr, New York, NY USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; Harvard University; Massachusetts General Hospital; Columbia University	Golub, TR (corresponding author), Broad Inst Harvard & MIT, Cambridge, MA USA.; Golub, TR (corresponding author), Dana Farber Canc Inst, Boston, MA 02115 USA.; Golub, TR (corresponding author), Harvard Univ, Sch Med, Boston, MA USA.; Golub, TR (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD USA.	golub@broadinstitute.org	Kung, Andrew/AAL-2384-2020; Kung, Andrew L/AEU-0826-2022	Kung, Andrew L/0000-0002-9091-488X; Yu, Channing/0000-0002-3231-2565; Tsherniak, Aviad/0000-0002-3797-1877; Metta Yvone, Griselda/0000-0003-4639-2372; Tamayo, Pablo/0000-0002-9360-4668	US National Institutes of Health (NIH) Genomics Based Drug Discovery consortium grants [RL1-CA133834, RL1-GM084437, UL1DE019585]; US National Cancer Institute Integrative Cancer Biology Program grant [U54CA112962]; Howard Hughes Medical Institute; Claudia Adams Barr Program in Cancer Research Innovative Basic Science Research Program Grant; American Society of Clinical Oncology Conquer Cancer Foundation Young Investigator Award; Prostate Cancer Foundation; NIH grant [RL1-HG004671]; NATIONAL CANCER INSTITUTE [RL1CA133834, U54CA112962] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [RL1HG004671] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [UL1DE019585] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [RL1GM084437] Funding Source: NIH RePORTER	US National Institutes of Health (NIH) Genomics Based Drug Discovery consortium grants; US National Cancer Institute Integrative Cancer Biology Program grant; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Claudia Adams Barr Program in Cancer Research Innovative Basic Science Research Program Grant; American Society of Clinical Oncology Conquer Cancer Foundation Young Investigator Award; Prostate Cancer Foundation; NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Kim, G. Bonamy, J. (J.) Che, J. Thibault, T. Huynh, I. Engels and A. Shipway at Novartis for sharing data before publication; A. Christie and T. Davis for technical assistance in animal studies; C. Hartland, S. Donovan, E. Rubin and E. Winchester for technical assistance in compound assays; J. Bittker, J. McGrath and G. Wendel for assistance in compound management; S. Le Quement and J. Duvall for assistance in compound synthesis; J. Gale for technical assistance in enzyme kinetic assays; S. Howell for assistance in curation of computational data sets; A. Koehler, S. Dandapani, B. Munoz, C. Scherer, D. Gray, D. Bachovchin, S. Santaguida and J. Elkins for expert scientific guidance; J. Barretina, N. Stransky, S. Nijman, B. Julian, W. Read-Button, J. Davis and D. Peck for technical advice; and members of the Golub laboratory for critical review of the manuscript. This work was supported in part by the US National Institutes of Health (NIH) Genomics Based Drug Discovery consortium grants RL1-CA133834, RL1-GM084437 and UL1DE019585 (administratively linked to NIH grant RL1-HG004671), US National Cancer Institute Integrative Cancer Biology Program grant U54CA112962, the Howard Hughes Medical Institute, the Claudia Adams Barr Program in Cancer Research Innovative Basic Science Research Program Grant, the American Society of Clinical Oncology Conquer Cancer Foundation Young Investigator Award and the Prostate Cancer Foundation.	Abaan OD, 2013, CANCER RES, V73, P4372, DOI 10.1158/0008-5472.CAN-12-3342; Andrews PD, 2003, CURR OPIN CELL BIOL, V15, P672, DOI 10.1016/j.ceb.2003.10.013; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Basu A, 2013, CELL, V154, P1151, DOI 10.1016/j.cell.2013.08.003; Carmena M, 2003, NAT REV MOL CELL BIO, V4, P842, DOI 10.1038/nrm1245; Comer E, 2011, P NATL ACAD SCI USA, V108, P6751, DOI 10.1073/pnas.1015255108; Davis MI, 2011, NAT BIOTECHNOL, V29, P1046, DOI 10.1038/nbt.1990; Ditchfield C, 2003, J CELL BIOL, V161, P267, DOI 10.1083/jcb.200208091; Du JY, 2009, NAT BIOTECHNOL, V27, P77, DOI 10.1038/nbt.1513; Flaherty KT, 2012, NEW ENGL J MED, V367, P107, DOI 10.1056/NEJMoa1203421; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Koivunen JP, 2008, CLIN CANCER RES, V14, P4275, DOI 10.1158/1078-0432.CCR-08-0168; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; Lowe JT, 2012, J ORG CHEM, V77, P7187, DOI 10.1021/jo300974j; Marcaurelle LA, 2010, J AM CHEM SOC, V132, P16962, DOI 10.1021/ja105119r; McDermott U, 2007, P NATL ACAD SCI USA, V104, P19936, DOI 10.1073/pnas.0707498104; Muellner MK, 2011, NAT CHEM BIOL, V7, P787, DOI 10.1038/nchembio.695; Peck D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r61; Schreiber SL, 2010, NAT BIOTECHNOL, V28, P904, DOI 10.1038/nbt0910-904; Sharma SV, 2010, NAT REV CANCER, V10, P241, DOI 10.1038/nrc2820; Sos ML, 2009, J CLIN INVEST, V119, P1727, DOI 10.1172/JCI37127; Turner NC, 2012, LANCET ONCOL, V13, pE178, DOI 10.1016/S1470-2045(11)70335-7; Wilhelm SM, 2008, MOL CANCER THER, V7, P3129, DOI 10.1158/1535-7163.MCT-08-0013; Zhang XHD, 2011, J BIOMOL SCREEN, V16, P775, DOI 10.1177/1087057111405851	25	132	136	1	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	APR	2016	34	4					419	+		10.1038/nbt.3460	http://dx.doi.org/10.1038/nbt.3460			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DI6NL	26928769	Green Accepted, Green Submitted			2022-12-25	WOS:000373616100023
J	Ding, M; Bruick, RK; Yu, YH				Ding, Ming; Bruick, Richard K.; Yu, Yonghao			Secreted IGFBP5 mediates mTORC1-dependent feedback inhibition of IGF-1 signalling	NATURE CELL BIOLOGY			English	Article							VIVO ANTITUMOR-ACTIVITY; PHASE-I TRIAL; GROWTH-FACTOR; TUBEROUS SCLEROSIS; MTOR; CANCER; PHOSPHORYLATION; COMPLEX; METABOLISM; STIMULATION	The PI(3) K-Akt-mTORC1 pathway is a highly dynamic network that is balanced and stabilized by a number of feedback inhibition loops(1,2). Specifically, activation of mTORC1 has been shown to lead to the inhibition of its upstream growth factor signalling. Activation of the growth factor receptors is triggered by the binding of their cognate ligands in the extracellular space. However, whether secreted proteins contribute to the mTORC1-dependent feedback loops remains unclear. We found that cells with hyperactive mTORC1 secrete a protein that potently inhibits the function of IGF-1. Using a large-scale, unbiased quantitative proteomic platform, we comprehensively characterized the rapamycin-sensitive secretome in TSC2(-/-) mouse embryonic fibroblasts, and identified IGFBP5 as a secreted, mTORC1 downstream effector protein. IGFBP5 is a direct transcriptional target of HIF1, which itself is a known mTORC1 target3. IGFBP5 is a potent inhibitor of both the signalling and functional outputs of IGF-1. Once secreted, IGFBP5 cooperates with intracellular branches of the feedback mechanisms to block the activation of IGF-1 signalling. Finally, IGFBP5 is a potential tumour suppressor, and the proliferation of IGFBP5-mutated cancer cells is selectively blocked by IGF-1R inhibitors.	[Ding, Ming; Bruick, Richard K.; Yu, Yonghao] Univ Texas SW Med Ctr Dallas, Dept Biochem, 5323 Harry Hines Blvd, Dallas, TX 75235 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Yu, YH (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Biochem, 5323 Harry Hines Blvd, Dallas, TX 75235 USA.	yonghao.yu@utsouthwestern.edu		Ding, Ming/0000-0002-9135-9275	UT Southwestern Endowed Scholar Program; Cancer Prevention and Research Institute of Texas (CPRIT) [R1103, RP130513]; Welch Foundation [I-1800, I-1568]; National Institutes of Health (NIH) [GM114160]; American Cancer Society [RSG-15-062-01-TBE, IRG-02-196-07]; Career Award in the Biomedical Sciences from the Burroughs Wellcome Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM114160] Funding Source: NIH RePORTER	UT Southwestern Endowed Scholar Program; Cancer Prevention and Research Institute of Texas (CPRIT); Welch Foundation(The Welch Foundation); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Career Award in the Biomedical Sciences from the Burroughs Wellcome Fund(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Goldstein, J. Blenis, M. White, M. Cobb and B. Tu for critically reviewing the manuscript. We thank J. Minna and D. Kwiatkowski for providing critical reagents, and N. Williams, H. Wang, H. Chen and L. Wu for input and technical guidance. This work was supported in part by grants from the UT Southwestern Endowed Scholar Program (to Y.Y. and R.K.B.), the Cancer Prevention and Research Institute of Texas (CPRIT R1103 to Y.Y. and CPRIT RP130513 to R.K.B.), the Welch Foundation (I-1800 to Y.Y. and I-1568 to R.K.B.), National Institutes of Health (NIH; GM114160 to Y.Y.), American Cancer Society (Research Scholar Grant, RSG-15-062-01-TBE, and Institutional Research Grant, IRG-02-196-07, to Y.Y.), and a Career Award in the Biomedical Sciences from the Burroughs Wellcome Fund (to R.K.B.). Y.Y. is a Virginia Murchison Linthicum Scholar in Medical Research and a CPRIT Scholar in Cancer Research. R.K.B. is the Michael L. Rosenberg Scholar in Medical Research.	Bhaskar PT, 2009, MOL CELL BIOL, V29, P5136, DOI 10.1128/MCB.01946-08; Bissler JJ, 2008, NEW ENGL J MED, V358, P140, DOI 10.1056/NEJMoa063564; Carboni JM, 2009, MOL CANCER THER, V8, P3341, DOI 10.1158/1535-7163.MCT-09-0499; Chandarlapaty S, 2011, CANCER CELL, V19, P58, DOI 10.1016/j.ccr.2010.10.031; Chen HX, 2013, CHIN J CANCER, V32, P242, DOI 10.5732/cjc.012.10263; Cloughesy TF, 2008, PLOS MED, V5, P139, DOI 10.1371/journal.pmed.0050008; Cornu M, 2014, P NATL ACAD SCI USA, V111, P11592, DOI 10.1073/pnas.1412047111; Cybulski N, 2009, P NATL ACAD SCI USA, V106, P9902, DOI 10.1073/pnas.0811321106; Dibble CC, 2013, NAT CELL BIOL, V15, P555, DOI 10.1038/ncb2763; Ding M., 2015, PROTOCOL EXCHANGE, DOI [http://dx.doi.org/10.1038/protex.2015.124, DOI 10.1038/PROTEX.2015.124]; Duvel K, 2010, MOL CELL, V39, P171, DOI 10.1016/j.molcel.2010.06.022; Guo YA, 2013, J PATHOL, V230, P17, DOI 10.1002/path.4176; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Hsu PP, 2011, SCIENCE, V332, P1317, DOI 10.1126/science.1199498; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Hwa V, 1999, ENDOCR REV, V20, P761, DOI 10.1210/er.20.6.761; Jehle PM, 1998, J ENDOCRINOL, V159, P297, DOI 10.1677/joe.0.1590297; Kong SE, 2002, ENDOCRINOLOGY, V143, P4505, DOI 10.1210/en.2002-220527; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Li SJ, 2010, P NATL ACAD SCI USA, V107, P3441, DOI 10.1073/pnas.0914798107; Liu PD, 2013, NAT CELL BIOL, V15, P1340, DOI 10.1038/ncb2860; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Maira SM, 2008, MOL CANCER THER, V7, P1851, DOI 10.1158/1535-7163.MCT-08-0017; Makridakis M, 2010, J PROTEOMICS, V73, P2291, DOI 10.1016/j.jprot.2010.07.001; Mendel DB, 2003, CLIN CANCER RES, V9, P327; Miyake H, 2000, CANCER RES, V60, P3058; Nanjappa V, 2014, NUCLEIC ACIDS RES, V42, pD959, DOI 10.1093/nar/gkt1251; Olsen JV, 2009, MOL CELL PROTEOMICS, V8, P2759, DOI 10.1074/mcp.M900375-MCP200; Owen JL, 2012, P NATL ACAD SCI USA, V109, P16184, DOI 10.1073/pnas.1213343109; Pearce LR, 2010, BIOCHEM J, V431, P245, DOI 10.1042/BJ20101024; Robitaille AM, 2013, SCIENCE, V339, P1320, DOI 10.1126/science.1228771; Salih DAM, 2004, P NATL ACAD SCI USA, V101, P4314, DOI 10.1073/pnas.0400230101; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Semenza GL, 1996, J BIOL CHEM, V271, P32529, DOI 10.1074/jbc.271.51.32529; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Shah OJ, 2006, MOL CELL BIOL, V26, P6425, DOI 10.1128/MCB.01254-05; Shimobayashi M, 2014, NAT REV MOL CELL BIO, V15, P155, DOI 10.1038/nrm3757; Villen J, 2007, P NATL ACAD SCI USA, V104, P1488, DOI 10.1073/pnas.0609836104; Wagle N, 2014, NEW ENGL J MED, V371, P1426, DOI 10.1056/NEJMoa1403352; Wagle N, 2014, CANCER DISCOV, V4, P546, DOI 10.1158/2159-8290.CD-13-0353; Wouters BG, 2008, NAT REV CANCER, V8, P851, DOI 10.1038/nrc2501; Yang G, 2015, CELL REP, V12, P937, DOI 10.1016/j.celrep.2015.07.016; Yu YH, 2011, SCIENCE, V332, P1322, DOI 10.1126/science.1199484; Zhang HB, 2007, J CLIN INVEST, V117, P730, DOI 10.1172/JCI28984; Zhang YJ, 2013, NAT METHODS, V10, P981, DOI 10.1038/nmeth.2603	45	41	42	4	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2016	18	3					319	+		10.1038/ncb3311	http://dx.doi.org/10.1038/ncb3311			29	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	DF0LT	26854565	Green Accepted			2022-12-25	WOS:000371031300013
J	Seo, J; Lee, EW; Sung, H; Seong, D; Dondelinger, Y; Shin, J; Jeong, M; Lee, HK; Kim, JH; Han, SY; Lee, C; Seong, JK; Vandenabeele, P; Song, J				Seo, Jinho; Lee, Eun-Woo; Sung, Hyerim; Seong, Daehyeon; Dondelinger, Yves; Shin, Jihye; Jeong, Manhyung; Lee, Hae-Kyung; Kim, Jung-Hoon; Han, Su Yeon; Lee, Cheolju; Seong, Je Kyung; Vandenabeele, Peter; Song, Jaewhan			CHIP controls necroptosis through ubiquitylation- and lysosome-dependent degradation of RIPK3	NATURE CELL BIOLOGY			English	Article							MIXED LINEAGE KINASE; DOMAIN-LIKE PROTEIN; CELL-DEATH; PROGRAMMED NECROSIS; APOPTOSIS; MLKL; UBIQUITINATION; CASPASE-8; ROLES; FADD	Receptor-interacting protein kinase 3 (RIPK3) functions as a key regulator of necroptosis. Here, we report that the RIPK3 expression level is negatively regulated by CHIP (carboxyl terminus of Hsp70-interacting protein; also known as STUB1) E3 ligase-mediated ubiquitylation. Chip(-/-) mouse embryonic fibroblasts and CHIP-depleted L929 and HT-29 cells exhibited higher levels of RIPK3 expression, resulting in increased sensitivity to necroptosis induced by TNF (also known as TNF alpha). These phenomena are due to the CHIP-mediated ubiquitylation of RIPK3, which leads to its lysosomal degradation. Interestingly, RIPK1 expression is also negatively regulated by CHIP-mediated ubiquitylation, validating the major role of CHIP in necrosome formation and sensitivity to TNF-mediated necroptosis. Chip(-/-) mice (C57BL/6) exhibit inflammation in the thymus and massive cell death and disintegration in the small intestinal tract, and die within a few weeks after birth. These phenotypes are rescued by crossing with Ripk3(-/-) mice. These results imply that CHIP is a bona fide negative regulator of the RIPK1-RIPK3 necrosome formation leading to desensitization of TNF-mediated necroptosis.	[Seo, Jinho; Lee, Eun-Woo; Seong, Daehyeon; Shin, Jihye; Jeong, Manhyung; Lee, Hae-Kyung; Kim, Jung-Hoon; Han, Su Yeon; Song, Jaewhan] Yonsei Univ, Dept Biochem, Coll Life Sci & Biotechnol, Seoul 120749, South Korea; [Sung, Hyerim; Seong, Je Kyung] Seoul Natl Univ, Program Creat Vet Sci Res BK21Plus, Lab Dev Biol & Genet,BIOMAX Inst,Korea Mouse Phen, Coll Vet Med,Interdisciplinary Program Bioinforma, Seoul 151742, South Korea; [Dondelinger, Yves; Vandenabeele, Peter] Univ Ghent, Dept Biomed Mol Biol, Technol Pk 927, B-9052 Zwijnaarde Ghent, Belgium; [Dondelinger, Yves; Vandenabeele, Peter] VIB, Inflammat Res Ctr, Technol Pk 927, B-9052 Zwijnaarde Ghent, Belgium; [Seo, Jinho; Lee, Eun-Woo] Korea Inst Sci & Technol, BRI, Seoul 136791, South Korea	Yonsei University; Seoul National University (SNU); Ghent University; Flanders Institute for Biotechnology (VIB); Korea Institute of Science & Technology (KIST)	Song, J (corresponding author), Yonsei Univ, Dept Biochem, Coll Life Sci & Biotechnol, Seoul 120749, South Korea.	jso678@yonsei.ac.kr	Lee, Eun-Woo/AAP-9603-2020; Vandenabeele, Peter/C-8597-2009; Vandenabeele, Peter/AAD-5793-2022	Vandenabeele, Peter/0000-0002-6669-8822; Song, Jaewhan/0000-0001-8152-9210; Dondelinger, Yves/0000-0002-5242-6834; Seong, Je Kyung/0000-0003-1177-6958; Lee, Eun-Woo/0000-0002-5156-0003	National R&D Program for Cancer Control; Ministry of Health & Welfare, Republic of Korea [NCC-1420300]; National Research Foundation of Korea (NRF) - Ministry of Education [2012R1A6A3A04040105]; Ministry of Science, ICT and Future Planning [NRF-2015R1A3A2066581]; Flemish grants (Research Foundation Flanders) [FWO G.0875.11, FWO G.0973.11, FWO G.0A45.12N, FWO G.0787.13N, FWO G0E04.16N]; Methusalem grant [BOF16/MET_V/007]; Ghent University grants (MRP, GROUP-ID consortium); Foundation against Cancer [F94]; VIB; BK21 Plus project of the National Research Foundation of Korea Grant; National Research Foundation of Korea (NRF)	National R&D Program for Cancer Control(Ministry of Health & Welfare (MOHW), Republic of Korea); Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); National Research Foundation of Korea (NRF) - Ministry of Education(National Research Foundation of KoreaMinistry of Education (MOE), Republic of Korea); Ministry of Science, ICT and Future Planning(Ministry of Science, ICT & Future Planning, Republic of Korea); Flemish grants (Research Foundation Flanders)(FWO); Methusalem grant; Ghent University grants (MRP, GROUP-ID consortium); Foundation against Cancer; VIB; BK21 Plus project of the National Research Foundation of Korea Grant(National Research Foundation of Korea); National Research Foundation of Korea (NRF)(National Research Foundation of Korea)	We thank S. Murata for the chip-1-mice and V M. Dixit for the Ripk3<SUP>-/-</SUP> mice. We thank the Cancer Metabolism Interest Group (cMIG) led by NCC Korea for discussion and advice. This research was supported by a grant from the National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea (NCC-1420300) (to J.Song) and by a grant from the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2012R1A6A3A04040105) (to E.-W.L.) and by the Ministry of Science, ICT and Future Planning (NRF-2015R1A3A2066581) (to J.Song). Research in the Vandenabeele group is supported by Flemish grants (Research Foundation Flanders: FWO G.0875.11, FWO G.0973.11, FWO G.0A45.12N, FWO G.0787.13N, FWO G0E04.16N), a Methusalem grant (BOF16/MET_V/007), Ghent University grants (MRP, GROUP-ID consortium), a grant from the Foundation against Cancer (F94), and grants from VIB. Additionally, this research was partly supported by the BK21 Plus project of the National Research Foundation of Korea Grant (to J.Seo, M.J., H.-K.L., D.S., J.-H.K. and S.Y.H.) and by the grants for KMPC (Korea Mouse Phenotype Center) (to J.K.S.) from National Research Foundation of Korea (NRF), and C.L. acknowledges institutional support by KIST.	Ahmed SF, 2012, J BIOL CHEM, V287, P15996, DOI 10.1074/jbc.M111.321083; Cai ZY, 2014, NAT CELL BIOL, V16, P55, DOI 10.1038/ncb2883; Chen WZ, 2015, NAT CELL BIOL, V17, P434, DOI 10.1038/ncb3120; Chen X, 2014, CELL RES, V24, P105, DOI 10.1038/cr.2013.171; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Cook WD, 2014, CELL DEATH DIFFER, V21, P1600, DOI 10.1038/cdd.2014.70; Dannappel M, 2014, NATURE, V513, P90, DOI 10.1038/nature13608; Dillon CP, 2014, CELL, V157, P1189, DOI 10.1016/j.cell.2014.04.018; Dondelinger Y, 2014, CELL REP, V7, P971, DOI 10.1016/j.celrep.2014.04.026; Duprez L, 2011, IMMUNITY, V35, P908, DOI 10.1016/j.immuni.2011.09.020; Esser C, 2005, J BIOL CHEM, V280, P27443, DOI 10.1074/jbc.M501574200; Galluzzi L, 2015, CELL DEATH DIFFER, V22, P58, DOI 10.1038/cdd.2014.137; Gunther C, 2011, NATURE, V477, P335, DOI 10.1038/nature10400; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Humphries F, 2015, CELL DEATH DIFFER, V22, P225, DOI 10.1038/cdd.2014.126; Kaiser WJ, 2011, NATURE, V471, P368, DOI 10.1038/nature09857; Kang TB, 2013, IMMUNITY, V38, P27, DOI 10.1016/j.immuni.2012.09.015; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Ko HR, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.79; Lawlor KE, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7282; Lee EW, 2015, CELL DEATH DIFFER, V22, P1463, DOI 10.1038/cdd.2014.234; Lee EW, 2012, BMB REP, V45, P496, DOI 10.5483/BMBRep.2012.45.9.186; Lee EW, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1981; Lee EW, 2009, EMBO J, V28, P2100, DOI 10.1038/emboj.2009.164; Lee IH, 2014, ONCOGENE, V33, P4675, DOI 10.1038/onc.2014.69; Li JX, 2012, CELL, V150, P339, DOI 10.1016/j.cell.2012.06.019; Linkermann A, 2014, NEW ENGL J MED, V370, P455, DOI 10.1056/NEJMra1310050; Mandal P, 2014, MOL CELL, V56, P481, DOI 10.1016/j.molcel.2014.10.021; Min JN, 2008, MOL CELL BIOL, V28, P4018, DOI 10.1128/MCB.00296-08; Mocarski ES, 2014, J IMMUNOL, V192, P2019, DOI 10.4049/jimmunol.1302426; Mollah S, 2007, RAPID COMMUN MASS SP, V21, P3357, DOI 10.1002/rcm.3227; Moriwaki K, 2014, IMMUNITY, V41, P567, DOI 10.1016/j.immuni.2014.09.016; Murphy JM, 2014, EMBO REP, V15, P155, DOI 10.1002/embr.201337970; Murphy JM, 2013, IMMUNITY, V39, P443, DOI 10.1016/j.immuni.2013.06.018; Newton K, 2014, SCIENCE, V343, P1357, DOI 10.1126/science.1249361; Oberst A, 2011, NATURE, V471, P363, DOI 10.1038/nature09852; Oh W, 2009, J CELL SCI, V122, P2613, DOI 10.1242/jcs.048066; Onizawa M, 2015, NAT IMMUNOL, V16, P618, DOI 10.1038/ni.3172; Orozco S, 2014, CELL DEATH DIFFER, V21, P1511, DOI 10.1038/cdd.2014.76; Park SY, 2014, CELL BIOCHEM FUNCT, V32, P62, DOI 10.1002/cbf.2972; Petersen SL, 2015, CELL DEATH DIFFER, V22, P1846, DOI 10.1038/cdd.2015.35; Petrucelli L, 2004, HUM MOL GENET, V13, P703, DOI 10.1093/hmg/ddh083; Remijsen Q, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.531; Rickard JA, 2014, CELL, V157, P1175, DOI 10.1016/j.cell.2014.04.019; Sahara N, 2005, J NEUROCHEM, V94, P1254, DOI 10.1111/j.1471-4159.2005.03272.x; Schisler JC, 2013, J CLIN INVEST, V123, P3588, DOI 10.1172/JCI69080; Silke J, 2015, NAT IMMUNOL, V16, P689, DOI [10.1038/ni0815-889b, 10.1038/ni.3206]; Sun LM, 2012, CELL, V148, P213, DOI 10.1016/j.cell.2011.11.031; Takahashi N, 2014, NATURE, V513, P95, DOI 10.1038/nature13706; Vanden Berghe T, 2003, J BIOL CHEM, V278, P5622, DOI 10.1074/jbc.M208925200; Vanden Berghe T, 2015, IMMUNITY, V43, P200, DOI 10.1016/j.immuni.2015.06.011; Vanden Berghe T, 2014, NAT REV MOL CELL BIO, V15, P134, DOI 10.1038/nrm3737; Vince JE, 2012, IMMUNITY, V36, P215, DOI 10.1016/j.immuni.2012.01.012; Wang HY, 2014, MOL CELL, V54, P133, DOI 10.1016/j.molcel.2014.03.003; Welz PS, 2011, NATURE, V477, P330, DOI 10.1038/nature10273; Wu JF, 2013, CELL RES, V23, P994, DOI 10.1038/cr.2013.91; Wu XN, 2014, CELL DEATH DIFFER, V21, P1709, DOI 10.1038/cdd.2014.77; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308; Zhang HB, 2011, NATURE, V471, P373, DOI 10.1038/nature09878	59	100	104	6	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2016	18	3					291	+		10.1038/ncb3314	http://dx.doi.org/10.1038/ncb3314			54	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	DF0LT	26900751				2022-12-25	WOS:000371031300010
J	Battles, MB; Langedijk, JP; Furmanova-Hollenstein, P; Chaiwatpongsakorn, S; Costello, HM; Kwanten, L; Vranckx, L; Vink, P; Jaensch, S; Jonckers, THM; Koul, A; Arnoult, E; Peeples, ME; Roymans, D; McLellan, JS				Battles, Michael B.; Langedijk, Johannes P.; Furmanova-Hollenstein, Polina; Chaiwatpongsakorn, Supranee; Costello, Heather M.; Kwanten, Leen; Vranckx, Luc; Vink, Paul; Jaensch, Steffen; Jonckers, Tim H. M.; Koul, Anil; Arnoult, Eric; Peeples, Mark E.; Roymans, Dirk; McLellan, Jason S.			Molecular mechanism of respiratory syncytial virus fusion inhibitors	NATURE CHEMICAL BIOLOGY			English	Article							STRUCTURAL-CHARACTERIZATION; INFLUENZA HEMAGGLUTININ; CONFORMATIONAL-CHANGES; HIV-1 INHIBITOR; IDENTIFICATION; ENVELOPE; PROTEIN; GS-5806; GLYCOPROTEIN; DISCOVERY	Respiratory syncytial virus (RSV) is a leading cause of pneumonia and bronchiolitis in young children and the elderly. Therapeutic small molecules have been developed that bind the RSV F glycoprotein and inhibit membrane fusion, yet their binding sites and molecular mechanisms of action remain largely unknown. Here we show that these inhibitors bind to a three-fold-symmetric pocket within the central cavity of the metastable prefusion conformation of RSV F. Inhibitor binding stabilizes this conformation by tethering two regions that must undergo a structural rearrangement to facilitate membrane fusion. Inhibitor-escape mutations occur in residues that directly contact the inhibitors or are involved in the conformational rearrangements required to accommodate inhibitor binding. Resistant viruses do not propagate as well as wild-type RSV in vitro, indicating a fitness cost for inhibitor escape. Collectively, these findings provide new insight into class I viral fusion proteins and should facilitate development of optimal RSV fusion inhibitors.	[Battles, Michael B.; McLellan, Jason S.] Geisel Sch Med Dartmouth, Dept Biochem, Hanover, NH USA; [Langedijk, Johannes P.; Furmanova-Hollenstein, Polina] Janssen Infect Dis & Vaccines, Leiden, Netherlands; [Chaiwatpongsakorn, Supranee; Costello, Heather M.; Peeples, Mark E.] Nationwide Childrens Hosp, Ctr Vaccines & Immun, Res Inst, Columbus, OH USA; [Kwanten, Leen; Vranckx, Luc; Koul, Anil; Roymans, Dirk] Janssen Infect Dis & Vaccines BVBA, Resp Infect Res, Beerse, Belgium; [Vink, Paul; Jaensch, Steffen] Janssen Pharmaceut NV, Discovery Sci, Beerse, Belgium; [Jonckers, Tim H. M.] Janssen Infect Dis & Vaccines BVBA, Med Chem Dept, Beerse, Belgium; [Arnoult, Eric] Janssen R&D LLC, Computat Chem, Spring House, PA USA; [Peeples, Mark E.] Ohio State Univ, Coll Med, Dept Pediat, Columbus, OH 43210 USA	Dartmouth College; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; Johnson & Johnson; Janssen Pharmaceuticals; Johnson & Johnson; Janssen Pharmaceuticals; University System of Ohio; Ohio State University	McLellan, JS (corresponding author), Geisel Sch Med Dartmouth, Dept Biochem, Hanover, NH USA.	Jason.S.McLellan@Dartmouth.edu	Peeples, Mark E./AAX-5193-2021; Roymans, Dirk/AFQ-3892-2022	Peeples, Mark E./0000-0002-4582-317X; McLellan, Jason/0000-0003-3991-542X; Battles, Michael/0000-0002-5321-7460	US National Institutes of Health, National Institute of General Medical Studies; Howard Hughes Medical Institute; US Department of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357]; Janssen Infectious Diseases Vaccines group; NIH grant [AI 095684]; Charles H. Hood Foundation, Inc., Boston, Massachusetts, USA; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI095684, P01AI112524, T32AI007519, R56AI095684] Funding Source: NIH RePORTER	US National Institutes of Health, National Institute of General Medical Studies; Howard Hughes Medical Institute(Howard Hughes Medical Institute); US Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); Janssen Infectious Diseases Vaccines group; NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Charles H. Hood Foundation, Inc., Boston, Massachusetts, USA; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors thank members of the McLellan lab and the Janssen Infectious Disease & Vaccines labs for comments on the manuscript, A. Draffan and C. Morton at Biota for BTA-9881 and BMS-433771, and E. Shipman for assistance with protein expression and purification. We thank P. Raboisson, S. Vendeville and J.-F. Bonfanti for design and assistance during synthesis of compounds, D. Wuyts for help in generating high-content imaging data, M. Van Ginderen and N. Verheyen for identification of mutant viruses, and I. Bisschop and R. Voorzaat for technical support. We thank C. Ralston, D. Bryant and members of the Berkeley Center for Structural Biology for help with X-ray diffraction data collection. The Berkeley Center for Structural Biology is supported in part by the US National Institutes of Health, National Institute of General Medical Studies, and Howard Hughes Medical Institute. Results shown in this report were also derived from work performed at Argonne National Laboratory, Structural Biology Center (SBC) at the Advanced Photon Source. We thank S. Ginell, J. Lazarz, M. Ficner-Radford and the beamline scientists for data collection support at SBC 19-ID. Argonne is operated by UChicago Argonne, LLC, for the US Department of Energy, Office of Biological and Environmental Research, under contract DE-AC02-06CH11357. This work was supported by the Janssen Infectious Diseases & Vaccines group, NIH grant AI 095684 (M.E.P.), and the Charles H. Hood Foundation, Inc., Boston, Massachusetts, USA (J.S.M.).	Acharya P, 2011, ACS CHEM BIOL, V6, P1069, DOI 10.1021/cb200068b; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Anderson LJ, 2013, VACCINE, V31, pB209, DOI 10.1016/j.vaccine.2012.11.106; Andries K, 2003, ANTIVIR RES, V60, P209, DOI 10.1016/j.antiviral.2003.07.004; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; BODIAN DL, 1993, BIOCHEMISTRY-US, V32, P2967, DOI 10.1021/bi00063a007; Bonfanti JF, 2008, J MED CHEM, V51, P875, DOI 10.1021/jm701284j; Branigan PJ, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-54; Cianci C, 2004, P NATL ACAD SCI USA, V101, P15046, DOI 10.1073/pnas.0406696101; Cianci C, 2004, ANTIMICROB AGENTS CH, V48, P413, DOI 10.1128/AAC.48.2.413-422.2004; Cornelissen F, 2012, J BIOMOL SCREEN, V17, P496, DOI 10.1177/1087057111432885; DeVincenzo JP, 2014, NEW ENGL J MED, V371, P711, DOI 10.1056/NEJMoa1401184; Douglas JL, 2005, ANTIMICROB AGENTS CH, V49, P2460, DOI 10.1128/AAC.49.6.2460-2466.2005; Douglas JL, 2003, J VIROL, V77, P5054, DOI 10.1128/JVI.77.9.5054-5064.2003; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Falsey AR, 2005, NEW ENGL J MED, V352, P1749, DOI 10.1056/NEJMoa043951; Hallak LK, 2000, VIROLOGY, V271, P264, DOI 10.1006/viro.2000.0293; Herschhorn A, 2014, NAT CHEM BIOL, V10, P845, DOI [10.1038/NCHEMBIO.1623, 10.1038/nchembio.1623]; Hotard AL, 2015, J VIROL, V89, P512, DOI 10.1128/JVI.02472-14; Karron RA, 1997, P NATL ACAD SCI USA, V94, P13961, DOI 10.1073/pnas.94.25.13961; Krarup A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9143; LaLonde JM, 2012, J MED CHEM, V55, P4382, DOI 10.1021/jm300265j; Lamb RA, 2007, CURR OPIN STRUC BIOL, V17, P427, DOI 10.1016/j.sbi.2007.08.016; Leneva IA, 2009, ANTIVIR RES, V81, P132, DOI 10.1016/j.antiviral.2008.10.009; Liljeroos L, 2013, P NATL ACAD SCI USA, V110, P11133, DOI 10.1073/pnas.1309070110; Lin PF, 2003, P NATL ACAD SCI USA, V100, P11013, DOI 10.1073/pnas.1832214100; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Luo GX, 1997, J VIROL, V71, P4062, DOI 10.1128/JVI.71.5.4062-4070.1997; Mackman RL, 2015, J MED CHEM, V58, P1630, DOI 10.1021/jm5017768; Madani N, 2008, STRUCTURE, V16, P1689, DOI 10.1016/j.str.2008.09.005; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McLellan JS, 2013, CURR TOP MICROBIOL, V372, P83, DOI 10.1007/978-3-642-38919-1_4; McLellan JS, 2011, J VIROL, V85, P7788, DOI 10.1128/JVI.00555-11; Morton CJ, 2003, VIROLOGY, V311, P275, DOI 10.1016/S0042-6822(03)00115-6; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Null D, 1998, PEDIATRICS, V102, P531, DOI 10.1542/peds.102.3.531; Roymans D., 2011, HUMAN RESP SYNCYTIAL, P197; Roymans D, 2010, P NATL ACAD SCI USA, V107, P308, DOI 10.1073/pnas.0910108106; Russell RJ, 2008, P NATL ACAD SCI USA, V105, P17736, DOI 10.1073/pnas.0807142105; Samuel D, 2015, ANTIMICROB AGENTS CH, V59, P7109, DOI 10.1128/AAC.00761-15; Si ZH, 2004, P NATL ACAD SCI USA, V101, P5036, DOI 10.1073/pnas.0307953101; Smart Kelly A, 2010, J Med Econ, V13, P453, DOI 10.3111/13696998.2010.499749; Terwilliger TC, 2007, ACTA CRYSTALLOGR D, V63, P101, DOI 10.1107/S0907444906046233; WALSH EE, 1983, J VIROL, V47, P171, DOI 10.1128/JVI.47.1.171-177.1983; Yan D, 2014, P NATL ACAD SCI USA, V111, pE3441, DOI 10.1073/pnas.1405198111; Yunus AS, 2010, VIROLOGY, V396, P226, DOI 10.1016/j.virol.2009.10.040; Zhao X, 2000, P NATL ACAD SCI USA, V97, P14172, DOI 10.1073/pnas.260499197; 2013, SCIENCE, V0340, P01113	50	87	89	1	29	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	FEB	2016	12	2					87	+		10.1038/NCHEMBIO.1982	http://dx.doi.org/10.1038/NCHEMBIO.1982			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DC6GG	26641933	Bronze, Green Accepted, Green Submitted			2022-12-25	WOS:000369317300010
J	de Waal, L; Lewis, TA; Rees, MG; Tsherniak, A; Wu, XY; Choi, PS; Gechijian, L; Hartigan, C; Faloon, PW; Hickey, MJ; Tolliday, N; Carr, SA; Clemons, PA; Munoz, B; Wagner, BK; Shamji, AF; Koehler, AN; Schenone, M; Burgin, AB; Schreiber, SL; Greulich, H; Meyerson, M				de Waal, Luc; Lewis, Timothy A.; Rees, Matthew G.; Tsherniak, Aviad; Wu, Xiaoyun; Choi, Peter S.; Gechijian, Lara; Hartigan, Christina; Faloon, Patrick W.; Hickey, Mark J.; Tolliday, Nicola; Carr, Steven A.; Clemons, Paul A.; Munoz, Benito; Wagner, Bridget K.; Shamji, Alykhan F.; Koehler, Angela N.; Schenone, Monica; Burgin, Alex B.; Schreiber, Stuart L.; Greulich, Heidi; Meyerson, Matthew			Identification of cancer-cytotoxic modulators of PDE3A by predictive chemogenomics	NATURE CHEMICAL BIOLOGY			English	Article							PHOSPHODIESTERASE TYPE 3A; MOLECULAR PHARMACOLOGY; DRUG; ANAGRELIDE; INHIBITION; DISCOVERY; MECHANISM	High cancer death rates indicate the need for new anticancer therapeutic agents. Approaches to discovering new cancer drugs include target-based drug discovery and phenotypic screening. Here, we identified phosphodiesterase 3A modulators as cell-selective cancer cytotoxic compounds through phenotypic compound library screening and target deconvolution by predictive chemogenomics. We found that sensitivity to 6-(4-(diethylamino)-3-nitrophenyl)-5-methyl-4,5-dihydropyridazin-3(2H)-one, or DNMDP, across 766 cancer cell lines correlates with expression of the gene PDE3A, encoding phosphodiesterase 3A. Like DNMDP, a subset of known PDE3A inhibitors kill selected cancer cells, whereas others do not. Furthermore, PDE3A depletion leads to DNMDP resistance. We demonstrated that DNMDP binding to PDE3A promotes an interaction between PDE3A and Schlafen 12 (SLFN12), suggestive of a neomorphic activity. Coexpression of SLFN12 with PDE3A correlates with DNMDP sensitivity, whereas depletion of SLFN12 results in decreased DNMDP sensitivity. Our results implicate PDE3A modulators as candidate cancer therapeutic agents and demonstrate the power of predictive chemogenomics in small-molecule discovery.	[de Waal, Luc; Lewis, Timothy A.; Rees, Matthew G.; Tsherniak, Aviad; Wu, Xiaoyun; Choi, Peter S.; Gechijian, Lara; Hartigan, Christina; Faloon, Patrick W.; Hickey, Mark J.; Tolliday, Nicola; Carr, Steven A.; Clemons, Paul A.; Munoz, Benito; Wagner, Bridget K.; Shamji, Alykhan F.; Koehler, Angela N.; Schenone, Monica; Burgin, Alex B.; Schreiber, Stuart L.; Greulich, Heidi; Meyerson, Matthew] Broad Inst Harvard & MIT, Cambridge, MA USA; [de Waal, Luc; Choi, Peter S.; Greulich, Heidi; Meyerson, Matthew] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Koehler, Angela N.] MIT, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Greulich, Heidi] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Meyerson, Matthew] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Greulich, H; Meyerson, M (corresponding author), Broad Inst Harvard & MIT, Cambridge, MA USA.; Greulich, H; Meyerson, M (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.; Greulich, H (corresponding author), Harvard Univ, Sch Med, Dept Med, Boston, MA USA.; Meyerson, M (corresponding author), Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA.	heidig@broadinstitute.org; matthew_meyerson@dfci.harvard.edu	Carr, Steven A./AAH-8366-2019	Lewis, Timothy/0000-0001-9748-9575; Meyerson, Matthew/0000-0002-9133-8108; Choi, Peter/0000-0002-2820-3032; Tsherniak, Aviad/0000-0002-3797-1877	US National Cancer Institute (NCI) [1R35CA197568]; American Cancer Society Research Professorship; Doctors Cancer Foundation; Friends of Dana-Farber Cancer Institute; US National Institutes of Health's Molecular Libraries Program Center Network (MLPCN) [3U54HG005032-05S1]; NCI's Cancer Target Discovery and Development (CTD2) Network [U01CA176152]; NATIONAL CANCER INSTITUTE [P30CA014051, U01CA176152, R35CA197568] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG005032] Funding Source: NIH RePORTER	US National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society Research Professorship(American Cancer Society); Doctors Cancer Foundation; Friends of Dana-Farber Cancer Institute; US National Institutes of Health's Molecular Libraries Program Center Network (MLPCN); NCI's Cancer Target Discovery and Development (CTD2) Network; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported in part by the US National Cancer Institute (NCI) Grant (grant number 1R35CA197568, awarded to M.M.), the American Cancer Society Research Professorship (awarded to M.M.), the Doctors Cancer Foundation (awarded to H.G.), the Friends of Dana-Farber Cancer Institute (awarded to H.G.), and the US National Institutes of Health's Molecular Libraries Program Center Network (MLPCN) (grant number 3U54HG005032-05S1, awarded to H.G., M.M. and S.L.S.). The cancer cell-line profiling studies were supported in part by the NCI's Cancer Target Discovery and Development (CTD2) Network (grant number U01CA176152, awarded to S.L.S.). We thank A. Bhatt, H. Gannon, J. Jung, T. Sharifnia and all members of the Meyerson laboratory for their advice and helpful discussions. S.L.S. is an Investigator of the Howard Hughes Medical Institute.	Ahmad F, 2012, HORM METAB RES, V44, P776, DOI 10.1055/s-0032-1312646; ALTMAN DG, 1983, J ROY STAT SOC D-STA, V32, P307, DOI 10.2307/2987937; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Basu A, 2013, CELL, V154, P1151, DOI 10.1016/j.cell.2013.08.003; Beca S, 2013, CIRC RES, V112, P289, DOI 10.1161/CIRCRESAHA.111.300003; Bedenis R, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003748.pub4; Bredel M, 2004, NAT REV GENET, V5, P262, DOI 10.1038/nrg1317; Burgin AB, 2010, NAT BIOTECHNOL, V28, P63, DOI 10.1038/nbt.1598; Card GL, 2004, STRUCTURE, V12, P2233, DOI 10.1016/j.str.2004.10.004; Chavez JA, 2006, BIOCHEM BIOPH RES CO, V342, P1218, DOI 10.1016/j.bbrc.2006.02.091; Collins I, 2006, NAT CHEM BIOL, V2, P689, DOI 10.1038/nchembio840; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Crews CM, 2010, CHEM BIOL, V17, P551, DOI 10.1016/j.chembiol.2010.05.011; Drake CG, 2014, NAT REV CLIN ONCOL, V11, P24, DOI 10.1038/nrclinonc.2013.208; Espasandin YR, 2015, J THROMB HAEMOST, V13, P631, DOI 10.1111/jth.12850; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Francis SH, 2011, PHYSIOL REV, V91, P651, DOI 10.1152/physrev.00030.2010; Fryknas M, 2006, J BIOMOL SCREEN, V11, P457, DOI 10.1177/1087057106288048; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Gurney ME, 2015, NEUROTHERAPEUTICS, V12, P49, DOI 10.1007/s13311-014-0309-7; Imielinski M, 2012, CELL, V150, P1107, DOI 10.1016/j.cell.2012.08.029; Kaheinen P, 2006, BASIC CLIN PHARMACOL, V98, P74, DOI 10.1111/j.1742-7843.2006.pto_231.x; Kronke J, 2014, SCIENCE, V343, P301, DOI 10.1126/science.1244851; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Ledermann J, 2014, LANCET ONCOL, V15, P852, DOI 10.1016/S1470-2045(14)70228-1; Lee ME, 2002, FEBS LETT, V530, P53, DOI 10.1016/S0014-5793(02)03396-3; Lu G, 2014, SCIENCE, V343, P305, DOI 10.1126/science.1244917; Malovannaya A, 2011, CELL, V145, P787, DOI 10.1016/j.cell.2011.05.006; Marks PA, 2007, NAT BIOTECHNOL, V25, P84, DOI 10.1038/nbt1272; Maurice DH, 2014, NAT REV DRUG DISCOV, V13, P290, DOI 10.1038/nrd4228; Millar JK, 2005, SCIENCE, V310, P1187, DOI 10.1126/science.1112915; Moffat JG, 2014, NAT REV DRUG DISCOV, V13, P588, DOI 10.1038/nrd4366; Movsesian M, 2011, CURR OPIN PHARMACOL, V11, P707, DOI 10.1016/j.coph.2011.09.001; Nagao M, 1989, Princess Takamatsu Symp, V20, P177; Nakajima H, 1998, EXP CELL RES, V241, P126, DOI 10.1006/excr.1998.4027; Pierson E, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004220; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Rubio MP, 2005, BIOCHEM J, V392, P163, DOI 10.1042/BJ20051103; RUPPERT D, 1982, LIFE SCI, V31, P2037, DOI 10.1016/0024-3205(82)90095-9; Simons SS, 2014, MOL ENDOCRINOL, V28, P173, DOI 10.1210/me.2013-1334; Staunton JE, 2001, P NATL ACAD SCI USA, V98, P10787, DOI 10.1073/pnas.191368598; Sun LP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090627; Swinney DC, 2011, NAT REV DRUG DISCOV, V10, P507, DOI 10.1038/nrd3480; TANG KM, 1994, EUR J PHARM-MOLEC PH, V268, P105; Tefferi A, 1997, SEMIN THROMB HEMOST, V23, P379, DOI 10.1055/s-2007-996112; Udeshi ND, 2012, MOL CELL PROTEOMICS, V11, P148, DOI 10.1074/mcp.M111.016857; Wang GS, 2005, BRIT J PHARMACOL, V146, P324, DOI 10.1038/sj.bjp.0706341; WEINSTEIN JN, 1992, SCIENCE, V258, P447, DOI 10.1126/science.1411538; Weinstein JN, 1997, SCIENCE, V275, P343, DOI 10.1126/science.275.5298.343; Zhang W, 2002, MOL PHARMACOL, V62, P514, DOI 10.1124/mol.62.3.514; Zheng X. F. Steven, 2002, Current Issues in Molecular Biology, V4, P33	52	55	56	1	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	FEB	2016	12	2					102	+		10.1038/NCHEMBIO.1984	http://dx.doi.org/10.1038/NCHEMBIO.1984			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DC6GG	26656089	Green Submitted, Green Accepted			2022-12-25	WOS:000369317300012
J	Sugai, Y; Katsuyama, Y; Ohnishi, Y				Sugai, Yoshinori; Katsuyama, Yohei; Ohnishi, Yasuo			A nitrous acid biosynthetic pathway for diazo group formation in bacteria	NATURE CHEMICAL BIOLOGY			English	Article							GENE-CLUSTER; NATURAL-PRODUCTS; CLONING; CREMEOMYCIN; EXPRESSION; OXIDATION; IDENTIFICATION; HYDROXAMATE; KINAMYCIN; AURF	Although some diazo compounds have bioactivities of medicinal interest, little is known about diazo group formation in nature. Here we describe an unprecedented nitrous acid biosynthetic pathway responsible for the formation of a diazo group in the biosynthesis of the ortho-diazoquinone secondary metabolite cremeomycin in Streptomyces cremeus. This finding provides important insights into the biosynthetic pathways not only for diazo compounds but also for other naturally occurring compounds containing nitrogen-nitrogen bonds.	[Sugai, Yoshinori; Katsuyama, Yohei; Ohnishi, Yasuo] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biotechnol, Bunkyo Ku, Tokyo, Japan	University of Tokyo	Ohnishi, Y (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biotechnol, Bunkyo Ku, Tokyo, Japan.	ayasuo@mail.ecc.u-tokyo.ac.jp		Ohnishi, Yasuo/0000-0001-7633-9236; Katsuyama, Yohei/0000-0003-4905-5320	Bureau of Science, Technology and Innovation Policy, Cabinet Office, Government of Japan [GS006]; NC-CARP project from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT);  [25850048]	Bureau of Science, Technology and Innovation Policy, Cabinet Office, Government of Japan; NC-CARP project from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT); 	We thank A. Luzhetskyy (Helmholtz Institute for Pharmaceutical Research Saarland), H. Onaka (University of Tokyo) and Y. Zhang (Gene Bridges) for providing pKGLP2, pTOYAMAcos and GB05dir, respectively. This research was supported in part by a funding program for next-generation world-leading researchers from the Bureau of Science, Technology and Innovation Policy, Cabinet Office, Government of Japan (GS006 to Y.O.), Grant-in-Aid for Young Scientists (B) (25850048 to Y.K.) and NC-CARP project from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) (to Y.K. and Y.O.).	BAXTER RL, 1988, J CHEM SOC CHEM COMM, P757, DOI 10.1039/c39880000757; Bergy M. E., 1967, Patent No. [US 3350269, 3350269, US3350269A]; BIBB MJ, 1985, GENE, V38, P215, DOI 10.1016/0378-1119(85)90220-3; Blair LM, 2013, J NAT PROD, V76, P794, DOI 10.1021/np400124n; Chanco E, 2014, BIOORGAN MED CHEM, V22, P5569, DOI 10.1016/j.bmc.2014.06.002; Doyle M.P., 1998, MODERN CATALYTIC MET; Franke J, 2013, ANGEW CHEM INT EDIT, V52, P8271, DOI 10.1002/anie.201303196; Fu J, 2012, NAT BIOTECHNOL, V30, P440, DOI 10.1038/nbt.2183; Gao JT, 2014, ANGEW CHEM INT EDIT, V53, P1334, DOI 10.1002/anie.201308363; Gould SJ, 1997, CHEM REV, V97, P2499, DOI 10.1021/cr9600215; Gould SJ, 1998, J ANTIBIOT, V51, P50, DOI 10.7164/antibiotics.51.50; Isobe K, 2014, MICROBES ENVIRON, V29, P4, DOI 10.1264/jsme2.ME13159; ITO S, 1970, J ANTIBIOT, V23, P315, DOI 10.7164/antibiotics.23.315; Janso JE, 2014, TETRAHEDRON, V70, P4156, DOI 10.1016/j.tet.2014.03.009; Le Goff G, 2014, BIOORGAN MED CHEM, V22, P6529, DOI 10.1016/j.bmc.2014.10.011; Li N, 2010, P NATL ACAD SCI USA, V107, P15722, DOI 10.1073/pnas.1002785107; Lin YM, 1999, J ORG CHEM, V64, P7451, DOI 10.1021/jo990769y; MCGUIRE JN, 1995, J ANTIBIOT, V48, P516, DOI 10.7164/antibiotics.48.516; Nawrat CC, 2011, NAT PROD REP, V28, P1426, DOI 10.1039/c1np00031d; NIHEI Y, 1993, J ANTIBIOT, V46, P900, DOI 10.7164/antibiotics.46.900; Noguchi A, 2010, NAT CHEM BIOL, V6, P641, DOI [10.1038/nchembio.418, 10.1038/NCHEMBIO.418]; Onaka H, 2003, J ANTIBIOT, V56, P950, DOI 10.7164/antibiotics.56.950; SALTZMAN BE, 1954, ANAL CHEM, V26, P1949, DOI 10.1021/ac60096a025; Smanski MJ, 2011, P NATL ACAD SCI USA, V108, P13498, DOI 10.1073/pnas.1106919108; Suzuki H, 2006, J BIOL CHEM, V281, P36944, DOI 10.1074/jbc.M608103200; Turner NJ, 2011, CURR OPIN CHEM BIOL, V15, P234, DOI 10.1016/j.cbpa.2010.11.009; Varley LM, 2008, SYNTHESIS-STUTTGART, P3601, DOI 10.1055/s-0028-1083204; Waldman AJ, 2015, CHEMBIOCHEM, V16, P2172, DOI 10.1002/cbic.201500407; Winkler R, 2005, ANGEW CHEM INT EDIT, V44, P4083, DOI 10.1002/anie.200500365; Winter JM, 2009, ANGEW CHEM INT EDIT, V48, P767, DOI 10.1002/anie.200805140; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; Zhang J, 2002, EUR J BIOCHEM, V269, P6302, DOI 10.1046/j.1432-1033.2002.03350.x	32	53	53	0	66	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	FEB	2016	12	2					73	+		10.1038/NCHEMBIO.1991	http://dx.doi.org/10.1038/NCHEMBIO.1991			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DC6GG	26689788				2022-12-25	WOS:000369317300007
J	Austen, K; Ringer, P; Mehlich, A; Chrostek-Grashoff, A; Kluger, C; Klingner, C; Sabass, B; Zent, R; Rief, M; Grashoff, C				Austen, Katharina; Ringer, Pia; Mehlich, Alexander; Chrostek-Grashoff, Anna; Kluger, Carleen; Klingner, Christoph; Sabass, Benedikt; Zent, Roy; Rief, Matthias; Grashoff, Carsten			Extracellular rigidity sensing by talin isoform-specific mechanical linkages	NATURE CELL BIOLOGY			English	Article							NANOSCALE ARCHITECTURE; VINCULIN BINDING; E-CADHERIN; INTEGRIN; FORCES; REVEALS; TENSION; ACTIVATION; PROTEINS	The ability of cells to adhere and sense differences in tissue stiffness is crucial for organ development and function. The central mechanisms by which adherent cells detect extracellular matrix compliance, however, are still unknown. Using two single-molecule-calibrated biosensors that allow the analysis of a previously inaccessible but physiologically highly relevant force regime in cells, we demonstrate that the integrin activator talin establishes mechanical linkages following cell adhesion, which are indispensable for cells to probe tissue stiffness. Talin linkages are exposed to a range of piconewton forces and bear, on average, 7-10 pN during cell adhesion depending on their association with F-actin and vinculin. Disruption of talin's mechanical engagement does not impair integrin activation and initial cell adhesion but prevents focal adhesion reinforcement and thus extracellular rigidity sensing. Intriguingly, talin mechanics are isoform specific so that expression of either talin-1 or talin-2 modulates extracellular rigidity sensing.	[Austen, Katharina; Ringer, Pia; Chrostek-Grashoff, Anna; Kluger, Carleen; Klingner, Christoph; Grashoff, Carsten] Max Planck Inst Biochem, Grp Mol Mechanotransduct, D-82152 Martinsried, Germany; [Mehlich, Alexander; Rief, Matthias] Tech Univ Munich, Dept Phys, D-85748 Garching, Germany; [Sabass, Benedikt] Princeton Univ, Dept Mech & Aerosp Engn, Princeton, NJ 08544 USA; [Zent, Roy] Vanderbilt Univ, Dept Med, Div Nephrol, Nashville, TN 37232 USA; [Rief, Matthias] Munich Ctr Integrated Prot Sci, D-81377 Munich, Germany	Max Planck Society; Technical University of Munich; Princeton University; Vanderbilt University; University of Munich	Grashoff, C (corresponding author), Max Planck Inst Biochem, Grp Mol Mechanotransduct, Klopferspitz 18A, D-82152 Martinsried, Germany.	cgrasho@biochem.mpg.de	Sabass, Benedikt/N-1431-2017	Sabass, Benedikt/0000-0002-7769-8043	German Research Council (DFG) [GR3399/2-1, GR3399/5-1]; Collaborative Research Centre [SFB863 (B9)]; Paul Gerson Unna Research Group of the Max Planck Forderstiftung; Nanosystems Initiative Munich (NIM); German Research Council through the Collaborative Research Centre [SFB863 (A2)]; VA Merit Award [1I01BX002196]; DAAD;  [R01-DK083187];  [R01-DK075594];  [R01-DK069221]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083187, R01DK075594, R01DK069921] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002196] Funding Source: NIH RePORTER	German Research Council (DFG)(German Research Foundation (DFG)); Collaborative Research Centre; Paul Gerson Unna Research Group of the Max Planck Forderstiftung; Nanosystems Initiative Munich (NIM); German Research Council through the Collaborative Research Centre; VA Merit Award(US Department of Veterans Affairs); DAAD(Deutscher Akademischer Austausch Dienst (DAAD)); ; ; ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	C.G. is supported by the German Research Council (DFG, GR3399/2-1 and GR3399/5-1), the Collaborative Research Centre SFB863 (B9) and a Paul Gerson Unna Research Group of the Max Planck Forderstiftung. A.M. is supported by the Nanosystems Initiative Munich (NIM); M.R. is supported by the German Research Council through the Collaborative Research Centre SFB863 (A2). R.Z. is supported by R01-DK083187, R01-DK075594, R01-DK069221 and VA Merit Award 1I01BX002196. B.S. acknowledges financial support from the DAAD. The authors thank R. Fassler for continuous support and helpful discussions; F. Schnorrer for critically reading the manuscript; A. Lambacher and the MPIB core facility for technical support; G. Zoldak for helpful discussion, A. Sechi for sharing data analysis software and D. Critchley (University of Leicester, UK) for providing talin-2 cDNA.	Anthis NJ, 2010, STRUCTURE, V18, P1654, DOI 10.1016/j.str.2010.09.018; Austen K, 2013, METHODS MOL BIOL, V1066, P169, DOI 10.1007/978-1-62703-604-7_15; Blakely BL, 2014, NAT METHODS, V11, P1229, DOI [10.1038/NMETH.3145, 10.1038/nmeth.3145]; Borghi N, 2012, P NATL ACAD SCI USA, V109, P12568, DOI 10.1073/pnas.1204390109; Cai DF, 2014, CELL, V157, P1146, DOI 10.1016/j.cell.2014.03.045; Carisey A, 2013, CURR BIOL, V23, P271, DOI 10.1016/j.cub.2013.01.009; Ciobanasu C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4095; Conway DE, 2013, CURR BIOL, V23, P1024, DOI 10.1016/j.cub.2013.04.049; Cost AL, 2015, CELL MOL BIOENG, V8, P96, DOI 10.1007/s12195-014-0368-1; Critchley DR, 2009, ANNU REV BIOPHYS, V38, P235, DOI 10.1146/annurev.biophys.050708.133744; del Rio A, 2009, SCIENCE, V323, P638, DOI 10.1126/science.1162912; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Duan Y, 1998, SCIENCE, V282, P740, DOI 10.1126/science.282.5389.740; Dumbauld DW, 2013, P NATL ACAD SCI USA, V110, P9788, DOI 10.1073/pnas.1216209110; Elosegui-Artola A, 2014, NAT MATER, V13, P631, DOI [10.1038/NMAT3960, 10.1038/nmat3960]; FINER JT, 1994, NATURE, V368, P113, DOI 10.1038/368113a0; Franze K, 2013, ANNU REV BIOMED ENG, V15, P227, DOI 10.1146/annurev-bioeng-071811-150045; Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593; Grashoff C, 2010, NATURE, V466, P263, DOI 10.1038/nature09198; Guo J, 2014, ANTIOXID REDOX SIGN, V20, P986, DOI 10.1089/ars.2013.5708; Heisenberg CP, 2013, CELL, V153, P948, DOI 10.1016/j.cell.2013.05.008; Hoffman BD, 2011, NATURE, V475, P316, DOI 10.1038/nature10316; Humphries JD, 2007, J CELL BIOL, V179, P1043, DOI 10.1083/jcb.200703036; Hytonen VP, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040024; Ingber DE, 2003, ANN MED, V35, P564, DOI 10.1080/07853890310016333; Kanchanawong P, 2010, NATURE, V468, P580, DOI 10.1038/nature09621; Krieg M, 2014, NAT CELL BIOL, V16, P224, DOI 10.1038/ncb2915; Liu JR, 2015, P NATL ACAD SCI USA, V112, pE4864, DOI 10.1073/pnas.1512025112; Lu PF, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005058; Miller K, 2000, J BIOMECH, V33, P1369, DOI 10.1016/S0021-9290(00)00120-2; Moser M, 2009, SCIENCE, V324, P895, DOI 10.1126/science.1163865; Paszek MJ, 2014, NATURE, V511, P319, DOI 10.1038/nature13535; Plotnikov SV, 2012, CELL, V151, P1513, DOI 10.1016/j.cell.2012.11.034; Praekelt U, 2012, EUR J CELL BIOL, V91, P180, DOI 10.1016/j.ejcb.2011.12.003; Schoen I, 2013, ANNU REV MATER RES, V43, P589, DOI 10.1146/annurev-matsci-062910-100407; Wang XF, 2013, SCIENCE, V340, P991, DOI 10.1126/science.1231041; Wozniak MA, 2009, NAT REV MOL CELL BIO, V10, P34, DOI 10.1038/nrm2592; Yao MX, 2014, SCI REP-UK, V4, DOI 10.1038/srep04610; Zhang X, 2008, NAT CELL BIOL, V10, P1062, DOI 10.1038/ncb1765; Zoldak G, 2013, P NATL ACAD SCI USA, V110, P18156, DOI 10.1073/pnas.1311495110	40	205	206	2	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2015	17	12					1597	1606		10.1038/ncb3268	http://dx.doi.org/10.1038/ncb3268			10	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CX8DH	26523364	Green Accepted			2022-12-25	WOS:000365932300012
J	Esposito, MT; Zhao, L; Fung, TK; Rane, JK; Wilson, A; Martin, N; Gil, J; Leung, AY; Ashworth, A; So, CWE				Esposito, Maria Teresa; Zhao, Lu; Fung, Tsz Kan; Rane, Jayant K.; Wilson, Amanda; Martin, Nadine; Gil, Jesus; Leung, Anskar Y.; Ashworth, Alan; So, Chi Wai Eric			7Synthetic lethal targeting of oncogenic transcription factors in acute leukemia by PARP inhibitors	NATURE MEDICINE			English	Article							ACUTE MYELOID-LEUKEMIA; ACUTE PROMYELOCYTIC LEUKEMIA; DNA-DAMAGE RESPONSE; STEM-CELLS; POLY(ADP-RIBOSE) POLYMERASE; HEMATOPOIETIC PROGENITORS; SYNTHETIC LETHALITY; MLL TRANSLOCATIONS; IN-VIVO; REPAIR	Acute myeloid leukemia (AML) is mostly driven by oncogenic transcription factors, which have been classically viewed as intractable targets using small-molecule inhibitor approaches. Here we demonstrate that AML driven by repressive transcription factors, including AML1-ETO (encoded by the fusion oncogene RUNX1-RUNX1T1) and PML-RAR alpha fusion oncoproteins (encoded by PML-RARA) are extremely sensitive to poly (ADP-ribose) polymerase (PARP) inhibition, in part owing to their suppressed expression of key homologous recombination (HR)-associated genes and their compromised DNA-damage response (DDR). In contrast, leukemia driven by mixed-lineage leukemia (MLL, encoded by KMT2A) fusions with dominant transactivation ability is proficient in DDR and insensitive to PARP inhibition. Intriguingly, genetic or pharmacological inhibition of an MLL downstream target, HOXA9, which activates expression of various HR-associated genes, impairs DDR and sensitizes MLL leukemia to PARP inhibitors (PARPis). Conversely, HOXA9 overexpression confers PARPi resistance to AML1-ETO and PML-RAR alpha transformed cells. Together, these studies describe a potential utility of PARPi-induced synthetic lethality for leukemia treatment and reveal a novel molecular mechanism governing PARPi sensitivity in AML.	[Esposito, Maria Teresa; Zhao, Lu; Fung, Tsz Kan; Rane, Jayant K.; Wilson, Amanda; So, Chi Wai Eric] Kings Coll London, Leukemia & Stem Cell Biol Grp, Dept Haematol Med, Div Canc Studies, London WC2R 2LS, England; [Martin, Nadine; Gil, Jesus] Univ London Imperial Coll Sci Technol & Med, Ctr Clin Sci, MRC, Cell Proliferat Grp, London, England; [Leung, Anskar Y.] Univ Hong Kong, Dept Med, Hong Kong, Hong Kong, Peoples R China; [Ashworth, Alan] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA	University of London; King's College London; Imperial College London; University of Hong Kong; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center	So, CWE (corresponding author), Kings Coll London, Leukemia & Stem Cell Biol Grp, Dept Haematol Med, Div Canc Studies, London WC2R 2LS, England.	eric.so@kcl.ac.uk	Gil, Jesus/C-7739-2012; Leung, Andrew Yee Tak/X-4743-2019; Esposito, Maria Teresa/X-3817-2019	Gil, Jesus/0000-0002-4303-6260; Esposito, Maria Teresa/0000-0002-9147-6906; Wilson, Amanda/0000-0001-5681-9611; Martin, Nadine/0000-0002-4806-2388	Bloodwise and Cancer Research UK; Cancer Research UK [16753] Funding Source: researchfish; Medical Research Council [MC_U120085810] Funding Source: researchfish; MRC [MC_U120085810] Funding Source: UKRI	Bloodwise and Cancer Research UK; Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank G. Mufti, S. Shall, T. Ng, and D. Weekes for insightful discussion; A. Zelent (Miller School of Medicine, University of Miami), M. Greaves (The Institute of Cancer Research, London) and O. Heidenreich (Northern Institute for Cancer Research, Newcastle University) for providing NB4-LR2, THP1 and Kasumi cell lines, respectively; I. Ahel (Sir William Dunn School of Pathology, University of Oxford), I. Gibbs-Seymour (Sir William Dunn School of Pathology, University of Oxford), and D. Livingston (Dana-Farber Cancer Institute, Harvard University) for tagged ALPF and PARP1 constructs; E. Soutoglou (Institut de Genetique de Biologie Moleculaire et Celluraire) and M. Jasin (Memorial Sloan Kettering Cancer Center) for DR-GFP HR reporter systems; H. Lee (School of Biological Sciences, Seoul National University) and M. Tarsounas (Oxford University for Radiation Oncology) for BRCA2-specific antibody; J. Hess (Department of Pathology, University of Michigan School of Medicine) for the MSCV-HA-Hoxa9-IRES-GFP construct; C. Lourenco and W. Vetharoy for technical assistance with mice experiments and FACS analysis; S. Tung, A. Innes and P. Lau for technical assistance with gene expression profiling; T. Gaymes for support with DNA damage repair experiments; and P. Tse for graphical illustration. This work was supported by program grants from Bloodwise and Cancer Research UK (to C.W.E.S.).	Alcalay M, 2003, J CLIN INVEST, V112, P1751, DOI 10.1172/JCI17595; Armstrong SA, 2002, NAT GENET, V30, P41, DOI 10.1038/ng765; Arteaga MF, 2013, CANCER CELL, V23, P376, DOI 10.1016/j.ccr.2013.02.014; Baumann P, 1996, CELL, V87, P757, DOI 10.1016/S0092-8674(00)81394-X; Blanpain C, 2011, CELL STEM CELL, V8, P16, DOI 10.1016/j.stem.2010.12.012; Boichuk S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025814; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Bryant HE, 2009, EMBO J, V28, P2601, DOI 10.1038/emboj.2009.206; Carreira A, 2009, CELL, V136, P1032, DOI 10.1016/j.cell.2009.02.019; Cheung N, 2011, FEBS LETT, V585, P2100, DOI 10.1016/j.febslet.2011.03.068; Chiba N, 2012, P NATL ACAD SCI USA, V109, P2760, DOI 10.1073/pnas.1018867108; Choi EJ, 2011, J CELL BIOCHEM, V112, P2392, DOI 10.1002/jcb.23162; Costa BM, 2010, CANCER RES, V70, P453, DOI 10.1158/0008-5472.CAN-09-2189; De Lorenzo SB, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00228; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; El-Khamisy SF, 2003, NUCLEIC ACIDS RES, V31, P5526, DOI 10.1093/nar/gkg761; Esposito MT, 2014, CHROMOSOMA, V123, P545, DOI 10.1007/s00412-014-0482-9; Faber J, 2009, BLOOD, V113, P2375, DOI 10.1182/blood-2007-09-113597; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Fung TK, 2013, ONCOTARGET, V4, P1128, DOI 10.18632/oncotarget.1244; Gaspar N, 2010, CANCER RES, V70, P9243, DOI 10.1158/0008-5472.CAN-10-1250; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gaymes TJ, 2002, ONCOGENE, V21, P2525, DOI 10.1038/sj.onc.1205331; Gaymes TJ, 2002, CANCER RES, V62, P2791; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Haince JF, 2008, J BIOL CHEM, V283, P1197, DOI 10.1074/jbc.M706734200; Haince JF, 2007, J BIOL CHEM, V282, P16441, DOI 10.1074/jbc.M608406200; Helleday T, 2008, NAT REV CANCER, V8, P193, DOI 10.1038/nrc2342; Helleday T, 2011, MOL ONCOL, V5, P387, DOI 10.1016/j.molonc.2011.07.001; Huang YS, 2012, BLOOD, V119, P388, DOI 10.1182/blood-2011-03-341081; Kraus WL, 2008, CURR OPIN CELL BIOL, V20, P294, DOI 10.1016/j.ceb.2008.03.006; Krishnakumar R, 2010, MOL CELL, V39, P8, DOI 10.1016/j.molcel.2010.06.017; Krivtsov AV, 2007, NAT REV CANCER, V7, P823, DOI 10.1038/nrc2253; Kumar AR, 2004, BLOOD, V103, P1823, DOI 10.1182/blood-2003-07-2582; Lawrence HJ, 2005, BLOOD, V106, P3988, DOI 10.1182/blood-2005-05-2003; Liu H, 2010, NATURE, V467, P343, DOI 10.1038/nature09350; Mah LJ, 2010, LEUKEMIA, V24, P679, DOI 10.1038/leu.2010.6; Martin N, 2013, EMBO J, V32, P982, DOI 10.1038/emboj.2013.37; Masson M, 1998, MOL CELL BIOL, V18, P3563, DOI 10.1128/MCB.18.6.3563; McLornan DP, 2014, NEW ENGL J MED, V371, P1725, DOI 10.1056/NEJMra1407390; Moynahan ME, 2010, NAT REV MOL CELL BIO, V11, P196, DOI 10.1038/nrm2851; Paddock MN, 2011, DNA REPAIR, V10, P338, DOI 10.1016/j.dnarep.2010.12.005; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Roy R, 2012, NAT REV CANCER, V12, P68, DOI 10.1038/nrc3181; Rubin E, 2007, CANCER RES, V67, P1527, DOI 10.1158/0008-5472.CAN-06-4283; Santos MA, 2014, NATURE, V514, P107, DOI 10.1038/nature13483; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Smith LL, 2011, CELL STEM CELL, V8, P649, DOI 10.1016/j.stem.2011.05.004; So CW, 2004, BLOOD, V103, P3192, DOI 10.1182/blood-2003-10-3722; So CW, 2003, CANCER CELL, V3, P161, DOI 10.1016/S1535-6108(03)00019-9; Takacova S, 2012, CANCER CELL, V21, P517, DOI 10.1016/j.ccr.2012.01.021; Turner N, 2004, NAT REV CANCER, V4, P814, DOI 10.1038/nrc1457; Tutt A, 2010, LANCET, V376, P235, DOI 10.1016/S0140-6736(10)60892-6; Valk PJM, 2004, NEW ENGL J MED, V350, P1617, DOI 10.1056/NEJMoa040465; Verhaak RGW, 2009, HAEMATOL-HEMATOL J, V94, P131, DOI 10.3324/haematol.13299; Viale A, 2009, NATURE, V457, P51, DOI 10.1038/nature07618; Wang Z, 2008, NATURE, V455, P1205, DOI 10.1038/nature07284; Wang Z, 2010, CANCER CELL, V17, P597, DOI 10.1016/j.ccr.2010.04.024; Yeung J, 2010, CANCER CELL, V18, P606, DOI 10.1016/j.ccr.2010.10.032; Yeung Jenny, 2009, V538, P301, DOI 10.1007/978-1-59745-418-6_15; Yeung PL, 2012, J CELL BIOCHEM, V113, P1787, DOI 10.1002/jcb.24050; Yip BH, 2013, EXP BIOL MED, V238, P315, DOI 10.1177/1535370213480717; Zeisig Bernd B, 2012, Cancer Cell, V22, P698, DOI 10.1016/j.ccr.2012.10.017; Zeisig Bernd B., 2009, V538, P207, DOI 10.1007/978-1-59745-418-6_10; Zong S, 1999, ONCOGENE, V18, P7941, DOI 10.1038/sj.onc.1203367	66	108	111	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2015	21	12					1481	+		10.1038/nm.3993	http://dx.doi.org/10.1038/nm.3993			12	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CX9EV	26594843	Green Accepted, Green Submitted, Green Published			2022-12-25	WOS:000366008700019
J	Pomerantz, MM; Li, FG; Takeda, DY; Lenci, R; Chonkar, A; Chabot, M; Cejas, P; Vazquez, F; Cook, J; Shivdasani, RA; Bowden, M; Lis, R; Hahn, WC; Kantoff, PW; Brown, M; Loda, M; Long, HW; Freedman, ML				Pomerantz, Mark M.; Li, Fugen; Takeda, David Y.; Lenci, Romina; Chonkar, Apurva; Chabot, Matthew; Cejas, Paloma; Vazquez, Francisca; Cook, Jennifer; Shivdasani, Ramesh A.; Bowden, Michaela; Lis, Rosina; Hahn, William C.; Kantoff, Philip W.; Brown, Myles; Loda, Massimo; Long, Henry W.; Freedman, Matthew L.			The androgen receptor cistrome is extensively reprogrammed in human prostate tumorigenesis	NATURE GENETICS			English	Article							TRANSCRIPTIONAL PROGRAM; CANCER; GENE; HOXB13; EXPRESSION; DIFFERENTIATION; MUTATIONS; ENHANCERS; ELEMENTS; FOXA1	Master transcription factors interact with DNA to establish cell type identity and to regulate gene expression in mammalian cells(1,2). The genome-wide map of these transcription factor binding sites has been termed the cistrome(3). Here we show that the androgen receptor (AR) cistrome undergoes extensive reprogramming during prostate epithelial transformation in man. Using human prostate tissue, we observed a core set of AR binding sites that are consistently reprogrammed in tumors. FOXA1 and HOXB13 colocalized at the reprogrammed AR binding sites in human tumor tissue. Introduction of FOXA1 and HOXB13 into an immortalized prostate cell line reprogrammed the AR cistrome to resemble that of a prostate tumor, functionally linking these specific factors to AR cistrome reprogramming. These findings offer mechanistic insights into a key set of events that drive normal prostate epithelium toward transformation and establish the centrality of epigenetic reprogramming in human prostate tumorigenesis.	[Pomerantz, Mark M.; Takeda, David Y.; Lenci, Romina; Chonkar, Apurva; Chabot, Matthew; Cejas, Paloma; Cook, Jennifer; Shivdasani, Ramesh A.; Hahn, William C.; Kantoff, Philip W.; Brown, Myles; Loda, Massimo; Long, Henry W.; Freedman, Matthew L.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Pomerantz, Mark M.; Takeda, David Y.; Lenci, Romina; Chonkar, Apurva; Chabot, Matthew; Cejas, Paloma; Cook, Jennifer; Shivdasani, Ramesh A.; Bowden, Michaela; Lis, Rosina; Hahn, William C.; Kantoff, Philip W.; Brown, Myles; Loda, Massimo; Long, Henry W.; Freedman, Matthew L.] Harvard Univ, Sch Med, Boston, MA USA; [Li, Fugen; Cejas, Paloma; Shivdasani, Ramesh A.; Brown, Myles; Long, Henry W.; Freedman, Matthew L.] Dana Farber Canc Inst, Ctr Funct Canc Epigenet, Boston, MA 02115 USA; [Li, Fugen] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Takeda, David Y.; Vazquez, Francisca; Hahn, William C.; Loda, Massimo; Freedman, Matthew L.] Eli & Edythe L Broad Inst, Cambridge, MA USA; [Bowden, Michaela; Lis, Rosina; Loda, Massimo] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Brigham & Women's Hospital	Freedman, ML (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.	freedman@broadinstitute.org	Brown, Myles/B-6906-2008; Vazquez, Francisca/ABC-4620-2020; Brown, Myles/AAX-5332-2021; Vazquez, Francisca/AAA-3751-2020	Brown, Myles/0000-0002-8213-1658; Vazquez, Francisca/0000-0002-2857-4685; Kantoff, Philip/0000-0001-7275-0597; Lenci, Romina/0000-0002-0025-3134; Bowden, Michaela/0000-0003-4375-7823; /0000-0003-4914-1157; Takeda, David/0000-0002-5986-1169	Prostate Cancer Foundation; H.L. Snyder Medical Foundation; US National Institutes of Health (NIH) grant [R01CA193910]; Anna Fuller Fund (PS) [6241901, Infoed 2013-0369]; NIH GAME-ON U19 [U19CA148537]; Dana-Farber Prostate Cancer Specialized Program of Research Excellence (SPORE) [NIH P50CA90381-11]; NIH [U01CA176058]; NATIONAL CANCER INSTITUTE [P50CA090381, U01CA176058, R01CA193910, U19CA148537, P30CA008748] Funding Source: NIH RePORTER	Prostate Cancer Foundation; H.L. Snyder Medical Foundation; US National Institutes of Health (NIH) grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Anna Fuller Fund (PS); NIH GAME-ON U19; Dana-Farber Prostate Cancer Specialized Program of Research Excellence (SPORE); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Z. Herbert and the Molecular Biology Core Facility at the Dana-Farber Cancer Institute for their sequencing expertise. We acknowledge funding from the Prostate Cancer Foundation (Challenge Award), the H.L. Snyder Medical Foundation (M.L.F.), US National Institutes of Health (NIH) grant R01CA193910, the Anna Fuller Fund (PS#6241901; Infoed 2013-0369), the NIH GAME-ON U19 (grant U19CA148537), the Dana-Farber Prostate Cancer Specialized Program of Research Excellence (SPORE; NIH P50CA90381-11) and the NIH grant U01CA176058 (F.V. and W.C.H.).	Augello MA, 2014, CANCER METAST REV, V33, P399, DOI 10.1007/s10555-013-9471-3; Barbieri CE, 2012, NAT GENET, V44, P685, DOI 10.1038/ng.2279; Berger MF, 2011, NATURE, V470, P214, DOI 10.1038/nature09744; Berger R, 2004, CANCER RES, V64, P8867, DOI 10.1158/0008-5472.CAN-04-2938; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Chen Y, 2013, NAT MED, V19, P1023, DOI 10.1038/nm.3216; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Economides KD, 2003, DEVELOPMENT, V130, P2061, DOI 10.1242/dev.00432; Ewing CM, 2012, NEW ENGL J MED, V366, P141, DOI 10.1056/NEJMoa1110000; Feng JX, 2012, NAT PROTOC, V7, P1728, DOI 10.1038/nprot.2012.101; Glinsky GV, 2004, J CLIN INVEST, V113, P913, DOI 10.1172/JCI200420032; He HSHS, 2012, GENOME RES, V22, P1015, DOI 10.1101/gr.133280.111; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Huang QL, 2014, NAT GENET, V46, P126, DOI 10.1038/ng.2862; HUGGINS C, 1967, CANCER RES, V27, P1925; Jin HJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4972; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Liu T, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r83; Lupien M, 2009, ENDOCR-RELAT CANCER, V16, P381, DOI 10.1677/ERC-09-0038; Massie CE, 2011, EMBO J, V30, P2719, DOI 10.1038/emboj.2011.158; Mills IG, 2014, NAT REV CANCER, V14, P187, DOI 10.1038/nrc3678; Robinson JLL, 2014, ONCOGENE, V33, P5666, DOI 10.1038/onc.2013.508; Sampson N, 2013, ENDOCR-RELAT CANCER, V20, pR49, DOI 10.1530/ERC-12-0401; Shao DD, 2013, GENOME RES, V23, P665, DOI 10.1101/gr.143586.112; Sharma NL, 2013, CANCER CELL, V23, P35, DOI 10.1016/j.ccr.2012.11.010; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Thompson IM, 2003, NEW ENGL J MED, V349, P215, DOI 10.1056/NEJMoa030660; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Wang D, 2011, NATURE, V474, P390, DOI 10.1038/nature10006; Wang QB, 2009, CELL, V138, P245, DOI 10.1016/j.cell.2009.04.056; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Xu JF, 2013, HUM GENET, V132, P5, DOI 10.1007/s00439-012-1229-4; Yu JD, 2010, CANCER CELL, V17, P443, DOI 10.1016/j.ccr.2010.03.018; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	36	215	216	2	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2015	47	11					1346	+		10.1038/ng.3419	http://dx.doi.org/10.1038/ng.3419			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CV1BN	26457646	Green Accepted, Green Submitted			2022-12-25	WOS:000363988200019
J	Chu, J; Oh, Y; Sens, A; Ataie, N; Dana, H; Macklin, JJ; Laviv, T; Welf, ES; Dean, KM; Zhang, FJ; Kim, BB; Tang, CT; Hu, M; Baird, MA; Davidson, MW; Kay, MA; Fiolka, R; Yasuda, R; Kim, DS; Ng, HL; Lin, MZ				Chu, Jun; Oh, Younghee; Sens, Alex; Ataie, Niloufar; Dana, Hod; Macklin, John J.; Laviv, Tal; Welf, Erik S.; Dean, Kevin M.; Zhang, Feijie; Kim, Benjamin B.; Tang, Clement Tran; Hu, Michelle; Baird, Michelle A.; Davidson, Michael W.; Kay, Mark A.; Fiolka, Reto; Yasuda, Ryohei; Kim, Douglas S.; Ng, Ho-Leung; Lin, Michael Z.			A bright cyan-excitable orange fluorescent protein facilitates dual-emission microscopy and enhances bioluminescence imaging in vivo	NATURE BIOTECHNOLOGY			English	Article							RESONANCE ENERGY-TRANSFER; RENILLA LUCIFERASE; ADAPTIVE OPTICS; DYNAMICS; CELLS; DEEP; REPORTER; MODEL; MUTAGENESIS	Orange-red fluorescent proteins (FPs) are widely used in biomedical research for multiplexed epifluorescence microscopy with GFP-based probes, but their different excitation requirements make multiplexing with new advanced microscopy methods difficult. Separately, orange-red FPs are useful for deep-tissue imaging in mammals owing to the relative tissue transmissibility of orange-red light, but their dependence on illumination limits their sensitivity as reporters in deep tissues. Here we describe CyOFP1, a bright, engineered, orange-red FP that is excitable by cyan light. We show that CyOFP1 enables single-excitation multiplexed imaging with GFP-based probes in single-photon and two-photon microscopy, including time-lapse imaging in light-sheet systems. CyOFP1 also serves as an efficient acceptor for resonance energy transfer from the highly catalytic blue-emitting luciferase NanoLuc. An optimized fusion of CyOFP1 and NanoLuc, called Antares, functions as a highly sensitive bioluminescent reporter in vivo, producing substantially brighter signals from deep tissues than firefly luciferase and other bioluminescent proteins.	[Chu, Jun; Oh, Younghee; Kim, Benjamin B.; Lin, Michael Z.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Chu, Jun; Oh, Younghee; Zhang, Feijie; Kay, Mark A.; Lin, Michael Z.] Stanford Univ, Dept Pediat, Stanford, CA 94305 USA; [Oh, Younghee; Lin, Michael Z.] Stanford Univ, Dept Neurol, Stanford, CA 94305 USA; [Sens, Alex; Ataie, Niloufar; Tang, Clement Tran; Hu, Michelle; Ng, Ho-Leung] Univ Hawaii Manoa, Dept Chem, Honolulu, HI 96822 USA; [Dana, Hod; Macklin, John J.; Kim, Douglas S.] Howard Hughes Med Inst, Janelia Res Campus, Ashburn, VA USA; [Laviv, Tal; Yasuda, Ryohei] Max Planck Florida Inst, Jupiter, FL USA; [Welf, Erik S.; Dean, Kevin M.; Fiolka, Reto] Univ Texas Southwestern Med Ctr, Dept Cell Biol, Dallas, TX USA; [Zhang, Feijie; Kay, Mark A.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Baird, Michelle A.; Davidson, Michael W.] Florida State Univ, Dept Biol Sci, B-157, Tallahassee, FL 32306 USA; [Baird, Michelle A.; Davidson, Michael W.] Florida State Univ, Natl High Magnet Field Lab, Tallahassee, FL 32306 USA; [Ng, Ho-Leung] Univ Hawaii, Ctr Canc, Honolulu, HI 96822 USA; [Chu, Jun] Chinese Acad Sci, Shenzhen Inst Adv Technol, Inst Biomed & Hlth Engn, Shenzhen, Peoples R China	Stanford University; Stanford University; Stanford University; University of Hawaii System; University of Hawaii Manoa; Howard Hughes Medical Institute; Max Planck Society; University of Texas System; University of Texas Southwestern Medical Center Dallas; Stanford University; State University System of Florida; Florida State University; State University System of Florida; Florida State University; Cancer Research Center of Hawaii; University of Hawaii System; Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS	Lin, MZ (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.; Lin, MZ (corresponding author), Stanford Univ, Dept Pediat, Stanford, CA 94305 USA.; Lin, MZ (corresponding author), Stanford Univ, Dept Neurol, Stanford, CA 94305 USA.	mzlin@stanford.edu	Ng, Ho Leung/Q-7167-2019; Laviv, Tal/AAN-6016-2020	Ng, Ho Leung/0000-0002-6415-1938; Yasuda, Ryohei/0000-0001-6263-9297; Lin, Michael/0000-0002-0492-1961; Kim, Douglas/0000-0001-9029-314X; Dean, Kevin/0000-0003-0839-2320; Kay, Mark/0000-0002-2799-2615; Dana, Hod/0000-0002-8093-2363	DOE Office of Biological and Environmental Research; National Institute of Health project MINOS [R01GM105404]; University of Hawaii at Manoa Undergraduate Research Opportunities Program; Human Frontier Science Program; NIH [R01HL064274, R01MH080047, 1U01NS090600, P50GM107615]; Shenzhen Basic Research Foundation grant [JCYJ20150521144320987]; Chinese Academy of Sciences [Y64401]; Burroughs Wellcome Foundation Career Award for Medical Scientists; Rita Allen Foundation Scholar Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064274] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM107615, F32GM117793, R01GM105404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH080047] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS090600] Funding Source: NIH RePORTER	DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institute of Health project MINOS; University of Hawaii at Manoa Undergraduate Research Opportunities Program; Human Frontier Science Program(Human Frontier Science Program); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shenzhen Basic Research Foundation grant; Chinese Academy of Sciences(Chinese Academy of Sciences); Burroughs Wellcome Foundation Career Award for Medical Scientists; Rita Allen Foundation Scholar Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank T. Doyle (Stanford University) for assistance with bioluminescence imaging, J. Chen (Shenzhen Institutes of Advanced Technology) for analysis of light-sheet microscopy data, S. Classen (ALS SIBYLS) for help with synchrotron X-ray data collection, P. Meisenheimer and T. Kirkland (Promega) for furimazine, and members of the Lin laboratory for general assistance and advice. The MV3 cells were a gift of P. Friedl, University of Texas MD Anderson Cancer Center. The Advanced Light Source (ALS), a national user facility operated by Lawrence Berkeley National Laboratory on behalf of the Department of Energy Office of Basic Energy Sciences, through the Integrated Diffraction Analysis Technologies (IDAT) program, is supported by the DOE Office of Biological and Environmental Research and National Institute of Health project MINOS (R01GM105404). This work was supported by the University of Hawaii at Manoa Undergraduate Research Opportunities Program (M.H. and C.T.T.), a long-term fellowship from the Human Frontier Science Program (T.L.), NIH grants R01HL064274 (M.K.), R01MH080047 (R.Y.), 1U01NS090600 (M.Z.L.), and P50GM107615 (M.Z.L.), Shenzhen Basic Research Foundation grant JCYJ20150521144320987 (J.C.), the Hundred Talents Program award (Y64401) from the Chinese Academy of Sciences (J.C.), a Burroughs Wellcome Foundation Career Award for Medical Scientists (M.Z.L.), and a Rita Allen Foundation Scholar Award (M.Z.L.).	Akerboom J, 2012, J NEUROSCI, V32, P13819, DOI 10.1523/JNEUROSCI.2601-12.2012; Ando Y, 2008, NAT PHOTONICS, V2, P44, DOI 10.1038/nphoton.2007.251; Baird GS, 2000, P NATL ACAD SCI USA, V97, P11984, DOI 10.1073/pnas.97.22.11984; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Branchini BR, 1998, BIOCHEMISTRY-US, V37, P15311, DOI 10.1021/bi981150d; Bruno TJ, 2006, CRC HDB FUNDAMENTAL; Chalfie M, 1998, GREEN FLUORESCENT PROTEIN: PROPERTIES, APPLICATIONS, AND PROTOCOLS, pVII; Chen BC, 2014, SCIENCE, V346, P439, DOI 10.1126/science.1257998; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chu J., 2014, FLUORESCENT PROTEIN, P153; Chu J, 2014, NAT METHODS, V11, P572, DOI [10.1038/NMETH.2888, 10.1038/nmeth.2888]; Close DM, 2011, SENSORS-BASEL, V11, P180, DOI 10.3390/s110100180; Contag CH, 1997, PHOTOCHEM PHOTOBIOL, V66, P523, DOI 10.1111/j.1751-1097.1997.tb03184.x; Dana H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108697; Dean KM, 2015, BIOPHYS J, V108, P2807, DOI 10.1016/j.bpj.2015.05.013; Dean KM, 2014, OPT EXPRESS, V22, P26141, DOI 10.1364/OE.22.026141; Depry C, 2013, PFLUG ARCH EUR J PHY, V465, P373, DOI 10.1007/s00424-012-1175-y; Dragulescu-Andrasi A, 2011, P NATL ACAD SCI USA, V108, P12060, DOI 10.1073/pnas.1100923108; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Gao L, 2012, CELL, V151, P1370, DOI 10.1016/j.cell.2012.10.008; Hall MP, 2012, ACS CHEM BIOL, V7, P1848, DOI 10.1021/cb3002478; Horton NG, 2013, NAT PHOTONICS, V7, P205, DOI [10.1038/NPHOTON.2012.336, 10.1038/nphoton.2012.336]; Ji N, 2010, NAT METHODS, V7, P141, DOI 10.1038/NMETH.1411; Katona G, 2012, NAT METHODS, V9, P201, DOI [10.1038/NMETH.1851, 10.1038/nmeth.1851]; Kawano H, 2008, NAT METHODS, V5, P373, DOI 10.1038/nmeth0508-373; Kogure T, 2006, NAT BIOTECHNOL, V24, P577, DOI 10.1038/nbt1207; Lam AJ, 2012, NAT METHODS, V9, P1005, DOI [10.1038/NMETH.2171, 10.1038/nmeth.2171]; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Li D, 2015, SCIENCE, V349, DOI 10.1126/science.aab3500; Liang YJ, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.1.016004; Liu Y, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6904; Loening AM, 2010, NAT METHODS, V7, P5, DOI 10.1038/nmeth0110-05; Lounis B, 2000, NATURE, V407, P491, DOI 10.1038/35035032; MATTHEWS JC, 1977, BIOCHEMISTRY-US, V16, P85, DOI 10.1021/bi00620a014; Mazo-Vargas A, 2014, MOL BIOL CELL, V25, P3699, DOI 10.1091/mbc.E14-07-1187; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mezzanotte L, 2013, CONTRAST MEDIA MOL I, V8, P505, DOI 10.1002/cmmi.1549; Miyawaki A, 2012, CURR OPIN STRUC BIOL, V22, P679, DOI 10.1016/j.sbi.2012.09.002; Morse D, 2012, MOL THER, V20, P692, DOI 10.1038/mt.2012.38; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Newman RH, 2011, CHEM REV, V111, P3614, DOI 10.1021/cr100002u; Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z; Otto-Duessel M, 2006, MOL IMAGING, V5, P57, DOI 10.2310/7290.2006.00006; Piatkevich KD, 2010, J AM CHEM SOC, V132, P10762, DOI 10.1021/ja101974k; Planchon TA, 2011, NAT METHODS, V8, P417, DOI [10.1038/NMETH.1586, 10.1038/nmeth.1586]; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; Saito K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2248; Shao L, 2011, NAT METHODS, V8, P1044, DOI [10.1038/NMETH.1734, 10.1038/nmeth.1734]; Shcherbakova DM, 2012, J AM CHEM SOC, V134, P7913, DOI 10.1021/ja3018972; SHIMOMURA O, 1969, SCIENCE, V164, P1299, DOI 10.1126/science.164.3885.1299; SHIMOMURA O, 1978, BIOCHEMISTRY-US, V17, P994, DOI 10.1021/bi00599a008; Si K, 2012, NAT PHOTONICS, V6, P657, DOI [10.1038/nphoton.2012.205, 10.1038/NPHOTON.2012.205]; Sinefeld D, 2015, OPT EXPRESS, V23, P31472, DOI 10.1364/OE.23.031472; WARD WW, 1978, PHOTOCHEM PHOTOBIOL, V27, P389, DOI 10.1111/j.1751-1097.1978.tb07621.x; Welf ES, 2016, DEV CELL, V36, P462, DOI 10.1016/j.devcel.2016.01.022; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yang J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064849; Yasuda R, 2006, NAT NEUROSCI, V9, P283, DOI 10.1038/nn1635; Yasuda R, 2006, CURR OPIN NEUROBIOL, V16, P551, DOI 10.1016/j.conb.2006.08.012; Zhao H, 2005, J BIOMED OPT, V10, DOI 10.1117/1.2032388	62	139	145	2	112	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUL	2016	34	7					760	+		10.1038/nbt.3550	http://dx.doi.org/10.1038/nbt.3550			11	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DT2TT	27240196	Green Accepted			2022-12-25	WOS:000381335400031
J	Morton, NM; Beltram, J; Carter, RN; Michailidou, Z; Gorjanc, G; McFadden, C; Barrios-Llerena, ME; Rodriguez-Cuenca, S; Gibbins, MTG; Aird, RE; Moreno-Navarrete, JM; Munger, SC; Svenson, KL; Gastaldello, A; Ramage, L; Naredo, G; Zeyda, M; Wang, ZV; Howie, AF; Saari, A; Sipila, P; Stulnig, TM; Gudnason, V; Kenyon, CJ; Seckl, JR; Walker, BR; Webster, SP; Dunbar, DR; Churchill, GA; Vidal-Puig, A; Fernandez-Real, JM; Emilsson, V; Horvat, S				Morton, Nicholas M.; Beltram, Jasmina; Carter, Roderick N.; Michailidou, Zoi; Gorjanc, Gregor; McFadden, Clare; Barrios-Llerena, Martin E.; Rodriguez-Cuenca, Sergio; Gibbins, Matthew T. G.; Aird, Rhona E.; Maria Moreno-Navarrete, Jose; Munger, Steven C.; Svenson, Karen L.; Gastaldello, Annalisa; Ramage, Lynne; Naredo, Gregorio; Zeyda, Maximilian; Wang, Zhao V.; Howie, Alexander F.; Saari, Aila; Sipila, Petra; Stulnig, Thomas M.; Gudnason, Vilmundur; Kenyon, Christopher J.; Seckl, Jonathan R.; Walker, Brian R.; Webster, Scott P.; Dunbar, Donald R.; Churchill, Gary A.; Vidal-Puig, Antonio; Manuel Fernandez-Real, Jose; Emilsson, Valur; Horvat, Simon			Genetic identification of thiosulfate sulfurtransferase as an adipocyte-expressed antidiabetic target in mice selected for leanness	NATURE MEDICINE			English	Article							ADIPOSE-TISSUE; INSULIN-RESISTANCE; OBESITY; RHODANESE; FAT; DIFFERENTIATION; DEHYDROGENASE; PREVALENCE; VARIANTS; CAPACITY	The discovery of genetic mechanisms for resistance to obesity and diabetes may illuminate new therapeutic strategies for the treatment of this global health challenge. We used the polygenic 'lean' mouse model, which has been selected for low adiposity over 60 generations, to identify mitochondrial thiosulfate sulfurtransferase (Tst; also known as rhodanese) as a candidate obesity resistance gene with selectively increased expression in adipocytes. Elevated adipose Tst expression correlated with indices of metabolic health across diverse mouse strains. Transgenic overexpression of Tst in adipocytes protected mice from diet-induced obesity and insulin-resistant diabetes. Tst-deficient mice showed markedly exacerbated diabetes, whereas pharmgcological activation of TST ameliorated diabetes in mice. Mechanistically, TST selectively augmented mitochondrial function combined with degradation of reactive oxygen species and sulfide. In humans, TST mRNA expression in adipose tissue correlated positively with insulin sensitivity in adipose tissue and negatively with fat mass. Thus, the genetic identification of Tst as a beneficial regulator of adipocyte mitochondrial function may have therapeutic significance for individuals with type 2 diabetes.	[Morton, Nicholas M.; Carter, Roderick N.; Michailidou, Zoi; McFadden, Clare; Barrios-Llerena, Martin E.; Gibbins, Matthew T. G.; Aird, Rhona E.; Gastaldello, Annalisa; Ramage, Lynne; Naredo, Gregorio; Kenyon, Christopher J.; Seckl, Jonathan R.; Walker, Brian R.; Webster, Scott P.; Dunbar, Donald R.] Univ Edinburgh, Univ British Heart Fdn Ctr Cardiovasc Sci, Queens Med Res Inst, Edinburgh, Midlothian, Scotland; [Beltram, Jasmina; Gorjanc, Gregor; Horvat, Simon] Univ Ljubljana, Dept Anim Sci, Biotech Fac, Ljubljana, Slovenia; [Rodriguez-Cuenca, Sergio; Vidal-Puig, Antonio] Wellcome Trust MRC Inst Metab Sci, Addenbrookes Hosp, Metab Res Labs, Level 4, Cambridge, England; [Maria Moreno-Navarrete, Jose; Manuel Fernandez-Real, Jose] Inst Invest Biomed Girona, Dept Diabet Endocrinol & Nutr, Girona, Spain; [Maria Moreno-Navarrete, Jose; Manuel Fernandez-Real, Jose] Univ Girona, Dept Med, Girona, Spain; [Maria Moreno-Navarrete, Jose; Manuel Fernandez-Real, Jose] Inst Salud Carlos III, Ctr Invest Biomed Red Fisiopatol Obesidad & Nutr, Girona, Spain; [Munger, Steven C.; Svenson, Karen L.; Churchill, Gary A.] Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA; [Zeyda, Maximilian; Stulnig, Thomas M.] Med Univ Vienna, Clin Div Endocrinol & Metab, Dept Med 3, Vienna, Austria; [Wang, Zhao V.] Univ Texas Southwestern Med Ctr, Touchstone Diabet Ctr, Dept Internal Med, Dallas, TX USA; [Howie, Alexander F.] Univ Edinburgh, Queens Med Res Inst, Med Res Council MRC Ctr Reprod Hlth, Edinburgh, Midlothian, Scotland; [Saari, Aila] Univ Turku, Inst Biomed, Dept Physiol, Turku, Finland; [Sipila, Petra] Univ Turku, Cent Anim Lab, Turku, Finland; [Gudnason, Vilmundur; Emilsson, Valur] Iceland Heart Assoc, Kopavogur, Iceland; [Vidal-Puig, Antonio] Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge, England; [Emilsson, Valur] Univ Iceland, Fac Pharmaceut Sci, Reykjavik, Iceland; [Horvat, Simon] Natl Inst Chem, Ljubljana, Slovenia	University of Edinburgh; University of Ljubljana; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Universitat de Girona; Girona University Hospital Dr. Josep Trueta; Institut d'Investigacio Biomedica de Girona (IDIBGI); Universitat de Girona; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; Jackson Laboratory; Medical University of Vienna; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Edinburgh; University of Turku; University of Turku; Icelandic Heart Association; Wellcome Trust Sanger Institute; University of Iceland; National Institute of Chemistry - Slovenia	Morton, NM (corresponding author), Univ Edinburgh, Univ British Heart Fdn Ctr Cardiovasc Sci, Queens Med Res Inst, Edinburgh, Midlothian, Scotland.; Horvat, S (corresponding author), Univ Ljubljana, Dept Anim Sci, Biotech Fac, Ljubljana, Slovenia.; Horvat, S (corresponding author), Natl Inst Chem, Ljubljana, Slovenia.	nik.morton@ed.ac.uk; simon.horvat@bf.uni-lj.si	Gorjanc, Gregor/D-3684-2014; Gastaldello, Annalisa/AAV-1629-2021; Gudnason, Vilmundur/AAE-7126-2019; Barrios-LLerena, Martin/AAM-8152-2020; Churchill, Gary/AAY-7496-2020; Fernández-Real, Jose Manuel/AGH-3599-2022; Morton, NICHOLAS/ABF-3774-2020; Moreno-Navarrete, José María/ABG-5548-2021; Sipilä, Petra/GYE-3323-2022; Moreno-Navarrete, José María/H-9772-2015; Gastaldello, Annalisa/H-9108-2019	Gorjanc, Gregor/0000-0001-8008-2787; Gudnason, Vilmundur/0000-0001-5696-0084; Churchill, Gary/0000-0001-9190-9284; Fernández-Real, Jose Manuel/0000-0002-7442-9323; Moreno-Navarrete, José María/0000-0002-2883-511X; Moreno-Navarrete, José María/0000-0002-2883-511X; Gastaldello, Annalisa/0000-0002-4365-1191; Vidal-Puig, Antonio/0000-0003-4220-9577; Emilsson, Valur/0000-0001-9982-0524; Sipila, Petra/0000-0001-8187-7143; Stulnig, Thomas/0000-0003-3300-6161; Zeyda, Maximilian/0000-0001-5000-1974; Barrios-LLerena, Martin/0000-0002-1416-8686; Webster, Scott/0000-0003-4656-4744	Wellcome Trust [100981/Z/13/Z]; Research Councils UK Fellowship; British Heart Foundation Centre of Research Excellence exchange award; Slovenian Research Agency [P4-0220, N5-0003 Syntol, J4-6804]; British Heart Foundation Research Excellence Award; Federal Ministry of Economy, Family and Youth; Austrian National Foundation for Research, Technology and Development; US National Institutes of Health [R01GM 070683]; FIS [PI11/00214]; UK Medical Research Council (MRC) MDU; MRC Programme grant; MRC DMC Core; MITIN [HEALTH-F4-2008-223450]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [F32HD074299] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA034196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM076468, R01GM070683] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BB/J009865/1] Funding Source: researchfish; Medical Research Council [G0400192, G0600717, MC_UU_12012/5, MC_UU_12012/5/B, G0802051, MC_G0802535, MC_UU_12012/2] Funding Source: researchfish; BBSRC [BB/J009865/1] Funding Source: UKRI; MRC [MC_UU_12012/2, MC_UU_12012/5, MC_G0802535, G0802051, G0400192, G0600717] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Research Councils UK Fellowship(UK Research & Innovation (UKRI)); British Heart Foundation Centre of Research Excellence exchange award; Slovenian Research Agency(Slovenian Research Agency - Slovenia); British Heart Foundation Research Excellence Award; Federal Ministry of Economy, Family and Youth; Austrian National Foundation for Research, Technology and Development; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FIS(Instituto de Salud Carlos III); UK Medical Research Council (MRC) MDU(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC Programme grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC DMC Core(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MITIN; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	N.M.M. was supported by a Career Development Fellowship, an Institutional Strategic Support Fund award and a New Investigator Award from the Wellcome Trust (100981/Z/13/Z), a Research Councils UK Fellowship and a British Heart Foundation Centre of Research Excellence exchange award. We thank the Slovenian Research Agency for support (core funding P4-0220; project N5-0003 Syntol and J4-6804; all to S.H.) and for a Young Scientist Fellowship (J.B.). We acknowledge support of the British Heart Foundation Research Excellence Award in support of the contribution by the Bioinformatics Core (D.R.D.). T.M.S. received funding from the Federal Ministry of Economy, Family and Youth and from the Austrian National Foundation for Research, Technology and Development. G.A.C. was supported by the US National Institutes of Health grant R01GM 070683. J.M.F.-R. acknowledges funding from FIS PI11/00214. A.V.-P. was funded by the UK Medical Research Council (MRC) MDU, an MRC Programme grant, MRC DMC Core and MITIN (HEALTH-F4-2008-223450). We thank M. Wabitsch (University of Ulm) for the gift of the SGBS human preadipocyte cell line.	BONOMI F, 1977, EUR J BIOCHEM, V72, P17, DOI 10.1111/j.1432-1033.1977.tb11219.x; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Feng XJ, 2009, BIOCHEM BIOPH RES CO, V380, P153, DOI 10.1016/j.bbrc.2009.01.059; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Gauss KA, 2003, FASEB J, V17, pC97; Geng B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073892; Hall AH, 2009, CRIT REV TOXICOL, V39, P541, DOI 10.1080/10408440802304944; Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361; Hawley SA, 2012, SCIENCE, V336, P918, DOI 10.1126/science.1215327; Hawley SA, 2010, CELL METAB, V11, P554, DOI 10.1016/j.cmet.2010.04.001; Held IM, 2010, NAT GENET, V42, P949; Herman MA, 2012, NATURE, V484, P333, DOI 10.1038/nature10986; Horvat S, 2000, MAMM GENOME, V11, P2, DOI 10.1007/s003350010002; Jacquemont S, 2011, NATURE, V478, P97, DOI 10.1038/nature10406; Kilpelainen TO, 2011, NAT GENET, V43, P753, DOI 10.1038/ng.866; Koh EH, 2007, DIABETES, V56, P2973, DOI 10.2337/db07-0510; Kusminski CM, 2012, NAT MED, V18, P1539, DOI 10.1038/nm.2899; Ljungvall A, 2012, SOC SCI MED, V75, P109, DOI 10.1016/j.socscimed.2012.03.003; Loos RJF, 2011, EUR J PHARMACOL, V660, P156, DOI 10.1016/j.ejphar.2011.01.033; Moreno-Navarrete JM, 2013, DIABETES, V62, P1923, DOI 10.2337/db12-0977; Mathes WF, 2011, BRIT J NUTR, V106, pS1, DOI 10.1017/S0007114511001905; Morton NM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023944; Morton NM, 2005, DIABETES, V54, P3371, DOI 10.2337/diabetes.54.12.3371; Nandi DL, 2000, INT J BIOCHEM CELL B, V32, P465, DOI 10.1016/S1357-2725(99)00035-7; PAGANI S, 1983, BIOCHIM BIOPHYS ACTA, V742, P278, DOI 10.1016/0167-4838(83)90312-6; Prevorsek Z, 2010, MAMM GENOME, V21, P172, DOI 10.1007/s00335-010-9252-z; Rung J, 2009, NAT GENET, V41, P1110, DOI 10.1038/ng.443; Sabelli R, 2008, FEBS J, V275, P3884, DOI 10.1111/j.1742-4658.2008.06535.x; Sen U, 2008, PHARMACOLOGY, V82, P201, DOI 10.1159/000156486; Simoncic M, 2008, BEHAV GENET, V38, P292, DOI 10.1007/s10519-008-9199-y; Smemo S, 2014, NATURE, V507, P371, DOI 10.1038/nature13138; Smirnov A, 2010, J BIOL CHEM, V285, P30792, DOI 10.1074/jbc.M110.151183; Soloveva V, 1997, MOL ENDOCRINOL, V11, P27, DOI 10.1210/me.11.1.27; Svenson KL, 2012, GENETICS, V190, P437, DOI 10.1534/genetics.111.132597; Tiranti V, 2009, NAT MED, V15, P200, DOI 10.1038/nm.1907; Tormos KV, 2011, CELL METAB, V14, P537, DOI 10.1016/j.cmet.2011.08.007; Vernochet C, 2012, CELL METAB, V16, P765, DOI 10.1016/j.cmet.2012.10.016; Vigouroux C, 2011, INT J BIOCHEM CELL B, V43, P862, DOI 10.1016/j.biocel.2011.03.002; Wabitsch M, 2001, INT J OBESITY, V25, P8, DOI 10.1038/sj.ijo.0801520; Wang R, 2012, PHYSIOL REV, V92, P791, DOI 10.1152/physrev.00017.2011; Wang ZV, 2010, ENDOCRINOLOGY, V151, P2933, DOI 10.1210/en.2010-0136; WESTLEY J, 1973, ADV ENZYMOL RAMB, V39, P327; Xu AM, 2003, J CLIN INVEST, V112, P91, DOI 10.1172/JCI200317797; Yanovski SZ, 2011, NEW ENGL J MED, V364, P987, DOI 10.1056/NEJMp1009229; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	45	40	40	0	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2016	22	7					771	779		10.1038/nm.4115	http://dx.doi.org/10.1038/nm.4115			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DQ7DK	27270587	Green Accepted			2022-12-25	WOS:000379366900016
J	Rennekamp, AJ; Huang, XP; Wang, Y; Patel, S; Lorello, PJ; Cade, L; Gonzales, APW; Yeh, JRJ; Caldarone, BJ; Roth, BL; Kokel, D; Peterson, RT				Rennekamp, Andrew J.; Huang, Xi-Ping; Wang, You; Patel, Samir; Lorello, Paul J.; Cade, Lindsay; Gonzales, Andrew P. W.; Yeh, Jing-Ruey Joanna; Caldarone, Barbara J.; Roth, Bryan L.; Kokel, David; Peterson, Randall T.			sigma(1) receptor ligands control a switch between passive and active threat responses	NATURE CHEMICAL BIOLOGY			English	Article							DANIO-RERIO RESPONDS; DEPRESSIVE-LIKE; KNOCKOUT MICE; ZEBRAFISH; MODULATION; AGONISTS; AMYGDALA; ANXIETY; SYSTEMS; STRESS	Humans and many animals show 'freezing' behavior in response to threatening stimuli. In humans, inappropriate threat responses are fundamental characteristics of several mental illnesses. To identify small molecules that modulate threat responses, we developed a high-throughput behavioral assay in zebrafish (Danio rerio) and evaluated 10,000 compounds for their effects on freezing behavior. We found three classes of compounds that switch the threat response from freezing to escape-like behavior. We then screened these for binding activity across 45 candidate targets. Using target profile clustering, we identified the sigma-1 (sigma(1)) receptor as having a role in the mechanism of behavioral switching and confirmed that known ligands also disrupt freezing behavior. Furthermore, mutation of the gene encoding sigma(1) prevented the behavioral effect of escape-inducing compounds. One compound, which we call finazine, potently bound mammalian sigma(1) and altered threat-response behavior in mice. Thus, pharmacological and genetic interrogation of the freezing response revealed sigma(1) as a mediator of threat responses in vertebrates.	[Rennekamp, Andrew J.; Wang, You; Patel, Samir; Cade, Lindsay; Gonzales, Andrew P. W.; Yeh, Jing-Ruey Joanna; Peterson, Randall T.] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Charlestown, MA USA; [Rennekamp, Andrew J.; Wang, You; Patel, Samir; Cade, Lindsay; Gonzales, Andrew P. W.; Yeh, Jing-Ruey Joanna; Peterson, Randall T.] Massachusetts Gen Hosp, Dept Med, Charlestown, MA USA; [Rennekamp, Andrew J.; Wang, You; Patel, Samir; Cade, Lindsay; Gonzales, Andrew P. W.; Yeh, Jing-Ruey Joanna; Peterson, Randall T.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Rennekamp, Andrew J.; Wang, You; Patel, Samir; Cade, Lindsay; Gonzales, Andrew P. W.; Peterson, Randall T.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA USA; [Rennekamp, Andrew J.; Wang, You; Patel, Samir; Cade, Lindsay; Gonzales, Andrew P. W.; Peterson, Randall T.] Broad Inst, Cambridge, MA USA; [Huang, Xi-Ping; Roth, Bryan L.] Univ N Carolina, NIMH, Psychoact Drug Screening Program, Chapel Hill, NC USA; [Huang, Xi-Ping; Roth, Bryan L.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC USA; [Lorello, Paul J.; Caldarone, Barbara J.] Brigham & Womens Hosp, Neurobehav Lab, Harvard NeuroDiscovery Ctr, 75 Francis St, Boston, MA 02115 USA; [Lorello, Paul J.; Caldarone, Barbara J.] Brigham & Womens Hosp, Dept Neurol, 75 Francis St, Boston, MA 02115 USA; [Roth, Bryan L.] Univ N Carolina, Eshelman Sch Pharm, Div Chem Biol & Med Chem, Chapel Hill, NC USA; [Kokel, David] Univ Calif San Francisco, Dept Physiol, Box 0444, San Francisco, CA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; University of North Carolina; University of North Carolina Chapel Hill; University of California System; University of California San Francisco	Peterson, RT (corresponding author), Massachusetts Gen Hosp, Cardiovasc Res Ctr, Charlestown, MA USA.; Peterson, RT (corresponding author), Massachusetts Gen Hosp, Dept Med, Charlestown, MA USA.; Peterson, RT (corresponding author), Harvard Univ, Sch Med, Dept Med, Boston, MA USA.; Peterson, RT (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA USA.; Peterson, RT (corresponding author), Broad Inst, Cambridge, MA USA.	peterson@cvrc.mgh.harvard.edu	Roth, Bryan L/F-3928-2010; Roth, Bryan/ABE-7032-2020	Roth, Bryan/0000-0002-0561-6520; Rennekamp, Andrew/0000-0001-6174-7253; Peterson, Randall/0000-0003-0727-3469; Yeh, Jing-Ruey Joanna/0000-0002-7768-4901; Huang, Xi-Ping/0000-0002-2585-653X	US National Institutes of Health (NIH) Psychoactive Drug Screening Program [HHSN-271-2008-025C]; NIH [T32 HL 007208, R01 MH 086867, R01 GM 088040, U01 MH 105027]; Charles and Ann Sanders MGH Research Scholar Award; Harvard NeuroDiscovery Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007208] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088040] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH105027, R01MH086867] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA022583] Funding Source: NIH RePORTER	US National Institutes of Health (NIH) Psychoactive Drug Screening Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Charles and Ann Sanders MGH Research Scholar Award; Harvard NeuroDiscovery Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	We thank C. Brady, J.J. Colund, I.T. Helenius, Y.N. Jin and A. Nath for helpful comments. Receptor binding profiles and K<INF>i</INF> data were provided by the US National Institutes of Health (NIH) Psychoactive Drug Screening Program, contract HHSN-271-2008-025C. This work was supported by NIH grants T32 HL 007208 (A.J.R.), R01 MH 086867 (R.T.P.), R01 GM 088040 (R.T.P.) and U01 MH 105027 (D.K. and J.-R.J.Y.); the Charles and Ann Sanders MGH Research Scholar Award (R.T.P.); and the Harvard NeuroDiscovery Center.	Adolphs R, 2013, CURR BIOL, V23, pR79, DOI 10.1016/j.cub.2012.11.055; Antoniadis EA, 2001, EXP BRAIN RES, V138, P200, DOI 10.1007/s002210000645; Backman TWH, 2011, NUCLEIC ACIDS RES, V39, pW486, DOI 10.1093/nar/gkr320; Bass SLS, 2008, BEHAV BRAIN RES, V186, P107, DOI 10.1016/j.bbr.2007.07.037; Besnard J, 2012, NATURE, V492, P215, DOI 10.1038/nature11691; Brewin CR, 2007, PROG BRAIN RES, V167, P217, DOI 10.1016/S0079-6123(07)67015-0; Bruni G, 2016, NAT CHEM BIOL, V12, P559, DOI [10.1038/NCHEMBIO.2097, 10.1038/nchembio.2097]; Bullen CR, 2003, REV FISH BIOL FISHER, V13, P201, DOI 10.1023/B:RFBF.0000019481.10670.94; Burgess HA, 2007, J EXP BIOL, V210, P2526, DOI 10.1242/jeb.003939; Chevallier N, 2011, J PSYCHOPHARMACOL, V25, P960, DOI 10.1177/0269881111400648; Colwill RM, 2011, REV NEUROSCIENCE, V22, P63, DOI 10.1515/RNS.2011.008; DECOSTA BR, 1989, FEBS LETT, V251, P53, DOI 10.1016/0014-5793(89)81427-9; Emran F, 2010, P NATL ACAD SCI USA, V107, P6034, DOI 10.1073/pnas.0914718107; Emran Farida, 2008, J Vis Exp, DOI 10.3791/923; Fishback JA, 2010, PHARMACOL THERAPEUT, V127, P271, DOI 10.1016/j.pharmthera.2010.04.003; Gerlai R, 2009, BEHAV BRAIN RES, V201, P318, DOI 10.1016/j.bbr.2009.03.003; Hartley CA, 2012, BIOL PSYCHIAT, V72, P113, DOI 10.1016/j.biopsych.2011.12.027; Hwang Woong Y, 2015, Methods Mol Biol, V1311, P317, DOI 10.1007/978-1-4939-2687-9_21; Hyman SE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003142; Kamei H, 1996, EUR J PHARMACOL, V299, P21, DOI 10.1016/0014-2999(95)00830-6; Kishimoto A, 2012, BIOL PSYCHIAT, V71, pE7, DOI 10.1016/j.biopsych.2011.10.014; Laviolette SR, 2007, SCHIZOPHRENIA BULL, V33, P971, DOI 10.1093/schbul/sbm048; Lever JR, 2006, SYNAPSE, V59, P350, DOI 10.1002/syn.20253; Matsuno K, 1996, EUR J PHARMACOL, V312, P267, DOI 10.1016/0014-2999(96)00497-9; Moritz C, 2015, NEUROSCI LETT, V591, P13, DOI 10.1016/j.neulet.2015.02.004; Paradiso S, 2003, AM J PSYCHIAT, V160, P1775, DOI 10.1176/appi.ajp.160.10.1775; Reddy DS, 1998, NEUROREPORT, V9, P3069, DOI 10.1097/00001756-199809140-00028; Rennekamp AJ, 2015, CURR OPIN CHEM BIOL, V24, P58, DOI 10.1016/j.cbpa.2014.10.025; Rosen Jeffrey B, 2004, Behav Cogn Neurosci Rev, V3, P23, DOI 10.1177/1534582304265945; Sabino V, 2009, BEHAV BRAIN RES, V198, P472, DOI 10.1016/j.bbr.2008.11.036; Sasaki T, 2013, PSYCHOTHER PSYCHOSOM, V82, P344, DOI 10.1159/000348585; Speedie N, 2008, BEHAV BRAIN RES, V188, P168, DOI 10.1016/j.bbr.2007.10.031; Urani A, 2001, J PHARMACOL EXP THER, V298, P1269; WALKER JM, 1990, PHARMACOL REV, V42, P355; Wang JJ, 2007, EUR NEUROPSYCHOPHARM, V17, P708, DOI 10.1016/j.euroneuro.2007.02.007; Williams LM, 2004, AM J PSYCHIAT, V161, P480, DOI 10.1176/appi.ajp.161.3.480; Yeh CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079406	37	26	27	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUL	2016	12	7					552	+		10.1038/NCHEMBIO.2089	http://dx.doi.org/10.1038/NCHEMBIO.2089			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9EP	27239788	Green Accepted, Green Submitted			2022-12-25	WOS:000378087500016
J	Lamas, B; Richard, ML; Leducq, V; Pham, HP; Michel, ML; Da Costa, G; Bridonneau, C; Jegou, S; Hoffmann, TW; Natividad, JM; Brot, L; Taleb, S; Couturier-Maillard, A; Nion-Larmurier, I; Merabtene, F; Seksik, P; Bourrier, A; Cosnes, J; Ryffel, B; Beaugerie, L; Launay, JM; Langella, P; Xavier, RJ; Sokol, H				Lamas, Bruno; Richard, Mathias L.; Leducq, Valentin; Pham, Hang-Phuong; Michel, Marie-Laure; Da Costa, Gregory; Bridonneau, Chantal; Jegou, Sarah; Hoffmann, Thomas W.; Natividad, Jane M.; Brot, Loic; Taleb, Soraya; Couturier-Maillard, Aurelie; Nion-Larmurier, Isabelle; Merabtene, Fatiha; Seksik, Philippe; Bourrier, Anne; Cosnes, Jacques; Ryffel, Bernhard; Beaugerie, Laurent; Launay, Jean-Marie; Langella, Philippe; Xavier, Ramnik J.; Sokol, Harry			CARD9 impacts colitis by altering gut microbiota metabolism of tryptophan into aryl hydrocarbon receptor ligands	NATURE MEDICINE			English	Article							ADAPTER PROTEIN CARD9; BACTERIAL-INFECTION; IL-22; CELLS; RESPONSES; INTERLEUKIN-22; IDENTIFICATION; PREVALENCE; DEFICIENCY; ACTIVATION	Complex interactions between the host and the gut microbiota govern intestinal homeostasis but remain poorly understood. Here we reveal a relationship between gut microbiota and caspase recruitment domain family member 9 (CARD9), a susceptibility gene for inflammatory bowel disease (IBD) that functions in the immune response against microorganisms. CARD9 promotes recovery from colitis by promoting interleukin (IL)-22 production, and Card9(-/-) mice are more susceptible to colitis. The microbiota is altered in Card9(-/-) mice, and transfer of the microbiota from Card9(-/-) to wild-type, germ-free recipients increases their susceptibility to colitis. The microbiota from Card9(-/-) mice fails to metabolize tryptophan into metabolites that act as aryl hydrocarbon receptor (AHR) ligands. Intestinal inflammation is attenuated after inoculation of mice with three Lactobacillus strains capable of metabolizing tryptophan or by treatment with an AHR agonist. Reduced production of AHR ligands is also observed in the microbiota from individuals with IBD, particularly in those with CARD9 risk alleles associated with IBD. Our findings reveal that host genes affect the composition and function of the gut microbiota, altering the production of microbial metabolites and intestinal inflammation.	[Lamas, Bruno; Leducq, Valentin; Jegou, Sarah; Brot, Loic; Sokol, Harry] Univ Paris 06, Sorbonne Univ, Paris, France; [Lamas, Bruno; Leducq, Valentin; Jegou, Sarah; Brot, Loic; Sokol, Harry] INSERM, Avenir Team Gut Microbiota & Immun, Equipe Rech Labelisee ERL 1157, Paris, France; [Lamas, Bruno; Leducq, Valentin; Jegou, Sarah; Brot, Loic; Sokol, Harry] CNRS, Unite Mixte Rech UMR 7203, Paris, France; [Lamas, Bruno; Leducq, Valentin; Jegou, Sarah; Brot, Loic; Sokol, Harry] Ctr Hosp Univ CHU St Antoine, Lab BioMol LBM, 27 Rue Chaligny, Paris, France; [Lamas, Bruno; Richard, Mathias L.; Michel, Marie-Laure; Da Costa, Gregory; Bridonneau, Chantal; Hoffmann, Thomas W.; Natividad, Jane M.; Langella, Philippe; Sokol, Harry] Univ Paris Saclay, Micalis Inst, INRA, AgroParisTech, Jouy En Josas, France; [Lamas, Bruno; Richard, Mathias L.; Leducq, Valentin; Michel, Marie-Laure; Da Costa, Gregory; Bridonneau, Chantal; Jegou, Sarah; Hoffmann, Thomas W.; Natividad, Jane M.; Brot, Loic; Langella, Philippe; Sokol, Harry] Inflammat Immunopathol Biotherapy Dept DHU i2B, Paris, France; [Pham, Hang-Phuong] Hop La Pitie Salpetriere, ILTOO Pharma Incubateur & Pepiniere Entreprises P, Paris, France; [Taleb, Soraya] INSERM, Paris Cardiovasc Res Ctr, U970, Paris, France; [Taleb, Soraya] Univ Paris 05, Paris, France; [Couturier-Maillard, Aurelie; Ryffel, Bernhard] Univ Orleans, CNRS, Lab Expt & Mol Immunol & Neurogenet, UMR 7355, Orleans, France; [Nion-Larmurier, Isabelle; Seksik, Philippe; Bourrier, Anne; Cosnes, Jacques; Beaugerie, Laurent; Sokol, Harry] UPMC, St Antoine Hosp, AP HP, Dept Gastroenterol, Paris, France; [Merabtene, Fatiha] INSERM, Ctr Rech St Antoine, Plateforme Morphol Petit Anim, UMR S938, Paris, France; [Ryffel, Bernhard] Univ Cape Town, Inst Infect Dis & Mol Med IDM, ZA-7925 Cape Town, South Africa; [Launay, Jean-Marie] Hop Lariboisiere, INSERM, Dept Biochem, UMR S942, F-75475 Paris, France; [Launay, Jean-Marie] Hop Lariboisiere, Ctr Biol Resources BB 0033 00064, F-75475 Paris, France; [Xavier, Ramnik J.] Broad Inst Massachusetts Inst Technol MIT & Harva, Cambridge, MA USA; [Xavier, Ramnik J.] Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Boston, MA 02114 USA; [Xavier, Ramnik J.] Harvard Univ, Sch Med, Boston, MA USA; [Xavier, Ramnik J.] Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA; [Xavier, Ramnik J.] Massachusetts Gen Hosp, Ctr Study Inflammatory Bowel Dis, Boston, MA 02114 USA; [Xavier, Ramnik J.] MIT, Ctr Microbiome Informat & Therapeut, 77 Massachusetts Ave, Cambridge, MA 02139 USA	UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Sorbonne Universite; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Orleans; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; University of Cape Town; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT)	Sokol, H (corresponding author), Univ Paris 06, Sorbonne Univ, Paris, France.; Sokol, H (corresponding author), INSERM, Avenir Team Gut Microbiota & Immun, Equipe Rech Labelisee ERL 1157, Paris, France.; Sokol, H (corresponding author), CNRS, Unite Mixte Rech UMR 7203, Paris, France.; Sokol, H (corresponding author), Ctr Hosp Univ CHU St Antoine, Lab BioMol LBM, 27 Rue Chaligny, Paris, France.; Sokol, H (corresponding author), Univ Paris Saclay, Micalis Inst, INRA, AgroParisTech, Jouy En Josas, France.; Sokol, H (corresponding author), Inflammat Immunopathol Biotherapy Dept DHU i2B, Paris, France.; Sokol, H (corresponding author), UPMC, St Antoine Hosp, AP HP, Dept Gastroenterol, Paris, France.	harry.sokol@aphp.fr	SEKSIK, Philippe/ABE-2962-2020; Taleb, Soraya/K-8176-2017; Sokol, Harry/E-2290-2019; Langella, Philippe/N-8368-2017; sokol, harry/ABA-8991-2020; Richard, Mathias L./GRR-7524-2022	Taleb, Soraya/0000-0002-6650-619X; Sokol, Harry/0000-0002-2914-1822; Langella, Philippe/0000-0001-5960-4341; sokol, harry/0000-0002-2914-1822; Richard, Mathias L./0000-0002-9256-8191; Michel, Marie-Laure/0000-0003-2657-4662; DA COSTA, Gregory/0000-0003-1436-916X; , blamas/0000-0002-7777-2127; SEKSIK, Philippe/0000-0003-3596-9893; PHAM, Hang-Phuong/0000-0002-7896-7401	Equipe ATIP-Avenir; INSERM-ITMO SP; ECCO grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351] Funding Source: NIH RePORTER	Equipe ATIP-Avenir; INSERM-ITMO SP; ECCO grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank the members of the ANAXEM germ-free platform, the members of the animal facilities of INRA, and T. Ledent of the animal facilities of Saint-Antoine Hospital for their assistance in mouse care; M. Moroldo and J. Lecardonnel from the CRB GADIE core facility for technical assistance in performing the microarray analyses; S. Dumont for technical help in histology and immunochemistry; and C. Aubry, N.M. Breyner, F. Chain, S. Le Guin, C. Cherbuy, N. Lapaque, and D. Skurnik for fruitful discussions and technical help. We also thank E. Drouet and the Clinical Research Assistant team of Unite de Recherche Clinique de l'Est Parisien for their help in obtaining samples from patients with IBD. Ido1<SUP>-/-</SUP> and Il22<SUP>-/-</SUP> mice were provided by S. Taleb (INSERM Unit 970) and B. Ryffel (CNRS, UMR7355), respectively. The H1L1.1c2 cell line was provided by M.S. Denison (University of California, Davis). Funding was provided by Equipe ATIP-Avenir 2012 (H.S.), INSERM-ITMO SP 2013 (H.S.) and ECCO grant 2012 (H.S.).	Ananthakrishnan AN, 2015, NAT REV GASTRO HEPAT, V12, P205, DOI 10.1038/nrgastro.2015.34; Andoh A, 2005, GASTROENTEROLOGY, V129, P969, DOI 10.1053/j.gastro.2005.06.071; Atarashi K, 2013, NATURE, V500, P232, DOI 10.1038/nature12331; Silva MJB, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/321241; Behnsen J, 2014, IMMUNITY, V40, P262, DOI 10.1016/j.immuni.2014.01.003; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chung KT, 2011, ENVIRON MOL MUTAGEN, V52, P81, DOI 10.1002/em.20588; Darfeuille-Michaud A, 2004, GASTROENTEROLOGY, V127, P412, DOI 10.1053/j.gastro.2004.04.061; De Luca A, 2010, MUCOSAL IMMUNOL, V3, P361, DOI 10.1038/mi.2010.22; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Gao XF, 2009, ANAL BIOCHEM, V393, P163, DOI 10.1016/j.ab.2009.06.036; Goodridge HS, 2009, J IMMUNOL, V182, P1146, DOI 10.4049/jimmunol.182.2.1146; Hara H, 2008, J IMMUNOL, V181, P918, DOI 10.4049/jimmunol.181.2.918; Hara H, 2007, NAT IMMUNOL, V8, P619, DOI 10.1038/ni1466; He GC, 2011, ENVIRON TOXICOL CHEM, V30, P1915, DOI 10.1002/etc.581; Hsu YMS, 2007, NAT IMMUNOL, V8, P198, DOI 10.1038/ni1426; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Iliev ID, 2012, SCIENCE, V336, P1314, DOI 10.1126/science.1221789; Ishigame H, 2009, IMMUNITY, V30, P108, DOI 10.1016/j.immuni.2008.11.009; Jin UH, 2014, MOL PHARMACOL, V85, P777, DOI 10.1124/mol.113.091165; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kim K, 2014, CARCINOGENESIS, V35, P1352, DOI 10.1093/carcin/bgu044; Koljalg U, 2013, MOL ECOL, V22, P5271, DOI 10.1111/mec.12481; Lanternier F, 2015, J ALLERGY CLIN IMMUN, V135, P1558, DOI 10.1016/j.jaci.2014.12.1930; Lee JS, 2012, NAT IMMUNOL, V13, P144, DOI 10.1038/ni.2187; Lin L, 2013, CURR MICROBIOL, V67, P209, DOI 10.1007/s00284-013-0348-z; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Maneglier B, 2004, CLIN CHEM, V50, P2166, DOI 10.1373/clinchem.2004.037465; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Molodecky NA, 2012, GASTROENTEROLOGY, V142, P46, DOI 10.1053/j.gastro.2011.10.001; Pickert G, 2009, J EXP MED, V206, P1465, DOI 10.1084/jem.20082683; Richard ML, 2015, INFLAMM BOWEL DIS, V21, P656, DOI 10.1097/MIB.0000000000000261; Rutz S, 2013, IMMUNOL REV, V252, P116, DOI 10.1111/imr.12027; Sabat R, 2014, NAT REV DRUG DISCOV, V13, P21, DOI 10.1038/nrd4176; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Sokol H, 2013, GASTROENTEROLOGY, V145, P591, DOI 10.1053/j.gastro.2013.05.047; Sonnenberg GF, 2011, NAT IMMUNOL, V12, P383, DOI 10.1038/ni.2025; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Stelter C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020749; Suau A, 1999, APPL ENVIRON MICROB, V65, P4799; Thioulouse J, 1997, STAT COMPUT, V7, P75, DOI 10.1023/A:1018513530268; Tomas J, 2013, FASEB J, V27, P645, DOI 10.1096/fj.12-216861; Wikoff WR, 2009, P NATL ACAD SCI USA, V106, P3698, DOI 10.1073/pnas.0812874106; Wu WH, 2009, NAT IMMUNOL, V10, P1208, DOI 10.1038/ni.1788; Zelante T, 2013, IMMUNITY, V39, P372, DOI 10.1016/j.immuni.2013.08.003; Zenewicz LA, 2013, J IMMUNOL, V190, P5306, DOI 10.4049/jimmunol.1300016; Zhao B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056860	52	685	731	28	293	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2016	22	6					598	+		10.1038/nm.4102	http://dx.doi.org/10.1038/nm.4102			12	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DO0NQ	27158904	Green Accepted			2022-12-25	WOS:000377476000012
J	Saheki, Y; Bian, X; Schauder, CM; Sawaki, Y; Surma, MA; Klose, C; Pincet, F; Reinisch, KM; De Camilli, P				Saheki, Yasunori; Bian, Xin; Schauder, Curtis M.; Sawaki, Yujin; Surma, Michal A.; Klose, Christian; Pincet, Frederic; Reinisch, Karin M.; De Camilli, Pietro			Control of plasma membrane lipid homeostasis by the extended synaptotagmins	NATURE CELL BIOLOGY			English	Article							ORGANELLE CONTACT SITES; PROTEIN-KINASE-C; ENDOPLASMIC-RETICULUM; PHOSPHOINOSITIDE METABOLISM; PHOSPHATIDIC-ACID; PHOSPHOLIPASE-C; SMP DOMAINS; CA2+ INFLUX; ER; CELLS	Acute metabolic changes in plasma membrane (PM) lipids, such as those mediating signalling reactions, are rapidly compensated by homeostatic responses whose molecular basis is poorly understood. Here we show that the extended synaptotagmins (E-Syts), endoplasmic reticulum (ER) proteins that function as PtdIns(4,5)P-2- and Ca2+-regulated tethers to the PM, participate in these responses. E-Syts transfer glycerolipids between bilayers in vitro, and this transfer requires Ca2+ and their lipid-harbouring SMP domain. Genome-edited cells lacking E-Syts do not exhibit abnormalities in the major glycerolipids at rest, but exhibit enhanced and sustained accumulation of PM diacylglycerol following PtdIns(4,5)P-2 hydrolysis by PLC activation, which can be rescued by expression of E-Syt1, but not by mutant E-Syt1 lacking the SMP domain. The formation of E-Syt-dependent ER-PM tethers in response to stimuli that cleave PtdIns(4,5)P-2 and elevate Ca2+ may help reverse accumulation of diacylglycerol in the PM by transferring it to the ER for metabolic recycling.	[Saheki, Yasunori; Bian, Xin; Sawaki, Yujin; De Camilli, Pietro] Yale Univ, Sch Med, Dept Neurosci, 333 Cedar St, New Haven, CT 06510 USA; [Saheki, Yasunori; Bian, Xin; Schauder, Curtis M.; Sawaki, Yujin; Pincet, Frederic; Reinisch, Karin M.; De Camilli, Pietro] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA; [Saheki, Yasunori; Bian, Xin; Sawaki, Yujin; De Camilli, Pietro] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA; [Saheki, Yasunori; Bian, Xin; Sawaki, Yujin; De Camilli, Pietro] Yale Univ, Sch Med, Kavli Inst Neurosci, 333 Cedar St, New Haven, CT 06510 USA; [Saheki, Yasunori; Bian, Xin; Sawaki, Yujin; De Camilli, Pietro] Yale Univ, Sch Med, Program Cellular Neurosci Neurodegenerat & Repair, 333 Cedar St, New Haven, CT 06510 USA; [Surma, Michal A.; Klose, Christian] Lipotype GmbH, Tatzberg 47-49, D-01307 Dresden, Germany; [Pincet, Frederic] Univ Paris Diderot, Univ Paris 06, Ecole Normale Super Paris, CNRS,UMR 8550,Lab Phys Stat, 24 Rue Lhomond, F-75005 Paris, France; [Saheki, Yasunori] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore 308232, Singapore	Yale University; Yale University; Howard Hughes Medical Institute; Yale University; Yale University; Yale University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Sorbonne Universite; Universite Paris Cite; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	De Camilli, P (corresponding author), Yale Univ, Sch Med, Dept Neurosci, 333 Cedar St, New Haven, CT 06510 USA.; De Camilli, P (corresponding author), Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA.; De Camilli, P (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA.; De Camilli, P (corresponding author), Yale Univ, Sch Med, Kavli Inst Neurosci, 333 Cedar St, New Haven, CT 06510 USA.; De Camilli, P (corresponding author), Yale Univ, Sch Med, Program Cellular Neurosci Neurodegenerat & Repair, 333 Cedar St, New Haven, CT 06510 USA.	pietro.decamilli@yale.edu	Surma, Michal/B-1955-2016; Saheki, Yasunori/D-5430-2016	Surma, Michal/0000-0001-7833-2214; Saheki, Yasunori/0000-0002-1229-6668; Bian, Xin/0000-0002-5501-0471; Klose, Christian/0000-0003-2853-4533; PINCET, FREDERIC/0000-0002-4243-2157	NIH [R37NS036251, DK45735, DA018343]; Uehara Memorial Foundation; Japan Society for the Promotion of Science; Human Frontier Science Program; NATIONAL CANCER INSTITUTE [P01CA046128] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK045735, R01DK082700] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080616] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS036251] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA018343] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Uehara Memorial Foundation(Uehara Memorial Foundation); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Human Frontier Science Program(Human Frontier Science Program); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank H. Shen, S. Ferguson, S. Tomita, R. Dong, W. Hancock-Cerutti, J. Lees and Y. Cai for discussion and/or sharing reagents. We thank F. Wilson, H. Czapla and L. Lucast for technical assistance. This work was supported in part by NIH grants R37NS036251, DK45735 and DA018343 to P.D.C. Y.Saheki was supported by fellowships from the Uehara Memorial Foundation and the Japan Society for the Promotion of Science, and X.B. by a Human Frontier Science Program long-term fellowship.	Aguilar PS, 2007, MOL BIOL CELL, V18, P547, DOI 10.1091/mbc.E06-09-0776; AhYoung AP, 2015, P NATL ACAD SCI USA, V112, pE3179, DOI 10.1073/pnas.1422363112; Chang CL, 2015, J BIOL CHEM, V290, P14289, DOI 10.1074/jbc.M114.621375; Chang CL, 2013, CELL REP, V5, P813, DOI 10.1016/j.celrep.2013.09.038; Codazzi F, 2001, CURR BIOL, V11, P1089, DOI 10.1016/S0960-9822(01)00326-8; COHEN CM, 1977, J CELL BIOL, V75, P119, DOI 10.1083/jcb.75.1.119; Craxton M, 2001, GENOMICS, V77, P43, DOI 10.1006/geno.2001.6619; Craxton M, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-259; Elbaz Y, 2011, TRENDS BIOCHEM SCI, V36, P616, DOI 10.1016/j.tibs.2011.08.004; Fernandez-Busnadiego R, 2015, P NATL ACAD SCI USA, V112, pE2004, DOI 10.1073/pnas.1503191112; Friedman JR, 2011, TRENDS CELL BIOL, V21, P709, DOI 10.1016/j.tcb.2011.07.004; Gallegos LL, 2006, J BIOL CHEM, V281, P30947, DOI 10.1074/jbc.M603741200; Giordano F, 2013, CELL, V153, P1494, DOI 10.1016/j.cell.2013.05.026; Herzog R, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r8; Holthuis JCM, 2005, NAT REV MOL CELL BIO, V6, P209, DOI 10.1038/nrm1591; Horowitz LF, 2005, J GEN PHYSIOL, V126, P243, DOI 10.1085/jgp.200509309; Idevall-Hagren O, 2015, EMBO J, V34, P2291, DOI 10.15252/embj.201591565; Idevall-Hagren O, 2012, P NATL ACAD SCI USA, V109, pE2316, DOI 10.1073/pnas.1211305109; Kim H, 2011, NAT METHODS, V8, P941, DOI [10.1038/NMETH.1733, 10.1038/nmeth.1733]; Kim YJ, 2015, DEV CELL, V33, P549, DOI 10.1016/j.devcel.2015.04.028; Kopec KO, 2011, BIOCHEM SOC T, V39, P1033, DOI 10.1042/BST0391033; Kopec KO, 2010, BIOINFORMATICS, V26, P1927, DOI 10.1093/bioinformatics/btq326; Kornmann B, 2009, SCIENCE, V325, P477, DOI 10.1126/science.1175088; Levy A, 2015, CURR BIOL, V25, P2018, DOI 10.1016/j.cub.2015.06.015; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Manford AG, 2012, DEV CELL, V23, P1129, DOI 10.1016/j.devcel.2012.11.004; Merida I, 2008, BIOCHEM J, V409, P1, DOI 10.1042/BJ20071040; Mesmin B, 2013, CELL, V155, P830, DOI 10.1016/j.cell.2013.09.056; Min SW, 2007, P NATL ACAD SCI USA, V104, P3823, DOI 10.1073/pnas.0611725104; MORGAN AJ, 1994, BIOCHEM J, V300, P665, DOI 10.1042/bj3000665; Oram JF, 2003, J BIOL CHEM, V278, P52379, DOI 10.1074/jbc.M310695200; Perez-Sancho J, 2015, PLANT PHYSIOL, V168, P132, DOI 10.1104/pp.15.00260; Prinz WA, 2014, J CELL BIOL, V205, P759, DOI 10.1083/jcb.201401126; Qiu XY, 2007, NAT STRUCT MOL BIOL, V14, P106, DOI 10.1038/nsmb1197; Sampaio JL, 2011, P NATL ACAD SCI USA, V108, P1903, DOI 10.1073/pnas.1019267108; Sanjana NE, 2012, NAT PROTOC, V7, P171, DOI 10.1038/nprot.2011.431; Schapire AL, 2008, PLANT CELL, V20, P3374, DOI 10.1105/tpc.108.063859; Schauder CM, 2014, NATURE, V510, P552, DOI 10.1038/nature13269; Shibata Y, 2008, J BIOL CHEM, V283, P18892, DOI 10.1074/jbc.M800986200; Stefan CJ, 2011, CELL, V144, P389, DOI 10.1016/j.cell.2010.12.034; Suh BC, 2004, J GEN PHYSIOL, V123, P663, DOI 10.1085/jgp.200409029; Toulmay A, 2012, J CELL SCI, V125, P49, DOI 10.1242/jcs.085118; Toulmay A, 2011, CURR OPIN CELL BIOL, V23, P458, DOI 10.1016/j.ceb.2011.04.006; Varnai P, 1998, J CELL BIOL, V143, P501, DOI 10.1083/jcb.143.2.501; Whatmore J, 1999, BIOCHEM J, V341, P435, DOI 10.1042/0264-6021:3410435; Willars GB, 1998, J BIOL CHEM, V273, P5037, DOI 10.1074/jbc.273.9.5037; Yamazaki T, 2008, PLANT CELL, V20, P3389, DOI 10.1105/tpc.108.062679	47	146	147	2	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAY	2016	18	5					504	+		10.1038/ncb3339	http://dx.doi.org/10.1038/ncb3339			26	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	DK3RH	27065097	Green Accepted			2022-12-25	WOS:000374834600008
J	Choi, SY; Park, SJ; Kim, WJ; Yang, JE; Lee, H; Shin, J; Lee, SY				Choi, So Young; Park, Si Jae; Kim, Won Jun; Yang, Jung Eun; Lee, Hyuk; Shin, Jihoon; Lee, Sang Yup			One-step fermentative production of poly(lactate-co-glycolate) from carbohydrates in Escherichia coli	NATURE BIOTECHNOLOGY			English	Article							GLYCOLIC ACID PRODUCTION; POLYLACTIC ACID; BIOSYNTHESIS; POLYESTERS; POLYHYDROXYALKANOATES; METABOLISM; COPOLYMERS; POLYMERS; SYNTHASE; PATHWAY	Poly(lactate-co-glycolate) (PLGA) is a widely used biodegradable and biocompatible synthetic polymer. Here we report one-step fermentative production of PLGA in engineered Escherichia coli harboring an evolved polyhydroxyalkanoate (PHA) synthase that polymerizes D-lactyl-CoA and glycolyl-CoA into PLGA. Introduction of the Dahms pathway enables production of glycolate from xylose. Deletion of ptsG enables simultaneous utilization of glucose and xylose. An evolved propionyl-CoA transferase converts D-lactate and glycolate to D-lactyl-CoA and glycolyl-CoA, respectively. Deletion of adhE, frdB, pflB and poxB prevents by-product formation. We also demonstrate modulation of the monomer fractions in PLGA by overexpressing ldhA and deleting dld to increase the proportion of D-lactate or by deleting aceB, glcB, glcD, glcE, glcF and glcG to increase the proportion of glycolate. Incorporation of 2-hydroxybutyrate is prevented by deleting ilvA or feeding strains with l-isoleucine. The utility of our approach for generating diverse forms of PLGA is shown by the production of copolymers containing 3-hydroxybutyrate, 4-hydroxybutyrate or 2-hydroxyisovalerate.	[Choi, So Young; Kim, Won Jun; Yang, Jung Eun; Lee, Sang Yup] Korea Adv Inst Sci & Technol, Ctr Syst & Synthet Biotechnol, Dept Chem & Biomol Engn,Plus Program BK21, Metab & Biomol Engn Natl Res Lab,BioProc Engn Res, Daejeon, South Korea; [Choi, So Young; Kim, Won Jun; Yang, Jung Eun; Lee, Sang Yup] Korea Adv Inst Sci & Technol, Inst BioCentury, Daejeon, South Korea; [Park, Si Jae] Myongji Univ, Dept Environm Engn & Energy, Yongin, Gyeonggido, South Korea; [Lee, Hyuk] Korea Res Inst Chem Technol, Div Drug Discovery Res, Daejeon, South Korea; [Shin, Jihoon] Korea Res Inst Chem Technol, Green Chem & Engn Div, Ctr Biobased Chem, Daejeon, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); Myongji University; Korea Research Institute of Chemical Technology (KRICT); Korea Research Institute of Chemical Technology (KRICT)	Lee, SY (corresponding author), Korea Adv Inst Sci & Technol, Ctr Syst & Synthet Biotechnol, Dept Chem & Biomol Engn,Plus Program BK21, Metab & Biomol Engn Natl Res Lab,BioProc Engn Res, Daejeon, South Korea.; Lee, SY (corresponding author), Korea Adv Inst Sci & Technol, Inst BioCentury, Daejeon, South Korea.	leesy@kaist.ac.kr	Lee, Sang Yup/C-1526-2011; 양, 정은/ABV-6071-2022	Lee, Sang Yup/0000-0003-0599-3091; 	Technology Development Program to Solve Climate Changes (Systems Metabolic Engineering for Biorefineries) of the Ministry of Science, ICT and Future Planning (MSIP) through the National Research Foundation of Korea [NRF-2012M1A2A2026556, NRF-2012M1A2A2026557]	Technology Development Program to Solve Climate Changes (Systems Metabolic Engineering for Biorefineries) of the Ministry of Science, ICT and Future Planning (MSIP) through the National Research Foundation of Korea	We thank S. Choi for the pTrc99s4 plasmid. This work was supported by the Technology Development Program to Solve Climate Changes (Systems Metabolic Engineering for Biorefineries) of the Ministry of Science, ICT and Future Planning (MSIP) through the National Research Foundation of Korea ((NRF-2012M1A2A2026556 and NRF-2012M1A2A2026557) to S.Y.C., W.J.K., J.E.Y., S.J.P. and S.Y.L.).	BRAUNEGG G, 1978, EUR J APPL MICROBIOL, V6, P29, DOI 10.1007/BF00500854; Cao H, 2012, INT J MOL SCI, V13, P12232, DOI 10.3390/ijms131012232; Chambellon E, 2009, J BACTERIOL, V191, P873, DOI 10.1128/JB.01114-08; Choi JI, 1999, BIOTECHNOL BIOENG, V62, P546, DOI 10.1002/(SICI)1097-0290(19990305)62:5<546::AID-BIT6>3.0.CO;2-0; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Jung YK, 2011, J BIOTECHNOL, V151, P94, DOI 10.1016/j.jbiotec.2010.11.009; Jung YK, 2010, BIOTECHNOL BIOENG, V105, P161, DOI 10.1002/bit.22548; Kataoka M, 2001, BIOSCI BIOTECH BIOCH, V65, P2265, DOI 10.1271/bbb.65.2265; Kim JM, 2008, FEMS MICROBIOL LETT, V278, P78, DOI 10.1111/j.1574-6968.2007.00981.x; Koivistoinen OM, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-82; Le Meur S, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-123; Lee SY, 2015, NAT BIOTECHNOL, V33, P1061, DOI 10.1038/nbt.3365; Li ZJ, 2010, METAB ENG, V12, P352, DOI 10.1016/j.ymben.2010.03.003; Lindenkamp N, 2013, APPL MICROBIOL BIOT, V97, P7699, DOI 10.1007/s00253-012-4624-9; Liu HW, 2013, APPL MICROBIOL BIOT, V97, P3409, DOI 10.1007/s00253-012-4618-7; Makadia HK, 2011, POLYMERS-BASEL, V3, P1377, DOI 10.3390/polym3031377; Martin CH, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2418; Matsumoto K, 2011, J BIOTECHNOL, V156, P214, DOI 10.1016/j.jbiotec.2011.07.040; Palmeros B, 2000, GENE, V247, P255, DOI 10.1016/S0378-1119(00)00075-5; Park JW, 2007, J MASS SPECTROM, V42, P1136, DOI 10.1002/jms.1240; Park SJ, 2013, METAB ENG, V20, P20, DOI 10.1016/j.ymben.2013.08.002; Park SJ, 2012, APPL MICROBIOL BIOT, V93, P273, DOI 10.1007/s00253-011-3530-x; PARK TG, 1995, BIOMATERIALS, V16, P1123, DOI 10.1016/0142-9612(95)93575-X; Sambrook J, 2001, MOL CLONING LAB MANU; Sodergard A, 2002, PROG POLYM SCI, V27, P1123, DOI 10.1016/s0079-6700(02)00012-6; Stephens C, 2007, J BACTERIOL, V189, P2181, DOI 10.1128/JB.01438-06; Taguchi S, 2008, P NATL ACAD SCI USA, V105, P17323, DOI 10.1073/pnas.0805653105; Woodruff MA, 2010, PROG POLYM SCI, V35, P1217, DOI 10.1016/j.progpolymsci.2010.04.002; Wu SJ, 2008, BIOTECHNOL BIOENG, V99, P717, DOI 10.1002/bit.21643; Wu XS, 2001, J BIOMAT SCI-POLYM E, V12, P21, DOI 10.1163/156856201744425; Yang JE, 2013, MICROB BIOTECHNOL, V6, P621, DOI 10.1111/1751-7915.12066; Yang TH, 2010, BIOTECHNOL BIOENG, V105, P150, DOI 10.1002/bit.22547; Zahoor A, 2014, J BIOTECHNOL, V192, P366, DOI 10.1016/j.jbiotec.2013.12.020; Zhang KC, 2008, P NATL ACAD SCI USA, V105, P20653, DOI 10.1073/pnas.0807157106	34	134	148	12	170	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	APR	2016	34	4					435	+		10.1038/nbt.3485	http://dx.doi.org/10.1038/nbt.3485			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DI6NL	26950748				2022-12-25	WOS:000373616100026
J	Hoyt, K; Hatchett, R				Hoyt, Kendall; Hatchett, Richard			Preparing for the next Zika	NATURE BIOTECHNOLOGY			English	Article									[Hoyt, Kendall] Geisel Sch Med Dartmouth, Hanover, NH USA; [Hatchett, Richard] Biomed Adv Res & Dev Author, HHS ASPR BARDA, Washington, DC USA	Dartmouth College	Hoyt, K (corresponding author), Geisel Sch Med Dartmouth, Hanover, NH USA.	kendallhoyt@mac.com						Borio L, 2015, NEW ENGL J MED, V373, P993, DOI 10.1056/NEJMp1508708; Commission on a Global Health Risk Framework for the Future, 2015, NEGL DIM GLOB SEC; Gates B, 2015, NEW ENGL J MED, V372, P1381, DOI 10.1056/NEJMp1502918; Hoyt Kendall, 2012, LONG SHOT VACCINES N; Lang T, 2015, NATURE, V524, P29, DOI 10.1038/524029a; Lee J.-W., 2004, LEARNING SARS PREPAR; Plotkin SA, 2015, NEW ENGL J MED, V373, P297, DOI 10.1056/NEJMp1506820; Pronker ES, 2011, VACCINE, V29, P5846, DOI 10.1016/j.vaccine.2011.06.051; Thomas M. R., EC IMPACT EBOLA SUBS; WHO, 2015, OUTC DOC FIN R D PRE; Wright S., 2015, WAKE CALL LESSONS EB	11	13	14	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	APR	2016	34	4					384	386		10.1038/nbt.3532	http://dx.doi.org/10.1038/nbt.3532			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DI6NL	27054989	Bronze, Green Published			2022-12-25	WOS:000373616100015
J	Liu, LF; Sommermeyer, D; Cabanov, A; Kosasih, P; Hill, T; Riddell, SR				Liu, Lingfeng; Sommermeyer, Daniel; Cabanov, Alexandra; Kosasih, Paula; Hill, Tyler; Riddell, Stanley R.			Inclusion of Strep-tag II in design of antigen receptors for T-cell immunotherapy	NATURE BIOTECHNOLOGY			English	Article							RECOGNITION; LYMPHOCYTES; ANTIBODIES; ANTI-CD3; AFFINITY; CLONES; DOMAIN	Adoptive immunotherapy with genetically engineered T cells has the potential to treat cancer and other diseases. The introduction of Strep-tag II sequences into specific sites in synthetic chimeric antigen receptors or natural T-cell receptors of diverse specificities provides engineered T cells with a marker for identification and rapid purification, a method for tailoring spacer length of chimeric receptors for optimal function, and a functional element for selective antibodycoated, microbead-driven, large-scale expansion. These receptor designs facilitate cGMP manufacturing of pure populations of engineered T cells for adoptive T-cell therapies and enable in vivo tracking and retrieval of transferred cells for downstream research applications.	[Liu, Lingfeng; Sommermeyer, Daniel; Cabanov, Alexandra; Kosasih, Paula; Hill, Tyler; Riddell, Stanley R.] Fred Hutchinson Canc Res Ctr, Program Immunol, 1124 Columbia St, Seattle, WA 98104 USA; [Riddell, Stanley R.] Univ Washington, Dept Med, Seattle, WA USA; [Riddell, Stanley R.] Tech Univ Munich, Inst Adv Study, D-80290 Munich, Germany	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Technical University of Munich	Riddell, SR (corresponding author), Fred Hutchinson Canc Res Ctr, Program Immunol, 1124 Columbia St, Seattle, WA 98104 USA.; Riddell, SR (corresponding author), Univ Washington, Dept Med, Seattle, WA USA.; Riddell, SR (corresponding author), Tech Univ Munich, Inst Adv Study, D-80290 Munich, Germany.	sriddell@fredhutch.org	Hill, Tyler/B-9138-2017	Hill, Tyler/0000-0002-9192-8327	Walker Immunotherapy Fellowship; Fred Hutchinson Cancer Research Center (FHCRC) Synergy Technology Fund; National Institute of Health (NIH) grants [CA136551, CA114536, P50 CA138293]; NATIONAL CANCER INSTITUTE [R01CA114536, R01CA136551, P50CA138293] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U54DK106829] Funding Source: NIH RePORTER	Walker Immunotherapy Fellowship; Fred Hutchinson Cancer Research Center (FHCRC) Synergy Technology Fund; National Institute of Health (NIH) grants; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank M. Comstock, L. Perkins and D.E. Parrilla for expertise in carrying out the mouse experiments, R.L. Lawler for conducting Luminex assays, B. Hoffstrom and N. Boiani for assistance in developing the anti-Strep-tag II monoclonal antibody, and D. Hamm in Adaptive Biotechnologies for analysis of TCR sequencing data. This work was supported by a Walker Immunotherapy Fellowship, the Fred Hutchinson Cancer Research Center (FHCRC) Synergy Technology Fund, and National Institute of Health (NIH) grants CA136551, CA114536 and P50 CA138293.	Brentjens RJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005930; Hudecek M, 2015, CANCER IMMUNOL RES, V3, P125, DOI 10.1158/2326-6066.CIR-14-0127; Hudecek M, 2013, CLIN CANCER RES, V19, P3153, DOI 10.1158/1078-0432.CCR-13-0330; Kalamasz D, 2004, J IMMUNOTHER, V27, P405, DOI 10.1097/00002371-200409000-00010; Kieback E, 2008, P NATL ACAD SCI USA, V105, P623, DOI 10.1073/pnas.0710198105; Kochenderfer JN, 2015, J CLIN ONCOL, V33, P540, DOI 10.1200/JCO.2014.56.2025; Korndorfer IP, 2002, PROTEIN SCI, V11, P883, DOI 10.1110/ps.4150102; Kuball J, 2007, BLOOD, V109, P2331, DOI 10.1182/blood-2006-05-023069; Leisegang M, 2008, J MOL MED, V86, P573, DOI 10.1007/s00109-008-0317-3; Levine BL, 1996, SCIENCE, V272, P1939, DOI 10.1126/science.272.5270.1939; Maude SL, 2014, HEMATOL-AM SOC HEMAT, P559, DOI 10.1182/asheducation-2014.1.559; Maude SL, 2014, NEW ENGL J MED, V371, P1507, DOI 10.1056/NEJMoa1407222; Morgan RA, 2006, SCIENCE, V314, P126, DOI 10.1126/science.1129003; RIDDELL SR, 1990, J IMMUNOL METHODS, V128, P189, DOI 10.1016/0022-1759(90)90210-M; Robbins PF, 2015, CLIN CANCER RES, V21, P1019, DOI 10.1158/1078-0432.CCR-14-2708; Robins H, 2012, J IMMUNOL METHODS, V375, P14, DOI 10.1016/j.jim.2011.09.001; Robins HS, 2009, BLOOD, V114, P4099, DOI 10.1182/blood-2009-04-217604; Sommermeyer D, 2010, J IMMUNOL, V184, P6223, DOI 10.4049/jimmunol.0902055; Stemberger C, 2014, BLOOD, V124, P628, DOI 10.1182/blood-2013-12-547349; Wang W, 2006, CANCER RES, V66, P6826, DOI 10.1158/0008-5472.CAN-05-3529; Wang XL, 2011, BLOOD, V118, P1255, DOI 10.1182/blood-2011-02-337360; Yam PY, 2002, MOL THER, V5, P479, DOI 10.1006/mthe.2002.0558	22	39	52	1	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	APR	2016	34	4					430	+		10.1038/nbt.3461	http://dx.doi.org/10.1038/nbt.3461			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DI6NL	26900664	Green Accepted			2022-12-25	WOS:000373616100025
J	Shojaee, S; Chan, LN; Buchner, M; Cazzaniga, V; Cosgun, KN; Geng, HM; Qiu, YH; von Minden, MD; Ernst, T; Hochhaus, A; Cazzaniga, G; Melnick, A; Kornblau, SM; Graeber, TG; Wu, H; Jumaa, H; Muschen, M				Shojaee, Seyedmehdi; Chan, Lai N.; Buchner, Maike; Cazzaniga, Valeria; Cosgun, Kadriye Nehir; Geng, Huimin; Qiu, Yi Hua; von Minden, Marcus Duehren; Ernst, Thomas; Hochhaus, Andreas; Cazzaniga, Giovanni; Melnick, Ari; Kornblau, Steven M.; Graeber, Thomas G.; Wu, Hong; Jumaa, Hassan; Mueschen, Markus			PTEN opposes negative selection and enables oncogenic transformation of pre-B cells	NATURE MEDICINE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; CHROMOSOME-10 PTEN; TUMOR-SUPPRESSOR; HUMAN CANCER; MOUSE MODEL; STEM-CELLS; RECEPTOR; GENE; PHOSPHATASE; INHIBITOR	Phosphatase and tensin homolog (PTEN) is a negative regulator of the phosphatidylinositol 3-kinase (PI3K) and protein kinase B (AKT) signaling pathway and a potent tumor suppressor in many types of cancer. To test a tumor suppressive role for PTEN in pre-B acute lymphoblastic leukemia (ALL), we induced Cre-mediated deletion of Pten in mouse models of pre-B ALL. In contrast to its role as a tumor suppressor in other cancers, loss of one or both alleles of Pten caused rapid cell death of pre-B ALL cells and was sufficient to clear transplant recipient mice of leukemia. Small-molecule inhibition of PTEN in human pre-B ALL cells resulted in hyperactivation of AKT, activation of the p53 tumor suppressor cell cycle checkpoint and cell death. Loss of PTEN function in pre-B ALL cells was functionally equivalent to acute activation of autoreactive pre-B cell receptor signaling, which engaged a deletional checkpoint for the removal of autoreactive B cells. We propose that targeted inhibition of PTEN and hyperactivation of AKT triggers a checkpoint for the elimination of autoreactive B cells and represents a new strategy to overcome drug resistance in human ALL.	[Shojaee, Seyedmehdi; Chan, Lai N.; Buchner, Maike; Cazzaniga, Valeria; Cosgun, Kadriye Nehir; Geng, Huimin; Mueschen, Markus] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [Cazzaniga, Valeria; Cazzaniga, Giovanni] Univ Milano Bicocca, Ctr Ric Tettamanti, Clin Pediat, Monza, Italy; [Qiu, Yi Hua; Kornblau, Steven M.] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA; [von Minden, Marcus Duehren; Jumaa, Hassan] Univ Ulm, Dept Immunol, D-89069 Ulm, Germany; [Ernst, Thomas; Hochhaus, Andreas] Univ Klinikum Jena, Klin Innere Med 2, Abt Hamatol Onkol, Jena, Germany; [Melnick, Ari] Weill Cornell Med Coll, Dept Pharmacol, New York, NY USA; [Graeber, Thomas G.; Wu, Hong] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA USA	University of California System; University of California San Francisco; University of Milano-Bicocca; University of Texas System; UTMD Anderson Cancer Center; Ulm University; Friedrich Schiller University of Jena; Cornell University; University of California System; University of California Los Angeles	Muschen, M (corresponding author), Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA.	markus.muschen@ucsf.edu	Melnick, Ari/AAA-5763-2020; Cazzaniga, Giovanni/K-6338-2016	Hochhaus, Andreas/0000-0003-0626-0834; Cosgun, Kadriye/0000-0003-4181-744X; Graeber, Thomas/0000-0001-8574-9181; Cazzaniga, Giovanni/0000-0003-2955-4528	US National Institutes of Health (NIH); National Cancer Institute [R01CA137060, R01CA139032, R01CA157644, R01CA169458, R01CA172558]; William Lawrence and Blanche Hughes Foundation; California Institute for Regenerative Medicine (CIRM) [TR2-01816]; Bloodwise; Research Scholar Award from the American Cancer Society [RSG-12-257-01-TBE]; Established Investigator Award from the Melanoma Research Alliance [20120279]; NIH-National Center for Advancing Translational Science (NCATS) UCLA CTSI grant [UL1TR000124]; NATIONAL CANCER INSTITUTE [R01CA213138, R01CA139032, R35CA197628, R01CA169458, R01CA172558, R01CA157644, R01CA137060] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); William Lawrence and Blanche Hughes Foundation; California Institute for Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); Bloodwise; Research Scholar Award from the American Cancer Society(American Cancer Society); Established Investigator Award from the Melanoma Research Alliance; NIH-National Center for Advancing Translational Science (NCATS) UCLA CTSI grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	We would like to thank L.M. Staudt (National Cancer Institute), D.A. Fruman (University of California, Irvine), T. Kurosaki (World Premier International (WPI) Immunology Frontier Research Center), S. Li (Dana-Farber Cancer Institute) and A. Weiss (University of California, San Francisco) for comments and critical discussion of this study. This work is supported by the US National Institutes of Health (NIH) and the National Cancer Institute through grants R01CA137060 (M.M.), R01CA139032 (M.M.), R01CA157644 (M.M.), R01CA169458 (M.M.) and R01CA172558 (M.M.), the William Lawrence and Blanche Hughes Foundation (M.M.), the California Institute for Regenerative Medicine (CIRM; grant TR2-01816; M.M.) and Bloodwise (M.M.). T.G.G. is the recipient of a Research Scholar Award from the American Cancer Society (award RSG-12-257-01-TBE), an Established Investigator Award from the Melanoma Research Alliance (award 20120279), and is supported by NIH-National Center for Advancing Translational Science (NCATS) UCLA CTSI grant UL1TR000124. M.M. is a Scholar of the Leukemia and Lymphoma Society and a Senior Investigator of the Wellcome Trust.	Aiba Y, 2008, BLOOD, V111, P1497, DOI 10.1182/blood-2007-08-109769; Anzelon AN, 2003, NAT IMMUNOL, V4, P287, DOI 10.1038/ni892; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Chen ZS, 2015, NATURE, V521, P357, DOI 10.1038/nature14231; Deau MC, 2014, J CLIN INVEST, V124, P3923, DOI 10.1172/JCI75746; Duvel K, 2010, MOL CELL, V39, P171, DOI 10.1016/j.molcel.2010.06.022; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Guo BC, 2000, IMMUNITY, V13, P243, DOI 10.1016/S1074-7613(00)00024-8; Gutierrez A, 2011, J EXP MED, V208, P1595, DOI 10.1084/jem.20101691; Gutierrez A, 2009, BLOOD, V114, P647, DOI 10.1182/blood-2009-02-206722; Keenan RA, 2008, SCIENCE, V321, P696, DOI 10.1126/science.1157533; Kharas MG, 2008, J CLIN INVEST, V118, P3038, DOI 10.1172/JCI33337; Khulan B, 2006, GENOME RES, V16, P1046, DOI 10.1101/gr.5273806; Koehler F, 2008, IMMUNITY, V29, P912, DOI 10.1016/j.immuni.2008.10.013; Lenz G, 2008, P NATL ACAD SCI USA, V105, P13520, DOI 10.1073/pnas.0804295105; Lesche R, 2002, GENESIS, V32, P148, DOI 10.1002/gene.10036; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Li YT, 2011, BLOOD, V117, P6702, DOI 10.1182/blood-2010-09-309864; Miletic AV, 2010, J EXP MED, V207, P2407, DOI 10.1084/jem.20091962; Okada T, 2000, IMMUNITY, V13, P817, DOI 10.1016/S1074-7613(00)00079-0; OSMOND DG, 1991, CURR OPIN IMMUNOL, V3, P179, DOI 10.1016/0952-7915(91)90047-5; Peng C, 2010, BLOOD, V115, P626, DOI 10.1182/blood-2009-06-228130; Pfeifer M, 2013, P NATL ACAD SCI USA, V110, P12420, DOI 10.1073/pnas.1305656110; Ramadani F, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001104; Roman-Gomez J, 2005, J CLIN ONCOL, V23, P7043, DOI 10.1200/JCO.2005.01.4944; Rosivatz E, 2006, ACS CHEM BIOL, V1, P780, DOI 10.1021/cb600352f; Shackelford DB, 2009, P NATL ACAD SCI USA, V106, P11137, DOI 10.1073/pnas.0900465106; Shojaee S, 2015, CANCER CELL, V28, P114, DOI 10.1016/j.ccell.2015.05.008; Srinivasan L, 2009, CELL, V139, P573, DOI 10.1016/j.cell.2009.08.041; Tesio M, 2013, J EXP MED, V210, P2337, DOI 10.1084/jem.20122768; Tibes R, 2006, MOL CANCER THER, V5, P2512, DOI 10.1158/1535-7163.MCT-06-0334; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; Xie HF, 2004, CELL, V117, P663, DOI 10.1016/S0092-8674(04)00419-2; Zhang JH, 2011, BLOOD, V118, P3080, DOI 10.1182/blood-2011-03-341412	35	74	75	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2016	22	4					379	+		10.1038/nm.4062	http://dx.doi.org/10.1038/nm.4062			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DI4GF	26974310	Green Published, Green Accepted			2022-12-25	WOS:000373457700013
J	Gusev, A; Ko, A; Shi, H; Bhatia, G; Chung, W; Penninx, BWJH; Jansen, R; de Geus, EJC; Boomsma, DI; Wright, FA; Sullivan, PF; Nikkola, E; Alvarez, M; Civelek, M; Lusis, AJ; Lehtimaki, T; Raitoharju, E; Kahonen, M; Seppala, I; Raitakari, OT; Kuusisto, J; Laakso, M; Price, AL; Pajukanta, P; Pasaniuc, B				Gusev, Alexander; Ko, Arthur; Shi, Huwenbo; Bhatia, Gaurav; Chung, Wonil; Penninx, Brenda W. J. H.; Jansen, Rick; de Geus, Eco J. C.; Boomsma, Dorret I.; Wright, Fred A.; Sullivan, Patrick F.; Nikkola, Elina; Alvarez, Marcus; Civelek, Mete; Lusis, Aldons J.; Lehtimaki, Terho; Raitoharju, Emma; Kahonen, Mika; Seppala, Ilkka; Raitakari, Olli T.; Kuusisto, Johanna; Laakso, Markku; Price, Alkes L.; Pajukanta, Paivi; Pasaniuc, Bogdan			Integrative approaches for large-scale transcriptome-wide association studies	NATURE GENETICS			English	Article							GENE-EXPRESSION; PARTITIONING HERITABILITY; MENDELIAN RANDOMIZATION; REGULATORY VARIATION; CARDIOVASCULAR RISK; COMPLEX TRAITS; STATISTICS; VARIANTS; IDENTIFICATION; ARCHITECTURE	Many genetic variants influence complex traits by modulating gene expression, thus altering the abundance of one or multiple proteins. Here we introduce a powerful strategy that integrates gene expression measurements with summary association statistics from large-scale genome-wide association studies (GWAS) to identify genes whose cis-regulated expression is associated with complex traits. We leverage expression imputation from genetic data to perform a transcriptome-wide association study (TWAS) to identify significant expression-trait associations. We applied our approaches to expression data from blood and adipose tissue measured in similar to 3,000 individuals overall. We imputed gene expression into GWAS data from over 900,000 phenotype measurements to identify 69 new genes significantly associated with obesity-related traits (BMI, lipids and height). Many of these genes are associated with relevant phenotypes in the Hybrid Mouse Diversity Panel. Our results showcase the power of integrating genotype, gene expression and phenotype to gain insights into the genetic basis of complex traits.	[Gusev, Alexander; Bhatia, Gaurav; Chung, Wonil; Price, Alkes L.] Harvard Univ, TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Gusev, Alexander; Bhatia, Gaurav; Price, Alkes L.] Harvard Univ, TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Gusev, Alexander; Bhatia, Gaurav; Price, Alkes L.] Broad Inst, Program Med & Populat Genet, Cambridge, MA USA; [Ko, Arthur; Nikkola, Elina; Alvarez, Marcus; Lusis, Aldons J.; Pajukanta, Paivi; Pasaniuc, Bogdan] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [Ko, Arthur; Pajukanta, Paivi] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA; [Shi, Huwenbo; Pasaniuc, Bogdan] Univ Calif Los Angeles, Bioinformat Interdept Program, Los Angeles, CA USA; [Penninx, Brenda W. J. H.; Jansen, Rick] Vrije Univ Amsterdam Med Ctr, Dept Psychiat, Amsterdam, Netherlands; [de Geus, Eco J. C.; Boomsma, Dorret I.] Vrije Univ Amsterdam, Dept Biol Psychol, Amsterdam, Netherlands; [Wright, Fred A.] N Carolina State Univ, Dept Biol Sci, Dept Stat, Bioinformat Res Ctr, Raleigh, NC 27695 USA; [Sullivan, Patrick F.] Univ N Carolina, Dept Genet, Chapel Hill, NC USA; [Sullivan, Patrick F.] Univ N Carolina, Dept Psychiat, Chapel Hill, NC USA; [Sullivan, Patrick F.] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Civelek, Mete; Lusis, Aldons J.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Lehtimaki, Terho; Raitoharju, Emma; Seppala, Ilkka] Fimlab Labs, Dept Clin Chem, Tampere, Finland; [Lehtimaki, Terho; Seppala, Ilkka] Univ Tampere, Sch Med, FIN-33101 Tampere, Finland; [Kahonen, Mika] Pirkanmaa Hosp Dist, Dept Clin Physiol, Tampere, Finland; [Kahonen, Mika] Univ Tampere, Sch Med, FIN-33101 Tampere, Finland; [Raitakari, Olli T.] Univ Turku, Res Ctr Appl & Prevent Cardiovasc Med, Turku, Finland; [Raitakari, Olli T.] Turku Univ Hosp, Dept Clin Physiol & Nucl Med, FIN-20520 Turku, Finland; [Kuusisto, Johanna; Laakso, Markku] Univ Eastern Finland, Dept Med, Kuopio, Finland; [Kuusisto, Johanna; Laakso, Markku] Kuopio Univ Hosp, SF-70210 Kuopio, Finland; [Pasaniuc, Bogdan] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; University of North Carolina; North Carolina State University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Karolinska Institutet; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Tampere University; Pirkanmaa Hospital District; Tampere University; University of Turku; University of Turku; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Gusev, A (corresponding author), Harvard Univ, TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA.; Gusev, A (corresponding author), Harvard Univ, TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA USA.; Gusev, A (corresponding author), Broad Inst, Program Med & Populat Genet, Cambridge, MA USA.; Pasaniuc, B (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA.; Pasaniuc, B (corresponding author), Univ Calif Los Angeles, Bioinformat Interdept Program, Los Angeles, CA USA.; Pasaniuc, B (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA.	agusev@hsph.harvard.edu; pasaniuc@ucla.edu	Raitakari, Olli/AAQ-7389-2021; de Geus, Eco J.C./M-9318-2015; Boomsma, Dorret I/AAX-4470-2020; Lehtimäki, Terho/AAD-1094-2022; Penninx, Brenda WJH/S-7627-2017	de Geus, Eco J.C./0000-0001-6022-2666; Lehtimäki, Terho/0000-0002-2555-4427; Penninx, Brenda WJH/0000-0001-7779-9672; Kahonen, Mika/0000-0002-4510-7341; Chung, Wonil/0000-0002-5766-6247; Jansen, Rick/0000-0002-3333-6737; Civelek, Mete/0000-0002-8141-0284; Raitoharju, Emma/0000-0002-7023-8706; Gusev, Alexander/0000-0002-7980-4620; Pasaniuc, Bogdan/0000-0002-0227-2056; Ko, Arthur/0000-0002-1523-7225	US National Institutes of Health (NIH) [F32 GM106584, RO1 GM053725, ROl GM105857, HL-28481, HL-095056]; US NIH training grant in Genomic Analysis and Interpretation [T32 HG002536]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095056, F31HL127921, P01HL028481] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG002536] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM105857, R25GM055052, F32GM106584] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US NIH training grant in Genomic Analysis and Interpretation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the individuals who participated in the study. We also acknowledge L. Yang for helpful discussions that have improved the quality of this manuscript. We also thank K. Mohlke, M. Boehnke and F. Collins for help with the METSIM data. This work was funded in part by US National Institutes of Health (NIH) grants F32 GM106584 (A.G.), RO1 GM053725 (B.P.), ROl GM105857 (A.L.P., A.G. and G.B.), HL-28481 (P.P., A.J.L. and M.C.) and HL-095056 (P.P. and B.P.) and by the US NIH training grant in Genomic Analysis and Interpretation T32 HG002536 (A.K.).	Albert FW, 2015, NAT REV GENET, V16, P197, DOI 10.1038/nrg3891; [Anonymous], 2015, FULFILLING PROMISE M; Brown CD, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003649; Buil A, 2015, NAT GENET, V47, P88, DOI 10.1038/ng.3162; Bulik-Sullivan B, 2015, NAT GENET, V47, P1236, DOI 10.1038/ng.3406; Chatterjee N, 2013, NAT GENET, V45, P400, DOI 10.1038/ng.2579; Davis LK, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003864; Dimas AS, 2009, SCIENCE, V325, P1246, DOI 10.1126/science.1174148; Dudbridge F, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003348; Finucane HK, 2015, NAT GENET, V47, P1228, DOI 10.1038/ng.3404; Gamazon ER, 2015, NAT GENET, V47, P1091, DOI 10.1038/ng.3367; Giambartolomei C, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004383; Grundberg E, 2012, NAT GENET, V44, P1084, DOI 10.1038/ng.2394; Gusev A, 2014, AM J HUM GENET, V95, P535, DOI 10.1016/j.ajhg.2014.10.004; Gusev A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003993; Kichaev G, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004722; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Lee D, 2015, BIOINFORMATICS, V31, P1176, DOI 10.1093/bioinformatics/btu816; Lee D, 2013, BIOINFORMATICS, V29, P2925, DOI 10.1093/bioinformatics/btt500; Letourneau A, 2014, NATURE, V508, P345, DOI 10.1038/nature13200; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; Musunuru K, 2010, NATURE, V466, P714, DOI 10.1038/nature09266; Nica AC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000895; Nicolae DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000888; Nuotio J, 2014, SCAND J PUBLIC HEALT, V42, P563, DOI 10.1177/1403494814541597; Pasaniuc B, 2014, BIOINFORMATICS, V30, P2906, DOI 10.1093/bioinformatics/btu416; Pers TH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6890; Pickrell JK, 2014, AM J HUM GENET, V94, P559, DOI 10.1016/j.ajhg.2014.03.004; Pierce BL, 2013, AM J EPIDEMIOL, V178, P1177, DOI 10.1093/aje/kwt084; Pritchard JK, 2002, HUM MOL GENET, V11, P2417, DOI 10.1093/hmg/11.20.2417; Raitakari OT, 2008, INT J EPIDEMIOL, V37, P1220, DOI 10.1093/ije/dym225; Raj T, 2014, SCIENCE, V344, P519, DOI 10.1126/science.1249547; Robinson GK., 1991, STAT SCI, V6, P18, DOI DOI 10.1214/SS/1177011926; Smith GD, 2003, INT J EPIDEMIOL, V32, P1, DOI 10.1093/ije/dyg070; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Torres JM, 2014, AM J HUM GENET, V95, P521, DOI 10.1016/j.ajhg.2014.10.001; Visscher PM, 2012, AM J HUM GENET, V90, P7, DOI 10.1016/j.ajhg.2011.11.029; Wen WQ, 2014, HUM MOL GENET, V23, P5492, DOI 10.1093/hmg/ddu248; Wen XQ, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005176; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; Wood AR, 2014, NAT GENET, V46, P1173, DOI 10.1038/ng.3097; Wood AR, 2014, NATURE, V514, pE3, DOI 10.1038/nature13691; Wray NR, 2013, NAT REV GENET, V14, P507, DOI 10.1038/nrg3457; Wright FA, 2014, NAT GENET, V46, P430, DOI 10.1038/ng.2951; Yang J, 2012, NAT GENET, V44, P369, DOI 10.1038/ng.2213; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Zhang XL, 2015, NAT GENET, V47, P345, DOI 10.1038/ng.3220; Zhou X, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003264	51	820	828	17	149	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2016	48	3					245	252		10.1038/ng.3506	http://dx.doi.org/10.1038/ng.3506			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DE8QW	26854917	Green Submitted, Green Accepted			2022-12-25	WOS:000370902600008
J	Maury, MM; Tsai, YH; Charlier, C; Touchon, M; Chenal-Francisque, V; Leclercq, A; Criscuolo, A; Gaultier, C; Roussel, S; Brisabois, A; Disson, O; Rocha, EPC; Brisse, S; Lecuit, M				Maury, Mylene M.; Tsai, Yu-Huan; Charlier, Caroline; Touchon, Marie; Chenal-Francisque, Viviane; Leclercq, Alexandre; Criscuolo, Alexis; Gaultier, Charlotte; Roussel, Sophie; Brisabois, Anne; Disson, Olivier; Rocha, Eduardo P. C.; Brisse, Sylvain; Lecuit, Marc			Uncovering Listeria monocytogenes hypervirulence by harnessing its biodiversity	NATURE GENETICS			English	Article							COMPARATIVE GENOMICS; VIRULENCE; EVOLUTION; SEQUENCE; DISTINCT; CLONES; IDENTIFICATION; INTERNALIN; LINEAGES; SEROVARS	Microbial pathogenesis studies are typically performed with reference strains, thereby overlooking within-species heterogeneity in microbial virulence. Here we integrated human epidemiological and clinical data with bacterial population genomics to harness the biodiversity of the model foodborne pathogen Listeria monocytogenes and decipher the basis of its neural and placental tropisms. Taking advantage of the clonal structure of this bacterial species, we identify clones epidemiologically associated either with food or with human central nervous system (CNS) or maternal-neonatal (MN) listeriosis. The latter clones are also most prevalent in patients without immunosuppressive comorbidities. Strikingly, CNS- and MN-associated clones are hypervirulent in a humanized mouse model of listeriosis. By integrating epidemiological data and comparative genomics, we have uncovered multiple new putative virulence factors and demonstrate experimentally the contribution of the first gene cluster mediating L. monocytogenes neural and placental tropisms. This study illustrates the exceptional power in harnessing microbial biodiversity to identify clinically relevant microbial virulence attributes.	[Maury, Mylene M.; Touchon, Marie; Rocha, Eduardo P. C.; Brisse, Sylvain] Inst Pasteur, Microbial Evolutionary Genom Unit, Paris, France; [Maury, Mylene M.; Touchon, Marie; Rocha, Eduardo P. C.; Brisse, Sylvain] CNRS, UMR 3525, Paris, France; [Maury, Mylene M.] Paris Diderot Univ, Sorbonne Paris Cite, Cellule Pasteur, Paris, France; [Tsai, Yu-Huan; Charlier, Caroline; Chenal-Francisque, Viviane; Leclercq, Alexandre; Gaultier, Charlotte; Disson, Olivier; Lecuit, Marc] Inst Pasteur, Biol Infect Unit, Paris, France; [Tsai, Yu-Huan; Gaultier, Charlotte; Disson, Olivier; Lecuit, Marc] INSERM, Unit 1117, Paris, France; [Chenal-Francisque, Viviane; Leclercq, Alexandre; Lecuit, Marc] Natl Reference Ctr Listeria, Paris, France; [Leclercq, Alexandre; Lecuit, Marc] WHO, Collaborating Ctr Listeria, Paris, France; [Charlier, Caroline; Lecuit, Marc] Paris Descartes Univ, Necker Enfants Malades Univ Hosp, AP HP,Sorborne Paris Cite, Inst Imagine,Div Infect Dis & Trop Med, Paris, France; [Criscuolo, Alexis] Inst Pasteur, Ctr Bioinformat Biostat & Integrat Biol, Paris, France; [Roussel, Sophie] Paris Est Univ, ANSES Agence Natl Secur Sanitaire Alimentat Envir, Food Safety Lab, Maisons Alfort, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); World Health Organization; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Ecole Nationale Veterinaire d'Alfort (ENVA)	Brisse, S (corresponding author), Inst Pasteur, Microbial Evolutionary Genom Unit, Paris, France.; Brisse, S (corresponding author), CNRS, UMR 3525, Paris, France.; Lecuit, M (corresponding author), Inst Pasteur, Biol Infect Unit, Paris, France.; Lecuit, M (corresponding author), INSERM, Unit 1117, Paris, France.; Lecuit, M (corresponding author), Natl Reference Ctr Listeria, Paris, France.; Lecuit, M (corresponding author), WHO, Collaborating Ctr Listeria, Paris, France.; Lecuit, M (corresponding author), Paris Descartes Univ, Necker Enfants Malades Univ Hosp, AP HP,Sorborne Paris Cite, Inst Imagine,Div Infect Dis & Trop Med, Paris, France.	sylvain.brisse@pasteur.fr; marc.lecuit@pasteur.fr	Disson, Olivier/H-6359-2016; Brisse, Sylvain/M-8723-2013; Lecuit, Marc/M-4126-2019; Alexandre, Leclercq Jean-Louis/H-2140-2018; Rocha, Eduardo/B-7009-2009; Lecuit, Marc/J-4073-2013; Disson, Olivier/P-9935-2019; Charlier, Caroline/AAH-8547-2020	Brisse, Sylvain/0000-0002-2516-2108; Lecuit, Marc/0000-0002-4491-1063; Alexandre, Leclercq Jean-Louis/0000-0003-3778-7313; Rocha, Eduardo/0000-0001-7704-822X; Lecuit, Marc/0000-0002-4491-1063; Disson, Olivier/0000-0002-7791-9782; Charlier, Caroline/0000-0002-9375-3620; Maury, Mylene/0000-0002-6816-9182; Touchon, marie/0000-0001-7389-447X; Roussel, Sophie/0000-0003-1830-5526; Criscuolo, Alexis/0000-0002-8212-5215	Institut Pasteur; INSERM; French government's Investissement d'Avenir program; Laboratoire d'Excellence 'Integrative Biology of Emerging Infectious Diseases' [ANR-10-LABX-62-IBEID]; European Research Council (ERC); ERANET Proantilis; Programme Hospitalier de Recherche Clinique MONALISA; Programme de Recherche Translationnelle (PTR) ANSES-Institut Pasteur; Institut de Veille Sanitaire (InVS)	Institut Pasteur(European Commission); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); French government's Investissement d'Avenir program(French National Research Agency (ANR)); Laboratoire d'Excellence 'Integrative Biology of Emerging Infectious Diseases'; European Research Council (ERC)(European Research Council (ERC)European Commission); ERANET Proantilis; Programme Hospitalier de Recherche Clinique MONALISA; Programme de Recherche Translationnelle (PTR) ANSES-Institut Pasteur; Institut de Veille Sanitaire (InVS)	We thank C. Soto Alvarez, G. Pontdeme, T. Cantinelli and L. Diancourt for their contributions to MLST data production and analysis, and S. Roche for providing low-virulence strains for genome sequencing. We also thank D. Mornico (Center of Bioinformatics, Biostatistics and Integrative Biology of the Institut Pasteur) for his help with the submission of genome reads and assemblies. This study was funded by the Institut Pasteur, INSERM, from the French government's Investissement d'Avenir program, Laboratoire d'Excellence 'Integrative Biology of Emerging Infectious Diseases' (grant ANR-10-LABX-62-IBEID), the European Research Council (ERC), ERANET Proantilis, the Programme Hospitalier de Recherche Clinique MONALISA and the Programme de Recherche Translationnelle (PTR) ANSES-Institut Pasteur. Listeriosis surveillance in France is funded by the Institut de Veille Sanitaire (InVS) and the Institut Pasteur.	Bille E, 2005, J EXP MED, V201, P1905, DOI 10.1084/jem.20050112; Chenal-Francisque V, 2013, J CLIN MICROBIOL, V51, P1868, DOI 10.1128/JCM.00606-13; Chenal-Francisque V, 2011, EMERG INFECT DIS, V17, P1110, DOI [10.3201/eid/1706.101778, 10.3201/eid1706.101778]; Cossart P, 1996, SCIENCE, V271, P315, DOI 10.1126/science.271.5247.315; Cossart P, 2011, P NATL ACAD SCI USA, V108, P19484, DOI 10.1073/pnas.1112371108; Cotter PD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000144; den Bakker HC, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-688; Disson O, 2008, NATURE, V455, P1114, DOI 10.1038/nature07303; Doumith M, 2004, J CLIN MICROBIOL, V42, P3819, DOI 10.1128/JCM.42.8.3819-3822.2004; Eisenreich W, 2010, NAT REV MICROBIOL, V8, P401, DOI 10.1038/nrmicro2351; Faith N, 2009, FOODBORNE PATHOG DIS, V6, P39, DOI 10.1089/fpd.2008.0154; FALKOW S, 1992, ANNU REV CELL BIOL, V8, P333, DOI 10.1146/annurev.cb.08.110192.002001; Glaser P, 2001, SCIENCE, V294, P849; Gray MJ, 2004, APPL ENVIRON MICROB, V70, P5833, DOI 10.1128/AEM.70.10.5833-5841.2004; Haase JK, 2014, ENVIRON MICROBIOL, V16, P405, DOI 10.1111/1462-2920.12342; Hain T, 2007, INT J MED MICROBIOL, V297, P541, DOI 10.1016/j.ijmm.2007.03.016; HENSEL M, 1995, SCIENCE, V269, P400, DOI 10.1126/science.7618105; Holden MTG, 2004, P NATL ACAD SCI USA, V101, P9786, DOI 10.1073/pnas.0402521101; Jacquet C, 2004, J INFECT DIS, V189, P2094, DOI 10.1086/420853; Kuenne C, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-47; Lecuit M, 2001, SCIENCE, V292, P1722, DOI 10.1126/science.1059852; Lecuit M, 2007, MICROBES INFECT, V9, P1216, DOI 10.1016/j.micinf.2007.05.009; MCLAUCHLIN J, 1990, EUR J CLIN MICROBIOL, V9, P210, DOI 10.1007/BF01963840; Nightingale KK, 2005, APPL ENVIRON MICROB, V71, P8764, DOI 10.1128/AEM.71.12.8764-8772.2005; Orsi RH, 2011, INT J MED MICROBIOL, V301, P79, DOI 10.1016/j.ijmm.2010.05.002; Paradis E, 2002, J THEOR BIOL, V218, P175, DOI 10.1006/jtbi.2002.3066; Parkhill J, 2003, NAT GENET, V35, P32, DOI 10.1038/ng1227; PIFFARETTI JC, 1989, P NATL ACAD SCI USA, V86, P3818, DOI 10.1073/pnas.86.10.3818; Ragon M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000146; Seeliger H.P.R., 1986, BERGEYS MANUAL SYSTE, P1235; TILNEY LG, 1989, J CELL BIOL, V109, P1597, DOI 10.1083/jcb.109.4.1597; Ward TJ, 2008, APPL ENVIRON MICROB, V74, P7629, DOI 10.1128/AEM.01127-08; Welch RA, 2002, P NATL ACAD SCI USA, V99, P17020, DOI 10.1073/pnas.252529799; Wiedmann M, 1997, INFECT IMMUN, V65, P2707, DOI 10.1128/IAI.65.7.2707-2716.1997	34	350	364	2	99	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2016	48	3					308	313		10.1038/ng.3501	http://dx.doi.org/10.1038/ng.3501			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DE8QW	26829754	Green Accepted			2022-12-25	WOS:000370902600015
J	Shi, XS; Huang, L; Lilley, DMJ; Harbury, PB; Herschlag, D				Shi, Xuesong; Huang, Lin; Lilley, David M. J.; Harbury, Pehr B.; Herschlag, Daniel			The solution structural ensembles of RNA kink-turn motifs and their protein complexes	NATURE CHEMICAL BIOLOGY			English	Article							RESIDUAL DIPOLAR COUPLINGS; SECONDARY STRUCTURE; L7AE PROTEIN; DYNAMICS; BINDING; EXPRESSION; RESOLUTION; DNA	With the growing number of crystal structures of RNA and RNA-protein complexes, a critical next step is understanding the dynamic solution behavior of these entities in terms of conformational ensembles and energy landscapes. To this end, we have used X-ray scattering interferometry (XSI) to probe the ubiquitous RNA kink-turn motif and its complexes with the canonical kink-turn binding protein L7Ae. XSI revealed that the folded kink-turn is best described as a restricted conformational ensemble. The ions present in solution alter the nature of this ensemble, and protein binding can perturb the kink-turn ensemble without collapsing it to a unique state. This study demonstrates how XSI can reveal structural and ensemble properties of RNAs and RNA-protein complexes and uncovers the behavior of an important RNA-protein motif. This type of information will be necessary to understand, predict and engineer the behavior and function of RNAs and their protein complexes.	[Shi, Xuesong; Harbury, Pehr B.; Herschlag, Daniel] Stanford Univ, Dept Biochem, Stanford, CA 94305 USA; [Huang, Lin; Lilley, David M. J.] Univ Dundee, Sch Life Sci, Nucle Acid Struct Res Grp, Dundee, Scotland; [Harbury, Pehr B.; Herschlag, Daniel] Stanford Univ, ChEM H, Stanford, CA 94305 USA; [Herschlag, Daniel] Stanford Univ, Dept Chem, Stanford, CA 94305 USA; [Herschlag, Daniel] Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA	Stanford University; University of Dundee; Stanford University; Stanford University; Stanford University	Shi, XS; Harbury, PB; Herschlag, D (corresponding author), Stanford Univ, Dept Biochem, Stanford, CA 94305 USA.; Harbury, PB; Herschlag, D (corresponding author), Stanford Univ, ChEM H, Stanford, CA 94305 USA.; Herschlag, D (corresponding author), Stanford Univ, Dept Chem, Stanford, CA 94305 USA.; Herschlag, D (corresponding author), Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA.	xuesongs@stanford.edu; harbury@stanford.edu; herschla@stanford.edu	Huang, Lin/M-2262-2019	Huang, Lin/0000-0002-2121-365X; Lilley, David/0000-0001-6882-2818	US National Institutes of Health [PO1 GM066275, DP-OD000429-01]; Cancer Research UK [C28/A4959]; Wellcome Trust project [092056]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM066275] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000429] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [B17092, BB/E001777/1] Funding Source: researchfish; Cancer Research UK [11722, 18604] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/J017094/1] Funding Source: researchfish; BBSRC [BB/E001777/1] Funding Source: UKRI; EPSRC [EP/J017094/1] Funding Source: UKRI	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research UK(Cancer Research UK); Wellcome Trust project(Wellcome Trust); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank T. Matsui and T. Weiss at beamline 4-2 of the Stanford Synchrotron Radiation Lab (SSRL) for technical support in synchrotron small-angle X-ray scattering experiments, and members of the Herschlag, the Lilley and the Harbury labs and H. Al-Hashimi for helpful discussions and comments on the manuscript. This work was supported by US National Institutes of Health grants PO1 GM066275 (D.H.) and DP-OD000429-01 (P.B.H.) and by grants from Cancer Research UK C28/A4959 and Wellcome Trust project 092056 to D.M.J.L.	Akopian D, 2013, ANNU REV BIOCHEM, V82, P693, DOI 10.1146/annurev-biochem-072711-164732; Al-Hashimi HM, 2013, J MAGN RESON, V237, P191, DOI 10.1016/j.jmr.2013.08.014; Autexier C, 2006, ANNU REV BIOCHEM, V75, P493, DOI 10.1146/annurev.biochem.75.103004.142412; Bai Y, 2008, J AM CHEM SOC, V130, P12334, DOI 10.1021/ja800854u; Bai Y, 2007, J AM CHEM SOC, V129, P14981, DOI 10.1021/ja075020g; Bailor MH, 2010, SCIENCE, V327, P202, DOI 10.1126/science.1181085; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Cech TR, 2014, CELL, V157, P77, DOI 10.1016/j.cell.2014.03.008; Charron C, 2004, J MOL BIOL, V342, P757, DOI 10.1016/j.jmb.2004.07.046; Cho IM, 2010, P NATL ACAD SCI USA, V107, P14573, DOI 10.1073/pnas.1005556107; Cruz JA, 2009, CELL, V136, P604, DOI 10.1016/j.cell.2009.02.003; Daldrop P, 2013, RNA, V19, P357, DOI 10.1261/rna.036657.112; Dass A, 2009, J AM CHEM SOC, V131, P11666, DOI 10.1021/ja904713f; DEDUVE C, 1988, NATURE, V333, P117, DOI 10.1038/333117a0; Dethoff EA, 2012, NATURE, V491, P724, DOI 10.1038/nature11498; Dethoff EA, 2012, NATURE, V482, P322, DOI 10.1038/nature10885; Draper DE, 2005, ANNU REV BIOPH BIOM, V34, P221, DOI 10.1146/annurev.biophys.34.040204.144511; Eddy SR, 2001, NAT REV GENET, V2, P919, DOI 10.1038/35103511; Eichhorn CD, 2012, RSC BIOMOL SCI, V25, P184, DOI 10.1039/9781849735391-00184; Fica SM, 2013, NATURE, V503, P229, DOI 10.1038/nature12734; Goody TA, 2004, RNA, V10, P254, DOI 10.1261/rna.5176604; Ha T, 1999, P NATL ACAD SCI USA, V96, P9077, DOI 10.1073/pnas.96.16.9077; Herschlag D, 2015, CURR OPIN STRUC BIOL, V30, P125, DOI 10.1016/j.sbi.2015.02.006; Ingwall Joanne S, 2006, J Cardiovasc Electrophysiol, V17 Suppl 1, pS127, DOI 10.1111/j.1540-8167.2006.00397.x; Jadzinsky PD, 2007, SCIENCE, V318, P430, DOI 10.1126/science.1148624; Kaikkonen MU, 2011, CARDIOVASC RES, V90, P430, DOI 10.1093/cvr/cvr097; Klein DJ, 2001, EMBO J, V20, P4214, DOI 10.1093/emboj/20.15.4214; MANNING GS, 1978, Q REV BIOPHYS, V11, P179, DOI 10.1017/S0033583500002031; Mathew-Fenn RS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003229; Mathew-Fenn RS, 2008, SCIENCE, V322, P446, DOI 10.1126/science.1158881; Matsumura S, 2003, NUCLEIC ACIDS RES, V31, P5544, DOI 10.1093/nar/gkg760; McPhee SA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6127; Moore PB, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003780; Moore T, 2004, STRUCTURE, V12, P807, DOI 10.1016/j.str.2004.02.033; POLIMENI PI, 1973, CIRC RES, V33, P367, DOI 10.1161/01.RES.33.4.367; Salmon L, 2014, ANNU REV PHYS CHEM, V65, P293, DOI 10.1146/annurev-physchem-040412-110059; Schroeder KT, 2010, RNA, V16, P1463, DOI 10.1261/rna.2207910; Shi XS, 2015, METHOD ENZYMOL, V558, P75, DOI 10.1016/bs.mie.2015.02.001; Shi XS, 2014, P NATL ACAD SCI USA, V111, pE1473, DOI 10.1073/pnas.1317032111; Shi XS, 2013, P NATL ACAD SCI USA, V110, pE1444, DOI 10.1073/pnas.1218830110; Stapleton JA, 2012, ACS SYNTH BIOL, V1, P83, DOI 10.1021/sb200005w; Stone MD, 2007, NATURE, V446, P458, DOI 10.1038/nature05600; Turner B, 2005, RNA, V11, P1192, DOI 10.1261/rna.2680605; Turner B, 2008, J MOL BIOL, V381, P431, DOI 10.1016/j.jmb.2008.05.052; Wang J, 2014, NUCLEIC ACIDS RES, V42, P5322, DOI 10.1093/nar/gku144; Wang J, 2012, BIOPHYS J, V103, P2541, DOI 10.1016/j.bpj.2012.11.006; Warf MB, 2010, TRENDS BIOCHEM SCI, V35, P169, DOI 10.1016/j.tibs.2009.10.004; Wozniak AK, 2005, RNA, V11, P1545, DOI 10.1261/rna.2950605	49	28	28	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAR	2016	12	3					146	152		10.1038/NCHEMBIO.1997	http://dx.doi.org/10.1038/NCHEMBIO.1997			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF5FK	26727239	Green Submitted, Green Accepted			2022-12-25	WOS:000371377000006
J	Vegas, AJ; Veiseh, O; Doloff, JC; Ma, ML; Tam, HH; Bratlie, K; Li, J; Bader, AR; Langan, E; Olejnik, K; Fenton, P; Kang, JW; Hollister-Locke, J; Bochenek, MA; Chiu, A; Siebert, S; Tang, K; Jhunjhunwala, S; Aresta-Dasilva, S; Dholakia, N; Thakrar, R; Vietti, T; Chen, M; Cohen, J; Siniakowicz, K; Qi, MRG; McGarrigle, J; Lyle, S; Harlan, DM; Greiner, DL; Oberholzer, J; Weir, GC; Langer, R; Anderson, DG				Vegas, Arturo J.; Veiseh, Omid; Doloff, Joshua C.; Ma, Minglin; Tam, Hok Hei; Bratlie, Kaitlin; Li, Jie; Bader, Andrew R.; Langan, Erin; Olejnik, Karsten; Fenton, Patrick; Kang, Jeon Woong; Hollister-Locke, Jennifer; Bochenek, Matthew A.; Chiu, Alan; Siebert, Sean; Tang, Katherine; Jhunjhunwala, Siddharth; Aresta-Dasilva, Stephanie; Dholakia, Nimit; Thakrar, Raj; Vietti, Thema; Chen, Michael; Cohen, Josh; Siniakowicz, Karolina; Qi, Meirigeng; McGarrigle, James; Lyle, Stephen; Harlan, David M.; Greiner, Dale L.; Oberholzer, Jose; Weir, Gordon C.; Langer, Robert; Anderson, Daniel G.			Combinatorial hydrogel library enables identification of materials that mitigate the foreign body response in primates	NATURE BIOTECHNOLOGY			English	Article							ALGINATE-BASED MICROCAPSULES; INFLAMMATORY RESPONSES; CONFOCAL RAMAN; ISLETS; ENCAPSULATION; PURIFICATION; ACTIVATION; MECHANISMS; EFFICACY	The foreign body response is an immune-mediated reaction that can lead to the failure of implanted medical devices and discomfort for the recipient(1-6). There is a critical need for biomaterials that overcome this key challenge in the development of medical devices. Here we use a combinatorial approach for covalent chemical modification to generate a large library of variants of one of the most widely used hydrogel biomaterials, alginate. We evaluated the materials in vivo and identified three triazole-containing analogs that substantially reduce foreign body reactions in both rodents and, for at least 6 months, in non-human primates. The distribution of the triazole modification creates a unique hydrogel surface that inhibits recognition by macrophages and fibrous deposition. In addition to the utility of the compounds reported here, our approach may enable the discovery of other materials that mitigate the foreign body response.	[Vegas, Arturo J.; Veiseh, Omid; Doloff, Joshua C.; Ma, Minglin; Tam, Hok Hei; Bratlie, Kaitlin; Li, Jie; Bader, Andrew R.; Langan, Erin; Olejnik, Karsten; Fenton, Patrick; Chiu, Alan; Siebert, Sean; Tang, Katherine; Jhunjhunwala, Siddharth; Aresta-Dasilva, Stephanie; Dholakia, Nimit; Thakrar, Raj; Vietti, Thema; Chen, Michael; Langer, Robert; Anderson, Daniel G.] MIT, David H Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Vegas, Arturo J.; Doloff, Joshua C.; Ma, Minglin; Li, Jie; Bader, Andrew R.; Langan, Erin; Olejnik, Karsten; Fenton, Patrick; Chiu, Alan; Siebert, Sean; Tang, Katherine; Jhunjhunwala, Siddharth; Aresta-Dasilva, Stephanie; Dholakia, Nimit; Thakrar, Raj; Vietti, Thema; Chen, Michael; Langer, Robert; Anderson, Daniel G.] Boston Childrens Hosp, Dept Anesthesiol, Boston, MA USA; [Veiseh, Omid; Tam, Hok Hei; Bratlie, Kaitlin; Langer, Robert; Anderson, Daniel G.] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Kang, Jeon Woong] MIT, Spect Lab, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Hollister-Locke, Jennifer; Cohen, Josh; Siniakowicz, Karolina; Weir, Gordon C.] Joslin Diabet Ctr, Div Res, Sect Islet Cell & Regenerat Biol, 1 Joslin Pl, Boston, MA 02215 USA; [Bochenek, Matthew A.; Qi, Meirigeng; McGarrigle, James; Oberholzer, Jose] Univ Illinois, Dept Surg, Div Transplantat, Chicago, IL 60680 USA; [Lyle, Stephen] Univ Massachusetts, Sch Med, Dept Canc Biol, Worcester, MA USA; [Harlan, David M.; Greiner, Dale L.] Univ Massachusetts, Sch Med, Diabet Ctr Excellence, Worcester, MA USA; [Langer, Robert; Anderson, Daniel G.] MIT, Inst Med Engn & Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Langer, Robert; Anderson, Daniel G.] MIT, Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Vegas, Arturo J.] Boston Univ, Dept Chem, 590 Commonwealth Ave, Boston, MA 02215 USA; [Ma, Minglin] Cornell Univ, Dept Biol & Environm Engn, Ithaca, NY USA; [Bratlie, Kaitlin] Iowa State Univ, Dept Mat Sci & Engn, Ames, IA USA; [Bratlie, Kaitlin] Iowa State Univ, Dept Chem & Biol Engn, Ames, IA USA; [Bader, Andrew R.] MIT, Dept Mech Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Harvard University; Boston Children's Hospital; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Joslin Diabetes Center, Inc.; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Boston University; Cornell University; Iowa State University; Iowa State University; Massachusetts Institute of Technology (MIT)	Anderson, DG (corresponding author), MIT, David H Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Anderson, DG (corresponding author), Boston Childrens Hosp, Dept Anesthesiol, Boston, MA USA.; Anderson, DG (corresponding author), MIT, Dept Chem Engn, Cambridge, MA 02139 USA.; Anderson, DG (corresponding author), MIT, Inst Med Engn & Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Anderson, DG (corresponding author), MIT, Div Hlth Sci & Technol, Cambridge, MA 02139 USA.	dgander@mit.edu	Veiseh, Omid/GLS-9547-2022; Jhunjhunwala, Siddharth/K-1526-2013; Veiseh, Omid/N-1137-2019; Qi, Meirigeng/B-5446-2014	Veiseh, Omid/0000-0003-1153-8079; Jhunjhunwala, Siddharth/0000-0001-8046-2288; Qi, Meirigeng/0000-0002-8531-8733; Bochenek, Matthew/0000-0001-5283-7388; Chen, Michael/0000-0002-1590-768X; Doloff, Joshua/0000-0002-4323-3264; Bratlie, Kaitlin/0000-0002-5197-0176	JDRF [3-SRA-2014-285-M-R]; Leona M. and the Harry B. Helmsley Charitable Trust [3-SRA-2014-285-M-R]; National Institutes of Health (NIH) [EB000244, EB000351, DE013023, CA151884, R01DK093909, P30DK036836]; NIH NIBIB [P41EB015871-27]; MIT SkolTech initiative; JDRF; Department of Defense/Congressionally Directed Medical Research Programs (DOD/CDMRP) [3-2013-178, W81XWH-13-1-0215]; National Institutes of Health (NIH, Joslin Diabetes Research Center and its Advanced Microscopy Core); Diabetes Research and Wellness Foundation; National Institutes of Health (NIH/NIDDK) [R01DK091526]; Chicago Diabetes Project; Koch Institute from the National Cancer Institute [P30-CA14051]; NATIONAL CANCER INSTITUTE [U54CA151884, P30CA014051] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000244, P41EB015871, R37EB000244, R01EB000351] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE013023] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK091526, R01DK093909, P30DK036836] Funding Source: NIH RePORTER	JDRF(Juvenile Diabetes Research Foundation); Leona M. and the Harry B. Helmsley Charitable Trust; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH NIBIB(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); MIT SkolTech initiative; JDRF(Juvenile Diabetes Research Foundation); Department of Defense/Congressionally Directed Medical Research Programs (DOD/CDMRP); National Institutes of Health (NIH, Joslin Diabetes Research Center and its Advanced Microscopy Core); Diabetes Research and Wellness Foundation; National Institutes of Health (NIH/NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Chicago Diabetes Project; Koch Institute from the National Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported jointly by the JDRF and Leona M. and the Harry B. Helmsley Charitable Trust (grant 3-SRA-2014-285-M-R), National Institutes of Health (NIH grants EB000244, EB000351, DE013023 and CA151884), NIH NIBIB (P41EB015871-27), MIT SkolTech initiative (J.W.K.), JDRF and the Department of Defense/Congressionally Directed Medical Research Programs (DOD/CDMRP postdoctoral fellowships 3-2013-178 and W81XWH-13-1-0215 for O.V.) and through a generous gift from the Tayebati Family Foundation. G.C.W. is supported by National Institutes of Health (NIH grants R01DK093909 and P30DK036836, the Joslin Diabetes Research Center and its Advanced Microscopy Core), as well as the Diabetes Research and Wellness Foundation. J.O. is supported by the National Institutes of Health (NIH/NIDDK) R01DK091526 and the Chicago Diabetes Project. This work was also supported in part by the Koch Institute Support (core) grant P30-CA14051 from the National Cancer Institute. We also thank the Koch Institute Swanson Biotechnology Center for technical support, specifically Tang Histology Facility, Microscopy, Flow Cytometry, Nanotechnology Materials, and Applied Therapeutics and Whole Animal Imaging. The authors would like to acknowledge the use of resources at W.M. Keck Biological Imaging Facility (Whitehead Institute).	Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004; Bernhardt A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129205; Bratlie KM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010032; BRAUKER JH, 1995, J BIOMED MATER RES, V29, P1517, DOI 10.1002/jbm.820291208; Brocchini S, 1998, J BIOMED MATER RES, V42, P66, DOI 10.1002/(SICI)1097-4636(199810)42:1<66::AID-JBM9>3.0.CO;2-M; Christen T, 2009, CIRCULATION, V119, P1925, DOI 10.1161/CIRCULATIONAHA.108.796888; Dang TT, 2013, BIOMATERIALS, V34, P5792, DOI 10.1016/j.biomaterials.2013.04.016; de Haan BJ, 2011, J BIOMED MATER RES A, V98A, P394, DOI 10.1002/jbm.a.33123; de Vos P, 2006, BIOMATERIALS, V27, P5603, DOI 10.1016/j.biomaterials.2006.07.010; de Vos P, 2009, BIOMATERIALS, V30, P2559, DOI 10.1016/j.biomaterials.2009.01.014; Dusseault J, 2006, J BIOMED MATER RES A, V76A, P243, DOI 10.1002/jbm.a.30541; Duvivier-Kali VF, 2001, DIABETES, V50, P1698, DOI 10.2337/diabetes.50.8.1698; Grainger DW, 2013, NAT BIOTECHNOL, V31, P507, DOI 10.1038/nbt.2600; Gu MH, 2013, BIOMATERIALS, V34, P6133, DOI 10.1016/j.biomaterials.2013.04.051; Haller J, 2008, J APPL PHYSIOL, V104, P795, DOI 10.1152/japplphysiol.00959.2007; Harding JL, 2014, TRENDS BIOTECHNOL, V32, P140, DOI 10.1016/j.tibtech.2013.12.004; Hetrick EM, 2007, BIOMATERIALS, V28, P4571, DOI 10.1016/j.biomaterials.2007.06.036; Hofman K, 2011, ANAL BIOCHEM, V417, P289, DOI 10.1016/j.ab.2011.06.019; Jacobs-Tulleneers-Thevissen D, 2013, DIABETOLOGIA, V56, P1605, DOI 10.1007/s00125-013-2906-0; Kang JW, 2012, NANO LETT, V12, P6170, DOI 10.1021/nl302991y; Kang JW, 2011, BIOMED OPT EXPRESS, V2, P2484, DOI 10.1364/BOE.2.002484; Kearney CJ, 2013, NAT MATER, V12, P1004, DOI [10.1038/NMAT3758, 10.1038/nmat3758]; Kenneth Ward W, 2008, J Diabetes Sci Technol, V2, P768; Kharb R, 2011, J ENZYM INHIB MED CH, V26, P1, DOI 10.3109/14756360903524304; Kim K, 2010, J BIOMED MATER RES A, V92A, P103, DOI 10.1002/jbm.a.32338; King A, 2001, J BIOMED MATER RES, V57, P374, DOI 10.1002/1097-4636(20011205)57:3<374::AID-JBM1180>3.0.CO;2-L; Langer R, 2009, ADV MATER, V21, P3235, DOI 10.1002/adma.200902589; Lee KY, 2012, PROG POLYM SCI, V37, P106, DOI 10.1016/j.progpolymsci.2011.06.003; LIM F, 1980, SCIENCE, V210, P908, DOI 10.1126/science.6776628; Lindstedt R, 2009, INT J IMMUNOPATH PH, V22, P29, DOI 10.1177/039463200902200105; Liu M, 2007, LANGMUIR, V23, P9378, DOI 10.1021/la7002996; Madden LR, 2010, P NATL ACAD SCI USA, V107, P15211, DOI 10.1073/pnas.1006442107; Manoury B, 2006, INT J IMMUNOPATH PH, V19, P471, DOI 10.1177/039463200601900303; Menard M, 2010, J BIOMED MATER RES B, V93B, P333, DOI 10.1002/jbm.b.31570; Omer A, 2005, TRANSPLANTATION, V79, P52, DOI 10.1097/01.TP.0000149340.37865.46; Omer A, 2003, DIABETES, V52, P69, DOI 10.2337/diabetes.52.1.69; Orive G, 2006, BIOMATERIALS, V27, P3691, DOI 10.1016/j.biomaterials.2006.02.048; Paredes-Juarez GA, 2014, MATERIALS, V7, P2087, DOI 10.3390/ma7032087; Paredes-Juarez GA, 2013, J CONTROL RELEASE, V172, P983, DOI 10.1016/j.jconrel.2013.09.009; Qi MRG, 2011, J SURG RES, V168, pE117, DOI 10.1016/j.jss.2011.01.040; Ratner BD, 2002, J CONTROL RELEASE, V78, P211, DOI 10.1016/S0168-3659(01)00502-8; Robitaille R, 2005, BIOMATERIALS, V26, P4119, DOI 10.1016/j.biomaterials.2004.10.028; Rodriguez A, 2009, J BIOMED MATER RES A, V89A, P152, DOI 10.1002/jbm.a.31939; Rokstad AM, 2011, ACTA BIOMATER, V7, P2566, DOI 10.1016/j.actbio.2011.03.011; Sato M, 2003, J IMMUNOL, V171, P417, DOI 10.4049/jimmunol.171.1.417; Scharp DW, 2014, ADV DRUG DELIVER REV, V67-68, P35, DOI 10.1016/j.addr.2013.07.018; Stoppel WL, 2014, J BIOMED MATER RES B, V102, P877, DOI 10.1002/jbm.b.33070; Sussman EM, 2014, ANN BIOMED ENG, V42, P1508, DOI 10.1007/s10439-013-0933-0; Tuch BE, 2009, DIABETES CARE, V32, P1887, DOI 10.2337/dc09-0744; Vegas AJ, 2016, NAT MED, V22, P306, DOI 10.1038/nm.4030; Veiseh O, 2015, NAT MATER, V14, P643, DOI [10.1038/NMAT4290, 10.1038/nmat4290]; Weir GC, 2013, DIABETOLOGIA, V56, P1458, DOI 10.1007/s00125-013-2921-1; Wick G, 2013, ANNU REV IMMUNOL, V31, P107, DOI 10.1146/annurev-immunol-032712-095937; Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023; Wynn TA, 2012, NAT MED, V18, P1028, DOI 10.1038/nm.2807; Zhang L, 2013, NAT BIOTECHNOL, V31, P553, DOI 10.1038/nbt.2580	56	296	311	14	319	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2016	34	3					345	+		10.1038/nbt.3462	http://dx.doi.org/10.1038/nbt.3462			14	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DG1CJ	26807527	Green Accepted, Green Published, Green Submitted			2022-12-25	WOS:000371802600033
J	Cao, ZW; Lis, R; Ginsberg, M; Chayez, D; Shido, K; Rabbany, SY; Fong, GH; Sakmar, TP; Rafii, S; Ding, BS				Cao, Zhongwei; Lis, Raphael; Ginsberg, Michael; Chayez, Deebly; Shido, Koji; Rabbany, Sina Y.; Fong, Guo-Hua; Sakmar, Thomas P.; Rafii, Shahin; Ding, Bi-Sen			Targeting of the pulmonary capillary vascular niche promotes lung alveolar repair and ameliorates fibrosis	NATURE MEDICINE			English	Article							SMOOTH-MUSCLE-CELLS; STEM-CELLS; MACROPHAGE REGULATION; SIGNALING PROMOTES; ENDOTHELIAL-CELLS; NOTCH; ANGIOGENESIS; DIFFERENTIATION; EPITHELIUM; CONTRIBUTES	Although the lung can undergo self-repair after injury, fibrosis in chronically injured or diseased lungs can occur at the expense of regeneration. Here we study how a hematopoietic-vascular niche regulates alveolar repair and lung fibrosis. Using intratracheal injection of bleomycin or hydrochloric acid in mice, we show that repetitive lung injury activates pulmonary capillary endothelial cells (PCECs) and perivascular macrophages, impeding alveolar repair and promoting fibrosis. Whereas the chemokine receptor CXCR7, expressed on PCECs, acts to prevent epithelial damage and ameliorate fibrosis after a single round of treatment with bleomycin or hydrochloric acid, repeated injury leads to suppression of CXCR7 expression and recruitment of vascular endothelial growth factor receptor 1 (VEGFR1)-expressing perivascular macrophages. This recruitment stimulates Wnt/beta-catenin-dependent persistent upregulation of the Notch ligand Jagged1 (encoded by Jag1) in PCECs, which in turn stimulates exuberant Notch signaling in perivascular fibroblasts and enhances fibrosis. Administration of a CXCR7 agonist or PCEC-targeted Jag1 shRNA after lung injury promotes alveolar repair and reduces fibrosis. Thus, targeting of a maladapted hematopoietic-vascular niche, in which macrophages, PCECs and perivascular fibroblasts interact, may help to develop therapy to spur lung regeneration and alleviate fibrosis.	[Cao, Zhongwei; Lis, Raphael; Chayez, Deebly; Shido, Koji; Rabbany, Sina Y.; Rafii, Shahin; Ding, Bi-Sen] Weill Cornell Med, Ansary Stem Cell Inst, New York, NY USA; [Cao, Zhongwei; Lis, Raphael; Shido, Koji; Rabbany, Sina Y.; Rafii, Shahin] Weill Cornell Med, Dept Med, Div Regenerat Med, New York, NY USA; [Cao, Zhongwei; Ding, Bi-Sen] Sichuan Univ, West China Univ Hosp 2, State Key Lab Biotherapy, Lab Birth Defects & Related Dis Women & Children, Chengdu 610064, Peoples R China; [Cao, Zhongwei; Ding, Bi-Sen] Collaborat Innovat Ctr Biotherapy, Chengdu, Peoples R China; [Ginsberg, Michael] Angiocrine Biosci, New York, NY USA; [Chayez, Deebly; Ding, Bi-Sen] Weill Cornell Med, Dept Med Genet, New York, NY USA; [Rabbany, Sina Y.] Hofstra Univ, Bioengn Program, Hempstead, NY 11550 USA; [Fong, Guo-Hua] Univ Connecticut, Dept Cell Biol, Farmington, CT USA; [Sakmar, Thomas P.] Rockefeller Univ, Lab Chem Biol & Signal Transduct, 1230 York Ave, New York, NY 10021 USA; [Sakmar, Thomas P.] Karolinska Inst, Ctr Alzheimer Res, Div Neurogeriatr, Huddinge, Sweden	Cornell University; Cornell University; Sichuan University; Cornell University; Hofstra University; University of Connecticut; Rockefeller University; Karolinska Institutet	Cao, ZW; Rafii, S; Ding, BS (corresponding author), Weill Cornell Med, Ansary Stem Cell Inst, New York, NY USA.; Cao, ZW; Rafii, S (corresponding author), Weill Cornell Med, Dept Med, Div Regenerat Med, New York, NY USA.; Cao, ZW; Ding, BS (corresponding author), Sichuan Univ, West China Univ Hosp 2, State Key Lab Biotherapy, Lab Birth Defects & Related Dis Women & Children, Chengdu 610064, Peoples R China.; Ding, BS (corresponding author), Collaborat Innovat Ctr Biotherapy, Chengdu, Peoples R China.; Ding, BS (corresponding author), Weill Cornell Med, Dept Med Genet, New York, NY USA.	zhc2007@med.cornell.edu; srafii@med.cornell.edu; bid2004@med.cornell.edu	Sakmar, Thomas P/D-1833-2015	Sakmar, Thomas P/0000-0002-2836-8953	New York Stem Cell Foundation; American Heart Association [12SDG1213004]; Ansary Stem Cell Institute; National Eye Institute [2R01EY019721-06A1]; Robertson Foundation; Empire State Stem Cell Board and New York State Department of Health [C024180, C026438, C026878, C028117]; National Heart, Lung, and Blood Institute [R01HL097797, R01HL119872]; Angiocrine Bioscience, New York; NATIONAL EYE INSTITUTE [R01EY019721] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL097797, R01HL119872] Funding Source: NIH RePORTER	New York Stem Cell Foundation; American Heart Association(American Heart Association); Ansary Stem Cell Institute; National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Robertson Foundation; Empire State Stem Cell Board and New York State Department of Health; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Angiocrine Bioscience, New York; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We are grateful to S. M. Albelda, M. Beers, and V. R. Muzykantov (University of Pennsylvania) for evaluating our study. Vector 2.2 for the generation of pseudotyped viral particle was a gift from I. Chen and K. Morizono (University of California, Los Angeles). Floxed Cxcr7 mice were kindly provided by Chemocentryx, CA. We would also like to thank R.H. Adams and T. Gridley for offering mouse lines of inducible EC-specific Cdh5(PAC)/VE-cadherin-Cre<SUP>ERT2</SUP> and floxed Jagl. Z.C. is supported by a Druckenmiller Fellowship from the New York Stem Cell Foundation. B.-S.D. is supported by a National Scientist Development Grant from the American Heart Association (12SDG1213004) and the Ansary Stem Cell Institute. G.-H.F. is supported by the National Eye Institute (2R01EY019721-06A1). T.P.S. receives support for this project from the Robertson Foundation. S.R. is supported by the Ansary Stem Cell Institute, the Empire State Stem Cell Board and New York State Department of Health grants (nos. C024180, C026438, C026878, C028117), and by grants from the National Heart, Lung, and Blood Institute (R01HL097797 and R01HL119872). M.G. is an employee of Angiocrine Bioscience, New York, New York, USA. S.R. is the founder of and a non-paid consultant to the Angiocrine Bioscience, New York.	Armulik A, 2011, DEV CELL, V21, P193, DOI 10.1016/j.devcel.2011.07.001; Barkauskas CE, 2013, J CLIN INVEST, V123, P3025, DOI 10.1172/JCI68782; Beers MF, 2011, J CLIN INVEST, V121, P2065, DOI 10.1172/JCI45961; Boulter L, 2012, NAT MED, V18, P572, DOI 10.1038/nm.2667; Bry M, 2014, PHYSIOL REV, V94, P779, DOI 10.1152/physrev.00028.2013; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Chow A, 2013, NAT MED, V19, P429, DOI 10.1038/nm.3057; Corada M, 2010, DEV CELL, V18, P938, DOI 10.1016/j.devcel.2010.05.006; De Palma M, 2013, CANCER CELL, V23, P277, DOI 10.1016/j.ccr.2013.02.013; Decaillot FM, 2011, J BIOL CHEM, V286, P32188, DOI 10.1074/jbc.M111.277038; Degryse AL, 2010, AM J PHYSIOL-LUNG C, V299, pL442, DOI 10.1152/ajplung.00026.2010; Desai TJ, 2014, NATURE, V507, P190, DOI 10.1038/nature12930; Ding BS, 2014, NATURE, V505, P97, DOI 10.1038/nature12681; Ding BS, 2011, CELL, V147, P539, DOI 10.1016/j.cell.2011.10.003; Du R, 2008, CANCER CELL, V13, P206, DOI 10.1016/j.ccr.2008.01.034; Epelman S, 2014, IMMUNITY, V41, P21, DOI 10.1016/j.immuni.2014.06.013; Farkas L, 2009, J CLIN INVEST, V119, P1298, DOI 10.1172/JCI36136; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Gibbons MA, 2011, AM J RESP CRIT CARE, V184, P569, DOI 10.1164/rccm.201010-1719OC; Henderson NC, 2013, NAT MED, V19, P1617, DOI 10.1038/nm.3282; Hergenreider E, 2012, NAT CELL BIOL, V14, P249, DOI 10.1038/ncb2441; High FA, 2008, P NATL ACAD SCI USA, V105, P1955, DOI 10.1073/pnas.0709663105; Ho VC, 2012, CIRCULATION, V126, P741, DOI 10.1161/CIRCULATIONAHA.112.091603; Hofmann JJ, 2010, DEVELOPMENT, V137, P4061, DOI 10.1242/dev.052118; Kotton DN, 2014, NAT MED, V20, P822, DOI 10.1038/nm.3642; Kozower BD, 2003, NAT BIOTECHNOL, V21, P392, DOI 10.1038/nbt806; Landsman L, 2007, J IMMUNOL, V178, P2000, DOI 10.4049/jimmunol.178.4.2000; Lazarus A, 2011, DEVELOPMENT, V138, P2359, DOI 10.1242/dev.060723; LeCouter J, 2003, SCIENCE, V299, P890, DOI 10.1126/science.1079562; Lee JH, 2014, CELL, V156, P440, DOI 10.1016/j.cell.2013.12.039; Li XD, 2009, NAT MED, V15, P1289, DOI 10.1038/nm.2021; Li XF, 2014, CIRCULATION, V129, P1244, DOI 10.1161/CIRCULATIONAHA.113.006840; Lin SL, 2010, P NATL ACAD SCI USA, V107, P4194, DOI 10.1073/pnas.0912228107; Liu H, 2009, CIRC RES, V104, P466, DOI 10.1161/CIRCRESAHA.108.184846; Liu TJ, 2009, AM J PATHOL, V174, P1745, DOI 10.2353/ajpath.2009.080618; Lobov IB, 2005, NATURE, V437, P417, DOI 10.1038/nature03928; Matthay MA, 2012, EUR RESPIR J, V39, P1062, DOI 10.1183/09031936.00204211; Morimoto M, 2010, J CELL SCI, V123, P213, DOI 10.1242/jcs.058669; Morizono K, 2005, NAT MED, V11, P346, DOI 10.1038/nm1192; Murakami M, 2008, ARTERIOSCL THROM VAS, V28, P658, DOI 10.1161/ATVBAHA.107.150433; Noble PW, 2012, J CLIN INVEST, V122, P2756, DOI 10.1172/JCI60323; Pardo-Saganta A, 2015, NATURE, V523, P597, DOI 10.1038/nature14553; Petrache I, 2005, NAT MED, V11, P491, DOI 10.1038/nm1238; Phng LK, 2009, DEV CELL, V16, P70, DOI 10.1016/j.devcel.2008.12.009; Rackley CR, 2012, J CLIN INVEST, V122, P2724, DOI 10.1172/JCI60519; Rafii S, 2015, NAT CELL BIOL, V17, P123, DOI 10.1038/ncb3096; Ramasamy SK, 2014, NATURE, V507, P376, DOI 10.1038/nature13146; Rock JR, 2011, P NATL ACAD SCI USA, V108, pE1475, DOI 10.1073/pnas.1117988108; Scheppke L, 2012, BLOOD, V119, P2149, DOI 10.1182/blood-2011-04-348706; Stenman JM, 2008, SCIENCE, V322, P1247, DOI 10.1126/science.1164594; Takeda Y, 2011, NATURE, V479, P122, DOI 10.1038/nature10507; Thannickal VJ, 2014, J CLIN INVEST, V124, P4673, DOI 10.1172/JCI74368; Tung JJ, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006601; Vaughan AE, 2015, NATURE, V517, P621, DOI 10.1038/nature14112; Westphalen K, 2014, NATURE, V506, P503, DOI 10.1038/nature12902; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Xu KL, 2010, AM J PHYSIOL-LUNG C, V298, pL45, DOI 10.1152/ajplung.90550.2008; Zavadil J, 2004, EMBO J, V23, P1155, DOI 10.1038/sj.emboj.7600069; Zeisberg EM, 2007, NAT MED, V13, P952, DOI 10.1038/nm1613; Zhou YL, 2014, J CLIN INVEST, V124, P3825, DOI 10.1172/JCI76431	60	135	148	2	105	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2016	22	2					154	162		10.1038/nm.4035	http://dx.doi.org/10.1038/nm.4035			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DC8JX	26779814	Green Accepted			2022-12-25	WOS:000369466800009
J	Wenger, N; Moraud, EM; Gandar, J; Musienko, P; Capogrosso, M; Baud, L; Le Goff, CG; Barraud, Q; Pavlova, N; Dominici, N; Minev, IR; Asboth, L; Hirsch, A; Duis, S; Kreider, J; Mortera, A; Haverbeck, O; Kraus, S; Schmitz, F; DiGiovanna, J; van den Brand, R; Bloch, J; Detemple, P; Lacour, SP; Bezard, E; Micera, S; Courtine, G				Wenger, Nikolaus; Moraud, Eduardo Martin; Gandar, Jerome; Musienko, Pavel; Capogrosso, Marco; Baud, Laetitia; Le Goff, Camille G.; Barraud, Quentin; Pavlova, Natalia; Dominici, Nadia; Minev, Ivan R.; Asboth, Leonie; Hirsch, Arthur; Duis, Simone; Kreider, Julie; Mortera, Andrea; Haverbeck, Oliver; Kraus, Silvio; Schmitz, Felix; DiGiovanna, Jack; van den Brand, Rubia; Bloch, Jocelyne; Detemple, Peter; Lacour, Stephanie P.; Bezard, Erwan; Micera, Silvestro; Courtine, Gregoire			Spatiotemporal neuromodulation therapies engaging muscle synergies improve motor control after spinal cord injury	NATURE MEDICINE			English	Article							EPIDURAL ELECTRICAL-STIMULATION; FUNCTIONAL WALKING; PRIMITIVES; CIRCUITS; LUMBAR; IDENTIFICATION; MODULATION; LOCOMOTION; COMPONENTS; MOVEMENTS	Electrical neuromodulation of lumbar segments improves motor control after spinal cord injury in animal models and humans. However, the physiological principles underlying the effect of this intervention remain poorly understood, which has limited the therapeutic approach to continuous stimulation applied to restricted spinal cord locations. Here we developed stimulation protocols that reproduce the natural dynamics of motoneuron activation during locomotion. For this, we computed the spatiotemporal activation pattern of muscle synergies during locomotion in healthy rats. Computer simulations identified optimal electrode locations to target each synergy through the recruitment of proprioceptive feedback circuits. This framework steered the design of spatially selective spinal implants and real-time control software that modulate extensor and flexor synergies with precise temporal resolution. Spatiotemporal neuromodulation therapies improved gait quality, weight-bearing capacity, endurance and skilled locomotion in several rodent models of spinal cord injury. These new concepts are directly translatable to strategies to improve motor control in humans.	[Wenger, Nikolaus; Gandar, Jerome; Musienko, Pavel; Baud, Laetitia; Le Goff, Camille G.; Barraud, Quentin; Pavlova, Natalia; Dominici, Nadia; Asboth, Leonie; Duis, Simone; Kreider, Julie; van den Brand, Rubia; Courtine, Gregoire] Swiss Fed Inst Technol EPFL, Ctr Neuroprosthet, Int Parapleg Fdn Chair Spinal Cord Repair, Lausanne, Switzerland; [Wenger, Nikolaus; Gandar, Jerome; Musienko, Pavel; Baud, Laetitia; Le Goff, Camille G.; Barraud, Quentin; Pavlova, Natalia; Dominici, Nadia; Asboth, Leonie; Duis, Simone; Kreider, Julie; van den Brand, Rubia; Courtine, Gregoire] Swiss Fed Inst Technol EPFL, Sch Life Sci, Brain Mind Inst, Lausanne, Switzerland; [Wenger, Nikolaus] Charite, Dept Neurol Expt Neurol, D-13353 Berlin, Germany; [Wenger, Nikolaus] Charite, Ctr Stroke Res Berlin, D-13353 Berlin, Germany; [Moraud, Eduardo Martin; Capogrosso, Marco; Mortera, Andrea; DiGiovanna, Jack; Micera, Silvestro] Ecole Polytech Fed Lausanne, Ctr Neuroprosthet, Bertarelli Fdn Chair Translat Neuroengn, CH-1015 Lausanne, Switzerland; [Moraud, Eduardo Martin; Capogrosso, Marco; Mortera, Andrea; DiGiovanna, Jack; Micera, Silvestro] Ecole Polytech Fed Lausanne, Sch Bioengn, Inst Bioengn, CH-1015 Lausanne, Switzerland; [Musienko, Pavel; Pavlova, Natalia] IP Pavlov Physiol Inst, Motor Physiol Lab, St Petersburg 199034, Russia; [Musienko, Pavel] St Petersburg State Univ, Inst Translat Biomed, Lab Neuroprosthet, St Petersburg 199034, Russia; [Musienko, Pavel] Inst Physiopulmonol, Dept Nonpulmonary TB, Childrens Surg & Orthoped Clin, Lab Neurophysiol & Expt Neurorehabil, St Petersburg, Russia; [Capogrosso, Marco; Micera, Silvestro] Scuola Super Sant Anna, BioRobot Inst, Pisa, Italy; [Dominici, Nadia] Vrije Univ Amsterdam, Fac Behav & Movement Sci, MOVE Res Inst Amsterdam, Amsterdam, Netherlands; [Minev, Ivan R.; Hirsch, Arthur; Lacour, Stephanie P.] Ecole Polytech Fed Lausanne, Ctr Neuroprosthet, Bertarelli Fdn Chair Neuroprosthet Technol, CH-1015 Lausanne, Switzerland; [Minev, Ivan R.; Hirsch, Arthur; Lacour, Stephanie P.] Ecole Polytech Fed Lausanne, Inst Bioengn, CH-1015 Lausanne, Switzerland; [Haverbeck, Oliver; Kraus, Silvio] Micromotive GmbH, Mainz, Germany; [Schmitz, Felix; Detemple, Peter] Fraunhofer Inst Chem Technol, Mainz Inst Microtechnol ICT IMM, Mainz, Germany; [Bloch, Jocelyne; Courtine, Gregoire] CHU Vaudois, Lausanne, Switzerland; [Bezard, Erwan] Motac Neurosci Inc, Beijing, Peoples R China; [Bezard, Erwan] Univ Bordeaux, Inst Malad Neurodegenerat, Bordeaux, France; [Bezard, Erwan] CNRS, Inst Malad Neurodegenerat, Bordeaux, France	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Russian Academy of Sciences; St. Petersburg Scientific Centre of the Russian Academy of Sciences; Pavlov Institute of Physiology Russian Academy of Sciences; Saint Petersburg State University; St. Petersburg State Research Institute of Phthisiopulmonology; Scuola Superiore Sant'Anna; Vrije Universiteit Amsterdam; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Fraunhofer Gesellschaft; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS)	Courtine, G (corresponding author), Swiss Fed Inst Technol EPFL, Ctr Neuroprosthet, Int Parapleg Fdn Chair Spinal Cord Repair, Lausanne, Switzerland.; Courtine, G (corresponding author), Swiss Fed Inst Technol EPFL, Sch Life Sci, Brain Mind Inst, Lausanne, Switzerland.; Courtine, G (corresponding author), CHU Vaudois, Lausanne, Switzerland.	gregoire.courtine@epfl.ch	courtine, gregoire/AAJ-1694-2020; Bezard, Erwan/ABD-5153-2021; Lacour, Stephanie P./E-6375-2010; Micera, Silvestro/AAD-6630-2021; Bloch, Jocelyne/A-9668-2017; Lacour, Stephanie/AAR-2213-2020; Minev, Ivan/AAI-6072-2021; Musienko, Pavel/L-6677-2015	courtine, gregoire/0000-0002-5744-4142; Bloch, Jocelyne/0000-0002-6405-1590; Lacour, Stephanie/0000-0001-9075-4022; Minev, Ivan/0000-0003-2055-7386; Bezard, Erwan/0000-0002-0410-4638; Barraud, Quentin/0000-0003-0894-1959; Asboth, Leonie/0000-0003-2414-9574; Dominici, Nadia/0000-0003-2312-915X; Martin Moraud, Eduardo/0000-0002-6148-7065; Capogrosso, Marco/0000-0002-0975-316X; Musienko, Pavel/0000-0002-7324-9021	Charite-Universitatsmedizin Berlin; Berlin Institute of Health; European Commission [CP-IP 258654]; European Research Council [ERC 261247]; Russian Science Foundation (RSF) [14-15-00788]; Swiss National Science Foundation Centre of Competence in Research (NCCR) in Robotics; Dynamo project; NanoTera.ch program (SpineRepair); Russian Science Foundation [14-15-00788] Funding Source: Russian Science Foundation	Charite-Universitatsmedizin Berlin; Berlin Institute of Health; European Commission(European CommissionEuropean Commission Joint Research Centre); European Research Council(European Research Council (ERC)European Commission); Russian Science Foundation (RSF)(Russian Science Foundation (RSF)); Swiss National Science Foundation Centre of Competence in Research (NCCR) in Robotics; Dynamo project; NanoTera.ch program (SpineRepair); Russian Science Foundation(Russian Science Foundation (RSF))	We thank people who have helped over the past 6 years to take care of injured animals and to test multiple iterations of neural implants. We also would like to thank D. Pioletti for providing access to the microcomputed tomography scanner. N.W. is a participant in the Charite Clinical Scientist Program funded by the Charite-Universitatsmedizin Berlin and the Berlin Institute of Health. Funding was provided by the European Commission's Seventh Framework Programme (CP-IP 258654, NeuWALK, G.C., S.M., E.B., J.B. and P.D.); a Starting Grant from the European Research Council (ERC 261247, Walk Again, G.C.); the Russian Science Foundation (RSF grant 14-15-00788, P.M.) and the Swiss National Science Foundation Centre of Competence in Research (NCCR) in Robotics (G.C., S.L., S.M.), Dynamo project (S.M.) and NanoTera.ch program (SpineRepair) (G.C., S.L. and S.M.).	Afshar P, 2013, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00117; Angeli CA, 2014, BRAIN, V137, P1394, DOI 10.1093/brain/awu038; Arber S, 2012, NEURON, V74, P975, DOI 10.1016/j.neuron.2012.05.011; Barthelemy D, 2007, J NEUROPHYSIOL, V97, P1986, DOI 10.1152/jn.00818.2006; Berniker M, 2009, P NATL ACAD SCI USA, V106, P7601, DOI 10.1073/pnas.0901512106; Bernstein N.A., 1967, COORDINATION REGULAT; Bizzi E, 2000, NAT REV NEUROSCI, V1, P101, DOI 10.1038/35039000; Borton D, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005968; Bourane S, 2015, CELL, V160, P503, DOI 10.1016/j.cell.2015.01.011; Canbay S, 2014, CLIN ANAT, V27, P227, DOI 10.1002/ca.22253; Capaday C, 2002, TRENDS NEUROSCI, V25, P370, DOI 10.1016/S0166-2236(02)02173-2; Capogrosso M, 2013, J NEUROSCI, V33, P19326, DOI 10.1523/JNEUROSCI.1688-13.2013; Cappellini G, 2010, J NEUROPHYSIOL, V104, P3064, DOI 10.1152/jn.00318.2010; Carhart MR, 2004, IEEE T NEUR SYS REH, V12, P32, DOI 10.1109/TNSRE.2003.822763; Clarac F, 2000, TRENDS NEUROSCI, V23, P199, DOI 10.1016/S0166-2236(99)01535-0; Consortium for Addressing Paralysis through Spinal Stimulation Technologies, 2015, FRAM RES STUD EP SPI; Courtine G, 2009, NAT NEUROSCI, V12, P1333, DOI 10.1038/nn.2401; Danner SM, 2015, BRAIN, V138, P577, DOI 10.1093/brain/awu372; Dominici N, 2011, SCIENCE, V334, P997, DOI 10.1126/science.1210617; Edgerton VR, 2008, BRAIN RES REV, V57, P241, DOI 10.1016/j.brainresrev.2007.09.002; Gad P, 2012, J NEUROENG REHABIL, V9, DOI 10.1186/1743-0003-9-38; Gerasimenko YP, 2006, J NEUROSCI METH, V157, P253, DOI 10.1016/j.jneumeth.2006.05.004; Gerasimenko YP, 2015, J NEUROTRAUM, V32, P1968, DOI 10.1089/neu.2015.4008; Giszter SF, 2015, CURR OPIN NEUROBIOL, V33, P156, DOI 10.1016/j.conb.2015.04.004; Grillner S, 2009, CURR OPIN NEUROBIOL, V19, P572, DOI 10.1016/j.conb.2009.10.011; Hagglund M, 2013, P NATL ACAD SCI USA, V110, P11589, DOI 10.1073/pnas.1304365110; Hart CB, 2010, J NEUROSCI, V30, P1322, DOI 10.1523/JNEUROSCI.5894-08.2010; Herman R, 2002, SPINAL CORD, V40, P65, DOI 10.1038/sj.sc.3101263; Hofstoetter US, 2015, J NEUROPHYSIOL, V114, P400, DOI 10.1152/jn.00136.2015; Holinski BJ, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/5/056008; Ichiyama RM, 2008, J NEUROSCI, V28, P7370, DOI 10.1523/JNEUROSCI.1881-08.2008; Ivanenko YP, 2003, J NEUROPHYSIOL, V90, P3555, DOI 10.1152/jn.00223.2003; Kargo WJ, 2010, J NEUROPHYSIOL, V103, P573, DOI 10.1152/jn.01054.2007; Kiehn O, 2006, ANNU REV NEUROSCI, V29, P279, DOI 10.1146/annurev.neuro.29.051605.112910; La Scaleia V, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00305; Ladenbauer J, 2010, IEEE T NEUR SYS REH, V18, P637, DOI 10.1109/TNSRE.2010.2054112; Lavrov I, 2008, J NEUROSCI, V28, P6022, DOI 10.1523/JNEUROSCI.0080-08.2008; Lee DD, 1999, NATURE, V401, P788, DOI 10.1038/44565; Levine AJ, 2014, NAT NEUROSCI, V17, P586, DOI 10.1038/nn.3675; Lozano AM, 2013, NEURON, V77, P406, DOI 10.1016/j.neuron.2013.01.020; Mariani B, 2013, IEEE T BIO-MED ENG, V60, P155, DOI 10.1109/TBME.2012.2227317; Minassian K, 2004, SPINAL CORD, V42, P401, DOI 10.1038/sj.sc.3101615; Rattay F, 2000, SPINAL CORD, V38, P473, DOI 10.1038/sj.sc.3101039; Rejc E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133998; Sayenko DG, 2014, J NEUROPHYSIOL, V111, P1088, DOI 10.1152/jn.00489.2013; Tripodi M, 2011, NATURE, V479, P61, DOI 10.1038/nature10538; van den Brand R, 2012, SCIENCE, V336, P1182, DOI 10.1126/science.1217416; Wenger N, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008325; Yakovenko S, 2002, J NEUROPHYSIOL, V87, P1542, DOI 10.1152/jn.00479.2001; Zeng Fan-Gang, 2008, IEEE Rev Biomed Eng, V1, P115, DOI 10.1109/RBME.2008.2008250	50	179	194	1	79	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2016	22	2					138	145		10.1038/nm.4025	http://dx.doi.org/10.1038/nm.4025			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DC8JX	26779815	Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000369466800007
J	Zhang, XY; Choi, PS; Francis, JM; Imielinski, M; Watanabe, H; Cherniack, AD; Meyerson, M				Zhang, Xiaoyang; Choi, Peter S.; Francis, Joshua M.; Imielinski, Marcin; Watanabe, Hideo; Cherniack, Andrew D.; Meyerson, Matthew			Identification of focally amplified lineage-specific super-enhancers in human epithelial cancers	NATURE GENETICS			English	Article							COPY-NUMBER ALTERATION; B-CELL LINE; LUNG ADENOCARCINOMA; GENE-EXPRESSION; TRANSCRIPTION FACTORS; HUMAN GENOME; C-MYC; SIGNATURES; LEUKEMIA; TRANSFORMATION	Whole-genome analysis approaches are identifying recurrent cancer-associated somatic alterations in noncoding DNA regions. We combined somatic copy number analysis of 12 tumor types with tissue-specific epigenetic profiling to identify significant regions of focal amplification harboring super-enhancers. Copy number gains of noncoding regions harboring super-enhancers near KLF5, USP12, PARD6B and MYC are associated with overexpression of these cancer-related genes. We show that two distinct focal amplifications of super-enhancers 3' to MYC in lung adenocarcinoma (MYC-LASE) and endometrial carcinoma (MYC-ECSE) are physically associated with the MYC promoter and correlate with MYC overexpression. CRISPR/Cas9-mediated repression or deletion of a constituent enhancer within the MYC-LASE region led to significant reductions in the expression of MYC and its target genes and to the impairment of anchorage independent and clonogenic growth, consistent with an oncogenic function. Our results suggest that genomic amplification of super-enhancers represents a common mechanism to activate cancer driver genes in multiple cancer types.	[Zhang, Xiaoyang; Choi, Peter S.; Francis, Joshua M.; Imielinski, Marcin; Meyerson, Matthew] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Zhang, Xiaoyang; Choi, Peter S.; Francis, Joshua M.; Imielinski, Marcin; Cherniack, Andrew D.; Meyerson, Matthew] Broad Inst Harvard & MIT, Canc Program, Cambridge, MA USA; [Imielinski, Marcin] Massachusetts Gen Hosp, Mol Pathol Unit, Charlestown, MA USA; [Watanabe, Hideo] Icahn Sch Med Mt Sinai, Dept Med, Div Pulm Crit Care & Sleep Med, New York, NY 10029 USA; [Watanabe, Hideo] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Meyerson, Matthew] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Meyerson, Matthew] Dana Farber Canc Inst, Ctr Canc Genome Discovery, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute	Meyerson, M (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.; Meyerson, M (corresponding author), Broad Inst Harvard & MIT, Canc Program, Cambridge, MA USA.; Meyerson, M (corresponding author), Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA.; Meyerson, M (corresponding author), Dana Farber Canc Inst, Ctr Canc Genome Discovery, Boston, MA 02115 USA.	matthew_meyerson@dfci.harvard.edu	Cherniack, Andrew D./AAY-8132-2020; Cherniack, Andrew/AAC-5310-2019	Cherniack, Andrew D./0000-0003-0470-0111; Meyerson, Matthew/0000-0002-9133-8108; Choi, Peter/0000-0002-2820-3032	US Department of Defense [W81XWH-12-1-0269]; National Cancer Institute [1R35CA197568, 1F32CA180662]; American Cancer Society; Lung Cancer Research Foundation; American Association for Cancer Research-John and Elizabeth Leonard Family Foundation; International Association for the Study of Lung Cancer; NATIONAL CANCER INSTITUTE [R35CA197568, F32CA180662] Funding Source: NIH RePORTER	US Department of Defense(United States Department of Defense); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); Lung Cancer Research Foundation; American Association for Cancer Research-John and Elizabeth Leonard Family Foundation; International Association for the Study of Lung Cancer; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank G. Ha and other members of the Meyerson laboratory for discussions. We acknowledge support from US Department of Defense grant W81XWH-12-1-0269 (KM.), National Cancer Institute grant 1R35CA197568 (KM.) and the American Cancer Society Research Professorship (KM.). X.Z. is supported by the Lung Cancer Research Foundation and the American Association for Cancer Research-John and Elizabeth Leonard Family Foundation Basic Cancer Research Fellowship. P.S.C. is supported by a fellowship from the International Association for the Study of Lung Cancer and National Cancer Institute grant 1F32CA180662.	Akhtar-Zaidi B, 2012, SCIENCE, V336, P736, DOI 10.1126/science.1217277; Bailey SD, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7186; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; BATTEY J, 1983, CELL, V34, P779, DOI 10.1016/0092-8674(83)90534-2; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bignell GR, 2010, NATURE, V463, P893, DOI 10.1038/nature08768; Bulger M, 2011, CELL, V144, P327, DOI 10.1016/j.cell.2011.01.024; Burska UL, 2013, J BIOL CHEM, V288, P32641, DOI 10.1074/jbc.M113.485912; Coller HA, 2000, P NATL ACAD SCI USA, V97, P3260, DOI 10.1073/pnas.97.7.3260; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Deng WL, 2012, CELL, V149, P1233, DOI 10.1016/j.cell.2012.03.051; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Francis JM, 2014, CANCER DISCOV, V4, P956, DOI 10.1158/2159-8290.CD-13-0879; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Graf T, 2009, NATURE, V462, P587, DOI 10.1038/nature08533; Groschel S, 2014, CELL, V157, P369, DOI 10.1016/j.cell.2014.02.019; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Herranz D, 2014, NAT MED, V20, P1130, DOI 10.1038/nm.3665; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Imielinski M, 2012, CELL, V150, P1107, DOI 10.1016/j.cell.2012.08.029; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kearns NA, 2015, NAT METHODS, V12, P401, DOI 10.1038/nmeth.3325; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Lupien M, 2008, CELL, V132, P958, DOI 10.1016/j.cell.2008.01.018; Mansour MR, 2014, SCIENCE, V346, P1373, DOI 10.1126/science.1259037; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Northcott PA, 2014, NATURE, V511, P428, DOI 10.1038/nature13379; Ong CT, 2011, NAT REV GENET, V12, P283, DOI 10.1038/nrg2957; Pott S, 2015, NAT GENET, V47, P8, DOI 10.1038/ng.3167; Qiu RG, 2000, CURR BIOL, V10, P697, DOI 10.1016/S0960-9822(00)00535-2; Schlosser I, 2005, ONCOGENE, V24, P520, DOI 10.1038/sj.onc.1208198; Schuhmacher M, 2001, NUCLEIC ACIDS RES, V29, P397, DOI 10.1093/nar/29.2.397; Shi J, 2013, GENE DEV, V27, P2648, DOI 10.1101/gad.232710.113; Stephens PJ, 2009, NATURE, V462, P1005, DOI 10.1038/nature08645; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Wang J, 2012, GENOME RES, V22, P1798, DOI 10.1101/gr.139105.112; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Xie W, 2013, SCIENCE, V341, P245, DOI 10.1126/science.1236254; Xue W, 2012, P NATL ACAD SCI USA, V109, P8212, DOI 10.1073/pnas.1206062109; Zeller KI, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r69	49	212	221	2	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2016	48	2					176	182		10.1038/ng.3470	http://dx.doi.org/10.1038/ng.3470			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DC2JV	26656844	Green Accepted, Green Submitted			2022-12-25	WOS:000369043900015
J	Kim, KH; Kim, W; Howard, TP; Vazquez, F; Tsherniak, A; Wu, JN; Wang, WS; Haswell, JR; Walensky, LD; Hahn, WC; Orkin, SH; Roberts, CWM				Kim, Kimberly H.; Kim, Woojin; Howard, Thomas P.; Vazquez, Francisca; Tsherniak, Aviad; Wu, Jennifer N.; Wang, Weishan; Haswell, Jeffrey R.; Walensky, Loren D.; Hahn, William C.; Orkin, Stuart H.; Roberts, Charles W. M.			SWI/SNF-mutant cancers depend on catalytic and non-catalytic activity of EZH2	NATURE MEDICINE			English	Article							METHYLTRANSFERASE EZH2; FREQUENT MUTATIONS; CELL CARCINOMA; POLYCOMB; COMPLEX; INHIBITION; LYMPHOMA; TUMORS; GENES; H3K27	Human cancer genome sequencing has recently revealed that genes that encode subunits of SWI/SNF chromatin remodeling complexes are frequently mutated across a wide variety of cancers, and several subunits of the complex have been shown to have bona fide tumor suppressor activity(1). However, whether mutations in SWI/SNF subunits result in shared dependencies is unknown. Here we show that EZH2, a catalytic subunit of the polycomb repressive complex 2 (PRC2), is essential in all tested cancer cell lines and xenografts harboring mutations of the SWI/SNF subunits ARID1A, PBRM1, and SMARCA4, which are several of the most frequently mutated SWI/SNF subunits in human cancer, but that co-occurrence of a Ras pathway mutation is correlated with abrogation of this dependence. Notably, we demonstrate that SWI/SNF-mutant cancer cells are primarily dependent on a non-catalytic role of EZH2 in the stabilization of the PRC2 complex, and that they are only partially dependent on EZH2 histone methyltransferase activity. These results not only reveal a shared dependency of cancers with genetic alterations in SWI/SNF subunits, but also suggest that EZH2 enzymatic inhibitors now in clinical development may not fully suppress the oncogenic activity of EZH2.	[Kim, Kimberly H.; Kim, Woojin; Howard, Thomas P.; Wu, Jennifer N.; Wang, Weishan; Haswell, Jeffrey R.; Walensky, Loren D.; Orkin, Stuart H.; Roberts, Charles W. M.] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Kim, Kimberly H.; Kim, Woojin; Howard, Thomas P.; Wu, Jennifer N.; Wang, Weishan; Haswell, Jeffrey R.; Walensky, Loren D.; Orkin, Stuart H.; Roberts, Charles W. M.] Boston Childrens Hosp, Div Hematol Oncol, Boston, MA USA; [Kim, Kimberly H.; Kim, Woojin; Howard, Thomas P.; Wu, Jennifer N.; Wang, Weishan; Haswell, Jeffrey R.; Walensky, Loren D.; Orkin, Stuart H.; Roberts, Charles W. M.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Vazquez, Francisca; Tsherniak, Aviad; Wu, Jennifer N.; Hahn, William C.; Roberts, Charles W. M.] Broad Inst Harvard & Massachusetts Inst Technol, Cambridge, MA USA; [Hahn, William C.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Hahn, William C.] Dana Farber Canc Inst, Ctr Canc Genome Discovery, Boston, MA 02115 USA; [Orkin, Stuart H.; Roberts, Charles W. M.] Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Howard Hughes Medical Institute	Roberts, CWM (corresponding author), St Jude Childrens Res Hosp, Ctr Comprehens Canc, Dept Oncol, 332 N Lauderdale St, Memphis, TN 38105 USA.	charles.roberts@stjude.org	Vazquez, Francisca/ABC-4620-2020; Roberts, Charles/N-2541-2018; Vazquez, Francisca/AAA-3751-2020	Roberts, Charles/0000-0003-1135-1896; Vazquez, Francisca/0000-0002-2857-4685; Tsherniak, Aviad/0000-0002-3797-1877; Howard, Thomas/0000-0002-3438-2831	National Cancer Center; US National Institutes of Health [R01CA172152, R01CA113794, U01CA176058]; Claudia Adams Barr grant; National Institute of General Medical Sciences [T32GM007753]; Cure AT/RT Now foundation; Avalanna Fund; Garrett B. Smith Foundation; Miles for Mary; Leukemia & Lymphoma Society Specialized Center of Research Award Project Grant; Todd J. Schwartz Memorial Fund; NATIONAL CANCER INSTITUTE [R01CA172152, R01CA113794, U01CA176058] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER	National Cancer Center; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Claudia Adams Barr grant; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Cure AT/RT Now foundation; Avalanna Fund; Garrett B. Smith Foundation; Miles for Mary; Leukemia & Lymphoma Society Specialized Center of Research Award Project Grant; Todd J. Schwartz Memorial Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	EZ005 was provided courtesy of J. Bradner (Dana-Farber Cancer Institute). Plasmids for wild-type and SET domain-truncated (SET) EZH2 were provided courtesy of M. Brown (Dana-Farber Cancer Institute). K.H.K. was supported by an award from National Cancer Center. This work was supported by US National Institutes of Health grants R01CA172152 (C.W.M.R.), R01CA113794 (C.W.M.R.) and U01CA176058 (W.C.H.). W.K. was supported by a Claudia Adams Barr grant. T.P.H. was supported by an award from the National Institute of General Medical Sciences (T32GM007753). The Cure AT/RT Now foundation, the Avalanna Fund, the Garrett B. Smith Foundation, Miles for Mary (C.W.M.R.), a Leukemia & Lymphoma Society Specialized Center of Research Award Project Grant (L.D.W.) and the Todd J. Schwartz Memorial Fund (L.D.W.) provided additional support.	Bultman SJ, 2008, ONCOGENE, V27, P460, DOI 10.1038/sj.onc.1210664; Cao R, 2004, MOL CELL, V15, P57, DOI 10.1016/j.molcel.2004.06.020; Cheung HW, 2011, P NATL ACAD SCI USA, V108, P12372, DOI 10.1073/pnas.1109363108; Cowley GS, 2014, SCI DATA, V1, DOI 10.1038/sdata.2014.35; De Raedt T, 2014, NATURE, V514, P247, DOI 10.1038/nature13561; Fujimoto A, 2012, NAT GENET, V44, P760, DOI 10.1038/ng.2291; Guan B., 2014, JNCI-J NATL CANCER I, V106, pdju46; Gui YT, 2011, NAT GENET, V43, P875, DOI 10.1038/ng.907; Jones S, 2010, SCIENCE, V330, P228, DOI 10.1126/science.1196333; Kadoch C, 2013, NAT GENET, V45, P592, DOI 10.1038/ng.2628; Kennison JA, 1995, ANNU REV GENET, V29, P289, DOI 10.1146/annurev.ge.29.120195.001445; Kia SK, 2008, MOL CELL BIOL, V28, P3457, DOI 10.1128/MCB.02019-07; Kim W, 2013, NAT CHEM BIOL, V9, P643, DOI [10.1038/NCHEMBIO.1331, 10.1038/nchembio.1331]; Knutson SK, 2013, P NATL ACAD SCI USA, V110, P7922, DOI 10.1073/pnas.1303800110; Knutson SK, 2012, NAT CHEM BIOL, V8, P890, DOI [10.1038/NCHEMBIO.1084, 10.1038/nchembio.1084]; Le Gallo M, 2012, NAT GENET, V44, P1310, DOI 10.1038/ng.2455; Li M, 2011, NAT GENET, V43, P828, DOI 10.1038/ng.903; MacConaill LE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007887; Margueron R, 2009, NATURE, V461, P762, DOI 10.1038/nature08398; McCabe MT, 2012, NATURE, V492, P108, DOI 10.1038/nature11606; McCabe MT, 2012, P NATL ACAD SCI USA, V109, P2989, DOI 10.1073/pnas.1116418109; Medina PP, 2008, HUM MUTAT, V29, P617, DOI 10.1002/humu.20730; Parsons DW, 2011, SCIENCE, V331, P435, DOI 10.1126/science.1198056; Pasini D, 2007, MOL CELL BIOL, V27, P3769, DOI 10.1128/MCB.01432-06; Qi W, 2012, P NATL ACAD SCI USA, V109, P21360, DOI 10.1073/pnas.1210371110; Roberts CWM, 2002, CANCER CELL, V2, P415, DOI 10.1016/S1535-6108(02)00185-X; Robinson G, 2012, NATURE, V488, P43, DOI 10.1038/nature11213; Sausen M, 2013, NAT GENET, V45, P12, DOI 10.1038/ng.2493; Shain AH, 2012, P NATL ACAD SCI USA, V109, pE252, DOI 10.1073/pnas.1114817109; Shao DD, 2013, GENOME RES, V23, P665, DOI 10.1101/gr.143586.112; Shao ZH, 1999, CELL, V98, P37, DOI 10.1016/S0092-8674(00)80604-2; TAMKUN JW, 1992, CELL, V68, P561, DOI 10.1016/0092-8674(92)90191-E; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Wei YK, 2011, NAT CELL BIOL, V13, P87, DOI 10.1038/ncb2139; Weissman B, 2009, CANCER RES, V69, P8223, DOI 10.1158/0008-5472.CAN-09-2166; Wiegand KC, 2010, NEW ENGL J MED, V363, P1532, DOI 10.1056/NEJMoa1008433; Wilson BG, 2011, NAT REV CANCER, V11, P481, DOI 10.1038/nrc3068; Wilson BG, 2010, CANCER CELL, V18, P316, DOI 10.1016/j.ccr.2010.09.006; Wu JI, 2009, CELL, V136, P200, DOI 10.1016/j.cell.2009.01.009; Xu KX, 2012, SCIENCE, V338, P1465, DOI 10.1126/science.1227604	40	268	276	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2015	21	12					1491	+		10.1038/nm.3968	http://dx.doi.org/10.1038/nm.3968			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CX9EV	26552009	Green Accepted			2022-12-25	WOS:000366008700020
J	Suarez-Zamorano, N; Fabbiano, S; Chevalier, C; Stojanovic, O; Colin, DJ; Stevanovic, A; Veyrat-Durebex, C; Tarallo, V; Rigo, D; Germain, S; Ilievska, M; Montet, X; Seimbille, Y; Hapfelmeier, S; Trajkovski, M				Suarez-Zamorano, Nicolas; Fabbiano, Salvatore; Chevalier, Claire; Stojanovic, Ozren; Colin, Didier J.; Stevanovic, Ana; Veyrat-Durebex, Christelle; Tarallo, Valentina; Rigo, Dorothee; Germain, Stephane; Ilievska, Miroslava; Montet, Xavier; Seimbille, Yann; Hapfelmeier, Siegfried; Trajkovski, Mirko			Microbiota depletion promotes browning of white adipose tissue and reduces obesity	NATURE MEDICINE			English	Article							GUT MICROBIOTA; INSULIN SENSITIVITY; ADAPTIVE THERMOGENESIS; BEIGE FAT; MACROPHAGES; ADIPOCYTES; ACTIVATION; MICE; CELL	Brown adipose tissue (BAT) promotes a lean and healthy phenotype and improves insulin sensitivity(1). In response to cold or exercise, brown fat cells also emerge in the white adipose tissue (WAT; also known as beige cells), a process known as browning(2-4). Here we show that the development of functional beige fat in the inguinal subcutaneous adipose tissue (ingSAT) and perigonadal visceral adipose tissue (pgVAT) is promoted by the depletion of microbiota either by means of antibiotic treatment or in germ-free mice. This leads to improved glucose tolerance and insulin sensitivity and decreased white fat and adipocyte size in lean mice, obese leptin-deficient (ob/ob) mice and high-fat diet (HFD)-fed mice. Such metabolic improvements are mediated by eosinophil infiltration, enhanced type 2 cytokine signaling and M2 macrophage polarization in the subcutaneous white fat depots of microbiota-depleted animals. The metabolic phenotype and the browning of the subcutaneous fat are impaired by the suppression of type 2 cytokine signaling, and they are reversed by recolonization of the antibiotic-treated or germ-free mice with microbes. These results provide insight into the microbiota-fat signaling axis and beige-fat development in health and metabolic disease.	[Suarez-Zamorano, Nicolas; Fabbiano, Salvatore; Chevalier, Claire; Stojanovic, Ozren; Stevanovic, Ana; Veyrat-Durebex, Christelle; Tarallo, Valentina; Rigo, Dorothee; Trajkovski, Mirko] Univ Geneva, Fac Med, Dept Cell Physiol & Metab, CMU, Geneva, Switzerland; [Suarez-Zamorano, Nicolas; Fabbiano, Salvatore; Chevalier, Claire; Stojanovic, Ozren; Stevanovic, Ana; Veyrat-Durebex, Christelle; Tarallo, Valentina; Rigo, Dorothee; Trajkovski, Mirko] Univ Geneva, Fac Med, Ctr Diabet, Geneva, Switzerland; [Colin, Didier J.; Germain, Stephane] Univ Hosp Geneva, Ctr BioMed Imaging CIBM, Geneva, Switzerland; [Ilievska, Miroslava] Alkaloid AD Skopje, Skopje, Macedonia; [Montet, Xavier] Univ Hosp Geneva, Div Radiol, Geneva, Switzerland; [Seimbille, Yann] Univ Hosp Geneva, Cyclotron Unit, Div Nucl Med, Geneva, Switzerland; [Hapfelmeier, Siegfried] Univ Bern, Inst Infect Dis, Bern, Switzerland; [Trajkovski, Mirko] UCL, Div Biosci, Inst Struct & Mol Biol, London, England	University of Geneva; University of Geneva; University of Geneva; University of Geneva; University of Geneva; University of Bern; University of London; Birkbeck University London; University College London	Trajkovski, M (corresponding author), Univ Geneva, Fac Med, Dept Cell Physiol & Metab, CMU, Geneva, Switzerland.	Mirko.Trajkovski@unige.ch	Stojanovic, Ozren/GQQ-1368-2022; Hapfelmeier, Siegfried/B-6005-2011; Colin, Didier J/GWR-1955-2022; Montet, Xavier/GMW-9003-2022	Stojanovic, Ozren/0000-0002-9418-3754; Hapfelmeier, Siegfried/0000-0002-6913-7932; Colin, Didier J/0000-0002-7067-8701; Veyrat-Durebex, Christelle/0000-0001-5301-6493; Trajkovski, Mirko/0000-0002-3152-9551; Fabbiano, Salvatore/0000-0003-0768-6028; chevalier, claire/0000-0003-0902-0756; Seimbille, Yann/0000-0002-9736-5318; Montet, Xavier/0000-0003-2442-5866	European Research Council under the European Union's Seventh Framework Programme (FP)/ERC Grant [336607 (ERC-2013-StG-336607)]; Louis-Jeantet Foundation; Fondation pour Recherches Medicales; Novartis Foundation [14B053]; Swiss National Science Foundation (SNSF) Professorship [PP00P3_144886];  [ERC-2013-StG-281904]	European Research Council under the European Union's Seventh Framework Programme (FP)/ERC Grant(European Research Council (ERC)); Louis-Jeantet Foundation; Fondation pour Recherches Medicales; Novartis Foundation(Novartis); Swiss National Science Foundation (SNSF) Professorship(Swiss National Science Foundation (SNSF)); 	We thank M. Gustafsson Trajkovska, C. Wollheim and R. Coppari for their discussions and critical reading of the manuscript; C. Darimont for help with bomb calorimetric measurements; P. Maechler and M. Karaca for help with and discussions about the OCR measurements; S. Startchik for help with image quantifications; ERC-2013-StG-281904 to S.H. for partial funding of the gnotobiotic research; and G. Waksman for support. The research leading to these results has received funding from the European Research Council under the European Union's Seventh Framework Programme (FP/2007-2013)/ERC Grant Agreement no. 336607 (ERC-2013-StG-336607); the Louis-Jeantet Foundation; Fondation pour Recherches Medicales; Novartis Foundation (14B053) and the Swiss National Science Foundation (SNSF) Professorship (PP00P3_144886) to M.T.	Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Chou CJ, 2008, NESTLE NUTR WORKS SE, V62, P127, DOI 10.1159/000146256; Cox LM, 2015, NAT REV ENDOCRINOL, V11, P182, DOI 10.1038/nrendo.2014.210; El Kaoutari A, 2013, NAT REV MICROBIOL, V11, P497, DOI 10.1038/nrmicro3050; Feldmann HM, 2009, CELL METAB, V9, P203, DOI 10.1016/j.cmet.2008.12.014; Ganeshan K, 2014, ANNU REV IMMUNOL, V32, P609, DOI 10.1146/annurev-immunol-032713-120236; Grivennikov SI, 2012, NATURE, V491, P254, DOI 10.1038/nature11465; Hwang I, 2015, FASEB J, V29, P2397, DOI 10.1096/fj.14-265983; Koren O, 2012, CELL, V150, P470, DOI 10.1016/j.cell.2012.07.008; Lee MW, 2015, CELL, V160, P74, DOI 10.1016/j.cell.2014.12.011; Liou AP, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005687; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Molofsky AB, 2015, IMMUNITY, V43, P161, DOI 10.1016/j.immuni.2015.05.019; Nguyen KD, 2011, NATURE, V480, P104, DOI 10.1038/nature10653; Peirce V, 2014, NATURE, V510, P76, DOI 10.1038/nature13477; Qiu YF, 2014, CELL, V157, P1292, DOI 10.1016/j.cell.2014.03.066; Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214; Stanford KI, 2013, J CLIN INVEST, V123, P215, DOI 10.1172/JCI62308; Sun L, 2014, METABOLISM, V63, P272, DOI 10.1016/j.metabol.2013.10.004; Trajkovski M, 2012, NAT CELL BIOL, V14, P1330, DOI 10.1038/ncb2612; Trajkovski M, 2011, NATURE, V474, P649, DOI 10.1038/nature10112; Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552; Wu J, 2013, GENE DEV, V27, P234, DOI 10.1101/gad.211649.112; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016	24	250	264	1	142	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2015	21	12					1497	+		10.1038/nm.3994	http://dx.doi.org/10.1038/nm.3994			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CX9EV	26569380	Green Accepted			2022-12-25	WOS:000366008700021
J	Ismail, IH; Gagne, JP; Genois, MM; Strickfaden, H; McDonald, D; Xu, ZZ; Poirier, GG; Masson, JY; Hendzel, MJ				Ismail, Ismail Hassan; Gagne, Jean-Philippe; Genois, Marie-Michelle; Strickfaden, Hilmar; McDonald, Darin; Xu, Zhizhong; Poirier, Guy G.; Masson, Jean-Yves; Hendzel, Michael J.			The RNF138 E3 ligase displaces Ku to promote DNA end resection and regulate DNA repair pathway choice	NATURE CELL BIOLOGY			English	Article							DOUBLE-STRAND BREAK; HOMOLOGOUS RECOMBINATION; UBIQUITIN LIGASES; ZINC FINGERS; PROTEINS; RECRUITMENT; MECHANISMS; REVEALS; ATM; DYNAMICS	DNA double-strand breaks (DSBs) are repaired mainly by non-homologous end joining or homologous recombination (HR). Cell cycle stage and DNA end resection are believed to regulate the commitment to HR repair. Here we identify RNF138 as a ubiquitin E3 ligase that regulates the HR pathway. RNF138 is recruited to DNA damage sites through zinc fingers that have a strong preference for DNA with 5'- or 3'-single-stranded overhangs. RNF138 stimulates DNA end resection and promotes AIR-dependent signalling and DSB repair by HR, thereby contributing to cell survival on exposure to DSB-inducing agents. Finally, we establish that RNF138-dependent Ku removal from DNA breaks is one mechanism whereby RNF138 can promote HR. These results establish RNF138 as an important regulator of DSB repair pathway choice.	[Ismail, Ismail Hassan; Strickfaden, Hilmar; McDonald, Darin; Xu, Zhizhong; Hendzel, Michael J.] Univ Alberta, Fac Med & Dent, Dept Oncol, Edmonton, AB T6G 1Z2, Canada; [Ismail, Ismail Hassan; Strickfaden, Hilmar; McDonald, Darin; Xu, Zhizhong; Hendzel, Michael J.] Univ Alberta, Fac Med & Dent, Dept Cell Biol, Edmonton, AB T6G 1Z2, Canada; [Ismail, Ismail Hassan] Cairo Univ, Fac Sci, Dept Biophys, Giza 12613, Egypt; [Gagne, Jean-Philippe; Poirier, Guy G.] CHU Quebec, Res Ctr, Oncol Axis, Quebec City, PQ G1V 4G2, Canada; [Gagne, Jean-Philippe; Genois, Marie-Michelle; Poirier, Guy G.; Masson, Jean-Yves] Univ Laval, Dept Mol Biol Med Biochem & Pathol, Quebec City, PQ G1V 0A6, Canada; [Genois, Marie-Michelle; Masson, Jean-Yves] Univ Laval, Genome Stabil Lab, CHU Quebec, Res Ctr,Oncol Axis, Quebec City, PQ G1R 2J6, Canada	University of Alberta; University of Alberta; Egyptian Knowledge Bank (EKB); Cairo University; Laval University; Laval University; Laval University	Ismail, IH (corresponding author), Univ Alberta, Fac Med & Dent, Dept Oncol, Edmonton, AB T6G 1Z2, Canada.	iismail@ualberta.ca; mhendzel@ualberta.ca	Hendzel, Michael/C-3391-2009; Strickfaden, Hilmar/AAW-3522-2021	Hendzel, Michael/0000-0002-9603-7945; Masson, Jean Yves/0000-0002-4403-7169; Poirier, Guy/0000-0002-4869-1424; Ismail, Ismail Hassan/0000-0002-5526-6063	Alberta Cancer Foundation postdoctoral fellowships; FRQS scholarship; Tier 1 Canada Chair in Proteomics; Canadian Institute of Health Research (CIHR)	Alberta Cancer Foundation postdoctoral fellowships; FRQS scholarship; Tier 1 Canada Chair in Proteomics; Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	We thank J. Stark (Department of Radiation Biology, Beckman Research Institute of the City of Hope, USA), R. Baer (Department of Pathology and Cell Biology, Columbia University, USA), S. M. Janicki (The Wistar Institute, USA), O. Hammarsten (Department of Clinical Chemistry, Goteborg University, Sweden), R. Greenberg (Department of Cancer Biology, Abramson Family Cancer Research Institute, USA) and J. Chen (Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, USA) for providing valuable reagents. We thank Y. Coulombe, M.-C. Caron and W. El Shemy for technical help. We also thank the Cellular Imaging Facility at the Cross Cancer Institute for the use of microscopes and image analysis software. The Proteomics Platform of the Quebec Genomics Center provided Mass spectrometry analysis. M.J.H. is an Alberta Innovates Health Solutions Senior Scholar. I.H.I. and H.S. are recipients of the Alberta Cancer Foundation postdoctoral fellowships. M.-M.G. was a CIHR Vanier scholar and is supported by a FRQS scholarship; G.G.P. holds a Tier 1 Canada Chair in Proteomics and J.-Y.M. is a FRQS Chercheur National Investigator. This work was supported by grants from the Canadian Institute of Health Research (CIHR).	Ardley HC, 2005, ESSAYS BIOCHEM, V41, P15, DOI 10.1042/EB0410015; Aylon Y, 2004, EMBO J, V23, P4868, DOI 10.1038/sj.emboj.7600469; Bernstein KA, 2009, CELL, V137, P807, DOI 10.1016/j.cell.2009.05.007; Branzei D, 2008, NAT REV MOL CELL BIO, V9, P297, DOI 10.1038/nrm2351; Britton S, 2013, J CELL BIOL, V202, P579, DOI 10.1083/jcb.201303073; Chapman JR, 2012, MOL CELL, V47, P497, DOI 10.1016/j.molcel.2012.07.029; Cheng Q, 2011, NUCLEIC ACIDS RES, V39, P9605, DOI 10.1093/nar/gkr656; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Delacote F, 2002, NUCLEIC ACIDS RES, V30, P3454, DOI 10.1093/nar/gkf452; Essers J, 2002, EMBO J, V21, P2030, DOI 10.1093/emboj/21.8.2030; Feng L, 2012, NAT STRUCT MOL BIOL, V19, P201, DOI 10.1038/nsmb.2211; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Frank-Vaillant M, 2002, MOL CELL, V10, P1189, DOI 10.1016/S1097-2765(02)00705-0; Giannini AL, 2008, BIOCHEM J, V410, P101, DOI 10.1042/BJ20070995; Hartlerode AJ, 2009, BIOCHEM J, V423, P157, DOI 10.1042/BJ20090942; Ismail IH, 2012, NUCLEIC ACIDS RES, V40, P5497, DOI 10.1093/nar/gks222; Jazayeri A, 2006, NAT CELL BIOL, V8, P37, DOI 10.1038/ncb1337; Karanam K, 2012, MOL CELL, V47, P320, DOI 10.1016/j.molcel.2012.05.052; Katyal S, 2014, NAT NEUROSCI, V17, P813, DOI 10.1038/nn.3715; Kim JS, 2005, J CELL BIOL, V170, P341, DOI 10.1083/jcb.200411083; Li W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001487; Lieber MR, 2008, J BIOL CHEM, V283, P1, DOI 10.1074/jbc.R700039200; Loughlin FE, 2006, IUBMB LIFE, V58, P731, DOI 10.1080/15216540600868445; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Pardo B, 2009, CELL MOL LIFE SCI, V66, P1039, DOI 10.1007/s00018-009-8740-3; Pierce AJ, 2001, GENE DEV, V15, P3237, DOI 10.1101/gad.946401; Postow L, 2008, J CELL BIOL, V182, P467, DOI 10.1083/jcb.200802146; Raderschall E, 1999, P NATL ACAD SCI USA, V96, P1921, DOI 10.1073/pnas.96.5.1921; Rodrigue A, 2006, EMBO J, V25, P222, DOI 10.1038/sj.emboj.7600914; Schmidt CK, 2015, NAT CELL BIOL, V17, P1458, DOI 10.1038/ncb3260; Shanbhag NM, 2010, CELL, V141, P970, DOI 10.1016/j.cell.2010.04.038; Shao ZP, 2012, DNA REPAIR, V11, P310, DOI 10.1016/j.dnarep.2011.12.007; Shim EY, 2010, EMBO J, V29, P3370, DOI 10.1038/emboj.2010.219; Symington LS, 2011, ANNU REV GENET, V45, P247, DOI 10.1146/annurev-genet-110410-132435; Wu DL, 2008, GENETICS, V178, P1237, DOI 10.1534/genetics.107.083535; Yamada M, 2006, J BIOL CHEM, V281, P20749, DOI 10.1074/jbc.M602089200; Zhou YX, 2012, ANAL CELL PATHOL, V35, P167, DOI [10.1155/2012/519037, 10.3233/ACP-2011-0051]	37	89	93	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2015	17	11					1446	1457		10.1038/ncb3259	http://dx.doi.org/10.1038/ncb3259			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CV4XT	26502055				2022-12-25	WOS:000364270500010
J	Smith, SA; Derdeyn, CA				Smith, S. Abigail; Derdeyn, Cynthia A.			A pathway to HIV-1 neutralization breadth	NATURE MEDICINE			English	Editorial Material							ANTIBODY	Neutralization breadth is thought to be an important feature of an effective vaccine against HIV-1. A study in one individual has now identified the specific viral variant that engaged the necessary antibody precursor, as well as the viral immunotypes that drove neutralization breadth, improving understanding of how to mimic this process with a vaccine.	[Smith, S. Abigail; Derdeyn, Cynthia A.] Emory Univ, Dept Pathol & Lab Med, Yerkes Natl Primate Res Ctr, Atlanta, GA 30322 USA	Emory University	Smith, SA (corresponding author), Emory Univ, Dept Pathol & Lab Med, Yerkes Natl Primate Res Ctr, Atlanta, GA 30322 USA.	cderdey@emory.edu			NIAID NIH HHS [R01 AI058706, U19 AI096187, R01-AI58706] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI058706, U19AI096187] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bhiman JN, 2015, NAT MED, V21, P1332, DOI 10.1038/nm.3963; Derdeyn CA, 2014, CURR OPIN HIV AIDS, V9, P210, DOI 10.1097/COH.0000000000000057; Doria-Rose NA, 2014, NATURE, V509, P55, DOI 10.1038/nature13036; Liao HX, 2013, NATURE, V496, P469, DOI 10.1038/nature12053; Lynch RM, 2011, J VIROL, V85, P905, DOI 10.1128/JVI.02006-10; McGuire AT, 2014, J VIROL, V88, P2645, DOI 10.1128/JVI.03228-13; Moore PL, 2015, TRENDS MICROBIOL, V23, P204, DOI 10.1016/j.tim.2014.12.007; Moore PL, 2013, J VIROL, V87, P4882, DOI 10.1128/JVI.03424-12; Moore PL, 2012, NAT MED, V18, P1688, DOI 10.1038/nm.2985; Murphy MK, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003173; Wibmer CK, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003738	11	3	3	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2015	21	11					1246	1247		10.1038/nm.3989	http://dx.doi.org/10.1038/nm.3989			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CV9QH	26540383	Green Accepted, Bronze			2022-12-25	WOS:000364621200005
J	Rogers, N				Rogers, Nala			A dormant danger: New therapies target a ubiquitous pathogen known as cytomegalovirus	NATURE MEDICINE			English	News Item														Hamilton, Stuart/0000-0002-2170-4889				Chemaly RF, 2014, NEW ENGL J MED, V370, P1781, DOI 10.1056/NEJMoa1309533; Griffiths P, 2014, CURR OPIN INFECT DIS, V27, P554, DOI 10.1097/QCO.0000000000000107; Marty FM, 2011, CURR OPIN VIROL, V1, P555, DOI 10.1016/j.coviro.2011.10.011; Marty FM, 2011, LANCET INFECT DIS, V11, P284, DOI 10.1016/S1473-3099(11)70024-X; Rieder F, 2014, CLIN MICROBIOL INFEC, V20, P95, DOI 10.1111/1469-0691.12449; Stoelben S, 2014, TRANSPL INT, V27, P77, DOI 10.1111/tri.12225; van Zuylen WJ, 2014, OBSTET MED, V7, P140, DOI 10.1177/1753495X14552719; Winston DJ, 2012, AM J TRANSPLANT, V12, P3021, DOI 10.1111/j.1600-6143.2012.04231.x	8	1	2	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	OCT	2015	21	10					1104	1105		10.1038/nm1015-1104	http://dx.doi.org/10.1038/nm1015-1104			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	VC0TO	26444624				2022-12-25	WOS:000427306000001
J	Dauch, D; Rudalska, R; Cossa, G; Nault, JC; Kang, TW; Wuestefeld, T; Hohmeyer, A; Imbeaud, S; Yevsa, T; Hoenicke, L; Pantsar, T; Bozko, P; Malek, NP; Longerich, T; Laufer, S; Poso, A; Zucman-Rossi, J; Eilers, M; Zender, L				Dauch, Daniel; Rudalska, Ramona; Cossa, Giacomo; Nault, Jean-Charles; Kang, Tae-Won; Wuestefeld, Torsten; Hohmeyer, Anja; Imbeaud, Sandrine; Yevsa, Tetyana; Hoenicke, Lisa; Pantsar, Tatu; Bozko, Przemyslaw; Malek, Nisar P.; Longerich, Thomas; Laufer, Stefan; Poso, Antti; Zucman-Rossi, Jessica; Eilers, Martin; Zender, Lars			A MYC-aurora kinase A protein complex represents an actionable drug target in p53-altered liver cancer	NATURE MEDICINE			English	Article							HEPATOCELLULAR-CARCINOMA; N-MYC; INHIBITION; IDENTIFICATION; ACTIVATION; P53; SURVEILLANCE; DEGRADATION; RESISTANCE; SENESCENCE	MYC oncoproteins are involved in the genesis and maintenance of the majority of human tumors but are considered undruggable. By using a direct in vivo shRNA screen, we show that liver cancer cells that have mutations in the gene encoding the tumor suppressor protein p53 (Trp53 in mice and TP53 in humans) and that are driven by the oncoprotein NRAS become addicted to MYC stabilization via a mechanism mediated by aurora kinase A (AURKA). This MYC stabilization enables the tumor cells to overcome a latent G2/M cell cycle arrest that is mediated by AURKA and the tumor suppressor protein p19(ARF). MYC directly binds to AURKA, and inhibition of this protein-protein interaction by conformation-changing AURKA inhibitors results in subsequent MYC degradation and cell death. These conformation-changing AURKA inhibitors, with one of them currently being tested in early clinical trials, suppressed tumor growth and prolonged survival in mice bearing Trp53-deficient, NRAS-driven MYC-expressing hepatocellular carcinomas (HCCs). TP53-mutated human HCCs revealed increased AURKA expression and a positive correlation between AURKA and MYC expression. In xenograft models, mice bearing TP53-mutated or TP53-deleted human HCCs were hypersensitive to treatment with conformation-changing AURKA inhibitors, thus suggesting a therapeutic strategy for this subgroup of human HCCs.	[Dauch, Daniel; Rudalska, Ramona; Kang, Tae-Won; Wuestefeld, Torsten; Hohmeyer, Anja; Yevsa, Tetyana; Hoenicke, Lisa; Poso, Antti; Zender, Lars] Univ Tubingen, Dept Internal Med 1, Div Translat Gastrointestinal Oncol, Tubingen, Germany; [Cossa, Giacomo; Eilers, Martin] Univ Wurzburg, Bioctr, Theodor Boveri Inst, Wurzburg, Germany; [Nault, Jean-Charles; Imbeaud, Sandrine; Zucman-Rossi, Jessica] INSERM, Paris, France; [Kang, Tae-Won; Zender, Lars] German Canc Res Ctr, German Consortium Translat Canc Res DKTK, Translat Gastrointestinal Oncol Grp, Heidelberg, Germany; [Pantsar, Tatu; Poso, Antti] Univ Eastern Finland, Sch Pharm, Kuopio, Finland; [Bozko, Przemyslaw; Malek, Nisar P.] Univ Tubingen, Dept Internal Med 1, Tubingen, Germany; [Longerich, Thomas] Univ Hosp RWTH Aachen, Inst Pathol, Aachen, Germany; [Laufer, Stefan] Univ Tubingen, Dept Pharmaceut Chem, Tubingen, Germany; [Eilers, Martin] Univ Wurzburg, Comprehens Canc Ctr Mainfranken, Wurzburg, Germany	Eberhard Karls University of Tubingen; University of Wurzburg; Institut National de la Sante et de la Recherche Medicale (Inserm); Helmholtz Association; German Cancer Research Center (DKFZ); University of Eastern Finland; Eberhard Karls University of Tubingen; RWTH Aachen University; RWTH Aachen University Hospital; Eberhard Karls University of Tubingen; University of Wurzburg	Zender, L (corresponding author), Univ Tubingen, Dept Internal Med 1, Div Translat Gastrointestinal Oncol, Tubingen, Germany.; Zender, L (corresponding author), German Canc Res Ctr, German Consortium Translat Canc Res DKTK, Translat Gastrointestinal Oncol Grp, Heidelberg, Germany.	Lars.Zender@med.uni-tuebingen.de	Kang, Tae Won/S-4864-2019; Cossa, Giacomo/AAE-7255-2020; zucman-rossi, Jessica/B-5098-2009; j, zucman-rossi/AAV-3594-2021; Imbeaud, Sandrine/P-8780-2017	Kang, Tae Won/0000-0003-1497-8926; Cossa, Giacomo/0000-0001-5826-5165; zucman-rossi, Jessica/0000-0002-5687-0334; j, zucman-rossi/0000-0002-5687-0334; Pantsar, Tatu/0000-0002-0369-2909; nault, jean charles/0000-0002-4875-9353; Laufer, Stefan/0000-0001-6952-1486; Poso, Antti/0000-0003-4196-4204; Yevsa, Tetyana/0000-0003-0377-9198; Imbeaud, Sandrine/0000-0001-8439-6732; Hoenicke, Lisa/0000-0003-0613-8337; Eilers, Martin/0000-0002-0376-6533	German Research Foundation (DFG) [FOR2314, SFB685]; Gottfried Wilhelm Leibniz Program; European Research Council; German Ministry for Education and Research. (BMBF); German Universities Excellence Initiative; German Center for Translational Cancer Research (DKTK); German-Israeli Cooperation in Cancer Research (DKFZ-MOST)	German Research Foundation (DFG)(German Research Foundation (DFG)); Gottfried Wilhelm Leibniz Program; European Research Council(European Research Council (ERC)European Commission); German Ministry for Education and Research. (BMBF)(Federal Ministry of Education & Research (BMBF)); German Universities Excellence Initiative; German Center for Translational Cancer Research (DKTK); German-Israeli Cooperation in Cancer Research (DKFZ-MOST)	We thank K. Schulze-Osthoff, S.W. Lowe, W Albrecht, K. Breuhahn, R. Geffers, S. Nahnsen, M. Gehringer, E. Rist, C. Fellmeth, P. Katiyar, S. Fillinger, M. Jarek, M. Scharfe, M. Diefenbacher and the members of the Zender laboratory for fruitful discussions, technical assistance or reagents. We thank the Center for Scientific Computing (Espoo, Finland) for software and hardware support. This work was supported by the German Research Foundation (DFG; grants FOR2314 (L.Z., D.D. and M.E.) and SFB685 (L.Z.)), the Gottfried Wilhelm Leibniz Program (L.Z.), the European Research Council (projects 'CholangioConcepf (L.Z.), 'Heptromic' (L.Z.) and 'Auromyc' (M.E.)), the German Ministry for Education and Research. (BMBF) (eMed (Multiscale HCC), the German Universities Excellence Initiative (third funding line: 'future concept') (L.Z.);the German Center for Translational Cancer Research (DKTK) (L.Z.) and the German-Israeli Cooperation in Cancer Research (DKFZ-MOST) (L.Z.).	Aliagas-Martin I, 2009, J MED CHEM, V52, P3300, DOI 10.1021/jm9000314; Amati B, 2004, P NATL ACAD SCI USA, V101, P8843, DOI 10.1073/pnas.0403046101; Beltran H, 2011, CANCER DISCOV, V1, P487, DOI 10.1158/2159-8290.CD-11-0130; Braumuller H, 2013, NATURE, V494, P361, DOI 10.1038/nature11824; Brockmann M, 2013, CANCER CELL, V24, P75, DOI 10.1016/j.ccr.2013.05.005; Bruix J, 2014, GUT, V63, P844, DOI 10.1136/gutjnl-2013-306627; Burgess DJ, 2008, P NATL ACAD SCI USA, V105, P9053, DOI 10.1073/pnas.0803513105; Calle EE, 2004, NAT REV CANCER, V4, P579, DOI 10.1038/nrc1408; Calvisi DF, 2006, GASTROENTEROLOGY, V130, P1117, DOI 10.1053/j.gastro.2006.01.006; Carlson CM, 2005, P NATL ACAD SCI USA, V102, P17059, DOI 10.1073/pnas.0502974102; Carpinelli P, 2007, MOL CANCER THER, V6, P3158, DOI 10.1158/1535-7163.MCT-07-0444; Chan KL, 2004, HUM PATHOL, V35, P1324, DOI 10.1016/j.humpath.2004.06.012; Crane R, 2004, BIOL CELL, V96, P215, DOI 10.1016/j.biolcel.2003.09.008; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Diefenbacher ME, 2015, CANCER RES, V75, P1181, DOI 10.1158/0008-5472.CAN-14-1726; EILERS M, 1991, EMBO J, V10, P133, DOI 10.1002/j.1460-2075.1991.tb07929.x; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; Falchook G, 2014, INVEST NEW DRUG, V32, P1181, DOI 10.1007/s10637-014-0121-6; Fancelli D, 2006, J MED CHEM, V49, P7247, DOI 10.1021/jm060897w; Farazi PA, 2006, NAT REV CANCER, V6, P674, DOI 10.1038/nrc1934; Felsher DW, 1999, MOL CELL, V4, P199, DOI 10.1016/S1097-2765(00)80367-6; Gustafson WC, 2014, CANCER CELL, V26, P414, DOI 10.1016/j.ccr.2014.07.015; Huesken D, 2005, NAT BIOTECHNOL, V23, P995, DOI 10.1038/nbt1118; Ito Y, 1998, HEPATOLOGY, V27, P951, DOI 10.1002/hep.510270409; Kang TW, 2011, NATURE, V479, P547, DOI 10.1038/nature10599; Katayama Hiroshi, 2003, Cancer and Metastasis Reviews, V22, P451, DOI 10.1023/A:1023789416385; Katsha A, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0375-4; Khwaja A, 1997, EMBO J, V16, P2783, DOI 10.1093/emboj/16.10.2783; Kimura MT, 2005, CANCER RES, V65, P3548, DOI 10.1158/0008-5472.CAN-04-2149; Klein A, 2008, MOL BIOL CELL, V19, P3667, DOI 10.1091/mbc.E08-01-0042; Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049; Liu JB, 2012, EUR J CANCER, V48, P2328, DOI 10.1016/j.ejca.2012.03.001; Lord R, 2011, INT J CLIN PRACT, V65, P182, DOI 10.1111/j.1742-1241.2010.02545.x; Lu LY, 2008, J BIOL CHEM, V283, P31785, DOI 10.1074/jbc.M805880200; Lu LF, 2015, MOL CARCINOGEN, V54, P1467, DOI 10.1002/mc.22223; Meek DW, 2009, NAT REV CANCER, V9, P714, DOI 10.1038/nrc2716; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; Mosquera JM, 2013, NEOPLASIA, V15, P1, DOI 10.1593/neo.121550; Otto T, 2009, CANCER CELL, V15, P67, DOI 10.1016/j.ccr.2008.12.005; Podsypanina K, 2008, P NATL ACAD SCI USA, V105, P5242, DOI 10.1073/pnas.0801197105; Rudalska R, 2014, NAT MED, V20, P1138, DOI 10.1038/nm.3679; Schmidt CM, 1997, BIOCHEM BIOPH RES CO, V236, P54, DOI 10.1006/bbrc.1997.6840; Shachaf CM, 2004, NATURE, V431, P1112, DOI 10.1038/nature03043; Sherr CJ, 2006, NAT REV CANCER, V6, P663, DOI 10.1038/nrc1954; Sherr CJ, 1998, GENE DEV, V12, P2984, DOI 10.1101/gad.12.19.2984; Soucek L, 2008, NATURE, V455, P679, DOI 10.1038/nature07260; TAMAYO RP, 1983, HEPATOLOGY, V3, P112; Tannapfel A, 2001, ONCOGENE, V20, P7104, DOI 10.1038/sj.onc.1204902; Taub R, 1996, FASEB J, V10, P413, DOI 10.1096/fasebj.10.4.8647340; Tward AD, 2005, COLD SH Q B, V70, P217, DOI 10.1101/sqb.2005.70.058; Vert JP, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-520; Watson JD, 2002, J BIOL CHEM, V277, P36921, DOI 10.1074/jbc.M201493200; Welsch C, 2012, GUT, V61, P36, DOI 10.1136/gutjnl-2012-302144; White DL, 2012, CLIN GASTROENTEROL H, V10, P1342, DOI 10.1016/j.cgh.2012.10.001; White P, 2005, J BIOL CHEM, V280, P3715, DOI 10.1074/jbc.M410844200; Wuestefeld T, 2013, CELL, V153, P389, DOI 10.1016/j.cell.2013.03.026; Yuan HF, 2012, CARCINOGENESIS, V33, P285, DOI 10.1093/carcin/bgr278; Zender L, 2003, P NATL ACAD SCI USA, V100, P7797, DOI 10.1073/pnas.1330920100; Zender L, 2008, CELL, V135, P852, DOI 10.1016/j.cell.2008.09.061; Zuber J, 2011, NATURE, V478, P524, DOI 10.1038/nature10334	60	158	164	3	53	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2016	22	7					744	753		10.1038/nm.4107	http://dx.doi.org/10.1038/nm.4107			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DQ7DK	27213815				2022-12-25	WOS:000379366900013
J	Wang, JG; Cazzato, E; Ladewig, E; Frattini, V; Rosenbloom, DIS; Zairis, S; Abate, F; Liu, ZQ; Elliott, O; Shin, YJ; Lee, JK; Lee, IH; Park, WY; Eoli, M; Blumberg, AJ; Lasorella, A; Nam, DH; Finocchiaro, G; Iavarone, A; Rabadan, R				Wang, Jiguang; Cazzato, Emanuela; Ladewig, Erik; Frattini, Veronique; Rosenbloom, Daniel I. S.; Zairis, Sakellarios; Abate, Francesco; Liu, Zhaoqi; Elliott, Oliver; Shin, Yong-Jae; Lee, Jin-Ku; Lee, In-Hee; Park, Woong-Yang; Eoli, Marica; Blumberg, Andrew J.; Lasorella, Anna; Nam, Do-Hyun; Finocchiaro, Gaetano; Iavarone, Antonio; Rabadan, Raul			Clonal evolution of glioblastoma under therapy	NATURE GENETICS			English	Article							TGF-BETA; GENOMIC ALTERATIONS; SEQUENCING DATA; BRAIN-TUMORS; CANCER GENOMICS; MSH6 MUTATIONS; GENE FUSIONS; GLIOMA; TEMOZOLOMIDE; LANDSCAPE	Glioblastoma (GBM) is the most common and aggressive primary brain tumor. To better understand how GBM evolves, we analyzed longitudinal genomic and transcriptomic data from 114 patients. The analysis shows a highly branched evolutionary pattern in which 63% of patients experience expression-based subtype changes. The branching pattern, together with estimates of evolutionary rate, suggests that relapse-associated clones typically existed years before diagnosis. Fifteen percent of tumors present hypermutation at relapse in highly expressed genes, with a clear mutational signature. We find that 11% of recurrence tumors harbor mutations in LTBP4, which encodes a protein binding to TGF-beta. Silencing LTBP4 in GBM cells leads to suppression of TGF-beta activity and decreased cell proliferation. In recurrent GBM with wild-type IDH1, high LTBP4 expression is associated with worse prognosis, highlighting the TGF-b pathway as a potential therapeutic target in GBM.	[Wang, Jiguang; Ladewig, Erik; Rosenbloom, Daniel I. S.; Zairis, Sakellarios; Abate, Francesco; Liu, Zhaoqi; Elliott, Oliver; Rabadan, Raul] Columbia Univ, Dept Syst Biol, New York, NY USA; [Wang, Jiguang; Ladewig, Erik; Rosenbloom, Daniel I. S.; Zairis, Sakellarios; Abate, Francesco; Liu, Zhaoqi; Elliott, Oliver; Rabadan, Raul] Columbia Univ, Dept Biomed Informat, New York, NY USA; [Cazzato, Emanuela; Eoli, Marica; Finocchiaro, Gaetano] Fdn IRCCS Ist Neurol Besta, Unit Mol Neurooncol, Milan, Italy; [Frattini, Veronique; Lasorella, Anna; Iavarone, Antonio] Columbia Univ, Inst Canc Genet, New York, NY USA; [Shin, Yong-Jae; Lee, Jin-Ku; Lee, In-Hee; Nam, Do-Hyun] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Neurosurg, Seoul, South Korea; [Park, Woong-Yang] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Samsung Genome Inst, Seoul, South Korea; [Blumberg, Andrew J.] Univ Texas Austin, Dept Math, Austin, TX 78712 USA; [Lasorella, Anna] Columbia Univ, Dept Pediat, New York, NY 10027 USA; [Lasorella, Anna; Iavarone, Antonio] Columbia Univ, Dept Pathol, New York, NY USA; [Nam, Do-Hyun] Sungkyunkwan Univ, SAIHST, Dept Hlth Sci & Technol, Seoul, South Korea; [Iavarone, Antonio] Columbia Univ, Dept Neurol, New York, NY USA	Columbia University; Columbia University; IRCCS Istituto Neurologico Besta; Columbia University; Sungkyunkwan University (SKKU); Samsung Medical Center; Samsung; Sungkyunkwan University (SKKU); Samsung Medical Center; University of Texas System; University of Texas Austin; Columbia University; Columbia University; Sungkyunkwan University (SKKU); Columbia University	Rabadan, R (corresponding author), Columbia Univ, Dept Syst Biol, New York, NY USA.; Rabadan, R (corresponding author), Columbia Univ, Dept Biomed Informat, New York, NY USA.; Finocchiaro, G (corresponding author), Fdn IRCCS Ist Neurol Besta, Unit Mol Neurooncol, Milan, Italy.; Iavarone, A (corresponding author), Columbia Univ, Inst Canc Genet, New York, NY USA.; Nam, DH (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Neurosurg, Seoul, South Korea.; Iavarone, A (corresponding author), Columbia Univ, Dept Pathol, New York, NY USA.; Nam, DH (corresponding author), Sungkyunkwan Univ, SAIHST, Dept Hlth Sci & Technol, Seoul, South Korea.; Iavarone, A (corresponding author), Columbia Univ, Dept Neurol, New York, NY USA.	nsnam@skku.edu; gaetano.finocchiaro@gmail.com; ai2102@columbia.edu; rr2579@cumc.columbia.edu	Rabadan, Raul/AAZ-7367-2020; Finocchiaro, Gaetano/AAG-6791-2020; Eoli, Marica/K-7748-2016; Wang, Jiguang/B-2717-2012	Eoli, Marica/0000-0003-4744-9377; Finocchiaro, Gaetano/0000-0003-3583-4040; Wang, Jiguang/0000-0002-6923-4097; Iavarone, Antonio/0000-0002-0683-4634; Lee, Jin-Ku/0000-0003-0263-3234; Lee, In-Hee/0000-0002-8857-1355; Park, Woong-Yang/0000-0003-4234-0380; Rabadan, Raul/0000-0001-7946-9255	NIH [U54 CA193313, R01 CA185486, R01 CA179044, R01 CA101644, R01 CA131126, R01 CA178546, R01 NS061776]; Precision Medicine Fellowship [UL1 TR000040]; Cancer Biology Training Program [T32 CA09503]; US National Library of Medicine [T15 LM007079]; Personalized Medicine Fellowship [TL1 TR000082]; NIH (Chemotherapy Foundation); American Brain Tumor Association (ABTA); Italian Ministry of Health; Korea Health Technology R&D Project through Korea Health Industry Development Institute (KHIDI); Ministry of Health and Welfare, Republic of Korea [HI14C3418]; NATIONAL CANCER INSTITUTE [R01CA185486, R01CA179044, R01CA178546, U54CA193313, T32CA009503, R01CA101644, R01CA131126] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR000082, UL1TR000040] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM117591] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS061776] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007079] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Precision Medicine Fellowship; Cancer Biology Training Program; US National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); Personalized Medicine Fellowship; NIH (Chemotherapy Foundation)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Brain Tumor Association (ABTA); Italian Ministry of Health(Ministry of Health, Italy); Korea Health Technology R&D Project through Korea Health Industry Development Institute (KHIDI)(Korea Health Industry Development Institute (KHIDI)); Ministry of Health and Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	R.R. acknowledges funding from the NIH (U54 CA193313, R01 CA185486, and R01 CA179044). J.W. is supported by a Precision Medicine Fellowship (UL1 TR000040). E.L. is supported by the Cancer Biology Training Program (T32 CA09503). D.I.S.R. is supported by the US National Library of Medicine (T15 LM007079). S.Z. is supported by a Personalized Medicine Fellowship (TL1 TR000082). This work is also supported by NIH grants to A.L. (R01 CA101644 and R01 CA131126) and A.I. (R01 CA178546 and R01 NS061776 and a grant from the Chemotherapy Foundation). V.F. is supported by a fellowship from the American Brain Tumor Association (ABTA). G.F. is partly funded by the Italian Ministry of Health. D.-H.N. is supported by a grant from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health and Welfare, Republic of Korea (HI14C3418).	Abate F, 2014, BMC SYST BIOL, V8, DOI 10.1186/s12918-014-0097-z; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Anido J, 2010, CANCER CELL, V18, P655, DOI 10.1016/j.ccr.2010.10.023; ARMITAGE P, 1954, BRIT J CANCER, V8, P1, DOI 10.1038/bjc.1954.1; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Cahill DP, 2007, CLIN CANCER RES, V13, P2038, DOI 10.1158/1078-0432.CCR-06-2149; Carro MS, 2010, NATURE, V463, P318, DOI 10.1038/nature08712; Carter SL, 2012, NAT BIOTECHNOL, V30, P413, DOI 10.1038/nbt.2203; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Ciriello G, 2012, GENOME RES, V22, P398, DOI 10.1101/gr.125567.111; Di Stefano AL, 2015, CLIN CANCER RES, V21, P3307, DOI 10.1158/1078-0432.CCR-14-2199; Fakhrai H, 1996, P NATL ACAD SCI USA, V93, P2909, DOI 10.1073/pnas.93.7.2909; Frattini V, 2013, NAT GENET, V45, P1141, DOI 10.1038/ng.2734; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gill BJ, 2014, P NATL ACAD SCI USA, V111, P12550, DOI 10.1073/pnas.1405839111; Han JF, 2015, AM J CANCER RES, V5, P945; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Hunter C, 2006, CANCER RES, V66, P3987, DOI 10.1158/0008-5472.CAN-06-0127; Iyer MK, 2011, BIOINFORMATICS, V27, P2903, DOI 10.1093/bioinformatics/btr467; Johnson BE, 2014, SCIENCE, V343, P189, DOI 10.1126/science.1239947; Joseph JV, 2013, BIOCHEM PHARMACOL, V85, P478, DOI 10.1016/j.bcp.2012.11.005; Kaminska B, 2013, ADV EXP MED BIOL, V986, P171, DOI 10.1007/978-94-007-4719-7_9; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Khalili JS, 2012, ONCOIMMUNOLOGY, V1, P1281, DOI 10.4161/onci.21511; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim H, 2015, GENOME RES, V25, P316, DOI 10.1101/gr.180612.114; Kim J, 2015, CANCER CELL, V28, P318, DOI 10.1016/j.ccell.2015.07.013; Kuan CT, 2001, ENDOCR-RELAT CANCER, V8, P83, DOI 10.1677/erc.0.0080083; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Magi A, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r120; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Mazor T, 2015, CANCER CELL, V28, P307, DOI 10.1016/j.ccell.2015.07.012; Melamed RD, 2015, J MOL CELL BIOL, V7, P203, DOI 10.1093/jmcb/mjv026; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; MIYAZONO K, 1991, EMBO J, V10, P1091, DOI 10.1002/j.1460-2075.1991.tb08049.x; Niola F, 2013, J CLIN INVEST, V123, P405, DOI 10.1172/JCI63811; NORDLING CO, 1953, BRIT J CANCER, V7, P68, DOI 10.1038/bjc.1953.8; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Patel AP, 2014, SCIENCE, V344, P1396, DOI 10.1126/science.1254257; Ricard D, 2012, LANCET, V379, P1984, DOI 10.1016/S0140-6736(11)61346-9; Roth A, 2014, NAT METHODS, V11, P396, DOI [10.1038/NMETH.2883, 10.1038/nmeth.2883]; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Singh D, 2012, SCIENCE, V337, P1231, DOI 10.1126/science.1220834; Sottoriva A, 2013, P NATL ACAD SCI USA, V110, P4009, DOI 10.1073/pnas.1219747110; Sterner-Kock A, 2002, GENE DEV, V16, P2264, DOI 10.1101/gad.229102; Stieglitz E, 2015, NAT GENET, V47, P1326, DOI 10.1038/ng.3400; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Suzuki H, 2015, NAT GENET, V47, P458, DOI 10.1038/ng.3273; Torres-Garcia W, 2014, BIOINFORMATICS, V30, P2224, DOI 10.1093/bioinformatics/btu169; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trifonov V, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-S2-S2; Trifonov V, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-25; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; Wang J, 2014, ELIFE, V3, DOI 10.7554/eLife.03496; Yates LR, 2012, NAT REV GENET, V13, P795, DOI 10.1038/nrg3317; Yip S, 2009, CLIN CANCER RES, V15, P4622, DOI 10.1158/1078-0432.CCR-08-3012; Zairis Sakellarios, 2014, Brain Informatics and Health. International Conference, BIH 2014. Proceedings: LNCS 8609, P528, DOI 10.1007/978-3-319-09891-3_48; Zhao XD, 2008, NAT CELL BIOL, V10, P643, DOI 10.1038/ncb1727	61	392	398	4	52	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2016	48	7					768	+		10.1038/ng.3590	http://dx.doi.org/10.1038/ng.3590			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DP9TK	27270107	Green Accepted, Bronze			2022-12-25	WOS:000378840100014
J	Baccile, JA; Spraker, JE; Le, HH; Brandenburger, E; Gomez, C; Bok, JW; Macheleidt, J; Brakhage, AA; Hoffmeister, D; Keller, NP; Schroeder, FC				Baccile, Joshua A.; Spraker, Joseph E.; Le, Henry H.; Brandenburger, Eileen; Gomez, Christian; Bok, Jin Woo; Macheleidt, Juliane; Brakhage, Axel A.; Hoffmeister, Dirk; Keller, Nancy P.; Schroeder, Frank C.			Plant-like biosynthesis of isoquinoline alkaloids in Aspergillus fumigatus	NATURE CHEMICAL BIOLOGY			English	Article							BERBERINE BRIDGE ENZYME; DEPENDENT PROTEIN-KINASE; NONRIBOSOMAL PEPTIDE; GENE CLUSTERS; SACCHAROMYCES-CEREVISIAE; FILAMENTOUS FUNGI; MECHANISM; YEAST; IDENTIFICATION; METABOLISM	Natural product discovery efforts have focused primarily on microbial biosynthetic gene clusters (BGCs) containing large multimodular polyketide synthases and nonribosomal peptide synthetases; however, sequencing of fungal genomes has revealed a vast number of BGCs containing smaller NRPS-like genes of unknown biosynthetic function. Using comparative metabolomics, we show that a BGC in the human pathogen Aspergillus fumigatus named fsq, which contains an NRPS-like gene lacking a condensation domain, produces several new isoquinoline alkaloids known as the fumisoquins. These compounds derive from carbon-carbon bond formation between two amino acid-derived moieties followed by a sequence that is directly analogous to isoquinoline alkaloid biosynthesis in plants. Fumisoquin biosynthesis requires the N-methyltransferase FsqC and the FAD-dependent oxidase FsqB, which represent functional analogs of coclaurine N-methyltransferase and berberine bridge enzyme in plants. Our results show that BGCs containing incomplete NRPS modules may reveal new biosynthetic paradigms and suggest that plant-like isoquinoline biosynthesis occurs in diverse fungi.	[Baccile, Joshua A.; Le, Henry H.; Gomez, Christian; Schroeder, Frank C.] Cornell Univ, Boyce Thompson Inst, Ithaca, NY USA; [Baccile, Joshua A.; Le, Henry H.; Gomez, Christian; Schroeder, Frank C.] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY USA; [Spraker, Joseph E.] Univ Wisconsin, Dept Plant Pathol, Madison, WI 53706 USA; [Brandenburger, Eileen; Hoffmeister, Dirk] Univ Jena, Dept Pharmaceut Microbiol, Hans Knoll Inst, Jena, Germany; [Bok, Jin Woo; Macheleidt, Juliane; Brakhage, Axel A.] Univ Jena, Inst Microbiol, Jena, Germany; [Macheleidt, Juliane; Brakhage, Axel A.] Leibniz Inst Nat Prod Res & Infect Biol HKI, Mol & Appl Microbiol, Jena, Germany; [Keller, Nancy P.] Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA; [Keller, Nancy P.] Univ Wisconsin, Dept Med Microbiol & Immunol, Madison, WI 53706 USA	Cornell University; Boyce Thompson Institute for Plant Research; Cornell University; University of Wisconsin System; University of Wisconsin Madison; Friedrich Schiller University of Jena; Hans Knoll Institute (HKI); Friedrich Schiller University of Jena; Hans Knoll Institute (HKI); University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Schroeder, FC (corresponding author), Cornell Univ, Boyce Thompson Inst, Ithaca, NY USA.; Schroeder, FC (corresponding author), Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY USA.; Keller, NP (corresponding author), Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA.; Keller, NP (corresponding author), Univ Wisconsin, Dept Med Microbiol & Immunol, Madison, WI 53706 USA.	npkeller@wisc.edu; schroeder@cornell.edu	Baccile, Joshua/AAV-6807-2020; Keller, Nancy P./ABC-5911-2021	Baccile, Joshua/0000-0003-4334-755X; Spraker, Joseph/0000-0002-5429-0328; Le, Henry/0000-0003-2942-2357; Schroeder, Frank/0000-0002-4420-0237	NIH [R01GM112739-01]; NIH CBI [T32GM008500]; NSF [DGE-1256259]; Deutsche Forschungsgemeinschaft (CRC ChemBioSys) [1127]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008500, R01GM112739] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH CBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Deutsche Forschungsgemeinschaft (CRC ChemBioSys); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was funded in part by NIH R01GM112739-01 (to N.P.K. and F.C.S.), NIH CBI training grant T32GM008500 (J.A.B.) and an NSF Graduate Research Fellowship under grant DGE-1256259 (to J.E.S.). A.A.B. and D.H. were supported by the Deutsche Forschungsgemeinschaft (CRC ChemBioSys 1127). The authors would like to thank D. Kiemle for his kind assistance in operating the Bruker Avance III HD 800 MHz NMR spectrometer.	Bentley KW, 2006, NAT PROD REP, V23, P444, DOI 10.1039/b509523a; Bok JW, 2009, NAT CHEM BIOL, V5, P462, DOI 10.1038/nchembio.177; Bok JW, 2005, EUKARYOT CELL, V4, P1574, DOI 10.1128/EC.4.9.1574-1582.2005; Bok JW, 2004, EUKARYOT CELL, V3, P527, DOI 10.1128/EC.3.2.527-535.2004; Brakhage AA, 2013, NAT REV MICROBIOL, V11, P21, DOI 10.1038/nrmicro2916; CARPENTER JF, 1993, J ORG CHEM, V58, P1607, DOI 10.1021/jo00058a056; DeLoache WC, 2015, NAT CHEM BIOL, V11, P465, DOI 10.1038/nchembio.1816; Dunn RV, 2010, CHEMBIOCHEM, V11, P1228, DOI 10.1002/cbic.201000184; FAN C, 1995, P NATL ACAD SCI USA, V92, P1172, DOI 10.1073/pnas.92.4.1172; Fawaz MV, 2011, BIOORG CHEM, V39, P185, DOI 10.1016/j.bioorg.2011.08.004; Fischbach MA, 2006, CHEM REV, V106, P3468, DOI 10.1021/cr0503097; Forseth RR, 2013, ANGEW CHEM INT EDIT, V52, P1590, DOI 10.1002/anie.201207456; Forseth Ry R, 2012, Methods Mol Biol, V944, P207, DOI 10.1007/978-1-62703-122-6_15; Forseth RR, 2011, CURR OPIN CHEM BIOL, V15, P38, DOI 10.1016/j.cbpa.2010.10.010; Fossati E, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4283; Galanie S, 2015, SCIENCE, V349, P1095, DOI 10.1126/science.aac9373; Galanie S, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0332-3; Gaweska HM, 2012, BIOCHEMISTRY-US, V51, P7342, DOI 10.1021/bi300887m; Glenn WS, 2013, CURR OPIN BIOTECH, V24, P354, DOI 10.1016/j.copbio.2012.08.003; Hagel JM, 2013, PLANT CELL PHYSIOL, V54, P647, DOI 10.1093/pcp/pct020; Hawkins KM, 2008, NAT CHEM BIOL, V4, P564, DOI 10.1038/nchembio.105; Imamura K, 2012, APPL ENVIRON MICROB, V78, P6996, DOI 10.1128/AEM.01770-12; Jenke-Kodama H, 2009, NAT PROD REP, V26, P874, DOI 10.1039/b810283j; Kalb D, 2014, APPL ENVIRON MICROB, V80, P6175, DOI 10.1128/AEM.01767-14; Keller NP, 2015, NAT CHEM BIOL, V11, P671, DOI [10.1038/NCHEMBIO.1897, 10.1038/nchembio.1897]; KUTCHAN TM, 1995, J BIOL CHEM, V270, P24475, DOI 10.1074/jbc.270.41.24475; Leonard E, 2009, NAT CHEM BIOL, V5, P292, DOI 10.1038/nchembio.160; Macheleidt J, 2015, MOL MICROBIOL, V96, P148, DOI 10.1111/mmi.12926; MacPherson S, 2006, MICROBIOL MOL BIOL R, V70, P583, DOI 10.1128/MMBR.00015-06; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; Mukherjee A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064753; Nagano N, 2016, FUNGAL GENET BIOL, V86, P58, DOI 10.1016/j.fgb.2015.12.010; Nakagawa A, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1327; Noike M, 2015, NAT CHEM BIOL, V11, P71, DOI 10.1038/nchembio.1697; Palmer JM, 2013, PEERJ, V1, DOI 10.7717/peerj.4; Sanchez JF, 2012, NAT PROD REP, V29, P351, DOI 10.1039/c2np00084a; Schneider P, 2007, CHEM BIOL, V14, P635, DOI 10.1016/j.chembiol.2007.05.005; Schneider P, 2008, FUNGAL GENET BIOL, V45, P1487, DOI 10.1016/j.fgb.2008.08.009; Scrutton NS, 2004, NAT PROD REP, V21, P722, DOI 10.1039/b306788m; Sekonyela R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062591; Shimizu K, 2001, GENETICS, V157, P591; Thodey K, 2014, NAT CHEM BIOL, V10, P837, DOI [10.1038/NCHEMBIO.1613, 10.1038/nchembio.1613]; Tobiasen C, 2007, CURR GENET, V51, P43, DOI 10.1007/s00294-006-0103-0; Wallner S, 2012, BIOCHEMISTRY-US, V51, P6139, DOI 10.1021/bi300411n; Walsh CT, 2013, ANGEW CHEM INT EDIT, V52, P7098, DOI 10.1002/anie.201208344; Wang M, 2014, CHEM BIOL, V21, P257, DOI 10.1016/j.chembiol.2013.12.005; Wiemann P, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00530; Winkler A, 2008, NAT CHEM BIOL, V4, P739, DOI 10.1038/nchembio.123; Yamada T, 2003, BIOCHEMISTRY-US, V42, P12854, DOI 10.1021/bi035324p; Yu JH, 2004, FUNGAL GENET BIOL, V41, P973, DOI 10.1016/j.fgb.2004.08.001	50	48	49	2	94	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUN	2016	12	6					419	U70		10.1038/NCHEMBIO.2061	http://dx.doi.org/10.1038/NCHEMBIO.2061			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DM2EW	27065235	Green Accepted			2022-12-25	WOS:000376160600011
J	Orhon, I; Dupont, N; Zaidan, M; Boitez, V; Burtin, M; Schmitt, A; Capiod, T; Viau, A; Beau, I; Kuehn, EW; Friedlander, G; Terzi, F; Codogno, P				Orhon, Idil; Dupont, Nicolas; Zaidan, Mohamad; Boitez, Valerie; Burtin, Martine; Schmitt, Alain; Capiod, Thierry; Viau, Amandine; Beau, Isabelle; Kuehn, E. Wolfgang; Friedlander, Gerard; Terzi, Fabiola; Codogno, Patrice			Primary-cilium-dependent autophagy controls epithelial cell volume in response to fluid flow	NATURE CELL BIOLOGY			English	Article							POLYCYSTIC KIDNEY-DISEASE; PROXIMAL TUBULE; STRESS; CILIOGENESIS; PROTEOLYSIS; MECHANISMS; EXPRESSION; HOMOLOG; PROTEIN; TG737	Autophagy is an adaptation mechanism that is vital for cellular homeostasis in response to various stress conditions. Previous reports indicate that there is a functional interaction between the primary cilium (PC) and autophagy. The PC, a microtubule-based structure present at the surface of numerous cell types, is a mechanical sensor. Here we show that autophagy induced by fluid flow regulates kidney epithelial cell volume in vitro and in vivo. PC ablation blocked autophagy induction and cell-volume regulation. In addition, inhibition of autophagy in ciliated cells impaired the flow-dependent regulation of cell volume. PC-dependent autophagy can be triggered either by mTOR inhibition or a mechanism dependent on the polycystin 2 channel. Only the LKB1-AMPK-mTOR signalling pathway was required for the flow-dependent regulation of cell volume by autophagy. These findings suggest that therapies regulating autophagy should be considered in developing treatments for PC-related diseases.	[Orhon, Idil; Dupont, Nicolas; Zaidan, Mohamad; Boitez, Valerie; Burtin, Martine; Capiod, Thierry; Friedlander, Gerard; Terzi, Fabiola; Codogno, Patrice] Univ Paris 05, UMR INSERM CNRS U1151 8253, INEM, Sorbonne Paris Cite, F-75993 Paris, France; [Schmitt, Alain] Univ Paris 05, INSERM CNRS UMR 8104 U1016, Inst Cochin, Sorbonne Paris Cite, F-75014 Paris, France; [Viau, Amandine; Kuehn, E. Wolfgang] Univ Freiburg, Univ Med Ctr, Dept Nephrol, Hugstetter Str 55, D-79106 Freiburg, Germany; [Beau, Isabelle] Univ Paris 11, INSERM UMR 1185, F-94276 Le Kremlin Bicetre, France; [Kuehn, E. Wolfgang] Univ Freiburg, Ctr Biol Signaling Studies Bioss, D-79104 Freiburg, Germany	UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Freiburg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; University of Freiburg	Codogno, P (corresponding author), Univ Paris 05, UMR INSERM CNRS U1151 8253, INEM, Sorbonne Paris Cite, F-75993 Paris, France.	patrice.codogno@inserm.fr	Beau, Isabelle/M-4423-2017; Dupont, Nicolas/AAJ-7192-2021; orhon, idil/AAB-1940-2020; CAPIOD, Thierry/K-4234-2017; Terzi, Fabiola/N-5482-2018	Beau, Isabelle/0000-0002-3352-6813; Dupont, Nicolas/0000-0002-3056-9906; orhon, idil/0000-0002-0779-8719; CAPIOD, Thierry/0000-0002-8448-7041; Friedlander, Gerard/0000-0002-6854-4261; Viau, Amandine/0000-0003-2890-7897	INSERM; CNRS; University Paris Descartes; ANR; INCa; Association pour la Recherche sur le Cancer (ARC); ERA-EDTA fellowship; DFG [KU1504-5/1]; Else-Kroner-Fresenius Stiftung [2011_A87]	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); University Paris Descartes; ANR(French National Research Agency (ANR)); INCa(Institut National du Cancer (INCA) France); Association pour la Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); ERA-EDTA fellowship; DFG(German Research Foundation (DFG)); Else-Kroner-Fresenius Stiftung	We thank F. Bienaime, T. Blanc, C. Nguyen and C. Bauvy for assistance. We also thank T. Yoshimori (Osaka University, Osaksa, Japan) for providing GFP-LC3 and RFP-GFP-LC3 constructs. We are grateful to A.M. Cuervo (Albert Einstein College, Bronx, New York, USA) for sharing KECs and IFT88<SUP>-/-</SUP> KECs. We acknowledge the design of the transgenic mouse strains by L. Goldstein, San Diego, California, USA (Kif3atm1Gsn), R. Koesters, Heidelberg, Germany (Tg(Pax8-rtTA2S*M2)1Koes), and D. Tenen, Boston, USA (Tg(TetOCre)1Dgt). We also acknowledge the Necker Institute Imaging Facility, the Fondation Imagine, the Cochin Imaging Electron Microscopy facility, and the Animal Histology and Morphology Core Facility (SFR Necker INSERM US24, CNRS UMS 3633). The work was supported by institutional funding from INSERM, CNRS, and University Paris Descartes and grants from ANR and INCa to P.C. N.D. is supported by a fellowship from Association pour la Recherche sur le Cancer (ARC), and A.V. was supported by an ERA-EDTA fellowship. E.W.K. is supported by the DFG (KU1504-5/1) and Else-Kroner-Fresenius Stiftung (2011_A87).	Abdul-Majeed S, 2012, CELL MOL LIFE SCI, V69, P165, DOI 10.1007/s00018-011-0744-0; Boehlke C, 2010, NAT CELL BIOL, V12, P1115, DOI 10.1038/ncb2117; Boya P, 2013, NAT CELL BIOL, V15, P713, DOI 10.1038/ncb2788; Briscoe J, 2013, NAT REV MOL CELL BIO, V14, P416, DOI 10.1038/nrm3598; Brown NE, 2003, KIDNEY INT, V63, P1220, DOI 10.1046/j.1523-1755.2003.00863.x; Canaud G, 2013, NAT MED, V19, P1288, DOI 10.1038/nm.3313; Cao M., 2016, CILIA, V5, P4; Cebotaru V, 2014, J BIOL CHEM, V289, P6404, DOI 10.1074/jbc.M113.501205; Chang TK, 2013, NAT CELL BIOL, V15, P1067, DOI 10.1038/ncb2804; Chapin HC, 2010, J CELL BIOL, V191, P701, DOI 10.1083/jcb.201006173; Delling M, 2013, NATURE, V504, P311, DOI 10.1038/nature12833; DuFort CC, 2011, NAT REV MOL CELL BIO, V12, P308, DOI 10.1038/nrm3112; Dupont N, 2014, METHOD ENZYMOL, V543, P73, DOI 10.1016/B978-0-12-801329-8.00004-0; Eggenschwiler JT, 2007, ANNU REV CELL DEV BI, V23, P345, DOI 10.1146/annurev.cellbio.23.090506.123249; El Boustany C, 2008, HEPATOLOGY, V47, P2068, DOI 10.1002/hep.22263; Fader CM, 2008, TRAFFIC, V9, P230, DOI 10.1111/j.1600-0854.2007.00677.x; Fliegauf M, 2007, NAT REV MOL CELL BIO, V8, P880, DOI 10.1038/nrm2278; FRENCH AS, 1992, ANNU REV PHYSIOL, V54, P135, DOI 10.1146/annurev.physiol.54.1.135; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; GRANTHAM JJ, 1987, KIDNEY INT, V31, P1145, DOI 10.1038/ki.1987.121; He CC, 2012, NATURE, V481, P511, DOI 10.1038/nature10758; Heo J, 2012, CELL PHYSIOL BIOCHEM, V30, P395, DOI 10.1159/000339033; Hildebrandt F, 2011, NEW ENGL J MED, V364, P1533, DOI 10.1056/NEJMra1010172; Hirokawa N, 2009, NAT REV MOL CELL BIO, V10, P682, DOI 10.1038/nrm2774; Hofherr A, 2011, ADV EXP MED BIOL, V704, P287, DOI 10.1007/978-94-007-0265-3_16; Huber TB, 2012, AUTOPHAGY, V8, P1009, DOI 10.4161/auto.19821; Hussain SNA, 2010, AM J RESP CRIT CARE, V182, P1377, DOI 10.1164/rccm.201002-0234OC; Jin GX, 2015, MOL CELL, V58, P989, DOI 10.1016/j.molcel.2015.05.010; Jin XJ, 2014, CELL MOL LIFE SCI, V71, P2165, DOI 10.1007/s00018-013-1483-1; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kallakuri S, 2015, J AM SOC NEPHROL, V26, P864, DOI 10.1681/ASN.2013121314; Kim ES, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118190; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Kimura T, 2011, J AM SOC NEPHROL, V22, P902, DOI 10.1681/ASN.2010070705; King JS, 2012, TRENDS MOL MED, V18, P583, DOI 10.1016/j.molmed.2012.08.002; Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356; Knodler A, 2010, P NATL ACAD SCI USA, V107, P6346, DOI 10.1073/pnas.1002401107; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Kotsis F, 2013, NEPHROL DIAL TRANSPL, V28, P518, DOI 10.1093/ndt/gfs524; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Lam HC, 2013, J CLIN INVEST, V123, P5212, DOI 10.1172/JCI69636; Masyuk AI, 2006, GASTROENTEROLOGY, V131, P911, DOI 10.1053/j.gastro.2006.07.003; McGrath J, 2003, CELL, V114, P61, DOI 10.1016/S0092-8674(03)00511-7; MEIJER AJ, 1993, EUR J BIOCHEM, V215, P449, DOI 10.1111/j.1432-1033.1993.tb18053.x; Meijer AJ, 2015, AMINO ACIDS, V47, P2037, DOI 10.1007/s00726-014-1765-4; Miettinen TP, 2015, CELL REP, V13, P2610, DOI 10.1016/j.celrep.2015.11.045; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Orhon I, 2015, CELL DEATH DIFFER, V22, P389, DOI 10.1038/cdd.2014.171; Pampliega O, 2016, CURR OPIN CELL BIOL, V39, P1, DOI 10.1016/j.ceb.2016.01.008; Pampliega O, 2013, NATURE, V502, P194, DOI 10.1038/nature12639; Patel A, 2010, NAT REV NEPHROL, V6, P530, DOI 10.1038/nrneph.2010.97; Pazour GJ, 2000, J CELL BIOL, V151, P709, DOI 10.1083/jcb.151.3.709; Puri C, 2013, CELL, V154, P1285, DOI 10.1016/j.cell.2013.08.044; Raghavan V, 2016, AM J PHYSIOL-RENAL, V310, pF1, DOI 10.1152/ajprenal.00373.2015; Raghavan V, 2014, P NATL ACAD SCI USA, V111, P8506, DOI 10.1073/pnas.1402195111; Ravichandran K, 2014, SEMIN NEPHROL, V34, P27, DOI 10.1016/j.semnephrol.2013.11.005; Satir P, 2007, ANNU REV PHYSIOL, V69, P377, DOI 10.1146/annurev.physiol.69.040705.141236; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Takiar V, 2011, BBA-MOL BASIS DIS, V1812, P1337, DOI 10.1016/j.bbadis.2010.11.014; Tang ZM, 2013, NATURE, V502, P254, DOI 10.1038/nature12606; Tanida I, 2005, AUTOPHAGY, V1, P84, DOI 10.4161/auto.1.2.1697; Thomas G, 1997, CURR OPIN CELL BIOL, V9, P782, DOI 10.1016/S0955-0674(97)80078-6; Tooze SA, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a018358; Viau A, 2010, J CLIN INVEST, V120, P4065, DOI 10.1172/JCI42004; vom Dahl S, 2003, J BIOL CHEM, V278, P27088, DOI 10.1074/jbc.M210699200; Wang SX, 2015, AUTOPHAGY, V11, P607, DOI 10.1080/15548627.2015.1023983; Wang ZB, 2014, ANTIOXID REDOX SIGN, V20, P519, DOI 10.1089/ars.2013.5363; Weinbaum S, 2010, AM J PHYSIOL-RENAL, V299, pF1220, DOI 10.1152/ajprenal.00453.2010; Yang ZF, 2010, NAT CELL BIOL, V12, P814, DOI 10.1038/ncb0910-814; Yoo KH, 2006, KIDNEY INT, V70, P1735, DOI 10.1038/sj.ki.5000357; Zaglia T, 2014, J CLIN INVEST, V124, P2410, DOI 10.1172/JCI66339; Zeng H, 2013, NATURE, V499, P485, DOI 10.1038/nature12297; Zimmerman K, 2015, CELL, V161, P692, DOI 10.1016/j.cell.2015.04.015	74	95	98	1	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUN	2016	18	6					657	+		10.1038/ncb3360	http://dx.doi.org/10.1038/ncb3360			23	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	DN0JL	27214279				2022-12-25	WOS:000376750100012
J	Pacold, ME; Brimacombe, KR; Chan, SH; Rohde, JM; Lewis, CA; Swier, LJYM; Possemato, R; Chen, WW; Sullivan, LB; Fiske, BP; Cho, S; Freinkman, E; Birsoy, K; Abu-Remaileh, M; Shaul, YD; Liu, CM; Zhou, M; Koh, MJ; Chung, H; Davidson, SM; Luengo, A; Wang, AQ; Xu, X; Yasgar, A; Liu, L; Rai, G; Westover, KD; Vander Heiden, MG; Shen, M; Gray, NS; Boxer, MB; Sabatini, DM				Pacold, Michael E.; Brimacombe, Kyle R.; Chan, Sze Ham; Rohde, Jason M.; Lewis, Caroline A.; Swier, Lotteke J. Y. M.; Possemato, Richard; Chen, Walter W.; Sullivan, Lucas B.; Fiske, Brian P.; Cho, Steve; Freinkman, Elizaveta; Birsoy, Kivanc; Abu-Remaileh, Monther; Shaul, Yoav D.; Liu, Chieh Min; Zhou, Minerva; Koh, Min Jung; Chung, Haeyoon; Davidson, Shawn M.; Luengo, Alba; Wang, Amy Q.; Xu, Xin; Yasgar, Adam; Liu, Li; Rai, Ganesha; Westover, Kenneth D.; Vander Heiden, Matthew G.; Shen, Min; Gray, Nathanael S.; Boxer, Matthew B.; Sabatini, David M.			A PHGDH inhibitor reveals coordination of serine synthesis and one-carbon unit fate	NATURE CHEMICAL BIOLOGY			English	Article							PHOSPHOGLYCERATE DEHYDROGENASE; METABOLISM; GLYCINE; BIOSYNTHESIS; PROLIFERATION; IMBALANCE; PATHWAY; CELLS; FLUX	Serine is both a proteinogenic amino acid and the source of one-carbon units essential for de novo purine and deoxythymidine synthesis. In the canonical pathway of glucose-derived serine synthesis, Homo sapiens phosphoglycerate dehydrogenase (PHGDH) catalyzes the first, rate-limiting step. Genetic loss of PHGDH is toxic toward PHGDH-overexpressing breast cancer cell lines even in the presence of exogenous serine. Here, we used a quantitative high-throughput screen to identify small-molecule PHGDH inhibitors. These compounds reduce the production of glucose-derived serine in cells and suppress the growth of PHGDH-dependent cancer cells in culture and in orthotopic xenograft tumors. Surprisingly, PHGDH inhibition reduced the incorporation into nucleotides of one-carbon units from glucose-derived and exogenous serine. We conclude that glycolytic serine synthesis coordinates the use of one-carbon units from endogenous and exogenous serine in nucleotide synthesis, and we suggest that one-carbon unit wasting thus may contribute to the efficacy of PHGDH inhibitors in vitro and in vivo.	[Pacold, Michael E.; Chan, Sze Ham; Swier, Lotteke J. Y. M.; Chen, Walter W.; Cho, Steve; Freinkman, Elizaveta; Abu-Remaileh, Monther; Liu, Chieh Min; Zhou, Minerva; Koh, Min Jung; Chung, Haeyoon; Sabatini, David M.] Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA; [Pacold, Michael E.; Chan, Sze Ham; Swier, Lotteke J. Y. M.; Chen, Walter W.; Cho, Steve; Abu-Remaileh, Monther; Liu, Chieh Min; Zhou, Minerva; Koh, Min Jung; Chung, Haeyoon; Sabatini, David M.] MIT, Howard Hughes Med Inst, Dept Biol, Cambridge, MA USA; [Pacold, Michael E.; Chan, Sze Ham; Lewis, Caroline A.; Swier, Lotteke J. Y. M.; Chen, Walter W.; Sullivan, Lucas B.; Fiske, Brian P.; Cho, Steve; Abu-Remaileh, Monther; Liu, Chieh Min; Zhou, Minerva; Koh, Min Jung; Chung, Haeyoon; Davidson, Shawn M.; Luengo, Alba; Vander Heiden, Matthew G.; Sabatini, David M.] Koch Inst Integrat Canc Res, Cambridge, MA USA; [Pacold, Michael E.; Chan, Sze Ham; Swier, Lotteke J. Y. M.; Chen, Walter W.; Cho, Steve; Abu-Remaileh, Monther; Liu, Chieh Min; Zhou, Minerva; Koh, Min Jung; Chung, Haeyoon; Sabatini, David M.] Broad Inst Harvard & Massachusetts Inst Technol, Cambridge, MA USA; [Pacold, Michael E.; Gray, Nathanael S.] Dana Farber Canc Inst, Longwood Ctr, Boston, MA 02115 USA; [Pacold, Michael E.; Chan, Sze Ham] Dana Farber Canc Inst, Dept Radiat Oncol, Boston, MA 02115 USA; [Brimacombe, Kyle R.; Rohde, Jason M.; Wang, Amy Q.; Xu, Xin; Yasgar, Adam; Liu, Li; Rai, Ganesha; Shen, Min; Boxer, Matthew B.] NIH, Natl Ctr Adv Translat Sci, Rockville, MD USA; [Possemato, Richard] NYU, Langone Med Ctr, New York, NY USA; [Birsoy, Kivanc] Rockefeller Univ, Lab Metab Regulat & Genet, 1230 York Ave, New York, NY 10021 USA; [Shaul, Yoav D.] Hebrew Univ Jerusalem, Hadassah Med Sch, Inst Med Res Israel Canada, Dept Biochem & Mol Biol, IL-91010 Jerusalem, Israel; [Westover, Kenneth D.] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS); New York University; NYU Langone Medical Center; Rockefeller University; Hebrew University of Jerusalem; University of Texas System; University of Texas Southwestern Medical Center Dallas	Sabatini, DM (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.; Sabatini, DM (corresponding author), MIT, Howard Hughes Med Inst, Dept Biol, Cambridge, MA USA.; Sabatini, DM (corresponding author), Koch Inst Integrat Canc Res, Cambridge, MA USA.; Sabatini, DM (corresponding author), Broad Inst Harvard & Massachusetts Inst Technol, Cambridge, MA USA.	sabatini@wi.mit.edu	Westover, Ken/AAZ-1795-2020; Shaul, Yoav/AAY-7011-2020; Abu-Remaileh, Monther/M-3747-2016	Westover, Ken/0000-0003-3653-5923; Fiske, Brian/0000-0001-5891-4268; Possemato, Richard/0000-0002-2401-0030; Yasgar, Adam/0000-0001-7350-1402; Sullivan, Lucas/0000-0002-6745-8222; Abu-Remaileh, Monther/0000-0003-3772-0477; Luengo, Alba/0000-0002-4236-0229; Chen, Walter/0000-0002-7752-9581; /0000-0002-1446-7256	Sally Gordon Fellowship of the Damon Runyon Cancer Research Foundation [DRG-112-12]; Department of Defense Breast Cancer Research Program Postdoctoral Fellowship [BC120208]; ASTRO Resident Seed Grant [RA-2011-1]; Susan G. Komen for the Cure; EMBO Long-Term Fellowship; NIH [1 R03 DA034602-01A1]; Stewart Trust; NATIONAL CANCER INSTITUTE [R01CA103866, K22CA193660, R21CA198028, R01CA129105, R01CA168653, P30CA014051] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [ZIATR000236] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI047389] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007287, T32GM007753] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R03DA034602] Funding Source: NIH RePORTER	Sally Gordon Fellowship of the Damon Runyon Cancer Research Foundation; Department of Defense Breast Cancer Research Program Postdoctoral Fellowship(United States Department of Defense); ASTRO Resident Seed Grant; Susan G. Komen for the Cure(Susan G. Komen Breast Cancer Foundation); EMBO Long-Term Fellowship(European Molecular Biology Organization (EMBO)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stewart Trust; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank T. Wang and E. Edenberg for critical reading of the manuscript, S. Murphy for assistance with mouse experiments, and J. Pacold of the Lawrence Berkeley National Laboratory for assistance in interpreting T<INF>m</INF> data. This research is supported by the Sally Gordon Fellowship of the Damon Runyon Cancer Research Foundation (DRG-112-12), a Department of Defense Breast Cancer Research Program Postdoctoral Fellowship (BC120208), and an ASTRO Resident Seed Grant (RA-2011-1) (all to M.E.P.)., by Susan G. Komen for the Cure (grant to R.L.P.), by an EMBO Long-Term Fellowship (to M.A.-R.), by the NIH (1 R03 DA034602-01A1 to D.M.S.) and by the Stewart Trust (to D.M.S.). D.M.S. is an investigator of the Howard Hughes Medical Institute.	Anastasiou D, 2012, NAT CHEM BIOL, V8, P839, DOI 10.1038/NCHEMBIO.1060; Birsoy K, 2015, CELL, V162, P540, DOI 10.1016/j.cell.2015.07.016; Cantor JR, 2012, CANCER DISCOV, V2, P881, DOI 10.1158/2159-8290.CD-12-0345; Chakraborty S, 2008, BIOSCI BIOTECH BIOCH, V72, P982, DOI 10.1271/bbb.70724; Chaneton B, 2012, NATURE, V491, P458, DOI 10.1038/nature11540; Chen JY, 2013, ONCOTARGET, V4, P2502, DOI 10.18632/oncotarget.1540; Cho K, 2014, ANAL CHEM, V86, P9358, DOI 10.1021/ac5029177; DeNicola GM, 2015, NAT GENET, V47, P1475, DOI 10.1038/ng.3421; Di L., 2007, SOLVENT SYSTEMS THEI; Fan J, 2014, NATURE, V510, P298, DOI 10.1038/nature13236; FARBER S, 1948, NEW ENGL J MED, V238, P787, DOI 10.1056/NEJM194806032382301; FELL DA, 1988, BIOCHEM J, V256, P97, DOI 10.1042/bj2560097; Foley TL, 2014, J MED CHEM, V57, P1063, DOI 10.1021/jm401752p; Hamiaux C, 2012, CURR BIOL, V22, P2032, DOI 10.1016/j.cub.2012.08.007; Inglese J, 2006, P NATL ACAD SCI USA, V103, P11473, DOI 10.1073/pnas.0604348103; Kim D, 2015, NATURE, V520, P363, DOI 10.1038/nature14363; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; Labuschagne CF, 2014, CELL REP, V7, P1248, DOI 10.1016/j.celrep.2014.04.045; Locasale JW, 2013, NAT REV CANCER, V13, P572, DOI 10.1038/nrc3557; Locasale JW, 2011, NAT GENET, V43, P869, DOI 10.1038/ng.890; LUND K, 1985, ARCH BIOCHEM BIOPHYS, V237, P186, DOI 10.1016/0003-9861(85)90268-1; Luo B, 2008, P NATL ACAD SCI USA, V105, P20380, DOI 10.1073/pnas.0810485105; Maddocks ODK, 2013, NATURE, V493, P542, DOI 10.1038/nature11743; Mattaini KR, 2015, CANCER METAB, V3, DOI 10.1186/s40170-015-0131-7; Narkewicz MR, 1996, BIOCHEM J, V313, P991, DOI 10.1042/bj3130991; Nilsson R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4128; Possemato R, 2011, NATURE, V476, P346, DOI 10.1038/nature10350; SNELL K, 1988, BRIT J CANCER, V57, P87, DOI 10.1038/bjc.1988.15; SNELL K, 1986, BIOCHEM J, V233, P617, DOI 10.1042/bj2330617; Sullivan LB, 2015, CELL, V162, P552, DOI 10.1016/j.cell.2015.07.017; Tibbetts AS, 2010, ANNU REV NUTR, V30, P57, DOI 10.1146/annurev.nutr.012809.104810; Vander Heiden MG, 2011, NAT REV DRUG DISCOV, V10, P671, DOI 10.1038/nrd3504; Walsh M. J., 2010, ML265 POTENT PKM2 AC; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Young L, 2010, NAT PROTOC, V5, P929, DOI 10.1038/nprot.2010.43; Zhang WC, 2012, CELL, V148, P259, DOI 10.1016/j.cell.2011.11.050	36	260	267	0	98	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUN	2016	12	6					452	U118		10.1038/NCHEMBIO.2070	http://dx.doi.org/10.1038/NCHEMBIO.2070			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DM2EW	27110680	Green Submitted, Green Accepted			2022-12-25	WOS:000376160600016
J	Saito, T; Nishikawa, H; Wada, H; Nagano, Y; Sugiyama, D; Atarashi, K; Maeda, Y; Hamaguchi, M; Ohkura, N; Sato, E; Nagase, H; Nishimura, J; Yamamoto, H; Takiguchi, S; Tanoue, T; Suda, W; Morita, H; Hattori, M; Honda, K; Mori, M; Doki, Y; Sakaguchi, S				Saito, Takuro; Nishikawa, Hiroyoshi; Wada, Hisashi; Nagano, Yuji; Sugiyama, Daisuke; Atarashi, Koji; Maeda, Yuka; Hamaguchi, Masahide; Ohkura, Naganari; Sato, Eiichi; Nagase, Hirotsugu; Nishimura, Junichi; Yamamoto, Hirofumi; Takiguchi, Shuji; Tanoue, Takeshi; Suda, Wataru; Morita, Hidetoshi; Hattori, Masahira; Honda, Kenya; Mori, Masaki; Doki, Yuichiro; Sakaguchi, Shimon			Two FOXP3(+)CD4(+) T cell subpopulations distinctly control the prognosis of colorectal cancers	NATURE MEDICINE			English	Article							TUMOR-INFILTRATING LYMPHOCYTES; FUSOBACTERIUM-NUCLEATUM; MICROBIOTA; TREG; SELF; TH17	CD4(+) T cells that express the forkhead box P3 (FOXP3) transcription factor function as regulatory T (T-reg) cells and hinder effective immune responses against cancer cells(1-3). Abundant Treg cell infiltration into tumors is associated with poor clinical outcomes in various types of cancers(3-7). However, the role of T-reg cells is controversial in colorectal cancers (CRCs), in which FOXP3(+) T cell infiltration indicated better prognosis in some studies(6-9). Here we show that CRCs, which are commonly infiltrated by suppression-competent FOXP3(hi) T-reg cells, can be classified into two types by the degree of additional infiltration of FOXP3(lo) nonsuppressive T cells(10). The latter, which are distinguished from FOXP3(+) T-reg cells by non-expression of the naive T cell marker CD45RA and instability of FOXP3, secreted inflammatory cytokines. Indeed, CRCs with abundant infiltration of FOXP3(lo) T cells showed significantly better prognosis than those with predominantly FOXP3(hi) T-reg cell infiltration. Development of such inflammatory FOXP3(lo) non-T-reg cells may depend on secretion of interleukin (IL)-12 and transforming growth factor (TGF)-beta by tissues and their presence was correlated with tumor invasion by intestinal bacteria, especially Fusobacterium nucleatum. Thus, functionally distinct subpopulations of tumor-infiltrating FOXP3(+) T cells contribute in opposing ways to determining CRC prognosis. Depletion of FOXP3(hi) T-reg cells from tumor tissues, which would augment antitumor immunity, could thus be used as an effective treatment strategy for CRCs and other cancers, whereas strategies that locally increase the population of FOXP3(lo) non-T-reg cells could be used to suppress or prevent tumor formation.	[Saito, Takuro; Nishikawa, Hiroyoshi; Sugiyama, Daisuke; Maeda, Yuka; Hamaguchi, Masahide; Ohkura, Naganari; Sakaguchi, Shimon] Osaka Univ, Grad Sch Med, World Premier Int Res Ctr WPI, Expt Immunol,Immunol Frontier Res Ctr, Osaka, Japan; [Saito, Takuro; Wada, Hisashi; Nagase, Hirotsugu; Nishimura, Junichi; Yamamoto, Hirofumi; Takiguchi, Shuji; Mori, Masaki; Doki, Yuichiro] Osaka Univ, Grad Sch Med, Dept Surg Gastroenterol, Osaka, Japan; [Wada, Hisashi] Osaka Univ, Grad Sch Med, Dept Clin Res Tumor Immunol, Osaka, Japan; [Nagano, Yuji; Atarashi, Koji; Tanoue, Takeshi; Honda, Kenya] RIKEN Ctr Integrat Med Sci IMS, Yokohama, Kanagawa, Japan; [Sato, Eiichi] Tokyo Med Univ, Inst Med Sci, Med Res Ctr, Dept Pathol, Tokyo 1608402, Japan; [Suda, Wataru; Hattori, Masahira] Univ Tokyo, Grad Sch Frontier Sci, Chiba, Japan; [Morita, Hidetoshi] Azabu Univ, Sch Vet Med, Sagamihara, Kanagawa, Japan; [Nishikawa, Hiroyoshi] Natl Canc Ctr, Exploratory Oncol Res & Clin Trial Ctr, Div Canc Immunol, Chiba, Japan	Osaka University; Osaka University; Osaka University; RIKEN; Tokyo Medical University; University of Tokyo; Azabu University; National Cancer Center - Japan	Nishikawa, H; Sakaguchi, S (corresponding author), Osaka Univ, Grad Sch Med, World Premier Int Res Ctr WPI, Expt Immunol,Immunol Frontier Res Ctr, Osaka, Japan.; Nishikawa, H (corresponding author), Natl Canc Ctr, Exploratory Oncol Res & Clin Trial Ctr, Div Canc Immunol, Chiba, Japan.	nisihiro@ifrec.osaka-u.ac.jp; shimon@ifrec.osaka-u.ac.jp	Atarashi, Koji/I-5363-2014; Sakaguchi, Shimon/C-9535-2009; Hattori, Masahira/AAD-3785-2019; Saito, Takuro/AAN-9682-2021; Suda, Wataru/AAF-4469-2019; Nishikawa, Hiroyoshi/AAI-7044-2020	Atarashi, Koji/0000-0001-5422-0736; Sugiyama, Daisuke/0000-0003-1490-3211; Wada, Hisashi/0000-0002-5444-6193; Hamaguchi, Masahide/0000-0002-8651-4445	Ministry of Education, Culture, Sports, Science and Technology of Japan [26253030, 26290054, 26670581]; Core Research for Evolutional Science and Technology (CREST) program from Japan Science and Technology Agency; Health and Labor Sciences Research Grants program from Japan Ministry of Health, Labor and Welfare [H24-Clinical Cancer Research-general-006]; Cancer Research Institute CLIP grant	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Core Research for Evolutional Science and Technology (CREST) program from Japan Science and Technology Agency; Health and Labor Sciences Research Grants program from Japan Ministry of Health, Labor and Welfare; Cancer Research Institute CLIP grant	We appreciate sample collection by members of the Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University. We thank J.B. Wing for helpful discussions and critical reading of this manuscript, and Y. Tada, K. Teshima, Y. Funabiki and Y. Nakamura for technical assistance. This study was supported by Grants-in-Aid for Scientific Research (A grant no. 26253030 (S.S.), B grant no. 26290054 (H. Nishikawa) and Challenging Exploratory Research grant no. 26670581 (H. Nishikawa)) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, the Core Research for Evolutional Science and Technology (CREST) program from the Japan Science and Technology Agency (S.S.), an H24-Clinical Cancer Research-general-006 grant from the Health and Labor Sciences Research Grants program (H. Nishikawa) from the Japan Ministry of Health, Labor and Welfare Grants-in-aid program for Research on Applying Health Technology and a Cancer Research Institute CLIP grant (H. Nishikawa). This study was done in part as a research program of the Project for Development of Innovative Research on Cancer Therapeutics (P-Direct), Ministry of Education, Culture, Sports, Science and Technology of Japan.	Atarashi K, 2013, NATURE, V500, P232, DOI 10.1038/nature12331; Berg JV, 2013, J EXP MED, V210, P2803, DOI 10.1084/jem.20130678; Blatner NR, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004566; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Dejea CM, 2014, P NATL ACAD SCI USA, V111, P18321, DOI 10.1073/pnas.1406199111; deLeeuw RJ, 2012, CLIN CANCER RES, V18, P3022, DOI 10.1158/1078-0432.CCR-11-3216; Frey DM, 2010, INT J CANCER, V126, P2635, DOI 10.1002/ijc.24989; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Grivennikov SI, 2012, NATURE, V491, P254, DOI 10.1038/nature11465; Gur C, 2015, IMMUNITY, V42, P344, DOI 10.1016/j.immuni.2015.01.010; Joller N, 2014, IMMUNITY, V40, P569, DOI 10.1016/j.immuni.2014.02.012; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Kim SW, 2013, DNA RES, V20, P241, DOI 10.1093/dnares/dst006; Kostic AD, 2013, CELL HOST MICROBE, V14, P207, DOI 10.1016/j.chom.2013.07.007; Mima K, 2015, GUT; Mima K, 2015, JAMA ONCOL, V1, P653, DOI 10.1001/jamaoncol.2015.1377; Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019; Nishikawa H, 2014, CURR OPIN IMMUNOL, V27, P1, DOI 10.1016/j.coi.2013.12.005; Ohkura N, 2012, IMMUNITY, V37, P785, DOI 10.1016/j.immuni.2012.09.010; Pages F, 2009, J CLIN ONCOL, V27, P5944, DOI 10.1200/JCO.2008.19.6147; Rech AJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003330; Rubinstein MR, 2013, CELL HOST MICROBE, V14, P195, DOI 10.1016/j.chom.2013.07.012; Said HS, 2014, DNA RES, V21, P15, DOI 10.1093/dnares/dst037; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; Sakaguchi S, 2010, NAT REV IMMUNOL, V10, P490, DOI 10.1038/nri2785; Salama P, 2009, J CLIN ONCOL, V27, P186, DOI 10.1200/JCO.2008.18.7229; Sato E, 2005, P NATL ACAD SCI USA, V102, P18538, DOI 10.1073/pnas.0509182102; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Sinicrope FA, 2009, GASTROENTEROLOGY, V137, P1270, DOI 10.1053/j.gastro.2009.06.053; Sugiyama D, 2013, P NATL ACAD SCI USA, V110, P17945, DOI 10.1073/pnas.1316796110; Tosolini M, 2011, CANCER RES, V71, P1263, DOI 10.1158/0008-5472.CAN-10-2907; Wu P, 2014, IMMUNITY, V40, P785, DOI 10.1016/j.immuni.2014.03.013; Yamaguchi T, 2013, P NATL ACAD SCI USA, V110, pE2116, DOI 10.1073/pnas.1307185110; Zou WP, 2006, NAT REV IMMUNOL, V6, P295, DOI 10.1038/nri1806	34	472	493	4	105	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2016	22	6					679	+		10.1038/nm.4086	http://dx.doi.org/10.1038/nm.4086			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DO0NQ	27111280				2022-12-25	WOS:000377476000026
J	Bivona, TG; Doebele, RC				Bivona, Trever G.; Doebele, Robert C.			A framework for understanding and targeting residual disease in oncogene-driven solid cancers	NATURE MEDICINE			English	Article							CELL LUNG-CANCER; RANDOMIZED PHASE-II; ACQUIRED-RESISTANCE; COMBINED BRAF; COLORECTAL-CANCER; MEK INHIBITION; RAF INHIBITORS; FEEDBACK ACTIVATION; DRUG-RESISTANCE; EGFR	Molecular targeted therapy has the potential to dramatically improve survival in patients with cancer. However, complete and durable responses to targeted therapy are rare in individuals with advanced-stage solid cancers. Even the most effective targeted therapies generally do not induce a complete tumor response, resulting in residual disease and tumor progression that limits patient survival. We discuss the emerging need to more fully understand the molecular basis of residual disease as a prelude to designing therapeutic strategies to minimize or eliminate residual disease so that we can move from temporary to chronic control of disease, or a cure, for patients with advanced-stage solid cancers. Ultimately, we propose a shift from the current reactive paradigm of analyzing and treating acquired drug resistance to a pre-emptive paradigm of defining the mechanisms that result in residual disease, to target and limit this disease reservoir.	[Bivona, Trever G.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Bivona, Trever G.] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Bivona, Trever G.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; [Doebele, Robert C.] Univ Colorado, Dept Med & Med Oncol, Anschutz Med Campus, Aurora, CO USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco; University of Colorado System; University of Colorado Anschutz Medical Campus	Bivona, TG (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA USA.; Bivona, TG (corresponding author), Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA.; Bivona, TG (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA.	trever.bivona@ucsf.edu	Doebele, Robert C./I-8230-2019	Doebele, Robert C./0000-0001-6728-6857	US National Institutes of Health Director's Office and Common Fund [DP2-CA174497]; National Cancer Institute [R01-CA169338]; HHMI Collaborative Innovation Award Program; Searle Scholars Program; Pew Charitable Trust; Addario Lung Cancer Foundation; V Foundation for Cancer Research; University of Colorado Lung Cancer SPORE; NATIONAL CANCER INSTITUTE [R01CA193935, R01CA169338, P50CA058187, DP2CA174497] Funding Source: NIH RePORTER	US National Institutes of Health Director's Office and Common Fund(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); HHMI Collaborative Innovation Award Program; Searle Scholars Program; Pew Charitable Trust; Addario Lung Cancer Foundation; V Foundation for Cancer Research; University of Colorado Lung Cancer SPORE; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	T.G.B. acknowledges funding support from the US National Institutes of Health Director's Office and Common Fund (New Innovators Award DP2-CA174497), the National Cancer Institute (R01-CA169338), the HHMI Collaborative Innovation Award Program, the Searle Scholars Program, the Pew Charitable Trust, and the Addario Lung Cancer Foundation. R.C.D. acknowledges funding support from the V Foundation for Cancer Research and the University of Colorado Lung Cancer SPORE.	Ahronian LG, 2015, CANCER DISCOV, V5, P358, DOI 10.1158/2159-8290.CD-14-1518; Alizadeh AA, 2015, NAT MED, V21, P846, DOI 10.1038/nm.3915; Behbehani GK, 2015, CANCER DISCOV, V5, P988, DOI 10.1158/2159-8290.CD-15-0298; Bhang HEC, 2015, NAT MED, V21, P440, DOI 10.1038/nm.3841; Blakely CM, 2015, CELL REP, V11, P98, DOI 10.1016/j.celrep.2015.03.012; Blumenthal GM, 2015, J CLIN ONCOL, V33, P1008, DOI 10.1200/JCO.2014.59.0489; Bollag G, 2010, NATURE, V467, P596, DOI 10.1038/nature09454; Boxer RB, 2004, CANCER CELL, V6, P577, DOI 10.1016/j.ccr.2004.10.013; Bozic I, 2013, ELIFE, V2, DOI 10.7554/eLife.00747; Burrell RA, 2014, MOL ONCOL, V8, P1095, DOI 10.1016/j.molonc.2014.06.005; Charakidis M, 2014, TRANSL LUNG CANCER R, V3, P395, DOI 10.3978/j.issn.2218-6751.2014.09.03; Collins FS, 2015, NEW ENGL J MED, V372, P793, DOI 10.1056/NEJMp1500523; Condeelis J, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003848; Coombs C.C., 2015, NAT REV CLIN ONCOL; Crystal AS, 2014, SCIENCE, V346, P1480, DOI 10.1126/science.1254721; de Bono JS, 2010, NATURE, V467, P543, DOI 10.1038/nature09339; de Bruin EC, 2014, SCIENCE, V346, P251, DOI 10.1126/science.1253462; De Silva N, 2015, BRIT J CANCER, V113, P1305, DOI 10.1038/bjc.2015.342; Doebele RC, 2012, CLIN CANCER RES, V18, P1472, DOI 10.1158/1078-0432.CCR-11-2906; Flaherty KT, 2012, NEW ENGL J MED, V367, P1694, DOI 10.1056/NEJMoa1210093; Gao D, 2014, CELL, V159, P176, DOI 10.1016/j.cell.2014.08.016; Garraway LA, 2012, CANCER DISCOV, V2, P214, DOI 10.1158/2159-8290.CD-12-0012; Gingras I, 2015, CURR OPIN ONCOL, V27, P560, DOI 10.1097/CCO.0000000000000223; Haq R, 2013, CANCER CELL, V23, P302, DOI 10.1016/j.ccr.2013.02.003; Hata AN, 2016, NAT MED, V22, P262, DOI 10.1038/nm.4040; Hiley C, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0453-8; Hrustanovic G, 2015, NAT MED, V21, P1038, DOI 10.1038/nm.3930; Hurvitz SA, 2015, LANCET ONCOL, V16, P816, DOI 10.1016/S1470-2045(15)00051-0; Janne PA, 2015, NEW ENGL J MED, V372, P1689, DOI 10.1056/NEJMoa1411817; Janne PA, 2014, J THORAC ONCOL, V9, P316, DOI 10.1097/JTO.0000000000000088; Jain RK, 2014, CANCER CELL, V26, P605, DOI 10.1016/j.ccell.2014.10.006; Janku F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022769; Johnson DB, 2014, J CLIN ONCOL, V32, P3697, DOI 10.1200/JCO.2014.57.3535; Johnson ML, 2015, J CLIN ONCOL, V33, P1666, DOI 10.1200/JCO.2014.59.7328; Karthaus WR, 2014, CELL, V159, P163, DOI 10.1016/j.cell.2014.08.017; Larkin J, 2015, NEW ENGL J MED, V373, P23, DOI [10.1056/NEJMc1509660, 10.1056/NEJMoa1504030]; Lee HJ, 2014, CANCER CELL, V26, P207, DOI 10.1016/j.ccr.2014.05.019; Li XN, 2014, NAT MED, V20, P769, DOI 10.1038/nm.3585; Lin LP, 2015, NAT GENET, V47, P250, DOI 10.1038/ng.3218; Lin NU, 2014, CURR TREAT OPTION NE, V16, DOI 10.1007/s11940-013-0276-z; Lito P, 2013, NAT MED, V19, P1401, DOI 10.1038/nm.3392; Lito P, 2012, CANCER CELL, V22, P668, DOI 10.1016/j.ccr.2012.10.009; Long GV, 2014, NEW ENGL J MED, V371, P1877, DOI 10.1056/NEJMoa1406037; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; MAYER RJ, 1994, NEW ENGL J MED, V331, P896, DOI 10.1056/NEJM199410063311402; Muller J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6712; Murtaza M, 2013, NATURE, V497, P108, DOI 10.1038/nature12065; Nakasone ES, 2012, CANCER CELL, V21, P488, DOI 10.1016/j.ccr.2012.02.017; Neesse A, 2015, GUT, V64, P1476, DOI 10.1136/gutjnl-2015-309304; Obenauf AC, 2015, NATURE, V520, P368, DOI 10.1038/nature14336; Piotrowska Z, 2015, CANCER DISCOV, V5, P713, DOI 10.1158/2159-8290.CD-15-0399; Planchard D., 2011, ASCO ANN M AM SOC CL, V8006; Poulikakos PI, 2011, NATURE, V480, P387, DOI 10.1038/nature10662; Poulikakos PI, 2010, NATURE, V464, P427, DOI 10.1038/nature08902; Prahallad A, 2012, NATURE, V483, P100, DOI 10.1038/nature10868; Price KA, 2010, J THORAC ONCOL, V5, P1623, DOI 10.1097/JTO.0b013e3181ec1531; Riely GJ, 2007, CLIN CANCER RES, V13, P5150, DOI 10.1158/1078-0432.CCR-07-0560; Rosell R, 2011, CLIN CANCER RES, V17, P1160, DOI 10.1158/1078-0432.CCR-10-2158; Sawyers Charles L, 2012, Trans Am Clin Climatol Assoc, V123, P114; Sawyers Charles L, 2009, Clin Adv Hematol Oncol, V7, P588; Sawyers CL, 2009, NAT MED, V15, P1158, DOI 10.1038/nm1009-1158; Schwaederle M, 2015, MOL CANCER THER, V14, P1488, DOI 10.1158/1535-7163.MCT-14-1061; Sequist LV, 2015, NEW ENGL J MED, V372, P1700, DOI 10.1056/NEJMoa1413654; Sequist LV, 2011, J CLIN ONCOL, V29, P3307, DOI 10.1200/JCO.2010.34.0570; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Shaw AT, 2014, NEW ENGL J MED, V370, P1189, DOI [10.1056/NEJMoa1311107, 10.1056/NEJMc1404894]; Siravegna G, 2015, NAT MED, V21, P795, DOI 10.1038/nm.3870; Spigel D.R., 2011, ASCO ANN M AM SOC CL, V7505; Straussman R, 2012, NATURE, V487, P500, DOI 10.1038/nature11183; Swain SM, 2015, NEW ENGL J MED, V372, P724, DOI 10.1056/NEJMoa1413513; Szmulewitz RZ, 2014, J CLIN PHARMACOL, V54, P375, DOI 10.1002/jcph.277; Thompson Craig B, 2009, Clin Adv Hematol Oncol, V7, P819; Thress KS, 2015, NAT MED, V21, P560, DOI 10.1038/nm.3854; Turke AB, 2010, CANCER CELL, V17, P77, DOI 10.1016/j.ccr.2009.11.022; Undevia SD, 2005, NAT REV CANCER, V5, P447, DOI 10.1038/nrc1629; Van Allen EM, 2014, NAT MED, V20, P682, DOI 10.1038/nm.3559; Van Allen EM, 2014, CANCER DISCOV, V4, P94, DOI 10.1158/2159-8290.CD-13-0617; Varmus H, 2010, NEW ENGL J MED, V362, P2028, DOI 10.1056/NEJMe0911933; Wagle N, 2014, CANCER DISCOV, V4, P61, DOI 10.1158/2159-8290.CD-13-0631; Wilson TR, 2012, NATURE, V487, P505, DOI 10.1038/nature11249; Witta SE, 2012, J CLIN ONCOL, V30, P2248, DOI 10.1200/JCO.2011.38.9411; Yaeger R, 2015, CLIN CANCER RES, V21, P1313, DOI 10.1158/1078-0432.CCR-14-2779; Yu HA, 2013, CLIN CANCER RES, V19, P2240, DOI 10.1158/1078-0432.CCR-12-2246; Zhang ZF, 2012, NAT GENET, V44, P852, DOI 10.1038/ng.2330	84	104	106	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2016	22	5					472	478		10.1038/nm.4091	http://dx.doi.org/10.1038/nm.4091			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DL3DI	27149220	Green Accepted			2022-12-25	WOS:000375514000009
J	Siu, LL; Lawler, M; Haussler, D; Knoppers, BM; Lewin, J; Vis, DJ; Liao, RG; Andre, F; Banks, I; Barrett, JC; Caldas, C; Camargo, AA; Fitzgerald, RC; Mao, M; Mattison, JE; Pao, W; Sellers, WR; Sullivan, P; Teh, BT; Ward, RL; ZenKlusen, JC; Sawyers, CL; Voest, EE				Siu, Lillian L.; Lawler, Mark; Haussler, David; Knoppers, Bartha Maria; Lewin, Jeremy; Vis, Daniel J.; Liao, Rachel G.; Andre, Fabrice; Banks, Ian; Barrett, J. Carl; Caldas, Carlos; Camargo, Anamaria Aranha; Fitzgerald, Rebecca C.; Mao, Mao; Mattison, John E.; Pao, William; Sellers, William R.; Sullivan, Patrick; Teh, Bin Tean; Ward, Robyn L.; ZenKlusen, Jean Claude; Sawyers, Charles L.; Voest, Emile E.			Facilitating a culture of responsible and effective sharing of cancer genome data	NATURE MEDICINE			English	Article							GLOBAL ALLIANCE; PRIVACY; CONSENT; LEGAL; CARE; CONSORTIUM; PROTECTION; SCIENCE; EUROPE; RIGHTS	Rapid and affordable tumor molecular profiling has led to an explosion of clinical and genomic data poised to enhance the diagnosis, prognostication and treatment of cancer. A critical point has now been reached at which the analysis and storage of annotated clinical and genomic information in unconnected silos will stall the advancement of precision cancer care. Information systems must be harmonized to overcome the multiple technical and logistical barriers to data sharing. Against this backdrop, the Global Alliance for Genomic Health (GA4GH) was established in 2013 to create a common framework that enables responsible, voluntary and secure sharing of clinical and genomic data. This Perspective from the GA4GH Clinical Working Group Cancer Task Team highlights the data-aggregation challenges faced by the field, suggests potential collaborative solutions and describes how GA4GH can catalyze a harmonized data-sharing culture.	[Siu, Lillian L.; Lewin, Jeremy] Univ Toronto, Princess Margaret Canc Ctr, Toronto, ON, Canada; [Lawler, Mark] Queens Univ Belfast, Ctr Canc Res & Cell Biol, Belfast, Antrim, North Ireland; [Haussler, David] Univ Calif Santa Cruz, UC Santa Cruz Genom Inst, Santa Cruz, CA 95064 USA; [Knoppers, Bartha Maria] McGill Univ, Ctr Genom & Policy, Montreal, PQ, Canada; [Vis, Daniel J.; Voest, Emile E.] Netherlands Canc Inst, Amsterdam, Netherlands; [Liao, Rachel G.] Global Alliance Genom & Hlth, Toronto, ON, Canada; [Andre, Fabrice] Gustave Roussy, Villejuif, France; [Andre, Fabrice] Univ Paris 11, Villejuif, France; [Banks, Ian] European Canc Org, Patients Advocacy Comm, Brussels, Belgium; [Barrett, J. Carl] AstraZeneca, Oncol IMED, Translat Sci, Waltham, MA USA; [Caldas, Carlos; Fitzgerald, Rebecca C.] Univ Cambridge, Dept Oncol, Cambridge, England; [Camargo, Anamaria Aranha] Hosp Sirio Libanes, Sao Paulo, Brazil; [Mao, Mao] Yonsei Univ, Coll Med, Yonsei Canc Res Inst, Seoul, South Korea; [Mattison, John E.] Kaiser Permanente, Pasadena, CA USA; [Pao, William] Roche, Pharma Res & Early Dev, Roche Innovat Ctr Basel, Basel, Switzerland; [Sellers, William R.] Novartis Inst Biomed Res, Cambridge, MA USA; [Sullivan, Patrick] Advocacy Canadian Children Oncol Network, Vancouver, BC, Canada; [Teh, Bin Tean] Natl Canc Ctr Singapore, Singapore, Singapore; [Ward, Robyn L.] Univ Queensland, St Lucia, Qld, Australia; [ZenKlusen, Jean Claude] NCI, Canc Genome Atlas, NIH, Bethesda, MD 20892 USA; [Sawyers, Charles L.] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; Queens University Belfast; University of California System; University of California Santa Cruz; McGill University; Netherlands Cancer Institute; UNICANCER; Gustave Roussy; UDICE-French Research Universities; Universite Paris Saclay; AstraZeneca; University of Cambridge; Hospital Sirio Libanes; Yonsei University; Yonsei University Health System; Kaiser Permanente; Roche Holding; Novartis; National Cancer Centre Singapore (NCCS); University of Queensland; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Center for Cancer Genomics (CCG); Memorial Sloan Kettering Cancer Center	Lawler, M (corresponding author), Queens Univ Belfast, Ctr Canc Res & Cell Biol, Belfast, Antrim, North Ireland.	mark.lawler@qub.ac.uk	Caldas, Carlos/U-7250-2019; ANDRE, Fabrice/AAL-2683-2020; Camargo, Anamaria A/E-9388-2012; Ward, Robyn L/I-2313-2013	Caldas, Carlos/0000-0003-3547-1489; ANDRE, Fabrice/0000-0001-5795-8357; Camargo, Anamaria A/0000-0002-6076-9597; Ward, Robyn L/0000-0002-6877-8906; Teh, Bin Tean/0000-0003-1514-1124; Fitzgerald, Rebecca/0000-0002-3434-3568	Cancer Care Ontario Research Chair and Applied Cancer Research Units Grant; Cancer Research UK; US National Institutes of Health [U54HG007990]; Quebec Breast Cancer Foundation; Howard Hughes Medical Institute; US National Cancer Institute [CA008748]; Barcode for Life Foundation; Hartwig Medical Foundation; Cancer Research UK [22720, 16942] Funding Source: researchfish; National Institute for Health Research [NF-SI-0515-10090, NF-SI-0611-10154] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG007990] Funding Source: NIH RePORTER	Cancer Care Ontario Research Chair and Applied Cancer Research Units Grant; Cancer Research UK(Cancer Research UK); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Quebec Breast Cancer Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); US National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Barcode for Life Foundation; Hartwig Medical Foundation; Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This manuscript is written on behalf of the GA4GH Clinical Working Group (WG). We thank the Data WG, Regulatory and Ethics WG and Security WG for their important contributions. L.L.S. is supported by the Cancer Care Ontario Research Chair and Applied Cancer Research Units Grant; M.L., C.C. and R.C.F. are supported by Cancer Research UK; D.H. is funded by the US National Institutes of Health (award #U54HG007990). B.M.K. is supported by the Quebec Breast Cancer Foundation; C.L.S. is supported by the Howard Hughes Medical Institute and US National Cancer Institute (Grant #CA008748); E.E.V. is supported by the Barcode for Life Foundation and the Hartwig Medical Foundation.	Alizadeh AA, 2015, NAT MED, V21, P846, DOI 10.1038/nm.3915; American Association for Cancer Research, PROJ GENIE GEN EV NE; Andre F, 2014, ANN ONCOL, V25, P2295, DOI 10.1093/annonc/mdu478; Andre F, 2014, LANCET ONCOL, V15, P267, DOI 10.1016/S1470-2045(13)70611-9; Aparicio S, 2013, NEW ENGL J MED, V368, P842, DOI 10.1056/NEJMra1204892; Boutros PC, 2014, NAT GENET, V46, P318, DOI 10.1038/ng.2932; Christensen KD, 2016, CLIN GENET, V89, P228, DOI 10.1111/cge.12626; Collins FS, 2015, NEW ENGL J MED, V372, P793, DOI 10.1056/NEJMp1500523; Conley BA, 2014, SEMIN ONCOL, V41, P297, DOI 10.1053/j.seminoncol.2014.05.002; Denny JC, 2013, NAT BIOTECHNOL, V31, P1102, DOI 10.1038/nbt.2749; Eggermont AMM, 2014, EUR J CANCER, V50, P2745, DOI 10.1016/j.ejca.2014.07.025; Erlich Y, 2014, NAT REV GENET, V15, P409, DOI 10.1038/nrg3723; European Commission, 2012, PROP REG EUR PARL CO; Ewing AD, 2015, NAT METHODS, V12, P623, DOI [10.1038/NMETH.3407, 10.1038/nmeth.3407]; Gargis AS, 2015, NAT BIOTECHNOL, V33, P689, DOI 10.1038/nbt.3237; Girdea M, 2013, HUM MUTAT, V34, P1057, DOI 10.1002/humu.22347; Global Al liance for Genomics and Health, 2016, DAT SHAR LEX; Global Alliance for Genomics and Health, 2015, CONS POL; Global Alliance for Genomics and Health, SEC INFR STAND IMPL; Global Alliance for Genomics and Health, 2016, ACC POL; Global Alliance for Genomics and Health, 2014, FRAM RESP SHAR GEN H; Global Alliance for Genomics and Health, 2014, GA P3G IPAC CONS TOO; Global Alliance for Genomics and Health, 2013, WHIT PAP CREAT GLOB; Global Alliance for Genomics and Health, 2015, PRIV SEC POL; Green RC, 2015, NEW ENGL J MED, V372, P397, DOI 10.1056/NEJMp1404776; Groza T, 2015, AM J HUM GENET, V97, P111, DOI 10.1016/j.ajhg.2015.05.020; Gymrek M, 2013, SCIENCE, V339, P321, DOI 10.1126/science.1229566; Haga SB, 2008, ADV GENET, V60, P505, DOI 10.1016/S0065-2660(07)00418-X; Hamosh A, 2013, HUM MUTAT, V34, P566, DOI 10.1002/humu.22283; Homer N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000167; Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987; Husedzinovic A, 2015, EUR J HUM GENET, V23, P1607, DOI 10.1038/ejhg.2015.27; Joly Y, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002549; Kaye J, 2015, INT LIBR ETH LAW TEC, V14, P101, DOI 10.1007/978-94-017-9573-9_8; Knoppers BM, 2014, HUM GENET, V133, P895, DOI 10.1007/s00439-014-1432-6; Knoppers BM, 2014, GENOME MED, V6, DOI 10.1186/gm530; Kohler S, 2014, NUCLEIC ACIDS RES, V42, pD966, DOI 10.1093/nar/gkt1026; Kosseim P, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0430-2; Lacombe D, 2014, NAT REV CLIN ONCOL, V11, P492, DOI 10.1038/nrclinonc.2014.98; Lawler M, 2015, CANCER DISCOV, V5, P1133, DOI 10.1158/2159-8290.CD-15-0821; Lawler M, 2014, ONCOLOGIST, V19, P217, DOI 10.1634/theoncologist.2013-0452; Lawler M, 2014, LANCET ONCOL, V15, P258, DOI 10.1016/S1470-2045(13)70552-7; Lin Z, 2004, SCIENCE, V305, P183, DOI 10.1126/science.1095019; Lolkema MP, 2013, J CLIN ONCOL, V31, P1842, DOI 10.1200/JCO.2012.45.2789; Lunshof JE, 2008, NAT REV GENET, V9, P406, DOI 10.1038/nrg2360; Mancini Julien, 2011, J Natl Cancer Inst, V103, P154, DOI 10.1093/jnci/djq498; McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i213; McCarty CA, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-13; McGuire AL, 2011, GENET MED, V13, P948, DOI 10.1097/GIM.0b013e3182227589; Meric-Bernstam F, 2015, J CLIN ONCOL, V33, P2753, DOI 10.1200/JCO.2014.60.4165; O'Doherty KC, 2011, SOC SCI MED, V73, P367, DOI 10.1016/j.socscimed.2011.05.046; Paten B, 2015, J AM MED INFORM ASSN, V22, P1143, DOI 10.1093/jamia/ocv047; Pillai U, 2014, BIOPRESERV BIOBANK, V12, P409, DOI 10.1089/bio.2014.0039; Rehm HL, 2015, NEW ENGL J MED, V372, P2235, DOI 10.1056/NEJMsr1406261; Rogith D, 2014, J AM MED INFORM ASSN, V21, pE320, DOI 10.1136/amiajnl-2013-002579; Schilsky RL, 2014, J CLIN ONCOL, V32, P2373, DOI 10.1200/JCO.2014.56.2124; Schilsky RL, 2014, NAT REV CLIN ONCOL, V11, P432, DOI 10.1038/nrclinonc.2014.54; Sioutos N, 2007, J BIOMED INFORM, V40, P30, DOI 10.1016/j.jbi.2006.02.013; Siva N, 2015, LANCET, V385, P103, DOI 10.1016/S0140-6736(14)62453-3; Stein LD, 2015, NATURE, V523, P149, DOI 10.1038/523149a; Tejpar S., 2012, 37 EUR SOC MED ONC C, p1382P; Tryka KA, 2014, NUCLEIC ACIDS RES, V42, pD975, DOI 10.1093/nar/gkt1211; US National Institutes of Health, 2014, NAT I HLTH GEN DAT S; Van Allen EM, 2014, NAT MED, V20, P682, DOI 10.1038/nm.3559; Walport M, 2011, LANCET, V377, P537, DOI 10.1016/S0140-6736(10)62234-9; Weinstein JN, 2013, NAT GENET, V45, P1113, DOI 10.1038/ng.2764; Wolf Leslie E, 2004, IRB, V26, P1, DOI 10.2307/3563696; Zika E, 2008, PHARMACOGENOMICS, V9, P773, DOI 10.2217/14622416.9.6.773	68	50	50	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2016	22	5					464	471		10.1038/nm.4089	http://dx.doi.org/10.1038/nm.4089			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DL3DI	27149219	Green Accepted			2022-12-25	WOS:000375514000008
J	Mo, F; Zhuang, XX; Liu, X; Yao, PY; Qin, B; Su, ZQ; Zang, JY; Wang, ZY; Zhang, JC; Dou, Z; Tian, CL; Teng, MK; Niu, LW; Hill, DL; Fang, GW; Ding, X; Fu, CH; Yao, XB				Mo, Fei; Zhuang, Xiaoxuan; Liu, Xing; Yao, Phil Y.; Qin, Bo; Su, Zeqi; Zang, Jianye; Wang, Zhiyong; Zhang, Jiancun; Dou, Zhen; Tian, Changlin; Teng, Maikun; Niu, Liwen; Hill, Donald L.; Fang, Guowei; Ding, Xia; Fu, Chuanhai; Yao, Xuebiao			Acetylation of Aurora B by TIP60 ensures accurate chromosomal segregation	NATURE CHEMICAL BIOLOGY			English	Article							DNA-DAMAGE; PROTEIN PHOSPHATASES; CENP-E; KINASE; KINETOCHORES; PHOSPHORYLATION; ACTIVATION; MPS1; LOCALIZATION; MICROTUBULES	Faithful segregation of chromosomes in mammalian cells requires bi-orientation of sister chromatids, which relies on the sensing of correct attachments between spindle microtubules and kinetochores. Although the mechanisms underlying cyclin-dependent kinase 1 (CDK1) activation, which triggers mitotic entry, have been extensively studied, the regulatory mechanisms that couple CDK1-cyclin B activity to chromosome stability are not well understood. Here, we identified a signaling axis in which Aurora B activity is modulated by CDK1-cyclin B via the acetyltransferase TIP60 in human cell division. CDK1-cyclin B phosphorylates Ser90 of TIP60, which elicits TIP60-dependent acetylation of Aurora B and promotes accurate chromosome segregation in mitosis. Mechanistically, TIP60 acetylation of Aurora B at Lys215 protects Aurora B's activation loop from dephosphorylation by the phosphatase PP2A to ensure a robust, error-free metaphase-anaphase transition. These findings delineate a conserved signaling cascade that integrates protein phosphorylation and acetylation with cell cycle progression for maintenance of genomic stability.	[Mo, Fei; Zhuang, Xiaoxuan; Liu, Xing; Qin, Bo; Zang, Jianye; Wang, Zhiyong; Zhang, Jiancun; Dou, Zhen; Tian, Changlin; Teng, Maikun; Niu, Liwen; Fang, Guowei; Fu, Chuanhai; Yao, Xuebiao] Anhui Key Lab Cellular Dynam & Chem Biol, Hefei, Peoples R China; [Mo, Fei; Zhuang, Xiaoxuan; Liu, Xing; Qin, Bo; Zang, Jianye; Wang, Zhiyong; Zhang, Jiancun; Dou, Zhen; Tian, Changlin; Teng, Maikun; Niu, Liwen; Fang, Guowei; Fu, Chuanhai; Yao, Xuebiao] Univ Sci & Technol China, Sch Life Sci, Lab Organelle Dynam & Plast Control, Hefei 230026, Peoples R China; [Liu, Xing; Zang, Jianye; Wang, Zhiyong; Dou, Zhen; Tian, Changlin; Teng, Maikun; Niu, Liwen; Fu, Chuanhai; Yao, Xuebiao] Chinese Acad Sci, Ctr Excellence Mol Cell Sci, Hefei, Peoples R China; [Liu, Xing; Zang, Jianye; Wang, Zhiyong; Dou, Zhen; Tian, Changlin; Teng, Maikun; Niu, Liwen; Fu, Chuanhai; Yao, Xuebiao] Hefei Natl Lab Phys Sci Nanoscale, Hefei, Peoples R China; [Liu, Xing; Yao, Phil Y.; Qin, Bo; Su, Zeqi; Ding, Xia] Morehouse Sch Med, Mol Imaging Ctr, Atlanta, GA 30310 USA; [Su, Zeqi; Ding, Xia] Beijing Univ Chinese Med, Dept Med Cell Biol, Beijing, Peoples R China; [Zhang, Jiancun] State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China; [Hill, Donald L.] Univ Alabama Birmingham, Ctr Comprehens Canc, Birmingham, AL 35294 USA	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; Morehouse School of Medicine; Beijing University of Chinese Medicine; State Key Laboratory of Respiratory Disease; University of Alabama System; University of Alabama Birmingham	Liu, X; Yao, XB (corresponding author), Anhui Key Lab Cellular Dynam & Chem Biol, Hefei, Peoples R China.; Liu, X; Yao, XB (corresponding author), Univ Sci & Technol China, Sch Life Sci, Lab Organelle Dynam & Plast Control, Hefei 230026, Peoples R China.; Liu, X; Yao, XB (corresponding author), Chinese Acad Sci, Ctr Excellence Mol Cell Sci, Hefei, Peoples R China.; Liu, X; Yao, XB (corresponding author), Hefei Natl Lab Phys Sci Nanoscale, Hefei, Peoples R China.; Liu, X (corresponding author), Morehouse Sch Med, Mol Imaging Ctr, Atlanta, GA 30310 USA.	xing1017@ustc.edu.cn; yaoxb@ustc.edu.cn	Liu, Xing/H-2989-2018; Mo, Fei/R-7626-2019; Fu, Chuanhai/G-8303-2016; Zhuang, Xiaoxuan/R-7836-2019; Yao, Xuebiao/P-5771-2014; DOU, ZHEN/N-2022-2013; Zang, Jianye/E-5228-2013	Liu, Xing/0000-0002-7480-5085; Fu, Chuanhai/0000-0003-4354-3796; Zhuang, Xiaoxuan/0000-0003-4004-5329; Mo, Fei/0000-0002-8601-2568; DOU, ZHEN/0000-0003-3303-9393	Natural Science Foundation of China [31430054, 31320103904, 91313303, 2002CB713700, 31501095, 81270466, 31371363, 31271439, 91213303]; 973 projects [2014CB964803, 2012CB917200, 2012CB945002, 2013CB911203, 2002CB713701]; MOE Innovative team [IRT13038]; Fundamental Research Funds for the Central Universities [WK2070000066]; Chinese Academy of Sciences Center of Excellence [2015HSC-UE010]; US National Institutes of Health [DK56292, CA164133]; NATIONAL CANCER INSTITUTE [R01CA164133] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056292, R01DK115812] Funding Source: NIH RePORTER	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 projects(National Basic Research Program of China); MOE Innovative team; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Chinese Academy of Sciences Center of Excellence; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We are grateful to Y. Shi (University of Science & Technology of China) and Y. Chen (Natural Science Foundation of China) for support; to S. Zhao (Fudan University) for mass spectrometric assistance; and to J. Chin (MRC Laboratory of Molecular Biology, Cambridge, UK) for reagents. This work was supported in part by the Natural Science Foundation of China (grants 31430054, 31320103904 and 91313303, 2002CB713700 to X.Y.; 31501095 to X.L.; 81270466 to X.D.; 31371363 to Z.D.; 31271439 to C.F.; and 91213303 to Z.W.), 973 projects (2014CB964803 to X.Y.; 2012CB917200 to J.Za., L.N.; 2012CB945002, 2013CB911203 to Z.D.; 2002CB713701 to C.F.); MOE Innovative team IRT13038, Fundamental Research Funds for the Central Universities WK2070000066; Chinese Academy of Sciences Center of Excellence 2015HSC-UE010; and the US National Institutes of Health (DK56292 and CA164133 to X.Y.).	Carmena M, 2012, NAT REV MOL CELL BIO, V13, P789, DOI 10.1038/nrm3474; Charvet C, 2011, MOL CELL, V42, P584, DOI 10.1016/j.molcel.2011.03.033; Cheng Z, 2008, ONCOGENE, V27, P931, DOI 10.1038/sj.onc.1210710; Chu YJ, 2011, J MOL CELL BIOL, V3, P260, DOI 10.1093/jmcb/mjq037; Cleveland DW, 2003, CELL, V112, P407, DOI 10.1016/S0092-8674(03)00115-6; Coffey K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045539; COHEN P, 1989, FEBS LETT, V250, P596, DOI 10.1016/0014-5793(89)80803-8; Ding X, 2010, CELL RES, V20, P1386, DOI 10.1038/cr.2010.167; Dou Z, 2004, FEBS LETT, V572, P51, DOI 10.1016/j.febslet.2004.06.092; Dou Z, 2015, P NATL ACAD SCI USA, V112, pE4546, DOI 10.1073/pnas.1508791112; Favre B, 1997, J BIOL CHEM, V272, P13856, DOI 10.1074/jbc.272.21.13856; Foley EA, 2013, NAT REV MOL CELL BIO, V14, P25, DOI 10.1038/nrm3494; Ghizzoni M, 2012, EUR J MED CHEM, V47, P337, DOI 10.1016/j.ejmech.2011.11.001; Hiruma Y, 2015, SCIENCE, V348, P1264, DOI 10.1126/science.aaa4055; Holland AJ, 2012, NAT MED, V18, P1630, DOI 10.1038/nm.2988; Honda R, 2003, MOL BIOL CELL, V14, P3325, DOI 10.1091/mbc.E02-11-0769; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Janssen A, 2011, SCIENCE, V333, P1895, DOI 10.1126/science.1210214; Ji ZJ, 2015, SCIENCE, V348, P1260, DOI 10.1126/science.aaa4029; Kabeche L, 2013, NATURE, V502, P110, DOI 10.1038/nature12507; Kaidi A, 2013, NATURE, V498, DOI 10.1038/nature12201; Lampson MA, 2004, NAT CELL BIOL, V6, P232, DOI 10.1038/ncb1102; Lee JH, 2004, SCIENCE, V304, P93, DOI 10.1126/science.1091496; Lemercier C, 2003, J BIOL CHEM, V278, P4713, DOI 10.1074/jbc.M211811200; Lin SY, 2012, SCIENCE, V336, P477, DOI 10.1126/science.1217032; Liu D, 2007, J BIOL CHEM, V282, P21415, DOI 10.1074/jbc.M609026200; Martin-Lluesma S, 2002, SCIENCE, V297, P2267, DOI 10.1126/science.1075596; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Neumann H, 2008, NAT CHEM BIOL, V4, P232, DOI 10.1038/nchembio.73; Neumann H, 2009, MOL CELL, V36, P153, DOI 10.1016/j.molcel.2009.07.027; Nijenhuis W, 2014, NAT CELL BIOL, V16, P1257, DOI 10.1038/ncb3065; Nishino T, 2012, CELL, V148, P487, DOI 10.1016/j.cell.2011.11.061; Orthwein A, 2014, SCIENCE, V344, P189, DOI 10.1126/science.1248024; Petsalaki E, 2014, J CELL BIOL, V205, P339, DOI 10.1083/jcb.201310071; Posch M, 2010, J CELL BIOL, V191, P61, DOI 10.1083/jcb.200912046; Ruchaud S, 2007, NAT REV MOL CELL BIO, V8, P798, DOI 10.1038/nrm2257; Skoufias DA, 2007, J CELL BIOL, V179, P671, DOI 10.1083/jcb.200704117; Stolz A, 2010, NAT CELL BIOL, V12, P492, DOI 10.1038/ncb2051; Sugiyama K, 2002, ONCOGENE, V21, P3103, DOI 10.1038/sj.onc.1205432; Sun YL, 2009, NAT CELL BIOL, V11, P1376, DOI 10.1038/ncb1982; Tao YY, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1779; Wood KW, 2010, P NATL ACAD SCI USA, V107, P5839, DOI 10.1073/pnas.0915068107; Xia P, 2012, P NATL ACAD SCI USA, V109, P16564, DOI 10.1073/pnas.1202639109; Xiao Y, 2014, CELL REP, V7, P1471, DOI 10.1016/j.celrep.2014.04.021; Yang Y, 2008, J BIOL CHEM, V283, P26726, DOI 10.1074/jbc.M804207200; Yao XB, 1997, J CELL BIOL, V139, P435, DOI 10.1083/jcb.139.2.435; Yasui Y, 2004, J BIOL CHEM, V279, P12997, DOI 10.1074/jbc.M311128200; Zachos G, 2007, DEV CELL, V12, P247, DOI 10.1016/j.devcel.2007.01.003; Zeitlin SG, 2001, J CELL BIOL, V155, P1147, DOI 10.1083/jcb.200108125	49	56	59	0	47	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	APR	2016	12	4					226	+		10.1038/NCHEMBIO.2017	http://dx.doi.org/10.1038/NCHEMBIO.2017			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH2DA	26829474	Green Accepted			2022-12-25	WOS:000372593200008
J	Valero-Gonzalez, J; Leonhard-Melief, C; Lira-Navarrete, E; Jimenez-Oses, G; Hernandez-Ruiz, C; Pallares, MC; Yruela, I; Vasudevan, D; Lostao, A; Corzana, F; Takeuchi, H; Haltiwanger, RS; Hurtado-Guerrero, R				Valero-Gonzalez, Jessika; Leonhard-Melief, Christina; Lira-Navarrete, Erandi; Jimenez-Oses, Gonzalo; Hernandez-Ruiz, Cristina; Pallares, Maria Carmen; Yruela, Inmaculada; Vasudevan, Deepika; Lostao, Anabel; Corzana, Francisco; Takeuchi, Hideyuki; Haltiwanger, Robert S.; Hurtado-Guerrero, Ramon			A proactive role of water molecules in acceptor recognition by protein O-fucosyltransferase 2	NATURE CHEMICAL BIOLOGY			English	Article							THROMBOSPONDIN TYPE-1 REPEATS; GROWTH FACTOR-LIKE; GLYCOSYLATION; INSIGHTS; GLYCANS; DOMAINS; DIMER; FOLD	Protein O-fucosyltransferase 2 (POFUT2) is an essential enzyme that fucosylates serine and threonine residues of folded thrombospondin type 1 repeats (TSRs). To date, the mechanism by which this enzyme recognizes very dissimilar TSRs has been unclear. By engineering a fusion protein, we report the crystal structure of Caenorhabditis elegans POFUT2 (CePOFUT2) in complex with GDP and human TSR1 that suggests an inverting mechanism for fucose transfer assisted by a catalytic base and shows that nearly half of the TSR1 is embraced by CePOFUT2. A small number of direct interactions and a large network of water molecules maintain the complex. Site-directed mutagenesis demonstrates that POFUT2 fucosylates threonine preferentially over serine and relies on folded TSRs containing the minimal consensus sequence C-X-X-S/T-C. Crystallographic and mutagenesis data, together with atomic-level simulations, uncover a binding mechanism by which POFUT2 promiscuously recognizes the structural fingerprint of poorly homologous TSRs through a dynamic network of water-mediated interactions.	[Valero-Gonzalez, Jessika; Lira-Navarrete, Erandi; Jimenez-Oses, Gonzalo; Hernandez-Ruiz, Cristina; Hurtado-Guerrero, Ramon] Univ Zaragoza, BIFI IQFR CSIC Joint Unit, Inst Biocomputat & Phys Complex Syst BIFI, Mariano Esquillor S-N,Campus Rio Ebro, Zaragoza, Spain; [Leonhard-Melief, Christina; Vasudevan, Deepika; Takeuchi, Hideyuki; Haltiwanger, Robert S.] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA; [Jimenez-Oses, Gonzalo] Univ Calif Los Angeles, Dept Chem & Biochem, 405 Hilgard Ave, Los Angeles, CA 90024 USA; [Jimenez-Oses, Gonzalo; Corzana, Francisco] Univ La Rioja, Dept Quim, Ctr Invest Sintesis Quim, Logrono, Spain; [Pallares, Maria Carmen; Lostao, Anabel] Univ Zaragoza, Inst Nanociencia Aragon, Lab Microscopias Avanzadas, Zaragoza, Spain; [Yruela, Inmaculada] Estn Expt Aula EEAD CSIC, Zaragoza, Spain; [Lostao, Anabel; Hurtado-Guerrero, Ramon] Fdn Agencia Aragonesa Invest & Desarrollo ARAID, Zaragoza, Spain; [Hurtado-Guerrero, Ramon] IIS A, Zaragoza, Spain; [Takeuchi, Hideyuki; Haltiwanger, Robert S.] Univ Georgia, Complex Carbohydrate Res Ctr, 220 Riverbend Rd, Athens, GA 30602 USA	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR); University of Zaragoza; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of California System; University of California Los Angeles; Universidad de La Rioja; University of Zaragoza; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental de Aula Dei (EEAD); University System of Georgia; University of Georgia	Hurtado-Guerrero, R (corresponding author), Univ Zaragoza, BIFI IQFR CSIC Joint Unit, Inst Biocomputat & Phys Complex Syst BIFI, Mariano Esquillor S-N,Campus Rio Ebro, Zaragoza, Spain.; Hurtado-Guerrero, R (corresponding author), Fdn Agencia Aragonesa Invest & Desarrollo ARAID, Zaragoza, Spain.; Hurtado-Guerrero, R (corresponding author), IIS A, Zaragoza, Spain.	rhurtado@bifi.es	Lira-Navarrete, Erandi/L-5359-2015; Lostao, Anabel/P-8693-2015; Yruela, Inmaculada/T-1239-2019; Valero, Jessika/P-4888-2017; Yruela, Inmaculada/A-9330-2015; Jiménez-Osés, Gonzalo/B-8057-2014; Corzana, Francisco/B-1310-2015	Lostao, Anabel/0000-0001-7460-5916; Yruela, Inmaculada/0000-0003-3608-4720; Yruela, Inmaculada/0000-0003-3608-4720; Jiménez-Osés, Gonzalo/0000-0003-0105-4337; Corzana, Francisco/0000-0001-5597-8127; Vasudevan, Deepika/0000-0003-1930-3549; Hurtado-Guerrero, Ramon/0000-0002-3122-9401	Agencia Aragonesa para la Investigacion y Desarrollo (ARAID); Ministerio de Economia y Competitividad (MEC) [BFU2010-19504, CTQ2013-44367-C2-2-P, CTQ2012-36365]; US National Institutes of Health [GM061126, CA123071]; Ramon y Cajal Programme; Diputacion General de Aragon (DGA) [B89]; EU Seventh Framework Programme under BioStruct-X [283570, BIOSTRUCTX 5186]; NATIONAL CANCER INSTITUTE [R01CA123071] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061126] Funding Source: NIH RePORTER	Agencia Aragonesa para la Investigacion y Desarrollo (ARAID); Ministerio de Economia y Competitividad (MEC); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ramon y Cajal Programme(Spanish Government); Diputacion General de Aragon (DGA)(Gobierno de Aragon); EU Seventh Framework Programme under BioStruct-X; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S.B. Engelsen (University of Copenhagen) for providing the software to calculate 2D-RDF functions and residence times for water molecules. We thank synchrotron radiation sources DLS (Oxford) and beamline I02 (experiment number MX10121-2), and Institute for Biocomputation and Physics of Complex Systems (BIFI), (Memento cluster) for supercomputer support. This work was supported by Agencia Aragonesa para la Investigacion y Desarrollo (ARAID), Ministerio de Economia y Competitividad (MEC; BFU2010-19504 to R.H.-G., CTQ2013-44367-C2-2-P to R.H.-G., CTQ2012-36365 to F.C.), the US National Institutes of Health (GM061126 and CA123071, both to R.S.H.), the Ramon y Cajal Programme (fellowship to G.J.-O.), Diputacion General de Aragon (DGA; B89 to R.H.-G.) and the EU Seventh Framework Programme (2007-2013) under BioStruct-X (grant agreement 283570 and BIOSTRUCTX 5186, to R.H.-G.).	Al-Shareffi E, 2013, GLYCOBIOLOGY, V23, P188, DOI 10.1093/glycob/cws140; Andersson C, 1999, J MOL GRAPH MODEL, V17, P101, DOI 10.1016/S1093-3263(99)00022-4; ANDREA TA, 1983, J CHEM PHYS, V79, P4576, DOI 10.1063/1.446373; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Ball P, 2008, CHEM REV, V108, P74, DOI 10.1021/cr068037a; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; Case DA, 2014, AMBER 14; Chen CI, 2012, EMBO J, V31, P3183, DOI 10.1038/emboj.2012.143; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; de Peredo AG, 2002, MOL CELL PROTEOMICS, V1, P11, DOI 10.1074/mcp.M100011-MCP200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Frisch M. J., 2009, GAUSSIAN 09 REVISION; Horcas I, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2432410; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Hurtado-Guerrero R, 2012, CURR OPIN CHEM BIOL, V16, P479, DOI 10.1016/j.cbpa.2012.10.013; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kirschner KN, 2008, J COMPUT CHEM, V29, P622, DOI 10.1002/jcc.20820; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Leonhard-Melief C, 2010, METHOD ENZYMOL, V480, P401, DOI 10.1016/S0076-6879(10)80018-7; Lira-Navarrete E, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7937; Lira-Navarrete E, 2014, ANGEW CHEM INT EDIT, V53, P8206, DOI 10.1002/anie.201402781; Lira-Navarrete E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025365; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Lostao A, 2010, BBA-PROTEINS PROTEOM, V1804, P1723, DOI 10.1016/j.bbapap.2010.04.002; Luca VC, 2015, SCIENCE, V347, P847, DOI 10.1126/science.1261093; Luo Y, 2006, J BIOL CHEM, V281, P9385, DOI 10.1074/jbc.M511974200; Luther KB, 2009, INT J BIOCHEM CELL B, V41, P1011, DOI 10.1016/j.biocel.2008.10.001; Marcuello C, 2013, BBA-PROTEINS PROTEOM, V1834, P665, DOI 10.1016/j.bbapap.2012.12.013; Moremen KW, 2012, NAT REV MOL CELL BIO, V13, P448, DOI 10.1038/nrm3383; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Naidoo KJ, 2001, J COMPUT CHEM, V22, P445, DOI 10.1002/1096-987X(200103)22:4<445::AID-JCC1015>3.0.CO;2-P; Parsegian VA, 1995, METHOD ENZYMOL, V259, P43; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rajapaksha A, 2015, BIOPHYS J, V108, P967, DOI 10.1016/j.bpj.2014.12.046; Ricketts LM, 2007, J BIOL CHEM, V282, P17014, DOI 10.1074/jbc.M700317200; Sahun-Roncero M, 2013, ANGEW CHEM INT EDIT, V52, P4582, DOI 10.1002/anie.201209660; Sakaidani Y, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1591; Soper AK, 2000, CHEM PHYS, V258, P121, DOI 10.1016/S0301-0104(00)00179-8; Sun TJ, 2014, SCIENCE, V343, P795, DOI 10.1126/science.1247407; Takeuchi H, 2014, BIOCHEM BIOPH RES CO, V453, P235, DOI 10.1016/j.bbrc.2014.05.115; Tan KM, 2002, J CELL BIOL, V159, P373, DOI 10.1083/jcb.200206062; Taylor P, 2014, P NATL ACAD SCI USA, V111, P7290, DOI 10.1073/pnas.1319683111; Vasudevan D, 2015, CURR BIOL, V25, P286, DOI 10.1016/j.cub.2014.11.049; Vasudevan D, 2014, GLYCOCONJUGATE J, V31, P417, DOI 10.1007/s10719-014-9556-4; Wang LW, 2007, J BIOL CHEM, V282, P17024, DOI 10.1074/jbc.M701065200; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yan C, 2008, PROTEIN J, V27, P59, DOI 10.1007/s10930-007-9108-x	48	43	44	1	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	APR	2016	12	4					240	+		10.1038/NCHEMBIO.2019	http://dx.doi.org/10.1038/NCHEMBIO.2019			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH2DA	26854667	Green Accepted, Green Submitted			2022-12-25	WOS:000372593200010
J	Gayen, A; Leninger, M; Traaseth, NJ				Gayen, Anindita; Leninger, Maureen; Traaseth, Nathaniel J.			Protonation of a glutamate residue modulates the dynamics of the drug transporter EmrE	NATURE CHEMICAL BIOLOGY			English	Article							SOLID-STATE NMR; INDUCED CONFORMATIONAL-CHANGES; MULTIDRUG-RESISTANCE PROTEIN; ESCHERICHIA-COLI; SUBSTRATE-BINDING; SPECTROSCOPY; ANTIPORTER; TOPOLOGY; PROVIDES; PATHWAY	Secondary active transport proteins play a central role in conferring bacterial multidrug resistance. In this work, we investigated the proton-coupled transport mechanism for the Escherichia coli drug efflux pump EmrE using NMR spectroscopy. Our results show that the global conformational motions necessary for transport are modulated in an allosteric fashion by the protonation state of a membrane-embedded glutamate residue. These observations directly correlate with the resistance phenotype for wild-type EmrE and the E14D mutant as a function of pH. Furthermore, our results support a model in which the pH gradient across the inner membrane of E. coli may be used on a mechanistic level to shift the equilibrium of the transporter in favor of an inward-open resting conformation poised for drug binding.	[Gayen, Anindita; Leninger, Maureen; Traaseth, Nathaniel J.] NYU, Dept Chem, New York, NY USA	New York University	Traaseth, NJ (corresponding author), NYU, Dept Chem, New York, NY USA.	traaseth@nyu.edu		Crames, Maureen/0000-0003-2879-9726; Traaseth, Nathaniel/0000-0002-1185-6088	US National Institutes of Health (NIH) [R01AI108889]; start-up funds from New York University (NYU); Margaret Strauss Kramer Fellowship; NIH S10 grant [OD016343]; NYSTAR; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI108889] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD016343] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); start-up funds from New York University (NYU); Margaret Strauss Kramer Fellowship; NIH S10 grant; NYSTAR; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by US National Institutes of Health (NIH) grant R01AI108889 and start-up funds from New York University (NYU) to N.J.T. M.L. acknowledges support from a Margaret Strauss Kramer Fellowship. The NMR data collected with a cryoprobe at NYU was supported by an NIH S10 grant (OD016343). Data collected at the New York Structural Biology Center was made possible by a grant from NYSTAR. The authors thank R. Turner at the University of Calgary for providing wild-type EmrE in the pMS119EH vector, M.-K. Cho for assistance of the initial NMR experiments, A. Sae Her for assistance in protein purification, and D. Buccella at NYU for use of the spectrofluorometer.	Adam Y, 2007, P NATL ACAD SCI USA, V104, P17989, DOI 10.1073/pnas.0704425104; Amadi ST, 2010, J BIOL CHEM, V285, P26710, DOI 10.1074/jbc.M110.132621; Banigan JR, 2015, J BIOL CHEM, V290, P805, DOI 10.1074/jbc.M114.601963; Bay DC, 2008, BBA-BIOMEMBRANES, V1778, P1814, DOI 10.1016/j.bbamem.2007.08.015; Brill S, 2015, J MOL BIOL, V427, P468, DOI 10.1016/j.jmb.2014.11.015; Brill S, 2012, P NATL ACAD SCI USA, V109, P16894, DOI 10.1073/pnas.1211831109; Chen YJ, 2007, P NATL ACAD SCI USA, V104, P18999, DOI 10.1073/pnas.0709387104; Cho MK, 2014, J AM CHEM SOC, V136, P8072, DOI 10.1021/ja503145x; deAzevedo ER, 2000, J MAGN RESON, V142, P86, DOI 10.1006/jmre.1999.1918; Dutta S, 2014, BIOPHYS J, V107, P613, DOI 10.1016/j.bpj.2014.06.030; Gayen A, 2013, ANGEW CHEM INT EDIT, V52, P10321, DOI 10.1002/anie.201303091; Higgins CF, 2007, NATURE, V446, P749, DOI 10.1038/nature05630; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; JENCKS WP, 1989, METHOD ENZYMOL, V171, P145; Marassi FM, 2000, J MAGN RESON, V144, P150, DOI 10.1006/jmre.2000.2035; Mordoch SS, 1999, J BIOL CHEM, V274, P19480, DOI 10.1074/jbc.274.27.19480; Muth TR, 2000, EMBO J, V19, P234, DOI 10.1093/emboj/19.2.234; Poulsen BE, 2009, J BIOL CHEM, V284, P9870, DOI 10.1074/jbc.M900182200; Rapp M, 2007, SCIENCE, V315, P1282, DOI 10.1126/science.1135406; Rotem D, 2004, J BIOL CHEM, V279, P48787, DOI 10.1074/jbc.M408187200; Schanda P, 2005, J AM CHEM SOC, V127, P8014, DOI 10.1021/ja051306e; Schuldiner S, 2014, SPRINGER SER BIOPHYS, V17, P233, DOI 10.1007/978-3-642-53839-1_10; Son MS, 2003, BIOCHEM BIOPH RES CO, V312, P914, DOI 10.1016/j.bbrc.2003.11.018; Ubarretxena-Belandia I, 2003, EMBO J, V22, P6175, DOI 10.1093/emboj/cdg611; Wang J, 2000, J MAGN RESON, V144, P162, DOI 10.1006/jmre.2000.2037; Wilks JC, 2007, J BACTERIOL, V189, P5601, DOI 10.1128/JB.00615-07; Yerushalmi H, 2000, J BIOL CHEM, V275, P5264, DOI 10.1074/jbc.275.8.5264	29	41	42	1	45	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAR	2016	12	3					141	145		10.1038/NCHEMBIO.1999	http://dx.doi.org/10.1038/NCHEMBIO.1999			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF5FK	26751516	Green Accepted			2022-12-25	WOS:000371377000005
J	Withers, DR; Hepworth, MR; Wang, XX; Mackley, EC; Halford, EE; Dutton, EE; Marriott, CL; Brucklacher-Waldert, V; Veldhoen, M; Kelsen, J; Baldassano, RN; Sonnenberg, GF				Withers, David R.; Hepworth, Matthew R.; Wang, Xinxin; Mackley, Emma C.; Halford, Emily E.; Dutton, Emma E.; Marriott, Clare L.; Brucklacher-Waldert, Verena; Veldhoen, Marc; Kelsen, Judith; Baldassano, Robert N.; Sonnenberg, Gregory F.			Transient inhibition of ROR-gamma t therapeutically limits intestinal inflammation by reducing T(H)17 cells and preserving group 3 innate lymphoid cells	NATURE MEDICINE			English	Article							ANTI-INTERLEUKIN-17 MONOCLONAL-ANTIBODY; CROHNS-DISEASE; HOST-DEFENSE; COMMENSAL BACTERIA; DOUBLE-BLIND; TH17 CELLS; DIFFERENTIATION; HOMEOSTASIS; MECHANISMS; MICROBIOTA	RAR-related orphan receptor-gamma t (ROR-gamma t) directs differentiation of proinflammatory T helper 17 (T(H)17) cells and is a potential therapeutic target in chronic autoimmune and inflammatory diseases(1-3). However, ROR-gamma t-dependent group 3 innate lymphoid cells ILC3s provide essential immunity and tissue protection in the intestine(4-11), suggesting that targeting ROR-gamma t could also result in impaired host defense after infection or enhanced tissue damage. Here, we demonstrate that transient chemical inhibition of ROR-gamma t in mice selectively reduces cytokine production from TH17 but not ILCs in the context of intestinal infection with Citrobacter rodentium, resulting in preserved innate immunity. Temporal deletion of Rorc (encoding ROR-gamma t) in mature ILCs also did not impair cytokine response in the steady state or during infection. Finally, pharmacologic inhibition of ROR-gamma t provided therapeutic benefit in mouse models of intestinal inflammation and reduced the frequency of T(H)17 cells but not ILCs isolated from primary intestinal samples of individuals with inflammatory bowel disease (IBD). Collectively, these results reveal differential requirements for ROR-gamma t in the maintenance of T(H)17 cell and ILC3 responses and suggest that transient inhibition of ROR-gamma t is a safe and effective therapeutic approach during intestinal inflammation.	[Withers, David R.; Mackley, Emma C.; Halford, Emily E.; Dutton, Emma E.; Marriott, Clare L.] Univ Birmingham, Coll Med & Dent Sci, Inst Immunol & lmmunotherapy, MRC Ctr Immune Regulat, Birmingham, W Midlands, England; [Hepworth, Matthew R.; Wang, Xinxin; Sonnenberg, Gregory F.] Weill Cornell Med, Div Gastroenterol, Joan & Sanford I Weill Dept Med, New York, NY USA; [Hepworth, Matthew R.; Wang, Xinxin; Sonnenberg, Gregory F.] Weill Cornell Med, Dept Microbiol & Immunol, New York, NY USA; [Hepworth, Matthew R.; Wang, Xinxin; Sonnenberg, Gregory F.] Weill Cornell Med, Jill Roberts Inst Res Inflammatory Bowel Dis, New York, NY USA; [Brucklacher-Waldert, Verena; Veldhoen, Marc] Babraham Inst, Babraham Res Campus, Cambridge, England; [Kelsen, Judith; Baldassano, Robert N.] Childrens Hosp Philadelphia, Div Gastroenterol Hepatol & Nutr, Philadelphia, PA 19104 USA	University of Birmingham; Cornell University; Cornell University; Cornell University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Withers, DR (corresponding author), Univ Birmingham, Coll Med & Dent Sci, Inst Immunol & lmmunotherapy, MRC Ctr Immune Regulat, Birmingham, W Midlands, England.; Sonnenberg, GF (corresponding author), Weill Cornell Med, Div Gastroenterol, Joan & Sanford I Weill Dept Med, New York, NY USA.; Sonnenberg, GF (corresponding author), Weill Cornell Med, Dept Microbiol & Immunol, New York, NY USA.; Sonnenberg, GF (corresponding author), Weill Cornell Med, Jill Roberts Inst Res Inflammatory Bowel Dis, New York, NY USA.	d.withers@bham.ac.uk; gfsonnenberg@med.cornell.edu	Dutton, Emma/GRO-1236-2022; Wang, Xin/GYU-1129-2022; Veldhoen, Marc/AAM-5357-2021; Wang, Xin/AAN-8435-2021; Withers, David/C-7055-2015	Wang, Xin/0000-0002-4457-7376; Hepworth, Matthew/0000-0002-9613-7858; Veldhoen, Marc/0000-0002-1478-9562; Withers, David/0000-0003-3757-7594	National Institutes of Health [DP5OD012116, R56AI114724, R01AI123368]; National Institute of Allergy and Infectious Diseases (NIAID) Mucosal Immunology Studies Team (MIST) Scholar Award in Mucosal Immunity; Institute for Translational Medicine and Therapeutics Transdisciplinary Program in Translational Medicine and Therapeutics from the US National Center for Research Resources [UL1-RR024134]; Crohn's and Colitis Foundation of America [297365]; Wellcome Trust; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024134] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI114724, R01AI123368] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD012116] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [1511338, BBS/E/B/0000S042] Funding Source: researchfish; Medical Research Council [G9818340] Funding Source: researchfish; BBSRC [BBS/E/B/000C0409, BBS/E/B/0000S042, BB/E021638/1] Funding Source: UKRI; MRC [G9818340] Funding Source: UKRI	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases (NIAID) Mucosal Immunology Studies Team (MIST) Scholar Award in Mucosal Immunity; Institute for Translational Medicine and Therapeutics Transdisciplinary Program in Translational Medicine and Therapeutics from the US National Center for Research Resources; Crohn's and Colitis Foundation of America; Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank members of G.F.Ss and D.R.W.'s laboratories for discussions and critical reading of the manuscript. We also thank C. Elson (University of Alabama at Birmingham) for providing CBir1 transgenic mice and valuable expertise, as well as T. Hohl (Memorial Sloan Kettering Cancer Center) for experimental expertise. Research in the G.F.S's laboratory is supported by the National Institutes of Health (DP5OD012116, R56AI114724 and R01AI123368 to G.F.S.), the National Institute of Allergy and Infectious Diseases (NIAID) Mucosal Immunology Studies Team (MIST) Scholar Award in Mucosal Immunity (to G.F.S.) and the Institute for Translational Medicine and Therapeutics Transdisciplinary Program in Translational Medicine and Therapeutics (UL1-RR024134 from the US National Center for Research Resources to G.F.S.) and the Crohn's and Colitis Foundation of America (297365 to M.R.H.). Research in the D.R.W. laboratory is supported by a Wellcome Trust Research Career Development Fellowship (to D.R.W.).	Basu R, 2012, IMMUNITY, V37, P1061, DOI 10.1016/j.immuni.2012.08.024; Bernink JH, 2013, NAT IMMUNOL, V14, P221, DOI 10.1038/ni.2534; Buonocore S, 2010, NATURE, V464, P1371, DOI 10.1038/nature08949; Cella M, 2009, NATURE, V457, P722, DOI 10.1038/nature07537; Colombel JF, 2013, GUT, V62, P800, DOI 10.1136/gutjnl-2012-304154; Cong YZ, 2009, P NATL ACAD SCI USA, V106, P19256, DOI 10.1073/pnas.0812681106; Eberl G, 2003, IMMUNOL REV, V195, P81, DOI 10.1034/j.1600-065X.2003.00074.x; Gaffen SL, 2014, NAT REV IMMUNOL, V14, P585, DOI 10.1038/nri3707; Genovese MC, 2010, ARTHRITIS RHEUM-US, V62, P929, DOI 10.1002/art.27334; Gladiator A, 2013, J IMMUNOL, V190, P521, DOI 10.4049/jimmunol.1202924; Hepworth MR, 2015, SCIENCE, V348, P1031, DOI 10.1126/science.aaa4812; Hepworth MR, 2013, NATURE, V498, P113, DOI 10.1038/nature12240; Hueber W, 2012, GUT, V61, P1693, DOI 10.1136/gutjnl-2011-301668; Huh JR, 2012, EUR J IMMUNOL, V42, P2232, DOI 10.1002/eji.201242740; Huh JR, 2011, NATURE, V472, P486, DOI 10.1038/nature09978; Ishigame H, 2009, IMMUNITY, V30, P108, DOI 10.1016/j.immuni.2008.11.009; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Kaser A, 2014, BEST PRACT RES CL GA, V28, P437, DOI 10.1016/j.bpg.2014.04.005; Kinugasa T, 2000, GASTROENTEROLOGY, V118, P1001, DOI 10.1016/S0016-5085(00)70351-9; Klose CSN, 2013, NATURE, V494, P261, DOI 10.1038/nature11813; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Leonardi C, 2012, NEW ENGL J MED, V366, P1190, DOI 10.1056/NEJMoa1109997; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Mortha A, 2014, SCIENCE, V343, P1477, DOI 10.1126/science.1249288; O'Connor W, 2009, NAT IMMUNOL, V10, P603, DOI 10.1038/ni.1736; Papp KA, 2012, NEW ENGL J MED, V366, P1181, DOI 10.1056/NEJMoa1109017; Sawa S, 2011, NAT IMMUNOL, V12, P320, DOI 10.1038/ni.2002; Sawa S, 2010, SCIENCE, V330, P665, DOI 10.1126/science.1194597; Solt LA, 2011, NATURE, V472, P491, DOI 10.1038/nature10075; Song C, 2015, J EXP MED, V212, P1869, DOI 10.1084/jem.20151403; Sonnenberg GF, 2015, NAT MED, V21, P698, DOI 10.1038/nm.3892; Sonnenberg GF, 2011, NAT IMMUNOL, V12, P383, DOI 10.1038/ni.2025; Sonnenberg GF, 2011, IMMUNITY, V34, P122, DOI 10.1016/j.immuni.2010.12.009; Soroosh P, 2014, P NATL ACAD SCI USA, V111, P12163, DOI 10.1073/pnas.1322807111; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Targan SR, 2012, GASTROENTEROLOGY, V143, pE26, DOI 10.1053/j.gastro.2012.07.084; Vonarbourg C, 2010, IMMUNITY, V33, P736, DOI 10.1016/j.immuni.2010.10.017; Xiao S, 2014, IMMUNITY, V40, P477, DOI 10.1016/j.immuni.2014.04.004; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720	39	154	162	2	51	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2016	22	3					319	323		10.1038/nm.4046	http://dx.doi.org/10.1038/nm.4046			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DF6DC	26878233	Green Accepted			2022-12-25	WOS:000371445100020
J	Arai, S; Kitada, K; Yamazaki, T; Takai, R; Zhang, XZ; Tsugawa, Y; Sugisawa, R; Matsumoto, A; Mori, M; Yoshihara, Y; Doi, K; Maehara, N; Kusunoki, S; Takahata, A; Noiri, E; Suzuki, Y; Yahagi, N; Nishiyama, A; Gunaratnam, L; Takano, T; Miyazaki, T				Arai, Satoko; Kitada, Kento; Yamazaki, Tomoko; Takai, Ryosuke; Zhang, Xizhong; Tsugawa, Yoji; Sugisawa, Ryoichi; Matsumoto, Ayaka; Mori, Mayumi; Yoshihara, Yasunori; Doi, Kent; Maehara, Natsumi; Kusunoki, Shunsuke; Takahata, Akiko; Noiri, Eisei; Suzuki, Yusuke; Yahagi, Naoki; Nishiyama, Akira; Gunaratnam, Lakshman; Takano, Tomoko; Miyazaki, Toru			Apoptosis inhibitor of macrophage protein enhances intraluminal debris clearance and ameliorates acute kidney injury in mice	NATURE MEDICINE			English	Article							EPITHELIAL-CELLS REPAIR; ACUTE-RENAL-FAILURE; SP-ALPHA; AIM; MOLECULE-1; DOMAIN; IMMUNOGLOBULIN; ACTIVATION; RECEPTOR; EFFEROCYTOSIS	Acute kidney injury (AKI) is associated with prolonged hospitalization and high mortality, and it predisposes individuals to chronic kidney disease. To date, no effective AKI treatments have been established. Here we show that the apoptosis inhibitor of macrophage (AIM) protein on intraluminal debris interacts with kidney injury molecule (KIM)-1 and promotes recovery from AKI. During AKI, the concentration of AIM increases in the urine, and AIM accumulates on necrotic cell debris within the kidney proximal tubules. The AIM present in this cellular debris binds to KIM -1, which is expressed on injured tubular epithelial cells, and enhances the phagocytic removal of the debris by the epithelial cells, thus contributing to kidney tissue repair. When subjected to ischemia-reperfusion (IR)-induced AKI, AIM-deficient mice exhibited abrogated debris clearance and persistent renal inflammation, resulting in higher mortality than wild-type (WT) mice due to progressive renal dysfunction. Treatment of mice with IR-induced AKI using recombinant AIM resulted in the removal of the debris, thereby ameliorating renal pathology. We observed this effect in both AIM-deficient and WT mice, but not in KIM-1-deficient mice. Our findings provide a basis for the development of potentially novel therapies for AKI.	[Arai, Satoko; Kitada, Kento; Yamazaki, Tomoko; Takai, Ryosuke; Tsugawa, Yoji; Sugisawa, Ryoichi; Matsumoto, Ayaka; Mori, Mayumi; Yoshihara, Yasunori; Maehara, Natsumi; Kusunoki, Shunsuke; Miyazaki, Toru] Univ Tokyo, Fac Med, Ctr Dis Biol & Integrat Med, Lab Mol Biomed Pathogenesis, Tokyo 113, Japan; [Zhang, Xizhong; Gunaratnam, Lakshman] Lawson Hlth Res Inst, Matthew Mailing Ctr Translat Transplant Studies, London, ON, Canada; [Yahagi, Naoki] Univ Tokyo, Grad Sch Med, Dept Emergency & Crit Care Med, Tokyo, Japan; [Takahata, Akiko] Juntendo Univ, Fac Med, Dept Internal Med, Div Nephrol, Tokyo, Japan; [Noiri, Eisei] Univ Tokyo, Grad Sch Med, Dept Nephrol & Endocrinol, Tokyo 113, Japan; [Nishiyama, Akira] Kagawa Univ, Fac Med, Dept Pharmacol, Takamatsu, Kagawa 760, Japan; [Gunaratnam, Lakshman] Univ Western Ontario, Dept Med, Schulich Sch Med & Dent, London, ON, Canada; [Takano, Tomoko] McGill Univ, Ctr Hlth, Dept Med, Div Nephrol, Quebec City, PQ, Canada; [Miyazaki, Toru] Japan Agcy Med Res & Dev, Agcy Med Res & Dev, Core Res Evolut Med Sci & Technol AMED CREST, Tokyo, Japan; [Miyazaki, Toru] Max Planck Univ Tokyo Ctr Integrat Inflammol, Tokyo, Japan; [Kitada, Kento] Vanderbilt Univ, Sch Med, Div Clin Pharmacol, Nashville, TN 37212 USA; [Mori, Mayumi] Univ Med Ctr Hamburg, Dept Obstet & Fetal Med, Lab Expt Fetomaternal Med, Hamburg, Germany	University of Tokyo; Western University (University of Western Ontario); University of Tokyo; Juntendo University; University of Tokyo; Kagawa University; Western University (University of Western Ontario); McGill University; Vanderbilt University; University of Hamburg; University Medical Center Hamburg-Eppendorf	Miyazaki, T (corresponding author), Univ Tokyo, Fac Med, Ctr Dis Biol & Integrat Med, Lab Mol Biomed Pathogenesis, Tokyo 113, Japan.	tm@m.u-tokyo.ac.jp	Gunaratnam, Lakshman/G-3299-2011	Gunaratnam, Lakshman/0000-0002-8845-1126; NOIRI, Eisei/0000-0002-9515-7582; Arai, Satoko/0000-0002-6145-8686; Mori, Mayumi/0000-0001-6190-9785; Sugisawa, Ryoichi/0000-0002-5912-5647; Nishiyama, Akira/0000-0001-5971-820X; Kitada, Kento/0000-0002-6738-1253; Miyazaki, Toru/0000-0003-3842-4362	Core Research for Evolutional Medical Science and Technology - Agency for Medical Research and Development (AMED-CREST); Onsendo Co., Ltd.; Canadian Institutes of Health Research [HDK244945]; Grants-in-Aid for Scientific Research [25253056] Funding Source: KAKEN	Core Research for Evolutional Medical Science and Technology - Agency for Medical Research and Development (AMED-CREST)(Japan Agency for Medical Research and Development (AMED)); Onsendo Co., Ltd.; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank M. Nagase, M. Nangaku, T. Fujita, M. Ono, T. Gohda, Y. Sonoda, T. Aruga, K. Kimura, T. Yasuda, Y. Ito and S. Matsuo for helpful advice and discussion; T. Sugaya for mProx24 cells; D. Ikeda and S. Yamashita for Cd36<SUP>-/-</SUP> mice; K. Yamamura and N. Takeda for help with animal experiments; A. Nishijima, K. Aoyama and M. Shinohara for general technical assistance; and S. Tomita and Y. Inoue for administrative cooperation. This work was supported by a Core Research for Evolutional Medical Science and Technology grant funded by the Agency for Medical Research and Development (AMED-CREST) (TM.), a research grant by Onsendo Co., Ltd. (T.M.) and an operating grant from the Canadian Institutes of Health Research (HDK244945) (L.G.).	Amdur RL, 2009, KIDNEY INT, V76, P1089, DOI 10.1038/ki.2009.332; Amin RA, 2004, ENVIRON HEALTH PERSP, V112, P465, DOI 10.1289/ehp.6683; Angiari S, 2014, TRENDS MOL MED, V20, P675, DOI 10.1016/j.molmed.2014.10.003; Arai S, 2005, CELL METAB, V1, P201, DOI 10.1016/j.cmet.2005.02.002; Arai S, 2014, SEMIN IMMUNOPATHOL, V36, P3, DOI 10.1007/s00281-013-0405-5; Arai S, 2013, CELL REP, V3, P1187, DOI 10.1016/j.celrep.2013.03.006; Bedford M, 2012, AM J KIDNEY DIS, V59, P485, DOI 10.1053/j.ajkd.2011.09.010; Bonventre Joseph V, 2014, Trans Am Clin Climatol Assoc, V125, P293; Bonventre JV, 2013, CLIN J AM SOC NEPHRO, V8, P1606, DOI 10.2215/CJN.06040613; Bonventre JV, 2011, J CLIN INVEST, V121, P4210, DOI 10.1172/JCI45161; Bonventre JV, 2003, J AM SOC NEPHROL, V14, pS55, DOI 10.1097/01.ASN.0000067652.51441.21; Brooks C, 2009, J CLIN INVEST, V119, P1275, DOI 10.1172/JCI37829; Charlton JR, 2014, NEPHROL DIAL TRANSPL, V29, P1301, DOI 10.1093/ndt/gft510; Chawla LS, 2014, NEW ENGL J MED, V371, P58, DOI 10.1056/NEJMra1214243; Coca SG, 2012, KIDNEY INT, V81, P442, DOI 10.1038/ki.2011.379; Duffield JS, 2014, J CLIN INVEST, V124, P2299, DOI 10.1172/JCI72267; Ferenbach DA, 2015, NAT REV NEPHROL, V11, P264, DOI 10.1038/nrneph.2015.3; Hamada M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4147; Henson Peter M, 2006, Proc Am Thorac Soc, V3, P713, DOI 10.1513/pats.200605-104SF; Humphreys BD, 2008, CELL STEM CELL, V2, P284, DOI 10.1016/j.stem.2008.01.014; Humphreys BD, 2013, J CLIN INVEST, V123, P4023, DOI 10.1172/JCI45361; Ichimura T, 1998, J BIOL CHEM, V273, P4135, DOI 10.1074/jbc.273.7.4135; Ichimura T, 2008, J CLIN INVEST, V118, P1657, DOI 10.1172/JCI34487; Ishani A, 2009, J AM SOC NEPHROL, V20, P223, DOI 10.1681/ASN.2007080837; Ismail OZ, 2015, AM J PATHOL, V185, P1207, DOI 10.1016/j.ajpath.2015.02.003; Iwamura Y, 2012, BIOCHEM BIOPH RES CO, V422, P476, DOI 10.1016/j.bbrc.2012.05.018; Jo SK, 2007, CLIN J AM SOC NEPHRO, V2, P356, DOI 10.2215/CJN.03280906; Joseph SB, 2004, CELL, V119, P299, DOI 10.1016/j.cell.2004.09.032; Juncadella IJ, 2013, NATURE, V493, P547, DOI 10.1038/nature11714; Kai T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097037; Kaushal GP, 2014, J AM SOC NEPHROL, V25, P877, DOI 10.1681/ASN.2013070780; Kim J, 2012, KIDNEY INT, V82, P193, DOI 10.1038/ki.2012.64; Kuchroo VK, 2003, NAT REV IMMUNOL, V3, P454, DOI 10.1038/nri1111; Kurokawa J, 2011, P NATL ACAD SCI USA, V108, P12072, DOI 10.1073/pnas.1101841108; Kurokawa J, 2010, CELL METAB, V11, P479, DOI 10.1016/j.cmet.2010.04.013; Kusaba T, 2014, P NATL ACAD SCI USA, V111, P1527, DOI 10.1073/pnas.1310653110; Liano F, 1996, KIDNEY INT, V50, P811, DOI 10.1038/ki.1996.380; Lim AI, 2013, J CELL PHYSIOL, V228, P917, DOI 10.1002/jcp.24267; Linkermann A, 2012, NEPHROL DIAL TRANSPL, V27, P3412, DOI 10.1093/ndt/gfs373; Linkermann A, 2012, KIDNEY INT, V81, P751, DOI 10.1038/ki.2011.450; Maehara N, 2014, CELL REP, V9, P61, DOI 10.1016/j.celrep.2014.08.058; Mehta RL, 2004, KIDNEY INT, V66, P1613, DOI 10.1111/j.1523-1755.2004.00927.x; Mera K, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/1471-230X-14-27; Miyazaki T, 1999, J EXP MED, V189, P413, DOI 10.1084/jem.189.2.413; Mochizuki A, 2014, J IMMUNOL, V192, P3847, DOI 10.4049/jimmunol.1303195; Molitoris BA, 2014, J CLIN INVEST, V124, P2355, DOI 10.1172/JCI72269; Nozaki Y, 2012, KIDNEY INT, V81, P844, DOI 10.1038/ki.2011.424; Price PM, 2012, KIDNEY INT, V81, P720, DOI 10.1038/ki.2011.495; Ravichandran KS, 2011, IMMUNITY, V35, P445, DOI 10.1016/j.immuni.2011.09.004; Sandahl M, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-122; Sarrias MR, 2005, J BIOL CHEM, V280, P35391, DOI 10.1074/jbc.M505042200; Susantitaphong P, 2013, CLIN J AM SOC NEPHRO, V8, P1482, DOI 10.2215/CJN.00710113; Thadhani R, 1996, NEW ENGL J MED, V334, P1448, DOI 10.1056/NEJM199605303342207; Tissot JD, 2002, ELECTROPHORESIS, V23, P1203, DOI 10.1002/1522-2683(200204)23:7/8<1203::AID-ELPS1203>3.0.CO;2-1; Valledor AF, 2004, P NATL ACAD SCI USA, V101, P17813, DOI 10.1073/pnas.0407749101; Wan E, 2013, CIRC RES, V113, P1004, DOI 10.1161/CIRCRESAHA.113.301198; Xiao S, 2012, P NATL ACAD SCI USA, V109, P12105, DOI 10.1073/pnas.1120914109; Yamazaki T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109123; Yang L, 2015, J CLIN INVEST, V125, P1620, DOI 10.1172/JCI75417; Yu WF, 2012, P NATL ACAD SCI USA, V109, P6680, DOI 10.1073/pnas.1116800109	60	121	133	5	51	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2016	22	2					183	193		10.1038/nm.4012	http://dx.doi.org/10.1038/nm.4012			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DC8JX	26726878				2022-12-25	WOS:000369466800012
J	Nowell, CS; Odermatt, PD; Azzolin, L; Hohnel, S; Wagner, EF; Fantner, GE; Lutolf, MP; Barrandon, Y; Piccolo, S; Radtke, F				Nowell, Craig S.; Odermatt, Pascal D.; Azzolin, Luca; Hohnel, Sylke; Wagner, Erwin F.; Fantner, Georg E.; Lutolf, Matthias P.; Barrandon, Yann; Piccolo, Stefano; Radtke, Freddy			Chronic inflammation imposes aberrant cell fate in regenerating epithelia through mechanotransduction	NATURE CELL BIOLOGY			English	Article							STEM-CELLS; T-CELL; EXTRACELLULAR-MATRIX; SQUAMOUS METAPLASIA; FIBROSIS; CANCER; DIFFERENTIATION; SUPPRESSION; ACTIVATION; YAP/TAZ	Chronic inflammation is associated with a variety of pathological conditions in epithelial tissues, including cancer, metaplasia and aberrant wound healing. In relation to this, a significant body of evidence suggests that aberration of epithelial stem and progenitor cell function is a contributing factor in inflammation-related disease, although the underlying cellular and molecular mechanisms remain to be fully elucidated. In this study, we have delineated the effect of chronic inflammation on epithelial stem/progenitor cells using the corneal epithelium as a model tissue. Using a combination of mouse genetics, pharmacological approaches and in vitro assays, we demonstrate that chronic inflammation elicits aberrant mechanotransduction in the regenerating corneal epithelium. As a consequence, a YAP-TAZ/beta-catenin cascade is triggered, resulting in the induction of epidermal differentiation on the ocular surface. Collectively, the results of this study demonstrate that chronic inflammation and mechanotransduction are linked and act to elicit pathological responses in regenerating epithelia.	[Nowell, Craig S.; Radtke, Freddy] Ecole Polytech Fed Lausanne, Swiss Inst Expt Canc Res ISREC, CH-1015 Lausanne, Switzerland; [Odermatt, Pascal D.; Fantner, Georg E.] Ecole Polytech Fed Lausanne, Inst Bioengn IBI, LBNI, CH-1015 Lausanne, Switzerland; [Azzolin, Luca; Piccolo, Stefano] Univ Padua, Dept Mol Med, Via G Colombo 3, I-35131 Padua, Italy; [Hohnel, Sylke; Lutolf, Matthias P.] Ecole Polytech Fed Lausanne, IBI, LSCB, CH-1015 Lausanne, Switzerland; [Wagner, Erwin F.] Natl Canc Res Ctr CNIO, F BBVA Canc Cell Biol Programme, Genes Dev & Dis Grp, Madrid 28029, Spain; [Barrandon, Yann] Ecole Polytech Fed Lausanne, IBI, Stem Cell Dynam Lab LDSC, CH-1015 Lausanne, Switzerland; [Nowell, Craig S.] Natl Inst Biol Stand & Controls, UKSCB, Blanche Lane S Mimms, Potters Bar EN6 3QG, Herts, England	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Padua; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; National Institute for Biological Standards & Control	Nowell, CS; Radtke, F (corresponding author), Ecole Polytech Fed Lausanne, Swiss Inst Expt Canc Res ISREC, CH-1015 Lausanne, Switzerland.; Nowell, CS (corresponding author), Natl Inst Biol Stand & Controls, UKSCB, Blanche Lane S Mimms, Potters Bar EN6 3QG, Herts, England.	craigscott.nowell@epfl.ch; freddy.radtke@epfl.ch	Radtke, Freddy/Q-3198-2017; Odermatt, Pascal D/AAF-2305-2020; Azzolin, Luca/K-8012-2016	Radtke, Freddy/0000-0003-4315-4045; Odermatt, Pascal D/0000-0002-1307-1364; Azzolin, Luca/0000-0002-2425-6153; Wagner, Erwin F/0000-0001-7872-0196; PICCOLO, STEFANO/0000-0002-2037-0004; Hoehnel, Sylke/0000-0001-8449-1692	OptiStem; Swiss National Science Foundation; Swiss Cancer League; Marie Curie Foundation; EuroSystem; Swiss National Science Foundation [205321_134786, 205320_152675]; European Union ERC [307338-NaMic]; AIRC; ERC	OptiStem; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Cancer League; Marie Curie Foundation(European Commission); EuroSystem(European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Union ERC(European Research Council (ERC)European Commission); AIRC(Fondazione AIRC per la ricerca sul cancro); ERC(European Research Council (ERC)European Commission)	This work was supported in part by OptiStem, the Swiss National Science Foundation, the Swiss Cancer League, the Marie Curie Foundation and EuroSystem. P.D.O. and G.E.F. acknowledge financial support from the Swiss National Science Foundation under award number 205321_134786 and 205320_152675 and European Union FP7/2007-2013 ERC under Grant Agreement No. 307338-NaMic. Work performed in the laboratory of S.P. was supported by grants from AIRC (5x1000 and PI) and the ERC. We thank R. Kemler (Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany) for providing the conditional beta-catenin mice, M. Taketo (Centre for Frontier Medicine, Kyoto University, Japan) for the Ctnnb1<SUP>Delta</SUP>Ex3 mice and P. Chambon and D. Metzger (Institute of Genetics and Molecular and Cellular Biology, Strasbourg, France) for the K5Cre<SUP>ERT</SUP> and K14Cre<SUP>ERT2</SUP> mice. We thank J. Huelsken (Swiss Institute for Experimental Cancer Research, EPFL, Lausanne, Switzerland) for providing the TCF luciferase reporter cells and the anti-periostin antibody. We would like to thank A. Radenovic, J. Artacho, J. Sordet-Dessimoz and M. Garcia for technical assistance with microscopy, histology and flow cytometry. We would like to thank G. Ferrand for guidance and advice concerning animal experiments.	Aceves SS, 2009, IMMUNOL ALLERGY CLIN, V29, P197, DOI 10.1016/j.iac.2008.10.003; Aragona M, 2013, CELL, V154, P1047, DOI 10.1016/j.cell.2013.07.042; Arwert EN, 2012, NAT REV CANCER, V12, P170, DOI 10.1038/nrc3217; Azzolin L, 2014, CELL, V158, P157, DOI 10.1016/j.cell.2014.06.013; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Behrens A, 2002, EMBO J, V21, P1782, DOI 10.1093/emboj/21.7.1782; Bonnans C, 2014, NAT REV MOL CELL BIO, V15, P786, DOI 10.1038/nrm3904; Boulter L, 2012, NAT MED, V18, P572, DOI 10.1038/nm.2667; Carey WA, 2010, AM J PHYSIOL-LUNG C, V299, pL785, DOI 10.1152/ajplung.00385.2009; Chappaz S, 2007, BLOOD, V110, P3862, DOI 10.1182/blood-2007-02-074245; Chen YT, 2012, LAB INVEST, V92, P556, DOI 10.1038/labinvest.2011.189; Chen YT, 2009, MOL VIS, V15, P563; Daniels JT, 2001, WOUND REPAIR REGEN, V9, P483, DOI 10.1046/j.1524-475x.2001.00483.x; Daniels JT, 2007, EXPERT OPIN BIOL TH, V7, P1, DOI 10.1517/14712598.7.1.1; De Wever O, 2008, INT J CANCER, V123, P2229, DOI 10.1002/ijc.23925; Demehri S, 2008, PLOS BIOL, V6, P992, DOI 10.1371/journal.pbio.0060123; Di Piazza M, 2012, CANCER CELL, V22, P479, DOI 10.1016/j.ccr.2012.08.016; Driessens G, 2012, NATURE, V488, P527, DOI 10.1038/nature11344; Dumortier A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009258; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Eckert RL, 2013, J SKIN CANCER, V2013, DOI 10.1155/2013/537028; Eyden B, 2008, J CELL MOL MED, V12, P22, DOI 10.1111/j.1582-4934.2007.00213.x; Fulkerson PC, 2006, AM J PATHOL, V169, P2117, DOI 10.2353/ajpath.2006.060617; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Guinea-Viniegra J, 2012, J CLIN INVEST, V122, P2898, DOI 10.1172/JCI63103; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; Herfs M, 2009, TRENDS MOL MED, V15, P245, DOI 10.1016/j.molmed.2009.04.002; Hertz H., 1882, J ANGEW MATH, V92, P156, DOI [10.1515/9783112342404-004, DOI 10.1515/CRLL.1882.92.156, 10.1515/crll.1882.92.156]; Huelsken J, 2001, CELL, V105, P533, DOI 10.1016/S0092-8674(01)00336-1; Humphrey JD, 2014, NAT REV MOL CELL BIO, V15, P802, DOI 10.1038/nrm3896; HUTTER JL, 1993, REV SCI INSTRUM, V64, P1868, DOI 10.1063/1.1143970; Indra AK, 1999, NUCLEIC ACIDS RES, V27, P4324, DOI 10.1093/nar/27.22.4324; Iredale JP, 2007, J CLIN INVEST, V117, P539, DOI 10.1172/JCI30542; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kenyon NJ, 2003, THORAX, V58, P772, DOI 10.1136/thorax.58.9.772; Kullberg MC, 2005, EUR J IMMUNOL, V35, P2886, DOI 10.1002/eji.200526106; Kuraguchi M, 2006, PLOS GENET, V2, P1362, DOI 10.1371/journal.pgen.0020146; Lawrance I. C., 2015, J CROHNS COLITIS; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Liang L, 2009, EYE, V23, P1946, DOI 10.1038/eye.2008.379; Lin SL, 2008, AM J PATHOL, V173, P1617, DOI 10.2353/ajpath.2008.080433; Majo F, 2008, NATURE, V456, P250, DOI 10.1038/nature07406; Mchedlidze T, 2013, IMMUNITY, V39, P357, DOI 10.1016/j.immuni.2013.07.018; McNamara NA, 2014, INVEST OPHTH VIS SCI, V55, P7079, DOI 10.1167/iovs.14-14828; Miyoshi K, 2002, P NATL ACAD SCI USA, V99, P219, DOI 10.1073/pnas.012414099; Mukhopadhyay M, 2006, DEVELOPMENT, V133, P2149, DOI 10.1242/dev.02381; Murthy A, 2012, IMMUNITY, V36, P105, DOI 10.1016/j.immuni.2012.01.005; Naik PK, 2012, AM J PHYSIOL-LUNG C, V303, pL1046, DOI 10.1152/ajplung.00139.2012; Omori-Miyake M, 2012, ALLERGOL INT, V61, P27, DOI 10.2332/allergolint.11-RAI-0374; Oshima H, 2001, CELL, V104, P233, DOI 10.1016/S0092-8674(01)00208-2; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Quante M, 2012, CANCER CELL, V21, P36, DOI 10.1016/j.ccr.2011.12.004; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Samson CM, 2002, OPHTHALMOLOGY, V109, P862, DOI 10.1016/S0161-6420(02)00994-6; Samuel MS, 2011, CELL CYCLE, V10, P3409, DOI 10.4161/cc.10.20.17722; Schonthaler HB, 2011, ANN RHEUM DIS, V70, pI109, DOI 10.1136/ard.2010.140533; Shenoy AK, 2012, CANCER RES, V72, P5091, DOI 10.1158/0008-5472.CAN-12-1806; Sziksz E, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/764641; Taniguchi K, 2015, NATURE, V519, P57, DOI 10.1038/nature14228; Tu S, 2008, CANCER CELL, V14, P408, DOI 10.1016/j.ccr.2008.10.011; Vauclair S, 2007, DEV CELL, V13, P242, DOI 10.1016/j.devcel.2007.06.012; Wang B, 2012, J AM SOC NEPHROL, V23, P252, DOI 10.1681/ASN.2011010055; Wu SG, 2009, NAT MED, V15, P1016, DOI 10.1038/nm.2015; Wurm S, 2015, GENE DEV, V29, P144, DOI 10.1101/gad.249748.114; Zhou Z, 1999, J CLIN INVEST, V103, P779, DOI 10.1172/JCI5909	65	85	88	1	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2016	18	2					168	+		10.1038/ncb3290	http://dx.doi.org/10.1038/ncb3290			23	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	DC3NZ	26689676	Green Published, Green Accepted			2022-12-25	WOS:000369127300006
J	Rahbari, R; Wuster, A; Lindsay, SJ; Hardwick, RJ; Alexandrov, LB; Al Turki, S; Dominiczak, A; Morris, A; Porteous, D; Smith, B; Stratton, MR; Hurles, ME				Rahbari, Raheleh; Wuster, Arthur; Lindsay, Sarah J.; Hardwick, Robert J.; Alexandrov, Ludmil B.; Al Turki, Saeed; Dominiczak, Anna; Morris, Andrew; Porteous, David; Smith, Blair; Stratton, Michael R.; Hurles, Matthew E.		UK10K Consortium	Timing, rates and spectra of human germline mutation	NATURE GENETICS			English	Article							HUMAN-DISEASE; GONADAL MOSAICISM; RECURRENCE RISK; AGE; INHERITANCE; EVOLUTION; VARIANTS; PATTERNS; GENETICS; GENOMES	Germline mutations are a driving force behind genome evolution and genetic disease. We investigated genome-wide mutation rates and spectra in multi-sibling families. The mutation rate increased with paternal age in all families, but the number of additional mutations per year differed by more than twofold between families. Meta-analysis of 6,570 mutations showed that germline methylation influences mutation rates. In contrast to somatic mutations, we found remarkable consistency in germline mutation spectra between the sexes and at different paternal ages. In parental germ line, 3.8% of mutations were mosaic, resulting in 1.3% of mutations being shared by siblings. The number of these shared mutations varied significantly between families. Our data suggest that the mutation rate per cell division is higher during both early embryogenesis and differentiation of primordial germ cells but is reduced substantially during post-pubertal spermatogenesis. These findings have important consequences for the recurrence risks of disorders caused by de novo mutations.	[Rahbari, Raheleh; Wuster, Arthur; Lindsay, Sarah J.; Hardwick, Robert J.; Alexandrov, Ludmil B.; Al Turki, Saeed; Stratton, Michael R.; Hurles, Matthew E.] Wellcome Trust Sanger Inst, Hinxton, England; [Wuster, Arthur] Genentech Inc, Dept Human Genet, San Francisco, CA 94080 USA; [Wuster, Arthur] Genentech Inc, Dept Bioinformat & Computat Biol, San Francisco, CA 94080 USA; [Dominiczak, Anna] Univ Glasgow, Coll Med Vet & Life Sci, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland; [Morris, Andrew; Smith, Blair] Univ Dundee, Med Res Inst, Dundee, Scotland; [Porteous, David] Univ Edinburgh, Inst Genet & Mol Med, Edinburgh, Midlothian, Scotland	Wellcome Trust Sanger Institute; Roche Holding; Genentech; Roche Holding; Genentech; University of Glasgow; University of Dundee; University of Edinburgh	Hurles, ME (corresponding author), Wellcome Trust Sanger Inst, Hinxton, England.	meh@sanger.ac.uk	Dominiczak, Anna F/P-9390-2017; Zheng, Houfeng/K-4424-2012; Jamshidi, Yalda/AAL-1377-2020; Lindsay, Sarah/CAF-4613-2022; Smith, Blair H/G-2834-2012; Alexandrov, Ludmil/AAS-1454-2021; Porteous, David/AAA-3446-2021; McQuillin, Andrew/C-1623-2008; Soler Artigas, Maria/L-6529-2013; Schmidts, Miriam/A-3777-2012; Collier, David/D-1649-2011	Dominiczak, Anna F/0000-0003-4913-3608; Zheng, Houfeng/0000-0001-5681-8598; Jamshidi, Yalda/0000-0003-0151-6482; Smith, Blair H/0000-0002-5362-9430; Alexandrov, Ludmil/0000-0003-3596-4515; Porteous, David/0000-0003-1249-6106; McQuillin, Andrew/0000-0003-1567-2240; MacArthur, Daniel/0000-0002-5771-2290; Soler Artigas, Maria/0000-0002-3213-1107; Swerdlow, Harold/0000-0002-9510-160X; Wilson, Scott/0000-0002-0357-1373; Lindsay, Sarah/0000-0002-0965-3070; Futema, Marta/0000-0002-2120-2088; Bochukova, Elena/0000-0003-0275-1548; Farooqi, Sadaf/0000-0001-7609-3504; Schmidts, Miriam/0000-0002-1714-6749; Rahbari, Raheleh/0000-0002-1839-7785; Kelly, Kirsten/0000-0003-4234-543X; Kilpinen, Helena/0000-0001-6692-6154; Wuster, Arthur/0000-0003-4162-5931; Wain, Louise/0000-0003-4951-1867; Collier, David/0000-0003-4087-1559	Wellcome Trust [WT098051, WT091310]; Chief Scientist Office of the Scottish Government Health Directorates [CZD/16/6]; Scottish Funding Council [HR03006]; MRC [MR/N005813/1] Funding Source: UKRI; Medical Research Council [MR/N005813/1, MC_UU_12012/5/B, MC_PC_15018] Funding Source: researchfish; National Institute for Health Research [NF-SI-0510-10268] Funding Source: researchfish; Chief Scientist Office [CZD/16/6/4] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Chief Scientist Office of the Scottish Government Health Directorates; Scottish Funding Council; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Chief Scientist Office	We thank D. Conrad and A. Ramu for their responsive development of the DeNovoGear software and A. Campbell and S. Kerr for their support in identifying relevant families. This research was funded by the Wellcome Trust (grant WT098051). Generation Scotland has received core funding from the Chief Scientist Office of the Scottish Government Health Directorates CZD/16/6 and the Scottish Funding Council HR03006. This study makes use of data generated by the UK10K Consortium, derived from samples from ALSPAC and TwinsUK. A full list of the investigators who contributed to the generation of the data is available from http://www.uk10k.org. Funding for UK10K was provided by the Wellcome Trust under award WT091310. Data can be accessed at the European Genome-phenome Archive (EGA) under accessions EGAS00001000108 and EGAS00001000090.	Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Anazi S, 2014, CLIN GENET, V85, P278, DOI 10.1111/cge.12156; Bachetti T, 2014, PEDIATR PULM, V49, pE45, DOI 10.1002/ppul.22790; Biesecker LG, 2013, NAT REV GENET, V14, P307, DOI 10.1038/nrg3424; Campbell CD, 2013, TRENDS GENET, V29, P575, DOI 10.1016/j.tig.2013.04.005; Campbell IM, 2014, AM J HUM GENET, V95, P345, DOI 10.1016/j.ajhg.2014.08.010; Campbell IM, 2014, AM J HUM GENET, V95, P173, DOI 10.1016/j.ajhg.2014.07.003; Conrad DF, 2011, NAT GENET, V43, P712, DOI 10.1038/ng.862; COOPER DN, 1989, HUM GENET, V83, P181, DOI 10.1007/BF00286715; Coticchio G., 2013, OOGENESIS; Crow JF, 2000, NAT REV GENET, V1, P40, DOI 10.1038/35049558; Dhamija R, 2014, AM J MED GENET A, V164, P2356, DOI 10.1002/ajmg.a.36621; DROST JB, 1995, ENVIRON MOL MUTAGEN, V25, P48, DOI 10.1002/em.2850250609; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Duret L, 2009, ANNU REV GENOM HUM G, V10, P285, DOI 10.1146/annurev-genom-082908-150001; Goriely A, 2012, AM J HUM GENET, V90, P175, DOI 10.1016/j.ajhg.2011.12.017; HALDANE JBS, 1947, ANN EUGENIC, V13, P262; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Kong A, 2012, NATURE, V488, P471, DOI 10.1038/nature11396; Lindahl T, 1999, SCIENCE, V286, P1897, DOI 10.1126/science.286.5446.1897; Liu G, 2014, MOL VIS, V20, P15; Lupski JR, 2013, SCIENCE, V341, P358, DOI 10.1126/science.1239503; MacArthur DG, 2014, NATURE, V508, P469, DOI 10.1038/nature13127; Michaelson JJ, 2012, CELL, V151, P1431, DOI 10.1016/j.cell.2012.11.019; Momand JR, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.103440; O'Rahilly R., 1987, DEV STAGES HUMAN EMB; Roach JC, 2010, SCIENCE, V328, P636, DOI 10.1126/science.1186802; Sayres MAW, 2011, BIOESSAYS, V33, P938, DOI 10.1002/bies.201100091; Scally A, 2012, NAT REV GENET, V13, P745, DOI 10.1038/nrg3295; Schaibley VM, 2013, GENOME RES, V23, P1974, DOI 10.1101/gr.154971.113; Segurel L, 2014, ANNU REV GENOM HUM G, V15, P47, DOI 10.1146/annurev-genom-031714-125740; Tajir M, 2013, GENE, V518, P476, DOI 10.1016/j.gene.2012.12.105; Venn O, 2014, SCIENCE, V344, P1272, DOI 10.1126/science.344.6189.1272; Voet T, 2011, CYTOGENET GENOME RES, V133, P160, DOI 10.1159/000324235; Walter CA, 1998, P NATL ACAD SCI USA, V95, P10015, DOI 10.1073/pnas.95.17.10015; Wang JB, 2012, CELL, V150, P402, DOI 10.1016/j.cell.2012.06.030	36	307	318	1	84	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2016	48	2					126	133		10.1038/ng.3469	http://dx.doi.org/10.1038/ng.3469			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DC2JV	26656846	Green Accepted, Green Submitted			2022-12-25	WOS:000369043900009
J	Zhou, YX; Wei, WS				Zhou, Yuexin; Wei, Wensheng			Mapping regulatory elements	NATURE BIOTECHNOLOGY			English	Editorial Material							HUMAN-CELLS; DISSECTION; ENHANCERS		[Zhou, Yuexin; Wei, Wensheng] Peking Tsinghua Ctr Life Sci, State Key Lab Prot & Plant Gene Res, Biodynam Optic Imaging Ctr BIOPIC, Beijing, Peoples R China; [Zhou, Yuexin; Wei, Wensheng] Peking Univ, Sch Life Sci, Beijing 100871, Peoples R China	Peking University	Wei, WS (corresponding author), Peking Tsinghua Ctr Life Sci, State Key Lab Prot & Plant Gene Res, Biodynam Optic Imaging Ctr BIOPIC, Beijing, Peoples R China.; Wei, WS (corresponding author), Peking Univ, Sch Life Sci, Beijing 100871, Peoples R China.	wswei@pku.edu.cn	Wei, Wensheng/AAF-1325-2020	Wei, Wensheng/0000-0002-8053-2423				Canver MC, 2015, NATURE, V527, P192, DOI 10.1038/nature15521; Koike-Yusa H, 2014, NAT BIOTECHNOL, V32, P267, DOI 10.1038/nbt.2800; Korkmaz G, 2016, NAT BIOTECHNOL, V34, P192, DOI 10.1038/nbt.3450; Mansour MR, 2014, SCIENCE, V346, P1373, DOI 10.1126/science.1259037; Melnikov A, 2012, NAT BIOTECHNOL, V30, P271, DOI 10.1038/nbt.2137; Patwardhan RP, 2012, NAT BIOTECHNOL, V30, P265, DOI 10.1038/nbt.2136; Rajagopal N, 2016, NAT BIOTECHNOL, V34, P167, DOI 10.1038/nbt.3468; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Sharon E, 2012, NAT BIOTECHNOL, V30, P521, DOI 10.1038/nbt.2205; Vahedi G, 2015, NATURE, V520, P558, DOI 10.1038/nature14154; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Zhou YX, 2014, NATURE, V509, P487, DOI 10.1038/nature13166	12	2	2	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2016	34	2					151	152		10.1038/nbt.3477	http://dx.doi.org/10.1038/nbt.3477			2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DD0OK	26849519				2022-12-25	WOS:000369619100015
J	DeNicola, GM; Chen, PH; Mullarky, E; Sudderth, JA; Hu, ZP; Wu, D; Tang, H; Xie, Y; Asara, JM; Huffman, KE; Wistuba, II; Minna, JD; DeBerardinis, RJ; Cantley, LC				DeNicola, Gina M.; Chen, Pei-Hsuan; Mullarky, Edouard; Sudderth, Jessica A.; Hu, Zeping; Wu, David; Tang, Hao; Xie, Yang; Asara, John M.; Huffman, Kenneth E.; Wistuba, Ignacio I.; Minna, John D.; DeBerardinis, Ralph J.; Cantley, Lewis C.			NRF2 regulates serine biosynthesis in non-small cell lung cancer	NATURE GENETICS			English	Article							GENE-EXPRESSION; KEAP1 MUTATIONS; GROWTH; ACTIVATION; CARCINOMA; GLUTAMINE; PATHWAY; GLUCOSE; PROTEIN; IMPAIR	Tumors have high energetic and anabolic needs for rapid cell growth and proliferation(1), and the serine biosynthetic pathway was recently identified as an important source of metabolic intermediates for these processes(2,3). We integrated metabolic tracing and transcriptional profiling of a large panel of non-small cell lung cancer (NSCLC) cell lines to characterize the activity and regulation of the serine/glycine biosynthetic pathway in NSCLC. Here we show that the activity of this pathway is highly heterogeneous and is regulated by NRF2, a transcription factor frequently deregulated in NSCLC. We found that NRF2 controls the expression of the key serine/glycine biosynthesis enzyme genes PHGDH, PSAT1 and SHMT2 via ATF4 to support glutathione and nucleotide production. Moreover, we show that expression of these genes confers poor prognosis in human NSCLC. Thus, a substantial fraction of human NSCLCs activates an NRF2-dependent transcriptional program that regulates serine and glycine metabolism and is linked to clinical aggressiveness.	[DeNicola, Gina M.; Mullarky, Edouard; Wu, David; Cantley, Lewis C.] Weill Cornell Med Coll, Dept Med, New York, NY 10065 USA; [Chen, Pei-Hsuan; Sudderth, Jessica A.; Hu, Zeping; DeBerardinis, Ralph J.] Univ Texas SW Med Ctr Dallas, Childrens Med Ctr, Res Inst, Dallas, TX 75390 USA; [Tang, Hao; Xie, Yang] Univ Texas SW Med Ctr Dallas, Dept Clin Sci, Quantitat Biomed Res Ctr, Dallas, TX 75390 USA; [Asara, John M.] Beth Israel Deaconess Med Ctr, Dept Med, Div Signal Transduct, Boston, MA 02215 USA; [Huffman, Kenneth E.; Minna, John D.] Univ Texas SW Med Ctr Dallas, Hamon Ctr Therapeut Oncol, Dallas, TX 75390 USA; [Wistuba, Ignacio I.] Univ Texas MD Anderson Canc Ctr, Dept Translat Mol Pathol, Houston, TX 77030 USA	Cornell University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Harvard University; Beth Israel Deaconess Medical Center; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; UTMD Anderson Cancer Center	Cantley, LC (corresponding author), Weill Cornell Med Coll, Dept Med, New York, NY 10065 USA.	lcantley@med.cornell.edu	Hu, Zeping/F-6205-2010; Cantley, Lewis C/D-1800-2014	Hu, Zeping/0000-0003-4146-7750; Cantley, Lewis C/0000-0002-1298-7653; DeNicola, Gina/0000-0001-6611-6696; Wu, David/0000-0003-4513-2739	US National Institutes of Health [P01 CA117969, R01 GM041890, R01 CA157996-01, 5R01 CA152301, P50 CA70907, 5P30 CA006516, 5 P01 CA120964]; Cancer Prevention Research Institute of Texas (CPRIT) [RP110708, RP120732, RP130272]; Welch Foundation [I-1733]; PanCAN/AACR Pathway to Leadership grant; NATIONAL CANCER INSTITUTE [P01CA120964, P01CA117969, P50CA070907, P30CA006516, R01CA157996, U01CA176284, R01CA152301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041890] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD010612] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention Research Institute of Texas (CPRIT); Welch Foundation(The Welch Foundation); PanCAN/AACR Pathway to Leadership grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank G. Poulogiannis for bioinformatics advice and H. Abbasi, C. Klimko and M. Yuan for technical support with mass spectrometry experiments. This work was supported by US National Institutes of Health grants P01 CA117969 and R01 GM041890 (L.C.C.), R01 CA157996-01 (R.J.D.), 5R01 CA152301 (Y.X.) and P50 CA70907 (J.D.M., I.I.W., Y.X. and K.E.H.) and by Cancer Prevention Research Institute of Texas (CPRIT) funding to J.D.M., Y.X., I.I.W. and K.E.H. (RP110708 and RP120732) and R.J.D. (RP130272). P.-H.C. was supported by a grant from the Welch Foundation to R.J.D. (I-1733). The mass spectrometry work was partially supported by US National Institutes of Health grants 5P30 CA006516 and 5 P01 CA120964 (J.M.A.). G.M.D. was the Malcolm A.S. Moore Hope Funds for Cancer Research Fellow and is supported by the PanCAN/AACR Pathway to Leadership grant.	Afonyushkin T, 2010, ARTERIOSCL THROM VAS, V30, P1007, DOI 10.1161/ATVBAHA.110.204354; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Cheng TL, 2011, P NATL ACAD SCI USA, V108, P8674, DOI 10.1073/pnas.1016627108; De Nicola GM, 2011, NATURE, V475, P106, DOI 10.1038/nature10189; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Hayes JD, 2009, TRENDS BIOCHEM SCI, V34, P176, DOI 10.1016/j.tibs.2008.12.008; He CH, 2001, J BIOL CHEM, V276, P20858, DOI 10.1074/jbc.M101198200; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Kim YR, 2010, J PATHOL, V220, P446, DOI 10.1002/path.2653; Konstantinopoulos PA, 2011, CANCER RES, V71, P5081, DOI 10.1158/0008-5472.CAN-10-4668; Locasale JW, 2011, NAT GENET, V43, P869, DOI 10.1038/ng.890; Meylan E, 2009, NATURE, V462, P104, DOI 10.1038/nature08462; Mitsuishi Y, 2012, CANCER CELL, V22, P66, DOI 10.1016/j.ccr.2012.05.016; Miyamoto N, 2011, INVEST OPHTH VIS SCI, V52, P1226, DOI 10.1167/iovs.10-5775; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Mullarky E, 2011, PIGM CELL MELANOMA R, V24, P1112, DOI 10.1111/j.1755-148X.2011.00919.x; Mullen AR, 2012, NATURE, V481, P385, DOI 10.1038/nature10642; Ohta T, 2008, CANCER RES, V68, P1303, DOI 10.1158/0008-5472.CAN-07-5003; Possemato R, 2011, NATURE, V476, P346, DOI 10.1038/nature10350; Radle B, 2013, JOVE-J VIS EXP, DOI 10.3791/50195; Seng S, 2009, ONCOGENE, V28, P378, DOI 10.1038/onc.2008.396; Shedden K, 2008, NAT MED, V14, P822, DOI 10.1038/nm.1790; Shibata T, 2008, P NATL ACAD SCI USA, V105, P13568, DOI 10.1073/pnas.0806268105; Singh A, 2008, CANCER RES, V68, P7975, DOI 10.1158/0008-5472.CAN-08-1401; Singh A, 2013, J CLIN INVEST, V123, P2921, DOI 10.1172/JCI66353; Solis LM, 2010, CLIN CANCER RES, V16, P3743, DOI 10.1158/1078-0432.CCR-09-3352; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Ye JB, 2012, P NATL ACAD SCI USA, V109, P6904, DOI 10.1073/pnas.1204176109; Ye P, 2014, MOL CELL BIOL, V34, P3421, DOI 10.1128/MCB.00221-14; Yuan M, 2012, NAT PROTOC, V7, P872, DOI 10.1038/nprot.2012.024; Zhang P, 2010, MOL CANCER THER, V9, P336, DOI 10.1158/1535-7163.MCT-09-0589	31	431	446	6	114	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2015	47	12					1475	+		10.1038/ng.3421	http://dx.doi.org/10.1038/ng.3421			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CX6LT	26482881	Green Accepted, Green Submitted			2022-12-25	WOS:000365813200021
J	Xu, ZZ; Kim, YH; Bang, SS; Zhang, Y; Berta, T; Wang, F; Oh, SB; Ji, RR				Xu, Zhen-Zhong; Kim, Yong Ho; Bang, Sangsu; Zhang, Yi; Berta, Temugin; Wang, Fan; Oh, Seog Bae; Ji, Ru-Rong			Inhibition of mechanical allodynia in neuropathic pain by TLR5-mediated A-fiber blockade	NATURE MEDICINE			English	Article							PRIMARY SENSORY NEURONS; TOLL-LIKE RECEPTOR-5; NERVE INJURY; SPINAL-CORD; TACTILE ALLODYNIA; FLAGELLIN; NOCICEPTORS; INNATE; ITCH; RATS	Mechanical allodynia, induced by normally innocuous low-threshold mechanical stimulation, represents a cardinal feature of neuropathic pain. Blockade or ablation of high-threshold, small-diameter unmyelinated group C nerve fibers (C-fibers) has limited effects on mechanical allodynia(1-4). Although large, myelinated group A fibers, in particular A beta-fibers, have previously been implicated in mechanical allodynia(5-7), an A-fiber-selective pharmacological blocker is still lacking. Here we report a new method for targeted silencing of A-fibers in neuropathic pain. We found that Toll-like receptor 5 (TLR5) is co-expressed with neurofilament-200 in large-diameter A-fiber neurons in the dorsal root ganglion (DRG). Activation of TLR5 with its ligand flagellin results in neuronal entry of the membrane-impermeable lidocaine derivative QX-314, leading to TLR5-dependent blockade of sodium currents, predominantly in A-fiber neurons of mouse DRGs. Intraplantar co-application of flagellin and QX-314 (flagellin/QX-314) dose-dependently suppresses mechanical allodynia after chemotherapy, nerve injury, and diabetic neuropathy, but this blockade is abrogated in Tlr5-deficient mice. In vivo electrophysiology demonstrated that co-application of flagellin/QX-314 selectively suppressed A beta-fiber conduction in naive and chemotherapy-treated mice. TLR5-mediated A beta-fiber blockade, but not capsaicin-mediated C-fiber blockade, also reduced chemotherapy-induced ongoing pain without impairing motor function. Finally, flagellin/QX-314 co-application suppressed sodium currents in large-diameter human DRG neurons. Thus, our findings provide a new tool for targeted silencing of A beta-fibers and neuropathic pain treatment.	[Xu, Zhen-Zhong; Kim, Yong Ho; Bang, Sangsu; Berta, Temugin; Ji, Ru-Rong] Duke Univ, Med Ctr, Dept Anesthesiol, Durham, NC 27710 USA; [Xu, Zhen-Zhong; Kim, Yong Ho; Bang, Sangsu; Zhang, Yi; Berta, Temugin; Wang, Fan; Ji, Ru-Rong] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; [Kim, Yong Ho; Oh, Seog Bae] Seoul Natl Univ, Sch Dent, Dent Res Inst, Pain Cognit Funct Res Ctr, Seoul, South Korea; [Kim, Yong Ho; Oh, Seog Bae] Seoul Natl Univ, Sch Dent, Dept Neurobiol & Physiol, Seoul, South Korea; [Oh, Seog Bae] Seoul Natl Univ, Coll Nat Sci, Dept Brain & Cognit Sci, Seoul 151742, South Korea	Duke University; Duke University; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Ji, RR (corresponding author), Duke Univ, Med Ctr, Dept Anesthesiol, Durham, NC 27710 USA.	ru-rong.ji@duke.edu	Berta, Temugin/A-6908-2016; Berta, Temugin/AAK-6365-2020; Bang, Sangsu/AAN-7238-2020; bang, sangsu/U-4313-2017; OH, Seog Bae/AAQ-2478-2020; Ji, Ru-Rong/L-7070-2017	Berta, Temugin/0000-0002-4486-8288; Berta, Temugin/0000-0002-4486-8288; bang, sangsu/0000-0002-9092-0075; Ji, Ru-Rong/0000-0002-9355-3688; Oh, Seog Bae/0000-0001-7975-6895; Xu, Zhen-Zhong/0000-0001-6578-211X	US National Institutes of Health (NIH) [NS67686, NS87988, NS89479, DE17794, DE22743]; NIH [NS82985, NS91779, DE19440]; Korea government [2012R1A3A2048834]; Korea National Research Foundation [2013R1A6A3A04065858]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE017794, R01DE022743, R01DE019440] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS091779, R01NS087988, R21NS082985, R01NS067686, R01NS089479] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Korea government(Korean Government); Korea National Research Foundation(National Research Foundation of Korea); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study is supported by US National Institutes of Health (NIH) R01 grants NS67686 (R.-R.J.), NS87988 (R.-R.J.), NS89479 (R.-R.J.), DE17794 (R.-R.J.), and DE22743 (R.-R.J.); NIH R21 grants NS82985 (Z.-Z.X.) and NS91779 (Z.-Z.X.); NIH R01 grant DE19440 (F.W.); a Korea government grant 2012R1A3A2048834 (S.B.O.); and a Korea National Research Foundation grant 2013R1A6A3A04065858 (Y.H.K.).	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; BENNETT GJ, 1988, PAIN, V33, P87, DOI 10.1016/0304-3959(88)90209-6; Binshtok AM, 2007, NATURE, V449, P607, DOI 10.1038/nature06191; Binshtok AM, 2008, J NEUROSCI, V28, P14062, DOI 10.1523/JNEUROSCI.3795-08.2008; Boada MD, 2014, PAIN, V155, P2646, DOI 10.1016/j.pain.2014.09.030; Brenneis C, 2013, J NEUROSCI, V33, P315, DOI 10.1523/JNEUROSCI.2804-12.2013; CAMPBELL JN, 1988, PAIN, V32, P89, DOI 10.1016/0304-3959(88)90027-9; Cavaletti G, 2010, NAT REV NEUROL, V6, P657, DOI 10.1038/nrneurol.2010.160; DEVOR M, 1991, BRIT MED BULL, V47, P619, DOI 10.1093/oxfordjournals.bmb.a072496; Duan B, 2014, CELL, V159, P1417, DOI 10.1016/j.cell.2014.11.003; Haroutounian S, 2014, PAIN, V155, P1272, DOI 10.1016/j.pain.2014.03.022; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Khan GM, 2002, NEUROSCIENCE, V114, P291, DOI 10.1016/S0306-4522(02)00372-X; Kim YH, 2012, NEURON, V74, P640, DOI 10.1016/j.neuron.2012.02.039; King T, 2011, PAIN, V152, P1997, DOI 10.1016/j.pain.2011.04.020; KOLTZENBURG M, 1992, PAIN, V51, P207, DOI 10.1016/0304-3959(92)90262-A; LAWSON SN, 1991, J PHYSIOL-LONDON, V435, P41, DOI 10.1113/jphysiol.1991.sp018497; Li LS, 2011, CELL, V147, P1615, DOI 10.1016/j.cell.2011.11.027; Liu CN, 2000, PAIN, V85, P503, DOI 10.1016/S0304-3959(00)00251-7; Liu T, 2012, J CLIN INVEST, V122, P2195, DOI 10.1172/JCI45414; Liu T, 2012, NEUROSCI BULL, V28, P131, DOI 10.1007/s12264-012-1219-5; Liu XJ, 2014, CELL RES, V24, P1374, DOI 10.1038/cr.2014.106; Lu Y, 2013, J CLIN INVEST, V123, P4050, DOI 10.1172/JCI70026; Ma C, 2003, J NEUROPHYSIOL, V89, P1588, DOI 10.1152/jn.00855.2002; McCoy ES, 2013, NEURON, V78, P138, DOI 10.1016/j.neuron.2013.01.030; MELZACK R, 1965, SCIENCE, V150, P971, DOI 10.1126/science.150.3699.971; Minett MS, 2014, CELL REP, V6, P301, DOI 10.1016/j.celrep.2013.12.033; Ossipov MH, 1999, PAIN, V79, P127, DOI 10.1016/S0304-3959(98)00187-0; Ossipov MH, 2002, J NEUROSCI, V22, P9858; Park CK, 2014, NEURON, V82, P47, DOI 10.1016/j.neuron.2014.02.011; Roberson DP, 2013, NAT NEUROSCI, V16, P910, DOI 10.1038/nn.3404; Seal RP, 2009, NATURE, V462, P651, DOI 10.1038/nature08505; Sfondrini L, 2006, J IMMUNOL, V176, P6624, DOI 10.4049/jimmunol.176.11.6624; Smith AK, 2013, MOL PAIN, V9, DOI 10.1186/1744-8069-9-61; Smith KD, 2003, NAT IMMUNOL, V4, P1247, DOI 10.1038/ni1011; Todd AJ, 2010, NAT REV NEUROSCI, V11, P823, DOI 10.1038/nrn2947; Usoskin D, 2015, NAT NEUROSCI, V18, P145, DOI 10.1038/nn.3881; Vijay-Kumar M, 2008, J IMMUNOL, V180, P8280, DOI 10.4049/jimmunol.180.12.8280; Xu ZZ, 2013, ANN NEUROL, V74, P490, DOI 10.1002/ana.23928	39	188	197	2	55	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2015	21	11					1326	1331		10.1038/nm.3978	http://dx.doi.org/10.1038/nm.3978			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CV9QH	26479925	Green Accepted			2022-12-25	WOS:000364621200017
J	Setty, M; Tadmor, MD; Reich-Zeliger, S; Ange, O; Salame, TM; Kathail, P; Choi, K; Bendall, S; Friedman, N; Pe'er, D				Setty, Manu; Tadmor, Michelle D.; Reich-Zeliger, Shlomit; Ange, Omer; Salame, Tomer Meir; Kathail, Pooja; Choi, Kristy; Bendall, Sean; Friedman, Nir; Pe'er, Dana			Wishbone identifies bifurcating developmental trajectories from single-cell data	NATURE BIOTECHNOLOGY			English	Article							GENE-EXPRESSION; TRANSCRIPTION FACTORS; DIFFUSION MAPS; RNA-SEQ; DIFFERENTIATION; TRANSFORMATION; HETEROGENEITY; MECHANISMS; LANDSCAPE; NETWORKS	Recent single-cell analysis technologies offer an unprecedented opportunity to elucidate developmental pathways. Here we present Wishbone, an algorithm for positioning single cells along bifurcating developmental trajectories with high resolution. Wishbone uses multi-dimensional single-cell data, such as mass cytometry or RNA-Seq data, as input and orders cells according to their developmental progression, and it pinpoints bifurcation points by labeling each cell as pre-bifurcation or as one of two post-bifurcation cell fates. Using 30-channel mass cytometry data, we show that Wishbone accurately recovers the known stages of T-cell development in the mouse thymus, including the bifurcation point. We also apply the algorithm to mouse myeloid differentiation and demonstrate its generalization to additional lineages. A comparison of Wishbone to diffusion maps, SCUBA and Monocle shows that it outperforms these methods both in the accuracy of ordering cells and in the correct identification of branch points.	[Setty, Manu; Tadmor, Michelle D.; Kathail, Pooja; Choi, Kristy; Pe'er, Dana] Columbia Univ, Dept Syst Biol, Dept Biol Sci, New York, NY USA; [Reich-Zeliger, Shlomit; Friedman, Nir] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel; [Ange, Omer] Univ British Columbia, Dept Math, Vancouver, BC, Canada; [Salame, Tomer Meir] Weizmann Inst Sci, Biol Serv Unit, IL-76100 Rehovot, Israel; [Bendall, Sean] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA	Columbia University; Weizmann Institute of Science; University of British Columbia; Weizmann Institute of Science; Stanford University	Pe'er, D (corresponding author), Columbia Univ, Dept Syst Biol, Dept Biol Sci, New York, NY USA.	dpeer@biology.columbia.edu	Bendall, Sean/AGG-0126-2022	Bendall, Sean/0000-0003-1341-2453; Pe'er, Dana/0000-0002-9259-8817; Setty, Manu/0000-0002-0344-2627	NSF; NSF [MCB-1149728]; NIH [DP1-HD084071, R01CA164729]; David and Fela Shapell Family Foundation INCPM Fund; Nissim Center, for the Development of Scientific Resources; ISF [1184/15]; Direct For Biological Sciences [1149728] Funding Source: National Science Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [DP1HD084071] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA164729] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); David and Fela Shapell Family Foundation INCPM Fund; Nissim Center, for the Development of Scientific Resources; ISF(Israel Science Foundation); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We would like to thank A. Bloemendal, Z. Good, N. Hacohen, S. Krishnaswamy, J. Levine and A.J. Carr for their helpful comments. M.D.T. is supported by an NSF graduate fellowship. This work was supported by NSF MCB-1149728, NIH DP1-HD084071, NIH R01CA164729 to D.P. D.P. holds a Packard Fellowship for Science and Engineering. This work was also supported by David and Fela Shapell Family Foundation INCPM Fund, the WIS staff scientists grant from the Nissim Center, for the Development of Scientific Resources, and ISF 1184/15 to N.F.	Bendall SC, 2014, CELL, V157, P714, DOI 10.1016/j.cell.2014.04.005; Bendall SC, 2011, SCIENCE, V332, P687, DOI 10.1126/science.1198704; Buettner F, 2015, NAT BIOTECHNOL, V33, P155, DOI 10.1038/nbt.3102; Coifman RR, 2005, P NATL ACAD SCI USA, V102, P7426, DOI 10.1073/pnas.0500334102; Doulatov S, 2010, NAT IMMUNOL, V11, P585, DOI 10.1038/ni.1889; Egawa T, 2015, ADV IMMUNOL, V125, P1, DOI 10.1016/bs.ai.2014.09.001; Haghverdi L, 2015, BIOINFORMATICS, V31, P2989, DOI 10.1093/bioinformatics/btv325; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Kaneko H, 2010, CURR OPIN HEMATOL, V17, P163, DOI 10.1097/MOH.0b013e32833800b8; Klein AM, 2015, CELL, V161, P1187, DOI 10.1016/j.cell.2015.04.044; Koch U, 2011, ANNU REV CELL DEV BI, V27, P539, DOI 10.1146/annurev-cellbio-092910-154008; Love PE, 2011, NAT REV IMMUNOL, V11, P469, DOI 10.1038/nri2989; Marco E, 2014, P NATL ACAD SCI USA, V111, pE5643, DOI 10.1073/pnas.1408993111; Mingueneau M, 2013, NAT IMMUNOL, V14, P619, DOI 10.1038/ni.2590; Moignard V, 2015, NAT BIOTECHNOL, V33, P269, DOI 10.1038/nbt.3154; Paul F, 2015, CELL, V163, P1663, DOI 10.1016/j.cell.2015.11.013; PINKUS GS, 1991, MODERN PATHOL, V4, P733; Rosenbauer F, 2007, NAT REV IMMUNOL, V7, P105, DOI 10.1038/nri2024; Shin J, 2015, CELL STEM CELL, V17, P360, DOI 10.1016/j.stem.2015.07.013; Singer A, 2008, NAT REV IMMUNOL, V8, P788, DOI 10.1038/nri2416; Stegle O, 2015, NAT REV GENET, V16, P133, DOI 10.1038/nrg3833; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tang FC, 2009, NAT METHODS, V6, P377, DOI [10.1038/NMETH.1315, 10.1038/nmeth.1315]; Trapnell C, 2014, NAT BIOTECHNOL, V32, P381, DOI 10.1038/nbt.2859; Wang L, 2008, NAT IMMUNOL, V9, P1122, DOI 10.1038/ni.1647; YAMASHITA I, 1993, INT IMMUNOL, V5, P1139, DOI 10.1093/intimm/5.9.1139; Yui MA, 2014, NAT REV IMMUNOL, V14, P529, DOI 10.1038/nri3702	27	336	340	3	66	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUN	2016	34	6					637	645		10.1038/nbt.3569	http://dx.doi.org/10.1038/nbt.3569			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DO5TT	27136076	Green Accepted			2022-12-25	WOS:000377846400031
J	Witek, K; Jupe, F; Witek, AI; Baker, D; Clark, MD; Jones, JDG				Witek, Kamil; Jupe, Florian; Witek, Agnieszka I.; Baker, David; Clark, Matthew D.; Jones, Jonathan D. G.			Accelerated cloning of a potato late blight-resistance gene using RenSeq and SMRT sequencing	NATURE BIOTECHNOLOGY			English	Article							PLANT IMMUNE-SYSTEM; PHYTOPHTHORA-INFESTANS; GENOME	Global yields of potato and tomato crops have fallen owing to potato late blight disease, which is caused by Phytophthora infestans. Although most commercial potato varieties are susceptible to blight, many wild potato relatives show variation for resistance and are therefore a potential source of Resistance to P. infestans (Rpi) genes. Resistance breeding has exploited Rpi genes from closely related tuber-bearing potato relatives, but is laborious and slow(1-3). Here we report that the wild, diploid non-tuber-bearing Solanum americanum harbors multiple Rpi genes. We combine resistance (R) gene sequence capture (RenSeq)(4) with single-molecule real-time (SMRT) sequencing (SMRT RenSeq) to clone Rpi-amr3i. This technology should enable de novo assembly of complete nucleotide-binding, leucine-rich repeat receptor (NLR) genes, their regulatory elements and complex multi-NLR loci from uncharacterized germplasm. SMRT RenSeq can be applied to rapidly clone multiple R genes for engineering pathogen-resistant crops.	[Witek, Kamil; Jupe, Florian; Witek, Agnieszka I.; Jones, Jonathan D. G.] Sainsbury Lab, Norwich Res Pk, Norwich, Norfolk, England; [Baker, David; Clark, Matthew D.] Genome Anal Ctr TGAC, Norwich Res Pk, Norwich, Norfolk, England; [Jupe, Florian] Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; The Genome Analysis Centre (TGAC); Salk Institute	Witek, K; Jones, JDG (corresponding author), Sainsbury Lab, Norwich Res Pk, Norwich, Norfolk, England.	kamil.witek@tsl.ac.uk; jonathan.jones@tsl.ac.uk	Jones, Jonathan DG/J-5129-2012	Jones, Jonathan DG/0000-0002-4953-261X; Jupe, Florian/0000-0001-5741-4931; Clark, Matthew/0000-0002-8049-5423	BBSRC [BB/H019820/1, BB/G02197X/1, BB/L011794/1, BB/L009757/1, BB/J010375/1]; Gatsby Charitable Foundation; NBI Computing infrastructure for Science (CiS) group through the provision of a High Performance Computing Cluster; BBSRC [BBS/E/T/000PR6193, BB/J003166/1, BBS/E/T/000PR5885, BB/L009293/1, BB/M017834/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G02197X/1, BB/M017834/1, BB/L009757/1, BBS/E/T/000PR5885, BB/L011794/1, BB/J003166/1, BBS/E/T/000PR6193, BB/L009293/1, BB/C007522/1, BB/H019820/1] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Gatsby Charitable Foundation; NBI Computing infrastructure for Science (CiS) group through the provision of a High Performance Computing Cluster; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We would like to thank S. Knapp, S. Kamoun, B. Wulff, B. Steuernagel, G. Rallapalli, O. Furzer and N. Champouret for useful discussions, The Genome Analysis Centre (TGAC) for excellent PacBio service, L. Tomlinson and W. Barrett for technical assistance, P. Lindhout for Solynta potato lines, S. Perkins and J. Campling for maintenance of plants in the greenhouse, M. Smoker and J. Pike for plant transformation, V. Vleeshouwers for the R2 construct, TSL Bioinformatics Support Team and specifically C. Schudoma for bioinformatics assistance, and A. Davis for photography. This work was financed from BBSRC grants nos BB/H019820/1, BB/G02197X/1, BB/L011794/1, BB/L009757/1, BB/J010375/1 and the Gatsby Charitable Foundation. This research was supported in part by the NBI Computing infrastructure for Science (CiS) group through the provision of a High Performance Computing Cluster. P. infestans isolate MP324 (ref. 25) was provided by J. Sliwka from the Plant Breeding and Acclimatization Institute National Research Institute, Mlochow Centre (Poland).	Andolfo G, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-120; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Cesari S, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00606; Dangl JL, 2013, SCIENCE, V341, P746, DOI 10.1126/science.1236011; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; Eid J, 2009, SCIENCE, V323, P133, DOI 10.1126/science.1162986; Haverkort AJ, 2008, POTATO RES, V51, P47, DOI 10.1007/s11540-008-9089-y; Jiao X., 2013, J DATA MINING GENOMI, V424, P1; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Jones JDG, 2014, PHILOS T R SOC B, V369, DOI [10.1098/rstb.2013.0087, 10.1098/rstb.2013.008]; Jupe F, 2013, PLANT J, V76, P530, DOI 10.1111/tpj.12307; Jupe F, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-75; Lebecka R, 2008, EUR J PLANT PATHOL, V120, P233, DOI 10.1007/s10658-007-9211-z; Narusaka M, 2009, PLANT J, V60, P218, DOI 10.1111/j.1365-313X.2009.03949.x; Rallapalli G, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-341; Rodewald J, 2013, MOL PLANT PATHOL, V14, P740, DOI 10.1111/mpp.12036; Sarris PF, 2015, CELL, V161, P1089, DOI 10.1016/j.cell.2015.04.024; Saunders DGO, 2012, PLANT CELL, V24, P3420, DOI 10.1105/tpc.112.099861; Sharon D, 2013, NAT BIOTECHNOL, V31, P1009, DOI 10.1038/nbt.2705; Sliwka J, 2006, THEOR APPL GENET, V113, P685, DOI 10.1007/s00122-006-0336-9; Steuernagel B, 2016, NAT BIOTECHNOL; Steuernagel B, 2015, BIOINFORMATICS, V31, P1665, DOI 10.1093/bioinformatics/btv005; Wang M, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1370-2	24	136	144	2	106	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUN	2016	34	6					656	660		10.1038/nbt.3540	http://dx.doi.org/10.1038/nbt.3540			5	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DO5TT	27111721	Green Accepted			2022-12-25	WOS:000377846400034
J	Conko, G; Kershen, DL; Miller, H; Parrott, WA				Conko, Gregory; Kershen, Drew L.; Miller, Henry; Parrott, Wayne A.			A risk-based approach to the regulation of genetically engineered organisms	NATURE BIOTECHNOLOGY			English	Article							DISEASE RESISTANCE; SAFETY ASSESSMENT; FEED SAFETY; FOOD; CROPS; TRANSGENE; HERBIVORY; PLANTS		[Conko, Gregory] Competit Enterprise Inst, Washington, DC USA; [Kershen, Drew L.] Univ Oklahoma, Coll Law, Law Emeritus, Norman, OK 73019 USA; [Miller, Henry] Stanford Univ, Hoover Inst, Sci Philosophy & Publ Policy, Stanford, CA 94305 USA; [Parrott, Wayne A.] Univ Georgia, Inst Plant Breeding Genet & Genom, Athens, GA 30602 USA	University of Oklahoma System; University of Oklahoma - Norman; Stanford University; University System of Georgia; University of Georgia	Miller, H (corresponding author), Stanford Univ, Hoover Inst, Sci Philosophy & Publ Policy, Stanford, CA 94305 USA.	himiller@stanford.edu						ACRE, 2013, MOR EFF APPR ENV RIS; ACRE, 2013, WHY MOD UND GEN DEM; Ahloowalia BS, 2004, EUPHYTICA, V135, P187, DOI 10.1023/B:EUPH.0000014914.85465.4f; AMES BN, 1990, P NATL ACAD SCI USA, V87, P7777, DOI 10.1073/pnas.87.19.7777; [Anonymous], 2006, NAT BIOTECHNOL, V24, P2; [Anonymous], 2011, COST TIME INVOLVED D; Bartholomaeus A, 2013, CRIT REV TOXICOL, V43, P1, DOI 10.3109/10408444.2013.842955; Barton J, 1997, NAT BIOTECHNOL, V15, P845, DOI 10.1038/nbt0997-845; Bradford KJ, 2005, NAT BIOTECHNOL, V23, P439, DOI 10.1038/nbt1084; Brune PD, 2013, J AGR FOOD CHEM, V61, P8243, DOI 10.1021/jf401097q; Burke JM, 2003, SCIENCE, V300, P1250, DOI 10.1126/science.1084960; Camachol A, 2014, NAT BIOTECHNOL, V32, P1087, DOI 10.1038/nbt.3057; Cellini F, 2004, FOOD CHEM TOXICOL, V42, P1089, DOI 10.1016/j.fct.2004.02.003; Centers for Disease Control and Prevention (CDC), 2009, BIOSAFETY MICROBIOLO; Clinton WJ, 1993, FED REGISTER, V58, P51735; Committee on Scientific Evaluation of the Introduction of Genetically Modified Microorganisms and Plants into the Environment NRC, 1989, FIELD TEST GEN ENG O; Delaney B, 2008, FOOD CHEM TOXICOL, V46, pS71, DOI 10.1016/j.fct.2008.01.045; EPA, 2014, PEST IMP WATCH NEWSL, V14, P3; EPA, 2013, PEST IMP ENF PION HI; EPA, 2010, BIOP REG ACT DOC PRO; European Union, 2010, 24473 EUR; Goodman RE, 2013, J AGR FOOD CHEM, V61, P8317, DOI 10.1021/jf400952y; GOODMAN RM, 1987, SCIENCE, V236, P48, DOI 10.1126/science.236.4797.48; GRACE (GMO Risk Assess. Commun. Evid.), 2015, CONCL REC AN FEED TR; Hajjar R, 2007, EUPHYTICA, V156, P1, DOI 10.1007/s10681-007-9363-0; Hammond B, 2013, CRIT REV TOXICOL, V43, P25, DOI 10.3109/10408444.2013.842956; Hancock J.F., 2004, PLANT EVOLUTION ORIG; IAEA/MVD, 2015, JOINT FAO IAEA MUT D; JONES SS, 1995, ANNU REV PHYTOPATHOL, V33, P429, DOI 10.1146/annurev.py.33.090195.002241; Jones W., 2015, GMO ANSWERS BLOG; KESSLER DA, 1992, SCIENCE, V256, P1747, DOI 10.1126/science.1615315; Konig A, 2004, FOOD CHEM TOXICOL, V42, P1047, DOI 10.1016/j.fct.2004.02.019; Kuiper HA, 2001, PLANT J, V27, P503, DOI 10.1046/j.1365-313X.2001.01119.x; Lee RY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052972; Liu WS, 2013, NAT REV GENET, V14, P781, DOI 10.1038/nrg3583; Matsuoka Y, 2011, PLANT CELL PHYSIOL, V52, P750, DOI 10.1093/pcp/pcr018; Miller H.I., 2004, THE FRANKENFOOD MYTH; Mumm RH, 2013, J AGR FOOD CHEM, V61, P8254, DOI 10.1021/jf400685y; Murray JD, 2016, P NATL ACAD SCI USA, V113, P3410, DOI 10.1073/pnas.1602474113; National Biotechnology Policy Board, 1992, BIOTECHNOL LAW REP, V12, P127; Newell-McGloughlin M, 2008, PLANT PHYSIOL, V147, P939, DOI 10.1104/pp.108.121947; Nicolia A, 2014, CRIT REV BIOTECHNOL, V34, P77, DOI 10.3109/07388551.2013.823595; *NRC, 1989, FIELD TEST GEN MOD O; *NRC, 1987, INTR REC DNA ENG ORG; NRC Committee on Scientific Evaluation of the Introduction of Genetically Modified Microorganisms and Plants into the Environment, 1989, FIELD TESTING GENETI; OECD, 1995, REC COUNCIL OECD IMP; OECD, 2005, GUID PRINC REG QUAL; OECD, 2012, RECOMMENDATION COUNC; Office of Science and Technology Policy, 1992, FED REGISTER, V57, P6753; Office of the Gene Regulator (OGTR) Australia, 2009, RISK ANAL FRAM; OSTP, 2011, PRINCIPLES REGULATIO; OSTP, 2015, WHITE HOUSE BLO 0702; Parrott W, 2010, FOOD CHEM TOXICOL, V48, P1773, DOI 10.1016/j.fct.2010.04.017; Pollack A., 2015, NY TIMES; Price WD, 2013, J AGR FOOD CHEM, V61, P8349, DOI 10.1021/jf401178d; Privalle LS, 2013, J AGR FOOD CHEM, V61, P8260, DOI 10.1021/jf400185q; Ricroch A., 2015, CRIT REV BIOTECHNOL, DOI [10.3109/07388551.2015.10045 21, DOI 10.3109/07388551.2015.10045]; Sasu MA, 2010, INT J PLANT SCI, V171, P1048, DOI 10.1086/656531; Schnell J, 2015, TRANSGENIC RES, V24, P1, DOI 10.1007/s11248-014-9843-7; Shewry PR, 2013, J AGR FOOD CHEM, V61, P8295, DOI 10.1021/jf3054092; Snow AA, 2003, ECOL APPL, V13, P279, DOI 10.1890/1051-0761(2003)013[0279:ABTRHA]2.0.CO;2; Staginnus C, 2006, TRENDS PLANT SCI, V11, P485, DOI 10.1016/j.tplants.2006.08.008; Steiner HY, 2013, PLANT PHYSIOL, V161, P1587, DOI 10.1104/pp.112.209817; Taheripour F., AGBIOFORUM IN PRESS; U.S. Food and Drug Administration, 1992, FED REGISTER, V57, P22984; U.S. Office of Science and Technology Policy, 1986, Fed Regist, V51, P23302; United Kingdom Advisory Committee on Releases to the Environment (ACRE), 2013, EV BAS REG SYST GMOS; US EPA, 2001, FED REGISTER, V66, P37772; USDA-APHIS Biotechnology Regulatory Services, 2016, REQ EXT NONR STAT PR; Van Eenennaam AL, 2014, J ANIM SCI, V92, P5293, DOI [10.2527/jas.2014-8124, 10.2527/jas2014-8124]; van Haver E, 2008, FOOD CHEM TOXICOL, V46, pS2, DOI 10.1016/j.fct.2008.02.008; Weber N, 2012, PLANT PHYSIOL, V160, P1842, DOI 10.1104/pp.112.204271; WHO/FAO, 442003 CAC GL; Wolt JD, 2010, TRANSGENIC RES, V19, P425, DOI 10.1007/s11248-009-9321-9; WTO, 1994, AGR EST WORLD TRAD O; YOUNG ND, 1989, THEOR APPL GENET, V77, P353, DOI 10.1007/BF00305828	77	47	49	0	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2016	34	5					493	503		10.1038/nbt.3568	http://dx.doi.org/10.1038/nbt.3568			11	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DL6FL	27153279				2022-12-25	WOS:000375735000026
J	Ishii, T; Pera, RAR				Ishii, Tetsuya; Pera, Renee A. Reijo			Creating human germ cells for unmet reproductive needs	NATURE BIOTECHNOLOGY			English	Letter							PLURIPOTENT STEM-CELLS; MITOCHONDRIAL REPLACEMENT; FATE; DIFFERENTIATION; DERIVATION; INDUCTION; FETAL; MEN		[Ishii, Tetsuya] Hokkaido Univ, Off Hlth & Safety, Sapporo, Hokkaido, Japan; [Pera, Renee A. Reijo] Montana State Univ, Dept Cell Biol & Neurosci, Bozeman, MT 59717 USA; [Pera, Renee A. Reijo] Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59717 USA	Hokkaido University; Montana State University System; Montana State University Bozeman; Montana State University System; Montana State University Bozeman	Ishii, T (corresponding author), Hokkaido Univ, Off Hlth & Safety, Sapporo, Hokkaido, Japan.	tishii@general.hokudai.ac.jp		Reijo Pera, Renee/0000-0002-6487-1329; Ishii, Tetsuya/0000-0002-7085-7750				Bucay N, 2009, STEM CELLS, V27, P68, DOI 10.1634/stemcells.2007-1018; Busardo FP, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/307160; Easley CA, 2012, CELL REP, V2, P440, DOI 10.1016/j.celrep.2012.07.015; Eguizabal C, 2011, STEM CELLS, V29, P1186, DOI 10.1002/stem.672; Garber K, 2015, NAT BIOTECHNOL, V33, P890, DOI 10.1038/nbt0915-890; Greenfield Dr Andy, 2014, 3 SCI REV SAFETY EFF; Hayashi K, 2012, SCIENCE, V338, P971, DOI 10.1126/science.1226889; Hayashi K, 2011, CELL, V146, P519, DOI 10.1016/j.cell.2011.06.052; Irie N, 2015, CELL, V160, P253, DOI 10.1016/j.cell.2014.12.013; Ishii T., 2015, BRIEFINGS FUNCT 1127, DOI [10.1093/bfgp/e1v053, DOI 10.1093/BFGP/E1V053]; Ishii T, 2014, REPROD BIOMED ONLINE, V29, P150, DOI 10.1016/j.rbmo.2014.04.001; Ishii T, 2013, CELL STEM CELL, V13, P145, DOI 10.1016/j.stem.2013.07.005; Kee K, 2009, NATURE, V462, P222, DOI 10.1038/nature08562; Lee E, 2015, HUM REPROD, V30, P473, DOI 10.1093/humrep/deu303; Levran D, 2000, FERTIL STERIL, V74, P443, DOI 10.1016/S0015-0282(00)00698-1; Lynch M, 2010, P NATL ACAD SCI USA, V107, P961, DOI 10.1073/pnas.0912629107; Medrano JV, 2012, STEM CELLS, V30, P441, DOI 10.1002/stem.1012; Nakaki F, 2013, NATURE, V501, P222, DOI 10.1038/nature12417; Orvieto R, 2013, J OVARIAN RES, V6, DOI 10.1186/1757-2215-6-77; Palacios-Gonzalez C, 2014, J MED ETHICS, V40, P752, DOI 10.1136/medethics-2013-101810; Panula S, 2011, HUM MOL GENET, V20, P752, DOI 10.1093/hmg/ddq520; Park TS, 2009, STEM CELLS, V27, P783, DOI 10.1002/stem.13; Quinn GP, 2015, CANCER-AM CANCER SOC, V121, P2993, DOI 10.1002/cncr.29322; Ramathal C, 2014, CELL REP, V7, P1284, DOI 10.1016/j.celrep.2014.03.067; Reinhardt K, 2013, SCIENCE, V341, P1345, DOI 10.1126/science.1237146; Ronen D, 2012, CURR OPIN GENET DEV, V22, P444, DOI 10.1016/j.gde.2012.09.003; Sasaki K, 2015, CELL STEM CELL, V17, P178, DOI 10.1016/j.stem.2015.06.014; Schattman GL, 2016, FERTIL STERIL, V105, P307, DOI 10.1016/j.fertnstert.2015.12.001; Strong K, 2014, BIOETHICS, V28, P187, DOI 10.1111/j.1467-8519.2012.02001.x; Tournaye H, 2014, LANCET, V384, P1295, DOI 10.1016/S0140-6736(14)60495-5; Trujillo JP, 2015, GENET MED, V17, P935, DOI 10.1038/gim.2014.206; Weismann A, 1893, GERM PLASM THEORY HE; White YAR, 2012, NAT MED, V18, P413, DOI 10.1038/nm.2669; Yamada M, 2014, NATURE, V510, P533, DOI 10.1038/nature13287; Zhang H, 2012, P NATL ACAD SCI USA, V109, P12580, DOI 10.1073/pnas.1206600109	35	9	10	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2016	34	5					470	473		10.1038/nbt.3559	http://dx.doi.org/10.1038/nbt.3559			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DL6FL	27153270	Green Submitted			2022-12-25	WOS:000375735000017
J	Brocard, C; Plantier, V; Boulenguez, P; Liabeuf, S; Bouhadfane, M; Viallat-Lieutaud, A; Vinay, L; Brocard, F				Brocard, Cecile; Plantier, Vanessa; Boulenguez, Pascale; Liabeuf, Sylvie; Bouhadfane, Mouloud; Viallat-Lieutaud, Annelise; Vinay, Laurent; Brocard, Frederic			Cleavage of Na+ channels by calpain increases persistent Na+ current and promotes spasticity after spinal cord injury	NATURE MEDICINE			English	Article							CENTRAL PATTERN GENERATOR; SODIUM CURRENT; RECEPTOR ACTIVATION; PLATEAU POTENTIALS; CALCIUM CURRENTS; NEONATAL-RATS; MUSCLE SPASMS; ADULT RATS; MOTONEURONS; RILUZOLE	Upregulation of the persistent sodium current (I-NaP) in motoneurons contributes to the development of spasticity after spinal cord injury (SCI). We investigated the mechanisms that regulate I-NaP and observed elevated expression of voltage-gated sodium (Nav) 1.6 channels in spinal lumbar motoneurons of adult rats with SCI. Furthermore, immunoblots revealed a proteolysis of Nav channels, and biochemical assays identified calpain as the main proteolytic factor. Calpain-dependent cleavage of Nav channels after neonatal SCI was associated with an upregulation of I-NaP in motoneurons. Similarly, the calpain-dependent cleavage of Nav1.6 channels expressed in human embryonic kidney (HEK) 293 cells caused the upregulation of I-NaP. The pharmacological inhibition of calpain activity by MDL28170 reduced the cleavage of Nav channels, I-NaP in motoneurons and spasticity in rats with SCI. Similarly, the blockade of I-NaP by riluzole alleviated spasticity. This study demonstrates that Nav channel expression in lumbar motoneurons is altered after SCI, and it shows a tight relationship between the calpain-dependent proteolysis of Nav1.6 channels, the upregulation of I-NaP and spasticity.	[Brocard, Cecile; Plantier, Vanessa; Boulenguez, Pascale; Liabeuf, Sylvie; Bouhadfane, Mouloud; Viallat-Lieutaud, Annelise; Vinay, Laurent; Brocard, Frederic] Aix Marseille Univ, UMR7289, Inst Neurosci Timone, Team P3M, Marseille, France; [Brocard, Cecile; Plantier, Vanessa; Boulenguez, Pascale; Liabeuf, Sylvie; Bouhadfane, Mouloud; Viallat-Lieutaud, Annelise; Vinay, Laurent; Brocard, Frederic] CNRS, Marseille, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Centre National de la Recherche Scientifique (CNRS)	Brocard, F (corresponding author), Aix Marseille Univ, UMR7289, Inst Neurosci Timone, Team P3M, Marseille, France.; Brocard, F (corresponding author), CNRS, Marseille, France.	frederic.brocard@univ-amu.fr		Brocard, Frederic/0000-0001-9444-9586	International Spinal Research Trust [STR110]; Fondation pour la Recherche Medicale [DEQ20130326540]; French Institut pour la Recherche sur la Moelle epiniere et l'Encephale; French National Institute of Health and Medical Research (INSERM)	International Spinal Research Trust; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); French Institut pour la Recherche sur la Moelle epiniere et l'Encephale; French National Institute of Health and Medical Research (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm))	We dedicate this article to the memory of our dear colleague and friend Laurent Vinay, who passed away on 26 March 2015. Vinay was absolutely dedicated to science and, specifically, to the field of spinal cord research. Everyone who interacted with him was marked by his kindness, humanity and devotion. Vinay will leave a great void behind. This study was supported by the International Spinal Research Trust (to L.V.; STR110), the Fondation pour la Recherche Medicale (to L.V. and F.B.; DEQ20130326540) and the French Institut pour la Recherche sur la Moelle epiniere et l'Encephale (to F.B.). P.B. is supported by the French National Institute of Health and Medical Research (INSERM). We thank the company NSrepair for their help in surgery and postoperative care. We thank A.J. Powell and M. Bird for providing us with the HEK293 cell line stably expressing Nav1.6 (GlaxoSmithKline, Stevenage, UK).	Arataki S, 2005, J NEUROTRAUM, V22, P398, DOI 10.1089/neu.2005.22.398; ARMSTRONG CM, 1973, J GEN PHYSIOL, V62, P375, DOI 10.1085/jgp.62.4.375; Banik NL, 1997, BRAIN RES, V752, P301, DOI 10.1016/S0006-8993(96)01488-6; Biering-Sorensen F, 2006, SPINAL CORD, V44, P708, DOI 10.1038/sj.sc.3101928; Bouhadfane M, 2013, J NEUROSCI, V33, P15626, DOI 10.1523/JNEUROSCI.1483-13.2013; Boulenguez P, 2010, NAT MED, V16, P302, DOI 10.1038/nm.2107; Boulenguez P, 2009, CURR OPIN NEUROBIOL, V19, P587, DOI 10.1016/j.conb.2009.10.005; Brocard F, 2013, NEURON, V77, P1047, DOI 10.1016/j.neuron.2013.01.026; Brocard F, 2010, NEUROSCIENTIST, V16, P139, DOI 10.1177/1073858409346339; Cifra A, 2013, NEUROSCIENTIST, V19, P137, DOI 10.1177/1073858412444932; Craner MJ, 2005, GLIA, V49, P220, DOI 10.1002/glia.20112; Croall DE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-218; Du S, 1999, EXP NEUROL, V157, P96, DOI 10.1006/exnr.1999.7041; Duflocq A, 2008, MOL CELL NEUROSCI, V39, P180, DOI 10.1016/j.mcn.2008.06.008; Fukuoka T, 2010, NEUROSCIENCE, V169, P994, DOI 10.1016/j.neuroscience.2010.05.058; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Gorassini MA, 2004, BRAIN, V127, P2247, DOI 10.1093/brain/awh243; Grossman RG, 2014, J NEUROTRAUM, V31, P239, DOI 10.1089/neu.2013.2969; Hains BC, 2007, PROG BRAIN RES, V161, P195, DOI 10.1016/S0079-6123(06)61013-3; Hama A, 2011, J NEUROTRAUM, V28, P127, DOI 10.1089/neu.2010.1539; Harvey PJ, 2006, J NEUROPHYSIOL, V96, P1171, DOI 10.1152/jn.00341.2006; Harvey PJ, 2006, J NEUROPHYSIOL, V96, P1158, DOI 10.1152/jn.01088.2005; Harvey PJ, 2006, J NEUROPHYSIOL, V96, P1141, DOI 10.1152/jn.00335.2005; Heckman CJ, 2005, MUSCLE NERVE, V31, P135, DOI 10.1002/mus.20261; HOUNSGAARD J, 1988, J PHYSIOL-LONDON, V405, P345, DOI 10.1113/jphysiol.1988.sp017336; Hunanyan AS, 2011, J NEUROPHYSIOL, V105, P1033, DOI 10.1152/jn.00810.2010; Kitzman PH, 2009, NEUROSCI LETT, V455, P150, DOI 10.1016/j.neulet.2009.03.016; Kunz S, 2004, PAIN, V110, P409, DOI 10.1016/j.pain.2004.04.031; Kuo JJ, 2006, J PHYSIOL-LONDON, V574, P819, DOI 10.1113/jphysiol.2006.107094; Lampert A, 2006, EXP BRAIN RES, V174, P660, DOI 10.1007/s00221-006-0511-x; Li X, 2007, J NEUROPHYSIOL, V97, P1236, DOI 10.1152/jn.00995.2006; Li YR, 2003, J NEUROPHYSIOL, V90, P857, DOI 10.1152/jn.00236.2003; Li YR, 2004, J NEUROPHYSIOL, V91, P767, DOI 10.1152/jn.00788.2003; Li ZH, 1996, NEUROCHEM RES, V21, P441, DOI 10.1007/BF02527708; Markgraf CG, 1998, STROKE, V29, P152, DOI 10.1161/01.STR.29.1.152; MEHDI S, 1991, TRENDS BIOCHEM SCI, V16, P150, DOI 10.1016/0968-0004(91)90058-4; Murray KC, 2011, J NEUROPHYSIOL, V105, P731, DOI 10.1152/jn.00774.2010; Murray KC, 2010, NAT MED, V16, P694, DOI 10.1038/nm.2160; Palecek J, 1999, J PHYSIOL-LONDON, V520, P485, DOI 10.1111/j.1469-7793.1999.00485.x; Ray SK, 1999, BRAIN RES, V816, P375, DOI 10.1016/S0006-8993(98)01128-7; Ray SK, 2003, CNS NEUROL DISORD-DR, V2, P173, DOI 10.2174/1568007033482887; Schoch KM, 2013, J NEUROCHEM, V125, P909, DOI 10.1111/jnc.12144; Schumacher PA, 1999, NEUROSCIENCE, V91, P733, DOI 10.1016/S0306-4522(98)00552-1; Shields DC, 2000, J NEUROSCI RES, V61, P146; Springer JE, 1997, J NEUROCHEM, V69, P1592, DOI 10.1046/j.1471-4159.1997.69041592.x; Svenningsen P, 2011, CURR OPIN NEPHROL HY, V20, P529, DOI 10.1097/MNH.0b013e328348bcc7; Tazerart S, 2008, J NEUROSCI, V28, P8577, DOI 10.1523/JNEUROSCI.1437-08.2008; Tazerart S, 2007, J NEUROPHYSIOL, V98, P613, DOI 10.1152/jn.00316.2007; Theiss RD, 2011, J NEUROPHYSIOL, V105, P2781, DOI 10.1152/jn.00570.2010; Undrovinas A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054436; Urbani A, 2000, EUR J NEUROSCI, V12, P3567, DOI 10.1046/j.1460-9568.2000.00242.x; Vallet V, 1997, NATURE, V389, P607, DOI 10.1038/39329; von Reyn CR, 2009, J NEUROSCI, V29, P10350, DOI 10.1523/JNEUROSCI.2339-09.2009; WANG KKW, 1990, TRENDS PHARMACOL SCI, V11, P139, DOI 10.1016/0165-6147(90)90060-L; Wienecke J, 2010, J NEUROPHYSIOL, V103, P761, DOI 10.1152/jn.00609.2009; Wu YC, 2013, J NEUROTRAUM, V30, P441, DOI 10.1089/neu.2012.2622; Yu CG, 2013, J NEUROTRAUM, V30, P427, DOI 10.1089/neu.2012.2561; Yu CG, 2008, J NEUROTRAUM, V25, P833, DOI 10.1089/neu.2007.0490; Zhou HY, 2012, J BIOL CHEM, V287, P33853, DOI 10.1074/jbc.M112.395830; Zijdewind I, 2012, J PHYSIOL-LONDON, V590, P1683, DOI 10.1113/jphysiol.2011.220103	60	47	49	1	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2016	22	4					404	+		10.1038/nm.4061	http://dx.doi.org/10.1038/nm.4061			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DI4GF	26974309	Green Published			2022-12-25	WOS:000373457700016
J	Gros, A; Parkhurst, MR; Tran, E; Pasetto, A; Robbins, PF; Ilyas, S; Prickett, TD; Gartner, JJ; Crystal, JS; Roberts, IM; Trebska-McGowan, K; Wunderlich, JR; Yang, JC; Rosenberg, SA				Gros, Alena; Parkhurst, Maria R.; Tran, Eric; Pasetto, Anna; Robbins, Paul F.; Ilyas, Sadia; Prickett, Todd D.; Gartner, Jared J.; Crystal, Jessica S.; Roberts, Ilana M.; Trebska-McGowan, Kasia; Wunderlich, John R.; Yang, James C.; Rosenberg, Steven A.			Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patients	NATURE MEDICINE			English	Article							ENHANCED ANTITUMOR-ACTIVITY; T-CELLS; METASTATIC MELANOMA; PD-1 BLOCKADE; TUMOR; RNA; IPILIMUMAB; ANTIGENS; TCR; IMMUNOTHERAPY	Detection of lymphocytes that target tumor-specific mutant neoantigens-derived from products encoded by mutated genes in the tumor-is mostly limited to tumor-resident lymphocytes(1,2), but whether these lymphocytes often occur in the circulation is unclear. We recently reported that intratumoral expression of the programmed cell death 1 (PD-1) receptor can guide the identification of the patient-specific repertoire of tumor-reactive CD8(+) lymphocytes that reside in the tumor3. In view of these findings, we investigated whether PD-1 expression on peripheral blood lymphocytes could be used as a biomarker to detect T cells that target neoantigens. By using a high-throughput personalized screening approach, we identified neoantigenspecific lymphocytes in the peripheral blood of three of four melanoma patients. Despite their low frequency in the circulation, we found that CD8(+) PD-1(+), but not CD8(+) PD-1-, cell populations had lymphocytes that targeted 3, 3 and 1 unique, patient-specific neoantigens, respectively. We show that neoantigen-specific T cells and gene-engineered lymphocytes expressing neoantigen-specific T cell receptors (TCRs) isolated from peripheral blood recognized autologous tumors. Notably, the tumor-antigen specificities and TCR repertoires of the circulating and tumor-infiltrating CD8(+) PD-1(+) cells appeared similar, implying that the circulating CD8(+) PD-1(+) lymphocytes could provide a window into the tumor-resident antitumor lymphocytes. Thus, expression of PD-1 identifies a diverse and patient-specific antitumor T cell response in peripheral blood, providing a novel noninvasive strategy to develop personalized therapies using neoantigen-reactive lymphocytes or TCRs to treat cancer.	[Gros, Alena; Parkhurst, Maria R.; Tran, Eric; Pasetto, Anna; Robbins, Paul F.; Ilyas, Sadia; Prickett, Todd D.; Gartner, Jared J.; Crystal, Jessica S.; Roberts, Ilana M.; Trebska-McGowan, Kasia; Wunderlich, John R.; Yang, James C.; Rosenberg, Steven A.] NCI, Surg Branch, NIH, Bldg 10, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Rosenberg, SA (corresponding author), NCI, Surg Branch, NIH, Bldg 10, Bethesda, MD 20892 USA.	SAR@nih.gov	Gros, Alena/AAH-2007-2019; Pasetto, Anna/K-6430-2012; Pasetto, Anna/AAD-6141-2019	Pasetto, Anna/0000-0002-5254-2173; Gros, Alena/0000-0002-1207-1880; Balmana, Judith/0000-0002-0762-6415	Center for Cancer Research intramural research program of the NCI, US National Institutes of Health (NIH); NATIONAL CANCER INSTITUTE [ZICBC010948, ZIABC011337, ZIABC010984, ZICBC011030] Funding Source: NIH RePORTER	Center for Cancer Research intramural research program of the NCI, US National Institutes of Health (NIH); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Center for Cancer Research intramural research program of the NCI, US National Institutes of Health (NIH). We thank the members of the Surgery branch for helpful discussions, R. Somerville and members of the tumor-infiltrating lymphocytes (TIL) lab for technical support, and L. Liu for kindly providing the PD-1-specific AMP-514 antibody. This work used the computational resources of the NIH High-Performance Computing (HPC) Biowulf cluster (http://hpc.nih.gov).	Ahmadzadeh M, 2009, BLOOD, V114, P1537, DOI 10.1182/blood-2008-12-195792; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; Bai Y, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-325; Baitsch L, 2011, J CLIN INVEST, V121, P2350, DOI 10.1172/JCI46102; Carreno BM, 2015, SCIENCE, V348, P803, DOI 10.1126/science.aaa3828; Cohen CJ, 2007, CANCER RES, V67, P3898, DOI 10.1158/0008-5472.CAN-06-3986; Cohen CJ, 2006, CANCER RES, V66, P8878, DOI 10.1158/0008-5472.CAN-06-1450; Cohen CJ, 2015, J CLIN INVEST, V125, P3981, DOI 10.1172/JCI82416; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Gros A, 2014, J CLIN INVEST, V124, P2246, DOI [10.1172/JC173639, 10.1172/JCI73639]; Haga-Friedman A, 2012, J IMMUNOL, V188, P5538, DOI 10.4049/jimmunol.1103020; Hamid O, 2013, NEW ENGL J MED, V369, P134, DOI 10.1056/NEJMoa1305133; Inozume T, 2010, J IMMUNOTHER, V33, P956, DOI 10.1097/CJI.0b013e3181fad2b0; Larkin J, 2015, NEW ENGL J MED, V373, P23, DOI [10.1056/NEJMc1509660, 10.1056/NEJMoa1504030]; Le DT, 2015, NEW ENGL J MED, V372, P2509, DOI 10.1056/NEJMoa1500596; Lee HB, 2015, CANCER CYTOPATHOL, V123, P669, DOI 10.1002/cncy.21599; Lennerz V, 2005, P NATL ACAD SCI USA, V102, P16013, DOI 10.1073/pnas.0500090102; Linnemann C, 2015, NAT MED, V21, P81, DOI 10.1038/nm.3773; Linnemann C, 2013, NAT MED, V19, P1534, DOI 10.1038/nm.3359; Lohr JG, 2014, NAT BIOTECHNOL, V32, P479, DOI 10.1038/nbt.2892; Lu YC, 2014, CLIN CANCER RES, V20, P3401, DOI 10.1158/1078-0432.CCR-14-0433; Murtaza M, 2013, NATURE, V497, P108, DOI 10.1038/nature12065; Nielsen JS, 2010, J IMMUNOL METHODS, V360, P149, DOI 10.1016/j.jim.2010.07.003; Postow MA, 2015, NEW ENGL J MED, V372, P2006, DOI 10.1056/NEJMoa1414428; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Robbins PF, 2013, NAT MED, V19, P747, DOI 10.1038/nm.3161; ROSENBERG SA, 1994, JAMA-J AM MED ASSOC, V271, P907, DOI 10.1001/jama.271.12.907; Rosenberg SA, 2015, SCIENCE, V348, P62, DOI 10.1126/science.aaa4967; Rosenberg SA, 2011, CLIN CANCER RES, V17, P4550, DOI 10.1158/1078-0432.CCR-11-0116; Schumacher TN, 2015, SCIENCE, V348, P69, DOI 10.1126/science.aaa4971; Snyder A, 2014, NEW ENGL J MED, V371, P2189, DOI 10.1056/NEJMoa1406498; Topalian SL, 2014, J CLIN ONCOL, V32, P1020, DOI 10.1200/JCO.2013.53.0105; Tran E, 2014, SCIENCE, V344, P641, DOI 10.1126/science.1251102; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Van Allen EM, 2014, NAT MED, V20, P682, DOI 10.1038/nm.3559; van Rooij N, 2013, J CLIN ONCOL, V31, pE439, DOI 10.1200/JCO.2012.47.7521; Vita R, 2015, NUCLEIC ACIDS RES, V43, pD405, DOI 10.1093/nar/gku938; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; WU TC, 1995, P NATL ACAD SCI USA, V92, P11671, DOI 10.1073/pnas.92.25.11671	40	527	551	9	146	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2016	22	4					433	+		10.1038/nm.4051	http://dx.doi.org/10.1038/nm.4051			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DI4GF	26901407	Green Accepted			2022-12-25	WOS:000373457700020
J	Hatzios, SK; Abel, S; Martell, J; Hubbard, T; Sasabe, J; Munera, D; Clark, L; Bachovchin, DA; Qadri, F; Ryan, ET; Davis, BM; Weerapana, E; Waldor, MK				Hatzios, Stavroula K.; Abel, Soeren; Martell, Julianne; Hubbard, Troy; Sasabe, Jumpei; Munera, Diana; Clark, Lars; Bachovchin, Daniel A.; Qadri, Firdausi; Ryan, Edward T.; Davis, Brigid M.; Weerapana, Eranthie; Waldor, Matthew K.			Chemoproteomic profiling of host and pathogen enzymes active in cholera	NATURE CHEMICAL BIOLOGY			English	Article							SERINE HYDROLASE ACTIVITIES; VIBRIO-CHOLERAE; PROTEOMIC ANALYSIS; PROTEIN; IDENTIFICATION; MECHANISMS; DISCOVERY; GALACTOFURANOSE; INTELECTIN-1; SUPERFAMILY	Activity-based protein profiling (ABPP) is a chemoproteomic tool for detecting active enzymes in complex biological systems. We used ABPP to identify secreted bacterial and host serine hydrolases that are active in animals infected with the cholera pathogen Vibrio cholerae. Four V. cholerae proteases were consistently active in infected rabbits, and one, VC0157 (renamed IvaP), was also active in human choleric stool. Inactivation of IvaP influenced the activity of other secreted V. cholerae and rabbit enzymes in vivo, and genetic disruption of all four proteases increased the abundance of intelectin, an intestinal lectin, and its binding to V. cholerae in infected rabbits. Intelectin also bound to other enteric bacterial pathogens, suggesting that it may constitute a previously unrecognized mechanism of bacterial surveillance in the intestine that is inhibited by pathogen-secreted proteases. Our work demonstrates the power of activity-based proteomics to reveal host-pathogen enzymatic dialog in an animal model of infection.	[Hatzios, Stavroula K.; Abel, Soeren; Hubbard, Troy; Sasabe, Jumpei; Munera, Diana; Clark, Lars; Davis, Brigid M.; Waldor, Matthew K.] Brigham & Womens Hosp, Div Infect Dis, 75 Francis St, Boston, MA 02115 USA; [Hatzios, Stavroula K.; Abel, Soeren; Hubbard, Troy; Sasabe, Jumpei; Munera, Diana; Clark, Lars; Davis, Brigid M.; Waldor, Matthew K.] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA USA; [Hatzios, Stavroula K.; Hubbard, Troy; Sasabe, Jumpei; Munera, Diana; Clark, Lars; Davis, Brigid M.; Waldor, Matthew K.] Howard Hughes Med Inst, Boston, MA 02115 USA; [Abel, Soeren] Arctic Univ Norway, Univ Tromso UiT, Dept Pharm, Tromso, Norway; [Martell, Julianne; Weerapana, Eranthie] Boston Coll, Dept Chem, Chestnut Hill, MA 02167 USA; [Bachovchin, Daniel A.] Eli & Edythe L Broad Inst, Cambridge, MA USA; [Qadri, Firdausi] Icddr B, Dhaka, Bangladesh; [Ryan, Edward T.] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA; [Ryan, Edward T.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; UiT The Arctic University of Tromso; Boston College; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; International Centre for Diarrhoeal Disease Research (ICDDR); Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Waldor, MK (corresponding author), Brigham & Womens Hosp, Div Infect Dis, 75 Francis St, Boston, MA 02115 USA.; Waldor, MK (corresponding author), Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA USA.; Waldor, MK (corresponding author), Howard Hughes Med Inst, Boston, MA 02115 USA.; Weerapana, E (corresponding author), Boston Coll, Dept Chem, Chestnut Hill, MA 02167 USA.	eranthie@bc.edu; mwaldor@research.bwh.harvard.edu	Al, Mamun M./AAF-5850-2019; Qadri, Firdausi/AAF-4583-2019	Waldor, Matthew/0000-0003-1843-7000; Hatzios, Stavroula/0000-0001-8658-8949	National Institutes of Health [R37 AI-042347, F31 AI-120665, R01 AI-106878, U01 AI-058935, T32 DK 7477-30]; Howard Hughes Medical Institute; Charles A. King Trust Postdoctoral Fellowship Program; Bank of America; Damon Runyon Cancer Research Foundation [DRR-18-12]; Smith Family Foundation; Swiss National Science Foundation [P300P3_155287/1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI058935, R37AI042347, F31AI120665, R01AI106878] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007477] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Charles A. King Trust Postdoctoral Fellowship Program; Bank of America; Damon Runyon Cancer Research Foundation; Smith Family Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We gratefully acknowledge R. LaRocque, Y. Millet and J. Lee for reagents and technical assistance, and members of M.K.W.'s lab for helpful discussions. We also thank V. Carey for the statistical analysis of MS data and D. Bak for help formatting MS data sets. This work was supported by the National Institutes of Health (R37 AI-042347 to M.K.W., F31 AI-120665 to T.H., R01 AI-106878 and U01 AI-058935 to E.T.R., Institutional Training Grant T32 DK 7477-30 to S.K.H.), the Howard Hughes Medical Institute (M.K.W.), the Charles A. King Trust Postdoctoral Fellowship Program, Bank of America, N.A., Co-Trustee (S.K.H.), the Damon Runyon Cancer Research Foundation (DRR-18-12 to E.W.), the Smith Family Foundation (E.W.) and the Swiss National Science Foundation (P300P3_155287/1 to S.A.).	Abel S., 2015, CURR PROTOC MICROBIO, V38; Altindis E, 2014, P NATL ACAD SCI USA, V111, pE1548, DOI 10.1073/pnas.1403683111; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bachovchin DA, 2014, NAT CHEM BIOL, V10, P656, DOI [10.1038/NCHEMBIO.1578, 10.1038/nchembio.1578]; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BRACCO U, 1994, AM J CLIN NUTR, V60, p1002S, DOI 10.1093/ajcn/60.6.1002S; BRESLOW NE, 1993, J AM STAT ASSOC, V88, P9, DOI 10.1080/01621459.1993.10594284; Chalfoun NR, 2013, J BIOL CHEM, V288, P14098, DOI 10.1074/jbc.M112.429423; Cravatt BF, 2008, ANNU REV BIOCHEM, V77, P383, DOI 10.1146/annurev.biochem.75.101304.124125; Drzazga A, 2014, ACTA POL PHARM, V71, P887; Ellis CN, 2015, INFECT IMMUN, V83, P1089, DOI 10.1128/IAI.02765-14; Faruque SM, 2006, P NATL ACAD SCI USA, V103, P6350, DOI 10.1073/pnas.0601277103; Fiore AE, 1997, INFECT IMMUN, V65, P3112, DOI 10.1128/IAI.65.8.3112-3117.1997; Gadwal S, 2014, J BIOL CHEM, V289, P8288, DOI 10.1074/jbc.M113.525261; Gloeckl S, 2013, MOL MICROBIOL, V89, P676, DOI 10.1111/mmi.12306; Hatzios SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043175; Hauske P, 2009, BIOORGAN MED CHEM, V17, P2920, DOI 10.1016/j.bmc.2009.01.073; Holmes RS, 2011, CHOLESTEROL, DOI 10.1155/2011/781643; Ivarsson ME, 2012, ANGEW CHEM INT EDIT, V51, P4024, DOI 10.1002/anie.201104384; Kamat SS, 2015, NAT CHEM BIOL, V11, P164, DOI [10.1038/NCHEMBIO.1721, 10.1038/nchembio.1721]; Kidd D, 2001, BIOCHEMISTRY-US, V40, P4005, DOI 10.1021/bi002579j; KILIAN M, 1988, MICROBIOL REV, V52, P296, DOI 10.1128/MMBR.52.2.296-303.1988; Lundwall A, 2008, CELL MOL LIFE SCI, V65, P2019, DOI 10.1007/s00018-008-8024-3; Mandlik A, 2011, CELL HOST MICROBE, V10, P165, DOI 10.1016/j.chom.2011.07.007; Park BR, 2015, J BACTERIOL, V197, P1051, DOI 10.1128/JB.02329-14; Patricelli MP, 2001, PROTEOMICS, V1, P1067, DOI 10.1002/1615-9861(200109)1:9<1067::AID-PROT1067>3.0.CO;2-4; Pedersen LL, 2003, CELL MOL LIFE SCI, V60, P259, DOI 10.1007/s000180300021; Pemberton AD, 2004, J IMMUNOL, V173, P1894, DOI 10.4049/jimmunol.173.3.1894; Pride AC, 2013, MBIO, V4, DOI 10.1128/mBio.00305-13; Puri AW, 2013, BIOCHEMISTRY-US, V52, P5985, DOI 10.1021/bi400854d; Ritchie JM, 2010, MBIO, V1, DOI 10.1128/mBio.00047-10; Ritchie JM, 2009, CURR TOP MICROBIOL, V337, P37, DOI 10.1007/978-3-642-01846-6_2; Ruiz-Perez F, 2014, CELL MOL LIFE SCI, V71, P745, DOI 10.1007/s00018-013-1355-8; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Shaw DK, 2012, MOL MICROBIOL, V83, P319, DOI 10.1111/j.1365-2958.2011.07932.x; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Siezen RJ, 1997, PROTEIN SCI, V6, P501; Sikora AE, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003126; Sikora AE, 2011, J BIOL CHEM, V286, P16555, DOI 10.1074/jbc.M110.211078; Simon GM, 2010, J BIOL CHEM, V285, P11051, DOI 10.1074/jbc.R109.097600; Steuber H, 2010, CURR TOP MED CHEM, V10, P323, DOI 10.2174/156802610790725470; STROUD RM, 1977, ANNU REV BIOPHYS BIO, V6, P177, DOI 10.1146/annurev.bb.06.060177.001141; Suzuki YA, 2001, BIOCHEMISTRY-US, V40, P15771, DOI 10.1021/bi0155899; Tamayo R, 2010, INFECT IMMUN, V78, P3560, DOI 10.1128/IAI.00048-10; Tsuji S, 2001, J BIOL CHEM, V276, P23456, DOI 10.1074/jbc.M103162200; Tsuji S, 2009, GLYCOBIOLOGY, V19, P518, DOI 10.1093/glycob/cwp013; Varina M, 2008, J BACTERIOL, V190, P6589, DOI 10.1128/JB.00535-08; Venables W.N., 2002, MODERN APPL STAT S, V4th ed, DOI DOI 10.1007/978-0-387-21706-2; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Voehringer D, 2007, EXP PARASITOL, V116, P458, DOI 10.1016/j.exppara.2007.02.015; Weadge JT, 2007, BIOCHEMISTRY-US, V46, P4932, DOI 10.1021/bi700254m; Weerapana E, 2007, NAT PROTOC, V2, P1414, DOI 10.1038/nprot.2007.194; Wesener DA, 2015, NAT STRUCT MOL BIOL, V22, P603, DOI 10.1038/nsmb.3053; WOLFINGER R, 1993, J STAT COMPUT SIM, V48, P233, DOI 10.1080/00949659308811554; Wrackmeyer U, 2006, BIOCHEMISTRY-US, V45, P9188, DOI 10.1021/bi060570x; Yang RZ, 2006, AM J PHYSIOL-ENDOC M, V290, pE1253, DOI 10.1152/ajpendo.00572.2004; Yeats C, 2003, BMC MICROBIOL, V3, DOI 10.1186/1471-2180-3-3	59	38	38	5	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	APR	2016	12	4					268	+		10.1038/NCHEMBIO.2025	http://dx.doi.org/10.1038/NCHEMBIO.2025			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH2DA	26900865	Green Accepted, Green Submitted			2022-12-25	WOS:000372593200014
J	Oliverio, M; Schmidt, E; Mauer, J; Baitzel, C; Hansmeier, N; Khani, S; Konieczka, S; Pradas-Juni, M; Brodesser, S; Van, TM; Bartsch, D; Bronneke, HS; Heine, M; Hilpert, H; Tarcitano, E; Garinis, GA; Frommolt, P; Heeren, J; Mori, MA; Bruning, JC; Kornfeld, JW				Oliverio, Matteo; Schmidt, Elena; Mauer, Jan; Baitzel, Catherina; Hansmeier, Nils; Khani, Sajjad; Konieczka, Sandra; Pradas-Juni, Marta; Brodesser, Susanne; Trieu-My Van; Bartsch, Deniz; Broenneke, Hella S.; Heine, Markus; Hilpert, Hans; Tarcitano, Emilio; Garinis, George A.; Frommolt, Peter; Heeren, Joerg; Mori, Marcelo A.; Bruening, Jens C.; Kornfeld, Jan-Wilhelm			Dicer1-miR-328-Bace1 signalling controls brown adipose tissue differentiation and function	NATURE CELL BIOLOGY			English	Article							TRANSGENIC MICE; BODY-WEIGHT; OBESITY; FAT; THERMOGENESIS; WHITE; ADIPOCYTES; BIOGENESIS; REDUCTION; ABLATION	Activation of brown adipose tissue (BAT) controls energy homeostasis in rodents and humans and has emerged as an innovative strategy for the treatment of obesity and type 2 diabetes mellitus(1-4). Here we show that ageing-and obesity-associated dysfunction of brown fat coincides with global microRNA downregulation due to reduced expression of the microRNA-processing node Dicer1. Consequently, heterozygosity of Dicer1 in BAT aggravated diet-induced-obesity (DIO)-evoked deterioration of glucose metabolism. Analyses of differential microRNA expression during preadipocyte commitment and mouse models of progeria, longevity and DIO identified miR-328 as a regulator of BAT differentiation. Reducing miR-328 blocked preadipocyte commitment, whereas miR-328 overexpression instigated BAT differentiation and impaired muscle progenitor commitment-partly through silencing of the beta-secretase Bace1. Loss of Bace1 enhanced brown preadipocyte specification in vitro and was overexpressed in BAT of obese and progeroid mice. In vivo Bace1 inhibition delayed DIO-induced weight gain and improved glucose tolerance and insulin sensitivity. These experiments reveal Dicer1-miR-328-Bace1 signalling as a determinant of BAT function, and highlight the potential of Bace1 inhibition as a therapeutic approach to improve not only neurodegenerative diseases but also ageing-and obesity-associated impairments of BAT function.	[Oliverio, Matteo; Schmidt, Elena; Mauer, Jan; Baitzel, Catherina; Hansmeier, Nils; Khani, Sajjad; Konieczka, Sandra; Pradas-Juni, Marta; Bartsch, Deniz; Broenneke, Hella S.; Bruening, Jens C.; Kornfeld, Jan-Wilhelm] Max Planck Inst Metab Res, D-50931 Cologne, Germany; [Oliverio, Matteo; Schmidt, Elena; Mauer, Jan; Baitzel, Catherina; Hansmeier, Nils; Khani, Sajjad; Konieczka, Sandra; Pradas-Juni, Marta; Brodesser, Susanne; Trieu-My Van; Bartsch, Deniz; Broenneke, Hella S.; Frommolt, Peter; Bruening, Jens C.; Kornfeld, Jan-Wilhelm] Cologne Cluster Excellence Cellular Stress Respon, D-50931 Cologne, Germany; [Mauer, Jan] Cornell Univ, Dept Pharmacol, Weill Med Coll, New York, NY 10035 USA; [Heine, Markus; Heeren, Joerg] Univ Hosp Hamburg Eppendorf, Dept Biochem & Mol Cell Biol, D-20246 Hamburg, Germany; [Hilpert, Hans] F Hoffmann La Roche & Co Ltd, Discovery Chem, Pharma Res & Early Dev, CH-4070 Basel, Switzerland; [Tarcitano, Emilio; Mori, Marcelo A.] Univ Fed Sao Paulo, Dept Biophys, Sao Paulo, Brazil; [Garinis, George A.] Fdn Res & Technol Hellas FORTH Heraklion, IMBB, GR-70013 Iraklion, Greece; [Bruening, Jens C.] Univ Hosp Cologne, Ctr Endocrinol Diabet & Prevent Med CEDP, D-50937 Cologne, Germany; [Bruening, Jens C.] German Ctr Diabet Res DZD, Berlin, Germany	University of Cologne; Cornell University; University of Hamburg; University Medical Center Hamburg-Eppendorf; Roche Holding; Universidade Federal de Sao Paulo (UNIFESP); University of Cologne	Kornfeld, JW (corresponding author), Max Planck Inst Metab Res, D-50931 Cologne, Germany.; Kornfeld, JW (corresponding author), Cologne Cluster Excellence Cellular Stress Respon, D-50931 Cologne, Germany.	Jan-Wilhelm.Kornfeld@sf.rnpg.de	Garinis, George A./B-2943-2012; Mori, Marcelo A/R-2881-2018; Tarcitano, Emilio/AAI-9072-2021; Frommolt, Peter/L-9656-2016; Kornfeld, Jan-Wilhelm/AAF-1170-2019	Garinis, George A./0000-0002-3200-5004; Mori, Marcelo A/0000-0001-7112-5263; Tarcitano, Emilio/0000-0002-0684-1068; Frommolt, Peter/0000-0002-1966-8014; Kornfeld, Jan-Wilhelm/0000-0002-6802-4442; Oliverio, Matteo/0000-0002-7969-2796; Hansmeier, Nils Rouven/0000-0001-7024-5351; Mauer, Jan/0000-0002-0189-5876; Schmidt, Dr. Elena/0000-0003-0829-1423; Bartsch, Deniz/0000-0003-3299-8330	Emmy-Noether Program (DFG) [KO4728/1.1]; CECAD; Evangelisches Studienwerk Villigst; DAAD; CNPq; CAPES; FAPESP [2010/52557-0]; Leibniz Preis [BR1492/7-1]; Cologne Center for Molecular Medicine Cologne (CMMC); 'Systems Biology of Ageing Cologne' (Sybacol).	Emmy-Noether Program (DFG)(German Research Foundation (DFG)); CECAD; Evangelisches Studienwerk Villigst; DAAD(Deutscher Akademischer Austausch Dienst (DAAD)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Leibniz Preis; Cologne Center for Molecular Medicine Cologne (CMMC); 'Systems Biology of Ageing Cologne' (Sybacol).	We thank B. Hampel, A. Schauss, H. Jacobsen, J. Altmuller and J. Alber for technical assistance and A. Tarakhovsky (Rockefeller University, USA) for providing Dicer1<SUP>loxP/loxP</SUP> mice. We are grateful for Ames<SUP>df</SUP> mice from A. Bartke (Southern Illinois University School of Medicine, USA). J.-W.K., M.O., N.H. and S. Konieczka are supported by the Emmy-Noether Program (DFG; KO4728/1.1) and CECAD. E.S. is supported by Evangelisches Studienwerk Villigst. S. Khani appreciates support from DAAD. E.T. and M.A.M. are supported by CNPq, CAPES and FAPESP (2010/52557-0). J.C.B. is supported by the Leibniz Preis (BR1492/7-1), CECAD, Cologne Center for Molecular Medicine Cologne (CMMC) and through financial support from 'Systems Biology of Ageing Cologne' (Sybacol).	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartelt A, 2014, NAT REV ENDOCRINOL, V10, P24, DOI 10.1038/nrendo.2013.204; Bartelt A, 2011, NAT MED, V17, P200, DOI 10.1038/nm.2297; Belgardt BF, 2010, P NATL ACAD SCI USA, V107, P6028, DOI 10.1073/pnas.1001796107; Boissonneault V, 2009, J BIOL CHEM, V284, P1971, DOI 10.1074/jbc.M807530200; Cannon B, 2009, P NUTR SOC, V68, P401, DOI 10.1017/S0029665109990255; Carthew RW, 2006, CURR OPIN GENET DEV, V16, P203, DOI 10.1016/j.gde.2006.02.012; Chen Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2742; Engblom D, 2007, GENE DEV, V21, P1157, DOI 10.1101/gad.426007; Feldmann HM, 2009, CELL METAB, V9, P203, DOI 10.1016/j.cmet.2008.12.014; Gao J, 2014, J CELL BIOL, V207, P213, DOI 10.1083/jcb.201403129; Guerra C, 2001, J CLIN INVEST, V108, P1205, DOI 10.1172/JCI200113103; Hilpert H, 2013, J MED CHEM, V56, P3980, DOI 10.1021/jm400225m; Ho L, 2004, FASEB J, V18, P902, DOI 10.1096/fj.03-0978fje; Kajimura S, 2010, CELL METAB, V11, P257, DOI 10.1016/j.cmet.2010.03.005; Kajimura S, 2009, NATURE, V460, P1154, DOI 10.1038/nature08262; KENNEDY GC, 1953, PROC R SOC SER B-BIO, V140, P578, DOI 10.1098/rspb.1953.0009; Kopecky J, 1996, AM J PHYSIOL-ENDOC M, V270, pE768, DOI 10.1152/ajpendo.1996.270.5.E768; Kornfeld JW, 2013, NATURE, V494, P111, DOI 10.1038/nature11793; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; LOWELL BB, 1993, NATURE, V366, P740, DOI 10.1038/366740a0; Mattson MP, 2010, AGEING RES REV, V9, P69, DOI 10.1016/j.arr.2009.11.004; Meakin PJ, 2012, BIOCHEM J, V441, P285, DOI 10.1042/BJ20110512; Mori MA, 2014, J CLIN INVEST, V124, P3339, DOI 10.1172/JCI73468; Mori MA, 2012, CELL METAB, V16, P336, DOI 10.1016/j.cmet.2012.07.017; Mudhasani R, 2011, J CELL PHYSIOL, V226, P1399, DOI 10.1002/jcp.22475; Ohno H, 2013, NATURE, V504, P163, DOI 10.1038/nature12652; Rogers NH, 2012, AGING CELL, V11, P1074, DOI 10.1111/acel.12010; Rupaimoole R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6202; Schulz TJ, 2013, NATURE, V495, P379, DOI 10.1038/nature11943; Shimizu I, 2014, J CLIN INVEST, V124, P2099, DOI 10.1172/JCI71643; Sun L, 2011, NAT CELL BIOL, V13, P958, DOI 10.1038/ncb2286; Trajkovski M, 2012, NAT CELL BIOL, V14, P1330, DOI 10.1038/ncb2612; Turpin SM, 2014, CELL METAB, V20, P678, DOI 10.1016/j.cmet.2014.08.002; van den Beucken T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6203; Vignini A, 2013, CURR DIABETES REV, V9, P218, DOI 10.2174/1573399811309030003; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Yoneshiro T, 2013, J CLIN INVEST, V123, P3404, DOI 10.1172/JCI67803	38	63	65	1	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2016	18	3					328	+		10.1038/ncb3316	http://dx.doi.org/10.1038/ncb3316			20	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	DF0LT	26900752				2022-12-25	WOS:000371031300014
J	Oxnard, GR				Oxnard, Geoffrey R.			The cellular origins of drug resistance in cancer	NATURE MEDICINE			English	Editorial Material							MUTANT LUNG-CANCER; EGFR T790M; AZD9291	Two new studies show that mechanisms of acquired resistance to targeted therapy in lung cancer do not necessarily pre-exist in resistant subclones. Instead, some cancers may harbor the potential to acquire a variety of drug-resistance mechanisms after response to targeted therapy.	[Oxnard, Geoffrey R.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Lowe Ctr Thorac Oncol, 44 Binney St, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Oxnard, GR (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Lowe Ctr Thorac Oncol, 44 Binney St, Boston, MA 02115 USA.	geoffrey_oxnard@dfci.harvard.edu	Oxnard, Geoffrey R./HCH-4397-2022					Arcila ME, 2011, CLIN CANCER RES, V17, P1169, DOI 10.1158/1078-0432.CCR-10-2277; Chmielecki J, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002356; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Hata AN, 2016, NAT MED, V22, P262, DOI 10.1038/nm.4040; Janne PA, 2015, NEW ENGL J MED, V372, P1689, DOI 10.1056/NEJMoa1411817; Oxnard GR, 2014, CLIN CANCER RES, V20, P1698, DOI 10.1158/1078-0432.CCR-13-2482; Ramirez M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10690; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Thress KS, 2015, NAT MED, V21, P560, DOI 10.1038/nm.3854; Tricker EM, 2015, CANCER DISCOV, V5, P960, DOI 10.1158/2159-8290.CD-15-0063; Ye X, 2013, J THORAC ONCOL, V8, P1118, DOI 10.1097/JTO.0b013e31829f691f; Zhou WJ, 2009, NATURE, V462, P1070, DOI 10.1038/nature08622	12	47	49	1	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2016	22	3					232	234		10.1038/nm.4058	http://dx.doi.org/10.1038/nm.4058			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DF6DC	26937615				2022-12-25	WOS:000371445100007
J	Fritsche, LG; Igl, W; Bailey, JNC; Grassmann, F; Sengupta, S; Bragg-Gresham, JL; Burdon, KP; Hebbring, SJ; Wen, C; Gorski, M; Kim, IK; Cho, D; Zack, D; Souied, E; Scholl, HPN; Bala, E; Lee, KE; Hunter, DJ; Sardell, RJ; Mitchell, P; Merriam, JE; Cipriani, V; Hoffman, JD; Schick, T; Lechanteur, YTE; Guymer, RH; Johnson, MP; Jiang, YD; Stanton, CM; Buitendijk, GHS; Zhan, XW; Kwong, AM; Boleda, A; Brooks, M; Gieser, L; Ratnapriya, R; Branham, KE; Foerster, JR; Heckenlively, JR; Othman, MI; Vote, BJ; Liang, HH; Souzeau, E; McAllister, IL; Isaacs, T; Hall, J; Lake, S; Mackey, DA; Constable, IJ; Craig, JE; Kitchner, TE; Yang, ZL; Su, ZG; Luo, HR; Chen, D; Hong, OY; Flagg, K; Lin, D; Mao, GP; Ferreyra, H; Starke, K; von Strachwitz, CN; Wolf, A; Brandl, C; Rudolph, G; Olden, M; Morrison, MA; Morgan, DJ; Schu, M; Ahn, J; Silvestri, G; Tsironi, EE; Park, KH; Farrer, LA; Orlin, A; Brucker, A; Li, MY; Curcio, CA; Mohand-Said, S; Sahel, JM; Audo, I; Benchaboune, M; Cree, AJ; Rennie, CA; Goverdhan, SV; Grunin, M; Hagbi-Levi, S; Campochiaro, P; Katsanis, N; Holz, FG; Blond, F; Blanche, H; Deleuze, JF; Igo, RP; Truitt, B; Peachey, NS; Meuer, SM; Myers, CE; Moore, EL; Klein, R; Hauser, MA; Postel, EA; Courtenay, MD; Schwartz, SG; Kovach, JL; Scott, WK; Liew, G; Tan, AG; Gopinath, B; Merriam, JC; Smith, RT; Khan, JC; Shahid, H; Moore, AT; McGrath, JA; Laux, R; Brantley, MA; Agarwal, A; Ersoy, L; Caramoy, A; Langmann, T; Saksens, NTM; de Jong, EK; Hoyng, CB; Cain, MS; Richardson, AJ; Martin, TM; Blangero, J; Weeks, DE; Dhillon, B; van Duijn, CM; Doheny, KF; Romm, J; Klaver, CCW; Hayward, C; Gorin, MB; Klein, ML; Baird, PN; den Hollander, AI; Fauser, S; Yates, JRW; Allikmets, R; Wang, JJ; Schaumberg, DA; Klein, BEK; Hagstrom, SA; Chowers, I; Lotery, AJ; Leveillard, T; Zhang, K; Brilliant, MH; Hewitt, AW; Swaroop, A; Chew, EY; Pericak-Vance, MA; DeAngelis, M; Stambolian, D; Haines, JL; Iyengar, SK; Weber, BHF; Abecasis, GR; Heid, IM				Fritsche, Lars G.; Igl, Wilmar; Bailey, Jessica N. Cooke; Grassmann, Felix; Sengupta, Sebanti; Bragg-Gresham, Jennifer L.; Burdon, Kathryn P.; Hebbring, Scott J.; Wen, Cindy; Gorski, Mathias; Kim, Ivana K.; Cho, David; Zack, Donald; Souied, Eric; Scholl, Hendrik P. N.; Bala, Elisa; Lee, Kristine E.; Hunter, David J.; Sardell, Rebecca J.; Mitchell, Paul; Merriam, Joanna E.; Cipriani, Valentina; Hoffman, Joshua D.; Schick, Tina; Lechanteur, Yara T. E.; Guymer, Robyn H.; Johnson, Matthew P.; Jiang, Yingda; Stanton, Chloe M.; Buitendijk, Gabrielle H. S.; Zhan, Xiaowei; Kwong, Alan M.; Boleda, Alexis; Brooks, Matthew; Gieser, Linn; Ratnapriya, Rinki; Branham, Kari E.; Foerster, Johanna R.; Heckenlively, John R.; Othman, Mohammad I.; Vote, Brendan J.; Liang, Helena Hai; Souzeau, Emmanuelle; McAllister, Ian L.; Isaacs, Timothy; Hall, Janette; Lake, Stewart; Mackey, David A.; Constable, Ian J.; Craig, Jamie E.; Kitchner, Terrie E.; Yang, Zhenglin; Su, Zhiguang; Luo, Hongrong; Chen, Daniel; Hong Ouyang; Flagg, Ken; Lin, Danni; Mao, Guanping; Ferreyra, Henry; Starke, Klaus; von Strachwitz, Claudia N.; Wolf, Armin; Brandl, Caroline; Rudolph, Guenther; Olden, Matthias; Morrison, Margaux A.; Morgan, Denise J.; Schu, Matthew; Ahn, Jeeyun; Silvestri, Giuliana; Tsironi, Evangelia E.; Park, Kyu Hyung; Farrer, Lindsay A.; Orlin, Anton; Brucker, Alexander; Li, Mingyao; Curcio, Christine A.; Mohand-Said, Saddek; Sahel, Jose-Main; Audo, Isabelle; Benchaboune, Mustapha; Cree, Angela J.; Rennie, Christina A.; Goverdhan, Srinivas V.; Grunin, Michelle; Hagbi-Levi, Shira; Campochiaro, Peter; Katsanis, Nicholas; Holz, Frank G.; Blond, Frederic; Blanche, Helene; Deleuze, Jean-Francois; Igo, Robert P., Jr.; Truitt, Barbara; Peachey, Neal S.; Meuer, Stacy M.; Myers, Chelsea E.; Moore, Emily L.; Klein, Ronald; Hauser, Michael A.; Postel, Eric A.; Courtenay, Monique D.; Schwartz, Stephen G.; Kovach, Jaclyn L.; Scott, William K.; Liew, Gerald; Tan, Ava G.; Gopinath, Bamini; Merriam, John C.; Smith, R. Theodore; Khan, Jane C.; Shahid, Humma; Moore, Anthony T.; McGrath, J. Allie; Laux, Renee; Brantley, Milam A., Jr.; Agarwal, Anita; Ersoy, Lebriz; Caramoy, Albert; Langmann, Thomas; Saksens, Nicole T. M.; de Jong, Eiko K.; Hoyng, Carel B.; Cain, Melinda S.; Richardson, Andrea J.; Martin, Tammy M.; Blangero, John; Weeks, Daniel E.; Dhillon, Bal; van Duijn, Cornelia M.; Doheny, Kimberly F.; Romm, Jane; Klaver, Caroline C. W.; Hayward, Caroline; Gorin, Michael B.; Klein, Michael L.; Baird, Paul N.; den Hollander, Anneke I.; Fauser, Sascha; Yates, John R. W.; Allikmets, Rando; Wang, Jie Jin; Schaumberg, Debra A.; Klein, Barbara E. K.; Hagstrom, Stephanie A.; Chowers, Itay; Lotery, Andrew J.; Leveillard, Thierry; Zhang, Kang; Brilliant, Murray H.; Hewitt, Alex W.; Swaroop, Anand; Chew, Emily Y.; Pericak-Vance, Margaret A.; DeAngelis, Margaret; Stambolian, Dwight; Haines, Jonathan L.; Iyengar, Sudha K.; Weber, Bernhard H. F.; Abecasis, Goncalo R.; Heid, Iris M.			A large genome-wide association study of age-related macular degeneration highlights contributions of rare and common variants	NATURE GENETICS			English	Article							SEQUENCING IDENTIFIES RARE; BODY-MASS INDEX; HIGH-RISK; SUSCEPTIBILITY LOCI; DISEASE; GENE; MUTATION; BIOLOGY; OSTEOARTHRITIS; METAANALYSIS	Advanced age-related macular degeneration (AMD) is the leading cause of blindness in the elderly, with limited therapeutic options. Here we report on a study of >12 million variants, including 163,714 directly genotyped, mostly rare, protein-altering variants. Analyzing 16,144 patients and 17,832 controls, we identify 52 independently associated common and rare variants (P < 5 x 10(-8)) distributed across 34 loci. Although wet and dry AMD subtypes exhibit predominantly shared genetics, we identify the first genetic association signal specific to wet AMD, near MMP9 (difference P value = 4.1 x 10(-10)). Very rare coding variants (frequency <0.1 %) in CFH, CFI and TIMP3 suggest causal roles for these genes, as does a splice variant in SLC16A8. Our results support the hypothesis that rare coding variants can pinpoint causal genes within known genetic loci and illustrate that applying the approach systematically to detect new loci requires extremely large sample sizes.	[Fritsche, Lars G.; Sengupta, Sebanti; Bragg-Gresham, Jennifer L.; Zhan, Xiaowei; Kwong, Alan M.; Foerster, Johanna R.; Abecasis, Goncalo R.] Univ Michigan, Dept Biostat, Ctr Stat Genet, Ann Arbor, MI 48109 USA; [Igl, Wilmar; Gorski, Mathias; Starke, Klaus; Brandl, Caroline; Olden, Matthias; Heid, Iris M.] Univ Regensburg, Dept Genet Epidemiol, D-93053 Regensburg, Germany; [Bailey, Jessica N. Cooke; Igo, Robert P., Jr.; Truitt, Barbara; Laux, Renee; Haines, Jonathan L.; Iyengar, Sudha K.] Case Western Reserve Univ, Sch Med, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA; [Grassmann, Felix; Brandl, Caroline; Weber, Bernhard H. F.] Univ Regensburg, Inst Human Genet, D-93053 Regensburg, Germany; [Bragg-Gresham, Jennifer L.] Univ Michigan, Dept Internal Med Nephrol, Kidney Epidemiol & Cost Ctr, Ann Arbor, MI 48109 USA; [Burdon, Kathryn P.; Vote, Brendan J.; Mackey, David A.; Hewitt, Alex W.] Univ Tasmania, Menzies Res Inst Tasmania, Sch Med, Hobart, Tas, Australia; [Hebbring, Scott J.; Kitchner, Terrie E.; Brilliant, Murray H.] Marshfield Clin Res Fdn, Ctr Human Genet, Marshfield, WI USA; [Wen, Cindy; Chen, Daniel; Lin, Danni; Mao, Guanping] Univ Calif San Diego, Dept Ophthalmol, San Diego, CA 92103 USA; [Wen, Cindy; Luo, Hongrong; Chen, Daniel; Hong Ouyang; Flagg, Ken; Lin, Danni; Mao, Guanping; Ferreyra, Henry; Zhang, Kang] Vet Affairs San Diego Hlth Syst, La Jolla, CA USA; [Kim, Ivana K.] Harvard Univ, Sch Med, Dept Ophthalmol, Retina Serv,Massachusetts Eye & Ear, Boston, MA USA; [Cho, David; Stambolian, Dwight] Univ Penn, Dept Ophthalmol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Zack, Donald; Scholl, Hendrik P. N.; Campochiaro, Peter] Johns Hopkins Univ, Sch Med, Wilmer Eye Inst, Dept Ophthalmol, Baltimore, MD 21205 USA; [Zack, Donald] Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; [Zack, Donald; Campochiaro, Peter] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Zack, Donald] Johns Hopkins Univ, Sch Med, Inst Genet Med, Baltimore, MD USA; [Zack, Donald] Univ Paris 06, Inst Vis, Paris, France; [Souied, Eric] Univ Paris Est Creteil, Hop Henri Mondor, Hop Intercommunal Creteil, Creteil, France; [Scholl, Hendrik P. N.; Holz, Frank G.] Univ Bonn, Dept Ophthalmol, Bonn, Germany; [Bala, Elisa; Peachey, Neal S.] Louis Stokes Cleveland Vet Affairs Med Ctr, Cleveland, OH USA; [Lee, Kristine E.; Meuer, Stacy M.; Myers, Chelsea E.; Moore, Emily L.; Klein, Ronald; Klein, Barbara E. K.] Univ Wisconsin, Dept Ophthalmol & Visual Sci, Madison, WI USA; [Hunter, David J.; Schaumberg, Debra A.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Hunter, David J.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Sardell, Rebecca J.; Courtenay, Monique D.; Scott, William K.; Pericak-Vance, Margaret A.] Univ Miami, Miller Sch Med, John P Hussman Inst Human Genom, Miami, FL 33136 USA; [Mitchell, Paul; Liew, Gerald; Tan, Ava G.; Gopinath, Bamini; Wang, Jie Jin] Univ Sydney, Dept Ophthalmol, Ctr Vis Res, Sydney, NSW 2006, Australia; [Merriam, Joanna E.; Merriam, John C.; Smith, R. Theodore; Allikmets, Rando] CUNY, Dept Ophthalmol, New York, NY 10021 USA; [Cipriani, Valentina; Sahel, Jose-Main; Moore, Anthony T.; Yates, John R. W.] UCL, Inst Ophthalmol, London, England; [Cipriani, Valentina; Moore, Anthony T.; Yates, John R. W.] Moorfields Eye Hosp, London, England; [Hoffman, Joshua D.; McGrath, J. Allie] Vanderbilt Univ, Med Ctr, Ctr Human Genet Res, Nashville, TN USA; [Schick, Tina; Ersoy, Lebriz; Caramoy, Albert; Langmann, Thomas; Fauser, Sascha] Univ Hosp Cologne, Dept Ophthalmol, Cologne, Germany; [Lechanteur, Yara T. E.; Saksens, Nicole T. M.; de Jong, Eiko K.; Hoyng, Carel B.; den Hollander, Anneke I.] Radboud Univ Nijmegen, Med Ctr, Dept Ophthalmol, NL-6525 ED Nijmegen, Netherlands; [Guymer, Robyn H.; Liang, Helena Hai; Mackey, David A.; Cain, Melinda S.; Richardson, Andrea J.; Baird, Paul N.; Hewitt, Alex W.] Univ Melbourne, Royal Victorian Eye & Ear Hosp, Ctr Eye Res Australia, East Melbourne, Vic, Australia; [Johnson, Matthew P.; Blangero, John] Univ Texas Rio Grande Valley, Sch Med, South Texas Diabet & Obes Inst, Brownsville, TX USA; [Jiang, Yingda; Weeks, Daniel E.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Biostat, Pittsburgh, PA 15261 USA; [Stanton, Chloe M.; Hayward, Caroline] Univ Edinburgh, Inst Genet & Mol Med, MRC, Human Genet Unit, Edinburgh, Midlothian, Scotland; [Buitendijk, Gabrielle H. S.; Klaver, Caroline C. W.] Erasmus MC, Dept Ophthalmol, Rotterdam, Netherlands; [Buitendijk, Gabrielle H. S.; van Duijn, Cornelia M.; Klaver, Caroline C. W.] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Zhan, Xiaowei] Univ Texas SW Med Ctr Dallas, Dept Clin Sci, Quantitat Biomed Res Ctr, Dallas, TX 75390 USA; [Zhan, Xiaowei] Univ Texas SW Med Ctr Dallas, Ctr Genet Host Def, Dallas, TX 75390 USA; [Boleda, Alexis; Brooks, Matthew; Gieser, Linn; Ratnapriya, Rinki; Swaroop, Anand] NEI, N NRL, US Natl Inst Hlth, Bethesda, MD USA; [Branham, Kari E.; Heckenlively, John R.; Othman, Mohammad I.] Univ Michigan, Kellogg Eye Ctr, Dept Ophthalmol & Visual Sci, Ann Arbor, MI 48109 USA; [Souzeau, Emmanuelle; Hall, Janette; Lake, Stewart; Craig, Jamie E.] Flinders Univ S Australia, Flinders Med Ctr, Dept Ophthalmol, Adelaide, SA 5001, Australia; [McAllister, Ian L.; Isaacs, Timothy; Mackey, David A.; Constable, Ian J.; Khan, Jane C.; Hewitt, Alex W.] Univ Western Australia, Lions Eye Inst, Ctr Ophthalmol & Visual Sci, Perth, WA 6009, Australia; [Yang, Zhenglin] Hosp Univ Elect Sci & Technol China, Sichuan Prov Key Lab Human Dis Gene Study, Chengdu, Peoples R China; [Yang, Zhenglin] Sichuan Prov Peoples Hosp, Chengdu, Peoples R China; [Yang, Zhenglin] Chinese Acad Sci, Sichuan Translat Med Hosp, Chengdu, Peoples R China; [Su, Zhiguang; Zhang, Kang] Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Mol Med Res Ctr, Chengdu 610064, Peoples R China; [von Strachwitz, Claudia N.] EyeCte Southwest, Stuttgart, Germany; [Wolf, Armin; Rudolph, Guenther] Univ Munich, Univ Eye Clin, Munich, Germany; [Brandl, Caroline] Univ Hosp Regensburg, Dept Ophthalmol, Regensburg, Germany; [Morrison, Margaux A.; Morgan, Denise J.; DeAngelis, Margaret] Univ Utah, Dept Ophthalmol & Visual Sci, Salt Lake City, UT USA; [Schu, Matthew; Farrer, Lindsay A.] Boston Univ, Sch Med, Dept Med Biomed Genet, Boston, MA 02118 USA; [Schu, Matthew; Farrer, Lindsay A.] Boston Univ, Sch Publ Hlth, Dept Med Biomed Genet, Boston, MA USA; [Schu, Matthew; Farrer, Lindsay A.] Boston Univ, Sch Med, Dept Ophthalmol, Boston, MA 02118 USA; [Schu, Matthew; Farrer, Lindsay A.] Boston Univ, Sch Publ Hlth, Dept Ophthalmol, Boston, MA USA; [Schu, Matthew; Farrer, Lindsay A.] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Schu, Matthew; Farrer, Lindsay A.] Boston Univ, Sch Publ Hlth, Dept Neurol, Boston, MA 02118 USA; [Schu, Matthew; Farrer, Lindsay A.] Boston Univ, Sch Med, Dept Epidemiol, Boston, MA 02118 USA; [Schu, Matthew; Farrer, Lindsay A.] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Schu, Matthew; Farrer, Lindsay A.] Boston Univ, Sch Med, Dept Biostat, Boston, MA 02118 USA; [Schu, Matthew; Farrer, Lindsay A.] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02118 USA; [Ahn, Jeeyun] Seoul Natl Univ, Boramae Med Ctr, Seoul Metropolitan Govt, Dept Ophthalmol, Seoul, South Korea; [Silvestri, Giuliana] Queens Univ, Ctr Expt Med, Belfast, Antrim, North Ireland; [Tsironi, Evangelia E.] Univ Thessaly, Sch Med, Dept Ophthalmol, Larisa, Greece; [Park, Kyu Hyung] Seoul Natl Univ, Bundang Hosp, Dept Ophthalmol, Songnam, South Korea; [Orlin, Anton] Weill Cornell Med Coll, Dept Ophthalmol, New York, NY USA; [Brucker, Alexander] Univ Penn, Dept Ophthalmol, Perelman Sch Med, Scheie Eye Inst, Philadelphia, PA 19104 USA; [Li, Mingyao] Univ Penn, Perelman Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [Curcio, Christine A.] Univ Alabama Birmingham, Dept Ophthalmol, Birmingham, AL 35294 USA; [Mohand-Said, Saddek; Sahel, Jose-Main; Audo, Isabelle; Blond, Frederic; Leveillard, Thierry] INSERM, Paris, France; [Mohand-Said, Saddek; Sahel, Jose-Main; Audo, Isabelle; Blond, Frederic; Leveillard, Thierry] Inst Vis, Dept Genet, Paris, France; [Mohand-Said, Saddek; Sahel, Jose-Main; Audo, Isabelle; Blond, Frederic; Leveillard, Thierry] CNRS, Paris, France; [Mohand-Said, Saddek; Sahel, Jose-Main; Benchaboune, Mustapha] Ctr Hosp Natl Ophtalmol Quinze Vingts, Paris, France; [Sahel, Jose-Main] Fdn Ophtalmol Adolphe Rothschild, Paris, France; [Sahel, Jose-Main] Acad Sci, Inst France, Paris, France; [Audo, Isabelle] Inst Ophthalmol, Dept Mol Genet, London, England; [Cree, Angela J.; Goverdhan, Srinivas V.; Lotery, Andrew J.] Univ Southampton, Fac Med, Clin & Expt Sci, Southampton SO9 5NH, Hants, England; [Rennie, Christina A.] Univ Hosp Southampton, Southampton, Hants, England; [Grunin, Michelle; Hagbi-Levi, Shira; Chowers, Itay] Hadassah Hebrew Univ, Med Ctr, Dept Ophthalmol, Jerusalem, Israel; [Katsanis, Nicholas] Duke Univ, Ctr Human Dis Modeling, Durham, NC USA; [Katsanis, Nicholas] Duke Univ, Dept Cell Biol, Durham, NC USA; [Katsanis, Nicholas] Duke Univ, Dept Pediat, Durham, NC 27706 USA; [Blanche, Helene; Deleuze, Jean-Francois] Fdn Jean Dausset, CEPH, Paris, France; [Deleuze, Jean-Francois] Commissariat Energie Atom & Energies Alternat CEA, Ctr Natl Genotypage, Inst Genom, Evry, France; [Peachey, Neal S.; Hagstrom, Stephanie A.] Cleveland Clin, Cole Eye Inst, Cleveland, OH 44106 USA; [Hauser, Michael A.; Postel, Eric A.] Duke Univ, Med Ctr, Dept Ophthalmol, Durham, NC 27710 USA; [Hauser, Michael A.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Hauser, Michael A.] Duke Univ, Med Ctr, Duke Mol Physiol Inst, Durham, NC USA; [Schwartz, Stephen G.; Kovach, Jaclyn L.] Univ Miami, Miller Sch Med, Bascom Palmer Eye Inst, Naples, FL USA; [Smith, R. Theodore] NYU, Sch Med, Dept Ophthalmol, New York, NY USA; [Khan, Jane C.] Royal Perth Hosp, Dept Ophthalmol, Perth, WA 6001, Australia; [Khan, Jane C.; Shahid, Humma; Yates, John R. W.] Univ Cambridge, Cambridge Inst Med Res, Dept Med Genet, Cambridge, England; [Shahid, Humma] Cambridge Univ Hosp Natl Hlth Serv NHS Fdn Trust, Dept Ophthalmol, Cambridge, England; [Moore, Anthony T.] Univ Calif San Francisco, Sch Med, Dept Ophthalmol, San Francisco, CA USA; [Brantley, Milam A., Jr.; Agarwal, Anita] Vanderbilt Univ, Dept Ophthalmol & Visual Sci, 221 Kirkland Hall, Nashville, TN 37235 USA; [Martin, Tammy M.; Klein, Michael L.] Oregon Hlth & Sci Univ, Casey Eye Inst, Portland, OR 97201 USA; [Weeks, Daniel E.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15261 USA; [Dhillon, Bal] Univ Edinburgh, Sch Clin Sci, Edinburgh, Midlothian, Scotland; [Doheny, Kimberly F.; Romm, Jane] Johns Hopkins Univ, Sch Med, Inst Med Genet, CIDR, Baltimore, MD USA; [Gorin, Michael B.] Univ Calif Los Angeles, Jules Stein Eye Inst, David Geffen Sch Med, Dept Ophthalmol, Los Angeles, CA 90024 USA; [Gorin, Michael B.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [den Hollander, Anneke I.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 ED Nijmegen, Netherlands; [Allikmets, Rando] Columbia Univ, Dept Pathol & Cell Biol, New York, NY USA; [Schaumberg, Debra A.] Univ Utah, Sch Med, Moran Eye Ctr, Ctr Translat Med, Salt Lake City, UT USA; [Schaumberg, Debra A.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Prevent Med, Boston, MA 02115 USA; [Chew, Emily Y.] NEI, Clin Trials Branch, Div Epidemiol & Clin Applicat, US Natl Inst Hlth, Bethesda, MD 20892 USA; [Haines, Jonathan L.] Case Western Reserve Univ, Sch Med, Inst Computat Biol, Cleveland, OH 44106 USA	University of Michigan System; University of Michigan; University of Regensburg; Case Western Reserve University; University of Regensburg; University of Michigan System; University of Michigan; University of Tasmania; Menzies Institute for Medical Research; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; University of Pennsylvania; Pennsylvania Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; CHI Creteil; University of Bonn; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; University of Wisconsin System; University of Wisconsin Madison; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; University of Miami; University of Sydney; City University of New York (CUNY) System; University of London; University College London; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; Vanderbilt University; University of Cologne; Radboud University Nijmegen; Centre for Eye Research Australia; Royal Victorian Eye & Ear Hospital; University of Melbourne; University of Texas System; University of Texas Rio Grande Valley; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Edinburgh; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); University of Michigan System; University of Michigan; Flinders Medical Centre; Flinders University South Australia; Lions Eye Institute; University of Western Australia; University of Electronic Science & Technology of China; Sichuan Provincial People's Hospital; Chinese Academy of Sciences; Sichuan University; University of Munich; University of Regensburg; Utah System of Higher Education; University of Utah; Boston University; Boston University; Boston University; Boston University; Boston University; Boston University; Boston University; Boston University; Boston University; Boston University; Seoul National University (SNU); Seoul National University Hospital; Queens University Belfast; University of Thessaly; Seoul National University (SNU); Cornell University; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Alabama System; University of Alabama Birmingham; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CHNO des Quinze-Vingts; UDICE-French Research Universities; Sorbonne Universite; Fondation Adolphe de Rothschild; University of London; University College London; University of Southampton; Hebrew University of Jerusalem; Hadassah University Medical Center; Duke University; Duke University; Duke University; Foundation Jean Dausset-CEPH; CEA; UDICE-French Research Universities; Universite Paris Saclay; Cleveland Clinic Foundation; Duke University; Duke University; Duke University; Bascom Palmer Eye Institute; New York University; Royal Perth Hospital; University of Western Australia; University of Cambridge; University of California System; University of California San Francisco; Vanderbilt University; Oregon Health & Science University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Edinburgh; Johns Hopkins University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Radboud University Nijmegen; Columbia University; Utah System of Higher Education; University of Utah; Harvard University; Brigham & Women's Hospital; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); Case Western Reserve University	Abecasis, GR (corresponding author), Univ Michigan, Dept Biostat, Ctr Stat Genet, Ann Arbor, MI 48109 USA.; Heid, IM (corresponding author), Univ Regensburg, Dept Genet Epidemiol, D-93053 Regensburg, Germany.; Iyengar, SK (corresponding author), Case Western Reserve Univ, Sch Med, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA.	ski@case.edu; goncalo@umich.edu; iris.heid@klinik.uni-regensburg.de	lake, stewart/AAH-6265-2021; de Jong, Eiko/P-3407-2015; Lechanteur, Yara/ABB-6875-2020; Mackey, David A/H-5340-2014; Stark, Klaus/L-7367-2013; Chen, Daniel Shin-Yu/AGD-8923-2022; Fritsche, Lars G/AAF-9387-2019; Liew, Gerald/AAB-6870-2022; Cipriani, Valentina/A-8549-2012; Lehtimäki, Terho/AAD-1094-2022; Su, Zhiguang/AFS-0022-2022; Burdon, Kathryn/AAD-2334-2022; Souzeau, Emmanuelle/AAB-5608-2022; /S-1190-2019; Gopinath, Bamini/K-4286-2019; Cooke Bailey, Jessica Nicole/AFQ-5925-2022; Bailey, Jessica Cooke/Q-5062-2019; Léveillard, Thierry/AAR-1804-2020; Blangero, John/ABA-7175-2021; Allikmets, Rando/ABD-4533-2021; wang, jie/GRS-0942-2022; Igo, Rob/P-3438-2019; Hewitt, Alex W/D-1936-2013; Peachey, Neal/G-5533-2010; Farrer, Lindsay/AAS-1035-2020; Mitchell, Paul/P-1498-2014; Sahel, Jose-Alain/F-3172-2017; Branham, Kari/AAA-8336-2022; Burdon, Kathryn/A-5026-2009; Grunin, Michelle/O-6044-2019; Hollander, Anneke den/N-4911-2014; Klaver, Caroline C.W./A-2013-2016; Weeks, Daniel E/B-2995-2012; Wang, Jie Jin/P-1499-2014; Haines, Jonathan/C-3374-2012; Langmann, Thomas/HHZ-9814-2022; Zhang, Kang/Y-2740-2019	lake, stewart/0000-0003-0078-3319; de Jong, Eiko/0000-0001-6520-0407; Lechanteur, Yara/0000-0003-0951-4625; Mackey, David A/0000-0001-7914-4709; Stark, Klaus/0000-0002-7832-1942; Chen, Daniel Shin-Yu/0000-0001-5085-3579; Fritsche, Lars G/0000-0002-2110-1690; Cipriani, Valentina/0000-0002-0839-9955; Lehtimäki, Terho/0000-0002-2555-4427; Burdon, Kathryn/0000-0001-8217-1249; Souzeau, Emmanuelle/0000-0002-2015-6577; /0000-0001-7488-250X; Gopinath, Bamini/0000-0003-3573-359X; Cooke Bailey, Jessica Nicole/0000-0002-4001-8702; Bailey, Jessica Cooke/0000-0002-4001-8702; Léveillard, Thierry/0000-0001-5692-8770; Igo, Rob/0000-0002-0024-1993; Hewitt, Alex W/0000-0002-5123-5999; Peachey, Neal/0000-0002-4419-7226; Sahel, Jose-Alain/0000-0002-4831-1153; Burdon, Kathryn/0000-0001-8217-1249; Grunin, Michelle/0000-0002-3155-2858; Weeks, Daniel E/0000-0001-9410-7228; Wang, Jie Jin/0000-0001-9491-4898; Haines, Jonathan/0000-0002-4351-4728; Langmann, Thomas/0000-0001-6826-529X; Zhang, Kang/0000-0002-4549-1697; Baird, Paul/0000-0002-1305-3502; Guymer, Robyn/0000-0002-9441-4356; Su, Zhiguang/0000-0001-8635-9310; Farrer, Lindsay/0000-0001-5533-4225; Klaver, Caroline/0000-0002-2355-5258; Branham, Kari/0000-0002-2492-254X; smith, theodore/0000-0002-1693-943X; Tan, Ava Grace/0000-0003-3344-0339; constable, ian/0000-0002-2140-6478; Van Duijn, Cornelia/0000-0002-2374-9204; Ahn, Jeeyun/0000-0001-9017-1652; Lotery, Andrew/0000-0001-5541-4305; Weber, Bernhard H.F./0000-0002-8808-7723; Grassmann, Felix/0000-0003-1390-7528; Blond, Frederic/0000-0002-2314-0570; Hagbi-Levi, Shira/0000-0002-2891-0079; Cree, Angela/0000-0002-1987-8900; Scott, William/0000-0001-9336-6404; Kim, Ivana/0000-0003-0310-6129; Blangero, John/0000-0001-6250-5723; Audo, Isabelle/0000-0003-0698-5309; Craig, Jamie/0000-0001-9955-9696; Ratnapriya, Rinki/0000-0002-0469-4631; Brandl, Caroline/0000-0001-8223-6137; Dichgans, Martin/0000-0002-0654-387X; Schu, Matthew/0000-0003-0630-1026	Center for Inherited Diseases Research (CIDR) Program [HHSN268201200008I];  [1X01HG006934-01];  [R01 EY022310]; MRC [MC_PC_U127561128, G0000067] Funding Source: UKRI; Medical Research Council [G0000067, MC_PC_U127561128] Funding Source: researchfish; National Institute for Health Research [NF-SI-0507-10204] Funding Source: researchfish; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000427] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY022310, U10EY006594, ZIAEY000489, P30EY001583, ZIAEY000546, R01EY013435, T32EY023194] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG006389] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079626] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM080178] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [K22LM011938] Funding Source: NIH RePORTER	Center for Inherited Diseases Research (CIDR) Program; ; ; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	We thank all participants of all the studies included for enabling this research by their participation in these studies. Computer resources for this project have been provided by the high-performance computing centers of the University of Michigan and the University of Regensburg. Group-specific acknowledgments can be found in the Supplementary Note. The Center for Inherited Diseases Research (CIDR) Program contract number is HHSN268201200008I. This and the main consortium work were predominantly funded by 1X01HG006934-01 to G.R.A. and R01 EY022310 to J.L.H.	Abecasis GR, 2004, AM J HUM GENET, V74, P482, DOI 10.1086/382786; Allikmets R, 1997, SCIENCE, V277, P1805, DOI 10.1126/science.277.5333.1805; Arakawa S, 2011, NAT GENET, V43, P1001, DOI 10.1038/ng.938; Chakravarthy U, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c981; Chen W, 2010, P NATL ACAD SCI USA, V107, P7401, DOI 10.1073/pnas.0912702107; Cruchaga C, 2014, NATURE, V505, P550, DOI 10.1038/nature12825; Daniele LL, 2008, AM J PHYSIOL-CELL PH, V295, pC451, DOI 10.1152/ajpcell.00124.2008; Do R, 2015, NATURE, V518, P102, DOI 10.1038/nature13917; Do R, 2012, HUM MOL GENET, V21, pR1, DOI 10.1093/hmg/dds387; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ferris FL, 2005, ARCH OPHTHALMOL-CHIC, V123, P1570; Flannick J, 2014, NAT GENET, V46, P357, DOI 10.1038/ng.2915; Fritsche LG, 2014, ANNU REV GENOM HUM G, V15, P151, DOI 10.1146/annurev-genom-090413-025610; Fritsche LG, 2013, NAT GENET, V45, P433, DOI 10.1038/ng.2578; Fritsche LG, 2012, INVEST OPHTH VIS SCI, V53, P2112, DOI 10.1167/iovs.11-8785; Gibson G, 2012, NAT REV GENET, V13, P135, DOI 10.1038/nrg3118; Halestrap AP, 2013, MOL ASPECTS MED, V34, P337, DOI 10.1016/j.mam.2012.05.003; Helgason H, 2013, NAT GENET, V45, P1371, DOI 10.1038/ng.2740; Hollborn M, 2007, INVEST OPHTH VIS SCI, V48, P4360, DOI 10.1167/iovs.06-1234; Hussain AA, 2011, INVEST OPHTH VIS SCI, V52, P4459, DOI 10.1167/iovs.10-6678; Johansen CT, 2010, NAT GENET, V42, P684, DOI 10.1038/ng.628; Kottgen A, 2010, NAT GENET, V42, P376, DOI 10.1038/ng.568; Lambert C, 2014, ARTHRITIS RHEUMATOL, V66, P960, DOI 10.1002/art.38315; Lange LA, 2014, AM J HUM GENET, V94, P233, DOI 10.1016/j.ajhg.2014.01.010; Lee SH, 2012, BIOINFORMATICS, V28, P2540, DOI 10.1093/bioinformatics/bts474; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Logue MW, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2013.12.007; Maller JB, 2012, NAT GENET, V44, P1294, DOI 10.1038/ng.2435; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Nelson MR, 2012, SCIENCE, V337, P100, DOI 10.1126/science.1217876; Price AL, 2010, AM J HUM GENET, V86, P832, DOI 10.1016/j.ajhg.2010.04.005; Raychaudhuri S, 2011, NAT GENET, V43, P1232, DOI 10.1038/ng.976; Rivas MA, 2011, NAT GENET, V43, P1066, DOI 10.1038/ng.952; Rudnicka AR, 2012, OPHTHALMOLOGY, V119, P571, DOI 10.1016/j.ophtha.2011.09.027; Seddon JM, 2013, NAT GENET, V45, P1366, DOI 10.1038/ng.2741; SHOSHAN V, 1981, P NATL ACAD SCI-BIOL, V78, P4828, DOI 10.1073/pnas.78.8.4828; Shungin D, 2015, NATURE, V518, P187, DOI 10.1038/nature14132; Smith W, 2001, OPHTHALMOLOGY, V108, P697, DOI 10.1016/S0161-6420(00)00580-7; SORSBY A, 1949, BRIT J OPHTHALMOL, V33, P67, DOI 10.1136/bjo.33.2.67; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Stranger BE, 2012, PLOS GENET, V8, P272, DOI 10.1371/journal.pgen.1002639; Styrkarsdottir U, 2014, NAT GENET, V46, P498, DOI 10.1038/ng.2957; Styrkarsdottir U, 2013, NATURE, V497, P517, DOI 10.1038/nature12124; van de Ven JPH, 2013, NAT GENET, V45, P813, DOI 10.1038/ng.2640; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Walters RG, 2010, NATURE, V463, P671, DOI 10.1038/nature08727; WEBER BHF, 1994, NAT GENET, V7, P158, DOI 10.1038/ng0694-158; Wen XQ, 2014, BIOMETRICS, V70, P73, DOI 10.1111/biom.12112; Wong WL, 2014, LANCET GLOB HEALTH, V2, pE106, DOI 10.1016/S2214-109X(13)70145-1; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Zhan XW, 2013, NAT GENET, V45, P1375, DOI 10.1038/ng.2758; Zuk O, 2014, P NATL ACAD SCI USA, V111, pE455, DOI 10.1073/pnas.1322563111	52	761	769	5	170	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2016	48	2					134	143		10.1038/ng.3448	http://dx.doi.org/10.1038/ng.3448			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DC2JV	26691988	Green Accepted, Green Submitted			2022-12-25	WOS:000369043900010
J	Ionita-Laza, I; McCallum, K; Xu, B; Buxbaum, JD				Ionita-Laza, Iuliana; McCallum, Kenneth; Xu, Bin; Buxbaum, Joseph D.			A spectral approach integrating functional genomic annotations for coding and noncoding variants	NATURE GENETICS			English	Article							DE-NOVO MUTATIONS; ESTIMATING RELATIVE RISKS; INTELLECTUAL DISABILITY; GENETIC-VARIANTS; WHOLE-GENOME; EXOME; AUTISM; SCHIZOPHRENIA; PATTERNS; NETWORK	Over the past few years, substantial effort has been put into the functional annotation of variation in human genome sequences. Such annotations can have a critical role in identifying putatively causal variants for a disease or trait among the abundant natural variation that occurs at a locus of interest. The main challenges in using these various annotations include their large numbers and their diversity. Here we develop an unsupervised approach to integrate these different annotations into one measure of functional importance (Eigen) that, unlike most existing methods, is not based on any labeled training data. We show that the resulting meta-score has better discriminatory ability using disease-associated and putatively benign variants from published studies (in both coding and noncoding regions) than the recently proposed CADD score. Across varied scenarios, the Eigen score performs generally better than any single individual annotation, representing a powerful single functional score that can be incorporated in fine-mapping studies.	[Ionita-Laza, Iuliana; McCallum, Kenneth] Columbia Univ, Dept Biostat, New York, NY USA; [Xu, Bin] Columbia Univ, Dept Psychiat, New York, NY USA; [Buxbaum, Joseph D.] Icahn Sch Med Mt Sinai, Seaver Autism Ctr Res & Treatment, New York, NY 10029 USA; [Buxbaum, Joseph D.] Icahn Sch Med Mt Sinai, Dept Psychiat, New York, NY 10029 USA; [Buxbaum, Joseph D.] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Buxbaum, Joseph D.] Icahn Sch Med Mt Sinai, Dept Neurosci, New York, NY 10029 USA; [Buxbaum, Joseph D.] Icahn Sch Med Mt Sinai, Mindich Child Hlth & Dev Inst, New York, NY 10029 USA	Columbia University; Columbia University; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Ionita-Laza, I (corresponding author), Columbia Univ, Dept Biostat, New York, NY USA.	ii2135@columbia.edu	Buxbaum, Joseph D/G-6001-2010	Buxbaum, Joseph/0000-0001-8898-8313	US National Institutes of Health [R01 MH095797, R01 MH100233]; Seaver Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH095797] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Seaver Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by US National Institutes of Health grants R01 MH095797 and R01 MH100233 and by the Seaver Foundation. All analyses were conducted on the Minerva HPC complex at the Icahn School of Medicine at Mount Sinai.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Allen AS, 2013, NATURE, V501, P217, DOI 10.1038/nature12439; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Bamshad MJ, 2011, NAT REV GENET, V12, P745, DOI 10.1038/nrg3031; Capanu M, 2008, STAT MED, V27, P1973, DOI 10.1002/sim.3196; Capanu M, 2011, BIOMETRICS, V67, P371, DOI 10.1111/j.1541-0420.2010.01469.x; Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013; Davydov EV, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001025; de Ligt J, 2012, NEW ENGL J MED, V367, P1921, DOI 10.1056/NEJMoa1206524; Dong S, 2014, CELL REP, V9, P16, DOI 10.1016/j.celrep.2014.08.068; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Fang H, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0089-z; Farh KKH, 2015, NATURE, V518, P337, DOI 10.1038/nature13835; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; Fromer M, 2014, NATURE, V506, P179, DOI 10.1038/nature12929; Girard SL, 2011, NAT GENET, V43, P860, DOI 10.1038/ng.886; Gudbjartsson DF, 2015, NAT GENET, V47, P435, DOI 10.1038/ng.3247; Gulko B, 2015, NAT GENET, V47, P276, DOI 10.1038/ng.3196; Gulsuner S, 2013, CELL, V154, P518, DOI 10.1016/j.cell.2013.06.049; Gusev A, 2014, AM J HUM GENET, V95, P535, DOI 10.1016/j.ajhg.2014.10.004; Ionita-Laza I, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004729; Iossifov I, 2014, NATURE, V515, P216, DOI 10.1038/nature13908; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; Kichaev G, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004722; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Ko A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4983; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Lam HYK, 2012, NAT BIOTECHNOL, V30, P78, DOI 10.1038/nbt.2065; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Liu XM, 2013, HUM MUTAT, V34, pE2393, DOI 10.1002/humu.22376; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; McCarthy SE, 2014, MOL PSYCHIATR, V19, P652, DOI 10.1038/mp.2014.29; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Meyer KB, 2013, AM J HUM GENET, V93, P1046, DOI 10.1016/j.ajhg.2013.10.026; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; Ng SB, 2010, NAT GENET, V42, P790, DOI 10.1038/ng.646; O'Rawe J, 2013, GENOME MED, V5, DOI 10.1186/gm432; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Pickrell JK, 2014, AM J HUM GENET, V94, P559, DOI 10.1016/j.ajhg.2014.03.004; Rauch A, 2012, LANCET, V380, P1674, DOI 10.1016/S0140-6736(12)61480-9; Ritchie GRS, 2014, NAT METHODS, V11, P294, DOI 10.1038/nmeth.2832; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Trynka G, 2013, NAT GENET, V45, P124, DOI 10.1038/ng.2504; Xu B, 2012, NAT GENET, V44, P1365, DOI 10.1038/ng.2446; Ye CJ, 2014, SCIENCE, V345, P1311, DOI 10.1126/science.1254665; Zhang J, 2011, J GENET GENOMICS, V38, P95, DOI 10.1016/j.jgg.2011.02.003	46	310	318	0	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2016	48	2					214	220		10.1038/ng.3477	http://dx.doi.org/10.1038/ng.3477			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DC2JV	26727659	Green Accepted			2022-12-25	WOS:000369043900021
J	Palmer, AC				Palmer, Adam C.			The many genes of drug mechanism	NATURE CHEMICAL BIOLOGY			English	News Item							SENSITIVITY; IDENTIFICATION; CELLS	A small molecule's biological activity in a cell depends on the actions of many gene products. Correlations between basal gene expression and compound sensitivity across hundreds of human cell lines reveal a broad view of cellular mechanisms of action.	[Palmer, Adam C.] Harvard Univ, Sch Med, Lab Syst Pharmacol, Boston, MA USA; [Palmer, Adam C.] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia	Harvard University; Harvard Medical School; University of New South Wales Sydney	Palmer, AC (corresponding author), Harvard Univ, Sch Med, Lab Syst Pharmacol, Boston, MA USA.; Palmer, AC (corresponding author), Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia.	adam_palmer@hms.harvard.edu	Palmer, Adam/N-5495-2019; Palmer, Adam C/J-3589-2012	Palmer, Adam/0000-0001-5028-7028; Palmer, Adam C/0000-0001-5028-7028				Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Basu A, 2013, CELL, V154, P1151, DOI 10.1016/j.cell.2013.08.003; de Waal L, 2016, NAT CHEM BIOL, V12, P102, DOI [10.1038/NCHEMBIO.1984, 10.1038/nchembio.1984]; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; McDermott U, 2007, P NATL ACAD SCI USA, V104, P19936, DOI 10.1073/pnas.0707498104; NITISS JL, 1992, CANCER RES, V52, P4467; Palmer AC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5296; Rees MG, 2016, NAT CHEM BIOL, V12, P109, DOI [10.1038/NCHEMBIO.1986, 10.1038/nchembio.1986]; Schenone M, 2013, NAT CHEM BIOL, V9, P232, DOI [10.1038/NCHEMBIO.1199, 10.1038/nchembio.1199]; Seashore-Ludlow B, 2015, CANCER DISCOV, V5, P1210, DOI 10.1158/2159-8290.CD-15-0235; Yu C., 2013, US Patent, Patent No. [WO 2013138585 A1, 2013138585]	11	1	1	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	FEB	2016	12	2					57	58		10.1038/nchembio.2010	http://dx.doi.org/10.1038/nchembio.2010			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DC6GG	26784844				2022-12-25	WOS:000369317300003
J	Rees, MG; Seashore-Ludlow, B; Cheah, JH; Adams, DJ; Price, EV; Gill, S; Javaid, S; Coletti, ME; Jones, VL; Bodycombe, NE; Soule, CK; Alexander, B; Li, A; Montgomery, P; Kotz, JD; Hon, CSY; Munoz, B; Liefeld, T; Dancik, V; Haber, DA; Clish, CB; Bittker, JA; Palmer, M; Wagner, BK; Clemons, PA; Shamji, AF; Schreiber, SL				Rees, Matthew G.; Seashore-Ludlow, Brinton; Cheah, Jaime H.; Adams, Drew J.; Price, Edmund V.; Gill, Shubhroz; Javaid, Sarah; Coletti, Matthew E.; Jones, Victor L.; Bodycombe, Nicole E.; Soule, Christian K.; Alexander, Benjamin; Li, Ava; Montgomery, Philip; Kotz, Joanne D.; Hon, C. Suk-Yee; Munoz, Benito; Liefeld, Ted; Dancik, Vlado; Haber, Daniel A.; Clish, Clary B.; Bittker, Joshua A.; Palmer, Michelle; Wagner, Bridget K.; Clemons, Paul A.; Shamji, Alykhan F.; Schreiber, Stuart L.			Correlating chemical sensitivity and basal gene expression reveals mechanism of action	NATURE CHEMICAL BIOLOGY			English	Article							SMALL MOLECULES; CANCER; IDENTIFICATION; INHIBITORS; TARGET; RESISTANCE; SIGNATURE; DISCOVERY; YM155	Changes in cellular gene expression in response to small-molecule or genetic perturbations have yielded signatures that can connect unknown mechanisms of action (MoA) to ones previously established. We hypothesized that differential basal gene expression could be correlated with patterns of small-molecule sensitivity across many cell lines to illuminate the actions of compounds whose MoA are unknown. To test this idea, we correlated the sensitivity patterns of 481 compounds with similar to 19,000 basal transcript levels across 823 different human cancer cell lines and identified selective outlier transcripts. This process yielded many novel mechanistic insights, including the identification of activation mechanisms, cellular transporters and direct protein targets. We found that ML239, originally identified in a phenotypic screen for selective cytotoxicity in breast cancer stem-like cells, most likely acts through activation of fatty acid desaturase 2 (FADS2). These data and analytical tools are available to the research community through the Cancer Therapeutics Response Portal.	[Rees, Matthew G.; Seashore-Ludlow, Brinton; Cheah, Jaime H.; Adams, Drew J.; Price, Edmund V.; Gill, Shubhroz; Coletti, Matthew E.; Jones, Victor L.; Bodycombe, Nicole E.; Soule, Christian K.; Alexander, Benjamin; Li, Ava; Montgomery, Philip; Kotz, Joanne D.; Hon, C. Suk-Yee; Munoz, Benito; Liefeld, Ted; Dancik, Vlado; Clish, Clary B.; Bittker, Joshua A.; Palmer, Michelle; Wagner, Bridget K.; Clemons, Paul A.; Shamji, Alykhan F.; Schreiber, Stuart L.] Broad Inst, Cambridge, MA USA; [Javaid, Sarah; Haber, Daniel A.] Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA USA; [Seashore-Ludlow, Brinton] Karolinska Inst, Chem Biol Consortium Sweden, Div Translat Med & Chem Biol, Sci Life Lab Stockholm,Dept Med Biochem & Biophys, Solna, Sweden; [Cheah, Jaime H.; Soule, Christian K.] MIT, Koch Inst Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Adams, Drew J.] Case Western Reserve Univ, Sch Med, Dept Genet & Genome Sci, Cleveland, OH 44106 USA; [Price, Edmund V.] Novartis Inst Biomed Res, Emeryville, CA USA; [Bodycombe, Nicole E.] Pfizer, Cambridge, MA USA; [Liefeld, Ted] Univ Calif San Diego, Sch Med, La Jolla, CA 92093 USA; [Palmer, Michelle] ImmunoGen, Waltham, MA USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Karolinska Institutet; Massachusetts Institute of Technology (MIT); Case Western Reserve University; Novartis; Pfizer; University of California System; University of California San Diego	Clemons, PA; Shamji, AF; Schreiber, SL (corresponding author), Broad Inst, Cambridge, MA USA.		Seashore-Ludlow, Brinton/E-2309-2017; Clish, Clary B/ABB-9374-2021; Clish, Clary/AAB-7124-2019; Alexander, Benjamin/M-7471-2015	Seashore-Ludlow, Brinton/0000-0001-8658-5967; Clish, Clary B/0000-0001-8259-9245; Alexander, Benjamin/0000-0002-0960-6119; Price, Edmund/0000-0001-6495-4725	US National Cancer Institute's Cancer Target Discovery and Development (CTD2) Network [U01CA176152]; NATIONAL CANCER INSTITUTE [U01CA176152] Funding Source: NIH RePORTER	US National Cancer Institute's Cancer Target Discovery and Development (CTD2) Network; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the US National Cancer Institute's Cancer Target Discovery and Development (CTD2) Network (grant number U01CA176152, awarded to S.L.S.). We acknowledge the following colleagues and centers for contributing compounds and for valuable critique: Boston University, J. Bradner, P. Brown, C. Chen, J. Clardy, CNIO (Spanish National Cancer Research Center), E.J. Corey, the Drug Synthesis and Chemistry Branch (Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute), Eutropics, J. Gutterman, E. Holson, Karyopharm, M. Meyerson, A. Myers, J. Porco, J. Qi, Sanford-Burnham, M. Serrano-Wu, M. Shair, B. Stockwell, L. Walensky, X. Wang and D. Zaharevitz. We thank A. Deik for conducting lipid profiling measurements; S. Chattopadhay, J. Law, G. Schaefer, M. Stewart, V. Viswanathan and other members of the Schreiber laboratory for advice and helpful discussions; S. Wang for helping curate the Informer Set; K. Emmith, J. Aseidu and the CSofT informatics group for development and support of cell-line and data-tracking software; A. Vrcic and the Broad Compound Management team for handling the Informer Set; J. Boehm, A. Tsherniak, A. Aguirre and the Broad Cancer Program for training and advice; the Broad Biological Samples Platform for providing CCLs; and L. Garraway and the Broad-Novartis Cancer Cell Line Encyclopedia (CCLE) team. S.L.S. is an Investigator of the Howard Hughes Medical Institute.	Adams DJ, 2014, ACS CHEM BIOL, V9, P2247, DOI 10.1021/cb500347p; Adams DJ, 2013, ACS CHEM BIOL, V8, P923, DOI 10.1021/cb300653v; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Basu A, 2013, CELL, V154, P1151, DOI 10.1016/j.cell.2013.08.003; Benetatos CA, 2014, MOL CANCER THER, V13, P867, DOI 10.1158/1535-7163.MCT-13-0798; Byers LA, 2013, CLIN CANCER RES, V19, P279, DOI 10.1158/1078-0432.CCR-12-1558; Catala A, 2009, CHEM PHYS LIPIDS, V157, P1, DOI 10.1016/j.chemphyslip.2008.09.004; Chen C, 2009, J PHARMACOL EXP THER, V329, P908, DOI 10.1124/jpet.109.152017; Cowley GS, 2014, SCI DATA, V1, DOI 10.1038/sdata.2014.35; Dancik V, 2014, J BIOMOL SCREEN, V19, P771, DOI 10.1177/1087057113520226; Fischer ES, 2014, NATURE, V512, P49, DOI 10.1038/nature13527; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Gamage N, 2006, TOXICOL SCI, V90, P5, DOI 10.1093/toxsci/kfj061; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Germain AR, 2012, BIOORG MED CHEM LETT, V22, P3571, DOI 10.1016/j.bmcl.2012.01.035; Glaros TG, 2012, CANCER CHEMOTH PHARM, V70, P207, DOI 10.1007/s00280-012-1868-0; Guo WC, 2005, CANCER RES, V65, P10006, DOI 10.1158/0008-5472.CAN-05-2029; Haibe-Kains B, 2013, NATURE, V504, P389, DOI 10.1038/nature12831; Hughes JP, 2011, BRIT J PHARMACOL, V162, P1239, DOI 10.1111/j.1476-5381.2010.01127.x; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Javaid S, 2013, CELL REP, V5, P1679, DOI 10.1016/j.celrep.2013.11.034; Kamath AV, 2005, CANCER CHEMOTH PHARM, V55, P110, DOI 10.1007/s00280-004-0873-3; Lafite P, 2007, ARCH BIOCHEM BIOPHYS, V464, P155, DOI 10.1016/j.abb.2007.03.028; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Long JZ, 2009, NAT CHEM BIOL, V5, P37, DOI 10.1038/nchembio.129; Marks KM, 2011, J NAT PROD, V74, P567, DOI 10.1021/np100429s; Nakahara T, 2007, CANCER RES, V67, P8014, DOI 10.1158/0008-5472.CAN-07-1343; Nomura DK, 2010, CELL, V140, P49, DOI 10.1016/j.cell.2009.11.027; Obukowicz MG, 1998, BIOCHEM PHARMACOL, V55, P1045, DOI 10.1016/S0006-2952(97)00665-5; Palmer AC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5296; Papillon-Cavanagh S, 2013, J AM MED INFORM ASSN, V20, P597, DOI 10.1136/amiajnl-2012-001442; Park WJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028186; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Rivera MI, 1999, BIOCHEM PHARMACOL, V57, P1283, DOI 10.1016/S0006-2952(99)00046-5; Salt MB, 2014, CANCER DISCOV, V4, P186, DOI 10.1158/2159-8290.CD-13-0520; Schenone M, 2013, NAT CHEM BIOL, V9, P232, DOI [10.1038/NCHEMBIO.1199, 10.1038/nchembio.1199]; Shoemaker RH, 2006, NAT REV CANCER, V6, P813, DOI 10.1038/nrc1951; Sprecher H, 2000, BBA-MOL CELL BIOL L, V1486, P219, DOI 10.1016/S1388-1981(00)00077-9; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Swinney DC, 2011, NAT REV DRUG DISCOV, V10, P507, DOI 10.1038/nrd3480; Taube JH, 2010, P NATL ACAD SCI USA, V107, P15449, DOI 10.1073/pnas.1004900107; Vance J., 2002, NEW COMPR BIOCH, P233, DOI 10.1016/S0167-7306(02)36011-3; Winter GE, 2014, NAT CHEM BIOL, V10, P768, DOI [10.1038/NCHEMBIO.1590, 10.1038/nchembio.1590]; Yang WS, 2014, CELL, V156, P317, DOI 10.1016/j.cell.2013.12.010; Yang XP, 2011, NAT METHODS, V8, P659, DOI [10.1038/NMETH.1638, 10.1038/nmeth.1638]; Young LC, 1999, CLIN CANCER RES, V5, P673; Yu C., 2013, US Patent, Patent No. [WO 2013138585 A1, 2013138585]; Zhai D, 2006, CELL DEATH DIFFER, V13, P1419, DOI 10.1038/sj.cdd.4401937; Zoppoli G, 2012, P NATL ACAD SCI USA, V109, P15030, DOI 10.1073/pnas.1205943109	49	374	375	1	63	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	FEB	2016	12	2					109	+		10.1038/NCHEMBIO.1986	http://dx.doi.org/10.1038/NCHEMBIO.1986			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DC6GG	26656090	Green Accepted, Green Submitted			2022-12-25	WOS:000369317300014
J	Anikeeva, P				Anikeeva, Polina			Optogenetics unleashed	NATURE BIOTECHNOLOGY			English	Editorial Material							WIRELESS; BRAIN	Two recent studies report the development of miniaturized, fully-implantable devices that enable wireless optogenetic neuromodulation in peripheral nerves and spinal cord.	[Anikeeva, Polina] MIT, Dept Mat Sci & Engn & Res Lab Elect, 77 Massachusetts Ave, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Anikeeva, P (corresponding author), MIT, Dept Mat Sci & Engn & Res Lab Elect, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	anikeeva@mit.edu						Agudo J, 2015, NAT BIOTECHNOL, V33, P1287, DOI 10.1038/nbt.3386; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Bruegmann T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8153; Jeong JW, 2015, CELL, V162, P662, DOI 10.1016/j.cell.2015.06.058; Kim TI, 2013, SCIENCE, V340, P211, DOI 10.1126/science.1232437; Lee ST, 2015, IEEE T NEUR SYS REH, V23, P655, DOI 10.1109/TNSRE.2015.2391282; Magown P, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9506; Montgomery KL, 2015, NAT METHODS, V12, P969, DOI [10.1038/NMETH.3536, 10.1038/nmeth.3536]; Nussinovitch U, 2015, NAT BIOTECHNOL, V33, P750, DOI 10.1038/nbt.3268; Yeh AJ, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4825272; Yizhar O, 2011, NEURON, V71, P9, DOI 10.1016/j.neuron.2011.06.004	11	5	5	0	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2016	34	1					43	44		10.1038/nbt.3458	http://dx.doi.org/10.1038/nbt.3458			2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DB8HQ	26744980				2022-12-25	WOS:000368758200023
J	Fu, JY; Lipinszki, Z; Rangone, H; Min, MW; Mykura, C; Chao-Chu, J; Schneider, S; Dzhindzhev, NS; Gottardo, M; Riparbelli, MG; Callaini, G; Glover, DM				Fu, Jingyan; Lipinszki, Zoltan; Rangone, Helene; Min, Mingwei; Mykura, Charlotte; Chao-Chu, Jennifer; Schneider, Sandra; Dzhindzhev, Nikola S.; Gottardo, Marco; Riparbelli, Maria Giovanna; Callaini, Giuliano; Glover, David M.			Conserved molecular interactions in centriole-to-centrosome conversion	NATURE CELL BIOLOGY			English	Article							PERICENTRIOLAR MATERIAL; DROSOPHILA EMBRYOS; 9-FOLD SYMMETRY; BASAL BODY; CELL-CYCLE; PROTEIN; DUPLICATION; PLK4; RECRUITMENT; BIOGENESIS	Centrioles are required to assemble centrosomes for cell division and cilia for motility and signalling. New centrioles assemble perpendicularly to pre-existing ones in G1-S and elongate throughout S and G2. Fully elongated daughter centrioles are converted into centrosomes during mitosis to be able to duplicate and organize pericentriolar material in the next cell cycle. Here we show that centriole-to-centrosome conversion requires sequential loading of Cep135, Ana1 (Cep295) and Asterless (Cep152) onto daughter centrioles during mitotic progression in both Drosophila melanogaster and human. This generates a molecular network spanning from the inner-to outermost parts of the centriole. Ana1 forms a molecular strut within the network, and its essential role can be substituted by an engineered fragment providing an alternative linkage between Asterless and Cep135. This conserved architectural framework is essential for loading Asterless or Cep152, the partner of the master regulator of centriole duplication, Plk4. Our study thus uncovers the molecular basis for centriole-to-centrosome conversion that renders daughter centrioles competent for motherhood.	[Fu, Jingyan; Lipinszki, Zoltan; Rangone, Helene; Min, Mingwei; Mykura, Charlotte; Chao-Chu, Jennifer; Schneider, Sandra; Dzhindzhev, Nikola S.; Glover, David M.] Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England; [Gottardo, Marco; Riparbelli, Maria Giovanna; Callaini, Giuliano] Univ Siena, Dept Life Sci, I-53100 Siena, Italy	University of Cambridge; University of Siena	Fu, JY (corresponding author), Univ Cambridge, Dept Genet, Downing St, Cambridge CB2 3EH, England.	jf453@cam.ac.uk	Lipinszki, Zoltan/AAI-9548-2021; MIN, MINGWEI/Y-8296-2019; Gottardo, Marco/G-7801-2018; Callaini, Giuliano/T-6353-2018; Lipinszki, Zoltan/I-6739-2012	Lipinszki, Zoltan/0000-0002-2067-0832; MIN, MINGWEI/0000-0002-9050-5330; Gottardo, Marco/0000-0001-8649-7799; Callaini, Giuliano/0000-0003-2252-0309; Lipinszki, Zoltan/0000-0002-2067-0832; Fu, Jingyan/0000-0002-5896-8132; Dzhindzhev, Nikola/0000-0001-9866-3600; Glover, David/0000-0003-0956-0103	Cancer Research UK; MRC Programme Grant; British Academy; Royal Society; Federation of European Biochemical Societies; Cancer Research UK [11431, 18795] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); MRC Programme Grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Academy; Royal Society(Royal Society of London); Federation of European Biochemical Societies; Cancer Research UK(Cancer Research UK)	J.F., Z.L., S.S. and N.S.D. are supported by a Programme Grant to D.M.G. from Cancer Research UK. H.R. is supported by an MRC Programme Grant to D.M.G. J.F. thanks the British Academy and the Royal Society for the Newton International Fellowship and Z.L. thanks the Federation of European Biochemical Societies for the Long-Term postdoctoral Fellowship. The authors thank N. Lawrence and A. Sossick for assistance with 3D-SIM.	Avidor-Reiss T, 2015, FRONT CELL DEV BIOL, V3, DOI 10.3389/fcell.2015.00021; Bettencourt-Dias M, 2005, CURR BIOL, V15, P2199, DOI 10.1016/j.cub.2005.11.042; Blachon S, 2009, GENETICS, V182, P133, DOI 10.1534/genetics.109.101709; Bornens M, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0452; Carvalho-Santos Z, 2012, DEV CELL, V23, P412, DOI 10.1016/j.devcel.2012.06.001; Carvalho-Santos Z, 2010, J CELL SCI, V123, P1414, DOI 10.1242/jcs.064931; Cizmecioglu O, 2010, J CELL BIOL, V191, P731, DOI 10.1083/jcb.201007107; Delgehyr N, 2012, CURR BIOL, V22, P502, DOI 10.1016/j.cub.2012.01.046; Dobbelaere J, 2008, PLOS BIOL, V6, P1975, DOI 10.1371/journal.pbio.0060224; Dzhindzhev NS, 2014, CURR BIOL, V24, P2526, DOI 10.1016/j.cub.2014.08.061; Dzhindzhev NS, 2010, NATURE, V467, P714, DOI 10.1038/nature09445; Fu JY, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a015800; Fu JY, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120104; Gopalakrishnan J, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1367; Goshima G, 2007, SCIENCE, V316, P417, DOI 10.1126/science.1141314; Grallert A, 2013, NAT CELL BIOL, V15, P88, DOI 10.1038/ncb2633; Habedanck R, 2005, NAT CELL BIOL, V7, P1140, DOI 10.1038/ncb1320; Hatch EM, 2010, J CELL BIOL, V191, P721, DOI 10.1083/jcb.201006049; Hiraki M, 2007, CURR BIOL, V17, P1778, DOI 10.1016/j.cub.2007.09.021; Izquierdo D, 2014, CELL REP, V8, P957, DOI 10.1016/j.celrep.2014.07.022; Jerka-Dziadosz M, 2010, CYTOSKELETON, V67, P161, DOI 10.1002/cm.20433; Kim K, 2008, EXP CELL RES, V314, P3692, DOI 10.1016/j.yexcr.2008.09.016; Kim TS, 2013, P NATL ACAD SCI USA, V110, pE4849, DOI 10.1073/pnas.1319656110; Kitagawa D, 2011, CELL, V144, P364, DOI 10.1016/j.cell.2011.01.008; Kleylein-Sohn J, 2007, DEV CELL, V13, P190, DOI 10.1016/j.devcel.2007.07.002; Knorz VJ, 2010, MOL BIOL CELL, V21, P3617, DOI 10.1091/mbc.E10-03-0246; Kohlmaier G, 2009, CURR BIOL, V19, P1012, DOI 10.1016/j.cub.2009.05.018; Lau L, 2012, BIOPHYS J, V102, P2926, DOI 10.1016/j.bpj.2012.05.015; Lawo S, 2012, NAT CELL BIOL, V14, P1148, DOI 10.1038/ncb2591; Lin YC, 2013, EMBO J, V32, P1141, DOI 10.1038/emboj.2013.56; Lipinszki Z, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6894; Lipinszki Z, 2014, METHODS MOL BIOL, V1170, P571, DOI 10.1007/978-1-4939-0888-2_33; Lukinaviclus G, 2013, CURR BIOL, V23, P265, DOI 10.1016/j.cub.2012.12.030; Martinez-Campos M, 2004, J CELL BIOL, V165, P673, DOI 10.1083/jcb.200402130; Mennella V, 2012, NAT CELL BIOL, V14, P1159, DOI 10.1038/ncb2597; Mottier-Pavie V, 2009, MOL BIOL CELL, V20, P2605, DOI 10.1091/mbc.E08-11-1115; Novak ZA, 2014, CURR BIOL, V24, P1276, DOI 10.1016/j.cub.2014.04.023; Ohta M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6267; Park SY, 2014, NAT STRUCT MOL BIOL, V21, P696, DOI 10.1038/nsmb.2846; Rodrigues-Martins A, 2007, SCIENCE, V316, P1046, DOI 10.1126/science.1142950; Roque H, 2012, J CELL SCI, V125, P5881, DOI 10.1242/jcs.113506; Schmidt TI, 2009, CURR BIOL, V19, P1005, DOI 10.1016/j.cub.2009.05.016; Sillibourne JE, 2011, CYTOSKELETON, V68, P619, DOI 10.1002/cm.20536; Sir JH, 2011, NAT GENET, V43, P1147, DOI 10.1038/ng.971; Sonnen KF, 2013, J CELL SCI, V126, P3223, DOI 10.1242/jcs.129502; Sonnen KF, 2012, BIOL OPEN, V1, P965, DOI 10.1242/bio.20122337; Tang CJC, 2009, NAT CELL BIOL, V11, P825, DOI 10.1038/ncb1889; van Breugel M, 2011, SCIENCE, V331, P1196, DOI 10.1126/science.1199325; Varmark H, 2007, CURR BIOL, V17, P1735, DOI 10.1016/j.cub.2007.09.031; Wang WJ, 2011, J CELL BIOL, V193, P727, DOI 10.1083/jcb.201101109	50	80	82	0	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2016	18	1					87	+		10.1038/ncb3274	http://dx.doi.org/10.1038/ncb3274			15	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CZ3VA	26595382	Green Accepted			2022-12-25	WOS:000367030900015
J	Kuleshov, V; Jiang, C; Zhou, WY; Jahanbani, F; Batzoglou, S; Snyder, M				Kuleshov, Volodymyr; Jiang, Chao; Zhou, Wenyu; Jahanbani, Fereshteh; Batzoglou, Serafim; Snyder, Michael			Synthetic long-read sequencing reveals intraspecies diversity in the human microbiome	NATURE BIOTECHNOLOGY			English	Article							GENOME; IDENTIFICATION; METAGENOMES; ASSEMBLIES; DROSOPHILA; COVERAGE; DATABASE; RARE	Identifying bacterial strains in metagenome and microbiome samples using computational analyses of short-read sequences remains a difficult problem. Here, we present an analysis of a human gut microbiome using TruSeq synthetic long reads combined with computational tools for metagenomic long-read assembly, variant calling and haplotyping (Nanoscope and Lens). Our analysis identifies 178 bacterial species, of which 51 were not found using shotgun reads alone. We recover bacterial contigs that comprise multiple operons, including 22 contigs of >1 Mbp. Furthermore, we observe extensive intraspecies variation within microbial strains in the form of haplotypes that span up to hundreds of Kbp. Incorporation of synthetic long-read sequencing technology with standard short-read approaches enables more precise and comprehensive analyses of metagenomic samples.	[Kuleshov, Volodymyr; Batzoglou, Serafim] Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA; [Kuleshov, Volodymyr; Jiang, Chao; Zhou, Wenyu; Jahanbani, Fereshteh; Snyder, Michael] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA	Stanford University; Stanford University	Kuleshov, V; Batzoglou, S (corresponding author), Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA.; Kuleshov, V; Batzoglou, S (corresponding author), Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA.	kuleshov@stanford.edu; serafim@cs.stanford.edu; mpsnyder@stanford.edu	Jiang, Chao/AAG-2439-2021	Jiang, Chao/0000-0003-0260-7271; Snyder, Michael/0000-0003-0784-7987	US National Institutes of Health/National Human Genome Research Institute (NIH/NHGRI) [T32 HG000044]; Natural Sciences and Engineering Research Council of Canada (NSERC); NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000044] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U54DK102556] Funding Source: NIH RePORTER	US National Institutes of Health/National Human Genome Research Institute (NIH/NHGRI); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by US National Institutes of Health/National Human Genome Research Institute (NIH/NHGRI) grant T32 HG000044. V.K. was supported by a Natural Sciences and Engineering Research Council of Canada (NSERC) post-graduate fellowship. We thank Illumina, Inc. for their assistance in sample preparation.	Albertsen M, 2013, NAT BIOTECHNOL, V31, P533, DOI 10.1038/nbt.2579; Alneberg J, 2014, NAT METHODS, V11, P1144, DOI [10.1038/nmeth.3103, 10.1038/NMETH.3103]; Berlin K, 2015, NAT BIOTECHNOL, V33, P623, DOI 10.1038/nbt.3238; Burton JN, 2014, G3-GENES GENOM GENET, V4, P1339, DOI 10.1534/g3.114.011825; Burton JN, 2013, NAT BIOTECHNOL, V31, P1119, DOI 10.1038/nbt.2727; Chen WH, 2012, NUCLEIC ACIDS RES, V40, pD901, DOI 10.1093/nar/gkr986; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Daniel R, 2005, NAT REV MICROBIOL, V3, P470, DOI 10.1038/nrmicro1160; Di Rienzi SC, 2013, ELIFE, V2, DOI 10.7554/eLife.01102; Eid J, 2009, SCIENCE, V323, P133, DOI 10.1126/science.1162986; Fichot EB, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-10; GUSFIELD D, 1991, NETWORKS, V21, P19, DOI 10.1002/net.3230210104; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Iverson V, 2012, SCIENCE, V335, P587, DOI 10.1126/science.1212665; Kuleshov V, 2014, NAT BIOTECHNOL, V32, P261, DOI 10.1038/nbt.2833; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Lieberman TD, 2011, NAT GENET, V43, P1275, DOI 10.1038/ng.997; Magoc T, 2013, BIOINFORMATICS, V29, P1718, DOI 10.1093/bioinformatics/btt273; Mao FL, 2009, NUCLEIC ACIDS RES, V37, pD459, DOI 10.1093/nar/gkn757; McCoy RC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106689; Myers EW, 2000, SCIENCE, V287, P2196, DOI 10.1126/science.287.5461.2196; Nielsen HB, 2014, NAT BIOTECHNOL, V32, P822, DOI 10.1038/nbt.2939; Parks DH, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-328; Rinke C, 2013, NATURE, V499, P431, DOI 10.1038/nature12352; Sharon I, 2015, GENOME RES, V25, P534, DOI 10.1101/gr.183012.114; Sommer DD, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-64; Thomas Torsten, 2012, Microb Inform Exp, V2, P3, DOI 10.1186/2042-5783-2-3; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Zhu WH, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq275	29	62	65	0	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2016	34	1					64	69		10.1038/nbt.3416	http://dx.doi.org/10.1038/nbt.3416			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DB8HQ	26655498	Green Accepted			2022-12-25	WOS:000368758200028
J	Peirs, C; Seal, RP				Peirs, Cedric; Seal, Rebecca P.			Targeting Toll-like receptors to treat chronic pain	NATURE MEDICINE			English	Editorial Material							INHIBITION	Chronic pain affects millions of people worldwide. A new study presents a promising therapeutic strategy in which Toll-like receptor (TLR) 5 stimulation enables the analgesic compound, QX-314, to specifically enter and silence large fiber sensory neurons, which convey pain in the setting of injury.	[Peirs, Cedric; Seal, Rebecca P.] Univ Pittsburgh, Sch Med, Dept Neurobiol, Pittsburgh, PA 15260 USA; [Peirs, Cedric; Seal, Rebecca P.] Univ Pittsburgh, Sch Med, Dept Otolaryngol, Pittsburgh, PA USA; [Peirs, Cedric; Seal, Rebecca P.] Univ Pittsburgh, Sch Med, Pittsburgh Ctr Pain Res, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Seal, RP (corresponding author), Univ Pittsburgh, Sch Med, Dept Neurobiol, Pittsburgh, PA 15260 USA.	rpseal@pitt.edu		Peirs, Cedric/0000-0002-2296-0323	NINDS NIH HHS [NS084191] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS084191] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Binshtok AM, 2007, NATURE, V449, P607, DOI 10.1038/nature06191; Burdelya LG, 2008, SCIENCE, V320, P226, DOI 10.1126/science.1154986; CAMPBELL JN, 1988, PAIN, V32, P89, DOI 10.1016/0304-3959(88)90027-9; Finnerup NB, 2010, PAIN, V150, P573, DOI 10.1016/j.pain.2010.06.019; Howell BA, 2014, CPT-PHARMACOMET SYST, V3, DOI 10.1038/psp.2013.74; Li LS, 2011, CELL, V147, P1615, DOI 10.1016/j.cell.2011.11.027; Liu T, 2012, NEUROSCI BULL, V28, P131, DOI 10.1007/s12264-012-1219-5; MELZACK R, 1965, SCIENCE, V150, P971, DOI 10.1126/science.150.3699.971; Park CK, 2014, NEURON, V82, P47, DOI 10.1016/j.neuron.2014.02.011; Patapoutian A, 2009, NAT REV DRUG DISCOV, V8, P55, DOI 10.1038/nrd2757; Roberson DP, 2013, NAT NEUROSCI, V16, P910, DOI 10.1038/nn.3404; Xu ZZ, 2015, NAT MED, V21, P1326, DOI 10.1038/nm.3978	12	10	11	1	17	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2015	21	11					1251	1252		10.1038/nm.3986	http://dx.doi.org/10.1038/nm.3986			2	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CV9QH	26540386				2022-12-25	WOS:000364621200008
J	Garcia-Pino, A; De Gieter, S; Talavera, A; De Greve, H; Efremov, RG; Loris, R				Garcia-Pino, Abel; De Gieter, Steven; Talavera, Ariel; De Greve, Henri; Efremov, Rouslan G.; Loris, Remy			An intrinsically disordered entropic switch determines allostery in Phd-Doc regulation	NATURE CHEMICAL BIOLOGY			English	Article							TOXIN-ANTITOXIN MODULES; SMALL-ANGLE SCATTERING; X-RAY-SCATTERING; TRANSCRIPTIONAL REPRESSION; CONDITIONAL COOPERATIVITY; MOLECULAR-DYNAMICS; PROTEIN; SYSTEM; PROMOTER; OPERON	Conditional cooperativity is a common mechanism involved in transcriptional regulation of prokaryotic type II toxin-antitoxin operons and is intricately related to bacterial persistence. It allows the toxin component of a toxin-antitoxin module to act as a co-repressor at low doses of toxin as compared to antitoxin. When toxin level exceeds a certain threshold, however, the toxin becomes a de-repressor. Most antitoxins contain an intrinsically disordered region (IDR) that typically is involved in toxin neutralization and repressor complex formation. To address how the antitoxin IDR is involved in transcription regulation, we studied the phd-doc operon from bacteriophage P1. We provide evidence that the IDR of Phd provides an entropic barrier precluding full operon repression in the absence of Doc. Binding of Doc results in a cooperativity switch and consequent strong operon repression, enabling context-specific modulation of the regulatory process. Variations of this theme are likely to be a common mechanism in the autoregulation of bacterial operons that involve intrinsically disordered regions.	[Garcia-Pino, Abel; De Gieter, Steven; Talavera, Ariel; De Greve, Henri; Efremov, Rouslan G.; Loris, Remy] Vrije Univ Brussel, Struct Biol Brussels, Dept Biotechnol, Brussels, Belgium; [Garcia-Pino, Abel] Univ Libre Bruxelles, Biol Struct & Biophys, Gosselies, Belgium; [De Gieter, Steven; Talavera, Ariel; De Greve, Henri; Efremov, Rouslan G.; Loris, Remy] VIB, Struct Biol Res Ctr, Brussels, Belgium	Vrije Universiteit Brussel; Universite Libre de Bruxelles; Flanders Institute for Biotechnology (VIB)	Garcia-Pino, A; Loris, R (corresponding author), Vrije Univ Brussel, Struct Biol Brussels, Dept Biotechnol, Brussels, Belgium.; Garcia-Pino, A (corresponding author), Univ Libre Bruxelles, Biol Struct & Biophys, Gosselies, Belgium.; Loris, R (corresponding author), VIB, Struct Biol Res Ctr, Brussels, Belgium.	agarciap@ulb.ac.be; reloris@vub.ac.be	Loris, Remy/GPG-0894-2022; Talavera, Ariel/AAG-9932-2019; Efremov, Rouslan/P-9085-2015	Efremov, Rouslan/0000-0001-7516-8658; Loris, Remy/0000-0002-8862-3338; DE GIETER, STEVEN/0000-0002-2776-3791	European Community's Seventh Framework Programme (FP7) under BioStruct-X [283570]; VIB; FWO-Vlaanderen; Hercules Foundation; Fonds National de Recherche Scientifique (FNRS); Fonds d'Encouragement a la Recherche ULB (FER-ULB)	European Community's Seventh Framework Programme (FP7) under BioStruct-X; VIB; FWO-Vlaanderen(FWO); Hercules Foundation; Fonds National de Recherche Scientifique (FNRS)(Fonds de la Recherche Scientifique - FNRS); Fonds d'Encouragement a la Recherche ULB (FER-ULB)	The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under BioStruct-X (grant agreement no. 283570) and from the VIB, FWO-Vlaanderen, the Hercules Foundation, the Fonds National de Recherche Scientifique (FNRS) and the Fonds d'Encouragement a la Recherche ULB (FER-ULB). S.D.G. and A.G.-P. acknowledge the receipt of individual predoctoral and postdoctoral fellowships, respectively, from FWO-Vlaanderen. We also acknowledge the use of beamtime at the synchrotron beamlines BM29 (ESRF Grenoble, France) and SWING and PROXIMA1 (Soleil Gif-sur-Yvette, France) and thank the beamline staff for their support.	Afif H, 2001, MOL MICROBIOL, V41, P73, DOI 10.1046/j.1365-2958.2001.02492.x; Anantharaman V, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-12-r81; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bernado P, 2007, J AM CHEM SOC, V129, P5656, DOI 10.1021/ja069124n; Bricogne G., 2011, BUSTER VERSION 2 10; Brown BL, 2013, J BIOL CHEM, V288, P1286, DOI 10.1074/jbc.M112.421008; Buts L, 2005, TRENDS BIOCHEM SCI, V30, P672, DOI 10.1016/j.tibs.2005.10.004; Castro-Roa D, 2013, NAT CHEM BIOL, V9, P811, DOI [10.1038/NCHEMBIO.1364, 10.1038/nchembio.1364]; Chan WT, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00677; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; De Gieter S, 2014, J BIOL CHEM, V289, P34013, DOI 10.1074/jbc.M114.572396; De Jonge N, 2009, MOL CELL, V35, P154, DOI 10.1016/j.molcel.2009.05.025; De la Cruz MA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003827; Elmlund H, 2013, STRUCTURE, V21, P1299, DOI 10.1016/j.str.2013.07.002; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferreon ACM, 2013, NATURE, V498, P390, DOI 10.1038/nature12294; Fuxreiter M, 2014, CHEM REV, V114, P6806, DOI 10.1021/cr4007329; Garcia-Pino A, 2008, J BIOL CHEM, V283, P30821, DOI 10.1074/jbc.M805654200; Garcia-Pino A, 2014, TRENDS BIOCHEM SCI, V39, P121, DOI 10.1016/j.tibs.2014.01.001; Garcia-Pino A, 2010, CELL, V142, P101, DOI 10.1016/j.cell.2010.05.039; Gazit E, 1999, J BIOL CHEM, V274, P2652, DOI 10.1074/jbc.274.5.2652; Gerdes K, 2005, NAT REV MICROBIOL, V3, P371, DOI 10.1038/nrmicro1147; Helaine S, 2014, SCIENCE, V343, P204, DOI 10.1126/science.1244705; Hilser VJ, 2007, P NATL ACAD SCI USA, V104, P8311, DOI 10.1073/pnas.0700329104; Hohn M, 2007, J STRUCT BIOL, V157, P47, DOI 10.1016/j.jsb.2006.07.003; Houtman JCD, 2007, PROTEIN SCI, V16, P30, DOI 10.1110/ps.062558507; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kamada K, 2005, MOL CELL, V19, P497, DOI 10.1016/j.molcel.2005.07.004; Konarev PV, 2006, J APPL CRYSTALLOGR, V39, P277, DOI 10.1107/S0021889806004699; LEHNHERR H, 1993, J MOL BIOL, V233, P414, DOI 10.1006/jmbi.1993.1521; Loris R, 2014, CHEM REV, V114, P6933, DOI 10.1021/cr400656f; Macke TJ, 1998, ACS SYM SER, V682, P379; Magnuson P, 1996, J BIOL CHEM, V271, P18705, DOI 10.1074/jbc.271.31.18705; Magnuson R, 1998, J BACTERIOL, V180, P6342; Maisonneuve E, 2013, CELL, V154, P1140, DOI 10.1016/j.cell.2013.07.048; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; McKinley JE, 2005, J BACTERIOL, V187, P765, DOI 10.1128/JB.187.2.765-770.2005; Monti MC, 2007, NUCLEIC ACIDS RES, V35, P1737, DOI 10.1093/nar/gkm073; Motlagh HN, 2014, NATURE, V508, P331, DOI 10.1038/nature13001; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Overgaard M, 2008, MOL MICROBIOL, V69, P841, DOI 10.1111/j.1365-2958.2008.06313.x; Pelikan M, 2009, GEN PHYSIOL BIOPHYS, V28, P174, DOI 10.4149/gpb_2009_02_174; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Rambo RP, 2013, NATURE, V496, P477, DOI 10.1038/nature12070; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schumacher MA, 2015, NATURE, V524, P59, DOI 10.1038/nature14662; Simanshu DK, 2013, MOL CELL, V52, P447, DOI 10.1016/j.molcel.2013.09.006; Smith JA, 2004, J BACTERIOL, V186, P2692, DOI 10.1128/JB.186.9.2692-2698.2004; Sterckx YGJ, 2015, PROTEIN EXPRES PURIF, V108, P30, DOI 10.1016/j.pep.2015.01.001; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Theobald DL, 2006, BIOINFORMATICS, V22, P2171, DOI 10.1093/bioinformatics/btl332; Tzeng SR, 2009, NATURE, V462, P368, DOI 10.1038/nature08560; Winther KS, 2012, NUCLEIC ACIDS RES, V40, P4347, DOI 10.1093/nar/gks029; Zhao XY, 2005, J BACTERIOL, V187, P1901, DOI 10.1128/JB.187.6.1901-1912.2005	56	23	24	0	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUL	2016	12	7					490	+		10.1038/NCHEMBIO.2078	http://dx.doi.org/10.1038/NCHEMBIO.2078			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9EP	27159580				2022-12-25	WOS:000378087500007
J	Han, T; Goralski, M; Capota, E; Padrick, SB; Kim, J; Xie, Y; Nijhawan, D				Han, Ting; Goralski, Maria; Capota, Emanuela; Padrick, Shae B.; Kim, Jiwoong; Xie, Yang; Nijhawan, Deepak			The antitumor toxin CD437 is a direct inhibitor of DNA polymerase alpha	NATURE CHEMICAL BIOLOGY			English	Article							SYNTHETIC RETINOID CD437; RECEPTOR-INDEPENDENT INDUCTION; LUNG-CARCINOMA CELLS; HUMAN HEAD; APOPTOSIS; APHIDICOLIN; MECHANISMS; GENE; DATABASE; ST1926	CD437 is a retinoid-like small molecule that selectively induces apoptosis in cancer cells, but not in normal cells, through an unknown mechanism. We used a forward-genetic strategy to discover mutations in POLA1 that coincide with CD437 resistance (POLA1(R)). Introduction of one of these mutations into cancer cells by CRISPR-Cas9 genome editing conferred CD437 resistance, demonstrating causality. POLA1 encodes DNA polymerase alpha, the enzyme responsible for initiating DNA synthesis during the S phase of the cell cycle. CD437 inhibits DNA replication in cells and recombinant POLA1 activity in vitro. Both effects are abrogated by the identified POLA1 mutations, supporting POLA1 as the direct antitumor target of CD437. In addition, we detected an increase in the total fluorescence intensity and anisotropy of CD437 in the presence of increasing concentrations of POLA1 that is consistent with a direct binding interaction. The discovery of POLA1 as the direct anticancer target for CD437 has the potential to catalyze the development of CD437 into an anticancer therapeutic.	[Han, Ting; Nijhawan, Deepak] UT Southwestern Med Ctr, Dept Biochem, Dallas, TX USA; [Goralski, Maria; Capota, Emanuela; Nijhawan, Deepak] UT Southwestern Med Ctr, Dept Internal Med, Dallas, TX USA; [Padrick, Shae B.] UT Southwestern Med Ctr, Dept Biophys, Dallas, TX USA; [Kim, Jiwoong; Xie, Yang] UT Southwestern Med Ctr, Quantitat Biomed Res Ctr, Dept Clin Sci, Dallas, TX USA; [Kim, Jiwoong; Xie, Yang; Nijhawan, Deepak] UT Southwestern Med Ctr, Harold C Simmons Comprehens Canc Ctr, Dallas, TX USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Nijhawan, D (corresponding author), UT Southwestern Med Ctr, Dept Biochem, Dallas, TX USA.; Nijhawan, D (corresponding author), UT Southwestern Med Ctr, Dept Internal Med, Dallas, TX USA.; Nijhawan, D (corresponding author), UT Southwestern Med Ctr, Harold C Simmons Comprehens Canc Ctr, Dallas, TX USA.	nijhawan@utsouthwestern.edu		Padrick, Shae/0000-0002-6916-6194; Han, Ting/0000-0003-3168-8699	NIGMS [R01-GM56322]; Cancer Prevention and Research Institute of Texas (CPRIT) [RP150596]; Harold C. Simmons Cancer Center Startup Awards; Disease Oriented Clinical Scholar (DOCS) award; Damon Runyon Clinical Investigator award [CI-68-13]; Welch Foundation [I-1879]; NATIONAL CANCER INSTITUTE [P30CA142543] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056322] Funding Source: NIH RePORTER	NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Cancer Prevention and Research Institute of Texas (CPRIT); Harold C. Simmons Cancer Center Startup Awards; Disease Oriented Clinical Scholar (DOCS) award; Damon Runyon Clinical Investigator award; Welch Foundation(The Welch Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank J. Ready, S.L. McKnight, and members of the Nijhawan laboratory for helpful comments. We thank the McDermott Sequencing Center at UT Southwestern Medical Center for Illumina sequencing, T. Tahirov for the pFastBac1 POLA1 plasmid, J. McKnight for site-directed mutagenesis of POLA1, and B.Li,H. Yu and L. Beatty for help with Sf9 culture. T. H. is a Howard Hughes Medical Institute Fellow of the Life Sciences Research Foundation. S.B.P. was supported by a grant to M.K. Rosen from NIGMS (R01-GM56322). J.K. was supported by the Cancer Prevention and Research Institute of Texas (CPRIT) grant RP150596. This research was supported by a Harold C. Simmons Cancer Center Startup Awards, a Disease Oriented Clinical Scholar (DOCS) award, a Damon Runyon Clinical Investigator award (CI-68-13) and a grant from the Welch Foundation (I-1879) to D. N.	Baranovskiy AG, 2014, NUCLEIC ACIDS RES, V42, P14013, DOI 10.1093/nar/gku1209; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Cincinelli R, 2005, J MED CHEM, V48, P4931, DOI 10.1021/jm049440h; Cincinelli R, 2003, J MED CHEM, V46, P909, DOI 10.1021/jm025593y; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; EDELSON RE, 1990, XENOBIOTICA, V20, P273, DOI 10.3109/00498259009046847; Finn RS, 2015, LANCET ONCOL, V16, P25, DOI 10.1016/S1470-2045(14)71159-3; Glaab WE, 1997, CARCINOGENESIS, V18, P1, DOI 10.1093/carcin/18.1.1; Hail N, 2001, J CELL PHYSIOL, V186, P24, DOI 10.1002/1097-4652(200101)186:1<24::AID-JCP1006>3.0.CO;2-S; Hashiguchi K, 2010, BIOCHEM BIOPH RES CO, V391, P621, DOI 10.1016/j.bbrc.2009.11.109; Holmes WF, 2003, J CELL BIOCHEM, V89, P262, DOI 10.1002/jcb.10505; Hsu CA, 1997, BLOOD, V89, P4470, DOI 10.1182/blood.V89.12.4470; Hsu SL, 1999, EXP CELL RES, V252, P332, DOI 10.1006/excr.1999.4625; IKEGAMI S, 1978, NATURE, V275, P458, DOI 10.1038/275458a0; Karolchik D, 2014, NUCLEIC ACIDS RES, V42, pD764, DOI 10.1093/nar/gkt1168; Lotan R, 2003, J BIOL REG HOMEOS AG, V17, P13; MARTIN B, 1992, SKIN PHARMACOL, V5, P57; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mishur RJ, 2011, BIOORG MED CHEM LETT, V21, P857, DOI 10.1016/j.bmcl.2010.11.073; Parrella E, 2006, MOL PHARMACOL, V70, P909, DOI 10.1124/mol.106.023614; Patel RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030619; PEDRALINOY G, 1980, NUCLEIC ACIDS RES, V8, P377, DOI 10.1093/nar/8.2.377; Pfahl M, 2003, ONCOGENE, V22, P9058, DOI 10.1038/sj.onc.1207109; PRASAD G, 1989, NUCLEIC ACIDS RES, V17, P6339, DOI 10.1093/nar/17.15.6339; Pruitt KD, 2014, NUCLEIC ACIDS RES, V42, pD756, DOI 10.1093/nar/gkt1114; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rees MG, 2016, NAT CHEM BIOL, V12, P109, DOI [10.1038/NCHEMBIO.1986, 10.1038/nchembio.1986]; Rishi AK, 1999, NUCLEIC ACIDS RES, V27, P3111, DOI 10.1093/nar/27.15.3111; Schadendorf D, 1996, J CELL BIOL, V135, P1889, DOI 10.1083/jcb.135.6.1889; SESSA C, 1991, J NATL CANCER I, V83, P1160, DOI 10.1093/jnci/83.16.1160; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Sun SY, 1997, J CELL PHYSIOL, V173, P279, DOI 10.1002/(SICI)1097-4652(199711)173:2<279::AID-JCP36>3.0.CO;2-8; Sun SY, 1999, ONCOGENE, V18, P2357, DOI 10.1038/sj.onc.1202543; Sun SY, 2000, MOL PHARMACOL, V58, P508, DOI 10.1124/mol.58.3.508; Sun SY, 2000, CLIN CANCER RES, V6, P1563; Valli C, 2008, MOL CANCER THER, V7, P2941, DOI 10.1158/1535-7163.MCT-08-0419; Wacker SA, 2012, NAT CHEM BIOL, V8, P235, DOI [10.1038/NCHEMBIO.779, 10.1038/nchembio.779]	37	47	48	2	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUL	2016	12	7					511	+		10.1038/NCHEMBIO.2082	http://dx.doi.org/10.1038/NCHEMBIO.2082			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9EP	27182663	Green Accepted			2022-12-25	WOS:000378087500010
J	Narumi, S; Amano, N; Ishii, T; Katsumata, N; Muroya, K; Adachi, M; Toyoshima, K; Tanaka, Y; Fukuzawa, R; Miyako, K; Kinjo, S; Ohga, S; Ihara, K; Inoue, H; Kinjo, T; Hara, T; Kohno, M; Yamada, S; Urano, H; Kitagawa, Y; Tsugawa, K; Higa, A; Miyawaki, M; Okutani, T; Kizaki, Z; Hamada, H; Kihara, M; Shiga, K; Yamaguchi, T; Kenmochi, M; Kitajima, H; Fukami, M; Shimizu, A; Kudoh, J; Shibata, S; Okano, H; Miyake, N; Matsumoto, N; Hasegawa, T				Narumi, Satoshi; Amano, Naoko; Ishii, Tomohiro; Katsumata, Noriyuki; Muroya, Koji; Adachi, Masanori; Toyoshima, Katsuaki; Tanaka, Yukichi; Fukuzawa, Ryuji; Miyako, Kenichi; Kinjo, Saori; Ohga, Shouichi; Ihara, Kenji; Inoue, Hirosuke; Kinjo, Tadamune; Hara, Toshiro; Kohno, Miyuki; Yamada, Shiro; Urano, Hironaka; Kitagawa, Yosuke; Tsugawa, Koji; Higa, Asumi; Miyawaki, Masakazu; Okutani, Takahiro; Kizaki, Zenro; Hamada, Hiroyuki; Kihara, Minako; Shiga, Kentaro; Yamaguchi, Tetsuya; Kenmochi, Manabu; Kitajima, Hiroyuki; Fukami, Maki; Shimizu, Atsushi; Kudoh, Jun; Shibata, Shinsuke; Okano, Hideyuki; Miyake, Noriko; Matsumoto, Naomichi; Hasegawa, Tomonobu			SAMD9 mutations cause a novel multisystem disorder, MIRAGE syndrome, and are associated with loss of chromosome 7	NATURE GENETICS			English	Article							FAMILIAL GLUCOCORTICOID DEFICIENCY; KILLER-CELL DEFICIENCY; HYPOGONADOTROPIC HYPOGONADISM; TUMORAL CALCINOSIS; ADRENAL HYPOPLASIA; SEQUENCING DATA; MONOSOMY-7; RECEPTOR; PROTEIN; DOMAIN	Adrenal hypoplasia is a rare, life-threatening congenital disorder. Here we define a new form of syndromic adrenal hypoplasia, which we propose to term MIRAGE (myelodysplasia, infection, restriction of growth, adrenal hypoplasia, genital phenotypes, and enteropathy) syndrome. By exome sequencing and follow-up studies, we identified 11 patients with adrenal hypoplasia and common extra-adrenal features harboring mutations in SAMD9. Expression of the wild-type SAMD9 protein, a facilitator of endosome fusion, caused mild growth restriction in cultured cells, whereas expression of mutants caused profound growth inhibition. Patient-derived fibroblasts had restricted growth, decreased plasma membrane EGFR expression, increased size of early endosomes, and intracellular accumulation of giant vesicles carrying a late endosome marker. Of interest, two patients developed myelodysplasitc syndrome (MDS) that was accompanied by loss of the chromosome 7 carrying the SAMD9 mutation. Considering the potent growth-restricting activity of the SAMD9 mutants, the loss of chromosome 7 presumably occurred as an adaptation to the growth-restricting condition.	[Narumi, Satoshi; Amano, Naoko; Ishii, Tomohiro; Hasegawa, Tomonobu] Keio Univ, Sch Med, Dept Pediat, Tokyo, Japan; [Narumi, Satoshi; Katsumata, Noriyuki; Fukami, Maki] Natl Res Inst Child Hlth & Dev, Dept Mol Endocrinol, Tokyo, Japan; [Muroya, Koji; Adachi, Masanori] Kanagawa Childrens Med Ctr, Dept Endocrinol & Metab, Yokohama, Kanagawa, Japan; [Toyoshima, Katsuaki] Kanagawa Childrens Med Ctr, Dept Neonatol, Yokohama, Kanagawa, Japan; [Tanaka, Yukichi] Kanagawa Childrens Med Ctr, Div Pathol, Yokohama, Kanagawa, Japan; [Fukuzawa, Ryuji] Tokyo Metropolitan Childrens Med Ctr, Dept Pathol, Tokyo, Japan; [Miyako, Kenichi] Fukuoka Childrens Hosp & Med Ctr Infect Dis, Dept Endocrinol & Metab, Fukuoka, Japan; [Kinjo, Saori] Okinawa Prefectural Chubu Hosp, Div Pediat, Okinawa, Japan; [Ohga, Shouichi; Ihara, Kenji; Inoue, Hirosuke; Kinjo, Tadamune; Hara, Toshiro] Kyushu Univ, Grad Sch Med Sci, Dept Pediat, Fukuoka, Japan; [Ohga, Shouichi] Kyushu Univ, Grad Sch Med Sci, Dept Perinatal & Pediat Med, Fukuoka, Japan; [Kohno, Miyuki; Yamada, Shiro] Gunma Univ, Grad Sch Med, Dept Pediat, Gunma, Japan; [Urano, Hironaka] Gunma Childrens Med Ctr, Div Neonatol, Gunma, Japan; [Kitagawa, Yosuke] Hirosaki Univ, Grad Sch Med, Dept Pediat, Aomori, Japan; [Tsugawa, Koji] Ohdate Municipal Hosp, Dept Pediat, Ohdate, Japan; [Higa, Asumi; Miyawaki, Masakazu; Okutani, Takahiro] Wakayama Med Univ, Dept Pediat, Wakayama, Japan; [Hamada, Hiroyuki] Japanese Red Cross Kyoto Daiichi Hosp, Dept Pediat, Kyoto, Japan; [Kihara, Minako] Japanese Red Cross Kyoto Daiichi Hosp, Dept Neonatol, Kyoto, Japan; [Shiga, Kentaro; Yamaguchi, Tetsuya] Yokohama City Univ, Med Ctr, Childrens Med Ctr, Dept Pediat, Yokohama, Kanagawa 232, Japan; [Kenmochi, Manabu] Kitasato Univ, Sch Med, Dept Pediat, Sagamihara, Kanagawa 228, Japan; [Kitajima, Hiroyuki] Osaka Med Ctr & Res Inst Maternal & Child Hlth, Dept Neonatol Med, Osaka, Japan; [Shimizu, Atsushi] Iwate Med Univ, Div Biomed Informat Anal, Iwate Tohoku Med Megabank Org, Morioka, Iwate, Japan; [Kudoh, Jun] Keio Univ, Sch Med, Lab Gene Med, Tokyo, Japan; [Shibata, Shinsuke; Okano, Hideyuki] Keio Univ, Sch Med, Dept Physiol, Tokyo, Japan; [Shibata, Shinsuke] Keio Univ, Sch Med, Electron Microscope Lab, Tokyo, Japan; [Miyake, Noriko; Matsumoto, Naomichi] Yokohama City Univ, Grad Sch Med, Dept Human Genet, Yokohama, Kanagawa, Japan	Keio University; National Center for Child Health & Development - Japan; Tokyo Metropolitan Children's Medical Center; Kyushu University; Kyushu University; Gunma University; Gunma Children's Medical Centre; Hirosaki University; Wakayama Medical University; Yokohama City University; Kitasato University; Iwate Medical University; Keio University; Keio University; Keio University; Yokohama City University	Narumi, S; Hasegawa, T (corresponding author), Keio Univ, Sch Med, Dept Pediat, Tokyo, Japan.; Narumi, S (corresponding author), Natl Res Inst Child Hlth & Dev, Dept Mol Endocrinol, Tokyo, Japan.	narumi@2001.jukuin.keio.ac.jp; thaseg@keio.jp	Ishii, Tomohiro/B-8711-2019; Fukami, Maki/ABE-4694-2020; Shibata, Shinsuke/AAM-6620-2020; Muroya, Koji/J-1304-2016; Okano, Hideyuki/X-9131-2019; Ihara, Kenji/AAE-3890-2020; Hasegawa, Tomonobu/L-3331-2013; Okano, Hideyuki/I-7584-2019	Ishii, Tomohiro/0000-0001-7360-2465; Fukami, Maki/0000-0001-9971-4035; Muroya, Koji/0000-0002-1810-9894; Okano, Hideyuki/0000-0001-7482-5935; Shibata, Shinsuke/0000-0002-1185-9043; Ihara, Kenji/0000-0002-8831-1991	Ministry of Health, Labour, and Welfare, Japan [Jitsuyoka Nanbyo-Ippan-014, Jitsuyoka Nanbyo-Ippan-005]; Japan Society for the Promotion of Science [23591516, 15K09599]; Japan Agency for Medical Research and Development [15ek0109049h0002]; Keio Gijuku Academic Development Funds; Keio University Medical Science Fund; Takeda Science Foundation; Grants-in-Aid for Scientific Research [24591515] Funding Source: KAKEN	Ministry of Health, Labour, and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); Keio Gijuku Academic Development Funds; Keio University Medical Science Fund; Takeda Science Foundation(Takeda Science Foundation (TSF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank all the patients and their families for participating in the study; Y. Kaneda (Osaka University) for providing the plasmid; K. Kurosawa and H. Ohashi for establishing skin fibroblast lines; I. Koya for assistance with exome sequencing; and all staff members of the Collaborative Research Resources, Keio University School of Medicine. This study was supported by grants from the Ministry of Health, Labour, and Welfare, Japan (Jitsuyoka Nanbyo-Ippan-014 to T. Hasegawa and Jitsuyoka Nanbyo-Ippan-005 to N. Matsumoto), grants from the Japan Society for the Promotion of Science (23591516 to T.I. and 15K09599 to T. Hasegawa), a grant from the Japan Agency for Medical Research and Development (15ek0109049h0002 to M.F.), a grant from Keio Gijuku Academic Development Funds (to T. Hasegawa), Research Grants for Life Sciences and Medicine from the Keio University Medical Science Fund (to S.N.), and a grant from the Takeda Science Foundation (to S.N.).	Amano N, 2008, AM J MED GENET A, V146A, P2130, DOI 10.1002/ajmg.a.32425; Aplenc R, 2002, LEUKEMIA, V16, P1865, DOI 10.1038/sj.leu.2402681; Arboleda VA, 2012, NAT GENET, V44, P788, DOI 10.1038/ng.2275; Chefetz I, 2008, J INVEST DERMATOL, V128, P1423, DOI 10.1038/sj.jid.5701203; CLARK AJL, 1993, LANCET, V341, P461, DOI 10.1016/0140-6736(93)90208-X; Duncan AW, 2012, J CLIN INVEST, V122, P3307, DOI 10.1172/JCI64026; Gineau L, 2012, J CLIN INVEST, V122, P821, DOI 10.1172/JCI61014; Haase D, 2007, BLOOD, V110, P4385, DOI 10.1182/blood-2007-03-082404; Hughes CR, 2012, J CLIN INVEST, V122, P814, DOI 10.1172/JCI60224; Le SQ, 1996, OBSTET GYNECOL, V87, P854; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; McDonald S, 2010, PEDIATR BLOOD CANCER, V54, P154, DOI 10.1002/pbc.22283; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Meimaridou E, 2012, NAT GENET, V44, P740, DOI 10.1038/ng.2299; Metherell LA, 2005, NAT GENET, V37, P166, DOI 10.1038/ng1501; MUSCATELLI F, 1994, NATURE, V372, P672, DOI 10.1038/372672a0; Nagamachi A, 2013, CANCER CELL, V24, P305, DOI 10.1016/j.ccr.2013.08.011; Niemeyer CM, 2008, SEMIN HEMATOL, V45, P60, DOI 10.1053/j.seminhematol.2007.10.006; Olney HJ, 2007, LEUKEMIA RES, V31, P427, DOI 10.1016/j.leukres.2006.10.023; Prasad R, 2014, J CLIN ENDOCR METAB, V99, pE1556, DOI 10.1210/jc.2013-3844; Takagi M, 2014, HORM RES PAEDIAT, V81, P133, DOI 10.1159/000355279; Tanaka M, 2010, INT J CANCER, V126, P1982, DOI 10.1002/ijc.24965; Topaz O, 2006, AM J HUM GENET, V79, P759, DOI 10.1086/508069; Tullio-Pelet A, 2000, NAT GENET, V26, P332, DOI 10.1038/81642; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603	25	173	179	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2016	48	7					792	+		10.1038/ng.3569	http://dx.doi.org/10.1038/ng.3569			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DP9TK	27182967				2022-12-25	WOS:000378840100017
J	Vinogradova, M; Gehling, VS; Gustafson, A; Arora, S; Tindell, CA; Wilson, C; Williamson, KE; Guler, GD; Gangurde, P; Manieri, W; Busby, J; Flynn, EM; Lan, F; Kim, HJ; Odate, S; Cochran, AG; Liu, YC; Wongchenko, M; Yang, YB; Cheung, TK; Maile, TM; Lau, T; Costa, M; Hegde, GV; Jackson, E; Pitti, R; Arnott, D; Bailey, C; Bellon, S; Cummings, RT; Albrecht, BK; Harmange, JC; Kiefer, JR; Trojer, P; Classon, M				Vinogradova, Maia; Gehling, Victor S.; Gustafson, Amy; Arora, Shilpi; Tindell, Charles A.; Wilson, Catherine; Williamson, Kaylyn E.; Guler, Gulfem D.; Gangurde, Pranoti; Manieri, Wanda; Busby, Jennifer; Flynn, E. Megan; Lan, Fei; Kim, Hyo-jin; Odate, Shobu; Cochran, Andrea G.; Liu, Yichin; Wongchenko, Matthew; Yang, Yibin; Cheung, Tommy K.; Maile, Tobias M.; Lau, Ted; Costa, Michael; Hegde, Ganapati V.; Jackson, Erica; Pitti, Robert; Arnott, David; Bailey, Christopher; Bellon, Steve; Cummings, Richard T.; Albrecht, Brian K.; Harmange, Jean-Christophe; Kiefer, James R.; Trojer, Patrick; Classon, Marie			An inhibitor of KDM5 demethylases reduces survival of drug-tolerant cancer cells	NATURE CHEMICAL BIOLOGY			English	Article							SMALL-MOLECULE INHIBITORS; MUTATIONAL LANDSCAPE; STRUCTURAL INSIGHTS; HISTONE DEMETHYLASE; IN-VIVO; DOMAIN; FAMILY; IDENTIFICATION; METHYLATION; MELANOMA	The KDM5 family of histone demethylases catalyzes the demethylation of histone H3 on lysine 4 (H3K4) and is required for the survival of drug-tolerant persister cancer cells (DTPs). Here we report the discovery and characterization of the specific KDM5 inhibitor CPI-455. The crystal structure of KDM5A revealed the mechanism of inhibition of CPI-455 as well as the topological arrangements of protein domains that influence substrate binding. CPI-455 mediated KDM5 inhibition, elevated global levels of H3K4 trimethylation (H3K4me3) and decreased the number of DTPs in multiple cancer cell line models treated with standard chemotherapy or targeted agents. These findings show that pretreatment of cancer cells with a KDM5-specific inhibitor results in the ablation of a subpopulation of cancer cells that can serve as the founders for therapeutic relapse.	[Vinogradova, Maia; Gustafson, Amy; Tindell, Charles A.; Wilson, Catherine; Guler, Gulfem D.; Flynn, E. Megan; Kim, Hyo-jin; Cochran, Andrea G.; Liu, Yichin; Wongchenko, Matthew; Yang, Yibin; Cheung, Tommy K.; Maile, Tobias M.; Lau, Ted; Costa, Michael; Hegde, Ganapati V.; Jackson, Erica; Pitti, Robert; Arnott, David; Kiefer, James R.; Classon, Marie] Genentech Inc, San Francisco, CA 94080 USA; [Gehling, Victor S.; Arora, Shilpi; Williamson, Kaylyn E.; Gangurde, Pranoti; Manieri, Wanda; Busby, Jennifer; Lan, Fei; Odate, Shobu; Bailey, Christopher; Bellon, Steve; Cummings, Richard T.; Albrecht, Brian K.; Harmange, Jean-Christophe; Trojer, Patrick] Constellat Pharmaceut, Cambridge, MA USA	Roche Holding; Genentech	Kiefer, JR; Classon, M (corresponding author), Genentech Inc, San Francisco, CA 94080 USA.; Trojer, P (corresponding author), Constellat Pharmaceut, Cambridge, MA USA.	kiefer.james@gene.com; patrick.trojer@constellationpharma.com; classonm@gene.com	Maile, Tobias M/A-7805-2016	Maile, Tobias M/0000-0003-0376-8683; Kiefer, James/0000-0001-6317-0902; Williamson, Kaylyn/0000-0002-3252-5050; Wongchenko, Matthew/0000-0003-1230-7117; Cochran, Andrea/0000-0001-6469-795X	Natural Sciences and Engineering Research Council of Canada; National Research Council Canada; Canadian Institutes of Health Research; Province of Saskatchewan; Western Economic Diversification Canada; University of Saskatchewan; National Institutes of Health, National Institute of General Medical Sciences; Howard Hughes Medical Institute; Office of Science of the US Department of Energy [DE-AC02-05CH11231]; Office of Basic Energy Sciences of the US Department of Energy [DE-AC02-05CH11231]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); National Research Council Canada; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Province of Saskatchewan; Western Economic Diversification Canada; University of Saskatchewan; National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Office of Science of the US Department of Energy(United States Department of Energy (DOE)); Office of Basic Energy Sciences of the US Department of Energy(United States Department of Energy (DOE))	We thank the Genentech Structural Biology Expression Group and J. Wu for additional protein expression and purification, as well as other members of the KDM5 team. We also thank J. Settleman for comments on the manuscript and B. Haley for short hairpin design. We thank Shamrock Structures, LLC, for diffraction data collection from beamline 08ID-1 at the Canadian Light Source, supported by the Natural Sciences and Engineering Research Council of Canada, the National Research Council Canada, the Canadian Institutes of Health Research, the Province of Saskatchewan, Western Economic Diversification Canada, and the University of Saskatchewan, and from beamline 5.0.2 of the Advanced Light Source. The Berkeley Center for Structural Biology is supported in part by the National Institutes of Health, National Institute of General Medical Sciences, and the Howard Hughes Medical Institute. The Advanced Light Source is supported by the Director, Office of Science and Office of Basic Energy Sciences, of the US Department of Energy under Contract No. DE-AC02-05CH11231.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bradley WD, 2014, CHEM BIOL, V21, P1463, DOI 10.1016/j.chembiol.2014.09.017; Catchpole S, 2011, INT J ONCOL, V38, P1267, DOI 10.3892/ijo.2011.956; Chen ZZ, 2006, CELL, V125, P691, DOI 10.1016/j.cell.2006.04.024; Christensen J, 2007, CELL, V128, P1063, DOI 10.1016/j.cell.2007.02.003; Dann CE, 2002, P NATL ACAD SCI USA, V99, P15351, DOI 10.1073/pnas.202614999; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fodor BD, 2006, GENE DEV, V20, P1557, DOI 10.1101/gad.388206; Garapaty-Rao S, 2013, CHEM BIOL, V20, P1329, DOI 10.1016/j.chembiol.2013.09.013; Garcia BA, 2007, NAT PROTOC, V2, P933, DOI 10.1038/nprot.2007.106; Gonzalez-Perez A, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-9-r106; Greer EL, 2012, NAT REV GENET, V13, P343, DOI 10.1038/nrg3173; Heinemann B, 2014, NATURE, V514, pE1, DOI 10.1038/nature13688; Herz HM, 2013, TRENDS BIOCHEM SCI, V38, P621, DOI 10.1016/j.tibs.2013.09.004; Horton JR, 2010, NAT STRUCT MOL BIOL, V17, P38, DOI 10.1038/nsmb.1753; Iwahara J, 2002, EMBO J, V21, P1197, DOI 10.1093/emboj/21.5.1197; Iwase S, 2007, CELL, V128, P1077, DOI 10.1016/j.cell.2007.02.017; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Klose RJ, 2007, CELL, V128, P889, DOI 10.1016/j.cell.2007.02.013; Klose RJ, 2006, NAT REV GENET, V7, P715, DOI 10.1038/nrg1945; Kooistra SM, 2012, NAT REV MOL CELL BIO, V13, P297, DOI 10.1038/nrm3327; Kruidenier L, 2012, NATURE, V488, P404, DOI 10.1038/nature11262; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Lin WC, 2011, P NATL ACAD SCI USA, V108, P13379, DOI 10.1073/pnas.1110104108; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Maile TM, 2015, MOL CELL PROTEOMICS, V14, P1148, DOI 10.1074/mcp.O114.046573; McDonough MA, 2006, P NATL ACAD SCI USA, V103, P9814, DOI 10.1073/pnas.0601283103; McGrath J, 2015, PHARMACOL THERAPEUT, V150, P1, DOI 10.1016/j.pharmthera.2015.01.002; Olsen JV, 2005, MOL CELL PROTEOMICS, V4, P2010, DOI 10.1074/mcp.T500030-MCP200; Ong SE, 2004, NAT METHODS, V1, P119, DOI 10.1038/NMETH715; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Raha D, 2014, CANCER RES, V74, P3579, DOI 10.1158/0008-5472.CAN-13-3456; Rasmussen PB, 2014, EPIGENOMICS-UK, V6, P277, DOI [10.2217/epi.14.14, 10.2217/EPI.14.14]; Roesch A, 2013, CANCER CELL, V23, P811, DOI 10.1016/j.ccr.2013.05.003; Roesch A, 2010, CELL, V141, P583, DOI 10.1016/j.cell.2010.04.020; Rose NR, 2011, CHEM SOC REV, V40, P4364, DOI 10.1039/c0cs00203h; Sayegh J, 2013, J BIOL CHEM, V288, P9408, DOI 10.1074/jbc.M112.419861; Sengoku T, 2011, GENE DEV, V25, P2266, DOI 10.1101/gad.172296.111; Seward DJ, 2007, NAT STRUCT MOL BIOL, V14, P240, DOI 10.1038/nsmb1200; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Thinnes CC, 2014, BBA-GENE REGUL MECH, V1839, P1416, DOI 10.1016/j.bbagrm.2014.05.009; Tu SJ, 2008, NAT STRUCT MOL BIOL, V15, P419, DOI 10.1038/nsmb.1400; Upadhyay AK, 2011, CURR OPIN STRUC BIOL, V21, P750, DOI 10.1016/j.sbi.2011.08.003; Yamane K, 2007, MOL CELL, V25, P801, DOI 10.1016/j.molcel.2007.03.001; Zack TI, 2013, NAT GENET, V45, P1134, DOI 10.1038/ng.2760	45	188	195	4	70	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUL	2016	12	7					531	+		10.1038/nchembio.2085	http://dx.doi.org/10.1038/nchembio.2085			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9EP	27214401				2022-12-25	WOS:000378087500013
J	Alagramam, KN; Gopal, SR; Geng, RS; Chen, DHC; Nemet, I; Lee, R; Tian, GL; Miyagi, M; Malagu, KF; Lock, CJ; Esmieu, WRK; Owens, AP; Lindsay, NA; Ouwehand, K; Albertus, F; Fischer, DF; Burli, RW; MacLeod, AM; Harte, WE; Palczewski, K; Imanishi, Y				Alagramam, Kumar N.; Gopal, Suhasini R.; Geng, Ruishuang; Chen, Daniel H-C; Nemet, Ina; Lee, Richard; Tian, Guilian; Miyagi, Masaru; Malagu, Karine F.; Lock, Christopher J.; Esmieu, William R. K.; Owens, Andrew P.; Lindsay, Nicola A.; Ouwehand, Krista; Albertus, Faywell; Fischer, David F.; Burli, Roland W.; MacLeod, Angus M.; Harte, William E.; Palczewski, Krzysztof; Imanishi, Yoshikazu			A small molecule mitigates hearing loss in a mouse model of Usher syndrome III	NATURE CHEMICAL BIOLOGY			English	Article							PHOTORECEPTOR OUTER SEGMENT; PROTEASOME INHIBITORS; FLUORESCENT PROTEIN; CLARIN-1; GENE; TRAFFICKING; DELTA-F508-CFTR; DEGRADATION; REVEAL; RESCUE	Usher syndrome type III (USH3), characterized by progressive deafness, variable balance disorder and blindness, is caused by destabilizing mutations in the gene encoding the clarin-1 (CLRN1) protein. Here we report a new strategy to mitigate hearing loss associated with a common USH3 mutation CLRN1(N48K) that involves cell-based high-throughput screening of small molecules capable of stabilizing CLRN1(N48K), followed by a secondary screening to eliminate general proteasome inhibitors, and finally an iterative process to optimize structure-activity relationships. This resulted in the identification of BioFocus 844 (BF844). To test the efficacy of BF844, we developed a mouse model that mimicked the progressive hearing loss associated with USH3. BF844 effectively attenuated progressive hearing loss and prevented deafness in this model. Because the CLRN1(N48K) mutation causes both hearing and vision loss, BF844 could in principle prevent both sensory deficiencies in patients with USH3. Moreover, the strategy described here could help identify drugs for other protein-destabilizing monogenic disorders.	[Alagramam, Kumar N.; Gopal, Suhasini R.; Geng, Ruishuang; Chen, Daniel H-C] Case Western Reserve Univ, Otolaryngol Head & Neck Surg, Univ Hosp Case Med Ctr, Cleveland, OH 44106 USA; [Alagramam, Kumar N.] Case Western Reserve Univ, Genet & Genome Sci, Cleveland, OH 44106 USA; [Alagramam, Kumar N.] Case Western Reserve Univ, Neurosci, Cleveland, OH 44106 USA; [Nemet, Ina; Lee, Richard; Tian, Guilian; Palczewski, Krzysztof; Imanishi, Yoshikazu] Case Western Reserve Univ, Pharmacol & Cleveland Ctr Membrane & Struct Biol, Cleveland, OH 44106 USA; [Miyagi, Masaru] Case Western Reserve Univ, Ctr Prote & Bioinformat, Cleveland, OH 44106 USA; [Malagu, Karine F.; Lock, Christopher J.; Esmieu, William R. K.; Owens, Andrew P.; Lindsay, Nicola A.; Burli, Roland W.; MacLeod, Angus M.] BioFocus, Chesterford Res Pk, Saffron Walden, Essex, England; [Ouwehand, Krista; Albertus, Faywell; Fischer, David F.] Charles River Nederland BV, Leiden, Netherlands; [Harte, William E.] Case Western Reserve Univ, Off Translat & Innovat, Cleveland, OH 44106 USA; [Geng, Ruishuang] Sunnybrook Res Inst, Biol Sci, Toronto, ON, Canada; [Lindsay, Nicola A.] AstraZeneca, Cambridge, England; [Burli, Roland W.] MedImmune, Cambridge, England	Case Western Reserve University; Case Western Reserve University Hospital; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; AstraZeneca; Medimmune	Alagramam, KN (corresponding author), Case Western Reserve Univ, Otolaryngol Head & Neck Surg, Univ Hosp Case Med Ctr, Cleveland, OH 44106 USA.; Alagramam, KN (corresponding author), Case Western Reserve Univ, Genet & Genome Sci, Cleveland, OH 44106 USA.; Alagramam, KN (corresponding author), Case Western Reserve Univ, Neurosci, Cleveland, OH 44106 USA.; Imanishi, Y (corresponding author), Case Western Reserve Univ, Pharmacol & Cleveland Ctr Membrane & Struct Biol, Cleveland, OH 44106 USA.	kna3@case.edu; yxi19@case.edu	Geng, Ruishuang/F-8255-2013; Nemet, Ina/ABG-2855-2021; Imanishi, Yoshikazu/E-8178-2010	Imanishi, Yoshikazu/0000-0003-4696-4836; Gopal, Suhasini/0000-0002-3525-3222; Nemet, Ina/0000-0002-0657-7121; Fischer, David/0000-0002-6690-0197; Lee, Richard/0000-0002-1557-7844	Usher III Initiative; Maniglia Endowed Funds; Hope for Vision; Prince Family Foundation; Case Western Reserve University (CWRU); US National Institutes of Health (NIH) [R01-DC010816, R01-EY020826, R24-EY021126]; Arnold and Mabel Beckman Foundation; Elden family via the Usher III Initiative; Prince Family Foundation via the Usher III Initiative; NATIONAL EYE INSTITUTE [R24EY021126, R01EY020826] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC010816] Funding Source: NIH RePORTER	Usher III Initiative; Maniglia Endowed Funds; Hope for Vision; Prince Family Foundation; Case Western Reserve University (CWRU); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Arnold and Mabel Beckman Foundation; Elden family via the Usher III Initiative; Prince Family Foundation via the Usher III Initiative; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by the Usher III Initiative (Y.I., K.N.A. and BioFocus group), the Maniglia Endowed Funds (K.N.A.), Hope for Vision (Y.I.), the Prince Family Foundation (Y.I.), start-up funding from Case Western Reserve University (CWRU) (Y.I.), the US National Institutes of Health (NIH) (grants R01-DC010816 (to K.N.A.), R01-EY020826 (to Y.I.) and R24-EY021126 (to K.P.)), and the Arnold and Mabel Beckman Foundation (K.P.). We thank the Elden family and the Prince Family Foundation for their generous support of our research via the Usher III Initiative, D. Saperstein for his leadership of the Initiative's research efforts, and A.R. Moise for useful suggestions and discussions before the inception of this project. We thank R. Papoian, S. Nelson and W. Seibel at the Drug Discovery Center (University of Cincinnati) for conducting the HTS. The monoclonal antibody E7 developed by M. Klymkowsky was obtained from the Developmental Studies Hybridoma Bank created by the National Institute of Child Health and Human Development (NICHD) of the NIH, and maintained at The University of Iowa, Iowa City, USA. Fluorescence microscopy was conducted to optimize the HTS assay at the light microscopy imaging core facility of CWRU. We thank Y. Chen at CWRU for providing the RHO<SUP>P23H</SUP> NIH/3T3 cell line, and L.T. Webster Jr. for insightful comments on this manuscript.	Adato A, 2002, EUR J HUM GENET, V10, P339, DOI 10.1038/sj.ejhg.5200831; Baell JB, 2010, J MED CHEM, V53, P2719, DOI 10.1021/jm901137j; Burkard RF., 2007, AUDITORY EVOKED POTE; Chen YY, 2015, INVEST OPHTH VIS SCI, V56, P2553, DOI 10.1167/iovs.14-16298; Chiang WC, 2015, MOL NEUROBIOL, V52, P679, DOI 10.1007/s12035-014-8881-8; Claessen JHL, 2012, TRENDS CELL BIOL, V22, P22, DOI 10.1016/j.tcb.2011.09.010; Cumming JG, 2013, NAT REV DRUG DISCOV, V12, P948, DOI 10.1038/nrd4128; Gee HY, 2011, CELL, V146, P746, DOI 10.1016/j.cell.2011.07.021; Geller SF, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000607; Geng RS, 2012, J NEUROSCI, V32, P9485, DOI 10.1523/JNEUROSCI.0311-12.2012; Geng RS, 2009, HUM MOL GENET, V18, P2748, DOI 10.1093/hmg/ddp210; Gopal SR, 2015, J NEUROSCI, V35, P10188, DOI 10.1523/JNEUROSCI.1096-15.2015; Guo Y, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/971857; Hajkova D, 2010, J PROTEOME RES, V9, P1173, DOI 10.1021/pr900819k; Joensuu T, 2001, AM J HUM GENET, V69, P673, DOI 10.1086/323610; Kisselev AF, 2012, CHEM BIOL, V19, P99, DOI 10.1016/j.chembiol.2012.01.003; KORSCHEN HG, 1995, NEURON, V15, P627, DOI 10.1016/0896-6273(95)90151-5; Lee JN, 2015, BIOCHEM BIOPH RES CO, V456, P269, DOI 10.1016/j.bbrc.2014.11.070; Li XQ, 1998, J BIOL CHEM, V273, P34970, DOI 10.1074/jbc.273.52.34970; Lobanova ES, 2013, P NATL ACAD SCI USA, V110, P9986, DOI 10.1073/pnas.1305521110; Lodowski KH, 2013, J NEUROSCI, V33, P13621, DOI 10.1523/JNEUROSCI.1520-13.2013; Lumpkin EA, 2003, GENE EXPR PATTERNS, V3, P389, DOI 10.1016/S1567-133X(03)00089-9; Luo Y, 2009, BIOCHEM J, V419, P211, DOI 10.1042/BJ20081869; MACKENZIE D, 1984, BIOCHEMISTRY-US, V23, P6544, DOI 10.1021/bi00321a041; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nemet I, 2014, CHANNELS, V8, P528, DOI 10.4161/19336950.2014.973776; Ness SL, 2003, J MED GENET, V40, P767, DOI 10.1136/jmg.40.10.767; PAKARINEN L, 1995, LARYNGOSCOPE, V105, P613, DOI 10.1288/00005537-199506000-00010; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Plantinga RF, 2005, AUDIOL NEURO-OTOL, V10, P79, DOI 10.1159/000083363; Polli JW, 2001, J PHARMACOL EXP THER, V299, P620; Sakami S, 2014, HUM MOL GENET, V23, P1723, DOI 10.1093/hmg/ddt561; Sakami S, 2011, J BIOL CHEM, V286, P10551, DOI 10.1074/jbc.M110.209759; Santhoshkumar P, 2001, J BIOL CHEM, V276, P47094, DOI 10.1074/jbc.M107737200; SCHINKEL AH, 1994, CELL, V77, P491, DOI 10.1016/0092-8674(94)90212-7; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Schulte TW, 1998, CANCER CHEMOTH PHARM, V42, P273, DOI 10.1007/s002800050817; Shearer AE, 2010, P NATL ACAD SCI USA, V107, P21104, DOI 10.1073/pnas.1012989107; Tian G, 2016, INVEST OPHTH VIS SCI, V57, P866, DOI 10.1167/iovs.15-16946; Tian G, 2009, J BIOL CHEM, V284, P18980, DOI 10.1074/jbc.M109.003160; Wang XD, 2006, CELL, V127, P803, DOI 10.1016/j.cell.2006.09.043; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; Wiseman RL, 2010, CELL, V140, P590, DOI 10.1016/j.cell.2010.02.006; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhou XM, 2006, BRAIN RES, V1091, P16, DOI 10.1016/j.brainres.2006.01.107	45	31	34	0	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUN	2016	12	6					444	U108		10.1038/NCHEMBIO.2069	http://dx.doi.org/10.1038/NCHEMBIO.2069			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DM2EW	27110679	Green Accepted			2022-12-25	WOS:000376160600015
J	Cheong, S; Clomburg, JM; Gonzalez, R				Cheong, Seokjung; Clomburg, James M.; Gonzalez, Ramon			Energy- and carbon-efficient synthesis of functionalized small molecules in bacteria using non-decarboxylative Claisen condensation reactions	NATURE BIOTECHNOLOGY			English	Article							BETA-OXIDATION CYCLE; ESCHERICHIA-COLI; TRANS-2-ENOYL-COA REDUCTASE; CLOSTRIDIUM-ACETOBUTYLICUM; PSEUDOMONAS-PUTIDA; CHEMICALS; PATHWAY; REVERSAL; BIOSYNTHESIS; FERMENTATION	Anabolic metabolism can produce an array of small molecules, but yields and productivities are low owing to carbon and energy inefficiencies and slow kinetics(1,2). Catabolic and fermentative pathways, on the other hand, are carbon and energy efficient but support only a limited product range(3,4). We used carbon and energy-efficient non-decarboxylative Claisen condensation reactions and subsequent beta-reduction reactions, which can accept a variety of functionalized primers and functionalized extender units and operate in an iterative manner, to synthesize functionalized small molecules. Using different omega- and omega-1-functionalized primers and alpha-functionalized extender units in combination with various termination pathways, we demonstrate the synthesis of 18 products from 10 classes, including omega-phenylalkanoic, alpha,omega-dicarboxylic, omega-hydroxy, omega-1-oxo, omega-1-methyl, 2-methyl, 2-methyl-2-enolic and 2,3-dihydroxy acids, beta-hydroxy-omega-lactones, and omega-1-methyl alcohols.	[Cheong, Seokjung; Clomburg, James M.; Gonzalez, Ramon] Rice Univ, Dept Chem & Biomol Engn, Houston, TX USA; [Gonzalez, Ramon] Rice Univ, Dept Bioengn, Houston, TX USA	Rice University; Rice University	Gonzalez, R (corresponding author), Rice Univ, Dept Chem & Biomol Engn, Houston, TX USA.; Gonzalez, R (corresponding author), Rice Univ, Dept Bioengn, Houston, TX USA.	ramon.gonzalez@rice.edu	Gonzalez, Ramon/B-1961-2010	Cheong, Seokjung/0000-0002-5699-2278	US National Science Foundation [EEC-0813570, CBET-1134541, CBET-1067565]	US National Science Foundation(National Science Foundation (NSF))	We thank J.E. Vick, M.D. Blankschien and S. Kim for assistance with constructs; G.N. Bennett (Rice University) for gDNA of Clostridium beijerinckii; and P.G. Bodager, B. Wilson, and S.P.T. Matsuda for assistance with GC-MS techniques. This work was supported by grants from the US National Science Foundation (EEC-0813570, CBET-1134541, and CBET-1067565).	Choi S, 2015, METAB ENG, V28, P223, DOI 10.1016/j.ymben.2014.12.007; Clomburg JM, 2012, ACS SYNTH BIOL, V1, P541, DOI 10.1021/sb3000782; Dellomonaco C, 2011, NATURE, V476, P355, DOI 10.1038/nature10333; HASLAM E, 1986, NAT PROD REP, V3, P217, DOI 10.1039/np9860300217; Hoffmeister M, 2005, J BIOL CHEM, V280, P4329, DOI 10.1074/jbc.M411010200; JONES DT, 1986, MICROBIOL REV, V50, P484, DOI 10.1128/MMBR.50.4.484-524.1986; Jullesson D, 2015, BIOTECHNOL ADV, V33, P1395, DOI 10.1016/j.biotechadv.2015.02.011; Kandasamy V, 2013, APPL MICROBIOL BIOT, V97, P1191, DOI 10.1007/s00253-012-4274-y; Koivistoinen OM, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-82; Koma D, 2012, APPL ENVIRON MICROB, V78, P6203, DOI 10.1128/AEM.01148-12; Lenneman EM, 2013, APPL ENVIRON MICROB, V79, P7055, DOI 10.1128/AEM.02420-13; Olivera ER, 2001, MOL MICROBIOL, V39, P863, DOI 10.1046/j.1365-2958.2001.02296.x; PARALES RE, 1992, J BACTERIOL, V174, P4657, DOI 10.1128/JB.174.14.4657-4666.1992; Park SJ, 2013, METAB ENG, V16, P42, DOI 10.1016/j.ymben.2012.11.011; Parke D, 2001, APPL ENVIRON MICROB, V67, P4817, DOI 10.1128/AEM.67.10.4817-4827.2001; PETERSEN DJ, 1990, APPL ENVIRON MICROB, V56, P3491, DOI 10.1128/AEM.56.11.3491-3498.1990; Polen T, 2013, J BIOTECHNOL, V167, P75, DOI 10.1016/j.jbiotec.2012.07.008; Rodriguez GM, 2014, NAT CHEM BIOL, V10, P259, DOI 10.1038/nchembio.1476; Sawers RG, 2004, ECOSAL PLUS, V1; Slater S, 1998, J BACTERIOL, V180, P1979, DOI 10.1128/JB.180.8.1979-1987.1998; Sohling B, 1996, J BACTERIOL, V178, P871; Sun XX, 2015, CHEM SOC REV, V44, P3760, DOI 10.1039/c5cs00159e; Taguchi S, 2008, P NATL ACAD SCI USA, V105, P17323, DOI 10.1073/pnas.0805653105; Teufel R, 2010, P NATL ACAD SCI USA, V107, P14390, DOI 10.1073/pnas.1005399107; Toth J, 1999, APPL ENVIRON MICROB, V65, P4973; Tucci S, 2007, FEBS LETT, V581, P1561, DOI 10.1016/j.febslet.2007.03.013; Vick JE, 2015, APPL ENVIRON MICROB, V81, P1406, DOI 10.1128/AEM.03521-14; Wenzel SC, 2005, CURR OPIN CHEM BIOL, V9, P447, DOI 10.1016/j.cbpa.2005.08.001; Westin MAK, 2005, J BIOL CHEM, V280, P38125, DOI 10.1074/jbc.M508479200; Yu G, 2010, PLANT PHYSIOL, V154, P67, DOI 10.1104/pp.110.157073	30	88	95	5	80	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2016	34	5					556	561		10.1038/nbt.3505	http://dx.doi.org/10.1038/nbt.3505			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DL6FL	27088721				2022-12-25	WOS:000375735000037
J	Desjardins, CA; Cohen, KA; Munsamy, V; Abeel, T; Maharaj, K; Walker, BJ; Shea, TP; Almeida, DV; Manson, AL; Salazar, A; Padayatchi, N; O'Donnell, MR; Mlisana, KP; Wortman, J; Birren, BW; Grosset, J; Earl, AM; Pym, AS				Desjardins, Christopher A.; Cohen, Keira A.; Munsamy, Vanisha; Abeel, Thomas; Maharaj, Kashmeel; Walker, Bruce J.; Shea, Terrance P.; Almeida, Deepak V.; Manson, Abigail L.; Salazar, Alex; Padayatchi, Nesri; O'Donnell, Max R.; Mlisana, Koleka P.; Wortman, Jennifer; Birren, Bruce W.; Grosset, Jacques; Earl, Ashlee M.; Pym, Alexander S.			Genomic and functional analyses of Mycobacterium tuberculosis strains implicate ald in D-cycloserine resistance	NATURE GENETICS			English	Article							D-ALANINE RACEMASE; MULTIDRUG-RESISTANT; MUTATIONS; GENE; BCG; BIOSYNTHESIS; PYRAZINAMIDE; EVOLUTION; COMPLEX; LIGASE	A more complete understanding of the genetic basis of drug resistance in Mycobacterium tuberculosis is critical for prompt diagnosis and optimal treatment, particularly for toxic second-line drugs such as D-cycloserine. Here we used the whole-genome sequences from 498 strains of M. tuberculosis to identify new resistance-conferring genotypes. By combining association and correlated evolution tests with strategies for amplifying signal from rare variants, we found that loss-of-function mutations in ald (Rv2780), encoding l-alanine dehydrogenase, were associated with unexplained drug resistance. Convergent evolution of this loss of function was observed exclusively among multidrug-resistant strains. Drug susceptibility testing established that ald loss of function conferred resistance to D-cycloserine, and susceptibility to the drug was partially restored by complementation of ald. Clinical strains with mutations in ald and alr exhibited increased resistance to D-cycloserine when cultured in vitro. Incorporation of D-cycloserine resistance in novel molecular diagnostics could allow for targeted use of this toxic drug among patients with susceptible infections.	[Desjardins, Christopher A.; Cohen, Keira A.; Abeel, Thomas; Walker, Bruce J.; Shea, Terrance P.; Manson, Abigail L.; Salazar, Alex; Wortman, Jennifer; Birren, Bruce W.; Earl, Ashlee M.] Broad Inst MIT & Harvard, Cambridge, MA USA; [Cohen, Keira A.] Harvard Univ, Brigham & Womens Hosp, Div Pulm & Crit Care Med, Sch Med, Boston, MA 02115 USA; [Cohen, Keira A.; Munsamy, Vanisha; Maharaj, Kashmeel; Almeida, Deepak V.; Grosset, Jacques; Pym, Alexander S.] KwaZulu Natal Res Inst TB & HIV K RITH, Durban, South Africa; [Abeel, Thomas; Salazar, Alex] Delft Univ Technol, Delft Bioinformat Lab, Delft, Netherlands; [Almeida, Deepak V.; Grosset, Jacques] Johns Hopkins Sch Med, Ctr TB Res, Baltimore, MD USA; [Padayatchi, Nesri; O'Donnell, Max R.] Ctr AIDS Programme Res South Africa CAPRISA, Durban, South Africa; [O'Donnell, Max R.] Columbia Univ Coll Phys & Surg, Div Pulm Allergy & Crit Care Med, 630 W 168th St, New York, NY 10032 USA; [O'Donnell, Max R.] Columbia Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA; [Mlisana, Koleka P.] Univ KwaZulu Natal, Sch Lab Med & Med Sci, Durban, South Africa; [Mlisana, Koleka P.] Natl Hlth Lab Serv, Durban, South Africa	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Delft University of Technology; Johns Hopkins University; Johns Hopkins Medicine; Columbia University; University of Kwazulu Natal	Earl, AM (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA USA.; Pym, AS (corresponding author), KwaZulu Natal Res Inst TB & HIV K RITH, Durban, South Africa.	aearl@broadinstitute.org; alex.pym@k-rith.org	padayatchi, nesri/Q-2780-2019; Cohen, Keira/S-8617-2018; Mlisana, Koleka/N-6204-2013	padayatchi, nesri/0000-0003-2543-9071; Cohen, Keira/0000-0002-4521-397X; Abeel, Thomas/0000-0002-7205-7431; Mlisana, Koleka/0000-0002-8436-3268; Pym, Alexander/0000-0002-6260-8180; Earl, Ashlee/0000-0001-7857-9145	NIAID, NIH, US Department of Health and Human Services [HHSN272200900018C]; IeDEA (NIH) [5U01AI069924-07]; NHLBI [T32HL007633]; Research Foundation-Flanders; US Centers for Disease Control and Prevention;  [U19AI51794];  [U19AI110818]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007633] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI069924, U19AI110818, U19AI051794] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T34GM007910] Funding Source: NIH RePORTER	NIAID, NIH, US Department of Health and Human Services; IeDEA (NIH); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Research Foundation-Flanders(FWO); US Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); ; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project has been funded in part with federal funds from NIAID, NIH, US Department of Health and Human Services, under contract HHSN272200900018C, IeDEA (NIH grant 5U01AI069924-07), and grant U19AI110818 to the Broad Institute. K.A.C. was supported by NHLBI grant T32HL007633. T.A. was supported by a postdoctoral fellowship from the Research Foundation-Flanders. Additional funding sources included grant U19AI51794 and the US Centers for Disease Control and Prevention. The contents of this publication are solely the responsibility of the authors and do not necessarily represent the official views of the NIH.	Angeby K, 2012, B WORLD HEALTH ORGAN, V90, P693, DOI 10.2471/BLT.11.096644; [Anonymous], 1973, JAMA-J AM MED ASSOC, V224, P515; [Anonymous], 1956, Am Rev Tuberc, V74, P196; BANKIER RG, 1965, CAN MED ASSOC J, V93, P35; Bastos ML, 2014, CLIN INFECT DIS, V59, P1364, DOI 10.1093/cid/ciu619; Bauer KA, 2014, CLIN INFECT DIS, V59, pS134, DOI 10.1093/cid/ciu547; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Brosch R, 2002, P NATL ACAD SCI USA, V99, P3684, DOI 10.1073/pnas.052548299; Caceres NE, 1997, J BACTERIOL, V179, P5046, DOI 10.1128/jb.179.16.5046-5055.1997; Casali N, 2014, NAT GENET, V46, P279, DOI 10.1038/ng.2878; Cegielski JP, 2014, CLIN INFECT DIS, V59, P1049, DOI 10.1093/cid/ciu572; Chavadi S, 2009, J BACTERIOL, V191, P7545, DOI 10.1128/JB.00619-09; Chen JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043467; Chen JM, 2003, INFECT IMMUN, V71, P708, DOI 10.1128/IAI.71.2.708-716.2003; Choi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046688; Cohen KA, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001880; Converse SE, 2003, P NATL ACAD SCI USA, V100, P6121, DOI 10.1073/pnas.1030024100; Department of Health, 2013, MAN DRUG RES TUB POL; Durek C, 2000, EUR UROL, V37, P21, DOI 10.1159/000052378; Falush D, 2006, TRENDS MICROBIOL, V14, P353, DOI 10.1016/j.tim.2006.06.003; Farhat MR, 2013, NAT GENET, V45, P1183, DOI 10.1038/ng.2747; Feng ZY, 2003, ANTIMICROB AGENTS CH, V47, P283, DOI 10.1128/AAC.47.1.283-291.2003; FINEGOLD SM, 1959, ARCH INTERN MED, V104, P15, DOI 10.1001/archinte.1959.00270070017003; Garnier T, 2003, P NATL ACAD SCI USA, V100, P7877, DOI 10.1073/pnas.1130426100; GEORGE KM, 1995, J BIOL CHEM, V270, P27292, DOI 10.1074/jbc.270.45.27292; GOH KS, 1991, RES MICROBIOL, V142, P659, DOI 10.1016/0923-2508(91)90079-P; HEYM B, 1995, MOL MICROBIOL, V15, P235, DOI 10.1111/j.1365-2958.1995.tb02238.x; Kahlmeter G, 2015, J ANTIMICROB CHEMOTH, V70, P2427, DOI 10.1093/jac/dkv145; Kam KM, 2010, INT J TUBERC LUNG D, V14, P282; Keating LA, 2005, MOL MICROBIOL, V56, P163, DOI 10.1111/j.1365-2958.2005.04524.x; Koser CU, 2013, NEW ENGL J MED, V369, P290, DOI 10.1056/NEJMc1215305; Koser CU, 2013, ANTIMICROB AGENTS CH, V57, P3461, DOI 10.1128/AAC.00626-13; LAMBERT MP, 1972, J BACTERIOL, V110, P978, DOI 10.1128/JB.110.3.978-987.1972; Lamichhane G, 2003, P NATL ACAD SCI USA, V100, P7213, DOI 10.1073/pnas.1231432100; Lange C, 2014, EUR RESPIR J, V44, P23, DOI 10.1183/09031936.00188313; Li GL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119013; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Maus CE, 2005, ANTIMICROB AGENTS CH, V49, P571, DOI 10.1128/AAC.49.2.571-577.2005; Merker M., 2013, PLOS ONE, V8; Morlock GP, 2003, ANTIMICROB AGENTS CH, V47, P3799, DOI 10.1128/AAC.47.12.3799-3805.2003; Morris RP, 2005, P NATL ACAD SCI USA, V102, P12200, DOI 10.1073/pnas.0505446102; PAGEL M, 1994, P ROY SOC B-BIOL SCI, V255, P37, DOI 10.1098/rspb.1994.0006; Pelayo MCG, 2009, INFECT IMMUN, V77, P2230, DOI 10.1128/IAI.01099-08; Pholwat S, 2015, MBIO, V6, DOI 10.1128/mBio.02273-14; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Prosser GA, 2013, ACS MED CHEM LETT, V4, P1233, DOI 10.1021/ml400349n; Reeves AZ, 2013, ANTIMICROB AGENTS CH, V57, P1857, DOI 10.1128/AAC.02191-12; Rist N, 1967, Rev Tuberc Pneumol (Paris), V31, P1060; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Scorpio A, 1996, NAT MED, V2, P662, DOI 10.1038/nm0696-662; Shell SS, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003419; Streicher EM, 2014, J CLIN MICROBIOL, V52, P4056, DOI 10.1128/JCM.02438-14; STROMINGER JL, 1960, J AM CHEM SOC, V82, P998, DOI 10.1021/ja01489a058; Theron G, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010705.pub2; Torrea G, 2015, J ANTIMICROB CHEMOTH, V70, P2300, DOI 10.1093/jac/dkv117; Vo SK, 2010, J CLIN MICROBIOL, V48, P2934, DOI 10.1128/JCM.00201-10; Walker BJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112963; Warit S, 2015, J GLOB ANTIMICROB RE, V3, P262, DOI 10.1016/j.jgar.2015.07.004; WIAME JM, 1955, NATURE, V176, P1073, DOI 10.1038/1761073b0; Wong SY, 2011, ANTIMICROB AGENTS CH, V55, P2515, DOI 10.1128/AAC.01814-10; Woods GL, 2000, CLIN INFECT DIS, V31, P1209; World Health Organization, 2014, COMP HDB WHO GUID PR; YEW WW, 1993, CLIN INFECT DIS, V17, P288, DOI 10.1093/clinids/17.2.288; Zhang HT, 2013, NAT GENET, V45, P1255, DOI 10.1038/ng.2735	65	98	108	1	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2016	48	5					544	+		10.1038/ng.3548	http://dx.doi.org/10.1038/ng.3548			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DK3RC	27064254	Green Submitted, Green Accepted			2022-12-25	WOS:000374834100014
J	Elosegui-Artola, A; Oria, R; Chen, YF; Kosmalska, A; Perez-Gonzalez, C; Castro, N; Zhu, C; Trepat, X; Roca-Cusachs, P				Elosegui-Artola, Alberto; Oria, Roger; Chen, Yunfeng; Kosmalska, Anita; Perez-Gonzalez, Carlos; Castro, Natalia; Zhu, Cheng; Trepat, Xavier; Roca-Cusachs, Pere			Mechanical regulation of a molecular clutch defines force transmission and transduction in response to matrix rigidity	NATURE CELL BIOLOGY			English	Article							LIGAND BINDING-KINETICS; FOCAL ADHESIONS; INTEGRIN ACTIVATION; VINCULIN BINDING; TRACTION STRESSES; CELL TRACTION; CATCH BONDS; TALIN; ACTIN; DYNAMICS	Cell function depends on tissue rigidity, which cells probe by applying and transmitting forces to their extracellular matrix, and then transducing them into biochemical signals. Here we show that in response to matrix rigidity and density, force transmission and transduction are explained by the mechanical properties of the actin-talin-integrin-fibronectin clutch. We demonstrate that force transmission is regulated by a dynamic clutch mechanism, which unveils its fundamental biphasic force/rigidity relationship on talin depletion. Force transduction is triggered by talin unfolding above a stiffness threshold. Below this threshold, integrins unbind and release force before talin can unfold. Above the threshold, talin unfolds and binds to vinculin, leading to adhesion growth and YAP nuclear translocation. Matrix density, myosin contractility, integrin ligation and talin mechanical stability differently and nonlinearly regulate both force transmission and the transduction threshold. In all cases, coupling of talin unfolding dynamics to a theoretical clutch model quantitatively predicts cell response.	[Elosegui-Artola, Alberto; Oria, Roger; Kosmalska, Anita; Perez-Gonzalez, Carlos; Castro, Natalia; Trepat, Xavier; Roca-Cusachs, Pere] Inst Bioengn Catalonia, Barcelona 08028, Spain; [Oria, Roger; Kosmalska, Anita; Perez-Gonzalez, Carlos; Trepat, Xavier; Roca-Cusachs, Pere] Univ Barcelona, E-08028 Barcelona, Spain; [Chen, Yunfeng; Zhu, Cheng] Georgia Inst Technol, Woodruff Sch Mech Engn, Atlanta, GA 30332 USA; [Chen, Yunfeng; Zhu, Cheng] Georgia Inst Technol, Parker H Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA; [Zhu, Cheng] Georgia Inst Technol, Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; [Trepat, Xavier] ICREA, Barcelona 08010, Spain; [Trepat, Xavier] Ctr Invest Biomed Red Bioingn Biomat & Nanomed, Madrid 28029, Spain	Barcelona Institute of Science & Technology; Institut de Bioenginyeria de Catalunya; University of Barcelona; University of Barcelona; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; ICREA; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN	Roca-Cusachs, P (corresponding author), Inst Bioengn Catalonia, Barcelona 08028, Spain.; Roca-Cusachs, P (corresponding author), Univ Barcelona, E-08028 Barcelona, Spain.	rocacusachs@ub.edu	Roca-Cusachs, Pere/D-4309-2009; Pérez-González, Carlos J/L-2880-2017; Chen, Yunfeng/N-5752-2019; Trepat, Xavier/I-3912-2015; Elosegui-Artola, Alberto/G-2691-2016	Roca-Cusachs, Pere/0000-0001-6947-961X; Pérez-González, Carlos J/0000-0003-0059-7161; Chen, Yunfeng/0000-0001-7618-107X; Trepat, Xavier/0000-0002-7621-5214; Elosegui-Artola, Alberto/0000-0003-0644-3294; Zhu, Cheng/0000-0002-1718-565X	Spanish Ministry for Economy and Competitiveness [BFU2011-23111, BFU2012-38146, BFU2014-52586-REDT]; European Community [PCIG10-GA-2011-303848]; European Research Council [242993, 240487]; Generalitat de Catalunya; Fundacio la Marato de TV3 [20133330]; National Institutes of Health (US NIH) [R01AI044902]; Spanish Ministry of Economy and Competitiveness; fundacio 'La Caixa'; Fundacio La Caixa; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044902] Funding Source: NIH RePORTER; ICREA Funding Source: Custom	Spanish Ministry for Economy and Competitiveness(Spanish Government); European Community(European Commission); European Research Council(European Research Council (ERC)European Commission); Generalitat de Catalunya(Generalitat de Catalunya); Fundacio la Marato de TV3; National Institutes of Health (US NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Spanish Ministry of Economy and Competitiveness(Spanish Government); fundacio 'La Caixa'(La Caixa FoundationEuropean Commission); Fundacio La Caixa(La Caixa FoundationEuropean Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); ICREA(ICREA)	We acknowledge support from the Spanish Ministry for Economy and Competitiveness (BFU2011-23111, BFU2012-38146 and BFU2014-52586-REDT), a Career Integration Grant within the seventh European Community Framework Programme (PCIG10-GA-2011-303848), the European Research Council (Grant Agreements 242993 and 240487), the Generalitat de Catalunya, Fundacio La Caixa, Fundacio la Marato de TV3 (project 20133330), and the National Institutes of Health (US NIH R01AI044902). A.E.-A., R.O. and C.P.-G. were supported respectively by a Juan de la Cierva Fellowship (Spanish Ministry of Economy and Competitiveness), a FI fellowship (Generalitat de Catalunya), and the fundacio 'La Caixa'. We thank R. Sunyer, J. Alcaraz, E. Bazellieres, F. Rico, S. Garcia-Manyes, N. Bate, N. Berrow and the members of the P.R.-C. and X.T. laboratories for technical assistance and discussions.	Alcaraz J, 2003, BIOPHYS J, V84, P2071, DOI 10.1016/S0006-3495(03)75014-0; Austen K, 2015, NAT CELL BIOL, V17, P1597, DOI 10.1038/ncb3268; Bangasser BL, 2013, CELL MOL BIOENG, V6, P449, DOI 10.1007/s12195-013-0296-5; Bangasser BL, 2013, BIOPHYS J, V105, P581, DOI 10.1016/j.bpj.2013.06.027; Bate N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034461; Butler JP, 2002, AM J PHYSIOL-CELL PH, V282, pC595, DOI 10.1152/ajpcell.00270.2001; Califano JP, 2010, CELL MOL BIOENG, V3, P68, DOI 10.1007/s12195-010-0102-6; Case LB, 2015, NAT CELL BIOL, V17, P955, DOI 10.1038/ncb3191; Case LB, 2015, NAT CELL BIOL, V17, P880, DOI 10.1038/ncb3180; Chan CE, 2008, SCIENCE, V322, P1687, DOI 10.1126/science.1163595; Chen H, 2006, J BIOL CHEM, V281, P40389, DOI 10.1074/jbc.M607324200; Chen W, 2010, J BIOL CHEM, V285, P35967, DOI 10.1074/jbc.M110.155770; Chen W, 2008, CELL MOL BIOENG, V1, P276, DOI 10.1007/s12195-008-0024-8; Chen YF, 2015, JOVE-J VIS EXP, DOI 10.3791/52975; Chesla SE, 1998, BIOPHYS J, V75, P1553, DOI 10.1016/S0006-3495(98)74074-3; Cohen DM, 2006, J BIOL CHEM, V281, P16006, DOI 10.1074/jbc.M600738200; del Rio A, 2009, SCIENCE, V323, P638, DOI 10.1126/science.1162912; DuFort CC, 2011, NAT REV MOL CELL BIO, V12, P308, DOI 10.1038/nrm3112; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Elosegui-Artola A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107393; Elosegui-Artola A, 2014, NAT MATER, V13, P631, DOI [10.1038/NMAT3960, 10.1038/nmat3960]; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Etienne J, 2015, P NATL ACAD SCI USA, V112, P2740, DOI 10.1073/pnas.1417113112; FRELINGER AL, 1991, J BIOL CHEM, V266, P17106; Ghassemi S, 2012, P NATL ACAD SCI USA, V109, P5328, DOI 10.1073/pnas.1119886109; Ghibaudo M, 2008, SOFT MATTER, V4, P1836, DOI 10.1039/b804103b; Gupta M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8525; Hirata H, 2014, AM J PHYSIOL-CELL PH, V306, pC607, DOI 10.1152/ajpcell.00122.2013; Humphries JD, 2007, J CELL BIOL, V179, P1043, DOI 10.1083/jcb.200703036; HUTTER JL, 1993, REV SCI INSTRUM, V64, P1868, DOI 10.1063/1.1143970; Iwamoto DV, 2015, CURR OPIN CELL BIOL, V36, P41, DOI 10.1016/j.ceb.2015.06.009; Klapholz B, 2015, CURR BIOL, V25, P847, DOI 10.1016/j.cub.2015.01.043; Kong F, 2009, J CELL BIOL, V185, P1275, DOI 10.1083/jcb.200810002; Margadant F, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001223; Moore SW, 2010, DEV CELL, V19, P194, DOI 10.1016/j.devcel.2010.07.018; Oakes PW, 2014, BIOPHYS J, V107, P825, DOI 10.1016/j.bpj.2014.06.045; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; PIERSCHBACHER MD, 1987, J BIOL CHEM, V262, P17294; Plotnikov SV, 2012, CELL, V151, P1513, DOI 10.1016/j.cell.2012.11.034; Plouffe SW, 2015, TRENDS MOL MED, V21, P212, DOI 10.1016/j.molmed.2015.01.003; Roca-Cusachs P, 2008, BIOPHYS J, V94, P4984, DOI 10.1529/biophysj.107.116863; Roca-Cusachs P, 2013, P NATL ACAD SCI USA, V110, pE1361, DOI 10.1073/pnas.1220723110; Roca-Cusachs P, 2012, J CELL SCI, V125, P3025, DOI 10.1242/jcs.095794; Roca-Cusachs P, 2009, P NATL ACAD SCI USA, V106, P16245, DOI 10.1073/pnas.0902818106; Saltel F, 2009, J CELL BIOL, V187, P715, DOI 10.1083/jcb.200908134; Schiller HB, 2013, NAT CELL BIOL, V15, P625, DOI 10.1038/ncb2747; Schoen I, 2013, ANNU REV MATER RES, V43, P589, DOI 10.1146/annurev-matsci-062910-100407; Serra-Picamal X, 2012, NAT PHYS, V8, P628, DOI [10.1038/NPHYS2355, 10.1038/nphys2355]; Simonson WTN, 2006, J IMMUNOL, V177, P7707, DOI 10.4049/jimmunol.177.11.7707; Swift J, 2013, SCIENCE, V341, DOI 10.1126/science.1240104; Takagi J, 2002, CELL, V110, P599, DOI 10.1016/S0092-8674(02)00935-2; Tanentzapf G, 2006, NAT CELL BIOL, V8, P601, DOI 10.1038/ncb1411; Thievessen I, 2013, J CELL BIOL, V202, P163, DOI 10.1083/jcb.201303129; Wegener KL, 2007, CELL, V128, P171, DOI 10.1016/j.cell.2006.10.048; Yao MX, 2014, SCI REP-UK, V4, DOI 10.1038/srep04610; Zhang X, 2008, NAT CELL BIOL, V10, P1062, DOI 10.1038/ncb1765	56	374	377	19	206	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAY	2016	18	5					540	+		10.1038/ncb3336	http://dx.doi.org/10.1038/ncb3336			26	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	DK3RH	27065098	Green Accepted			2022-12-25	WOS:000374834600011
J	Li, L; Grausam, KB; Wang, J; Lun, MP; Ohli, J; Lidov, HGW; Calicchio, ML; Zeng, EL; Salisbury, JL; Wechsler-Reya, RJ; Lehtinen, MK; Schuller, U; Zhao, HT				Li, Li; Grausam, Katie B.; Wang, Jun; Lun, Melody P.; Ohli, Jasmin; Lidov, Hart G. W.; Calicchio, Monica L.; Zeng, Erliang; Salisbury, Jeffrey L.; Wechsler-Reya, Robert J.; Lehtinen, Maria K.; Schueller, Ulrich; Zhao, Haotian			Sonic Hedgehog promotes proliferation of Notch-dependent monociliated choroid plexus tumour cells	NATURE CELL BIOLOGY			English	Article							CEREBELLAR RHOMBIC-LIP; DORSAL NEURAL-TUBE; ROOF PLATE; EPITHELIAL-CELLS; PRIMARY CILIUM; EXPRESSION; ZEBRAFISH; SPECIFICATION; CARCINOMAS; GENES	Aberrant Notch signalling has been linked to many cancers including choroid plexus (CP) tumours, a group of rare and predominantly paediatric brain neoplasms. We developed animal models of CP tumours, by inducing sustained expression of Notch1, that recapitulate properties of human CP tumours with aberrant NOTCH signalling. Whole-transcriptome and functional analyses showed that tumour cell proliferation is associated with Sonic Hedgehog (Shh) in the tumour microenvironment. Unlike CP epithelial cells, which have multiple primary cilia, tumour cells possess a solitary primary cilium as a result of Notch-mediated suppression of multiciliate differentiation. A Shh-driven signalling cascade in the primary cilium occurs in tumour cells but not in epithelial cells. Lineage studies show that CP tumours arise from monociliated progenitors in the roof plate characterized by elevated Notch signalling. Abnormal SHH signalling and distinct ciliogenesis are detected in human CP tumours, suggesting the SHH pathway and cilia differentiation as potential therapeutic avenues.	[Li, Li; Grausam, Katie B.; Zhao, Haotian] Sanford Res, Childrens Hlth Res Ctr, 2301 E 60th St North, Sioux Falls, SD 57104 USA; [Grausam, Katie B.; Zhao, Haotian] Univ S Dakota, Sanford Sch Med, Div Basic Biomed Sci, 414 E Clark St, Vermillion, SD 57069 USA; [Grausam, Katie B.; Salisbury, Jeffrey L.] Sanford Burnham Prebys Med Discovery Inst, Tumor Initiat & Maintenance Programme, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA; [Lun, Melody P.; Lidov, Hart G. W.; Calicchio, Monica L.; Lehtinen, Maria K.] Boston Childrens Hosp, Dept Pathol, Boston, MA 02115 USA; [Lun, Melody P.] Boston Univ, Sch Med, Dept Pathol & Lab Med, Boston, MA 02118 USA; [Ohli, Jasmin; Schueller, Ulrich] Univ Munich, Ctr Neuropathol & Prion Res, D-81377 Munich, Germany; [Calicchio, Monica L.] Univ S Dakota, Dept Biol, 414 E Clark St, Vermillion, SD 57069 USA; [Zeng, Erliang] Univ S Dakota, Dept Comp Sci, 414 E Clark St, Vermillion, SD 57069 USA; [Salisbury, Jeffrey L.] Mayo Clin, Dept Biochem & Mol Biol, Guggenheim 14,200 First St SW, Rochester, MN 55905 USA; [Salisbury, Jeffrey L.] Mayo Clin, Microscopy & Cell Anal Core, Guggenheim 14,200 First St SW, Rochester, MN 55905 USA; [Zhao, Haotian] Sanford Res, Canc Biol Res Ctr, 2301 E 60th St N, Sioux Falls, SD 57104 USA; [Zhao, Haotian] Univ S Dakota, Sanford Sch Med, Dept Pediat, 1400 W 22nd St, Sioux Falls, SD 57105 USA; [Zhao, Haotian] S Dakota State Univ, Dept Chem & Biochem, Avera Hlth Sci Ctr SAV, 131 Brookings, Brookings, SD 57007 USA	Sanford Health; University of South Dakota; Sanford Burnham Prebys Medical Discovery Institute; Harvard University; Boston Children's Hospital; Boston University; University of Munich; University of South Dakota; University of South Dakota; Mayo Clinic; Mayo Clinic; Sanford Health; University of South Dakota; South Dakota State University	Zhao, HT (corresponding author), Sanford Res, Childrens Hlth Res Ctr, 2301 E 60th St North, Sioux Falls, SD 57104 USA.; Zhao, HT (corresponding author), Univ S Dakota, Sanford Sch Med, Div Basic Biomed Sci, 414 E Clark St, Vermillion, SD 57069 USA.; Zhao, HT (corresponding author), Sanford Res, Canc Biol Res Ctr, 2301 E 60th St N, Sioux Falls, SD 57104 USA.; Zhao, HT (corresponding author), Univ S Dakota, Sanford Sch Med, Dept Pediat, 1400 W 22nd St, Sioux Falls, SD 57105 USA.; Zhao, HT (corresponding author), S Dakota State Univ, Dept Chem & Biochem, Avera Hlth Sci Ctr SAV, 131 Brookings, Brookings, SD 57007 USA.	Haotian.Zhao@sanfordhealth.org	Zeng, Erliang/AAH-2289-2019; Zeng, Erliang/E-9663-2010	Zeng, Erliang/0000-0003-3354-6416; Zeng, Erliang/0000-0002-2891-6497; Salisbury, Jeffrey/0000-0001-9257-4578; Schuller, Ulrich/0000-0002-8731-1121	b.r.a.i.n child; Meagan's Walk; Boston Children's Hospital IDDRC [P30 HD18655]; Sanford Research, and Institutional Development Awards (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health (NIH) [5P20GM103548]; NIH [1P20GM103620-01A1]; Shared Instrumentation grant from the NIH [1S10OD016167]; National Brain Tumor Society; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM010362, P20GM103620, P20GM103548] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD016167] Funding Source: NIH RePORTER	b.r.a.i.n child; Meagan's Walk; Boston Children's Hospital IDDRC; Sanford Research, and Institutional Development Awards (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health (NIH); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shared Instrumentation grant from the NIH; National Brain Tumor Society; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank all members of the laboratory for helpful discussions. We are grateful to K. Millen (Seattle Children's Hospital Research Institute, USA), J. Kim (University of Texas Southwestern Medical Center, USA) and R. Kageyama (Institute for Virus Research Kyoto University, Japan) for providing the Lmx1a Cre transgenic mouse strain, Smo antibody, and Hes1 antibodies, respectively, and C. Eberhart (Johns Hopkins University School of Medicine, USA), M. Taylor (The Hospital for Sick Children, Canada) and S. Santagata (Boston Children's Hospital, USA) for providing human CP tumour samples. We wish to acknowledge the Labatt Brain Tumour Research Centre Tumour and Tissue Repository, which is supported by b.r.a.i.n child and Meagan's Walk. We are indebted to C. Evans, A. Kelsch and E. Grandprey for excellent technical assistance. We thank W.K. Miskimins and K. Surendran for helpful suggestions, and J. Tao and D. Maher for critical reading of the manuscript and helpful discussions. This project is supported by: Boston Children's Hospital IDDRC P30 HD18655, Sanford Research, and Institutional Development Awards (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health (NIH) under grant number 5P20GM103548 (Cancer), which also supports Cores at Sanford Research together with NIH grant 1P20GM103620-01A1 (Pediatrics). The RNA In Situ Hybridization Core facility at Baylor College of Medicine is supported by a Shared Instrumentation grant from the NIH (1S10OD016167). Additional support was provided by the National Brain Tumor Society (R.J.W.-R.).	Awatramani R, 2003, NAT GENET, V35, P70, DOI 10.1038/ng1228; Barakat MT, 2010, TRENDS MOL MED, V16, P337, DOI 10.1016/j.molmed.2010.05.003; Beschorner R, 2013, HISTOL HISTOPATHOL, V28, P1055, DOI 10.14670/HH-28.1055; Bill BR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003114; Bowyer JF, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-147; Broom ER, 2012, DEVELOPMENT, V139, P4261, DOI 10.1242/dev.082255; Caspary T, 2007, DEV CELL, V12, P767, DOI 10.1016/j.devcel.2007.03.004; Chen JK, 2002, P NATL ACAD SCI USA, V99, P14071, DOI 10.1073/pnas.182542899; Chizhikov VV, 2006, DEVELOPMENT, V133, P2793, DOI 10.1242/dev.02441; Chizhikov VV, 2010, P NATL ACAD SCI USA, V107, P10725, DOI 10.1073/pnas.0910786107; Choksi SP, 2014, DEVELOPMENT, V141, P3410, DOI 10.1242/dev.108209; Dang L, 2006, ONCOGENE, V25, P487, DOI 10.1038/sj.onc.1209074; De Smaele E, 2010, CURR OPIN INVEST DR, V11, P707; Elsen GE, 2008, DEV BIOL, V314, P376, DOI 10.1016/j.ydbio.2007.12.006; Fouladi M, 2011, J CLIN ONCOL, V29, P3529, DOI 10.1200/JCO.2011.35.7806; Garcia-Lecea M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003090; Gomperts BN, 2004, J CELL SCI, V117, P1329, DOI 10.1242/jcs.00978; Gopal P, 2008, ARCH PATHOL LAB MED, V132, P1350, DOI 10.1043/1543-2165(2008)132[1350:CPC]2.0.CO;2; Groth C, 2012, SEMIN CELL DEV BIOL, V23, P465, DOI 10.1016/j.semcdb.2012.01.016; Hasselblatt M, 2009, CANCER RES, V69, P2219, DOI 10.1158/0008-5472.CAN-08-3176; Hoh RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052166; Huang X, 2010, P NATL ACAD SCI USA, V107, P8422, DOI 10.1073/pnas.0911838107; Huang X, 2009, DEVELOPMENT, V136, P2535, DOI 10.1242/dev.033795; Hunter NL, 2007, DEVELOPMENT, V134, P3449, DOI 10.1242/dev.003095; Imai Masaaki, 2011, Surg Neurol Int, V2, P151, DOI 10.4103/2152-7806.86228; Imayoshi I, 2008, DEVELOPMENT, V135, P2531, DOI 10.1242/dev.021535; Janssen SF, 2014, FLUIDS BARRIERS CNS, V11, DOI 10.1186/2045-8118-11-2; Jiang J, 2008, DEV CELL, V15, P801, DOI 10.1016/j.devcel.2008.11.010; Johansson PA, 2013, DEVELOPMENT, V140, P1055, DOI 10.1242/dev.090860; Kim J, 2010, P NATL ACAD SCI USA, V107, P13432, DOI 10.1073/pnas.1006822107; Koch U, 2010, CURR TOP DEV BIOL, V92, P411, DOI 10.1016/S0070-2153(10)92013-9; Kong JH, 2015, DEV CELL, V33, P373, DOI 10.1016/j.devcel.2015.03.005; Lehtinen MK, 2013, J NEUROSCI, V33, P17553, DOI 10.1523/JNEUROSCI.3258-13.2013; Liu Y, 2004, DEVELOPMENT, V131, P1017, DOI 10.1242/dev.00994; Lun MP, 2015, NAT REV NEUROSCI, V16, P445, DOI 10.1038/nrn3921; Lun MP, 2015, J NEUROSCI, V35, P4903, DOI 10.1523/JNEUROSCI.3081-14.2015; Machold R, 2005, NEURON, V48, P17, DOI 10.1016/j.neuron.2005.08.028; Mahjoub MR, 2013, ORGANOGENESIS, V9, P61, DOI 10.4161/org.25144; Mahjoub MR, 2012, CURR BIOL, V22, P1628, DOI 10.1016/j.cub.2012.06.057; Marcet B, 2011, NAT CELL BIOL, V13, P693, DOI 10.1038/ncb2241; Marques F, 2011, FLUIDS BARRIERS CNS, V8, DOI 10.1186/2045-8118-8-10; Matei V, 2005, DEV DYNAM, V234, P633, DOI 10.1002/dvdy.20551; McMahon Ariel R, 2010, BMC Res Notes, V3, P167, DOI 10.1186/1756-0500-3-167; Merino DM, 2015, CLIN CANCER RES, V21, P184, DOI 10.1158/1078-0432.CCR-14-1324; Morimoto M, 2010, J CELL SCI, V123, P213, DOI 10.1242/jcs.058669; Murtaugh LC, 2003, P NATL ACAD SCI USA, V100, P14920, DOI 10.1073/pnas.2436557100; Nielsen CM, 2010, DEV BIOL, V340, P430, DOI 10.1016/j.ydbio.2010.01.032; Nupponen NN, 2008, MODERN PATHOL, V21, P265, DOI 10.1038/modpathol.3800989; Ogiwara H, 2012, BRIT J NEUROSURG, V26, P32, DOI 10.3109/02688697.2011.601820; Rose MF, 2009, NEURON, V64, P341, DOI 10.1016/j.neuron.2009.10.023; Ruland V, 2014, GENE CHROMOSOME CANC, V53, P373, DOI 10.1002/gcc.22148; Safaee M, 2013, J NEURO-ONCOL, V113, P117, DOI 10.1007/s11060-013-1097-3; Safaee M, 2013, NEURO-ONCOLOGY, V15, P255, DOI 10.1093/neuonc/nos289; South AP, 2012, SEMIN CELL DEV BIOL, V23, P458, DOI 10.1016/j.semcdb.2012.01.017; Spatazza J, 2013, CELL REP, V3, P1815, DOI 10.1016/j.celrep.2013.05.014; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Stasiulewicz M, 2015, DEVELOPMENT, V142, P2291, DOI 10.1242/dev.125237; Stubbs JL, 2012, NAT CELL BIOL, V14, P140, DOI 10.1038/ncb2406; Sun MZ, 2014, NEUROSURG REV, V37, P179, DOI 10.1007/s10143-013-0499-1; Tabori U, 2010, J CLIN ONCOL, V28, P1995, DOI 10.1200/JCO.2009.26.8169; Tan FE, 2013, DEVELOPMENT, V140, P4277, DOI 10.1242/dev.094102; The WHO, 2020, CLASSIFICATION TUMOU; Thomas J, 2010, BIOL CELL, V102, P499, DOI 10.1042/BC20100035; Tong YA, 2015, CANCER CELL, V27, P712, DOI 10.1016/j.ccell.2015.04.005; Wang VY, 2005, NEURON, V48, P31, DOI 10.1016/j.neuron.2005.08.024; Xie JW, 2013, ONCOTARGETS THER, V6, P1425, DOI 10.2147/OTT.S34678; Yaylaoglu MB, 2005, DEV DYNAM, V234, P371, DOI 10.1002/dvdy.20441; Yu XW, 2008, NAT GENET, V40, P1445, DOI 10.1038/ng.263; Zhao H, 2008, GENE DEV, V22, P722, DOI 10.1101/gad.1636408	69	37	37	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2016	18	4					418	+		10.1038/ncb3327	http://dx.doi.org/10.1038/ncb3327			25	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	DH7LX	26999738	Green Accepted			2022-12-25	WOS:000372976600009
J	Stuckey, JI; Dickson, BM; Cheng, N; Liu, YL; Norris, JL; Cholensky, SH; Tempel, W; Qin, S; Huber, KG; Sagum, C; Black, K; Li, FL; Huang, XP; Roth, BL; Baughman, BM; Senisterra, G; Pattenden, SG; Vedadi, M; Browne, PJ; Bedford, MT; Min, JR; Arrowsmith, CH; James, LI; Frye, SV				Stuckey, Jacob I.; Dickson, Bradley M.; Cheng, Nancy; Liu, Yanli; Norris, Jacqueline L.; Cholensky, Stephanie H.; Tempel, Wolfram; Qin, Su; Huber, Katherine G.; Sagum, Cari; Black, Karynne; Li, Fengling; Huang, Xi-Ping; Roth, Bryan L.; Baughman, Brandi M.; Senisterra, Guillermo; Pattenden, Samantha G.; Vedadi, Masoud; Browne, Peter J.; Bedford, Mark T.; Min, Jinrong; Arrowsmith, Cheryl H.; James, Lindsey I.; Frye, Stephen V.			A cellular chemical probe targeting the chromodomains of Polycomb repressive complex 1	NATURE CHEMICAL BIOLOGY			English	Article							CHROMOBOX PROTEIN CBX7; METHYLATION; METHYLTRANSFERASES; SPECIFICITY; INHIBITION; PHENOTYPE; MECHANISM; DYNAMICS; FAMILY; GROWTH	We report the design and characterization of UNC3866, a potent antagonist of the methyllysine (Kme) reading function of the Polycomb CBX and CDY families of chromodomains. Polycomb CBX proteins regulate gene expression by targeting Polycomb repressive complex 1 (PRC1) to sites of H3K27me3 via their chromodomains. UNC3866 binds the chromodomains of CBX4 and CBX7 most potently, with a K-d of similar to 100 nM for each, and is 6- to 18-fold selective as compared to seven other CBX and CDY chromodomains while being highly selective over >250 other protein targets. X-ray crystallography revealed that UNC3866's interactions with the CBX chromodomains closely mimic those of the methylated H3 tail. UNC4195, a biotinylated derivative of UNC3866, was used to demonstrate that UNC3866 engages intact PRC1 and that EED incorporation into PRC1 is isoform dependent in PC3 prostate cancer cells. Finally, UNC3866 inhibits PC3 cell proliferation, consistent with the known ability of CBX7 overexpression to confer a growth advantage, whereas UNC4219, a methylated negative control compound, has negligible effects.	[Stuckey, Jacob I.; Dickson, Bradley M.; Cheng, Nancy; Norris, Jacqueline L.; Cholensky, Stephanie H.; Huber, Katherine G.; Baughman, Brandi M.; Pattenden, Samantha G.; James, Lindsey I.; Frye, Stephen V.] Univ N Carolina, UNC Eshelman Sch Pharm, Div Chem Biol & Med Chem, Ctr Integrat Chem Biol & Drug Discovery, Chapel Hill, NC USA; [Liu, Yanli; Tempel, Wolfram; Qin, Su; Li, Fengling; Senisterra, Guillermo; Vedadi, Masoud; Browne, Peter J.; Min, Jinrong; Arrowsmith, Cheryl H.] Univ Toronto, Struct Genom Consortium, Toronto, ON, Canada; [Sagum, Cari; Black, Karynne; Bedford, Mark T.] Univ Texas MD Anderson Canc Ctr, Dept Epigenet & Mol Carcinogenesis, Smithville, TX USA; [Huang, Xi-Ping; Roth, Bryan L.] Univ N Carolina, Sch Med, Natl Inst Mental Hlth, Psychoact Drug Screening Program, Chapel Hill, NC USA; [Huang, Xi-Ping; Roth, Bryan L.] Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of Toronto; Structural Genomics Consortium; University of Texas System; UTMD Anderson Cancer Center; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	James, LI; Frye, SV (corresponding author), Univ N Carolina, UNC Eshelman Sch Pharm, Div Chem Biol & Med Chem, Ctr Integrat Chem Biol & Drug Discovery, Chapel Hill, NC USA.	ingerman@email.unc.edu; svfrye@email.unc.edu	Roth, Bryan L/F-3928-2010; Liu, Yanli/AAA-3283-2019; Min, Jinrong/G-3449-2011; Roth, Bryan/ABE-7032-2020; Qin, Su/Y-3750-2019	Liu, Yanli/0000-0003-0197-7617; Min, Jinrong/0000-0001-5210-3130; Roth, Bryan/0000-0002-0561-6520; Qin, Su/0000-0001-9437-6292; Brown, Peter/0000-0002-8454-0367; Arrowsmith, Cheryl/0000-0002-4971-3250	National Institute of General Medical Sciences, US National Institutes of Health (NIH) [R01GM100919]; US Department of Energy (DOE) Office of Science User Facility; Carolina Partnership; University Cancer Research Fund; University of North Carolina at Chapel Hill; Welch Foundation [G-1847]; AbbVie [1097737]; Boehringer Ingelheim; Canada Foundation for Innovation (CFI); Canadian Institutes of Health Research (CIHR); Genome Canada; Ontario Genomics Institute Grant [OGI-055]; GlaxoSmithKline; Janssen; Lilly Canada; Novartis Research Foundation; Ontario Ministry of Economic Development and Innovation; Pfizer; Takeda; Wellcome Trust [092809/Z/10/Z]; Cancer Prevention Research Institute of Texas [RP130432]; Centre for Environmental and Molecular Carcinogenesis at the MD Anderson Cancer Center; NATIONAL CANCER INSTITUTE [P30CA016086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100919] Funding Source: NIH RePORTER	National Institute of General Medical Sciences, US National Institutes of Health (NIH); US Department of Energy (DOE) Office of Science User Facility(United States Department of Energy (DOE)); Carolina Partnership; University Cancer Research Fund; University of North Carolina at Chapel Hill; Welch Foundation(The Welch Foundation); AbbVie(AbbVie); Boehringer Ingelheim(Boehringer Ingelheim); Canada Foundation for Innovation (CFI)(Canada Foundation for Innovation); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Genome Canada(Genome Canada); Ontario Genomics Institute Grant; GlaxoSmithKline(GlaxoSmithKline); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Lilly Canada(Eli Lilly); Novartis Research Foundation; Ontario Ministry of Economic Development and Innovation; Pfizer(Pfizer); Takeda(Takeda Pharmaceutical Company Ltd); Wellcome Trust(Wellcome TrustEuropean Commission); Cancer Prevention Research Institute of Texas; Centre for Environmental and Molecular Carcinogenesis at the MD Anderson Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank K. Pearce (UNC Chapel Hill) for useful discussions and careful reading of the manuscript, O. Fedorov (SGC Oxford) for support with the bromodomain selectivity screening, A. Tumber (SGC Oxford) for support with the lysine demethylase selectivity screening and J.R. Walker for the review of the crystal structures. We thank G. Wang (UNC) for providing PHF1, PHF19, PHF23 and JARID1A protein constructs. We thank the labs of T. Magnuson (UNC) and D. Margolis (UNC) for providing EED and BMI-1 antibodies, respectively. We also thank N. Sciaky (UNC) for help with cell counting using the high content imaging microscope. Results shown in this report are derived from work performed at Argonne National Laboratory, Structural Biology Center at the Advanced Photon Source, a US Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under contract no. DE-AC02-06CH11357. The research described here was supported by the National Institute of General Medical Sciences, US National Institutes of Health (NIH, grant R01GM100919), the Carolina Partnership and the University Cancer Research Fund, University of North Carolina at Chapel Hill, and the Welch Foundation (G-1847). The SGC is a registered charity (no. 1097737) that receives funds from AbbVie, Boehringer Ingelheim, the Canada Foundation for Innovation (CFI), the Canadian Institutes of Health Research (CIHR), Genome Canada, Ontario Genomics Institute Grant OGI-055, GlaxoSmithKline, Janssen, Lilly Canada, the Novartis Research Foundation, the Ontario Ministry of Economic Development and Innovation, Pfizer, Takeda and Wellcome Trust Grant 092809/Z/10/Z. M.T.B. directs the Protein Array Core, which is supported by the Cancer Prevention Research Institute of Texas (RP130432) and by the Centre for Environmental and Molecular Carcinogenesis at the MD Anderson Cancer Center.	Arrowsmith CH, 2012, NAT REV DRUG DISCOV, V11, P384, DOI 10.1038/nrd3674; Bernard D, 2005, ONCOGENE, V24, P5543, DOI 10.1038/sj.onc.1208735; Besnard J, 2012, NATURE, V492, P215, DOI 10.1038/nature11691; Bunnage ME, 2013, NAT CHEM BIOL, V9, P195, DOI 10.1038/nchembio.1197; Cao Q, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4127; Clermont PL, 2014, BRIT J CANCER, V111, P1663, DOI 10.1038/bjc.2014.474; Dickson BM, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.037701; Eskeland R, 2010, MOL CELL, V38, P452, DOI 10.1016/j.molcel.2010.02.032; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Fischle W, 2008, J BIOL CHEM, V283, P19626, DOI 10.1074/jbc.M802655200; Forzati F, 2012, J CLIN INVEST, V122, P612, DOI 10.1172/JCI58620; Frye SV, 2010, NAT CHEM BIOL, V6, P159, DOI 10.1038/nchembio.296; Gil J, 2004, NAT CELL BIOL, V6, P67, DOI 10.1038/ncb1077; Hashizume R, 2014, NAT MED, V20, P1394, DOI 10.1038/nm.3716; Hopkinson RJ, 2013, ANGEW CHEM INT EDIT, V52, P7709, DOI 10.1002/anie.201303282; James LI, 2013, NAT CHEM BIOL, V9, P184, DOI [10.1038/NCHEMBIO.1157, 10.1038/nchembio.1157]; Jarrard DF, 1997, GENE CHROMOSOME CANC, V19, P90, DOI 10.1002/(SICI)1098-2264(199706)19:2<90::AID-GCC4>3.0.CO;2-V; Jin BL, 2012, CELL REP, V2, P1411, DOI 10.1016/j.celrep.2012.10.017; Karamitopoulou E, 2010, EUR J CANCER, V46, P1438, DOI 10.1016/j.ejca.2010.01.033; Kaustov L, 2011, J BIOL CHEM, V286, P521, DOI 10.1074/jbc.M110.191411; Klauke K, 2013, NAT CELL BIOL, V15, P353, DOI 10.1038/ncb2701; Kong Y, 2011, J AGING RES, V2011, DOI [10.4061/2011/963172, DOI 10.4061/2011/963172]; Konze KD, 2013, ACS CHEM BIOL, V8, P1324, DOI [10.1021/cb400133J, 10.1021/cb400133j]; Kroeze WK, 2015, NAT STRUCT MOL BIOL, V22, P362, DOI 10.1038/nsmb.3014; Kuzmichev A, 2004, MOL CELL, V14, P183, DOI 10.1016/S1097-2765(04)00185-6; Li QA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013732; Mansueto Gelsomina, 2010, Genes Cancer, V1, P210, DOI 10.1177/1947601910366860; Mirochnik Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031052; Molina DM, 2013, SCIENCE, V341, P84, DOI 10.1126/science.1233606; Montgomery ND, 2007, J MOL BIOL, V374, P1145, DOI 10.1016/j.jmb.2007.10.040; Morey L, 2013, CELL REP, V3, P60, DOI 10.1016/j.celrep.2012.11.026; Munoz V, 1997, NATURE, V390, P196, DOI 10.1038/36626; Ntziachristos P, 2014, NATURE, V514, P513, DOI 10.1038/nature13605; Pallante P, 2008, CANCER RES, V68, P6770, DOI 10.1158/0008-5472.CAN-08-0695; Pallante P, 2010, EUR J CANCER, V46, P2304, DOI 10.1016/j.ejca.2010.05.011; Ren CY, 2015, CHEM BIOL, V22, P161, DOI 10.1016/j.chembiol.2014.11.021; Ren XJ, 2008, MOL CELL BIOL, V28, P2884, DOI 10.1128/MCB.00949-07; Sauvageau M, 2008, PLOS BIOL, V6, P678, DOI 10.1371/journal.pbio.0060113; Scott CL, 2007, P NATL ACAD SCI USA, V104, P5389, DOI 10.1073/pnas.0608721104; Shinjo K, 2014, INT J CANCER, V135, P308, DOI 10.1002/ijc.28692; Simhadri C, 2014, J MED CHEM, V57, P2874, DOI 10.1021/jm401487x; Tan JY, 2011, CANCER CELL, V20, P563, DOI 10.1016/j.ccr.2011.09.008; Vandamme J, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.002642; Wagner T, 2014, CHEMMEDCHEM, V9, P466, DOI 10.1002/cmdc.201300422; Wang BQ, 2013, ANN SURG ONCOL, V20, pS684, DOI 10.1245/s10434-013-3171-7; Workman P, 2010, CHEM BIOL, V17, P561, DOI 10.1016/j.chembiol.2010.05.013; Xiao Y, 2009, INT J MOL SCI, V10, P2838, DOI 10.3390/ijms10062838; Yaqinuddin A, 2008, CANCER CELL INT, V8, DOI 10.1186/1475-2867-8-13; Yaqinuddin A, 2009, J UROLOGY, V182, P756, DOI 10.1016/j.juro.2009.03.082; Zhang XW, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-114	50	97	101	0	47	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAR	2016	12	3					180	187		10.1038/nchembio.2007	http://dx.doi.org/10.1038/nchembio.2007			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF5FK	26807715	Green Submitted, Green Accepted			2022-12-25	WOS:000371377000011
J	Baruch, K; Deczkowska, A; Rosenzweig, N; Tsitsou-Kampeli, A; Sharif, AM; Matcovitch-Natan, O; Kertser, A; David, E; Amit, I; Schwartz, M				Baruch, Kuti; Deczkowska, Aleksandra; Rosenzweig, Neta; Tsitsou-Kampeli, Afroditi; Sharif, Alaa Mohammad; Matcovitch-Natan, Orit; Kertser, Alexander; David, Eyal; Amit, Ido; Schwartz, Michal			PD-1 immune checkpoint blockade reduces pathology and improves memory in mouse models of Alzheimer's disease	NATURE MEDICINE			English	Article							CHOROID-PLEXUS; NEURODEGENERATION; RECRUITMENT; MACROPHAGES; ACTIVATION	Systemic immune suppression may curtail the ability to mount the protective, cell-mediated immune responses that are needed for brain repair. By using mouse models of Alzheimer's disease (AD), we show that immune checkpoint blockade directed against the programmed death-1 (PD-1) pathway evokes an interferon (IFN)-gamma-dependent systemic immune response, which is followed by the recruitment of monocyte-derived macrophages to the brain. When induced in mice with established pathology, this immunological response leads to clearance of cerebral amyloid-beta (A beta) plaques and improved cognitive performance. Repeated treatment sessions were required to maintain a long-lasting beneficial effect on disease pathology. These findings suggest that immune checkpoints may be targeted therapeutically in AD.	[Baruch, Kuti; Deczkowska, Aleksandra; Rosenzweig, Neta; Tsitsou-Kampeli, Afroditi; Sharif, Alaa Mohammad; Matcovitch-Natan, Orit; Kertser, Alexander; Schwartz, Michal] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel; [Matcovitch-Natan, Orit; David, Eyal; Amit, Ido] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel	Weizmann Institute of Science; Weizmann Institute of Science	Baruch, K; Schwartz, M (corresponding author), Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel.	Kuti.Baruch@weizmann.ac.il; Michal.Schwartz@weizmann.ac.il	Baruch, Kuti/I-3535-2016	Baruch, Kuti/0000-0002-1466-8795	Advanced European Research Council (ERC) [232835, 309788]; EU [279017]; Israeli Science Foundation [1782/11]; Weizmann-Tanz collaboration for research in Alzheimer's disease	Advanced European Research Council (ERC)(European Research Council (ERC)); EU(European Commission); Israeli Science Foundation(Israel Science Foundation); Weizmann-Tanz collaboration for research in Alzheimer's disease	We thank I. Slutsky (Tel Aviv University, Tel Aviv, Israel) for APP/PSI mice, S. Schwarzbaum for proofreading the manuscript, M. Azulai for animal handling and the Krenter Institute for equipment grant support. This work was supported by Advanced European Research Council (ERC) grants (no. 232835 to M.S. and no. 309788 to I.A.), by the EU Seventh Framework Program HEALTH-2011 (grant no. 279017 to M.S.), by an Israeli Science Foundation grant (no. 1782/11 to I.A.) and by the Weizmann-Tanz collaboration for research in Alzheimer's disease (to M.S.). M.S. holds the Maurice and use Katz Professorial Chair in Neuroimmunology.	Arvanitakis Z, 2008, NEUROLOGY, V70, P2219, DOI 10.1212/01.wnl.0000313813.48505.86; Baruch K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8967; Baruch K, 2014, SCIENCE, V346, P89, DOI 10.1126/science.1252945; Chinai JM, 2015, TRENDS PHARMACOL SCI, V36, P587, DOI 10.1016/j.tips.2015.06.005; ElKhoury J, 1996, NATURE, V382, P716; Gate D, 2010, J NEURAL TRANSM, V117, P961, DOI 10.1007/s00702-010-0422-7; Heneka MT, 2014, NAT REV IMMUNOL, V14, P463, DOI 10.1038/nri3705; Jankowsky JL, 2004, HUM MOL GENET, V13, P159, DOI 10.1093/hmg/ddh019; Kong YCM, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00206; Kunis G, 2013, BRAIN, V136, P3427, DOI 10.1093/brain/awt259; Lesokhin AM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010274; Moalem G, 1999, NAT MED, V5, P49, DOI 10.1038/4734; Naert G, 2013, J MOL CELL BIOL, V5, P284, DOI 10.1093/jmcb/mjt028; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; Okazaki T, 2013, NAT IMMUNOL, V14, P1212, DOI 10.1038/ni.2762; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Peng WY, 2012, CANCER RES, V72, P5209, DOI 10.1158/0008-5472.CAN-12-1187; Schwartz M, 2014, EMBO J, V33, P7, DOI 10.1002/embj.201386609; Shechter R, 2013, IMMUNITY, V38, P555, DOI 10.1016/j.immuni.2013.02.012; Wyss-Coray T, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006346	20	203	219	1	101	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2016	22	2					135	137		10.1038/nm.4022	http://dx.doi.org/10.1038/nm.4022			3	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DC8JX	26779813				2022-12-25	WOS:000369466800006
J	Poon, LLM; Song, T; Rosenfeld, R; Lin, XD; Rogers, MB; Zhou, B; Sebra, R; Halpin, RA; Guan, Y; Twaddle, A; DePasse, JV; Stockwell, TB; Wentworth, DE; Holmes, EC; Greenbaum, B; Peiris, JSM; Cowling, BJ; Ghedin, E				Poon, Leo L. M.; Song, Timothy; Rosenfeld, Roni; Lin, Xudong; Rogers, Matthew B.; Zhou, Bin; Sebra, Robert; Halpin, Rebecca A.; Guan, Yi; Twaddle, Alan; DePasse, Jay V.; Stockwell, Timothy B.; Wentworth, David E.; Holmes, Edward C.; Greenbaum, Benjamin; Peiris, Joseph S. M.; Cowling, Benjamin J.; Ghedin, Elodie			Quantifying influenza virus diversity and transmission in humans	NATURE GENETICS			English	Article							HEMAGGLUTININ; MUTATION; RATES; H1N1	Influenza A virus is characterized by high genetic diversity(1-3). However, most of what is known about influenza evolution has come from consensus sequences sampled at the epidemiological scale(4) that only represent the dominant virus lineage within each infected host. Less is known about the extent of within host virus diversity and what proportion of this diversity is transmitted between individuals(5). To characterize virus variants that achieve sustainable transmission in new hosts, we examined within-host virus genetic diversity in household donor-recipient pairs from the first wave of the 2009 H1N1 pandemic when seasonal H3N2 was co-circulating. Although the same variants were found in multiple members of the community, the relative frequencies of variants fluctuated, with patterns of genetic variation more similar within than between households. We estimated the effective population size of influenza A virus across donor-recipient pairs to be approximately 100-200 contributing members, which enabled the transmission of multiple lineages, including antigenic variants.	[Poon, Leo L. M.; Guan, Yi; Peiris, Joseph S. M.] Univ Hong Kong, Sch Publ Hlth, Publ Hlth Lab Sci, Hong Kong, Hong Kong, Peoples R China; [Song, Timothy; Rogers, Matthew B.] Univ Pittsburgh, Sch Med, Dept Computat & Syst Biol, Pittsburgh, PA USA; [Song, Timothy; Zhou, Bin; Twaddle, Alan; Ghedin, Elodie] NYU, Dept Biol, Ctr Genom & Syst Biol, New York, NY 10003 USA; [Rosenfeld, Roni] Carnegie Mellon Univ, Sch Comp Sci, Pittsburgh, PA 15213 USA; [Lin, Xudong; Halpin, Rebecca A.; Stockwell, Timothy B.; Wentworth, David E.] J Craig Venter Inst, Rockville, MD USA; [Sebra, Robert] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [DePasse, Jay V.] Carnegie Mellon Univ, Pittsburgh Supercomp Ctr, Pittsburgh, PA 15213 USA; [Holmes, Edward C.] Univ Sydney, Sch Biol Sci, Charles Perkins Ctr, Marie Bashir Inst Infect Dis & Biosecur, Sydney, NSW 2006, Australia; [Holmes, Edward C.] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia; [Greenbaum, Benjamin] Icahn Sch Med Mt Sinai, Tisch Canc Inst, Dept Med, New York, NY 10029 USA; [Greenbaum, Benjamin] Icahn Sch Med Mt Sinai, Tisch Canc Inst, Dept Hematol & Med Oncol, New York, NY 10029 USA; [Greenbaum, Benjamin] Icahn Sch Med Mt Sinai, Tisch Canc Inst, Dept Pathol, New York, NY 10029 USA; [Cowling, Benjamin J.] Univ Hong Kong, Sch Publ Hlth, Epidemiol & Biostat, Hong Kong, Hong Kong, Peoples R China; [Ghedin, Elodie] NYU, Coll Global Publ Hlth, New York, NY USA; [Rogers, Matthew B.] Univ Pittsburgh, Childrens Hosp Pittsburgh, Sch Med, Pittsburgh, PA USA; [Wentworth, David E.] Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA USA	University of Hong Kong; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; New York University; Carnegie Mellon University; J. Craig Venter Institute; Icahn School of Medicine at Mount Sinai; Carnegie Mellon University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Sydney; University of Sydney; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of Hong Kong; New York University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Centers for Disease Control & Prevention - USA	Ghedin, E (corresponding author), NYU, Dept Biol, Ctr Genom & Syst Biol, New York, NY 10003 USA.; Cowling, BJ (corresponding author), Univ Hong Kong, Sch Publ Hlth, Epidemiol & Biostat, Hong Kong, Hong Kong, Peoples R China.; Ghedin, E (corresponding author), NYU, Coll Global Publ Hlth, New York, NY USA.	bcowling@hku.hk; elodie.ghedin@nyu.edu	Ghedin, Elodie/Y-5654-2019; Holmes, Edward/Y-2789-2019; Poon, Leo Lit Man/C-4382-2009; Cowling, Benjamin John/C-4263-2009; Poon, Leo/AAP-6887-2020; Holmes, Edward/GVR-9499-2022; Zhou, Bin/H-8688-2014	Ghedin, Elodie/0000-0002-1515-725X; Holmes, Edward/0000-0001-9596-3552; Poon, Leo Lit Man/0000-0002-9101-7953; Cowling, Benjamin John/0000-0002-6297-7154; Guan, Yi/0000-0001-6057-9243; Stockwell, Timothy/0000-0002-3595-4539; Zhou, Bin/0000-0002-1535-6283; Rosenfeld, Ronald/0000-0002-3274-5862	US National Institutes of Health as part of the HHMI-NIBIB Interfaces Initiative [T32 EB009403]; Research Grants Council of the Hong Kong Special Administrative Region, China [T11-705/14N]; National Institute of Allergy and Infectious Diseases; US National Institutes of Health; US Department of Health and Human Services [HHS-N272201400006C, HHS-N266200700005C, HHS-N272200900007C]; National Institute of General Medical Science, US National Institutes of Health [U54 GM088491, U54 GM088558]; National Health and Medical Research Council of Australia [AF30]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB009403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM088558, U54GM088491] Funding Source: NIH RePORTER	US National Institutes of Health as part of the HHMI-NIBIB Interfaces Initiative(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Grants Council of the Hong Kong Special Administrative Region, China(Hong Kong Research Grants Council); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Health and Human Services; National Institute of General Medical Science, US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	T.S. was a predoctoral trainee supported by US National Institutes of Health T32 training grant T32 EB009403 as part of the HHMI-NIBIB Interfaces Initiative. This research was supported with a grant from the Research Grants Council of the Hong Kong Special Administrative Region, China(project T11-705/14N) (L.L.M.P., Y.G., J.S.M.P. and B.J.C.), federal funds from the National Institute of Allergy and Infectious Diseases, US National Institutes of Health, US Department of Health and Human Services, under contract numbers HHS-N272201400006C (L.L.M.P., Y.G. and J.S.M.P.), HHS-N266200700005C (B.J.C.) and HHS-N272200900007C (E.G., X.L., R.A.H., T.B.S. and D.E.W), the National Institute of General Medical Science, US National Institutes of Health, under award numbers U54 GM088491 (E.G., R.R. and J.V.D.) and U54 GM088558 (B.J.C.), and National Health and Medical Research Council of Australia Fellowship AF30 (E.C.H.). The data for this manuscript were generated and prepared while D.E.W. was employed at the J. Craig Venter Institute. The opinions expressed in this article are the authors' own and do not reflect the views of the Centers for Disease Control and Prevention, the US Department of Health and Human Services or the US government.	Bush RM, 1999, MOL BIOL EVOL, V16, P1457, DOI 10.1093/oxfordjournals.molbev.a026057; Combe M, 2015, CELL HOST MICROBE, V18, P424, DOI 10.1016/j.chom.2015.09.009; Cong YL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012591; Cowling BJ, 2010, NEW ENGL J MED, V362, P2175, DOI 10.1056/NEJMoa0911530; Drake JW, 1999, P NATL ACAD SCI USA, V96, P13910, DOI 10.1073/pnas.96.24.13910; DRAKE JW, 1993, P NATL ACAD SCI USA, V90, P4171, DOI 10.1073/pnas.90.9.4171; Emmett K.J., 2015, PLOS CURR; Fordyce SL, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-116; Ghedin E, 2010, J VIROL, V84, P5715, DOI 10.1128/JVI.00018-10; Hughes J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003081; Jombart T, 2011, HEREDITY, V106, P383, DOI 10.1038/hdy.2010.78; Kitikoon P, 2012, J VIROL, V86, P6804, DOI 10.1128/JVI.00197-12; Lee N, 2010, ANN INTERN MED, V152, P618, DOI 10.7326/0003-4819-152-9-201005040-00021; Poon LLM, 2011, J CLIN VIROL, V52, P146, DOI 10.1016/j.jcv.2011.06.022; Tharakaraman K, 2013, SCI REP-UK, V3, DOI 10.1038/srep01822; Varble A, 2014, CELL HOST MICROBE, V16, P691, DOI 10.1016/j.chom.2014.09.020; Viboud C, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0199; Westgeest KB, 2014, J VIROL, V88, P2844, DOI 10.1128/JVI.02163-13; Xu R, 2010, SCIENCE, V328, P357, DOI 10.1126/science.1186430	19	117	118	1	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2016	48	2					195	200		10.1038/ng.3479	http://dx.doi.org/10.1038/ng.3479			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DC2JV	26727660	Green Accepted			2022-12-25	WOS:000369043900018
J	Huang, PS; Feldmeier, K; Parmeggiani, F; Velasco, DAF; Hocker, B; Baker, D				Huang, Po-Ssu; Feldmeier, Kaspar; Parmeggiani, Fabio; Alejandro Fernandez Velasco, D.; Hoecker, Birte; Baker, David			De novo design of a four-fold symmetric TIM-barrel protein with atomic-level accuracy	NATURE CHEMICAL BIOLOGY			English	Article							STRUCTURE ALIGNMENT ALGORITHM; (BETA-ALPHA)(8)-BARREL ENZYME; COMPUTATIONAL DESIGN; REPEAT PROTEIN; EVOLUTION; STABILITY; ALPHA; REFINEMENT; PRINCIPLES	Despite efforts for over 25 years, de novo protein design has not succeeded in achieving the TIM-barrel fold. Here we describe the computational design of four-fold symmetrical (beta/alpha)(8) barrels guided by geometrical and chemical principles. Experimental characterization of 33 designs revealed the importance of side chain-backbone hydrogen bonds for defining the strand register between repeat units. The X-ray crystal structure of a designed thermostable 184-residue protein is nearly identical to that of the designed TIM-barrel model. PSI-BLAST searches do not identify sequence similarities to known TIM-barrel proteins, and sensitive profile-profile searches indicate that the design sequence is distant from other naturally occurring TIM-barrel superfamilies, suggesting that Nature has sampled only a subset of the sequence space available to the TIM-barrel fold. The ability to design TIM barrels de novo opens new possibilities for custom-made enzymes.	[Huang, Po-Ssu; Parmeggiani, Fabio; Baker, David] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Huang, Po-Ssu; Parmeggiani, Fabio; Baker, David] Univ Washington, Inst Prot Design, Seattle, WA 98195 USA; [Feldmeier, Kaspar; Hoecker, Birte] Max Planck Inst Dev Biol, Tubingen, Germany; [Alejandro Fernandez Velasco, D.] Univ Nacl Autonoma Mexico, Fac Med, Mexico City 04510, DF, Mexico; [Baker, David] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Max Planck Society; Universidad Nacional Autonoma de Mexico; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Huang, PS (corresponding author), Univ Washington, Dept Biochem, Seattle, WA 98195 USA.	possu.huang@gmail.com; Birte.Hoecker@tuebingen.mpg.de; dabaker@uw.edu	Baker, David/K-8941-2012; Parmeggiani, Fabio/B-9344-2016; Parmeggiani, Fabio/P-3661-2019	Baker, David/0000-0001-7896-6217; Parmeggiani, Fabio/0000-0001-8548-1090; Parmeggiani, Fabio/0000-0001-8548-1090; Hocker, Birte/0000-0002-8250-9462; Fernandez Velasco, D. Alejandro/0000-0003-2368-6378; Huang, Possu/0000-0002-7948-2895	Direccion General de Asuntos del Personal Academico UNAM; International Max Planck Research School (IMPRS) "From Molecules to Organisms" Tubingen; Human Frontier Science Program Long-term fellowship [LT000070/2009-1]; US National Science Foundation; US Department of Energy's Office of Science; Defense Threat Reduction Agency (DTRA); Howard Hughes Medical Institute; Deutsche Forschungsgemeinschaft grant [HO4022/1-2]; Max Planck funds; CONACYT [99857]; PAPIIT-UNAM [IN219913]	Direccion General de Asuntos del Personal Academico UNAM(Universidad Nacional Autonoma de Mexico); International Max Planck Research School (IMPRS) "From Molecules to Organisms" Tubingen; Human Frontier Science Program Long-term fellowship(Human Frontier Science Program); US National Science Foundation(National Science Foundation (NSF)); US Department of Energy's Office of Science(United States Department of Energy (DOE)); Defense Threat Reduction Agency (DTRA)(United States Department of DefenseDefense Threat Reduction Agency); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Deutsche Forschungsgemeinschaft grant(German Research Foundation (DFG)); Max Planck funds; CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); PAPIIT-UNAM(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)Universidad Nacional Autonoma de Mexico)	We thank R. Krishnamurty and C. Tinberg for comments on the manuscript, as well as S. Ovchinnikov, A.C. Stiel and S. Schmidt for technical advice. D.A.F.V. thanks the Direccion General de Asuntos del Personal Academico UNAM for a sabbatical stay fellowship, and K.F. acknowledges a fellowship from the International Max Planck Research School (IMPRS) "From Molecules to Organisms" Tubingen. F.P. was supported by Human Frontier Science Program Long-term fellowship LT000070/2009-1. This work was facilitated through the use of advanced computational storage and networking infrastructure provided by the Hyak supercomputer system at the University of Washington. This research was also done using resources provided by the Open Science Grid (OSG), which is supported by the US National Science Foundation and the US Department of Energy's Office of Science. We would like to particularly thank M. Rynge and J. McGee of the OSG Engagement Team at the Renaissance Computing Institute (RENCI) and M. Livny and the HTCondor Team of the University of Wisconsin-Madison for their technical and logistical guidance in our use of OSG resources. This work was supported by grants from the Defense Threat Reduction Agency (DTRA) and the Howard Hughes Medical Institute to D.B., Deutsche Forschungsgemeinschaft grant HO4022/1-2 and Max Planck funds to B.H., and grants CONACYT 99857 and PAPIIT-UNAM IN219913 to D.A.F.V.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Alva V, 2010, PROTEIN SCI, V19, P124, DOI 10.1002/pro.297; Bellows-Peterson ML, 2012, J MED CHEM, V55, P4159, DOI 10.1021/jm201609k; Claren J, 2009, P NATL ACAD SCI USA, V106, P3704, DOI 10.1073/pnas.0810342106; Correia BE, 2014, NATURE, V507, P201, DOI 10.1038/nature12966; DiMaio F, 2013, NAT METHODS, V10, P1102, DOI [10.1038/nmeth.2648, 10.1038/NMETH.2648]; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Farias-Rico JA, 2014, NAT CHEM BIOL, V10, P710, DOI [10.1038/NCHEMBIO.1579, 10.1038/nchembio.1579]; Figueroa M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071858; Fortenberry C, 2011, J AM CHEM SOC, V133, P18026, DOI 10.1021/ja2051217; Frickey T, 2004, BIOINFORMATICS, V20, P3702, DOI 10.1093/bioinformatics/bth444; Gerlt JA, 2000, NAT STRUCT BIOL, V7, P171, DOI 10.1038/73249; Giger L, 2013, NAT CHEM BIOL, V9, P494, DOI 10.1038/nchembio.1276; GORAJ K, 1990, PROTEIN ENG, V3, P259, DOI 10.1093/protein/3.4.259; Hocker B, 2005, BIOMOL ENG, V22, P31, DOI 10.1016/j.bioeng.2004.09.005; Hocker B, 2004, P NATL ACAD SCI USA, V101, P16448, DOI 10.1073/pnas.0405832101; Hocker B, 2001, NAT STRUCT BIOL, V8, P32; Hocker B, 2009, BIOCHEMISTRY-US, V48, P1145, DOI 10.1021/bi802125b; HOUBRECHTS A, 1995, PROTEIN ENG, V8, P249, DOI 10.1093/protein/8.3.249; Huang PS, 2014, SCIENCE, V346, P481, DOI 10.1126/science.1257481; Huang PS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024109; Joh NH, 2014, SCIENCE, V346, P1520, DOI 10.1126/science.1261172; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Khoury GA, 2014, TRENDS BIOTECHNOL, V32, P99, DOI 10.1016/j.tibtech.2013.10.008; Kiss G, 2013, ANGEW CHEM INT EDIT, V52, P5700, DOI 10.1002/anie.201204077; Koga N, 2012, NATURE, V491, P222, DOI 10.1038/nature11600; Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427; Minami S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-24; MURZIN AG, 1994, J MOL BIOL, V236, P1369, DOI 10.1016/0022-2836(94)90064-7; Nagarajan D, 2015, BMC BIOCHEM, V16, DOI 10.1186/s12858-015-0047-4; Ochoa-Leyva A, 2011, J MOL BIOL, V411, P143, DOI 10.1016/j.jmb.2011.05.027; Ochoa-Leyva A, 2009, J MOL BIOL, V387, P949, DOI 10.1016/j.jmb.2009.02.022; Offredi F, 2003, J MOL BIOL, V325, P163, DOI 10.1016/S0022-2836(02)01206-8; Parmeggiani F, 2015, J MOL BIOL, V427, P563, DOI 10.1016/j.jmb.2014.11.005; Ramisch S, 2014, P NATL ACAD SCI USA, V111, P17875, DOI 10.1073/pnas.1413638111; Remmert M, 2012, NAT METHODS, V9, P173, DOI [10.1038/NMETH.1818, 10.1038/nmeth.1818]; Romero-Romero S, 2015, PHYS CHEM CHEM PHYS, V17, P20699, DOI 10.1039/c5cp01599e; Smadbeck J, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003718; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Song YF, 2013, STRUCTURE, V21, P1735, DOI 10.1016/j.str.2013.08.005; Sterner R, 2005, CHEM REV, V105, P4038, DOI 10.1021/cr030191z; TANAKA T, 1994, PROTEIN SCI, V3, P419; Yang XY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007179; Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524	46	128	134	6	137	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2016	12	1					29	+		10.1038/NCHEMBIO.1966	http://dx.doi.org/10.1038/NCHEMBIO.1966			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY8QW	26595462	Green Accepted, Green Submitted			2022-12-25	WOS:000366674400008
J	Lu, JF; Zhong, XF; Liu, HS; Hao, L; Huang, CTL; Sherafat, MA; Jones, J; Ayala, M; Li, LJ; Zhang, SC				Lu, Jianfeng; Zhong, Xuefei; Liu, Huisheng; Hao, Ling; Huang, Cindy Tzu-Ling; Sherafat, Mohammad Amin; Jones, Jeffrey; Ayala, Melvin; Li, Lingjun; Zhang, Su-Chun			Generation of serotonin neurons from human pluripotent stem cells	NATURE BIOTECHNOLOGY			English	Article							DOPAMINE NEURONS; HUMAN ES; FUNCTIONAL-CHARACTERIZATION; PARKINSONS-DISEASE; NEURAL PROGENITORS; IN-VITRO; SPECIFICATION; TRAMADOL; MIDBRAIN; RELEASE	Serotonin neurons located in the raphe nucleus of the hindbrain have crucial roles in regulating brain functions and have been implicated in various psychiatric disorders. Yet functional human serotonin neurons are not available for in vitro studies. Through manipulation of the WNT pathway, we demonstrate efficient differentiation of human pluripotent stem cells (hPSCs) to cells resembling central serotonin neurons, primarily those located in the rhombomeric segments 2-3 of the rostra! raphe, which participate in high-order brain functions. The serotonin neurons express a series of molecules essential for serotonergic development, including tryptophan hydroxylase 2, exhibit typical electrophysiological properties and release serotonin in an activity-dependent manner. When treated with the FDA-approved drugs tramadol and escitalopram oxalate, they release or uptake serotonin in a dose- and time-dependent manner, suggesting the utility of these cells for the evaluation of drug candidates.	[Lu, Jianfeng; Liu, Huisheng; Huang, Cindy Tzu-Ling; Sherafat, Mohammad Amin; Jones, Jeffrey; Ayala, Melvin; Zhang, Su-Chun] Univ Wisconsin, Waisman Ctr, Madison, WI 53705 USA; [Zhong, Xuefei; Hao, Ling; Li, Lingjun] Univ Wisconsin, Sch Pharm, 425 N Charter St, Madison, WI 53706 USA; [Li, Lingjun] Univ Wisconsin, Dept Chem, 1101 Univ Ave, Madison, WI 53706 USA; [Zhang, Su-Chun] Univ Wisconsin, Sch Med & Publ Hlth, Dept Neurosci, Madison, WI USA; [Zhang, Su-Chun] Univ Wisconsin, Dept Neurol, Sch Med & Publ Hlth, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Zhang, SC (corresponding author), Univ Wisconsin, Waisman Ctr, Madison, WI 53705 USA.; Zhang, SC (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Neurosci, Madison, WI USA.; Zhang, SC (corresponding author), Univ Wisconsin, Dept Neurol, Sch Med & Publ Hlth, Madison, WI 53706 USA.	Zhang@waisman.wisc.edu		Jones, Jeffrey/0000-0002-7570-2571; Ayala, Melvin/0000-0002-8669-1046; hao, ling/0000-0002-0106-5266	US National Institutes of Health (NIH) [NS045926, MH099587, MH100031, 1R01DK071801]; National Institute of Child Health and Human Development (NICHD) [P30 HD03352]; NIH shared instrument grant (NIH-National Center for Research Resources (NCRR)) [S10RR029531]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD003352, P01HD076892] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR029531] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071801] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH100031, R01MH099587] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R24NS086604, R01NS045926, R01NS076352] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIH shared instrument grant (NIH-National Center for Research Resources (NCRR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was partially supported by US National Institutes of Health (NIH) grants (NS045926, MH099587 and MH100031 to S.C.Z.; 1R01DK071801 to L.L.) and the National Institute of Child Health and Human Development (NICHD; P30 HD03352). The Q-Exactive Orbitrap mass spectrometer was purchased through the support of an NIH shared instrument grant (NIH-National Center for Research Resources (NCRR) S10RR029531 to L.L.). L.L. acknowledges an H.I. Romnes Faculty Research Fellowship. S.C.Z. acknowledges a Steenbock Professorship.	Alenina N, 2006, STEM CELL REV, V2, P5, DOI 10.1385/SCR:2:1:5; Alonso A, 2013, BRAIN STRUCT FUNCT, V218, P1229, DOI 10.1007/s00429-012-0456-8; Bang SJ, 2012, EUR J NEUROSCI, V35, P85, DOI 10.1111/j.1460-9568.2011.07936.x; Barberi T, 2003, NAT BIOTECHNOL, V21, P1200, DOI 10.1038/nbt870; Baumann MH, 2000, SYNAPSE, V36, P102, DOI 10.1002/(SICI)1098-2396(200005)36:2<102::AID-SYN3>3.0.CO;2-#; Calizo LH, 2011, NEUROPHARMACOLOGY, V61, P524, DOI 10.1016/j.neuropharm.2011.04.008; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Chen J, 2008, DEV BIOL, V320, P30, DOI 10.1016/j.ydbio.2008.03.038; Deneris ES, 2012, NAT NEUROSCI, V15, P519, DOI 10.1038/nn.3039; DRIESSEN B, 1992, BRIT J PHARMACOL, V105, P147, DOI 10.1111/j.1476-5381.1992.tb14226.x; Goridis C, 2002, NAT REV NEUROSCI, V3, P531, DOI 10.1038/nrn871; Gouti M, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001937; Guthrie S, 2007, NAT REV NEUROSCI, V8, P859, DOI 10.1038/nrn2254; Hu BY, 2009, DEVELOPMENT, V136, P1443, DOI 10.1242/dev.029447; JACOBS BL, 1992, PHYSIOL REV, V72, P165, DOI 10.1152/physrev.1992.72.1.165; Kiecker C, 2001, DEVELOPMENT, V128, P4189; Kim JH, 2002, NATURE, V418, P50, DOI 10.1038/nature00900; Kirkeby A, 2012, CELL REPORTS, V1, P703, DOI 10.1016/j.celrep.2012.04.009; Kizilbash A, 2014, J PAIN RES, V7, P149, DOI 10.2147/JPR.S49502; Koch P, 2009, P NATL ACAD SCI USA, V106, P3225, DOI 10.1073/pnas.0808387106; Kriks S, 2011, NATURE, V480, P547, DOI 10.1038/nature10648; Kumar M, 2009, STEM CELLS DEV, V18, P615, DOI 10.1089/scd.2008.0181; Lee SH, 2000, NAT BIOTECHNOL, V18, P675, DOI 10.1038/76536; Li XJ, 2005, NAT BIOTECHNOL, V23, P215, DOI 10.1038/nbt1063; Lu JF, 2013, CELL REP, V3, P1580, DOI 10.1016/j.celrep.2013.04.004; Maury Y, 2015, NAT BIOTECHNOL, V33, P89, DOI 10.1038/nbt.3049; Pastoor D, 2014, EXPERT OPIN DRUG MET, V10, P121, DOI 10.1517/17425255.2014.863873; Pudovkina OL, 2003, SYNAPSE, V50, P77, DOI 10.1002/syn.10245; RAFFA RB, 1992, J PHARMACOL EXP THER, V260, P275; Rhinn M, 2001, CURR OPIN NEUROBIOL, V11, P34, DOI 10.1016/S0959-4388(00)00171-9; Rothman RB, 2002, PHARMACOL BIOCHEM BE, V71, P825, DOI 10.1016/S0091-3057(01)00669-4; Salli U, 2004, EXP NEUROL, V188, P351, DOI 10.1016/j.expneurol.2004.04.015; Scott MM, 2005, P NATL ACAD SCI USA, V102, P16472, DOI 10.1073/pnas.0504510102; Smidt MP, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00200; Tokuyama Y, 2010, EXP BIOL MED, V235, P649, DOI 10.1258/ebm.2010.009307; Xi JJ, 2012, STEM CELLS, V30, P1655, DOI 10.1002/stem.1152; Ye WL, 1998, CELL, V93, P755, DOI 10.1016/S0092-8674(00)81437-3	37	95	99	2	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2016	34	1					89	94		10.1038/nbt.3435	http://dx.doi.org/10.1038/nbt.3435			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DB8HQ	26655496	Green Accepted			2022-12-25	WOS:000368758200032
J	Gao, H; Korn, JM; Ferretti, S; Monahan, JE; Wang, YZ; Singh, M; Zhang, C; Schnell, C; Yang, GZ; Zhang, Y; Balbin, OA; Barbe, S; Cai, HB; Casey, F; Chatterjee, S; Chiang, DY; Chuai, S; Cogan, SM; Collins, SD; Dammassa, E; Ebel, N; Embry, M; Green, J; Kauffmann, A; Kowa, C; Leary, RJ; Lehar, J; Liang, Y; Loo, A; Lorenzana, E; McDonald, ER; McLaughlin, ME; Merkin, J; Meyer, R; Naylor, TL; Patawaran, M; Reddy, A; Roelli, C; Ruddy, DA; Salangsang, F; Santacroce, F; Singh, AP; Tang, Y; Tinetto, W; Tobler, S; Velazquez, R; Venkatesan, K; Von Arx, F; Wang, HQ; Wang, ZY; Wiesmann, M; Wyss, D; Xu, F; Bitter, H; Atadja, P; Lees, E; Hofmann, F; Li, E; Keen, N; Cozens, R; Jensen, MR; Pryer, NK; Williams, JA; Sellers, WR				Gao, Hui; Korn, Joshua M.; Ferretti, Stephane; Monahan, John E.; Wang, Youzhen; Singh, Mallika; Zhang, Chao; Schnell, Christian; Yang, Guizhi; Zhang, Yun; Balbin, O. Alejandro; Barbe, Stephanie; Cai, Hongbo; Casey, Fergal; Chatterjee, Susmita; Chiang, Derek Y.; Chuai, Shannon; Cogan, Shawn M.; Collins, Scott D.; Dammassa, Ernesta; Ebel, Nicolas; Embry, Millicent; Green, John; Kauffmann, Audrey; Kowa, Colleen; Leary, Rebecca J.; Lehar, Joseph; Liang, Ying; Loo, Alice; Lorenzana, Edward; McDonald, E. Robert, III; McLaughlin, Margaret E.; Merkin, Jason; Meyer, Ronald; Naylor, Tara L.; Patawaran, Montesa; Reddy, Anupama; Roeelli, Claudia; Ruddy, David A.; Salangsang, Fernando; Santacroce, Francesca; Singh, Angad P.; Tang, Yan; Tinetto, Walter; Tobler, Sonja; Velazquez, Roberto; Venkatesan, Kavitha; Von Arx, Fabian; Wang, Hui Qin; Wang, Zongyao; Wiesmann, Marion; Wyss, Daniel; Xu, Fiona; Bitter, Hans; Atadja, Peter; Lees, Emma; Hofmann, Francesco; Li, En; Keen, Nicholas; Cozens, Robert; Jensen, Michael Rugaard; Pryer, Nancy K.; Williams, Juliet A.; Sellers, William R.			High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response	NATURE MEDICINE			English	Article							MTOR INHIBITOR RIDAFOROLIMUS; B-RAF INHIBITOR; PHASE-II; ANTIBODY DALOTUZUMAB; ACQUIRED-RESISTANCE; MELANOMA; CANCER; BRAF; COMBINATION; PATHWAY	Profiling candidate therapeutics with limited cancer models during preclinical development hinders predictions of clinical efficacy and identifying factors that underlie heterogeneous patient responses for patient-selection strategies. We established similar to 1,000 patient-derived tumor xenograft models (PDXs) with a diverse set of driver mutations. With these PDXs, we performed in vivo compound screens using a 1 x 1 x 1 experimental design (PDX clinical trial or PCT) to assess the population responses to 62 treatments across six indications. We demonstrate both the reproducibility and the clinical translatability of this approach by identifying associations between a genotype and drug response, and established mechanisms of resistance. In addition, our results suggest that PCTs may represent a more accurate approach than cell line models for assessing the clinical potential of some therapeutic modalities. We therefore propose that this experimental paradigm could potentially improve preclinical evaluation of treatment modalities and enhance our ability to predict clinical trial responses.	[Gao, Hui; Korn, Joshua M.; Yang, Guizhi; Balbin, O. Alejandro; Cai, Hongbo; Chiang, Derek Y.; Cogan, Shawn M.; Collins, Scott D.; Green, John; Kowa, Colleen; Leary, Rebecca J.; Loo, Alice; McDonald, E. Robert, III; Merkin, Jason; Singh, Angad P.; Velazquez, Roberto; Venkatesan, Kavitha; Bitter, Hans; Keen, Nicholas; Williams, Juliet A.; Sellers, William R.] Novartis Inst Biomed Res, Oncol Dis Area, Cambridge, MA 02139 USA; [Ferretti, Stephane; Schnell, Christian; Barbe, Stephanie; Dammassa, Ernesta; Ebel, Nicolas; Kauffmann, Audrey; Roeelli, Claudia; Santacroce, Francesca; Tinetto, Walter; Tobler, Sonja; Von Arx, Fabian; Wiesmann, Marion; Wyss, Daniel; Hofmann, Francesco; Cozens, Robert; Jensen, Michael Rugaard] Novartis Inst Biomed Res, Oncol Dis Area, Basel, Switzerland; [Monahan, John E.; Lehar, Joseph; McLaughlin, Margaret E.; Meyer, Ronald; Naylor, Tara L.; Reddy, Anupama; Ruddy, David A.; Wang, Hui Qin] Novartis Inst Biomed Res, Dept Oncol Translat Med, Cambridge, MA USA; [Wang, Youzhen; Zhang, Chao; Zhang, Yun; Chuai, Shannon; Liang, Ying; Wang, Zongyao; Xu, Fiona; Atadja, Peter; Li, En] China Novartis Inst Biomed Res, Shanghai, Peoples R China; [Singh, Mallika; Casey, Fergal; Chatterjee, Susmita; Embry, Millicent; Lorenzana, Edward; Patawaran, Montesa; Salangsang, Fernando; Tang, Yan; Lees, Emma; Pryer, Nancy K.] Novartis Inst Biomed Res, Oncol Dis Area, Emeryville, CA USA	Novartis; Novartis; Novartis; Novartis; Novartis	Williams, JA (corresponding author), Novartis Inst Biomed Res, Oncol Dis Area, Cambridge, MA 02139 USA.	juliet.williams@novartis.com	Chiang, Derek/L-6452-2019; wang, hui/GRS-4730-2022; wang, edwin/G-5372-2010	Chiang, Derek/0000-0002-1131-6065; Monahan, John/0000-0002-3125-8704				Arrowsmith J, 2013, NAT REV DRUG DISCOV, V12, P568, DOI 10.1038/nrd4090; Arrowsmith J, 2011, NAT REV DRUG DISCOV, V10, P1, DOI 10.1038/nrd3439; Ascierto PA, 2013, J CLIN ONCOL, V31, P3205, DOI 10.1200/JCO.2013.49.8691; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bertotti A, 2011, CANCER DISCOV, V1, P508, DOI 10.1158/2159-8290.CD-11-0109; Brana I, 2014, BRIT J CANCER, V111, P1932, DOI 10.1038/bjc.2014.497; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Das Thakur M, 2013, NATURE, V494, P251, DOI 10.1038/nature11814; de Plater L, 2010, BRIT J CANCER, V103, P1192, DOI 10.1038/sj.bjc.6605900; DeRose YS, 2011, NAT MED, V17, P1514, DOI 10.1038/nm.2454; Di Cosimo S, 2015, CLIN CANCER RES, V21, P49, DOI 10.1158/1078-0432.CCR-14-0940; DiMasi JA, 2013, CLIN PHARMACOL THER, V94, P329, DOI 10.1038/clpt.2013.117; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; Ebi H, 2011, J CLIN INVEST, V121, P4311, DOI 10.1172/JCI57909; Einarsdottir BO, 2014, ONCOTARGET, V5, P9609, DOI 10.18632/oncotarget.2445; Eirew P, 2015, NATURE, V518, P422, DOI 10.1038/nature13952; Flaherty KT, 2012, NEW ENGL J MED, V367, P107, DOI 10.1056/NEJMoa1203421; Flanigan SA, 2013, CLIN CANCER RES, V19, P6219, DOI 10.1158/1078-0432.CCR-13-0145; Friedbichler K, 2014, MOL CANCER THER, V13, P399, DOI 10.1158/1535-7163.MCT-13-0598; Fritsch C, 2014, MOL CANCER THER, V13, P1117, DOI 10.1158/1535-7163.MCT-13-0865; Halaban R, 2010, PIGM CELL MELANOMA R, V23, P190, DOI 10.1111/j.1755-148X.2010.00685.x; Hennessey PT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020584; Hidalgo M, 2014, CANCER DISCOV, V4, P998, DOI 10.1158/2159-8290.CD-14-0001; Julien S, 2012, CLIN CANCER RES, V18, P5314, DOI 10.1158/1078-0432.CCR-12-0372; Juric D, 2015, NATURE, V518, P240, DOI 10.1038/nature13948; Kaplan FM, 2011, ONCOGENE, V30, P366, DOI 10.1038/onc.2010.408; Mattie M, 2013, NEOPLASIA, V15, P1124, DOI 10.1593/neo.13922; Migliardi G, 2012, CLIN CANCER RES, V18, P2515, DOI 10.1158/1078-0432.CCR-11-2683; Molina-Arcas M, 2013, CANCER DISCOV, V3, P548, DOI 10.1158/2159-8290.CD-12-0446; Moran T, 2014, EXP HEMATOL ONCOL, V3, DOI 10.1186/2162-3619-3-26; Papadopoulos KP, 2015, CANCER CHEMOTH PHARM, V75, P887, DOI 10.1007/s00280-015-2712-0; Paul SM, 2010, NAT REV DRUG DISCOV, V9, P203, DOI 10.1038/nrd3078; Rizos H, 2014, CLIN CANCER RES, V20, P1965, DOI 10.1158/1078-0432.CCR-13-3122; Robert C, 2015, NEW ENGL J MED, V372, P30, DOI 10.1056/NEJMoa1412690; Rosfjord E, 2014, BIOCHEM PHARMACOL, V91, P135, DOI 10.1016/j.bcp.2014.06.008; Sasai K, 2006, CANCER RES, V66, P4215, DOI 10.1158/0008-5472.CAN-05-4505; Scagliotti GV, 2015, ANN ONCOL, V26, P497, DOI 10.1093/annonc/mdu517; Shi HB, 2014, CANCER DISCOV, V4, P80, DOI 10.1158/2159-8290.CD-13-0642; Shi HB, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1727; Siolas D, 2013, CANCER RES, V73, P5315, DOI 10.1158/0008-5472.CAN-13-1069; Sosman JA, 2012, NEW ENGL J MED, V366, P707, DOI 10.1056/NEJMoa1112302; Tentler JJ, 2012, NAT REV CLIN ONCOL, V9, P338, DOI 10.1038/nrclinonc.2012.61; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Wagle N, 2014, CANCER DISCOV, V4, P61, DOI 10.1158/2159-8290.CD-13-0631	44	739	764	6	154	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2015	21	11					1318	1325		10.1038/nm.3954	http://dx.doi.org/10.1038/nm.3954			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CV9QH	26479923				2022-12-25	WOS:000364621200016
J	Jefferson, OA; Kollhofer, D; Ehrich, TH; Jefferson, RA				Jefferson, Osmat A.; Koellhofer, Deniz; Ehrich, Thomas H.; Jefferson, Richard A.			The ownership question of plant gene and genome intellectual properties	NATURE BIOTECHNOLOGY			English	Editorial Material								The restructuring of the crop agriculture industry over the past two decades has enabled patent holders to exclude, prevent and deter others from using certain research tools and delay or block further follow-on inventions.	[Jefferson, Osmat A.; Koellhofer, Deniz; Ehrich, Thomas H.; Jefferson, Richard A.] Queensland Univ Technol, Brisbane, Qld 4001, Australia; [Jefferson, Osmat A.; Koellhofer, Deniz; Ehrich, Thomas H.; Jefferson, Richard A.] Cambia, Canberra, ACT, Australia	Queensland University of Technology (QUT)	Jefferson, OA (corresponding author), Queensland Univ Technol, Brisbane, Qld 4001, Australia.	osmat@cambia.org; raj@cambia.org		Jefferson, Osmat Azzam/0000-0002-0607-8728; Jefferson, Richard/0000-0001-5352-4498; Ehrich, Thomas/0000-0003-3475-4321				Abbott F.M., 2014, EMERGING MARKETS WOR, P3; Agris CH, 1999, NAT BIOTECHNOL, V17, P197, DOI 10.1038/6205; [Anonymous], 1985, USPQ, V227, P433; Atkinson RC, 2003, SCIENCE, V301, P174, DOI 10.1126/science.1085553; Curtin SJ, 2012, PLANT GENOME-US, V5, P42, DOI 10.3835/plantgenome2012.06.0008; Foote H., 2014, INT IP PROTECTION PL; Fuglie KO, 2014, AM J AGR ECON, V96, P862, DOI 10.1093/ajae/aat107; Howard Philip H., 2009, Sustainability, V1, P1266, DOI 10.3390/su1041266; Information and Media Relations Division of the WTO Secretariat, 2008, REVIEWS; Jefferson OA, 2015, NAT BIOTECHNOL, V33, P1033, DOI 10.1038/nbt.3364; Jefferson OA, 2013, NAT BIOTECHNOL, V31, P1086, DOI 10.1038/nbt.2755; Marco A.C., 2007, CUDARE WORKING PAPER, V1036; Moss D.L., 2014, WISCONSIN STATE L RE, V337, P338; USDA National Genetic Resources Program, 2014, GERMPL RES INF NETW; WIPO Committee on Development and Intellectual Property, 2014, 13 SESS GEN MAY 19 2, P7; World Intellectual Property Organization, 2014, QUEST EXC LIM PAT RI	16	18	19	1	12	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2015	33	11					1138	1144		10.1038/nbt.3393	http://dx.doi.org/10.1038/nbt.3393			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CW3TY	26544141	Green Published			2022-12-25	WOS:000364916000015
J	Mulder, MPC; Witting, K; Berlin, I; Pruneda, JN; Wu, KP; Chang, JG; Merkx, R; Bialas, J; Groettrup, M; Vertegaal, ACO; Schulman, BA; Komander, D; Neefjes, J; El Oualid, F; Ovaa, H				Mulder, Monique P. C.; Witting, Katharina; Berlin, Ilana; Pruneda, Jonathan N.; Wu, Kuen-Phon; Chang, Jer-Gung; Merkx, Remco; Bialas, Johanna; Groettrup, Marcus; Vertegaal, Alfred C. O.; Schulman, Brenda A.; Komander, David; Neefjes, Jacques; El Oualid, Farid; Ovaa, Huib			A cascading activity-based probe sequentially targets E1-E2-E3 ubiquitin enzymes	NATURE CHEMICAL BIOLOGY			English	Article							PROTEIN-ACTIVATION; COMPLEX REVEALS; E1; INSIGHTS; LIGASE; MECHANISM; CYSTEINE; DEHYDROALANINE; INHIBITORS; SUBSTRATE	Post-translational modifications of proteins with ubiquitin (Ub) and ubiquitin-like modifiers (Ubls), orchestrated by a cascade of specialized E1, E2 and E3 enzymes, control a wide range of cellular processes. To monitor catalysis along these complex reaction pathways, we developed a cascading activity-based probe, UbDha. Similarly to the native Ub, upon ATP-dependent activation by the E1, UbDha can travel downstream to the E2 (and subsequently E3) enzymes through sequential trans-thioesterifications. Unlike the native Ub, at each step along the cascade, UbDha has the option to react irreversibly with active site cysteine residues of target enzymes, thus enabling their detection. We show that our cascading probe 'hops' and 'traps' catalytically active Ub-modifying enzymes (but not their substrates) by a mechanism diversifiable to Ubls. Our founder methodology, amenable to structural studies, proteome-wide profiling and monitoring of enzymatic activity in living cells, presents novel and versatile tools to interrogate Ub and Ubl cascades.	[Mulder, Monique P. C.; Witting, Katharina; Berlin, Ilana; Merkx, Remco; Neefjes, Jacques; El Oualid, Farid; Ovaa, Huib] Netherlands Canc Inst, Div Cell Biol, Amsterdam, Netherlands; [Pruneda, Jonathan N.; Komander, David] MRC, Mol Biol Lab, Div Prot & Nucle Acid Chem, Hills Rd, Cambridge CB2 2QH, England; [Wu, Kuen-Phon; Schulman, Brenda A.] St Jude Childrens Res Hosp, Dept Biol Struct, 332 N Lauderdale St, Memphis, TN 38105 USA; [Chang, Jer-Gung; Vertegaal, Alfred C. O.] Leiden Univ, Med Ctr, Dept Mol Cell Biol, Leiden, Netherlands; [Bialas, Johanna; Groettrup, Marcus] Univ Konstanz, Dept Biol, Div Immunol, Constance, Germany; [Schulman, Brenda A.] St Jude Childrens Res Hosp, Howard Hughes Med Inst, Memphis, TN 38105 USA; [El Oualid, Farid] UbiQ Bio BV, Amsterdam, Netherlands	Netherlands Cancer Institute; MRC Laboratory Molecular Biology; St Jude Children's Research Hospital; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Konstanz; Howard Hughes Medical Institute; St Jude Children's Research Hospital	Ovaa, H (corresponding author), Netherlands Canc Inst, Div Cell Biol, Amsterdam, Netherlands.	farideloualid@ubiqbio.com; h.ovaa@nki.nl	Groettrup, Marcus/AAT-2623-2020; Mulder, Monique Priscilla Catharina/AAA-4990-2022; Vertegaal, Alfred/ABG-8141-2021; Neefjes, Jacques J.C./H-8780-2017; Vertegaal, Alfred CO/Y-3875-2018; Wu, Kuen-Phon/B-7983-2009; Wu, Kuen-Phon/I-1789-2019; ovaa, huib/M-2334-2016	Mulder, Monique Priscilla Catharina/0000-0001-5386-7132; Vertegaal, Alfred/0000-0002-7989-0493; Neefjes, Jacques J.C./0000-0001-6763-2211; Vertegaal, Alfred CO/0000-0002-7989-0493; Wu, Kuen-Phon/0000-0002-1525-6004; Wu, Kuen-Phon/0000-0002-1525-6004; ovaa, huib/0000-0002-0068-054X; Witting, Katharina/0000-0002-9736-0373; Pruneda, Jonathan/0000-0002-0304-4418; Schulman, Brenda/0000-0002-3083-1126	Netherlands Organization for Scientific Research (NWO) [724013002]; Marie Curie ITN fellowship [290257]; EMBO long-term fellowships; Medical Research Council [U105192732]; European Research Council [309756, 310913]; Lister Institute for Preventive Medicine; ALSAC; HHMI; NIH [R37GM069530]; NWO [93511037]; German Research Foundation (DFG) [CRC969]; Graduate School Chemical Biology Ko-RSCB; Medical Research Council [MC_U105192732] Funding Source: researchfish; MRC [MC_U105192732] Funding Source: UKRI; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM069530] Funding Source: NIH RePORTER	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Marie Curie ITN fellowship; EMBO long-term fellowships; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Research Council(European Research Council (ERC)European Commission); Lister Institute for Preventive Medicine; ALSAC(American Lebanese Syrian Associated Charities (ALSAC)); HHMI(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NWO(Netherlands Organization for Scientific Research (NWO)); German Research Foundation (DFG)(German Research Foundation (DFG)); Graduate School Chemical Biology Ko-RSCB; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of H.O.'s lab for helpful discussion and reagents, J. Brown and S. Armour (Ubiquigent) for providing the E2 scan kit and D. El Atmioui for solid phase peptide synthesis. We acknowledge beamline staff at Diamond I04-1 for expert help. Work was supported by a VICI grant from the Netherlands Organization for Scientific Research (NWO) (724013002) to H.O., a Marie Curie ITN fellowship (290257) to K.W. and EMBO long-term fellowships to I.B. and J.N.P. Work in D.K.'s lab is funded by Medical Research Council (U105192732), the European Research Council (309756), and the Lister Institute for Preventive Medicine. Work in B.A.S.'s lab is funded by ALSAC, HHMI and NIH grant R37GM069530. Work in A.C.O.V.'s lab is funded by the NWO (93511037) and the European Research Council (310913). Work in M.G.'s lab is funded by the German Research Foundation (DFG) CRC969, project C01. J.B. received a stipend from the Graduate School Chemical Biology Ko-RSCB.	Adams PD, 2011, METHODS, V55, P94, DOI 10.1016/j.ymeth.2011.07.005; An H, 2016, CHEM COMMUN, V52, P2477, DOI 10.1039/c5cc08592f; An H, 2013, J AM CHEM SOC, V135, P16948, DOI 10.1021/ja4099643; Andersen PL, 2005, J CELL BIOL, V170, P745, DOI 10.1083/jcb.200502113; Bernardes GJL, 2008, J AM CHEM SOC, V130, P5052, DOI 10.1021/ja800800p; Borodovsky A, 2002, CHEM BIOL, V9, P1149, DOI 10.1016/S1074-5521(02)00248-X; Borodovsky A, 2001, EMBO J, V20, P5187, DOI 10.1093/emboj/20.18.5187; Chalker JM, 2011, CHEM SCI, V2, P1666, DOI 10.1039/c1sc00185j; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Cravatt BF, 2008, ANNU REV BIOCHEM, V77, P383, DOI 10.1146/annurev.biochem.75.101304.124125; da Silva SR, 2013, J MED CHEM, V56, P2165, DOI 10.1021/jm301420b; Dantuma NP, 2006, J CELL BIOL, V173, P19, DOI 10.1083/jcb.200510071; Ekkebus R, 2014, CURR OPIN CHEM BIOL, V23, P63, DOI 10.1016/j.cbpa.2014.10.005; Ekkebus R, 2013, J AM CHEM SOC, V135, P2867, DOI 10.1021/ja309802n; El Oualid F, 2010, ANGEW CHEM INT EDIT, V49, P10149, DOI 10.1002/anie.201005995; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Favier A, 2011, J BIOMOL NMR, V49, P9, DOI 10.1007/s10858-010-9461-5; HODGINS RRW, 1992, J BIOL CHEM, V267, P8807; Huang L, 1999, SCIENCE, V286, P1321, DOI 10.1126/science.286.5443.1321; Jin JP, 2007, NATURE, V447, P1135, DOI 10.1038/nature05902; JOHNSON JP, 1981, EUR J IMMUNOL, V11, P825, DOI 10.1002/eji.1830111015; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kamadurai HB, 2009, MOL CELL, V36, P1095, DOI 10.1016/j.molcel.2009.11.010; Kee Y, 2005, EMBO J, V24, P2414, DOI 10.1038/sj.emboj.7600710; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Kramer HB, 2012, BBA-MOL CELL RES, V1823, P2029, DOI 10.1016/j.bbamcr.2012.05.014; Liu J, 2015, BBA-REV CANCER, V1855, P50, DOI 10.1016/j.bbcan.2014.11.005; Lu XQ, 2010, J AM CHEM SOC, V132, P1748, DOI 10.1021/ja9088549; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Menon MB, 2013, BIOCHEM J, V456, P163, DOI 10.1042/BJ20130755; Nakada S, 2010, NATURE, V466, P941, DOI 10.1038/nature09297; Olsen SK, 2013, MOL CELL, V49, P884, DOI 10.1016/j.molcel.2013.01.013; Olsen SK, 2010, NATURE, V463, P906, DOI 10.1038/nature08765; Page RC, 2012, BIOCHEMISTRY-US, V51, P4175, DOI 10.1021/bi300058m; PICKART CM, 1994, J BIOL CHEM, V269, P7115; Plechanovova A, 2012, NATURE, V489, P115, DOI 10.1038/nature11376; Pohl C, 2008, CELL, V132, P832, DOI 10.1016/j.cell.2008.01.012; Pruneda JN, 2012, MOL CELL, V47, P933, DOI 10.1016/j.molcel.2012.07.001; Pruneda JN, 2011, BIOCHEMISTRY-US, V50, P1624, DOI 10.1021/bi101913m; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; Roux KJ, 2012, J CELL BIOL, V196, P801, DOI 10.1083/jcb.201112098; Sadaghiani AM, 2007, CURR OPIN CHEM BIOL, V11, P20, DOI 10.1016/j.cbpa.2006.11.030; Schafer A, 2014, ACTA CRYSTALLOGR D, V70, P1311, DOI 10.1107/S1399004714002910; Schulman BA, 2009, NAT REV MOL CELL BIO, V10, P319, DOI 10.1038/nrm2673; Scott DC, 2014, CELL, V157, P1671, DOI 10.1016/j.cell.2014.04.037; Sommer S, 2015, CHEMBIOCHEM, V16, P1183, DOI 10.1002/cbic.201500011; Steele-Mortimer O, 2011, TRAFFIC, V12, P162, DOI 10.1111/j.1600-0854.2010.01137.x; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Sugaya K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096666; van der Kant R, 2013, J CELL SCI, V126, P3462, DOI 10.1242/jcs.129270; van Wijk SJL, 2010, FASEB J, V24, P981, DOI 10.1096/fj.09-136259; Walden H, 2003, MOL CELL, V12, P1427, DOI 10.1016/S1097-2765(03)00452-0; Wiener R, 2012, NATURE, V483, P618, DOI 10.1038/nature10911; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yang YL, 2007, CANCER RES, V67, P9472, DOI 10.1158/0008-5472.CAN-07-0568	56	87	87	2	45	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUL	2016	12	7					523	+		10.1038/nchembio.2084	http://dx.doi.org/10.1038/nchembio.2084			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9EP	27182664	Green Accepted, Green Submitted			2022-12-25	WOS:000378087500012
J	Vaccari, M; Gordon, SN; Fourati, S; Schifanella, L; Liyanage, NPM; Cameron, M; Keele, BF; Shen, XY; Tomaras, GD; Billings, E; Rao, M; Chung, AW; Dowell, KG; Bailey-Kellogg, C; Brown, EP; Ackerman, ME; Vargas-Inchaustegui, DA; Whitney, S; Doster, MN; Binello, N; Pegu, P; Montefiori, DC; Foulds, K; Quinn, DS; Donaldson, M; Liang, F; Lore, K; Roederer, M; Koup, RA; McDermott, A; Ma, ZM; Miller, CJ; Phan, TB; Forthal, DN; Blackburn, M; Caccuri, F; Bissa, M; Ferrari, G; Kalyanaraman, V; Ferrari, MG; Thompson, D; Robert-Guroff, M; Ratto-Kim, S; Kim, JH; Michael, NL; Phogat, S; Barnett, SW; Tartaglia, J; Venzon, D; Stablein, DM; Alter, G; Sekaly, RP; Franchini, G				Vaccari, Monica; Gordon, Shari N.; Fourati, Slim; Schifanella, Luca; Liyanage, Namal P. M.; Cameron, Mark; Keele, Brandon F.; Shen, Xiaoying; Tomaras, Georgia D.; Billings, Erik; Rao, Mangala; Chung, Amy W.; Dowell, Karen G.; Bailey-Kellogg, Chris; Brown, Eric P.; Ackerman, Margaret E.; Vargas-Inchaustegui, Diego A.; Whitney, Stephen; Doster, Melvin N.; Binello, Nicolo; Pegu, Poonam; Montefiori, David C.; Foulds, Kathryn; Quinn, David S.; Donaldson, Mitzi; Liang, Frank; Lore, Karin; Roederer, Mario; Koup, Richard A.; McDermott, Adrian; Ma, Zhong-Min; Miller, Christopher J.; Phan, Tran B.; Forthal, Donald N.; Blackburn, Matthew; Caccuri, Francesca; Bissa, Massinilliano; Ferrari, Guido; Kalyanaraman, Vaniambadi; Ferrari, Maria G.; Thompson, DeVon; Robert-Guroff, Marjorie; Ratto-Kim, Silvia; Kim, Jerome H.; Michael, Nelson L.; Phogat, Sanjay; Barnett, Susan W.; Tartaglia, Jim; Venzon, David; Stablein, Donald M.; Alter, Galit; Sekaly, Rafick-Pierre; Franchini, Genoveffa			Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisition	NATURE MEDICINE			English	Article							HIV-1 VACCINE EFFICACY; ACTIVATION; CELLS; PROTECTION; ANTIBODIES; INFECTION; IMMUNOGENICITY; GLYCOSYLATION; EXPRESSION; RESPONSES	A recombinant vaccine containing Aventis Pasteur's canarypox vector (ALVAC)-HIV and gp120 alum. decreased the risk of HIV acquisition in the RV144 vaccine trial. The substitution, of alum with the more immunogenic MF59 adjuvant is under consideration for the next efficacy human trial. We found here that an ALVAC-simian immunodeficiency virus (SIV) and gp120 alum (ALVAC-SIV + gp120) equivalent vaccine, but not an ALVAC-SIV + gp120 MF59 vaccine, was efficacious in delaying the onset of SIVmac251 in rhesus macaques, despite the higher immunogenicity of the latter adjuvant. Vaccine efficacy was associated with alum-induced, but not with MF59-induced, envelope (Env)-dependent mucosal innate lymphoid cells (ILCs) that produce interleukin (IL)-17, as well as with mucosal IgG to the gp120 variable region 2 (V2) and the expression of 12 genes, ten of which are part of the RAS pathway. The association between RAS activation and vaccine efficacy was also observed in an independent efficacious SIV-vaccine approach. Whether RAS activation, mucosal ILCs and antibodies to V2 are also important hallmarks of HIV-vaccine efficacy in humans will require further studies.	[Vaccari, Monica; Gordon, Shari N.; Schifanella, Luca; Liyanage, Namal P. M.; Doster, Melvin N.; Binello, Nicolo; Pegu, Poonam; Blackburn, Matthew; Caccuri, Francesca; Bissa, Massinilliano; Franchini, Genoveffa] NCI, Anim Models & Vaccine Sect, Bethesda, MD 20892 USA; [Fourati, Slim; Sekaly, Rafick-Pierre] Case Wetern Reserve, Dept Pathol, Cleveland, OH USA; [Schifanella, Luca] Univ Milan, L Sacco Hosp, Dept Biomed & Clin Sci, Milan, Italy; [Cameron, Mark] Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH USA; [Keele, Brandon F.] Leidos Biomed Res Inc, Frederick Natl Lab, AIDS & Canc Virus Program, Frederick, MD USA; [Shen, Xiaoying; Tomaras, Georgia D.; Ferrari, Guido] Duke Human Vaccine Inst, Durham, NC USA; [Billings, Erik; Rao, Mangala; Ratto-Kim, Silvia; Kim, Jerome H.; Michael, Nelson L.] Walter Red Army Inst Res, US Mil HIV Res Program, Silver Spring, MD USA; [Chung, Amy W.; Alter, Galit] Massachusetts Inst Technol & Harvard, Massachusetts Gen Hosp, Ragon Inst, Boston, MA USA; [Dowell, Karen G.; Bailey-Kellogg, Chris] Darthmouth Coll, Dept Comp Sci, Hanover, NH USA; [Brown, Eric P.; Ackerman, Margaret E.] Dartmouth Coll, Thayer Sch Engn, Hanover, NH 03755 USA; [Vargas-Inchaustegui, Diego A.; Robert-Guroff, Marjorie] NCI, Immune Biol Retrovial Infect Sect, Bethesda, MD USA; [Whitney, Stephen; Kalyanaraman, Vaniambadi; Ferrari, Maria G.; Thompson, DeVon] Adv Biosci Labs, Rockville, MD USA; [Montefiori, David C.] Duke Univ, Med Ctr, Durham, NC USA; [Foulds, Kathryn; Quinn, David S.; Donaldson, Mitzi; Roederer, Mario; Koup, Richard A.; McDermott, Adrian] US Natl Inst Hlth, Vaccine Res Ctr, Bethesda, MD USA; [Liang, Frank; Lore, Karin] Karolinska Inst, Stockholm, Sweden; [Ma, Zhong-Min; Miller, Christopher J.] Univ Calif Davis, Calif Natl Primate Res Ctr, Davis, CA USA; [Phan, Tran B.; Forthal, Donald N.] Univ Calif Irvine, Irvine Sch Med, Irvine, CA USA; [Phogat, Sanjay; Tartaglia, Jim] Sanofi Pasteur, Swiftwater, PA USA; [Barnett, Susan W.] Novartis Vaccines & Diagonst Inc, Cambridge, MA USA; [Venzon, David] NCI, Biostat & Data Management Sect, NIH, Bethesda, MD USA; [Stablein, Donald M.] EMMES Corp, Rockville, MD USA; [Barnett, Susan W.] GSK Vaccines, Cambridge, MA USA; [Kim, Jerome H.] Int Vaccine Inst, Seoul, South Korea	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Case Western Reserve University; University of Milan; Luigi Sacco Hospital; Case Western Reserve University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Walter Reed Army Institute of Research (WRAIR); Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Dartmouth College; Dartmouth College; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Duke University; National Institutes of Health (NIH) - USA; Karolinska Institutet; University of California System; University of California Davis; University of California System; University of California Irvine; Sanofi-Aventis; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Emmes Corporation; GlaxoSmithKline; International Vaccine Institute	Franchini, G (corresponding author), NCI, Anim Models & Vaccine Sect, Bethesda, MD 20892 USA.	franchig@mail.nih.gov	Roederer, Mario/G-1887-2011; Liyanage, Namal P M/AAU-1392-2021; Caccuri, Francesca/AAC-1281-2022; Liang, Frank/AAT-6566-2020; Ferrari, Guido/Z-2137-2019; Ferrari, Guido/A-6088-2015; Cameron, Mark/O-6775-2019	Liyanage, Namal P M/0000-0001-7362-3282; Caccuri, Francesca/0000-0002-1923-9033; Ferrari, Guido/0000-0001-7747-3349; Cameron, Mark/0000-0003-4768-4094; Chung, Amy/0000-0003-0020-9704; Quinn, David/0000-0002-5335-8968; Liang, Frank/0000-0003-3675-3816; Bissa, Massimiliano/0000-0003-3455-3992; Fourati, Slim/0000-0001-6609-7587; McDermott, Adrian/0000-0003-0616-9117; Ratto-Kim, Silvia/0000-0003-2025-6399	Simian Vaccine Evaluation Unit (SVEU) [HHSN266200600005C]; intramural US National Cancer Institute (NCI) program; extramural US National Institute of Allergy and Infectious Diseases (NIAID) program; US Army Medical Research and Material Command (USAMRMC) [W81XWH-07-2-0067]; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.; US Department of Defense; Collaboration for AIDS Vaccine Discovery (CAVD) grants from the Bill and Melinda Gates Foundation [OPP1032325, OPP1032817]; NCI; US National Institutes of Health (NIH) [HHSN261200800001E]; NIH [HHSN27201100016C]; Center for AIDS Research [AI064518]; Bill and Melinda Gates' Foundation [OPP111572]; NIH/NIAID [5R01AI102691]; Intramural Research Program of the Vaccine Research Center, NIAID, NIH; CAVD from the Bill and Melinda Gates Foundation [OPP1032325, R01 AI118581, R01 AI102715]; NATIONAL CANCER INSTITUTE [ZIABC011126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI102715, ZICAI005103, R01AI118581, P30AI064518, R01AI102691] Funding Source: NIH RePORTER	Simian Vaccine Evaluation Unit (SVEU); intramural US National Cancer Institute (NCI) program; extramural US National Institute of Allergy and Infectious Diseases (NIAID) program; US Army Medical Research and Material Command (USAMRMC)(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.; US Department of Defense(United States Department of Defense); Collaboration for AIDS Vaccine Discovery (CAVD) grants from the Bill and Melinda Gates Foundation; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for AIDS Research; Bill and Melinda Gates' Foundation(Bill & Melinda Gates Foundation); NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Intramural Research Program of the Vaccine Research Center, NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); CAVD from the Bill and Melinda Gates Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We would like to thank T. Nolan and D. Abram for their editorial assistance, N. Miller and A. Shultz for their help in the study design, and J. Warren for support with systems biology and several antibody assays under Simian Vaccine Evaluation Unit (SVEU) contract number HHSN266200600005C, awarded to Advanced BioScience Laboratories, Inc. (ABL). This work was supported by the intramural US National Cancer Institute (NCI) program and the extramural US National Institute of Allergy and Infectious Diseases (NIAID) program, together with the US Army Medical Research and Material Command (USAMRMC) (W81XWH-07-2-0067), the Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., the US Department of Defense, the Collaboration for AIDS Vaccine Discovery (CAVD) grants OPP1032325 and OPP1032817 from the Bill and Melinda Gates Foundation, and in part, with federal funds from the NCI, US National Institutes of Health (NIH), under contract no. HHSN261200800001E (to the whole team). We would like to acknowledge the following institutions for the grants supporting the authors: NIH primate grant HHSN27201100016C (D.M.); Center for AIDS Research grant AI064518 (G.F.); Bill and Melinda Gates' Foundation grant OPP111572 (M.E.A., C.B.K., E.F.B., K.G.D.); NIH/NIAID grant 5R01AI102691 (M.E.A, E.F.B.); Intramural Research Program of the Vaccine Research Center, NIAID, NIH, and CAVD from the Bill and Melinda Gates Foundation grants OPP1032325 (R.A.K.), R01 AI118581 and R01 AI102715 (D.F.). The views expressed are those of the authors and should not be construed to represent the positions of the US Army, the Department of Defense or the Department of Health and Human Services. Mention of trade names, commercial products, or organizations do not imply endorsement by the US Government. The following reagent was obtained through the NIH AIDS Reagent Program, Division of AIDS, NIAID, NIH: CEM.NKR CCR5<SUP>+</SUP> by P. Creswell. The anti-alpha 4 beta 7 in APC was kindly provided by A. A. Ansari (cat. #11718, 1:50 dilution) through the NIH AIDS Reagent Program, Division of AIDS, NIAID.	Ackerman ME, 2013, J CLIN INVEST, V123, P2183, DOI 10.1172/JCI65708; Awad A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094492; Bambard ND, 2010, SCAND J IMMUNOL, V71, P210, DOI 10.1111/j.1365-3083.2009.02367.x; Bogdan C, 2011, METHODS MOL BIOL, V677, P375, DOI 10.1007/978-1-60761-869-0_24; Chung AW, 2014, AIDS, V28, P2523, DOI 10.1097/QAD.0000000000000444; Dedio J, 2001, FASEB J, V15, P79, DOI 10.1096/fj.00-0078com; Fox CB, 2013, EXPERT REV VACCINES, V12, P747, DOI 10.1586/14760584.2013.811188; Franchini Genoveffa, 2004, Expert Rev Vaccines, V3, pS75, DOI 10.1586/14760584.3.4.S75; Fric J, 2012, BLOOD, V120, P1380, DOI 10.1182/blood-2012-02-404475; Gottardo R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075665; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Iborra S, 2011, BLOOD, V117, P5102, DOI 10.1182/blood-2010-10-315770; Kaneko Y, 2006, SCIENCE, V313, P670, DOI 10.1126/science.1129594; Liu XV, 2012, J IMMUNOL, V189, P1826, DOI 10.4049/jimmunol.1200965; Liyanage NPM, 2014, VIROLOGY, V450, P359, DOI 10.1016/j.virol.2013.12.003; Nakajima C, 2002, EUR J IMMUNOL, V32, P1792, DOI 10.1002/1521-4141(200206)32:6<1792::AID-IMMU1792>3.0.CO;2-0; Nitayaphan S, 2004, J INFECT DIS, V190, P702, DOI 10.1086/422258; Pegu P, 2013, J VIROL, V87, P1708, DOI 10.1128/JVI.02544-12; Ragab A, 2011, EMBO J, V30, P1123, DOI 10.1038/emboj.2011.4; Reeves RK, 2011, BLOOD, V118, P3321, DOI 10.1182/blood-2011-04-347260; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Rolland M, 2012, NATURE, V490, P417, DOI 10.1038/nature11519; Sanchez-Ruiz J, 2011, J IMMUNOL, V187, P2433, DOI 10.4049/jimmunol.1003089; Sedy JR, 2013, J IMMUNOL, V191, P828, DOI 10.4049/jimmunol.1300894; Selinger C, 2014, CLIN VACCINE IMMUNOL, V21, P1650, DOI 10.1128/CVI.00455-14; Strbo N, 2013, J IMMUNOL, V190, P2495, DOI 10.4049/jimmunol.1202655; Tomaras GD, 2008, J VIROL, V82, P12449, DOI 10.1128/JVI.01708-08; Underhill GH, 2003, BLOOD, V101, P4013, DOI 10.1182/blood-2002-08-2673; Vaccari M, 2013, J VIROL, V87, P3538, DOI 10.1128/JVI.02863-12; Waddell SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009753; Zhang Z, 2015, J CLIN INVEST, V125, P3692, DOI 10.1172/JCI82124	31	147	152	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2016	22	7					762	770		10.1038/nm.4105	http://dx.doi.org/10.1038/nm.4105			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DQ7DK	27239761	Green Accepted			2022-12-25	WOS:000379366900015
J	Day, FR; Helgason, H; Chasman, DI; Rose, LM; Loh, PR; Scott, RA; Helgason, A; Kong, A; Masson, G; Magnusson, OT; Gudbjartsson, D; Thorsteinsdottir, U; Buring, JE; Ridker, PM; Sulem, P; Stefansson, K; Ong, KK; Perry, JRB				Day, Felix R.; Helgason, Hannes; Chasman, Daniel I.; Rose, Lynda M.; Loh, Po-Ru; Scott, Robert A.; Helgason, Agnar; Kong, Augustine; Masson, Gisli; Magnusson, Olafur Th; Gudbjartsson, Daniel; Thorsteinsdottir, Unnur; Buring, Julie E.; Ridker, Paul M.; Sulem, Patrick; Stefansson, Kari; Ong, Ken K.; Perry, John R. B.			Physical and neurobehavioral determinants of reproductive onset and success	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; EXECUTIVE FUNCTION; AGE; SCHIZOPHRENIA; HEALTH; MENARCHE; BEHAVIOR; PUBERTY; INTERCOURSE; ESTROGENS	The ages of puberty, first sexual intercourse and first birth signify the onset of reproductive ability, behavior and success, respectively. In a genome-wide association study of 125,667 UK Biobank participants, we identify 38 loci associated (P < 5 x 10(-8)) with age at first sexual intercourse. These findings were taken forward in 241,910 men and women from Iceland and 20,187 women from the Women's Genome Health Study. Several of the identified loci also exhibit associations (P < 5 x 10(-8)) with other reproductive and behavioral traits, including age at first birth (variants in or near ESR1 and RBM6-SEMA3F), number of children (CADM2 and ESR1), irritable temperament (MSRA) and risk-taking propensity (CADM2). Mendelian randomization analyses infer causal influences of earlier puberty timing on earlier first sexual intercourse, earlier first birth and lower educational attainment. In turn, likely causal consequences of earlier first sexual intercourse include reproductive, educational, psychiatric and cardiometabolic outcomes.	[Day, Felix R.; Scott, Robert A.; Ong, Ken K.; Perry, John R. B.] Univ Cambridge, Inst Metab Sci, MRC Epidemiol Unit, Cambridge, England; [Helgason, Hannes; Helgason, Agnar; Kong, Augustine; Masson, Gisli; Magnusson, Olafur Th; Gudbjartsson, Daniel; Thorsteinsdottir, Unnur; Sulem, Patrick; Stefansson, Kari] deCODE Genet Amgen Inc, Reykjavik, Iceland; [Helgason, Hannes; Kong, Augustine; Gudbjartsson, Daniel] Univ Iceland, Sch Engn & Nat Sci, Reykjavik, Iceland; [Chasman, Daniel I.; Rose, Lynda M.; Buring, Julie E.; Ridker, Paul M.] Brigham & Womens Hosp, Div Prevent Med, 75 Francis St, Boston, MA 02115 USA; [Chasman, Daniel I.; Buring, Julie E.; Ridker, Paul M.] Harvard Univ, Sch Med, Boston, MA USA; [Loh, Po-Ru] Harvard Univ, TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Loh, Po-Ru] Broad Inst Harvard & MIT, Program Med & Populat Genet, Cambridge, MA USA; [Helgason, Agnar] Univ Iceland, Dept Anthropol, Reykjavik, Iceland; [Thorsteinsdottir, Unnur; Stefansson, Kari] Univ Iceland, Sch Hlth Sci, Fac Med, Reykjavik, Iceland	University of Cambridge; University of Iceland; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Iceland; University of Iceland	Ong, KK; Perry, JRB (corresponding author), Univ Cambridge, Inst Metab Sci, MRC Epidemiol Unit, Cambridge, England.	ken.ong@mrc-epid.cam.ac.uk; john.perry@mrc-epid.cam.ac.uk	Stefansson, Kari/AAE-7187-2019; Helgason, Agnar/K-1522-2015	Kong, Augustine/0000-0001-8193-5438; Masson, Gisli/0000-0003-0493-8242; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Day, Felix/0000-0003-3789-7651	Medical Research Council [MC_UU_12015/1, MC_UU_12015/2]; MRC [MC_U106179472, MC_UU_12015/1, MC_UU_12015/2] Funding Source: UKRI; Medical Research Council [MC_U106179472, MC_PC_13046, MC_qA137853] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10135] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [UM1CA182913] Funding Source: NIH RePORTER	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research has been conducted using the UK Biobank Resource. This work was supported by the Medical Research Council (Unit Programme numbers MC_UU_12015/1 and MC_UU_12015/2).	Allen JP, 2014, CHILD DEV, V85, P1866, DOI 10.1111/cdev.12250; Allen NE, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008601; Altmae S, 2007, MOL HUM REPROD, V13, P521, DOI 10.1093/molehr/gam035; Baams L, 2015, J ADOLESCENT HEALTH, V56, P586, DOI 10.1016/j.jadohealth.2014.11.019; Bulik-Sullivan B, 2015, NAT GENET, V47, P1236, DOI 10.1038/ng.3406; Burgess S, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7325; Carreau S, 2010, PHILOS T R SOC B, V365, P1517, DOI 10.1098/rstb.2009.0235; Charalampopoulos D, 2014, AM J EPIDEMIOL, V180, P29, DOI 10.1093/aje/kwu113; Couse JF, 1999, SCIENCE, V286, P2328, DOI 10.1126/science.286.5448.2328; Day FR, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9842; Day FR, 2015, SCI REP-UK, V5, DOI 10.1038/srep11208; de Mattos CS, 2014, J OVARIAN RES, V7, DOI 10.1186/s13048-014-0114-2; Dinzeo TJ, 2007, J NERV MENT DIS, V195, P421, DOI 10.1097/01.nmd.0000253795.69089.ec; Drummond AE, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-16; Emiliani FE, 2014, CURR OPIN PSYCHIATR, V27, P185, DOI 10.1097/YCO.0000000000000054; Eriksson N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000993; Gaudineau A, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-175; Gluckman PD, 2006, TRENDS ENDOCRIN MET, V17, P7, DOI 10.1016/j.tem.2005.11.006; Gudbjartsson DF, 2015, NAT GENET, V47, P435, DOI 10.1038/ng.3247; Harden KP, 2011, CHILD DEV, V82, P1327, DOI 10.1111/j.1467-8624.2011.01607.x; Hawes ZC, 2010, J SEX RES, V47, P137, DOI 10.1080/00224490903509399; Hess RA, 1997, NATURE, V390, P509, DOI 10.1038/37352; Hochberg Z, 2011, INT J PEDIATR ENDOCR, DOI 10.1186/1687-9856-2011-2; Hoptman MJ, 2015, CNS SPECTRUMS, V20, P280, DOI 10.1017/S1092852915000206; Ibrahim-Verbaas CA, 2016, MOL PSYCHIATR, V21, P189, DOI 10.1038/mp.2015.37; INGHAM R, 1991, J COMMUNITY APPL SOC, V1, P117, DOI 10.1002/casp.2450010206; Lahat A, 2012, DEV PSYCHOPATHOL, V24, P847, DOI 10.1017/S0954579412000405; Lam TH, 2002, ARCH SEX BEHAV, V31, P359, DOI 10.1023/A:1016228427210; Lee H, 2014, NATURE, V509, P627, DOI 10.1038/nature13169; Lehmann A, 2010, ANTHROPOL ANZ, V68, P85, DOI 10.1127/0003-5548/2010/0086; Lenciauskiene I, 2008, SCAND J PUBLIC HEALT, V36, P607, DOI 10.1177/1403494807088460; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Loh PR, 2015, NAT GENET, V47, P1385, DOI 10.1038/ng.3431; Loh PR, 2015, NAT GENET, V47, P284, DOI 10.1038/ng.3190; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Martin AK, 2014, GENES BRAIN BEHAV, V13, P104, DOI 10.1111/gbb.12066; MARTIN NG, 1977, J BIOSOC SCI, V9, P91, DOI 10.1017/S0021932000000493; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Parent AS, 2003, ENDOCR REV, V24, P668, DOI 10.1210/er.2002-0019; Perry JRB, 2014, NATURE, V514, P92, DOI 10.1038/nature13545; Ridker PM, 2008, CLIN CHEM, V54, P249, DOI 10.1373/clinchem.2007.099366; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Ruan H, 2002, P NATL ACAD SCI USA, V99, P2748, DOI 10.1073/pnas.032671199; Sohn K., 2015, DISCUSSION PAPER SER, V1-34; Stulp G, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0211; Sudlow C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001779; Sulem P, 2007, NAT GENET, V39, P1443, DOI 10.1038/ng.2007.13; Waldron M, 2015, J ADOLESCENT HEALTH, V56, P550, DOI 10.1016/j.jadohealth.2015.01.011; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Waylen A, 2004, EUR J ENDOCRINOL, V151, pU151, DOI 10.1530/eje.0.151U151; Wood AR, 2014, NAT GENET, V46, P1173, DOI 10.1038/ng.3097; Zhang S, 2013, MOL ASPECTS MED, V34, P939, DOI 10.1016/j.mam.2012.12.011	52	78	78	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2016	48	6					617	+		10.1038/ng.3551	http://dx.doi.org/10.1038/ng.3551			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	DN0HE	27089180	Green Accepted, Green Submitted			2022-12-25	WOS:000376744200008
J	Kawashima, CG; Guimaraes, GA; Nogueira, SR; MacLean, D; Cook, DR; Steuernagel, B; Baek, J; Bouyioukos, C; Melo, BDA; Tristao, G; de Oliveira, JC; Rauscher, G; Mittal, S; Panichelli, L; Bacot, K; Johnson, E; Iyer, G; Tabor, G; Wulff, BBH; Ward, E; Rairdan, GJ; Broglie, KE; Wu, GS; van Esse, HP; Jones, JDG; Brommonschenkel, SH				Kawashima, Cintia G.; Guimaraes, Gustavo Augusto; Nogueira, Sonia Regina; MacLean, Dan; Cook, Doug R.; Steuernagel, Burkhard; Baek, Jongmin; Bouyioukos, Costas; Melo, Bernardo do V. A.; Tristao, Gustavo; de Oliveira, Jamile Camargos; Rauscher, Gilda; Mittal, Shipra; Panichelli, Lisa; Bacot, Karen; Johnson, Ebony; Iyer, Geeta; Tabor, Girma; Wulff, Brande B. H.; Ward, Eric; Rairdan, Gregory J.; Broglie, Karen E.; Wu, Gusui; van Esse, H. Peter; Jones, Jonathan D. G.; Brommonschenkel, Sergio H.			A pigeonpea gene confers resistance to Asian soybean rust in soybean	NATURE BIOTECHNOLOGY			English	Article							PHAKOPSORA-PACHYRHIZI; DISEASE RESISTANCE; PATHOGEN; LOCUS; RPP1; IDENTIFICATION; EFFECTOR; BRAZIL; AGENT	Asian soybean rust (ASR), caused by the fungus Phakopsora pachyrhizi, is one of the most economically important crop diseases, but is only treatable with fungicides, which are becoming less effective owing to the emergence of fungicide resistance. There are no commercial soybean cultivars with durable resistance to P. pachyrhizi, and although soybean resistance loci have been mapped, no resistance genes have been cloned. We report the cloning of a P. pachyrhizi resistance gene CcRppl (Cajanus cajan Resistance against Phakopsora pachyrhizi 1) from pigeonpea (Cajanus cajan) and show that CcRppl confers full resistance to P. pachyrhizi in soybean. Our findings show that legume species related to soybean such as pigeonpea, cowpea, common bean and others could provide a valuable and diverse pool of resistance traits for crop improvement.	[Kawashima, Cintia G.; MacLean, Dan; Steuernagel, Burkhard; Bouyioukos, Costas; Wulff, Brande B. H.; van Esse, H. Peter; Jones, Jonathan D. G.] Sainsbury Lab, Norwich, Norfolk, England; [Guimaraes, Gustavo Augusto; Nogueira, Sonia Regina; Melo, Bernardo do V. A.; Tristao, Gustavo; de Oliveira, Jamile Camargos; Brommonschenkel, Sergio H.] Univ Fed Vicosa, Dept Fitopatol, BR-36570 Vicosa, MG, Brazil; [Cook, Doug R.; Baek, Jongmin] Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA; [Rauscher, Gilda; Mittal, Shipra; Panichelli, Lisa; Bacot, Karen; Johnson, Ebony; Iyer, Geeta; Tabor, Girma; Rairdan, Gregory J.; Broglie, Karen E.; Wu, Gusui] DuPont Pioneer, Agr Biotechnol, Wilmington, DC USA; [Ward, Eric] 2Blades Fdn, Evanston, IL USA; [Steuernagel, Burkhard; Wulff, Brande B. H.] John Innes Ctr, Norwich, Norfolk, England; [Bouyioukos, Costas] Inst Syst & Synthet Biol, Evry, France; [Ward, Eric] AgBiome Inc, Res Triangle Pk, NC USA	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Universidade Federal de Vicosa; University of California System; University of California Davis; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; UDICE-French Research Universities; Universite Paris Saclay	van Esse, HP (corresponding author), Sainsbury Lab, Norwich, Norfolk, England.	peter.vanesse@tsl.ac.uk	van Esse, Peter/U-5304-2018; Jones, Jonathan DG/J-5129-2012; Wulff, Brande BH/C-7465-2013; Nogueira, Sônia/AAS-9596-2021; MacLean, Dan/C-7046-2013	van Esse, Peter/0000-0002-3667-060X; Jones, Jonathan DG/0000-0002-4953-261X; Wulff, Brande BH/0000-0003-4044-4346; Bouyioukos, Costas/0000-0002-7443-3736; MacLean, Dan/0000-0003-1032-0887	2Blades Foundation; Universidade Federal de Vicosa; DuPont-Pioneer; NSF [DBI 0605251]; Biotechnology and Biological Sciences Research Council [BB/L011794/1, BBS/E/J/000CA562, BB/J003166/1, BBS/E/J/000C0673] Funding Source: researchfish; BBSRC [BB/J003166/1, BB/L011794/1, BBS/E/J/000C0673, BBS/E/J/000CA562] Funding Source: UKRI	2Blades Foundation; Universidade Federal de Vicosa; DuPont-Pioneer; NSF(National Science Foundation (NSF)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research was supported by grants from the 2Blades Foundation to The Sainsbury Laboratory and the Universidade Federal de Vicosa. 2Blades support was funded in part by DuPont-Pioneer. We wish to thank R. Godoy for providing the seeds of the C. cajan accessions used in this work. Work performed by D.R.C. and J.B. was supported by NSF award DBI 0605251. Next-generation and BAC sequencing was financed by the 2Blades Foundation. We thank G. Etherington and C. Schudoma for bioinformatics support, J. Pike for assisting in the preparation of the Solexa sequencing libraries, S. Perkins and the JIC horticultural team for excellent plant care, and the TSL support team for media preparation. We thank the DuPont Pioneer Soybean Transformation group for generating CcRpp1 transgenic events and the Controlled Environment group for growth, maintenance and seed advancement of transgenic material. We thank N. Penido, E. Feitosa Araajo and T. Castro Silva for excellent technical support during the high-resolution genotyping screenings and E.S. Mizubuti for helping with drawing Figure 1b. We thank D. Da Silva Toledo and L. Carlos Costa for plant care at UFV. We thank J. Pacheco Badel for implanting and curating a searchable seed database to support our genetic studies. We thank Y. Yamaoka for kindly providing the Japanese isolate T1-4. We acknowledge D. Horvath, M. Moscou and B. Staskawicz for many helpful discussions.	Akamatsu H, 2013, J GEN PLANT PATHOL, V79, P28, DOI 10.1007/s10327-012-0421-7; Allen RL, 2008, MOL PLANT PATHOL, V9, P511, DOI 10.1111/J.1364-3703.2008.00481.X; Bonde MR, 2008, PLANT DIS, V92, P30, DOI 10.1094/PDIS-92-1-0030; Dodds PN, 2010, NAT REV GENET, V11, P539, DOI 10.1038/nrg2812; Doyle JJ, 2003, PLANT PHYSIOL, V131, P900, DOI 10.1104/pp.102.018150; Ellis J, 2006, PLANT CELL, V18, P523, DOI 10.1105/tpc.105.040584; Garcia A, 2008, THEOR APPL GENET, V117, P545, DOI 10.1007/s00122-008-0798-z; Goellner K, 2010, MOL PLANT PATHOL, V11, P169, DOI 10.1111/j.1364-3703.2009.00589.x; Gurr SJ, 2005, TRENDS BIOTECHNOL, V23, P275, DOI 10.1016/j.tibtech.2005.04.007; Hartman, 2006, PLANT HLTH PROG, DOI 10.1094/php-2006-0104-01-rs; Hyten DL, 2007, CROP SCI, V47, P837, DOI 10.2135/cropsci2006.07.0484; Hyten DL, 2009, CROP SCI, V49, P265, DOI 10.2135/cropsci2008.08.0511; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Jones JDG, 2014, PHILOS T R SOC B, V369, DOI [10.1098/rstb.2013.0087, 10.1098/rstb.2013.008]; Kelly HY, 2015, PHYTOPATHOLOGY, V105, P905, DOI 10.1094/PHYTO-02-15-0054-FI; Kim KS, 2012, THEOR APPL GENET, V125, P1339, DOI 10.1007/s00122-012-1932-5; Langenbach C., 2015, PLANT BIOTECHNOL J; Li SX, 2012, THEOR APPL GENET, V125, P133, DOI 10.1007/s00122-012-1821-y; Meyer JDF, 2009, PLANT PHYSIOL, V150, P295, DOI 10.1104/pp.108.134551; Monteros MJ, 2007, CROP SCI, V47, P829, DOI 10.2135/cropsci06.07.0462; ONO Y, 1992, MYCOL RES, V96, P825, DOI 10.1016/S0953-7562(09)81029-0; Paul C, 2013, PLANT DIS, V97, P1379, DOI 10.1094/PDIS-02-13-0182-PDN; Provazi M, 2007, REV BRAS ZOOTECN, V36, P328, DOI 10.1590/S1516-35982007000200008; Ravensdale M, 2011, MOL PLANT PATHOL, V12, P93, DOI 10.1111/j.1364-3703.2010.00657.x; Reis Erlei Melo, 2015, Summa phytopathol., V41, P21, DOI 10.1590/0100-5405/1975; Scherm H, 2009, CROP PROT, V28, P774, DOI 10.1016/j.cropro.2009.05.006; Silva DCG, 2008, THEOR APPL GENET, V117, P57, DOI 10.1007/s00122-008-0752-0; Slaminko TL, 2008, PLANT DIS, V92, P767, DOI 10.1094/PDIS-92-5-0767; Yorinori JT, 2005, PLANT DIS, V89, P675, DOI 10.1094/PD-89-0675; Yu N, 2015, THEOR APPL GENET, V128, P387, DOI 10.1007/s00122-014-2438-0	30	63	67	2	50	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUN	2016	34	6					661	665		10.1038/nbt.3554	http://dx.doi.org/10.1038/nbt.3554			5	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DO5TT	27111723	Green Published, Green Accepted			2022-12-25	WOS:000377846400035
J	Oakes, BL; Nadler, DC; Flamholz, A; Fellmann, C; Staahl, BT; Doudna, JA; Savage, DF				Oakes, Benjamin L.; Nadler, Dana C.; Flamholz, Avi; Fellmann, Christof; Staahl, Brett T.; Doudna, Jennifer A.; Savage, David F.			Profiling of engineering hotspots identifies an allosteric CRISPR-Cas9 switch	NATURE BIOTECHNOLOGY			English	Article							STRUCTURAL BASIS; GENE-EXPRESSION; GUIDE RNA; CAS9; PROTEIN; TRANSCRIPTION; ESTROGEN; COMPLEX; DOMAIN; RECOGNITION	The clustered, regularly interspaced, short palindromic repeats (CRISPR)-associated protein Cas9 from Streptococcus pyogenes is an RNA-guided DNA endonuclease with widespread utility for genome modification. However, the structural constraints limiting the engineering of Cas9 have not been determined. Here we experimentally profile Cas9 using randomized insertional mutagenesis and delineate hotspots in the structure capable of tolerating insertions of a PDZ domain without disruption of the enzyme's binding and cleavage functions. Orthogonal domains or combinations of domains can be inserted into the identified sites with minimal functional consequence. To illustrate the utility of the identified sites, we construct an allosterically regulated Cas9 by insertion of the estrogen receptor-alpha ligand-binding domain. This protein showed robust, ligand-dependent activation in prokaryotic and eukaryotic cells, establishing a versatile one-component system for inducible and reversible Cas9 activation. Thus, domain insertion profiling facilitates the rapid generation of new Cas9 functionalities and provides useful data for future engineering of Cas9.	[Oakes, Benjamin L.; Nadler, Dana C.; Flamholz, Avi; Fellmann, Christof; Staahl, Brett T.; Doudna, Jennifer A.; Savage, David F.] Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Innovat Genom Initiat, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Doudna, Jennifer A.; Savage, David F.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Savage, David F.] Univ Calif Berkeley, Energy Biosci Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Savage, DF (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.; Savage, DF (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.; Savage, DF (corresponding author), Univ Calif Berkeley, Energy Biosci Inst, Berkeley, CA 94720 USA.	savage@berkeley.edu		Flamholz, Avi/0000-0002-9278-5479; Fellmann, Christof/0000-0002-9545-5723; Nadler, Dana/0000-0002-9792-145X	NIH [1DP2EB018658-01]; Basil O'Connor Starter Scholar Research Award from the March of Dimes; National Science Foundation [IQJEDMS001]; National Science Foundation; Roche Postdoctoral Fellowship [RPF 311]; Div Of Molecular and Cellular Bioscience [1244557] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [DP2EB018658] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM066698] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Basil O'Connor Starter Scholar Research Award from the March of Dimes; National Science Foundation(National Science Foundation (NSF)); National Science Foundation(National Science Foundation (NSF)); Roche Postdoctoral Fellowship; Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Qi (Stanford) and J. Dueber (UC Berkeley) for providing the E. coli strain and the PDZ and SH3 domains, respectively. We would like to thank M. O'Connell, S. Sternberg, A. Wright and S. Higgins for productive discussions and readings of the manuscript. This work was supported by a NIH New Innovator Award (1DP2EB018658-01) and a Basil O'Connor Starter Scholar Research Award from the March of Dimes (D.F.S.) and by the National Science Foundation (IQJEDMS001 to J.A.D.); A.F. is funded by a National Science Foundation Graduate Research Fellow, and B.T.S. is funded by a Roche Postdoctoral Fellowship (RPF 311).	Anders C, 2014, NATURE, V513, P569, DOI 10.1038/nature13579; Briner AE, 2014, MOL CELL, V56, P333, DOI 10.1016/j.molcel.2014.09.019; Chen BH, 2013, CELL, V155, P1479, DOI 10.1016/j.cell.2013.12.001; Chothia C, 2003, SCIENCE, V300, P1701, DOI 10.1126/science.1085371; Davis KM, 2015, NAT CHEM BIOL, V11, P316, DOI [10.1038/NCHEMBIO.1793, 10.1038/nchembio.1793]; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Dow LE, 2015, NAT BIOTECHNOL, V33, P390, DOI 10.1038/nbt.3155; Dueber JE, 2009, NAT BIOTECHNOL, V27, P753, DOI 10.1038/nbt.1557; Edwards WR, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn363; Feil R, 1996, P NATL ACAD SCI USA, V93, P10887, DOI 10.1073/pnas.93.20.10887; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Gonzalez F, 2014, CELL STEM CELL, V15, P215, DOI 10.1016/j.stem.2014.05.018; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; GOSSEN M, 1995, SCIENCE, V268, P1766, DOI 10.1126/science.7792603; Guilinger JP, 2014, NAT BIOTECHNOL, V32, P577, DOI 10.1038/nbt.2909; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Jiang FG, 2015, SCIENCE, V348, P1477, DOI 10.1126/science.aab1452; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kearns NA, 2014, DEVELOPMENT, V141, P219, DOI 10.1242/dev.103341; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; McIsaac RS, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1313; Nihongaki Y, 2015, NAT BIOTECHNOL, V33, P755, DOI 10.1038/nbt.3245; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Oakes BL, 2014, METHOD ENZYMOL, V546, P491, DOI 10.1016/B978-0-12-801185-0.00024-6; Peisajovich SG, 2010, SCIENCE, V328, P368, DOI 10.1126/science.1182376; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Reynolds KA, 2011, CELL, V147, P1564, DOI 10.1016/j.cell.2011.10.049; Schultz J, 1998, NAT STRUCT BIOL, V5, P19, DOI 10.1038/nsb0198-19; Shechner DM, 2015, NAT METHODS, V12, P664, DOI [10.1038/NMETH.3433, 10.1038/nmeth.3433]; Shiau AK, 1998, CELL, V95, P927, DOI 10.1016/S0092-8674(00)81717-1; Stein V, 2015, TRENDS BIOTECHNOL, V33, P101, DOI 10.1016/j.tibtech.2014.11.010; Tanenbaum DM, 1998, P NATL ACAD SCI USA, V95, P5998, DOI 10.1073/pnas.95.11.5998; Tanenbaum ME, 2014, CELL, V159, P635, DOI 10.1016/j.cell.2014.09.039; Truong DJJ, 2015, NUCLEIC ACIDS RES, V43, P6450, DOI 10.1093/nar/gkv601; Tsai SQ, 2014, NAT BIOTECHNOL, V32, P569, DOI 10.1038/nbt.2908; Tucker CL, 2001, NAT BIOTECHNOL, V19, P1042, DOI 10.1038/nbt1101-1042; Warnmark A, 2002, J BIOL CHEM, V277, P21862, DOI 10.1074/jbc.M200764200; Zalatan JG, 2015, CELL, V160, P339, DOI 10.1016/j.cell.2014.11.052; Zetsche B, 2015, NAT BIOTECHNOL, V33, P139, DOI 10.1038/nbt.3149	40	121	130	1	58	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUN	2016	34	6					646	651		10.1038/nbt.3528	http://dx.doi.org/10.1038/nbt.3528			6	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DO5TT	27136077	Green Accepted			2022-12-25	WOS:000377846400032
J	Toriyama, M; Lee, CJ; Taylor, SP; Duran, I; Cohn, DH; Bruel, AL; Tabler, JM; Drew, K; Kelly, MR; Kim, S; Park, TJ; Braun, DA; Pierquin, G; Biver, A; Wagner, K; Malfroot, A; Panigrahi, I; Franco, B; Al-Lami, HA; Yeung, Y; Choi, YJ; Duffourd, Y; Faivre, L; Riviere, JB; Chen, J; Liu, KJ; Marcotte, EM; Hildebrandt, F; Thauvin-Robinet, C; Krakow, D; Jackson, PK; Wallingford, JB				Toriyama, Michinori; Lee, Chanjae; Taylor, S. Paige; Duran, Ivan; Cohn, Daniel H.; Bruel, Ange-Line; Tabler, Jacqueline M.; Drew, Kevin; Kelly, Marcus R.; Kim, Sukyoung; Park, Tae Joo; Braun, Daniela A.; Pierquin, Ghislaine; Biver, Armand; Wagner, Kerstin; Malfroot, Anne; Panigrahi, Inusha; Franco, Brunella; Al-Lami, Hadeel Adel; Yeung, Yvonne; Choi, Yeon Ja; Duffourd, Yannis; Faivre, Laurence; Riviere, Jean-Baptiste; Chen, Jiang; Liu, Karen J.; Marcotte, Edward M.; Hildebrandt, Friedhelm; Thauvin-Robinet, Christel; Krakow, Deborah; Jackson, Peter K.; Wallingford, John B.		Univ Washington Ctr Mendelian Geno	The ciliopathy-associated CPLANE proteins direct basal body recruitment of intraflagellar transport machinery	NATURE GENETICS			English	Article							PLANAR CELL POLARITY; CILIARY VESICLE DOCKING; IFT-A COMPLEX; JOUBERT SYNDROME; TUBULIN TRANSPORT; KINESIN-II; GENE; FUZZY; CILIOGENESIS; MECHANISMS	Cilia use microtubule-based intraflagellar transport (IFT) to organize intercellular signaling. Ciliopathies are a spectrum of human diseases resulting from defects in cilia structure or function. The mechanisms regulating the assembly of ciliary multiprotein complexes and the transport of these complexes to the base of cilia remain largely unknown. Combining proteomics, in vivo imaging and genetic analysis of proteins linked to planar cell polarity (Inturned, Fuzzy and Wdpcp), we identified and characterized a new genetic module, which we term CPLANE (ciliogenesis and planar polarity effector), and an extensive associated protein network. CPLANE proteins physically and functionally interact with the poorly understood ciliopathy-associated protein Jbts17 at basal bodies, where they act to recruit a specific subset of IFT-A proteins. In the absence of CPLANE, defective IFT-A particles enter the axoneme and IFT-B trafficking is severely perturbed. Accordingly, mutation of CPLANE genes elicits specific ciliopathy phenotypes in mouse models and is associated with ciliopathies in human patients.	[Toriyama, Michinori; Lee, Chanjae; Tabler, Jacqueline M.; Drew, Kevin; Kim, Sukyoung; Park, Tae Joo; Marcotte, Edward M.; Wallingford, John B.] Univ Texas Austin, Dept Mol Biosci, Austin, TX 78712 USA; [Taylor, S. Paige; Duran, Ivan] Univ Calif Los Angeles, David Geffen Sch Med, Dept Orthopaed Surg, Los Angeles, CA 90095 USA; [Taylor, S. Paige; Duran, Ivan] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [Taylor, S. Paige; Duran, Ivan] Univ Calif Los Angeles, David Geffen Sch Med, Dept Obstet & Gynecol, Los Angeles, CA 90095 USA; [Cohn, Daniel H.; Krakow, Deborah] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA USA; [Bruel, Ange-Line; Duffourd, Yannis; Faivre, Laurence; Riviere, Jean-Baptiste; Thauvin-Robinet, Christel] Burgundy Univ, Fac Med, FHU TRANSLAD, Genet Dev Anomalies EA4271GAD, Dijon, France; [Kelly, Marcus R.; Jackson, Peter K.] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Baxter Lab, Stanford, CA 94305 USA; [Braun, Daniela A.; Hildebrandt, Friedhelm] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston Childrens Hosp, Boston, MA 02115 USA; [Braun, Daniela A.; Hildebrandt, Friedhelm] Harvard Univ, Sch Med, Dept Med, Boston Childrens Hosp, Boston, MA USA; [Pierquin, Ghislaine] Univ Hosp Ctr, Clin Genet Ctr, Liege, Belgium; [Biver, Armand] Ctr Hosp, Pediat Unit, Luxembourg, Luxembourg; [Wagner, Kerstin] Ctr Hosp, Cardiol Pediat Unit, Luxembourg, Luxembourg; [Malfroot, Anne] Univ Ziekenhuis Brussel, Clin Pediat Resp Dis, Brussels, Belgium; [Malfroot, Anne] Univ Ziekenhuis Brussel, Travel Clin, Infectious Dis, Brussels, Belgium; [Malfroot, Anne] Univ Ziekenhuis Brussel, Cyst Fibrosis Clin, Brussels, Belgium; [Panigrahi, Inusha] Pediat Ctr Pigmer, Dept Pediat Adv, Chandigarh, India; [Franco, Brunella] Univ Naples Federico II, Dept Med Translat Sci, Div Pediat, Naples, Italy; [Franco, Brunella] Telethon Inst Genet & Med TIGEM, Naples, Italy; [Al-Lami, Hadeel Adel; Yeung, Yvonne; Liu, Karen J.] Kings Coll London, Inst Dent, Dept Craniofacial & Stem Cell Biol, London WC2R 2LS, England; [Choi, Yeon Ja; Chen, Jiang] SUNY Stony Brook, Dept Pathol, Stony Brook, NY 11794 USA; [Choi, Yeon Ja; Chen, Jiang] SUNY Stony Brook, Dept Dermatol, Stony Brook, NY 11794 USA; [Faivre, Laurence] CHU Dijon, Children Hosp, FHU TRANSLAD, Clin Genet Ctr, Dijon, France; [Faivre, Laurence] CHU Dijon, Children Hosp, FHU TRANSLAD, Eastern Referral Ctr Dev Anomalies & Malformat Sy, Dijon, France; [Riviere, Jean-Baptiste; Thauvin-Robinet, Christel] CHU Dijon, PTB, FHU TRANSLAD, Mol Genet Lab, Dijon, France; [Park, Tae Joo] UNIST, Ulsan, South Korea	University of Texas System; University of Texas Austin; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; Institut Agro; AgroSup Dijon; Universite de Bourgogne; Stanford University; Harvard University; Boston Children's Hospital; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Boston Children's Hospital; Harvard Medical School; Luxembourg Hospital Center; Luxembourg Hospital Center; University Hospital Brussels; Vrije Universiteit Brussel; University Hospital Brussels; Vrije Universiteit Brussel; University Hospital Brussels; Vrije Universiteit Brussel; University of Naples Federico II; Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); University of London; King's College London; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; CHU Dijon Bourgogne; CHU Dijon Bourgogne; CHU Dijon Bourgogne; Ulsan National Institute of Science & Technology (UNIST)	Wallingford, JB (corresponding author), Univ Texas Austin, Dept Mol Biosci, Austin, TX 78712 USA.	wallingford@austin.utexas.edu	Park, Tae Joo/G-1460-2011; Krakow, Deborah/B-5778-2009; Al-Lami, Hadeel Adel/ABE-8854-2020; Braun, Daniela A/R-2259-2017; Duran, Ivan/M-3185-2016; Duran, Ivan/ADN-5665-2022; Liu, Karen/F-2870-2010; Panigrahi, Inusha/L-6965-2018; FRANCO, Brunella/S-2882-2018	Park, Tae Joo/0000-0003-3176-177X; Krakow, Deborah/0000-0001-9906-4968; Al-Lami, Hadeel Adel/0000-0002-3757-1822; Braun, Daniela A/0000-0003-3146-1566; Duran, Ivan/0000-0001-6097-0402; Duran, Ivan/0000-0001-6097-0402; Liu, Karen/0000-0002-2483-2165; Panigrahi, Inusha/0000-0001-7375-9892; TORIYAMA, Michinori/0000-0003-2551-4334; FRANCO, Brunella/0000-0001-5588-4569; Marcotte, Edward/0000-0001-8808-180X; Drew, Kevin/0000-0002-1260-4413; Kelly, Marcus/0000-0003-3670-8126; Faivre, Laurence/0000-0001-9770-444X; Blue, Elizabeth/0000-0002-0633-0305; Jackson, Peter/0000-0002-1742-2539	Lung GO Sequencing Project [HL-102923]; WHI Sequencing Project [HL-102924]; Broad GO Sequencing Project [HL-102925]; Seattle GO Sequencing Project [HL-102926]; Heart GO Sequencing Project [HL-103010]; NHGRI; NHLBI [1U54 HG006493, HL117164]; Uehara Memorial Foundation Fellowship; NIDCR NRSA; French Rare Diseases Foundation; French Ministry of Health (PHRC national) [2010-A01014-35]; Regional Council of Burgundy; NIDDK [DK1068306]; NIAMS [AR061485]; BBSRC [BB/K010492/1]; MRC [MR/L017237/1]; NIH; NSF; CPRIT; Welch Foundation [F-1515]; March of Dimes [R01 AR066124]; Joseph Drown Foundation; NIH/NCATS UCLA CTSI grant [UL1TR000124, R01 AR062651]; NIGMS [GM114276, GM104853]; Baxter Laboratory; Stanford Department of Research; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [UC2HL102925, RC2HL102923, UC2HL102926, UC2HL102923, UC2HL103010, R01HL117164, RC2HL103010, RC2HL102925, RC2HL102926, UC2HL102924, RC2HL102924] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [UM1HG006504, UM1HG006493, U54HG006493] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR061485, R01AR066124, R01AR062651] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068306] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086627, DP1GM106408, R01GM121565, R01GM104853, F32GM112495, R01GM114276] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BB/K010492/1] Funding Source: researchfish; Medical Research Council [MR/L017237/1] Funding Source: researchfish	Lung GO Sequencing Project; WHI Sequencing Project; Broad GO Sequencing Project; Seattle GO Sequencing Project; Heart GO Sequencing Project; NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Uehara Memorial Foundation Fellowship; NIDCR NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); French Rare Diseases Foundation; French Ministry of Health (PHRC national); Regional Council of Burgundy(Region Bourgogne-Franche-Comte); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); CPRIT; Welch Foundation(The Welch Foundation); March of Dimes(March of Dimes); Joseph Drown Foundation; NIH/NCATS UCLA CTSI grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Baxter Laboratory; Stanford Department of Research; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank the patients and their families, the IntegraGen society for exome analysis and the NHLBI GO Exome Sequencing Project, which produced and provided exome variant calls for comparison: Lung GO Sequencing Project (HL-102923), WHI Sequencing Project (HL-102924), Broad GO Sequencing Project (HL-102925), Seattle GO Sequencing Project (HL-102926) and Heart GO Sequencing Project (HL-103010). We thank the Biological Resources Center-Ferdinand Cabanne (Dijon, France) for fibroblast centralization and storage. Sequencing was provided by the University of Washington Center for Mendelian Genomics (UW CMG) and was funded by the NHGRI and NHLBI (grant 1U54 HG006493) to D. Nickerson, J. Shendure and M. Bamshad. This work was supported by grants from the following: Uehara Memorial Foundation Fellowship to M.T.; an NIDCR NRSA to J.M.T.; the French Rare Diseases Foundation, the French Ministry of Health (PHRC national 2010-A01014-35 to C.T.-R.) and the Regional Council of Burgundy to C.T.-R.; NIDDK (DK1068306) to F.H., who is a Howard Hughes Medical Institute investigator, a Doris Duke Distinguished Clinical Scientist and the Warren E. Grupe Professor; NIAMS (AR061485) to J.C.; BBSRC (BB/K010492/1) and MRC (MR/L017237/1) to K.J.L.; NIH, NSF, CPRIT and the Welch Foundation (F-1515) to E.M.M.; R01 AR066124, March of Dimes and the Joseph Drown Foundation, NIH/NCATS UCLA CTSI grant UL1TR000124 to D.K.; R01 AR062651 to D.H.C.; NIGMS (GM114276), Baxter Laboratory, the Stanford Department of Research and NIGMS (GM114276) to P.K.J.; and NIGMS (GM104853) and NHLBI (HL117164) to J.B.W., who was a Howard Hughes Medical Institute Early Career Scientist.	ADLER PN, 1994, GENETICS, V137, P829; Alazami AM, 2012, HUM MUTAT, V33, P1423, DOI 10.1002/humu.22134; Behal RH, 2012, J BIOL CHEM, V287, P11689, DOI 10.1074/jbc.M111.287102; Bhogaraju S, 2013, SCIENCE, V341, P1009, DOI 10.1126/science.1240985; Brooks Eric R, 2013, Cilia, V2, P13, DOI 10.1186/2046-2530-2-13; Brooks ER, 2012, J CELL BIOL, V198, P37, DOI 10.1083/jcb.201204072; Butler MT, 2015, DEVELOPMENT, V142, P3429, DOI 10.1242/dev.121384; Cole DG, 1998, J CELL BIOL, V141, P993, DOI 10.1083/jcb.141.4.993; Collier S, 2005, GENETICS, V169, P2035, DOI 10.1534/genetics.104.033381; Collier S, 1997, DEVELOPMENT, V124, P4029; Craft JM, 2015, J CELL BIOL, V208, P223, DOI 10.1083/jcb.201409036; Cui C, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001720; Damerla RR, 2015, HUM MOL GENET, V24, P3994, DOI 10.1093/hmg/ddv137; Diggle CP, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004577; Garcia-Gonzalo FR, 2011, NAT GENET, V43, P776, DOI 10.1038/ng.891; Giles RH, 2014, NAT PROTOC, V9, P2725, DOI 10.1038/nprot.2014.181; Goetz SC, 2012, CELL, V151, P847, DOI 10.1016/j.cell.2012.10.010; Gray RS, 2009, NAT CELL BIOL, V11, P1225, DOI 10.1038/ncb1966; Gurrieri F, 2007, AM J MED GENET A, V143A, P3314, DOI 10.1002/ajmg.a.32032; Harris JA, 2016, MOL BIOL CELL, V27, P295, DOI 10.1091/mbc.E15-08-0608; Hasegawa H, 2009, CURR OPIN STRUC BIOL, V19, P341, DOI 10.1016/j.sbi.2009.04.003; Hildebrandt F, 2011, NEW ENGL J MED, V364, P1533, DOI 10.1056/NEJMra1010172; Horani A, 2012, AM J HUM GENET, V91, P685, DOI 10.1016/j.ajhg.2012.08.022; Hsieh YC, 1999, AM J MED GENET, V86, P278, DOI 10.1002/(SICI)1096-8628(19990917)86:3<278::AID-AJMG16>3.0.CO;2-C; Huttlin EL, 2015, CELL, V162, P425, DOI 10.1016/j.cell.2015.06.043; Iomini C, 2001, J CELL BIOL, V153, P13, DOI 10.1083/jcb.153.1.13; Joo K, 2013, P NATL ACAD SCI USA, V110, P5987, DOI 10.1073/pnas.1220927110; Karpinka JB, 2015, NUCLEIC ACIDS RES, V43, pD756, DOI 10.1093/nar/gku956; Kim SK, 2010, SCIENCE, V329, P1337, DOI 10.1126/science.1191184; Kobayashi D, 2012, DIFFERENTIATION, V83, pS23, DOI 10.1016/j.diff.2011.11.009; KOZMINSKI KG, 1993, P NATL ACAD SCI USA, V90, P5519, DOI 10.1073/pnas.90.12.5519; Lee Chanjae, 2008, CSH Protoc, V2008, DOI 10.1101/pdb.prot4957; Li Y, 2015, NATURE, V521, P520, DOI 10.1038/nature14269; Liem KF, 2012, J CELL BIOL, V197, P789, DOI 10.1083/jcb.201110049; Lobley A, 2009, BIOINFORMATICS, V25, P1761, DOI 10.1093/bioinformatics/btp302; Lopez E, 2014, HUM GENET, V133, P367, DOI 10.1007/s00439-013-1385-1; Lucker BF, 2005, J BIOL CHEM, V280, P27688, DOI 10.1074/jbc.M505062200; Merrill AE, 2009, AM J HUM GENET, V84, P542, DOI 10.1016/j.ajhg.2009.03.015; Mill P, 2011, AM J HUM GENET, V88, P508, DOI 10.1016/j.ajhg.2011.03.015; Mitchison HM, 2012, NAT GENET, V44, P381, DOI 10.1038/ng.1106; MOODY SA, 1990, ANAT EMBRYOL, V182, P347, DOI 10.1007/BF02433495; Mukhopadhyay S, 2010, GENE DEV, V24, P2180, DOI 10.1101/gad.1966210; Nachury MV, 2007, CELL, V129, P1201, DOI 10.1016/j.cell.2007.03.053; Nakayama T, 2014, METHOD ENZYMOL, V546, P355, DOI 10.1016/B978-0-12-801185-0.00017-9; Oh EC, 2012, DEVELOPMENT, V139, P443, DOI 10.1242/dev.050054; Omran H, 2008, NATURE, V456, P611, DOI 10.1038/nature07471; Ooi YS, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003835; Ou GS, 2005, NATURE, V436, P583, DOI 10.1038/nature03818; Pan XY, 2006, J CELL BIOL, V174, P1035, DOI 10.1083/jcb.200606003; Panigrahi I, 2013, CLIN DYSMORPHOL, V22, P109, DOI 10.1097/MCD.0b013e32835fe161; Park TJ, 2008, NAT GENET, V40, P871, DOI 10.1038/ng.104; Park TJ, 2006, NAT GENET, V38, P303, DOI 10.1038/ng1753; Pazour GJ, 1998, J CELL BIOL, V141, P979, DOI 10.1083/jcb.141.4.979; Pedersen LB, 2006, CURR BIOL, V16, P450, DOI 10.1016/j.cub.2006.02.020; Piperno G, 1998, J CELL BIOL, V143, P1591, DOI 10.1083/jcb.143.6.1591; Rompolas P, 2007, J CELL SCI, V120, P3653, DOI 10.1242/jcs.012773; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Saari J, 2015, AM J MED GENET A, V167, P421, DOI 10.1002/ajmg.a.36852; Sang LY, 2011, CELL, V145, P513, DOI 10.1016/j.cell.2011.04.019; Seo JH, 2011, HUM MOL GENET, V20, P4324, DOI 10.1093/hmg/ddr359; Seo S, 2010, P NATL ACAD SCI USA, V107, P1488, DOI 10.1073/pnas.0910268107; Shaheen R, 2013, EUR J HUM GENET, V21, P762, DOI 10.1038/ejhg.2012.254; Singla V, 2010, DEV CELL, V18, P410, DOI 10.1016/j.devcel.2009.12.022; Sive Hazel L., 2000, EARLY DEV XENOPUS LA; Snow JJ, 2004, NAT CELL BIOL, V6, P1109, DOI 10.1038/ncb1186; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Srour M, 2012, AM J HUM GENET, V90, P693, DOI 10.1016/j.ajhg.2012.02.011; Tabler JM, 2013, DEV CELL, V25, P623, DOI 10.1016/j.devcel.2013.05.021; Tarkar A, 2013, NAT GENET, V45, P995, DOI 10.1038/ng.2707; Taschner M, 2012, DIFFERENTIATION, V83, pS12, DOI 10.1016/j.diff.2011.11.001; van Dam TJP, 2013, P NATL ACAD SCI USA, V110, P6943, DOI 10.1073/pnas.1221011110; Wang Y, 2014, DEV BIOL, V394, P156, DOI 10.1016/j.ydbio.2014.07.013; Ye X, 2014, P NATL ACAD SCI USA, V111, P2164, DOI 10.1073/pnas.1318737111; Zeng HQ, 2010, DEV BIOL, V339, P418, DOI 10.1016/j.ydbio.2010.01.003; Zhang QH, 2012, J BIOL CHEM, V287, P20625, DOI 10.1074/jbc.M112.341487; Zilber Y, 2013, MOL BIOL CELL, V24, P555, DOI 10.1091/mbc.E12-06-0437	76	84	95	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2016	48	6					648	+		10.1038/ng.3558	http://dx.doi.org/10.1038/ng.3558			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DN0HE	27158779	Green Accepted, Green Submitted			2022-12-25	WOS:000376744200012
J	Du, YL; Singh, R; Alkhalaf, LM; Kuatsjah, E; He, HY; Eltis, LD; Ryan, KS				Du, Yi-Ling; Singh, Rahul; Alkhalaf, Lona M.; Kuatsjah, Eugene; He, Hai-Yan; Eltis, Lindsay D.; Ryan, Katherine S.			A pyridoxal phosphate-dependent enzyme that oxidizes an unactivated carbon-carbon bond	NATURE CHEMICAL BIOLOGY			English	Article							DOPA DECARBOXYLASE; CRYSTAL-STRUCTURE; OXIDATION; BIOSYNTHESIS; MECHANISM; SYNTHASE; COMPLEX; ACIDS	Pyridoxal 5'-phosphate (PLP)-dependent enzymes have wide catalytic versatility but are rarely known for their ability to react with oxygen to catalyze challenging reactions. Here, using in vitro reconstitution and kinetic analysis, we report that the indolmycin biosynthetic enzyme Ind4, from Streptomyces griseus ATCC 12648, is an unprecedented O-2- and PLP-dependent enzyme that carries out a four-electron oxidation of L-arginine, including oxidation of an unactivated carbon-carbon (C-C) bond. We show that the conjugated product of this reaction, which is susceptible to nonenzymatic deamination, is efficiently intercepted and stereospecifically reduced by the partner enzyme Ind5 to give D-4,5-dehydroarginine. Thus, Ind4 couples the redox potential of 02 with the ability of PLP to stabilize anions to efficiently oxidize an unactivated C-C bond, with the subsequent stereochemical inversion by Ind5 preventing off-pathway reactions. Altogether, these results expand our knowledge of the catalytic versatility of PLP-dependent enzymes and enrich the toolbox for oxidative biocatalysis.	[Du, Yi-Ling; Alkhalaf, Lona M.; He, Hai-Yan; Ryan, Katherine S.] Univ British Columbia, Dept Chem, Vancouver, BC, Canada; [Singh, Rahul; Eltis, Lindsay D.] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V5Z 1M9, Canada; [Kuatsjah, Eugene] Univ British Columbia, Genome Sci & Technol Program, Vancouver, BC V5Z 1M9, Canada	University of British Columbia; University of British Columbia; University of British Columbia	Ryan, KS (corresponding author), Univ British Columbia, Dept Chem, Vancouver, BC, Canada.	ksryan@chem.ubc.ca	Singh, Rahul/A-6891-2009; He, Hai-Yan/I-4474-2014; Kuatsjah, Eugene/GLN-5085-2022; Eltis, Lindsay/J-8272-2015	Singh, Rahul/0000-0002-1467-7915; He, Hai-Yan/0000-0002-3540-1707; Kuatsjah, Eugene/0000-0002-8793-2331; Eltis, Lindsay/0000-0002-6774-8158	Genome British Columbia [SOF148]; Natural Sciences and Engineering Research Council of Canada [402631-2011, 171359-13]; Michael Smith Foundation for Health Research Trainee Award; Canadian Institutes of Health Research New Investigator Award	Genome British Columbia; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Michael Smith Foundation for Health Research Trainee Award(Michael Smith Foundation for Health Research); Canadian Institutes of Health Research New Investigator Award(Canadian Institutes of Health Research (CIHR))	We are grateful to O. Li (Zhejiang Sci-Tech University) for the gift of genomic DNA of Paenibacillus elgii, to M. Tanner for helpful discussions and use of equipment for anaerobic work, and to B. Moore for feedback on the manuscript. This work is supported by grants from Genome British Columbia (SOF148, to K.S.R.) and Natural Sciences and Engineering Research Council of Canada (402631-2011, to K.S.R., and 171359-13, to L.D.E.). Y.-L.D. was supported by a Michael Smith Foundation for Health Research Trainee Award, K.S.R. is supported by a Canadian Institutes of Health Research New Investigator Award, and L.D.E. holds a Tier 1 Canada Research Chair.	ABELL LM, 1991, BIOCHEMISTRY-US, V30, P7883, DOI 10.1021/bi00246a002; ANUMULA KR, 1995, ANAL BIOCHEM, V230, P24, DOI 10.1006/abio.1995.1432; Barry SM, 2012, NAT CHEM BIOL, V8, P814, DOI 10.1038/nchembio.1048; Bertoldi M, 2008, BIOCHEMISTRY-US, V47, P7187, DOI 10.1021/bi800478s; Bertoldi M, 2009, ARCH BIOCHEM BIOPHYS, V488, P130, DOI 10.1016/j.abb.2009.06.019; Bunik Victoria I, 2011, Adv Enzymol Relat Areas Mol Biol, V77, P307; Chang WC, 2013, NATURE, V496, P114, DOI 10.1038/nature11998; Dengler U, 1997, J MOL BIOL, V267, P640, DOI 10.1006/jmbi.1996.0864; Du YL, 2015, P NATL ACAD SCI USA, V112, P2717, DOI 10.1073/pnas.1419964112; Eliot AC, 2004, ANNU REV BIOCHEM, V73, P383, DOI 10.1146/annurev.biochem.73.011303.074021; Fetzner S, 2010, APPL MICROBIOL BIOT, V86, P791, DOI 10.1007/s00253-010-2455-0; Fujii K, 1997, ANAL CHEM, V69, P5146, DOI 10.1021/ac970289b; Hiratsuka T, 2013, CHEM BIOL, V20, P1523, DOI 10.1016/j.chembiol.2013.10.011; Hu YC, 2014, NAT CHEM BIOL, V10, P552, DOI [10.1038/NCHEMBIO.1527, 10.1038/nchembio.1527]; Kaminaga Y, 2006, J BIOL CHEM, V281, P23357, DOI 10.1074/jbc.M602708200; Li C, 2009, P NATL ACAD SCI USA, V106, P906, DOI 10.1073/pnas.0808269106; Linster CL, 2013, NAT CHEM BIOL, V9, P72, DOI [10.1038/NCHEMBIO.1141, 10.1038/nchembio.1141]; Palfey B. A., 1995, ACTIVE OXYGEN BIOCH, P37, DOI DOI 10.1007/978-94-011-0609-2_2; Phillips RS, 2015, BBA-PROTEINS PROTEOM, V1854, P1167, DOI 10.1016/j.bbapap.2014.12.028; Rossi F, 2004, J BIOL CHEM, V279, P50214, DOI 10.1074/jbc.M409291200; Silverman R.B., 2002, ORGANIC CHEM ENZYME, V2nd; Solomon EI, 2001, ANGEW CHEM INT EDIT, V40, P4570, DOI 10.1002/1521-3773(20011217)40:24<4570::AID-ANIE4570>3.0.CO;2-4; Teufel R, 2013, NATURE, V503, P552, DOI 10.1038/nature12643; Tsunematsu Y, 2013, NAT CHEM BIOL, V9, P818, DOI [10.1038/NCHEMBIO.1366, 10.1038/nchembio.1366]; Turner NJ, 2011, CHEM REV, V111, P4073, DOI 10.1021/cr200111v; VLESSIS AA, 1990, BIOCHEM BIOPH RES CO, V170, P1281, DOI 10.1016/0006-291X(90)90532-R; Walsh CT, 2013, NAT PROD REP, V30, P175, DOI 10.1039/c2np20069d	27	29	29	3	67	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAR	2016	12	3					194	199		10.1038/NCHEMBIO.2009	http://dx.doi.org/10.1038/NCHEMBIO.2009			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF5FK	26807714				2022-12-25	WOS:000371377000013
J	Jabara, HH; Boyden, SE; Chou, J; Ramesh, N; Massaad, MJ; Benson, H; Bainter, W; Fraulino, D; Rahimov, F; Sieff, C; Liu, ZJ; Alshemmari, SH; Al-Ramadi, BK; Al-Dhekri, H; Arnaout, R; Abu-Shukair, M; Vatsayan, A; Silver, E; Ahuja, S; Davies, EG; Sola-Visner, M; Ohsumi, TK; Andrews, NC; Notarangelo, LD; Fleming, MD; Al-Herz, W; Kunkel, LM; Geha, RS				Jabara, Haifa H.; Boyden, Steven E.; Chou, Janet; Ramesh, Narayanaswamy; Massaad, Michel J.; Benson, Halli; Bainter, Wayne; Fraulino, David; Rahimov, Fedik; Sieff, Colin; Liu, Zhi-Jian; Alshemmari, Salem H.; Al-Ramadi, Basel K.; Al-Dhekri, Hasan; Arnaout, Rand; Abu-Shukair, Mohammad; Vatsayan, Anant; Silver, Eli; Ahuja, Sanjay; Davies, E. Graham; Sola-Visner, Martha; Ohsumi, Toshiro K.; Andrews, Nancy C.; Notarangelo, Luigi D.; Fleming, Mark D.; Al-Herz, Waleed; Kunkel, Louis M.; Geha, Raif S.			A missense mutation in TFRC, encoding transferrin receptor 1, causes combined immunodeficiency	NATURE GENETICS			English	Article							IRON HOMEOSTASIS; INDUCTION; INTERNALIZATION; IDENTIFICATION; LYMPHOCYTE; PROTEINS; SIGNAL; CD40	Patients with a combined immunodeficiency characterized by normal numbers but impaired function of T and B cells had a homozygous p. Tyr20His substitution in transferrin receptor 1 (TfR1), encoded by TFRC. The substitution disrupts the TfR1 internalization motif, resulting in defective receptor endocytosis and markedly increased TfR1 expression on the cell surface. Iron citrate rescued the lymphocyte defects, and expression of wild-type but not mutant TfR1 rescued impaired transferrin uptake in patient-derived fibroblasts. Tfrc(Y20H/Y20H) mice recapitulated the immunological defects of patients. Despite the critical role of TfR1 in erythrocyte development and function, patients had only mild anemia and only slightly increased TfR1 expression in erythroid precursors. We show that STEAP3, a metalloreductase expressed in erythroblasts, associates with TfR1 and partially rescues transferrin uptake in patient-derived fibroblasts, suggesting that STEAP3 may provide an accessory TfR1 endocytosis signal that spares patients from severe anemia. These findings demonstrate the importance of TfR1 in adaptive immunity.	[Jabara, Haifa H.; Chou, Janet; Ramesh, Narayanaswamy; Massaad, Michel J.; Benson, Halli; Bainter, Wayne; Fraulino, David; Notarangelo, Luigi D.; Geha, Raif S.] Boston Childrens Hosp, Div Immunol, Boston, MA 02115 USA; [Jabara, Haifa H.; Chou, Janet; Ramesh, Narayanaswamy; Massaad, Michel J.; Sieff, Colin; Liu, Zhi-Jian; Sola-Visner, Martha; Notarangelo, Luigi D.; Kunkel, Louis M.; Geha, Raif S.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Boyden, Steven E.; Rahimov, Fedik; Kunkel, Louis M.] Boston Childrens Hosp, Div Genet & Genom, Boston, MA USA; [Boyden, Steven E.; Rahimov, Fedik; Kunkel, Louis M.] Boston Childrens Hosp, Manton Ctr Orphan Dis Res, Boston, MA USA; [Boyden, Steven E.; Ohsumi, Toshiro K.; Kunkel, Louis M.] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Sieff, Colin] Boston Childrens Hosp, Div Hematol, Boston, MA USA; [Liu, Zhi-Jian; Sola-Visner, Martha] Boston Childrens Hosp, Div Neonatol, Boston, MA USA; [Alshemmari, Salem H.] Kuwait Univ, Fac Med, Dept Med, Kuwait, Kuwait; [Al-Ramadi, Basel K.] United Arab Emirates Univ, Coll Med & Hlth Sci, Dept Med Microbiol & Immunol, Al Ain, U Arab Emirates; [Al-Dhekri, Hasan; Arnaout, Rand] King Faisal Specialist Hosp & Res Ctr, Riyadh 11211, Saudi Arabia; [Abu-Shukair, Mohammad] Queen Rania Hosp Children, Immunol Allergy & Rheumatol Div, Amman, Jordan; [Vatsayan, Anant; Ahuja, Sanjay] Case Western Reserve Univ, Rainbow Babies & Childrens Hosp, Univ Hosp, Dept Pediat Hematol Oncol, Cleveland, OH 44106 USA; [Silver, Eli] Case Western Reserve Univ, Rainbow Babies & Childrens Hosp, Univ Hosp, Div Pulmonol & Sleep Med, Cleveland, OH 44106 USA; [Davies, E. Graham] Great Ormond St Hosp Sick Children, Ctr Immunodeficiency, London, England; [Davies, E. Graham] Inst Child Hlth, London, England; [Ohsumi, Toshiro K.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Andrews, Nancy C.] Duke Univ, Dept Pediat, Sch Med, Durham, NC 27706 USA; [Andrews, Nancy C.] Duke Univ, Sch Med, Dept Pharmacol & Canc Biol, Durham, NC USA; [Fleming, Mark D.] Boston Childrens Hosp, Dept Pathol, Boston, MA USA; [Fleming, Mark D.] Harvard Univ, Sch Med, Boston, MA USA; [Al-Herz, Waleed] Kuwait Univ, Fac Med, Dept Pediat, Kuwait, Kuwait	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Kuwait University; United Arab Emirates University; King Faisal Specialist Hospital & Research Center; Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Rainbow Babies & Children's Hospital; Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Rainbow Babies & Children's Hospital; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London; Harvard University; Massachusetts General Hospital; Duke University; Duke University; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Kuwait University	Geha, RS (corresponding author), Boston Childrens Hosp, Div Immunol, Boston, MA 02115 USA.	raif.geha@childrens.harvard.edu	Alshemmari, Salem/AHA-2072-2022; Ahuja, Sanjay/AFT-3324-2022; Notarangelo, Luigi D/F-9718-2016	Alshemmari, Salem/0000-0002-5597-5839; Ahuja, Sanjay/0000-0002-0178-7947; Notarangelo, Luigi D/0000-0002-8335-0262; Rahimov, Fedik/0000-0001-6519-7404; Andrews, Nancy/0000-0003-0243-4462; Fleming, Mark/0000-0003-0948-4024	US National Institutes of Health (NIH) [AI-076210, AI-007512, 1K08AI116979- 01, DK-089705]; Dubai Harvard Foundation for Medical Research; Perkins Fund; Howard Hughes Medical Institute; Manton Center for Orphan Disease Research; Kuwait Foundation for Advancement of Sciences [2010-1302-05]; Jeffrey Modell Foundation Translational Research Program Grant; Manton Center Pilot Award; US NIH grant through the Intellectual and Developmental Disabilities Research Center [P30-HD18655]; US NIH grant through the Neuromuscular Disease Project [P50-NS40828]; US NIH Tetramer Core Facility [HHSN272201300006C]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD090255, P30HD018655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI076210, T32AI007512] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK087992, R01DK089705] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS040828] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dubai Harvard Foundation for Medical Research; Perkins Fund; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Manton Center for Orphan Disease Research; Kuwait Foundation for Advancement of Sciences; Jeffrey Modell Foundation Translational Research Program Grant; Manton Center Pilot Award; US NIH grant through the Intellectual and Developmental Disabilities Research Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US NIH grant through the Neuromuscular Disease Project(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US NIH Tetramer Core Facility; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	thank F. Alkuraya, H. Oettgen and T. Chatila for valuable discussions and the immunology laboratory staff at the Faculty of Medicine of Kuwait University for technical assistance. This work was supported by US National Institutes of Health (NIH) grants AI-076210, AI-007512 (R.S.G.), 1K08AI116979- 01 (J.C.) and DK-089705 (N.C.A.), a grant from the Dubai Harvard Foundation for Medical Research (R.S.G.), the Perkins Fund (R.S.G.), the Howard Hughes Medical Institute (L.M.K.), the Manton Center for Orphan Disease Research (L.M.K.), the Kuwait Foundation for Advancement of Sciences 2010-1302-05 (W.A.-H.), a Jeffrey Modell Foundation Translational Research Program Grant award (J.C.) and a Manton Center Pilot Award (J.C.). Microarray genotyping and Sanger DNA sequencing were performed in the Molecular Genetics Core Facility at Boston Children's Hospital, supported by US NIH grant P30-HD18655 through the Intellectual and Developmental Disabilities Research Center and US NIH grant P50-NS40828 through the Neuromuscular Disease Project. We acknowledge the US NIH Tetramer Core Facility (contract HHSN272201300006C) for provision of the mouse CD1d tetramers.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Al-Herz W, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00162; Andrews NC, 2000, NAT REV GENET, V1, P208, DOI 10.1038/35042073; Arezes J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079870; COLLAWN JF, 1993, J BIOL CHEM, V268, P21686; Crotzer VL, 2004, J EXP MED, V199, P981, DOI 10.1084/jem.20031105; Drmanac R, 2010, SCIENCE, V327, P78, DOI 10.1126/science.1181498; JABARA HH, 1990, J EXP MED, V172, P1861, DOI 10.1084/jem.172.6.1861; Jabara HH, 2001, J CLIN INVEST, V107, P371, DOI 10.1172/JCI10168; JABARA HH, 1990, J IMMUNOL, V145, P3468; JING SQ, 1990, J CELL BIOL, V110, P283, DOI 10.1083/jcb.110.2.283; Lambe T, 2009, BLOOD, V113, P1805, DOI 10.1182/blood-2007-11-120402; Lespagnol A, 2008, CELL DEATH DIFFER, V15, P1723, DOI 10.1038/cdd.2008.104; Levy JE, 1999, NAT GENET, V21, P396, DOI 10.1038/7727; MCGRAW TE, 1990, CELL REGUL, V1, P369, DOI 10.1091/mbc.1.4.369; McHeyzer-Williams LJ, 2005, ANNU REV IMMUNOL, V23, P487, DOI 10.1146/annurev.immunol.23.021704.115732; NECKERS LM, 1983, P NATL ACAD SCI-BIOL, V80, P3494, DOI 10.1073/pnas.80.11.3494; Ned RM, 2003, BLOOD, V102, P3711, DOI 10.1182/blood-2003-04-1086; Ohgami RS, 2006, BLOOD, V108, P1388, DOI 10.1182/blood-2006-02-003681; Ohgami RS, 2005, NAT GENET, V37, P1264, DOI 10.1038/ng1658; Pinto JP, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00024; Roebroek AJM, 2011, METHODS MOL BIOL, V693, P257, DOI 10.1007/978-1-60761-974-1_15; Rouault TA, 2006, NAT CHEM BIOL, V2, P406, DOI 10.1038/nchembio807; Sobel E, 2001, HUM HERED, V52, P121, DOI 10.1159/000053366	24	130	133	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2016	48	1					74	+		10.1038/ng.3465	http://dx.doi.org/10.1038/ng.3465			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CZ7BQ	26642240	Green Accepted, Green Submitted			2022-12-25	WOS:000367255300016
J	Shafaq-Zadah, M; Gomes-Santos, CS; Bardin, S; Maiuri, P; Maurin, M; Iranzo, J; Gautreau, A; Lamaze, C; Caswell, P; Goud, B; Johannes, L				Shafaq-Zadah, Massiullah; Gomes-Santos, Carina S.; Bardin, Sabine; Maiuri, Paolo; Maurin, Mathieu; Iranzo, Julian; Gautreau, Alexis; Lamaze, Christophe; Caswell, Patrick; Goud, Bruno; Johannes, Ludger			Persistent cell migration and adhesion rely on retrograde transport of beta(1) integrin	NATURE CELL BIOLOGY			English	Article							MONOCLONAL-ANTIBODY; RECYCLING PATHWAYS; EARLY ENDOSOMES; RETROMER; ACTIVATION; POLARITY; LIGAND; ALPHA-V-BETA-3; ALPHA-5-BETA-1; IDENTIFICATION	Integrins have key functions in cell adhesion and migration. How integrins are dynamically relocalized to the leading edge in highly polarized migratory cells has remained unexplored. Here, we demonstrate that beta(1) integrin (known as PAT-3 in Caenorhabditis elegans), but not beta(3), is transported from the plasma membrane to the trans-Golgi network, to be resecreted in a polarized manner. This retrograde trafficking is restricted to the non-ligand-bound conformation of beta(1) integrin. Retrograde trafficking inhibition abrogates several beta(1)-integrin-specific functions such as cell adhesion in early embryonic development of mice, and persistent cell migration in the developing posterior gonad arm of C. elegans. Our results establish a paradigm according to which retrograde trafficking, and not endosomal recycling, is the key driver for beta(1) integrin function in highly polarized cells. These data more generally suggest that the retrograde route is used to relocalize plasma membrane machinery from previous sites of function to the leading edge of migratory cells.	[Shafaq-Zadah, Massiullah; Johannes, Ludger] PSL Res Univ, Inst Curie, Endocyt Trafficking & Therapeut Delivery Grp, F-75248 Paris 05, France; [Shafaq-Zadah, Massiullah; Lamaze, Christophe; Johannes, Ludger] CNRS, UMR3666, F-75005 Paris, France; [Shafaq-Zadah, Massiullah; Lamaze, Christophe; Johannes, Ludger] INSERM, U1143, F-75005 Paris, France; [Gomes-Santos, Carina S.; Bardin, Sabine; Goud, Bruno] PSL Res Univ, Inst Curie, Mol Mech Intracellular Transport Grp, F-75248 Paris 05, France; [Gomes-Santos, Carina S.; Bardin, Sabine; Goud, Bruno] CNRS, UMR144, F-75005 Paris, France; [Maiuri, Paolo] PSL Res Univ, Inst Curie, Syst Cell Biol Cell Polar & Cell Div, F-75248 Paris 05, France; [Maurin, Mathieu] PSL Res Univ, Inst Curie, Proteases & Immun Grp, F-75248 Paris 05, France; [Maurin, Mathieu] INSERM, U932, F-75005 Paris, France; [Iranzo, Julian] PSL Res Univ, Inst Curie, CNRS, UMR 3215,INSERM,U934, F-75248 Paris 05, France; [Gautreau, Alexis] Ecole Polytech, CNRS, UMR7654, F-91128 Palaiseau, France; [Lamaze, Christophe] PSL Res Univ, Inst Curie, Membrane Dynam & Mech Intracellular Signaling Grp, F-75248 Paris 05, France; [Caswell, Patrick] Univ Manchester, Fac Life Sci, Wellcome Trust Ctr Cell Matrix Res, Manchester M13 9PT, Lancs, England	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut Polytechnique de Paris; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; University of Manchester	Goud, B (corresponding author), PSL Res Univ, Inst Curie, Mol Mech Intracellular Transport Grp, F-75248 Paris 05, France.	bruno.goud@curie.fr; ludger.johannes@curie.fr	Johannes, Ludger/W-8593-2019; Massiullah, SHAFAQ-ZADAH/G-5560-2017; Gautreau, Alexis/AAT-2751-2020; Johannes, Ludger/M-9778-2017; Goud, Bruno/GWC-4807-2022; Lamaze, Christophe/M-4912-2017; Caswell, Patrick/N-3063-2015	Johannes, Ludger/0000-0002-2168-0004; Massiullah, SHAFAQ-ZADAH/0000-0002-7582-8131; Gautreau, Alexis/0000-0002-2369-4362; Johannes, Ludger/0000-0002-2168-0004; Caswell, Patrick/0000-0002-2633-2324; Maiuri, Paolo/0000-0001-5079-445X; LAMAZE, Christophe/0000-0001-5430-2707	Marie Curie Fellowship [PIEF-GA-2011-299756]; Agence Nationale pour la Recherche [ANR-11 BSV2 014 03, ANR-14-CE14-0002-02]; Human Frontier Science Program [RGP0029-2014]; European Research Council advanced grants [340485, 339847]	Marie Curie Fellowship(European Commission); Agence Nationale pour la Recherche(French National Research Agency (ANR)); Human Frontier Science Program(Human Frontier Science Program); European Research Council advanced grants	We thank M. Piel, A. M. Lennon-Dumenil and D. Bourc'his for helpful discussions. We acknowledge the following people for providing materials: J. Bonifacino (National Institutes of Health, Bethesda, USA) for anti-vps35 antibody (no. 764), K. Schauer (Institut Curie, Paris, France) for the RPE-1 GFP-Rab1 stable cell line, G. Michaux (Institut de Genetique et Developpement de Rennes, France) and R. Legouis (Institut de Biologie Integrative de la Cellule, Gif-sur-Yvette, France) for C. elegans reagents and materials, the CGC (University of Minnesota, USA) for providing strains. We thank the staff of the animal facility at Institut Curie for mouse breeding and crossing. C.S.G.-S. was financially supported by a Marie Curie Fellowship PIEF-GA-2011-299756. This work was supported by grants from the Agence Nationale pour la Recherche (ANR-11 BSV2 014 03 and ANR-14-CE14-0002-02 to L.J.), Human Frontier Science Program grant RGP0029-2014 to L.J., and by European Research Council advanced grants (project 340485 to L.J. and project 339847 'MYODYN' to B.G.). We acknowledge the Recombinant Protein and Antibody Platform of the Institut Curie (http://umr144.curie.fr/en/plateform/protein-and-antibody-laboratory-001279) for the production of human recombinant antibodies against Rab6:GTP. The Johannes and Goud teams are members of Labex CelTisPhyBio (11-LBX-0038) and Idex Paris Sciences et Lettres (ANR-10-IDEX-0001-02 PSL). The facilities as well as scientific and technical assistance from staff in the PICT-IBiSA/Nikon Imaging Centre at Institut Curie-CNRS, Proteomics and Mass Spectrometry Laboratory, Institut Curie (Damarys Loew and Florent Dingli), Cell and Tissue Imaging Platform-PICT-IBiSA (member of France-Bioimaging), the Genetics and Developmental Biology Department (UMR3215/U934), and the France-BioImaging infrastructure (ANR-10-INSB-04) are acknowledged.	AKIYAMA SK, 1989, J CELL BIOL, V109, P863, DOI 10.1083/jcb.109.2.863; Amessou M, 2007, J CELL SCI, V120, P1457, DOI 10.1242/jcs.03436; Arighi CN, 2004, J CELL BIOL, V165, P123, DOI 10.1083/jcb.200312055; Arjonen A, 2012, TRAFFIC, V13, P610, DOI 10.1111/j.1600-0854.2012.01327.x; Aumailley M, 2000, J CELL SCI, V113, P259; Bardin S., 2015, BIOL CELL; BAZZONI G, 1995, J BIOL CHEM, V270, P25570, DOI 10.1074/jbc.270.43.25570; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Bonifacino JS, 2006, NAT REV MOL CELL BIO, V7, P568, DOI 10.1038/nrm1985; BRENNER S, 1974, GENETICS, V77, P71; BRETSCHER MS, 1992, EMBO J, V11, P405, DOI 10.1002/j.1460-2075.1992.tb05068.x; Caswell PT, 2006, TRAFFIC, V7, P14, DOI 10.1111/j.1600-0854.2005.00362.x; Danen EHJ, 2005, J CELL BIOL, V169, P515, DOI 10.1083/jcb.200412081; Darido C, 2013, ADV WOUND CARE, V2, P87, DOI 10.1089/wound.2011.0352; De Franceschi N, 2015, J CELL SCI, V128, P839, DOI 10.1242/jcs.161653; Dessau Ram Benny, 2008, Ugeskr Laeger, V170, P328; DUNCAN JR, 1988, J CELL BIOL, V106, P617, DOI 10.1083/jcb.106.3.617; Etienne-Manneville S, 2004, J CELL SCI, V117, P1291, DOI 10.1242/jcs.01115; Etienne-Manneville S, 2001, CELL, V106, P489, DOI 10.1016/S0092-8674(01)00471-8; FASSLER R, 1995, GENE DEV, V9, P1896, DOI 10.1101/gad.9.15.1896; Franch-Marro X, 2008, NAT CELL BIOL, V10, P170, DOI 10.1038/ncb1678; Giannone G, 2002, J BIOL CHEM, V277, P26364, DOI 10.1074/jbc.M203952200; Huttenlocher A, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005074; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Johannes L, 2013, METHOD CELL BIOL, V118, P139, DOI 10.1016/B978-0-12-417164-0.00009-4; Johannes L, 2010, NAT REV MICROBIOL, V8, P105, DOI 10.1038/nrmicro2279; Johannes L, 2008, CELL, V135, P1175, DOI 10.1016/j.cell.2008.12.009; Jones MC, 2006, CURR OPIN CELL BIOL, V18, P549, DOI 10.1016/j.ceb.2006.08.003; Kamath RS, 2003, METHODS, V30, P313, DOI 10.1016/S1046-2023(03)00050-1; Lee M, 2001, J BIOL CHEM, V276, P36404, DOI 10.1074/jbc.M105795200; Lobert VH, 2010, DEV CELL, V19, P148, DOI 10.1016/j.devcel.2010.06.010; Lohikangas L, 2001, EXP CELL RES, V265, P135, DOI 10.1006/excr.2001.5170; Maiuri P, 2012, CURR BIOL, V22, pR673, DOI 10.1016/j.cub.2012.07.052; Mallard F, 2002, J CELL BIOL, V156, P653, DOI 10.1083/jcb.200110081; Moore R, 2014, MOL CELL BIOL, V34, P560, DOI 10.1128/MCB.00937-13; MOULD AP, 1995, FEBS LETT, V363, P118, DOI 10.1016/0014-5793(95)00301-O; Ni HY, 1998, J BIOL CHEM, V273, P7981, DOI 10.1074/jbc.273.14.7981; Nishiwaki K, 1999, GENETICS, V152, P985; Pellinen T, 2006, J CELL BIOL, V173, P767, DOI 10.1083/jcb.200509019; Perez-Victoria FJ, 2008, MOL BIOL CELL, V19, P2350, DOI 10.1091/mbc.E07-11-1189; Petrie RJ, 2009, NAT REV MOL CELL BIO, V10, P538, DOI 10.1038/nrm2729; Powelka AM, 2004, TRAFFIC, V5, P20, DOI 10.1111/j.1600-0854.2004.00150.x; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Riggs KA, 2012, J CELL SCI, V125, P3827, DOI 10.1242/jcs.102566; Roberts M, 2001, CURR BIOL, V11, P1392, DOI 10.1016/S0960-9822(01)00442-0; Sandvig K, 2010, FEBS LETT, V584, P2626, DOI 10.1016/j.febslet.2010.04.008; Schauer K, 2013, METHOD CELL BIOL, V118, P325, DOI 10.1016/B978-0-12-417164-0.00020-3; Schiller HB, 2013, NAT CELL BIOL, V15, P625, DOI 10.1038/ncb2747; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schlaepfer DD, 1999, PROG BIOPHYS MOL BIO, V71, P435, DOI 10.1016/S0079-6107(98)00052-2; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Seaman MNJ, 2004, J CELL BIOL, V165, P111, DOI 10.1083/jcb.200312034; Shattil SJ, 2010, NAT REV MOL CELL BIO, V11, P288, DOI 10.1038/nrm2871; Shi GT, 2012, TRAFFIC, V13, P914, DOI 10.1111/j.1600-0854.2012.01357.x; TAKADA Y, 1987, NATURE, V326, P607, DOI 10.1038/326607a0; TAKADA Y, 1993, J BIOL CHEM, V268, P17597; Theisen U, 2012, DEV CELL, V23, P1153, DOI 10.1016/j.devcel.2012.11.005; Thery M, 2006, P NATL ACAD SCI USA, V103, P19771, DOI 10.1073/pnas.0609267103; Vielemeyer O, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-59; White DP, 2007, J CELL BIOL, V177, P515, DOI 10.1083/jcb.200609004; Wilcke M, 2000, J CELL BIOL, V151, P1207, DOI 10.1083/jcb.151.6.1207; Wolfenson H, 2013, DEV CELL, V24, P447, DOI 10.1016/j.devcel.2013.02.012; Yadav S, 2009, MOL BIOL CELL, V20, P1728, DOI 10.1091/mbc.E08-10-1077; Yang PT, 2008, DEV CELL, V14, P140, DOI 10.1016/j.devcel.2007.12.004; Yu W, 2005, MOL BIOL CELL, V16, P433, DOI 10.1091/mbc.e04-05-0435; Zhang D, 2012, J CELL BIOL, V196, P85, DOI 10.1083/jcb.201104141	66	65	66	0	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2016	18	1					54	+		10.1038/ncb3287	http://dx.doi.org/10.1038/ncb3287			13	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CZ3VA	26641717				2022-12-25	WOS:000367030900011
J	Horton, ER; Byron, A; Askari, JA; Ng, DHJ; Millon-Fremillon, A; Robertson, J; Koper, EJ; Paul, NR; Warwood, S; Knight, D; Humphries, JD; Humphries, MJ				Horton, Edward R.; Byron, Adam; Askari, Janet A.; Ng, Daniel H. J.; Millon-Fremillon, Angelique; Robertson, Joseph; Koper, Ewa J.; Paul, Nikki R.; Warwood, Stacey; Knight, David; Humphries, Jonathan D.; Humphries, Martin J.			Definition of a consensus integrin adhesome and its dynamics during adhesion complex assembly and disassembly	NATURE CELL BIOLOGY			English	Article							TRANSLATION INITIATION-FACTORS; ALPHA-ACTININ; MYOSIN-II; PROTEOMIC ANALYSIS; MESSENGER-RNA; NASCENT ADHESIONS; BINDING PROTEINS; MATRIX ADHESIONS; FOCAL ADHESIONS; CELL-MIGRATION	Integrin receptor activation initiates the formation of integrin adhesion complexes (IACs) at the cell membrane that transduce adhesion-dependent signals to control a multitude of cellular functions. Proteomic analyses of isolated IACs have revealed an unanticipated molecular complexity; however, a global view of the consensus composition and dynamics of IACs is lacking. Here, we have integrated several IAC proteomes and generated a 2,412-protein integrin adhesome. Analysis of this data set reveals the functional diversity of proteins in IACs and establishes a consensus adhesome of 60 proteins. The consensus adhesome is likely to represent a core cell adhesion machinery, centred around four axes comprising ILK PINCH kindlin, FAK paxillin, talin vinculin and alpha-actinin zyxin VASP, and includes underappreciated IAC components such as Rsu-1 and caldesmon. Proteomic quantification of IAC assembly and disassembly detailed the compositional dynamics of the core cell adhesion machinery. The definition of this consensus view of integrin adhesome components provides a resource for the research community.	[Horton, Edward R.; Byron, Adam; Askari, Janet A.; Ng, Daniel H. J.; Millon-Fremillon, Angelique; Robertson, Joseph; Koper, Ewa J.; Paul, Nikki R.; Humphries, Jonathan D.; Humphries, Martin J.] Univ Manchester, Fac Life Sci, Wellcome Trust Ctr Cell Matrix Res, Manchester M13 9PT, Lancs, England; [Byron, Adam] Univ Edinburgh, Inst Genet & Mol Med, Edinburgh Canc Res UK Ctr, Edinburgh EH4 2XR, Midlothian, Scotland; [Warwood, Stacey; Knight, David] Univ Manchester, Fac Life Sci, Biol Mass Spectrometry Core Facil, Manchester M13 9PT, Lancs, England	University of Manchester; University of Edinburgh; University of Manchester	Byron, A (corresponding author), Univ Manchester, Fac Life Sci, Wellcome Trust Ctr Cell Matrix Res, Manchester M13 9PT, Lancs, England.	adam.byron@igmm.ed.ac.uk; martin.humphries@manchester.ac.uk	Byron, Adam/AID-5111-2022; Horton, Edward/F-3863-2016; Humphries, Jonathan D./AAE-7760-2022; Ng, Daniel/AAN-2799-2020; Byron, Adam/C-4871-2008	Horton, Edward/0000-0001-9530-9585; Humphries, Jonathan D./0000-0002-8953-7079; Byron, Adam/0000-0002-5939-9883; Humphries, Martin/0000-0002-4331-6967	Wellcome Trust [092015]; Wellcome Trust Institutional Strategic Support Fund [097820]; Biotechnology and Biological Sciences Research Council studentship from the Systems Biology Doctoral Training Centre; Biotechnology and Biological Sciences Research Council; University of Manchester Strategic Fund; Biotechnology and Biological Sciences Research Council [1087621] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Wellcome Trust Institutional Strategic Support Fund(Wellcome Trust); Biotechnology and Biological Sciences Research Council studentship from the Systems Biology Doctoral Training Centre(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); University of Manchester Strategic Fund; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank S. E. Craig for technical assistance, J. N. Selley for bioinformatic support, M. Manca for preliminary data analysis, P. March, S. Marsden and E. Zindy for assistance with microscopy, the PRIDE team for assistance with MS data deposition and G. Jacquemet, M. C. Jones and A. P. Mould for discussions. We are grateful to K. Clark, M. L. Cutler, I. J. Fidler, M. E. Hemler, D. Vestweber, J. A. Wilkins and K. M. Yamada for reagents. This work was supported by the Wellcome Trust (grant 092015 to M.J.H.), a Wellcome Trust Institutional Strategic Support Fund award (grant 097820 to the University of Manchester) and a Biotechnology and Biological Sciences Research Council studentship from the Systems Biology Doctoral Training Centre (to E.R.H.). The mass spectrometers and microscopes used in this study were purchased with grants from the Biotechnology and Biological Sciences Research Council, Wellcome Trust and the University of Manchester Strategic Fund. Data are available from ProteomeXchange with identifiers PXD000018, PXD002159 and PXD002129.	Attanasio F, 2011, EUR J CELL BIOL, V90, P115, DOI 10.1016/j.ejcb.2010.05.004; Bachir AI, 2014, CURR BIOL, V24, P1845, DOI 10.1016/j.cub.2014.07.011; Bai SW, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-54; BEGGS AH, 1992, J BIOL CHEM, V267, P9281; Bialkowska K, 2010, J BIOL CHEM, V285, P18640, DOI 10.1074/jbc.M109.085746; Bulgakova NA, 2012, CURR OPIN CELL BIOL, V24, P702, DOI 10.1016/j.ceb.2012.07.006; Buxbaum AR, 2014, SCIENCE, V343, P419, DOI 10.1126/science.1242939; Byron A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7135; Byron A, 2012, PROTEOMICS, V12, P2107, DOI 10.1002/pmic.201100487; Byron A, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001827; CERVERO P, 2012, J CELL BIOL, V91, P908, DOI DOI 10.1016/J.EJCB.2012.05.005; Chicurel ME, 1998, NATURE, V392, P730, DOI 10.1038/33719; Choi CK, 2008, NAT CELL BIOL, V10, P1039, DOI 10.1038/ncb1763; de Hoog CL, 2004, CELL, V117, P649, DOI 10.1016/S0092-8674(04)00456-8; Dougherty GW, 2008, EUR J CELL BIOL, V87, P721, DOI 10.1016/j.ejcb.2008.02.011; Etheridge T, 2015, FASEB J, V29, P1235, DOI 10.1096/fj.14-259119; Ezratty EJ, 2005, NAT CELL BIOL, V7, P581, DOI 10.1038/ncb1262; Geiger T, 2012, CURR OPIN CELL BIOL, V24, P562, DOI 10.1016/j.ceb.2012.05.004; Huang IH, 2014, J CELL SCI, V127, P4186, DOI 10.1242/jcs.150227; Humphries JD, 2015, TRENDS CELL BIOL, V25, P388, DOI 10.1016/j.tcb.2015.02.008; Humphries JD, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000396; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; JANOVICK JA, 1991, ENDOCRINOLOGY, V129, P68, DOI 10.1210/endo-129-1-68; Jones M. C., 2015, CURR PROTOC CELL BIO, V66; Kanchanawong P, 2010, NATURE, V468, P580, DOI 10.1038/nature09621; Karakose E, 2010, J CELL SCI, V123, P2353, DOI 10.1242/jcs.064600; Katz ZB, 2012, GENE DEV, V26, P1885, DOI 10.1101/gad.190413.112; Kelly DF, 2005, J STRUCT BIOL, V149, P290, DOI 10.1016/j.jsb.2004.11.010; Kuo JC, 2011, METHODS MOL BIOL, V757, P297, DOI 10.1007/978-1-61779-166-6_19; Kuo JC, 2011, NAT CELL BIOL, V13, P383, DOI 10.1038/ncb2216; Liu SC, 2000, J CELL SCI, V113, P3563; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; Mellacheruvu D, 2013, NAT METHODS, V10, P730, DOI 10.1038/nmeth.2557; Meller J, 2015, MOL BIOL CELL, V26, P786, DOI 10.1091/mbc.E14-08-1294; Morse EM, 2014, BIOCHEMISTRY-US, V53, P810, DOI 10.1021/bi401596q; Ng DHJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115213; OTEY CA, 1990, J CELL BIOL, V111, P721, DOI 10.1083/jcb.111.2.721; Robertson J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7265; Rolland T, 2014, CELL, V159, P1212, DOI 10.1016/j.cell.2014.10.050; Rossier O, 2012, NAT CELL BIOL, V14, P1057, DOI 10.1038/ncb2588; Schiller HB, 2013, NAT CELL BIOL, V15, P625, DOI 10.1038/ncb2747; Schiller HB, 2013, EMBO REP, V14, P509, DOI 10.1038/embor.2013.49; Schiller HB, 2011, EMBO REP, V12, P259, DOI 10.1038/embor.2011.5; Sebe-Pedros A, 2010, P NATL ACAD SCI USA, V107, P10142, DOI 10.1073/pnas.1002257107; Smith MA, 2014, TRENDS CELL BIOL, V24, P575, DOI [10.1016/J.tcb.2014.04.009, 10.1016/j.tcb.2014.04.009]; Uemura A, 2011, BIOPHYS J, V101, P1069, DOI 10.1016/j.bpj.2011.08.001; Wickstrom SA, 2010, EMBO J, V29, P281, DOI 10.1038/emboj.2009.376; Willett M, 2011, BIOCHEM J, V438, P217, DOI 10.1042/BJ20110435; Willett M, 2010, BIOL CELL, V102, P265, DOI 10.1042/BC20090141; Winograd-Katz SE, 2014, NAT REV MOL CELL BIO, V15, P273, DOI 10.1038/nrm3769; Yue JP, 2014, DEV CELL, V31, P572, DOI 10.1016/j.devcel.2014.10.025; Zaidel-Bar R, 2004, BIOCHEM SOC T, V32, P416, DOI 10.1042/BST0320416; Zaidel-Bar R, 2003, J CELL SCI, V116, P4605, DOI 10.1242/jcs.00792; Zaidel-Bar R, 2007, NAT CELL BIOL, V9, P858, DOI 10.1038/ncb0807-858; Zaidel-Bar R, 2010, J CELL SCI, V123, P1385, DOI 10.1242/jcs.066183; Zhang Y, 2015, ONCOGENE, V34, P1451, DOI 10.1038/onc.2014.36	56	304	309	3	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2015	17	12					1577	1587		10.1038/ncb3257	http://dx.doi.org/10.1038/ncb3257			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CX8DH	26479319	Green Accepted			2022-12-25	WOS:000365932300010
J	Moore, JW; Herrera-Foessel, S; Lan, CX; Schnippenkoetter, W; Ayliffe, M; Huerta-Espino, J; Lillemo, M; Viccars, L; Milne, R; Periyannan, S; Kong, XY; Spielmeyer, W; Talbot, M; Bariana, H; Patrick, JW; Dodds, P; Singh, R; Lagudah, E				Moore, John W.; Herrera-Foessel, Sybil; Lan, Caixia; Schnippenkoetter, Wendelin; Ayliffe, Michael; Huerta-Espino, Julio; Lillemo, Morten; Viccars, Libby; Milne, Ricky; Periyannan, Sambasivam; Kong, Xiuying; Spielmeyer, Wolfgang; Talbot, Mark; Bariana, Harbans; Patrick, John W.; Dodds, Peter; Singh, Ravi; Lagudah, Evans			A recently evolved hexose transporter variant confers resistance to multiple pathogens in wheat	NATURE GENETICS			English	Article							ADULT-PLANT RESISTANCE; LEAF RUST RESISTANCE; STRIPE RUST; POWDERY MILDEW; FUNCTIONAL-CHARACTERIZATION; SACCHAROMYCES-CEREVISIAE; DURABLE RESISTANCE; FUNGAL PATHOGENS; AESTIVUM L.; STEM RUST	As there are numerous pathogen species that cause disease and limit yields of crops, such as wheat (Triticum aestivum), single genes that provide resistance to multiple pathogens are valuable in crop improvement(1,2). The mechanistic basis of multi-pathogen resistance is largely unknown. Here we use comparative genomics, mutagenesis and transformation to isolate the wheat Lr67 gene, which confers partial resistance to all three wheat rust pathogen species and powdery mildew. The Lr67 resistance gene encodes a predicted hexose transporter (LR67res) that differs from the susceptible form of the same protein (LR67sus) by two amino acids that are conserved in orthologous hexose transporters. Sugar uptake assays show that LR67sus, and related proteins encoded by homeoalleles, function as high-affinity glucose transporters. LR67res exerts a dominant-negative effect through heterodimerization with these functional transporters to reduce glucose uptake. Alterations in hexose transport in infected leaves may explain its ability to reduce the growth of multiple biotrophic pathogen species.	[Moore, John W.; Schnippenkoetter, Wendelin; Ayliffe, Michael; Viccars, Libby; Milne, Ricky; Periyannan, Sambasivam; Spielmeyer, Wolfgang; Talbot, Mark; Dodds, Peter; Lagudah, Evans] Commonwealth Sci & Ind Res Org CSIRO Agr, Canberra, ACT, Australia; [Herrera-Foessel, Sybil; Lan, Caixia; Singh, Ravi] Int Maize & Wheat Improvement Ctr CIMMYT, Mexico City, DF, Mexico; [Huerta-Espino, Julio] Campo Expt Valle Mexico INIFAP, Chapingo, Edo De Mexico, Mexico; [Lillemo, Morten] Norwegian Univ Life Sci, Dept Plant Sci, As, Norway; [Kong, Xiuying] Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing 100193, Peoples R China; [Bariana, Harbans] Univ Sydney, Plant Breeding Inst Cobbitty, Narellan, Australia; [Patrick, John W.] Univ Newcastle, Sch Environm & Life Sci, Callaghan, NSW 2308, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); CGIAR; International Maize & Wheat Improvement Center (CIMMYT); Norwegian University of Life Sciences; Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; University of Sydney; University of Newcastle	Lagudah, E (corresponding author), Commonwealth Sci & Ind Res Org CSIRO Agr, Canberra, ACT, Australia.	evans.lagudah@csiro.au	Ayliffe, Michael A/A-2089-2010; Milne, Ricky J/C-3386-2016; Huerta-Espino, Julio/E-7345-2010; Spielmeyer, Wolfgang/M-3254-2018; Lillemo, Morten/H-9406-2019; Singh, Ravi Prakash/I-5575-2019; Periyannan, Sambasivam/C-1722-2014; Lagudah, Evans/A-2007-2010; Huerta-Espino, Julio JH/N-9840-2018; Dodds, Peter/D-1181-2009	Milne, Ricky J/0000-0002-9792-4175; Huerta-Espino, Julio/0000-0001-8334-9862; Spielmeyer, Wolfgang/0000-0002-5115-7820; Lillemo, Morten/0000-0002-8594-8794; Periyannan, Sambasivam/0000-0002-5421-2872; Lagudah, Evans/0000-0002-6234-1789; Huerta-Espino, Julio JH/0000-0001-8334-9862; Dodds, Peter/0000-0003-0620-5923; Patrick, John/0000-0003-0964-9327; Schnippenkoetter, Wendelin/0000-0003-4120-4379	Grains Research and Development Corporation, Australia [CSP00161, CSP00164]; Office of the Chief Executive (OCE) Post Doctoral Fellowship of the Commonwealth Scientific and Industrial Research Organisation (CSIRO), Australia	Grains Research and Development Corporation, Australia(Grains R&D Corp); Office of the Chief Executive (OCE) Post Doctoral Fellowship of the Commonwealth Scientific and Industrial Research Organisation (CSIRO), Australia	This work was supported by funds provided through Grains Research and Development Corporation (CSP00161, CSP00164), Australia, and the Office of the Chief Executive (OCE) Post Doctoral Fellowship of the Commonwealth Scientific and Industrial Research Organisation (CSIRO), Australia. We are grateful to S. Chandramohan, V. Calvo-Salazar, T. Richardson, H. Miah and X. Xia for technical assistance. We thank A. Ashton, I. Dry, P. Ryan and A. Rae for helpful discussions.	Ayliffe M, 2013, MOL PLANT MICROBE IN, V26, P658, DOI 10.1094/MPMI-12-12-0291-R; Buttner M, 2010, PLANT BIOLOGY, V12, P35, DOI 10.1111/j.1438-8677.2010.00383.x; CGIAR Research Program on Wheat, 2014, WHEAT CRP ANN REP 20; Chen LQ, 2010, NATURE, V468, P527, DOI 10.1038/nature09606; Dangl JL, 2013, SCIENCE, V341, P746, DOI 10.1126/science.1236011; DYCK PL, 1979, CAN J PLANT SCI, V59, P329, DOI 10.4141/cjps79-053; DYCK PL, 1994, GENOME, V37, P556, DOI 10.1139/g94-079; Ellis JG, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00641; Fu DL, 2009, SCIENCE, V323, P1357, DOI 10.1126/science.1166289; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Gou JY, 2015, PLANT CELL, V27, P1755, DOI 10.1105/tpc.114.134296; Hayes MA, 2007, J EXP BOT, V58, P1985, DOI 10.1093/jxb/erm061; Hayes MA, 2010, PLANT PHYSIOL, V153, P211, DOI 10.1104/pp.110.154765; Herrera-Foessel SA, 2014, THEOR APPL GENET, V127, P781, DOI 10.1007/s00122-013-2256-9; Herrera-Foessel SA, 2011, THEOR APPL GENET, V122, P239, DOI 10.1007/s00122-010-1439-x; Hiebert CW, 2010, THEOR APPL GENET, V121, P1083, DOI 10.1007/s00122-010-1373-y; Hulbert S, 2014, MOL PLANT MICROBE IN, V27, P207, DOI 10.1094/MPMI-09-13-0295-FI; Ishida Y, 2015, METHODS MOL BIOL, V1223, P189, DOI 10.1007/978-1-4939-1695-5_15; JORGENSEN JH, 1992, EUPHYTICA, V63, P141, DOI 10.1007/BF00023919; Kolmer JA, 2008, CROP SCI, V48, P1841, DOI 10.2135/cropsci2007.08.0474; Krattinger SG, 2009, SCIENCE, V323, P1360, DOI 10.1126/science.1166453; Lagudah ES, 2009, THEOR APPL GENET, V119, P889, DOI 10.1007/s00122-009-1097-z; LEMOINE R, 1987, PHYSIOL PLANTARUM, V69, P639, DOI 10.1111/j.1399-3054.1987.tb01978.x; Lemonnier P, 2014, PLANT MOL BIOL, V85, P473, DOI 10.1007/s11103-014-0198-5; Liesche J, 2011, J PLANT PHYSIOL, V168, P1426, DOI 10.1016/j.jplph.2011.02.005; McCurdy DW, 2010, MOL PLANT, V3, P1049, DOI 10.1093/mp/ssq050; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; Norholm MHH, 2006, FEBS LETT, V580, P2381, DOI 10.1016/j.febslet.2006.03.064; Omasits U, 2014, BIOINFORMATICS, V30, P884, DOI 10.1093/bioinformatics/btt607; Panstruga R, 2005, BIOCHEM SOC T, V33, P389, DOI 10.1042/BST0330389; Periyannan S, 2013, SCIENCE, V341, P786, DOI 10.1126/science.1239028; PETERSON RF, 1948, CAN J RES C, V26, P496, DOI 10.1139/cjr48c-033; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Proels RK, 2014, MOL PLANT PATHOL, V15, P858, DOI 10.1111/mpp.12139; Richardson T, 2014, PLANT CELL TISS ORG, V119, P647, DOI 10.1007/s11240-014-0564-7; Risk JM, 2012, PLANT BIOTECHNOL J, V10, P477, DOI 10.1111/j.1467-7652.2012.00683.x; Rolland F, 2006, ANNU REV PLANT BIOL, V57, P675, DOI 10.1146/annurev.arplant.57.032905.105441; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Sonnewald S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051763; Spielmeyer W, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-96; Stodart BJ, 2007, GENET RESOUR CROP EV, V54, P759, DOI 10.1007/s10722-006-9150-0; Tingay S, 1997, PLANT J, V11, P1369, DOI 10.1046/j.1365-313X.1997.11061369.x; Wang MB, 1998, ACTA HORTIC, P401, DOI 10.17660/ActaHortic.1998.461.46; Wieczorke R, 1999, FEBS LETT, V464, P123, DOI 10.1016/S0014-5793(99)01698-1; Xuan YH, 2013, P NATL ACAD SCI USA, V110, pE3685, DOI 10.1073/pnas.1311244110	45	344	364	13	129	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2015	47	12					1494	1498		10.1038/ng.3439	http://dx.doi.org/10.1038/ng.3439			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CX6LT	26551671				2022-12-25	WOS:000365813200024
J	Tada, T; Zhang, YZ; Koyama, T; Tobiume, M; Tsunetsugu-Yokota, Y; Yamaoka, S; Fujita, H; Tokunaga, K				Tada, Takuya; Zhang, Yanzhao; Koyama, Takayoshi; Tobiume, Minoru; Tsunetsugu-Yokota, Yasuko; Yamaoka, Shoji; Fujita, Hideaki; Tokunaga, Kenzo			MARCH8 inhibits HIV-1 infection by reducing virion incorporation of envelope glycoproteins	NATURE MEDICINE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; E3 UBIQUITIN LIGASE; COMPLEX CLASS-I; CELL-SURFACE; PERSISTENT INFECTION; ANTIGEN PRESENTATION; DOWN-REGULATION; NEF PROTEIN; VPU PROTEIN; T-CELLS	Membrane-associated RING-CH 8 (MARCH8) is one of 11 members of the recently discovered MARCH family of RING (really interesting new gene)-finger E3 ubiquitin ligases(1,2). MARCH8 downregulates several host transmembrane proteins, including major histocompatibility complex (MHC)-II, CD86, interleukin (IL)-1 receptor accessory protein, TNFrelated apoptosis-inducing ligand (TRAIL) receptor 1 and the transferrin receptor(3-7). However, its physiological roles remain largely unknown. Here we identify MARCH8 as a novel antiviral factor. The ectopic expression of MARCH8 in virusproducing cells does not affect levels of lentivirus production, but it does markedly reduce viral infectivity. MARCH8 blocks the incorporation of HIV-1 envelope glycoprotein into virus particles by downregulating it from the cell surface, probably through their interaction, resulting in a substantial reduction in the efficiency of viral entry. The inhibitory effect of MARCH8 on vesicular stomatitis virus G-glycoprotein is even more remarkable, suggesting a broad-spectrum inhibition of enveloped viruses by MARCH8. Notably, the endogenous expression of MARCH8 is high in monocyte-derived macrophages and dendritic cells, and MARCH8 knockdown or knockout in macrophages significantly increases the infectivity of virions produced by these cells. Our findings thus indicate that MARCH8 is highly expressed in terminally differentiated myeloid cells, and that it is a potent antiviral protein that targets viral envelope glycoproteins and reduces their incorporation into virions.	[Tada, Takuya; Zhang, Yanzhao; Koyama, Takayoshi; Tobiume, Minoru; Tokunaga, Kenzo] Natl Inst Infect Dis, Dept Pathol, Tokyo, Japan; [Zhang, Yanzhao; Yamaoka, Shoji] Tokyo Med & Dent Univ, Dept Mol Virol, Tokyo, Japan; [Tsunetsugu-Yokota, Yasuko] Natl Inst Infect Dis, Dept Immunol, Tokyo, Japan; [Fujita, Hideaki] Nagasaki Int Univ, Fac Pharmaceut Sci, Nagasaki, Japan	National Institute of Infectious Diseases (NIID); Tokyo Medical & Dental University (TMDU); National Institute of Infectious Diseases (NIID); Nagasaki International University	Tokunaga, K (corresponding author), Natl Inst Infect Dis, Dept Pathol, Tokyo, Japan.	tokunaga@nih.go.jp	Yanzhao, Zhang/AAI-4175-2021; Tokunaga, Kenzo/Q-9914-2018; Tada, Takuya/GOP-1100-2022	Yanzhao, Zhang/0000-0002-1937-4438; Tokunaga, Kenzo/0000-0002-2625-5322; Tada, Takuya/0000-0003-0779-9954; Yokota, Yasuko/0000-0002-1168-8846; Fujita, Hideaki/0000-0002-4105-4430	Ministry of Health, Labor and Welfare of Japan (Research on HIV/AIDS) [H24-005, H24-008, H25-010]; Japan Society for the Promotion of Science (KAKENHI) [26460086]; Japan Agency for Medical Research and Development, AMED (Research Program on HIV/AIDS); Japan Foundation for AIDS Prevention; Otsuka Toshimi Foundation Scholarship	Ministry of Health, Labor and Welfare of Japan (Research on HIV/AIDS)(Ministry of Health, Labour and Welfare, Japan); Japan Society for the Promotion of Science (KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Agency for Medical Research and Development, AMED (Research Program on HIV/AIDS)(Japan Agency for Medical Research and Development (AMED)); Japan Foundation for AIDS Prevention; Otsuka Toshimi Foundation Scholarship	We are grateful to F. Barre-Sinoussi for critical reading of the manuscript. We thank D. Trono (Ecole Polytechnique Federale de Lausanne, Switzerland, for pWPI; pLVTHM; and pMDLg/pRRE), M.D. Miller (Merck, USA, for pMM310), K. Tomonaga (Kyoto University, Japan, for pBDV-G), Y. Koyanagi (Kyoto University, Japan, for pJRFL); R.H. Silverman and B. Dong (US National Institutes of Health (NIH) AIDS Research and Reference Program, for VP62/pcDNA3.1) F. Zhang (Massachusetts Institute of Technology, USA, for lentiCRISPR-v2), A. Adachi (the University of Tokushima, Japan, for pGL-AN-.Env+Luc), Y. Ishizaka (National Center for Global Health and Medicine, Japan, for 8D1), K. Ikuta (Osaka University, Japan, for 4H4), F. Maldarelli and K. Strebel (US NIH AIDS Research and Reference Program, for anti-Vpu rabbit serum), and T. Sata (Toyama Institute of Health, Japan, for Nu24). This work was supported by grants from the Ministry of Health, Labor and Welfare of Japan (Research on HIV/AIDS project no. H24-005, H24-008 and H25-010 to K.T.), the Japan Society for the Promotion of Science (KAKENHI 26460086 to H.F.), the Japan Agency for Medical Research and Development, AMED (Research Program on HIV/AIDS) (to K.T.). T.T. is a recipient of a Research Resident Fellowship from the Japan Foundation for AIDS Prevention. Y.Z. is a recipient of the Otsuka Toshimi Foundation Scholarship.	ADACHI A, 1987, J VIROL, V61, P209, DOI 10.1128/JVI.61.1.209-213.1987; Bartee E, 2004, J VIROL, V78, P1109, DOI 10.1128/JVI.78.3.1109-1120.2004; Bartee E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015132; Chen R, 2012, P NATL ACAD SCI USA, V109, P14128, DOI 10.1073/pnas.1205246109; Coscoy L, 2000, P NATL ACAD SCI USA, V97, P8051, DOI 10.1073/pnas.140129797; Daito T, 2011, J VIROL, V85, P12170, DOI 10.1128/JVI.05554-11; Dong B, 2007, P NATL ACAD SCI USA, V104, P1655, DOI 10.1073/pnas.0610291104; Eyster CA, 2011, MOL BIOL CELL, V22, P3218, DOI 10.1091/mbc.E10-11-0874; Fouchier RAM, 1997, EMBO J, V16, P4531, DOI 10.1093/emboj/16.15.4531; Fujita H, 2013, J CELL SCI, V126, P2798, DOI 10.1242/jcs.119909; Goto E, 2003, J BIOL CHEM, V278, P14657, DOI 10.1074/jbc.M211285200; Goujon C, 2013, NATURE, V502, P559, DOI 10.1038/nature12542; Haller C, 2014, J VIROL, V88, P14241, DOI 10.1128/JVI.02333-14; Harris RS, 2003, CELL, V113, P803, DOI 10.1016/S0092-8674(03)00423-9; Hrecka K, 2011, NATURE, V474, P658, DOI 10.1038/nature10195; Ishido S, 2000, J VIROL, V74, P5300, DOI 10.1128/JVI.74.11.5300-5309.2000; Iwabu Y, 2010, J BIOL CHEM, V285, P35350, DOI 10.1074/jbc.M110.173286; Iwabu Y, 2009, J BIOL CHEM, V284, P35060, DOI 10.1074/jbc.M109.058305; Jahnke M, 2012, J BIOL CHEM, V287, P28779, DOI 10.1074/jbc.M112.381541; Kane M, 2013, NATURE, V502, P563, DOI 10.1038/nature12653; Kinomoto M, 2005, J VIROL, V79, P5996, DOI 10.1128/JVI.79.10.5996-6004.2005; Kinomoto M, 2007, NUCLEIC ACIDS RES, V35, P2955, DOI 10.1093/nar/gkm181; Kitagawa Y, 2008, VIROLOGY, V373, P171, DOI 10.1016/j.virol.2007.11.033; Koyama T, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-21; KOYANAGI Y, 1987, SCIENCE, V236, P819, DOI 10.1126/science.3646751; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Lapaque N, 2009, J BIOL CHEM, V284, P7007, DOI 10.1074/jbc.M805736200; Liu ZL, 2013, CELL HOST MICROBE, V14, P398, DOI 10.1016/j.chom.2013.08.015; MALDARELLI F, 1993, J VIROL, V67, P5056, DOI 10.1128/JVI.67.8.5056-5061.1993; Mashiba M, 2014, CELL HOST MICROBE, V16, P722, DOI 10.1016/j.chom.2014.10.014; Mochizuki N, 1999, AIDS RES HUM RETROV, V15, P1321, DOI 10.1089/088922299310223; NAIDU YM, 1988, J VIROL, V62, P4691, DOI 10.1128/JVI.62.12.4691-4696.1988; Nakai-Murakami C, 2007, ONCOGENE, V26, P477, DOI 10.1038/sj.onc.1209831; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Nomaguchi M, 2014, MICROBES INFECT, V16, P695, DOI 10.1016/j.micinf.2014.06.004; Ohmura-Hoshino M, 2006, J IMMUNOL, V177, P341, DOI 10.4049/jimmunol.177.1.341; OTAKE K, 1994, J IMMUNOL, V153, P5826; Perez-Caballero D, 2009, CELL, V139, P499, DOI 10.1016/j.cell.2009.08.039; Pham HM, 2004, J VIROL, V78, P13072, DOI 10.1128/JVI.78.23.13072-13081.2004; Ross TM, 1999, CURR BIOL, V9, P613, DOI 10.1016/S0960-9822(99)80283-8; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; SHIBATA R, 1990, J VIROL, V64, P742, DOI 10.1128/JVI.64.2.742-747.1990; Stevenson PG, 2000, P NATL ACAD SCI USA, V97, P8455, DOI 10.1073/pnas.150240097; Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343; Tobiume M, 2003, J VIROL, V77, P10645, DOI 10.1128/JVI.77.19.10645-10650.2003; Tokarev Andrey, 2011, Cell Logist, V1, P90; Tokunaga K, 2001, J VIROL, V75, P6776, DOI 10.1128/JVI.75.15.6776-6785.2001; TSUNETSUGUYOKOTA Y, 1995, J VIROL, V69, P4544, DOI 10.1128/JVI.69.7.4544-4547.1995; Tze LE, 2011, J EXP MED, V208, P149, DOI 10.1084/jem.20092203; Van Damme N, 2008, CELL HOST MICROBE, V3, P245, DOI 10.1016/j.chom.2008.03.001; van de Kooij B, 2013, J BIOL CHEM, V288, P6617, DOI 10.1074/jbc.M112.448209; Wiznerowicz M, 2003, J VIROL, V77, P8957, DOI 10.1128/JVI.77.16.8957-8951.2003; Yang HC, 2009, P NATL ACAD SCI USA, V106, P6321, DOI 10.1073/pnas.0809536106	55	74	76	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2015	21	12					1502	+		10.1038/nm.3956	http://dx.doi.org/10.1038/nm.3956			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CX9EV	26523972				2022-12-25	WOS:000366008700022
J	Bruni, G; Rennekamp, AJ; Velenich, A; McCarroll, M; Gendelev, L; Fertsch, E; Taylor, J; Lakhani, P; Lensen, D; Evron, T; Lorello, PJ; Huang, XP; Kolczewski, S; Carey, G; Caldarone, BJ; Prinssen, E; Roth, BL; Keiser, MJ; Peterson, RT; Kokel, D				Bruni, Giancarlo; Rennekamp, Andrew J.; Velenich, Andrea; McCarroll, Matthew; Gendelev, Leo; Fertsch, Ethan; Taylor, Jack; Lakhani, Parth; Lensen, Dennis; Evron, Tama; Lorello, Paul J.; Huang, Xi-Ping; Kolczewski, Sabine; Carey, Galen; Caldarone, Barbara J.; Prinssen, Eric; Roth, Bryan L.; Keiser, Michael J.; Peterson, Randall T.; Kokel, David			Zebrafish behavioral profiling identifies multitarget antipsychotic-like compounds	NATURE CHEMICAL BIOLOGY			English	Article							PSYCHIATRIC DRUG DISCOVERY; SMALL MOLECULES; IN-VIVO; PHENCYCLIDINE; CLOZAPINE; SEROTONIN; DOPAMINE; HALOPERIDOL; DISORDERS; PHENOMICS	Many psychiatric drugs act on multiple targets and therefore require screening assays that encompass a wide target space. With sufficiently rich phenotyping and a large sampling of compounds, it should be possible to identify compounds with desired mechanisms of action on the basis of behavioral profiles alone. Although zebrafish (Danio rerio) behavior has been used to rapidly identify neuroactive compounds, it is not clear what types of behavioral assays would be necessary to identify multitarget compounds such as antipsychotics. Here we developed a battery of behavioral assays in larval zebrafish to determine whether behavioral profiles can provide sufficient phenotypic resolution to identify and classify psychiatric drugs. Using the antipsychotic drug haloperidol as a test case, we found that behavioral profiles of haloperidol-treated zebrafish could be used to identify previously uncharacterized compounds with desired antipsychotic-like activities and multitarget mechanisms of action.	[Bruni, Giancarlo; Rennekamp, Andrew J.; Peterson, Randall T.] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Charlestown, MA USA; [Bruni, Giancarlo; Velenich, Andrea; Lensen, Dennis; Evron, Tama; Carey, Galen] Teleos Therapeut, Medford, MA USA; [Rennekamp, Andrew J.; Peterson, Randall T.] Massachusetts Gen Hosp, Div Cardiol, Dept Med, Charlestown, MA USA; [Rennekamp, Andrew J.; Peterson, Randall T.] Harvard Univ, Sch Med, Dept Syst Biol, Charlestown, MA USA; [Rennekamp, Andrew J.; Peterson, Randall T.] Broad Inst, Cambridge, MA USA; [McCarroll, Matthew; Fertsch, Ethan; Taylor, Jack; Lakhani, Parth; Kokel, David] Univ Calif San Francisco, Dept Physiol, Box 0444, San Francisco, CA USA; [McCarroll, Matthew; Gendelev, Leo; Fertsch, Ethan; Taylor, Jack; Lakhani, Parth; Keiser, Michael J.; Kokel, David] Univ Calif San Francisco, Inst Neurodegenerat Dis, San Francisco, CA 94143 USA; [Gendelev, Leo; Keiser, Michael J.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA USA; [Gendelev, Leo; Keiser, Michael J.] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA; [Lorello, Paul J.; Caldarone, Barbara J.] Brigham & Womens Hosp, Neurobehav Lab, Harvard NeuroDiscovery Ctr, 75 Francis St, Boston, MA 02115 USA; [Lorello, Paul J.; Caldarone, Barbara J.] Brigham & Womens Hosp, Dept Neurol, 75 Francis St, Boston, MA 02115 USA; [Huang, Xi-Ping; Roth, Bryan L.] Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC USA; [Huang, Xi-Ping; Roth, Bryan L.] Univ N Carolina, Sch Med, NIMH Psychoact Drug Screening Program, Chapel Hill, NC USA; [Kolczewski, Sabine; Prinssen, Eric] Roche Innovat Ctr Basel, Roche Pharmaceut Res & Early Dev, Basel, Switzerland	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Roche Holding	Kokel, D (corresponding author), Univ Calif San Francisco, Dept Physiol, Box 0444, San Francisco, CA USA.; Kokel, D (corresponding author), Univ Calif San Francisco, Inst Neurodegenerat Dis, San Francisco, CA 94143 USA.	david.kokel@ucsf.edu	Roth, Bryan L/F-3928-2010; Keiser, Michael J./F-2825-2016; Roth, Bryan/ABE-7032-2020	Keiser, Michael J./0000-0002-1240-2192; Roth, Bryan/0000-0002-0561-6520; Rennekamp, Andrew/0000-0001-6174-7253; McCarroll, Matthew/0000-0001-7080-3210; Peterson, Randall/0000-0003-0727-3469; Bruni, Giancarlo/0000-0003-2850-4633	US National Institutes of Health (NIH) [K01MH091449, U01MH105027, R01AA022583, R44GM093456, T32EB009383, T32GM008284, R01MH086867, R21MH085205]; Charles and Ann Sanders MGH Research Scholar Award; Glenn Foundation Award for Research in Biological Mechanisms of Aging; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007208] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB009383] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R44GM093456, T32GM008284] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH105027, R21MH085205, R01MH086867, K01MH091449] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA022583] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Charles and Ann Sanders MGH Research Scholar Award; Glenn Foundation Award for Research in Biological Mechanisms of Aging; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	We thank members of our research groups for helpful advice. This work was supported by US National Institutes of Health (NIH) grants K01MH091449, U01MH105027 and R01AA022583 (D.K.); R44GM093456 (M.J.K.), T32EB009383 and T32GM008284 (L.G.) and R01MH086867 and R21MH085205 (R.T.P.); the Charles and Ann Sanders MGH Research Scholar Award (R.T.P.); and the Glenn Foundation Award for Research in Biological Mechanisms of Aging (D.K. and M.J.K.).	Ahrens MB, 2012, NATURE, V485, P471, DOI 10.1038/nature11057; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arana GW, 2000, J CLIN PSYCHIAT, V61, P5; Baraban SC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3410; Bencan Z, 2009, PHARMACOL BIOCHEM BE, V94, P75, DOI 10.1016/j.pbb.2009.07.009; Besnard J, 2012, NATURE, V492, P215, DOI 10.1038/nature11691; Boulay D, 2000, EUR J PHARMACOL, V391, P63, DOI 10.1016/S0014-2999(99)00916-4; Bymaster FP, 2001, NEUROPSYCHOPHARMACOL, V25, P871, DOI 10.1016/S0893-133X(01)00298-6; Castagne V, 2009, ADV PHARMACOL, V57, P381, DOI 10.1016/S1054-3589(08)57010-4; Conn PJ, 2008, NEUROPSYCHOPHARMACOL, V33, P2048, DOI 10.1038/sj.npp.1301638; DUBINSKY B, 1982, PSYCHOPHARMACOLOGY, V78, P1, DOI 10.1007/BF00470578; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Egan RJ, 2009, BEHAV BRAIN RES, V205, P38, DOI 10.1016/j.bbr.2009.06.022; FREED WJ, 1984, NEUROPHARMACOLOGY, V23, P175, DOI 10.1016/S0028-3908(84)80011-8; Giacomini NJ, 2006, NEUROTOXICOL TERATOL, V28, P245, DOI 10.1016/j.ntt.2006.01.013; Gleason SD, 1997, PSYCHOPHARMACOLOGY, V129, P79, DOI 10.1007/s002130050165; Gunsalus KC, 2004, NUCLEIC ACIDS RES, V32, pD406, DOI 10.1093/nar/gkh110; Hayashi T., 2005, Current Neuropharmacology, V3, P267, DOI 10.2174/157015905774322516; HIPPIUS H, 1989, PSYCHOPHARMACOLOGY, V99, pS3, DOI 10.1007/BF00442551; HOFFMAN DC, 1995, PSYCHOPHARMACOLOGY, V120, P128, DOI 10.1007/BF02246184; Houle D, 2010, NAT REV GENET, V11, P855, DOI 10.1038/nrg2897; Howe K, 2013, NATURE, V496, P498, DOI 10.1038/nature12111; Hyman SE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003142; IRWIN S, 1968, PSYCHOPHARMACOLOGIA, V13, P222, DOI 10.1007/BF00401402; Jentsch JD, 1999, NEUROPSYCHOPHARMACOL, V20, P201, DOI 10.1016/S0893-133X(98)00060-8; Jin K, 2012, NUCLEIC ACIDS RES, V40, pD687, DOI 10.1093/nar/gkr827; Keiser MJ, 2007, NAT BIOTECHNOL, V25, P197, DOI 10.1038/nbt1284; Kokel D, 2013, NAT CHEM BIOL, V9, P257, DOI [10.1038/NCHEMBIO.1183, 10.1038/nchembio.1183]; Kokel D, 2012, TRENDS BIOTECHNOL, V30, P421, DOI 10.1016/j.tibtech.2012.05.001; Kokel D, 2010, NAT CHEM BIOL, V6, P231, DOI 10.1038/NCHEMBIO.307; Kokel David, 2008, Briefings in Functional Genomics & Proteomics, V7, P483, DOI 10.1093/bfgp/eln040; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Landrum G., 2015, RDKIT OPEN SOURCE CH; Lecrubier Y, 2003, EUR NEUROPSYCHOPHARM, V13, pS167, DOI 10.1016/S0924-977X(03)91703-2; LIEBERMAN JA, 1988, J CLIN PSYCHIAT, V49, P271; LIEBERMAN JA, 1991, BRIT J PSYCHIAT, V158, P503, DOI 10.1192/bjp.158.4.503; Lopez-Munoz F, 2009, BRAIN RES BULL, V79, P130, DOI 10.1016/j.brainresbull.2009.01.005; Lopez-Patino MA, 2008, PHYSIOL BEHAV, V93, P160, DOI 10.1016/j.physbeh.2007.08.013; Lounkine E, 2012, NATURE, V486, P361, DOI 10.1038/nature11159; McGonigle P, 2014, BIOCHEM PHARMACOL, V87, P140, DOI 10.1016/j.bcp.2013.06.016; MELTZER HY, 1994, J CLIN PSYCHIAT, V55, P47; Pangalos MN, 2007, NAT REV DRUG DISCOV, V6, P521, DOI 10.1038/nrd2094; Pardo-Martin C, 2010, NAT METHODS, V7, P634, DOI [10.1038/NMETH.1481, 10.1038/nmeth.1481]; Paul SM, 2010, NAT REV DRUG DISCOV, V9, P203, DOI 10.1038/nrd3078; PEROUTKA SJ, 1980, AM J PSYCHIAT, V137, P1518; Porsolt RD, 2010, J PHARMACOL EXP THER, V333, P632, DOI 10.1124/jpet.110.166710; Rennekamp A. J., 2016, NAT CHEM BIOL, DOI [10.1038/nchembiol.2089, DOI 10.1038/NCHEMBIOL.2089]; Rihel J, 2010, SCIENCE, V327, P348, DOI 10.1126/science.1183090; Roth BL, 2004, NAT REV DRUG DISCOV, V3, P353, DOI 10.1038/nrd1346; Vardy E, 2015, CHEM BIOL, V22, P764, DOI 10.1016/j.chembiol.2015.05.012; Wolman MA, 2011, P NATL ACAD SCI USA, V108, P15468, DOI 10.1073/pnas.1107156108; World Health Organization, 2013, WHO MOD LIST ESS MED	52	79	81	0	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUL	2016	12	7					559	+		10.1038/NCHEMBIO.2097	http://dx.doi.org/10.1038/NCHEMBIO.2097			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9EP	27239787	Green Accepted, Green Submitted			2022-12-25	WOS:000378087500017
J	Scarlett, JM; Rojas, JM; Matsen, ME; Kaiyala, KJ; Stefanovski, D; Bergman, RN; Nguyen, HT; Dorfman, MD; Lantier, L; Wasserman, DH; Mirzadeh, Z; Unterman, TG; Morton, GJ; Schwartz, MW				Scarlett, Jarrad M.; Rojas, Jennifer M.; Matsen, Miles E.; Kaiyala, Karl J.; Stefanovski, Darko; Bergman, Richard N.; Nguyen, Hong T.; Dorfman, Mauricio D.; Lantier, Louise; Wasserman, David H.; Mirzadeh, Zaman; Unterman, Terry G.; Morton, Gregory J.; Schwartz, Michael W.			Central injection of fibroblast growth factor 1 induces sustained remission of diabetic hyperglycemia in rodents	NATURE MEDICINE			English	Article							INTRAVENOUS GLUCOSE-TOLERANCE; INSULIN; TANYCYTES; SUPPRESSION; MODEL; DIETARY; BRAIN; FGF1	Type 2 diabetes (T2D) is among the most common and costly disorders worldwide(1). The goal of current medical management for T2D is to transiently ameliorate hyperglycemia through daily dosing of one or more antidiabetic drugs. Hypoglycemia and weight gain are common side effects of therapy, and sustained disease remission is not obtainable with nonsurgical approaches. On the basis of the potent glucose-lowering response elicited by activation of brain fibroblast growth factor (FGF) receptors(2-4), we explored the antidiabetic efficacy of centrally administered FGF1, which, unlike other FGF peptides, activates all FGF receptor subtypes(5). We report that a single intracerebroventricular injection of FGF1 at a dose one-tenth of that needed for antidiabetic efficacy following peripheral injection induces sustained diabetes remission in both mouse and rat models of T2D. This antidiabetic effect is not secondary to weight loss, does not increase the risk of hypoglycemia, and involves a novel and incompletely understood mechanism for increasing glucose clearance from the bloodstream. We conclude that the brain has an inherent potential to induce diabetes remission and that brain FGF receptors are potential pharmacological targets for achieving this goal.	[Scarlett, Jarrad M.; Rojas, Jennifer M.; Matsen, Miles E.; Nguyen, Hong T.; Dorfman, Mauricio D.; Morton, Gregory J.; Schwartz, Michael W.] Univ Washington, Dept Med, Diabet & Obes Ctr Excellence, Seattle, WA USA; [Scarlett, Jarrad M.] Seattle Childrens Hosp, Dept Pediat Gastroenterol & Hepatol, Seattle, WA USA; [Kaiyala, Karl J.] Univ Washington, Sch Dent, Dept Oral Hlth Sci, Seattle, WA 98195 USA; [Stefanovski, Darko] Univ Penn, Sch Vet Med, New Bolton Ctr, Philadelphia, PA 19104 USA; [Bergman, Richard N.] Cedars Sinai Med Ctr, Diabet & Obes Res Inst, Los Angeles, CA 90048 USA; [Lantier, Louise; Wasserman, David H.] Vanderbilt Univ Sch Med, Dept Mol Physiol & Biophys, Nashville, TN USA; [Mirzadeh, Zaman] St Josephs Hosp, Barrow Neurol Inst, Phoenix, AZ USA; [Unterman, Terry G.] Univ Illinois, Coll Med, Dept Med, Sect Endocrinol Diabet & Metab, Chicago, IL 60607 USA; [Unterman, Terry G.] Jesse Brown Virginia Med Ctr, Med Serv, Chicago, IL USA	University of Washington; University of Washington Seattle; Seattle Children's Hospital; University of Washington; University of Washington Seattle; University of Pennsylvania; Cedars Sinai Medical Center; Vanderbilt University; Barrow Neurological Institute; St. Joseph's Hospital and Medical Center; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Schwartz, MW (corresponding author), Univ Washington, Dept Med, Diabet & Obes Ctr Excellence, Seattle, WA USA.	mschwart@u.washington.edu		Bergman, Richard/0000-0003-1539-4471	US National Institute of Diabetes and Digestive and Kidney Diseases [DK083042, DK090320, DK101997, DK089056, DK007742, DK104461, DK007247, DK103375, DK27619, DK29867]; Department of Veterans Affairs Merit Review Program; Novo Nordisk; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK104461, R01DK083042, T32DK007247, P30DK035816, P30DK017047, R01DK027619, R01DK029867, F32DK108596, R01DK101997, U24DK059637, T32DK007742, R01DK089056, R01DK090320, F32DK103375] Funding Source: NIH RePORTER	US National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Department of Veterans Affairs Merit Review Program(US Department of Veterans Affairs); Novo Nordisk(Novo Nordisk); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors are grateful to the Vanderbilt University Mouse Metabolic Phenotyping Center (DK059637) for the performance of the basal glucose turnover, FSIGT and [2-<SUP>14</SUP>C]DG studies, the Nutrition Obesity Research Center (DK035816), the Diabetes Research Center (DK017047) at the University of Washington, and the technical assistance provided by T. Meek, V. Damian, L. Nguyen, T. Harvey, and J. Brown (all at University of Washington) and by D. Bracy and A. Locke (both at Vanderbilt University). We gratefully acknowledge L. Schaffer (Novo Nordisk) for providing the insulin receptor antagonist (S961). This work was supported by the US National Institute of Diabetes and Digestive and Kidney Diseases (grant nos. DK083042 (M.W.S.), DK090320 (M.W.S.), DK101997 (M.W.S.), DK089056 (G.J.M.), DK007742 (J.M.S.), DK104461 (J.M.S.), DK007247 (J.M.R.), DK103375 (J.M.R.), DK27619 (R.N.B.), and DK29867 (R.N.B.)), the Department of Veterans Affairs Merit Review Program (T.G.U.), and by funding supplied by Novo Nordisk (M.W.S.).	ADER M, 1985, DIABETES, V34, P1092, DOI 10.2337/diabetes.34.11.1092; Alonso LC, 2012, OBESITY, V20, P1403, DOI 10.1038/oby.2012.36; BEST JD, 1981, DIABETES, V30, P847, DOI 10.2337/diabetes.30.10.847; Bolborea M, 2013, TRENDS NEUROSCI, V36, P91, DOI 10.1016/j.tins.2012.12.008; Cheng X, 2011, NEUROL RES, V33, P675, DOI 10.1179/1743132810Y.0000000004; DAVIS MA, 1987, METABOLISM, V36, P856, DOI 10.1016/0026-0495(87)90094-1; Elizondo-Vega R, 2015, J CELL MOL MED, V19, P1471, DOI 10.1111/jcmm.12590; Fischer A, 2007, NATURE, V447, P178, DOI 10.1038/nature05772; Fu L, 2004, ENDOCRINOLOGY, V145, P2594, DOI 10.1210/en.2003-1671; Grayson BE, 2013, NAT REV NEUROSCI, V14, P24, DOI 10.1038/nrn3409; Gresl TA, 2001, AM J PHYSIOL-ENDOC M, V281, pE757, DOI 10.1152/ajpendo.2001.281.4.E757; International Diabetes Federation, 2015, IDF DIABETES ATLAS; Ito J, 2005, J LIPID RES, V46, P679, DOI 10.1194/jlr.M400313-JLR200; Jonker JW, 2012, NATURE, V485, P391, DOI 10.1038/nature10998; KAHN SE, 1994, DIABETES, V43, P587, DOI 10.2337/diabetes.43.4.587; King AJF, 2012, BRIT J PHARMACOL, V166, P877, DOI 10.1111/j.1476-5381.2012.01911.x; Lou G, 2012, NEUROSCIENCE, V223, P225, DOI 10.1016/j.neuroscience.2012.08.003; Lu MJ, 2012, NAT MED, V18, P388, DOI 10.1038/nm.2686; Marcelin G, 2014, MOL METAB, V3, P19, DOI 10.1016/j.molmet.2013.10.002; Mirzadeh Zaman, 2010, J Vis Exp, DOI 10.3791/1938; Moore MC, 2012, ADV NUTR, V3, P286, DOI 10.3945/an.112.002089; Morton GJ, 2013, J CLIN INVEST, V123, P4799, DOI 10.1172/JCI70710; O-Sullivan I, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8079; OOMURA Y, 1992, AM J CLIN NUTR, V55, P278; Orellana JA, 2012, GLIA, V60, P53, DOI 10.1002/glia.21246; Ornitz DM, 2015, WIRES DEV BIOL, V4, P215, DOI 10.1002/wdev.176; Perry RJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7980; Pinto JGA, 2015, FRONT NEURAL CIRCUIT, V9, DOI 10.3389/fncir.2015.00003; PORTE D, 1991, DIABETES, V40, P166, DOI 10.2337/diabetes.40.2.166; Robins SC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3049; Rojas JM, 2015, MOL METAB, V4, P561, DOI 10.1016/j.molmet.2015.05.005; Ryan KK, 2013, ENDOCRINOLOGY, V154, P9, DOI 10.1210/en.2012-1891; Schaffer L, 2008, BIOCHEM BIOPH RES CO, V376, P380, DOI 10.1016/j.bbrc.2008.08.151; Schwartz MW, 2013, NATURE, V503, P59, DOI 10.1038/nature12709; Stefanovski D, 2012, DIABETES CARE, V35, P1015, DOI 10.2337/dc11-1540; Stetler RA, 2009, CURR MOL MED, V9, P863, DOI 10.2174/156652409789105561; Suh JM, 2014, NATURE, V513, P436, DOI 10.1038/nature13540; Suzuki S, 2001, EUR J NEUROSCI, V13, P2299, DOI 10.1046/j.0953-816x.2001.01606.x; Titchenell PM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8078; Xu J, 2009, AM J PHYSIOL-ENDOC M, V297, pE1105, DOI 10.1152/ajpendo.00348.2009	40	89	94	0	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2016	22	7					800	806		10.1038/nm.4101	http://dx.doi.org/10.1038/nm.4101			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DQ7DK	27213816	Green Accepted			2022-12-25	WOS:000379366900019
J	Mullard, A				Mullard, Asher			DNA-encoded drug libraries come of age	NATURE BIOTECHNOLOGY			English	News Item																		1992, P NATL ACAD SCI US, V89, P5381; 2007, ANN REV BIOCH, V76, P331	2	11	11	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2016	34	5					450	451						2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DL6FL	27153258				2022-12-25	WOS:000375735000004
J	Bonilla, X; Parmentier, L; King, B; Bezrukov, F; Kaya, G; Zoete, V; Seplyarskiy, VB; Sharpe, HJ; McKee, T; Letourneau, A; Ribaux, PG; Popadin, K; Basset-Seguin, N; Ben Chaabene, R; Santoni, FA; Andrianova, MA; Guipponi, M; Garieri, M; Verdan, C; Grosdemange, K; Sumara, O; Eilers, M; Aifantis, I; Michielin, O; de Sauvage, FJ; Antonarakis, SE; Nikolaev, SI				Bonilla, Ximena; Parmentier, Laurent; King, Bryan; Bezrukov, Fedor; Kaya, Gurkan; Zoete, Vincent; Seplyarskiy, Vladimir B.; Sharpe, Hayley J.; McKee, Thomas; Letourneau, Audrey; Ribaux, Pascale G.; Popadin, Konstantin; Basset-Seguin, Nicole; Ben Chaabene, Rouaa; Santoni, Federico A.; Andrianova, Maria A.; Guipponi, Michel; Garieri, Marco; Verdan, Carole; Grosdemange, Kerstin; Sumara, Olga; Eilers, Martin; Aifantis, Iannis; Michielin, Olivier; de Sauvage, Frederic J.; Antonarakis, Stylianos E.; Nikolaev, Sergey I.			Genomic analysis identifies new drivers and progression pathways in skin basal cell carcinoma	NATURE GENETICS			English	Article							HEDGEHOG SIGNALING PATHWAY; KINETOCHORE GENE KNSTRN; C-MYC; TUMOR-SUPPRESSOR; MUTATIONAL LANDSCAPE; UBIQUITIN LIGASE; POINT MUTATIONS; CANCER; GROWTH; TRANSCRIPTION	Basal cell carcinoma (BCC) of the skin is the most common malignant neoplasm in humans. BCC is primarily driven by the Sonic Hedgehog (Hh) pathway. However, its phenotypic variation remains unexplained. Our genetic profiling of 293 BCCs found the highest mutation rate in cancer (65 mutations/Mb). Eighty-five percent of the BCCs harbored mutations in Hh pathway genes (PTCH1, 73% or SMO, 20% (P = 6.6 x 10(-8)) and SUFU, 8%) and in TP53 (61%). However, 85% of the BCCs also harbored additional driver mutations in other cancer-related genes. We observed recurrent mutations in MYCN (30%), PPP6C (15%), STK19 (10%), LATS1 (8%), ERBB2 (4%), PIK3CA (2%), and NRAS, KRAS or HRAS (2%), and loss-of-function and deleterious missense mutations were present in PTPN14 (23%), RB1 (8%) and FBXW7 (5%). Consistent with the mutational profiles, N-Myc and Hippo-YAP pathway target genes were upregulated. Functional analysis of the mutations in MYCN, PTPN14 and LATS1 suggested their potential relevance in BCC tumorigenesis.	[Bonilla, Ximena; Letourneau, Audrey; Ribaux, Pascale G.; Popadin, Konstantin; Ben Chaabene, Rouaa; Santoni, Federico A.; Garieri, Marco; Antonarakis, Stylianos E.; Nikolaev, Sergey I.] Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland; [Parmentier, Laurent] Hosp Valais, Dept Dermatol, Sierre, Switzerland; [King, Bryan; Aifantis, Iannis] NYU, Sch Med, Dept Pathol, New York, NY USA; [Bezrukov, Fedor] Univ Connecticut, Dept Phys, Storrs, CT USA; [Bezrukov, Fedor] Brookhaven Natl Lab, RIKEN BNL Res Ctr, Upton, NY 11973 USA; [Kaya, Gurkan; Grosdemange, Kerstin] Univ Hosp Geneva, Dept Dermatol, Geneva, Switzerland; [Zoete, Vincent; Michielin, Olivier] Swiss Inst Bioinformat, Lausanne, Switzerland; [Seplyarskiy, Vladimir B.; Andrianova, Maria A.] Russian Acad Sci, Inst Informat Transmiss Problems, Moscow, Russia; [Seplyarskiy, Vladimir B.; Andrianova, Maria A.] Pirogov Russian Natl Res Med Univ, Moscow, Russia; [Seplyarskiy, Vladimir B.; Andrianova, Maria A.] Moscow MV Lomonosov State Univ, Moscow, Russia; [Sharpe, Hayley J.; de Sauvage, Frederic J.] Genentech Inc, Dept Mol Oncol, San Francisco, CA 94080 USA; [McKee, Thomas; Verdan, Carole] Univ Hosp Geneva, Serv Clin Pathol, Geneva, Switzerland; [Basset-Seguin, Nicole] Univ Paris 07, St Louis Hosp, Dept Dermatol, Paris, France; [Santoni, Federico A.; Guipponi, Michel; Antonarakis, Stylianos E.; Nikolaev, Sergey I.] Univ Hosp Geneva, Serv Genet Med, Geneva, Switzerland; [Sumara, Olga; Eilers, Martin] Univ Wurzburg, Dept Biochem & Mol Biol, D-97070 Wurzburg, Germany; [Eilers, Martin] Univ Wurzburg, Comprehens Canc Ctr Mainfranken, D-97070 Wurzburg, Germany; [Michielin, Olivier] Univ Lausanne, Dept Oncol, Lausanne, Switzerland; [Michielin, Olivier] CHU Vaudois, CH-1011 Lausanne, Switzerland; [Antonarakis, Stylianos E.] Inst Genet & Genom Geneva iGE3, Geneva, Switzerland	University of Geneva; New York University; University of Connecticut; RIKEN; United States Department of Energy (DOE); Brookhaven National Laboratory; University of Geneva; Swiss Institute of Bioinformatics; Kharkevich Institute for Information Transmission Problems of the RAS; Russian Academy of Sciences; Pirogov Russian National Research Medical University; Lomonosov Moscow State University; Roche Holding; Genentech; University of Geneva; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Geneva; University of Wurzburg; University of Wurzburg; University of Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Antonarakis, SE; Nikolaev, SI (corresponding author), Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland.; Antonarakis, SE; Nikolaev, SI (corresponding author), Univ Hosp Geneva, Serv Genet Med, Geneva, Switzerland.; Antonarakis, SE (corresponding author), Inst Genet & Genom Geneva iGE3, Geneva, Switzerland.	stylianos.antonarakis@unige.ch; sergey.nikolaev@unige.ch	sharpe, Hayley/U-2214-2019; Antonarakis, Stylianos E/N-8866-2014; de Sauvage, Frederic/ABE-8400-2020; Michielin, Olivier/ABE-7924-2020; Bezrukov, Fedor/AAA-3468-2021; Popadin, Konstantin/L-7459-2017; Andrianova, Maria/G-1786-2015; Bonilla, Ximena/AAI-7910-2021	sharpe, Hayley/0000-0002-4723-298X; Antonarakis, Stylianos E/0000-0001-8907-5823; de Sauvage, Frederic/0000-0002-5275-2584; Bezrukov, Fedor/0000-0003-3601-1003; Andrianova, Maria/0000-0002-4516-5082; Sumara, Olga/0000-0002-0845-3720; Eilers, Martin/0000-0002-0376-6533; Bonilla, Ximena/0000-0002-4950-6825; Ben Chaabene, Rouaa/0000-0003-1617-6206; Santoni, Federico/0000-0002-3258-4747; McKee, Thomas/0000-0002-2147-3136	Swiss Cancer League [LSCC 2939-02-2012]; Dinu Lipatti; Novartis [14B065]	Swiss Cancer League; Dinu Lipatti; Novartis(Novartis)	We thank Z. Modrusan (next-generation sequencing), R. Piskol (computational biology), G. Pau (computational biology), F. Peale (pathology) and S. Jillo (collaboration management) from Genentech, Inc. This work was supported by Swiss Cancer League (LSCC 2939-02-2012), Dinu Lipatti 2014 and Novartis (14B065) research grants to S.I.N.	Akbani R, 2015, CELL, V161, P1681, DOI 10.1016/j.cell.2015.05.044; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Atwood SX, 2015, CANCER CELL, V27, P342, DOI 10.1016/j.ccell.2015.02.002; Bahram F, 2000, BLOOD, V95, P2104, DOI 10.1182/blood.V95.6.2104; Basset-Seguin N, 2015, LANCET ONCOL, V16, P729, DOI 10.1016/S1470-2045(15)70198-1; Besaratinia A, 2007, P NATL ACAD SCI USA, V104, P5953, DOI 10.1073/pnas.0610534104; Brash DE, 2015, PHOTOCHEM PHOTOBIOL, V91, P15, DOI 10.1111/php.12377; Brastianos PK, 2013, NAT GENET, V45, P285, DOI 10.1038/ng.2526; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; Chang ALS, 2012, ARCH DERMATOL, V148, P1324, DOI 10.1001/archdermatol.2012.2354; Chen CL, 2010, GENOME RES, V20, P447, DOI 10.1101/gr.098947.109; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Clark VE, 2013, SCIENCE, V339, P1077, DOI 10.1126/science.1233009; Couzens AL, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004712; Almeida ACD, 2015, NAT GENET, V47, P1465, DOI 10.1038/ng.3442; Dinkel H, 2014, NUCLEIC ACIDS RES, V42, pD259, DOI 10.1093/nar/gkt1047; Dreno B, 2014, ONCOLOGIST, V19, P790, DOI 10.1634/theoncologist.2014-0003; DROBETSKY EA, 1993, MUTAT RES, V289, P131, DOI 10.1016/0027-5107(93)90062-K; Duman-Scheel M, 2002, NATURE, V417, P299, DOI 10.1038/417299a; Ellison DW, 2011, ACTA NEUROPATHOL, V121, P381, DOI 10.1007/s00401-011-0800-8; Webb Benjamin, 2016, Curr Protoc Bioinformatics, V54, DOI [10.1002/0471140864.ps0209s50, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/cpbi.3]; Freier K, 2006, ONCOL REP, V15, P1141; GERDES J, 1992, J PATHOL, V168, P85, DOI 10.1002/path.1711680114; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Hahn H, 1996, CELL, V85, P841, DOI 10.1016/S0092-8674(00)81268-4; Hammond D, 2013, J CELL SCI, V126, P3429, DOI 10.1242/jcs.128397; HANAWALT PC, 1994, CURR BIOL, V4, P518, DOI 10.1016/S0960-9822(00)00112-3; Hao YW, 2008, J BIOL CHEM, V283, P5496, DOI 10.1074/jbc.M709037200; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Hu JC, 2015, GENE DEV, V29, P948, DOI 10.1101/gad.261271.115; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Iwasaki JK, 2012, J AM ACAD DERMATOL, V66, pE167, DOI 10.1016/j.jaad.2010.06.054; Jaju PD, 2015, J INVEST DERMATOL, V135, P3197, DOI 10.1038/jid.2015.339; Jayaraman SS, 2014, J INVEST DERMATOL, V134, P213, DOI 10.1038/jid.2013.276; KATO GJ, 1992, FASEB J, V6, P3065, DOI 10.1096/fasebj.6.12.1521738; King B, 2013, CELL, V153, P1552, DOI 10.1016/j.cell.2013.05.041; Knoepfler PS, 2006, CELL CYCLE, V5, P47, DOI 10.4161/cc.5.1.2292; Krauthammer M, 2012, NAT GENET, V44, P1006, DOI 10.1038/ng.2359; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Laurendeau I, 2010, MOL MED, V16, P262, DOI 10.2119/molmed.2010.00005; Lawrence MS, 2015, NATURE, V517, P576, DOI 10.1038/nature14129; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Lee CS, 2014, NAT GENET, V46, P1060, DOI 10.1038/ng.3091; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li LL, 2013, FEBS LETT, V587, P3921, DOI 10.1016/j.febslet.2013.10.042; Lodrini M, 2013, NUCLEIC ACIDS RES, V41, P6018, DOI 10.1093/nar/gkt346; MARIONNET C, 1995, J MOL BIOL, V252, P550, DOI 10.1006/jmbi.1995.0519; McGregor JM, 1999, J INVEST DERMATOL, V112, P317, DOI 10.1046/j.1523-1747.1999.00507.x; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Murphy AJ, 2014, PEDIATR BLOOD CANCER, V61, P198, DOI 10.1002/pbc.24788; Nikolaev S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6690; Nikolaev SI, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5654; Nikolaev SI, 2012, NAT GENET, V44, P133, DOI 10.1038/ng.1026; Nikolayeva O, 2014, METHODS MOL BIOL, V1150, P45, DOI 10.1007/978-1-4939-0512-6_3; Oue T, 2010, J PEDIATR SURG, V45, P387, DOI 10.1016/j.jpedsurg.2009.10.081; Pfister S, 2009, J CLIN ONCOL, V27, P1627, DOI 10.1200/JCO.2008.17.9432; Pomeroy SL, 2002, NATURE, V415, P436, DOI 10.1038/415436a; Pugh TJ, 2013, NAT GENET, V45, P279, DOI 10.1038/ng.2529; Reifenberger J, 2005, BRIT J DERMATOL, V152, P43, DOI 10.1111/J.1365-2133.2005.06353.X; Santos GC, 2007, J CLIN PATHOL, V60, P1, DOI 10.1136/jcp.2005.034389; Schlegelmilch K, 2011, CELL, V144, P782, DOI 10.1016/j.cell.2011.02.031; Sekulic A, 2012, NEW ENGL J MED, V366, P2171, DOI 10.1056/NEJMoa1113713; Sharpe HJ, 2015, CANCER CELL, V27, P327, DOI 10.1016/j.ccell.2015.02.001; Smith MJ, 2014, J CLIN ONCOL, V32, P4155, DOI 10.1200/JCO.2014.58.2569; Stacey SN, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7825; Stefansson B, 2007, CELL CYCLE, V6, P1386, DOI 10.4161/cc.6.11.4276; Strano S, 2007, ONCOGENE, V26, P2212, DOI 10.1038/sj.onc.1210296; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sweeney RT, 2014, NAT GENET, V46, P722, DOI 10.1038/ng.2986; Tate G, 2015, MED MOL MORPHOL, V48, P177, DOI 10.1007/s00795-014-0086-8; Valentijn LJ, 2012, P NATL ACAD SCI USA, V109, P19190, DOI 10.1073/pnas.1208215109; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Von Hoff DD, 2009, NEW ENGL J MED, V361, P1164, DOI 10.1056/NEJMoa0905360; Wang WQ, 2012, GENE DEV, V26, P1959, DOI 10.1101/gad.192955.112; Welcker M, 2004, P NATL ACAD SCI USA, V101, P9085, DOI 10.1073/pnas.0402770101; Welcker M, 2008, NAT REV CANCER, V8, P83, DOI 10.1038/nrc2290; Williams RD, 2015, ONCOTARGET, V6, P7232, DOI 10.18632/oncotarget.3377; Wilson KE, 2014, J BIOL CHEM, V289, P23693, DOI 10.1074/jbc.M113.534701; Wong YH, 2007, NUCLEIC ACIDS RES, V35, pW588, DOI 10.1093/nar/gkm322; Xiao WF, 2013, BIOCHEM BIOPH RES CO, V439, P167, DOI 10.1016/j.bbrc.2013.08.071; Xu LS, 2012, MOL CELL BIOCHEM, V364, P235, DOI 10.1007/s11010-011-1222-6; Youssef KK, 2010, NAT CELL BIOL, V12, P299, DOI 10.1038/ncb2031; Zhang HY, 2011, P NATL ACAD SCI USA, V108, P2270, DOI 10.1073/pnas.1019603108; Zhang H, 2009, J BIOL CHEM, V284, P13355, DOI 10.1074/jbc.M900843200	87	258	260	1	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2016	48	4					398	+		10.1038/ng.3525	http://dx.doi.org/10.1038/ng.3525			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DH6NZ	26950094				2022-12-25	WOS:000372908800011
J	Joyal, JS; Sun, Y; Gantner, ML; Shao, Z; Evans, LP; Saba, N; Fredrick, T; Burnim, S; Kim, JS; Patel, G; Juan, AM; Hurst, CG; Hatton, CJ; Cui, ZH; Pierce, KA; Bherer, P; Aguilar, E; Powner, MB; Vevis, K; Boisvert, M; Fu, ZJ; Levy, E; Fruttiger, M; Packard, A; Rezende, FA; Maranda, B; Sapieha, P; Chen, J; Friedlander, M; Clish, CB; Smith, LEH				Joyal, Jean-Sebastien; Sun, Ye; Gantner, Marin L.; Shao, Zhuo; Evans, Lucy P.; Saba, Nicholas; Fredrick, Thomas; Burnim, Samuel; Kim, Jin Sung; Patel, Gauri; Juan, Aimee M.; Hurst, Christian G.; Hatton, Colman J.; Cui, Zhenghao; Pierce, Kerry A.; Bherer, Patrick; Aguilar, Edith; Powner, Michael B.; Vevis, Kristis; Boisvert, Michel; Fu, Zhongjie; Levy, Emile; Fruttiger, Marcus; Packard, Alan; Rezende, Flavio A.; Maranda, Bruno; Sapieha, Przemyslaw; Chen, Jing; Friedlander, Martin; Clish, Clary B.; Smith, Lois E. H.			Retinal lipid and glucose metabolism dictates angiogenesis through the lipid sensor Ffar1	NATURE MEDICINE			English	Article							ENERGY-METABOLISM; RECEPTOR GPR40; INSULIN-SECRETION; FATTY-ACIDS; EXPRESSION; RETINOPATHY; DEGENERATION; NEOVASCULARIZATION; INFLAMMATION; TUMORS	Tissues with high metabolic rates often use lipids, as well as glucose, for energy, conferring a survival advantage during feast and famine(1). Current dogma suggests that high-energy-consuming photoreceptors depend on glucose(2,3). Here we show that the retina also uses fatty acid beta-oxidation for energy. Moreover, we identify a lipid sensor, free fatty acid receptor 1 (Ffar1), that curbs glucose uptake when fatty acids are available. Very-low-density lipoprotein receptor (Vldlr), which is present in photoreceptors(4) and is expressed in other tissues with a high metabolic rate, facilitates the uptake of triglyceride-derived fatty acid(5,6). In the retinas of Vldlr(-/-) mice with low fatty acid uptake(6) but high circulating lipid levels, we found that Ffar1 suppresses expression of the glucose transporter Glut1. Impaired glucose entry into photoreceptors results in a dual (lipid and glucose) fuel shortage and a reduction in the levels of the Krebs cycle intermediate alpha-ketoglutarate (alpha-KG). Low alpha-KG levels promotes stabilization of hypoxia-induced factor 1a (Hif1a) and secretion of vascular endothelial growth factor A (Vegfa) by starved Vldlr(-/-) photoreceptors, leading to neovascularization. The aberrant vessels in the Vldlr(-/) retinas, which invade normally avascular photoreceptors, are reminiscent of the vascular defects in retinal angiomatous proliferation, a subset of neovascular age-related macular degeneration (AMD)(7), which is associated with high vitreous VEGFA levels in humans. Dysregulated lipid and glucose photoreceptor energy metabolism may therefore be a driving force in macular telangiectasia, neovascular AMD and other retinal diseases.	[Joyal, Jean-Sebastien] Univ Montreal, Dept Pediat, Ctr Hosp Univ CHU St Justine Res Ctr, Montreal, PQ H3C 3J7, Canada; [Joyal, Jean-Sebastien; Patel, Gauri] Univ Montreal, Dept Pharmacol, Montreal, PQ H3C 3J7, Canada; [Joyal, Jean-Sebastien; Kim, Jin Sung] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ, Canada; [Sun, Ye; Shao, Zhuo; Evans, Lucy P.; Saba, Nicholas; Fredrick, Thomas; Burnim, Samuel; Juan, Aimee M.; Hurst, Christian G.; Hatton, Colman J.; Cui, Zhenghao; Fu, Zhongjie; Chen, Jing; Smith, Lois E. H.] Harvard Univ, Sch Med, Boston Childrens Hosp, Dept Ophthalmol, Boston, MA 02115 USA; [Gantner, Marin L.] Lowy Med Res Inst, La Jolla, CA USA; [Pierce, Kerry A.; Clish, Clary B.] Broad Inst Massachusetts Inst Technol MIT & Harva, Metabolite Profiling Platform, Cambridge, MA 02139 USA; [Bherer, Patrick; Maranda, Bruno] Univ Sherbrooke, Dept Genet, Sherbrooke, PQ J1K 2R1, Canada; [Aguilar, Edith; Friedlander, Martin] Scripps Res Inst, Dept Cell & Mol Biol, La Jolla, CA 92037 USA; [Powner, Michael B.; Vevis, Kristis; Fruttiger, Marcus] UCL, Inst Ophthalmol, London, England; [Boisvert, Michel; Levy, Emile] Univ Montreal, Ctr Hosp Univ CHU St Justine Res Ctr, Dept Nutr, Montreal, PQ, Canada; [Packard, Alan] Harvard Univ, Sch Med, Dept Radiol, Boston Childrens Hosp, Boston, MA 02115 USA; [Rezende, Flavio A.; Sapieha, Przemyslaw] Univ Montreal, Maisonneuve Rosemont Hosp Res Ctr, Dept Ophthalmol, Montreal, PQ, Canada	Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Universite de Montreal; McGill University; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Sherbrooke; Scripps Research Institute; University of London; University College London; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Harvard University; Boston Children's Hospital; Harvard Medical School; Universite de Montreal	Joyal, JS (corresponding author), Univ Montreal, Dept Pediat, Ctr Hosp Univ CHU St Justine Res Ctr, Montreal, PQ H3C 3J7, Canada.; Joyal, JS (corresponding author), Univ Montreal, Dept Pharmacol, Montreal, PQ H3C 3J7, Canada.; Joyal, JS (corresponding author), McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ, Canada.; Smith, LEH (corresponding author), Harvard Univ, Sch Med, Boston Childrens Hosp, Dept Ophthalmol, Boston, MA 02115 USA.	js.joyal@umontreal.ca; lois.smith@childrens.harvard.edu	Clish, Clary B/ABB-9374-2021; Clish, Clary/AAB-7124-2019; Powner, Michael/CAG-7455-2022	Clish, Clary B/0000-0001-8259-9245; FU, ZHONGJIE/0000-0002-8182-2983; Fruttiger, Marcus/0000-0002-6962-5485; Juan, Aimee/0000-0002-0221-2280; Powner, Michael/0000-0003-4913-1004; Sun, Ye/0000-0002-7674-9056	US National Institutes of Health (NIH) [EY024864, EY017017, EY022275, P01 HD18655, EY024963, EY11254]; Lowy Medical Research Institute; European Commission FP7 project PREVENT-ROP [305485]; Burroughs Wellcome Fund Career Award for Medical Scientists; Foundation Fighting Blindness; Canadian Institute of Health Research (CIHR) grant [143077]; Fonds de Recherche du Quebec-Sante (FRQS); Canadian Child Health Clinician Scientist Program; CIHR New Investigator Award; Knights Templar Eye Foundation; Bernadotte Foundation; Canada Research chair and CIHR grant [221478]; Boston Children's Hospital Ophthalmology Foundation; Boston Children's Hospital Faculty Career Development Award; Bright Focus Foundation; Massachussetts Lions Eye Research Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655, U54HD090255] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R24EY024864, R01EY011254, R01EY017017, R01EY008670, R01EY022275, R01EY024963] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lowy Medical Research Institute; European Commission FP7 project PREVENT-ROP; Burroughs Wellcome Fund Career Award for Medical Scientists(Burroughs Wellcome Fund); Foundation Fighting Blindness(European Commission); Canadian Institute of Health Research (CIHR) grant(Canadian Institutes of Health Research (CIHR)); Fonds de Recherche du Quebec-Sante (FRQS); Canadian Child Health Clinician Scientist Program; CIHR New Investigator Award(Canadian Institutes of Health Research (CIHR)); Knights Templar Eye Foundation; Bernadotte Foundation; Canada Research chair and CIHR grant; Boston Children's Hospital Ophthalmology Foundation; Boston Children's Hospital Faculty Career Development Award; Bright Focus Foundation(BrightFocus Foundation); Massachussetts Lions Eye Research Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the US National Institutes of Health (NIH) grants EY024864 (L.E.H.S.), EY017017 (L.E.H.S.), EY022275 (L.E.H.S.), P01 HD18655 (L.E.H.S.) and EY024963 (J.C.) and EY11254 (M. Friedlander), the Lowy Medical Research Institute (M. Friedlander, L.E.H.S. and M. Fruttiger), the European Commission FP7 project 305485 PREVENT-ROP (L.E.H.S.), a Burroughs Wellcome Fund Career Award for Medical Scientists (J.-S.J.), the Foundation Fighting Blindness (J.-S.J.), the Canadian Institute of Health Research (CIHR) grant 143077 (J.-S.J.), the Fonds de Recherche du Quebec-Sante (FRQS) (J.-S.J.), the Canadian Child Health Clinician Scientist Program (J.-S.J.), a CIHR New Investigator Award (J.-S.J.), the Knights Templar Eye Foundation (Z.F.), the Bernadotte Foundation (Z.F.), the Canada Research chair and CIHR grant 221478 (P.S.), the Boston Children's Hospital Ophthalmology Foundation (J.C.), a Boston Children's Hospital Faculty Career Development Award (J.C.), the Bright Focus Foundation (J.C.) and the Massachussetts Lions Eye Research Fund, Inc. (J.C.). We thank M. Puder and P. Nandivada (Harvard Medical School, Boston Children's Hospital) for sharing the Ffar1<SUP>-/-</SUP> mice; M. Al-Ubaidi (University of Oklahoma) for sharing the 661W photoreceptor cells; Z. Lin and W.T. Pu (Harvard Medical School, Boston Children's Hospital) for sharing a modified CAG-GFP-miR30 construct; and C. Cepko (Harvard Medical School) and T. Li (National Eye Institute) for providing the pAAV-RK-GFP vector.	Alquier T, 2009, DIABETES, V58, P2607, DOI 10.2337/db09-0362; ALUBAIDI MR, 1992, J CELL BIOL, V119, P1681, DOI 10.1083/jcb.119.6.1681; Bottoni F, 2005, ARCH OPHTHALMOL-CHIC, V123, P1644, DOI 10.1001/archopht.123.12.1644; Briscoe CP, 2003, J BIOL CHEM, V278, P11303, DOI 10.1074/jbc.M211495200; Cahill G F Jr, 1970, N Engl J Med, V282, P668, DOI 10.1056/NEJM197003052821026; Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985; Chen Y, 2009, MICROVASC RES, V78, P119, DOI 10.1016/j.mvr.2009.02.005; COHEN LH, 1960, J NEUROCHEM, V5, P253, DOI 10.1111/j.1471-4159.1960.tb13363.x; Committee for the Update of the Guide for the Care and Use of Laboratory Animals; National Research Council, 2011, GUIDE CARE USE LAB A; Deerinck T. J., 2010, MICROSC MICROANAL, V16, P1138, DOI [10.1017/S1431927610055170, DOI 10.1017/S1431927610055170]; Dorrell MI, 2009, J CLIN INVEST, V119, P611, DOI 10.1172/JCI35977; FERRANNINI E, 1983, J CLIN INVEST, V72, P1737, DOI 10.1172/JCI111133; Fletcher AL, 2012, MOL GENET METAB, V106, P18, DOI 10.1016/j.ymgme.2012.02.015; Furukawa T, 1997, CELL, V91, P531, DOI 10.1016/S0092-8674(00)80439-0; Gospe SM, 2010, J CELL SCI, V123, P3639, DOI 10.1242/jcs.072389; Goudriaan JR, 2004, J LIPID RES, V45, P1475, DOI 10.1194/jlr.M400009-JLR200; Grieger JC, 2006, NAT PROTOC, V1, P1412, DOI 10.1038/nprot.2006.207; Honore JC, 2013, ARTERIOSCL THROM VAS, V33, P954, DOI 10.1161/ATVBAHA.112.300943; Hu WZ, 2008, INVEST OPHTH VIS SCI, V49, P407, DOI 10.1167/iovs.07-0870; Itoh Y, 2003, NATURE, V422, P173, DOI 10.1038/nature01478; Jain M, 2012, SCIENCE, V336, P1040, DOI 10.1126/science.1218595; Kaelin WG, 2011, COLD SH Q B, V76, P335, DOI 10.1101/sqb.2011.76.010975; Kebede M, 2008, DIABETES, V57, P2432, DOI 10.2337/db08-0553; Keech AC, 2007, LANCET, V370, P1687, DOI 10.1016/S0140-6736(07)61607-9; Khani SC, 2007, INVEST OPHTH VIS SCI, V48, P3954, DOI 10.1167/iovs.07-0257; Klepper J, 2008, EPILEPSIA, V49, P46, DOI 10.1111/j.1528-1167.2008.01833.x; Lefebvre P, 2006, J CLIN INVEST, V116, P571, DOI 10.1172/JCI27989; Lim LS, 2012, LANCET, V379, P1728, DOI 10.1016/S0140-6736(12)60282-7; Lopaschuk GD, 2010, PHYSIOL REV, V90, P207, DOI 10.1152/physrev.00015.2009; MANTYCH GJ, 1993, ENDOCRINOLOGY, V133, P600, DOI 10.1210/en.133.2.600; Naik H, 2012, J CLIN PHARMACOL, V52, P1007, DOI 10.1177/0091270011409230; Nakamura MT, 2014, PROG LIPID RES, V53, P124, DOI 10.1016/j.plipres.2013.12.001; Niu YG, 2011, J LIPIDS, V2011, DOI 10.1155/2011/189876; Obunike JC, 2001, J BIOL CHEM, V276, P8934, DOI 10.1074/jbc.M008813200; Ohno-Matsui K, 2002, AM J PATHOL, V160, P711, DOI 10.1016/S0002-9440(10)64891-2; Okawa H, 2008, CURR BIOL, V18, P1917, DOI 10.1016/j.cub.2008.10.029; Park YK, 2008, NUCLEIC ACIDS RES, V36, pW97, DOI 10.1093/nar/gkn280; Sarac O, 2012, OPHTHALMIC GENET, V33, P249, DOI 10.3109/13816810.2012.689412; Spahis S, 2015, PROSTAG LEUKOTR ESS, V99, P25, DOI 10.1016/j.plefa.2015.04.010; Stahl A, 2009, ANGIOGENESIS, V12, P297, DOI 10.1007/s10456-009-9155-3; Stahl A, 2010, AM J PATHOL, V177, P2715, DOI 10.2353/ajpath.2010.100526; Steneberg R, 2005, CELL METAB, V1, P245, DOI 10.1016/j.cmet.2005.03.007; Tan E, 2004, INVEST OPHTH VIS SCI, V45, P764, DOI 10.1167/iovs.03-1114; Townsend MK, 2013, CLIN CHEM, V59, P1657, DOI 10.1373/clinchem.2012.199133; Trick GL, 2005, PROG RETIN EYE RES, V24, P259, DOI 10.1016/j.preteyeres.2004.08.001; Tyni T, 2004, PEDIATR RES, V56, P744, DOI 10.1203/01.PDR.0000141967.52759.83; Vandenberghe LH, 2010, HUM GENE THER, V21, P1251, DOI 10.1089/hum.2010.107; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wauson EM, 2013, MOL ENDOCRINOL, V27, P1188, DOI 10.1210/me.2013-1100; WINKLER BS, 1981, J GEN PHYSIOL, V77, P667, DOI 10.1085/jgp.77.6.667; Wong-Riley M, 2010, EYE BRAIN, V2, P99; Yannuzzi Lawrence A, 2012, Retina, V32 Suppl 1, P450; Zhao SM, 2009, SCIENCE, V324, P261, DOI 10.1126/science.1170944; Zhou XH, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016733, 10.1371/journal.pone.0017812]	54	142	146	3	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2016	22	4					439	+		10.1038/nm.4059	http://dx.doi.org/10.1038/nm.4059			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DI4GF	26974308	Green Submitted, Green Accepted			2022-12-25	WOS:000373457700021
J	Drier, Y; Cotton, MJ; Williamson, KE; Gillespie, SM; Ryan, RJH; Kluk, MJ; Carey, CD; Rodig, SJ; Sholl, LM; Afrogheh, AH; Faquin, WC; Queimado, L; Qi, J; Wick, MJ; El-Naggar, AK; Bradner, JE; Moskaluk, CA; Asters, JC; Knoechel, B; Bernstein, BE				Drier, Yotam; Cotton, Matthew J.; Williamson, Kaylyn E.; Gillespie, Shawn M.; Ryan, Russell J. H.; Kluk, Michael J.; Carey, Christopher D.; Rodig, Scott J.; Sholl, Lynette M.; Afrogheh, Amir H.; Faquin, William C.; Queimado, Lurdes; Qi, Jun; Wick, Michael J.; El-Naggar, Adel K.; Bradner, James E.; Moskaluk, Christopher A.; Asters, Jon C.; Knoechel, Birgit; Bernstein, Bradley E.			An oncogenic MYB feedback loop drives alternate cell fates in adenoid cystic carcinoma	NATURE GENETICS			English	Article							TRANSCRIPTION FACTOR GENES; SELECTIVE-INHIBITION; RECURRENT FUSION; SUPER-ENHANCERS; BREAST-CANCER; TARGET GENES; EXPRESSION; P63; LEUKEMIA; NOTCH	Translocation events are frequent in cancer and may create chimeric fusions or 'regulatory rearrangements' that drive oncogene overexpression. Here we identify super-enhancer translocations that drive overexpression of the oncogenic transcription factor MYB as a recurrent theme in adenoid cystic carcinoma (ACC). Whole-genome sequencing data and chromatin maps highlight distinct chromosomal rearrangements that juxtapose super-enhancers to the MYB locus. Chromosome conformation capture confirms that the translocated enhancers interact with the MYB promoter. Remarkably, MYB protein binds to the translocated enhancers, creating a positive feedback loop that sustains its expression. MYB also binds enhancers that drive different regulatory programs in alternate cell lineages in ACC, cooperating with TP63 in myoepithelial cells and a Notch program in lumina! epithelial cells. Bromodomain inhibitors slow tumor growth in ACC primagraft models in vivo. Thus, our study identifies super-enhancer translocations that drive MYB expression and provides insight into downstream MYB functions in alternate ACC lineages.	[Drier, Yotam; Cotton, Matthew J.; Williamson, Kaylyn E.; Gillespie, Shawn M.; Ryan, Russell J. H.; Knoechel, Birgit; Bernstein, Bradley E.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Drier, Yotam; Cotton, Matthew J.; Williamson, Kaylyn E.; Gillespie, Shawn M.; Ryan, Russell J. H.; Kluk, Michael J.; Carey, Christopher D.; Rodig, Scott J.; Sholl, Lynette M.; Asters, Jon C.; Knoechel, Birgit; Bernstein, Bradley E.] Harvard Univ, Sch Med, Boston, MA USA; [Drier, Yotam; Cotton, Matthew J.; Williamson, Kaylyn E.; Gillespie, Shawn M.; Ryan, Russell J. H.; Bernstein, Bradley E.] Massachusetts Gen Hosp, Ctr Canc Res, Boston, MA 02114 USA; [Drier, Yotam; Cotton, Matthew J.; Williamson, Kaylyn E.; Gillespie, Shawn M.; Ryan, Russell J. H.; Bradner, James E.; Knoechel, Birgit; Bernstein, Bradley E.] Broad Inst MIT & Harvard, Cambridge, MA USA; [Drier, Yotam; Cotton, Matthew J.; Williamson, Kaylyn E.; Gillespie, Shawn M.; Ryan, Russell J. H.; Bernstein, Bradley E.] Howard Hughes Med Inst, Chevy Chase, MD USA; [Kluk, Michael J.; Carey, Christopher D.; Rodig, Scott J.; Sholl, Lynette M.; Asters, Jon C.] Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA; [Queimado, Lurdes] Univ Oklahoma, Hlth Sci Ctr, Dept Otorhinolaryngol, Oklahoma City, OK USA; [Qi, Jun] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Wick, Michael J.] South Texas Accelerated Res Therapeut, San Antonio, TX USA; [El-Naggar, Adel K.] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Moskaluk, Christopher A.] Univ Virginia, Hlth Sci Ctr, Dept Pathol, Charlottesville, VA USA; [Knoechel, Birgit] Boston Childrens Hosp, Div Hematol Oncol, Boston, MA USA; [Knoechel, Birgit] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Howard Hughes Medical Institute; Harvard University; Brigham & Women's Hospital; University of Oklahoma System; University of Oklahoma Health Sciences Center; Harvard University; Dana-Farber Cancer Institute; University of Texas System; UTMD Anderson Cancer Center; University of Virginia; Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute	Knoechel, B; Bernstein, BE (corresponding author), Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA.; Knoechel, B; Bernstein, BE (corresponding author), Harvard Univ, Sch Med, Boston, MA USA.; Knoechel, B; Bernstein, BE (corresponding author), Massachusetts Gen Hosp, Ctr Canc Res, Boston, MA 02114 USA.; Knoechel, B; Bernstein, BE (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA USA.; Bernstein, BE (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD USA.; Knoechel, B (corresponding author), Boston Childrens Hosp, Div Hematol Oncol, Boston, MA USA.; Knoechel, B (corresponding author), Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA.	birgit_knoechel@dfci.harvard.edu; bernstein.bradley@mgh.harvard.edu	Queimado, Lurdes/L-7465-2013; Drier, Yotam/K-5208-2012; Rodig, Scott/Y-3889-2019; Queimado, Lurdes/AAY-2545-2021	Queimado, Lurdes/0000-0002-1106-4873; Drier, Yotam/0000-0003-1725-2995; Queimado, Lurdes/0000-0002-1106-4873; Ryan, Russell/0000-0001-8174-3962; Carey, Christopher/0000-0002-4293-3920; Williamson, Kaylyn/0000-0002-3252-5050; Gillespie, Shawn/0000-0003-1913-0860	National Institute of Dental and Craniofacial Research (NIDCR) [HHSN268200900039C 04]; Adenoid Cystic Carcinoma Research Foundation; Temares Family Foundation; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006991] Funding Source: NIH RePORTER	National Institute of Dental and Craniofacial Research (NIDCR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Adenoid Cystic Carcinoma Research Foundation; Temares Family Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank M. Rivera, N. Riggi, S. Puram, P. van Galen, J. Lohr and J. Kaufman for helpful discussions and critical comments on the manuscript; J. Voisine, R. Isenhart, R. Issner, H. Whitton, A. Spooner, M. Uziel, C. Epstein and N. Shoresh for technical assistance; T. Chan and V. Makarov for help with wholegenome sequencing data access; and the Salivary Gland Tumor Biorepository for providing the primary tumors (National Institute of Dental and Craniofacial Research (NIDCR) award reference HHSN268200900039C 04). This work was supported by the Adenoid Cystic Carcinoma Research Foundation (B.E.B. and B.K.), the Temares Family Foundation and the Howard Hughes Medical Institute. B.E.B. is an American Cancer Society Research Professor.	Adelstein DJ, 2012, SEMIN RADIAT ONCOL, V22, P245, DOI 10.1016/j.semradonc.2012.03.009; Barbareschi M, 2001, AM J SURG PATHOL, V25, P1054, DOI 10.1097/00000478-200108000-00010; Bell D, 2012, CANCER-AM CANCER SOC, V118, P1288, DOI 10.1002/cncr.26412; Bell D, 2011, CANCER BIOL THER, V12, P569, DOI 10.4161/cbt.12.7.17008; Brill LB, 2011, MODERN PATHOL, V24, P1169, DOI 10.1038/modpathol.2011.86; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Groschel S, 2014, CELL, V157, P369, DOI 10.1016/j.cell.2014.02.019; Haydu JE, 2012, BLOOD, V119, P5211, DOI 10.1182/blood-2011-10-388504; Ho AS, 2013, NAT GENET, V45, P791, DOI 10.1038/ng.2643; Knoechel B, 2014, NAT GENET, V46, P364, DOI 10.1038/ng.2913; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Mansour MR, 2014, SCIENCE, V346, P1373, DOI 10.1126/science.1259037; Mitani Y, 2011, AM J PATHOL, V179, P391, DOI 10.1016/j.ajpath.2011.03.037; Mitani Y, 2010, CLIN CANCER RES, V16, P4722, DOI 10.1158/1078-0432.CCR-10-0463; Moll UM, 2004, MOL CANCER RES, V2, P371; Moskaluk CA, 2011, LAB INVEST, V91, P1480, DOI 10.1038/labinvest.2011.105; Nguyen BC, 2006, GENE DEV, V20, P1028, DOI 10.1101/gad.1406006; NICOLAIDES NC, 1991, MOL CELL BIOL, V11, P6166, DOI 10.1128/MCB.11.12.6166; NOMURA T, 1993, J BIOL CHEM, V268, P21914; Northcott PA, 2014, NATURE, V511, P428, DOI 10.1038/nature13379; OHNO H, 1990, P NATL ACAD SCI USA, V87, P628, DOI 10.1073/pnas.87.2.628; Persson M, 2009, P NATL ACAD SCI USA, V106, P18740, DOI 10.1073/pnas.0909114106; Queimado L, 1999, INT J CANCER, V81, P793, DOI 10.1002/(SICI)1097-0215(19990531)81:5<793::AID-IJC21>3.0.CO;2-4; Quintana AM, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-30; RABBITTS TH, 1994, NATURE, V372, P143, DOI 10.1038/372143a0; Ramsay RG, 2008, NAT REV CANCER, V8, P523, DOI 10.1038/nrc2439; Rivera CM, 2013, CELL, V155, P39, DOI 10.1016/j.cell.2013.09.011; Robinson DR, 2011, NAT MED, V17, P1646, DOI 10.1038/nm.2580; Roe JS, 2015, MOL CELL, V58, P1028, DOI 10.1016/j.molcel.2015.04.011; Sato K, 2006, VIRCHOWS ARCH, V448, P204, DOI 10.1007/s00428-005-0054-8; Stephens PJ, 2013, J CLIN INVEST, V123, P2965, DOI 10.1172/JCI67201; Stoeck A, 2014, CANCER DISCOV, V4, P1154, DOI 10.1158/2159-8290.CD-13-0830; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Yalcin-Ozuysal O, 2010, CELL DEATH DIFFER, V17, P1600, DOI 10.1038/cdd.2010.37; YAMAMOTO Y, 1992, J LARYNGOL OTOL, V106, P1016, DOI 10.1017/S0022215100121656; Zhao L, 2011, NUCLEIC ACIDS RES, V39, P4664, DOI 10.1093/nar/gkr024	38	148	155	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2016	48	3					265	272		10.1038/ng.3502	http://dx.doi.org/10.1038/ng.3502			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DE8QW	26829750	Green Accepted, Green Submitted			2022-12-25	WOS:000370902600010
J	Chang, MT; Asthana, S; Gao, SP; Lee, BH; Chapman, JS; Kandoth, C; Gao, JJ; Socci, ND; Solit, DB; Olshen, AB; Schultz, N; Taylor, BS				Chang, Matthew T.; Asthana, Saurabh; Gao, Sizhi Paul; Lee, Byron H.; Chapman, Jocelyn S.; Kandoth, Cyriac; Gao, JianJiong; Socci, Nicholas D.; Solit, David B.; Olshen, Adam B.; Schultz, Nikolaus; Taylor, Barry S.			Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity	NATURE BIOTECHNOLOGY			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; LUNG-CANCER; TUMOR TYPES; METASTATIC MELANOMA; SIGNALING PATHWAYS; BREAST CANCERS; PROTEIN TC21; CELL-LINE; RAS; SENSITIVITY	Mutational hotspots indicate selective pressure across a population of tumor samples, but their prevalence within and across cancer types is incompletely characterized. An approach to detect significantly mutated residues, rather than methods that identify recurrently mutated genes, may uncover new biologically and therapeutically relevant driver mutations. Here, we developed a statistical algorithm to identify recurrently mutated residues in tumor samples. We applied the algorithm to 11,119 human tumors, spanning 41 cancer types, and identified 470 somatic substitution hotspots in 275 genes. We find that half of all human tumors possess one or more mutational hotspots with widespread lineage-, position-and mutant allele-specific differences, many of which are likely functional. In total, 243 hotspots were novel and appeared to affect a broad spectrum of molecular function, including hotspots at paralogous residues of Ras-related small GTPases RAC1 and RRAS2. Redefining hotspots at mutant amino acid resolution will help elucidate the allele-specific differences in their function and could have important therapeutic implications.	[Chang, Matthew T.; Gao, Sizhi Paul; Solit, David B.; Taylor, Barry S.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USA; [Chang, Matthew T.; Schultz, Nikolaus; Taylor, Barry S.] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA; [Chang, Matthew T.] Univ Calif San Francisco, Dept Bioengn, San Francisco, CA 94143 USA; [Chang, Matthew T.] Univ Calif San Francisco, Dept Therapeut Sci, San Francisco, CA 94143 USA; [Asthana, Saurabh] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Lee, Byron H.] Mem Sloan Kettering Canc Ctr, Dept Surg, 1275 York Ave, New York, NY 10021 USA; [Chapman, Jocelyn S.] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA USA; [Kandoth, Cyriac; Gao, JianJiong; Socci, Nicholas D.; Solit, David B.; Schultz, Nikolaus; Taylor, Barry S.] Mem Sloan Kettering Canc Ctr, Marie Josee & Henry R Kravis Ctr Mol Oncol, 1275 York Ave, New York, NY 10021 USA; [Socci, Nicholas D.] Mem Sloan Kettering Canc Ctr, Bioinformat Core, 1275 York Ave, New York, NY 10021 USA; [Solit, David B.] Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA; [Solit, David B.] Cornell Univ, Weill Cornel Med Coll, New York, NY 10021 USA; [Olshen, Adam B.] Univ Calif San Francisco, Epidemiol & Biostat, San Francisco, CA 94143 USA; [Olshen, Adam B.] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Memorial Sloan Kettering Cancer Center; University of California System; University of California San Francisco; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center	Taylor, BS (corresponding author), Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USA.; Taylor, BS (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA.; Taylor, BS (corresponding author), Mem Sloan Kettering Canc Ctr, Marie Josee & Henry R Kravis Ctr Mol Oncol, 1275 York Ave, New York, NY 10021 USA.	taylorb@mskcc.org	wang, edwin/G-5372-2010; Solit, David B./AAC-5309-2019; Schultz, Nikolaus/ABE-6347-2020; Gao, JianJiong/B-5673-2016	Gao, JianJiong/0000-0002-5739-1781; Lee, Byron/0000-0002-8755-9688; Kandoth, Cyriac/0000-0002-1345-3573; Solit, David/0000-0002-6614-802X	US National Institutes of Health (NIH) [T32 GM007175]; NIH [P30 CA82103]; NIH Core Grant [P30 CA008748]; Josie Robertson Foundation; Prostate Cancer Foundation; Sontag Foundation; Cycle for Survival; NATIONAL CANCER INSTITUTE [P30CA082103, P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007175] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Core Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Josie Robertson Foundation; Prostate Cancer Foundation; Sontag Foundation; Cycle for Survival; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank the members of the Taylor and Schultz laboratories and members of the Marie-Josee and Henry R. Kravis Center for Molecular Oncology for useful discussions throughout this work. M.T.C. was supported by the US National Institutes of Health (NIH) training grant T32 GM007175 and A.B.O. was supported by NIH grant P30 CA82103. This work has been further supported by an NIH Core Grant (P30 CA008748, PI: Thompson); the Josie Robertson and Prostate Cancer Foundations (N.S. and B.S.T.), the Sontag Foundation and Cycle for Survival (B.S.T.).	Al-Ahmadie H, 2014, CANCER DISCOV, V4, P1014, DOI 10.1158/2159-8290.CD-14-0380; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Bao L, 2014, BIOINFORMATICS, V30, P1056, DOI 10.1093/bioinformatics/btt759; Barker KT, 1998, BRIT J CANCER, V78, P296, DOI 10.1038/bjc.1998.490; Benjamini Y, 2001, ANN STAT, V29, P1165; Burd CE, 2014, CANCER DISCOV, V4, P1418, DOI 10.1158/2159-8290.CD-14-0729; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Cheng DT, 2015, J MOL DIAGN, V17, P251, DOI 10.1016/j.jmoldx.2014.12.006; Cheung LWT, 2014, CANCER CELL, V26, P479, DOI 10.1016/j.ccell.2014.08.017; Clark GJ, 1996, ONCOGENE, V12, P169; de Bruin EC, 2014, SCIENCE, V346, P251, DOI 10.1126/science.1253462; Ehrhardt A, 2002, EXP HEMATOL, V30, P1089, DOI 10.1016/S0301-472X(02)00904-9; Erdogan M, 2007, J BIOL CHEM, V282, P27713, DOI 10.1074/jbc.M703037200; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Garassino MC, 2011, ANN ONCOL, V22, P235, DOI 10.1093/annonc/mdq680; Garraway LA, 2013, CELL, V153, P17, DOI 10.1016/j.cell.2013.03.002; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Gonzalez-Perez A, 2013, NAT METHODS, V10, P1081, DOI [10.1038/NMETH.2642, 10.1038/nmeth.2642]; Grabiner BC, 2014, CANCER DISCOV, V4, P554, DOI 10.1158/2159-8290.CD-13-0929; Hart T, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145216; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; HUANG Y, 1995, ONCOGENE, V11, P1255; Ihle NT, 2012, JNCI-J NATL CANCER I, V104, P228, DOI 10.1093/jnci/djr523; Iyer G, 2012, SCIENCE, V338, P221, DOI 10.1126/science.1226344; Jaiswal BS, 2013, CANCER CELL, V23, P603, DOI 10.1016/j.ccr.2013.04.012; Janakiraman M, 2010, CANCER RES, V70, P5901, DOI 10.1158/0008-5472.CAN-10-0192; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Karolchik D, 2014, NUCLEIC ACIDS RES, V42, pD764, DOI 10.1093/nar/gkt1168; Krauthammer M, 2012, NAT GENET, V44, P1006, DOI 10.1038/ng.2359; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Lee CS, 2014, NAT GENET, V46, P1060, DOI 10.1038/ng.3091; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; Menzies AM, 2012, CLIN CANCER RES, V18, P3242, DOI 10.1158/1078-0432.CCR-12-0052; Mullighan CG, 2011, NATURE, V471, P235, DOI 10.1038/nature09727; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nik-Zainal S, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.023; Rong R, 2002, ONCOGENE, V21, P1062, DOI 10.1038/sj.onc.1205154; Rosario M, 1999, EMBO J, V18, P1270, DOI 10.1093/emboj/18.5.1270; Rosario M, 2001, MOL CELL BIOL, V21, P3750, DOI 10.1128/MCB.21.11.3750-3762.2001; Santarius T, 2010, NAT REV CANCER, V10, P59, DOI 10.1038/nrc2771; Tamborero D, 2013, SCI REP-UK, V3, DOI 10.1038/srep02650; Van Allen EM, 2014, CANCER DISCOV, V4, P94, DOI 10.1158/2159-8290.CD-13-0617; Vivanco I, 2012, CANCER DISCOV, V2, P458, DOI 10.1158/2159-8290.CD-11-0284; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Watson IR, 2014, CANCER RES, V74, P4845, DOI 10.1158/0008-5472.CAN-14-1232-T; Weinstein JN, 2014, NATURE, V507, P315, DOI 10.1038/nature12965; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Westcott PMK, 2015, NATURE, V517, P489, DOI 10.1038/nature13898; Whitehall VLJ, 2012, INT J CANCER, V131, P813, DOI 10.1002/ijc.26440; Yu HA, 2015, J THORAC ONCOL, V10, P431, DOI 10.1097/JTO.0000000000000432	52	464	469	1	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2016	34	2					155	+		10.1038/nbt.3391	http://dx.doi.org/10.1038/nbt.3391			11	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DD0OK	26619011	Green Accepted, Bronze, Green Submitted			2022-12-25	WOS:000369619100017
J	Du, Y; Yamaguchi, H; Wei, Y; Hsu, JL; Wang, HL; Hsu, YH; Lin, WC; Yu, WH; Leonard, PG; Lee, GR; Chen, MK; Nakai, K; Hsu, MC; Chen, CT; Sun, Y; Wu, Y; Chang, WC; Huang, WC; Liu, CL; Chang, YC; Chen, CH; Park, M; Jones, P; Hortobagyi, GN; Hung, MC				Du, Yi; Yamaguchi, Hirohito; Wei, Yongkun; Hsu, Jennifer L.; Wang, Hung-Ling; Hsu, Yi-Hsin; Lin, Wan-Chi; Yu, Wen-Hsuan; Leonard, Paul G.; Lee, Gilbert R.; Chen, Mei-Kuang; Nakai, Katsuya; Hsu, Ming-Chuan; Chen, Chun-Te; Sun, Ye; Wu, Yun; Chang, Wei-Chao; Huang, Wen-Chien; Liu, Chien-Liang; Chang, Yuan-Ching; Chen, Chung-Hsuan; Park, Morag; Jones, Philip; Hortobagyi, Gabriel N.; Hung, Mien-Chie			Blocking c-Met-mediated PARP1 phosphorylation enhances anti-tumor effects of PARP inhibitors	NATURE MEDICINE			English	Article							NEGATIVE BREAST-CANCER; OXIDATIVE DNA-DAMAGE; POLY(ADP-RIBOSE) POLYMERASE; CELLS; TRAFFICKING; GROWTH; REPAIR; INSTABILITY; CARCINOMA; FEATURES	Poly (ADP-ribose) polymerase (PARP) inhibitors have emerged as promising therapeutics for many diseases, including cancer, in clinical trials'. One PARP inhibitor, olaparib (Lynparza, AstraZeneca), was recently approved by the FDA to treat ovarian cancer with mutations in BRCA genes. BRCA1 and BRCA2 have essential roles in repairing DNA double-strand breaks, and a deficiency of BRCA proteins sensitizes cancer cells to PARP inhibition(2,3). Here we show that the receptor tyrosine kinase c-Met associates with and phosphorylates PARP1 at Tyr907 (PARP1 pTyr907 or pY907). PARP1 pY907 increases PARP1 enzymatic activity and reduces binding to a PARP inhibitor, thereby rendering cancer cells resistant to PARP inhibition. The combination of c-Met and PARP1 inhibitors synergized to suppress the growth of breast cancer cells in vitro and xenograft tumor models, and we observed similar synergistic effects in a lung cancer xenograft tumor model. These results suggest that the abundance of PARP1 pY907 may predict tumor resistance to PARP inhibitors, and that treatment with a combination of c-Met and PARP inhibitors may benefit patients whose tumors show high c-Met expression and who do not respond to PARP inhibition alone.	[Du, Yi; Yamaguchi, Hirohito; Wei, Yongkun; Hsu, Jennifer L.; Hsu, Yi-Hsin; Lin, Wan-Chi; Yu, Wen-Hsuan; Chen, Mei-Kuang; Nakai, Katsuya; Hsu, Ming-Chuan; Chen, Chun-Te; Sun, Ye; Hung, Mien-Chie] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Wang, Hung-Ling; Chang, Wei-Chao; Hung, Mien-Chie] China Med Univ, Grad Inst Canc Biol, Taichung, Taiwan; [Wang, Hung-Ling; Chang, Wei-Chao; Hung, Mien-Chie] China Med Univ, Ctr Mol Med, Taichung, Taiwan; [Yu, Wen-Hsuan; Chen, Mei-Kuang; Hung, Mien-Chie] Univ Texas Houston, Grad Sch Biomed Sci Houston, Houston, TX USA; [Leonard, Paul G.; Lee, Gilbert R.] Univ Texas MD Anderson Canc Ctr, Dept Genom Med, Houston, TX 77030 USA; [Leonard, Paul G.; Lee, Gilbert R.; Jones, Philip] Univ Texas MD Anderson Canc Ctr, Inst Appl Canc Sci, Houston, TX 77030 USA; [Wu, Yun] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Chang, Wei-Chao; Chen, Chung-Hsuan] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Huang, Wen-Chien; Liu, Chien-Liang; Chang, Yuan-Ching] Mackay Mem Hosp, Dept Surg, Taipei, Taiwan; [Park, Morag] McGill Univ, Dept Biochem, Montreal, PQ, Canada; [Hortobagyi, Gabriel N.] Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USA; [Hung, Mien-Chie] Asia Univ, Dept Biotechnol, Taichung, Taiwan	University of Texas System; UTMD Anderson Cancer Center; China Medical University Taiwan; China Medical University Taiwan; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Academia Sinica - Taiwan; Mackay Memorial Hospital; McGill University; University of Texas System; UTMD Anderson Cancer Center; Asia University Taiwan	Hung, MC (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA.; Hung, MC (corresponding author), China Med Univ, Grad Inst Canc Biol, Taichung, Taiwan.; Hung, MC (corresponding author), China Med Univ, Ctr Mol Med, Taichung, Taiwan.; Hung, MC (corresponding author), Univ Texas Houston, Grad Sch Biomed Sci Houston, Houston, TX USA.; Hung, MC (corresponding author), Asia Univ, Dept Biotechnol, Taichung, Taiwan.	mhung@mdanderson.org	CHEN, MEI-KUANG/V-9284-2017; Sun, Ye/AAN-4214-2021; Hsu, MC/AAE-5310-2020; Hung, Mien-Chie/ABD-5911-2021	Sun, Ye/0000-0002-3464-4600; Hung, Mien-Chie/0000-0003-4317-4740; Du, Yi/0000-0002-3969-2652; CHEN, MEI-KUANG/0000-0001-8027-8990; Yu, Wen-Hsuan/0000-0002-0816-7409; NAKAI, KATSUYA/0000-0003-4142-8508	US National Institutes of Health [CA109311, CA099031]; Cancer Center Support Grant [CA16672]; Susan G. Komen Foundation [SAC100016]; Breast Cancer Research Foundation; Patel Memorial Breast Cancer Endowment Fund; University of Texas MD Anderson-China Medical University and Hospital Sister Institution Fund; Ministry of Science and Technology, International Research-intensive Centers of Excellence in Taiwan (I-RiCE) [MOST 104-2911-1-002-302]; Ministry of Health and Welfare, China Medical University Hospital Cancer Research Center of Excellence [MOHW104-TDU-B-212-124-002]; Center for Biological Pathways at The University of Texas MD Anderson Cancer Center; Ting Tsung and Wei Fong Chao Research Fund; NATIONAL CANCER INSTITUTE [R01CA109311, P01CA099031, P30CA016672] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center Support Grant; Susan G. Komen Foundation(Susan G. Komen Breast Cancer Foundation); Breast Cancer Research Foundation; Patel Memorial Breast Cancer Endowment Fund; University of Texas MD Anderson-China Medical University and Hospital Sister Institution Fund; Ministry of Science and Technology, International Research-intensive Centers of Excellence in Taiwan (I-RiCE); Ministry of Health and Welfare, China Medical University Hospital Cancer Research Center of Excellence; Center for Biological Pathways at The University of Texas MD Anderson Cancer Center; Ting Tsung and Wei Fong Chao Research Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was funded in part by the following: the US National Institutes of Health grants (nos. CA109311 (M.-C. Hung) and CA099031 (M.-C. Hung), and a Cancer Center Support Grant CA16672); the Susan G. Komen Foundation (SAC100016 (M.-C. Hung)); the Breast Cancer Research Foundation; the Patel Memorial Breast Cancer Endowment Fund; The University of Texas MD Anderson-China Medical University and Hospital Sister Institution Fund; the Ministry of Science and Technology, International Research-intensive Centers of Excellence in Taiwan (I-RiCE; MOST 104-2911-1-002-302 (M.-C. Hung)); the Ministry of Health and Welfare, China Medical University Hospital Cancer Research Center of Excellence (MOHW104-TDU-B-212-124-002 (M.-C. Hung)); the Center for Biological Pathways at The University of Texas MD Anderson Cancer Center; and the Ting Tsung and Wei Fong Chao Research Fund. We also thank S. Patterson of the Department of Scientific Publications at The University of Texas MD Anderson Cancer Center for her editorial assistance.	Anders CK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061359; Badve S, 2011, MODERN PATHOL, V24, P157, DOI 10.1038/modpathol.2010.200; Boccaccio C, 2006, NAT REV CANCER, V6, P637, DOI 10.1038/nrc1912; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Casaletto JB, 2012, NAT REV CANCER, V12, P386, DOI 10.1038/nrc3277; Chiarugi P, 2003, TRENDS BIOCHEM SCI, V28, P509, DOI 10.1016/S0968-0004(03)00174-9; Du Y, 2014, ONCOGENE, V33, P756, DOI 10.1038/onc.2013.1; El-Khamisy SF, 2003, NUCLEIC ACIDS RES, V31, P5526, DOI 10.1093/nar/gkg761; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Feng FY, 2015, MOL CELL, V58, P925, DOI 10.1016/j.molcel.2015.04.016; Gelmon KA, 2011, LANCET ONCOL, V12, P852, DOI 10.1016/S1470-2045(11)70214-5; Gomes DA, 2008, J BIOL CHEM, V283, P4344, DOI 10.1074/jbc.M706550200; Ho-Yen CM, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0547-6; Hsu YH, 2014, CANCER RES, V74, P4822, DOI 10.1158/0008-5472.CAN-14-0584; Irani K, 1997, SCIENCE, V275, P1649, DOI 10.1126/science.275.5306.1649; Jagadeeswaran R, 2007, AM J PHYSIOL-LUNG C, V292, pL1488, DOI 10.1152/ajplung.00147.2006; Javle M, 2011, BRIT J CANCER, V105, P1114, DOI 10.1038/bjc.2011.382; Knight JF, 2013, P NATL ACAD SCI USA, V110, pE1301, DOI 10.1073/pnas.1210353110; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Linding R, 2007, CELL, V129, P1415, DOI 10.1016/j.cell.2007.05.052; Lips EH, 2013, BRIT J CANCER, V108, P2172, DOI 10.1038/bjc.2013.144; Matteucci E, 2009, CARCINOGENESIS, V30, P937, DOI 10.1093/carcin/bgp080; Maynard S, 2009, CARCINOGENESIS, V30, P2, DOI 10.1093/carcin/bgn250; Narod SA, 2004, NAT REV CANCER, V4, P665, DOI 10.1038/nrc1431; Nowsheen S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046614; O'Connor MJ, 2015, MOL CELL, V60, P547, DOI 10.1016/j.molcel.2015.10.040; Radisky DC, 2005, NATURE, V436, P123, DOI 10.1038/nature03688; Robaszkiewicz A, 2012, FREE RADICAL BIO MED, V53, P1552, DOI 10.1016/j.freeradbiomed.2012.08.567; Ruf A, 1996, P NATL ACAD SCI USA, V93, P7481, DOI 10.1073/pnas.93.15.7481; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Sonnenblick A, 2015, NAT REV CLIN ONCOL, V12, P27, DOI 10.1038/nrclinonc.2014.163; Speers C, 2009, CLIN CANCER RES, V15, P6327, DOI 10.1158/1078-0432.CCR-09-1107; Swindall Amanda F, 2013, Cancers (Basel), V5, P943, DOI 10.3390/cancers5030943; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Tutt A, 2010, LANCET, V376, P235, DOI 10.1016/S0140-6736(10)60892-6; Wang YN, 2010, ONCOGENE, V29, P3997, DOI 10.1038/onc.2010.157; Wang YN, 2012, J BIOL CHEM, V287, P16869, DOI 10.1074/jbc.M111.314799; Wang YN, 2010, BIOCHEM BIOPH RES CO, V399, P498, DOI 10.1016/j.bbrc.2010.07.096; Zagouri F, 2013, BRIT J CANCER, V108, P1100, DOI 10.1038/bjc.2013.31	40	147	157	2	62	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2016	22	2					194	201		10.1038/nm.4032	http://dx.doi.org/10.1038/nm.4032			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DC8JX	26779812	Green Accepted			2022-12-25	WOS:000369466800013
J	Mole, DJ; Webster, SP; Uings, I; Zheng, XZ; Binnie, M; Wilson, K; Hutchinson, JP; Mirguet, O; Walker, A; Beaufils, B; Ancellin, N; Trottet, L; Beneton, V; Mowat, CG; Wilkinson, M; Rowlands, P; Haslam, C; McBride, A; Homer, NZM; Baily, JE; Sharp, MGF; Garden, OJ; Hughes, J; Howie, SEM; Holmes, DS; Liddle, J; Iredale, JP				Mole, Damian J.; Webster, Scott P.; Uings, Iain; Zheng, Xiaozhong; Binnie, Margaret; Wilson, Kris; Hutchinson, Jonathan P.; Mirguet, Olivier; Walker, Ann; Beaufils, Benjamin; Ancellin, Nicolas; Trottet, Lionel; Beneton, Veronique; Mowat, Christopher G.; Wilkinson, Martin; Rowlands, Paul; Haslam, Carl; McBride, Andrew; Homer, Natalie Z. M.; Baily, James E.; Sharp, Matthew G. F.; Garden, O. James; Hughes, Jeremy; Howie, Sarah E. M.; Holmes, Duncan S.; Liddle, John; Iredale, John P.			Kynurenine-3-monooxygenase inhibition prevents multiple organ failure in rodent models of acute pancreatitis	NATURE MEDICINE			English	Article							ARYL-HYDROCARBON RECEPTOR; NEURONAL CELL-DEATH; KYNURENINE 3-MONOOXYGENASE; HYDROGEN-PEROXIDE; LUNG INJURY; IN-VITRO; TRYPTOPHAN; 3-HYDROXYKYNURENINE; DEGRADATION; METABOLITES	Acute pancreatitis (AP) is a common and devastating inflammatory condition of the pancreas that is considered to be a paradigm of sterile inflammation leading to systemic multiple organ dysfunction syndrome (MODS) and death(1,2). Acute mortality from AP-MODS exceeds 20% (ref. 3), and the lifespans of those who survive the initial episode are typically shorter than those of the general population(4). There are no specific therapies available to protect individuals from AP-MODS. Here we show that kynurenine-3-monooxygenase (KMO), a key enzyme of tryptophan metabolism(5), is central to the pathogenesis of AP-MODS. We created a mouse strain that is deficient for Kmo (encoding KMO) and that has a robust biochemical phenotype that protects against extrapancreatic tissue injury to the lung, kidney and liver in experimental AP-MODS. A medicinal chemistry strategy based on modifications of the kynurenine substrate led to the discovery of the oxazolidinone GSK180 as a potent and specific inhibitor of KMO. The binding mode of the inhibitor in the active site was confirmed by X-ray co-crystallography at 3.2 A resolution. Treatment with GSK180 resulted in rapid changes in the levels of kynurenine pathway metabolites in vivo, and it afforded therapeutic protection against MODS in a rat model of AR Our findings establish KMO inhibition as a novel therapeutic strategy in the treatment of AP-MODS, and they open up a new area for drug discovery in critical illness.	[Mole, Damian J.; Zheng, Xiaozhong; Hughes, Jeremy; Howie, Sarah E. M.; Iredale, John P.] Univ Edinburgh, Ctr Inflammat Res, MRC, Edinburgh, Midlothian, Scotland; [Mole, Damian J.; Garden, O. James] Univ Edinburgh, Surg Clin, Edinburgh, Midlothian, Scotland; [Webster, Scott P.; Binnie, Margaret; Wilson, Kris; McBride, Andrew; Baily, James E.] Univ Edinburgh, Univ British Heart Fdn Ctr Cardiovasc Surg, Edinburgh, Midlothian, Scotland; [Uings, Iain; Walker, Ann; Holmes, Duncan S.; Liddle, John] GlaxoSmithKline, Discovery Partnerships Acad, Stevenage, Herts, England; [Hutchinson, Jonathan P.; Rowlands, Paul; Haslam, Carl] GlaxoSmithKline, Mol Discovery Res, Stevenage, Herts, England; [Mirguet, Olivier; Beaufils, Benjamin; Ancellin, Nicolas; Trottet, Lionel; Beneton, Veronique] GlaxoSmithKline, Flexible Discovery Unit, Paris, France; [Mowat, Christopher G.; Wilkinson, Martin] Univ Edinburgh, EastChem Sch Chem, Edinburgh, Midlothian, Scotland; [Homer, Natalie Z. M.] Univ Edinburgh, Mass Spectrometry Core, Edinburgh, Midlothian, Scotland; [Sharp, Matthew G. F.] Univ Edinburgh, Cent Biores Serv, Edinburgh, Midlothian, Scotland	University of Edinburgh; University of Edinburgh; University of Edinburgh; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; University of Edinburgh; University of Edinburgh; University of Edinburgh	Mole, DJ (corresponding author), Univ Edinburgh, Ctr Inflammat Res, MRC, Edinburgh, Midlothian, Scotland.; Mole, DJ (corresponding author), Univ Edinburgh, Surg Clin, Edinburgh, Midlothian, Scotland.	damian.mole@ed.ac.uk	Homer, Natalie ZM/AAZ-3747-2021; Homer, Natalie/AAD-2343-2019; Mirguet, Olivier/Q-1682-2018	Homer, Natalie ZM/0000-0002-9262-2098; Mirguet, Olivier/0000-0002-5486-0386; Hughes, Jeremy/0000-0002-3470-0422; McGuire, Kris/0000-0002-4411-1170; Webster, Scott/0000-0003-4656-4744; Martin, Wilkinson/0000-0001-5490-613X; Mole, Damian/0000-0001-6884-7302; Iredale, John/0000-0003-2174-5127; Howie, Sarah/0000-0001-7291-3499	Clinician Scientist Fellowship from the Health Foundation/Academy of Medical Sciences; Medical Research Council Developmental Pathway Funding Stream; Wellcome Trust Institutional Strategic Support Fund; Medical Research Council; Medical Research Council Centre for Inflammation Research; Medical Research Council [G0600033, MR/J010766/1, G0901697, MC_G0900869] Funding Source: researchfish; MRC [MC_G0900869, MR/J010766/1, G0600033, G0901697] Funding Source: UKRI	Clinician Scientist Fellowship from the Health Foundation/Academy of Medical Sciences; Medical Research Council Developmental Pathway Funding Stream(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust Institutional Strategic Support Fund(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council Centre for Inflammation Research(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	D.J.M. is supported by a Clinician Scientist Fellowship from the Health Foundation/Academy of Medical Sciences, the Medical Research Council Developmental Pathway Funding Stream and Wellcome Trust Institutional Strategic Support Fund. J.P.I. acknowledges the support of the Medical Research Council. We thank D. Harbison, Edinburgh Bioquarter, the staff of the Central Bioresearch Services, University of Edinburgh; F. Howie, D. Mauchline, M. McMillan, L. Boswell and M. Millar; and colleagues in the Medical Research Council Centre for Inflammation Research for support and advice.	Amaral M, 2013, NATURE, V496, P382, DOI 10.1038/nature12039; Bessede A, 2014, NATURE, V511, P184, DOI 10.1038/nature13323; Chiarugi A, 2001, J NEUROIMMUNOL, V120, P190, DOI 10.1016/S0165-5728(01)00418-0; Courtney S, 2010, TOP MED CHEM SER, V6, P149, DOI 10.1007/7355_2010_9; EASTMAN CL, 1990, NEUROCHEM RES, V15, P1101, DOI 10.1007/BF01101711; Forrest CM, 2011, J NEUROCHEM, V119, P136, DOI 10.1111/j.1471-4159.2011.07414.x; Genestet C, 2014, FREE RADICAL BIO MED, V73, P400, DOI 10.1016/j.freeradbiomed.2014.06.003; Giles GI, 2003, BIOCHEM BIOPH RES CO, V300, P719, DOI 10.1016/S0006-291X(02)02917-0; Giorgini F, 2013, J BIOL CHEM, V288, P36554, DOI 10.1074/jbc.M113.503813; Jones SP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131389; Kipari T, 2006, AM J PATHOL, V169, P388, DOI 10.2353/ajpath.2006.050964; Logters TT, 2009, SHOCK, V32, P29, DOI 10.1097/SHK.0b013e31819714fa; Lowe DM, 2014, J BIOMOL SCREEN, V19, P508, DOI 10.1177/1087057113518069; Lowenfels Albert B, 2009, Curr Gastroenterol Rep, V11, P97; MCARTHUR JN, 1969, J PHARM PHARMACOL, V21, P744, DOI 10.1111/j.2042-7158.1969.tb08163.x; McKay CJ, 2003, PANCREATOLOGY, V3, P111, DOI 10.1159/000070078; Mezrich JD, 2010, J IMMUNOL, V185, P3190, DOI 10.4049/jimmunol.0903670; Mole DJ, 2008, BRIT J SURG, V95, P855, DOI 10.1002/bjs.6112; Mole DJ, 2009, HPB, V11, P166, DOI 10.1111/j.1477-2574.2009.00038.x; Moroni F, 2012, J NEURAL TRANSM, V119, P133, DOI 10.1007/s00702-011-0763-x; Murakami Y, 2013, INT J TRYPTOPHAN RES, P47, DOI 10.4137/IJTR.S11558; Nakagami Y, 1996, JPN J PHARMACOL, V71, P183, DOI 10.1254/jjp.71.183; Nathani N, 2008, CRIT CARE, V12, DOI 10.1186/cc6785; Nguyen NT, 2010, P NATL ACAD SCI USA, V107, P19961, DOI 10.1073/pnas.1014465107; Okuda S, 1998, J NEUROCHEM, V70, P299; Okuda S, 1996, P NATL ACAD SCI USA, V93, P12553, DOI 10.1073/pnas.93.22.12553; Opitz CA, 2011, NATURE, V478, P197, DOI 10.1038/nature10491; Pastor CM, 2003, CHEST, V124, P2341, DOI 10.1378/chest.124.6.2341; Pawlak K, 2009, ATHEROSCLEROSIS, V204, P309, DOI 10.1016/j.atherosclerosis.2008.08.014; Pellegrin K, 2005, SHOCK, V23, P209, DOI 10.1097/01.shk.000150773.16613.d3; Sato H, 2004, EUR RESPIR J, V23, P142, DOI 10.1183/09031936.03.00070303; Skouras C., 2014, HPB OXFORD; Vecsei L, 2013, NAT REV DRUG DISCOV, V12, P64, DOI 10.1038/nrd3793; von Bubnoff D, 2002, J IMMUNOL, V169, P1810, DOI 10.4049/jimmunol.169.4.1810; Wang JH, 2006, J BIOL CHEM, V281, P22021, DOI 10.1074/jbc.M603503200; Wang QX, 2014, CIRC RES, V114, P480, DOI 10.1161/CIRCRESAHA.114.302113; Wang YT, 2010, NAT MED, V16, P279, DOI 10.1038/nm.2092; Zhang H, 2013, J CLIN INVEST, V123, P1019, DOI 10.1172/JCI64931; Zunszain PA, 2012, NEUROPSYCHOPHARMACOL, V37, P939, DOI 10.1038/npp.2011.277; Zwilling D, 2011, CELL, V145, P863, DOI 10.1016/j.cell.2011.05.020	40	98	105	2	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2016	22	2					202	209		10.1038/nm.4020	http://dx.doi.org/10.1038/nm.4020			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DC8JX	26752518	Green Accepted, Green Submitted			2022-12-25	WOS:000369466800014
J	Sercin, O; Larsimont, JC; Karambelas, AE; Marthiens, V; Moers, V; Boeckx, B; Le Mercier, M; Lambrechts, D; Basto, R; Blanpain, C				Sercin, Ozdemirhan; Larsimont, Jean-Christophe; Karambelas, Andrea E.; Marthiens, Veronique; Moers, Virginie; Boeckx, Bram; Le Mercier, Marie; Lambrechts, Diether; Basto, Renata; Blanpain, Cedric			Transient PLK4 overexpression accelerates tumorigenesis in p53-deficient epidermis	NATURE CELL BIOLOGY			English	Article							FOLLICLE STEM-CELLS; CENTROSOME AMPLIFICATION; CHROMOSOMAL INSTABILITY; TUMOR-SUPPRESSOR; SKIN-CANCER; MOUSE SKIN; BREAST-CANCER; DNA-REPAIR; ANEUPLOIDY; P53	Aneuploidy is found in most solid tumours, but it remains unclear whether it is the cause or the consequence of tumorigenesis. Using Plk4 overexpression (PLK4OE) during epidermal development, we assess the impact of centrosome amplification and aneuploidy on skin development and tumorigenesis. PLK4OE in the developing epidermis induced centrosome amplification and multipolar divisions, leading to p53 stabilization and apoptosis of epidermal progenitors. The resulting delayed epidermal stratification led to skin barrier defects. Plk4 transgene expression was shut down postnatally in the surviving mice and PLK4OE mice never developed skin tumours. Concomitant PLK4OE and p53 deletion (PLK4OE/p53cKO) rescued the differentiation defects, but did not prevent the apoptosis of PLK4OE cells. Remarkably, the short-term presence of cells with supernumerary centrosomes in PLK4OE/p53cKO mice was sufficient to generate aneuploidy in the adult epidermis and triggered spontaneous skin cancers with complete penetrance. These results reveal that aneuploidy induced by transient centrosome amplification can accelerate tumorigenesis in p53-deficient cells.	[Sercin, Ozdemirhan; Larsimont, Jean-Christophe; Karambelas, Andrea E.; Moers, Virginie; Blanpain, Cedric] Univ Libre Bruxelles, IRIBHM, B-1070 Brussels, Belgium; [Marthiens, Veronique; Basto, Renata] Inst Curie, Ctr Rech, F-75248 Paris, France; [Boeckx, Bram; Lambrechts, Diether] Katholieke Univ Leuven, Dept Oncol, Lab Translat Genet, B-3000 Louvain, Belgium; [Boeckx, Bram; Lambrechts, Diether] VIB, Vesalius Res Ctr, B-3000 Leuven, Belgium; [Le Mercier, Marie] Univ Libre Bruxelles, Erasme Hosp, Dept Pathol, B-1070 Brussels, Belgium	Universite Libre de Bruxelles; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; KU Leuven; Flanders Institute for Biotechnology (VIB); Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Libre de Bruxelles	Blanpain, C (corresponding author), Univ Libre Bruxelles, IRIBHM, B-1070 Brussels, Belgium.	Cedric.Blanpain@ulb.ac.be	Blanpain, Cedric/ABD-8392-2021; Marthiens, Veronique/D-8673-2017; Lambrechts, Diether/AAJ-3167-2020	Lambrechts, Diether/0000-0002-3429-302X; marthiens, veronique/0000-0002-1360-0617; Sercin, Ozdemirhan/0000-0002-4893-9135	TELEVIE fellowship; FNRS; TELEVIE; PAI programme; Fondation contre le Cancer; ULB Fondation; foundation Bettencourt Schueller; foundation Baillet Latour; European Research Council (ERC); AICR now worldwide cancer research [13-0170]	TELEVIE fellowship; FNRS(Fonds de la Recherche Scientifique - FNRS); TELEVIE; PAI programme; Fondation contre le Cancer; ULB Fondation; foundation Bettencourt Schueller; foundation Baillet Latour; European Research Council (ERC)(European Research Council (ERC)); AICR now worldwide cancer research	C.B. is an investigator of WELBIO; O.S. is supported by a TELEVIE fellowship. This work was supported by the FNRS, TELEVIE, the PAI programme, a research grant from the Fondation contre le Cancer, the ULB Fondation, the foundation Bettencourt Schueller, the foundation Baillet Latour, a grant from the European Research Council (ERC) and a grant from AICR now worldwide cancer research (13-0170) to V.M. and R.B.	Anderhub SJ, 2012, CANCER LETT, V322, P8, DOI 10.1016/j.canlet.2012.02.006; Basto R, 2008, CELL, V133, P1032, DOI 10.1016/j.cell.2008.05.039; Berg RJW, 1996, P NATL ACAD SCI USA, V93, P274, DOI 10.1073/pnas.93.1.274; Bettencourt-Dias M, 2011, TRENDS GENET, V27, P307, DOI 10.1016/j.tig.2011.05.004; Blanpain C, 2006, GENE DEV, V20, P3022, DOI 10.1101/gad.1477606; Boukamp P, 2005, CARCINOGENESIS, V26, P1657, DOI 10.1093/carcin/bgi123; Chesnokova V, 2005, MOL ENDOCRINOL, V19, P2371, DOI 10.1210/me.2005-0137; Firat-Karalar EN, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0460; Foijer F, 2013, P NATL ACAD SCI USA, V110, P2928, DOI 10.1073/pnas.1217388110; Harris H, 2008, J CELL SCI, V121, P3, DOI 10.1242/jcs.025742; Holland AJ, 2012, GENE DEV, V26, P2684, DOI 10.1101/gad.207027.112; Holland AJ, 2010, J CELL BIOL, V188, P191, DOI 10.1083/jcb.200911102; Holland AJ, 2009, NAT REV MOL CELL BIO, V10, P478, DOI 10.1038/nrm2718; Izumi H, 2012, P NATL ACAD SCI USA, V109, P18048, DOI 10.1073/pnas.1205525109; Jonkers J, 2001, NAT GENET, V29, P418, DOI 10.1038/ng747; Kleylein-Sohn J, 2007, DEV CELL, V13, P190, DOI 10.1016/j.devcel.2007.07.002; Koster MI, 2007, ANNU REV CELL DEV BI, V23, P93, DOI 10.1146/annurev.cellbio.23.090506.123357; Lechler T, 2005, NATURE, V437, P275, DOI 10.1038/nature03922; Lingle WL, 2002, P NATL ACAD SCI USA, V99, P1978, DOI 10.1073/pnas.032479999; Liu X, 2007, P NATL ACAD SCI USA, V104, P12111, DOI 10.1073/pnas.0702969104; Marthiens V, 2013, NAT CELL BIOL, V15, P731, DOI 10.1038/ncb2746; McGranahan N, 2012, EMBO REP, V13, P528, DOI 10.1038/embor.2012.61; Nassar D, 2015, NAT MED, V21, P946, DOI 10.1038/nm.3878; Nigg EA, 2009, CELL, V139, P663, DOI 10.1016/j.cell.2009.10.036; Perez-Losada J, 2003, NAT REV CANCER, V3, P434, DOI 10.1038/nrc1095; Pihan GA, 2003, CANCER RES, V63, P1398; Rao CV, 2005, P NATL ACAD SCI USA, V102, P4365, DOI 10.1073/pnas.0407822102; Ricke RM, 2011, J CELL BIOL, V193, P1049, DOI 10.1083/jcb.201012035; RUGGERI B, 1991, CANCER RES, V51, P6615; Sabino D, 2015, CURR BIOL, V25, P879, DOI 10.1016/j.cub.2015.01.066; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Solomon DA, 2011, SCIENCE, V333, P1039, DOI 10.1126/science.1203619; Sotiropoulou PA, 2013, GENE DEV, V27, P39, DOI 10.1101/gad.206573.112; Sotiropoulou PA, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008383; Sotiropoulou PA, 2010, NAT CELL BIOL, V12, P572, DOI 10.1038/ncb2059; Sussan TE, 2008, NATURE, V451, P73, DOI 10.1038/nature06446; Torchia EC, 2013, J INVEST DERMATOL, V133, P78, DOI 10.1038/jid.2012.249; Vasioukhin V, 1999, P NATL ACAD SCI USA, V96, P8551, DOI 10.1073/pnas.96.15.8551; Weaver BAA, 2007, CANCER CELL, V11, P25, DOI 10.1016/j.ccr.2006.12.003; Weaver BAA, 2006, CURR OPIN CELL BIOL, V18, P658, DOI 10.1016/j.ceb.2006.10.002; Williams SE, 2014, NAT CELL BIOL, V16, P758, DOI 10.1038/ncb3001; ZIEGLER A, 1994, NATURE, V372, P773, DOI 10.1038/372773a0; Zyss D, 2009, TRENDS CELL BIOL, V19, P334, DOI 10.1016/j.tcb.2009.04.001	43	103	105	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2016	18	1					100	+		10.1038/ncb3270	http://dx.doi.org/10.1038/ncb3270			13	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CZ3VA	26595384				2022-12-25	WOS:000367030900003
J	Lynn, GM; Laga, R; Darrah, PA; Ishizuka, AS; Balaci, AJ; Dulcey, AE; Pechar, M; Pola, R; Gerner, MY; Yamamoto, A; Buechler, CR; Quinn, KM; Smelkinson, MG; Vanek, O; Cawood, R; Hills, T; Vasalatiy, O; Kastenmuller, K; Francica, JR; Stutts, L; Tom, JK; Ryu, KA; Esser-Kahn, AP; Etrych, T; Fisher, KD; Seymour, LW; Seder, RA				Lynn, Geoffrey M.; Laga, Richard; Darrah, Patricia A.; Ishizuka, Andrew S.; Balaci, Alexandra J.; Dulcey, Andres E.; Pechar, Michal; Pola, Robert; Gerner, Michael Y.; Yamamoto, Ayako; Buechler, Connor R.; Quinn, Kylie M.; Smelkinson, Margery G.; Vanek, Ondrej; Cawood, Ryan; Hills, Thomas; Vasalatiy, Olga; Kastenmueller, Kathrin; Francica, Joseph R.; Stutts, Lalisa; Tom, Janine K.; Ryu, Keun Ah; Esser-Kahn, Aaron P.; Etrych, Tomas; Fisher, Kerry D.; Seymour, Leonard W.; Seder, Robert A.			In vivo characterization of the physicochemical properties of polymer-linked TLR agonists that enhance vaccine immunogenicity	NATURE BIOTECHNOLOGY			English	Article							T-CELL IMMUNITY; DENDRITIC CELLS; INNATE IMMUNITY; LYMPH-NODES; ADJUVANT; RESPONSES; ANTIGEN; PROTECTION; ACTIVATION; COPOLYMERS	The efficacy of vaccine adjuvants such as Toll-like receptor agonists (TLRa) can be improved through formulation and delivery approaches. Here, we attached small molecule TLR-7/8a to polymer scaffolds (polymer-TLR-7/8a) and evaluated how different physicochemical properties of the TLR-7/8a and polymer carrier influenced the location, magnitude and duration of innate immune activation in vivo. Particle formation by polymer-TLR-7/8a was the most important factor for restricting adjuvant distribution and prolonging activity in draining lymph nodes. The improved pharmacokinetic profile by particulate polymer-TLR-7/8a was also associated with reduced morbidity and enhanced vaccine immunogenicity for inducing antibodies and T cell immunity. We extended these findings to the development of a modular approach in which protein antigens are site-specifically linked to temperature-responsive polymer-TLR-7/8a adjuvants that self-assemble into immunogenic particles at physiologic temperatures in vivo. Our findings provide a chemical and structural basis for optimizing adjuvant design to elicit broad-based antibody and T cell responses with protein antigens.	[Lynn, Geoffrey M.; Darrah, Patricia A.; Ishizuka, Andrew S.; Balaci, Alexandra J.; Yamamoto, Ayako; Buechler, Connor R.; Quinn, Kylie M.; Kastenmueller, Kathrin; Francica, Joseph R.; Seder, Robert A.] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [Lynn, Geoffrey M.; Laga, Richard; Cawood, Ryan; Hills, Thomas; Fisher, Kerry D.; Seymour, Leonard W.] Univ Oxford, Dept Oncol, Oxford, England; [Laga, Richard; Pechar, Michal; Pola, Robert; Etrych, Tomas] Acad Sci Czech Republic, Inst Macromol Chem, Prague, Czech Republic; [Dulcey, Andres E.; Vasalatiy, Olga] NHLBI, Imaging Probe Dev Ctr, NIH, Rockville, MD USA; [Gerner, Michael Y.] NIAID, Lymphocyte Biol Sect, Lab Syst Biol, NIH, Bethesda, MD 20892 USA; [Smelkinson, Margery G.] NIAID, Biol Imaging Sect, Res Technol Branch, NIH, Bethesda, MD 20892 USA; [Vanek, Ondrej] Charles Univ Prague, Fac Sci, Dept Biochem, Prague, Czech Republic; [Stutts, Lalisa; Tom, Janine K.; Ryu, Keun Ah; Esser-Kahn, Aaron P.] Univ Calif Irvine, Dept Chem, Irvine, CA 92717 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Oxford; Czech Academy of Sciences; Institute of Macromolecular Chemistry of the Czech Academy of Sciences; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Charles University Prague; University of California System; University of California Irvine	Seder, RA (corresponding author), NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	rseder@mail.nih.gov	Quinn, Kylie/AAJ-5066-2021; Pola, Robert/G-5723-2014; Pechar, Michal/G-6423-2014; Etrych, Tomas/G-3420-2014; Laga, Richard/G-3627-2014; Vaněk, Ondřej/I-7022-2016	Pola, Robert/0000-0003-0025-2016; Etrych, Tomas/0000-0001-5908-5182; Vaněk, Ondřej/0000-0003-1190-8535; Smelkinson, Margery/0000-0001-7777-5574; Ishizuka, Andrew/0000-0002-3024-7536; Hills, Thomas/0000-0003-0322-5822; Quinn, Kylie/0000-0002-0417-3625; Ryu, Keun Ah/0000-0001-6244-0878; seymour, len/0000-0003-3825-0841; Gerner, Michael/0000-0001-5406-8308	BIOPOL project (Ministry of Education, Youth and Sports of the Czech Republic) [EE2.3.30.0029]; Czech Science Foundation [15-15181S]; Charles University [UNCE 204025/2012]; Cancer Research UK [C552/A17720]; Office of AIDS Research of the US National Institutes of Health; National Institute of Allergy and Infectious Diseases of the US National Institutes of Health; Cancer Research UK [17720] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K22AI108628] Funding Source: NIH RePORTER	BIOPOL project (Ministry of Education, Youth and Sports of the Czech Republic); Czech Science Foundation(Grant Agency of the Czech Republic); Charles University; Cancer Research UK(Cancer Research UK); Office of AIDS Research of the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases of the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Cancer Research UK(Cancer Research UK); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors wish to acknowledge M. Dillon, K. Wuddie and C. Chiedi at the Vaccine Research Center and B. Klaunberg and V. Diaz at the Mouse Imaging Facility (MIF) for their valuable support and assistance with the animal studies. We would also like to thank K. Ulbrich, R. Swenson and G. Griffiths for their support and helpful insights. This work was supported in part by the BIOPOL project (Grant of the Ministry of Education, Youth and Sports of the Czech Republic, no. EE2.3.30.0029); by the Czech Science Foundation (15-15181S); by Charles University (UNCE 204025/2012); by a Cancer Research UK grant (C552/A17720); and by the Office of AIDS Research and the National Institute of Allergy and Infectious Diseases of the US National Institutes of Health.	Andersen P, 2014, TRENDS IMMUNOL, V35, P387, DOI 10.1016/j.it.2014.04.006; Arens R, 2013, SEMIN IMMUNOL, V25, P182, DOI 10.1016/j.smim.2013.04.008; Bachmann MF, 2010, NAT REV IMMUNOL, V10, P787, DOI 10.1038/nri2868; Blander JM, 2006, NATURE, V440, P808, DOI 10.1038/nature04596; Brito LA, 2014, J CONTROL RELEASE, V190, P563, DOI 10.1016/j.jconrel.2014.06.027; Chou HY, 2010, J IMMUNOL, V185, P5468, DOI 10.4049/jimmunol.1001875; Coffman RL, 2010, IMMUNITY, V33, P492, DOI 10.1016/j.immuni.2010.10.002; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; de Titta A, 2013, P NATL ACAD SCI USA, V110, P19902, DOI 10.1073/pnas.1313152110; Epstein JE, 2011, SCIENCE, V334, P475, DOI 10.1126/science.1211548; Fox CB, 2013, VACCINE, V31, P5848, DOI 10.1016/j.vaccine.2013.09.069; Gerner MY, 2012, IMMUNITY, V37, P364, DOI 10.1016/j.immuni.2012.07.011; Gerster JF, 2005, J MED CHEM, V48, P3481, DOI 10.1021/jm049211v; Gorden KB, 2005, J IMMUNOL, V174, P1259, DOI 10.4049/jimmunol.174.3.1259; Guy B, 2007, NAT REV MICROBIOL, V5, P505, DOI 10.1038/nrmicro1681; Hruby M, 2007, J CONTROL RELEASE, V119, P25, DOI 10.1016/j.jconrel.2007.02.009; Ilyinskii PO, 2014, VACCINE, V32, P2882, DOI 10.1016/j.vaccine.2014.02.027; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Jewell CM, 2011, P NATL ACAD SCI USA, V108, P15745, DOI 10.1073/pnas.1105200108; Jing P, 2008, BIOMACROMOLECULES, V9, P2438, DOI 10.1021/bm800459v; Kastenmuller K, 2011, J CLIN INVEST, V121, P1782, DOI 10.1172/JCI45416; Kasturi SP, 2011, NATURE, V470, P543, DOI 10.1038/nature09737; Kourtis IC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061646; KRIEG AM, 1995, ANTISENSE RES DEV, V5, P241, DOI 10.1089/ard.1995.5.241; Lahoud MH, 2012, P NATL ACAD SCI USA, V109, P16270, DOI 10.1073/pnas.1208796109; Liu HP, 2014, NATURE, V507, P519, DOI 10.1038/nature12978; Liu HP, 2011, ANGEW CHEM INT EDIT, V50, P7052, DOI 10.1002/anie.201101266; Liu XM, 2010, ADV DRUG DELIVER REV, V62, P258, DOI 10.1016/j.addr.2009.10.006; Manolova V, 2008, EUR J IMMUNOL, V38, P1404, DOI 10.1002/eji.200737984; Moon JJ, 2012, P NATL ACAD SCI USA, V109, P1080, DOI 10.1073/pnas.1112648109; Nair-Gupta P, 2014, CELL, V158, P506, DOI 10.1016/j.cell.2014.04.054; Nordly P, 2009, EXPERT OPIN DRUG DEL, V6, P657, DOI 10.1517/17425240903018863; Pechar M, 2013, BIOTECHNOL ADV, V31, P90, DOI 10.1016/j.biotechadv.2012.01.003; Plotkin SA, 2010, CLIN VACCINE IMMUNOL, V17, P1055, DOI 10.1128/CVI.00131-10; Pockros PJ, 2007, J HEPATOL, V47, P174, DOI 10.1016/j.jhep.2007.02.025; Quinn KM, 2013, J IMMUNOL, V190, P2720, DOI 10.4049/jimmunol.1202861; Reddy ST, 2006, J CONTROL RELEASE, V112, P26, DOI 10.1016/j.jconrel.2006.01.006; Russo C, 2011, BLOOD, V117, P5683, DOI 10.1182/blood-2010-12-328138; Ryu KA, 2014, J AM CHEM SOC, V136, P10823, DOI 10.1021/ja412314j; Savage P, 1996, BRIT J CANCER, V74, P1482, DOI 10.1038/bjc.1996.569; Scott EA, 2012, BIOMATERIALS, V33, P6211, DOI 10.1016/j.biomaterials.2012.04.060; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Seymour LW, 2002, J CLIN ONCOL, V20, P1668, DOI 10.1200/JCO.2002.20.6.1668; SEYMOUR LW, 1987, J BIOMED MATER RES, V21, P1341, DOI 10.1002/jbm.820211106; Shakya AK, 2013, VACCINE, V31, P3519, DOI 10.1016/j.vaccine.2013.05.084; Sharp FA, 2009, P NATL ACAD SCI USA, V106, P870, DOI 10.1073/pnas.0804897106; Shi HS, 2012, CARBOHYD POLYM, V89, P1101, DOI 10.1016/j.carbpol.2012.03.073; Shukla NM, 2011, BIOORG MED CHEM LETT, V21, P3232, DOI 10.1016/j.bmcl.2011.04.050; Shukla NM, 2010, J MED CHEM, V53, P4450, DOI 10.1021/jm100358c; Skeiky YAW, 2002, VACCINE, V20, P3292, DOI 10.1016/S0264-410X(02)00302-X; Smirnov D, 2011, VACCINE, V29, P5434, DOI 10.1016/j.vaccine.2011.05.061; Subr V, 2006, REACT FUNCT POLYM, V66, P1525, DOI 10.1016/j.reactfunctpolym.2006.05.002; Tyring S.K., 2009, J DRUGS DERMATOL, V8, P467; Vecchi S, 2014, EUR J PHARM BIOPHARM, V87, P310, DOI 10.1016/j.ejpb.2014.01.002; Wille-Reece U, 2005, P NATL ACAD SCI USA, V102, P15190, DOI 10.1073/pnas.0507484102; Wu CCN, 2007, P NATL ACAD SCI USA, V104, P3990, DOI 10.1073/pnas.0611624104; Wu TYH, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009980	58	283	289	14	243	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2015	33	11					1201	+		10.1038/nbt.3371	http://dx.doi.org/10.1038/nbt.3371			13	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CW3TY	26501954	Green Accepted			2022-12-25	WOS:000364916000028
J	Pickrell, JK; Berisa, T; Liu, JZ; Segurel, L; Tung, JY; Hinds, DA				Pickrell, Joseph K.; Berisa, Tomaz; Liu, Jimmy Z.; Segurel, Laure; Tung, Joyce Y.; Hinds, David A.			Detection and interpretation of shared genetic influences on 42 human traits	NATURE GENETICS			English	Article							BODY-MASS INDEX; GENOME-WIDE ASSOCIATION; MENDELIAN RANDOMIZATION; AUTOIMMUNE-DISEASES; COMPLEX DISEASES; CARDIOVASCULAR-DISEASE; SUSCEPTIBILITY LOCI; COMMON VARIATION; BLOOD-GROUP; SCHIZOPHRENIA	We performed a scan for genetic variants associated with multiple phenotypes by comparing large genome-wide association studies (GWAS) of 42 traits or diseases. We identified 341 loci (at a false discovery rate of 10%) associated with multiple traits. Several loci are associated with multiple phenotypes; for example, a nonsynonymous variant in the zinc transporter SLC39A8 influences seven of the traits, including risk of schizophrenia (rs13107325: log-transformed odds ratio (log OR) = 0.15, P = 2 x 10(-12)) and Parkinson disease (log OR = -0.15, P = 1.6 x 10(-7)), among others. Second, we used these loci to identify traits that have multiple genetic causes in common. For example, variants associated with increased risk of schizophrenia also tended to be associated with increased risk of inflammatory bowel disease. Finally, we developed a method to identify pairs of traits that show evidence of a causal relationship. For example, we show evidence that increased body mass index causally increases triglyceride levels.	[Pickrell, Joseph K.; Berisa, Tomaz; Liu, Jimmy Z.] New York Genome Ctr, New York, NY USA; [Pickrell, Joseph K.] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Segurel, Laure] Univ Paris Diderot, Sorbonne Paris Cite, CNRS, UMR Ecoanthropol & Ethnobiol 7206,MNHN, Paris, France; [Tung, Joyce Y.; Hinds, David A.] 23andMe Inc, Mountain View, CA USA	Columbia University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Universite Paris Cite	Pickrell, JK (corresponding author), New York Genome Ctr, New York, NY USA.; Pickrell, JK (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.	jkpickrell@nygenome.org		Segurel, Laure/0000-0001-7339-0976; Hinds, David/0000-0002-4911-803X	National Human Genome Research Institute of the National Institutes of Health [R44HG006981]; National Institute of Mental Health [R01MH106842]; French National Foundation; LABEX (Laboratory of Excellence program investment for the future) DISTALZ grant; INSERM; Institut Pasteur de Lille, Universite de Lille 2; Lille University Hospital; Medical Research Council [503480]; Alzheimer's Research UK [503176]; Wellcome Trust [082604/2/07/Z]; German Federal Ministry of Education and Research (BMBF): Competence Network Dementia (CND) [01GI0102, 01GI0711, 01GI0420]; NIH/NIA [R01 AG033193, U01 AG032984, U24 AG021886, U01 AG016976]; NIA [AG081220]; AGES [N01-AG-12100]; NHLBI [R01 HL105756]; Icelandic Heart Association; Erasmus Medical Center; Erasmus University; Alzheimer's Association [ADGC-10-196728]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105756] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R44HG006981] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH106842] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG033193, U24AG021886, U01AG016976, N01AG012100, U01AG032984] Funding Source: NIH RePORTER	National Human Genome Research Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); French National Foundation; LABEX (Laboratory of Excellence program investment for the future) DISTALZ grant; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Institut Pasteur de Lille, Universite de Lille 2; Lille University Hospital; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Alzheimer's Research UK(Alzheimer's Research UK (ARUK)); Wellcome Trust(Wellcome Trust); German Federal Ministry of Education and Research (BMBF): Competence Network Dementia (CND)(Federal Ministry of Education & Research (BMBF)); NIH/NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); AGES; NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Icelandic Heart Association; Erasmus Medical Center; Erasmus University; Alzheimer's Association(Alzheimer's Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by the National Human Genome Research Institute of the National Institutes of Health (grant R44HG006981 to 23andMe) and the National Institute of Mental Health (grant R01MH106842 to J.K.P.). We thank the customers of 23andMe for making this work possible, the GWAS consortia that made summary statistics available to us, L. Jostins for providing updated summary statistics from the Crohn's disease and ulcerative colitis GWAS, and G. Coop and M. Stephens for helpful discussions. We thank D. Golan and J. Pritchard for comments on a previous version of this manuscript. We thank D. Cesarini and the Social Science Genetic Association Consortium for access to summary statistics from the association study of educational attainment.; We thank the International Genomics of Alzheimer's Project (IGAP) for providing summary results data for these analyses. The investigators within IGAP contributed to the design and implementation of IGAP and/or provided data but did not participate in analysis or writing of this report. IGAP was made possible by the generous participation of the control subjects, the patients, and their families. The iSelect chips were funded by the French National Foundation on Alzheimer disease and related disorders. EADI was supported by LABEX (Laboratory of Excellence program investment for the future) DISTALZ grant, INSERM, Institut Pasteur de Lille, Universite de Lille 2, and the Lille University Hospital. GERAD was supported by the Medical Research Council (grant 503480), Alzheimer's Research UK (grant 503176), the Wellcome Trust (grant 082604/2/07/Z), and German Federal Ministry of Education and Research (BMBF): Competence Network Dementia (CND) grants 01GI0102, 01GI0711, and 01GI0420. CHARGE was partly supported by NIH/NIA grant R01 AG033193 and NIA grant AG081220 and AGES contract N01-AG-12100, NHLBI grant R01 HL105756, the Icelandic Heart Association, and the Erasmus Medical Center and Erasmus University. ADGC was supported by NIH/NIA grants U01 AG032984, U24 AG021886, and U01 AG016976, and by Alzheimer's Association grant ADGC-10-196728.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Andreassen OA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003455; Andreassen OA, 2013, AM J HUM GENET, V92, P197, DOI 10.1016/j.ajhg.2013.01.001; Benros ME, 2011, AM J PSYCHIAT, V168, P1303, DOI 10.1176/appi.ajp.2011.11030516; Bulik-Sullivan B, 2015, NAT GENET, V47, P1236, DOI 10.1038/ng.3406; CHILLON M, 1995, NEW ENGL J MED, V332, P1475, DOI 10.1056/NEJM199506013322204; Claussnitzer M, 2015, NEW ENGL J MED, V373, P895, DOI 10.1056/NEJMoa1502214; Cotsapas C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002254; Davey Smith G, 2014, HUM MOL GENET, V23, pR89, DOI 10.1093/hmg/ddu328; De Silva NMG, 2011, DIABETES, V60, P1008, DOI 10.2337/db10-1317; Denny JC, 2013, NAT BIOTECHNOL, V31, P1102, DOI 10.1038/nbt.2749; Eaton WW, 2006, AM J PSYCHIAT, V163, P521, DOI 10.1176/appi.ajp.163.3.521; Eaton WW, 2004, BRIT MED J, V328, P438, DOI 10.1136/bmj.328.7437.438; Elks CE, 2010, NAT GENET, V42, P1077, DOI 10.1038/ng.714; Elliott KS, 2013, ANN RHEUM DIS, V72, P935, DOI 10.1136/annrheumdis-2012-202081; Espeland M, 2007, DIABETES CARE, V30, P1374; Estrada K, 2012, NAT GENET, V44, P491, DOI 10.1038/ng.2249; Evans DM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003919; Flint J, 2009, GENOME RES, V19, P723, DOI 10.1101/gr.086660.108; Fortune MD, 2015, NAT GENET, V47, P839, DOI 10.1038/ng.3330; Franchini M, 2015, BMC MED, V13, DOI 10.1186/s12916-014-0250-y; Freathy RM, 2008, DIABETES, V57, P1419, DOI 10.2337/db07-1466; Giambartolomei C, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004383; GIANOLA D, 1982, THEOR APPL GENET, V62, P225, DOI 10.1007/BF00276244; Gieger C, 2011, NATURE, V480, P201, DOI 10.1038/nature10659; Granell R, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001669; HAMILTON JB, 1951, ANN NY ACAD SCI, V53, P708, DOI 10.1111/j.1749-6632.1951.tb31971.x; Holmes MV, 2014, AM J HUM GENET, V94, P198, DOI 10.1016/j.ajhg.2013.12.014; Jeck WR, 2012, AGING CELL, V11, P727, DOI 10.1111/j.1474-9726.2012.00871.x; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; KATAN MB, 1986, LANCET, V1, P507; Kominato Y, 1997, J BIOL CHEM, V272, P25890, DOI 10.1074/jbc.272.41.25890; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; Lee SH, 2012, BIOINFORMATICS, V28, P2540, DOI 10.1093/bioinformatics/bts474; Li L, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007191; Li R, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002746; Lim ET, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004494; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Loh PR, 2015, NAT GENET, V47, P1385, DOI 10.1038/ng.3431; Manning AK, 2012, NAT GENET, V44, P659, DOI 10.1038/ng.2274; Moltke I, 2014, NATURE, V512, P190, DOI 10.1038/nature13425; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; MULLER C., 1938, ACTA MED SCAND SUPPL, V89, P75; Okada Y, 2014, NATURE, V506, P376, DOI 10.1038/nature12873; Okbay A, 2016, NATURE, V533, P539, DOI 10.1038/nature17671; Paaby AB, 2013, TRENDS GENET, V29, P66, DOI 10.1016/j.tig.2012.10.010; Panoutsopoulou K, 2014, ANN RHEUM DIS, V73, P2082, DOI 10.1136/annrheumdis-2013-203772; Parkes M, 2013, NAT REV GENET, V14, P661, DOI 10.1038/nrg3502; Pasaniuc B, 2014, BIOINFORMATICS, V30, P2906, DOI 10.1093/bioinformatics/btu416; Pearl J., 2000, CAUSALITY MODELS REA, DOI DOI 10.1017/CBO9780511803161; PEDERSEN TR, 1994, LANCET, V344, P1383; Pendergrass SA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003087; Perry JRB, 2014, NATURE, V514, P92, DOI 10.1038/nature13545; Pichler I, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001462; Pickrell JK, 2014, AM J HUM GENET, V94, P559, DOI 10.1016/j.ajhg.2014.03.004; R Core Team, 2021, R LANG ENV STAT COMP; Richard-Miceli C, 2012, GENOME MED, V4, DOI 10.1186/gm305; Richards JB, 2008, NAT GENET, V40, P1282, DOI 10.1038/ng.255; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; RIVKEES SA, 1988, NEW ENGL J MED, V318, P599, DOI 10.1056/NEJM198803103181003; Schunkert H, 2011, NAT GENET, V43, P333, DOI [10.1038/ng.784, 10.1161/CIRCGENETICS.111.960443]; Shai I, 2008, NEW ENGL J MED, V359, P229, DOI 10.1056/NEJMoa0708681; Shungin D, 2015, NATURE, V518, P187, DOI 10.1038/nature14132; Sivakumaran S, 2011, AM J HUM GENET, V89, P607, DOI 10.1016/j.ajhg.2011.10.004; Smemo S, 2014, NATURE, V507, P371, DOI 10.1038/nature13138; Smith GD, 2004, INT J EPIDEMIOL, V33, P30, DOI 10.1093/ije/dyh132; Smoller JW, 2013, LANCET, V381, P1371, DOI 10.1016/S0140-6736(12)62129-1; Solovieff N, 2013, NAT REV GENET, V14, P483, DOI 10.1038/nrg3461; Stearns FW, 2010, GENETICS, V186, P767, DOI 10.1534/genetics.110.122549; Stefansson H, 2014, NATURE, V505, P361, DOI 10.1038/nature12818; Steinberg D, 2002, NAT MED, V8, P1211, DOI 10.1038/nm1102-1211; STEINBERG D, 1989, CIRCULATION, V80, P1070, DOI 10.1161/01.CIR.80.4.1070; Styrkarsdottir U, 2013, NATURE, V497, P517, DOI 10.1038/nature12124; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Ueland PM, 2001, TRENDS PHARMACOL SCI, V22, P195, DOI 10.1016/S0165-6147(00)01675-8; van der Harst P, 2012, NATURE, V492, P369, DOI 10.1038/nature11677; Visscher PM, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004269; Visscher PM, 2012, AM J HUM GENET, V90, P7, DOI 10.1016/j.ajhg.2011.11.029; Voight BF, 2012, LANCET, V380, P572, DOI 10.1016/S0140-6736(12)60312-2; Wessel J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6897; Wood AR, 2014, NAT GENET, V46, P1173, DOI 10.1038/ng.3097; Wurtz P, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001765; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Zhang G, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001865	84	600	609	2	109	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2016	48	7					709	+		10.1038/ng.3570	http://dx.doi.org/10.1038/ng.3570			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DP9TK	27182965	Green Submitted, Green Accepted			2022-12-25	WOS:000378840100006
J	Andrews, FH; Shinsky, SA; Shanle, EK; Bridgers, JB; Gest, A; Tsun, IK; Krajewski, K; Shi, XB; Strahl, BD; Kutateladze, TG				Andrews, Forest H.; Shinsky, Stephen A.; Shanle, Erin K.; Bridgers, Joseph B.; Gest, Anneliese; Tsun, Ian K.; Krajewski, Krzysztof; Shi, Xiaobing; Strahl, Brian D.; Kutateladze, Tatiana G.			The Taf14 YEATS domain is a reader of histone crotonylation	NATURE CHEMICAL BIOLOGY			English	Article							TRANSCRIPTION; COMPLEX; ASSOCIATION; INTERACTS; PROTEINS; BINDING; DIRECTS; INO80; LINKS	The discovery of new histone modifications is unfolding at startling rates; however, the identification of effectors capable of interpreting these modifications has lagged behind. Here we report the YEATS domain as an effective reader of histone lysine crotonylation, an epigenetic signature associated with active transcription. We show that the Taf14 YEATS domain engages crotonyllysine via a unique pi-pi-pi-stacking mechanism and that other YEATS domains have crotonyllysine-binding activity.	[Andrews, Forest H.; Kutateladze, Tatiana G.] Univ Colorado, Sch Med, Dept Pharmacol, Aurora, CO USA; [Shinsky, Stephen A.; Shanle, Erin K.; Bridgers, Joseph B.; Tsun, Ian K.; Krajewski, Krzysztof; Strahl, Brian D.] Univ N Carolina, Sch Med, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Gest, Anneliese; Shi, Xiaobing] Univ Texas MD Anderson Canc Ctr, Dept Epigenet & Mol Carcinogenesis, Houston, TX 77030 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Texas System; UTMD Anderson Cancer Center	Kutateladze, TG (corresponding author), Univ Colorado, Sch Med, Dept Pharmacol, Aurora, CO USA.; Strahl, BD (corresponding author), Univ N Carolina, Sch Med, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA.	brian_strahl@med.unc.edu; tatiana.kutateladze@ucdenver.edu	Peptide Synthesis and Array Facility, High-Throughput/AFI-7866-2022; Strahl, Brian D/C-7601-2012	Shi, Xiaobing/0000-0001-5242-8189; Shinsky, Stephen/0000-0001-5437-1729; Bridgers, Joseph/0000-0002-0585-4131; Krajewski, Krzysztof/0000-0001-7159-617X; Strahl, Brian D/0000-0002-4947-6259; Gest, Anneliese/0000-0002-0923-2989; Kutateladze, Tatiana/0000-0001-7375-6990	NIH [R01 GM106416, GM100907, GM110058, T32AA007464, K12-GM000678]; CPRIT [RP160237]; UNC Lineberger Cancer Center Postdoctoral Fellowship Award; CPRIT Research Training grant [RP140106]; NATIONAL CANCER INSTITUTE [P30CA016086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM110058, K12GM000678, R01GM106416, R01GM100907] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [T32AA007464] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CPRIT; UNC Lineberger Cancer Center Postdoctoral Fellowship Award; CPRIT Research Training grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	We thank L. Aponte-Collazo for help with experiments and M. Bedford, K. Chua, D. Stillman, and J. Tyler for kindly providing some original DNA constructs of YEATS and bromodomains, as well as the yeast strains and extracts. This work was supported by NIH grants R01 GM106416 and GM100907 to T.G.K. and GM110058 to B.D.S. and by CPRIT RP160237 to X.S. F.H.A. is supported by the NIH grant T32AA007464, E.K.S. is supported by the NIH grant K12-GM000678, S.A.S. is supported by a UNC Lineberger Cancer Center Postdoctoral Fellowship Award, and A.G. is supported by the CPRIT Research Training grant RP140106.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ali M, 2013, P NATL ACAD SCI USA, V110, P11296, DOI 10.1073/pnas.1310156110; Andrews FH, 2016, TRANSCR-AUSTIN, V7, P14, DOI 10.1080/21541264.2015.1125987; Bao XC, 2014, ELIFE, V3, DOI 10.7554/eLife.02999; Cairns BR, 1996, MOL CELL BIOL, V16, P3308; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Filippakopoulos P, 2012, CELL, V149, P214, DOI 10.1016/j.cell.2012.02.013; Flynn EM, 2015, STRUCTURE, V23, P1801, DOI 10.1016/j.str.2015.08.004; John S, 2000, GENE DEV, V14, P1196; Kabani M, 2005, BIOCHEM BIOPH RES CO, V332, P398, DOI 10.1016/j.bbrc.2005.04.158; Keogh MC, 2006, GENE DEV, V20, P660, DOI 10.1101/gad.1388106; Li YY, 2014, CELL, V159, P558, DOI 10.1016/j.cell.2014.09.049; Lin HN, 2012, ACS CHEM BIOL, V7, P947, DOI 10.1021/cb3001793; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Musselman CA, 2012, NAT STRUCT MOL BIOL, V19, P1218, DOI 10.1038/nsmb.2436; Rothbart SB, 2014, BBA-GENE REGUL MECH, V1839, P627, DOI 10.1016/j.bbagrm.2014.03.001; Rothbart SB, 2012, NAT STRUCT MOL BIOL, V19, P1155, DOI 10.1038/nsmb.2391; Sabari BR, 2015, MOL CELL, V58, P203, DOI 10.1016/j.molcel.2015.02.029; Schulze JM, 2009, BIOCHEM CELL BIOL, V87, P65, DOI 10.1139/O08-111; Shanle EK, 2015, GENE DEV, V29, P1795, DOI 10.1101/gad.269977.115; Shen XT, 2004, METHOD ENZYMOL, V377, P401; Tan MJ, 2011, CELL, V146, P1015, DOI 10.1016/j.cell.2011.08.008	22	139	143	1	43	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUN	2016	12	6					396	U33		10.1038/nchembio.2065	http://dx.doi.org/10.1038/nchembio.2065			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DM2EW	27089029	Green Accepted, Green Submitted			2022-12-25	WOS:000376160600007
J	Pietras, EM; Mirantes-Barbeito, C; Fong, S; Loeffler, D; Kovtonyuk, LV; Zhang, SY; Lakshminarasimhan, R; Chin, CP; Techner, JM; Will, B; Nerlov, C; Steidl, U; Manz, MG; Schroeder, T; Passegue, E				Pietras, Eric M.; Mirantes-Barbeito, Cristina; Fong, Sarah; Loeffler, Dirk; Kovtonyuk, Larisa V.; Zhang, SiYi; Lakshminarasimhan, Ranjani; Chin, Chih Peng; Techner, Jose-Marc; Will, Britta; Nerlov, Claus; Steidl, Ulrich; Manz, Markus G.; Schroeder, Timm; Passegue, Emmanuelle			Chronic interleukin-1 exposure drives haematopoietic stem cells towards precocious myeloid differentiation at the expense of self-renewal	NATURE CELL BIOLOGY			English	Article							LINEAGE COMMITMENT; PROGENITOR CELLS; IL-1; INFLAMMATION; MICE; PU.1; HOMEOSTASIS; REGULATORS; CYTOKINES; RECEPTOR	Haematopoietic stem cells (HSCs) maintain lifelong blood production and increase blood cell numbers in response to chronic and acute injury. However, the mechanism(s) by which inflammatory insults are communicated to HSCs and their consequences for HSC activity remain largely unknown. Here, we demonstrate that interleukin-1 (IL-1), which functions as a key pro-inflammatory 'emergency' signal, directly accelerates cell division and myeloid differentiation of HSCs through precocious activation of a PU.1-dependent gene program. Although this effect is essential for rapid myeloid recovery following acute injury to the bone marrow, chronic IL-1 exposure restricts HSC lineage output, severely erodes HSC self-renewal capacity, and primes IL-1-exposed HSCs to fail massive replicative challenges such as transplantation. Importantly, these damaging effects are transient and fully reversible on IL-1 withdrawal. Our results identify a critical regulatory circuit that tailors HSC responses to acute needs, and is likely to underlie deregulated blood homeostasis in chronic inflammation conditions.	[Pietras, Eric M.; Mirantes-Barbeito, Cristina; Fong, Sarah; Zhang, SiYi; Lakshminarasimhan, Ranjani; Chin, Chih Peng; Techner, Jose-Marc; Passegue, Emmanuelle] Univ Calif San Francisco, Dept Med, Div Hematol Oncol, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA; [Loeffler, Dirk; Schroeder, Timm] Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, CH-4058 Basel, Switzerland; [Kovtonyuk, Larisa V.; Manz, Markus G.] Univ Zurich Hosp, Div Hematol, CH-8091 Zurich, Switzerland; [Will, Britta; Steidl, Ulrich] Albert Einstein Coll Med, Dept Cell Biol, Queens, NY 10461 USA; [Nerlov, Claus] Univ Oxford, Weatherall Inst Mol Med, Oxford OX3 9DS, England; [Pietras, Eric M.] Univ Colorado Denver, Div Hematol, Aurora, CO 80045 USA	University of California System; University of California San Francisco; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; University Zurich Hospital; Yeshiva University; University of Oxford; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Passegue, E (corresponding author), Univ Calif San Francisco, Dept Med, Div Hematol Oncol, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA.	eric.pietras@ucdenver.edu	Fong, Sarah/P-3088-2017	Fong, Sarah/0000-0003-0900-5505; Will, Britta/0000-0002-9534-6690; Passegue, Emmanuelle/0000-0002-3516-297X; Techner, Jose-Marc/0000-0001-6327-3581; Kovtonyuk, Larisa/0000-0002-0342-3127; Loeffler, Dirk/0000-0001-9870-0088; Schroeder, Timm/0000-0001-9320-0252; Zhang, Si Yi/0000-0002-5793-1151; Manz, Markus/0000-0002-4676-7931	NIH [F32 HL106989, K01DK098315, R01 HL092471]; Institute of Health Carlos III (ISCIII) fellowship; CIRM Bridges internship; Swiss National Science Foundation [310030_146528/1]; LLS Scholar Award; NATIONAL CANCER INSTITUTE [R01CA166429] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL106989, R01HL092471] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007334] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK105134, K01DK098315] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BB/M024350/1] Funding Source: researchfish; Medical Research Council [G0900892, MC_UU_12009/7, G0701761] Funding Source: researchfish; BBSRC [BB/M024350/1] Funding Source: UKRI; MRC [MC_UU_12009/7, G0701761, G0900892] Funding Source: UKRI	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institute of Health Carlos III (ISCIII) fellowship; CIRM Bridges internship; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); LLS Scholar Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank M. Kissner and M. Lee for management of our Flow Cytometry Core Facility andmembers of the Passegue laboratory for insights and suggestions. E.M.P. was supported by NIH F32 HL106989 and K01DK098315, C.M.-B. by an Institute of Health Carlos III (ISCIII) fellowship, R.L. by a CIRM Bridges internship and M.G.M. by the Swiss National Science Foundation (310030_146528/1). E.P. and research were supported by a LLS Scholar Award and NIH R01 HL092471.	Adamson John W, 2008, Hematology Am Soc Hematol Educ Program, P159, DOI 10.1182/asheducation-2008.1.159; Baldridge MT, 2010, NATURE, V465, P793, DOI 10.1038/nature09135; Bonadies N, 2010, ONCOGENE, V29, P1062, DOI 10.1038/onc.2009.371; Busch K, 2015, NATURE, V518, P542, DOI 10.1038/nature14242; Cabezas-Wallscheid N, 2014, CELL STEM CELL, V15, P507, DOI 10.1016/j.stem.2014.07.005; Cain D, 2009, J INVEST DERMATOL, V129, P266, DOI 10.1038/jid.2008.286; Chow A, 2011, J EXP MED, V208, P261, DOI 10.1084/jem.20101688; Cullen SP, 2015, CELL REP, V11, P1535, DOI 10.1016/j.celrep.2015.05.003; Dakic A, 2007, TRENDS IMMUNOL, V28, P108, DOI 10.1016/j.it.2007.01.006; DAMIA G, 1992, CANCER RES, V52, P4082; Dinarello CA, 2005, J EXP MED, V201, P1355, DOI 10.1084/jem.20050640; Dinarello CA, 2012, NAT REV DRUG DISCOV, V11, P633, DOI 10.1038/nrd3800; Dorshkind K., 1988, J IMMUNOL, V6, P1191; Espin-Palazon R, 2014, CELL, V159, P1070, DOI 10.1016/j.cell.2014.10.031; Essers MAG, 2009, NATURE, V458, P904, DOI 10.1038/nature07815; Flach J, 2014, NATURE, V512, P198, DOI 10.1038/nature13619; Gekas C, 2013, BLOOD, V121, P4463, DOI 10.1182/blood-2012-09-457929; Glaccum MB, 1997, J IMMUNOL, V159, P3364; Haas S, 2015, CELL STEM CELL, V17, P422, DOI 10.1016/j.stem.2015.07.007; HESTDAL K, 1994, BLOOD, V84, P125; Hirai H, 2006, NAT IMMUNOL, V7, P732, DOI 10.1038/ni1354; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Iwasaki H, 2007, IMMUNITY, V26, P726, DOI 10.1016/j.immuni.2007.06.004; King KY, 2011, NAT REV IMMUNOL, V11, P685, DOI 10.1038/nri3062; Li Y, 2014, GENE DEV, V28, P2597, DOI 10.1101/gad.253302.114; Manz MG, 2014, NAT REV IMMUNOL, V14, P302, DOI 10.1038/nri3660; Martin MU, 2002, BBA-MOL CELL RES, V1592, P265, DOI 10.1016/S0167-4889(02)00320-8; Matatall KA, 2014, STEM CELLS, V32, P3023, DOI 10.1002/stem.1799; May G, 2013, CURR BIOL, V23, pR662, DOI 10.1016/j.cub.2013.06.054; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Mendelson A, 2014, NAT MED, V20, P833, DOI 10.1038/nm.3647; Mirantes C, 2014, EXP CELL RES, V329, P248, DOI 10.1016/j.yexcr.2014.08.017; Miyawaki K, 2015, STEM CELLS, V33, P976, DOI 10.1002/stem.1906; Mohrin M, 2010, CELL STEM CELL, V7, P174, DOI 10.1016/j.stem.2010.06.014; MORRISSEY P, 1988, J IMMUNOL, V140, P4204; Mossadegh-Keller N, 2013, NATURE, V497, P239, DOI 10.1038/nature12026; Nagai Y, 2006, IMMUNITY, V24, P801, DOI 10.1016/j.immuni.2006.04.008; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Pietras EM, 2015, CELL STEM CELL, V17, P35, DOI 10.1016/j.stem.2015.05.003; Pietras EM, 2014, J EXP MED, V211, P245, DOI 10.1084/jem.20131043; Pietras EM, 2011, J CELL BIOL, V195, P709, DOI 10.1083/jcb.201102131; Pronk CJH, 2011, J EXP MED, V208, P1563, DOI 10.1084/jem.20110752; Rieger MA, 2009, SCIENCE, V325, P217, DOI 10.1126/science.1171461; Rosenbauer F, 2004, NAT GENET, V36, P624, DOI 10.1038/ng1361; Schepers K, 2015, CELL STEM CELL, V16, P254, DOI 10.1016/j.stem.2015.02.014; Schepers K, 2013, CELL STEM CELL, V13, P285, DOI 10.1016/j.stem.2013.06.009; Schuettpelz LG, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00204; Sims JE, 2010, NAT REV IMMUNOL, V10, P89, DOI 10.1038/nri2691; SMITH MA, 1992, ANN RHEUM DIS, V51, P753, DOI 10.1136/ard.51.6.753; Staber PB, 2013, MOL CELL, V49, P934, DOI 10.1016/j.molcel.2013.01.007; Steidl U, 2007, J CLIN INVEST, V117, P2611, DOI 10.1172/JCI30525; Sun JL, 2014, NATURE, V514, P322, DOI 10.1038/nature13824; Takizawa H, 2012, BLOOD, V119, P2991, DOI 10.1182/blood-2011-12-380113; Takizawa H, 2011, J EXP MED, V208, P273, DOI 10.1084/jem.20101643; Ueda Y, 2009, J IMMUNOL, V182, P6477, DOI 10.4049/jimmunol.0803961; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Yamamoto R, 2013, CELL, V154, P1112, DOI 10.1016/j.cell.2013.08.007; Zhang P, 2000, BLOOD, V96, P2641; Zhao JL, 2014, CELL STEM CELL, V14, P445, DOI 10.1016/j.stem.2014.01.007	59	343	347	6	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUN	2016	18	6					607	+		10.1038/ncb3346	http://dx.doi.org/10.1038/ncb3346			23	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	DN0JL	27111842	Green Accepted, Green Submitted			2022-12-25	WOS:000376750100007
J	Koskimaki, JJ; Kajula, M; Hokkanen, J; Ihantola, EL; Kim, JH; Hautajarvi, H; Hankala, E; Suokas, M; Pohjanen, J; Podolich, O; Kozyrovska, N; Turpeinen, A; Paakkonen, M; Mattila, S; Campbell, BC; Pirttila, AM				Koskimaki, Janne J.; Kajula, Marena; Hokkanen, Juho; Ihantola, Emmi-Leena; Kim, Jong H.; Hautajarvi, Heidi; Hankala, Elina; Suokas, Marko; Pohjanen, Johanna; Podolich, Olga; Kozyrovska, Natalia; Turpeinen, Ari; Paakkonen, Mirva; Mattila, Sampo; Campbell, Bruce C.; Pirttila, Anna Maria			Methyl-esterified 3-hydroxybutyrate oligomers protect bacteria from hydroxyl radicals	NATURE CHEMICAL BIOLOGY			English	Article							POLY-BETA-HYDROXYBUTYRATE; PINUS-SYLVESTRIS L.; OXIDATIVE STRESS; REACTIVE OXYGEN; SCOTS PINE; LEGIONELLA-PNEUMOPHILA; DISEASE; IRON; DEGRADATION; INFECTION	Bacteria rely mainly on enzymes, glutathione and other low-molecular weight thiols to overcome oxidative stress. However, hydroxyl radicals are the most cytotoxic reactive oxygen species, and no known enzymatic system exists for their detoxification. We now show that methyl-esterified dimers and trimers of 3-hydroxybutyrate (ME-3HB), produced by bacteria capable of polyhydroxybutyrate biosynthesis, have 3-fold greater hydroxyl radical-scavenging activity than glutathione and 11-fold higher activity than vitamin C or the monomer 3-hydroxybutyric acid. We found that ME-3HB oligomers protect hypersensitive yeast deletion mutants lacking oxidative stress-response genes from hydroxyl radical stress. Our results show that phaC and phaZ, encoding polymerase and depolymerase, respectively, are activated and polyhydroxybutyrate reserves are degraded for production of ME-3HB oligomers in bacteria infecting plant cells and exposed to hydroxyl radical stress. We found that ME-3HB oligomer production is widespread, especially in bacteria adapted to stressful environments. We discuss how ME-3HB oligomers could provide opportunities for numerous applications in human health.	[Koskimaki, Janne J.; Ihantola, Emmi-Leena; Hankala, Elina; Suokas, Marko; Pohjanen, Johanna; Pirttila, Anna Maria] Univ Oulu, Genet & Physiol, Oulu, Finland; [Kajula, Marena; Turpeinen, Ari; Paakkonen, Mirva; Mattila, Sampo] Univ Oulu, Dept Chem, FIN-90570 Oulu, Finland; [Kajula, Marena; Hokkanen, Juho; Hautajarvi, Heidi] Admescope Ltd, Oulu, Finland; [Ihantola, Emmi-Leena] Univ Eastern Finland, Inst Clin Microbiol, Kuopio, Finland; [Kim, Jong H.; Campbell, Bruce C.] ARS, Foodborne Toxin Detect & Prevent Res Unit, Western Reg Res Ctr, Dept Agr, Albany, CA USA; [Podolich, Olga; Kozyrovska, Natalia] Natl Acad Sci Ukraine, Inst Mol Biol & Genet, Kiev, Ukraine	University of Oulu; University of Oulu; University of Eastern Finland; National Academy of Sciences Ukraine; Institute of Molecular Biology & Genetics of NASU	Pirttila, AM (corresponding author), Univ Oulu, Genet & Physiol, Oulu, Finland.	am.pirttila@oulu.fi	Kozyrovska, Natalia O./P-1635-2017; Ihantola, Emmi-Leena/C-6675-2019	Ihantola, Emmi-Leena/0000-0001-7272-6255; Pirttila, Anna Maria/0000-0002-2455-6375; Koskimaki, Janne/0000-0001-8241-3500; KIM, JONG H./0000-0003-0944-6685; Kozyrovska, Natalia/0000-0002-2849-3471	Academy of Finland [105586, 118569, 129852, 113607]; University of Oulu; Niemi Foundation; Tauno Tonning Foundation; ARS [ARS-0430817] Funding Source: Federal RePORTER	Academy of Finland(Academy of Finland); University of Oulu; Niemi Foundation; Tauno Tonning Foundation; ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	The authors thank A. C. Frank, J. Lahdenpera, M. V. Tejesvi, A. Hohtola, E. L. Lagendijk, M. Svenning, P. Ardanov, S. Sutela, O. Halonen, J. Pukki and P. Tegelberg. This work was supported by the Academy of Finland (105586, 118569, 129852, 113607), the University of Oulu, the Niemi Foundation and the Tauno Tonning Foundation.	Andersson SGE, 1998, NATURE, V396, P133, DOI 10.1038/24094; Aneja P, 2005, CAN J MICROBIOL, V51, P599, DOI 10.1139/W05-042; Athlan A, 1997, J ENVIRON POLYM DEGR, V5, P243; Aurass P, 2009, APPL ENVIRON MICROB, V75, P4506, DOI 10.1128/AEM.00187-09; Balsanelli E, 2016, ENVIRON MICROBIOL, V18, P2343, DOI 10.1111/1462-2920.12887; Cabiscol Elisa, 2000, International Microbiology, V3, P3; Cao CK, 2013, CELL REP, V4, P302, DOI 10.1016/j.celrep.2013.06.022; Cheng BH, 2013, NEUROCHEM INT, V62, P620, DOI 10.1016/j.neuint.2012.09.011; Chien MC, 2004, SCIENCE, V305, P1966, DOI 10.1126/science.1099776; DOI Y, 1990, FEMS MICROBIOL LETT, V67, P165, DOI 10.1016/0378-1097(90)90188-V; Dwyer DJ, 2014, P NATL ACAD SCI USA, V111, pE2100, DOI 10.1073/pnas.1401876111; Fahey RC, 2013, BBA-GEN SUBJECTS, V1830, P3182, DOI 10.1016/j.bbagen.2012.10.006; Fall R, 1996, MICROBIAL GROWTH ON C(1) COMPOUNDS, P343; Haces ML, 2008, EXP NEUROL, V211, P85, DOI 10.1016/j.expneurol.2007.12.029; Imlay JA, 2013, NAT REV MICROBIOL, V11, P443, DOI 10.1038/nrmicro3032; Jang SJ, 2007, J BIOL CHEM, V282, P929, DOI 10.1074/jbc.M607646200; Jendrossek D, 2002, ANNU REV MICROBIOL, V56, P403, DOI 10.1146/annurev.micro.56.012302.160838; Kadouri D, 2003, APPL ENVIRON MICROB, V69, P3244, DOI 10.1128/AEM.69.6.3244-3250.2003; Kawata Y, 2012, APPL MICROBIOL BIOT, V96, P913, DOI 10.1007/s00253-012-4218-6; Kehrer JP, 2000, TOXICOLOGY, V149, P43, DOI 10.1016/S0300-483X(00)00231-6; Khosravi-Darani K, 2013, APPL MICROBIOL BIOT, V97, P1407, DOI 10.1007/s00253-012-4649-0; Kim JH, 2005, APPL MICROBIOL BIOT, V67, P807, DOI 10.1007/s00253-004-1821-1; Klocker AA, 2013, DIABETIC MED, V30, P818, DOI 10.1111/dme.12136; Koskimaki JJ, 2015, MBIO, V6, DOI 10.1128/mBio.00039-15; Krol E, 2004, MOL GENET GENOMICS, V272, P1, DOI 10.1007/s00438-004-1030-8; Lamb C, 1997, ANNU REV PLANT PHYS, V48, P251, DOI 10.1146/annurev.arplant.48.1.251; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Lee SY, 1999, BIOTECHNOL BIOENG, V65, P363, DOI 10.1002/(SICI)1097-0290(19991105)65:3<363::AID-BIT15>3.0.CO;2-1; Lemoigne M, 1926, B SOC HCIM BIOL PARI, V8, P770; Liu GS, 2007, J CELL SCI, V120, P596, DOI 10.1242/jcs.001362; Lushchak VI, 2011, COMP BIOCHEM PHYS C, V153, P175, DOI 10.1016/j.cbpc.2010.10.004; Madison LL, 1999, MICROBIOL MOL BIOL R, V63, P21, DOI 10.1128/MMBR.63.1.21-53.1999; Markowitz VM, 2012, NUCLEIC ACIDS RES, V40, pD115, DOI 10.1093/nar/gkr1044; Moore J, 2006, J AGR FOOD CHEM, V54, P617, DOI 10.1021/jf052555p; Mucha J, 2012, PLANTA, V236, P975, DOI 10.1007/s00425-012-1646-6; OSTLE AG, 1982, APPL ENVIRON MICROB, V44, P238, DOI 10.1128/AEM.44.1.238-241.1982; Ou BX, 2001, J AGR FOOD CHEM, V49, P4619, DOI 10.1021/jf010586o; Pirttila AM, 2000, APPL ENVIRON MICROB, V66, P3073, DOI 10.1128/AEM.66.7.3073-3077.2000; Pirttila AM, 2005, TREE PHYSIOL, V25, P289, DOI 10.1093/treephys/25.3.289; Pirttila AM, 2004, PHYSIOL PLANTARUM, V121, P305, DOI 10.1111/j.0031-9317.2004.00330.x; Pirttila AM, 2008, PLANT CELL TISS ORG, V95, P47, DOI 10.1007/s11240-008-9413-x; Pohjanen J, 2014, TREE PHYSIOL, V34, P993, DOI 10.1093/treephys/tpu062; Raberg M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095907; Ren Q, 2009, BIOMACROMOLECULES, V10, P916, DOI 10.1021/bm801431c; Santos R, 2001, MOL PLANT MICROBE IN, V14, P758, DOI 10.1094/MPMI.2001.14.6.758; Shimazu T, 2013, SCIENCE, V339, P211, DOI 10.1126/science.1227166; Silva-Gomes S, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00096; Talaat AM, 2000, NAT BIOTECHNOL, V18, P679, DOI 10.1038/76543; Tanaka A, 2006, PLANT CELL, V18, P1052, DOI 10.1105/tpc.105.039263; Thi EP, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002551; ThordalChristensen H, 1997, PLANT J, V11, P1187, DOI 10.1046/j.1365-313X.1997.11061187.x; Tieu K, 2003, J CLIN INVEST, V112, P892, DOI 10.1172/JCI200318797; Trautwein K, 2008, APPL ENVIRON MICROB, V74, P2267, DOI 10.1128/AEM.02381-07; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Wang H, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00311; Wang Q, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-47; Wesche AM, 2009, J FOOD PROTECT, V72, P1121, DOI 10.4315/0362-028X-72.5.1121; Wider G, 2006, J AM CHEM SOC, V128, P2571, DOI 10.1021/ja055336t; Zhang JY, 2013, BIOMATERIALS, V34, P7552, DOI 10.1016/j.biomaterials.2013.06.043; Zhao YH, 2007, FEMS MICROBIOL LETT, V276, P34, DOI 10.1111/j.1574-6968.2007.00904.x	60	42	42	0	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAY	2016	12	5					332	+		10.1038/NCHEMBIO.2043	http://dx.doi.org/10.1038/NCHEMBIO.2043			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DJ6KY	26974813				2022-12-25	WOS:000374322800007
J	Dominguez-Bello, MG; De Jesus-Laboy, KM; Shen, N; Cox, LM; Amir, A; Gonzalez, A; Bokulich, NA; Song, SJ; Hoashi, M; Rivera-Vinas, JI; Mendez, K; Knight, R; Clemente, JC				Dominguez-Bello, Maria G.; De Jesus-Laboy, Kassandra M.; Shen, Nan; Cox, Laura M.; Amir, Amnon; Gonzalez, Antonio; Bokulich, Nicholas A.; Song, Se Jin; Hoashi, Marina; Rivera-Vinas, Juana I.; Mendez, Keimari; Knight, Rob; Clemente, Jose C.			Partial restoration of the microbiota of cesarean-born infants via vaginal microbial transfer	NATURE MEDICINE			English	Article							HUMAN GUT MICROBIOME; INTESTINAL MICROBIOTA; SECTION; DELIVERY; CHILDREN; AGE	Exposure of newborns to the maternal vaginal microbiota is interrupted with cesarean birthing. Babies delivered by cesarean section (C-section) acquire a microbiota that differs from that of vaginally delivered infants, and C-section delivery has been associated with increased risk for immune and metabolic disorders. Here we conducted a pilot study in which infants delivered by C-section were exposed to maternal vaginal fluids at birth. Similarly to vaginally delivered babies, the gut, oral and skin bacterial communities of these newborns during the first 30 d of life was enriched in vaginal bacteria which were underrepresented in unexposed C-section-delivered infants and the microbiome similarity to those of vaginally delivered infants was greater in oral and skin samples than in anal samples. Although the long-term health consequences of restoring the microbiota of C-section-delivered infants remain unclear, our results demonstrate that vaginal microbes can be partially restored at birth in C-section-delivered babies.	[Dominguez-Bello, Maria G.; Cox, Laura M.; Bokulich, Nicholas A.; Hoashi, Marina] NYU, Sch Med, New York, NY USA; [Dominguez-Bello, Maria G.; De Jesus-Laboy, Kassandra M.] Univ Puerto Rico, Dept Biol, Rio Piedras Campus, San Juan, PR 00936 USA; [Shen, Nan; Clemente, Jose C.] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Amir, Amnon; Gonzalez, Antonio; Song, Se Jin; Knight, Rob] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Song, Se Jin] Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA; [Hoashi, Marina] NYU, Tandon Sch Engn, New York, NY USA; [Rivera-Vinas, Juana I.; Mendez, Keimari] Univ Puerto Rico, Dept Obstet & Gynecol, Med Sci Campus, San Juan, PR 00936 USA; [Knight, Rob] Univ Calif San Diego, Dept Comp Sci & Engn, La Jolla, CA 92093 USA; [Clemente, Jose C.] Icahn Sch Med Mt Sinai, Div Clin Immunol, Dept Med, New York, NY 10029 USA	New York University; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico Rio Piedras; Icahn School of Medicine at Mount Sinai; University of California System; University of California San Diego; University of Colorado System; University of Colorado Boulder; New York University; New York University Tandon School of Engineering; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of California System; University of California San Diego; Icahn School of Medicine at Mount Sinai	Dominguez-Bello, MG (corresponding author), NYU, Sch Med, New York, NY USA.; Dominguez-Bello, MG (corresponding author), Univ Puerto Rico, Dept Biol, Rio Piedras Campus, San Juan, PR 00936 USA.; Clemente, JC (corresponding author), Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA.; Clemente, JC (corresponding author), Icahn Sch Med Mt Sinai, Div Clin Immunol, Dept Med, New York, NY 10029 USA.	maria.dominguez-bello@nyumc.org; jose.clemente@mssm.edu	Cox, Laura/ABG-5883-2020; Gonzalez, Antonio/A-6421-2018	Cox, Laura/0000-0002-9564-9894; Hoashi, Marina/0000-0003-3643-9632; Knight, Rob/0000-0002-0975-9019; Bokulich, Nicholas/0000-0002-1784-8935	CD Research Fund; US National Institutes of Health [R01 DK090989]; Crohn's and Colitis Foundation of America [362048]; Sinai Ulcerative Colitis: Clinical, Experimental & Systems Studies philanthropic grant; Laura and Isaac Perlmutter Cancer Center [P30CA016087]; NATIONAL CANCER INSTITUTE [P30CA016087, P30CA023100] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090989] Funding Source: NIH RePORTER	CD Research Fund; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's and Colitis Foundation of America; Sinai Ulcerative Colitis: Clinical, Experimental & Systems Studies philanthropic grant; Laura and Isaac Perlmutter Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was partially supported by the C&D Research Fund (M.G.D.-B.), the US National Institutes of Health grant no. R01 DK090989 (M.G.D.-B), the Crohn's and Colitis Foundation of America grant no. 362048 (J.C.C.) and the Sinai Ulcerative Colitis: Clinical, Experimental & Systems Studies philanthropic grant (J.C.C.). Sequencing at the New York University Genome Technology Center was partially supported by the Cancer Center Support grant no. P30CA016087 at the Laura and Isaac Perlmutter Cancer Center. Computing was partially supported by the Department of Scientific Computing at the Icahn School of Medicine at Mount Sinai. We acknowledge the contribution of the students who participated in obtaining the samples and the metadata: S.M. Rodriguez, J.F. Ruiz, N. Garcia and J.L. Rivera-Correa. We also thank M.J. Blaser for discussions and critical comments, and three anonymous reviewers for their suggestions to improve this manuscript.	Aagaard K, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008599; [Anonymous], 1985, LANCET, V2, P436; Backhed F, 2015, CELL HOST MICROBE, V17, P690, DOI [10.1016/j.chom.2015.05.012, 10.1016/j.chom.2015.04.004]; Barber EL, 2011, OBSTET GYNECOL, V118, P29, DOI 10.1097/AOG.0b013e31821e5f65; Clemente JC, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500183; Cox LM, 2014, CELL, V158, P705, DOI 10.1016/j.cell.2014.05.052; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; Fardini Y, 2010, INFECT IMMUN, V78, P1789, DOI 10.1128/IAI.01395-09; Finger C, 2003, LANCET, V362, P628, DOI 10.1016/S0140-6736(03)14204-3; Huh SY, 2012, ARCH DIS CHILD, V97, P610, DOI 10.1136/archdischild-2011-301141; Knights D, 2011, CELL HOST MICROBE, V10, P292, DOI 10.1016/j.chom.2011.09.003; Knights D, 2011, NAT METHODS, V8, P761, DOI 10.1038/nmeth.1650; Olszak T, 2012, SCIENCE, V336, P489, DOI 10.1126/science.1219328; Pantoja-Feliciano IG, 2013, ISME J, V7, P1112, DOI 10.1038/ismej.2013.15; Pistiner M, 2008, J ALLERGY CLIN IMMUN, V122, P274, DOI 10.1016/j.jaci.2008.05.007; Sevelsted A, 2015, PEDIATRICS, V135, pE92, DOI 10.1542/peds.2014-0596; Thavagnanam S, 2008, CLIN EXP ALLERGY, V38, P629, DOI 10.1111/j.1365-2222.2007.02780.x; WHO, 2010, WOR HEALT REP, P1; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053	19	505	537	11	229	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2016	22	3					250	253		10.1038/nm.4039	http://dx.doi.org/10.1038/nm.4039			4	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DF6DC	26828196	Green Accepted, Green Submitted			2022-12-25	WOS:000371445100011
J	Deverman, BE; Pravdo, PL; Simpson, BP; Kumar, SR; Chan, KY; Banerjee, A; Wu, WL; Yang, B; Huber, N; Pasca, SP; Gradinaru, V				Deverman, Benjamin E.; Pravdo, Piers L.; Simpson, Bryan P.; Kumar, Sripriya Ravindra; Chan, Ken Y.; Banerjee, Abhik; Wu, Wei-Li; Yang, Bin; Huber, Nina; Pasca, Sergiu P.; Gradinaru, Viviana			Cre-dependent selection yields AAV variants for widespread gene transfer to the adult brain	NATURE BIOTECHNOLOGY			English	Article							ADENOASSOCIATED VIRUS TYPE-2; IN-VIVO; NEUTRALIZING ANTIBODIES; DIRECTED EVOLUTION; NONHUMAN-PRIMATES; RECOMBINANT AAV; NERVOUS-SYSTEM; VIRAL-VECTORS; SPINAL-CORD; THERAPY	Recombinant adeno-associated viruses (rAAVs) are commonly used vehicles for in vivo gene transfer(1-6). However, the tropism repertoire of naturally occurring AAVs is limited, prompting a search for novel AAV capsids with desired characteristics(7-13). Here we describe a capsid selection method, called Cre recombination-based AAV targeted evolution (CREATE), that enables the development of AAV capsids that more efficiently transduce defined Cre-expressing cell populations in vivo. We use CREATE to generate AAV variants that efficiently and widely transduce the adult mouse central nervous system (CNS) after intravenous injection. One variant, AAV-PHP.B, transfers genes throughout the CNS with an efficiency that is at least 40-fold greater than that of the current standard, AAV9 (refs. 14-17), and transduces the majority of astrocytes and neurons across multiple CNS regions. In vitro, it transduces human neurons and astrocytes more efficiently than does AAV9, demonstrating the potential of CREATE to produce customized AAV vectors for biomedical applications.	[Deverman, Benjamin E.; Pravdo, Piers L.; Simpson, Bryan P.; Kumar, Sripriya Ravindra; Chan, Ken Y.; Banerjee, Abhik; Wu, Wei-Li; Yang, Bin; Gradinaru, Viviana] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA; [Huber, Nina; Pasca, Sergiu P.] Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA	California Institute of Technology; Stanford University	Deverman, BE; Gradinaru, V (corresponding author), CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA.	bd@caltech.edu; viviana@caltech.edu	Pasca, Sergiu/AAY-3949-2021; Wu, Wei-Li/ADY-3311-2022	Pasca, Sergiu/0000-0002-3216-3248; Chan, Ken/0000-0002-8853-5186; Simpson, Bryan/0000-0003-0192-6027; Deverman, Benjamin/0000-0002-6223-9303	Hereditary Disease Foundation; Caltech-City of Hope Biomedical Initiative; National Institutes of Health (NIH) Director's New Innovator [1DP2NS087949]; NIH/National Institute on Aging (NIA) [1R01AG047664]; Beckman Institute for CLARITY, Optogenetics and Vector Engineering Research; Gordon and Betty Moore Foundation [GBMF2809]; Caltech Programmable Molecular Technology Initiative; NIH BRAIN [1U01NS090577]; NIH/National Institute of Mental Health (NIMH) [1R21MH103824-01]; Pew Charitable Trust; Sloan Foundation; Kimmel Foundation; Human Frontiers in Science Program; Caltech-GIST; NIMH [1R01MH100900, 1R01MH100900-02S1]; NIMH BRAINS [R01MH107800]; California Institute of Regenerative Medicine (CIRM); MQ Fellow Award; Donald E. and Delia B. Baxter Foundation Scholar Award; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH103824, R01MH100900, R01MH107800] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS090577, DP2NS087949] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG047664] Funding Source: NIH RePORTER	Hereditary Disease Foundation; Caltech-City of Hope Biomedical Initiative; National Institutes of Health (NIH) Director's New Innovator(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Beckman Institute for CLARITY, Optogenetics and Vector Engineering Research; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Caltech Programmable Molecular Technology Initiative; NIH BRAIN(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Pew Charitable Trust; Sloan Foundation(Alfred P. Sloan Foundation); Kimmel Foundation; Human Frontiers in Science Program(Human Frontier Science Program); Caltech-GIST; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH BRAINS; California Institute of Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); MQ Fellow Award; Donald E. and Delia B. Baxter Foundation Scholar Award; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This article and the naming of the novel AAV clones are dedicated to the memory of Paul H. Patterson (P.H.P.), who passed away during the preparation of this manuscript. We wish to thank L. Rodriguez and P. Anguiano for administrative assistance, A. Balazs and S. Cassenaer and the entire Gradinaru and Patterson laboratories for helpful discussions, and A. Choe for helpful comments on the manuscript. We thank the University of Pennsylvania vector core for the AAV2/9 Rep-Cap plasmid, A. Balazs and D. Baltimore for the AAV genome plasmid, and the Biological Imaging Facility, supported by the Caltech Beckman Institute and the Arnold and Mabel Beckman Foundation, for use of imaging equipment. This work was supported by grants from the Hereditary Disease Foundation and the Caltech-City of Hope Biomedical Initiative (to P. H. P.) and from the National Institutes of Health (NIH) Director's New Innovator 1DP2NS087949; NIH/National Institute on Aging (NIA) 1R01AG047664; Beckman Institute for CLARITY, Optogenetics and Vector Engineering Research; and the Gordon and Betty Moore Foundation through grant GBMF2809 to the Caltech Programmable Molecular Technology Initiative (to V.G.). Work in the Gradinaru laboratory is also funded by the following awards (to V.G.): NIH BRAIN 1U01NS090577; NIH/National Institute of Mental Health (NIMH) 1R21MH103824-01; Pew Charitable Trust; Sloan Foundation; Kimmel Foundation; Human Frontiers in Science Program; Caltech-GIST; Caltech-City of Hope Biomedical Initiative. Work in the Pasca laboratory is supported by a NIMH 1R01MH100900 and 1R01MH100900-02S1, the NIMH BRAINS Award (R01MH107800), the California Institute of Regenerative Medicine (CIRM), the MQ Fellow Award and the Donald E. and Delia B. Baxter Foundation Scholar Award (to S.P.P.).	ALBERT H, 1995, PLANT J, V7, P649, DOI 10.1046/j.1365-313X.1995.7040649.x; Ayuso E, 2010, GENE THER, V17, P503, DOI 10.1038/gt.2009.157; Bartlett JS, 1999, NAT BIOTECHNOL, V17, P181, DOI 10.1038/6185; Bartlett JS, 1998, HUM GENE THER, V9, P1181, DOI 10.1089/hum.1998.9.8-1181; Belmonte JCI, 2015, NEURON, V86, P617, DOI 10.1016/j.neuron.2015.03.021; Betley JN, 2011, HUM GENE THER, V22, P669, DOI 10.1089/hum.2010.204; Bevan AK, 2011, MOL THER, V19, P1971, DOI 10.1038/mt.2011.157; Borel F, 2014, MOL THER, V22, P692, DOI 10.1038/mt.2013.285; Boutin S, 2010, HUM GENE THER, V21, P704, DOI 10.1089/hum.2009.182; Calcedo R, 2009, J INFECT DIS, V199, P381, DOI 10.1086/595830; Chakrabarty P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067680; Chiorini JA, 1999, J VIROL, V73, P1309, DOI 10.1128/JVI.73.2.1309-1319.1999; Dalkara D, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005708; Denise A, 2004, NAT NEUROSCI, V7, P1233, DOI 10.1038/nn1340; Dufour BD, 2014, MOL THER, V22, P797, DOI 10.1038/mt.2013.289; Excoffon KJDA, 2009, P NATL ACAD SCI USA, V106, P3865, DOI 10.1073/pnas.0813365106; Farris KD, 2008, HUM GENE THER, V19, P1421, DOI 10.1089/hgt.2008.118; Foust KD, 2009, NAT BIOTECHNOL, V27, P59, DOI 10.1038/nbt.1515; Gaudet D, 2010, ATHEROSCLEROSIS SUPP, V11, P55, DOI 10.1016/j.atherosclerosissup.2010.03.004; Gray SJ, 2011, CURR PROTOC NEUROS S, V57; Gray SJ, 2011, MOL THER, V19, P1058, DOI 10.1038/mt.2011.72; Grimm D, 2008, J VIROL, V82, P5887, DOI 10.1128/JVI.00254-08; Guenthner CJ, 2013, NEURON, V78, P773, DOI 10.1016/j.neuron.2013.03.025; HANCOCK JF, 1991, EMBO J, V10, P4033, DOI 10.1002/j.1460-2075.1991.tb04979.x; High KH, 2014, HAEMOPHILIA, V20, P43, DOI 10.1111/hae.12411; Kaplitt MG, 2007, LANCET, V369, P2097, DOI 10.1016/S0140-6736(07)60982-9; Kawashima T, 2013, NAT METHODS, V10, P889, DOI [10.1038/NMETH.2559, 10.1038/nmeth.2559]; LEVITT N, 1989, GENE DEV, V3, P1019, DOI 10.1101/gad.3.7.1019; Lisowski L, 2014, NATURE, V506, P382, DOI 10.1038/nature12875; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; Maguire C, 2014, NEUROTHERAPEUTICS, V11, P817, DOI 10.1007/s13311-014-0299-5; Maheshri N, 2006, NAT BIOTECHNOL, V24, P198, DOI 10.1038/nbt1182; Muller OJ, 2003, NAT BIOTECHNOL, V21, P1040, DOI 10.1038/nbt856; Nathwani AC, 2011, MOL THER, V19, P876, DOI 10.1038/mt.2010.274; Ojala DS, 2015, NEUROSCIENTIST, V21, P84, DOI 10.1177/1073858414521870; Pasca AM, 2015, NAT METHODS, V12, P671, DOI [10.1038/nmeth.3415, 10.1038/NMETH.3415]; Pulicherla N, 2011, MOL THER, V19, P1070, DOI 10.1038/mt.2011.22; Samaranch L, 2012, HUM GENE THER, V23, P382, DOI 10.1089/hum.2011.200; Shaner NC, 2013, NAT METHODS, V10, P407, DOI [10.1038/NMETH.2413, 10.1038/nmeth.2413]; Sonntag F, 2010, P NATL ACAD SCI USA, V107, P10220, DOI 10.1073/pnas.1001673107; Treweek JB, 2015, NAT PROTOC, V10, P1860, DOI 10.1038/nprot.2015.122; van der Marel S, 2011, INFLAMM BOWEL DIS, V17, P2436, DOI 10.1002/ibd.21673; Wall NR, 2010, P NATL ACAD SCI USA, V107, P21848, DOI 10.1073/pnas.1011756107; Wang HY, 2014, HUM MOL GENET, V23, P668, DOI 10.1093/hmg/ddt454; Wobus CE, 2000, J VIROL, V74, P9281, DOI 10.1128/JVI.74.19.9281-9293.2000; Wu ZJ, 2006, MOL THER, V14, P316, DOI 10.1016/j.ymthe.2006.05.009; Xie J, 2011, MOL THER, V19, P526, DOI 10.1038/mt.2010.279; Yang B, 2014, CELL, V158, P945, DOI 10.1016/j.cell.2014.07.017; Ying Y, 2010, GENE THER, V17, P980, DOI 10.1038/gt.2010.44; Zolotukhin S, 1999, GENE THER, V6, P973, DOI 10.1038/sj.gt.3300938	50	499	555	12	115	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2016	34	2					204	+		10.1038/nbt.3440	http://dx.doi.org/10.1038/nbt.3440			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DD0OK	26829320	Green Accepted			2022-12-25	WOS:000369619100024
J	Saleh, T; Jankowski, W; Sriram, G; Rossi, P; Shah, S; Lee, KB; Cruz, LA; Rodriguez, AJ; Birge, RB; Kalodimos, CG				Saleh, Tamjeed; Jankowski, Wojciech; Sriram, Ganapathy; Rossi, Paolo; Shah, Shreyas; Lee, Ki-Bum; Cruz, Lissette Alicia; Rodriguez, Alexis J.; Birge, Raymond B.; Kalodimos, Charalampos G.			Cyclophilin A promotes cell migration via the Abl-Crk signaling pathway	NATURE CHEMICAL BIOLOGY			English	Article							ADAPTER PROTEIN CRK; TYROSINE KINASE; BREAST-CANCER; C-CRK; STRUCTURAL BASIS; BINDING-PROTEIN; TUMOR-GROWTH; IN-VIVO; PHOSPHORYLATION; ISOMERIZATION	Cyclophilin A (CypA) is overexpressed in a number of human cancer types, but the mechanisms by which the protein promotes oncogenic properties of cells are not understood. Here we demonstrate that CypA binds the CrkII adaptor protein and prevents it from switching to the inhibited state. CrkII influences cell motility and invasion by mediating signaling through its SH2 and SH3 domains. CrkII Tyr221 phosphorylation by the Abl or EGFR kinases induces an inhibited state of CrkII by means of an intramolecular SH2-pTyr221 interaction, causing signaling interruption. We show that the CrkII phosphorylation site constitutes a binding site for CypA. Recruitment of CypA sterically restricts the accessibility of Tyr221 to kinases, thereby suppressing CrkII phosphorylation and promoting the active state. Structural, biophysical and in vivo data show that CypA augments CrkII-mediated signaling. A strong stimulation of cell migration is observed in cancer cells wherein both CypA and CrkII are greatly upregulated.	[Saleh, Tamjeed; Rossi, Paolo; Kalodimos, Charalampos G.] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN USA; [Saleh, Tamjeed; Jankowski, Wojciech; Rossi, Paolo; Kalodimos, Charalampos G.] Rutgers State Univ, Ctr Integrat Prote Res, Piscataway, NJ USA; [Saleh, Tamjeed; Jankowski, Wojciech; Rossi, Paolo; Shah, Shreyas; Lee, Ki-Bum; Kalodimos, Charalampos G.] Rutgers State Univ, Dept Chem & Chem Biol, Piscataway, NJ USA; [Sriram, Ganapathy; Birge, Raymond B.] Rutgers New Jersey Med Sch, Dept Biochem & Mol Biol, Newark, NJ USA; [Cruz, Lissette Alicia; Rodriguez, Alexis J.] Rutgers State Univ, Dept Biol Sci, Newark, NJ 07102 USA	University of Minnesota System; University of Minnesota Twin Cities; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University Newark; Rutgers State University New Brunswick	Kalodimos, CG (corresponding author), Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN USA.; Kalodimos, CG (corresponding author), Rutgers State Univ, Ctr Integrat Prote Res, Piscataway, NJ USA.; Kalodimos, CG (corresponding author), Rutgers State Univ, Dept Chem & Chem Biol, Piscataway, NJ USA.	ckalodim@umn.edu	Kalodimos, Charalampos/Q-9846-2018; Shah, Shreyas/GLU-6655-2022; Saleh, Tamjeed/M-8698-2016	Kalodimos, Charalampos/0000-0001-6354-2796; Shah, Shreyas/0000-0002-9570-6262; Saleh, Tamjeed/0000-0002-7539-7300; Cruz, Lissette/0000-0001-9175-8754; LEE, Ki-Bum/0000-0002-8164-0047	US National Institutes of Health [GM80308, CA165077]; Rutgers University Busch Biomedical Research Grant; NIH [1DP20D006462-01]; NATIONAL CANCER INSTITUTE [R01CA165077] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080308] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rutgers University Busch Biomedical Research Grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank N. Sheth for helping with the cell biological experiments. This work was supported by the US National Institutes of Health (GM80308 to C.G.K. and CA165077 to R.B.B.), the Rutgers University Busch Biomedical Research Grant (to A.J.R.) and the NIH Director's Innovator Award (1DP20D006462-01 to K.-B.L.).	Bell Emily S, 2012, Genes Cancer, V3, P341, DOI 10.1177/1947601912459951; Birge RB, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-13; Bonfils C, 2010, BIOCHEM BIOPH RES CO, V393, P325, DOI 10.1016/j.bbrc.2010.01.135; Bosco DA, 2002, P NATL ACAD SCI USA, V99, P5247, DOI 10.1073/pnas.082100499; Bravo-Cordero JJ, 2012, CURR OPIN CELL BIOL, V24, P277, DOI 10.1016/j.ceb.2011.12.004; Brazin KN, 2002, P NATL ACAD SCI USA, V99, P1899, DOI 10.1073/pnas.042529199; Chodniewicz D, 2004, BBA-MOL CELL RES, V1692, P63, DOI 10.1016/j.bbamcr.2004.03.006; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; Deakin NO, 2008, J CELL SCI, V121, P2435, DOI 10.1242/jcs.018044; deJong R, 1997, ONCOGENE, V14, P507, DOI 10.1038/sj.onc.1200885; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Diemert S, 2012, J NEUROSCI METH, V203, P69, DOI 10.1016/j.jneumeth.2011.09.012; Escalante M, 2000, J BIOL CHEM, V275, P24787, DOI 10.1074/jbc.M000711200; Fathers KE, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3183; FELLER SM, 1994, EMBO J, V13, P2341, DOI 10.1002/j.1460-2075.1994.tb06518.x; FILMUS J, 1985, BIOCHEM BIOPH RES CO, V128, P898, DOI 10.1016/0006-291X(85)90131-7; Fischer G, 1998, FEBS LETT, V426, P17, DOI 10.1016/S0014-5793(98)00242-7; Gothel SF, 1999, CELL MOL LIFE SCI, V55, P423, DOI 10.1007/s000180050299; Guntert Peter, 2004, Methods Mol Biol, V278, P353; HANDSCHUMACHER RE, 1984, SCIENCE, V226, P544, DOI 10.1126/science.6238408; Hashimoto Y, 1998, J BIOL CHEM, V273, P17186, DOI 10.1074/jbc.273.27.17186; Hemmeryckx B, 2002, ONCOGENE, V21, P3225, DOI 10.1038/sj.onc.1205452; Howard BA, 2005, CANCER RES, V65, P8853, DOI 10.1158/0008-5472.CAN-05-1219; Howard BR, 2003, NAT STRUCT BIOL, V10, P475, DOI 10.1038/nsb927; Hu YL, 2014, SCI REP-UK, V4, DOI 10.1038/srep06024; Jankowski W, 2012, NAT CHEM BIOL, V8, P590, DOI [10.1038/NCHEMBIO.954, 10.1038/nchembio.954]; Klemke RL, 1998, J CELL BIOL, V140, P961, DOI 10.1083/jcb.140.4.961; Kobashigawa Y, 2007, NAT STRUCT MOL BIOL, V14, P503, DOI 10.1038/nsmb1241; Kumar S, 2014, J CELL BIOCHEM, V115, P819, DOI 10.1002/jcb.24749; Lee J, 2010, J INT MED RES, V38, P1561, DOI 10.1177/147323001003800501; Li ZY, 2008, MOL CELL PROTEOMICS, V7, P1810, DOI 10.1074/mcp.M700544-MCP200; Linghu H, 2006, ONCOGENE, V25, P3547, DOI 10.1038/sj.onc.1209398; Miller CT, 2003, ONCOGENE, V22, P7950, DOI 10.1038/sj.onc.1206529; Nath PR, 2014, J IMMUNOL, V193, P3966, DOI 10.4049/jimmunol.1303485; Nigro P, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.410; Nishihara H, 2002, CANCER LETT, V180, P55, DOI 10.1016/S0304-3835(01)00763-7; Noren NK, 2006, NAT CELL BIOL, V8, P815, DOI 10.1038/ncb1438; Obchoei S, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-102; Petschnigg J, 2014, NAT METHODS, V11, P585, DOI [10.1038/NMETH.2895, 10.1038/nmeth.2895]; Piotukh K, 2005, J BIOL CHEM, V280, P23668, DOI 10.1074/jbc.M503405200; Reichman C, 2005, ONCOGENE, V24, P8187, DOI 10.1038/sj.onc.1208988; ROSEN MK, 1995, NATURE, V374, P477, DOI 10.1038/374477a0; RYFFEL B, 1991, IMMUNOLOGY, V72, P399; Sarkar P, 2007, MOL CELL, V25, P413, DOI 10.1016/j.molcel.2007.01.004; Sarkar P, 2011, NAT CHEM BIOL, V7, P51, DOI 10.1038/NCHEMBIO.494; Schmidpeter PAM, 2014, ACS CHEM BIOL, V9, P1145, DOI 10.1021/cb500001n; Shen Y, 2013, J BIOMOL NMR, V56, P227, DOI 10.1007/s10858-013-9741-y; Shishido T, 2001, GENES CELLS, V6, P431, DOI 10.1046/j.1365-2443.2001.00431.x; Sirvent A, 2008, BIOL CELL, V100, P617, DOI 10.1042/BC20080020; Sriram G, 2011, ONCOGENE, V30, P4645, DOI 10.1038/onc.2011.170; STEWART T, 1995, LANCET, V346, P796, DOI 10.1016/S0140-6736(95)91618-0; Takino T, 2003, J CELL SCI, V116, P3145, DOI 10.1242/jcs.00632; Takino T, 2003, CANCER RES, V63, P2335; Ting AY, 2001, P NATL ACAD SCI USA, V98, P15003, DOI 10.1073/pnas.211564598; Watanabe T, 2009, MOL CANCER RES, V7, P1582, DOI 10.1158/1541-7786.MCR-09-0064; Yamada S, 2011, CANCER LETT, V303, P84, DOI 10.1016/j.canlet.2011.01.004	56	22	27	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	FEB	2016	12	2					117	+		10.1038/NCHEMBIO.1981	http://dx.doi.org/10.1038/NCHEMBIO.1981			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DC6GG	26656091	Green Accepted			2022-12-25	WOS:000369317300015
J	Chang, JH; Wang, YY; Shao, LJ; Laberge, RM; Demaria, M; Campisi, J; Janakiraman, K; Sharpless, NE; Ding, S; Feng, W; Luo, Y; Wang, XY; Aykin-Burns, N; Krager, K; Ponnappan, U; Hauer-Jensen, M; Meng, AM; Zhou, DH				Chang, Jianhui; Wang, Yingying; Shao, Lijian; Laberge, Remi-Martin; Demaria, Marco; Campisi, Judith; Janakiraman, Krishnamurthy; Sharpless, Norman E.; Ding, Sheng; Feng, Wei; Luo, Yi; Wang, Xiaoyan; Aykin-Burns, Nukhet; Krager, Kimberly; Ponnappan, Usha; Hauer-Jensen, Martin; Meng, Aimin; Zhou, Daohong			Clearance of senescent cells by ABT263 rejuvenates aged hematopoietic stem cells in mice	NATURE MEDICINE			English	Article							IONIZING-RADIATION; IN-VIVO; CELLULAR SENESCENCE; SECRETORY PHENOTYPE; INHIBITOR; P16(INK4A); POTENT; EXPRESSION; FAMILY; INJURY	Senescent cells (SCs) accumulate with age and after genotoxic stress, such as total-body irradiation (TBI)(1-6). Clearance of SCs in a progeroid mouse model using a transgenic approach delays several age-associated disorders(7), suggesting that SCs play a causative role in certain age-related pathologies. Thus, a 'senolytic' pharmacological agent that can selectively kill SCs holds promise for rejuvenating tissue stem cells and extending health span. To test this idea, we screened a collection of compounds and identified ABT263 (a specific inhibitor of the anti-apoptotic proteins BCL-2 and BCL-xL) as a potent senolytic drug. We show that ABT263 selectively kills SCs in culture in a cell type-and species-independent manner by inducing apoptosis. Oral administration of ABT263 to either sublethally irradiated or normally aged mice effectively depleted SCs, including senescent bone marrow hematopoietic stem cells (HSCs) and senescent muscle stem cells (MuSCs). Notably, this depletion mitigated TBI-induced premature aging of the hematopoietic system and rejuvenated the aged HSCs and MuSCs in normally aged mice. Our results demonstrate that selective clearance of SCs by a pharmacological agent is beneficial in part through its rejuvenation of aged tissue stem cells. Thus, senolytic drugs may represent a new class of radiation mitigators and anti-aging agents.	[Chang, Jianhui; Wang, Yingying; Shao, Lijian; Feng, Wei; Luo, Yi; Wang, Xiaoyan; Aykin-Burns, Nukhet; Krager, Kimberly; Hauer-Jensen, Martin; Zhou, Daohong] Univ Arkansas Med Sci, Dept Pharmaceut Sci, Little Rock, AR 72205 USA; [Chang, Jianhui; Wang, Yingying; Shao, Lijian; Feng, Wei; Luo, Yi; Wang, Xiaoyan; Aykin-Burns, Nukhet; Krager, Kimberly; Hauer-Jensen, Martin; Zhou, Daohong] Univ Arkansas Med Sci, Winthrop P Rockefeller Canc Inst, Little Rock, AR 72205 USA; [Wang, Yingying; Meng, Aimin] Chinese Acad Med Sci, Peking Union Med Coll, Inst Radiat Med, Tianjin, Peoples R China; [Laberge, Remi-Martin; Demaria, Marco; Campisi, Judith] Buck Inst Res Aging, Novato, CA USA; [Campisi, Judith] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA; [Janakiraman, Krishnamurthy; Sharpless, Norman E.] Univ N Carolina, Dept Med & Genet, Chapel Hill, NC USA; [Ding, Sheng] Gladstone Inst Cardiovasc Dis, San Francisco, CA USA; [Ponnappan, Usha] Univ Arkansas Med Sci, Dept Microbiol & Immunol, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Radiation Medicine - CAMS; Peking Union Medical College; Buck Institute for Research on Aging; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of North Carolina; University of North Carolina Chapel Hill; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of Arkansas System; University of Arkansas Medical Sciences	Zhou, DH (corresponding author), Univ Arkansas Med Sci, Dept Pharmaceut Sci, Little Rock, AR 72205 USA.	dzhou@uams.edu	Demaria, Marco/AAH-9235-2019; wang, yi/GVT-8516-2022; wang, yan/GSE-6489-2022; wang, yingying/GRS-3058-2022; Shao, Lijian/AAA-1074-2020	Demaria, Marco/0000-0002-8429-4813; Sharpless, Norman/0000-0001-7078-9455	US National Institutes of Health (NIH) [R01 CA122023, R01 AI080421, P20 GM109005, R37 AG009909]; Edward P. Evans Foundation; National Natural Science Foundation of China [81129020]; China National Program on Key Basic Research Project [2011CB964800-G]; Arkansas Research Alliance Scholarship from the Arkansas Science & Technology Authority; NATIONAL CANCER INSTITUTE [R01CA122023] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080421] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM109005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG024379, R37AG009909] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Edward P. Evans Foundation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China National Program on Key Basic Research Project; Arkansas Research Alliance Scholarship from the Arkansas Science & Technology Authority; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank G. van Zant (University of Kentucky) for FBMD-1 stromal cells. This study was supported by the US National Institutes of Health (NIH) grants R01 CA122023 (D.Z.), R01 AI080421 (D.Z.), P20 GM109005 (M.H.-J. and D.Z.) and R37 AG009909 (J. Campisi); a grant from the Edward P. Evans Foundation (D.Z. and M.H.-J.); National Natural Science Foundation of China grant no. 81129020 (D.Z.); China National Program on Key Basic Research Project 2011CB964800-G (A.M.); and an Arkansas Research Alliance Scholarship from the Arkansas Science & Technology Authority (D.Z.).	Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600; Beerman I, 2010, CURR OPIN IMMUNOL, V22, P500, DOI 10.1016/j.coi.2010.06.007; Blau HM, 2015, NAT MED, V21, P854, DOI 10.1038/nm.3918; Burd CE, 2013, CELL, V152, P340, DOI 10.1016/j.cell.2012.12.010; Carbonneau CL, 2012, BLOOD, V119, P717, DOI 10.1182/blood-2011-06-361626; Caserta TM, 2003, APOPTOSIS, V8, P345, DOI 10.1023/A:1024116916932; Cerletti M, 2012, CELL STEM CELL, V10, P515, DOI 10.1016/j.stem.2012.04.002; Childs BG, 2014, EMBO REP, V15, P1139, DOI 10.15252/embr.201439245; Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Cosgrove BD, 2014, NAT MED, V20, P255, DOI 10.1038/nm.3464; Czabotar PE, 2014, NAT REV MOL CELL BIO, V15, P49, DOI 10.1038/nrm3722; Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191; Demaria M, 2014, DEV CELL, V31, P722, DOI 10.1016/j.devcel.2014.11.012; Dykstra B, 2011, J EXP MED, V208, P2691, DOI 10.1084/jem.20111490; Finney D.J, 1952, STAT METHOD BIOL ASS; Fleenor CJ, 2010, CELL CYCLE, V9, P3005, DOI 10.4161/cc.9.15.12311; GALE RP, 1988, HEMATOPOIESIS LONG T, P63; Geiger H, 2005, P NATL ACAD SCI USA, V102, P5102, DOI 10.1073/pnas.0408654102; Geiger H, 2013, NAT REV IMMUNOL, V13, P376, DOI 10.1038/nri3433; Harfouche G, 2010, MUTAT RES-REV MUTAT, V704, P167, DOI 10.1016/j.mrrev.2010.01.007; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Janzen V, 2006, NATURE, V443, P421, DOI 10.1038/nature05159; Jozefczuk J, 2012, JOVE-J VIS EXP, DOI 10.3791/3854; Le Couteur DG, 2012, J GERONTOL A-BIOL, V67, P168, DOI 10.1093/gerona/glr095; Le ONL, 2010, AGING CELL, V9, P398, DOI 10.1111/j.1474-9726.2010.00567.x; Lessene G, 2013, NAT CHEM BIOL, V9, P390, DOI [10.1038/NCHEMBIO.1246, 10.1038/nchembio.1246]; LOHRMANN HPE, 1988, HEMATOPOIESIS LONG T, P325; Munoz-Espin D, 2014, NAT REV MOL CELL BIO, V15, P482, DOI 10.1038/nrm3823; Richardson RB, 2009, AGING-US, V1, P887, DOI 10.18632/aging.100081; Rudin CM, 2012, CLIN CANCER RES, V18, P3163, DOI 10.1158/1078-0432.CCR-11-3090; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Shao LJ, 2014, BLOOD, V123, P3105, DOI 10.1182/blood-2013-07-515619; Shao LJ, 2014, ANTIOXID REDOX SIGN, V20, P1447, DOI 10.1089/ars.2013.5635; Sorrentino JA, 2014, J CLIN INVEST, V124, P169, DOI 10.1172/JCI70960; Souers AJ, 2013, NAT MED, V19, P202, DOI 10.1038/nm.3048; Tchkonia T, 2013, J CLIN INVEST, V123, P966, DOI 10.1172/JCI64098; TESTA NG, 1985, ANTICANCER RES, V5, P101; Tse C, 2008, CANCER RES, V68, P3421, DOI 10.1158/0008-5472.CAN-07-5836; van Deursen JM, 2014, NATURE, V509, P439, DOI 10.1038/nature13193; Wang Y, 2004, EXP CELL RES, V298, P188, DOI 10.1016/j.yexcr.2004.04.012; Wang Y, 2006, BLOOD, V107, P358, DOI 10.1182/blood-2005-04-1418; Wang Y, 2011, INT J RADIAT ONCOL, V81, P839, DOI 10.1016/j.ijrobp.2010.09.048; Zhu Y, 2015, AGING CELL, V14, P644, DOI 10.1111/acel.12344	44	889	917	9	225	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2016	22	1					78	+		10.1038/nm.4010	http://dx.doi.org/10.1038/nm.4010			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DA1YA	26657143	Green Submitted, Green Accepted, Green Published			2022-12-25	WOS:000367590700018
J	Wanzel, I; Vischedyk, JB; Gittler, MP; Gremke, N; Seiz, JR; Hefter, M; Noack, M; Savai, R; Mernberger, M; Charles, JP; Schneikert, J; Bretz, AC; Nist, A; Stiewe, T				Wanzel, Ichael; Vischedyk, Jonas B.; Gittler, Miriam P.; Gremke, Niklas; Seiz, Julia R.; Hefter, Mirjam; Noack, Magdalena; Savai, Rajkumar; Mernberger, Marco; Charles, Joel P.; Schneikert, Jean; Bretz, Anne Catherine; Nist, Andrea; Stiewe, Thorsten			CRISPR-Cas9-based target validation for p53-reactivating model compounds	NATURE CHEMICAL BIOLOGY			English	Article							SMALL-MOLECULE RITA; IN-VIVO; P53 RESTORATION; FANCD2 MONOUBIQUITINATION; CANCER-CELLS; MUTANT P53; DNA; ACTIVATION; RESISTANCE; PATHWAY	Inactivation of the p53 tumor suppressor by Mdm2 is one of the most frequent events in cancer, so compounds targeting the p53-Mdm2 interaction are promising for cancer therapy. Mechanisms conferring resistance to p53-reactivating compounds are largely unknown. Here we show using CRISPR-Cas9-based target validation in lung and colorectal cancer that the activity of nutlin, which blocks the p53-binding pocket of Mdm2, strictly depends on functional p53. In contrast, sensitivity to the drug RITA, which binds the Mdm2-interacting N terminus of p53, correlates with induction of DNA damage. Cells with primary or acquired RITA resistance display cross-resistance to DNA crosslinking compounds such as cisplatin and show increased DNA cross-link repair. Inhibition of FancD2 by RNA interference or pharmacological mTOR inhibitors restores RITA sensitivity. The therapeutic response to p53-reactivating compounds is therefore limited by compound-specific resistance mechanisms that can be resolved by CRISPR-Cas9-based target validation and should be considered when allocating patients to p53-reactivating treatments.	[Wanzel, Ichael; Vischedyk, Jonas B.; Gittler, Miriam P.; Gremke, Niklas; Seiz, Julia R.; Hefter, Mirjam; Noack, Magdalena; Mernberger, Marco; Charles, Joel P.; Schneikert, Jean; Bretz, Anne Catherine; Nist, Andrea; Stiewe, Thorsten] Univ Marburg, Inst Mol Oncol, Marburg, Germany; [Wanzel, Ichael; Savai, Rajkumar; Stiewe, Thorsten] UGMLC, German Ctr Lung Res DZL, Berlin, Germany; [Savai, Rajkumar] Max Planck Inst Heart & Lung Res, Dept Lung Dev & Remodeling, Bad Nauheim, Germany; [Savai, Rajkumar] Univ Giessen, Dept Internal Med, Giessen, Germany; [Nist, Andrea; Stiewe, Thorsten] Univ Marburg, Genom Core Facil, Marburg, Germany	Philipps University Marburg; Max Planck Society; Justus Liebig University Giessen; Philipps University Marburg	Wanzel, I (corresponding author), Univ Marburg, Inst Mol Oncol, Marburg, Germany.	thorsten.stiewe@uni-marburg.de		Stiewe, Thorsten/0000-0003-0134-7826; Vischedyk, Jonas Bernhard/0000-0001-7759-8934	Deutsche Forschungsgemeinschaft grants [WA 2725/1-1, TRR81, STI 182/3-2, STI 182/7-1]; European Research Council grant [P73CANCER 260431]; Deutsche Krebshilfe grant [111250]; Deutsche Jose Carreras Leukamie-Stiftung grant; Von-Behring-Rontgen-Stiftung grant; Rhon Klinikum AG grant; LOEWE Universities of Giessen and Marburg Lung Center grant	Deutsche Forschungsgemeinschaft grants(German Research Foundation (DFG)); European Research Council grant(European Research Council (ERC)); Deutsche Krebshilfe grant(Deutsche Krebshilfe); Deutsche Jose Carreras Leukamie-Stiftung grant; Von-Behring-Rontgen-Stiftung grant; Rhon Klinikum AG grant; LOEWE Universities of Giessen and Marburg Lung Center grant	We thank B. Vogelstein (John Hopkins University) for providing HCT116 p53<SUP>-/-</SUP> cells and A. Filmer for excellent technical assistance with next-generation sequencing. The authors are grateful to the members of the Stiewe laboratory for fruitful discussions and support of the project. This research was supported by Deutsche Forschungsgemeinschaft grants WA 2725/1-1 (M.W.), TRR81 (T.S.), STI 182/3-2 (T.S.) and STI 182/7-1 (T.S.); European Research Council grant P73CANCER 260431 (T.S.); Deutsche Krebshilfe grant 111250 (T.S.); Deutsche Jose Carreras Leukamie-Stiftung grant (T.S.), Von-Behring-Rontgen-Stiftung grant (T.S.), Rhon Klinikum AG grant (T.S.) and LOEWE Universities of Giessen and Marburg Lung Center grant (T.S.).	Beck B, 2013, NAT REV CANCER, V13, P727, DOI 10.1038/nrc3597; Bertolini G, 2009, P NATL ACAD SCI USA, V106, P16281, DOI 10.1073/pnas.0905653106; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Burmakin M, 2013, CLIN CANCER RES, V19, P5092, DOI 10.1158/1078-0432.CCR-12-2211; Charles JP, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4981; Cheok CF, 2011, NAT REV CLIN ONCOL, V8, P25, DOI 10.1038/nrclinonc.2010.174; Chresta CM, 2010, CANCER RES, V70, P288, DOI 10.1158/0008-5472.CAN-09-1751; de Lange J, 2012, CELL DEATH DIFFER, V19, P980, DOI 10.1038/cdd.2011.182; Enge M, 2009, CANCER CELL, V15, P171, DOI 10.1016/j.ccr.2009.01.019; Feldser DM, 2010, NATURE, V468, P572, DOI 10.1038/nature09535; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Grinkevich VV, 2009, CANCER CELL, V15, P441, DOI 10.1016/j.ccr.2009.03.021; Guo F, 2013, LEUKEMIA, V27, P2040, DOI 10.1038/leu.2013.93; Guzman C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092444; Hedstrom E, 2009, CELL CYCLE, V8, P3584, DOI 10.4161/cc.8.21.9977; Hoe KK, 2014, NAT REV DRUG DISCOV, V13, P217, DOI 10.1038/nrd4236; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Issaeva N, 2004, NAT MED, V10, P1321, DOI 10.1038/nm1146; Kachnic LA, 2011, CANCER LETT, V305, P86, DOI 10.1016/j.canlet.2011.02.030; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Kasap C, 2014, NAT CHEM BIOL, V10, P626, DOI 10.1038/nchembio.1551; Kelland L, 2007, NAT REV CANCER, V7, P573, DOI 10.1038/nrc2167; Kim H, 2012, GENE DEV, V26, P1393, DOI 10.1101/gad.195248.112; Krajewski M, 2005, NAT MED, V11, P1135, DOI 10.1038/nm1105-1135; Kussie PH, 1996, SCIENCE, V274, P948, DOI 10.1126/science.274.5289.948; Lau LMS, 2008, ONCOGENE, V27, P997, DOI 10.1038/sj.onc.1210707; Martins CP, 2006, CELL, V127, P1323, DOI 10.1016/j.cell.2006.12.007; Meng XJ, 2009, ONCOL REP, V21, P995, DOI 10.3892/or_00000314; Michaelis M, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.129; Michaelis M, 2009, CANCER RES, V69, P416, DOI 10.1158/0008-5472.CAN-08-1856; Niedernhofer LJ, 2004, MOL CELL BIOL, V24, P5776, DOI 10.1128/MCB.24.13.5776-5787.2004; Nieves-Neira W, 1999, MOL PHARMACOL, V56, P478, DOI 10.1124/mol.56.3.478; Pant V, 2014, GENE DEV, V28, P1739, DOI 10.1101/gad.247452.114; Park HK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013313; Pickering A, 2013, CELL CYCLE, V12, P3448, DOI 10.4161/cc.26387; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Schlereth K, 2010, MOL CELL, V38, P356, DOI 10.1016/j.molcel.2010.02.037; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shen CX, 2013, CANCER RES, V73, P3393, DOI 10.1158/0008-5472.CAN-12-4282; Smurnyy Y, 2014, NAT CHEM BIOL, V10, P623, DOI 10.1038/nchembio.1550; Song IY, 2010, J BIOL CHEM, V285, P31525, DOI 10.1074/jbc.M110.138206; Tovar C, 2006, P NATL ACAD SCI USA, V103, P1888, DOI 10.1073/pnas.0507493103; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Wei X, 2012, BIOINFORMATICS, V28, P301, DOI 10.1093/bioinformatics/btr676; Weilbacher A, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.284; Williams SA, 2011, BLOOD, V117, P5078, DOI 10.1182/blood-2010-10-311761; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Zhang J, 2008, CELL CYCLE, V7, P407, DOI 10.4161/cc.7.3.5156; Zhao CY, 2010, CELL CYCLE, V9, P1847, DOI 10.4161/cc.9.9.11545	51	59	63	0	57	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2016	12	1					22	+		10.1038/NCHEMBIO.1965	http://dx.doi.org/10.1038/NCHEMBIO.1965			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY8QW	26595461	Green Accepted			2022-12-25	WOS:000366674400007
J	Fromme, P				Fromme, Petra			XFELs open a new era in structural chemical biology	NATURE CHEMICAL BIOLOGY			English	Article							SERIAL FEMTOSECOND CRYSTALLOGRAPHY; FREE-ELECTRON LASER; DELTA-OPIOID RECEPTOR; X-RAY LASER; CRYSTAL-STRUCTURE; PROTEIN NANOCRYSTALLOGRAPHY; RESOLUTION		[Fromme, Petra] Arizona State Univ, Sch Mol Sci, Tempe, AZ 85281 USA; [Fromme, Petra] Arizona State Univ, Biodesign Inst, Ctr Appl Struct Discovery, Tempe, AZ USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe	Fromme, P (corresponding author), Arizona State Univ, Sch Mol Sci, Tempe, AZ 85281 USA.	pfromme@asu.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095583, U54GM094599] Funding Source: NIH RePORTER; NIGMS NIH HHS [U54GM094599, R01 GM095583] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abdallah BG, 2015, ANAL CHEM, V87, P4159, DOI 10.1021/acs.analchem.5b00589; Aquila A, 2012, OPT EXPRESS, V20, P2706, DOI 10.1364/OE.20.002706; Barends TRM, 2014, NATURE, V505, P244, DOI 10.1038/nature12773; Boutet S, 2012, SCIENCE, V337, P362, DOI 10.1126/science.1217737; Chapman HN, 2006, NAT PHYS, V2, P839, DOI 10.1038/nphys461; Chapman HN, 2011, NATURE, V470, P73, DOI 10.1038/nature09750; Chen JPJ, 2014, ACTA CRYSTALLOGR A, V70, P154, DOI 10.1107/S2053273313032725; Conrad CE, 2015, IUCRJ, V2, P421, DOI 10.1107/S2052252515009811; Fenalti G, 2015, NAT STRUCT MOL BIOL, V22, P265, DOI 10.1038/nsmb.2965; Fenalti G, 2014, NATURE, V506, P191, DOI 10.1038/nature12944; Hirata K, 2014, NAT METHODS, V11, P734, DOI [10.1038/nmeth.2962, 10.1038/NMETH.2962]; Hunter MS, 2011, METHODS, V55, P387, DOI 10.1016/j.ymeth.2011.12.006; Kang YY, 2015, NATURE, V523, P561, DOI 10.1038/nature14656; Kern J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5371; Kissick DJ, 2011, ANNU REV ANAL CHEM, V4, P419, DOI 10.1146/annurev.anchem.111808.073722; Koopmann R, 2012, NAT METHODS, V9, P259, DOI [10.1038/NMETH.1859, 10.1038/nmeth.1859]; Kupitz C, 2014, NATURE, V513, P261, DOI 10.1038/nature13453; Kupitz C, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0316; Liu W, 2013, SCIENCE, V342, P1521, DOI 10.1126/science.1244142; Neutze R, 2012, CURR OPIN STRUC BIOL, V22, P651, DOI 10.1016/j.sbi.2012.08.006; Nogly P, 2015, IUCRJ, V2, P168, DOI 10.1107/S2052252514026487; Redecke L, 2013, SCIENCE, V339, P227, DOI 10.1126/science.1229663; Sawaya MR, 2014, P NATL ACAD SCI USA, V111, P12769, DOI 10.1073/pnas.1413456111; SAYRE D, 1952, ACTA CRYSTALLOGR, V5, P843, DOI 10.1107/S0365110X52002276; Suga M, 2015, NATURE, V517, P99, DOI 10.1038/nature13991; Tenboer J, 2014, SCIENCE, V346, P1242, DOI 10.1126/science.1259357; Wang DJ, 2014, J SYNCHROTRON RADIAT, V21, P1364, DOI 10.1107/S160057751401858X; Weierstall U, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.3693040; Weierstall U, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4309; Zhang HT, 2015, CELL, V161, P833, DOI 10.1016/j.cell.2015.04.011	30	29	29	1	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2015	11	12					895	899		10.1038/nchembio.1968	http://dx.doi.org/10.1038/nchembio.1968			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX6TG	26575227	Green Accepted			2022-12-25	WOS:000365834000003
J	Miner, JJ; Daniels, BP; Shrestha, B; Proenca-Modena, JL; Lew, ED; Lazear, HM; Gorman, MJ; Lemke, G; Klein, RS; Diamond, MS				Miner, Jonathan J.; Daniels, Brian P.; Shrestha, Bimmi; Proenca-Modena, Jose L.; Lew, Erin D.; Lazear, Helen M.; Gorman, Matthew J.; Lemke, Greg; Klein, Robyn S.; Diamond, Michael S.			The TAM receptor Mertk protects against neuroinvasive viral infection by maintaining blood-brain barrier integrity	NATURE MEDICINE			English	Article							WEST-NILE-VIRUS; CENTRAL-NERVOUS-SYSTEM; CD8(+) T-CELLS; TYROSINE KINASES; IMMUNE-RESPONSES; THROMBUS STABILIZATION; APOPTOTIC CELLS; IN-VIVO; AXL; ACTIVATION	The TAM receptors Tyro3, Axl and Mertk are receptor tyrosine kinases that dampen host innate immune responses following engagement with their ligands Gas6 and Protein S, which recognize phosphatidylserine on apoptotic cells. In a form of apoptotic mimicry, many enveloped viruses display phosphatidylserine on the outer leaflet of their membranes, enabling TAM receptor activation and downregulation of antiviral responses. Accordingly, we hypothesized that a deficiency of TAM receptors would enhance antiviral responses and protect against viral infection. Unexpectedly, mice lacking Mertk and/or Axl, but not Tyro3, exhibited greater vulnerability to infection with neuroinvasive West Nile and La Crosse encephalitis viruses. This phenotype was associated with increased blood-brain barrier permeability, which enhanced virus entry into and infection of the brain. Activation of Mertk synergized with interferon-b to tighten cell junctions and prevent virus transit across brain microvascular endothelial cells. Because TAM receptors restrict pathogenesis of neuroinvasive viruses, these findings have implications for TAM antagonists that are currently in clinical development.	[Miner, Jonathan J.; Shrestha, Bimmi; Proenca-Modena, Jose L.; Lazear, Helen M.; Klein, Robyn S.; Diamond, Michael S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Daniels, Brian P.; Klein, Robyn S.] Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; [Proenca-Modena, Jose L.] Univ Campinas UNICAMP, Inst Biol, Dept Genet Evolut & Bioagents, Campinas, SP, Brazil; [Lew, Erin D.; Lemke, Greg] Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA USA; [Lazear, Helen M.] Univ N Carolina, Sch Med, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA; [Gorman, Matthew J.; Klein, Robyn S.; Diamond, Michael S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA; [Diamond, Michael S.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Diamond, Michael S.] Washington Univ, Sch Med, Ctr Human Immunol & Immunotherapy Programs, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL); Universidade de Sao Paulo; Universidade Estadual de Campinas; Salk Institute; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.	diamond@borcim.wustl.edu	Proenca-Modena, Jose Luiz/C-8231-2014; Diamond, Michael/AAH-1733-2019	Proenca-Modena, Jose Luiz/0000-0002-4996-3153; Diamond, Michael/0000-0002-8791-3165; Lazear, Helen/0000-0002-8649-4579	US National Institutes of Health (NIH) [U19 AI083019, R01 AI101400, R01 NS052632, R01 NS085296]; NIH training grant [T32-AR007279]; Rheumatology Research Foundation Scientist Development Award; National Science Foundation Graduate Research Fellowship [DGE-1143954]; NIH predoctoral fellowship [F31-NS07866]; Leukemia and Lymphoma Society; Nomis Foundation; NATIONAL CANCER INSTITUTE [P30CA014195] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI101400, U19AI083019] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007279] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS085296, R01NS052632] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH training grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rheumatology Research Foundation Scientist Development Award; National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); NIH predoctoral fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Nomis Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by US National Institutes of Health (NIH) grants U19 AI083019 (M.S.D. and R.S.K.), R01 AI101400 (M.S.D. and G.L.), R01 NS052632 (R.S.K.) and R01 NS085296 (G.L.). J.J.M. was supported by an NIH training grant (T32-AR007279) and a Rheumatology Research Foundation Scientist Development Award. B.P.D. was supported by a National Science Foundation Graduate Research Fellowship (DGE-1143954) and an NIH predoctoral fellowship (F31-NS07866). E.D.L. was supported by postdoctoral fellowships from the Leukemia and Lymphoma Society and the Nomis Foundation. We thank A. Pekosz (Johns Hopkins University) for the original LACV strain.	Angelillo-Scherrer A, 2005, J CLIN INVEST, V115, P237, DOI 10.1172/JCI200522079; Bhattacharyya S, 2013, CELL HOST MICROBE, V14, P136, DOI 10.1016/j.chom.2013.07.005; Brien JD, 2007, EUR J IMMUNOL, V37, P1855, DOI 10.1002/eji.200737196; Brinton MA, 2014, VIRUSES-BASEL, V6, P13, DOI 10.3390/v6010013; Burstyn-Cohen T, 2009, J CLIN INVEST, V119, P2942, DOI 10.1172/JCI39325; Caraux A, 2006, NAT IMMUNOL, V7, P747, DOI 10.1038/ni1353; Chung WS, 2013, NATURE, V504, P394, DOI 10.1038/nature12776; Cosemans JMEM, 2010, J THROMB HAEMOST, V8, P1797, DOI 10.1111/j.1538-7836.2010.03935.x; Daniels BP, 2014, MBIO, V5, DOI 10.1128/mBio.01476-14; Diamond MS, 2003, J EXP MED, V198, P1853, DOI 10.1084/jem.20031223; Diamond MS, 2003, J VIROL, V77, P2578, DOI 10.1128/JVI.77.4.2578-2586.2003; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fraineau S, 2012, BLOOD, V120, P5073, DOI 10.1182/blood-2012-05-429183; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Graham DK, 2014, NAT REV CANCER, V14, P769, DOI 10.1038/nrc3847; Holland SJ, 2010, CANCER RES, V70, P1544, DOI 10.1158/0008-5472.CAN-09-2997; Holland SJ, 2005, CANCER RES, V65, P9294, DOI 10.1158/0008-5472.CAN-05-0993; Howell GR, 2012, J CLIN INVEST, V122, P1246, DOI 10.1172/JCI61135; Ji R, 2013, J IMMUNOL, V191, P6165, DOI 10.4049/jimmunol.1302229; Lazear HM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4304; Lazear HM, 2013, J VIROL, V87, P11401, DOI 10.1128/JVI.01403-13; Lemke G, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a009076; Lew ED, 2014, ELIFE, V3, DOI 10.7554/eLife.03385; Li QT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064812; Lu QX, 2001, SCIENCE, V293, P306, DOI 10.1126/science.1061663; Mahajan NP, 2003, J BIOL CHEM, V278, P42596, DOI 10.1074/jbc.M305817200; McJunkin JE, 2001, NEW ENGL J MED, V344, P801, DOI 10.1056/NEJM200103153441103; Meertens L, 2012, CELL HOST MICROBE, V12, P544, DOI 10.1016/j.chom.2012.08.009; Mehlhop E, 2006, J EXP MED, V203, P1371, DOI 10.1084/jem.20052388; Paolino M, 2014, NATURE, V507, P508, DOI 10.1038/nature12998; Prasad D, 2006, MOL CELL NEUROSCI, V33, P96, DOI 10.1016/j.mcn.2006.06.011; Prieto AL, 2000, J COMP NEUROL, V425, P295; Purtha WE, 2007, EUR J IMMUNOL, V37, P1845, DOI 10.1002/eji.200737192; Rothlin CV, 2007, CELL, V131, P1124, DOI 10.1016/j.cell.2007.10.034; Samuel MA, 2006, J VIROL, V80, P7009, DOI 10.1128/JVI.00489-06; Scott RS, 2001, NATURE, V411, P207, DOI 10.1038/35075603; Sheehan KCF, 2006, J INTERF CYTOK RES, V26, P804, DOI 10.1089/jir.2006.26.804; Sheridan C, 2013, NAT BIOTECHNOL, V31, P775, DOI 10.1038/nbt0913-775a; Shibata T, 2014, J IMMUNOL, V192, P3569, DOI 10.4049/jimmunol.1302766; Shrestha B, 2004, J VIROL, V78, P8312, DOI [10.1128/JVI.78.15.8312-8321.2004, 10.1128/jvi.78.15.8312-8321.2004]; Suarez RM, 2013, EUR J MED CHEM, V61, P2, DOI 10.1016/j.ejmech.2012.06.005; Subramanian M, 2014, J CLIN INVEST, V124, P1296, DOI 10.1172/JCI72051; Thackray LB, 2014, J VIROL, V88, P11007, DOI 10.1128/JVI.01545-14; Thackray LB, 2012, J VIROL, V86, P13515, DOI 10.1128/JVI.01824-12; Tibrewal N, 2008, J BIOL CHEM, V283, P3618, DOI 10.1074/jbc.M706906200; van den Brand BT, 2013, ARTHRITIS RHEUM-US, V65, P671, DOI 10.1002/art.37786; Verma A, 2011, MOL CANCER THER, V10, P1763, DOI 10.1158/1535-7163.MCT-11-0116; Wang T, 2004, NAT MED, V10, P1366, DOI 10.1038/nm1140; Zagorska A, 2014, NAT IMMUNOL, V15, P920, DOI 10.1038/ni.2986; Zhu DH, 2010, BLOOD, V115, P4963, DOI 10.1182/blood-2010-01-262386	50	87	93	0	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2015	21	12					1464	+		10.1038/nm.3974	http://dx.doi.org/10.1038/nm.3974			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CX9EV	26523970	Green Accepted, Green Submitted			2022-12-25	WOS:000366008700017
J	Sosso, D; Luo, DP; Li, QB; Sasse, J; Yang, JL; Gendrot, G; Suzuki, M; Koch, KE; McCarty, DR; Chourey, PS; Rogowsky, PM; Ross-Ibarra, J; Yang, B; Frommer, WB				Sosso, Davide; Luo, Dangping; Li, Qin-Bao; Sasse, Joelle; Yang, Jinliang; Gendrot, Ghislaine; Suzuki, Masaharu; Koch, Karen E.; McCarty, Donald R.; Chourey, Prem S.; Rogowsky, Peter M.; Ross-Ibarra, Jeffrey; Yang, Bing; Frommer, Wolf B.			Seed filling in domesticated maize and rice depends on SWEET-mediated hexose transport	NATURE GENETICS			English	Article							CELL-WALL INVERTASE; ZEA-MAYS-L; GENE-EXPRESSION; ENDOSPERM; CARBON; DIFFERENTIATION; TRANSCRIPTION; METABOLISM; MECHANISMS; NUTRITION	Carbohydrate import into seeds directly determines seed size and must have been increased through domestication. However, evidence of the domestication of sugar translocation and the identities of seed-filling transporters have been elusive. Maize ZmSWEET4c, as opposed to its sucrose-transporting homologs, mediates transepithelial hexose transport across the basal endosperm transfer layer (BETL), the entry point of nutrients into the seed, and shows signatures indicative of selection during domestication. Mutants of both maize ZmSWEET4c and its rice ortholog OsSWEET4 are defective in seed filling, indicating that a lack of hexose transport at the BETL impairs further transfer of sugars imported from the maternal phloem. In both maize and rice, SWEET4 was likely recruited during domestication to enhance sugar import into the endosperm.	[Sosso, Davide; Sasse, Joelle; Frommer, Wolf B.] Carnegie Sci, Dept Plant Biol, Stanford, CA 94305 USA; [Luo, Dangping; Yang, Bing] Iowa State Univ, Dept Genet Dev & Cell Biol, Ames, IA USA; [Li, Qin-Bao; Chourey, Prem S.] USDA ARS, Gainesville, FL USA; [Yang, Jinliang] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; [Gendrot, Ghislaine; Rogowsky, Peter M.] Univ Lyon 1, Ecole Normale Super Lyon, Unite Reprod & Dev Plantes, F-69365 Lyon, France; [Suzuki, Masaharu; Koch, Karen E.; McCarty, Donald R.; Chourey, Prem S.] Univ Florida, Dept Agron, Plant Mol & Cellular Biol, Gainesville, FL 32611 USA; [Ross-Ibarra, Jeffrey] Univ Calif Davis, Ctr Populat Biol, Dept Plant Sci, Davis, CA 95616 USA; [Ross-Ibarra, Jeffrey] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA	Carnegie Institution for Science; Iowa State University; United States Department of Agriculture (USDA); University of California System; University of California Davis; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); State University System of Florida; University of Florida; University of California System; University of California Davis; University of California System; University of California Davis	Sosso, D (corresponding author), Carnegie Sci, Dept Plant Biol, Stanford, CA 94305 USA.	dsosso@carnegiescience.edu	Ross-Ibarra, Jeffrey/D-7782-2011; Luo, Dangping/Z-3973-2019; Yang, Jinliang/U-6219-2019; Yang, Bing/D-3628-2019; Frommer, Wolf B/A-8256-2008; Frommer, Wolf B/K-5042-2017	Ross-Ibarra, Jeffrey/0000-0003-1656-4954; Yang, Bing/0000-0002-2293-3384; Frommer, Wolf B/0000-0001-6465-0115; Frommer, Wolf B/0000-0001-6465-0115; Rogowsky, Peter/0000-0003-4822-3783; Yang, Jinliang/0000-0002-0999-3518; Schlapfer, Joelle/0000-0001-5705-9888	Office of Basic Energy Sciences of the US Department of Energy [DE-FG02-04ER15542]; National Science Foundation [IOS-1258018, IOS-1116561, IOS-1025976, IOS-1238014]; USDA-NIFA [2010-04228]; Direct For Biological Sciences [1258103] Funding Source: National Science Foundation; Division Of Integrative Organismal Systems [1116561, 1258018] Funding Source: National Science Foundation; Div Of Molecular and Cellular Bioscience [1025976] Funding Source: National Science Foundation	Office of Basic Energy Sciences of the US Department of Energy(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF)); USDA-NIFA(United States Department of Agriculture (USDA)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We are grateful to D. Ehrhardt and H. Cartwright for confocal microscopy. For the rice experiments, we are grateful to T. Li for constructing the TALEN vector targeting OsSWEET4, B. Liu for rice transgenics, C. Ji for the isolation and transfection of rice protoplasts in the laboratory of B. Y. and X. Li for help with domestication analysis of OsSWEET4. We thank M. Greenfield, A. Grimault and K.M. Wong for plant care, Y. Gong for the yeast complementation assay, M. Evans for providing teosinte plant material and C. Stefan for renaming ZmSWEET4 with "c" for her initial. Work performed on maize in the laboratory of W.B.F. was made possible by support from the Office of Basic Energy Sciences of the US Department of Energy under grant DE-FG02-04ER15542, and work on rice was supported by the National Science Foundation under grant IOS-1258018 (B.Y. and W.B.F.); the other laboratories were supported by the National Science Foundation (IOS-1116561 to D.R.M. and K.E.K., IOS-1025976 to K.E.K. and IOS-1238014 to J.R.-I.), as well as USDA-NIFA 2010-04228 (K.E.K., D.R.M. and M.S.).	Barrero C, 2009, PLANTA, V229, P235, DOI 10.1007/s00425-008-0823-0; Berjak P, 2013, FRONT PLANT SCI, V4, DOI [10.3389/fpls.2013.00177, 10.3389/fpls.2013.00478]; Bleckmann A, 2010, PLANT PHYSIOL, V152, P166, DOI 10.1104/pp.109.149930; Borisjuk L, 2004, PLANT BIOLOGY, V6, P375, DOI 10.1055/s-2004-817908; Chen HY, 2015, PLANT J, V83, P1046, DOI 10.1111/tpj.12948; Chen LQ, 2015, PLANT CELL, V27, P607, DOI 10.1105/tpc.114.134585; Chen LQ, 2012, SCIENCE, V335, P207, DOI 10.1126/science.1213351; Chen LQ, 2010, NATURE, V468, P527, DOI 10.1038/nature09606; Cheng WH, 1996, PLANT CELL, V8, P971, DOI 10.1105/tpc.8.6.971; Cheng WH, 1999, THEOR APPL GENET, V98, P485, DOI 10.1007/s001220051096; Chourey P, 2006, PLANTA, V223, P159, DOI 10.1007/s00425-005-0039-5; Chourey PS, 2012, PLANT SCI, V184, P45, DOI 10.1016/j.plantsci.2011.12.011; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; Davidson RM, 2011, PLANT GENOME-US, V4, P191, DOI 10.3835/plantgenome2011.05.0015; de Oliveira RR, 2010, PLANT MOL BIOL REP, V28, P460, DOI 10.1007/s11105-009-0173-5; DUPREE P, 1991, PLANT J, V1, P115, DOI 10.1111/j.1365-313X.1991.00115.x; Eom JS, 2015, CURR OPIN PLANT BIOL, V25, P53, DOI 10.1016/j.pbi.2015.04.005; Flint-Garcia SA, 2009, THEOR APPL GENET, V119, P1129, DOI 10.1007/s00122-009-1115-1; Glemin S, 2009, NEW PHYTOL, V183, P273, DOI 10.1111/j.1469-8137.2009.02884.x; Gomez E, 2009, PLANT CELL, V21, P2022, DOI 10.1105/tpc.108.065409; Guo WJ, 2014, PLANT PHYSIOL, V164, P777, DOI 10.1104/pp.113.232751; Hou BH, 2011, NAT PROTOC, V6, P1818, DOI 10.1038/nprot.2011.392; Huang XH, 2012, NATURE, V490, P497, DOI 10.1038/nature11532; HUDSON RR, 1992, MOL BIOL EVOL, V9, P138; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; Hufford MB, 2012, NAT GENET, V44, P808, DOI 10.1038/ng.2309; Hunter CT, 2014, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00545; Jackson DP, 1991, MOL PLANT PATHOL, P163; JEFFERSON RA, 1987, EMBO J, V6, P3901; Kellett GL, 2008, ANNU REV NUTR, V28, P35, DOI 10.1146/annurev.nutr.28.061807.155518; Klemens PAW, 2013, PLANT PHYSIOL, V163, P1338, DOI 10.1104/pp.113.224972; Koch K, 2004, CURR OPIN PLANT BIOL, V7, P235, DOI 10.1016/j.pbi.2004.03.014; Lalonde S, 2004, ANNU REV PLANT BIOL, V55, P341, DOI 10.1146/annurev.arplant.55.031903.141758; Lemmon ZH, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004745; Li GS, 2014, P NATL ACAD SCI USA, V111, P7582, DOI 10.1073/pnas.1406383111; Li T, 2014, METHODS, V69, P9, DOI 10.1016/j.ymeth.2014.03.019; Li T, 2012, NAT BIOTECHNOL, V30, P390, DOI 10.1038/nbt.2199; Lin IW, 2014, NATURE, V508, P1, DOI 10.1038/nature13082; Lucas WJ, 2013, J INTEGR PLANT BIOL, V55, P294, DOI 10.1111/jipb.12041; McCarty DR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077172; McCarty DR, 2005, PLANT J, V44, P52, DOI 10.1111/j.1365-313X.2005.02509.x; Paradis E, 2010, BIOINFORMATICS, V26, P419, DOI 10.1093/bioinformatics/btp696; Peng JR, 1999, NATURE, V400, P256, DOI 10.1038/22307; Piperno DR, 2009, P NATL ACAD SCI USA, V106, P5019, DOI 10.1073/pnas.0812525106; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; SCHMALSTIG JG, 1987, PLANT PHYSIOL, V85, P902, DOI 10.1104/pp.85.4.902; Sekhon RS, 2011, PLANT J, V66, P553, DOI 10.1111/j.1365-313X.2011.04527.x; SHANNON JC, 1972, PLANT PHYSIOL, V49, P198, DOI 10.1104/pp.49.2.198; Sosso D, 2011, ADV MAIZE, V3, P163; Tao YY, 2015, NATURE, V527, P259, DOI 10.1038/nature15391; Thompson RD, 2001, PLANT SCI, V160, P775, DOI 10.1016/S0168-9452(01)00345-4; Thornton K, 2003, BIOINFORMATICS, V19, P2325, DOI 10.1093/bioinformatics/btg316; Wang C, 2010, PLANT MOL BIOL REP, V28, P438, DOI 10.1007/s11105-009-0172-6; Wang E, 2008, NAT GENET, V40, P1370, DOI 10.1038/ng.220; Wardini T, 2007, PROTOPLASMA, V230, P75, DOI 10.1007/s00709-006-0194-y; Wieczorke R, 1999, FEBS LETT, V464, P123, DOI 10.1016/S0014-5793(99)01698-1; Wright SI, 2005, SCIENCE, V308, P1310, DOI 10.1126/science.1107891; Xiong YQ, 2011, PLANT MOL BIOL REP, V29, P835, DOI 10.1007/s11105-011-0291-8; Zhang Y, 2011, PLANT METHODS, V7, DOI 10.1186/1746-4811-7-30; Zheng YK, 2010, PLANT CELL REP, V29, P935, DOI 10.1007/s00299-010-0891-z; Zhou JH, 2015, PLANT J, V82, P632, DOI 10.1111/tpj.12838	61	241	262	17	206	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2015	47	12					1489	+		10.1038/ng.3422	http://dx.doi.org/10.1038/ng.3422			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CX6LT	26523777				2022-12-25	WOS:000365813200023
J	Tardito, S; Oudin, A; Ahmed, SU; Fack, F; Keunen, O; Zhene, L; Miletic, H; Sakariassent, PO; Weinstock, A; Wagner, A; Lindsay, SL; Hock, AK; Barnett, SC; Ruppin, E; Morkve, SH; Lund-Johansen, M; Chalmers, AJ; Bjerkvig, R; Niclou, SP; Gottlieb, E				Tardito, Saverio; Oudin, Anais; Ahmed, Shafiq U.; Fack, Fred; Keunen, Olivier; Zhene, Liang; Miletic, Hrvoje; Sakariassent, Per Oystein; Weinstock, Adam; Wagner, Allon; Lindsay, Susan L.; Hock, Andreas K.; Barnett, Susan C.; Ruppin, Eytan; Morkve, Svein Harald; Lund-Johansen, Morten; Chalmers, Anthony J.; Bjerkvig, Rolf; Niclou, Simone P.; Gottlieb, Eyal			Glutamine synthetase activity fuels nucleotide biosynthesis and supports growth of glutamine-restricted glioblastoma	NATURE CELL BIOLOGY			English	Article							HEPATOCELLULAR-CARCINOMA; REDUCTIVE CARBOXYLATION; TRANSFORMED-CELLS; METABOLISM; EXPRESSION; REGULATOR; OXIDATION; SURVIVAL; PROTEIN; LINES	L-Giutamine (Gin) functions physiologically to balance the carbon and nitrogen requirements of tissues. It has been proposed that in cancer cells undergoing aerobic glycolysis, accelerated anabolism is sustained by Gin-derived carbons, which replenish the tricarboxylic acid (TCA) cycle (anapierosis). However, it is shown here that in glioblastoma (GBM) cells, almost half of the Gin-derived glutamate (Glu) is secreted and does not enter the TCA cycle, and that inhibiting glutaminolysis does not affect cell proliferation. Moreover, Gin-starved cells are not rescued by TCA cycle replenishment. Instead, the conversion of Giu to Gin by glutamine synthetase (GS; cataplerosis) confers Gln prototrophy, and fuels de novo purine biosynthesis. In both orthotopic GBM models and in patients, C-13-glucose tracing showed that GS produces Gin from TCA-cycle-derived carbons. Finally, the Gin required for the growth of GBM tumours is contributed only marginally by the circulation, and is mainly either autonomously synthesized by GS-positive glioma cells, or supplied by astrocytes.	[Tardito, Saverio; Zhene, Liang; Hock, Andreas K.; Gottlieb, Eyal] Beatson Inst, Canc Res UK, Canc Metab Res Unit, Glasgow G61 1BD, Lanark, Scotland; [Oudin, Anais; Fack, Fred; Keunen, Olivier; Bjerkvig, Rolf; Niclou, Simone P.] Luxembourg Inst Hlth, Dept Oncol, NorLux Neurooncol Lab, L-1526 Luxembourg, Luxembourg; [Ahmed, Shafiq U.; Chalmers, Anthony J.] Univ Glasgow, Inst Canc Sci, Glasgow G12 8QQ, Lanark, Scotland; [Miletic, Hrvoje; Sakariassent, Per Oystein; Bjerkvig, Rolf; Niclou, Simone P.] Univ Bergen, Dept Biomed, Kristian Gerhard Jebsen Brain Tumour Res Ctr, N-5009 Bergen, Norway; [Weinstock, Adam; Wagner, Allon; Ruppin, Eytan] Tel Aviv Univ, Blavatn Sch Comp Sci, IL-69978 Tel Aviv, Israel; [Lindsay, Susan L.; Barnett, Susan C.] Univ Glasgow, Coll Med Vet & Life Sci, Inst Infect Immun & Inflammat, Glasgow G12 8TA, Lanark, Scotland; [Ruppin, Eytan] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel; [Morkve, Svein Harald; Lund-Johansen, Morten] Haukeland Hosp, Dept Neurosurg, N-5021 Bergen, Norway; [Lund-Johansen, Morten] Univ Bergen, Dept Clin Med, N-5020 Bergen, Norway	Beatson Institute; Cancer Research UK; Luxembourg Institute of Health; University of Glasgow; University of Bergen; Tel Aviv University; University of Glasgow; Tel Aviv University; Sackler Faculty of Medicine; University of Bergen; Haukeland University Hospital; University of Bergen	Gottlieb, E (corresponding author), Beatson Inst, Canc Res UK, Canc Metab Res Unit, Switchback Rd, Glasgow G61 1BD, Lanark, Scotland.	e.gottlieb@beatson.gla.ac.uk	Tardito, Saverio/AAJ-7727-2020; Keunen, Olivier/AAD-1483-2022; Niclou, Simone/P-2304-2018; Ruppin, Eytan/R-9698-2017; Gottlieb, Eyal/G-6450-2010	Tardito, Saverio/0000-0002-5294-8683; Keunen, Olivier/0000-0003-2203-7026; Niclou, Simone/0000-0002-3417-9534; Ruppin, Eytan/0000-0002-7862-3940; Gottlieb, Eyal/0000-0002-9770-0956; Oudin, Anais/0000-0001-5552-9823; Wagner, Allon/0000-0001-5095-6009; Ahmed, Shafiq U/0000-0001-8701-6889	Cancer Research UK; AIRC/Marie Curie International Fellowship; Norwegian Cancer Society; Norwegian Research Council; Helse Vest; Haukeland University Hospital; K.G-Jebsen Foundation; MRC [G0802755, MR/J004731/1] Funding Source: UKRI; Cancer Research UK [18278, 18274] Funding Source: researchfish; Medical Research Council [MR/J004731/1, G0802755] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); AIRC/Marie Curie International Fellowship(Fondazione AIRC per la ricerca sul cancro); Norwegian Cancer Society(Norwegian Cancer Society); Norwegian Research Council(Research Council of NorwayEuropean Commission); Helse Vest; Haukeland University Hospital; K.G-Jebsen Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study has been supported by Cancer Research UK. S.T. is a recipient of an AIRC/Marie Curie International Fellowship for Cancer Research. The human and animal metabolomic studies were supported by The Norwegian Cancer Society, The Norwegian Research Council, Helse Vest, Haukeland University Hospital and the K.G-Jebsen Foundation. We acknowledge A. Golebiewska, V. Baus-Talko, N. Van Den Broek, G. MacKay, C. Nixon and E. MacKenzie for excellent technical assistance and A. King for excellent editorial work.	Bagga P, 2014, J CEREBR BLOOD F MET, V34, P1666, DOI 10.1038/jcbfm.2014.129; Bax DA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005209; Calise SJ, 2014, CELL MOL LIFE SCI, V71, P2963, DOI 10.1007/s00018-014-1567-6; Carruthers R, 2015, MOL ONCOL, V9, P192, DOI 10.1016/j.molonc.2014.08.003; Chiu M, 2014, BRIT J CANCER, V111, P1159, DOI 10.1038/bjc.2014.425; Dal Bello B, 2010, CLIN CANCER RES, V16, P2157, DOI 10.1158/1078-0432.CCR-09-1978; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; Duarte NC, 2007, P NATL ACAD SCI USA, V104, P1777, DOI 10.1073/pnas.0610772104; Fan J, 2013, J BIOL CHEM, V288, P31363, DOI 10.1074/jbc.M113.502740; Filonov GS, 2011, NAT BIOTECHNOL, V29, P757, DOI 10.1038/nbt.1918; Gameiro PA, 2013, CELL METAB, V17, P372, DOI 10.1016/j.cmet.2013.02.002; Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823; Had-Aissouni L, 2012, AMINO ACIDS, V42, P181, DOI 10.1007/s00726-011-0863-9; Hock AK, 2014, CELL CYCLE, V13, P220, DOI 10.4161/cc.26985; Kamphorst JJ, 2013, P NATL ACAD SCI USA, V110, P8882, DOI 10.1073/pnas.1307237110; KREBS HANS ADOLF, 1935, BIOCHEM JOUR, V29, P1951; Lewerenz J, 2013, ANTIOXID REDOX SIGN, V18, P522, DOI 10.1089/ars.2011.4391; Maher EA, 2012, NMR BIOMED, V25, P1234, DOI 10.1002/nbm.2794; Marin-Valencia I, 2012, CELL METAB, V15, P827, DOI 10.1016/j.cmet.2012.05.001; Metallo CM, 2012, NATURE, V481, P380, DOI 10.1038/nature10602; Meyerand ME, 1999, AM J NEURORADIOL, V20, P117; MOREADITH RW, 1984, J BIOL CHEM, V259, P6215; Mullen AR, 2012, NATURE, V481, P385, DOI 10.1038/nature10642; Parmentier JH, 2015, LEUKEMIA RES, V39, P757, DOI 10.1016/j.leukres.2015.04.008; Reznik E, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003195; Rosati A, 2013, NEURO-ONCOLOGY, V15, P618, DOI 10.1093/neuonc/nos338; Rosati A, 2009, J NEURO-ONCOL, V93, P319, DOI 10.1007/s11060-008-9794-z; Scott DA, 2011, J BIOL CHEM, V286, P42626, DOI 10.1074/jbc.M111.282046; Son J, 2013, NATURE, V496, P101, DOI 10.1038/nature12040; Suzuki S, 2010, P NATL ACAD SCI USA, V107, P7461, DOI 10.1073/pnas.1002459107; Takano T, 2001, NAT MED, V7, P1010, DOI 10.1038/nm0901-1010; Tardito S, 2011, CURR CANCER DRUG TAR, V11, P929, DOI 10.2174/156800911797264725; VANDENBE.CJ, 1971, BIOCHEM J, V123, P211, DOI 10.1042/bj1230211; Wang JB, 2010, CANCER CELL, V18, P207, DOI 10.1016/j.ccr.2010.08.009; Willems L, 2013, BLOOD, V122, P3521, DOI 10.1182/blood-2013-03-493163; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; Yin Y, 2013, J NEURO-ONCOL, V114, P59, DOI 10.1007/s11060-013-1168-5; Yuneva M, 2007, J CELL BIOL, V178, P93, DOI 10.1083/jcb.200703099; Yuneva MO, 2012, CELL METAB, V15, P157, DOI 10.1016/j.cmet.2011.12.015	39	325	333	4	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2015	17	12					1556	1568		10.1038/ncb3272	http://dx.doi.org/10.1038/ncb3272			13	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CX8DH	26595383	Green Accepted			2022-12-25	WOS:000365932300008
J	Zhao, C; Rajashankar, KR; Marcia, M; Pyle, AM				Zhao, Chen; Rajashankar, Kanagalaghatta R.; Marcia, Marco; Pyle, Anna Marie			Crystal structure of group II intron domain 1 reveals a template for RNA assembly	NATURE CHEMICAL BIOLOGY			English	Article							SECONDARY STRUCTURE; RIBOZYME DOMAIN; INTERMEDIATE; CONFORMATION; SUBDOMAINS; PRINCIPLES; STABILITY; MECHANISM; PATHWAYS; INSIGHTS	Although the importance of large noncoding RNAs is increasingly appreciated, our understanding of their structures and architectural dynamics remains limited. In particular, we know little about RNA folding intermediates and how they facilitate the productive assembly of RNA tertiary structures. Here, we report the crystal structure of an obligate intermediate that is required during the earliest stages of group II intron folding. Composed of domain 1 from the Oceanobacillus iheyensis group II intron (266 nucleotides), this intermediate retains native-like features but adopts a compact conformation in which the active site cleft is closed. Transition between this closed and the open (native) conformation is achieved through discrete rotations of hinge motifs in two regions of the molecule. The open state is then stabilized by sequential docking of downstream intron domains, suggesting a 'first come, first folded' strategy that may represent a generalizable pathway for assembly of large RNA and ribonucleoprotein structures.	[Zhao, Chen] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Rajashankar, Kanagalaghatta R.] Argonne Natl Lab, Northeastern Collaborat Access Team NECAT, Argonne, IL 60439 USA; [Rajashankar, Kanagalaghatta R.] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY USA; [Marcia, Marco; Pyle, Anna Marie] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT USA; [Pyle, Anna Marie] Yale Univ, Dept Chem, New Haven, CT USA; [Pyle, Anna Marie] Howard Hughes Med Inst, Chevy Chase, MD USA	Yale University; United States Department of Energy (DOE); Argonne National Laboratory; Cornell University; Yale University; Yale University; Howard Hughes Medical Institute	Zhao, C (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA.	mmarcia@embl.fr; anna.pyle@yale.edu	Marcia, Marco/M-2887-2014	Marcia, Marco/0000-0003-2430-0713; Zhao, Chen/0000-0002-2323-6951	Gruber Science Fellowship; US National Institute of Health (NIH) [RO1GM50313]; National Institute of General Medical Sciences from the NIH [P41 GM103403]; NIH-ORIP HEI grant [S10 RR029205]; DOE Office of Science by Argonne National Laboratory [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103403, R01GM050313] Funding Source: NIH RePORTER	Gruber Science Fellowship; US National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences from the NIH; NIH-ORIP HEI grant; DOE Office of Science by Argonne National Laboratory(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank S. Somarowthu for constructive discussions and O. Fedorova, S. Somarowthu and T. Dickey for reading the manuscript. C.Z. is supported by Gruber Science Fellowship. A.M.P. is a Howard Hughes Medical Institute Investigator. This work is supported by the US National Institute of Health (NIH) (RO1GM50313) and is based upon research conducted at the Northeastern Collaborative Access Team beamlines, which are funded by the National Institute of General Medical Sciences from the NIH (P41 GM103403). The Pilatus 6M detector on 24-ID-C beam line is funded by a NIH-ORIP HEI grant (S10 RR029205). This research used resources of the Advanced Photon Source, a US Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under contract no. DE-AC02-06CH11357.	Bailor MH, 2011, CURR OPIN STRUC BIOL, V21, P296, DOI 10.1016/j.sbi.2011.03.009; Bailor MH, 2010, SCIENCE, V327, P202, DOI 10.1126/science.1181085; Baird NJ, 2005, J MOL BIOL, V352, P712, DOI 10.1016/j.jmb.2005.07.010; Behrouzi R, 2012, CELL, V149, P348, DOI 10.1016/j.cell.2012.01.057; Bhutani N, 2003, PROTEIN SCI, V12, P1719, DOI 10.1110/ps.0239503; BRYNGELSON JD, 1995, PROTEINS, V21, P167, DOI 10.1002/prot.340210302; Cate JH, 1996, SCIENCE, V273, P1678, DOI 10.1126/science.273.5282.1678; Chillon I, 2015, METHOD ENZYMOL, V558, P3, DOI 10.1016/bs.mie.2015.01.008; Chu VB, 2009, RNA, V15, P2195, DOI 10.1261/rna.1747509; Chworos A, 2004, SCIENCE, V306, P2068, DOI 10.1126/science.1104686; Coonrod LA, 2012, BIOCHEMISTRY-US, V51, P8330, DOI 10.1021/bi300829w; Drenth J, 2007, PRINCIPLES PROTEIN X, P64; Duarte CM, 2003, NUCLEIC ACIDS RES, V31, P4755, DOI 10.1093/nar/gkg682; Duarte CM, 1998, J MOL BIOL, V284, P1465, DOI 10.1006/jmbi.1998.2233; DYSON HJ, 1993, CURR OPIN STRUC BIOL, V3, P60, DOI 10.1016/0959-440X(93)90203-W; Fedorova O, 2012, J MOL BIOL, V422, P347, DOI 10.1016/j.jmb.2012.05.037; Guo F, 2004, MOL CELL, V16, P351, DOI 10.1016/S1097-2765(04)00592-1; Han DR, 2011, SCIENCE, V332, P342, DOI 10.1126/science.1202998; HUGHSON FM, 1990, SCIENCE, V249, P1544, DOI 10.1126/science.2218495; Johnson TH, 2005, P NATL ACAD SCI USA, V102, P10176, DOI 10.1073/pnas.0501498102; Juneau K, 2001, STRUCTURE, V9, P221, DOI 10.1016/S0969-2126(01)00579-2; Keating KS, 2011, Q REV BIOPHYS, V44, P433, DOI 10.1017/S0033583511000059; KIM PS, 1990, ANNU REV BIOCHEM, V59, P631, DOI 10.1146/annurev.biochem.59.1.631; Konforti BB, 1998, EMBO J, V17, P7105, DOI 10.1093/emboj/17.23.7105; Krasilnikov AS, 2004, SCIENCE, V306, P104, DOI 10.1126/science.1101489; Llinas M, 1998, PROTEIN SCI, V7, P96, DOI 10.1002/pro.5560070110; Marcia M, 2014, RNA, V20, P516, DOI 10.1261/rna.043414.113; Marcia M, 2013, ACTA CRYSTALLOGR D, V69, P2174, DOI 10.1107/S0907444913013218; Marcia M, 2012, CELL, V151, P497, DOI 10.1016/j.cell.2012.09.033; MICHELS WJ, 1995, BIOCHEMISTRY-US, V34, P2965, DOI 10.1021/bi00009a028; Mohan S, 2014, P NATL ACAD SCI USA, V111, P13325, DOI 10.1073/pnas.1413731111; Pan T, 2006, ANNU REV BIOPH BIOM, V35, P161, DOI 10.1146/annurev.biophys.35.040405.102053; Pan T, 2010, PROTEIN REV, V10, P79, DOI 10.1007/978-1-4419-1142-1_5; Pyle AM, 2007, TRENDS BIOCHEM SCI, V32, P138, DOI 10.1016/j.tibs.2007.01.005; Pyle AM, 2006, COLD SPRING HARB MON, V43, P469; Pyle AM, 2010, CRIT REV BIOCHEM MOL, V45, P215, DOI 10.3109/10409231003796523; Qin PZF, 1997, BIOCHEMISTRY-US, V36, P4718, DOI 10.1021/bi962665c; Robertson MP, 2008, ACTA CRYSTALLOGR D, V64, P738, DOI 10.1107/S0907444908011578; Somarowthu S, 2015, MOL CELL, V58, P353, DOI 10.1016/j.molcel.2015.03.006; Sosnick TR, 2003, CURR OPIN STRUC BIOL, V13, P309, DOI 10.1016/S0959-440X(03)00066-6; Su LJ, 2005, NUCLEIC ACIDS RES, V33, P6674, DOI 10.1093/nar/gki973; Toor N, 2008, SCIENCE, V320, P77, DOI 10.1126/science.1153803; Toor N, 2010, RNA, V16, P57, DOI 10.1261/rna.1844010; Torres-Larios A, 2005, NATURE, V437, P584, DOI 10.1038/nature04074; Treiber DK, 2001, CURR OPIN STRUC BIOL, V11, P309, DOI 10.1016/S0959-440X(00)00206-2; Uzawa T, 2008, P NATL ACAD SCI USA, V105, P13859, DOI 10.1073/pnas.0804033105; Waldsich C, 2008, J MOL BIOL, V375, P572, DOI 10.1016/j.jmb.2007.10.052; Woodson SA, 2000, CELL MOL LIFE SCI, V57, P796, DOI 10.1007/s000180050042; Woodson SA, 2010, ANNU REV BIOPHYS, V39, P61, DOI 10.1146/annurev.biophys.093008.131334; WU LC, 1994, PROTEIN SCI, V3, P369	50	19	19	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2015	11	12					967	972		10.1038/NCHEMBIO.1949	http://dx.doi.org/10.1038/NCHEMBIO.1949			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX6TG	26502156	Green Submitted, Green Accepted			2022-12-25	WOS:000365834000016
J	Bhiman, JN; Anthony, C; Doria-Rose, NA; Karimanzira, O; Schramm, CA; Khoza, T; Kitchin, D; Botha, G; Gorman, J; Garrett, NJ; Karim, SSA; Shapiro, L; Williamson, C; Kwong, PD; Mascola, JR; Morris, L; Moore, PL				Bhiman, Jinal N.; Anthony, Colin; Doria-Rose, Nicole A.; Karimanzira, Owen; Schramm, Chaim A.; Khoza, Thandeka; Kitchin, Dale; Botha, Gordon; Gorman, Jason; Garrett, Nigel J.; Karim, Salim S. Abdool; Shapiro, Lawrence; Williamson, Carolyn; Kwong, Peter D.; Mascola, John R.; Morris, Lynn; Moore, Penny L.			Viral variants that initiate and drive maturation of V1V2-directed HIV-1 broadly neutralizing antibodies	NATURE MEDICINE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; B-CELL RECEPTORS; INFECTION; VACCINE; PATHWAYS; ESCAPE; TARGET	The elicitation of broadly neutralizing antibodies (bNAbs) is likely to be essential for a preventative HIV-1 vaccine, but this has not yet been achieved by immunization. In contrast, some HIV-1-infected individuals naturally mount bNAb responses during chronic infection, suggesting that years of maturation may be required for neutralization breadth(1-6). Recent studies have shown that viral diversification precedes the emergence of bNAbs, but the significance of this observation is unknown(7,8). Here we delineate the key viral events that drove neutralization breadth within the CAP256-VRC26 family of 33 monoclonal antibodies (mAbs) isolated from a superinfected individual. First, we identified minority viral variants, termed bNAb-initiating envelopes, that were distinct from both of the transmitted/founder (T/F) viruses and that efficiently engaged the bNAb precursor. Second, deep sequencing revealed a pool of diverse epitope variants (immunotypes) that were preferentially neutralized by broader members of the antibody lineage. In contrast, a 'dead-end' antibody sublineage unable to neutralize these immunotypes showed limited evolution and failed to develop breadth. Thus, early viral escape at key antibody-virus contact sites selects for antibody sublineages 'that Can tolerate these changes, thereby providing a mechanism for the generation of neutralization breadth within a developing antibody lineage.	[Bhiman, Jinal N.; Karimanzira, Owen; Khoza, Thandeka; Kitchin, Dale; Morris, Lynn; Moore, Penny L.] NICD, Ctr HIV & STIs, NHLS, Johannesburg, South Africa; [Bhiman, Jinal N.; Morris, Lynn; Moore, Penny L.] Univ Witwatersrand, Fac Hlth Sci, Johannesburg, South Africa; [Anthony, Colin; Botha, Gordon; Williamson, Carolyn] Univ Cape Town, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa; [Doria-Rose, Nicole A.; Gorman, Jason; Shapiro, Lawrence; Kwong, Peter D.; Mascola, John R.] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [Schramm, Chaim A.; Shapiro, Lawrence] Columbia Univ, Dept Biochem & Syst Biol, New York, NY USA; [Garrett, Nigel J.; Karim, Salim S. Abdool; Williamson, Carolyn; Morris, Lynn; Moore, Penny L.] Univ KwaZulu Natal, Ctr AIDS Programme Res South Africa CAPRISA, Durban, South Africa; [Williamson, Carolyn] Natl Hlth Lab Serv, Johannesburg, South Africa	National Health Laboratory Service; National Institute for Communicable Diseases (NICD); University of Witwatersrand; University of Cape Town; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Columbia University; University of Kwazulu Natal; National Health Laboratory Service	Moore, PL (corresponding author), NICD, Ctr HIV & STIs, NHLS, Johannesburg, South Africa.	pennym@nicd.ac.za	Karim, Salim Abdool/AAE-7118-2019; Shapiro, Lawrence/AAE-7172-2019; Bhiman, Jinal/ABA-6029-2021; Morris, Lynn/V-3941-2018; Mascola, John/AAI-7193-2021; Gorman, Jason/AGG-9417-2022; Karim, Salim Abdool/P-3117-2019	Bhiman, Jinal/0000-0001-6354-4003; Morris, Lynn/0000-0003-3961-7828; Karim, Salim Abdool/0000-0002-4986-2133; Gorman, Jason/0000-0002-3775-6560; , Carolyn/0000-0003-0125-1226; Moore, Penny/0000-0001-8719-4028	Centre for the AIDS Programme of Research (CAPRISA); South African Medical Research Council (MRC) SHIP program; NIH [AI116086-01]; Vaccine Research Center; National Institute of Allergy and Infectious Diseases (NIAID); South African HIV/AIDS Research and Innovation Platform of the South African Department of Science and Technology; US NIAID, NIH, US Department of Health and Human Services grant [U19 AI51794]; Columbia University-Southern African Fogarty AIDS International Training and Research Program through the Fogarty International Center, NIH [5 D43 TW000231]; University of the Witwatersrand Postgraduate Merit Award; Poliomyelitis Research Foundation PhD Bursary; National Research Foundation of South Africa Innovation PhD Bursary; National Research Foundation of South Africa; Wellcome Trust Intermediate Fellowship in Public Health and Tropical Medicine [089933/Z/09/Z]; FOGARTY INTERNATIONAL CENTER [D43TW000231] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI005023, U19AI051794, U01AI116086] Funding Source: NIH RePORTER	Centre for the AIDS Programme of Research (CAPRISA); South African Medical Research Council (MRC) SHIP program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vaccine Research Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); South African HIV/AIDS Research and Innovation Platform of the South African Department of Science and Technology; US NIAID, NIH, US Department of Health and Human Services grant; Columbia University-Southern African Fogarty AIDS International Training and Research Program through the Fogarty International Center, NIH; University of the Witwatersrand Postgraduate Merit Award; Poliomyelitis Research Foundation PhD Bursary; National Research Foundation of South Africa Innovation PhD Bursary; National Research Foundation of South Africa(National Research Foundation - South Africa); Wellcome Trust Intermediate Fellowship in Public Health and Tropical Medicine(Wellcome Trust); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank the participants in the CAPRISA 002 cohort for their commitment to attending the CAPRISA clinics in South Africa. Thanks to the CAPRISA 002 study team (including N. Naicker, V. Asari, N. Majola, T. Cekwane, N. Samsunder, Z. Mchunu, D. Nkosi, H. Shozi, S. Ndlovu, P. Radebe, K. Leask and M. Upfold) for managing the cohort and providing specimens. We are grateful to C. K. Wibmer for useful discussions. We thank P. Labuschagne, D. Matten and T. York for assistance with viral next-generation sequence analysis, R. Bailer and M. Louder for the CAP256-VRC26 UCA neutralization data against the large virus panel and J. Mulllikin and the US National Institutes of Health (NIH) Intramural Sequencing Center (NISC) Comparative Sequencing Program for antibody NGS data at 34 weeks. We are grateful to J. Baalwa, D. Ellenberger, F. Gao, B. Hahn, K. Hong, J. Kim, F. McCutchan, D. Montefiori, J. Overbaugh, E. Sanders-Buell, G. Shaw, R. Swanstrom, M. Thomson, S. Tovanabutra and L. Zhang for contributing the HIV-1 envelope plasmids used in our neutralization panel. The JC53bl-13 (TZM-bl) and 293T cell lines were obtained through the NIH AIDS Reagent Program, Division of AIDS, NIAID, NIH from J.C. Kappes, X. Wu and Tranzyme, Inc., and A. Rice, respectively. We acknowledge research funding from the Centre for the AIDS Programme of Research (CAPRISA) (S.S.A.K.), the South African Medical Research Council (MRC) SHIP program (P.L.M.), the NIH through a U01 grant (AI116086-01) (P.L.M.), the intramural research programs of the Vaccine Research Center and the National Institute of Allergy and Infectious Diseases (NIAID) (J.R.M.). CAPRISA is funded by the South African HIV/AIDS Research and Innovation Platform of the South African Department of Science and Technology, and was initially supported by the US NIAID, NIH, US Department of Health and Human Services grant U19 AI51794 (S.S.A.K.). Funding was received by J.N.B. and CA. from the Columbia University-Southern African Fogarty AIDS International Training and Research Program through the Fogarty International Center, NIH grant 5 D43 TW000231 (to Quarraisha Abdool Karim). Additional fellowships included a University of the Witwatersrand Postgraduate Merit Award (J.N.B.), a Poliomyelitis Research Foundation PhD Bursary (J.N.B.), a National Research Foundation of South Africa Innovation PhD Bursary (J.N.B.), a National Research Foundation of South Africa Postdoctoral Fellowship (CA.), and a Wellcome Trust Intermediate Fellowship in Public Health and Tropical Medicine, grant 089933/Z/09/Z (P.L.M.).	Briney BS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036750; Doria-Rose N.A., J VIROL IN PRESS; Doria-Rose NA, 2014, NATURE, V509, P55, DOI 10.1038/nature13036; Euler Z, 2012, J VIROL, V86, P2045, DOI 10.1128/JVI.06091-11; Gao F, 2014, CELL, V158, P481, DOI 10.1016/j.cell.2014.06.022; Gray ES, 2011, J VIROL, V85, P4828, DOI 10.1128/JVI.00198-11; Hraber P, 2014, AIDS, V28, P163, DOI 10.1097/QAD.0000000000000106; Jardine J, 2013, SCIENCE, V340, P711, DOI 10.1126/science.1234150; Klein F, 2013, SCIENCE, V341, P1199, DOI 10.1126/science.1241144; Kwong PD, 2013, NAT REV IMMUNOL, V13, P693, DOI 10.1038/nri3516; Liao HX, 2013, NATURE, V496, P469, DOI 10.1038/nature12053; Mascola JR, 2013, IMMUNOL REV, V254, P225, DOI 10.1111/imr.12075; McGuire AT, 2013, J EXP MED, V210, P655, DOI 10.1084/jem.20122824; Moore PL, 2013, J VIROL, V87, P4882, DOI 10.1128/JVI.03424-12; Moore PL, 2012, NAT MED, V18, P1688, DOI 10.1038/nm.2985; Mouquet H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024078; Pappas L, 2014, NATURE, V516, P418, DOI 10.1038/nature13764; Piantadosi A, 2009, J VIROL, V83, P10269, DOI 10.1128/JVI.01149-09; Sather DN, 2009, J VIROL, V83, P757, DOI 10.1128/JVI.02036-08; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Sok D, 2014, P NATL ACAD SCI USA, V111, P17624, DOI 10.1073/pnas.1415789111; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001028; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; Wibmer CK, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003738	26	145	147	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2015	21	11					1332	1336		10.1038/nm.3963	http://dx.doi.org/10.1038/nm.3963			5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CV9QH	26457756	Green Accepted, Green Submitted			2022-12-25	WOS:000364621200018
J	Muller, S; Chaikuad, A; Gray, NS; Knapp, S				Mueller, Susanne; Chaikuad, Apirat; Gray, Nathanael S.; Knapp, Stefan			The ins and outs of selective kinase inhibitor development	NATURE CHEMICAL BIOLOGY			English	Article							PROTEIN-KINASE; BINDING-SITE; TYROSINE KINASE; DISCOVERY; ABL; CONFORMATION; MECHANISMS		[Mueller, Susanne; Chaikuad, Apirat; Knapp, Stefan] Univ Oxford, Nuffield Dept Clin Med, Struct Genom Consortium, Oxford, England; [Gray, Nathanael S.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Knapp, Stefan] Goethe Univ Frankfurt, Inst Pharmaceut Chem, Frankurt, Germany; [Knapp, Stefan] Goethe Univ Frankfurt, Buchmann Inst Mol Life Sci, Frankurt, Germany	University of Oxford; Harvard University; Harvard Medical School; Goethe University Frankfurt; Goethe University Frankfurt	Muller, S (corresponding author), Univ Oxford, Nuffield Dept Clin Med, Struct Genom Consortium, Oxford, England.	nathanael_gray@dfci.harvard.edu; knapp@pharmchem.uni-frankfurt.de	Knapp, Stefan/AAG-2347-2019	Knapp, Stefan/0000-0001-5995-6494; Chaikuad, Apirat/0000-0003-1120-2209	Wellcome Trust [106169] Funding Source: Medline; NATIONAL CANCER INSTITUTE [U54CA156732] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Axten JM, 2012, J MED CHEM, V55, P7193, DOI 10.1021/jm300713s; Bantscheff M, 2007, NAT BIOTECHNOL, V25, P1035, DOI 10.1038/nbt1328; Chaikuad A, 2014, NAT CHEM BIOL, V10, P853, DOI [10.1038/NCHEMBIO.1629, 10.1038/nchembio.1629]; Ciceri P, 2014, NAT CHEM BIOL, V10, P305, DOI 10.1038/nchembio.1471; Davis MI, 2011, NAT BIOTECHNOL, V29, P1046, DOI 10.1038/nbt.1990; Debreczeni JE, 2006, ANGEW CHEM INT EDIT, V45, P1580, DOI 10.1002/anie.200503468; Di Paolo JA, 2011, NAT CHEM BIOL, V7, P41, DOI 10.1038/NCHEMBIO.481; Fabian MA, 2005, NAT BIOTECHNOL, V23, P329, DOI 10.1038/nbt1068; Fedorov O, 2010, NAT CHEM BIOL, V6, P166, DOI 10.1038/nchembio.297; Gammons MV, 2013, INVEST OPHTH VIS SCI, V54, P6052, DOI 10.1167/iovs.13-12422; Guimaraes CRW, 2011, J CHEM INF MODEL, V51, P1199, DOI 10.1021/ci200153c; Hill ZB, 2012, ACS CHEM BIOL, V7, P487, DOI 10.1021/cb200387g; Hindie V, 2009, NAT CHEM BIOL, V5, P758, DOI 10.1038/nchembio.208; Knapp S, 2014, CURR OPIN PHARMACOL, V17, P58, DOI 10.1016/j.coph.2014.07.015; KNIGHTON DR, 1991, SCIENCE, V253, P414, DOI 10.1126/science.1862343; Koeberle SC, 2012, NAT CHEM BIOL, V8, P141, DOI 10.1038/nchembio.761; Liu QS, 2013, CHEM BIOL, V20, P146, DOI 10.1016/j.chembiol.2012.12.006; Pike ACW, 2008, EMBO J, V27, P704, DOI 10.1038/emboj.2008.8; Schindler T, 2000, SCIENCE, V289, P1938, DOI 10.1126/science.289.5486.1938; Wood ER, 2004, CANCER RES, V64, P6652, DOI 10.1158/0008-5472.CAN-04-1168; Woyach JA, 2014, NEW ENGL J MED, V370, P2286, DOI 10.1056/NEJMoa1400029; Yang JS, 2011, CHEM BIOL, V18, P177, DOI 10.1016/j.chembiol.2010.12.013; Yap TA, 2011, J CLIN ONCOL, V29, P4688, DOI 10.1200/JCO.2011.35.5263; Zhang JM, 2010, NATURE, V463, P501, DOI 10.1038/nature08675; Zhao Z, 2014, ACS CHEM BIOL, V9, P1230, DOI 10.1021/cb500129t	25	177	179	2	65	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	NOV	2015	11	11					818	821		10.1038/nchembio.1938	http://dx.doi.org/10.1038/nchembio.1938			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CU1HS	26485069				2022-12-25	WOS:000363272100001
J	Loh, PR; Palamara, PF; Price, AL				Loh, Po-Ru; Palamara, Pier Francesco; Price, Alkes L.			Fast and accurate long-range phasing in a UK Biobank cohort	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; GENETIC EPIDEMIOLOGY RESEARCH; OF-FUNCTION VARIANTS; AGING GERA COHORT; GENOTYPE IMPUTATION; COMMON VARIANTS; HIGH-RISK; LINKAGE DISEQUILIBRIUM; DETECTING IDENTITY; RARE VARIANT	Recent work has leveraged the extensive genotyping of the Icelandic population to perform long-range phasing (LRP), enabling accurate imputation and association analysis of rare variants in target samples typed on genotyping arrays. Here we develop a fast and accurate LRP method, Eagle, that extends this paradigm to populations with much smaller proportions of genotyped samples by harnessing long (> 4-cM) identical-bydescent (IBD) tracts shared among distantly related individuals. We applied Eagle to N approximate to 150,000 samples (0.2% of the British population) from the UK Biobank, and we determined that it is 1-2 orders of magnitude faster than existing methods while achieving similar or better phasing accuracy (switch error rate approximate to 0.3%, corresponding to perfect phase in a majority of 10-Mb segments). We also observed that, when used within an imputation pipeline, Eagle prephasing improved downstream imputation accuracy in comparison to prephasing in batches using existing methods, as necessary to achieve comparable computational cost.	[Loh, Po-Ru; Palamara, Pier Francesco; Price, Alkes L.] Harvard Univ, Dept Epidemiol, TH Chan Sch Publ Hlth, Boston, MA 02115 USA; [Loh, Po-Ru; Palamara, Pier Francesco; Price, Alkes L.] Broad Inst Harvard & MIT, Program Med & Populat Genet, Cambridge, MA USA; [Price, Alkes L.] Harvard Univ, Dept Biostat, TH Chan Sch Publ Hlth, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard T.H. Chan School of Public Health	Loh, PR; Price, AL (corresponding author), Harvard Univ, Dept Epidemiol, TH Chan Sch Publ Hlth, Boston, MA 02115 USA.; Loh, PR; Price, AL (corresponding author), Broad Inst Harvard & MIT, Program Med & Populat Genet, Cambridge, MA USA.; Price, AL (corresponding author), Harvard Univ, Dept Biostat, TH Chan Sch Publ Hlth, Boston, MA 02115 USA.	loh@hsph.harvard.edu; aprice@hsph.harvard.edu		Palamara, Pier Francesco/0000-0002-7999-1972	US National Institutes of Health [R01 HG006399, R01 MH101244, F32 HG007805]; NCRR [1S10RR028832-01]; Netherlands Scientific Organization (NWO) [480-05-003]; Dutch Brain Foundation; VU University Amsterdam; Medical Research Council [MC_qA137853] Funding Source: researchfish; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR028832] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [F32HG007805, R01HG006399] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH101244] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Netherlands Scientific Organization (NWO)(Netherlands Organization for Scientific Research (NWO)); Dutch Brain Foundation; VU University Amsterdam; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We are grateful to G. Bhatia, S. Gusev, M. Lipson, B. Pasaniuc, N. Patterson, and N. Zaitlen for helpful discussions. This research was conducted using the UK Biobank Resource and was supported by US National Institutes of Health grants R01 HG006399 and R01 MH101244 and US National Institutes of Health fellowship F32 HG007805. Computational analyses were performed on the Orchestra High-Performance Compute Cluster at Harvard Medical School, which is partially supported by grant NCRR 1S10RR028832-01, and on the Lisa Genetic Cluster Computer hosted by SURFsara and financially supported by the Netherlands Scientific Organization (NWO 480-05-003, principal investigator D. Posthuma) along with a supplement from the Dutch Brain Foundation and VU University Amsterdam.	Banda Y, 2015, GENETICS, V200, P1285, DOI 10.1534/genetics.115.178616; Browning BL, 2016, AM J HUM GENET, V98, P116, DOI 10.1016/j.ajhg.2015.11.020; Browning BL, 2013, GENETICS, V194, P459, DOI 10.1534/genetics.113.150029; Browning BL, 2011, AM J HUM GENET, V88, P173, DOI 10.1016/j.ajhg.2011.01.010; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Browning SR, 2011, NAT REV GENET, V12, P703, DOI 10.1038/nrg3054; Bulik-Sullivan BK, 2015, NAT GENET, V47, P291, DOI 10.1038/ng.3211; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Chen CY, 2013, BIOINFORMATICS, V29, P1399, DOI 10.1093/bioinformatics/btt144; Delaneau O, 2013, AM J HUM GENET, V93, P687, DOI 10.1016/j.ajhg.2013.09.002; Delaneau O, 2013, NAT METHODS, V10, P5, DOI 10.1038/nmeth.2307; Delaneau O, 2012, NAT METHODS, V9, P179, DOI [10.1038/NMETH.1785, 10.1038/nmeth.1785]; Durbin R, 2014, BIOINFORMATICS, V30, P1266, DOI 10.1093/bioinformatics/btu014; Galinsky KJ, 2016, AM J HUM GENET, V98, P456, DOI 10.1016/j.ajhg.2015.12.022; Gionis A, 1999, PROCEEDINGS OF THE TWENTY-FIFTH INTERNATIONAL CONFERENCE ON VERY LARGE DATA BASES, P518; Gudbjartsson DF, 2015, NAT GENET, V47, P435, DOI 10.1038/ng.3247; Gudmundsson J, 2012, NAT GENET, V44, P1326, DOI 10.1038/ng.2437; Gudmundsson J, 2012, NAT GENET, V44, P319, DOI 10.1038/ng.1046; Gusev A, 2009, GENOME RES, V19, P318, DOI 10.1101/gr.081398.108; Helgason H, 2015, NAT GENET, V47, P906, DOI 10.1038/ng.3342; Helgason H, 2013, NAT GENET, V45, P1371, DOI 10.1038/ng.2740; Henn BM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034267; Holm H, 2011, NAT GENET, V43, P316, DOI 10.1038/ng.781; Howie B, 2012, NAT GENET, V44, P955, DOI 10.1038/ng.2354; Huang L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092713; Indyk P., 1998, Proceedings of the Thirtieth Annual ACM Symposium on Theory of Computing, P604, DOI 10.1145/276698.276876; Kong A, 2008, NAT GENET, V40, P1068, DOI 10.1038/ng.216; Kong A, 2014, NAT GENET, V46, P11, DOI 10.1038/ng.2833; Kong A, 2010, NATURE, V467, P1099, DOI 10.1038/nature09525; Kong A, 2009, NATURE, V462, P868, DOI 10.1038/nature08625; Kvale MN, 2015, GENETICS, V200, P1051, DOI 10.1534/genetics.115.178905; Li N, 2003, GENETICS, V165, P2213; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Marchini J, 2010, NAT REV GENET, V11, P499, DOI 10.1038/nrg2796; O'Connell J., 2016, NAT GENET; O'Connell J, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004234; Palin K, 2011, GENET EPIDEMIOL, V35, P853, DOI 10.1002/gepi.20635; Rafnar T, 2011, NAT GENET, V43, P1104, DOI 10.1038/ng.955; Rodriguez JM, 2015, GENOME RES, V25, P280, DOI 10.1101/gr.173641.114; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Stefansson H, 2009, NATURE, V460, P744, DOI 10.1038/nature08186; Steinberg S, 2015, NAT GENET, V47, P445, DOI 10.1038/ng.3246; Steinthorsdottir V, 2014, NAT GENET, V46, P294, DOI 10.1038/ng.2882; Stephens M, 2005, AM J HUM GENET, V76, P449, DOI 10.1086/428594; Sudlow C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001779; Thorleifsson G, 2010, NAT GENET, V42, P906, DOI 10.1038/ng.661; Wiliams AL, 2012, AM J HUM GENET, V91, P238, DOI 10.1016/j.ajhg.2012.06.013	49	150	152	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2016	48	7					811	+		10.1038/ng.3571	http://dx.doi.org/10.1038/ng.3571			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DP9TK	27270109	Green Submitted, Green Accepted			2022-12-25	WOS:000378840100020
J	Campbell, JD; Alexandrov, A; Kim, J; Wala, J; Berger, AH; Pedamallu, CS; Shukla, SA; Guo, GW; Brooks, AN; Murray, BA; Imielinski, M; Hu, X; Ling, SY; Akbani, R; Rosenberg, M; Cibulskis, C; Ramachandran, A; Collisson, EA; Kwiatkowski, DJ; Lawrence, MS; Weinstein, JN; Verhaak, RGW; Wu, CJ; Hammerman, PS; Cherniack, AD; Getz, G; Artyomov, MN; Schreiber, R; Govindan, R; Meyerson, M				Campbell, Joshua D.; Alexandrov, Anton; Kim, Jaegil; Wala, Jeremiah; Berger, Alice H.; Pedamallu, Chandra Sekhar; Shukla, Sachet A.; Guo, Guangwu; Brooks, Angela N.; Murray, Bradley A.; Imielinski, Marcin; Hu, Xin; Ling, Shiyun; Akbani, Rehan; Rosenberg, Mara; Cibulskis, Carrie; Ramachandran, Aruna; Collisson, Eric A.; Kwiatkowski, David J.; Lawrence, Michael S.; Weinstein, John N.; Verhaak, Roel G. W.; Wu, Catherine J.; Hammerman, Peter S.; Cherniack, Andrew D.; Getz, Gad; Artyomov, Maxim N.; Schreiber, Robert; Govindan, Ramaswamy; Meyerson, Matthew		Canc Genome Atlas Res Network	Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas	NATURE GENETICS			English	Article							MUTATIONAL PROCESSES; DRIVER MUTATIONS; CANCER; LANDSCAPE; KINASE; QUANTIFICATION; IDENTIFICATION; HETEROGENEITY; EXPRESSION; PREDICTION	To compare lung adenocarcinoma (ADC) and lung squamous cell carcinoma (SqCC) and to identify new drivers of lung carcinogenesis, we examined the exome sequences and copy number profiles of 660 lung ADC and 484 lung SqCC tumor-normal pairs. Recurrent alterations in lung SqCCs were more similar to those of other squamous carcinomas than to alterations in lung ADCs. New significantly mutated genes included PPP3CA, DOT1L, and FTSJD1 in lung ADC, RASA1 in lung SqCC, and KLF5, EP300, and CREBBP in both tumor types. New amplification peaks encompassed MIR21 in lung ADC, MIR205 in lung SqCC, and MAPK1 in both. Lung ADCs lacking receptor tyrosine kinase-Ras-Raf pathway alterations had mutations in SOS1, VAV1, RASA1, and ARHGAP35. Regarding neoantigens, 47% of the lung ADC and 53% of the lung SqCC tumors had at least five predicted neoepitopes. Although targeted therapies for lung ADC and SqCC are largely distinct, immunotherapies may aid in treatment for both subtypes.	[Campbell, Joshua D.; Kim, Jaegil; Wala, Jeremiah; Berger, Alice H.; Pedamallu, Chandra Sekhar; Shukla, Sachet A.; Guo, Guangwu; Brooks, Angela N.; Murray, Bradley A.; Imielinski, Marcin; Rosenberg, Mara; Cibulskis, Carrie; Ramachandran, Aruna; Kwiatkowski, David J.; Lawrence, Michael S.; Wu, Catherine J.; Hammerman, Peter S.; Cherniack, Andrew D.; Getz, Gad; Meyerson, Matthew] Eli & Edythe L Broad Inst Harvard & MIT, Canc Program, Cambridge, MA USA; [Campbell, Joshua D.; Wala, Jeremiah; Berger, Alice H.; Pedamallu, Chandra Sekhar; Shukla, Sachet A.; Guo, Guangwu; Brooks, Angela N.; Murray, Bradley A.; Imielinski, Marcin; Ramachandran, Aruna; Wu, Catherine J.; Hammerman, Peter S.; Cherniack, Andrew D.; Meyerson, Matthew] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Alexandrov, Anton; Artyomov, Maxim N.; Schreiber, Robert] Washington Univ, Dept Pathol & Immunol, St Louis, MO USA; [Alexandrov, Anton] ITMO Univ, Comp Technol Lab, St Petersburg, Russia; [Imielinski, Marcin] Massachusetts Gen Hosp, Mol Pathol Unit, Charlestown, MA USA; [Hu, Xin; Ling, Shiyun; Akbani, Rehan; Weinstein, John N.; Verhaak, Roel G. W.] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA; [Collisson, Eric A.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Kwiatkowski, David J.] Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA; [Getz, Gad] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Govindan, Ramaswamy] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Meyerson, Matthew] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; Washington University (WUSTL); ITMO University; Harvard University; Massachusetts General Hospital; University of Texas System; UTMD Anderson Cancer Center; University of California System; University of California San Francisco; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Washington University (WUSTL); Harvard University; Harvard Medical School	Meyerson, M (corresponding author), Eli & Edythe L Broad Inst Harvard & MIT, Canc Program, Cambridge, MA USA.; Meyerson, M (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.; Govindan, R (corresponding author), Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.; Meyerson, M (corresponding author), Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA.	rgovinda@dom.wustl.edu; matthew_meyerson@dfci.harvard.edu	Cherniack, Andrew/AAC-5310-2019; Pedamallu, Chandra Sekhar/AAV-6723-2020; Lawrence, Michael/AAC-8202-2020; Schreiber, Robert/Q-7550-2019; Van Den Berg, David J/G-8598-2017; Verhaak, Roel/ABE-7058-2020; Marra, Marco A/B-5987-2008; Pedamallu, Chandra Sekhar/AAV-6745-2020; Laird, Peter W/G-8683-2012; Akbani, Rehan/AAG-1490-2019; Cherniack, Andrew D./AAY-8132-2020	Van Den Berg, David J/0000-0002-5404-5218; Marra, Marco A/0000-0001-7146-7175; Laird, Peter W/0000-0001-9117-3641; Cherniack, Andrew D./0000-0003-0470-0111; Auman, James/0000-0002-9328-8829; Tsao, Ming/0000-0002-9160-5405; Rosenberg, Mara/0000-0001-6400-3161; Weinstein, John/0000-0001-9401-6908; Meyerson, Matthew/0000-0002-9133-8108; Schreiber, Robert/0000-0003-1590-2341; Peifer, Martin/0000-0002-5243-5503; Mieczkowski, Piotr/0000-0003-2418-0096; Hoadley, Katherine/0000-0002-1216-477X; Bowen, Jay/0000-0001-6861-9043; Tarnuzzer, Roy/0000-0002-3725-4173	National Cancer Institute as part of The Cancer Genome Atlas project [U24CA126546, U24CA143867, U24CA143845, U24CA126544, U24CA143883]; National Cancer Institute [K08CA163677, R35CA197568]; government of the Russian Federation [074-U01]; US Department of Defense [W81XWH-12-1-0269]; American Cancer Society Research Professor Award; NATIONAL CANCER INSTITUTE [U24CA199461, P30CA016672, K08CA163677, U24CA126544, U24CA143867, U24CA144025, R01CA155010, R01CA184922, P01CA120964, R35CA197568, U24CA143845, U24CA143848, K99CA197762, U24CA126546, U24CA143883] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG002295] Funding Source: NIH RePORTER	National Cancer Institute as part of The Cancer Genome Atlas project; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); government of the Russian Federation; US Department of Defense(United States Department of Defense); American Cancer Society Research Professor Award(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by grants from the National Cancer Institute as part of The Cancer Genome Atlas project: U24CA126546, U24CA143867, U24CA143845, U24CA126544, and U24CA143883. Additionally, this work was funded by National Cancer Institute grant K08CA163677 (P.S.H.), grant 074-U01 from the government of the Russian Federation (A.A.), US Department of Defense contract W81XWH-12-1-0269 (M.M.), the American Cancer Society Research Professor Award (M.M.), and National Cancer Institute grant R35CA197568 (M.M.).	Akagi I, 2013, CANCER RES, V73, P3821, DOI 10.1158/0008-5472.CAN-13-0031; Alberts B, 2002, MOL BIOL CELL; Alexandrov LB, 2015, NAT GENET, V47, P1402, DOI 10.1038/ng.3441; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Alexandrov LB, 2013, CELL REP, V3, P246, DOI 10.1016/j.celrep.2012.12.008; Bernards A, 2003, BBA-REV CANCER, V1603, P47, DOI 10.1016/S0304-419X(02)00082-3; Brooks AN, 2011, GENOME RES, V21, P193, DOI 10.1101/gr.108662.110; Brzezianska E, 2006, MUTAT RES-FUND MOL M, V599, P26, DOI 10.1016/j.mrfmmm.2005.12.013; Cancer Genome Atlas Research Network, 2014, Nature, V511, P543, DOI [10.1038/s41586-018-0228-6, 10.1038/nature13385]; Cardarella S, 2013, AM J RESP CRIT CARE, V188, P770, DOI 10.1164/rccm.201305-0843PP; Carter SL, 2012, NAT BIOTECHNOL, V30, P413, DOI 10.1038/nbt.2203; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Cibulskis K, 2011, BIOINFORMATICS, V27, P2601, DOI 10.1093/bioinformatics/btr446; de Bruin EC, 2014, SCIENCE, V346, P251, DOI 10.1126/science.1253462; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; Gallant JN, 2015, CANCER DISCOV, V5, P1155, DOI 10.1158/2159-8290.CD-15-0654; Govindan R, 2012, CELL, V150, P1121, DOI 10.1016/j.cell.2012.08.024; Gubin MM, 2014, NATURE, V515, P577, DOI 10.1038/nature13988; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Hast BE, 2014, CANCER RES, V74, P808, DOI 10.1158/0008-5472.CAN-13-1655; Hoadley KA, 2014, CELL, V158, P929, DOI 10.1016/j.cell.2014.06.049; Hoof I, 2009, IMMUNOGENETICS, V61, P1, DOI 10.1007/s00251-008-0341-z; Imielinski M, 2012, CELL, V150, P1107, DOI 10.1016/j.cell.2012.08.029; Kim HS, 2013, CELL, V155, P552, DOI 10.1016/j.cell.2013.09.041; Kim Y, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-394; Lawrence MS, 2015, NATURE, V517, P576, DOI 10.1038/nature14129; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Lebanony D, 2009, J CLIN ONCOL, V27, P2030, DOI 10.1200/JCO.2008.19.4134; Lepri F, 2011, HUM MUTAT, V32, P760, DOI 10.1002/humu.21492; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Liu Y, 2013, CANCER DISCOV, V3, P870, DOI 10.1158/2159-8290.CD-13-0015; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Nielsen M, 2003, PROTEIN SCI, V12, P1007, DOI 10.1110/ps.0239403; Nielsen M, 2005, IMMUNOGENETICS, V57, P33, DOI 10.1007/s00251-005-0781-7; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Oxnard GR, 2013, J CLIN ONCOL, V31, P1097, DOI 10.1200/JCO.2012.42.9829; Pao W, 2012, NAT MED, V18, P349, DOI 10.1038/nm.2697; Pao W, 2011, LANCET ONCOL, V12, P175, DOI 10.1016/S1470-2045(10)70087-5; Peifer M, 2012, NAT GENET, V44, P1104, DOI 10.1038/ng.2396; Peters B, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-132; Quesada V, 2012, NAT GENET, V44, P47, DOI 10.1038/ng.1032; Rajalingam K, 2007, BBA-MOL CELL RES, V1773, P1177, DOI 10.1016/j.bbamcr.2007.01.012; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Roberts SA, 2013, NAT GENET, V45, P970, DOI 10.1038/ng.2702; Saito M, 2011, CLIN CANCER RES, V17, P1875, DOI 10.1158/1078-0432.CCR-10-2961; Samet JM, 2009, CLIN CANCER RES, V15, P5626, DOI 10.1158/1078-0432.CCR-09-0376; Shan L, 2015, LUNG CANCER, V89, P337, DOI 10.1016/j.lungcan.2015.06.008; Sholl LM, 2009, CANCER RES, V69, P8341, DOI 10.1158/0008-5472.CAN-09-2477; Shukla SA, 2015, NAT BIOTECHNOL, V33, P1152, DOI 10.1038/nbt.3344; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Stephen AG, 2014, CANCER CELL, V25, P272, DOI 10.1016/j.ccr.2014.02.017; Stewart B. W., 2003, World Cancer Report; Stransky N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5846; Swanson KD, 2008, GENE CHROMOSOME CANC, V47, P253, DOI 10.1002/gcc.20527; Torres-Garcia W, 2014, BIOINFORMATICS, V30, P2224, DOI 10.1093/bioinformatics/btu169; Vaishnavi A, 2013, NAT MED, V19, P1469, DOI 10.1038/nm.3352; Wan HJ, 2008, DEVELOPMENT, V135, P2563, DOI 10.1242/dev.021964; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq622; Weinstein JN, 2014, NATURE, V507, P315, DOI 10.1038/nature12965; Ye K, 2016, NAT MED, V22, P97, DOI 10.1038/nm.4002; Yoshihara K, 2015, ONCOGENE, V34, P4845, DOI 10.1038/onc.2014.406; Yu BK, 2010, CELL, V140, P246, DOI 10.1016/j.cell.2009.12.033; Zack TI, 2013, NAT GENET, V45, P1134, DOI 10.1038/ng.2760; Zhang JJ, 2014, SCIENCE, V346, P256, DOI 10.1126/science.1256930; Zhang XY, 2016, NAT GENET, V48, P176, DOI 10.1038/ng.3470; Zhao D, 2010, CANCER RES, V70, P4728, DOI 10.1158/0008-5472.CAN-10-0040	68	653	660	6	96	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2016	48	6					607	+		10.1038/ng.3564	http://dx.doi.org/10.1038/ng.3564			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DN0HE	27158780	Green Submitted, Green Accepted			2022-12-25	WOS:000376744200007
J	Smith, GA; Uchida, K; Weiss, A; Taunton, J				Smith, Geoffrey A.; Uchida, Kenji; Weiss, Arthur; Taunton, Jack			Essential biphasic role for JAK3 catalytic activity in IL-2 receptor signaling	NATURE CHEMICAL BIOLOGY			English	Article							T-CELL DEVELOPMENT; DIFFERENTIAL REGULATION; KINASES; INTERLEUKIN-2; PROLIFERATION; INHIBITION; ACTIVATION; SUPPRESSOR; CYTOKINES; RESPONSES	To drive lymphocyte proliferation and differentiation, common gamma-chain (gamma(c)) cytokine receptors require hours to days of sustained stimulation. JAK1 and JAK3 kinases are found together in all gamma(c)-receptor complexes, but how their respective catalytic activities contribute to signaling over time is not known. Here we dissect the temporal requirements for JAK3 kinase activity with a selective covalent inhibitor (JAK3i). By monitoring phosphorylation of the transcription factor STAT5 over 20 h in CD4(+) T cells stimulated with interleukin 2 (IL-2), we document a second wave of signaling that is much more sensitive to JAK3i than the first wave. Selective inhibition of this second wave is sufficient to block cyclin expression and entry to S phase. An inhibitor-resistant JAK3 mutant (C905S) rescued all effects of JAK3i in isolated T cells and in mice. Our chemical genetic toolkit elucidates a biphasic requirement for JAK3 kinase activity in IL-2-driven T cell proliferation and will find broad utility in studies of gamma(c)-receptor signaling.	[Smith, Geoffrey A.; Uchida, Kenji; Taunton, Jack] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; [Smith, Geoffrey A.; Weiss, Arthur] Univ Calif San Francisco, Dept Med, Div Rheumatol, Rosalind Russell & Ephraim P Engleman Arthrit Res, San Francisco, CA USA; [Weiss, Arthur] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA USA; [Uchida, Kenji] Kyowa Hakko Kirin Co Ltd, R&D Div, Chem Res Labs, Shizuoka, Japan	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; Kyowa Kirin Ltd	Taunton, J (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA.	jack.taunton@ucsf.edu	Smith, Geoffrey/ABG-6914-2020	Smith, Geoffrey/0000-0002-1638-4219	Rosalind Russell and Ephraim P. Engleman Rheumatology Research Center; Howard Hughes Medical Institute; San Francisco Medical Scientist Training Program; US National Institute of Allergy and Infectious Diseases [F30AI120517-01]; University of California; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F30AI120517] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007618, T32GM064337] Funding Source: NIH RePORTER	Rosalind Russell and Ephraim P. Engleman Rheumatology Research Center; Howard Hughes Medical Institute(Howard Hughes Medical Institute); San Francisco Medical Scientist Training Program; US National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); University of California(University of California System); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank B. Au-Yeung, J. Carelli, H. Wang and K. Shokat for helpful discussion and suggestions and A. Roque for animal husbandry. This work was funded by the Rosalind Russell and Ephraim P. Engleman Rheumatology Research Center (A.W.) and the Howard Hughes Medical Institute (A.W. and J.T.). G.A.S. was supported by the University of California, San Francisco Medical Scientist Training Program and the US National Institute of Allergy and Infectious Diseases (F30AI120517-01).	Ahearn S.P., 2013, WIPO patent, Patent No. [085802 A1, 085802]; Arneja A, 2014, J IMMUNOL, V192, P123, DOI 10.4049/jimmunol.1302291; Babon JJ, 2012, IMMUNITY, V36, P239, DOI 10.1016/j.immuni.2011.12.015; Brennan P, 1997, IMMUNITY, V7, P679, DOI 10.1016/S1074-7613(00)80388-X; CANTRELL DA, 1984, SCIENCE, V224, P1312, DOI 10.1126/science.6427923; Clark JD, 2014, J MED CHEM, V57, P5023, DOI 10.1021/jm401490p; Cornish AL, 2003, J BIOL CHEM, V278, P22755, DOI 10.1074/jbc.M303021200; Cornish GH, 2006, BLOOD, V108, P600, DOI 10.1182/blood-2005-12-4827; Dowty ME, 2014, J PHARMACOL EXP THER, V348, P165, DOI 10.1124/jpet.113.209304; Ghoreschi K, 2011, J IMMUNOL, V186, P4234, DOI 10.4049/jimmunol.1003668; Ghoreschi K, 2009, IMMUNOL REV, V228, P273, DOI 10.1111/j.1600-065X.2008.00754.x; Goedken ER, 2015, J BIOL CHEM, V290, P4573, DOI 10.1074/jbc.M114.595181; Haan C, 2011, CHEM BIOL, V18, P314, DOI 10.1016/j.chembiol.2011.01.012; Krutzik PO, 2006, NAT METHODS, V3, P361, DOI 10.1038/NMETH872; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; Liao W, 2014, P NATL ACAD SCI USA, V111, P3508, DOI 10.1073/pnas.1301138111; Liao W, 2013, IMMUNITY, V38, P13, DOI 10.1016/j.immuni.2013.01.004; Lin JX, 2012, IMMUNITY, V36, P586, DOI 10.1016/j.immuni.2012.02.017; Lockyer HM, 2007, J IMMUNOL, V179, P5301, DOI 10.4049/jimmunol.179.8.5301; London N, 2014, NAT CHEM BIOL, V10, P1066, DOI 10.1038/nchembio.1666; MIYAZAKI T, 1994, SCIENCE, V266, P1045, DOI 10.1126/science.7973659; Perona-Wright G, 2010, NAT IMMUNOL, V11, P520, DOI 10.1038/ni.1866; Readinger JA, 2009, IMMUNOL REV, V228, P93, DOI 10.1111/j.1600-065X.2008.00757.x; Rochman Y, 2009, NAT REV IMMUNOL, V9, P480, DOI 10.1038/nri2580; Rowell EA, 2006, CRIT REV IMMUNOL, V26, P189, DOI 10.1615/CritRevImmunol.v26.i3.10; Schaeffer EM, 1999, SCIENCE, V284, P638, DOI 10.1126/science.284.5414.638; Swainson L, 2007, BLOOD, V109, P1034, DOI 10.1182/blood-2006-06-027912; Tan L, 2015, J MED CHEM, V58, P6589, DOI 10.1021/acs.jmedchem.5b00710; Thomis DC, 1997, J EXP MED, V185, P197, DOI 10.1084/jem.185.2.197; THOMIS DC, 1995, SCIENCE, V270, P794, DOI 10.1126/science.270.5237.794; Witthuhn BA, 1999, LEUKEMIA LYMPHOMA, V32, P289, DOI 10.3109/10428199909167389; Wormald S, 2006, J BIOL CHEM, V281, P11135, DOI 10.1074/jbc.M509595200; Xing LZ, 2014, NAT MED, V20, P1043, DOI 10.1038/nm.3645; Yang XXO, 2013, NAT IMMUNOL, V14, P732, DOI 10.1038/ni.2633; Yao ZJ, 2006, P NATL ACAD SCI USA, V103, P1000, DOI 10.1073/pnas.0507350103	35	62	62	1	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAY	2016	12	5					373	+		10.1038/NCHEMBIO.2056	http://dx.doi.org/10.1038/NCHEMBIO.2056			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DJ6KY	27018889	Green Accepted, Green Submitted			2022-12-25	WOS:000374322800013
J	Feng, X; Barth, P				Feng, Xiang; Barth, Patrick			A topological and conformational stability alphabet for multipass membrane proteins	NATURE CHEMICAL BIOLOGY			English	Article							NOVO STRUCTURE PREDICTION; HELIX-PACKING; DESIGN; PROPENSITIES; ASSOCIATION; MUTATIONS; SELECTION; RESIDUES; LIBRARY; DOMAINS	Multipass membrane proteins perform critical signal transduction and transport across membranes. How transmembrane helix (TMH) sequences encode the topology and conformational flexibility regulating these functions remains poorly understood. Here we describe a comprehensive analysis of the sequence-structure relationships at multiple interacting TMHs from all membrane proteins with structures in the Protein Data Bank (PDB). We found that membrane proteins can be deconstructed in interacting TMH trimer units, which mostly fold into six distinct structural classes of topologies and conformations. Each class is enriched in recurrent sequence motifs from functionally unrelated proteins, revealing unforeseen consensus and evolutionary conserved networks of stabilizing interhelical contacts. Interacting TMHs' topology and local protein conformational flexibility were remarkably well predicted in a blinded fashion from the identified binding-hotspot motifs. Our results reveal universal sequence-structure principles governing the complex anatomy and plasticity of multipass membrane proteins that may guide de novo structure prediction, design, and studies of folding and dynamics.	[Feng, Xiang; Barth, Patrick] Baylor Coll Med, Dept Pharmacol, 1 Baylor Plaza, Houston, TX 77030 USA; [Barth, Patrick] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Barth, Patrick] Baylor Coll Med, Struct & Computat Biol & Mol Biophys Grad Program, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Barth, P (corresponding author), Baylor Coll Med, Dept Pharmacol, 1 Baylor Plaza, Houston, TX 77030 USA.; Barth, P (corresponding author), Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA.; Barth, P (corresponding author), Baylor Coll Med, Struct & Computat Biol & Mol Biophys Grad Program, Houston, TX 77030 USA.	patrickb@bcm.edu	Feng, Xiang/AGG-8475-2022	Feng, Xiang/0000-0002-4441-3152; Barth, Patrick/0000-0002-0744-6844	US National Institute of Health [1R01GM097207-01A1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097207] Funding Source: NIH RePORTER	US National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the members of the Barth laboratory for insightful discussions during this study and critical comments on the manuscript. This work was supported by a grant from the US National Institute of Health (1R01GM097207-01A1) and by a supercomputer allocation from XSEDE (Extreme Science and Engineering Discovery Environment; MCB120101) to P.B.	Barth P, 2007, P NATL ACAD SCI USA, V104, P15682, DOI 10.1073/pnas.0702515104; Barth P, 2009, P NATL ACAD SCI USA, V106, P1409, DOI 10.1073/pnas.0808323106; Bill RM, 2011, NAT BIOTECHNOL, V29, P335, DOI 10.1038/nbt.1833; Bowie JU, 1997, J MOL BIOL, V272, P780, DOI 10.1006/jmbi.1997.1279; Bystroff C, 1998, J MOL BIOL, V281, P565, DOI 10.1006/jmbi.1998.1943; Cammett TJ, 2010, P NATL ACAD SCI USA, V107, P3447, DOI 10.1073/pnas.0915057107; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chen KYM, 2012, P NATL ACAD SCI USA, V109, P13284, DOI 10.1073/pnas.1205512109; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Cymer F, 2015, J MOL BIOL, V427, P999, DOI 10.1016/j.jmb.2014.09.014; Dror RO, 2011, P NATL ACAD SCI USA, V108, P18684, DOI 10.1073/pnas.1110499108; Gurezka R, 2001, J BIOL CHEM, V276, P45580, DOI 10.1074/jbc.M105362200; Hopf TA, 2012, CELL, V149, P1607, DOI 10.1016/j.cell.2012.04.012; Joh NH, 2014, SCIENCE, V346, P1520, DOI 10.1126/science.1261172; King NP, 2014, NATURE, V510, P103, DOI 10.1038/nature13404; Koga N, 2012, NATURE, V491, P222, DOI 10.1038/nature11600; Krishnamurthy H, 2009, NATURE, V459, P347, DOI 10.1038/nature08143; Langosch D, 2009, PROTEIN SCI, V18, P1343, DOI 10.1002/pro.154; Liu Y, 2002, GENOME BIOL, V3; Marks DS, 2012, NAT BIOTECHNOL, V30, P1072, DOI 10.1038/nbt.2419; Matthews EE, 2006, CELL, V127, P447, DOI 10.1016/j.cell.2006.10.016; MINOR DL, 1994, NATURE, V367, P660, DOI 10.1038/367660a0; Mueller BK, 2014, P NATL ACAD SCI USA, V111, pE888, DOI 10.1073/pnas.1319944111; Nugent T, 2012, P NATL ACAD SCI USA, V109, pE1540, DOI 10.1073/pnas.1120036109; Partridge AW, 2004, PROTEINS, V54, P648, DOI 10.1002/prot.10611; Petukhov M, 1998, J MOL BIOL, V278, P279, DOI 10.1006/jmbi.1998.1682; Rakoczy EP, 2011, J MOL BIOL, V405, P584, DOI 10.1016/j.jmb.2010.11.003; Sarkar CA, 2008, P NATL ACAD SCI USA, V105, P14808, DOI 10.1073/pnas.0803103105; Schneider D, 2004, FEBS LETT, V577, P5, DOI 10.1016/j.febslet.2004.10.029; Senes A, 2000, J MOL BIOL, V296, P921, DOI 10.1006/jmbi.1999.3488; von Heijne G, 2006, NAT REV MOL CELL BIO, V7, P909, DOI 10.1038/nrm2063; Walters RFS, 2006, P NATL ACAD SCI USA, V103, P13658, DOI 10.1073/pnas.0605878103; Wang Y, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8196; Wolf E, 1997, PROTEIN SCI, V6, P1179, DOI 10.1002/pro.5560060606; Zhang SQ, 2015, STRUCTURE, V23, P527, DOI 10.1016/j.str.2015.01.009; Zheng F, 2015, STRUCTURE, V23, P961, DOI 10.1016/j.str.2015.03.015	36	21	22	1	25	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAR	2016	12	3					167	173		10.1038/NCHEMBIO.2001	http://dx.doi.org/10.1038/NCHEMBIO.2001			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF5FK	26780406	Green Accepted			2022-12-25	WOS:000371377000009
J	Hata, AN; Niederst, MJ; Archibald, HL; Gomez-Caraballo, M; Siddiqui, FM; Mulvey, HE; Maruvka, YE; Ji, F; Bhang, HEC; Radhakrishna, VK; Siravegna, G; Hu, HC; Raoof, S; Lockerman, E; Kalsy, A; Lee, D; Keating, CL; Ruddy, DA; Damon, LJ; Crystal, AS; Costa, C; Piotrowska, Z; Bardelli, A; Iafrate, AJ; Sadreyev, RI; Stegmeier, F; Getz, G; Sequist, LV; Faber, AC; Engelman, JA				Hata, Aaron N.; Niederst, Matthew J.; Archibald, Hannah L.; Gomez-Caraballo, Maria; Siddiqui, Faria M.; Mulvey, Hillary E.; Maruvka, Yosef E.; Ji, Fei; Bhang, Hyo-eun C.; Radhakrishna, Viveksagar Krishnamurthy; Siravegna, Giulia; Hu, Haichuan; Raoof, Sana; Lockerman, Elizabeth; Kalsy, Anuj; Lee, Dana; Keating, Celina L.; Ruddy, David A.; Damon, Leah J.; Crystal, Adam S.; Costa, Carlotta; Piotrowska, Zofia; Bardelli, Alberto; Iafrate, Anthony J.; Sadreyev, Ruslan I.; Stegmeier, Frank; Getz, Gad; Sequist, Lecia V.; Faber, Anthony C.; Engelman, Jeffrey A.			Tumor cells can follow distinct evolutionary paths to become resistant to epidermal growth factor receptor inhibition	NATURE MEDICINE			English	Article							EGFR KINASE INHIBITORS; LUNG-CANCER; ACQUIRED-RESISTANCE; MET AMPLIFICATION; GEFITINIB; MUTATION; AZD9291; T790M; HETEROGENEITY; MODELS	Although mechanisms of acquired resistance of epidermal growth factor receptor (EGFR)-mutant non -small -cell lung cancers to EGFR inhibitors have been identified, little is known about how resistant clones evolve during drug therapy. Here we observe that acquired resistance caused by the EGFR(T79OM) gatekeeper mutation can occur either by selectiori of pre-existing EGFR(T79M)-positive clones or via genetic evolution of initially EGFR(T790M)-negative drug -tolerant cells. The path to resistance impacts the biology of the resistant clone, as those that evolved from drug -tolerant cells had a diminished apoptotic response to third generation EGFR inhibitors that target EGFR(T790M); treatment with navitoclax, an inhibitor of the anti-apoptotic factors BCL-xL and BCL-2 restored sensitivity. We corroborated these findings using cultures derived directly from EGFR inhibitor -resistant patient tumors. These findings provide evidence that clinically relevant drug -resistant cancer cells can both pre-exist and evolve from drug -tolerant cells, and they point to therapeutic opportunities to prevent or overcome resistance in the clinic.	[Hata, Aaron N.; Niederst, Matthew J.; Archibald, Hannah L.; Gomez-Caraballo, Maria; Siddiqui, Faria M.; Mulvey, Hillary E.; Maruvka, Yosef E.; Hu, Haichuan; Raoof, Sana; Lockerman, Elizabeth; Kalsy, Anuj; Lee, Dana; Damon, Leah J.; Crystal, Adam S.; Costa, Carlotta; Piotrowska, Zofia; Getz, Gad; Sequist, Lecia V.; Engelman, Jeffrey A.] Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA USA; [Hata, Aaron N.; Niederst, Matthew J.; Raoof, Sana; Costa, Carlotta; Piotrowska, Zofia; Sequist, Lecia V.; Engelman, Jeffrey A.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Maruvka, Yosef E.; Getz, Gad] Broad Inst MIT & Harvard Univ, Cambridge, MA USA; [Ji, Fei; Sadreyev, Ruslan I.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Bhang, Hyo-eun C.; Radhakrishna, Viveksagar Krishnamurthy; Keating, Celina L.; Stegmeier, Frank] Novartis Inst Biomed Res, Oncol Dis Area, Cambridge, MA USA; [Siravegna, Giulia; Bardelli, Alberto] Univ Turin, Dept Oncol, Turin, Italy; [Siravegna, Giulia; Bardelli, Alberto] IRCCS, FPO, Candiolo Canc Inst, Candiolo, Italy; [Ruddy, David A.] Novartis Inst Biomed Res, Translat Clin Oncol, Cambridge, England; [Iafrate, Anthony J.; Sadreyev, Ruslan I.; Getz, Gad] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Getz, Gad] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Faber, Anthony C.] Virginia Commonwealth Univ, Philips Inst Oral Hlth Res, Sch Dent, Richmond, VA USA; [Faber, Anthony C.] Virginia Commonwealth Univ, Massey Canc Ctr, Richmond, VA USA; [Crystal, Adam S.] Novartis Inst Biomed Res, Translat Clin Oncol, Cambridge, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Novartis; University of Turin; IRCCS Fondazione del Piemonte per l'Oncologia; Novartis; University of London; University College London; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Virginia Commonwealth University; Virginia Commonwealth University; Novartis	Engelman, JA (corresponding author), Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA USA.; Engelman, JA (corresponding author), Harvard Univ, Sch Med, Dept Med, Boston, MA USA.	jengelman@partners.org	Siravegna, Giulia/Z-2826-2019; BARDELLI, Alberto/J-9721-2018	Siravegna, Giulia/0000-0002-7132-6484; Maruvka, Yosef/0000-0002-8918-9887; Costa, Carlotta/0000-0002-1199-2485; Damon, Leah/0000-0002-0863-0328; BARDELLI, Alberto/0000-0003-1647-5070	US National Institutes of Health (NIH) [R01CA137008]; Department of Defense; LunGevity; Uniting Against Lung Cancer; Conquer Cancer Foundation of the American Society of Clinical Oncology; Lung Cancer Research Foundation; Targeting a Cure for Lung Cancer; Be a Piece of the Solution; John and Carol Barry Foundation; NATIONAL CANCER INSTITUTE [R01CA137008] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK040561] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); LunGevity; Uniting Against Lung Cancer; Conquer Cancer Foundation of the American Society of Clinical Oncology; Lung Cancer Research Foundation; Targeting a Cure for Lung Cancer; Be a Piece of the Solution; John and Carol Barry Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank C. Benes and all members of the Engelman and Benes laboratories for helpful discussions and feedback. This study was funded by support from the US National Institutes of Health (NIH) (grant R01CA137008; J.A.E.), the Department of Defense (L.V.S. and J.A.E.), LunGevity (L.V.S. and J.A.E.), Uniting Against Lung Cancer (A.N.H. and M.J.N.), the Conquer Cancer Foundation of the American Society of Clinical Oncology (A.N.H.), the Lung Cancer Research Foundation (M.J.N.), Targeting a Cure for Lung Cancer (J.A.E.), Be a Piece of the Solution (J.A.E.), and the John and Carol Barry Foundation (A.N.H.).	Bhang HEC, 2015, NAT MED, V21, P440, DOI 10.1038/nm.3841; Byers LA, 2013, CLIN CANCER RES, V19, P279, DOI 10.1158/1078-0432.CCR-12-1558; Camidge DR, 2014, NAT REV CLIN ONCOL, V11, P473, DOI 10.1038/nrclinonc.2014.104; Corcoran RB, 2013, CANCER CELL, V23, P121, DOI 10.1016/j.ccr.2012.11.007; Costa DB, 2007, PLOS MED, V4, P1669, DOI 10.1371/journal.pmed.0040315; Cragg MS, 2008, J CLIN INVEST, V118, P3651, DOI 10.1172/JCI35437; Cragg MS, 2007, PLOS MED, V4, P1681, DOI 10.1371/journal.pmed.0040316; Cross DAE, 2014, CANCER DISCOV, V4, P1046, DOI 10.1158/2159-8290.CD-14-0337; Crystal AS, 2014, SCIENCE, V346, P1480, DOI 10.1126/science.1254721; de Bruin EC, 2014, SCIENCE, V346, P251, DOI 10.1126/science.1253462; Eberlein CA, 2015, CANCER RES, V75, P2489, DOI 10.1158/0008-5472.CAN-14-3167; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Faber AC, 2011, CANCER DISCOV, V1, P352, DOI 10.1158/2159-8290.CD-11-0106; Gong YX, 2007, PLOS MED, V4, P1655, DOI 10.1371/journal.pmed.0040294; Hata AN, 2015, CANCER DISCOV, V5, P475, DOI 10.1158/2159-8290.CD-15-0011; Hindson BJ, 2011, ANAL CHEM, V83, P8604, DOI 10.1021/ac202028g; Hirata E, 2015, CANCER CELL, V27, P574, DOI 10.1016/j.ccell.2015.03.008; Janne PA, 2015, NEW ENGL J MED, V372, P1689, DOI 10.1056/NEJMoa1411817; Lee HJ, 2014, CANCER CELL, V26, P207, DOI 10.1016/j.ccr.2014.05.019; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Maheswaran S, 2008, NEW ENGL J MED, V359, P366, DOI 10.1056/NEJMoa0800668; McGranahan N, 2015, CANCER CELL, V27, P15, DOI 10.1016/j.ccell.2014.12.001; Misale S, 2014, CANCER DISCOV, V4, P1269, DOI 10.1158/2159-8290.CD-14-0462; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Ohashi K, 2012, P NATL ACAD SCI USA, V109, pE2127, DOI 10.1073/pnas.1203530109; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Piotrowska Z, 2015, CANCER DISCOV, V5, P713, DOI 10.1158/2159-8290.CD-15-0399; Ramirez, NAT COMMUN IN PRESS; Robasky K, 2014, NAT REV GENET, V15, P56, DOI 10.1038/nrg3655; Sequist LV, 2015, NEW ENGL J MED, V372, P1700, DOI 10.1056/NEJMoa1413654; Sequist LV, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002003; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Su KY, 2012, J CLIN ONCOL, V30, P433, DOI 10.1200/JCO.2011.38.3224; Thress KS, 2015, NAT MED, V21, P560, DOI 10.1038/nm.3854; Turke AB, 2010, CANCER CELL, V17, P77, DOI 10.1016/j.ccr.2009.11.022; Wilson TR, 2012, NATURE, V487, P505, DOI 10.1038/nature11249; Ye X, 2013, J THORAC ONCOL, V8, P1118, DOI 10.1097/JTO.0b013e31829f691f; Zheng ZL, 2014, NAT MED, V20, P1479, DOI 10.1038/nm.3729; Zhou WJ, 2009, NATURE, V462, P1070, DOI 10.1038/nature08622	39	530	546	3	171	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2016	22	3					262	269		10.1038/nm.4040	http://dx.doi.org/10.1038/nm.4040			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DF6DC	26828195	Green Submitted, Green Accepted			2022-12-25	WOS:000371445100013
J	Baek, ST; Copeland, B; Yun, EJ; Kwon, SK; Guemez-Gamboa, A; Schaffer, AE; Kim, S; Kang, HC; Song, S; Mathern, GW; Gleeson, JG				Baek, Seung Tae; Copeland, Brett; Yun, Eun-Jin; Kwon, Seok-Kyu; Guemez-Gamboa, Alicia; Schaffer, Ashleigh E.; Kim, Sangwoo; Kang, Hoon-Chul; Song, Saera; Mathern, Gary W.; Gleeson, Joseph G.			An AKT3-FOXG1-reelin network underlies defective migration in human focal malformations of cortical development	NATURE MEDICINE			English	Article							CONTROL NEURONAL MIGRATION; LHERMITTE-DUCLOS-DISEASE; COPY-NUMBER VARIATION; SOMATIC MUTATIONS; CEREBRAL-CORTEX; TRANSCRIPTION FACTOR; DEVELOPING NEOCORTEX; PIK3CA CAUSE; HUMAN BRAIN; REELIN	Focal malformations of cortical development (FMCDs) account for the majority of drug-resistant pediatric epilepsy. Postzygotic somatic mutations activating the phosphatidylinositol-4,5-bisphosphate-3-kinase (PI3K)-protein kinase B (AKT)-mammalian target of rapamycin (mTOR) pathway are found in a wide range of brain diseases, including FMCDs. It remains unclear how a mutation in a small fraction of cells disrupts the architecture of the entire hemisphere. Within human FMCD-affected brain, we found that cells showing activation of the PI3K-AKT-mTOR pathway were enriched for the AKT3(E17K) mutation. Introducing the FMCD-causing mutation into mouse brain resulted in electrographic seizures and impaired hemispheric architecture. Mutation-expressing neural progenitors showed misexpression of reelin, which led to a non-cell autonomous migration defect in neighboring cells, due at least in part to derepression of reelin transcription in a manner dependent on the forkhead box (FOX) transcription factor FOXG1. Treatments aimed at either blocking downstream AKT signaling or inactivating reelin restored migration. These findings suggest a central AKT-FOXG1-reelin signaling pathway in FMCD and support pathway inhibitors as potential treatments or therapies for some forms of focal epilepsy.	[Baek, Seung Tae; Copeland, Brett; Guemez-Gamboa, Alicia; Kang, Hoon-Chul; Song, Saera; Gleeson, Joseph G.] Rockefeller Univ, Lab Pediat Brain Dis, New York, NY 10021 USA; [Baek, Seung Tae; Schaffer, Ashleigh E.; Gleeson, Joseph G.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Yun, Eun-Jin] Univ Texas SW Med Ctr Dallas, Dept Urol, Dallas, TX 75390 USA; [Kwon, Seok-Kyu] Columbia Univ, Dept Neurosci, New York, NY USA; [Kim, Sangwoo] Yonsei Univ, Coll Med, Severance Biomed Sci Inst, Seoul, South Korea; [Kang, Hoon-Chul] Severance Childrens Hosp, Pediat Epilepsy Clin, Div Pediat Neurol, Dept Pediat, Seoul, South Korea; [Kang, Hoon-Chul] Yonsei Univ, Coll Med, Epilepsy Res Ctr, Seoul, South Korea; [Mathern, Gary W.] Univ Calif Los Angeles, David Geffen Sch Med, Mattel Childrens Hosp, Dept Neurosurg, Los Angeles, CA 90095 USA; [Mathern, Gary W.] Univ Calif Los Angeles, David Geffen Sch Med, Mattel Childrens Hosp, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA; [Gleeson, Joseph G.] Howard Hughes Med Inst, Neurogenet Lab, Chevy Chase, MD USA	Rockefeller University; University of California System; University of California San Diego; University of Texas System; University of Texas Southwestern Medical Center Dallas; Columbia University; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Howard Hughes Medical Institute	Gleeson, JG (corresponding author), Rockefeller Univ, Lab Pediat Brain Dis, 1230 York Ave, New York, NY 10021 USA.	jogleeson@ucsd.edu	Mathern, Gary W./J-2483-2016	Kim, Sangwoo/0000-0001-5356-0827; Kang, Hoon-Chul/0000-0002-3659-8847; Copeland, Brett/0000-0003-2933-6061; Guemez-Gamboa, Alicia/0000-0001-6890-4661; Schaffer, Ashleigh/0000-0002-1164-697X; Baek, Seung Tae/0000-0003-0040-1501; Kwon, Seok-Kyu/0000-0002-7280-9867	US National Institutes of Health [R01NS083823]; Simons Foundation for Autism Research [275275]; Howard Hughes Medical Institute; National Alliance for Research on Schizophrenia and Depression (NARSAD) Young Investigator Grant from the Brain & Behavior Research Foundation [22892]; Human Frontier Science Program Long-Term Fellowship; A.P. Giannini Foundation Fellowship; NIH NICHD K99/R00 Pathway to Independence Award [K99HD082337]; Dr. Alfonsina Q. Davies Endowed Chair in honor of Paul Crandall MD; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K99HD082337] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH108898] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS083823, P30NS047101] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Simons Foundation for Autism Research; Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Alliance for Research on Schizophrenia and Depression (NARSAD) Young Investigator Grant from the Brain & Behavior Research Foundation; Human Frontier Science Program Long-Term Fellowship(Human Frontier Science Program); A.P. Giannini Foundation Fellowship; NIH NICHD K99/R00 Pathway to Independence Award; Dr. Alfonsina Q. Davies Endowed Chair in honor of Paul Crandall MD; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank N. Cai, M. Huynh, T. Chirwa, K. Um, J. Silhavy and U. Yang for technical expertise. This work was supported by the US National Institutes of Health (grant no. R01NS083823; J.G.G. and G.W.M.), the Simons Foundation for Autism Research (grant no. 275275; J.G.G.), the Howard Hughes Medical Institute (J.G.G.), the 2014 National Alliance for Research on Schizophrenia and Depression (NARSAD) Young Investigator Grant from the Brain & Behavior Research Foundation (grant no. 22892; S.T.B.), a Human Frontier Science Program Long-Term Fellowship (S.-K.K.), an A.P. Giannini Foundation Fellowship (A.E.S.) and an NIH NICHD K99/R00 Pathway to Independence Award (grant no. K99HD082337; A.E.S.). G.W.M. was supported by the Dr. Alfonsina Q. Davies Endowed Chair in honor of Paul Crandall MD for Epilepsy Research. We thank the UCSD Neuroscience Microscopy Core P30 NS047101 for imaging support, K. Jepsen from the UCSD Institute for Genomic Medicine Core Facility, the UCSD Human Embryonic Stem Cell Core Facility, A. Roberts from the Scripps Research Institute Animal Core Facility, I. Verma (Salk Institute) for the pBOB-Switch vector, A. Acharya (University of Texas Southwestern Medical Center) for the Cre-expressing adenovirus, G. Fishell (New York University) for the Foxg1 plasmid, and P. Mischel, I. Martin-Valencia, T. Curran and T. Park for discussions.	Adams JR, 2011, CANCER RES, V71, P2706, DOI 10.1158/0008-5472.CAN-10-0738; Ariani F, 2008, AM J HUM GENET, V83, P89, DOI 10.1016/j.ajhg.2008.05.015; Aronica E, 2012, BRAIN PATHOL, V22, P380, DOI 10.1111/j.1750-3639.2012.00581.x; Backman SA, 2001, NAT GENET, V29, P396, DOI 10.1038/ng782; Baek ST, 2014, NEURON, V82, P1255, DOI 10.1016/j.neuron.2014.04.036; Bateup HS, 2013, NEURON, V78, P510, DOI 10.1016/j.neuron.2013.03.017; Blumcke I, 2011, EPILEPSIA, V52, P158, DOI 10.1111/j.1528-1167.2010.02777.x; Blumcke I, 2009, EPILEPTIC DISORD, V11, P181, DOI 10.1684/epd.2009.0261; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Cai XY, 2014, CELL REP, V8, P1280, DOI 10.1016/j.celrep.2014.07.043; Cepeda C, 2006, EPILEPSY BEHAV, V9, P219, DOI 10.1016/j.yebeh.2006.05.012; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Chow LML, 2011, CANCER CELL, V19, P305, DOI 10.1016/j.ccr.2011.01.039; Conti V, 2015, CLIN GENET, V88, P241, DOI 10.1111/cge.12476; Crunelli V, 2002, NAT REV NEUROSCI, V3, P371, DOI 10.1038/nrn811; DArcangelo G, 1997, J NEUROSCI, V17, P23, DOI 10.1523/JNEUROSCI.17-01-00023.1997; Evrony GD, 2012, CELL, V151, P483, DOI 10.1016/j.cell.2012.09.035; Fauser S, 2015, EPILEPSIA, V56, P66, DOI 10.1111/epi.12876; Feliciano DM, 2011, J CLIN INVEST, V121, P1596, DOI 10.1172/JCI44909; Franco SJ, 2011, NEURON, V69, P482, DOI 10.1016/j.neuron.2011.01.003; Fraser MM, 2004, CANCER RES, V64, P7773, DOI 10.1158/0008-5472.CAN-04-2487; Friedmann-Morvinski D, 2012, SCIENCE, V338, P1080, DOI 10.1126/science.1226929; Gutmann DH, 1995, INT J DEV BIOL, V39, P895; Hadjivassiliou G, 2010, ACTA NEUROPATHOL, V120, P517, DOI 10.1007/s00401-010-0686-x; Hanashima C, 2004, SCIENCE, V303, P56, DOI 10.1126/science.1090674; Hashimoto-Torii K, 2008, NEURON, V60, P273, DOI 10.1016/j.neuron.2008.09.026; Hong SE, 2000, NAT GENET, V26, P93, DOI 10.1038/79246; Jossin Y, 2011, NAT NEUROSCI, V14, P697, DOI 10.1038/nn.2816; Keppler-Noreuil KM, 2014, AM J MED GENET A, V164, P1713, DOI 10.1002/ajmg.a.36552; Kubo K, 2010, J NEUROSCI, V30, P10953, DOI 10.1523/JNEUROSCI.0486-10.2010; Kupferman JV, 2014, CELL, V158, P1335, DOI 10.1016/j.cell.2014.07.035; Kurek KC, 2012, AM J HUM GENET, V90, P1108, DOI 10.1016/j.ajhg.2012.05.006; Kwon CH, 2001, NAT GENET, V29, P404, DOI 10.1038/ng781; Kwon CH, 2006, NEURON, V50, P377, DOI 10.1016/j.neuron.2006.03.023; Lee JH, 2012, NAT GENET, V44, P941, DOI 10.1038/ng.2329; Lim JS, 2015, NAT MED, V21, P395, DOI 10.1038/nm.3824; Lindhurst MJ, 2011, NEW ENGL J MED, V365, P611, DOI 10.1056/NEJMoa1104017; LoTurco JJ, 2006, TRENDS NEUROSCI, V29, P407, DOI 10.1016/j.tins.2006.05.006; Matsuki T, 2010, CELL, V143, P826, DOI 10.1016/j.cell.2010.10.029; McConnell MJ, 2013, SCIENCE, V342, P632, DOI 10.1126/science.1243472; Nakashima M, 2015, ANN NEUROL, V78, P375, DOI 10.1002/ana.24444; National Research Council, 2011, GUIDE CARE USE LAB A; Persico AM, 2001, MOL PSYCHIATR, V6, P150, DOI 10.1038/sj.mp.4000850; Poduri A, 2013, SCIENCE, V341, P43, DOI 10.1126/science.1237758; Poduri A, 2012, NEURON, V74, P41, DOI 10.1016/j.neuron.2012.03.010; Pujadas L, 2010, J NEUROSCI, V30, P4636, DOI 10.1523/JNEUROSCI.5284-09.2010; Regad T, 2007, NAT CELL BIOL, V9, P531, DOI 10.1038/ncb1573; Riviere JB, 2012, NAT GENET, V44, P934, DOI 10.1038/ng.2331; Sarnat HB, 2013, CLIN NEUROPATHOL, V32, P340, DOI 10.5414/NP300638; Sekine K, 2014, NEUROSCI RES, V86, P50, DOI 10.1016/j.neures.2014.06.004; Sekine K, 2012, NEURON, V76, P353, DOI 10.1016/j.neuron.2012.07.020; Tavazoie SF, 2005, NAT NEUROSCI, V8, P1727, DOI 10.1038/nn1566; TAYLOR DC, 1971, J NEUROL NEUROSUR PS, V34, P369, DOI 10.1136/jnnp.34.4.369; Tegenge MA, 2011, CELL MOL LIFE SCI, V68, P2089, DOI 10.1007/s00018-010-0554-9; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Truccolo W, 2011, NAT NEUROSCI, V14, P635, DOI 10.1038/nn.2782; Tsai PT, 2012, NATURE, V488, P647, DOI 10.1038/nature11310; XUAN SH, 1995, NEURON, V14, P1141, DOI 10.1016/0896-6273(95)90262-7; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.11772/j.issn.1001-9081.2014.07.1929, 10.1523/JNEUROSCI.1860-14.2014]; Zhou J, 2012, CURR OPIN NEUROBIOL, V22, P873, DOI 10.1016/j.conb.2012.05.004	61	70	71	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2015	21	12					1445	+		10.1038/nm.3982	http://dx.doi.org/10.1038/nm.3982			12	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CX9EV	26523971	Green Accepted, Green Published			2022-12-25	WOS:000366008700015
J	Goedeke, L; Rotllan, N; Canfran-Duque, A; Aranda, JF; Ramirez, CM; Araldi, E; Lin, CS; Anderson, NN; Wagschal, A; de Cabo, R; Horton, JD; Lasuncion, MA; Naar, AM; Suarez, Y; Fernandez-Hernando, C				Goedeke, Leigh; Rotllan, Noemi; Canfran-Duque, Alberto; Aranda, Juan. F.; Ramirez, Cristina M.; Araldi, Elisa; Lin, Chin-Sheng; Anderson, Norma N.; Wagschal, Alexandre; de Cabo, Rafael; Horton, Jay D.; Lasuncion, Miguel A.; Naeaer, Anders M.; Suarez, Yajaira; Fernandez-Hernando, Carlos			MicroRNA-148a regulates LDL receptor and ABCA1 expression to control circulating lipoprotein levels	NATURE MEDICINE			English	Article							LOW-DENSITY-LIPOPROTEIN; LEUCINE ZIPPER PROTEIN; CHOLESTEROL HOMEOSTASIS; LIPID-METABOLISM; TRANSCRIPTION FACTOR; NONHUMAN-PRIMATES; MESSENGER-RNAS; TARGET GENES; HUMAN GENOME; MICE	The hepatic low-density lipoprotein receptor (LDLR) pathway is essential for clearing circulating LDL cholesterol (LDL-C). Whereas the transcriptional regulation of LDLR is well characterized, the post-transcriptional mechanisms that govern LDLR expression are just beginning to emerge. Here we develop a high-throughput genome-wide screening assay to systematically identify microRNAs (miRNAs) that regulate LDLR activity in human hepatic cells. From this screen we identified and characterized miR-148a as a negative regulator of LDLR expression and activity and defined a sterol regulatory element binding protein 1 (SREBP1)-mediated pathway through which miR-148a regulates LDL-C uptake. In mice, inhibition of miR-148a increased hepatic LDLR expression and decreased plasma LDL-C. Moreover, we found that miR-148a regulates hepatic expression of ATP-binding cassette, subfamily A, member 1 (ABCA1) and circulating high-density lipoprotein cholesterol (HDL-C) levels in vivo. These studies uncover a role for miR-148a as a key regulator of hepatic LDL-C clearance through direct modulation of LDLR expression and demonstrate the therapeutic potential of inhibiting miR-148a to ameliorate an elevated LDL-C/HDL-C ratio, a prominent risk factor for cardiovascular disease.	[Goedeke, Leigh; Rotllan, Noemi; Canfran-Duque, Alberto; Aranda, Juan. F.; Ramirez, Cristina M.; Araldi, Elisa; Suarez, Yajaira; Fernandez-Hernando, Carlos] Yale Univ, Sch Med, Vasc Biol & Therapeut Program, New Haven, CT 06520 USA; [Goedeke, Leigh; Rotllan, Noemi; Canfran-Duque, Alberto; Aranda, Juan. F.; Ramirez, Cristina M.; Araldi, Elisa; Suarez, Yajaira; Fernandez-Hernando, Carlos] Yale Univ, Sch Med, Comparat Med Sect, Integrat Cell Signaling & Neurobiol Metab Program, New Haven, CT 06510 USA; [Goedeke, Leigh; Aranda, Juan. F.; Araldi, Elisa; Lin, Chin-Sheng; Suarez, Yajaira; Fernandez-Hernando, Carlos] NYU, Sch Med, Dept Med, Leon H Charney Div Cardiol, New York, NY USA; [Goedeke, Leigh; Araldi, Elisa; Lin, Chin-Sheng; Suarez, Yajaira; Fernandez-Hernando, Carlos] NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA; [Anderson, Norma N.; Horton, Jay D.] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA; [Anderson, Norma N.; Horton, Jay D.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Wagschal, Alexandre; Naeaer, Anders M.] Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA USA; [Wagschal, Alexandre; Naeaer, Anders M.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA USA; [de Cabo, Rafael] NIA, Translat Gerontol Branch, NIH, Baltimore, MD 21224 USA; [Lasuncion, Miguel A.] Hosp Univ Ramon y Cajal, Serv Bioquim Invest, Inst Ramon y Cajal Invest Sanitaria, Madrid, Spain; [Lasuncion, Miguel A.] Ctr Invest Biomed Red Fisiopatol Obesidad & Nutr, Madrid, Spain	Yale University; Yale University; New York University; New York University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Hospital Universitario Ramon y Cajal; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN	Fernandez-Hernando, C (corresponding author), Yale Univ, Sch Med, Vasc Biol & Therapeut Program, New Haven, CT 06520 USA.	carlos.fernandez@yale.edu	Araldi, Elisa/AAZ-5946-2021; Lasunción, Miguel A./K-6167-2014; de Cabo, Rafael/E-7996-2010; Aranda, Juan Francisco/S-6388-2018; Ramírez, Cristina/ABI-1568-2020; Vila, Noemi Rotllan/AAQ-8050-2020; Ramírez, Cristina/A-6975-2016; de Cabo, Rafael Carlos/J-5230-2016; de Cabo, Rafael/J-5230-2016	Lasunción, Miguel A./0000-0003-0299-9391; de Cabo, Rafael/0000-0003-2830-5693; Aranda, Juan Francisco/0000-0002-5598-2465; Ramírez, Cristina/0000-0003-2589-0786; Vila, Noemi Rotllan/0000-0002-0587-8045; Ramírez, Cristina/0000-0003-2589-0786; de Cabo, Rafael Carlos/0000-0003-2830-5693; Goedeke, Leigh/0000-0002-7690-1572; de Cabo, Rafael/0000-0002-3354-2442; Suarez, Yajaira/0000-0003-4549-2953; Araldi, Elisa/0000-0002-6596-6784	US National Institutes of Health (NIH) [R01HL107953, R01HL107953-04S1, R01HL106063, R01HL105945, 1F31AG043318, P30KD034989]; American Heart Association [15SDG23000025]; Howard Hughes Medical Institute International Student Research Fellowship; Foundation Leducq Transatlantic Network of Excellence in Cardiovascular Research; Ministerio de Industria y Comercio, Spain [SAF2011-29951]; NIH, National Institute of Aging; NIH [R01DK 094184, U24 DK059635]; Laura and Isaac Perlmutter Cancer Center (NIH, National Cancer Institute grant) [P30CA16087]; New York State Stem Cell Science (NYSTEM) [C026719]; NATIONAL CANCER INSTITUTE [P30CA016087] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107953, R01HL106063, R01HL105945, P01HL020948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK094184, U24DK059635] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F31AG043318] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Howard Hughes Medical Institute International Student Research Fellowship(Howard Hughes Medical Institute); Foundation Leducq Transatlantic Network of Excellence in Cardiovascular Research; Ministerio de Industria y Comercio, Spain; NIH, National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Laura and Isaac Perlmutter Cancer Center (NIH, National Cancer Institute grant); New York State Stem Cell Science (NYSTEM); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank C. Yun, J. Recio, S. Katz and R. DasGupta at the New York University (NYU) RNAi Core for their advice and assistance with the miRNA screen, K. Harry and members of the Yale University Liver Center for primary mouse hepatocyte isolation, members of the Iwakiri laboratory for reagents and advice on primary hepatocyte culture, the Yale University School of Medicine Mouse Metabolic Phenotyping Center (MMPC) for liver toxicity measurements, P. Tontonoz (UCLA) for generously providing the LDLR-GFP plasmid, the Nonhuman Primate Core of the National Institute on Aging for providing liver samples and E. Fisher (NYU School of Medicine) for kindly providing the human hepatocellular carcinoma cell line (Huh7) and mouse hepatic cell line (Hepal-6). This work was supported through grants by the US National Institutes of Health (NIH; grants R01HL107953, R01HL107953-04S1 and R01HL106063 (C.F.-H.); grant R01HL105945 (Y.S.); grant 1F31AG043318 (L.G.); grant P30KD034989 (Yale University Liver Center), the American Heart Association (grant 15SDG23000025 (C.M.R.)), the Howard Hughes Medical Institute International Student Research Fellowship (E.A.), the Foundation Leducq Transatlantic Network of Excellence in Cardiovascular Research (C.F.-H.) and the Ministerio de Industria y Comercio, Spain (grant SAF2011-29951 (M.A.L.)). Centro de Investigacion Biomedica en Red Fisiopatologia de Obesidad y Nutricion (CIBERobn) is an initiative of Instituto de Salud Carlos III (ISCIII), Spain. R.d.C. is supported by the Intramural Research Program of the NIH, National Institute of Aging. A.M.N. and A.W. are supported by NIH grant R01DK 094184. The NYU RNAi core is supported by the Laura and Isaac Perlmutter Cancer Center (NIH, National Cancer Institute grant P30CA16087) and the New York State Stem Cell Science (NYSTEM) contract C026719. The Yale University School of Medicine MMPC is supported by NIH grant U24 DK059635.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Arora A, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-r82; Barad O, 2004, GENOME RES, V14, P2486, DOI 10.1101/gr.2845604; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Beaven SW, 2006, ANNU REV MED, V57, P313, DOI 10.1146/annurev.med.57.121304.131428; Birmingham A, 2009, NAT METHODS, V6, P569, DOI 10.1038/nmeth.1351; BROWN MS, 1973, P NATL ACAD SCI USA, V70, P2162, DOI 10.1073/pnas.70.7.2162; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; DIETSCHY JM, 1993, J LIPID RES, V34, P1637; Do R, 2013, NAT GENET, V45, P1345, DOI 10.1038/ng.2795; Down TA, 2002, GENOME RES, V12, P458, DOI 10.1101/gr.216102; Dweep H, 2014, METHODS MOL BIOL, V1182, P289, DOI 10.1007/978-1-4939-1062-5_25; Elmen J, 2008, NATURE, V452, P896, DOI 10.1038/nature06783; Elmen J, 2008, NUCLEIC ACIDS RES, V36, P1153, DOI 10.1093/nar/gkm1113; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Ernst J, 2010, NAT BIOTECHNOL, V28, P817, DOI 10.1038/nbt.1662; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Glass CK, 2001, CELL, V104, P503, DOI 10.1016/S0092-8674(01)00238-0; GOLDSTEIN JL, 1976, CELL, V7, P85, DOI 10.1016/0092-8674(76)90258-0; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Horton JD, 1998, P NATL ACAD SCI USA, V95, P5987, DOI 10.1073/pnas.95.11.5987; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; HUA XX, 1993, P NATL ACAD SCI USA, V90, P11603, DOI 10.1073/pnas.90.24.11603; Huan TX, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7601; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jeon TI, 2013, CELL METAB, V18, P51, DOI 10.1016/j.cmet.2013.06.010; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Maxwell KN, 2003, J LIPID RES, V44, P2109, DOI 10.1194/jlr.M300203-JLR200; Mercer J, 2012, CELL REP, V2, P1036, DOI 10.1016/j.celrep.2012.09.003; Najafi-Shoushtari SH, 2010, SCIENCE, V328, P1566, DOI 10.1126/science.1189123; Oram JF, 2000, CURR OPIN LIPIDOL, V11, P253, DOI 10.1097/00041433-200006000-00005; Peet DJ, 1998, CELL, V93, P693, DOI 10.1016/S0092-8674(00)81432-4; Ramirez CM, 2013, CIRC RES, V112, P1592, DOI 10.1161/CIRCRESAHA.112.300626; Rayner KJ, 2011, NATURE, V478, P404, DOI 10.1038/nature10486; Rayner KJ, 2011, J CLIN INVEST, V121, P2921, DOI 10.1172/JCI57275; Rayner KJ, 2010, SCIENCE, V328, P1570, DOI 10.1126/science.1189862; Rottiers V, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006840; Saini HK, 2007, P NATL ACAD SCI USA, V104, P17719, DOI 10.1073/pnas.0703890104; Shimomura I, 1999, J BIOL CHEM, V274, P30028, DOI 10.1074/jbc.274.42.30028; Shimomura I, 1997, J CLIN INVEST, V99, P838, DOI 10.1172/JCI119247; Soh J, 2013, NAT MED, V19, P892, DOI 10.1038/nm.3200; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; TONTONOZ P, 1993, MOL CELL BIOL, V13, P4753, DOI 10.1128/MCB.13.8.4753; Trajkovski M, 2011, NATURE, V474, P649, DOI 10.1038/nature10112; Vallim TQD, 2013, CIRC RES, V112, P1602, DOI 10.1161/CIRCRESAHA.112.300648; Vickers KC, 2014, P NATL ACAD SCI USA, V111, P14518, DOI 10.1073/pnas.1215767111; Vickers KC, 2013, HEPATOLOGY, V57, P533, DOI 10.1002/hep.25846; Walker AK, 2011, CELL, V147, P840, DOI 10.1016/j.cell.2011.09.045; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; Yang MH, 2014, J LIPID RES, V55, P226, DOI 10.1194/jlr.M041335; YOKOYAMA C, 1993, CELL, V75, P187, DOI 10.1016/S0092-8674(05)80095-9; Yoshikawa T, 2001, MOL CELL BIOL, V21, P2991, DOI 10.1128/MCB.21.9.2991-3000.2001; Zelcer N, 2009, SCIENCE, V325, P100, DOI 10.1126/science.1168974; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	60	165	177	1	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2015	21	11					1280	1289		10.1038/nm.3949	http://dx.doi.org/10.1038/nm.3949			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CV9QH	26437365	Green Accepted, Green Submitted			2022-12-25	WOS:000364621200012
J	Johnston, AB; Collins, A; Goode, BL				Johnston, Adam B.; Collins, Agnieszka; Goode, Bruce L.			High-speed depolymerization at actin filament ends jointly catalysed by Twinfilin and Srv2/CAP	NATURE CELL BIOLOGY			English	Article							CYCLASE-ASSOCIATED PROTEIN; F-ACTIN; CYTOSKELETAL DYNAMICS; ADP-ACTIN; COFILIN; YEAST; MECHANISM; TURNOVER; LAMELLIPODIA; STEREOCILIA	Purified actin filaments depolymerize slowly, and cytosolic conditions strongly favour actin assembly over disassembly, which has left our understanding of how actin filaments are rapidly turned over in vivo incomplete(1,2). One mechanism for driving filament disassembly is severing by factors such as Cofilin. However, even after severing, pointed-end depolymerization remains slow and unable to fully account for observed rates of actin filament turnover in vivo. Here we describe a mechanism by which Twinfilin and Cyclase-associated protein work in concert to accelerate depolymerization of actin filaments by 3-fold and 17-fold at their barbed and pointed ends, respectively. This mechanism occurs even under assembly conditions, allowing reconstitution and direct visualization of individual filaments undergoing tunable, accelerated treadmilling. Further, we use specific mutations to demonstrate that this activity is critical for Twinfilin function in vivo. These findings fill a major gap in our knowledge of cellular disassembly mechanisms, and suggest that depolymerization and severing may be deployed separately or together to control the dynamics and architecture of distinct actin networks.	[Johnston, Adam B.; Collins, Agnieszka; Goode, Bruce L.] Brandeis Univ, Dept Biol, Rosenstiel Basic Med Sci Res Ctr, Waltham, MA 02454 USA	Brandeis University	Goode, BL (corresponding author), Brandeis Univ, Dept Biol, Rosenstiel Basic Med Sci Res Ctr, Waltham, MA 02454 USA.	goode@brandeis.edu			NIH [GM063691]; National Science Foundation [DMR-MRSEC-0820429]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063691, T32GM007122] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are extremely grateful to D. Breitsprecher, M. Cataldo, Z. Dogic, J. Eskin, S. Guo, J. Henty-Ridilla, S. Jansen, J. Moseley and A. Rodal for helpful comments on the manuscript. We thank A. Goodman for extensive help with the cellular concentration experiments. This work was supported by grants from the NIH (GM063691) and the National Science Foundation (DMR-MRSEC-0820429) to B.L.G.	Blanchoin L, 1999, J BIOL CHEM, V274, P15538, DOI 10.1074/jbc.274.22.15538; Breitkreutz A, 2010, SCIENCE, V328, P1043, DOI 10.1126/science.1176495; Brieher W, 2013, MOL BIOL CELL, V24, P2299, DOI 10.1091/mbc.E12-09-0694; Campellone KG, 2010, NAT REV MOL CELL BIO, V11, P237, DOI 10.1038/nrm2867; Chaudhry F, 2013, MOL BIOL CELL, V24, P31, DOI 10.1091/mbc.E12-08-0589; Goode BL, 1998, J CELL BIOL, V142, P723, DOI 10.1083/jcb.142.3.723; Helfer E, 2006, EMBO J, V25, P1184, DOI 10.1038/sj.emboj.7601019; Iwasa JH, 2007, CURR BIOL, V17, P395, DOI 10.1016/j.cub.2007.02.012; Jansen S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8202; Jansen S, 2014, J BIOL CHEM, V289, P30732, DOI 10.1074/jbc.M114.601765; Kuhn JR, 2005, BIOPHYS J, V88, P1387, DOI 10.1529/biophysj.104.047399; McGough A, 1997, J CELL BIOL, V138, P771, DOI 10.1083/jcb.138.4.771; Miyoshi T, 2013, CYTOSKELETON, V70, P179, DOI 10.1002/cm.21098; Normoyle KPM, 2012, J BIOL CHEM, V287, P35722, DOI 10.1074/jbc.M112.396051; Okada K, 1999, J CELL SCI, V112, P1553; Ono S, 2007, INT REV CYTOL, V258, P1, DOI 10.1016/S0074-7696(07)58001-0; Ono S, 2013, J CELL SCI, V126, P3249, DOI 10.1242/jcs.128231; Paavilainen VO, 2007, P NATL ACAD SCI USA, V104, P3113, DOI 10.1073/pnas.0608725104; Paavilainen VO, 2002, J BIOL CHEM, V277, P43089, DOI 10.1074/jbc.M208225200; Palmgren S, 2001, J CELL BIOL, V155, P251, DOI 10.1083/jcb.200106157; Peng AW, 2009, J NEUROSCI, V29, P15083, DOI 10.1523/JNEUROSCI.2782-09.2009; POLLARD TD, 1986, J CELL BIOL, V103, P2747, DOI 10.1083/jcb.103.6.2747; Poukkula M, 2011, CYTOSKELETON, V68, P471, DOI 10.1002/cm.20530; Quintero-Monzon O, 2009, J BIOL CHEM, V284, P10923, DOI 10.1074/jbc.M808760200; Rzadzinska AK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007097; Tarassov K, 2008, SCIENCE, V320, P1465, DOI 10.1126/science.1153878; Vartiainen M, 2000, MOL CELL BIOL, V20, P1772, DOI 10.1128/MCB.20.5.1772-1783.2000; Vartiainen MK, 2003, J BIOL CHEM, V278, P34347, DOI 10.1074/jbc.M303642200; Wahlstrom G, 2001, J CELL BIOL, V155, P787, DOI 10.1083/jcb.200108022; Watanabe N, 2002, SCIENCE, V295, P1083, DOI 10.1126/science.1067470	30	74	74	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2015	17	11					1504	1511		10.1038/ncb3252	http://dx.doi.org/10.1038/ncb3252			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CV4XT	26458246	Green Accepted			2022-12-25	WOS:000364270500015
J	Schmidt, CK; Galanty, Y; Sczaniecka-Clift, M; Coates, J; Jhujh, S; Demir, M; Cornwell, M; Beli, P; Jackson, SP				Schmidt, Christine K.; Galanty, Yaron; Sczaniecka-Clift, Matylda; Coates, Julia; Jhujh, Satpal; Demir, Mukerrem; Cornwell, Matthew; Beli, Petra; Jackson, Stephen P.			Systematic E2 screening reveals a UBE2D-RNF138-CtIP axis promoting DNA repair	NATURE CELL BIOLOGY			English	Article							STRAND-BREAK REPAIR; FANCONI-ANEMIA PATHWAY; DAMAGE RESPONSE; END RESECTION; E3 LIGASE; UBIQUITIN; UBIQUITYLATION; BINDING; PROTEINS; DYNAMICS	Ubiquitylation is crucial for proper cellular responses to DNA double-strand breaks (DSBs). If unrepaired, these highly cytotoxic lesions cause genome instability, tumorigenesis, neurodegeneration or premature ageing. Here, we conduct a comprehensive, multilayered screen to systematically profile all human ubiquitin E2 enzymes for impacts on cellular DSB responses. With a widely applicable approach, we use an exemplary E2 family, UBE2Ds, to identify ubiquitylation-cascade components downstream of E2s. Thus, we uncover the nuclear E3 ligase RNF138 as a key homologous recombination (HR)-promoting factor that functions with UBE2Ds in cells. Mechanistically, UBE2Ds and RNF138 accumulate at DNA-damage sites and act at early resection stages by promoting CtIP ubiquitylation and accrual. This work supplies insights into regulation of DSB repair by HR. Moreover, it provides a rich information resource on E2s that can be exploited by follow-on studies.	[Schmidt, Christine K.; Galanty, Yaron; Sczaniecka-Clift, Matylda; Coates, Julia; Jhujh, Satpal; Demir, Mukerrem; Cornwell, Matthew; Jackson, Stephen P.] Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst, Cambridge CB2 1QN, England; [Schmidt, Christine K.; Galanty, Yaron; Sczaniecka-Clift, Matylda; Coates, Julia; Jhujh, Satpal; Demir, Mukerrem; Cornwell, Matthew; Jackson, Stephen P.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QN, England; [Beli, Petra] IMB, D-55128 Mainz, Germany; [Jackson, Stephen P.] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England	University of Cambridge; University of Cambridge; Institute of Molecular Biology (IMB); Wellcome Trust Sanger Institute	Galanty, Y (corresponding author), Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst, Cambridge CB2 1QN, England.	y.galanty@gurdon.cam.ac.uk; s.jackson@gurdon.cam.ac.uk	Schmidt, Christine/AAF-2625-2021; Jackson, Stephen Philip/R-4548-2019	Schmidt, Christine/0000-0002-8363-7933; Jackson, Stephen Philip/0000-0001-9317-7937; Beli, Petra/0000-0001-9507-9820; Galanty, Yaron/0000-0001-7167-9004; Jhujh, Satpal Singh/0000-0001-5766-659X	Cancer Research UK Program [C6/A11224]; European Research Council (DDREAM); European Community Seventh Framework Programme [HEALTH-F2-2010-259893]; Cancer Research UK [C6946/A14492]; Wellcome Trust [WT092096]; University of Cambridge; FEBS Return-to-Europe fellowship; Emmy Noether Programme of the German Research Foundation (DFG) [BE 5342/1-1]; Cancer Research UK [18796, 11224] Funding Source: researchfish	Cancer Research UK Program(Cancer Research UK); European Research Council (DDREAM); European Community Seventh Framework Programme(European Commission); Cancer Research UK(Cancer Research UK); Wellcome Trust(Wellcome Trust); University of Cambridge(University of Cambridge); FEBS Return-to-Europe fellowship; Emmy Noether Programme of the German Research Foundation (DFG)(German Research Foundation (DFG)); Cancer Research UK(Cancer Research UK)	We are grateful to all S.P.J. laboratory members for support and comments. We thank T. Oelschlaegel (Gurdon Institute, Cambridge University, UK) for polydonal GFP-Flag-MRE11 U2OS cells, J. Forment (Gordon Institute, Cambridge University, UK) for stable GFP-CtIP-WT U2OS cells, C. le Sage for helping to generate U2OS cells stably expressing GFP-CtIP variants (12KR, 6KR and 5KR), J. Travers (Gordon Institute, Cambridge University, UK) for the pEGFP-C1/TO plasmid and for helping establish inducible GFP-RNF138 U2OS cells, the Y. Shiloh laboratory for the RPA2 mouse hybridoma, the Y. Shiloh (Department of Human Molecular Genetics and Biochemistry Sackler School of Medicine, Tel Aviv University, Israel) and M. Oren (The Weizmann Institute of Science, Israel) laboratories for HA-ubiquitin plasmid, the P. Cohen (MRC Protein Phosphorylation and Ubiquitylation Unit, University of Dundee, UK) laboratory for UBE2T plasmid, L. Pellegrini and N. Rzechorzek (Department of Biochemistry, Cambridge University UK) for providing baculovirus-purified CtIP, R. Carazo-Salas for access to the Opera, A. Riddell for flow-cytometry cell sorting support, M. Herzog and N. Smith for advice on Circos plots, the Gurdon Institute bioinformatics core facility, in particular C. Bradshaw and G. Allen, and the Gordon Institute imaging facility, in particular A. Sossick, N. Lawrence and R. Butler. Research in the S.P.J. laboratory is funded by Cancer Research UK Program Grant C6/A11224, the European Research Council (DDREAM), the European Community Seventh Framework Programme grant agreement no. HEALTH-F2-2010-259893 (DDResponse). Core infrastructure funding was provided by Cancer Research UK Grant C6946/A14492 and Wellcome Trust Grant WT092096. S.P.J. receives a salary from the University of Cambridge, supplemented by Cancer Research UK. C.K.S. was financially supported by a FEBS Return-to-Europe fellowship. P.B. is supported by the Emmy Noether Programme of the German Research Foundation (DFG, BE 5342/1-1).	Adamson B, 2012, NAT CELL BIOL, V14, P318, DOI 10.1038/ncb2426; Andres SN, 2015, NAT STRUCT MOL BIOL, V22, P158, DOI 10.1038/nsmb.2945; Certo MT, 2011, NAT METHODS, V8, P671, DOI [10.1038/nmeth.1648, 10.1038/NMETH.1648]; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Cruz-Garcia A, 2014, CELL REP, V9, P451, DOI 10.1016/j.celrep.2014.08.076; Curtin NJ, 2012, NAT REV CANCER, V12, P801, DOI 10.1038/nrc3399; Davies OR, 2015, NAT STRUCT MOL BIOL, V22, P150, DOI 10.1038/nsmb.2937; Deriano L, 2013, ANNU REV GENET, V47, P433, DOI 10.1146/annurev-genet-110711-155540; Galanty Y, 2012, GENE DEV, V26, P1179, DOI 10.1101/gad.188284.112; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Giannini AL, 2008, BIOCHEM J, V410, P101, DOI 10.1042/BJ20070995; Greenberg RA, 2006, GENE DEV, V20, P34, DOI 10.1101/gad.1381306; Gudjonsson T, 2012, CELL, V150, P697, DOI 10.1016/j.cell.2012.06.039; Husnjak K, 2012, ANNU REV BIOCHEM, V81, P291, DOI 10.1146/annurev-biochem-051810-094654; Ikura T, 2007, MOL CELL BIOL, V27, P7028, DOI 10.1128/MCB.00579-07; Inagaki A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023155; Ismail IH, 2015, NAT CELL BIOL, V17, P1446, DOI 10.1038/ncb3259; Jackson SP, 2013, MOL CELL, V49, P795, DOI 10.1016/j.molcel.2013.01.017; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Jacquemont C, 2007, CANCER RES, V67, P7395, DOI 10.1158/0008-5472.CAN-07-1015; Jazayeri A, 2006, NAT CELL BIOL, V8, P37, DOI 10.1038/ncb1337; Kaidi A, 2010, SCIENCE, V329, P1348, DOI 10.1126/science.1192049; Kakarougkas A, 2013, NUCLEIC ACIDS RES, V41, P10298, DOI 10.1093/nar/gkt802; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kulathu Y, 2012, NAT REV MOL CELL BIO, V13, P508, DOI 10.1038/nrm3394; Liu C, 2013, J CELL SCI, V126, P2042, DOI 10.1242/jcs.122945; Long DT, 2014, MOL CELL, V56, P174, DOI 10.1016/j.molcel.2014.08.012; Machida YJ, 2006, MOL CELL, V23, P589, DOI 10.1016/j.molcel.2006.06.024; Marechal A, 2014, MOL CELL, V53, P235, DOI 10.1016/j.molcel.2013.11.002; Markson G, 2009, GENOME RES, V19, P1905, DOI 10.1101/gr.093963.109; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Mattern MR, 2012, BBA-MOL CELL RES, V1823, P2014, DOI 10.1016/j.bbamcr.2012.05.005; Morris JR, 2004, HUM MOL GENET, V13, P807, DOI 10.1093/hmg/ddh095; Murakawa Y, 2007, CANCER RES, V67, P8536, DOI 10.1158/0008-5472.CAN-07-1166; Murina O, 2014, CELL REP, V7, P1030, DOI 10.1016/j.celrep.2014.03.069; Parsons JL, 2008, MOL CELL, V29, P477, DOI 10.1016/j.molcel.2007.12.027; Paulsen RD, 2009, MOL CELL, V35, P228, DOI 10.1016/j.molcel.2009.06.021; Polanowska J, 2006, EMBO J, V25, P2178, DOI 10.1038/sj.emboj.7601102; Polato F, 2014, J EXP MED, V211, P1027, DOI 10.1084/jem.20131939; Polo SE, 2011, GENE DEV, V25, P409, DOI 10.1101/gad.2021311; Povlsen LK, 2012, NAT CELL BIOL, V14, P1089, DOI 10.1038/ncb2579; Sartori AA, 2007, NATURE, V450, P509, DOI 10.1038/nature06337; Shiloh Y, 2013, NAT REV MOL CELL BIO, V14, P197, DOI 10.1038/nrm3546; Smeenk G, 2013, J CELL SCI, V126, P889, DOI 10.1242/jcs.109413; Watanabe K, 2009, NUCLEIC ACIDS RES, V37, P2176, DOI 10.1093/nar/gkp082; Wenzel DM, 2011, BIOCHEM J, V433, P31, DOI 10.1042/BJ20100985; Yamada M, 2006, J BIOL CHEM, V281, P20749, DOI 10.1074/jbc.M602089200; Ye YH, 2009, NAT REV MOL CELL BIO, V10, P755, DOI 10.1038/nrm2780; You ZS, 2010, TRENDS CELL BIOL, V20, P402, DOI 10.1016/j.tcb.2010.04.002; You ZS, 2009, MOL CELL, V36, P954, DOI 10.1016/j.molcel.2009.12.002; Zhang YY, 2011, MOL CELLS, V31, P113, DOI 10.1007/s10059-011-0015-9; Zhou Y, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt1309	52	72	75	0	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2015	17	11					1458	1470		10.1038/ncb3260	http://dx.doi.org/10.1038/ncb3260			13	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CV4XT	26502057	Green Accepted			2022-12-25	WOS:000364270500011
J	Jefferson, OA; Kollhofer, D; Ehrich, TH; Jefferson, RA				Jefferson, Osmat A.; Koellhofer, Deniz; Ehrich, Thomas H.; Jefferson, Richard A.			Gene patent practice across plant and human genomes	NATURE BIOTECHNOLOGY			English	Editorial Material									[Jefferson, Osmat A.; Koellhofer, Deniz; Ehrich, Thomas H.; Jefferson, Richard A.] Queensland Univ Technol, Brisbane, Qld 4001, Australia; [Jefferson, Osmat A.; Koellhofer, Deniz; Ehrich, Thomas H.; Jefferson, Richard A.] Cambia, Canberra, ACT, Australia	Queensland University of Technology (QUT)	Jefferson, OA (corresponding author), Queensland Univ Technol, Brisbane, Qld 4001, Australia.	osmat@cambia.org; raj@cambia.org		Jefferson, Osmat Azzam/0000-0002-0607-8728; Ehrich, Thomas/0000-0003-3475-4321; Koellhofer, Deniz/0000-0003-0313-4672; Jefferson, Richard/0000-0001-5352-4498				Association of University Technology Managers the Council on Governmental Relations the Association of American Universities and the Association of Public and Land-grant Universities, 2014, COMM USPTOS GUID DET; Hayden EC, 2014, NATURE, V511, P138, DOI 10.1038/511138a; Holman CM, 2013, BIOTECHNOL LAW REP, V32, P289, DOI 10.1089/blr.2013.9883; Jefferson OA, 2013, NAT BIOTECHNOL, V31, P1086, DOI 10.1038/nbt.2755; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Moran N, 2014, NAT BIOTECHNOL, V32, P403, DOI 10.1038/nbt0514-403a; Nottenburg Carol, 2008, P699, DOI 10.1007/978-0-387-72290-0_20; Storz U, 2012, MABS-AUSTIN, V4, P274, DOI 10.4161/mabs.4.2.19253; The Association for Molecular Pathology, 2014, RE GUID DET SUBJ MAT; US Patent and Trademark Office, 2014, GUID DET SUBJ MATT E	10	2	2	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2015	33	10					1033	1039						7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CT1JX	26448084	Green Published, Bronze			2022-12-25	WOS:000362555700019
J	Han, B; Pouget, JG; Slowikowski, K; Stahl, E; Lee, CH; Diogo, D; Hu, XL; Park, YR; Kim, E; Gregersen, PK; Dahlqvist, SR; Worthington, J; Martin, J; Eyre, S; Klareskog, L; Huizinga, T; Chen, WM; Onengut-Gumuscu, S; Rich, SS; Wray, NR; Raychaudhuri, S				Han, Buhm; Pouget, Jennie G.; Slowikowski, Kamil; Stahl, Eli; Lee, Cue Hyunkyu; Diogo, Dorothee; Hu, Xinli; Park, Yu Rang; Kim, Eunji; Gregersen, Peter K.; Dahlqvist, Solbritt Rantapaa; Worthington, Jane; Martin, Javier; Eyre, Steve; Klareskog, Lars; Huizinga, Tom; Chen, Wei-Min; Onengut-Gumuscu, Suna; Rich, Stephen S.; Wray, Naomi R.; Raychaudhuri, Soumya		Psychiat Genom Consortium	A method to decipher pleiotropy by detecting underlying heterogeneity driven by hidden subgroups applied to autoimmune and neuropsychiatric diseases	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; INFLAMMATORY-BOWEL-DISEASE; RHEUMATOID-ARTHRITIS; DIAGNOSTIC MISCLASSIFICATION; GENETIC CORRELATIONS; SUSCEPTIBILITY LOCI; MAJOR DEPRESSION; COMPLEX DISEASES; VARIANTS; DISORDER	There is growing evidence of shared risk alleles for complex traits (pleiotropy), including autoimmune and neuropsychiatric diseases. This might be due to sharing among all individuals (whole-group pleiotropy) or a subset of individuals in a genetically heterogeneous cohort (subgroup heterogeneity). Here we describe the use of a well-powered statistic, BUHMBOX, to distinguish between those two situations using genotype data. We observed a shared genetic basis for 11 autoimmune diseases and type 1 diabetes (T1D; P < 1 x 10(-4)) and for 11 autoimmune diseases and rheumatoid arthritis (RA; P < 1 x 10(-3)). This sharing was not explained by subgroup heterogeneity (corrected P-BUHMBOX > 0.2; 6,670 T1D cases and 7,279 RA cases). Genetic sharing between seronegative and seropostive RA (P < 1 x 10(-9)) had significant evidence of subgroup heterogeneity, suggesting a subgroup of seropositive-like cases within seronegative cases (P-BUHMBOX = 0.008; 2,406 seronegative RA cases). We also observed a shared genetic basis for major depressive disorder (MDD) and schizophrenia (P < 1 x 10(-4)) that was not explained by subgroup heterogeneity (P-BUHMBOX = 0.28; 9,238 MDD cases).	[Han, Buhm; Pouget, Jennie G.; Slowikowski, Kamil; Diogo, Dorothee; Hu, Xinli; Raychaudhuri, Soumya] Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA; [Han, Buhm; Pouget, Jennie G.; Slowikowski, Kamil; Diogo, Dorothee; Hu, Xinli; Raychaudhuri, Soumya] Harvard Univ, Sch Med, Boston, MA USA; [Han, Buhm] Univ Ulsan, Coll Med, Dept Convergence Med, Seoul, South Korea; [Han, Buhm] Asan Med Ctr, Asan Inst Life Sci, Seoul, South Korea; [Han, Buhm; Slowikowski, Kamil; Diogo, Dorothee; Hu, Xinli; Raychaudhuri, Soumya] Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA USA; [Han, Buhm; Diogo, Dorothee; Hu, Xinli; Raychaudhuri, Soumya] Partners Ctr Personalized Genet Med, Boston, MA USA; [Pouget, Jennie G.] Campbell Family Mental Hlth Res Inst, Ctr Addict & Mental Hlth, Toronto, ON, Canada; [Pouget, Jennie G.] Univ Toronto, Inst Med Sci, Toronto, ON, Canada; [Pouget, Jennie G.] Univ Toronto, Dept Psychiat, Toronto, ON, Canada; [Slowikowski, Kamil] Harvard Univ, Bioinformat & Integrat Genom, Cambridge, MA USA; [Stahl, Eli] Mt Sinai Sch Med, Dept Psychiat, New York, NY USA; [Lee, Cue Hyunkyu; Park, Yu Rang; Kim, Eunji] Univ Ulsan, Coll Med, Asan Med Ctr, Asan Inst Life Sci, Seoul, South Korea; [Hu, Xinli] Harvard MIT Div Hlth Sci & Technol, Boston, MA USA; [Park, Yu Rang] Asan Med Ctr, Dept Biomed Informat, Seoul, South Korea; [Kim, Eunji] Seoul Natl Univ, Dept Chem, Seoul, South Korea; [Gregersen, Peter K.] Feinstein Inst Med Res, Robert S Boas Ctr Genom & Human Genet, Manhasset, NY USA; [Dahlqvist, Solbritt Rantapaa] Umea Univ, Rheumatol, Dept Publ Hlth & Clin Med, Umea, Sweden; [Worthington, Jane; Eyre, Steve] Univ Manchester, Manchester Acad Hlth Sci Ctr, Arthritis Res UK Ctr Genet & Genom, Inst Inflammat & Repair,Musculoskeletal Res Ctr, Manchester, Lancs, England; [Worthington, Jane; Eyre, Steve] Cent Manchester Univ Hosp Natl Hlth Serv Fdn Trus, Manchester Musculoskeletal Biomed Res Unit, Natl Inst Hlth Res, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England; [Martin, Javier] CSIC, Inst Parasitol & Biomed Lopez Neyra, Granada, Spain; [Klareskog, Lars; Raychaudhuri, Soumya] Karolinska Inst, Dept Med, Rheumatol Unit, Stockholm, Sweden; [Klareskog, Lars; Raychaudhuri, Soumya] Karolinska Univ, Hosp Solna, Stockholm, Sweden; [Huizinga, Tom] Leiden Univ, Med Ctr, Dept Rheumatol, Leiden, Netherlands; [Chen, Wei-Min; Onengut-Gumuscu, Suna; Rich, Stephen S.] Univ Virginia, Ctr Publ Hlth Gen, Charlottesville, VA USA; [Wray, Naomi R.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia; [Raychaudhuri, Soumya] Univ Manchester, Inst Inflammat & Repair, Manchester, Lancs, England	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Ulsan; University of Ulsan; Asan Medical Center; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Toronto; University of Toronto; Harvard University; Icahn School of Medicine at Mount Sinai; University of Ulsan; Asan Medical Center; Harvard University; University of Ulsan; Asan Medical Center; Seoul National University (SNU); Northwell Health; Umea University; University of Manchester; University of Manchester; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Parasitologia y Biomedicina Lopez-Neyra (IPBLN); Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Virginia; University of Queensland; University of Manchester	Han, B; Raychaudhuri, S (corresponding author), Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA.; Han, B; Raychaudhuri, S (corresponding author), Harvard Univ, Sch Med, Boston, MA USA.; Han, B (corresponding author), Univ Ulsan, Coll Med, Dept Convergence Med, Seoul, South Korea.; Han, B (corresponding author), Asan Med Ctr, Asan Inst Life Sci, Seoul, South Korea.; Han, B; Raychaudhuri, S (corresponding author), Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA USA.; Han, B; Raychaudhuri, S (corresponding author), Partners Ctr Personalized Genet Med, Boston, MA USA.; Raychaudhuri, S (corresponding author), Karolinska Inst, Dept Med, Rheumatol Unit, Stockholm, Sweden.; Raychaudhuri, S (corresponding author), Karolinska Univ, Hosp Solna, Stockholm, Sweden.; Raychaudhuri, S (corresponding author), Univ Manchester, Inst Inflammat & Repair, Manchester, Lancs, England.	buhm.han@amc.seoul.kr; soumya@broadinstitute.org	Slowikowski, Kamil/K-3728-2016; Martin, Javier/B-8141-2008; eyre, stephen/K-3776-2017; Wray, Naomi/C-8639-2015; Han, Buhm/AAQ-9672-2020; Martín, María/HDL-9512-2022; Webb, Bradley T/B-1459-2009; Martín, Javier/AAV-5209-2021; Kloiber, Stefan/AAW-8786-2021; Grove, Jakob/K-8112-2015	Slowikowski, Kamil/0000-0002-2843-6370; Martin, Javier/0000-0002-2202-0622; eyre, stephen/0000-0002-1251-6974; Wray, Naomi/0000-0001-7421-3357; Webb, Bradley T/0000-0002-0576-5366; Kloiber, Stefan/0000-0002-6838-4114; Rich, Stephen/0000-0003-3872-7793; Raychaudhuri, Soumya/0000-0002-1901-8265; Grove, Jakob/0000-0003-2284-5744; Rantapaa Dahlqvist, Solbritt/0000-0001-8259-3863; Chen, Wei-Min/0000-0002-2643-2333	US National Institutes of Health (NIH) [1R01AR063759, 1R01AR062886, 1UH2AR067677-01, U19AI111224-01]; Doris Duke Charitable Foundation [2013097]; Asan Institute for Life Sciences, Asan Medical Center, Seoul, Republic of Korea [2016-0717]; Korean Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea [HI14C1731]; Fulbright Canada; Weston Foundation; Brain Canada through Canada Brain Research Fund; NIH [T32HG002295]; Australian National Health and Medical Research Council [1087889, 1078901]; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National Institute of Allergy and Infectious Diseases (NIAID); National Human Genome Research Institute (NHGRI); National Institute of Child Health and Human Development (NICHD); Juvenile Diabetes Research Foundation International (JDRF);  [U01DK062418]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG002295] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI111224] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR062886, R01AR063759, UH2AR067677] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK062418] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753, U01GM092691] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); Asan Institute for Life Sciences, Asan Medical Center, Seoul, Republic of Korea; Korean Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea; Fulbright Canada; Weston Foundation; Brain Canada through Canada Brain Research Fund; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Juvenile Diabetes Research Foundation International (JDRF)(Juvenile Diabetes Research Foundation); ; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by funding from the US National Institutes of Health (NIH) (1R01AR063759 (S.R.), 1R01AR062886 (S.R.), 1UH2AR067677-01 (S.R.), and U19AI111224-01 (S.R.)) and Doris Duke Charitable Foundation grant 2013097. B.H. is supported by the Asan Institute for Life Sciences, Asan Medical Center, Seoul, Republic of Korea (2016-0717) and the Korean Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea (HI14C1731). J.G.P. is supported by Fulbright Canada, the Weston Foundation, and Brain Canada through the Canada Brain Research Fund. K.S. is supported by an NIH training grant (T32HG002295). N.R.W. is supported by the Australian National Health and Medical Research Council (1087889 and 1078901). This research uses resources provided by the Type 1 Diabetes Genetics Consortium, a collaborative clinical study sponsored by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institute of Allergy and Infectious Diseases (NIAID), National Human Genome Research Institute (NHGRI), National Institute of Child Health and Human Development (NICHD), and Juvenile Diabetes Research Foundation International (JDRF) and supported by grant U01DK062418.	Bromet EJ, 2011, AM J PSYCHIAT, V168, P1186, DOI 10.1176/appi.ajp.2011.11010048; Bulik-Sullivan B, 2015, NAT GENET, V47, P1236, DOI 10.1038/ng.3406; Burrell RA, 2013, NATURE, V501, P338, DOI 10.1038/nature12625; Cho JH, 2015, NAT MED, V21, P730, DOI 10.1038/nm.3897; Collins FS, 2015, NEW ENGL J MED, V372, P793, DOI 10.1056/NEJMp1500523; Cotsapas C, 2013, TRENDS IMMUNOL, V34, P22, DOI 10.1016/j.it.2012.09.001; Cotsapas C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002254; Criswell LA, 2005, AM J HUM GENET, V76, P561, DOI 10.1086/429096; Eyre S, 2012, NAT GENET, V44, P1336, DOI 10.1038/ng.2462; Festen EAM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001283; Flint J, 2014, NEURON, V81, P484, DOI [10.1016/j.neuron.2014.01.027, 10.1016/j.neuron.2014.02.033]; Fortune MD, 2015, NAT GENET, V47, P839, DOI 10.1038/ng.3330; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Gibson P, 2010, NATURE, V468, P1095, DOI 10.1038/nature09587; Han B, 2014, AM J HUM GENET, V94, P522, DOI 10.1016/j.ajhg.2014.02.013; JENNRICH RI, 1970, J AM STAT ASSOC, V65, P904, DOI 10.2307/2284596; Jeste SS, 2014, NAT REV NEUROL, V10, P74, DOI 10.1038/nrneurol.2013.278; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; KENDLER KS, 1992, ARCH GEN PSYCHIAT, V49, P716; Lee SH, 2012, BIOINFORMATICS, V28, P2540, DOI 10.1093/bioinformatics/bts474; Lee SH, 2015, INT J EPIDEMIOL, V44, P1706, DOI 10.1093/ije/dyv136; Lee SH, 2013, NAT GENET, V45, P984, DOI 10.1038/ng.2711; Lin DY, 2009, AM J HUM GENET, V85, P862, DOI 10.1016/j.ajhg.2009.11.001; Onengut-Gumuscu S, 2015, NAT GENET, V47, P381, DOI 10.1038/ng.3245; Pendergrass SA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003087; Power RA, 2015, NAT NEUROSCI, V18, P953, DOI 10.1038/nn.4040; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Raychaudhuri S, 2009, NAT GENET, V41, P1313, DOI 10.1038/ng.479; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Silverberg MS, 2001, GUT, V49, P773, DOI 10.1136/gut.49.6.773; Sivakumaran S, 2011, AM J HUM GENET, V89, P607, DOI 10.1016/j.ajhg.2011.10.004; Smoller JW, 2013, LANCET, V381, P1371, DOI 10.1016/S0140-6736(12)62129-1; Smoller JW, 2000, AM J MED GENET, V96, P817, DOI 10.1002/1096-8628(20001204)96:6<817::AID-AJMG25>3.0.CO;2-A; Smyth DJ, 2008, NEW ENGL J MED, V359, P2767, DOI 10.1056/NEJMoa0807917; Solovieff N, 2013, NAT REV GENET, V14, P483, DOI 10.1038/nrg3461; Sullivan PF, 2013, MOL PSYCHIATR, V18, P497, DOI 10.1038/mp.2012.21; van der Linden MPM, 2009, ARTHRITIS RHEUM-US, V60, P2232, DOI 10.1002/art.24716; WEI LJ, 1989, J AM STAT ASSOC, V84, P1065, DOI 10.2307/2290084; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Wiik AS, 2010, AUTOIMMUN REV, V10, P90, DOI 10.1016/j.autrev.2010.08.009; Wray NR, 2007, GENOME RES, V17, P1520, DOI 10.1101/gr.6665407; Wray NR, 2012, EUR J HUM GENET, V20, P668, DOI 10.1038/ejhg.2011.257; Wray NR., 2014, CURR EPIDEMIOL REP, V1, P220, DOI DOI 10.1007/S40471-014-0023-3; Zhernakova A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002004	45	42	42	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2016	48	7					803	+		10.1038/ng.3572	http://dx.doi.org/10.1038/ng.3572			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DP9TK	27182969	Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000378840100019
J	Li, B; Li, TW; Pignon, JC; Wang, BB; Wang, JZ; Shukla, SA; Dou, RX; Chen, QM; Hodi, FS; Choueiri, TK; Wu, C; Hacohen, N; Signoretti, S; Liu, JS; Liu, XS				Li, Bo; Li, Taiwen; Pignon, Jean-Christophe; Wang, Binbin; Wang, Jinzeng; Shukla, Sachet A.; Dou, Ruoxu; Chen, Qianming; Hodi, F. Stephen; Choueiri, Toni K.; Wu, Catherine; Hacohen, Nir; Signoretti, Sabina; Liu, Jun S.; Liu, X. Shirley			Landscape of tumor-infiltrating T cell repertoire of human cancers	NATURE GENETICS			English	Article							RNA-SEQ READS; ANTIGEN; BLOCKADE; SEQUENCE; RECOGNITION; RECEPTORS; AFFINITY; LENGTH	We developed a computational method to infer the complementarity-determining region 3 (CDR3) sequences of tumor-infiltrating T cells in 9,142 RNA-seq samples across 29 cancer types. We identified over 600,000 CDR3 sequences, including 15% that were full length. CDR3 sequence length distribution and amino acid conservation, as well as variable gene usage, for infiltrating T cells in many tumors, except in brain and kidney cancers, resembled those for peripheral blood cells from healthy donors. We observed a strong association between T cell diversity and tumor mutation load, and we predicted SPAG5 and TSSK6 as putative immunogenic cancer/testis antigens in multiple cancers. Finally, we identified three potential immunogenic somatic mutations on the basis of their co-occurrence with CDR3 sequences. One of them, a PRAMEF4 mutation encoding p. Phe300Val, was predicted to result in peptide binding strongly to both MHC class I and class II molecules, with matched HLA types in its carriers. Our analyses have the potential to simultaneously identify immunogenic neoantigens and tumor-reactive T cell clonotypes.	[Li, Bo; Li, Taiwen; Liu, X. Shirley] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Li, Bo; Liu, Jun S.; Liu, X. Shirley] Harvard Univ, Dept Stat, Boston, MA 02115 USA; [Li, Taiwen; Chen, Qianming] Sichuan Univ, West China Hosp Stomatol, State Key Lab Oral Dis, Chengdu 610064, Peoples R China; [Pignon, Jean-Christophe; Signoretti, Sabina] Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA; [Wang, Binbin; Wang, Jinzeng] Tongji Univ, Sch Life Sci & Technol, Shanghai 200092, Peoples R China; [Shukla, Sachet A.; Wu, Catherine] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Dou, Ruoxu] Sun Yat Sen Univ, Dept Colorectal Surg, Affiliated Hosp 6, Guangzhou 510275, Guangdong, Peoples R China; [Hodi, F. Stephen] Harvard Univ, Sch Med, Ctr ImmunoOncol, Boston, MA USA; [Choueiri, Toni K.] Dana Farber Canc Inst, Kidney Canc Ctr, Boston, MA 02115 USA; [Hacohen, Nir] Massachusetts Gen Hosp, Ctr Canc Immunotherapy, Boston, MA 02114 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Sichuan University; Harvard University; Brigham & Women's Hospital; Tongji University; Harvard University; Dana-Farber Cancer Institute; Sun Yat Sen University; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts General Hospital	Liu, XS (corresponding author), Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA.; Liu, JS; Liu, XS (corresponding author), Harvard Univ, Dept Stat, Boston, MA 02115 USA.	jliu@stat.harvard.edu; xsliu@jimmy.harvard.edu	Wang, Binbin/AAH-7215-2019; Choueiri, Toni/K-5238-2019; Li, Taiwen/GQP-1715-2022	Wang, Binbin/0000-0003-2885-6428; Choueiri, Toni/0000-0002-9201-3217; Li, Taiwen/0000-0001-7940-8196; Liu, Xiaole/0000-0003-4736-7339	NCI [1U01 CA180980]; National Natural Science Foundation of China [31329003]; Chinese Scholarship Council; NIH/NCI DF/HCC Kidney Cancer SPORE [P50 CA101942]; NATIONAL CANCER INSTITUTE [R01CA155010, U01CA180980, P50CA101942, R01CA184922] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Scholarship Council(China Scholarship Council); NIH/NCI DF/HCC Kidney Cancer SPORE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank G. Freeman for helpful discussion during manuscript preparation. We also acknowledge the following funding sources for supporting our work: NCI grant 1U01 CA180980, National Natural Science Foundation of China grant 31329003 and a Chinese Scholarship Council Fellowship. This work was supported in part by NIH/NCI DF/HCC Kidney Cancer SPORE P50 CA101942 to S.S. and T.K.C.	ALT FW, 1992, IMMUNOL TODAY, V13, P306, DOI 10.1016/0167-5699(92)90043-7; Andreatta M, 2016, BIOINFORMATICS, V32, P511, DOI 10.1093/bioinformatics/btv639; Andreatta M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026781; Blachly JS, 2015, P NATL ACAD SCI USA, V112, P4322, DOI 10.1073/pnas.1503587112; Bolotin DA, 2013, NAT METHODS, V10, P813, DOI [10.1038/nmeth.2555, 10.1038/NMETH.2555]; Brown SD, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0248-x; Caballero OL, 2009, CANCER SCI, V100, P2014, DOI 10.1111/j.1349-7006.2009.01303.x; Chien YH, 2000, SPRINGER SEMIN IMMUN, V22, P239, DOI 10.1007/PL00006752; Chowell D, 2015, P NATL ACAD SCI USA, V112, pE1754, DOI 10.1073/pnas.1500973112; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; Dean J, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0238-z; Del Monte U, 2009, CELL CYCLE, V8, P505, DOI 10.4161/cc.8.3.7608; Drake CG, 2014, NAT REV CLIN ONCOL, V11, P24, DOI 10.1038/nrclinonc.2013.208; Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991; Emerson RO, 2013, J PATHOL, V231, P433, DOI 10.1002/path.4260; Freeman JD, 2009, GENOME RES, V19, P1817, DOI 10.1101/gr.092924.109; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Grupp SA, 2013, NEW ENGL J MED, V368, P1509, DOI 10.1056/NEJMoa1215134; He C, 2007, CARCINOGENESIS, V28, P2484, DOI 10.1093/carcin/bgm194; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Lefranc Marie-Paule, 2011, Cold Spring Harb Protoc, V2011, P595, DOI 10.1101/pdb.top115; Li B, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0473-4; Nielsen M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-238; Obenaus M, 2015, NAT BIOTECHNOL, V33, P402, DOI 10.1038/nbt.3147; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Porter DL, 2011, NEW ENGL J MED, V365, P725, DOI 10.1056/NEJMoa1103849; R Development Core Team, 2014, R LANG ENV STAT COMP; Robins HS, 2009, BLOOD, V114, P4099, DOI 10.1182/blood-2009-04-217604; ROCK EP, 1994, J EXP MED, V179, P323, DOI 10.1084/jem.179.1.323; Rooney MS, 2015, CELL, V160, P48, DOI 10.1016/j.cell.2014.12.033; Rosenberg SA, 2008, NAT REV CANCER, V8, P299, DOI 10.1038/nrc2355; Savage PA, 2008, SCIENCE, V319, P215, DOI 10.1126/science.1148886; SCHUURS AHWM, 1990, J STEROID BIOCHEM, V35, P157, DOI 10.1016/0022-4731(90)90270-3; Sharma P, 2011, NAT REV CANCER, V11, P805, DOI 10.1038/nrc3153; Shukla SA, 2015, NAT BIOTECHNOL, V33, P1152, DOI 10.1038/nbt.3344; Silina K, 2011, J IMMUNOTHER, V34, P28, DOI 10.1097/CJI.0b013e3181fb64fa; Simpson AJG, 2005, NAT REV CANCER, V5, P615, DOI 10.1038/nrc1669; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954; Twyman-Saint Victor C, 2015, NATURE, V520, P373, DOI 10.1038/nature14292; van Heijst JWJ, 2013, NAT MED, V19, P372, DOI 10.1038/nm.3100; Venturi V, 2008, NAT REV IMMUNOL, V8, P231, DOI 10.1038/nri2260; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq622; Warren RL, 2011, GENOME RES, V21, P790, DOI 10.1101/gr.115428.110; Warren RL, 2009, BIOINFORMATICS, V25, P458, DOI 10.1093/bioinformatics/btp010	45	188	193	3	49	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2016	48	7					725	+		10.1038/ng.3581	http://dx.doi.org/10.1038/ng.3581			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DP9TK	27240091	Green Submitted, Green Accepted			2022-12-25	WOS:000378840100009
J	Komura, N; Suzuki, KGN; Ando, H; Konishi, M; Koikeda, M; Imamura, A; Chadda, R; Fujiwara, TK; Tsuboi, H; Sheng, R; Cho, W; Furukawa, K; Furukawa, K; Yamauchi, Y; Ishida, H; Kusumi, A; Kiso, M				Komura, Naoko; Suzuki, Kenichi G. N.; Ando, Hiromune; Konishi, Miku; Koikeda, Machi; Imamura, Akihiro; Chadda, Rahul; Fujiwara, Takahiro K.; Tsuboi, Hisae; Sheng, Ren; Cho, Wonhwa; Furukawa, Koichi; Furukawa, Keiko; Yamauchi, Yoshio; Ishida, Hideharu; Kusumi, Akihiro; Kiso, Makoto			Raft-based interactions of gangliosides with a GPI-anchored receptor	NATURE CHEMICAL BIOLOGY			English	Article							SINGLE-MOLECULE TRACKING; PLASMA-MEMBRANE VESICLES; 1ST TOTAL-SYNTHESIS; PHASE-SEPARATION; CELL-MEMBRANE; CROSS-LINKING; PRION PROTEIN; LIVING CELLS; DIFFUSION; GM1	Gangliosides, glycosphingolipids containing one or more sialic acid(s) in the glyco-chain, are involved in various important physiological and pathological processes in the plasma membrane. However, their exact functions are poorly understood, primarily because of the scarcity of suitable fluorescent ganglioside analogs. Here, we developed methods for systematically synthesizing analogs that behave like their native counterparts in regard to partitioning into raft-related membrane domains or preparations. Single-fluorescent-molecule imaging in the live-cell plasma membrane revealed the clear but transient colocalization and codiffusion of fluorescent ganglioside analogs with a fluorescently labeled glycosylphosphatidylinisotol (GPI)-anchored protein, human CD59, with lifetimes of 12 ms for CD59 monomers, 40 ms for CD59's transient homodimer rafts in quiescent cells, and 48 ms for engaged-CD59-cluster rafts, in cholesterol-and GPI-anchoring-dependent manners. The ganglioside molecules were always mobile in quiescent cells. These results show that gangliosides continually and dynamically exchange between raft domains and the bulk domain, indicating that raft domains are dynamic entities.	[Komura, Naoko; Suzuki, Kenichi G. N.; Ando, Hiromune; Konishi, Miku; Chadda, Rahul; Fujiwara, Takahiro K.; Tsuboi, Hisae; Kusumi, Akihiro; Kiso, Makoto] Kyoto Univ, Inst Integrated Cell Mat Sci WPI iCeMS, Kyoto, Japan; [Komura, Naoko; Ando, Hiromune; Konishi, Miku; Koikeda, Machi; Imamura, Akihiro; Ishida, Hideharu; Kiso, Makoto] Gifu Univ, Dept Appl Bioorgan Chem, Gifu 50111, Japan; [Suzuki, Kenichi G. N.] NCBS, Inst Stem Cell Biol & Regenerat Med InStem, Bangalore, Karnataka, India; [Sheng, Ren; Cho, Wonhwa] Univ Illinois, Dept Chem, Chicago, IL USA; [Furukawa, Koichi; Yamauchi, Yoshio] Nagoya Univ, Dept Biochem 2, Nagoya, Aichi 4648601, Japan; [Furukawa, Keiko] Chubu Univ, Dept Life & Med Sci, Nagoya, Aichi, Japan; [Kusumi, Akihiro] Kyoto Univ, Inst Frontier Med Sci, Kyoto, Japan; [Kusumi, Akihiro] Okinawa Inst Sci & Technol, Membrane Cooperat Unit, Onna Son, Okinawa, Japan	Kyoto University; Gifu University; Department of Biotechnology (DBT) India; Institute for Stem Cell Biology & Regenerative Medicine - inStem; Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Nagoya University; Chubu University; Kyoto University; Okinawa Institute of Science & Technology Graduate University	Kusumi, A; Kiso, M (corresponding author), Kyoto Univ, Inst Integrated Cell Mat Sci WPI iCeMS, Kyoto, Japan.; Kiso, M (corresponding author), Gifu Univ, Dept Appl Bioorgan Chem, Gifu 50111, Japan.; Kusumi, A (corresponding author), Kyoto Univ, Inst Frontier Med Sci, Kyoto, Japan.; Kusumi, A (corresponding author), Okinawa Inst Sci & Technol, Membrane Cooperat Unit, Onna Son, Okinawa, Japan.	akusumi@frontier.kyoto-u.ac.jp; kiso@gifu-u.ac.jp	Fujiwara, Takahiro/G-2755-2012; Yamauchi, Yoshio/I-7539-2014; Chadda, Rahul/AAM-2085-2020; Ando, Hiromune/J-8294-2017	Fujiwara, Takahiro/0000-0001-5576-759X; Yamauchi, Yoshio/0000-0001-5559-4596; Suzuki, Kenichi/0000-0002-8436-5757; Ando, Hiromune/0000-0002-0551-0830	Japan Society for the Promotion of Science [23688014, 24370055, 15H04351, 15H04495, 24390078, 22380067, 24247029]; Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [24110505, 26110704, 23110001, 23110008, 25113515, 26115707]; Core Research for Evolutional Science and Technology (CREST project of "Creation of Fundamental Technologies for Understanding and Control of Biosystem Dynamics) of Japan Science and Technology Agency (JST); NIH [GM68849]; World Premiere Research Center Initiative (WPI) of the MEXT; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068849] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [15H04351, 16K08618, 25460385, 13F03404, 16H06386] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Core Research for Evolutional Science and Technology (CREST project of "Creation of Fundamental Technologies for Understanding and Control of Biosystem Dynamics) of Japan Science and Technology Agency (JST); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); World Premiere Research Center Initiative (WPI) of the MEXT; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank M. Sokabe of Nagoya University, B. Baird of Cornell University, S. Ohnishi of Kyoto University, and V. Horejsi of Academy of Sciences of the Czech Republic for their kind gifts of human epithelial T24 cells, RBL-2H3 cells, NRK cells, and a mouse hybridoma cell line MEM43/5 which produces anti CD59 monoclonal antibody, respectively, as well as R.S. Kasai, K.A.K. Tanaka, and K.M. Hirosawa for setting up the single-molecule tracking station and useful discussions. This work was supported in part by Grants-in-Aid for scientific research from the Japan Society for the Promotion of Science (Wakate A to H.A. (23688014), Kiban B to K.G.N.S. (24370055 and 15H04351), H.A. (15H04495), K.F. (24390078), and M.K. (22380067), and Kiban A to A.K. (24247029)); by Grants-in-Aid for Innovative Areas (Deciphering sugar chain-based signals regulating integrative neuronal functions) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan to H.A. (24110505 and 26110704), K.G.N.S. (23110001), K.F. (23110008), and T.K.F. (25113515 and 26115707); by a grant from Core Research for Evolutional Science and Technology (CREST project of "Creation of Fundamental Technologies for Understanding and Control of Biosystem Dynamics) of Japan Science and Technology Agency (JST) to A.K.; and by a grant awarded by the NIH to W.C. (GM68849). WPI-iCeMS of Kyoto University is supported by the World Premiere Research Center Initiative (WPI) of the MEXT.	Anderson K, 2000, ANAL BIOCHEM, V287, P337, DOI 10.1006/abio.2000.4829; Ando H, 2005, ANGEW CHEM INT EDIT, V44, P6759, DOI 10.1002/anie.200501608; Ando H, 2003, TETRAHEDRON LETT, V44, P6883, DOI 10.1016/S0040-4039(03)01707-6; Baumgart T, 2007, P NATL ACAD SCI USA, V104, P3165, DOI 10.1073/pnas.0611357104; Chen Y, 2012, MOL CELL, V46, P226, DOI 10.1016/j.molcel.2012.02.012; Chinnapen DJF, 2012, DEV CELL, V23, P573, DOI 10.1016/j.devcel.2012.08.002; Coskun U, 2011, P NATL ACAD SCI USA, V108, P9044, DOI 10.1073/pnas.1105666108; Dunne PD, 2009, BIOPHYS J, V97, pL5, DOI 10.1016/j.bpj.2009.05.046; Eggeling C, 2009, NATURE, V457, P1159, DOI 10.1038/nature07596; Fleming FE, 2014, J VIROL, V88, P4558, DOI 10.1128/JVI.03431-13; Fujikawa K, 2011, CHEM-EUR J, V17, P5641, DOI 10.1002/chem.201003357; Fujita A, 2007, MOL BIOL CELL, V18, P2112, DOI 10.1091/mbc.E07-01-0071; Fujiwara T, 2002, J CELL BIOL, V157, P1071, DOI 10.1083/jcb.200202050; Hammond AT, 2005, P NATL ACAD SCI USA, V102, P6320, DOI 10.1073/pnas.0405654102; Harder T, 1998, J CELL BIOL, V141, P929, DOI 10.1083/jcb.141.4.929; Hiramoto-Yamaki N, 2014, TRAFFIC, V15, P583, DOI 10.1111/tra.12163; Honigmann A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6412; Huang H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121777; Imamura A, 2009, J ORG CHEM, V74, P3009, DOI 10.1021/jo8027888; Iwayama Y, 2009, CHEM-EUR J, V15, P4637, DOI 10.1002/chem.200802706; Jones R, 2010, DEV BIOL, V339, P398, DOI 10.1016/j.ydbio.2009.12.044; Kaiser HJ, 2009, P NATL ACAD SCI USA, V106, P16645, DOI 10.1073/pnas.0908987106; Kasai RS, 2011, J CELL BIOL, V192, P463, DOI 10.1083/jcb.201009128; Kenworthy AK, 2004, J CELL BIOL, V165, P735, DOI 10.1083/jcb.200312170; Koyama-Honda I, 2005, BIOPHYS J, V88, P2126, DOI 10.1529/biophysj.104.048967; Kusumi A, 2005, BBA-MOL CELL RES, V1746, P234, DOI 10.1016/j.bbamcr.2005.10.001; Larsson EA, 2007, CARBOHYD RES, V342, P482, DOI 10.1016/j.carres.2006.10.002; Lenne PF, 2006, EMBO J, V25, P3245, DOI 10.1038/sj.emboj.7601214; Levental I, 2011, P NATL ACAD SCI USA, V108, P11411, DOI 10.1073/pnas.1105996108; Lingwood D, 2008, P NATL ACAD SCI USA, V105, P10005, DOI 10.1073/pnas.0804374105; Lingwood D, 2011, NAT CHEM BIOL, V7, P260, DOI 10.1038/nchembio.551; Man HY, 2000, NEURON, V25, P649, DOI 10.1016/S0896-6273(00)81067-3; Marushchak D, 2007, MOL MEMBR BIOL, V24, P102, DOI 10.1080/09687860600995235; MAYOR S, 1994, SCIENCE, V264, P1948, DOI 10.1126/science.7516582; Murase K, 2004, BIOPHYS J, V86, P4075, DOI 10.1529/biophysj.103.035717; Nakashima S, 2012, CHEM-ASIAN J, V7, P1041, DOI 10.1002/asia.201100928; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; PAGANO RE, 1985, SCIENCE, V229, P1051, DOI 10.1126/science.4035344; Polyakova O, 2009, EUR BIOPHYS J BIOPHY, V38, P209, DOI 10.1007/s00249-008-0371-3; Polyakova SM, 2009, EUR J ORG CHEM, V2009, P5162, DOI 10.1002/ejoc.200900645; Raghupathy R, 2015, CELL, V161, P581, DOI 10.1016/j.cell.2015.03.048; Sahl SJ, 2010, P NATL ACAD SCI USA, V107, P6829, DOI 10.1073/pnas.0912894107; Sampaio JL, 2011, P NATL ACAD SCI USA, V108, P1903, DOI 10.1073/pnas.1019267108; Schwarzmann G, 2005, GLYCOBIOLOGY, V15, P1302, DOI 10.1093/glycob/cwj018; SCHWARZMANN G, 1995, J BIOL CHEM, V270, P21271, DOI 10.1074/jbc.270.36.21271; Sezgin E, 2012, BBA-BIOMEMBRANES, V1818, P1777, DOI 10.1016/j.bbamem.2012.03.007; Simons K, 2010, NAT REV MOL CELL BIO, V11, P688, DOI 10.1038/nrm2977; SIMSON R, 1995, BIOPHYS J, V69, P989, DOI 10.1016/S0006-3495(95)79972-6; Smith DC, 2004, SEMIN CELL DEV BIOL, V15, P397, DOI 10.1016/j.semcdb.2004.03.005; Sternberg R.S., 1983, IEEE COMPUT, V16, P22; Suzuki KGN, 2007, J CELL BIOL, V177, P731, DOI 10.1083/jcb.200609175; Suzuki KGN, 2007, J CELL BIOL, V177, P717, DOI 10.1083/jcb.200609174; Suzuki KGN, 2012, NAT CHEM BIOL, V8, P774, DOI [10.1038/nchembio.1028, 10.1038/NCHEMBIO.1028]; Svistounov D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046134; Takamiya K, 1998, P NATL ACAD SCI USA, V95, P12147, DOI 10.1073/pnas.95.21.12147; Tamai H, 2011, ANGEW CHEM INT EDIT, V50, P2330, DOI 10.1002/anie.201006035; Tanaka KAK, 2010, NAT METHODS, V7, P865, DOI 10.1038/nmeth.f.314; Taylor DR, 2005, J CELL SCI, V118, P5141, DOI 10.1242/jcs.02627; Tsurifune T, 2000, INT J ONCOL, V17, P159; YAMASHIRO S, 1995, J BIOL CHEM, V270, P6149, DOI 10.1074/jbc.270.11.6149	60	119	119	0	74	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUN	2016	12	6					402	U51		10.1038/nchembio.2059	http://dx.doi.org/10.1038/nchembio.2059			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DM2EW	27043189				2022-12-25	WOS:000376160600009
J	Fujimoto, A; Furuta, M; Totoki, Y; Tsunoda, T; Kato, M; Shiraishi, Y; Tanaka, H; Taniguchi, H; Kawakami, Y; Ueno, M; Gotoh, K; Ariizumi, S; Wardell, CP; Hayami, S; Nakamura, T; Aikata, H; Arihiro, K; Boroevich, KA; Abe, T; Nakano, K; Maejima, K; Sasaki-Oku, A; Ohsawa, A; Shibuya, T; Nakamura, H; Hama, N; Hosoda, F; Arai, Y; Ohashi, S; Urushidate, T; Nagae, G; Yamamoto, S; Ueda, H; Tatsuno, K; Ojima, H; Hiraoka, N; Okusaka, T; Kubo, M; Marubashi, S; Yamada, T; Hirano, S; Yamamoto, M; Ohdan, H; Shimada, K; Ishikawa, O; Yamaue, H; Chayama, K; Miyano, S; Aburatani, H; Shibata, T; Nakagawa, H				Fujimoto, Akihiro; Furuta, Mayuko; Totoki, Yasushi; Tsunoda, Tatsuhiko; Kato, Mamoru; Shiraishi, Yuichi; Tanaka, Hiroko; Taniguchi, Hiroaki; Kawakami, Yoshiiku; Ueno, Masaki; Gotoh, Kunihito; Ariizumi, Shun-ichi; Wardell, Christopher P.; Hayami, Shinya; Nakamura, Toru; Aikata, Hiroshi; Arihiro, Koji; Boroevich, Keith A.; Abe, Tetsuo; Nakano, Kaoru; Maejima, Kazuhiro; Sasaki-Oku, Aya; Ohsawa, Ayako; Shibuya, Tetsuo; Nakamura, Hiromi; Hama, Natsuko; Hosoda, Fumie; Arai, Yasuhito; Ohashi, Shoko; Urushidate, Tomoko; Nagae, Genta; Yamamoto, Shogo; Ueda, Hiroki; Tatsuno, Kenji; Ojima, Hidenori; Hiraoka, Nobuyoshi; Okusaka, Takuji; Kubo, Michiaki; Marubashi, Shigeru; Yamada, Terumasa; Hirano, Satoshi; Yamamoto, Masakazu; Ohdan, Hideki; Shimada, Kazuaki; Ishikawa, Osamu; Yamaue, Hiroki; Chayama, Kazuki; Miyano, Satoru; Aburatani, Hiroyuki; Shibata, Tatsuhiro; Nakagawa, Hidewaki			Whole-genome mutational landscape and characterization of noncoding and structural mutations in liver cancer	NATURE GENETICS			English	Article							TUMOR-SUPPRESSOR GENE; HEPATOCELLULAR-CARCINOMA; SOMATIC MUTATIONS; RECURRENT MUTATIONS; COLORECTAL-CANCER; BREAST-CANCER; EXPRESSION; DNA; SIGNATURES; INTEGRATION	Liver cancer, which is most often associated with virus infection, is prevalent worldwide, and its underlying etiology and genomic structure are heterogeneous. Here we provide a whole-genome landscape of somatic alterations in 300 liver cancers from Japanese individuals. Our comprehensive analysis identified point mutations, structural variations (STVs), and virus integrations, in noncoding and coding regions. We discovered mutational signatures related to liver carcinogenesis and recurrently mutated coding and noncoding regions, such as long intergenic noncoding RNA genes (NEAT1 and MALAT1), promoters, CTCF-binding sites, and regulatory regions. STV analysis found a significant association with replication timing and identified known (CDKN2A, CCND1, APC, and TERT) and new (ASH1L, NCOR1, and MACROD2) cancer-related genes that were recurrently affected by STVs, leading to altered expression. These results emphasize the value of whole-genome sequencing analysis in discovering cancer driver mutations and understanding comprehensive molecular profiles of liver cancer, especially with regard to STVs and noncoding mutations.	[Fujimoto, Akihiro; Furuta, Mayuko; Taniguchi, Hiroaki; Wardell, Christopher P.; Nakano, Kaoru; Maejima, Kazuhiro; Sasaki-Oku, Aya; Ohsawa, Ayako; Nakagawa, Hidewaki] RIKEN Ctr Integrat Med Sci, Lab Genome Sequencing Anal, Tokyo, Japan; [Totoki, Yasushi; Nakamura, Hiromi; Hama, Natsuko; Hosoda, Fumie; Arai, Yasuhito; Ohashi, Shoko; Shibata, Tatsuhiro] Natl Canc Ctr, Res Inst, Div Canc Genom, Chuo Ku, Tokyo 104, Japan; [Tsunoda, Tatsuhiko; Boroevich, Keith A.; Abe, Tetsuo] RIKEN Ctr Integrat Med Sci, Lab Med Sci Math, Yokohama, Kanagawa, Japan; [Tsunoda, Tatsuhiko] Tokyo Med & Dent Univ, Med Res Inst, Dept Med Sci Math, Tokyo, Japan; [Tsunoda, Tatsuhiko; Kato, Mamoru] JST, CREST, Tokyo, Japan; [Kato, Mamoru] Natl Canc Ctr, Res Inst, Dept Bioinformat, Chuo Ku, Tokyo 104, Japan; [Shiraishi, Yuichi; Tanaka, Hiroko; Miyano, Satoru] Univ Tokyo, Inst Med Sci, Lab DNA Informat Anal, Ctr Human Genome, Tokyo, Japan; [Kawakami, Yoshiiku; Aikata, Hiroshi; Chayama, Kazuki] Hiroshima Univ, Sch Med, Dept Med & Mol Sci, Hiroshima, Japan; [Ueno, Masaki; Hayami, Shinya; Yamaue, Hiroki] Wakayama Med Univ, Dept Surg 2, Wakayama, Japan; [Gotoh, Kunihito; Marubashi, Shigeru; Yamada, Terumasa; Ishikawa, Osamu] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Surg, Osaka, Japan; [Ariizumi, Shun-ichi; Yamamoto, Masakazu] Tokyo Womens Med Univ, Inst Gastroenterol, Dept Surg, Tokyo, Japan; [Nakamura, Toru; Hirano, Satoshi] Hokkaido Univ, Grad Sch Med, Dept Gastroenterol Surg 2, Sapporo, Hokkaido, Japan; [Arihiro, Koji] Hiroshima Univ, Sch Med, Dept Anat Pathol, Hiroshima, Japan; [Shibuya, Tetsuo; Miyano, Satoru] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Lab Sequence Anal, Tokyo, Japan; [Urushidate, Tomoko; Shibata, Tatsuhiro] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Lab Mol Med, Tokyo, Japan; [Nagae, Genta; Yamamoto, Shogo; Ueda, Hiroki; Tatsuno, Kenji; Aburatani, Hiroyuki] Univ Tokyo, Genome Sci Div, Res Ctr Adv Sci & Technol, Tokyo, Japan; [Ojima, Hidenori] Keio Univ, Sch Med, Dept Pathol, Shinjyuku Ku, Tokyo 160, Japan; [Hiraoka, Nobuyoshi] Natl Canc Ctr, Div Pathol & Clin Labs, Chuo Ku, Tokyo, Japan; [Okusaka, Takuji] Natl Canc Ctr, Dept Hepatobiliary & Pancreat Oncol, Chuo Ku, Tokyo, Japan; [Kubo, Michiaki] RIKEN Ctr Integrat Med Sci, Lab Genotyping Dev, Yokohama, Kanagawa, Japan; [Ohdan, Hideki] Hiroshima Univ, Sch Med, Dept Surg Gastroenterol, Hiroshima, Japan; [Shimada, Kazuaki] Natl Canc Ctr, Hepatobiliary & Pancreat Surg Div, Chuo Ku, Tokyo, Japan; [Chayama, Kazuki] RIKEN Ctr Integrat Med Sci, Lab Digest Dis, Hiroshima, Japan	RIKEN; National Cancer Center - Japan; RIKEN; Tokyo Medical & Dental University (TMDU); Japan Science & Technology Agency (JST); National Cancer Center - Japan; University of Tokyo; Hiroshima University; Wakayama Medical University; Osaka Medical Center for Cancer & Cardiovascular Diseases; Tokyo Women's Medical University; Hokkaido University; Hiroshima University; University of Tokyo; University of Tokyo; University of Tokyo; Keio University; National Cancer Center - Japan; National Cancer Center - Japan; RIKEN; Hiroshima University; National Cancer Center - Japan; RIKEN	Shibata, T; Nakagawa, H (corresponding author), RIKEN Ctr Integrat Med Sci, Lab Genome Sequencing Anal, Tokyo, Japan.; Shibata, T (corresponding author), Natl Canc Ctr, Res Inst, Div Canc Genom, Chuo Ku, Tokyo 104, Japan.; Shibata, T (corresponding author), Univ Tokyo, Inst Med Sci, Ctr Human Genome, Lab Mol Med, Tokyo, Japan.	tashibat@ncc.go.jp; hidewaki@ims.u-tokyo.ac.jp	Shibata, Tatsuhiro/ABA-8234-2020; Nagae, Genta/AAN-1167-2021; Nagae, Genta/H-6579-2019; Tsunoda, Tatsuhiko/K-2061-2014; Hayami, Shinya/Y-3354-2019; Shibata, Tatsuhiro/AAO-1278-2021; Tatsuno, Kenji/B-1765-2008; Wardell, Christopher/B-5053-2018; Ohdan, Hideki/G-4719-2019	Nagae, Genta/0000-0002-2929-7990; Tsunoda, Tatsuhiko/0000-0002-5439-7918; Hayami, Shinya/0000-0001-8392-2382; Wardell, Christopher/0000-0002-9416-7818; Ohdan, Hideki/0000-0002-9066-1288; Taniguchi, Hiroaki/0000-0001-7270-390X; Boroevich, Keith/0000-0001-7095-7332; Chayama, Kazuaki/0000-0002-5530-5341; Miyano, Satoru/0000-0002-1753-6616; Arai, Yasuhito/0000-0001-6306-9409	RIKEN President's Fund; JSPS [25134717, 25670375, 23114001, 15H04814]; Princess Takamatsu Cancer Research Fund; Takeda Science Foundation; Practical Research for Innovative Cancer Control from the Japan Agency for Medical Research and Development; CREST from the Japan Science and Technology Agency; National Cancer Center Research and Development Funds [26-A-5]; National Cancer Center Biobank - National Cancer Center Research and Development Fund, Japan	RIKEN President's Fund; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Princess Takamatsu Cancer Research Fund; Takeda Science Foundation(Takeda Science Foundation (TSF)); Practical Research for Innovative Cancer Control from the Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); CREST from the Japan Science and Technology Agency(Core Research for Evolutional Science and Technology (CREST)); National Cancer Center Research and Development Funds; National Cancer Center Biobank - National Cancer Center Research and Development Fund, Japan	The supercomputing resource 'SHIROKANE' was provided by the Human Genome Center at The University of Tokyo. This work was supported in part by RIKEN President's Fund 2011, a Grant-in-Aid for the RIKEN CGM and IMS, a Grant-in-Aid for Scientific Research on Innovative Areas from JSPS grants (25134717, 25670375, 23114001, and 15H04814), the Princess Takamatsu Cancer Research Fund, the Takeda Science Foundation, the Practical Research for Innovative Cancer Control from the Japan Agency for Medical Research and Development, CREST from the Japan Science and Technology Agency, and National Cancer Center Research and Development Funds (26-A-5); the National Cancer Center Biobank is supported by the National Cancer Center Research and Development Fund, Japan.	Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Alexandrov LB, 2013, CELL REP, V3, P246, DOI 10.1016/j.celrep.2012.12.008; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bignell GR, 2010, NATURE, V463, P893, DOI 10.1038/nature08768; Bill CA, 2004, P NATL ACAD SCI USA, V101, P11135, DOI 10.1073/pnas.0403925101; Ceol CJ, 2011, NATURE, V471, P513, DOI 10.1038/nature09806; Chakravarty D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6383; Choudhry H, 2015, ONCOGENE, V34, P4482, DOI 10.1038/onc.2014.378; De S, 2011, NAT BIOTECHNOL, V29, P1103, DOI 10.1038/nbt.2030; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Fujimoto A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7120; Fujimoto A, 2012, NAT GENET, V44, P760, DOI 10.1038/ng.2291; George J, 2015, NATURE, V524, P47, DOI 10.1038/nature14664; Guichard C, 2012, NAT GENET, V44, P694, DOI 10.1038/ng.2256; Guo T, 2015, TUMOR BIOL, V36, P7649, DOI 10.1007/s13277-015-3463-6; Ha G, 2012, GENOME RES, V22, P1995, DOI 10.1101/gr.137570.112; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Heidari N, 2014, GENOME RES, V24, P1905, DOI 10.1101/gr.176586.114; Hirose T, 2014, MOL BIOL CELL, V25, P169, DOI 10.1091/mbc.E13-09-0558; Hofree M, 2013, NAT METHODS, V10, P1108, DOI [10.1038/NMETH.2651, 10.1038/nmeth.2651]; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang J, 2012, NAT GENET, V44, P1117, DOI 10.1038/ng.2391; Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987; Jankevicius G, 2013, NAT STRUCT MOL BIOL, V20, P508, DOI 10.1038/nsmb.2523; Jhunjhunwala S, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0436-9; Jiang ZS, 2012, GENOME RES, V22, P593, DOI 10.1101/gr.133926.111; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Kan ZY, 2013, GENOME RES, V23, P1422, DOI 10.1101/gr.154492.113; Kaneda A, 2004, CANCER RES, V64, P6410, DOI 10.1158/0008-5472.CAN-04-1543; Kawaguchi T, 2015, P NATL ACAD SCI USA, V112, P4304, DOI 10.1073/pnas.1423819112; Li M, 2011, NAT GENET, V43, P828, DOI 10.1038/ng.903; Li YL, 2015, ONCOTARGET, V6, P27641, DOI 10.18632/oncotarget.4737; Liu QQ, 2012, P NATL ACAD SCI USA, V109, P14568, DOI 10.1073/pnas.1211611109; Miyakawa Y, 2003, INTERVIROLOGY, V46, P329, DOI 10.1159/000074988; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nault JC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3218; Nault JC, 2015, NAT GENET, V47, P1187, DOI 10.1038/ng.3389; Ni SB, 2013, CANCER SCI, V104, P817, DOI 10.1111/cas.12157; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; Northcott PA, 2014, NATURE, V511, P428, DOI 10.1038/nature13379; Pitkanen E, 2014, ONCOTARGET, V5, P853, DOI 10.18632/oncotarget.1781; Polak P, 2015, NATURE, V518, P360, DOI 10.1038/nature14221; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Schulze K, 2015, NAT GENET, V47, P505, DOI 10.1038/ng.3252; Shiraishi Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114263; Si-Tayeb K, 2010, DEV CELL, V18, P175, DOI 10.1016/j.devcel.2010.01.011; Song SW, 2003, J BIOL CHEM, V278, P43893, DOI 10.1074/jbc.C300401200; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Sung WK, 2012, NAT GENET, V44, P765, DOI 10.1038/ng.2295; Tomasetti C, 2013, P NATL ACAD SCI USA, V110, P1999, DOI 10.1073/pnas.1221068110; Totoki Y, 2014, NAT GENET, V46, P1267, DOI 10.1038/ng.3126; Totoki Y, 2011, NAT GENET, V43, P464, DOI 10.1038/ng.804; Tsai WC, 2009, HEPATOLOGY, V49, P1571, DOI 10.1002/hep.22806; Vanunu O, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000641; Waddell N, 2015, NATURE, V518, P495, DOI 10.1038/nature14169; Walker SR, 2013, MOL CELL BIOL, V33, P2879, DOI 10.1128/MCB.01620-12; Weinhold N, 2014, NAT GENET, V46, P1160, DOI 10.1038/ng.3101; Weischenfeldt J, 2013, NAT REV GENET, V14, P125, DOI 10.1038/nrg3373; Wong CM, 2007, HEPATOLOGY, V45, P1129, DOI 10.1002/hep.21578; Woo YH, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1982; Xu C, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-118; Yoon HG, 2003, EMBO J, V22, P1336, DOI 10.1093/emboj/cdg120	63	430	440	7	141	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2016	48	5					500	+		10.1038/ng.3547	http://dx.doi.org/10.1038/ng.3547			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DK3RC	27064257				2022-12-25	WOS:000374834100008
J	Karpinski, J; Hauber, I; Chemnitz, J; Schafer, C; Paszkowski-Rogacz, M; Chakraborty, D; Beschorner, N; Hofmann-Sieber, H; Lange, UC; Grundhoff, A; Hackmann, K; Schrock, E; Abi-Ghanem, J; Pisabarro, MT; Surendranath, V; Schambach, A; Lindner, C; van Lunzen, J; Hauber, J; Buchholz, F				Karpinski, Janet; Hauber, Ilona; Chemnitz, Jan; Schaefer, Carola; Paszkowski-Rogacz, Maciej; Chakraborty, Deboyoti; Beschorner, Niklas; Hofmann-Sieber, Helga; Lange, Ulrike C.; Grundhoff, Adam; Hackmann, Karl; Schrock, Evelin; Abi-Ghanem, Josephine; Pisabarro, M. Teresa; Surendranath, Vineeth; Schambach, Axel; Lindner, Christoph; van Lunzen, Jan; Hauber, Joachim; Buchholz, Frank			Directed evolution of a recombinase that excises the provirus of most HIV-1 primary isolates with high specificity	NATURE BIOTECHNOLOGY			English	Article							ZINC-FINGER-NUCLEASES; SITE-SPECIFIC RECOMBINATION; OFF-TARGET CLEAVAGE; CD4(+) T-CELLS; CRE RECOMBINASE; ANTIRETROVIRAL THERAPY; DRUG-RESISTANCE; GENE-THERAPY; IN-VITRO; DNA	Current combination antiretroviral therapies (cART) efficiently suppress HIV-1 reproduction in humans, but the virus persists as integrated proviral reservoirs in small numbers of cells. To generate an antiviral agent capable of eradicating the provirus from infected cells, we employed 145 cycles of substrate-linked directed evolution to evolve a recombinase (Brec1) that site-specifically recognizes a 34-bp sequence present in the long terminal repeats (LTRs) of the majority of the clinically relevant HIV-1 strains and subtypes. Brec1 efficiently, precisely and safely removes the integrated provirus from infected cells and is efficacious on clinical HIV-1 isolates in vitro and in vivo, including in mice humanized with patient-derived cells. Our data suggest that Brec1 has potential for clinical application as a curative HIV-1 therapy.	[Karpinski, Janet; Paszkowski-Rogacz, Maciej; Chakraborty, Deboyoti; Buchholz, Frank] Tech Univ Dresden, Med Fac Carl Gustav Carus, UCC, Med Syst Biol, Dresden, Germany; [Karpinski, Janet; Hauber, Ilona; Chemnitz, Jan; Schaefer, Carola; Beschorner, Niklas; Hofmann-Sieber, Helga; Lange, Ulrike C.; Grundhoff, Adam; van Lunzen, Jan; Hauber, Joachim] Leibniz Inst Expt Virol, Heinrich Pette Inst, Hamburg, Germany; [Schaefer, Carola; Hofmann-Sieber, Helga; Lange, Ulrike C.; Grundhoff, Adam; van Lunzen, Jan; Hauber, Joachim] German Ctr Infect Res DZIF, Partner Site Hamburg, Braunschweig, Germany; [Lange, Ulrike C.] Univ Med Ctr Hamburg Eppendorf, Dept Anesthesiol, Hamburg, Germany; [Hackmann, Karl; Schrock, Evelin] Tech Univ Dresden, Univ Hosp, Inst Clin Genet, Dresden, Germany; [Hackmann, Karl; Schrock, Evelin] Tech Univ Dresden, Med Fac Carl Gustav Carus, Dresden, Germany; [Abi-Ghanem, Josephine; Pisabarro, M. Teresa] BIOTEC TU Dresden, Struct Bioinformat, Dresden, Germany; [Surendranath, Vineeth; Buchholz, Frank] Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany; [Schambach, Axel] Hannover Med Sch, Inst Expt Hematol, Hannover, Germany; [Lindner, Christoph] Agaples Diakonieklinikum, Gynecol, Hamburg, Germany; [van Lunzen, Jan] Univ Med Ctr Hamburg Eppendorf, Infect Dis Unit, Hamburg, Germany	Technische Universitat Dresden; Carl Gustav Carus University Hospital; University of Hamburg; University Medical Center Hamburg-Eppendorf; Heinrich Pette Institute; German Center for Infection Research; University of Hamburg; University Medical Center Hamburg-Eppendorf; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Technische Universitat Dresden; Max Planck Society; Hannover Medical School; University of Hamburg; University Medical Center Hamburg-Eppendorf	Buchholz, F (corresponding author), Tech Univ Dresden, Med Fac Carl Gustav Carus, UCC, Med Syst Biol, Dresden, Germany.; Hauber, J (corresponding author), Leibniz Inst Expt Virol, Heinrich Pette Inst, Hamburg, Germany.; Hauber, J (corresponding author), German Ctr Infect Res DZIF, Partner Site Hamburg, Braunschweig, Germany.; Buchholz, F (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany.	joachim.hauber@hpi.uni-hamburg.de; frank.buchholz@tu-dresden.de	Chakraborty, Debojyoti/Y-7627-2018; Buchholz, Frank/B-4700-2017; /F-4368-2012; Pisabarro, M. Teresa/D-4270-2012; Chakraborty, Debojyoti/GRI-9445-2022; Schambach, Axel/C-5491-2011	Chakraborty, Debojyoti/0000-0003-1460-7594; Buchholz, Frank/0000-0002-4577-3344; /0000-0003-0351-4579; Abi Ghanem, josephine/0000-0002-8281-1266; Chakraborty, Debojyoti/0000-0002-2300-4333; Grundhoff, Adam/0000-0003-0940-7045	DFG [BU 1400/7-1]; BMBF [GO-Bio FKZ 0315090]; Else Kroner-Fresenius-Stiftung [2010_A82]; "Viral Latency" program at the Heinrich Pette Institute-Leibniz Institute for Experimental Virology, Hamburg	DFG(German Research Foundation (DFG)); BMBF(Federal Ministry of Education & Research (BMBF)); Else Kroner-Fresenius-Stiftung; "Viral Latency" program at the Heinrich Pette Institute-Leibniz Institute for Experimental Virology, Hamburg	The authors are indebted to M. Karimova (TU Dresden; TUD) for providing reagents, R. Kuhnert (TUD) for help with mouse work, A. Kassner-Frensel (TUD) for SKY analyses, R. Naumann (Max Planck Institute for Molecular Cell Biology and Genetics; MPI-CBG) for the generation of transgenic mice, S. Winkler (MPI-CBG) and A. Dahl (DFG-Forschungszentrum fur Regenerative Therapien Dresden) for DNA sequencing, D. Dubrau (Heinrich Pette Institute) for initial ASLV-vector construction, G. Pilnitz-Stolze, B. Weseloh and B. Abel (Heinrich Pette Institute) for technical assistance, and D. Indenbirken and M. Alawi (Heinrich Pette Institute) for next-generation sequencing of nrLAM-PCR products. This work was supported by the DFG (BU 1400/7-1), the BMBF (GO-Bio FKZ 0315090), the Else Kroner-Fresenius-Stiftung (2010_A82), and the "Viral Latency" program at the Heinrich Pette Institute-Leibniz Institute for Experimental Virology, Hamburg. The reporter plasmid pCAGGS-loxP-mCherry-loxP-EGFP, where a floxed mCherry gene was inserted between the CAG enhancer/promoter module and the EGFP gene, was a generous gift from E.M. Tanaka (DFG-Forschungszentrum fur Regenerative Therapien Dresden). The mammalian expression vector pCAGGS-IRES-puro was a generous gift from K. Anastassiadis (TUD).	Abi-Ghanem J, 2013, NUCLEIC ACIDS RES, V41, P2394, DOI 10.1093/nar/gks1308; Akay C, 2014, J NEUROVIROL, V20, P39, DOI 10.1007/s13365-013-0227-1; Anastassiadis K, 2009, DIS MODEL MECH, V2, P508, DOI 10.1242/dmm.003087; Archin NM, 2012, NATURE, V487, P482, DOI 10.1038/nature11286; Battistini A, 2014, VIRUSES-BASEL, V6, P1715, DOI 10.3390/v6041715; Beltran LM, 2015, VASC HEALTH RISK MAN, V11, P35, DOI 10.2147/VHRM.S65885; Blankson JN, 2014, INFECT DIS CLIN N AM, V28, P633, DOI 10.1016/j.idc.2014.08.007; Buchholz F, 2001, NAT BIOTECHNOL, V19, P1047, DOI 10.1038/nbt1101-1047; Buchholz F, 2011, METHODS, V53, P102, DOI 10.1016/j.ymeth.2010.06.014; Caskey M, 2015, NATURE, V522, P487, DOI 10.1038/nature14411; Chomont N, 2009, NAT MED, V15, P893, DOI 10.1038/nm.1972; Chun TW, 1999, NATURE, V401, P874, DOI 10.1038/44755; Crowell TA, 2015, J INFECT DIS, V211, P1692, DOI 10.1093/infdis/jiu809; Deeks SG, 2012, NATURE, V487, P439, DOI 10.1038/487439a; Ebina H, 2013, SCI REP-UK, V3, DOI 10.1038/srep02510; Ennifar E, 2003, NUCLEIC ACIDS RES, V31, P5449, DOI 10.1093/nar/gkg732; Fauci AS, 2014, JAMA-J AM MED ASSOC, V312, P335, DOI 10.1001/jama.2014.4754; Gabriel R, 2011, NAT BIOTECHNOL, V29, P816, DOI 10.1038/nbt.1948; Hauber I, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003587; Herrera-Carrillo E, 2015, VIRUSES-BASEL, V7, P3910, DOI 10.3390/v7072804; Holt N, 2010, NAT BIOTECHNOL, V28, P839, DOI 10.1038/nbt.1663; Hu WH, 2014, P NATL ACAD SCI USA, V111, P11461, DOI 10.1073/pnas.1405186111; Josefsson L, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003432; Josefsson L, 2011, P NATL ACAD SCI USA, V108, P11199, DOI 10.1073/pnas.1107729108; Karimova M, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1037; Katlama C, 2013, LANCET, V381, P2109, DOI 10.1016/S0140-6736(13)60104-X; Kim H, 2014, NAT REV GENET, V15, P321, DOI 10.1038/nrg3686; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Maartens G, 2014, LANCET, V384, P258, DOI 10.1016/S0140-6736(14)60164-1; Mbonye U, 2014, VIROLOGY, V454, P328, DOI 10.1016/j.virol.2014.02.008; Munch RC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7246; Nachega Jean B., 2011, Infectious Disorders - Drug Targets, V11, P167; Passaes CP, 2014, VIROLOGY, V454, P340, DOI 10.1016/j.virol.2014.02.021; Pattanayak V, 2011, NAT METHODS, V8, P765, DOI 10.1038/nmeth.1670; Perez EE, 2008, NAT BIOTECHNOL, V26, P808, DOI 10.1038/nbt1410; Petoumenos K, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.2.17426; Pinoges L, 2015, JAIDS-J ACQ IMM DEF, V68, P527, DOI 10.1097/QAI.0000000000000513; Prufer K, 2008, BIOINFORMATICS, V24, P1530, DOI 10.1093/bioinformatics/btn223; Qu XY, 2013, NUCLEIC ACIDS RES, V41, P7771, DOI 10.1093/nar/gkt571; Rappold M, 2014, J INT AIDS SOC, V17, P167, DOI 10.7448/IAS.17.4.19768; Richman DD, 2006, ANTIVIR RES, V71, P117, DOI 10.1016/j.antiviral.2006.03.004; Ringrose L, 1999, EMBO J, V18, P6630, DOI 10.1093/emboj/18.23.6630; Santarosa M, 2004, BBA-REV CANCER, V1654, P105, DOI 10.1016/j.bbcan.2004.01.001; Santoro SW, 2002, P NATL ACAD SCI USA, V99, P4185, DOI 10.1073/pnas.022039799; Sarkar I, 2007, SCIENCE, V316, P1912, DOI 10.1126/science.1141453; Sauer B, 2004, NUCLEIC ACIDS RES, V32, P6086, DOI 10.1093/nar/gkh941; Schackman BR, 2006, MED CARE, V44, P990, DOI 10.1097/01.mlr.0000228021.89490.2a; Scherer LJ, 2011, HUM MOL GENET, V20, pR100, DOI 10.1093/hmg/ddr160; Suerth JD, 2010, J VIROL, V84, P6626, DOI 10.1128/JVI.00182-10; Surendranath V, 2010, NUCLEIC ACIDS RES, V38, pW293, DOI 10.1093/nar/gkq523; Suzuki E, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1280; Taylor BS, 2008, NEW ENGL J MED, V358, P1590, DOI 10.1056/NEJMra0706737; Tebas P, 2014, NEW ENGL J MED, V370, P901, DOI 10.1056/NEJMoa1300662; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; Van Duyne GD, 2001, ANNU REV BIOPH BIOM, V30, P87, DOI 10.1146/annurev.biophys.30.1.87; Wang XL, 2015, NAT BIOTECHNOL, V33, P175, DOI 10.1038/nbt.3127; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Whitney JB, 2014, NATURE, V512, P74, DOI 10.1038/nature13594	59	78	100	0	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	APR	2016	34	4					401	+		10.1038/nbt.3467	http://dx.doi.org/10.1038/nbt.3467			13	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DI6NL	26900663				2022-12-25	WOS:000373616100020
J	Xu, R; Zhang, GD; Mai, JH; Deng, XY; Segura-Ibarra, V; Wu, SH; Shen, JL; Liu, HR; Hu, ZH; Chen, LX; Huang, Y; Koay, E; Huang, Y; Liu, J; Ensor, JE; Blanco, E; Liu, XW; Ferrari, M; Shen, HF				Xu, Rong; Zhang, Guodong; Mai, Junhua; Deng, Xiaoyong; Segura-Ibarra, Victor; Wu, Suhong; Shen, Jianliang; Liu, Haoran; Hu, Zhenhua; Chen, Lingxiao; Huang, Yi; Koay, Eugene; Huang, Yu; Liu, Jun; Ensor, Joe E.; Blanco, Elvin; Liu, Xuewu; Ferrari, Mauro; Shen, Haifa			An injectable nanoparticle generator enhances delivery of cancer therapeutics	NATURE BIOTECHNOLOGY			English	Article							PEGYLATED LIPOSOMAL DOXORUBICIN; BREAST-CANCER; MULTIDRUG-RESISTANCE; METASTASIS; PH; VASCULATURE; PARTICLES; THERAPY; DESIGN; FUSION	The efficacy of cancer drugs is often limited because only a small fraction of the administered dose accumulates in tumors. Here we report an injectable nanoparticle generator (iNPG) that overcomes multiple biological barriers to cancer drug delivery. The iNPG is a discoidal micrometer-sized particle that can be loaded with chemotherapeutics. We conjugate doxorubicin to poly(l-glutamic acid) by means of a pH-sensitive cleavable linker, and load the polymeric drug (pDox) into iNPG to assemble iNPG-pDox. Once released from iNPG, pDox spontaneously forms nanometer-sized particles in aqueous solution. Intravenously injected iNPG-pDox accumulates at tumors due to natural tropism and enhanced vascular dynamics and releases pDox nanoparticles that are internalized by tumor cells. Intracellularly, pDox nanoparticles are transported to the perinuclear region and cleaved into Dox, thereby avoiding excretion by drug efflux pumps. Compared to its individual components or current therapeutic formulations, iNPG-pDox shows enhanced efficacy in MDA-MB-231 and 4T1 mouse models of metastatic breast cancer, including functional cures in 40-50% of treated mice.	[Xu, Rong; Zhang, Guodong; Mai, Junhua; Deng, Xiaoyong; Segura-Ibarra, Victor; Wu, Suhong; Shen, Jianliang; Liu, Haoran; Hu, Zhenhua; Chen, Lingxiao; Huang, Yi; Koay, Eugene; Huang, Yu; Blanco, Elvin; Liu, Xuewu; Ferrari, Mauro; Shen, Haifa] Houston Methodist Res Inst, Dept Nanomed, Houston, TX USA; [Xu, Rong] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Basic Med, Dept Pharmacol, Wuhan 430074, Peoples R China; [Koay, Eugene] Univ Texas MD Anderson Canc Ctr, Div Radiat Oncol, Houston, TX 77030 USA; [Liu, Jun] Univ Texas Houston, Sch Med, Dept Pathol & Lab Med, Houston, TX 77030 USA; [Ensor, Joe E.] Houston Methodist Canc Ctr, Houston, TX USA; [Ferrari, Mauro] Weill Cornell Med Coll, Dept Med, New York, NY USA; [Shen, Haifa] Weill Cornell Med Coll, Dept Cell & Dev Biol, New York, NY USA; [Deng, Xiaoyong] Shanghai Univ, Inst Nanochem & Nanobiol, Shanghai, Peoples R China; [Huang, Yu] Univ S Dakota, Dept Biomed Engn, Sioux Falls, SD USA	The Methodist Hospital System; The Methodist Hospital - Houston; Huazhong University of Science & Technology; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; The Methodist Hospital System; The Methodist Hospital - Houston; Cornell University; Cornell University; Shanghai University; University of South Dakota	Ferrari, M; Shen, HF (corresponding author), Houston Methodist Res Inst, Dept Nanomed, Houston, TX USA.; Ferrari, M (corresponding author), Weill Cornell Med Coll, Dept Med, New York, NY USA.; Shen, HF (corresponding author), Weill Cornell Med Coll, Dept Cell & Dev Biol, New York, NY USA.	mferrari@HoustonMethodist.org; hshen@HoustonMethodist.org	Liu, Haoran/L-2057-2019; Segura, Victor/AAS-5236-2021; Deng, Xiaoyong/A-5682-2012	Deng, Xiaoyong/0000-0001-6967-7050; Mai, Junhua/0000-0001-8374-4352; Ensor, Joe/0000-0003-3533-4388	Department of Defense grants [W81XWH-09-1-0212, W81XWH-12-1-0414]; National Institute of Health grants NIH [U54CA143837, U54CA151668, 1R01CA193880-01A1]; Welch Foundation grant [AU-1714]; National Natural Science Foundation of China [81301314]; NATIONAL CANCER INSTITUTE [U54CA151668, U54CA143837, R01CA193880] Funding Source: NIH RePORTER	Department of Defense grants(United States Department of Defense); National Institute of Health grants NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation grant(The Welch Foundation); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	M.F. is grateful for the Ernest Cockrell Jr. Distinguished Endowed Chair in the Department of Nanomedicine at the Houston Methodist Research Institute. The authors acknowledge financial support from Department of Defense grants W81XWH-09-1-0212 and W81XWH-12-1-0414, National Institute of Health grants NIH U54CA143837, U54CA151668 (M.F.) and 1R01CA193880-01A1 (H.S.), Welch Foundation grant AU-1714 (J.L.), and National Natural Science Foundation of China 81301314 (R.X.). The authors thank the Nanofabrication Core of the Houston Methodist Research Institute for porous silicon microparticle fabrication and surface chemical modification. We acknowledge J. Gu for AFM analysis, D. Kirui for intravital microscopy, and H.H. Hoang for manuscript proofreading and editing.	Alhareth K, 2012, J CHROMATOGR B, V887, P128, DOI 10.1016/j.jchromb.2012.01.025; Bae Y, 2003, ANGEW CHEM INT EDIT, V42, P4640, DOI 10.1002/anie.200250653; Blanco E, 2015, NAT BIOTECHNOL, V33, P941, DOI 10.1038/nbt.3330; Decuzzi P, 2010, J CONTROL RELEASE, V141, P320, DOI 10.1016/j.jconrel.2009.10.014; Decuzzi P, 2009, PHARM RES-DORD, V26, P235, DOI 10.1007/s11095-008-9697-x; Demaurex N, 2002, NEWS PHYSIOL SCI, V17, P1; Ferrari M, 2010, TRENDS BIOTECHNOL, V28, P181, DOI 10.1016/j.tibtech.2009.12.007; Fojo T, 2007, ANN ONCOL, V18, pV3, DOI 10.1093/annonc/mdm172; Godin B, 2012, ADV FUNCT MATER, V22, P4225, DOI 10.1002/adfm.201200869; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Hurst DR, 2009, CANCER RES, V69, P1279, DOI 10.1158/0008-5472.CAN-08-3559; Lesniak A, 2013, J AM CHEM SOC, V135, P1438, DOI 10.1021/ja309812z; Liedtke C, 2008, J CLIN ONCOL, V26, P1275, DOI 10.1200/JCO.2007.14.4147; Lien MY, 2014, ANTICANCER RES, V34, P7319; Lu X, 2009, P NATL ACAD SCI USA, V106, P9385, DOI 10.1073/pnas.0900108106; Maeda H, 2001, ADV ENZYME REGUL, V41, P189, DOI 10.1016/S0065-2571(00)00013-3; Maeda H, 2015, ADV DRUG DELIVER REV, V91, P3, DOI 10.1016/j.addr.2015.01.002; McConnell KI, 2014, J CONTROL RELEASE, V194, P113, DOI 10.1016/j.jconrel.2014.08.020; Michor F, 2011, NAT REV CANCER, V11, P657, DOI 10.1038/nrc3092; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Moghimi SM, 1998, ADV DRUG DELIVER REV, V32, P45, DOI 10.1016/S0169-409X(97)00131-2; Padilla-Parra S, 2012, P NATL ACAD SCI USA, V109, P17627, DOI 10.1073/pnas.1211714109; Peer D, 2007, NAT NANOTECHNOL, V2, P751, DOI 10.1038/nnano.2007.387; Shen HF, 2012, ADV HEALTHC MATER, V1, P84, DOI 10.1002/adhm.201100005; Tasciotti E, 2008, NAT NANOTECHNOL, V3, P151, DOI 10.1038/nnano.2008.34; van de Ven AL, 2012, J CONTROL RELEASE, V158, P148, DOI 10.1016/j.jconrel.2011.10.021; Verma S, 2008, CANCER TREAT REV, V34, P391, DOI 10.1016/j.ctrv.2008.01.008; VONHOFF DD, 1979, ANN INTERN MED, V91, P710, DOI 10.7326/0003-4819-91-5-710; WIKEHOOLEY JL, 1984, RADIOTHER ONCOL, V2, P343, DOI 10.1016/S0167-8140(84)80077-8; Zhang S, 2012, NAT MED, V18, P1639, DOI 10.1038/nm.2919	30	214	217	13	438	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	APR	2016	34	4					414	+		10.1038/nbt.3506	http://dx.doi.org/10.1038/nbt.3506			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DI6NL	26974511	Green Accepted			2022-12-25	WOS:000373616100022
J	Richardson, CD; Ray, GJ; DeWitt, MA; Curie, GL; Corn, JE				Richardson, Christopher D.; Ray, Graham J.; DeWitt, Mark A.; Curie, Gemma L.; Corn, Jacob E.			Enhancing homology-directed genome editing by catalytically active and inactive CRISPR-Cas9 using asymmetric donor DNA	NATURE BIOTECHNOLOGY			English	Article							DOUBLE-STRAND BREAK; ZINC-FINGER NUCLEASES; BACTERIAL IMMUNITY; TARGET DNA; CAS9; RNA; REPAIR; CELLS; ENDONUCLEASE; INTERROGATION	Targeted genomic manipulation by Cas9 can efficiently generate knockout cells and organisms via error-prone nonhomologous end joining (NHEJ), but the efficiency of precise sequence replacement by homology-directed repair (HDR) is substantially lower(1,2). Here we investigate the interaction of Cas9 with target DNA and use our findings to improve HDR efficiency. We show that dissociation of Cas9 from double-stranded DNA (dsDNA) substrates is slow (lifetime similar to 6 h) but that, before complete dissociation, Cas9 asymmetrically releases the 3 end of the cleaved DNA strand that is not complementary to the sgRNA (nontarget strand). By rationally designing single-stranded DNA (ssDNA) donors of the optimal length complementary to the strand that is released first, we increase the rate of HDR in human cells when using Cas9 or nickase variants to up to 60%. We also demonstrate HDR rates of up to 0.7% using a catalytically inactive Cas9 mutant (dCas9), which binds DNA without cleaving it.	[Richardson, Christopher D.; Ray, Graham J.; DeWitt, Mark A.; Curie, Gemma L.; Corn, Jacob E.] Univ Calif Berkeley, Innovat Genom Initiat, Berkeley, CA 94720 USA; [Richardson, Christopher D.; Ray, Graham J.; DeWitt, Mark A.; Curie, Gemma L.; Corn, Jacob E.] Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Corn, JE (corresponding author), Univ Calif Berkeley, Innovat Genom Initiat, Berkeley, CA 94720 USA.; Corn, JE (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	jcorn@berkeley.edu		Richardson, Chris/0000-0003-3122-4851; Ray, Graham/0000-0002-1245-8428; Corn, Jacob/0000-0002-7798-5309	Li Ka Shing Foundation	Li Ka Shing Foundation	We thank J. Doudna, M. Botchan, and members of the Corn laboratory for critical reading of the manuscript. We thank the Doudna lab for the gift of wtCas9 expression plasmids and the Berkeley Macrolab for support with protein expression and purification. This work was supported by the Li Ka Shing Foundation. Reagents described in this work are available on Addgene (https://www.addgene.org/Jacob_Corn/), and detailed protocols are available on protocols.io (https://www.protocols.io/g/innovative-genomics-initiative).	Abdiche Y, 2008, ANAL BIOCHEM, V377, P209, DOI 10.1016/j.ab.2008.03.035; Anders C, 2014, METHOD ENZYMOL, V546, P1, DOI 10.1016/B978-0-12-801185-0.00001-5; Anders C, 2014, NATURE, V513, P569, DOI 10.1038/nature13579; Aparicio O, 2005, CURR PROTOC MOL BIOL, V69; Bitinaite J, 1998, P NATL ACAD SCI USA, V95, P10570, DOI 10.1073/pnas.95.18.10570; Carroll D, 2011, GENETICS, V188, P773, DOI 10.1534/genetics.111.131433; Cathomen T, 2010, METHODS MOL BIOL, V649, P227, DOI 10.1007/978-1-60761-753-2_13; Chen FQ, 2011, NAT METHODS, V8, P753, DOI 10.1038/nmeth.1653; Davis L, 2014, P NATL ACAD SCI USA, V111, pE924, DOI 10.1073/pnas.1400236111; DeWitt M., 2015, CA9 RNP NUCLEOFECTIO, DOI 10.17504/protocols.io.dm649d; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Genovese P, 2014, NATURE, V510, P235, DOI 10.1038/nature13420; Heler R, 2015, NATURE, V519, P199, DOI 10.1038/nature14245; Jiang WY, 2015, ANNU REV MICROBIOL, V69, P209, DOI 10.1146/annurev-micro-091014-104441; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kim S, 2014, GENOME RES, V24, P1012, DOI 10.1101/gr.171322.113; Knight SC, 2015, SCIENCE, V350, P823, DOI 10.1126/science.aac6572; Lin S, 2014, ELIFE, V3, DOI 10.7554/eLife.04766; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Maruyama T, 2015, NAT BIOTECHNOL, V33, P538, DOI 10.1038/nbt.3190; McVey M, 2008, TRENDS GENET, V24, P529, DOI 10.1016/j.tig.2008.08.007; METZGER L, 1991, INT J RADIAT BIOL, V59, P1325, DOI 10.1080/09553009114551201; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Sfeir A, 2015, TRENDS BIOCHEM SCI, V40, P701, DOI 10.1016/j.tibs.2015.08.006; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; Storici F, 2006, MOL CELL BIOL, V26, P7645, DOI 10.1128/MCB.00672-06; Trevino AE, 2014, METHOD ENZYMOL, V546, P161, DOI 10.1016/B978-0-12-801185-0.00008-8; Tsai SQ, 2014, NAT BIOTECHNOL, V32, P569, DOI 10.1038/nbt.2908; Chu VT, 2015, NAT BIOTECHNOL, V33, P543, DOI 10.1038/nbt.3198; Yang LH, 2013, NUCLEIC ACIDS RES, V41, P9049, DOI 10.1093/nar/gkt555; Yin H, 2014, NAT BIOTECHNOL, V32, P551, DOI 10.1038/nbt.2884	33	600	666	12	190	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2016	34	3					339	+		10.1038/nbt.3481	http://dx.doi.org/10.1038/nbt.3481			7	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DG1CJ	26789497				2022-12-25	WOS:000371802600032
J	Tack, DS; Ellefson, JW; Thyer, R; Wang, B; Gollihar, J; Forster, MT; Ellington, AD				Tack, Drew S.; Ellefson, Jared W.; Thyer, Ross; Wang, Bo; Gollihar, Jimmy; Forster, Matthew T.; Ellington, Andrew D.			Addicting diverse bacteria to a noncanonical amino acid	NATURE CHEMICAL BIOLOGY			English	Article							ESCHERICHIA-COLI; GENETIC-CODE; ORGANISMS; SUPPRESSION	Engineered orthogonal translation systems have greatly enabled the expansion of the genetic code using noncanonical amino acids (NCAAs). However, the impact of NCAAs on organismal evolution remains unclear, in part because it is difficult to force the adoption of new genetic codes in organisms. By reengineering TEM-1 beta-lactamase to be dependent on a NCAA, we maintained bacterial NCAA dependence for hundreds of generations without escape.	[Tack, Drew S.; Ellefson, Jared W.; Thyer, Ross; Wang, Bo; Gollihar, Jimmy; Forster, Matthew T.; Ellington, Andrew D.] Univ Texas Austin, Ctr Syst & Synthet Biol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Ellington, AD (corresponding author), Univ Texas Austin, Ctr Syst & Synthet Biol, Austin, TX 78712 USA.	ellingtonlab@gmail.com		Tack, Drew/0000-0002-9380-4643; Thyer, Ross/0000-0002-0356-5790; Gollihar, Jimmy/0000-0003-3957-2092	National Security Science and Engineering Faculty Fellowship [FA9550-10-1-0169]; Welch Foundation [F-1654]; Defense Advanced Research Projects Agency [N66001-14-2-4051, HR0011-15-C0095]; Air Force Office of Scientific Research grant [FA9550-14-1-0089]	National Security Science and Engineering Faculty Fellowship; Welch Foundation(The Welch Foundation); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Air Force Office of Scientific Research grant(United States Department of DefenseAir Force Office of Scientific Research (AFOSR))	This work was supported by the following grants: National Security Science and Engineering Faculty Fellowship grant FA9550-10-1-0169 to A.D.E. Welch Foundation grant F-1654. Defense Advanced Research Projects Agency N66001-14-2-4051 to A.D.E. Air Force Office of Scientific Research grant FA9550-14-1-0089 to A.D.E. Defense Advanced Research Projects Agency HR0011-15-C0095 to A.D.E.	Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bacher JM, 2003, BMC EVOL BIOL, V3, DOI 10.1186/1471-2148-3-24; Bacher JM, 2001, J BACTERIOL, V183, P5414, DOI 10.1128/JB.183.18.5414-5425.2001; Bradford PA, 2001, CLIN MICROBIOL REV, V14, P933, DOI 10.1128/CMR.14.4.933-951.2001; Chin JW, 2002, J AM CHEM SOC, V124, P9026, DOI 10.1021/ja027007w; Cooley RB, 2014, BIOCHEMISTRY-US, V53, P1916, DOI 10.1021/bi5001239; FONZE E, 1995, ACTA CRYSTALLOGR D, V51, P682, DOI 10.1107/S0907444994014496; Hammerling MJ, 2014, NAT CHEM BIOL, V10, P178, DOI [10.1038/nchembio.1450, 10.1038/NCHEMBIO.1450]; Kato Y, 2015, PEERJ, V3, DOI 10.7717/peerj.1247; Lajoie MJ, 2013, SCIENCE, V342, P357, DOI 10.1126/science.1241459; LEMEIGNAN B, 1993, J MOL BIOL, V231, P161, DOI 10.1006/jmbi.1993.1269; Liu CC, 2010, ANNU REV BIOCHEM, V79, P413, DOI 10.1146/annurev.biochem.052308.105824; Mandell DJ, 2015, NATURE, V518, P55, DOI 10.1038/nature14121; Ohtake K, 2015, SCI REP-UK, V5, DOI 10.1038/srep09762; Rovner AJ, 2015, NATURE, V518, P89, DOI 10.1038/nature14095; Sakamoto K, 2009, STRUCTURE, V17, P335, DOI 10.1016/j.str.2009.01.008; Thyer R, 2015, J AM CHEM SOC, V137, P46, DOI 10.1021/ja510695g; Wang JY, 2006, J AM CHEM SOC, V128, P8738, DOI 10.1021/ja062666k; Wang Q, 2014, CHEMBIOCHEM, V15, P1744, DOI 10.1002/cbic.201402235; WONG JTF, 1983, P NATL ACAD SCI-BIOL, V80, P6303, DOI 10.1073/pnas.80.20.6303; Xie JM, 2007, ACS CHEM BIOL, V2, P474, DOI 10.1021/cb700083w	21	36	37	0	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAR	2016	12	3					138	140		10.1038/NCHEMBIO.2002	http://dx.doi.org/10.1038/NCHEMBIO.2002			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF5FK	26780407				2022-12-25	WOS:000371377000004
J	Alphey, L				Alphey, Luke			Can CRISPR-Cas9 gene drives curb malaria?	NATURE BIOTECHNOLOGY			English	Editorial Material							MOSQUITO; VECTOR; POPULATIONS; EFFICIENT; SYSTEM		[Alphey, Luke] Pirbright Inst, Ash Rd, Woking, Surrey, England; [Alphey, Luke] Univ Oxford, Dept Zool, S Parks Rd, Oxford, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute; University of Oxford	Alphey, L (corresponding author), Pirbright Inst, Ash Rd, Woking, Surrey, England.; Alphey, L (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford, England.	luke.alphey@pirbright.ac.uk		Alphey, Luke/0000-0002-2916-3802	BBSRC [BBS/E/I/00001892] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/I/00001892] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Alphey L, 2014, ANNU REV ENTOMOL, V59, P205, DOI 10.1146/annurev-ento-011613-162002; Burt A, 2003, P ROY SOC B-BIOL SCI, V270, P921, DOI 10.1098/rspb.2002.2319; Burt A, 2006, GENES CONFLICT BIOL; Carvalho DO, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003864; Davis S, 2001, J THEOR BIOL, V212, P83, DOI 10.1006/jtbi.2001.2357; Deredec A, 2008, GENETICS, V179, P2013, DOI 10.1534/genetics.108.089037; Galizi R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4977; Gantz VM, 2015, P NATL ACAD SCI USA, V112, pE6736, DOI 10.1073/pnas.1521077112; Gantz VM, 2015, SCIENCE, V348, P442, DOI 10.1126/science.aaa5945; Hammond A, 2016, NAT BIOTECHNOL, V34, P78, DOI 10.1038/nbt.3439	10	36	38	2	94	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2016	34	2					149	150		10.1038/nbt.3473	http://dx.doi.org/10.1038/nbt.3473			2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DD0OK	26849518	Green Submitted			2022-12-25	WOS:000369619100014
J	Fuzik, J; Zeisel, A; Mate, Z; Calvigioni, D; Yanagawa, Y; Szabo, G; Linnarsson, S; Harkany, T				Fuzik, Janos; Zeisel, Amit; Mate, Zoltan; Calvigioni, Daniela; Yanagawa, Yuchio; Szabo, Gabor; Linnarsson, Sten; Harkany, Tibor			Integration of electrophysiological recordings with single-cell RNA-seq data identifies neuronal subtypes	NATURE BIOTECHNOLOGY			English	Article							VESICULAR GLUTAMATE TRANSPORTERS; GENE-EXPRESSION; GABAERGIC INTERNEURONS; RECEPTORS; DIVERSITY; RESOLUTION; SYNAPSES; DYNAMICS; FEATURES; CORTEX	Traditionally, neuroscientists have defined the identity of neurons by the cells' location, morphology, connectivity and excitability. However, the direct relationship between these parameters and the molecular phenotypes has remained largely unexplored. Here, we present a method for obtaining full transcriptome data from single neocortical pyramidal cells and interneurons after whole-cell patch-clamp recordings in mouse brain slices. In our approach, termed Patch-seq, a patch-clamp stimulus protocol is followed by the aspiration of the entire somatic compartment into the recording pipette, reverse transcription of RNA including addition of unique molecular identifiers, cDNA amplification, Illumina library preparation and sequencing. We show that Patch-seq reveals a close link between electrophysiological characteristics, responses to acute chemical challenges and RNA expression of neurotransmitter receptors and channels. Moreover, it distinguishes neuronal subpopulations that correspond to both well-established and, to our knowledge, hitherto undescribed neuronal subtypes. Our findings demonstrate the ability of Patch-seq to precisely map neuronal subtypes and predict their network contributions in the brain.	[Fuzik, Janos; Zeisel, Amit; Calvigioni, Daniela; Linnarsson, Sten; Harkany, Tibor] Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden; [Fuzik, Janos; Calvigioni, Daniela; Harkany, Tibor] Med Univ Vienna, Dept Mol Neurosci, Ctr Brain Res, Vienna, Austria; [Mate, Zoltan; Szabo, Gabor] Hungarian Acad Sci, Inst Expt Med, Budapest, Hungary; [Yanagawa, Yuchio] Gunma Univ, Grad Sch Med, Dept Genet & Behav Neurosci, Maebashi, Gunma 371, Japan	Karolinska Institutet; Medical University of Vienna; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine; Gunma University	Linnarsson, S; Harkany, T (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden.	sten.linnarsson@ki.se; tibor.harkany@ki.se	Szabo, Gabor/A-5087-2008; Linnarsson, Sten/HCH-3909-2022	Szabo, Gabor/0000-0001-5438-5151; Harkany, Tibor/0000-0002-6637-5900	European Research Council (BRAINCELL) [261063]; Swedish Research Council; Human Frontier Science Program; European Commission 7th Framework Program (PAINCAGE); Hjarnfonden; NovoNordisk Foundation; Alzheimers Research UK [ART-EG2009A-1] Funding Source: researchfish; Novo Nordisk Fonden [NNF15OC0015964, NNF14OC0010695] Funding Source: researchfish	European Research Council (BRAINCELL); Swedish Research Council(Swedish Research CouncilEuropean Commission); Human Frontier Science Program(Human Frontier Science Program); European Commission 7th Framework Program (PAINCAGE); Hjarnfonden; NovoNordisk Foundation(Novo Nordisk Foundation); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); Novo Nordisk Fonden(Novo Nordisk Foundation)	We thank A. Jureus for DNA sequencing, and the CLICK Imaging Facility at Karolinska Institutet for making the Imaris software package available for neuronal reconstructions, T. Klausberger and E. Borok for discussions and assistance with Neurolucida reconstructions. This work was supported by the European Research Council (BRAINCELL 261063, to S.L.), the Swedish Research Council (to S.L. and T.H.); Human Frontier Science Program (to A.Z.), the European Commission 7th Framework Program (PAINCAGE, to T.H.), Hjarnfonden (to T.H.) and the NovoNordisk Foundation (to T.H.).	Angulo MC, 1997, J NEUROSCI, V17, P6685; Arganda S, 2007, NAT NEUROSCI, V10, P1467, DOI 10.1038/nn1982; Ascoli GA, 2008, NAT REV NEUROSCI, V9, P557, DOI 10.1038/nrn2402; Baranauskas G, 2003, NAT NEUROSCI, V6, P258, DOI 10.1038/nn1019; Caiati MD, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00063; Cauli B, 1997, J NEUROSCI, V17, P3894; Cauli B, 2000, P NATL ACAD SCI USA, V97, P6144, DOI 10.1073/pnas.97.11.6144; Chaudhry FA, 1998, J NEUROSCI, V18, P9733; Citri A, 2012, NAT PROTOC, V7, P118, DOI 10.1038/nprot.2011.430; Ferezou I, 2002, J NEUROSCI, V22, P7389; Fishell G, 2008, NEURON, V57, P333, DOI 10.1016/j.neuron.2008.01.018; Fremeau RT, 2001, NEURON, V31, P247, DOI 10.1016/S0896-6273(01)00344-0; Freund TF, 2003, TRENDS NEUROSCI, V26, P489, DOI 10.1016/S0166-2236(03)00227-3; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Gupta A, 2000, SCIENCE, V287, P273, DOI 10.1126/science.287.5451.273; Hashimoto T, 2008, MOL PSYCHIATR, V13, P147, DOI 10.1038/sj.mp.4002011; Holt CE, 2013, NEURON, V80, P648, DOI 10.1016/j.neuron.2013.10.036; Islam S, 2014, NAT METHODS, V11, P163, DOI [10.1038/NMETH.2772, 10.1038/nmeth.2772]; Islam S, 2012, NAT PROTOC, V7, P813, DOI 10.1038/nprot.2012.022; Kaneko T, 2002, J COMP NEUROL, V444, P39, DOI 10.1002/cne.10129; Katona I, 1999, J NEUROSCI, V19, P4544; Kawaguchi Y, 1998, NEUROSCIENCE, V85, P677, DOI 10.1016/S0306-4522(97)00685-4; Kirischuk S, 2012, TRENDS NEUROSCI, V35, P497, DOI 10.1016/j.tins.2012.04.003; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Markram H, 2006, NAT REV NEUROSCI, V7, P153, DOI 10.1038/nrn1848; Mate Z, 2013, CELL TISSUE RES, V352, P199, DOI 10.1007/s00441-013-1552-7; Mindell JA, 2001, GENOME BIOL, V2; Morozov YM, 2003, NEUROSCIENCE, V120, P923, DOI 10.1016/S0306-4522(03)00409-3; Munoz-Manchado AB, 2016, CEREB CORTEX, V26, P96, DOI 10.1093/cercor/bhu179; Okaty BW, 2011, J NEUROSCI, V31, P6939, DOI 10.1523/JNEUROSCI.0626-11.2011; Okaty BW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016493; Qiu Shenfeng, 2012, Frontiers in Genetics, V3, P124, DOI 10.3389/fgene.2012.00124; Rakic P, 2006, CEREB CORTEX, V16, pI3, DOI 10.1093/cercor/bhk036; Rakic P, 2009, NAT REV NEUROSCI, V10, P724, DOI 10.1038/nrn2719; Romanov RA, 2015, EMBO J, V34, P36, DOI 10.15252/embj.201488977; Schmidt MJ, 2014, MOL PSYCHIATR, V19, P580, DOI 10.1038/mp.2013.167; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Subkhankulova T, 2010, FRONT MOL NEUROSCI, V3, DOI 10.3389/fnmol.2010.00010; Susaki EA, 2014, CELL, V157, P726, DOI 10.1016/j.cell.2014.03.042; Tainaka K, 2014, CELL, V159, P911, DOI 10.1016/j.cell.2014.10.034; Tamamaki N, 2003, J COMP NEUROL, V467, P60, DOI 10.1002/cne.10905; Tamas G, 2000, NAT NEUROSCI, V3, P366, DOI 10.1038/73936; Tomer R, 2014, NAT PROTOC, V9, P1682, DOI 10.1038/nprot.2014.123; Tricoire L, 2011, J NEUROSCI, V31, P10948, DOI 10.1523/JNEUROSCI.0323-11.2011; Tsou K, 1998, NEUROSCIENCE, V83, P393, DOI 10.1016/S0306-4522(97)00436-3; Usoskin D, 2015, NAT NEUROSCI, V18, P145, DOI 10.1038/nn.3881; Varga V, 2009, SCIENCE, V326, P449, DOI 10.1126/science.1178307; Veys K, 2012, J NEUROSCI METH, V209, P227, DOI 10.1016/j.jneumeth.2012.06.008; Zeisel A, 2015, SCIENCE, V347, P1138, DOI 10.1126/science.aaa1934; Zivraj KH, 2010, J NEUROSCI, V30, P15464, DOI 10.1523/JNEUROSCI.1800-10.2010	50	223	225	3	99	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2016	34	2					175	+		10.1038/nbt.3443	http://dx.doi.org/10.1038/nbt.3443			11	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DD0OK	26689544	Green Accepted			2022-12-25	WOS:000369619100020
J	Kries, H; Caputi, L; Stevenson, CEM; Kamileen, MO; Sherden, NH; Geu-Flores, F; Lawson, DM; O'Connor, SE				Kries, Hajo; Caputi, Lorenzo; Stevenson, Clare E. M.; Kamileen, Mohammed O.; Sherden, Nathaniel H.; Geu-Flores, Fernando; Lawson, David M.; O'Connor, Sarah E.			Structural determinants of reductive terpene cyclization in iridoid biosynthesis	NATURE CHEMICAL BIOLOGY			English	Article							PROGESTERONE 5-BETA-REDUCTASE; DIGITALIS-LANATA; STRUCTURE VALIDATION; CARDENOLIDES; REFINEMENT; CHEMISTRY; BIOLOGY; FAMILY	The carbon skeleton of ecologically and pharmacologically important iridoid monoterpenes is formed in a reductive cyclization reaction unrelated to canonical terpene cyclization. Here we report the crystal structure of the recently discovered iridoid cyclase (from Catharanthus roseus) bound to a mechanism-inspired inhibitor that illuminates substrate binding and catalytic function of the enzyme. Key features that distinguish iridoid synthase from its close homolog progesterone 5 beta-reductase are highlighted.	[Kries, Hajo; Caputi, Lorenzo; Stevenson, Clare E. M.; Kamileen, Mohammed O.; Sherden, Nathaniel H.; Lawson, David M.; O'Connor, Sarah E.] John Innes Ctr, Dept Biol Chem, Norwich, Norfolk, England; [Geu-Flores, Fernando] Univ Copenhagen, Copenhagen Plant Sci Ctr, Dept Plant & Environm Sci, Copenhagen, Denmark; [Geu-Flores, Fernando] Sect Plant Biochem, Copenhagen, Denmark	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; University of Copenhagen	Kries, H (corresponding author), John Innes Ctr, Dept Biol Chem, Norwich Res Pk, Norwich, Norfolk, England.	sarah.o'connor@jic.ac.uk	Caputi, Lorenzo/C-9925-2011; Geu-Flores, Fernando/B-2737-2015; O'Connor, Sarah Ellen/X-2893-2019; O'Connor, Sarah/O-5850-2016	Caputi, Lorenzo/0000-0002-7783-6733; Geu-Flores, Fernando/0000-0002-5735-9810; Stevenson, Clare/0000-0001-6695-8201; Kries, Hajo/0000-0002-4919-2811; O'Connor, Sarah/0000-0003-0356-6213; Kamileen, Mohamed Omar/0000-0002-1346-1055	European Research Council [ERC R20359]; BBSRC Institute Strategic Programme grant (MET) [BB/J004561/1]; SNF Early Postdoc Mobility Fellowship; Biotechnology and Biological Sciences Research Council [BB/J009091/1, BBS/E/J/000CA512] Funding Source: researchfish; BBSRC [BBS/E/J/000CA512, BB/J009091/1] Funding Source: UKRI	European Research Council(European Research Council (ERC)European Commission); BBSRC Institute Strategic Programme grant (MET)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); SNF Early Postdoc Mobility Fellowship; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Funds were made available by the European Research Council (ERC R20359) and a BBSRC Institute Strategic Programme grant (MET; BB/J004561/1) to S.E.O'C., and an SNF Early Postdoc Mobility Fellowship to H.K. The Diamond Light Source provided access to beamlines I03, I04 and I04-1 (proposal MX9475).	Berrow NS, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm047; Birkett MA, 2003, PHYTOCHEMISTRY, V62, P651, DOI 10.1016/S0031-9422(02)00568-X; Bjelic S, 2013, ACS CHEM BIOL, V8, P749, DOI 10.1021/cb3006227; Cane DE, 2012, ACCOUNTS CHEM RES, V45, P463, DOI 10.1021/ar200198d; CASPI E, 1967, SCIENCE, V156, P519, DOI 10.1126/science.156.3774.519; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Christianson DW, 2006, CHEM REV, V106, P3412, DOI 10.1021/cr050286w; Dinda B, 2011, CHEM PHARM BULL, V59, P803, DOI 10.1248/cpb.59.803; Dobler S, 2011, PHYTOCHEMISTRY, V72, P1593, DOI 10.1016/j.phytochem.2011.04.015; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Garrabou X, 2015, ANGEW CHEM INT EDIT, V54, P5609, DOI 10.1002/anie.201500217; GARTNER DE, 1990, FEBS LETT, V271, P239, DOI 10.1016/0014-5793(90)80415-F; Geu-Flores F, 2012, NATURE, V492, P138, DOI 10.1038/nature11692; Joosten RP, 2009, J APPL CRYSTALLOGR, V42, P376, DOI 10.1107/S0021889809008784; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kavanagh K, 2008, CELL MOL LIFE SCI, V65, P3895, DOI 10.1007/s00018-008-8588-y; Krissinel E., 2005, COMPUTATIONAL LIFE S; Kunert M, 2013, CHEMBIOCHEM, V14, P353, DOI 10.1002/cbic.201200689; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Lindemann P, 2015, STEROIDS, V103, P145, DOI 10.1016/j.steroids.2015.08.007; Lindner S, 2014, CHEM BIOL, V21, P1452, DOI 10.1016/j.chembiol.2014.09.010; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Munkert J, 2015, PLANT BIOLOGY, V17, P1113, DOI 10.1111/plb.12361; Munkert J, 2015, MOL PLANT, V8, P136, DOI 10.1016/j.molp.2014.11.005; O'Connor SE, 2006, NAT PROD REP, V23, P532, DOI 10.1039/b512615k; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Petersen J, 2016, J BIOMOL STRUCT DYN, V34, P1667, DOI 10.1080/07391102.2015.1088797; Rudolph K, 2014, BIOCHIMIE, V101, P31, DOI 10.1016/j.biochi.2013.12.010; Thorn A, 2008, J BIOL CHEM, V283, P17260, DOI 10.1074/jbc.M706185200; Tundis R, 2008, MINI-REV MED CHEM, V8, P399, DOI 10.2174/138955708783955926; Viljoen A, 2012, CURR MED CHEM, V19, P2104; Winberg JO, 1999, J MOL BIOL, V294, P601, DOI 10.1006/jmbi.1999.3235; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2	35	47	47	2	64	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2016	12	1					6	+		10.1038/nchembio.1955	http://dx.doi.org/10.1038/nchembio.1955			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY8QW	26551396	Green Accepted			2022-12-25	WOS:000366674400004
J	Muller, NA; Wijnen, CL; Srinivasan, A; Ryngajllo, M; Ofner, I; Lin, T; Ranjan, A; West, D; Maloof, JN; Sinha, NR; Huang, SW; Zamir, D; Jimenez-Gomez, JM				Mueller, Niels A.; Wijnen, Cris L.; Srinivasan, Arunkumar; Ryngajllo, Malgorzata; Ofner, Itai; Lin, Tao; Ranjan, Aashish; West, Donnelly; Maloof, Julin N.; Sinha, Neelima R.; Huang, Sanwen; Zamir, Dani; Jimenez-Gomez, Jose M.			Domestication selected for deceleration of the circadian clock in cultivated tomato	NATURE GENETICS			English	Article							NATURAL VARIATION; READ ALIGNMENT; ADAPTATION; GENE; PHOTOPERIOD; MUTATION; FITNESS; GENOME; LIGHT; POPULATION	The circadian clock is a critical regulator of plant physiology and development, controlling key agricultural traits in crop plants(1). In addition, natural variation in circadian rhythms is important for local adaptation(2-4). However, quantitative modulation of circadian rhythms due to artificial selection has not yet been reported. Here we show that the circadian clock of cultivated tomato (Solanum lycopersicum) has slowed during domestication. Allelic variation of the tomato homolog of the Arabidopsis gene EID1 is responsible for a phase delay. Notably, the genomic region harboring EID1 shows signatures of a selective sweep. We find that the EID1 allele in cultivated tomatoes enhances plant performance specifically under long day photoperiods, suggesting that humans selected slower circadian rhythms to adapt the cultivated species to the long summer days it encountered as it was moved away from the equator.	[Mueller, Niels A.; Wijnen, Cris L.; Srinivasan, Arunkumar; Ryngajllo, Malgorzata; Jimenez-Gomez, Jose M.] Max Planck Inst Plant Breeding Res, Dept Plant Breeding & Genet, Cologne, Germany; [Ofner, Itai; Zamir, Dani] Hebrew Univ Jerusalem, Inst Plant Sci, IL-76100 Rehovot, Israel; [Lin, Tao; Huang, Sanwen] Chinese Acad Agr Sci, Key Lab Biol & Genet Improvement Hort Crops, Sinodutch Joint Lab Hort Genom, Minist Agr,Inst Vegetables & Flowers, Beijing 100193, Peoples R China; [Lin, Tao; Huang, Sanwen] Chinese Acad Agr Sci, Agr Genom Inst Shenzhen, Shenzhen, Peoples R China; [Ranjan, Aashish; West, Donnelly; Maloof, Julin N.; Sinha, Neelima R.] Univ Calif Davis, Dept Plant Biol, Davis, CA 95616 USA; [Jimenez-Gomez, Jose M.] Univ Paris Saclay, CNRS, AgroParisTech, Inst Jean Pierre Bourgin,INRA, Versailles, France	Max Planck Society; Hebrew University of Jerusalem; Chinese Academy of Agricultural Sciences; Institute of Vegetables & Flowers, CAAS; Ministry of Agriculture & Rural Affairs; Chinese Academy of Agricultural Sciences; Agriculture Genomes Institute at Shenzhen, CAAS; University of California System; University of California Davis; AgroParisTech; Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Paris Saclay	Jimenez-Gomez, JM (corresponding author), Max Planck Inst Plant Breeding Res, Dept Plant Breeding & Genet, Cologne, Germany.	jmjimenez@mpipz.mpg.de	Ryngajłło, Małgorzata/M-2959-2018; Huang, Sanwen/ABE-9053-2020	Ryngajłło, Małgorzata/0000-0002-0430-0102; Huang, Sanwen/0000-0002-8547-5309; Jimenez-Gomez, Jose M/0000-0002-5033-7192; Ranjan, Aashish/0000-0003-3447-4442; Muller, Niels A./0000-0001-5213-042X	Max Planck Society; German Research Foundation under the German-Israeli Project Cooperation program (DFG DIP project) [FE552/12-1]	Max Planck Society(Max Planck Society); German Research Foundation under the German-Israeli Project Cooperation program (DFG DIP project)(German Research Foundation (DFG))	We thank M. Koornneef and A. de Montaigu for helpful discussions and critical reading of the manuscript, U. Tartler and M. Pohe for technical assistance, members of the department, members of the Plan Breeding and Genetics Department at the Max Planck Institute for Plant Breeding Research and S.J. Davis for comments and advice, E.M. Willing for technical advice, and A.W. van Heusden for providing seeds and genotype information for the S. pimpinellifolium RIL population. We acknowledge funding from a core grant from the Max Planck Society. N.A.M., A.S. and C.L.W. were funded from a core grant from the Max Planck Society. M.R. was supported by funding from the German Research Foundation under the German-Israeli Project Cooperation program (DFG DIP project number FE552/12-1 awarded to J.M.J.-G.). D.Z. received a European Research Council Advanced grant (YIELD).	Aflitos S, 2014, PLANT J, V80, P136, DOI 10.1111/tpj.12616; Beaver LM, 2002, P NATL ACAD SCI USA, V99, P2134, DOI 10.1073/pnas.032426699; Blanca J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048198; Bolger A, 2014, NAT GENET, V46, P1034, DOI 10.1038/ng.3046; Broman KW, 2009, STAT BIOL HEALTH, P1, DOI 10.1007/978-0-387-92125-9_1; Campoli C, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-97; Chitwood DH, 2013, PLANT CELL, V25, P2465, DOI 10.1105/tpc.113.112391; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dieterle M, 2001, GENE DEV, V15, P939, DOI 10.1101/gad.197201; Dodd AN, 2005, SCIENCE, V309, P630, DOI 10.1126/science.1115581; Edgar RS, 2012, NATURE, V485, P459, DOI 10.1038/nature11088; ESHED Y, 1995, GENETICS, V141, P1147; Exposito-Rodriguez M, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-131; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Faure S, 2012, P NATL ACAD SCI USA, V109, P8328, DOI 10.1073/pnas.1120496109; Filichkin SA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016907; Gao H, 2014, P NATL ACAD SCI USA, V111, P16337, DOI 10.1073/pnas.1418204111; Green RM, 2002, PLANT PHYSIOL, V129, P576, DOI 10.1104/pp.004374; Hayden N., RSAMTOOLS BINARY ALI; Hsu PY, 2014, TRENDS PLANT SCI, V19, P240, DOI 10.1016/j.tplants.2013.11.007; Joshi DS, 1999, CAN J ZOOL, V77, P865, DOI 10.1139/cjz-77-6-865; Kazmi RH, 2012, PLANT CELL ENVIRON, V35, P929, DOI 10.1111/j.1365-3040.2011.02463.x; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Koenig D, 2013, P NATL ACAD SCI USA, V110, pE2655, DOI 10.1073/pnas.1309606110; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Lawrence M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003118; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lin T, 2014, NAT GENET, V46, P1220, DOI 10.1038/ng.3117; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Markwell J, 1995, PHOTOSYNTH RES, V46, P467, DOI 10.1007/BF00032301; McClung C Robertson, 2014, F1000Prime Rep, V6, P2, DOI 10.12703/P6-2; MCCORMICK S, 1986, PLANT CELL REP, V5, P81, DOI 10.1007/BF00269239; Michael TP, 2003, SCIENCE, V302, P1049, DOI 10.1126/science.1082971; Monson-Miller J, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-72; Murphy RL, 2011, P NATL ACAD SCI USA, V108, P16469, DOI 10.1073/pnas.1106212108; Nagel DH, 2012, CURR BIOL, V22, pR648, DOI 10.1016/j.cub.2012.07.025; Nakagawa T, 2007, J BIOSCI BIOENG, V104, P34, DOI 10.1263/jbb.104.34; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pin PA, 2012, CURR BIOL, V22, P1095, DOI 10.1016/j.cub.2012.04.007; PITTENDRIGH CS, 1989, J BIOL RHYTHM, V4, P217; Plautz JD, 1997, J BIOL RHYTHM, V12, P204, DOI 10.1177/074873049701200302; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Salathia N, 2007, THEOR APPL GENET, V114, P683, DOI 10.1007/s00122-006-0468-y; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Somers DE, 1998, SCIENCE, V282, P1488, DOI 10.1126/science.282.5393.1488; Turner A, 2005, SCIENCE, V310, P1031, DOI 10.1126/science.1117619; Velez-Ramirez AI, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5549; Velez-Ramirez AI, 2011, TRENDS PLANT SCI, V16, P310, DOI 10.1016/j.tplants.2011.02.003; Weller JL, 2012, P NATL ACAD SCI USA, V109, P21158, DOI 10.1073/pnas.1207943110; Woelfle MA, 2004, CURR BIOL, V14, P1481, DOI 10.1016/j.cub.2004.08.023; Yang R, 2010, BIOINFORMATICS, V26, pi168, DOI 10.1093/bioinformatics/btq189; Zakhrabekova S, 2012, P NATL ACAD SCI USA, V109, P4326, DOI 10.1073/pnas.1113009109	53	107	111	5	151	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2016	48	1					89	+		10.1038/ng.3447	http://dx.doi.org/10.1038/ng.3447			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CZ7BQ	26569124				2022-12-25	WOS:000367255300019
J	Osorio, FG; Soria-Valles, C; Santiago-Fernandez, O; Bernal, T; Mittelbrunn, M; Colado, E; Rodriguez, F; Bonzon-Kulichenko, E; Vazquez, J; Porta-de-la-Riva, M; Ceron, J; Fueyo, A; Li, J; Green, AR; Freije, JMP; Lopez-Otin, C				Osorio, Fernando G.; Soria-Valles, Clara; Santiago-Fernandez, Olaya; Bernal, Teresa; Mittelbrunn, Maria; Colado, Enrique; Rodriguez, Francisco; Bonzon-Kulichenko, Elena; Vazquez, Jesus; Porta-de-la-Riva, Montserrat; Ceron, Julian; Fueyo, Antonio; Li, Juan; Green, Anthony R.; Freije, Jose M. P.; Lopez-Otin, Carlos			Loss of the proteostasis factor AIRAPL causes myeloid transformation by deregulating IGF-1 signaling	NATURE MEDICINE			English	Article							TYROSINE KINASE JAK2; POLYCYTHEMIA-VERA; MYELOPROLIFERATIVE NEOPLASMS; HEMATOPOIETIC STEM; MUTATIONS; INSULIN; DISEASE; STRESS; CELLS; CANCER	AIRAPL (arsenite-inducible RNA-associated protein-like) is an evolutionarily conserved regulator of cellular proteostasis linked to longevity in nematodes, but its biological function in mammals is unknown(1-3). We show herein that AIRAPL-deficient mice develop a fully-penetrant myeloproliferative neoplastic process. Proteomic analysis of AIRAPL-deficient mice revealed that this protein exerts its antineoplastic function through the regulation of the insulin/insulin-like growth factor 1 (IGF-1) signaling pathway. We demonstrate that AIRAPL interacts with newly synthesized insulin-related growth factor-1 receptor (IGF1R) polypeptides, promoting their ubiquitination and proteasome-mediated degradation. Accordingly, genetic and pharmacological IGF1R inhibitory strategies prevent the hematological disease found in AIRAPL-deficient mice as well as that in mice carrying the Jak2(V617F) mutation, thereby demonstrating the causal involvement of this pathway in the pathogenesis of myeloproliferative neoplasms(4-6). Consistent with its proposed role as a tumor suppressor of myeloid transformation, AIRAPL expression is widely abrogated in human myeloproliferative disorders. Collectively, these findings support the oncogenic relevance of proteostasis deregulation in hematopoietic cells, and they unveil novel therapeutic targets for these frequent hematological neoplasias.	[Osorio, Fernando G.; Soria-Valles, Clara; Santiago-Fernandez, Olaya; Bernal, Teresa; Mittelbrunn, Maria; Rodriguez, Francisco; Freije, Jose M. P.; Lopez-Otin, Carlos] Univ Oviedo, Inst Univ Oncol IUOPA, Fac Med, Dept Bioquim & Biol Mol, Oviedo, Spain; [Bernal, Teresa; Colado, Enrique] Hosp Univ Cent Asturias, Serv Hematol, Oviedo, Spain; [Mittelbrunn, Maria] Hosp 12 Octubre i 12, Inst Invest Sanitaria, Madrid, Spain; [Mittelbrunn, Maria] Univ Autonoma Madrid, Fac Med, Dept Bioquim, Madrid, Spain; [Bonzon-Kulichenko, Elena; Vazquez, Jesus] Ctr Nacl Invest Cardiovasc, Lab Cardiovasc Prote, Madrid, Spain; [Porta-de-la-Riva, Montserrat; Ceron, Julian] Bellvitge Biomed Res Inst IDIBELL, Area Canc & Human Mol Genet, Barcelona, Spain; [Porta-de-la-Riva, Montserrat] Bellvitge Biomed Res Inst IDIBELL, Caenorhabditis Elegans Facil, Barcelona, Spain; [Fueyo, Antonio] Univ Oviedo, Fac Med, Dept Biol Func, Area Fisiol, Oviedo, Spain; [Li, Juan; Green, Anthony R.] Univ Cambridge, Stem Cell Inst, Wellcome Trust Med Res Council, Cambridge, England; [Li, Juan; Green, Anthony R.] Univ Cambridge, Dept Haematol, Cambridge, England; [Green, Anthony R.] Addenbrookes Hosp, Dept Haematol, Cambridge CB2 2QQ, England	University of Oviedo; Instituto Universitario de Oncologia de Asturias; Central University Hospital Asturias; Hospital Universitario 12 de Octubre; Autonomous University of Madrid; Centro Nacional de Investigaciones Cardiovasculares (CNIC); Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Oviedo; University of Cambridge; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Lopez-Otin, C (corresponding author), Univ Oviedo, Inst Univ Oncol IUOPA, Fac Med, Dept Bioquim & Biol Mol, Oviedo, Spain.	jmpf@uniovi.es; clo@uniovi.es	Santiago-Fernández, Olaya/AAP-4039-2021; Vazquez, Jesus/B-7697-2015; Bonzon-Kulichenko, Elena/R-4208-2018; Fueyo, Antonio/ABH-3243-2020; Freije, José M.P./A-6535-2008; Mittelbrunn, Maria/I-5882-2015; Mittelbrunn, Maria/J-9146-2019; Colado, Enrique/Z-6326-2019; López-Otín, Carlos/AAB-2106-2020; Colado, Enrique/GXF-7705-2022; Bernal, Teresa/AAS-9731-2021; ceron, julian/AAA-8008-2019	Santiago-Fernández, Olaya/0000-0002-5933-3104; Vazquez, Jesus/0000-0003-1461-5092; Bonzon-Kulichenko, Elena/0000-0003-0852-7520; Fueyo, Antonio/0000-0002-7121-9398; Freije, José M.P./0000-0002-4688-8266; Mittelbrunn, Maria/0000-0003-3487-8762; Mittelbrunn, Maria/0000-0003-3487-8762; Colado, Enrique/0000-0001-8675-8207; López-Otín, Carlos/0000-0001-6964-1904; Bernal, Teresa/0000-0002-2338-513X; Ceron, Julian/0000-0003-4739-2243	Ministerio de Economia y Competitividad; Instituto de Salud Carlos III (RTICC); Principado de Asturias, Spain; Fundacion Bancaria Caja de Ahorros de Asturias; Banco Santander through its Santander Universities Global Division; Bloodwise [13003]; Wellcome Trust [104710/Z/14/Z]; Medical Research Council; Kay Kendall Leukaemia Fund; Cambridge National Institute for Health Research Biomedical Research Center; Cambridge Experimental Cancer Medicine Centre; Leukemia and Lymphoma Society of America [07037]; Wellcome Trust	Ministerio de Economia y Competitividad(Spanish Government); Instituto de Salud Carlos III (RTICC)(Instituto de Salud Carlos III); Principado de Asturias, Spain(Principality of Asturias); Fundacion Bancaria Caja de Ahorros de Asturias; Banco Santander through its Santander Universities Global Division; Bloodwise; Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Kay Kendall Leukaemia Fund; Cambridge National Institute for Health Research Biomedical Research Center; Cambridge Experimental Cancer Medicine Centre; Leukemia and Lymphoma Society of America(Leukemia and Lymphoma Society); Wellcome Trust(Wellcome Trust)	We thank A. A. Ferrando, D.A. Puente, A.R. Folgueras, G.R. Ordonez, I. Martin-Subero, A. Gutierrez-Fernandez, G. Marino and E. Luno for advice. We also thank S. Jeay (Novartis Pharma AG, Basel Area, Switzerland; NVP-AEW541), M. Holzenberger (Faculte de medecine Pierre et Marie Curie, Paris; Igf1r-haploinsuficient mice), M.J. Munoz Ruiz (Universidad Pablo de Olavide, Sevilla; GM6 C. elegans strain) and F.G. Wulczyn (Universitatsmedizin Berlin, Berlin; miR-125a sponge) for providing reagents. We thank A. Moyano and R. Feijoo for excellent technical assistance, and the Servicio de Histopatologia (IUOPA) for histological studies. This work was supported by grants from Ministerio de Economia y Competitividad (C.L.-O.), Instituto de Salud Carlos III (RTICC) (C.L.-O.), and Principado de Asturias, Spain (J.M.P.F). We also thank the generous support by J. I. Cabrera, A. I. Campos and M. Secades. The Instituto Universitario de Oncologia is supported by Fundacion Bancaria Caja de Ahorros de Asturias. C.L.-O. is an Investigator of the Botin Foundation supported by Banco Santander through its Santander Universities Global Division. Work in the Green laboratory is supported by Bloodwise (grant ref. 13003), the Wellcome Trust (grant ref. 104710/Z/14/Z), the Medical Research Council, the Kay Kendall Leukaemia Fund, the Cambridge National Institute for Health Research Biomedical Research Center, the Cambridge Experimental Cancer Medicine Centre, the Leukemia and Lymphoma Society of America (grant ref. 07037), and a core support grant from the Wellcome Trust and the Medical Research Council to the Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute.	Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; Braunstein I, 2015, MOL BIOL CELL, V26, P3719, DOI 10.1091/mbc.E15-02-0085; Campbell PJ, 2006, NEW ENGL J MED, V355, P2452, DOI 10.1056/NEJMra063728; Ferguson AA, 2010, MOL CELL BIOL, V30, P2651, DOI 10.1128/MCB.01340-09; Gallagher EJ, 2011, ENDOCRINOLOGY, V152, P2546, DOI 10.1210/en.2011-0231; Garcia-Echeverria C, 2004, CANCER CELL, V5, P231, DOI 10.1016/S1535-6108(04)00051-0; Glinka Tal, 2014, Biochem J, V457, P253, DOI 10.1042/BJ20130710; Guo SQ, 2012, P NATL ACAD SCI USA, V109, P16636, DOI 10.1073/pnas.1213196109; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Hassan WM, 2009, HUM MOL GENET, V18, P2739, DOI 10.1093/hmg/ddp209; Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298; Inoue D, 2013, J CLIN INVEST, V123, P4627, DOI 10.1172/JCI70739; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Kamath RS, 2003, METHODS, V30, P313, DOI 10.1016/S1046-2023(03)00050-1; Kang SW, 2006, CELL, V127, P999, DOI 10.1016/j.cell.2006.10.032; Khatib AM, 2001, J BIOL CHEM, V276, P30686, DOI 10.1074/jbc.M101725200; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Klampfl T, 2013, NEW ENGL J MED, V369, P2379, DOI 10.1056/NEJMoa1311347; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Levine RL, 2008, BLOOD, V112, P2190, DOI 10.1182/blood-2008-03-077966; Li J, 2014, BLOOD, V123, P3139, DOI 10.1182/blood-2013-06-510222; Li JA, 2010, BLOOD, V116, P1528, DOI 10.1182/blood-2009-12-259747; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Lovly CM, 2014, NAT MED, V20, P1027, DOI 10.1038/nm.3667; Meyer SC, 2015, CANCER CELL, V28, P15, DOI 10.1016/j.ccell.2015.06.006; Mullally A, 2013, BLOOD, V121, P3692, DOI 10.1182/blood-2012-05-432989; Nangalia J, 2013, NEW ENGL J MED, V369, P2391, DOI 10.1056/NEJMoa1312542; Norfo R, 2014, BLOOD, V124, pE21, DOI 10.1182/blood-2013-12-544197; Pollak M, 2008, NAT REV CANCER, V8, P915, DOI 10.1038/nrc2536; Porta-de-la-Riva M, 2012, JOVE-J VIS EXP, DOI 10.3791/4019; Puente XS, 2015, NATURE, V526, P519, DOI 10.1038/nature14666; Renehan AG, 2004, LANCET, V363, P1346, DOI 10.1016/S0140-6736(04)16044-3; Rual JF, 2004, GENOME RES, V14, P2162, DOI 10.1101/gr.2505604; Rybak A, 2008, NAT CELL BIOL, V10, P987, DOI 10.1038/ncb1759; Scott LM, 2007, NEW ENGL J MED, V356, P459, DOI 10.1056/NEJMoa065202; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; Soria-Valles C, 2015, NAT CELL BIOL, V17, P1004, DOI 10.1038/ncb3207; Tefferi A, 2011, J CLIN ONCOL, V29, P573, DOI 10.1200/JCO.2010.29.8711; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Villarroya-Beltri C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3980; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wernig G, 2006, BLOOD, V107, P4274, DOI 10.1182/blood-2005-12-4824; Yildirim E, 2013, CELL, V152, P727, DOI 10.1016/j.cell.2013.01.034; Yun C, 2008, P NATL ACAD SCI USA, V105, P7094, DOI 10.1073/pnas.0707025105; Zhou T, 2015, BLOOD, V126, P1057, DOI 10.1182/blood-2015-01-624239	48	25	32	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2016	22	1					91	+		10.1038/nm.4013	http://dx.doi.org/10.1038/nm.4013			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DA1YA	26692333				2022-12-25	WOS:000367590700020
J	Sun, SY; Shi, GJ; Sha, HB; Ji, YW; Han, XM; Shu, X; Ma, HM; Inoue, T; Gao, BX; Kim, H; Bu, PC; Guber, RD; Shen, XL; Lee, AH; Iwawaki, T; Paton, AW; Paton, JC; Fang, DY; Tsai, B; Yates, JR; Wu, HQ; Kersten, S; Long, QM; Duhamel, GE; Simpson, KW; Qi, L				Sun, Shengyi; Shi, Guojun; Sha, Haibo; Ji, Yewei; Han, Xuemei; Shu, Xin; Ma, Hongming; Inoue, Takamasa; Gao, Beixue; Kim, Hana; Bu, Pengcheng; Guber, Robert D.; Shen, Xiling; Lee, Ann-Hwee; Iwawaki, Takao; Paton, Adrienne W.; Paton, James C.; Fang, Deyu; Tsai, Billy; Yates, John R., III; Wu, Haoquan; Kersten, Sander; Long, Qiaoming; Duhamel, Gerald E.; Simpson, Kenneth W.; Qi, Ling			IRE1 alpha is an endogenous substrate of endoplasmic-reticulum-associated degradation	NATURE CELL BIOLOGY			English	Article							UNFOLDED-PROTEIN RESPONSE; ER-ASSOCIATED DEGRADATION; MISFOLDED GLYCOPROTEINS; UBIQUITIN-LIGASE; INTESTINAL INFLAMMATION; TRANSMEMBRANE PROTEIN; CHAPERONE BIP; STRESS; PATHWAY; SEL1L	Endoplasmic reticulum (ER)-associated degradation (ERAD) represents a principle quality control mechanism to clear misfolded proteins in the ER; however, its physiological significance and the nature of endogenous ERAD substrates remain largely unexplored. Here we discover that IRE1 alpha, the sensor of the unfolded protein response (UPR), is a bona fide substrate of the Sel1L-Hrdl ERAD complex. ERAD-mediated IRE1 alpha degradation occurs under basal conditions in a BiP-dependent manner, requires both the intramembrane hydrophilic residues of IRE1 alpha and the lectin protein OS9, and is attenuated by ER stress. ERAD deficiency causes IRE1 alpha protein stabilization, accumulation and mild activation both in vitro and in vivo. Although enterocyte-specific Sel1L-knockout mice (Se/1L(Delta IEC)) are viable and seem normal, they are highly susceptible to experimental colitis and inflammation-associated dysbiosis, in an IRE1 alpha-dependent but CHOP-independent manner. Hence, Sel1L-Hrdl ERAD serves a distinct, essential function in restraint of IRE1 alpha signalling in vivo by managing its protein turnover.	[Sun, Shengyi; Qi, Ling] Cornell Univ, Grad Program Biochem Mol & Cell Biol, Ithaca, NY 14853 USA; [Shi, Guojun; Sha, Haibo; Ji, Yewei; Shu, Xin; Kim, Hana; Guber, Robert D.; Qi, Ling] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA; [Han, Xuemei; Yates, John R., III] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Ma, Hongming; Wu, Haoquan] Texas Tech Univ, Hlth Sci Ctr, Paul L Foster Sch Med, Dept Biomed Sci, El Paso, TX 79905 USA; [Inoue, Takamasa; Tsai, Billy] Univ Michigan, Sch Med, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA; [Gao, Beixue; Fang, Deyu] Northwestern Univ, Dept Pathol, Chicago, IL 60611 USA; [Bu, Pengcheng; Shen, Xiling] Cornell Univ, Dept Elect & Comp Engn, Ithaca, NY 14853 USA; [Bu, Pengcheng; Shen, Xiling] Cornell Univ, Dept Biomed Engn, Ithaca, NY 14853 USA; [Shen, Xiling] Duke Univ, Dept Biomed Engn, Durham, NC 27708 USA; [Lee, Ann-Hwee] Weill Cornell Med Coll, Dept Pathol & Lab Med, New York, NY 10021 USA; [Iwawaki, Takao] Gunma Univ, Grad Sch Med, Educ & Res Support Ctr, Maebashi, Gunma 3718511, Japan; [Paton, Adrienne W.; Paton, James C.] Univ Adelaide, Sch Mol & Biomed Sci, Res Ctr Infect Dis, Adelaide, SA 5005, Australia; [Kersten, Sander] Wageningen Univ, Nutr Metab & Gen Grp, NL-6703 HD Wageningen, Netherlands; [Long, Qiaoming] Soochow Univ, Coll Med, Lab Anim Res Ctr, Suzhou 215006, Jiangsu, Peoples R China; [Duhamel, Gerald E.] Cornell Univ, Coll Vet Med, Dept Biomed Sci, Ithaca, NY 14853 USA; [Simpson, Kenneth W.] Cornell Univ, Coll Vet Med, Dept Clin Sci, Ithaca, NY 14853 USA	Cornell University; Cornell University; Scripps Research Institute; Texas Tech University System; Texas Tech University; University of Michigan System; University of Michigan; Northwestern University; Cornell University; Cornell University; Duke University; Cornell University; Gunma University; University of Adelaide; Wageningen University & Research; Soochow University - China; Cornell University; Cornell University	Long, QM (corresponding author), Soochow Univ, Coll Med, Lab Anim Res Ctr, Suzhou 215006, Jiangsu, Peoples R China.	qmlong@suda.edu.cn; lq35@cornell.edu	Shi, Guojun/F-4491-2018; Kersten, Sander/A-1116-2011; Long, Qiaoming/L-5074-2017	Shi, Guojun/0000-0002-3098-6662; Kersten, Sander/0000-0003-4488-7734; Long, Qiaoming/0000-0001-8243-589X; Bu, Pengcheng/0000-0002-3208-0354; Wu, Haoquan/0000-0001-9386-3187; Qi, Ling/0000-0001-8229-0184; Sun, Shengyi/0000-0002-1734-3902	American Diabetes Association; Chinese National Natural Science Foundation [31371391]; National Heart, Lung, and Blood Institute Proteomics Center [HHSN268201000035C, R01 MH067880, 8P41GM103533-17]; NIH of the Clinical and Translation Science Center at Weill Cornell Medical College [R01DK105393, R01GM113188, UL1TR000457]; ADA [1-12-CD-04]; Cornell VERG seed grant;  [59107338];  [R21AI085332];  [1R03AI114344]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000457] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI108634, R03AI114344, R01AI079056, R21AI085332] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR066634] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK105393] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103533, R01GM113188] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067880] Funding Source: NIH RePORTER	American Diabetes Association(American Diabetes Association); Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National Heart, Lung, and Blood Institute Proteomics Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH of the Clinical and Translation Science Center at Weill Cornell Medical College; ADA(American Diabetes Association); Cornell VERG seed grant; ; ; ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank K.-L. Tung for help with the organoid culture; and other members of the Qi laboratory for comments and technical assistance. S.S. is an International Student Research Fellow of the Howard Hughes Medical Institute (59107338). L.Q. is the recipient of the Junior Faculty and Career Development Awards from American Diabetes Association (ADA). This work was supported by R21AI085332 (G.E.D.), 1R03AI114344 (H.W.), Chinese National Natural Science Foundation Grant 31371391 (Q.L.), National Heart, Lung, and Blood Institute Proteomics Center Award HHSN268201000035C, R01 MH067880 and 8P41GM103533-17 (J.R.Y. III), NIH R01DK105393, R01GM113188, UL1TR000457 of the Clinical and Translation Science Center at Weill Cornell Medical College, ADA 1-12-CD-04 and Cornell VERG seed grant (L.Q.).	Adolph TE, 2013, NATURE, V503, P272, DOI 10.1038/nature12599; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Bhamidipati A, 2005, MOL CELL, V19, P741, DOI 10.1016/j.molcel.2005.07.027; Brodsky JL, 1999, J BIOL CHEM, V274, P3453, DOI 10.1074/jbc.274.6.3453; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; Christianson JC, 2012, NAT CELL BIOL, V14, P93, DOI 10.1038/ncb2383; COX JS, 1993, CELL, V73, P1197, DOI 10.1016/0092-8674(93)90648-A; Craven M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041594; Dogan B, 2014, INFLAMM BOWEL DIS, V20, P1919, DOI 10.1097/MIB.0000000000000183; Gardner RG, 2000, J CELL BIOL, V151, P69, DOI 10.1083/jcb.151.1.69; Gething MJ, 1999, SEMIN CELL DEV BIOL, V10, P465, DOI 10.1006/scdb.1999.0318; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Guerriero CJ, 2012, PHYSIOL REV, V92, P537, DOI 10.1152/physrev.00027.2011; Hampton RY, 1996, MOL BIOL CELL, V7, P2029, DOI 10.1091/mbc.7.12.2029; He Y, 2010, GENE EXPRESSION, V15, P13, DOI 10.3727/105221610X12819686555051; Kaser A, 2008, CELL, V134, P743, DOI 10.1016/j.cell.2008.07.021; Kikkert M, 2004, J BIOL CHEM, V279, P3525, DOI 10.1074/jbc.M307453200; Kim W, 2005, MOL CELL, V19, P753, DOI 10.1016/j.molcel.2005.08.010; MORI K, 1993, CELL, V74, P743; Mueller B, 2008, P NATL ACAD SCI USA, V105, P12325, DOI 10.1073/pnas.0805371105; Mueller B, 2006, J CELL BIOL, V175, P261, DOI 10.1083/jcb.200605196; OKAYASU I, 1990, GASTROENTEROLOGY, V98, P694, DOI 10.1016/0016-5085(90)90290-H; Okuda-Shimizu Y, 2007, MOL CELL, V28, P544, DOI 10.1016/j.molcel.2007.09.012; Olzmann JA, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013185; Park SW, 2009, P NATL ACAD SCI USA, V106, P6950, DOI 10.1073/pnas.0808722106; Paton AW, 2006, NATURE, V443, P548, DOI 10.1038/nature05124; Plemper R. K., 1997, NATURE, V388, P891; Plemper RK, 1999, J CELL SCI, V112, P4123; Qi L, 2011, METHOD ENZYMOL, V490, P137, DOI 10.1016/B978-0-12-385114-7.00008-8; Redl H., 2013, CYTOKINES SEVERE SEP; Sato BK, 2009, MOL CELL, V34, P212, DOI 10.1016/j.molcel.2009.03.010; Sha HB, 2014, CELL METAB, V20, P458, DOI 10.1016/j.cmet.2014.06.015; Sha HB, 2009, CELL METAB, V9, P556, DOI 10.1016/j.cmet.2009.04.009; Sun SY, 2014, P NATL ACAD SCI USA, V111, pE582, DOI 10.1073/pnas.1318114111; Ushroda R., 2013, MOL BIOL CELL, V24, P3155; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Xue Z, 2011, J BIOL CHEM, V286, P30859, DOI 10.1074/jbc.M111.273714; Yang L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011621; Zhang T, 2014, DNA CELL BIOL, V33, P477, DOI 10.1089/dna.2014.2452; Zhao F, 2010, DEV BIOL, V338, P268, DOI 10.1016/j.ydbio.2009.12.008; Zhou JH, 2006, P NATL ACAD SCI USA, V103, P14343, DOI 10.1073/pnas.0606480103	41	118	120	2	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2015	17	12					1546	1555		10.1038/ncb3266	http://dx.doi.org/10.1038/ncb3266			10	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CX8DH	26551274	Green Accepted			2022-12-25	WOS:000365932300007
J	Valentijn, LJ; Koster, J; Zwijnenburg, DA; Hasselt, NE; van Sluis, P; Volckmann, R; van Noesel, MM; George, RE; Tytgat, GAM; Molenaar, JJ; Versteeg, R				Valentijn, Linda J.; Koster, Jan; Zwijnenburg, Danny A.; Hasselt, Nancy E.; van Sluis, Peter; Volckmann, Richard; van Noesel, Max M.; George, Rani E.; Tytgat, Godelieve A. M.; Molenaar, Jan J.; Versteeg, Rogier			TERT rearrangements are frequent in neuroblastoma and identify aggressive tumors	NATURE GENETICS			English	Article							PROMOTER MUTATIONS; TRANSCRIPTION; LANDSCAPE	Whole-genome sequencing detected structural rearrangements of TERT in 17 of 75 high-stage neuroblastomas, with five cases resulting from chromothripsis. Rearrangements were associated with increased TERT expression and targeted regions immediately up-and downstream of TERT, positioning a super-enhancer close to the breakpoints in seven cases. TERT rearrangements (23%), ATRX deletions (11%) and MYCN amplifications (37%) identify three almost non-overlapping groups of high-stage neuroblastoma, each associated with very poor prognosis.	[Valentijn, Linda J.; Koster, Jan; Zwijnenburg, Danny A.; Hasselt, Nancy E.; van Sluis, Peter; Volckmann, Richard; Molenaar, Jan J.; Versteeg, Rogier] Univ Amsterdam, Acad Med Ctr, Dept Oncogen, NL-1105 AZ Amsterdam, Netherlands; [van Noesel, Max M.; Tytgat, Godelieve A. M.] Princess Maxima Ctr Pediat Oncol, Utrecht, Netherlands; [George, Rani E.] Dana Farber Canc Inst, Dept Pediat Hematol Oncol, Boston, MA 02115 USA; [George, Rani E.] Boston Childrens Hosp, Boston, MA USA; [George, Rani E.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Tytgat, Godelieve A. M.] Univ Amsterdam, Acad Med Ctr, Dept Pediat Oncol, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Harvard University; Dana-Farber Cancer Institute; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; University of Amsterdam; Academic Medical Center Amsterdam	Versteeg, R (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Oncogen, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	r.versteeg@amc.uva.nl	Koster, Jan/C-5934-2008; Versteeg, Rogier/AAQ-1765-2020; George, Rani/AAG-7635-2019; tytgat, g/ABF-6481-2020	Koster, Jan/0000-0002-0890-7585; Versteeg, Rogier/0000-0001-7172-0388; Tytgat, Lieve/0000-0003-4452-0748; Zwijnenburg, Danny/0000-0002-9353-8904	Villa Joep Foundation; Children Cancer-Free Foundation; KWF/Netherlands Cancer Foundation; European Union European Research Council (ERC) Advanced grant	Villa Joep Foundation; Children Cancer-Free Foundation; KWF/Netherlands Cancer Foundation; European Union European Research Council (ERC) Advanced grant	This study was supported by grants from the Villa Joep Foundation, the Children Cancer-Free Foundation (KIKA) and the KWF/Netherlands Cancer Foundation and by a European Union European Research Council (ERC) Advanced grant to R. Versteeg.	Bell RJA, 2015, SCIENCE, V348, P1036, DOI 10.1126/science.aab0015; Cheung NKV, 2012, JAMA-J AM MED ASSOC, V307, P1062, DOI 10.1001/jama.2012.228; Chipumuro E, 2014, CELL, V159, P1126, DOI 10.1016/j.cell.2014.10.024; Davis CF, 2014, CANCER CELL, V26, P319, DOI 10.1016/j.ccr.2014.07.014; Eckel-Passow JE, 2015, NEW ENGL J MED, V372, P2499, DOI 10.1056/NEJMoa1407279; Heaphy CM, 2011, SCIENCE, V333, P425, DOI 10.1126/science.1207313; Horn S, 2013, SCIENCE, V339, P959, DOI 10.1126/science.1230062; Huang FW, 2013, SCIENCE, V339, P957, DOI 10.1126/science.1229259; Killela PJ, 2013, P NATL ACAD SCI USA, V110, P6021, DOI 10.1073/pnas.1303607110; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Lindner S, 2015, BIOMED REP, V3, P443, DOI 10.3892/br.2015.463; Molenaar JJ, 2012, NATURE, V483, P589, DOI 10.1038/nature10910; Pugh TJ, 2013, NAT GENET, V45, P279, DOI 10.1038/ng.2529; Sausen M, 2013, NAT GENET, V45, P12, DOI 10.1038/ng.2493; Zhao YJ, 2014, NUCLEIC ACIDS RES, V42, P10385, DOI 10.1093/nar/gku721; Zhao YJ, 2009, GENE CHROMOSOME CANC, V48, P963, DOI 10.1002/gcc.20698	16	222	226	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2015	47	12					1411	+		10.1038/ng.3438	http://dx.doi.org/10.1038/ng.3438			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CX6LT	26523776				2022-12-25	WOS:000365813200012
J	Wen, QJ; Yang, Q; Goldenson, B; Malinge, S; Lasho, T; Schneider, RK; Breyfogle, LJ; Schultz, R; Gilles, L; Koppikar, P; Abdel-Wahab, O; Pardanani, A; Stein, B; Gurbuxani, S; Mullally, A; Levine, RL; Tefferi, A; Crispino, JD				Wen, Qiang Jeremy; Yang, Qiong; Goldenson, Benjamin; Malinge, Sebastien; Lasho, Terra; Schneider, Rebekka K.; Breyfogle, Lawrence J.; Schultz, Rachael; Gilles, Laure; Koppikar, Priya; Abdel-Wahab, Omar; Pardanani, Animesh; Stein, Brady; Gurbuxani, Sandeep; Mullally, Ann; Levine, Ross L.; Tefferi, Ayalew; Crispino, John D.			Targeting megakaryocytic-induced fibrosis in myeloproliferative neoplasms by AURKA inhibition	NATURE MEDICINE			English	Article							HEMATOPOIETIC STEM; BONE-MARROW; AURORA KINASES; JAK2 INHIBITOR; MURINE MODEL; MYELOFIBROSIS; EXPRESSION; RUXOLITINIB; MUTATIONS; THERAPY	Primary myelofibrosis (PMF) is characterized by bone marrow fibrosis, myeloproliferation, extramedullary hematopoiesis, splenomegaly and leukemic progression. Moreover, the bone marrow and spleens of individuals with PMF contain large numbers of atypical megakaryocytes that are postulated to contribute to fibrosis through the release of cytokines, including transforming growth factor (TGF)-beta. Although the Janus kinase inhibitor ruxolitinib provides symptomatic relief, it does not reduce the mutant allele burden or substantially reverse fibrosis. Here we show through pharmacologic and genetic studies that aurora kinase A (AURKA) represents a new therapeutic target in PMF. Treatment with MLN8237, a selective AURKA inhibitor, promoted polyploidization and differentiation of megakaryocytes with PMF-associated mutations and had potent antifibrotic and antitumor activity in vivo in mouse models of PMF. Moreover, heterozygous deletion of Aurka was sufficient to ameliorate fibrosis and other PMF features in vivo. Our data suggest that megakaryocytes drive fibrosis in PMF and that targeting them with AURKA inhibitors has the potential to provide therapeutic benefit.	[Wen, Qiang Jeremy; Yang, Qiong; Goldenson, Benjamin; Schultz, Rachael; Gilles, Laure; Stein, Brady; Crispino, John D.] Northwestern Univ, Dept Med, Div Hematol & Oncol, Chicago, IL 60611 USA; [Malinge, Sebastien] Inst Gustave Roussy, Paris, France; [Lasho, Terra; Pardanani, Animesh; Tefferi, Ayalew] Mayo Clin, Div Hematol, Rochester, MN USA; [Schneider, Rebekka K.; Breyfogle, Lawrence J.; Mullally, Ann] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Hematol,Dept Med, Boston, MA 02115 USA; [Koppikar, Priya; Abdel-Wahab, Omar; Levine, Ross L.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10021 USA; [Gurbuxani, Sandeep] Univ Chicago, Hematopathol Sect, Chicago, IL 60637 USA	Northwestern University; UNICANCER; Gustave Roussy; Mayo Clinic; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Memorial Sloan Kettering Cancer Center; University of Chicago	Crispino, JD (corresponding author), Northwestern Univ, Dept Med, Div Hematol & Oncol, Chicago, IL 60611 USA.	j-crispino@northwestern.edu	levine, ross/AAE-7658-2019; Malinge, Sebastien/B-3507-2014; Malinge, Sebastien/AAP-9452-2021; Malinge, Sebastien/AAK-1158-2021	Malinge, Sebastien/0000-0002-9533-7778; Malinge, Sebastien/0000-0002-9533-7778; Gilles, Laure/0000-0001-6567-256X; Crispino, John/0000-0002-8182-8306; Goldenson, Benjamin/0000-0001-6724-7858	US National Institutes of Health (NIH) [HL112792]; Leukemia and Lymphoma Society Translational Research Project grant; Samuel Waxman Cancer Research Foundation; Northwestern Memorial Foundation; Northwestern University Clinical and Translational Sciences Institute; American Cancer Society [278808]; National Center for Research Resources (NCRR); National Center for Advancing Translational Sciences (NCATS); NIH [TL1R000108]; NATIONAL CANCER INSTITUTE [P30CA060553] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR000108] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL112792] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society Translational Research Project grant; Samuel Waxman Cancer Research Foundation; Northwestern Memorial Foundation; Northwestern University Clinical and Translational Sciences Institute; American Cancer Society(American Cancer Society); National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences (NCATS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank A. Stern, J. Licht, Z. Huang and members of the Crispino lab for helpful discussions, and T. Van Dyke (National Cancer Institute) for the generous gift of Aurka-floxed mice. We also thank Z. Huang (Wuhan University) for providing the CALR T1 and CALR T2 plasmids, G. Gilliland (Fred Hutchinson Cancer Research Center) for the MPLW515L construct, M. Weiss (St. Jude Children's Research Hospital) for the G1ME cells and T. Arima (Kagoshima University) for the SET-2 cells. This work was supported by US National Institutes of Health (NIH) grant no. HL112792 (J.D.C.), a Leukemia and Lymphoma Society Translational Research Project grant (J.D.C.), the Samuel Waxman Cancer Research Foundation (J.D.C.), a Dixon Young Investigator Award from Northwestern Memorial Foundation (Q.J.W.), the Northwestern University Clinical and Translational Sciences Institute (Q.J.W.) and American Cancer Society grant no. 278808 (Q.J.W.). The project was also supported by the National Center for Research Resources (NCRR), the National Center for Advancing Translational Sciences (NCATS) and the NIH through grant no. TL1R000108 (B.G.).	Abdel-Wahab O, 2012, AM J HEMATOL, V87, P562, DOI 10.1002/ajh.23169; Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Bock O, 2008, AM J PATHOL, V172, P951, DOI 10.2353/ajpath.2008.071030; Bruns I, 2014, NAT MED, V20, P1315, DOI 10.1038/nm.3707; Castro-Malaspina H, 1984, Prog Clin Biol Res, V154, P427; Chagraoui H, 2002, BLOOD, V100, P3495, DOI 10.1182/blood-2002-04-1133; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Ciurea SO, 2007, BLOOD, V110, P986, DOI 10.1182/blood-2006-12-064626; Cowley DO, 2009, MOL CELL BIOL, V29, P1059, DOI 10.1128/MCB.01062-08; de Boer J, 2003, EUR J IMMUNOL, V33, P314, DOI 10.1002/immu.200310005; den Hollander J, 2010, BLOOD, V116, P1498, DOI 10.1182/blood-2009-11-251074; Dodson CA, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003910; Gangat N, 2011, J CLIN ONCOL, V29, P392, DOI 10.1200/JCO.2010.32.2446; Goldenson B, 2015, ONCOGENE, V34, P537, DOI 10.1038/onc.2014.14; Goldenson B, 2015, BLOOD, V125, P2141, DOI 10.1182/blood-2014-12-615401; Harrison C, 2013, EXPERT REV HEMATOL, V6, P511, DOI 10.1586/17474086.2013.827413; Harrison C, 2012, NEW ENGL J MED, V366, P787, DOI 10.1056/NEJMoa1110556; Hoermann G, 2012, FASEB J, V26, P894, DOI 10.1096/fj.11-193078; Klampfl T, 2013, NEW ENGL J MED, V369, P2379, DOI 10.1056/NEJMoa1311347; Koppikar P, 2010, BLOOD, V115, P2919, DOI 10.1182/blood-2009-04-218842; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Le Bousse-Kerdiles MC, 2001, PATHOL BIOL, V49, P153, DOI 10.1016/S0369-8114(00)00021-3; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; MARTYRE MC, 1991, BRIT J HAEMATOL, V77, P80, DOI 10.1111/j.1365-2141.1991.tb07952.x; Mascarenhas J, 2013, BLOOD, V121, P4832, DOI 10.1182/blood-2013-02-482232; Mullally A, 2010, CANCER CELL, V17, P584, DOI 10.1016/j.ccr.2010.05.015; Nangalia J, 2013, NEW ENGL J MED, V369, P2391, DOI 10.1056/NEJMoa1312542; Schepers K, 2013, CELL STEM CELL, V13, P285, DOI 10.1016/j.stem.2013.06.009; Shivdasani RA, 1997, EMBO J, V16, P3965, DOI 10.1093/emboj/16.13.3965; Stachura DL, 2006, BLOOD, V107, P87, DOI 10.1182/blood-2005-07-2740; Sumi K, 2011, FEBS LETT, V585, P1884, DOI 10.1016/j.febslet.2011.04.068; Tam CS, 2013, EXPERT OPIN INV DRUG, V22, P687, DOI 10.1517/13543784.2013.774373; Tefferi A, 2012, BLOOD, V119, P2721, DOI 10.1182/blood-2011-11-395228; Tibes R, 2012, MOL DIAGN THER, V16, P269, DOI 10.1007/s40291-012-0006-3; Uozumi K, 2000, LEUKEMIA, V14, P142, DOI 10.1038/sj.leu.2401608; Vannucchi AM, 2013, LEUKEMIA, V27, P1861, DOI 10.1038/leu.2013.119; Vannucchi AM, 2002, BLOOD, V100, P1123, DOI 10.1182/blood-2002-06-1913; Vannucchi AM, 2005, AM J PATHOL, V167, P849, DOI 10.1016/S0002-9440(10)62056-1; Verstovsek S, 2012, NEW ENGL J MED, V366, P799, DOI 10.1056/NEJMoa1110557; Villeval JL, 1997, BLOOD, V90, P4369; Wen Q, 2012, CELL, V150, P575, DOI 10.1016/j.cell.2012.06.032; Wernig G, 2008, BLOOD, V111, P3751, DOI 10.1182/blood-2007-07-102186; Werning G, 2008, CANCER CELL, V13, P311, DOI 10.1016/j.ccr.2008.02.009; Zhao M, 2014, NAT MED, V20, P1321, DOI 10.1038/nm.3706	44	105	109	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	DEC	2015	21	12					1473	+		10.1038/nm.3995	http://dx.doi.org/10.1038/nm.3995			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CX9EV	26569382	Green Accepted, Green Submitted			2022-12-25	WOS:000366008700018
J	Lettre, G; Hirschhorn, JN				Lettre, Guillaume; Hirschhorn, Joel N.			Small island, big genetic discoveries	NATURE GENETICS			English	Editorial Material							ASSOCIATION ANALYSES; ARCHITECTURE; SARDINIA; HEIGHT	Three new studies have identified new genes and sequence variants implicated in blood lipids, inflammatory markers, hemoglobin levels and adult height variation in Sardinia. These reports highlight the usefulness of large-scale genotype imputation based on whole-genome sequencing, particularly in isolated populations, in studying the genetics of complex human phenotypes.	[Lettre, Guillaume] Montreal Heart Inst, Montreal, PQ H1T 1C8, Canada; [Lettre, Guillaume] Univ Montreal, Fac Med, Montreal, PQ H3C 3J7, Canada; [Hirschhorn, Joel N.] Boston Childrens Hosp, Div Endocrinol, Boston, MA USA; [Hirschhorn, Joel N.] Boston Childrens Hosp, Ctr Basic & Translat Obes Res, Boston, MA USA; [Hirschhorn, Joel N.] Broad Inst Harvard & MIT, Program Med & Populat Genet, Cambridge, MA USA; [Hirschhorn, Joel N.] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA	Universite de Montreal; Universite de Montreal; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School	Lettre, G (corresponding author), Montreal Heart Inst, Montreal, PQ H1T 1C8, Canada.	guillaume.lettre@umontreal.ca; joelh@broadinstitute.org		Hirschhorn, Joel/0000-0002-1650-7901				Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Danjou F, 2015, NAT GENET, V47, P1264, DOI 10.1038/ng.3307; Do R, 2015, NATURE, V518, P102, DOI 10.1038/nature13917; Kong A, 2008, NAT GENET, V40, P1068, DOI 10.1038/ng.216; Peltonen L, 2000, NAT REV GENET, V1, P182, DOI 10.1038/35042049; Sankaran VG, 2010, ANN NY ACAD SCI, V1214, P47, DOI 10.1111/j.1749-6632.2010.05821.x; Sidore C, 2015, NAT GENET, V47, P1272, DOI 10.1038/ng.3368; Wood AR, 2014, NAT GENET, V46, P1173, DOI 10.1038/ng.3097; Zoledziewska M, 2015, NAT GENET, V47, P1352, DOI 10.1038/ng.3403	9	11	11	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2015	47	11					1224	1225		10.1038/ng.3426	http://dx.doi.org/10.1038/ng.3426			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CV1BN	26506900				2022-12-25	WOS:000363988200003
J	Hinchcliffe, EH; Day, CA; Karanjeet, KB; Fadness, S; Langfald, A; Vaughan, KT; Dong, Z				Hinchcliffel, Edward H.; Day, Charles A.; Karanjeet, Kul B.; Fadness, Sela; Langfald, Alyssa; Vaughan, Kevin T.; Dong, Zigang			Chromosome missegregation during anaphase triggers p53 cell cycle arrest through histone H3.3 Ser31 phosphorylation	NATURE CELL BIOLOGY			English	Article							SPINDLE ASSEMBLY CHECKPOINT; DNA-DAMAGE; MAMMALIAN DEVELOPMENT; CANCER-CELLS; IN-VITRO; AURORA B; MITOSIS; CENTROMERE; ERRORS; SEGREGATION	Maloriented chromosomes can evade the spindle assembly checkpoint and generate aneuploidy, a common feature of tumorigenesis(1-4). But chromosome missegregation in non-transformed cells triggers a p53-dependent fail-safe mechanism that blocks proliferation of normal cells that inadvertently become aneuploid(5,6). How this fail-safe is triggered is not known(7,8). Here we identify a conserved feedback mechanism that monitors missegregating chromosomes during anaphase through the differential phosphorylation of histone H3.3 at Ser31(9). We do this by inducing transient chromosome missegregation in diploid cells(10). During anaphase, H3.3 Ser31 is phosphorylated along the arms of lagging or misaligned chromosomes. Within minutes, Ser31 phosphorylation (Ser31P) spreads to all of the chromatids of both daughter cells, which persists into G1. Masking H3.3 Ser31P by antibody microinjection prevents nuclear p53 accumulation in the aneuploid daughters. Previous work demonstrated that prolonged prometaphase and DNA damage during abnormal mitosis can activate p53(11-15). We show that p53 activation in response to chromosome missegregation can occur without prolonged mitosis or DNA damage. Our study provides insight into how aneuploidy caused by chromosome missegregation is normally monitored and suppressed.	[Hinchcliffel, Edward H.; Day, Charles A.; Karanjeet, Kul B.; Fadness, Sela; Langfald, Alyssa; Dong, Zigang] Univ Minnesota, Hormel Inst, 801 16th Ave NE, Austin, MN 55912 USA; [Vaughan, Kevin T.] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA	University of Minnesota System; University of Notre Dame	Hinchcliffe, EH; Dong, Z (corresponding author), Univ Minnesota, Hormel Inst, 801 16th Ave NE, Austin, MN 55912 USA.	ehinchcliffe@hi.umn.edu; zgdong@hi.umn.edu		Day, Charles A/0000-0001-6277-2004	Hormel Institute SURE programme; Hormel Foundation; Austin 'Paint the Town Pink'; US Department of Defense (CDMRP) [CA130436]; National Institutes of Health [R01 CA166011]; NATIONAL CANCER INSTITUTE [R01CA166011] Funding Source: NIH RePORTER	Hormel Institute SURE programme; Hormel Foundation; Austin 'Paint the Town Pink'; US Department of Defense (CDMRP)(United States Department of Defense); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	S.F. was supported by the Hormel Institute SURE programme. This work was supported by the Hormel Foundation, Austin 'Paint the Town Pink', US Department of Defense (CDMRP) grant CA130436 to E.H.H. and National Institutes of Health grant R01 CA166011 to Z.D.	Bakhoum SF, 2014, CURR BIOL, V24, pR148, DOI 10.1016/j.cub.2014.01.019; Bakhoum SF, 2009, NAT CELL BIOL, V11, P27, DOI 10.1038/ncb1809; Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; Chang FTM, 2015, NUCLEIC ACIDS RES, V43, P2603, DOI 10.1093/nar/gkv104; Chang NS, 2005, ONCOGENE, V24, P714, DOI 10.1038/sj.onc.1208124; Crasta K, 2012, NATURE, V482, P53, DOI 10.1038/nature10802; Dick AE, 2013, NAT CELL BIOL, V15, P1370, DOI 10.1038/ncb2842; Durcan TM, 2008, J CELL BIOL, V181, P595, DOI 10.1083/jcb.200711160; Elsasser SJ, 2012, NATURE, V491, P560, DOI 10.1038/nature11608; Fukagawa T, 2014, DEV CELL, V30, P497, DOI 10.1016/j.devcel.2014.08.016; Ganem NJ, 2012, J CELL BIOL, V199, P871, DOI 10.1083/jcb.201210040; Gorbsky GJ, 1998, J CELL BIOL, V141, P1193, DOI 10.1083/jcb.141.5.1193; Guse A, 2011, NATURE, V477, P354, DOI 10.1038/nature10379; Hake SB, 2005, P NATL ACAD SCI USA, V102, P6344, DOI 10.1073/pnas.0502413102; Hayashi MT, 2012, NAT STRUCT MOL BIOL, V19, P387, DOI 10.1038/nsmb.2245; Hinchcliffe EH, 2014, INT REV CEL MOL BIO, V313, P179, DOI 10.1016/B978-0-12-800177-6.00006-2; Hinchcliffe EH, 1999, J CELL SCI, V112, P1139; Hornick JE, 2011, CURR BIOL, V21, P598, DOI 10.1016/j.cub.2011.02.049; Jang CW, 2015, GENE DEV, V29, P1377, DOI 10.1101/gad.264150.115; Janssen A, 2011, SCIENCE, V333, P1895, DOI 10.1126/science.1210214; Kasuboski JM, 2011, MOL BIOL CELL, V22, P3318, DOI 10.1091/mbc.E11-03-0213; Lanni JS, 1998, MOL CELL BIOL, V18, P1055, DOI 10.1128/MCB.18.2.1055; Loncarek J, 2007, NATURE, V450, P745, DOI 10.1038/nature06344; London N., 2014, NAT REV CELL MOL BIO, V360, P553; Maze I, 2014, NAT REV GENET, V15, P259, DOI 10.1038/nrg3673; Pfau SJ, 2012, EMBO REP, V13, P515, DOI 10.1038/embor.2012.65; Reaper PM, 2011, NAT CHEM BIOL, V7, P428, DOI [10.1038/NCHEMBIO.573, 10.1038/nchembio.573]; Rieder CL, 2004, DEV CELL, V7, P637, DOI 10.1016/j.devcel.2004.09.002; RIGAUDY P, 1989, NUCLEIC ACIDS RES, V17, P8375, DOI 10.1093/nar/17.20.8375; Simanshu DK, 2013, NATURE, V500, P463, DOI 10.1038/nature12332; Subramanian R, 2013, NAT CELL BIOL, V15, P1261, DOI 10.1038/ncb2876; Tagami H, 2004, CELL, V116, P51, DOI 10.1016/S0092-8674(03)01064-X; Thompson SL, 2011, P NATL ACAD SCI USA, V108, P17974, DOI 10.1073/pnas.1109720108; Thompson SL, 2010, J CELL BIOL, V188, P369, DOI 10.1083/jcb.200905057; Uetake Y, 2010, CURR BIOL, V20, P1666, DOI 10.1016/j.cub.2010.08.018; Vagnarelli P, 2006, NAT CELL BIOL, V8, P1133, DOI 10.1038/ncb1475; Wang FW, 2012, J CELL BIOL, V199, P251, DOI 10.1083/jcb.201205106; Wang FW, 2010, SCIENCE, V330, P231, DOI 10.1126/science.1189435; You ZS, 2007, NAT CELL BIOL, V9, P311, DOI 10.1038/ncb1651	39	51	51	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUN	2016	18	6					668	+		10.1038/ncb3348	http://dx.doi.org/10.1038/ncb3348			15	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	DN0JL	27136267				2022-12-25	WOS:000376750100013
J	Li, CL; Gu, LF; Gao, L; Chen, C; Wei, CQ; Qiu, Q; Chien, CW; Wang, SK; Jiang, LH; Ai, LF; Chen, CY; Yang, SG; Nguyen, V; Qi, YH; Snyder, MP; Burlingame, AL; Kohalmi, SE; Huang, SZ; Cao, XF; Wang, ZY; Wu, KQ; Chen, XM; Cui, YH				Li, Chenlong; Gu, Lianfeng; Gao, Lei; Chen, Chen; Wei, Chuang-Qi; Qiu, Qi; Chien, Chih-Wei; Wang, Suikang; Jiang, Lihua; Ai, Lian-Feng; Chen, Chia-Yang; Yang, Songguang; Nguyen, Vi; Qi, Yanhua; Snyder, Michael P.; Burlingame, Alma L.; Kohalmi, Susanne E.; Huang, Shangzhi; Cao, Xiaofeng; Wang, Zhi-Yong; Wu, Keqiang; Chen, Xuemei; Cui, Yuhai			Concerted genomic targeting of H3K27 demethylase REF6 and chromatin-remodeling ATPase BRM in Arabidopsis	NATURE GENETICS			English	Article							HISTONE MODIFICATIONS; SWI/SNF COMPLEX; GENE; TRANSCRIPTION; PROTEINS; EXPRESSION; RESPONSES; RNA; MODULATION; MECHANISMS	SWI/SNF-type chromatin remodelers, such as BRAHMA (BRM), and H3K27 demethylases both have active roles in regulating gene expression at the chromatin level(1-5), but how they are recruited to specific genomic sites remains largely unknown. Here we show that RELATIVE OF EARLY FLOWERING 6 (REF6), a plant-unique H3K27 demethylase(6), targets genomic loci containing a CTCTGYTY motif via its zinc-finger (ZnF) domains and facilitates the recruitment of BRM. Genome-wide analyses showed that REF6 colocalizes with BRM at many genomic sites with the CTCTGYTY motif. Loss of REF6 results in decreased BRM occupancy at BRM-REF6 co-targets. Furthermore, REF6 directly binds to the CTCTGYTY motif in vitro, and deletion of the motif from a target gene renders it inaccessible to REF6 in vivo. Finally, we show that, when its ZnF domains are deleted, REF6 loses its genomic targeting ability. Thus, our work identifies a new genomic targeting mechanism for an H3K27 demethylase and demonstrates its key role in recruiting the BRM chromatin remodeler.	[Li, Chenlong; Chen, Chen; Nguyen, Vi; Cui, Yuhai] Agr & Agri Food Canada, London Res & Dev Ctr, London, ON, Canada; [Li, Chenlong; Chen, Chen; Kohalmi, Susanne E.; Cui, Yuhai] Univ Western Ontario, Dept Biol, London, ON, Canada; [Gu, Lianfeng] Fujian Agr & Forestry Univ, Haixia Inst Sci & Technol, Fuzhou, Peoples R China; [Gu, Lianfeng; Gao, Lei; Wang, Suikang; Chen, Xuemei] Univ Calif Riverside, Inst Integrat Genome Biol, Dept Bot & Plant Sci, Riverside, CA 92521 USA; [Gu, Lianfeng; Qiu, Qi; Cao, Xiaofeng] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Plant Genom, Beijing, Peoples R China; [Gu, Lianfeng; Qiu, Qi; Cao, Xiaofeng] Chinese Acad Sci, Inst Genet & Dev Biol, Natl Ctr Plant Gene Res, Beijing, Peoples R China; [Wei, Chuang-Qi; Chien, Chih-Wei; Wang, Zhi-Yong] Carnegie Inst Sci, Dept Plant Biol, 290 Panama St, Stanford, CA 94305 USA; [Wei, Chuang-Qi] Hebei Normal Univ, Life Sci Coll, Shijiazhuang, Peoples R China; [Wang, Suikang; Qi, Yanhua] Zhejiang Univ, Coll Life Sci, State Key Lab Plant Physiol & Biochem, Hangzhou 310003, Zhejiang, Peoples R China; [Jiang, Lihua; Snyder, Michael P.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Ai, Lian-Feng] Hebei Entry Exit Inspect & Quarantine Bur, Shijiazhuang, Peoples R China; [Chen, Chia-Yang; Wu, Keqiang] Natl Taiwan Univ, Coll Life Sci, Inst Plant Biol, Taipei 10764, Taiwan; [Yang, Songguang] Chinese Acad Sci, South China Bot Garden, Key Lab South China Agr Plant Mol Anal & Gene Imp, Guangzhou, Guangdong, Peoples R China; [Burlingame, Alma L.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA USA; [Huang, Shangzhi] Sun Yat Sen Univ, State Key Lab Biocontrol, Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China; [Huang, Shangzhi] Sun Yat Sen Univ, Guangdong Prov Key Lab Plant Resource, Guangzhou 510275, Guangdong, Peoples R China; [Cao, Xiaofeng] Collaborat Innovat Ctr Genet & Dev, Shanghai, Peoples R China; [Cao, Xiaofeng] Chinese Acad Sci, Inst Genet & Dev Biol, CAS Ctr Excellence Mol Plant Sci, Beijing, Peoples R China; [Chen, Xuemei] Univ Calif Riverside, Howard Hughes Med Inst, Riverside, CA 92521 USA	Agriculture & Agri Food Canada; Western University (University of Western Ontario); Fujian Agriculture & Forestry University; University of California System; University of California Riverside; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Carnegie Institution for Science; Hebei Normal University; Zhejiang University; Stanford University; National Taiwan University; Chinese Academy of Sciences; South China Botanical Garden, CAS; University of California System; University of California San Francisco; Sun Yat Sen University; Sun Yat Sen University; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Howard Hughes Medical Institute; University of California System; University of California Riverside	Cui, YH (corresponding author), Agr & Agri Food Canada, London Res & Dev Ctr, London, ON, Canada.; Cui, YH (corresponding author), Univ Western Ontario, Dept Biol, London, ON, Canada.	yuhai.cui@agr.gc.ca	Wang, Zhi-Yong/E-3810-2012; Alex, Chen/AAH-7096-2021; Gao, Lei/I-4159-2013; Wu, Keqiang/C-9743-2013; chen, chen/AAK-1684-2021	Wang, Zhi-Yong/0000-0003-4602-3390; Gao, Lei/0000-0002-6488-0292; Wu, Keqiang/0000-0002-5791-3594; Wei, Chuangqi/0000-0001-7781-7674; Chen, Chen/0000-0001-6196-3255; Snyder, Michael/0000-0003-0784-7987; Li, Chenlong/0000-0003-3405-6056; Chen, Xuemei/0000-0002-5209-1157	Agriculture and Agri-Food Canada A-base; National Science and Engineering Research Council of Canada [R4019A01]; Natural Science Foundation of China [31128001, 31210103901]; State Key Laboratory of Plant Genomics [2015B0129-01]; US National Institutes of Health [GM061146, R01GM066258]; Chinese Scholarship Council; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066258, R01GM061146] Funding Source: NIH RePORTER	Agriculture and Agri-Food Canada A-base(Agriculture & Agri Food Canada); National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Plant Genomics; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chinese Scholarship Council(China Scholarship Council); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Arabidopsis Biological Resource Center (ABRC) for seeds for T-DNA insertion lines; A. Molnar for help with figure preparation; X. Shi of the Clinical Genomics Centre at Mount Sinai Hospital for overseeing the next-generation sequencing; and S. Rothstein for critical reading of the manuscript. C.C. is supported by a graduate fellowship from the Chinese Scholarship Council. This work was supported by funding from the Agriculture and Agri-Food Canada A-base and the National Science and Engineering Research Council of Canada (R4019A01) to Y.C., the Natural Science Foundation of China (31128001 to K.W. and Y.C. and 31210103901 to X. Cao and X. Chen), the State Key Laboratory of Plant Genomics (2015B0129-01 to X. Cao), and the US National Institutes of Health to X. Chen (GM061146) and Z.-Y.W. (R01GM066258).	Archacki R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058588; Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Brown RS, 2005, CURR OPIN STRUC BIOL, V15, P94, DOI 10.1016/j.sbi.2005.01.006; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; Efroni I, 2013, DEV CELL, V24, P438, DOI 10.1016/j.devcel.2013.01.019; Gendrel AV, 2005, NAT METHODS, V2, P213, DOI 10.1038/nmeth0305-213; Goldberg AD, 2007, CELL, V128, P635, DOI 10.1016/j.cell.2007.02.006; Han SK, 2012, PLANT CELL, V24, P4892, DOI 10.1105/tpc.112.105114; Hansen KH, 2008, NAT CELL BIOL, V10, P1291, DOI 10.1038/ncb1787; Ho L, 2011, NAT CELL BIOL, V13, P903, DOI 10.1038/ncb2285; Hurtado L, 2006, PLANT MOL BIOL, V62, P291, DOI 10.1007/s11103-006-9021-2; Jerzmanowski A, 2007, BBA-GENE STRUCT EXPR, V1769, P330, DOI 10.1016/j.bbaexp.2006.12.003; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Klug A, 2010, ANNU REV BIOCHEM, V79, P213, DOI 10.1146/annurev-biochem-010909-095056; Kooistra SM, 2012, NAT REV MOL CELL BIO, V13, P297, DOI 10.1038/nrm3327; Lamesch P, 2012, NUCLEIC ACIDS RES, V40, pD1202, DOI 10.1093/nar/gkr1090; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li CL, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004944; Li CL, 2009, J EXP BOT, V60, P4371, DOI 10.1093/jxb/erp275; Lu FL, 2008, J INTEGR PLANT BIOL, V50, P886, DOI 10.1111/j.1744-7909.2008.00692.x; Lu FL, 2011, NAT GENET, V43, P715, DOI 10.1038/ng.854; Lu Q, 2010, PLANT J, V61, P259, DOI 10.1111/j.1365-313X.2009.04048.x; Luo CY, 2013, PLANT J, V73, P77, DOI 10.1111/tpj.12017; Machanick P, 2011, BIOINFORMATICS, V27, P1696, DOI 10.1093/bioinformatics/btr189; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Margueron R, 2009, NATURE, V461, P762, DOI 10.1038/nature08398; Masiero S, 2004, DEVELOPMENT, V131, P5981, DOI 10.1242/dev.01517; Narlikar GJ, 2002, CELL, V108, P475, DOI 10.1016/S0092-8674(02)00654-2; Nicol JW, 2009, BIOINFORMATICS, V25, P2730, DOI 10.1093/bioinformatics/btp472; Noh B, 2004, PLANT CELL, V16, P2601, DOI 10.1105/tpc.104.025353; Oh E, 2012, NAT CELL BIOL, V14, P802, DOI 10.1038/ncb2545; Reyes JC, 2014, MOL PLANT, V7, P454, DOI 10.1093/mp/sst147; Smaczniak C, 2012, P NATL ACAD SCI USA, V109, P1560, DOI 10.1073/pnas.1112871109; Tang XR, 2008, PLANT PHYSIOL, V147, P1143, DOI 10.1104/pp.108.121996; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Vercruyssen L, 2014, PLANT CELL, V26, P210, DOI 10.1105/tpc.113.115907; Wu MF, 2012, P NATL ACAD SCI USA, V109, P3576, DOI 10.1073/pnas.1113409109; Yang SG, 2015, PLANT CELL, V27, P1670, DOI 10.1105/tpc.15.00091; Ye T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1287; Yu XF, 2008, P NATL ACAD SCI USA, V105, P7618, DOI 10.1073/pnas.0802254105; Yuan W, 2012, SCIENCE, V337, P971, DOI 10.1126/science.1225237; Zang CZ, 2009, BIOINFORMATICS, V25, P1952, DOI 10.1093/bioinformatics/btp340; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhao ML, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005125	47	131	136	2	113	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2016	48	6					687	+		10.1038/ng.3555	http://dx.doi.org/10.1038/ng.3555			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DN0HE	27111034	Green Accepted			2022-12-25	WOS:000376744200018
J	Bredeson, JV; Lyons, JB; Prochnik, SE; Wu, GA; Ha, CM; Edsinger-Gonzales, E; Grimwood, J; Schmutz, J; Rabbi, IY; Egesi, C; Nauluvula, P; Lebot, V; Ndunguru, J; Mkamilo, G; Bart, RS; Setter, TL; Gleadow, RM; Kulakow, P; Ferguson, ME; Rounsley, S; Rokhsar, DS				Bredeson, Jessen V.; Lyons, Jessica B.; Prochnik, Simon E.; Wu, G. Albert; Ha, Cindy M.; Edsinger-Gonzales, Eric; Grimwood, Jane; Schmutz, Jeremy; Rabbi, Ismail Y.; Egesi, Chiedozie; Nauluvula, Poasa; Lebot, Vincent; Ndunguru, Joseph; Mkamilo, Geoffrey; Bart, Rebecca S.; Setter, Tim L.; Gleadow, Roslyn M.; Kulakow, Peter; Ferguson, Morag E.; Rounsley, Steve; Rokhsar, Daniel S.			Sequencing wild and cultivated cassava and related species reveals extensive interspecific hybridization and genetic diversity	NATURE BIOTECHNOLOGY			English	Article							MANIHOT-ESCULENTA CRANTZ; GENOMIC SELECTION; MANIOC MANIHOT; RESISTANCE; ORIGIN; DOMESTICATION; ACCESSIONS	Cassava (Manihot esculenta) provides calories and nutrition for more than half a billion people. It was domesticated by native Amazonian peoples through cultivation of the wild progenitor M. esculenta ssp. flabellifolia and is now grown in tropical regions worldwide. Here we provide a high-quality genome assembly for cassava with improved contiguity, linkage, and completeness; almost 97% of genes are anchored to chromosomes. We find that paleotetraploidy in cassava is shared with the related rubber tree Hevea, providing a resource for comparative studies. We also sequence a global collection of 58 Manihot accessions, including cultivated and wild cassava accessions and related species such as Ceara or India rubber (M. glaziovii), and genotype 268 African cassava varieties. We find widespread interspecific admixture, and detect the genetic signature of past cassava breeding programs. As a clonally propagated crop, cassava is especially vulnerable to pathogens and abiotic stresses. This genomic resource will inform future genome-enabled breeding efforts to improve this staple crop.	[Bredeson, Jessen V.; Lyons, Jessica B.; Ha, Cindy M.; Edsinger-Gonzales, Eric; Rokhsar, Daniel S.] Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA; [Prochnik, Simon E.; Wu, G. Albert; Grimwood, Jane; Schmutz, Jeremy; Rokhsar, Daniel S.] US DOE, Joint Genome Inst, Walnut Creek, CA USA; [Grimwood, Jane; Schmutz, Jeremy] HudsonAlpha Inst Biotechnol, Huntsville, AL USA; [Rabbi, Ismail Y.; Kulakow, Peter] IITA, Ibadan, Nigeria; [Egesi, Chiedozie] NRCRI, Umudike, Nigeria; [Nauluvula, Poasa] Minist Primary Ind, Koronivia Res Stn, Dept Agr, Suva, Fiji; [Lebot, Vincent] Ctr Cooperat Int Rech Agron Dev CIRAD, Port Vila, Vanuatu; [Ndunguru, Joseph] MARI, Dar Es Salaam, Tanzania; [Mkamilo, Geoffrey] NARI, Mtwara, Tanzania; [Bart, Rebecca S.] Donald Danforth Plant Sci Ctr, St Louis, MO USA; [Setter, Tim L.] Cornell Univ, Sch Integrat Plant Sci, Sect Soil & Crop Sci, Ithaca, NY USA; [Gleadow, Roslyn M.] Monash Univ, Sch Biol Sci, Melbourne, Vic 3004, Australia; [Ferguson, Morag E.] IITA, Nairobi, Kenya; [Rounsley, Steve] Dow AgroSci, Indianapolis, IN USA; [Rokhsar, Daniel S.] Okinawa Inst Sci & Technol Grad Univ, Mol Genet Unit, Onna, Japan; [Ha, Cindy M.] Univ Colorado, Anschutz Med Campus, Denver, CO 80202 USA; [Edsinger-Gonzales, Eric] Marine Biol Lab, Woods Hole, MA 02543 USA; [Nauluvula, Poasa] South Pacific Community, Kolonia, Micronesia	University of California System; University of California Berkeley; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; HudsonAlpha Institute for Biotechnology; CGIAR; International Institute of Tropical Agriculture (IITA); CIRAD; Donald Danforth Plant Science Center; Cornell University; Monash University; Dow Chemical Company; Okinawa Institute of Science & Technology Graduate University; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Marine Biological Laboratory - Woods Hole	Bredeson, JV; Rokhsar, DS (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.; Rokhsar, DS (corresponding author), US DOE, Joint Genome Inst, Walnut Creek, CA USA.; Rokhsar, DS (corresponding author), Okinawa Inst Sci & Technol Grad Univ, Mol Genet Unit, Onna, Japan.	jessenbredeson@berkeley.edu; dsrokhsar@gmail.com	Setter, Tim/GNH-3718-2022; Gleadow, Roslyn/H-7778-2019; Lyons, Jessica/ABB-5014-2020; Wu, Guohong/W-3217-2019; Bart, Rebecca S/M-2838-2013; Schmutz, Jeremy/N-3173-2013; Grimwood, Jane/ABD-5737-2021	Gleadow, Roslyn/0000-0003-4756-0411; Lyons, Jessica/0000-0002-3886-2146; Schmutz, Jeremy/0000-0001-8062-9172; Setter, Tim/0000-0002-0736-1453; Bredeson, Jessen/0000-0001-5489-8512; Rokhsar, Daniel/0000-0002-8704-2224; Bart, Rebecca/0000-0003-1378-3481; Kulakow, Peter/0000-0002-7574-2645	Bill and Melinda Gates Foundation (BMGF) [OPPGD1493]; University of Arizona; BMGF [OPP1048542, OPPGD1016]; United Kingdom Department for International Development; CGIAR Research Programme on Roots, Tubers, and Bananas (CRP-RTB); Office of Science of the US Department of Energy [DE-AC02-05CH11231]; National Institutes of Health [S10RR029668, S10RR027303]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027303, S10RR029668] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation (BMGF)(Bill & Melinda Gates Foundation); University of Arizona; BMGF; United Kingdom Department for International Development; CGIAR Research Programme on Roots, Tubers, and Bananas (CRP-RTB); Office of Science of the US Department of Energy(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank K. Swaminathan for advice on and protocols for DNA isolation; J. Burke for collecting the AM560-2 material, and J. Vrebaloy for preparing the DNA used for fosmid, mate pair, and Dovetail "Chicago" libraries; M. Hall for early project planning; M. Chung, J. Choi, K. Lundy, and other members of the VCGSL at UC Berkeley for advice and technical assistance with Illumine library preparation and sequencing; J. Galina-Mehlman and J. Still at the University of Arizona Genetics Core for library preparation and sequencing; R. McEwan and C. Evans for sequencing performed at Dow AgroSciences; L.B. Boston for mate pair library construction at HudsonAlpha; N. Putnam and J. Stites at Dovetail Genomics for performing HiRise assembly; B. Keough and Lucigen for fosmid library construction and sequencing; P. Hyde for providing cassava tissue from the Setter laboratory; M. Cohn and the Staskawicz laboratory for cassava tissue; C. Hershey and L.A.B. Lopez-Lavalle for permission to sequence CIAT accessions and background on CIAT nomenclature; E. Kanju for origin information on accession KBH 2006/18; and E. Amans and C. Exner for copyediting. J.B.L., J.V.B., C.M.H., and work at UC Berkeley were funded by Bill and Melinda Gates Foundation (BMGF) Grant OPPGD1493 to S.R., D.S.R., and the University of Arizona. NextGen Cassava Breeding grant OPP1048542 from BMGF and the United Kingdom Department for International Development supported S.E.P., J.V.B., and work at NRCRI. Work at IITA was supported by the CGIAR Research Programme on Roots, Tubers, and Bananas (CRP-RTB), and in East Africa, grant OPPGD1016 from BMGF. The work conducted by the US Department of Energy Joint Genome Institute is supported by the Office of Science of the US Department of Energy under Contract No. DE-AC02-05CH11231. This work used the VCGSL at UC Berkeley, supported by the National Institutes of Health S10 Instrumentation Grants S10RR029668 and S10RR027303.	Alaba OA, 2015, G3-GENES GENOM GENET, V5, P133, DOI 10.1534/g3.114.015008; Alabi O. J., 2011, CASSAVA MOSAIC DIS C, DOI DOI 10.1094/APSNETFEATURE-2011-0701; Allem Antonio C., 2001, P1, DOI 10.1079/9780851995243.0001; Ceballos H, 2015, THEOR APPL GENET, V128, P1647, DOI 10.1007/s00122-015-2555-4; Clement C. R., 2010, Diversity, V2, P72; De Carvalho R, 2002, HEREDITAS, V136, P159, DOI 10.1034/j.1601-5223.2002.1360212.x; Duque L., 2012, THESIS CORNELL U; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Ferguson M, 2012, TROP PLANT BIOL, V5, P95, DOI 10.1007/s12042-011-9087-0; Fessenden M., 2014, SCI AM; Fu YB, 2014, CONSERV GENET, V15, P1463, DOI 10.1007/s10592-014-0631-y; Howeler R., 2013, SAVE GROW CASSAVA GU, DOI [DOI 10.1002/JSFA.2740310104, 10.1002/jsfa.2740310104]; Jannink JL, 2010, BRIEF FUNCT GENOMICS, V9, P166, DOI 10.1093/bfgp/elq001; Jennings D. L., 1976, African cassava mosaic. Report of an interdisciplinary workshop held at Muguga, Kenya, 19-22 February 1976., P39; JENNINGS DL, 1963, EUPHYTICA, V12, P69, DOI 10.1007/BF00022358; Jones W. O., 1959, MANIOC IN AFRICA; Kabeya M. J., 2012, World Journal of Agricultural Sciences, V8, P637; Kawuki R. S., 2010, Second RUFORUM Biennial Regional Conference on "Building capacity for food security in Africa", Entebbe, Uganda, 20-24 September 2010, P377; Lokko Y, 2009, J FOOD AGRIC ENVIRON, V7, P156; LOZANO JC, 1974, PHYTOPATHOLOGY, V64, P83, DOI 10.1094/Phyto-64-83; Nassar NMA, 2008, GENET MOL RES, V7, P16, DOI 10.4238/vol7-1gmr389; Nassar Nagib M. A., 2002, Genetics and Molecular Research, V1, P298; NASSAR NMA, 1989, CAN J PLANT SCI, V69, P1071, DOI 10.4141/cjps89-129; NASSAR NMA, 1978, ECON BOT, V32, P311, DOI 10.1007/BF02864705; Nichols R. F. W., 1947, EAST AFRICAN AGRIC JOUR, V12, P184; Nweke F., 2002, CASSAVA TRANSFORMATI; Nweke F.I., 2004, NEW CHALLENGES CASSA, V118; Nyaboga E, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00526; Ogwok E, 2012, MOL PLANT PATHOL, V13, P1019, DOI 10.1111/j.1364-3703.2012.00812.x; Olsen KM, 2004, PLANT MOL BIOL, V56, P517, DOI 10.1007/s11103-004-5043-9; Olsen KM, 1999, P NATL ACAD SCI USA, V96, P5586, DOI 10.1073/pnas.96.10.5586; Olsen KM, 2001, AM J BOT, V88, P131, DOI 10.2307/2657133; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Pax F., 1924, DAS PFLAZENREICH, V147, P196; Prochnik S, 2012, TROP PLANT BIOL, V5, P88, DOI 10.1007/s12042-011-9088-z; Putnam NH, 2016, GENOME RES, V26, P342, DOI 10.1101/gr.193474.115; Rabbi I, 2014, CROP SCI, V54, P1384, DOI 10.2135/cropsci2013.07.0482; Rabbi IY, 2014, VIRUS RES, V186, P87, DOI 10.1016/j.virusres.2013.12.028; Rahman AYA, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-75; Rival L, 2008, CURR ANTHROPOL, V49, P1116, DOI 10.1086/593119; Rogers D., 1973, FLORA NEOTROPICA MON, V13; Sanchez G, 1999, GENOME, V42, P163, DOI 10.1139/gen-42-2-163; Second G., 2001, BROADENING GENETIC B; Tang H, 2005, GENET EPIDEMIOL, V28, P289, DOI 10.1002/gepi.20064; Taylor N, 2004, PLANT MOL BIOL, V56, P671, DOI 10.1007/s11103-004-4872-x; Turyagyenda L. F., 2012, African Crop Science Journal, V20, P15; UGENT D, 1986, ECON BOT, V40, P78, DOI 10.1007/BF02858949; UMANAH EE, 1973, J AM SOC HORTIC SCI, V98, P272; Wang WQ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6110	49	224	234	5	79	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2016	34	5					562	570		10.1038/nbt.3535	http://dx.doi.org/10.1038/nbt.3535			9	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DL6FL	27088722	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000375735000038
J	Deans, RM; Morgens, DW; Okesli, A; Pillay, S; Horlbeck, MA; Kampmann, M; Gilbert, LA; Li, A; Mateo, R; Smith, M; Glenn, JS; Carette, JE; Khosla, C; Bassik, MC				Deans, Richard M.; Morgens, David W.; Okesli, Ayse; Pillay, Sirika; Horlbeck, Max A.; Kampmann, Martin; Gilbert, Luke A.; Li, Amy; Mateo, Roberto; Smith, Mark; Glenn, Jeffrey S.; Carette, Jan E.; Khosla, Chaitan; Bassik, Michael C.			Parallel shRNA and CRISPR-Cas9 screens enable antiviral drug target identification	NATURE CHEMICAL BIOLOGY			English	Article							FLAVOENZYME DIHYDROOROTATE DEHYDROGENASE; NOVO PYRIMIDINE SYNTHESIS; GENETIC INTERACTION MAPS; HUMAN-CELLS; SMALL MOLECULES; DENGUE VIRUS; OF-ACTION; GENERATION; EXPRESSION; INHIBITOR	Broad-spectrum antiviral drugs targeting host processes could potentially treat a wide range of viruses while reducing the likelihood of emergent resistance. Despite great promise as therapeutics, such drugs remain largely elusive. Here we used parallel genome-wide high-coverage short hairpin RNA (shRNA) and clustered regularly interspaced short palindromic repeats (CRISPR)-Cas9 screens to identify the cellular target and mechanism of action of GSK983, a potent broad-spectrum antiviral with unexplained cytotoxicity. We found that GSK983 blocked cell proliferation and dengue virus replication by inhibiting the pyrimidine biosynthesis enzyme dihydroorotate dehydrogenase (DHODH). Guided by mechanistic insights from both genomic screens, we found that exogenous deoxycytidine markedly reduced GSK983 cytotoxicity but not antiviral activity, providing an attractive new approach to improve the therapeutic window of DHODH inhibitors against RNA viruses. Our results highlight the distinct advantages and limitations of each screening method for identifying drug targets, and demonstrate the utility of parallel knockdown and knockout screens for comprehensive probing of drug activity.	[Deans, Richard M.; Okesli, Ayse; Khosla, Chaitan] Stanford Univ, Dept Chem, Stanford, CA 94305 USA; [Deans, Richard M.; Morgens, David W.; Li, Amy; Bassik, Michael C.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Pillay, Sirika; Mateo, Roberto; Glenn, Jeffrey S.; Carette, Jan E.] Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Horlbeck, Max A.; Kampmann, Martin; Gilbert, Luke A.] Calif Inst Quantitat Biomed Res, Dept Cellular & Mol Pharmacol, San Francisco, CA USA; [Horlbeck, Max A.; Kampmann, Martin; Gilbert, Luke A.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA USA; [Smith, Mark; Glenn, Jeffrey S.; Carette, Jan E.; Khosla, Chaitan; Bassik, Michael C.] Stanford Univ, Chem Engn & Med Human Hlth ChEM H, Stanford, CA 94305 USA; [Glenn, Jeffrey S.] Stanford Univ, Sch Med, Div Gastroenterol & Hepatol, Stanford, CA 94305 USA; [Khosla, Chaitan] Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA; [Khosla, Chaitan] Stanford Univ, Dept Biochem, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; University of California System; University of California San Francisco; Stanford University; Stanford University; Stanford University; Stanford University	Khosla, C (corresponding author), Stanford Univ, Dept Chem, Stanford, CA 94305 USA.; Bassik, MC (corresponding author), Stanford Univ, Dept Genet, Stanford, CA 94305 USA.; Khosla, C; Bassik, MC (corresponding author), Stanford Univ, Chem Engn & Med Human Hlth ChEM H, Stanford, CA 94305 USA.; Khosla, C (corresponding author), Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA.; Khosla, C (corresponding author), Stanford Univ, Dept Biochem, Stanford, CA 94305 USA.	khosla@stanford.edu; bassik@stanford.edu	Gilbert, Luke/AAC-5300-2019	Gilbert, Luke/0000-0001-5854-0825; Khosla, Chaitan/0000-0001-6529-495X; Kampmann, Martin/0000-0002-3819-7019; Carette, Jan/0000-0002-5187-8070	NIH/NCI [K99/R00 CA181494]; National Science Foundation Graduate Research Fellowship [DGE-114747]; Burt and DeeDee McMurtry Stanford Graduate Fellowship; US National Institues of Health [U19-AI109662]; Director's New Innovator Award Program [1DP2HD084069-01]; seed grant from Stanford ChEM-H; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [DP2HD084069] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [K99CA181494, R00CA181494] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI109662, DP2AI104557] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB009383] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007790, T32GM007618, T32GM008284] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); Burt and DeeDee McMurtry Stanford Graduate Fellowship; US National Institues of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Director's New Innovator Award Program; seed grant from Stanford ChEM-H; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Weissman, O. Chen, K. Han, B. Lowry, J. Kuo, N. Plugis and K. Nguyen for helpful discussions, and A. Brunet, J. Sage and D. Vollrath for critical reading of this manuscript. M.K. was supported by NIH/NCI K99/R00 CA181494. This material is based upon work supported by the National Science Foundation Graduate Research Fellowship under Grant No. DGE-114747 (R.M.D.). R.M.D. was additionally supported by a Burt and DeeDee McMurtry Stanford Graduate Fellowship. This work was funded by US National Institues of Health grants U19-AI109662 and Director's New Innovator Award Program 1DP2HD084069-01, and a seed grant from Stanford ChEM-H. Any opinion, findings and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the National Science Foundation.	Aman MJ, 2009, ANTIVIR RES, V83, P245, DOI 10.1016/j.antiviral.2009.06.001; Atasheva S, 2010, J VIROL, V84, P10004, DOI 10.1128/JVI.01151-10; Bader B, 1998, PROTEIN EXPRES PURIF, V13, P414, DOI 10.1006/prep.1998.0925; Bar-Peled L, 2014, TRENDS CELL BIOL, V24, P400, DOI 10.1016/j.tcb.2014.03.003; Bar-Peled L, 2013, SCIENCE, V340, P1100, DOI 10.1126/science.1232044; Bassik MC, 2013, CELL, V152, P909, DOI 10.1016/j.cell.2013.01.030; Bassik MC, 2009, NAT METHODS, V6, P443, DOI [10.1038/nmeth.1330, 10.1038/NMETH.1330]; Ben-Sahra I, 2013, SCIENCE, V339, P1323, DOI 10.1126/science.1228792; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Boggs SD, 2007, ORG PROCESS RES DEV, V11, P539, DOI 10.1021/op060223v; Bonavia A, 2011, P NATL ACAD SCI USA, V108, P6739, DOI 10.1073/pnas.1017142108; Chen BH, 2013, CELL, V155, P1479, DOI 10.1016/j.cell.2013.12.001; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Davis JP, 1996, BIOCHEMISTRY-US, V35, P1270, DOI 10.1021/bi952168g; Debing Y, 2013, CURR OPIN VIROL, V3, P217, DOI 10.1016/j.coviro.2013.03.001; Echeverri CJ, 2006, NAT REV GENET, V7, P373, DOI 10.1038/nrg1836; FAIRBANKS LD, 1995, J BIOL CHEM, V270, P29682; Fox RI, 1999, CLIN IMMUNOL, V93, P198, DOI 10.1006/clim.1999.4777; Giaever G, 2004, P NATL ACAD SCI USA, V101, P793, DOI 10.1073/pnas.0307490100; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Gregori-Puigjane E, 2012, P NATL ACAD SCI USA, V109, P11178, DOI 10.1073/pnas.1204524109; Gudmundsson KS, 2009, BIOORG MED CHEM LETT, V19, P4110, DOI 10.1016/j.bmcl.2009.06.001; Harvey R, 2009, ANTIVIR RES, V82, P1, DOI 10.1016/j.antiviral.2008.12.015; Hoffmann HH, 2011, P NATL ACAD SCI USA, V108, P5777, DOI 10.1073/pnas.1101143108; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Kampmann M, 2015, P NATL ACAD SCI USA, V112, pE3384, DOI 10.1073/pnas.1508821112; Kampmann M, 2014, NAT PROTOC, V9, P1825, DOI 10.1038/nprot.2014.103; Kampmann M, 2013, P NATL ACAD SCI USA, V110, pE2317, DOI 10.1073/pnas.1307002110; Kinch MS, 2009, AM J TRANSL RES, V1, P87; Kinney RM, 1997, VIROLOGY, V230, P300, DOI 10.1006/viro.1997.8500; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Liu SP, 2000, STRUCT FOLD DES, V8, P25, DOI 10.1016/S0969-2126(00)00077-0; Lou ZY, 2014, TRENDS PHARMACOL SCI, V35, P86, DOI 10.1016/j.tips.2013.11.006; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Matheny CJ, 2013, CHEM BIOL, V20, P1352, DOI 10.1016/j.chembiol.2013.09.014; Panchal RG, 2012, ANTIVIR RES, V93, P23, DOI 10.1016/j.antiviral.2011.10.011; Parsons AB, 2006, CELL, V126, P611, DOI 10.1016/j.cell.2006.06.040; Petrone FM, 2012, ACS CHEM BIOL, V7, P1399, DOI 10.1021/cb3001028; Qing M, 2010, ANTIMICROB AGENTS CH, V54, P3686, DOI 10.1128/AAC.00561-10; Robitaille AM, 2013, SCIENCE, V339, P1320, DOI 10.1126/science.1228771; Samsa MM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000632; Schenone M, 2013, NAT CHEM BIOL, V9, P232, DOI [10.1038/NCHEMBIO.1199, 10.1038/nchembio.1199]; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Sidrauski C, 2015, ELIFE, V4, DOI 10.7554/eLife.07314; Ullrich A, 2001, EUR J BIOCHEM, V268, P1861, DOI 10.1046/j.1432-1033.2001.02061.x; Wang QY, 2011, J VIROL, V85, P6548, DOI 10.1128/JVI.02510-10; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981	49	119	119	0	49	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAY	2016	12	5					361	+		10.1038/NCHEMBIO.2050	http://dx.doi.org/10.1038/NCHEMBIO.2050			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DJ6KY	27018887	Green Submitted, Green Accepted			2022-12-25	WOS:000374322800011
J	Dooley, J; Tian, L; Schonefeldt, S; Delghingaro-Augusto, V; Garcia-Perez, JE; Pasciuto, E; Di Marino, D; Carr, EJ; Oskolkov, N; Lyssenko, V; Franckaert, D; Lagou, V; Overbergh, L; Vandenbussche, J; Allemeersch, J; Chabot-Roy, G; Dahlstrom, JE; Laybutt, DR; Petrovsky, N; Socha, L; Gevaert, K; Jetten, AM; Lambrechts, D; Linterman, MA; Goodnow, CC; Nolan, CJ; Lesage, S; Schlenner, SM; Liston, A				Dooley, James; Tian, Lei; Schonefeldt, Susann; Delghingaro-Augusto, Viviane; Garcia-Perez, Josselyn E.; Pasciuto, Emanuela; Di Marino, Daniele; Carr, Edward J.; Oskolkov, Nikolay; Lyssenko, Valeriya; Franckaert, Dean; Lagou, Vasiliki; Overbergh, Lut; Vandenbussche, Jonathan; Allemeersch, Joke; Chabot-Roy, Genevieve; Dahlstrom, Jane E.; Laybutt, D. Ross; Petrovsky, Nikolai; Socha, Luis; Gevaert, Kris; Jetten, Anton M.; Lambrechts, Diether; Linterman, Michelle A.; Goodnow, Chris C.; Nolan, Christopher J.; Lesage, Sylvie; Schlenner, Susan M.; Liston, Adrian			Genetic predisposition for beta cell fragility underlies type 1 and type 2 diabetes	NATURE GENETICS			English	Article							ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; TRANSGENIC MOUSE MODEL; MOLECULAR-DYNAMICS; DNA; EXPRESSION; ORGAN; MICE; RNA; INSULITIS	Type 1 (T1D) and type 2 (T2D) diabetes share pathophysiological characteristics, yet mechanistic links have remained elusive. T1D results from autoimmune destruction of pancreatic beta cells, whereas beta cell failure in T2D is delayed and progressive. Here we find a new genetic component of diabetes susceptibility in T1D non-obese diabetic (NOD) mice, identifying immune-independent beta cell fragility. Genetic variation in Xrcc4 and Glis3 alters the response of NOD beta cells to unfolded protein stress, enhancing the apoptotic and senescent fates. The same transcriptional relationships were observed in human islets, demonstrating the role of beta cell fragility in genetic predisposition to diabetes.	[Dooley, James; Tian, Lei; Schonefeldt, Susann; Garcia-Perez, Josselyn E.; Pasciuto, Emanuela; Franckaert, Dean; Lagou, Vasiliki; Schlenner, Susan M.; Liston, Adrian] VIB, Ctr Biol Dis, Leuven, Belgium; [Dooley, James; Tian, Lei; Schonefeldt, Susann; Garcia-Perez, Josselyn E.; Pasciuto, Emanuela; Franckaert, Dean; Lagou, Vasiliki; Schlenner, Susan M.; Liston, Adrian] Univ Leuven, Dept Microbiol & Immunol, Leuven, Belgium; [Delghingaro-Augusto, Viviane; Dahlstrom, Jane E.; Nolan, Christopher J.] Australian Natl Univ, Sch Med, Canberra, ACT, Australia; [Di Marino, Daniele] Univ Svizzera Italiana, Dept Informat, Lugano, Switzerland; [Carr, Edward J.; Linterman, Michelle A.] Babraham Inst, Lymphocyte Signaling & Dev Inst Strateg Programme, Cambridge, England; [Oskolkov, Nikolay; Lyssenko, Valeriya] Lund Univ, Dept Clin Sci Diabet & Endocrinol, Malmo, Sweden; [Lyssenko, Valeriya] Steno Diabet Ctr, Dept Translat Pathophysiol, DK-2820 Gentofte, Denmark; [Lagou, Vasiliki] Univ Leuven, Dept Neurosci, Leuven, Belgium; [Overbergh, Lut] Univ Leuven, Dept Clin & Expt Med, Leuven, Belgium; [Vandenbussche, Jonathan; Gevaert, Kris] VIB, Dept Med Prot Res, Ghent, Belgium; [Vandenbussche, Jonathan; Gevaert, Kris] Univ Ghent, Dept Biochem, B-9000 Ghent, Belgium; [Allemeersch, Joke] Univ Leuven, VIB Nucle Core, Leuven, Belgium; [Chabot-Roy, Genevieve; Lesage, Sylvie] Hop Maison Neuve Rosemont, Immunol Oncol Sect, Montreal, PQ H1T 2M4, Canada; [Chabot-Roy, Genevieve; Lesage, Sylvie] Univ Montreal, Dept Microbiol Infectiol & Immunol, Montreal, PQ, Canada; [Dahlstrom, Jane E.] Canberra Hosp, Dept Anat Pathol, Garran, ACT, Australia; [Laybutt, D. Ross; Goodnow, Chris C.] Univ New S Wales, Garvan Inst Med Res, Sydney, NSW, Australia; [Petrovsky, Nikolai] Flinders Univ S Australia, Dept Endocrinol, Adelaide, SA 5001, Australia; [Socha, Luis] Australian Natl Univ, John Curtin Sch Med Res, Canberra, ACT 2601, Australia; [Jetten, Anton M.] NIEHS, Immun Inflammat & Dis Lab, US Natl Inst Hlth, POB 12233, Res Triangle Pk, NC 27709 USA; [Lambrechts, Diether] VIB, Vesalius Res Ctr, Leuven, Belgium; [Lambrechts, Diether] Univ Leuven, Dept Oncol, Leuven, Belgium; [Nolan, Christopher J.] Canberra Hosp, Dept Endocrinol, Garran, ACT, Australia	Flanders Institute for Biotechnology (VIB); KU Leuven; Australian National University; Universita della Svizzera Italiana; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; Lund University; Steno Diabetes Center; KU Leuven; KU Leuven; Flanders Institute for Biotechnology (VIB); Ghent University; Flanders Institute for Biotechnology (VIB); KU Leuven; Universite de Montreal; Universite de Montreal; Australian National University; Canberra Hospital; Garvan Institute of Medical Research; University of New South Wales Sydney; Flinders University South Australia; Australian National University; John Curtin School of Medical Research; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Flanders Institute for Biotechnology (VIB); KU Leuven; Australian National University; Canberra Hospital	Liston, A (corresponding author), VIB, Ctr Biol Dis, Leuven, Belgium.; Liston, A (corresponding author), Univ Leuven, Dept Microbiol & Immunol, Leuven, Belgium.	adrian.liston@vib.be	Liston, Adrian/G-8606-2013; Petrovsky, Nikolai/P-1912-2017; Gevaert, Kris/AAE-4212-2019; Overbergh, Lut/AAC-3515-2020; Lambrechts, Diether/AAJ-3167-2020; Delghingaro-Augusto, Viviane/AAG-8696-2019; Pasciuto, Emanuela/AAP-2982-2020; Nolan, Christopher J/B-2026-2008; Jetten, Anton/C-3736-2019; Goodnow, Christopher C/V-8108-2018; Di Marino, Daniele/AAB-9653-2019; Gevaert, Kris/D-6489-2017; Oskolkov, Nikolay/AAH-2349-2019; Di Marino, Daniele/ABB-2333-2020; Linterman, Michelle/AAN-4210-2021; Schlenner, Susan/P-7905-2017; Dahlstrom, Jane/E-4683-2018	Liston, Adrian/0000-0002-6272-4085; Petrovsky, Nikolai/0000-0002-1580-5245; Gevaert, Kris/0000-0002-4237-0283; Lambrechts, Diether/0000-0002-3429-302X; Delghingaro-Augusto, Viviane/0000-0002-5107-2384; Nolan, Christopher J/0000-0002-6964-3819; Jetten, Anton/0000-0003-0954-4445; Goodnow, Christopher C/0000-0001-5296-6155; Di Marino, Daniele/0000-0001-6961-3129; Gevaert, Kris/0000-0002-4237-0283; Linterman, Michelle/0000-0001-6047-1996; Lagou, Vasiliki/0000-0003-3165-8940; Schlenner, Susan/0000-0002-8553-3388; Dahlstrom, Jane/0000-0001-5608-693X; Carr, Edward/0000-0001-9343-4593; Lesage, Sylvie/0000-0002-0968-2795; Dooley, James/0000-0003-3154-4708; Pasciuto, Emanuela/0000-0002-5391-9585	VIB; European Research Council (ERC); Juvenile Diabetes Research Foundation (JDRF); National Health and Medical Research Council of Australia [1028108]; Swedish Research Council [2009-1039]; Biotechnology and Biological Sciences Research Council [BBS/E/B/000C0409] Funding Source: researchfish; National Institute for Health Research [ACF-2014-14-003] Funding Source: researchfish; Novo Nordisk Fonden [NNF15OC0016416] Funding Source: researchfish; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES100485] Funding Source: NIH RePORTER; BBSRC [BBS/E/B/000C0409] Funding Source: UKRI	VIB; European Research Council (ERC)(European Research Council (ERC)European Commission); Juvenile Diabetes Research Foundation (JDRF)(Juvenile Diabetes Research Foundation); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Swedish Research Council(Swedish Research CouncilEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Institute for Health Research(National Institute for Health Research (NIHR)); Novo Nordisk Fonden(Novo Nordisk Foundation); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the VIB, European Research Council (ERC) and a Juvenile Diabetes Research Foundation (JDRF) Career Development Award (A.L.) and by the National Health and Medical Research Council of Australia (project grant 1028108; C.J.N.). N.O. and V. Lyssenko acknowledge support by a Strategic Research Grant from the Swedish Research Council (2009-1039).	Akkaraju S, 1997, IMMUNITY, V7, P255, DOI 10.1016/S1074-7613(00)80528-2; Apostolou A, 2008, EXP CELL RES, V314, P2454, DOI 10.1016/j.yexcr.2008.05.001; Back SH, 2012, ANNU REV BIOCHEM, V81, P767, DOI 10.1146/annurev-biochem-072909-095555; Bessaoud K, 2006, DIABETIC MED, V23, P857, DOI 10.1111/j.1464-5491.2006.01925.x; Betts P, 2005, DIABETIC MED, V22, P144, DOI 10.1111/j.1464-5491.2004.01368.x; Bradfield JP, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002293; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Ceriotti M, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.020601; Cervin C, 2008, DIABETES, V57, P1433, DOI 10.2337/db07-0299; Chaparro RJ, 2006, P NATL ACAD SCI USA, V103, P12475, DOI 10.1073/pnas.0604317103; CHEATHAM TE, 1995, J AM CHEM SOC, V117, P4193, DOI 10.1021/ja00119a045; Davenport EL, 2007, BLOOD, V110, P2641, DOI 10.1182/blood-2006-11-053728; Delepine M, 2000, NAT GENET, V25, P406, DOI 10.1038/78085; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Donahue RP, 1997, DIABETES CARE, V20, P1670, DOI 10.2337/diacare.20.11.1670; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Engin F, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006534; Fadista J, 2014, P NATL ACAD SCI USA, V111, P13924, DOI 10.1073/pnas.1402665111; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Fortune MD, 2015, NAT GENET, V47, P839, DOI 10.1038/ng.3330; Gale EAM, 2001, DIABETOLOGIA, V44, P3, DOI 10.1007/s001250051573; Ghesquiere B, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006866; Gysemans CA, 2005, DIABETES, V54, P2396, DOI 10.2337/diabetes.54.8.2396; Hall E, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-103; Helsens K, 2010, PROTEOMICS, V10, P1261, DOI 10.1002/pmic.200900409; Hill NJ, 2000, DIABETES, V49, P1744, DOI 10.2337/diabetes.49.10.1744; HILL SW, 1980, EUR J IMMUNOL, V10, P384, DOI 10.1002/eji.1830100513; Islam Md Shahidul, 2012, Methods Mol Biol, V933, P161, DOI 10.1007/978-1-62703-068-7_10; Iwawaki T, 2004, NAT MED, V10, P98, DOI 10.1038/nm970; Izumi T, 2003, DIABETES, V52, P409, DOI 10.2337/diabetes.52.2.409; Janssens S, 2014, NAT IMMUNOL, V15, P910, DOI 10.1038/ni.2991; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kang HS, 2009, MOL CELL BIOL, V29, P6366, DOI 10.1128/MCB.01259-09; Kornete M, 2013, AUTOIMMUNITY, V46, P259, DOI 10.3109/08916934.2012.752462; Laybutt DR, 2007, DIABETOLOGIA, V50, P752, DOI 10.1007/s00125-006-0590-z; Leiter EH, 2007, DIABETES OBES METAB, V9, P14, DOI 10.1111/j.1463-1326.2007.00770.x; Leitman J, 2014, MOL BIOL CELL, V25, P1050, DOI 10.1091/mbc.E13-06-0350; Lesage S, 2002, J EXP MED, V196, P1175, DOI 10.1084/jem.20020735; Li DS, 2009, NAT PROTOC, V4, P1649, DOI 10.1038/nprot.2009.150; Lindahl M, 2014, CELL REP, V7, P366, DOI 10.1016/j.celrep.2014.03.023; Liston A, 2004, IMMUNITY, V21, P817, DOI 10.1016/S1074-7613(04)00313-9; Liston A, 2004, J EXP MED, V200, P1015, DOI 10.1084/jem.20040581; Liston A, 2003, NAT IMMUNOL, V4, P350, DOI 10.1038/ni906; Lyons PA, 2000, GENOME RES, V10, P446, DOI 10.1101/gr.10.4.446; Lyons PA, 2000, IMMUNITY, V13, P107, DOI 10.1016/S1074-7613(00)00012-1; Mahajan A, 2014, NAT GENET, V46, P234, DOI 10.1038/ng.2897; Mao CH, 2004, NAT MED, V10, P1013, DOI 10.1038/nm1004-1013; McCullough KD, 2001, MOL CELL BIOL, V21, P1249, DOI 10.1128/MCB.21.4.1249-1259.2001; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Neuber O, 2005, NAT CELL BIOL, V7, P993, DOI 10.1038/ncb1298; Nijnik A, 2007, NATURE, V447, P686, DOI 10.1038/nature05875; Nogueira TC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003532; Oprescu AI, 2007, DIABETES, V56, P2927, DOI 10.2337/db07-0075; Patterson CC, 2009, LANCET, V373, P2027, DOI 10.1016/S0140-6736(09)60568-7; Planas R, 2010, IMMUNOL LETT, V133, P55, DOI 10.1016/j.imlet.2010.08.001; PODOLIN PL, 1993, J EXP MED, V178, P793, DOI 10.1084/jem.178.3.793; PROCHAZKA M, 1992, P NATL ACAD SCI USA, V89, P3290, DOI 10.1073/pnas.89.8.3290; Puebla-Osorio N, 2014, ONCOGENE, V33, P2748, DOI 10.1038/onc.2013.234; Raj DBTG, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.74; Ramsey C, 2002, HUM MOL GENET, V11, P397, DOI 10.1093/hmg/11.4.397; Rewers M, 2008, ANN NY ACAD SCI, V1150, P1, DOI 10.1196/annals.1447.062; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Senee V, 2006, NAT GENET, V38, P682, DOI 10.1038/ng1802; Sibanda BL, 2001, NAT STRUCT BIOL, V8, P1015, DOI 10.1038/nsb725; Sone H, 2005, DIABETOLOGIA, V48, P58, DOI 10.1007/s00125-004-1605-2; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tavana O, 2010, DIABETES, V59, P135, DOI 10.2337/db09-0792; Tersey SA, 2012, DIABETES, V61, P818, DOI 10.2337/db11-1293; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; WICK G, 1986, IMMUNOL REV, V94, P113, DOI 10.1111/j.1600-065X.1986.tb01167.x; Wicker LS, 2005, J AUTOIMMUN, V25, P29, DOI 10.1016/j.jaut.2005.09.009; WICKER LS, 1995, ANNU REV IMMUNOL, V13, P179, DOI 10.1146/annurev.iy.13.040195.001143; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831	76	81	81	0	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2016	48	5					519	+		10.1038/ng.3531	http://dx.doi.org/10.1038/ng.3531			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DK3RC	26998692	Green Accepted			2022-12-25	WOS:000374834100011
J	von Schaper, E				von Schaper, Eva			Celltrion's infliximab copy shows path to biosimilars in US	NATURE BIOTECHNOLOGY			English	News Item																		2015, NAT BIOTECHNOL, V33, P222; 2015, NAT BIOTECHNOL, V33, P19	2	4	5	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2016	34	5					454	455						2	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DL6FL	27153263				2022-12-25	WOS:000375735000010
J	Bertioli, DJ; Cannon, SB; Froenicke, L; Huang, GD; Farmer, AD; Cannon, EKS; Liu, X; Gao, DY; Clevenger, J; Dash, S; Ren, LH; Moretzsohn, MC; Shirasawa, K; Huang, W; Vidigal, B; Abernathy, B; Chu, Y; Niederhuth, CE; Umale, P; Araujo, ACG; Kozik, A; Do Kim, K; Burow, MD; Varshney, RK; Wang, XJ; Zhang, XY; Barkley, N; Guimaraes, PM; Isobe, S; Guo, BZ; Liao, BS; Stalker, HT; Schmitz, RJ; Scheffler, BE; Leal-Bertioli, SCM; Xun, X; Jackson, SA; Michelmore, R; Ozias-Akins, P				Bertioli, David John; Cannon, Steven B.; Froenicke, Lutz; Huang, Guodong; Farmer, Andrew D.; Cannon, Ethalinda K. S.; Liu, Xin; Gao, Dongying; Clevenger, Josh; Dash, Sudhansu; Ren, Longhui; Moretzsohn, Marcio C.; Shirasawa, Kenta; Huang, Wei; Vidigal, Bruna; Abernathy, Brian; Chu, Ye; Niederhuth, Chad E.; Umale, Pooja; Araujo, Ana Claudia G.; Kozik, Alexander; Do Kim, Kyung; Burow, Mark D.; Varshney, Rajeev K.; Wang, Xingjun; Zhang, Xinyou; Barkley, Noelle; Guimaraes, Patricia M.; Isobe, Sachiko; Guo, Baozhu; Liao, Boshou; Stalker, H. Thomas; Schmitz, Robert J.; Scheffler, Brian E.; Leal-Bertioli, Soraya C. M.; Xun, Xu; Jackson, Scott A.; Michelmore, Richard; Ozias-Akins, Peggy			The genome sequences of Arachis duranensis and Arachis ipaensis, the diploid ancestors of cultivated peanut	NATURE GENETICS			English	Article							GENETIC-LINKAGE MAP; RNA-SEQ DATA; DOMESTICATED PEANUT; QUALITY-CONTROL; B-GENOME; HYPOGAEA; MARKERS; IDENTIFICATION; DIVERGENCE; TOOL	Cultivated peanut (Arachis hypogaea) is an allotetraploid with closely related subgenomes of a total size of similar to 2.7 Gb. This makes the assembly of chromosomal pseudomolecules very challenging. As a foundation to understanding the genome of cultivated peanut, we report the genome sequences of its diploid ancestors (Arachis duranensis and Arachis ipaensis). We show that these genomes are similar to cultivated peanut's A and B subgenomes and use them to identify candidate disease resistance genes, to guide tetraploid transcript assemblies and to detect genetic exchange between cultivated peanut's subgenomes. On the basis of remarkably high DNA identity of the A. ipaensis genome and the B subgenome of cultivated peanut and biogeographic evidence, we conclude that A. ipaensis may be a direct descendant of the same population that contributed the B subgenome to cultivated peanut.	[Bertioli, David John; Vidigal, Bruna] Univ Brasilia, Inst Biol Sci, Brasilia, DF, Brazil; [Bertioli, David John; Gao, Dongying; Abernathy, Brian; Do Kim, Kyung; Leal-Bertioli, Soraya C. M.; Jackson, Scott A.] Univ Georgia, Ctr Appl Genet Technol, Athens, GA 30602 USA; [Cannon, Steven B.] USDA ARS, Corn Insects & Crop Genet Res Unit, Ames, IA USA; [Froenicke, Lutz; Kozik, Alexander; Michelmore, Richard] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA; [Froenicke, Lutz; Michelmore, Richard] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; [Huang, Guodong; Liu, Xin; Xun, Xu] BGI Shenzhen, Shenzhen, Peoples R China; [Farmer, Andrew D.; Dash, Sudhansu; Umale, Pooja] Natl Ctr Genome Resources, Santa Fe, NM USA; [Cannon, Ethalinda K. S.] Iowa State Univ, Dept Comp Sci, Ames, IA USA; [Clevenger, Josh; Ozias-Akins, Peggy] Univ Georgia, Inst Plant Breeding Genet & Genom, Tifton, GA USA; [Ren, Longhui] Iowa State Univ, Interdept Genet Grad Program, Ames, IA USA; [Moretzsohn, Marcio C.; Vidigal, Bruna; Araujo, Ana Claudia G.; Guimaraes, Patricia M.; Leal-Bertioli, Soraya C. M.] Embrapa Genet Resources & Biotechnol, Brasilia, DF, Brazil; [Shirasawa, Kenta; Isobe, Sachiko] Kazusa DNA Res Inst, Dept Frontier Res, Kisarazu, Japan; [Huang, Wei] Iowa State Univ, Dept Agron, Ames, IA USA; [Chu, Ye; Ozias-Akins, Peggy] Univ Georgia, Dept Hort, Tifton, GA USA; [Niederhuth, Chad E.; Schmitz, Robert J.] Univ Georgia, Dept Genet, Athens, GA 30602 USA; [Burow, Mark D.] Texas A&M AgriLife Res, Lubbock, TX USA; [Burow, Mark D.] Texas Tech Univ, Dept Plant & Soil Sci, Lubbock, TX 79409 USA; [Varshney, Rajeev K.] Int Crops Res Inst Semi Arid Trop, Hyderabad, Andhra Pradesh, India; [Wang, Xingjun] Shandong Acad Agr Sci, Biotechnol Res Ctr, Jinan, Peoples R China; [Zhang, Xinyou] Henan Acad Agr Sci, Zhengzhou, Peoples R China; [Barkley, Noelle] USDA ARS, Plant Genet Resources Conservat Unit, Griffin, GA USA; [Barkley, Noelle] Int Potato Ctr, Lima, Peru; [Guo, Baozhu] USDA ARS, Crop Protect & Management Res Unit, Tifton, GA 31793 USA; [Liao, Boshou] Chinese Acad Agr Sci, Oil Crops Res Inst, Wuhan, Peoples R China; [Stalker, H. Thomas] N Carolina State Univ, Dept Crop Sci, Raleigh, NC 27695 USA; [Scheffler, Brian E.] USDA ARS, Middle So Area Genom Lab, Stoneville, MS 38776 USA	Universidade de Brasilia; University System of Georgia; University of Georgia; United States Department of Agriculture (USDA); University of California System; University of California Davis; University of California System; University of California Davis; Beijing Genomics Institute (BGI); National Center for Genome Resources (NCGR); Iowa State University; University System of Georgia; University of Georgia; Iowa State University; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Kazusa DNA Research Institute; Iowa State University; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; Texas A&M University System; Texas A&M University College Station; Texas A&M AgriLife Research; Texas Tech University System; Texas Tech University; CGIAR; International Crops Research Institute for the Semi-Arid-Tropics (ICRISAT); Shandong Academy of Agricultural Sciences; Henan Academy of Agricultural Sciences; United States Department of Agriculture (USDA); CGIAR; International Potato Center (CIP); United States Department of Agriculture (USDA); Chinese Academy of Agricultural Sciences; Oil Crops Research Institute, CAAS; University of North Carolina; North Carolina State University; United States Department of Agriculture (USDA)	Bertioli, DJ (corresponding author), Univ Brasilia, Inst Biol Sci, Brasilia, DF, Brazil.; Bertioli, DJ (corresponding author), Univ Georgia, Ctr Appl Genet Technol, Athens, GA 30602 USA.	djbertioli@gmail.com	Varshney, Rajeev K/C-5295-2014; Guimaraes, Patricia messenberg/G-1824-2012; Xu, Xun/AAI-6763-2020; Schmitz, Robert/AAY-7659-2020; Moretzsohn, Marcio C/E-5517-2014; Shirasawa, Kenta/L-9141-2019	Varshney, Rajeev K/0000-0002-4562-9131; Xu, Xun/0000-0002-5338-5173; Schmitz, Robert/0000-0001-7538-6663; Moretzsohn, Marcio C/0000-0003-1708-1508; Shirasawa, Kenta/0000-0001-7880-6221; jackson, scott/0000-0002-3172-1607; Liu, Xin/0000-0003-3256-2940; Ren, Longhui/0000-0003-3699-5946; Niederhuth, Chad/0000-0003-3268-9079; Guimaraes, patricia/0000-0001-9799-3042; Anglin, Noelle L./0000-0002-3454-1142; BERTIOLI, SORAYA/0000-0002-9683-5357; Bertioli, David/0000-0003-0294-7284; Cannon, Ethalinda/0000-0002-0678-8754; Scheffler, Brian/0000-0003-1968-8952; Cannon, Steven/0000-0003-2777-8034	Agriculture and Food Research Initiative from the US Department of Agriculture [2012-85117-19435]; US National Science Foundation [NSF-MCB-1339194]; EMBRAPA (Brazil) [02.11.08.006.00]; National High-Technology Research and Development Program (China) [2012AA02A701]; Division Of Integrative Organismal Systems [1339194, 1402183] Funding Source: National Science Foundation; Div Of Biological Infrastructure [1444806] Funding Source: National Science Foundation; ARS [ARS-0425040] Funding Source: Federal RePORTER	Agriculture and Food Research Initiative from the US Department of Agriculture; US National Science Foundation(National Science Foundation (NSF)); EMBRAPA (Brazil)(Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)); National High-Technology Research and Development Program (China)(National High Technology Research and Development Program of China); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	We would like to thank G. Birdsong, V. Nwosu, J. Elder, D. Smyth, F. Luo, D. Hoisington, H. Shapiro, H. Valentine, R. Wilson and D. Ward for their support of and work for the Peanut Genome Initiative. We thank J.F.M. Valls, C. Simpson and G. Seijo for valuable discussions. Major financial contributors for this work were from Mars, US peanut sheller associations, the National Peanut Board and other industry groups. A full list can be downloaded at http://peanutbioscience.com/peanutgenomeproject.html. We also thank the generous support of the Agriculture and Food Research Initiative for grant 2012-85117-19435 from the US Department of Agriculture, the US National Science Foundation for grant NSF-MCB-1339194 to R.J.S., EMBRAPA (Brazil) for project 02.11.08.006.00 and the National High-Technology Research and Development Program (China) for grant 2012AA02A701.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ameline-Torregrosa C, 2008, PLANT PHYSIOL, V146, P5, DOI 10.1104/pp.107.104588; Bennetzen JL, 2005, ANN BOT-LONDON, V95, P127, DOI 10.1093/aob/mci008; Bertioli DJ, 2011, PLANT GENET RESOUR-C, V9, P134, DOI 10.1017/S1479262110000444; Bertioli DJ, 2013, ANN BOT-LONDON, V112, P545, DOI 10.1093/aob/mct128; Boetzer M, 2011, BIOINFORMATICS, V27, P578, DOI 10.1093/bioinformatics/btq683; Bonavia Duccio, 1982, PRECERAMICO PERUANO; Burow MD, 1996, MOL BREEDING, V2, P369, DOI 10.1007/BF00437915; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Campbell MS, 2014, PLANT PHYSIOL, V164, P513, DOI 10.1104/pp.113.230144; Cannon Ethalinda K S, 2011, Int J Plant Genomics, V2011, P373875, DOI 10.1155/2011/373875; Cuc LM, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-55; DHILLON SS, 1980, PLANT PHYSIOL, V65, P1121, DOI 10.1104/pp.65.6.1121; Dillehay TD, 2008, SCIENCE, V320, P784, DOI 10.1126/science.1156533; Dillehay TD, 2007, SCIENCE, V316, P1890, DOI 10.1126/science.1141395; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Favero AP, 2006, CROP SCI, V46, P1546, DOI 10.2135/cropsci2005.09-0331; Feng SH, 2010, P NATL ACAD SCI USA, V107, P8689, DOI 10.1073/pnas.1002720107; Fonceka D, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-103; Garcia GM, 1996, GENOME, V39, P836, DOI 10.1139/g96-106; Gautami B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041213; Godoy I.J., 2003, CULTIVARES AMENDOIM; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Grabiele M, 2012, PLANT SYST EVOL, V298, P1151, DOI 10.1007/s00606-012-0627-3; Haas BJ, 2004, BIOINFORMATICS, V20, P3643, DOI 10.1093/bioinformatics/bth397; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hallab A., 2015, THESIS U BONN; HALWARD T, 1992, PLANT MOL BIOL, V18, P315, DOI 10.1007/BF00034958; Holbrook CC, 2007, J PLANT REGIST, V1, P124, DOI 10.3198/jpr2006.09.0575crc; Holt C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-491; Hong YB, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-17; HUSTED L., 1936, Cytologia, V7, P396, DOI 10.1508/cytologia.7.396; Jiao YP, 2014, NAT GENET, V46, P1039, DOI 10.1038/ng0914-1039; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; KOCHERT G, 1991, THEOR APPL GENET, V81, P565, DOI 10.1007/BF00226719; Kochert G, 1996, AM J BOT, V83, P1282, DOI 10.2307/2446112; Korf I, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-59; Krapovickas A., 2007, BONPLANDIA, V16, P1, DOI 10.30972/bon.160158; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; Leal-Bertioli S, 2015, GENETICS, V199, P1093, DOI 10.1534/genetics.115.174607; Leal-Bertioli SCM, 2016, G3-GENES GENOM GENET, V6, P377, DOI 10.1534/g3.115.023044; Leal-Bertioli SCM, 2015, G3-GENES GENOM GENET, V5, P1403, DOI 10.1534/g3.115.018796; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Liu BH, 2012, BIOINFORMATICS, V28, P2870, DOI 10.1093/bioinformatics/bts563; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; McCoy RC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106689; Moretzsohn MC, 2013, ANN BOT-LONDON, V111, P113, DOI 10.1093/aob/mcs237; Moretzsohn MC, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-40; Moretzsohn MC, 2005, THEOR APPL GENET, V111, P1060, DOI 10.1007/s00122-005-0028-x; Nagy ED, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-469; Nagy ED, 2010, MOL BREEDING, V26, P357, DOI 10.1007/s11032-010-9430-4; Nielen S, 2012, MOL GENET GENOMICS, V287, P21, DOI 10.1007/s00438-011-0656-6; Nielen S, 2010, CHROMOSOME RES, V18, P227, DOI 10.1007/s10577-009-9109-z; Qin HD, 2012, THEOR APPL GENET, V124, P653, DOI 10.1007/s00122-011-1737-y; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; R Development Core Team, 2014, R LANG ENV STAT COMP; Ramos ML, 2006, MOL GENET GENOMICS, V275, P578, DOI 10.1007/s00438-006-0114-z; Robledo G, 2009, THEOR APPL GENET, V118, P1295, DOI 10.1007/s00122-009-0981-x; Robledo G, 2010, THEOR APPL GENET, V121, P1033, DOI 10.1007/s00122-010-1369-7; Samoluk SS, 2015, GENET RESOUR CROP EV, V62, P747, DOI 10.1007/s10722-014-0193-3; Schiex T, 1997, ISMB-97 - FIFTH INTERNATIONAL CONFERENCE ON INTELLIGENT SYSTEMS FOR MOLECULAR BIOLOGY, PROCEEDINGS, P258; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Schultz MD, 2012, TRENDS GENET, V28, P583, DOI 10.1016/j.tig.2012.10.012; Samoluk SS, 2015, GENETICA, V143, P113, DOI 10.1007/s10709-015-9820-y; Seijo G, 2007, AM J BOT, V94, P1963, DOI 10.3732/ajb.94.12.1963; Shirasawa K, 2013, DNA RES, V20, P173, DOI 10.1093/dnares/dss042; Shirasawa K, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-80; Simpson C.E., 2001, PEANUT SCI, V28, P78, DOI [10.3146/i0095-3679-28-2-7, DOI 10.3146/I0095-3679-28-2-7]; SMITH BW, 1950, AM J BOT, V37, P802, DOI 10.2307/2437758; Sujay V, 2012, MOL BREEDING, V30, P773, DOI 10.1007/s11032-011-9661-z; Tian ZX, 2009, GENOME RES, V19, P2221, DOI 10.1101/gr.083899.108; Wu TD, 2005, BIOINFORMATICS, V21, P1859, DOI 10.1093/bioinformatics/bti310; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zemach A, 2010, SCIENCE, V328, P916, DOI 10.1126/science.1186366; Zhang GY, 2012, NAT BIOTECHNOL, V30, P549, DOI 10.1038/nbt.2195; Zhou XJ, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-351	82	476	526	10	128	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2016	48	4					438	+		10.1038/ng.3517	http://dx.doi.org/10.1038/ng.3517			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DH6NZ	26901068	Green Published, hybrid			2022-12-25	WOS:000372908800015
J	Song, S; Miranda, CJ; Braun, L; Meyer, K; Frakes, AE; Ferraiuolo, L; Likhite, S; Bevan, AK; Foust, KD; McConnell, MJ; Walker, CM; Kaspar, BK				Song, SungWon; Miranda, Carlos J.; Braun, Lyndsey; Meyer, Kathrin; Frakes, Ashley E.; Ferraiuolo, Laura; Likhite, Shibi; Bevan, Adam K.; Foust, Kevin D.; McConnell, Michael J.; Walker, Christopher M.; Kaspar, Brian K.			Major histocompatibility complex class I molecules protect motor neurons from astrocyte-induced toxicity in amyotrophic lateral sclerosis	NATURE MEDICINE			English	Article							MHC CLASS-I; ENDOPLASMIC-RETICULUM STRESS; CENTRAL-NERVOUS-SYSTEM; SELECTIVE ER STRESS; NEURAL STEM-CELLS; SYNAPTIC PLASTICITY; DISEASE PROGRESSION; HLA-F; EXTENDS SURVIVAL; SPORADIC ALS	Astrocytes isolated from individuals with amyotrophic lateral sclerosis (ALS) are toxic to motor neurons (MNs) and play a non-cell autonomous role in disease pathogenesis. The mechanisms underlying the susceptibility of MNs to cell death remain unclear. Here we report that astrocytes derived from either mice bearing mutations in genes associated with ALS or human subjects with ALS reduce the expression of major histocompatibility complex class I (MHCI) molecules on MNs; reduced MHCI expression makes these MNs susceptible to astrocyte-induced cell death. Increasing MHCI expression on MNs increases survival and motor performance in a mouse model of ALS and protects MNs against astrocyte toxicity. Overexpression of a single MHCI molecule, HLA-F, protects human MNs from ALS astrocyte-mediated toxicity, whereas knockdown of its receptor, the killer cell immunoglobulin-like receptor KIR3DL2, on human astrocytes results in enhanced MN death. Thus, our data indicate that, in ALS, loss of MHCI expression on MNs renders them more vulnerable to astrocyte-mediated toxicity.	[Song, SungWon; Miranda, Carlos J.; Braun, Lyndsey; Meyer, Kathrin; Frakes, Ashley E.; Ferraiuolo, Laura; Likhite, Shibi; Bevan, Adam K.; Foust, Kevin D.; Kaspar, Brian K.] Nationwide Childrens Hosp, Res Inst, Ctr Gene Therapy, Columbus, OH USA; [Song, SungWon; Likhite, Shibi; Kaspar, Brian K.] Ohio State Univ, Mol Cellular & Dev Biol Grad Program, Columbus, OH 43210 USA; [Frakes, Ashley E.; Bevan, Adam K.; Kaspar, Brian K.] Ohio State Univ, Biomed Sci Grad Program, Columbus, OH 43210 USA; [Foust, Kevin D.; Kaspar, Brian K.] Ohio State Univ, Dept Neurosci, Columbus, OH 43210 USA; [McConnell, Michael J.] Univ Virginia, Ctr Brain Immunol & Glia, Dept Biochem & Mol Genet, Charlottesville, VA USA; [Walker, Christopher M.] Nationwide Childrens Hosp, Res Inst, Ctr Vaccines & Immun, Columbus, OH USA; [Walker, Christopher M.; Kaspar, Brian K.] Ohio State Univ, Dept Pediat, Coll Med & Publ Hlth, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of Virginia; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University	Kaspar, BK (corresponding author), Nationwide Childrens Hosp, Res Inst, Ctr Gene Therapy, Columbus, OH USA.; Kaspar, BK (corresponding author), Ohio State Univ, Mol Cellular & Dev Biol Grad Program, Columbus, OH 43210 USA.; Kaspar, BK (corresponding author), Ohio State Univ, Dept Neurosci, Columbus, OH 43210 USA.; Kaspar, BK (corresponding author), Ohio State Univ, Dept Pediat, Coll Med & Publ Hlth, Columbus, OH 43210 USA.	Brian.Kaspar@NationwideChildrens.org	Ferraiuolo, Laura/E-5834-2010	Ferraiuolo, Laura/0000-0001-9118-5714; Likhite, Shibi/0000-0002-7040-3820; Meyer, Kathrin/0000-0002-5052-2101	US National Institutes of Health (NIH)-NINDS grant [P30NS055077]; NIH [R01-NS644912, RC2-NS69476]; Robert Packard Center for ALS Research; Project A.L.S.; Helping Link Foundation; Swiss National Science Foundation; Marie Curie Foundation; NINDS Training in Neuromuscular Disease; Ohio State University Presidential Fellowship; Ohio State University and Nationwide Children's Hospital Muscle Group Fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS077984, P30NS055077, RC2NS069476, R01NS064492] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)-NINDS grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert Packard Center for ALS Research; Project A.L.S.; Helping Link Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Marie Curie Foundation(European Commission); NINDS Training in Neuromuscular Disease; Ohio State University Presidential Fellowship(Ohio State University); Ohio State University and Nationwide Children's Hospital Muscle Group Fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank C. Shatz (Stanford University) for critical discussions; S. Eckardt for expert editorial assistance; the National Disease Research Institute (NDRI), A. Burghes (Ohio State University), J.R. Mendell (Nationwide Children's Hospital), J. Glass and M. Gearing (Emory University; supported by US National Institutes of Health (NIH)-NINDS grant no. P30NS055077) for providing human spinal cord specimens; F. Gage (Salk Institute) for providing human post-mortem neural progenitor cells (NPCs) that were used to generate non-ALS astrocytes; M. Hester for guidance with iPSC generation; T. Jessell (Columbia University) for HBG3 cells; and K. Campbell for technical assistance. This work was supported by NIH grants R01-NS644912 (B.K.K.) and RC2-NS69476 (B.K.K.), funding from the Robert Packard Center for ALS Research (B.K.K.), the Project A.L.S. (B.K.K.) and the Helping Link Foundation (B.K.K.). The authors that were a part of this work also received research fellowships from the Swiss National Science Foundation (K.M.), the Marie Curie Foundation (L.F.), the NINDS Training in Neuromuscular Disease (A.E.F.), the Ohio State University Presidential Fellowship (S.W.S.) and the Ohio State University and Nationwide Children's Hospital Muscle Group Fellowship (S.W.S.).	Bevan AK, 2011, MOL THER, V19, P1971, DOI 10.1038/mt.2011.157; Bosco DA, 2010, NAT NEUROSCI, V13, P1396, DOI 10.1038/nn.2660; Boulanger LM, 2009, NEURON, V64, P93, DOI 10.1016/j.neuron.2009.09.001; Brown RH, 1997, ARCH NEUROL-CHICAGO, V54, P1246, DOI 10.1001/archneur.1997.00550220050013; Chakrabarty P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067680; Chiu IM, 2008, P NATL ACAD SCI USA, V105, P17913, DOI 10.1073/pnas.0804610105; Clarke LE, 2013, NAT REV NEUROSCI, V14, P311, DOI 10.1038/nrn3484; de L'Etang AF, 2015, NAT NEUROSCI, V18, P227, DOI 10.1038/nn.3903; Diaz-Amarilla P, 2011, P NATL ACAD SCI USA, V108, P18126, DOI 10.1073/pnas.1110689108; Dodge JC, 2008, MOL THER, V16, P1056, DOI 10.1038/mt.2008.60; Fourgeaud L, 2010, P NATL ACAD SCI USA, V107, P22278, DOI 10.1073/pnas.0914064107; Foust KD, 2013, MOL THER, V21, P2148, DOI 10.1038/mt.2013.211; Foust KD, 2009, NAT BIOTECHNOL, V27, P59, DOI 10.1038/nbt.1515; Frakes AE, 2014, NEURON, V81, P1009, DOI 10.1016/j.neuron.2014.01.013; Freria CM, 2010, J COMP NEUROL, V518, P990, DOI 10.1002/cne.22259; Goddard CA, 2007, P NATL ACAD SCI USA, V104, P6828, DOI 10.1073/pnas.0702023104; Goodridge JP, 2013, J IMMUNOL, V191, P3553, DOI 10.4049/jimmunol.1300081; Gruzman A, 2007, P NATL ACAD SCI USA, V104, P12524, DOI 10.1073/pnas.0705044104; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Haidet-Phillips AM, 2011, NAT BIOTECHNOL, V29, P824, DOI 10.1038/nbt.1957; Hansen TH, 2009, NAT REV IMMUNOL, V9, P503, DOI 10.1038/nri2575; Hardiman O, 2011, NAT REV NEUROL, V7, P639, DOI 10.1038/nrneurol.2011.153; Hester ME, 2011, MOL THER, V19, P1905, DOI 10.1038/mt.2011.135; Hester ME, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007044; Huh GS, 2000, SCIENCE, V290, P2155, DOI 10.1126/science.290.5499.2155; Ilieva H, 2009, J CELL BIOL, V187, P761, DOI 10.1083/jcb.200908164; Ishigami S, 2013, J SURG RES, V184, P802, DOI 10.1016/j.jss.2013.04.003; Israelson A, 2015, NEURON, V86, P218, DOI 10.1016/j.neuron.2015.02.034; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Kikuchi H, 2006, P NATL ACAD SCI USA, V103, P6025, DOI 10.1073/pnas.0509227103; Kim JB, 2008, NATURE, V454, P646, DOI 10.1038/nature07061; Kim T, 2013, SCIENCE, V341, P1399, DOI 10.1126/science.1242077; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Lautenschlaeger J, 2012, AMYOTROPH LATERAL SC, V13, P166, DOI 10.3109/17482968.2011.641569; Lee HM, 2014, NATURE, V509, P195, DOI 10.1038/nature13154; Linda H, 1999, J NEUROIMMUNOL, V101, P76, DOI 10.1016/S0165-5728(99)00135-6; Liu JN, 2013, NEUROCHEM RES, V38, P290, DOI 10.1007/s11064-012-0920-0; Long EO, 1999, ANNU REV IMMUNOL, V17, P875, DOI 10.1146/annurev.immunol.17.1.875; Ludolph AC, 2010, AMYOTROPH LATERAL SC, V11, P38, DOI 10.3109/17482960903545334; Lutz C., 2009, WORKING ALS MICE GUI; Marchetto MCN, 2008, CELL STEM CELL, V3, P649, DOI 10.1016/j.stem.2008.10.001; Mayer-Proschel M., 1998, CULTURE ASTROCYTES O; McConnell MJ, 2009, P NATL ACAD SCI USA, V106, P6784, DOI 10.1073/pnas.0902018106; Meyer K, 2015, MOL THER, V23, P477, DOI 10.1038/mt.2014.210; Meyer K, 2014, P NATL ACAD SCI USA, V111, P829, DOI 10.1073/pnas.1314085111; Miranda CJ, 2012, AGING CELL, V11, P542, DOI 10.1111/j.1474-9726.2012.00816.x; Miyazaki Y, 2012, NAT MED, V18, P1136, DOI 10.1038/nm.2791; Moscoso J, 2006, TRANSPL IMMUNOL, V17, P61, DOI 10.1016/j.trim.2006.09.010; Nagai M, 2007, NAT NEUROSCI, V10, P615, DOI 10.1038/nn1876; Nardo G, 2013, BRAIN, V136, P3305, DOI 10.1093/brain/awt250; Needleman LA, 2010, P NATL ACAD SCI USA, V107, P16999, DOI 10.1073/pnas.1006087107; Nishitoh H, 2008, GENE DEV, V22, P1451, DOI 10.1101/gad.1640108; Oliveira ALR, 2004, P NATL ACAD SCI USA, V101, P17843, DOI 10.1073/pnas.0408154101; Philips T, 2014, EXP NEUROL, V262, P111, DOI 10.1016/j.expneurol.2014.05.015; Ray J, 2006, MOL CELL NEUROSCI, V31, P560, DOI 10.1016/j.mcn.2005.11.010; Re DB, 2014, NEURON, V81, P1001, DOI 10.1016/j.neuron.2014.01.011; Rivera-Quinones C, 1998, NAT MED, V4, P187, DOI 10.1038/nm0298-187; Robbins KL, 2014, HUM MOL GENET, V23, P4559, DOI 10.1093/hmg/ddu169; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Saxena S, 2009, NAT NEUROSCI, V12, P627, DOI 10.1038/nn.2297; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Staats KA, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00249; Syken J, 2003, P NATL ACAD SCI USA, V100, P13048, DOI 10.1073/pnas.1735415100; Tay CH, 1998, CURR TOP MICROBIOL, V230, P193; Thams S, 2009, J NEUROSCI, V29, P13503, DOI 10.1523/JNEUROSCI.0981-09.2009; Thompson A, 2006, IMMUNOGENETICS, V58, P865, DOI 10.1007/s00251-006-0163-9; Tian L, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-155; Van Deerlin VM, 2008, LANCET NEUROL, V7, P409, DOI 10.1016/S1474-4422(08)70071-1; Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942; Zhang JG, 2013, HUM IMMUNOL, V74, P828, DOI 10.1016/j.humimm.2013.03.002	71	82	84	1	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2016	22	4					397	+		10.1038/nm.4052	http://dx.doi.org/10.1038/nm.4052			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DI4GF	26928464	Green Accepted			2022-12-25	WOS:000373457700015
J	Suzuki, A; Badger, BL; Haase, J; Ohashi, T; Erickson, HP; Salmon, ED; Bloom, K				Suzuki, Aussie; Badger, Benjamin L.; Haase, Julian; Ohashi, Tomoo; Erickson, Harold P.; Salmon, Edward D.; Bloom, Kerry			How the kinetochore couples microtubule force and centromere stretch to move chromosomes	NATURE CELL BIOLOGY			English	Article							MITOTIC SPINDLE INTEGRITY; NDC80 COMPLEX; SACCHAROMYCES-CEREVISIAE; DUO1P/DAM1P COMPLEX; PLUS ENDS; DAM1 RING; YEAST; ATTACHMENT; METAPHASE; PROTEINS	The Ndc80 complex (Ndc80, Nuf2, Spc24 and Spc25) is a highly conserved kinetochore protein essential for end-on anchorage to spindle microtubule plus ends and for force generation coupled to plus-end polymerization and depolymerization. Spc24/Spc25 at one end of the Ndc80 complex binds the kinetochore. The N-terminal tail and CH domains of Ndc80 bind microtubules, and an internal domain binds microtubule-associated proteins (MAPs) such as the Dam1 complex. To determine how the microtubule-and MAP-binding domains of Ndc80 contribute to force production at the kinetochore in budding yeast, we have inserted a FRET tension sensor into the Ndc80 protein about halfway between its microtubule-binding and internal loop domains. The data support a mechanical model of force generation at metaphase where the position of the kinetochore relative to the microtubule plus end reflects the relative strengths of microtubule depolymerization, centromere stretch and microtubule-binding interactions with the Ndc80 and Dam1 complexes.	[Suzuki, Aussie; Badger, Benjamin L.; Haase, Julian; Salmon, Edward D.; Bloom, Kerry] Univ N Carolina, Dept Biol, CB 3280, Chapel Hill, NC 27599 USA; [Ohashi, Tomoo; Erickson, Harold P.] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA	University of North Carolina; University of North Carolina Chapel Hill; Duke University	Suzuki, A (corresponding author), Univ N Carolina, Dept Biol, CB 3280, Chapel Hill, NC 27599 USA.	suzukia@email.unc.edu	Suzuki, Aussie/ABF-4170-2021	Bloom, Kerry/0000-0002-3457-004X; Suzuki, Aussie/0000-0001-7390-5116; Haase, Julian/0000-0001-5891-4241	Uehara Memorial Foundation; Kazato Research Foundation; Japan Society and Promotion of Science; Summer Undergraduate Research Fellowship from UNC; National Institutes of Health [R37GM024364, R01GM24364, R37GM32238, R01GM66014]; NATIONAL CANCER INSTITUTE [P30CA016086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066014, R37GM024364, R01GM032238, R01GM024364, R37GM032238] Funding Source: NIH RePORTER	Uehara Memorial Foundation(Uehara Memorial Foundation); Kazato Research Foundation(Kazato Research Foundation); Japan Society and Promotion of Science; Summer Undergraduate Research Fellowship from UNC; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank E. Yeh (UNC, USA), K. Plevock (UNC, USA), D. Pellman (Harvard, USA) and S. Biggins (Fred Hutch, USA) for critical reagents and valuable suggestions. We would also like to thank A. McAnish for providing the drawing tool for the model. This work was supported by the Uehara Memorial Foundation, Kazato Research Foundation, and Japan Society and Promotion of Science (A.S.), the Summer Undergraduate Research Fellowship from UNC (B.L.B.), and by R37GM024364 and R01GM24364 (E.D.S.), R37GM32238 (K.B.) and R01GM66014 (H.P.E.) from the National Institutes of Health.	Akiyoshi B, 2009, GENETICS, V183, P1591, DOI 10.1534/genetics.109.109041; Chacon JM, 2014, J CELL BIOL, V205, P313, DOI 10.1083/jcb.201312024; Cheeseman IM, 2001, J CELL BIOL, V152, P197, DOI 10.1083/jcb.152.1.197; Ciferri C, 2008, CELL, V133, P427, DOI 10.1016/j.cell.2008.03.020; DeLuca KF, 2011, J CELL SCI, V124, P622, DOI 10.1242/jcs.072629; Demirel PB, 2012, GENETICS, V192, P753, DOI 10.1534/genetics.112.143818; Dumont S, 2012, SCIENCE, V337, P355, DOI 10.1126/science.1221886; Enquist-Newman M, 2001, MOL BIOL CELL, V12, P2601, DOI 10.1091/mbc.12.9.2601; Franck AD, 2007, NAT CELL BIOL, V9, P832, DOI 10.1038/ncb1609; Gardner MK, 2005, MOL BIOL CELL, V16, P3764, DOI 10.1091/mbc.E05-04-0275; Grishchuk EL, 2008, P NATL ACAD SCI USA, V105, P15423, DOI 10.1073/pnas.0807859105; Haase J, 2013, CURR BIOL, V23, P1939, DOI 10.1016/j.cub.2013.07.083; Hofmann C, 1998, J CELL BIOL, V143, P1029, DOI 10.1083/jcb.143.4.1029; Hsu KS, 2011, CURR BIOL, V21, P214, DOI 10.1016/j.cub.2010.12.048; INOUE S, 1995, MOL BIOL CELL, V6, P1619, DOI 10.1091/mbc.6.12.1619; Janke C, 2002, EMBO J, V21, P181, DOI 10.1093/emboj/21.1.181; Joglekar AP, 2010, CURR OPIN CELL BIOL, V22, P57, DOI 10.1016/j.ceb.2009.12.010; Joglekar AP, 2009, CURR BIOL, V19, P694, DOI 10.1016/j.cub.2009.02.056; Lampert F, 2013, J CELL BIOL, V200, P21, DOI 10.1083/jcb.201210091; Lampert F, 2010, J CELL BIOL, V189, P641, DOI 10.1083/jcb.200912021; Lawrimore J, 2011, J CELL BIOL, V195, P573, DOI 10.1083/jcb.201106036; Li YM, 2002, GENE DEV, V16, P183, DOI 10.1101/gad.959402; Maddox PS, 2003, CURR BIOL, V13, P1423, DOI 10.1016/S0960-9822(03)00547-5; Marco E, 2013, CELL, V154, P1127, DOI 10.1016/j.cell.2013.08.008; Maure JF, 2011, CURR BIOL, V21, P207, DOI 10.1016/j.cub.2010.12.050; McIntosh JR, 2013, J CELL BIOL, V200, P459, DOI 10.1083/jcb.201209154; NICKLAS RB, 1989, J CELL SCI, V94, P415; Nogales E, 2009, J CELL SCI, V122, P3831, DOI 10.1242/jcs.004689; Ohashi T, 2007, PROTEIN SCI, V16, P1429, DOI 10.1110/ps.072845607; Pearson CG, 2003, MOL BIOL CELL, V14, P4181, DOI 10.1091/mbc.e03-03-0180; Pearson CG, 2006, MOL BIOL CELL, V17, P4069, DOI 10.1091/mbc.E06-04-0312; Powers AF, 2009, CELL, V136, P865, DOI 10.1016/j.cell.2008.12.045; Sarangapani KK, 2013, P NATL ACAD SCI USA, V110, P7282, DOI 10.1073/pnas.1220700110; Shimogawa MM, 2006, CURR BIOL, V16, P1489, DOI 10.1016/j.cub.2006.06.063; Slep KC, 2007, MOL CELL, V27, P976, DOI 10.1016/j.molcel.2007.07.023; Suzuki A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9161; Suzuki A, 2014, DEV CELL, V30, P717, DOI 10.1016/j.devcel.2014.08.003; Tanaka K, 2005, NATURE, V434, P987, DOI 10.1038/nature03483; Tien JF, 2010, J CELL BIOL, V189, P713, DOI 10.1083/jcb.200910142; Verdaasdonk JS, 2013, MOL CELL, V52, P819, DOI 10.1016/j.molcel.2013.10.021; Volkov VA, 2013, P NATL ACAD SCI USA, V110, P7708, DOI 10.1073/pnas.1305821110; Wang HW, 2008, J MOL BIOL, V383, P894, DOI 10.1016/j.jmb.2008.08.077; Wei RR, 2007, NAT STRUCT MOL BIOL, V14, P54, DOI 10.1038/nsmb1186; Westermann S, 2005, MOL CELL, V17, P277, DOI 10.1016/j.molcel.2004.12.019; Winey M, 2012, GENETICS, V190, P1197, DOI 10.1534/genetics.111.128710; Zaytsev AV, 2015, MOL BIOL CELL, V26, P1829, DOI 10.1091/mbc.E14-11-1539; Zaytsev AV, 2014, J CELL BIOL, V206, P45, DOI 10.1083/jcb.201312107; Zhang G, 2012, J CELL SCI, V125, P3243, DOI 10.1242/jcs.104208	48	49	49	1	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2016	18	4					382	+		10.1038/ncb3323	http://dx.doi.org/10.1038/ncb3323			24	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	DH7LX	26974660	Green Accepted, Green Submitted			2022-12-25	WOS:000372976600006
J	Ambrogio, C; Gomez-Lopez, G; Falcone, M; Vidal, A; Nadal, E; Crosetto, N; Blasco, RB; Fernandez-Marcos, PJ; Sanchez-Cespedes, M; Ren, XM; Wang, Z; Ding, K; Hidalgo, M; Serrano, M; Villanueva, A; Santamaria, D; Barbacid, M				Ambrogio, Chiara; Gomez-Lopez, Gonzalo; Falcone, Mattia; Vidal, August; Nadal, Ernest; Crosetto, Nicola; Blasco, Rafael B.; Fernandez-Marcos, Pablo J.; Sanchez-Cespedes, Montserrat; Ren, Xiaomei; Wang, Zhen; Ding, Ke; Hidalgo, Manuel; Serrano, Manuel; Villanueva, Alberto; Santamaria, David; Barbacid, Mariano			Combined inhibition of DDR1 and Notch signaling is a therapeutic strategy for KRAS-driven lung adenocarcinoma	NATURE MEDICINE			English	Article							DOMAIN RECEPTOR 1; K-RAS ONCOGENE; TYROSINE KINASE; POOR-PROGNOSIS; CELL-SURVIVAL; C-RAF; CANCER; TUMOR; EXPRESSION; PATHWAY	Patients with advanced Kirsten rat sarcoma viral oncogene homolog (KRAS)-mutant lung adenocarcinoma are currently treated with standard chemotherapy because of a lack of efficacious targeted therapies. We reasoned that the identification of mediators of Kras signaling in early mouse lung hyperplasias might bypass the difficulties that are imposed by intratumor heterogeneity in advanced tumors, and that it might unveil relevant therapeutic targets. Transcriptional profiling of Kras(G12V)-driven mouse hyperplasias revealed intertumor diversity with a subset that exhibited an aggressive transcriptional profile analogous to that of advanced human adenocarcinomai. The top-scoring gene in this profile encodes the tyrosine kinase receptor DDR1. The genetic and pharmacological inhibition of DDR1 blocked tumor initiation and tumor progression, respectively. The concomitant inhibition of both DDR1 and Notch signaling induced the regression of KRAS;TP53-mutant patient-derived lung xenografts (PDX) with a therapeutic efficacy that was at least comparable to that of standard chemotherapy. Our data indicate that the combined inhibition of DDR1 and Notch signaling could be an effective targeted therapy for patients with KRAS-mutant lung adenocarcinoma.	[Ambrogio, Chiara; Falcone, Mattia; Blasco, Rafael B.; Santamaria, David; Barbacid, Mariano] CNIO, Mol Oncol Programme, Expt Oncol, Madrid, Spain; [Gomez-Lopez, Gonzalo] CNIO, Struct Biol & Biocomp Programme, Bioinformat Unit, Madrid, Spain; [Vidal, August] Univ Hosp Bellvitge, Dept Pathol, Bellvitge Biomed Res Inst IDIBELL, Barcelona, Spain; [Vidal, August; Villanueva, Alberto] Xenopat SL, Business Bioincubator, Bellvitge Hlth Sci Campus, Barcelona, Spain; [Nadal, Ernest] Catalan Inst Oncol ICO, Dept Med Oncol, Thorac Oncol Unit, Barcelona, Spain; [Crosetto, Nicola] Karolinska Inst, Dept Med Biochem & Biophys, Div Translat Med & Chem Biol, Sci Life Lab, Stockholm, Sweden; [Fernandez-Marcos, Pablo J.; Serrano, Manuel] CNIO, Mol Oncol Programme, Tumour Suppress, Madrid, Spain; [Sanchez-Cespedes, Montserrat] IDIBELL, Canc Epigenet & Biol Program PEBC, Barcelona, Spain; [Ren, Xiaomei; Wang, Zhen; Ding, Ke] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, State Key Lab Resp Dis, Guangzhou 510530, Guangdong, Peoples R China; [Hidalgo, Manuel] CNIO, Gastrointestinal Canc Clin Res Unit, Madrid, Spain; [Villanueva, Alberto] ICO, IDIBELL, Program Canc Therapeut Resistance ProCURE, Chemoresistance & Predict Factors Grp, Barcelona, Spain; [Falcone, Mattia] Deutsch Krebsforschungszentrum DKFZ, Div Stem Cells & Canc, Heidelberg, Germany; [Blasco, Rafael B.] Harvard Univ, Sch Med, Dept Pathol, Boston Childrens Hosp, Boston, MA 02115 USA	Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO); Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; Catalan Institute of Oncology; Karolinska Institutet; Centro Nacional de Investigaciones Oncologicas (CNIO); Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; State Key Laboratory of Respiratory Disease; Centro Nacional de Investigaciones Oncologicas (CNIO); Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; Helmholtz Association; German Cancer Research Center (DKFZ); Harvard University; Boston Children's Hospital; Harvard Medical School	Ambrogio, C; Santamaria, D; Barbacid, M (corresponding author), CNIO, Mol Oncol Programme, Expt Oncol, Madrid, Spain.	cambrogio@cnio.es; dsantamaria@cnio.es; mbarbacid@cnio.es	Vidal, August/N-4662-2016; Santamaria, David/D-3930-2011; Gomez-Lopez, Gonzalo/D-9123-2016; Fernandez, Pablo J/F-1840-2016; Sanchez-Cespedes, Montse/H-8485-2012; Serrano, Manuel/H-2634-2015	Vidal, August/0000-0001-5727-2099; Santamaria, David/0000-0002-4711-3569; Gomez-Lopez, Gonzalo/0000-0002-4146-0551; Fernandez, Pablo J/0000-0003-3515-4125; Sanchez-Cespedes, Montse/0000-0002-6045-5627; Serrano, Manuel/0000-0001-7177-9312; Nadal, Ernest/0000-0002-9674-5554; Ding, Ke/0000-0001-9016-812X; Falcone, Mattia/0000-0003-0906-5735; Wang, Zhen/0000-0001-8762-6089; Ambrogio, Chiara/0000-0003-4122-701X	European Research Council [ERC-AG/250297-RAS AEAD]; EU-Framework Programme [LSHG-CT-2007-037665/CHEMORES, HEALTH-F2-2010-259770/LUNGTARGET, HEALTH-2010-260791/EUROCANPLATFORM]; Spanish Ministry of Economy and Competitiveness [SAF2011-30173, SAF2014-59864-R]; Autonomous Community of Madrid [S2011/BDM-2470/ONCOCYCLE]; Endowed Chair from the AXA Research Fund; Fondo de Investigaciones Sanitarias FIS [PI13-01339]; Fundacion Mutua Madrilena [AP150932014]; Juan Rodes fellowship from the Carlos III Health Institute [JR13/0002]; Fondo de Investigaciones Sanitarias [FIS PI14-01109]; National Science Fund for Distinguished Young Scholars of China [81425021]; Spanish Association Against Cancer, AECC	European Research Council(European Research Council (ERC)European Commission); EU-Framework Programme; Spanish Ministry of Economy and Competitiveness(Spanish Government); Autonomous Community of Madrid; Endowed Chair from the AXA Research Fund(AXA Research Fund); Fondo de Investigaciones Sanitarias FIS(Instituto de Salud Carlos III); Fundacion Mutua Madrilena(Instituto de Salud Carlos III); Juan Rodes fellowship from the Carlos III Health Institute; Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); National Science Fund for Distinguished Young Scholars of China(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Spanish Association Against Cancer, AECC	We thank T. Hoey (OncoMed Pharmaceuticals) for providing us with demcizumab and for critical analysis of the data, as well as A. Vivancos (VHIO) for MiSeq analysis. We are thankful to S. Lee (Massachusetts General Hospital and Harvard University) for advice and reagents. We are grateful to O. Kocher, R. Pal and M. Joseph (Beth Israel Deaconess Medical Center) for help with LCM. This work was supported by grants from the European Research Council (ERC-AG/250297-RAS AEAD), the EU-Framework Programme (LSHG-CT-2007-037665/CHEMORES; HEALTH-F2-2010-259770/LUNGTARGET; and HEALTH-2010-260791/EUROCANPLATFORM), the Spanish Ministry of Economy and Competitiveness (SAF2011-30173 and SAF2014-59864-R), the Autonomous Community of Madrid (S2011/BDM-2470/ONCOCYCLE) and an Endowed Chair from the AXA Research Fund (all to M.B.), Fondo de Investigaciones Sanitarias FIS (PI13-01339 and Oncoprofile) and Fundacion Mutua Madrilena AP150932014 (to A.Villanueva), a Juan Rodes fellowship from the Carlos III Health Institute (JR13/0002) and Fondo de Investigaciones Sanitarias (FIS PI14-01109) (to RN.), the National Science Fund for Distinguished Young Scholars of China (81425021; to K.D.) and a postdoctoral fellowship from the Spanish Association Against Cancer, AECC (to C.A.). We thank R. Chiarle, T. Cash, S. Marro, M.L. De Bonis and A. Maraver for their critical reading of the manuscript and L. Paz-Ares for constructive discussion.	Andersson ER, 2014, NAT REV DRUG DISCOV, V13, P359, DOI 10.1038/nrd4252; Bailis W, 2014, METHODS MOL BIOL, V1187, P247, DOI 10.1007/978-1-4939-1139-4_19; Blasco RB, 2011, CANCER CELL, V19, P652, DOI 10.1016/j.ccr.2011.04.002; Burrell RA, 2014, CURR OPIN GENET DEV, V24, P61, DOI 10.1016/j.gde.2013.11.011; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chen Z, 2012, NATURE, V483, P613, DOI 10.1038/nature10937; Chetoui N, 2011, J CELL BIOCHEM, V112, P3666, DOI 10.1002/jcb.23300; Crystal AS, 2014, SCIENCE, V346, P1480, DOI 10.1126/science.1254721; Day CP, 2015, CELL, V163, P39, DOI 10.1016/j.cell.2015.08.068; Desai TJ, 2014, NATURE, V507, P190, DOI 10.1038/nature12930; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gao MS, 2013, J MED CHEM, V56, P3281, DOI 10.1021/jm301824k; Gerlinger M, 2014, ANNU REV GENET, V48, P215, DOI 10.1146/annurev-genet-120213-092314; Gould SE, 2015, NAT MED, V21, P431, DOI 10.1038/nm.3853; Gridelli C, 2014, CANCER TREAT REV, V40, P300, DOI 10.1016/j.ctrv.2013.07.002; Guerra C, 2003, CANCER CELL, V4, P111, DOI 10.1016/S1535-6108(03)00191-0; Guerrot D, 2011, AM J PATHOL, V179, P83, DOI 10.1016/j.ajpath.2011.03.023; Hassan KA, 2013, CLIN CANCER RES, V19, P1972, DOI 10.1158/1078-0432.CCR-12-0370; Hegde GV, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004438; Ito T, 2000, Development, V127, P3913; Janne PA, 2013, LANCET ONCOL, V14, P38, DOI 10.1016/S1470-2045(12)70489-8; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Johnson FM, 2010, J CLIN ONCOL, V28, P4609, DOI 10.1200/JCO.2010.30.5474; Karreth FA, 2011, CANCER DISCOV, V1, P128, DOI 10.1158/2159-8290.CD-10-0044; Kim HG, 2011, J BIOL CHEM, V286, P17672, DOI 10.1074/jbc.M111.236612; Leitinger B, 2014, INT REV CEL MOL BIO, V310, P39, DOI 10.1016/B978-0-12-800180-6.00002-5; Li JN, 2010, NAT CHEM BIOL, V6, P291, DOI [10.1038/NCHEMBIO.332, 10.1038/nchembio.332]; Licciulli S, 2013, CANCER RES, V73, P5974, DOI 10.1158/0008-5472.CAN-13-1384; Mainardi S, 2014, P NATL ACAD SCI USA, V111, P255, DOI 10.1073/pnas.1320383110; Maraver A, 2012, CANCER CELL, V22, P222, DOI 10.1016/j.ccr.2012.06.014; Meacham CE, 2013, NATURE, V501, P328, DOI 10.1038/nature12624; Meng DQ, 2013, LUNG CANCER, V81, P1, DOI 10.1016/j.lungcan.2013.03.019; Miao LY, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0626-4; Monti S, 2003, MACH LEARN, V52, P91, DOI 10.1023/A:1023949509487; Okayama H, 2012, CANCER RES, V72, P100, DOI 10.1158/0008-5472.CAN-11-1403; Oxnard GR, 2013, J CLIN ONCOL, V31, P1097, DOI 10.1200/JCO.2012.42.9829; Peters S, 2014, CANCER TREAT REV, V40, P917, DOI 10.1016/j.ctrv.2014.06.010; Pikor LA, 2013, LUNG CANCER, V82, P179, DOI 10.1016/j.lungcan.2013.07.025; Pirker R, 2014, CURR OPIN ONCOL, V26, P145, DOI 10.1097/CCO.0000000000000056; Reck M, 2014, LANCET ONCOL, V15, P143, DOI 10.1016/S1470-2045(13)70586-2; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; SANCHEZ MP, 1994, P NATL ACAD SCI USA, V91, P1819, DOI 10.1073/pnas.91.5.1819; Sweet-Cordero A, 2005, NAT GENET, V37, P48, DOI 10.1038/ng1490; Valencia K, 2012, CLIN CANCER RES, V18, P969, DOI 10.1158/1078-0432.CCR-11-1686; Valiathan RR, 2012, CANCER METAST REV, V31, P295, DOI 10.1007/s10555-012-9346-z; Vogel WF, 2001, MOL CELL BIOL, V21, P2906, DOI 10.1128/MCB.21.8.2906-2917.2001; Weijzen S, 2002, NAT MED, V8, P979, DOI 10.1038/nm754; Westhoff B, 2009, P NATL ACAD SCI USA, V106, P22293, DOI 10.1073/pnas.0907781106; Yang SH, 2010, ONCOL REP, V24, P311, DOI 10.3892/or_00000861; Yen WC, 2012, CLIN CANCER RES, V18, P5374, DOI 10.1158/1078-0432.CCR-12-0736; Zheng YY, 2013, CANCER CELL, V24, P59, DOI 10.1016/j.ccr.2013.05.021	51	122	134	5	49	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2016	22	3					270	277		10.1038/nm.4041	http://dx.doi.org/10.1038/nm.4041			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DF6DC	26855149				2022-12-25	WOS:000371445100014
J	Nelson, CE; Gersbach, CA				Nelson, Christopher E.; Gersbach, Charles A.			Cas9 loosens its grip on off-target sites	NATURE BIOTECHNOLOGY			English	Article							NUCLEASES		[Gersbach, Charles A.] Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA; Duke Univ, Ctr Genom & Computat Biol, Durham, NC USA	Duke University; Duke University	Gersbach, CA (corresponding author), Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA.	charles.gersbach@duke.edu	Gersbach, Charles/Y-3412-2019	Nelson, Christopher/0000-0002-8423-8854				Anders C, 2014, NATURE, V513, P569, DOI 10.1038/nature13579; Bolukbasi MF, 2016, NAT METHODS, V13, P41, DOI [10.1038/NMETH.3684, 10.1038/nmeth.3684]; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Maeder ML, 2016, MOL THER, V24, P430, DOI 10.1038/mt.2016.10; Nelson CE, 2016, SCIENCE, V351, P403, DOI 10.1126/science.aad5143; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Thakore PI, 2016, NAT METHODS, V13, P127, DOI [10.1038/nmeth.3733, 10.1038/NMETH.3733]	10	7	10	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAR	2016	34	3					298	299		10.1038/nbt.3501	http://dx.doi.org/10.1038/nbt.3501			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DG1CJ	26963555	Bronze			2022-12-25	WOS:000371802600025
J	Prevo, B; Mangeol, P; Oswald, F; Scholey, JM; Peterman, EJG				Prevo, Brain; Mangeol, Pierre; Oswald, Felix; Scholey, Jonathan M.; Peterman, Erwin J. G.			Functional differentiation of cooperating kinesin-2 motors orchestrates cargo import and transport in C. elegans cilia	NATURE CELL BIOLOGY			English	Article							INTRAFLAGELLAR TRANSPORT; SENSORY CILIA; CYTOPLASMIC DYNEIN; TUBULIN TRANSPORT; TRANSITION ZONE; IFT PARTICLES; PROTEINS; MOTILITY; LOCALIZATION; MAINTENANCE	Intracellular transport depends on cooperation between distinct motor proteins. Two anterograde intraflagellar transport (IFT) motors, heterotrimeric kinesin-Il and homodimeric OSM-3, cooperate to move cargo along Caenorhabditis elegans cilia. Here, using quantitative fluorescence microscopy, with single-molecule sensitivity, of IFT in living strains containing single-copy transgenes encoding fluorescent IFT proteins, we show that kinesin-II transports IFT trains through the ciliary base and transition zone to a `handover zone' on the proximal axoneme. There, OSM-3 gradually replaces kinesin-II, yielding velocity profiles inconsistent with in vitro motility assays, and then drives transport to the ciliary tip. Dissociated kinesin-Il motors undergo rapid turnaround and recycling to the ciliary base, whereas OSM-3 is recycled mainly to the handover zone. This reveals a functional differentiation in which the slower, less processive kinesin-Il imports IFT trains into the cilium and OSM-3 drives their long-range transport, thereby optimizing cargo delivery.	[Prevo, Brain; Mangeol, Pierre; Oswald, Felix; Peterman, Erwin J. G.] Vrije Univ Amsterdam, Dept Phys & Astron & LaserLaB Amsterdam, NL-1081 HV Amsterdam, Netherlands; [Scholey, Jonathan M.] Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA	Vrije Universiteit Amsterdam; University of California System; University of California Davis	Peterman, EJG (corresponding author), Vrije Univ Amsterdam, Dept Phys & Astron & LaserLaB Amsterdam, Boelelaan 1081, NL-1081 HV Amsterdam, Netherlands.	e.j.g.peterman@vu.nl	Peterman, Erwin/G-5529-2010	Peterman, Erwin/0000-0003-1058-249X; Prevo, Bram/0000-0002-6526-5590	NIH Office of Research Infrastructure Programs [P40 OD010440]; Netherlands Organisation for Scientific Research (NWO) via a Vici, an NWO-Groot; ALW Open Program grant, via the STW research programme Nanoscopy; FOM programme 'Barriers in the Brain; NanoNextNL of the Government of the Netherlands; NIH [GM50718]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050718] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	NIH Office of Research Infrastructure Programs(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Netherlands Organisation for Scientific Research (NWO) via a Vici, an NWO-Groot(Netherlands Organization for Scientific Research (NWO)); ALW Open Program grant, via the STW research programme Nanoscopy; FOM programme 'Barriers in the Brain(FOM (The Netherlands)); NanoNextNL of the Government of the Netherlands(Netherlands Government); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	During initial stages of the project, B.P. was a visiting student in the Scholey Laboratory, Department of MCB at UC Davis. We thank S. Acar, L. Hao (UC Davis), D. Cheerambathur and A. Desai (UC San Diego) for discussion; S. Mitani (NPB, Japan) for the tm3433 deletion mutant; E. Kroezinga for biochemical support; P. Noordeloos for technical support; J. Girard and J. Mija1kovic for critical reading of the manuscript (VU University Amsterdam). Some strains were provided by the CGC, which is funded by NIH Office of Research Infrastructure Programs (P40 OD010440). We acknowledge financial support from the Netherlands Organisation for Scientific Research (NWO) via a Vici, an NWO-Groot and an ALW Open Program grant, via the STW research programme Nanoscopy, the FOM programme 'Barriers in the Brain; a grant from NanoNextNL of the Government of the Netherlands and 130 partners (E.J.G.P.), and from an NIH grant no. GM50718 (J.M.S.).	Bhogaraju S, 2013, SCIENCE, V341, P1009, DOI 10.1126/science.1240985; Bieling P, 2010, CURR BIOL, V20, P763, DOI 10.1016/j.cub.2010.02.067; Brunnbauer M, 2010, P NATL ACAD SCI USA, V107, P10460, DOI 10.1073/pnas.1005177107; Buisson J, 2013, J CELL SCI, V126, P327, DOI 10.1242/jcs.117069; Burghoorn J, 2007, P NATL ACAD SCI USA, V104, P7157, DOI 10.1073/pnas.0606974104; Cole DG, 1998, J CELL BIOL, V141, P993, DOI 10.1083/jcb.141.4.993; COLE DG, 1993, NATURE, V366, P268, DOI 10.1038/366268a0; Craft JM, 2015, J CELL BIOL, V208, P223, DOI 10.1083/jcb.201409036; Derr ND, 2012, SCIENCE, V338, P662, DOI 10.1126/science.1226734; Encalada SE, 2014, ANNU REV BIOPHYS, V43, P141, DOI 10.1146/annurev-biophys-051013-022746; Engel BD, 2012, J CELL BIOL, V199, P151, DOI 10.1083/jcb.201206068; Evans JE, 2006, J CELL BIOL, V172, P663, DOI 10.1083/jcb.200509115; Furuta K, 2013, P NATL ACAD SCI USA, V110, P501, DOI 10.1073/pnas.1201390110; Hao LM, 2011, NAT CELL BIOL, V13, P790, DOI 10.1038/ncb2268; Hirokawa N, 2009, NAT REV MOL CELL BIO, V10, P682, DOI 10.1038/nrm2774; Hoeprich GJ, 2014, BIOPHYS J, V106, P1691, DOI 10.1016/j.bpj.2014.02.034; Hou YQ, 2015, EXP CELL RES, V334, P26, DOI 10.1016/j.yexcr.2015.02.017; Imanishi M, 2006, J CELL BIOL, V174, P931, DOI 10.1083/jcb.200605179; Ishikawa H, 2011, NAT REV MOL CELL BIO, V12, P222, DOI 10.1038/nrm3085; Jiang L, 2015, J BIOL CHEM, V290, P12765, DOI 10.1074/jbc.M115.638437; Jolly AL, 2011, BIOCHEM SOC T, V39, P1126, DOI 10.1042/BST0391126; KOZMINSKI KG, 1995, J CELL BIOL, V131, P1517, DOI 10.1083/jcb.131.6.1517; KOZMINSKI KG, 1993, P NATL ACAD SCI USA, V90, P5519, DOI 10.1073/pnas.90.12.5519; Liang YW, 2014, DEV CELL, V30, P585, DOI 10.1016/j.devcel.2014.07.019; Ludington WB, 2013, P NATL ACAD SCI USA, V110, P3925, DOI 10.1073/pnas.1217354110; Malicki J, 2012, VISION RES, V75, P33, DOI 10.1016/j.visres.2012.10.008; Mallik R, 2013, TRENDS CELL BIOL, V23, P575, DOI 10.1016/j.tcb.2013.06.003; Marshall WF, 2001, J CELL BIOL, V155, P405, DOI 10.1083/jcb.200106141; Milic B, 2014, P NATL ACAD SCI USA, V111, P14136, DOI 10.1073/pnas.1410943111; Mueller J, 2005, MOL BIOL CELL, V16, P1341, DOI 10.1091/mbc.E04-10-0931; Nachury MV, 2010, ANNU REV CELL DEV BI, V26, P59, DOI 10.1146/annurev.cellbio.042308.113337; Norris SR, 2014, J CELL BIOL, V207, P393, DOI 10.1083/jcb.201407086; O'Hagan R, 2011, CURR BIOL, V21, P1685, DOI 10.1016/j.cub.2011.08.049; Orozco JT, 1999, NATURE, V398, P674, DOI 10.1038/19448; Ou GS, 2005, NATURE, V436, P583, DOI 10.1038/nature03818; Pan XY, 2006, J CELL BIOL, V174, P1035, DOI 10.1083/jcb.200606003; Pazour GJ, 1999, J CELL BIOL, V144, P473, DOI 10.1083/jcb.144.3.473; Pedersen LB, 2006, CURR BIOL, V16, P450, DOI 10.1016/j.cub.2006.02.020; Pedersen LB, 2008, CURR TOP DEV BIOL, V85, P23, DOI 10.1016/S0070-2153(08)00802-8; PERKINS LA, 1986, DEV BIOL, V117, P456, DOI 10.1016/0012-1606(86)90314-3; Pigino G, 2009, J CELL BIOL, V187, P135, DOI 10.1083/jcb.200905103; Porter ME, 1999, MOL BIOL CELL, V10, P693, DOI 10.1091/mbc.10.3.693; Reiter JF, 2012, EMBO REP, V13, P608, DOI 10.1038/embor.2012.73; Rogers AR, 2009, PHYS CHEM CHEM PHYS, V11, P4882, DOI 10.1039/b900964g; Scholey JM, 2013, ANNU REV CELL DEV BI, V29, P443, DOI 10.1146/annurev-cellbio-101512-122335; Schroeder HW, 2012, BIOPHYS J, V103, P48, DOI 10.1016/j.bpj.2012.05.037; Signor D, 1999, J CELL BIOL, V147, P519, DOI 10.1083/jcb.147.3.519; Sirajuddin M, 2014, NAT CELL BIOL, V16, P335, DOI 10.1038/ncb2920; Snow JJ, 2004, NAT CELL BIOL, V6, P1109, DOI 10.1038/ncb1186; STARICH TA, 1995, GENETICS, V139, P171; Trivedi D, 2012, J NEUROSCI, V32, P10587, DOI 10.1523/JNEUROSCI.0015-12.2012; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; Verhey KJ, 2011, BIOCHEM SOC T, V39, P1120, DOI 10.1042/BST0391120; Verhey KJ, 2009, NAT REV MOL CELL BIO, V10, P765, DOI 10.1038/nrm2782; WALTHER Z, 1994, J CELL BIOL, V126, P175, DOI 10.1083/jcb.126.1.175; Wedaman KP, 1996, J CELL BIOL, V132, P371, DOI 10.1083/jcb.132.3.371; Williams CL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6813; Williams CL, 2011, J CELL BIOL, V192, P1023, DOI 10.1083/jcb.201012116	58	99	100	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2015	17	12					1536	1545		10.1038/ncb3263	http://dx.doi.org/10.1038/ncb3263			10	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CX8DH	26523365				2022-12-25	WOS:000365932300006
J	Johansson, C; Velupillai, S; Tumber, A; Szykowska, A; Hookway, ES; Nowak, RP; Strain-Damerell, C; Gileadi, C; Philpott, M; Burgess-Brown, N; Wu, N; Kopec, J; Nuzzi, A; Steuber, H; Egner, U; Badock, V; Munro, S; LaThangue, NB; Westaway, S; Brown, J; Athanasou, N; Prinjha, R; Brennan, PE; Oppermann, U				Johansson, Catrine; Velupillai, Srikannathasan; Tumber, Anthony; Szykowska, Aleksandra; Hookway, Edward S.; Nowak, Radoslaw P.; Strain-Damerell, Claire; Gileadi, Carina; Philpott, Martin; Burgess-Brown, Nicola; Wu, Na; Kopec, Jola; Nuzzi, Andrea; Steuber, Holger; Egner, Ursula; Badock, Volker; Munro, Shonagh; LaThangue, Nicholas B.; Westaway, Sue; Brown, Jack; Athanasou, Nick; Prinjha, Rab; Brennan, Paul E.; Oppermann, Udo			Structural analysis of human KDM5B guides histone demethylase inhibitor development	NATURE CHEMICAL BIOLOGY			English	Article							TRANSCRIPTIONAL REPRESSION; H3K4 DEMETHYLASE; JUMONJI; OXYGENASES; FAMILY; DOMAIN; 2-OXOGLUTARATE; INTEGRATION; MECHANISMS; BINDING	Members of the KDM5 (also known as JARID1) family are 2-oxoglutarate- and Fee.-dependent oxygenases that act as histone H3K4 demethylases, thereby regulating cell proliferation and stem cell self-renewal and differentiation. Here we report crystal structures of the catalytic core of the human KDM5B enzyme in complex with three inhibitor chemotypes. These scaffolds exploit several aspects of the KDM5 active site, and their selectivity profiles reflect their hybrid features with respect to the KDM4 and KDM6 families. Whereas GSK-J1, a previously identified KDM6 inhibitor, showed about sevenfold less inhibitory activity toward KDM5B than toward KDM6 proteins, KDM5-C49 displayed 25-100-fold selectivity between KDM5B and KDM6B. The cell-permeable derivative KDM5-C70 had an antiproliferative effect in myeloma cells, leading to genome-wide elevation of H3K 4me3 levels. The selective inhibitor GSK 467 exploited unique binding modes, but it lacked cellular potency in the myeloma system. Taken together, these structural leads deliver multiple starting points for further rational and selective inhibitor design.	[Johansson, Catrine; Velupillai, Srikannathasan; Tumber, Anthony; Szykowska, Aleksandra; Nowak, Radoslaw P.; Strain-Damerell, Claire; Gileadi, Carina; Burgess-Brown, Nicola; Kopec, Jola; Nuzzi, Andrea; Brennan, Paul E.; Oppermann, Udo] Univ Oxford, Struct Genom Consortium, Headington, England; [Johansson, Catrine; Hookway, Edward S.; Nowak, Radoslaw P.; Philpott, Martin; Wu, Na; Athanasou, Nick; Oppermann, Udo] Univ Oxford, NIHR Oxford Biomed Res Unit, Botnar Res Ctr, Oxford, England; [Tumber, Anthony; Nuzzi, Andrea; Brennan, Paul E.] Univ Oxford, Nuffield Dept Med, Target Discovery Inst, Oxford, England; [Steuber, Holger; Egner, Ursula; Badock, Volker] Bayer Healthcare Pharmaceut, Berlin, Germany; [Munro, Shonagh; LaThangue, Nicholas B.] Univ Oxford, Dept Oncol, Oxford, England; [Westaway, Sue; Brown, Jack; Prinjha, Rab] GlaxoSmithKline R&D, Epinova DPU, Immunoinflammat Therapy Area, Stevenage, Herts, England	University of Oxford; University of Oxford; University of Oxford; Bayer AG; Bayer Healthcare Pharmaceuticals; University of Oxford; GlaxoSmithKline	Johansson, C; Oppermann, U (corresponding author), Univ Oxford, Struct Genom Consortium, Headington, England.; Johansson, C; Oppermann, U (corresponding author), Univ Oxford, NIHR Oxford Biomed Res Unit, Botnar Res Ctr, Oxford, England.	catrine.johansson@chem.ox.ac.uk; udo.oppermann@sgc.ox.ac.uk	Nowak, Radoslaw/L-2654-2019; Hookway, Edward S/I-2613-2018	Nowak, Radoslaw/0000-0002-0605-0071; Hookway, Edward S/0000-0003-0528-7402; Brennan, Paul/0000-0002-8950-7646; Philpott, Martin/0000-0003-3632-0084	Arthritis Research UK [20522]; NIHR Oxford Biomedical Research Unit; Sarcoma UK; Bone Cancer Research Trust; Rosetrees Trust; Cancer Research UK [C8717/A18245, 300/A13058]; CRUK Oxford Development Fund; AbbVie; Bayer Pharma AG; Boehringer Ingelheim; Canada Foundation for Innovation; Genome Canada; GlaxoSmithKline; Janssen; Lilly Canada; Merck Co.; Novartis Research Foundation; Ontario Ministry of Economic Development and Innovation; Pfizer; Sao Paulo Research Foundation-FAPESP; Takeda; Wellcome Trust [092809/Z/10/Z]; MRC [G0500905, G9400953, G1000807] Funding Source: UKRI; Cancer Research UK [20776, 18245, 13058] Funding Source: researchfish; Engineering and Physical Sciences Research Council [1100667] Funding Source: researchfish; Medical Research Council [G0500905, G1000807, G9400953] Funding Source: researchfish; Rosetrees Trust [M289, M289-F1, M271-F1] Funding Source: researchfish; Versus Arthritis [20522] Funding Source: researchfish	Arthritis Research UK(Versus Arthritis); NIHR Oxford Biomedical Research Unit; Sarcoma UK; Bone Cancer Research Trust; Rosetrees Trust(Rosetrees Trust); Cancer Research UK(Cancer Research UK); CRUK Oxford Development Fund; AbbVie(AbbVie); Bayer Pharma AG; Boehringer Ingelheim(Boehringer Ingelheim); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Genome Canada(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Lilly Canada(Eli Lilly); Merck Co.(Merck & Company); Novartis Research Foundation; Ontario Ministry of Economic Development and Innovation; Pfizer(Pfizer); Sao Paulo Research Foundation-FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Takeda(Takeda Pharmaceutical Company Ltd); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Rosetrees Trust(Rosetrees Trust); Versus Arthritis(Versus Arthritis)	Research in our laboratories is supported by funding from Arthritis Research UK (program grant number 20522 to U.O.), the NIHR Oxford Biomedical Research Unit (U.O.), Sarcoma UK (N.A.), the Bone Cancer Research Trust (N.A.), the Rosetrees Trust (N.A. and U.O.), and Cancer Research UK (grants C8717/A18245 (to C.J.) and 300/A13058 (to N.B.L.) and CRUK Oxford Development Fund to U.O. and C.J). The Structural Genomics Consortium is a registered charity (number 1097737) that receives funds from AbbVie, Bayer Pharma AG, Boehringer Ingelheim, the Canada Foundation for Innovation, Genome Canada, GlaxoSmithKline, Janssen, Lilly Canada, Merck & Co., the Novartis Research Foundation, the Ontario Ministry of Economic Development and Innovation, Pfizer, Sao Paulo Research Foundation-FAPESP, Takeda, and the Wellcome Trust (092809/Z/10/Z). We thank Diamond Light Source for beamtime (proposal mx10619) and the stall of beamlines 102 and 103 for assistance with crystal testing and data collection. We are grateful to R. Rambo for help with SANS data collection and analysis at the Diamond Light Source beamline B21, and to R. Klose (Department of Chemistry, Oxford University, Oxford, UK) for the human KDM5A construct and the FDH expression clone. We also acknowledge a sample of GSK467 kindly provided by GlaxoSmithKline.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Allis CD, 2007, CELL, V131, P633, DOI 10.1016/j.cell.2007.10.039; Chang KH, 2011, CHEMMEDCHEM, V6, P759, DOI 10.1002/cmdc.201100026; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Chowdhury R, 2014, NATURE, V510, P422, DOI 10.1038/nature13263; Clifton IJ, 2006, J INORG BIOCHEM, V100, P644, DOI 10.1016/j.jinorgbio.2006.01.024; Copeland RA., 2000, ENZYME PRACTICAL INT, P266, DOI 10.1002/0471220639.ch8; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Frye SV, 2010, NAT CHEM BIOL, V6, P159, DOI 10.1038/nchembio.296; Heinemann B, 2014, NATURE, V514, pE1, DOI 10.1038/nature13688; Hillringhaus L, 2011, J BIOL CHEM, V286, P41616, DOI 10.1074/jbc.M111.283689; Horton JR, 2016, J BIOL CHEM, V291, P2631, DOI 10.1074/jbc.M115.698449; Horton JR, 2010, NAT STRUCT MOL BIOL, V17, P38, DOI 10.1038/nsmb.1753; Hutchinson SE, 2012, J BIOMOL SCREEN, V17, P39, DOI 10.1177/1087057111416660; Johansson C, 2014, EPIGENOMICS-UK, V6, P89, DOI 10.2217/epi.13.79; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; King ONF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015535; Kooistra SM, 2012, NAT REV MOL CELL BIO, V13, P297, DOI 10.1038/nrm3327; Kruidenier L, 2012, NATURE, V488, P404, DOI 10.1038/nature11262; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McDonough MA, 2010, CURR OPIN STRUC BIOL, V20, P659, DOI 10.1016/j.sbi.2010.08.006; Ng SS, 2009, CELL MOL LIFE SCI, V66, P407, DOI 10.1007/s00018-008-8303-z; Ng SS, 2007, NATURE, V448, P87, DOI 10.1038/nature05971; Pasini D, 2008, GENE DEV, V22, P1345, DOI 10.1101/gad.470008; Pilke ES, 2015, DRUG DISCOV TODAY, V20, P743, DOI 10.1016/j.drudis.2014.12.013; Rasmussen PB, 2014, EPIGENOMICS-UK, V6, P277, DOI [10.2217/epi.14.14, 10.2217/EPI.14.14]; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rose NR, 2012, J MED CHEM, V55, P6639, DOI 10.1021/jm300677j; Rose NR, 2010, J MED CHEM, V53, P1810, DOI 10.1021/jm901680b; Ross-Innes CS, 2012, NATURE, V481, P389, DOI 10.1038/nature10730; Sakurai M, 2010, MOL BIOSYST, V6, P357, DOI 10.1039/b912993f; Sanchez R, 2011, TRENDS BIOCHEM SCI, V36, P364, DOI 10.1016/j.tibs.2011.03.005; Sayegh J, 2013, J BIOL CHEM, V288, P9408, DOI 10.1074/jbc.M112.419861; Shen L, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-284; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Tahiliani M, 2007, NATURE, V447, P601, DOI 10.1038/nature05823; Torres IO, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7204; Walport LJ, 2014, J BIOL CHEM, V289, P18302, DOI 10.1074/jbc.M114.555052; Walport LJ, 2012, CURR OPIN CHEM BIOL, V16, P525, DOI 10.1016/j.cbpa.2012.09.015; Westaway SM, 2016, J MED CHEM, V59, P1370, DOI 10.1021/acs.jmedchem.5b01538; Winter G, 2013, ACTA CRYSTALLOGR D, V69, P1260, DOI 10.1107/S0907444913015308; Woon ECY, 2012, ANGEW CHEM INT EDIT, V51, P1631, DOI 10.1002/anie.201107833; Yamane K, 2007, MOL CELL, V25, P801, DOI 10.1016/j.molcel.2007.03.001; Zhang Y, 2014, PROTEIN CELL, V5, P837, DOI 10.1007/s13238-014-0078-4; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	49	107	110	0	54	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUL	2016	12	7					539	+		10.1038/NCHEMBIO.2087	http://dx.doi.org/10.1038/NCHEMBIO.2087			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9EP	27214403	Green Submitted			2022-12-25	WOS:000378087500014
J	Yumerefendi, H; Lerner, AM; Zimmerman, SP; Hahn, K; Bear, JE; Strahl, BD; Kuhlman, B				Yumerefendi, Hayretin; Lerner, Andrew Michael; Zimmerman, Seth Parker; Hahn, Klaus; Bear, James E.; Strahl, Brian D.; Kuhlman, Brian			Light-induced nuclear export reveals rapid dynamics of epigenetic modifications	NATURE CHEMICAL BIOLOGY			English	Article							HISTONE H2B UBIQUITYLATION; RNA-POLYMERASE-II; LOCALIZATION SIGNAL; YEAST; UBIQUITINATION; CHROMATIN; PROTEINS; CELLS	We engineered a photoactivatable system for rapidly and reversibly exporting proteins from the nucleus by embedding a nuclear export signal in the LOV2 domain from phototropin 1. Fusing the chromatin modifier Bre1 to the photoswitch, we achieved light-dependent control of histone H2B monou-biquitylation in yeast, revealing fast turnover of the ubiquitin mark. Moreover, this inducible system allowed us to dynamically monitor the status of epigenetic modifications dependent on H2B ubiquitylation.	[Yumerefendi, Hayretin; Lerner, Andrew Michael; Zimmerman, Seth Parker; Strahl, Brian D.; Kuhlman, Brian] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC USA; [Hahn, Klaus] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC USA; [Hahn, Klaus; Bear, James E.; Strahl, Brian D.; Kuhlman, Brian] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Bear, James E.] Univ N Carolina, Dept Cell Biol & Physiol, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Kuhlman, B (corresponding author), Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC USA.; Kuhlman, B (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.	bkuhlman@email.unc.edu	; Strahl, Brian D/C-7601-2012	Hahn, Klaus/0000-0002-1970-7562; Kuhlman, Brian/0000-0003-4907-9699; Strahl, Brian D/0000-0002-4947-6259	NIH [GM111557, DA036877];  [GM102924]; NATIONAL CANCER INSTITUTE [P30CA016086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102924, R01GM111557] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA036877] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We would like to thank D. Dickinson for help with C. elegans injections, H. Meriesh for providing a plasmid containing BRE1, and R. Dronamraju and Z.-W. Sun for helpful discussions. Funding: J.E.B. (NIH GM111557), B.K., K.H., B.S. (NIH DA036877), K.H. (GM102924).	Briggs SD, 2002, NATURE, V418, P498, DOI 10.1038/nature00970; Cai L, 2008, CELL, V134, P828, DOI 10.1016/j.cell.2008.06.054; Fuchs G, 2014, GENOME RES, V24, P1572, DOI 10.1101/gr.176487.114; Gautier A, 2010, J AM CHEM SOC, V132, P4086, DOI 10.1021/ja910688s; Gietz RD, 2007, NAT PROTOC, V2, P35, DOI 10.1038/nprot.2007.14; Guttler T, 2010, NAT STRUCT MOL BIOL, V17, P1367, DOI 10.1038/nsmb.1931; Guntas G, 2015, P NATL ACAD SCI USA, V112, P112, DOI 10.1073/pnas.1417910112; Hallett RA, 2016, ACS SYNTH BIOL, V5, P53, DOI 10.1021/acssynbio.5b00119; Harper SM, 2003, SCIENCE, V301, P1541, DOI 10.1126/science.1086810; Henry KW, 2003, GENE DEV, V17, P2648, DOI 10.1101/gad.1144003; Hodel AE, 2006, J BIOL CHEM, V281, P23545, DOI 10.1074/jbc.M601718200; Hodel MR, 2001, J BIOL CHEM, V276, P1317, DOI 10.1074/jbc.M008522200; Huang F, 2015, J BIOL CHEM, V290, P28760, DOI 10.1074/jbc.M115.693085; Hutten S, 2007, TRENDS CELL BIOL, V17, P193, DOI 10.1016/j.tcb.2007.02.003; Katan-Khaykovich Y, 2005, EMBO J, V24, P2138, DOI 10.1038/sj.emboj.7600692; Kosugi S, 2009, P NATL ACAD SCI USA, V106, P10171, DOI 10.1073/pnas.0900604106; Niopek D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5404; Sun ZW, 2002, NATURE, V418, P104, DOI 10.1038/nature00883; Tischer D, 2014, NAT REV MOL CELL BIO, V15, P551, DOI 10.1038/nrm3837; Xiao TJ, 2005, MOL CELL BIOL, V25, P637, DOI 10.1128/MCB.25.2.637-651.2005; Yang XJ, 2013, MOL BIOL CELL, V24, P2419, DOI 10.1091/mbc.E13-03-0126; Yumerefendi H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128443; Zayner JP, 2012, J MOL BIOL, V419, P61, DOI 10.1016/j.jmb.2012.02.037	23	70	70	3	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUN	2016	12	6					399	U38		10.1038/nchembio.2068	http://dx.doi.org/10.1038/nchembio.2068			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DM2EW	27089030	Green Accepted, Green Submitted			2022-12-25	WOS:000376160600008
J	Huypens, P; Sass, S; Wu, M; Dyckhoff, D; Tschop, M; Theis, F; Marschall, S; de Angelis, MH; Beckers, J				Huypens, Peter; Sass, Steffen; Wu, Moya; Dyckhoff, Daniela; Tschoep, Matthias; Theis, Fabian; Marschall, Susan; de Angelis, Martin Hrabe; Beckers, Johannes			Epigenetic germline inheritance of diet-induced obesity and insulin resistance	NATURE GENETICS			English	Article							BODY-MASS INDEX; HIGH-FAT DIET; MATERNAL OBESITY; PROGRAMS; CONTRIBUTE; ALTERS	There is considerable controversy regarding epigenetic inheritance in mammalian gametes. Using in vitro fertilization to ensure exclusive inheritance via the gametes, we show that a parental high-fat diet renders offspring more susceptible to developing obesity and diabetes in a sex-and parent of origin-specific mode. The epigenetic inheritance of acquired metabolic disorders may contribute to the current obesity and diabetes pandemic.	[Huypens, Peter; Wu, Moya; Dyckhoff, Daniela; Marschall, Susan; de Angelis, Martin Hrabe; Beckers, Johannes] Helmholtz Zentrum Munchen, Inst Expt Genet, Neuherberg, Germany; [Huypens, Peter; Wu, Moya; Dyckhoff, Daniela; Marschall, Susan; de Angelis, Martin Hrabe; Beckers, Johannes] Helmholtz Zentrum Munchen, German Mouse Clin, Neuherberg, Germany; [Huypens, Peter; Dyckhoff, Daniela; Tschoep, Matthias; de Angelis, Martin Hrabe; Beckers, Johannes] German Ctr Diabet Res DZD, Neuherberg, Germany; [Sass, Steffen; Theis, Fabian] Helmholtz Zentrum Munchen, Inst Computat Biol, Neuherberg, Germany; [Tschoep, Matthias] Helmholtz Zentrum Munchen, Inst Diabet & Obes, Neuherberg, Germany; [Tschoep, Matthias] Tech Univ Munich, Dept Med, Div Metab Dis, D-80290 Munich, Germany; [Theis, Fabian] Tech Univ Munich, Dept Math, Garching, Germany; [de Angelis, Martin Hrabe; Beckers, Johannes] Tech Univ Munich, Chair Expt Genet, Freising Weihenstephan, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Technical University of Munich; Technical University of Munich	Huypens, P; Beckers, J (corresponding author), Helmholtz Zentrum Munchen, Inst Expt Genet, Neuherberg, Germany.; Huypens, P; Beckers, J (corresponding author), Helmholtz Zentrum Munchen, German Mouse Clin, Neuherberg, Germany.; Huypens, P; Beckers, J (corresponding author), German Ctr Diabet Res DZD, Neuherberg, Germany.; Beckers, J (corresponding author), Tech Univ Munich, Chair Expt Genet, Freising Weihenstephan, Germany.	peter.huypens@helmholtz-muenchen.de; beckers@helmholtz-muenchen.de	Beckers, Johannes/K-7237-2012; Huypens, Peter/B-3617-2010; de Angelis, Martin Hrabe/F-5531-2012; Theis, Fabian J/ABD-5212-2021	Beckers, Johannes/0000-0001-7874-3822; Huypens, Peter/0000-0001-7922-5787; de Angelis, Martin Hrabe/0000-0002-7898-2353; Theis, Fabian J/0000-0002-2419-1943; Tschoep, Matthias/0000-0002-4744-371X	Helmholtz Portfolio Theme 'Metabolic Dysfunction and Common Disease'; Helmholtz Alliance 'Imaging and Curing Environmental Metabolic Diseases' (ICEMED); German Federal Ministry of Education and Research, INFRAFRONTIER [01KX1012]	Helmholtz Portfolio Theme 'Metabolic Dysfunction and Common Disease'; Helmholtz Alliance 'Imaging and Curing Environmental Metabolic Diseases' (ICEMED); German Federal Ministry of Education and Research, INFRAFRONTIER	The authors are grateful for the expert technical assistance of M. Bamberger, A. Bettenbrock, S. Dunst, J. Worner, M. Bruckl, B. Rey and the animal caretakers of the German Mouse Clinic. This work was supported by grants from the Helmholtz Portfolio Theme 'Metabolic Dysfunction and Common Disease' (J. B.), the Helmholtz Alliance 'Imaging and Curing Environmental Metabolic Diseases' (ICEMED; J. B.) and the German Federal Ministry of Education and Research, INFRAFRONTIER grant 01KX1012 (M.H.d.A.).	Beckers J, 2009, NAT REV GENET, V10, P371, DOI 10.1038/nrg2578; Borengasser SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084209; Borengasser SJ, 2013, ENDOCRINOLOGY, V154, P4113, DOI 10.1210/en.2012-2255; Bromfield JJ, 2014, P NATL ACAD SCI USA, V111, P2200, DOI 10.1073/pnas.1305609111; Chen Q, 2016, SCIENCE, V351, P397, DOI 10.1126/science.aad7977; Curley JP, 2011, HORM BEHAV, V59, P306, DOI 10.1016/j.yhbeh.2010.06.018; de Angelis MH, 2015, NAT GENET, V47, P969, DOI 10.1038/ng.3360; Fox CS, 2014, OBESITY, V22, P919, DOI 10.1002/oby.20564; Fullston T, 2013, FASEB J, V27, P4226, DOI 10.1096/fj.12-224048; Grandjean V, 2015, SCI REP-UK, V5, DOI 10.1038/srep18193; Kivimaki M, 2007, AM J CLIN NUTR, V86, P1509, DOI 10.1093/ajcn/86.5.1509; Lake JK, 1997, ARCH DIS CHILD, V77, P376, DOI 10.1136/adc.77.5.376; Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506; Meehan TF, 2015, NUCLEIC ACIDS RES, V43, pD1171, DOI 10.1093/nar/gku1193; Meigs JB, 2000, DIABETES, V49, P2201, DOI 10.2337/diabetes.49.12.2201; NEEL JV, 1962, AM J HUM GENET, V14, P353; Ng SF, 2010, NATURE, V467, P963, DOI 10.1038/nature09491; Sasson IE, 2015, DIABETOLOGIA, V58, P615, DOI 10.1007/s00125-014-3466-7; Shankar K, 2008, AM J PHYSIOL-REG I, V294, pR528, DOI 10.1152/ajpregu.00316.2007; Shankar K, 2011, ENDOCRINOLOGY, V152, P4158, DOI 10.1210/en.2010-1078; Shankar K, 2010, ENDOCRINOLOGY, V151, P2577, DOI 10.1210/en.2010-0017; Sharma U, 2016, SCIENCE, V351, P391, DOI 10.1126/science.aad6780; Stoger R, 2008, BIOESSAYS, V30, P156, DOI 10.1002/bies.20700; Sun B, 2012, DIABETES, V61, P2833, DOI 10.2337/db11-0957; Vogt MC, 2014, CELL, V156, P495, DOI 10.1016/j.cell.2014.01.008; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Wei YC, 2014, P NATL ACAD SCI USA, V111, P1873, DOI 10.1073/pnas.1321195111	27	202	207	2	87	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2016	48	5					497	+		10.1038/ng.3527	http://dx.doi.org/10.1038/ng.3527			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DK3RC	26974008				2022-12-25	WOS:000374834100007
J	Tsai, SQ; Topkar, VV; Joung, JK; Aryee, MJ				Tsai, Shengdar Q.; Topkar, Ved V.; Joung, J. Keith; Aryee, Martin J.			Open-source guideseq software for analysis of GUIDE-seq data	NATURE BIOTECHNOLOGY			English	Letter									[Tsai, Shengdar Q.; Topkar, Ved V.; Joung, J. Keith; Aryee, Martin J.] Massachusetts Gen Hosp, Mol Pathol Unit, Charlestown, MA USA; [Tsai, Shengdar Q.; Topkar, Ved V.; Joung, J. Keith; Aryee, Martin J.] Massachusetts Gen Hosp, Ctr Canc Res, Charlestown, MA USA; [Tsai, Shengdar Q.; Topkar, Ved V.; Joung, J. Keith] Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Charlestown, MA USA; [Tsai, Shengdar Q.; Joung, J. Keith; Aryee, Martin J.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Aryee, Martin J.] Harvard Univ, TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Joung, JK; Aryee, MJ (corresponding author), Massachusetts Gen Hosp, Mol Pathol Unit, Charlestown, MA USA.; Joung, JK; Aryee, MJ (corresponding author), Massachusetts Gen Hosp, Ctr Canc Res, Charlestown, MA USA.; Joung, JK (corresponding author), Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Charlestown, MA USA.; Joung, JK; Aryee, MJ (corresponding author), Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA.; Aryee, MJ (corresponding author), Harvard Univ, TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA.	jjoung@mgh.harvard.edu; aryee.martin@mgh.harvard.edu	Aryee, Martin/AAC-8113-2020; Tsai, Shengdar Q./G-4600-2012	Tsai, Shengdar Q./0000-0001-9161-3993; Aryee, Martin/0000-0002-6848-1344					0	34	39	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2016	34	5					483	483		10.1038/nbt.3534	http://dx.doi.org/10.1038/nbt.3534			1	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DL6FL	27153277				2022-12-25	WOS:000375735000024
J	Gebala, V; Collins, R; Geudens, I; Phng, LK; Gerhardt, H				Gebala, Veronique; Collins, Russell; Geudens, Ilse; Phng, Li-Kun; Gerhardt, Holger			Blood flow drives lumen formation by inverse membrane blebbing during angiogenesis in vivo	NATURE CELL BIOLOGY			English	Article							ACTIN POLYMERIZATION; ENDOTHELIAL-CELLS; CORTICAL ACTIN; TIP; MORPHOGENESIS	How vascular tubes build, maintain and adapt continuously perfused lumens to meet local metabolic needs remains poorly understood. Recent studies showed that blood flow itself plays a critical role in the remodelling of vascular networks(1,2), and suggested it is also required for the lumenization of new vascular connections(3,4). However, it is still unknown how haemodynamic forces contribute to the formation of new vascular lumens during blood vessel morphogenesis. Here we report that blood flow drives lumen expansion during sprouting angiogenesis in vivo by inducing spherical deformations of the apical membrane of endothelial cells, in a process that we have termed inverse blebbing. We show that endothelial cells react to these membrane intrusions by local and transient recruitment and contraction of actomyosin, and that this mechanism is required for single, unidirectional lumen expansion in angiogenic sprouts. Our work identifies inverse membrane blebbing as a cellular response to high external pressure. We show that in the case of blood vessels such membrane dynamics can drive local cell shape changes required for global tissue morphogenesis, shedding light on a pressure-driven mechanism of lumen formation in vertebrates.	[Gebala, Veronique] Francis Crick Inst, Lincolns Inn Fields Lab, 44 Lincolns Inn Fields, London WC2A 3LY, England; [Gebala, Veronique; Collins, Russell; Gerhardt, Holger] Max Delbruck Ctr Mol Med Helmholtz Assoc MDC, Integrat Vasc Biol, Robert Rossle Str 10, D-13125 Berlin, Germany; [Geudens, Ilse; Phng, Li-Kun; Gerhardt, Holger] Katholieke Univ Leuven, Dept Oncol, Vasc Patterning Lab, Vesalius Res Ctr,VIB, Herestr 49, B-3000 Leuven, Belgium; [Phng, Li-Kun] Natl Cerebral & Cardiovasc Ctr, Res Inst, Dept Cell Biol, Osaka 5658565, Japan; [Gerhardt, Holger] DZHK German Ctr Cardiovasc Res, Partner Site Berlin, Berlin, Germany; [Gerhardt, Holger] BIH, Berlin, Germany	Francis Crick Institute; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Flanders Institute for Biotechnology (VIB); KU Leuven; National Cerebral & Cardiovascular Center - Japan; German Centre for Cardiovascular Research; Berlin Institute of Health	Gerhardt, H (corresponding author), Max Delbruck Ctr Mol Med Helmholtz Assoc MDC, Integrat Vasc Biol, Robert Rossle Str 10, D-13125 Berlin, Germany.; Gerhardt, H (corresponding author), Katholieke Univ Leuven, Dept Oncol, Vasc Patterning Lab, Vesalius Res Ctr,VIB, Herestr 49, B-3000 Leuven, Belgium.; Gerhardt, H (corresponding author), DZHK German Ctr Cardiovasc Res, Partner Site Berlin, Berlin, Germany.; Gerhardt, H (corresponding author), BIH, Berlin, Germany.	holger.gerhardt@mdc-berlin.de	Gerhardt, Holger/G-4610-2011	Gerhardt, Holger/0000-0002-3030-0384; Collins, Russell T/0000-0002-1847-4517	Cancer Research UK; HFSP Long-Term Fellowship; European Research Council starting grant REshape [311719]; Berlin Institute of Health (BIH); DZHK (German Center for Cardiovascular Research); BMBF (German Ministry of Education and Research); Lister Institute for Preventive Medicine	Cancer Research UK(Cancer Research UK); HFSP Long-Term Fellowship; European Research Council starting grant REshape; Berlin Institute of Health (BIH); DZHK (German Center for Cardiovascular Research); BMBF (German Ministry of Education and Research)(Federal Ministry of Education & Research (BMBF)); Lister Institute for Preventive Medicine	We thank members of the Vascular Biology and Vascular Patterning Laboratories for helpful discussions. We thank the Cancer Research UK London Research Institute Animal and Fish Facilities, and the Aquatic Facilities at the Max Delbruck Center for Molecular Medicine and Vesalius Research Center for animal care. We thank T. Surrey and N. Cade for access to the inverted 3i spinning-disc confocal, and P. Vanden Berghe for access to the Andor spinning-disc confocal of the Cell Imaging Core facility at KU Leuven. We thank G. Kelly from the Francis Crick Institute (London, UK) for help with statistics. V.G. is financially supported by Cancer Research UK. L.-K.P. is financially supported by a HFSP Long-Term Fellowship. H.G. is financially supported by Cancer Research UK, the Lister Institute for Preventive Medicine, a European Research Council starting grant REshape (311719) and the Berlin Institute of Health (BIH). This work was supported by the DZHK (German Center for Cardiovascular Research) and the BMBF (German Ministry of Education and Research).	Charpentier MS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116086; Charras G, 2008, NAT REV MOL CELL BIO, V9, P730, DOI 10.1038/nrm2453; Charras GT, 2008, BIOPHYS J, V94, P1836, DOI 10.1529/biophysj.107.113605; Chen Q, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001374; CUNNINGHAM CC, 1995, J CELL BIOL, V129, P1589, DOI 10.1083/jcb.129.6.1589; Davis GE, 1996, EXP CELL RES, V224, P39, DOI 10.1006/excr.1996.0109; Emelyanov A, 2008, DEV BIOL, V320, P113, DOI 10.1016/j.ydbio.2008.04.042; Herwig L, 2011, CURR BIOL, V21, P1942, DOI 10.1016/j.cub.2011.10.016; Hogan BM, 2009, NAT GENET, V41, P396, DOI 10.1038/ng.321; Iwasaki T, 2001, CELL STRUCT FUNCT, V26, P677, DOI 10.1247/csf.26.677; Jakobsson L, 2010, NAT CELL BIOL, V12, P943, DOI 10.1038/ncb2103; Jinn SW, 2005, DEVELOPMENT, V132, P5199, DOI 10.1242/dev.02087; Kamei M, 2006, NATURE, V442, P453, DOI 10.1038/nature04923; Kawakami K, 2004, DEV CELL, V7, P133, DOI 10.1016/j.devcel.2004.06.005; Keller H, 1998, CELL MOTIL CYTOSKEL, V41, P181, DOI 10.1002/(SICI)1097-0169(1998)41:2<181::AID-CM8>3.3.CO;2-M; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kochhan E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075060; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Lenard A, 2013, DEV CELL, V25, P492, DOI 10.1016/j.devcel.2013.05.010; Martin M, 2013, EMBO J, V32, P2491, DOI 10.1038/emboj.2013.187; Martin-Belmonte F, 2007, CELL, V128, P383, DOI 10.1016/j.cell.2006.11.051; Paluch E, 2005, BIOPHYS J, V89, P724, DOI 10.1529/biophysj.105.060590; Pelton JC, 2014, DEVELOPMENT, V141, P4121, DOI 10.1242/dev.110296; Phng LK, 2015, DEV CELL, V32, P123, DOI 10.1016/j.devcel.2014.11.017; Phng LK, 2013, DEVELOPMENT, V140, P4031, DOI 10.1242/dev.097352; Potente M, 2011, CELL, V146, P873, DOI 10.1016/j.cell.2011.08.039; Riedl J, 2010, NAT METHODS, V7, P168, DOI 10.1038/nmeth0310-168; Sauteur L, 2014, CELL REP, V9, P504, DOI 10.1016/j.celrep.2014.09.024; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Strilic B, 2009, DEV CELL, V17, P505, DOI 10.1016/j.devcel.2009.08.011; Tinevez JY, 2009, P NATL ACAD SCI USA, V106, P18581, DOI 10.1073/pnas.0903353106; Wang Y, 2010, DEVELOPMENT, V137, P3119, DOI 10.1242/dev.048785; Xu K, 2011, DEV CELL, V20, P526, DOI 10.1016/j.devcel.2011.02.010; Yu JXA, 2015, DEVELOPMENT, V142, P2951, DOI 10.1242/dev.123174	35	101	102	1	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2016	18	4					443	+		10.1038/ncb3320	http://dx.doi.org/10.1038/ncb3320			12	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	DH7LX	26928868	Green Accepted			2022-12-25	WOS:000372976600011
J	Broderick, R; Niemnuszczy, J; Baddock, HT; Deshpande, RA; Gileadi, O; Paull, TT; McHugh, PJ; Niedzwiedz, W				Broderick, Ronan; Niemnuszczy, Jadwiga; Baddock, Hannah T.; Deshpande, Rajashree A.; Gileadi, Opher; Paull, Tanya T.; McHugh, Peter J.; Niedzwiedz, Wojciech			EXD2 promotes homologous recombination by facilitating DNA end resection	NATURE CELL BIOLOGY			English	Article							DOUBLE-STRAND BREAKS; REPAIR PATHWAY; DAMAGE RESPONSE; MRE11 COMPLEX; CELL-CYCLE; PROTEIN; SAE2; NUCLEASE; SGS1; MRE11-RAD50-XRS2	Repair of DNA double-strand breaks (DSBs) by homologous recombination (HR) is critical for survival and genome stability of individual cells and organisms, but also contributes to the genetic diversity of species. A vital step in HR is MRN-CtIP-dependent end resection, which generates the 3' single-stranded DNA overhangs required for the subsequent strand exchange reaction. Here, we identify EXD2 (also known as EXDL2) as an exonuclease essential for DSB resection and efficient HR. EXD2 is recruited to chromatin in a damage-dependent manner and confers resistance to DSB-inducing agents. EXD2 functionally interacts with the MRN complex to accelerate resection through its 3'-5' exonuclease activity, which efficiently processes double-stranded DNA substrates containing nicks. Finally, we establish that EXD2 stimulates both short-and long-range DSB resection, and thus, together with MRE11, is required for efficient HR. This establishes a key role for EXD2 in controlling the initial steps of chromosomal break repair.	[Broderick, Ronan; Niemnuszczy, Jadwiga; McHugh, Peter J.; Niedzwiedz, Wojciech] Univ Oxford, Dept Oncol, Weatherall Inst Mol Med, Oxford OX3 9DS, England; [Baddock, Hannah T.; Gileadi, Opher] Univ Oxford, Struct Genom Consortium, Old Rd Campus Res Bldg,Roosevelt Dr, Oxford OX3 7DQ, England; [Deshpande, Rajashree A.; Paull, Tanya T.] Univ Texas Austin, Howard Hughes Med Inst, Austin, TX 78712 USA; [Deshpande, Rajashree A.; Paull, Tanya T.] Univ Texas Austin, Inst Cellular & Mol Biol, Dept Mol Biosci, Austin, TX 78712 USA	University of Oxford; University of Oxford; Howard Hughes Medical Institute; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Niedzwiedz, W (corresponding author), Univ Oxford, Dept Oncol, Weatherall Inst Mol Med, Oxford OX3 9DS, England.	wojciech.niedzwiedz@imm.ox.ac.uk	; Gileadi, Opher/F-1105-2013	McHugh, Peter/0000-0002-8679-4627; niedzwiedz, wojciech/0000-0002-8518-6304; Baddock, Hannah/0000-0001-9187-1132; broderick, ronan/0000-0001-6840-4755; Gileadi, Opher/0000-0001-6886-898X; Paull, Tanya/0000-0002-2991-651X	Worldwide Cancer Research; MRC Senior Non-Clinical Fellowships; MRC Grant; Cancer Research UK Studentship; Cancer Research and Prevention Institute of Texas (CPRIT) grant [RP110465-P4]; Medical Research Council [MR/L007665/1, G0902418] Funding Source: researchfish; Worldwide Cancer Research [07-0922] Funding Source: researchfish; MRC [MR/L007665/1, G0902418] Funding Source: UKRI	Worldwide Cancer Research; MRC Senior Non-Clinical Fellowships; MRC Grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK Studentship(Cancer Research UK); Cancer Research and Prevention Institute of Texas (CPRIT) grant; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Worldwide Cancer Research; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank S. Jackson, M. de Bruijn, J. Riepsaame, V. Macaulay, G. Legube, G. Stewart, F. Esashi, C. Green and R. Chapman for cell lines, plasmids and antibodies; J. A. Tainer for the provision of MRE11 exo- and endonuclease inhibitors; the Mass Spectrometry Laboratory (IBB PAS, Warsaw, Poland) for their work on analyses of GFP - CtIP IP experiments; J. A. Newman for advice on protein purification and D. Waithe for helpwith image analysis. We also thank G. Ira for critical reading of the manuscript. R.B., J.N. and W.N. are funded by Worldwide Cancer Research and MRC Senior Non-Clinical Fellowships awarded to W.N., P.J.M. and O.G. are funded by an MRC Grant, H.T.B. is funded by a Cancer Research UK Studentship and R.A.D. and T.T.P. are funded by the Cancer Research and Prevention Institute of Texas (CPRIT) grant RP110465-P4.	Baumann P, 1996, CELL, V87, P757, DOI 10.1016/S0092-8674(00)81394-X; Bhaskara V, 2007, MOL CELL, V25, P647, DOI 10.1016/j.molcel.2007.01.028; Blackford AN, 2015, MOL CELL, V57, P1133, DOI 10.1016/j.molcel.2015.02.012; Blackwood JK, 2013, BIOCHEM SOC T, V41, P314, DOI 10.1042/BST20120307; Buis J, 2008, CELL, V135, P85, DOI 10.1016/j.cell.2008.08.015; Cannavo E, 2014, NATURE, V514, P122, DOI 10.1038/nature13771; Cejka P, 2010, NATURE, V467, P112, DOI 10.1038/nature09355; Choi JM, 2007, J BIOL CHEM, V282, P9941, DOI 10.1074/jbc.M609657200; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Eggler AL, 2002, J BIOL CHEM, V277, P39280, DOI 10.1074/jbc.M204328200; Esashi F, 2007, NAT STRUCT MOL BIOL, V14, P468, DOI 10.1038/nsmb1245; Filippone S, 2008, CHEM-EUR J, V14, P5198, DOI 10.1002/chem.200800096; Garcia V, 2011, NATURE, V479, P241, DOI 10.1038/nature10515; Gravel S, 2008, GENE DEV, V22, P2767, DOI 10.1101/gad.503108; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Huertas P, 2008, NATURE, V455, P689, DOI 10.1038/nature07215; Huertas P, 2010, NAT STRUCT MOL BIOL, V17, P11, DOI 10.1038/nsmb.1710; Iacovoni JS, 2010, EMBO J, V29, P1446, DOI 10.1038/emboj.2010.38; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Jazayeri A, 2008, EMBO J, V27, P1953, DOI 10.1038/emboj.2008.128; Kousholt AN, 2012, J CELL BIOL, V197, P869, DOI 10.1083/jcb.201111065; Krogh BO, 2004, ANNU REV GENET, V38, P233, DOI 10.1146/annurev.genet.38.072902.091500; Li BM, 2009, AGING-US, V1, P289, DOI 10.18632/aging.100032; Limbo O, 2007, MOL CELL, V28, P134, DOI 10.1016/j.molcel.2007.09.009; Malkova A, 2012, ANNU REV GENET, V46, P455, DOI 10.1146/annurev-genet-110711-155547; McCabe N, 2006, CANCER RES, V66, P8109, DOI 10.1158/0008-5472.CAN-06-0140; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Mimitou EP, 2008, NATURE, V455, P770, DOI 10.1038/nature07312; Mimitou EP, 2011, DNA REPAIR, V10, P344, DOI 10.1016/j.dnarep.2010.12.004; Nicolette ML, 2010, NAT STRUCT MOL BIOL, V17, P1478, DOI 10.1038/nsmb.1957; Nimonkar AV, 2011, GENE DEV, V25, P350, DOI 10.1101/gad.2003811; Niu HY, 2010, NATURE, V467, P108, DOI 10.1038/nature09318; Paull TT, 2010, DNA REPAIR, V9, P1283, DOI 10.1016/j.dnarep.2010.09.015; Paull TT, 1998, MOL CELL, V1, P969, DOI 10.1016/S1097-2765(00)80097-0; Pierce AJ, 2001, GENE DEV, V15, P3237, DOI 10.1101/gad.946401; Rass E, 2009, NAT STRUCT MOL BIOL, V16, P819, DOI 10.1038/nsmb.1641; RUBNITZ J, 1984, MOL CELL BIOL, V4, P2253, DOI 10.1128/MCB.4.11.2253; Sartori AA, 2007, NATURE, V450, P509, DOI 10.1038/nature06337; Savitsky P, 2010, J STRUCT BIOL, V172, P3, DOI 10.1016/j.jsb.2010.06.008; Sengerova B, 2012, J BIOL CHEM, V287, P26254, DOI 10.1074/jbc.M112.367243; Shen B, 2014, NAT METHODS, V11, P399, DOI [10.1038/nmeth.2857, 10.1038/NMETH.2857]; Shibata A, 2014, MOL CELL, V53, P7, DOI 10.1016/j.molcel.2013.11.003; Smogorzewska A, 2010, MOL CELL, V39, P36, DOI 10.1016/j.molcel.2010.06.023; Stracker TH, 2011, NAT REV MOL CELL BIO, V12, P90, DOI 10.1038/nrm3047; SUGAWARA N, 1992, MOL CELL BIOL, V12, P563, DOI 10.1128/MCB.12.2.563; Sung P, 2003, J BIOL CHEM, V278, P42729, DOI 10.1074/jbc.R300027200; SUNG P, 1995, CELL, V82, P453, DOI 10.1016/0092-8674(95)90434-4; Suzuki K, 2011, NAT PROTOC, V6, P134, DOI 10.1038/nprot.2010.183; Symington LS, 2011, ANNU REV GENET, V45, P247, DOI 10.1146/annurev-genet-110410-132435; Tuschl T., 2006, CSH PROTOC, DOI [http://dx.doi.org/10.1101/pdb.prot4342, DOI 10.1101/PDB.PR0T4342]; Wang QH, 2014, EMBO J, V33, P862, DOI 10.1002/embj.201386064; Yun MH, 2009, NATURE, V459, P460, DOI 10.1038/nature07955; Zhou Y, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt1309; Zhu L, 1999, VET IMMUNOL IMMUNOP, V71, P277, DOI 10.1016/S0165-2427(99)00099-9; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037	57	48	53	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2016	18	3					271	+		10.1038/ncb3303	http://dx.doi.org/10.1038/ncb3303			23	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	DF0LT	26807646	Green Accepted			2022-12-25	WOS:000371031300008
J	Sun, C; Molineros, JE; Looger, LL; Zhou, XJ; Kim, K; Okada, Y; Ma, JY; Qi, YY; Kim-Howard, X; Motghare, P; Bhattarai, K; Adler, A; Bang, SY; Lee, HS; Kim, TH; Kang, YM; Suh, CH; Chung, WT; Park, YB; Choe, JY; Shim, SC; Kochi, Y; Suzuki, A; Kubo, M; Sumida, T; Yamamoto, K; Lee, SS; Kim, YJ; Han, BG; Dozmorov, M; Kaufman, KM; Wren, JD; Harley, JB; Shen, N; Chua, KH; Zhang, H; Bae, SC; Nath, SK				Sun, Celi; Molineros, Julio E.; Looger, Loren L.; Zhou, Xu-jie; Kim, Kwangwoo; Okada, Yukinori; Ma, Jianyang; Qi, Yuan-yuan; Kim-Howard, Xana; Motghare, Prasenjeet; Bhattarai, Krishna; Adler, Adam; Bang, So-Young; Lee, Hye-Soon; Kim, Tae-Hwan; Kang, Young Mo; Suh, Chang-Hee; Chung, Won Tae; Park, Yong-Beom; Choe, Jung-Yoon; Shim, Seung Cheol; Kochi, Yuta; Suzuki, Akari; Kubo, Michiaki; Sumida, Takayuki; Yamamoto, Kazuhiko; Lee, Shin-Seok; Kim, Young Jin; Han, Bok-Ghee; Dozmorov, Mikhail; Kaufman, Kenneth M.; Wren, Jonathan D.; Harley, John B.; Shen, Nan; Chua, Kek Heng; Zhang, Hong; Bae, Sang-Cheol; Nath, Swapan K.			High-density genotyping of immune-related loci identifies new SLE risk variants in individuals with Asian ancestry	NATURE GENETICS			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; MULTIPLE AUTOIMMUNE-DISEASES; GENOME-WIDE ASSOCIATION; CD226 GLY307SER ASSOCIATION; PRIMARY SJOGRENS-SYNDROME; WILLIAMS-BEUREN SYNDROME; CHINESE HAN POPULATION; TFII-I; SUSCEPTIBILITY LOCI; CLINICAL-FEATURES	Systemic lupus erythematosus (SLE) has a strong but incompletely understood genetic architecture. We conducted an association study with replication in 4,478 SLE cases and 12,656 controls from six East Asian cohorts to identify new SLE susceptibility loci and better localize known loci. We identified ten new loci and confirmed 20 known loci with genome-wide significance. Among the new loci, the most significant locus was GTF2IRDI-GTF21 at 7q11.23 (rs73366469, P-meta = 3.75 x 10(-117), odds ratio (OR) = 2.38), followed by DEF6, IL128, TCF7, TERT, CD226, PCNXL3, RASGRP1, SYNGR1 and SIGLEC6. We identified the most likely functional variants at each locus by analyzing epigenetic marks and gene expression data. Ten candidate variants are known to alter gene expression in cis or in trans. Enrichment analysis highlights the importance of these loci in B cell and T cell biology. The new loci, together with previously known loci, increase the explained heritability of SLE to 24%. The new loci share functional and ontological characteristics with previously reported loci and are possible drug targets for SLE therapeutics.	[Sun, Celi; Molineros, Julio E.; Kim-Howard, Xana; Motghare, Prasenjeet; Bhattarai, Krishna; Adler, Adam; Wren, Jonathan D.; Nath, Swapan K.] Oklahoma Med Res Fdn, Arthrit & Clin Immunol Res Program, 825 NE 13th St, Oklahoma City, OK 73104 USA; [Looger, Loren L.] Janelia Res Campus, Howard Hughes Med Inst, Ashburn, VA USA; [Zhou, Xu-jie; Qi, Yuan-yuan; Zhang, Hong] Peking Univ, Hosp 1, Inst Nephrol, Key Lab Renal Dis,Minist Hlth China,Div Renal, Beijing 100871, Peoples R China; [Zhou, Xu-jie; Qi, Yuan-yuan; Zhang, Hong] Peking Univ, Minist Educ, Key Lab Chron Kidney Dis Prevent & Treatment, Beijing 100871, Peoples R China; [Kim, Kwangwoo; Bang, So-Young; Lee, Hye-Soon; Kim, Tae-Hwan; Bae, Sang-Cheol] Hanyang Univ, Dept Rheumatol, Hosp Rheumat Dis, Seoul 133791, South Korea; [Okada, Yukinori] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Human Genet & Dis Divers, Tokyo, Japan; [Okada, Yukinori] RIKEN Ctr Integrat Med Sci, Lab Stat Anal, Yokohama, Kanagawa, Japan; [Ma, Jianyang; Shen, Nan] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Shanghai Inst Rheumatol, Shanghai 200030, Peoples R China; [Kang, Young Mo] Kyungpook Natl Univ Hosp, Sch Med, Daegu, South Korea; [Suh, Chang-Hee] Ajou Univ Hosp, Dept Rheumatol, Suwon, South Korea; [Chung, Won Tae] Dong A Univ Hosp, Dept Internal Med, Busan, South Korea; [Park, Yong-Beom] Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Choe, Jung-Yoon] Daegu Catholic Univ Hosp, Dept Internal Med, Daegu, South Korea; [Shim, Seung Cheol] Chungnam Natl Univ Hosp, Daejeon Rheumatoid & Degenerat Arthrit Ctr, Daejeon, South Korea; [Kochi, Yuta; Suzuki, Akari; Yamamoto, Kazuhiko] RIKEN, Ctr Integrat Med Sci, Lab Autoimmune Dis, Yokohama, Kanagawa, Japan; [Kubo, Michiaki] RIKEN Ctr Integrat Med Sci, Lab Genotyping Dev, Yokohama, Kanagawa, Japan; [Sumida, Takayuki] Univ Tsukuba, Fac Med, Dept Internal Med, Tsukuba, Ibaraki, Japan; [Yamamoto, Kazuhiko] Univ Tokyo, Grad Sch Med, Dept Allergy & Rheumatol, Tokyo, Japan; [Lee, Shin-Seok] Chonnam Natl Univ Hosp, Dept Rheumatol, Gwangju, South Korea; [Kim, Young Jin; Han, Bok-Ghee] Korea Natl Inst Hlth, Osong, South Korea; [Dozmorov, Mikhail] Virginia Commonwealth Univ, Dept Biostat, Richmond, VA USA; [Kaufman, Kenneth M.; Harley, John B.] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Cincinnati, OH 45229 USA; [Kaufman, Kenneth M.; Harley, John B.] US Dept Vet Affairs, Med Ctr, Cincinnati, OH USA; [Shen, Nan] Cincinnati Childrens Hosp Med Ctr, CAGE, Cincinnati, OH 45229 USA; [Chua, Kek Heng] Univ Malaya, Fac Med, Dept Biomed Sci, Kuala Lumpur, Malaysia	Oklahoma Medical Research Foundation; Howard Hughes Medical Institute; Peking University; Peking University; Hanyang University; Tokyo Medical & Dental University (TMDU); RIKEN; Shanghai Jiao Tong University; Kyungpook National University; Kyungpook National University Hospital; Ajou University; Ajou University Hospital; Dong A University; Yonsei University; Yonsei University Health System; Catholic University of Daegu; Chungnam National University; Chungnam National University Hospital; RIKEN; RIKEN; University of Tsukuba; University of Tokyo; Chonnam National University; Chonnam National University Hospital; Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Virginia Commonwealth University; Cincinnati Children's Hospital Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Cincinnati VA Medical Center; Cincinnati Children's Hospital Medical Center; Universiti Malaya	Nath, SK (corresponding author), Oklahoma Med Res Fdn, Arthrit & Clin Immunol Res Program, 825 NE 13th St, Oklahoma City, OK 73104 USA.; Bae, SC (corresponding author), Hanyang Univ, Dept Rheumatol, Hosp Rheumat Dis, Seoul 133791, South Korea.	scbae@hanyang.ac.kr; naths@omrf.org	Zhou, Xu-jie/A-3740-2012; Suzuki, Akari/N-5389-2015; CHUA, KEK HENG/B-5261-2010; Wren, Jonathan D/E-5611-2011; Suh, Chang-Hee/H-9723-2019; Dozmorov, Mikhail/B-1374-2009; Kochi, Yuta/P-4487-2018; Kim, Young-jin/GSD-3168-2022; Shen, Nan/AGK-6807-2022; Lee, Shin-Seok/AAC-6779-2021	Zhou, Xu-jie/0000-0002-7215-707X; CHUA, KEK HENG/0000-0002-0452-9994; Wren, Jonathan D/0000-0003-2776-3545; Suh, Chang-Hee/0000-0001-6156-393X; Dozmorov, Mikhail/0000-0002-0086-8358; Shen, Nan/0000-0002-5875-4417; Molineros, Julio/0000-0001-8497-6788; Shim, Seung cheol/0000-0002-3199-359X; Bae, Sang-Cheol/0000-0003-4658-1093; Kim, Kwangwoo/0000-0001-8926-6216; qi, yuan yuan/0000-0002-5872-3311	Korea Center for Disease Control and Prevention at the Korea National Institute of Health; Ministry of Health and Welfare, Republic of Korea; US National Institutes of Health [AR060366, MD007909, AI103399, AI024717, AI083194, AI107176, TR001425, HG008666, HG006828]; US Department of Defense [PR094002]; US Department of Veterans Affairs; National Basic Research Program of China (973 program) [2014CB541902]; Research Fund of Beijing Municipal Science and Technology for the Outstanding PhD Program [20121000110]; National Natural Science Foundation of China [81200524, 81230072]; High-Impact Research Ministry of Education, Malaysia [UM.C/625/1/HIR/MoE/E000044-20001]; Korea Healthcare Technology RAMP;D Project, Ministry for Health and Welfare, Republic of Korea [HI13C2124]; Korea Center for Disease Control and Prevention at the Korea National Institute of Health; Ministry of Health and Welfare, Republic of Korea; US National Institutes of Health [AR060366, MD007909, AI103399, AI024717, AI083194, AI107176, TR001425, HG008666, HG006828]; US Department of Defense [PR094002]; US Department of Veterans Affairs; National Basic Research Program of China (973 program) [2014CB541902]; Research Fund of Beijing Municipal Science and Technology for the Outstanding PhD Program [20121000110]; National Natural Science Foundation of China [81200524, 81230072]; High-Impact Research Ministry of Education, Malaysia [UM.C/625/1/HIR/MoE/E000044-20001]; Korea Healthcare Technology RAMP;D Project, Ministry for Health and Welfare, Republic of Korea [HI13C2124]; Grants-in-Aid for Scientific Research [15H05670] Funding Source: KAKEN; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001425, UL1TR001417] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG006828, U01HG008666] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI024717, R01AI024717, R21AI107176, P01AI083194, R21AI103399] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060366] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [R01MD007909] Funding Source: NIH RePORTER	Korea Center for Disease Control and Prevention at the Korea National Institute of Health; Ministry of Health and Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Defense(United States Department of Defense); US Department of Veterans Affairs(US Department of Veterans Affairs); National Basic Research Program of China (973 program)(National Basic Research Program of China); Research Fund of Beijing Municipal Science and Technology for the Outstanding PhD Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); High-Impact Research Ministry of Education, Malaysia; Korea Healthcare Technology RAMP;D Project, Ministry for Health and Welfare, Republic of Korea; Korea Center for Disease Control and Prevention at the Korea National Institute of Health; Ministry of Health and Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Defense(United States Department of Defense); US Department of Veterans Affairs(US Department of Veterans Affairs); National Basic Research Program of China (973 program)(National Basic Research Program of China); Research Fund of Beijing Municipal Science and Technology for the Outstanding PhD Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); High-Impact Research Ministry of Education, Malaysia; Korea Healthcare Technology RAMP;D Project, Ministry for Health and Welfare, Republic of Korea; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	We are grateful to the affected and unaffected individuals who participated in this study. We thank the research assistants, coordinators and physicians who helped in the recruitment of subjects, including the individuals in the coordinating projects. A part of the Korean control data was provided from the Korean Biobank Project supported by the Korea Center for Disease Control and Prevention at the Korea National Institute of Health. Genomic DNA from similar to 100 Korean patients with SLE was obtained from the Korean National Biobank at Wonkwang University Hospital, which is supported by the Ministry of Health and Welfare, Republic of Korea.r This work was supported by grants from the US National Institutes of Health (AR060366, MD007909, AI103399, AI024717, AI083194, AI107176, TR001425, HG008666 and HG006828), the US Department of Defense (PR094002), the US Department of Veterans Affairs, the National Basic Research Program of China (973 program) (2014CB541902), the Research Fund of Beijing Municipal Science and Technology for the Outstanding PhD Program (20121000110), the National Natural Science Foundation of China (81200524, 81230072) and High-Impact Research Ministry of Education Grant UM.C/625/1/HIR/MoE/E000044-20001, Malaysia. This study was also supported by a grant from the Korea Healthcare Technology R&D Project (HI13C2124), Ministry for Health and Welfare, Republic of Korea.	Alcina A, 2010, GENES IMMUN, V11, P439, DOI 10.1038/gene.2010.30; Antonell A, 2010, J MED GENET, V47, P312, DOI 10.1136/jmg.2009.071712; Berndt SI, 2013, NAT GENET, V45, P868, DOI 10.1038/ng.2652; Biswas PS, 2012, J EXP MED, V209, P581, DOI 10.1084/jem.20111195; Boackle SA, 2013, CURR OPIN RHEUMATOL, V25, P561, DOI 10.1097/BOR.0b013e328363eb4e; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Chu Q, 2013, CELL PROLIFERAT, V46, P254, DOI 10.1111/cpr.12037; Cortes A, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3204; Danchenko N, 2006, LUPUS, V15, P308, DOI 10.1191/0961203306lu2305xx; Deshmukh HA, 2011, J RHEUMATOL, V38, P1866, DOI 10.3899/jrheum.110199; Du Y, 2011, TISSUE ANTIGENS, V77, P65, DOI 10.1111/j.1399-0039.2010.01568.x; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Farh KKH, 2015, NATURE, V518, P337, DOI 10.1038/nature13835; Forrest ARR, 2014, NATURE, V507, P462, DOI 10.1038/nature13182; Gateva V, 2009, NAT GENET, V41, P1228, DOI 10.1038/ng.468; Gorski KS, 2003, MOL IMMUNOL, V40, P35, DOI 10.1016/S0161-5890(03)00085-3; Gupta S, 2003, J BIOL CHEM, V278, P43541, DOI 10.1074/jbc.M308960200; Guthridge JM, 2014, AM J HUM GENET, V94, P586, DOI 10.1016/j.ajhg.2014.03.008; Hafler JP, 2009, GENES IMMUN, V10, P5, DOI 10.1038/gene.2008.82; Harley ITW, 2009, NAT REV GENET, V10, P285, DOI 10.1038/nrg2571; He CF, 2010, LUPUS, V19, P1181, DOI 10.1177/0961203310367918; Howard ML, 2012, NEUROBIOL DIS, V45, P913, DOI 10.1016/j.nbd.2011.12.010; Hu XL, 2011, AM J HUM GENET, V89, P496, DOI 10.1016/j.ajhg.2011.09.002; Iatropoulos P, 2009, PSYCHIAT GENET, V19, P237, DOI 10.1097/YPG.0b013e32832cebf7; Iguchi-Manaka A, 2008, J EXP MED, V205, P2959, DOI 10.1084/jem.20081611; Jakes RW, 2012, ARTHRIT CARE RES, V64, P159, DOI 10.1002/acr.20683; Johnatty SE, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001016; Kamburov A, 2013, NUCLEIC ACIDS RES, V41, pD793, DOI 10.1093/nar/gks1055; Kim K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6902; Kim K, 2015, ANN RHEUM DIS, V74, DOI 10.1136/annrheumdis-2013-204749; Klapper W, 2004, ANN RHEUM DIS, V63, P1681, DOI 10.1136/ard.2003.016022; Lessard CJ, 2013, NAT GENET, V45, P1284, DOI 10.1038/ng.2792; Lessard CJ, 2012, AM J HUM GENET, V90, P648, DOI 10.1016/j.ajhg.2012.02.023; Li YZ, 2013, NAT GENET, V45, P1361, DOI 10.1038/ng.2779; Liu JZ, 2012, NAT GENET, V44, P1137, DOI 10.1038/ng.2395; Maiti AK, 2014, HUM MOL GENET, V23, P4161, DOI 10.1093/hmg/ddu106; Maiti AK, 2010, RHEUMATOLOGY, V49, P1239, DOI 10.1093/rheumatology/kep470; Malcolm T, 2008, FEBS LETT, V582, P3903, DOI 10.1016/j.febslet.2008.10.032; Maller JB, 2012, NAT GENET, V44, P1294, DOI 10.1038/ng.2435; Molineros JE, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003222; Noble JA, 2003, DIABETES, V52, P1579, DOI 10.2337/diabetes.52.6.1579; Patel N, 1999, J BIOL CHEM, V274, P22729, DOI 10.1074/jbc.274.32.22729; Perl A, 2009, CURR OPIN RHEUMATOL, V21, P443, DOI 10.1097/BOR.0b013e32832efe6b; Qiu ZX, 2013, HUM IMMUNOL, V74, P249, DOI 10.1016/j.humimm.2012.10.009; Roy AL, 2012, GENE, V492, P32, DOI 10.1016/j.gene.2011.10.030; So HC, 2011, GENET EPIDEMIOL, V35, P310, DOI 10.1002/gepi.20579; Stoeckman AK, 2006, GENES IMMUN, V7, P583, DOI 10.1038/sj.gene.6364334; Tantin D, 2004, J BIOL CHEM, V279, P5460, DOI 10.1074/jbc.M311177200; Trost B, 2013, BIOINFORMATICS, V29, P1693, DOI 10.1093/bioinformatics/btt265; Vandeweyer G, 2012, AM J HUM GENET, V90, P1071, DOI 10.1016/j.ajhg.2012.04.020; Wandstrat A, 2001, NAT IMMUNOL, V2, P802, DOI 10.1038/ni0901-802; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; Wieczorek S, 2009, GENES IMMUN, V10, P591, DOI 10.1038/gene.2009.44; Wren JD, 2004, BIOINFORMATICS, V20, P389, DOI 10.1093/bioinformatics/btg421; Xiong W, 2014, NAT REV RHEUMATOL, V10, P97, DOI 10.1038/nrrheum.2013.157; Yang WL, 2013, AM J HUM GENET, V92, P41, DOI 10.1016/j.ajhg.2012.11.018; Yasuda S, 2007, J IMMUNOL, V179, P4890, DOI 10.4049/jimmunol.179.7.4890; Zheng JF, 2015, RHEUMATOLOGY, V54, P562, DOI 10.1093/rheumatology/keu466	58	154	158	2	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2016	48	3					323	330		10.1038/ng.3496	http://dx.doi.org/10.1038/ng.3496			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DE8QW	26808113	Green Published, Green Accepted			2022-12-25	WOS:000370902600018
J	Wang, WZ; Wang, XL; Fujioka, H; Hoppel, C; Whone, AL; Caldwell, MA; Cullen, PJ; Liu, J; Zhu, XW				Wang, Wenzhang; Wang, Xinglong; Fujioka, Hisashi; Hoppel, Charles; Whone, Alan L.; Caldwell, Maeve A.; Cullen, Peter J.; Liu, Jun; Zhu, Xiongwei			Parkinson's disease-associated mutant VPS35 causes mitochondrial dysfunction by recycling DLP1 complexes	NATURE MEDICINE			English	Article							RETROMER COMPLEX; D620N MUTATION; WASH COMPLEX; FISSION; FUSION; CARGO; INHIBITION; TRANSPORT; DYNAMICS; PROMOTES	Mitochondrial dysfunction represents a critical step during the pathogenesis of Parkinson's disease (PD), and increasing evidence suggests abnormal mitochondrial dynamics and quality control as important underlying mechanisms. The VPS35 gene, which encodes a key component of the membrane protein-recycling retromer complex, is the third autosomal-dominant gene associated with PD. However, how VPS35 mutations lead to neurodegeneration remains unclear. Here we demonstrate that PD-associated VPS35 mutations caused mitochondrial fragmentation and cell death in cultured neurons in vitro, in mouse substantia nigra neurons in vivo and in human fibroblasts from an individual with PD who has the VPS35(D620N) mutation. VPS35-induced mitochondrial deficits and neuronal dysfunction could be prevented by inhibition of mitochondrial fission. VPS35 mutants showed increased interaction with dynamin-like protein (DLP) 1, which enhanced turnover of the mitochondrial DLP1 complexes via the mitochondria-derived vesicle-dependent trafficking of the complexes to lysosomes for degradation. Notably, oxidative stress increased the VPS35-DLP1 interaction, which we also found to be increased in the brains of sporadic PD cases. These results revealed a novel cellular mechanism for the involvement of VPS35 in mitochondrial fission, dysregulation of which is probably involved in the pathogenesis of familial, and possibly sporadic, PD.	[Wang, Wenzhang; Wang, Xinglong; Zhu, Xiongwei] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; [Fujioka, Hisashi] Case Western Reserve Univ, Electron Microscopy Core Facil, Cleveland, OH 44106 USA; [Hoppel, Charles] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA; [Hoppel, Charles] Case Western Reserve Univ, Dept Med, Ctr Mitochondrial Dis, Cleveland, OH 44106 USA; [Whone, Alan L.] Univ Bristol, Inst Clin Neurosci, Southmead Hosp, Bristol, Avon, England; [Caldwell, Maeve A.] Trinity Coll Dublin, Trinity Coll, Inst Neurosci, Dublin, Ireland; [Cullen, Peter J.] Univ Bristol, Sch Biochem, Henry Wellcome Integrated Signaling Labs, Bristol, Avon, England; [Liu, Jun] Shanghai Jiao Tong Univ, Dept Neurol, Ruijin Hosp, Sch Med, Shanghai 200030, Peoples R China	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Southmead Hospital; University of Bristol; Trinity College Dublin; University of Bristol; Shanghai Jiao Tong University	Zhu, XW (corresponding author), Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA.	xinglong.wang@case.edu; jly0520@hotmail.com; xiongwei.zhu@case.edu	Whone, Alan/AAZ-4125-2020; Caldwell, Maeve/HHN-1986-2022; Zhu, Xiongwei/A-9629-2009; Wang, Wenzhang/H-8581-2015	Caldwell, Maeve/0000-0001-7442-711X; Zhu, Xiongwei/0000-0003-2092-6508; Cullen, Peter/0000-0002-9070-8349; Wang, Wenzhang/0000-0003-4426-019X; Whone, Alan/0000-0002-8931-4422	US National Institutes of Health (NIH) [NS071184, NS083498, NS085747]; Clinical and Translational Science Collaborative of Cleveland; National Center for Advancing Translational Sciences component of the NIH; NIH Roadmap for Medical Research [UL1TR000439]; Chinese Overseas, Hong Kong and Macao Scholars Collaborated Research Fund [81228007]; Shanghai Orientalist program; Dr. Robert M. Kohrman Memorial Fund; National Natural Science Fund of China [81228007, 81071024, 81171202, 30870879, 81471287]; Wellcome Trust [089928, 085743]; Medical Research Council [MR/K018299/1]; Public Health Service contract [HHS-NIH-NIDA (MH)-13-265]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS085747, R01NS089604, R21NS071184, R01NS083498] Funding Source: NIH RePORTER; Parkinson&quot;s UK [H-1002] Funding Source: researchfish; Wellcome Trust [104568/Z/14/Z] Funding Source: researchfish; MRC [MR/K018299/1] Funding Source: UKRI	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Clinical and Translational Science Collaborative of Cleveland(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Center for Advancing Translational Sciences component of the NIH; NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chinese Overseas, Hong Kong and Macao Scholars Collaborated Research Fund; Shanghai Orientalist program; Dr. Robert M. Kohrman Memorial Fund; National Natural Science Fund of China(National Natural Science Foundation of China (NSFC)); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Public Health Service contract; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Parkinson&quot;s UK(Parkinson&apos;s UK); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work is partly supported by the US National Institutes of Health (NIH) (grant no. NS071184 (X.Z.), NS083498 (X.Z.) and NS085747 (X.W.)); the Clinical and Translational Science Collaborative of Cleveland; the National Center for Advancing Translational Sciences component of the NIH and the NIH Roadmap for Medical Research (grant no. UL1TR000439; pilot award to X.Z.); the Chinese Overseas, Hong Kong and Macao Scholars Collaborated Research Fund (grant no. 81228007; X.Z.); the Shanghai Orientalist program (X.Z.), the Dr. Robert M. Kohrman Memorial Fund (X.Z.); the National Natural Science Fund of China (grant no. 81071024, 81171202, 30870879, 81228007 and 81471287; all to J.L.); the Wellcome Trust (grant no. 089928 and 085743; both to P.J.C.) and the Medical Research Council (grant no. MR/K018299/1; P.J.C.). We thank I. Kelmanson (Evrogen) for the mito-TagBFP construct and Y. Yoon (University of Rochester) for the DLP1<SUP>WT</SUP> and DLP1<SUP>K38A</SUP> constructs. Some Parkinson's disease tissue samples were obtained from the Harvard Brain Tissue Resource Center, which is supported in part by the Public Health Service contract (HHS-NIH-NIDA (MH)-13-265), and from the NIH Neurobiobank at the University of Maryland.	Bonifacino JS, 2008, CURR OPIN CELL BIOL, V20, P427, DOI 10.1016/j.ceb.2008.03.009; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; Braschi E, 2010, CURR BIOL, V20, P1310, DOI 10.1016/j.cub.2010.05.066; Burd C, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016774; Burte F, 2015, NAT REV NEUROL, V11, P11, DOI 10.1038/nrneurol.2014.228; Cassidy-Stone A, 2008, DEV CELL, V14, P193, DOI 10.1016/j.devcel.2007.11.019; Chan DC, 2006, ANNU REV CELL DEV BI, V22, P79, DOI 10.1146/annurev.cellbio.22.010305.104638; Chan DC, 2012, ANNU REV GENET, V46, P265, DOI 10.1146/annurev-genet-110410-132529; Chen Y, 2013, SCIENCE, V340, P471, DOI 10.1126/science.1231031; Chowdhury SKR, 2012, BRAIN, V135, P1751, DOI 10.1093/brain/aws097; Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; Follett J, 2014, TRAFFIC, V15, P230, DOI 10.1111/tra.12136; Fujioka H, 2013, MICROSC RES TECHNIQ, V76, P1213, DOI 10.1002/jemt.22287; Fujioka H, 2011, ANAT REC, V294, P1825, DOI 10.1002/ar.21486; HANAICHI T, 1986, J ELECTRON MICROSC, V35, P304; Irrcher I, 2010, HUM MOL GENET, V19, P3734, DOI 10.1093/hmg/ddq288; Kumar KR, 2012, ARCH NEUROL-CHICAGO, V69, P1360, DOI 10.1001/archneurol.2011.3367; Lackner LL, 2009, BBA-MOL BASIS DIS, V1792, P1138, DOI 10.1016/j.bbadis.2008.11.011; Lesage S, 2012, NEUROLOGY, V78, P1449, DOI 10.1212/WNL.0b013e318253d5f2; Lim KL, 2012, ANTIOXID REDOX SIGN, V16, P935, DOI 10.1089/ars.2011.4105; Liu T, 2013, EXP CELL RES, V319, P2893, DOI 10.1016/j.yexcr.2013.07.010; Lucin KM, 2013, NEURON, V79, P873, DOI 10.1016/j.neuron.2013.06.046; McGough IJ, 2014, CURR BIOL, V24, P1670, DOI 10.1016/j.cub.2014.06.024; McLelland GL, 2014, EMBO J, V33, P282, DOI 10.1002/embj.201385902; Merrill RA, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000612; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Neuspiel M, 2008, CURR BIOL, V18, P102, DOI 10.1016/j.cub.2007.12.038; Seaman MNJ, 2012, J CELL SCI, V125, P4693, DOI 10.1242/jcs.103440; Sharma M, 2012, J MED GENET, V49, P721, DOI 10.1136/jmedgenet-2012-101155; Soubannier V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052830; Soubannier V, 2012, CURR BIOL, V22, P135, DOI 10.1016/j.cub.2011.11.057; Su YC, 2013, HUM MOL GENET, V22, P4545, DOI 10.1093/hmg/ddt301; Sugiura A, 2014, EMBO J, V33, P2142, DOI 10.15252/embj.201488104; Tsika E, 2014, HUM MOL GENET, V23, P4621, DOI 10.1093/hmg/ddu178; Vilarino-Guell C, 2011, AM J HUM GENET, V89, P162, DOI 10.1016/j.ajhg.2011.06.001; Vives-Bauza C, 2010, PROG BRAIN RES, V183, P99, DOI 10.1016/S0079-6123(10)83006-7; Wang XL, 2008, AM J PATHOL, V173, P470, DOI 10.2353/ajpath.2008.071208; Wang XL, 2012, J NEUROCHEM, V121, P830, DOI 10.1111/j.1471-4159.2012.07734.x; Wang XL, 2012, HUM MOL GENET, V21, P1931, DOI 10.1093/hmg/dds003; Wang XL, 2009, J NEUROSCI, V29, P9090, DOI 10.1523/JNEUROSCI.1357-09.2009; Yan MH, 2013, FREE RADICAL BIO MED, V62, P90, DOI 10.1016/j.freeradbiomed.2012.11.014; Yoon Y, 1998, J CELL BIOL, V140, P779, DOI 10.1083/jcb.140.4.779; Zavodszky E, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4828; Zhao J, 2011, EMBO J, V30, P2762, DOI 10.1038/emboj.2011.198; Zhu PP, 2004, J BIOL CHEM, V279, P35967, DOI 10.1074/jbc.M404105200; Zimprich A, 2011, AM J HUM GENET, V89, P168, DOI 10.1016/j.ajhg.2011.06.008; Zunino R, 2009, J BIOL CHEM, V284, P17783, DOI 10.1074/jbc.M901902200	47	195	202	2	69	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2016	22	1					54	+		10.1038/nm.3983	http://dx.doi.org/10.1038/nm.3983			13	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DA1YA	26618722	Green Accepted			2022-12-25	WOS:000367590700015
J	Gur-Cohen, S; Itkin, T; Chakrabarty, S; Graf, C; Kollet, O; Ludin, A; Golan, K; Kalinkovich, A; Ledergor, G; Wong, E; Niemeyer, E; Porat, Z; Erez, A; Sagi, I; Esmon, CT; Ruf, W; Lapidot, T				Gur-Cohen, Shiri; Itkin, Tomer; Chakrabarty, Sagarika; Graf, Claudine; Kollet, Orit; Ludin, Aya; Golan, Karin; Kalinkovich, Alexander; Ledergor, Guy; Wong, Eitan; Niemeyer, Elisabeth; Porat, Ziv; Erez, Ayelet; Sagi, Irit; Esmon, Charles T.; Ruf, Wolfram; Lapidot, Tsvee			PAR1 signaling regulates the retention and recruitment of EPCR-expressing bone marrow hematopoietic stem cells	NATURE MEDICINE			English	Article							ACTIVATED PROTEIN-C; RAPID MOBILIZATION; PROGENITOR CELLS; RECEPTOR GENE; THROMBIN; CDC42; MICE; NICHE; QUIESCENCE; MIGRATION	Retention of long-term repopulating hematopoietic stem cells (LT-HSCs) in the bone marrow is essential for hematopoiesis and for protection from myelotoxic injury. We report that signaling cascades that are traditionally viewed as coagulation related also control retention of endothelial protein C receptor-positive (EPCR+) LT-HSCs in the bone marrow and their recruitment to the blood via two pathways mediated by protease activated receptor 1 (PAR 1). Thrombin-PAR1 signaling induces nitric oxide (NO) production, leading to EPCR shedding mediated by tumor necrosis factor-alpha-converting enzyme (TACE), enhanced CXCL12-CXCR4-induced motility and rapid stem and progenitor cell mobilization. Conversely, bone marrow blood vessels provide a microenvironment enriched with activated protein C (aPC) that retains EPCR+ LT-HSCs by limiting NO generation, reducing Cdc42 activity and enhancing integrin VLA4 affinity and adhesion. Inhibition of NO production by aPC-EPCR-PAR1 signaling reduces progenitor cell egress from the bone marrow, increases retention of bone marrow NOlow EPCR+ LT-HSCs and protects mice from chemotherapy-induced hematological failure and death. Our study reveals new roles for PAR1 and EPCR in controlling NO production to balance maintenance and recruitment of bone marrow EPCR+ LT-HSCs, with potential clinical relevance for stem cell transplantation.	[Gur-Cohen, Shiri; Itkin, Tomer; Kollet, Orit; Ludin, Aya; Golan, Karin; Kalinkovich, Alexander; Ledergor, Guy; Niemeyer, Elisabeth; Lapidot, Tsvee] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel; [Chakrabarty, Sagarika; Ruf, Wolfram] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Graf, Claudine; Ruf, Wolfram] Johannes Gutenberg Univ Med Ctr, Ctr Thrombosis & Hemostasis, Mainz, Germany; [Ledergor, Guy] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Internal Med Dept T, IL-69978 Tel Aviv, Israel; [Wong, Eitan; Erez, Ayelet; Sagi, Irit] Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel; [Niemeyer, Elisabeth] Univ Lubeck, Klin Strahlentherapie, Univ Klinikum Schleswig Holstein, Lubeck, Germany; [Porat, Ziv] Weizmann Inst Sci, Dept Biol Serv, Flow Cytometry Unit, IL-76100 Rehovot, Israel; [Esmon, Charles T.] Univ Oklahoma, Hlth Sci Ctr, Oklahoma Med Res Fdn, Coagulat Biol Lab, Oklahoma City, OK USA; [Esmon, Charles T.] Univ Oklahoma, Hlth Sci Ctr, Dept Pathol, Oklahoma City, OK USA; [Esmon, Charles T.] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73190 USA	Weizmann Institute of Science; Scripps Research Institute; Johannes Gutenberg University of Mainz; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Weizmann Institute of Science; University of Kiel; Schleswig Holstein University Hospital; University of Lubeck; Weizmann Institute of Science; Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Lapidot, T (corresponding author), Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel.	ruf@scripps.edu; tsvee.lapidot@weizmann.ac.il	Wong, Eitan/GRN-9218-2022; Porat, Ziv/K-1672-2012; Wong, Eitan/AHB-8360-2022	Porat, Ziv/0000-0003-3059-181X; Ledergor, Guy/0000-0003-0443-6066	Israel Science Foundation [851/13]; Ernest and Bonnie Beutler Research Program of Excellence in Genomic Medicine and FP7-HEALTH [CELL-PID 261387]; NIH [HL-31950, HL-60742]; BMBF [01EO1003]; Humboldt Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL031950, R01HL060742] Funding Source: NIH RePORTER	Israel Science Foundation(Israel Science Foundation); Ernest and Bonnie Beutler Research Program of Excellence in Genomic Medicine and FP7-HEALTH; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BMBF(Federal Ministry of Education & Research (BMBF)); Humboldt Foundation(Alexander von Humboldt Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Procr<SUP>low</SUP> mice were provided by F.J. Castellino (University of Notre Dame). F2r<SUP>-/-</SUP> and F2rl2<SUP>-/-</SUP> were provided by P. Andrade-Gordon (Johnson & Johnson). Thbd<SUP>Pro/Pro</SUP> mice were provided by H. Weiler (Blood Center of Wisconsin). Anti-TACE prodomain antibody was provided by C. Blobel (Hospital of Special Surgery). We thank C.E. Dunbar (NIH) for critically reviewing this manuscript and R. Rotkopf (Weizmann Institute of Science) for assistance in data statistical analysis. This study was supported by the Israel Science Foundation (851/13), the Ernest and Bonnie Beutler Research Program of Excellence in Genomic Medicine and FP7-HEALTH-2010 (CELL-PID 261387) (T.L.) and NIH grants HL-31950, HL-60742, BMBF 01EO1003 and the Humboldt Foundation (W.R.).	Adamo L, 2009, NATURE, V459, P1131, DOI 10.1038/nature08073; Aicher A, 2003, NAT MED, V9, P1370, DOI 10.1038/nm948; Aronovich A, 2013, BLOOD, V122, P2562, DOI 10.1182/blood-2012-08-447458; Balazs AB, 2006, BLOOD, V107, P2317, DOI 10.1182/blood-2005-06-2249; Broxmeyer HE, 2005, J EXP MED, V201, P1307, DOI 10.1084/jem.20041385; Bruns I, 2014, NAT MED, V20, P1315, DOI 10.1038/nm.3707; Castellino FJ, 2002, THROMB HAEMOSTASIS, V88, P462; Colognato R, 2003, BLOOD, V102, P2645, DOI 10.1182/blood-2002-08-2497; Dar A, 2011, LEUKEMIA, V25, P1286, DOI 10.1038/leu.2011.62; Disse J, 2011, J BIOL CHEM, V286, P5756, DOI 10.1074/jbc.M110.201228; Esmon CT, 2004, MATURITAS, V47, P305, DOI 10.1016/j.maturitas.2003.10.015; Florian MC, 2012, CELL STEM CELL, V10, P520, DOI 10.1016/j.stem.2012.04.007; Geiger H, 2007, CELL CYCLE, V6, P884, DOI 10.4161/cc.6.8.4131; Geiger H, 2012, NAT MED, V18, P1123, DOI 10.1038/nm.2813; Griffin JH, 2015, BLOOD, V125, P2898, DOI 10.1182/blood-2015-02-355974; Gu JM, 2000, BLOOD, V95, P1687, DOI 10.1182/blood.V95.5.1687.005k08_1687_1693; Gu JM, 2002, J BIOL CHEM, V277, P43335, DOI 10.1074/jbc.M207538200; HEIN L, 1994, J BIOL CHEM, V269, P27719; Heissig B, 2002, CELL, V109, P625, DOI 10.1016/S0092-8674(02)00754-7; Ho IAW, 2009, STEM CELLS, V27, P1366, DOI 10.1002/stem.50; Ishikawa ET, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2645; Iwasaki H, 2010, BLOOD, V116, P544, DOI 10.1182/blood-2009-08-240903; Karp JM, 2005, BONE, V37, P337, DOI 10.1016/j.bone.2005.04.022; Kent DG, 2009, BLOOD, V113, P6342, DOI 10.1182/blood-2008-12-192054; Kolluru GK, 2010, BIOCHIMIE, V92, P1186, DOI 10.1016/j.biochi.2010.03.020; Ludin A, 2012, NAT IMMUNOL, V13, P1072, DOI 10.1038/ni.2408; Mendez-Ferrer S, 2008, NATURE, V452, P442, DOI 10.1038/nature06685; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; North TE, 2009, CELL, V137, P736, DOI 10.1016/j.cell.2009.04.023; Papayannopoulou T, 1998, BLOOD, V91, P2231, DOI 10.1182/blood.V91.7.2231.2231_2231_2239; Papayannopoulou T, 2008, BLOOD, V111, P3923, DOI 10.1182/blood-2007-08-078147; Pepler L, 2015, BLOOD, V126, P673, DOI 10.1182/blood-2014-02-558940; Petit I, 2002, NAT IMMUNOL, V3, P687, DOI 10.1038/ni813; Priestley GV, 2007, BLOOD, V109, P109, DOI 10.1182/blood-2006-06-026427; Qu D, 2007, J THROMB HAEMOST, V5, P395, DOI 10.1111/j.1538-7836.2007.02347.x; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; Riewald M, 2005, J BIOL CHEM, V280, P19808, DOI 10.1074/jbc.M500747200; Riewald M, 2002, SCIENCE, V296, P1880, DOI 10.1126/science.1071699; Sagi I., 2015, US patent, Patent No. [20150132281 A1, 20150132281]; Sanjuan-Pla A, 2013, NATURE, V502, P232, DOI 10.1038/nature12495; Schaffner F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061071; Schajnovitz A, 2011, NAT IMMUNOL, V12, P391, DOI 10.1038/ni.2017; Slungaard A, 2003, BLOOD, V102, P146, DOI 10.1182/blood-2002-11-3529; Spiegel A, 2008, CELL STEM CELL, V3, P484, DOI 10.1016/j.stem.2008.10.006; StearnsKurosawa DJ, 1996, P NATL ACAD SCI USA, V93, P10212, DOI 10.1073/pnas.93.19.10212; Steidl U, 2002, BLOOD, V99, P2037, DOI 10.1182/blood.V99.6.2037; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Tjwa M, 2009, J CLIN INVEST, V119, P1008, DOI 10.1172/JCI36010; Tudpor K, 2015, BONE, V72, P14, DOI 10.1016/j.bone.2014.11.004; Wang DS, 2015, NATURE, V517, P81, DOI 10.1038/nature13851; Wang L, 2006, BLOOD, V107, P98, DOI 10.1182/blood-2005-05-2171; Wang L, 2011, BLOOD, V118, P4102, DOI 10.1182/blood-2011-05-353235; Wautier F, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-104; Weiler-Guettler H, 1998, J CLIN INVEST, V101, P1983, DOI 10.1172/JCI2006; Williams DA, 2008, METHOD ENZYMOL, V439, P365, DOI 10.1016/S0076-6879(07)00427-2; Wilson NK, 2015, CELL STEM CELL, V16, P712, DOI 10.1016/j.stem.2015.04.004; Yang FC, 2001, P NATL ACAD SCI USA, V98, P5614, DOI 10.1073/pnas.101546898; Yang L, 2007, P NATL ACAD SCI USA, V104, P5091, DOI 10.1073/pnas.0610819104; Zhang YY, 2007, STEM CELLS, V25, P211, DOI 10.1634/stemcells.2006-0468; Zhao M, 2014, NAT MED, V20, P1321, DOI 10.1038/nm.3706	60	92	93	0	13	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2015	21	11					1307	1317		10.1038/nm.3960	http://dx.doi.org/10.1038/nm.3960			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CV9QH	26457757	Green Accepted			2022-12-25	WOS:000364621200015
J	[Anonymous]				[Anonymous]			Stabilizing prospects for a universal flu vaccine	NATURE BIOTECHNOLOGY			English	Editorial Material							HEMAGGLUTININ-STEM; INFLUENZA; VIRUS											Impagliazzo A, 2015, SCIENCE, V349, P1301, DOI 10.1126/science.aac7263; Kashyap AK, 2008, P NATL ACAD SCI USA, V105, P5986, DOI 10.1073/pnas.0801367105; Pica N, 2012, P NATL ACAD SCI USA, V109, P2573, DOI 10.1073/pnas.1200039109; Yassine HM, 2015, NAT MED, V21, P1065, DOI 10.1038/nm.3927	4	0	0	0	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	OCT	2015	33	10					1043	1044						3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CT1JX	26448088				2022-12-25	WOS:000362555700022
J	O'Connell, J; Sharp, K; Shrine, N; Wain, L; Hall, I; Tobin, M; Zagury, JF; Delaneau, O; Marchini, J				O'Connell, Jared; Sharp, Kevin; Shrine, Nick; Wain, Louise; Hall, Ian; Tobin, Martin; Zagury, Jean-Francois; Delaneau, Olivier; Marchini, Jonathan			Haplotype estimation for biobank-scale data sets	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; GENOTYPE IMPUTATION; RECOMBINATION; DISEASE	The UK Biobank (UKB) has recently released genotypes on 152,328 individuals together with extensive phenotypic and lifestyle information. We present a new phasing method, SHAPEIT3, that can handle such biobank-scale data sets and results in switch error rates as low as similar to 0.3%. The method exhibits O(NlogN) scaling with sample size N, enabling fast and accurate phasing of even larger cohorts.	[O'Connell, Jared; Marchini, Jonathan] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [O'Connell, Jared; Sharp, Kevin; Marchini, Jonathan] Univ Oxford, Dept Stat, Oxford OX1 3TG, England; [Shrine, Nick; Wain, Louise; Tobin, Martin] Univ Leicester, Dept Hlth Sci, Leicester, Leics, England; [Hall, Ian] Univ Nottingham, Sch Med, Nottingham, England; [Zagury, Jean-Francois] Conservatoire Natl Arts & Metiers, Equipe Accueil 4627, Lab Genom Bioinformat & Applicat, Chaire Bioinformat, Paris, France; [Delaneau, Olivier] Univ Geneva, Dept Genet & Dev, Geneva, Switzerland	University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; University of Leicester; University of Nottingham; heSam Universite; Conservatoire National Arts & Metiers (CNAM); University of Geneva	Marchini, J (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England.; Marchini, J (corresponding author), Univ Oxford, Dept Stat, Oxford OX1 3TG, England.	marchini@stats.ox.ac.uk	/AAR-2792-2021; Marchini, Jonathan/ABE-9024-2020	Marchini, Jonathan/0000-0003-0610-8322; Shrine, Nick/0000-0003-3641-4371; Tobin, Martin/0000-0002-3596-7874; Hall, Ian/0000-0001-9933-3216; Wain, Louise/0000-0003-4951-1867; Delaneau, Olivier/0000-0002-3906-8446	Medical Research Council (MRC) [MC_PC_12010]; National Institute for Health Research (NIHR); ERC [617306]; Medical Research Council [MC_PC_12010, MC_qA137853, G1000861] Funding Source: researchfish; MRC [G1000861, MC_PC_12010] Funding Source: UKRI	Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); ERC(European Research Council (ERC)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	UK BiLEVE was funded by a Medical Research Council (MRC) strategic award to M.T., I.H., D. Strachan and L.W. (MC_PC_12010). We would like to thank the UK BiLEVE study investigators, array design team, analysis group and steering group. This research has been conducted using the UK Biobank Resource. This article presents independent research funded partially by the National Institute for Health Research (NIHR). The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the UK Department of Health. J.M. acknowledges support from the ERC (grant 617306).	Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Chen ZM, 2011, INT J EPIDEMIOL, V40, P1652, DOI 10.1093/ije/dyr120; Delaneau O, 2013, NAT METHODS, V10, P5, DOI 10.1038/nmeth.2307; Delaneau O, 2012, NAT METHODS, V9, P179, DOI [10.1038/NMETH.1785, 10.1038/nmeth.1785]; Hellenthal G, 2014, SCIENCE, V343, P747, DOI 10.1126/science.1243518; Hinch AG, 2011, NATURE, V476, P170, DOI 10.1038/nature10336; Hoffmann TJ, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004930; Howie B, 2012, NAT GENET, V44, P955, DOI 10.1038/ng.2354; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Koga H, 2007, KNOWL INF SYST, V12, P25, DOI 10.1007/s10115-006-0027-5; Kong A, 2008, NAT GENET, V40, P1068, DOI 10.1038/ng.216; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; LLOYD SP, 1982, IEEE T INFORM THEORY, V28, P129, DOI 10.1109/TIT.1982.1056489; Loh P.-R., 2016, NAT GENET; Manichaikul A, 2010, BIOINFORMATICS, V26, P2867, DOI 10.1093/bioinformatics/btq559; Marchini J, 2010, NAT REV GENET, V11, P499, DOI 10.1038/nrg2796; Martin HC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8846; McCarthy S., 2015, BIORXIV; O'Connell J, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004234; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Sharp K., 2016, BIOINFORMATICS; Wain LV, 2015, LANCET RESP MED, V3, P769, DOI 10.1016/S2213-2600(15)00283-0; Wiliams AL, 2012, AM J HUM GENET, V91, P238, DOI 10.1016/j.ajhg.2012.06.013	23	97	97	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2016	48	7					817	+		10.1038/ng.3583	http://dx.doi.org/10.1038/ng.3583			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DP9TK	27270105	Green Accepted, Green Submitted			2022-12-25	WOS:000378840100021
J	Ngo, JT; Adams, SR; Deerinck, TJ; Boassa, D; Rodriguez-Rivera, F; Palida, SF; Bertozzi, CR; Ellisman, MH; Tsien, RY				Ngo, John T.; Adams, Stephen R.; Deerinck, Thomas J.; Boassa, Daniela; Rodriguez-Rivera, Frances; Palida, Sakina F.; Bertozzi, Carolyn R.; Ellisman, Mark H.; Tsien, Roger Y.			Click-EM for imaging metabolically tagged nonprotein biomolecules	NATURE CHEMICAL BIOLOGY			English	Article							IN-VIVO; ELECTRON-MICROSCOPY; TERMINAL ALKYNES; QUANTUM YIELDS; XANTHENE DYES; LIVING CELLS; HUMAN NUCLEI; AMINO-ACIDS; CYCLOADDITION; FLUORESCENCE	EM has long been the main technique for imaging cell structures with nanometer resolution but has lagged behind light microscopy in the crucial ability to make specific molecules stand out. Here we introduce click-EM, a labeling technique for correlative light microscopy and EM imaging of nonprotein biomolecules. In this approach, metabolic labeling substrates containing bioorthogonal functional groups are provided to cells for incorporation into biopolymers by endogenous biosynthetic machinery. The unique chemical functionality of these analogs is exploited for selective attachment of singlet oxygen-generating fluorescent dyes via bioorthogonal 'click chemistry' ligations. Illumination of dye-labeled structures generates singlet oxygen to locally catalyze the polymerization of diaminobenzidine into an osmiophilic reaction product that is readily imaged by EM. We describe the application of click-EM in imaging metabolically tagged DNA, RNA and lipids in cultured cells and neurons and highlight its use in tracking peptidoglycan synthesis in the Gram-positive bacterium Listeria monocytogenes.	[Ngo, John T.; Adams, Stephen R.; Palida, Sakina F.; Tsien, Roger Y.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Deerinck, Thomas J.; Boassa, Daniela; Ellisman, Mark H.; Tsien, Roger Y.] Univ Calif San Diego, Natl Ctr Microscopy & Imaging Res, La Jolla, CA 92093 USA; [Rodriguez-Rivera, Frances] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Bertozzi, Carolyn R.] Stanford Univ, Dept Chem, Stanford, CA 94305 USA; [Bertozzi, Carolyn R.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Ellisman, Mark H.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Tsien, Roger Y.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Tsien, Roger Y.] Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA; [Ngo, John T.] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California Berkeley; Stanford University; Howard Hughes Medical Institute; Stanford University; University of California System; University of California San Diego; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego; Boston University	Tsien, RY (corresponding author), Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA.; Tsien, RY (corresponding author), Univ Calif San Diego, Natl Ctr Microscopy & Imaging Res, La Jolla, CA 92093 USA.; Tsien, RY (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA.; Tsien, RY (corresponding author), Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA.	rtsien@ucsd.edu		Ngo, John/0000-0003-3508-1915	NIH [GM086197, GM058867, AI051622, P41 GM103412]; Ford Foundation; UC Berkeley; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051622] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086197, T32GM007752, R37GM058867, P41GM103412] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS027177] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ford Foundation; UC Berkeley; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We gratefully acknowledge S. Phan for assistance with SBEM image processing, C. Woodford for assistance with NMR, L. Gross for assistance with MS and C. Hill for providing wild-type and lmo2754::tn EGD-e L. monocytogenes. Funding for this work was provided by NIH GM086197 (to R.Y.T. and M.H.E.), NIH GM058867 (to C.R.B.), and NIH AI051622 (to C.R.B.). The work described herein was carried out using shared research resources at the National Center for Microscopy and Imaging Research (NCMIR) at UCSD supported by the NIH under award number P41 GM103412 (to M.H.E.). F.R. was supported by a Ford Foundation Predoctoral Fellowship and a Chancellor's fellowship from UC Berkeley.	Agard NJ, 2004, J AM CHEM SOC, V126, P15046, DOI 10.1021/ja044996f; [Anonymous], 2012, AGR FOOD ANAL BACTER; Bensaude O, 2011, TRANSCR-AUSTIN, V2, P103, DOI 10.4161/trns.2.3.16172; BOWERS PG, 1967, PROC R SOC LON SER-A, V299, P348, DOI 10.1098/rspa.1967.0141; Capani F, 2001, J HISTOCHEM CYTOCHEM, V49, P1351, DOI 10.1177/002215540104901103; Caputo G., 2002, European patent, Patent No. [1221465A1, 1221465]; Cava F, 2011, EMBO J, V30, P3442, DOI 10.1038/emboj.2011.246; Chagin VO, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000737; Chibisov AK, 1996, J CHEM SOC FARADAY T, V92, P4917, DOI 10.1039/ft9969204917; Debets MF, 2010, CHEM COMMUN, V46, P97, DOI 10.1039/b917797c; DEERINCK TJ, 1994, J CELL BIOL, V126, P901, DOI 10.1083/jcb.126.4.901; Devaraj NK, 2010, ANGEW CHEM INT EDIT, V49, P2869, DOI 10.1002/anie.200906120; Dieck ST, 2015, NAT METHODS, V12, P411, DOI [10.1038/nmeth.3319, 10.1038/NMETH.3319]; Dieterich DC, 2010, NAT NEUROSCI, V13, P897, DOI 10.1038/nn.2580; Dimitrova DS, 2002, J CELL SCI, V115, P4037, DOI 10.1242/jcs.00087; Fang X, 2006, MOL BIOSYST, V2, P69, DOI 10.1039/b515328j; FLEMING GR, 1977, J AM CHEM SOC, V99, P4306, DOI 10.1021/ja00455a017; Gaietta G, 2002, SCIENCE, V296, P503, DOI 10.1126/science.1068793; GANDIN E, 1983, PHOTOCHEM PHOTOBIOL, V37, P271, DOI 10.1111/j.1751-1097.1983.tb04472.x; Gorner H., 2004, CRC HDB ORGANIC PHOT; GUPTA BL, 1973, J MICROSC-OXFORD, V99, P1, DOI 10.1111/j.1365-2818.1973.tb03848.x; Iborra FJ, 1998, J HISTOCHEM CYTOCHEM, V46, P985, DOI 10.1177/002215549804600901; Iborra FJ, 1996, J CELL SCI, V109, P1427; Jao CY, 2008, P NATL ACAD SCI USA, V105, P15779, DOI 10.1073/pnas.0808480105; Jao CY, 2009, P NATL ACAD SCI USA, V106, P15332, DOI 10.1073/pnas.0907864106; Jewett JC, 2010, CHEM SOC REV, V39, P1272, DOI 10.1039/b901970g; Kishimoto S, 2015, FREE RADICAL BIO MED, V85, P24, DOI 10.1016/j.freeradbiomed.2015.03.038; Korsak D, 2005, FEMS MICROBIOL LETT, V251, P281, DOI 10.1016/j.femsle.2005.08.009; Lam SS, 2015, NAT METHODS, V12, P51, DOI 10.1038/nmeth.3179; Laughlin ST, 2008, SCIENCE, V320, P664, DOI 10.1126/science.1155106; Li CS, 2014, PHOTOCHEM PHOTOBIOL, V90, P686, DOI 10.1111/php.12234; LITTAU VC, 1964, P NATL ACAD SCI USA, V52, P93, DOI 10.1073/pnas.52.1.93; Martell JD, 2012, NAT BIOTECHNOL, V30, P1143, DOI 10.1038/nbt.2375; MUJUMDAR RB, 1993, BIOCONJUGATE CHEM, V4, P105, DOI 10.1021/bc00020a001; Ngo JT, 2011, ACCOUNTS CHEM RES, V44, P677, DOI 10.1021/ar200144y; Paez-Segala M. G., 2015, NAT METHODS, V12, P4; Paez-Segala MG, 2015, NAT METHODS, V12, P215, DOI [10.1038/nmeth.3225, 10.1038/NMETH.3225]; Pal P, 1996, PHOTOCHEM PHOTOBIOL, V63, P161, DOI 10.1111/j.1751-1097.1996.tb03008.x; Papantonis A, 2013, CHEM REV, V113, P8683, DOI 10.1021/cr300513p; Perkovic M, 2014, J STRUCT BIOL, V186, P205, DOI 10.1016/j.jsb.2014.03.018; Robinson PV, 2015, J AM CHEM SOC, V137, P10452, DOI 10.1021/jacs.5b04279; Rostovtsev VV, 2002, ANGEW CHEM INT EDIT, V41, P2596, DOI 10.1002/1521-3773(20020715)41:14<2596::AID-ANIE2596>3.0.CO;2-4; Salic A, 2008, P NATL ACAD SCI USA, V105, P2415, DOI 10.1073/pnas.0712168105; Sanman LE, 2014, ANNU REV BIOCHEM, V83, P249, DOI 10.1146/annurev-biochem-060713-035352; Shieh P, 2015, J AM CHEM SOC, V137, P7145, DOI 10.1021/jacs.5b02383; Shu XK, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001041; Siegrist MS, 2015, FEMS MICROBIOL REV, V39, P184, DOI 10.1093/femsre/fuu012; Siegrist MS, 2013, ACS CHEM BIOL, V8, P500, DOI 10.1021/cb3004995; STIRLING JW, 1990, J HISTOCHEM CYTOCHEM, V38, P145, DOI 10.1177/38.2.2405054; Tornoe CW, 2002, J ORG CHEM, V67, P3057, DOI 10.1021/jo011148j; Tyagi S, 2009, NAT METHODS, V6, P331, DOI [10.1038/NMETH.1321, 10.1038/nmeth.1321]; USUI Y, 1973, CHEM LETT, P743, DOI 10.1246/cl.1973.743; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Velapoldi RA, 2004, J FLUORESC, V14, P465, DOI 10.1023/B:JOFL.0000031828.96368.c1; Wang Q, 2003, J AM CHEM SOC, V125, P3192, DOI 10.1021/ja021381e	55	55	55	6	181	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUN	2016	12	6					459	U128		10.1038/NCHEMBIO.2076	http://dx.doi.org/10.1038/NCHEMBIO.2076			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DM2EW	27110681	Green Accepted, Green Submitted			2022-12-25	WOS:000376160600017
J	Kim, JW; Botvinnik, OB; Abudayyeh, O; Birger, C; Rosenbluh, J; Shrestha, Y; Abazeed, ME; Hammerman, PS; DiCara, D; Konieczkowski, DJ; Johannessen, CM; Liberzon, A; Alizad-Rahvar, AR; Alexe, G; Aguirre, A; Ghandi, M; Greulich, H; Vazquez, F; Weir, BA; Van Allen, EM; Tsherniak, A; Shao, DD; Zack, TI; Noble, M; Getz, G; Beroukhim, R; Garraway, LA; Ardakani, M; Romualdi, C; Sales, G; Barbie, DA; Boehm, JS; Hahn, WC; Mesirov, JP; Tamayo, P				Kim, Jong Wook; Botvinnik, Olga B.; Abudayyeh, Omar; Birger, Chet; Rosenbluh, Joseph; Shrestha, Yashaswi; Abazeed, Mohamed E.; Hammerman, Peter S.; DiCara, Daniel; Konieczkowski, David J.; Johannessen, Cory M.; Liberzon, Arthur; Alizad-Rahvar, Amir Reza; Alexe, Gabriela; Aguirre, Andrew; Ghandi, Mahmoud; Greulich, Heidi; Vazquez, Francisca; Weir, Barbara A.; Van Allen, Eliezer M.; Tsherniak, Aviad; Shao, Diane D.; Zack, Travis I.; Noble, Michael; Getz, Gad; Beroukhim, Rameen; Garraway, Levi A.; Ardakani, Masoud; Romualdi, Chiara; Sales, Gabriele; Barbie, David A.; Boehm, Jesse S.; Hahn, William C.; Mesirov, Jill P.; Tamayo, Pablo			Characterizing genomic alterations in cancer by complementary functional associations	NATURE BIOTECHNOLOGY			English	Article							MUTUAL INFORMATION; CELL; REVEALS; GENES; NRF2; VULNERABILITIES; DEPENDENCIES; SUPPRESSION; MUTATIONS; DISCOVERY	Systematic efforts to sequence the cancer genome have identified large numbers of mutations and copy number alterations in human cancers. However, elucidating the functional consequences of these variants, and their interactions to drive or maintain oncogenic states, remains a challenge in cancer research. We developed REVEALER, a computational method that identifies combinations of mutually exclusive genomic alterations correlated with functional phenotypes, such as the activation or gene dependency of oncogenic pathways or sensitivity to a drug treatment. We used REVEALER to uncover complementary genomic alterations associated with the transcriptional activation of beta-catenin and NRF2, MEK-inhibitor sensitivity, and KRAS dependency. REVEALER successfully identified both known and new associations, demonstrating the power of combining functional profiles with extensive characterization of genomic alterations in cancer genomes.	[Kim, Jong Wook; Botvinnik, Olga B.; Abudayyeh, Omar; Birger, Chet; Rosenbluh, Joseph; Shrestha, Yashaswi; Abazeed, Mohamed E.; Hammerman, Peter S.; DiCara, Daniel; Konieczkowski, David J.; Johannessen, Cory M.; Liberzon, Arthur; Alexe, Gabriela; Aguirre, Andrew; Ghandi, Mahmoud; Greulich, Heidi; Vazquez, Francisca; Weir, Barbara A.; Van Allen, Eliezer M.; Tsherniak, Aviad; Shao, Diane D.; Zack, Travis I.; Noble, Michael; Getz, Gad; Beroukhim, Rameen; Garraway, Levi A.; Barbie, David A.; Boehm, Jesse S.; Hahn, William C.; Mesirov, Jill P.; Tamayo, Pablo] Eli & Edythe Broad Inst Harvard & Massachusetts I, Cambridge, MA USA; [Kim, Jong Wook; Abudayyeh, Omar; Rosenbluh, Joseph; Shrestha, Yashaswi; Konieczkowski, David J.; Johannessen, Cory M.; Aguirre, Andrew; Greulich, Heidi; Vazquez, Francisca; Van Allen, Eliezer M.; Shao, Diane D.; Beroukhim, Rameen; Garraway, Levi A.; Barbie, David A.; Hahn, William C.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Botvinnik, Olga B.] Univ Calif San Diego, Bioinformat & Syst Biol Program, La Jolla, CA 92093 USA; [Botvinnik, Olga B.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Botvinnik, Olga B.] Univ Calif San Diego, Stem Cell Program, La Jolla, CA 92093 USA; [Botvinnik, Olga B.] Univ Calif San Diego, Inst Genom Med, La Jolla, CA 92093 USA; [Abudayyeh, Omar; Hammerman, Peter S.] Harvard Univ, Sch Med, Boston, MA USA; [Abazeed, Mohamed E.] Cleveland Clin, Dept Radiat Oncol, Cleveland, OH 44106 USA; [Hammerman, Peter S.] Dana Farber Canc Inst, Dept Med, Boston, MA 02115 USA; [Alizad-Rahvar, Amir Reza; Ardakani, Masoud] Univ Alberta, Dept Elect & Comp Engn, Edmonton, AB, Canada; [Alexe, Gabriela] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Alexe, Gabriela] Boston Childrens Hosp, Boston, MA USA; [Alexe, Gabriela] Boston Univ, Bioinformat Grad Program, Boston, MA 02215 USA; [Greulich, Heidi; Beroukhim, Rameen; Garraway, Levi A.; Hahn, William C.] Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA; [Zack, Travis I.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Zack, Travis I.; Beroukhim, Rameen] Harvard Univ, Program Biophys, Boston, MA 02115 USA; [Romualdi, Chiara; Sales, Gabriele] Univ Padua, Dept Biol, Padua, Italy; [Hahn, William C.] Dana Farber Canc Inst, Ctr Canc Genome Discovery, Boston, MA 02115 USA; [Mesirov, Jill P.; Tamayo, Pablo] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Mesirov, Jill P.; Tamayo, Pablo] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Harvard University; Harvard Medical School; Cleveland Clinic Foundation; Harvard University; Dana-Farber Cancer Institute; University of Alberta; Harvard University; Dana-Farber Cancer Institute; Harvard University; Boston Children's Hospital; Boston University; Harvard University; Brigham & Women's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; University of Padua; Harvard University; Dana-Farber Cancer Institute; University of California System; University of California San Diego; University of California System; University of California San Diego	Tamayo, P (corresponding author), Eli & Edythe Broad Inst Harvard & Massachusetts I, Cambridge, MA USA.; Tamayo, P (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.; Tamayo, P (corresponding author), Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA.	ptamayo@ucsd.edu	Romualdi, Chiara/K-1132-2016; Mesirov, Jill/AGF-7626-2022; Vazquez, Francisca/AAA-3751-2020; Abudayyeh, Omar/ABF-1746-2020; Alizad-Rahvar, Amir Reza/AAR-7594-2021; Vazquez, Francisca/ABC-4620-2020; Shao, Diane/GRO-3470-2022; Abazeed, Mohamed/AAN-2376-2020; Sales, Gabriele/K-5065-2016	Romualdi, Chiara/0000-0003-4792-9047; Vazquez, Francisca/0000-0002-2857-4685; Abudayyeh, Omar/0000-0002-7979-3220; Alizad-Rahvar, Amir Reza/0000-0001-8543-9925; Abazeed, Mohamed/0000-0002-6614-4440; Sales, Gabriele/0000-0003-2078-5661; Ghandi, Mahmoud/0000-0003-1897-2265; Tsherniak, Aviad/0000-0002-3797-1877; Rosenbluh, Joseph/0000-0001-9815-8049; Shao, Diane/0000-0003-2087-4082	US National Institutes of Health [R01 CA154480, R01 CA121941, U01 CA176058, R01 CA109467, U01 CA184898-02]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD090255] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA121941, P30CA023100, U01CA176058, R01CA109467, R01CA154480, U01CA184898, U24CA194107] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001102] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074024, T32GM007753] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was supported in part by US National Institutes of Health grants R01 CA154480, R01 CA121941, U01 CA176058, R01 CA109467 and U01 CA184898-02.	Abazeed ME, 2013, CANCER RES, V73, P6289, DOI 10.1158/0008-5472.CAN-13-1616; Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; Boehm JS, 2011, NAT REV GENET, V12, P487, DOI 10.1038/nrg3013; Brar SS, 2003, AM J PHYSIOL-CELL PH, V285, pC353, DOI 10.1152/ajpcell.00525.2002; Butte A. J., 2000, PAC S BIOCOMPUT, P418, DOI [DOI 10.1142/9789814447331_, DOI 10.1142/9789814447331_0040]; Cheung HW, 2011, P NATL ACAD SCI USA, V108, P12372, DOI 10.1073/pnas.1109363108; Chin L, 2006, GENE DEV, V20, P2149, DOI 10.1101/gad.1437206; Chin L, 2011, GENE DEV, V25, P534, DOI 10.1101/gad.2017311; Ciriello G, 2012, GENOME RES, V22, P398, DOI 10.1101/gr.125567.111; De Nicola GM, 2011, NATURE, V475, P106, DOI 10.1038/nature10189; Firestein R, 2008, NATURE, V455, P547, DOI 10.1038/nature07179; Gu YY, 2013, MOL BIOSYST, V9, P467, DOI 10.1039/c2mb25528f; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Hollern DP, 2013, ONCOGENE, V32, P1296, DOI 10.1038/onc.2012.142; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Leiserson MDM, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003054; Luo B, 2008, P NATL ACAD SCI USA, V105, P20380, DOI 10.1073/pnas.0810485105; Malhotra D, 2010, NUCLEIC ACIDS RES, V38, P5718, DOI 10.1093/nar/gkq212; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; McCubrey JA, 2007, BBA-MOL CELL RES, V1773, P1263, DOI 10.1016/j.bbamcr.2006.10.001; Meyerson M, 2010, NAT REV GENET, V11, P685, DOI 10.1038/nrg2841; Miller CA, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-34; Minde DP, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-101; Nijhawan D, 2012, CELL, V150, P842, DOI 10.1016/j.cell.2012.07.023; Pandey D, 2012, AM J PHYSIOL-HEART C, V302, pH1919, DOI 10.1152/ajpheart.00910.2011; Pendyala S, 2010, RESP PHYSIOL NEUROBI, V174, P265, DOI 10.1016/j.resp.2010.09.016; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Raeder MB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054873; Rosenbluh J, 2012, CELL, V151, P1457, DOI 10.1016/j.cell.2012.11.026; Scholl C, 2009, CELL, V137, P821, DOI 10.1016/j.cell.2009.03.017; Shao DD, 2013, GENOME RES, V23, P665, DOI 10.1101/gr.143586.112; Singh A, 2006, PLOS MED, V3, P1865, DOI 10.1371/journal.pmed.0030420; Solis LM, 2010, CLIN CANCER RES, V16, P3743, DOI 10.1158/1078-0432.CCR-09-3352; Steuer R, 2002, BIOINFORMATICS, V18, pS231, DOI 10.1093/bioinformatics/18.suppl_2.S231; Valenta T, 2012, EMBO J, V31, P2714, DOI 10.1038/emboj.2012.150; Vandin F, 2012, GENOME RES, V22, P375, DOI 10.1101/gr.120477.111; Vandin F, 2011, J COMPUT BIOL, V18, P507, DOI 10.1089/cmb.2010.0265; Vaske CJ, 2010, BIOINFORMATICS, V26, pi237, DOI 10.1093/bioinformatics/btq182; Waldron L, 2011, BIOINFORMATICS, V27, P3399, DOI 10.1093/bioinformatics/btr591; Weinstein JN, 2013, NAT GENET, V45, P1113, DOI 10.1038/ng.2764; Young A, 2009, ADV CANCER RES, V102, P1, DOI 10.1016/S0065-230X(09)02001-6; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	45	57	58	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2016	34	5					539	546		10.1038/nbt.3527	http://dx.doi.org/10.1038/nbt.3527			8	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DL6FL	27088724	Green Accepted, Green Submitted			2022-12-25	WOS:000375735000035
J	Laklai, H; Miroshnikova, YA; Pickup, MW; Collisson, EA; Kim, GE; Barrett, AS; Hill, RC; Lakins, JN; Schlaepfer, DD; Mouw, JK; LeBleu, VS; Roy, N; Novitskiy, SV; Johansen, JS; Poli, V; Kalluri, R; Iacobuzio-Donahue, CA; Wood, LD; Hebrok, M; Hansen, K; Moses, HL; Weaver, VM				Laklai, Hanane; Miroshnikova, Yekaterina A.; Pickup, Michael W.; Collisson, Eric A.; Kim, Grace E.; Barrett, Alex S.; Hill, Ryan C.; Lakins, Johnathon N.; Schlaepfer, David D.; Mouw, Janna K.; LeBleu, Valerie S.; Roy, Nilotpal; Novitskiy, Sergey V.; Johansen, Julia S.; Poli, Valeria; Kalluri, Raghu; Iacobuzio-Donahue, Christine A.; Wood, Laura D.; Hebrok, Matthias; Hansen, Kirk; Moses, Harold L.; Weaver, Valerie M.			Genotype tunes pancreatic ductal adenocarcinoma tissue tension to induce matricellular fibrosis and tumor progression	NATURE MEDICINE			English	Article							MOUSE MODEL; MESENCHYMAL TRANSITION; DRUG-DELIVERY; CANCER; ACTIVATION; EXPRESSION; STROMA; STAT3; INHIBITION; GENE	Fibrosis compromises pancreatic ductal carcinoma (PDAC) treatment and contributes to patient mortality, yet antistromal therapies are controversial. We found that human PDACs with impaired epithelial transforming growth factor-beta (TGF-beta) signaling have high epithelial STAT3 activity and develop stiff, matricellular-enriched fibrosis associated with high epithelial tension and shorter patient survival. In several KRAS-driven mouse models, both the loss of TGF-beta signaling and elevated beta 1-integrin mechanosignaling engaged a positive feedback loop whereby STAT3 signaling promotes tumor progression by increasing matricellular fibrosis and tissue tension. In contrast, epithelial STAT3 ablation attenuated tumor progression by reducing the stromal stiffening and epithelial contractility induced by loss of TGF-beta signaling. In PDAC patient biopsies, higher matricellular protein and activated STAT3 were associated with SMAD4 mutation and shorter survival. The findings implicate epithelial tension and matricellular fibrosis in the aggressiveness of SMAD4 mutant pancreatic tumors and highlight STAT3 and mechanics as key drivers of this phenotype.	[Laklai, Hanane; Miroshnikova, Yekaterina A.; Pickup, Michael W.; Lakins, Johnathon N.; Mouw, Janna K.; Weaver, Valerie M.] Univ Calif San Francisco, Dept Surg, Ctr Bioengn & Tissue Regenerat, San Francisco, CA USA; [Collisson, Eric A.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Kim, Grace E.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA; [Barrett, Alex S.; Hill, Ryan C.; Hansen, Kirk] Univ Colorado, Dept Biochem & Mol Genet, Aurora, CO USA; [Schlaepfer, David D.] Univ Calif San Diego, Moores Canc Ctr, Dept Reprod Med, La Jolla, CA 92093 USA; [LeBleu, Valerie S.; Kalluri, Raghu] Univ Texas MD Anderson Canc Ctr, Metastasis Res Ctr, Dept Canc Biol, Houston, TX 77030 USA; [Roy, Nilotpal; Hebrok, Matthias] Univ Calif San Francisco, Dept Med, Ctr Diabet, San Francisco, CA USA; [Novitskiy, Sergey V.; Moses, Harold L.] Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37212 USA; [Johansen, Julia S.] Copenhagen Univ Hosp, Herlev Hosp, Dept Oncol, Copenhagen, Denmark; [Poli, Valeria] Univ Turin, Ctr Mol Biotechnol, Dept Mol Biotechnol & Hlth Sci, Turin, Italy; [Iacobuzio-Donahue, Christine A.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, David Rubenstein Ctr Pancreat Canc Res, Dept Pathol, 1275 York Ave, New York, NY 10021 USA; [Wood, Laura D.] Johns Hopkins Univ, Gastrointestinal & Liver Pathol Dept, Baltimore, MD USA; [Weaver, Valerie M.] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; [Weaver, Valerie M.] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA; [Weaver, Valerie M.] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA; [Weaver, Valerie M.] Univ Calif San Francisco, Helen Diller Comprehens Canc Ctr, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Colorado System; University of Colorado Anschutz Medical Campus; University of California System; University of California San Diego; University of Texas System; UTMD Anderson Cancer Center; University of California System; University of California San Francisco; Vanderbilt University; University of Copenhagen; Herlev & Gentofte Hospital; University of Turin; Memorial Sloan Kettering Cancer Center; Johns Hopkins University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center	Weaver, VM (corresponding author), Univ Calif San Francisco, Dept Surg, Ctr Bioengn & Tissue Regenerat, San Francisco, CA USA.; Weaver, VM (corresponding author), Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA.; Weaver, VM (corresponding author), Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA.; Weaver, VM (corresponding author), Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA.; Weaver, VM (corresponding author), Univ Calif San Francisco, Helen Diller Comprehens Canc Ctr, San Francisco, CA 94143 USA.	valerie.weaver@ucsf.edu	Iacobuzio-Donahue, Christine/ABF-1295-2020; Wood, Laura/ABF-1531-2020; Poli, Valeria/A-9215-2012; Kalluri, Raghu/E-2677-2015	Iacobuzio-Donahue, Christine/0000-0002-4672-3023; Poli, Valeria/0000-0002-3739-3966; Kalluri, Raghu/0000-0002-2190-547X; Kim, Grace/0000-0003-4603-9448; Mouw, Janna K/0000-0002-9846-8466; Weaver, Valerie marie/0000-0003-4786-6752	US National Institutes of Health NCI [U01 CA151925-01, R33 CA183685-01, R01 CA138818-01A1, U54CA143836-01, CA102310, R01CA178015-02, R01 CA172045, T32CA108462, F31CA180422]; Pancreatic Cancer Action Network AACR Innovative Grant [30-60-25-WEAV]; NSF GRFP [1144247]; NIH [TL1 TR001081]; NATIONAL CANCER INSTITUTE [U01CA151925, R01CA180769, R01CA192914, F31CA180422, U54CA143836, T32CA108462, U01CA202241, R33CA183685, P30CA016672, R01CA172045, R01CA178015, R01CA102310, R01CA138818] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001082, TL1TR001081] Funding Source: NIH RePORTER	US National Institutes of Health NCI; Pancreatic Cancer Action Network AACR Innovative Grant; NSF GRFP(National Science Foundation (NSF)NSF - Office of the Director (OD)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	We thank M. Dembo for the LIBTRC 2.0 traction force software. We thank M. Tempero for helpful discussions, and L. Korets and N. Korets for animal handling and tissue processing. This work was supported by US National Institutes of Health NCI grants U01 CA151925-01 (V.M.W. and H.L.M. and R.K.), R33 CA183685-01 (V.M.W. and K.H.), R01 CA138818-01A1 (V.M.W.), U54CA143836-01 (V.M.W.), CA102310 (D.D.S.), R01CA178015-02 (E.A.C.), R01 CA172045 (R.N. and M.H.), T32CA108462 (M.W.P.), F31CA180422 (Y.A.M.), the Pancreatic Cancer Action Network AACR Innovative Grant 30-60-25-WEAV (V.M.W.), NSF GRFP 1144247 (Y.A.M.) and NIH TL1 TR001081 (A.S.B.).	Alonzi T, 2001, MOL CELL BIOL, V21, P1621, DOI 10.1128/MCB.21.5.1621-1632.2001; Barbieri I, 2010, CANCER RES, V70, P2558, DOI 10.1158/0008-5472.CAN-09-2840; Bever KM, 2015, HPB, V17, P292, DOI 10.1111/hpb.12334; Blackford A, 2009, CLIN CANCER RES, V15, P4674, DOI 10.1158/1078-0432.CCR-09-0227; Chauhan VP, 2014, CANCER CELL, V26, P14, DOI 10.1016/j.ccr.2014.06.003; Chauhan VP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3516; Cheung KJ, 2013, CELL, V155, P1639, DOI 10.1016/j.cell.2013.11.029; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; Collisson EA, 2011, NAT MED, V17, P500, DOI 10.1038/nm.2344; Dangi-Garimella S, 2011, CANCER RES, V71, P1019, DOI 10.1158/0008-5472.CAN-10-1855; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Erkan M, 2008, CLIN GASTROENTEROL H, V6, P1155, DOI 10.1016/j.cgh.2008.05.006; Esposito I, 2006, J PATHOL, V208, P673, DOI 10.1002/path.1935; Fukuda A, 2011, CANCER CELL, V19, P441, DOI 10.1016/j.ccr.2011.03.002; Herreros-Villanueva M, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.23; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; Hoadley KA, 2014, CELL, V158, P929, DOI 10.1016/j.cell.2014.06.049; Iacobuzio-Donahue CA, 2009, J CLIN ONCOL, V27, P1806, DOI 10.1200/JCO.2008.17.7188; Ijichi H, 2006, GENE DEV, V20, P3147, DOI 10.1101/gad.1475506; Ijichi H, 2011, J CLIN INVEST, V121, P4106, DOI 10.1172/JCI42754; Jain RK, 2014, ANNU REV BIOMED ENG, V16, P321, DOI 10.1146/annurev-bioeng-071813-105259; Jiang JX, 2015, CANCER LETT, V356, P962, DOI 10.1016/j.canlet.2014.11.007; Kabashima A, 2009, INT J CANCER, V124, P2771, DOI 10.1002/ijc.24349; Kohler I, 2015, J GASTROEN HEPATOL, V30, P78, DOI 10.1111/jgh.12752; Lesina M, 2011, CANCER CELL, V19, P456, DOI 10.1016/j.ccr.2011.03.009; Li RH, 2003, SCIENCE, V300, P795, DOI 10.1126/science.1079441; Luna A, 2016, MAGN RESON IMAGING C, V24, P157, DOI 10.1016/j.mric.2015.08.005; Macias MJ, 2015, TRENDS BIOCHEM SCI, V40, P296, DOI 10.1016/j.tibs.2015.03.012; Moffitt RA, 2015, NAT GENET, V47, P1168, DOI 10.1038/ng.3398; Mouw JK, 2014, NAT MED, V20, P360, DOI 10.1038/nm.3497; Nagathihalli NS, 2015, GASTROENTEROLOGY, V149, P1932, DOI 10.1053/j.gastro.2015.07.058; Neesse A, 2011, GUT, V60, P861, DOI 10.1136/gut.2010.226092; Ozdemir BC, 2014, CANCER CELL, V25, P719, DOI 10.1016/j.ccr.2014.04.005; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; Paron I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021684; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Perez-Mancera PA, 2012, GASTROENTEROLOGY, V142, P1079, DOI 10.1053/j.gastro.2012.03.002; Provenzano PP, 2013, BRIT J CANCER, V108, P1, DOI 10.1038/bjc.2012.569; Provenzano PP, 2012, CANCER CELL, V21, P418, DOI 10.1016/j.ccr.2012.01.007; Rath N, 2012, EMBO REP, V13, P900, DOI 10.1038/embor.2012.127; Rhim AD, 2014, CANCER CELL, V25, P735, DOI 10.1016/j.ccr.2014.04.021; Rosow DE, 2012, SURGERY, V152, pS19, DOI 10.1016/j.surg.2012.05.030; Samuel MS, 2011, CANCER CELL, V19, P776, DOI 10.1016/j.ccr.2011.05.008; Sanz-Moreno V, 2011, CANCER CELL, V20, P229, DOI 10.1016/j.ccr.2011.06.018; Schrader J, 2011, HEPATOLOGY, V53, P1192, DOI 10.1002/hep.24108; Schultz NA, 2012, MODERN PATHOL, V25, P1609, DOI 10.1038/modpathol.2012.122; Shao DD, 2014, CELL, V158, P171, DOI 10.1016/j.cell.2014.06.004; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Sinn M, 2014, BRIT J CANCER, V111, P1917, DOI 10.1038/bjc.2014.495; Stromnes IM, 2014, CARCINOGENESIS, V35, P1451, DOI 10.1093/carcin/bgu115; Sugimoto H, 2006, CANCER BIOL THER, V5, P1640, DOI 10.4161/cbt.5.12.3354; Swartz MA, 2012, NAT REV CANCER, V12, P210, DOI 10.1038/nrc3186; Wang WQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071189; Wang Y, 2001, EXP LUNG RES, V27, P255, DOI 10.1080/019021401300054028; Whittle MC, 2015, CELL, V161, P1345, DOI 10.1016/j.cell.2015.04.048; Yachida S, 2012, CLIN CANCER RES, V18, P6339, DOI 10.1158/1078-0432.CCR-12-1215; Yimlamai D, 2014, CELL, V157, P1324, DOI 10.1016/j.cell.2014.03.060; Yu M, 2012, CANCER CELL, V21, P327, DOI 10.1016/j.ccr.2012.03.002	59	337	345	6	104	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2016	22	5					497	505		10.1038/nm.4082	http://dx.doi.org/10.1038/nm.4082			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DL3DI	27089513	Green Submitted, Green Accepted			2022-12-25	WOS:000375514000012
J	Ma, HH; Tu, LC; Naseri, A; Huisman, M; Zhang, SJ; Grunwald, D; Pederson, T				Ma, Hanhui; Tu, Li-Chun; Naseri, Ardalan; Huisman, Maximiliaan; Zhang, Shaojie; Grunwald, David; Pederson, Thoru			Multiplexed labeling of genomic loci with dCas9 and engineered sgRNAs using CRISPRainbow	NATURE BIOTECHNOLOGY			English	Article							DNA-SEQUENCES; RNA; ACTIVATION; VISUALIZATION; CELLS	A lack of techniques to image multiple genomic loci in living cells has limited our ability to investigate chromosome dynamics. Here we describe CRISPRainbow, a system for labeling DNA in living cells based on nuclease-dead (d) Cas9 combined with engineered single guide RNA (sgRNA) scaffolds that bind sets of fluorescent proteins. We demonstrate simultaneous imaging of up to six chromosomal loci in individual live cells and document large differences in the dynamic properties of different chromosomal loci.	[Ma, Hanhui; Pederson, Thoru] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA USA; [Tu, Li-Chun; Huisman, Maximiliaan; Grunwald, David] Univ Massachusetts, Sch Med, RNA Therapeut Inst, Worcester, MA USA; [Naseri, Ardalan; Zhang, Shaojie] Univ Cent Florida, Dept Comp Sci, Orlando, FL 32816 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; State University System of Florida; University of Central Florida	Ma, HH (corresponding author), Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA USA.	hanhui.ma@umassmed.edu	Naseri, Ardalan/ABH-3903-2020; Tu, Li-Chun/AAQ-4495-2021	Zhang, Shaojie/0000-0002-4051-5549; Tu, Li-Chun/0000-0002-7421-4007; Grunwald, David/0000-0001-9067-804X; Naseri, Ardalan/0000-0002-2747-2193; Pederson, Thoru/0000-0002-3703-7806	Vitold Arnett Fund; NIH [R01 GM102515, U01 EB021238]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [U01EB021238] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102515, P50GM082545] Funding Source: NIH RePORTER	Vitold Arnett Fund; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. Smith in D. Grunwald laboratory for microscopy suggestions and S.A. Wolfe, M. Fatih Bolukbasi and A. Gupta of this institution for valuable discussion. This work was supported by the Vitold Arnett Fund to T.P. and NIH grants R01 GM102515 to S.Z. and U01 EB021238 to D.G.	Anton T, 2014, NUCLEUS-PHILA, V5, P163, DOI 10.4161/nucl.28488; Austin RJ, 2002, J AM CHEM SOC, V124, P10966, DOI 10.1021/ja026610b; Chen B., 2016, NUCL ACIDS RES; Chen BH, 2013, CELL, V155, P1479, DOI 10.1016/j.cell.2013.12.001; Dahlman JE, 2015, NAT BIOTECHNOL, V33, P1159, DOI 10.1038/nbt.3390; Daigle N, 2007, NAT METHODS, V4, P633, DOI 10.1038/NMETH1065; Esvelt KM, 2013, NAT METHODS, V10, P1116, DOI [10.1038/NMETH.2681, 10.1038/nmeth.2681]; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Jegou T, 2009, MOL BIOL CELL, V20, P2070, DOI 10.1091/mbc.E08-02-0108; Jiang FG, 2015, SCIENCE, V348, P1477, DOI 10.1126/science.aab1452; Kiani S, 2015, NAT METHODS, V12, P1051, DOI [10.1038/NMETH.3580, 10.1038/nmeth.3580]; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Ma HH, 2015, P NATL ACAD SCI USA, V112, P3002, DOI 10.1073/pnas.1420024112; Ma HH, 2013, P NATL ACAD SCI USA, V110, P21048, DOI 10.1073/pnas.1319097110; Shechner DM, 2015, NAT METHODS, V12, P664, DOI [10.1038/NMETH.3433, 10.1038/nmeth.3433]; Smith CS, 2015, J CELL BIOL, V209, P609, DOI 10.1083/jcb.201411032; Zalatan JG, 2015, CELL, V160, P339, DOI 10.1016/j.cell.2014.11.052	19	229	247	7	128	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2016	34	5					528	530		10.1038/nbt.3526	http://dx.doi.org/10.1038/nbt.3526			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DL6FL	27088723	Green Accepted			2022-12-25	WOS:000375735000033
J	Frandsen, KEH; Simmons, TJ; Dupree, P; Poulsen, JCN; Hemsworth, GR; Ciano, L; Johnston, EM; Tovborg, M; Johansen, KS; von Freiesleben, P; Marmuse, L; Fort, S; Cottaz, S; Driguez, H; Henrissat, B; Lenfant, N; Tuna, F; Baldansuren, A; Davies, GJ; Lo Leggio, L; Walton, PH				Frandsen, Kristian E. H.; Simmons, Thomas J.; Dupree, Paul; Poulsen, Jens-Christian N.; Hemsworth, Glyn R.; Ciano, Luisa; Johnston, Esther M.; Tovborg, Morten; Johansen, Katja S.; von Freiesleben, Pernille; Marmuse, Laurence; Fort, Sebastien; Cottaz, Sylvain; Driguez, Hugues; Henrissat, Bernard; Lenfant, Nicolas; Tuna, Floriana; Baldansuren, Amgalanbaatar; Davies, Gideon J.; Lo Leggio, Leila; Walton, Paul H.			The molecular basis of polysaccharide cleavage by lytic polysaccharide monooxygenases	NATURE CHEMICAL BIOLOGY			English	Article							SUBSTRATE-SPECIFICITY; CELLULOSE DEGRADATION; ENZYME; CONFORMATION; COORDINATION; ACTIVATION; OXYGENASES; DISCOVERY; CHEMISTRY; MECHANISM	Lytic polysaccharide monooxygenases (LPMOs) are copper-containing enzymes that oxidatively break down recalcitrant polysaccharides such as cellulose and chitin. Since their discovery, LPMOs have become integral factors in the industrial utilization of biomass, especially in the sustainable generation of cellulosic bioethanol. We report here a structural determination of an LPMO-oligosaccharide complex, yielding detailed insights into the mechanism of action of these enzymes. Using a combination of structure and electron paramagnetic resonance spectroscopy, we reveal the means by which LPMOs interact with saccharide substrates. We further uncover electronic and structural features of the enzyme active site, showing how LPMOs orchestrate the reaction of oxygen with polysaccharide chains.	[Frandsen, Kristian E. H.; Poulsen, Jens-Christian N.; Lo Leggio, Leila] Univ Copenhagen, Dept Chem, DK-2100 Copenhagen, Denmark; [Simmons, Thomas J.; Dupree, Paul] Univ Cambridge, Dept Biochem, Tennis Court Rd, Cambridge CB2 1QW, England; [Hemsworth, Glyn R.; Ciano, Luisa; Johnston, Esther M.; Davies, Gideon J.; Walton, Paul H.] Univ York, Dept Chem, York YO10 5DD, N Yorkshire, England; [Tovborg, Morten; Johansen, Katja S.; von Freiesleben, Pernille] Novozymes AS, Bagsvaerd, Denmark; [Marmuse, Laurence; Fort, Sebastien; Cottaz, Sylvain; Driguez, Hugues] Univ Grenoble Alpes, CNRS, Ctr Rech Macromol Vegetales CERMAV, Grenoble, France; [Henrissat, Bernard; Lenfant, Nicolas] Aix Marseille Univ, CNRS, AFMB, Marseille, France; [Henrissat, Bernard; Lenfant, Nicolas] INRA, AFMB, Marseille, France; [Henrissat, Bernard] King Abdulaziz Univ, Dept Biol Sci, Jeddah 21413, Saudi Arabia; [Tuna, Floriana; Baldansuren, Amgalanbaatar] Univ Manchester, EPSRC, Natl EPR Facil, Sch Chem, Manchester, Lancs, England; [Tuna, Floriana; Baldansuren, Amgalanbaatar] Univ Manchester, Photon Sci Inst, Manchester, Lancs, England; [Johansen, Katja S.] Chalmers, Div Ind Biotechnol, S-41296 Gothenburg, Sweden	University of Copenhagen; University of Cambridge; University of York - UK; Novozymes; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; INRAE; UDICE-French Research Universities; Aix-Marseille Universite; King Abdulaziz University; UK Research & Innovation (UKRI); Engineering & Physical Sciences Research Council (EPSRC); University of Manchester; University of Manchester; Chalmers University of Technology	Lo Leggio, L (corresponding author), Univ Copenhagen, Dept Chem, DK-2100 Copenhagen, Denmark.; Walton, PH (corresponding author), Univ York, Dept Chem, York YO10 5DD, N Yorkshire, England.	leila@chem.ku.dk; paul.walton@york.ac.uk	Fort, Sebastien/A-9906-2012; Johansen, Katja/J-7939-2016; Davies, Gideon J/A-9042-2011; Leggio, Leila Lo/B-4287-2015; Ciano, Luisa/AHH-4191-2022; Hemsworth, Glyn/AAS-5473-2021; Tuna, Floriana/K-5198-2016; Dupree, Paul/T-2568-2018; Baldansuren, Amgalanbaatar/B-5555-2015; Henrissat, Bernard/J-2475-2012	Fort, Sebastien/0000-0002-6133-9900; Johansen, Katja/0000-0002-7587-5990; Davies, Gideon J/0000-0002-7343-776X; Leggio, Leila Lo/0000-0002-5135-0882; Ciano, Luisa/0000-0002-1667-0856; Hemsworth, Glyn/0000-0002-8226-1380; Tuna, Floriana/0000-0002-5541-1750; Dupree, Paul/0000-0001-9270-6286; Baldansuren, Amgalanbaatar/0000-0001-8767-3731; Henrissat, Bernard/0000-0002-3434-8588; Johnston, Esther M./0000-0001-7807-4729; Frandsen, Kristian E. H./0000-0002-7136-9820; Lenfant, Nicolas/0000-0002-0519-1120; Walton, Paul/0000-0002-1152-1480; cottaz, sylvain/0000-0001-8674-0162	UK Biotechnology and Biological Sciences Research Council [BB/L000423, BB/L021633/1]; Agence Francaise de l'Environnement et de la Maitrise de l'Energie [1201C102]; Danish Council for Strategic Research [12-134923, 12-134922]; European Community [283570]; Institut de Chimie Moleculaire de Grenoble [FR 2607]; LabEx ARCANE [ANR-11-LABX-0003-01]; PolyNat Carnot Institute; French Agence Nationale de la Recherche [PNRB2005-11]; BBSRC [BB/L000423/1, BB/L021633/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/L000423/1, BB/L021633/1] Funding Source: researchfish	UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Agence Francaise de l'Environnement et de la Maitrise de l'Energie; Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF)); European Community(European Commission); Institut de Chimie Moleculaire de Grenoble; LabEx ARCANE; PolyNat Carnot Institute; French Agence Nationale de la Recherche(French National Research Agency (ANR)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank K. Rasmussen and R.M. Borup for experimental assistance, and MAXLAB, Sweden and the European Synchrotron Radiation Facility (ESRF), France, for synchrotron beam time and assistance. This work was supported by the UK Biotechnology and Biological Sciences Research Council (grant numbers BB/L000423 to P.D., G.J.D. and P.H.W., and BB/L021633/1 to G.J.D. and P.H.W.), Agence Francaise de l'Environnement et de la Maitrise de l'Energie (grant number 1201C102 to B.H.), the Danish Council for Strategic Research (grant numbers 12-134923 to L.L.L. and 12-134922 to K.S.J.). Travel to synchrotrons was supported by the Danish Ministry of Higher Education and Science through the Instrument Center DANSCATT and the European Community's Seventh Framework Programme (FP7/2007-2013) under BioStruct-X (grant agreement 283570). L.M., S.F., S.C. and H.D. were supported by Institut de Chimie Moleculaire de Grenoble FR 2607, LabEx ARCANE (ANR-11-LABX-0003-01), the PolyNat Carnot Institute and the French Agence Nationale de la Recherche (PNRB2005-11).	Aachmann F.L., 2015, ENCY INORGANIC BIOIN, V111, P1; Aachmann FL, 2012, P NATL ACAD SCI USA, V109, P18779, DOI 10.1073/pnas.1208822109; Agger JW, 2014, P NATL ACAD SCI USA, V111, P6287, DOI 10.1073/pnas.1323629111; Beeson WT, 2015, ANNU REV BIOCHEM, V84, P923, DOI 10.1146/annurev-biochem-060614-034439; Bennati-Granier C, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0274-3; Borisova AS, 2015, J BIOL CHEM, V290, P22955, DOI 10.1074/jbc.M115.660183; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Davies GJ, 2012, ACCOUNTS CHEM RES, V45, P308, DOI 10.1021/ar2001765; Dhar D, 2015, J AM CHEM SOC, V137, P1322, DOI 10.1021/ja512014z; Donoghue PJ, 2011, J AM CHEM SOC, V133, P17602, DOI 10.1021/ja207882h; EGLI M, 1995, P NATL ACAD SCI USA, V92, P180, DOI 10.1073/pnas.92.1.180; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ERIKSSON KE, 1974, FEBS LETT, V49, P282, DOI 10.1016/0014-5793(74)80531-4; Forsberg Z, 2011, PROTEIN SCI, V20, P1479, DOI 10.1002/pro.689; Gao JS, 2013, J AM CHEM SOC, V135, P10684, DOI 10.1021/ja402810t; GEMPERLE C, 1990, J MAGN RESON, V88, P241, DOI 10.1016/0022-2364(90)90181-8; Gudmundsson M, 2014, J BIOL CHEM, V289, P18782, DOI 10.1074/jbc.M114.563494; Harris PV, 2010, BIOCHEMISTRY-US, V49, P3305, DOI 10.1021/bi100009p; Hemsworth GR, 2014, NAT CHEM BIOL, V10, P122, DOI 10.1038/nchembio.1417; Hemsworth GR, 2013, CURR OPIN STRUC BIOL, V23, P660, DOI 10.1016/j.sbi.2013.05.006; Hemsworth GR, 2013, J AM CHEM SOC, V135, P6069, DOI 10.1021/ja402106e; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; Horn SJ, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-45; IWAIZUMI M, 1986, INORG CHEM, V25, P1546, DOI 10.1021/ic00230a008; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karlin K.D, 2011, COPPER OXYGEN CHEM; Kim D, 2013, ANGEW CHEM INT EDIT, V52, P1139, DOI 10.1002/anie.201208108; Kim S, 2014, P NATL ACAD SCI USA, V111, P149, DOI 10.1073/pnas.1316609111; Kjaergaard CH, 2014, P NATL ACAD SCI USA, V111, P8797, DOI 10.1073/pnas.1408115111; Lee JY, 2015, CURR OPIN CHEM BIOL, V25, P184, DOI 10.1016/j.cbpa.2015.02.014; Li X, 2012, STRUCTURE, V20, P1051, DOI 10.1016/j.str.2012.04.002; Liu YY, 1999, ANAL BIOCHEM, V267, P331, DOI 10.1006/abio.1998.3014; Lo Leggio L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6961; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Loose JSM, 2014, FEBS LETT, V588, P3435, DOI 10.1016/j.febslet.2014.07.036; Asensio JL, 2013, ACCOUNTS CHEM RES, V46, P946, DOI 10.1021/ar300024d; Merino ST, 2007, ADV BIOCHEM ENG BIOT, V108, P95, DOI 10.1007/10_2007_066; Muller G, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0376-y; Nishio M, 2011, PHYS CHEM CHEM PHYS, V13, P13873, DOI 10.1039/c1cp20404a; Novozymes A/S, 2014, [No title captured], Patent No. [WO 2014/066141 A2, 2014066141, WO2014066141A2]; Pavlakos I, 2015, ANGEW CHEM INT EDIT, V54, P8169, DOI 10.1002/anie.201502103; Payne CM, 2015, CHEM REV, V115, P1308, DOI 10.1021/cr500351c; Phillips CM, 2011, ACS CHEM BIOL, V6, P1399, DOI 10.1021/cb200351y; Quinlan RJ, 2011, P NATL ACAD SCI USA, V108, P15079, DOI 10.1073/pnas.1105776108; Roeser D, 2006, P NATL ACAD SCI USA, V103, P81, DOI 10.1073/pnas.0507592102; Sheldon RA, 2014, GREEN CHEM, V16, P950, DOI [10.1039/c3gc41935e, 10.1039/C3GC41935E]; Singh SK, 2015, PHYS CHEM CHEM PHYS, V17, P9596, DOI 10.1039/c4cp05536e; Vaaje-Kolstad G, 2010, SCIENCE, V330, P219, DOI 10.1126/science.1192231; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Wu M, 2013, J BIOL CHEM, V288, P12828, DOI 10.1074/jbc.M113.459396	51	212	216	22	325	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	APR	2016	12	4					298	+		10.1038/NCHEMBIO.2029	http://dx.doi.org/10.1038/NCHEMBIO.2029			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH2DA	26928935	Green Accepted, Green Submitted			2022-12-25	WOS:000372593200019
J	Yamazaki, Y; Palmer, L; Alexandre, C; Kakugawa, S; Beckett, K; Gaugue, I; Palmer, RH; Vincent, JP				Yamazaki, Yasuo; Palmer, Lucy; Alexandre, Cyrille; Kakugawa, Satoshi; Beckett, Karen; Gaugue, Isabelle; Palmer, Ruth H.; Vincent, Jean-Paul			Godzilla-dependent transcytosis promotes Wingless signalling in Drosophila wing imaginal discs	NATURE CELL BIOLOGY			English	Article							POLARIZED EPITHELIAL-CELLS; MORPHOGEN GRADIENT; TRANSMEMBRANE PROTEIN; DALLY-LIKE; SECRETION; EXPRESSION; TRANSPORT; PATHWAY; WLS; LOCALIZATION	The apical and basolateral membranes of epithelia are insulated from each other, preventing the transfer of extracellular proteins from one side to the other(1). Thus, a signalling protein produced apically is not expected to reach basolateral receptors. Evidence suggests that Wingless, the main Drosophila Wnt, is secreted apically in the embryonic epidermis(2,3). However, in the wing imaginal disc epithelium, Wingless is mostly seen on the basolateral membrane where it spreads from secreting to receiving cells(4,5). Here we examine the apico-basal movement of Wingless in Wingless-producing cells of wing imaginal discs. We find that it is presented first on the apical surface before making its way to the basolateral surface, where it is released and allowed to interact with signalling receptors. We show that Wingless transcytosis involves dynamin-dependent endocytosis from the apical surface. Subsequent trafficking from early apical endosomes to the basolateral surface requires Godzilla, a member of the RNF family of membrane-anchored E3 ubiquitin ligases. Without such transport, Wingless signalling is strongly reduced in this tissue.	[Yamazaki, Yasuo; Palmer, Ruth H.] Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Med Biochem & Cell Biol, Medicinaregatan 9A, S-40539 Gothenburg, Sweden; [Palmer, Lucy; Alexandre, Cyrille; Kakugawa, Satoshi; Beckett, Karen; Vincent, Jean-Paul] Francis Crick Inst, Mill Hill Lab, Mill Hill, London NW7 1AA, England; [Gaugue, Isabelle] CNRS, Inst Curie, Polar Div & Morphogenesis Team, INSERM,U934,UMR 3215, 26 Rue Ulm, F-75248 Paris, France	University of Gothenburg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm)	Palmer, RH (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Med Biochem & Cell Biol, Medicinaregatan 9A, S-40539 Gothenburg, Sweden.; Vincent, JP (corresponding author), Francis Crick Inst, Mill Hill Lab, Mill Hill, London NW7 1AA, England.	ruth.palmer@gu.se; jp.vincent@crick.ac.uk		Palmer, Lucy/0000-0002-2218-6104; Yamazaki, Yasuo/0000-0001-5297-9837; Isabelle, Gaugue/0000-0001-6618-3899	MRC [U117584268]; European Union (ERC grant WNTEXPORT) [294523]; Swedish Cancer Society [15/391]; Swedish Children Cancer Foundation [2015-0096]; Swedish Research Council [2015-04466]; SSF Programme Grant [RB13-0204]; Medical Research Council [MC_U117584268] Funding Source: researchfish; The Francis Crick Institute [10205, 10204] Funding Source: researchfish; MRC [MC_U117584268] Funding Source: UKRI	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union (ERC grant WNTEXPORT); Swedish Cancer Society(Swedish Cancer Society); Swedish Children Cancer Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); SSF Programme Grant; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); The Francis Crick Institute; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the MRC (U117584268 to J.-P.V.), the European Union (ERC grant WNTEXPORT; 294523 to J.-P.V.), the Swedish Cancer Society (15/391 to R.H.P.), the Swedish Children Cancer Foundation (2015-0096 to R.H.P.), the Swedish Research Council (2015-04466 to R.H.P.) and the SSF Programme Grant (RB13-0204 to R.H.P.). We thank the Centre for Cellular Imaging (CCI) at the University of Gothenburg for providing confocal imaging support. We are indebted to L.-A.B.-Lopez for devising the idea of tag switching, to C. O'Kane for providing the syb144 allele, to H. Nojima for help with generating Fig. 5c and Supplementary Fig. 5 and Y. Bellaiche for discussion. We are also grateful to SWEDBO for organizing the conference where our collaboration began.	Alexandre C, 2014, NATURE, V505, P180, DOI 10.1038/nature12879; Baena-Lopez LA, 2013, DEVELOPMENT, V140, P4818, DOI 10.1242/dev.100933; Banziger C, 2006, CELL, V125, P509, DOI 10.1016/j.cell.2006.02.049; Bartscherer K, 2006, CELL, V125, P523, DOI 10.1016/j.cell.2006.04.009; Bhattacharya S, 2002, P NATL ACAD SCI USA, V99, P13867, DOI 10.1073/pnas.202335999; Cadigan KM, 1998, CELL, V93, P767, DOI 10.1016/S0092-8674(00)81438-5; Callejo A, 2011, P NATL ACAD SCI USA, V108, P12591, DOI 10.1073/pnas.1106881108; Coombs GS, 2010, J CELL SCI, V123, P3357, DOI 10.1242/jcs.072132; COUSO JP, 1994, DEVELOPMENT, V120, P621; de Lau W, 2014, GENE DEV, V28, P305, DOI 10.1101/gad.235473.113; Franch-Marro X, 2005, DEVELOPMENT, V132, P659, DOI 10.1242/dev.01639; Gallet A, 2008, DEV CELL, V14, P712, DOI 10.1016/j.devcel.2008.03.001; Goodman RM, 2006, DEVELOPMENT, V133, P4901, DOI 10.1242/dev.02674; Han C, 2005, DEVELOPMENT, V132, P667, DOI 10.1242/dev.01636; Herr P, 2012, DEV BIOL, V361, P392, DOI 10.1016/j.ydbio.2011.11.003; Kakugawa S, 2015, NATURE, V519, P187, DOI 10.1038/nature14259; Kicheva A, 2007, SCIENCE, V315, P521, DOI 10.1126/science.1135774; Mertens G, 1996, J CELL BIOL, V132, P487, DOI 10.1083/jcb.132.3.487; Oshima K, 2011, J CELL SCI, V124, P2861, DOI 10.1242/jcs.087700; RULIFSON EJ, 1995, DEVELOPMENT, V121, P2813; Seto ES, 2006, J CELL BIOL, V173, P95, DOI 10.1083/jcb.200510123; Simmonds AJ, 2001, CELL, V105, P197, DOI 10.1016/S0092-8674(01)00311-7; Strigini M, 2000, CURR BIOL, V10, P293, DOI 10.1016/S0960-9822(00)00378-X; Tuma PL, 2003, PHYSIOL REV, V83, P871, DOI 10.1152/physrev.00001.2003; VANDERBLIEK AM, 1991, NATURE, V351, P411, DOI 10.1038/351411a0; Wilkie GS, 2001, CELL, V105, P209, DOI 10.1016/S0092-8674(01)00312-9; Wu J, 2004, PLOS BIOL, V2, P1004, DOI 10.1371/journal.pbio.0020158; Yamamoto H, 2013, J CELL SCI, V126, P2931, DOI 10.1242/jcs.126052; Yamazaki Y, 2013, EMBO J, V32, P524, DOI 10.1038/emboj.2013.1; Yu J, 2014, DEV CELL, V29, P277, DOI 10.1016/j.devcel.2014.03.016; Zecca M, 1996, CELL, V87, P833, DOI 10.1016/S0092-8674(00)81991-1; Zhang Y, 2011, NAT CELL BIOL, V13, P623, DOI 10.1038/ncb2222	32	58	59	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2016	18	4					451	+		10.1038/ncb3325	http://dx.doi.org/10.1038/ncb3325			13	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	DH7LX	26974662	Green Accepted, Green Submitted			2022-12-25	WOS:000372976600012
J	Vegas, AJ; Veiseh, O; Gurtler, M; Millman, JR; Pagliuca, FW; Bader, AR; Doloff, JC; Li, J; Chen, M; Olejnik, K; Tam, HH; Jhunjhunwala, S; Langan, E; Aresta-Dasilva, S; Gandham, S; McGarrigle, JJ; Bochenek, MA; Hollister-Lock, J; Oberholzer, J; Greiner, DL; Weir, GC; Melton, DA; Langer, R; Anderson, DG				Vegas, Arturo J.; Veiseh, Omid; Guertler, Mads; Millman, Jeffrey R.; Pagliuca, Felicia W.; Bader, Andrew R.; Doloff, Joshua C.; Li, Jie; Chen, Michael; Olejnik, Karsten; Tam, Hok Hei; Jhunjhunwala, Siddharth; Langan, Erin; Aresta-Dasilva, Stephanie; Gandham, Srujan; McGarrigle, James J.; Bochenek, Matthew A.; Hollister-Lock, Jennifer; Oberholzer, Jose; Greiner, Dale L.; Weir, Gordon C.; Melton, Douglas A.; Langer, Robert; Anderson, Daniel G.			Long-term glycemic control using polymer-encapsulated human stem cell-derived beta cells in immune-competent mice	NATURE MEDICINE			English	Article							IMMUNOCOMPETENT DIABETIC MICE; INSULIN-PRODUCING CELLS; ISLET TRANSPLANTATION; NONIMMUNOSUPPRESSED PATIENTS; FOLLOW-UP; IN-VITRO; IMMUNOISOLATION; MATURATION; ALLOGRAFTS; PRIMATES	The transplantation of glucose-responsive, insulin-producing cells offers the potential for restoring glycemic control in individuals with diabetes'. Pancreas transplantation and the infusion of cadaveric islets are currently implemented clinically(2), but these approaches are limited by the adverse effects of immunosuppressive therapy over the lifetime of the recipient and the limited supply of donor tissue(3). The latter concern may be addressed by recently described glucose-responsive mature beta cells that are derived from human embryonic stem cells (referred to as SC-beta cells), which may represent an unlimited source of human cells for pancreas replacement therapy(4). Strategies to address the immunosuppression concerns include immunoisolation of insulin-producing cells with porous biomaterials that function as an immune barrier(5,6). However, clinical implementation has been challenging because of host immune responses to the implant materials(7). Here we report the first long-term glycemic correction of a diabetic, immunocompetent animal model using human SC-beta cells. SC-beta cells were encapsulated with alginate derivatives capable of mitigating foreign-body responses in vivo and implanted into the intraperitoneal space of C57BL/6J mice treated with streptozotocin, which is an animal model for chemically induced type 1 diabetes. These implants induced glycemic correction without any immunosuppression until their removal at 174 d after implantation. Human C-peptide concentrations and in vivo glucose responsiveness demonstrated therapeutically relevant glycemic control. Implants retrieved after 174 d contained viable insulin-producing cells.	[Vegas, Arturo J.; Veiseh, Omid; Bader, Andrew R.; Doloff, Joshua C.; Li, Jie; Chen, Michael; Olejnik, Karsten; Tam, Hok Hei; Jhunjhunwala, Siddharth; Langan, Erin; Aresta-Dasilva, Stephanie; Gandham, Srujan; Langer, Robert; Anderson, Daniel G.] MIT, David H Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Vegas, Arturo J.; Veiseh, Omid; Bader, Andrew R.; Doloff, Joshua C.; Li, Jie; Chen, Michael; Olejnik, Karsten; Tam, Hok Hei; Jhunjhunwala, Siddharth; Langan, Erin; Aresta-Dasilva, Stephanie; Gandham, Srujan; Langer, Robert; Anderson, Daniel G.] Boston Childrens Hosp, Dept Anesthesiol, Boston, MA USA; [Veiseh, Omid; Tam, Hok Hei; Langer, Robert; Anderson, Daniel G.] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Guertler, Mads; Millman, Jeffrey R.; Pagliuca, Felicia W.; Melton, Douglas A.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [McGarrigle, James J.; Bochenek, Matthew A.; Oberholzer, Jose] Univ Illinois, Dept Surg, Div Transplantat, Chicago, IL 60680 USA; [Hollister-Lock, Jennifer; Weir, Gordon C.] Joslin Diabet Ctr, Div Res, Sect Islet Cell & Regenerat Biol, 1 Joslin Pl, Boston, MA 02215 USA; [Greiner, Dale L.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA USA; [Melton, Douglas A.] Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA; [Langer, Robert; Anderson, Daniel G.] MIT, Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Langer, Robert; Anderson, Daniel G.] MIT, Inst Med Engn & Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Vegas, Arturo J.] Boston Univ, Dept Chem, 590 Commonwealth Ave, Boston, MA 02215 USA; [Bader, Andrew R.] MIT, Dept Mech Engn, Cambridge, MA 02139 USA; [Millman, Jeffrey R.] Washington Univ, Sch Med, Div Endocrinol Metab & Lipid Res, St Louis, MO USA; [Millman, Jeffrey R.] Washington Univ, Dept Biomed Engn, St Louis, MO USA	Massachusetts Institute of Technology (MIT); Harvard University; Boston Children's Hospital; Massachusetts Institute of Technology (MIT); Harvard University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Harvard University; Joslin Diabetes Center, Inc.; University of Massachusetts System; University of Massachusetts Worcester; Harvard University; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Boston University; Massachusetts Institute of Technology (MIT); Washington University (WUSTL); Washington University (WUSTL)	Anderson, DG (corresponding author), MIT, David H Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Anderson, DG (corresponding author), Boston Childrens Hosp, Dept Anesthesiol, Boston, MA USA.; Anderson, DG (corresponding author), MIT, Dept Chem Engn, Cambridge, MA 02139 USA.; Anderson, DG (corresponding author), MIT, Div Hlth Sci & Technol, Cambridge, MA 02139 USA.; Anderson, DG (corresponding author), MIT, Inst Med Engn & Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	dgander@mit.edu	Veiseh, Omid/N-1137-2019; Young, Richard A/F-6495-2012; Jhunjhunwala, Siddharth/K-1526-2013; Veiseh, Omid/GLS-9547-2022	Young, Richard A/0000-0001-8855-8647; Jhunjhunwala, Siddharth/0000-0001-8046-2288; Veiseh, Omid/0000-0003-1153-8079; Millman, Jeffrey/0000-0003-0426-3492; Chen, Michael/0000-0002-1590-768X; Bochenek, Matthew/0000-0001-5283-7388; Doloff, Joshua/0000-0002-4323-3264	JDRF; Leona M. and Harry B. Helmsley Charitable Trust [3-SRA-2014-285-M-R]; US National Institutes of Health [EB000244, EB000351, DE013023, CA151884, UC4DK104218]; Department of Defense Congressionally Directed Medical Research Program (DOD/CDMRP) postdoctoral fellowships [3-2013-178, W81XWH-13-1-0215]; Harvard Stem Cell Institute; Chicago Diabetes Project; NATIONAL CANCER INSTITUTE [U54CA151884] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R37EB000244, R01EB000351, R01EB000244] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE013023] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [UC4DK104218, P30DK036836] Funding Source: NIH RePORTER	JDRF(Juvenile Diabetes Research Foundation); Leona M. and Harry B. Helmsley Charitable Trust; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense Congressionally Directed Medical Research Program (DOD/CDMRP) postdoctoral fellowships; Harvard Stem Cell Institute; Chicago Diabetes Project; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported jointly by the JDRF and the Leona M. and Harry B. Helmsley Charitable Trust (grant no. 3-SRA-2014-285-M-R (R.L. and D.G.A.)), the US National Institutes of Health (grants EB000244 (R.L.), EB000351 (R.L.), DE013023 (R.L.), CA151884 (R.L.) and UC4DK104218 (D.L.G.)), and through a generous gift from the Tayebati Family Foundation (D.G.A. and R.L.). O.V. was supported by JDRF and Department of Defense Congressionally Directed Medical Research Program (DOD/CDMRP) postdoctoral fellowships (grants 3-2013-178 and W81XWH-13-1-0215, respectively). J.R.M. was supported by a fellowship from the Harvard Stem Cell Institute. J.O. is supported by the Chicago Diabetes Project. The authors acknowledge R. Bogorad for useful discussions and, assistance and the Koch Institute Swanson Biotechnology Center for technical support, specifically for the use of the Hope Babette Tang Histology, Microscopy, Flow Cytometry and Animal Imaging and preclinical testing core facilities. We acknowledge the use of imaging resources at the Harvard University Center for Nanoscale Systems, the W.M. Keck Biological Imaging Facility (Whitehead Institute) and the histology core of the Harvard Stem Cell Institute. We would like to thank A. Graham, W Salmon, C. MacGillivray and J. Wyckoff for their assistance.	Basta G, 2011, DIABETES CARE, V34, P2406, DOI 10.2337/dc11-0731; Calafiore R, 2006, DIABETES CARE, V29, P137, DOI 10.2337/diacare.29.01.06.dc05-1270; Dang TT, 2011, BIOMATERIALS, V32, P4464, DOI 10.1016/j.biomaterials.2011.02.048; de Groot M, 2004, J SURG RES, V121, P141, DOI 10.1016/j.jss.2004.02.018; Dolgin E, 2014, NAT MED, V20, P9, DOI 10.1038/nm0114-9; Elliott RB, 2005, TRANSPL P, V37, P3505, DOI 10.1016/j.transproceed.2005.09.038; Hirshberg Boaz, 2007, Curr Diab Rep, V7, P301, DOI 10.1007/s11892-007-0048-9; Jacobs-Tulleneers-Thevissen D, 2013, DIABETOLOGIA, V56, P1605, DOI 10.1007/s00125-013-2906-0; King A, 2001, J BIOMED MATER RES, V57, P374, DOI 10.1002/1097-4636(20011205)57:3<374::AID-JBM1180>3.0.CO;2-L; Kolb M, 2002, AM J RESP CELL MOL, V27, P141, DOI 10.1165/ajrcmb.27.2.4674; Lee SH, 2009, TRANSPLANTATION, V87, P983, DOI 10.1097/TP.0b013e31819c86ea; LIM F, 1980, SCIENCE, V210, P908, DOI 10.1126/science.6776628; LUM ZP, 1991, DIABETES, V40, P1511, DOI 10.2337/diabetes.40.11.1511; Omer A, 2003, DIABETES, V52, P69, DOI 10.2337/diabetes.52.1.69; Pagliuca FW, 2014, CELL, V159, P428, DOI 10.1016/j.cell.2014.09.040; Peppas NA, 2006, ADV MATER, V18, P1345, DOI 10.1002/adma.200501612; Pepper AR, 2015, NAT BIOTECHNOL, V33, P518, DOI 10.1038/nbt.3211; Pickup JC, 2012, NEW ENGL J MED, V366, P1616, DOI 10.1056/NEJMct1113948; Qi M, 2014, ACTA DIABETOL, V51, P833, DOI 10.1007/s00592-014-0627-6; Rezania A, 2014, NAT BIOTECHNOL, V32, P1121, DOI 10.1038/nbt.3033; Rezania A, 2012, DIABETES, V61, P2016, DOI 10.2337/db11-1711; Robertson RP, 2004, NEW ENGL J MED, V350, P694, DOI 10.1056/NEJMra032425; Scharp DW, 2014, ADV DRUG DELIVER REV, V67-68, P35, DOI 10.1016/j.addr.2013.07.018; Schneider S, 2005, DIABETES, V54, P687, DOI 10.2337/diabetes.54.3.687; Shapiro A M James, 2012, Rev Diabet Stud, V9, P385, DOI 10.1900/RDS.2012.9.385; Shapiro AMJ, 2006, NEW ENGL J MED, V355, P1318, DOI 10.1056/NEJMoa061267; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; SOONSHIONG P, 1994, LANCET, V343, P950, DOI 10.1016/S0140-6736(94)90067-1; Tuch BE, 2009, DIABETES CARE, V32, P1887, DOI 10.2337/dc09-0744; Vegas AJ, 2016, NAT BIOTECHNOL, V34, P345, DOI 10.1038/nbt.3462; Veiseh O, 2015, NAT MATER, V14, P643, DOI [10.1038/NMAT4290, 10.1038/nmat4290]; Veiseh O, 2015, NAT REV DRUG DISCOV, V14, P45, DOI 10.1038/nrd4477; Vogel G, 2014, SCIENCE, V346, P148, DOI 10.1126/science.346.6206.148; Wang T, 1997, NAT BIOTECHNOL, V15, P358, DOI 10.1038/nbt0497-358	35	409	427	5	305	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2016	22	3					306	311		10.1038/nm.4030	http://dx.doi.org/10.1038/nm.4030			6	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DF6DC	26808346	Green Submitted, Green Accepted			2022-12-25	WOS:000371445100018
J	Menardo, F; Praz, CR; Wyder, S; Ben-David, R; Bourras, S; Matsumae, H; McNally, KE; Parlange, F; Riba, A; Roffler, S; Schaefer, LK; Shimizu, KK; Valenti, L; Zbinden, H; Wicker, T; Keller, B				Menardo, Fabrizio; Praz, Coraline R.; Wyder, Stefan; Ben-David, Roi; Bourras, Salim; Matsumae, Hiromi; McNally, Kaitlin E.; Parlange, Francis; Riba, Andrea; Roffler, Stefan; Schaefer, Luisa K.; Shimizu, Kentaro K.; Valenti, Luca; Zbinden, Helen; Wicker, Thomas; Keller, Beat			Hybridization of powdery mildew strains gives rise to pathogens on novel agricultural crop species	NATURE GENETICS			English	Article							TRITICALE; RESISTANCE; EMERGENCE; EVOLUTION; GRAMINIS; LINEAGE; HYBRID; WHEAT; WILD	Throughout the history of agriculture, many new crop species (polyploids or artificial hybrids) have been introduced to diversify products or to increase yield. However, little is known about how these new crops influence the evolution of new pathogens and diseases. Triticale is an artificial hybrid of wheat and rye, and it was resistant to the fungal pathogen powdery mildew (Blumeria graminis) until 2001 (refs. 1-3). We sequenced and compared the genomes of 46 powdery mildew isolates covering several formae speciales. We found that B. graminis f. sp. triticale, which grows on triticale and wheat, is a hybrid between wheat powdery mildew (B. graminis f. sp. tritici) and mildew specialized on rye (B. graminis f. sp. secalis). Our data show that the hybrid of the two mildews specialized on two different hosts can infect the hybrid plant species originating from those two hosts. We conclude that hybridization between mildews specialized on different species is a mechanism of adaptation to new crops introduced by agriculture.	[Menardo, Fabrizio; Praz, Coraline R.; Wyder, Stefan; Ben-David, Roi; Bourras, Salim; McNally, Kaitlin E.; Parlange, Francis; Roffler, Stefan; Schaefer, Luisa K.; Valenti, Luca; Zbinden, Helen; Wicker, Thomas; Keller, Beat] Univ Zurich, Dept Plant & Microbial Biol, Zurich, Switzerland; [Matsumae, Hiromi; Shimizu, Kentaro K.] Univ Zurich, Inst Evolutionary Biol & Environm Studies, Zurich, Switzerland; [Riba, Andrea] Univ Basel, Biozentrum, Basel, Switzerland; [Ben-David, Roi] Agr Res Org, Volcani Ctr, Inst Plant Sci, IL-50250 Bet Dagan, Israel	University of Zurich; University of Zurich; University of Basel; VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH	Wicker, T; Keller, B (corresponding author), Univ Zurich, Dept Plant & Microbial Biol, Zurich, Switzerland.	wicker@botinst.uzh.ch; bkeller@botinst.uzh.ch	Wicker, Thomas/Z-1978-2019; Riba, Andrea/AAD-4515-2019; Keller, Beat/K-3093-2019; Matsumae, Hiromi/AAH-2196-2019	Riba, Andrea/0000-0002-6920-4592; Keller, Beat/0000-0003-2379-9225; Matsumae, Hiromi/0000-0003-1858-3833; , Thomas/0000-0002-6777-7135; Praz, Coraline Rosalie/0000-0002-9133-4406; Bourras, Salim/0000-0003-0855-5433; Schaefer, Luisa Katharina/0000-0003-1195-4996; Shimizu, Kentaro K./0000-0002-6483-1781; Menardo, Fabrizio/0000-0002-7885-4482; Wyder, Stefan/0000-0002-3412-0292	University Research Priority Program (URPP) 'Evolution in Action of the University of Zurich; Swiss National Science Foundation [310030B_144081/1]; Swiss Federal Office for Agriculture; European Research Council [ERC-2009-AdG 249996]	University Research Priority Program (URPP) 'Evolution in Action of the University of Zurich; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Federal Office for Agriculture; European Research Council(European Research Council (ERC)European Commission)	We want to thank S. Brunner for advice and support, A. Dinoor, V. Troch and F. Mascher for mildew isolates, C. Aquino and H. Rehrauer for their help with sequencing and bioinformatic analysis, and A. Widmer for reading and commenting on the manuscript. This work was supported by the University Research Priority Program (URPP) 'Evolution in Action of the University of Zurich, Swiss National Science Foundation grant 310030B_144081/1, a grant from the Swiss Federal Office for Agriculture and an Advanced Investigator Grant from the European Research Council (ERC-2009-AdG 249996, Durableresistance).	Birch PRJ, 2008, CURR OPIN PLANT BIOL, V11, P373, DOI 10.1016/j.pbi.2008.04.005; Brasier C, 2000, NATURE, V405, P134, DOI 10.1038/35012193; Brasier CM, 2010, PLANT PATHOL, V59, P186, DOI 10.1111/j.1365-3059.2009.02157.x; Brasier CM, 1999, P NATL ACAD SCI USA, V96, P5878, DOI 10.1073/pnas.96.10.5878; Degnan JH, 2005, EVOLUTION, V59, P24; Eshed N., 1994, PHYTOPARASITICA, V22, P49; Farrer RA, 2011, P NATL ACAD SCI USA, V108, P18732, DOI 10.1073/pnas.1111915108; Feldman M, 2012, GENETICS, V192, P763, DOI 10.1534/genetics.112.146316; Goss EM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024543; Hein H., 2005, GENES GENEALOGIES VA; LUIG NH, 1972, AUST J BIOL SCI, V25, P335, DOI 10.1071/BI9720335; Mascher F., 2005, REV SUISSE AGR, V38, P193; Middleton CP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085761; Newcombe G, 2000, MYCOL RES, V104, P261, DOI 10.1017/S0953756299001665; Oettler G, 2005, J AGR SCI-CAMBRIDGE, V143, P329, DOI 10.1017/S0021859605005290; Salamini F, 2002, NAT REV GENET, V3, P429, DOI 10.1038/nrg817; Sota T, 2002, POPUL ECOL, V44, P145, DOI 10.1007/s101440200018; Stukenbrock EH, 2012, P NATL ACAD SCI USA, V109, P10954, DOI 10.1073/pnas.1201403109; Than C, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-322; Tian SM, 2004, Z PFLANZENK PFLANZEN, V111, P461; Troch V, 2013, PLANT DIS, V97, P410, DOI 10.1094/PDIS-02-12-0161-RE; Troch V, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-76; Walker AS, 2011, PLANT PATHOL, V60, P207, DOI 10.1111/j.1365-3059.2010.02379.x; Wicker T, 2013, NAT GENET, V45, P1092, DOI 10.1038/ng.2704; Xu JP, 2000, MOL ECOL, V9, P1471, DOI 10.1046/j.1365-294x.2000.01021.x; Yu Y, 2012, PLOS GENET, V8, P456, DOI 10.1371/journal.pgen.1002660; Yu Y, 2011, SYST BIOL, V60, P138, DOI 10.1093/sysbio/syq084	27	110	113	1	65	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2016	48	2					201	205		10.1038/ng.3485	http://dx.doi.org/10.1038/ng.3485			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DC2JV	26752267	Green Accepted			2022-12-25	WOS:000369043900019
J	Abella, JVG; Galloni, C; Pernier, J; Barry, DJ; Kjaer, S; Carlier, MF; Way, M				Abella, Jasmine V. G.; Galloni, Chiara; Pernier, Julien; Barry, David J.; Kjaer, Svend; Carlier, Marie-France; Way, Michael			Isoform diversity in the Arp2/3 complex determines actin filament dynamics	NATURE CELL BIOLOGY			English	Article							ALDRICH-SYNDROME PROTEIN; DEPOLYMERIZING FACTOR COFILIN; WASP FAMILY PROTEINS; N-WASP; VACCINIA VIRUS; CORONIN 1B; WASP/SCAR PROTEINS; CORTACTIN; ACTIVATION; NUCLEATION	The Arp2/3 complex consists of seven evolutionarily conserved subunits (Arp2, Arp3 and ARPC1-5) and plays an essential role in generating branched actin filament networks during many different cellular processes. In mammals, however, the ARPC1 and ARPC5 subunits are each encoded by two isoforms that are 67% identical. This raises the possibility that Arp2/3 complexes with different properties may exist. We found that Arp2/3 complexes containing ARPC1B and ARPC5L are significantly better at promoting actin assembly than those with ARPC1A and ARPC5, both in cells and in vitro. Branched actin networks induced by complexes containing ARPC1B or ARPC5L are also disassembled similar to 2-fold slower than those formed by their counterparts. This difference reflects the ability of cortactin to stabilize ARPC1B- and ARPC5L- but not ARPC1A- and ARPC5-containing complexes against coronin-mediated disassembly. Our observations demonstrate that the Arp2/3 complex in higher eukaryotes is actually a family of complexes with different properties.	[Abella, Jasmine V. G.; Galloni, Chiara; Barry, David J.; Way, Michael] Francis Crick Inst, Lincolns Inn Fields Lab, Cellular Signalling & Cytoskeletal Funct, London WC2A 3LY, England; [Pernier, Julien; Carlier, Marie-France] CNRS, I2BC, Lab Enzymol & Biochim Struct, F-91198 Gif Sur Yvette, France; [Kjaer, Svend] Francis Crick Inst, Lincolns Inn Fields Lab, Struct Biol Sci Technol Platform, London WC2A 3LY, England	Francis Crick Institute; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Francis Crick Institute	Way, M (corresponding author), Francis Crick Inst, Lincolns Inn Fields Lab, Cellular Signalling & Cytoskeletal Funct, 44 Lincolns Inn Fields, London WC2A 3LY, England.	michael.way@crick.ac.uk	Barry, David J/D-6154-2018	Barry, David J/0000-0003-2763-5244; Pernier, Julien/0000-0002-0480-9355; Way, Michael/0000-0001-7207-2722; Galloni, Chiara/0000-0003-1769-7249	Cancer Research UK; FRQS (Fonds de recherche du Quebec - Sante); EMBO; Canadian Institutes of Health Research (CIHR); ERC [249982, FP7 241548]; The Francis Crick Institute [10008, 10015] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); FRQS (Fonds de recherche du Quebec - Sante); EMBO(European Molecular Biology Organization (EMBO)); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); ERC(European Research Council (ERC)European Commission); The Francis Crick Institute	We would like to thank members of the Way laboratory, R. Treisman (The Francis Crick Institute) and H. Walden (University of Dundee) for comments on the manuscript, M. Howell (The Francis Crick Institute) for his helpful discussions, J. Cockburn (University of Leeds) for his structural insights into Arp2/3, R. George (The Francis Crick Institute) for his help with Arp2/3 purification, and B. Wharam for his contribution to this project during his summer studentship. We would like to thank J. Bear (University of North Carolina, Chapel Hill, USA) for coronin antibodies, I. Berger (University of Bristol, UK) for the pFL vector, and E. Benanti and M. Welch (University of California, Berkeley, USA) for helpful discussions concerning production of recombinant Arp2/3. This work was supported by Cancer Research UK (C.G. and M.W.) and by postdoctoral fellowships from FRQS (Fonds de recherche du Quebec - Sante), EMBO and the Canadian Institutes of Health Research (CIHR) to J.V.G.A. M.-F.C. was supported by ERC advanced grant no. 249982 and FP7 241548.	Arakawa Y, 2007, CELL HOST MICROBE, V1, P227, DOI 10.1016/j.chom.2007.04.006; Balasubramanian MK, 1996, EMBO J, V15, P6426, DOI 10.1002/j.1460-2075.1996.tb01034.x; Beltzner CC, 2004, J MOL BIOL, V336, P551, DOI 10.1016/j.jmb.2003.12.017; Blanchoin L, 2000, NATURE, V404, P1007, DOI 10.1038/35010008; Boczkowska M, 2008, STRUCTURE, V16, P695, DOI 10.1016/j.str.2008.02.013; Boczkowska M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4308; Brieher WM, 2006, J CELL BIOL, V175, P315, DOI 10.1083/jcb.200603149; Cai L, 2005, J BIOL CHEM, V280, P31913, DOI 10.1074/jbc.M504146200; Cai L, 2008, CELL, V134, P828, DOI 10.1016/j.cell.2008.06.054; Cai L, 2007, CELL, V128, P915, DOI 10.1016/j.cell.2007.01.031; Campellone KG, 2010, NAT REV MOL CELL BIO, V11, P237, DOI 10.1038/nrm2867; Carlier MF, 1997, J CELL BIOL, V136, P1307, DOI 10.1083/jcb.136.6.1307; Chan KT, 2012, BIOCHEM J, V444, P89, DOI 10.1042/BJ20120209; Chan KT, 2011, TRENDS CELL BIOL, V21, P481, DOI 10.1016/j.tcb.2011.04.004; Chereau D, 2005, P NATL ACAD SCI USA, V102, P16644, DOI 10.1073/pnas.0507021102; Churchman LS, 2005, P NATL ACAD SCI USA, V102, P1419, DOI 10.1073/pnas.0409487102; Co C, 2007, CELL, V128, P901, DOI 10.1016/j.cell.2006.12.049; Donnelly SK, 2013, CURR BIOL, V23, P999, DOI 10.1016/j.cub.2013.04.051; Egile C, 2005, PLOS BIOL, V3, P1902, DOI 10.1371/journal.pbio.0030383; Egile C, 1999, J CELL BIOL, V146, P1319, DOI 10.1083/jcb.146.6.1319; Fitzgerald DJ, 2006, NAT METHODS, V3, P1021, DOI 10.1038/nmeth983; Frischknecht F, 1999, NATURE, V401, P926, DOI 10.1038/44860; Frishknecht F, 2001, TRENDS CELL BIOL, V11, P30, DOI 10.1016/S0962-8924(00)01871-7; Goley ED, 2004, MOL CELL, V16, P269, DOI 10.1016/j.molcel.2004.09.018; Goley ED, 2006, NAT REV MOL CELL BIO, V7, P713, DOI 10.1038/nrm2026; Helgeson LA, 2014, J BIOL CHEM, V289, P28856, DOI 10.1074/jbc.M114.587527; Helgeson LA, 2013, ELIFE, V2, DOI 10.7554/eLife.00884; HILLER G, 1985, J VIROL, V55, P651, DOI 10.1128/JVI.55.3.651-659.1985; Humphries AC, 2014, J CELL SCI, V127, P673, DOI 10.1242/jcs.141366; Humphries AC, 2012, CELL HOST MICROBE, V12, P346, DOI 10.1016/j.chom.2012.08.002; Jansen S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8202; Jay P, 2000, EUR J BIOCHEM, V267, P2921, DOI 10.1046/j.1432-1327.2000.01306.x; Kirkbride KC, 2011, CELL ADHES MIGR, V5, P187, DOI 10.4161/cam.5.2.14773; Lai FP, 2008, EMBO J, V27, P982, DOI 10.1038/emboj.2008.34; Le Clainche C, 2003, P NATL ACAD SCI USA, V100, P6337, DOI 10.1073/pnas.1130513100; Le Clainche C, 2001, J BIOL CHEM, V276, P46689, DOI 10.1074/jbc.C100476200; MACHESKY LM, 1994, J CELL BIOL, V127, P107, DOI 10.1083/jcb.127.1.107; Marchand JB, 2001, NAT CELL BIOL, V3, P76, DOI 10.1038/35050590; Millard TH, 2003, CELL MOTIL CYTOSKEL, V54, P81, DOI 10.1002/cm.10087; Mueller J, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001765; Mullins RD, 1998, P NATL ACAD SCI USA, V95, P6181, DOI 10.1073/pnas.95.11.6181; Padrick SB, 2011, P NATL ACAD SCI USA, V108, pE472, DOI 10.1073/pnas.1100236108; Panchal SC, 2003, NAT STRUCT BIOL, V10, P591, DOI 10.1038/nsb952; Pernier J, 2013, NAT STRUCT MOL BIOL, V20, P1069, DOI 10.1038/nsmb.2639; Robinson RC, 2001, SCIENCE, V294, P1679, DOI 10.1126/science.1066333; Rosenblatt J, 1997, J CELL BIOL, V136, P1323, DOI 10.1083/jcb.136.6.1323; Rottner K, 2010, TRENDS CELL BIOL, V20, P650, DOI 10.1016/j.tcb.2010.08.014; Rouiller I, 2008, J CELL BIOL, V180, P887, DOI 10.1083/jcb.200709092; Sbalzarini IF, 2005, J STRUCT BIOL, V151, P182, DOI 10.1016/j.jsb.2005.06.002; Siton O, 2011, CURR BIOL, V21, P2092, DOI 10.1016/j.cub.2011.11.010; Smith BA, 2013, ELIFE, V2, DOI 10.7554/eLife.01008; Snapper SB, 2001, NAT CELL BIOL, V3, P897, DOI 10.1038/ncb1001-897; Steffen A, 2006, MOL BIOL CELL, V17, P2581, DOI 10.1091/mbc.E05-11-1088; Suraneni P, 2012, J CELL BIOL, V197, P239, DOI 10.1083/jcb.201112113; Svitkina TM, 1999, J CELL BIOL, V145, P1009, DOI 10.1083/jcb.145.5.1009; Ti SC, 2011, P NATL ACAD SCI USA, V108, pE463, DOI 10.1073/pnas.1100125108; Uruno T, 2003, J BIOL CHEM, V278, P26086, DOI 10.1074/jbc.M301997200; Uruno T, 2001, NAT CELL BIOL, V3, P259, DOI 10.1038/35060051; Vinzenz M, 2012, J CELL SCI, V125, P2775, DOI 10.1242/jcs.107623; Volkmann N, 2001, SCIENCE, V293, P2456, DOI 10.1126/science.1063025; Weaver AM, 2001, CURR BIOL, V11, P370, DOI 10.1016/S0960-9822(01)00098-7; Weed SA, 2000, J CELL BIOL, V151, P29, DOI 10.1083/jcb.151.1.29; Weisswange I, 2009, NATURE, V458, P87, DOI 10.1038/nature07773; Welch MD, 2013, CELL HOST MICROBE, V14, P242, DOI 10.1016/j.chom.2013.08.011; Welch MD, 1998, SCIENCE, V281, P105, DOI 10.1126/science.281.5373.105; Welman A, 2010, J BIOL CHEM, V285, P11607, DOI 10.1074/jbc.M110.102392; Xu XP, 2012, EMBO J, V31, P236, DOI 10.1038/emboj.2011.343; Zalevsky J, 2001, CURR BIOL, V11, P1903, DOI 10.1016/S0960-9822(01)00603-0	68	102	102	0	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2016	18	1					76	+		10.1038/ncb3286	http://dx.doi.org/10.1038/ncb3286			13	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CZ3VA	26655834				2022-12-25	WOS:000367030900014
J	Xue, L; Karpenko, IA; Hiblot, J; Johnsson, K				Xue, Lin; Karpenko, Iuliia A.; Hiblot, Julien; Johnsson, Kai			Imaging and manipulating proteins in live cells through covalent labeling	NATURE CHEMICAL BIOLOGY			English	Article							TIME-RESOLVED FRET; IONOTROPIC GLUTAMATE-RECEPTOR; INFRARED FLUORESCENCE PROBE; GENETIC-CODE EXPANSION; DIELS-ALDER REACTIONS; LIVING CELLS; FAR-RED; IN-VIVO; SUPERRESOLUTION MICROSCOPY; FLUOROGENIC PROBES	The past 20 years have witnessed the advent of numerous technologies to specifically and covalently label proteins in cellulo and in vivo with synthetic probes. These technologies range from self-labeling proteins tags to non-natural amino acids, and the question is no longer how we can specifically label a given protein but rather with what additional functionality we wish to equip it. In addition, progress in fields such as super-resolution microscopy and genome editing have either provided additional motivation to label proteins with advanced synthetic probes or removed some of the difficulties of conducting such experiments. By focusing on two particular applications, live-cell imaging and the generation of reversible protein switches, we outline the opportunities and challenges of the field and how the synergy between synthetic chemistry and protein engineering will make it possible to conduct experiments that are not feasible with conventional approaches.	[Xue, Lin; Karpenko, Iuliia A.; Hiblot, Julien; Johnsson, Kai] Ecole Polytech Fed Lausanne, Inst Chem Sci & Engn ISIC, Inst Bioengn, Natl Ctr Competence Res NCCR Chem Biol, CH-1015 Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Xue, L (corresponding author), Ecole Polytech Fed Lausanne, Inst Chem Sci & Engn ISIC, Inst Bioengn, Natl Ctr Competence Res NCCR Chem Biol, CH-1015 Lausanne, Switzerland.	kai.johnsson@epfl.ch	Karpenko, Iuliia/L-2965-2019; Xue, Lin/W-3515-2018; Hiblot, Julien/AAA-4452-2020; Johnsson, Kai/P-4222-2014	Karpenko, Iuliia/0000-0002-7633-3691; Xue, Lin/0000-0002-4540-3386; Hiblot, Julien/0000-0002-7883-8079; Johnsson, Kai/0000-0002-8002-1981	Swiss National Science Foundation; NCCR Chemical Biology; EMBO Long-Term Fellowship [ALTF 302-2015]; Marie Curie Action [GA-2013-609409]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NCCR Chemical Biology(Swiss National Science Foundation (SNSF)); EMBO Long-Term Fellowship(European Molecular Biology Organization (EMBO)); Marie Curie Action(European Commission)	The Johnsson laboratory acknowledges support from the Swiss National Science Foundation and the NCCR Chemical Biology. The authors are grateful to P. Heppenstall (EMBL Monterotondo) and G. Lukinavicius (EPFL) for providing images. I.A.K. acknowledges funding through an EMBO Long-Term Fellowship (ALTF 302-2015) co-funded by Marie Curie Action (LTFCOFUND2013, GA-2013-609409).	Albizu L, 2010, NAT CHEM BIOL, V6, P587, DOI [10.1038/nchembio.396, 10.1038/NCHEMBIO.396]; Banghart M, 2004, NAT NEUROSCI, V7, P1381, DOI 10.1038/nn1356; Bianco A, 2012, NAT CHEM BIOL, V8, P748, DOI [10.1038/nchembio.1043, 10.1038/NCHEMBIO.1043]; Borrmann A, 2012, CHEMBIOCHEM, V13, P2094, DOI 10.1002/cbic.201200407; Broichhagen J, 2015, ACCOUNTS CHEM RES, V48, P1947, DOI 10.1021/acs.accounts.5b00129; Brun MA, 2012, J AM CHEM SOC, V134, P7676, DOI 10.1021/ja3002277; Brun MA, 2011, J AM CHEM SOC, V133, P16235, DOI 10.1021/ja206915m; Caporale N, 2011, MOL THER, V19, P1212, DOI 10.1038/mt.2011.103; Davis L, 2012, NAT REV MOL CELL BIO, V13, P168, DOI 10.1038/nrm3286; Deschout H, 2014, NAT METHODS, V11, P253, DOI 10.1038/nmeth.2843; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Egawa T, 2011, J AM CHEM SOC, V133, P14157, DOI 10.1021/ja205809h; Erazo-Oliveras A, 2014, NAT METHODS, V11, P861, DOI [10.1038/NMETH.2998, 10.1038/nmeth.2998]; Erdmann RS, 2014, ANGEW CHEM INT EDIT, V53, P10242, DOI 10.1002/anie.201403349; Fornasiero EF, 2015, BIOESSAYS, V37, P436, DOI 10.1002/bies.201400170; Frangioni JV, 2003, CURR OPIN CHEM BIOL, V7, P626, DOI 10.1016/j.cbpa.2003.08.007; Fu MY, 2008, CHEM COMMUN, P1780, DOI 10.1039/b718544h; Gorostiza P, 2007, P NATL ACAD SCI USA, V104, P10865, DOI 10.1073/pnas.0701274104; Greiss S, 2011, J AM CHEM SOC, V133, P14196, DOI 10.1021/ja2054034; Grimm JB, 2015, NAT METHODS, V12, P244, DOI [10.1038/NMETH.3256, 10.1038/nmeth.3256]; Griss R, 2014, NAT CHEM BIOL, V10, P598, DOI [10.1038/NCHEMBIO.1554, 10.1038/nchembio.1554]; Hayashi T, 2012, ACCOUNTS CHEM RES, V45, P1460, DOI 10.1021/ar200334r; Hell SW, 2015, ANGEW CHEM INT EDIT, V54, P8054, DOI 10.1002/anie.201504181; Hilderbrand SA, 2010, CURR OPIN CHEM BIOL, V14, P71, DOI 10.1016/j.cbpa.2009.09.029; Hounsou C, 2015, ACS CHEM BIOL, V10, P466, DOI 10.1021/cb5007568; Jack T, 2015, NEUROPHARMACOLOGY, V90, P63, DOI 10.1016/j.neuropharm.2014.11.007; Jing CR, 2011, ACCOUNTS CHEM RES, V44, P784, DOI 10.1021/ar200099f; Johnsson N, 2005, CHEMBIOCHEM, V6, P47, DOI 10.1002/cbic.200400290; Keppler A, 2003, NAT BIOTECHNOL, V21, P86, DOI 10.1038/nbt765; Kim E, 2014, CHEM COMMUN, V50, P4504, DOI 10.1039/c4cc00144c; Koide Y, 2011, J AM CHEM SOC, V133, P5680, DOI 10.1021/ja111470n; Koide Y, 2011, ACS CHEM BIOL, V6, P600, DOI 10.1021/cb1002416; Komatsu T, 2011, J AM CHEM SOC, V133, P6745, DOI 10.1021/ja200225m; Krishnamurthy VM, 2007, J AM CHEM SOC, V129, P1312, DOI 10.1021/ja066780e; Lang K, 2014, ACS CHEM BIOL, V9, P16, DOI 10.1021/cb4009292; Lang K, 2012, J AM CHEM SOC, V134, P10317, DOI 10.1021/ja302832g; Lang K, 2012, NAT CHEM, V4, P298, DOI 10.1038/nchem.1250; Lavis LD, 2014, ACS CHEM BIOL, V9, P855, DOI 10.1021/cb500078u; Levitz J, 2013, NAT NEUROSCI, V16, P507, DOI 10.1038/nn.3346; Li XH, 2014, CHEM REV, V114, P590, DOI 10.1021/cr300508p; Liu TK, 2014, ACS CHEM BIOL, V9, P2359, DOI 10.1021/cb500502n; Los GV, 2008, ACS CHEM BIOL, V3, P373, DOI 10.1021/cb800025k; Lukinavicius G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9497; Lukinavicius G, 2014, NAT METHODS, V11, P731, DOI [10.1038/NMETH.2972, 10.1038/nmeth.2972]; Lukinavicius G, 2013, NAT CHEM, V5, P132, DOI [10.1038/nchem.1546, 10.1038/NCHEM.1546]; Lukinaviclus G, 2013, CURR BIOL, V23, P265, DOI 10.1016/j.cub.2012.12.030; Machida T, 2015, BIOCONJUGATE CHEM, V26, P802, DOI 10.1021/acs.bioconjchem.5b00101; Masharina A, 2012, J AM CHEM SOC, V134, P19026, DOI 10.1021/ja306320s; Miki T, 2014, CHEM BIOL, V21, P1013, DOI 10.1016/j.chembiol.2014.07.013; Nikic I, 2014, ANGEW CHEM INT EDIT, V53, P2245, DOI 10.1002/anie.201309847; Numano R, 2009, P NATL ACAD SCI USA, V106, P6814, DOI 10.1073/pnas.0811899106; Oueslati N, 2015, METHODS MOL BIOL, V1272, P23, DOI 10.1007/978-1-4939-2336-6_2; Plass T, 2012, ANGEW CHEM INT EDIT, V51, P4166, DOI 10.1002/anie.201108231; Sachdeva A, 2014, J AM CHEM SOC, V136, P7785, DOI 10.1021/ja4129789; Schena A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8830; Schena A, 2014, ANGEW CHEM INT EDIT, V53, P1302, DOI 10.1002/anie.201307754; Stein V, 2015, TRENDS BIOTECHNOL, V33, P101, DOI 10.1016/j.tibtech.2014.11.010; Szymanski W, 2013, CHEM REV, V113, P6114, DOI 10.1021/cr300179f; Takaoka Y, 2013, ANGEW CHEM INT EDIT, V52, P4088, DOI 10.1002/anie.201207089; Tsai YH, 2015, NAT CHEM, V7, P554, DOI [10.1038/NCHEM.2253, 10.1038/nchem.2253]; Tsukiji S, 2014, CURR OPIN CHEM BIOL, V21, P136, DOI 10.1016/j.cbpa.2014.07.012; Uno SN, 2014, NAT CHEM, V6, P681, DOI [10.1038/nchem.2002, 10.1038/NCHEM.2002]; Uttamapinant C, 2015, J AM CHEM SOC, V137, P4602, DOI 10.1021/ja512838z; Volgraf M, 2006, NAT CHEM BIOL, V2, P47, DOI 10.1038/nchembio756; Wang KH, 2014, NAT CHEM, V6, P393, DOI [10.1038/nchem.1919, 10.1038/NCHEM.1919]; Wang L, 2005, ANGEW CHEM INT EDIT, V44, P34, DOI 10.1002/anie.200460627; Weissleder R, 2001, NAT BIOTECHNOL, V19, P316, DOI 10.1038/86684; Wyart C, 2009, NATURE, V461, P407, DOI 10.1038/nature08323; Wysocki LM, 2011, CURR OPIN CHEM BIOL, V15, P752, DOI 10.1016/j.cbpa.2011.10.013; Yan Q, 2015, CELL TISSUE RES, V360, P179, DOI 10.1007/s00441-015-2145-4; Yang GY, 2015, NAT METHODS, V12, P137, DOI [10.1038/NMETH.3207, 10.1038/nmeth.3207]; Yuan L, 2013, CHEM SOC REV, V42, P622, DOI 10.1039/c2cs35313j; Zheng QS, 2014, CHEM SOC REV, V43, P1044, DOI 10.1039/c3cs60237k; Zhou HX, 2006, BIOPHYS J, V91, P3170, DOI 10.1529/biophysj.106.090258	74	128	129	9	205	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2015	11	12					917	923		10.1038/nchembio.1959	http://dx.doi.org/10.1038/nchembio.1959			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX6TG	26575238				2022-12-25	WOS:000365834000008
J	Deng, HX; Shi, Y; Yang, Y; Ahmeti, KB; Miller, N; Huang, C; Cheng, LJ; Zhai, H; Deng, S; Nuytemans, K; Corbett, NJ; Kim, MJ; Deng, H; Tang, BS; Yang, ZQ; Xu, YM; Chan, P; Huang, B; Gao, XP; Song, Z; Liu, ZH; Fecto, F; Siddique, N; Foroud, T; Jankovic, J; Ghetti, B; Nicholson, DA; Krainc, D; Melen, O; Vance, JM; Pericak-Vance, MA; Ma, YC; Rajput, AH; Siddique, T				Deng, Han-Xiang; Shi, Yong; Yang, Yi; Ahmeti, Kreshnik B.; Miller, Nimrod; Huang, Cao; Cheng, Lijun; Zhai, Hong; Deng, Sheng; Nuytemans, Karen; Corbett, Nicola J.; Kim, Myung Jong; Deng, Hao; Tang, Beisha; Yang, Ziquang; Xu, Yanming; Chan, Piu; Huang, Bo; Gao, Xiao-Ping; Song, Zhi; Liu, Zhenhua; Fecto, Faisal; Siddique, Nailah; Foroud, Tatiana; Jankovic, Joseph; Ghetti, Bernardino; Nicholson, Daniel A.; Krainc, Dimitri; Melen, Onur; Vance, Jeffery M.; Pericak-Vance, Margaret A.; Ma, Yong-Chao; Rajput, Ali H.; Siddique, Teepu			Identification of TMEM230 mutations in familial Parkinson's disease	NATURE GENETICS			English	Article							AUTOSOMAL-DOMINANT PARKINSONISM; ALPHA-SYNUCLEIN TOXICITY; PROTEIN-STRUCTURE; GENE; VPS35; LOCUS; PEDIGREE; JUVENILE; EIF4G1; WEB	Parkinson's disease is the second most common neurodegenerative disorder without effective treatment. It is generally sporadic with unknown etiology. However, genetic studies of rare familial forms have led to the identification of mutations in several genes, which are linked to typical Parkinson's disease or parkinsonian disorders. The pathogenesis of Parkinson's disease remains largely elusive. Here we report a locus for autosomal dominant, clinically typical and Lewy body-confirmed Parkinson's disease on the short arm of chromosome 20 (20pter-p12) and identify TMEM230 as the disease-causing gene. We show that TMEM230 encodes a transmembrane protein of secretory/recycling vesicles, including synaptic vesicles in neurons. Disease-linked TMEM230 mutants impair synaptic vesicle trafficking. Our data provide genetic evidence that a mutant transmembrane protein of synaptic vesicles in neurons is etiologically linked to Parkinson's disease, with implications for understanding the pathogenic mechanism of Parkinson's disease and for developing rational therapies.	[Deng, Han-Xiang; Shi, Yong; Yang, Yi; Ahmeti, Kreshnik B.; Cheng, Lijun; Zhai, Hong; Deng, Sheng; Kim, Myung Jong; Yang, Ziquang; Fecto, Faisal; Siddique, Nailah; Krainc, Dimitri; Melen, Onur; Siddique, Teepu] Northwestern Univ, Feinberg Sch Med, Ken & Ruth Davee Dept Neurol, Chicago, IL 60611 USA; [Miller, Nimrod; Ma, Yong-Chao] Northwestern Univ, Dept Pediat, Lurie Childrens Hosp, Chicago Res Ctr, Chicago, IL 60611 USA; [Huang, Cao; Huang, Bo] Thomas Jefferson Univ, Dept Pathol, Philadelphia, PA 19107 USA; [Deng, Sheng] Cent S Univ, Xiangya Hosp, Dept Pharm, Changsha, Hunan, Peoples R China; [Nuytemans, Karen; Vance, Jeffery M.; Pericak-Vance, Margaret A.] Univ Miami, Miller Sch Med, John P Hussman Inst Human Genom, Miami, FL 33136 USA; [Corbett, Nicola J.; Nicholson, Daniel A.] Rush Univ, Med Ctr, Dept Neurol Sci, Chicago, IL 60612 USA; [Deng, Hao] Cent S Univ, Xiangya Hosp 3, Ctr Med Expt, Changsha, Hunan, Peoples R China; [Deng, Hao; Song, Zhi] Cent S Univ, Xiangya Hosp 3, Dept Neurol, Changsha, Hunan, Peoples R China; [Tang, Beisha; Liu, Zhenhua] Cent S Univ, Xiangya Hosp, Dept Neurol, Changsha, Hunan, Peoples R China; [Tang, Beisha] Cent S Univ, Natl Lab Med Genet China, Changsha, Hunan, Peoples R China; [Yang, Ziquang] Cent S Univ, Xiangya Hosp, Dept Neurosurg, Changsha, Hunan, Peoples R China; [Xu, Yanming] Sichuan Univ, West China Hosp, Dept Neurol, Chengdu 610064, Peoples R China; [Chan, Piu] Capital Med Univ, Beijing Xuanwu Hosp, Dept Neurol, Beijing, Peoples R China; [Gao, Xiao-Ping] Peoples Hosp Hunan Prov, Dept Neurol, Changsha, Hunan, Peoples R China; [Foroud, Tatiana] Indiana Univ, Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA; [Jankovic, Joseph] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; [Ghetti, Bernardino] Indiana Univ, Sch Med, Dept Pathol & Lab Med, Indianapolis, IN USA; [Rajput, Ali H.] Univ Saskatchewan, Div Neurol, Saskatoon, SK, Canada; [Rajput, Ali H.] Saskatoon Hlth Reg, Saskatoon, SK, Canada	Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Jefferson University; Central South University; University of Miami; Rush University; Central South University; Central South University; Central South University; Central South University; Central South University; Sichuan University; Capital Medical University; Indiana University System; Indiana University-Purdue University Indianapolis; Baylor College of Medicine; Indiana University System; Indiana University-Purdue University Indianapolis; University of Saskatchewan; University of Saskatchewan	Deng, HX; Siddique, T (corresponding author), Northwestern Univ, Feinberg Sch Med, Ken & Ruth Davee Dept Neurol, Chicago, IL 60611 USA.	h-deng@northwestern.edu; t-siddique@northwestern.edu	Liu, Zhenhua/AAG-1303-2021; Chan, Piu/I-4580-2016; Xu, yanming/Q-4931-2019; Deng, Hao/O-6340-2017; Siddique, Teepu/AAT-8166-2021	Chan, Piu/0000-0003-1346-881X; Deng, Hao/0000-0003-3240-4352; Siddique, Teepu/0000-0001-7293-9146; HUANG, CAO/0000-0001-7033-2498; Corbett, Nicola/0000-0002-7531-7462; Fecto, Faisal/0000-0002-7587-8024; Miller, Nimrod/0000-0002-2221-139X; Deng, Sheng/0000-0002-8313-6522; Ma, Yongchao/0000-0002-2469-4356; Deng, Han-Xiang/0000-0002-0030-8465; Vance, Jeffery/0000-0003-3815-8199	American Parkinson's Disease Association; US National Institutes of Health [NS074366, NS37167, NS078287, NS094564, AG10133, AG043970, NS095972]; National Natural Science Foundation of China [81271921, 81430023, 81471300]; Les Turner ALS Foundation/Herbert and Florence C. Wenske Foundation; George Link Jr. Foundation; Les Turner ALS Foundation; Foglia Family Foundation; National Institutes of Health [CA060553]; NATIONAL CANCER INSTITUTE [P30CA060553] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS074366, P50NS071674, R01NS037167, R01NS078287, R01NS094564, R01NS095972, R56NS037167] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K02AG050767, R01AG047073, R21AG043970, P30AG010133] Funding Source: NIH RePORTER	American Parkinson's Disease Association; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Les Turner ALS Foundation/Herbert and Florence C. Wenske Foundation; George Link Jr. Foundation; Les Turner ALS Foundation; Foglia Family Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by the American Parkinson's Disease Association, the US National Institutes of Health (NS074366, NS37167, NS078287, NS094564, AG10133, AG043970 and NS095972), the National Natural Science Foundation of China (81271921, 81430023 and 81471300), the Les Turner ALS Foundation/Herbert and Florence C. Wenske Foundation Professorship, the George Link Jr. Foundation, the Les Turner ALS Foundation and the Foglia Family Foundation. Whole-exome sequencing was performed at the John P. Hussman Institute for Human Genomics, University of Miami, Miller School of Medicine. Imaging work was performed at the Northwestern University Cell Image Facility supported by the National Institutes of Health (CA060553).	[Anonymous], 2015, NAT GENET, V47, P1371, DOI 10.1038/ng.3463; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; BUCCI C, 1992, CELL, V70, P715, DOI 10.1016/0092-8674(92)90306-W; Caviston JP, 2009, TRENDS CELL BIOL, V19, P147, DOI 10.1016/j.tcb.2009.01.005; Chartier-Harlin MC, 2011, AM J HUM GENET, V89, P398, DOI 10.1016/j.ajhg.2011.08.009; Chung CY, 2013, SCIENCE, V342, P983, DOI 10.1126/science.1245296; Dawson TM, 2010, NEURON, V66, P646, DOI 10.1016/j.neuron.2010.04.034; Deng HX, 2011, NATURE, V477, P211, DOI 10.1038/nature10353; Deng HX, 2010, NAT GENET, V42, P165, DOI 10.1038/ng.509; Deng HX, 2006, P NATL ACAD SCI USA, V103, P7142, DOI 10.1073/pnas.0602046103; Edvardson S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036458; Fuchs J, 2007, NEUROLOGY, V68, P916, DOI 10.1212/01.wnl.0000254458.17630.c5; Goedert M, 2013, NAT REV NEUROL, V9, P13, DOI 10.1038/nrneurol.2012.242; Kallberg M, 2012, NAT PROTOC, V7, P1511, DOI 10.1038/nprot.2012.085; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Klein C, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a008888; Krebs CE, 2013, HUM MUTAT, V34, P1200, DOI 10.1002/humu.22372; Langston JW, 2015, NAT GENET, V47, P1378, DOI 10.1038/ng.3454; LATHROP GM, 1984, AM J HUM GENET, V36, P460; Lautier C, 2008, AM J HUM GENET, V82, P822, DOI 10.1016/j.ajhg.2008.01.015; Leroy E, 1998, NATURE, V395, P451, DOI 10.1038/26652; Martin I, 2011, ANNU REV GENOM HUM G, V12, P301, DOI 10.1146/annurev-genom-082410-101440; Mata IF, 2015, MOL NEURODEGENER, V10, DOI 10.1186/s13024-015-0045-4; Nuytemans K, 2013, NEUROLOGY, V80, P982, DOI 10.1212/WNL.0b013e31828727d4; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Paisan-Ruiz C, 2009, ANN NEUROL, V65, P19, DOI 10.1002/ana.21415; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Quadri M, 2013, HUM MUTAT, V34, P1208, DOI 10.1002/humu.22373; Ramirez A, 2006, NAT GENET, V38, P1184, DOI 10.1038/ng1884; Ross OA, 2008, ANN NEUROL, V63, P743, DOI 10.1002/ana.21380; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Shojaee S, 2008, AM J HUM GENET, V82, P1375, DOI 10.1016/j.ajhg.2008.05.005; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Song AH, 2009, CELL, V136, P1148, DOI 10.1016/j.cell.2009.01.016; Spanaki C, 2006, NEUROLOGY, V67, P1518, DOI 10.1212/01.wnl.0000239829.33936.73; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Steger M, 2016, ELIFE, V5, DOI 10.7554/eLife.12813; Strauss KM, 2005, HUM MOL GENET, V14, P2099, DOI 10.1093/hmg/ddi215; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Tardiff DF, 2013, SCIENCE, V342, P979, DOI 10.1126/science.1245321; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Vilarino-Guell C, 2014, HUM MOL GENET, V23, P1794, DOI 10.1093/hmg/ddt570; Vilarino-Guell C, 2011, AM J HUM GENET, V89, P162, DOI 10.1016/j.ajhg.2011.06.001; Wider C, 2008, PARKINSONISM RELAT D, V14, P465, DOI 10.1016/j.parkreldis.2007.11.013; Wszolek ZK, 2004, NEUROLOGY, V62, P1619, DOI 10.1212/01.WNL.0000125015.06989.DB; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005; Zimprich A, 2011, AM J HUM GENET, V89, P168, DOI 10.1016/j.ajhg.2011.06.008	48	120	126	3	56	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2016	48	7					733	+		10.1038/ng.3589	http://dx.doi.org/10.1038/ng.3589			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DP9TK	27270108	Green Accepted, Green Submitted			2022-12-25	WOS:000378840100010
J	Huang, LL; Zhang, HB; Cheng, CY; Wen, F; Tam, POS; Zhao, PQ; Chen, HY; Li, Z; Chen, LJ; Tai, ZF; Yamashiro, K; Deng, SP; Zhu, XJ; Chen, WQ; Cai, L; Lu, F; Li, YF; Cheung, CMG; Shi, Y; Miyake, M; Lin, Y; Gong, B; Liu, XQ; Sim, KS; Yang, JY; Mori, K; Zhang, XZ; Cackett, PD; Tsujikawa, M; Nishida, K; Hao, F; Ma, S; Lin, H; Cheng, J; Fei, P; Lai, TYY; Tang, SB; Laude, A; Inoue, S; Yeo, IY; Sakurada, Y; Zhou, Y; Iijima, H; Honda, S; Lei, CT; Zhang, L; Zheng, H; Jiang, D; Zhu, X; Wong, TY; Khor, CC; Pang, CP; Yoshimura, N; Yang, ZL				Huang, Lulin; Zhang, Houbin; Cheng, Ching-Yu; Wen, Feng; Tam, Pancy O. S.; Zhao, Peiquan; Chen, Haoyu; Li, Zheng; Chen, Lijia; Tai, Zhengfu; Yamashiro, Kenji; Deng, Shaoping; Zhu, Xianjun; Chen, Weiqi; Cai, Li; Lu, Fang; Li, Yuanfeng; Cheung, Chui-Ming G.; Shi, Yi; Miyake, Masahiro; Lin, Yin; Gong, Bo; Liu, Xiaoqi; Sim, Kar-Seng; Yang, Jiyun; Mori, Keisuke; Zhang, Xiongzhe; Cackett, Peter D.; Tsujikawa, Motokazu; Nishida, Kohji; Hao, Fang; Ma, Shi; Lin, He; Cheng, Jing; Fei, Ping; Lai, Timothy Y. Y.; Tang, Sibo; Laude, Augustinus; Inoue, Satoshi; Yeo, Ian Y.; Sakurada, Yoichi; Zhou, Yu; Iijima, Hiroyuki; Honda, Shigeru; Lei, Chuntao; Zhang, Lin; Zheng, Hong; Jiang, Dan; Zhu, Xiong; Wong, Tien-Ying; Khor, Chiea-Chuen; Pang, Chi-Pui; Yoshimura, Nagahisa; Yang, Zhenglin			A missense variant in FGD6 confers increased risk of polypoidal choroidal vasculopathy	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; FACTOR-H GENE; NUCLEOTIDE EXCHANGE FACTOR; COMPLEMENT COMPONENT 2; MACULAR DEGENERATION; OXIDIZED PHOSPHOLIPIDS; DENSITY-LIPOPROTEIN; OXIDATIVE STRESS; POLYMORPHISM; SUSCEPTIBILITY	Polypoidal choroidal vasculopathy (PCV), a subtype of 'wet' age-related macular degeneration (AMD), constitutes up to 55% of cases of wet AMD in Asian patients. In contrast to the choroidal neovascularization (CNV) subtype, the genetic risk factors for PCV are relatively unknown. Exome sequencing analysis of a Han Chinese cohort followed by replication in four independent cohorts identified a rare c.986A>G (p.Lys329Arg) variant in the FGD6 gene as significantly associated with PCV (P = 2.19 x 10(-16), odds ratio (OR) = 2.12) but not with CNV (P = 0.26, OR = 1.13). The intracellular localization of FGD6-Arg329 is distinct from that of FGD6-Lys329. In vitro, FGD6 could regulate proangiogenic activity, and oxidized phospholipids increased expression of FGD6. FGD6-Arg329 promoted more abnormal vessel development in the mouse retina than FGD6-Lys329. Collectively, our data suggest that oxidized phospholipids and FGD6-Arg329 might act synergistically to increase susceptibility to PCV.	[Huang, Lulin; Zhang, Houbin; Tai, Zhengfu; Zhu, Xianjun; Cai, Li; Lu, Fang; Li, Yuanfeng; Shi, Yi; Lin, Yin; Gong, Bo; Liu, Xiaoqi; Yang, Jiyun; Hao, Fang; Ma, Shi; Lin, He; Cheng, Jing; Zhou, Yu; Zhang, Lin; Zheng, Hong; Jiang, Dan; Zhu, Xiong; Yang, Zhenglin] Univ Elect Sci & Technol China, Sch Med, Sichuan Acad Med Sci, Key Lab Human Dis Gene Study, Chengdu 610054, Peoples R China; [Huang, Lulin; Zhang, Houbin; Tai, Zhengfu; Zhu, Xianjun; Cai, Li; Lu, Fang; Li, Yuanfeng; Shi, Yi; Lin, Yin; Gong, Bo; Liu, Xiaoqi; Yang, Jiyun; Hao, Fang; Ma, Shi; Lin, He; Cheng, Jing; Zhou, Yu; Zhang, Lin; Zheng, Hong; Jiang, Dan; Zhu, Xiong; Yang, Zhenglin] Univ Elect Sci & Technol China, Sch Med, Sichuan Prov Peoples Hosp, Chengdu 610054, Peoples R China; [Huang, Lulin; Tai, Zhengfu; Yang, Zhenglin] Chinese Acad Sci, Inst Chengdu Biol, Chengdu, Peoples R China; [Huang, Lulin; Tai, Zhengfu; Yang, Zhenglin] Chinese Acad Sci, Sichuan Translat Med Hosp, Chengdu, Peoples R China; [Huang, Lulin; Zhang, Houbin; Tai, Zhengfu; Zhu, Xianjun; Shi, Yi; Lin, Yin; Zhang, Lin; Yang, Zhenglin] Univ Elect Sci & Technol China, Ctr Informat Biomed, Chengdu 610054, Peoples R China; [Cheng, Ching-Yu; Li, Zheng; Cheung, Chui-Ming G.; Cackett, Peter D.; Yeo, Ian Y.; Wong, Tien-Ying; Khor, Chiea-Chuen] Singapore Natl Eye Ctr, Singapore Eye Res Inst, Singapore, Singapore; [Cheng, Ching-Yu; Li, Zheng; Cheung, Chui-Ming G.; Wong, Tien-Ying; Khor, Chiea-Chuen] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117595, Singapore; [Cheng, Ching-Yu; Yeo, Ian Y.; Wong, Tien-Ying] Duke Natl Univ Singapore Grad Med Sch, Singapore, Singapore; [Wen, Feng; Tam, Pancy O. S.; Zhang, Xiongzhe; Tang, Sibo] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou, Peoples R China; [Zhao, Peiquan; Fei, Ping] Shanghai Jiao Tong Univ, Xinhua Hosp, Dept Ophthalmol, Shanghai, Peoples R China; [Chen, Haoyu; Chen, Weiqi] Shantou Univ, Joint Shantou Int Eye Ctr, Shantou, Peoples R China; [Chen, Haoyu; Chen, Weiqi] Chinese Univ Hong Kong, Shantou, Peoples R China; [Li, Zheng; Sim, Kar-Seng; Khor, Chiea-Chuen] Genome Inst Singapore, Dept Human Genet, Singapore, Singapore; [Chen, Lijia; Lai, Timothy Y. Y.; Pang, Chi-Pui] Chinese Univ Hong Kong, Dept Ophthalmol & Visual Sci, Hong Kong, Hong Kong, Peoples R China; [Yamashiro, Kenji; Miyake, Masahiro; Yoshimura, Nagahisa] Kyoto Univ, Grad Sch Med, Dept Ophthalmol & Visual Sci, Kyoto, Japan; [Deng, Shaoping; Mori, Keisuke] Saitama Med Univ, Dept Ophthalmol, Iruma, Saitama, Japan; [Cackett, Peter D.] Princess Alexandra Eye Pavil, Edinburgh, Midlothian, Scotland; [Tsujikawa, Motokazu; Nishida, Kohji] Osaka Univ, Sch Med, Dept Ophthalmol, Osaka, Japan; [Laude, Augustinus] Tan Tock Seng Hosp, Natl Hlth Care Grp Eye Inst, Singapore, Singapore; [Inoue, Satoshi] Saitama Med Univ, Res Ctr Genom Med, Div Gene Regulat & Signal Transduct, Saitama, Japan; [Sakurada, Yoichi; Honda, Shigeru] Kobe Univ, Grad Sch Med, Div Ophthalmol, Dept Surg, Kobe, Hyogo 657, Japan; [Iijima, Hiroyuki] Univ Yamanashi, Fac Med, Dept Ophthalmol, Yamanashi, Japan; [Lei, Chuntao] Sichuan Acad Med Sci, Dept Ophthalmol, Chengdu, Peoples R China; [Lei, Chuntao] Sichuan Prov Peoples Hosp, Chengdu, Peoples R China	Sichuan Provincial People's Hospital; University of Electronic Science & Technology of China; Sichuan Provincial People's Hospital; University of Electronic Science & Technology of China; Chinese Academy of Sciences; Chinese Academy of Sciences; University of Electronic Science & Technology of China; National University of Singapore; Singapore National Eye Center; National University of Singapore; Sun Yat Sen University; Shanghai Jiao Tong University; Shantou University; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Chinese University of Hong Kong; Kyoto University; Saitama Medical University; Osaka University; Tan Tock Seng Hospital; Saitama Medical University; Kobe University; University of Yamanashi; Sichuan Provincial People's Hospital; Sichuan Provincial People's Hospital	Yang, ZL (corresponding author), Univ Elect Sci & Technol China, Sch Med, Sichuan Acad Med Sci, Key Lab Human Dis Gene Study, Chengdu 610054, Peoples R China.; Yang, ZL (corresponding author), Univ Elect Sci & Technol China, Sch Med, Sichuan Prov Peoples Hosp, Chengdu 610054, Peoples R China.; Yang, ZL (corresponding author), Chinese Acad Sci, Inst Chengdu Biol, Chengdu, Peoples R China.; Yang, ZL (corresponding author), Chinese Acad Sci, Sichuan Translat Med Hosp, Chengdu, Peoples R China.; Yang, ZL (corresponding author), Univ Elect Sci & Technol China, Ctr Informat Biomed, Chengdu 610054, Peoples R China.	zliny@yahoo.com	KOSUGI, Shinji/GYR-2946-2022; Hao, Fang/GRJ-3165-2022; Chen, Haoyu/A-7432-2013; Miyake, Masahiro/V-1261-2019; Honda, Shigeru/W-4761-2019; Wong, Tien Yin/AAC-9724-2020; Chen, Li Jia/I-5078-2014; Yang, Jiyun/AAS-3937-2020; Lai, Timothy Y Y/AAC-2120-2020; Zhang, Houbin/A-8887-2012; Cheng, Ching-Yu/Y-2229-2019	Chen, Haoyu/0000-0003-0676-4610; Miyake, Masahiro/0000-0001-7410-3764; Wong, Tien Yin/0000-0002-8448-1264; Chen, Li Jia/0000-0003-3500-5840; Lai, Timothy Y Y/0000-0002-7832-6428; Cheng, Ching-Yu/0000-0003-0655-885X; Zhang, Houbin/0000-0002-2968-7454; Li, Zheng/0000-0002-7060-2213; Sim, Kar Seng/0000-0002-3822-7759; Nishida, Kohji/0000-0001-9069-3610; Zhu, Xianjun/0000-0002-2531-7552; Yamashiro, Kenji/0000-0001-9354-8558; Khor, Chiea Chuen/0000-0002-1128-4729; Cheung, Chui Ming Gemmy/0000-0003-3358-3516	National Natural Science Foundation of China [81170883, 81430008, 81200723, 81300802, 81170882, 81371030, 81271005]; Department of Science and Technology of Sichuan Province, China [2014SZ0169, 2015SZ0052, 2015SZ0060, 2016HH00X, 2015JQO057, 2014HH0009, 2014JZ0004]; General Research Fund, Hong Kong [467708, 468810]; National Medical Research Council, Singapore [NMRC/TCR/002-SERI/2008, R626/47/2008TCR, CSA R613/34/2008, NMRC 0796/2003, STaR/0003/2008]; National Research Foundation of Singapore, Biomedical Research Council, Singapore [BMRC 09/1/35/19/616, 08/1/35/19/550, 10/1/35/19/675]; Genome Institute of Singapore [GIS/12-AR2105]; National Medical Research Council (NMRC) [0796/2003, IRG07nov013, IRG09nov014, NMRC 1176/2008, NIG/1003/2009, CG/SERI/2010, CSA/033/2012]; Biomedical Research Council in Singapore [BMRC 08/1/35/19/550, 09/1/35/19/616, 10/1/35/19/671]; Bright Focus Foundation, USA [M2011068]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Department of Science and Technology of Sichuan Province, China; General Research Fund, Hong Kong; National Medical Research Council, Singapore(National Medical Research Council, SingaporeUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Research Foundation of Singapore, Biomedical Research Council, Singapore(National Research Foundation, Singapore); Genome Institute of Singapore; National Medical Research Council (NMRC)(National Medical Research Council, Singapore); Biomedical Research Council in Singapore(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Bright Focus Foundation, USA(BrightFocus Foundation)	We thank all the patients with AMD and their families for participating in this study. This work was carried out on behalf of the Genetics of AMD in Asians (GAMA) Consortium. This research project was supported by the National Natural Science Foundation of China (81170883, 81430008 (Z.Y.), 81200723 and 81300802 (L.H.), 81170882 (Y. Shi), 81371030 (H. Zhang), and 81271005 (Xianjun Zhu)); grants from the Department of Science and Technology of Sichuan Province, China (2014SZ0169, 2015SZ0052 (Z.Y.), 2015SZ0060 (Y.L.), 2016HH00X, 2015JQO057 (L.H.), 2014HH0009 (H. Zhang), and 2014JZ0004 (Y. Shi)); research grants 467708 and 468810 from the General Research Fund, Hong Kong; the National Medical Research Council, Singapore (NMRC/TCR/002-SERI/2008 (R626/47/2008TCR), CSA R613/34/2008, NMRC 0796/2003, and STaR/0003/2008); the National Research Foundation of Singapore, Biomedical Research Council, Singapore (BMRC 09/1/35/19/616, 08/1/35/19/550, and 10/1/35/19/675); and the Genome Institute of Singapore (GIS/12-AR2105). This research was also supported by the National Medical Research Council (NMRC grants 0796/2003, IRG07nov013, IRG09nov014, NMRC 1176/2008, NIG/1003/2009, CG/SERI/2010, and CSA/033/2012) and the Biomedical Research Council (BMRC 08/1/35/19/550, 09/1/35/19/616, and 10/1/35/19/671) in Singapore; the Bright Focus Foundation, USA (M2011068); and the National Medical Research Council, Singapore (CSA/033/2012).	Arakawa S, 2011, NAT GENET, V43, P1001, DOI 10.1038/ng.938; Berliner JA, 2005, NEW ENGL J MED, V353, P9, DOI 10.1056/NEJMp058118; Berliner JA, 2009, J LIPID RES, V50, pS207, DOI 10.1194/jlr.R800074-JLR200; Bochkov VN, 2006, CIRC RES, V99, P900, DOI 10.1161/01.RES.0000245485.04489.ee; Bonne C, 2000, J FR OPHTALMOL, V23, P835; Chen YH, 2014, NAT GENET, V46, P1115, DOI 10.1038/ng.3078; Cheng CY, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7063; Cheung CMG, 2011, NEW ENGL J MED, V365, P2237, DOI 10.1056/NEJMc1107895; Cheung CMG, 2012, CLIN EXP OPHTHALMOL, V40, P727, DOI 10.1111/j.1442-9071.2012.02765.x; Cheung CMG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101057; Coscas G, 2014, AM J OPHTHALMOL, V158, P309, DOI 10.1016/j.ajo.2014.05.004; Davila S, 2010, NAT GENET, V42, P772, DOI 10.1038/ng.640; Dewan A, 2006, SCIENCE, V314, P989, DOI 10.1126/science.1133807; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Fu WQ, 2013, NATURE, V493, P216, DOI 10.1038/nature11690; Garcia M, 2015, ACTA OPHTHALMOL, V93, pE658, DOI 10.1111/aos.12790; Gold B, 2006, NAT GENET, V38, P458, DOI 10.1038/ng1750; Gotoh N, 2006, HUM GENET, V120, P139, DOI 10.1007/s00439-006-0187-0; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Honda S, 2014, OPHTHALMOLOGICA, V231, P59, DOI 10.1159/000355488; Imamura Y, 2010, SURV OPHTHALMOL, V55, P501, DOI 10.1016/j.survophthal.2010.03.004; Japanese Study Group of Polypoidal Choroidal Vasculopathy, 2005, Nippon Ganka Gakkai Zasshi, V109, P417; Johnson RC, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-724; Kim SW, 2011, RETINA-J RET VIT DIS, V31, P1904, DOI 10.1097/IAE.0b013e31821801c5; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Kondo N, 2007, AM J OPHTHALMOL, V144, P608, DOI 10.1016/j.ajo.2007.06.003; Kondo N, 2009, OPHTHALMOLOGY, V116, P304, DOI 10.1016/j.ophtha.2008.11.011; Kurogane Y, 2012, ARTERIOSCL THROM VAS, V32, P988, DOI 10.1161/ATVBAHA.111.244004; Laude A, 2010, PROG RETIN EYE RES, V29, P19, DOI 10.1016/j.preteyeres.2009.10.001; Lavanya R, 2009, OPHTHAL EPIDEMIOL, V16, P325, DOI 10.3109/09286580903144738; Lee KY, 2008, INVEST OPHTH VIS SCI, V49, P2613, DOI 10.1167/iovs.07-0860; Lee S, 2012, CIRC RES, V111, P778, DOI 10.1161/CIRCRESAHA.111.256859; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lim LS, 2012, LANCET, V379, P1728, DOI 10.1016/S0140-6736(12)60282-7; Lim TH, 2010, EYE, V24, P483, DOI 10.1038/eye.2009.323; Lin JM, 2008, RETINA-J RET VIT DIS, V28, P1416, DOI 10.1097/IAE.0b013e318184661d; Liu K, 2014, OPHTHALMOLOGY, V121, P911, DOI 10.1016/j.ophtha.2013.10.042; Liu K, 2013, OPHTHALMOLOGY, V120, P837, DOI 10.1016/j.ophtha.2012.10.003; Lu F, 2013, INVEST OPHTH VIS SCI, V54, P2911, DOI 10.1167/iovs.12-11381; Marchini J, 2005, NAT GENET, V37, P413, DOI 10.1038/ng1537; Matsumiya W, 2011, J OPHTHALMOL, V2011, DOI 10.1155/2011/742020; McKay GJ, 2009, INVEST OPHTH VIS SCI, V50, P533, DOI 10.1167/iovs.08-2275; Miyamoto Y, 2003, J BIOL CHEM, V278, P29890, DOI 10.1074/jbc.M301559200; Moltke I, 2014, NATURE, V512, P190, DOI 10.1038/nature13425; Mookiah MRK, 2014, COMPUT BIOL MED, V53, P55, DOI 10.1016/j.compbiomed.2014.07.015; Mudvari SS, 2007, RETINA-J RET VIT DIS, V27, P1168, DOI 10.1097/IAE.0b013e318156db8a; Ng TK, 2008, INVEST OPHTH VIS SCI, V49, P3312, DOI 10.1167/iovs.07-1517; Oskolkova OV, 2008, BLOOD, V112, P330, DOI 10.1182/blood-2007-09-112870; Price AL, 2010, AM J HUM GENET, V86, P832, DOI 10.1016/j.ajhg.2010.04.005; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Purcell SM, 2014, NATURE, V506, P185, DOI 10.1038/nature12975; Romanoski CE, 2010, AM J HUM GENET, V86, P399, DOI 10.1016/j.ajhg.2010.02.002; Sakurada Y, 2011, OPHTHALMOLOGY, V118, P1402, DOI 10.1016/j.ophtha.2010.12.010; Shaw PX, 2012, P NATL ACAD SCI USA, V109, P13757, DOI 10.1073/pnas.1121309109; Sobrin L, 2012, OPHTHALMOLOGY, V119, P1874, DOI 10.1016/j.ophtha.2012.03.014; Steenblock C, 2014, J BIOL CHEM, V289, P18347, DOI 10.1074/jbc.M113.504894; Strange A, 2010, NAT GENET, V42, P985, DOI 10.1038/ng.694; Suzuki M, 2012, J CELL SCI, V125, P2407, DOI 10.1242/jcs.097683; Tang HY, 2014, NAT GENET, V46, P45, DOI 10.1038/ng.2827; Tiwari HK, 1997, GENET EPIDEMIOL, V14, P1131, DOI 10.1002/(SICI)1098-2272(1997)14:6<1131::AID-GEPI95>3.3.CO;2-7; Tual-Chalot S, 2013, JOVE-J VIS EXP, DOI 10.3791/50546; Wang CL, 2014, NAT GENET, V46, P409, DOI 10.1038/ng.2924; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Watson AD, 1997, J BIOL CHEM, V272, P13597, DOI 10.1074/jbc.272.21.13597; Weismann D, 2011, NATURE, V478, P76, DOI 10.1038/nature10449; Wong R, 2004, EYE, V18, P262, DOI 10.1038/sj.eye.6700637; Wong WL, 2014, LANCET GLOB HEALTH, V2, pE106, DOI 10.1016/S2214-109X(13)70145-1; Wu ZH, 2007, J BIOL CHEM, V282, P22414, DOI 10.1074/jbc.M702321200; Yang ZL, 2006, SCIENCE, V314, P992, DOI 10.1126/science.1133811; YANNUZZI LA, 1990, RETINA-J RET VIT DIS, V10, P1, DOI 10.1097/00006982-199001010-00001; Yannuzzi LA, 2000, OPHTHALMOLOGY, V107, P767, DOI 10.1016/S0161-6420(99)00173-6; Zhao JY, 2006, AM J HUM GENET, V79, P831, DOI 10.1086/508571; [No title captured]	75	47	56	2	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2016	48	6					640	+		10.1038/ng.3546	http://dx.doi.org/10.1038/ng.3546			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DN0HE	27089177				2022-12-25	WOS:000376744200011
J	Pozzi, C; Cuomo, A; Spadoni, I; Magni, E; Silvola, A; Conte, A; Sigismund, S; Ravenda, PS; Bonaldi, T; Zampino, MG; Cancelliere, C; Di Fiore, PP; Bardelli, A; Penna, G; Rescigno, M				Pozzi, Chiara; Cuomo, Alessandro; Spadoni, Ilaria; Magni, Elena; Silvola, Alessio; Conte, Alexia; Sigismund, Sara; Ravenda, Paola Simona; Bonaldi, Tiziana; Zampino, Maria Giulia; Cancelliere, Carlotta; Di Fiore, Pier Paolo; Bardelli, Alberto; Penna, Giuseppe; Rescigno, Maria			The EGFR-specific antibody cetuximab combined with chemotherapy triggers immunogenic cell death	NATURE MEDICINE			English	Article							METASTATIC COLORECTAL-CANCER; 1ST-LINE TREATMENT; BRAF MUTATION; CALRETICULIN EXPOSURE; ENDOPLASMIC-RETICULUM; PLUS IRINOTECAN; POOLED ANALYSIS; COLON-CANCER; KRAS; EFFICACY	Cetuximab is a monoclonal antibody that is effective in the treatment of metastatic colorectal cancer (mCRC). Cetuximab blocks epidermal growth factor receptor (EGFR)-ligand interaction and inhibits downstream RAS-ERK activation. However, only some activating mutations in RAS affect cetuximab efficacy, and it is not clear what else mediates treatment success. Here we hypothesized that cetuximab induces immunogenic cell death (ICD) that activates a potent antitumor response. We found that cetuximab, in combination with chemotherapy, fostered ICD in CRC cells, which we measured via the endoplasmic reticulum (ER) stress response and an increase in phagocytosis by dendritic cells. ICD induction depended on the mutational status of the EGFR signaling pathway and on the inhibition of the splicing of X-box binding protein 1 (XBP1), an unfolded protein response (UPR) mediator. We confirmed the enhanced immunogenicity elicited by cetuximab in a mouse model of human EGFR-expressing CRC. Overall, we demonstrate a new, immune-related mechanism of action of cetuximab that may help to tailor personalized medicine.	[Pozzi, Chiara; Cuomo, Alessandro; Spadoni, Ilaria; Silvola, Alessio; Bonaldi, Tiziana; Di Fiore, Pier Paolo; Penna, Giuseppe; Rescigno, Maria] European Inst Oncol, Dept Expt Oncol, Milan, Italy; [Magni, Elena; Ravenda, Paola Simona; Zampino, Maria Giulia] European Inst Oncol, Div Med Oncol, Unit Gastrointestinal & Neuroendocrine Tumors, Milan, Italy; [Conte, Alexia; Sigismund, Sara; Di Fiore, Pier Paolo; Bardelli, Alberto] Fdn Ist FIRC Fdn Italiana Ric Canc Oncol Mol, IFOM, Milan, Italy; [Cancelliere, Carlotta] FPO, IRCCS, Candiolo Canc Inst, Candiolo, Italy; [Di Fiore, Pier Paolo; Rescigno, Maria] Univ Milan, Dept Oncol & Hematooncol, Milan, Italy; [Bardelli, Alberto] Univ Turin, Dept Oncol, Turin, Italy	IRCCS European Institute of Oncology (IEO); IRCCS European Institute of Oncology (IEO); IFOM - FIRC Institute of Molecular Oncology; IRCCS Fondazione del Piemonte per l'Oncologia; University of Milan; University of Turin	Rescigno, M (corresponding author), European Inst Oncol, Dept Expt Oncol, Milan, Italy.; Rescigno, M (corresponding author), Univ Milan, Dept Oncol & Hematooncol, Milan, Italy.	maria.rescigno@ieo.eu	Penna, Giuseppe/AAB-8784-2019; Sigismund, Sara/H-3687-2017; Ravenda, Paola Simona/AAC-2048-2019; Zampino, Maria Giulia/AAQ-4795-2020; Di Fiore, Pier Paolo/K-2130-2012; Pozzi, Chiara/K-4481-2018; cuomo, alessandro/AAB-7372-2019; Spadoni, Ilaria/K-1054-2018; BARDELLI, Alberto/J-9721-2018; Rescigno, Maria/J-9704-2012; Bonaldi, Tiziana/K-5075-2016	Penna, Giuseppe/0000-0003-3534-7090; Sigismund, Sara/0000-0002-1396-4453; Zampino, Maria Giulia/0000-0001-5142-1778; Di Fiore, Pier Paolo/0000-0002-2252-0950; Pozzi, Chiara/0000-0003-2153-6130; BARDELLI, Alberto/0000-0003-1647-5070; Cuomo, Alessandro/0000-0002-9778-7190; Rescigno, Maria/0000-0002-6464-509X; Spadoni, Ilaria/0000-0002-1067-0695; Bonaldi, Tiziana/0000-0003-3556-1265	Italian Association for Cancer Research (AIRC) [IG11863]; Italian Ministry of Health [RF-2011-02348920]	Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); Italian Ministry of Health(Ministry of Health, Italy)	This work has been funded by grants of the Italian Association for Cancer Research (AIRC) (IG11863 to M.R.) and the Italian Ministry of Health (Ricerca finalizzata) (RF-2011-02348920 to M.R.). We thank S. Chiocca for editing the manuscript.	Arteaga CL, 2014, CANCER CELL, V25, P282, DOI 10.1016/j.ccr.2014.02.025; Bokemeyer C, 2011, ANN ONCOL, V22, P1535, DOI 10.1093/annonc/mdq632; Bokemeyer C, 2012, EUR J CANCER, V48, P1466, DOI 10.1016/j.ejca.2012.02.057; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cunningham D, 2004, NEW ENGL J MED, V351, P337, DOI 10.1056/NEJMoa033025; Di Nicolantonio F, 2008, J CLIN ONCOL, V26, P5705, DOI 10.1200/JCO.2008.18.0786; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Elias JE, 2010, METHODS MOL BIOL, V604, P55, DOI 10.1007/978-1-60761-444-9_5; Fakih MG, 2015, J CLIN ONCOL, V33, P1809, DOI 10.1200/JCO.2014.59.7633; Galluzzi L, 2012, NAT REV DRUG DISCOV, V11, P215, DOI 10.1038/nrd3626; Garrido G, 2011, J IMMUNOL, V187, P4954, DOI 10.4049/jimmunol.1003477; Karapetis CS, 2014, CLIN CANCER RES, V20, P744, DOI 10.1158/1078-0432.CCR-13-0606; Kato H, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00093; Kepp O, 2014, ONCOIMMUNOLOGY, V3, DOI 10.4161/21624011.2014.955691; Kishiki T, 2014, ONCOL REP, V32, P57, DOI 10.3892/or.2014.3179; Lamba S, 2014, CELL REP, V8, P1475, DOI 10.1016/j.celrep.2014.07.033; Licitra L, 2013, EUR J CANCER, V49, P1161, DOI 10.1016/j.ejca.2012.11.018; Modest DP, 2012, ONCOLOGY-BASEL, V83, P241, DOI 10.1159/000339534; Obeid M, 2008, J IMMUNOL, V181, P2533, DOI 10.4049/jimmunol.181.4.2533; Olsen JV, 2009, MOL CELL PROTEOMICS, V8, P2759, DOI 10.1074/mcp.M900375-MCP200; Panaretakis T, 2009, EMBO J, V28, P578, DOI 10.1038/emboj.2009.1; Peeters M, 2012, CANCER TREAT REV, V38, P397, DOI 10.1016/j.ctrv.2011.08.002; Pietrantonio F, 2015, EUR J CANCER, V51, P587, DOI 10.1016/j.ejca.2015.01.054; Prenen H, 2009, CLIN CANCER RES, V15, P3184, DOI 10.1158/1078-0432.CCR-08-2961; Price TJ, 2014, LANCET ONCOL, V15, P569, DOI 10.1016/S1470-2045(14)70118-4; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Rimoldi M, 2005, BLOOD, V106, P2818, DOI 10.1182/blood-2004-11-4321; Sahin IH, 2013, J CANCER, V4, P320, DOI 10.7150/jca.3619; Samowitz WS, 2006, J NATL CANCER I, V98, P1731, DOI 10.1093/jnci/djj468; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Sigismund S, 2013, EMBO J, V32, P2140, DOI 10.1038/emboj.2013.149; Sorich MJ, 2015, ANN ONCOL, V26, P13, DOI 10.1093/annonc/mdu378; Tesniere A, 2010, ONCOGENE, V29, P482, DOI 10.1038/onc.2009.356; Tol J, 2009, NEW ENGL J MED, V361, P98, DOI 10.1056/NEJMc0904160; Tyanova S, 2014, METHODS MOL BIOL, V1188, P351, DOI 10.1007/978-1-4939-1142-4_24; Vacchelli E, 2014, ONCOIMMUNOLOGY, V3, DOI [10.4161/onci.27048, 10.4161/onci.27878]; Van Cutsem E, 2011, J CLIN ONCOL, V29, P2011, DOI 10.1200/JCO.2010.33.5091; Van Cutsem E, 2009, NEW ENGL J MED, V360, P1408, DOI 10.1056/NEJMoa0805019; Wang M, 2014, NAT REV CANCER, V14, P581, DOI 10.1038/nrc3800; Zitvogel L, 2010, CLIN CANCER RES, V16, P3100, DOI 10.1158/1078-0432.CCR-09-2891	40	157	158	0	62	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2016	22	6					624	+		10.1038/nm.4078	http://dx.doi.org/10.1038/nm.4078			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DO0NQ	27135741				2022-12-25	WOS:000377476000019
J	Souroullas, GP; Jeck, WR; Parker, JS; Simon, JM; Liu, JY; Paulk, J; Xiong, J; Clark, KS; Fedoriw, Y; Qi, J; Burd, CE; Bradner, JE; Sharpless, NE				Souroullas, George P.; Jeck, William R.; Parker, Joel S.; Simon, Jeremy M.; Liu, Jie-Yu; Paulk, Joshiawa; Xiong, Jessie; Clark, Kelly S.; Fedoriw, Yuri; Qi, Jun; Burd, Christin E.; Bradner, James E.; Sharpless, Norman E.			An oncogenic Ezh2 mutation induces tumors through global redistribution of histone 3 lysine 27 trimethylation	NATURE MEDICINE			English	Article							POLYCOMB-GROUP GENES; SOMATIC MUTATIONS; PROTEIN EZH2; MOUSE MODEL; CELL; LYMPHOMA; EXPRESSION; MYC; H3; HYPERTRIMETHYLATION	B cell lymphoma and melanoma harbor recurrent mutations in the gene encoding the EZH2 histone methyltransferase (EZH2), but the carcinogenic role of these mutations is unclear. Here we describe a mouse model in which the most common somatic Ezh2 gain-of-function mutation (EZH2(Y646F) in human; Ezh2(Y641F) in mouse) is conditionally expressed. Expression of Ezh2(Y641F) in mouse B cells or melanocytes caused high-penetrance lymphoma or melanoma, respectively. Overexpression of the anti-apoptotic protein Bcl2, but not the oncoprotein Myc, or loss of the tumor suppressor protein p53 (encoded by Trp53 in mice) further accelerated lymphoma progression. Expression of the mutant Braf but not the mutant Nras oncoprotein further accelerated melanoma progression. Although expression of Ezh2(Y641F) globally increased the abundance of trimethylated Lys27 of histone H3 (H3K27me3), it also caused a widespread redistribution of this repressive mark, including a loss of H3K27me3 that was associated with increased transcription at many loci. These results suggest that Ezh2(Y641F) induces lymphoma and melanoma through a vast reorganization of chromatin structure, inducing both repression and activation of polycomb-regulated loci.	[Souroullas, George P.; Jeck, William R.; Simon, Jeremy M.; Liu, Jie-Yu; Sharpless, Norman E.] Univ N Carolina, Sch Med, Dept Genet, Chapel Hill, NC USA; [Souroullas, George P.; Jeck, William R.; Simon, Jeremy M.; Liu, Jie-Yu; Xiong, Jessie; Clark, Kelly S.; Fedoriw, Yuri; Sharpless, Norman E.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Sch Med, Chapel Hill, NC 27599 USA; [Paulk, Joshiawa; Qi, Jun; Bradner, James E.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, 44 Binney St, Boston, MA 02115 USA; [Fedoriw, Yuri] Univ N Carolina, Sch Med, Dept Pathol & Lab Med, Chapel Hill, NC USA; [Burd, Christin E.] Ohio State Univ, Dept Mol Genet, Columbus, OH 43210 USA; [Burd, Christin E.] Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Bradner, James E.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Sharpless, Norman E.] Univ N Carolina, Sch Med, Dept Med, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Harvard University; Harvard Medical School; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Sharpless, NE (corresponding author), Univ N Carolina, Sch Med, Dept Genet, Chapel Hill, NC USA.; Sharpless, NE (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Sch Med, Chapel Hill, NC 27599 USA.; Sharpless, NE (corresponding author), Univ N Carolina, Sch Med, Dept Med, Chapel Hill, NC USA.	nes@med.unc.edu	Ariel, Pablo/AGJ-4118-2022; , Pathology Services Core/CEZ-2246-2022; , UNC Flow Cytometry Core/AGU-9839-2022; Parker, Joel/AAG-1108-2019	Sharpless, Norman/0000-0001-7078-9455; Souroullas, George P./0000-0003-2196-8662	US National Cancer Institute [R01-CA163896, CA185353, T32-CA009156]; US National Institute of Aging [R01-AG024379]; US National Heart, Lung and Blood Institute [F32-HL117581]; NATIONAL CANCER INSTITUTE [R01CA185353, P01CA142106, P30CA016086, P30CA016058, T32CA009156, R01CA163896] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL117581] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG024379] Funding Source: NIH RePORTER	US National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); US National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); US National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank the UNC Lineberger Animal Histopathology Core, Flow Cytometry Core, Animal Models Core and Microscopy Services Laboratory for technical assistance, and the Mouse Phase 1 Unit (D. Darr and J. Roques) for providing animals and expertise. This work was supported by the US National Cancer Institute grants R01-CA163896 (N.E.S.), CA185353 (N.E.S.) and T32-CA009156 (G.P.S.), the US National Institute of Aging grant R01-AG024379 (N.E.S.) and the US National Heart, Lung and Blood Institute grant F32-HL117581 (G.P.S.).	Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Beguelin W, 2013, CANCER CELL, V23, P677, DOI 10.1016/j.ccr.2013.04.011; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bitler BG, 2015, NAT MED, V21, P231, DOI 10.1038/nm.3799; Bosenberg M, 2006, GENESIS, V44, P262, DOI 10.1002/dvg.20205; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Boylan KLM, 2007, CANCER RES, V67, P4069, DOI 10.1158/0008-5472.CAN-06-3699; Bracken AP, 2007, GENE DEV, V21, P525, DOI 10.1101/gad.415507; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Burd CE, 2014, CANCER DISCOV, V4, P1418, DOI 10.1158/2159-8290.CD-14-0729; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chen HA, 2009, GENE DEV, V23, P975, DOI 10.1101/gad.1742509; Dankort D, 2007, GENE DEV, V21, P379, DOI 10.1101/gad.1516407; Dankort D, 2009, NAT GENET, V41, P544, DOI 10.1038/ng.356; Forbes S, 2006, BRIT J CANCER, V94, P318, DOI 10.1038/sj.bjc.6602928; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Jiao LY, 2015, SCIENCE, V350, DOI 10.1126/science.aac4383; Kamminga LM, 2006, BLOOD, V107, P2170, DOI 10.1182/blood-2005-09-3585; Knutson SK, 2013, P NATL ACAD SCI USA, V110, P7922, DOI 10.1073/pnas.1303800110; Kondo Y, 2008, NAT GENET, V40, P741, DOI 10.1038/ng.159; Konze KD, 2013, ACS CHEM BIOL, V8, P1324, DOI [10.1021/cb400133J, 10.1021/cb400133j]; Kotake Y, 2007, GENE DEV, V21, P49, DOI 10.1101/gad.1499407; Krauthammer M, 2012, NAT GENET, V44, P1006, DOI 10.1038/ng.2359; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; LaFave LM, 2015, NAT MED, V21, P1344, DOI 10.1038/nm.3947; Lessard J, 1999, GENE DEV, V13, P2691, DOI 10.1101/gad.13.20.2691; Lohr JG, 2012, P NATL ACAD SCI USA, V109, P3879, DOI 10.1073/pnas.1121343109; McCabe MT, 2012, NATURE, V492, P108, DOI 10.1038/nature11606; McCabe MT, 2012, P NATL ACAD SCI USA, V109, P2989, DOI 10.1073/pnas.1116418109; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Monahan KB, 2010, ONCOGENE, V29, P5809, DOI 10.1038/onc.2010.314; Mori S, 2008, CANCER RES, V68, P8525, DOI 10.1158/0008-5472.CAN-08-1329; Morin RD, 2011, NATURE, V476, P298, DOI 10.1038/nature10351; Morin RD, 2010, NAT GENET, V42, P181, DOI 10.1038/ng.518; Nikoloski G, 2010, NAT GENET, V42, P665, DOI 10.1038/ng.620; Ntziachristos P, 2012, NAT MED, V18, P298, DOI 10.1038/nm.2651; Pajic A, 2000, INT J CANCER, V87, P787, DOI 10.1002/1097-0215(20000915)87:6<787::AID-IJC4>3.0.CO;2-6; Pasqualucci L, 2008, NAT GENET, V40, P108, DOI 10.1038/ng.2007.35; Pasqualucci L, 2011, NATURE, V471, P189, DOI 10.1038/nature09730; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Raaphorst FM, 2000, AM J PATHOL, V157, P709, DOI 10.1016/S0002-9440(10)64583-X; Rickert RC, 1997, NUCLEIC ACIDS RES, V25, P1317, DOI 10.1093/nar/25.6.1317; Sander S, 2008, BLOOD, V112, P4202, DOI 10.1182/blood-2008-03-147645; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Sneeringer CJ, 2010, P NATL ACAD SCI USA, V107, P20980, DOI 10.1073/pnas.1012525107; Su IH, 2003, NAT IMMUNOL, V4, P124, DOI 10.1038/ni876; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; VANDERLUGT NMT, 1994, GENE DEV, V8, P757, DOI 10.1101/gad.8.7.757; Visser HPJ, 2001, BRIT J HAEMATOL, V112, P950, DOI 10.1046/j.1365-2141.2001.02641.x; Yap DB, 2011, BLOOD, V117, P2451, DOI 10.1182/blood-2010-11-321208; Young MD, 2011, NUCLEIC ACIDS RES, V39, P7415, DOI 10.1093/nar/gkr416; Zhang XW, 2012, CANCER CELL, V22, P506, DOI 10.1016/j.ccr.2012.09.003; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zuo T, 2011, CANCER RES, V71, P1752, DOI 10.1158/0008-5472.CAN-10-3573	56	133	136	0	16	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	JUN	2016	22	6					632	+		10.1038/nm.4092	http://dx.doi.org/10.1038/nm.4092			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DO0NQ	27135738	Green Submitted, Green Accepted			2022-12-25	WOS:000377476000020
J	Wang, JW; Morita, Y; Han, B; Niemann, S; Loffler, B; Rudolph, KL				Wang, Jianwei; Morita, Yohei; Han, Bing; Niemann, Silke; Loeffler, Bettina; Rudolph, K. Lenhard			Per2 induction limits lymphoid-biased haematopoietic stem cells and lymphopoiesis in the context of DNA damage and ageing	NATURE CELL BIOLOGY			English	Article							TELOMERE DYSFUNCTION; SELF-RENEWAL; LIFE-SPAN; MICE; DIFFERENTIATION; DISEASE; STRESS; PHOSPHORYLATION; MAINTENANCE; DEFICIENT	Ageing-associated impairments in haemato-lymphopoiesis are associated with DNA damage accumulation and reduced maintenance of lymphoid-biased (Ly-biased) compared with myeloid-biased (My-biased) haematopoietic stem cells (HSCs). Here, in vivo RNAi screening identifies period circadian clock 2 (Per2) as a critical factor limiting the maintenance of HSCs in response to DNA damage and ageing. Under these conditions, Per2 is activated predominantly in Ly-biased HSCs and stimulates DNA damage signalling and p53-dependent apoptosis in haematopoietic cells. Per2 deletion ameliorates replication stress and DNA damage responses in haematopoietic cells, thereby improving the maintenance of Ly-biased HSCs, lymphopoiesis, and immune function in ageing mice without increasing the accumulation of DNA damage. Per2-deficient mice retain Batf/p53-dependent induction of differentiation of HSCs in response to DNA damage and exhibit an elongated lifespan. Together, these results identify Per2 as a negative regulator of Ly-biased HSCs and immune functions in response to DNA damage and ageing.	[Wang, Jianwei; Morita, Yohei; Han, Bing; Rudolph, K. Lenhard] FLI, Leibniz Inst Aging, Res Grp Stem Cell Aging, Beutenbergstr 11, D-07745 Jena, Germany; [Niemann, Silke] Univ Hosp Munster, Inst Med Microbiol, Domagkstr 10, D-48149 Munster, Germany; [Loeffler, Bettina] Jena Univ Hosp UKJ, Inst Med Microbiol, D-07747 Jena, Germany; [Rudolph, K. Lenhard] Univ Jena, Res Grp Mol Aging, Fac Med, D-07745 Jena, Germany; [Wang, Jianwei] Tsinghua Univ, Inst Stem Cell Biol & Regenerat Med, Beijing 100084, Peoples R China	Friedrich Loeffler Institute; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); University of Munster; Friedrich Schiller University of Jena; Tsinghua University	Rudolph, KL (corresponding author), FLI, Leibniz Inst Aging, Res Grp Stem Cell Aging, Beutenbergstr 11, D-07745 Jena, Germany.; Rudolph, KL (corresponding author), Univ Jena, Res Grp Mol Aging, Fac Med, D-07745 Jena, Germany.	Lenhard.Rudolph@Leibniz-FLI.de	Morita, Yohei/N-1260-2014	Morita, Yohei/0000-0003-4163-5080; Rudolph, Karl Lenhard/0000-0002-4839-2862	European Union (advanced ERC grant) [323136]; e:Med program (HaematoOpt) of the German Federal Ministry of Education and Research (BMBF); German Research Foundation [DFG-RU745-10]; Baden-Wurttemberg-Stiftung [P1301029]; Leibniz association; State of Thuringia [FZ-12001-514]	European Union (advanced ERC grant); e:Med program (HaematoOpt) of the German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); German Research Foundation(German Research Foundation (DFG)); Baden-Wurttemberg-Stiftung; Leibniz association; State of Thuringia	This work was supported by the European Union (advanced ERC grant to K.L.R., grant 323136-StemCellGerontoGenes), within the e:Med program (HaematoOpt) of the German Federal Ministry of Education and Research (BMBF), the German Research Foundation (DFG-RU745-10), the Baden-Wurttemberg-Stiftung (P1301029), the Leibniz association, and the State of Thuringia (FZ-12001-514). We thank Z.-Q. Wang from the Leibniz Institute on Aging for supplying ATM-deficient mice.	Alsadeq A, 2014, J IMMUNOL, V193, P268, DOI 10.4049/jimmunol.1203040; Beerman I, 2014, CELL STEM CELL, V15, P37, DOI 10.1016/j.stem.2014.04.016; Beerman I, 2013, CELL STEM CELL, V12, P413, DOI 10.1016/j.stem.2013.01.017; Beerman I, 2010, P NATL ACAD SCI USA, V107, P5465, DOI 10.1073/pnas.1000834107; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Calado RT, 2008, BLOOD, V111, P4446, DOI 10.1182/blood-2007-08-019729; Chin L, 1999, CELL, V97, P527, DOI 10.1016/S0092-8674(00)80762-X; Cho RH, 2008, BLOOD, V111, P5553, DOI 10.1182/blood-2007-11-123547; Choudhury AR, 2007, NAT GENET, V39, P99, DOI 10.1038/ng1937; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Flach J, 2014, NATURE, V512, P198, DOI 10.1038/nature13619; Frasca D, 2003, J IMMUNOL, V170, P719, DOI 10.4049/jimmunol.170.2.719; Fu LN, 2002, CELL, V111, P41, DOI 10.1016/S0092-8674(02)00961-3; Gazit R, 2008, SEMIN HEMATOL, V45, P218, DOI 10.1053/j.seminhematol.2008.07.010; Geiger H, 2005, P NATL ACAD SCI USA, V102, P5102, DOI 10.1073/pnas.0408654102; Geiger H, 2009, TRENDS IMMUNOL, V30, P360, DOI 10.1016/j.it.2009.03.010; Hayashi EA, 2005, J IMMUNOL, V174, P6639, DOI 10.4049/jimmunol.174.11.6639; Herrera E, 1999, EMBO J, V18, P2950, DOI 10.1093/emboj/18.11.2950; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Ito K, 2006, NAT MED, V12, P446, DOI 10.1038/nm1388; Ito K, 2004, NATURE, V431, P997, DOI 10.1038/nature02989; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Ju ZY, 2007, NAT MED, V13, P742, DOI 10.1038/nm1578; Kaufmann C, 2003, EMBO J, V22, P2211, DOI 10.1093/emboj/cdg186; KOPF M, 1994, NATURE, V368, P339, DOI 10.1038/368339a0; Lee S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010995; Limnander A, 2011, NAT IMMUNOL, V12, P425, DOI 10.1038/ni.2016; Linton PJ, 2004, NAT IMMUNOL, V5, P133, DOI 10.1038/ni1033; Miller JP, 2003, J IMMUNOL, V171, P2326, DOI 10.4049/jimmunol.171.5.2326; Minegishi Y, 1999, SCIENCE, V286, P1954, DOI 10.1126/science.286.5446.1954; Morrison SJ, 1996, NAT MED, V2, P1011, DOI 10.1038/nm0996-1011; Nippe N, 2011, J INVEST DERMATOL, V131, P125, DOI 10.1038/jid.2010.282; Nurieva R, 2007, NATURE, V448, P480, DOI 10.1038/nature05969; OHYASHIKI JH, 1994, CANCER RES, V54, P3557; Pang WW, 2011, P NATL ACAD SCI USA, V108, P20012, DOI 10.1073/pnas.1116110108; Pasqualucci L, 2006, J EXP MED, V203, P311, DOI 10.1084/jem.20052204; Puel A, 1998, NAT GENET, V20, P394, DOI 10.1038/3877; Rossi DJ, 2007, NATURE, V447, P725, DOI 10.1038/nature05862; Rossi DJ, 2005, P NATL ACAD SCI USA, V102, P9194, DOI 10.1073/pnas.0503280102; Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2; Rube CE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017487; Sangoram AM, 1998, NEURON, V21, P1101, DOI 10.1016/S0896-6273(00)80627-3; Santos MA, 2014, NATURE, V514, P107, DOI 10.1038/nature13483; Setoguchi R, 2005, J EXP MED, V201, P723, DOI 10.1084/jem.20041982; Shao RG, 1999, EMBO J, V18, P1397, DOI 10.1093/emboj/18.5.1397; Simard N, 2011, J IMMUNOL, V186, P5244, DOI 10.4049/jimmunol.1004040; Song ZF, 2010, BLOOD, V115, P1481, DOI 10.1182/blood-2009-08-237230; Sudo K, 2000, J EXP MED, V192, P1273, DOI 10.1084/jem.192.9.1273; Toh KL, 2001, SCIENCE, V291, P1040, DOI 10.1126/science.1057499; Vassin VM, 2009, J CELL SCI, V122, P4070, DOI 10.1242/jcs.053702; VAZIRI H, 1994, P NATL ACAD SCI USA, V91, P9857, DOI 10.1073/pnas.91.21.9857; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Vidarsson G, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00520; Walter D, 2015, NATURE, V520, P549, DOI 10.1038/nature14131; Wang JW, 2012, CELL, V148, P1001, DOI 10.1016/j.cell.2012.01.040; Wang JW, 2011, CURR OPIN IMMUNOL, V23, P532, DOI 10.1016/j.coi.2011.05.004; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	57	37	38	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAY	2016	18	5					480	+		10.1038/ncb3342	http://dx.doi.org/10.1038/ncb3342			21	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	DK3RH	27088856				2022-12-25	WOS:000374834600006
J	Wang, JJ; Zou, JX; Xue, XQ; Cai, DM; Zhang, Y; Duan, ZJ; Xiang, QP; Yang, JC; Louie, MC; Borowsky, AD; Gao, AC; Evans, CP; Lam, KS; Xu, JZ; Kung, HJ; Evans, RM; Xu, Y; Chen, HW				Wang, Junjian; Zou, June X.; Xue, Xiaoqian; Cai, Demin; Zhang, Yan; Duan, Zhijian; Xiang, Qiuping; Yang, Joy C.; Louie, Maggie C.; Borowsky, Alexander D.; Gao, Allen C.; Evans, Christopher P.; Lam, Kit S.; Xu, Jianzhen; Kung, Hsing-Jien; Evans, Ronald M.; Xu, Yong; Chen, Hong-Wu			ROR-gamma drives androgen receptor expression and represents a therapeutic target in castration-resistant prostate cancer	NATURE MEDICINE			English	Article							NUCLEAR RECEPTORS; SMALL-MOLECULE; NETWORK; IDENTIFICATION; ENZALUTAMIDE; DEGRADATION; COACTIVATOR; DISCOVERY; VARIANTS; BINDING	The androgen receptor (AR) is overexpressed and hyperactivated in human castration-resistant prostate cancer (CRPC). However, the determinants of AR overexpression in CRPC are poorly defined. Here we show that retinoic acid receptor-related orphan receptor gamma (ROR-gamma) is overexpressed and amplified in metastatic CRPC tumors, and that ROR-gamma drives AR expression in the tumors. ROR-gamma recruits nuclear receptor coactivator 1 and 3 (NCOA1 and NCOA3, also known as SRC-1 and SRC-3) to an AR-ROR response element (RORE) to stimulate AR gene transcription. ROR-gamma antagonists suppress the expression of both AR and its variant AR-V7 in prostate cancer (PCa) cell lines and tumors. ROR-gamma antagonists also markedly diminish genome-wide AR binding, H3K27ac abundance and expression of the AR target gene network. Finally, ROR-gamma antagonists suppressed tumor growth in multiple AR-expressing, but not AR-negative, xenograft PCa models, and they effectively sensitized CRPC tumors to enzalutamide, without overt toxicity, in mice. Taken together, these results establish ROR-gamma as a key player in CRPC by acting upstream of AR and as a potential therapeutic target for advanced PCa.	[Wang, Junjian; Zou, June X.; Cai, Demin; Duan, Zhijian; Lam, Kit S.; Kung, Hsing-Jien; Chen, Hong-Wu] Univ Calif Davis, Sch Med, Dept Biochem & Mol Med, Sacramento, CA 95817 USA; [Xue, Xiaoqian; Zhang, Yan; Xiang, Qiuping; Xu, Yong] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Inst Chem Biol, Guangzhou, Guangdong, Peoples R China; [Yang, Joy C.; Gao, Allen C.; Evans, Christopher P.] Univ Calif Davis, Sch Med, Dept Urol, Sacramento, CA 95817 USA; [Louie, Maggie C.] Dominican Univ Calif, Dept Nat Sci & Math, San Rafael, CA USA; [Borowsky, Alexander D.] Univ Calif Davis, Sch Med, Dept Pathol & Lab Med, Sacramento, CA 95817 USA; [Gao, Allen C.; Evans, Christopher P.; Lam, Kit S.; Kung, Hsing-Jien; Chen, Hong-Wu] Univ Calif Davis, Ctr Comprehens Canc, Sacramento, CA 95817 USA; [Xu, Jianzhen] Shantou Univ, Coll Med, Shantou, Peoples R China; [Evans, Ronald M.] Salk Inst Biol Studies, Howard Hughes Med Inst, Gene Express Lab, La Jolla, CA USA; [Chen, Hong-Wu] Vet Affairs Northern Calif Hlth Care Syst Mather, Mather, CA USA	University of California System; University of California Davis; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; Shantou University; Howard Hughes Medical Institute; Salk Institute	Chen, HW (corresponding author), Univ Calif Davis, Sch Med, Dept Biochem & Mol Med, Sacramento, CA 95817 USA.; Xu, Y (corresponding author), Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Inst Chem Biol, Guangzhou, Guangdong, Peoples R China.; Chen, HW (corresponding author), Univ Calif Davis, Ctr Comprehens Canc, Sacramento, CA 95817 USA.; Chen, HW (corresponding author), Vet Affairs Northern Calif Hlth Care Syst Mather, Mather, CA USA.	xu_yong@gibh.ac.cn; hwzchen@ucdavis.edu	Evans, Ronald/AAF-4001-2019; Wang, Junjian/S-5574-2019; Borowsky, Alexander D/S-5404-2017; Cai, Demin/AAT-7742-2021; Xu, Jianzhen/G-2456-2011	Evans, Ronald/0000-0002-9986-5965; Cai, Demin/0000-0003-0500-5292; Xu, Jianzhen/0000-0002-0697-9075; Wang, Junjian/0000-0002-5328-2908	University of California, Davis, Research Office; US National Institutes of Health (NIH) [R01CA206222]; US Department of Veterans Affairs; Office of Biomedical Laboratory Research and Development Service [I01BX002237]; Chinese Academy of Sciences; National Natural Science Foundation; Guangzhou Healthcare Collaborative Innovation Programs; Key Basic Research Program of China [81373325, 20150820225]; Key Basic Research Program of China (973 program) [2013CB910601]; Howard Hughes Medical Institute; NIH [P30CA014195, DK057978, HL088093, HL105278, R01CA150197, R01CA165263]; Ipsen Biomeasure; Samuel Waxman Cancer Research Foundation; US Department of Defense [PC111467]; Stand Up To Cancer-Prostate Cancer Foundation-Prostate Dream Team Translational Cancer Research Grant; Movember Foundation; NATIONAL CANCER INSTITUTE [R01CA165263, R01CA168601, R01CA150197, R01CA206222, P30CA014195] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105278, P01HL088093] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK057978] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002237] Funding Source: NIH RePORTER	University of California, Davis, Research Office; US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Veterans Affairs(US Department of Veterans Affairs); Office of Biomedical Laboratory Research and Development Service; Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Guangzhou Healthcare Collaborative Innovation Programs; Key Basic Research Program of China(National Basic Research Program of China); Key Basic Research Program of China (973 program)(National Basic Research Program of China); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ipsen Biomeasure(Ipsen); Samuel Waxman Cancer Research Foundation; US Department of Defense(United States Department of Defense); Stand Up To Cancer-Prostate Cancer Foundation-Prostate Dream Team Translational Cancer Research Grant; Movember Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	We thank D. Wu, Q. Wang, D. Chen, F. Wu, F. Li, Y. He and J. Shen for their technical expertise and for their critical comments. We thank C. Sawyers and A. van Bokhoven for providing LAPC4 and PC346C cells. This work was supported in part by grants from the Bridge Program of the University of California, Davis, Research Office (to H.-W.C.); the US National Institutes of Health (NIH) (R01CA206222 to H.-WC.); the US Department of Veterans Affairs; the Office of Biomedical Laboratory Research and Development Service (Merit Award I01BX002237 to H.-WC.); the 100 Talents Projects of Chinese Academy of Sciences, the National Natural Science Foundation, the Guangzhou Healthcare Collaborative Innovation Programs and the Key Basic Research Program of China (grant 81373325, grant 20150820225 and 973 program grant 2013CB910601 to Y.X.); the Howard Hughes Medical Institute; the NIH (P30CA014195, DK057978, HL088093 and HL105278 to R.M.E.) and grants from Ipsen Biomeasure and the Samuel Waxman Cancer Research Foundation (to R.M.E.); the NIH (R01CA150197 and R01CA165263 to H.-J. K.); the US Department of Defense (PC111467 to C.P.E.) and a Stand Up To Cancer-Prostate Cancer Foundation-Prostate Dream Team Translational Cancer Research Grant. This research-grant is made possible by the generous support of the Movember Foundation. Stand Up To Cancer is a program of the Entertainment Industry Foundation administered by the American Association for Cancer Research (SU2C-AACR-PCF DT0812 to C.P.E.) and the NIH (R01CA168601 to A.C.G.).	Agoulnik IU, 2006, CANCER RES, V66, P10594, DOI 10.1158/0008-5472.CAN-06-1023; Antonarakis ES, 2014, NEW ENGL J MED, V371, P1028, DOI 10.1056/NEJMoa1315815; Asangani IA, 2014, NATURE, V510, P278, DOI 10.1038/nature13229; Chang MR, 2014, ARTHRITIS RHEUMATOL, V66, P579, DOI 10.1002/art.38272; Ciofani M, 2012, CELL, V151, P289, DOI 10.1016/j.cell.2012.09.016; Deblois G, 2013, NAT REV CANCER, V13, P27, DOI 10.1038/nrc3396; Ferraldeschi R, 2015, ONCOGENE, V34, P1745, DOI 10.1038/onc.2014.115; Flaveny CA, 2015, CANCER CELL, V28, P42, DOI 10.1016/j.ccell.2015.05.007; Frigo DE, 2011, CANCER RES, V71, P528, DOI 10.1158/0008-5472.CAN-10-2581; GIGUERE V, 1994, GENE DEV, V8, P538, DOI 10.1101/gad.8.5.538; Hu R, 2012, CANCER RES, V72, P3457, DOI 10.1158/0008-5472.CAN-11-3892; Karantanos T, 2015, EUR UROL, V67, P470, DOI 10.1016/j.eururo.2014.09.049; Kojetin DJ, 2014, NAT REV DRUG DISCOV, V13, P197, DOI 10.1038/nrd4100; Kumar N, 2012, ACS CHEM BIOL, V7, P672, DOI 10.1021/cb200496y; Kumar N, 2011, ACS CHEM BIOL, V6, P218, DOI 10.1021/cb1002762; Lai KP, 2013, AM J PATHOL, V182, P460, DOI 10.1016/j.ajpath.2012.10.029; Lange T, 2014, CLIN CANCER RES, V20, P1791, DOI 10.1158/1078-0432.CCR-13-2308; Lee E, 2013, P NATL ACAD SCI USA, V110, P15710, DOI 10.1073/pnas.1218168110; Li YR, 2009, CANCER RES, V69, P3332, DOI 10.1158/0008-5472.CAN-08-3380; Liu CF, 2014, CLIN CANCER RES, V20, P3198, DOI 10.1158/1078-0432.CCR-13-3296; Malik R, 2015, NAT MED, V21, P344, DOI 10.1038/nm.3830; Meissburger B, 2011, EMBO MOL MED, V3, P637, DOI 10.1002/emmm.201100172; Mendiratta P, 2009, J CLIN ONCOL, V27, P2022, DOI 10.1200/JCO.2008.17.2882; Mostaghel EA, 2014, CLIN CANCER RES, V20, P791, DOI 10.1158/1078-0432.CCR-12-3601; Myung JK, 2013, J CLIN INVEST, V123, P2948, DOI 10.1172/JCI66398; Qin J, 2014, J CLIN INVEST, V124, P5013, DOI 10.1172/JCI76412; Rene O, 2015, ACS MED CHEM LETT, V6, P276, DOI 10.1021/ml500420y; Robinson D, 2015, CELL, V161, P1215, DOI 10.1016/j.cell.2015.05.001; Sharma A, 2010, J CLIN INVEST, V120, P4478, DOI 10.1172/JCI44239; Sharma NL, 2013, CANCER CELL, V23, P35, DOI 10.1016/j.ccr.2012.11.010; Solt LA, 2012, ACS CHEM BIOL, V7, P1515, DOI 10.1021/cb3002649; Strasner A, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00128; Sun ZM, 2000, SCIENCE, V288, P2369, DOI 10.1126/science.288.5475.2369; Takeda Y, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004331; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Tien JCY, 2013, CANCER RES, V73, P3997, DOI 10.1158/0008-5472.CAN-12-3929; Wang Y, 2014, CANCER RES, V74, P1506, DOI 10.1158/0008-5472.CAN-13-2939; Wang YH, 2014, BIOORGAN MED CHEM, V22, P692, DOI 10.1016/j.bmc.2013.12.021; Watson PA, 2015, NAT REV CANCER, V15, P701, DOI 10.1038/nrc4016; Xiao S, 2014, IMMUNITY, V40, P477, DOI 10.1016/j.immuni.2014.04.004; Yu JD, 2010, CANCER CELL, V17, P443, DOI 10.1016/j.ccr.2010.03.018; Yu ZY, 2014, CLIN CANCER RES, V20, P4075, DOI 10.1158/1078-0432.CCR-14-0292; Zhang LY, 2009, AM J PATHOL, V175, P489, DOI 10.2353/ajpath.2009.080727; Zhang QY, 2012, CANCER RES, V72, P2589, DOI 10.1158/0008-5472.CAN-11-3795; Zhang Y, 2015, ACTA PHARMACOL SIN, V36, P71, DOI 10.1038/aps.2014.120; Zhang Y, 2014, EUR J MED CHEM, V78, P431, DOI 10.1016/j.ejmech.2014.03.065; Zhao X, 2014, EMBO REP, V15, P518, DOI 10.1002/embr.201338271; Zhong J, 2014, CANCER RES, V74, P1870, DOI 10.1158/0008-5472.CAN-13-2485; Zou JX, 2009, CANCER RES, V69, P3339, DOI 10.1158/0008-5472.CAN-08-3440	49	117	121	2	50	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2016	22	5					488	496		10.1038/nm.4070	http://dx.doi.org/10.1038/nm.4070			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DL3DI	27019329	Green Submitted, Green Accepted			2022-12-25	WOS:000375514000011
J	Gupta, P; Liu, B; Klepacki, D; Gupta, V; Schulten, K; Mankinl, AS; Vazquez-Laslop, N				Gupta, Pulkit; Liu, Bo; Klepacki, Dorota; Gupta, Vrinda; Schulten, Klaus; Mankinl, Alexander S.; Vazquez-Laslop, Nora			Nascent peptide assists the ribosome in recognizing chemically distinct small molecules	NATURE CHEMICAL BIOLOGY			English	Article							TRANSFERASE CENTER; POSTTRANSCRIPTIONAL MODIFICATION; ANTIBIOTICS; TRANSLATION; RESISTANCE; INDUCTION; MECHANISM; SITE; LINCOSAMIDES; CONFORMATION	Regulation of gene expression in response to the changing environment is critical for cell survival. For instance, binding of macrolide antibiotics to the ribosome promotes translation arrest at the leader open reading frames ermCL and ermBL, which is necessary for inducing the antibiotic resistance genes ermC and ermB. Cladinose-containing macrolides such as erythromycin (ERY), but not ketolides such as telithromycin (TEL), arrest translation of ermCL, whereas either ERY or TEL stall ermBL translation. How the ribosome distinguishes between chemically similar small molecules is unknown. We show that single amino acid changes in the leader peptide switch the specificity of recognition of distinct molecules, triggering gene activation in response to ERY alone, to TEL alone or to both antibiotics or preventing stalling altogether. Thus, the ribosomal response to chemical signals can be modulated by minute changes in the nascent peptide, suggesting that protein sequences could have been optimized for rendering translation sensitive to environmental cues.	[Gupta, Pulkit; Klepacki, Dorota; Gupta, Vrinda; Mankinl, Alexander S.; Vazquez-Laslop, Nora] Univ Illinois, Ctr Biomol Sci, Chicago, IL USA; [Liu, Bo; Schulten, Klaus] Univ Illinois, Beckman Inst, Urbana, IL 61801 USA; [Liu, Bo; Schulten, Klaus] Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL 61801 USA; [Gupta, Pulkit] Merck & Co Inc, Kenilworth, NJ USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Merck & Company	Mankinl, AS; Vazquez-Laslop, N (corresponding author), Univ Illinois, Ctr Biomol Sci, Chicago, IL USA.	shura@uic.edu; nvazquez@uic.edu	Liu, Bo/V-3768-2019	Liu, Bo/0000-0002-9383-9205; Vazquez-Laslop, Nora/0000-0003-2256-693X	National Science Foundation [MCB 1244455, 9P41GM104601, PHY0822613, OCI 07-25070]; Great Lakes Consortium for Petascale Computation on the Blue Waters Computer; Oak Ridge Leadership Computing Facility at Oak Ridge National Laboratory; Office of Science of the Department of Energy [DE-AC05-00OR22725]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM104601] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); Great Lakes Consortium for Petascale Computation on the Blue Waters Computer; Oak Ridge Leadership Computing Facility at Oak Ridge National Laboratory; Office of Science of the Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Wilson and S. Arenz (Gene Center, Munich) for helpful discussions, R. Bovee for help with some experiments and P. Fernandes (Cempra Pharmaceuticals) for providing telithromycin. This work was supported by a grant from the National Science Foundation (MCB 1244455) to A.S.M. and N.V.-L. and 9P41GM104601 (to K.S.) and the National Science Foundation (PHY0822613) (to KS.). MD modeling was facilitated by a grant from the Great Lakes Consortium for Petascale Computation on the Blue Waters Computer, financed by the National Science Foundation (OCI 07-25070) and the Oak Ridge Leadership Computing Facility at Oak Ridge National Laboratory, which is supported by the Office of Science of the Department of Energy under Contract DE-AC05-00OR22725.	Arenz S, 2014, MOL CELL, V56, P446, DOI 10.1016/j.molcel.2014.09.014; Arenz S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4501; Bailey M, 2008, ANTIMICROB AGENTS CH, V52, P866, DOI 10.1128/AAC.01266-07; Bonnefoy A, 1997, J ANTIMICROB CHEMOTH, V40, P85, DOI 10.1093/jac/40.1.85; Bulkley D, 2010, P NATL ACAD SCI USA, V107, P17158, DOI 10.1073/pnas.1008685107; Davis AR, 2014, P NATL ACAD SCI USA, V111, P15379, DOI 10.1073/pnas.1410356111; Dunkle JA, 2010, P NATL ACAD SCI USA, V107, P17152, DOI 10.1073/pnas.1007988107; Englander MT, 2015, P NATL ACAD SCI USA, V112, P6038, DOI 10.1073/pnas.1424712112; GRYCZAN TJ, 1980, NUCLEIC ACIDS RES, V8, P6081, DOI 10.1093/nar/8.24.6081; Gupta P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2984; Hansen LH, 1999, MOL MICROBIOL, V31, P623, DOI 10.1046/j.1365-2958.1999.01202.x; HORINOUCHI S, 1980, P NATL ACAD SCI-BIOL, V77, P7079, DOI 10.1073/pnas.77.12.7079; Kamimiya S, 1997, ANTIMICROB AGENTS CH, V41, P530, DOI 10.1128/AAC.41.3.530; Kannan K, 2014, P NATL ACAD SCI USA, V111, P15958, DOI 10.1073/pnas.1417334111; Kannan K, 2012, CELL, V151, P508, DOI 10.1016/j.cell.2012.09.018; Llano-Sotelo B, 2010, ANTIMICROB AGENTS CH, V54, P4961, DOI 10.1128/AAC.00860-10; MAYFORD M, 1990, J BACTERIOL, V172, P3772, DOI 10.1128/jb.172.7.3772-3779.1990; Oh TG, 1998, J BACTERIOL, V180, P5788, DOI 10.1128/JB.180.21.5788-5791.1998; Ramu H, 2011, MOL CELL, V41, P321, DOI 10.1016/j.molcel.2010.12.031; Ramu H, 2009, MOL MICROBIOL, V71, P811, DOI 10.1111/j.1365-2958.2008.06576.x; Schlunzen F, 2001, NATURE, V413, P814, DOI 10.1038/35101544; Sothiselvam S, 2014, P NATL ACAD SCI USA, V111, P9804, DOI 10.1073/pnas.1403586111; Subramanian SL, 2012, ANTIBIOTIC DISCOVERY AND DEVELOPMENT, VOLS 1 AND 2, P455, DOI 10.1007/978-1-4614-1400-1_13; SUTCLIFFE JA, 2002, MIL DRUG TH, P281; Tenson T, 2003, J MOL BIOL, V330, P1005, DOI 10.1016/S0022-2836(03)00662-4; Tu D, 2005, CELL, V121, P257, DOI 10.1016/j.cell.2005.02.005; Vazquez-Laslop N, 2008, MOL CELL, V30, P190, DOI 10.1016/j.molcel.2008.02.026; Vazquez-Laslop N, 2011, P NATL ACAD SCI USA, V108, P10496, DOI 10.1073/pnas.1103474108; Voorhees RM, 2009, NAT STRUCT MOL BIOL, V16, P528, DOI 10.1038/nsmb.1577; WEISBLUM B, 1995, ANTIMICROB AGENTS CH, V39, P797, DOI 10.1128/AAC.39.4.797; WEISBLUM B, 1995, ANTIMICROB AGENTS CH, V39, P577, DOI 10.1128/AAC.39.3.577; Xiong LQ, 1999, MOL MICROBIOL, V31, P633, DOI 10.1046/j.1365-2958.1999.01203.x; Zaher HS, 2011, EMBO J, V30, P2445, DOI 10.1038/emboj.2011.142	33	34	36	0	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAR	2016	12	3					153	158		10.1038/NCHEMBIO.1998	http://dx.doi.org/10.1038/NCHEMBIO.1998			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF5FK	26727240	Green Accepted			2022-12-25	WOS:000371377000007
J	Muller, MM; Fierz, B; Bittova, L; Liszczak, G; Muir, TW				Mueller, Manuel M.; Fierz, Beat; Bittova, Lenka; Liszczak, Glen; Muir, Tom W.			A two-state activation mechanism controls the histone methyltransferase Suv39h1	NATURE CHEMICAL BIOLOGY			English	Article							PERICENTRIC HETEROCHROMATIN; LYSINE-9 METHYLATION; EPIGENETIC CONTROL; CHROMATIN FIBER; MODEL SYSTEM; SET DOMAIN; BINDING; MAINTENANCE; HP1; ESTABLISHMENT	Specialized chromatin domains contribute to nuclear organization and regulation of gene expression. Gene-poor regions are di- and trimethylated at lysine 9 of histone H3 (H3K9me2 and H3K9me3) by the histone methyltransferase Suv39h1. This enzyme harnesses a positive feedback loop to spread H3K9me2 and H3K9me3 over extended heterochromatic regions. However, little is known about how feedback loops operate on complex biopolymers such as chromatin, in part because of the difficulty in obtaining suitable substrates. Here we describe the synthesis of multidomain 'designer chromatin' templates and their application to dissecting the regulation of human Suv39h1. We uncovered a two-step activation switch where H3K9me3 recognition and subsequent anchoring of the enzyme to chromatin allosterically promotes methylation activity and confirmed that this mechanism contributes to chromatin recognition in cells. We propose that this mechanism serves as a paradigm in chromatin biochemistry, as it enables highly dynamic sampling of chromatin state combined with targeted modification of desired genomic regions.	[Mueller, Manuel M.; Fierz, Beat; Bittova, Lenka; Liszczak, Glen; Muir, Tom W.] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA; [Fierz, Beat] Ecole Polytech Fed Lausanne, Lausanne, Switzerland	Princeton University; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Muir, TW (corresponding author), Princeton Univ, Dept Chem, Princeton, NJ 08544 USA.	muir@princeton.edu	Muir, Tom/AHD-0860-2022; Fierz, Beat/H-3143-2012; Bittova, Lenka/K-4375-2015; Mueller, Manuel M/D-5562-2017	Muir, Tom/0000-0001-9635-0344; Fierz, Beat/0000-0002-2991-3044; Bittova, Lenka/0000-0002-3556-5234; Mueller, Manuel M/0000-0001-6701-0893	Swiss National Science Foundation; US National Institutes of Health [R01-GM107047]; NATIONAL CANCER INSTITUTE [P01CA196539] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM110880, R01GM107047] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank U. Nguyen and Y. David for help with tissue culture; G. Laevsky for advice on microscopy; P. Lewis for providing biotinylated H3 peptides; C.D. Allis, G. Debelouchina, Z. Brown, B. Wang and C. Jenness for helpful discussions; and K. Jani for careful proofreading of this manuscript. NIH-3T3 cells were a gift from J. Schwarzbauer (Princeton University). Funding provided by the Swiss National Science Foundation (postdoctoral fellowships to M.M.M. and B.F.) and the US National Institutes of Health (grant R01-GM107047 to T.W.M.).	Al-Sady B, 2013, MOL CELL, V51, P80, DOI 10.1016/j.molcel.2013.06.013; Blacketer MJ, 2010, J BIOL CHEM, V285, P34597, DOI 10.1074/jbc.M110.140061; Brown ZZ, 2015, ANGEW CHEM INT EDIT, V54, P6457, DOI 10.1002/anie.201500085; Chin HG, 2006, BIOCHEMISTRY-US, V45, P3272, DOI 10.1021/bi051997r; Erdel F, 2013, ANN NY ACAD SCI, V1305, P29, DOI 10.1111/nyas.12262; Grewal SIS, 2003, SCIENCE, V301, P798, DOI 10.1126/science.1086887; Hahn M, 2010, J APPL PHYSIOL, V109, P232, DOI 10.1152/japplphysiol.00053.2010; Hall IM, 2002, SCIENCE, V297, P2232, DOI 10.1126/science.1076466; Hansen JC, 2002, ANNU REV BIOPH BIOM, V31, P361, DOI 10.1146/annurev.biophys.31.101101.140858; Hathaway NA, 2012, CELL, V149, P1447, DOI 10.1016/j.cell.2012.03.052; Hsieh THS, 2015, CELL, V162, P108, DOI 10.1016/j.cell.2015.05.048; Johnson A, 2009, MOL CELL, V35, P769, DOI 10.1016/j.molcel.2009.07.030; KORNBERG RD, 1977, ANNU REV BIOCHEM, V46, P931, DOI 10.1146/annurev.bi.46.070177.004435; Krouwels IM, 2005, J CELL BIOL, V170, P537, DOI 10.1083/jcb.200502154; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Li SS, 2009, J BIOL CHEM, V284, P9411, DOI 10.1074/jbc.M809617200; Liu N, 2015, GENE DEV, V29, P379, DOI 10.1101/gad.254425.114; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Margueron R, 2009, NATURE, V461, P762, DOI 10.1038/nature08398; McGinty RK, 2015, CHEM REV, V115, P2255, DOI 10.1021/cr500373h; Melcher M, 2000, MOL CELL BIOL, V20, P3728, DOI 10.1128/MCB.20.10.3728-3741.2000; Min JR, 2002, NAT STRUCT BIOL, V9, P828, DOI 10.1038/nsb860; Muller MM, 2015, CHEM REV, V115, P2296, DOI 10.1021/cr5003529; Muller-Ott K, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145377; Muramatsu D, 2013, J BIOL CHEM, V288, P25285, DOI 10.1074/jbc.M113.470724; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Nguyen UTT, 2014, NAT METHODS, V11, P834, DOI [10.1038/NMETH.3022, 10.1038/nmeth.3022]; Noma K, 2001, SCIENCE, V293, P1150, DOI 10.1126/science.1064150; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Porro A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6379; Rando OJ, 2007, CURR OPIN GENET DEV, V17, P94, DOI 10.1016/j.gde.2007.02.006; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Song F, 2014, SCIENCE, V344, P376, DOI 10.1126/science.1251413; Sprague BL, 2004, BIOPHYS J, V86, P3473, DOI 10.1529/biophysj.103.026765; Stewart MD, 2005, MOL CELL BIOL, V25, P2525, DOI 10.1128/MCB.25.7.2525-2538.2005; Talbert PB, 2006, NAT REV GENET, V7, P793, DOI 10.1038/nrg1920; Torres IO, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7204; Wang T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052977; Woodcock CL, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000596; Wu H, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008570, 10.1371/journal.pone.0013316]; Yamamoto K, 2003, BIOCHEM BIOPH RES CO, V301, P287, DOI 10.1016/S0006-291X(02)03021-8; Zhang K, 2008, NAT STRUCT MOL BIOL, V15, P381, DOI 10.1038/nsmb.1406; Zheng CY, 2003, J BIOL CHEM, V278, P24217, DOI 10.1074/jbc.M302817200	43	63	64	0	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAR	2016	12	3					188	193		10.1038/NCHEMBIO.2008	http://dx.doi.org/10.1038/NCHEMBIO.2008			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF5FK	26807716	Green Submitted, Green Accepted			2022-12-25	WOS:000371377000012
J	Savova, V; Chun, S; Sohail, M; McCole, RB; Witwicki, R; Gai, LS; Lenz, TL; Wu, CT; Sunyaev, SR; Gimelbrant, AA				Savova, Virginia; Chun, Sung; Sohail, Mashaal; McCole, Ruth B.; Witwicki, Robert; Gai, Lisa; Lenz, Tobias L.; Wu, C-ting; Sunyaev, Shamil R.; Gimelbrant, Alexander A.			Genes with monoallelic expression contribute disproportionately to genetic diversity in humans	NATURE GENETICS			English	Article							MUTATIONS; EVOLUTION; SELECTION; PATTERNS; RATES	An unexpectedly large number of human autosomal genes are subject to monoallelic expression (MAE). Our analysis of 4,227 such genes uncovers surprisingly high genetic variation across human populations. This increased diversity is unlikely to reflect relaxed purifying selection. Remarkably, MAE genes exhibit an elevated recombination rate and an increased density of hypermutable sequence contexts. However, these factors do not fully account for the increased diversity. We find that the elevated nucleotide diversity of MAE genes is also associated with greater allelic age: variants in these genes tend to be older and are enriched in polymorphisms shared by Neanderthals and chimpanzees. Both synonymous and nonsynonymous alleles of MAE genes have elevated average population frequencies. We also observed strong enrichment of the MAE signature among genes reported to evolve under balancing selection. We propose that an important biological function of widespread MAE might be the generation of cell-to-cell heterogeneity; the increased genetic variation contributes to this heterogeneity.	[Savova, Virginia; Witwicki, Robert; Gai, Lisa; Gimelbrant, Alexander A.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Savova, Virginia; McCole, Ruth B.; Wu, C-ting; Gimelbrant, Alexander A.] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Chun, Sung; Sohail, Mashaal; Lenz, Tobias L.; Sunyaev, Shamil R.] Harvard Univ, Brigham & Womens Hosp, Dept Med, Sch Med,Div Genet, Boston, MA 02115 USA; [Savova, Virginia] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA USA; [Lenz, Tobias L.] Max Planck Inst Evolutionary Biol, Evolutionary Immunogen, Dept Evolutionary Ecol, Plon, Germany	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Max Planck Society	Gimelbrant, AA (corresponding author), Dana Farber Canc Inst, Boston, MA 02115 USA.; Gimelbrant, AA (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA USA.; Sunyaev, SR (corresponding author), Harvard Univ, Brigham & Womens Hosp, Dept Med, Sch Med,Div Genet, Boston, MA 02115 USA.	ssunyaev@rics.bwh.harvard.edu; gimelbrant@mail.dfci.harvard.edu	Lenz, Tobias L/D-1387-2009; Chun, Sung/I-2212-2015	Lenz, Tobias L/0000-0002-7203-0044; Chun, Sung/0000-0003-3440-1913; Gimelbrant, Alexander/0000-0001-6986-0285	US National Institutes of Health (NIH) [ROl GM114864, RO1 GM078598, GM105857, MH101244]; Pew scholar award; German Research Foundation (DFG) [LE 2593/1-1, LE 2593/2-1]; US NIH [U54 LM008748]; US NIH/National Institute of General Medical Sciences [R01 GM61936, 5DP1 GM106412]; Harvard Medical School; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM105857, R01GM114864, DP1GM106412, R01GM078598, R01GM061936] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH101244] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [U54LM008748] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pew scholar award; German Research Foundation (DFG)(German Research Foundation (DFG)); US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US NIH/National Institute of General Medical Sciences; Harvard Medical School; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	We thank D. Balick for useful discussions and I. Adzhubei for help with PolyPhen analysis. This work was supported in part by the following US National Institutes of Health (NIH) awards: ROl GM114864 to A.A.G. and RO1 GM078598, GM105857 and MH101244 to S.R.S. A.A.G. was supported in part by the Pew scholar award; T.L.L. was supported by a fellowship from the German Research Foundation (DFG; LE 2593/1-1 and LE 2593/2-1); L.G. was a summer scholar in the Harvard/Massachusetts Institute of Technology BIG program (supported by US NIH award U54 LM008748); and R.B.M. and C.W. were supported by grants from the US NIH/National Institute of General Medical Sciences (R01 GM61936 and 5DP1 GM106412) and Harvard Medical School.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Andres AM, 2009, MOL BIOL EVOL, V26, P2755, DOI 10.1093/molbev/msp190; BEGUN DJ, 1992, NATURE, V356, P519, DOI 10.1038/356519a0; Chamary JV, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-9-r75; CHARLESWORTH B, 1993, GENETICS, V134, P1289; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; Chess A, 2012, NAT REV GENET, V13, P421, DOI 10.1038/nrg3239; DeGiorgio M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004561; Deng QL, 2014, SCIENCE, V343, P193, DOI 10.1126/science.1245316; Drmanac R, 2010, SCIENCE, V327, P78, DOI 10.1126/science.1181498; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Eckersley-Maslin MA, 2014, DEV CELL, V28, P351, DOI 10.1016/j.devcel.2014.01.017; Eisenberg E, 2013, TRENDS GENET, V29, P569, DOI 10.1016/j.tig.2013.05.010; Francioli LC, 2015, NAT GENET, V47, P822, DOI 10.1038/ng.3292; Gendre AV, 2014, DEV CELL, V28, P366, DOI 10.1016/j.devcel.2014.01.016; Gimelbrant A, 2007, SCIENCE, V318, P1136, DOI 10.1126/science.1148910; Hellmann I, 2005, GENOME RES, V15, P1222, DOI 10.1101/gr.3461105; Hoehe MR, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6569; Jeffries AR, 2012, STEM CELLS, V30, P1938, DOI 10.1002/stem.1155; Kiezun A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003301; KIMURA M, 1977, NATURE, V267, P275, DOI 10.1038/267275a0; Kong A, 2010, NATURE, V467, P1099, DOI 10.1038/nature09525; Leffler EM, 2013, SCIENCE, V339, P1578, DOI 10.1126/science.1234070; Li SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031751; Li W. H, 1997, MOL EVOLUTION; Nag A, 2015, G3-GENES GENOM GENET, V5, P1713, DOI 10.1534/g3.115.018853; Nag A, 2013, ELIFE, V2, DOI 10.7554/eLife.01256; Necsulea A, 2009, TRENDS GENET, V25, P519, DOI 10.1016/j.tig.2009.10.001; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; Pereira JP, 2003, NAT IMMUNOL, V4, P464, DOI 10.1038/ni917; Rasmussen MD, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004342; Samocha KE, 2014, NAT GENET, V46, P944, DOI 10.1038/ng.3050; Savova V, 2013, CURR OPIN GENET DEV, V23, P642, DOI 10.1016/j.gde.2013.09.001; Sellis D, 2011, P NATL ACAD SCI USA, V108, P20666, DOI 10.1073/pnas.1114573108; Smith JM, 2007, GENET RES, V89, P391, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; Spencer HG, 2000, ANNU REV GENET, V34, P457, DOI 10.1146/annurev.genet.34.1.457; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Veyrieras JB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000214; Walser JC, 2010, GENOME RES, V20, P875, DOI 10.1101/gr.103283.109; Wilkins JF, 2003, NAT REV GENET, V4, P359, DOI 10.1038/nrg1062; Wu C-ting, 2002, Adv Genet, V46, pxvii; Yang SH, 2015, NATURE, V523, P463, DOI 10.1038/nature14649; Zwemer LM, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-2-r10	43	41	44	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2016	48	3					231	237		10.1038/ng.3493	http://dx.doi.org/10.1038/ng.3493			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DE8QW	26808112	Green Submitted, Green Accepted			2022-12-25	WOS:000370902600006
J	Doench, JG; Fusi, N; Sullender, M; Hegde, M; Vaimberg, EW; Donovan, KF; Smith, I; Tothova, Z; Wilen, C; Orchard, R; Virgin, HW; Listgarten, J; Root, DE				Doench, John G.; Fusi, Nicolo; Sullender, Meagan; Hegde, Mudra; Vaimberg, Emma W.; Donovan, Katherine F.; Smith, Ian; Tothova, Zuzana; Wilen, Craig; Orchard, Robert; Virgin, Herbert W.; Listgarten, Jennifer; Root, David E.			Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9	NATURE BIOTECHNOLOGY			English	Article							GENETIC SCREENS; CELL-LINE; GENOME; CAS9; DNA; RAF; IDENTIFICATION; ENDONUCLEASE; SPECIFICITY; RESISTANCE	CRISPR-Cas9-based genetic screens are a powerful new tool in biology. By simply altering the sequence of the single-guide RNA (sgRNA), one can reprogram Cas9 to target different sites in the genome with relative ease, but the on-target activity and off-target effects of individual sgRNAs can vary widely. Here, we use recently devised sgRNA design rules to create human and mouse genome-wide libraries, perform positive and negative selection screens and observe that the use of these rules produced improved results. Additionally, we profile the off-target activity of thousands of sgRNAs and develop a metric to predict off-target sites. We incorporate these findings from large-scale, empirical data to improve our computational design rules and create optimized sgRNA libraries that maximize on-target activity and minimize off-target effects to enable more effective and efficient genetic screens and genome engineering.	[Doench, John G.; Sullender, Meagan; Hegde, Mudra; Vaimberg, Emma W.; Donovan, Katherine F.; Smith, Ian; Tothova, Zuzana; Root, David E.] Broad Inst MIT & Harvard, Cambridge, MA USA; [Fusi, Nicolo; Listgarten, Jennifer] Microsoft Res New England, Cambridge, MA USA; [Tothova, Zuzana] Dana Farber Canc Inst, Div Hematol Malignancies, Boston, MA 02115 USA; [Wilen, Craig; Orchard, Robert; Virgin, Herbert W.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Microsoft; Harvard University; Dana-Farber Cancer Institute; Washington University (WUSTL)	Doench, JG; Root, DE (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA USA.; Fusi, N; Listgarten, J (corresponding author), Microsoft Res New England, Cambridge, MA USA.	jdoench@broadinstitute.org; fusi@microsoft.com; jennl@microsoft.com; droot@broadinstitute.org	Doench, John/ABE-6251-2020; Doench, John G/HCI-9570-2022; ravegnini, gloria/K-1330-2016; Kim, Hyongbum Henry/D-5804-2019	Doench, John/0000-0002-3707-9889; Doench, John G/0000-0002-3707-9889; ravegnini, gloria/0000-0002-7774-402X; Kim, Hyongbum Henry/0000-0002-4693-738X; Wilen, Craig/0000-0003-2495-9403; Virgin, Herbert/0000-0001-8580-7628; Hegde, Mudra/0000-0003-4530-4633; Sullender, Meagan/0000-0001-6666-8650	NIH [5K12CA087723-12]; ASCO Young Investigator Award; LLS Special Fellow Award; Next Generation Fund at the Broad Institute of MIT and Harvard; NATIONAL CANCER INSTITUTE [K12CA087723] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007163, U19AI109725] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ASCO Young Investigator Award; LLS Special Fellow Award; Next Generation Fund at the Broad Institute of MIT and Harvard; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank M. Tomko, M. Greene, A. Brown, D. Alan and T. Green for software engineering support, and T. Nguyen, N. Tran and X. Yang for library production support (Broad Institute). Z.T. is funded by NIH 5K12CA087723-12, ASCO Young Investigator Award, LLS Special Fellow Award. J.G.D. is a Merkin Institute Fellow and is supported by the Next Generation Fund at the Broad Institute of MIT and Harvard.	Bae S, 2014, NAT METHODS, V11, P705, DOI 10.1038/nmeth.3015; Bae S, 2014, BIOINFORMATICS, V30, P1473, DOI 10.1093/bioinformatics/btu048; Bae S, 2012, FEBS LETT, V586, P3057, DOI 10.1016/j.febslet.2012.07.022; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Ben-Hur A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000173; BLASI E, 1987, EUR J IMMUNOL, V17, P1491, DOI 10.1002/eji.1830171016; Bollag G, 2010, NATURE, V467, P596, DOI 10.1038/nature09454; Brinkman EK, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku936; CASKEY CT, 1979, CELL, V16, P1, DOI 10.1016/0092-8674(79)90182-X; Chari R, 2015, NAT METHODS, V12, P823, DOI [10.1038/NMETH.3473, 10.1038/nmeth.3473]; Cheok MH, 2006, NAT REV CANCER, V6, P117, DOI 10.1038/nrc1800; Cock PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Davies BR, 2007, MOL CANCER THER, V6, P2209, DOI 10.1158/1535-7163.MCT-07-0231; Doench JG, 2014, NAT BIOTECHNOL, V32, P1262, DOI 10.1038/nbt.3026; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gamper AM, 2008, MOL CELL BIOL, V28, P2517, DOI 10.1128/MCB.01461-07; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Guilinger JP, 2014, NAT BIOTECHNOL, V32, P577, DOI 10.1038/nbt.2909; Hart T, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145216; Hartenian E, 2015, FEBS J, V282, P1383, DOI 10.1111/febs.13248; Heigwer F, 2014, NAT METHODS, V11, P122, DOI 10.1038/nmeth.2812; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Jinek M, 2014, SCIENCE, V343, P1215, DOI 10.1126/science.1247997; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Johannessen CM, 2010, NATURE, V468, P968, DOI 10.1038/nature09627; Kampmann M, 2015, P NATL ACAD SCI USA, V112, pE3384, DOI 10.1073/pnas.1508821112; Koike-Yusa H, 2014, NAT BIOTECHNOL, V32, P267, DOI 10.1038/nbt.2800; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Le Novere N, 2001, BIOINFORMATICS, V17, P1226, DOI 10.1093/bioinformatics/17.12.1226; Li W, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0554-4; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Lin YN, 2014, NUCLEIC ACIDS RES, V42, P7473, DOI 10.1093/nar/gku402; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shi JW, 2015, NAT BIOTECHNOL, V33, P661, DOI 10.1038/nbt.3235; Stansley B, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-115; STEIGER JH, 1980, PSYCHOL BULL, V87, P245, DOI 10.1037/0033-2909.87.2.245; Stemmer M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124633; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; Veres A, 2014, CELL STEM CELL, V15, P27, DOI 10.1016/j.stem.2014.04.020; Wang T, 2015, SCIENCE, V350, P1096, DOI 10.1126/science.aac7041; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Whittaker SR, 2013, CANCER DISCOV, V3, P350, DOI 10.1158/2159-8290.CD-12-0470; Xu H, 2015, GENOME RES, V25, P1147, DOI 10.1101/gr.191452.115; Zha MW, 2008, J MOL BIOL, V379, P568, DOI 10.1016/j.jmb.2008.04.006	53	1545	1623	31	519	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2016	34	2					184	+		10.1038/nbt.3437	http://dx.doi.org/10.1038/nbt.3437			12	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DD0OK	26780180	Green Accepted			2022-12-25	WOS:000369619100021
J	McDonald, A; Glusman, G; Price, ND				McDonald, Aniel; Glusman, Gustavo; Price, Nathan D.			Personalized nutrition through big data	NATURE BIOTECHNOLOGY			English	Editorial Material									[McDonald, Aniel; Glusman, Gustavo; Price, Nathan D.] Inst Syst Biol, Seattle, WA USA	Institute for Systems Biology (ISB)	Price, ND (corresponding author), Inst Syst Biol, Seattle, WA USA.	nprice@systemsbiology.org		Price, Nathan/0000-0002-4157-0267; Glusman, Gustavo/0000-0001-8060-5955				Ausiello D, 2015, BIG DATA, V3, P203, DOI 10.1089/big.2015.0016; Dodd H, 2011, AM J CLIN NUTR, V94, P992, DOI 10.3945/ajcn.111.012138; Hood L, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008665; Olle B, 2013, NAT BIOTECHNOL, V31, P309, DOI 10.1038/nbt.2548; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Zeevi D, 2015, CELL, V163, P1079, DOI 10.1016/j.cell.2015.11.001; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	8	13	15	1	26	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	FEB	2016	34	2					152	154		10.1038/nbt.3476	http://dx.doi.org/10.1038/nbt.3476			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DD0OK	26849520				2022-12-25	WOS:000369619100016
J	Evans, RM; Brooke, EJ; Wehlin, SAM; Nomerotskaia, E; Sargent, F; Carr, SB; Phillips, SEV; Armstrong, FA				Evans, Rhiannon M.; Brooke, Emily J.; Wehlin, Sara A. M.; Nomerotskaia, Elena; Sargent, Frank; Carr, Stephen B.; Phillips, Simon E. V.; Armstrong, Fraser A.			Mechanism of hydrogen activation by [NiFe] hydrogenases	NATURE CHEMICAL BIOLOGY			English	Article							ACTIVE-SITE; OXYGEN-TOLERANT; OXIDATION; HYDRIDE; PROTEIN; ELECTRON; ARGININE; MUTANTS; ENZYMES; CYCLE	The active site of [NiFe] hydrogenases contains a strictly conserved arginine that suspends a guanidine nitrogen atom <4.5 angstrom above the nickel and iron atoms. The guanidine headgroup interacts with the side chains of two conserved aspartic acid residues to complete an outer-shell canopy that has thus far proved intractable to investigation by site-directed mutagenesis. Using hydrogenase-1 from Escherichia coli, the strictly conserved residues R509 and D574 have been replaced by lysine (R509K) and asparagine (D574N) and the highly conserved D118 has been replaced by alanine (D118A) or asparagine (D118N/D574N). Each enzyme variant is stable, and their [(RS)(2)Ni mu(SR)(2)Fe(CO)(CN)(2)] inner coordination shells are virtually unchanged. The R509K variant had >100-fold lower activity than native enzyme. Conversely, the variants D574N, D118A and D118N/D574N, in which the position of the guanidine headgroup is retained, showed 83%, 26% and 20% activity, respectively. The special kinetic requirement for R509 implicates the suspended guanidine group as the general base in H-2 activation by [NiFe] hydrogenases.	[Evans, Rhiannon M.; Brooke, Emily J.; Wehlin, Sara A. M.; Nomerotskaia, Elena; Armstrong, Fraser A.] Univ Oxford, Dept Chem, Oxford OX1 3QZ, England; [Sargent, Frank] Univ Dundee, Sch Life Sci, Div Mol Microbiol, Dundee, Scotland; [Carr, Stephen B.; Phillips, Simon E. V.] Rutherford Appleton Lab, Didcot OX11 0QX, Oxon, England	University of Oxford; University of Dundee; UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory	Evans, RM (corresponding author), Univ Oxford, Dept Chem, Oxford OX1 3QZ, England.	stephen.carr@rc-harwell.ac.uk; Simon.Phillips@rc-harwell.ac.uk; fraser.armstrong@chem.ox.ac.uk		Evans, Rhiannon/0000-0002-9549-4220; Sargent, Frank/0000-0002-6841-3624; Phillips, Simon/0000-0001-8922-0250; Wehlin, Sara/0000-0002-7265-2644	UK Biological and Biotechnology Sciences Research Council [BB/I022309-1, BB/L009722/1, BB/L008521/1]; Global Innovation Initiative; UK Engineering and Physical Sciences Research Council; Biotechnology and Biological Sciences Research Council [BB/L009722/1, BB/L008521/1, BB/I022309/1, BB/N006321/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [1509088] Funding Source: researchfish; Medical Research Council [MC_EX_G0901251] Funding Source: researchfish; BBSRC [BB/N006321/1, BB/I022309/1, BB/L009722/1, BB/L008521/1] Funding Source: UKRI; MRC [MC_EX_G0901251] Funding Source: UKRI	UK Biological and Biotechnology Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Global Innovation Initiative; UK Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the UK Biological and Biotechnology Sciences Research Council, grants BB/I022309-1 and BB/L009722/1 to F.A.A. and BB/L008521/1 to F.S. A studentship for E.J.B. was supported by grants from Global Innovation Initiative and the UK Engineering and Physical Sciences Research Council. F.A.A. is a Royal Society Wolfson Research Merit Award holder. We thank the Diamond Light Source for beam time proposal mx9306 and the staff of beamlines i02, i04 and i04-1 for their assistance during data collection.	Armstrong FA, 2009, PHOTOSYNTH RES, V102, P541, DOI 10.1007/s11120-009-9428-0; Armstrong FA, 2009, CHEM SOC REV, V38, P36, DOI 10.1039/b801144n; ARP DJ, 1981, BIOCHEMISTRY-US, V20, P2234, DOI 10.1021/bi00511a025; Bard A. J., 2001, ELECTROCHEMICAL METH; Berggren G, 2013, NATURE, V499, P66, DOI 10.1038/nature12239; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; deLacey AL, 1997, J AM CHEM SOC, V119, P7181, DOI 10.1021/ja963802w; DeLacey AL, 2003, J BIOL INORG CHEM, V8, P129, DOI 10.1007/s00775-002-0397-4; Dementin S, 2004, J BIOL CHEM, V279, P10508, DOI 10.1074/jbc.M312716200; Domagala M, 2009, CHEM PHYS, V363, P42, DOI 10.1016/j.chemphys.2009.07.007; DULMAGE WJ, 1951, ACTA CRYSTALLOGR, V4, P330, DOI 10.1107/S0365110X51001070; Dutta A, 2014, P NATL ACAD SCI USA, V111, P16286, DOI 10.1073/pnas.1416381111; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans RM, 2014, METHODS MOL BIOL, V1122, P73, DOI 10.1007/978-1-62703-794-5_6; Evans RM, 2013, J AM CHEM SOC, V135, P2694, DOI 10.1021/ja311055d; Fontecilla-Camps JC, 2007, CHEM REV, V107, P4273, DOI 10.1021/cr050195z; HAMILTON CM, 1989, J BACTERIOL, V171, P4617, DOI 10.1128/jb.171.9.4617-4622.1989; Hatzixanthis K, 2003, MOL MICROBIOL, V49, P1377, DOI 10.1046/j.1365-2958.2003.03642.x; Hexter SV, 2012, P NATL ACAD SCI USA, V109, P11516, DOI 10.1073/pnas.1204770109; Hwang HJ, 2007, BIOCHEMISTRY-US, V46, P11987, DOI 10.1021/bi701387b; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Lubitz W, 2014, CHEM REV, V114, P4081, DOI 10.1021/cr4005814; Lukey MJ, 2011, J AM CHEM SOC, V133, P16881, DOI 10.1021/ja205393w; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Morris RH, 2014, J AM CHEM SOC, V136, P1948, DOI 10.1021/ja410718r; Murphy BJ, 2014, ENERG ENVIRON SCI, V7, P1426, DOI 10.1039/c3ee43652g; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Ogata H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8890; Ogata H, 2015, NATURE, V520, P571, DOI 10.1038/nature14110; Ogo S, 2013, SCIENCE, V339, P682, DOI 10.1126/science.1231345; Pankhurst KL, 2006, J BIOL CHEM, V281, P20589, DOI 10.1074/jbc.M603077200; Schlippe YVG, 2005, ARCH BIOCHEM BIOPHYS, V433, P266, DOI 10.1016/j.abb.2004.09.018; Simmons TR, 2014, COORDIN CHEM REV, V270, P127, DOI 10.1016/j.ccr.2013.12.018; Stephan DW, 2010, ANGEW CHEM INT EDIT, V49, P46, DOI 10.1002/anie.200903708; Szori-Doroghazi E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034666; Tedeschi G, 2001, BIOCHEMISTRY-US, V40, P4738, DOI 10.1021/bi002406u; Volbeda A, 1996, J AM CHEM SOC, V118, P12989, DOI 10.1021/ja962270g; Volbeda A, 2015, J BIOL INORG CHEM, V20, P11, DOI 10.1007/s00775-014-1203-9; Volbeda A, 2012, P NATL ACAD SCI USA, V109, P5305, DOI 10.1073/pnas.1119806109; Weber K, 2012, J AM CHEM SOC, V134, P20745, DOI 10.1021/ja309563p	41	77	77	0	119	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2016	12	1					46	+		10.1038/NCHEMBIO.1976	http://dx.doi.org/10.1038/NCHEMBIO.1976			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY8QW	26619250	Green Submitted			2022-12-25	WOS:000366674400011
J	Lambacher, NJ; Bruel, AL; van Dam, TJP; Szymanska, K; Slaats, GG; Kuhns, S; McManus, GJ; Kennedy, JE; Gaff, K; Wu, KM; van der Lee, R; Burglen, L; Doummar, D; Riviere, JB; Faivre, L; Attie-Bitach, T; Saunier, S; Curd, A; Peckham, M; Giles, RH; Johnson, CA; Huynen, MA; Thauvin-Robinet, C; Blacque, OE				Lambacher, Nils J.; Bruel, Ange-Line; van Dam, Teunis J. P.; Szymanska, Katarzyna; Slaats, Gisela G.; Kuhns, Stefanie; McManus, Gavin J.; Kennedy, Julie E.; Gaff, Karl; Wu, Ka Ma; van der Lee, Robin; Burglen, Lydie; Doummar, Diane; Riviere, Jean-Baptiste; Faivre, Laurence; Attie-Bitach, Tania; Saunier, Sophie; Curd, Alistair; Peckham, Michelle; Giles, Rachel H.; Johnson, Colin A.; Huynen, Martijn A.; Thauvin-Robinet, Christel; Blacque, Oliver E.			TMEM107 recruits ciliopathy proteins to subdomains of the ciliary transition zone and causes Joubert syndrome	NATURE CELL BIOLOGY			English	Article							CAENORHABDITIS-ELEGANS; PRIMARY CILIUM; C. ELEGANS; CILIOGENESIS; MEMBRANE; MUTATIONS; COMPLEX; NEPHROCYSTINS; EVOLUTION; TRANSPORT	The transition zone (TZ) ciliary subcompartment is thought to control cilium composition and signalling by facilitating a protein diffusion barrier at the ciliary base. TZ defects cause ciliopathies such as Meckel-Gruber syndrome (MKS), nephronophthisis (NPHP) and Joubert syndrome' (JBTS). However, the molecular composition and mechanisms underpinning TZ organization and barrier regulation are poorly understood. To uncover candidate TZ genes, we employed bioinformatics (coexpression and co-evolution) and identified TMEM107 as a TZ protein mutated in oral-facial-digital syndrome and JBTS patients. Mechanistic studies in Caenorhabditis elegans showed that TMEM-107 controls ciliary composition and functions redundantly with NPHP-4 to regulate cilium integrity, TZ docking and assembly of membrane to microtubule Y-link connectors. Furthermore, nematode TMEM-107 occupies an intermediate layer of the TZ-localized MKS module by organizing recruitment of the ciliopathy proteins MKS-1, TMEM-231 (JBTS20) and JBTS-14 (TMEM237). Finally, MKS module membrane proteins are immobile and super-resolution microscopy in worms and mammalian cells reveals periodic localizations within the TZ. This work expands the MKS module of ciliopathy-causing TZ proteins associated with diffusion barrier formation and provides insight into TZ subdomain architecture.	[Lambacher, Nils J.; Kuhns, Stefanie; Kennedy, Julie E.; Gaff, Karl; Blacque, Oliver E.] Univ Coll Dublin, UCD Conway Inst, Sch Biomol & Biomed Sci, Dublin 4, Ireland; [Bruel, Ange-Line; Riviere, Jean-Baptiste; Faivre, Laurence; Thauvin-Robinet, Christel] Burgundy Univ, GAD EA4271, Genet Dev Abnormal, F-21078 Dijon, France; [van Dam, Teunis J. P.; van der Lee, Robin; Huynen, Martijn A.] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Ctr Mol & Biomol Informat, NL-6525 GA Nijmegen, Netherlands; [Szymanska, Katarzyna; Johnson, Colin A.] Univ Leeds, Leeds Inst Biomol & Clin Sci, Sect Ophthalmol & Neurosci, Leeds LS9 7TF, W Yorkshire, England; [Slaats, Gisela G.; Wu, Ka Ma; Giles, Rachel H.] Univ Med Ctr Utrecht, Dept Hypertens & Nephrol, NL-3584 CX Utrecht, Netherlands; [McManus, Gavin J.] Univ Dublin Trinity Coll, Trinity Biomed Sci Inst, Microscopy Facil, Sch Biochem & Immunol, Dublin 2, Ireland; [Burglen, Lydie; Doummar, Diane] Hop Trousseau, APHP, Ctr Reference Malformat & Malad Congenitales Cerv, F-75012 Paris, France; [Burglen, Lydie; Doummar, Diane] Hop Trousseau, APHP, Serv Genet, F-75012 Paris, France; [Burglen, Lydie] INSERM, U1141, F-75019 Paris, France; [Riviere, Jean-Baptiste; Faivre, Laurence; Thauvin-Robinet, Christel] CHU Dijon, FHU TRANSLAD, F-21079 Dijon, France; [Attie-Bitach, Tania; Saunier, Sophie] Hop Necker Enfants Malad, INSERM, UMR1163, F-75015 Paris, France; [Attie-Bitach, Tania; Saunier, Sophie] Univ Paris 05, Sorbonne Paris Cite, F-75006 Paris, France; [Attie-Bitach, Tania; Saunier, Sophie] Inst IMAGINE, F-75015 Paris, France; [Attie-Bitach, Tania] Hop Necker Enfants Malad, AP HP, Dept Genet, F-75015 Paris, France; [Curd, Alistair; Peckham, Michelle] Univ Leeds, Fac Biol Sci, Sch Mol & Cellular Biol, Leeds LS2 9JT, W Yorkshire, England	University College Dublin; Institut Agro; AgroSup Dijon; Universite de Bourgogne; Radboud University Nijmegen; University of Leeds; Utrecht University; Utrecht University Medical Center; Trinity College Dublin; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; CHU Dijon Bourgogne; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Leeds	Huynen, MA (corresponding author), Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Ctr Mol & Biomol Informat, Geert Grooteplein 26-28, NL-6525 GA Nijmegen, Netherlands.	martijn.huijnen@radboudumc.nl; christel.thauvin@chu-dijon.fr; oliver.blacque@ucd.ie	Curd, Alistair/ABH-4758-2020; van Dam, Teunis JP/P-6049-2015; van der Lee, Robin/P-6920-2015; Kuhns, Stefanie/GLT-9556-2022; Slaats, Gisela/HDO-1608-2022; ATTIE-BITACH, Tania/K-1453-2017; Peckham, Michelle/J-4991-2015; Wu, Ka/P-8151-2015; Saunier, Sophie/G-6044-2015; Blacque, Oliver/AAL-8860-2021; Huynen, Martijn A/A-1530-2014	van Dam, Teunis JP/0000-0002-8122-190X; van der Lee, Robin/0000-0001-7391-9438; Kuhns, Stefanie/0000-0002-3065-7818; Slaats, Gisela/0000-0002-4567-0134; ATTIE-BITACH, Tania/0000-0002-1155-3626; Peckham, Michelle/0000-0002-3754-2028; Wu, Ka/0000-0002-6295-7137; Saunier, Sophie/0000-0002-1069-0047; Huynen, Martijn A/0000-0001-6189-5491; Curd, Alistair/0000-0002-3949-7523; Johnson, Colin/0000-0002-2979-8234; Faivre, Laurence/0000-0001-9770-444X; Blacque, Oliver/0000-0003-1598-2695; McManus, Gavin/0000-0001-8594-1229; Giles, Rachel/0000-0001-9133-2008	European Community's Seventh Framework Programme [241955]; Science Foundation Ireland [11/PI/1037]; Dutch Kidney Foundation [CP11.18]; GIS-Institut des Maladies Rares; French Fondation for Rare Disease; Virgo consortium [FE50908]; Netherlands Genomics Initiative [050-060-452]; French Ministry of Health (PHRC national) [2010-A01014-35]; Fondation pour la Recherche Medicale [DEQ20130326532]; Regional Council of Burgundy; Sir Jules Thorn Award for Biomedical Research [JTA/09]; UK Medical Research Council [MR/K011154/1, MR1K015613/1]; Lung GO Sequencing Project [HL-102923]; WHI Sequencing Project [HL-102924]; Broad GO Sequencing Project [HL-102925]; Seattle GO Sequencing Project [HL-102926]; Heart GO Sequencing Project [HL-103010]; University of Leeds; Medical Research Council [MR/M000532/1, MR/K011154/1, MR/K015613/1] Funding Source: researchfish; The Sir Jules Thorn Charitable Trust [09JTA] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [UC2HL102923, UC2HL102925, RC2HL103010, RC2HL102924, UC2HL102924, UC2HL102926, RC2HL102926, RC2HL102925, UC2HL103010, RC2HL102923] Funding Source: NIH RePORTER; MRC [MR/K015613/1, MR/K011154/1, MR/M000532/1] Funding Source: UKRI	European Community's Seventh Framework Programme(European Commission); Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Dutch Kidney Foundation; GIS-Institut des Maladies Rares; French Fondation for Rare Disease; Virgo consortium; Netherlands Genomics Initiative; French Ministry of Health (PHRC national); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Regional Council of Burgundy(Region Bourgogne-Franche-Comte); Sir Jules Thorn Award for Biomedical Research; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Lung GO Sequencing Project; WHI Sequencing Project; Broad GO Sequencing Project; Seattle GO Sequencing Project; Heart GO Sequencing Project; University of Leeds; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); The Sir Jules Thorn Charitable Trust; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was financially supported via the European Community's Seventh Framework Programme FP7/2009 (SYSCILIA grant agreement 241955 to O.E.B., M.A.H., R.H.G. and C.A.J., and Gencodys to M.A.H.), Science Foundation Ireland (11/PI/1037 to O.E.B.), the Dutch Kidney Foundation CP11.18 'KOUNCIL' (to R.H.G.), the GIS-Institut des Maladies Rares (HTS to C.T.-R.), the French Fondation for Rare Disease (to C.T.-R.), the Virgo consortium (FE50908 to M.A.H.), the Netherlands Genomics Initiative (050-060-452, RvdL to M.A.H.), the French Ministry of Health (PHRC national 2010-A01014-35 and 2013 to C.T.-R.), the Fondation pour la Recherche Medicale (DEQ20130326532 to S.S.), the Regional Council of Burgundy (to C.T.-R.), a Sir Jules Thorn Award for Biomedical Research (JTA/09 to C.A.J.), and the UK Medical Research Council (MR/K011154/1 to C.A.J., and MR1K015613/1 to M.P.). We thank the patients and their families for their participation. We also thank the NHLBI GO Exome Sequencing Project and its ongoing studies that produced and provided exome variant calls for comparison: the Lung GO Sequencing Project (HL-102923), the WHI Sequencing Project (HL-102924), the Broad GO Sequencing Project (HL-102925), the Seattle GO Sequencing Project (HL-102926) and the Heart GO Sequencing Project (HL-103010). We thank M. Leroux (Simon Fraser University, Canada), B. Yoder (University of Alabama, USA), the Caenorhabditis elegans Genetics Center (Minnesota, USA), the National Bioresource project (Tokyo, Japan), the International C. elegans gene knockout consortium, and the C. elegans Million Mutation Project for nematode reagents. We are grateful to C. Eggeling and C. Lagerholm (We atherall Institute of Molecular Medicine and the Wolfson Imaging Center, Oxford, UK) for assistance with STED microscopy, D. Scholz and T. Toivonen (UCD Conway Institute imaging facility, Dublin, IRL) for imaging support, and R. Dijkstra (Scientific Volume Imaging by, Hilversum, NL) for assistance with STED image deconvolution. We also thank A. Cleasby (Faculty of Biological Sciences, University of Leeds, Leeds, UK) for help with developing the dSTORM technique, B. Chih (Genentech, South San Francisco, CA, USA) for the kind gift of polyclonal anti-TMEM17 and TMEM231 antibodies, and T. McMorrow (University College Dublin, Dublin, Ireland) for the generous gift of the RPTEC/TERT1 cells. We thank D. Rodriguez (Trousseau hospital, Paris) for assistance with analysis of brain MRIs. The dSTORM microscope was generously funded by alumnus M. Beverly, in support of the University of Leeds 'making a world of difference campaign'.	Arts HH, 2007, NAT GENET, V39, P882, DOI 10.1038/ng2069; Barker AR, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-531; Baughman JM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000590; Blacque OE, 2014, ORGANOGENESIS, V10, P126, DOI 10.4161/org.28830; Cevik S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003977; Chih B, 2012, NAT CELL BIOL, V14, P61, DOI 10.1038/ncb2410; Christopher KJ, 2012, DEV BIOL, V368, P382, DOI 10.1016/j.ydbio.2012.06.008; Craige B, 2010, J CELL BIOL, V190, P927, DOI 10.1083/jcb.201006105; Dawe HR, 2009, J CELL SCI, V122, P2716, DOI 10.1242/jcs.043794; Friedland AE, 2013, NAT METHODS, V10, P741, DOI 10.1038/nmeth.2532; Garcia-Gonzalo FR, 2011, NAT GENET, V43, P776, DOI 10.1038/ng.891; Giles RH, 2014, NAT PROTOC, V9, P2725, DOI 10.1038/nprot.2014.181; GILULA NB, 1972, J CELL BIOL, V53, P494, DOI 10.1083/jcb.53.2.494; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; HELLER RF, 1986, EXP LUNG RES, V10, P137, DOI 10.3109/01902148609061489; Hobert O, 2002, BIOTECHNIQUES, V32, P728, DOI 10.2144/02324bm01; Hsiao Yi-Chun, 2012, Cilia, V1, P4, DOI 10.1186/2046-2530-1-4; Hu QC, 2010, SCIENCE, V329, P436, DOI 10.1126/science.1191054; Huang LJ, 2011, AM J HUM GENET, V89, P713, DOI 10.1016/j.ajhg.2011.11.005; Iglesias A, 2014, GENET MED, V16, P922, DOI 10.1038/gim.2014.58; Jauregui AR, 2008, J CELL BIOL, V180, P973, DOI 10.1083/jcb.200707090; Jensen V, 2015, EMBO J, V34, P2537, DOI 10.15252/embj.201488044; Kee HL, 2012, NAT CELL BIOL, V14, P431, DOI 10.1038/ncb2450; Kensche PR, 2008, J R SOC INTERFACE, V5, P151, DOI 10.1098/rsif.2007.1047; Nakada C, 2003, NAT CELL BIOL, V5, P626, DOI 10.1038/ncb1009; Reiter JF, 2012, EMBO REP, V13, P608, DOI 10.1038/embor.2012.73; Roberson EC, 2015, J CELL BIOL, V209, P129, DOI 10.1083/jcb.201411087; Sanders AAWM, 2015, METHOD CELL BIOL, V127, P323, DOI 10.1016/bs.mcb.2015.01.010; Schouteden C, 2015, J CELL BIOL, V210, P35, DOI 10.1083/jcb.201501013; Shaheen R, 2015, HUM MOL GENET, V24, P5211, DOI 10.1093/hmg/ddv242; STARICH TA, 1995, GENETICS, V139, P171; Valente EM, 2010, NAT GENET, V42, P619, DOI 10.1038/ng.594; van Dam TJP, 2013, P NATL ACAD SCI USA, V110, P6943, DOI 10.1073/pnas.1221011110; van Dam Teunis Jp, 2013, Cilia, V2, P7, DOI 10.1186/2046-2530-2-7; Williams CL, 2008, MOL BIOL CELL, V19, P2154, DOI 10.1091/mbc.E07-10-1070; Williams CL, 2011, J CELL BIOL, V192, P1023, DOI 10.1083/jcb.201012116; Williams CL, 2010, J AM SOC NEPHROL, V21, P782, DOI 10.1681/ASN.2009060597; Xu K, 2013, SCIENCE, V339, P452, DOI 10.1126/science.1232251; York AG, 2011, NAT METHODS, V8, P327, DOI 10.1038/NMETH.1571	39	78	84	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2016	18	1					122	+		10.1038/ncb3273	http://dx.doi.org/10.1038/ncb3273			13	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CZ3VA	26595381	Green Accepted			2022-12-25	WOS:000367030900005
J	Dar, S; Kamerkar, SC; Pucadyil, TJ				Dar, Srishti; Kamerkar, Sukrut C.; Pucadyil, Thomas J.			A high-throughput platform for real-time analysis of membrane fission reactions reveals dynamin function	NATURE CELL BIOLOGY			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; PLECKSTRIN HOMOLOGY DOMAIN; CONSTRICTION; MODEL; BILAYERS; GTPASE	Dynamin, the paradigmatic membrane fission catalyst, assembles as helical scaffolds that hydrolyse GTP to sever the tubular necks of clathrin-coated pits. Using a facile assay system of supported membrane tubes (SMrT) engineered to mimic the dimensions of necks of clathrin-coated pits, we monitor the dynamics of a dynamin-catalysed tube-severing reaction in real time using fluorescence microscopy. We find that GTP hydrolysis by an intact helical scaffold causes progressive constriction of the underlying membrane tube. On reaching a critical dimension of 7.3 nm in radius, the tube undergoes scission and concomitant splitting of the scaffold. In a constant GTP turnover scenario, scaffold assembly and GTP hydrolysis-induced tube constriction are kinetically inseparable events leading to tube-severing reactions occurring at timescales similar to the characteristic fission times seen in vivo. We anticipate SMrT templates to allow dynamic fluorescence-based detection of conformational changes occurring in self-assembling proteins that remodel membranes.	[Dar, Srishti; Kamerkar, Sukrut C.; Pucadyil, Thomas J.] Indian Inst Sci Educ & Res, Pune 411008, Maharashtra, India	Indian Institute of Science Education & Research (IISER) Pune	Pucadyil, TJ (corresponding author), Indian Inst Sci Educ & Res, Dr Homi Bhabha Rd, Pune 411008, Maharashtra, India.	pucadyil@iiserpune.ac.in	Pucadyil, Thomas/AAJ-3974-2020	Pucadyil, Thomas/0000-0002-2907-9889; DAR, SRISHTI/0000-0003-0250-5128; KAMERKAR, SUKRUT/0000-0003-2848-7132	Council for Scientific and Industrial Research (CSIR); Alliance Pune; IISER Pune	Council for Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); Alliance Pune; IISER Pune	We thank S. Schmid, R. Mallik and the Pucadyil laboratory members for discussions and critical comments on the manuscript, S. Holkar for the scanning electron microscopy, and V. Vitthal for confocal microscopy. S.D. and S.C.K. acknowledge the Council for Scientific and Industrial Research (CSIR) for fellowships. T.J.P. is an Intermediate Fellow of the Wellcome Trust-DBT India Alliance and thanks the Alliance and IISER Pune for funds.	Bashkirov PV, 2008, CELL, V135, P1276, DOI 10.1016/j.cell.2008.11.028; Chappie JS, 2013, J CELL SCI, V126, P2773, DOI 10.1242/jcs.108845; Chappie JS, 2011, CELL, V147, P209, DOI 10.1016/j.cell.2011.09.003; Chappie JS, 2010, NATURE, V465, P435, DOI 10.1038/nature09032; Cocucci E, 2014, MOL BIOL CELL, V25, P3595, DOI 10.1091/mbc.E14-07-1240; Danino D, 2004, J STRUCT BIOL, V147, P259, DOI 10.1016/j.jsb.2004.04.005; Doyon JB, 2011, NAT CELL BIOL, V13, P331, DOI 10.1038/ncb2175; Faelber K, 2012, STRUCTURE, V20, P1621, DOI 10.1016/j.str.2012.08.028; Ferguson SM, 2012, NAT REV MOL CELL BIO, V13, P75, DOI 10.1038/nrm3266; Frolov VA, 2015, CHEM PHYS LIPIDS, V185, P129, DOI 10.1016/j.chemphyslip.2014.07.006; Fuhrmans M, 2015, SOFT MATTER, V11, P1464, DOI 10.1039/c4sm02533d; Hsieh WT, 2012, LANGMUIR, V28, P12838, DOI 10.1021/la302205b; Iversen TG, 2003, P NATL ACAD SCI USA, V100, P5175, DOI 10.1073/pnas.0534231100; Jung H, 2009, J AM CHEM SOC, V131, P1006, DOI 10.1021/ja804542p; Kozlovsky Y, 2003, BIOPHYS J, V85, P85, DOI 10.1016/S0006-3495(03)74457-9; Lemmon MA, 2000, BIOCHEM J, V350, P1, DOI 10.1042/0264-6021:3500001; Mattila JP, 2015, NATURE, V524, P109, DOI 10.1038/nature14509; Mears JA, 2007, STRUCTURE, V15, P1190, DOI 10.1016/j.str.2007.08.012; Mehrotra N, 2014, MOL BIOL CELL, V25, P879, DOI 10.1091/mbc.E13-09-0548; Morlot S, 2012, CELL, V151, P619, DOI 10.1016/j.cell.2012.09.017; Pucadyil TJ, 2008, CELL, V135, P1263, DOI 10.1016/j.cell.2008.11.020; Ramachandran R, 2009, MOL BIOL CELL, V20, P4630, DOI 10.1091/mbc.E09-08-0683; Roux A, 2006, NATURE, V441, P528, DOI 10.1038/nature04718; Roux Aurelien, 2014, F1000Prime Rep, V6, P86, DOI 10.12703/P6-86; Roux A, 2010, P NATL ACAD SCI USA, V107, P4141, DOI 10.1073/pnas.0913734107; Schmid SL, 2011, ANNU REV CELL DEV BI, V27, P79, DOI 10.1146/annurev-cellbio-100109-104016; Shnyrova AV, 2013, SCIENCE, V339, P1433, DOI 10.1126/science.1233920; Sundborger AC, 2014, CELL REP, V8, P734, DOI 10.1016/j.celrep.2014.06.054; Sweitzer SM, 1998, CELL, V93, P1021, DOI 10.1016/S0092-8674(00)81207-6; Taylor MJ, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000604; Vallis Y, 1999, CURR BIOL, V9, P257, DOI 10.1016/S0960-9822(99)80114-6; Zhang PJ, 2001, NAT CELL BIOL, V3, P922, DOI 10.1038/ncb1001-922	32	32	32	1	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2015	17	12					1588	1596		10.1038/ncb3254	http://dx.doi.org/10.1038/ncb3254			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CX8DH	26479317				2022-12-25	WOS:000365932300011
J	Paternoster, L; Standl, M; Waage, J; Baurecht, H; Hotze, M; Strachan, DP; Curtin, JA; Bonnelykke, K; Tian, C; Takahashi, A; Esparza-Gordillo, J; Alves, AC; Thyssen, JP; den Dekker, HT; Ferreira, MA; Altmaier, E; Sleiman, PMA; Xiao, FL; Gonzalez, JR; Marenholz, I; Kalb, B; Pino-Yanes, M; Xu, CJ; Carstensen, L; Groen-Blokhuis, MM; Venturini, C; Pennell, CE; Barton, SJ; Levin, AM; Curjuric, I; Bustamante, M; Kreiner-Moller, E; Lockett, GA; Bacelis, J; Bunyavanich, S; Myers, RA; Matanovic, A; Kumar, A; Tung, JY; Hirota, T; Kubo, M; McArdle, WL; Henderson, AJ; Kemp, JP; Zheng, J; Smith, GD; Rueschendorf, F; Bauerfeind, A; Lee-Kirsch, MA; Arnold, A; Homuth, G; Schmidt, CO; Mangold, E; Cichon, S; Keil, T; Rodriguez, E; Peters, A; Franke, A; Lieb, W; Novak, N; Foelster-Holst, R; Horikoshi, M; Pekkanen, J; Sebert, S; Husemoen, LL; Grarup, N; De Jongste, JC; Rivadeneira, F; Hofman, A; Jaddoe, VWV; Pasmans, SGMA; Elbert, NJ; Uitterlinden, AG; Marks, GB; Thompson, PJ; Matheson, MC; Robertson, CF; Ried, JS; Li, J; Zuo, XB; Zheng, XD; Yin, XY; Sun, LD; McAleer, MA; O'Regan, GM; Fahy, CMR; Campbell, LE; Macek, M; Kurek, M; Hu, D; Eng, C; Postma, DS; Feenstra, B; Geller, F; Hottenga, JJ; Middeldorp, CM; Hysi, P; Bataille, V; Spector, T; Tiesler, CMT; Thiering, E; Pahukasahasram, B; Yang, JJ; Imboden, M; Huntsman, S; Vilor-Tejedor, N; Relton, CL; Myhre, R; Nystad, W; Custovic, A; Weiss, ST; Meyers, DA; Soederhaell, C; Melen, E; Ober, C; Raby, BA; Simpson, A; Jacobsson, B; Holloway, JW; Bisgaard, H; Sunyer, J; Probst-Hensch, NM; Williams, LK; Godfrey, KM; Wang, CA; Boomsma, DI; Melbye, M; Koppelman, GH; Jarvis, D; McLean, WHI; Irvine, AD; Zhang, XJ; Hakonarson, H; Gieger-, C; Burchard, EG; Martin, NG; Duijts, L; Linneberg, A; Jarvelin, MR; Noethen, MM; Lau, S; Huebner, N; Lee, YA; Tamari, M; Hinds, DA; Glass, D; Brown, SJ; Heinrich, J; Evans, DM; Weidinger, S				Paternoster, Lavinia; Standl, Marie; Waage, Johannes; Baurecht, Hansjoerg; Hotze, Melanie; Strachan, David P.; Curtin, John A.; Bonnelykke, Klaus; Tian, Chao; Takahashi, Atsushi; Esparza-Gordillo, Jorge; Alves, Alexessander Couto; Thyssen, Jacob P.; den Dekker, Herman T.; Ferreira, Manuel A.; Altmaier, Elisabeth; Sleiman, Patrick M. A.; Xiao, Feng Li; Gonzalez, Juan R.; Marenholz, Ingo; Kalb, Birgit; Pino-Yanes, Maria; Xu, Cheng-Jian; Carstensen, Lisbeth; Groen-Blokhuis, Maria M.; Venturini, Cristina; Pennell, Craig E.; Barton, Sheila J.; Levin, Albert M.; Curjuric, Ivan; Bustamante, Mariona; Kreiner-Moller, Eskil; Lockett, Gabrielle A.; Bacelis, Jonas; Bunyavanich, Supinda; Myers, Rachel A.; Matanovic, Anja; Kumar, Ashish; Tung, Joyce Y.; Hirota, Tomomitsu; Kubo, Michiaki; McArdle, Wendy L.; Henderson, A. John; Kemp, John P.; Zheng, Jie; Smith, George Davey; Rueschendorf, Franz; Bauerfeind, Anja; Lee-Kirsch, Min Ae; Arnold, Andreas; Homuth, Georg; Schmidt, Carsten O.; Mangold, Elisabeth; Cichon, Sven; Keil, Thomas; Rodriguez, Elke; Peters, Annette; Franke, Andre; Lieb, Wolfgang; Novak, Natalija; Foelster-Holst, Regina; Horikoshi, Momoko; Pekkanen, Juha; Sebert, Sylvain; Husemoen, Lise L.; Grarup, Niels; De Jongste, Johan C.; Rivadeneira, Fernando; Hofman, Albert; Jaddoe, Vincent W. V.; Pasmans, Suzanne G. M. A.; Elbert, Niels J.; Uitterlinden, Andre G.; Marks, Guy B.; Thompson, Philip J.; Matheson, Melanie C.; Robertson, Colin F.; Ried, Janina S.; Li, Jin; Zuo, Xian Bo; Zheng, Xiao Dong; Yin, Xian Yong; Sun, Liang Dan; McAleer, Maeve A.; O'Regan, Grainne M.; Fahy, Caoimhe M. R.; Campbell, Linda E.; Macek, Milan; Kurek, Michael; Hu, Donglei; Eng, Celeste; Postma, Dirkje S.; Feenstra, Bjarke; Geller, Frank; Hottenga, Jouke Jan; Middeldorp, Christel M.; Hysi, Pirro; Bataille, Veronique; Spector, Tim; Tiesler, Carla M. T.; Thiering, Elisabeth; Pahukasahasram, Badri; Yang, James J.; Imboden, Medea; Huntsman, Scott; Vilor-Tejedor, Natalia; Relton, Caroline L.; Myhre, Ronny; Nystad, Wenche; Custovic, Adnan; Weiss, Scott T.; Meyers, Deborah A.; Soederhaell, Cilla; Melen, Erik; Ober, Carole; Raby, Benjamin A.; Simpson, Angela; Jacobsson, Bo; Holloway, John W.; Bisgaard, Hans; Sunyer, Jordi; Probst-Hensch, Nicole M.; Williams, L. Keoki; Godfrey, Keith M.; Wang, Carol A.; Boomsma, Dorret I.; Melbye, Mads; Koppelman, Gerard H.; Jarvis, Deborah; McLean, W. H. Irwin; Irvine, Alan D.; Zhang, Xue Jun; Hakonarson, Hakon; Gieger-, Christian; Burchard, Esteban G.; Martin, Nicholas G.; Duijts, Liesbeth; Linneberg, Allan; Jarvelin, Marjo-Riitta; Noethen, Markus M.; Lau, Susanne; Huebner, Norbert; Lee, Young-Ae; Tamari, Mayumi; Hinds, David A.; Glass, Daniel; Brown, Sara J.; Heinrich, Joachim; Evans, David M.; Weidinger, Stephan		AAGC; EArly Genetics Lifecourse Epidemio	Multi-ancestry genome-wide association study of 21,000 cases and 95,000 controls identifies new risk loci for atopic dermatitis	NATURE GENETICS			English	Article							SUSCEPTIBILITY LOCI; INTERLEUKIN-7 RECEPTOR; VARIANTS; METAANALYSIS; DISEASE; ASTHMA; FILAGGRIN; CELLS; IL-7; SKIN	Genetic association studies have identified 21 loci associated with atopic dermatitis risk predominantly in populations of European ancestry. To identify further susceptibility loci for this common, complex skin disease, we performed a meta-analysis of >15 million genetic variants in 21,399 cases and 95,464 controls from populations of European, African, Japanese and Latino ancestry, followed by replication in 32,059 cases and 228,628 controls from 18 studies. We identified ten new risk loci, bringing the total number of known atopic dermatitis risk loci to 31 (with new secondary signals at four of these loci). Notably, the new loci include candidate genes with roles in the regulation of innate host defenses and T cell function, underscoring the important contribution of (auto) immune mechanisms to atopic dermatitis pathogenesis.	[Paternoster, Lavinia] Univ Bristol, Med Res Council MRC Integrat Epidemiol Unit, Bristol, Avon, England; [Paternoster, Lavinia; Kemp, John P.; Zheng, Jie; Smith, George Davey; Relton, Caroline L.; Evans, David M.] Univ Bristol, Med Res Council MRC Integrat Epidemiol Unit, Bristol, Avon, England; [Paternoster, Lavinia; McArdle, Wendy L.; Henderson, A. John; Kemp, John P.; Zheng, Jie; Smith, George Davey; Evans, David M.] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Standl, Marie; Tiesler, Carla M. T.; Thiering, Elisabeth; Heinrich, Joachim] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol 1, Neuherberg, Germany; [Waage, Johannes; Bonnelykke, Klaus; Kreiner-Moller, Eskil; Bisgaard, Hans] Univ Copenhagen, Herlev & Gentofte Hosp, Copenhagen Prospect Studies Asthma Childhood COPS, Copenhagen, Denmark; [Baurecht, Hansjoerg; Hotze, Melanie; Rodriguez, Elke; Foelster-Holst, Regina; Weidinger, Stephan] Univ Hosp Schleswig Holstein, Dept Dermatol Allergol & Venereol, Kiel, Germany; [Strachan, David P.] Univ London, Populat Hlth Res Inst, St Georges, London, England; [Curtin, John A.; Custovic, Adnan; Simpson, Angela] Univ Manchester, Manchester Acad Hlth Sci Ctr, Inst Inflammat & Repair, Ctr Resp Med & Allergy, Manchester, Lancs, England; [Curtin, John A.; Custovic, Adnan; Simpson, Angela] Univ Hosp South Manchester Natl Hlth Serv NHS Fdn, Manchester, Lancs, England; [Tian, Chao; Tung, Joyce Y.; Hinds, David A.] 23andMe Inc, Mountain View, CA USA; [Takahashi, Atsushi] Inst Phys & Chem Res RIKEN, Ctr Integrat Med Sci, Lab Stat Anal, Yokohama, Kanagawa, Japan; [Esparza-Gordillo, Jorge; Marenholz, Ingo; Kalb, Birgit; Rueschendorf, Franz; Bauerfeind, Anja; Huebner, Norbert; Lee, Young-Ae] Max Delbruck Ctr Mol Med, Berlin, Germany; [Esparza-Gordillo, Jorge; Marenholz, Ingo; Matanovic, Anja; Lee, Young-Ae] Charite, Expt & Clin Res Ctr, Clin Pediat Allergy, D-13353 Berlin, Germany; [Alves, Alexessander Couto] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Epidemiol & Biostat, London, England; [Thyssen, Jacob P.] Univ Copenhagen, Herlev & Gentofte Hosp, Dept Dermatol & Allergol, Natl Allergy Res Ctr, Copenhagen, Denmark; [den Dekker, Herman T.; De Jongste, Johan C.; Jaddoe, Vincent W. V.; Duijts, Liesbeth] Erasmus Univ, Med Ctr, Dept Pediat, Rotterdam, Netherlands; [den Dekker, Herman T.; Rivadeneira, Fernando; Hofman, Albert; Jaddoe, Vincent W. V.; Uitterlinden, Andre G.; Duijts, Liesbeth] Erasmus Univ, Med Ctr, Dept Epidemiol, Rotterdam, Netherlands; [den Dekker, Herman T.; Rivadeneira, Fernando; Jaddoe, Vincent W. V.; Elbert, Niels J.; Duijts, Liesbeth] Erasmus Univ, Med Ctr, Generat Study Grp R, Rotterdam, Netherlands; [Ferreira, Manuel A.; Martin, Nicholas G.] QIMR Berghofer Med Res Inst, Brisbane, Qld, Australia; [Altmaier, Elisabeth; Gieger-, Christian] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Res Unit Mol Epidemiol, Neuherberg, Germany; [Altmaier, Elisabeth; Peters, Annette; Gieger-, Christian] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol 2, Neuherberg, Germany; [Altmaier, Elisabeth; Ried, Janina S.; Gieger-, Christian] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Genet Epidemiol, Neuherberg, Germany; [Sleiman, Patrick M. A.; Li, Jin; Hakonarson, Hakon] Childrens Hosp Philadelphia, Ctr Appl Genom, Philadelphia, PA 19104 USA; [Sleiman, Patrick M. A.; Hakonarson, Hakon] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Xiao, Feng Li; Zuo, Xian Bo; Zheng, Xiao Dong; Yin, Xian Yong; Sun, Liang Dan; Zhang, Xue Jun] Anhui Med Univ, Inst Dermatol, Hefei, Peoples R China; [Gonzalez, Juan R.; Bustamante, Mariona; Vilor-Tejedor, Natalia; Sunyer, Jordi] Ctr Res Environm Epidemiol CREAL, Barcelona, Spain; [Gonzalez, Juan R.; Bustamante, Mariona; Vilor-Tejedor, Natalia; Sunyer, Jordi] UPF, Barcelona, Spain; [Gonzalez, Juan R.; Bustamante, Mariona; Vilor-Tejedor, Natalia; Sunyer, Jordi] CIBERESP, Barcelona, Spain; [Kalb, Birgit; Lau, Susanne] Charite, Pediat Pneumol & Immunol, D-13353 Berlin, Germany; [Pino-Yanes, Maria; Hu, Donglei; Eng, Celeste; Huntsman, Scott; Burchard, Esteban G.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Pino-Yanes, Maria] Inst Salud Carlos III, Ctr Invest Biomed Red CIBER Enfermedades Resp, Madrid, Spain; [Pino-Yanes, Maria] Hosp Univ Nuestra Senora de Candelaria, Res Unit, Santa Cruz De Tenerife, Spain; [Xu, Cheng-Jian; Postma, Dirkje S.] Univ Groningen, Univ Med Ctr Groningen, Dept Pulmonol, Groningen Res Inst Asthma & COPD GRIAC, NL-9700 AB Groningen, Netherlands; [Xu, Cheng-Jian] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen Res Inst Asthma & COPD GRIAC, NL-9700 AB Groningen, Netherlands; [Carstensen, Lisbeth; Feenstra, Bjarke; Geller, Frank; Melbye, Mads] Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen, Denmark; [Groen-Blokhuis, Maria M.; Hottenga, Jouke Jan; Middeldorp, Christel M.; Boomsma, Dorret I.] Vrije Univ Amsterdam, Netherlands Twin Register, Dept Biol Psychol, Amsterdam, Netherlands; [Venturini, Cristina; Hysi, Pirro; Bataille, Veronique; Spector, Tim; Glass, Daniel] Kings Coll London, Dept Twin Res & Genet Epidemiol, London WC2R 2LS, England; [Pennell, Craig E.; Wang, Carol A.] Univ Western Australia, Sch Womens & Infants Hlth, Perth, WA 6009, Australia; [Barton, Sheila J.; Godfrey, Keith M.] Univ Southampton, Lifecourse Epidemiol Unit, MRC, Southampton, Hants, England; [Levin, Albert M.] Henry Ford Hlth Syst, Dept Publ Hlth Sci, Detroit, MI USA; [Curjuric, Ivan; Kumar, Ashish; Imboden, Medea; Probst-Hensch, Nicole M.] Swiss Trop & Publ Hlth Inst, Dept Epidemiol & Publ Hlth, Basel, Switzerland; [Curjuric, Ivan; Kumar, Ashish; Imboden, Medea; Probst-Hensch, Nicole M.] Univ Basel, Basel, Switzerland; [Bustamante, Mariona] CRG, Barcelona, Spain; [Lockett, Gabrielle A.; Holloway, John W.] Univ Southampton, Fac Med, Human Dev & Hlth, Southampton SO9 5NH, Hants, England; [Bacelis, Jonas; Jacobsson, Bo] Sahlgrens Univ Hosp, Sahlgrenska Acad, Inst Clin Sci, Dept Obstet & Gynecol, Gothenburg, Sweden; [Bunyavanich, Supinda] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Myers, Rachel A.; Ober, Carole] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Kumar, Ashish; Melen, Erik] Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden; [Kumar, Ashish; Horikoshi, Momoko] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Hirota, Tomomitsu; Tamari, Mayumi] Inst Phys & Chem Res RIKEN, Ctr Integrat Med Sci, Lab Resp & Allerg Dis, Yokohama, Kanagawa, Japan; [Kubo, Michiaki] Inst Phys & Chem Res RIKEN, Ctr Integrat Med Sci, Lab Genotyping Dev, Yokohama, Kanagawa, Japan; [Kemp, John P.; Evans, David M.] Univ Queensland, Translat Res Inst, Diamantina Inst, Brisbane, Qld, Australia; [Lee-Kirsch, Min Ae] Tech Univ Dresden, Klin Kinder & Jugendmed, D-01062 Dresden, Germany; [Arnold, Andreas] Univ Med Greifswald, Clin & Polyclin Dermatol, Greifswald, Germany; [Homuth, Georg] Med Univ Med, Interfac Inst Genet & Funct Genom, Dept Funct Genom, Greifswald, Germany; [Homuth, Georg] Ernst Moritz Arndt Univ Greifswald, Greifswald, Germany; [Schmidt, Carsten O.] Univ Med Greifswald, Study Hlth Pomerania KEF Klin Epidemiol Forsch, Inst Community Med, Greifswald, Germany; [Mangold, Elisabeth; Cichon, Sven; Noethen, Markus M.] Univ Bonn, Inst Human Genet, Bonn, Germany; [Cichon, Sven; Noethen, Markus M.] Univ Bonn, Life & Brain Ctr, Dept Genom, Bonn, Germany; [Cichon, Sven] Univ Basel Hosp, Div Med Genet, CH-4031 Basel, Switzerland; [Cichon, Sven] Univ Basel, Dept Biomed, Basel, Switzerland; [Cichon, Sven] Res Ctr Julich, Struct & Funct Org Brain Genom Imaging, Inst Neurosci & Med INM 1, Julich, Germany; [Keil, Thomas] Charite, Inst Social Med Epidemiol & Hlth Econ, D-13353 Berlin, Germany; [Keil, Thomas] Univ Wurzburg, Inst Clin Epidemiol & Biometry, D-97070 Wurzburg, Germany; [Peters, Annette] Munich Heart Alliance, DZHK German Res Ctr Cardiovasc Res, Munich, Germany; [Franke, Andre] Univ Kiel, Inst Clin Mol Biol, Kiel, Germany; [Lieb, Wolfgang] Univ Kiel, Inst Epidemiol, Kiel, Germany; [Novak, Natalija] Univ Bonn, Dept Dermatol & Allergy, Bonn, Germany; [Pekkanen, Juha] Natl Inst Hlth & Welf, Unit Living Environm & Hlth, Kuopio, Finland; [Pekkanen, Juha] Univ Helsinki, Dept Publ Hlth, Helsinki, Finland; [Sebert, Sylvain; Jarvelin, Marjo-Riitta] Univ Oulu, Fac Med, Ctr Life Course Epidemiol & Syst Med, Oulu, Finland; [Sebert, Sylvain; Jarvelin, Marjo-Riitta] Univ Oulu, Bioctr Oulu, Oulu, Finland; [Husemoen, Lise L.; Linneberg, Allan] Capital Region Denmark, Res Ctr Prevent & Hlth, Copenhagen, Denmark; [Grarup, Niels] Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn Ctr Basic Metab Res, Copenhagen, Denmark; [Rivadeneira, Fernando; Uitterlinden, Andre G.] Erasmus Univ, Med Ctr, Dept Internal Med, Rotterdam, Netherlands; [Pasmans, Suzanne G. M. A.; Elbert, Niels J.] Erasmus Univ, Med Ctr, Dept Dermatol, Rotterdam, Netherlands; [Marks, Guy B.] Univ Sydney, Woolcock Inst Med Res, Sydney, NSW 2006, Australia; [Thompson, Philip J.] Queen Elizabeth II Med Ctr, Lung Inst Western Australia, Nedlands, WA, Australia; [Thompson, Philip J.] Univ Western Australia, Sch Med & Pharmacol, Perth, WA 6009, Australia; [Matheson, Melanie C.] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Melbourne, Vic, Australia; [Robertson, Colin F.] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [McAleer, Maeve A.; Irvine, Alan D.] Natl Childrens Res Ctr, Dublin, Ireland; [McAleer, Maeve A.; O'Regan, Grainne M.; Irvine, Alan D.] Our Ladys Childrens Hosp, Dept Pediat Dermatol, Dublin, Ireland; [Fahy, Caoimhe M. R.; Irvine, Alan D.] Univ Dublin Trinity Coll, Clin Med, Dublin 2, Ireland; [Campbell, Linda E.; McLean, W. H. Irwin; Brown, Sara J.] Univ Dundee, Ctr Dermatol & Genet Med, Dundee, Scotland; [Macek, Milan] Univ Hosp Motol, Dept Biol & Med Genet, Prague, Czech Republic; [Macek, Milan] Charles Univ Prague, Fac Med 2, Prague, Czech Republic; [Kurek, Michael] Pomeranian Med Univ, Dept Clin Allergol, Szczecin, Poland; [Tiesler, Carla M. T.; Thiering, Elisabeth] Univ Munich, Dr von Hauner Childrens Hosp, Div Metab Dis & Nutr Med, Munich, Germany; [Pahukasahasram, Badri; Williams, L. Keoki] Henry Ford Hlth Syst, Ctr Hlth Policy & Hlth Serv Res, Detroit, MI USA; [Yang, James J.] Univ Michigan, Sch Nursing, Ann Arbor, MI 48109 USA; [Relton, Caroline L.] Newcastle Univ, Inst Genet Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Myhre, Ronny; Nystad, Wenche; Jacobsson, Bo] Norwegian Inst Publ Hlth, Div Epidemiol, Oslo, Norway; [Raby, Benjamin A.] Brigham & Womens Hosp, Channing Div Network Med, Boston, MA 02115 USA; [Weiss, Scott T.; Raby, Benjamin A.] Harvard Univ, Sch Med, Boston, MA USA; [Meyers, Deborah A.] Wake Forest Sch Med, Ctr Genom & Personalized Med Res, Winston Salem, NC USA; Karolinska Inst, Dept Biosci & Nutr, Stockholm, Sweden; [Soederhaell, Cilla] Karolinska Inst, Ctr Innovat Med CIMED, Stockholm, Sweden; [Melen, Erik] Sachs Childrens Hosp, Stockholm, Sweden; [Holloway, John W.] Univ Southampton, Fac Med, Clin & Expt Sci, Southampton SO9 5NH, Hants, England; [Sunyer, Jordi] Hosp del Mar Med Res Inst IMIM, Barcelona, Spain; [Williams, L. Keoki] Henry Ford Hlth Syst, Dept Internal Med, Detroit, MI USA; [Godfrey, Keith M.] Univ Southampton, Southampton Biomed Res Ctr, Natl Inst Hlth Res, Southampton, Hants, England; [Godfrey, Keith M.] Univ Hosp Southampton Natl Hlth Serv NHS Fdn Trus, Southampton, Hants, England; [Boomsma, Dorret I.] Vrije Univ Amsterdam, Inst Hlth & Care Res EMGO, Amsterdam, Netherlands; [Melbye, Mads; Linneberg, Allan] Univ Copenhagen, Fac Hlth & Med Sci, Dept Clin Med, Copenhagen, Denmark; [Melbye, Mads] Stanford Sch Med, Dept Med, Stanford, CA USA; [Koppelman, Gerard H.] Univ Groningen, Univ Med Ctr Groningen, Dept Pediat Pulmonol & Pediat Allergol, Beatrix Childrens Hosp,Groningen Res Inst Asthma, Groningen, Netherlands; [Koppelman, Gerard H.] Univ Groningen, Univ Med Ctr Groningen, COPD GRIAC, Groningen, Netherlands; [Jarvis, Deborah] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Resp Epidemiol Occupat Med & Publ Hlth, London, England; [Jarvis, Deborah] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Med Res Council Publ Hlth England Ctr Environm &, Dept Epidemiol & Biostat, London, England; [Burchard, Esteban G.] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA; [Linneberg, Allan] Rigshosp, Dept Clin Expt Res, Glostrup, Denmark; [Jarvelin, Marjo-Riitta] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Med Res Council Publ Hlth England Ctr Environm &, Dept Epidemiol & Biostat, London, England; [Jarvelin, Marjo-Riitta] Oulu Univ Hosp, Unit Primary Care, Oulu, Finland; [Brown, Sara J.] Univ Dundee, Ninewells Hosp & Med Sch, Dept Dermatol, Dundee DD1 9SY, Scotland	University of Bristol; University of Bristol; University of Bristol; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Copenhagen; University of Kiel; Schleswig Holstein University Hospital; University of London; University of Manchester; Wythenshawe Hospital NHS Foundation Trust; RIKEN; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Imperial College London; University of Copenhagen; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; QIMR Berghofer Medical Research Institute; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Anhui Medical University; Pompeu Fabra University; Pompeu Fabra University; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of California System; University of California San Francisco; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Instituto de Salud Carlos III; University of Groningen; University of Groningen; Statens Serum Institut; Vrije Universiteit Amsterdam; University of London; King's College London; University of Western Australia; University of Southampton; Henry Ford Health System; Henry Ford Hospital; University of Basel; Swiss Tropical & Public Health Institute; University of Basel; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); University of Southampton; Sahlgrenska University Hospital; University of Gothenburg; Icahn School of Medicine at Mount Sinai; University of Chicago; Karolinska Institutet; University of Oxford; Wellcome Centre for Human Genetics; RIKEN; RIKEN; University of Queensland; Technische Universitat Dresden; Greifswald Medical School; Ernst Moritz Arndt Universitat Greifswald; Greifswald Medical School; University of Bonn; University of Bonn; University of Basel; University of Basel; Helmholtz Association; Research Center Julich; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Wurzburg; German Centre for Cardiovascular Research; Munich Heart Alliance; University of Kiel; University of Kiel; University of Bonn; Finland National Institute for Health & Welfare; University of Helsinki; University of Oulu; University of Oulu; Novo Nordisk Foundation; University of Copenhagen; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of Sydney; Woolcock Institute of Medical Research; University of Western Australia; University of Western Australia; University of Melbourne; Murdoch Children's Research Institute; National Children's Research Centre (NCRC); Trinity College Dublin; National Children's Research Centre (NCRC); Our Ladys Children Hospital Crumlin; Trinity College Dublin; University of Dundee; Motol University Hospital; Charles University Prague; Pomeranian Medical University; University of Munich; Henry Ford Health System; Henry Ford Hospital; University of Michigan System; University of Michigan; Newcastle University - UK; Norwegian Institute of Public Health (NIPH); Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Wake Forest University; Karolinska Institutet; Karolinska Institutet; University of Southampton; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Henry Ford Health System; Henry Ford Hospital; University of Southampton; Vrije Universiteit Amsterdam; University of Copenhagen; Stanford University; University of Groningen; University of Groningen; Imperial College London; Imperial College London; University of California System; University of California San Francisco; Rigshospitalet; Imperial College London; University of Oulu; University of Dundee	Paternoster, L (corresponding author), Univ Bristol, Med Res Council MRC Integrat Epidemiol Unit, Bristol, Avon, England.	l.paternoster@bristol.ac.uk	Pennell, Craig/ABD-6902-2020; Pasmans, Suzanne/AAI-6016-2021; Raby, Benjamin/AAK-3866-2021; Heinrich, Joachim/N-1720-2013; Boomsma, Dorret I/AAX-4470-2020; Matheson, Melanie C/O-4721-2015; Horikoshi, Momoko/AAF-9034-2019; Rodríguez, Elke/C-4259-2013; Weidinger, Stephan/C-8461-2011; Bisgaard, Hans/N-4761-2016; Franke, Andre/B-2151-2010; Jacobsson, Bo/O-8007-2014; Thyssen, Jacob/ABD-8517-2020; Lieb, Wolfgang/AAC-7650-2022; Tamari, Mayumi/N-5378-2015; tian, chao/GYD-3462-2022; Rivadeneira, Fernando/O-5385-2015; Sunyer, Jordi/G-6909-2014; Irvine, Alan D/A-3982-2008; Holloway, John W/B-5424-2009; Grarup, Niels/K-2807-2015; Koppelman, Gerard/AAG-9187-2020; Pino-Yanes, Maria/C-8498-2017; Bustamante, Mariona/ABB-9142-2021; Evans, David M/H-6325-2013; Davey Smith, George/A-7407-2013; Xu, Cheng-Jian/G-9144-2018; Marks, Guy B./F-5058-2013; Schmidt, Carsten Oliver/AAH-2778-2019; Gonzalez, Juan R/B-7860-2018; Relton, Caroline/AAC-5904-2019; Krause, Lutz/G-6283-2013; Kemp, John P./R-3091-2018; Peters, Annette/A-6117-2011; Kubo, Michiaki/N-7947-2015; Custovic, Adnan/A-2435-2012; Middeldorp, Christel M/L-7728-2017; Lee-Kirsch, Min Ae/C-5769-2018; Paternoster, Lavinia/C-1292-2015; Baurecht, Hansjorg/C-4035-2013; Cichon, Sven/B-9618-2014	Pennell, Craig/0000-0002-0937-6165; Pasmans, Suzanne/0000-0003-1018-4475; Heinrich, Joachim/0000-0002-9620-1629; Matheson, Melanie C/0000-0002-5822-3499; Rodríguez, Elke/0000-0003-3692-3950; Weidinger, Stephan/0000-0003-3944-252X; Bisgaard, Hans/0000-0003-4131-7592; Franke, Andre/0000-0003-1530-5811; Jacobsson, Bo/0000-0001-5079-2374; Rivadeneira, Fernando/0000-0001-9435-9441; Sunyer, Jordi/0000-0002-2602-4110; Irvine, Alan D/0000-0002-9048-2044; Holloway, John W/0000-0001-9998-0464; Grarup, Niels/0000-0001-5526-1070; Pino-Yanes, Maria/0000-0003-0332-437X; Bustamante, Mariona/0000-0003-0127-2860; Evans, David M/0000-0003-0663-4621; Davey Smith, George/0000-0002-1407-8314; Xu, Cheng-Jian/0000-0003-1586-4672; Marks, Guy B./0000-0002-8976-8053; Schmidt, Carsten Oliver/0000-0001-5266-9396; Gonzalez, Juan R/0000-0003-3267-2146; Krause, Lutz/0000-0003-3806-0845; Kemp, John P./0000-0002-9105-2249; Peters, Annette/0000-0001-6645-0985; Custovic, Adnan/0000-0001-5218-7071; Middeldorp, Christel M/0000-0002-6218-0428; Paternoster, Lavinia/0000-0003-2514-0889; Zheng, Jie/0000-0002-6623-6839; Geller, Frank/0000-0002-9238-3269; Venturini, Cristina/0000-0002-4769-7912; Pekkanen, Juha/0000-0002-1083-8777; Lau, Susanne/0000-0002-5189-4265; Sebert, Sylvain/0000-0001-6681-6983; Couto Alves, Alex/0000-0001-8519-7356; Relton, Caroline/0000-0003-2052-4840; Bacelis, Jonas/0000-0002-2450-732X; Wang, Carol/0000-0002-4301-3974; Koppelman, Gerard/0000-0001-8567-3252; Baurecht, Hansjorg/0000-0002-9265-5594; Kalb, Birgit/0000-0002-3104-6736; Hinds, David/0000-0002-4911-803X; Standl, Marie/0000-0002-5345-2049; Gieger, Christian/0000-0001-6986-9554; Kumar, Ashish/0000-0002-7075-5930; s, hema/0000-0002-3440-9475; Linneberg, Allan/0000-0002-0994-0184; Simpson, Angela/0000-0003-2733-6666; Strachan, David/0000-0001-7854-1366; Thyssen, Jacob Pontoppidan/0000-0003-3770-1743; Cichon, Sven/0000-0002-9475-086X; Jarvelin, Marjo-Riitta/0000-0002-2149-0630; Barton, Sheila/0000-0003-4963-4242; Ober, Carole/0000-0003-4626-9809; Bonnelykke, Klaus/0000-0003-2003-1018; Nothen, Markus/0000-0002-8770-2464; Kreiner, Eskil/0000-0003-1204-2438; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Hysi, Pirro/0000-0001-5752-2510; Dharmage, Shyamali/0000-0001-6063-1937; Jarvis, Deborah/0000-0002-1753-3896; Vilor-Tejedor, Natalia/0000-0003-4935-6721; melbye, mads/0000-0001-8264-6785; Godfrey, Keith/0000-0002-4643-0618; Thiering, Elisabeth/0000-0002-5429-9584	MRC Population Health Scientist Fellowship [MR/J012165/1]; Australian Research Council Future Fellowship [FT130101709]; Medical Research Council program grant [MC_UU_12013/4]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI118833] Funding Source: NIH RePORTER; Lundbeck Foundation [R163-2013-16235, R139-2012-12679] Funding Source: researchfish; Medical Research Council [G1001799, G0601361, MR/N01104X/1, G0700314, MR/K002449/2, MR/K002449/1, MC_UU_12013/4, MC_UU_12011/4, MC_UU_12013/2, MC_UU_12013/1, G9815508, MR/J012165/1, MC_PC_15018, G0802780] Funding Source: researchfish; MRC [MR/J012165/1, G1001799, G0601361, MR/K002449/1, MR/K002449/2, G0802780, MC_UU_12013/1, G0700314, MR/N01104X/1, MC_UU_12013/4, MC_UU_12011/4, MC_UU_12013/2] Funding Source: UKRI	MRC Population Health Scientist Fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Australian Research Council Future Fellowship(Australian Research Council); Medical Research Council program grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Lundbeck Foundation(Lundbeckfonden); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This publication is the work of the authors, and L.P. will serve as guarantor for the contents of this paper. This research was specifically funded by an MRC Population Health Scientist Fellowship awarded to L.P. (MR/J012165/1). D.M.E. is supported by an Australian Research Council Future Fellowship (FT130101709) and a Medical Research Council program grant (MC_UU_12013/4). Individual study acknowledgment and funding statements can be found in the Supplementary Note.	Agarwala V, 2013, NAT GENET, V45, P1418, DOI 10.1038/ng.2804; Baker BS, 2006, CLIN EXP IMMUNOL, V144, P1, DOI 10.1111/j.1365-2249.2005.02980.x; Baron S, 2005, GUT, V54, P357, DOI 10.1136/gut.2004.054353; Bataille V, 2012, J EUR ACAD DERMATOL, V26, P1067, DOI 10.1111/j.1468-3083.2011.04444.x; Baurecht H, 2015, AM J HUM GENET, V96, P104, DOI 10.1016/j.ajhg.2014.12.004; Beck LA, 2014, NEW ENGL J MED, V371, P130, DOI 10.1056/NEJMoa1314768; Bernstein BE, 2010, NAT BIOTECHNOL, V28, P1045, DOI 10.1038/nbt1010-1045; Blair DR, 2013, CELL, V155, P70, DOI 10.1016/j.cell.2013.08.030; Bonnelykke K, 2013, NAT GENET, V45, P902, DOI 10.1038/ng.2694; Bradfield JP, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002293; Cole C, 2014, J ALLERGY CLIN IMMUN, V134, P82, DOI 10.1016/j.jaci.2014.04.021; Cortes A, 2013, NAT GENET, V45, P730, DOI 10.1038/ng.2667; de Jong MAWP, 2010, TRENDS IMMUNOL, V31, P452, DOI 10.1016/j.it.2010.08.002; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ellinghaus D, 2013, NAT GENET, V45, P808, DOI 10.1038/ng.2642; Esparza-Gordillo J, 2013, J ALLERGY CLIN IMMUN, V132, P371, DOI 10.1016/j.jaci.2013.01.057; Esparza-Gordillo J, 2009, NAT GENET, V41, P596, DOI 10.1038/ng.347; Ferreira MAR, 2014, J ALLERGY CLIN IMMUN, V133, P1564, DOI 10.1016/j.jaci.2013.10.030; Ferreira MAR, 2011, LANCET, V378, P1006, DOI 10.1016/S0140-6736(11)60874-X; Giarnbartolomei C., 2014, PLOS GENET, V10; Granada M, 2012, J ALLERGY CLIN IMMUN, V129, P840, DOI 10.1016/j.jaci.2011.09.029; Gregory SG, 2007, NAT GENET, V39, P1083, DOI 10.1038/ng2103; Grundberg E, 2012, NAT GENET, V44, P1084, DOI 10.1038/ng.2394; HENSELER T, 1995, J AM ACAD DERMATOL, V32, P982, DOI 10.1016/0190-9622(95)91336-X; Himes BE, 2009, AM J HUM GENET, V84, P581, DOI 10.1016/j.ajhg.2009.04.006; Hinds DA, 2013, NAT GENET, V45, P907, DOI 10.1038/ng.2686; Hirota T, 2012, NAT GENET, V44, P1222, DOI 10.1038/ng.2438; Hirota T, 2011, NAT GENET, V43, P893, DOI 10.1038/ng.887; Irvine AD, 2011, NEW ENGL J MED, V365, P1315, DOI 10.1056/NEJMra1011040; Jakobsen C, 2013, J CROHNS COLITIS, V7, P79, DOI 10.1016/j.crohns.2012.05.024; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kitabatake M, 2012, J IMMUNOL, V189, P1193, DOI 10.4049/jimmunol.1102774; Lundmark F, 2007, NAT GENET, V39, P1108, DOI 10.1038/ng2106; Lundstrom W, 2012, SEMIN IMMUNOL, V24, P218, DOI 10.1016/j.smim.2012.02.005; Lundstrom W, 2013, P NATL ACAD SCI USA, V110, pE1761, DOI 10.1073/pnas.1222303110; Lupski JR, 2011, CELL, V147, P32, DOI 10.1016/j.cell.2011.09.008; Malissen B, 2014, NAT REV IMMUNOL, V14, P417, DOI 10.1038/nri3683; Maller JB, 2012, NAT GENET, V44, P1294, DOI 10.1038/ng.2435; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Mertens-Talcott SU, 2007, CANCER RES, V67, P11001, DOI 10.1158/0008-5472.CAN-07-2416; Milner JD, 2008, NATURE, V452, P773, DOI 10.1038/nature06764; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Moisan J, 2007, J EXP MED, V204, P2825, DOI 10.1084/jem.20070994; Morris AP, 2011, GENET EPIDEMIOL, V35, P809, DOI 10.1002/gepi.20630; Nagarajan P, 2010, J CELL SCI, V123, P3566, DOI 10.1242/jcs.062240; Niwa Y, 2004, J INVEST DERMATOL, V123, P999, DOI 10.1111/j.0022-202X.2004.23462.x; Noguchi E, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002170; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; Okada Y, 2014, NATURE, V506, P376, DOI 10.1038/nature12873; Palmer CNA, 2006, NAT GENET, V38, P441, DOI 10.1038/ng1767; Paternoster L, 2012, NAT GENET, V44, P187, DOI 10.1038/ng.1017; Ramasamy A, 2011, J ALLERGY CLIN IMMUN, V128, P996, DOI 10.1016/j.jaci.2011.08.030; Rodriguez E, 2009, J ALLERGY CLIN IMMUN, V123, P1361, DOI 10.1016/j.jaci.2009.03.036; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Segre AV, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001058; Sleiman PMA, 2010, NEW ENGL J MED, V362, P36, DOI 10.1056/NEJMoa0901867; So HC, 2011, GENET EPIDEMIOL, V35, P447, DOI 10.1002/gepi.20593; Steward-Tharp SM, 2014, BLOOD, V123, P2978, DOI 10.1182/blood-2013-09-523167; Stritesky GL, 2012, ANNU REV IMMUNOL, V30, P95, DOI 10.1146/annurev-immunol-020711-075035; Sun LD, 2011, NAT GENET, V43, P690, DOI 10.1038/ng.851; Tang TS, 2012, J ALLERGY CLIN IMMUN, V129, P1209, DOI 10.1016/j.jaci.2012.02.002; Tintle S, 2011, J ALLERGY CLIN IMMUN, V128, P583, DOI 10.1016/j.jaci.2011.05.042; Tsoi LC, 2012, NAT GENET, V44, P1341, DOI 10.1038/ng.2467; Uehira M, 1998, J INVEST DERMATOL, V110, P740, DOI 10.1046/j.1523-1747.1998.00179.x; Wang X, 2013, HUM MOL GENET, V22, P2303, DOI 10.1093/hmg/ddt064; Weidinger S, 2016, LANCET, V387, P1109, DOI 10.1016/S0140-6736(15)00149-X; Weidinger S, 2013, HUM MOL GENET, V22, P4841, DOI 10.1093/hmg/ddt317; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Yang J, 2012, NAT GENET, V44, P369, DOI 10.1038/ng.2213	69	335	343	4	72	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2015	47	12					1449	+		10.1038/ng.3424	http://dx.doi.org/10.1038/ng.3424			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CX6LT	26482879	Green Submitted, Green Accepted			2022-12-25	WOS:000365813200017
J	Bement, WM; Leda, M; Moe, AM; Kita, AM; Larson, ME; Golding, AE; Pfeuti, C; Su, KC; Miller, AL; Goryachev, AB; von Dassow, G				Bement, William M.; Leda, Marcin; Moe, Alison M.; Kita, Angela M.; Larson, Matthew E.; Golding, Adriana E.; Pfeuti, Courtney; Su, Kuan-Chung; Miller, Ann L.; Goryachev, Andrew B.; von Dassow, George			Activator-inhibitor coupling between Rho signalling and actin assembly makes the cell cortex an excitable medium	NATURE CELL BIOLOGY			English	Article							SURFACE CONTRACTION WAVES; MESENCHYMAL TRANSITION; FURROW FORMATION; CYTOKINESIS; XENOPUS; CYCLE; DYNAMICS; PHASE; PROTRUSION; MOTILITY	Animal cell cytokinesis results from patterned activation of the small GTPase Rho, which directs assembly of actomyosin in the equatorial cortex. Cytokinesis is restricted to a portion of the cell cycle following anaphase onset in which the cortex is responsive to signals from the spindle. We show that shortly after anaphase onset oocytes and embryonic cells of frogs and echinoderms exhibit cortical waves of Rho activity and F-actin polymerization. The waves are modulated by cyclin-dependent kinase 1 (Cdk1) activity and require the Rho GEF (guanine nucleotide exchange factor), Ect2. Surprisingly, during wave propagation, although Rho activity elicits F-actin assembly, F-actin subsequently inactivates Rho. Experimental and modelling results show that waves represent excitable dynamics of a reaction diffusion system with Rho as the activator and F-actin the inhibitor. We propose that cortical excitability explains fundamental features of cytokinesis including its cell cycle regulation.	[Bement, William M.; Moe, Alison M.; Kita, Angela M.; Larson, Matthew E.; Golding, Adriana E.; Pfeuti, Courtney] Univ Wisconsin, Grad Program Cell & Mol Biol, Lab Cell & Mol Biol, Madison, WI 53706 USA; [Leda, Marcin; Goryachev, Andrew B.] Univ Edinburgh, Ctr Synthet & Syst Biol, Edinburgh EH9 3BF, Midlothian, Scotland; [Su, Kuan-Chung] MIT, Whitehead Inst Biomed Res, Boston, MA 02142 USA; [Miller, Ann L.] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48190 USA; [von Dassow, George] Univ Oregon, Oregon Inst Marine Biol, Charleston, OR 97420 USA	University of Wisconsin System; University of Wisconsin Madison; University of Edinburgh; Massachusetts Institute of Technology (MIT); Whitehead Institute; University of Michigan System; University of Michigan; University of Oregon	Bement, WM (corresponding author), Univ Wisconsin, Grad Program Cell & Mol Biol, Lab Cell & Mol Biol, Madison, WI 53706 USA.	wmbement@wisc.edu; andrew.goryachev@ed.ac.uk; DASSOW@uoregon.edu	Goryachev, Andrew B/A-6553-2013; Bement, William/AAA-5444-2021; Larson, Matthew E/GYR-1980-2022	Goryachev, Andrew B/0000-0002-1332-4819; Larson, Matthew E/0000-0002-1125-6760; Miller, Ann/0000-0002-7293-764X	National Institutes of Health [GM52932]; National Science Foundation [NSF MCB-0917887, MCB-1041200]; NIH instrumentation grant [1S10RR026729-01]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NIH instrumentation grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Many thanks to S. Maslakova for laboratory space and to B. Dlouhy-Massengale and S. Yang for technical assistance. This work was supported by the National Institutes of Health (GM52932 to W.M.B.) and the National Science Foundation (NSF MCB-0917887 and MCB-1041200 to G.v.D.) and by NIH instrumentation grant 1S10RR026729-01 (K. Eliceiri PI).	Allard J, 2013, CURR OPIN CELL BIOL, V25, P107, DOI 10.1016/j.ceb.2012.08.012; Arai Y, 2010, P NATL ACAD SCI USA, V107, P12399, DOI 10.1073/pnas.0908278107; Bement WM, 2006, BIOESSAYS, V28, P983, DOI 10.1002/bies.20477; Bement WM, 2005, J CELL BIOL, V170, P91, DOI 10.1083/jcb.200501131; Benink HA, 2005, J CELL BIOL, V168, P429, DOI 10.1083/jcb.200411109; Berndt JD, 2008, DEV BIOL, V324, P236, DOI 10.1016/j.ydbio.2008.09.013; Burkel BM, 2007, CELL MOTIL CYTOSKEL, V64, P822, DOI 10.1002/cm.20226; Burkel BM, 2012, DEV CELL, V23, P384, DOI 10.1016/j.devcel.2012.05.025; Canman JC, 2000, CURR BIOL, V10, P611, DOI 10.1016/S0960-9822(00)00490-5; Chang JB, 2013, NATURE, V500, P603, DOI 10.1038/nature12321; Charras GT, 2006, J CELL BIOL, V175, P477, DOI 10.1083/jcb.200602085; Clay MR, 2013, DEVELOPMENT, V140, P3198, DOI 10.1242/dev.095448; Goryachev AB, 2008, FEBS LETT, V582, P1437, DOI 10.1016/j.febslet.2008.03.029; Gray N, 1999, CURR MED CHEM, V6, P859; Green RA, 2012, ANNU REV CELL DEV BI, V28, P29, DOI 10.1146/annurev-cellbio-101011-155718; LECHLEITER J, 1991, SCIENCE, V252, P123, DOI 10.1126/science.2011747; Lim D, 2003, J BIOL CHEM, V278, P42505, DOI 10.1074/jbc.M301851200; Miller AL, 2009, NAT CELL BIOL, V11, P71, DOI 10.1038/ncb1814; MURRAY AW, 1989, NATURE, V339, P275, DOI 10.1038/339275a0; Perez-Mongiovi D, 1998, J CELL SCI, V111, P385; Piekny AJ, 2010, SEMIN CELL DEV BIOL, V21, P881, DOI 10.1016/j.semcdb.2010.08.002; Rankin S, 1997, CURR BIOL, V7, P451, DOI 10.1016/S0960-9822(06)00192-8; RAPPAPORT R, 1965, J EXP ZOOL, V158, P373, DOI 10.1002/jez.1401580311; Rappaport R., 1996, CYTOKINESIS ANIMAL C; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Ryan GL, 2012, BIOPHYS J, V102, P1493, DOI 10.1016/j.bpj.2012.03.005; Shibata T, 2012, J CELL SCI, V125, P5138, DOI 10.1242/jcs.108373; Shuster CB, 2002, CURR BIOL, V12, P854, DOI 10.1016/S0960-9822(02)00838-2; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Su KC, 2014, MOL BIOL CELL, V25, P4049, DOI 10.1091/mbc.E14-04-0859; Su KC, 2011, DEV CELL, V21, P1104, DOI 10.1016/j.devcel.2011.11.003; Taniguchi D, 2013, P NATL ACAD SCI USA, V110, P5016, DOI 10.1073/pnas.1218025110; von Dassow G, 2009, J CELL BIOL, V187, P831, DOI 10.1083/jcb.200907090; Weiner OD, 2007, PLOS BIOL, V5, P2053, DOI 10.1371/journal.pbio.0050221; WINFREE AT, 1994, SCIENCE, V266, P1003, DOI 10.1126/science.7973648; Wrholmes WR, 2012, PHYS BIOL, V9, DOI 10.1088/1478-3975/9/4/046005; Yoo SK, 2010, DEV CELL, V18, P226, DOI 10.1016/j.devcel.2009.11.015	37	151	152	1	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	NOV	2015	17	11					1471	1483		10.1038/ncb3251	http://dx.doi.org/10.1038/ncb3251			13	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CV4XT	26479320	Green Accepted			2022-12-25	WOS:000364270500012
J	van Karnebeek, CDM; Bonafe, L; Wen, XY; Tarailo-Graovac, M; Balzano, S; Royer-Bertrand, B; Ashikov, A; Garavelli, L; Mammi, I; Turolla, L; Breen, C; Donnai, D; Cormier-Daire, V; Heron, D; Nishimura, G; Uchikawa, S; Campos-Xavier, B; Rossi, A; Hennet, T; Brand-Arzamendi, K; Rozmus, J; Harshman, K; Stevenson, BJ; Girardi, E; Superti-Furga, G; Dewan, T; Collingridge, A; Halparin, J; Ross, CJ; Van Allen, MI; Rossi, A; Engelke, UF; Kluijtmans, LAJ; van der Heeft, E; Renkema, H; de Brouwer, A; Huijben, K; Zijlstra, F; Heise, T; Boltje, T; Wasserman, WW; Rivolta, C; Unger, S; Lefeber, DJ; Wevers, RA; Superti-Furga, A				van Karnebeek, Clara D. M.; Bonafe, Luisa; Wen, Xiao-Yan; Tarailo-Graovac, Maja; Balzano, Sara; Royer-Bertrand, Beryl; Ashikov, Angel; Garavelli, Livia; Mammi, Isabella; Turolla, Licia; Breen, Catherine; Donnai, Dian; Cormier-Daire, Valerie; Heron, Delphine; Nishimura, Gen; Uchikawa, Shinichi; Campos-Xavier, Belinda; Rossi, Antonio; Hennet, Thierry; Brand-Arzamendi, Koroboshka; Rozmus, Jacob; Harshman, Keith; Stevenson, Brian J.; Girardi, Enrico; Superti-Furga, Giulio; Dewan, Tammie; Collingridge, Alissa; Halparin, Jessie; Ross, Colin J.; Van Allen, Margot I.; Rossi, Andrea; Engelke, Udo F.; Kluijtmans, Leo A. J.; van der Heeft, Ed; Renkema, Herma; de Brouwer, Arjan; Huijben, Karin; Zijlstra, Fokje; Heise, Torben; Boltje, Thomas; Wasserman, Wyeth W.; Rivolta, Carlo; Unger, Sheila; Lefeber, Dirk J.; Wevers, Ron A.; Superti-Furga, Andrea			NANS-mediated synthesis of sialic acid is required for brain and skeletal development	NATURE GENETICS			English	Article							INTELLECTUAL DISABILITY; ESSENTIAL NUTRIENT; MASS-SPECTROMETRY; DISORDERS; QUANTIFICATION; CLASSIFICATION; METABOLISM; MUTATIONS; DYSPLASIA; DIAGNOSIS	We identified biallelic mutations in NANS, the gene encoding the synthase for N-acetylneuraminic acid (NeuNAc; sialic acid), in nine individuals with infantile-onset severe developmental delay and skeletal dysplasia. Patient body fluids showed an elevation in N-acetyl-d-mannosamine levels, and patient-derived fibroblasts had reduced NANS activity and were unable to incorporate sialic acid precursors into sialylated glycoproteins. Knockdown of nansa in zebrafish embryos resulted in abnormal skeletal development, and exogenously added sialic acid partially rescued the skeletal phenotype. Thus, NANS-mediated synthesis of sialic acid is required for early brain development and skeletal growth. Normal sialylation of plasma proteins was observed in spite of NANS deficiency. Exploration of endogenous synthesis, nutritional absorption, and rescue pathways for sialic acid in different tissues and developmental phases is warranted to design therapeutic strategies to counteract NANS deficiency and to shed light on sialic acid metabolism and its implications for human nutrition.	[van Karnebeek, Clara D. M.; Rozmus, Jacob; Dewan, Tammie; Collingridge, Alissa; Halparin, Jessie; Ross, Colin J.] Univ British Columbia, Dept Pediat, Vancouver, BC V6T 1W5, Canada; [van Karnebeek, Clara D. M.; Tarailo-Graovac, Maja; Ross, Colin J.; Wasserman, Wyeth W.] Univ British Columbia, Child & Family Res Inst, Ctr Mol Med, Vancouver, BC V5Z 1M9, Canada; [Bonafe, Luisa; Royer-Bertrand, Beryl; Campos-Xavier, Belinda; Superti-Furga, Andrea] Univ Lausanne, Lausanne Univ Hosp CHUV, Ctr Mol Dis, Lausanne, Switzerland; [Wen, Xiao-Yan; Brand-Arzamendi, Koroboshka] St Michaels Hosp, Keenan Res Ctr Biomed Sci, Zebrafish Ctr Adv Drug Discovery, 30 Bond St, Toronto, ON M5B 1W8, Canada; [Wen, Xiao-Yan; Brand-Arzamendi, Koroboshka] Univ Toronto, Dept Med, Toronto, ON, Canada; [Tarailo-Graovac, Maja; Ross, Colin J.; Van Allen, Margot I.; Wasserman, Wyeth W.] Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada; [Balzano, Sara; Royer-Bertrand, Beryl; Rivolta, Carlo] Univ Lausanne, Dept Med Genet, Lausanne, Switzerland; [Ashikov, Angel; Lefeber, Dirk J.] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Dept Neurol, NL-6525 ED Nijmegen, Netherlands; [Garavelli, Livia] IRCCS S Maria Nuova Hosp, Clin Genet Unit, Reggio Emilia, Italy; [Mammi, Isabella] Osped Dolo, UO Ginecol Ostetricia, Ambulatorio Genet Med ULSS 13, Dolo, Italy; [Turolla, Licia] Local Hlth Author ULSS 9, Med Genet Unit, Treviso, Italy; [Breen, Catherine; Donnai, Dian] Univ Manchester, St Marys Hosp,Manchester Ctr Genom Med, Manchester Acad Hlth Sci Ctr,Inst Human Dev, Cent Manchester Univ Hosp NHS Fdn Trust,Fac Med &, Manchester M13 0JH, Lancs, England; [Cormier-Daire, Valerie; Heron, Delphine] Hop Necker Enfants Malad, Inst IMAGINE, Paris, France; [Nishimura, Gen] Tokyo Metropolitan Childrens Med Ctr, Dept Radiol, Tokyo, Japan; [Uchikawa, Shinichi] Natl Ctr Child Hlth & Dev, Dept Orthoped, Tokyo, Japan; [Rossi, Antonio] Univ Pavia, Biochem Unit, Dept Mol Med, Via Palestro 3, I-27100 Pavia, Italy; [Hennet, Thierry] Univ Zurich, Dept Physiol, Winterthurerstr 190, CH-8057 Zurich, Switzerland; [Harshman, Keith] Univ Lausanne, Fac Biol & Med, Genom Technol Facil, Lausanne, Switzerland; [Stevenson, Brian J.] Univ Lausanne, Swiss Inst Bioinformat, Vital IT Grp, Lausanne, Switzerland; [Girardi, Enrico; Superti-Furga, Giulio] Austrian Acad Sci, CeMM Res Ctr Mol Med, A-1010 Vienna, Austria; [Superti-Furga, Giulio] Med Univ Vienna, Ctr Physiol & Pharmacol, Vienna, Austria; [Rossi, Andrea] G Gaslini Childrens Hosp, Dept Neuroradiol, Genoa, Italy; [Engelke, Udo F.; Kluijtmans, Leo A. J.; van der Heeft, Ed; Renkema, Herma; Huijben, Karin; Zijlstra, Fokje; Lefeber, Dirk J.; Wevers, Ron A.] Radboud Univ Nijmegen, Med Ctr, Dept Lab Med, Translat Metab Lab, NL-6525 ED Nijmegen, Netherlands; [de Brouwer, Arjan] Radboud Univ Nijmegen, Dept Genet, NL-6525 ED Nijmegen, Netherlands; [Heise, Torben; Boltje, Thomas] Radboud Univ Nijmegen, Dept Organ Chem, NL-6525 ED Nijmegen, Netherlands; [Unger, Sheila] Univ Lausanne, Univ Lausanne Hosp, Med Genet Serv, Lausanne, Switzerland; [Superti-Furga, Andrea] Univ Lausanne, Univ Lausanne Hosp, Dept Pediat, Lausanne, Switzerland	University of British Columbia; Child & Family Research Institute; University of British Columbia; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of British Columbia; University of Lausanne; Radboud University Nijmegen; ULSS 3 Serenissima; Presidio Ospedaliero di Dolo; University of Manchester; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Tokyo Metropolitan Children's Medical Center; National Center for Child Health & Development - Japan; University of Pavia; University of Zurich; University of Lausanne; Swiss Institute of Bioinformatics; University of Lausanne; Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences; Medical University of Vienna; University of Genoa; IRCCS Istituto Giannina Gaslini; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	van Karnebeek, CDM (corresponding author), Univ British Columbia, Dept Pediat, Vancouver, BC V6T 1W5, Canada.; van Karnebeek, CDM (corresponding author), Univ British Columbia, Child & Family Res Inst, Ctr Mol Med, Vancouver, BC V5Z 1M9, Canada.; Superti-Furga, A (corresponding author), Univ Lausanne, Lausanne Univ Hosp CHUV, Ctr Mol Dis, Lausanne, Switzerland.; Wevers, RA (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Lab Med, Translat Metab Lab, NL-6525 ED Nijmegen, Netherlands.; Superti-Furga, A (corresponding author), Univ Lausanne, Univ Lausanne Hosp, Dept Pediat, Lausanne, Switzerland.	cvankarnebeek@cw.bc.ca; ron.wevers@radboudumc.nl; asuperti@unil.ch	Girardi, Enrico/L-4033-2014; Garavelli, Livia/AAA-8132-2021; Superti-Furga, Giulio/AAE-5681-2019; Girardi, Enrico/AAD-2260-2020; Rossi, Andrea/A-4146-2011; Heise, Torben/E-1157-2017; Kluijtmans, Leo A/L-4437-2015; Lefeber, Dirk DJ/A-2146-2014; Wevers, Ron A./H-8116-2014; Campos-Xavier, Belinda/P-9917-2019; Renkema, Herma/L-1489-2015; de Brouwer, Arjan PM/P-5949-2015; Boltje, Thomas/F-9695-2015; Ashikov, Angel/N-7714-2015; Rossi, Antonio/E-9935-2012; superti-furga, andrea/E-9162-2015; cormier-daire, valerie/H-6520-2017	Girardi, Enrico/0000-0003-3508-2723; Garavelli, Livia/0000-0002-7684-3982; Girardi, Enrico/0000-0003-3508-2723; Rossi, Andrea/0000-0001-8575-700X; Heise, Torben/0000-0003-2949-0456; Wevers, Ron A./0000-0003-2278-9746; Campos-Xavier, Belinda/0000-0002-6271-0724; Renkema, Herma/0000-0002-8174-6538; Ashikov, Angel/0000-0001-9679-7955; superti-furga, andrea/0000-0002-3543-7531; Tarailo-Graovac, Maja/0000-0002-4472-8584; Ross, Colin/0000-0003-1476-7037; , Jacob/0000-0003-4036-2105; Turolla, Licia/0000-0001-8899-4588; Wen, Xiao-Yan/0000-0001-6728-0025; Wasserman, Wyeth/0000-0001-6098-6412; cormier-daire, valerie/0000-0002-2839-9856; Unger, Sheila/0000-0002-9539-8941; Rivolta, Carlo/0000-0002-0733-9950	Leenaards Foundation in Lausanne, Switzerland; Faculty of Biology and Medicine of the University of Lausanne; BC Children's Hospital Foundation (Treatable Intellectual Disability Endeavour in British Columbia: First Collaborative Area of Innovation); Genome BC [SOF-195]; Rare Diseases Foundation; Rare Diseases Models and Mechanisms Network; Canadian Institutes of Health Research [301221]; Dutch Organization for Scientific Research, ZONMW [40-00506-98-9001]; Dutch Organization for Scientific Research, ZONMW (VIDI) [91713359]; Canadian Rare Disease Models and Mechanisms Network; Brain Canada Foundation; Natural Sciences and Engineering Research Council of Canada (NSERC); Canada Foundation for Innovation (CFI); Genome BC; Genome Canada (ABC4DE Project); Vital-IT Project of the Swiss Institute of Bioinformatics (SIB; Lausanne, Switzerland); Canadian Institutes of Health Research; Michael Smith Foundation for Health Research Scholar Award (Vancouver, Canada); Marie Sklodowska-Curie fellowship [MSCA-IF-661491]	Leenaards Foundation in Lausanne, Switzerland; Faculty of Biology and Medicine of the University of Lausanne; BC Children's Hospital Foundation (Treatable Intellectual Disability Endeavour in British Columbia: First Collaborative Area of Innovation); Genome BC; Rare Diseases Foundation; Rare Diseases Models and Mechanisms Network; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Dutch Organization for Scientific Research, ZONMW(Netherlands Organization for Scientific Research (NWO)Netherlands Organization for Health Research and Development); Dutch Organization for Scientific Research, ZONMW (VIDI); Canadian Rare Disease Models and Mechanisms Network; Brain Canada Foundation; Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation for Innovation (CFI)(Canada Foundation for Innovation); Genome BC; Genome Canada (ABC4DE Project)(Genome Canada); Vital-IT Project of the Swiss Institute of Bioinformatics (SIB; Lausanne, Switzerland); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research Scholar Award (Vancouver, Canada); Marie Sklodowska-Curie fellowship	This work has been supported by funding from the Leenaards Foundation in Lausanne, Switzerland; the Faculty of Biology and Medicine of the University of Lausanne; the BC Children's Hospital Foundation (Treatable Intellectual Disability Endeavour in British Columbia: First Collaborative Area of Innovation); Genome BC (grant SOF-195); the Rare Diseases Foundation; the Rare Diseases Models and Mechanisms Network; the Canadian Institutes of Health Research (grant 301221); and the Dutch Organization for Scientific Research, ZONMW (Medium Investment Grant 40-00506-98-9001 and VIDI Grant 91713359 to D.J.L.). The zebrafish studies were supported by funding to X.-Y.W. from the Canadian Rare Disease Models and Mechanisms Network, the Brain Canada Foundation, the Natural Sciences and Engineering Research Council of Canada (NSERC), and the Canada Foundation for Innovation (CFI). The informatics infrastructures were supported by Genome BC and Genome Canada (ABC4DE Project) as well as by the Vital-IT Project of the Swiss Institute of Bioinformatics (SIB; Lausanne, Switzerland). C.J.R. is funded by a Canadian Institutes of Health Research New Investigator Award. C.D.M.v.K. is a recipient of the Michael Smith Foundation for Health Research Scholar Award (Vancouver, Canada). E.G. is supported by a Marie Sklodowska-Curie fellowship (MSCA-IF-661491).	American Psychiatric Association, 2013, DIAGN STAT MAN MENT, V5, DOI 10.1176/appi.books.9780890425596; Boccuto L, 2014, HUM MOL GENET, V23, P418, DOI 10.1093/hmg/ddt434; Bode L, 2012, GLYCOBIOLOGY, V22, P1147, DOI 10.1093/glycob/cws074; Bonafe L, 2015, AM J MED GENET A, V167, P2869, DOI 10.1002/ajmg.a.37365; Bull C, 2015, ACS CHEM BIOL, V10, P2353, DOI 10.1021/acschembio.5b00501; CAMERA G, 1993, PEDIATR RADIOL, V23, P611, DOI 10.1007/BF02014981; Cotton TR, 2014, BBA-PROTEINS PROTEOM, V1844, P2257, DOI 10.1016/j.bbapap.2014.09.014; de Ligt J, 2012, NEW ENGL J MED, V367, P1921, DOI 10.1056/NEJMoa1206524; Eisen JS, 2008, DEVELOPMENT, V135, P1735, DOI 10.1242/dev.001115; Engelke UFH, 2006, NMR BIOMED, V19, P271, DOI 10.1002/nbm.1018; Fragaki K, 2013, EUR J HUM GENET, V21, P528, DOI 10.1038/ejhg.2012.202; Fuhrer A, 2010, J EXP MED, V207, P2843, DOI 10.1084/jem.20101098; Galuska SP, 2010, ANAL CHEM, V82, P4591, DOI 10.1021/ac100627e; Genevieve D, 2005, EUR J HUM GENET, V13, P541, DOI 10.1038/sj.ejhg.5201339; Gilissen C, 2014, NATURE, V511, P344, DOI [10.1038/nature13394, 10.3389/fnhum.2013.00444]; Gunawan J, 2005, J BIOL CHEM, V280, P3555, DOI 10.1074/jbc.M411942200; Hamada T, 2006, PROTEIN SCI, V15, P1010, DOI 10.1110/ps.051700406; Hu H, 2011, AM J HUM GENET, V89, P407, DOI 10.1016/j.ajhg.2011.08.008; Jansen JC, 2016, AM J HUM GENET, V98, P310, DOI 10.1016/j.ajhg.2015.12.010; Javidan Y, 2004, METHOD CELL BIOL, V76, P415; Link V, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-1; Malicdan MCV, 2009, NAT MED, V15, P690, DOI 10.1038/nm.1956; Mohamed M, 2013, NEUROLOGY, V81, P681, DOI 10.1212/WNL.0b013e3182a08f53; NOHLE U, 1981, H-S Z PHYSIOL CHEM, V362, P1495, DOI 10.1515/bchm2.1981.362.2.1495; Oetke C, 2001, EUR J BIOCHEM, V268, P4553, DOI 10.1046/j.1432-1327.2001.02379.x; Rajavel KS, 2001, MOL CELL BIOL, V21, P5512, DOI 10.1128/MCB.21.16.5512-5519.2001; Riemersma M, 2015, HUM MOL GENET, V24, P2241, DOI 10.1093/hmg/ddu742; Rohrig CH, 2017, CRIT REV FOOD SCI, V57, P1017, DOI 10.1080/10408398.2015.1040113; ROUGHLEY PJ, 1981, J BIOL CHEM, V256, P2699; Salama I, 2005, BIOCHEM BIOPH RES CO, V328, P221, DOI 10.1016/j.bbrc.2004.12.157; Salvador-Carulla L, 2011, WORLD PSYCHIATRY, V10, P175; Samraj AN, 2015, P NATL ACAD SCI USA, V112, P542, DOI 10.1073/pnas.1417508112; Simpson MA, 2004, NAT GENET, V36, P1225, DOI 10.1038/ng1460; Sodek J, 2000, CRIT REV ORAL BIOL M, V11, P279, DOI 10.1177/10454411000110030101; Sprenger N, 2012, ADV NUTR, V3, p392S, DOI 10.3945/an.111.001479; Superti-Furga A, 2001, AM J MED GENET, V106, P282, DOI 10.1002/ajmg.10233; Tangvoranuntakul P, 2003, P NATL ACAD SCI USA, V100, P12045, DOI 10.1073/pnas.2131556100; Tarailo-Graovac M., N ENGL J ME IN PRESS; Valianpour F, 2004, CLIN CHEM, V50, P403, DOI 10.1373/clinchem.2003.027169; Stormo Gary D, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1110s43, 10.1002/0471250953.bi1201s43]; van der Ham M, 2010, J CHROMATOGR B, V878, P1098, DOI 10.1016/j.jchromb.2010.03.020; van Karnebeek CDM, 2012, MOL GENET METAB, V105, P368, DOI 10.1016/j.ymgme.2011.11.191; Van Scherpenzeel M, 2015, TRANSL RES, V166, P639, DOI 10.1016/j.trsl.2015.07.005; Vincent K, 2013, J MOL GRAPH MODEL, V39, P108, DOI 10.1016/j.jmgm.2012.10.007; Wang B, 2003, EUR J CLIN NUTR, V57, P1351, DOI 10.1038/sj.ejcn.1601704; Wang B, 2012, ADV NUTR, V3, p465S, DOI 10.3945/an.112.001875; Wang B, 2009, ANNU REV NUTR, V29, P177, DOI 10.1146/annurev.nutr.28.061807.155515; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wishart DS, 2013, NUCLEIC ACIDS RES, V41, pD801, DOI 10.1093/nar/gks1065; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213	50	89	91	1	41	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2016	48	7					777	+		10.1038/ng.3578	http://dx.doi.org/10.1038/ng.3578			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DP9TK	27213289	Green Accepted			2022-12-25	WOS:000378840100015
J	Planas-Paz, L; Orsini, V; Boulter, L; Calabrese, D; Pikiolek, M; Nigsch, F; Xie, Y; Roma, G; Donovan, A; Marti, P; Beckmann, N; Dill, MT; Carbone, W; Bergling, S; Isken, A; Mueller, M; Kinzel, B; Yang, Y; Mao, XH; Nicholson, TB; Zamponi, R; Capodieci, P; Valdez, R; Rivera, D; Loew, A; Ukomadu, C; Terracciano, LM; Bouwmeester, T; Cong, F; Heim, MH; Forbes, SJ; Ruffner, H; Tchorz, JS				Planas-Paz, Lara; Orsini, Vanessa; Boulter, Luke; Calabrese, Diego; Pikiolek, Monika; Nigsch, Florian; Xie, Yang; Roma, Guglielmo; Donovan, Adriana; Marti, Patricia; Beckmann, Nicolau; Dill, Michael T.; Carbone, Walter; Bergling, Sebastian; Isken, Andrea; Mueller, Matthias; Kinzel, Bernd; Yang, Yi; Mao, Xiaohong; Nicholson, Thomas B.; Zamponi, Raffaella; Capodieci, Paola; Valdez, Reginald; Rivera, Daniel; Loew, Andreas; Ukomadu, Chinweike; Terracciano, Luigi M.; Bouwmeester, Tewis; Cong, Feng; Heim, Markus H.; Forbes, Stuart J.; Ruffner, Heinz; Tchorz, Jan S.			The RSPO-LGR4/5-ZNRF3/RNF43 module controls liver zonation and size	NATURE CELL BIOLOGY			English	Article							WNT/BETA-CATENIN PATHWAY; BETA-CATENIN; STEM-CELLS; PARTIAL-HEPATECTOMY; WNT RECEPTORS; REGENERATION; GENE; MICE; LGR5; EXPRESSION	LGR4/5 receptors and their cognate RSPO ligands potentiate Wnt/beta-catenin signalling and promote proliferation and tissue homeostasis in epithelial stem cell compartments. In the liver, metabolic zonation requires a Wnt/beta-catenin signalling gradient, but the instructive mechanism controlling its spatiotemporal regulation is not known. We have now identified the RSPO-LGR4/5-ZNRF3/RNF43 module as a master regulator of Wnt/beta-catenin-mediated metabolic liver zonation. Liver-specific LGR4/5 loss of function (LOF) or RSPO blockade disrupted hepatic Wnt/beta-catenin signalling and zonation. Conversely, pathway activation in ZNRF3/RNF43 LOF mice or with recombinant RSPO1 protein expanded the hepatic Wnt/beta-catenin signalling gradient in a reversible and LGR4/5-dependent manner. Recombinant RSPO1 protein increased liver size and improved liver regeneration, whereas LGR4/5 LOF caused the opposite effects, resulting in hypoplastic livers. Furthermore, we show that LGR4(+) hepatocytes throughout the lobule contribute to liver homeostasis without zonal dominance. Taken together, our results indicate that the RSPO-LGR4/5-ZNRF3/RNF43 module controls metabolic liver zonation and is a hepatic growth/size rheostat during development, homeostasis and regeneration.	[Planas-Paz, Lara; Orsini, Vanessa; Pikiolek, Monika; Nigsch, Florian; Roma, Guglielmo; Marti, Patricia; Beckmann, Nicolau; Carbone, Walter; Bergling, Sebastian; Isken, Andrea; Mueller, Matthias; Kinzel, Bernd; Bouwmeester, Tewis; Ruffner, Heinz; Tchorz, Jan S.] Novartis Pharma AG, Novartis Inst BioMed Res, CH-4056 Basel, Switzerland; [Boulter, Luke] Univ Edinburgh, MRC, Human Genet Unit, Inst Genet & Mol Med, Edinburgh EH4 2XU, Midlothian, Scotland; [Calabrese, Diego; Dill, Michael T.; Heim, Markus H.] Univ Basel Hosp, Div Gastroenterol & Hepatol, CH-4031 Basel, Switzerland; [Xie, Yang; Donovan, Adriana; Yang, Yi; Mao, Xiaohong; Nicholson, Thomas B.; Zamponi, Raffaella; Capodieci, Paola; Valdez, Reginald; Rivera, Daniel; Loew, Andreas; Ukomadu, Chinweike; Cong, Feng] Novartis Pharma AG, Novartis Inst BioMed Res, Cambridge, MA 02139 USA; [Terracciano, Luigi M.] Univ Basel Hosp, Inst Pathol, CH-4031 Basel, Switzerland; [Forbes, Stuart J.] Univ Edinburgh, Ctr Regenerat Med, MRC, Edinburgh EH16 4UU, Midlothian, Scotland; [Loew, Andreas] Elstar Therapeut Inc, Cambridge, MA 02139 USA	Novartis; University of Edinburgh; University of Basel; Novartis; University of Basel; University of Edinburgh	Tchorz, JS (corresponding author), Novartis Pharma AG, Novartis Inst BioMed Res, CH-4056 Basel, Switzerland.	jan.tchorz@novartis.com	Dill, Michael T/G-6253-2010; Zamponi, Raffaella/V-5683-2018; Heim, Markus/A-7526-2008; Terracciano, Luigi M./AAB-5335-2022; Nigsch, Florian/ABB-9306-2021; Beckmann, Nicolau/H-7616-2019	Dill, Michael T/0000-0002-1926-4204; Heim, Markus/0000-0002-7523-4894; Terracciano, Luigi M./0000-0002-9393-9660; Nigsch, Florian/0000-0002-2919-8749; Forbes, Stuart/0000-0003-3715-2561; Boulter, Luke/0000-0002-7954-6705; Carbone, Walter/0000-0001-6150-8295; Planas-Paz, Lara/0000-0001-9603-9257; Zamponi, Raffaella/0000-0002-3313-1387; Calabrese, Diego/0000-0002-0259-8611; Bergling, Sebastian/0000-0002-6840-3266	Leverhulme Trust [ECF-2012-262]; SNF grant [310030B_147089]; MRC Centre Grant; UKRMP Niche hub grant [MR/K026666/1]; Novartis Institutes for BioMedical Research Postdoctoral Program; MRC [MR/K026666/1] Funding Source: UKRI; Medical Research Council [MR/K026666/1] Funding Source: researchfish	Leverhulme Trust(Leverhulme Trust); SNF grant; MRC Centre Grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UKRMP Niche hub grant; Novartis Institutes for BioMedical Research Postdoctoral Program; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank J. Wirsching, C. Manneville, M. Lemaistre, M. Haffner, B. Leonhard, S. Ley, N. Guo, T. Lewis, M. Li, M. van de Velde, D. Breustedt, H. Lei, R. Boomer, S.Zurbruegg, L. Perrot, F. Cordoba, S. Schuierer, A. Arif and J. Gfeller for technical assistance. For helpful discussion and critical reading of the manuscript, we thank E. Wiellette, G. Hintzen, B. Dietrich, D. Liu, F. Bassilana, C. Parker, K. Seuwen and J. Porter. This work was supportedby the Leverhulme Trust ECF-2012-262 to L.B., SNF grant 310030B_147089 to M.H.H., MRC Centre Grant and UKRMP Niche hub grant MR/K026666/1 to S.J.F. and the Novartis Institutes for BioMedical Research Postdoctoral Program.	Apte U, 2009, AM J PATHOL, V175, P1056, DOI 10.2353/ajpath.2009.080976; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Benhamouche S, 2006, DEV CELL, V10, P759, DOI 10.1016/j.devcel.2006.03.015; Bird TG, 2015, CELL STEM CELL, V17, P377, DOI 10.1016/j.stem.2015.09.007; Boulter L, 2012, NAT MED, V18, P572, DOI 10.1038/nm.2667; BRALET MP, 1994, AM J PATHOL, V144, P896; Burke ZD, 2009, GASTROENTEROLOGY, V136, P2316, DOI 10.1053/j.gastro.2009.02.063; Carmon KS, 2011, P NATL ACAD SCI USA, V108, P11452, DOI 10.1073/pnas.1106083108; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Clevers H, 2014, SCIENCE, V346, P54, DOI 10.1126/science.1248012; Colnot S., 2011, MOL PATHOLOGY LIB; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; Dill MT, 2013, HEPATOLOGY, V57, P1607, DOI 10.1002/hep.26165; Ferrer-Vaquer A, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-121; Fitamant J, 2015, CELL REP, V10, P1692, DOI 10.1016/j.celrep.2015.02.027; Font-Burgada J, 2015, CELL, V162, P766, DOI 10.1016/j.cell.2015.07.026; Gebhardt R, 2010, DEV DYNAM, V239, P45, DOI 10.1002/dvdy.22041; Gerbal-Chaloin S, 2014, MOL PHARMACOL, V86, P624, DOI 10.1124/mol.114.094797; Glinka A, 2011, EMBO REP, V12, P1055, DOI 10.1038/embor.2011.175; Gougelet A, 2014, HEPATOLOGY, V59, P2344, DOI 10.1002/hep.26924; Hao HX, 2012, NATURE, V485, P195, DOI 10.1038/nature11019; Huch M, 2013, NATURE, V494, P247, DOI 10.1038/nature11826; Jungermann K, 1996, ANNU REV NUTR, V16, P179, DOI 10.1146/annurev.nu.16.070196.001143; JUNGERMANN K, 1989, PHYSIOL REV, V69, P708, DOI 10.1152/physrev.1989.69.3.708; Karaca G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083987; Kinzel B, 2014, DEV BIOL, V390, P181, DOI 10.1016/j.ydbio.2014.03.009; Klochendler A, 2012, DEV CELL, V23, P681, DOI 10.1016/j.devcel.2012.08.009; Koo BK, 2014, GASTROENTEROLOGY, V147, P289, DOI 10.1053/j.gastro.2014.05.007; Koo BK, 2012, NATURE, V488, P665, DOI 10.1038/nature11308; Lu WY, 2015, NAT CELL BIOL, V17, P971, DOI 10.1038/ncb3203; Marti P, 2015, HEPATOLOGY, V62, P1497, DOI 10.1002/hep.27992; Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60; Mitchell C, 2008, NAT PROTOC, V3, P1167, DOI 10.1038/nprot.2008.80; Miyajima A, 2014, CELL STEM CELL, V14, P561, DOI 10.1016/j.stem.2014.04.010; Monga SS, 2014, GENE EXPRESSION, V16, P51, DOI 10.3727/105221614X13919976902138; Monga SPS, 2001, HEPATOLOGY, V33, P1098, DOI 10.1053/jhep.2001.23786; Nejak-Bowen Kari, 2008, Organogenesis, V4, P92; Nejak-Bowen KN, 2010, HEPATOLOGY, V51, P1603, DOI 10.1002/hep.23538; Niehrs C, 2012, NAT REV MOL CELL BIO, V13, P767, DOI 10.1038/nrm3470; Ong CK, 2012, NAT GENET, V44, P690, DOI 10.1038/ng.2273; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; Ruffner H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040976; Sekine S, 2006, HEPATOLOGY, V43, P817, DOI 10.1002/hep.21131; Sekine S, 2007, HEPATOLOGY, V45, P361, DOI 10.1002/hep.21523; Si-Tayeb K, 2010, DEV CELL, V18, P175, DOI 10.1016/j.devcel.2010.01.011; Snippert HJ, 2010, SCIENCE, V327, P1385, DOI 10.1126/science.1184733; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tchorz JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030011; Torre C, 2011, INT J BIOCHEM CELL B, V43, P271, DOI 10.1016/j.biocel.2009.11.004; Wang B, 2015, NATURE, V524, P180, DOI 10.1038/nature14863; Wieland S, 2014, HEPATOLOGY, V59, P2121, DOI 10.1002/hep.26770; Wu D, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks461; Yang J, 2014, HEPATOLOGY, V60, P964, DOI 10.1002/hep.27082; Zaret KS, 2015, NATURE, V524, P165, DOI 10.1038/nature15201; Zaret KS, 2002, NAT REV GENET, V3, P499, DOI 10.1038/nrg837	56	183	188	0	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAY	2016	18	5					467	+		10.1038/ncb3337	http://dx.doi.org/10.1038/ncb3337			22	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	DK3RH	27088858	Green Accepted			2022-12-25	WOS:000374834600005
J	Nim, S; Jeon, J; Corbi-Verge, C; Seo, MH; Ivarsson, Y; Moffat, J; Tarasova, N; Kim, PM				Nim, Satra; Jeon, Jouhyun; Corbi-Verge, Carles; Seo, Moon-Hyeong; Ivarsson, Ylva; Moffat, Jason; Tarasova, Nadya; Kim, Philip M.			Pooled screening for antiproliferative inhibitors of protein-protein interactions	NATURE CHEMICAL BIOLOGY			English	Article							FRET MICROSCOPY; GENE DELIVERY; PEPTIDE; P53; APOPTOSIS; BINDING; TRANSDUCTION; ACTIVATION; RESOURCE; THERAPY	Protein-protein interactions (PPIs) are emerging as a promising new class of drug targets. Here, we present a novel high-throughput approach to screen inhibitors of PPIs in cells. We designed a library of 50,000 human peptide-binding motifs and used a pooled lentiviral system to express them intracellularly and screen for their effects on cell proliferation. We thereby identified inhibitors that drastically reduced the viability of a pancreatic cancer line (RWP1) while leaving a control line virtually unaffected. We identified their target interactions computationally, and validated a subset in experiments. We also discovered their potential mechanisms of action, including apoptosis and cell cycle arrest. Finally, we confirmed that synthetic lipopeptide versions of our inhibitors have similarly specific and dosage-dependent effects on cancer cell growth. Our screen reveals new drug targets and peptide drug leads, and it provides a rich data set covering phenotypes for the inhibition of thousands of interactions.	[Nim, Satra; Jeon, Jouhyun; Corbi-Verge, Carles; Seo, Moon-Hyeong; Moffat, Jason; Kim, Philip M.] Univ Toronto, Terrence Donnelly Ctr Cellular & Biomol Res, Toronto, ON, Canada; [Ivarsson, Ylva] Uppsala Univ, Dept Chem, Biomed Ctr BMC, Uppsala, Sweden; [Moffat, Jason; Kim, Philip M.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Moffat, Jason] Canadian Inst Adv Res, Toronto, ON, Canada; [Tarasova, Nadya] NCI, Canc & Inflammat Program, Ctr Canc Res, Frederick, MD USA; [Kim, Philip M.] Univ Toronto, Dept Comp Sci, Toronto, ON, Canada	University of Toronto; Uppsala University; University of Toronto; Canadian Institute for Advanced Research (CIFAR); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Toronto	Kim, PM (corresponding author), Univ Toronto, Terrence Donnelly Ctr Cellular & Biomol Res, Toronto, ON, Canada.; Kim, PM (corresponding author), Univ Toronto, Dept Mol Genet, Toronto, ON, Canada.; Kim, PM (corresponding author), Univ Toronto, Dept Comp Sci, Toronto, ON, Canada.	pi@kimlab.org	Ivarsson, Ylva/HGE-0283-2022; Moffat, Jason/AAC-1110-2020; Verge, Carles Corbi/I-4852-2019	Ivarsson, Ylva/0000-0002-7081-3846; Moffat, Jason/0000-0002-5663-8586; Verge, Carles Corbi/0000-0002-7654-4405; Tarasova, Nadya/0000-0002-4949-0069	Canadian Institute of Health Research (CIHR) [MOP-123526]; Innovation Grant from the Canadian Cancer Society Research Institute (CCSRI) [702884]; Intramural Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC011306] Funding Source: NIH RePORTER	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Innovation Grant from the Canadian Cancer Society Research Institute (CCSRI); Intramural Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank the members of the Moffat laboratory for valuable technical assistance with lentiviral screening technology, usage of reagents and equipment. We thank A. Emili, T. Hughes and M. Garton for helpful comments on the manuscript. We thank A. Musacchio (Department of Mechanistic Cell Biology, Max Planck Institute of Molecular Physiology) for providing us with the INCENP cDNA clone. We thank F. Sicheri (Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto) for use of the ITC machine. P.M.K. acknowledges an Operating Grant from the Canadian Institute of Health Research (CIHR MOP-123526) and an Innovation Grant from the Canadian Cancer Society Research Institute (CCSRI# 702884). J.M. is a Tier 2 Canada Research Chair in Functional Genomics of Cancer. The research was supported in part by the Intramural Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research (N.I.T.).	Abraham J, 2003, EMBO J, V22, P6137, DOI 10.1093/emboj/cdg580; Amado RG, 1999, SCIENCE, V285, P674, DOI 10.1126/science.285.5428.674; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Booth B, 2004, NAT REV DRUG DISCOV, V3, P451, DOI 10.1038/nrd1384; Bossi A, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.17; Chang YS, 2013, P NATL ACAD SCI USA, V110, pE3445, DOI 10.1073/pnas.1303002110; Chen JD, 1996, MOL CELL BIOL, V16, P2445; Chene P, 2000, J MOL BIOL, V299, P245, DOI 10.1006/jmbi.2000.3738; Collins JM, 2014, ORG LETT, V16, P940, DOI 10.1021/ol4036825; Dinkel H, 2014, NUCLEIC ACIDS RES, V42, pD259, DOI 10.1093/nar/gkt1047; Fuller JC, 2009, DRUG DISCOV TODAY, V14, P155, DOI 10.1016/j.drudis.2008.10.009; Grant S, 2009, CELL MOL LIFE SCI, V66, P1163, DOI 10.1007/s00018-008-8539-7; Hermeking H, 1997, MOL CELL, V1, P3, DOI 10.1016/S1097-2765(00)80002-7; Higgins ME, 2007, NUCLEIC ACIDS RES, V35, pD721, DOI 10.1093/nar/gkl811; Hoe KK, 2014, NAT REV DRUG DISCOV, V13, P217, DOI 10.1038/nrd4236; Ito K, 2007, J PHARMACOL EXP THER, V321, P1, DOI 10.1124/jpet.106.111674; Ivarsson Y, 2014, P NATL ACAD SCI USA, V111, P2542, DOI 10.1073/pnas.1312296111; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Lamers F, 2011, ENDOCR-RELAT CANCER, V18, P657, DOI 10.1530/ERC-11-0207; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Liu M, 2010, P NATL ACAD SCI USA, V107, P14321, DOI 10.1073/pnas.1008930107; Marcotte R, 2012, CANCER DISCOV, V2, P172, DOI 10.1158/2159-8290.CD-11-0224; Masters SC, 2001, J BIOL CHEM, V276, P45193, DOI 10.1074/jbc.M105971200; Mullard A, 2012, NAT REV DRUG DISCOV, V11, P172, DOI 10.1038/nrd3680; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Natarajan V, 2014, P NATL ACAD SCI USA, V111, pE474, DOI 10.1073/pnas.1311945111; Neduva V, 2005, PLOS BIOL, V3, P2090, DOI 10.1371/journal.pbio.0030405; Neduva V, 2005, FEBS LETT, V579, P3342, DOI 10.1016/j.febslet.2005.04.005; Nero TL, 2014, NAT REV CANCER, V14, P248, DOI 10.1038/nrc3690; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Pamidi A, 2007, CANCER RES, V67, P8527, DOI 10.1158/0008-5472.CAN-07-1161; Poyurovsky MV, 2010, NAT STRUCT MOL BIOL, V17, P982, DOI 10.1038/nsmb.1872; PUMIGLIA KM, 1995, J BIOL CHEM, V270, P14251, DOI 10.1074/jbc.270.24.14251; Rajagopalan S, 2008, NUCLEIC ACIDS RES, V36, P5983, DOI 10.1093/nar/gkn598; Sekar RB, 2003, J CELL BIOL, V160, P629, DOI 10.1083/jcb.200210140; Shangary S, 2009, ANNU REV PHARMACOL, V49, P223, DOI 10.1146/annurev.pharmtox.48.113006.094723; Sims D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-r104; Souers AJ, 2013, NAT MED, V19, P202, DOI 10.1038/nm.3048; van Delft MF, 2006, CANCER CELL, V10, P389, DOI 10.1016/j.ccr.2006.08.027; Wallrabe H, 2003, BIOPHYS J, V85, P559, DOI 10.1016/S0006-3495(03)74500-7; Wang BC, 1999, BIOCHEMISTRY-US, V38, P12499, DOI 10.1021/bi991353h; Wazir U, 2013, CANCER GENOM PROTEOM, V10, P69; Yoda A., 2013, MOL CANC THER S11, V12, pPR07; Zhang L, 2012, CURR MED CHEM, V19, P1602; Zhong Q, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.80; Zhou MX, 2002, J PHARMACOL EXP THER, V303, P124, DOI 10.1124/jpet.102.037192; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	49	25	25	0	28	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	APR	2016	12	4					275	+		10.1038/NCHEMBIO.2026	http://dx.doi.org/10.1038/NCHEMBIO.2026			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH2DA	26900867	Green Accepted			2022-12-25	WOS:000372593200016
J	Imsland, F; McGowan, K; Rubin, CJ; Henegar, C; Sundstrom, E; Berglund, J; Schwochow, D; Gustafson, U; Imsland, P; Lindblad-Toh, K; Lindgren, G; Mikko, S; Millon, L; Wade, C; Schubert, M; Orlando, L; Penedo, MCT; Barsh, GS; Andersson, L				Imsland, Freyja; McGowan, Kelly; Rubin, Carl-Johan; Henegar, Corneliu; Sundstrom, Elisabeth; Berglund, Jonas; Schwochow, Doreen; Gustafson, Ulla; Imsland, Pall; Lindblad-Toh, Kerstin; Lindgren, Gabriella; Mikko, Sofia; Millon, Lee; Wade, Claire; Schubert, Mikkel; Orlando, Ludovic; Penedo, Maria Cecilia T.; Barsh, Gregory S.; Andersson, Leif			Regulatory mutations in TBX3 disrupt asymmetric hair pigmentation that underlies Dun camouflage color in horses	NATURE GENETICS			English	Article							GENOME SEQUENCE; EXPRESSION; MICE; DIFFERENTIATION; MIGRATION; SURVIVAL; DEFECTS	Dun is a wild-type coat color in horses characterized by pigment dilution with a striking pattern of dark areas termed primitive markings. Here we show that pigment dilution in Dun horses is due to radially asymmetric deposition of pigment in the growing hair caused by localized expression of the T-box 3 (TBX3) transcription factor in hair follicles, which in turn determines the distribution of hair follicle melanocytes. Most domestic horses are non-dun, a more intensely pigmented phenotype caused by regulatory mutations impairing TBX3 expression in the hair follicle, resulting in a more circumferential distribution of melanocytes and pigment granules in individual hairs. We identified two different alleles (non-dun1 and non-dun2) causing non-dun color. non-dun2 is a recently derived allele, whereas the Dun and non-dun1 alleles are found in ancient horse DNA, demonstrating that this polymorphism predates horse domestication. These findings uncover a new developmental role for T-box genes and new aspects of hair follicle biology and pigmentation.	[Imsland, Freyja; Rubin, Carl-Johan; Sundstrom, Elisabeth; Berglund, Jonas; Lindblad-Toh, Kerstin; Andersson, Leif] Uppsala Univ, Dept Med Biochem & Microbiol, Sci Life Lab Uppsala, Uppsala, Sweden; [McGowan, Kelly; Barsh, Gregory S.] HudsonAlpha Inst Biotechnol, Huntsville, AL USA; [McGowan, Kelly; Henegar, Corneliu; Barsh, Gregory S.] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; [Schwochow, Doreen; Gustafson, Ulla; Lindgren, Gabriella; Mikko, Sofia; Andersson, Leif] Swedish Univ Agr Sci, Dept Anim Breeding & Genet, Uppsala, Sweden; [Schwochow, Doreen] AgroParisTech, INRA, Genet Anim & Biol Integrat, Jouy En Josas, France; [Imsland, Pall] Menntaskolinn Vio Hamrahlio, Reykjavik, Iceland; [Lindblad-Toh, Kerstin; Wade, Claire] Broad Inst Harvard & MIT, Cambridge, MA USA; [Millon, Lee; Penedo, Maria Cecilia T.] Univ Calif Davis, Sch Vet Med, Vet Genet Lab, Davis, CA 95616 USA; [Schubert, Mikkel; Orlando, Ludovic] Univ Copenhagen, Nat Hist Museum Denmark, Ctr GeoGenet, Copenhagen, Denmark; [Andersson, Leif] Texas A&M Univ, Dept Vet Integrat Biosci, Coll Vet Med & Biomed Sci, College Stn, TX USA	Uppsala University; HudsonAlpha Institute for Biotechnology; Stanford University; Swedish University of Agricultural Sciences; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of California System; University of California Davis; University of Copenhagen; Texas A&M University System; Texas A&M University College Station	Andersson, L (corresponding author), Uppsala Univ, Dept Med Biochem & Microbiol, Sci Life Lab Uppsala, Uppsala, Sweden.; Barsh, GS (corresponding author), HudsonAlpha Inst Biotechnol, Huntsville, AL USA.; Barsh, GS (corresponding author), Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA.; Andersson, L (corresponding author), Swedish Univ Agr Sci, Dept Anim Breeding & Genet, Uppsala, Sweden.; Andersson, L (corresponding author), Texas A&M Univ, Dept Vet Integrat Biosci, Coll Vet Med & Biomed Sci, College Stn, TX USA.	gbarsh@hudsonalpha.org; leif.andersson@imbim.uu.se	Orlando, Ludovic/A-8932-2013; Schubert, Mikkel/I-6911-2013; Mikko, Sofia/F-1347-2017; Henegar, Corneliu R/K-9166-2013	Orlando, Ludovic/0000-0003-3936-1850; Schubert, Mikkel/0000-0003-2401-9921; Mikko, Sofia/0000-0002-6375-1376; Henegar, Corneliu R/0000-0002-8486-5591; Rubin, Carl-Johan/0000-0001-8238-5052; Imsland, Freyja/0000-0002-9452-5566; Wade, Claire/0000-0003-3413-4771	Knut and Alice Wallenberg foundation; US National Institutes of Health; Erasmus Mundus fellowship within the framework of the European Graduate School of Animal Breeding and Genetics; Uppsala University and Hospital; Swedish Research Council [80576801, 70374401]; Science for Life Laboratory; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR067925] Funding Source: NIH RePORTER	Knut and Alice Wallenberg foundation(Knut & Alice Wallenberg Foundation); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Erasmus Mundus fellowship within the framework of the European Graduate School of Animal Breeding and Genetics; Uppsala University and Hospital; Swedish Research Council(Swedish Research CouncilEuropean Commission); Science for Life Laboratory; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank the numerous horse owners who provided samples, T. Raudsepp and I. Randlaht for samples from Estonian native horses, C. Asa and M. Fischer (St. Louis Zoo) and F. Marshall for providing hair samples from the Somali wild ass, W Zimmerman for photographs of Przewalski's horse, S. Fard, H. Ring and F. Hallbook for advice on histological characterization, O. Ryder, L. Chemnick and C. Steiner for delivering DNA extracts from Przewalski's horses, C. Der Sarkissian and L. Ermini for assistance in whole-genome resequencing at the Centre for GeoGenetics, Denmark, and the HudsonAlpha Genomic Services Laboratory for RNA-seq. This work was supported by grants from the Knut and Alice Wallenberg foundation (to L.A.) and the US National Institutes of Health (to G.S.B.), as well as by an Erasmus Mundus fellowship within the framework of the European Graduate School of Animal Breeding and Genetics (to D.S.). Sequencing was performed by the SNP&SEQ Technology Platform, supported by Uppsala University and Hospital, the Science for Life Laboratory and the Swedish Research Council (80576801 and 70374401).	ADALSTEINSSON S, 1978, J HERED, V69, P146, DOI 10.1093/oxfordjournals.jhered.a108913; Andersson LS, 2012, NATURE, V488, P642, DOI 10.1038/nature11399; Bamshad M, 1997, NAT GENET, V16, P311, DOI 10.1038/ng0797-311; BOWLING AT, 1987, J HERED, V78, P75, DOI 10.1093/oxfordjournals.jhered.a110340; Fang MY, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000341; Frank DU, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067841; Gremmel F, 1939, J HERED, V30, P437, DOI 10.1093/jhered/30.10.437; Kayserili H, 2009, HUM MOL GENET, V18, P4357, DOI 10.1093/hmg/ddp391; Kumar PP, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004247; Kunisada T, 1998, DEVELOPMENT, V125, P2915; Ma L, 2003, DEVELOPMENT, V130, P379, DOI 10.1242/dev.00201; Orlando L, 2013, NATURE, V499, P74, DOI 10.1038/nature12323; Pruvost M, 2011, P NATL ACAD SCI USA, V108, P18626, DOI 10.1073/pnas.1108982108; REGINELLI AD, 1995, DEVELOPMENT, V121, P1065; Satokata I, 2000, NAT GENET, V24, P391, DOI 10.1038/74231; Schubert M., P NATL ACAD SCI US, V111, pE5661; St-Jacques B, 1998, CURR BIOL, V8, P1058, DOI 10.1016/S0960-9822(98)70443-9; Steingrimsson E, 2004, ANNU REV GENET, V38, P365, DOI 10.1146/annurev.genet.38.072902.092717; Thomas-Chollier M, 2011, NAT PROTOC, V6, P1860, DOI 10.1038/nprot.2011.409; van den Boogaard M, 2012, J CLIN INVEST, V122, P2519, DOI 10.1172/JCI62613; Wade CM, 2009, SCIENCE, V326, P865, DOI 10.1126/science.1178158; Yoshida H, 2001, J INVEST DERM SYMP P, V6, P1, DOI 10.1046/j.0022-202x.2001.00006.x	22	38	44	0	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2016	48	2					152	158		10.1038/ng.3475	http://dx.doi.org/10.1038/ng.3475			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DC2JV	26691985	Green Accepted			2022-12-25	WOS:000369043900012
J	Zhang, T; Zhang, Y; Cui, MY; Jin, L; Wang, YM; Lv, FX; Liu, YL; Zheng, W; Shang, HB; Zhang, J; Zhang, M; Wu, HK; Guo, JJ; Zhang, XQ; Hu, XL; Cao, CM; Xiao, RP				Zhang, Ting; Zhang, Yan; Cui, Mingyao; Jin, Li; Wang, Yimei; Lv, Fengxiang; Liu, Yuli; Zheng, Wen; Shang, Haibao; Zhang, Jun; Zhang, Mao; Wu, Hongkun; Guo, Jiaojiao; Zhang, Xiuqin; Hu, Xinli; Cao, Chun-Mei; Xiao, Rui-Ping			CaMKII is a RIP3 substrate mediating ischemia- and oxidative stress-induced myocardial necroptosis	NATURE MEDICINE			English	Article							MITOCHONDRIAL PERMEABILITY TRANSITION; RECEPTOR INTERACTING PROTEIN-3; MIXED LINEAGE KINASE; CELL-DEATH; PROGRAMMED NECROSIS; DOMAIN-LIKE; INDEPENDENT ACTIVATION; INHIBITION PROTECTS; CARDIAC-HYPERTROPHY; APOPTOSIS	Regulated necrosis (necroptosis) and apoptosis are crucially involved in severe cardiac pathological conditions, including myocardial infarction, ischemia-reperfusion injury and heart failure. Whereas apoptotic signaling is well defined, the mechanisms that underlie cardiomyocyte necroptosis remain elusive. Here we show that receptor-interacting protein 3 (RIP3) triggers myocardial necroptosis, in addition to apoptosis and inflammation, through activation of Ca2+-calmodulin-dependent protein kinase (CaMKII) rather than through the well-established RIP3 partners RIP1 and MLKL. In mice, RIP3 deficiency or CaMKII inhibition ameliorates myocardial necroptosis and heart failure induced by ischemia-reperfusion or by doxorubicin treatment. RIP3-induced activation of CaMKII, via phosphorylation or oxidation or both, triggers opening of the mitochondrial permeability transition pore and myocardial necroptosis. These findings identify CaMKII as a new RIP3 substrate and delineate a RIP3-CaMKII-mPTP myocardial necroptosis pathway, a promising target for the treatment of ischemia- and oxidative stress-induced myocardial damage and heart failure.	[Zhang, Ting; Zhang, Yan; Cui, Mingyao; Jin, Li; Wang, Yimei; Lv, Fengxiang; Liu, Yuli; Zheng, Wen; Shang, Haibao; Zhang, Jun; Zhang, Mao; Wu, Hongkun; Guo, Jiaojiao; Zhang, Xiuqin; Hu, Xinli; Cao, Chun-Mei; Xiao, Rui-Ping] Peking Univ, Inst Mol Med, Beijing 100871, Peoples R China; [Zhang, Ting; Zhang, Yan; Cui, Mingyao; Jin, Li; Wang, Yimei; Lv, Fengxiang; Liu, Yuli; Zheng, Wen; Shang, Haibao; Zhang, Jun; Zhang, Mao; Wu, Hongkun; Guo, Jiaojiao; Zhang, Xiuqin; Hu, Xinli; Cao, Chun-Mei; Xiao, Rui-Ping] Peking Univ, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100871, Peoples R China; [Xiao, Rui-Ping] Peking Univ, Peking Tsinghua Ctr Life Sci, Beijing 100871, Peoples R China; [Xiao, Rui-Ping] Peking Univ, Beijing City Key Lab Cardiometab Mol Med, Beijing 100871, Peoples R China	Peking University; Peking University; Peking University; Peking University	Zhang, Y; Xiao, RP (corresponding author), Peking Univ, Inst Mol Med, Beijing 100871, Peoples R China.; Zhang, Y; Xiao, RP (corresponding author), Peking Univ, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100871, Peoples R China.; Xiao, RP (corresponding author), Peking Univ, Peking Tsinghua Ctr Life Sci, Beijing 100871, Peoples R China.; Xiao, RP (corresponding author), Peking Univ, Beijing City Key Lab Cardiometab Mol Med, Beijing 100871, Peoples R China.	zhangyan9876@pku.edu.cn; xiaor@pku.edu.cn	Yimei, Wang/AAE-4083-2019; Xiao, Rui-Ping/AAE-2629-2019	Zhang, Mao/0000-0002-5283-6497; Zhang, Xiuqin/0000-0001-8692-7146; Wu, Hong-Kun/0000-0002-9459-6583; Cui, Mingyao/0000-0002-1701-2548	National Basic Research Program of China [2013CB531200, 2012CB518000, 2012CB944500]; National Natural Science Foundation of China [81170100, 81370234, 81130073, 81370233, 91439107, 81270190, 31221002]; National Science and Technology Major Projects for Major New Drugs Innovation and Development [2013ZX09508104]; Specialized Research Fund for the Doctoral Program of Higher Education [20110001120119]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Major Projects for Major New Drugs Innovation and Development; Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	We thank X.-D. Wang for Ripk3<SUP>-/-</SUP> mice, M. Anderson for CaMKII plasmids, and H. Cheng and I.C. Bruce for comments on the manuscript. This work was supported by the National Basic Research Program of China (2013CB531200 (Y.Z.), 2012CB518000 (R.-P.X.) and 2012CB944500 (C.-M.C.)), the National Natural Science Foundation of China (81170100 (Y.Z.), 81370234 (Y.Z.), 81130073 (R.-P.X.), 81370233 (C.-M.C.), 91439107 (C.-M.C.), 81270190 (F.L.) and 31221002 (R.-P.X.)), National Science and Technology Major Projects for Major New Drugs Innovation and Development (2013ZX09508104) (R.-P.X.) and the Specialized Research Fund for the Doctoral Program of Higher Education (20110001120119) (Y.Z.).	Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Brenner C, 2012, CIRC RES, V111, P1237, DOI 10.1161/CIRCRESAHA.112.265942; Buja LM, 2005, CARDIOVASC PATHOL, V14, P170, DOI 10.1016/j.carpath.2005.03.006; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Coupienne I, 2011, LASER SURG MED, V43, P557, DOI 10.1002/lsm.21088; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; Erickson JR, 2008, CELL, V133, P462, DOI 10.1016/j.cell.2008.02.048; Erickson JR, 2011, PHYSIOL REV, V91, P889, DOI 10.1152/physrev.00018.2010; Ferreira A. L. A., 2008, Cardiovascular & Hematological Agents in Medicinal Chemistry, V6, P278, DOI 10.2174/187152508785909474; Gewirtz DA, 1999, BIOCHEM PHARMACOL, V57, P727, DOI 10.1016/S0006-2952(98)00307-4; Hausenloy DJ, 2013, J CLIN INVEST, V123, P92, DOI 10.1172/JCI62874; He BJ, 2011, NAT MED, V17, P1610, DOI 10.1038/nm.2506; He SD, 2011, P NATL ACAD SCI USA, V108, P20054, DOI 10.1073/pnas.1116302108; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Humphries F, 2015, CELL DEATH DIFFER, V22, P225, DOI 10.1038/cdd.2014.126; Joiner MLA, 2012, NATURE, V491, P269, DOI 10.1038/nature11444; Kaiser WJ, 2011, NATURE, V471, P368, DOI 10.1038/nature09857; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Kung G, 2011, CIRC RES, V108, P1017, DOI 10.1161/CIRCRESAHA.110.225730; Li Q, 2010, J BIOL CHEM, V285, P9535, DOI 10.1074/jbc.M109.071332; Lim SY, 2007, CARDIOVASC DRUG THER, V21, P467, DOI 10.1007/s10557-007-6067-6; Ling HY, 2013, CIRC RES, V112, P935, DOI 10.1161/CIRCRESAHA.112.276915; Ling HY, 2009, J CLIN INVEST, V119, P1230, DOI 10.1172/JCI38022; Luedde M, 2014, CARDIOVASC RES, V103, P206, DOI 10.1093/cvr/cvu146; Minotti G, 2004, PHARMACOL REV, V56, P185, DOI 10.1124/pr.56.2.6; Montaigne D, 2011, MITOCHONDRION, V11, P22, DOI 10.1016/j.mito.2010.06.001; Montaigne D, 2010, TOXICOL APPL PHARM, V244, P300, DOI 10.1016/j.taap.2010.01.006; Moriwaki K, 2013, GENE DEV, V27, P1640, DOI 10.1101/gad.223321.113; Nakagawa T, 2005, NATURE, V434, P652, DOI 10.1038/nature03317; Nakayama H, 2007, J CLIN INVEST, V117, P2431, DOI 10.1172/JCI31060; Oberst A, 2011, NATURE, V471, P363, DOI 10.1038/nature09852; Oerlemans MIFJ, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0270-8; Pazdernik NJ, 1999, MOL CELL BIOL, V19, P6500; Roychowdhury S, 2013, HEPATOLOGY, V57, P1773, DOI 10.1002/hep.26200; Salas MA, 2010, J MOL CELL CARDIOL, V48, P1298, DOI 10.1016/j.yjmcc.2009.12.015; Singal PK, 1998, NEW ENGL J MED, V339, P900, DOI 10.1056/NEJM199809243391307; Smith CCT, 2007, CARDIOVASC DRUG THER, V21, P227, DOI 10.1007/s10557-007-6035-1; Sun LM, 2012, CELL, V148, P213, DOI 10.1016/j.cell.2011.11.031; Sun XQ, 1999, J BIOL CHEM, V274, P16871, DOI 10.1074/jbc.274.24.16871; Upton JW, 2012, CELL HOST MICROBE, V11, P290, DOI [10.1016/j.chom.2012.01.016, 10.1016/j.chom.2019.09.004]; Upton JW, 2010, CELL HOST MICROBE, V7, P302, DOI 10.1016/j.chom.2010.03.006; Vila-Petroff M, 2007, CARDIOVASC RES, V73, P689, DOI 10.1016/j.cardiores.2006.12.003; Wang HY, 2014, MOL CELL, V54, P133, DOI 10.1016/j.molcel.2014.03.003; Welz PS, 2011, NATURE, V477, P330, DOI 10.1038/nature10273; Whelan RS, 2010, ANNU REV PHYSIOL, V72, P19, DOI 10.1146/annurev.physiol.010908.163111; Wu JF, 2013, CELL RES, V23, P994, DOI 10.1038/cr.2013.91; Yeh ETH, 2009, J AM COLL CARDIOL, V53, P2231, DOI 10.1016/j.jacc.2009.02.050; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308; Zhang R, 2005, NAT MED, V11, P409, DOI 10.1038/nm1215; Zhang T, 2003, CIRC RES, V92, P912, DOI 10.1161/01.RES.0000069686.31472.C5; Zhao J, 2012, P NATL ACAD SCI USA, V109, P5322, DOI 10.1073/pnas.1200012109; Zhu WZ, 2007, J BIOL CHEM, V282, P10833, DOI 10.1074/jbc.M611507200; Zhu WZ, 2003, J CLIN INVEST, V111, P617, DOI 10.1172/JCI200316326	53	426	465	11	212	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	FEB	2016	22	2					175	182		10.1038/nm.4017	http://dx.doi.org/10.1038/nm.4017			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DC8JX	26726877				2022-12-25	WOS:000369466800011
J	Andor, N; Graham, TA; Jansen, M; Xia, LC; Aktipis, CA; Petritsch, C; Ji, HP; Maley, CC				Andor, Noemi; Graham, Trevor A.; Jansen, Marnix; Xia, Li C.; Aktipis, C. Athena; Petritsch, Claudia; Ji, Hanlee P.; Maley, Carlo C.			Pan-cancer analysis of the extent and consequences of intratumor heterogeneity	NATURE MEDICINE			English	Article							CLONAL EVOLUTION; WHOLE-GENOME; GENERAL FRAMEWORK; MUTATIONS; INFERENCE; PROGRESSION; INHIBITORS; SIGNATURES; LANDSCAPE; PURITY	Intratumor heterogeneity (ITH) drives neoplastic progression and therapeutic resistance. We used the bioinformatics tools 'expanding ploidy and allele frequency on nested subpopulations' (EXPANDS) and PyClone to detect clones that are present at a >= 10% frequency in 1,165 exome sequences from tumors in The Cancer Genome Atlas. 86% of tumors across 12 cancer types had at least two clones. ITH in the morphology of nuclei was associated with genetic ITH (Spearman's correlation coefficient, rho = 0.24-0.41; P < 0.001). Mutation of a driver gene that typically appears in smaller clones was a survival risk factor (hazard ratio (HR) = 2.15, 95% confidence interval (CI): 1.71-2.69). The risk of mortality also increased when > 2 clones coexisted in the same tumor sample (HR = 1.49, 95% CI: 1.20-1.87). In two independent data sets, copy-number alterations affecting either < 25% or > 75% of a tumor's genome predicted reduced risk (HR = 0.15, 95% CI: 0.08-0.29). Mortality risk also declined when > 4 clones coexisted in the sample, suggesting a trade-off between the costs and benefits of genomic instability. ITH and genomic instability thus have the potential to be useful measures that can universally be applied to all cancers.	[Andor, Noemi; Xia, Li C.; Ji, Hanlee P.] Stanford Univ, Dept Med, Sch Med, Div Oncol, Stanford, CA 94305 USA; [Andor, Noemi] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Bioinformat & Syst Biol, Neuherberg, Germany; [Graham, Trevor A.; Jansen, Marnix] Queen Mary Univ London, Barts Canc Inst, Barts & London Sch Med & Dent, Evolut & Canc Lab, London, England; [Aktipis, C. Athena] Univ Calif San Francisco, Ctr Evolut & Canc, San Francisco, CA 94143 USA; [Aktipis, C. Athena] Arizona State Univ, Dept Psychol, Tempe, AZ 85287 USA; [Petritsch, Claudia] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Petritsch, Claudia] Univ Calif San Francisco, Dept Neurol Surg, Brain Tumor Res Ctr, San Francisco, CA USA; [Petritsch, Claudia] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA; [Ji, Hanlee P.] Stanford Univ, Stanford Genome Technol Ctr, Palo Alto, CA 94304 USA; [Maley, Carlo C.] Inst Canc Res, Ctr Evolut & Canc, London SW3 6JB, England; [Maley, Carlo C.] Arizona State Univ, Biodesign Inst, Tempe, AZ USA	Stanford University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of London; Queen Mary University London; University of California System; University of California San Francisco; Arizona State University; Arizona State University-Tempe; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Stanford University; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Arizona State University; Arizona State University-Tempe	Ji, HP (corresponding author), Stanford Univ, Dept Med, Sch Med, Div Oncol, Stanford, CA 94305 USA.	hanleeji@stanford.edu; maley@asu.edu	Petritsch, Claudia/AAP-9597-2021; Xia, Li (Charlie)/AAD-8271-2020	Xia, Li (Charlie)/0000-0003-0868-1923; Jansen, Marnix/0000-0003-0645-564X; Graham, Trevor/0000-0001-9582-1597	US National Institutes of Health (NIH) [P01 CA91955, R01 CA149566, R01 CA170595, R01 CA185138, R01 CA140657, P01 HG000205, U01CA151920, U01CA17629901, R01 HG006137, R01 CA164746, R01 NS08061904]; Breast Cancer Research Program Breakthrough Award [BC132057]; Congressionally Directed Medical Research Program (CDMRP); Doris Duke Clinical Foundation Clinical Scientist Development Award; Research Scholar Grant from the American Cancer Society [RSG-13-297-01-TBG]; Howard Hughes Medical Institute Early Career Grant; Don and Ruth Seiler Fund; National Cancer Institute (NCI) Cancer Target Discovery and Development (CTDD) Consortium [U01CA17629901]; Higher Education Founding Council for England (HEFCE); NATIONAL CANCER INSTITUTE [R01CA140657, R01CA170595, U01CA176299, R01CA164746, R01CA149566, U01CA151920, P01CA091955, R01CA185138] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P01HG000205, R01HG006137] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS080619] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Breast Cancer Research Program Breakthrough Award; Congressionally Directed Medical Research Program (CDMRP)(United States Department of Defense); Doris Duke Clinical Foundation Clinical Scientist Development Award; Research Scholar Grant from the American Cancer Society(American Cancer Society); Howard Hughes Medical Institute Early Career Grant; Don and Ruth Seiler Fund; National Cancer Institute (NCI) Cancer Target Discovery and Development (CTDD) Consortium; Higher Education Founding Council for England (HEFCE); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by the US National Institutes of Health (NIH) (grant no. P01 CA91955 (C.C.M.), R01 CA149566 (C.C.M.), R01 CA170595 (C.C.M.), R01 CA185138 (C.C.M.), R01 CA140657 (C.C.M.), P01 HG000205 (H.P.J.), U01CA151920 (H.P.J.), U01CA17629901 (H.P.J.), R01 HG006137 (H.P.J.), R01 CA164746 (C.P.), R01 NS08061904 (C.P.) and R01 HG006137 (L.C.X.)). Additional support to C.C.M. came from the Breast Cancer Research Program Breakthrough Award (award no. BC132057), a Congressionally Directed Medical Research Program (CDMRP). Additional support to H.P.J. came from the Doris Duke Clinical Foundation Clinical Scientist Development Award, a Research Scholar Grant from the American Cancer Society (award no. RSG-13-297-01-TBG) and a Howard Hughes Medical Institute Early Career Grant. N.A. was supported by awards from the Don and Ruth Seiler Fund and the National Cancer Institute (NCI) Cancer Target Discovery and Development (CTDD) Consortium (grant no. U01CA17629901). T.A.G. was supported by the Higher Education Founding Council for England (HEFCE). We are grateful to W. Mewes for advice on the presentation of our results and for insightful discussions about their implications; S.T. Jensen for advice on statistical data analysis; and C.W. Turck and M. Oft for reviewing the manuscript. The results presented here are in part based upon data generated by TCGA Research Network. We thank Hoffmann H. (University of Bonn, Germany) for the availability of the MATLAB function 'violin' that we used to generate the violin plots for the distribution of clone numbers and clone sizes.	Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Almendro V, 2014, CELL REP, V6, P514, DOI 10.1016/j.celrep.2013.12.041; Andor N, 2014, BIOINFORMATICS, V30, P50, DOI 10.1093/bioinformatics/btt622; Barber LJ, 2015, CURR OPIN GENET DEV, V30, P1, DOI 10.1016/j.gde.2014.12.001; Birkbak NJ, 2011, CANCER RES, V71, P3447, DOI 10.1158/0008-5472.CAN-10-3667; Bochtler T, 2013, J CLIN ONCOL, V31, P3898, DOI 10.1200/JCO.2013.50.7921; Bonavia R, 2011, CANCER RES, V71, P4055, DOI 10.1158/0008-5472.CAN-11-0153; Brat DJ, 2015, NEW ENGL J MED, V372, P2481, DOI 10.1056/NEJMoa1402121; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Cazier JB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4756; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Ciriello G, 2013, NAT GENET, V45, P1127, DOI 10.1038/ng.2762; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Goode Adam, 2013, J Pathol Inform, V4, P27, DOI 10.4103/2153-3539.119005; Greaves M, 2012, NATURE, V481, P306, DOI 10.1038/nature10762; Griffith M, 2013, NAT METHODS, V10, P1209, DOI [10.1038/NMETH.2689, 10.1038/nmeth.2689]; Ha G, 2014, GENOME RES, V24, P1881, DOI 10.1101/gr.180281.114; Hartwell KA, 2013, NAT CHEM BIOL, V9, P840, DOI [10.1038/NCHEMBIO.1367, 10.1038/nchembio.1367]; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Imielinski M, 2012, CELL, V150, P1107, DOI 10.1016/j.cell.2012.08.029; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Landau DA, 2013, CELL, V152, P714, DOI 10.1016/j.cell.2013.01.019; Li B, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0473-4; Maley CC, 2006, NAT GENET, V38, P468, DOI 10.1038/ng1768; Marusyk A, 2010, BBA-REV CANCER, V1805, P105, DOI 10.1016/j.bbcan.2009.11.002; McGranahan N, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa1408; Merlo LMF, 2010, CANCER PREV RES, V3, P1388, DOI 10.1158/1940-6207.CAPR-10-0108; Mroz EA, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001786; Nik-Zainal S, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.023; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Oesper L, 2014, BIOINFORMATICS, V30, P3532, DOI 10.1093/bioinformatics/btu651; Roth A, 2014, NAT METHODS, V11, P396, DOI [10.1038/NMETH.2883, 10.1038/nmeth.2883]; Roth A, 2012, BIOINFORMATICS, V28, P907, DOI 10.1093/bioinformatics/bts053; Roylance R, 2011, CANCER EPIDEM BIOMAR, V20, P2183, DOI 10.1158/1055-9965.EPI-11-0343; Sakurada A, 2008, J THORAC ONCOL, V3, P527, DOI 10.1097/JTO.0b013e318168be93; Sathirapongsasuti JF, 2011, BIOINFORMATICS, V27, P2648, DOI 10.1093/bioinformatics/btr462; Swanton C, 2015, NEW ENGL J MED, V372, P661, DOI 10.1056/NEJMe1414288; Tajiri R, 2014, HUM PATHOL, V45, P725, DOI 10.1016/j.humpath.2013.11.004; Vitale M, 2013, THYROID, V23, P517, DOI 10.1089/thy.2012.0614; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wang W, 2010, CYTOM PART A, V77A, P485, DOI 10.1002/cyto.a.20853; Wang Y, 2014, NATURE, V512, P155, DOI 10.1038/nature13600; Yadav VK, 2015, BRIEF BIOINFORM, V16, P232, DOI 10.1093/bib/bbu002; Yamamoto S, 2013, BREAST CANCER-TOKYO, V20, P262, DOI 10.1007/s12282-012-0332-7; Yoshihara K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3612; Zack TI, 2013, NAT GENET, V45, P1134, DOI 10.1038/ng.2760	48	447	455	4	106	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2016	22	1					105	+		10.1038/nm.3984	http://dx.doi.org/10.1038/nm.3984			12	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DA1YA	26618723	Green Accepted			2022-12-25	WOS:000367590700022
J	Alam, MS; Gaida, MM; Bergmann, F; Lasitschka, F; Giese, T; Giese, NA; Hackert, T; Hinz, U; Hussain, SP; Kozlov, SV; Ashwell, JD				Alam, Muhammad S.; Gaida, Matthias M.; Bergmann, Frank; Lasitschka, Felix; Giese, Thomas; Giese, Nathalia A.; Hackert, Thilo; Hinz, Ulf; Hussain, S. Perwez; Kozlov, Serguei V.; Ashwell, Jonathan D.			Selective inhibition of the p38 alternative activation pathway in infiltrating T cells inhibits pancreatic cancer progression	NATURE MEDICINE			English	Article							DUCTAL ADENOCARCINOMA; PROTEIN-KINASE; TUMOR-GROWTH; INFLAMMATION; MICE; THERAPY; METASTASIS; PROGNOSIS; NEOPLASIA; CARCINOMA	Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive neoplasm characterized by a marked fibro-inflammatory microenvironment(1), the presence of which can promote both cancer induction and growth(2-4). Therefore, selective manipulation of local cytokines is an attractive, although unrealized, therapeutic approach. T cells possess a unique mechanism of p38 mitogen-activated protein kinase (MAPK) activation downstream of T cell receptor (TCR) engagement through the phosphorylation of Tyr323 (pY323). This alternative p38 activation pathway is required for pro-inflammatory cytokine production(5,6). Here we show in human PDAC that a high percentage of infiltrating pY323(+) T cells was associated with large numbers of tumor necrosis factor (TNF)-alpha- and interleukin (IL)-17-producing CD4(+) tumor-infiltrating lymphocytes (TILs) and aggressive disease. The growth of mouse pancreatic tumors was inhibited by genetic ablation of the alternative p38 pathway, and transfer of wild-type CD4(+) T cells, but not those lacking the alternative pathway, enhanced tumor growth in T cell-deficient mice. Notably, a plasma membrane-permeable peptide derived from GADD45-alpha, the naturally occurring inhibitor of p38 pY323(+) (ref. 7), reduced CD4(+) TIL production of INF-alpha, IL-17A, IL-10 and secondary cytokines, halted growth of implanted tumors and inhibited progression of spontaneous KRAS-driven adenocarcinoma in mice. Thus, TCR-mediated activation of CD4(+) TILs results in alternative p38 activation and production of protumorigenic factors and can be targeted for therapeutic benefit.	[Alam, Muhammad S.; Gaida, Matthias M.; Ashwell, Jonathan D.] NCI, Lab Immune Cell Biol, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Gaida, Matthias M.; Bergmann, Frank; Lasitschka, Felix] Univ Heidelberg Hosp, Inst Pathol, Heidelberg, Germany; [Giese, Thomas] Heidelberg Univ, Inst Immunol, Heidelberg, Germany; [Giese, Nathalia A.; Hackert, Thilo; Hinz, Ulf] Univ Heidelberg Hosp, Dept Surg, Heidelberg, Germany; [Hussain, S. Perwez] NCI, Pancreat Canc Unit, Human Carcinogenesis Lab, Ctr Canc Res,NIH, Bethesda, MD 20892 USA; [Kozlov, Serguei V.] NCI, Canc & Dev Biol Lab, Ctr Canc Res, Frederick, MD 21701 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Ashwell, JD (corresponding author), NCI, Lab Immune Cell Biol, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	jda@pop.nci.nih.gov		Hussain, S. Perwez/0000-0002-2294-522X	Intramural Research Program of the Center for Cancer Research, National Cancer Institute, National Institutes of Health; German Research Foundation (DFG) [Ga-1818/1-1]; German Research Foundation [SFB 938/TP Z2]; NATIONAL CANCER INSTITUTE [ZIABC011185, ZIABC010774] Funding Source: NIH RePORTER	Intramural Research Program of the Center for Cancer Research, National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); German Research Foundation (DFG)(German Research Foundation (DFG)); German Research Foundation(German Research Foundation (DFG)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank J. Scheuerer, M. Clauter, B. Walter and E. Castro for expert technical assistance, J. Greiner for Panc02 cells, the Center for Advanced Preclinical Research (CAPR) program at the Frederick National Laboratory for Cancer Research for providing KPC mice for some studies, T. Longerich and B. Lahrmann for technical advice in computer-based tissue analysis and P. Schirmacher for critical review of the manuscript. This work was supported by the Intramural Research Program of the Center for Cancer Research, National Cancer Institute, National Institutes of Health. M.M.G. was supported by a fellowship from the German Research Foundation (DFG; Ga-1818/1-1). The work of F.L. was in part funded by the German Research Foundation (grant no. SFB 938/TP Z2).	Alam MS, 2014, J EXP MED, V211, P1257, DOI 10.1084/jem.20131917; Ben-Baruch A, 2012, CANCER MICROENVIRON, V5, P151, DOI 10.1007/s12307-011-0094-3; Bulavin DV, 2003, MOL CELL BIOL, V23, P3859, DOI 10.1128/MCB.23.11.3859-3871.2003; Collisson EA, 2011, NAT MED, V17, P500, DOI 10.1038/nm.2344; Coussens LM, 2013, SCIENCE, V339, P286, DOI 10.1126/science.1232227; Egberts JH, 2008, CANCER RES, V68, P1443, DOI 10.1158/0008-5472.CAN-07-5704; Germano G, 2013, CANCER CELL, V23, P249, DOI 10.1016/j.ccr.2013.01.008; Grivennikov SI, 2012, NATURE, V491, P254, DOI 10.1038/nature11465; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; Jirmanova L, 2011, BLOOD, V118, P3280, DOI 10.1182/blood-2011-01-333039; Kleeff J, 2007, INT J CANCER, V121, P699, DOI 10.1002/ijc.22871; Lin WW, 2007, J CLIN INVEST, V117, P1175, DOI 10.1172/JCI31537; Liu CY, 2013, LAB INVEST, V93, P844, DOI 10.1038/labinvest.2013.69; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Mathew E, 2014, CELL REP, V9, P484, DOI 10.1016/j.celrep.2014.09.010; Matsushita M, 2001, J NEUROSCI, V21, P6000, DOI 10.1523/JNEUROSCI.21-16-06000.2001; Mayorek N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012715; McAllister F, 2014, CANCER CELL, V25, P621, DOI 10.1016/j.ccr.2014.03.014; Neesse A, 2011, GUT, V60, P861, DOI 10.1136/gut.2010.226092; Noguchi H, 2004, NAT MED, V10, P305, DOI 10.1038/nm994; Ozdemir BC, 2014, CANCER CELL, V25, P719, DOI 10.1016/j.ccr.2014.04.005; Park EJ, 2010, CELL, V140, P197, DOI 10.1016/j.cell.2009.12.052; Raczkowski F, 2013, P NATL ACAD SCI USA, V110, P15019, DOI 10.1073/pnas.1309378110; Rao CV, 2012, NEOPLASIA, V14, P778, DOI 10.1593/neo.121026; Salvador JM, 2005, NAT IMMUNOL, V6, P396, DOI 10.1038/ni1176; Salvador JM, 2005, NAT IMMUNOL, V6, P390, DOI 10.1038/ni1177; Sato E, 2005, P NATL ACAD SCI USA, V102, P18538, DOI 10.1073/pnas.0509182102; Steele CW, 2013, BRIT J CANCER, V108, P997, DOI 10.1038/bjc.2013.24; Takagi K, 2005, J GASTROENTEROL, V40, P402, DOI 10.1007/s00535-004-1556-x; Waetzig GH, 2002, J IMMUNOL, V168, P5342, DOI 10.4049/jimmunol.168.10.5342; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Waterston AM, 2004, BRIT J CANCER, V90, P1279, DOI 10.1038/sj.bjc.6601670; Zhang YQ, 2014, CANCER IMMUNOL RES, V2, P423, DOI 10.1158/2326-6066.CIR-14-0016-T	34	44	46	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2015	21	11					1337	1343		10.1038/nm.3957	http://dx.doi.org/10.1038/nm.3957			7	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CV9QH	26479921	Green Accepted			2022-12-25	WOS:000364621200019
J	Reinisch, A; Thomas, D; Corces, MR; Zhang, XH; Gratzinger, D; Hong, WJ; Schallmoser, K; Strunk, D; Majeti, R				Reinisch, Andreas; Thomas, Daniel; Corces, M. Ryan; Zhang, Xiaohua; Gratzinger, Dita; Hong, Wan-Jen; Schallmoser, Katharina; Strunk, Dirk; Majeti, Ravindra			A humanized bone marrow ossicle xenotransplantation model enables improved engraftment of healthy and leukemic human hematopoietic cells	NATURE MEDICINE			English	Article							ACUTE PROMYELOCYTIC LEUKEMIA; ACUTE MYELOID-LEUKEMIA; STEM-CELL; CD34(+) CELLS; GM-CSF; MICE; NICHE; PROGENITORS; IDENTIFICATION; MYELOFIBROSIS	Xenotransplantation models represent powerful tools for the investigation of healthy and malignant human hematopoiesis. However, current models do not fully mimic the components of the human bone marrow (BM) microenvironment, and they enable only limited engraftment of samples from some human malignancies. Here we show that a xenotransplantation model bearing subcutaneous humanized ossicles with an accessible BM microenvironment, formed by in situ differentiation of human BM-derived mesenchymal stromal cells, enables the robust engraftment of healthy human hematopoietic stem and progenitor cells, as well as primary acute myeloid leukemia (AML) samples, at levels much greater than those in unmanipulated mice. Direct intraossicle transplantation accelerated engraftment and resulted in the detection of substantially higher leukemia-initiating cell (LIC) frequencies. We also observed robust engraftment of acute promyelocytic leukemia (APL) and myelofibrosis (MF) samples, and identified LICs in these malignancies. This humanized ossicle xenotransplantation approach provides a system for, modeling a wide variety of human hematological diseases.	[Reinisch, Andreas; Thomas, Daniel; Corces, M. Ryan; Zhang, Xiaohua; Hong, Wan-Jen; Majeti, Ravindra] Stanford Univ, Dept Med, Div Hematol, Sch Med, Stanford, CA 94305 USA; [Reinisch, Andreas; Thomas, Daniel; Corces, M. Ryan; Zhang, Xiaohua; Hong, Wan-Jen; Majeti, Ravindra] Stanford Univ, Inst Canc, Sch Med, Stanford, CA 94305 USA; [Reinisch, Andreas; Thomas, Daniel; Corces, M. Ryan; Zhang, Xiaohua; Hong, Wan-Jen; Majeti, Ravindra] Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Sch Med, Stanford, CA 94305 USA; [Gratzinger, Dita] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA; [Schallmoser, Katharina] Paracelsus Med Univ, Dept Blood Grp Serol & Transfus Med, Salzburg, Austria; [Schallmoser, Katharina; Strunk, Dirk] Paracelsus Med Univ, Spinal Cord Injury & Tissue Regenerat Ctr Salzbur, Salzburg, Austria; [Strunk, Dirk] Paracelsus Med Univ, Expt & Clin Cell Therapy Inst, Salzburg, Austria	Stanford University; Stanford University; Stanford University; Stanford University; Paracelsus Private Medical University; Paracelsus Private Medical University; Paracelsus Private Medical University	Majeti, R (corresponding author), Stanford Univ, Dept Med, Div Hematol, Sch Med, Stanford, CA 94305 USA.; Majeti, R (corresponding author), Stanford Univ, Inst Canc, Sch Med, Stanford, CA 94305 USA.; Majeti, R (corresponding author), Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Sch Med, Stanford, CA 94305 USA.	rmajeti@stanford.edu	Strunk, Dirk/V-4598-2017; Schallmoser, Katharina/V-4734-2017; Corces, M. Ryan/ABG-6947-2020	Strunk, Dirk/0000-0003-1810-867X; Schallmoser, Katharina/0000-0002-7204-0058; Corces, M. Ryan/0000-0001-7465-7652; Reinisch, Andreas/0000-0001-9333-7689; Gratzinger, Dita/0000-0002-9182-8123; Majeti, Ravindra/0000-0002-5814-0984	Erwin-Schroedinger Research Fellowship (Austrian Science Fund); CJ Martin Overseas Biomedical Research Fellowship (NHMRC, Australia); New York Stem Cell Foundation; National Institutes of Health [R01CA188055, U01HL099999]; European Union [668724]; Austrian Science Fund (FWF) [J 3358] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [R01CA188055] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL099999] Funding Source: NIH RePORTER	Erwin-Schroedinger Research Fellowship (Austrian Science Fund); CJ Martin Overseas Biomedical Research Fellowship (NHMRC, Australia)(National Health and Medical Research Council (NHMRC) of Australia); New York Stem Cell Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Union(European Commission); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We acknowledge the Hematology Division Tissue Bank and the patients for donating their samples. We acknowledge F. Zhao for lab management; N. Hofmann and B. Luo for technical assistance with ossicle analysis and calreticulin sequencing; and the Stanford Cytogenetics Lab for FISH analysis. A.R. is supported by an Erwin-Schroedinger Research Fellowship (Austrian Science Fund) and D.T. by a CJ Martin Overseas Biomedical Research Fellowship (NHMRC, Australia). R.M. is a New York Stem Cell Foundation Robertson Investigator. This research was supported by the New York Stem Cell Foundation and National Institutes of Health grants R01CA188055 and U01HL099999 to R.M. and by funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No. 668724 to D.S.	Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; DAMESHEK W, 1951, BLOOD, V6, P372, DOI 10.1182/blood.V6.4.372.372; Doulatov S, 2012, CELL STEM CELL, V10, P120, DOI 10.1016/j.stem.2012.01.006; Goardon N, 2011, CANCER CELL, V19, P138, DOI 10.1016/j.ccr.2010.12.012; Goyama S, 2015, BLOOD, V125, P2630, DOI 10.1182/blood-2014-11-570218; Grignani F, 2000, BLOOD, V96, P1531, DOI 10.1182/blood.V96.4.1531.h8001531_1531_1537; Grimwade D, 2004, LEUKEMIA, V18, P375, DOI 10.1038/sj.leu.2403234; Groen RWJ, 2012, BLOOD, V120, pE9, DOI 10.1182/blood-2012-03-414920; Guibal FC, 2009, BLOOD, V114, P5415, DOI 10.1182/blood-2008-10-182071; Haferlach T, 1998, BRIT J HAEMATOL, V103, P93, DOI 10.1046/j.1365-2141.1998.00959.x; Ishii T, 2007, EXP HEMATOL, V35, P1633, DOI 10.1016/j.exphem.2007.07.005; Ishikawa F, 2007, NAT BIOTECHNOL, V25, P1315, DOI 10.1038/nbt1350; James C, 2008, BLOOD, V112, P2429, DOI 10.1182/blood-2008-02-137877; Kim D, 2012, LEUKEMIA, V26, P2530, DOI 10.1038/leu.2012.140; Kim D, 2012, LEUKEMIA, V26, P2538, DOI 10.1038/leu.2012.141; Klampfl T, 2013, NEW ENGL J MED, V369, P2379, DOI 10.1056/NEJMoa1311347; Klco JM, 2014, CANCER CELL, V25, P379, DOI 10.1016/j.ccr.2014.01.031; KNUUTILA S, 1994, GENE CHROMOSOME CANC, V10, P95, DOI 10.1002/gcc.2870100204; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Majeti R, 2007, CELL STEM CELL, V1, P635, DOI 10.1016/j.stem.2007.10.001; Matsushita H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111082; Medyouf H, 2014, CELL STEM CELL, V14, P824, DOI 10.1016/j.stem.2014.02.014; Mendelson A, 2014, NAT MED, V20, P833, DOI 10.1038/nm.3647; Nangalia J, 2013, NEW ENGL J MED, V369, P2391, DOI 10.1056/NEJMoa1312542; Nicolini FE, 2004, LEUKEMIA, V18, P341, DOI 10.1038/sj.leu.2403222; Pang WW, 2013, P NATL ACAD SCI USA, V110, P3011, DOI 10.1073/pnas.1222861110; Patel S, 2012, LEUKEMIA, V26, P2432, DOI 10.1038/leu.2012.154; Pettway GJ, 2005, BONE, V36, P959, DOI 10.1016/j.bone.2005.02.015; Reinisch A, 2015, BLOOD, V125, P249, DOI 10.1182/blood-2014-04-572255; Rongvaux A, 2014, NAT BIOTECHNOL, V32, P364, DOI 10.1038/nbt.2858; Rongvaux A, 2011, P NATL ACAD SCI USA, V108, P2378, DOI 10.1073/pnas.1019524108; Saito Y, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000349; Sanchez PV, 2009, LEUKEMIA, V23, P2109, DOI 10.1038/leu.2009.143; Sarry JE, 2011, J CLIN INVEST, V121, P384, DOI 10.1172/JCI41495; Schepers K, 2015, CELL STEM CELL, V16, P254, DOI 10.1016/j.stem.2015.02.014; Song JH, 2010, BLOOD, V115, P2592, DOI 10.1182/blood-2009-01-200071; TAKATSUKI H, 1993, BRIT J HAEMATOL, V85, P477; TURHAN AG, 1995, BLOOD, V85, P2154, DOI 10.1182/blood.V85.8.2154.bloodjournal8582154; Wang XL, 2012, J CLIN INVEST, V122, P3888, DOI 10.1172/JCI64397; Wang XL, 2010, BLOOD, V116, P5972, DOI 10.1182/blood-2010-02-269696; Willinger T, 2011, TRENDS IMMUNOL, V32, P321, DOI 10.1016/j.it.2011.04.005; Willinger T, 2011, P NATL ACAD SCI USA, V108, P2390, DOI 10.1073/pnas.1019682108; Wunderlich M, 2010, LEUKEMIA, V24, P1785, DOI 10.1038/leu.2010.158; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	46	138	140	0	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2016	22	7					812	821		10.1038/nm.4103	http://dx.doi.org/10.1038/nm.4103			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DQ7DK	27213817	Green Accepted			2022-12-25	WOS:000379366900021
J	Helgadottir, A; Gretarsdottir, S; Thorleifsson, G; Hjartarson, E; Sigurdsson, A; Magnusdottir, A; Jonasdottir, A; Kristjansson, H; Sulem, P; Oddsson, A; Sveinbjornsson, G; Steinthorsdottir, V; Rafnar, T; Masson, G; Jonsdottir, I; Olafsson, I; Eyjolfsson, GI; Sigurdardottir, O; Daneshpour, MS; Khalili, D; Azizi, F; Swinkels, DW; Kiemeney, L; Quyyumi, AA; Levey, AI; Patel, RS; Hayek, SS; Gudmundsdottir, IJ; Thorgeirsson, G; Thorsteinsdottir, U; Gudbjartsson, DF; Holm, H; Stefansson, K				Helgadottir, Anna; Gretarsdottir, Solveig; Thorleifsson, Gudmar; Hjartarson, Eirikur; Sigurdsson, Asgeir; Magnusdottir, Audur; Jonasdottir, Aslaug; Kristjansson, Helgi; Sulem, Patrick; Oddsson, Asmundur; Sveinbjornsson, Gardar; Steinthorsdottir, Valgerdur; Rafnar, Thorunn; Masson, Gisli; Jonsdottir, Ingileif; Olafsson, Isleifur; Eyjolfsson, Gudmundur I.; Sigurdardottir, Olof; Daneshpour, Maryam S.; Khalili, Davood; Azizi, Fereidoun; Swinkels, Dorine W.; Kiemeney, Lambertus; Quyyumi, Arshed A.; Levey, Allan I.; Patel, Riyaz S.; Hayek, Salim S.; Gudmundsdottir, Ingibjorg J.; Thorgeirsson, Gudmundur; Thorsteinsdottir, Unnur; Gudbjartsson, Daniel F.; Holm, Hilma; Stefansson, Kari			Variants with large effects on blood lipids and the role of cholesterol and triglycerides in coronary disease	NATURE GENETICS			English	Article							SEQUENCING IDENTIFIES RARE; LOW-FREQUENCY; GENETIC-VARIANTS; HEART-DISEASE; RISK; ASSOCIATION; MUTATIONS; PLASMA	Sequence variants affecting blood lipids and coronary artery disease (CAD) may enhance understanding of the atherogenicity of lipid fractions. Using a large resource of whole-genome sequence data, we examined rare and low-frequency variants for association with non-HDL cholesterol, HDL cholesterol, LDL cholesterol, and triglycerides in up to 119,146 Icelanders. We discovered 13 variants with large effects (within ANGPTL3, APOB, ABCA1, NR1H3, APOA1, LIPC, CETP, LDLR, and APOC1) and replicated 14 variants. Five variants within PCSK9, APOA1, ANGPTL4, and LDLR associate with CAD (33,090 cases and 236,254 controls). We used genetic risk scores for the lipid fractions to examine their causal relationship with CAD. The non-HDL cholesterol genetic risk score associates most strongly with CAD (P = 2.7 x 10(-28)), and no other genetic risk score associates with CAD after accounting for non-HDL cholesterol. The genetic risk score for non-HDL cholesterol confers CAD risk beyond that of LDL cholesterol (P = 5.5 x 10(-8)), suggesting that targeting atherogenic remnant cholesterol may reduce cardiovascular risk.	[Helgadottir, Anna; Gretarsdottir, Solveig; Thorleifsson, Gudmar; Hjartarson, Eirikur; Sigurdsson, Asgeir; Magnusdottir, Audur; Jonasdottir, Aslaug; Kristjansson, Helgi; Sulem, Patrick; Oddsson, Asmundur; Sveinbjornsson, Gardar; Steinthorsdottir, Valgerdur; Rafnar, Thorunn; Masson, Gisli; Jonsdottir, Ingileif; Thorsteinsdottir, Unnur; Gudbjartsson, Daniel F.; Holm, Hilma; Stefansson, Kari] Amgen Inc, deCODE Genet, Reykjavik, Iceland; [Helgadottir, Anna; Jonsdottir, Ingileif; Thorgeirsson, Gudmundur; Thorsteinsdottir, Unnur; Stefansson, Kari] Univ Iceland, Fac Med, Reykjavik, Iceland; [Jonsdottir, Ingileif] Landspitali Natl Univ Hosp, Dept Immunol, Reykjavik, Iceland; [Olafsson, Isleifur] Landspitali Natl Univ Hosp, Dept Clin Biochem, Reykjavik, Iceland; [Eyjolfsson, Gudmundur I.] Lab Mjodd RAM, Reykjavik, Iceland; [Sigurdardottir, Olof] Akureyri Hosp, Dept Clin Biochem, Akureyri, Iceland; [Daneshpour, Maryam S.] Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Cellular & Mol Endocrine Res Ctr, Tehran, Iran; [Khalili, Davood] Shahid Beheshti Univ Med Sci, Prevent Metab Disorders Res Ctr, Res Inst Endocrine Sci, Tehran, Iran; [Azizi, Fereidoun] Shahid Beheshti Univ Med Sci, Endocrine Res Ctr, Res Inst Endocrine Sci, Tehran, Iran; [Swinkels, Dorine W.] Radboud Univ Nijmegen, Dept Lab Med, Med Ctr, Radboud Inst Mol Life Sci, NL-6525 ED Nijmegen, Netherlands; [Kiemeney, Lambertus] Radboud Univ Nijmegen, Radboud Inst Hlth Sci, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Quyyumi, Arshed A.; Levey, Allan I.; Patel, Riyaz S.; Hayek, Salim S.] Emory Univ, Sch Med, Atlanta, GA USA; [Gudmundsdottir, Ingibjorg J.; Thorgeirsson, Gudmundur; Holm, Hilma] Landspitali Natl Univ Hosp, Dept Internal Med, Div Cardiol, Reykjavik, Iceland; [Gudbjartsson, Daniel F.] Univ Iceland, Sch Engn & Nat Sci, Reykjavik, Iceland	University of Iceland; Landspitali National University Hospital; Landspitali National University Hospital; Shahid Beheshti University Medical Sciences; Shahid Beheshti University Medical Sciences; Shahid Beheshti University Medical Sciences; Radboud University Nijmegen; Radboud University Nijmegen; Emory University; Landspitali National University Hospital; University of Iceland	Holm, H; Stefansson, K (corresponding author), Amgen Inc, deCODE Genet, Reykjavik, Iceland.; Stefansson, K (corresponding author), Univ Iceland, Fac Med, Reykjavik, Iceland.; Holm, H (corresponding author), Landspitali Natl Univ Hosp, Dept Internal Med, Div Cardiol, Reykjavik, Iceland.	hilma.holm@decode.is; kstefans@decode.is	Kiemeney, Lambertus A./D-3357-2009; Swinkels, Dorine W./H-8098-2014; Hayek, Salim S./E-6932-2013; Stefansson, Kari/AAE-7187-2019; Levey, Allan/F-2104-2011; Azizi, Fereidoun/ABD-4136-2021; Girelli, Domenico/B-1183-2008; Khalili, Davood/T-2913-2017	Kiemeney, Lambertus A./0000-0002-2368-1326; Swinkels, Dorine W./0000-0002-1040-9446; Hayek, Salim S./0000-0003-0180-349X; Levey, Allan/0000-0002-3153-502X; Azizi, Fereidoun/0000-0002-6470-2517; Girelli, Domenico/0000-0001-9684-1899; Khalili, Davood/0000-0003-4956-1039; Steinthorsdottir, Valgerdur/0000-0003-1846-6274; Sveinbjornsson, Gardar/0000-0003-2429-9468; Masson, Gisli/0000-0003-0493-8242; Gudmundsdottir, Ingibjorg/0000-0001-5475-5044; daneshpour, maryam alsadat/0000-0003-1525-8672	Emory Neuroscience NINDS Core Facilities grant [P30NS055077]; deCODE Genetics/Amgen; Emory by NIH grants from the Clinical and Translational Science Award program [UL1RR025008, R01HL089650-02]; British Heart Foundation [FS/14/76/30933] Funding Source: researchfish; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025008] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089650] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS055077] Funding Source: NIH RePORTER	Emory Neuroscience NINDS Core Facilities grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); deCODE Genetics/Amgen; Emory by NIH grants from the Clinical and Translational Science Award program; British Heart Foundation(British Heart Foundation); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank all the individuals who participated in this study and whose contribution made this work possible. We also thank our valued colleagues who contributed to the data collection and phenotypic characterization of clinical samples as well as to the genotyping and analysis of the whole-genome association data. Funding was provided by deCODE Genetics/Amgen and at Emory by NIH grants UL1RR025008 from the Clinical and Translational Science Award program, R01HL089650-02, and Emory Neuroscience NINDS Core Facilities grant P30NS055077.	Azizi F, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-5; Barter PJ, 2007, NEW ENGL J MED, V357, P2109, DOI 10.1056/NEJMoa0706628; Bennet AM, 2007, JAMA-J AM MED ASSOC, V298, P1300, DOI 10.1001/jama.298.11.1300; Berbee JFP, 2005, J LIPID RES, V46, P297, DOI 10.1194/jlr.M400301-JLR200; Bowden J, 2015, INT J EPIDEMIOL, V44, P512, DOI 10.1093/ije/dyv080; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; Brunham LR, 2015, PROG LIPID RES, V58, P14, DOI 10.1016/j.plipres.2015.01.001; Clarke R, 2009, NEW ENGL J MED, V361, P2518, DOI 10.1056/NEJMoa0902604; Crosby J, 2014, NEW ENGL J MED, V371, P22, DOI 10.1056/NEJMoa1307095; Di Angelantonio E, 2009, JAMA-J AM MED ASSOC, V302, P1993, DOI 10.1001/jama.2009.1619; Do R, 2015, NATURE, V518, P102, DOI 10.1038/nature13917; Do R, 2013, NAT GENET, V45, P1345, DOI 10.1038/ng.2795; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gudnason V, 1997, HUM MUTAT, V10, P36, DOI 10.1002/(SICI)1098-1004(1997)10:1<36::AID-HUMU5>3.0.CO;2-K; Helgadottir A, 2007, SCIENCE, V316, P1491, DOI 10.1126/science.1142842; Helgason A, 2003, ANN HUM GENET, V67, P281, DOI 10.1046/j.1469-1809.2003.00046.x; Holmes MV, 2015, EUR HEART J, V36, P539, DOI 10.1093/eurheartj/eht571; Jorgensen AB, 2014, NEW ENGL J MED, V371, P32, DOI 10.1056/NEJMoa1308027; Khalili D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105804; Kong A, 2008, NAT GENET, V40, P1068, DOI 10.1038/ng.216; Kong A, 2009, NATURE, V462, P868, DOI 10.1038/nature08625; Kutyavin IV, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl679; Landray MJ, 2014, NEW ENGL J MED, V371, P203, DOI 10.1056/NEJMoa1300955; Lange LA, 2014, AM J HUM GENET, V94, P233, DOI 10.1016/j.ajhg.2014.01.010; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; Peloso GM, 2014, AM J HUM GENET, V94, P223, DOI 10.1016/j.ajhg.2014.01.009; RAPAPORT E, 1979, CIRCULATION, V59, P607; Rohatgi A, 2014, NEW ENGL J MED, V371, P2383, DOI 10.1056/NEJMoa1409065; Scanlon PJ, 1999, CIRCULATION, V99, P2345, DOI 10.1161/01.CIR.99.17.2345; Schwartz GG, 2012, NEW ENGL J MED, V367, P2089, DOI 10.1056/NEJMoa1206797; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Steinthorsdottir V, 2014, NAT GENET, V46, P294, DOI 10.1038/ng.2882; Styrkarsdottir U, 2013, NATURE, V497, P517, DOI 10.1038/nature12124; Sveinbjornsson G, 2016, NAT GENET, V48, P314, DOI 10.1038/ng.3507; Tontonoz P, 2003, MOL ENDOCRINOL, V17, P985, DOI 10.1210/me.2003-0061; Varbo A, 2013, J AM COLL CARDIOL, V61, P427, DOI 10.1016/j.jacc.2012.08.1026; Voight BF, 2012, LANCET, V380, P572, DOI 10.1016/S0140-6736(12)60312-2; Wetzels JFM, 2007, KIDNEY INT, V72, P632, DOI 10.1038/sj.ki.5002374; Whitfield AJ, 2004, CLIN CHEM, V50, P1725, DOI 10.1373/clinchem.2004.038026; Wurtz P, 2013, J AM COLL CARDIOL, V62, P1906, DOI 10.1016/j.jacc.2013.07.085	41	165	170	1	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2016	48	6					634	+		10.1038/ng.3561	http://dx.doi.org/10.1038/ng.3561			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DN0HE	27135400	Green Accepted			2022-12-25	WOS:000376744200010
J	Ellinghaus, D; Jostins, L; Spain, SL; Cortes, A; Bethune, J; Han, B; Park, YR; Raychaudhuri, S; Pouget, JG; Hubenthal, M; Folseraas, T; Wang, YP; Esko, T; Metspalu, A; Westra, HJ; Franke, L; Pers, TH; Weersma, RK; Collij, V; D'Amato, M; Halfvarson, J; Jensen, AB; Lieb, W; Degenhardt, F; Forstner, AJ; Hofmann, A; Schreiber, S; Mrowietz, U; Juran, BD; Lazaridis, KN; Brunak, S; Dale, AM; Trembath, RC; Weidinger, S; Weichenthal, M; Ellinghaus, E; Elder, JT; Barker, JNWN; Andreassen, OA; McGovern, DP; Karlsen, TH; Barrett, JC; Parkes, M; Brown, MA; Franke, A				Ellinghaus, David; Jostins, Luke; Spain, Sarah L.; Cortes, Adrian; Bethune, Joern; Han, Buhm; Park, Yu Rang; Raychaudhuri, Soumya; Pouget, Jennie G.; Huebenthal, Matthias; Folseraas, Trine; Wang, Yunpeng; Esko, Tonu; Metspalu, Andres; Westra, Harm-Jan; Franke, Lude; Pers, Tune H.; Weersma, Rinse K.; Collij, Valerie; D'Amato, Mauro; Halfvarson, Jonas; Jensen, Anders Boeck; Lieb, Wolfgang; Degenhardt, Franziska; Forstner, Andreas J.; Hofmann, Andrea; Schreiber, Stefan; Mrowietz, Ulrich; Juran, Brian D.; Lazaridis, Konstantinos N.; Brunak, Soren; Dale, Anders M.; Trembath, Richard C.; Weidinger, Stephan; Weichenthal, Michael; Ellinghaus, Eva; Elder, James T.; Barker, Jonathan N. W. N.; Andreassen, Ole A.; McGovern, Dermot P.; Karlsen, Tom H.; Barrett, Jeffrey C.; Parkes, Miles; Brown, Matthew A.; Franke, Andre		IIBDGC; IGAS; IPSCSG; GAPC; PAGE	Analysis of five chronic inflammatory diseases identifies 27 new associations and highlights disease-specific patterns at shared loci	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; KINASE C-THETA; BOWEL-DISEASE; RISK LOCI; SUSCEPTIBILITY LOCI; GENE-EXPRESSION; METAANALYSIS; PSORIASIS; VARIANTS; COMMON	We simultaneously investigated the genetic landscape of ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis and ulcerative colitis to investigate pleiotropy and the relationship between these clinically related diseases. Using high-density genotype data from more than 86,000 individuals of European ancestry, we identified 244 independent multidisease signals, including 27 new genome-wide significant susceptibility loci and 3 unreported shared risk loci. Complex pleiotropy was supported when contrasting multidisease signals with expression data sets from human, rat and mouse together with epigenetic and expressed enhancer profiles. The comorbidities among the five immune diseases were best explained by biological pleiotropy rather than heterogeneity (a subgroup of cases genetically identical to those with another disease, possibly owing to diagnostic misclassification, molecular subtypes or excessive comorbidity). In particular, the strong comorbidity between primary sclerosing cholangitis and inflammatory bowel disease is likely the result of a unique disease, which is genetically distinct from classical inflammatory bowel disease phenotypes.	[Ellinghaus, David; Bethune, Joern; Huebenthal, Matthias; Schreiber, Stefan; Ellinghaus, Eva; Franke, Andre] Univ Kiel, Inst Clin Mol Biol, Kiel, Germany; [Jostins, Luke; Spain, Sarah L.; Barrett, Jeffrey C.] Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Hinxton, England; [Cortes, Adrian] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Neurosci, Div Clin Neurol, Oxford OX3 9DU, England; [Cortes, Adrian] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Han, Buhm] Univ Ulsan, Coll Med, Dept Convergence Med, Seoul, South Korea; [Han, Buhm] Asan Med Ctr, Asan Inst Life Sci, Seoul, South Korea; [Park, Yu Rang] Univ Ulsan, Asan Inst Life Sci, Asan Med Ctr, Coll Med, Seoul, South Korea; [Raychaudhuri, Soumya; Westra, Harm-Jan; Pers, Tune H.] Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA USA; [Raychaudhuri, Soumya; Westra, Harm-Jan] Brigham & Womens Hosp, Div Genet, 75 Francis St, Boston, MA 02115 USA; [Raychaudhuri, Soumya; Westra, Harm-Jan] Brigham & Womens Hosp, Div Rheumatol, 75 Francis St, Boston, MA 02115 USA; [Raychaudhuri, Soumya; Westra, Harm-Jan] Harvard Sch Med, Dept Med, Boston, MA USA; [Pouget, Jennie G.] Campbell Family Mental Hlth Res Inst, Ctr Addict & Mental Hlth, Toronto, ON, Canada; [Pouget, Jennie G.] Univ Toronto, Dept Psychiat, Toronto, ON, Canada; [Folseraas, Trine; Karlsen, Tom H.] Oslo Univ Hosp, Norwegian PSC Res Ctr, Div Canc Med Surg & Transplantat, Dept Transplantat Med,Rikshosp, N-0450 Oslo, Norway; [Folseraas, Trine; Karlsen, Tom H.] Univ Oslo, KG Jebsen Inflammat Res Ctr, Inst Clin Med, Oslo, Norway; [Folseraas, Trine; Karlsen, Tom H.] Oslo Univ Hosp, Res Inst Internal Med, Div Canc Med Surg & Transplantat, Rikshosp, Oslo, Norway; [Folseraas, Trine; Karlsen, Tom H.] Oslo Univ Hosp, Dept Transplantat Med, Gastroenterol Sect, N-0450 Oslo, Norway; [Wang, Yunpeng; Dale, Anders M.] Univ Calif San Diego, Dept Neurosci, San Diego, CA 92103 USA; [Esko, Tonu; Metspalu, Andres] Univ Tartu, Estonian Genome Ctr, Ulikooli 18, EE-50090 Tartu, Estonia; [Esko, Tonu] Boston Childrens Hosp, Div Endocrinol, Cambridge, MA USA; [Esko, Tonu; Pers, Tune H.] Boston Childrens Hosp, Ctr Basic & Translat Obes Res, Cambridge, MA USA; [Franke, Lude] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands; [Pers, Tune H.] Univ Copenhagen, Novo Nordisk Fdn, Ctr Basic Metab Res, Copenhagen, Denmark; [Pers, Tune H.] Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen, Denmark; [Weersma, Rinse K.; Collij, Valerie] Univ Groningen, Univ Med Ctr Groningen, Dept Gastroenterol & Hepatol, Groningen, Netherlands; [D'Amato, Mauro] Karolinska Inst, Dept Biosci & Nutr, Stockholm, Sweden; [D'Amato, Mauro] BioCruces Hlth Res Inst, Bilbao, Spain; [D'Amato, Mauro] Ikerbasque, Basque Fdn Sci, E-48011 Bilbao, Spain; [Halfvarson, Jonas] Univ Orebro, Dept Gastroenterol, Fac Med & Hlth, SE-70182 Orebro, Sweden; [Jensen, Anders Boeck; Brunak, Soren] Univ Copenhagen, Novo Nordisk Fdn Ctr Prot Res, Fac Hlth & Med Sci, Copenhagen, Denmark; [Lieb, Wolfgang] Univ Hosp Schleswig Holstein, Inst Epidemiol, Kiel, Germany; [Lieb, Wolfgang] Univ Hosp Schleswig Holstein, PopGen Biobank, Kiel, Germany; [Degenhardt, Franziska; Forstner, Andreas J.; Hofmann, Andrea] Univ Bonn, Inst Human Genet, Bonn, Germany; [Degenhardt, Franziska; Forstner, Andreas J.; Hofmann, Andrea] Univ Bonn, Dept Genom Life & Brain Ctr, Bonn, Germany; [Schreiber, Stefan] Univ Klinikum Schleswig Holstein, Dept Gen Internal Med, Campus Kiel, Kiel, Germany; [Mrowietz, Ulrich; Weidinger, Stephan; Weichenthal, Michael] Univ Kiel, Dept Dermatol, Univ Hosp, Schleswig Holstein, Schittenhelmstr 7, Kiel, Germany; [Juran, Brian D.; Lazaridis, Konstantinos N.] Mayo Clin, Ctr Basic Res Digest Dis, Div Gastroenterol & Hepatol, Coll Med, Rochester, MN USA; [Dale, Anders M.] Univ Calif San Diego, Dept Radiol, La Jolla, CA 92093 USA; [Trembath, Richard C.] Kings Coll London, Div Genet & Mol Med, London, England; [Elder, James T.] Univ Michigan, Dept Dermatol, Ann Arbor, MI 48109 USA; [Elder, James T.] Ann Arbor Vet Affairs Hosp, Ann Arbor, MI USA; [Barker, Jonathan N. W. N.] Kings Coll London, St Johns Inst Dermatol, Div Genet & Mol Med, London, England; [Andreassen, Ole A.] Univ Oslo, NORMENT, KG Jebsen Ctr Psychosis Res, Inst Clin Med, Oslo, Norway; [Andreassen, Ole A.] Oslo Univ Hosp, Div Mental Hlth & Addict, Oslo, Norway; [McGovern, Dermot P.] F Widjaja Fdn Inflammatory Bowel & Immunobiol Res, Los Angeles, CA USA; [McGovern, Dermot P.] Cedars Sinai Med Ctr, Inst Med Genet, Los Angeles, CA 90048 USA; [Parkes, Miles] Univ Cambridge, Addenbrookes Hosp, Inflammatory Bowel Dis Res Grp, Cambridge CB2 2QQ, England; [Brown, Matthew A.] Univ Queensland, Diamantina Inst, Translat Res Inst, Brisbane, Qld, Australia; [Brown, Matthew A.] Queensland Univ Technol, IHBI, Translat Res Inst, Brisbane, Qld 4001, Australia; [Ellinghaus, David] Univ Kiel, Inst Clin Mol Biol, Kiel, Germany	University of Kiel; Wellcome Trust Sanger Institute; University of Oxford; University of Oxford; Wellcome Centre for Human Genetics; University of Ulsan; University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Toronto; University of Oslo; National Hospital Norway; University of Oslo; University of Oslo; National Hospital Norway; University of Oslo; University of California System; University of California San Diego; University of Tartu; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; University of Groningen; Novo Nordisk Foundation; University of Copenhagen; Statens Serum Institut; University of Groningen; Karolinska Institutet; Basque Foundation for Science; Orebro University; University of Copenhagen; University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Schleswig Holstein University Hospital; University of Bonn; University of Bonn; University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Schleswig Holstein University Hospital; Mayo Clinic; University of California System; University of California San Diego; University of London; King's College London; University of Michigan System; University of Michigan; University of London; King's College London; University of Oslo; University of Oslo; Cedars Sinai Medical Center; Cedars Sinai Medical Center; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Queensland; Queensland University of Technology (QUT); University of Kiel	Ellinghaus, D (corresponding author), Univ Kiel, Inst Clin Mol Biol, Kiel, Germany.	d.ellinghaus@ikmb.uni-kiel.de	Hübenthal, Matthias/M-8149-2015; Ellinghaus, Eva/E-6490-2012; Weersma, Rinse/ABE-3807-2021; Ellinghaus, David/ABC-3610-2020; Weidinger, Stephan/C-8461-2011; Ellinghaus, David/G-4467-2012; Franke, Andre/B-2151-2010; Han, Buhm/AAQ-9672-2020; D'Amato, Mauro/B-5050-2019; Andreassen, Ole A./AAY-7531-2020; Degenhardt, Franziska/H-4169-2017; Lieb, Wolfgang/AAC-7650-2022; Halfvarson, Jonas/AAU-4687-2020; D'Amato, Mauro/F-2450-2010; Brown, Matthew A/E-5749-2010; Franke, Lude/P-7036-2016; Wang, Yunpeng/W-8871-2018; Bethune, Jorn/A-9502-2016; Brunak, Soren/O-6621-2016; Spain, Sarah/G-1968-2010	Hübenthal, Matthias/0000-0002-5956-3006; Ellinghaus, Eva/0000-0003-2914-3382; Ellinghaus, David/0000-0002-4332-6110; Weidinger, Stephan/0000-0003-3944-252X; Franke, Andre/0000-0003-1530-5811; D'Amato, Mauro/0000-0003-2743-5197; D'Amato, Mauro/0000-0003-2743-5197; Brown, Matthew A/0000-0003-0538-8211; Franke, Lude/0000-0002-5159-8802; Wang, Yunpeng/0000-0001-9831-1090; Pers, Tune/0000-0003-0207-4831; Trembath, Richard/0000-0003-0550-3400; Bethune, Jorn/0000-0002-6919-2595; Brunak, Soren/0000-0003-0316-5866; Barrett, Jeffrey/0000-0002-1152-370X; Barker, Jonathan/0000-0002-9030-183X; Spain, Sarah/0000-0002-7591-8364; Li, Zhixiu/0000-0002-2924-9120; Parkes, Miles/0000-0002-6467-0631; Raychaudhuri, Soumya/0000-0002-1901-8265; Collij, Valerie/0000-0003-3743-1544; Harrison, Pille/0000-0003-4117-6910; Jensen, Anders Boeck/0000-0002-5784-308X	German Federal Ministry of Education and Research (BMBF) [01ZX1306A]; Estonian Research Council [IUT20-60]; Center of Excellence in Genomics (EXCEGEN); University of Tartu (SP1GVARENG); UK Department of Health via National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre awards to Guy's and St Thomas' National Health Service (NHS) Foundation Trust; King's College London; University of Cambridge; German Federal Ministry of Education and Research (BMBF), within the context of National Genome Research Network [2 (NGFN-2)]; National Genome Research Network plus (NGFNplus); Integrated Genome Research Network (IG) MooDS [01GS08144, 01GS08147]; Netherlands Organization for Scientific Research (NWO) [016.136.308]; Swedish Research Council [521-2011-2764]; US NIH [1R01AR063759, 5U01GM092691-05, 1UH2AR067677-01, U19AI111224-01, 1R01DK084960-05]; Doris Duke Charitable Foundation [2013097]; Novo Nordisk Foundation [NNF14CC0001]; H2020 project MedBioinformatics [634143]; Norwegian PSC Research Center; German Federal Ministry of Education and Research (BMBF) [01ZX1306A]; Estonian Research Council [IUT20-60]; Center of Excellence in Genomics (EXCEGEN); University of Tartu (SP1GVARENG); UK Department of Health via National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre awards to Guy's and St Thomas' National Health Service (NHS) Foundation Trust; King's College London; University of Cambridge; German Federal Ministry of Education and Research (BMBF), within the context of National Genome Research Network [2 (NGFN-2)]; National Genome Research Network plus (NGFNplus); Integrated Genome Research Network (IG) MooDS [01GS08144, 01GS08147]; Netherlands Organization for Scientific Research (NWO) [016.136.308]; Swedish Research Council [521-2011-2764]; US NIH [1R01AR063759, 5U01GM092691-05, 1UH2AR067677-01, U19AI111224-01, 1R01DK084960-05]; Doris Duke Charitable Foundation [2013097]; Novo Nordisk Foundation [NNF14CC0001]; H2020 project MedBioinformatics [634143]; Norwegian PSC Research Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI111224] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR042742, R01AR063759, R01AR050511, R01AR063611, R01AR065183, UH2AR067677] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK084960] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM092691] Funding Source: NIH RePORTER; Lundbeck Foundation [R190-2014-3904] Funding Source: researchfish; Medical Research Council [G0800675] Funding Source: researchfish; Medical Research Foundation [C0482] Funding Source: researchfish; NNF Center for Basic Metabolic Research [Pers Group] Funding Source: researchfish; Novo Nordisk Foundation Center for Protein Research [PI S�ren Brunak] Funding Source: researchfish; Crohn&quot;s and Colitis UK [M11-1] Funding Source: researchfish; MRC [G0800675] Funding Source: UKRI	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Estonian Research Council(Estonian Research Council); Center of Excellence in Genomics (EXCEGEN); University of Tartu (SP1GVARENG); UK Department of Health via National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre awards to Guy's and St Thomas' National Health Service (NHS) Foundation Trust; King's College London(General Electric); University of Cambridge(University of Cambridge); German Federal Ministry of Education and Research (BMBF), within the context of National Genome Research Network(Federal Ministry of Education & Research (BMBF)); National Genome Research Network plus (NGFNplus); Integrated Genome Research Network (IG) MooDS; Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Swedish Research Council(Swedish Research CouncilEuropean Commission); US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); H2020 project MedBioinformatics; Norwegian PSC Research Center; German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Estonian Research Council(Estonian Research Council); Center of Excellence in Genomics (EXCEGEN); University of Tartu (SP1GVARENG); UK Department of Health via National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre awards to Guy's and St Thomas' National Health Service (NHS) Foundation Trust; King's College London(General Electric); University of Cambridge(University of Cambridge); German Federal Ministry of Education and Research (BMBF), within the context of National Genome Research Network(Federal Ministry of Education & Research (BMBF)); National Genome Research Network plus (NGFNplus); Integrated Genome Research Network (IG) MooDS; Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Swedish Research Council(Swedish Research CouncilEuropean Commission); US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); H2020 project MedBioinformatics; Norwegian PSC Research Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Lundbeck Foundation(Lundbeckfonden); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Medical Research Foundation(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NNF Center for Basic Metabolic Research(Novo Nordisk Foundation); Novo Nordisk Foundation Center for Protein Research; Crohn&quot;s and Colitis UK; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank all patients with ankylosing spondylitis, Crohn's disease, PSC, psoriasis and ulcerative colitis, their families, healthy control individuals and clinicians for their participation in this study. We thank T. Wesse, T. Henke, S. Sedghpour Sabet, R. Vogler, G. Jacobs, I. Urbach, W. Albrecht, V. Pelkonen, K. Holm, H. Dahlen Sollid, B. Woldseth, J.A. Anmarkrud and L. Wenche Torbjornsen for expert help. F. Braun, W. Kreisel, T. Berg and R. Gunther are acknowledged for contributing German patients with PSC. B. A. Lie and the Norwegian Bone Marrow Donor Registry at Oslo University Hospital, Rikshospitalet, in Oslo and the Nord-Trondelag Health Study (HUNT) are acknowledged for sharing the healthy Norwegian controls. This work was supported by the German Federal Ministry of Education and Research (BMBF) within the framework of the e:Med research and funding concept (SysInflame grant 01ZX1306A). This project received infrastructure support from Deutsche Forschungsgemeinschaft (DFG) Excellence Cluster 306 'Inflammation at Interfaces' and the PopGen Biobank. A. F. receives an endowment professorship by the Foundation for Experimental Medicine (Zurich, Switzerland). The Estonian Genome Center at the University of Tartu (EGCUT) received targeted financing from Estonian Research Council grant IUT20-60, the Center of Excellence in Genomics (EXCEGEN) and the University of Tartu (SP1GVARENG). We acknowledge EGCUT technical personnel, especially V. Soo and S. Smit. Data analyses were carried out in part at the High-Performance Computing Center of the University of Tartu. We acknowledge support from the UK Department of Health via National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre awards to Guy's and St Thomas' National Health Service (NHS) Foundation Trust in partnership with King's College London and to Addenbrooke's Hospital in partnership with the University of Cambridge. The study was supported by the German Federal Ministry of Education and Research (BMBF), within the context of National Genome Research Network 2 (NGFN-2), National Genome Research Network plus (NGFNplus) and the Integrated Genome Research Network (IG) MooDS (grants 01GS08144 and 01GS08147). R. K. W. is supported by a VIDI grant (016.136.308) from the Netherlands Organization for Scientific Research (NWO). J.H. was supported by the Swedish Research Council (521-2011-2764). This work is supported in part by funding from the US NIH (1R01AR063759 (S. R.), 5U01GM092691-05 (S. R.), 1UH2AR067677-01 (S. R.), U19AI111224-01 (S. R.) and 1R01DK084960-05 (K.N.L.)) and Doris Duke Charitable Foundation grant 2013097. A.B.J. and S. B. acknowledge funding from the Novo Nordisk Foundation (grant NNF14CC0001) and the H2020 project MedBioinformatics (grant 634143). The study was supported by the Norwegian PSC Research Center. We thank G. Trynka for assistance in setting up GoShifter.	Abraham G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093766; Adams DH, 2006, NAT REV IMMUNOL, V6, P244, DOI 10.1038/nri1784; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Anderson CA, 2011, NAT GENET, V43, P246, DOI 10.1038/ng.764; Apetoh L, 2007, NAT MED, V13, P1050, DOI 10.1038/nm1622; Bhattacharjee S, 2012, AM J HUM GENET, V90, P821, DOI 10.1016/j.ajhg.2012.03.015; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Chen GB, 2014, HUM MOL GENET, V23, P4710, DOI 10.1093/hmg/ddu174; Cortes A, 2013, NAT GENET, V45, P730, DOI 10.1038/ng.2667; de Vries AB, 2015, WORLD J GASTROENTERO, V21, P1956, DOI 10.3748/wjg.v21.i6.1956; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Fairfax BP, 2012, NAT GENET, V44, P502, DOI 10.1038/ng.2205; Fehrmann RSN, 2015, NAT GENET, V47, P115, DOI 10.1038/ng.3173; Fehrmann RSN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002197; Forrest ARR, 2014, NATURE, V507, P462, DOI 10.1038/nature13182; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Goyette P, 2015, NAT GENET, V47, P172, DOI 10.1038/ng.3176; Grant AJ, 2002, LANCET, V359, P150, DOI 10.1016/S0140-6736(02)07374-9; Grant SFA, 2009, DIABETES, V58, P290, DOI 10.2337/db08-1022; Gusev A, 2014, AM J HUM GENET, V95, P535, DOI 10.1016/j.ajhg.2014.10.004; Han B., 2015, BIORXIV, DOI [10.1101/030783, DOI 10.1101/030783]; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Isakov N, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00273; Jensen AB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5022; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kamburov A, 2011, NUCLEIC ACIDS RES, V39, pD712, DOI 10.1093/nar/gkq1156; Karlsen TH, 2013, J HEPATOL, V59, P571, DOI 10.1016/j.jhep.2013.03.015; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Lee SH, 2012, BIOINFORMATICS, V28, P2540, DOI 10.1093/bioinformatics/bts474; Lee SH, 2011, AM J HUM GENET, V88, P294, DOI 10.1016/j.ajhg.2011.02.002; Liu JZ, 2015, NAT GENET, V47, P979, DOI 10.1038/ng.3359; Liu JZ, 2013, NAT GENET, V45, P670, DOI 10.1038/ng.2616; Loftus EV, 2005, GUT, V54, P91, DOI 10.1136/gut.2004.046615; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; Morris JA, 2010, BIOINFORMATICS, V26, P1786, DOI 10.1093/bioinformatics/btq280; Najarian DJ, 2003, J AM ACAD DERMATOL, V48, P805, DOI 10.1067/mjd.2003.540; Nelis M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005472; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Parkes M, 2013, NAT REV GENET, V14, P661, DOI 10.1038/nrg3502; Pers TH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6890; Price AL, 2008, AM J HUM GENET, V83, P132, DOI 10.1016/j.ajhg.2008.06.005; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Prohinar P, 2010, J IMMUNOL, V184, P4362, DOI 10.4049/jimmunol.0903142; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Solovieff N, 2013, NAT REV GENET, V14, P483, DOI 10.1038/nrg3461; Stahl EA, 2010, NAT GENET, V42, P508, DOI 10.1038/ng.582; Taylor JE, 2007, BIOMETRIKA, V94, P1, DOI 10.1093/biomet/asm004; Trynka G, 2015, AM J HUM GENET, V97, P139, DOI 10.1016/j.ajhg.2015.05.016; Trynka G, 2011, NAT GENET, V43, P1193, DOI 10.1038/ng.998; Tsoi LC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8001; Tsoi LC, 2012, NAT GENET, V44, P1341, DOI 10.1038/ng.2467; Wachowicz K, 2014, BIOCHEM SOC T, V42, P1512, DOI 10.1042/BST20140179; Wang ZM, 2014, HUM MOL GENET, V23, P6616, DOI 10.1093/hmg/ddu363; Zanin-Zhorov A, 2010, SCIENCE, V328, P372, DOI 10.1126/science.1186068	55	397	403	6	79	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2016	48	5					510	+		10.1038/ng.3528	http://dx.doi.org/10.1038/ng.3528			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DK3RC	26974007	Green Submitted, Green Accepted			2022-12-25	WOS:000374834100010
J	Liu, L; Shah, S; Fan, J; Park, JO; Wellen, KE; Rabinowitz, JD				Liu, Ling; Shah, Supriya; Fan, Jing; Park, Junyoung O.; Wellen, Kathryn E.; Rabinowitz, Joshua D.			Malic enzyme tracers reveal hypoxia-induced switch in adipocyte NADPH pathway usage	NATURE CHEMICAL BIOLOGY			English	Article							ATP-CITRATE LYASE; ADIPOSE-TISSUE; METABOLIC SWITCH; MECHANISM; GLUCOSE; CELLS; DIFFERENTIATION; IDENTIFICATION; CARBOXYLATION; REQUIREMENT	The critical cellular hydride donor NADPH is produced through various means, including the oxidative pentose phosphate pathway (oxPPP), folate metabolism and malic enzyme. In growing cells, it is efficient to produce NADPH via the oxPPP and folate metabolism, which also make nucleotide precursors. In nonproliferating adipocytes, a metabolic cycle involving malic enzyme holds the potential to make both NADPH and two-carbon units for fat synthesis. Recently developed deuterium (H-2) tracer methods have enabled direct measurement of NADPH production by the oxPPP and folate metabolism. Here we enable tracking of NADPH production by malic enzyme with [2,2,3,3-H-2] dimethyl-succinate and [4-H-2] glucose. Using these tracers, we show that most NADPH in differentiating 3T3-L1 mouse adipocytes is made by malic enzyme. The associated metabolic cycle is disrupted by hypoxia, which switches the main adipocyte NADPH source to the oxPPP. Thus, H-2-labeled tracers enable dissection of NADPH production routes across cell types and environmental conditions.	[Liu, Ling; Fan, Jing; Park, Junyoung O.; Rabinowitz, Joshua D.] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; [Liu, Ling; Fan, Jing; Rabinowitz, Joshua D.] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA; [Park, Junyoung O.] Princeton Univ, Dept Chem & Biol Engn, Princeton, NJ 08544 USA; [Shah, Supriya; Wellen, Kathryn E.] Univ Penn, Dept Canc Biol, Philadelphia, PA 19104 USA; [Liu, Ling; Shah, Supriya; Wellen, Kathryn E.; Rabinowitz, Joshua D.] Univ Penn, Diabet Res Ctr, Philadelphia, PA 19104 USA	Princeton University; Princeton University; Princeton University; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine	Rabinowitz, JD (corresponding author), Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA.; Rabinowitz, JD (corresponding author), Princeton Univ, Dept Chem, Princeton, NJ 08544 USA.; Rabinowitz, JD (corresponding author), Univ Penn, Diabet Res Ctr, Philadelphia, PA 19104 USA.	joshr@princeton.edu	Park, Junyoung/AAL-8090-2020; Rabinowitz, Joshua/GPP-4019-2022	Rabinowitz, Joshua/0000-0002-1247-4727; Park, Jun/0000-0001-9869-8993; Wellen, Kathryn/0000-0002-2281-0042; Fan, Jing/0000-0002-5326-5358	US National Institutes of Health [R01CA163591, R01AI097382, P30DK019525]; Howard Hughes Medical Institute fellowship; American Diabetes Association [7-12-JF-59];  [5T32CA009140-40]; NATIONAL CANCER INSTITUTE [T32CA009140, R01CA163591] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI097382] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK019525] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute fellowship(Howard Hughes Medical Institute); American Diabetes Association(American Diabetes Association); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank C. Thompson and M. Birnbaum for helpful discussions. This work was supported by US National Institutes of Health grants R01CA163591 (J.D.R.), R01AI097382 (J.D.R.) and P30DK019525 (to the University of Pennsylvania Diabetes Research Center). J.F. was supported by a Howard Hughes Medical Institute fellowship. K.E.W. is supported by American Diabetes Association grant 7-12-JF-59. S.S. is supported by postdoctoral fellowship 5T32CA009140-40.	Al-Dwairi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046716; [Anonymous], 1989, B WORLD HEALTH ORGAN, V67, P601; Antoniewicz MR, 2006, METAB ENG, V8, P324, DOI 10.1016/j.ymben.2006.01.004; Boucher A, 2004, J BIOL CHEM, V279, P27263, DOI 10.1074/jbc.M401167200; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; Edens WA, 1997, BIOCHEMISTRY-US, V36, P1141, DOI 10.1021/bi962128s; Fan J, 2014, NATURE, V510, P298, DOI 10.1038/nature13236; FLATT JP, 1964, J BIOL CHEM, V239, P675; GREEN H, 1974, CELL, V3, P127, DOI 10.1016/0092-8674(74)90116-0; HERMES JD, 1982, BIOCHEMISTRY-US, V21, P5106, DOI 10.1021/bi00263a040; Hosogai N, 2007, DIABETES, V56, P901, DOI 10.2337/db06-0911; Jiang P, 2013, NATURE, V493, P689, DOI 10.1038/nature11776; Jitrapakdee S, 2008, BIOCHEM J, V413, P369, DOI 10.1042/BJ20080709; Kamphorst JJ, 2014, CANCER METAB, V2, DOI 10.1186/2049-3002-2-23; KATHER H, 1972, BIOCHEM J, V128, P1097, DOI 10.1042/bj1281097; KATZ J, 1966, J BIOL CHEM, V241, P3600; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Koh HJ, 2004, J BIOL CHEM, V279, P39968, DOI 10.1074/jbc.M402260200; LEE CY, 1980, BIOCHEMISTRY-US, V19, P5098, DOI 10.1021/bi00563a025; Lewis CA, 2014, MOL CELL, V55, P253, DOI 10.1016/j.molcel.2014.05.008; Lu CW, 2008, J BIOL CHEM, V283, P28106, DOI 10.1074/jbc.M803508200; Lu WY, 2010, ANAL CHEM, V82, P3212, DOI 10.1021/ac902837x; Mullen AR, 2012, NATURE, V481, P385, DOI 10.1038/nature10642; Munger J, 2008, NAT BIOTECHNOL, V26, P1179, DOI 10.1038/nbt.1500; Nguyen P, 2008, J ANIM PHYSIOL AN N, V92, P272, DOI 10.1111/j.1439-0396.2007.00752.x; OCHOA S, 1948, J BIOL CHEM, V174, P979; Price NE, 1996, ARCH BIOCHEM BIOPHYS, V336, P215, DOI 10.1006/abbi.1996.0551; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; RUTTER WJ, 1958, J BIOL CHEM, V233, P374; SEYAMA Y, 1978, BIOMED MASS SPECTROM, V5, P357, DOI 10.1002/bms.1200050507; SHREVE DS, 1980, J BIOL CHEM, V255, P2670; Si YG, 2007, AM J PHYSIOL-ENDOC M, V292, pE1637, DOI 10.1152/ajpendo.00670.2006; Si YG, 2009, METAB ENG, V11, P382, DOI 10.1016/j.ymben.2009.08.001; Sutterlin HA, 2014, J BACTERIOL, V196, P3214, DOI 10.1128/JB.01876-14; Tibbetts AS, 2010, ANNU REV NUTR, V30, P57, DOI 10.1146/annurev.nutr.012809.104810; Trayhurn P, 2013, PHYSIOL REV, V93, P1, DOI 10.1152/physrev.00017.2012; Voet D., 2005, BIOCHEMISTRY-US; Waltz RA, 2006, MATH PROGRAM, V107, P391, DOI 10.1007/s10107-004-0560-5; Weitzel M, 2013, BIOINFORMATICS, V29, P143, DOI 10.1093/bioinformatics/bts646; Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097; Wiechert W, 1999, BIOTECHNOL BIOENG, V66, P69; Wise DR, 2011, P NATL ACAD SCI USA, V108, P19611, DOI 10.1073/pnas.1117773108; WISE EM, 1964, P NATL ACAD SCI USA, V52, P1255, DOI 10.1073/pnas.52.5.1255; WISE LS, 1984, J BIOL CHEM, V259, P4827; YANG XM, 1993, BIOCHEMISTRY-US, V32, P1118, DOI 10.1021/bi00092a022; YOUNG JW, 1964, BIOCHEMISTRY-US, V3, P1687, DOI 10.1021/bi00899a015; YUAN ZY, 1984, J BIOL CHEM, V259, P6748	47	80	82	1	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAY	2016	12	5					345	+		10.1038/NCHEMBIO.2047	http://dx.doi.org/10.1038/NCHEMBIO.2047			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DJ6KY	26999781	Green Accepted			2022-12-25	WOS:000374322800009
J	Al-Ahmadie, HA; Iyer, G; Lee, BH; Scott, SN; Mehra, R; Bagrodia, A; Jordan, EJ; Gao, SP; Ramirez, R; Cha, EK; Desai, NB; Zabor, EC; Ostrovnaya, I; Gopalan, A; Chen, YB; Fine, SW; Tickoo, SK; Gandhi, A; Hreiki, J; Viale, A; Arcila, ME; Dalbagni, G; Rosenberg, JE; Bochner, BH; Bajorin, DF; Berger, MF; Reuter, VE; Taylor, BS; Solit, DB				Al-Ahmadie, Hikmat A.; Iyer, Gopa; Lee, Byron H.; Scott, Sasinya N.; Mehra, Rohit; Bagrodia, Aditya; Jordan, Emmet J.; Gao, Sizhi Paul; Ramirez, Ricardo; Cha, Eugene K.; Desai, Neil B.; Zabor, Emily C.; Ostrovnaya, Irina; Gopalan, Anuradha; Chen, Ying-Bei; Fine, Samson W.; Tickoo, Satish K.; Gandhi, Anupama; Hreiki, Joseph; Viale, Agnss; Arcila, Maria E.; Dalbagni, Guido; Rosenberg, Jonathan E.; Bochner, Bernard H.; Bajorin, Dean F.; Berger, Michael F.; Reuter, Victor E.; Taylor, Barry S.; Solit, David B.			Frequent somatic CDH1 loss-of-function mutations in plasmacytoid variant bladder cancer	NATURE GENETICS			English	Article							UROTHELIAL CARCINOMA; POOR-PROGNOSIS; HUMAN BREAST; FRAMEWORK; DELETIONS	Plasmacytoid bladder cancer is an aggressive histologic variant with a high risk of disease-specific mortality. Using whole-exome and targeted sequencing, we find that truncating somatic alterations in the CDH1 gene occur in 84% of plasmacytoid carcinomas and are specific to this histologic variant. Consistent with the aggressive clinical behavior of plasmacytoid carcinomas, which frequently recur locally, CRISPR/Cas9-mediated knockout of CDH1 in bladder cancer cells enhanced cell migration.	[Al-Ahmadie, Hikmat A.; Scott, Sasinya N.; Gopalan, Anuradha; Chen, Ying-Bei; Fine, Samson W.; Tickoo, Satish K.; Gandhi, Anupama; Arcila, Maria E.; Berger, Michael F.; Reuter, Victor E.] Mem Sloan Kettering Canc Ctr, Dept Pathol, 1275 York Ave, New York, NY 10021 USA; [Iyer, Gopa; Dalbagni, Guido; Rosenberg, Jonathan E.; Bochner, Bernard H.; Bajorin, Dean F.; Reuter, Victor E.; Solit, David B.] Cornell Univ, Weill Cornell Med Coll, New York, NY 10021 USA; [Iyer, Gopa; Jordan, Emmet J.; Rosenberg, Jonathan E.; Bajorin, Dean F.; Solit, David B.] Mem Sloan Kettering Canc Ctr, Dept Med, Genitourinary Oncol Serv, 1275 York Ave, New York, NY 10021 USA; [Lee, Byron H.; Bagrodia, Aditya; Cha, Eugene K.; Dalbagni, Guido; Bochner, Bernard H.] Mem Sloan Kettering Canc Ctr, Dept Surg, Urol Serv, 1275 York Ave, New York, NY 10021 USA; [Mehra, Rohit] Univ Michigan Hlth Syst, Dept Pathol, Ann Arbor, MI USA; [Gao, Sizhi Paul; Ramirez, Ricardo; Taylor, Barry S.; Solit, David B.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USA; [Ramirez, Ricardo] Cornell Univ, Weill Cornell Grad Sch Med Sci, New York, NY 10021 USA; [Desai, Neil B.] Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, 1275 York Ave, New York, NY 10021 USA; [Zabor, Emily C.; Ostrovnaya, Irina; Taylor, Barry S.] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA; [Hreiki, Joseph; Viale, Agnss; Arcila, Maria E.; Berger, Michael F.; Taylor, Barry S.; Solit, David B.] Mem Sloan Kettering Canc Ctr, Marie Josee & Henry R Kravis Ctr Mol Oncol, 1275 York Ave, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Cornell University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; University of Michigan System; University of Michigan; Memorial Sloan Kettering Cancer Center; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Solit, DB (corresponding author), Cornell Univ, Weill Cornell Med Coll, New York, NY 10021 USA.; Solit, DB (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Med, Genitourinary Oncol Serv, 1275 York Ave, New York, NY 10021 USA.; Solit, DB (corresponding author), Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USA.; Solit, DB (corresponding author), Mem Sloan Kettering Canc Ctr, Marie Josee & Henry R Kravis Ctr Mol Oncol, 1275 York Ave, New York, NY 10021 USA.	solitd@mskcc.org	Solit, David B./AAC-5309-2019; chen, ying/HHS-8254-2022; Arcila, Maria/ABE-2235-2021	Solit, David/0000-0002-6614-802X; Lee, Byron/0000-0002-8755-9688; Bagrodia, Aditya/0000-0002-3358-1193; Bochner, Bernard/0000-0003-0846-0848; Iyer, Gopa/0000-0002-5093-6099; Cha, Eugene/0000-0002-8807-2353; Chen, Ying-Bei/0000-0001-5207-3648	Translational and Integrative Medicine Research Fund; Cycle for Survival; Josie Robertson Foundation; Marie-Josee and Henry R. Kravis Center for Molecular Oncology; Sloan Kettering Institute for Cancer Research Cancer Center [P30CA008748]; NATIONAL CANCER INSTITUTE [R01CA182587, P30CA008748] Funding Source: NIH RePORTER	Translational and Integrative Medicine Research Fund; Cycle for Survival; Josie Robertson Foundation; Marie-Josee and Henry R. Kravis Center for Molecular Oncology; Sloan Kettering Institute for Cancer Research Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by the Translational and Integrative Medicine Research Fund award (H.A.A.), Cycle for Survival (H.A.A. and B.S.T.), the Josie Robertson Foundation (B.S.T.) and the Marie-Josee and Henry R. Kravis Center for Molecular Oncology. This study was also funded in part by the Sloan Kettering Institute for Cancer Research Cancer Center Support Grant (P30CA008748).	Amin MB, 2009, MODERN PATHOL, V22, pS96, DOI 10.1038/modpathol.2009.26; Bass AJ, 2014, NATURE, V513, P202, DOI 10.1038/nature13480; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chalasani Venu, 2009, Can Urol Assoc J, V3, pS193; Cheng DT, 2015, J MOL DIAGN, V17, P251, DOI 10.1016/j.jmoldx.2014.12.006; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Corso G, 2013, J CLIN ONCOL, V31, P868, DOI 10.1200/JCO.2012.44.4612; Dayyani F, 2013, J UROLOGY, V189, P1656, DOI 10.1016/j.juro.2012.11.084; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Grady WM, 2000, NAT GENET, V26, P16, DOI 10.1038/79120; GRAFF JR, 1995, CANCER RES, V55, P5195; Johnson BE, 2014, SCIENCE, V343, P189, DOI 10.1126/science.1239947; Kaimakliotis HZ, 2014, UROLOGY, V83, P1112, DOI 10.1016/j.urology.2013.12.035; Keck B, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-71; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Nigwekar P, 2009, AM J SURG PATHOL, V33, P417, DOI 10.1097/PAS.0b013e318186c45e; Rohde C, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-230; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Won H. H., 2013, JOVE-J VIS EXP, V80; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394	23	103	107	0	21	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2016	48	4					356	+		10.1038/ng.3503	http://dx.doi.org/10.1038/ng.3503			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DH6NZ	26901067	Green Accepted			2022-12-25	WOS:000372908800006
J	Di Stefano, B; Collombet, S; Jakobsen, JS; Wierer, M; Sardina, JL; Lackner, A; Stadhouders, R; Segura-Morales, C; Francesconi, M; Limone, F; Mann, M; Porse, B; Thieffry, D; Graf, T				Di Stefano, Bruno; Collombet, Samuel; Jakobsen, Janus Schou; Wierer, Michael; Luis Sardina, Jose; Lackner, Andreas; Stadhouders, Ralph; Segura-Morales, Carolina; Francesconi, Mirko; Limone, Francesco; Mann, Matthias; Porse, Bo; Thieffry, Denis; Graf, Thomas			C/EBP alpha creates elite cells for iPSC reprogramming by upregulating Klf4 and increasing the levels of Lsd1 and Brd4	NATURE CELL BIOLOGY			English	Article							TRANSCRIPTION FACTORS; SELECTIVE-INHIBITION; SIGNALING PATHWAYS; HIGHLY EFFICIENT; SUPER-ENHANCERS; STEM-CELLS; CHROMATIN; TRANSDIFFERENTIATION; DIFFERENTIATION; PLURIPOTENCY	Reprogramming somatic cells into induced pluripotent stem cells (iPSCs) is typically inefficient and has been explained by elite-cell and stochastic models. We recently reported that B cells exposed to a pulse of C/EBP alpha (B alpha' cells) behave as elite cells, in that they can be rapidly and efficiently reprogrammed into iPSCs by the Yamanaka factors OSKM. Here we show that C/EBP alpha post-transcriptionally increases the abundance of several hundred proteins, including Lsd1, Hdac1, Brd4, Med1 and Cdk9, components of chromatin-modifying complexes present at super-enhancers. Lsd1 was found to be required for B cell gene silencing and Brd4 for the activation of the pluripotency program. C/EBP alpha also promotes chromatin accessibility in pluripotent cells and upregulates Klf4 by binding to two haematopoietic enhancers. B alpha' cells share many properties with granulocyte/macrophage progenitors, naturally occurring elite cells that are obligate targets for leukaemic transformation, whose formation strictly requires C/EBP alpha.	[Di Stefano, Bruno; Luis Sardina, Jose; Lackner, Andreas; Stadhouders, Ralph; Segura-Morales, Carolina; Francesconi, Mirko; Limone, Francesco; Graf, Thomas] Barcelona Inst Sci & Technol, Ctr Genom Regulat CRG, Dr Aiguader 88, Barcelona 08003, Spain; [Di Stefano, Bruno; Luis Sardina, Jose; Lackner, Andreas; Stadhouders, Ralph; Segura-Morales, Carolina; Francesconi, Mirko; Limone, Francesco; Graf, Thomas] Univ Pompeu Fabra, Barcelona 08003, Spain; [Collombet, Samuel; Thieffry, Denis] PSL Res Univ, Ecole Normale Super, IBENS, CNRS,INSERM,U1024,UMR8197, F-75005 Paris, France; [Jakobsen, Janus Schou; Porse, Bo] Univ Copenhagen, Fac Hlth Sci, Rigshosp, Finsen Lab, Ole Maaloes Vej 5, DK-2200 Copenhagen, Denmark; [Jakobsen, Janus Schou; Porse, Bo] Univ Copenhagen, BRIC, Ole Maaloes Vej 5, DK-2200 Copenhagen, Denmark; [Jakobsen, Janus Schou; Porse, Bo] Univ Copenhagen, Fac Hlth Sci, Danish Stem Cell Ctr DanStem, 3B Blegdamsvej, DK-2200 Copenhagen, Denmark; [Wierer, Michael; Mann, Matthias] Max Planck Inst Biochem, D-82152 Munich, Germany; [Di Stefano, Bruno] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Di Stefano, Bruno] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Lackner, Andreas] Univ Vienna, Max F Perutz Labs, Vienna Bioctr VBC, Dr Bohr Gasse 9-3, A-1030 Vienna, Austria	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Rigshospitalet; University of Copenhagen; University of Copenhagen; University of Copenhagen; Max Planck Society; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL)	Di Stefano, B; Graf, T (corresponding author), Barcelona Inst Sci & Technol, Ctr Genom Regulat CRG, Dr Aiguader 88, Barcelona 08003, Spain.; Di Stefano, B; Graf, T (corresponding author), Univ Pompeu Fabra, Barcelona 08003, Spain.; Di Stefano, B (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.; Di Stefano, B (corresponding author), Harvard Univ, Sch Med, Boston, MA 02114 USA.	distefano@molbio.mgh.harvard.edu; thomas.graf@crg.eu	Sardina, José Luis/H-7047-2015; Di Stefano, Bruno/K-5020-2017; francesconi, mirko/O-8080-2015; Thieffry, Denis/Y-3930-2019; Morales, Carolina Segura/AAL-1694-2021; Stadhouders, Ralph/J-8663-2015; collombet, Samuel/AAS-8227-2021; Jakobsen, Janus Schou/P-1679-2014	Sardina, José Luis/0000-0002-8493-3937; Di Stefano, Bruno/0000-0003-2532-3087; francesconi, mirko/0000-0002-8702-0877; Morales, Carolina Segura/0000-0002-1746-6865; Stadhouders, Ralph/0000-0002-1060-5607; collombet, samuel/0000-0002-0111-7177; Porse, Bo/0000-0001-6043-0844; Thieffry, Denis/0000-0003-0271-1757; Jakobsen, Janus Schou/0000-0001-6135-5815	Ministerio de Educacion y Ciencia [SAF.2012-37167]; Fundacio La Marato [TV3 120410]; AGAUR [SGR 1136]; European Research Council Synergy Grant (4D-Genome); EMBO Long-term Fellowship (ALTF) [1201-2014]; Marie Curie Individual Fellowship (H2020-MSCA-IF); MINECO [IJCI-2014-21872]; NovoNordisk Foundation (Section for Stem Cell Biology in Human Disease) [R179-A1513]; Novo Nordisk Foundation Section for Basic Stem Cell Biology [Porse group] Funding Source: researchfish	Ministerio de Educacion y Ciencia(Spanish Government); Fundacio La Marato; AGAUR(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); European Research Council Synergy Grant (4D-Genome); EMBO Long-term Fellowship (ALTF); Marie Curie Individual Fellowship (H2020-MSCA-IF); MINECO(Spanish Government); NovoNordisk Foundation (Section for Stem Cell Biology in Human Disease); Novo Nordisk Foundation Section for Basic Stem Cell Biology	We thank J. E. Bradner (Dana Farber Cancer Institute, Harvard Medical School, USA) for the JQ1 compound, J. Zuber (Research Institute of Molecular Pathology (IMP), Vienna Biocenter (VBC), Austria) for the Brd4 shRNA construct, R. Levine (Memorial Sloan Kettering Cancer Center, USA) for the Tet2 shRNA construct, L. de Andres for help with GMP isolations, L. Batlle for help with the chimaeric mice, the Genomics Facility and the Biomolecular Screening & Protein Technologies Facility of the CRG for technical assistance and members of the Graf laboratory for discussions. This work was supported by Ministerio de Educacion y Ciencia, SAF.2012-37167, Fundacio La Marato TV3 120410, AGAUR SGR 1136 and European Research Council Synergy Grant (4D-Genome). R.S. was supported by an EMBO Long-term Fellowship (ALTF 1201-2014) and a Marie Curie Individual Fellowship (H2020-MSCA-IF-2014). J.L.S. was supported by MINECO (IJCI-2014-21872). Work in the Porse laboratory was supported through a Centre grant from the NovoNordisk Foundation (Section for Stem Cell Biology in Human Disease and R179-A1513).	Adam RC, 2015, NATURE, V521, P366, DOI 10.1038/nature14289; Bar-Nur O, 2014, NAT METHODS, V11, P1170, DOI [10.1038/nmeth.3142, 10.1038/NMETH.3142]; Boiani M, 2002, GENE DEV, V16, P1209, DOI 10.1101/gad.966002; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Bueno C., 2015, LEUKEMIA; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Buganim Y, 2013, NAT REV GENET, V14, P427, DOI 10.1038/nrg3473; Bussmann LH, 2009, CELL STEM CELL, V5, P554, DOI 10.1016/j.stem.2009.10.004; Canettieri G, 2010, NAT CELL BIOL, V12, P132, DOI 10.1038/ncb2013; Carey BW, 2010, NAT METHODS, V7, P56, DOI [10.1038/NMETH.1410, 10.1038/nmeth.1410]; Chen JK, 2013, NAT GENET, V45, P1504, DOI 10.1038/ng.2807; Chen JK, 2013, NAT GENET, V45, P34, DOI 10.1038/ng.2491; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Di Micco R, 2014, CELL REP, V9, P234, DOI 10.1016/j.celrep.2014.08.055; Di Stefano B., 2014, METHOD MOL BIOL, V1357, P45; Di Stefano B., 2016, NAT PROTOC EXCH; Di Stefano B, 2014, NATURE, V506, P235, DOI 10.1038/nature12885; Di Tullio A, 2011, P NATL ACAD SCI USA, V108, P17016, DOI 10.1073/pnas.1112169108; Eminli S, 2009, NAT GENET, V41, P968, DOI 10.1038/ng.428; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Grebien F, 2015, NAT CHEM BIOL, V11, P571, DOI [10.1038/nchembio.1859, 10.1038/NCHEMBIO.1859]; Guo SQ, 2014, CELL, V156, P649, DOI 10.1016/j.cell.2014.01.020; Harris WJ, 2012, CANCER CELL, V21, P473, DOI 10.1016/j.ccr.2012.03.014; Hasemann MS, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004079; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Jakobsen JS, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-014-1195-4; Ji X, 2015, P NATL ACAD SCI USA, V112, P3841, DOI 10.1073/pnas.1502971112; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Krivtsov AV, 2013, LEUKEMIA, V27, P852, DOI 10.1038/leu.2012.363; Krizhanovsky V, 2009, NATURE, V460, P1085, DOI 10.1038/4601085a; Kulak NA, 2014, NAT METHODS, V11, P319, DOI [10.1038/nmeth.2834, 10.1038/NMETH.2834]; Lara-Astiaso D, 2014, SCIENCE, V345, P943, DOI 10.1126/science.1256271; Laurent B, 2015, MOL CELL, V57, P957, DOI 10.1016/j.molcel.2015.01.010; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; Liang GY, 2012, NAT CELL BIOL, V14, P457, DOI 10.1038/ncb2483; Liu LQ, 2014, CELL STEM CELL, V15, P574, DOI 10.1016/j.stem.2014.09.018; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Maherali N, 2009, CURR BIOL, V19, P1718, DOI 10.1016/j.cub.2009.08.025; Maza I, 2015, NAT BIOTECHNOL, V33, P769, DOI 10.1038/nbt.3270; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Northrup DL, 2008, IMMUNOL RES, V42, P106, DOI 10.1007/s12026-008-8043-z; Ohlsson E, 2014, J EXP MED, V211, P5, DOI 10.1084/jem.20130932; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Onder TT, 2012, NATURE, V483, P598, DOI 10.1038/nature10953; Pijnappel WWMP, 2013, NATURE, V495, P516, DOI 10.1038/nature11970; Rais Y, 2013, NATURE, V502, P65, DOI 10.1038/nature12587; Roe JS, 2015, MOL CELL, V58, P1028, DOI 10.1016/j.molcel.2015.04.011; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Soufi A, 2015, CELL, V161, P555, DOI 10.1016/j.cell.2015.03.017; Stadhouders R, 2013, NAT PROTOC, V8, P509, DOI 10.1038/nprot.2013.018; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; van Oevelen C, 2015, STEM CELL REP, V5, P232, DOI 10.1016/j.stemcr.2015.06.007; Vidal SE, 2014, STEM CELL REP, V3, P574, DOI 10.1016/j.stemcr.2014.08.003; Wang GL, 2008, J BIOL CHEM, V283, P26169, DOI 10.1074/jbc.M803544200; Wang Y, 2008, NAT GENET, V40, P1478, DOI 10.1038/ng.250; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Whyte WA, 2012, NATURE, V482, P221, DOI 10.1038/nature10805; Wu YD, 2013, CELL REP, V5, P224, DOI 10.1016/j.celrep.2013.08.030; Yamanaka S, 2009, NATURE, V460, P49, DOI 10.1038/nature08180; Ye M, 2015, CELL STEM CELL, V17, P611, DOI 10.1016/j.stem.2015.08.011; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Zhang DE, 1997, P NATL ACAD SCI USA, V94, P569, DOI 10.1073/pnas.94.2.569; Zuber J, 2011, NATURE, V478, P524, DOI 10.1038/nature10334	69	62	62	1	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	APR	2016	18	4					371	+		10.1038/ncb3326	http://dx.doi.org/10.1038/ncb3326			25	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	DH7LX	26974661				2022-12-25	WOS:000372976600005
J	Grimm, SS; Isacoff, EY				Grimm, Sasha S.; Isacoff, Ehud Y.			Allosteric substrate switching in a voltage-sensing lipid phosphatase	NATURE CHEMICAL BIOLOGY			English	Article							TENSIN HOMOLOG PTEN; SHAKER K+ CHANNEL; POTASSIUM CHANNEL; CI-VSP; SENSOR; CHARGE; STATE; PORE; PHOSPHOINOSITIDES; TRANSITIONS	Allostery provides a critical control over enzyme activity, biasing the catalytic site between inactive and active states. We found that the Ciona intestinalis voltage-sensing phosphatase (Ci-VSP), which modifies phosphoinositide signaling lipids (PIPs), has not one but two sequential active states with distinct substrate specificities, whose occupancy is allosterically controlled by sequential conformations of the voltage-sensing domain (VSD). Using fast fluorescence resonance energy transfer (FRET) reporters of PIPs to monitor enzyme activity and voltage-clamp fluorometry to monitor conformational changes in the VSD, we found that Ci-VSP switches from inactive to a PIP3-preferring active state when the VSD undergoes an initial voltage-sensing motion and then into a second PIP2-preferring active state when the VSD activates fully. This two-step allosteric control over a dual-specificity enzyme enables voltage to shape PIP concentrations in time, and provides a mechanism for the complex modulation of PIP-regulated ion channels, transporters, cell motility, endocytosis and exocytosis.	[Grimm, Sasha S.; Isacoff, Ehud Y.] Univ Calif Berkeley, Biophys Grad Grp, Berkeley, CA 94720 USA; [Isacoff, Ehud Y.] Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA; [Isacoff, Ehud Y.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [Isacoff, Ehud Y.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Isacoff, EY (corresponding author), Univ Calif Berkeley, Biophys Grad Grp, Berkeley, CA 94720 USA.; Isacoff, EY (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.; Isacoff, EY (corresponding author), Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA.; Isacoff, EY (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA.	ehud@berkeley.edu	isacoff, ehud/AAP-1459-2020	Isacoff, Ehud Y./0000-0003-4775-9359	US National Institutes of Health [R01GM117051, T32GM008295]; UC Berkeley Chancellors Fellowship for Graduate Study; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM117051, T32GM008295] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS090527] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UC Berkeley Chancellors Fellowship for Graduate Study; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Y. Okamura (Osaka University) for Ci-VSP, M. Matsuda (Kyoto University) for Fllip-pm, T. Meyer (Stanford University) for GFP-PLC-PH, T. Balla (US National Institutes of Health) for GFP-TAPP-PH, H. Okada, C. Stanley and Z. Fu for technical support, as well as A. Reiner, S. Bharill, S. Kohout, E. Carroll and other current and former members of the Isacoff laboratory for guidance on analysis and helpful discussions. This work was supported by the US National Institutes of Health (R01GM117051 and T32GM008295; E.Y.I.) as well as fellowship support for provided by the UC Berkeley Chancellors Fellowship for Graduate Study (S.S.G.).	Baker OS, 1998, NEURON, V20, P1283, DOI 10.1016/S0896-6273(00)80507-3; Campos FV, 2007, P NATL ACAD SCI USA, V104, P7904, DOI 10.1073/pnas.0702638104; Castle PM, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00063; CATTERALL WA, 1986, ANNU REV BIOCHEM, V55, P953, DOI 10.1146/annurev.biochem.55.1.953; Cha A, 1997, NEURON, V19, P1127, DOI 10.1016/S0896-6273(00)80403-1; Chamberlin A, 2014, P NATL ACAD SCI USA, V111, pE273, DOI 10.1073/pnas.1318018111; CHANGEUX JP, 1961, COLD SPRING HARB SYM, V26, P313, DOI 10.1101/SQB.1961.026.01.037; Gandhi CS, 2000, NEURON, V27, P585, DOI 10.1016/S0896-6273(00)00068-4; GUY HR, 1986, P NATL ACAD SCI USA, V83, P508, DOI 10.1073/pnas.83.2.508; Halaszovich CR, 2009, J BIOL CHEM, V284, P2106, DOI 10.1074/jbc.M803543200; Hilser VJ, 2010, SCIENCE, V327, P653, DOI 10.1126/science.1186121; Hobiger Kirstin, 2015, Front Pharmacol, V6, P20, DOI 10.3389/fphar.2015.00020; Hobiger K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070272; Hobiger K, 2012, BIOPHYS J, V102, P1313, DOI 10.1016/j.bpj.2012.02.027; Hossain MI, 2008, J BIOL CHEM, V283, P18248, DOI 10.1074/jbc.M706184200; Idevall-Hagren O, 2015, BBA-MOL CELL BIOL L, V1851, P736, DOI 10.1016/j.bbalip.2014.12.008; Iwasaki H, 2008, P NATL ACAD SCI USA, V105, P7970, DOI 10.1073/pnas.0803936105; Kalli AC, 2014, BIOCHEMISTRY-US, V53, P1724, DOI 10.1021/bi5000299; Koch HP, 2008, P NATL ACAD SCI USA, V105, P9111, DOI 10.1073/pnas.0801553105; Kohout SC, 2008, NAT STRUCT MOL BIOL, V15, P106, DOI 10.1038/nsmb1320; Kohout SC, 2010, NAT CHEM BIOL, V6, P369, DOI 10.1038/nchembio.349; Kurokawa T, 2012, P NATL ACAD SCI USA, V109, P10089, DOI 10.1073/pnas.1203799109; Lacroix J, 2011, J BIOL CHEM, V286, P17945, DOI 10.1074/jbc.M110.201749; Lacroix JJ, 2014, P NATL ACAD SCI USA, V111, pE1950, DOI 10.1073/pnas.1406161111; Lacroix JJ, 2012, J GEN PHYSIOL, V140, P635, DOI 10.1085/jgp.201210827; Lacroix JJ, 2011, P NATL ACAD SCI USA, V108, P6444, DOI 10.1073/pnas.1103397108; Li QF, 2014, NAT STRUCT MOL BIOL, V21, P244, DOI 10.1038/nsmb.2768; Liu LJ, 2012, NAT STRUCT MOL BIOL, V19, P633, DOI 10.1038/nsmb.2289; Mannuzzu LM, 1996, SCIENCE, V271, P213, DOI 10.1126/science.271.5246.213; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Matsuda M, 2011, J BIOL CHEM, V286, P23368, DOI 10.1074/jbc.M110.214361; Mavrantoni A, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00068; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; MONOD J, 1961, COLD SPRING HARB SYM, V26, P389, DOI 10.1101/SQB.1961.026.01.048; Motlagh HN, 2014, NATURE, V508, P331, DOI 10.1038/nature13001; Murata Y, 2005, NATURE, V435, P1239, DOI 10.1038/nature03650; Murata Y, 2007, J PHYSIOL-LONDON, V583, P875, DOI 10.1113/jphysiol.2007.134775; Nishioka T, 2008, MOL BIOL CELL, V19, P4213, DOI 10.1091/mbc.E08-03-0315; Okamura Y, 2011, PHYSIOLOGY, V26, P6, DOI 10.1152/physiol.00035.2010; PAPAZIAN DM, 1995, NEURON, V14, P1293, DOI 10.1016/0896-6273(95)90276-7; PAPAZIAN DM, 1991, NATURE, V349, P305, DOI 10.1038/349305a0; Pathak M, 2005, J GEN PHYSIOL, V125, P57, DOI 10.1085/jgp.200409197; Pathak MM, 2007, NEURON, V56, P124, DOI 10.1016/j.neuron.2007.09.023; PEROZO E, 1994, BIOPHYS J, V66, P345, DOI 10.1016/S0006-3495(94)80783-0; Pless SA, 2011, NAT CHEM BIOL, V7, P617, DOI [10.1038/nchembio.622, 10.1038/NCHEMBIO.622]; Sakata S, 2014, J PHYSIOL-LONDON, V592, P899, DOI 10.1113/jphysiol.2013.263640; Sakata S, 2011, J PHYSIOL-LONDON, V589, P2687, DOI 10.1113/jphysiol.2011.208165; Sato M, 2003, NAT CELL BIOL, V5, P1016, DOI 10.1038/ncb1054; Schoppa NE, 1998, J GEN PHYSIOL, V111, P313, DOI 10.1085/jgp.111.2.313; Seoh SA, 1996, NEURON, V16, P1159, DOI 10.1016/S0896-6273(00)80142-7; Starace DM, 2004, NATURE, V427, P548, DOI 10.1038/nature02270; Suh BC, 2008, ANNU REV BIOPHYS, V37, P175, DOI 10.1146/annurev.biophys.37.032807.125859; Tao X, 2010, SCIENCE, V328, P67, DOI 10.1126/science.1185954; Tombola F, 2005, NEURON, V48, P719, DOI 10.1016/j.neuron.2005.11.024; Tombola F, 2006, ANNU REV CELL DEV BI, V22, P23, DOI 10.1146/annurev.cellbio.21.020404.145837; Villalba-Galea CA, 2008, P NATL ACAD SCI USA, V105, P17600, DOI 10.1073/pnas.0807387105; Villalba-Galea CA, 2013, J GEN PHYSIOL, V142, P543, DOI 10.1085/jgp.201310993; Villalba-Galea CA, 2009, J GEN PHYSIOL, V134, P5, DOI 10.1085/jgp.200910215; Worby CA, 2005, MOL INTERV, V5, P274, DOI 10.1124/mi.5.5.5; Yoshizaki H, 2007, MOL BIOL CELL, V18, P119, DOI 10.1091/mbc.E06-05-0467	60	23	23	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	APR	2016	12	4					261	+		10.1038/NCHEMBIO.2022	http://dx.doi.org/10.1038/NCHEMBIO.2022			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH2DA	26878552	Green Accepted			2022-12-25	WOS:000372593200013
J	Noll, EM; Eisen, C; Stenzinger, A; Espinet, E; Muckenhuber, A; Klein, C; Vogel, V; Klaus, B; Nadler, W; Rosli, C; Lutz, C; Kulke, M; Engelhardt, J; Zickgraf, FM; Espinosa, O; Schlesner, M; Jiang, XQ; Kopp-Schneider, A; Neuhaus, P; Bahra, M; Sinn, BV; Eils, R; Giese, NA; Hackert, T; Strobel, O; Werner, J; Buchler, MW; Weichert, W; Trumpp, A; Sprick, MR				Noll, Elisa M.; Eisen, Christian; Stenzinger, Albrecht; Espinet, Elisa; Muckenhuber, Alexander; Klein, Corinna; Vogel, Vanessa; Klaus, Bernd; Nadler, Wiebke; Roesli, Christoph; Lutz, Christian; Kulke, Michael; Engelhardt, Jan; Zickgraf, Franziska M.; Espinosa, Octavio; Schlesner, Matthias; Jiang, Xiaoqi; Kopp-Schneider, Annette; Neuhaus, Peter; Bahra, Marcus; Sinn, Bruno V.; Eils, Roland; Giese, Nathalia A.; Hackert, Thilo; Strobel, Oliver; Werner, Jens; Buechler, Markus W.; Weichert, Wilko; Trumpp, Andreas; Sprick, Martin R.			CYP3A5 mediates basal and acquired therapy resistance in different subtypes of pancreatic ductal adenocarcinoma	NATURE MEDICINE			English	Article							X-RECEPTOR PXR; DRUG-METABOLISM; HUMAN LIVER; CYTOCHROME-P450; CANCER; EXPRESSION; GEMCITABINE; IDENTIFICATION; INDUCTION; DASATINIB	Although subtypes of pancreatic ductal adenocarcinoma (PDAC) have been described, this malignancy is clinically still treated as a single disease. Here we present patient-derived models representing the full spectrum of previously identified quasi-mesenchymal (QM-PDA), classical and exocrine-like PDAC subtypes, and identify two markers HNF1A and KRT81 that enable stratification of tumors into different subtypes by using immunohistochemistry. Individuals with tumors of these subtypes showed substantial differences in overall survival, and their tumors differed in drug sensitivity, with the exocrine-like subtype being resistant to tyrosine kinase inhibitors and paclitaxel. Cytochrome P450 3A5 (CYP3A5) metabolizes these compounds in tumors of the exocrine-like subtype, and pharmacological or short hairpin RNA (shRNA)-mediated CYP3A5 inhibition sensitizes tumor cells to these drugs. Whereas hepatocyte nuclear factor 4, alpha (HNF4A) controls basal expression of CYP3A5, drug-induced CYP3A5 upregulation is mediated by the nuclear receptor NR112. CYP3A5 also contributes to acquired drug resistance in QM-PDA and classical PDAC, and it is highly expressed in several additional malignancies. These findings designate CYP3A5 as a predictor of therapy response and as a tumor cell-autonomous detoxification mechanism that must be overcome to prevent drug resistance.	[Noll, Elisa M.; Eisen, Christian; Espinet, Elisa; Klein, Corinna; Vogel, Vanessa; Nadler, Wiebke; Roesli, Christoph; Engelhardt, Jan; Zickgraf, Franziska M.; Trumpp, Andreas; Sprick, Martin R.] Heidelberg Inst Stem Cell Technol & Expt Med HI S, Heidelberg, Germany; [Noll, Elisa M.; Eisen, Christian; Espinet, Elisa; Nadler, Wiebke; Engelhardt, Jan; Zickgraf, Franziska M.; Trumpp, Andreas; Sprick, Martin R.] German Canc Res Ctr, Divison Stem Cells & Canc, Heidelberg, Germany; [Stenzinger, Albrecht; Muckenhuber, Alexander; Weichert, Wilko] Heidelberg Univ, Dept Pathol, Heidelberg, Germany; [Stenzinger, Albrecht; Weichert, Wilko] Natl Ctr Tumor Dis NCT, Heidelberg, Germany; [Klaus, Bernd] European Mol Biol Lab, Genome Biol Unit, Heidelberg, Germany; [Lutz, Christian; Kulke, Michael] Heidelberg Pharma GmbH, Ladenburg, Germany; [Espinosa, Octavio; Schlesner, Matthias; Eils, Roland] German Canc Res Ctr, Div Theoret Bioinformat, Heidelberg, Germany; [Jiang, Xiaoqi; Kopp-Schneider, Annette] German Canc Res Ctr, Div Biostat, Heidelberg, Germany; [Neuhaus, Peter; Bahra, Marcus] Charite, Dept Gen Visceral & Transplantat Surg, D-13353 Berlin, Germany; [Sinn, Bruno V.] Charite, Inst Pathol, D-13353 Berlin, Germany; [Eils, Roland] Heidelberg Univ, Bioquant, Inst Pharm & Mol Biotechnol, Heidelberg, Germany; [Eils, Roland] German Canc Res Ctr, Heidelberg Ctr Personalized Oncol DKFZ HIPO, Heidelberg, Germany; [Giese, Nathalia A.; Hackert, Thilo; Strobel, Oliver; Werner, Jens; Buechler, Markus W.] Univ Heidelberg Hosp, Dept Gen & Visceral Surg, Heidelberg, Germany; [Buechler, Markus W.; Weichert, Wilko; Trumpp, Andreas; Sprick, Martin R.] German Canc Consortium DKTK, Heidelberg, Germany; [Stenzinger, Albrecht] Massachusetts Gen Hosp, Dept Pathol, Ctr Integrated Diagnost, Boston, MA 02114 USA; [Muckenhuber, Alexander; Weichert, Wilko] Tech Univ Munich, Inst Pathol, D-80290 Munich, Germany; [Roesli, Christoph] Sandoz Biopharmaceut, Oberhaching, Germany; [Werner, Jens] Univ Munich, Dept Gen Visceral & Transplant Surg, Munich, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; European Molecular Biology Laboratory (EMBL); Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Harvard University; Massachusetts General Hospital; Technical University of Munich; Novartis; Sandoz; University of Munich	Trumpp, A; Sprick, MR (corresponding author), Heidelberg Inst Stem Cell Technol & Expt Med HI S, Heidelberg, Germany.; Trumpp, A; Sprick, MR (corresponding author), German Canc Res Ctr, Divison Stem Cells & Canc, Heidelberg, Germany.; Trumpp, A; Sprick, MR (corresponding author), German Canc Consortium DKTK, Heidelberg, Germany.	a.trumpp@dkfz.de; martin.sprick@hi-stem.de	Sprick, Martin R./I-7995-2019; Espinet, Elisa/ABI-5385-2020; Eils, Roland/B-6121-2009; Roesli, Christoph/B-9527-2018; Trumpp, Andreas/Z-2141-2019; Schlesner, Matthias/I-4030-2013	Sprick, Martin R./0000-0001-9691-7574; Espinet, Elisa/0000-0002-0690-9878; Eils, Roland/0000-0002-0034-4036; Trumpp, Andreas/0000-0002-6212-3466; Strobel, Oliver/0000-0001-5100-8449; Schlesner, Matthias/0000-0002-5896-4086	DKFZ-HIPO [HIPO-015]; Dietmar Hopp Foundation; BioRN Spitzencluster 'Molecular- and Cell-based Medicine'; German Bundesministerium fur Bildung and Forschung (BMBF) e:Med program for systems biology (PANC-STRAT consortium) [01ZX1305]; Helmholtz Preclinical Comprehensive Cancer Center; DKFZ-NCT program [NCT3.0]; NCT-Heidelberg School of Oncology (HSO); EMBO long-term fellowship [ALTF 344-2013]; Heidelberger Stiftung Chirurgie; BMBF [01GS08114]; Biomaterial Bank Heidelberg-BMBH (BMBF) [01EY1101]	DKFZ-HIPO; Dietmar Hopp Foundation; BioRN Spitzencluster 'Molecular- and Cell-based Medicine'; German Bundesministerium fur Bildung and Forschung (BMBF) e:Med program for systems biology (PANC-STRAT consortium)(Federal Ministry of Education & Research (BMBF)); Helmholtz Preclinical Comprehensive Cancer Center; DKFZ-NCT program; NCT-Heidelberg School of Oncology (HSO); EMBO long-term fellowship(European Molecular Biology Organization (EMBO)); Heidelberger Stiftung Chirurgie; BMBF(Federal Ministry of Education & Research (BMBF)); Biomaterial Bank Heidelberg-BMBH (BMBF)(Federal Ministry of Education & Research (BMBF))	We thank E. Soyka, S. Bauer and A. Hieronymus for excellent technical assistance. We also thank the microarray and the next-generation sequencing (NGS) unit of the Genomics and Proteomics Core Facility, DKFZ, for providing expression profiling, NGS and related services, and all members of the flow cytometry core facility for excellent support. We thank DKFZ-HIPO for technical support and funding through grant no. HIPO-015 (M.S., R.E.,N.A.G., O.S., T.H., A.T. and M.R.S.). This work was supported in part by the Dietmar Hopp Foundation and the BioRN Spitzencluster 'Molecular- and Cell-based Medicine' (E.M.N., C.E., E.E., C.K., V.V., W.N., C.R., J.E., F.M.Z., A.T. and M.R.S.), the German Bundesministerium fur Bildung and Forschung (BMBF) e:Med program for systems biology (PANC-STRAT consortium, grant no. 01ZX1305; AT., M.R.S., MS., RE., N.A.G., T.H., O.S., A.S., A.M. and W.W.), the Helmholtz Preclinical Comprehensive Cancer Center (E.E., A.T. and M.R.S.) and the DKFZ-NCT program NCT3.0 (A.T., M.R.S., O.E., MS., RE., N.A.G., T.H. and O.S.). A.S. was supported by a fellowship from the NCT-Heidelberg School of Oncology (HSO). E.E. is recipient of an EMBO long-term fellowship (ALTF 344-2013). The collection and processing of the specimens via PancoBank was supported by Heidelberger Stiftung Chirurgie (M.W.B.), BMBF (grant no. 01GS08114; M.W.B.) and Biomaterial Bank Heidelberg-BMBH (BMBF grant no. 01EY1101; A.S. and WW.).	Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Basseville A, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-80; Bergheim I, 2007, WORLD J GASTROENTERO, V13, P997, DOI 10.3748/wjg.v13.i7.997; Biankin AV, 2015, CANCER CELL, V28, P411, DOI 10.1016/j.ccell.2015.09.020; Biankin AV, 2012, NATURE, V491, P399, DOI 10.1038/nature11547; Bruno RD, 2007, BIOORGAN MED CHEM, V15, P5047, DOI 10.1016/j.bmc.2007.05.046; Burk O, 2004, N-S ARCH PHARMACOL, V369, P105, DOI 10.1007/s00210-003-0815-3; Burk O, 2004, J BIOL CHEM, V279, P38379, DOI 10.1074/jbc.M404949200; Burris HA, 1997, J CLIN ONCOL, V15, P2403, DOI 10.1200/JCO.1997.15.6.2403; Christopher LJ, 2008, DRUG METAB DISPOS, V36, P1357, DOI 10.1124/dmd.107.018267; Collisson EA, 2011, NAT MED, V17, P500, DOI 10.1038/nm.2344; Conroy T, 2011, NEW ENGL J MED, V364, P1817, DOI 10.1056/NEJMoa1011923; Dhaini HR, 2003, J CLIN ONCOL, V21, P2481, DOI 10.1200/JCO.2003.06.015; Ding X, 2010, COMPREHENSIVE TOXICOLOGY, VOL 4: BIOTRANSFORMATION, 2ND EDITION, P9; Ding XX, 2003, ANNU REV PHARMACOL, V43, P149, DOI 10.1146/annurev.pharmtox.43.100901.140251; Downie D, 2005, CLIN CANCER RES, V11, P7369, DOI 10.1158/1078-0432.CCR-05-0466; George TJ, 2014, ONCOLOGIST, V19, P211, DOI 10.1634/theoncologist.2013-0410; Gharavi N, 2004, CURR DRUG METAB, V5, P203, DOI 10.2174/1389200043489045; Guengrich F.P., 2010, COMPREHENSIVE TOXICO, P943; Haaz MC, 1998, CANCER RES, V58, P468; Hidalgo M, 2010, NEW ENGL J MED, V362, P1605, DOI 10.1056/NEJMra0901557; Hong DS, 2013, INVEST NEW DRUG, V31, P918, DOI 10.1007/s10637-012-9898-3; Hruban RHPM., 2007, TUMORS PANCREAS, V4th ed; Hukkanen J, 2000, AM J RESP CELL MOL, V22, P360, DOI 10.1165/ajrcmb.22.3.3845; Janne PA, 2009, NAT REV DRUG DISCOV, V8, P709, DOI 10.1038/nrd2871; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kim S, 2014, BIOMED ENG ONLINE, V13, DOI 10.1186/1475-925X-13-S2-S5; Koutsounas I, 2013, CURR DRUG METAB, V14, P341, DOI 10.2174/1389200211314030009; Kuehl P, 2001, NAT GENET, V27, P383, DOI 10.1038/86882; Li J, 2007, CLIN CANCER RES, V13, P3731, DOI 10.1158/1078-0432.CCR-07-0088; Ling J, 2006, DRUG METAB DISPOS, V34, P420, DOI 10.1124/dmd.105.007765; Malvezzi M, 2014, ANN ONCOL, V25, P1650, DOI 10.1093/annonc/mdu138; McFadyen MCE, 2004, BRIT J CANCER, V91, P966, DOI 10.1038/sj.bjc.6602053; Michael M, 2005, J CLIN ONCOL, V23, P205, DOI 10.1200/JCO.2005.02.120; Michael M, 2007, EXPERT OPIN DRUG MET, V3, P783, DOI 10.1517/17425255.3.6.783; Moore MJ, 2007, J CLIN ONCOL, V25, P1960, DOI 10.1200/JCO.2006.07.9525; Murray GI, 2010, HISTOPATHOLOGY, V57, P202, DOI 10.1111/j.1365-2559.2010.03606.x; Oyama T, 2004, FRONT BIOSCI-LANDMRK, V9, P1967, DOI 10.2741/1378; Oyama Tsunehiro, 2012, Front Biosci (Schol Ed), V4, P1539; Pavek P, 2008, CURR DRUG METAB, V9, P129, DOI 10.2174/138920008783571774; Rochat B, 2005, CLIN PHARMACOKINET, V44, P349, DOI 10.2165/00003088-200544040-00002; Schmidt R, 2004, BRIT J CANCER, V90, P911, DOI 10.1038/sj.bjc.6601492; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; SONNICHSEN DS, 1994, CLIN PHARMACOKINET, V27, P256, DOI 10.2165/00003088-199427040-00002; Sugawara M, 2010, DRUG METAB DISPOS, V38, P526, DOI 10.1124/dmd.109.030668; Tirona RG, 2003, NAT MED, V9, P220, DOI 10.1038/nm815; Tompkins LM, 2007, J BIOCHEM MOL TOXIC, V21, P176, DOI 10.1002/jbt.20180; Trevino JG, 2006, AM J PATHOL, V168, P962, DOI 10.2353/ajpath.2006.050570; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Vincent A, 2011, LANCET, V378, P607, DOI 10.1016/S0140-6736(10)62307-0; Von Hoff DD, 2013, NEW ENGL J MED, V369, P1691, DOI 10.1056/NEJMoa1304369; Walsky RL, 2012, DRUG METAB DISPOS, V40, P1686, DOI 10.1124/dmd.112.045302; Wang LF, 2008, DRUG METAB DISPOS, V36, P1828, DOI 10.1124/dmd.107.020255; Westlind-Johnsson A, 2003, DRUG METAB DISPOS, V31, P755, DOI 10.1124/dmd.31.6.755; Wolfgang CL, 2013, CA-CANCER J CLIN, V63, P318, DOI 10.3322/caac.21190; Wu BJ, 2013, DRUG DISCOV TODAY, V18, P574, DOI 10.1016/j.drudis.2013.01.001; Yachida S, 2013, ONCOGENE, V32, P5253, DOI 10.1038/onc.2013.29; Yuan XH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005609	58	131	134	1	35	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1078-8956	1546-170X		NAT MED	Nat. Med.	MAR	2016	22	3					278	287		10.1038/nm.4038	http://dx.doi.org/10.1038/nm.4038			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DF6DC	26855150	Green Published, Green Accepted			2022-12-25	WOS:000371445100015
J	Araya, CL; Cenik, C; Reuters, JA; Kiss, G; Pande, VS; Snyder, MP; Greenleaf, W				Araya, Carlos L.; Cenik, Can; Reuters, Jason A.; Kiss, Gert; Pande, Vijay S.; Snyder, Michael P.; Greenleaf, William J.			Identification of significantly mutated regions across cancer types highlights a rich landscape of functional molecular alterations	NATURE GENETICS			English	Article							SOMATIC MUTATIONS; TRANSCRIPTION FACTOR; DRIVER MUTATIONS; BREAST-CANCER; GENE; ACTIVATION; EXPRESSION; ONCOGENE; REVEALS; GENOME	Cancer sequencing studies have primarily identified cancer driver genes by the accumulation of protein-altering mutations. An improved method would be annotation independent, sensitive to unknown distributions of functions within proteins and inclusive of noncoding drivers. We employed density-based clustering methods in 21 tumor types to detect variably sized significantly mutated regions (SMRs). SMRs reveal recurrent alterations across a spectrum of coding and noncoding elements, including transcription factor binding sites and untranslated regions mutated in up to similar to 15% of specific tumor types. SMRs demonstrate spatial clustering of alterations in molecular domains and at interfaces, often with associated changes in signaling. Mutation frequencies in SMRs demonstrate that distinct protein regions are differentially mutated across tumor types, as exemplified by a linker region of PIK3CA in which biophysical simulations suggest that mutations affect regulatory interactions. The functional diversity of SMRs underscores both the varied mechanisms of oncogenic misregulation and the advantage of functionally agnostic driver identification.	[Araya, Carlos L.; Cenik, Can; Reuters, Jason A.; Snyder, Michael P.; Greenleaf, William J.] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; [Kiss, Gert; Pande, Vijay S.] Stanford Univ, Dept Chem, Stanford, CA 94305 USA; [Greenleaf, William J.] Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Araya, CL; Snyder, MP; Greenleaf, W (corresponding author), Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA.; Greenleaf, W (corresponding author), Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA.	claraya@stanford.edu; mpsnyder@stanford.edu; wjg@stanford.edu	Pande, Vijay/ABE-8145-2020	Cenik, Can/0000-0001-6370-0889; Araya, Carlos/0000-0002-5512-3062; Snyder, Michael/0000-0003-0784-7987	US National Institutes of Health (NIH) [3U54DK10255602, 1P50HG00773501]; Child Health Research Institute; Lucile Packard Foundation for Children's Health; US NIH Clinical and Translational Science Award [UL1TR000093]; Damon Runyon Cancer Research Foundation; US NIH [1U01HG007919-01]; Lawrence Scholars Program; US NIH Simbios Program [U54GM072970]; Center for Molecular Analysis and Design at Stanford University; Blue Waters project via US National Science Foundation [OCI-0725070, ACI-1238993]; state of Illinois; National Center for Multiscale Modeling of Biological Systems [P41GM103712-S1, PSCA13072P]; Rita Allen Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000093, UL1TR001085] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG007735, U54HG006996, U01HG007919] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U54DK102556] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM072970, P41GM103712] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Child Health Research Institute; Lucile Packard Foundation for Children's Health; US NIH Clinical and Translational Science Award; Damon Runyon Cancer Research Foundation; US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lawrence Scholars Program; US NIH Simbios Program; Center for Molecular Analysis and Design at Stanford University; Blue Waters project via US National Science Foundation; state of Illinois; National Center for Multiscale Modeling of Biological Systems; Rita Allen Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the TCGA, ICGC and TCPA for making these large-scale cancer data sets available to the scientific community. We thank H. Tang for discussions regarding statistical analyses. We thank M.M. Winslow, D.M. Fowler, S. Fields and D.E. Webster for critical reading and suggestions to the manuscript. C.L.A. was supported by US National Institutes of Health (NIH) grants 3U54DK10255602 and 1P50HG00773501. C.C. was supported by the Child Health Research Institute, the Lucile Packard Foundation for Children's Health and US NIH Clinical and Translational Science Award grant UL1TR000093. J.A.R. was supported by the Damon Runyon Cancer Research Foundation and US NIH award 1U01HG007919-01. G.K. acknowledges support from the Lawrence Scholars Program, the US NIH Simbios Program (U54GM072970) and the Center for Molecular Analysis and Design at Stanford University. Biophysical simulations were supported by the Blue Waters project via US National Science Foundation awards OCI-0725070 and ACI-1238993 and the state of Illinois. Further support was provided by the National Center for Multiscale Modeling of Biological Systems (P41GM103712-S1) through Anton-1 resources provided by the Pittsburgh Supercomputing Center under grant PSCA13072P. This work was supported by the Rita Allen Foundation.	Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Araya CL, 2014, NATURE, V512, P400, DOI 10.1038/nature13497; Araya CL, 2012, P NATL ACAD SCI USA, V109, P16858, DOI 10.1073/pnas.1209751109; Barbieri CE, 2012, NAT GENET, V44, P685, DOI 10.1038/ng.2279; Budinska E, 2013, J PATHOL, V231, P63, DOI 10.1002/path.4212; Buenrostro JD, 2014, NAT BIOTECHNOL, V32, P562, DOI 10.1038/nbt.2880; Burke JE, 2012, P NATL ACAD SCI USA, V109, P15259, DOI 10.1073/pnas.1205508109; Cenik C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001366; Cheng FX, 2014, MOL BIOL EVOL, V31, P2156, DOI 10.1093/molbev/msu167; Cheng KW, 2004, NAT MED, V10, P1251, DOI 10.1038/nm1125; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; De Nicola GM, 2011, NATURE, V475, P106, DOI 10.1038/nature10189; Dees ND, 2012, GENOME RES, V22, P1589, DOI 10.1101/gr.134635.111; Ding L, 2014, NAT REV GENET, V15, P556, DOI 10.1038/nrg3767; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ester M., 1996, KDD-96 Proceedings. Second International Conference on Knowledge Discovery and Data Mining, P226; Fleming NI, 2013, CANCER RES, V73, P725, DOI 10.1158/0008-5472.CAN-12-2706; Fredriksson NJ, 2014, NAT GENET, V46, P1258, DOI 10.1038/ng.3141; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Gerstberger S, 2014, NAT REV GENET, V15, P829, DOI 10.1038/nrg3813; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Ghersi D, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt1305; Gkeka P, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003895; Guenther UP, 2013, NATURE, V502, P385, DOI 10.1038/nature12543; Haling JR, 2014, CANCER CELL, V26, P402, DOI 10.1016/j.ccr.2014.07.007; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Hofree M, 2013, NAT METHODS, V10, P1108, DOI [10.1038/NMETH.2651, 10.1038/nmeth.2651]; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Huang CH, 2007, SCIENCE, V318, P1744, DOI 10.1126/science.1150799; Huang FW, 2013, SCIENCE, V339, P957, DOI 10.1126/science.1229259; Jager D, 2001, CANCER RES, V61, P2055; Ji Q, 2004, CANCER RES, V64, P7610, DOI 10.1158/0008-5472.CAN-04-1608; Kane DP, 2014, CANCER RES, V74, P1895, DOI 10.1158/0008-5472.CAN-13-2892; Kar G, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000601; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Lara R, 2013, CANCER RES, V73, P5301, DOI 10.1158/0008-5472.CAN-12-4448; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Leiserson MDM, 2015, NAT GENET, V47, P106, DOI 10.1038/ng.3168; Li J, 2013, NAT METHODS, V10, P1046, DOI [10.1038/nmeth.2650, 10.1038/NMETH.2650]; Lord CJ, 2012, NATURE, V481, P287, DOI 10.1038/nature10760; Malhotra A, 2013, GENOME RES, V23, P762, DOI 10.1101/gr.143677.112; Mei YP, 2012, ONCOGENE, V31, P2794, DOI 10.1038/onc.2011.449; Melton C, 2015, NAT GENET, V47, P710, DOI 10.1038/ng.3332; Miled N, 2007, SCIENCE, V317, P239, DOI 10.1126/science.1135394; Okugawa Y, 2015, GUT; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Polak P, 2015, NATURE, V518, P360, DOI 10.1038/nature14221; Porta-Pardo E, 2014, BIOINFORMATICS, V30, P3109, DOI 10.1093/bioinformatics/btu499; Puente XS, 2015, NATURE, V526, P519, DOI 10.1038/nature14666; Reijns MAM, 2015, NATURE, V518, P502, DOI 10.1038/nature14183; Rizner TL, 2006, MOL CELL ENDOCRINOL, V248, P126, DOI 10.1016/j.mce.2005.10.009; Roberts SA, 2013, NAT GENET, V45, P970, DOI 10.1038/ng.2702; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Santarius T, 2010, NAT REV CANCER, V10, P59, DOI 10.1038/nrc2771; Schnall-Levin M, 2010, P NATL ACAD SCI USA, V107, P15751, DOI 10.1073/pnas.1006172107; Stanbrough M, 2006, CANCER RES, V66, P2815, DOI 10.1158/0008-5472.CAN-05-4000; Stergachis AB, 2014, NATURE, V515, P365, DOI 10.1038/nature13972; Stergachis AB, 2013, SCIENCE, V342, P1367, DOI 10.1126/science.1243490; Supek F, 2015, NATURE, V521, P81, DOI 10.1038/nature14173; Supek F, 2014, CELL, V156, P1324, DOI 10.1016/j.cell.2014.01.051; Tamborero D, 2013, BIOINFORMATICS, V29, P2238, DOI 10.1093/bioinformatics/btt395; Thorpe LM, 2015, NAT REV CANCER, V15, P7, DOI 10.1038/nrc3860; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Vejnar CE, 2012, NUCLEIC ACIDS RES, V40, P11673, DOI 10.1093/nar/gks901; Weinhold N, 2014, NAT GENET, V46, P1160, DOI 10.1038/ng.3101; Wolfe AL, 2014, NATURE, V513, P65, DOI 10.1038/nature13485; Wu XY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5961; Xiong HY, 2015, SCIENCE, V347, DOI 10.1126/science.1254806; Yuen BTK, 2013, CANCER CELL, V24, P567, DOI 10.1016/j.ccr.2013.09.015; Zhang JX, 2013, CARCINOGENESIS, V34, P2401, DOI 10.1093/carcin/bgt187; Zhao L, 2008, P NATL ACAD SCI USA, V105, P2652, DOI 10.1073/pnas.0712169105	73	48	51	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2016	48	2					117	125		10.1038/ng.3471	http://dx.doi.org/10.1038/ng.3471			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DC2JV	26691984	Green Accepted, Green Submitted			2022-12-25	WOS:000369043900008
J	Okosun, J; Wolfson, RL; Wang, J; Araf, S; Wilkins, L; Castellanos, BM; Escudero-Ibarz, L; Al Seraihi, AF; Richter, J; Bernhart, SH; Efeyan, A; Iqbal, S; Matthews, J; Clear, A; Guerra-Assuncao, JA; Bodor, C; Quentmeier, H; Mansbridge, C; Johnson, P; Davies, A; Strefford, JC; Packham, G; Barrans, S; Jack, A; Du, MQ; Calaminici, M; Lister, TA; Auer, R; Montoto, S; Gribben, JG; Siebert, R; Chelala, C; Zoncu, R; Sabatini, DM; Fitzgibbon, J				Okosun, Jessica; Wolfson, Rachel L.; Wang, Jun; Araf, Shamzah; Wilkins, Lucy; Castellanos, Brian M.; Escudero-Ibarz, Leire; Al Seraihi, Ahad Fahad; Richter, Julia; Bernhart, Stephan H.; Efeyan, Alejo; Iqbal, Sameena; Matthews, Janet; Clear, Andrew; Guerra-Assuncao, Jose Afonso; Boedoer, Csaba; Quentmeier, Hilmar; Mansbridge, Christopher; Johnson, Peter; Davies, Andrew; Strefford, Jonathan C.; Packham, Graham; Barrans, Sharon; Jack, Andrew; Du, Ming-Qing; Calaminici, Maria; Lister, T. Andrew; Auer, Rebecca; Montoto, Silvia; Gribben, John G.; Siebert, Reiner; Chelala, Claude; Zoncu, Roberto; Sabatini, David M.; Fitzgibbon, Jude			Recurrent mTORC1-activating RRAGC mutations in follicular lymphoma	NATURE GENETICS			English	Article							B-CELL LYMPHOMA; AMINO-ACID SUFFICIENCY; SOMATIC MUTATIONS; RAG GTPASES; GUANINE-NUCLEOTIDES; STRUCTURAL-ANALYSIS; TUMOR-SUPPRESSOR; MTORC1; COMPLEX; GENES	Follicular lymphoma is an incurable B cell malignancy) characterized by the 1(14;18) translocation and mutations affecting the epigenome(2,3). Although frequent gene mutations in key signaling pathways, including JAK-STAT, NOTCH and NF-kappa B, have also been defined(2-7), the spectrum of these mutations typically overlaps with that in the closely related diffuse large B cell lymphoma (DLBCL)(6-13). Using a combination of discovery exome and extended targeted sequencing, we identified recurrent somatic mutations in RRAGC uniquely enriched in patients with follicular lymphoma (17%). More than half of the mutations preferentially co-occurred with mutations in ATP6V1B2 and ATP6AP1, which encode components of the vacuolar H+-ATP ATPase (V-ATPase) known to be necessary for amino acid-induced activation of mTORC1. The RagC variants increased raptor binding while rendering mTORC1 signaling resistant to amino acid deprivation. The activating nature of the RRAGC mutations, their existence in the dominant clone-and their stability during disease progression support their potential as an excellent candidate for therapeutic targeting.	[Okosun, Jessica; Araf, Shamzah; Wilkins, Lucy; Al Seraihi, Ahad Fahad; Iqbal, Sameena; Matthews, Janet; Clear, Andrew; Calaminici, Maria; Lister, T. Andrew; Auer, Rebecca; Montoto, Silvia; Gribben, John G.; Fitzgibbon, Jude] Queen Mary Univ London, Barts Canc Inst, Ctr Haematooncol, London, England; [Wolfson, Rachel L.; Efeyan, Alejo; Sabatini, David M.] Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA; [Wolfson, Rachel L.; Efeyan, Alejo; Sabatini, David M.] MIT, Dept Biol, Cambridge, MA USA; [Wolfson, Rachel L.; Efeyan, Alejo; Sabatini, David M.] MIT, Dept Biol, Howard Hughes Med Inst, Cambridge, MA USA; [Wang, Jun; Guerra-Assuncao, Jose Afonso; Chelala, Claude] Queen Mary Univ London, Barts Canc Inst, Ctr Mol Oncol, London, England; [Castellanos, Brian M.; Zoncu, Roberto] Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA; [Escudero-Ibarz, Leire; Du, Ming-Qing] Univ Cambridge, Dept Pathol, Div Mol Histopathol, Tennis Court Rd, Cambridge CB2 1QP, England; [Richter, Julia; Siebert, Reiner] Univ Hosp Schleswig Holstein Campus Kiel, Inst Human Genet, Kiel, Germany; [Richter, Julia; Siebert, Reiner] Univ Kiel, Kiel, Germany; [Bernhart, Stephan H.] LIFE Res Ctr Civilizat Dis, Transcriptome Bioinformat, Leipzig, Germany; [Bernhart, Stephan H.] Univ Leipzig, Interdisciplinary Ctr Bioinformat, D-04109 Leipzig, Germany; [Bernhart, Stephan H.] Univ Leipzig, Dept Comp Sci, Bioinformat Grp, D-04109 Leipzig, Germany; [Boedoer, Csaba] Semmelweis Univ, Dept Pathol & Expt Canc Res 1, MTA SE Lendulet Mol Oncohematol Res Grp, H-1085 Budapest, Hungary; [Quentmeier, Hilmar] German Collect Microorganisms & Cell Cultures, Leibniz Inst DSMZ, Braunschweig, Germany; [Mansbridge, Christopher; Johnson, Peter; Davies, Andrew; Strefford, Jonathan C.; Packham, Graham] Univ Southampton, Fac Med, Canc Sci Unit, Southampton SO9 5NH, Hants, England; [Barrans, Sharon; Jack, Andrew] St Jamess Inst Oncol, Haematol Malignancy Diagnost Serv, Leeds, W Yorkshire, England; [Sabatini, David M.] Koch Inst Integrat Canc Res, Cambridge, MA USA; [Sabatini, David M.] Broad Inst Harvard & MIT, Cambridge, MA USA	University of London; Queen Mary University London; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); University of London; Queen Mary University London; University of California System; University of California Berkeley; University of Cambridge; University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Leipzig University; Leipzig University; Semmelweis University; Leibniz Institut fur Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); University of Southampton; Saint James's University Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Okosun, J (corresponding author), Queen Mary Univ London, Barts Canc Inst, Ctr Haematooncol, London, England.; Sabatini, DM (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.; Sabatini, DM (corresponding author), MIT, Dept Biol, Cambridge, MA USA.; Sabatini, DM (corresponding author), MIT, Dept Biol, Howard Hughes Med Inst, Cambridge, MA USA.; Sabatini, DM (corresponding author), Koch Inst Integrat Canc Res, Cambridge, MA USA.; Sabatini, DM (corresponding author), Broad Inst Harvard & MIT, Cambridge, MA USA.	j.e.okosun@qmul.ac.uk; sabatini@wi.mit.edu	Efeyan, Alejo/J-8197-2016; Johnson, Peter/L-2403-2018; Bodor, Csaba/O-4524-2017	Efeyan, Alejo/0000-0002-3806-6799; Okosun, Jessica/0000-0001-6021-5044; Du, Ming-Qing/0000-0002-1017-5045; C Strefford, Professor Jonathan/0000-0002-0972-2881; Castellano, Brian/0000-0001-6545-6429; Johnson, Peter/0000-0003-2306-4974; Montoto, Silvia/0000-0002-3006-9725; Wang, Jun/0000-0003-2509-9599; chelala, claude/0000-0002-2488-0669; Fitzgibbon, Jude/0000-0002-9069-1866; Bodor, Csaba/0000-0002-0729-692X; Davies, Andrew/0000-0002-7517-6938; , Stephan/0000-0002-5928-9449; Packham, Graham/0000-0002-9232-5691; Al Seraihi, Ahad/0000-0001-6397-9402	Kay Kendall Leukaemia Fund; Cancer Research UK; US National Institutes of Health (NIH) [R01 CA103866, AI47389]; US Department of Defense [W81XWH-07-0448]; US NIH [T32 GM007753, F30 CA189333]; Kay Kendall Leukaemia Fund Junior Clinical Research Fellowship [KKL 557]; Cancer Research UK [15968] Funding Source: researchfish; National Institute for Health Research [ACF-2011-19-002] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [DP2CA195761, R01CA129105, R01CA103866, F30CA189333] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047389, R37AI047389] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER	Kay Kendall Leukaemia Fund; Cancer Research UK(Cancer Research UK); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Defense(United States Department of Defense); US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kay Kendall Leukaemia Fund Junior Clinical Research Fellowship; Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are indebted to the patients for donating tumor specimens as part of this study. We thank G. Clark at the Francis Crick Institute for automated DNA sequencing and the Queen Mary University of London Genome Centre for Illumina MiSeq sequencing. We acknowledge the support of Barts, Cambridge, Leeds and Southampton's Experimental Cancer Medicine and Cancer Research UK Centers. This work was supported by grants from the Kay Kendall Leukaemia Fund and Cancer Research UK (awarded to J.F.), grants from the US National Institutes of Health (NIH; R01 CA103866 and AI47389) and the US Department of Defense (W81XWH-07-0448) to D.M.S., and fellowship support from the US NIH to R.L.W. (T32 GM007753 and F30 CA189333). D.M.S. is an investigator of the Howard Hughes Medical Institute. J.O. is a recipient of the Kay Kendall Leukaemia Fund Junior Clinical Research Fellowship (KKL 557).	Bar-Peled L, 2013, SCIENCE, V340, P1100, DOI 10.1126/science.1232044; Bar-Peled L, 2012, CELL, V150, P1196, DOI 10.1016/j.cell.2012.07.032; Bea S, 2013, P NATL ACAD SCI USA, V110, P18250, DOI 10.1073/pnas.1314608110; Ben-Sahra I, 2013, SCIENCE, V339, P1323, DOI 10.1126/science.1228792; Bodor C, 2013, BLOOD, V122, P3165, DOI 10.1182/blood-2013-04-496893; Compagno M, 2009, NATURE, V459, P717, DOI 10.1038/nature07968; FARNSWORTH CL, 1991, MOL CELL BIOL, V11, P4822, DOI 10.1128/MCB.11.10.4822; FEIG LA, 1988, MOL CELL BIOL, V8, P2472, DOI 10.1128/MCB.8.6.2472; Feig LA, 1999, NAT CELL BIOL, V1, pE25, DOI 10.1038/10018; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Green MR, 2013, BLOOD, V121, P1604, DOI 10.1182/blood-2012-09-457283; Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484; HOFFENBERG S, 1995, BIOCHEM BIOPH RES CO, V215, P241, DOI 10.1006/bbrc.1995.2459; Iadevaia V, 2012, BIOCHEM SOC T, V40, P168, DOI 10.1042/BST20110682; Jansen EJR, 2012, CURR PROTEIN PEPT SC, V13, P124; JOHN J, 1993, J BIOL CHEM, V268, P923; Karube K, 2014, J PATHOL, V234, P423, DOI 10.1002/path.4428; Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753; KRENGEL U, 1990, CELL, V62, P539, DOI 10.1016/0092-8674(90)90018-A; LAI CC, 1993, MOL CELL BIOL, V13, P1345, DOI 10.1128/MCB.13.3.1345; Landau DA, 2013, CELL, V152, P714, DOI 10.1016/j.cell.2013.01.019; Lenz G, 2008, SCIENCE, V319, P1676, DOI 10.1126/science.1153629; Lohr JG, 2014, CANCER CELL, V25, P91, DOI 10.1016/j.ccr.2013.12.015; Lohr JG, 2012, P NATL ACAD SCI USA, V109, P3879, DOI 10.1073/pnas.1121343109; Morin RD, 2013, BLOOD, V122, P1256, DOI 10.1182/blood-2013-02-483727; Morin RD, 2011, NATURE, V476, P298, DOI 10.1038/nature10351; Morin RD, 2010, NAT GENET, V42, P181, DOI 10.1038/ng.518; Nakashima N, 1999, GENETICS, V152, P853; Ngo VN, 2011, NATURE, V470, P115, DOI 10.1038/nature09671; Nicklin P, 2009, CELL, V136, P521, DOI 10.1016/j.cell.2008.11.044; Okosun J, 2014, NAT GENET, V46, P176, DOI 10.1038/ng.2856; Pasqualucci L, 2014, CELL REP, V6, P130, DOI 10.1016/j.celrep.2013.12.027; Pasqualucci L, 2011, NAT GENET, V43, P830, DOI 10.1038/ng.892; Pasqualucci L, 2011, NATURE, V471, P189, DOI 10.1038/nature09730; PROUD CG, 1986, TRENDS BIOCHEM SCI, V11, P73, DOI 10.1016/0968-0004(86)90269-0; Rebsamen M, 2015, NATURE, V519, P477, DOI 10.1038/nature14107; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Schmidt G, 1996, ONCOGENE, V12, P87; Schmitz R, 2012, NATURE, V490, P116, DOI 10.1038/nature11378; Sekiguchi T, 2001, J BIOL CHEM, V276, P7246, DOI 10.1074/jbc.M004389200; Swenson WT, 2005, J CLIN ONCOL, V23, P5019, DOI 10.1200/JCO.2005.04.503; Tsun ZY, 2013, MOL CELL, V52, P495, DOI 10.1016/j.molcel.2013.09.016; Wang SY, 2015, SCIENCE, V347, P188, DOI 10.1126/science.1257132; Yildiz M, 2015, BLOOD, V125, P668, DOI 10.1182/blood-2014-06-582650; Zoncu R, 2011, SCIENCE, V334, P678, DOI 10.1126/science.1207056	47	115	120	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2016	48	2					183	188		10.1038/ng.3473	http://dx.doi.org/10.1038/ng.3473			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DC2JV	26691987	Green Submitted, Green Accepted			2022-12-25	WOS:000369043900016
J	Yang, TP; Li, XM; Bao, XC; Fung, YME; Li, XD				Yang, Tangpo; Li, Xiao-Meng; Bao, Xiucong; Fung, Yi Man Eva; Li, Xiang David			Photo-lysine captures proteins that bind lysine post-translational modifications	NATURE CHEMICAL BIOLOGY			English	Article							HISTONE; METHYLTRANSFERASE; IDENTIFICATION; PURIFICATION; RECOGNITION; METHYLATION; MECHANISM; CELLS	Post-translational modifications (PTMs) have key roles in regulating protein-protein interactions in living cells. However, it remains a challenge to identify these PTM-mediated interactions. Here we develop a new lysine-based photo-reactive amino acid, termed photo-lysine. We demonstrate that photo-lysine, which is readily incorporated into proteins by native mammalian translation machinery, can be used to capture and identify proteins that recognize lysine PTMs, including 'readers' and 'erasers' of histone modifications.	[Yang, Tangpo; Li, Xiao-Meng; Bao, Xiucong; Fung, Yi Man Eva; Li, Xiang David] Univ Hong Kong, Dept Chem, Pokfulam Rd, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong	Li, XD (corresponding author), Univ Hong Kong, Dept Chem, Pokfulam Rd, Hong Kong, Hong Kong, Peoples R China.	xiangli@hku.hk	Yang, Tangpo/AAA-6801-2021; LI, Xiao-Meng/G-9761-2018; Li, Xiang/ABG-9385-2020; BAO, XIUCONG/ABF-4176-2020	Yang, Tangpo/0000-0002-4174-5709; LI, Xiao-Meng/0000-0002-8486-6826; Li, Xiang/0000-0002-2797-4134; BAO, XIUCONG/0000-0001-8069-8194; /0000-0001-5896-1558	Hong Kong Research Grants Council [GRF 17303114, GRF 17127915, HKU 709813P, CRF C7037-14G]; University of Hong Kong [201411159101, 201409160027, 201311159007, 201309176090]	Hong Kong Research Grants Council(Hong Kong Research Grants Council); University of Hong Kong(University of Hong Kong)	We acknowledge support from the Hong Kong Research Grants Council General Research Fund (GRF 17303114, GRF 17127915), Early Career Scheme (ECS) (HKU 709813P) and Collaborative Research Fund (CRF C7037-14G). We acknowledge the University of Hong Kong for an e-SRT on Integrative Biology and grants from the Seed Funding Program (201411159101, 201409160027, 201311159007 and 201309176090). We thank X. Li for discussion. We thank E. Verdin (University of California, San Francisco), Q. Hao (The University of Hong Kong), H. Li (Tsinghua University), R.C. Trievel (University of Michigan), K. Guan (Fudan University) and H. Sun (City University of Hong Kong) for providing the plasmids.	Bao XC, 2014, ELIFE, V3, DOI 10.7554/eLife.02999; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; Chin JW, 2014, ANNU REV BIOCHEM, V83, P379, DOI 10.1146/annurev-biochem-060713-035737; Chou CJ, 2011, CHEM SCI, V2, P480, DOI 10.1039/c0sc00373e; Couture JF, 2006, NAT STRUCT MOL BIOL, V13, P140, DOI 10.1038/nsmb1045; Du JT, 2011, SCIENCE, V334, P806, DOI 10.1126/science.1207861; Filippakopoulos P, 2012, CELL, V149, P214, DOI 10.1016/j.cell.2012.02.013; Goldberg D, 2007, J PROTEOME RES, V6, P3995, DOI 10.1021/pr070239f; Houtkooper RH, 2012, NAT REV MOL CELL BIO, V13, P225, DOI 10.1038/nrm3293; Hubbard BP, 2013, SCIENCE, V339, P1216, DOI 10.1126/science.1231097; Lan F, 2007, NATURE, V448, P718, DOI 10.1038/nature06034; Li YY, 2014, CELL, V159, P558, DOI 10.1016/j.cell.2014.09.049; Muir TW, 2003, ANNU REV BIOCHEM, V72, P249, DOI 10.1146/annurev.biochem.72.121801.161900; Musrati RA, 1998, GEN PHYSIOL BIOPHYS, V17, P193; NEMOTO T, 1995, EUR J BIOCHEM, V233, P1, DOI 10.1111/j.1432-1033.1995.001_1.x; Nishioka K, 2002, GENE DEV, V16, P479, DOI 10.1101/gad.967202; Pham ND, 2013, CURR OPIN CHEM BIOL, V17, P90, DOI 10.1016/j.cbpa.2012.10.034; Roth SY, 2001, ANNU REV BIOCHEM, V70, P81, DOI 10.1146/annurev.biochem.70.1.81; Shechter D, 2007, NAT PROTOC, V2, P1445, DOI 10.1038/nprot.2007.202; Suchanek M, 2005, NAT METHODS, V2, P261, DOI 10.1038/NMETH752; Tippmann EM, 2007, CHEMBIOCHEM, V8, P2210, DOI 10.1002/cbic.200700460; Walker JR, 2001, NATURE, V412, P607, DOI 10.1038/35088000; Walsh C., 2006, POSTTRANSLATIONAL MO; Wang HB, 2001, MOL CELL, V8, P1207, DOI 10.1016/S1097-2765(01)00405-1; Yang TP, 2015, CHEM SCI, V6, P1011, DOI 10.1039/c4sc02328e; Yang YY, 2010, CHEM BIOL, V17, P1212, DOI 10.1016/j.chembiol.2010.09.012; Zhang M, 2011, NAT CHEM BIOL, V7, P671, DOI [10.1038/NCHEMBIO.644, 10.1038/nchembio.644]	27	59	59	2	87	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	FEB	2016	12	2					70	+		10.1038/NCHEMBIO.1990	http://dx.doi.org/10.1038/NCHEMBIO.1990			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DC6GG	26689789				2022-12-25	WOS:000369317300006
J	Petkova, D; Novembre, J; Stephens, M				Petkova, Desislava; Novembre, John; Stephens, Matthew			Visualizing spatial population structure with estimated effective migration surfaces	NATURE GENETICS			English	Article							GENOME-WIDE PATTERNS; MAXIMUM-LIKELIHOOD-ESTIMATION; PRINCIPAL-COMPONENTS-ANALYSIS; AFRICAN ELEPHANT POPULATIONS; GENETIC-VARIATION; RESISTANCE-DISTANCE; CIRCUIT-THEORY; MODEL; STRATIFICATION; LANDSCAPE	Genetic data often exhibit patterns broadly consistent with 'isolation by distance'-a phenomenon where genetic similarity decays with geographic distance. In a heterogeneous habitat, this may occur more quickly in some regions than in others: for example, barriers to gene flow can accelerate differentiation between neighboring groups. We use the concept of 'effective migration' to model the relationship between genetics and geography. In this paradigm, effective migration is low in regions where genetic similarity decays quickly. We present a method to visualize variation in effective migration across a habitat from geographically indexed genetic data. Our approach uses a population genetic model to relate effective migration rates to expected genetic dissimilarities. We illustrate its potential and limitations using simulations and data from elephant, human and Arabidopsis thaliana populations. The resulting visualizations highlight important spatial features of population structure that are difficult to discern using existing methods for summarizing genetic variation.	[Petkova, Desislava; Stephens, Matthew] Univ Chicago, Dept Stat, Chicago, IL 60637 USA; [Petkova, Desislava] Wellcome Trust Ctr Human Genet, Oxford, England; [Novembre, John; Stephens, Matthew] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA	University of Chicago; University of Oxford; Wellcome Centre for Human Genetics; University of Chicago	Novembre, J (corresponding author), Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA.	jnovembre@uchicago.edu; mstephens@uchicago.edu			US National Institutes of Health (NIH) [U01 CA198933, HG02585]; NATIONAL CANCER INSTITUTE [U01CA198933] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002585] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank S. Wasser for access to the African elephant data and I. Moltke for compiling the human data set from sub-Saharan Africa. We also thank B. McRae for helpful discussions on resistance distances. This work was supported in part by US National Institutes of Health (NIH) grant U01 CA198933 to J.N. and grant HG02585 to M.S.	Babic D, 2002, INT J QUANTUM CHEM, V90, P166, DOI 10.1002/qua.10057; Bahlo M, 2001, J MATH BIOL, V43, P397, DOI 10.1007/s002850100104; Beaumont MA, 2004, MOL ECOL, V13, P969, DOI 10.1111/j.1365-294X.2004.02125.x; Beaumont MA, 1996, P ROY SOC B-BIOL SCI, V263, P1619, DOI 10.1098/rspb.1996.0237; Becquet C, 2007, GENOME RES, V17, P1505, DOI 10.1101/gr.6409707; Beerli P, 2001, P NATL ACAD SCI USA, V98, P4563, DOI 10.1073/pnas.081068098; Campbell CD, 2005, NAT GENET, V37, P868, DOI 10.1038/ng1607; CAVALLISFORZA LL, 1967, AM J HUM GENET, V19, P233, DOI 10.2307/2406616; Comstock KE, 2002, MOL ECOL, V11, P2489, DOI 10.1046/j.1365-294X.2002.01615.x; DeGiorgio M, 2013, MOL BIOL EVOL, V30, P480, DOI 10.1093/molbev/mss233; Duforet-Frebourg N, 2014, EVOLUTION, V68, P1110, DOI 10.1111/evo.12342; FELSENSTEIN J, 1975, AM NAT, V109, P359, DOI 10.1086/283003; FELSENSTEIN J, 1973, AM J HUM GENET, V25, P471; GEORGIADIS N, 1994, J HERED, V85, P100, DOI 10.1093/oxfordjournals.jhered.a111405; Gonder MK, 2011, P NATL ACAD SCI USA, V108, P4766, DOI 10.1073/pnas.1015422108; Guillot G, 2005, GENETICS, V170, P1261, DOI 10.1534/genetics.104.033803; Hanks EM, 2013, J AM STAT ASSOC, V108, P22, DOI 10.1080/01621459.2012.724647; Henn BM, 2011, P NATL ACAD SCI USA, V108, P5154, DOI 10.1073/pnas.1017511108; HEY J, 1991, THEOR POPUL BIOL, V39, P30, DOI 10.1016/0040-5809(91)90039-I; Hinch AG, 2011, NATURE, V476, P170, DOI 10.1038/nature10336; Horton MW, 2012, NAT GENET, V44, P212, DOI 10.1038/ng.1042; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; KIMURA M, 1964, GENETICS, V49, P561; KLEIN DJ, 1993, J MATH CHEM, V12, P81, DOI 10.1007/BF01164627; Kronforst MR, 2006, EVOLUTION, V60, P1254, DOI 10.1554/06-005.1; Lao O, 2008, CURR BIOL, V18, P1241, DOI 10.1016/j.cub.2008.07.049; Lawson DJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002453; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Light A., 2004, EOS T AM GEOPHYS UN, V85, P385, DOI [10.1029/2004EO400002, DOI 10.1029/2004EO400002, 10.1029/2004-o400002, DOI 10.1029/2004-O400002, DOI 10.1029/2004E0400002]; Manel S, 2007, MOL ECOL, V16, P2031, DOI 10.1111/j.1365-294X.2007.03293.x; Manni F, 2004, HUM BIOL, V76, P173, DOI 10.1353/hub.2004.0034; Mathieson I, 2012, NAT GENET, V44, P243, DOI 10.1038/ng.1074; McCullagh P, 2009, STAT SINICA, V19, P631; Mcrae BH, 2008, ECOLOGY, V89, P2712, DOI 10.1890/07-1861.1; McRae BH, 2006, EVOLUTION, V60, P1551, DOI 10.1111/j.0014-3820.2006.tb00500.x; McVean G, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000686; Nelson MR, 2008, AM J HUM GENET, V83, P347, DOI 10.1016/j.ajhg.2008.08.005; Nordborg M, 2005, PLOS BIOL, V3, P1289, DOI 10.1371/journal.pbio.0030196; Novembre J, 2008, NATURE, V456, P98, DOI 10.1038/nature07331; Novembre J, 2008, NAT GENET, V40, P646, DOI 10.1038/ng.139; OKane SL, 1997, NOVON, V7, P323, DOI 10.2307/3391949; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Pickrell JK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002967; Platt A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000843; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Price AL, 2010, NAT REV GENET, V11, P459, DOI 10.1038/nrg2813; Pritchard JK, 2000, GENETICS, V155, P945; Reich D, 2009, NATURE, V461, P489, DOI 10.1038/nature08365; Rousset F, 1997, GENETICS, V145, P1219; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Teeter KC, 2008, GENOME RES, V18, P67, DOI 10.1101/gr.6757907; Tian C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040004; Wang CL, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002886; Wasser SK, 2015, SCIENCE, V349, P84, DOI 10.1126/science.aaa2457; Wasser SK, 2004, P NATL ACAD SCI USA, V101, P14847, DOI 10.1073/pnas.0403170101; Xing JC, 2010, GENOMICS, V96, P199, DOI 10.1016/j.ygeno.2010.07.004; Yang WY, 2012, NAT GENET, V44, P725, DOI 10.1038/ng.2285	57	244	245	5	113	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2016	48	1					94	+		10.1038/ng.3464	http://dx.doi.org/10.1038/ng.3464			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CZ7BQ	26642242	Green Accepted, Green Submitted			2022-12-25	WOS:000367255300020
J	Siprashvili, Z; Webster, DE; Johnston, D; Shenoy, RM; Ungewickell, AJ; Bhaduri, A; Flockhart, R; Zarnegar, BJ; Che, YL; Meschi, F; Puglisi, JD; Khavari, PA				Siprashvili, Zurab; Webster, Dan E.; Johnston, Danielle; Shenoy, Rajani M.; Ungewickell, Alexander J.; Bhaduri, Aparna; Flockhart, Ross; Zarnegar, Brian J.; Che, Yonglu; Meschi, Francesca; Puglisi, Joseph D.; Khavari, Paul A.			The noncoding RNAs SNORD50A and SNORD50B bind K-Ras and are recurrently deleted in human cancer	NATURE GENETICS			English	Article							SMALL NUCLEOLAR RNAS; PROXIMITY LIGATION; GTPASE ACTIVATION; CELL LYMPHOMA; RIBOSOMAL-RNA; GENE; RIBONUCLEOPROTEINS; DIFFERENTIATION; TUMORIGENESIS; COMPLEXES	Small nucleolar RNAs (snoRNAs) are conserved noncoding RNAs best studied as ribonucleoprotein (RNP) guides in RNA modification(1,2). To explore their role in cancer, we compared 5,473 tumor-normal genome pairs to identify snoRNAs with frequent copy number loss. The SNORD50A-SNORD50B snoRNA locus was deleted in 10-40% of 12 common cancers, where its loss was associated with reduced survival. A human protein microarray screen identified direct SNORD50A and SNORD50B RNA binding to K-Ras. Loss of SNORD50A and SNORD50B increased the amount of GTP-bound, active K-Ras and hyperactivated Ras-ERK1/ERK2 signaling. Loss of these snoRNAs also increased binding by farnesyltransferase to K-Ras and increased K-Ras prenylation, suggesting that KRAS mutation might synergize with SNORD50A and SNORD50B loss in cancer. In agreement with this hypothesis, CRISPR-mediated deletion of SNORD50A and SNORD50B in KRAS-mutant tumor cells enhanced tumorigenesis, and SNORD50A and SNORD50B deletion and oncogenic KRAS mutation co-occurred significantly in multiple human tumor types. SNORD50A and SNORD50B snoRNAs thus directly bind and inhibit K-Ras and are recurrently deleted in human cancer.	[Siprashvili, Zurab; Webster, Dan E.; Johnston, Danielle; Shenoy, Rajani M.; Ungewickell, Alexander J.; Bhaduri, Aparna; Flockhart, Ross; Zarnegar, Brian J.; Che, Yonglu; Khavari, Paul A.] Stanford Univ, Program Epithelial Biol, Sch Med, Stanford, CA 94305 USA; [Meschi, Francesca; Puglisi, Joseph D.] Stanford Univ, Dept Struct Biol, Sch Med, Stanford, CA 94305 USA; [Khavari, Paul A.] Vet Affairs Palo Alto Healthcare Syst, Palo Alto, CA USA	Stanford University; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Khavari, PA (corresponding author), Stanford Univ, Program Epithelial Biol, Sch Med, Stanford, CA 94305 USA.	khavari@stanford.edu		Webster, Dan/0000-0001-6874-8451	US Veterans Affairs Office of Research and Development; US National Institutes of Health/National Cancer Institute [CA142635]; US National Institutes of Health/National Institute of Arthritis Musculoskeletal and Skin Diseases [AR49737]; NATIONAL CANCER INSTITUTE [T32CA009302, R01CA142635] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049737] Funding Source: NIH RePORTER	US Veterans Affairs Office of Research and Development(US Department of Veterans Affairs); US National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); US National Institutes of Health/National Institute of Arthritis Musculoskeletal and Skin Diseases; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank J. Crabtree, J. Ferrell, S. Artandi, A. Oro, H. Chang and members of the Khavari laboratory for presubmission review and advice. This work was supported by the US Veterans Affairs Office of Research and Development and by US National Institutes of Health/National Cancer Institute grant CA142635 and by US National Institutes of Health/National Institute of Arthritis Musculoskeletal and Skin Diseases grant AR49737 to P.A.K.	Bellodi C, 2013, CELL REP, V3, P1493, DOI 10.1016/j.celrep.2013.04.030; Bhartiya D, 2012, HUM MUTAT, V33, pE2367, DOI 10.1002/humu.22158; Clementi N, 2010, RNA BIOL, V7, P521, DOI 10.4161/rna.7.5.12467; Clementi N, 2010, NAT CHEM BIOL, V6, P344, DOI 10.1038/nchembio.341; Dong XY, 2008, HUM MOL GENET, V17, P1031, DOI 10.1093/hmg/ddm375; Falaleeva M, 2013, BIOESSAYS, V35, P46, DOI 10.1002/bies.201200117; Fernandez-Medarde Alberto, 2011, Genes Cancer, V2, P344, DOI 10.1177/1947601911411084; Flockhart RJ, 2012, GENOME RES, V22, P1006, DOI 10.1101/gr.140061.112; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Karbstein K, 2005, MOL CELL, V20, P633, DOI 10.1016/j.molcel.2005.09.017; Kiss T, 2001, EMBO J, V20, P3617, DOI 10.1093/emboj/20.14.3617; Kretz M, 2013, NATURE, V493, P231, DOI 10.1038/nature11661; Lazarov M, 2002, NAT MED, V8, P1105, DOI 10.1038/nm779; Mannoor K, 2012, BBA-REV CANCER, V1826, P121, DOI 10.1016/j.bbcan.2012.03.005; Matera AG, 2007, NAT REV MOL CELL BIO, V8, P209, DOI 10.1038/nrm2124; Mei YP, 2012, ONCOGENE, V31, P2794, DOI 10.1038/onc.2011.449; Michel CI, 2011, CELL METAB, V14, P33, DOI 10.1016/j.cmet.2011.04.009; Piccaluga PP, 2007, J CLIN INVEST, V117, P823, DOI 10.1172/JCI26833; Pritchard AL, 2013, CLIN CANCER RES, V19, P2301, DOI 10.1158/1078-0432.CCR-12-0383; Rebane A, 2002, BMC MOL BIOL, V3, DOI 10.1186/1471-2199-3-1; Reichow SL, 2007, NUCLEIC ACIDS RES, V35, P1452, DOI 10.1093/nar/gkl1172; Sahoo T, 2008, NAT GENET, V40, P719, DOI 10.1038/ng.158; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Siprashvili Z, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-633; Skrzypczak M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013091; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Tanaka R, 2000, GENES CELLS, V5, P277, DOI 10.1046/j.1365-2443.2000.00325.x; Wang C, 2004, EMBO J, V23, P1857, DOI 10.1038/sj.emboj.7600181; Weibrecht I, 2010, EXPERT REV PROTEOMIC, V7, P401, DOI 10.1586/EPR.10.10; Williams GT, 2012, NAT REV CANCER, V12, P84, DOI 10.1038/nrc3195; Yin QF, 2012, MOL CELL, V48, P219, DOI 10.1016/j.molcel.2012.07.033	31	111	118	1	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2016	48	1					53	+		10.1038/ng.3452	http://dx.doi.org/10.1038/ng.3452			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CZ7BQ	26595770	Green Accepted			2022-12-25	WOS:000367255300013
J	Vargas, P; Maiuri, P; Bretou, M; Saez, PJ; Pierobon, P; Maurin, M; Chabaud, M; Lankar, D; Obino, D; Terriac, E; Raab, M; Thiam, HR; Brocker, T; Kitchen-Goosen, SM; Alberts, AS; Sunareni, P; Xia, S; Li, R; Voituriez, R; Piel, M; Lennon-Dumenil, AM				Vargas, Pablo; Maiuri, Paolo; Bretou, Marine; Saez, Pablo J.; Pierobon, Paolo; Maurin, Mathieu; Chabaud, Melanie; Lankar, Danielle; Obino, Dorian; Terriac, Emmanuel; Raab, Matthew; Thiam, Hawa-Racine; Brocker, Thomas; Kitchen-Goosen, Susan M.; Alberts, Arthur S.; Sunareni, Praveen; Xia, Sheng; Li, Rong; Voituriez, Raphael; Piel, Matthieu; Lennon-Dumenil, Ana-Maria			Innate control of actin nucleation determines two distinct migration behaviours in dendritic cells	NATURE CELL BIOLOGY			English	Article							ARP2/3 COMPLEX; LEUKOCYTE MIGRATION; FORMIN MDIA1; MACROPINOCYTOSIS; MOTILITY; RECEPTOR; MECHANISMS; PROTEIN; DRIVEN; MICE	Dendritic cell (DC) migration in peripheral tissues serves two main functions: antigen sampling by immature DCs, and chemokine-guided migration towards lymphatic vessels (LVs) on maturation. These migratory events determine the efficiency of the adaptive immune response. Their regulation by the core cell locomotion machinery has not been determined. Here, we show that the migration of immature DCs depends on two main actin pools: a RhoA mDial-dependent actin pool located at their rear, which facilitates forward locomotion; and a Cdc42 Arp2/3-dependent actin pool present at their front, which limits migration but promotes antigen capture. Following TLR4 MyD88-induced maturation, Arp2/3-dependent actin enrichment at the cell front is markedly reduced. Consequently, mature DCs switch to a faster and more persistent mDial-dependent locomotion mode that facilitates chemotactic migration to LVs and lymph nodes. Thus, the differential use of actin-nucleating machineries optimizes the migration of immature and mature DCs according to their specific function.	[Vargas, Pablo; Bretou, Marine; Saez, Pablo J.; Pierobon, Paolo; Maurin, Mathieu; Chabaud, Melanie; Lankar, Danielle; Obino, Dorian; Lennon-Dumenil, Ana-Maria] Inst Curie, INSERM, U932, F-75005 Paris, France; [Vargas, Pablo; Maiuri, Paolo; Terriac, Emmanuel; Raab, Matthew; Thiam, Hawa-Racine; Piel, Matthieu] Inst Curie, CNRS, UMR144, F-75005 Paris, France; [Brocker, Thomas] Univ Munich, Inst Immunol, D-80336 Munich, Germany; [Kitchen-Goosen, Susan M.; Alberts, Arthur S.] Van Andel Res Inst, Grand Rapids, MI 49503 USA; [Sunareni, Praveen; Xia, Sheng; Li, Rong] Johns Hopkins Univ, Sch Med, Baltimore, MD 21205 USA; [Voituriez, Raphael] Univ Paris 06, CNRS, UMR 7600, F-75005 Paris, France; [Voituriez, Raphael] Univ Paris 06, CNRS, FRE 3231, F-75005 Paris, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; University of Munich; Van Andel Institute; Johns Hopkins University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite	Vargas, P (corresponding author), Inst Curie, INSERM, U932, 12 Rue Lhomond, F-75005 Paris, France.	pablo.vargas@curie.fr; mpiel@curie.fr; amlennon@curie.fr	VARGAS, Pablo/HHM-4543-2022; voituriez, raphael/V-3418-2017; Thiam, Hawa Racine/AAY-4658-2021; Sáez, Pablo J./AAB-4458-2019; Lennon-Dumenil, Ana-Maria/I-6716-2016; Thiam, Hawa Racine/AAQ-2006-2020; Vargas, Pablo/L-9858-2017	VARGAS, Pablo/0000-0002-6475-494X; Thiam, Hawa Racine/0000-0002-2381-1442; Sáez, Pablo J./0000-0003-0521-9426; Vargas, Pablo/0000-0002-6475-494X; voituriez, raphael/0000-0001-8746-5713; Obino, Dorian/0000-0002-4108-2714; Brocker, Thomas/0000-0001-7060-5433; Terriac, Emmanuel/0000-0002-8769-242X; Maiuri, Paolo/0000-0001-5079-445X	Region Ile-de-France; Fondation pour la Recherche Medicale (ERNI); Institut Curie; Association pour la Recherche contre le Cancer; ERNI; Grand Rapids Community; Lunn Hope Foundations; Van Andel Endowment; Purple Community; DEG [SFB 1054-B03, SFB 914-A06]; City of Paris; European Research Council; DCBIOL Labex [ANR-10-IDEX-0001-02, ANR-11-LABX-0043]; Association Nationale pour la Recherche [ANR-09-PIRI-0027-PCVI]; InnaBiosante foundation (Micemico); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK089502] Funding Source: NIH RePORTER	Region Ile-de-France(Region Ile-de-France); Fondation pour la Recherche Medicale (ERNI)(Fondation pour la Recherche Medicale); Institut Curie; Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); ERNI; Grand Rapids Community; Lunn Hope Foundations; Van Andel Endowment; Purple Community; DEG; City of Paris(Region Ile-de-France); European Research Council(European Research Council (ERC)European Commission); DCBIOL Labex; Association Nationale pour la Recherche; InnaBiosante foundation (Micemico); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank the PICT IBiSA platform at Institut Curie (CNRS UMR144, especially V. Fraisier) and the Institut Curie animal facility. P.V. thanks B. Goic for support, patience and critical reading of the manuscript. P.V. was supported by fellowships from Region Ile-de-France, Fondation pour la Recherche Medicale (ERNI) and Institut Curie. M.B. and M.C. benefited from fellowships from Association pour la Recherche contre le Cancer and ERNI respectively. S.M.K.-G. and A.S.A. were supported by the Grand Rapids Community and the Lunn Hope Foundations, the Van Andel Endowment, and the Purple Community T.B. was supported by DEG SFB 1054-B03 and SFB 914-A06. This work was financially supported by grants from: the City of Paris, the European Research Council and the DCBIOL Labex (ANR-10-IDEX-0001-02-PSL* and ANR-11-LABX-0043) to A.-M.L.-D. (Strapacemi 243103) and the Association Nationale pour la Recherche (ANR-09-PIRI-0027-PCVI) and the InnaBiosante foundation (Micemico) to A.-M.L.-D., M.P. and R.V.	Acton SE, 2012, IMMUNITY, V37, P276, DOI 10.1016/j.immuni.2012.05.022; Bailly M, 2001, CURR BIOL, V11, P620, DOI 10.1016/S0960-9822(01)00152-X; Barton GM, 2003, SCIENCE, V300, P1524, DOI 10.1126/science.1085536; Blanchoin L, 2000, NATURE, V404, P1007, DOI 10.1038/35010008; Bovellan M, 2014, CURR BIOL, V24, P1628, DOI 10.1016/j.cub.2014.05.069; Cella M, 1997, CURR OPIN IMMUNOL, V9, P10, DOI 10.1016/S0952-7915(97)80153-7; Chabaud M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8526; Eisenmann KM, 2007, J BIOL CHEM, V282, P25152, DOI 10.1074/jbc.M703243200; Farache J, 2013, IMMUNITY, V38, P581, DOI 10.1016/j.immuni.2013.01.009; Faure-Andre G, 2008, SCIENCE, V322, P1705, DOI 10.1126/science.1159894; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Garrett WS, 2000, CELL, V102, P325, DOI 10.1016/S0092-8674(00)00038-6; Goley ED, 2010, P NATL ACAD SCI USA, V107, P8159, DOI 10.1073/pnas.0911668107; Hawkins RJ, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.058103; Heit Bryan, 2003, Sci STKE, V2003, pPL5, DOI 10.1126/stke.2003.170.pl5; Heuze ML, 2013, IMMUNOL REV, V256, P240, DOI 10.1111/imr.12108; Higashida C, 2004, SCIENCE, V303, P2007, DOI 10.1126/science.1093923; Koivusalo M, 2010, J CELL BIOL, V188, P547, DOI 10.1083/jcb.200908086; Lammermann T, 2008, NATURE, V453, P51, DOI 10.1038/nature06887; Li F, 2003, CURR BIOL, V13, P1335, DOI 10.1016/S0960-9822(03)00540-2; Luckashenak N, 2013, J IMMUNOL, V190, P27, DOI 10.4049/jimmunol.1201082; Machesky LM, 1999, P NATL ACAD SCI USA, V96, P3739, DOI 10.1073/pnas.96.7.3739; Maiuri P, 2012, CURR BIOL, V22, pR673, DOI 10.1016/j.cub.2012.07.052; Martin-Fontecha A, 2003, J EXP MED, V198, P615, DOI 10.1084/jem.20030448; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Ng LG, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000222; Nolen BJ, 2009, NATURE, V460, P1031, DOI 10.1038/nature08231; Peng J, 2003, CURR BIOL, V13, P534, DOI 10.1016/S0960-9822(03)00170-2; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Preibisch S, 2009, BIOINFORMATICS, V25, P1463, DOI 10.1093/bioinformatics/btp184; Pruyne D, 2002, SCIENCE, V297, P612, DOI 10.1126/science.1072309; R Core Team, 2014, R LANG ENV STAT COMP; Renkawitz J, 2009, NAT CELL BIOL, V11, P1438, DOI 10.1038/ncb1992; Riedl J, 2010, NAT METHODS, V7, P168, DOI 10.1038/nmeth0310-168; Rizvi SA, 2009, CHEM BIOL, V16, P1158, DOI 10.1016/j.chembiol.2009.10.006; Sakata D, 2007, J EXP MED, V204, P2031, DOI 10.1084/jem.20062647; SALLUSTO F, 1995, J EXP MED, V182, P389, DOI 10.1084/jem.182.2.389; Sarris M, 2012, CURR BIOL, V22, P2375, DOI 10.1016/j.cub.2012.11.018; Selmeczi D, 2005, BIOPHYS J, V89, P912, DOI 10.1529/biophysj.105.061150; Svitkina TM, 1999, J CELL BIOL, V145, P1009, DOI 10.1083/jcb.145.5.1009; Tal O, 2011, J EXP MED, V208, P2141, DOI 10.1084/jem.20102392; Tanizaki H, 2010, BLOOD, V116, P5875, DOI 10.1182/blood-2010-01-264150; Turley SJ, 2000, SCIENCE, V288, P522, DOI 10.1126/science.288.5465.522; Vargas P, 2014, JOVE-J VIS EXP, DOI 10.3791/51099; Veltman DM, 2014, J CELL BIOL, V204, P497, DOI 10.1083/jcb.201309081; Weber Michele, 2013, Methods Mol Biol, V1013, P215, DOI 10.1007/978-1-62703-426-5_14; Weber M, 2013, SCIENCE, V339, P328, DOI 10.1126/science.1228456; Wilson K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3896; Wolf K, 2013, J CELL BIOL, V201, P1069, DOI 10.1083/jcb.201210152	50	115	121	0	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2016	18	1					43	+		10.1038/ncb3284	http://dx.doi.org/10.1038/ncb3284			13	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CZ3VA	26641718	Green Accepted			2022-12-25	WOS:000367030900009
J	Hosono, C; Matsuda, R; Adryan, B; Samakovlis, C				Hosono, Chie; Matsuda, Ryo; Adryan, Boris; Samakovlis, Christos			Transient junction anisotropies orient annular cell polarization in the Drosophila airway tubes	NATURE CELL BIOLOGY			English	Article							ACTIN STRESS FIBERS; PLANAR POLARITY; FOCAL ADHESIONS; MORPHOGENESIS; PROTEIN; GROWTH; MATRIX; APKC	In contrast to planes, three-dimensional (3D) structures such as tubes are physically anisotropic. Tubular organs exhibit a striking orientation of landmarks according to the physical anisotropy of the 3D shape(1-4), in addition to planar cell polarization(5,6). However, the influence of 3D tissue topography on the constituting cells remains underexplored(7-9). Here, we identify a regulatory network polarizing cellular biochemistry according to the physical anisotropy of the 3D tube geometry (tube cell polarization) by a genome-wide, tissue-specific RNAi screen. During Drosophila airway remodelling, each apical cellular junction is equipotent to establish perpendicular actomyosin cables, irrespective of the longitudinal or transverse tube axis. A dynamic transverse enrichment of atypical protein kinase C (aPKC) shifts the balance and transiently targets activated small GTPase RhoA, myosin phosphorylation and Rab11 vesicle trafficking to longitudinal junctions. We propose that the PAR complex translates tube physical anisotropy into longitudinal junctional anisotropy, where cell cell communication aligns the contractile cytoskeleton of neighbouring cells.	[Hosono, Chie; Matsuda, Ryo; Samakovlis, Christos] Stockholm Univ, Wenner Gren Inst, Dept Mol Biosci, S-10691 Stockholm, Sweden; [Adryan, Boris] Univ Cambridge, Cambridge Syst Biol Ctr, Cambridge CB2 1QR, England; [Samakovlis, Christos] Univ Giessen, ECCPS, D-35392 Giessen, Germany	Stockholm University; University of Cambridge; Justus Liebig University Giessen	Samakovlis, C (corresponding author), Stockholm Univ, Wenner Gren Inst, Dept Mol Biosci, S-10691 Stockholm, Sweden.	christos.samakovlis@su.se			Swedish Research Council; Swedish Cancer Society	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society)	We thank the members of the fly community, who isolated, characterized or distributed fly strains or antibodies, especially B. Dickson, K. Keleman, R. Klug, T. Micheler and the VDRC team for primary screen support, S. Bogdan, C. Doe, J. Knoblich, G. Longmore, J. Mihaly, BDSC, NIG, TRiP and DSHB for strains and antibodies. We thank Flybase for the Drosophila genomic resources and M. Yamazaki for advice on the virginizer strain and database construction. We thank IFSU and members of the Mannervik, Samakovlis and Astrom laboratories for support, especially M. Bjork for fly service and V. Tsarouhas for continuous support. Thanks to C. Betsholtz, L. Claesson-Welsh, M. Mannervik, V. Tsarouhas and S. Astrom for comments on the manuscript. We apologize for many reference omissions due to space limitation. This work was supported by grants from the Swedish Research Council and the Swedish Cancer Society to C.S. B.A. is a Royal Society University Research Fellow.	Amano M, 1997, SCIENCE, V275, P1308, DOI 10.1126/science.275.5304.1308; Beitel GJ, 2000, DEVELOPMENT, V127, P3271; Betschinger J, 2003, NATURE, V422, P326, DOI 10.1038/nature01486; Djiane A, 2005, CELL, V121, P621, DOI 10.1016/j.cell.2005.03.014; DRENCKHAHN D, 1986, J CELL BIOL, V102, P1738, DOI 10.1083/jcb.102.5.1738; Forster D, 2012, NAT CELL BIOL, V14, P526, DOI 10.1038/ncb2456; Glasheen BM, 2010, DEV BIOL, V344, P772, DOI 10.1016/j.ydbio.2010.05.504; Goodrich LV, 2011, DEVELOPMENT, V138, P1877, DOI 10.1242/dev.054080; Heisenberg CP, 2013, CELL, V153, P948, DOI 10.1016/j.cell.2013.05.008; Krauss-Etschmann S, 2013, THORAX, V68, P380, DOI 10.1136/thoraxjnl-2012-201902; Lanzetti L, 2007, CURR OPIN CELL BIOL, V19, P453, DOI 10.1016/j.ceb.2007.04.017; Leckband D, 2013, NAT CELL BIOL, V15, P345, DOI 10.1038/ncb2715; Levayer R, 2011, NAT CELL BIOL, V13, P734, DOI 10.1038/ncb0611-734a; Lubarsky B, 2003, CELL, V112, P19, DOI 10.1016/S0092-8674(02)01283-7; Matsuda R, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004929; Matusek T, 2006, DEVELOPMENT, V133, P957, DOI 10.1242/dev.02266; Miller LAD, 2004, DEV DYNAM, V231, P57, DOI 10.1002/dvdy.20105; Mummery-Widmer JL, 2009, NATURE, V458, P987, DOI 10.1038/nature07936; Nelson KS, 2012, NAT CELL BIOL, V14, P518, DOI 10.1038/ncb2467; Nelson W. J., 2009, COLD SPRING HARB PER, V1; Niewiadomska P, 1999, J CELL BIOL, V144, P533, DOI 10.1083/jcb.144.3.533; Rangamani P, 2013, CELL, V154, P1356, DOI 10.1016/j.cell.2013.08.026; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Roper K, 2012, DEV CELL, V23, P939, DOI 10.1016/j.devcel.2012.09.013; Samakovlis C, 1996, DEVELOPMENT, V122, P1395; Schnorrer F, 2010, NATURE, V464, P287, DOI 10.1038/nature08799; Schwartz MA, 2013, SCIENCE, V339, P402, DOI 10.1126/science.1233814; Shiga Y, 1996, DEV GROWTH DIFFER, V38, P99; Shyer AE, 2013, SCIENCE, V342, P212, DOI 10.1126/science.1238842; Simoes SD, 2010, DEV CELL, V19, P377, DOI 10.1016/j.devcel.2010.08.011; St Johnston D, 2010, CELL, V141, P757, DOI 10.1016/j.cell.2010.05.011; Tang N, 2011, SCIENCE, V333, P342, DOI 10.1126/science.1204831; Tepass U, 2012, ANNU REV CELL DEV BI, V28, P655, DOI 10.1146/annurev-cellbio-092910-154033; Tsarouhas V, 2007, DEV CELL, V13, P214, DOI 10.1016/j.devcel.2007.06.008; Vladar EK, 2012, CURR BIOL, V22, P2203, DOI 10.1016/j.cub.2012.09.046; Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890; Warrington SJ, 2013, DEVELOPMENT, V140, P1045, DOI 10.1242/dev.088724; Welz T, 2014, TRENDS CELL BIOL, V24, P407, DOI 10.1016/j.tcb.2014.02.004; Zhang L, 2009, DEV BIOL, V336, P201, DOI 10.1016/j.ydbio.2009.09.040	39	19	19	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2015	17	12					1569	1576		10.1038/ncb3267	http://dx.doi.org/10.1038/ncb3267			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CX8DH	26551273				2022-12-25	WOS:000365932300009
J	Mapp, AK; Pricer, R; Sturlis, S				Mapp, Anna K.; Pricer, Rachel; Sturlis, Steven			Targeting transcription is no longer a quixotic quest	NATURE CHEMICAL BIOLOGY			English	Article							SMALL-MOLECULE; MULTIPROTEIN COMPLEXES; KIX DOMAIN; PROTEIN; COACTIVATOR; MECHANISMS; INHIBITORS; CBP/P300; LIGAND; P53		[Mapp, Anna K.; Pricer, Rachel; Sturlis, Steven] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; [Mapp, Anna K.; Pricer, Rachel; Sturlis, Steven] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Mapp, AK (corresponding author), Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA.	amapp@umich.edu	, Dr Anna Mapp/GPX-8261-2022		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065330, T32GM008597] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM065330, T32 GM008597] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arkin MR, 2014, CHEM BIOL, V21, P1102, DOI 10.1016/j.chembiol.2014.09.001; Bradner JE, 2006, NAT PROTOC, V1, P2344, DOI 10.1038/nprot.2006.282; Cesa LC, 2015, FRONT BIOENG BIOTECH, V3, DOI 10.3389/fbioe.2015.00119; Cesa LC, 2013, ACS CHEM BIOL, V8, P1988, DOI 10.1021/cb400356m; Fuxreiter M, 2008, NAT CHEM BIOL, V4, P728, DOI 10.1038/nchembio.127; Gee CT, 2015, ANGEW CHEM INT EDIT, V54, P3735, DOI 10.1002/anie.201411658; Hargreaves DC, 2011, CELL RES, V21, P396, DOI 10.1038/cr.2011.32; Hoe KK, 2014, NAT REV DRUG DISCOV, V13, P217, DOI 10.1038/nrd4236; JACOB F, 1961, J MOL BIOL, V3, P318, DOI 10.1016/S0022-2836(61)80072-7; Kar A, 2013, CRIT REV BIOCHEM MOL, V48, P522, DOI 10.3109/10409238.2013.838202; Krishnamurthy M, 2011, ACS CHEM BIOL, V6, P1321, DOI 10.1021/cb200308e; Law SM, 2014, P NATL ACAD SCI USA, V111, P12067, DOI 10.1073/pnas.1405831111; Lee CW, 2010, P NATL ACAD SCI USA, V107, P19290, DOI 10.1073/pnas.1013078107; Leonard SE, 2014, ACS CHEM BIOL, V9, P1894, DOI 10.1021/cb500371g; Lin CY, 2012, CELL, V151, P56, DOI 10.1016/j.cell.2012.08.026; Majmudar CY, 2012, ANGEW CHEM INT EDIT, V51, P11258, DOI 10.1002/anie.201206815; Niu S, 2013, CURR OPIN CHEM BIOL, V17, P809, DOI 10.1016/j.cbpa.2013.06.019; Pattabiraman DR, 2014, BLOOD, V123, P2682, DOI 10.1182/blood-2012-02-413187; Pop MS, 2014, MOL CANCER THER, V13, P1492, DOI 10.1158/1535-7163.MCT-13-0689; Shammas SL, 2014, P NATL ACAD SCI USA, V111, P12055, DOI 10.1073/pnas.1405815111; Thakur JK, 2014, NUCLEIC ACIDS RES, V42, P2112, DOI 10.1093/nar/gkt1147; Thompson AD, 2012, ACS CHEM BIOL, V7, P1311, DOI 10.1021/cb300255p; Wang NK, 2014, P NATL ACAD SCI USA, V111, P12061, DOI 10.1073/pnas.1406033111; Wang NK, 2013, J AM CHEM SOC, V135, P3363, DOI 10.1021/ja3122334; Xie X, 2014, ONCOGENE, V33, P1037, DOI 10.1038/onc.2013.25	25	17	17	0	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2015	11	12					891	894		10.1038/nchembio.1962	http://dx.doi.org/10.1038/nchembio.1962			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX6TG	26575226	Green Accepted			2022-12-25	WOS:000365834000002
J	Min, D; Jefferson, RE; Bowie, JU; Yoon, TY				Min, Duyoung; Jefferson, Robert E.; Bowie, James U.; Yoon, Tae-Young			Mapping the energy landscape for second-stage folding of a single membrane protein	NATURE CHEMICAL BIOLOGY			English	Article							INTRAMEMBRANE PROTEOLYSIS; LIPID-BILAYERS; MECHANISMS; STABILITY; REVEALS; DSBB	Membrane proteins are designed to fold and function in a lipid membrane, yet folding experiments within a native membrane environment are challenging to design. Here we show that single-molecule forced unfolding experiments can be adapted to study helical membrane protein folding under native-like bicelle conditions. Applying force using magnetic tweezers, we find that a transmembrane helix protein, Escherichia coli rhomboid protease GlpG, unfolds in a highly cooperative manner, largely unraveling as one physical unit in response to mechanical tension above 25 pN. Considerable hysteresis is observed, with refolding occurring only at forces below 5 pN. Characterizing the energy landscape reveals only modest thermodynamic stability (Delta G = 6.5 k(B)T) but a large unfolding barrier (21.3 k(B)T) that can maintain the protein in a folded state for long periods of time (t1/2 similar to 3.5 h). The observed energy landscape may have evolved to limit the existence of troublesome partially unfolded states and impart rigidity to the structure.	[Min, Duyoung; Yoon, Tae-Young] Korea Adv Inst Sci & Technol, Natl Creat Res Initiat, Ctr Single Mol Syst Biol, Daejeon, South Korea; [Min, Duyoung; Yoon, Tae-Young] Korea Adv Inst Sci & Technol, Dept Phys, Daejeon, South Korea; [Min, Duyoung; Jefferson, Robert E.; Bowie, James U.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90024 USA	Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); University of California System; University of California Los Angeles	Min, D (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, 405 Hilgard Ave, Los Angeles, CA 90024 USA.	bowie@mbi.ucla.edu; tyyoon@kaist.ac.kr	Min, Duyoung/AAA-5205-2019; Yoon, Tae-Young/C-1687-2011	Min, Duyoung/0000-0002-2856-8082; Yoon, Tae-Young/0000-0002-5184-7725; Jefferson, Robert/0000-0002-8641-8736	National Creative Research Initiative Program - National Research Foundation of Korea and Marine Biotechnology Program - Ministry of Oceans and Fisheries of Korea [20150220]; US National Institutes of Health [2R01GM063919]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007185, R01GM063919] Funding Source: NIH RePORTER	National Creative Research Initiative Program - National Research Foundation of Korea and Marine Biotechnology Program - Ministry of Oceans and Fisheries of Korea; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Creative Research Initiative Program (Center for Single-Molecule Systems Biology to T.-Y.Y.) funded by the National Research Foundation of Korea and Marine Biotechnology Program (20150220 to T.-Y.Y.) funded by the Ministry of Oceans and Fisheries of Korea, and supported by US National Institutes of Health grant 2R01GM063919 to J.U.B.	Alegre-Cebollada J, 2011, NAT CHEM, V3, P882, DOI [10.1038/NCHEM.1155, 10.1038/nchem.1155]; Bae W, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6654; Baker RP, 2012, NAT CHEM BIOL, V8, P759, DOI [10.1038/NCHEMBIO.1021, 10.1038/nchembio.1021]; Beaugrand M, 2014, LANGMUIR, V30, P6162, DOI 10.1021/la5004353; Ben-Shem A, 2007, P NATL ACAD SCI USA, V104, P462, DOI 10.1073/pnas.0609773104; Bowie JU, 2005, NATURE, V438, P581, DOI 10.1038/nature04395; Carrion-Vazquez M, 1999, P NATL ACAD SCI USA, V96, P3694, DOI 10.1073/pnas.96.7.3694; Cecconi C, 2005, SCIENCE, V309, P2057, DOI 10.1126/science.1116702; Cecconi C, 2011, METHODS MOL BIOL, V749, P255, DOI 10.1007/978-1-61779-142-0_18; Chang YC, 2014, P NATL ACAD SCI USA, V111, P219, DOI 10.1073/pnas.1318576111; Curnow P, 2007, P NATL ACAD SCI USA, V104, P18970, DOI 10.1073/pnas.0705067104; Curnow P, 2011, P NATL ACAD SCI USA, V108, P14133, DOI 10.1073/pnas.1012594108; Cymer F, 2015, J MOL BIOL, V427, P999, DOI 10.1016/j.jmb.2014.09.014; De Vlaminck I, 2012, ANNU REV BIOPHYS, V41, P453, DOI 10.1146/annurev-biophys-122311-100544; Durr UHN, 2012, CHEM REV, V112, P6054, DOI 10.1021/cr300061w; Engel A, 2008, ANNU REV BIOCHEM, V77, P127, DOI 10.1146/annurev.biochem.77.062706.154450; Engelman DM, 2003, FEBS LETT, V555, P122, DOI 10.1016/S0014-5793(03)01106-2; Faham S, 2002, J MOL BIOL, V316, P1, DOI 10.1006/jmbi.2001.5295; Freeman M, 2008, ANNU REV GENET, V42, P191, DOI 10.1146/annurev.genet.42.110807.091628; Gosse C, 2002, BIOPHYS J, V82, P3314, DOI 10.1016/S0006-3495(02)75672-5; Greenleaf WJ, 2008, SCIENCE, V319, P630, DOI 10.1126/science.1151298; Ha Y, 2013, J BIOL CHEM, V288, P15430, DOI 10.1074/jbc.R112.422378; Hong H, 2010, P NATL ACAD SCI USA, V107, P19802, DOI 10.1073/pnas.1010348107; Jefferson RE, 2013, J AM CHEM SOC, V135, P15183, DOI 10.1021/ja407232b; Joh NH, 2008, NATURE, V453, P1266, DOI 10.1038/nature06977; Kedrov A, 2007, ANNU REV BIOPH BIOM, V36, P233, DOI 10.1146/annurev.biophys.36.040306.132640; Kim BL, 2014, P NATL ACAD SCI USA, V111, P11031, DOI 10.1073/pnas.1410529111; Kim K, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp725; Kim SJ, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00201; Lemberg MK, 2007, MOL CELL, V28, P930, DOI 10.1016/j.molcel.2007.12.003; Lemberg MK, 2013, TRENDS CELL BIOL, V23, P210, DOI 10.1016/j.tcb.2013.01.002; Lipfert J, 2009, BIOPHYS J, V96, P5040, DOI 10.1016/j.bpj.2009.03.055; Liphardt J, 2001, SCIENCE, V292, P733, DOI 10.1126/science.1058498; Min D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2692; Oesterhelt F, 2000, SCIENCE, V288, P143, DOI 10.1126/science.288.5463.143; Otzen DE, 2011, PROTEIN ENG DES SEL, V24, P139, DOI 10.1093/protein/gzq079; Otzen DE, 2003, J MOL BIOL, V330, P641, DOI 10.1016/S0022-2836(03)00624-7; Paslawski W, 2015, P NATL ACAD SCI USA, V112, P7978, DOI 10.1073/pnas.1424751112; Saleh OA, 2005, CHEMPHYSCHEM, V6, P813, DOI 10.1002/cphc.200400635; Shank EA, 2010, NATURE, V465, P637, DOI 10.1038/nature09021; Stigler J, 2011, SCIENCE, V334, P512, DOI 10.1126/science.1207598; Vinothkumar KR, 2013, CURR OPIN STRUC BIOL, V23, P851, DOI 10.1016/j.sbi.2013.07.014; Vinothkumar KR, 2011, J MOL BIOL, V407, P232, DOI 10.1016/j.jmb.2011.01.029; Wang YC, 2006, NATURE, V444, P179, DOI 10.1038/nature05255; Watters AL, 2007, CELL, V128, P613, DOI 10.1016/j.cell.2006.12.042; White SH, 2008, ANNU REV BIOPHYS, V37, P23, DOI 10.1146/annurev.biophys.37.032807.125904; Wu ZR, 2006, NAT STRUCT MOL BIOL, V13, P1084, DOI 10.1038/nsmb1179; Zocher M, 2012, ACS NANO, V6, P961, DOI 10.1021/nn204624p	48	46	47	3	50	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2015	11	12					981	987		10.1038/nchembio.1939	http://dx.doi.org/10.1038/nchembio.1939			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX6TG	26479439	Green Accepted			2022-12-25	WOS:000365834000018
J	Tsankov, AM; Akopian, V; Pop, R; Chetty, S; Gifford, CA; Daheron, L; Tsankova, NM; Meissner, A				Tsankov, Alexander M.; Akopian, Veronika; Pop, Ramona; Chetty, Sundari; Gifford, Casey A.; Daheron, Laurence; Tsankova, Nadejda M.; Meissner, Alexander			A qPCRCR ScoreCard quantifies the differentiation potential of human pluripotent stem cells	NATURE BIOTECHNOLOGY			English	Article							HUMAN ES; SPECIFICATION; DISRUPTION; DYNAMICS; LINES	Research on human pluripotent stem cells has been hampered by the lack of a standardized, quantitative, scalable assay of pluripotency. We previously described an assay called ScoreCard that used gene expression signatures to quantify differentiation efficiency. Here we report an improved version of the assay based on qPCR that enables faster, more quantitative assessment of functional pluripotency. We provide an in-depth characterization of the revised signature panel (commercially available as the TaqMan hPSC Scorecard Assay) through embryoid body and directed differentiation experiments as well as a detailed comparison to the teratoma assay. We further show that the improved ScoreCard enables a wider range of applications, such as screening of small molecules, genetic perturbations and assessment of culture conditions. Our approach can be extended beyond stem cell applications to characterize and assess the utility of other cell types and lineages.	[Tsankov, Alexander M.; Akopian, Veronika; Pop, Ramona; Gifford, Casey A.; Meissner, Alexander] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Tsankov, Alexander M.; Akopian, Veronika; Pop, Ramona; Gifford, Casey A.; Daheron, Laurence; Meissner, Alexander] Harvard Stem Cell Inst, Cambridge, MA USA; [Tsankov, Alexander M.; Akopian, Veronika; Pop, Ramona; Chetty, Sundari; Gifford, Casey A.; Meissner, Alexander] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Tsankova, Nadejda M.] Columbia Univ, Med Ctr, Dept Pathol & Cell Biol, New York, NY USA; [Tsankova, Nadejda M.] Icahn Sch Med Mt Sinai, Dept Pathol, New York, NY 10029 USA; [Tsankova, Nadejda M.] Icahn Sch Med Mt Sinai, Dept Neurosci, New York, NY 10029 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard University; Columbia University; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Meissner, A (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.	alexander_meissner@harvard.edu		Gifford, Casey/0000-0002-7757-573X	NIH under Ruth L. Kirschstein National Research Service Award (NRSA) fellowship [5F32DK095537]; National Institute of General Medical Sciences (NIGMS) [P01GM099117]; National Human Genome Research Institute (NHGRI) [1P50HG006193]; New York Stem Cell Foundation; Life Technologies; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG006193] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK095537] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM099117] Funding Source: NIH RePORTER	NIH under Ruth L. Kirschstein National Research Service Award (NRSA) fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); New York Stem Cell Foundation; Life Technologies; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank all members of the Meissner laboratory as well as D. Tieberg and U. Lakshmipathy for their valuable support and insightful feedback, L. Solomon and L. Gaffney for graphical support, I.S. Kim and B. Bernstein for the JQ1 inhibitor molecule and insight, L. Rubin for the partially reprogrammed cell lines and C. MacGillivray (HSCI Histology core) for teratoma sectioning, fixation and histochemical staining for markers of the three germ layers. A.M.T. is supported by the NIH under Ruth L. Kirschstein National Research Service Award (NRSA) fellowship 5F32DK095537. This work was supported by the National Institute of General Medical Sciences (NIGMS) (P01GM099117), National Human Genome Research Institute (NHGRI) (1P50HG006193), the New York Stem Cell Foundation, and a research grant from Life Technologies. A.M. is a New York Stem Cell Foundation, Robertson Investigator.	Bock C, 2011, CELL, V144, P439, DOI 10.1016/j.cell.2010.12.032; Borowiak M, 2009, CELL STEM CELL, V4, P348, DOI 10.1016/j.stem.2009.01.014; Boulting GL, 2011, NAT BIOTECHNOL, V29, P279, DOI 10.1038/nbt.1783; Choi J, 2015, NAT BIOTECHNOL, V33, P1173, DOI 10.1038/nbt.3388; Daley GQ, 2012, CELL STEM CELL, V10, P740, DOI 10.1016/j.stem.2012.05.010; Dolgin E, 2010, NAT MED, V16, P1354, DOI 10.1038/nm1210-1354; Gifford CA, 2013, CELL, V153, P1149, DOI 10.1016/j.cell.2013.04.037; Liao J, 2015, NAT GENET, V47, P469, DOI 10.1038/ng.3258; Liptak T., 1958, MAGYAR TUD AKAD MAT, V3, P171; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Muller FJ, 2011, NAT METHODS, V8, P315, DOI 10.1038/NMETH.1580; Muller FJ, 2010, CELL STEM CELL, V6, P412, DOI 10.1016/j.stem.2010.04.009; Pikkarainen S, 2004, CARDIOVASC RES, V63, P196, DOI 10.1016/j.cardiores.2004.03.025; Stouffer SA, 1949, AM SOLDIER ADJUSTMEN, V1; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Teo AKK, 2011, GENE DEV, V25, P238, DOI 10.1101/gad.607311; Tsankov AM, 2015, NATURE, V518, P344, DOI 10.1038/nature14233; Wang Z, 2012, CELL STEM CELL, V10, P440, DOI 10.1016/j.stem.2012.02.016; Ziller MJ, 2015, NATURE, V518, P355, DOI 10.1038/nature13990	20	89	89	0	10	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2015	33	11					1182	U117		10.1038/nbt.3387	http://dx.doi.org/10.1038/nbt.3387			15	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CW3TY	26501952	Green Submitted, Green Accepted			2022-12-25	WOS:000364916000026
J	Banga, R; Procopio, FA; Noto, A; Pollakis, G; Cavassini, M; Ohmiti, K; Corpataux, JM; de Leval, L; Pantaleo, G; Perreau, M				Banga, Riddhima; Procopio, Francesco Andrea; Noto, Alessandra; Pollakis, Georgios; Cavassini, Matthias; Ohmiti, Khalid; Corpataux, Jean-Marc; de Leval, Laurence; Pantaleo, Giuseppe; Perreau, Matthieu			PD-1(+) and follicular helper T cells are responsible for persistent HIV-1 transcription in treated aviremic individuals	NATURE MEDICINE			English	Article							CXC CHEMOKINE RECEPTOR-5; LATENT RESERVOIR; STEM-CELL; REPLICATION	The mechanisms responsible for the persistence of HIV-1 after many years of suppressive antiretroviral therapy (ART) have been only partially elucidated. Most of the studies investigating HIV-1 persistence have been performed with blood, although it is well known that germinal centers (GCs) within lymph nodes (LNs) serve as primary sites for HIV-1 replication. We sought to identify the memory CD4 T cell populations in blood and LNs that are responsible for the production of replication-competent and infectious HIV-1, as well as for active and persistent virus transcription in ART-treated (for 1.5-14.0 years), aviremic (<50 HIV RNA copies/ml) HIV-infected individuals. We demonstrate that LN CD4 T cells that express programmed cell death 1 (PDCD1; also known as PD-1), which are composed of about 65% T follicular helper cells as defined by the expression of the cell surface receptors CXCR5 and PD-1, are the major source of replication-competent HIV-1 and of infectious virus, as compared to any other (CXCR5-PD-1- and CXCR5(+)PD-1(-)) blood or LN memory CD4 T cell populations. LN PD-1(+) cells accounted for 46% and 96% of the total pools of memory CD4 T cells containing inducible replication-competent or infectious virus, respectively. Notably, higher levels of cell-associated HIV-1 RNA were present in LN PD-1(+) cells after long-term (up to 12 years) ART than in other memory CD4 T cell subpopulations. These results indicate that LN PD-1(+) cells are the major CD4 T cell compartment in the blood and LNs for the production of replication-competent and infectious HIV-1, and for active and persistent virus transcription in long-term-ART-treated aviremic individuals. Thus, these cells may represent a major obstacle to finding a functional cure for HIV-1 infection.	[Banga, Riddhima; Procopio, Francesco Andrea; Noto, Alessandra; Ohmiti, Khalid; Pantaleo, Giuseppe; Perreau, Matthieu] Univ Lausanne, Univ Lausanne Hosp, Serv Immunol & Allergy, Lausanne, Switzerland; [Pollakis, Georgios] Univ Liverpool, Inst Infect & Global Hlth IGH, Dept Clin Infect Microbiol & Immunol CIMI, Liverpool, Merseyside, England; [Cavassini, Matthias] Univ Lausanne, Univ Lausanne Hosp, Infect Dis Serv, Lausanne, Switzerland; [Corpataux, Jean-Marc] Univ Lausanne, Univ Lausanne Hosp, Serv Vasc Surg, Lausanne, Switzerland; [de Leval, Laurence] Univ Lausanne, Univ Lausanne Hosp, Inst Pathol, Lausanne, Switzerland; [Pantaleo, Giuseppe] Univ Lausanne, Univ Lausanne Hosp, Swiss Vaccine Res Inst, Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Liverpool; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Pantaleo, G; Perreau, M (corresponding author), Univ Lausanne, Univ Lausanne Hosp, Serv Immunol & Allergy, Lausanne, Switzerland.; Pantaleo, G (corresponding author), Univ Lausanne, Univ Lausanne Hosp, Swiss Vaccine Res Inst, Lausanne, Switzerland.	giuseppe.pantaleo@chuv.ch; matthieu.perreau@chuv.ch	Perreau, Matthieu/D-6309-2017; Pantaleo, Giuseppe/K-6163-2016; Georgios, Pollakis/Y-2341-2019; de Leval, Laurence/M-4889-2017; Procopio, Francesco/ABD-8065-2021; cavassini, matthias/F-8987-2017	de Leval, Laurence/0000-0003-3994-516X; Pollakis, Georgios/0000-0002-9659-5461; cavassini, matthias/0000-0003-0933-7833	Bristol-Myers Squibb	Bristol-Myers Squibb(Bristol-Myers Squibb)	We are grateful to N. Grandchamp, P. Pochon, X. Bron, M: Graff, A. Cretignier, R. Mamin, F. Bellanger, L. Leuenberger and C. Andre for technical assistance, and to D. Alves and the study manager N. Rettby. This work was funded by an educational grant from Bristol-Myers Squibb (M.P.).	Altman D.G., 1991, PRACTICAL STATISTIC; Banga R, 2016, J VIROL, V90, P1858, DOI 10.1128/JVI.02359-15; Breitfeld D, 2000, J EXP MED, V192, P1545, DOI 10.1084/jem.192.11.1545; Bullen CK, 2014, NAT MED, V20, P425, DOI 10.1038/nm.3489; Buzon MJ, 2014, NAT MED, V20, P139, DOI 10.1038/nm.3445; Casazza J.P.I., 2015, C RETR OPP INF SEATT, V49; Chomont N, 2009, NAT MED, V15, P893, DOI 10.1038/nm.1972; Chun TW, 1997, NATURE, V387, P183, DOI 10.1038/387183a0; Chun TW, 1997, P NATL ACAD SCI USA, V94, P13193, DOI 10.1073/pnas.94.24.13193; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; Fletcher CV, 2014, P NATL ACAD SCI USA, V111, P2307, DOI 10.1073/pnas.1318249111; Fukazawa Y, 2015, NAT MED, V21, P132, DOI 10.1038/nm.3781; Ganusov VV, 2007, TRENDS IMMUNOL, V28, P514, DOI 10.1016/j.it.2007.08.009; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Kim CH, 2001, J EXP MED, V193, P1373, DOI 10.1084/jem.193.12.1373; Locci M, 2013, IMMUNITY, V39, P758, DOI 10.1016/j.immuni.2013.08.031; Lorenzo-Redondo R, 2016, NATURE, V530, P51, DOI 10.1038/nature16933; Morita R, 2011, IMMUNITY, V34, P108, DOI 10.1016/j.immuni.2010.12.012; Perreau M, 2013, J EXP MED, V210, P143, DOI 10.1084/jem.20121932; Procopio FA, 2015, EBIOMEDICINE, V2, P874, DOI 10.1016/j.ebiom.2015.06.019; Schaerli P, 2000, J EXP MED, V192, P1553, DOI 10.1084/jem.192.11.1553; Siliciano JD, 2003, NAT MED, V9, P727, DOI 10.1038/nm880; Sobolewski M.C.A., 2013, C RETR OPP INF ATL I, V174LB; Vandergeeten C, 2014, J VIROL, V88, P12385, DOI 10.1128/JVI.00609-14; Wong JK, 1997, SCIENCE, V278, P1291, DOI 10.1126/science.278.5341.1291	25	300	309	0	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2016	22	7					754	761		10.1038/nm.4113	http://dx.doi.org/10.1038/nm.4113			8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DQ7DK	27239760				2022-12-25	WOS:000379366900014
J	Fan, RR; Toubal, A; Goni, S; Drareni, K; Huang, ZQ; Alzaid, F; Ballaire, R; Ancel, P; Liang, N; Damdimopoulos, A; Hainault, I; Soprani, A; Aron-Wisnewsky, J; Foufelle, F; Lawrence, T; Gautier, JF; Venteclef, N; Treuter, E				Fan, Rongrong; Toubal, Amine; Goni, Saioa; Drareni, Karima; Huang, Zhiqiang; Alzaid, Fawaz; Ballaire, Raphaelle; Ancel, Patricia; Liang, Ning; Damdimopoulos, Anastasios; Hainault, Isabelle; Soprani, Antoine; Aron-Wisnewsky, Judith; Foufelle, Fabienne; Lawrence, Toby; Gautier, Jean-Francois; Venteclef, Nicolas; Treuter, Eckardt			Loss of the co-repressor GPS2 sensitizes macrophage activation upon metabolic stress induced by obesity and type 2 diabetes	NATURE MEDICINE			English	Article							ADIPOSE-TISSUE; COREPRESSOR COMPLEX; INSULIN-RESISTANCE; KAPPA-B; RECEPTOR; INFLAMMATION; PATHWAYS; HDAC3; SMRT; PHOSPHORYLATION	Humans with obesity differ in their susceptibility to developing insulin resistance and type 2 diabetes (T2D). This variation may relate to the extent of adipose tissue (AT) inflammation that develops as their obesity progresses. The state of macrophage activation has a central role in determining the degree of AT inflammation and thus its dysfunction, and these states are driven by epigenomic alterations linked to gene expression. The underlying mechanisms that regulate these alterations, however, are poorly defined. Here we demonstrate that a co-repressor complex containing G protein pathway suppressor 2 (GPS2) crucially controls the macrophage epigenome during activation by metabolic stress. The study of AT from humans with and without obesity revealed correlations between reduced GPS2 expression in macrophages, elevated systemic and AT inflammation, and diabetic status. The causality of this relationship was confirmed by using macrophage-specific Gps2-knockout (KO) mice, in which inappropriate co-repressor complex function caused enhancer activation, pro-inflammatory gene expression and hypersensitivity toward metabolic-stress signals. By contrast, transplantation of GPS2-overexpressing bone marrow into two mouse models of obesity (ob/ob and diet-induced obesity) reduced inflammation and improved insulin sensitivity. Thus, our data reveal a potentially reversible disease mechanism that links co-repressor-dependent epigenomic alterations in macrophages to AT inflammation and the development of T2D.	[Fan, Rongrong; Goni, Saioa; Huang, Zhiqiang; Liang, Ning; Damdimopoulos, Anastasios; Treuter, Eckardt] Karolinska Inst, Dept Biosci & Nutr, Huddinge, Sweden; [Toubal, Amine; Drareni, Karima; Alzaid, Fawaz; Ballaire, Raphaelle; Hainault, Isabelle; Soprani, Antoine; Foufelle, Fabienne; Gautier, Jean-Francois; Venteclef, Nicolas] Univ Paris 06, Sorbonne Univ, INSERM, UMR S Cordeliers Res 1138, Paris, France; [Toubal, Amine; Drareni, Karima; Alzaid, Fawaz; Ballaire, Raphaelle; Hainault, Isabelle; Aron-Wisnewsky, Judith; Foufelle, Fabienne; Venteclef, Nicolas] Inst Cardiometab & Nutr, Paris, France; [Ancel, Patricia] Aix Marseille Univ, Nutr Obesite & Risque Thrombot, INSERM, UMR 1062,INRA 1260, Marseille, France; [Soprani, Antoine] Clin Geoffroy St Hilaire, Gen Sante, Paris, France; [Aron-Wisnewsky, Judith] Hop La Pitie Salpetriere, AP HP, Heart & Metab Div, Paris, France; [Aron-Wisnewsky, Judith] Univ Paris 06, Sorbonne Univ, INSERM, NutriOm Team,UMR S U1166, Paris, France; [Lawrence, Toby] Aix Marseille Univ, CIML, UM2, Marseille, France; [Lawrence, Toby] INSERM, U1104, Marseille, France; [Lawrence, Toby] CNRS, UMR7280, Marseille, France; [Gautier, Jean-Francois] Univ Paris Diderot, Lariboisiere Hosp, AP HP, Dept Diabet,Clin Invest Ctr CIC 9504, Paris, France	Karolinska Institutet; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite	Treuter, E (corresponding author), Karolinska Inst, Dept Biosci & Nutr, Huddinge, Sweden.; Venteclef, N (corresponding author), Univ Paris 06, Sorbonne Univ, INSERM, UMR S Cordeliers Res 1138, Paris, France.; Venteclef, N (corresponding author), Inst Cardiometab & Nutr, Paris, France.	nicolas.venteclef@upmc.fr; eckardt.treuter@ki.se	ARON-WISNEWSKY, judith/AAH-7608-2020; Ancel, Patricia/AAK-4469-2020; Fan, Rongrong/N-3446-2017; Fan, Rongrong/AAG-2200-2019; Venteclef, Nicolas/K-8484-2017; Lawrence, Toby/GLU-3895-2022; Goñi Irigoyen, Saioa/M-6330-2015	Ancel, Patricia/0000-0001-5567-1539; Fan, Rongrong/0000-0002-5707-1497; Fan, Rongrong/0000-0002-5707-1497; Lawrence, Toby/0000-0003-0967-6122; Goñi Irigoyen, Saioa/0000-0002-2368-7373; Venteclef, Nicolas/0000-0002-6313-1214; Huang, Zhiqiang/0000-0001-5208-008X; FOUFELLE, Fabienne/0000-0002-0752-622X; Liang, Ning/0000-0002-7848-2893; Treuter, Eckardt/0000-0002-4147-8989; Damdimopoulos, Anastasios/0000-0003-4425-1189; Alzaid, Fawaz/0000-0003-3056-3640	Swedish Research Council (Vetenskapsradet); Swedish Cancer Society (Cancerfonden); Swedish Diabetes Foundation (Diabetesfonden); Novo Nordisk Foundation (Novo Nordisk Fonden); Center for Biosciences (CIMED) at Karolinska Institutet; French National Agency of Research (CONRAD); French National Agency of Research [ANR CE12 2014]; French National Agency of Research (FATMAC); Region Ile de France (CORDDIM); Paris city (EMERGENCE); French Foundation for Medical Research [Equipe FRM DEQ20140329504]; French government [ANR-10-IAH, ICAN MetaMACS]; Assistance Publique des Hopitaux de Paris (APHP), Programs of Clinical Investigation (CRC Fibrota) [AOO759-32]; PHRC Glucostress [P081122]; 'Ministere de la Recherche et de l'Enseignement superieur'; China Scholarship Council (CRC); Karolinska Institutet (KID)	Swedish Research Council (Vetenskapsradet)(Swedish Research Council); Swedish Cancer Society (Cancerfonden)(Swedish Cancer Society); Swedish Diabetes Foundation (Diabetesfonden); Novo Nordisk Foundation (Novo Nordisk Fonden)(Novo Nordisk); Center for Biosciences (CIMED) at Karolinska Institutet; French National Agency of Research (CONRAD); French National Agency of Research(French National Research Agency (ANR)); French National Agency of Research (FATMAC); Region Ile de France (CORDDIM)(Region Ile-de-France); Paris city (EMERGENCE); French Foundation for Medical Research(Fondation pour la Recherche Medicale); French government; Assistance Publique des Hopitaux de Paris (APHP), Programs of Clinical Investigation (CRC Fibrota); PHRC Glucostress; 'Ministere de la Recherche et de l'Enseignement superieur'; China Scholarship Council (CRC)(China Scholarship Council); Karolinska Institutet (KID)	We acknowledge Ozgene Pty, Ltd. for generating foxed GPS2 mice. We acknowledge V. Benes and the team at the EMBL Genomics Core Facility for ChIP-seq library preparation and sequencing. We thank S. Mandrup (University of Southern Denmark), K. de Bosscher (Ghent University), J. Taipale (Karolinska Institutet), and F. Zhang (Broad Institute) for providing plasmids, and T. Jakobsson for his advice in establishing the CRISPR-Cas9 system. We also thank F. Fagerstrom-Billai and co-workers at the BEA Core Facility (Karolinska Institutet) for microarray preparation and analysis. For assistance with pathological analysis and FACS sorting, we thank R. Kuiper, T. Schroder, and A.-L. Dackland (Department of Laboratory Medicine, Karolinska Institutet). We thank R. Chiche, J. Cady, and S. Gueroult (Geoffroy Saint-Hilaire Clinic Paris) for human AT sampling, and J.-L. Nguewa for his help in PHRC Glucostress. This work was supported by grants from the Swedish Research Council (Vetenskapsradet, E.T.); the Swedish Cancer Society (Cancerfonden, E.T.); the Swedish Diabetes Foundation (Diabetesfonden, E.T.); the Novo Nordisk Foundation (Novo Nordisk Fonden, E.T.); the Center for Biosciences (former CB, now CIMED) at Karolinska Institutet (E.T.); the French National Agency of Research (CONRAD, N.V.; ANR CE12 2014, FATMAC, T.B.); Region Ile de France (CORDDIM, N.V.); Paris city (EMERGENCE, N.V.); the French Foundation for Medical Research (Equipe FRM DEQ20140329504, N.V. and F.F.); a French government grant managed by the National Agency of Research (program 'Investments for the Future reference ANR-10-IAH, ICAN MetaMACS, N.V. and F.F.); Assistance Publique des Hopitaux de Paris (APHP), Programs of Clinical Investigation (CRC Fibrota AOO759-32 to J.A.-W.; and PHRC Glucostress P081122 to J.-F.G.). A.T. and K.D. received a doctoral fellowship from the 'Ministere de la Recherche et de l'Enseignement superieur'. Z.H. received a doctoral fellowship from the China Scholarship Council (CRC), and N.L. received a doctoral faculty grant from the Karolinska Institutet (KID funding).	Ahima RS, 2013, SCIENCE, V341, P856, DOI 10.1126/science.1241244; Arner E, 2010, NEW ENGL J MED, V362, P1151, DOI 10.1056/NEJMc0910718; Barish GD, 2012, CELL METAB, V15, P554, DOI 10.1016/j.cmet.2012.02.012; Cardamone MD, 2014, CELL REP, V8, P163, DOI 10.1016/j.celrep.2014.05.041; Cardamone MD, 2012, MOL CELL, V46, P91, DOI 10.1016/j.molcel.2012.01.025; Chen XF, 2012, P NATL ACAD SCI USA, V109, pE2865, DOI 10.1073/pnas.1121131109; Dalmas E, 2015, NAT MED, V21, P610, DOI 10.1038/nm.3829; Dalmas E, 2011, TRENDS IMMUNOL, V32, P307, DOI 10.1016/j.it.2011.04.008; Garber M, 2012, MOL CELL, V47, P810, DOI 10.1016/j.molcel.2012.07.030; Ghisletti S, 2009, GENE DEV, V23, P681, DOI 10.1101/gad.1773109; Glass CK, 2016, NAT IMMUNOL, V17, P26, DOI 10.1038/ni.3306; Glass CK, 2012, CELL METAB, V15, P635, DOI 10.1016/j.cmet.2012.04.001; Glass CK, 2010, NAT REV IMMUNOL, V10, P365, DOI 10.1038/nri2748; Gosselin D, 2014, IMMUNOL REV, V262, P96, DOI 10.1111/imr.12213; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Guenther MG, 2000, GENE DEV, V14, P1048; Guenther MG, 2001, MOL CELL BIOL, V21, P6091, DOI 10.1128/MCB.21.18.6091-6101.2001; Hah N, 2015, P NATL ACAD SCI USA, V112, pE297, DOI 10.1073/pnas.1424028112; Hambleton J, 1996, P NATL ACAD SCI USA, V93, P2774, DOI 10.1073/pnas.93.7.2774; Ito A, 2015, ELIFE, V4, DOI 10.7554/eLife.08009; Jonas BA, 2004, J BIOL CHEM, V279, P54676, DOI 10.1074/jbc.M410128200; Kaikkonen MU, 2013, MOL CELL, V51, P310, DOI 10.1016/j.molcel.2013.07.010; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Kang S, 2015, NAT CELL BIOL, V17, P44, DOI 10.1038/ncb3080; Kratz M, 2014, CELL METAB, V20, P614, DOI 10.1016/j.cmet.2014.08.010; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; Lawrence T, 2011, NAT REV IMMUNOL, V11, P750, DOI 10.1038/nri3088; Lee SK, 2000, J BIOL CHEM, V275, P12470, DOI 10.1074/jbc.275.17.12470; Li PP, 2013, CELL, V155, P200, DOI 10.1016/j.cell.2013.08.054; Li PP, 2011, CELL, V147, P815, DOI 10.1016/j.cell.2011.09.050; Link V.M., 2015, COLD SPRING HARB SYM; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Mauer J, 2014, NAT IMMUNOL, V15, P423, DOI 10.1038/ni.2865; Medzhitov R, 2009, NAT REV IMMUNOL, V9, P692, DOI 10.1038/nri2634; Mullican SE, 2011, GENE DEV, V25, P2480, DOI 10.1101/gad.175950.111; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Nagareddy PR, 2014, CELL METAB, V19, P821, DOI 10.1016/j.cmet.2014.03.029; Oberoi J, 2011, NAT STRUCT MOL BIOL, V18, P177, DOI 10.1038/nsmb.1983; Ogawa S, 2004, P NATL ACAD SCI USA, V101, P14461, DOI 10.1073/pnas.0405786101; Stasevich TJ, 2014, NATURE, V516, P272, DOI 10.1038/nature13714; Sun K, 2011, J CLIN INVEST, V121, P2094, DOI 10.1172/JCI45887; Sun Z, 2013, MOL CELL, V52, P769, DOI 10.1016/j.molcel.2013.10.022; Tchernof A, 2013, PHYSIOL REV, V93, P359, DOI 10.1152/physrev.00033.2011; Toubal A, 2013, TRENDS ENDOCRIN MET, V24, P625, DOI 10.1016/j.tem.2013.09.006; Toubal A, 2013, J CLIN INVEST, V123, P362, DOI 10.1172/JCI64052; Uhlenhaut NH, 2013, MOL CELL, V49, P158, DOI 10.1016/j.molcel.2012.10.013; Venteclef N, 2010, GENE DEV, V24, P381, DOI 10.1101/gad.545110; Weiss C, 2003, EMBO J, V22, P3686, DOI 10.1093/emboj/cdg364; Wolter S, 2008, MOL CELL BIOL, V28, P4407, DOI 10.1128/MCB.00535-07; Xu XY, 2013, CELL METAB, V18, P816, DOI 10.1016/j.cmet.2013.11.001; Zhang JS, 2002, MOL CELL, V9, P611, DOI 10.1016/S1097-2765(02)00468-9	51	57	59	1	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JUL	2016	22	7					780	791		10.1038/nm.4114	http://dx.doi.org/10.1038/nm.4114			12	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DQ7DK	27270589				2022-12-25	WOS:000379366900017
J	Nakano, S; Suzuki, T; Kawarada, L; Iwata, H; Asano, K; Suzuki, T				Nakano, Saori; Suzuki, Takeo; Kawarada, Layla; Iwata, Hiroyoshi; Asano, Kana; Suzuki, Tsutomu			NSUN3 methylase initiates 5-formylcytidine biogenesis in human mitochondrial tRNA(Met)	NATURE CHEMICAL BIOLOGY			English	Article							WOBBLE MODIFICATION DEFICIENCY; MUTANT TRANSFER-RNAS; RIBOSOMAL-RNA; 1ST POSITION; BOVINE LIVER; ANTICODON; METHYLTRANSFERASE; NUCLEOTIDE; EXPRESSION; MUTATION	In human mitochondria, the AUA codon encodes methionine via a mitochondrial transfer RNA for methionine (mt-tRNA(Met)) that contains 5-formylcytidine (f(5)C) at the first position of the anticodon (position 34). f(5)C34 is required for deciphering the AUA codon during protein synthesis. Until now, the biogenesis and physiological role of f(5)C34 were unknown. We demonstrate that biogenesis of f(5)C34 is initiated by S-adenosylmethionine (AdoMet)-dependent methylation catalyzed by NSUN3, a putative methyltransferase in mitochondria. NSUN3-knockout cells showed strong reduction in mitochondrial protein synthesis and reduced oxygen consumption, leading to deficient mitochondrial activity. We reconstituted formation of 5-methylcytidine (m(5)C) at position 34 (m(5)C34) on mt-tRNA(Met) with recombinant NSUN3 in the presence of AdoMet, demonstrating that NSUN3-mediated m(5)C34 formation initiates f(5)C34 biogenesis. We also found two disease-associated point mutations in mt-tRNAmet that impaired m(5)C34 formation by NSUN3, indicating that a lack of f(5)C34 has pathological consequences.	[Nakano, Saori; Suzuki, Takeo; Kawarada, Layla; Iwata, Hiroyoshi; Asano, Kana; Suzuki, Tsutomu] Univ Tokyo, Grad Sch Engn, Dept Chem & Biotechnol, Tokyo, Japan	University of Tokyo	Suzuki, T (corresponding author), Univ Tokyo, Grad Sch Engn, Dept Chem & Biotechnol, Tokyo, Japan.	ts@chembio.t.u-tokyo.ac.jp	Suzuki, Tsutomu/J-1776-2015	Suzuki, Tsutomu/0000-0002-9731-1731	Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT); Japan Society for the Promotion of Science (JSPS)	Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We are grateful to Y. Sakaguchi, K Miyauchi, T Ohira, S. Kimura, H. Hojo, H. Lin, T. Chujo, Y. Ikeuchi and other members of Tsutomu Suzuki's laboratory for technical support and insightful discussions. Special thanks to O. Nureki, I. Koyama-Honda, N. Mizushima (University of Tokyo), C. Ushida (Hirosaki University) and Primetech Inc. (Japan) for materials and technical support. This work was supported by Grants in Aid for Scientific Research on Priority Areas from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) and the Japan Society for the Promotion of Science (JSPS) (to Tsutomu Suzuki and Takeo Suzuki).	ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Arai T, 2015, P NATL ACAD SCI USA, V112, pE4707, DOI 10.1073/pnas.1506749112; Bjork Glenn R., 1995, P165; Brzezicha B, 2006, NUCLEIC ACIDS RES, V34, P6034, DOI 10.1093/nar/gkl765; Cantara WA, 2013, P NATL ACAD SCI USA, V110, P10964, DOI 10.1073/pnas.1222641110; Chi L, 2013, GENE EXPR PATTERNS, V13, P319, DOI 10.1016/j.gep.2013.06.003; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; deBarros JPP, 1996, NUCLEIC ACIDS RES, V24, P1489; Gao Y, 2013, ANAL CHEM, V85, P4713, DOI 10.1021/ac400448t; Haag S, 2015, RNA, V21, P1532, DOI 10.1261/rna.051524.115; Hallberg BM, 2014, CELL METAB, V20, P226, DOI 10.1016/j.cmet.2014.07.001; Harris T, 2007, BIOL REPROD, V77, P376, DOI 10.1095/biolreprod.106.058669; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Huber SM, 2015, CHEMBIOCHEM, V16, P752, DOI 10.1002/cbic.201500013; Hussain S, 2013, CELL REP, V4, P255, DOI 10.1016/j.celrep.2013.06.029; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Kato K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076983; Kirino Y, 2005, P NATL ACAD SCI USA, V102, P7127, DOI 10.1073/pnas.0500563102; Kirino Y, 2004, P NATL ACAD SCI USA, V101, P15070, DOI 10.1073/pnas.0405173101; Kurata S, 2008, J BIOL CHEM, V283, P18801, DOI 10.1074/jbc.M800233200; Lott Marie T, 2013, Curr Protoc Bioinformatics, V44, DOI 10.1002/0471250953.bi0123s44; Lu ZQ, 2011, EUR J HUM GENET, V19, P1181, DOI 10.1038/ejhg.2011.111; Machnicka MA, 2013, NUCLEIC ACIDS RES, V41, pD262, DOI 10.1093/nar/gks1007; Metodiev MD, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004110; Miyauchi K, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1129; Momb J, 2014, BIRTH DEFECTS RES A, V100, P576, DOI 10.1002/bdra.23268; MORIYA J, 1994, BIOCHEMISTRY-US, V33, P2234, DOI 10.1021/bi00174a033; Pyzocha NK, 2014, METHODS MOL BIOL, V1114, P269, DOI 10.1007/978-1-62703-761-7_17; Qu J, 2006, INVEST OPHTH VIS SCI, V47, P475, DOI 10.1167/iovs.05-0665; Reed SE, 2006, J VIROL METHODS, V138, P85, DOI 10.1016/j.jviromet.2006.07.024; Rhee HW, 2013, SCIENCE, V339, P1328, DOI 10.1126/science.1230593; ROBINSON BH, 1992, BIOCHEM MED METAB B, V48, P122, DOI 10.1016/0885-4505(92)90056-5; Rooijers K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3886; SAMPSON JR, 1988, P NATL ACAD SCI USA, V85, P1033, DOI 10.1073/pnas.85.4.1033; Sharma S, 2013, NUCLEIC ACIDS RES, V41, P9062, DOI 10.1093/nar/gkt679; Spahr H, 2012, P NATL ACAD SCI USA, V109, P15253, DOI 10.1073/pnas.1210688109; Spencer AC, 2004, BIOCHEMISTRY-US, V43, P9743, DOI 10.1021/bi049639w; Squires JE, 2012, NUCLEIC ACIDS RES, V40, P5023, DOI 10.1093/nar/gks144; Stiernagle Theresa, 2006, WormBook, P1; Suzuki T, 2002, EMBO J, V21, P6581, DOI 10.1093/emboj/cdf656; Suzuki T, 2005, TOP CURR GENET, V12, P23, DOI 10.1007/b106361; Suzuki T, 2014, NUCLEIC ACIDS RES, V42, P7346, DOI 10.1093/nar/gku390; Suzuki T, 2011, ANNU REV GENET, V45, P299, DOI 10.1146/annurev-genet-110410-132531; Suzuki T, 2011, WIRES RNA, V2, P376, DOI 10.1002/wrna.65; Takemoto C, 1999, Nucleic Acids Symp Ser, P77; Takemoto C, 2009, NUCLEIC ACIDS RES, V37, P1616, DOI 10.1093/nar/gkp001; Takeuchi N, 1998, J BIOL CHEM, V273, P15085, DOI 10.1074/jbc.273.24.15085; Tang S, 2013, HUM MUTAT, V34, P882, DOI 10.1002/humu.22307; Umeda N, 2005, J BIOL CHEM, V280, P1613, DOI 10.1074/jbc.M409306200; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; WATANABE YI, 1994, J BIOL CHEM, V269, P22902; Wu H, 2014, CELL, V156, P45, DOI 10.1016/j.cell.2013.12.019; Yasukawa T, 2005, FEBS LETT, V579, P2948, DOI 10.1016/j.febslet.2005.04.038; Yasukawa T, 2000, J BIOL CHEM, V275, P4251, DOI 10.1074/jbc.275.6.4251; Yasukawa T, 2000, FEBS LETT, V467, P175, DOI 10.1016/S0014-5793(00)01145-5; Yue YN, 2015, GENE DEV, V29, P1343, DOI 10.1101/gad.262766.115	56	101	103	1	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUL	2016	12	7					546	+		10.1038/NCHEMBIO.2099	http://dx.doi.org/10.1038/NCHEMBIO.2099			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9EP	27214402				2022-12-25	WOS:000378087500015
J	Guo, RQ; Gaffney, K; Yang, ZY; Kim, M; Sungsuwan, S; Huang, XF; Hubbell, WL; Hong, H				Guo, Ruiqiong; Gaffney, Kristen; Yang, Zhongyu; Kim, Miyeon; Sungsuwan, Suttipun; Huang, Xuefei; Hubbell, Wayne L.; Hong, Heedeok			Steric trapping reveals a cooperativity network in the intramembrane protease GlpG	NATURE CHEMICAL BIOLOGY			English	Article							MEMBRANE-PROTEIN; RHOMBOID PROTEASE; MASS-SPECTROMETRY; ENERGY LANDSCAPE; PROTEOLYSIS; STABILITY; COMPLEX; BINDING; STATES; SITE	Membrane proteins are assembled through balanced interactions among proteins, lipids and water. Studying their folding while maintaining the native lipid environment is necessary but challenging. Here we present methods for analyzing key elements of membrane protein folding including thermodynamic stability, compactness of the unfolded state and folding cooperativity under native conditions. The methods are based on steric trapping, which couples the unfolding of a doubly biotinylated protein to the binding of monovalent streptavidin (mSA). We further advanced this technology for general application by developing versatile biotin probes possessing spectroscopic reporters that are sensitized by mSA binding or protein unfolding. By applying these methods to the Escherichia coli intramembrane protease GlpG, we elucidated a widely unraveled unfolded state, subglobal unfolding of the region encompassing the active site, and a network of cooperative and localized interactions to maintain stability. These findings provide crucial insights into the folding energy landscape of membrane proteins.	[Guo, Ruiqiong; Kim, Miyeon; Sungsuwan, Suttipun; Huang, Xuefei; Hong, Heedeok] Michigan State Univ, Dept Chem, E Lansing, MI 48824 USA; [Gaffney, Kristen; Hong, Heedeok] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA; [Yang, Zhongyu; Hubbell, Wayne L.] Univ Calif Los Angeles, Jules Stein Eye Inst, Los Angeles, CA 90024 USA; [Yang, Zhongyu; Hubbell, Wayne L.] Univ Calif Los Angeles, Dept Chem & Biochem, 405 Hilgard Ave, Los Angeles, CA 90024 USA; [Yang, Zhongyu] N Dakota State Univ, Dept Chem & Biochem, Fargo, ND 58105 USA	Michigan State University; Michigan State University; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; North Dakota State University Fargo	Hong, H (corresponding author), Michigan State Univ, Dept Chem, E Lansing, MI 48824 USA.; Hong, H (corresponding author), Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA.	honghd@msu.edu	Huang, Xuefei/G-3371-2014; Hong, Heedeok/E-9231-2018	Huang, Xuefei/0000-0002-6468-5526; Guo, ruiqiong/0000-0003-2781-5384; Hong, Heedeok/0000-0003-0118-5193	Michigan State University; Hunt for a Cure grant for basic cystic fibrosis research; US National Cancer Institute [R01CA149451]; US National Eye Institute [R01EY005216]; Jules Stein Professor endowment; NATIONAL CANCER INSTITUTE [R01CA149451] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY000331, R01EY005216] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM118685] Funding Source: NIH RePORTER	Michigan State University; Hunt for a Cure grant for basic cystic fibrosis research; US National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); US National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Jules Stein Professor endowment; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by startup funds from Michigan State University (H.H.), a Hunt for a Cure grant for basic cystic fibrosis research (H.H.), US National Cancer Institute R01CA149451 (X.H.), US National Eye Institute R01EY005216 (W.L.H.) and the Jules Stein Professor endowment (W.L.H.). The authors thank J. McCracken for general advice on electron paramagnetic resonance (EPR) and for helping with continuous-wave EPR measurements and C. Altenbach for the DEER analysis program. We thank E. Deans and C. Arthur for helping with protein preparations. We also thank R. Jefferson, N. Woodall, Y.-C. Chang, D. Weliky, L. Kroos, J. McCracken and J. Bowie for critical reading of the manuscript. We appreciate suggestions from the anonymous reviewers, which greatly helped improving the quality of this manuscript.	Akiyama Y, 2007, MOL MICROBIOL, V64, P1028, DOI 10.1111/j.1365-2958.2007.05715.x; Arutyunova E, 2014, EMBO J, V33, P1869, DOI 10.15252/embj.201488149; Bai YW, 1996, PROTEINS, V24, P145, DOI 10.1002/(SICI)1097-0134(199602)24:2<145::AID-PROT1>3.0.CO;2-I; BAI YW, 1995, SCIENCE, V269, P192, DOI 10.1126/science.7618079; Baker RP, 2012, NAT CHEM BIOL, V8, P759, DOI [10.1038/NCHEMBIO.1021, 10.1038/nchembio.1021]; Bedard S, 2008, J MOL BIOL, V376, P1142, DOI 10.1016/j.jmb.2007.12.020; Blois TM, 2009, J AM CHEM SOC, V131, P13914, DOI 10.1021/ja905725n; BOLEN DW, 1988, BIOCHEMISTRY-US, V27, P8069, DOI 10.1021/bi00421a015; BRYNGELSON JD, 1995, PROTEINS, V21, P167, DOI 10.1002/prot.340210302; BYLER DM, 1986, BIOPOLYMERS, V25, P469, DOI 10.1002/bip.360250307; Chamberlain AK, 1996, NAT STRUCT BIOL, V3, P782, DOI 10.1038/nsb0996-782; Chang YC, 2014, P NATL ACAD SCI USA, V111, P219, DOI 10.1073/pnas.1318576111; Cui Q, 2008, PROTEIN SCI, V17, P1295, DOI 10.1110/ps.03259908; DILL KA, 1991, ANNU REV BIOCHEM, V60, P795, DOI 10.1146/annurev.bi.60.070191.004051; Dill KA, 1997, NAT STRUCT BIOL, V4, P10, DOI 10.1038/nsb0197-10; Dockter C, 2009, P NATL ACAD SCI USA, V106, P18485, DOI 10.1073/pnas.0906462106; Dutta A, 2010, BIOCHEMISTRY-US, V49, P6329, DOI 10.1021/bi100339x; Hong H, 2013, METHODS MOL BIOL, V1063, P37, DOI 10.1007/978-1-62703-583-5_3; Hong H, 2011, J AM CHEM SOC, V133, P11389, DOI 10.1021/ja204524c; Hong H, 2010, P NATL ACAD SCI USA, V107, P19802, DOI 10.1073/pnas.1010348107; Howarth M, 2006, NAT METHODS, V3, P267, DOI 10.1038/NMETH861; Hubbell WL, 2000, NAT STRUCT BIOL, V7, P735, DOI 10.1038/78956; Jefferson RE, 2013, J AM CHEM SOC, V135, P15183, DOI 10.1021/ja407232b; Jeschke G, 2012, ANNU REV PHYS CHEM, V63, P419, DOI 10.1146/annurev-physchem-032511-143716; Joh NH, 2008, NATURE, V453, P1266, DOI 10.1038/nature06977; Klumb LA, 1998, BIOCHEMISTRY-US, V37, P7657, DOI 10.1021/bi9803123; Krishnamani V, 2012, BIOCHEMISTRY-US, V51, P1051, DOI 10.1021/bi201769z; le Coutre J, 1998, P NATL ACAD SCI USA, V95, P6114, DOI 10.1073/pnas.95.11.6114; Lee JR, 2001, CELL, V107, P161, DOI 10.1016/S0092-8674(01)00526-8; Lemberg MK, 2007, GENOME RES, V17, P1634, DOI 10.1101/gr.6425307; Liu T, 2007, P NATL ACAD SCI USA, V104, P4347, DOI 10.1073/pnas.0607132104; Llinas M, 1999, NAT STRUCT BIOL, V6, P1072; McQuibban GA, 2003, NATURE, V423, P537, DOI 10.1038/nature01633; Min D, 2015, NAT CHEM BIOL, V11, P981, DOI 10.1038/nchembio.1939; Mok YK, 1999, J MOL BIOL, V289, P619, DOI 10.1006/jmbi.1999.2769; MYERS JK, 1995, PROTEIN SCI, V4, P2138, DOI 10.1002/pro.5560041020; Nussinov R, 2013, CELL, V153, P293, DOI 10.1016/j.cell.2013.03.034; Oliveberg M, 2005, Q REV BIOPHYS, V38, P245, DOI 10.1017/S0033583506004185; Otzen DE, 2003, J MOL BIOL, V330, P641, DOI 10.1016/S0022-2836(03)00624-7; Park C, 2004, J MOL BIOL, V343, P1467, DOI 10.1016/j.jmb.2004.08.085; Paslawski W, 2015, P NATL ACAD SCI USA, V112, P7978, DOI 10.1073/pnas.1424751112; Renthal R, 2006, BIOCHEMISTRY-US, V45, P14559, DOI 10.1021/bi0620454; Sekhar A, 2013, P NATL ACAD SCI USA, V110, P12867, DOI 10.1073/pnas.1305688110; Sharon M, 2007, ANNU REV BIOCHEM, V76, P167, DOI 10.1146/annurev.biochem.76.061005.090816; Sherratt AR, 2012, BIOCHEMISTRY-US, V51, P7794, DOI 10.1021/bi301087c; Stevenson LG, 2007, P NATL ACAD SCI USA, V104, P1003, DOI 10.1073/pnas.0608140104; Urban S, 2001, CELL, V107, P173, DOI 10.1016/S0092-8674(01)00525-6; Vosyka O, 2013, P NATL ACAD SCI USA, V110, P2472, DOI 10.1073/pnas.1215076110; Wang YC, 2007, J MOL BIOL, V374, P1104, DOI 10.1016/j.jmb.2007.10.014; Wu ZR, 2006, NAT STRUCT MOL BIOL, V13, P1084, DOI 10.1038/nsmb1179; Xue Y, 2013, J BIOL CHEM, V288, P16645, DOI 10.1074/jbc.M112.438127; Zoll S, 2014, EMBO J, V33, P2408, DOI 10.15252/embj.201489367	52	29	29	1	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAY	2016	12	5					353	+		10.1038/NCHEMBIO.2048	http://dx.doi.org/10.1038/NCHEMBIO.2048			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DJ6KY	26999782	Green Accepted, Green Submitted			2022-12-25	WOS:000374322800010
J	Nader, GPF; Ezratty, EJ; Gundersen, GG				Nader, Guilherme P. F.; Ezratty, Ellen J.; Gundersen, Gregg G.			FAK, talin and PIPKI gamma regulate endocytosed integrin activation to polarize focal adhesion assembly	NATURE CELL BIOLOGY			English	Article							PHOSPHATIDYLINOSITOL PHOSPHATE KINASE; CELL-MIGRATION; TYROSINE PHOSPHORYLATION; ALPHA-5-BETA-1 INTEGRIN; FIBRONECTIN RECEPTOR; FIBROBLAST MIGRATION; 3D MICROENVIRONMENTS; DYNAMICS; SRC; MEMBRANE	Integrin endocytic recycling is critical for cell migration, yet how recycled integrins assemble into new adhesions is unclear. By synchronizing endocytic disassembly of focal adhesions (FAs), we find that recycled integrins reassemble FAs coincident with their return to the cell surface and dependent on Rab5 and Rab11. Unexpectedly, endocytosed integrins remained in an active but unliganded state in endosomes. FAK and Src kinases co-localized with endocytosed integrin and were critical for FA reassembly by regulating integrin activation and recycling, respectively. FAK sustained the active integrin conformation by maintaining talin association with Rab11 endosomes in a type I phosphatidylinositol phosphate kinase (PIPKI gamma)-dependent manner. In migrating cells, endocytosed integrins reassembled FAs polarized towards the leading edge, and this polarization required FAK. These studies identify unanticipated roles for FA proteins in maintaining endocytosed integrin in an active conformation. We propose that the conformational memory of endocytosed integrin enhances polarized reassembly of FAs to enable directional cell migration.	[Nader, Guilherme P. F.; Ezratty, Ellen J.; Gundersen, Gregg G.] Columbia Univ, Dept Pathol & Cell Biol, P&S 15-420,630 West 168th St, New York, NY 10032 USA	Columbia University	Gundersen, GG (corresponding author), Columbia Univ, Dept Pathol & Cell Biol, P&S 15-420,630 West 168th St, New York, NY 10032 USA.	ggg1@columbia.edu			NIH [GM062939, GM099481]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099481, R01GM062939] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank G. DiPaolo and E. Marcantonio for suggestions and R. Horwitz (Allen Institute for Cell Science, USA), J. Goldenring (Vanderbilt University, USA), D. Calderwood (Yale University, USA), D. Schlaepfer (University of California, San Diego, USA) and R. Anderson (University of Wisconsin-Madison, USA) for reagents. This work was supported by NIH grants GM062939 and GM099481 to G.G.G.	Alanko J, 2015, NAT CELL BIOL, V17, P1412, DOI 10.1038/ncb3250; Belleudi F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029159; Berginski ME, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022025; Bouaouina M, 2008, J BIOL CHEM, V283, P6118, DOI 10.1074/jbc.M709527200; Bouaouina M, 2011, METHODS MOL BIOL, V757, P325, DOI 10.1007/978-1-61779-166-6_20; Brenner KA, 2000, ONCOGENE, V19, P3156, DOI 10.1038/sj.onc.1203626; BRETSCHER MS, 1989, EMBO J, V8, P1341, DOI 10.1002/j.1460-2075.1989.tb03514.x; Bretscher MS, 1998, CURR OPIN CELL BIOL, V10, P537, DOI 10.1016/S0955-0674(98)80070-7; BRETSCHER MS, 1992, EMBO J, V11, P405, DOI 10.1002/j.1460-2075.1992.tb05068.x; Burridge K, 1997, TRENDS CELL BIOL, V7, P342, DOI 10.1016/S0962-8924(97)01127-6; Byron A, 2009, J CELL SCI, V122, P4009, DOI 10.1242/jcs.056770; Caswell PT, 2008, J CELL BIOL, V183, P143, DOI 10.1083/jcb.200804140; Caswell PT, 2007, DEV CELL, V13, P496, DOI 10.1016/j.devcel.2007.08.012; Caswell PT, 2009, NAT REV MOL CELL BIO, V10, P843, DOI 10.1038/nrm2799; Chao WT, 2010, MOL CELL BIOL, V30, P4463, DOI 10.1128/MCB.01207-09; Chao WT, 2009, FEBS LETT, V583, P1337, DOI 10.1016/j.febslet.2009.03.037; ChrzanowskaWodnicka M, 1996, J CELL BIOL, V133, P1403, DOI 10.1083/jcb.133.6.1403; CROWLEY E, 1995, J CELL BIOL, V131, P525, DOI 10.1083/jcb.131.2.525; Di Paolo G, 2002, NATURE, V420, P85, DOI 10.1038/nature01147; Ezratty EJ, 2005, NAT CELL BIOL, V7, P581, DOI 10.1038/ncb1262; Ezratty EJ, 2009, J CELL BIOL, V187, P733, DOI 10.1083/jcb.200904054; Franco S, 2004, EXP CELL RES, V299, P179, DOI 10.1016/j.yexcr.2004.05.021; Franco SJ, 2004, NAT CELL BIOL, V6, P977, DOI 10.1038/ncb1175; GAILIT J, 1988, J BIOL CHEM, V263, P12927; Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593; Goksoy E, 2008, MOL CELL, V31, P124, DOI 10.1016/j.molcel.2008.06.011; Gomes ER, 2006, METHOD ENZYMOL, V406, P579, DOI 10.1016/S0076-6879(06)06045-9; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; Ilic D, 1998, J CELL BIOL, V143, P547; ILLC D, 1995, NATURE, V377, P539; Junutula JR, 2004, J BIOL CHEM, V279, P33430, DOI 10.1074/jbc.M404633200; KAPLAN KB, 1992, J CELL BIOL, V118, P321, DOI 10.1083/jcb.118.2.321; Kim C, 2011, ANNU REV CELL DEV BI, V27, P321, DOI 10.1146/annurev-cellbio-100109-104104; Laukaitis CM, 2001, J CELL BIOL, V153, P1427, DOI 10.1083/jcb.153.7.1427; Lawson C, 2012, J CELL BIOL, V196, P223, DOI 10.1083/jcb.201108078; Li J, 2005, DEV CELL, V9, P663, DOI 10.1016/j.devcel.2005.09.012; Ling K, 2003, J CELL BIOL, V163, P1339, DOI 10.1083/jcb.200310067; Ling K, 2002, NATURE, V420, P89, DOI 10.1038/nature01082; Lobert VH, 2010, DEV CELL, V19, P148, DOI 10.1016/j.devcel.2010.06.010; Martel V, 2001, J BIOL CHEM, V276, P21217, DOI 10.1074/jbc.M102373200; Michael KE, 2009, MOL BIOL CELL, V20, P2508, DOI 10.1091/mbc.E08-01-0076; Mohl C, 2012, J CELL SCI, V125, P155, DOI 10.1242/jcs.090746; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Pellinen T, 2006, J CELL BIOL, V173, P767, DOI 10.1083/jcb.200509019; Powelka AM, 2004, TRAFFIC, V5, P20, DOI 10.1111/j.1600-0854.2004.00150.x; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Roberts M, 2001, CURR BIOL, V11, P1392, DOI 10.1016/S0960-9822(01)00442-0; Roberts MS, 2004, MOL CELL BIOL, V24, P1505, DOI 10.1128/MCB.24.4.1505-1515.2004; Ross TD, 2013, CURR OPIN CELL BIOL, V25, P613, DOI 10.1016/j.ceb.2013.05.006; Sandilands E, 2004, DEV CELL, V7, P855, DOI 10.1016/j.devcel.2004.09.019; Sandilands E, 2007, EMBO REP, V8, P1162, DOI 10.1038/sj.embor.7401097; Sandilands E, 2007, J CELL SCI, V120, P2555, DOI 10.1242/jcs.003657; Schill NJ, 2009, BIOCHEM J, V422, P473, DOI 10.1042/BJ20090638; Schiller HB, 2013, EMBO REP, V14, P509, DOI 10.1038/embor.2013.49; Schober M, 2007, J CELL BIOL, V176, P667, DOI 10.1083/jcb.200608010; Shattil SJ, 2010, NAT REV MOL CELL BIO, V11, P288, DOI 10.1038/nrm2871; Sieg DJ, 1999, J CELL SCI, V112, P2677; Slack-Davis JK, 2007, J BIOL CHEM, V282, P14845, DOI 10.1074/jbc.M606695200; Smilenov LB, 1999, SCIENCE, V286, P1172, DOI 10.1126/science.286.5442.1172; Sonoda Y, 2000, J BIOL CHEM, V275, P16309, DOI 10.1074/jbc.275.21.16309; Stehbens SJ, 2014, NAT CELL BIOL, V16, P558, DOI 10.1038/ncb2975; Takino T, 2004, CANCER RES, V64, P1044, DOI 10.1158/0008-5472.CAN-03-1843; Vicente-Manzanares M, 2009, NAT REV MOL CELL BIO, V10, P778, DOI 10.1038/nrm2786; Wang Y, 2011, MOL BIOL CELL, V22, P1529, DOI 10.1091/mbc.E10-09-0785; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; White DP, 2007, J CELL BIOL, V177, P515, DOI 10.1083/jcb.200609004; Wu XY, 2008, CELL, V135, P137, DOI 10.1016/j.cell.2008.07.045; Yeo MG, 2006, MOL CELL BIOL, V26, P4399, DOI 10.1128/MCB.01147-05; Yue JP, 2014, DEV CELL, V31, P572, DOI 10.1016/j.devcel.2014.10.025	69	94	97	1	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAY	2016	18	5					491	+		10.1038/ncb3333	http://dx.doi.org/10.1038/ncb3333			29	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	DK3RH	27043085				2022-12-25	WOS:000374834600007
J	Whalen, S; Truty, RM; Pollard, KS				Whalen, Sean; Truty, Rebecca M.; Pollard, Katherine S.			Enhancer-promoter interactions are encoded by complex genomic signatures on looping chromatin	NATURE GENETICS			English	Article							HUMAN GENETIC-VARIATION; TRANSCRIPTION FACTOR; POLYCOMB; BINDING; DISCOVERY; VARIANTS; PROTEIN; CLASSIFICATION; COACTIVATOR; ANNOTATION	Discriminating the gene target of a distal regulatory element from other nearby transcribed genes is a challenging problem with the potential to illuminate the causal underpinnings of complex diseases. We present TargetFinder, a computational method that reconstructs regulatory landscapes from diverse features along the genome. The resulting models accurately predict individual enhancer-promoter interactions across multiple cell lines with a false discovery rate up to 15 times smaller than that obtained using the closest gene. By evaluating the genomic features driving this accuracy, we uncover interactions between structural proteins, transcription factors, epigenetic modifications, and transcription that together distinguish interacting from non-interacting enhancer-promoter pairs. Most of this signature is not proximal to the enhancers and promoters but instead decorates the looping DNA. We conclude that complex but consistent combinations of marks on the one-dimensional genome encode the three-dimensional structure of fine-scale regulatory interactions.	[Whalen, Sean; Pollard, Katherine S.] Gladstone Inst, San Francisco, CA USA; [Whalen, Sean; Pollard, Katherine S.] Univ Calif San Francisco, Div Biostat, Inst Human Genet, San Francisco, CA 94143 USA; [Whalen, Sean; Pollard, Katherine S.] Univ Calif San Francisco, Inst Computat Hlth Sci, San Francisco, CA 94143 USA; [Truty, Rebecca M.] Invitae Corp, San Francisco, CA USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Whalen, S; Pollard, KS (corresponding author), Gladstone Inst, San Francisco, CA USA.; Whalen, S; Pollard, KS (corresponding author), Univ Calif San Francisco, Div Biostat, Inst Human Genet, San Francisco, CA 94143 USA.; Whalen, S; Pollard, KS (corresponding author), Univ Calif San Francisco, Inst Computat Hlth Sci, San Francisco, CA 94143 USA.	sean.whalen@gladstone.ucsf.edu; kpollard@gladstone.ucsf.edu			NHLBI [U01HL098179, UM1HL098179]; NIH/NHLBI [HL089707]; San Simeon Fund; Gladstone Institutes; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL089707, U01HL098179, UM1HL098179] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH109907] Funding Source: NIH RePORTER	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); San Simeon Fund; Gladstone Institutes(University of California System); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This project was supported by the Bench to Bassinet Program of the NHLBI (U01HL098179 and UM1HL098179), the NIH/NHLBI (HL089707), the San Simeon Fund, and the Gladstone Institutes.	Adelman K, 2012, NAT REV GENET, V13, P720, DOI 10.1038/nrg3293; Alexandrov NN, 2006, PLANT MOL BIOL, V60, P69, DOI 10.1007/s11103-005-2564-9; Ambroise C, 2002, P NATL ACAD SCI USA, V99, P6562, DOI 10.1073/pnas.102102699; Aran D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-3-r21; Bailey SD, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7186; Benveniste D, 2014, P NATL ACAD SCI USA, V111, P13367, DOI 10.1073/pnas.1412081111; Bernstein BE, 2010, NAT BIOTECHNOL, V28, P1045, DOI 10.1038/nbt1010-1045; Bertolino E, 2002, MOL CELL, V10, P397, DOI 10.1016/S1097-2765(02)00597-X; Blackwood EM, 1998, SCIENCE, V281, P60, DOI 10.1126/science.281.5373.60; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Burges CJC, 1998, DATA MIN KNOWL DISC, V2, P121, DOI 10.1023/A:1009715923555; Celniker SE, 2009, NATURE, V459, P927, DOI 10.1038/459927a; Corradin O, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0085-3; de Wit E, 2012, GENE DEV, V26, P11, DOI 10.1101/gad.179804.111; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Deshane J, 2010, J BIOL CHEM, V285, P16476, DOI 10.1074/jbc.M109.058586; Dixon JR, 2015, NATURE, V518, P331, DOI 10.1038/nature14222; Dorsett D, 2014, CURR BIOL, V24, pR535, DOI 10.1016/j.cub.2014.04.037; Dostie J, 2006, GENOME RES, V16, P1299, DOI 10.1101/gr.5571506; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ernst J, 2012, NAT METHODS, V9, P215, DOI 10.1038/nmeth.1906; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Fabre PJ, 2015, P NATL ACAD SCI USA, V112, P13964, DOI 10.1073/pnas.1517972112; Frazer KA, 2009, NAT REV GENET, V10, P241, DOI 10.1038/nrg2554; Friedman J., 2001, ELEMENTS STAT LEARNI, DOI DOI 10.1007/978-0-387-84858-7; Friedman JH, 2002, COMPUT STAT DATA AN, V38, P367, DOI 10.1016/S0167-9473(01)00065-2; Fujioka S, 2004, MOL CELL BIOL, V24, P7806, DOI 10.1128/MCB.24.17.7806-7819.2004; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; Gulko B, 2015, NAT GENET, V47, P276, DOI 10.1038/ng.3196; Gusev A, 2014, AM J HUM GENET, V95, P535, DOI 10.1016/j.ajhg.2014.10.004; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; Hanlon M, 1999, J BIOL CHEM, V274, P14224, DOI 10.1074/jbc.274.20.14224; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Hillier LW, 2008, NAT METHODS, V5, P183, DOI 10.1038/NMETH.1179; Hoffman MM, 2012, NAT METHODS, V9, P473, DOI [10.1038/NMETH.1937, 10.1038/nmeth.1937]; Ing-Simmons E, 2015, GENOME RES, V25, P504, DOI 10.1101/gr.184986.114; Islam ABMMK, 2011, CELL CYCLE, V10, P413, DOI 10.4161/cc.10.3.14705; Jozwik KM, 2012, NAT REV CANCER, V12, P381, DOI 10.1038/nrc3263; Kingsford C, 2008, NAT BIOTECHNOL, V26, P1011, DOI 10.1038/nbt0908-1011; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Kvon EZ, 2014, NATURE, V512, P91, DOI 10.1038/nature13395; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Lettice LA, 2003, HUM MOL GENET, V12, P1725, DOI 10.1093/hmg/ddg180; Levine SS, 2002, MOL CELL BIOL, V22, P6070, DOI 10.1128/MCB.22.17.6070-6078.2002; Li QH, 2011, ANN APPL STAT, V5, P1752, DOI 10.1214/11-AOAS466; Lindblad-Toh K, 2011, NATURE, V478, P476, DOI 10.1038/nature10530; Listman JA, 2005, J BIOL CHEM, V280, P41421, DOI 10.1074/jbc.M509143200; Liu Z, 2011, CELL, V146, P720, DOI 10.1016/j.cell.2011.08.005; Lomelin D, 2010, GENOME RES, V20, P311, DOI 10.1101/gr.094151.109; MacPherson MJ, 2009, MOL CELL BIOL, V29, P714, DOI 10.1128/MCB.00825-08; Manolio TA, 2008, J CLIN INVEST, V118, P1590, DOI 10.1172/JCI34772; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Massouras A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003055; Maston GA, 2006, ANNU REV GENOM HUM G, V7, P29, DOI 10.1146/annurev.genom.7.080505.115623; McKinney W., 2012, PYTHON DATA ANAL DAT; Michaud J, 2013, GENOME RES, V23, P907, DOI 10.1101/gr.150078.112; Mifsud B, 2015, NAT GENET, V47, P598, DOI 10.1038/ng.3286; Moore BL, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0661-x; Nimura K, 2009, NATURE, V460, P287, DOI 10.1038/nature08086; Niskanen EA, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0717-y; Nolis IK, 2009, P NATL ACAD SCI USA, V106, P20222, DOI 10.1073/pnas.0902454106; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ramskold D, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000598; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Rodelsperger C, 2011, NUCLEIC ACIDS RES, V39, P2492, DOI 10.1093/nar/gkq1081; Sanyal A, 2012, NATURE, V489, P109, DOI 10.1038/nature11279; Schaub MA, 2012, GENOME RES, V22, P1748, DOI 10.1101/gr.136127.111; Schoenfelder S, 2015, GENOME RES, V25, P582, DOI 10.1101/gr.185272.114; Schwartz C, 2003, EMBO J, V22, P882, DOI 10.1093/emboj/cdg076; Sharma MJ, 2003, EMBO J, V22, P6101, DOI 10.1093/emboj/cdg585; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Tang RQ, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r25; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Upadhyay G, 2014, P NATL ACAD SCI USA, V111, P8071, DOI 10.1073/pnas.1404292111; van Riel B, 2014, BIOL CHEM, V395, P1265, DOI 10.1515/hsz-2014-0195; Vernimmen D, 2011, GENE DEV, V25, P1583, DOI 10.1101/gad.16985411; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Wang D, 2013, NUCLEIC ACIDS RES, V41, P1450, DOI 10.1093/nar/gks1339; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Wilczynski B, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002798; Yip KY, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r48; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhang YB, 2013, NATURE, V504, P306, DOI 10.1038/nature12716	86	207	213	1	49	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2016	48	5					488	+		10.1038/ng.3539	http://dx.doi.org/10.1038/ng.3539			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DK3RC	27064255	Green Submitted, Green Accepted			2022-12-25	WOS:000374834100006
J	Xiao, Y; Bowen, CH; Liu, D; Zhang, FZ				Xiao, Yi; Bowen, Christopher H.; Liu, Di; Zhang, Fuzhong			Exploiting nongenetic cell-to-cell variation for enhanced biosynthesis	NATURE CHEMICAL BIOLOGY			English	Article							ESCHERICHIA-COLI; SYNTHETIC BIOLOGY; FATTY-ACIDS; POPULATION HETEROGENEITY; METABOLIC VARIABILITY; SINGLE CELLS; AMINO-ACIDS; E. COLI; EVOLUTION; PATHWAYS	Biosynthesis enables renewable production of manifold compounds, yet often biosynthetic performance must be improved for it to be economically feasible. Nongenetic, cell-to-cell variations in protein and metabolite concentrations are naturally inherent, suggesting the existence of both high- and low-performance variants in all cultures. Although having an intrinsic source of low performers might cause suboptimal ensemble biosynthesis, the existence of high performers suggests an avenue for performance enhancement. Here we develop in vivo population quality control (PopQC) to continuously select for high- performing, nongenetic variants. We apply PopQC to two biosynthetic pathways using two alternative design principles and demonstrate threefold enhanced production of both free fatty acid (FFA) and tyrosine. We confirm that PopQC improves ensemble biosynthesis by selecting for nongenetic high performers. Additionally, we use PopQC in fed-batch FFA production and achieve 21.5 g I-1 titer and 0.5 g I-1 h(-1) productivity. Given the ubiquity of nongenetic variation, PopQC should be applicable to a variety of metabolic pathways for enhanced biosynthesis.	[Xiao, Yi; Bowen, Christopher H.; Liu, Di; Zhang, Fuzhong] Washington Univ, Dept Energy Environm & Chem Engn, St Louis, MO USA; [Zhang, Fuzhong] Washington Univ, Div Biol & Biomed Sci, St Louis, MO USA; [Zhang, Fuzhong] Washington Univ, Inst Mat Sci & Engn, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Zhang, FZ (corresponding author), Washington Univ, Dept Energy Environm & Chem Engn, St Louis, MO USA.; Zhang, FZ (corresponding author), Washington Univ, Div Biol & Biomed Sci, St Louis, MO USA.; Zhang, FZ (corresponding author), Washington Univ, Inst Mat Sci & Engn, St Louis, MO USA.	fzhang@seas.wustl.edu		Zhang, Fuzhong/0000-0001-6979-7909; Xiao, Yi/0000-0002-5232-8513	Washington University; Defense Advanced Research Projects Agency [D13AP00038]; National Science Foundation [MCB1453147, MCB1331194]; Human Frontier Science Program [RGY0076/2015]; International Center for Advanced Renewable Energy and Sustainability (I-CARES)	Washington University; Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); National Science Foundation(National Science Foundation (NSF)); Human Frontier Science Program(Human Frontier Science Program); International Center for Advanced Renewable Energy and Sustainability (I-CARES)	The authors acknowledge D. Liu at Harvard University for the GFP reporter gene. The authors would like to thank K. Naegle, C. Immethun, A. Hoynes-O'Connor, D. Giblin, F.-F. Hsu and E. Lantelme for technical assistance and the Genome Technology Access Center in the Department of Genetics at Washington University School of Medicine for helping with genomic analysis. This work was supported by a start-up package from Washington University, the Defense Advanced Research Projects Agency (D13AP00038 to F.Z.), the National Science Foundation (MCB1453147 and MCB1331194, both to F.Z.), the Human Frontier Science Program (RGY0076/2015 to F.Z.) and the International Center for Advanced Renewable Energy and Sustainability (I-CARES).	Barber WP, 1999, WATER RES, V33, P1559, DOI 10.1016/S0043-1354(98)00371-6; Blazeck J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4131; Chou HH, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3595; Conrad TM, 2010, P NATL ACAD SCI USA, V107, P20500, DOI 10.1073/pnas.0911253107; Dahl RH, 2013, NAT BIOTECHNOL, V31, P1039, DOI 10.1038/nbt.2689; Delvigne F, 2014, TRENDS BIOTECHNOL, V32, P608, DOI 10.1016/j.tibtech.2014.10.002; Dietrich JA, 2013, ACS SYNTH BIOL, V2, P47, DOI 10.1021/sb300091d; Doroshenko V, 2007, FEMS MICROBIOL LETT, V275, P312, DOI 10.1111/j.1574-6968.2007.00894.x; Engler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003647; Fernandes RL, 2011, BIOTECHNOL ADV, V29, P575, DOI 10.1016/j.biotechadv.2011.03.007; Foster PL, 2007, CRIT REV BIOCHEM MOL, V42, P373, DOI 10.1080/10409230701648494; Gronenberg LS, 2013, CURR OPIN CHEM BIOL, V17, P462, DOI 10.1016/j.cbpa.2013.03.037; Guimaraes JC, 2014, NUCLEIC ACIDS RES, V42, P4791, DOI 10.1093/nar/gku126; Jablonka E, 2009, Q REV BIOL, V84, P131, DOI 10.1086/598822; Juminaga D, 2012, APPL ENVIRON MICROB, V78, P89, DOI 10.1128/AEM.06017-11; Keasling JD, 2010, SCIENCE, V330, P1355, DOI 10.1126/science.1193990; Kempe K, 1996, J BIOL CHEM, V271, P17287, DOI 10.1074/jbc.271.29.17287; Kim E, 2015, NAT CHEM BIOL, V11, P649, DOI [10.1038/NCHEMBIO.1893, 10.1038/nchembio.1893]; Kiviet DJ, 2014, NATURE, V514, P376, DOI 10.1038/nature13582; Labhsetwar P, 2013, P NATL ACAD SCI USA, V110, P14006, DOI 10.1073/pnas.1222569110; Lawrence MS, 2007, J AM CHEM SOC, V129, P10110, DOI 10.1021/ja071641y; Lee TS, 2011, J BIOL ENG, V5, DOI 10.1186/1754-1611-5-12; Levine E, 2007, P NATL ACAD SCI USA, V104, P9224, DOI 10.1073/pnas.0610987104; Li GW, 2011, NATURE, V475, P308, DOI 10.1038/nature10315; Lidstrom ME, 2010, NAT CHEM BIOL, V6, P705, DOI [10.1038/NCHEMBIO.436, 10.1038/nchembio.436]; Liu D, 2015, ACS SYNTH BIOL, V4, P132, DOI 10.1021/sb400158w; Love KR, 2010, BIOTECHNOL BIOENG, V106, P319, DOI 10.1002/bit.22688; Lu XF, 2008, METAB ENG, V10, P333, DOI 10.1016/j.ymben.2008.08.006; Luetke-Eversloh T, 2007, APPL MICROBIOL BIOT, V77, P751, DOI 10.1007/s00253-007-1243-y; Muller S, 2010, CURR OPIN BIOTECH, V21, P100, DOI 10.1016/j.copbio.2010.01.002; Mustafi N, 2012, METAB ENG, V14, P449, DOI 10.1016/j.ymben.2012.02.002; Na D, 2013, NAT BIOTECHNOL, V31, P170, DOI 10.1038/nbt.2461; Nakata K, 2010, APPL MICROBIOL BIOT, V87, P1895, DOI 10.1007/s00253-010-2638-8; Nielsen J, 2014, NAT CHEM BIOL, V10, P319, DOI 10.1038/nchembio.1519; Oyarzun DA, 2015, ACS SYNTH BIOL, V4, P116, DOI 10.1021/sb400126a; Paddon CJ, 2014, NAT REV MICROBIOL, V12, P355, DOI 10.1038/nrmicro3240; Paige JS, 2012, SCIENCE, V335, P1194, DOI 10.1126/science.1218298; Pittard J, 2005, MOL MICROBIOL, V55, P16, DOI 10.1111/j.1365-2958.2004.04385.x; Raman S, 2014, P NATL ACAD SCI USA, V111, P17803, DOI 10.1073/pnas.1409523111; Schirmer A, 2010, SCIENCE, V329, P559, DOI 10.1126/science.1187936; Tanaka A, 1990, Adv Biochem Eng Biotechnol, V42, P97; Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308; van Heerden JH, 2014, SCIENCE, V343, P987, DOI 10.1126/science.1245114; Veening JW, 2008, ANNU REV MICROBIOL, V62, P193, DOI 10.1146/annurev.micro.62.081307.163002; Wang BL, 2014, NAT BIOTECHNOL, V32, P473, DOI 10.1038/nbt.2857; Woolston BM, 2013, ANNU REV CHEM BIOMOL, V4, P259, DOI 10.1146/annurev-chembioeng-061312-103312; Xu P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2425; Zenobi R, 2013, SCIENCE, V342, P1201, DOI 10.1126/science.1243259; Zhang FZ, 2012, NAT BIOTECHNOL, V30, P354, DOI 10.1038/nbt.2149; Zhang FZ, 2011, TRENDS MICROBIOL, V19, P323, DOI 10.1016/j.tim.2011.05.003	50	140	153	5	125	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	MAY	2016	12	5					339	+		10.1038/NCHEMBIO.2046	http://dx.doi.org/10.1038/NCHEMBIO.2046			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DJ6KY	26999780				2022-12-25	WOS:000374322800008
J	Speciale, G; Jin, Y; Davies, GJ; Williams, SJ; Goddard-Borger, ED				Speciale, Gaetano; Jin, Yi; Davies, Gideon J.; Williams, Spencer J.; Goddard-Borger, Ethan D.			YihQ is a sulfoquinovosidase that cleaves sulfoquinovosyl diacylglyceride sulfolipids	NATURE CHEMICAL BIOLOGY			English	Article							SULFUR CYCLE; ESCHERICHIA-COLI; GLUCOSIDASES; DEGRADATION; PROTEINS; BACTERIA; CULTURES	Sulfoquinovose is produced by photosynthetic organisms at a rate of 10(10) tons per annum and is degraded by bacteria as a source of carbon and sulfur. We have identified Escherichia coli YihQ as the first dedicated sulfoquinovosidase and the gateway enzyme to sulfoglycolytic pathways. Structural and mutagenesis studies unveiled the sequence signatures for binding the distinguishing sulfonate residue and revealed that sulfoquinovoside degradation is widespread across the tree of life.	[Speciale, Gaetano; Williams, Spencer J.] Univ Melbourne, Sch Chem, Parkville, Vic 3052, Australia; [Speciale, Gaetano; Williams, Spencer J.] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3052, Australia; [Jin, Yi; Davies, Gideon J.] Univ York, Dept Chem, York YO10 5DD, N Yorkshire, England; [Goddard-Borger, Ethan D.] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, ACRF Chem Biol Div, Parkville, Vic 3050, Australia; [Goddard-Borger, Ethan D.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3052, Australia	University of Melbourne; University of Melbourne; University of York - UK; Royal Melbourne Hospital; Walter & Eliza Hall Institute; University of Melbourne	Goddard-Borger, ED (corresponding author), Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, ACRF Chem Biol Div, Parkville, Vic 3050, Australia.; Goddard-Borger, ED (corresponding author), Univ Melbourne, Dept Med Biol, Parkville, Vic 3052, Australia.	goddard-borger.e@wehi.edu.au	Davies, Gideon J/A-9042-2011; Jin 金轶, Yi/J-7748-2016; Williams, Spencer/C-3545-2009	Davies, Gideon J/0000-0002-7343-776X; Jin 金轶, Yi/0000-0002-6927-4371; Williams, Spencer/0000-0001-6341-4364; Speciale, Gaetano/0000-0001-6354-605X; Goddard-Borger, Ethan/0000-0002-8181-9733	UK Biotechnology and Biological Sciences Research Council; European Research Council [AdG-322942]; Australian Research Council; Ramaciotti Foundation; Victorian Endowment for Science Knowledge and Innovation; Australian Cancer Research Foundation; Victorian State Government Operational Infrastructure Support, NHMRC IRIISS grant [9000220]	UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Research Council(European Research Council (ERC)European Commission); Australian Research Council(Australian Research Council); Ramaciotti Foundation; Victorian Endowment for Science Knowledge and Innovation; Australian Cancer Research Foundation; Victorian State Government Operational Infrastructure Support, NHMRC IRIISS grant(National Health and Medical Research Council (NHMRC) of Australia)	We thank S.G. Withers for the gift of 5-fluoro-beta-L-idopyranosyl fluoride and N.A. Williamson for technical assistance. This work was supported by grants from the UK Biotechnology and Biological Sciences Research Council and the European Research Council (AdG-322942 to G.J.D.), the Australian Research Council (to S.J.W.), the Ramaciotti Foundation and the Victorian Endowment for Science Knowledge and Innovation, with additional support from the Australian Cancer Research Foundation and Victorian State Government Operational Infrastructure Support, NHMRC IRIISS grant 9000220 (to E.D.G.-B.). We thank the Diamond Light Source (Didcot, UK) for access to beamlines IO4, IO4-1 and IO2 (proposal number mx-9948).	Andersson L, 1996, BBA-LIPID LIPID MET, V1302, P236, DOI 10.1016/0005-2760(96)00068-9; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Benning C, 1998, ANNU REV PLANT PHYS, V49, P53, DOI 10.1146/annurev.arplant.49.1.53; Celniker G, 2013, ISR J CHEM, V53, P199, DOI 10.1002/ijch.201200096; Collaborative Computational Project, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112; Davies GJ, 2012, ACCOUNTS CHEM RES, V45, P308, DOI 10.1021/ar2001765; Denger K, 2014, NATURE, V507, P114, DOI 10.1038/nature12947; Denger K, 2012, FEMS MICROBIOL LETT, V328, P39, DOI 10.1111/j.1574-6968.2011.02477.x; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Durham BP, 2015, P NATL ACAD SCI USA, V112, P453, DOI 10.1073/pnas.1413137112; Felux AK, 2015, P NATL ACAD SCI USA, V112, pE4298, DOI 10.1073/pnas.1507049112; Harwood JL, 1979, BIOCHEM SOC T, V7, P440, DOI 10.1042/bst0070440; Lee SS, 2002, J AM CHEM SOC, V124, P4948, DOI 10.1021/ja0255610; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; MARTELLI HL, 1964, BIOCHIM BIOPHYS ACTA, V93, P169, DOI 10.1016/0304-4165(64)90272-7; McCarter JD, 1996, J AM CHEM SOC, V118, P241, DOI 10.1021/ja952732a; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; Okuyama M, 2004, PROTEIN EXPRES PURIF, V37, P170, DOI 10.1016/j.pep.2004.05.008; Okuyama M, 2001, EUR J BIOCHEM, V268, P2270, DOI 10.1046/j.1432-1327.2001.02104.x; QUARONI A, 1976, J BIOL CHEM, V251, P3250; Roy AB, 2003, APPL ENVIRON MICROB, V69, P6434, DOI 10.1128/AEM.69.11.6434-6441.2003; SHIBUYA I, 1961, NATURE, V192, P1186, DOI 10.1038/1921186a0; Shimojima M, 2011, PROG LIPID RES, V50, P234, DOI 10.1016/j.plipres.2011.02.003; Speciale G, 2014, CURR OPIN STRUC BIOL, V28, P1, DOI 10.1016/j.sbi.2014.06.003; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Sugimoto K, 2007, FEBS LETT, V581, P4519, DOI 10.1016/j.febslet.2007.08.035; Tagami T, 2013, J BIOL CHEM, V288, P19296, DOI 10.1074/jbc.M113.465211; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701	28	38	39	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	APR	2016	12	4					215	+		10.1038/NCHEMBIO.2023	http://dx.doi.org/10.1038/NCHEMBIO.2023			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH2DA	26878550	Green Accepted			2022-12-25	WOS:000372593200006
J	Li, QS; Zhang, Y; Pluchon, P; Robens, J; Herr, K; Mercade, M; Thiery, JP; Yu, H; Viasnoff, V				Li, Qiushi; Zhang, Yue; Pluchon, Perrine; Robens, Jeffrey; Herr, Keira; Mercade, Myriam; Thiery, Jean-Paul; Yu, Hanry; Viasnoff, Virgile			Extracellular matrix scaffolding guides lumen elongation by inducing anisotropic intercellular mechanical tension	NATURE CELL BIOLOGY			English	Article							EPITHELIAL MORPHOGENESIS; HEPATOCYTE POLARIZATION; MOLECULAR-MECHANISMS; RAT HEPATOCYTES; BILE FORMATION; LONG-TERM; LIVER; POLARITY; CHOLESTASIS; SECRETION	The de novo formation of secretory lumens plays an important role during organogenesis. It involves the establishment of a cellular apical pole(1) and the elongation of luminal cavities(2). The molecular parameters controlling cell polarization have been heavily scrutinized(3-5). In particular, signalling from the extracellular matrix (ECM) proved essential to the proper localization of the apical pole by directed protein transport(6). However, little is known about the regulation of the shape and the directional development of lumen into tubes. We demonstrate that the spatial scaffolding of cells by ECM can control tube shapes and can direct their elongation. We developed a minimal organ approach comprising of hepatocyte doublets cultured in artificial microniches to precisely control the spatial organization of cellular adhesions in three dimensions. This approach revealed a mechanism by which the spatial repartition of integrin-based adhesion can elicit an anisotropic intercellular mechanical stress guiding the osmotically driven elongation of lumens in the direction of minimal tension. This mechanical guidance accounts for the different morphologies of lumen in various microenvironmental conditions.	[Li, Qiushi; Zhang, Yue; Robens, Jeffrey; Yu, Hanry; Viasnoff, Virgile] Natl Univ Singapore, Mechanobiol Inst, Singapore 117411, Singapore; [Pluchon, Perrine; Viasnoff, Virgile] Natl Univ Singapore, Dept Biol Sci, Singapore 117411, Singapore; [Herr, Keira; Thiery, Jean-Paul; Viasnoff, Virgile] ASTAR, Inst Mol Cell Biol, 61 Biopolis Dr, Singapore 138673, Singapore; [Mercade, Myriam] Univ Toulouse, Lab Ingn Syst Biol & Proc, INSA, INRA,CNRS, F-31077 Toulouse, France; [Yu, Hanry] Natl Univ Hlth Syst, Dept Physiol, Yong Loo Lin Sch Med, Singapore 117597, Singapore; [Yu, Hanry] Agcy Sci Technol & Res, IBN, Singapore 138669, Singapore; [Viasnoff, Virgile] CNRS, UMI3639, Singapore 117411, Singapore	National University of Singapore; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS); National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Bioengineering & Bioimaging (IBB); A*STAR - Institute of Bioengineering & Nanotechnology (IBN)	Viasnoff, V (corresponding author), Natl Univ Singapore, Mechanobiol Inst, Singapore 117411, Singapore.; Viasnoff, V (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore 117411, Singapore.; Viasnoff, V (corresponding author), ASTAR, Inst Mol Cell Biol, 61 Biopolis Dr, Singapore 138673, Singapore.; Viasnoff, V (corresponding author), CNRS, UMI3639, Singapore 117411, Singapore.	dbsvvnr@nus.edu.sg	Yu, Hanry/L-6050-2019; viasnoff, virgile/H-8832-2012; Robens, Jeffrey/K-4621-2019; Thiery, Jean Paul/M-9387-2019; Yu, Hanry/C-1031-2013; Thiery, Jean Paul/H-1550-2011	Yu, Hanry/0000-0002-0339-3685; viasnoff, virgile/0000-0003-3949-2244; Robens, Jeffrey/0000-0003-2344-0036; Yu, Hanry/0000-0002-0339-3685; Thiery, Jean Paul/0000-0003-0478-5020	MBI; IBN; NRF [CRP 001-084]; ANR	MBI; IBN; NRF; ANR(French National Research Agency (ANR))	The authors thank S. Wolf, A. Wong and L. Bulavina for their help with manuscript writing and illustration. We thank J. J. Fan and S. Mo for in vivo imaging. We thank T. Saunders and R. Zaidel-Bar for insightful comments on the manuscripts. This work was supported mostly by MBI and IBN core funding, NRF grant CRP 001-084, and ANR grant Defis generique 2014.	Akhtar N, 2013, NAT CELL BIOL, V15, P17, DOI 10.1038/ncb2646; Bayless KJ, 2002, J CELL SCI, V115, P1123; Boyer JL, 2013, COMPR PHYSIOL, V3, P1035, DOI 10.1002/cphy.c120027; Bryant DM, 2008, NAT REV MOL CELL BIO, V9, P887, DOI 10.1038/nrm2523; Bryant DM, 2014, DEV CELL, V31, P171, DOI 10.1016/j.devcel.2014.08.027; Debnath J, 2002, CELL, V111, P29, DOI 10.1016/S0092-8674(02)01001-2; DUNN JCY, 1991, BIOTECHNOL PROGR, V7, P237, DOI 10.1021/bp00009a007; Engl W, 2014, NAT CELL BIOL, V16, P584, DOI 10.1038/ncb2973; Fu D, 2011, P NATL ACAD SCI USA, V108, P1403, DOI 10.1073/pnas.1018376108; Gimenes D, 2006, CELL BIOCHEM FUNCT, V24, P313, DOI 10.1002/cbf.1228; HALL HG, 1982, P NATL ACAD SCI-BIOL, V79, P4672, DOI 10.1073/pnas.79.15.4672; Herr KJ, 2014, SCI REP-UK, V4, DOI 10.1038/srep06835; Herwig L, 2011, CURR BIOL, V21, P1942, DOI 10.1016/j.cub.2011.10.016; Iruela-Arispe ML, 2009, DEV CELL, V16, P222, DOI 10.1016/j.devcel.2009.01.013; Jungermann K, 2000, HEPATOLOGY, V31, P255, DOI 10.1002/hep.510310201; Kamei M, 2006, NATURE, V442, P453, DOI 10.1038/nature04923; Larocca MC, 2009, AM J PHYSIOL-GASTR L, V296, pG93, DOI 10.1152/ajpgi.90410.2008; Levi BP, 2006, DEVELOPMENT, V133, P2383, DOI 10.1242/dev.02404; Lubarsky B, 2003, CELL, V112, P19, DOI 10.1016/S0092-8674(02)01283-7; Marinelli RA, 2011, FRONT BIOSCI-LANDMRK, V16, P2642, DOI 10.2741/3877; Martin-Belmonte F, 2008, CURR BIOL, V18, P507, DOI 10.1016/j.cub.2008.02.076; Martin-Belmonte F, 2009, INT REV CEL MOL BIO, V274, P129, DOI 10.1016/S1937-6448(08)02003-0; Masters T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044261; Quistorff B, 1990, Methods Mol Biol, V5, P151, DOI 10.1385/0-89603-150-0:151; Rodriguez-Fraticelli Alejo E, 2013, Small GTPases, V4, P136, DOI 10.4161/sgtp.24303; Rodriguez-Fraticelli AE, 2012, J CELL BIOL, V198, P1011, DOI 10.1083/jcb.201203075; Sawyer JM, 2010, DEV BIOL, V341, P5, DOI 10.1016/j.ydbio.2009.09.009; Schlosser SF, 1996, P NATL ACAD SCI USA, V93, P9948, DOI 10.1073/pnas.93.18.9948; SPERBER I, 1959, PHARMACOL REV, V11, P109; Treyer A, 2013, COMPR PHYSIOL, V3, P243, DOI 10.1002/cphy.c120009; TSUKADA N, 1995, HEPATOLOGY, V21, P1106, DOI 10.1002/hep.1840210433; Tuschl G, 2009, CHEM-BIOL INTERACT, V181, P124, DOI 10.1016/j.cbi.2009.05.015; Wang T, 2014, J CELL SCI, V127, P2483, DOI 10.1242/jcs.139923; Yeh TH, 2010, HEPATOLOGY, V52, P1410, DOI 10.1002/hep.23801; Yu W, 2005, MOL BIOL CELL, V16, P433, DOI 10.1091/mbc.e04-05-0435; Zong YW, 2009, DEVELOPMENT, V136, P1727, DOI 10.1242/dev.029140	36	45	45	0	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2016	18	3					311	+		10.1038/ncb3310	http://dx.doi.org/10.1038/ncb3310			16	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	DF0LT	26878396				2022-12-25	WOS:000371031300012
J	Myeku, N; Clelland, CL; Emrani, S; Kukushkin, NV; Yu, WH; Goldberg, AL; Duff, KE				Myeku, Natura; Clelland, Catherine L.; Emrani, Sheina; Kukushkin, Nikolay V.; Yu, Wai Haung; Goldberg, Alfred L.; Duff, Karen E.			Tau-driven 26S proteasome impairment and cognitive dysfunction can be prevented early in disease by activating cAMP-PKA signaling	NATURE MEDICINE			English	Article							UBIQUITINATED PROTEINS ACTIVATE; HELICAL FILAMENT-TAU; ALZHEIMERS-DISEASE; TRANSGENIC MICE; MOUSE MODEL; KINASE-A; PHOSPHORYLATION; DEGRADATION; SYSTEM; AGGREGATION	The ubiquitin proteasome system (UPS) degrades misfolded proteins including those implicated in neurodegenerative diseases. We investigated the effects of tau accumulation on proteasome function in a mouse model of tauopathy and in a cross to a UPS reporter mouse (line Ub-G76V-GFP). Accumulation of insoluble tau was associated with a decrease in the peptidase activity of brain 26S proteasomes, higher levels of ubiquitinated proteins and undegraded Ub-G76V-GFP. 26S proteasomes from mice with tauopathy were physically associated with tau and were less active in hydrolyzing ubiquitinated proteins, small peptides and ATP. 26S proteasomes from normal mice incubated with recombinant oligomers or fibrils also showed lower hydrolyzing capacity in the same assays, implicating tau as a proteotoxin. Administration of an agent that activates cAMP-protein kinase A (PKA) signaling led to attenuation of proteasome dysfunction, probably through proteasome subunit phosphorylation. In vivo, this led to lower levels of aggregated tau and improvements in cognitive performance.	[Myeku, Natura; Clelland, Catherine L.; Emrani, Sheina; Yu, Wai Haung; Duff, Karen E.] Columbia Univ, Taub Inst Alzheimers Dis Res, Dept Pathol & Cell Biol, New York, NY 10027 USA; [Kukushkin, Nikolay V.; Goldberg, Alfred L.] Boston Univ, Sch Med, Dept Cell Biol, Boston, MA 02118 USA; [Duff, Karen E.] New York State Psychiat Inst & Hosp, Dept Psychiat, Div Integrat Neurosci, New York, NY 10032 USA	Columbia University; Boston University; New York State Psychiatry Institute	Duff, KE (corresponding author), Columbia Univ, Taub Inst Alzheimers Dis Res, Dept Pathol & Cell Biol, New York, NY 10027 USA.	ked2115@columbia.edu	Clelland, Catherine/AAZ-8551-2021	Duff, Karen/0000-0002-6177-868X; Yu, Wai Haung/0000-0001-7186-6731; , Sheina/0000-0002-1235-5285	US National Institute of Neurological Disorders and Stroke [NS074593]; CurePSP Foundation; US National Institute of General Medical Sciences [GM051923]; Fidelity Biosciences Research Initiative; Multiple Myeloma Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051923] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS074593] Funding Source: NIH RePORTER	US National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); CurePSP Foundation; US National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Fidelity Biosciences Research Initiative; Multiple Myeloma Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank J. Lewis and K. Ashe for providing rTg4510 and JNPL3 mice and P. Davies for the generous gift of tau antibodies. We thank L. Liu for assisting with mice perfusion. This work was supported by grants from the US National Institute of Neurological Disorders and Stroke NS074593 (K.E.D.), CurePSP Foundation (N.M.), the US National Institute of General Medical Sciences GM051923 (to A.L.G.), the Fidelity Biosciences Research Initiative (A.L.G.) and the Multiple Myeloma Research Foundation (N.V.K.).	Asai M, 2009, J MOL CELL CARDIOL, V46, P452, DOI 10.1016/j.yjmcc.2008.11.001; Bar-Nun S, 2012, BBA-MOL CELL RES, V1823, P67, DOI 10.1016/j.bbamcr.2011.07.009; Beck F, 2012, P NATL ACAD SCI USA, V109, P14870, DOI 10.1073/pnas.1213333109; Besche HC, 2012, METHODS MOL BIOL, V832, P423, DOI 10.1007/978-1-61779-474-2_29; Cherra SJ, 2010, J CELL BIOL, V190, P533, DOI 10.1083/jcb.201002108; Cripps D, 2006, J BIOL CHEM, V281, P10825, DOI 10.1074/jbc.M512786200; David DC, 2002, J NEUROCHEM, V83, P176, DOI 10.1046/j.1471-4159.2002.01137.x; de Calignon A, 2012, NEURON, V73, P685, DOI 10.1016/j.neuron.2011.11.033; Duff K, 2002, J MOL NEUROSCI, V19, P317, DOI 10.1385/JMN:19:3:317; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Han DH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6633; Kandel ER, 2014, CELL, V157, P163, DOI 10.1016/j.cell.2014.03.001; Keck S, 2003, J NEUROCHEM, V85, P115, DOI 10.1046/j.1471-4159.2003.01642.x; Keller JN, 2000, J NEUROCHEM, V75, P436, DOI 10.1046/j.1471-4159.2000.0750436.x; Lam YA, 2005, METHOD ENZYMOL, V398, P379, DOI 10.1016/S0076-6879(05)98031-2; Lander GC, 2012, NATURE, V482, P186, DOI 10.1038/nature10774; Lee BH, 2010, NATURE, V467, P179, DOI 10.1038/nature09299; Lee MJ, 2013, PROG NEUROBIOL, V105, P49, DOI 10.1016/j.pneurobio.2013.03.001; Lewis J, 2000, NAT GENET, V25, P402, DOI 10.1038/78078; Lin JT, 2013, MOL CELL BIOL, V33, P1073, DOI 10.1128/MCB.01434-12; Lindsten K, 2003, NAT BIOTECHNOL, V21, P897, DOI 10.1038/nbt851; Liu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031302; Lokireddy S., P NATL ACAD IN PRESS; Metcalfe MJ, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.70; Morris M, 2015, NAT NEUROSCI, V18, P1183, DOI 10.1038/nn.4067; Myeku N, 2012, NEUROSCI LETT, V527, P126, DOI 10.1016/j.neulet.2012.08.051; Myeku N, 2011, METHODS MOL BIOL, V793, P273, DOI 10.1007/978-1-61779-328-8_18; Myeku N, 2011, J BIOL CHEM, V286, P22426, DOI 10.1074/jbc.M110.149252; Park SJ, 2012, CELL, V148, P421, DOI 10.1016/j.cell.2012.01.017; Peth A, 2013, J BIOL CHEM, V288, P29215, DOI 10.1074/jbc.M113.482570; Peth A, 2013, J BIOL CHEM, V288, P7781, DOI 10.1074/jbc.M112.441907; Peth A, 2010, MOL CELL, V40, P671, DOI 10.1016/j.molcel.2010.11.002; Peth A, 2009, MOL CELL, V36, P794, DOI 10.1016/j.molcel.2009.11.015; Sadik G, 2009, J NEUROCHEM, V108, P33, DOI 10.1111/j.1471-4159.2008.05716.x; Saeki Y, 2005, METHOD ENZYMOL, V399, P215, DOI 10.1016/S0076-6879(05)99014-9; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; Schneider A, 1999, BIOCHEMISTRY-US, V38, P3549, DOI 10.1021/bi981874p; Sha Z, 2011, P NATL ACAD SCI USA, V108, P18573, DOI 10.1073/pnas.1115315108; Smith DM, 2011, CELL, V144, P526, DOI 10.1016/j.cell.2011.02.005; Tai HC, 2012, AM J PATHOL, V181, P1426, DOI 10.1016/j.ajpath.2012.06.033; Thomas SN, 2009, METHODS MOL BIOL, V566, P109, DOI 10.1007/978-1-59745-562-6_8; Verma R, 2001, MOL CELL, V8, P439, DOI 10.1016/S1097-2765(01)00308-2; Zhang FX, 2007, J BIOL CHEM, V282, P22460, DOI 10.1074/jbc.M702439200; Zhu B, 2010, AM J PHYSIOL-LUNG C, V299, pL493, DOI 10.1152/ajplung.00431.2009	45	252	258	1	60	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	JAN	2016	22	1					46	+		10.1038/nm.4011	http://dx.doi.org/10.1038/nm.4011			11	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DA1YA	26692334	Green Accepted			2022-12-25	WOS:000367590700014
J	Ming, R; VanBuren, R; Wai, CM; Tang, HB; Schatz, MC; Bowers, JE; Lyons, E; Wang, ML; Chen, J; Biggers, E; Zhang, JS; Huang, LX; Zhang, LM; Miao, WJ; Zhang, J; Ye, ZY; Miao, CY; Lin, ZC; Wang, H; Zhou, HY; Yim, WC; Priest, HD; Zheng, CF; Woodhouse, M; Edger, PP; Guyot, R; Guo, HB; Guo, H; Zheng, GY; Singh, R; Sharma, A; Min, XJ; Zheng, Y; Lee, H; Gurtowski, J; Sedlazeck, FJ; Harkess, A; McKain, MR; Liao, ZY; Fang, JP; Liu, J; Zhang, XD; Zhang, Q; Hu, WC; Qin, Y; Wang, K; Chen, LY; Shirley, N; Lin, YR; Liu, LY; Hernandez, AG; Wright, CL; Bulone, V; Tuskan, GA; Heath, K; Zee, F; Moore, PH; Sunkar, R; Leebens-Mack, JH; Mockler, T; Bennetzen, JL; Freeling, M; Sankoff, D; Paterson, AH; Zhu, XG; Yang, XH; Smith, JAC; Cushman, JC; Paull, RE; Yu, QY				Ming, Ray; VanBuren, Robert; Wai, Ching Man; Tang, Haibao; Schatz, Michael C.; Bowers, John E.; Lyons, Eric; Wang, Ming-Li; Chen, Jung; Biggers, Eric; Zhang, Jisen; Huang, Lixian; Zhang, Lingmao; Miao, Wenjing; Zhang, Jian; Ye, Zhangyao; Miao, Chenyong; Lin, Zhicong; Wang, Hao; Zhou, Hongye; Yim, Won C.; Priest, Henry D.; Zheng, Chunfang; Woodhouse, Margaret; Edger, Patrick P.; Guyot, Romain; Guo, Hao-Bo; Guo, Hong; Zheng, Guangyong; Singh, Ratnesh; Sharma, Anupma; Min, Xiangjia; Zheng, Yun; Lee, Hayan; Gurtowski, James; Sedlazeck, Fritz J.; Harkess, Alex; McKain, Michael R.; Liao, Zhenyang; Fang, Jingping; Liu, Juan; Zhang, Xiaodan; Zhang, Qing; Hu, Weichang; Qin, Yuan; Wang, Kai; Chen, Li-Yu; Shirley, Neil; Lin, Yann-Rong; Liu, Li-Yu; Hernandez, Alvaro G.; Wright, Chris L.; Bulone, Vincent; Tuskan, Gerald A.; Heath, Katy; Zee, Francis; Moore, Paul H.; Sunkar, Ramanjulu; Leebens-Mack, James H.; Mockler, Todd; Bennetzen, Jeffrey L.; Freeling, Michael; Sankoff, David; Paterson, Andrew H.; Zhu, Xinguang; Yang, Xiaohan; Smith, J. Andrew C.; Cushman, John C.; Paull, Robert E.; Yu, Qingyi			The pineapple genome and the evolution of CAM photosynthesis	NATURE GENETICS			English	Article							CRASSULACEAN ACID METABOLISM; EXPRESSION ANALYSIS; GENE; SEQUENCE; PLANTS; IDENTIFICATION; ARABIDOPSIS; DIVERGENCE; C-4; DIVERSIFICATION	Pineapple (Ananas comosus (L.) Merr.) is the most economically valuable crop possessing crassulacean acid metabolism (CAM), a photosynthetic carbon assimilation pathway with high water-use efficiency, and the second most important tropical fruit. We sequenced the genomes of pineapple varieties F153 and MD2 and a wild pineapple relative, Ananas bracteatus accession CB5. The pineapple genome has one fewer ancient whole-genome duplication event than sequenced grass genomes and a conserved karyotype with seven chromosomes from before the. duplication event. The pineapple lineage has transitioned from C-3 photosynthesis to CAM, with CAM-related genes exhibiting a diel expression pattern in photosynthetic tissues. CAM pathway genes were enriched with cis-regulatory elements associated with the regulation of circadian clock genes, providing the first cis-regulatory link between CAM and circadian clock regulation. Pineapple CAM photosynthesis evolved by the reconfiguration of pathways in C-3 plants, through the regulatory neofunctionalization of preexisting genes and not through the acquisition of neofunctionalized genes via whole-genome or tandem gene duplication.	[Ming, Ray; VanBuren, Robert; Wai, Ching Man; Tang, Haibao; Zhang, Jisen; Huang, Lixian; Zhang, Lingmao; Miao, Wenjing; Zhang, Jian; Ye, Zhangyao; Miao, Chenyong; Lin, Zhicong; Liao, Zhenyang; Fang, Jingping; Liu, Juan; Zhang, Xiaodan; Zhang, Qing; Hu, Weichang; Qin, Yuan; Wang, Kai; Chen, Li-Yu] Fujian Agr & Forestry Univ, Fujian Agr & Forestry Univ & Univ Illinois Urbana, Fuzhou, Peoples R China; [Ming, Ray; VanBuren, Robert; Wai, Ching Man; Tang, Haibao; Zhang, Jisen; Huang, Lixian; Zhang, Lingmao; Miao, Wenjing; Zhang, Jian; Ye, Zhangyao; Miao, Chenyong; Lin, Zhicong; Liao, Zhenyang; Fang, Jingping; Liu, Juan; Zhang, Xiaodan; Zhang, Qing; Hu, Weichang; Qin, Yuan; Wang, Kai; Chen, Li-Yu] Fujian Agr & Forestry Univ, Fujian Taiwan Joint Ctr Ecol Control Crop Pests, Fuzhou, Peoples R China; [Ming, Ray; VanBuren, Robert; Wai, Ching Man; Heath, Katy] Univ Illinois, Dept Plant Biol, Urbana, IL USA; [VanBuren, Robert; Priest, Henry D.; McKain, Michael R.; Mockler, Todd] Donald Danforth Plant Sci Ctr, St Louis, MO USA; [Tang, Haibao; Lyons, Eric] Univ Arizona, iPlant Collaborat, Tucson, AZ USA; [Schatz, Michael C.; Biggers, Eric; Lee, Hayan; Gurtowski, James; Sedlazeck, Fritz J.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Bowers, John E.; Wang, Hao; Zhou, Hongye; Harkess, Alex; Leebens-Mack, James H.; Bennetzen, Jeffrey L.] Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA; [Wang, Ming-Li; Moore, Paul H.] Hawaii Agr Res Ctr, Kunia, HI USA; [Chen, Jung; Paull, Robert E.] Univ Hawaii, Dept Trop Plant & Soil Sci, Honolulu, HI 96822 USA; [Yim, Won C.; Cushman, John C.] Univ Nevada, Dept Biochem & Mol Biol, Reno, NV 89557 USA; [Zheng, Chunfang; Sankoff, David] Univ Ottawa, Dept Math & Stat, Ottawa, ON, Canada; [Woodhouse, Margaret; Edger, Patrick P.; Freeling, Michael] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; [Guyot, Romain] IRD, Divers Adaptat & Dev Plantes, Montpellier, France; [Guo, Hao-Bo; Guo, Hong] Univ Tennessee, Dept Biochem & Cellular & Mol Biol, Knoxville, TN USA; [Zheng, Guangyong; Zhu, Xinguang] Chinese Acad Sci, Shanghai Inst Biol Sci, Max Planck Gesell Partner Inst Computat Biol, Key Lab Computat Biol, Shanghai, Peoples R China; [Singh, Ratnesh; Sharma, Anupma; Yu, Qingyi] Texas A&M Univ Syst, Dept Plant Pathol & Microbiol, Texas A&M AgriLife Res, Dallas, TX USA; [Min, Xiangjia] Youngstown State Univ, Dept Biol Sci, Youngstown, OH 44555 USA; [Zheng, Yun] Kunming Univ Sci & Technol, Fac Life Sci & Technol, Kunming, Peoples R China; [Shirley, Neil; Bulone, Vincent] Univ Adelaide, Sch Agr Food & Wine, Australian Res Council ARC Ctr Excellence Plant C, Adelaide, SA, Australia; [Lin, Yann-Rong; Liu, Li-Yu] Natl Taiwan Univ, Dept Agron, Taipei, Taiwan; [Hernandez, Alvaro G.; Wright, Chris L.] Univ Illinois, WM Keck Ctr, Urbana, IL USA; [Tuskan, Gerald A.; Yang, Xiaohan] Oak Ridge Natl Lab, Biosci Div, Oak Ridge, TN USA; [Zee, Francis] USDA ARS, Pacific Basin Agr Res Ctr, Hilo, HI USA; [Sunkar, Ramanjulu] Oklahoma State Univ, Dept Biochem & Mol Biol, Noble Res Ctr, Stillwater, OK 74078 USA; [Paterson, Andrew H.] Univ Georgia, Plant Genome Mapping Lab, Athens, GA 30602 USA; [Smith, J. Andrew C.] Univ Oxford, Dept Plant Sci, Oxford, England	Fujian Agriculture & Forestry University; Fujian Agriculture & Forestry University; University of Illinois System; University of Illinois Urbana-Champaign; Donald Danforth Plant Science Center; University of Arizona; Cold Spring Harbor Laboratory; University System of Georgia; University of Georgia; University of Hawaii System; Nevada System of Higher Education (NSHE); University of Nevada Reno; University of Ottawa; University of California System; University of California Berkeley; Institut de Recherche pour le Developpement (IRD); University of Tennessee System; University of Tennessee Knoxville; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Max Planck Society; Texas A&M University System; Texas A&M University College Station; Texas A&M AgriLife Research; University System of Ohio; Youngstown State University; Kunming University of Science & Technology; University of Adelaide; National Taiwan University; University of Illinois System; University of Illinois Urbana-Champaign; United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Agriculture (USDA); Oklahoma State University System; Oklahoma State University - Stillwater; University System of Georgia; University of Georgia; University of Oxford	Ming, R (corresponding author), Fujian Agr & Forestry Univ, Fujian Agr & Forestry Univ & Univ Illinois Urbana, Fuzhou, Peoples R China.	rming@life.uiuc.edu; qyu@ag.tamu.edu	Yang, Xiaohan/A-6975-2011; Sedlazeck, Fritz J/E-4548-2018; Zheng, Yun/I-7011-2012; Schatz, Michael/L-2690-2019; Bowers, John/B-9245-2009; Bulone, Vincent/C-8492-2019; Guo, Hao-Bo/B-7486-2009; Yang, Xiaohan/AAM-2449-2020; Zheng, Yun/AAS-1149-2021; Min, Xiangjia Jack/O-9509-2014; Tuskan, Gerald/A-6225-2011; LIN, Yann-rong/AAI-4096-2020; Edger, Patrick/AAP-3846-2021; guyot, romain/AAE-2262-2021; Bulone, Vincent/D-7469-2013; Mockler, Todd C/L-2609-2013; Leebens-Mack, James/AAF-6770-2019; Yu, Qingyi/E-8899-2019; Bowers, John/AAD-7601-2019; guyot, romain/M-1118-2015; Smith, J.A.C./M-3338-2014; Edger, Patrick/ABE-6442-2020; Tang, Haibao/A-6715-2011; Yim, Won Cheol/K-9100-2016; Wang, Kai/A-2143-2011; Singh, Ratnesh/I-1392-2015	Yang, Xiaohan/0000-0001-5207-4210; Sedlazeck, Fritz J/0000-0001-6040-2691; Zheng, Yun/0000-0003-4292-9806; Schatz, Michael/0000-0002-4118-4446; Bowers, John/0000-0001-8984-9796; Bulone, Vincent/0000-0003-2809-4160; Guo, Hao-Bo/0000-0003-1321-1758; Yang, Xiaohan/0000-0001-5207-4210; Zheng, Yun/0000-0003-4292-9806; Min, Xiangjia Jack/0000-0001-7978-0596; Tuskan, Gerald/0000-0003-0106-1289; LIN, Yann-rong/0000-0001-6833-8276; guyot, romain/0000-0002-7016-7485; Mockler, Todd C/0000-0002-0462-5775; Leebens-Mack, James/0000-0003-4811-2231; Yu, Qingyi/0000-0001-5393-5764; guyot, romain/0000-0002-7016-7485; Smith, J.A.C./0000-0001-9188-0258; Tang, Haibao/0000-0002-3460-8570; Yim, Won Cheol/0000-0002-7489-0435; Wang, Kai/0000-0002-1074-0438; Bowers, John/0000-0001-5693-2796; chen, li yu/0000-0002-5199-6237; Shirley, Neil/0000-0001-8114-9891; Singh, Ratnesh/0000-0001-5647-3390; Zhang, Xiaodan/0000-0001-8192-0666; Zhang, Jian/0000-0002-0790-4462; Lee, Hayan/0000-0003-0571-3192; Zhou, Hongye/0000-0003-4373-8083; Liu, Li-yu/0000-0001-6997-8101; Miao, Chenyong/0000-0002-0904-3707; Lyons, Eric/0000-0002-3348-8845	Fujian Agriculture and Forestry University; USDA T-START grant through the University of Hawaii; University of Illinois at Urbana-Champaign; Fujian provincial government; US National Science Foundation (NSF) Plant Genome Program [0922545]; NSF [DBI-1401572, IOS-1444567]; US National Institutes of Health [R01-HG006677]; US NSF [DBI-1350041, DBI-1265383]; US Department of Energy, Office of Science, Genomic Science Program [DE-SC0008834]; Direct For Biological Sciences [1442199] Funding Source: National Science Foundation; Division Of Integrative Organismal Systems [1401572, 0922742] Funding Source: National Science Foundation; Div Of Biological Infrastructure [1627442] Funding Source: National Science Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006677] Funding Source: NIH RePORTER	Fujian Agriculture and Forestry University; USDA T-START grant through the University of Hawaii; University of Illinois at Urbana-Champaign; Fujian provincial government; US National Science Foundation (NSF) Plant Genome Program(National Science Foundation (NSF)); NSF(National Science Foundation (NSF)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US NSF(National Science Foundation (NSF)); US Department of Energy, Office of Science, Genomic Science Program(United States Department of Energy (DOE)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank R. Kai and C. Mayo Riley for maintaining the pineapple plants and the collection of leaf tissues; M. Conway at Dole Plantation for assistance in time-course leaf sample collection; G. Sanewski for providing the MD2 pedigree; and M. Cushman for providing clarifying comments on the manuscript. This project is supported by funding from the Fujian Agriculture and Forestry University to R. M.; a USDA T-START grant through the University of Hawaii to Q.Y., R.M., P.H.M. and R.E.P.; and funding from the University of Illinois at Urbana-Champaign to R.M. H.T. is supported by the 100 Talent Plan award from the Fujian provincial government. Analyses of the pineapple genome are supported by the following funding sources: US National Science Foundation (NSF) Plant Genome Program grant 0922545 to R.M., P.H.M. and Q.Y. and NSF grant DBI-1401572 to R.V.; NSF grant IOS-1444567 to J.H.L.-M.; and US National Institutes of Health award R01-HG006677 and US NSF awards DBI-1350041 and DBI-1265383 to M.C.S. W.C.Y., H.-B.G., H.G., G.A.T., X.Y. and J.C.C. acknowledge support from the US Department of Energy, Office of Science, Genomic Science Program, under award DE-SC0008834.	Al-Dous EK, 2011, NAT BIOTECHNOL, V29, P521, DOI 10.1038/nbt.1860; Albert VA, 2013, SCIENCE, V342, P1467, DOI 10.1126/science.1241089; Antony E, 2008, J EXP BOT, V59, P1895, DOI 10.1093/jxb/ern077; Arumuganathan K., 1991, PLANT MOL BIOL REP, V9, P208, DOI [10.1007/BF02672069, DOI 10.1007/BF02672069]; Bartholomew D.P., 2002, PINEAPPLE BOT PRODUC; Beauman Fran, 2006, PINEAPPLE KING FRUIT; Borland AM, 2014, TRENDS PLANT SCI, V19, P327, DOI 10.1016/j.tplants.2014.01.006; BREWBAKER JL, 1967, AM J BOT, V54, P611, DOI 10.2307/2440666; Cai J, 2015, NAT GENET, V47, P65, DOI 10.1038/ng.3149; Cantarel BL, 2008, GENOME RES, V18, P188, DOI 10.1101/gr.6743907; CARNAL NW, 1983, PLANT PHYSIOL, V71, P150, DOI 10.1104/pp.71.1.150; Chepyshko H, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-309; Christin PA, 2014, J EXP BOT, V65, P3609, DOI 10.1093/jxb/eru087; Clement C. R., 2010, Diversity, V2, P72; Collins JL, 1960, PINEAPPLE BOT CULTIV; D'Hont A, 2012, NATURE, V488, P213, DOI 10.1038/nature11241; DITTRICH P, 1973, PLANT PHYSIOL, V52, P357, DOI 10.1104/pp.52.4.357; Dolezel J, 2003, CYTOM PART A, V51A, P127, DOI 10.1002/cyto.a.10013; Edwards EJ, 2012, INT J PLANT SCI, V173, P724, DOI 10.1086/666098; Franco-Zorrilla JM, 2014, P NATL ACAD SCI USA, V111, P2367, DOI 10.1073/pnas.1316278111; Freeling M, 2008, GENOME RES, V18, P1924, DOI 10.1101/gr.081026.108; Givnish TJ, 2014, MOL PHYLOGENET EVOL, V71, P55, DOI 10.1016/j.ympev.2013.10.010; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Haas BJ, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r7; Holtum JAM, 2005, FUNCT PLANT BIOL, V32, P429, DOI 10.1071/FP04189; Hudson ME, 2003, PLANT PHYSIOL, V133, P1605, DOI 10.1104/pp.103.030437; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Jiao YN, 2014, PLANT CELL, V26, P2792, DOI 10.1105/tpc.114.127597; KENYON WH, 1985, PLANT PHYSIOL, V77, P183, DOI 10.1104/pp.77.1.183; Kielbasa SM, 2011, GENOME RES, V21, P487, DOI 10.1101/gr.113985.110; Korf I, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-59; Kramer EM, 1998, GENETICS, V149, P765; Lomsadze A, 2005, NUCLEIC ACIDS RES, V33, P6494, DOI 10.1093/nar/gki937; Lyons E, 2008, PLANT PHYSIOL, V148, P1772, DOI 10.1104/pp.108.124867; Magallon S, 2015, NEW PHYTOL, V207, P437, DOI 10.1111/nph.13264; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; McCarthy EM, 2003, BIOINFORMATICS, V19, P362, DOI 10.1093/bioinformatics/btf878; McRae SR, 2002, FUNCT PLANT BIOL, V29, P717, DOI 10.1071/PP01227; Meyers BC, 2001, GENOME RES, V11, P1660, DOI 10.1101/gr.188201; Michael TP, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040014; Michael TP, 2002, PLANT PHYSIOL, V130, P627, DOI 10.1104/pp.004929; Ming R, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-5-r41; Mirarab S., 2015, RES COMPUTATIONAL MO, P177; Nam J, 2004, P NATL ACAD SCI USA, V101, P1910, DOI 10.1073/pnas.0308430100; NOBEL PS, 1991, NEW PHYTOL, V119, P183, DOI 10.1111/j.1469-8137.1991.tb01022.x; OSMOND CB, 1978, ANNU REV PLANT PHYS, V29, P379, DOI 10.1146/annurev.pp.29.060178.002115; Paterson AH, 2004, P NATL ACAD SCI USA, V101, P9903, DOI 10.1073/pnas.0307901101; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Silvera K, 2010, FUNCT PLANT BIOL, V37, P995, DOI 10.1071/FP10084; Singh R, 2013, NATURE, V500, P335, DOI 10.1038/nature12309; Skinner ME, 2009, GENOME RES, V19, P1630, DOI 10.1101/gr.094607.109; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stanke M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-62; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Tang HB, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-102; Tang HB, 2010, P NATL ACAD SCI USA, V107, P472, DOI 10.1073/pnas.0908007107; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; VanBuren R., 2011, Tropical Plant Biology, V4, P228, DOI 10.1007/s12042-011-9084-3; von Caemmerer S, 2012, SCIENCE, V336, P1671, DOI 10.1126/science.1220177; Wang W, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4311; Wang XY, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r68; Woodhouse MR, 2011, PLANT CELL, V23, P4241, DOI 10.1105/tpc.111.093567; Woodhouse MR, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000409; Xu Z, 2007, NUCLEIC ACIDS RES, V35, pW265, DOI 10.1093/nar/gkm286; Yang XH, 2015, NEW PHYTOL, V207, P491, DOI 10.1111/nph.13393; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847	66	305	329	10	210	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2015	47	12					1435	+		10.1038/ng.3435	http://dx.doi.org/10.1038/ng.3435			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CX6LT	26523774	hybrid, Green Submitted, Green Published, Green Accepted			2022-12-25	WOS:000365813200015
J	Song, NJ; Choi, S; Rajbhandari, P; Chang, SH; Kim, S; Vergnes, L; Kwon, SM; Yoon, JH; Lee, S; Ku, JM; Lee, JS; Reue, K; Koo, SH; Tontonoz, P; Park, KW				Song, No-Joon; Choi, Seri; Rajbhandari, Prashant; Chang, Seo-Hyuk; Kim, Suji; Vergnes, Laurent; Kwon, So-Mi; Yoon, Jung-Hoon; Lee, Sukchan; Ku, Jin-Mo; Lee, Jeong-Soo; Reue, Karen; Koo, Seung-Hoi; Tontonoz, Peter; Park, Kye Won			Prdm4 induction by the small molecule butein promotes white adipose tissue browning	NATURE CHEMICAL BIOLOGY			English	Article							FAT DEVELOPMENT; ADIPOCYTES; OBESITY; THERMOGENESIS; EXPRESSION; ABLATION; MOUSE; CELL	Increasing the thermogenic activity of adipocytes holds promise as an approach to combating human obesity and related metabolic diseases. We identified induction of mouse PR domain containing 4 (Prdm4) by the small molecule butein as a means to induce expression of uncoupling protein 1 (Ucp1), increase energy expenditure, and stimulate the generation of thermogenic adipocytes. This study highlights a Prdm4 dependent pathway, modulated by small molecules, that stimulates browning of white adipose tissue.	[Song, No-Joon; Chang, Seo-Hyuk; Kim, Suji; Kwon, So-Mi; Yoon, Jung-Hoon; Park, Kye Won] Sungkyunkwan Univ, Dept Food Sci & Biotechnol, Suwon, South Korea; [Choi, Seri; Koo, Seung-Hoi] Korea Univ, Div Life Sci, Seoul, South Korea; [Tontonoz, Peter] Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90024 USA; [Vergnes, Laurent; Reue, Karen] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [Lee, Sukchan] Sungkyunkwan Univ, Dept Genet Engn, Suwon, South Korea; [Ku, Jin-Mo] Gyeonggi Bioctr, Gyeonggi Inst Sci & Technol Promot, Nat Product Res Team, Suwon, South Korea; [Lee, Jeong-Soo] Korea Res Inst Biosci & Biotechnol, Daejeon, South Korea; [Lee, Jeong-Soo] Univ Sci & Technol, Major Funct Genom, Daejeon, South Korea; [Reue, Karen] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Rajbhandari, Prashant; Tontonoz, Peter] Univ Calif Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA USA	Sungkyunkwan University (SKKU); Korea University; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Sungkyunkwan University (SKKU); Korea Research Institute of Bioscience & Biotechnology (KRIBB); University of Science & Technology (UST); University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles	Park, KW (corresponding author), Sungkyunkwan Univ, Dept Food Sci & Biotechnol, Suwon, South Korea.	kwpark@skku.edu	Ku, Jin Mo/AAE-7079-2020; CHOI, SERI/ABA-4559-2021	Ku, Jin Mo/0000-0003-0218-810X; vergnes, laurent/0000-0002-8804-589X; Choi, Seri/0000-0002-0295-7370; Park, Kye Won/0000-0003-2771-249X; Rajbhandari, Prashant/0000-0002-8146-3861	National Research Foundation of Korea (NRF) - Ministry of Education, Science, and Technology [NRF-2013R1A1A2060447]; KRIBB Research Initiative Program; US National Institutes of Health [HL090553, F32 DK104484-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL090553] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK104484] Funding Source: NIH RePORTER	National Research Foundation of Korea (NRF) - Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of Korea); KRIBB Research Initiative Program; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	T37i cells were kindly provided by M. Lombes. We thank T.H. Kwak for technical advice. This study was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF), funded by the Ministry of Education, Science, and Technology (NRF-2013R1A1A2060447 to K.W.P.), and by the KRIBB Research Initiative Program (J.-S.L.). This study was also supported by the US National Institutes of Health (HL090553 to K.R. and F32 DK104484-01 to P.R.).	Barbatelli G, 2010, AM J PHYSIOL-ENDOC M, V298, pE1244, DOI 10.1152/ajpendo.00600.2009; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cohen P, 2014, CELL, V156, P304, DOI 10.1016/j.cell.2013.12.021; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Feldmann HM, 2009, CELL METAB, V9, P203, DOI 10.1016/j.cmet.2008.12.014; Ghorbani M, 1997, INT J OBESITY, V21, P465, DOI 10.1038/sj.ijo.0800432; Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361; Harms MJ, 2014, CELL METAB, V19, P593, DOI 10.1016/j.cmet.2014.03.007; Kiefer FW, 2012, NAT MED, V18, P918, DOI 10.1038/nm.2757; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Nedergaard J, 2007, AM J PHYSIOL-ENDOC M, V293, pE444, DOI 10.1152/ajpendo.00691.2006; Park KW, 2008, MOL ENDOCRINOL, V22, P2038, DOI 10.1210/me.2007-0454; Park KW, 2010, J LIPID RES, V51, P2775, DOI 10.1194/jlr.M008490; Peirce V, 2014, NATURE, V510, P76, DOI 10.1038/nature13477; Roberts LD, 2014, CELL METAB, V19, P96, DOI 10.1016/j.cmet.2013.12.003; Rosenwald M, 2013, NAT CELL BIOL, V15, P659, DOI 10.1038/ncb2740; Samuel VT, 2006, DIABETES, V55, P2042, DOI 10.2337/db05-0705; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Seale P, 2007, CELL METAB, V6, P38, DOI 10.1016/j.cmet.2007.06.001; Seale P, 2015, DIABETES, V64, P2369, DOI 10.2337/db15-0203; Song NJ, 2013, J LIPID RES, V54, P1385, DOI 10.1194/jlr.M035576; Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9; Timmons JA, 2007, P NATL ACAD SCI USA, V104, P4401, DOI 10.1073/pnas.0610615104; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; van Dam AD, 2015, DIABETES, V64, P1544, DOI 10.2337/db14-1125; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Wu ZN, 2013, DEV BIOL, V373, P235, DOI 10.1016/j.ydbio.2012.10.031; Zhang ZG, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6493	29	38	41	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUL	2016	12	7					479	+		10.1038/NCHEMBIO.2081	http://dx.doi.org/10.1038/NCHEMBIO.2081			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9EP	27159578	Green Accepted, Green Submitted			2022-12-25	WOS:000378087500005
J	van Ree, JH; Nam, HJ; Jeganathan, KB; Kanakkanthara, A; van Deursen, JM				van Ree, Janine H.; Nam, Hyun-Ja; Jeganathan, Karthik B.; Kanakkanthara, Arun; van Deursen, Jan M.			Pten regulates spindle pole movement through Dlg1-mediated recruitment of Eg5 to centrosomes	NATURE CELL BIOLOGY			English	Article							TENSIN HOMOLOG PTEN; NUCLEAR PTEN; TUMOR; PROTEIN; KINASE; PHOSPHATASE; SEPARATION; CANCER; PHOSPHORYLATION; INSTABILITY	Phosphatase and tensin homologue (Pten) suppresses neoplastic growth by negatively regulating PI(3)K signalling through its phosphatase activity(1). To gain insight into the actions of non-catalytic Pten domains in normal physiological processes and tumorigenesis(2,3), we engineered mice lacking the PDZ-binding domain (PDZ-BD). Here, we show that the PDZ-BD regulates centrosome movement and that its heterozygous or homozygous deletion promotes aneuploidy and tumour formation. We found that Pten is recruited to pre-mitotic centrosomes in a Plk1-dependent fashion to create a docking site for protein complexes containing the PDZ-domain-containing protein Dlg1 (also known as Sap97) and Eg5 (also known as Kif11), a kinesin essential for centrosome movement and bipolar spindle formation(4). Docking of Dlg1-Eg5 complexes to Pten depended on Eg5 phosphorylation by the Nek9-Nek6 mitotic kinase cascade and Cdk1. PDZ-BD deletion or Dlg1 ablation impaired loading of Eg5 onto centrosomes and spindle pole motility, yielding asymmetrical spindles that are prone to chromosome missegregation. Collectively, these data demonstrate that Pten, through the Dlg1-binding ability of its PDZ-BD, accumulates phosphorylated Eg5 at duplicated centrosomes to establish symmetrical bipolar spindles that properly segregate chromosomes, and suggest that this function contributes to tumour suppression.	[van Ree, Janine H.; Nam, Hyun-Ja; Jeganathan, Karthik B.; Kanakkanthara, Arun; van Deursen, Jan M.] Mayo Clin, Coll Med, Dept Pediat, Rochester, MN 55905 USA; [van Ree, Janine H.; Nam, Hyun-Ja; Jeganathan, Karthik B.; Kanakkanthara, Arun; van Deursen, Jan M.] Mayo Clin, Coll Med, Dept Adolescent Med, Rochester, MN 55905 USA; [van Deursen, Jan M.] Mayo Clin, Coll Med, Dept Biochem, Rochester, MN 55905 USA; [van Deursen, Jan M.] Mayo Clin, Coll Med, Dept Mol Biol, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	van Deursen, JM (corresponding author), Mayo Clin, Coll Med, Dept Pediat, Rochester, MN 55905 USA.; van Deursen, JM (corresponding author), Mayo Clin, Coll Med, Dept Adolescent Med, Rochester, MN 55905 USA.; van Deursen, JM (corresponding author), Mayo Clin, Coll Med, Dept Biochem, Rochester, MN 55905 USA.; van Deursen, JM (corresponding author), Mayo Clin, Coll Med, Dept Mol Biol, Rochester, MN 55905 USA.	vandeursen.jan@mayo.edu	KANAKKANTHARA, ARUN/R-9286-2016	Jeganathan, KARTHIK/0000-0001-5587-1266	National Institutes of Health [CA168709]; NATIONAL CANCER INSTITUTE [R01CA168709] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank W. Zhou and M. Li of Mayo Clinic's Gene Knockout Mouse Core Facility for embyronic stem cell microinjection and chimaera breeding, and A. Alimonti, P. Galardy, D. Baker, R. Naylor and members of the van Deursen laboratory for critical reading of the manuscript and for providing helpful comments and discussion. We are grateful to J. Roig for providing various critical reagents. This work was supported by the National Institutes of Health (CA168709 to J.M.v.D.).	Baker DJ, 2013, NAT CELL BIOL, V15, P96, DOI 10.1038/ncb2643; Baker DJ, 2009, CANCER CELL, V16, P475, DOI 10.1016/j.ccr.2009.10.023; Bassi C, 2013, SCIENCE, V341, P395, DOI 10.1126/science.1236188; Blangy A, 1995, CELL, V83, P1159, DOI 10.1016/0092-8674(95)90142-6; Bonifant CL, 2007, J CELL BIOCHEM, V102, P878, DOI 10.1002/jcb.21518; Bruinsma W, 2012, TRENDS BIOCHEM SCI, V37, P534, DOI 10.1016/j.tibs.2012.09.005; Chalhoub N, 2009, ANNU REV PATHOL-MECH, V4, P127, DOI 10.1146/annurev.pathol.4.110807.092311; Choi BH, 2014, J BIOL CHEM, V289, P17951, DOI 10.1074/jbc.M114.559005; Choi BH, 2014, J BIOL CHEM, V289, P14066, DOI 10.1074/jbc.M114.558155; Cross RA, 2014, NAT REV MOL CELL BIO, V15, P257, DOI 10.1038/nrm3768; Di Cristofano A, 1998, NAT GENET, V19, P348, DOI 10.1038/1235; EBLEN ST, 1995, CELL GROWTH DIFFER, V6, P915; HARRIS AW, 1988, J EXP MED, V167, P353, DOI 10.1084/jem.167.2.353; Holland AJ, 2012, EMBO REP, V13, P501, DOI 10.1038/embor.2012.55; Jeganathan K, 2007, J CELL BIOL, V179, P255, DOI 10.1083/jcb.200706015; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Kawabata T, 2011, MOL CELL, V41, P543, DOI 10.1016/j.molcel.2011.02.006; Knafo S, 2016, NAT NEUROSCI, V19, P443, DOI 10.1038/nn.4225; Kohn AD, 1996, J BIOL CHEM, V271, P21920, DOI 10.1074/jbc.271.36.21920; Leonard MK, 2013, CELL CYCLE, V12, P1406, DOI 10.4161/cc.24516; Mardin BR, 2012, J CELL BIOL, V197, P11, DOI 10.1083/jcb.201108006; Mayer TU, 1999, SCIENCE, V286, P971, DOI 10.1126/science.286.5441.971; Nam HJ, 2014, NAT CELL BIOL, V16, P535, DOI 10.1038/ncb2952; Papa A, 2014, CELL, V157, P595, DOI 10.1016/j.cell.2014.03.027; Podsypanina K, 1999, P NATL ACAD SCI USA, V96, P1563, DOI 10.1073/pnas.96.4.1563; Ramaswamy S, 1999, P NATL ACAD SCI USA, V96, P2110, DOI 10.1073/pnas.96.5.2110; Ricke RM, 2012, J CELL BIOL, V199, P931, DOI 10.1083/jcb.201205115; Saadaoui M, 2014, J CELL BIOL, V206, P707, DOI 10.1083/jcb.201405060; Shen WH, 2007, CELL, V128, P157, DOI 10.1016/j.cell.2006.11.042; Silkworth WT, 2012, MOL BIOL CELL, V23, P401, DOI 10.1091/mbc.E11-02-0095; Smith E, 2011, EMBO J, V30, P2233, DOI 10.1038/emboj.2011.120; Song MS, 2012, NAT REV MOL CELL BIO, V13, P283, DOI 10.1038/nrm3330; Song MS, 2011, CELL, V144, P187, DOI 10.1016/j.cell.2010.12.020; Sun Z, 2014, CELL REP, V6, P844, DOI 10.1016/j.celrep.2014.01.030; Tang SHE, 2002, GENESIS, V32, P199, DOI 10.1002/gene.10030; Bertran MT, 2011, EMBO J, V30, P2634, DOI 10.1038/emboj.2011.179; Vazquez F, 2000, MOL CELL BIOL, V20, P5010, DOI 10.1128/MCB.20.14.5010-5018.2000; Welburn JPI, 2010, MOL CELL, V38, P383, DOI 10.1016/j.molcel.2010.02.034; Whang YE, 1998, P NATL ACAD SCI USA, V95, P5246, DOI 10.1073/pnas.95.9.5246; Zhou WG, 2008, J NEUROSCI, V28, P10220, DOI 10.1523/JNEUROSCI.3434-08.2008	40	39	39	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUL	2016	18	7					814	+		10.1038/ncb3369	http://dx.doi.org/10.1038/ncb3369			10	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	DP9TS	27240320	Green Accepted			2022-12-25	WOS:000378840900013
J	Opgenorth, PH; Korman, TP; Bowie, JU				Opgenorth, Paul H.; Korman, Tyler P.; Bowie, James U.			A synthetic biochemistry module for production of bio-based chemicals from glucose	NATURE CHEMICAL BIOLOGY			English	Article							IN-VITRO; ESCHERICHIA-COLI; SYNTHASE; POLYHYDROXYALKANOATES; BIOTRANSFORMATIONS; OPPORTUNITIES; CHALLENGES; SYSTEMS; ACID); XFP	Synthetic biochemistry, the cell-free production of biologically based chemicals, is a potentially high-yield, flexible alternative to in vivo metabolic engineering. To limit costs, cell-free systems must be designed to operate continuously with minimal addition of feedstock chemicals. We describe a robust, efficient synthetic glucose breakdown pathway and implement it for the production of bioplastic. The system's performance suggests that synthetic biochemistry has the potential to become a viable industrial alternative.	[Opgenorth, Paul H.; Korman, Tyler P.; Bowie, James U.] Univ Calif Los Angeles, Inst Mol Biol, Dept Chem & Biochem, UCLA DOE Inst, Los Angeles, CA 90024 USA	United States Department of Energy (DOE); University of California System; University of California Los Angeles	Bowie, JU (corresponding author), Univ Calif Los Angeles, Inst Mol Biol, Dept Chem & Biochem, UCLA DOE Inst, Los Angeles, CA 90024 USA.	bowie@mbi.ucla.edu			US DOE grant [DE-FC02-02ER63421]; ARPA-E grant [DE-AR0000556]	US DOE grant(United States Department of Energy (DOE)); ARPA-E grant	This work was supported by US DOE grant DE-FC02-02ER63421 and ARPA-E grant DE-AR0000556.	Bujara M, 2010, BIOTECHNOL BIOENG, V106, P376, DOI 10.1002/bit.22666; Dien BS, 2003, APPL MICROBIOL BIOT, V63, P258, DOI 10.1007/s00253-003-1444-y; Gibson DG, 2008, SCIENCE, V319, P1215, DOI 10.1126/science.1151721; Glenn K, 2015, J BACTERIOL, V197, P1157, DOI 10.1128/JB.02380-14; Hankermeyer C R, 1999, Rev Environ Contam Toxicol, V159, P1; Hold C, 2009, J R SOC INTERFACE, V6, DOI 10.1098/rsif.2009.0110.focus; Jewett MC, 2004, BIOTECHNOL PROGR, V20, P102, DOI 10.1021/bp0341693; Jossek R, 1998, FEMS MICROBIOL LETT, V168, P319, DOI 10.1016/S0378-1097(98)00456-X; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; Liu SJ, 2000, APPL MICROBIOL BIOT, V53, P545, DOI 10.1007/s002530051655; Meile L, 2001, J BACTERIOL, V183, P2929, DOI 10.1128/JB.183.9.2929-2936.2001; Opgenorth PH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5113; Rollin JA, 2013, GREEN CHEM, V15, P1708, DOI 10.1039/c3gc40625c; Satoh Y, 2003, J BIOSCI BIOENG, V95, P335, DOI 10.1016/S1389-1723(03)80064-6; Schultheisz HL, 2008, ACS CHEM BIOL, V3, P499, DOI 10.1021/cb800066p; Schultheisz HL, 2011, J AM CHEM SOC, V133, P297, DOI 10.1021/ja1059685; Sheu DS, 2012, J BACTERIOL, V194, P2620, DOI 10.1128/JB.06543-11; Singh M, 2015, INDIAN J MICROBIOL, V55, P235, DOI 10.1007/s12088-015-0528-6; Verlinden RAJ, 2007, J APPL MICROBIOL, V102, P1437, DOI 10.1111/j.1365-2672.2007.03335.x; Yu XY, 2011, P NATL ACAD SCI USA, V108, P18643, DOI 10.1073/pnas.1110852108; Zhang SM, 2000, BIOMACROMOLECULES, V1, P244, DOI 10.1021/bm005513c; Zhang YHP, 2011, ACS CATAL, V1, P998, DOI 10.1021/cs200218f; Zhang YHP, 2010, BIOTECHNOL BIOENG, V105, P663, DOI 10.1002/bit.22630	23	78	83	4	84	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JUN	2016	12	6					393	U29		10.1038/nchembio.2062	http://dx.doi.org/10.1038/nchembio.2062			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DM2EW	27065234				2022-12-25	WOS:000376160600006
J	Steuernage, B; Periyannan, SK; Hernandez-Pinzon, I; Witek, K; Rouse, MN; Yu, GT; Hatta, A; Ayliffe, M; Bariana, H; Jones, JDG; Lagudah, ES; Wulff, BBH				Steuernage, Burkhard; Periyannan, Sambasivam K.; Hernandez-Pinzon, Inmaculada; Witek, Kamil; Rouse, Matthew N.; Yu, Guotai; Hatta, Asyraf; Ayliffe, Mick; Bariana, Harbans; Jones, Jonathan D. G.; Lagudah, Evans S.; Wulff, Brande B. H.			Rapid cloning of disease-resistance genes in plants using mutagenesis and sequence capture	NATURE BIOTECHNOLOGY			English	Article							STEM RUST RESISTANCE; WHEAT; EVOLUTION; IDENTIFICATION	Wild relatives of domesticated crop species harbor multiple, diverse, disease resistance (R) genes that could be used to engineer sustainable disease control. However, breeding R genes into crop lines often requires long breeding timelines of 5-15 years to break linkage between R genes and deleterious alleles (linkage drag). Further, when R genes are bred one at a time into crop lines, the protection that they confer is often overcome within a few seasons by pathogen evolution(1). If several cloned R genes were available, it would be possible to pyramid R genes(2) in a crop, which might provide more durable resistance(1). We describe a three-step method (MutRenSeq)-that combines chemical mutagenesis with exome capture and sequencing for rapid R gene cloning. We applied MutRenSeq to clone stem rust resistance genes Sr22 and Sr45 from hexaploid bread wheat. MutRenSeq can be applied to other commercially relevant crops and their relatives, including, for example, pea, bean, barley, oat, rye, rice and maize.	[Steuernage, Burkhard; Hernandez-Pinzon, Inmaculada; Witek, Kamil; Jones, Jonathan D. G.; Wulff, Brande B. H.] Sainsbury Lab, Norwich, Norfolk, England; [Steuernage, Burkhard; Yu, Guotai; Hatta, Asyraf; Wulff, Brande B. H.] John Innes Ctr, Norwich, Norfolk, England; [Periyannan, Sambasivam K.; Ayliffe, Mick; Lagudah, Evans S.] CSIRO, Agr, Canberra, ACT, Australia; [Rouse, Matthew N.] Univ Minnesota, USDA ARS, Cereal Dis Lab, St Paul, MN 55108 USA; [Rouse, Matthew N.] Univ Minnesota, Dept Plant Pathol, St Paul, MN 55108 USA; [Hatta, Asyraf] Univ Putra Malaysia, Dept Agr Technol, Serdang 43400, Malaysia; [Bariana, Harbans] Univ Sydney, Plant Breeding Inst, Cobbitty, NSW, Australia	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Commonwealth Scientific & Industrial Research Organisation (CSIRO); United States Department of Agriculture (USDA); University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Universiti Putra Malaysia; University of Sydney	Wulff, BBH (corresponding author), Sainsbury Lab, Norwich, Norfolk, England.; Wulff, BBH (corresponding author), John Innes Ctr, Norwich, Norfolk, England.; Lagudah, ES (corresponding author), CSIRO, Agr, Canberra, ACT, Australia.	evans.lagudah@csiro.au; brande.wulff@jic.ac.uk	Wulff, Brande BH/C-7465-2013; Jones, Jonathan DG/J-5129-2012; Ayliffe, Michael A/A-2089-2010; Lagudah, Evans/A-2007-2010; Periyannan, Sambasivam/C-1722-2014; Rouse, Matthew N/G-5474-2011	Wulff, Brande BH/0000-0003-4044-4346; Jones, Jonathan DG/0000-0002-4953-261X; Lagudah, Evans/0000-0002-6234-1789; Periyannan, Sambasivam/0000-0002-5421-2872; Yu, Guotai/0000-0002-9676-7382; Md Hatta, Muhammad Asyraf/0000-0002-8952-5684	Gatsby Charitable Foundation, UK; Two Blades Foundation, USA; Biotechnology and Biological Sciences Research Council, UK; Borlaug Global Rust Initiative (BGRI) Durable Rust Resistance in Wheat (DRRW) Project; Bill & Melinda Gates Foundation; UK Department for International Development; USDA-ARS National Plant Disease Recovery System; Grains Research and Development Corporation, Australia; Universiti Putra Malaysia (UPM), Malaysia; NBI Computing infrastructure for Science (CiS) group; ARS [ARS-0423040] Funding Source: Federal RePORTER; BBSRC [BB/L009293/1, BBS/E/J/000C0673, BB/L011794/1, BBS/E/J/000CA562, BB/M003809/1, BB/J003166/1, BB/H019820/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H019820/1, BBS/E/J/000CA562, BB/J003166/1, BBS/E/J/000C0673, BB/M003809/1, BB/L009293/1, BB/L011794/1] Funding Source: researchfish	Gatsby Charitable Foundation, UK; Two Blades Foundation, USA; Biotechnology and Biological Sciences Research Council, UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Borlaug Global Rust Initiative (BGRI) Durable Rust Resistance in Wheat (DRRW) Project; Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); UK Department for International Development; USDA-ARS National Plant Disease Recovery System; Grains Research and Development Corporation, Australia(Grains R&D Corp); Universiti Putra Malaysia (UPM), Malaysia; NBI Computing infrastructure for Science (CiS) group; ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research was supported by funds from the Gatsby Charitable Foundation, UK; Two Blades Foundation, USA; Biotechnology and Biological Sciences Research Council, UK; Borlaug Global Rust Initiative (BGRI) Durable Rust Resistance in Wheat (DRRW) Project (administered by Cornell University with a grant from the Bill & Melinda Gates Foundation and the UK Department for International Development); USDA-ARS National Plant Disease Recovery System; Grains Research and Development Corporation, Australia; and a fellowship to A.H. from Universiti Putra Malaysia (UPM), Malaysia. We are grateful to colleagues in The Sainsbury Laboratory and the Two Blades Foundation for helpful discussions. This research was supported in part by the NBI Computing infrastructure for Science (CiS) group and Dan MacLean's group by providing computational infrastructure.	Andolfo G, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-120; Dangl JL, 2013, SCIENCE, V341, P746, DOI 10.1126/science.1236011; Gaut BS, 2007, NAT REV GENET, V8, P77, DOI 10.1038/nrg1970; GERECHTERAMITAI ZK, 1971, EUPHYTICA, V20, P281, DOI 10.1007/BF00056088; Henry IM, 2014, PLANT CELL, V26, P1382, DOI 10.1105/tpc.113.121590; Hulbert SH, 2001, ANNU REV PHYTOPATHOL, V39, P285, DOI 10.1146/annurev.phyto.39.1.285; Jupe F, 2013, PLANT J, V76, P530, DOI 10.1111/tpj.12307; KERBER ER, 1969, CAN J GENET CYTOL, V11, P639, DOI 10.1139/g69-076; Kuang H, 2004, PLANT CELL, V16, P2870, DOI 10.1105/tpc.104.025502; Marais G. F., 1994, South African Journal of Plant and Soil, V11, P15; McDonald BA, 2002, ANNU REV PHYTOPATHOL, V40, P349, DOI 10.1146/annurev.phyto.40.120501.101443; Miller TS, 1988, P 7 INT WHEAT GEN S, P901; Olivera P, 2015, PHYTOPATHOLOGY, V105, P917, DOI 10.1094/PHYTO-11-14-0302-FI; Periyannan S, 2014, THEOR APPL GENET, V127, P947, DOI 10.1007/s00122-014-2270-6; Periyannan S, 2013, SCIENCE, V341, P786, DOI 10.1126/science.1239028; Rouse MN, 2011, PLANT DIS, V95, P941, DOI 10.1094/PDIS-04-10-0260; Saintenac C, 2013, SCIENCE, V341, P783, DOI 10.1126/science.1239022; Smith SM, 2004, GENETICS, V167, P1939, DOI 10.1534/genetics.104.029371; Steuernagel B, 2015, BIOINFORMATICS, V31, P1665, DOI 10.1093/bioinformatics/btv005; THE TT, 1973, NATURE-NEW BIOL, V241, P256, DOI 10.1038/newbio241256a0; Witek K., 2016, NAT BIOTECHNOL	21	229	241	6	200	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JUN	2016	34	6					652	655		10.1038/nbt.3543	http://dx.doi.org/10.1038/nbt.3543			4	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DO5TT	27111722	Green Accepted			2022-12-25	WOS:000377846400033
J	Burridge, PW; Li, YF; Matsa, E; Wu, HD; Ong, SG; Sharma, A; Holmstrom, A; Chang, AC; Coronado, MJ; Ebert, AD; Knowles, JW; Telli, ML; Witteles, RM; Blau, HM; Bernstein, D; Altman, RB; Wu, JC				Burridge, Paul W.; Li, Yong Fuga; Matsa, Elena; Wu, Haodi; Ong, Sang-Ging; Sharma, Arun; Holmstrom, Alexandra; Chang, Alex C.; Coronado, Michael J.; Ebert, Antje D.; Knowles, Joshua W.; Telli, Melinda L.; Witteles, Ronald M.; Blau, Helen M.; Bernstein, Daniel; Altman, Russ B.; Wu, Joseph C.			Human induced pluripotent stem cell-derived cardiomyocytes recapitulate the predilection of breast cancer patients to doxorubicin-induced cardiotoxicity	NATURE MEDICINE			English	Article							ANTHRACYCLINE-INDUCED CARDIOTOXICITY; MUSCLE GENE-EXPRESSION; INDUCED CARDIOMYOPATHY; OXIDATIVE STRESS; RISK-FACTORS; HEART; DEXRAZOXANE; INHIBITION; MATURATION; SURVIVORS	Doxorubicin is an anthracycline chemotherapy agent effective in treating a wide range of malignancies, but it causes a dose-related cardiotoxicity that can lead to heart failure in a subset of patients. At present, it is not possible to predict which patients will be affected by doxorubicin-induced cardiotoxicity (DIC). Here we demonstrate that patient-specific human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) can recapitulate the predilection to DIC of individual patients at the cellular level. hiPSC-CMs derived from individuals with breast cancer who experienced DIC were consistently more sensitive to doxorubicin toxicity than hiPSC-CMs from patients who did not experience DIC, with decreased cell viability, impaired mitochondria! and metabolic function, impaired calcium handling, decreased antioxidant pathway activity, and increased reactive oxygen species production. Taken together, our data indicate that hiPSC-CMs are a suitable platform to identify and characterize the genetic basis and molecular mechanisms of DIC.	[Burridge, Paul W.; Matsa, Elena; Wu, Haodi; Ong, Sang-Ging; Sharma, Arun; Holmstrom, Alexandra; Chang, Alex C.; Ebert, Antje D.; Knowles, Joshua W.; Witteles, Ronald M.; Blau, Helen M.; Bernstein, Daniel; Wu, Joseph C.] Stanford Univ, Sch Med, Stanford Cardiovasc Inst, Stanford, CA 94305 USA; [Burridge, Paul W.; Matsa, Elena; Wu, Haodi; Ong, Sang-Ging; Sharma, Arun; Holmstrom, Alexandra; Chang, Alex C.; Ebert, Antje D.; Blau, Helen M.; Wu, Joseph C.] Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Burridge, Paul W.; Matsa, Elena; Wu, Haodi; Ong, Sang-Ging; Sharma, Arun; Holmstrom, Alexandra; Ebert, Antje D.; Knowles, Joshua W.; Witteles, Ronald M.; Wu, Joseph C.] Stanford Univ, Sch Med, Div Cardiovasc Med, Dept Med, Stanford, CA 94305 USA; [Burridge, Paul W.] Northwestern Univ, Feinberg Sch Med, Dept Pharmacol, Chicago, IL 60611 USA; [Burridge, Paul W.] Northwestern Univ, Feinberg Sch Med, Ctr Pharmacogen, Chicago, IL 60611 USA; [Li, Yong Fuga] Stanford Univ, Sch Med, Stanford Genome Technol Ctr, Stanford, CA 94305 USA; [Li, Yong Fuga; Altman, Russ B.] Stanford Univ, Sch Med, Dept Bioengn, Stanford, CA 94305 USA; [Chang, Alex C.; Blau, Helen M.] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Coronado, Michael J.; Bernstein, Daniel] Stanford Univ, Sch Med, Div Cardiol, Dept Pediat, Stanford, CA 94305 USA; [Telli, Melinda L.] Stanford Univ, Dept Med, Div Oncol, Sch Med, Stanford, CA 94305 USA; [Altman, Russ B.] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University	Burridge, PW; Wu, JC (corresponding author), Stanford Univ, Sch Med, Stanford Cardiovasc Inst, Stanford, CA 94305 USA.; Burridge, PW; Wu, JC (corresponding author), Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA.; Wu, JC (corresponding author), Stanford Univ, Sch Med, Div Cardiovasc Med, Dept Med, Stanford, CA 94305 USA.	paul.burridge@northwestern.edu; joewu@stanford.edu	Burridge, Paul Wesley/AAI-2717-2021; WU, HAODI/G-7659-2019; Wu, Joseph/H-1067-2013	Wu, Joseph/0000-0002-6068-8041; Bernstein, Daniel/0000-0001-7761-5853; Sharma, Arun/0000-0002-0607-5455; Altman, Russ/0000-0003-3859-2905; Chang, Alex Chia Yu/0000-0001-9441-4033	US National Institutes of Health (NIH) [K99/R00 HL121177, R21 HL123655, R01 LM05652, R01 GM102365, R24 GM61374, R01 HL123968, R01 HL126527, R01 HL128170, R01 HL130020, R01 AR063963, R01 AG020961, R21 AG04481501, R01 NS089533]; American Heart Association (AHA) [AHA 14BGIA20480329, AHA 13POST14480004, AHA 13EIA14420025]; Dixon Translational Research Grant Young Investigator Award; California Institute of Regenerative Medicine (CIRM) [IT1-06596, TR3-05501, RB5-07469]; Muscular Dystrophy Association [4320]; Baxter Foundation; Burroughs Wellcome Fund Innovation in Regulatory Science Award; NATIONAL CANCER INSTITUTE [P30CA124435] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL121177, R01HL128170, R01HL126527, R21HL123655, R00HL121177, R01HL123968, R01HL130020, K99HL129474, T32HL094274] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR063963] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102365, R24GM061374, U01GM061374] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS089533] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG044815, R01AG020961] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM005652] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association (AHA)(American Heart Association); Dixon Translational Research Grant Young Investigator Award; California Institute of Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); Muscular Dystrophy Association(Muscular Dystrophy Association); Baxter Foundation; Burroughs Wellcome Fund Innovation in Regulatory Science Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	We thank J. Odegaard for analysis of teratoma slides. This work was supported by the US National Institutes of Health (NIH) grants K99/R00 HL121177 (P.W.B.), R21 HL123655 (D.B.), R01 LM05652 (R.B.A.), R01 GM102365 (R.B.A.), R24 GM61374 (R.B.A.), R01 HL123968 (J.C.W.), R01 HL126527 (J.C.W.), R01 HL128170 (J.C.W.), R01 HL130020 (J.C.W.), R01 AR063963 (H.M.B.), R01 AG020961 (H.M.B.), R21 AG04481501 (H.M.B.), and R01 NS089533 (H.M.B.); the American Heart Association (AHA) grants AHA 14BGIA20480329 (P.W.B.), AHA 13POST14480004 (A.C.C.), and AHA 13EIA14420025 (J.C.W.); a Dixon Translational Research Grant Young Investigator Award (P.W.B.), the California Institute of Regenerative Medicine (CIRM) awards IT1-06596 (J.C.W.), TR3-05501 (H.M.B.) and RB5-07469 (H.M.B.); the Muscular Dystrophy Association grant 4320 (H.M.B.); the Baxter Foundation (H.M.B.); and a Burroughs Wellcome Fund Innovation in Regulatory Science Award (J.C.W.).	Aminkeng F, 2015, NAT GENET, V47, P1079, DOI 10.1038/ng.3374; Arts-de Jong M, 2014, CRIT REV ONCOL HEMAT, V91, P159, DOI 10.1016/j.critrevonc.2014.01.008; Berdichevski A, 2010, J PHARMACOL EXP THER, V332, P413, DOI 10.1124/jpet.109.161158; Bernstein D, 2014, PROG PEDIATR CARDIOL, V37, P23, DOI 10.1016/j.ppedcard.2014.10.006; Bramwell V.H.C., 2002, SAFETY EFFICACY MULT; Brown SA, 2015, NAT REV CLIN ONCOL, V12, P718, DOI 10.1038/nrclinonc.2015.168; Burridge PW, 2016, METHODS MOL BIOL, V1353, P119, DOI 10.1007/7651_2015_196; Burridge PW, 2014, NAT METHODS, V11, P855, DOI [10.1038/NMETH.2999, 10.1038/nmeth.2999]; Burridge PW, 2015, CURR PROTOC HUM GENE, V87; Cahan P, 2013, NAT REV MOL CELL BIO, V14, P357, DOI 10.1038/nrm3584; Chen B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035743; David R, 2012, PHYSIOLOGY, V27, P119, DOI 10.1152/physiol.00044.2011; Deavall DG, 2012, J TOXICOL-US, V2012, DOI 10.1155/2012/645460; Deng SW, 2015, BRIT J PHARMACOL, V172, P2246, DOI 10.1111/bph.13046; Denning C, 2015, BIOCH BIOPHYS ACTA, V2, pS0167; DOROSHOW JH, 1983, CANCER RES, V43, P460; DOROSHOW JH, 1980, J CLIN INVEST, V65, P128, DOI 10.1172/JCI109642; Engreitz JM, 2010, J BIOMED INFORM, V43, P932, DOI 10.1016/j.jbi.2010.07.001; Farshid AA, 2014, CARDIOVASC TOXICOL, V14, P153, DOI 10.1007/s12012-013-9239-6; Giordano SH, 2012, J CLIN ONCOL, V30, P2232, DOI 10.1200/JCO.2011.40.1273; GOORMAGHTIGH E, 1987, BIOCHEMISTRY-US, V26, P1789, DOI 10.1021/bi00380a043; Granger CB, 2006, CIRCULATION, V114, P2432, DOI 10.1161/CIRCULATIONAHA.106.666248; Hanna AD, 2014, MOL PHARMACOL, V86, P438, DOI 10.1124/mol.114.093849; Hattori F, 2010, NAT METHODS, V7, P61, DOI [10.1038/NMETH.1403, 10.1038/nmeth.1403]; HOLMBERG SRM, 1990, CIRC RES, V67, P272, DOI 10.1161/01.RES.67.2.272; Hussner J, 2012, MOL PHARMACOL, V81, P679, DOI 10.1124/mol.111.075994; Ichikawa Y, 2014, J CLIN INVEST, V124, P617, DOI 10.1172/JCI72931; ITO H, 1990, P NATL ACAD SCI USA, V87, P4275, DOI 10.1073/pnas.87.11.4275; Khiati S, 2014, CLIN CANCER RES, V20, P4873, DOI 10.1158/1078-0432.CCR-13-3373; KIM HD, 1994, ANAT REC, V238, P199, DOI 10.1002/ar.1092380206; Kremer LCM, 2002, ANN ONCOL, V13, P819, DOI 10.1093/annonc/mdf167; Lebrecht D, 2005, J PATHOL, V207, P436, DOI 10.1002/path.1863; LEFRAK EA, 1973, CANCER-AM CANCER SOC, V32, P302, DOI 10.1002/1097-0142(197308)32:2<302::AID-CNCR2820320205>3.0.CO;2-2; Lim CC, 2004, J BIOL CHEM, V279, P8290, DOI 10.1074/jbc.M308033200; Lipshultz SE, 2015, ANNU REV MED, V66, P161, DOI 10.1146/annurev-med-070213-054849; Lipshultz SE, 2013, NAT REV CLIN ONCOL, V10, P697, DOI 10.1038/nrclinonc.2013.195; Mathur A, 2015, SCI REP-UK, V5, DOI 10.1038/srep08883; Mercola M, 2013, CIRC RES, V112, P534, DOI 10.1161/CIRCRESAHA.111.250266; Naidu SR, 2009, ONCOGENE, V28, P2492, DOI 10.1038/onc.2009.121; Octavia Y, 2012, J MOL CELL CARDIOL, V52, P1213, DOI 10.1016/j.yjmcc.2012.03.006; Peterson SE, 2014, J BIOL CHEM, V289, P4578, DOI 10.1074/jbc.R113.516419; Rana P, 2012, TOXICOL SCI, V130, P117, DOI 10.1093/toxsci/kfs233; ROBERT J, 1985, CANCER TREAT REP, V69, P633; Ruan Y, 2015, CELL PHYSIOL BIOCHEM, V35, P1116, DOI 10.1159/000373937; Shakir Douraid K, 2009, J Clin Med Res, V1, P8, DOI 10.4021/jocmr2009.02.1225; Shi Y, 2011, HERZ, V36, P296, DOI 10.1007/s00059-011-3470-3; Swain SM, 1997, J CLIN ONCOL, V15, P1318, DOI 10.1200/JCO.1997.15.4.1318; Swain SM, 2003, CANCER, V97, P2869, DOI 10.1002/cncr.11407; Thorn CF, 2011, PHARMACOGENET GENOM, V21, P440, DOI 10.1097/FPC.0b013e32833ffb56; Torti SV, 1998, J MOL CELL CARDIOL, V30, P1173, DOI 10.1006/jmcc.1998.0681; Vejpongsa P, 2014, J AM COLL CARDIOL, V64, P938, DOI 10.1016/j.jacc.2014.06.1167; Venditti P, 1998, CARDIOVASC RES, V38, P695, DOI 10.1016/S0008-6363(98)00034-0; Visscher H, 2013, PEDIATR BLOOD CANCER, V60, P1375, DOI 10.1002/pbc.24505; VONHOFF DD, 1979, ANN INTERN MED, V91, P710, DOI 10.7326/0003-4819-91-5-710; Xu XX, 2005, MOL PHARMACOL, V68, P261, DOI 10.1124/mol.105.013383; Yang XL, 2014, J MOL CELL CARDIOL, V72, P296, DOI 10.1016/j.yjmcc.2014.04.005; Zhang S, 2012, NAT MED, V18, P1639, DOI 10.1038/nm.2919; Zhu RJ, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt507; Zhu WQ, 2014, CARDIOVASC RES, V103, P81, DOI 10.1093/cvr/cvu118	59	421	428	3	134	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2016	22	5					547	556		10.1038/nm.4087	http://dx.doi.org/10.1038/nm.4087			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DL3DI	27089514	Green Accepted			2022-12-25	WOS:000375514000018
J	Su, KH; Cao, JY; Tang, ZJ; Dai, SY; He, YS; Sampson, SB; Benjamin, IJ; Dai, CK				Su, Kuo-Hui; Cao, Junyue; Tang, Zijian; Dai, Siyuan; He, Yishu; Sampson, Stephen Byers; Benjamin, Ivor J.; Dai, Chengkai			HSF1 critically attunes proteotoxic stress sensing by mTORC1 to combat stress and promote growth	NATURE CELL BIOLOGY			English	Article							SMALL-MOLECULE INHIBITOR; HEAT-SHOCK RESPONSE; SIGNAL-TRANSDUCTION; INSULIN-RESISTANCE; PROTEIN-SYNTHESIS; CELL-GROWTH; RAG GTPASES; MOUSE MODEL; KINASE; COMPLEX	To cope with proteotoxic stress, cells attenuate protein synthesis. However, the precise mechanisms underlying this fundamental adaptation remain poorly defined. Here we report that mTORC1 acts as an immediate cellular sensor of proteotoxic stress. Surprisingly, the multifaceted stress-responsive kinase JNK constitutively associates with mTORC1 under normal growth conditions. On activation by proteotoxic stress, JNK phosphorylates both RAPTOR at S863 and mTOR at S567, causing partial disintegration of mTORC1 and subsequent translation inhibition. Importantly, HSF1, the central player in the proteotoxic stress response (PSR), preserves mTORC1 integrity and function by inactivating JNK, independently of its canonical transcriptional action. Thereby, HSF1 translationally augments the PSR. Beyond promoting stress resistance, this intricate HSF1-JNK-mTORC1 interplay, strikingly, regulates cell, organ and body sizes. Thus, these results illuminate a unifying mechanism that controls stress adaptation and growth.	[Su, Kuo-Hui; Cao, Junyue; Tang, Zijian; Dai, Siyuan; He, Yishu; Sampson, Stephen Byers; Dai, Chengkai] Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA; [Tang, Zijian] Univ Maine, Dept Mol & Biomed Sci, Graduate Programs, 5735 Hitchner Hall, Orono, ME 04469 USA; [Benjamin, Ivor J.] Med Coll Wisconsin, Div Cardiovasc Med, Milwaukee, WI 53226 USA	Jackson Laboratory; University of Maine System; University of Maine Orono; Medical College of Wisconsin	Dai, CK (corresponding author), Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.	Chengkai.Dai@jax.org	Su, Kuo-Hui/K-2234-2016	Su, Kuo-Hui/0000-0002-0834-8568; Cao, Junyue/0000-0003-4097-489X	NIH [1DP1OD006438, 1DP2OD007070]; Jackson Laboratory Cancer Center Support Grant [3P30CA034196]; Ellison Medical Foundation [AS-NS-0599-09]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD039404] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA034196] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [DP1HL117650] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD006438, DP2OD007070] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jackson Laboratory Cancer Center Support Grant; Ellison Medical Foundation(Lawrence Ellison Foundation); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We would like to thank members of the Dai laboratory for discussions and technical assistance. This work was supported by a grant from the NIH (1DP1OD006438) to I.J.B.; and The Jackson Laboratory Cancer Center Support Grant (3P30CA034196), and grants from the NIH (1DP2OD007070) and the Ellison Medical Foundation (AS-NS-0599-09) to C.D.	Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Betz C, 2013, J CELL BIOL, V203, P563, DOI 10.1083/jcb.201306041; Bogoyevitch MA, 2006, MICROBIOL MOL BIOL R, V70, P1061, DOI 10.1128/MMBR.00025-06; Chaveroux C, 2009, MOL CELL BIOL, V29, P6515, DOI 10.1128/MCB.00489-09; Chen J, 2010, ONCOGENE, V29, P4399, DOI 10.1038/onc.2010.198; Clausson CM, 2011, NAT METHODS, V8, P892, DOI 10.1038/nmeth.1743; Cui HY, 2007, CANCER RES, V67, P3345, DOI 10.1158/0008-5472.CAN-06-2519; Dai C, 2007, CELL, V130, P1005, DOI 10.1016/j.cell.2007.07.020; Dai CK, 2012, J CLIN INVEST, V122, P3742, DOI 10.1172/JCI62727; Dai CK, 2012, J CELL PHYSIOL, V227, P2982, DOI 10.1002/jcp.24017; Dai SY, 2015, EMBO J, V34, P275, DOI 10.15252/embj.201489062; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; Dong C, 1998, SCIENCE, V282, P2092, DOI 10.1126/science.282.5396.2092; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; Fingar DC, 2002, GENE DEV, V16, P1472, DOI 10.1101/gad.995802; Freeman A, 2003, J VIRAL HEPATITIS, V10, P345, DOI 10.1046/j.1365-2893.2003.00454.x; Geiger PC, 2005, AM J PHYSIOL-ENDOC M, V288, pE782, DOI 10.1152/ajpendo.00477.2004; Goyal L, 2013, CLIN CANCER RES, V19, P2310, DOI 10.1158/1078-0432.CCR-12-2791; Gupta S, 1996, EMBO J, V15, P2760, DOI 10.1002/j.1460-2075.1996.tb00636.x; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Jewell JL, 2013, NAT REV MOL CELL BIO, V14, P133, DOI 10.1038/nrm3522; Jez JM, 2003, CHEM BIOL, V10, P361, DOI 10.1016/S1074-5521(03)00075-9; Jin XJ, 2011, CELL METAB, V14, P91, DOI 10.1016/j.cmet.2011.03.025; Jorgensen P, 2004, CURR BIOL, V14, pR1014, DOI 10.1016/j.cub.2004.11.027; Kawaguchi Y, 2003, CELL, V115, P727, DOI 10.1016/S0092-8674(03)00939-5; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Kwiatkowski DJ, 2002, HUM MOL GENET, V11, P525, DOI 10.1093/hmg/11.5.525; Kyriakis JM, 2012, PHYSIOL REV, V92, P689, DOI 10.1152/physrev.00028.2011; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lei K, 2002, MOL CELL BIOL, V22, P4929, DOI 10.1128/MCB.22.13.4929-4942.2002; Leu JIJ, 2009, MOL CELL, V36, P15, DOI 10.1016/j.molcel.2009.09.023; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; LINDQUIST S, 1981, NATURE, V293, P311, DOI 10.1038/293311a0; Liu J, 2012, P NATL ACAD SCI USA, V109, P413, DOI 10.1073/pnas.1111561108; Manning AM, 2003, NAT REV DRUG DISCOV, V2, P554, DOI 10.1038/nrd1132; Massey AJ, 2010, CANCER CHEMOTH PHARM, V66, P535, DOI 10.1007/s00280-009-1194-3; Meng L, 2010, ONCOGENE, V29, P5204, DOI 10.1038/onc.2010.277; Min JN, 2007, ONCOGENE, V26, P5086, DOI 10.1038/sj.onc.1210317; Morimoto RI, 2011, COLD SPRING HARB SYM, V76, P91, DOI DOI 10.1101/SQB.2012.76.010637; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Pickart CM, 2004, BBA-MOL CELL RES, V1695, P55, DOI 10.1016/j.bbamcr.2004.09.019; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; Qian SB, 2010, J BIOL CHEM, V285, P27385, DOI 10.1074/jbc.M110.120295; Rosner M, 2008, HUM MOL GENET, V17, P2934, DOI 10.1093/hmg/ddn192; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Soliman GA, 2010, J BIOL CHEM, V285, P7866, DOI 10.1074/jbc.M109.096222; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Tang ZJ, 2015, CELL, V160, P729, DOI 10.1016/j.cell.2015.01.028; Trepel J, 2010, NAT REV CANCER, V10, P537, DOI 10.1038/nrc2887; Um SH, 2006, CELL METAB, V3, P393, DOI 10.1016/j.cmet.2006.05.003; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Xiao XZ, 1999, EMBO J, V18, P5943, DOI 10.1093/emboj/18.21.5943; Yang DD, 1998, IMMUNITY, V9, P575, DOI 10.1016/S1074-7613(00)80640-8; Zhang H, 2004, J BIOL CHEM, V279, P19457, DOI 10.1074/jbc.M311377200; Zhang T, 2012, CHEM BIOL, V19, P140, DOI 10.1016/j.chembiol.2011.11.010	61	46	48	2	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAY	2016	18	5					527	+		10.1038/ncb3335	http://dx.doi.org/10.1038/ncb3335			33	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	DK3RH	27043084	Green Accepted			2022-12-25	WOS:000374834600010
J	Isojima, H; Iino, R; Niitani, Y; Noji, H; Tomishige, M				Isojima, Hiroshi; Iino, Ryota; Niitani, Yamato; Noji, Hiroyuki; Tomishige, Michio			Direct observation of intermediate states during the stepping motion of kinesin-1	NATURE CHEMICAL BIOLOGY			English	Article							HAND-OVER-HAND; ATP HYDROLYSIS; NECK LINKER; INTERNAL STRAIN; MOTOR DOMAINS; FRONT HEAD; PROCESSIVITY; MICROTUBULE; MECHANISM; MOVEMENT	The dimeric motor protein kinesin-1 walks along microtubules by alternatingly hydrolyzing ATP and moving two motor domains ('heads'). Nanometer-precision single-molecule studies demonstrated that kinesin takes regular 8-nm steps upon hydrolysis of each ATP; however, the intermediate states between steps have not been directly visualized. Here, we employed high-temporal resolution dark-field microscopy to directly visualize the binding and unbinding of kinesin heads to or from microtubules during processive movement. Our observations revealed that upon unbinding from microtubules, the labeled heads were displaced rightward and underwent tethered diffusive movement. Structural and kinetic analyses of wild-type and mutant kinesins with altered neck linker lengths provided evidence that rebinding of the unbound head to the rear-binding site is prohibited by a tension increase in the neck linker and that ATP hydrolysis by the leading head is suppressed when both heads are bound to the microtubule, thereby explaining how the two heads coordinate to move in a hand-over-hand manner.	[Isojima, Hiroshi; Niitani, Yamato; Tomishige, Michio] Univ Tokyo, Dept Appl Phys, Sch Engn, 7-3-1 Hongo, Tokyo 113, Japan; [Iino, Ryota] Natl Inst Nat Sci, Inst Mol Sci, Okazaki Inst Integrat Biosci, Nagakute, Aichi, Japan; [Iino, Ryota] Grad Univ Adv Studies SOKENDAI, Sch Phys Sci, Dept Funct Mol Sci, Hayama, Kanagawa, Japan; [Niitani, Yamato] Univ Tokyo, Sch Engn, Quantum Phase Elect Ctr, Tokyo, Japan; [Noji, Hiroyuki] Univ Tokyo, Sch Engn, Dept Appl Chem, Tokyo, Japan	University of Tokyo; National Institutes of Natural Sciences (NINS) - Japan; Institute for Molecular Science (IMS); Okazaki Institute for Integrative Bioscience (OIIB); Graduate University for Advanced Studies - Japan; University of Tokyo; University of Tokyo	Tomishige, M (corresponding author), Univ Tokyo, Dept Appl Phys, Sch Engn, 7-3-1 Hongo, Tokyo 113, Japan.	tomishige@ap.t.u-tokyo.ac.jp	Ishida, Mari/AAU-3379-2020; Iino, Ryota/B-7746-2011	Iino, Ryota/0000-0003-0110-5704	Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology [24370063, 24370062, 26104507, 25251016]; Grants-in-Aid for Scientific Research [26000011] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank M. Nakajima for support with cloning, M. Tanigawara for support with the preparation of colloidal gold and R. Vale for useful comments on the manuscript. We also acknowledge that the neck-linker mutants were first established by M.T. with R. Vale. H.I. is supported by Research Fellowships for Young Scientists from the Japan Society for the Promotion of Science. M.T. (no. 24370063), R. I. (no. 24370062, no. 26104507) and H.N. (no. 25251016) are supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology.	Alonso MC, 2007, SCIENCE, V316, P120, DOI 10.1126/science.1136985; Asbury CL, 2005, CURR OPIN CELL BIOL, V17, P89, DOI 10.1016/j.ceb.2004.12.002; Asbury CL, 2003, SCIENCE, V302, P2130, DOI 10.1126/science.1092985; Asenjo AB, 2003, NAT STRUCT BIOL, V10, P836, DOI 10.1038/nsb984; Asenjo AB, 2009, P NATL ACAD SCI USA, V106, P5657, DOI 10.1073/pnas.0808355106; Auerbach SD, 2005, J BIOL CHEM, V280, P37048, DOI 10.1074/jbc.M502984200; Block SM, 2007, BIOPHYS J, V92, P2986, DOI 10.1529/biophysj.106.100677; Cao LY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6364; Carter NJ, 2005, NATURE, V435, P308, DOI 10.1038/nature03528; Clancy BE, 2011, NAT STRUCT MOL BIOL, V18, P1020, DOI 10.1038/nsmb.2104; Cross RA, 2004, TRENDS BIOCHEM SCI, V29, P301, DOI 10.1016/j.tibs.2004.04.010; Dogan MY, 2015, CELL REP, V10, P1967, DOI 10.1016/j.celrep.2015.02.061; Dunn AR, 2007, NAT STRUCT MOL BIOL, V14, P246, DOI 10.1038/nsmb1206; Gennerich A, 2009, CURR OPIN CELL BIOL, V21, P59, DOI 10.1016/j.ceb.2008.12.002; Gilbert SP, 1998, BIOCHEMISTRY-US, V37, P792, DOI 10.1021/bi971117b; Gutierrez-Medina B, 2009, P NATL ACAD SCI USA, V106, P17007, DOI 10.1073/pnas.0907133106; Guydosh NR, 2006, P NATL ACAD SCI USA, V103, P8054, DOI 10.1073/pnas.0600931103; Guydosh NR, 2009, NATURE, V461, P125, DOI 10.1038/nature08259; Hackney DD, 2007, SCIENCE, V316, P58, DOI 10.1126/science.1141549; HACKNEY DD, 1994, P NATL ACAD SCI USA, V91, P6865, DOI 10.1073/pnas.91.15.6865; Hackney DD, 2005, P NATL ACAD SCI USA, V102, P18338, DOI 10.1073/pnas.0505288102; Hackney DD, 2003, BIOCHEMISTRY-US, V42, P12011, DOI 10.1021/bi0349118; Hancock WO, 1999, P NATL ACAD SCI USA, V96, P13147, DOI 10.1073/pnas.96.23.13147; Hua W, 1997, NATURE, V388, P390, DOI 10.1038/41118; Hua W, 2002, SCIENCE, V295, P844, DOI 10.1126/science.1063089; Hyeon C, 2007, P NATL ACAD SCI USA, V104, P17382, DOI 10.1073/pnas.0708828104; Hyeon C, 2007, P NATL ACAD SCI USA, V104, P2175, DOI 10.1073/pnas.0610939104; Hyeon C, 2011, BIOPHYS J, V101, P2749, DOI 10.1016/j.bpj.2011.10.037; Kaseda K, 2003, NAT CELL BIOL, V5, P1079, DOI 10.1038/ncb1067; Kerssemakers JWJ, 2006, NATURE, V442, P709, DOI 10.1038/nature04928; Kikkawa M, 2008, TRENDS CELL BIOL, V18, P128, DOI 10.1016/j.tcb.2008.01.002; Klumpp LM, 2004, P NATL ACAD SCI USA, V101, P3444, DOI 10.1073/pnas.0307691101; Ma YZ, 1997, J BIOL CHEM, V272, P724, DOI 10.1074/jbc.272.2.724; Milic B, 2014, P NATL ACAD SCI USA, V111, P14136, DOI 10.1073/pnas.1410943111; Mori T, 2007, NATURE, V450, P750, DOI 10.1038/nature06346; Nishikawa S, 2010, CELL, V142, P879, DOI 10.1016/j.cell.2010.08.033; Rice S, 1999, NATURE, V402, P778, DOI 10.1038/45483; Rosenfeld SS, 2003, J BIOL CHEM, V278, P18550, DOI 10.1074/jbc.M300849200; Schnitzer MJ, 1997, NATURE, V388, P386, DOI 10.1038/41111; Shastry S, 2010, CURR BIOL, V20, P939, DOI 10.1016/j.cub.2010.03.065; SVOBODA K, 1993, NATURE, V365, P721, DOI 10.1038/365721a0; T Valentine M, 2007, CURR OPIN CELL BIOL, V19, P75, DOI 10.1016/j.ceb.2006.12.011; Tomishige M, 2006, NAT STRUCT MOL BIOL, V13, P887, DOI 10.1038/nsmb1151; Uemura S, 2003, NAT STRUCT BIOL, V10, P308, DOI 10.1038/nsb911; Ueno H, 2010, BIOPHYS J, V98, P2014, DOI 10.1016/j.bpj.2010.01.011; Vale RD, 2000, SCIENCE, V288, P88, DOI 10.1126/science.288.5463.88; Verbrugge S, 2009, P NATL ACAD SCI USA, V106, P17741, DOI 10.1073/pnas.0905177106; Visscher K, 1999, NATURE, V400, P184, DOI 10.1038/22146; Yildiz A, 2004, SCIENCE, V303, P676, DOI 10.1126/science.1093753; Yildiz A, 2008, CELL, V134, P1030, DOI 10.1016/j.cell.2008.07.018	51	82	82	2	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	APR	2016	12	4					290	+		10.1038/NCHEMBIO.2028	http://dx.doi.org/10.1038/NCHEMBIO.2028			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH2DA	26928936				2022-12-25	WOS:000372593200018
J	Ge, YJ; Zhang, L; Nikolova, M; Reva, B; Fuchs, E				Ge, Yejing; Zhang, Liang; Nikolova, Maria; Reva, Boris; Fuchs, Elaine			Strand-specific in vivo screen of cancer-associated miRNAs unveils a role for miR-21*in SCC progression	NATURE CELL BIOLOGY			English	Article							SQUAMOUS-CELL CARCINOMA; TUMOR-SUPPRESSOR; BREAST-CANCER; TGF-BETA; STEM-CELLS; EXPRESSION; SKIN; MIR-21; TUMORIGENESIS; MICRORNAS	MicroRNAs play diverse roles in both normal and malignant stem cells. Focusing on miRs and/or miR*s abundant in squamous cell carcinoma (SCC) stem cells, we engineer an efficient, strand-specific expression library, and apply functional genomics screening in mice to identify which of 169 cancer-associated miRs are key drivers in malignant progression. Not previously linked functionally to cancer, miR-21* was the second top hit, surfacing in >12% of tumours. miR-21* also correlates with poor prognosis in human SCCs and enhances tumour progression in xenografts. On deleting the miR-21 gene and rescuing each strand separately, we document the dual, but independent, oncogenicity of miR-21 and miR-21*. A cohort of predicted miR-21* targets inversely correlate with miR-21* in SCCs. Of particular interest is Phactr4, which we show is a miR-21* target in SCCs, acting through the Rb/E2F cell cycle axis. Through in vivo physiological miR screens, our findings add an interesting twist to an increasingly important oncomiR locus.	[Ge, Yejing; Zhang, Liang; Nikolova, Maria; Fuchs, Elaine] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA; [Ge, Yejing; Zhang, Liang; Nikolova, Maria; Fuchs, Elaine] Rockefeller Univ, Lab Mammalian Cell Biol & Dev, New York, NY 10065 USA; [Reva, Boris] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY 10029 USA	Howard Hughes Medical Institute; Rockefeller University; Rockefeller University; Icahn School of Medicine at Mount Sinai	Fuchs, E (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA.	fuchslb@rockefeller.edu	Reva, Boris/AAB-8932-2022; Fuchs, Elaine/G-1565-2016	Zhang, Liang/0000-0003-4396-9199	Women Sr Science Postdoctoral Fellowship; Department of Defense Breast Cancer Postdoctoral Fellowship; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R37AR027883] Funding Source: NIH RePORTER	Women Sr Science Postdoctoral Fellowship; Department of Defense Breast Cancer Postdoctoral Fellowship; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We especially thank D. Schramek for intellectual input into the design of the allograft assay. We also thank D. Schramek and A. Sendoel for advice regarding data presentation; J. Racelis for technical assistance; A. Aldeguer, L. Polak, J. Levorse, S. Hacker, M. Sribour, D. Oristian and N. Stokes for assistance with mouse handling and experiments; and Z. Shen, N. Oshimori, S. Luo, K. Lay, M. Kadaja, B. Keyes, A. Asare, M. Laurin, R. Adam and A. Kulukian for helpful discussions. We thank the Comparative Bioscience Center (AAALAC accredited) for care of mice in accordance with National Institutes of Health (NIH) guidelines; Rockefeller Genomics Resource Center (C. Zhao, Director) and Weill Cornell Genomics Resource Center (J. Xiang, Director) for sequencing; Flow Cytometry facility (S. Mazel, Director) for FACS sorting. E.F. is an Investigator of the Howard Hughes Medical Institute. Y.G. is the recipient of a Women Sr Science Postdoctoral Fellowship, and a Department of Defense Breast Cancer Postdoctoral Fellowship.	Adam RC, 2015, NATURE, V521, P366, DOI 10.1038/nature14289; Adams BD, 2014, CURR BIOL, V24, pR762, DOI 10.1016/j.cub.2014.06.043; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Benaich N, 2014, CELL REP, V9, P104, DOI 10.1016/j.celrep.2014.08.062; Beronja S, 2013, NATURE, V501, P185, DOI 10.1038/nature12464; Beronja S, 2010, NAT MED, V16, P821, DOI 10.1038/nm.2167; Bhandari A, 2013, ONCOGENE, V32, P1497, DOI 10.1038/onc.2012.168; Chen X, 2009, P NATL ACAD SCI USA, V106, P7979, DOI 10.1073/pnas.0900343106; Darido C, 2011, CANCER CELL, V20, P635, DOI 10.1016/j.ccr.2011.10.014; Di Leva G, 2014, ANNU REV PATHOL-MECH, V9, P287, DOI 10.1146/annurev-pathol-012513-104715; Frankel LB, 2008, J BIOL CHEM, V283, P1026, DOI 10.1074/jbc.M707224200; Fujita S, 2008, J MOL BIOL, V378, P492, DOI 10.1016/j.jmb.2008.03.015; Ge YJ, 2011, J CELL BIOL, V192, P69, DOI 10.1083/jcb.201007165; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Hatley ME, 2010, CANCER CELL, V18, P282, DOI 10.1016/j.ccr.2010.08.013; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Keyes BE, 2013, P NATL ACAD SCI USA, V110, pE4950, DOI 10.1073/pnas.1320301110; Kim TH, 2007, DEV CELL, V13, P87, DOI 10.1016/j.devcel.2007.04.018; Lapouge G, 2012, EMBO J, V31, P4563, DOI 10.1038/emboj.2012.312; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lujambio A, 2012, NATURE, V482, P347, DOI 10.1038/nature10888; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Ma XD, 2011, P NATL ACAD SCI USA, V108, P10144, DOI 10.1073/pnas.1103735108; Medina PP, 2010, NATURE, V467, P86, DOI 10.1038/nature09284; Nassar D, 2015, NAT MED, V21, P946, DOI 10.1038/nm.3878; Oshimori N, 2015, CELL, V160, P963, DOI 10.1016/j.cell.2015.01.043; Pink RC, 2015, GYNECOL ONCOL, V137, P143, DOI 10.1016/j.ygyno.2014.12.042; QUINTANILLA M, 1986, NATURE, V322, P78, DOI 10.1038/322078a0; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Schober M, 2011, P NATL ACAD SCI USA, V108, P10544, DOI 10.1073/pnas.1107807108; Schramek D, 2014, SCIENCE, V343, P309, DOI 10.1126/science.1248627; Solimini NL, 2013, P NATL ACAD SCI USA, V110, pE407, DOI 10.1073/pnas.1221385110; Talotta F, 2009, ONCOGENE, V28, P73, DOI 10.1038/onc.2008.370; Taylor MA, 2013, J CLIN INVEST, V123, P150, DOI 10.1172/JCI64946; Yi R, 2006, NAT GENET, V38, P356, DOI 10.1038/ng1744; Zhang L, 2014, GENE DEV, V28, P2532, DOI 10.1101/gad.248377.114	39	52	53	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2016	18	1					111	+		10.1038/ncb3275	http://dx.doi.org/10.1038/ncb3275			13	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CZ3VA	26619149	Green Accepted			2022-12-25	WOS:000367030900004
J	Sun, SS; Shah, P; Eshghi, ST; Yang, WM; Trikannad, N; Yang, S; Chen, LJ; Aiyetan, P; Hoti, N; Zhang, Z; Chan, DW; Zhang, H				Sun, Shisheng; Shah, Punit; Eshghi, Shadi Toghi; Yang, Weiming; Trikannad, Namita; Yang, Shuang; Chen, Lijun; Aiyetan, Paul; Hoti, Naseruddin; Zhang, Zhen; Chan, Daniel W.; Zhang, Hui			Comprehensive analysis of protein glycosylation by solid-phase extraction of N-linked glycans and glycosite-containing peptides	NATURE BIOTECHNOLOGY			English	Article							HYDROPHILIC INTERACTION CHROMATOGRAPHY; MASS-SPECTROMETRY; GLYCOPEPTIDES; IDENTIFICATION; GLYCOPROTEINS; HETEROGENEITY; ENRICHMENT; DATABASE; SITES; TOOLS	Comprehensive characterization of protein glycosylation is critical for understanding the structure and function of glycoproteins. However, due to the complexity and heterogeneity of glycoprotein conformations, current glycoprotein analyses focus mainly on either the deglycosylated glycosylation site (glycosite)-containing peptides or the released glycans. Here, we describe a chemoenzymatic method called solid phase extraction of N-linked glycans and glycosite-containing peptides (NGAG) for the comprehensive characterization of glycoproteins that is able to determine glycan heterogeneity for individual glycosites in addition to providing information about the total N-linked glycan, glycosite-containing peptide and glycoprotein content of complex samples. The NGAG method can also be applied to quantitatively detect glycoprotein alterations in total and site-specific glycan occupancies.	[Sun, Shisheng; Shah, Punit; Eshghi, Shadi Toghi; Yang, Weiming; Trikannad, Namita; Yang, Shuang; Chen, Lijun; Aiyetan, Paul; Hoti, Naseruddin; Zhang, Zhen; Chan, Daniel W.; Zhang, Hui] Johns Hopkins Univ, Dept Pathol, Baltimore, MD USA	Johns Hopkins University	Zhang, H (corresponding author), Johns Hopkins Univ, Dept Pathol, Baltimore, MD USA.	hzhang32@jhmi.edu	Sun, Shisheng/P-5027-2019; Yang, Weiming/D-8480-2017	Yang, Weiming/0000-0002-5023-2155; Sun, Shisheng/0000-0002-7242-7164; Toghi Eshghi, Shadi/0000-0002-0254-7814	National Institutes of Health, National Cancer Institute, Clinical Proteomic Tumor Analysis Consortium [U24CA160036]; Early Detection Research Network (EDRN) [U01CA152813, U24CA115102]; National Institutes of Health, National Heart, Lung, and Blood Institute Programs of Excellence in Glycosciences (PEG) [P01HL107153]; Johns Hopkins Proteomics Center [N01-HV-00240];  [R01CA112314]; NATIONAL CANCER INSTITUTE [U24CA115102, R01CA112314, U01CA152813, U24CA160036] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107153] Funding Source: NIH RePORTER	National Institutes of Health, National Cancer Institute, Clinical Proteomic Tumor Analysis Consortium; Early Detection Research Network (EDRN)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health, National Heart, Lung, and Blood Institute Programs of Excellence in Glycosciences (PEG); Johns Hopkins Proteomics Center; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institutes of Health, National Cancer Institute, Clinical Proteomic Tumor Analysis Consortium (U24CA160036), the Early Detection Research Network (EDRN, U01CA152813 and U24CA115102) and R01CA112314, and by the National Institutes of Health, National Heart, Lung, and Blood Institute Programs of Excellence in Glycosciences (PEG, P01HL107153) and the Johns Hopkins Proteomics Center (N01-HV-00240).	Bern M., 2012, CURRENT PROTOCOLS BI; Brancia FL, 2000, RAPID COMMUN MASS SP, V14, P2070, DOI 10.1002/1097-0231(20001115)14:21<2070::AID-RCM133>3.0.CO;2-G; Breidenbach MA, 2010, P NATL ACAD SCI USA, V107, P3988, DOI 10.1073/pnas.0911247107; Chen SM, 2007, NAT METHODS, V4, P437, DOI 10.1038/NMETH1035; Drake PM, 2010, CLIN CHEM, V56, P223, DOI 10.1373/clinchem.2009.136333; Eshghi ST, 2015, ANAL CHEM, V87, P5181, DOI 10.1021/acs.analchem.5b00024; Freeze H., 2009, ESSENTIALS GLYCOBIOL, P66; Jensen PH, 2012, NAT PROTOC, V7, P1299, DOI 10.1038/nprot.2012.063; Kaji H, 2003, NAT BIOTECHNOL, V21, P667, DOI 10.1038/nbt829; Kolarich D, 2012, NAT PROTOC, V7, P1285, DOI 10.1038/nprot.2012.062; Lattova E, 2006, ANAL CHEM, V78, P2977, DOI 10.1021/ac0519918; Liu T, 2001, ANAL CHEM, V73, P5875, DOI 10.1021/ac0106748; Moremen KW, 2012, NAT REV MOL CELL BIO, V13, P448, DOI 10.1038/nrm3383; Nilsson J, 2009, NAT METHODS, V6, P809, DOI [10.1038/NMETH.1392, 10.1038/nmeth.1392]; Nothaft H, 2010, NAT REV MICROBIOL, V8, P765, DOI 10.1038/nrmicro2383; Parker BL, 2013, J PROTEOME RES, V12, P5791, DOI 10.1021/pr400783j; PAXTON RJ, 1987, P NATL ACAD SCI USA, V84, P920, DOI 10.1073/pnas.84.4.920; Pompach P, 2012, J PROTEOME RES, V11, P1728, DOI 10.1021/pr201183w; Scott NE, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M000031-MCP201; Shah P, 2013, ANAL CHEM, V85, P3606, DOI 10.1021/ac3033867; Tian YA, 2007, NAT PROTOC, V2, P334, DOI 10.1038/nprot.2007.42; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; Wada Y, 2004, ANAL CHEM, V76, P6560, DOI 10.1021/ac049062o; Wu SW, 2014, ANAL CHEM, V86, P5478, DOI 10.1021/ac500945m; Wu SW, 2013, J PROTEOMICS, V84, P1, DOI 10.1016/j.jprot.2013.03.026; Yang WM, 2014, ANAL CHEM, V86, P6959, DOI 10.1021/ac500876p; Yu L, 2009, CHEM-EUR J, V15, P12618, DOI 10.1002/chem.200902370; Zhang H, 2003, NAT BIOTECHNOL, V21, P660, DOI 10.1038/nbt827; Zhang W, 2011, ANAL CHEM, V83, P4975, DOI 10.1021/ac200753e; Zielinska DF, 2010, CELL, V141, P897, DOI 10.1016/j.cell.2010.04.012	30	157	162	14	272	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	JAN	2016	34	1					84	88		10.1038/nbt.3403	http://dx.doi.org/10.1038/nbt.3403			5	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DB8HQ	26571101	Green Accepted			2022-12-25	WOS:000368758200031
J	Maurano, MT; Haugen, E; Sandstrom, R; Vierstra, J; Shafer, A; Kaul, R; Stamatoyannopoulos, JA				Maurano, Matthew T.; Haugen, Eric; Sandstrom, Richard; Vierstra, Jeff; Shafer, Anthony; Kaul, Rajinder; Stamatoyannopoulos, John A.			Large-scale identification of sequence variants influencing human transcription factor occupancy in vivo	NATURE GENETICS			English	Article							GLUCOCORTICOID-RECEPTOR BINDING; GENE-EXPRESSION; DNA-BINDING; HUMAN GENOME; CHROMATIN ACCESSIBILITY; HISTONE MODIFICATIONS; DATABASE; CELLS; METHYLATION; SPECIFICITY	The function of human regulatory regions depends exquisitely on their local genomic environment and on cellular context, complicating experimental analysis of common disease- and trait-associated variants that localize within regulatory DNA. We use allelically resolved genomic DNase I footprinting data encompassing 166 individuals and 114 cell types to identify >60,000 common variants that directly influence transcription factor occupancy and regulatory DNA accessibility in vivo. The unprecedented scale of these data enables systematic analysis of the impact of sequence variation on transcription factor occupancy in vivo. We leverage this analysis to develop accurate models of variation affecting the recognition sites for diverse transcription factors and apply these models to discriminate nearly 500,000 common regulatory variants likely to affect transcription factor occupancy across the human genome. The approach and results provide a new foundation for the analysis and interpretation of noncoding variation in complete human genomes and for systems-level investigation of disease-associated variants.	[Maurano, Matthew T.; Haugen, Eric; Sandstrom, Richard; Vierstra, Jeff; Shafer, Anthony; Kaul, Rajinder; Stamatoyannopoulos, John A.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Kaul, Rajinder] Univ Washington, Dept Med, Div Med Genet, Seattle, WA 98195 USA; [Stamatoyannopoulos, John A.] Univ Washington, Dept Med, Div Oncol, Seattle, WA 98195 USA; [Stamatoyannopoulos, John A.] Altius Inst Biomed Sci, Seattle, WA USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Maurano, MT (corresponding author), NYU, Langone Med Ctr, Inst Syst Genet, New York, NY 10012 USA.	matthew.maurano@nyumc.org; jstam@uw.edu		Haugen, Eric/0000-0001-7444-8981; Kaul, Rajinder/0000-0002-7895-9284; Vierstra, Jeff/0000-0001-6406-8563; Sandstrom, Richard/0000-0002-3356-1547	US National Institutes of Health [U54HG004592, U54HG007010, U01ES01156, 1S10RR026770, 1S10OD017999]; National Institute of Mental Health [F31MH094073]; National Science Foundation Graduate Research Fellowship [DGE-071824]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026770] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG004592, U54HG007010] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES017156] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH094073] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD017999] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by US National Institutes of Health grants U54HG004592, U54HG007010, U01ES01156, 1S10RR026770 and 1S10OD017999 to J.A.S. and National Institute of Mental Health fellowship F31MH094073 to M.T.M.J.V. was supported by a National Science Foundation Graduate Research Fellowship under grant DGE-071824.	Aalfs JD, 2000, TRENDS BIOCHEM SCI, V25, P548, DOI 10.1016/S0968-0004(00)01689-3; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; ARCHER TK, 1992, SCIENCE, V255, P1573, DOI 10.1126/science.1347958; Badis G, 2009, SCIENCE, V324, P1720, DOI 10.1126/science.1162327; Biddie SC, 2011, MOL CELL, V43, P145, DOI 10.1016/j.molcel.2011.06.016; Cooper GM, 2004, GENOME RES, V14, P539, DOI 10.1101/gr.2034704; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; Degner JF, 2012, NATURE, V482, P390, DOI 10.1038/nature10808; Ding J, 2010, AM J HUM GENET, V87, P779, DOI 10.1016/j.ajhg.2010.10.024; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Flutre T, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003486; GALAS DJ, 1978, NUCLEIC ACIDS RES, V5, P3157, DOI 10.1093/nar/5.9.3157; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; GROSS DS, 1988, ANNU REV BIOCHEM, V57, P159, DOI 10.1146/annurev.bi.57.070188.001111; Grundberg E, 2012, NAT GENET, V44, P1084, DOI 10.1038/ng.2394; Gulko B, 2015, NAT GENET, V47, P276, DOI 10.1038/ng.3196; Gupta S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r24; Heap GA, 2010, HUM MOL GENET, V19, P122, DOI 10.1093/hmg/ddp473; Henikoff S, 2011, TRENDS GENET, V27, P389, DOI 10.1016/j.tig.2011.06.006; John Sam, 2013, Curr Protoc Mol Biol, VChapter 27, DOI 10.1002/0471142727.mb2127s103; John S, 2011, NAT GENET, V43, P264, DOI 10.1038/ng.759; Jolma A, 2013, CELL, V152, P327, DOI 10.1016/j.cell.2012.12.009; Kasowski M, 2010, SCIENCE, V328, P232, DOI 10.1126/science.1183621; Kilpinen H, 2013, SCIENCE, V342, P744, DOI 10.1126/science.1242463; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Knight JC, 2003, NAT GENET, V33, P469, DOI 10.1038/ng1124; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lazarovici A, 2013, P NATL ACAD SCI USA, V110, P6376, DOI 10.1073/pnas.1216822110; Le Novere N, 2001, BIOINFORMATICS, V17, P1226, DOI 10.1093/bioinformatics/17.12.1226; Lee D, 2015, NAT GENET, V47, P955, DOI 10.1038/ng.3331; Lee JH, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000718; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Maurano MT, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002599; McDaniell R, 2010, SCIENCE, V328, P235, DOI 10.1126/science.1184655; McVicker G, 2013, SCIENCE, V342, P747, DOI 10.1126/science.1242429; Meijsing SH, 2009, SCIENCE, V324, P407, DOI 10.1126/science.1164265; Mendenhall EM, 2013, NAT BIOTECHNOL, V31, P1133, DOI 10.1038/nbt.2701; Neph S, 2012, NATURE, V489, P83, DOI 10.1038/nature11212; Neph S, 2012, BIOINFORMATICS, V28, P1919, DOI 10.1093/bioinformatics/bts277; Newburger DE, 2009, NUCLEIC ACIDS RES, V37, pD77, DOI 10.1093/nar/gkn660; Ni YY, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-46; PALMITER RD, 1986, ANNU REV GENET, V20, P465, DOI 10.1146/annurev.ge.20.120186.002341; PETERSON KR, 1993, MOL CELL BIOL, V13, P4836, DOI 10.1128/MCB.13.8.4836; Portales-Casamar E, 2010, NUCLEIC ACIDS RES, V38, pD105, DOI 10.1093/nar/gkp950; Price AL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001317; Reddy TE, 2012, GENOME RES, V22, P860, DOI 10.1101/gr.131201.111; Rohs R, 2009, NATURE, V461, P1248, DOI 10.1038/nature08473; Ronald J, 2005, GENOME RES, V15, P284, DOI 10.1101/gr.2850605; Sanyal A, 2012, NATURE, V489, P109, DOI 10.1038/nature11279; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Spivakov M, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r49; Stergachis AB, 2013, SCIENCE, V342, P1367, DOI 10.1126/science.1243490; Thanos D, 1995, CELL, V83, P1091, DOI 10.1016/0092-8674(95)90136-1; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Veyrieras JB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000214; Wang H, 2012, GENOME RES, V22, P1680, DOI 10.1101/gr.136101.111; Zhang K, 2009, NAT METHODS, V6, P613, DOI 10.1038/nmeth.1357; Zhao Y, 2011, NAT BIOTECHNOL, V29, P480, DOI 10.1038/nbt.1893	62	134	135	1	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2015	47	12					1393	+		10.1038/ng.3432	http://dx.doi.org/10.1038/ng.3432			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CX6LT	26502339	Green Accepted			2022-12-25	WOS:000365813200008
J	Sperber, H; Mathieu, J; Wang, YL; Ferreccio, A; Hesson, J; Xu, ZJ; Fischer, KA; Devi, A; Detraux, D; Gu, HW; Battle, SL; Showalter, M; Valensisi, C; Bielas, JH; Ericson, NG; Margaretha, L; Robitaille, AM; Margineantu, D; Fiehn, O; Hockenbery, D; Blau, CA; Raftery, D; Margolin, AA; Hawldns, RD; Moon, RT; Ware, CB; Ruohola-Baker, H				Sperber, Henrik; Mathieu, Julie; Wang, Yuliang; Ferreccio, Amy; Hesson, Jennifer; Xu, Zhuojin; Fischer, Karin A.; Devi, Arikketh; Detraux, Damien; Gu, Haiwei; Battle, Stephanie L.; Showalter, Megan; Valensisi, Cristina; Bielas, Jason H.; Ericson, Nolan G.; Margaretha, Lilyana; Robitaille, Aaron M.; Margineantu, Daciana; Fiehn, Oliver; Hockenbery, David; Blau, C. Anthony; Raftery, Daniel; Margolin, Adam A.; Hawldns, R. David; Moon, Randall T.; Ware, Carol B.; Ruohola-Baker, Hannele			The metabolome regulates the epigenetic landscape during naive-to-primed human embryonic stem cell transition	NATURE CELL BIOLOGY			English	Article							NICOTINAMIDE N-METHYLTRANSFERASE; HUMAN PREIMPLANTATION EMBRYOS; ENERGY-METABOLISM; PLURIPOTENT STATE; DIFFERENTIATION; MAINTENANCE; DERIVATION; DISTINCT; CATENIN; CANCER	For nearly a century developmental biologists have recognized that cells from embryos can differ in their potential to differentiate into distinct cell types. Recently, it has been recognized that embryonic stem cells derived from both mice and humans exhibit two stable yet epigenetically distinct states of pluripotency: naive and primed. We now show that nicotinamide N-methyltransferase (NNMT) and the metabolic state regulate pluripotency in human embryonic stem cells (hESCs). Specifically, in naive hESCs, NNMT and its enzymatic product 1-methylnicotinamide are highly upregulated, and NNMT is required for low S-adenosyl methionine (SAM) levels and the H3K27me3 repressive state. NNMT consumes SAM in naive cells, making it unavailable for histone methylation that represses Wnt and activates the HIF pathway in primed hESCs. These data support the hypothesis that the metabolome regulates the epigenetic landscape of the earliest steps in human development.	[Sperber, Henrik; Mathieu, Julie; Ferreccio, Amy; Fischer, Karin A.; Devi, Arikketh; Detraux, Damien; Ruohola-Baker, Hannele] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Sperber, Henrik; Mathieu, Julie; Ferreccio, Amy; Hesson, Jennifer; Xu, Zhuojin; Fischer, Karin A.; Devi, Arikketh; Detraux, Damien; Gu, Haiwei; Battle, Stephanie L.; Valensisi, Cristina; Margaretha, Lilyana; Robitaille, Aaron M.; Blau, C. Anthony; Raftery, Daniel; Hawldns, R. David; Moon, Randall T.; Ware, Carol B.; Ruohola-Baker, Hannele] Univ Washington, Inst Stem Cell & Regenerat Med, Seattle, WA 98109 USA; [Sperber, Henrik] Univ Washington, Dept Chem, Seattle, WA 98195 USA; [Wang, Yuliang; Margolin, Adam A.] Dept Biomed Engn, Portland, OR 97239 USA; [Wang, Yuliang; Margolin, Adam A.] Oregon Hlth & Sci Univ, Computat Biol Program, Sch Med, Portland, OR 97239 USA; [Hesson, Jennifer; Ware, Carol B.] Univ Washington, Dept Comparat Med, Seattle, WA 98195 USA; [Devi, Arikketh] SRM Univ, Dept Genet Engn, Kattankulathur 603203, India; [Gu, Haiwei; Raftery, Daniel] Univ Washington, Northwest Metab Res Ctr, Dept Anesthesiol & Pain Med, Seattle, WA 98195 USA; [Battle, Stephanie L.; Valensisi, Cristina; Hawldns, R. David] Univ Washington, Dept Med, Div Med Genet, Seattle, WA 98195 USA; [Battle, Stephanie L.; Valensisi, Cristina; Hawldns, R. David] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Showalter, Megan; Fiehn, Oliver] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA; [Bielas, Jason H.; Ericson, Nolan G.; Margineantu, Daciana; Hockenbery, David; Raftery, Daniel] Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA; [Bielas, Jason H.] Univ Washington, Sch Med, Dept Pathol, Seattle, WA 98195 USA; [Fiehn, Oliver] King Abdulaziz Univ, Fac Sci, Dept Biochem, Jeddah 21589, Saudi Arabia; [Blau, C. Anthony] Univ Washington, Dept Med, Div Hematol, Seattle, WA 98195 USA; [Moon, Randall T.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Moon, Randall T.] Univ Washington, Dept Pharmacol, Seattle, WA 98109 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Oregon Health & Science University; University of Washington; University of Washington Seattle; SRM Institute of Science & Technology Chennai; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of California System; University of California Davis; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; King Abdulaziz University; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Ruohola-Baker, H (corresponding author), Univ Washington, Dept Biochem, Seattle, WA 98195 USA.	hannele@uw.edu	A, Devi/ABE-6011-2021; Wang, Yuliang/H-9070-2012	Wang, Yuliang/0000-0002-3788-5477; Robitaille, Aaron Mark/0000-0003-2774-2066; ARIKKETH, DEVI/0000-0002-8542-3760; Hesson, Jennifer/0000-0001-5685-6279; Detraux, Damien/0000-0002-9704-2076; Sperber, Henrik/0000-0002-3235-1396	University of Washington's Proteomics Resource [UWPR95794]; American Heart Association; Ellison Medical Foundation [AG-NS-0577-09]; Schultz Fellowship; National Institutes of Health [1U24DK097154, RO1ES019319, R01GM097372, R01GM97372-03S1, R01GM083867, 1P01GM081619]; NHLBI Progenitor Cell Biology Consortium [U01HL099997, U01HL099993]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL099997, U01HL099993] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK097154] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES019319] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097372, R01GM083867, P01GM081619] Funding Source: NIH RePORTER	University of Washington's Proteomics Resource; American Heart Association(American Heart Association); Ellison Medical Foundation(Lawrence Ellison Foundation); Schultz Fellowship; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI Progenitor Cell Biology Consortium; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Ruohola-Baker laboratory for helpful discussions throughout this work We thank D. Djukovic and J. K. Meissen for help with mass spectrometry, D. Jones for help with RNA-seq analysis, W Zhou, A. Nelson, S. Shannon, S. Sidhu, C. Cavanaugh, Y. Zhang, W Heath, K. Sankary, E. Engelhart and K. Toor for technical help, K. Au for performing karyotype analysis, A. Madan for performing RNA-seq, P. Treuting for teratoma analysis, K. Bomsztyk (University of Washington, USA) for providing BED antibody, B. Cravatt (Scripps Research Institute, USA) for providing NNMT overexpression constructs and R. Jaenisch (Whitehead Institute for Biomedical Research, USA) and J. Hanna (Weizmann Institute of Science, Israel) for providing WINI cells and LIS1 cells, respectively. This work is supported in part by the University of Washington's Proteomics Resource (UWPR95794). R.T.M. is an Investigator, and A.M.R. and Z.X. are Associates, of the HHMI. This work was supported by fellowship from the American Heart Association to J.M., AG-NS-0577-09 from the Ellison Medical Foundation for J.H.B., Schultz Fellowship for H.S., grants from the National Institutes of Health 1U24DK097154 for O.F., RO1ES019319 for J.H.B., R01GM097372, R01GM97372-03S1 and R01GM083867 for H.R.-B., 1P01GM081619 for C.A.B., R.T.M., C.B.W., A.M. and H.R.-B., and the NHLBI Progenitor Cell Biology Consortium (U01HL099997; U01HL099993) for H.R.-B.	Bernstein BE, 2010, NAT BIOTECHNOL, V28, P1045, DOI 10.1038/nbt1010-1045; Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; Blauwkamp TA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2064; Bracha AL, 2010, NAT CHEM BIOL, V6, P202, DOI 10.1038/NCHEMBIO.301; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Buecker C, 2014, CELL STEM CELL, V14, P838, DOI 10.1016/j.stem.2014.04.003; Chan YS, 2013, CELL STEM CELL, V13, P663, DOI 10.1016/j.stem.2013.11.015; Clevers H, 2014, SCIENCE, V346, P54, DOI 10.1126/science.1248012; Davidson KC, 2012, P NATL ACAD SCI USA, V109, P4485, DOI 10.1073/pnas.1118777109; Duggal G, 2015, STEM CELLS, V33, P2686, DOI 10.1002/stem.2071; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Escobar TM, 2014, IMMUNITY, V40, P865, DOI 10.1016/j.immuni.2014.03.014; Factor DC, 2014, CELL STEM CELL, V14, P854, DOI 10.1016/j.stem.2014.05.005; Folmes CDL, 2011, CELL METAB, V14, P264, DOI 10.1016/j.cmet.2011.06.011; Gafni O, 2013, NATURE, V504, P282, DOI 10.1038/nature12745; Gilles C, 2003, CANCER RES, V63, P2658; Graf U, 2011, GENES-BASEL, V2, P280, DOI 10.3390/genes2010280; Greer SN, 2012, EMBO J, V31, P2448, DOI 10.1038/emboj.2012.125; Grow EJ, 2015, NATURE, V522, P221, DOI 10.1038/nature14308; Kraus D, 2014, NATURE, V508, P258, DOI 10.1038/nature13198; Landeira D, 2011, TRENDS CELL BIOL, V21, P74, DOI 10.1016/j.tcb.2010.10.004; Mathieu J, 2014, CELL STEM CELL, V14, P592, DOI 10.1016/j.stem.2014.02.012; Mathieu J, 2013, STEM CELLS, V31, P1737, DOI 10.1002/stem.1446; Mazumdar J, 2010, NAT CELL BIOL, V12, P1007, DOI 10.1038/ncb2102; Shyh-Chang N, 2013, SCIENCE, V339, P222, DOI 10.1126/science.1226603; Nguyen-Tran DH, 2014, DIS MODEL MECH, V7, P41, DOI 10.1242/dmm.013631; Opitz CA, 2011, NATURE, V478, P197, DOI 10.1038/nature10491; Panopoulos AD, 2012, CELL RES, V22, P168, DOI 10.1038/cr.2011.177; Prigione A, 2010, INT J DEV BIOL, V54, P1729, DOI 10.1387/ijdb.103198ap; Rafalski VA, 2012, J CELL SCI, V125, P5597, DOI 10.1242/jcs.114827; Shiraki N, 2014, CELL METAB, V19, P780, DOI 10.1016/j.cmet.2014.03.017; Simonson TS, 2010, SCIENCE, V329, P72, DOI 10.1126/science.1189406; Takashima Y, 2014, CELL, V158, P1254, DOI 10.1016/j.cell.2014.08.029; Ten Berge D, 2011, NAT CELL BIOL, V13, P1070, DOI 10.1038/ncb2314; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Theunissen TW, 2014, CELL STEM CELL, V15, P524, DOI 10.1016/j.stem.2014.09.003; Tomida M, 2008, J CANCER RES CLIN, V134, P551, DOI 10.1007/s00432-007-0318-6; Trojer P, 2006, CELL, V125, P213, DOI 10.1016/j.cell.2006.04.003; Ulanovskaya OA, 2013, NAT CHEM BIOL, V9, P300, DOI [10.1038/nchembio.1204, 10.1038/NCHEMBIO.1204]; Valamehr B, 2014, STEM CELL REP, V2, P366, DOI 10.1016/j.stemcr.2014.01.014; Varum S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020914; Ware CB, 2014, P NATL ACAD SCI USA, V111, P4484, DOI 10.1073/pnas.1319738111; Wu J, 2015, NATURE, V521, P316, DOI 10.1038/nature14413; Yan LY, 2013, NAT STRUCT MOL BIOL, V20, P1131, DOI 10.1038/nsmb.2660; Yanes O, 2010, NAT CHEM BIOL, V6, P411, DOI 10.1038/nchembio.364; Zhang J, 2011, EMBO J, V30, P4860, DOI 10.1038/emboj.2011.401; Zhou WY, 2012, EMBO J, V31, P2103, DOI 10.1038/emboj.2012.71; Zhou WY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027460	48	240	244	1	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	DEC	2015	17	12					1523	1535		10.1038/ncb3264	http://dx.doi.org/10.1038/ncb3264			13	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CX8DH	26571212	Green Accepted, Green Submitted			2022-12-25	WOS:000365932300005
J	Stieglitz, E; Taylor-Weiner, AN; Chang, TY; Gelston, LC; Wang, YD; Mazor, T; Esquivel, E; Yu, A; Seepo, S; Olsen, SR; Rosenberg, M; Archambeault, SL; Abusin, G; Beckman, K; Brown, PA; Briones, M; Carcamo, B; Cooper, T; Dahl, GV; Emanuel, PD; Fluchel, MN; Goyal, RK; Hayashi, RJ; Hitzler, J; Hugge, C; Liu, YL; Messinger, YH; Mahoney, DH; Monteleone, P; Nemecek, ER; Roehrs, PA; Schore, RJ; Stine, KC; Takemoto, CM; Toretsky, JA; Costello, JF; Olshen, AB; Stewart, C; Li, YJ; Ma, J; Gerbing, RB; Alonzo, TA; Getz, G; Gruber, TA; Golub, TR; Stegmaier, K; Loh, ML				Stieglitz, Elliot; Taylor-Weiner, Amaro N.; Chang, Tiffany Y.; Gelston, Laura C.; Wang, Yong-Dong; Mazor, Tali; Esquivel, Emilio; Yu, Ariel; Seepo, Sara; Olsen, Scott R.; Rosenberg, Mara; Archambeault, Sophie L.; Abusin, Ghada; Beckman, Kyle; Brown, Patrick A.; Briones, Michael; Carcamo, Benjamin; Cooper, Todd; Dahl, Gary V.; Emanuel, Peter D.; Fluchel, Mark N.; Goyal, Rakesh K.; Hayashi, Robert J.; Hitzler, Johann; Hugge, Christopher; Liu, Y. Lucy; Messinger, Yoav H.; Mahoney, Donald H., Jr.; Monteleone, Philip; Nemecek, Eneida R.; Roehrs, Philip A.; Schore, Reuven J.; Stine, Kimo C.; Takemoto, Clifford M.; Toretsky, Jeffrey A.; Costello, Joseph F.; Olshen, Adam B.; Stewart, Chip; Li, Yongjin; Ma, Jing; Gerbing, Robert B.; Alonzo, Todd A.; Getz, Gad; Gruber, Tanja A.; Golub, Todd R.; Stegmaier, Kimberly; Loh, Mignon L.			The genomic landscape of juvenile myelomonocytic leukemia	NATURE GENETICS			English	Article							GATA2 MUTATIONS; NEUROFIBROMATOSIS TYPE-1; MONOMAC SYNDROME; POINT MUTATIONS; POOR-PROGNOSIS; CBL MUTATIONS; NF1 GENE; LNK; EXPRESSION; CHILDREN	Juvenile myelomonocytic leukemia (JMML) is a myeloproliferative neoplasm (MPN) of childhood with a poor prognosis. Mutations in NF1, NRAS, KRAS, PTPN11 or CBL occur in 85% of patients, yet there are currently no risk stratification algorithms capable of predicting which patients will be refractory to conventional treatment and could therefore be candidates for experimental therapies. In addition, few molecular pathways aside from the RAS-MAPK pathway have been identified that could serve as the basis for such novel therapeutic strategies. We therefore sought to genomically characterize serial samples from patients at diagnosis through relapse and transformation to acute myeloid leukemia to expand knowledge of the mutational spectrum in JMML. We identified recurrent mutations in genes involved in signal transduction, splicing, Polycomb repressive complex 2 (PRC2) and transcription. Notably, the number of somatic alterations present at diagnosis appears to be the major determinant of outcome.	[Stieglitz, Elliot; Chang, Tiffany Y.; Gelston, Laura C.; Esquivel, Emilio; Yu, Ariel; Archambeault, Sophie L.; Beckman, Kyle; Loh, Mignon L.] Univ Calif San Francisco, Dept Pediat, Benioff Childrens Hosp, San Francisco, CA 94143 USA; [Taylor-Weiner, Amaro N.; Seepo, Sara; Rosenberg, Mara; Stewart, Chip; Getz, Gad; Golub, Todd R.; Stegmaier, Kimberly] Broad Inst MIT & Harvard, Cambridge, MA USA; [Wang, Yong-Dong; Li, Yongjin] St Jude Childrens Res Hosp, Dept Computat Biol, Memphis, TN 38105 USA; [Mazor, Tali] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA USA; [Olsen, Scott R.] St Jude Childrens Res Hosp, Hartwell Ctr Bioinformat & Biotechnol, Memphis, TN 38105 USA; [Abusin, Ghada] Univ Iowa, Carver Coll Med, Stead Family Dept Pediat, Iowa City, IA USA; [Brown, Patrick A.; Takemoto, Clifford M.] Johns Hopkins Univ Hosp, Dept Pediat, Baltimore, MD 21287 USA; [Briones, Michael] Emory Univ, Sch Med, Dept Pediat, Aflac Canc & Blood Disorder Ctr, Atlanta, GA USA; [Carcamo, Benjamin] Texas Tech Univ, Dept Pediat, El Paso, TX USA; [Cooper, Todd] Seattle Childrens Hosp, Dept Pediat, Seattle, WA USA; [Dahl, Gary V.] Stanford Sch Med, Dept Pediat, Stanford, CA USA; [Emanuel, Peter D.] Univ Arkansas Med Sci, Winthrop P Rockefeller Canc Inst, Little Rock, AR 72205 USA; [Fluchel, Mark N.] Univ Utah, Dept Pediat Hematol Oncol, Salt Lake City, UT USA; [Goyal, Rakesh K.] Univ Pittsburgh, Childrens Hosp Pittsburgh, Med Ctr, Dept Pediat, Pittsburgh, PA 15213 USA; [Hayashi, Robert J.] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [Hitzler, Johann] Hosp Sick Children, Div Hematol Oncol, Toronto, ON M5G 1X8, Canada; [Hugge, Christopher] SSM Cardinal Glennon Childrens Med Ctr, Pediat Hematol Oncol, St Louis, MO USA; [Messinger, Yoav H.] Childrens Hosp & Clin Minnesota, Div Pediat Hematol Oncol, Minneapolis, MN USA; [Mahoney, Donald H., Jr.] Texas Childrens Hosp, Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Monteleone, Philip] Pediat Specialists Lehigh Valley Hosp, Pediat Hematol Oncol, Bethlehem, PA USA; [Nemecek, Eneida R.] Oregon Hlth & Sci Univ, Pediat Bone Marrow Transplant Program, Portland, OR 97201 USA; [Roehrs, Philip A.] Univ N Carolina, Dept Pediat, Chapel Hill, NC USA; [Schore, Reuven J.] Childrens Natl Med Ctr, Div Pediat Oncol, Washington, DC 20010 USA; [Stine, Kimo C.] Univ Arkansas Med Sci, Dept Pediat, Little Rock, AR 72205 USA; [Toretsky, Jeffrey A.] Georgetown Univ, Dept Pediat, Washington, DC 20057 USA; [Toretsky, Jeffrey A.] Georgetown Univ, Dept Oncol, Washington, DC USA; [Olshen, Adam B.] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Olshen, Adam B.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Ma, Jing; Gruber, Tanja A.] St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA; [Gerbing, Robert B.] Childrens Oncol Grp, Dept Stat, Monrovia, CA USA; [Alonzo, Todd A.] Univ So Calif, Keck Sch Med, Los Angeles, CA 90033 USA; [Getz, Gad; Golub, Todd R.; Stegmaier, Kimberly] Harvard Univ, Sch Med, Boston, MA USA; [Getz, Gad] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Getz, Gad] Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA; [Gruber, Tanja A.] St Jude Childrens Res Hosp, Dept Oncol, Memphis, TN 38105 USA; [Golub, Todd R.; Stegmaier, Kimberly] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Golub, Todd R.; Stegmaier, Kimberly] Boston Childrens Hosp, Div Hematol Oncol, Boston, MA USA; [Loh, Mignon L.] Univ Calif San Francisco, Dept Pediat, Benioff Childrens Hosp, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA USA	University of California System; University of California San Francisco; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; St Jude Children's Research Hospital; University of California System; University of California San Francisco; St Jude Children's Research Hospital; University of Iowa; Johns Hopkins University; Johns Hopkins Medicine; Emory University; Texas Tech University System; Texas Tech University; Seattle Children's Hospital; Stanford University; University of Arkansas System; University of Arkansas Medical Sciences; Utah System of Higher Education; University of Utah; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Washington University (WUSTL); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Children's Hospitals & Clinics of Minnesota; Baylor College of Medicine; Lehigh Valley Hospital; Oregon Health & Science University; University of North Carolina; University of North Carolina Chapel Hill; Children's National Health System; University of Arkansas System; University of Arkansas Medical Sciences; Georgetown University; Georgetown University; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco; St Jude Children's Research Hospital; Children's Oncology Group (COG); University of Southern California; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; St Jude Children's Research Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Boston Children's Hospital; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center	Stieglitz, E (corresponding author), Univ Calif San Francisco, Dept Pediat, Benioff Childrens Hosp, San Francisco, CA 94143 USA.	elliot.stieglitz@ucsf.edu; mignon.loh@ucsf.edu	Wang, Yong-Dong/K-3563-2013; hayashi, robert james/AAH-2077-2019; Takemoto, Clifford M/Y-7558-2018; LI, YONGJIN/E-1688-2011; Gruber, Tanja/AAH-1248-2021	hayashi, robert james/0000-0002-1140-1139; Archambeault, Sophie/0000-0001-9409-7541; Rosenberg, Mara/0000-0001-6400-3161; Stieglitz, Elliot/0000-0001-7032-4623; Carcamo, Benjamin/0000-0002-2423-1458; YU, ARIEL/0000-0003-3941-2195; Loh, Mignon/0000-0003-4099-4700	Carlos Slim Foundation in Mexico as part of the Slim Initiative for Genomic Medicine; St. Baldrick's Foundation; Alex's Lemonade Stand Foundation; Leukemia and Lymphoma Society [6059-09, 6466-15]; Leukemia and Lymphoma Society Scholar award; US National Institutes of Health, National Cancer Institute [T32CA128583, R01CA173085]; National Cancer Institute Cancer Center [5P30CA082103]; Children's Oncology Group (COG) Statistics and Data Center [1U10CA180899]; COG Chair's Grant [5U10CA098543]; US National Institutes of Health [P30CA82103]; Frank A. Campini Foundation; Hyundai Hope on Wheels; University of California San Francisco Dean's Commitment to the Center for Advanced Technologies facility; NATIONAL CANCER INSTITUTE [T32CA128583, U10CA098543, P30CA082103, R01CA173085, P30CA021765, U10CA180899] Funding Source: NIH RePORTER	Carlos Slim Foundation in Mexico as part of the Slim Initiative for Genomic Medicine; St. Baldrick's Foundation; Alex's Lemonade Stand Foundation; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Leukemia and Lymphoma Society Scholar award(Leukemia and Lymphoma Society); US National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Institute Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Children's Oncology Group (COG) Statistics and Data Center; COG Chair's Grant; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Frank A. Campini Foundation; Hyundai Hope on Wheels; University of California San Francisco Dean's Commitment to the Center for Advanced Technologies facility; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Carlos Slim Foundation in Mexico as part of the Slim Initiative for Genomic Medicine; the St. Baldrick's Foundation (E.S.); Alex's Lemonade Stand Foundation (E.S.); the Leukemia and Lymphoma Society (grants 6059-09 and 6466-15) (M.L.L.) and a Leukemia and Lymphoma Society Scholar award (K.S.)); US National Institutes of Health, National Cancer Institute grants T32CA128583 (E.S.) and R01CA173085 (M.L.L.), National Cancer Institute Cancer Center Support grant 5P30CA082103, Children's Oncology Group (COG) Statistics and Data Center grant 1U10CA180899 (T.A.A.), COG Chair's Grant 5U10CA098543 (T.A.A.) and US National Institutes of Health grant P30CA82103 (A.B.O.); the Frank A. Campini Foundation (E.S. and M.L.L.); Hyundai Hope on Wheels (M.L.L.); and a University of California San Francisco Dean's Commitment to the Center for Advanced Technologies facility.	Abu Kar S, 2013, HAEMATOLOGICA, V98, P107, DOI 10.3324/haematol.2012.064048; Albert MH, 2010, BLOOD, V115, P3231, DOI 10.1182/blood-2009-09-239087; Archambeault S, 2008, BLOOD, V111, P1124, DOI 10.1182/blood-2007-06-093302; Bresolin S, 2010, J CLIN ONCOL, V28, P1919, DOI 10.1200/JCO.2009.24.4426; CHAN AML, 1994, P NATL ACAD SCI USA, V91, P7558, DOI 10.1073/pnas.91.16.7558; Chan RJ, 2009, LEUKEMIA RES, V33, P355, DOI 10.1016/j.leukres.2008.08.022; Chang T, 2013, J CLIN INVEST, V123, P335, DOI 10.1172/JCI63193; Chang TY, 2014, BLOOD, V124, P2487, DOI 10.1182/blood-2014-03-300319; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; COX DR, 1972, J R STAT SOC B, V34, P187; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dulak AM, 2013, NAT GENET, V45, P478, DOI 10.1038/ng.2591; Dvorak CC, 2014, FRONT PEDIATR, V2, DOI 10.3389/fped.2014.00025; Fasan A, 2013, LEUKEMIA, V27, P482, DOI 10.1038/leu.2012.174; Flex E, 2014, HUM MOL GENET, V23, P4315, DOI 10.1093/hmg/ddu148; Flotho C, 1999, LEUKEMIA, V13, P32, DOI 10.1038/sj.leu.2401240; Flotho C, 2008, BLOOD, V111, P966, DOI 10.1182/blood-2007-09-111831; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; Furlan I, 2009, BLOOD, V113, P2867, DOI 10.1182/blood-2008-12-195693; Gambacorti-Passerini CB, 2015, BLOOD, V125, P499, DOI 10.1182/blood-2014-06-579466; Graham SM, 1999, ONCOGENE, V18, P2107, DOI 10.1038/sj.onc.1202517; GRAY RJ, 1988, ANN STAT, V16, P1141, DOI 10.1214/aos/1176350951; Greaves M, 2012, NATURE, V481, P306, DOI 10.1038/nature10762; Hahn CN, 2011, NAT GENET, V43, P1012, DOI 10.1038/ng.913; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Hirabayashi S, 2012, BLOOD, V119, pE96, DOI 10.1182/blood-2011-12-395087; Hsu AP, 2011, BLOOD, V118, P2653, DOI 10.1182/blood-2011-05-356352; Huang H, 2013, BLOOD, V122, P45; Hurtado C, 2011, LEUKEMIA RES, V35, P1537, DOI 10.1016/j.leukres.2011.07.009; Jankowska AM, 2011, BLOOD, V118, P3932, DOI 10.1182/blood-2010-10-311019; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kazenwadel J, 2012, BLOOD, V119, P1283, DOI 10.1182/blood-2011-08-374363; Kotecha N, 2008, CANCER CELL, V14, P335, DOI 10.1016/j.ccr.2008.08.014; Kothari A, 2015, LEUKEMIA LYMPHOMA, V56, P1175, DOI 10.3109/10428194.2014.953152; Lasho TL, 2010, NEW ENGL J MED, V363, P1189, DOI 10.1056/NEJMc1006966; Lee ML, 2016, PEDIATR NEONATOL, V57, P149, DOI 10.1016/j.pedneo.2013.06.009; Ley TJ, 2010, NEW ENGL J MED, V363, P2424, DOI 10.1056/NEJMoa1005143; Locatelli F, 2015, BLOOD, V125, P1083, DOI 10.1182/blood-2014-08-550483; Loh ML, 2009, BLOOD, V114, P1859, DOI 10.1182/blood-2009-01-198416; Loh ML, 2004, BLOOD, V103, P2325, DOI 10.1182/blood-2003-09-3287; Lyubynska N, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001069; Madan V, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7042; Matsuda K, 2007, BLOOD, V109, P5477, DOI 10.1182/blood-2006-09-046649; Matsuda K, 2010, BLOOD, V115, P5429, DOI 10.1182/blood-2009-12-260729; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McMullin MF, 2011, AM J HEMATOL, V86, P962, DOI 10.1002/ajh.22154; Niemeyer CM, 2010, NAT GENET, V42, P794, DOI 10.1038/ng.641; Oh ST, 2010, BLOOD, V116, P988, DOI 10.1182/blood-2010-02-270108; Osato M, 2004, ONCOGENE, V23, P4284, DOI 10.1038/sj.onc.1207779; Ostergaard P, 2011, NAT GENET, V43, P929, DOI 10.1038/ng.923; Papaemmanuil E, 2013, BLOOD, V122, P3616, DOI 10.1182/blood-2013-08-518886; Pasquet M, 2013, BLOOD, V121, P822, DOI 10.1182/blood-2012-08-447367; Patmore DM, 2012, CANCER RES, V72, P5317, DOI 10.1158/0008-5472.CAN-12-1972; Perez B, 2010, BRIT J HAEMATOL, V151, P460, DOI 10.1111/j.1365-2141.2010.08393.x; Perez-Garcia A, 2013, BLOOD, V122, P2425, DOI 10.1182/blood-2013-05-500850; Reva B, 2011, NUCLEIC ACIDS RES, V39, pE118, DOI 10.1093/nar/gkr407; Ribeiro AFT, 2012, BLOOD, V119, P5824, DOI 10.1182/blood-2011-07-367961; Rudd C E, 2001, Sci STKE, V2001, ppe1; Russler-Germain DA, 2014, CANCER CELL, V25, P442, DOI 10.1016/j.ccr.2014.02.010; Sakaguchi H, 2013, NAT GENET, V45, P937, DOI 10.1038/ng.2698; Sano H, 2012, INT J HEMATOL, V96, P279, DOI 10.1007/s12185-012-1130-x; Side L, 1997, NEW ENGL J MED, V336, P1713, DOI 10.1056/NEJM199706123362404; Side LE, 1998, BLOOD, V92, P267, DOI 10.1182/blood.V92.1.267.413a31_267_272; Stephens K, 2006, BLOOD, V108, P1684, DOI 10.1182/blood-2005-11-011486; Stieglitz E, 2015, PEDIATR BLOOD CANCER, V62, P629, DOI 10.1002/pbc.25342; Stieglitz E, 2015, BLOOD, V125, P516, DOI 10.1182/blood-2014-09-601690; Stieglitz E, 2014, BLOOD, V123, P1426, DOI 10.1182/blood-2013-11-531079; Sugimoto Y, 2010, BRIT J HAEMATOL, V150, P83, DOI 10.1111/j.1365-2141.2010.08196.x; Takita J, 2012, LEUKEMIA, V26, P1879, DOI 10.1038/leu.2012.45; Tartaglia M, 2003, NAT GENET, V34, P148, DOI 10.1038/ng1156; Tinschert S, 2000, EUR J HUM GENET, V8, P455, DOI 10.1038/sj.ejhg.5200493; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Triche TJ, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt090; Venkatraman ES, 2007, BIOINFORMATICS, V23, P657, DOI 10.1093/bioinformatics/btl646; Yang ZY, 2009, MOL CELL BIOL, V29, P4376, DOI 10.1128/MCB.01330-08; Yoshimi A, 2013, PEDIATR BLOOD CANCER, V60, P836, DOI 10.1002/pbc.24359	78	164	175	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2015	47	11					1326	+		10.1038/ng.3400	http://dx.doi.org/10.1038/ng.3400			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CV1BN	26457647	Green Accepted, Green Submitted			2022-12-25	WOS:000363988200016
J	McPherson, A; Roth, A; Laks, E; Masud, T; Bashashati, A; Zhang, AW; Ha, G; Biele, J; Yap, D; Wan, A; Prentice, LM; Khattra, J; Smith, MA; Nielsen, CB; Mullaly, SC; Kalloger, S; Karnezis, A; Shumansky, K; Siu, C; Rosner, J; Chan, HL; Ho, J; Melnyk, N; Senz, J; Yang, W; Moore, R; Mungall, AJ; Marra, MA; Bouchard-Cote, A; Gilks, CB; Huntsman, DG; McAlpine, JN; Aparicio, S; Shah, SP				McPherson, Andrew; Roth, Andrew; Laks, Emma; Masud, Tehmina; Bashashati, Ali; Zhang, Allen W.; Ha, Gavin; Biele, Justina; Yap, Damian; Wan, Adrian; Prentice, Leah M.; Khattra, Jaswinder; Smith, Maia A.; Nielsen, Cydney B.; Mullaly, Sarah C.; Kalloger, Steve; Karnezis, Anthony; Shumansky, Karey; Siu, Celia; Rosner, Jamie; Chan, Hector Li; Ho, Julie; Melnyk, Nataliya; Senz, Janine; Yang, Winnie; Moore, Richard; Mungall, Andrew J.; Marra, Marco A.; Bouchard-Cote, Alexandre; Gilks, C. Blake; Huntsman, David G.; McAlpine, Jessica N.; Aparicio, Samuel; Shah, Sohrab P.			Divergent modes of clonal spread and intraperitoneal mixing in high-grade serous ovarian cancer	NATURE GENETICS			English	Article							BRCA2 MUTATIONS; EVOLUTION; CARCINOMA; INFERENCE; DYNAMICS; DOLLO; TP53	We performed phylogenetic analysis of high-grade serous ovarian cancers (68 samples from seven patients), identifying constituent clones and quantifying their relative abundances at multiple intraperitoneal sites. Through whole-genome and single-nucleus sequencing, we identified evolutionary features including mutation loss, convergence of the structural genome and temporal activation of mutational processes that patterned clonal progression. We then determined the precise clonal mixtures comprising each tumor sample. The majority of sites were clonally pure or composed of clones from a single phylogenetic clade. However, each patient contained at least one site composed of polyphyletic clones. Five patients exhibited monoclonal and unidirectional seeding from the ovary to intraperitoneal sites, and two patients demonstrated polyclonal spread and reseeding. Our findings indicate that at least two distinct modes of intraperitoneal spread operate in clonal dissemination and highlight the distribution of migratory potential over clonal populations comprising high-grade serous ovarian cancers.	[McPherson, Andrew; Roth, Andrew; Laks, Emma; Masud, Tehmina; Bashashati, Ali; Zhang, Allen W.; Ha, Gavin; Biele, Justina; Yap, Damian; Wan, Adrian; Khattra, Jaswinder; Smith, Maia A.; Mullaly, Sarah C.; Kalloger, Steve; Shumansky, Karey; Siu, Celia; Rosner, Jamie; Huntsman, David G.; Aparicio, Samuel; Shah, Sohrab P.] BC Canc Agcy, Dept Mol Oncol, Vancouver, BC, Canada; [McPherson, Andrew] Simon Fraser Univ, Sch Comp Sci, Burnaby, BC V5A 1S6, Canada; [McPherson, Andrew; Roth, Andrew; Zhang, Allen W.; Ha, Gavin; Smith, Maia A.] Univ British Columbia, Grad Bioinformat Training Program, Vancouver, BC V5Z 1M9, Canada; [McPherson, Andrew; Masud, Tehmina; Nielsen, Cydney B.; Huntsman, David G.; Aparicio, Samuel; Shah, Sohrab P.] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada; [Zhang, Allen W.] Child & Family Res Inst, Ctr Mol Med & Therapeut, Vancouver, BC, Canada; [Ha, Gavin] Dana Farber Canc Inst, Boston, MA 02115 USA; [Ha, Gavin] Broad Inst MIT & Harvard, Cambridge, MA USA; [Prentice, Leah M.; Karnezis, Anthony; Chan, Hector Li; Ho, Julie; Melnyk, Nataliya; Senz, Janine; Yang, Winnie; Huntsman, David G.] BC Canc Agcy, Ctr Translat & Appl Gen, Vancouver, BC, Canada; [Moore, Richard; Mungall, Andrew J.; Marra, Marco A.; Shah, Sohrab P.] BC Canc Agcy, Michael Smith Genome Sci Ctr, Vancouver, BC, Canada; [Bouchard-Cote, Alexandre] Univ British Columbia, Dept Stat, Vancouver, BC V6T 1W5, Canada; [Gilks, C. Blake] Vancouver Gen Hosp, Dept Pathol, 855 W 12Th Ave, Vancouver, BC V5Z 1M9, Canada; [McAlpine, Jessica N.] Univ British Columbia, Dept Gynecol & Obstet, Vancouver, BC V5Z 1M9, Canada	British Columbia Cancer Agency; Simon Fraser University; University of British Columbia; University of British Columbia; Child & Family Research Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; British Columbia Cancer Agency; British Columbia Cancer Agency; University of British Columbia; University of British Columbia; University of British Columbia	Aparicio, S; Shah, SP (corresponding author), BC Canc Agcy, Dept Mol Oncol, Vancouver, BC, Canada.; Aparicio, S; Shah, SP (corresponding author), Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada.; Shah, SP (corresponding author), BC Canc Agcy, Michael Smith Genome Sci Ctr, Vancouver, BC, Canada.	saparicio@bccrc.ca; sshah@bccrc.ca	Huntsman, David/ABE-6082-2020; Ha, Gavin/N-1984-2019; Marra, Marco A/B-5987-2008; wang, edwin/G-5372-2010; Mungall, Andrew J./U-7067-2018; McPherson, Andrew/J-6552-2015	Ha, Gavin/0000-0001-7578-7272; Marra, Marco A/0000-0001-7146-7175; Mungall, Andrew J./0000-0002-0905-2742; Yap, Damian/0000-0002-5370-4592; McPherson, Andrew/0000-0002-5654-5101; Aparicio, Samuel/0000-0002-0487-9599	BC Cancer Foundation; Canadian Breast Cancer Foundation; Canadian Cancer Society Research Institute [701584]; Terry Fox Research Institute; Genome Canada/Genome BC [173-CIC, 177-EVO]; Canadian Institutes for Health Research (CIHR) [MOP-115170, MOP-126119, FDN-143246]; TFRI; Canada Research Chairs; NSERC CGS scholarship; CIHR CGS scholarship; Canadian Breast Cancer Foundation British Columbia/Yukon Postdoctoral Fellowship;  [MSH-261515]	BC Cancer Foundation; Canadian Breast Cancer Foundation(Canadian Cancer Society (CCS)); Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); Terry Fox Research Institute; Genome Canada/Genome BC(Genome Canada); Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); TFRI; Canada Research Chairs(Canada Research ChairsCGIAR); NSERC CGS scholarship(Natural Sciences and Engineering Research Council of Canada (NSERC)); CIHR CGS scholarship(Canadian Institutes of Health Research (CIHR)); Canadian Breast Cancer Foundation British Columbia/Yukon Postdoctoral Fellowship; 	We thank V. Earle for the artwork depicting anatomical sites sampled in the study. We acknowledge generous long-term funding support provided by the BC Cancer Foundation. In addition, the groups of S.P.S. and S.A. receive operating funds from the Canadian Breast Cancer Foundation, the Canadian Cancer Society Research Institute (grant 701584), the Terry Fox Research Institute, Genome Canada/Genome BC (173-CIC and 177-EVO), the Canadian Institutes for Health Research (CIHR) (MOP-115170, MOP-126119, and FDN-143246), a new investigator grant to J.N.M. (MSH-261515), and a TFRI new investigator award to S.P.S. S.P.S. and S.A. are supported by Canada Research Chairs. S.P.S. is a Michael Smith Foundation for Health Research scholar. A.M. is supported by a NSERC CGS scholarship. A.R. is supported by a CIHR CGS scholarship. T.M. is supported by a Canadian Breast Cancer Foundation British Columbia/Yukon Postdoctoral Fellowship.	Ahmed AA, 2010, J PATHOL, V221, P49, DOI 10.1002/path.2696; Alekseyenko AV, 2008, SYST BIOL, V57, P772, DOI 10.1080/10635150802434394; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Bamford S, 2004, BRIT J CANCER, V91, P355, DOI 10.1038/sj.bjc.6601894; Bashashati A, 2013, J PATHOL, V231, P21, DOI 10.1002/path.4230; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Blei DM, 2003, J MACH LEARN RES, V3, P993, DOI 10.1162/jmlr.2003.3.4-5.993; Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; Cooke SL, 2011, LANCET ONCOL, V12, P1169, DOI 10.1016/S1470-2045(11)70123-1; Eirew P, 2015, NATURE, V518, P422, DOI 10.1038/nature13952; Gawad C, 2014, P NATL ACAD SCI USA, V111, P17947, DOI 10.1073/pnas.1420822111; Gerlinger M, 2014, NAT GENET, V46, P225, DOI 10.1038/ng.2891; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Gundem G, 2015, NATURE, V520, P353, DOI 10.1038/nature14347; Ha G, 2014, GENOME RES, V24, P1881, DOI 10.1101/gr.180281.114; Hoogstraat M, 2014, GENOME RES, V24, P200, DOI 10.1101/gr.161026.113; JACOBS IJ, 1992, J NATL CANCER I, V84, P1793, DOI 10.1093/jnci/84.23.1793; Khalique L, 2009, INT J CANCER, V124, P1579, DOI 10.1002/ijc.24148; Langyel E, 2010, AM J PATHOL, V177, P1053, DOI 10.2353/ajpath.2010.100105; McAlpine JN, 2012, MODERN PATHOL, V25, P740, DOI 10.1038/modpathol.2011.211; Patch AM, 2015, NATURE, V521, P489, DOI 10.1038/nature14410; Roth A., 2016, NAT METHODS; Roth A, 2014, NAT METHODS, V11, P396, DOI [10.1038/NMETH.2883, 10.1038/nmeth.2883]; Ryder RJ, 2011, J R STAT SOC C-APPL, V60, P71, DOI 10.1111/j.1467-9876.2010.00743.x; Schrader KA, 2012, OBSTET GYNECOL, V120, P235, DOI 10.1097/AOG.0b013e31825f3576; Schwarz RF, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001789; Wang Y, 2014, NATURE, V512, P155, DOI 10.1038/nature13600	27	191	192	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2016	48	7					758	+		10.1038/ng.3573	http://dx.doi.org/10.1038/ng.3573			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DP9TK	27182968				2022-12-25	WOS:000378840100013
J	Dou, DR; Calvanese, V; Sierra, MI; Nguyen, AT; Minasian, A; Saarikoski, P; Sasidharan, R; Ramirez, CM; Zack, JA; Crooks, GM; Galic, Z; Mikkola, HKA				Dou, Diana R.; Calvanese, Vincenzo; Sierra, Maria I.; Nguyen, Andrew T.; Minasian, Arazin; Saarikoski, Pamela; Sasidharan, Rajkumar; Ramirez, Christian M.; Zack, Jerome A.; Crooks, Gay M.; Galic, Zoran; Mikkola, Hanna K. A.			Medial HOXA genes demarcate haematopoietic stem cell fate during human development	NATURE CELL BIOLOGY			English	Article							RETINOIC ACID; PROGENITOR CELLS; DIFFERENTIATION CULTURES; MYELOID-LEUKEMIA; YOLK-SAC; RNA-SEQ; EXPRESSION; BLOOD; ENDOTHELIUM; GENERATION	Pluripotent stem cells (PSCs) may provide a potential source of haematopoietic stem/progenitor cells (HSPCs) for transplantation; however, unknown molecular barriers prevent the self-renewal of PSC-HSPCs. Using two-step differentiation, human embryonic stem cells (hESCs) differentiated in vitro into multipotent haematopoietic cells that had the CD34(+)CD38(-/lo)CD90(+)CD45(+) GPI-80(+) fetal liver (FL) HSPC immunophenotype, but exhibited poor expansion potential and engraftment ability. Transcriptome analysis of immunophenotypic hESC-HSPCs revealed that, despite their molecular resemblance to FL-HSPCs, medial HOXA genes remained suppressed. Knockdown of HOXA7 disrupted FL-HSPC function and caused transcriptome dysregulation that resembled hESC-derived progenitors. Overexpression of medial HOXA genes prolonged FL-HSPC maintenance but was insufficient to confer self-renewal to hESC-HSPCs. Stimulation of retinoic acid signalling during endothelial-to-haematopoietic transition induced the HOXA cluster and other HSC/definitive haemogenic endothelium genes, and prolonged HSPC maintenance in culture. Thus, medial HOXA gene expression induced by retinoic acid signalling marks the establishment of the definitive HSPC fate and controls HSPC identity and function.	[Dou, Diana R.; Calvanese, Vincenzo; Sierra, Maria I.; Nguyen, Andrew T.; Minasian, Arazin; Saarikoski, Pamela; Sasidharan, Rajkumar; Crooks, Gay M.; Mikkola, Hanna K. A.] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; [Dou, Diana R.; Calvanese, Vincenzo; Sierra, Maria I.; Minasian, Arazin; Saarikoski, Pamela; Sasidharan, Rajkumar; Zack, Jerome A.; Crooks, Gay M.; Galic, Zoran; Mikkola, Hanna K. A.] Univ Calif Los Angeles, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90095 USA; [Dou, Diana R.; Mikkola, Hanna K. A.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Ramirez, Christian M.] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Dept Biostat, Los Angeles, CA 90095 USA; [Zack, Jerome A.; Galic, Zoran] Univ Calif Los Angeles, Dept Med, Div Hematol Oncol, Los Angeles, CA 90095 USA; [Zack, Jerome A.] Univ Calif Los Angeles, Dept Microbiol Mol Genet & Immunol, Los Angeles, CA 90095 USA; [Crooks, Gay M.] Univ Calif Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Mikkola, HKA (corresponding author), Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA.; Mikkola, HKA (corresponding author), Univ Calif Los Angeles, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90095 USA.; Mikkola, HKA (corresponding author), Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA.	hmikkola@mcdb.ucla.edu	Calvanese, Vincenzo/AAO-4311-2020; Calvanese, Vincenzo/E-1145-2016	Calvanese, Vincenzo/0000-0002-7937-1511; Calvanese, Vincenzo/0000-0002-7937-1511; Dou, Diana/0000-0001-6269-9636; Ramirez, Christina/0000-0002-8435-0416	NIH [AI028697-21, RO1 DK100959, P01 GM081621, PO1 HL073104]; CIRM [RN1-00557, RT3-07763, RB3-05217]; LLS Scholar award; Rose Hills Foundation Scholar Award; Broad Stem Cell Research Center at UCLA; JCC Foundation; NSF GRFP; Ruth L. Kirschstein National Research Service Award [GM007185, HL086345]; LLS Special Fellow Award; BSCRC post-doctoral fellow award; Beckman Scholarship; Eugene V. Cota-Robles fellowship; NATIONAL CANCER INSTITUTE [P30CA016042] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL073104, T32HL086345] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI028697] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK100959] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007185, P01GM081621] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIRM(California Institute for Regenerative Medicine); LLS Scholar award; Rose Hills Foundation Scholar Award; Broad Stem Cell Research Center at UCLA; JCC Foundation; NSF GRFP(National Science Foundation (NSF)NSF - Office of the Director (OD)); Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); LLS Special Fellow Award; BSCRC post-doctoral fellow award; Beckman Scholarship; Eugene V. Cota-Robles fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank BSCRC FACS Core at UCLA, the UCLA Clinical Pathology Microarray Core, BSCRC Sequencing Core, UCLA Tissue and Pathology Core and CFAR Gene and Cell Therapy Core (NIH grant AI028697-21) and Novogenix LLC. We thank H. Coller for discussions, T. Bolan for assistance with experiments, Y. Xing and Y.-T. Tseng for consultation on RNA sequencing analysis, and T. Stoyanova, D. Johnson and O. Witte for help with NSG mice. This work was supported by CIRM RN1-00557 and RT3-07763, NIH RO1 DK100959, LLS Scholar award and Rose Hills Foundation Scholar Award to H.K.A.M; Broad Stem Cell Research Center at UCLA and JCC Foundation; NIH P01 GM081621 to J.A.Z. and Z.G.; and NIH PO1 HL073104 and CIRM RB3-05217 to G.M.C. D.R.D. was supported by the NSF GRFP and Ruth L. Kirschstein National Research Service Award GM007185, V.C. by an LLS Special Fellow Award and a BSCRC post-doctoral fellow award, M.I.S. by Ruth L. Kirschstein National Research Service Award HL086345, A.T.N. by a Beckman Scholarship, and P.S. by the Eugene V. Cota-Robles fellowship.	Aguilo F, 2011, BLOOD, V117, P5057, DOI 10.1182/blood-2010-08-300145; Alharbi RA, 2013, LEUKEMIA, V27, P1000, DOI 10.1038/leu.2012.356; Balmer JE, 2002, J LIPID RES, V43, P1773, DOI 10.1194/jlr.R100015-JLR200; Bauchwitz R, 2000, HUM MOL GENET, V9, P561, DOI 10.1093/hmg/9.4.561; Beachy SH, 2013, EXP HEMATOL, V41, P518, DOI 10.1016/j.exphem.2013.02.006; Bordignon C, 2006, NATURE, V441, P1100, DOI 10.1038/nature04962; Boucherat O, 2013, AM J PHYSIOL-LUNG C, V304, pL817, DOI 10.1152/ajplung.00006.2013; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Cano E, 2014, J DEV BIOL, V2, P18, DOI 10.3390/jdb2010018; Chanda B, 2013, CELL, V155, P215, DOI 10.1016/j.cell.2013.08.055; Chen F, 1998, MECH DEVELOP, V77, P49, DOI 10.1016/S0925-4773(98)00126-9; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; DELESCLUSE C, 1991, MOL PHARMACOL, V40, P556; Ditadi A, 2015, NAT CELL BIOL, V17, P580, DOI 10.1038/ncb3161; Dou D. R., 2016, PROTOCOL EXCHANGE; Doulatov S, 2013, CELL STEM CELL, V13, P459, DOI 10.1016/j.stem.2013.09.002; Dravid G, 2011, MOL THER, V19, P768, DOI 10.1038/mt.2010.281; Gavalas A, 2000, CURR OPIN GENET DEV, V10, P380, DOI 10.1016/S0959-437X(00)00100-3; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hilpert M, 2014, STEM CELL REP, V3, P1085, DOI 10.1016/j.stemcr.2014.10.005; Keller G, 2005, GENE DEV, V19, P1129, DOI 10.1101/gad.1303605; Kennedy M, 2012, CELL REP, V2, P1722, DOI 10.1016/j.celrep.2012.11.003; Kishimoto H, 1998, J BIOL CHEM, V273, P15429, DOI 10.1074/jbc.273.25.15429; Klimmeck D, 2014, STEM CELL REP, V3, P858, DOI 10.1016/j.stemcr.2014.08.012; Kyba M, 2003, EXP HEMATOL, V31, P994, DOI 10.1016/j.exphem.2003.08.002; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Lawrence HJ, 2005, BLOOD, V106, P3988, DOI 10.1182/blood-2005-05-2003; Leandra S, 2015, CELL STEM CELL, V16, P80, DOI 10.1016/j.stem.2014.10.020; Lebert-Ghali CE, 2016, BLOOD, V127, P87, DOI 10.1182/blood-2015-02-626390; Lebert-Ghali CE, 2010, EXP HEMATOL, V38, P1074, DOI 10.1016/j.exphem.2010.07.006; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Magnusson M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053912; Marshall H, 1996, FASEB J, V10, P969, DOI 10.1096/fasebj.10.9.8801179; Martin CH, 2008, BLOOD, V112, P2730, DOI 10.1182/blood-2008-01-133801; McGrath KE, 2005, EXP HEMATOL, V33, P1021, DOI 10.1016/j.exphem.2005.06.012; McKinney-Freeman S, 2012, CELL STEM CELL, V11, P701, DOI 10.1016/j.stem.2012.07.018; Mikkola HKA, 2006, DEVELOPMENT, V133, P3733, DOI 10.1242/dev.02568; Muramoto GG, 2010, STEM CELLS, V28, P523, DOI 10.1002/stem.299; Olsen AL, 2006, BLOOD, V107, P1265, DOI 10.1182/blood-2005-09-3621; Pereira CF, 2013, CELL STEM CELL, V13, P205, DOI 10.1016/j.stem.2013.05.024; Pick M, 2007, STEM CELLS, V25, P2206, DOI 10.1634/stemcells.2006-0713; Pluta K, 2005, J GENE MED, V7, P803, DOI 10.1002/jgm.712; Qiu CH, 2005, EXP HEMATOL, V33, P1450, DOI 10.1016/j.exphem.2005.09.003; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ramirez F, 2014, NUCLEIC ACIDS RES, V42, pW187, DOI 10.1093/nar/gku365; Ramos-Mejia V, 2014, BLOOD, V124, P3065, DOI 10.1182/blood-2014-03-558825; Riddell J, 2014, CELL, V157, P549, DOI 10.1016/j.cell.2014.04.006; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Ronn RE, 2015, STEM CELL REP, V4, P269, DOI 10.1016/j.stemcr.2015.01.009; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Salvagiotto G, 2008, EXP HEMATOL, V36, P1377, DOI 10.1016/j.exphem.2008.06.015; Shaut CAE, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000073; Shojaei F, 2008, EXP HEMATOL, V36, P1436, DOI 10.1016/j.exphem.2008.06.001; Slukvin II, 2013, BLOOD, V122, P4035, DOI 10.1182/blood-2013-07-474825; Swiers G, 2013, BLOOD CELL MOL DIS, V51, P206, DOI 10.1016/j.bcmd.2013.09.005; Szatmari I, 2010, STEM CELLS, V28, P1518, DOI 10.1002/stem.484; THOMA SJ, 1994, BLOOD, V83, P2103; Thorsteinsdottir U, 2002, BLOOD, V99, P121, DOI 10.1182/blood.V99.1.121; Tian XH, 2008, CURR OPIN HEMATOL, V15, P312, DOI 10.1097/MOH.0b013e328302f429; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Van Handel B, 2010, BLOOD, V116, P3321, DOI 10.1182/blood-2010-04-279489; Vodyanik MA, 2005, BLOOD, V105, P617, DOI 10.1182/blood-2004-04-1649; Vodyanik MA, 2006, BLOOD, V108, P2095, DOI 10.1182/blood-2006-02-003327; Wang LS, 2006, METH MOL B, V331, P179; Wang LS, 2005, J EXP MED, V201, P1603, DOI 10.1084/jem.20041888; Wang LS, 2004, IMMUNITY, V21, P31, DOI 10.1016/j.immuni.2004.06.006; Wang Y, 2006, BLOOD, V107, P358, DOI 10.1182/blood-2005-04-1418; Zambidis ET, 2005, BLOOD, V106, P860, DOI 10.1182/blood-2004-11-4522; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	70	51	54	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUN	2016	18	6					595	+		10.1038/ncb3354	http://dx.doi.org/10.1038/ncb3354			22	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	DN0JL	27183470	Green Submitted, Green Accepted			2022-12-25	WOS:000376750100006
J	Pradeepa, MM; Grimes, GR; Kumar, Y; Olley, G; Taylor, GCA; Schneider, R; Bickmore, WA				Pradeepa, Madapura M.; Grimes, Graeme R.; Kumar, Yatendra; Olley, Gabrielle; Taylor, Gillian C. A.; Schneider, Robert; Bickmore, Wendy A.			Histone H3 globular domain acetylation identifies a new class of enhancers	NATURE GENETICS			English	Article							EMBRYONIC STEM-CELLS; TRANSCRIPTION FACTORS; LATERAL SURFACE; GENES; SIGNATURES; TRITHORAX; DISTINCT; H3K27	Histone acetylation is generally associated with active chromatin, but most studies have focused on the acetylation of histone tails. Various histone H3 and H4 tail acetylations mark the promoters of active genes(1). These modifications include acetylation of histone H3 at lysine 27 (H3K27ac), which blocks Polycomb-mediated trimethylation of H3K27 (H3K27me3)(2). H3K27ac is also widely used to identify active enhancers(3,4), and the assumption has been that profiling H3K27ac is a comprehensive way of cataloguing the set of active enhancers in mammalian cell types. Here we show that acetylation of lysine residues in the globular domain of histone H3 (lysine 64 (H3K64ac) and lysine 122 (H3K122ac)) marks active gene promoters and also a subset of active enhancers. Moreover, we find a new class of active functional enhancers that is marked by H3K122ac but lacks H3K27ac. This work suggests that, to identify enhancers, a more comprehensive analysis of histone acetylation is required than has previously been considered.	[Pradeepa, Madapura M.; Grimes, Graeme R.; Kumar, Yatendra; Olley, Gabrielle; Taylor, Gillian C. A.; Bickmore, Wendy A.] Univ Edinburgh, MRC Inst Genet & Mol Med, MRC Human Genet Unit, Edinburgh, Midlothian, Scotland; [Pradeepa, Madapura M.] Univ Essex, Sch Biol Sci, Colchester CO4 3SQ, Essex, England; [Schneider, Robert] Univ Strasbourg, INSERM U964, CNRS UMR 7104, Inst Genet & Biol Mol & Cellulaire, Illkirch Graffenstaden, France; [Schneider, Robert] Helmholtz Zentrum Munchen, Inst Funct Epigenet, Neuherberg, Germany	University of Edinburgh; University of Essex; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Pradeepa, MM; Bickmore, WA (corresponding author), Univ Edinburgh, MRC Inst Genet & Mol Med, MRC Human Genet Unit, Edinburgh, Midlothian, Scotland.; Pradeepa, MM (corresponding author), Univ Essex, Sch Biol Sci, Colchester CO4 3SQ, Essex, England.	pmadap@essex.ac.uk; wendy.bickmore@igmm.ed.ac.uk	madapura, Pradeepa/AAS-1288-2020	madapura, Pradeepa/0000-0001-9095-9247	Medical Research Council UK; European Research Council advanced grant [249956]; Fondation pour la Recherche Medicale (FRM); Agence Nationale de Recherche (ANR); La Ligue National Contre La Cancer (Equipe Labellise); INSERM Plan Cancer (Epigenetique et Cancer); Agence Nationale de Recherche (CoreAc); Medical Research Council [MC_PC_U127527202, 1584120] Funding Source: researchfish; MRC [MC_PC_U127527202] Funding Source: UKRI	Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Research Council advanced grant(European Research Council (ERC)); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Agence Nationale de Recherche (ANR)(French National Research Agency (ANR)); La Ligue National Contre La Cancer (Equipe Labellise); INSERM Plan Cancer (Epigenetique et Cancer); Agence Nationale de Recherche (CoreAc)(French National Research Agency (ANR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank R. Illingworth, R. Young and P. Tropberger for discussions, U. Basu (Albert Einstein College of Medicine) for sharing mapped RNA-seq data from Exosc3<SUP>-/-</SUP> mESCs and S. Qi (Stanford University) for sharing a CRISPR gRNA plasmid backbone. This work was supported by the Medical Research Council UK and by European Research Council advanced grant 249956 (W.A.B.). Work in the laboratory of R.S. is supported by the Fondation pour la Recherche Medicale (FRM), the Agence Nationale de Recherche (ANR, CoreAc), La Ligue National Contre La Cancer (Equipe Labellise) and INSERM Plan Cancer (Epigenetique et Cancer).	Andersson R, 2014, NATURE, V507, P455, DOI 10.1038/nature12787; Bogu GK, 2016, MOL CELL BIOL, V36, P809, DOI 10.1128/MCB.00955-15; Bowman SK, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-466; Chen BH, 2013, CELL, V155, P1479, DOI 10.1016/j.cell.2013.12.001; Cheng AW, 2013, CELL RES, V23, P1163, DOI 10.1038/cr.2013.122; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Daujat S, 2009, NAT STRUCT MOL BIOL, V16, P777, DOI 10.1038/nsmb.1629; Di Cerbo V, 2014, ELIFE, V3, DOI 10.7554/eLife.01632; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Halley JE, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000401; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Kim TW, 2015, STEM CELLS, V33, P2442, DOI 10.1002/stem.2046; Konermann S, 2013, NATURE, V500, P472, DOI 10.1038/nature12466; Ku M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000242; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li XZ, 2012, CELL STEM CELL, V11, P163, DOI 10.1016/j.stem.2012.04.023; Long HK, 2013, ELIFE, V2, DOI 10.7554/eLife.00348; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Neumann H, 2009, MOL CELL, V36, P153, DOI 10.1016/j.molcel.2009.07.027; Pefanis E, 2015, CELL, V161, P774, DOI 10.1016/j.cell.2015.04.034; Pradeepa MM, 2014, NUCLEIC ACIDS RES, V42, P9021, DOI 10.1093/nar/gku647; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Ramirez F, 2014, NUCLEIC ACIDS RES, V42, pW187, DOI 10.1093/nar/gku365; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ravens S, 2014, ELIFE, V3, DOI 10.7554/eLife.02104; Shen L, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-284; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; Simon M, 2011, P NATL ACAD SCI USA, V108, P12711, DOI 10.1073/pnas.1106264108; Smith ER, 2005, MOL CELL BIOL, V25, P9175, DOI 10.1128/MCB.25.21.9175-9188.2005; Taylor GCA, 2013, GENOME RES, V23, P2053, DOI 10.1101/gr.155028.113; Tie F, 2014, DEVELOPMENT, V141, P1129, DOI 10.1242/dev.102392; Tropberger P, 2013, NAT STRUCT MOL BIOL, V20, P657, DOI 10.1038/nsmb.2581; Tropberger P, 2013, CELL, V152, P859, DOI 10.1016/j.cell.2013.01.032; Voigt P, 2013, GENE DEV, V27, P1318, DOI 10.1101/gad.219626.113; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Zang CZ, 2009, BIOINFORMATICS, V25, P1952, DOI 10.1093/bioinformatics/btp340; Zentner GE, 2011, GENOME RES, V21, P1273, DOI 10.1101/gr.122382.111; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	46	123	130	1	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2016	48	6					681	+		10.1038/ng.3550	http://dx.doi.org/10.1038/ng.3550			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DN0HE	27089178	Green Accepted			2022-12-25	WOS:000376744200017
J	Bray, NL; Pimentel, H; Melsted, P; Pachter, L				Bray, Nicolas L.; Pimentel, Harold; Melsted, Pall; Pachter, Lior			Near-optimal probabilistic RNA-seq quantification	NATURE BIOTECHNOLOGY			English	Article							GENOME; TRANSCRIPTOMES	We present kallisto, an RNA-seq quantification program that is two orders of magnitude faster than previous approaches and achieves similar accuracy. Kallisto pseudoaligns reads to a reference, producing a list of transcripts that are compatible with each read while avoiding alignment of individual bases. We use kallisto to analyze 30 million unaligned paired-end RNA-seq reads in <10 min on a standard laptop computer. This removes a major computational bottleneck in RNA-seq analysis.	[Bray, Nicolas L.] Univ Calif Berkeley, Innovat Genom Initiat, Berkeley, CA 94720 USA; [Pimentel, Harold; Pachter, Lior] Univ Calif Berkeley, Dept Comp Sci, Berkeley, CA 94720 USA; [Melsted, Pall] Univ Iceland, Fac Ind Engn Mech Engn & Comp Sci, Reykjavik, Iceland; [Pachter, Lior] Univ Calif Berkeley, Dept Math, Berkeley, CA 94720 USA; [Pachter, Lior] Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of Iceland; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Pachter, L (corresponding author), Univ Calif Berkeley, Dept Math, Berkeley, CA 94720 USA.; Pachter, L (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	lpachter@math.berkeley.edu		Pimentel, Harold/0000-0001-8556-2499	NIH [R01 HG006129]; Fulbright fellowship; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006129] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fulbright fellowship; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	N.L.B., H.P. and L.P. were partially funded by NIH R01 HG006129. P.M. was partially funded by a Fulbright fellowship.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Compeau PEC, 2011, NAT BIOTECHNOL, V29, P987, DOI 10.1038/nbt.2023; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Marconi J. C., 2008, GENOME RES, V18, P1509; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nicolae M, 2010, LECT N BIOINFORMAT, V6293, P202, DOI 10.1007/978-3-642-15294-8_17; Patro R, 2014, NAT BIOTECHNOL, V32, P462, DOI 10.1038/nbt.2862; Roberts A, 2013, NAT METHODS, V10, P71, DOI [10.1038/NMETH.2251, 10.1038/nmeth.2251]; Roberts A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r22; Su ZQ, 2014, NAT BIOTECHNOL, V32, P903, DOI 10.1038/nbt.2957; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Wold B, 2008, NAT METHODS, V5, P19, DOI 10.1038/NMETH1157	14	1040	1043	11	201	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2016	34	5					525	527		10.1038/nbt.3519	http://dx.doi.org/10.1038/nbt.3519			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DL6FL	27043002				2022-12-25	WOS:000375735000032
J	Carlson, DF; Lancto, CA; Zang, B; Kim, ES; Walton, M; Oldeschulte, D; Seabury, C; Sonstegard, TS; Fahrenkrug, SC				Carlson, Daniel F.; Lancto, Cheryl A.; Zang, Bin; Kim, Eui-Soo; Walton, Mark; Oldeschulte, David; Seabury, Christopher; Sonstegard, Tad S.; Fahrenkrug, Scott C.			Production of hornless dairy cattle from genome-edited cell lines	NATURE BIOTECHNOLOGY			English	Letter									[Carlson, Daniel F.; Lancto, Cheryl A.; Kim, Eui-Soo; Walton, Mark; Sonstegard, Tad S.; Fahrenkrug, Scott C.] Recombinetics, St Paul, MN USA; [Zang, Bin] Univ Minnesota, Program Sci Computat, Minneapolis, MN USA; [Oldeschulte, David; Seabury, Christopher] Texas A&M Univ, Coll Vet Med, Dept Vet Pathobiol, College Stn, TX 77843 USA	University of Minnesota System; University of Minnesota Twin Cities; Texas A&M University System; Texas A&M University College Station	Fahrenkrug, SC (corresponding author), Recombinetics, St Paul, MN USA.	scott@recombinetics.com		Fahrenkrug, Scott/0000-0002-7176-6551; Carlson, Daniel/0000-0001-6095-2108				Bouie F. A., 2002, FARM ANIMAL WELFARE, V2; Dorshorst B., 2014, PROGR DAIRYMAN  0117; Medugorac I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039477; Ross PJ, 2010, METHODS MOL BIOL, V636, P155, DOI 10.1007/978-1-60761-691-7_10; Rothammer S, 2014, GENET SEL EVOL, V46, DOI 10.1186/1297-9686-46-44; Spurlock DM, 2014, J DAIRY SCI, V97, P5265, DOI 10.3168/jds.2013-7746; Stafford KJ, 2005, VET J, V169, P337, DOI 10.1016/j.tvjl.2004.02.005; Swanson A. F., 2015, NPR THE SALT; Tan WF, 2013, P NATL ACAD SCI USA, V110, P16526, DOI 10.1073/pnas.1310478110; Tan W, 2012, ADV GENET, V80, P37, DOI 10.1016/B978-0-12-404742-6.00002-8; Wilcox CS, 2013, J DAIRY SCI, V96, P7223, DOI 10.3168/jds.2013-6944	11	170	182	5	60	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	MAY	2016	34	5					479	481		10.1038/nbt.3560	http://dx.doi.org/10.1038/nbt.3560			3	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	DL6FL	27153274				2022-12-25	WOS:000375735000021
J	Peuker, K; Muff, S; Wang, J; Kunzel, S; Bosse, E; Zeissig, Y; Luzzi, G; Basic, M; Strigli, A; Ulbricht, A; Kaser, A; Arlt, A; Chavakis, T; van den Brink, GR; Schafmayer, C; Egberts, JH; Becker, T; Bianchi, ME; Bleich, A; Rocken, C; Hampe, J; Schreiber, S; Baines, JF; Blumberg, RS; Zeissig, S				Peuker, Kenneth; Muff, Stefanie; Wang, Jun; Kuenzel, Sven; Bosse, Esther; Zeissig, Yvonne; Luzzi, Giuseppina; Basic, Marijana; Strigli, Anne; Ulbricht, Andrea; Kaser, Arthur; Arlt, Alexander; Chavakis, Triantafyllos; van den Brink, Gijs R.; Schafmayer, Clemens; Egberts, Jan-Hendrik; Becker, Thomas; Bianchi, Marco E.; Bleich, Andre; Roecken, Christoph; Hampe, Jochen; Schreiber, Stefan; Baines, John F.; Blumberg, Richard S.; Zeissig, Sebastian			Epithelial calcineurin controls microbiota-dependent intestinal tumor development	NATURE MEDICINE			English	Article							ACTIVATED T-CELLS; NUCLEAR FACTOR; STEM-CELLS; TRANSCRIPTION FACTOR; COLORECTAL-CANCER; COLON; TUMORIGENESIS; EXPRESSION; INFLAMMATION; MARKER	Inflammation-associated pathways are active in intestinal epithelial cells (IECs) and contribute to the pathogenesis of colorectal cancer (CRC). Calcineurin, a phosphatase required for the activation of the nuclear factor of activated T cells (NFAT) family of transcription factors, shows increased expression in CRC. We therefore investigated the role of calcineurin in intestinal tumor development. We demonstrate that calcineurin and NFAT factors are constitutively expressed by primary IECs and selectively activated in intestinal tumors as a result of impaired stratification of the tumor-associated microbiota and toll-like receptor signaling. Epithelial calcineurin supports the survival and proliferation of cancer stem cells in an NFAT-dependent manner and promotes the development of intestinal tumors in mice. Moreover, somatic mutations that have been identified in human CRC are associated with constitutive activation of calcineurin, whereas nuclear translocation of NFAT is associated with increased death from CRC. These findings highlight an epithelial cell intrinsic pathway that integrates signals derived from the commensal microbiota to promote intestinal tumor development.	[Peuker, Kenneth; Muff, Stefanie; Bosse, Esther; Luzzi, Giuseppina; Ulbricht, Andrea; Arlt, Alexander; Hampe, Jochen; Schreiber, Stefan; Zeissig, Sebastian] Univ Med Ctr Schleswig Holstein, Dept Internal Med 1, Kiel, Germany; [Peuker, Kenneth; Luzzi, Giuseppina; Strigli, Anne; Zeissig, Sebastian] Tech Univ Dresden, Ctr Regenerat Therapies, D-01062 Dresden, Germany; [Wang, Jun; Kuenzel, Sven; Baines, John F.] Max Planck Inst Evolutionary Biol, Plon, Germany; [Wang, Jun; Kuenzel, Sven; Baines, John F.] Univ Kiel, Inst Expt Med, Kiel, Germany; [Zeissig, Yvonne] Univ Med Ctr Schleswig Holstein, Dept Gen Pediat, Kiel, Germany; [Zeissig, Yvonne] Tech Univ Dresden, Univ Med Ctr Dresden, Dept Pediat, D-01062 Dresden, Germany; [Basic, Marijana; Bleich, Andre] Hannover Med Sch, Inst Lab Anim Sci, Hannover, Germany; [Basic, Marijana; Bleich, Andre] Hannover Med Sch, Cent Anim Facil, Hannover, Germany; [Kaser, Arthur] Univ Cambridge, Addenbrooke Hosp, Div Gastroenterol, Cambridge, England; [Chavakis, Triantafyllos] Tech Univ Dresden, Fac Med, Dept Clin Pathobiochem, D-01062 Dresden, Germany; [Chavakis, Triantafyllos] Tech Univ Dresden, Fac Med, Inst Clin Chem & Lab Med, D-01062 Dresden, Germany; [van den Brink, Gijs R.] Univ Amsterdam, Acad Med Ctr, Tytgat Inst Liver & Intestinal Res, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [van den Brink, Gijs R.] Univ Amsterdam, Acad Med Ctr, Dept Gastroenterol & Hepatol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [Schafmayer, Clemens; Egberts, Jan-Hendrik; Becker, Thomas] Univ Hosp Schleswig Holstein, Dept Gen Surg & Thorac Surg, Kiel, Germany; [Bianchi, Marco E.] San Raffaele Univ, Milan, Italy; [Bianchi, Marco E.] Inst Sci, Milan, Italy; [Roecken, Christoph] Univ Med Ctr Schleswig Holstein, Inst Pathol, Kiel, Germany; [Hampe, Jochen; Zeissig, Sebastian] Tech Univ Dresden, Univ Med Ctr Dresden, Dept Med 1, D-01062 Dresden, Germany; [Blumberg, Richard S.; Zeissig, Sebastian] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Gastroenterol Hepatol & Endoscopy, Boston, MA 02115 USA	University of Kiel; Schleswig Holstein University Hospital; Technische Universitat Dresden; Max Planck Society; University of Kiel; University of Kiel; Schleswig Holstein University Hospital; Technische Universitat Dresden; Hannover Medical School; Hannover Medical School; University of Cambridge; Technische Universitat Dresden; Technische Universitat Dresden; University of Amsterdam; University of Amsterdam; University of Kiel; Schleswig Holstein University Hospital; Vita-Salute San Raffaele University; University of Kiel; Schleswig Holstein University Hospital; Technische Universitat Dresden; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Zeissig, S (corresponding author), Univ Med Ctr Schleswig Holstein, Dept Internal Med 1, Kiel, Germany.; Zeissig, S (corresponding author), Tech Univ Dresden, Ctr Regenerat Therapies, D-01062 Dresden, Germany.; Zeissig, S (corresponding author), Tech Univ Dresden, Univ Med Ctr Dresden, Dept Med 1, D-01062 Dresden, Germany.; Blumberg, RS; Zeissig, S (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Gastroenterol Hepatol & Endoscopy, Boston, MA 02115 USA.	rblumberg@partners.org; sebastian.zeissig@uniklinikum-dresden.de	Bianchi, Marco Emilio/K-3417-2018; Zeissig, Sebastian/B-6297-2012; Hampe, Jochen/A-2555-2010; Baines, John F/B-3580-2010; Chavakis, Triantafyllos/ABE-8845-2020; Arlt, Alexander/G-7308-2019; Röcken, Christoph/A-9239-2010	Bianchi, Marco Emilio/0000-0002-5329-6445; Zeissig, Sebastian/0000-0001-5124-0897; Hampe, Jochen/0000-0002-2421-6127; Baines, John F/0000-0002-8132-4909; Arlt, Alexander/0000-0002-6160-1059; Röcken, Christoph/0000-0002-6989-8002; Luzzi, Giuseppina/0000-0003-1983-2176	Deutsche Forschungsgemeinschaft (DFG) [ZE814/5-1, BA2863/5-1, CH279/5-1]; European Research Council (ERC) [336528]; Crohn's and Colitis Foundation of America; European Commission [256363]; DFG Excellence Cluster 'Inflammation at Interfaces'; DFG Excellence Cluster 'Center for Regenerative Therapies'; US National Institutes of Health [DK044319, DK051362, DK053056, DK088199]; Harvard Digestive Diseases Center (HDDC) [DK0034854]; AIRC [IG-14233]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053056, P30DK034854, R01DK044319, R01DK051362, R37DK044319, R01DK088199] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); European Research Council (ERC)(European Research Council (ERC)European Commission); Crohn's and Colitis Foundation of America; European Commission(European CommissionEuropean Commission Joint Research Centre); DFG Excellence Cluster 'Inflammation at Interfaces'(German Research Foundation (DFG)); DFG Excellence Cluster 'Center for Regenerative Therapies'(German Research Foundation (DFG)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Digestive Diseases Center (HDDC); AIRC(Fondazione AIRC per la ricerca sul cancro); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank L.H. Glimcher (Weill Cornell Medical College), M.B. Greenblatt (Weill Cornell Medical College) and A.O. Aliprantis (Brigham and Women's Hospital, Harvard Medical School) for Nfatc/fufl mice and for helpful discussions; G.R. Crabtree (Center for Regenerative Therapies, Dresden) for Ppp3r1<SUP>fl/fl</SUP> and Nfatc3<SUP>fl/fl</SUP> mice; L. Niederreiter (Addenbrooke Hospital) for help with in situ hybridization; K. Schmidt, A. Gerneth, M. Pein (University Medical Center Schleswig-Holstein), S. Kruger (University Medical Center Schleswig-Holstein) and M. Jager (Stanford University) for assistance with immunofluorescence, immunohistochemistry and TMA stainings; K. Cloppenborg-Schmidt (Institute for Experimental Medicine) for assistance with NGS library preparation; S. Robine (Institut Curie CNRS) for villin-CreER<SUP>T2</SUP> mice; S. Akira (Research Institute for Microbial Diseases) for Myd88<SUP>-/-</SUP> mice; R.H. Whitehead (Vanderbilt University Medical Center) for the YAMC, IMCE and IMCE-Ras cells; C.M. Norris (Molecular and Biomedical Pharmacology) for the Ad5-CMV-VIVIT construct; R. Moon (University of Washington) for the TOPFlash plasmid; A. Rao (La Jolla Institute for Allergy and Immunology) for the NFAT-Luc and NFATc3-eGFP plasmids; and W. Garrett (Harvard T.H. Chan School of Public Health), S. Scholch and D.E. Stange (University Medical Center Dresden) for helpful discussions. This work was supported by the Deutsche Forschungsgemeinschaft (DFG) grants ZE814/5-1 (S.Z.), BA2863/5-1 (J.F.B.) and CH279/5-1 (T.C.), the European Research Council (ERC) starting grant 336528 (S.Z.), a Postdoctoral Fellowship Award from the Crohn's and Colitis Foundation of America (S.Z.), the European Commission (Marie Curie International Reintegration grant 256363; S.Z.), the DFG Excellence Cluster 'Inflammation at Interfaces' (S.Z. and J.F.B.), the DFG Excellence Cluster 'Center for Regenerative Therapies' (S.Z.); the US National Institutes of Health grants DK044319 (R.S.B.), DK051362 (R.S.B.), DK053056 (R.S.B.) and DK088199 (R.S.B.), the Harvard Digestive Diseases Center (HDDC) grant DK0034854 (R.S.B.), and the AIRC grant IG-14233 (M.E.B.).	Adami J, 2003, BRIT J CANCER, V89, P1221, DOI 10.1038/sj.bjc.6601219; Anderson MJ, 2003, ECOLOGY, V84, P511, DOI 10.1890/0012-9658(2003)084[0511:CAOPCA]2.0.CO;2; Aramburu J, 1999, SCIENCE, V285, P2129, DOI 10.1126/science.285.5436.2129; Armesilla AL, 1999, MOL CELL BIOL, V19, P2032; Arthur JC, 2012, SCIENCE, V338, P120, DOI 10.1126/science.1224820; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bollrath J, 2009, CANCER CELL, V15, P91, DOI 10.1016/j.ccr.2009.01.002; Buchholz M, 2006, EMBO J, V25, P3714, DOI 10.1038/sj.emboj.7601246; Cancer Genome Atlas Network, 2012, NATURE, V487, P33; Carvalho LDS, 2007, CELL CYCLE, V6, P1789, DOI 10.4161/cc.6.14.4473; Castellarin M, 2012, GENOME RES, V22, P299, DOI 10.1101/gr.126516.111; Dantal J, 1998, LANCET, V351, P623, DOI 10.1016/S0140-6736(97)08496-1; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; Dejea CM, 2014, P NATL ACAD SCI USA, V111, P18321, DOI 10.1073/pnas.1406199111; Dove WF, 1997, CANCER RES, V57, P812; Dupont A, 2015, GUT, V64, P222, DOI 10.1136/gutjnl-2014-307150; Duque J, 2005, J BIOL CHEM, V280, P8686, DOI 10.1074/jbc.M413076200; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Grivennikov SI, 2012, NATURE, V491, P254, DOI 10.1038/nature11465; Gunther C, 2015, GUT, V64, P601, DOI 10.1136/gutjnl-2014-307226; Jauliac S, 2002, NAT CELL BIOL, V4, P540, DOI 10.1038/ncb816; Keyes BE, 2013, P NATL ACAD SCI USA, V110, pE4950, DOI 10.1073/pnas.1320301110; Koenig A, 2010, GASTROENTEROLOGY, V138, P1189, DOI 10.1053/j.gastro.2009.10.045; Kostic AD, 2013, CELL HOST MICROBE, V14, P207, DOI 10.1016/j.chom.2013.07.007; Kostic AD, 2012, GENOME RES, V22, P292, DOI 10.1101/gr.126573.111; Lakshmikuttyamma A, 2005, J CELL BIOCHEM, V95, P731, DOI 10.1002/jcb.20437; Lee SH, 2010, NAT MED, V16, P665, DOI 10.1038/nm.2143; Li HM, 2011, TRENDS CELL BIOL, V21, P91, DOI 10.1016/j.tcb.2010.09.011; Li YH, 2012, CARCINOGENESIS, V33, P1231, DOI 10.1093/carcin/bgs137; Liu SL, 2009, J IMMUNOL, V183, P5537, DOI 10.4049/jimmunol.0900083; Marchesi JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020447; Masuo T, 2009, CANCER LETT, V285, P66, DOI 10.1016/j.canlet.2009.05.001; MOSER AR, 1990, SCIENCE, V247, P322, DOI 10.1126/science.2296722; MULDER JWR, 1994, LANCET, V344, P1470, DOI 10.1016/S0140-6736(94)90290-9; Neal MD, 2012, J BIOL CHEM, V287, P37296, DOI 10.1074/jbc.M112.375881; OKEEFE SJ, 1992, NATURE, V357, P692, DOI 10.1038/357692a0; Rakoff-Nahoum S, 2007, SCIENCE, V317, P124, DOI 10.1126/science.1140488; Rallabhandi P, 2008, J IMMUNOL, V180, P1139, DOI 10.4049/jimmunol.180.2.1139; Rivera A, 2005, J BIOL CHEM, V280, P29346, DOI 10.1074/jbc.M504852200; Saneyoshi T, 2002, NATURE, V417, P295, DOI 10.1038/417295a; Santaolalla R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063298; Scheeren FA, 2014, NAT CELL BIOL, V16, P1238, DOI 10.1038/ncb3058; Schwitalla S, 2013, CELL, V152, P25, DOI 10.1016/j.cell.2012.12.012; Sears CL, 2014, CELL HOST MICROBE, V15, P317, DOI 10.1016/j.chom.2014.02.007; Seshagiri S, 2012, NATURE, V488, P660, DOI 10.1038/nature11282; Shinmen N, 2009, FEBS LETT, V583, P1916, DOI 10.1016/j.febslet.2009.04.041; Song XY, 2014, IMMUNITY, V40, P140, DOI 10.1016/j.immuni.2013.11.018; Terzic J, 2010, GASTROENTEROLOGY, V138, P2101, DOI 10.1053/j.gastro.2010.01.058; Tjalsma H, 2012, NAT REV MICROBIOL, V10, P575, DOI 10.1038/nrmicro2819; Todaro M, 2014, CELL STEM CELL, V14, P342, DOI 10.1016/j.stem.2014.01.009; Wang EL, 2010, BRIT J CANCER, V102, P908, DOI 10.1038/sj.bjc.6605558; Wang JY, 2012, CELL SIGNAL, V24, P162, DOI 10.1016/j.cellsig.2011.08.017; WOODROW M, 1993, J EXP MED, V178, P1517, DOI 10.1084/jem.178.5.1517; Wu SG, 2009, NAT MED, V15, P1016, DOI 10.1038/nm.2015; Wu XW, 2010, NATURE, V465, P368, DOI 10.1038/nature08996; Zanoni I, 2009, NATURE, V460, P264, DOI 10.1038/nature08118; Zeilstra J, 2014, ONCOGENE, V33, P665, DOI 10.1038/onc.2012.611; Zeilstra J, 2008, CANCER RES, V68, P3655, DOI 10.1158/0008-5472.CAN-07-2940; Zhang X, 2012, J BIOL CHEM, V287, P30468, DOI 10.1074/jbc.M112.373738; Zhou YN, 2012, MOL BIOL CELL, V23, P2963, DOI 10.1091/mbc.E12-01-0037	63	68	70	3	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	MAY	2016	22	5					506	515		10.1038/nm.4072	http://dx.doi.org/10.1038/nm.4072			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DL3DI	27043494	Green Accepted			2022-12-25	WOS:000375514000013
J	Camarda, R; Zhou, AY; Kohnz, RA; Balakrishnan, S; Mahieu, C; Anderton, B; Eyob, H; Kajimura, S; Tward, A; Krings, G; Nomura, DK; Goga, A				Camarda, Roman; Zhou, Alicia Y.; Kohnz, Rebecca A.; Balakrishnan, Sanjeev; Mahieu, Celine; Anderton, Brittany; Eyob, Henok; Kajimura, Shingo; Tward, Aaron; Krings, Gregor; Nomura, Daniel K.; Goga, Andrei			Inhibition of fatty acid oxidation as a therapy for MYC-overexpressing triple-negative breast cancer	NATURE MEDICINE			English	Article							CELL-SURVIVAL; GROWTH; PREDICTOR; STRESS	Expression of the oncogenic transcription factor MYC is disproportionately elevated in triple-negative breast cancer (TNBC), as compared to estrogen receptor-, progesterone receptor-or human epidermal growth factor 2 receptor-positive (RP) breast cancer(1,2). We and others have shown that MYC alters metabolism during tumorigenesis(3,4). However, the role of MYC in TNBC metabolism remains mostly unexplored. We hypothesized that MYC-dependent metabolic dysregulation is essential for the growth of MYC-overexpressing TNBC cells and may identify new therapeutic targets for this clinically challenging subset of breast cancer. Using a targeted metabolomics approach, we identified fatty acid oxidation (FAO) intermediates as being dramatically upregulated in a MYC-driven model of TNBC. We also identified a lipid metabolism gene signature in patients with TNBC that were identified from The Cancer Genome Atlas database and from multiple other clinical data sets, implicating FAO as a dysregulated pathway that is critical for TNBC cell metabolism. We found that pharmacologic inhibition of FAO catastrophically decreased energy metabolism in MYC-overexpressing TNBC cells and blocked tumor growth in a MYC-driven transgenic TNBC model and in a MYC-overexpressing TNBC patient-erived xenograft. These findings demonstrate that MYC-overexpressing TNBC shows an increased bioenergetic reliance on FAO and identify the inhibition of FAO as a potential therapeutic strategy for this subset of breast cancer.	[Camarda, Roman; Zhou, Alicia Y.; Balakrishnan, Sanjeev; Mahieu, Celine; Anderton, Brittany; Eyob, Henok; Kajimura, Shingo; Goga, Andrei] Univ Calif San Francisco, Dept Cell & Tissue Biol, San Francisco, CA 94143 USA; [Camarda, Roman; Anderton, Brittany] Univ Calif San Francisco, Biomed Sci Grad Program, San Francisco, CA 94143 USA; [Kohnz, Rebecca A.; Nomura, Daniel K.] Univ Calif Berkeley, Program Metab Biol, Berkeley, CA 94720 USA; [Kajimura, Shingo] Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA; [Kajimura, Shingo] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA; [Tward, Aaron] Univ Calif San Francisco, Dept Otolaryngol, San Francisco, CA 94143 USA; [Krings, Gregor] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA; [Goga, Andrei] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Goga, Andrei] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Berkeley; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center	Goga, A (corresponding author), Univ Calif San Francisco, Dept Cell & Tissue Biol, San Francisco, CA 94143 USA.; Goga, A (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA USA.; Goga, A (corresponding author), Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA.	andrei.goga@ucsf.edu	Kajimura, Shingo/AAC-5090-2019	Kajimura, Shingo/0000-0003-0672-5910; Kohnz, Rebecca/0000-0002-4114-3345; Zhou, Alicia/0000-0003-0388-8909	US Department of Defense-ongressionally Directed Medical Research Programs' Era of Hope Scholar award [W81XWH-12-1-0272]; US National Institutes of Health (NIH) [R01 CA170447]; Diabetes, Endocrinology and Metabolism training grant [T32 DK007418]; Molecular and Cellular Mechanisms of Cancer training grant [T32 CA108462]; Atwater Foundation; NATIONAL CANCER INSTITUTE [R01CA170447, T32CA108462, R01CA172667] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007334] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063720, R01DK097441, T32DK007418] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008568] Funding Source: NIH RePORTER	US Department of Defense-ongressionally Directed Medical Research Programs' Era of Hope Scholar award; US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Diabetes, Endocrinology and Metabolism training grant; Molecular and Cellular Mechanisms of Cancer training grant; Atwater Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in part, by the US Department of Defense-ongressionally Directed Medical Research Programs' Era of Hope Scholar award W81XWH-12-1-0272 (A.G.), the US National Institutes of Health (NIH) grant R01 CA170447 (A.G.), the Diabetes, Endocrinology and Metabolism training grant T32 DK007418 (R.C.), the Molecular and Cellular Mechanisms of Cancer training grant T32 CA108462 (A.Y.Z.) and the Atwater Foundation (A.G.). The authors thank A. Welm for guidance in the use of patient-derived xenografts, D. Lowe and A. Beardsley for technical guidance and helpful discussions, K.A. Fontaine for helpful discussions and comments on the manuscript, and S. Samson for a helpful consumer advocate perspective and guidance on our work.	Bensaad K, 2014, CELL REP, V9, P349, DOI 10.1016/j.celrep.2014.08.056; Bonnefont Jean-Paul, 2004, Molecular Aspects of Medicine, V25, P495, DOI 10.1016/j.mam.2004.06.004; Carracedo A, 2012, J CLIN INVEST, V122, P3088, DOI 10.1172/JCI62129; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; Cowley GS, 2014, SCI DATA, V1, DOI 10.1038/sdata.2014.35; D'Cruz CM, 2001, NAT MED, V7, P235, DOI 10.1038/84691; DeRose YS, 2011, NAT MED, V17, P1514, DOI 10.1038/nm.2454; Esserman LJ, 2012, BREAST CANCER RES TR, V132, P1049, DOI 10.1007/s10549-011-1895-2; Hatzis C, 2011, JAMA-J AM MED ASSOC, V305, P1873, DOI 10.1001/jama.2011.593; Holubarsch CJF, 2007, CLIN SCI, V113, P205, DOI 10.1042/CS20060307; Horiuchi D, 2012, J EXP MED, V209, P679, DOI 10.1084/jem.20111512; Hu S, 2011, CELL METAB, V14, P131, DOI 10.1016/j.cmet.2011.04.012; Jeon SM, 2012, NATURE, V485, P661, DOI 10.1038/nature11066; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Langfelder P, 2012, J STAT SOFTW, V46, P1; LITTLEWOOD TD, 1995, NUCLEIC ACIDS RES, V23, P1686, DOI 10.1093/nar/23.10.1686; Morris EM, 2012, AM J PHYSIOL-GASTR L, V303, pG979, DOI 10.1152/ajpgi.00169.2012; Mukhopadhyay R, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2477; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Pfefferle AD, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-11-r125; Schafer ZT, 2009, NATURE, V461, P109, DOI 10.1038/nature08268; Sean D, 2007, BIOINFORMATICS, V23, P1846, DOI 10.1093/bioinformatics/btm254; Shen LL, 2015, P NATL ACAD SCI USA, V112, P5425, DOI 10.1073/pnas.1501555112; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Varemo L, 2013, NUCLEIC ACIDS RES, V41, P4378, DOI 10.1093/nar/gkt111; Wahlstrom T, 2015, BBA-GENE REGUL MECH, V1849, P563, DOI 10.1016/j.bbagrm.2014.07.004; Yau C, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2753; Zaugg K, 2011, GENE DEV, V25, P1041, DOI 10.1101/gad.1987211	30	263	275	2	86	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2016	22	4					427	+		10.1038/nm.4055	http://dx.doi.org/10.1038/nm.4055			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DI4GF	26950360	Green Accepted, Green Submitted			2022-12-25	WOS:000373457700019
J	Hessell, AJ; Jaworski, JP; Epson, E; Matsuda, K; Pandey, S; Kahl, C; Reed, J; Sutton, WF; Hammond, KB; Cheever, TA; Barnette, PT; Legasse, AW; Planer, S; Stanton, JJ; Pegu, A; Chen, XJ; Wang, KY; Siess, D; Burke, D; Park, BS; Axthelm, MK; Lewis, A; Hirsch, VM; Graham, BS; Mascola, JR; Sacha, JB; Haigwood, NL				Hessell, Ann J.; Jaworski, J. Pablo; Epson, Erin; Matsuda, Kenta; Pandey, Shilpi; Kahl, Christoph; Reed, Jason; Sutton, William F.; Hammond, Katherine B.; Cheever, Tracy A.; Barnette, Philip T.; Legasse, Alfred W.; Planer, Shannon; Stanton, Jeffrey J.; Pegu, Amarendra; Chen, Xuejun; Wang, Keyun; Siess, Don; Burke, David; Park, Byung S.; Axthelm, Michael K.; Lewis, Anne; Hirsch, Vanessa M.; Graham, Barney S.; Mascola, John R.; Sacha, Jonah B.; Haigwood, Nancy L.			Early short-term treatment with neutralizing human monoclonal antibodies halts SHIV infection in infant macaques	NATURE MEDICINE			English	Article							SIMIAN IMMUNODEFICIENCY VIRUS; HIGHLY PATHOGENIC SIV; IN-VITRO; VAGINAL TRANSMISSION; HIV-1; MUCOSAL; PROTECTION; VIREMIA; DISSEMINATION; POTENT	Prevention of mother-to-child transmission (MTCT) of HIV remains a major objective where antenatal care is not readily accessible. We tested HIV-1-specific human neutralizing monoclonal antibodies (NmAbs) as a post-exposure therapy in an infant macaque model for intrapartum MTCT. One-month-old rhesus macaques were inoculated orally with the simian-human immunodeficiency virus SHIVSF162P3. On days 1, 4, 7 and 10 after virus exposure, we injected animals subcutaneously with NmAbs and quantified systemic distribution of NmAbs in multiple tissues within 24 h after antibody administration. Replicating virus was found in multiple tissues by day 1 in animals that were not treated. All NmAb-treated macaques were free of virus in blood and tissues at 6 months after exposure. We detected no anti-SHIV T cell responses in blood or tissues at necropsy, and no virus emerged after CD8(+) T cell depletion. These results suggest that early passive immunotherapy can eliminate early viral foci and thereby prevent the establishment of viral reservoirs.	[Hessell, Ann J.; Jaworski, J. Pablo; Epson, Erin; Pandey, Shilpi; Kahl, Christoph; Sutton, William F.; Cheever, Tracy A.; Barnette, Philip T.; Legasse, Alfred W.; Planer, Shannon; Stanton, Jeffrey J.; Siess, Don; Burke, David; Park, Byung S.; Axthelm, Michael K.; Lewis, Anne; Sacha, Jonah B.; Haigwood, Nancy L.] Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Beaverton, OR USA; [Hessell, Ann J.; Reed, Jason; Hammond, Katherine B.; Axthelm, Michael K.; Sacha, Jonah B.; Haigwood, Nancy L.] Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Beaverton, OR USA; [Matsuda, Kenta; Hirsch, Vanessa M.] NIAID, Lab Mol Microbiol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Pegu, Amarendra; Chen, Xuejun; Wang, Keyun; Graham, Barney S.; Mascola, John R.] NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA	Oregon Health & Science University; Oregon National Primate Research Center; Oregon Health & Science University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Haigwood, NL (corresponding author), Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Beaverton, OR USA.; Haigwood, NL (corresponding author), Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Beaverton, OR USA.	haigwoon@ohsu.edu	Haigwood, Nancy Logan/AAV-7484-2020; Jaworski, Juan/ABA-4503-2020; Pegu, Amarendra/X-1361-2019; Mascola, John/AAI-7193-2021; Graham, Barney S./AAC-5898-2019	Jaworski, Juan/0000-0002-1311-060X; Pegu, Amarendra/0000-0003-3564-6453; Graham, Barney S./0000-0001-8112-0853; Haigwood, Nancy/0000-0002-1477-9575; Ordonez, Tracy/0000-0002-2378-0690; Hessell, Ann/0000-0001-7471-9366; Barnette, Philip/0000-0002-8985-6192	NIH [R01-HD080459, P51-OD011092]; Elizabeth Glaser Pediatric AIDS Foundation; American Foundation for AIDS Research (amfAR) [108823-55-RGRL]; intramural research program of the Vaccine Research Center; Laboratory of Molecular Microbiology, NIAID, NIH, Division of Health and Human Services, US Public Health Service; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD080459] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000370, ZIAAI000686, ZIAAI005009, U24AI126683] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011092, R24OD010976] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Elizabeth Glaser Pediatric AIDS Foundation; American Foundation for AIDS Research (amfAR); intramural research program of the Vaccine Research Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Laboratory of Molecular Microbiology, NIAID, NIH, Division of Health and Human Services, US Public Health Service; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank D. Malherbe for helpful discussions and C. Corbacci for graphic design work. We appreciate the expertise, dedication and thoughtful care provided to the infant macaques by H. Sidener and the ONPRC nursery animal care technicians. Titrated stocks of SHIVSF162P3 (passage 3) virus were obtained through the AIDS Research and Reference Reagent Program, Division of AIDS, National Institute of Allergy and Infectious Diseases NIAID), NIH (catalog number 6526; contributors J. Harouse, C. Cheng-Mayer and R. Pal) for each study. The SIV<INF>smE660</INF> stock was kindly provided by V.M. Hirsch. The linearized pBSII-SIVgag was kindly gifted by Michael Piatak, National Cancer Institute at the NIH. Funding was provided by US Public Health Service grants from the NIH (grant no. R01-HD080459 (N.L.H.), P51-OD011092 (J. Robertson), P51-OD011092 pilot funding (E.E.)), the Elizabeth Glaser Pediatric AIDS Foundation (N.L.H.) and the American Foundation for AIDS Research (amfAR) (grant no. 108823-55-RGRL; N.L.H.). This work was also funded, in part, by the intramural research program of the Vaccine Research Center (B.S.G. and J.R.M.) and the Laboratory of Molecular Microbiology, NIAID, NIH, Division of Health and Human Services, US Public Health Service (V.M.H.).	Abel K, 2006, J VIROL, V80, P6357, DOI 10.1128/JVI.02240-05; Allers K, 2011, BLOOD, V117, P2791, DOI 10.1182/blood-2010-09-309591; Baba TW, 2000, NAT MED, V6, P200, DOI 10.1038/72309; Barouch DH, 2013, NATURE, V503, P224, DOI 10.1038/nature12744; Bolton DL, 2016, J VIROL, V90, P1321, DOI 10.1128/JVI.02454-15; Bomsel M, 2011, IMMUNITY, V34, P269, DOI 10.1016/j.immuni.2011.01.015; Carias AM, 2013, J VIROL, V87, P11388, DOI 10.1128/JVI.01377-13; Caskey M, 2015, NATURE, V522, P487, DOI 10.1038/nature14411; Cline AN, 2005, J MED PRIMATOL, V34, P303; Committee for the Update of the Guide for the Care and Use of Laboratory Animals; National Research Council, 2011, GUIDE CARE USE LAB A; Demberg T, 2009, INT REV IMMUNOL, V28, P20, DOI 10.1080/08830180802684331; Devito C, 2000, J IMMUNOL, V165, P5170, DOI 10.4049/jimmunol.165.9.5170; Ferrantelli F, 2003, AIDS, V17, P301, DOI 10.1097/00002030-200302140-00003; Frankel SS, 1998, J VIROL, V72, P9788, DOI 10.1128/JVI.72.12.9788-9794.1998; Haase AT, 2011, ANNU REV MED, V62, P127, DOI 10.1146/annurev-med-080709-124959; Haigwood NL, 2004, J VIROL, V78, P5983, DOI 10.1128/JVI.78.11.5983-5995.2004; Hansen SG, 2013, NATURE, V502, P100, DOI 10.1038/nature12519; Hansen SG, 2011, NATURE, V473, P523, DOI 10.1038/nature10003; Harouse JM, 2001, J VIROL, V75, P1990, DOI 10.1128/JVI.75.4.1990-1995.2001; Hessell AJ, 2007, NATURE, V449, P101, DOI 10.1038/nature06106; Hessell AJ, 2009, NAT MED, V15, P951, DOI 10.1038/nm.1974; Hessell AJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000433; HIRSCH VM, 1995, J VIROL, V69, P955, DOI 10.1128/JVI.69.2.955-967.1995; Jaworski JP, 2013, J VIROL, V87, P10447, DOI 10.1128/JVI.00049-13; Jayaraman P, 2007, J VIROL, V81, P822, DOI 10.1128/JVI.01759-06; Julien JP, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003342; Kong R, 2015, J VIROL, V89, P2659, DOI 10.1128/JVI.03136-14; Kozlowski PA, 1999, J INFECT DIS, V179, pS493, DOI 10.1086/314810; Kumwenda NI, 2008, NEW ENGL J MED, V359, P119, DOI 10.1056/NEJMoa0801941; Leary S, 2013, AVMA GUIDELINES EUTH; Ledgerwood JE, 2015, CLIN EXP IMMUNOL, V182, P289, DOI 10.1111/cei.12692; Lynch RM, 2012, J VIROL, V86, P7588, DOI 10.1128/JVI.00734-12; Malherbe DC, 2014, J VIROL, V88, P12949, DOI 10.1128/JVI.01812-14; Malherbe DC, 2011, J VIROL, V85, P5262, DOI 10.1128/JVI.02419-10; Malouli D, 2014, J CLIN INVEST, V124, P1928, DOI 10.1172/JCI67420; Mascola JR, 2000, NAT MED, V6, P207, DOI 10.1038/72318; Migueles SA, 2012, IMMUNITY, V36, P320, DOI 10.1016/j.immuni.2012.03.006; Miller CJ, 2005, J VIROL, V79, P9217, DOI 10.1128/JVI.79.14.9217-9227.2005; Milush JA, 2004, AIDS, V18, P2371; Mofenson LM, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001636; Mofenson LM, 2011, JAIDS-J ACQ IMM DEF, V58, P359, DOI 10.1097/QAI.0b013e318235517e; Moldt B, 2012, P NATL ACAD SCI USA, V109, P18921, DOI 10.1073/pnas.1214785109; Ng CT, 2010, NAT MED, V16, P1117, DOI 10.1038/nm.2233; Okwundu CI, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007189.pub3; Parren PWHI, 2001, ADV IMMUNOL, V77, P195, DOI 10.1016/S0065-2776(01)77018-6; Pegu A, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008992; Persaud D, 2013, NEW ENGL J MED, V369, P1828, DOI 10.1056/NEJMoa1302976; Persaud D, 2011, AIDS RES HUM RETROV, V27, P823, DOI [10.1089/aid.2010.0346, 10.1089/AID.2010.0346]; Rudicell RS, 2014, J VIROL, V88, P12669, DOI 10.1128/JVI.02213-14; Safrit JT, 2004, JAIDS-J ACQ IMM DEF, V35, P169, DOI 10.1097/00126334-200402010-00012; Shah SK, 2014, LANCET INFECT DIS, V14, P797, DOI 10.1016/S1473-3099(14)70893-X; Shingai M, 2014, J EXP MED, V211, P2061, DOI 10.1084/jem.20132494; Shingai M, 2013, NATURE, V503, P277, DOI 10.1038/nature12746; Veazey RS, 2003, NAT MED, V9, P343, DOI 10.1038/nm833; Voronin Y, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001616; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Whitney JB, 2014, NATURE, V512, P74, DOI 10.1038/nature13594; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Zhou TQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099881	59	136	139	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	APR	2016	22	4					362	+		10.1038/nm.4063	http://dx.doi.org/10.1038/nm.4063			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	DI4GF	26998834	Green Accepted			2022-12-25	WOS:000373457700011
J	Hunt, VL; Tsai, IJ; Coghlan, A; Reid, AJ; Holroyd, N; Foth, BJ; Tracey', A; Cotton', JA; Stanley, EJ; Beasley, H; Bennett, HM; Brooks, K; Harsha, B; Kajitani, R; Kulkarni, A; Harbecke, D; Nagayasu, E; Nichol, S; Ogura, Y; Quail, MA; Randle, N; Xia, D; Brattig, NW; Soblik, H; Ribeiro, DM; Sanchez-Flores, A; Hayashi, T; Itoh, T; Denver, DR; Grant, W; Stoltzfus, JD; Lok, JB; Murayama, H; Wastling, J; Streit, A; Kikuchi, T; Viney, M; Berriman, M				Hunt, Vicky L.; Tsai, Isheng J.; Coghlan, Avril; Reid, Adam J.; Holroyd, Nancy; Foth, Bernardo J.; Tracey', Alan; Cotton', James A.; Stanley, Eleanor J.; Beasley, Helen; Bennett, Hayley M.; Brooks, Karen; Harsha, Bhavana; Kajitani, Rei; Kulkarni, Arpita; Harbecke, Dorothee; Nagayasu, Eiji; Nichol, Sarah; Ogura, Yoshitoshi; Quail, Michael A.; Randle, Nadine; Xia, Dong; Brattig, Norbert W.; Soblik, Hanns; Ribeiro, Diogo M.; Sanchez-Flores, Alejandro; Hayashi, Tetsuya; Itoh, Takehiko; Denver, Dee R.; Grant, Warwick; Stoltzfus, Jonathan D.; Lok, James B.; Murayama, Haruhiko; Wastling, Jonathan; Streit, Adrian; Kikuchi, Taisei; Viney, Mark; Berriman, Matthew			The genomic basis of parasitism in the Strongyloides clade of nematodes	NATURE GENETICS			English	Article							MITOCHONDRIAL GENOME; PARASTRONGYLOIDES-TRICHOSURI; CHROMATIN DIMINUTION; INTESTINAL NEMATODE; ASPARTIC PROTEASES; MOLECULAR-CLONING; SEX DETERMINATION; ASTACIN FAMILY; C-ELEGANS; HOOKWORM	Soil-transmitted nematodes, including the Strongyloides genus, cause one of the most prevalent neglected tropical diseases. Here we compare the genomes of four Strongyloides species, including the human pathogen Strongyloides stercoralis, and their close relatives that are facultatively parasitic (Parastrongyloides frichosuri) and free-living (Rhabditophanes sp. KR3021). A significant paralogous expansion of key gene families families encoding astacin-like and SCP/TAPS proteins is associated with the evolution of parasitism in this Glade. Exploiting the unique Strongyloides life cycle, we compare the transcriptomes of the parasitic and free-living stages and find that these same gene families are upregulated in the parasitic stages, underscoring their role in nematode parasitism.	[Hunt, Vicky L.; Viney, Mark] Univ Bristol, Sch Biol Sci, Bristol, Avon, England; [Tsai, Isheng J.] Acad Sinica, Biodivers Res Ctr, Taipei 115, Taiwan; [Tsai, Isheng J.; Nagayasu, Eiji; Murayama, Haruhiko; Kikuchi, Taisei] Miyazaki Univ, Fac Med, Div Parasitol, Miyazaki, Japan; [Coghlan, Avril; Reid, Adam J.; Holroyd, Nancy; Foth, Bernardo J.; Tracey', Alan; Cotton', James A.; Stanley, Eleanor J.; Beasley, Helen; Bennett, Hayley M.; Brooks, Karen; Harsha, Bhavana; Nichol, Sarah; Quail, Michael A.; Ribeiro, Diogo M.; Sanchez-Flores, Alejandro; Berriman, Matthew] Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Hinxton, England; [Kajitani, Rei; Itoh, Takehiko] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Meguro Ku, Tokyo 152, Japan; [Kulkarni, Arpita; Harbecke, Dorothee; Streit, Adrian] Max Planck Inst Dev Biol, Tubingen, Germany; [Ogura, Yoshitoshi; Hayashi, Tetsuya] Kyushu Univ, Fac Med Sci, Dept Bacteriol, Fukuoka 812, Japan; [Randle, Nadine; Xia, Dong; Wastling, Jonathan] Univ Liverpool, Dept Infect Biol, Inst Infect & Global Hlth, Liverpool L69 3BX, Merseyside, England; [Randle, Nadine; Xia, Dong; Wastling, Jonathan] Univ Liverpool, Sch Vet Sci, Liverpool L69 3BX, Merseyside, England; [Brattig, Norbert W.; Soblik, Hanns] Bernhard Nocht Inst Trop Med, Dept Mol Med, Bernhard Nocht Str 74, D-20359 Hamburg, Germany; [Sanchez-Flores, Alejandro] Univ Nacl Autonoma Mexico, Inst Biotecnol, Unidad Secuenciac Masiva & Bioinformat, Cuernavaca 62191, Morelos, Mexico; [Denver, Dee R.] Oregon State Univ, Dept Integrat Biol, Corvallis, OR 97331 USA; [Grant, Warwick] La Trobe Univ, Dept Anim Plant & Soil Sci, Melbourne, Vic, Australia; [Stoltzfus, Jonathan D.; Lok, James B.] Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA; [Wastling, Jonathan] Keele Univ, Fac Nat Sci, Keele ST5 5BG, Staffs, England	University of Bristol; Academia Sinica - Taiwan; University of Miyazaki; Wellcome Trust Sanger Institute; Tokyo Institute of Technology; Max Planck Society; Kyushu University; University of Liverpool; University of Liverpool; Bernhard Nocht Institut fur Tropenmedizin; Universidad Nacional Autonoma de Mexico; Oregon State University; La Trobe University; University of Pennsylvania; Keele University	Viney, M (corresponding author), Univ Bristol, Sch Biol Sci, Bristol, Avon, England.; Kikuchi, T (corresponding author), Miyazaki Univ, Fac Med, Div Parasitol, Miyazaki, Japan.; Berriman, M (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Hinxton, England.	taisei_kikuchi@med.miyazaki-u.ac.jp; mark.viney@bristol.ac.uk; mb4@sanger.ac.uk	Tsai, Isheng J/H-6606-2014; Grant, Warwick/AAF-5854-2020; Stoltzfus, Jonathan D./AAU-6735-2020; Tsai, Isheng Jason/ABB-8273-2021; Berriman, Matthew/A-7618-2011; Cotton, James A/B-8806-2008; Hayashi, Tetsuya/ABA-1074-2020; Itoh, Takehiko/E-8873-2014; Quail, michael/ABE-6131-2020; Sanchez-Flores, Alejandro/L-9454-2016	Grant, Warwick/0000-0002-1187-5270; Stoltzfus, Jonathan D./0000-0002-4006-5306; Tsai, Isheng Jason/0000-0002-2123-5058; Berriman, Matthew/0000-0002-9581-0377; Cotton, James A/0000-0001-5475-3583; Itoh, Takehiko/0000-0002-6113-557X; Harsha, Bhavana/0000-0001-8234-9174; Sanchez-Flores, Alejandro/0000-0003-0476-3139; Kikuchi, Taisei/0000-0003-2759-9167; Reid, Adam/0000-0002-5926-7768; Xia, Dong/0000-0003-4571-2776; Ribeiro, Diogo/0000-0002-0482-7342; Kulkarni, Arpita/0000-0003-0775-8044; Coghlan, Avril/0000-0002-2775-5951; Hunt, Vicky/0000-0002-7094-044X; Kajitani, Rei/0000-0002-5013-0052	Wellcome Trust [094462/Z/10/Z, 098051]; Japan Society for the Promotion of Science (JSPS) KAKENHI [24310142, 21590466, 24780044]; KAKENHI [221S0002]; Integrated Research Project for Human and Veterinary Medicine of the University of Miyazaki; Academia Sinica; US National Institutes of Health (NIH) [AI050668, AI105856]; Resource-Related Research Grant from the US NIH [RR02512]; US NIH training [AI060516]; Max Planck Society; NATIONAL CENTER FOR RESEARCH RESOURCES [P40RR002512] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050668, R33AI105856, T32AI060516, R21AI105856] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Integrated Research Project for Human and Veterinary Medicine of the University of Miyazaki; Academia Sinica(Academia Sinica - Taiwan); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Resource-Related Research Grant from the US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US NIH training(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Max Planck Society(Max Planck SocietyFoundation CELLEX); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank, from the Wellcome Trust Sanger Institute, C. Griffiths, D. Willey, R. Rance and DNA Pipelines; J. Keane and D. Gordon for bioinformatics support; M. Dunn for the S. venezuelensis optical map; A. Babbage for laboratory support; and M. Zarowiecki for gene finding and functional annotation advice. We thank for technical help L. Hughes and L. Weldon (University of Bristol); H. Massey, Jr., X. Li and H. Shao (University of Pennsylvania); D.K. Howe and R.I. Wernick (Oregon State University); H. Denise (European Bioinformatics Institute); M. Yabana (Tokyo Institute of Technology); and A. Hino and R. Tanaka (University of Miyazaki) and A. Toyoda (National Institute of Genetics) for sequencing. The S. ratti transcriptome and proteome work was funded by Wellcome Trust grant 094462/Z/10/Z awarded to M.V., J.W. and M.B. The S. ratti, S. stercoralis, S. papillosus, P. trichosuri and Rhabditophanes sp. KR3021 genome sequencing and the S. venezuelensis optical mapping were funded by Wellcome Trust grant 098051. The S. venezuelensis work was supported by Japan Society for the Promotion of Science (JSPS) KAKENHI (24310142, 21590466 and 24780044), KAKENHI for Innovative Areas 'Genome Science' (221S0002) and the Integrated Research Project for Human and Veterinary Medicine of the University of Miyazaki. I.J.T. was supported by Academia Sinica. Work was funded by grants AI050668 and AI105856 from the US National Institutes of Health (NIH) to J.B.L. and by Resource-Related Research Grant RR02512 from the US NIH to M. Haskins, which provided research materials for the study. J.D.S. received support from US NIH training grant AI060516. A.K. was supported by a predoctoral stipend from the Max Planck Society. Work by AK., D.H. and A.S. was funded by the Max Planck Society.	ALBERTSON DG, 1979, CHROMOSOMA, V75, P75, DOI 10.1007/BF00330626; Albonico M, 1999, ADV PARASIT, V42, P277, DOI 10.1016/S0065-308X(08)60151-7; Armstrong MR, 2000, GENETICS, V154, P181; Ballard JWO, 2004, MOL ECOL, V13, P729, DOI 10.1046/j.1365-294X.2003.02063.x; Bethony JM, 2008, VACCINE, V26, P2408, DOI 10.1016/j.vaccine.2008.02.049; Blaxter M., NEXT GENERA IN PRESS; Blaxter ML, 1998, NATURE, V392, P71, DOI 10.1038/32160; BOLLA RI, 1968, J PARASITOL, V54, P849, DOI 10.2307/3277110; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Cantacessi C, 2009, BIOTECHNOL ADV, V27, P376, DOI 10.1016/j.biotechadv.2009.02.005; Chehayeb JF, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002939; Crompton D.W.T., 1987, BAILLIERE CLIN TROP, P489; Del Valle A, 2003, MOL BIOCHEM PARASIT, V129, P167, DOI 10.1016/S0166-6851(03)00121-X; Dorris M, 2002, INT J PARASITOL, V32, P1507, DOI 10.1016/S0020-7519(02)00156-X; Foss EJ, 2007, NAT GENET, V39, P1369, DOI 10.1038/ng.2007.22; Foth BJ, 2014, NAT GENET, V46, P693, DOI 10.1038/ng.3010; Gallego SG, 2005, PARASITOL INT, V54, P123, DOI 10.1016/j.parint.2005.02.002; Ghazalpour A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001393; Gibson T, 2007, J MOL EVOL, V64, P463, DOI 10.1007/s00239-006-0187-7; Goud GN, 2005, VACCINE, V23, P4754, DOI 10.1016/j.vaccine.2005.04.040; Grant WN, 2006, INT J PARASITOL, V36, P475, DOI 10.1016/j.ijpara.2005.12.002; Grant WN, 2006, INT J PARASITOL, V36, P453, DOI 10.1016/j.ijpara.2005.11.009; Guiliano DB, 2006, PLOS GENET, V2, P1871, DOI 10.1371/journal.pgen.0020198; Haider S, 2013, CURR GENOMICS, V14, P91, DOI 10.2174/1389202911314020003; HAMMOND MP, 1994, J PARASITOL, V80, P689, DOI 10.2307/3283247; Harvey SC, 2001, GENETICS, V158, P1527; Hillier LW, 2007, PLOS BIOL, V5, P1603, DOI 10.1371/journal.pbio.0050167; Hino A, 2014, PARASITOLOGY, V141, P1736, DOI 10.1017/S0031182014001036; Hu M, 2003, INT J PARASITOL, V33, P1393, DOI 10.1016/S0020-7519(03)00130-9; Humphreys-Pereira DA, 2015, GENE, V560, P173, DOI 10.1016/j.gene.2015.01.065; Jacob J, 2007, GENE, V402, P9, DOI 10.1016/j.gene.2007.07.015; Jing YJ, 2010, MOL BIOCHEM PARASIT, V174, P101, DOI 10.1016/j.molbiopara.2010.07.004; Kikuchi T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002219; Kulkarni A, 2013, PARASITOLOGY, V140, P1822, DOI 10.1017/S0031182013001315; Kwon JE, 2006, J BIOL CHEM, V281, P12664, DOI 10.1074/jbc.M600204200; Laing R, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-8-r88; Li XS, 2006, INT J PARASITOL, V36, P671, DOI 10.1016/j.ijpara.2005.12.007; Li X, 2011, MOL BIOCHEM PARASIT, V179, P114, DOI 10.1016/j.molbiopara.2011.06.002; Longbottom D, 1997, MOL BIOCHEM PARASIT, V88, P63, DOI 10.1016/S0166-6851(97)00074-1; Lun HM, 2003, PARASITOL RES, V90, P27, DOI 10.1007/s00436-002-0815-0; Lunt DH, 1997, NATURE, V387, P247, DOI 10.1038/387247a0; MACKERRAS M. JOSEPHINE, 1959, AUSTRALIAN JOUR ZOOL, V7, P87, DOI 10.1071/ZO9590087; Maruyama H, 2000, J IMMUNOL, V164, P3749, DOI 10.4049/jimmunol.164.7.3749; Maruyama H, 2003, PARASITOLOGY, V126, P165, DOI 10.1017/S0031182002002718; Mello LV, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-611; MOYLE M, 1994, J BIOL CHEM, V269, P10008; Nemetschke L, 2010, CURR BIOL, V20, P1687, DOI 10.1016/j.cub.2010.08.014; Nemetschke L, 2010, MOL BIOCHEM PARASIT, V169, P124, DOI 10.1016/j.molbiopara.2009.10.008; Park JO, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-14; Parkinson J, 2004, NAT GENET, V36, P1259, DOI 10.1038/ng1472; Piganeau G, 2004, MOL BIOL EVOL, V21, P2319, DOI 10.1093/molbev/msh244; Pullan RL, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-81; Richardson SJ, 2005, ANN NY ACAD SCI, V1040, P448, DOI 10.1196/annals.1327.086; Saverwyns H, 2008, INT J PARASITOL, V38, P1545, DOI 10.1016/j.ijpara.2008.04.004; Savioli L, 2004, NAT REV MICROBIOL, V2, P618, DOI 10.1038/nrmicro962; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Schwarz EM, 2015, NAT GENET, V47, P416, DOI 10.1038/ng.3237; Schwarz EM, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-8-r89; Selkirk ME, 2005, PARASITOLOGY, V131, pS3; Semenova SA, 2009, BIOCHEM MOSC-SUPPL S, V3, P17, DOI 10.1134/S199075080901003X; Shao HG, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002871; Soblik H, 2011, MOL CELL PROTEOMICS, V10, DOI [10.1074/mcp.M111.010157-1, 10.1074/mcp.M111.010157]; Stoltzfus JD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001854; Sultana T, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-12; Sun LH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098558; Tang YT, 2014, NAT GENET, V46, P261, DOI 10.1038/ng.2875; TINDALL NR, 1990, PARASITOLOGY, V100, P281, DOI 10.1017/S003118200006128X; van Megen H, 2009, NEMATOLOGY, V11, P927, DOI 10.1163/156854109X456862; Vilella AJ, 2009, GENOME RES, V19, P327, DOI 10.1101/gr.073585.107; Viney Mark E, 2015, WormBook, P1, DOI 10.1895/wormbook.1.141.2; VINEY ME, 1993, P ROY SOC B-BIOL SCI, V254, P213, DOI 10.1098/rspb.1993.0148; VINEY ME, 1994, PARASITOLOGY, V109, P511, DOI 10.1017/S0031182000080768; Williamson AL, 2006, INFECT IMMUN, V74, P961, DOI 10.1128/IAI.74.2.961-967.2006; Williamson AL, 2002, FASEB J, V16, P1458, DOI 10.1096/fj.02-0181fje	74	138	143	1	42	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2016	48	3					299	307		10.1038/ng.3495	http://dx.doi.org/10.1038/ng.3495			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DE8QW	26829753	Green Submitted, Green Accepted, hybrid			2022-12-25	WOS:000370902600014
J	Kerridge, S; Munjal, A; Philippe, JM; Jha, A; de las Bayonas, AG; Saurin, AJ; Lecuit, T				Kerridge, Stephen; Munjal, Akankshi; Philippe, Jean-Marc; Jha, Ankita; Garcia de las Bayonas, Alain; Saurin, Andrew J.; Lecuit, Thomas			Modular activation of Rho1 by GPCR signalling imparts polarized myosin II activation during morphogenesis	NATURE CELL BIOLOGY			English	Article							CELL-SHAPE CHANGES; NEURAL-TUBE CLOSURE; DROSOPHILA GASTRULATION; TISSUE MORPHOGENESIS; APICAL CONSTRICTION; G-PROTEIN; FOLDED-GASTRULATION; EPITHELIAL MORPHOGENESIS; CONVERGENT EXTENSION; PLANAR POLARITY	Polarized cell shape changes during tissue morphogenesis arise by controlling the subcellular distribution of myosin II. For instance, during Drosophila melanogaster gastrulation, apical constriction and cell intercalation are mediated by medial-apical myosin II pulses that power deformations, and polarized accumulation of myosin II that stabilizes these deformations. It remains unclear how tissue-specific factors control different patterns of myosin II activation and the ratchet-like myosin II dynamics. Here we report the function of a common pathway comprising the heterotrimeric G proteins G alpha(12/13), G beta 13F and G gamma 1 in activating and polarizing myosin II during Drosophila gastrulation. G alpha(12/13) and the G beta 13F/gamma 1 complex constitute distinct signalling modules, which regulate myosin II dynamics medial-apically and/or junctionally in a tissue-dependent manner. We identify a ubiquitously expressed GPCR called Smog required for cell intercalation and apical constriction. Smog functions with other GPCRs to quantitatively control G proteins, resulting in stepwise activation of myosin II and irreversible cell shape changes. We propose that GPCR and G proteins constitute a general pathway for controlling actomyosin contractility in epithelia and that the activity of this pathway is polarized by tissue-specific regulators.	[Kerridge, Stephen; Munjal, Akankshi; Philippe, Jean-Marc; Jha, Ankita; Garcia de las Bayonas, Alain; Saurin, Andrew J.; Lecuit, Thomas] Aix Marseille Univ, CNRS, IBDM UMR7288, F-13009 Marseille, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite	Kerridge, S; Lecuit, T (corresponding author), Aix Marseille Univ, CNRS, IBDM UMR7288, F-13009 Marseille, France.	stephen.kerridge@univ-amu.fr; thomas.lecuit@univ-amu.fr		Garcia De Las Bayonas, Alain/0000-0002-2415-7147; Saurin, Andrew/0000-0001-5162-003X	ERC (Biomecamorph) [323027]; ANR Archiplast (Programme Blanc); Labex INFORM (A*MIDEX program) [ANR-11-LABX-0054, ANR-11-IDEX-0001-02]; CNRS; Ministere de l'Education nationale; Association pour la Recherche contre le Cancer (ARC); Agence Nationale de la Recherche [ANR-10-INSB-04-01]	ERC (Biomecamorph); ANR Archiplast (Programme Blanc)(French National Research Agency (ANR)); Labex INFORM (A*MIDEX program)(French National Research Agency (ANR)); CNRS(Centre National de la Recherche Scientifique (CNRS)); Ministere de l'Education nationale; Association pour la Recherche contre le Cancer (ARC)(Fondation ARC pour la Recherche sur le CancerFrench National Research Agency (ANR)); Agence Nationale de la Recherche(French National Research Agency (ANR))	We are grateful to K. Zinn (Caltech, USA), N. Fuse (Kyoto, Japan), J. Knoblich (IMBA, Austria), M. Leptin (Cologne, Germany), A. Martin (MIT, USA), V. Mirouse (Clermont, USA), E. Wieschaus (Princeton, USA), J. Zallen (Sloan-Kettering, USA), the Drosophila Genetic Resource Center and the Bloomington Stock Center for the gift of flies. A. Ratnaparkhi (IISER, India) provided plasmids. We thank D. Coiffier for the in situ hybridization shown in Supplementary Fig. 3e. This work benefited greatly from the stimulating discussions in the Lecuit and Lenne laboratories and from the Labex INFORM ((ANR-11-LABX-0054) under the A*MIDEX program (ANR-11-IDEX-0001-02)). This work was financially supported by the ERC (Biomecamorph no. 323027), the ANR Archiplast (Programme Blanc) and the CNRS (S.K. and T.L.). A.M. was supported by the Ministere de l'Education nationale and the Association pour la Recherche contre le Cancer (ARC). This work was performed using the France-BioImaging infrastructure supported by the Agence Nationale de la Recherche (ANR-10-INSB-04-01, call 'Investissements d'Avenir').	Ackerman SD, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7122; Bardet PL, 2013, DEV CELL, V25, P534, DOI 10.1016/j.devcel.2013.04.020; Bertet C, 2004, NATURE, V429, P667, DOI 10.1038/nature02590; Blankenship JT, 2006, DEV CELL, V11, P459, DOI 10.1016/j.devcel.2006.09.007; Buchsbaum RJ, 2007, J CELL SCI, V120, P1149, DOI 10.1242/jcs.03428; Chen Z, 2012, J BIOL CHEM, V287, P25490, DOI 10.1074/jbc.M111.333716; CHOU TB, 1992, GENETICS, V131, P643; COSTA M, 1994, CELL, V76, P1075, DOI 10.1016/0092-8674(94)90384-0; Dawes-Hoang RE, 2005, DEVELOPMENT, V132, P4165, DOI 10.1242/dev.01938; Fox DT, 2007, DEVELOPMENT, V134, P567, DOI 10.1242/dev.02748; Fuse N, 2013, DEVELOPMENT, V140, P4246, DOI 10.1242/dev.093625; Gong WJ, 2003, P NATL ACAD SCI USA, V100, P2556, DOI 10.1073/pnas.0535280100; Guillot C, 2013, SCIENCE, V340, P1185, DOI 10.1126/science.1235249; Hacker U, 1998, GENE DEV, V12, P274, DOI 10.1101/gad.12.2.274; Hanlon CD, 2015, J CELL SCI, V128, P3533, DOI 10.1242/jcs.175158; Hashimoto H, 2015, DEV CELL, V32, P241, DOI 10.1016/j.devcel.2014.12.017; He L, 2010, NAT CELL BIOL, V12, P1133, DOI 10.1038/ncb2124; Heisenberg CP, 2013, CELL, V153, P948, DOI 10.1016/j.cell.2013.05.008; Huang J, 2009, P NATL ACAD SCI USA, V106, P8284, DOI 10.1073/pnas.0900641106; IRVINE KD, 1994, DEVELOPMENT, V120, P827; Izumi Y, 2004, J CELL BIOL, V164, P729, DOI 10.1083/jcb.200309162; Kanesaki T, 2013, MECH DEVELOP, V130, P132, DOI 10.1016/j.mod.2012.10.001; Kasza KE, 2014, P NATL ACAD SCI USA, V111, P11732, DOI 10.1073/pnas.1400520111; Kolsch V, 2007, SCIENCE, V315, P384, DOI 10.1126/science.1134833; LEPTIN M, 1990, DEVELOPMENT, V110, P73; Li X, 2013, DEVELOPMENT, V140, P3028, DOI 10.1242/dev.094839; Manning AJ, 2014, DEV BIOL, V394, P6, DOI 10.1016/j.ydbio.2014.08.003; Manning AJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004427; Martin AC, 2014, DEVELOPMENT, V141, P1987, DOI 10.1242/dev.102228; Martin AC, 2010, J CELL BIOL, V188, P735, DOI 10.1083/jcb.200910099; Martin AC, 2009, NATURE, V457, P495, DOI 10.1038/nature07522; Mason FM, 2013, NAT CELL BIOL, V15, P926, DOI 10.1038/ncb2796; Mason FM, 2011, CURR OPIN GENET DEV, V21, P671, DOI 10.1016/j.gde.2011.08.002; Mathew SJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007437; Morize P, 1998, DEVELOPMENT, V125, P589; Munjal A, 2015, NATURE, V524, P351, DOI 10.1038/nature14603; Munjal A, 2014, DEVELOPMENT, V141, P1789, DOI 10.1242/dev.091645; Ni JQ, 2011, NAT METHODS, V8, P405, DOI [10.1038/NMETH.1592, 10.1038/nmeth.1592]; Nikolaidou KK, 2004, CURR BIOL, V14, P1822, DOI 10.1016/j.cub.2004.09.080; Nishimura T, 2012, CELL, V149, P1084, DOI 10.1016/j.cell.2012.04.021; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; Pare AC, 2014, NATURE, V515, P523, DOI 10.1038/nature13953; PARKS S, 1991, CELL, V64, P447, DOI 10.1016/0092-8674(91)90652-F; Rauzi M, 2010, NATURE, V468, P1110, DOI 10.1038/nature09566; Roh-Johnson M, 2012, SCIENCE, V335, P1232, DOI 10.1126/science.1217869; Rozbicki E, 2015, NAT CELL BIOL, V17, P397, DOI 10.1038/ncb3138; Schaefer M, 2001, CELL, V107, P183, DOI 10.1016/S0092-8674(01)00521-9; Sherrard K, 2010, CURR BIOL, V20, P1499, DOI 10.1016/j.cub.2010.06.075; Simoes SD, 2014, J CELL BIOL, V204, P575, DOI 10.1083/jcb.201307070; Simoes SD, 2010, DEV CELL, V19, P377, DOI 10.1016/j.devcel.2010.08.011; Solon J, 2009, CELL, V137, P1331, DOI 10.1016/j.cell.2009.03.050; SWEETON D, 1991, DEVELOPMENT, V112, P775; Vasquez CG, 2014, J CELL BIOL, V206, P435, DOI 10.1083/jcb.201402004; Walck-Shannon E, 2014, NAT REV MOL CELL BIO, V15, P34, DOI 10.1038/nrm3723; Wu SY, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001403; Zallen JA, 2004, DEV CELL, V6, P343, DOI 10.1016/S1534-5807(04)00060-7	56	77	77	2	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	MAR	2016	18	3					261	+		10.1038/ncb3302	http://dx.doi.org/10.1038/ncb3302			20	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	DF0LT	26780298				2022-12-25	WOS:000371031300007
J	Williams, MJ; Werner, B; Barnes, CP; Graham, TA; Sottoriva, A				Williams, Marc J.; Werner, Benjamin; Barnes, Chris P.; Graham, Trevor A.; Sottoriva, Andrea			Identification of neutral tumor evolution across cancer types	NATURE GENETICS			English	Article							INTRATUMOR HETEROGENEITY; COLORECTAL-CANCER; CLONAL EVOLUTION; MUTATIONS; PROGRESSION; GROWTH; MODEL; DIVERSITY; DYNAMICS; DRIVER	Despite extraordinary efforts to profile cancer genomes, interpreting the vast amount of genomic data in the light of cancer evolution remains challenging. Here we demonstrate that neutral tumor evolution results in a power-law distribution of the mutant allele frequencies reported by next-generation sequencing of tumor bulk samples. We find that the neutral power law fits with high precision 323 of 904 cancers from 14 types and from different cohorts. In malignancies identified as evolving neutrally, all clonal selection seemingly occurred before the onset of cancer growth and not in later-arising subclones, resulting in numerous passenger mutations that are responsible for intratumoral heterogeneity. Reanalyzing cancer sequencing data within the neutral framework allowed the measurement, in each patient, of both the in vivo mutation rate and the order and timing of mutations. This result provides a new way to interpret existing cancer genomic data and to discriminate between functional and non-functional intratumoral heterogeneity.	[Williams, Marc J.; Graham, Trevor A.] Queen Mary Univ London, Evolut & Canc Lab, Barts Canc Inst, London, England; [Williams, Marc J.; Barnes, Chris P.] UCL, Dept Cell & Dev Biol, London, England; [Williams, Marc J.] UCL, Ctr Math & Phys Life Sci & Expt Biol CoMPLEX, London, England; [Werner, Benjamin; Sottoriva, Andrea] Inst Canc Res, Ctr Evolut & Canc, London SW3 6JB, England; [Barnes, Chris P.] UCL, Dept Genet Evolut & Environm, London, England	University of London; Queen Mary University London; University of London; University College London; University of London; University College London; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of London; University College London	Graham, TA (corresponding author), Queen Mary Univ London, Evolut & Canc Lab, Barts Canc Inst, London, England.; Sottoriva, A (corresponding author), Inst Canc Res, Ctr Evolut & Canc, London SW3 6JB, England.	t.graham@qmul.ac.uk; andrea.sottoriva@icr.ac.uk		Barnes, Chris/0000-0002-9459-1395; Graham, Trevor/0000-0001-9582-1597; Werner, Benjamin/0000-0002-6857-8699; Williams, Marc/0000-0001-5524-4174; Sottoriva, Andrea/0000-0001-6709-9533	Chris Rokos Fellowship in Evolution and Cancer; Geoffrey W Lewis Post-Doctoral Training fellowship; Wellcome Trust [105104/Z/14/Z]; Wellcome Trust through a Research Career Development Fellowship [097319/Z/11/Z]; Cancer Research UK Career Development Award; UK Medical Research Council student fellowship; Cancer Research UK [19771] Funding Source: researchfish; Medical Research Council [1503539] Funding Source: researchfish	Chris Rokos Fellowship in Evolution and Cancer; Geoffrey W Lewis Post-Doctoral Training fellowship; Wellcome Trust(Wellcome TrustEuropean Commission); Wellcome Trust through a Research Career Development Fellowship(Wellcome Trust); Cancer Research UK Career Development Award(Cancer Research UK); UK Medical Research Council student fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	A.S. is supported by The Chris Rokos Fellowship in Evolution and Cancer. B.W. is supported by the Geoffrey W Lewis Post-Doctoral Training fellowship. This work was supported by the Wellcome Trust (105104/Z/14/Z). C.P.B. acknowledges funding from the Wellcome Trust through a Research Career Development Fellowship (097319/Z/11/Z). This work was supported by a Cancer Research UK Career Development Award to T.A.G. M.J.W. is supported by a UK Medical Research Council student fellowship.	Almendro V, 2014, CELL REP, V6, P514, DOI 10.1016/j.celrep.2013.12.041; Attolini CSO, 2010, P NATL ACAD SCI USA, V107, P17604, DOI 10.1073/pnas.1009117107; Baca SC, 2013, CELL, V153, P666, DOI 10.1016/j.cell.2013.03.021; BAK P, 1987, PHYS REV LETT, V59, P381, DOI 10.1103/PhysRevLett.59.381; Basanta D, 2013, INTERFACE FOCUS, V3, DOI 10.1098/rsfs.2013.0020; Bozic I, 2010, P NATL ACAD SCI USA, V107, P18545, DOI 10.1073/pnas.1010978107; Burrell RA, 2013, NATURE, V501, P338, DOI 10.1038/nature12625; de Bruin EC, 2014, SCIENCE, V346, P251, DOI 10.1126/science.1253462; Donnelly P, 1995, ANNU REV GENET, V29, P401, DOI 10.1146/annurev.ge.29.120195.002153; Driessens G, 2012, NATURE, V488, P527, DOI 10.1038/nature11344; Durrett R, 2004, THEOR POPUL BIOL, V66, P129, DOI 10.1016/j.tpb.2004.04.002; Durrett R, 2013, ANN APPL PROBAB, V23, P230, DOI 10.1214/11-AAP824; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Gerstung M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027136; Greaves M, 2012, NATURE, V481, P306, DOI 10.1038/nature10762; Griffiths R., 1998, COMMUN STAT STOCH MO, V14, P273, DOI [10.1080/15326349808807471, DOI 10.1080/15326349808807471]; Guo J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089244; Helleday T, 2014, NAT REV GENET, V15, P585, DOI 10.1038/nrg3729; Heng HHQ, 2006, J CELL PHYSIOL, V208, P461, DOI 10.1002/jcp.20685; Jesinghaus M, 2015, AM J SURG PATHOL, V39, P1140, DOI 10.1097/PAS.0000000000000423; Jones S, 2008, P NATL ACAD SCI USA, V105, P4283, DOI 10.1073/pnas.0712345105; Kessler DA, 2013, P NATL ACAD SCI USA, V110, P11682, DOI 10.1073/pnas.1309667110; Luria SE, 1943, GENETICS, V28, P491; Marusyk A, 2014, NATURE, V514, P54, DOI 10.1038/nature13556; Marusyk A, 2012, NAT REV CANCER, V12, P323, DOI 10.1038/nrc3261; Maruvka YE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026480; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Nik-Zainal S, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.023; Ohta T, 1996, THEOR POPUL BIOL, V49, P128, DOI 10.1006/tpbi.1996.0007; Polyak K, 2014, NAT MED, V20, P344, DOI 10.1038/nm.3518; Shou WY, 2015, ELIFE, V4, DOI 10.7554/eLife.07158; Sottoriva A, 2015, NAT GENET, V47, P209, DOI 10.1038/ng.3214; Sottoriva A, 2013, P NATL ACAD SCI USA, V110, P4009, DOI 10.1073/pnas.1219747110; Sprouffske K, 2011, CANCER PREV RES, V4, P1135, DOI 10.1158/1940-6207.CAPR-10-0374; Sun SH, 2014, BMC SYST BIOL, V8, DOI 10.1186/1752-0509-8-S3-S2; Tabassum DP, 2015, NAT REV CANCER, V15, P473, DOI 10.1038/nrc3971; Vermeulen L, 2013, SCIENCE, V342, P995, DOI 10.1126/science.1243148; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wang K, 2014, NAT GENET, V46, P573, DOI 10.1038/ng.2983; Wang Y, 2014, NATURE, V512, P155, DOI 10.1038/nature13600; Zhang JJ, 2014, SCIENCE, V346, P256, DOI 10.1126/science.1256930	42	334	339	1	51	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2016	48	3					238	244		10.1038/ng.3489	http://dx.doi.org/10.1038/ng.3489			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DE8QW	26780609	Green Submitted, Green Accepted			2022-12-25	WOS:000370902600007
J	Lin, AF; Li, CL; Xing, Z; Hu, QS; Liang, K; Han, L; Wang, C; Hawke, DH; Wang, SY; Zhang, YY; Wei, YK; Ma, GL; Park, PK; Zhou, JW; Zhou, Y; Hu, ZB; Zhou, YB; Marks, JR; Liang, H; Hung, MC; Lin, CR; Yang, LQ				Lin, Aifu; Li, Chunlai; Xing, Zhen; Hu, Qingsong; Liang, Ke; Han, Leng; Wang, Cheng; Hawke, David H.; Wang, Shouyu; Zhang, Yanyan; Wei, Yongkun; Ma, Guolin; Park, Peter K.; Zhou, Jianwei; Zhou, Yan; Hu, Zhibin; Zhou, Yubin; Marks, Jeffery R.; Liang, Han; Hung, Mien-Chie; Lin, Chunru; Yang, Liuqing			The LINK-A lncRNA activates normoxic HIF1 alpha signalling in triple-negative breast cancer	NATURE CELL BIOLOGY			English	Article							LONG NONCODING RNAS; TYROSINE KINASE; TUMOR-GROWTH; EPIGENETIC REGULATION; BINDING SITES; HYPOXIA; PROMOTES; PROTEIN; HIF-1; TARGET	Although long non-coding RNAs (lncRNAs) predominately reside in the nucleus and exert their functions in many biological processes, their potential involvement in cytoplasmic signal transduction remains unexplored. Here, we identify a cytoplasmic lncRNA, LINK-A (long intergenic non-coding RNA for kinase activation), which mediates HB-EGF-triggered, EGFR:GPNMB heterodimer-dependent HIF1 alpha phosphorylation at Tyr 565 and Ser 797 by BRK and LRRK2, respectively. These events cause HIF1 alpha stabilization, HIF1 alpha-p300 interaction, and activation of HIF1 alpha transcriptional programs under normoxic conditions. Mechanistically, LINK-A facilitates the recruitment of BRK to the EGFR:GPNMB complex and BRK kinase activation. The BRK-dependent HIF1 alpha Tyr 565 phosphorylation interferes with Pro 564 hydroxylation, leading to normoxic HIF1 alpha stabilization. Both LINK-A expression and LINK-A-dependent signalling pathway activation correlate with triple-negative breast cancer (TNBC), promoting breast cancer glycolysis reprogramming and tumorigenesis. Our findings illustrate the magnitude and diversity of cytoplasmic lncRNAs in signal transduction and highlight the important roles of lncRNAs in cancer.	[Lin, Aifu; Li, Chunlai; Xing, Zhen; Hu, Qingsong; Liang, Ke; Wang, Shouyu; Zhang, Yanyan; Wei, Yongkun; Park, Peter K.; Hung, Mien-Chie; Lin, Chunru; Yang, Liuqing] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Han, Leng] Univ Texas Hlth Sci Ctr Houston, McGroven Med Sch, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Wang, Cheng; Hu, Zhibin] Nanjing Med Univ, Dept Epidemiol & Biostat, Nanjing 210029, Jiangsu, Peoples R China; [Wang, Cheng; Hu, Zhibin] Nanjing Med Univ, Sch Publ Hlth, Minist Educ MOE, Nanjing 210029, Jiangsu, Peoples R China; [Hawke, David H.; Liang, Han] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA; [Ma, Guolin; Zhou, Yubin] Texas A&M Univ, Hlth Sci Ctr, Inst Biosci & Technol, Ctr Translat Canc Res, Houston, TX 77030 USA; [Zhou, Jianwei] Nanjing Med Univ, Sch Publ Hlth, Dept Mol Cell Biol & Toxicol, 140 Hanzhong Rd, Nanjing 210029, Jiangsu, Peoples R China; [Zhou, Yan] Yixing Peoples Hosp, Dept Oncol, 75 Zhenguan Rd, Yixing 214200, Peoples R China; [Marks, Jeffery R.] Duke Univ, Sch Med, Div Surg Sci, Dept Surg, Durham, NC 27710 USA; [Liang, Han] Univ Texas MD Anderson Canc Ctr, Div Quantitat Sci, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA; [Hung, Mien-Chie; Lin, Chunru; Yang, Liuqing] Univ Texas MD Anderson Canc Ctr, Grad Sch Biomed Sci, Houston, TX 77030 USA; [Hung, Mien-Chie] China Med Univ, Ctr Mol Med, Taichung 404, Taiwan; [Hung, Mien-Chie] China Med Univ, Grad Inst Canc Biol, Taichung 404, Taiwan; [Yang, Liuqing] Univ Texas MD Anderson Canc Ctr, Ctr RNA Interference & Noncoding RNAs, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; Nanjing Medical University; Nanjing Medical University; University of Texas System; UTMD Anderson Cancer Center; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; University of Texas Health Science Center Houston; Nanjing Medical University; Duke University; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; China Medical University Taiwan; China Medical University Taiwan; University of Texas System; UTMD Anderson Cancer Center	Lin, CR; Yang, LQ (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA.; Lin, CR; Yang, LQ (corresponding author), Univ Texas MD Anderson Canc Ctr, Grad Sch Biomed Sci, Houston, TX 77030 USA.; Yang, LQ (corresponding author), Univ Texas MD Anderson Canc Ctr, Ctr RNA Interference & Noncoding RNAs, Houston, TX 77030 USA.	clin2@mdanderson.org; lyang7@mdanderson.org	Han, Leng/HCH-3491-2022; Ma, Guolin/D-2504-2018; Zhang, Yanyan/P-9931-2018; Hung, Mien-Chie/ABD-5911-2021; Li, Chunlai/AAI-8839-2021; Zhou, Yubin/D-4748-2011	Han, Leng/0000-0002-7380-2640; Ma, Guolin/0000-0001-5460-3446; Zhang, Yanyan/0000-0002-6037-5918; Hung, Mien-Chie/0000-0003-4317-4740; Li, Chunlai/0000-0003-1897-9889; Zhou, Yubin/0000-0001-7962-0517; Hawke, David/0000-0002-6102-7843	NIH [R00DK094981, R00CA166527]; UT Startup grant; UT STARS grant; CPRIT award [R1218]; NATIONAL CANCER INSTITUTE [R00CA166527, P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R00DK094981] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM112003] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD012304] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UT Startup grant; UT STARS grant; CPRIT award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank S. Kopetz for providing cetuximab and J. Chen for providing SFB-tagged expression vector. We thank D. Aten for assistance with figure presentation. This work was supported by the NIH R00 award (R00DK094981), UT Startup and UT STARS grants to C.Lin, and the NIH R00 award (R00CA166527), CPRIT award (R1218), UT Startup and UT STARS grants to L.Y.	Agalliu I, 2015, JAMA NEUROL, V72, P58, DOI 10.1001/jamaneurol.2014.1973; Anderson DM, 2015, CELL, V160, P595, DOI 10.1016/j.cell.2015.01.009; Anderson TMR, 2013, CANCER RES, V73, P5810, DOI 10.1158/0008-5472.CAN-13-0523; Andrews SJ, 2014, NAT REV GENET, V15, P193, DOI 10.1038/nrg3520; Badve S, 2011, MODERN PATHOL, V24, P157, DOI 10.1038/modpathol.2010.200; Batista PJ, 2013, CELL, V152, P1298, DOI 10.1016/j.cell.2013.02.012; Benita Y, 2009, NUCLEIC ACIDS RES, V37, P4587, DOI 10.1093/nar/gkp425; Borowicz S, 2014, JOVE-J VIS EXP, DOI 10.3791/51998; Brauer PM, 2010, BBA-REV CANCER, V1806, P66, DOI 10.1016/j.bbcan.2010.02.003; Bubb KL, 2006, GENETICS, V173, P2165, DOI 10.1534/genetics.106.055715; Carrieri C, 2012, NATURE, V491, P454, DOI 10.1038/nature11508; Castello A, 2012, CELL, V149, P1393, DOI 10.1016/j.cell.2012.04.031; Cheetham SW, 2013, BRIT J CANCER, V108, P2419, DOI 10.1038/bjc.2013.233; Ciesla J, 2006, ACTA BIOCHIM POL, V53, P11; Denko NC, 2008, NAT REV CANCER, V8, P705, DOI 10.1038/nrc2468; Foulkes WD, 2010, NEW ENGL J MED, V363, P1938, DOI 10.1056/NEJMra1001389; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Gutschner T, 2012, RNA BIOL, V9, P703, DOI 10.4161/rna.20481; Han L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4963; Hudis CA, 2011, ONCOLOGIST, V16, P1, DOI 10.1634/theoncologist.2011-S1-01; Kamalati T, 1996, J BIOL CHEM, V271, P30956, DOI 10.1074/jbc.271.48.30956; Knowles HJ, 2006, CANCER RES, V66, P2600, DOI 10.1158/0008-5472.CAN-05-2351; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kuschel A, 2012, J CELL PHYSIOL, V227, P514, DOI 10.1002/jcp.22798; Lee JT, 2012, SCIENCE, V338, P1435, DOI 10.1126/science.1231776; Livasy CA, 2006, MODERN PATHOL, V19, P264, DOI 10.1038/modpathol.3800528; Lunde BM, 2007, NAT REV MOL CELL BIO, V8, P479, DOI 10.1038/nrm2178; Mahon PC, 2001, GENE DEV, V15, P2675, DOI 10.1101/gad.924501; Maric G, 2015, ONCOGENE, V34, P5494, DOI 10.1038/onc.2015.8; Martin I, 2014, CELL, V157, P472, DOI 10.1016/j.cell.2014.01.064; Mercer TR, 2013, NAT STRUCT MOL BIOL, V20, P300, DOI 10.1038/nsmb.2480; Miah S, 2012, ONCOGENESIS, V1, DOI 10.1038/oncsis.2012.11; Min JH, 2002, SCIENCE, V296, P1886, DOI 10.1126/science.1073440; Morlando M, 2014, CHEMMEDCHEM, V9, P505, DOI 10.1002/cmdc.201300569; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Orom UA, 2010, COLD SH Q B, V75, P325, DOI 10.1101/sqb.2010.75.058; Ortiz-Barahona A, 2010, NUCLEIC ACIDS RES, V38, P2332, DOI 10.1093/nar/gkp1205; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Prensner JR, 2013, NAT GENET, V45, P1392, DOI 10.1038/ng.2771; Prensner JR, 2011, CANCER DISCOV, V1, P391, DOI 10.1158/2159-8290.CD-11-0209; Qiu HQ, 2002, J BIOL CHEM, V277, P34634, DOI 10.1074/jbc.M203877200; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Rose AAN, 2010, CLIN CANCER RES, V16, P2147, DOI 10.1158/1078-0432.CCR-09-1611; Ruiz-Orera J, 2014, ELIFE, V3, DOI 10.7554/eLife.03523; Saito Y, 2001, MOL CELL BIOL, V21, P6387, DOI 10.1128/MCB.21.19.6387-6394.2001; Schodel J, 2011, BLOOD, V117, pE207, DOI 10.1182/blood-2010-10-314427; Schwab LP, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3087; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Stroka DM, 2001, FASEB J, V15, P2445, DOI 10.1096/fj.01-0125com; Trimarchi T, 2014, CELL, V158, P593, DOI 10.1016/j.cell.2014.05.049; Ueno NT, 2011, J CANCER, V2, P324, DOI 10.7150/jca.2.324; Vance KW, 2014, TRENDS GENET, V30, P348, DOI 10.1016/j.tig.2014.06.001; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq622; Wang P, 2014, SCIENCE, V344, P310, DOI 10.1126/science.1251456; Wang XT, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003756; Wong CCL, 2011, P NATL ACAD SCI USA, V108, P16369, DOI 10.1073/pnas.1113483108; Xing Z, 2014, CELL, V159, P1110, DOI 10.1016/j.cell.2014.10.013; Yang LQ, 2013, NATURE, V500, P598, DOI 10.1038/nature12451; Yoon JH, 2013, J MOL BIOL, V425, P3723, DOI 10.1016/j.jmb.2012.11.024; Yu XC, 2002, MOL BIOL CELL, V13, P2547, DOI 10.1091/mbc.01-08-0411; Yuan JH, 2014, CANCER CELL, V25, P666, DOI 10.1016/j.ccr.2014.03.010	61	357	376	3	145	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	FEB	2016	18	2					213	+		10.1038/ncb3295	http://dx.doi.org/10.1038/ncb3295			27	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	DC3NZ	26751287	Green Accepted			2022-12-25	WOS:000369127300010
J	Bai, H; Harmanci, AS; Erson-Omay, EZ; Li, J; Coskun, S; Simon, M; Krischek, B; Ozduman, K; Omay, SB; Sorensen, EA; Turcan, S; Bakirciglu, M; Carrion-Grant, G; Murray, PB; Clark, VE; Ercan-Sencicek, AG; Knight, J; Sencar, L; Altinok, S; Kaulen, LD; Gulez, B; Timmer, M; Schramm, J; Mishra-Gorur, K; Henegariu, O; Moliterno, J; Louvi, A; Chan, TA; Tannheimer, SL; Pamir, MN; Vortmeyer, AO; Bilguvar, K; Yasuno, K; Gunel, M				Bai, Hanwen; Harmanci, Akdes Serin; Erson-Omay, E. Zeynep; Li, Jie; Coskun, Sueleyman; Simon, Matthias; Krischek, Boris; Ozduman, Koray; Omay, S. Buelent; Sorensen, Eric A.; Turcan, Sevin; Bakirciglu, Mehmet; Carrion-Grant, Geneive; Murray, Phillip B.; Clark, Victoria E.; Ercan-Sencicek, A. Gulhan; Knight, James; Sencar, Leman; Altinok, Selin; Kaulen, Leon D.; Guelez, Burcu; Timmer, Marco; Schramm, Johannes; Mishra-Gorur, Ketu; Henegariu, Octavian; Moliterno, Jennifer; Louvi, Angeliki; Chan, Timothy A.; Tannheimer, Stacey L.; Pamir, M. Necmettin; Vortmeyer, Alexander O.; Bilguvar, Kaya; Yasuno, Katsuhito; Guenel, Murat			Integrated genomic characterization of IDH1-mutant glioma malignant progression	NATURE GENETICS			English	Article							GROUP PROTEIN EZH2; MUTATIONAL LANDSCAPE; DNA METHYLATION; ADJUVANT TEMOZOLOMIDE; TRANSCRIPTION FACTORS; SOMATIC MUTATIONS; C-MYC; CANCER; GENE; GLIOBLASTOMA	Gliomas represent approximately 30% of all central nervous system tumors and 80% of malignant brain tumors(1). To understand the molecular mechanisms underlying the malignant progression of low-grade gliomas with mutations in IDH1 (encoding isocitrate dehydrogenase 1), we studied paired tumor samples from 41 patients, comparing higher-grade, progressed samples to their lower-grade counterparts. Integrated genomic analyses, including whole-exome sequencing and copy number, gene expression and DNA methylation profiling, demonstrated nonlinear clonal expansion of the original tumors and identified oncogenic pathways driving progression. These include activation of the MYC and RTK-RAS-PI3K pathways and upregulation of the FOXM1- and E2F2-mediated cell cycle transitions, as well as epigenetic silencing of developmental transcription factor genes bound by Polycomb repressive complex 2 in human embryonic stem cells. Our results not only provide mechanistic insight into the genetic and epigenetic mechanisms driving glioma progression but also identify inhibition of the bromodomain and extraterminal (BET) family as a potential therapeutic approach.	[Bai, Hanwen; Clark, Victoria E.; Knight, James; Mishra-Gorur, Ketu; Henegariu, Octavian; Bilguvar, Kaya; Guenel, Murat] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; [Bai, Hanwen; Harmanci, Akdes Serin; Erson-Omay, E. Zeynep; Coskun, Sueleyman; Omay, S. Buelent; Carrion-Grant, Geneive; Clark, Victoria E.; Ercan-Sencicek, A. Gulhan; Sencar, Leman; Altinok, Selin; Kaulen, Leon D.; Guelez, Burcu; Mishra-Gorur, Ketu; Henegariu, Octavian; Moliterno, Jennifer; Bilguvar, Kaya; Yasuno, Katsuhito; Guenel, Murat] Yale Univ, Sch Med, Program Brain Tumor Res, New Haven, CT USA; [Harmanci, Akdes Serin; Erson-Omay, E. Zeynep; Coskun, Sueleyman; Omay, S. Buelent; Carrion-Grant, Geneive; Clark, Victoria E.; Ercan-Sencicek, A. Gulhan; Sencar, Leman; Altinok, Selin; Kaulen, Leon D.; Guelez, Burcu; Mishra-Gorur, Ketu; Henegariu, Octavian; Moliterno, Jennifer; Louvi, Angeliki; Yasuno, Katsuhito; Guenel, Murat] Yale Univ, Sch Med, Dept Neurosurg, New Haven, CT USA; [Li, Jie; Vortmeyer, Alexander O.] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA; [Simon, Matthias; Schramm, Johannes] Univ Bonn, Sch Med, Dept Neurosurg, Bonn, Germany; [Krischek, Boris; Timmer, Marco] Univ Hosp Cologne, Dept Gen Neurosurg, Cologne, Germany; [Ozduman, Koray; Bakirciglu, Mehmet; Pamir, M. Necmettin] Acibadem Univ, Sch Med, Dept Neurosurg, Istanbul, Turkey; [Sorensen, Eric A.; Tannheimer, Stacey L.] Gilead Sci Inc, Translat Med, Biomarkers, Foster City, CA 94404 USA; [Turcan, Sevin; Chan, Timothy A.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10021 USA; [Murray, Phillip B.] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA; [Knight, James; Bilguvar, Kaya] Yale Univ, Sch Med, Yale Ctr Genome Anal, Orange, CT USA; [Mishra-Gorur, Ketu; Henegariu, Octavian; Louvi, Angeliki; Guenel, Murat] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT USA; [Mishra-Gorur, Ketu; Henegariu, Octavian; Louvi, Angeliki; Bilguvar, Kaya; Guenel, Murat] Yale Univ, Sch Med, Yale Program Neurogenet, New Haven, CT USA; [Chan, Timothy A.] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA; [Guenel, Murat] Yale Univ, Sch Med, Yale Comprehens Canc Ctr, New Haven, CT USA	Yale University; Yale University; Yale University; Yale University; University of Bonn; University of Cologne; Acibadem University; Gilead Sciences; Memorial Sloan Kettering Cancer Center; Yale University; Yale University; Yale University; Yale University; Memorial Sloan Kettering Cancer Center; Yale University	Gunel, M (corresponding author), Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA.	murat.gunel@yale.edu	Chan, Timothy A/ABD-5850-2021; Turcan, Sevin/AAF-1095-2019; Yasuno, Katsuhito/E-1960-2012; Ozduman, Koray/D-7007-2015	Turcan, Sevin/0000-0002-0885-5607; Coskun, Suleyman/0000-0002-4830-0606; Yasuno, Katsuhito/0000-0002-3606-532X; Ozduman, Koray/0000-0002-3543-0401	Gregory M. Kiez and Mehmet Kutman Foundation; Yale University Department of Neurosurgery; Gilead Sciences, Inc.; Yale University; NATIONAL CANCER INSTITUTE [P30CA008748, R01CA177828] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007205] Funding Source: NIH RePORTER	Gregory M. Kiez and Mehmet Kutman Foundation; Yale University Department of Neurosurgery; Gilead Sciences, Inc.(Gilead Sciences); Yale University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to the patients and their families for donating tissues for this research. This study was supported by the Gregory M. Kiez and Mehmet Kutman Foundation and the Yale University Department of Neurosurgery. Partial funding was provided through a research agreement between Gilead Sciences, Inc., and Yale University.	Agrawal N, 2011, SCIENCE, V333, P1154, DOI 10.1126/science.1206923; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Azari H, 2011, JOVE-J VIS EXP, DOI 10.3791/3633; Barbieri CE, 2012, NAT GENET, V44, P685, DOI 10.1038/ng.2279; Bilguvar K, 2010, NATURE, V467, P207, DOI 10.1038/nature09327; Bolli N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms3997; Brat DJ, 2015, NEW ENGL J MED, V372, P2481, DOI 10.1056/NEJMoa1402121; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Cheng ZX, 2013, CLIN CANCER RES, V19, P1748, DOI 10.1158/1078-0432.CCR-12-3066; Clark VE, 2013, SCIENCE, V339, P1077, DOI 10.1126/science.1233009; Claus EB, 2006, CANCER-AM CANCER SOC, V106, P1358, DOI 10.1002/cncr.21733; Comino-Mendez I, 2011, NAT GENET, V43, P663, DOI 10.1038/ng.861; Cordle J, 2008, NAT STRUCT MOL BIOL, V15, P849, DOI 10.1038/nsmb.1457; Croft D, 2011, NUCLEIC ACIDS RES, V39, pD691, DOI 10.1093/nar/gkq1018; Dang CV, 2006, SEMIN CANCER BIOL, V16, P253, DOI 10.1016/j.semcancer.2006.07.014; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Eckel-Passow JE, 2015, NEW ENGL J MED, V372, P2499, DOI 10.1056/NEJMoa1407279; Efron B, 2007, ANN APPL STAT, V1, P107, DOI 10.1214/07-AOAS101; Erson-Omay EZ, 2015, NEURO-ONCOLOGY, V17, P1356, DOI 10.1093/neuonc/nov027; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Harvey KF, 2013, NAT REV CANCER, V13, P246, DOI 10.1038/nrc3458; Hill DA, 2009, SCIENCE, V325, P965, DOI 10.1126/science.1174334; Hollern DP, 2014, MOL CELL BIOL, V34, P3229, DOI 10.1128/MCB.00737-14; Jaeckle KA, 2011, J NEURO-ONCOL, V104, P253, DOI 10.1007/s11060-010-0476-2; Johnson BE, 2014, SCIENCE, V343, P189, DOI 10.1126/science.1239947; Keshet I, 2006, NAT GENET, V38, P149, DOI 10.1038/ng1719; Kim HS, 2012, CANCER RES, V72, P6065, DOI 10.1158/0008-5472.CAN-12-2594; Koo CY, 2012, BBA-GENE REGUL MECH, V1819, P28, DOI 10.1016/j.bbagrm.2011.09.004; Kumar MS, 2009, GENE DEV, V23, P2700, DOI 10.1101/gad.1848209; Labreche K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8207; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Laoukili J, 2007, BBA-REV CANCER, V1775, P92, DOI 10.1016/j.bbcan.2006.08.006; Leek JT, 2012, BIOINFORMATICS, V28, P882, DOI 10.1093/bioinformatics/bts034; Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lim WK, 2014, NAT GENET, V46, P877, DOI 10.1038/ng.3037; Liu MG, 2006, CANCER RES, V66, P3593, DOI 10.1158/0008-5472.CAN-05-2912; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Lunter G, 2011, GENOME RES, V21, P936, DOI 10.1101/gr.111120.110; Makinen N, 2011, SCIENCE, V334, P252, DOI 10.1126/science.1208930; Martin M., 2011, EMBNET J, V17, P10, DOI [DOI 10.14806/EJ.17.1.200, 10.14806/ej.17.1.200]; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Mertz JA, 2011, P NATL ACAD SCI USA, V108, P16669, DOI 10.1073/pnas.1108190108; Ostrom QT, 2014, NEURO-ONCOLOGY, V16, P1, DOI 10.1093/neuonc/nou223; Pastori C, 2014, EPIGENETICS-US, V9, P611, DOI 10.4161/epi.27906; Pickering CR, 2014, CLIN CANCER RES, V20, P6582, DOI 10.1158/1078-0432.CCR-14-1768; Ritz C, 2005, J STAT SOFTW, V12, P1; Rohle D, 2013, SCIENCE, V340, P626, DOI 10.1126/science.1236062; Saito R, 2012, NAT METHODS, V9, P1069, DOI [10.1038/nmeth.2212, 10.1038/NMETH.2212]; Schlesinger Y, 2007, NAT GENET, V39, P232, DOI 10.1038/ng1950; Shi JW, 2014, MOL CELL, V54, P728, DOI 10.1016/j.molcel.2014.05.016; Shi W, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq871; Shin HJ, 2009, BIOINFORMATICS, V25, P2605, DOI 10.1093/bioinformatics/btp479; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Song S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045835; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Suzuki H, 2015, NAT GENET, V47, P458, DOI 10.1038/ng.3273; Teschendorff AE, 2013, BIOINFORMATICS, V29, P189, DOI 10.1093/bioinformatics/bts680; Therneau TM, 2000, MODELING SURVIVAL DA; Topham C, 2015, CANCER CELL, V28, P129, DOI 10.1016/j.ccell.2015.06.001; Triche TJ, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt090; Turcan S, 2012, NATURE, V483, P479, DOI 10.1038/nature10866; van den Boom J, 2003, AM J PATHOL, V163, P1033, DOI 10.1016/S0002-9440(10)63463-3; Stormo Gary D, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1110s43, 10.1002/0471250953.bi1201s43]; van Thuijl HF, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0471-6; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Wang D, 2012, BIOINFORMATICS, V28, P729, DOI 10.1093/bioinformatics/bts013; Wang JL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003769; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wilkerson MD, 2010, BIOINFORMATICS, V26, P1572, DOI 10.1093/bioinformatics/btq170; Wu LZ, 2001, NATURE, V414, P457, DOI 10.1038/35106593; Zack TI, 2013, NAT GENET, V45, P1134, DOI 10.1038/ng.2760; Zheng HW, 2008, NATURE, V455, P1129, DOI 10.1038/nature07443	83	179	185	2	43	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2016	48	1					59	+		10.1038/ng.3457	http://dx.doi.org/10.1038/ng.3457			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CZ7BQ	26618343	Green Accepted			2022-12-25	WOS:000367255300014
J	Baskin, JM; Wu, XD; Christiano, R; Oh, MS; Schauder, CM; Gazzerro, E; Messa, M; Baldassari, S; Assereto, S; Biancheri, R; Zara, F; Minetti, C; Raimondi, A; Simons, M; Walther, TC; Reinisch, KM; De Camilli, P				Baskin, Jeremy M.; Wu, Xudong; Christiano, Romain; Oh, Michael S.; Schauder, Curtis M.; Gazzerro, Elisabetta; Messa, Mirko; Baldassari, Simona; Assereto, Stefania; Biancheri, Roberta; Zara, Federico; Minetti, Carlo; Raimondi, Andrea; Simons, Mikael; Walther, Tobias C.; Reinisch, Karin M.; De Camilli, Pietro			The leukodystrophy protein FAM126A (hyccin) regulates PtdIns(4)P synthesis at the plasma membrane	NATURE CELL BIOLOGY			English	Article							CENTRAL-NERVOUS-SYSTEM; MYELIN BASIC-PROTEIN; CONGENITAL CATARACT; PHOSPHATIDYLINOSITOL 4-KINASE; PHASE DETERMINATION; CELL REGULATION; HYPOMYELINATION; REMYELINATION; CNS; PHOSPHOINOSITIDES	Genetic defects in myelin formation and maintenance cause leukodystrophies, a group of white matter diseases whose mechanistic underpinnings are poorly understood(1,2). Hypomyelination and congenital cataract (HCC), one of these disorders, is caused by mutations in FAM126A, a gene of unknown function(3). We show that FAM126A, also known as hyccin, regulates the synthesis of phosphatidylinositol 4-phosphate (PtdIns(4)P), a determinant of plasma membrane identity(4-6). HCC patient fibroblasts exhibit reduced PtdIns(4)P levels. FAM126A is an intrinsic component of the plasma membrane phosphatidylinositol 4-kinase complex that comprises PI4KIII alpha and its adaptors TTC7 and EFR3 (refs 5,7). A FAM126A TTC7 alpha-crystal structure reveals an all-alpha-helical heterodimer with a large protein protein interface and a conserved surface that may mediate binding to PI4KIII alpha. Absence of FAM126A, the predominant FAM126 isoform in oligodendrocytes, destabilizes the PI4KIII alpha complex in mouse brain and patient fibroblasts. We propose that HCC pathogenesis involves defects in PtdIns(4)P production in oligodendrocytes, whose specialized function requires massive plasma membrane expansion and thus generation of PtdIns(4)P and downstream phosphoinositides(8-11). Our results point to a role for FAM126A in supporting myelination, an important process in development and also following acute exacerbations in multiple sclerosis(12-14).	[Baskin, Jeremy M.; Wu, Xudong; Christiano, Romain; Oh, Michael S.; Schauder, Curtis M.; Messa, Mirko; Walther, Tobias C.; Reinisch, Karin M.; De Camilli, Pietro] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA; [Baskin, Jeremy M.; Oh, Michael S.; Messa, Mirko; De Camilli, Pietro] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA; [Baskin, Jeremy M.; Oh, Michael S.; Messa, Mirko; De Camilli, Pietro] Yale Univ, Sch Med, Program Cellular Neurosci Neurodegenerat & Repair, New Haven, CT 06510 USA; [Gazzerro, Elisabetta; Baldassari, Simona; Assereto, Stefania; Zara, Federico; Minetti, Carlo] Ist Giannina Gaslini, Unit Pediat Neurol, I-16147 Genoa, Italy; [Biancheri, Roberta] Ist Giannina Gaslini, Dept Neurosci, I-16147 Genoa, Italy; [Minetti, Carlo] Univ Genoa, Dept Neurosci, I-16132 Genoa, Italy; [Raimondi, Andrea] Ist Sci San Raffaele, Expt Imaging Ctr, I-20132 Milan, Italy; [Simons, Mikael] Univ Gottingen, Max Planck Inst Expt Med, D-37075 Gottingen, Germany; [Simons, Mikael] Univ Gottingen, Dept Neurol, D-37075 Gottingen, Germany; [De Camilli, Pietro] Yale Univ, Sch Med, Dept Neurosci, New Haven, CT 06510 USA; [De Camilli, Pietro] Yale Univ, Sch Med, Kavli Inst Neurosci, New Haven, CT 06510 USA	Yale University; Howard Hughes Medical Institute; Yale University; Yale University; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Genoa; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Max Planck Society; University of Gottingen; University of Gottingen; Yale University; Yale University	Reinisch, KM (corresponding author), Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA.	karin.reinisch@yale.edu; pietro.decamilli@yale.edu	Wu, Xudong/ABG-3732-2020; Baldassari, Simona/AAB-2383-2019; Raimondi, Andrea/AAN-2475-2020; Baskin, Jeremy/X-7077-2019; Minetti, Carlo/K-4666-2018; Zara, Federico/U-3477-2017	Wu, Xudong/0000-0001-9594-479X; Baldassari, Simona/0000-0002-5304-3608; Baskin, Jeremy/0000-0003-2939-3138; Minetti, Carlo/0000-0002-0640-1804; Zara, Federico/0000-0001-9744-5222; Simons, Mikael/0000-0001-5329-192X; Raimondi, Andrea/0000-0002-4563-386X; Walther, Tobias/0000-0003-1442-1327; Oh, Michael/0000-0002-7206-771X	National Institutes of Health [R37N5036251, R01DK082700, P30DK45735, P30DA018343, R01GM080616, R01GM095982, K99GM110121]; Simons Foundation; Telethon [GP2007250]; Mariani Foundation; San Paolo Foundation; European Leukodystrophy Association Foundation; Jane Coffin Childs Memorial Fund fellowship; National Science Foundation [DGE-1122492]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082700, P30DK045735] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080616, R01GM095982, R00GM110121, K99GM110121, R01GM114068] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS036251] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA018343] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Simons Foundation; Telethon(Fondazione Telethon); Mariani Foundation; San Paolo Foundation(Compagnia di San Paolo); European Leukodystrophy Association Foundation; Jane Coffin Childs Memorial Fund fellowship; National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank F. Nakatsu for helpful discussions and J. Chung, H. Czapla, L. Lucast and F. Wilson for technical assistance. HCC patient and control fibroblasts were kindly provided by the Cell Line and DNA Biobank from Patients Affected by Genetic Diseases (Giannina Gaslini Institute), part of the Telethon Network of Genetic Biobanks (project no. GTB12001). Primate brain samples were generously provided by N. Sestan and A. Sousa (Yale University). This work was supported by the National Institutes of Health (R37N5036251, R01DK082700, P30DK45735 and P30DA018343 to P.D.C., R01GM080616 to K.M.R., R01GM095982 to T.C.W., and K99GM110121 to J.M.B.), the Simons Foundation (to P.D.C.), Telethon (GP2007250 to C.M.), the Mariani Foundation (C.M.), the San Paolo Foundation (to C.M.), and the European Leukodystrophy Association Foundation (to C.M.). J.M.B. was a recipient of a Jane Coffin Childs Memorial Fund fellowship, and C.M.S. was a recipient of a National Science Foundation Graduate Research Fellowship (DGE-1122492).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Aggarwal S, 2011, TRENDS CELL BIOL, V21, P585, DOI 10.1016/j.tcb.2011.06.004; Audhya A, 2000, MOL BIOL CELL, V11, P2673, DOI 10.1091/mbc.11.8.2673; Audhya A, 2002, DEV CELL, V2, P593, DOI 10.1016/S1534-5807(02)00168-5; Baird D, 2008, J CELL BIOL, V183, P1061, DOI 10.1083/jcb.200804003; Balla A, 2005, MOL BIOL CELL, V16, P1282, DOI 10.1091/mbc.E04-07-0578; Balla T, 2013, PHYSIOL REV, V93, P1019, DOI 10.1152/physrev.00028.2012; Biancheri R, 2007, ANN NEUROL, V62, P121, DOI 10.1002/ana.21175; Biancheri R, 2011, ARCH NEUROL-CHICAGO, V68, P1191, DOI 10.1001/archneurol.2011.201; Bojjireddy N, 2014, J BIOL CHEM, V289, P6120, DOI 10.1074/jbc.M113.531426; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Crawford AH, 2013, J COMP PATHOL, V149, P242, DOI 10.1016/j.jcpa.2013.05.004; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fancy SPJ, 2011, ANNU REV NEUROSCI, V34, P21, DOI 10.1146/annurev-neuro-061010-113629; Fancy SPJ, 2009, GENE DEV, V23, P1571, DOI 10.1101/gad.1806309; Fitzner D, 2006, EMBO J, V25, P5037, DOI 10.1038/sj.emboj.7601376; Franklin RJM, 2008, NAT REV NEUROSCI, V9, P839, DOI 10.1038/nrn2480; Gazzerro E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032180; Goebbels S, 2010, J NEUROSCI, V30, P8953, DOI 10.1523/JNEUROSCI.0219-10.2010; Graf von Keyserlingk D., 1984, ANAT ANZEIGER, V157, P97; Hammond GRV, 2012, SCIENCE, V337, P727, DOI 10.1126/science.1222483; Hendrickson WA, 1997, METHOD ENZYMOL, V276, P494, DOI 10.1016/S0076-6879(97)76074-9; Hubner NC, 2011, METHODS, V53, P453, DOI 10.1016/j.ymeth.2010.12.016; Kawasoe T, 2000, CANCER RES, V60, P3354; Musse AA, 2008, BIOCHEMISTRY-US, V47, P10372, DOI 10.1021/bi801302b; Nakatsu F, 2012, J CELL BIOL, V199, P1003, DOI 10.1083/jcb.201206095; Nawaz S, 2009, J NEUROSCI, V29, P4794, DOI 10.1523/JNEUROSCI.3955-08.2009; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perlman SJ, 2012, ADV EXP MED BIOL, V724, P154, DOI 10.1007/978-1-4614-0653-2_13; Snaidero N, 2014, CELL, V156, P277, DOI 10.1016/j.cell.2013.11.044; Tan J, 2014, CRIT REV BIOCHEM MOL, V49, P33, DOI 10.3109/10409238.2013.853024; Tan JL, 2014, J CELL SCI, V127, P954, DOI 10.1242/jcs.129031; TOMASCH J, 1954, ANAT REC, V119, P119, DOI 10.1002/ar.1091190109; Traverso M, 2013, BIOCHEM BIOPH RES CO, V439, P369, DOI 10.1016/j.bbrc.2013.08.077; Trotter PJ, 1998, J BIOL CHEM, V273, P13189, DOI 10.1074/jbc.273.21.13189; Wu XD, 2014, DEV CELL, V28, P19, DOI 10.1016/j.devcel.2013.11.012; Zara F, 2006, NAT GENET, V38, P1111, DOI 10.1038/ng1870	40	69	76	1	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JAN	2016	18	1					132	+		10.1038/ncb3271	http://dx.doi.org/10.1038/ncb3271			10	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	CZ3VA	26571211	Green Accepted			2022-12-25	WOS:000367030900006
J	Castro, MAA; de Santiago, I; Campbell, TM; Vaughn, C; Hickey, TE; Ross, E; Tilley, WD; Markowetz, F; Ponder, BAJ; Meyer, KB				Castro, Mauro A. A.; de Santiago, Ines; Campbell, Thomas M.; Vaughn, Courtney; Hickey, Theresa E.; Ross, Edith; Tilley, Wayne D.; Markowetz, Florian; Ponder, Bruce A. J.; Meyer, Kerstin B.			Regulators of genetic risk of breast cancer identified by integrative network analysis	NATURE GENETICS			English	Article							ESTROGEN-RECEPTOR; MAMMARY-GLAND; ANDROGEN RECEPTOR; STEM-CELLS; C/EBP-BETA; GWAS DATA; EXPRESSION; FOXA1; TRANSCRIPTION; TUMORS	Genetic risk for breast cancer is conferred by a combination of multiple variants of small effect. To better understand how risk loci might combine, we examined whether risk-associated genes share regulatory mechanisms. We created a breast cancer gene regulatory network comprising transcription factors and groups of putative target genes (regulons) and asked whether specific regulons are enriched for genes associated with risk loci via expression quantitative trait loci (eQTLs). We identified 36 overlapping regulons that were enriched for risk loci and formed a distinct cluster within the network, suggesting shared biology. The risk transcription factors driving these regulons are frequently mutated in cancer and lie in two opposing subgroups, which relate to estrogen receptor (ER)(+) luminal A or luminal B and ER-basal-like cancers and to different luminal epithelial cell populations in the adult mammary gland. Our network approach provides a foundation for determining the regulatory circuits governing breast cancer, to identify targets for intervention, and is transferable to other disease settings.	[Castro, Mauro A. A.] Fed Univ Parana UFPR, Polytech Ctr, Bioinformat & Syst Biol Lab, BR-80060000 Curitiba, Parana, Brazil; [de Santiago, Ines; Campbell, Thomas M.; Vaughn, Courtney; Ross, Edith; Markowetz, Florian; Ponder, Bruce A. J.; Meyer, Kerstin B.] Univ Cambridge, Li Ka Shing Ctr, Canc Res UK Cambridge Inst, Cambridge, England; [de Santiago, Ines; Campbell, Thomas M.; Vaughn, Courtney; Ponder, Bruce A. J.; Meyer, Kerstin B.] Univ Cambridge, Dept Oncol, Hutchison Med Res Council MRC, Res Ctr, Cambridge, England; [Hickey, Theresa E.; Tilley, Wayne D.] Univ Adelaide, Sch Med, Dame Roma Mitchell Canc Res Labs, Adelaide, SA, Australia	Universidade Federal do Parana; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; University of Cambridge; University of Adelaide	Meyer, KB (corresponding author), Univ Cambridge, Li Ka Shing Ctr, Canc Res UK Cambridge Inst, Cambridge, England.	kerstin.meyer@cruk.cam.ac.uk	Markowetz, Florian/H-6883-2019; de Santiago, Ines/AAP-5859-2020; Castro, Mauro A. A./A-5467-2008	Markowetz, Florian/0000-0002-2784-5308; de Santiago, Ines/0000-0002-8172-1322; Castro, Mauro A. A./0000-0003-4942-8131; Hickey, Theresa/0000-0002-2752-730X; Ross, Edith/0000-0001-9676-9823; Tilley, Wayne/0000-0003-1893-2626	Cancer Research UK; Breast Cancer Research Foundation; National Research Council (CNPq) of Brazil; Royal Adelaide Hospital Career Development Fellowship (Australia) [W81XWH-11-1-0592]; National Health and Medical Research Council (NHMRC) of Australia [1008349, 1084416]; Cancer Australia/National Breast Cancer Foundation [627229, ID: PS-15-041]; University of Cambridge; Hutchison Whampoa, Ltd.; Cancer Research UK [19275, 19274] Funding Source: researchfish; National Breast Cancer Foundation [PD-13-03] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008719] Funding Source: NIH RePORTER	Cancer Research UK(Cancer Research UK); Breast Cancer Research Foundation; National Research Council (CNPq) of Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Royal Adelaide Hospital Career Development Fellowship (Australia); National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Cancer Australia/National Breast Cancer Foundation; University of Cambridge(University of Cambridge); Hutchison Whampoa, Ltd.; Cancer Research UK(Cancer Research UK); National Breast Cancer Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Califano for helpful discussions and J. Stingl for advice and critical reading of the manuscript. We are grateful to the genomics and bioinformatics cores at the Cancer Research UK Cambridge Institute for their support. This work was funded by Cancer Research UK and the Breast Cancer Research Foundation. M.A.A.C. is funded by the National Research Council (CNPq) of Brazil. T.E.H. held a fellowship from the US Department of Defense Breast Cancer Research Program (W81XWH-11-1-0592) and is currently supported by a Royal Adelaide Hospital Career Development Fellowship (Australia). T.E.H. and W.D.T. are funded by the National Health and Medical Research Council (NHMRC) of Australia (1008349 to W.D.T. and 1084416 to W.D.T. and T.E.H.) and Cancer Australia/National Breast Cancer Foundation (627229 to W.D.T. and T.E.H.; ID: PS-15-041-W.D.T.). B.A.J.P. is a Gibb Fellow of Cancer Research UK and a National Institute for Health Research (NIHR) Senior Investigator. We would like to acknowledge the support of the University of Cambridge, Cancer Research UK and Hutchison Whampoa, Ltd.	Ai LB, 2014, CANCER RES, V74, P4875, DOI 10.1158/0008-5472.CAN-13-3579; Andres SA, 2011, ENDOCRINE, V40, P212, DOI 10.1007/s12020-011-9522-x; Basso K, 2005, NAT GENET, V37, P382, DOI 10.1038/ng1532; Benjamini Y, 2001, ANN STAT, V29, P1165; Bernardo GM, 2013, ONCOGENE, V32, P554, DOI 10.1038/onc.2012.62; Bertucci F, 2006, CANCER RES, V66, P4636, DOI 10.1158/0008-5472.CAN-06-0031; Califano A, 2012, NAT GENET, V44, P841, DOI 10.1038/ng.2355; Carro MS, 2010, NATURE, V463, P318, DOI 10.1038/nature08712; Castro MAA, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-4-r29; Cimino-Mathews A, 2013, HUM PATHOL, V44, P959, DOI 10.1016/j.humpath.2012.09.005; Cowper-Sal-lari R, 2012, NAT GENET, V44, P1191, DOI 10.1038/ng.2416; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Davies AH, 2014, STEM CELLS, V32, P1437, DOI 10.1002/stem.1707; Fachal L, 2015, CURR OPIN GENET DEV, V30, P32, DOI 10.1016/j.gde.2015.01.004; Fletcher MNC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3464; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; Fu JY, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002431; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Haughian JM, 2012, P NATL ACAD SCI USA, V109, P2742, DOI 10.1073/pnas.1106509108; Hickey TE, 2012, MOL ENDOCRINOL, V26, P1252, DOI 10.1210/me.2012-1107; Hurtado A, 2011, NAT GENET, V43, P27, DOI 10.1038/ng.730; Johansson J, 2013, ONCOGENE, V32, P5614, DOI 10.1038/onc.2013.322; Kalyuga M, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001461; Kittler R, 2013, CELL REP, V3, P538, DOI 10.1016/j.celrep.2013.01.004; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kong SL, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.59; Lafkas D, 2013, J CELL BIOL, V203, P47, DOI 10.1083/jcb.201307046; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Leiserson MDM, 2013, CURR OPIN GENET DEV, V23, P602, DOI 10.1016/j.gde.2013.09.003; Li QY, 2013, CELL, V152, P633, DOI 10.1016/j.cell.2012.12.034; Lim E, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2560; Lim E, 2009, NAT MED, V15, P907, DOI 10.1038/nm.2000; Marcotte R, 2012, CANCER DISCOV, V2, P172, DOI 10.1158/2159-8290.CD-11-0224; Michailidou K, 2013, NAT GENET, V45, P353, DOI 10.1038/ng.2563; Molyneux G, 2010, CELL STEM CELL, V7, P403, DOI 10.1016/j.stem.2010.07.010; Montgomery SB, 2011, NAT REV GENET, V12, P277, DOI 10.1038/nrg2969; Moon HG, 2011, MOL ONCOL, V5, P538, DOI 10.1016/j.molonc.2011.08.002; Oakes SR, 2008, GENE DEV, V22, P581, DOI 10.1101/gad.1614608; Perou CM, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003293; Risbridger GP, 2010, NAT REV CANCER, V10, P205, DOI 10.1038/nrc2795; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robinson JLL, 2011, EMBO J, V30, P3019, DOI 10.1038/emboj.2011.216; Rodilla V, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002069; Ross-Innes CS, 2010, GENE DEV, V24, P171, DOI 10.1101/gad.552910; Schliekelman P, 2008, GENETICS, V178, P2201, DOI 10.1534/genetics.107.076687; Schmidt D, 2009, METHODS, V48, P240, DOI 10.1016/j.ymeth.2009.03.001; Seagroves TN, 1998, GENE DEV, V12, P1917, DOI 10.1101/gad.12.12.1917; Shabalin AA, 2012, BIOINFORMATICS, V28, P1353, DOI 10.1093/bioinformatics/bts163; Shehata M, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3334; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Van Keymeulen A, 2011, NATURE, V479, P189, DOI 10.1038/nature10573; Venet D, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002240	52	101	101	0	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2016	48	1					12	+		10.1038/ng.3458	http://dx.doi.org/10.1038/ng.3458			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CZ7BQ	26618344	Green Accepted			2022-12-25	WOS:000367255300008
J	Dawaliby, R; Trubbia, C; Delporte, C; Masureel, M; Van Antwerpen, P; Kobilka, BK; Govaerts, C				Dawaliby, Rosie; Trubbia, Cataldo; Delporte, Cedric; Masureel, Matthieu; Van Antwerpen, Pierre; Kobilka, Brian K.; Govaerts, Cedric			Allosteric regulation of G protein-coupled receptor activity by phospholipids	NATURE CHEMICAL BIOLOGY			English	Article							MONOMERIC RHODOPSIN; MEMBRANE-PROTEINS; CRYSTAL-STRUCTURE; DYNAMIC PROCESS; CHOLESTEROL; LIPIDS; BINDING; STABILITY; BILAYER; COMPLEX	Lipids are emerging as key regulators of membrane protein structure and activity. These effects can be attributed either to the modification of bilayer properties (thickness, curvature and surface tension) or to the binding of specific lipids to the protein surface. For G protein-coupled receptors (GPCRs), the effects of phospholipids on receptor structure and activity remain poorly understood. Here we reconstituted purified beta 2-adrenergic receptor (beta 2R) in high-density lipoparticles to systematically characterize the effect of biologically relevant phospholipids on receptor activity. We observed that the lipid headgroup type affected ligand binding (agonist and antagonist) and receptor activation. Specifically, phosphatidylgycerol markedly favored agonist binding and facilitated receptor activation, whereas phosphatidylethanolamine favored antagonist binding and stabilized the inactive state of the receptor. We then showed that these effects could be recapitulated with detergent-solubilized lipids, demonstrating that the functional modulation occurred in the absence of a bilayer. Our data suggest that phospholipids act as direct allosteric modulators of GPCR activity.	[Dawaliby, Rosie; Trubbia, Cataldo; Govaerts, Cedric] Univ Libre Bruxelles, Ctr Struct Biol & Bioinformat, Lab Struct & Funct Biol Membranes, Brussels, Belgium; [Delporte, Cedric; Van Antwerpen, Pierre] Univ Libre Bruxelles, Fac Pharm, Lab Pharmaceut Chem, Brussels, Belgium; [Delporte, Cedric; Van Antwerpen, Pierre] Univ Libre Bruxelles, Fac Pharm, Analyt Platform Fac Pharm, Brussels, Belgium; [Masureel, Matthieu; Kobilka, Brian K.] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA	Universite Libre de Bruxelles; Universite Libre de Bruxelles; Universite Libre de Bruxelles; Stanford University	Dawaliby, R (corresponding author), Univ Libre Bruxelles, Ctr Struct Biol & Bioinformat, Lab Struct & Funct Biol Membranes, Brussels, Belgium.	kobilka@stanford.edu; cedric.govaerts@ulb.ac.be	; Delporte, Cedric/C-2228-2013	Van Antwerpen, Pierre/0000-0002-4934-8863; Dawaliby, Rosie/0000-0001-7476-0350; Delporte, Cedric/0000-0001-7453-7028; Kobilka, Brian/0000-0001-5958-3990	Fonds de la Recherche Scientifique (FRS FNRS) [F.4523.12, 34553.08, T.0136.13]; US National Institute of Health [R01 NS028471, R01GM083118]; "Fond Extraordinaire de Recherche" (FER) of the Universite Libre de Bruxelles; Hoover Foundation Brussels Fellowship from the Belgian American Educational Foundation (BAEF); American Heart Association (AHA) Award [15POST22700020]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083118] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028471] Funding Source: NIH RePORTER	Fonds de la Recherche Scientifique (FRS FNRS)(Fonds de la Recherche Scientifique - FNRS); US National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); "Fond Extraordinaire de Recherche" (FER) of the Universite Libre de Bruxelles; Hoover Foundation Brussels Fellowship from the Belgian American Educational Foundation (BAEF); American Heart Association (AHA) Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank R. Efremov for assistance with electron microscopy, E. Pardon and J. Steyaert (Vrije Universiteit Brussel) for providing purified Nb80, A. Manglik and D. Hilger for help with receptor production, L. Pardo for help with the statistical tests, R. Sunahara (University of California, San Diego) for providing the apoA-I plasmid and J.-M. Ruysschaert for helpful discussions. We acknowledge support from the Fonds de la Recherche Scientifique (FRS-FNRS) (grants F.4523.12, and T.0136.13), the US National Institute of Health (grants R01 NS028471 and R01GM083118) and a grant from the "Fond Extraordinaire de Recherche" (FER) 2007 of the Universite Libre de Bruxelles. C.D. is a postdoctoral fellow of the FRS-FNRS. C.G. is a Chercheur Qualifie of the FRS-FNRS and a WELBIO investigator. M.M. was supported by a Hoover Foundation Brussels Fellowship from the Belgian American Educational Foundation (BAEF) and an American Heart Association (AHA) Award 15POST22700020.	Albert AD, 1996, BBA-BIOMEMBRANES, V1285, P47, DOI 10.1016/S0005-2736(96)00145-9; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Botelho AV, 2006, BIOPHYS J, V91, P4464, DOI 10.1529/biophysj.106.082776; Botelho AV, 2002, BIOCHEMISTRY-US, V41, P6354, DOI 10.1021/bi011995g; Brown MF, 2012, BIOCHEMISTRY-US, V51, P9782, DOI 10.1021/bi301332v; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; FLIESLER SJ, 1983, PROG LIPID RES, V22, P79; Gimpl G, 2002, BBA-BIOMEMBRANES, V1564, P384, DOI 10.1016/S0005-2736(02)00475-3; Gourdon P, 2011, CRYST GROWTH DES, V11, P2098, DOI 10.1021/cg101360d; Granier S, 2007, J BIOL CHEM, V282, P13895, DOI 10.1074/jbc.M611904200; Guan L, 2006, P NATL ACAD SCI USA, V103, P1723, DOI 10.1073/pnas.0510922103; Hanson MA, 2008, STRUCTURE, V16, P897, DOI 10.1016/j.str.2008.05.001; Huang P, 2007, BIOCHEM PHARMACOL, V73, P534, DOI 10.1016/j.bcp.2006.10.032; Hunte C, 2008, CURR OPIN STRUC BIOL, V18, P406, DOI 10.1016/j.sbi.2008.03.008; Inagaki S, 2012, J MOL BIOL, V417, P95, DOI 10.1016/j.jmb.2012.01.023; Jastrzebska B, 2009, BIOCHEMISTRY-US, V48, P5159, DOI 10.1021/bi900284x; Kenakin T, 2002, ANNU REV PHARMACOL, V42, P349, DOI 10.1146/annurev.pharmtox.42.091401.113012; Koshy C, 2013, EMBO J, V32, P3096, DOI 10.1038/emboj.2013.226; Laganowsky A, 2014, NATURE, V510, P172, DOI 10.1038/nature13419; Lee AG, 2004, BBA-BIOMEMBRANES, V1666, P62, DOI 10.1016/j.bbamem.2004.05.012; Lee AG, 2011, TRENDS BIOCHEM SCI, V36, P493, DOI 10.1016/j.tibs.2011.06.007; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Manglik A, 2015, CELL, V161, P1101, DOI 10.1016/j.cell.2015.04.043; MITCHELL DC, 1990, BIOCHEMISTRY-US, V29, P9143, DOI 10.1021/bi00491a007; Nygaard R, 2013, CELL, V152, P532, DOI 10.1016/j.cell.2013.01.008; Oates J, 2012, BBA-BIOMEMBRANES, V1818, P2228, DOI 10.1016/j.bbamem.2012.04.010; Oates J, 2011, CURR OPIN STRUC BIOL, V21, P802, DOI 10.1016/j.sbi.2011.09.007; Ostrom RS, 2004, BRIT J PHARMACOL, V143, P235, DOI 10.1038/sj.bjp.0705930; Pucadyil TJ, 2004, BBA-BIOMEMBRANES, V1663, P188, DOI 10.1016/j.bbamem.2004.03.010; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Schuler Mary A, 2013, Methods Mol Biol, V974, P415, DOI 10.1007/978-1-62703-275-9_18; Soubias O, 2006, J BIOL CHEM, V281, P33233, DOI 10.1074/jbc.M603059200; Soubias O, 2010, BIOPHYS J, V99, P817, DOI 10.1016/j.bpj.2010.04.068; Tapley TL, 2004, J BIOL CHEM, V279, P28435, DOI 10.1074/jbc.M400803200; Tsukamoto H, 2011, BIOCHEMISTRY-US, V50, P5086, DOI 10.1021/bi200391a; Tsukamoto H, 2010, J MOL BIOL, V399, P501, DOI 10.1016/j.jmb.2010.04.029; Velez-Ruiz GA, 2011, METHODS MOL BIOL, V756, P167, DOI 10.1007/978-1-61779-160-4_8; Whorton MR, 2008, J BIOL CHEM, V283, P4387, DOI 10.1074/jbc.M703346200; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104; Yao XJ, 2009, P NATL ACAD SCI USA, V106, P9501, DOI 10.1073/pnas.0811437106	41	186	186	3	146	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	JAN	2016	12	1					35	+		10.1038/NCHEMBIO.1960	http://dx.doi.org/10.1038/NCHEMBIO.1960			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CY8QW	26571351	Green Accepted			2022-12-25	WOS:000366674400009
J	Sundaram, S; Heine, D; Hertweck, C				Sundaram, Srividhya; Heine, Daniel; Hertweck, Christian			Polyketide synthase chimeras reveal key role of ketosynthase domain in chain branching	NATURE CHEMICAL BIOLOGY			English	Article							FUNGUS RHIZOPUS-MICROSPORUS; ENZYMATIC MICHAEL ADDITION; BACTERIAL ENDOSYMBIONT; RHIZOXIN DERIVATIVES; MUTATIONAL ANALYSIS; BIOSYNTHESIS; CYCLOHEXIMIDE	Biosynthesis of rhizoxin in Burkholderia rhizoxinica affords an unusual polyketide synthase module with ketosynthase and branching domains that install the delta-lactone, conferring antimitotic activity. To investigate their functions in chain branching, we designed chimeric modules with structurally similar domains from a glutarimide-forming module and a dehydratase. Biochemical, kinetic and mutational analyses reveal a structural role of the accessory domains and multifarious catalytic actions of the ketosynthase.	[Sundaram, Srividhya; Heine, Daniel; Hertweck, Christian] Leibniz Inst Nat Prod Res & Infect Biol HKI, Dept Biomol Chem, Jena, Germany; [Hertweck, Christian] Univ Jena, Chair Nat Prod Chem, Jena, Germany	Hans Knoll Institute (HKI); Friedrich Schiller University of Jena	Sundaram, S (corresponding author), Leibniz Inst Nat Prod Res & Infect Biol HKI, Dept Biomol Chem, Jena, Germany.	christian.hertweck@leibniz-hki.de	Hertweck, Christian/AAZ-8452-2021	Hertweck, Christian/0000-0002-0367-337X	International Leibniz Research School; Studienstiftung des Deutschen Volkes	International Leibniz Research School; Studienstiftung des Deutschen Volkes	We thank A. Perner for MS analyses and M. Poetsch for MALDI measurements. We are grateful for financial support by the International Leibniz Research School (to S.S.) and the Studienstiftung des Deutschen Volkes (to D.H.).	Bretschneider T, 2013, NATURE, V502, P124, DOI 10.1038/nature12588; Bretschneider T, 2012, NAT CHEM BIOL, V8, P154, DOI 10.1038/nchembio.746; Calderone CT, 2008, NAT PROD REP, V25, P845, DOI 10.1039/b807243d; Chen S, 2003, CHEM BIOL, V10, P1065, DOI 10.1016/j.chembiol.2003.10.007; Fuchs SW, 2013, ANGEW CHEM INT EDIT, V52, P4108, DOI 10.1002/anie.201210116; Heine D, 2015, CHEM COMMUN, V51, P9872, DOI 10.1039/c5cc03085d; Heine D, 2014, ANGEW CHEM INT EDIT, V53, P11645, DOI 10.1002/anie.201407282; Hertweck C, 2009, ANGEW CHEM INT EDIT, V48, P4688, DOI 10.1002/anie.200806121; Hothersall J, 2007, J BIOL CHEM, V282, P15451, DOI 10.1074/jbc.M701490200; Kusebauch B, 2011, CHEMMEDCHEM, V6, P1998, DOI 10.1002/cmdc.201100319; Kusebauch B, 2009, ANGEW CHEM INT EDIT, V48, P5001, DOI 10.1002/anie.200900277; Lackner G, 2009, TRENDS MICROBIOL, V17, P570, DOI 10.1016/j.tim.2009.09.003; Lim SK, 2009, J BIOL CHEM, V284, P29746, DOI 10.1074/jbc.M109.046805; Nguyen T, 2008, NAT BIOTECHNOL, V26, P225, DOI 10.1038/nbt1379; Partida-Martinez LP, 2007, CHEMBIOCHEM, V8, P41, DOI 10.1002/cbic.200600393; Partida-Martinez LP, 2005, NATURE, V437, P884, DOI 10.1038/nature03997; Rajski SR, 2010, CHEMBIOCHEM, V11, P1951, DOI 10.1002/cbic.201000370; Scherlach K, 2006, J AM CHEM SOC, V128, P11529, DOI 10.1021/ja062953o; Scherlach K, 2012, ANGEW CHEM INT EDIT, V51, P9615, DOI 10.1002/anie.201204540; Schmitt I, 2008, ISME J, V2, P632, DOI 10.1038/ismej.2008.19; Schneider-Poetsch T, 2010, NAT CHEM BIOL, V6, P209, DOI 10.1038/NCHEMBIO.304; Wang B, 2013, ORG LETT, V15, P1278, DOI 10.1021/ol400224n; Xu ZL, 2014, CHEMBIOCHEM, V15, P1274, DOI 10.1002/cbic.201402071; Yin M, 2014, ORG LETT, V16, P3072, DOI 10.1021/ol501179w; Zocher G, 2015, CHEM SCI, V6, P6525, DOI 10.1039/c5sc02488a	25	14	15	1	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2015	11	12					949	951		10.1038/NCHEMBIO.1932	http://dx.doi.org/10.1038/NCHEMBIO.1932			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX6TG	26479442				2022-12-25	WOS:000365834000012
J	Wassermann, AM; Lounkine, E; Hoepfner, D; Le Goff, G; King, FJ; Studer, C; Peltier, JM; Grippo, ML; Prindle, V; Tao, JS; Schuffenhauer, A; Wallace, IM; Chen, SN; Krastel, P; Cobos-Correa, A; Parker, CN; Davies, JW; Glick, M				Wassermann, Anne Mai; Lounkine, Eugen; Hoepfner, Dominic; Le Goff, Gaelle; King, Frederick J.; Studer, Christian; Peltier, John M.; Grippo, Melissa L.; Prindle, Vivian; Tao, Jianshi; Schuffenhauer, Ansgar; Wallace, Iain M.; Chen, Shanni; Krastel, Philipp; Cobos-Correa, Amanda; Parker, Christian N.; Davies, John W.; Glick, Meir			Dark chemical matter as a promising starting point for drug lead discovery	NATURE CHEMICAL BIOLOGY			English	Article							PROTOPORPHYRINOGEN OXIDASE; SMALL MOLECULES; LIBRARIES; PROMISCUITY; DIVERSITY; BIOLOGY; CLIFFS; GENE	High-throughput screening (HTS) is an integral part of early drug discovery. Herein, we focused on those small molecules in a screening collection that have never shown biological activity despite having been exhaustively tested in HTS assays. These compounds are referred to as 'dark chemical matter' (DCM). We quantified DCM, validated it in quality control experiments, described its physicochemical properties and mapped it into chemical space. Through analysis of prospective reporter-gene assay, gene expression and yeast chemogenomics experiments, we evaluated the potential of DCM to show biological activity in future screens. We demonstrated that, despite the apparent lack of activity, occasionally these compounds can result in potent hits with unique activity and clean safety profiles, which makes them valuable starting points for lead optimization efforts. Among the identified DCM hits was a new antifungal chemotype with strong activity against the pathogen Cryptococcus neoformans but little activity at targets relevant to human safety.	[Wassermann, Anne Mai; Lounkine, Eugen; Le Goff, Gaelle; King, Frederick J.; Peltier, John M.; Grippo, Melissa L.; Wallace, Iain M.; Chen, Shanni; Davies, John W.; Glick, Meir] Novartis Inst BioMed Res Inc, Cambridge, MA USA; [Hoepfner, Dominic; Studer, Christian; Schuffenhauer, Ansgar; Krastel, Philipp; Cobos-Correa, Amanda; Parker, Christian N.] Novartis Inst BioMed Res Inc, Basel, Switzerland; [King, Frederick J.; Prindle, Vivian; Tao, Jianshi] Novartis Res Fdn, Genom Inst, San Diego, CA USA	Novartis; Novartis; Novartis	Wassermann, AM (corresponding author), Pfizer Inc, Cambridge, MA 02139 USA.	anne.wassermann@pfizer.com; meir.glick@merck.com	Wallace, Iain/B-9464-2009	Wallace, Iain/0000-0002-9491-7025	Education Office of the Novartis Institutes for BioMedical Research	Education Office of the Novartis Institutes for BioMedical Research	A.M.W. and G.L.G. were presidential postdoctoral fellows supported by the Education Office of the Novartis Institutes for BioMedical Research. The authors thank M. Schirle, R. Nutiu, S. Reiling and E. Gregori-Puigjane for valuable discussions; T. Aust, O. Galuba and R. Riedl for support with the HIP and follow-up experiments; M. Popov and F. Nigsch for help with data mining; P. Selzer for the cell permeability model; G. Wendel, B. Burakowska and L. Koppes for help with compound management; and R. Guha, J. Bittker and J. Braisted for help with BARD.	Austin CP, 2004, SCIENCE, V306, P1138, DOI 10.1126/science.1105511; Azzaoui K, 2007, CHEMMEDCHEM, V2, P874, DOI 10.1002/cmdc.200700036; Bickerton GR, 2012, NAT CHEM, V4, P90, DOI [10.1038/NCHEM.1243, 10.1038/nchem.1243]; Breinbauer R, 2002, CURR MED CHEM, V9, P2129, DOI 10.2174/0929867023368773; CAMADRO JM, 1991, BIOCHEM J, V277, P17, DOI 10.1042/bj2770017; Chuprina A, 2010, J CHEM INF MODEL, V50, P470, DOI 10.1021/ci900464s; Dimova D, 2012, J MED CHEM, V55, P10220, DOI 10.1021/jm301292a; Dobson CM, 2004, NATURE, V432, P824, DOI 10.1038/nature03192; DURSTENFELD R, 1964, COMMUN ACM, V7, P420, DOI 10.1145/364520.364540; Gaulton A, 2012, NUCLEIC ACIDS RES, V40, pD1100, DOI 10.1093/nar/gkr777; Gleeson MP, 2011, NAT REV DRUG DISCOV, V10, P197, DOI 10.1038/nrd3367; Glerum DM, 1996, YEAST, V12, P1421; Hamon J, 2009, FUTURE MED CHEM, V1, P645, DOI 10.4155/FMC.09.51; Hoepfner D, 2014, MICROBIOL RES, V169, P107, DOI 10.1016/j.micres.2013.11.004; Kenseth JR, 2004, CURR OPIN CHEM BIOL, V8, P418, DOI 10.1016/j.cbpa.2004.06.004; King FJ, 2009, JALA-J LAB AUTOM, V14, P374, DOI 10.1016/j.jala.2009.08.001; Krier M, 2006, J CHEM INF MODEL, V46, P512, DOI 10.1021/ci050352v; Lee AY, 2014, SCIENCE, V344, P208, DOI 10.1126/science.1250217; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Macarron R, 2011, NAT REV DRUG DISCOV, V10, P188, DOI 10.1038/nrd3368; Nigsch F, 2012, EURASIP J BIOINFORM, DOI 10.1186/1687-4153-2012-2; Nissink JWM, 2014, FUTURE MED CHEM, V6, P1113, DOI [10.4155/fmc.14.72, 10.4155/FMC.14.72]; Oprea TI, 2009, NAT CHEM BIOL, V5, P441, DOI 10.1038/nchembio0709-441; Petrone FM, 2012, ACS CHEM BIOL, V7, P1399, DOI 10.1021/cb3001028; Petrone PM, 2013, DRUG DISCOV TODAY, V18, P674, DOI 10.1016/j.drudis.2013.02.005; Qin XH, 2011, FASEB J, V25, P653, DOI 10.1096/fj.10-170811; Rogers D, 2010, J CHEM INF MODEL, V50, P742, DOI 10.1021/ci100050t; Rose PW, 2015, NUCLEIC ACIDS RES, V43, pD345, DOI 10.1093/nar/gku1214; Stumpfe D, 2014, J MED CHEM, V57, P18, DOI 10.1021/jm401120g; Wang YL, 2014, NUCLEIC ACIDS RES, V42, pD1075, DOI 10.1093/nar/gkt978; Wang YP, 2012, NUCLEIC ACIDS RES, V40, DOI [10.1093/nar/gkr1293, 10.1093/nar/gkr1132]; Watkins RE, 2001, SCIENCE, V292, P2329, DOI 10.1126/science.1060762; Wawer MJ, 2014, P NATL ACAD SCI USA, V111, P10911, DOI 10.1073/pnas.1410933111	33	84	85	0	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1552-4450	1552-4469		NAT CHEM BIOL	Nat. Chem. Biol.	DEC	2015	11	12					958	966		10.1038/nchembio.1936	http://dx.doi.org/10.1038/nchembio.1936			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX6TG	26479441				2022-12-25	WOS:000365834000015
J	Caye, A; Strullu, M; Guidez, F; Cassinat, B; Gazal, S; Fenneteau, O; Lainey, E; Nouri, K; Nakhaei-Rad, S; Dvorsky, R; Lachenaud, J; Pereira, S; Vivent, J; Verger, E; Vidaud, D; Galambrun, C; Picard, C; Petit, A; Contet, A; Poiree, M; Sirvent, N; Mechinaud, F; Adjaoud, D; Paillard, C; Nelken, B; Reguerre, Y; Bertrand, Y; Haussinger, D; Dalle, JH; Ahmadian, MR; Baruchel, A; Chomienne, C; Cave, H				Caye, Aurelie; Strullu, Marion; Guidez, Fabien; Cassinat, Bruno; Gazal, Steven; Fenneteau, Odile; Lainey, Elodie; Nouri, Kazem; Nakhaei-Rad, Saeideh; Dvorsky, Radovan; Lachenaud, Julie; Pereira, Sabrina; Vivent, Jocelyne; Verger, Emmanuelle; Vidaud, Dominique; Galambrun, Claire; Picard, Capucine; Petit, Arnaud; Contet, Audrey; Poiree, Marilyne; Sirvent, Nicolas; Mechinaud, Francoise; Adjaoud, Dalila; Paillard, Catherine; Nelken, Brigitte; Reguerre, Yves; Bertrand, Yves; Haeussinger, Dieter; Dalle, Jean-Hugues; Ahmadian, Mohammad Reza; Baruchel, Andre; Chomienne, Christine; Cave, Helene			Juvenile myelomonocytic leukemia displays mutations in components of the RAS pathway and the PRC2 network	NATURE GENETICS			English	Article							DETECTABLE CLONAL MOSAICISM; SOMATIC MUTATIONS; MULTIPLE MECHANISMS; COMPLEX; TRANSFORMATION; JARID2; CBL; HEMATOPOIESIS; ABNORMALITIES; HYPOTHESIS	Juvenile myelomonocytic leukemia (JMML) is a rare and severe myelodysplastic and myeloproliferative neoplasm of early childhood initiated by germline or somatic RAS-activating mutations1-3. Genetic profiling and whole-exome sequencing of a large JMML cohort (118 and 30 cases, respectively) uncovered additional genetic abnormalities in 56 cases (47%). Somatic events were rare (0.38 events/Mb/case) and restricted to sporadic (49/78; 63%) or neurofibromatosis type 1 (NF1)-associated (8/8; 100%) JMML cases. Multiple concomitant genetic hits targeting the RAS pathway were identified in 13 of 78 cases (17%), disproving the concept of mutually exclusive RAS pathway mutations and defining new pathways activated in JMML involving phosphoinositide 3-kinase (PI3K) and the mTORC2 complex through RAC2 mutation. Furthermore, this study highlights PRC2 loss (26/78; 33% of sporadic JMML cases) that switches the methylation/acetylation status of lysine 27 of histone H3 in JMML cases with altered RAS and PRC2 pathways. Finally, the association between JMML outcome and mutational profile suggests a dose-dependent effect for RAS pathway activation, distinguishing very aggressive JMML rapidly progressing to acute myeloid leukemia.	[Caye, Aurelie; Strullu, Marion; Guidez, Fabien; Lainey, Elodie; Lachenaud, Julie; Vivent, Jocelyne; Verger, Emmanuelle; Chomienne, Christine; Cave, Helene] Inst Univ Hematol, INSERM, UMR 1131, Paris, France; [Caye, Aurelie; Lainey, Elodie; Dalle, Jean-Hugues; Baruchel, Andre; Chomienne, Christine; Cave, Helene] Univ Paris Diderot, Sorbonne Paris Cite, Paris, France; [Caye, Aurelie; Strullu, Marion; Lachenaud, Julie; Pereira, Sabrina; Vivent, Jocelyne; Cave, Helene] Hop Robert Debre, AP HP, Dept Genet, F-75019 Paris, France; [Cassinat, Bruno; Verger, Emmanuelle; Chomienne, Christine] Hop St Louis, AP HP, Serv Biol Cellulaire, Paris, France; [Gazal, Steven] Plateforme Genet Constitut Nord PfGC Nord, AP HP, Paris, France; [Gazal, Steven] INSERM, UMR 1137, Infect Antimicrobial Modelling & Evolut IAME Lab, Paris, France; [Fenneteau, Odile; Lainey, Elodie] Hop Robert Debre, AP HP, Serv Hematol Biol, F-75019 Paris, France; [Nouri, Kazem; Nakhaei-Rad, Saeideh; Dvorsky, Radovan; Ahmadian, Mohammad Reza] Univ Dusseldorf, Fac Med, Inst Biochem & Mol Biol 2, Dusseldorf, Germany; [Vidaud, Dominique] Univ Paris 05, Sorbonne Paris Cite, Equipe Accueil 7331, Fac Pharm Paris, Paris, France; [Vidaud, Dominique] Hop Cochin, AP HP, Serv Biochim Genet, F-75674 Paris, France; [Galambrun, Claire] Hop La Timone, Assistance Publ Hop Marseille, Serv Hematol Pediat, Marseille, France; [Picard, Capucine] Hop Necker Enfants Malad, AP HP, Ctr Etud Deficits Immunitaires, Immunohematol Unit, Paris, France; [Picard, Capucine] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [Picard, Capucine] INSERM, UMR 1163, Inst Imagine, Lab Human Genet Infect Dis, Paris, France; [Petit, Arnaud] Hop Armand Trousseau, AP HP, Serv Hematol Oncol Pediat, Paris, France; [Contet, Audrey] Hop Enfants Brabois, Serv Oncohematol Pediat, Vandoeuvre Les Nancy, France; [Poiree, Marilyne] Hop Archet, Serv Oncohematol Pediat, Nice, France; [Sirvent, Nicolas] CHU Montpellier, Serv Oncohematol Pediat, Montpellier, France; [Mechinaud, Francoise] CHU Nantes, Serv Oncohematol Pediat, F-44035 Nantes 01, France; [Adjaoud, Dalila] CHU Grenoble, Serv Oncohematol Pediat, F-38043 Grenoble, France; [Paillard, Catherine] Hop Hautepierre, Serv Pediat, Strasbourg, France; [Nelken, Brigitte] CHU Lille, Unite Hematol Pediat, F-59037 Lille, France; [Reguerre, Yves] Ctr Hosp Felix Guyon, St Denis, La Reunion, France; [Bertrand, Yves] Inst Hematooncol Pediat IHOP, Dept Immunol & Hematol Pediat, Lyon, France; [Haeussinger, Dieter] Univ Dusseldorf, Fac Med, Clin Gastroenterol Hepatol & Infect Dis, Dusseldorf, Germany; [Dalle, Jean-Hugues; Baruchel, Andre] Hop Robert Debre, AP HP, Serv Hematol Pediat, F-75019 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Heinrich Heine University Dusseldorf; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; CHU de Nancy; CHU Nice; Universite de Montpellier; CHU de Montpellier; Nantes Universite; CHU de Nantes; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Universite de Lille - ISITE; CHU Lille; CHU Reunion; Heinrich Heine University Dusseldorf; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite	Cave, H (corresponding author), Inst Univ Hematol, INSERM, UMR 1131, Paris, France.	helene.cave@rdb.aphp.fr	Guidez, Fabien/B-3750-2009; Nakhaeirad, Saeideh/AAV-1771-2020; Dvorsky, Radovan/ABE-3042-2020; Guidez, Fabien/P-4220-2019; POIREE, Marilyne/O-5759-2016; A, Petit/H-1633-2011; VIDAUD, Dominique/O-7357-2017; CASSINAT, BRUNO/N-2752-2017; Dalle, jean-hugues/GRY-2936-2022; Gazal, Steven/AAK-3764-2020	Nakhaeirad, Saeideh/0000-0001-8966-8960; Guidez, Fabien/0000-0003-1380-4473; A, Petit/0000-0001-8363-1622; CASSINAT, BRUNO/0000-0002-6514-3905; Nouri, Kazem/0000-0001-7787-1304; paillard, catherine/0000-0003-1662-5446; Cave, Helene/0000-0003-2840-1511; CHOMIENNE, Christine/0000-0001-5513-5752; Gazal, Steven/0000-0003-4510-5730; Nelken, Brigitte/0000-0003-1048-1517	Ligue contre le Cancer (LCC)-Ile-de-France; Societe Francaise de Lutte contre les Cancers et Leucemies de l'Enfant (SFCE); Association pour la Recherche et pour les Etudes dans les Maladies Infantiles Graves (AREMIG, Nancy); German Research Foundation (Deutsche Forschungsgemeinschaft, DFG) [Collaborative Research Center 974 SFB 974]; International Graduate School of Protein Science and Technology (iGRASP)	Ligue contre le Cancer (LCC)-Ile-de-France; Societe Francaise de Lutte contre les Cancers et Leucemies de l'Enfant (SFCE); Association pour la Recherche et pour les Etudes dans les Maladies Infantiles Graves (AREMIG, Nancy); German Research Foundation (Deutsche Forschungsgemeinschaft, DFG)(German Research Foundation (DFG)); International Graduate School of Protein Science and Technology (iGRASP)	This work was supported by the Ligue contre le Cancer (LCC)-Ile-de-France, by the Societe Francaise de Lutte contre les Cancers et Leucemies de l'Enfant (SFCE), the Association pour la Recherche et pour les Etudes dans les Maladies Infantiles Graves (AREMIG, Nancy) and the German Research Foundation (Deutsche Forschungsgemeinschaft, DFG) through the Collaborative Research Center 974 (SFB 974) Communication and Systems Relevance during Liver Injury and Regeneration and the International Graduate School of Protein Science and Technology (iGRASP).	Abdel-Wahab O, 2013, BLOOD, V121, P3563, DOI 10.1182/blood-2013-01-451781; Abdel-Wahab O, 2012, CANCER CELL, V22, P180, DOI 10.1016/j.ccr.2012.06.032; Ahmadian MR, 1997, NAT STRUCT BIOL, V4, P686, DOI 10.1038/nsb0997-686; Brown KM, 2013, P NATL ACAD SCI USA, V110, pE1533, DOI 10.1073/pnas.1303004110; Chan RJ, 2009, LEUKEMIA RES, V33, P355, DOI 10.1016/j.leukres.2008.08.022; Chang TY, 2014, BLOOD, V124, P2487, DOI 10.1182/blood-2014-03-300319; Ciferri C, 2012, ELIFE, V1, DOI 10.7554/eLife.00005; Cutts BA, 2009, BLOOD, V114, P3629, DOI 10.1182/blood-2009-02-205146; De Raedt T, 2014, NATURE, V514, P247, DOI 10.1038/nature13561; Eberth Alexander, 2009, Curr Protoc Cell Biol, VChapter 14, DOI 10.1002/0471143030.cb1409s43; Eberth A, 2009, BIOCHEM J, V417, P371, DOI 10.1042/BJ20081535; Emanuel PD, 2014, BLOOD, V123, P2751, DOI 10.1182/blood-2014-03-559039; Flex E, 2014, HUM MOL GENET, V23, P4315, DOI 10.1093/hmg/ddu148; Genovese G, 2014, NEW ENGL J MED, V371, P2477, DOI 10.1056/NEJMoa1409405; Goodwin CB, 2014, BLOOD, V123, P2838, DOI 10.1182/blood-2013-10-535104; Gremer L, 2011, HUM MUTAT, V32, P33, DOI 10.1002/humu.21377; Hemsath L, 2005, METHODS, V37, P173, DOI 10.1016/j.ymeth.2005.05.014; Huether R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4630; Innocenti M, 2003, J CELL BIOL, V160, P17, DOI 10.1083/jcb.200206079; Jacobs KB, 2012, NAT GENET, V44, P651, DOI 10.1038/ng.2270; Jaiswal M, 2012, METHODS MOL BIOL, V827, P37, DOI 10.1007/978-1-61779-442-1_3; Jaiswal S, 2014, NEW ENGL J MED, V371, P2488, DOI 10.1056/NEJMoa1408617; KALRA R, 1994, BLOOD, V84, P3435; Kato M, 2013, J PEDIATR-US, V162, P1285, DOI 10.1016/j.jpeds.2013.01.003; Kawazu M, 2013, P NATL ACAD SCI USA, V110, P3029, DOI 10.1073/pnas.1216141110; Khan SN, 2013, LEUKEMIA, V27, P1301, DOI 10.1038/leu.2013.80; Kim E, 2015, CANCER CELL, V27, P617, DOI 10.1016/j.ccell.2015.04.006; Kinkel SA, 2015, BLOOD, V125, P1890, DOI 10.1182/blood-2014-10-603969; Laurie CC, 2012, NAT GENET, V44, P642, DOI 10.1038/ng.2271; Lee W, 2014, NAT GENET, V46, P1227, DOI 10.1038/ng.3095; Leiserson MDM, 2015, NAT GENET, V47, P106, DOI 10.1038/ng.3168; Locatelli F, 2005, BLOOD, V105, P410, DOI 10.1182/blood-2004-05-1944; Locatelli F, 2015, BLOOD, V125, P1083, DOI 10.1182/blood-2014-08-550483; Makishima H, 2013, NAT GENET, V45, P942, DOI 10.1038/ng.2696; Matsuda K, 2007, HAEMATOLOGICA, V92, P1576, DOI 10.3324/haematol.11503; Matsuda K, 2007, BLOOD, V109, P5477, DOI 10.1182/blood-2006-09-046649; Morreale A, 2000, NAT STRUCT BIOL, V7, P384; Nakhaei-Rad S, 2015, J BIOL CHEM, V290, P15892, DOI 10.1074/jbc.M115.640607; Nassar N, 1998, NAT STRUCT BIOL, V5, P1047, DOI 10.1038/4156; Niemeyer CM, 2010, NAT GENET, V42, P794, DOI 10.1038/ng.641; Niemeyer CM, 1997, BLOOD, V89, P3534; Nlemeyer CM, 2014, HAEMATOLOGICA, V99, P1653, DOI 10.3324/haematol.2014.114595; Offenhauser N, 2004, MOL BIOL CELL, V15, P91, DOI 10.1091/mbc.E03-06-0427; Pasini D, 2010, NUCLEIC ACIDS RES, V38, P4958, DOI 10.1093/nar/gkq244; Perez B, 2010, J MED GENET, V47, P686, DOI 10.1136/jmg.2010.076836; Perez B, 2010, BRIT J HAEMATOL, V151, P460, DOI 10.1111/j.1365-2141.2010.08393.x; Puda A, 2012, AM J HEMATOL, V87, P245, DOI 10.1002/ajh.22257; Sakaguchi H, 2013, NAT GENET, V45, P937, DOI 10.1038/ng.2698; Shang X, 2011, J BIOL CHEM, V286, P24068, DOI 10.1074/jbc.M111.226951; Shlien A, 2015, NAT GENET, V47, P257, DOI 10.1038/ng.3202; Son J, 2013, GENE DEV, V27, P2663, DOI 10.1101/gad.225888.113; Strullu M, 2014, J MED GENET, V51, P689, DOI 10.1136/jmedgenet-2014-102611; Takagi M, 2013, LEUKEMIA, V27, P1926, DOI 10.1038/leu.2013.82; Wang JY, 2011, BLOOD, V118, P368, DOI 10.1182/blood-2010-12-326058; Worthylake DK, 2000, NATURE, V408, P682, DOI 10.1038/35047014; Worzfeld T, 2014, P NATL ACAD SCI USA, V111, P2194, DOI 10.1073/pnas.1308418111; Xu J, 2013, CANCER DISCOV, V3, P993, DOI 10.1158/2159-8290.CD-13-0096; Yang F, 2013, EPIGENOMICS-UK, V5, P481, DOI 10.2217/epi.13.48; Zhang M, 2014, NAT GENET, V46, P1170, DOI 10.1038/ng.3116; Zhang Y, 2011, J BIOL CHEM, V286, P42414, DOI 10.1074/jbc.M111.271064	60	107	109	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2015	47	11					1334	+		10.1038/ng.3420	http://dx.doi.org/10.1038/ng.3420			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CV1BN	26457648				2022-12-25	WOS:000363988200017
J	Morizane, R; Lam, AQ; Freedman, BS; Kishi, S; Valerius, MT; Bonventre, JV				Morizane, Ryuji; Lam, Albert Q.; Freedman, Benjamin S.; Kishi, Seiji; Valerius, M. Todd; Bonventre, Joseph V.			Nephron organoids derived from human pluripotent stem cells model kidney development and injury	NATURE BIOTECHNOLOGY			English	Article							MOUSE KIDNEY; DIRECTED DIFFERENTIATION; METANEPHRIC MESENCHYME; INTERMEDIATE MESODERM; TUBULE FORMATION; IN-VIVO; PROGENITORS; EXPRESSION; FATE; MORPHOGENESIS	Kidney cells and tissues derived from human pluripotent stem cells (hPSCs) may enable organ regeneration, disease modeling and drug screening. We report an efficient, chemically defined protocol for differentiating hPSCs into multipotent nephron progenitor cells (NPCs) that can form nephron-like structures. By recapitulating metanephric kidney development in vitro, we generate SIX2(+)SALL1(+)WT1(+)PAX2(+) NPCs with 90% efficiency within 9 days of differentiation. The NPCs possess the developmental potential of their in vivo counterparts and form PAX8(+)LHX1(+) renal vesicles that self-organize into nephron structures. In both two-and three-dimensional culture, NPCs form kidney organoids containing epithelial nephron-like structures expressing markers of podocytes, proximal tubules, loops of Henle and distal tubules in an organized, continuous arrangement that resembles the nephron in vivo. We also show that this organoid culture system can be used to study mechanisms of human kidney development and toxicity.	[Morizane, Ryuji; Lam, Albert Q.; Freedman, Benjamin S.; Kishi, Seiji; Valerius, M. Todd; Bonventre, Joseph V.] Brigham & Womens Hosp, Dept Med, Div Renal, Boston, MA 02115 USA; [Morizane, Ryuji; Lam, Albert Q.; Freedman, Benjamin S.; Kishi, Seiji; Valerius, M. Todd; Bonventre, Joseph V.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Lam, Albert Q.; Valerius, M. Todd; Bonventre, Joseph V.] Harvard Stem Cell Inst, Cambridge, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University	Morizane, R (corresponding author), Brigham & Womens Hosp, Dept Med, Div Renal, 75 Francis St, Boston, MA 02115 USA.	morizanr@da2.so-net.ne.jp; jbonventre@partners.org	Wilson, Matthew H/K-3193-2013; Valerius, M. Todd/AAK-3063-2020; Morizane, R/AAC-3215-2021	Valerius, M. Todd/0000-0001-8143-9231; Morizane, R/0000-0002-0377-5667	US National Institutes of Health (NIH) [R37 DK039773, R01 DK072381]; Postdoctoral Fellowship for Research Abroad; American Heart Association [11FTF7320023]; Harvard Stem Cell Institute; NIH [DK102826]; National Kidney Foundation Young Investigator Grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK039773, R01DK072381, K01DK102826, F32DK092036] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Postdoctoral Fellowship for Research Abroad; American Heart Association(American Heart Association); Harvard Stem Cell Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Kidney Foundation Young Investigator Grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank V. Bijol for providing electron microscopy images of normal human kidneys, L. Racusen (Johns Hopkins Hospital) for HKC-8, J. Barasch (Columbia University) for a mouse ureteric bud cell line, and A.P. McMahon (University of Southern California) for NIH3T3-Wnt4. This study was supported by US National Institutes of Health (NIH) grants R37 DK039773 and R01 DK072381 (J.V.B.); Grant-in-Aid for JSPS (Japan Society for the Promotion of Science); Postdoctoral Fellowship for Research Abroad (R.M.); American Heart Association grant 11FTF7320023 (A.Q.L.); Harvard Stem Cell Institute (A.Q.L., J.V.B. and M.T.V.); and NIH DK102826 and National Kidney Foundation Young Investigator Grant (B.S.F.).	Attia L, 2012, DEVELOPMENT, V139, P4143, DOI 10.1242/dev.085258; Barak H, 2012, DEV CELL, V22, P1191, DOI 10.1016/j.devcel.2012.04.018; Barasch J, 1996, AM J PHYSIOL-RENAL, V271, pF50, DOI 10.1152/ajprenal.1996.271.1.F50; Bock C, 2011, CELL, V144, P439, DOI 10.1016/j.cell.2010.12.032; Boyle S, 2008, DEV BIOL, V313, P234, DOI 10.1016/j.ydbio.2007.10.014; Carroll TJ, 2005, DEV CELL, V9, P283, DOI 10.1016/j.devcel.2005.05.016; Cheng HT, 2003, DEVELOPMENT, V130, P5031, DOI 10.1242/dev.00697; Cheng HT, 2007, DEVELOPMENT, V134, P801, DOI 10.1242/dev.02773; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Deschamps J, 2005, DEVELOPMENT, V132, P2931, DOI 10.1242/dev.01897; Freedman BS, 2013, J AM SOC NEPHROL, V24, P1571, DOI 10.1681/ASN.2012111089; Georgas KM, 2011, DEV DYNAM, V240, P1600, DOI 10.1002/dvdy.22640; Georgas K, 2008, HISTOCHEM CELL BIOL, V130, P927, DOI 10.1007/s00418-008-0454-3; Georgas K, 2009, DEV BIOL, V332, P273, DOI 10.1016/j.ydbio.2009.05.578; Grote D, 2006, DEVELOPMENT, V133, P53, DOI 10.1242/dev.02184; HERZLINGER D, 1992, DEVELOPMENT, V114, P565; HINCHLIFFE SA, 1991, LAB INVEST, V64, P777; Humphreys BD, 2008, CELL STEM CELL, V2, P284, DOI 10.1016/j.stem.2008.01.014; Iimura T, 2006, NATURE, V442, P568, DOI 10.1038/nature04838; Imberti B, 2015, SCI REP-UK, V5, DOI 10.1038/srep08826; Kang M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094888; Kim D, 2005, J AM SOC NEPHROL, V16, P3527, DOI 10.1681/ASN.2005050544; Kispert A, 1998, DEVELOPMENT, V125, P4225; Kobayashi A, 2008, CELL STEM CELL, V3, P169, DOI 10.1016/j.stem.2008.05.020; Lam AQ, 2014, SEMIN NEPHROL, V34, P445, DOI 10.1016/j.semnephrol.2014.06.011; Lam AQ, 2014, J AM SOC NEPHROL, V25, P1211, DOI 10.1681/ASN.2013080831; Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517; Lengerke C, 2008, CELL STEM CELL, V2, P72, DOI 10.1016/j.stem.2007.10.022; Liu PT, 1999, NAT GENET, V22, P361, DOI 10.1038/11932; Mae SI, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2378; Mahlapuu M, 2001, DEVELOPMENT, V128, P155; McCracken KW, 2014, NATURE, V516, P400, DOI 10.1038/nature13863; Morizane R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064843; Morizane R, 2009, BIOCHEM BIOPH RES CO, V390, P1334, DOI 10.1016/j.bbrc.2009.10.148; Nakai S, 2003, DEVELOPMENT, V130, P4751, DOI 10.1242/dev.00666; Narayanan K, 2013, KIDNEY INT, V83, P593, DOI 10.1038/ki.2012.442; Narlis M, 2007, J AM SOC NEPHROL, V18, P1121, DOI 10.1681/ASN.2006070739; NOUWEN EJ, 1993, KIDNEY INT, V44, P147, DOI 10.1038/ki.1993.225; Osafune K, 2008, NAT BIOTECHNOL, V26, P313, DOI 10.1038/nbt1383; Park JS, 2012, DEV CELL, V23, P637, DOI 10.1016/j.devcel.2012.07.008; Potter SS, 2007, GENESIS, V45, P432, DOI 10.1002/dvg.20309; Self M, 2006, EMBO J, V25, P5214, DOI 10.1038/sj.emboj.7601381; Taguchi A, 2015, KIDNEY INT, V87, P894, DOI 10.1038/ki.2014.358; Taguchi A, 2014, CELL STEM CELL, V14, P53, DOI 10.1016/j.stem.2013.11.010; Takasato M, 2014, NAT CELL BIOL, V16, P118, DOI 10.1038/ncb2894; Uchino S, 2005, JAMA-J AM MED ASSOC, V294, P813, DOI 10.1001/jama.294.7.813; Vaidya VS, 2010, NAT BIOTECHNOL, V28, P478, DOI 10.1038/nbt.1623; Vigneau C, 2007, J AM SOC NEPHROL, V18, P1709, DOI 10.1681/ASN.2006101078; Whiting PH, 1996, RENAL FAILURE, V18, P899, DOI 10.3109/08860229609047716; Xia Y, 2013, NAT CELL BIOL, V15, P1507, DOI 10.1038/ncb2872; Zimmerman LB, 1996, CELL, V86, P599, DOI 10.1016/S0092-8674(00)80133-6	51	472	480	16	129	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2015	33	11					1193	U127		10.1038/nbt.3392	http://dx.doi.org/10.1038/nbt.3392			10	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CW3TY	26458176	Green Accepted, Green Submitted			2022-12-25	WOS:000364916000027
J	Rotem, A; Ram, O; Shoresh, N; Sperling, RA; Goren, A; Weitz, DA; Bernstein, BE				Rotem, Assaf; Ram, Oren; Shoresh, Noam; Sperling, Ralph A.; Goren, Alon; Weitz, David A.; Bernstein, Bradley E.			Single-cell ChIP-seq reveals cell subpopulations defined by chromatin state	NATURE BIOTECHNOLOGY			English	Article							EMBRYONIC STEM-CELLS; RNA-SEQ; GENOME; PLURIPOTENT; EXPRESSION; HETEROGENEITY; DYNAMICS; CANCER; IMMUNOPRECIPITATION; DIFFERENTIATION	Chromatin profiling provides a versatile means to investigate functional genomic elements and their regulation. However, current methods yield ensemble profiles that are insensitive to cell-to-cell variation. Here we combine microfluidics, DNA barcoding and sequencing to collect chromatin data at single-cell resolution. We demonstrate the utility of the technology by assaying thousands of individual cells and using the data to deconvolute a mixture of ES cells, fibroblasts and hematopoietic progenitors into high-quality chromatin state maps for each cell type. The data from each single cell are sparse, comprising on the order of 1,000 unique reads. However, by assaying thousands of ES cells, we identify a spectrum of subpopulations defined by differences in chromatin signatures of pluripotency and differentiation priming. We corroborate these findings by comparison to orthogonal single-cell gene expression data. Our method for single-cell analysis reveals aspects of epigenetic heterogeneity not captured by transcriptional analysis alone.	[Rotem, Assaf; Sperling, Ralph A.; Weitz, David A.] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Rotem, Assaf; Sperling, Ralph A.; Weitz, David A.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Rotem, Assaf; Ram, Oren; Shoresh, Noam; Bernstein, Bradley E.] Broad Inst MIT & Harvard, Epigen Program, Cambridge, MA 02142 USA; [Ram, Oren; Bernstein, Bradley E.] Howard Hughes Med Inst, Chevy Chase, MD USA; [Ram, Oren; Bernstein, Bradley E.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Ram, Oren; Bernstein, Bradley E.] Harvard Univ, Sch Med, Boston, MA USA; [Goren, Alon] Broad Inst MIT & Harvard, Broad Technol Labs, Cambridge, MA USA	Harvard University; Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Howard Hughes Medical Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Bernstein, BE (corresponding author), Broad Inst MIT & Harvard, Epigen Program, Cambridge, MA 02142 USA.	Weitz@seas.harvard.edu; Bernstein.Bradley@mgh.harvard.edu		Goren, Alon/0000-0001-5669-9357	Howard Hughes Medical Institute; National Human Genome Research Institute's Centers of Excellence in Genome Sciences [P50HG006193]; ENCODE Project [U54HG006991]; National Heart, Lung, and Blood Institute [U01HL100395]; National Science Foundation [DMR-1310266]; Harvard Materials Research Science and Engineering Center [DMR-1420570]; Defense Advanced Research Projects Agency [HR0011-11-C-0093]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL100395] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006991, P50HG006193] Funding Source: NIH RePORTER; Division Of Materials Research [1310266] Funding Source: National Science Foundation	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Human Genome Research Institute's Centers of Excellence in Genome Sciences; ENCODE Project; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Science Foundation(National Science Foundation (NSF)); Harvard Materials Research Science and Engineering Center(National Science Foundation (NSF)); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Division Of Materials Research(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank A. Regev, N. Yosef, E. Shema, I. Tirosh, H. Zhang, S. Gillespie and J. Xing for their valuable comments and critiques of this work. We also thank G. Kelsey for sharing single-cell data for comparisons. This research was supported by funds from Howard Hughes Medical Institute, the National Human Genome Research Institute's Centers of Excellence in Genome Sciences (P50HG006193), ENCODE Project (U54HG006991), the National Heart, Lung, and Blood Institute (U01HL100395), the National Science Foundation (DMR-1310266), the Harvard Materials Research Science and Engineering Center (DMR-1420570) and the Defense Advanced Research Projects Agency (HR0011-11-C-0093).	Adli M, 2010, NAT METHODS, V7, P615, DOI [10.1038/NMETH.1478, 10.1038/nmeth.1478]; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Baylin SB, 2011, NAT REV CANCER, V11, P726, DOI 10.1038/nrc3130; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Brown CR, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001621; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Cusanovich DA, 2015, SCIENCE, V348, P910, DOI 10.1126/science.aab1601; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Farlik M, 2015, CELL REP, V10, P1386, DOI 10.1016/j.celrep.2015.02.001; Guo MT, 2012, LAB CHIP, V12, P2146, DOI 10.1039/c2lc21147e; Guttman M, 2010, NAT BIOTECHNOL, V28, P503, DOI 10.1038/nbt.1633; Hackett JA, 2014, CELL STEM CELL, V15, P416, DOI 10.1016/j.stem.2014.09.015; Hough SR, 2014, STEM CELL REP, V2, P881, DOI 10.1016/j.stemcr.2014.04.014; Kalisky T, 2011, NAT METHODS, V8, P311, DOI 10.1038/nmeth0411-311; Klein AM, 2015, CELL, V161, P1187, DOI 10.1016/j.cell.2015.04.044; Ku M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000242; Kumar RM, 2014, NATURE, V516, P56, DOI 10.1038/nature13920; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Lara-Astiaso D, 2014, SCIENCE, V345, P943, DOI 10.1126/science.1256271; Li ZY, 2012, CELL, V151, P1608, DOI 10.1016/j.cell.2012.11.018; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; Mazutis L, 2013, NAT PROTOC, V8, P870, DOI 10.1038/nprot.2013.046; Meshorer E, 2006, NAT REV MOL CELL BIO, V7, P540, DOI 10.1038/nrm1938; Munsky B, 2012, SCIENCE, V336, P183, DOI 10.1126/science.1216379; Murphy PJ, 2013, P NATL ACAD SCI USA, V110, P7772, DOI 10.1073/pnas.1218495110; Nagano T, 2013, NATURE, V502, P59, DOI 10.1038/nature12593; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; O'Neill LP, 2006, NAT GENET, V38, P835, DOI 10.1038/ng1820; Patel AP, 2014, SCIENCE, V344, P1396, DOI 10.1126/science.1254257; Rotem A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116328; Sackmann EK, 2014, NATURE, V507, P181, DOI 10.1038/nature13118; Shalek AK, 2013, NATURE, V498, P236, DOI 10.1038/nature12172; Singer ZS, 2014, MOL CELL, V55, P319, DOI 10.1016/j.molcel.2014.06.029; Smallwood SA, 2014, NAT METHODS, V11, P817, DOI [10.1038/NMETH.3035, 10.1038/nmeth.3035]; Treutlein B, 2014, NATURE, V509, P371, DOI 10.1038/nature13173; Venables W.N., 2002, MODERN APPL STAT S, V4th ed, DOI DOI 10.1007/978-0-387-21706-2; Wang Y, 2014, NATURE, V512, P155, DOI 10.1038/nature13600; Wu AR, 2009, LAB CHIP, V9, P1365, DOI 10.1039/b819648f; Xu X, 2012, CELL, V148, P886, DOI 10.1016/j.cell.2012.02.025; Zhu J, 2013, CELL, V152, P642, DOI 10.1016/j.cell.2012.12.033	44	511	571	8	208	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	NOV	2015	33	11					1165	U91		10.1038/nbt.3383	http://dx.doi.org/10.1038/nbt.3383			11	Biotechnology & Applied Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology	CW3TY	26458175	Green Submitted, Green Accepted			2022-12-25	WOS:000364916000024
J	Schmid, E; Neef, S; Berlin, C; Tomasovic, A; Kahlert, K; Nordbeck, P; Deiss, K; Denzinger, S; Herrmann, S; Wettwer, E; Weidendorfer, M; Becker, D; Schafer, F; Wagner, N; Ergun, S; Schmitt, JP; Katus, HA; Weidemann, F; Ravens, U; Maack, C; Hein, L; Ertl, G; Muller, OJ; Maier, LS; Lohse, MJ; Lorenz, K				Schmid, Evelyn; Neef, Stefan; Berlin, Christopher; Tomasovic, Angela; Kahlert, Katrin; Nordbeck, Peter; Deiss, Katharina; Denzinger, Sabrina; Herrmann, Sebastian; Wettwer, Erich; Weidendorfer, Markus; Becker, Daniel; Schaefer, Florian; Wagner, Nicole; Erguen, Sitleyman; Schmitt, Joachim P.; Katus, Hugo A.; Weidemann, Frank; Ravens, Ursula; Maack, Christoph; Hein, Lutz; Ertl, Georg; Mueller, Oliver J.; Maier, Lars S.; Lohse, Martin J.; Lorenz, Kristina			Cardiac RKIP induces a beneficial beta-adrenoceptor-dependent positive inotropy	NATURE MEDICINE			English	Article							PROTEIN-KINASE-C; RYANODINE RECEPTOR PHOSPHORYLATION; HEART-FAILURE; BETA(2)-ADRENERGIC RECEPTOR; GENE-THERAPY; DILATED CARDIOMYOPATHY; RYR2 PHOSPHORYLATION; TARGETED DISRUPTION; FLIGHT RESPONSE; CONTRACTILITY	In heart failure therapy, it is generally assumed that attempts to produce a long-term increase in cardiac contractile force are almost always accompanied by structural and functional damage. Here we show that modest overexpression of the Raf kinase inhibitor protein (RKIP), encoded by Pebp1 in mice, produces a well-tolerated, persistent increase in cardiac contractility that is mediated by the beta(1)-adrenoceptor (beta(1)AR). This result is unexpected, as beta(1)AR activation, a major driver of cardiac contractility, usually has long-term adverse effects. RKIP overexpression achieves this tolerance via simultaneous activation of the beta(2)AR subtype. Analogously, RKIP deficiency exaggerates pressure overload-induced cardiac failure. We find that RKIP expression is upregulated in mouse and human heart failure, indicative of an adaptive role for RKIP. Pebp1 gene transfer in a mouse model of heart failure has beneficial effects, suggesting a new therapeutic strategy for heart failure therapy.	[Schmid, Evelyn; Berlin, Christopher; Tomasovic, Angela; Kahlert, Katrin; Deiss, Katharina; Denzinger, Sabrina; Weidendorfer, Markus; Becker, Daniel; Schaefer, Florian; Schmitt, Joachim P.; Lohse, Martin J.; Lorenz, Kristina] Inst Pharmacol & Toxicol, Dept Pharmacol, Wurzburg, Germany; [Neef, Stefan; Maier, Lars S.] Univ Hosp Regensburg, Dept Internal Med 2, Regensburg, Germany; [Nordbeck, Peter; Herrmann, Sebastian; Weidemann, Frank; Ertl, Georg; Lohse, Martin J.; Lorenz, Kristina] Comprehens Heart Failure Ctr, Wurzburg, Germany; [Nordbeck, Peter; Herrmann, Sebastian; Weidemann, Frank; Ertl, Georg] Univ Wurzburg, Dept Internal Med 1, D-97070 Wurzburg, Germany; [Wettwer, Erich; Ravens, Ursula] Tech Univ Dresden, Med Fac Gustav Carus, Dept Pharmacol & Toxicol, Dresden, Germany; [Wagner, Nicole; Erguen, Sitleyman] Inst Anat & Cell Biol, Wurzburg, Germany; [Katus, Hugo A.; Mueller, Oliver J.] Univ Heidelberg Hosp, Dept Internal Med 3, Heidelberg, Germany; [Katus, Hugo A.; Mueller, Oliver J.] Univ Heidelberg Hosp, German Ctr Cardiovasc Res, Heidelberg, Germany; [Maack, Christoph] Saarland Univ Hosp, Clin Internal Med 3, Homburg, Germany; [Hein, Lutz] Inst Expt & Clin Pharmacol & Toxicol, Freiburg, Germany; [Hein, Lutz] Univ Freiburg, Ctr Biol Signalling Studies BIOSS, D-79106 Freiburg, Germany	University of Wurzburg; University of Regensburg; University of Wurzburg; University of Wurzburg; Technische Universitat Dresden; Ruprecht Karls University Heidelberg; German Centre for Cardiovascular Research; Ruprecht Karls University Heidelberg; Universitatsklinikum des Saarlandes; University of Freiburg	Lorenz, K (corresponding author), Inst Pharmacol & Toxicol, Dept Pharmacol, Wurzburg, Germany.	lohse@toxi.uni-wuerzburg.de; lorenz@toxi.uni-wuerzburg.de	Nordbeck, Peter/D-4771-2018; Maier, Lars/AAQ-8313-2021; Müller, Oliver J./H-4739-2016; Schmitt, Joachim/GQP-7068-2022; Hein, Lutz/GRJ-8644-2022; Lohse, Martin J/A-7160-2012; Müller, Oliver/AAA-4399-2021; Lorenz, Kristina/F-3522-2016	Nordbeck, Peter/0000-0002-2560-4068; Maier, Lars/0000-0001-9915-4429; Lohse, Martin J/0000-0002-0599-3510; Müller, Oliver/0000-0001-8223-2638; Maack, Christoph/0000-0003-3694-4559; Lorenz, Kristina/0000-0002-5747-2207; Berlin, Christopher/0000-0001-9727-1533	Deutsche Forschungsgemeinschaft (DFG) [Sonderforschungsbereich SFB688, TPA17]; Bundesministerium fur Bildung und Forschung (BMBF; Comprehensive Heart Failure Center Wurzburg) [A2]; Mutant Mouse Regional Resource Center (MMRRC, a National Center for Research Resources) [030379-UCD]; US National Institutes of Health [030379-UCD]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung (BMBF; Comprehensive Heart Failure Center Wurzburg); Mutant Mouse Regional Resource Center (MMRRC, a National Center for Research Resources); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by Deutsche Forschungsgemeinschaft (DFG; Sonderforschungsbereich SFB688, TPA17 to K.L.) and by Bundesministerium fur Bildung und Forschung (BMBF; Comprehensive Heart Failure Center Wurzburg; project A2 to K.L., M.J.L. and F.W.). RKIP heterozygous knockout (Pebp1<SUP>+/-</SUP>) mice were kindly provided by the Mutant Mouse Regional Resource Center (MMRRC, a National Center for Research Resources and US National Institutes of Health-funded strain repository at the University of California, Davis; identification number 030379-UCD) and Adrb1<SUP>-/-</SUP> and Adrb2<SUP>-/-</SUP> mice by B. Kobilka (Department of Molecular and Cellular Physiology, Stanford University). We thank U. Zabel, A. Jungmann, R. Gilsbach, E. Schmitteckert, C. Hoffmann, S. Wagner and J. Bauer for valuable feedback and discussions and N. Yurdagul-Hemmrich, M. Babl, M. Fischer, T. Sowa, T. Schulte, L. Vlaskin, A.-K. Lamprecht and J. Becker for their excellent technical support.	Ahmet I, 2008, J PHARMACOL EXP THER, V325, P491, DOI 10.1124/jpet.107.135335; Anderson ME, 2011, J MOL CELL CARDIOL, V51, P468, DOI 10.1016/j.yjmcc.2011.01.012; Antos CL, 2001, CIRC RES, V89, P997, DOI 10.1161/hh2301.100003; Bers DM, 2012, CIRC RES, V110, P796, DOI 10.1161/CIRCRESAHA.112.265579; Braz JC, 2004, NAT MED, V10, P248, DOI 10.1038/nm1000; Chesley A, 2000, CIRC RES, V87, P1172, DOI 10.1161/01.RES.87.12.1172; Chruscinski AJ, 1999, J BIOL CHEM, V274, P16694, DOI 10.1074/jbc.274.24.16694; Communal C, 1999, CIRCULATION, V100, P2210, DOI 10.1161/01.CIR.100.22.2210; Corbit KC, 2003, J BIOL CHEM, V278, P13061, DOI 10.1074/jbc.M210015200; Daaka Y, 1997, NATURE, V390, P88, DOI 10.1038/36362; Deiss K, 2012, J BIOL CHEM, V287, P23407, DOI 10.1074/jbc.M112.363812; Dobrev D, 2014, CIRC RES, V114, P1311, DOI 10.1161/CIRCRESAHA.114.300568; Dorn GW, 1999, P NATL ACAD SCI USA, V96, P12798, DOI 10.1073/pnas.96.22.12798; El-Armouche A, 2008, CARDIOVASC RES, V80, P396, DOI 10.1093/cvr/cvn208; Engelhardt S, 1999, P NATL ACAD SCI USA, V96, P7059, DOI 10.1073/pnas.96.12.7059; Eschenhagen T, 2010, J CLIN INVEST, V120, P4197, DOI 10.1172/JCI45251; Fu XB, 2013, J BIOL CHEM, V288, P7738, DOI 10.1074/jbc.M112.428078; Greenberg B, 2014, JACC-HEART FAIL, V2, P84, DOI 10.1016/j.jchf.2013.09.008; Guo T, 2006, CIRC RES, V99, P398, DOI 10.1161/01.RES.0000236756.06252.13; Hambleton M, 2006, CIRCULATION, V114, P574, DOI 10.1161/CIRCULATIONAHA.105.592550; Huke S, 2008, BIOCHEM BIOPH RES CO, V376, P80, DOI 10.1016/j.bbrc.2008.08.084; Kairouz V, 2012, ANN NY ACAD SCI, V1254, P42, DOI 10.1111/j.1749-6632.2012.06520.x; Koval OM, 2010, P NATL ACAD SCI USA, V107, P4996, DOI 10.1073/pnas.0913760107; Kranias EG, 2012, CIRC RES, V110, P1646, DOI 10.1161/CIRCRESAHA.111.259754; Kuschel M, 1999, J BIOL CHEM, V274, P22048, DOI 10.1074/jbc.274.31.22048; Lehnart SE, 2009, HEART FAIL REV, V14, P213, DOI 10.1007/s10741-009-9146-x; Liggett SB, 2000, CIRCULATION, V101, P1707; Liggett SB, 1998, J CLIN INVEST, V102, P1534, DOI 10.1172/JCI4059; Ling HY, 2009, J CLIN INVEST, V119, P1230, DOI 10.1172/JCI38022; Lorenz K, 2003, NATURE, V426, P574, DOI 10.1038/nature02158; Lorenz K, 2014, PFLUG ARCH EUR J PHY, V466, P1151, DOI 10.1007/s00424-014-1462-x; Lorenz K, 2009, NAT MED, V15, P75, DOI 10.1038/nm.1893; Maillet M, 2013, NAT REV MOL CELL BIO, V14, P38, DOI 10.1038/nrm3495; Matkovich SJ, 2006, CIRC RES, V99, P996, DOI 10.1161/01.RES.0000247932.71270.2c; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; Nikolaev VO, 2010, SCIENCE, V327, P1653, DOI 10.1126/science.1185988; Orchard C, 2008, CARDIOVASC RES, V77, P237, DOI 10.1093/cvr/cvm002; PALCZEWSKI K, 1993, J BIOL CHEM, V268, P6004; Paur H, 2012, CIRCULATION, V126, P697, DOI 10.1161/CIRCULATIONAHA.112.111591; Pleger ST, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002097; Raake PW, 2008, CIRC RES, V103, P413, DOI 10.1161/CIRCRESAHA.107.168336; Raake PW, 2012, CIRCULATION, V125, P2108, DOI 10.1161/CIRCULATIONAHA.111.044255; Respress JL, 2012, CIRC RES, V110, P1474, DOI 10.1161/CIRCRESAHA.112.268094; Rockman HA, 2002, NATURE, V415, P206, DOI 10.1038/415206a; Rohrer DK, 1999, J BIOL CHEM, V274, P16701, DOI 10.1074/jbc.274.24.16701; Rohrer DK, 1996, P NATL ACAD SCI USA, V93, P7375, DOI 10.1073/pnas.93.14.7375; Rohrer DK, 1998, AM J PHYSIOL-HEART C, V274, pH1184, DOI 10.1152/ajpheart.1998.274.4.H1184; Ruppert C, 2013, P NATL ACAD SCI USA, V110, P7440, DOI 10.1073/pnas.1221999110; Shan J, 2010, J CLIN INVEST, V120, P4388, DOI 10.1172/JCI32726; Shao YZ, 2013, INT J CARDIOL, V168, P1943, DOI 10.1016/j.ijcard.2012.12.092; Shiferaw Y, 2012, CARDIOVASC RES, V95, P265, DOI 10.1093/cvr/cvs155; Siedlecka U, 2008, AM J PHYSIOL-HEART C, V295, pH1917, DOI 10.1152/ajpheart.00258.2008; Slack JP, 2001, J MOL CELL CARDIOL, V33, P1031, DOI 10.1006/jmcc.2001.1370; Tacon CL, 2012, INTENS CARE MED, V38, P359, DOI 10.1007/s00134-011-2435-6; Talan MI, 2011, J MOL CELL CARDIOL, V51, P529, DOI 10.1016/j.yjmcc.2010.09.019; Vidal M, 2012, CARDIOVASC RES, V96, P255, DOI 10.1093/cvr/cvs249; Volkers M, 2011, CIRC RES, V108, P27, DOI 10.1161/CIRCRESAHA.110.225201; Xiao R P, 2001, Sci STKE, V2001, pre15, DOI 10.1126/stke.2001.104.re15; Xiao RP, 1999, CIRC RES, V84, P43; Yeung K, 1999, NATURE, V401, P173, DOI 10.1038/43686	60	43	44	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2015	21	11					1298	1306		10.1038/nm.3972	http://dx.doi.org/10.1038/nm.3972			9	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CV9QH	26479924				2022-12-25	WOS:000364621200014
J	Waning, DL; Mohammad, KS; Reiken, S; Xie, WJ; Andersson, DC; John, S; Chiechi, A; Wright, LE; Umanskaya, A; Niewolna, M; Trivedi, T; Charkhzarrin, S; Khatiwada, P; Wronska, A; Haynes, A; Benassi, MS; Witzmannt, FA; Zhen, GH; Wang, X; Cao, X; Roodman, GD; Marks, AR; Guise, TA				Waning, David L.; Mohammad, Khalid S.; Reiken, Steven; Xie, Wenjun; Andersson, Daniel C.; John, Sutha; Chiechi, Antonella; Wright, Laura E.; Umanskaya, Alisa; Niewolna, Maria; Trivedi, Trupti; Charkhzarrin, Sahba; Khatiwada, Pooja; Wronska, Anetta; Haynes, Ashley; Benassi, Maria Serena; Witzmannt, Frank A.; Zhen, Gehua; Wang, Xiao; Cao, Xu; Roodman, G. David; Marks, Andrew R.; Guise, Theresa A.			Excess TGF-beta mediates muscle weakness associated with bone metastases in mice	NATURE MEDICINE			English	Article							GROWTH-FACTOR-BETA; CAMURATI-ENGELMANN-DISEASE; HORMONE-RELATED PROTEIN; RYANODINE RECEPTOR; INTRACELLULAR CALCIUM; DYSTROPHIC MUSCLE; CANCER CACHEXIA; IN-VIVO; RELEASE; CELLS	Cancer-associated muscle weakness is a poorly understood phenomenon, and there is no effective treatment. Here we find that seven different mouse models of human osteolytic bone metastases representing breast, lung and prostate cancers, as well as multiple myeloma exhibited impaired muscle function, implicating a role for the tumor-bone microenvironment in cancer-associated muscle weakness. We found that transforming growth factor (TGF)-beta, released from the bone surface as a result of metastasis-induced bone destruction, upregulated NADPH oxidase 4 (Nox4), resulting in elevated oxidization of skeletal muscle proteins, including the ryanodine receptor and calcium (Ca2+) release channel (RyR1). The oxidized RyR1 channels leaked Ca2+, resulting in lower intracellular signaling, which is required for proper muscle contraction. We found that inhibiting RyR1 leakage, TGF-beta signaling, TGF-beta release from bone or Nox4 activity improved muscle function in mice with MDA-MB-231 bone metastases. Humans with breast- or lung cancer-associated bone metastases also had oxidized skeletal muscle RyR1 that is not seen in normal muscle. Similarly, skeletal muscle weakness, increased Nox4 binding to RyR1 and oxidation of RyR1 were present in a mouse model of Camurati-Engelmann disease, a nonmalignant metabolic bone disorder associated with increased TGF-beta activity. Thus, pathological TGF-beta release from bone contributes to muscle weakness by decreasing Ca2+-induced muscle force production.	[Waning, David L.; Mohammad, Khalid S.; John, Sutha; Chiechi, Antonella; Wright, Laura E.; Niewolna, Maria; Trivedi, Trupti; Charkhzarrin, Sahba; Khatiwada, Pooja; Guise, Theresa A.] Indiana Univ Sch Med, Dept Med, Indianapolis, IN 46202 USA; [Reiken, Steven; Xie, Wenjun; Andersson, Daniel C.; Umanskaya, Alisa; Wronska, Anetta; Haynes, Ashley; Marks, Andrew R.] Columbia Univ Coll Phys & Surg, Dept Physiol & Cellular Biophys, Helen & Clyde Wu Ctr Mol Cardiol, New York, NY 10032 USA; [Benassi, Maria Serena] Inst Ortoped Rizzoli, Expt Oncol Lab, Bologna, Italy; [Witzmannt, Frank A.] Indiana Univ Sch Med, Dept Cellular & Integrat Physiol, Indianapolis, IN 46202 USA; [Zhen, Gehua; Wang, Xiao; Cao, Xu] Johns Hopkins Univ, Sch Med, Dept Orthoped Surg, Baltimore, MD USA; [Roodman, G. David] Indiana Univ Sch Med, Div Hematol & Oncol, Dept Med, Indianapolis, IN 46202 USA; [Roodman, G. David] Richard L Roudebush Virginia Med Ctr, Indianapolis, IN USA	Indiana University System; Indiana University Bloomington; Columbia University; Indiana University System; Indiana University Bloomington; Johns Hopkins University; Indiana University System; Indiana University Bloomington; US Department of Veterans Affairs; Veterans Health Administration (VHA); Richard L. Roudebush VA Medical Center	Guise, TA (corresponding author), Indiana Univ Sch Med, Dept Med, Indianapolis, IN 46202 USA.	tguise@iu.edu	Andersson, Daniel/AAE-9968-2019; Xie, Wenjun/O-4637-2019; Mohammad, Khalid/AAE-9569-2022; Mohammad, Khalid/AFE-4205-2022; Xie, Wenjun/AAD-6881-2021	Andersson, Daniel/0000-0003-4548-702X; Xie, Wenjun/0000-0003-0493-062X; Xie, Wenjun/0000-0003-0493-062X; Wright, Laura/0000-0001-9568-4561; Wang, Xiao/0000-0001-6395-706X	US National Institutes of Health (NIH) [U01CA143057]; National Cancer Institute (NCI) Tumor Microenvironment Network [NCI-R01CA69158, NCI-R21CA179017, NHLBI-R01HL061503, NHLBI-R01HL102040, NIAMS-R01AR060037]; NIH [T32 HL120826]; NIH-NINDS [R25NS076445]; NIH-NIAMS [R01AR063943]; NIH-NHLBI [T35 HL110854-01]; Susan G. Komen Foundation [SAC 110013]; Indiana Economic Development Grant; Jerry and Peggy Throgmartin Endowment of the Indiana University Simon Cancer Center; Indiana University Simon Cancer Center Breast Cancer Program; American Cancer Society; Indiana University Simon Cancer Center [IRG-84-002-28]; Indiana University Health Strategic Research Initiative in Oncology; VA Merit Review Award; Fondation Leducq; Ellison Foundation; Swedish Heart Lung Foundation; Stockholm County Council;  [NINDS-R25NS076445]; NATIONAL CANCER INSTITUTE [R21CA179017, R01CA069158, U01CA143057] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T35HL110854, T32HL120826, R01HL102040, R01HL061503] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR063943, R01AR060037] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R25NS076445] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute (NCI) Tumor Microenvironment Network; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH-NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH-NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIH-NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Susan G. Komen Foundation(Susan G. Komen Breast Cancer Foundation); Indiana Economic Development Grant; Jerry and Peggy Throgmartin Endowment of the Indiana University Simon Cancer Center; Indiana University Simon Cancer Center Breast Cancer Program; American Cancer Society(American Cancer Society); Indiana University Simon Cancer Center; Indiana University Health Strategic Research Initiative in Oncology; VA Merit Review Award(US Department of Veterans Affairs); Fondation Leducq(Leducq Foundation); Ellison Foundation(Lawrence Ellison Foundation); Swedish Heart Lung Foundation(Swedish Heart-Lung Foundation); Stockholm County Council(Stockholm County Council); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the US National Institutes of Health (NIH) (grant U01CA143057 (T.A.G.) from the National Cancer Institute (NCI) Tumor Microenvironment Network, NCI-R01CA69158 (T.A.G.), NCI-R21CA179017 (G.D.R.), NHLBI-R01HL061503 (A.R.M.), NHLBI-R01HL102040 (A.R.M.), NIAMS-R01AR060037 (A.R.M.), NIH T32 HL120826 (A.R.M.), NINDS-R25NS076445 (A.R.M.), NIH-NINDS R25NS076445 (A.H.), NIH-NIAMS R01AR063943 (X.C.), and NIH-NHLBI T35 HL110854-01 (S.C. and P.K.)), the Susan G. Komen Foundation (grant SAC 110013; T.A.G.), the Indiana Economic Development Grant (T.A.G.), the Jerry and Peggy Throgmartin Endowment of the Indiana University Simon Cancer Center (T.A.G.), the Indiana University Simon Cancer Center Breast Cancer Program (T.A.G.), the American Cancer Society and Indiana University Simon Cancer Center (grant IRG-84-002-28; D.L.W.), the Indiana University Health Strategic Research Initiative in Oncology (D.L.W.), the VA Merit Review Award (G.D.R.), the Fondation Leducq (A.R.M.), the Ellison Foundation (A.R.M.), the Swedish Heart Lung Foundation and Stockholm County Council (D.C.A.) and a generous donation from the Withycombe family (T.A.G.). Camurati-Engelmann disease (CED) mice were previously described and provided by X. Cao (Johns Hopkins, Baltimore, MD).	Andersson DC, 2011, CELL METAB, V14, P196, DOI 10.1016/j.cmet.2011.05.014; Andersson Daniel C, 2010, Drug Discov Today Dis Mech, V7, pe151, DOI 10.1016/j.ddmec.2010.09.009; Bellinger AM, 2008, P NATL ACAD SCI USA, V105, P2198, DOI 10.1073/pnas.0711074105; Bellinger AM, 2009, NAT MED, V15, P325, DOI 10.1038/nm.1916; Biswas S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027090; Bogdanovich S, 2002, NATURE, V420, P418, DOI 10.1038/nature01154; Carmona-Cuenca I, 2008, J HEPATOL, V49, P965, DOI 10.1016/j.jhep.2008.07.021; Coleman RE, 2010, CANCER TREAT REV, V36, P615, DOI 10.1016/j.ctrv.2010.04.003; Dallas SL, 2002, J BIOL CHEM, V277, P21352, DOI 10.1074/jbc.M111663200; DASCH JR, 1989, J IMMUNOL, V142, P1536; Fearon KCH, 2012, CELL METAB, V16, P153, DOI 10.1016/j.cmet.2012.06.011; Gentry B, 2011, MUSCLE NERVE, V43, P49, DOI 10.1002/mus.21796; Guise TA, 1996, J CLIN INVEST, V98, P1544, DOI 10.1172/JCI118947; GUISE TA, 1993, J CLIN ENDOCR METAB, V77, P40, DOI 10.1210/jc.77.1.40; Hjorth-Hansen H, 1999, J BONE MINER RES, V14, P256, DOI 10.1359/jbmr.1999.14.2.256; Hubackova S, 2012, AGING-US, V4, P932, DOI 10.18632/aging.100520; Janssens K, 2000, NAT GENET, V26, P273, DOI 10.1038/81563; Janssens K, 2003, J BIOL CHEM, V278, P7718, DOI 10.1074/jbc.M208857200; Jiang JX, 2012, FREE RADICAL BIO MED, V53, P289, DOI 10.1016/j.freeradbiomed.2012.05.007; Kang YB, 2005, P NATL ACAD SCI USA, V102, P13909, DOI 10.1073/pnas.0506517102; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Korpal M, 2009, NAT MED, V15, P960, DOI 10.1038/nm.1943; Lu X, 2009, P NATL ACAD SCI USA, V106, P9385, DOI 10.1073/pnas.0900108106; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; Mendias CL, 2006, J APPL PHYSIOL, V101, P898, DOI 10.1152/japplphysiol.00126.2006; Mendias CL, 2012, MUSCLE NERVE, V45, P55, DOI 10.1002/mus.22232; Michaeloudes C, 2011, AM J PHYSIOL-LUNG C, V300, pL295, DOI 10.1152/ajplung.00134.2010; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Sun QA, 2011, P NATL ACAD SCI USA, V108, P16098, DOI 10.1073/pnas.1109546108; Tang Y, 2009, NAT MED, V15, P757, DOI 10.1038/nm.1979; Vera-Ramirez L, 2011, CRIT REV ONCOL HEMAT, V80, P347, DOI 10.1016/j.critrevonc.2011.01.004; Weilbaecher KN, 2011, NAT REV CANCER, V11, P411, DOI 10.1038/nrc3055; Yan F, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.551; Yin JJ, 1999, J CLIN INVEST, V103, P197, DOI 10.1172/JCI3523; Zalk R, 2007, ANNU REV BIOCHEM, V76, P367, DOI 10.1146/annurev.biochem.76.053105.094237; Zhou XL, 2010, CELL, V142, P531, DOI 10.1016/j.cell.2010.07.011	36	217	222	0	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	NOV	2015	21	11					1262	1271		10.1038/nm.3961	http://dx.doi.org/10.1038/nm.3961			10	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CV9QH	26457758	Green Accepted, Green Submitted			2022-12-25	WOS:000364621200010
